Comparison	|O
with	|O
alkaline	|B-PROTEIN
phosphatases	|I-PROTEIN
and	|O
5	|B-PROTEIN
-	|I-PROTEIN
nucleotidase	|I-PROTEIN

Pharmacologic	|O
aspects	|O
of	|O
neonatal	|O
hyperbilirubinemia	|O
.	|O

When	|O
CSF	|O
[	|O
HCO3	|O
-	|O
]	|O
is	|O
shown	|O
as	|O
a	|O
function	|O
of	|O
CSF	|O
PCO2	|O
the	|O
data	|O
of	|O
K	|O
-	|O
depleted	|O
rats	|O
are	|O
no	|O
longer	|O
displaced	|O
when	|O
compared	|O
to	|O
controls	|O
but	|O
still	|O
have	|O
a	|O
significantly	|O
greater	|O
slope	|O
(	|O
1.21	|O
+	|O
/	|O
-	|O
0.23	|O
vs.	|O

Flurazepam	|O
thus	|O
appears	|O
to	|O
be	|O
an	|O
effective	|O
hypnotic	|O
drug	|O
with	|O
the	|O
optimum	|O
dose	|O
for	|O
use	|O
in	|O
general	|O
practice	|O
being	|O
15	|O
mg	|O
at	|O
night	|O
.	|O

Beta	|O
blocking	|O
agents	|O
.	|O

When	|O
extracorporeal	|O
CO2	|O
removal	|O
approximated	|O
CO2	|O
production	|O
(	|O
VCO2	|O
)	|O
,	|O
alveolar	|O
ventilation	|O
almost	|O
ceased	|O
.	|O

Intravenous	|O
administration	|O
(	|O
25	|O
mg	|O
/	|O
kg	|O
)	|O
of	|O
carbonic	|B-PROTEIN
anhydrase	|I-PROTEIN
inhibitors	|O
(	|O
acetazolamide	|O
,	|O
methazolamide	|O
,	|O
dichlorphenamide	|O
,	|O
sulthiame	|O
)	|O
induced	|O
an	|O
early	|O
important	|O
rise	|O
of	|O
cortical	|O
p	|O
O2	|O
,	|O
which	|O
is	|O
not	|O
dependent	|O
on	|O
increase	|O
of	|O
p	|O
O2	|O
and	|O
p	|O
CO2	|O
and	|O
decrease	|O
of	|O
pH	|O
in	|O
arterial	|O
blood	|O
.	|O

Teratological	|O
study	|O
of	|O
etoperidone	|O
in	|O
the	|O
rat	|O
and	|O
rabbit	|O
.	|O

Colorectal	|O
polyps	|O
should	|O
be	|O
removed	|O
endoscopically	|O
whenever	|O
possible	|O
.	|O

The	|O
variable	|O
HMG	|B-PROTEIN
dosage	|O
regimen	|O
was	|O
found	|O
to	|O
offer	|O
no	|O
advantages	|O
when	|O
compared	|O
with	|O
our	|O
standard	|O
daily	|O
dosage	|O
regimen	|O
.	|O

When	|O
the	|O
CO2	|O
content	|O
reached	|O
9	|O
Vol	|O
%	|O
the	|O
animals	|O
became	|O
apathic	|O
and	|O
lost	|O
body	|O
weight	|O
.	|O

Serum	|O
gamma	|B-PROTEIN
glutamyltransferase	|I-PROTEIN
in	|O
the	|O
diagnosis	|O
of	|O
liver	|O
disease	|O
in	|O
cattle	|O
.	|O

By	|O
contrast	|O
,	|O
secretory	|O
HI	|B-PROTEIN
antibodies	|O
were	|O
not	|O
demonstrated	|O
at	|O
the	|O
onset	|O
of	|O
illness	|O
in	|O
any	|O
of	|O
the	|O
patients	|O
,	|O
but	|O
their	|O
formation	|O
started	|O
early	|O
and	|O
the	|O
antibodies	|O
reached	|O
maximal	|O
levels	|O
about	|O
10	|O
days	|O
after	|O
onset	|O
of	|O
illness	|O
.	|O

With	|O
the	|O
exception	|O
of	|O
virus	|O
assay	|O
and	|O
quantitation	|O
,	|O
these	|O
methods	|O
are	|O
simple	|O
and	|O
inexpensive	|O
enough	|O
to	|O
be	|O
done	|O
in	|O
typical	|O
shellfish	|O
microbiology	|O
laboratories	|O
.	|O

Characteristics	|O
of	|O
lipase	|B-PROTEIN
activity	|O
.	|O

Takayasu	|O
's	|O
disease	|O
:	|O
association	|O
with	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
B5	|I-PROTEIN
.	|O

SGPT	|B-PROTEIN
,	|O
SGOT	|B-PROTEIN
,	|O
and	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
concentrations	|O
were	|O
essentially	|O
normal	|O
in	|O
all	|O
subjects	|O
.	|O

Gamma	|B-PROTEIN
glutamyl	|I-PROTEIN
transpeptidase	|I-PROTEIN
(	|O
GGTP	|B-PROTEIN
)	|O
activity	|O
in	|O
the	|O
seminal	|O
fluid	|O

Patients	|O
with	|O
Parkinson	|O
's	|O
disease	|O
showed	|O
a	|O
relatively	|O
high	|O
incidence	|O
to	|O
psychoses	|O
during	|O
drug	|O
treatment	|O
(	|O
51.47%	|O
)	|O
.	|O

Selective	|O
stimulation	|O
of	|O
central	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
autoreceptors	|I-PROTEIN
following	|O
treatment	|O
with	|O
alpha	|O
-	|O
methyldopa	|O
and	|O
FLA	|O
136	|O
.	|O

Anti	|O
-	|O
anxiety	|O
action	|O
of	|O
diazepam	|O
after	|O
intra	|O
-	|O
amygdaloid	|O
application	|O
in	|O
the	|O
rat	|O
.	|O

Abstracts	|O
.	|O

Removal	|O
of	|O
thick	|O
,	|O
permanently	|O
altered	|O
mucoas	|O
is	|O
recommended	|O
even	|O
in	|O
the	|O
absence	|O
of	|O
squamous	|O
epithelium	|O
.	|O

An	|O
IgG	|B-PROTEIN
monoclonal	|O
gammopathy	|O
was	|O
present	|O
in	|O
the	|O
serum	|O
of	|O
4	|O
patients	|O
and	|O
Bence	|O
-	|O
Joanes	|O
proteinuria	|O
was	|O
found	|O
in	|O
1	|O
patient	|O
.	|O

Studies	|O
on	|O
immunoglobulin	|B-PROTEIN
E	|I-PROTEIN
:	|O
the	|O
impact	|O
of	|O
a	|O
sojourn	|O
with	|O
Professor	|O
Dan	|O
H.	|O

Peroxydase	|B-PROTEIN
reaction	|O
stains	|O
were	|O
negative	|O
,	|O
chloroacetate	|B-PROTEIN
esterase	|I-PROTEIN
were	|O
strongly	|O
positive	|O
.	|O

Ten	|O
out	|O
-	|O
patients	|O
with	|O
pustulosis	|O
palmaris	|O
et	|O
plantaris	|O
were	|O
examined	|O
with	|O
direct	|O
immunofluorescence	|O
(	|O
IF	|O
)	|O
technique	|O
for	|O
deposition	|O
of	|O
fibrinogen	|B-PROTEIN
,	|O
fibrin	|B-PROTEIN
or	|O
its	|O
degradation	|O
products	|O
(	|O
FR	|B-PROTEIN
-	|I-PROTEIN
antigen	|I-PROTEIN
)	|O
in	|O
affected	|O
and	|O
unaffected	|O
skin	|O
,	|O
together	|O
with	|O
heparin	|O
-	|O
precipitable	|O
fraction	|O
(	|O
HPF	|O
)	|O
,	|O
cryoglobulin	|B-PROTEIN
and	|O
total	|O
plasma	|O
fibrinogen	|B-PROTEIN
in	|O
the	|O
blood	|O
.	|O

Of	|O
600	|O
mediastinoscopies	|O
carried	|O
out	|O
from	|O
1966	|O
to	|O
1973	|O
,	|O
479	|O
were	|O
performed	|O
to	|O
assess	|O
the	|O
operability	|O
of	|O
a	|O
pulmonary	|O
carcinoma	|O
.	|O

A	|O
mixture	|O
of	|O
human	|O
albumin	|B-PROTEIN
5%	|O
and	|O
hydroxy	|O
-	|O
ethyl	|O
-	|O
starch	|O
was	|O
used	|O
as	|O
a	|O
solution	|O
for	|O
dilution	|O
.	|O

In	|O
the	|O
matched	|O
control	|O
group	|O
the	|O
acquisition	|O
-	|O
rate	|O
of	|O
both	|O
symptomatic	|O
and	|O
asymptomatic	|O
0acteriuria	|O
was	|O
over	|O
12%	|O
,	|O
a	|O
figure	|O
similar	|O
to	|O
the	|O
percentage	|O
of	|O
women	|O
present	|O
in	|O
the	|O
practice	|O
population	|O
during	|O
one	|O
year	|O
with	|O
transient	|O
,	|O
symptomatic	|O
,	|O
and	|O
persistent	|O
A.B.	|O

Late	|O
complications	|O
of	|O
catheterisation	|O
for	|O
intravenous	|O
nutrition	|O
.	|O

Prenatal	|O
diagnosis	|O
of	|O
galactosaemia	|O
.	|O

Sings	|O
which	|O
are	|O
indicative	|O
of	|O
metaplastic	|O
erythropoiesis	|O
are	|O
absent	|O
.	|O

False	|O
positive	|O
amniotic	|O
fluid	|O
alpha	|B-PROTEIN
fetoprotein	|I-PROTEIN
levels	|O
resulting	|O
from	|O
contamination	|O
with	|O
fetal	|O
blood	|O
:	|O
results	|O
of	|O
an	|O
experiment	|O
.	|O

Serum	|O
-	|O
ferritin	|B-PROTEIN
in	|O
diagnosis	|O
of	|O
haemochromatosis	|O
.	|O

In	|O
2	|O
subjects	|O
the	|O
phytomitogen	|O
reactivity	|O
of	|O
the	|O
lymphocytes	|O
was	|O
improved	|O
after	|O
treatment	|O
.	|O

Patients	|O
at	|O
risk	|O
of	|O
hypothyroidism	|O
.	|O

Albumin	|B-PROTEIN
and	|O
cyclic	|O
AMP	|O
levels	|O
in	|O
peritoneal	|O
fluids	|O
in	|O
the	|O
child	|O

Preface	|O
.	|O

Thirty	|O
-	|O
five	|O
strains	|O
of	|O
Legionnaires	|O
'	|O
disease	|O
bacteria	|O
were	|O
shown	|O
to	|O
belong	|O
in	|O
four	|O
distinct	|O
serologic	|O
groups	|O
on	|O
the	|O
basis	|O
of	|O
findings	|O
obtained	|O
with	|O
direct	|O
fluorescent	|O
antibody	|O
testing	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
factor	|B-PROTEIN
IX	|I-PROTEIN
activity	|O
is	|O
decreased	|O
in	|O
coumarin	|O
treatment	|O
with	|O
factor	|B-PROTEIN
IX	|I-PROTEIN
antigen	|O
remaining	|O
normal	|O
.	|O

The	|O
concentration	|O
of	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
macroglobulin	|I-PROTEIN
,	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
antitrypsin	|I-PROTEIN
,	|O
plasminogen	|B-PROTEIN
,	|O
C3	|B-PROTEIN
-	|O
complement	|O
,	|O
fibrinogen	|B-PROTEIN
degradation	|O
products	|O
(	|O
FDP	|B-PROTEIN
)	|O
and	|O
fibrinolytic	|O
activity	|O
,	|O
were	|O
studied	|O
in	|O
the	|O
aqueous	|O
humour	|O
and	|O
serum	|O
from	|O
nine	|O
patients	|O
with	|O
Fuchs	|O
'	|O
endothelial	|O
dystrophy	|O
,	|O
17	|O
patients	|O
with	|O
uncomplicated	|O
senile	|O
cataract	|O
and	|O
in	|O
the	|O
secondary	|O
aqueous	|O
from	|O
six	|O
cataract	|O
patients	|O
.	|O

Only	|O
17%	|O
of	|O
all	|O
patients	|O
admitted	|O
it	|O
at	|O
all	|O
times	|O
.	|O

Prazosin	|O
alone	|O
was	|O
effective	|O
in	|O
volume	|O
responsive	|O
patients	|O
at	|O
a	|O
dose	|O
of	|O
5	|O
+	|O
/	|O
-	|O
1.0	|O
mg	|O
daily	|O
.	|O

T4	|O
and	|O
FT4I	|O
followed	|O
parallel	|O
courses	|O
in	|O
both	|O
groups	|O
;	|O
during	|O
the	|O
first	|O
45	|O
days	|O
,	|O
however	|O
,	|O
the	|O
values	|O
were	|O
significantly	|O
lower	|O
in	|O
premature	|O
infants	|O
under	|O
34	|O
weeks	|O
'	|O
EGA	|O
than	|O
in	|O
term	|O
infants	|O
(	|O
P	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

A	|O
three	|O
-	|O
phased	|O
analysis	|O
of	|O
treatment	|O
plans	|O
for	|O
45	|O
patients	|O
was	|O
undertaken	|O
.	|O

Aspirin	|O
intolerance	|O
:	|O
unaltered	|O
susceptibility	|O
of	|O
platelet	|O
cyclo	|B-PROTEIN
-	|I-PROTEIN
oxygenase	|I-PROTEIN
to	|O
inhibition	|O
by	|O
aspirin	|O
in	|O
vitro	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
cynomolgus	|O
monkeys	|O
are	|O
either	|O
less	|O
sensitive	|O
or	|O
respond	|O
differently	|O
than	|O
rhesus	|O
monkeys	|O
to	|O
some	|O
of	|O
the	|O
pharmacological	|O
effects	|O
of	|O
norcocaine	|O
.	|O

59	|O
cases	|O
of	|O
surgically	|O
resectable	|O
cancers	|O
(	|O
T1	|O
,	|O
T2	|O
,	|O
T3	|O
,	|O
N0	|O
,	|O
N1	|O
)	|O
had	|O
a	|O
minimum	|O
followup	|O
of	|O
two	|O
years	|O
(	|O
average	|O
4	|O
years	|O
+	|O
/	|O
-	|O
3	|O
months	|O
)	|O
.	|O

The	|O
effect	|O
of	|O
CBZ	|O
and	|O
DPH	|O
can	|O
be	|O
explained	|O
by	|O
interference	|O
with	|O
thyroid	|O
hormone	|O
binding	|O
to	|O
TBG	|B-PROTEIN
combined	|O
with	|O
enzyme	|O
-	|O
induced	|O
increased	|O
metabolic	|O
clearance	|O
rate	|O
of	|O
thyroid	|O
hormones	|O
without	|O
homeostatic	|O
maintenance	|O
of	|O
premedication	|O
levels	|O
of	|O
FT4	|O
and	|O
FT3	|O
.	|O

The	|O
present	|O
research	|O
evaluated	|O
the	|O
possibility	|O
that	|O
polyethylene	|O
glycol	|O
400	|O
(	|O
PEG	|O
400	|O
)	|O
might	|O
be	|O
efficacious	|O
,	|O
toxic	|O
,	|O
or	|O
both	|O
.	|O

According	|O
to	|O
their	|O
functional	|O
properties	|O
the	|O
latter	|O
neurons	|O
were	|O
subdivided	|O
into	|O
:	|O
(	|O
a	|O
)	|O
neurons	|O
responding	|O
to	|O
stimuli	|O
near	|O
the	|O
eyes	|O
;	|O
(	|O
b	|O
)	|O
neurons	|O
triggered	|O
by	|O
complex	|O
visual	|O
stimuli	|O
;	|O
(	|O
c	|O
)	|O
neurons	|O
inhibited	|O
by	|O
visual	|O
stimuli	|O
.	|O

Pentobarbital	|O
(	|O
1	|O
,	|O
3	|O
,	|O
10	|O
,	|O
and	|O
17.5	|O
mg	|O
/	|O
kg	|O
)	|O
was	|O
also	|O
tested	|O
in	|O
combination	|O
with	|O
rate	|O
-	|O
decreasing	|O
doses	|O
of	|O
normeperidine	|O
(	|O
17.5	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
anileridine	|O
(	|O
10	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
alphaprodine	|O
(	|O
10	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
and	|O
fentanyl	|O
(	|O
0.3	|O
mg	|O
/	|O
kg	|O
)	|O
.	|O

Pb	|O
foil	|O
(	|O
0.55	|O
gcm	|O
-	|O
2	|O
)	|O
provided	|O
the	|O
best	|O
overall	|O
improvement	|O
.	|O

An	|O
anatomical	|O
and	|O
histochemical	|O
study	|O
has	|O
been	|O
undertaken	|O
and	|O
as	|O
a	|O
result	|O
emphasis	|O
is	|O
given	|O
to	|O
recent	|O
hypotheses	|O
that	|O
suggest	|O
there	|O
are	|O
similarities	|O
with	|O
Type	|O
IV	|O
glycogen	|O
storage	|O
disease	|O
(	|O
Andersen	|O
's	|O
disease	|O
)	|O
which	|O
,	|O
although	|O
clinically	|O
distinct	|O
,	|O
has	|O
the	|O
same	|O
enzyme	|O
defect	|O
.	|O

All	|O
groups	|O
were	|O
tested	|O
in	|O
a	|O
Hebb	|O
-	|O
Williams	|O
maze	|O
at	|O
100	|O
approximately	|O
10	|O
days	|O
of	|O
age	|O
.	|O

Erythromycin	|O
and	|O
clindamycin	|O
resistance	|O
in	|O
Corynebacterium	|O
diphtheriae	|O
from	|O
skin	|O
lesions	|O
.	|O

Imposed	|O
angular	|O
displacements	|O
of	|O
monkey	|O
's	|O
wrist	|O
produce	|O
three	|O
major	|O
peaks	|O
of	|O
activity	|O
(	|O
terms	|O
M1	|O
,	|O
M2	|O
,	|O
and	|O
M3	|O
peaks	|O
)	|O
in	|O
the	|O
averaged	|O
gross	|O
EMG	|O
activity	|O
ot	|O
the	|O
stretched	|O
muscles	|O
.	|O

Hemolytic	|O
disease	|O
of	|O
African	|O
newborn	|O
.	|O

In	|O
this	|O
animal	|O
,	|O
infected	|O
with	|O
what	|O
was	|O
judged	|O
previously	|O
to	|O
be	|O
the	|O
less	|O
virulent	|O
of	|O
the	|O
two	|O
T.	|O
cruzi	|O
stocks	|O
used	|O
(	|O
's	|O
train	|O
7'	|O
)	|O
,	|O
there	|O
was	|O
severe	|O
myocarditis	|O
,	|O
with	|O
myofibre	|O
degeneration	|O
,	|O
and	|O
lesions	|O
of	|O
the	|O
oesophagus	|O
.	|O

The	|O
majority	|O
of	|O
MRF	|O
units	|O
were	|O
behaviorally	|O
incongruent	|O
;	|O
in	|O
the	|O
most	|O
frequently	|O
observed	|O
case	|O
,	|O
their	|O
activity	|O
failed	|O
to	|O
change	|O
reliably	|O
when	|O
behavior	|O
habituated	|O
.	|O

Variability	|O
within	|O
Down	|O
's	|O
syndrome	|O
(	|O
trisomy	|O
-	|O
21	|O
)	|O
:	|O
empirically	|O
observed	|O
sex	|O
differences	|O
in	|O
IQs	|O
.	|O

VII	|O
.	|O

Several	|O
demographic	|O
indices	|O
of	|O
isolated	|O
populations	|O
in	|O
Uzbekistan	|O

2	|O
.	|O
-	|O
-	|O
concepts	|O
of	|O
higher	|O
nervous	|O
function	|O
in	|O
the	|O
USSR	|O
.	|O

The	|O
maintenance	|O
of	|O
increased	|O
myocardial	|O
capillary	|O
density	|O
required	|O
a	|O
similar	|O
amount	|O
of	|O
exercise	|O
,	|O
and	|O
at	|O
least	|O
1	|O
h	|O
of	|O
exercise	|O
once	|O
a	|O
week	|O
was	|O
necessary	|O
to	|O
maintain	|O
the	|O
enlargement	|O
of	|O
ECA.2	|O
0	|O

These	|O
observations	|O
have	|O
led	|O
us	|O
to	|O
conclude	|O
that	|O
an	|O
elevated	|O
VIII	|O
-	|O
ratio	|O
is	|O
a	|O
very	|O
sensitive	|O
indicator	|O
of	|O
intravascular	|O
coagulation	|O
.	|O

Eight	|O
hours	|O
after	|O
the	|O
administration	|O
of	|O
colchicine	|O
,	|O
the	|O
serum	|O
ceruloplasmin	|B-PROTEIN
level	|O
began	|O
to	|O
rise	|O
again	|O
in	|O
female	|O
rats	|O
,	|O
but	|O
not	|O
in	|O
male	|O
rats	|O
.	|O

Radioimmunoassays	|O
of	|O
pregnenolone	|O
,	|O
progesterone	|O
,	|O
dehydroepiandrosterone	|O
(	|O
DHA	|O
)	|O
16	|O
alpha	|O
-	|O
hydroxy	|O
-	|O
DHA	|O
,	|O
estriol	|O
,	|O
and	|O
cortisol	|O
were	|O
performed	|O
on	|O
a	|O
total	|O
of	|O
0	|O
;	|O
1	|O
ml	|O
;	|O
of	|O
fetal	|O
plasma	|O
,	|O
collected	|O
during	|O
the	|O
course	|O
of	|O
normal	|O
vaginal	|O
delivery	|O
.	|O

In	|O
only	|O
two	|O
patients	|O
were	|O
we	|O
able	|O
to	|O
demonstrate	|O
changes	|O
suggestive	|O
of	|O
pulmonary	|O
metastases	|O
any	|O
earlier	|O
with	|O
a	|O
99mTc	|O
-	|O
EHDP	|O
scan	|O
than	|O
with	|O
chest	|O
radiographs	|O
and	|O
one	|O
of	|O
these	|O
resolved	|O
spontaneously	|O
.	|O

The	|O
majority	|O
of	|O
tumors	|O
occurred	|O
in	|O
the	|O
nasal	|O
cavities	|O
,	|O
although	|O
significant	|O
incidences	|O
were	|O
also	|O
found	|O
in	|O
the	|O
larynx	|O
,	|O
trachea	|O
and	|O
stem	|O
bronchi	|O
.	|O

Prediction	|O
of	|O
the	|O
times	|O
of	|O
sandfly	|O
development	|O

Native	|O
human	|O
fibrinogen	|B-PROTEIN
was	|O
brought	|O
to	|O
coagulation	|O
by	|O
adding	|O
thrombin	|B-PROTEIN
.	|O

No	|O
post	|O
-	|O
operative	|O
haemorrhages	|O
from	|O
the	|O
prostheses	|O
were	|O
observed	|O
.	|O

The	|O
Southern	|O
technique	|O
allowed	|O
a	|O
further	|O
localization	|O
of	|O
the	|O
region	|O
of	|O
most	|O
extensive	|O
transcription	|O
to	|O
a	|O
1.8	|O
kb	|O
HindIII	|B-PROTEIN
-	|O
EcoRI	|B-PROTEIN
fragment	|O
.	|O

Accepting	|O
arbitrarily	|O
chosen	|O
limits	|O
of	|O
maximized	|O
errors	|O
of	|O
+	|O
/	|O
-	|O
10%	|O
,	|O
it	|O
could	|O
be	|O
shown	|O
that	|O
the	|O
system	|O
did	|O
not	|O
work	|O
acceptably	|O
when	|O
the	|O
mean	|O
carbon	|O
dioxide	|O
concentration	|O
was	|O
below	|O
1.5	|O
vol.	|O
%	|O
within	|O
the	|O
fresh	|O
gas	|O
flow	|O
rates	|O
(	|O
2.2	|O
-	|O
-	|O
7.7	|O
1	|O
min	|O
-	|O
1	|O
)	|O
and	|O
the	|O
range	|O
of	|O
minute	|O
ventilation	|O
(	|O
4	|O
-	|O
-	|O
10	|O
1	|O
min	|O
-	|O
1	|O
)	|O
employed	|O
.	|O

SV	|O
increased	|O
less	|O
in	|O
SHR	|O
,	|O
mainly	|O
reflecting	|O
the	|O
reduced	|O
diastolic	|O
compliance	|O
of	|O
the	|O
hypertrophied	|O
SHR	|O
left	|O
ventricle	|O
and	|O
the	|O
consequent	|O
rightward	|O
shift	|O
of	|O
its	|O
Frank	|O
-	|O
Starling	|O
curve	|O
.	|O

The	|O
carcass	|O
of	|O
a	|O
great	|O
horned	|O
owl	|O
(	|O
Bubo	|O
virginianus	|O
)	|O
,	|O
which	|O
had	|O
been	|O
found	|O
moribund	|O
in	|O
southern	|O
Ontario	|O
,	|O
was	|O
presented	|O
for	|O
necropsy	|O
.	|O

The	|O
inner	|O
ears	|O
were	|O
exposed	|O
by	|O
microdissection	|O
,	|O
and	|O
the	|O
vestibular	|O
sensory	|O
regions	|O
were	|O
either	|O
sectioned	|O
and	|O
studied	|O
with	|O
light	|O
or	|O
electron	|O
microscopy	|O
,	|O
or	|O
prepared	|O
and	|O
studied	|O
with	|O
the	|O
surface	|O
specimen	|O
technique	|O
.	|O

Patulin	|O
is	|O
extracted	|O
from	|O
apple	|O
butter	|O
samples	|O
with	|O
ethyl	|O
acetate	|O
and	|O
the	|O
extract	|O
is	|O
cleaned	|O
up	|O
on	|O
a	|O
silica	|O
gel	|O
column	|O
,	|O
using	|O
benzene	|O
-	|O
ethyl	|O
acetate	|O
(	|O
75	|O
+	|O
25	|O
)	|O
as	|O
the	|O
eluant	|O
.	|O

Steroid	|O
glucuronides	|O
in	|O
amniotic	|O
fluid	|O
at	|O
term	|O
.	|O

The	|O
matrix	|O
surrounding	|O
the	|O
clusters	|O
either	|O
showed	|O
a	|O
normal	|O
morphology	|O
or	|O
a	|O
homogeneous	|O
appearance	|O
,	|O
within	|O
which	|O
faint	|O
cross	|O
striations	|O
but	|O
no	|O
distinctly	|O
fibrillar	|O
outlines	|O
could	|O
be	|O
identified	|O
.	|O

Riboflavin	|O
did	|O
not	|O
affect	|O
the	|O
percentage	|O
of	|O
aflatoxin	|O
-	|O
treated	|O
animals	|O
with	|O
abnormal	|O
urinary	|O
excretion	|O
patterns	|O
,	|O
but	|O
did	|O
increase	|O
the	|O
magnitude	|O
of	|O
the	|O
disturbances	|O
in	|O
elimination	|O
of	|O
kynurenic	|O
and	|O
xanthurenic	|O
acids	|O
.	|O

Polyglactin	|O
910	|O
suture	|O
absorption	|O
and	|O
the	|O
role	|O
of	|O
cellular	|O
enzymes	|O
.	|O

The	|O
incidence	|O
of	|O
DNCB	|O
reactions	|O
was	|O
78	|O
per	|O
cent	|O
for	|O
Stage	|O
I	|O
and	|O
II	|O
cancers	|O
(	|O
37	|O
patinets	|O
)	|O
,	|O
73	|O
per	|O
cent	|O
for	|O
resectable	|O
Stage	|O
III	|O
cancer	|O
(	|O
22	|O
patients	|O
)	|O
,	|O
and	|O
66	|O
per	|O
cent	|O
in	|O
patients	|O
with	|O
unresectable	|O
or	|O
inoperable	|O
Stage	|O
III	|O
cancer	|O
.	|O

Studies	|O
of	|O
lipoproteins	|O
should	|O
,	|O
however	|O
,	|O
be	|O
made	|O
in	|O
children	|O
from	|O
families	|O
known	|O
to	|O
have	|O
FH	|O
or	|O
early	|O
coronary	|O
heart	|O
disease	|O
.	|O

Sixteen	|O
other	|O
normal	|O
subjects	|O
with	|O
2	|O
g	|O
of	|O
Metyrapone	|O
are	|O
best	|O
responses	|O
.	|O

EEG	|O
theta	|O
waves	|O
and	|O
psychological	|O
phenomena	|O
:	|O
a	|O
review	|O
and	|O
analysis	|O
.	|O

REM	|O
dream	|O
content	|O
was	|O
scored	|O
for	|O
categories	|O
suggesting	|O
the	|O
predominant	|O
influence	|O
of	|O
the	|O
left	|O
hemisphere	|O
,	|O
e.g.	|O
,	|O
good	|O
ego	|O
functioning	|O
,	|O
verbalization	|O
,	|O
or	|O
the	|O
right	|O
hemisphere	|O
,	|O
e.g.	|O
,	|O
music	|O
,	|O
spatial	|O
salience	|O
,	|O
bizarreness	|O
.	|O

Innervation	|O
of	|O
the	|O
ventral	|O
diaphragm	|O
of	|O
the	|O
locust	|O
(	|O
Locusta	|O
migratoria	|O
)	|O
.	|O

Ectopic	|O
ACTH	|B-PROTEIN
syndrome	|O
and	|O
medullary	|O
thyroid	|O
carcinoma	|O
.	|O

A	|O
striking	|O
finding	|O
in	|O
all	|O
of	|O
the	|O
studies	|O
was	|O
a	|O
positive	|O
correlation	|O
between	|O
PI	|O
ACTH	|B-PROTEIN
and	|O
MSH	|B-PROTEIN
contents	|O
.	|O

Chronic	|O
hypophosphatemia	|O
is	|O
the	|O
most	|O
common	|O
type	|O
of	|O
"	|O
resistant	|O
"	|O
rickets	|O
.	|O

There	|O
was	|O
no	|O
correlation	|O
between	|O
serum	|O
LH	|B-PROTEIN
and	|O
chronological	|O
or	|O
bone	|O
age	|O
in	|O
this	|O
age	|O
group	|O
,	|O
which	|O
suggests	|O
that	|O
the	|O
correlation	|O
found	|O
is	|O
not	|O
due	|O
to	|O
age	|O
-	|O
related	|O
parallel	|O
phenomena	|O
.	|O

Molecular	|O
neurochemistry	|O
of	|O
addictive	|O
drugs	|O
.	|O

Efforts	|O
were	|O
made	|O
to	|O
determine	|O
the	|O
amount	|O
of	|O
time	|O
required	|O
for	|O
kidney	|O
lesions	|O
to	|O
develop	|O
and	|O
,	|O
if	|O
possible	|O
,	|O
to	|O
delineate	|O
the	|O
potential	|O
site	|O
of	|O
action	|O
of	|O
PBB	|O
.	|O

Effect	|O
of	|O
succimer	|O
on	|O
the	|O
intensity	|O
of	|O
tricarboxylic	|B-PROTEIN
acid	|I-PROTEIN
dehydrogenase	|I-PROTEIN
reactions	|O
in	|O
the	|O
brain	|O
of	|O
rats	|O
poisoned	|O
with	|O
mercuric	|O
chloride	|O

Distribution	|O
and	|O
correlations	|O
of	|O
serum	|O
uric	|O
-	|O
acid	|O
in	|O
two	|O
French	|O
adult	|O
populations	|O
:	|O
13,885	|O
men	|O
and	|O
6,861	|O
women	|O

The	|O
incidence	|O
of	|O
hepatitis	|B-PROTEIN
B	|I-PROTEIN
antigen	|I-PROTEIN
following	|O
transfusion	|O
was	|O
about	|O
2.8	|O
per	|O
cent	|O
.	|O

Technetium	|O
-	|O
99m	|O
stannous	|O
pyrophosphate	|O
myocardial	|O
scintigrams	|O
were	|O
obtained	|O
in	|O
138	|O
clinically	|O
stable	|O
patients	|O
32.7	|O
+	|O
/	|O
-	|O
47.3	|O
weeks	|O
(	|O
range	|O
6	|O
to	|O
260	|O
)	|O
after	|O
acute	|O
myocardial	|O
infarction	|O
.	|O

A	|O
similar	|O
phenomenon	|O
has	|O
been	|O
reported	|O
in	|O
a	|O
few	|O
humans	|O
.	|O

The	|O
decline	|O
in	|O
the	|O
activity	|O
of	|O
cytochrome	|B-PROTEIN
oxidase	|I-PROTEIN
,	|O
peroxidase	|B-PROTEIN
and	|O
in	|O
the	|O
lipid	|O
content	|O
of	|O
peripheral	|O
neutrophils	|O
was	|O
followed	|O
by	|O
a	|O
decrease	|O
in	|O
the	|O
phagocytic	|O
activity	|O
.	|O

Treatment	|O
of	|O
2	|O
patients	|O
with	|O
pseudohypoparathyroidism	|O
type	|O
I	|O
with	|O
vitamin	|O
-	|O
D	|O
-	|O
3	|O
and	|O
1	|O
alpha	|O
-	|O
Hydroxycholecalciferol	|O
consecutively	|O
resulted	|O
in	|O
a	|O
nonuniform	|O
response	|O
with	|O
regard	|O
to	|O
the	|O
normalisation	|O
of	|O
serum	|O
-	|O
calcium	|O
.	|O

Workers	|O
with	|O
"	|O
sensitivity	|O
"	|O
to	|O
toluene	|O
diisocyanate	|O
(	|O
TDI	|O
)	|O
studied	|O
in	|O
depth	|O
in	|O
an	|O
attempt	|O
to	|O
determine	|O
mechanisms	|O
of	|O
bronchial	|O
hyperreactivity	|O
.	|O

Total	|O
VO2	|O
was	|O
decreased	|O
in	|O
both	|O
groups	|O
during	|O
severe	|O
hypoxia	|O
but	|O
limb	|O
VO2	|O
was	|O
maintained	|O
in	|O
the	|O
beta	|O
-	|O
block	|O
group	|O
.	|O
beta	|O
-	|O
Block	|O
prevented	|O
the	|O
fall	|O
in	|O
total	|O
and	|O
limb	|O
peripheral	|O
resistance	|O
seen	|O
in	|O
severe	|O
hypoxia	|O
but	|O
did	|O
not	|O
alter	|O
the	|O
consistently	|O
more	|O
efficient	|O
utilization	|O
of	|O
total	|O
O2	|O
delivery	|O
shown	|O
by	|O
the	|O
limb	|O
in	|O
comparison	|O
to	|O
the	|O
whole	|O
body	|O
by	|O
higher	|O
O2	|O
extraction	|O
ratios	|O
and	|O
lower	|O
venous	|O
O2	|O
pressure	|O
.	|O
beta	|B-PROTEIN
-	|I-PROTEIN
Vasodilator	|I-PROTEIN
receptors	|I-PROTEIN
evidently	|O
played	|O
an	|O
active	|O
part	|O
in	|O
the	|O
vasodilatation	|O
seen	|O
during	|O
severe	|O
hypoxia	|O
.	|O

Phenobarbital	|O
-	|O
induced	|O
alterations	|O
in	|O
the	|O
metabolism	|O
of	|O
[	|O
3H	|O
]	|O
vitamin	|O
D3	|O
by	|O
the	|O
perfused	|O
rachitic	|O
rat	|O
liver	|O
in	|O
vitro	|O
.	|O

Modulation	|O
of	|O
25	|B-PROTEIN
-	|I-PROTEIN
hydroxyvitamin	|I-PROTEIN
D3	|I-PROTEIN
-	|I-PROTEIN
24	|I-PROTEIN
-	|I-PROTEIN
hydroxylase	|I-PROTEIN
by	|O
aminophylline	|O
:	|O
a	|O
cytochrome	|B-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
450	|I-PROTEIN
monooxygenase	|O
system	|O
.	|O

In	|O
both	|O
these	|O
respects	|O
,	|O
however	|O
,	|O
the	|O
DBP	|B-PROTEIN
mRNA	|O
resembles	|O
the	|O
late	|O
messengers	|O
of	|O
SV40	|O
and	|O
polyoma	|O
viruses	|O
.	|O

Effect	|O
of	|O
corticosteroid	|O
-	|O
containing	|O
antirheumatic	|O
combination	|O
drugs	|O
on	|O
endogenous	|O
ACTH	|B-PROTEIN
and	|O
cortisol	|O
production	|O
.	|O

Serum	|O
ACTH	|B-PROTEIN
did	|O
not	|O
respond	|O
to	|O
insulin	|B-PROTEIN
and	|O
metyrapone	|O
.	|O

Anatomy	|O
of	|O
the	|O
RNA	|O
and	|O
gene	|O
products	|O
of	|O
MC29	|O
and	|O
MH2	|O
,	|O
two	|O
defective	|O
avian	|O
tumor	|O
viruses	|O
causing	|O
acute	|O
leukemia	|O
and	|O
carcinoma	|O
:	|O
evidence	|O
for	|O
a	|O
new	|O
class	|O
of	|O
transforming	|O
genes	|O
.	|O

Bertioga	|O
(	|O
Guama	|O
group	|O
)	|O
and	|O
Anhembi	|O
(	|O
Bunyamwera	|O
group	|O
)	|O
,	|O
two	|O
new	|O
arboviruses	|O
isolated	|O
in	|O
Sao	|O
Paulo	|O
,	|O
Brazil	|O
.	|O

Gamma	|B-PROTEIN
glutamyl	|I-PROTEIN
transpeptidase	|I-PROTEIN
activity	|O
was	|O
increased	|O
up	|O
to	|O
15	|O
times	|O
above	|O
the	|O
upper	|O
normal	|O
limit	|O
in	|O
children	|O
,	|O
who	|O
received	|O
aminopyrine	|O
for	|O
two	|O
weeks	|O
or	|O
longer	|O
.	|O

XXI	|O
.	|O

A	|O
gas	|O
-	|O
liquid	|O
chromatographic	|O
method	|O
for	|O
the	|O
determination	|O
of	|O
p	|O
-	|O
chlorophenoxyisobutyric	|O
(	|O
CPIB	|O
)	|O
acid	|O
in	|O
blood	|O
plasma	|O
is	|O
described	|O
.	|O

Dopamine	|B-PROTEIN
receptor	|I-PROTEIN
blockade	|O
and	|O
the	|O
neuroleptics	|O
,	|O
a	|O
crystallographic	|O
study	|O
.	|O

V.	|O

A	|O
rapid	|O
fluorimetric	|O
procedure	|O
for	|O
the	|O
determination	|O
of	|O
the	|O
fungicide	|O
5	|O
-	|O
fluorocytosine	|O
in	|O
serum	|O
is	|O
described	|O
.	|O

The	|O
'	|O
field	|O
of	|O
stress	|O
'	|O
of	|O
the	|O
supervisory	|O
nurse	|O

How	|O
do	|O
graduates	|O
of	|O
different	|O
types	|O
of	|O
programs	|O
perform	|O
on	|O
state	|O
boards	|O
?	|O

Similarly	|O
,	|O
maternal	|O
serum	|O
somatomedin	|B-PROTEIN
A	|I-PROTEIN
was	|O
significantly	|O
reduced	|O
in	|O
rats	|O
nursing	|O
large	|O
litters	|O
.	|O

The	|O
sequences	|O
following	|O
the	|O
X.	|O
borealis	|O
oocyte	|O
and	|O
somatic	|O
5S	|B-PROTEIN
genes	|O
are	|O
identical	|O
in	|O
12	|O
of	|O
the	|O
first	|O
14	|O
residues	|O
and	|O
contain	|O
two	|O
or	|O
more	|O
T	|O
clusters	|O
,	|O
as	|O
does	|O
the	|O
corresponding	|O
region	|O
of	|O
X.	|O
laevis	|O
oocyte	|O
5S	|B-PROTEIN
DNA	|O
.	|O

This	|O
mechanism	|O
is	|O
not	|O
due	|O
to	|O
the	|O
observed	|O
grain	|O
boundary	|O
precipitates	|O
.	|O

This	|O
report	|O
has	|O
reviewed	|O
some	|O
of	|O
the	|O
reasons	|O
for	|O
treatment	|O
failures	|O
and	|O
has	|O
presented	|O
a	|O
philosophy	|O
for	|O
their	|O
management	|O
.	|O

Diagnosis	|O
and	|O
treatment	|O
planning	|O
in	|O
Class	|O
II	|O
,	|O
division	|O
2	|O

Because	|O
of	|O
serious	|O
infections	|O
(	|O
fever	|O
larger	|O
than	|O
or	|O
equal	|O
to	|O
101	|O
degrees	|O
F.	|O
granulocytes	|O
less	|O
than	|O
1,000	|O
/	|O
mm	|O
,	|O
3	|O
and	|O
hospitalization	|O
)	|O
and	|O
1	|O
drug	|O
death	|O
in	|O
the	|O
first	|O
4	|O
patients	|O
,	|O
oral	|O
calcium	|O
leucovorin	|O
,	|O
20	|O
to	|O
30	|O
mg	|O
/	|O
m2	|O
orally	|O
,	|O
was	|O
given	|O
2	|O
days	|O
after	|O
methotrexate	|O
in	|O
subsequent	|O
treatment	|O
cycles	|O
.	|O

It	|O
seems	|O
that	|O
the	|O
way	|O
in	|O
which	|O
drugs	|O
modify	|O
a	|O
patient	|O
's	|O
serum	|O
chemistry	|O
may	|O
be	|O
used	|O
to	|O
assess	|O
the	|O
efficacy	|O
with	|O
which	|O
they	|O
control	|O
the	|O
inflammatory	|O
process	|O
.	|O

Here	|O
the	|O
conventional	|O
tests	|O
clearly	|O
pointed	|O
to	|O
the	|O
presence	|O
of	|O
retrocochlear	|O
disease	|O
.	|O

The	|O
end	|O
-	|O
stage	|O
or	|O
involutional	|O
phase	|O
of	|O
proliferative	|O
diabetic	|O
retinopathy	|O
may	|O
result	|O
in	|O
stabilization	|O
of	|O
vision	|O
for	|O
long	|O
periods	|O
of	|O
time	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
serum	|O
alpha1AT	|B-PROTEIN
quantitation	|O
,	|O
newborn	|O
infants	|O
may	|O
be	|O
separated	|O
into	|O
two	|O
groups	|O
,	|O
characterized	|O
respectively	|O
by	|O
concentrations	|O
above	|O
or	|O
below	|O
150	|O
mg	|O
%	|O
.	|O

In	|O
patients	|O
who	|O
were	|O
not	|O
vented	|O
,	|O
there	|O
was	|O
overall	|O
significant	|O
depression	|O
of	|O
function	|O
(	|O
67	|O
+	|O
/	|O
-	|O
5%	|O
of	|O
control	|O
;	|O
range	|O
,	|O
91	|O
-	|O
-	|O
45%	|O
,	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

Changes	|O
in	|O
body	|O
weight	|O
and	|O
agonistic	|O
behavior	|O
were	|O
also	|O
recorded	|O
.	|O

The	|O
uterine	|O
response	|O
to	|O
prostaglandin	|O
E2	|O
(	|O
PGE2	|O
)	|O
and	|O
prostaglandin	|O
F2alpha	|O
(	|O
administered	|O
by	|O
intravenous	|O
and	|O
intrauterine	|O
routes	|O
)	|O
was	|O
evaluated	|O
during	|O
different	|O
phases	|O
of	|O
the	|O
menstrual	|O
cycle	|O
in	|O
five	|O
functionally	|O
infertile	|O
women	|O
.	|O

A	|O
total	|O
of	|O
26	|O
BCG	|O
strains	|O
,	|O
out	|O
of	|O
them	|O
10	|O
Czechoslovak	|O
strains	|O
(	|O
2	|O
lyophilized	|O
cultures	|O
of	|O
BCG	|O
of	|O
different	|O
batch	|O
,	|O
6	|O
strains	|O
isolated	|O
from	|O
abscesses	|O
of	|O
children	|O
after	|O
BCG	|O
-	|O
vaccination	|O
and	|O
2	|O
strains	|O
from	|O
fatal	|O
cases	|O
after	|O
BCG	|O
-	|O
vaccination	|O
)	|O
and	|O
16	|O
strains	|O
obtained	|O
from	|O
foreign	|O
laboratories	|O
,	|O
were	|O
used	|O
.	|O

High	|O
levels	|O
of	|O
serum	|O
calcitonin	|B-PROTEIN
were	|O
found	|O
in	|O
patients	|O
with	|O
chronic	|O
renal	|O
failure	|O
.	|O

Detection	|O
of	|O
anti	|O
-	|O
lymphocyte	|O
antibodies	|O
using	|O
the	|O
immunoperoxidase	|B-PROTEIN
antiglobulin	|O
technic	|O
.	|O

The	|O
response	|O
of	|O
serum	|O
GH	|B-PROTEIN
to	|O
arginine	|O
infusion	|O
was	|O
normal	|O
,	|O
while	|O
that	|O
to	|O
insulin	|B-PROTEIN
-	|O
induced	|O
hypoglycemia	|O
was	|O
poor	|O
.	|O

The	|O
mortality	|O
rate	|O
and	|O
histopathological	|O
features	|O
of	|O
Nocardia	|O
asteroides	|O
and	|O
Nocardia	|O
brasiliensis	|O
infections	|O
in	|O
congenitally	|O
athymic	|O
(	|O
nude	|O
)	|O
mice	|O
of	|O
ICR	|O
and	|O
C3H	|O
/	|O
eB	|O
origins	|O
were	|O
quite	|O
different	|O
from	|O
what	|O
we	|O
found	|O
for	|O
Swiss	|O
white	|O
mice	|O
and	|O
other	|O
inbred	|O
mouse	|O
strains	|O
(	|O
namely	|O
,	|O
C57	|O
/	|O
BL	|O
/	|O
6J	|O
,	|O
New	|O
Zealand	|O
Black	|O
,	|O
BALB	|O
/	|O
c	|O
,	|O
CBA	|O
/	|O
LAC	|O
,	|O
and	|O
C3H	|O
/	|O
eB	|O
)	|O
.	|O

Williams	|O
,	|O
2	|O
August	|O
1977	|O
.	|O

Use	|O
of	|O
radioactive	|O
isotopes	|O
in	|O
the	|O
chemistry	|O
of	|O
proteins	|O

(	|O
Emeritus	|O
)	|O
John	|O
Henri	|O
Roosegaarde	|O
Bisschop	|O

Disrupted	|O
vaccines	|O
and	|O
whole	|O
-	|O
virus	|O
vaccines	|O
containing	|O
type	|B-PROTEIN
B	|I-PROTEIN
antigen	|I-PROTEIN
only	|O
did	|O
not	|O
cause	|O
significant	|O
reactivity	|O
.	|O

255-61	|O
.	|O

Antenatal	|O
diagnosis	|O
of	|O
haematological	|O
disorders	|O
-	|O
-	|O
'	|O
1978	|O
'	|O
.	|O

Hepatic	|O
oxygen	|O
supply	|O
and	|O
selected	|O
blood	|O
parameters	|O
were	|O
recorded	|O
in	|O
fasted	|O
male	|O
rates	|O
given	|O
20	|O
-	|O
-	|O
30	|O
mg	|O
/	|O
kg	|O
Escherichia	|B-PROTEIN
coli	|I-PROTEIN
endotoxin	|I-PROTEIN
intraperitoneally	|O
.	|O

Gonadal	|O
dysfunction	|O
in	|O
patients	|O
with	|O
ataxia	|O
telangiectasia	|O
.	|O

The	|O
maximum	|O
period	|O
of	|O
treatment	|O
was	|O
73	|O
(	|O
oral	|O
)	|O
,	|O
73	|O
(	|O
intraperitoneal	|O
)	|O
or	|O
75	|O
(	|O
dermal	|O
)	|O
weeks	|O
.	|O

A	|O
study	|O
of	|O
the	|O
comparative	|O
efficacy	|O
of	|O
diflucortolone	|O
valerate	|O
0.3%	|O
ointment	|O
and	|O
clobetasol	|O
propionate	|O
0.05%	|O
ointment	|O
.	|O

Most	|O
of	|O
the	|O
phenomena	|O
of	|O
azotaemic	|O
osteodystrophy	|O
are	|O
encountered	|O
in	|O
simple	|O
vitamin	|O
D	|O
deficiency	|O
;	|O
as	|O
in	|O
that	|O
condition	|O
,	|O
deficiency	|O
of	|O
1,25	|O
-	|O
dihydroxycholecalciferol	|O
may	|O
be	|O
of	|O
primary	|O
significance	|O
in	|O
causing	|O
secondary	|O
hyperparathyroidism	|O
in	|O
renal	|O
failure	|O
.	|O

Basal	|O
FSH	|B-PROTEIN
and	|O
LH	|B-PROTEIN
levels	|O
were	|O
significantly	|O
lower	|O
in	|O
addicts	|O
;	|O
after	|O
GnRH	|B-PROTEIN
stimulation	|O
the	|O
addicts	|O
'	|O
FSH	|B-PROTEIN
and	|O
LH	|B-PROTEIN
values	|O
increased	|O
but	|O
not	|O
significantly	|O
compared	|O
to	|O
controls	|O
.	|O

Adriamycin	|O
:	|O
comparison	|O
of	|O
a	|O
5	|O
-	|O
week	|O
schedule	|O
with	|O
a	|O
3	|O
-	|O
week	|O
schedule	|O
in	|O
the	|O
treatment	|O
of	|O
breast	|O
cancer	|O
.	|O

Follow	|O
-	|O
up	|O
controls	|O
of	|O
luteinizing	|B-PROTEIN
hormone	|I-PROTEIN
(	|O
LH	|B-PROTEIN
)	|O
,	|O
follicle	|B-PROTEIN
stimulating	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
FSH	|B-PROTEIN
)	|O
,	|O
prolactin	|B-PROTEIN
(	|O
HPRL	|B-PROTEIN
)	|O
,	|O
oestradiol	|O
(	|O
E2	|O
)	|O
,	|O
progesterone	|O
(	|O
P	|O
)	|O
and	|O
testosterone	|O
(	|O
T	|O
)	|O
in	|O
the	|O
catabolic	|O
and	|O
healing	|O
phase	|O
of	|O
burn	|O
disease	|O
.	|O

Renin	|B-PROTEIN
studies	|O
performed	|O
in	|O
34	|O
hypertensive	|O
patients	|O
and	|O
in	|O
a	|O
control	|O
group	|O
of	|O
11	|O
recipients	|O
showed	|O
that	|O
elevation	|O
of	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
and	|O
of	|O
plasma	|O
aldosterone	|O
level	|O
is	|O
frequent	|O
but	|O
difficult	|O
to	|O
interpret	|O
,	|O
particularly	|O
when	|O
a	|O
renal	|O
artery	|O
stenosis	|O
is	|O
observed	|O
.	|O

A	|O
randomized	|O
clinical	|O
trial	|O
in	|O
sixty	|O
-	|O
two	|O
adult	|O
patients	|O
suffering	|O
from	|O
typhoid	|O
fever	|O
,	|O
proved	|O
by	|O
blood	|O
and	|O
marrow	|O
culture	|O
,	|O
showed	|O
that	|O
amoxycillin	|O
in	|O
a	|O
dosage	|O
schedule	|O
of	|O
1	|O
g	|O
8	|O
-	|O
hourly	|O
orally	|O
for	|O
fourteen	|O
days	|O
was	|O
better	|O
than	|O
chloramphenicol	|O
with	|O
regard	|O
to	|O
clinical	|O
and	|O
temperature	|O
response	|O
and	|O
in	|O
respect	|O
of	|O
carriers	|O
and	|O
relapse	|O
rates	|O
.	|O

202-8	|O
.	|O

Bone	|O
marrow	|O
transplantation	|O
-	|O
1979	|O
.	|O

In	|O
this	|O
article	|O
,	|O
the	|O
clinical	|O
actions	|O
of	|O
the	|O
principal	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
stimulating	|O
agents	|O
(	|O
apomorphine	|O
and	|O
its	|O
derivatives	|O
;	|O
piribedil	|O
,	|O
rye	|O
-	|O
ergot	|O
derivatives	|O
)	|O
are	|O
discussed	|O
on	|O
the	|O
basis	|O
of	|O
their	|O
biochemical	|O
and	|O
pharmacological	|O
properties	|O
.	|O

The	|O
unilateral	|O
vestibular	|O
hypofunction	|O
.	|O

Thus	|O
,	|O
the	|O
inhibition	|O
of	|O
pepsin	|B-PROTEIN
in	|O
human	|O
gastric	|O
juice	|O
does	|O
not	|O
appear	|O
to	|O
have	|O
a	|O
major	|O
influence	|O
on	|O
the	|O
healing	|O
of	|O
duodenal	|O
ulcer	|O
.	|O

The	|O
IDF	|O
standard	|O
method	|O
for	|O
the	|O
detection	|O
of	|O
penicillin	|O
in	|O
milk	|O
is	|O
not	|O
suitable	|O
for	|O
the	|O
detection	|O
of	|O
sulphonamide	|O
residues	|O
in	|O
milk	|O
.	|O

Capsular	|O
antigens	|O
of	|O
Staphylococcus	|O
aureus	|O

The	|O
course	|O
of	|O
endotoxin	|O
fever	|O
remained	|O
uninfluenced	|O
by	|O
ALS	|O
.	|O

2	|O
new	|O
Algerian	|O
cases	|O

Seventy	|O
-	|O
one	|O
percent	|O
of	|O
patients	|O
treated	|O
with	|O
ticarcillin	|O
alone	|O
responded	|O
favorably	|O
.	|O

Accurate	|O
pathologic	|O
staging	|O
identifies	|O
patients	|O
who	|O
are	|O
potentially	|O
curable	|O
with	|O
radiotherapy	|O
.	|O

Inherent	|O
hematology	|O
of	|O
old	|O
age	|O

Neomycin	|O
is	|O
fairly	|O
effective	|O
against	|O
staphylococci	|O
,	|O
less	|O
effective	|O
against	|O
streptococci	|O
,	|O
and	|O
fairly	|O
effective	|O
against	|O
gram	|O
-	|O
negative	|O
intestinal	|O
organisms	|O
.	|O

It	|O
was	|O
concluded	|O
,	|O
that	|O
on	|O
a	|O
given	|O
section	|O
,	|O
75,7	|O
per	|O
cent	|O
of	|O
the	|O
trabeculae	|O
were	|O
in	|O
contact	|O
with	|O
vascular	|O
cavities	|O
.	|O

2	|O
.	|O

Changes	|O
in	|O
tissue	|O
PCO2	|O
were	|O
less	|O
dramatic	|O
and	|O
did	|O
not	|O
vary	|O
significantly	|O
from	|O
those	|O
recorded	|O
in	|O
venous	|O
blood	|O
.	|O

Ultrasonic	|O
evaluation	|O
of	|O
renal	|O
calculi	|O
.	|O

Recognition	|O
of	|O
emphysema	|O
was	|O
poor	|O
when	|O
radiographs	|O
of	|O
inadequate	|O
quality	|O
were	|O
included	|O
(	|O
anteroposterior	|O
films	|O
or	|O
films	|O
from	|O
patients	|O
with	|O
acute	|O
or	|O
chronic	|O
lung	|O
disease	|O
)	|O
.	|O

Isolation	|O
of	|O
T.	|O
gambiense	|O
strains	|O
in	|O
Zaire	|O
and	|O
their	|O
adaptation	|O
to	|O
laboratory	|O
animals	|O

Pharmacokinetic	|O
profile	|O
of	|O
clonazepam	|O
in	|O
rhesus	|O
monkeys	|O
.	|O

Immunologic	|O
mechanisms	|O
in	|O
chronic	|O
brucellosis	|O
in	|O
humans	|O
.	|O

Intestinal	|O
adaptation	|O
(	|O
first	|O
of	|O
two	|O
parts	|O
)	|O
.	|O

In	|O
patients	|O
who	|O
had	|O
received	|O
no	|O
previous	|O
drug	|O
treatment	|O
,	|O
log	|O
baseline	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
and	|O
change	|O
in	|O
mean	|O
blood	|O
pressure	|O
after	|O
SQ	|O
20881	|O
correlated	|O
significantly	|O
(	|O
r	|O
=	|O
0.651	|O
,	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

These	|O
techniques	|O
have	|O
been	|O
used	|O
by	|O
many	|O
people	|O
for	|O
many	|O
years	|O
and	|O
no	|O
claim	|O
is	|O
being	|O
made	|O
for	|O
any	|O
innovation	|O
in	|O
this	|O
regard	|O
.	|O

40	|O
patients	|O
with	|O
chronic	|O
osteomyelitis	|O
were	|O
treated	|O
per	|O
os	|O
with	|O
the	|O
bactericidal	|O
beta	|O
-	|O
lactam	|O
-	|O
antibiotic	|O
cephalexin	|O
during	|O
3	|O
to	|O
60	|O
weeks	|O
.	|O

A	|O
total	|O
of	|O
57	|O
patients	|O
with	|O
Hodgkin	|O
's	|O
disease	|O
limited	|O
to	|O
above	|O
the	|O
diaphragm	|O
(	|O
Stages	|O
I	|O
and	|O
II	|O
,	|O
A	|O
and	|O
B	|O
)	|O
were	|O
treated	|O
with	|O
radiation	|O
therapy	|O
alone	|O
at	|O
the	|O
University	|O
of	|O
Florida	|O
between	|O
1964	|O
and	|O
1974	|O
.	|O

Year	|O
one	|O
of	|O
the	|O
first	|O
general	|O
practitioner	|O
medical	|O
unit	|O
in	|O
the	|O
greater	|O
Glasgow	|O
area	|O
.	|O

This	|O
multiple	|O
-	|O
electrode	|O
array	|O
for	|O
round	|O
window	|O
cochlear	|O
implantation	|O
is	|O
a	|O
robust	|O
,	|O
reliable	|O
system	|O
for	|O
inserting	|O
20	|O
mm	|O
along	|O
the	|O
scala	|O
tympani	|O
with	|O
a	|O
minimum	|O
of	|O
trauma	|O
and	|O
can	|O
provide	|O
for	|O
bipolar	|O
stimulation	|O
.	|O

As	|O
authorized	|O
by	|O
the	|O
World	|O
Health	|O
Organization	|O
29th	|O
Expert	|O
Committee	|O
on	|O
Biological	|O
Standardization	|O
,	|O
the	|O
preparation	|O
of	|O
human	|O
prolactin	|B-PROTEIN
in	|O
ampoules	|O
coded	|O
75/504	|O
has	|O
been	|O
established	|O
as	|O
the	|O
International	|O
Reference	|O
Preparation	|O
(	|O
IRP	|O
)	|O
of	|O
human	|O
prolactin	|B-PROTEIN
for	|O
immunoassay	|O
.	|O

i	|O
.	|O

Biliary	|O
-	|O
enteric	|O
fistulas	|O

Plasma	|O
ion	|O
changes	|O
in	|O
venous	|O
blood	|O
incubated	|O
with	|O
beta	|B-PROTEIN
receptor	|I-PROTEIN
blockers	|O
and	|O
subjected	|O
to	|O
tonometry	|O
in	|O
vitro	|O
.	|O

Such	|O
marked	|O
differences	|O
are	|O
found	|O
occasionally	|O
in	|O
the	|O
literature	|O
:	|O
heterophile	|O
antibodies	|O
against	|O
bovine	|O
gammaglobulin	|B-PROTEIN
are	|O
regarded	|O
as	|O
responsible	|O
for	|O
the	|O
interference	|O
in	|O
the	|O
Sephadex	|O
system	|O
of	|O
RIST	|O
.	|O

"	|O
Let	|O
the	|O
hundred	|O
flowers	|O
bloom	|O
"	|O
.	|O

Various	|O
treatment	|O
modalities	|O
are	|O
reviewed	|O
in	|O
the	|O
context	|O
of	|O
the	|O
psychology	|O
as	|O
well	|O
as	|O
the	|O
physiology	|O
of	|O
severe	|O
intractable	|O
pain	|O
.	|O

Lethal	|O
Tachmalcor	|O
(	|O
4	|O
-	|O
(	|O
3'	|O
-	|O
diethylamino	|O
-	|O
2'	|O
-	|O
hydroxypropyl	|O
)	|O
-	|O
ajmaline	|O
)	|O
poisoning	|O
in	|O
childhood	|O

Ophthalmosonographic	|O
evaluation	|O
of	|O
blood	|O
flow	|O
velocity	|O
in	|O
arteriocavernous	|O
fistula	|O

Serum	|O
ferritin	|B-PROTEIN
concentration	|O
and	|O
bone	|O
marrow	|O
iron	|O
stores	|O
.	|O

The	|O
systolic	|O
pressure	|O
gradient	|O
(	|O
SPG	|O
)	|O
between	|O
the	|O
left	|O
ventricle	|O
(	|O
LV	|O
)	|O
and	|O
left	|O
atrium	|O
(	|O
LA	|O
)	|O
was	|O
obtained	|O
from	|O
high	|O
-	|O
fidelity	|O
pressure	|O
transducers	|O
.	|O

A	|O
prospective	|O
trail	|O
comparing	|O
hysterectomy	|O
,	|O
hysterectomy	|O
plus	|O
vaginal	|O
radium	|O
,	|O
and	|O
uterine	|O
radium	|O
plus	|O
hysterectomy	|O
in	|O
stage	|O
I	|O
endometrial	|O
carcinoma	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
a	|O
patient	|O
's	|O
report	|O
of	|O
one	|O
inaccurate	|O
Clinitemp	|O
,	|O
we	|O
undertook	|O
to	|O
investigate	|O
the	|O
accuracy	|O
of	|O
this	|O
thermometer	|O
.	|O

Cryoglobulinemia	|O
in	|O
Raynaud	|O
's	|O
syndrome	|O

Data	|O
were	|O
processed	|O
with	|O
a	|O
semi	|O
-	|O
automatic	|O
computer	|O
program	|O
which	|O
develops	|O
an	|O
averaged	|O
-	|O
volume	|O
curve	|O
from	|O
an	|O
assigned	|O
LV	|O
region	|O
-	|O
of	|O
-	|O
interest	|O
.	|O

The	|O
preferential	|O
serum	|O
IgA	|B-PROTEIN
response	|O
observed	|O
in	|O
the	|O
patient	|O
population	|O
suggests	|O
that	|O
bronchial	|O
associated	|O
lymphoid	|O
tissue	|O
in	|O
the	|O
diseased	|O
lung	|O
is	|O
an	|O
important	|O
source	|O
of	|O
circulating	|O
IgA	|B-PROTEIN
.	|O

Ultimate	|O
strengthes	|O
seem	|O
to	|O
be	|O
reached	|O
for	|O
cast	|O
cobalt	|O
alloys	|O
,	|O
whereas	|O
titanium	|O
alloys	|O
,	|O
such	|O
as	|O
Ta	|O
6	|O
V	|O
,	|O
present	|O
very	|O
high	|O
fatigue	|O
limit	|O
under	|O
corrosion	|O
.	|O

The	|O
effects	|O
of	|O
intracisternal	|O
injection	|O
(	|O
i.c.i	|O
.	|O
)	|O
of	|O
clonidine	|O
(	|O
1	|O
microgram	|O
kg	|O
-	|O
1	|O
)	|O
on	|O
blood	|O
pressure	|O
and	|O
heart	|O
rate	|O
were	|O
studied	|O
in	|O
conscious	|O
rabbits	|O
with	|O
an	|O
implanted	|O
catheter	|O
in	|O
the	|O
cisterna	|O
magna	|O
.	|O

Platelet	|O
number	|O
and	|O
life	|O
span	|O
were	|O
determined	|O
in	|O
the	|O
last	|O
trimester	|O
of	|O
pregnancy	|O
in	|O
22	|O
women	|O
who	|O
were	|O
delivered	|O
of	|O
small	|O
-	|O
for	|O
-	|O
gestational	|O
age	|O
(	|O
SGA	|O
)	|O
infants	|O
and	|O
in	|O
21	|O
women	|O
with	|O
infants	|O
having	|O
normal	|O
birth	|O
weights	|O
.	|O

Serial	|O
measurements	|O
of	|O
total	|O
serum	|O
IgE	|B-PROTEIN
appears	|O
to	|O
be	|O
a	|O
useful	|O
index	|O
of	|O
disease	|O
activity	|O
in	|O
ABPA	|O
.	|O

In	|O
the	|O
8	|O
patients	|O
the	|O
difference	|O
betweent	|O
he	|O
mean	|O
diastolic	|O
values	|O
of	|O
delta	|O
PU	|O
and	|O
delta	|O
PM	|O
was	|O
-	|O
0.54	|O
+	|O
/	|O
-	|O
1.0	|O
(	|O
SD	|O
)	|O
mmHg	|O
.	|O

A	|O
rise	|O
of	|O
hemoglobin	|B-PROTEIN
concentration	|O
accompanied	|O
by	|O
an	|O
increase	|O
of	|O
the	|O
total	|O
iron	|O
in	|O
the	|O
blood	|O
serum	|O
of	|O
white	|O
mice	|O
was	|O
found	|O
under	|O
oxygen	|O
pressure	|O
of	|O
4	|O
atm	|O
for	|O
an	|O
hour	|O
(	|O
preconvulsive	|O
state	|O
)	|O
and	|O
6	|O
atm	|O
(	|O
convulsive	|O
state	|O
)	|O
.	|O

Nernst	|O
-	|O
-	|O
Planck	|O
analog	|O
equations	|O
and	|O
stationary	|O
state	|O
membrane	|O
electric	|O
potentials	|O
.	|O

Effects	|O
of	|O
methylene	|O
chloride	|O
,	|O
trichloroethane	|O
,	|O
trichloroethylene	|O
,	|O
tetrachloroethylene	|O
and	|O
toluene	|O
on	|O
the	|O
development	|O
of	|O
chick	|O
embryos	|O
.	|O

Effect	|O
of	|O
intraventricular	|O
administration	|O
of	|O
streptolysin	|B-PROTEIN
O	|I-PROTEIN
on	|O
the	|O
electroencephalogram	|O
of	|O
rabbits	|O
.	|O

In	|O
this	|O
situation	|O
the	|O
convlusion	|O
threshold	|O
for	|O
the	|O
8	|O
substances	|O
is	|O
as	|O
follows	|O
:	|O
pethidine	|O
20	|O
mg.k	|O
g	|O
-	|O
1	|O
I.V.	|O
,	|O
piritramide	|O
30	|O
,	|O
morphine	|O
180	|O
,	|O
phenoperidine	|O
4	|O
,	|O
R	|O
39	|O
209	|O
5	|O
,	|O
fentanyl	|O
4	|O
,	|O
sufentanil	|O
4	|O
and	|O
R	|O
34	|O
995	|O
10	|O
mg.k	|O
g	|O
-	|O
1	|O
I.V.	|O

The	|O
biochemistry	|O
of	|O
amniotic	|O
fluid	|O
with	|O
poor	|O
fetal	|O
growth	|O
.	|O

Roentgenographically	|O
,	|O
the	|O
lesion	|O
was	|O
usually	|O
a	|O
well	|O
-	|O
defined	|O
and	|O
benign	|O
appearing	|O
one	|O
,	|O
either	|O
purely	|O
lytic	|O
(	|O
3	|O
cases	|O
)	|O
or	|O
with	|O
central	|O
radiodensity	|O
(	|O
2	|O
cases	|O
)	|O
.	|O

Effects	|O
of	|O
chronic	|O
descending	|O
tractotomy	|O
on	|O
the	|O
response	|O
patterns	|O
of	|O
neurons	|O
in	|O
the	|O
trigeminal	|O
nuclei	|O
principalis	|O
and	|O
oralis	|O
.	|O

Efficacy	|O
of	|O
a	|O
three	|O
-	|O
versus	|O
a	|O
five	|O
-	|O
week	|O
alcohol	|O
treatment	|O
program	|O
.	|O

Resistance	|O
to	|O
the	|O
simulated	|O
physiologic	|O
environment	|O
was	|O
tested	|O
by	|O
measured	|O
retention	|O
of	|O
mechanical	|O
properties	|O
after	|O
immersion	|O
times	|O
in	|O
pseudo	|O
-	|O
extracellular	|O
fluid	|O
(	|O
PECF	|O
)	|O
at	|O
37	|O
degrees	|O
C	|O
for	|O
as	|O
long	|O
as	|O
three	|O
years	|O
.	|O

Isolated	|O
calcaneal	|O
tuberculous	|O
osteomyelitis	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
opiate	|B-PROTEIN
receptors	|I-PROTEIN
bordering	|O
the	|O
fourth	|O
cerebral	|O
ventricle	|O
mediate	|O
the	|O
cardiovascular	|O
and	|O
hypnotic	|O
action	|O
of	|O
fentanyl	|O
.	|O

In	|O
case	|O
of	|O
a	|O
pathologically	|O
convoluted	|O
internal	|O
carotid	|O
the	|O
common	|O
carotid	|O
artery	|O
was	|O
resected	|O
with	|O
an	|O
end	|O
-	|O
to	|O
-	|O
end	|O
anastomosis	|O
.	|O

This	|O
expression	|O
assumes	|O
:	|O
(	|O
1	|O
)	|O
a	|O
laminar	|O
flow	|O
regimen	|O
during	|O
expiration	|O
,	|O
and	|O
(	|O
2	|O
)	|O
a	|O
constant	|O
CT	|O
value	|O
over	|O
the	|O
range	|O
of	|O
VT	|O
.	|O

These	|O
data	|O
confirm	|O
the	|O
existence	|O
of	|O
hyperlipemic	|O
abdominal	|O
crisis	|O
as	|O
a	|O
distinct	|O
entity	|O
and	|O
testify	|O
to	|O
the	|O
importance	|O
of	|O
recognizing	|O
this	|O
syndrome	|O
in	|O
order	|O
to	|O
avoid	|O
the	|O
occurrence	|O
of	|O
acute	|O
pancreatitis	|O
and	|O
the	|O
performance	|O
of	|O
unnecessary	|O
and	|O
potentially	|O
harmful	|O
surgery	|O
.	|O

In	|O
addition	|O
a	|O
significant	|O
Treatment	|O
X	|O
Strain	|O
interaction	|O
was	|O
due	|O
to	|O
the	|O
larger	|O
defecation	|O
numbers	|O
displayed	|O
by	|O
the	|O
taurine	|O
-	|O
injected	|O
MR	|O
rats	|O
relative	|O
to	|O
the	|O
saline	|O
-	|O
injected	|O
MR	|O
rats	|O
.	|O

Their	|O
conduction	|O
velocity	|O
ranged	|O
from	|O
0.23	|O
to	|O
0.98	|O
m	|O
/	|O
sec	|O
(	|O
group	|O
C	|O
)	|O
.	|O

The	|O
failures	|O
frequently	|O
were	|O
related	|O
to	|O
patient	|O
intolerance	|O
or	|O
poor	|O
mechanical	|O
fit	|O
and	|O
occurred	|O
in	|O
the	|O
first	|O
few	|O
days	|O
or	|O
first	|O
few	|O
months	|O
after	|O
insertion	|O
.	|O

The	|O
major	|O
urinary	|O
metabolites	|O
were	|O
3	|O
-	|O
(	|O
3	|O
-	|O
carboxyphenyl	|O
)	|O
-	|O
5	|O
-	|O
hydroxymethyl	|O
-	|O
2	|O
-	|O
oxazolidinone	|O
and	|O
a	|O
glucuronide	|O
of	|O
toloxatone	|O
.	|O

These	|O
characteristics	|O
indicated	|O
the	|O
pronounced	|O
activity	|O
of	|O
collagenous	|O
fiber	|O
synthesis	|O
and	|O
the	|O
matrix	|O
of	|O
the	|O
osteoid	|O
tissue	|O
.	|O

The	|O
ventilation	|O
did	|O
not	|O
increase	|O
when	|O
PACO2	|O
was	|O
increased	|O
.	|O

Carbohydrate	|O
metabolism	|O
and	|O
the	|O
semen	|O
profile	|O
:	|O
glucose	|O
,	|O
insulin	|B-PROTEIN
,	|O
and	|O
sperm	|O
studies	|O
.	|O

It	|O
has	|O
come	|O
out	|O
that	|O
CAEC	|O
is	|O
between	|O
CC	|O
and	|O
CIEC	|O
and	|O
that	|O
attacks	|O
of	|O
biliary	|O
fever	|O
and	|O
high	|O
levels	|O
of	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
and	|O
transaminases	|O
in	|O
the	|O
serum	|O
are	|O
the	|O
helpful	|O
findings	|O
for	|O
preoperative	|O
diagnosis	|O
.	|O

The	|O
sub	|O
-	|O
acute	|O
inhalation	|O
toxicity	|O
of	|O
furfural	|O
was	|O
studied	|O
in	|O
Syrian	|O
golden	|O
hamsters	|O
.	|O

Changes	|O
of	|O
thirtynine	|O
serum	|O
protein	|O
components	|O
following	|O
surgical	|O
stress	|O
.	|O

These	|O
differences	|O
are	|O
smaller	|O
than	|O
those	|O
described	|O
in	|O
standard	|O
textbooks	|O
.	|O

A	|O
study	|O
of	|O
the	|O
E.O.R.T.C.	|O

The	|O
present	|O
study	|O
examined	|O
the	|O
dependence	|O
of	|O
difference	|O
tone	|O
level	|O
[	|O
L	|O
(	|O
f2	|O
-	|O
f1	|O
)	|O
]	|O
on	|O
the	|O
following	|O
parameters	|O
of	|O
the	|O
two	|O
-	|O
tone	|O
input	|O
:	|O
f1	|O
,	|O
f2	|O
/	|O
f1	|O
(	|O
f2	|O
greater	|O
than	|O
f1	|O
)	|O
,	|O
L1	|O
,	|O
L2	|O
,	|O
and	|O
L1	|O
=	|O
L2	|O
.	|O

An	|O
intravenous	|O
preparation	|O
of	|O
doxycycline	|O
(	|O
DOTC	|O
,	|O
Vibramycin	|O
'	|O
Pfizer	|O
'	|O
)	|O
,	|O
a	|O
long	|O
-	|O
lasting	|O
tetracycline	|O
,	|O
was	|O
administered	|O
mainly	|O
by	|O
drip	|O
infusion	|O
for	|O
a	|O
series	|O
of	|O
study	|O
in	|O
the	|O
pediatrics	|O
field	|O
,	|O
and	|O
the	|O
results	|O
were	|O
as	|O
follows	|O
:	|O
1	|O
)	|O
DOTC	|O
(	|O
100	|O
mg	|O
)	|O
was	|O
dissolved	|O
in	|O
a	|O
100	|O
ml	|O
of	|O
glucose	|O
solution	|O
and	|O
2	|O
-	|O
-	|O
3	|O
mg	|O
/	|O
kg	|O
was	|O
administered	|O
intravenously	|O
.	|O

5	|O
)	|O
Before	|O
and	|O
ten	|O
days	|O
after	|O
DOTC	|O
infusion	|O
,	|O
laboratory	|O
tests	|O
for	|O
liver	|O
and	|O
renal	|O
functions	|O
and	|O
blood	|O
were	|O
performed	|O
.	|O

Structural	|O
characteristics	|O
of	|O
the	|O
erythrocyte	|O
membrane	|O
,	|O
peroxidation	|O
processes	|O
and	|O
antioxidant	|O
function	|O
in	|O
children	|O
with	|O
diffuse	|O
glomerulonephritis	|O

The	|O
enteric	|O
route	|O
is	|O
the	|O
principal	|O
mode	|O
of	|O
transmission	|O
for	|O
hepatitis	|O
A	|O
,	|O
but	|O
maximal	|O
levels	|O
of	|O
hepatitis	|O
A	|O
virus	|O
excretion	|O
occur	|O
before	|O
the	|O
onset	|O
of	|O
jaundice	|O
.	|O

All	|O
13	|O
patients	|O
showed	|O
endoscopic	|O
evidence	|O
of	|O
oesophagitis	|O
,	|O
moderate	|O
in	|O
4	|O
and	|O
severe	|O
in	|O
9	|O
.	|O

Urinary	|O
excretion	|O
of	|O
oestrone	|O
,	|O
oestradiol	|O
-	|O
17	|O
beta	|O
and	|O
oestriol	|O
in	|O
pregnancies	|O
complicated	|O
by	|O
steroid	|B-PROTEIN
sulphatase	|I-PROTEIN
deficiency	|O
.	|O

Both	|O
reduced	|O
spontaneous	|O
locomotor	|O
activity	|O
in	|O
mice	|O
,	|O
protected	|O
them	|O
from	|O
death	|O
from	|O
amphetamine	|O
induced	|O
toxicity	|O
,	|O
prolonged	|O
hexobarbitone	|O
sleeping	|O
time	|O
and	|O
caused	|O
a	|O
depletion	|O
of	|O
catecholamines	|O
from	|O
various	|O
organs	|O
of	|O
the	|O
rat	|O
.	|O

On	|O
the	|O
role	|O
of	|O
transferrin	|B-PROTEIN
in	|O
the	|O
uptake	|O
of	|O
gallium	|O
by	|O
tumor	|O
cells	|O
.	|O

Irradiation	|O
of	|O
human	|O
blood	|O
platelets	|O
with	|O
UV	|O
-	|O
A	|O
in	|O
vitro	|O
impairs	|O
their	|O
ability	|O
to	|O
aggregate	|O
after	|O
challenge	|O
with	|O
collagen	|B-PROTEIN
.	|O

With	|O
certain	|O
exceptions	|O
the	|O
method	|O
was	|O
considered	|O
suitable	|O
in	|O
the	|O
routine	|O
intravenous	|O
cholangiography	|O
.	|O

Following	|O
the	|O
satisfactory	|O
results	|O
and	|O
taking	|O
into	|O
account	|O
that	|O
the	|O
complications	|O
had	|O
reduced	|O
to	|O
a	|O
very	|O
low	|O
rate	|O
(	|O
in	|O
2	|O
cases	|O
lead	|O
tip	|O
displacement	|O
and	|O
pouch	|O
haematoma	|O
occurred	|O
respectively	|O
)	|O
,	|O
the	|O
Authors	|O
consider	|O
the	|O
adopted	|O
method	|O
an	|O
useful	|O
approach	|O
for	|O
PMK	|O
implantation	|O
particularly	|O
when	|O
the	|O
use	|O
of	|O
the	|O
vena	|O
cephalica	|O
is	|O
deemed	|O
impossible	|O
.	|O

When	|O
two	|O
determinations	|O
were	|O
performed	|O
on	|O
12	|O
samples	|O
of	|O
plasma	|O
taken	|O
from	|O
normal	|O
adults	|O
in	|O
October	|O
,	|O
the	|O
values	|O
were	|O
22.6	|O
+	|O
/	|O
-	|O
4.8	|O
and	|O
21.0	|O
+	|O
/	|O
-	|O
3.6	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
ng	|O
/	|O
ml	|O
,	|O
respectively	|O
.	|O

The	|O
six	|O
commonest	|O
causes	|O
of	|O
death	|O
varied	|O
in	|O
the	|O
three	|O
ethnic	|O
groups	|O
.	|O

Although	|O
Grice	|O
's	|O
operation	|O
has	|O
been	|O
used	|O
all	|O
over	|O
the	|O
world	|O
,	|O
no	|O
systematic	|O
account	|O
of	|O
it	|O
has	|O
been	|O
found	|O
in	|O
the	|O
literature	|O
(	|O
including	|O
publications	|O
dealing	|O
with	|O
technique	|O
)	|O
,	|O
which	|O
presents	|O
it	|O
in	|O
terms	|O
related	|O
to	|O
the	|O
basic	|O
"	|O
classical	|O
"	|O
principles	|O
on	|O
which	|O
the	|O
operation	|O
was	|O
conceived	|O
.	|O

(	|O
5	|O
)	|O
No	|O
changes	|O
were	|O
observed	|O
in	|O
the	|O
gastric	|O
venous	|O
blood	|O
flow	|O
by	|O
continuous	|O
intravenous	|O
injection	|O
of	|O
cimetidine	|O
,	|O
but	|O
by	|O
rapid	|O
injection	|O
both	|O
the	|O
flow	|O
was	|O
augmented	|O
and	|O
the	|O
systemic	|O
blood	|O
pressure	|O
decreased	|O
transiently	|O
.	|O

Study	|O
on	|O
re	|O
-	|O
establishment	|O
of	|O
ovulation	|O
after	|O
termination	|O
of	|O
sex	|O
-	|O
steroidal	|O
treatment	|O
-	|O
-	|O
compared	|O
with	|O
re	|O
-	|O
appearance	|O
of	|O
ovulation	|O
after	|O
abortion	|O
and	|O
premature	|O
delivery	|O
.	|O

Pharmacokinetics	|O
of	|O
Carbamazepine	|O
in	|O
man	|O
:	|O
a	|O
review	|O
.	|O

Of	|O
the	|O
compounds	|O
tested	|O
,	|O
alpha	|O
-	|O
(	|O
3	|O
-	|O
methyl	|O
-	|O
2	|O
-	|O
quinoxalinyl	|O
)	|O
-	|O
N	|O
-	|O
methylnitrone	|O
1,4	|O
-	|O
dioxide	|O
(	|O
2	|O
)	|O
was	|O
the	|O
most	|O
active	|O
agent	|O
in	|O
vivo	|O
against	|O
the	|O
gram	|O
-	|O
negative	|O
and	|O
the	|O
gram	|O
-	|O
positive	|O
organisms	|O
.	|O

Changes	|O
in	|O
ionic	|O
content	|O
of	|O
the	|O
mucous	|O
suggest	|O
that	|O
cholinergic	|O
mechanisms	|O
affect	|O
pressure	|O
in	|O
the	|O
excretory	|O
duct	|O
of	|O
the	|O
gland	|O
.	|O

Calves	|O
fed	|O
MCT	|O
-	|O
milk	|O
had	|O
significantly	|O
lower	|O
blood	|O
cholesterol	|O
than	|O
calves	|O
fed	|O
T	|O
-	|O
or	|O
SBO	|O
-	|O
milk	|O
.	|O

Delayed	|O
mortality	|O
of	|O
mice	|O
following	|O
inhalation	|O
of	|O
acute	|O
doses	|O
of	|O
CH2O	|O
,	|O
SO2Cl2	|O
,	|O
and	|O
Br2	|O
.	|O

Guinea	|O
pigs	|O
weighing	|O
300	|O
approximately	|O
350	|O
g	|O
were	|O
used	|O
.	|O

Under	|O
halothane	|O
anesthesia	|O
,	|O
the	|O
flow	|O
pneumocardiogram	|O
(	|O
PnCG	|O
)	|O
and	|O
its	|O
time	|O
derivative	|O
(	|O
acceleration	|O
pneumocardiogram	|O
or	|O
dPn	|O
/	|O
dt	|O
)	|O
were	|O
transduced	|O
during	|O
apnea	|O
by	|O
a	|O
small	|O
high	|O
-	|O
gain	|O
pneumotachograph	|O
.	|O

Sensory	|O
kindling	|O
:	|O
implications	|O
for	|O
development	|O
of	|O
sensory	|O
prostheses	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
stereotypy	|O
can	|O
be	|O
evoked	|O
also	|O
in	|O
the	|O
case	|O
when	|O
the	|O
striatal	|O
dopaminergic	|O
tone	|O
is	|O
normal	|O
or	|O
even	|O
below	|O
normal	|O
:	|O
it	|O
is	|O
the	|O
equilibrium	|O
of	|O
the	|O
striatal	|O
cholinergic	|O
-	|O
dopaminergic	|O
systems	|O
which	|O
must	|O
be	|O
shifted	|O
towards	|O
dopamine	|O
,	|O
which	|O
is	|O
necessary	|O
for	|O
the	|O
development	|O
of	|O
this	|O
behavioral	|O
manifestation	|O
.	|O

None	|O
of	|O
the	|O
cystometrograms	|O
showed	|O
uninhibited	|O
detrusor	|O
contractions	|O
.	|O

In	|O
the	|O
duodenum	|O
a	|O
small	|O
part	|O
of	|O
the	|O
administered	|O
dose	|O
was	|O
transformed	|O
to	|O
3H	|O
-	|O
alpha	|O
-	|O
acetyldigoxin	|O
.	|O

Functional	|O
effects	|O
following	|O
subacute	|O
administration	|O
.	|O

Treatment	|O
of	|O
Graves	|O
'	|O
disease	|O
.	|O

Although	|O
it	|O
has	|O
been	|O
shown	|O
that	|O
it	|O
is	|O
possible	|O
to	|O
use	|O
orally	|O
administered	|O
testosterone	|O
to	|O
maintain	|O
se	|O
-	|O
T	|O
levels	|O
in	|O
the	|O
normal	|O
male	|O
range	|O
,	|O
the	|O
convenience	|O
to	|O
the	|O
patient	|O
must	|O
be	|O
balanced	|O
against	|O
the	|O
cost	|O
and	|O
possible	|O
side	|O
effects	|O
of	|O
the	|O
large	|O
doses	|O
required	|O
.	|O

Contrary	|O
to	|O
1,8	|O
-	|O
dihydroxy	|O
-	|O
9	|O
-	|O
anthrone	|O
,	|O
1,8,9	|O
-	|O
triacetoxyanthracene	|O
and	|O
1,8	|O
-	|O
diacetoxy	|O
-	|O
9	|O
-	|O
anthrone	|O
are	|O
effective	|O
against	|O
psoriatic	|O
lesions	|O
without	|O
accompanying	|O
inflammations	|O
of	|O
the	|O
skin	|O
.	|O

Etiopathogenetic	|O
and	|O
therapeutic	|O
problems	|O
in	|O
acute	|O
orbital	|O
inflammation	|O

Nursing	|O
of	|O
patients	|O
with	|O
gynecological	|O
diseases	|O

We	|O
measured	|O
basal	|O
plasma	|O
prolactin	|B-PROTEIN
concentrations	|O
(	|O
in	|O
samples	|O
obtained	|O
during	|O
the	|O
early	|O
follicular	|O
phase	|O
)	|O
in	|O
25	|O
normal	|O
(	|O
control	|O
)	|O
women	|O
and	|O
in	|O
a	|O
similar	|O
group	|O
of	|O
40	|O
patients	|O
with	|O
a	|O
long	|O
-	|O
standing	|O
history	|O
of	|O
infertility	|O
.	|O

Ovarian	|O
allotransplantation	|O
in	|O
human	|O
.	|O

Allergic	|O
reaction	|O
to	|O
Patent	|O
Blue	|O
Violet	|O
during	|O
lymphography	|O
.	|O

Screening	|O
of	|O
asthma	|O
patients	|O
by	|O
determination	|O
of	|O
IgE	|B-PROTEIN
and	|O
by	|O
comprehension	|O
of	|O
spectrum	|O
of	|O
allergospecific	|O
IgE	|B-PROTEIN
antibodies	|O

The	|O
induction	|O
of	|O
seizures	|O
in	|O
"	|O
Papio	|O
papio	|O
"	|O
following	|O
allylglycine	|O
alone	|O
or	|O
in	|O
combination	|O
with	|O
intermittent	|O
photic	|O
stimulation	|O

A	|O
highly	|O
significant	|O
correlation	|O
was	|O
found	|O
between	|O
the	|O
presence	|O
of	|O
fibrinolytic	|O
degradation	|O
products	|O
(	|O
FDP	|O
)	|O
and	|O
the	|O
incidence	|O
of	|O
nephropathy	|O
and	|O
renal	|O
insufficiency	|O
,	|O
as	|O
well	|O
as	|O
between	|O
the	|O
presence	|O
of	|O
fibrin	|B-PROTEIN
monomers	|O
(	|O
Godal	|O
's	|O
ethanol	|O
-	|O
gelification	|O
test	|O
)	|O
and	|O
the	|O
evolutive	|O
signs	|O
of	|O
the	|O
primary	|O
disease	|O
(	|O
fever	|O
,	|O
accelerated	|O
ESR	|O
)	|O
.	|O

One	|O
-	|O
third	|O
of	|O
the	|O
men	|O
with	|O
azoospermia	|O
and	|O
with	|O
sperm	|O
density	|O
of	|O
less	|O
than	|O
10	|O
million	|O
had	|O
marked	|O
FSH	|B-PROTEIN
elevation	|O
and	|O
our	|O
experience	|O
confirms	|O
the	|O
work	|O
of	|O
others	|O
that	|O
this	|O
indicates	|O
a	|O
poor	|O
prognosis	|O
.	|O

In	|O
girls	|O
prolactin	|B-PROTEIN
levels	|O
rise	|O
at	|O
stage	|O
2	|O
,	|O
and	|O
are	|O
higher	|O
after	|O
menarche	|O
;	|O
in	|O
boys	|O
there	|O
is	|O
no	|O
change	|O
in	|O
prolactin	|B-PROTEIN
levels	|O
.	|O

It	|O
was	|O
concluded	|O
that	|O
both	|O
of	|O
these	|O
surgical	|O
procedures	|O
were	|O
as	|O
effective	|O
as	|O
pinealectomy	|O
in	|O
reversing	|O
the	|O
pineal	|O
-	|O
induced	|O
alterations	|O
in	|O
the	|O
reproductive	|O
physiology	|O
of	|O
the	|O
blind	|O
-	|O
anosmic	|O
female	|O
rat	|O
.	|O

2	|O
cases	|O
of	|O
toxic	|O
lymphomononucleosis	|O

Such	|O
an	|O
hemoglobin	|B-PROTEIN
solution	|O
was	|O
shown	|O
to	|O
exhibit	|O
a	|O
high	|O
affinity	|O
for	|O
oxygen	|O
and	|O
a	|O
low	|O
Bohr	|O
effect	|O
(	|O
assessed	|O
from	|O
the	|O
delta	|O
log	|O
Po2	|O
/	|O
delta	|O
pH	|O
ratio	|O
)	|O
.	|O

A	|O
one	|O
-	|O
week	|O
ulcer	|O
therapy	|O
with	|O
atropine	|O
and	|O
Vikalin	|O
(	|O
Roter	|O
)	|O
led	|O
to	|O
a	|O
significant	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
reduction	|O
of	|O
the	|O
nocturnal	|O
proteolytic	|O
activity	|O
.	|O

In	|O
one	|O
patient	|O
with	|O
severe	|O
diarrhea	|O
the	|O
estriol	|O
concentration	|O
in	|O
serum	|O
was	|O
low	|O
until	|O
the	|O
intestinal	|O
function	|O
normalised	|O
and	|O
the	|O
estriol	|O
concentration	|O
went	|O
up	|O
exactly	|O
when	|O
the	|O
diarrhea	|O
stopped	|O
.	|O

Serum	|O
levels	|O
of	|O
IgG	|B-PROTEIN
and	|O
IgM	|B-PROTEIN
were	|O
also	|O
raised	|O
,	|O
but	|O
contrary	|O
to	|O
the	|O
findings	|O
of	|O
other	|O
observers	|O
IgA	|B-PROTEIN
levels	|O
were	|O
normal	|O
.	|O

Experimental	|O
ischemic	|O
heart	|O
disease	|O
induced	|O
by	|O
thromboxane	|O
A2	|O
in	|O
rabbits	|O
.	|O

Vitrectomy	|O
in	|O
ocular	|O
traumatology	|O

To	|O
study	|O
the	|O
sensitivity	|O
of	|O
some	|O
central	|O
brain	|O
structures	|O
to	|O
the	|O
action	|O
of	|O
an	|O
electromagnetic	|O
field	|O
of	|O
decimeter	|O
waves	|O
(	|O
EMF	|O
of	|O
DW	|O
)	|O
a	|O
dynamic	|O
investigation	|O
of	|O
single	|O
unit	|O
activity	|O
was	|O
undertaken	|O
.	|O

No	|O
systematic	|O
L	|O
-	|O
R	|O
differences	|O
were	|O
observed	|O
.	|O

A	|O
decrease	|O
of	|O
the	|O
lysozyme	|B-PROTEIN
activity	|O
coincided	|O
with	|O
the	|O
clinical	|O
improvement	|O
of	|O
the	|O
bacterial	|O
meningitis	|O
.	|O

This	|O
implies	|O
that	|O
the	|O
groups	|O
do	|O
not	|O
just	|O
differ	|O
along	|O
one	|O
dimension	|O
,	|O
but	|O
along	|O
three	|O
dimensions	|O
.	|O

Deep	|O
tans	|O
were	|O
induced	|O
over	|O
the	|O
backs	|O
of	|O
volunteers	|O
with	|O
repeated	|O
exposure	|O
to	|O
longwave	|O
ultraviolet	|O
radiation	|O
(	|O
UV	|O
-	|O
A	|O
)	|O
.	|O

1	|O
The	|O
effects	|O
in	|O
normal	|O
subjects	|O
of	|O
a	|O
single	|O
oral	|O
dose	|O
of	|O
Motival	|O
(	|O
one	|O
tablet	|O
,	|O
containing	|O
fluphenazine	|O
0.5	|O
mg	|O
and	|O
nortriptyline	|O
10	|O
mg	|O
)	|O
on	|O
the	|O
contingent	|O
negative	|O
variation	|O
(	|O
CNV	|O
)	|O
,	|O
reaction	|O
time	|O
,	|O
heart	|O
rate	|O
,	|O
blood	|O
pressure	|O
and	|O
self	|O
-	|O
rating	|O
scales	|O
for	|O
alertness	|O
,	|O
anxiety	|O
,	|O
tension	|O
,	|O
detachment	|O
and	|O
depression	|O
were	|O
compared	|O
with	|O
those	|O
of	|O
diazepam	|O
(	|O
5	|O
mg	|O
and	|O
7.5	|O
mg	|O
)	|O
and	|O
placebo	|O
or	|O
propranolol	|O
(	|O
60	|O
mg	|O
)	|O
.	|O

Stress	|O
effects	|O
on	|O
affiliation	|O
preferences	|O
among	|O
subjects	|O
possessing	|O
the	|O
type	|O
A	|O
coronary	|O
-	|O
prone	|O
behavior	|O
pattern	|O
.	|O

These	|O
show	|O
that	|O
the	|O
collagen	|B-PROTEIN
in	|O
this	|O
tissue	|O
is	|O
modified	|O
compared	|O
with	|O
that	|O
in	|O
tendon	|O
.	|O

Smoking	|O
was	|O
regarded	|O
as	|O
the	|O
major	|O
contribution	|O
to	|O
pulmonary	|O
dysfunction	|O
.	|O

The	|O
malignity	|O
of	|O
nevoid	|O
lentigo	|O
.	|O

Elimination	|O
of	|O
bagassosis	|O
in	|O
Louisiana	|O
paper	|O
manufacturing	|O
plant	|O
workers	|O
.	|O

These	|O
responses	|O
were	|O
compared	|O
with	|O
others	|O
in	|O
the	|O
same	|O
subjects	|O
under	|O
the	|O
same	|O
conditions	|O
and	|O
it	|O
was	|O
concluded	|O
that	|O
the	|O
antihypertensive	|O
effect	|O
of	|O
labetalol	|O
is	|O
explained	|O
by	|O
concurrent	|O
blockade	|O
of	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
adrenoceptors	|I-PROTEIN
.	|O

Diuretics	|O
:	|O
basic	|O
clinical	|O
pharmacology	|O
and	|O
therapeutic	|O
use	|O
.	|O

Three	|O
patients	|O
with	|O
four	|O
renoureteral	|O
units	|O
have	|O
undergone	|O
single	|O
-	|O
stage	|O
reconstruction	|O
involving	|O
ureteroureterostomy	|O
and	|O
ipsilateral	|O
ureteroneocystostomy	|O
following	|O
temporary	|O
loop	|O
cutaneous	|O
ureterostomy	|O
.	|O

Evaluation	|O
of	|O
the	|O
Du	|O
Pont	|O
aca	|O
ammonia	|O
procedure	|O
.	|O

Internally	|O
oriented	|O
patients	|O
'	|O
scores	|O
on	|O
Rotter	|O
's	|O
Internal	|O
-	|O
External	|O
Locus	|O
of	|O
Control	|O
Scale	|O
remained	|O
the	|O
same	|O
over	|O
treatment	|O
but	|O
those	|O
of	|O
externally	|O
oriented	|O
patients	|O
shifted	|O
toward	|O
greater	|O
internal	|O
control	|O
.	|O

Action	|O
of	|O
strontium	|O
-	|O
90	|O
and	|O
metaphos	|O
on	|O
Cyprinus	|O
carpio	|O

Kodak	|O
XV	|O
-	|O
2	|O
film	|O
is	|O
wrapped	|O
around	|O
a	|O
cylindrical	|O
water	|O
-	|O
filled	|O
phantom	|O
and	|O
the	|O
dose	|O
distribution	|O
is	|O
recorded	|O
.	|O

Diagnosis	|O
and	|O
differential	|O
diagnosis	|O

The	|O
multiple	|O
factors	|O
affecting	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
in	|O
essential	|O
hypertension	|O
.	|O

Cortisone	|O
induced	|O
bone	|O
changes	|O
and	|O
its	|O
response	|O
to	|O
lipid	|O
clearing	|O
agents	|O
.	|O

2	|O
)	|O
The	|O
time	|O
-	|O
sharing	|O
principle	|O
was	|O
applied	|O
to	|O
gain	|O
high	|O
stability	|O
.	|O

When	|O
blood	|O
samples	|O
of	|O
patients	|O
with	|O
hyperbilirubinemia	|O
were	|O
analyzed	|O
,	|O
direct	|O
measurement	|O
of	|O
ZPP	|O
by	|O
this	|O
fluorimeter	|O
yielded	|O
significantly	|O
higher	|O
levels	|O
than	|O
did	|O
an	|O
alternate	|O
extraction	|O
method	|O
.	|O

Delayed	|O
hypersensitivity	|O
in	|O
man	|O
:	|O
effects	|O
of	|O
systemic	|O
anticoagulation	|O
.	|O

In	|O
three	|O
of	|O
the	|O
seven	|O
,	|O
inhalation	|O
of	|O
2	|O
ml	|O
normal	|O
saline	|O
produced	|O
FEV1	|O
falls	|O
of	|O
25%	|O
to	|O
30%	|O
,	|O
but	|O
these	|O
falls	|O
were	|O
not	|O
as	|O
great	|O
as	|O
each	|O
subject	|O
's	|O
reactions	|O
to	|O
the	|O
test	|O
solutions	|O
.	|O

Experimental	|O
studies	|O
on	|O
virus	|O
excretion	|O
and	|O
non	|O
-	|O
arthropod	|O
transmission	|O
.	|O

Potency	|O
of	|O
enflurane	|O
in	|O
dogs	|O
:	|O
comparison	|O
with	|O
halothane	|O
and	|O
isoflurane	|O
.	|O

Prevention	|O
of	|O
acute	|O
paraquat	|O
toxicity	|O
in	|O
rats	|O
by	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
.	|O

Measurement	|O
of	|O
magnesium	|O
absorption	|O
in	|O
man	|O
using	|O
stable	|O
26Mg	|O
as	|O
a	|O
tracer	|O
.	|O

Increased	|O
urinary	|O
riboflavin	|O
excretion	|O
resulting	|O
from	|O
boric	|O
acid	|O
ingestion	|O
.	|O

Radionuclide	|O
angiography	|O
and	|O
static	|O
whole	|O
body	|O
imaging	|O
performed	|O
with	|O
technetium	|O
-	|O
99m	|O
-	|O
labeled	|O
particulates	|O
can	|O
clearly	|O
demonstrate	|O
differential	|O
shunting	|O
in	|O
patients	|O
with	|O
patent	|O
ductus	|O
arteriosus	|O
(	|O
PDA	|O
)	|O
with	|O
Eisenmenger	|O
physiology	|O
.	|O

Looming	|O
detectors	|O
in	|O
the	|O
human	|O
visual	|O
pathway	|O
.	|O

Escherichia	|O
of	|O
a	|O
single	|O
sero	|O
-	|O
anzymatic	|O
type	|O
(	|O
06a6b	|O
:	|O
K13	|O
:	|O
H1	|O
)	|O
were	|O
isolated	|O
in	|O
a	|O
group	|O
affection	|O
.	|O

The	|O
method	|O
described	|O
may	|O
prove	|O
useful	|O
in	|O
studying	|O
the	|O
physiology	|O
of	|O
the	|O
nasal	|O
cycle	|O
.	|O

At	|O
the	|O
same	|O
time	|O
we	|O
obtained	|O
easily	|O
understandable	|O
EEG	|O
-	|O
information	|O
which	|O
has	|O
never	|O
previously	|O
been	|O
available	|O
to	|O
us	|O
.	|O

Analysis	|O
of	|O
liver	|O
biopsy	|O
specimens	|O
from	|O
patients	|O
with	|O
hepatitis	|O
showed	|O
a	|O
large	|O
variation	|O
in	|O
the	|O
mean	|O
iron	|O
content	|O
of	|O
the	|O
liver	|O
ferritin	|B-PROTEIN
molecules	|O
.	|O

Female	|O
mice	|O
were	|O
significantly	|O
more	|O
resistant	|O
to	|O
infection	|O
than	|O
males	|O
.	|O

During	|O
the	|O
following	|O
9	|O
1/2	|O
years	|O
three	|O
sequential	|O
liver	|O
biopsies	|O
were	|O
performed	|O
.	|O

Angiotensin	|B-PROTEIN
effect	|O
in	|O
the	|O
human	|O
kidney	|O
.	|O

Procion	|O
yellow	|O
dye	|O
was	|O
injected	|O
intracellularly	|O
into	|O
large	|O
auditory	|O
fibers	|O
of	|O
goldfish	|O
to	|O
investigate	|O
the	|O
relationship	|O
between	|O
the	|O
response	|O
type	|O
of	|O
these	|O
fibers	|O
and	|O
their	|O
site	|O
of	|O
termination	|O
in	|O
the	|O
saccular	|O
macula	|O
.	|O

Incidental	|O
findings	|O
in	|O
the	|O
epidermis	|O
and	|O
in	|O
the	|O
intraepidermal	|O
eccrine	|O
sweat	|O
duct	|O
units	|O
.	|O

Silicosis	|O
mortality	|O

These	|O
consisted	|O
of	|O
beading	|O
and	|O
strictures	|O
mainly	|O
of	|O
the	|O
intrahepatic	|O
biliary	|O
tree	|O
(	|O
IHB	|O
)	|O
.	|O

Pentane	|O
and	|O
ethane	|O
,	|O
which	|O
arise	|O
during	|O
lipid	|O
peroxidation	|O
in	|O
vivo	|O
,	|O
were	|O
measured	|O
by	|O
gas	|O
chromatography	|O
in	|O
breath	|O
samples	|O
of	|O
rats	|O
fed	|O
for	|O
8	|O
weeks	|O
a	|O
vitamin	|O
E	|O
-	|O
deficient	|O
diet	|O
to	|O
which	|O
had	|O
been	|O
added	|O
0	|O
,	|O
11	|O
,	|O
or	|O
40	|O
IU	|O
vitamin	|O
E	|O
acetate	|O
per	|O
kg	|O
.	|O

Thromboplastic	|O
and	|O
fibrynolytic	|O
activity	|O
of	|O
the	|O
blood	|O
after	|O
administration	|O
of	|O
intralipid	|O
in	|O
men	|O
with	|O
history	|O
of	|O
myocardial	|O
infarction	|O
up	|O
to	|O
45	|O
year	|O
of	|O
life	|O

The	|O
authors	|O
report	|O
the	|O
clinicopathologic	|O
findings	|O
in	|O
four	|O
cases	|O
of	|O
adult	|O
women	|O
with	|O
rhabdomyosarcomas	|O
that	|O
originated	|O
in	|O
the	|O
endometrium	|O
or	|O
cervix	|O
,	|O
or	|O
both	|O
.	|O

The	|O
effect	|O
of	|O
pure	|O
natural	|O
porcine	|O
secretin	|B-PROTEIN
on	|O
endocrine	|O
and	|O
exocrine	|O
pancreatic	|O
secretion	|O
was	|O
studied	|O
in	|O
the	|O
totally	|O
isolated	|O
perfused	|O
porcine	|O
pancreas	|O
.	|O

Biometric	|O
analysis	|O
of	|O
intraocular	|O
lens	|O
power	|O
required	|O
to	|O
produce	|O
emmetropia	|O
:	|O
results	|O
of	|O
450	|O
implants	|O
.	|O

Urine	|O
antibodies	|O
could	|O
not	|O
be	|O
demonstrated	|O
in	|O
any	|O
other	|O
cases	|O
.	|O

Althoug	|O
RBF	|O
tended	|O
to	|O
increase	|O
after	|O
the	|O
therapy	|O
,	|O
there	|O
was	|O
no	|O
statistically	|O
significant	|O
change	|O
in	|O
RBF	|O
,	|O
GFR	|O
and	|O
cardiac	|O
output	|O
.	|O

99mTc	|O
phytate	|O
,	|O
198Au	|O
colloid	|O
,	|O
and	|O
99mTc	|O
antimony	|O
sulfide	|O
have	|O
been	|O
used	|O
;	|O
the	|O
last	|O
appears	|O
to	|O
have	|O
been	|O
the	|O
most	|O
satisfactory	|O
.	|O

Six	|O
patients	|O
with	|O
glomerulonephritis	|O
in	|O
association	|O
with	|O
a	|O
ventriculovascular	|O
shunt	|O
were	|O
treated	|O
with	|O
three	|O
basic	|O
modes	|O
of	|O
therapy	|O
.	|O

The	|O
mass	|O
of	|O
UO2	|O
in	|O
the	|O
extrapulmonary	|O
bronchi	|O
and	|O
first	|O
bifurcation	|O
decreased	|O
more	|O
slowly	|O
over	|O
0	|O
-	|O
-	|O
8	|O
d	|O
after	|O
inhalation	|O
than	|O
the	|O
corresponding	|O
mass	|O
on	|O
the	|O
trachea	|O
.	|O

Synovial	|O
cysts	|O
of	|O
the	|O
hip	|O
joint	|O

A	|O
suspected	|O
hypothalamic	|O
dysfunction	|O
and	|O
a	|O
slightly	|O
impaired	|O
pituitary	|O
function	|O
manifested	|O
as	|O
GH	|B-PROTEIN
deficiency	|O
were	|O
their	|O
common	|O
endocrinological	|O
features	|O
.	|O

A	|O
sharp	|O
outbreak	|O
of	|O
influenza	|O
A	|O
occurred	|O
on	|O
the	|O
base	|O
during	|O
February	|O
that	|O
was	|O
due	|O
to	|O
an	|O
A	|O
/	|O
Texas	|O
/	|O
1/77	|O
-	|O
like	|O
virus	|O
,	|O
a	|O
variant	|O
of	|O
the	|O
A	|O
/	|O
Victoria	|O
/	|O
3/75	|O
prototpye	|O
.	|O

Because	|O
decreases	|O
in	|O
the	|O
disfluency	|O
rates	|O
of	|O
stutterers	|O
were	|O
observed	|O
during	|O
the	|O
presentation	|O
of	|O
all	|O
three	|O
stimulus	|O
words	|O
,	|O
the	|O
data	|O
failed	|O
to	|O
support	|O
the	|O
operant	|O
model	|O
.	|O

Effect	|O
of	|O
time	|O
and	|O
dose	|O
on	|O
alterations	|O
following	|O
inhalation	|O
of	|O
plutonium	|O
-	|O
239	|O
dioxide	|O
aerosol	|O
in	|O
rat	|O
.	|O

In	|O
biopsies	|O
CK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
fraction	|O
of	|O
total	|O
myocardial	|O
CPK	|B-PROTEIN
was	|O
37%	|O
,	|O
the	|O
total	|B-PROTEIN
-	|I-PROTEIN
CPK	|I-PROTEIN
activity	|O
of	|O
human	|O
skeletal	|O
muscles	|O
still	|O
shows	|O
a	|O
5%	|O
fraction	|O
of	|O
CK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
.	|O

Value	|O
of	|O
determination	|O
of	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
isoenzymes	|O
for	|O
differential	|O
diagnosis	|O
of	|O
obstructive	|O
jaundice	|O
and	|O
biliary	|O
liver	|O
cirrhosis	|O

A	|O
one	|O
-	|O
way	|O
analysis	|O
of	|O
variance	|O
,	|O
performed	|O
separately	|O
for	|O
men	|O
and	|O
women	|O
for	|O
differences	|O
among	|O
the	|O
three	|O
phobic	|O
groups	|O
on	|O
field	|O
dependence	|O
,	|O
showed	|O
significance	|O
(	|O
rho	|O
less	|O
than	|O
.05	|O
)	|O
for	|O
the	|O
females	|O
,	|O
with	|O
the	|O
famale	|O
agoraphobic	|O
being	|O
more	|O
field	|O
dependent	|O
than	|O
the	|O
female	|O
simple	|O
phobic	|O
groups	|O
,	|O
but	|O
not	|O
for	|O
the	|O
males	|O
.	|O

Several	|O
free	|O
2nd	|O
-	|O
generation	|O
schizonts	|O
,	|O
which	|O
varied	|O
in	|O
diameter	|O
from	|O
11	|O
to	|O
21.6	|O
micrometer	|O
,	|O
were	|O
found	|O
on	|O
the	|O
epithelial	|O
surface	|O
of	|O
the	|O
cecum	|O
.	|O

The	|O
calculated	|O
pD2	|O
values	|O
were	|O
8.8	|O
for	|O
E	|O
,	|O
8.6	|O
for	|O
DHE	|O
and	|O
6.6	|O
for	|O
M.	|O

Newcastle	|O
disease	|O
virus	|O
surveillance	|O
in	|O
Hong	|O
Kong	|O
on	|O
local	|O
and	|O
imported	|O
poultry	|O
.	|O

It	|O
was	|O
postulated	|O
that	|O
persistent	|O
challenge	|O
by	|O
M.	|O
leprae	|O
or	|O
its	|O
antigens	|O
to	|O
the	|O
IgA	|B-PROTEIN
immunocytes	|O
of	|O
the	|O
intestinal	|O
epithelium	|O
might	|O
have	|O
induced	|O
tolerance	|O
leading	|O
to	|O
IgA	|B-PROTEIN
deficiency	|O
and	|O
subsequent	|O
subtotal	|O
atrophy	|O
of	|O
the	|O
intestinal	|O
villi	|O
in	|O
the	|O
patients	|O
with	|O
lepromatous	|O
leprosy	|O
.	|O

Treatment	|O
of	|O
hypertension	|O
with	|O
a	|O
combination	|O
of	|O
the	|O
adrenergic	|B-PROTEIN
beta	|I-PROTEIN
receptor	|I-PROTEIN
blockader	|O
,	|O
obsidan	|O
,	|O
and	|O
the	|O
vasodilator	|O
,	|O
apressin	|O

Orthop	|O
.	|O

Thyroid	|O
disease	|O
and	|O
pregnancy	|O
.	|O

Residues	|O
removed	|O
from	|O
transcripts	|O
by	|O
splicing	|O
were	|O
identified	|O
.	|O

To	|O
minimize	|O
reflux	|O
into	|O
the	|O
blind	|O
loop	|O
,	|O
a	|O
number	|O
of	|O
technical	|O
steps	|O
are	|O
considered	|O
indispensable	|O
:	|O
1	|O
)	|O
fluted	|O
section	|O
of	|O
the	|O
jejunal	|O
stump	|O
;	|O
2	|O
)	|O
isoperistaltic	|O
construction	|O
of	|O
the	|O
anastomosis	|O
and	|O
,	|O
particularly	|O
,	|O
3	|O
)	|O
the	|O
creation	|O
of	|O
a	|O
single	|O
or	|O
double	|O
valve	|O
system	|O
upstream	|O
from	|O
the	|O
anastomosis	|O
by	|O
spiral	|O
introflexion	|O
of	|O
the	|O
mucosa	|O
using	|O
seroserous	|O
stitches	|O
parallel	|O
and	|O
perpendicular	|O
to	|O
the	|O
ileal	|O
lumen	|O
.	|O

At	|O
this	|O
stage	|O
,	|O
the	|O
eventual	|O
high	|O
mortality	|O
of	|O
acute	|O
ischemia	|O
is	|O
established	|O
whatever	|O
the	|O
urgency	|O
of	|O
the	|O
operation	|O
or	|O
the	|O
skill	|O
with	|O
which	|O
it	|O
is	|O
performed	|O
.	|O

Pathogens	|O
(	|O
Staphylococcus	|O
aureus	|O
or	|O
Gram	|O
-	|O
negative	|O
bacilli	|O
)	|O
were	|O
isolated	|O
from	|O
only	|O
one	|O
member	|O
of	|O
staff	|O
in	|O
small	|O
numbers	|O
and	|O
irregularly	|O
and	|O
rarely	|O
in	|O
large	|O
numbers	|O
from	|O
patients	|O
.	|O

The	|O
histochemistry	|O
and	|O
ultrastructure	|O
of	|O
calcified	|O
cerebellar	|O
deposits	|O
described	|O
by	|O
Tonge	|O
et	|O
al.	|O

A	|O
36	|O
year	|O
-	|O
old	|O
woman	|O
was	|O
given	|O
Ergotamine	|O
Tartrate	|O
4.5	|O
mg	|O
p.d	|O
.	|O
during	|O
seven	|O
days	|O
,	|O
after	|O
an	|O
abortion	|O
(	|O
a	|O
still	|O
birth	|O
)	|O
.	|O

Reaction	|O
times	|O
to	|O
tachistoscopically	|O
presented	|O
stimuli	|O
in	|O
diabetics	|O

Two	|O
out	|O
of	|O
five	|O
patients	|O
undergoing	|O
selective	|O
spinal	|O
arteriography	|O
developed	|O
transient	|O
neurological	|O
complications	|O
during	|O
the	|O
injection	|O
of	|O
Urografin	|O
310	|O
M.	|O

The	|O
data	|O
indicate	|O
a	|O
three	|O
-	|O
phase	|O
reaction	|O
after	|O
B1	|O
injection	|O
:	|O
Phase	|O
1	|O
-	|O
-	|O
shortly	|O
after	|O
injection	|O
there	|O
is	|O
a	|O
drop	|O
of	|O
all	|O
parameters	|O
lasting	|O
for	|O
30	|O
sec	|O
.	|O

Serum	|O
relaxin	|B-PROTEIN
levels	|O
in	|O
prostaglandin	|O
E2	|O
induced	|O
abortions	|O
.	|O

A	|O
-	|O
-	|O
A	|O
natural	|O
hydrostatic	|O
phenomenon	|O
,	|O
at	|O
the	|O
level	|O
of	|O
the	|O
ends	|O
of	|O
the	|O
plantar	|O
arcs	|O
,	|O
diffuses	|O
body	|O
weight	|O
,	|O
as	|O
PAIN	|O
plays	|O
the	|O
role	|O
of	|O
outsentry	|O
(	|O
fig	|O
.	|O
-	|O
-	|O
1	|O
)	|O
(	|O
5	|O
)	|O
;	|O
B	|O
-	|O
-	|O
Plantar	|O
perforating	|O
ulceration	|O
(	|O
PPU	|O
)	|O
is	|O
caused	|O
by	|O
a	|O
combination	|O
of	|O
INSENSITIVITY	|O
and	|O
TRAUMATIS	|O
(	|O
1	|O
)	|O
;	|O
C	|O
-	|O
-	|O
The	|O
patient	|O
reposing	|O
,	|O
as	|O
body	|O
weight	|O
(	|O
traumatism	|O
)	|O
effects	|O
disappear	|O
,	|O
cicatrization	|O
process	|O
can	|O
be	|O
easily	|O
observed	|O
;	|O
D	|O
-	|O
-	|O
PNEUMATIC	|O
INSOLE	|O
,	|O
being	|O
elastic	|O
,	|O
diffuses	|O
localized	|O
compression	|O
at	|O
the	|O
ends	|O
of	|O
the	|O
plantar	|O
arcs	|O
,	|O
reduces	|O
attrition	|O
,	|O
makes	|O
easier	|O
blood	|O
circulation	|O
,	|O
as	|O
well	|O
as	|O
cure	|O
and	|O
prophylaxis	|O
of	|O
PPU	|O
(	|O
fig	|O
.	|O
-	|O
-	|O
6	|O
)	|O
(	|O
3	|O
)	|O
.	|O

Effect	|O
of	|O
indoramin	|O
in	|O
small	|O
doses	|O
on	|O
the	|O
central	|O
vasomotor	|O
loci	|O
has	|O
been	|O
studied	|O
in	|O
chloralose	|O
anesthetized	|O
cats	|O
by	|O
localizing	|O
it	|O
to	|O
the	|O
central	|O
sites	|O
.	|O

As	|O
expected	|O
,	|O
the	|O
heparin	|O
did	|O
produce	|O
increased	|O
recalcification	|O
times	|O
and	|O
the	|O
development	|O
of	|O
occasional	|O
subcutaneous	|O
hematomas	|O
.	|O

Contingency	|O
contracting	|O
between	|O
clients	|O
and	|O
their	|O
parents	|O
/	|O
caregivers	|O
was	|O
used	|O
to	|O
specify	|O
consequences	|O
for	|O
daily	|O
self	|O
-	|O
monitoring	|O
,	|O
reduced	|O
caloric	|O
intake	|O
,	|O
weight	|O
loss	|O
,	|O
and	|O
exercise	|O
.	|O

Dietetics	|O
of	|O
childhood	|O
-	|O
and	|O
juvenile	|O
diabetes	|O

The	|O
results	|O
of	|O
a	|O
quantitative	|O
study	|O
of	|O
vasculosyncytial	|O
membranes	|O
in	|O
123	|O
placentas	|O
are	|O
presented	|O
.	|O

The	|O
micromethod	|O
uses	|O
microcuvettes	|O
and	|O
substitutes	|O
ferrozine	|O
for	|O
the	|O
bathophenanthroline	|O
chromogen	|O
of	|O
the	|O
ICSH	|O
.	|O

Platelet	|O
serotonin	|O
(	|O
5	|O
-	|O
HT	|O
)	|O
and	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT	|I-PROTEIN
releasing	|I-PROTEIN
factor	|I-PROTEIN
in	|O
plasma	|O
of	|O
migrainous	|O
patients	|O
.	|O

The	|O
overall	|O
incidence	|O
of	|O
SIDS	|O
was	|O
1.43	|O
per	|O
1,000	|O
live	|O
births	|O
.	|O

The	|O
vigilance	|O
task	|O
and	|O
the	|O
measurement	|O
of	|O
attentional	|O
deficits	|O
.	|O

The	|O
December	|O
armed	|O
revolt	|O
in	|O
Moscow	|O
and	|O
the	|O
paramedical	|O
personnel	|O

Significant	|O
increases	|O
in	|O
mean	|O
serum	|O
E2	|O
concentration	|O
(	|O
100	|O
to	|O
150	|O
pg	|O
/	|O
ml	|O
)	|O
were	|O
noted	|O
at	|O
6	|O
and	|O
8	|O
hours	|O
after	|O
administration	|O
on	|O
day	|O
1	|O
and	|O
at	|O
8	|O
hours	|O
on	|O
day	|O
4	|O
.	|O

The	|O
motor	|O
unit	|O
viewed	|O
from	|O
above	|O
.	|O

Avian	|O
reproductive	|O
system	|O
:	|O
daily	|O
variations	|O
in	|O
responses	|O
to	|O
hormones	|O
.	|O

Biological	|O
properties	|O
of	|O
sumithion	|O
.	|O

Serological	|O
studies	|O
of	|O
antibodies	|O
to	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
in	|O
infectious	|O
mononucleosis	|O

Carcinoembryonic	|B-PROTEIN
antigen	|I-PROTEIN
(	|O
CEA	|B-PROTEIN
)	|O
procedures	|O
and	|O
clinical	|O
evaluation	|O
.	|O

We	|O
remain	|O
convinced	|O
that	|O
antilymphocyte	|B-PROTEIN
globulin	|I-PROTEIN
(	|O
ALG	|B-PROTEIN
)	|O
is	|O
a	|O
potent	|O
immunosuppressive	|O
agent	|O
in	|O
humans	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
a	|O
global	|O
assessment	|O
patients	|O
showed	|O
a	|O
highly	|O
significant	|O
preference	|O
for	|O
imipramine	|O
compared	|O
with	|O
placebo	|O
as	|O
adjunctive	|O
therapy	|O
.	|O

39-47	|O
.	|O

Patients	|O
were	|O
subclassified	|O
into	|O
age	|O
-	|O
matched	|O
groups	|O
of	|O
primary	|O
untreated	|O
cancer	|O
(	|O
21	|O
)	|O
,	|O
recurrent	|O
cancer	|O
(	|O
18	|O
)	|O
,	|O
and	|O
"	|O
cured	|O
"	|O
patients	|O
who	|O
had	|O
been	|O
free	|O
of	|O
disease	|O
for	|O
at	|O
least	|O
9	|O
months	|O
(	|O
16	|O
)	|O
.	|O

Absorption	|O
varied	|O
between	|O
65	|O
and	|O
95	|O
per	|O
cent	|O
,	|O
with	|O
a	|O
mean	|O
absorption	|O
of	|O
80	|O
per	|O
cent	|O
,	|O
in	|O
both	|O
pregnant	|O
and	|O
non	|O
-	|O
pregnant	|O
subjects	|O
.	|O

Bacteriostatic	|O
and	|O
bacteriacidal	|O
activity	|O
of	|O
hydroxy	|O
-	|O
9	|O
ellipticine	|O
in	|O
vitro	|O

Advances	|O
in	|O
the	|O
management	|O
of	|O
gynecologic	|O
cancer	|O
-	|O
-	|O
radiation	|O
therapy	|O
.	|O

The	|O
clinico	|O
-	|O
pathological	|O
data	|O
from	|O
a	|O
patient	|O
with	|O
irreversible	|O
post	|O
-	|O
partum	|O
renal	|O
failure	|O
(	|O
IPRF	|O
)	|O
are	|O
presented	|O
.	|O

Personal	|O
satisfaction	|O
in	|O
nursing	|O
:	|O
an	|O
encounter	|O
with	|O
extremely	|O
hostile	|O
patients	|O

Dialyzable	|O
transfer	|B-PROTEIN
factor	|I-PROTEIN
.	|O

19-32	|O
.	|O

Rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
and	|O
antinuclear	|O
antibody	|O
tests	|O
were	|O
frequently	|O
positive	|O
,	|O
and	|O
reactions	|O
to	|O
gold	|O
therapy	|O
were	|O
more	|O
frequent	|O
than	|O
in	|O
other	|O
rheumatoid	|O
populations	|O
.	|O

The	|O
effect	|O
of	|O
hydrostatic	|O
pressure	|O
on	|O
the	|O
swimming	|O
activity	|O
of	|O
three	|O
hyponeustonic	|O
crustacea	|O
,	|O
Anomalocera	|O
patersoni	|O
,	|O
Pontella	|O
mediterranea	|O
,	|O
Labidocera	|O
wollastoni	|O

This	|O
report	|O
presents	|O
an	|O
analysis	|O
of	|O
the	|O
vocal	|O
repertoire	|O
of	|O
howler	|O
monkeys	|O
(	|O
Alouatta	|O
palliata	|O
)	|O
observed	|O
during	|O
a	|O
field	|O
study	|O
in	|O
southwestern	|O
Panama	|O
.	|O

Up	|O
to	|O
now	|O
the	|O
number	|O
of	|O
patients	|O
examined	|O
is	|O
about	|O
300	|O
,	|O
additionally	|O
6	|O
persons	|O
who	|O
underwent	|O
binephrectomy	|O
.	|O

Deflunia	|O
was	|O
well	|O
tolerated	|O
by	|O
25	|O
patients	|O
,	|O
very	|O
well	|O
tolerated	|O
by	|O
2	|O
.	|O

III	|O
.	|O

A	|O
new	|O
instrument	|O
has	|O
been	|O
designed	|O
for	|O
freeze	|O
-	|O
fracturing	|O
of	|O
biological	|O
material	|O
in	|O
ultra	|O
high	|O
vacuum	|O
.	|O

Pancreatic	|O
and	|O
biliary	|O
secretion	|O
and	|O
gastric	|O
emptying	|O
rates	|O
of	|O
a	|O
liquid	|O
test	|O
meal	|O
(	|O
LTM	|O
)	|O
were	|O
determined	|O
in	|O
normal	|O
persons	|O
,	|O
in	|O
patients	|O
with	|O
subtotal	|O
gastrectomy	|O
with	|O
gastroduodenostomy	|O
(	|O
STG	|O
-	|O
BI	|O
)	|O
or	|O
with	|O
gastrojejunostomy	|O
(	|O
STG	|O
-	|O
BII	|O
)	|O
,	|O
and	|O
in	|O
patients	|O
with	|O
truncal	|O
vagotomy	|O
and	|O
pyloroplasty	|O
(	|O
V	|O
&	|O
P	|O
)	|O
.	|O

Abnormal	|O
calcium	|O
metabolism	|O
in	|O
normocalcaemic	|O
sarcoidosis	|O
.	|O

Also	|O
,	|O
except	|O
in	|O
one	|O
patient	|O
who	|O
developed	|O
gallstones	|O
following	|O
institution	|O
of	|O
colestipol	|O
,	|O
saturation	|O
of	|O
gallbladder	|O
bile	|O
with	|O
cholesterol	|O
was	|O
not	|O
markedly	|O
increased	|O
by	|O
this	|O
drug	|O
alone	|O
.	|O

A	|O
five	|O
-	|O
phase	|O
experiment	|O
was	|O
designed	|O
to	|O
investigate	|O
(	|O
a	|O
)	|O
whether	|O
contingent	|O
music	|O
-	|O
listening	|O
would	|O
act	|O
as	|O
a	|O
reinforcer	|O
to	|O
increase	|O
arithmetic	|O
performance	|O
of	|O
EMR	|O
children	|O
and	|O
(	|O
b	|O
)	|O
whether	|O
this	|O
contingent	|O
reinforcement	|O
would	|O
affect	|O
preference	|O
for	|O
that	|O
reinforcer	|O
.	|O

The	|O
responsiveness	|O
of	|O
visual	|O
cortex	|O
(	|O
VC	|O
)	|O
and	|O
superior	|O
colliculus	|O
(	|O
SC	|O
)	|O
was	|O
simultaneously	|O
compared	|O
following	|O
conditioning	|O
"	|O
ON	|O
"	|O
or	|O
"	|O
OFF	|O
"	|O
stimulation	|O
,	|O
in	|O
the	|O
rabbit	|O
.	|O

A	|O
diagnosis	|O
of	|O
MS	|O
was	|O
made	|O
based	|O
on	|O
subtle	|O
neurologic	|O
signs	|O
,	|O
spinal	|O
fluid	|O
gamma	|B-PROTEIN
globulin	|I-PROTEIN
elevations	|O
,	|O
and	|O
abnormalities	|O
in	|O
neuropsychological	|O
testing	|O
.	|O

If	|O
,	|O
however	|O
,	|O
the	|O
mean	|O
temperature	|O
rise	|O
was	|O
higher	|O
(	|O
0.57	|O
degrees	|O
C	|O
or	|O
0.69	|O
degrees	|O
C	|O
)	|O
,	|O
such	|O
a	|O
selection	|O
practically	|O
resulted	|O
in	|O
the	|O
disappearance	|O
of	|O
'	|O
passable	|O
'	|O
qualifications	|O
in	|O
the	|O
triplet	|O
groups	|O
and	|O
a	|O
great	|O
predominance	|O
of	|O
't	|O
o	|O
be	|O
rejected	|O
'	|O
qualifications	|O
in	|O
the	|O
large	|O
groups	|O
.	|O

The	|O
elevated	|O
Viso	|O
V	|O
in	|O
the	|O
RDS	|O
group	|O
suggests	|O
an	|O
increase	|O
in	|O
small	|O
airway	|O
resistance	|O
secondary	|O
to	|O
the	|O
disease	|O
or	|O
to	|O
its	|O
therapy	|O
.	|O

The	|O
psychological	|O
tests	|O
consisted	|O
of	|O
a	|O
free	|O
-	|O
recall	|O
task	|O
,	|O
a	|O
test	|O
for	|O
visuomotor	|O
coordination	|O
and	|O
a	|O
recognition	|O
task	|O
.	|O

Selective	|O
bronchial	|O
intubation	|O
in	|O
the	|O
management	|O
of	|O
unilateral	|O
pulmonary	|O
interstitial	|O
emphysema	|O
.	|O

The	|O
background	|O
processes	|O
depending	|O
on	|O
the	|O
etiological	|O
factor	|O
and	|O
the	|O
character	|O
of	|O
lesion	|O
of	|O
the	|O
epithelium	|O
are	|O
divided	|O
into	|O
dyshormonal	|O
,	|O
inflammatory	|O
,	|O
and	|O
posttraumatic	|O
.	|O

The	|O
sense	|O
of	|O
self	|O
.	|O

Eleven	|O
strains	|O
of	|O
Fusarium	|O
poae	|O
and	|O
F.	|O
sporotrichioides	|O
from	|O
the	|O
U.S.S.R.	|O
and	|O
7	|O
strains	|O
of	|O
these	|O
species	|O
and	|O
one	|O
of	|O
F.	|O
sporotrichioides	|O
var	|O
.	|O
tricinctum	|O
from	|O
U.S.A.	|O
and	|O
France	|O
have	|O
been	|O
compared	|O
as	|O
to	|O
their	|O
capacity	|O
to	|O
yield	|O
T	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
toxin	|I-PROTEIN
.	|O

Current	|O
diagnostic	|O
uses	|O
of	|O
computerized	|O
tomography	|O
in	|O
clinical	|O
medicine	|O
.	|O

A	|O
follow	|O
-	|O
up	|O
study	|O
of	|O
22	|O
patients	|O
with	|O
Ebstein	|O
's	|O
anomaly	|O
has	|O
been	|O
performed	|O
.	|O

Deaths	|O
stopped	|O
11	|O
hours	|O
after	|O
copper	|O
concentrations	|O
decreased	|O
below	|O
0.2	|O
ppm	|O
and	|O
signs	|O
of	|O
distress	|O
stopped	|O
in	|O
surviving	|O
pinfish	|O
by	|O
approximately	|O
6	|O
hours	|O
after	|O
the	|O
last	|O
death	|O
.	|O

Recurrence	|O
of	|O
bladder	|O
tumors	|O
among	|O
the	|O
original	|O
9	|O
cases	|O
has	|O
occurred	|O
only	|O
among	|O
the	|O
5	|O
whose	|O
properdin	|B-PROTEIN
levels	|O
remained	|O
below	|O
the	|O
median	|O
.	|O

Adaptation	|O
of	|O
taurocholate	|O
transport	|O
maximum	|O
to	|O
increased	|O
secretory	|O
load	|O
in	|O
the	|O
rat	|O
.	|O

Dangers	|O
in	|O
use	|O
of	|O
live	|O
-	|O
virus	|O
vaccines	|O
.	|O

Treatment	|O
with	|O
heparin	|O
,	|O
plasminogen	|B-PROTEIN
activators	|O
and	|O
fibrinogenolytic	|O
agents	|O
was	|O
disappointing	|O
although	|O
renal	|O
function	|O
has	|O
stabilized	|O
in	|O
one	|O
patient	|O
on	|O
long	|O
term	|O
oral	|O
anticoagulant	|O
therapy	|O
.	|O

In	|O
diethyl	|O
ether	|O
solution	|O
the	|O
main	|O
peak	|O
is	|O
that	|O
of	|O
2	|O
-	|O
benzylidenamio	|O
-	|O
1	|O
-	|O
phenylpropane	|O
,	|O
which	|O
has	|O
a	|O
retention	|O
time	|O
of	|O
23,2	|O
minutes	|O
under	|O
the	|O
condition	|O
delineated	|O
.	|O

Amikacin	|O
was	|O
used	|O
in	|O
the	|O
treatment	|O
of	|O
56	|O
serious	|O
gram	|O
-	|O
negative	|O
infections	|O
in	|O
54	|O
patients	|O
of	|O
whom	|O
47	|O
survived	|O
.	|O

The	|O
data	|O
normally	|O
available	|O
are	|O
insufficient	|O
and	|O
take	|O
no	|O
account	|O
of	|O
the	|O
direction	|O
of	|O
recirculation	|O
,	|O
which	|O
may	|O
be	|O
a	|O
determining	|O
factor	|O
.	|O

During	|O
activity	|O
III	|O
,	|O
one	|O
patient	|O
developed	|O
angina	|O
.	|O

Estimation	|O
of	|O
L	|O
-	|O
alanine	|O
in	|O
serum	|O
or	|O
plasma	|O
using	|O
the	|O
LKB	|O
reaction	|O
rate	|O
analyser	|O
.	|O

The	|O
acids	|O
were	|O
obtained	|O
by	|O
hydrolysis	|O
of	|O
the	|O
corresponding	|O
esters	|O
,	|O
and	|O
their	|O
anti	|O
-	|O
inflammatory	|O
activity	|O
was	|O
tested	|O
.	|O

Unrecognized	|O
amnionitis	|O
and	|O
prematurity	|O
:	|O
a	|O
preliminary	|O
report	|O
.	|O

Evaluation	|O
of	|O
the	|O
new	|O
Gravigard	|O
IUCD	|O
inserter	|O
.	|O

Bacterial	|O
meningitis	|O
secondary	|O
to	|O
abscess	|O
of	|O
the	|O
nasal	|O
septum	|O
.	|O

Serum	|O
amylase	|B-PROTEIN
became	|O
markedly	|O
elevated	|O
(	|O
2,624	|O
CU	|O
/	|O
100	|O
ml	|O
)	|O
,	|O
as	|O
did	|O
the	|O
serum	|O
FFA	|O
(	|O
29.19	|O
mEq	|O
/	|O
liter	|O
)	|O
.	|O

In	|O
the	|O
control	|O
preparation	|O
before	|O
weight	|O
was	|O
allowed	|O
to	|O
increase	|O
,	|O
isogravimetric	|O
capillary	|O
pressure	|O
(	|O
Pci	|O
)	|O
averaged	|O
8	|O
mmHg	|O
lower	|O
than	|O
colloid	|O
osmotic	|O
pressure	|O
of	|O
the	|O
plasma	|O
(	|O
IIp	|O
)	|O
.	|O

Infants	|O
who	|O
died	|O
in	|O
the	|O
first	|O
12	|O
hours	|O
from	|O
'	|O
IVH	|O
only	|O
'	|O
had	|O
suffered	|O
severe	|O
birth	|O
asphyxia	|O
but	|O
in	|O
those	|O
who	|O
died	|O
later	|O
the	|O
main	|O
symptom	|O
was	|O
recurrent	|O
apnoea	|O
.	|O

The	|O
morphological	|O
effects	|O
of	|O
two	|O
snake	|O
venoms	|O
,	|O
N.	|O
naja	|O
and	|O
A.	|O
piscivorus	|O
,	|O
and	|O
of	|O
the	|O
Direct	|B-PROTEIN
Lytic	|I-PROTEIN
Factor	|I-PROTEIN
and	|O
Phospholipase	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|O
compounds	|O
purified	|O
from	|O
N.	|O
naja	|O
crude	|O
venom	|O
,	|O
were	|O
investigated	|O
on	|O
lung	|O
and	|O
cremaster	|O
vessels	|O
of	|O
rats	|O
.	|O

Since	|O
GAGs	|O
are	|O
the	|O
components	|O
of	|O
cartilage	|O
matrix	|O
,	|O
the	|O
depletion	|O
of	|O
which	|O
is	|O
associated	|O
with	|O
osteoarthrosis	|O
,	|O
a	|O
method	|O
for	|O
measuring	|O
sulphated	|O
GAG	|O
synthesis	|O
in	|O
culture	|O
has	|O
been	|O
investigated	|O
.	|O

The	|O
length	|O
scales	|O
of	|O
the	|O
turbulence	|O
were	|O
also	|O
estimated	|O
:	|O
at	|O
a	|O
Reynolds	|O
number	|O
near	|O
4,000	|O
the	|O
macroscale	|O
is	|O
about	|O
1.25	|O
mm	|O
,	|O
the	|O
Taylor	|O
microscale	|O
is	|O
about	|O
0.85	|O
mm	|O
,	|O
and	|O
the	|O
Kolmogoroff	|O
scale	|O
is	|O
near	|O
0.075	|O
mm	|O
.	|O

Well	|O
-	|O
visualised	|O
arteriograms	|O
of	|O
the	|O
limbs	|O
can	|O
be	|O
obtained	|O
by	|O
xeroradiography	|O
after	|O
rapid	|O
manual	|O
injection	|O
of	|O
contrast	|O
-	|O
medium	|O
into	|O
an	|O
arm	|O
vein	|O
,	|O
as	|O
demonstrated	|O
in	|O
28	|O
patients	|O
.	|O

No	|O
hypotension	|O
was	|O
noted	|O
in	|O
patients	|O
with	|O
toxemia	|O
and	|O
only	|O
2	|O
ran	|O
a	|O
fever	|O
above	|O
37.5	|O
degrees	|O
C.	|O

The	|O
sera	|O
and	|O
nasal	|O
secretions	|O
of	|O
142	|O
patients	|O
,	|O
who	|O
were	|O
positive	|O
in	|O
HD	|O
or	|O
mites	|O
skin	|O
test	|O
,	|O
were	|O
subjected	|O
to	|O
a	|O
radioallergosorbent	|O
test	|O
(	|O
RAST	|O
)	|O
for	|O
estimating	|O
the	|O
specific	|O
IgE	|B-PROTEIN
antibody	|O
activity	|O
to	|O
mites	|O
.	|O

Wherever	|O
the	|O
site	|O
of	|O
the	|O
conditioning	|O
stimulation	|O
,	|O
these	|O
modifications	|O
disappeared	|O
after	|O
ischaemia	|O
of	|O
the	|O
leg	|O
.	|O

Diallylnitrosamine	|O
(	|O
DAN	|O
)	|O
,	|O
one	|O
of	|O
the	|O
few	|O
nitrosamines	|O
tested	|O
thus	|O
far	|O
that	|O
has	|O
not	|O
induced	|O
neoplasms	|O
in	|O
rats	|O
,	|O
caused	|O
a	|O
high	|O
incidence	|O
of	|O
respiratory	|O
tract	|O
tumors	|O
in	|O
Syrian	|O
golden	|O
hamsters	|O
treated	|O
sc	|O
with	|O
single	|O
or	|O
weekly	|O
doses	|O
of	|O
the	|O
compound	|O
.	|O

Near	|O
term	|O
,	|O
under	|O
experimental	|O
conditions	|O
,	|O
maternal	|O
and	|O
fetal	|O
blood	|O
gases	|O
,	|O
pH	|O
,	|O
uterine	|O
and	|O
umbilical	|O
blood	|O
flows	|O
were	|O
measured	|O
or	|O
calculated	|O
.	|O

Haemodynamic	|O
responses	|O
to	|O
antagonism	|O
of	|O
bocurarine	|O
block	|O
with	|O
atropine	|O
-	|O
neostigmine	|O
mixture	|O
in	|O
children	|O
.	|O

The	|O
mechanism	|O
by	|O
which	|O
large	|O
molecules	|O
,	|O
such	|O
as	|O
the	|O
diphosphonate	|O
99mTc	|O
-	|O
labeled	|O
EHDP	|O
or	|O
99mTc	|O
-	|O
labeled	|O
pyrophosphate	|O
,	|O
pass	|O
through	|O
capillaries	|O
in	|O
bone	|O
is	|O
by	|O
passive	|O
diffusion	|O
.	|O

Twenty	|O
-	|O
nine	|O
days	|O
after	|O
injection	|O
of	|O
5.8	|O
mCi	|O
of	|O
Tc	|O
-	|O
99m	|O
,	|O
which	|O
gives	|O
28	|O
rads	|O
to	|O
the	|O
testis	|O
,	|O
the	|O
number	|O
of	|O
sperm	|O
hads	|O
decreased	|O
to	|O
70%	|O
of	|O
control	|O
.	|O

Self	|O
-	|O
emasculation	|O
is	|O
the	|O
end	|O
result	|O
of	|O
an	|O
unusual	|O
psychiatric	|O
disorder	|O
,	|O
which	|O
initially	|O
requires	|O
surgical	|O
treatment	|O
.	|O

Possibility	|O
of	|O
a	|O
TSH	|B-PROTEIN
-	|O
Screening	|O
method	|O
for	|O
detection	|O
of	|O
hypothyroidism	|O
in	|O
the	|O
newborn	|O

Thus	|O
analysis	|O
indicated	|O
no	|O
reliable	|O
evidence	|O
that	|O
conscious	|O
presleep	|O
suggestions	|O
become	|O
incorporated	|O
into	|O
dream	|O
content	|O
.	|O

The	|O
prevalence	|O
of	|O
hepatitis	|B-PROTEIN
B	|I-PROTEIN
surface	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
HBsAg	|B-PROTEIN
)	|O
and	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBs	|I-PROTEIN
was	|O
determined	|O
by	|O
a	|O
sensitive	|O
double	|O
-	|O
antibody	|O
radio	|O
-	|O
immunoassay	|O
technique	|O
in	|O
a	|O
series	|O
of	|O
patients	|O
with	|O
chronic	|O
liver	|O
diseases	|O
.	|O

It	|O
was	|O
concluded	|O
that	|O
patients	|O
with	|O
acute	|O
respiratory	|O
failure	|O
requiring	|O
artificial	|O
ventilation	|O
have	|O
two	|O
componenents	|O
of	|O
the	|O
pulmonary	|O
shunt	|O
,	|O
one	|O
parallel	|O
with	|O
and	|O
the	|O
other	|O
inversely	|O
related	|O
with	|O
the	|O
PAO2	|O
.	|O

Decreased	|O
cardiac	|O
glycogen	|O
following	|O
phenformin	|O
injection	|O
in	|O
hyperglycemic	|O
,	|O
hyperinsulinemic	|O
anaesthetized	|O
rats	|O
.	|O

Biological	|O
evaluation	|O
of	|O
mibolerone	|O
in	|O
the	|O
female	|O
Beagle	|O
.	|O

Levels	|O
of	|O
both	|O
PGF	|O
and	|O
PGFM	|O
were	|O
significantly	|O
higher	|O
during	|O
early	|O
spontaneous	|O
labour	|O
,	|O
at	|O
a	|O
cervical	|O
dilatation	|O
of	|O
less	|O
than	|O
4	|O
cm	|O
,	|O
than	|O
before	|O
the	|O
onset	|O
of	|O
labour	|O
.	|O

The	|O
most	|O
common	|O
cause	|O
of	|O
renal	|O
deterioration	|O
in	|O
the	|O
spinal	|O
cord	|O
injured	|O
patient	|O
is	|O
irreversible	|O
vesicoureteral	|O
reflux	|O
.	|O

Propranolol	|O
(	|O
Inderal	|O
)	|O
administered	|O
in	|O
a	|O
dose	|O
which	|O
blocks	|O
the	|O
beta	|O
-	|O
adrenergic	|O
apparatus	|O
of	|O
the	|O
heart	|O
prevents	|O
the	|O
development	|O
of	|O
the	|O
positive	|O
inotropic	|O
effect	|O
of	|O
therapeutic	|O
doses	|O
of	|O
strophanthin	|O
K	|O
on	|O
a	|O
hypodynamic	|O
left	|O
ventricular	|O
myocardium	|O
.	|O

Recent	|O
studies	|O
have	|O
shown	|O
the	|O
rat	|O
larynx	|O
to	|O
be	|O
an	|O
important	|O
organ	|O
in	|O
the	|O
evaluation	|O
of	|O
irritancy	|O
of	|O
inhaled	|O
materials	|O
.	|O

Scanning	|O
electron	|O
microscopic	|O
investigations	|O
on	|O
the	|O
formation	|O
of	|O
Reissner	|O
's	|O
fiber	|O
in	|O
Rattus	|O
rattus	|O

Feeding	|O
behavior	|O
,	|O
circannual	|O
body	|O
weight	|O
and	|O
hibernation	|O
rhythms	|O
in	|O
European	|O
hamsters	|O
lesioned	|O
in	|O
the	|O
noradrenergic	|O
ascending	|O
bundles	|O

Role	|O
of	|O
the	|O
infectious	|O
-	|O
disease	|O
specialist	|O
of	|O
a	|O
polyclinic	|O
in	|O
reducing	|O
the	|O
incidence	|O
of	|O
communicable	|O
diseases	|O

These	|O
observed	|O
drug	|O
interactions	|O
,	|O
plus	|O
the	|O
known	|O
effect	|O
of	|O
probenecid	|O
to	|O
block	|O
secretion	|O
of	|O
PZA	|O
,	|O
have	|O
to	|O
be	|O
considered	|O
in	|O
evaluating	|O
the	|O
effect	|O
of	|O
the	|O
two	|O
drugs	|O
given	|O
together	|O
,	|O
compared	|O
to	|O
the	|O
effect	|O
of	|O
each	|O
drug	|O
given	|O
separately	|O
.	|O

Circulatory	|O
arrest	|O
in	|O
the	|O
operating	|O
room	|O
.	|O

At	|O
a	|O
systolic	|O
blood	|O
pressure	|O
(	|O
BP	|O
)	|O
of	|O
60	|O
mmHg	|O
,	|O
C02	|O
responsiveness	|O
was	|O
abolished	|O
,	|O
but	|O
was	|O
maintained	|O
at	|O
higher	|O
levels	|O
of	|O
BP	|O
.	|O

Iodine	|O
-	|O
123	|O
was	|O
satisfactorily	|O
imaged	|O
only	|O
with	|O
the	|O
MEC	|O
and	|O
pinhole	|O
collimators	|O
,	|O
which	|O
in	|O
turn	|O
yielded	|O
MTF	|O
values	|O
comparable	|O
to	|O
those	|O
measured	|O
for	|O
99mTc	|O
.	|O

Petrous	|O
meningioma	|O
en	|O
plaque	|O
presenting	|O
as	|O
a	|O
right	|O
middle	|O
ear	|O
tumor	|O
.	|O

The	|O
difficulties	|O
to	|O
analyse	|O
prostaglandins	|O
(	|O
PG	|O
)	|O
by	|O
gas	|O
-	|O
liquid	|O
chromatography	|O
are	|O
mainly	|O
due	|O
to	|O
the	|O
lack	|O
of	|O
sensitivity	|O
of	|O
the	|O
gas	|O
-	|O
chromatograph	|O
itself	|O
(	|O
higher	|O
than	|O
200	|O
ng	|O
)	|O
and	|O
to	|O
the	|O
poor	|O
resolution	|O
of	|O
the	|O
packed	|O
columns	|O
.	|O

On	|O
cessation	|O
of	|O
steroid	|O
therapy	|O
the	|O
patient	|O
was	|O
noted	|O
to	|O
have	|O
radiologic	|O
manifestations	|O
of	|O
hypertrophic	|O
osteoarthropathy	|O
(	|O
HOA	|O
)	|O
as	|O
well	|O
as	|O
clinical	|O
and	|O
laboratory	|O
features	|O
of	|O
rheumatoid	|O
arthritis	|O
(	|O
RA	|O
)	|O
.	|O

The	|O
effect	|O
of	|O
food	|O
on	|O
procainamide	|O
absorption	|O
.	|O

After	|O
giving	|O
a	|O
survey	|O
on	|O
the	|O
situation	|O
of	|O
antibiotic	|O
resistance	|O
in	|O
the	|O
region	|O
of	|O
Northern	|O
Bavaria	|O
during	|O
1973/74	|O
and	|O
comparing	|O
the	|O
activity	|O
of	|O
a	|O
sulfamethoxazole	|O
(	|O
SMZ	|O
)	|O
trimethoprim	|O
(	|O
TMP	|O
)	|O
combination	|O
to	|O
other	|O
commonly	|O
used	|O
antibiotics	|O
and	|O
chemotherapeutic	|O
agents	|O
,	|O
the	|O
results	|O
of	|O
tests	|O
with	|O
the	|O
new	|O
combination	|O
of	|O
N1	|O
-	|O
(	|O
4,5	|O
-	|O
dimethyl	|O
-	|O
2	|O
-	|O
oxazolyl	|O
)	|O
-	|O
sulfanilamide	|O
)	|O
(	|O
sulfamoxole	|O
)	|O
and	|O
2,4	|O
-	|O
diamino	|O
-	|O
5	|O
-	|O
(	|O
3,4,5	|O
-	|O
trimethoxy	|O
-	|O
benzyl	|O
)	|O
-	|O
pyrimidine	|O
(	|O
trimethoprim	|O
)	|O
at	|O
a	|O
ratio	|O
of	|O
5	|O
:	|O
1	|O
(	|O
CN	|O
3123	|O
;	|O
Nevin	|O
,	|O
Supristol	|O
)	|O
are	|O
compared	|O
to	|O
those	|O
of	|O
tests	|O
with	|O
TMP	|O
/	|O
SMZ	|O
.	|O

RESULTS	|O
:	|O
Total	|O
IgE	|B-PROTEIN
levels	|O
showed	|O
a	|O
tendency	|O
to	|O
diminish	|O
.	|O

Does	|O
afferent	|O
loop	|O
syndrome	|O
exist	|O
?	|O
]	|O
It	|O
is	|O
the	|O
author	|O
's	|O
opinion	|O
that	|O
diagnosis	|O
of	|O
the	|O
"	|O
adducent	|O
loop	|O
syndrome	|O
"	|O
is	|O
unlikely	|O
to	|O
be	|O
correct	|O
in	|O
patients	|O
subjected	|O
to	|O
Billroth	|O
-	|O
II	|O
gastrectomy	|O
.	|O

Letter	|O
:	|O
Is	|O
actinic	|O
(	|O
solar	|O
)	|O
damage	|O
the	|O
provoking	|O
cause	|O
of	|O
'	|O
post	|O
-	|O
inflammatory	|O
elastolysis	|O
and	|O
cutis	|O
laxa	|O
(	|O
PECL	|O
)	|O
'	|O
?	|O

These	|O
data	|O
suggest	|O
that	|O
spontaneous	|O
recovery	|O
of	|O
central	|O
respiratory	|O
function	|O
after	|O
intoxication	|O
with	|O
Soman	|O
or	|O
Sarin	|O
may	|O
not	|O
be	|O
related	|O
to	|O
the	|O
return	|O
of	|O
AChE	|B-PROTEIN
activity	|O
.	|O

Batch	|O
cultures	|O
of	|O
S.	|O
mutans	|O
serotype	|O
a	|O
demonstrated	|O
no	|O
growth	|O
on	|O
MSB	|O
agar	|O
.	|O

Also	|O
,	|O
samples	|O
of	|O
serum	|O
were	|O
absorbed	|O
with	|O
the	|O
various	|O
solid	|O
-	|O
phase	|O
allergens	|O
and	|O
the	|O
reactivity	|O
of	|O
the	|O
remaining	|O
IgE	|B-PROTEIN
antibodies	|O
was	|O
determined	|O
.	|O

Crisis	|O
of	|O
the	|O
therapeutic	|O
community	|O
in	|O
Great	|O
Britain	|O

Pregnant	|O
women	|O
at	|O
term	|O
had	|O
the	|O
lowest	|O
levels	|O
of	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
.	|O

Hematology	|O
problem	|O
of	|O
the	|O
month	|O
:	|O
band	|O
or	|O
seg	|O
?	|O

It	|O
is	|O
possible	|O
that	|O
cyclic	|O
variations	|O
in	|O
heme	|O
turnover	|O
are	|O
related	|O
to	|O
changes	|O
in	|O
erythrocyte	|O
characteristics	|O
during	|O
the	|O
progesterone	|O
phase	|O
.	|O

Haemodilution	|O
in	|O
cardiopulmonary	|O
bypass	|O
using	|O
a	|O
gelatine	|O
derivative	|O
for	|O
priming	|O
.	|O

Extramedullary	|O
plasmacytoma	|O
of	|O
the	|O
parotid	|O
gland	|O

I.	|O

The	|O
recovered	|O
calves	|O
were	|O
tested	|O
for	|O
immunity	|O
to	|O
homologous	|O
severe	|O
challenge	|O
,	|O
50	|O
or	|O
73	|O
days	|O
after	|O
the	|O
first	|O
infection	|O
.	|O

The	|O
performance	|O
of	|O
three	|O
commonly	|O
used	|O
chemical	|O
cartridge	|O
respirators	|O
for	|O
SO2	|O
was	|O
measured	|O
under	|O
working	|O
conditions	|O
in	|O
a	|O
copper	|O
smelter	|O
.	|O

The	|O
neuroleptic	|O
-	|O
induced	|O
increase	|O
in	|O
central	|O
DA	|O
turnover	|O
(	|O
an	|O
indicator	|O
for	|O
the	|O
degree	|O
of	|O
DA	|B-PROTEIN
receptor	|I-PROTEIN
blocking	|O
)	|O
was	|O
found	|O
to	|O
be	|O
positively	|O
correlated	|O
with	|O
the	|O
therapeutic	|O
effect	|O
of	|O
neuroleptics	|O
and	|O
the	|O
development	|O
of	|O
hypokinetic	|O
-	|O
rigid	|O
symptoms	|O
.	|O

Rainbow	|O
trout	|O
were	|O
obtained	|O
from	|O
a	|O
commercial	|O
trout	|O
farm	|O
,	|O
kept	|O
in	|O
running	|O
water	|O
and	|O
feeding	|O
in	|O
experimental	|O
pellets	|O
for	|O
4	|O
to	|O
8	|O
weeks	|O
.	|O

Stimulation	|O
of	|O
macrophage	|O
function	|O
by	|O
killed	|O
Bordetella	|O
pertussis	|O
cells	|O
did	|O
not	|O
show	|O
any	|O
beneficial	|O
effect	|O
as	|O
an	|O
increased	|O
susceptibility	|O
became	|O
apparent	|O
.	|O

Primary	|O
amenorrhoea	|O
in	|O
a	|O
phenotypically	|O
female	|O
individual	|O
with	|O
a	|O
karyotype	|O
46	|O
,	|O
xy	|O
and	|O
bilateral	|O
gonadoblastoma	|O

Toward	|O
absolute	|O
methods	|O
in	|O
clinical	|O
chemistry	|O
:	|O
application	|O
of	|O
mass	|O
fragmentography	|O
to	|O
high	|O
-	|O
accuracy	|O
analyses	|O
.	|O

Application	|O
of	|O
the	|O
2	|O
-	|O
deoxy	|O
-	|O
D	|O
-	|O
glucose	|O
method	|O
to	|O
the	|O
coupling	|O
of	|O
cerebral	|O
metabolism	|O
and	|O
blood	|O
flow	|O
.	|O

Serum	|O
gastrin	|B-PROTEIN
levels	|O
did	|O
not	|O
change	|O
in	|O
either	|O
group	|O
;	|O
however	|O
,	|O
background	|O
serum	|O
gastrin	|B-PROTEIN
concentrations	|O
were	|O
significantly	|O
greater	|O
for	|O
V	|O
&	|O
P	|O
patients	|O
than	|O
V	|O
&	|O
A	|O
patients	|O
throughout	|O
the	|O
study	|O
.	|O

Efferent	|O
projections	|O
of	|O
the	|O
ventral	|O
portion	|O
of	|O
the	|O
putamen	|O
to	|O
the	|O
frontal	|O
,	|O
parietal	|O
and	|O
temporal	|O
regions	|O
of	|O
the	|O
cat	|O
cerebral	|O
cortex	|O

Preflight	|O
,	|O
inflight	|O
,	|O
and	|O
postflight	|O
exercise	|O
response	|O
tests	|O
were	|O
conducted	|O
on	|O
the	|O
astronauts	|O
of	|O
the	|O
second	|O
Skylab	|O
mission	|O
(	|O
Skylab	|O
3	|O
)	|O
as	|O
part	|O
of	|O
an	|O
evaluation	|O
of	|O
physiological	|O
adaptation	|O
to	|O
long	|O
-	|O
term	|O
weightlessness	|O
.	|O

Mean	|O
corpuscular	|O
hemoglobin	|B-PROTEIN
concentrations	|O
remained	|O
normal	|O
for	|O
48	|O
h	|O
and	|O
then	|O
decreased	|O
in	|O
both	|O
groups	|O
,	|O
the	|O
CO2	|O
group	|O
showing	|O
the	|O
larger	|O
decrease	|O
.	|O

All	|O
Cu	|O
values	|O
obtained	|O
from	|O
the	|O
organs	|O
investigated	|O
had	|O
reached	|O
a	|O
saturation	|O
level	|O
at	|O
8	|O
mug	|O
Cu	|O
/	|O
g	|O
diet	|O
with	|O
the	|O
exception	|O
of	|O
the	|O
values	|O
for	|O
body	|O
Cu	|O
found	|O
in	|O
the	|O
dams	|O
that	|O
were	|O
killed	|O
on	|O
the	|O
day	|O
of	|O
delivery	|O
.	|O

The	|O
effect	|O
of	|O
calcitonin	|B-PROTEIN
,	|O
a	|O
large	|O
amount	|O
of	|O
calcium	|O
given	|O
orally	|O
,	|O
pentagastrin	|O
and	|O
glucagon	|B-PROTEIN
on	|O
plasma	|O
47Ca	|O
radioactivity	|O
curves	|O
in	|O
subjects	|O
pretreated	|O
with	|O
47Ca	|O
was	|O
examined	|O
.	|O

State	|O
of	|O
the	|O
body	|O
in	|O
disorders	|O
of	|O
diurnal	|O
physiological	|O
rhythms	|O
and	|O
long	|O
-	|O
term	|O
hypokinesia	|O

Oxygen	|O
tension	|O
of	|O
the	|O
small	|O
lymph	|O
vessels	|O
(	|O
PLO2	|O
)	|O
of	|O
the	|O
rabbit	|O
hind	|O
limb	|O
was	|O
measured	|O
with	|O
both	|O
a	|O
flow	|O
-	|O
through	|O
micro	|O
chamber	|O
and	|O
a	|O
polarographic	|O
catheter	|O
-	|O
tip	|O
oxygen	|O
electrode	|O
to	|O
obtain	|O
experimental	|O
data	|O
on	|O
the	|O
source	|O
of	|O
oxygen	|O
in	|O
the	|O
lymph	|O
.	|O

The	|O
response	|O
of	|O
the	|O
plasma	|O
fibrinogen	|B-PROTEIN
level	|O
to	|O
the	|O
subucutaneous	|O
injection	|O
of	|O
turpentine	|O
and	|O
to	|O
the	|O
intravenous	|O
injection	|O
of	|O
endotoxin	|O
was	|O
measured	|O
in	|O
normal	|O
rabbits	|O
and	|O
in	|O
rabbits	|O
made	|O
granulocytopenic	|O
and	|O
thrombocytopenic	|O
with	|O
busulfan	|O
.	|O

Constantly	|O
rectilinear	|O
pressure	|O
curves	|O
without	|O
uterine	|O
activities	|O
are	|O
interpreted	|O
as	|O
characteristic	|O
tocographic	|O
criteria	|O
of	|O
an	|O
advanced	|O
ectopic	|O
gravidity	|O
.	|O

Since	|O
myoglobin	|B-PROTEIN
is	|O
co	|O
-	|O
extracted	|O
with	|O
the	|O
hemoglobin	|B-PROTEIN
,	|O
the	|O
2	|O
heme	|O
pigments	|O
are	|O
separated	|O
in	|O
one	|O
portion	|O
of	|O
the	|O
extract	|O
by	|O
precipitating	|O
the	|O
hemoglobin	|B-PROTEIN
in	|O
an	|O
85%	|O
(	|O
NH4	|O
)	|O
2SO4	|O
solution	|O
.	|O

Considering	|O
these	|O
sources	|O
of	|O
error	|O
some	|O
of	|O
the	|O
variability	|O
in	|O
the	|O
present	|O
investigation	|O
might	|O
be	|O
avoided	|O
by	|O
systematic	|O
instructions	|O
.	|O

E	|O
50	|O
,	|O
843	|O
(	|O
1994	|O
)	|O
]	|O
.	|O

Six	|O
patients	|O
with	|O
the	|O
diagnosis	|O
of	|O
acute	|O
mania	|O
were	|O
treated	|O
with	|O
high	|O
doses	|O
of	|O
the	|O
beta	|O
-	|O
adrenergic	|O
blocking	|O
agent	|O
propranolol	|O
.	|O

Effect	|O
of	|O
trauma	|O
on	|O
plasma	|O
glucagon	|B-PROTEIN
and	|O
insulin	|B-PROTEIN
concentrations	|O
in	|O
sheep	|O
.	|O

With	|O
the	|O
help	|O
of	|O
a	|O
nomogram	|O
one	|O
can	|O
read	|O
off	|O
the	|O
refraction	|O
,	|O
when	|O
axis	|O
length	|O
and	|O
corneal	|O
curvature	|O
are	|O
known	|O
.	|O

This	|O
up	|O
-	|O
grading	|O
of	|O
the	|O
final	|O
score	|O
by	|O
the	|O
CA	|O
component	|O
is	|O
greater	|O
(	|O
3-8%	|O
)	|O
in	|O
the	|O
less	|O
able	|O
students	|O
with	|O
scores	|O
below	|O
the	|O
mean	|O
level	|O
.	|O

Compared	|O
to	|O
controls	|O
,	|O
both	|O
UB	|O
and	|O
OCS	|O
rats	|O
showed	|O
a	|O
small	|O
but	|O
significant	|O
post	|O
-	|O
operative	|O
reduction	|O
in	|O
the	|O
nocturnality	|O
of	|O
drinking	|O
.	|O

Effect	|O
of	|O
indomethacin	|O
on	|O
coronary	|O
circulation	|O
:	|O
effect	|O
on	|O
ECG	|O
tracing	|O

Dual	|O
innervation	|O
of	|O
fast	|O
fibers	|O
in	|O
trunk	|O
muscles	|O
of	|O
lamprey	|O
larvae	|O

The	|O
feed	|O
consumed	|O
which	|O
was	|O
lowered	|O
by	|O
25%	|O
initially	|O
,	|O
did	|O
not	|O
alter	|O
later	|O
.	|O

Certain	|O
characteristics	|O
of	|O
eye	|O
changes	|O
in	|O
patients	|O
with	|O
pheochromocytoma	|O
including	|O
Sipple	|O
's	|O
syndrome	|O

The	|O
color	|O
-	|O
word	|O
interference	|O
effect	|O
previously	|O
reported	|O
with	|O
normal	|O
populations	|O
when	|O
given	|O
the	|O
Stroop	|O
test	|O
was	|O
demonstrated	|O
for	|O
this	|O
retarded	|O
sample	|O
using	|O
a	|O
special	|O
format	|O
.	|O

It	|O
was	|O
found	|O
that	|O
under	|O
the	|O
selected	|O
conditions	|O
a	|O
linear	|O
dependence	|O
exists	|O
between	|O
the	|O
betaI	|O
%	|O
value	|O
and	|O
lgC	|O
within	|O
the	|O
range	|O
of	|O
0.5	|O
-	|O
-	|O
10	|O
mug	|O
ruscogenin	|O
.	|O

The	|O
influence	|O
of	|O
adrenergic	|O
nerves	|O
of	|O
the	|O
response	|O
of	|O
blood	|O
vessels	|O
in	|O
the	|O
rabbit	|O
ear	|O
to	|O
2	|B-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
phenylalanine	|I-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
-	|I-PROTEIN
lysine	|I-PROTEIN
vasopressin	|I-PROTEIN
(	|O
Octapressin	|B-PROTEIN
)	|O
.	|O

Potscoital	|O
test	|O

I.	|O

When	|O
a	|O
tumour	|O
is	|O
present	|O
nipple	|O
discharge	|O
is	|O
of	|O
little	|O
importance	|O
for	|O
the	|O
diagnosis	|O
and	|O
treatment	|O
.	|O

Studies	|O
of	|O
biochemical	|O
and	|O
morphological	|O
changes	|O
(	|O
between	|O
normal	|O
and	|O
treated	|O
animals	|O
)	|O
show	|O
that	|O
chrysotile	|O
induces	|O
an	|O
increase	|O
in	|O
the	|O
lung	|O
free	|O
cell	|O
population	|O
and	|O
pulmonary	|O
surfactant	|O
levels	|O
.	|O

Infrared	|O
measurements	|O
of	|O
temperature	|O
changes	|O
and	|O
estimates	|O
of	|O
the	|O
heating	|O
produced	|O
at	|O
the	|O
mical	|O
.	|O

Who	|O
says	|O
'	|O
National	|O
Health	|O
Dis	|O
-	|O
service	|O
'	|O
.	|O

Is	|O
criticism	|O
of	|O
patient	|O
care	|O
justified	|O
and	|O
does	|O
it	|O
have	|O
educational	|O
value	|O
?	|O
Patients	|O
'	|O
criticism	|O
contributes	|O
to	|O
improved	|O
patient	|O
care	|O

Critique	|O
of	|O
"	|O
Interactive	|O
Effects	|O
of	|O
Test	|O
Anxiety	|O
and	|O
Credit	|O
/	|O
No	|O
Credit	|O
or	|O
A	|O
-	|O
F	|O
Grade	|O
Condition	|O
upon	|O
Short	|O
-	|O
term	|O
and	|O
Long	|O
-	|O
term	|O
Recall	|O
of	|O
Course	|O
Information	|O
.	|O

These	|O
studies	|O
have	|O
shown	|O
that	|O
the	|O
majority	|O
of	|O
tested	|O
staphylococci	|O
were	|O
resistant	|O
to	|O
penicillin	|O
G	|O
,	|O
erythromycin	|O
,	|O
and	|O
produced	|O
beta	|B-PROTEIN
-	|I-PROTEIN
lactamase	|I-PROTEIN
.	|O

Since	|O
1968	|O
,	|O
a	|O
steep	|O
decrease	|O
in	|O
the	|O
number	|O
of	|O
strains	|O
resistant	|O
to	|O
three	|O
or	|O
more	|O
antibiotics	|O
(	|O
multiple	|O
-	|O
resistant	|O
)	|O
and	|O
in	|O
strains	|O
of	|O
the	|O
83A	|O
complex	|O
was	|O
noticed	|O
.	|O

Improvement	|O
of	|O
nursing	|O
instruction	|O
to	|O
be	|O
given	|O
at	|O
the	|O
time	|O
of	|O
discharge	|O
from	|O
the	|O
ward	|O
for	|O
premature	|O
infants	|O

No	|O
difference	|O
in	|O
the	|O
clinical	|O
acceptability	|O
could	|O
be	|O
ascertained	|O
between	|O
the	|O
two	|O
groups	|O
.	|O

After	|O
90	|O
d	|O
a	|O
subsurface	|O
,	|O
radiolucent	|O
caries	|O
-	|O
like	|O
lesion	|O
was	|O
observed	|O
in	|O
two	|O
specimens	|O
only	|O
.	|O

The	|O
contraceptive	|O
pattern	|O
of	|O
157	|O
women	|O
was	|O
analysed	|O
and	|O
13.8	|O
percent	|O
were	|O
using	|O
inefficient	|O
methods	|O
.	|O

Plethysmographic	|O
technique	|O
and	|O
indirect	|O
blood	|O
pressure	|O
recordings	|O
were	|O
used	|O
.	|O

I.	|O

The	|O
second	|O
and	|O
third	|O
responded	|O
similarly	|O
to	|O
either	|O
a	|O
combined	|O
cyclophosphamide	|O
+	|O
antilymphocyte	|B-PROTEIN
globulin	|I-PROTEIN
(	|O
ALG	|B-PROTEIN
)	|O
treatment	|O
or	|O
to	|O
ALG	|B-PROTEIN
administration	|O
preceded	|O
by	|O
a	|O
small	|O
dosage	|O
of	|O
cyclophosphamide	|O
,	|O
which	|O
had	|O
proved	|O
ineffective	|O
when	|O
administered	|O
alone	|O
.	|O

Evidence	|O
is	|O
presented	|O
that	|O
Leber	|O
's	|O
military	|O
aneurysm	|O
retinitis	|O
is	|O
not	|O
a	|O
separate	|O
entity	|O
but	|O
a	|O
special	|O
form	|O
of	|O
Coats	|O
'	|O
disease	|O
.	|O

Fibrin	|B-PROTEIN
cloaking	|O
along	|O
the	|O
catheter	|O
was	|O
found	|O
in	|O
20	|O
patients	|O
studied	|O
by	|O
pull	|O
-	|O
out	|O
arteriography	|O
and	|O
was	|O
unassociated	|O
with	|O
clinical	|O
symptoms	|O
.	|O

The	|O
influence	|O
of	|O
a	|O
mobile	|O
pupil	|O
on	|O
the	|O
response	|O
in	|O
the	|O
DC	|O
-	|O
ERG	|O
is	|O
demonstrated	|O
.	|O

A	|O
newly	|O
synthesized	|O
anti	|O
-	|O
inflammatory	|O
agent	|O
,	|O
Y	|O
-	|O
8004	|O
demonstrated	|O
a	|O
greater	|O
inhibition	|O
than	|O
did	|O
indomethacin	|O
(	|O
IM	|O
)	|O
.	|O
on	|O
inflammatory	|O
response	|O
such	|O
as	|O
ultraviolet	|O
erythema	|O
in	|O
guinea	|O
pigs	|O
,	|O
carrageenin	|O
edema	|O
,	|O
evans	|O
blue	|O
and	|O
carrageenin	|O
-	|O
induced	|O
pleuritis	|O
and	|O
acetic	|O
acid	|O
-	|O
induced	|O
peritonitis	|O
in	|O
rats	|O
.	|O

As	|O
stands	|O
shifted	|O
in	|O
dominance	|O
from	|O
pine	|O
to	|O
fir	|O
with	|O
age	|O
,	|O
subalpine	|O
fir	|O
appeared	|O
to	|O
maintain	|O
gradually	|O
increasing	|O
rates	|O
of	|O
whole	|O
-	|O
forest	|O
productivity	|O
until	|O
stands	|O
were	|O
approximately	|O
400	|O
years	|O
old	|O
.	|O

Alpha	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
antitrypsin	|I-PROTEIN
and	|O
Indian	|O
childhood	|O
cirrhosis	|O
.	|O

Lymphocyte	|O
subpopulations	|O
,	|O
serum	|O
IgE	|B-PROTEIN
and	|O
total	|O
eosinophil	|O
counts	|O
in	|O
patients	|O
with	|O
bronchial	|O
asthma	|O
.	|O

A	|O
range	|O
of	|O
normal	|O
ventricular	|O
measurements	|O
for	|O
the	|O
EMI	|O
scan	|O
is	|O
suggested	|O
.	|O

A	|O
comparison	|O
of	|O
physical	|O
and	|O
cytogenetic	|O
estimates	|O
of	|O
radiation	|O
dose	|O
in	|O
patients	|O
treated	|O
with	|O
iodine	|O
-	|O
131	|O
for	|O
thyroid	|O
carcinoma	|O
.	|O

Technique	|O
for	|O
obtaining	|O
refined	|O
ceramics	|O
with	|O
dense	|O
mass	|O

Mean	|O
total	|O
lung	|O
capacity	|O
,	|O
functional	|O
residual	|O
capacity	|O
,	|O
and	|O
residual	|O
volume	|O
increased	|O
significantly	|O
,	|O
and	|O
the	|O
mean	|O
closing	|O
volume	|O
,	|O
the	|O
lung	|O
volume	|O
above	|O
residual	|O
volume	|O
at	|O
which	|O
phase	|O
IV	|O
begins	|O
,	|O
decreased	|O
significantly	|O
with	|O
11	|O
cm	|O
H20	|O
continuous	|O
positive	|O
airway	|O
pressure	|O
;	|O
differences	|O
at	|O
5	|O
cm	|O
H20	|O
were	|O
not	|O
significant	|O
.	|O

Current	|O
status	|O
of	|O
zinc	|O
deficiency	|O
in	|O
the	|O
pathogenesis	|O
of	|O
neurological	|O
,	|O
dermatological	|O
and	|O
musculoskeletal	|O
disorders	|O
.	|O

Calcium	|O
and	|O
phosphorus	|O
metabolism	|O
in	|O
chronic	|O
uremia	|O
.	|O

Modern	|O
studies	|O
,	|O
conducted	|O
with	|O
Delta	|O
-	|O
9	|O
-	|O
THC	|O
,	|O
in	|O
healthy	|O
voluntaries	|O
,	|O
again	|O
suggest	|O
the	|O
comparison	|O
or	|O
even	|O
the	|O
identity	|O
of	|O
the	|O
modifications	|O
caused	|O
by	|O
cannabis	|O
with	|O
sleep	|O
and	|O
dream	|O
.	|O

The	|O
correcting	|O
action	|O
of	|O
tropatepine	|O
hydrochloride	|O
upon	|O
the	|O
extrapyramidal	|O
effects	|O
induced	|O
by	|O
neuroleptics	|O
has	|O
been	|O
studied	|O
in	|O
32	|O
acute	|O
psychotic	|O
states	|O
.	|O

Epididymal	|O
growth	|O
was	|O
retarded	|O
in	|O
animals	|O
maintained	|O
solely	|O
on	|O
chickpea	|O
haulm	|O
and	|O
improved	|O
with	|O
supplementation	|O
.	|O

Two	|O
patients	|O
were	|O
treated	|O
with	|O
both	|O
regimens	|O
.	|O

Results	|O
obtained	|O
for	|O
chloramphenicol	|O
-	|O
containing	|O
preparations	|O
are	|O
presented	|O
,	|O
and	|O
both	|O
dissolution	|O
curves	|O
and	|O
cup	|O
-	|O
plate	|O
assays	|O
demonstrate	|O
that	|O
chloramphenicol	|O
has	|O
far	|O
superior	|O
release	|O
(	|O
and	|O
hence	|O
activity	|O
)	|O
from	|O
creams	|O
than	|O
from	|O
ophthalmic	|O
ointments	|O
.	|O

IgG	|B-PROTEIN
levels	|O
of	|O
1/100	|O
were	|O
present	|O
in	|O
only	|O
four	|O
out	|O
of	|O
ten	|O
samples	|O
obtained	|O
150	|O
days	|O
after	|O
the	|O
clinical	|O
onset	|O
.	|O

Letter	|O
:	|O
Perspectives	|O
in	|O
bone	|O
marrow	|O
transplantation	|O
.	|O

Assessment	|O
of	|O
the	|O
carcinogenicity	|O
of	|O
non	|O
-	|O
nutritive	|O
sweetners	|O
II	|O
:	|O
Cyclamates	|O
and	|O
cyclohexylamine	|O
.	|O

The	|O
discordant	|O
behaviour	|O
in	|O
weakly	|O
infected	|O
mice	|O
was	|O
due	|O
to	|O
the	|O
occurrence	|O
in	|O
some	|O
animals	|O
of	|O
a	|O
second	|O
phase	|O
of	|O
more	|O
rapid	|O
increase	|O
of	|O
the	|O
parasitemia	|O
.	|O

Residual	|O
amphotericin	|O
B	|O
was	|O
detected	|O
in	|O
the	|O
feces	|O
of	|O
the	|O
mice	|O
only	|O
while	|O
they	|O
were	|O
receiving	|O
the	|O
0.3	|O
mg	|O
/	|O
ml	|O
dose	|O
level	|O
.	|O

There	|O
was	|O
a	|O
slight	|O
increase	|O
in	|O
total	|O
transferrin	|B-PROTEIN
2	|O
hr	|O
after	|O
1	|O
tablet	|O
and	|O
values	|O
remained	|O
high	|O
throughout	|O
the	|O
experiment	|O
.	|O

Following	|O
intravenous	|O
administration	|O
,	|O
the	|O
myocardial	|O
concentration	|O
of	|O
tracer	|O
thallium	|O
-	|O
201	|O
,	|O
potassium	|O
-	|O
43	|O
,	|O
and	|O
rubidium	|O
-	|O
81	|O
were	|O
determined	|O
in	|O
mice	|O
;	|O
thallium	|O
was	|O
present	|O
in	|O
the	|O
greatest	|O
concentration	|O
in	|O
the	|O
myocardium	|O
(	|O
2.08%	|O
compared	|O
1.25%	|O
for	|O
potassium	|O
and	|O
1.15%	|O
for	|O
rubidium	|O
at	|O
10	|O
minutes	|O
)	|O
.	|O

Thromboplastin	|B-PROTEIN
time	|O
,	|O
partial	|O
thromboplastin	|B-PROTEIN
time	|O
,	|O
thrombin	|B-PROTEIN
time	|O
,	|O
heat	|O
-	|O
dependent	|O
fibrin	|B-PROTEIN
,	|O
clot	|O
retraction	|O
,	|O
and	|O
clotting	|B-PROTEIN
factors	|I-PROTEIN
II	|I-PROTEIN
,	|I-PROTEIN
V	|I-PROTEIN
,	|I-PROTEIN
VIII	|I-PROTEIN
,	|I-PROTEIN
IX	|I-PROTEIN
,	|I-PROTEIN
X	|I-PROTEIN
,	|O
and	|O
the	|O
platelet	|O
count	|O
were	|O
determined	|O
.	|O

The	|O
data	|O
support	|O
the	|O
notion	|O
that	|O
suppression	|O
of	|O
images	|O
during	|O
binocular	|O
rivalry	|O
is	|O
independent	|O
in	|O
both	|O
eyes	|O
.	|O

Glycogen	|O
utilization	|O
was	|O
increased	|O
,	|O
but	|O
tissue	|O
levels	|O
of	|O
creatine	|O
phosphate	|O
,	|O
ATP	|O
,	|O
and	|O
lactate	|O
were	|O
similar	|O
to	|O
those	|O
in	|O
hearts	|O
receiving	|O
normal	|O
flow	|O
.	|O

The	|O
records	|O
from	|O
1948	|O
through	|O
1967	|O
of	|O
344	|O
previously	|O
untreated	|O
patients	|O
with	|O
squamous	|O
cell	|O
carcinoma	|O
of	|O
the	|O
oral	|O
cavity	|O
,	|O
oropharynx	|O
,	|O
supraglottic	|O
larynx	|O
and	|O
hypopharynx	|O
who	|O
had	|O
clinically	|O
positive	|O
cervical	|O
lymph	|O
node	|O
metastases	|O
staged	|O
N1	|O
,	|O
N2A	|O
,	|O
or	|O
N2B	|O
,	|O
and	|O
whose	|O
initial	|O
neck	|O
treatment	|O
consisted	|O
of	|O
external	|O
radiation	|O
therapy	|O
alone	|O
were	|O
reviewed	|O
.	|O

With	|O
0.5	|O
vol.	|O
-	|O
%	|O
,	|O
the	|O
corresponding	|O
values	|O
were	|O
345	|O
mumol	|O
/	|O
1	|O
(	|O
5.72	|O
mg	|O
/	|O
100	|O
ml	|O
)	|O
and	|O
137	|O
mumol	|O
/	|O
1	|O
(	|O
2.25	|O
mg	|O
/	|O
100	|O
ml	|O
)	|O
respectively	|O
.	|O

The	|O
authors	|O
describe	|O
the	|O
technique	|O
of	|O
transverse	|O
axial	|O
tomography	|O
of	|O
the	|O
spine	|O
and	|O
give	|O
a	|O
detailed	|O
description	|O
of	|O
the	|O
axial	|O
anatomy	|O
of	|O
the	|O
normal	|O
lumbar	|O
spine	|O
from	|O
L	|O
-	|O
4	|O
to	|O
the	|O
sacrum	|O
.	|O

Owing	|O
to	|O
parental	|O
attitude	|O
,	|O
a	|O
low	|O
protein	|O
diet	|O
(	|O
1-5	|O
g	|O
/	|O
kg	|O
)	|O
was	|O
introduced	|O
only	|O
late	|O
.	|O

In	|O
none	|O
of	|O
the	|O
44	|O
type	|O
I	|O
attacks	|O
and	|O
29	|O
type	|O
II	|O
attacks	|O
which	|O
were	|O
recorded	|O
did	|O
circulatory	|O
changes	|O
;	|O
the	|O
latter	|O
were	|O
different	|O
in	|O
the	|O
two	|O
groups	|O
.	|O

A	|O
clinically	|O
useful	|O
diagnostic	|O
method	|O
has	|O
been	|O
developed	|O
for	|O
detecting	|O
and	|O
quantitating	|O
periods	|O
of	|O
apnea	|O
in	|O
pediatric	|O
patients	|O
.	|O

The	|O
other	|O
hypoglycaemic	|O
patient	|O
showed	|O
an	|O
exaggerated	|O
insulin	|B-PROTEIN
release	|O
in	|O
response	|O
to	|O
tolbutamide	|O
.	|O

Nerve	|O
stimulation	|O
(	|O
1.5-12	|O
cycles	|O
/	|O
s	|O
)	|O
produced	|O
frequency	|O
-	|O
dependent	|O
reductions	|O
in	|O
CBF	|O
,	|O
a	|O
decrease	|O
of	|O
50	|O
percent	|O
occurring	|O
with	|O
the	|O
highest	|O
frequency	|O
.	|O

Effect	|O
of	|O
ingestion	|O
of	|O
Norbiogest	|O
during	|O
the	|O
quiescent	|O
period	|O
of	|O
the	|O
genital	|O
organs	|O

Risk	|O
of	|O
infection	|O
in	|O
the	|O
treatment	|O
of	|O
fractures	|O

Bulbar	|O
pouches	|O
were	|O
perfused	|O
with	|O
solutions	|O
of	|O
0.9%	|O
Na	|O
C1	|O
,	|O
0.1	|O
N	|O
HC1	|O
,	|O
40%	|O
glucose	|O
,	|O
40%	|O
NaC1	|O
,	|O
and	|O
40%	|O
peptone	|O
or	|O
with	|O
0.1%	|O
solutions	|O
of	|O
acetylcholine	|O
chloride	|O
.	|O

Liver	|O
microsomes	|O
of	|O
the	|O
shag	|O
showed	|O
smaller	|O
than	|O
8%	|O
of	|O
the	|O
epoxide	|B-PROTEIN
hydrase	|I-PROTEIN
activity	|O
and	|O
smaller	|O
than	|O
14%	|O
of	|O
the	|O
hydroxylating	|O
capacity	|O
of	|O
liver	|O
microsomes	|O
from	|O
the	|O
rat	|O
.	|O

Prolonged	|O
heavy	|O
work	|O
effected	|O
an	|O
increase	|O
of	|O
10.3	|O
plus	|O
or	|O
minus	|O
0.9	|O
mmHg	|O
in	|O
in	|O
vivo	|O
P50	|O
(	|O
7.30	|O
PH	|O
-	|O
v	|O
,	|O
41	|O
degrees	|O
C	|O
-	|O
v	|O
,	|O
and	|O
45	|O
Pv	|O
-	|O
CO2	|O
)	|O
;	|O
due	|O
entirely	|O
to	|O
the	|O
additive	|O
effects	|O
of	|O
increased	|O
venous	|O
temperature	|O
and	|O
[	|O
H+	|O
]	|O
.	|O

A	|O
clinical	|O
,	|O
serological	|O
and	|O
prognostic	|O
study	|O

The	|O
American	|O
Burkitt	|O
Lymphoma	|O
Registry	|O
:	|O
a	|O
progress	|O
report	|O
.	|O

Vitrectomy	|O
with	|O
an	|O
alternative	|O
instrument	|O
system	|O
.	|O

The	|O
metabolic	|O
clearance	|O
rate	|O
of	|O
progesterone	|O
was	|O
295	|O
+	|O
/	|O
-	|O
49	|O
(	|O
S.E.	|O
)	|O
1	|O
/	|O
day	|O
.	|O

This	|O
sequence	|O
is	|O
almost	|O
identical	|O
with	|O
that	|O
of	|O
human	|O
luteinizing	|B-PROTEIN
hormone	|I-PROTEIN
(	|O
Sairam	|O
,	|O
M.	|O

The	|O
mean	|O
plasma	|O
sodium	|O
concentration	|O
which	|O
was	|O
135.95	|O
(	|O
+	|O
/	|O
-	|O
SD	|O
4.14	|O
)	|O
mEq	|O
/	|O
kg	|O
before	|O
diuretic	|O
treatment	|O
was	|O
significantly	|O
decreased	|O
during	|O
treatment	|O
to	|O
129.19	|O
(	|O
+	|O
/	|O
-	|O
SD	|O
2.77	|O
)	|O
mEq	|O
/	|O
kg	|O
,	|O
P	|O
less	|O
than	|O
0.001	|O
.	|O

Editorial	|O
:	|O
Low	|O
-	|O
dose	|O
heparin	|O
and	|O
the	|O
prevention	|O
of	|O
venous	|O
thromboembolic	|O
disease	|O
.	|O

At	|O
the	|O
very	|O
high	|O
dose	|O
levels	|O
used	|O
,	|O
sodium	|O
saccharin	|O
and	|O
sodium	|O
cyclamate	|O
were	|O
weak	|O
solitary	|O
carcinogens	|O
producing	|O
4/253	|O
and	|O
3/228	|O
bladder	|O
tumours	|O
respectively	|O
,	|O
and	|O
the	|O
first	|O
of	|O
these	|O
tumours	|O
did	|O
not	|O
appear	|O
for	|O
more	|O
than	|O
80	|O
weeks	|O
.	|O

Effects	|O
of	|O
perceptual	|O
salience	|O
on	|O
the	|O
matrix	|O
task	|O
performance	|O
of	|O
four	|O
-	|O
and	|O
six	|O
-	|O
year	|O
-	|O
old	|O
children	|O
.	|O

Glucose	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
dehydrogenase	|I-PROTEIN
(	|O
G	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
PD	|I-PROTEIN
)	|O
deficiency	|O
in	|O
the	|O
newborn	|O
.	|O

The	|O
eluting	|O
solvent	|O
was	|O
methanol	|O
-	|O
chloroform	|O
(	|O
10	|O
+	|O
90	|O
)	|O
at	|O
a	|O
flow	|O
rate	|O
of	|O
2.0	|O
ml	|O
/	|O
min	|O
.	|O

The	|O
bronchial	|O
epithelia	|O
of	|O
all	|O
smoke	|O
-	|O
exposed	|O
animals	|O
were	|O
hyperplastic	|O
,	|O
and	|O
their	|O
ultrastructure	|O
showed	|O
invaginations	|O
,	|O
tilt	|O
of	|O
nuclear	|O
axes	|O
,	|O
an	|O
increase	|O
in	|O
the	|O
number	|O
and	|O
size	|O
of	|O
lysosomes	|O
and	|O
multivesiculated	|O
bodies	|O
,	|O
and	|O
increased	|O
numbers	|O
of	|O
enlarged	|O
intramitochondrial	|O
granules	|O
.	|O

The	|O
routine	|O
administration	|O
of	|O
fat	|O
-	|O
soluble	|O
vitamins	|O
appears	|O
unnecessary	|O
but	|O
it	|O
is	|O
prudent	|O
to	|O
measure	|O
prothrombin	|B-PROTEIN
time	|O
and	|O
serum	|O
vitamins	|O
A	|O
and	|O
E	|O
at	|O
intervals	|O
.	|O

Prostaglandins	|O
F	|O
(	|O
PGF	|O
)	|O
were	|O
measured	|O
in	|O
uterine	|O
vein	|O
,	|O
ovarian	|O
artery	|O
,	|O
and	|O
jugular	|O
vein	|O
plasma	|O
and	|O
in	|O
the	|O
endometrial	|O
tissues	|O
at	|O
various	|O
times	|O
during	|O
the	|O
bovine	|O
estrous	|O
cycle	|O
,	|O
and	|O
were	|O
compared	|O
to	|O
peripheral	|O
plasma	|O
progesterone	|O
levels	|O
.	|O

Before	|O
this	|O
date	|O
,	|O
the	|O
drug	|O
directly	|O
inhibits	|O
fetal	|O
weight	|O
gain	|O
,	|O
whereas	|O
the	|O
sensitivity	|O
of	|O
the	|O
placenta	|O
is	|O
only	|O
transient	|O
at	|O
day	|O
16	|O
resulting	|O
in	|O
maximum	|O
weight	|O
decrease	|O
of	|O
this	|O
organ	|O
24	|O
h	|O
later	|O
.	|O

Groups	|O
of	|O
ten	|O
dependent	|O
and	|O
ten	|O
saline	|O
mice	|O
were	|O
singly	|O
tested	|O
in	|O
both	|O
light	|O
and	|O
dark	|O
conditions	|O
in	|O
each	|O
of	|O
five	|O
covered	|O
cylinders	|O
(	|O
2-23	|O
in	|O
high	|O
)	|O
.	|O

The	|O
effects	|O
initiated	|O
from	|O
the	|O
nucleus	|O
accumbens	|O
septi	|O
were	|O
most	|O
marked	|O
.	|O

The	|O
appearance	|O
of	|O
dyskinetic	|O
movement	|O
disorders	|O
in	|O
humans	|O
following	|O
the	|O
chronic	|O
use	|O
of	|O
levodopa	|O
or	|O
amphetamine	|O
may	|O
be	|O
a	|O
manifestation	|O
of	|O
similarly	|O
increased	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
site	|O
sensitivity	|O
within	|O
the	|O
striatum	|O
.	|O

Association	|O
with	|O
HL	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
W	|I-PROTEIN
-	|I-PROTEIN
27	|I-PROTEIN
.	|O

Letter	|O
:	|O
Lactose	|O
tolerance	|O
tests	|O
as	|O
a	|O
predictor	|O
of	|O
milk	|O
tolerance	|O
.	|O

Retinoblastoma	|O
:	|O
a	|O
study	|O
of	|O
natural	|O
history	|O
and	|O
prognosis	|O
of	|O
268	|O
cases	|O
.	|O

Like	|O
pineal	|O
melatonin	|O
,	|O
serum	|O
melatonin	|O
was	|O
high	|O
at	|O
mid	|O
-	|O
dark	|O
and	|O
low	|O
at	|O
mid	|O
-	|O
light	|O
.	|O

D.	|O

Atherosclerosis	|O

The	|O
authors	|O
concluded	|O
that	|O
ultrasonic	|O
Doppler	|O
-	|O
cardiography	|O
can	|O
be	|O
used	|O
for	|O
measuring	|O
the	|O
relative	|O
changes	|O
in	|O
the	|O
stroke	|O
volume	|O
.	|O

The	|O
attainment	|O
of	|O
sexual	|O
maturity	|O
in	|O
terms	|O
of	|O
secondary	|O
sexual	|O
characteristics	|O
,	|O
the	|O
production	|O
of	|O
spermatozoa	|O
in	|O
the	|O
male	|O
,	|O
and	|O
the	|O
cyclical	|O
female	|O
pattern	|O
with	|O
release	|O
of	|O
ova	|O
are	|O
end	|O
-	|O
points	|O
of	|O
the	|O
developmental	|O
process	|O
.	|O

However	|O
,	|O
a	|O
10	|O
-	|O
-	|O
15%	|O
lengthening	|O
of	|O
the	|O
partial	|O
thromboplastin	|B-PROTEIN
time	|O
is	|O
evident	|O
after	|O
24	|O
hours	|O
of	|O
storage	|O
.	|O

Caution	|O
should	|O
be	|O
exercised	|O
in	|O
the	|O
use	|O
of	|O
these	|O
dyes	|O
for	|O
lymphograms	|O
.	|O

This	|O
reveals	|O
a	|O
new	|O
test	|O
for	|O
short	|O
saphenous	|O
incompetence	|O
and	|O
shows	|O
that	|O
14	|O
per	|O
cent	|O
of	|O
varices	|O
stem	|O
from	|O
a	|O
saphenopopliteal	|O
reflux	|O
.	|O

Three	|O
groups	|O
of	|O
patients	|O
who	|O
had	|O
undergone	|O
subtotal	|O
thyroidectomy	|O
for	|O
Graves	|O
's	|O
disease	|O
,	|O
toxic	|O
multinodular	|O
goitre	|O
,	|O
or	|O
euthyroid	|O
multinodular	|O
goitre	|O
12	|O
to	|O
15	|O
years	|O
before	|O
and	|O
in	|O
whom	|O
a	|O
normal	|O
serum	|O
thyroxine	|O
(	|O
T	|O
-	|O
4	|O
)	|O
level	|O
was	|O
found	|O
were	|O
each	|O
divided	|O
into	|O
two	|O
subgroups	|O
on	|O
the	|O
basis	|O
of	|O
a	|O
normal	|O
or	|O
a	|O
raised	|O
serum	|O
thyrotrophin	|B-PROTEIN
concentration	|O
.	|O

Routine	|O
isotope	|O
cystography	|O
using	|O
99M	|O
Tc	|O
sulfur	|O
colloid	|O
for	|O
detection	|O
and	|O
follow	|O
-	|O
up	|O
of	|O
vesico	|O
-	|O
ureteral	|O
reflux	|O

Air	|O
ion	|O
action	|O
on	|O
bacteria	|O
.	|O

No	|O
evidence	|O
of	|O
either	|O
positive	|O
or	|O
negative	|O
chemography	|O
was	|O
found	|O
.	|O

The	|O
interpretation	|O
of	|O
antibiotic	|O
disc	|O
sensitivities	|O
.	|O

Following	|O
retransfusion	|O
,	|O
the	|O
affected	|O
epithelial	|O
lining	|O
appeared	|O
greatly	|O
distended	|O
over	|O
the	|O
oedematous	|O
lamina	|O
propria	|O
,	|O
with	|O
almost	|O
complete	|O
loss	|O
of	|O
structural	|O
detail	|O
.	|O

A	|O
study	|O
of	|O
chromosomes	|O
of	|O
lymphocytes	|O
from	|O
patients	|O
treated	|O
with	|O
hycanthone	|O
.	|O

Characteristics	|O
of	|O
anesthesia	|O
and	|O
resuscitation	|O
in	|O
emergency	|O
lung	|O
surgery	|O

Study	|O
of	|O
the	|O
physico	|O
-	|O
chemical	|O
state	|O
of	|O
plutonium	|O
-	|O
239	|O
in	|O
a	|O
citrate	|O
solution	|O
-	|O
blood	|O
system	|O

Tobramycin	|O
60	|O
mg	|O
did	|O
not	|O
show	|O
any	|O
remarkable	|O
effect	|O
,	|O
but	|O
dibecacin	|O
100	|O
mg	|O
produced	|O
a	|O
slight	|O
potentiating	|O
effect	|O
on	|O
the	|O
action	|O
of	|O
d	|O
-	|O
tubocurarine	|O
.	|O

In	|O
about	|O
one	|O
third	|O
of	|O
the	|O
cases	|O
this	|O
operation	|O
results	|O
in	|O
tonal	|O
and	|O
vocal	|O
improvement	|O
for	|O
patients	|O
suffering	|O
from	|O
progressive	|O
perceptive	|O
deafness	|O
.	|O

The	|O
specific	|O
electrical	|O
resistance	|O
of	|O
the	|O
cerebrospinal	|O
fluid	|O
was	|O
measured	|O
by	|O
means	|O
of	|O
conductometry	|O
in	|O
14	|O
cases	|O
of	|O
meningitis	|O
purulenta	|O
,	|O
17	|O
cases	|O
of	|O
meningitis	|O
serosa	|O
,	|O
10	|O
cases	|O
of	|O
encephalitis	|O
and	|O
in	|O
32	|O
control	|O
subjects	|O
.	|O

2	|O
-	|O
Chemical	|O
occlusion	|O
of	|O
vas	|O
is	|O
quite	|O
effective	|O
in	|O
producing	|O
a	|O
block	|O
in	|O
the	|O
vas	|O
deferens	|O
of	|O
dogs	|O
.	|O

Besides	|O
,	|O
we	|O
found	|O
in	|O
3	|O
patients	|O
increased	|O
serum	|O
immunoglobulins	|B-PROTEIN
,	|O
chiefly	|O
IgG	|B-PROTEIN
,	|O
as	|O
first	|O
Russe	|O
,	|O
Busey	|O
and	|O
Barbeau	|O
demonstrated	|O
in	|O
a	|O
large	|O
French	|O
-	|O
Canadian	|O
family	|O
.	|O

We	|O
suggest	|O
that	|O
such	|O
occlusions	|O
occurred	|O
at	|O
the	|O
time	|O
of	|O
the	|O
infarction	|O
.	|O

Streptococcal	|O
preparation	|O
(	|O
OK	|O
-	|O
432	|O
)	|O
,	|O
a	|O
new	|O
type	|O
of	|O
anti	|O
-	|O
cancer	|O
agent	|O
,	|O
was	|O
given	|O
to	|O
the	|O
patients	|O
with	|O
advanced	|O
cancer	|O
in	|O
combination	|O
with	|O
Mitomycin	|O
-	|O
C	|O
,	|O
5	|O
-	|O
FU	|O
and	|O
Cytosine	|O
arabinoside	|O
.	|O

Generally	|O
,	|O
a	|O
correlation	|O
was	|O
observed	|O
between	|O
highest	|O
concentrations	|O
of	|O
CSF	|O
immunoglobulins	|B-PROTEIN
and	|O
degree	|O
of	|O
meningeal	|O
inflammatory	|O
response	|O
,	|O
even	|O
if	|O
this	|O
was	|O
a	|O
component	|O
of	|O
other	|O
neurological	|O
diseases	|O
.	|O

Maternal	|O
lactation	|O

Experimental	|O
cardiotoxicity	|O
of	|O
adriamycin	|O

Muscular	|O
pathology	|O

Demonstration	|O
of	|O
the	|O
agent	|O
was	|O
performed	|O
from	|O
the	|O
6th	|O
to	|O
the	|O
11th	|O
day	|O
p.i	|O
.	|O
by	|O
direct	|O
microscopic	|O
methods	|O
(	|O
Stamp	|O
and	|O
auramine	|O
staining	|O
,	|O
fluorescent	|O
antibody	|O
technique	|O
)	|O
;	|O
the	|O
Coxiella	|O
content	|O
was	|O
determined	|O
by	|O
titration	|O
in	|O
embryonated	|O
hen	|O
's	|O
eggs	|O
.	|O

The	|O
patients	|O
were	|O
divided	|O
into	|O
4	|O
groups	|O
receiving	|O
NLA	|O
II	|O
with	|O
or	|O
without	|O
nalorphine	|O
,	|O
morphine	|O
or	|O
Micoren	|O
.	|O

The	|O
alterations	|O
of	|O
5	|O
-	|O
HT	|O
and	|O
5	|O
-	|O
HIAA	|O
levels	|O
in	|O
several	|O
regions	|O
of	|O
the	|O
brain	|O
under	|O
the	|O
conditions	|O
examined	|O
may	|O
indicate	|O
that	|O
IDPN	|O
's	|O
neurotoxicity	|O
primarily	|O
affects	|O
5	|O
-	|O
HT	|O
-	|O
containing	|O
neurones	|O
.	|O

(	|O
5	|O
)	|O
An	|O
increase	|O
in	|O
leukocyte	|O
-	|O
counts	|O
occurred	|O
on	|O
the	|O
administration	|O
of	|O
serum	|O
obtained	|O
from	|O
rabbit	|O
during	|O
phase	|O
-	|O
2	|O
.	|O

The	|O
results	|O
obtained	|O
tend	|O
to	|O
prove	|O
that	|O
the	|O
reticuloendothelial	|O
system	|O
mainly	|O
participated	|O
in	|O
beryllium	|O
retention	|O
.	|O

In	|O
both	|O
cases	|O
,	|O
at	|O
the	|O
end	|O
of	|O
exposure	|O
the	|O
same	|O
level	|O
of	|O
blood	|O
carboxyhemoglobin	|B-PROTEIN
(	|O
COHb	|B-PROTEIN
)	|O
(	|O
about	|O
50%	|O
)	|O
was	|O
reached	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
increased	|O
pulmonary	|O
blood	|O
flow	|O
and	|O
decreased	|O
pulmonary	|O
vascular	|O
resistance	|O
with	|O
advancing	|O
gestation	|O
are	|O
due	|O
to	|O
an	|O
increase	|O
in	|O
the	|O
total	|O
number	|O
of	|O
vessels	|O
and	|O
increased	|O
vasomotor	|O
reactivity	|O
is	|O
related	|O
to	|O
an	|O
increase	|O
in	|O
the	|O
total	|O
amount	|O
of	|O
smooth	|O
muscle	|O
while	|O
the	|O
thickness	|O
of	|O
muscle	|O
in	|O
individual	|O
vessels	|O
remains	|O
constant	|O
.	|O

Reduction	|O
in	|O
dosage	|O
restored	|O
normal	|O
taste	|O
sense	|O
in	|O
all	|O
three	|O
,	|O
but	|O
in	|O
two	|O
the	|O
drug	|O
had	|O
to	|O
be	|O
discontinued	|O
because	|O
of	|O
persisting	|O
high	|O
transaminase	|O
levels	|O
.	|O

The	|O
calcium	|O
ratio	|O
(	|O
mean	|O
ratio	|O
of	|O
the	|O
predicted	|O
to	|O
measured	|O
TBCa	|O
)	|O
in	|O
men	|O
was	|O
1.000	|O
+	|O
/	|O
-	|O
7.8%	|O
and	|O
in	|O
women	|O
0.996	|O
+	|O
/	|O
-	|O
7.1%	|O
.	|O

A	|O
late	|O
diagnosis	|O
of	|O
retinoblastoma	|O
is	|O
an	|O
unquestionable	|O
fact	|O
that	|O
allows	|O
its	|O
growth	|O
and	|O
leads	|O
to	|O
a	|O
deterioration	|O
in	|O
the	|O
outlook	|O
.	|O

Total	|O
cholesterol	|O
was	|O
measured	|O
in	|O
amniotic	|O
fluids	|O
collected	|O
at	|O
different	|O
stages	|O
of	|O
gestation	|O
.	|O

Her	|O
serum	|O
FT3	|O
concentration	|O
was	|O
,	|O
however	|O
,	|O
much	|O
higher	|O
than	|O
the	|O
ranges	|O
in	|O
normal	|O
pregnancy	|O
or	|O
in	|O
GTD	|O
patients	|O
without	|O
clinical	|O
hyperthyroidism	|O
.	|O

The	|O
authors	|O
found	|O
that	|O
except	|O
for	|O
fear	|O
and	|O
pugnacity	|O
all	|O
husband	|O
-	|O
wife	|O
trait	|O
correlations	|O
were	|O
positive	|O
,	|O
in	|O
contrast	|O
to	|O
Winch	|O
's	|O
principle	|O
of	|O
type	|O
I	|O
complementarity	|O
.	|O

A	|O
note	|O
on	|O
the	|O
phase	|O
-	|O
plane	|O
technique	|O
representation	|O
of	|O
cardiac	|O
action	|O
potentials	|O
.	|O

3	|O
activities	|O
of	|O
the	|O
factor	|B-PROTEIN
II	|I-PROTEIN
molecule	|O
in	|O
the	|O
newborn	|O
infant	|O
at	|O
term	|O

The	|O
concept	|O
of	|O
"	|O
structural	|O
identifiability	|O
"	|O
is	|O
employed	|O
in	|O
this	|O
analysis	|O
to	|O
determine	|O
which	|O
model	|O
parameters	|O
can	|O
be	|O
and	|O
which	|O
cannot	|O
be	|O
determined	|O
"	|O
uniquely	|O
"	|O
from	|O
given	|O
input	|O
-	|O
output	|O
data	|O
;	|O
a	|O
step	|O
-	|O
by	|O
-	|O
step	|O
procedure	|O
based	|O
on	|O
an	|O
extension	|O
of	|O
this	|O
concept	|O
is	|O
presented	|O
for	|O
adapting	|O
the	|O
overall	|O
approach	|O
to	|O
the	|O
experimental	|O
design	|O
problem	|O
.	|O

However	|O
,	|O
we	|O
did	|O
detect	|O
lot	|O
-	|O
to	|O
-	|O
lot	|O
variation	|O
and	|O
differences	|O
in	|O
performance	|O
between	|O
narrow	|O
bandpass	|O
and	|O
wide	|O
bandpass	|O
spectrophotometers	|O
.	|O

The	|O
cochlear	|O
compromise	|O
.	|O

A	|O
case	|O
observed	|O
in	|O
Saigon	|O

Hypertonic	|O
glucose	|O
administered	|O
intrajejunally	|O
in	|O
Heidenhain	|O
pouch	|O
dogs	|O
resulted	|O
in	|O
an	|O
equal	|O
inhibition	|O
of	|O
pentagastrin	|O
-	|O
induced	|O
acid	|O
secretion	|O
from	|O
the	|O
pouch	|O
and	|O
the	|O
main	|O
stomach	|O
,	|O
whereas	|O
hypertonic	|O
saline	|O
had	|O
no	|O
effect	|O
.	|O

Acquired	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
inhibitor	|O
in	|O
non	|O
-	|O
hemophilic	|O
patients	|O

Biohydrogenation	|O
of	|O
linoleic	|O
acid	|O
into	|O
octadecenoic	|O
acid	|O
was	|O
observed	|O
.	|O

The	|O
study	|O
of	|O
calcium	|O
metabolism	|O
in	|O
ten	|O
thalassaemic	|O
children	|O
comperatively	|O
with	|O
controls	|O
after	|O
oral	|O
administration	|O
of	|O
47Ca	|O
has	|O
shown	|O
diminished	|O
intestinal	|O
absorption	|O
.	|O

Chlamydial	|O
agents	|O
were	|O
isolated	|O
from	|O
the	|O
semen	|O
near	|O
the	|O
end	|O
of	|O
the	|O
chlamydemic	|O
phase	|O
.	|O

Because	|O
of	|O
the	|O
increased	|O
CPK	|B-PROTEIN
activity	|O
found	|O
in	|O
normal	|O
newborns	|O
,	|O
screening	|O
for	|O
Duchenne	|O
-	|O
type	|O
muscular	|O
dystrophy	|O
should	|O
be	|O
postponed	|O
for	|O
a	|O
few	|O
weeks	|O
after	|O
delivery	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
insulin	|B-PROTEIN
response	|O
had	|O
returned	|O
to	|O
the	|O
non	|O
-	|O
pregnant	|O
value	|O
by	|O
the	|O
second	|O
day	|O
of	|O
the	|O
puerperium	|O
.	|O

The	|O
authors	|O
report	|O
the	|O
results	|O
of	|O
a	|O
series	|O
of	|O
toxicological	|O
tests	|O
conducted	|O
on	|O
plastic	|O
materials	|O
(	|O
polyethylene	|O
)	|O
activated	|O
with	|O
tetraphenylbutadiene	|O
(	|O
TPB	|O
)	|O
an	|O
additive	|O
recently	|O
proposed	|O
as	|O
a	|O
sensitizer	|O
capable	|O
of	|O
photodegrading	|O
plastic	|O
materials	|O
.	|O

Mutational	|O
analysis	|O
of	|O
the	|O
major	|O
homology	|O
region	|O
of	|O
Mason	|O
-	|O
Pfizer	|O
monkey	|O
virus	|O
by	|O
use	|O
of	|O
saturation	|O
mutagenesis	|O
.	|O

One	|O
site	|O
,	|O
PAL	|B-PROTEIN
,	|O
occurs	|O
within	|O
the	|O
10	|O
bp	|O
sequence	|O
GGGGAGGAGG	|O
.	|O

Nuclear	|O
extracts	|O
prepared	|O
from	|O
both	|O
neural	|O
and	|O
non	|O
-	|O
neural	|O
cell	|O
lines	|O
,	|O
mouse	|O
brain	|O
,	|O
and	|O
mouse	|O
liver	|O
contain	|O
proteins	|O
that	|O
recognize	|O
and	|O
bind	|O
to	|O
the	|O
PROX	|O
and	|O
PAL	|O
sequences	|O
indicating	|O
that	|O
proteins	|O
which	|O
bind	|O
to	|O
these	|O
target	|O
sequences	|O
are	|O
widespread	|O
.	|O

To	|O
determine	|O
if	|O
the	|O
NF	|B-PROTEIN
(	|I-PROTEIN
H	|I-PROTEIN
)	|I-PROTEIN
promoter	|O
can	|O
be	|O
activated	|O
in	|O
a	|O
tissue	|O
specific	|O
manner	|O
during	|O
development	|O
transgenic	|O
mice	|O
containing	|O
the	|O
promoter	|O
region	|O
linked	|O
to	|O
a	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
reporter	|O
gene	|O
were	|O
generated	|O
.	|O

Here	|O
we	|O
describe	|O
and	|O
map	|O
two	|O
more	|O
new	|O
genes	|O
identified	|O
as	|O
allele	|O
-	|O
specific	|O
suppressors	|O
that	|O
compensate	|O
for	|O
carboxy	|O
-	|O
terminal	|O
truncation	|O
of	|O
PET122	|B-PROTEIN
.	|O

Previous	|O
studies	|O
have	|O
shown	|O
[	|O
Hisanaga	|O
,	|O
S.	|O
,	|O
Kusubata	|O
,	|O
M.	|O
,	|O
Okumura	|O
,	|O
E.	|O
&	|O
Kishimoto	|O
,	|O
T.	|O

Treatment	|O
and	|O
staining	|O
of	|O
smears	|O
and	|O
sections	|O
for	|O
detection	|O
of	|O
microorganisms	|O

The	|O
apparent	|O
Kd	|O
of	|O
the	|O
MetRS	|B-PROTEIN
/	|I-PROTEIN
CAU	|I-PROTEIN
operator	|O
complex	|O
is	|O
one	|O
order	|O
magnitude	|O
higher	|O
than	|O
that	|O
of	|O
the	|O
ThrRS	|B-PROTEIN
/	|I-PROTEIN
CGU	|I-PROTEIN
operator	|O
complex	|O
.	|O

A	|O
significant	|O
direct	|O
relationship	|O
was	|O
observed	|O
between	|O
the	|O
percent	|O
area	|O
density	|O
of	|O
smooth	|O
muscle	|O
and	|O
the	|O
percent	|O
change	|O
in	|O
peak	|O
urinary	|O
flow	|O
rate	|O
.	|O

Rabbit	|O
skeletal	|O
muscle	|O
glycogenin	|B-PROTEIN
.	|O

Characterization	|O
of	|O
the	|O
human	|O
gene	|O
encoding	|O
cytokeratin	|B-PROTEIN
17	|I-PROTEIN
and	|O
its	|O
expression	|O
pattern	|O
.	|O

Animals	|O
that	|O
received	|O
DSP	|O
-	|O
4	|O
were	|O
significantly	|O
retarded	|O
in	|O
motor	|O
recovery	|O
compared	|O
with	|O
the	|O
saline	|O
group	|O
.	|O

The	|O
prophylactic	|O
use	|O
of	|O
new	|O
medication	|O
for	|O
patients	|O
between	|O
the	|O
first	|O
and	|O
second	|O
cycle	|O
of	|O
chemotherapy	|O
,	|O
in	|O
agreement	|O
with	|O
the	|O
estimates	|O
calculated	|O
,	|O
does	|O
not	|O
save	|O
health	|O
care	|O
costs	|O
but	|O
may	|O
improve	|O
the	|O
quality	|O
of	|O
life	|O
in	|O
these	|O
patients	|O
and	|O
permit	|O
the	|O
continuation	|O
of	|O
a	|O
therapeutic	|O
schedule	|O
without	|O
interruption	|O
which	|O
may	|O
improve	|O
the	|O
life	|O
expectancy	|O
of	|O
the	|O
patient	|O
.	|O

AP	|O
was	|O
induced	|O
by	|O
intraductal	|O
infusion	|O
of	|O
two	|O
different	|O
concentrations	|O
of	|O
glycodeoxycholic	|O
acid	|O
(	|O
GDOC	|O
17	|O
mmol	|O
and	|O
34	|O
mmol	|O
)	|O
.	|O

The	|O
isolation	|O
of	|O
this	|O
gene	|O
was	|O
based	|O
on	|O
the	|O
identification	|O
of	|O
the	|O
Y	|O
-	|O
231	|O
cosmid	|O
that	|O
contains	|O
CpG	|O
rich	|O
sequences	|O
(	|O
HTF	|O
islands	|O
)	|O
in	|O
its	|O
human	|O
insert	|O
.	|O

Tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
,	|O
its	|O
inhibitor	|O
and	|O
other	|O
parameters	|O
of	|O
fibrinolysis	|O
in	|O
blood	|O
of	|O
patients	|O
operated	|O
for	|O
mild	|O
hypertrophy	|O
of	|O
the	|O
prostate	|O

Gene	|O
constructs	|O
consisting	|O
of	|O
human	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
(	|O
hGH	|B-PROTEIN
)	|O
gene	|O
driven	|O
by	|O
promoter	|O
/	|O
regulatory	|O
sequence	|O
of	|O
mouse	|B-PROTEIN
metallothionein	|I-PROTEIN
(	|O
mMT	|B-PROTEIN
)	|O
,	|O
viral	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
vTK	|B-PROTEIN
)	|O
,	|O
rat	|O
cholecystokinin	|B-PROTEIN
(	|O
rCCK	|B-PROTEIN
)	|O
,	|O
or	|O
chicken	|O
beta	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
(	|O
cBA	|B-PROTEIN
)	|O
gene	|O
were	|O
injected	|O
into	|O
the	|O
cytoplasm	|O
of	|O
fertilized	|O
medaka	|O
eggs	|O
via	|O
the	|O
micropyle	|O
.	|O

Serum	|O
gastrin	|B-PROTEIN
and	|O
AFP	|B-PROTEIN
levels	|O
had	|O
the	|O
same	|O
evolution	|O
and	|O
appear	|O
to	|O
have	|O
the	|O
same	|O
interest	|O
to	|O
follow	|O
the	|O
course	|O
of	|O
the	|O
disease	|O
.	|O

Prospects	|O
for	|O
controlled	|O
-	|O
delivery	|O
systems	|O
.	|O

The	|O
mean	|O
(	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
PaO2	|O
increased	|O
from	|O
80.8	|O
+	|O
/	|O
-	|O
26.9	|O
mmHg	|O
before	|O
to	|O
89.8	|O
+	|O
/	|O
-	|O
27.3	|O
mmHg	|O
after	|O
the	|O
infusion	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
and	|O
the	|O
PaCO2	|O
decreased	|O
from	|O
42.4	|O
+	|O
/	|O
-	|O
8.3	|O
to	|O
39.6	|O
+	|O
/	|O
-	|O
7.9	|O
mmHg	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

Though	|O
hepatomegaly	|O
and	|O
mild	|O
elevation	|O
of	|O
enzymes	|O
can	|O
be	|O
observed	|O
in	|O
a	|O
significant	|O
proportion	|O
of	|O
patients	|O
,	|O
involvement	|O
of	|O
liver	|O
leading	|O
to	|O
acute	|O
hepatitis	|O
or	|O
liver	|O
cell	|O
necrosis	|O
is	|O
a	|O
relatively	|O
uncommon	|O
complication	|O
in	|O
P.	|O
falciparum	|O
malaria	|O
.	|O

For	|O
the	|O
first	|O
group	|O
,	|O
the	|O
maximal	|O
decrease	|O
in	|O
plasma	|O
potassium	|O
elicited	|O
by	|O
salbutamol	|O
was	|O
0.80	|O
+	|O
/	|O
-	|O
0.19	|O
,	|O
0.48	|O
+	|O
/	|O
-	|O
0.22	|O
,	|O
and	|O
0.78	|O
+	|O
/	|O
-	|O
0.46	|O
mmol	|O
/	|O
l	|O
,	|O
and	|O
for	|O
the	|O
second	|O
group	|O
,	|O
maximal	|O
decrement	|O
was	|O
1.31	|O
+	|O
/	|O
-	|O
0.37	|O
,	|O
0.70	|O
+	|O
/	|O
-	|O
0.24	|O
,	|O
and	|O
0.84	|O
+	|O
/	|O
-	|O
0.17	|O
mmol	|O
/	|O
l	|O
for	|O
the	|O
iv	|O
,	|O
po	|O
,	|O
and	|O
it	|O
routes	|O
,	|O
respectively	|O
.	|O

The	|O
two	|O
drugs	|O
increase	|O
the	|O
rate	|O
of	|O
early	|O
diastolic	|O
filling	|O
.	|O

A	|O
statistically	|O
significant	|O
improvement	|O
due	|O
to	|O
the	|O
administration	|O
of	|O
Bromergon	|O
was	|O
observed	|O
in	|O
symptoms	|O
associated	|O
with	|O
overreactiveness	|O
to	|O
normal	|O
prolactin	|B-PROTEIN
levels	|O
,	|O
i.e.	|O
abdominal	|O
tension	|O
,	|O
edema	|O
,	|O
weight	|O
gain	|O
and	|O
breast	|O
tenderness	|O
.	|O

The	|O
magnitude	|O
of	|O
the	|O
early	|O
response	|O
was	|O
241	|O
+	|O
/	|O
-	|O
51%	|O
in	|O
A	|O
(	|O
%	|O
baseline	|O
RL	|O
;	|O
mean	|O
+	|O
/	|O
-	|O
SE	|O
)	|O
,	|O
and	|O
significantly	|O
less	|O
in	|O
B	|O
(	|O
119	|O
+	|O
/	|O
-	|O
7%	|O
)	|O
and	|O
C	|O
(	|O
131	|O
+	|O
/	|O
-	|O
16%	|O
)	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
.	|O

Most	|O
of	|O
the	|O
patients	|O
presented	|O
with	|O
Transient	|O
Ischemic	|O
Attacks	|O
(	|O
64%	|O
)	|O
or	|O
Reversible	|O
Ischemic	|O
Neurologic	|O
Deficits	|O
(	|O
19%	|O
)	|O
.	|O

We	|O
cloned	|O
the	|O
third	|O
human	|O
gene	|O
for	|O
the	|O
LD78	|B-PROTEIN
,	|O
termed	|O
LD78	|B-PROTEIN
gamma	|I-PROTEIN
and	|O
the	|O
sequence	|O
analysis	|O
showed	|O
that	|O
it	|O
is	|O
a	|O
5'	|O
-	|O
truncated	|O
pseudogene	|O
.	|O

This	|O
analysis	|O
,	|O
together	|O
with	|O
a	|O
consideration	|O
of	|O
the	|O
SCBs	|O
found	|O
upstream	|O
of	|O
known	|O
SWI4	|B-PROTEIN
,	|I-PROTEIN
6	|I-PROTEIN
-	|O
dependent	|O
genes	|O
,	|O
leads	|O
to	|O
the	|O
proposal	|O
of	|O
a	|O
revised	|O
consensus	|O
sequence	|O
for	|O
this	|O
important	|O
regulatory	|O
element	|O
.	|O

Mutational	|O
analysis	|O
of	|O
a	|O
DNA	|O
sequence	|O
involved	|O
in	|O
linking	|O
gene	|O
expression	|O
to	|O
the	|O
cell	|O
cycle	|O
.	|O

The	|O
natural	|O
history	|O
of	|O
these	|O
lesions	|O
,	|O
locoregional	|O
efficiency	|O
of	|O
the	|O
different	|O
treatments	|O
used	|O
,	|O
the	|O
part	|O
played	|O
by	|O
chemotherapy	|O
,	|O
survival	|O
,	|O
causes	|O
of	|O
death	|O
and	|O
therapeutic	|O
modalities	|O
used	|O
as	|O
a	|O
last	|O
measure	|O
,	|O
have	|O
been	|O
analysed	|O
.	|O

The	|O
method	|O
was	|O
adapted	|O
for	|O
the	|O
determination	|O
of	|O
nadolol	|O
racemate	|O
A	|O
by	|O
a	|O
change	|O
in	|O
mobile	|O
phase	|O
composition	|O
.	|O

In	|O
general	|O
,	|O
however	|O
,	|O
this	|O
study	|O
provided	|O
little	|O
evidence	|O
of	|O
any	|O
effect	|O
of	|O
supplementation	|O
to	|O
athletic	|O
performance	|O
for	|O
athletes	|O
consuming	|O
the	|O
dietary	|O
RDIs	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
histological	|O
criteria	|O
,	|O
which	|O
it	|O
is	|O
difficult	|O
to	|O
demand	|O
in	|O
view	|O
of	|O
the	|O
variability	|O
of	|O
results	|O
and	|O
potential	|O
dangers	|O
of	|O
endomyocardial	|O
biopsy	|O
involving	|O
such	|O
thin	|O
and	|O
fragile	|O
ventricular	|O
walls	|O
,	|O
the	|O
diagnosis	|O
of	|O
ACRV	|O
is	|O
based	|O
upon	|O
the	|O
concomitant	|O
existence	|O
of	|O
:	|O
(	|O
1	|O
)	|O
electrophysiological	|O
criteria	|O
:	|O
ventricular	|O
arrhythmias	|O
,	|O
in	|O
particular	|O
sustained	|O
monomorphous	|O
VT	|O
,	|O
with	|O
the	|O
particular	|O
feature	|O
of	|O
a	|O
very	|O
high	|O
degree	|O
of	|O
sensitivity	|O
to	|O
adrenergic	|O
stimulation	|O
(	|O
exercise	|O
)	|O
,	|O
the	|O
existence	|O
of	|O
late	|O
potentials	|O
on	|O
the	|O
high	|O
amplification	|O
ECG	|O
,	|O
a	|O
highly	|O
specific	|O
sign	|O
,	|O
though	|O
unfortunately	|O
of	|O
poor	|O
sensitivity	|O
in	|O
localized	|O
froms	|O
,	|O
those	|O
which	|O
are	|O
most	|O
difficult	|O
to	|O
identify	|O
(	|O
2	|O
)	|O
;	|O
segmentary	|O
morphological	|O
and	|O
kinetic	|O
RV	|O
abnormalities	|O
,	|O
most	|O
often	|O
resulting	|O
in	|O
localized	|O
akinetic	|O
or	|O
dyskinetic	|O
parietal	|O
vaulting	|O
,	|O
with	|O
stasis	|O
"	|O
in	|O
situ	|O
"	|O
.	|O

In	|O
7	|O
of	|O
9	|O
cases	|O
,	|O
the	|O
enhancer	|O
is	|O
fused	|O
to	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
bearing	|O
sequences	|O
of	|O
chromosome	|O
8	|O
.	|O

These	|O
components	|O
both	|O
had	|O
a	|O
median	|O
R2	|O
of	|O
0.84	|O
,	|O
compared	|O
to	|O
median	|O
R2s	|O
ranging	|O
from	|O
0.37	|O
to	|O
0.83	|O
for	|O
five	|O
commonly	|O
used	|O
ad	|O
hoc	|O
EEG	|O
components	|O
.	|O

The	|O
obtained	|O
results	|O
were	|O
compared	|O
with	|O
control	|O
group	|O
(	|O
10	|O
female	|O
volunteers	|O
)	|O
.	|O

100	|O
years	|O
of	|O
dentistry	|O
at	|O
the	|O
Friedrich	|O
Schiller	|O
University	|O
in	|O
Jena	|O

The	|O
target	|O
contained	|O
between	|O
positions	|O
-	|O
403	|O
and	|O
-	|O
125	|O
acts	|O
independently	|O
of	|O
orientation	|O
,	|O
in	|O
different	|O
cell	|O
types	|O
and	|O
species	|O
,	|O
and	|O
in	|O
the	|O
context	|O
of	|O
a	|O
heterologous	|O
promoter	|O
.	|O

66	|O
:	|O
469-479	|O
,	|O
1992	|O
)	|O
.	|O

Synergistic	|O
transactivation	|O
of	|O
the	|O
BMRF1	|B-PROTEIN
promoter	|O
by	|O
the	|O
Z	|B-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
combination	|O
appears	|O
to	|O
involve	|O
direct	|O
binding	|O
by	|O
the	|O
Z	|B-PROTEIN
protein	|O
but	|O
not	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
protein	|O
.	|O

The	|O
UCR	|O
core	|O
sequence	|O
,	|O
CGCCATTTT	|O
,	|O
binds	|O
a	|O
ubiquitous	|O
nuclear	|O
factor	|O
and	|O
mediates	|O
negative	|O
regulation	|O
of	|O
MuLV	|O
promoter	|O
activity	|O
.	|O

These	|O
studies	|O
show	|O
that	|O
UCRBP	|B-PROTEIN
binds	|O
to	|O
various	|O
target	|O
motifs	|O
that	|O
are	|O
distinct	|O
from	|O
the	|O
UCR	|O
motif	|O
:	|O
the	|O
adeno	|O
-	|O
associated	|O
virus	|O
P5	|B-PROTEIN
promoter	|O
and	|O
elements	|O
in	|O
the	|O
immunoglobulin	|B-PROTEIN
light	|I-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
heavy	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
genes	|O
,	|O
as	|O
well	|O
as	|O
elements	|O
in	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
genes	|O
.	|O

Possibly	|O
,	|O
the	|O
scr1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutation	|O
does	|O
not	|O
affect	|O
signal	|O
recognition	|O
or	|O
translational	|O
arrest	|O
but	|O
instead	|O
results	|O
in	|O
maintenance	|O
of	|O
translational	|O
arrest	|O
of	|O
AEP	|B-PROTEIN
synthesis	|O
.	|O

The	|O
cellular	|O
sequences	|O
5'	|O
to	|O
the	|O
viral	|O
integration	|O
site	|O
exhibited	|O
85	|O
to	|O
97%	|O
identity	|O
to	|O
several	|O
sequences	|O
belonging	|O
to	|O
the	|O
mouse	|O
L1	|B-PROTEIN
family	|O
of	|O
long	|O
interspersed	|O
repetitive	|O
sequences	|O
.	|O

Both	|O
Rep78	|B-PROTEIN
and	|O
Rep68	|B-PROTEIN
cut	|O
the	|O
terminal	|O
AAV	|O
sequence	|O
at	|O
the	|O
same	|O
site	|O
(	|O
nucleotide	|O
124	|O
)	|O
.	|O

Nucleotide	|O
sequence	|O
analysis	|O
revealed	|O
that	|O
TAR	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
is	|O
very	|O
similar	|O
to	|O
the	|O
CREB2	|B-PROTEIN
protein	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
both	|O
N	|O
-	|O
and	|O
C	|O
-	|O
terminal	|O
mutations	|O
are	|O
required	|O
to	|O
inhibit	|O
transrepression	|O
by	|O
FBR	|B-PROTEIN
protein	|O
and	|O
that	|O
multiple	|O
structural	|O
mutations	|O
accompanied	|O
by	|O
posttranslational	|O
protein	|O
modification	|O
alter	|O
gene	|O
regulation	|O
by	|O
FBR	|B-PROTEIN
protein	|O
.	|O

The	|O
JS78	|O
mutation	|O
changes	|O
Gln243	|O
in	|O
gp0.7	|B-PROTEIN
to	|O
an	|O
amber	|O
codon	|O
,	|O
which	|O
explains	|O
the	|O
production	|O
of	|O
the	|O
truncated	|O
,	|O
30	|O
-	|O
kDa	|O
gp0.7	|B-PROTEIN
-	|O
related	|O
polypeptide	|O
,	|O
and	|O
implicates	|O
the	|O
11	|O
-	|O
kDa	|O
C	|O
-	|O
terminal	|O
domain	|O
in	|O
host	|O
transcription	|O
shut	|O
-	|O
off	|O
.	|O

A	|O
patient	|O
suffering	|O
from	|O
heparin	|O
-	|O
associated	|O
thrombocytopenia	|O
(	|O
HAT	|O
)	|O
,	|O
recurrent	|O
arteriothromboses	|O
,	|O
and	|O
acute	|O
renal	|O
failure	|O
after	|O
treatment	|O
with	|O
standard	|O
heparin	|O
is	|O
described	|O
.	|O

The	|O
predicted	|O
receptor	|O
structure	|O
includes	|O
a	|O
cysteine	|O
-	|O
rich	|O
extracellular	|O
domain	|O
,	|O
a	|O
single	|O
hydrophobic	|O
transmembrane	|O
domain	|O
,	|O
and	|O
a	|O
predicted	|O
cytoplasmic	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
kinase	|I-PROTEIN
domain	|O
.	|O

Drosophila	|O
UbcD1	|B-PROTEIN
encodes	|O
a	|O
highly	|O
conserved	|O
ubiquitin	|B-PROTEIN
-	|O
conjugating	|O
enzyme	|O
involved	|O
in	|O
selective	|O
protein	|O
degradation	|O
.	|O

Analysis	|O
of	|O
the	|O
entire	|O
16.7	|O
-	|O
kb	|O
mt	|O
genome	|O
determined	|O
that	|O
a	|O
MDP1	|B-PROTEIN
mediates	|O
cleavage	|O
of	|O
chick	|O
mtDNA	|O
in	|O
vitro	|O
at	|O
three	|O
H	|O
-	|O
and	|O
two	|O
L	|O
-	|O
strand	|O
sequence	|O
-	|O
specific	|O
target	|O
sites	|O
located	|O
within	|O
a	|O
90	|O
-	|O
bp	|O
A	|O
+	|O
T	|O
-	|O
rich	|O
genomic	|O
tract	|O
,	|O
theoretically	|O
capable	|O
of	|O
forming	|O
stable	|O
secondary	|O
structures	|O
,	|O
approximately	|O
200	|O
bases	|O
upstream	|O
from	|O
the	|O
H	|O
-	|O
strand	|O
origin	|O
(	|O
OH	|O
)	|O
of	|O
replication	|O
.	|O

The	|O
goal	|O
of	|O
the	|O
present	|O
study	|O
was	|O
to	|O
determine	|O
the	|O
feasibility	|O
of	|O
retrovirus	|O
mediated	|O
expression	|O
of	|O
rp47phox	|B-PROTEIN
in	|O
the	|O
HL60	|O
and	|O
U937	|O
human	|O
hematopoietic	|O
cell	|O
lines	|O
,	|O
and	|O
in	|O
an	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
transformed	|O
B	|O
-	|O
lymphocyte	|O
cell	|O
line	|O
(	|O
EBV	|O
-	|O
BCL	|O
)	|O
derived	|O
from	|O
a	|O
p47phox	|B-PROTEIN
-	|O
deficient	|O
CGD	|O
patient	|O
.	|O

Comparison	|O
with	|O
the	|O
sequence	|O
databanks	|O
show	|O
that	|O
Tactile	|B-PROTEIN
is	|O
a	|O
member	|O
of	|O
the	|O
immunoglobulin	|B-PROTEIN
gene	|O
superfamily	|O
,	|O
with	|O
similarity	|O
to	|O
Drosophila	|O
amalgam	|B-PROTEIN
,	|O
the	|O
melanoma	|B-PROTEIN
Ag	|I-PROTEIN
MUC	|O
-	|O
18	|O
,	|O
members	|O
of	|O
the	|O
carcinoembryonic	|B-PROTEIN
Ag	|I-PROTEIN
family	|O
,	|O
the	|O
poliovirus	|B-PROTEIN
receptor	|I-PROTEIN
,	|O
and	|O
the	|O
neural	|B-PROTEIN
cell	|I-PROTEIN
adhesion	|I-PROTEIN
molecule	|I-PROTEIN
.	|O

A	|O
rather	|O
similar	|O
pattern	|O
of	|O
results	|O
was	|O
obtained	|O
with	|O
respect	|O
to	|O
LMP2B	|B-PROTEIN
mRNA	|O
expression	|O
,	|O
such	|O
transcripts	|O
being	|O
detectable	|O
only	|O
in	|O
a	|O
subset	|O
of	|O
tumors	|O
,	|O
and	|O
then	|O
at	|O
apparently	|O
low	|O
levels	|O
.	|O

The	|O
phenotypes	|O
of	|O
the	|O
ICP0	|B-PROTEIN
nonsense	|O
mutants	|O
were	|O
intermediate	|O
between	|O
those	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
virus	|O
and	|O
7134	|O
in	|O
that	|O
the	|O
more	|O
ICP0	|B-PROTEIN
-	|O
coding	|O
sequence	|O
expressed	|O
by	|O
a	|O
given	|O
nonsense	|O
mutant	|O
,	|O
the	|O
more	|O
wild	|O
type	|O
-	|O
like	|O
was	|O
its	|O
phenotype	|O
.	|O

Analysis	|O
of	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
rightmost	|O
43	|O
kbp	|O
of	|O
herpesvirus	|O
saimiri	|O
(	|O
HVS	|O
)	|O
L	|O
-	|O
DNA	|O
:	|O
general	|O
conservation	|O
of	|O
genetic	|O
organization	|O
between	|O
HVS	|O
and	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
.	|O

Treatment	|O
with	|O
MK	|O
-	|O
801	|O
induced	|O
a	|O
burst	|O
suppression	|O
in	|O
the	|O
EEG	|O
and	|O
a	|O
transient	|O
drop	|O
(	|O
11.4	|O
+	|O
/	|O
-	|O
6.5	|O
mm	|O
Hg	|O
)	|O
in	|O
the	|O
mean	|O
arterial	|O
pressure	|O
.	|O

In	|O
contrast	|O
,	|O
gel	|O
mobility	|O
shift	|O
experiments	|O
have	|O
failed	|O
to	|O
reveal	|O
that	|O
HAP2	|B-PROTEIN
or	|O
HAP3	|B-PROTEIN
binds	|O
to	|O
domain	|O
1	|O
or	|O
that	|O
hap3	|B-PROTEIN
mutations	|O
affect	|O
the	|O
complexes	|O
bound	|O
to	|O
it	|O
.	|O

Myogenic	|O
differentiation	|O
can	|O
be	|O
inhibited	|O
by	|O
the	|O
adenovirus	|O
E1a	|B-PROTEIN
protein	|O
in	|O
the	|O
rat	|O
L6	|O
muscle	|O
cell	|O
line	|O
.	|O

The	|O
experiment	|O
results	|O
showed	|O
:	|O
(	|O
i	|O
)	|O
not	|O
only	|O
1O2	|O
,	|O
but	|O
also	|O
free	|O
radicals	|O
(	|O
O2	|O
-	|O
.	|O
.	|O
OH	|O
and	|O
YHPD	|O
-	|O
.	|O
)	|O
can	|O
be	|O
formed	|O
by	|O
the	|O
aid	|O
of	|O
YHPD	|O
;	|O
and	|O
(	|O
ii	|O
)	|O
as	|O
to	|O
the	|O
ability	|O
of	|O
producing	|O
1O2	|O
,	|O
YHPD	|O
less	|O
than	|O
BHPD	|O
,	|O
while	|O
for	|O
generating	|O
O2	|O
-	|O
.	|O
and	|O
.	|O
OH	|O
,	|O
YHPD	|O
greater	|O
than	|O
BHPD	|O
.	|O

Two	|O
points	|O
are	|O
indicated	|O
:	|O
first	|O
,	|O
the	|O
photosensitized	|O
damage	|O
of	|O
YHPD	|O
is	|O
interrelated	|O
to	|O
not	|O
only	|O
1O2	|O
,	|O
but	|O
also	|O
free	|O
radicals	|O
(	|O
O2	|O
-	|O
.	|O
.	|O
OH	|O
and	|O
YHPD	|O
-	|O
.	|O
)	|O
;	|O
second	|O
,	|O
although	|O
the	|O
photosensitized	|O
damage	|O
of	|O
YHPD	|O
is	|O
stronger	|O
than	|O
that	|O
of	|O
BHPD	|O
,	|O
yet	|O
the	|O
photosensitized	|O
damage	|O
is	|O
negatively	|O
correlated	|O
to	|O
the	|O
yield	|O
of	|O
1O2	|O
but	|O
positively	|O
correlated	|O
to	|O
those	|O
of	|O
O2	|O
-	|O
.	|O
and	|O
OH	|O
.	|O

Acad	|O
.	|O

Both	|O
in	|O
vitro	|O
-	|O
synthesized	|O
S2	|B-PROTEIN
protein	|O
and	|O
synthetic	|O
peptides	|O
corresponding	|O
to	|O
S2	|B-PROTEIN
are	|O
shown	|O
to	|O
react	|O
positively	|O
with	|O
sera	|O
obtained	|O
from	|O
EIAV	|O
-	|O
infected	|O
horses	|O
,	|O
providing	|O
the	|O
first	|O
direct	|O
evidence	|O
of	|O
expression	|O
of	|O
this	|O
protein	|O
in	|O
infected	|O
animals	|O
.	|O

Many	|O
canonical	|O
TATA	|O
sequences	|O
are	|O
present	|O
upstream	|O
from	|O
these	|O
VZV	|O
transcriptional	|O
start	|O
sites	|O
but	|O
,	|O
apparently	|O
,	|O
are	|O
not	|O
used	|O
.	|O

The	|O
ORF	|O
4	|O
gene	|O
was	|O
minimally	|O
active	|O
,	|O
whereas	|O
the	|O
ORF	|O
62	|O
gene	|O
gave	|O
twofold	|O
induction	|O
;	|O
both	|O
genes	|O
,	|O
acting	|O
together	|O
,	|O
gave	|O
fivefold	|O
induction	|O
.	|O

Interestingly	|O
,	|O
the	|O
IR5	|B-PROTEIN
ORF	|O
of	|O
EHV	|O
-	|O
1	|O
possesses	|O
a	|O
sequence	|O
of	|O
13	|O
amino	|O
acids	|O
(	|O
CAYWCCLGHAFAC	|O
)	|O
that	|O
is	|O
a	|O
perfect	|O
match	|O
to	|O
the	|O
consensus	|O
zinc	|O
finger	|O
motif	|O
(	|O
C	|O
-	|O
X2	|O
-	|O
4	|O
-	|O
C	|O
-	|O
X2	|O
-	|O
15	|O
-	|O
C	|O
/	|O
H	|O
-	|O
X2	|O
-	|O
4	|O
-	|O
C	|O
/	|O
H	|O
)	|O
.	|O

The	|O
DNA	|O
sequence	|O
of	|O
the	|O
sulfate	|B-PROTEIN
activation	|I-PROTEIN
locus	|I-PROTEIN
from	|O
Escherichia	|O
coli	|O
K	|O
-	|O
12	|O
has	|O
been	|O
determined	|O
.	|O

The	|O
unphosphorylated	|O
form	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
is	|O
designated	|O
IIA	|O
,	|O
whereas	|O
the	|O
phosphorylated	|O
form	|O
is	|O
designated	|O
IIO	|O
.	|O

RNA	|B-PROTEIN
polymerase	|I-PROTEIN
IIA	|I-PROTEIN
was	|O
recovered	|O
in	|O
transcriptionally	|O
active	|O
complexes	|O
in	|O
reactions	|O
in	|O
which	|O
the	|O
input	|O
enzyme	|O
was	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
IIA	|I-PROTEIN
.	|O

Fructokinase	|B-PROTEIN
activity	|O
is	|O
elevated	|O
up	|O
to	|O
twofold	|O
when	|O
Z.	|O
mobilis	|O
was	|O
grown	|O
on	|O
fructose	|O
instead	|O
of	|O
glucose	|O
,	|O
and	|O
there	|O
was	|O
a	|O
parallel	|O
increase	|O
in	|O
frk	|B-PROTEIN
mRNA	|O
levels	|O
.	|O

Plasma	|O
membranes	|O
of	|O
cultured	|O
cells	|O
contain	|O
high	|O
affinity	|O
receptors	|O
for	|O
high	|B-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
(	|O
HDL	|B-PROTEIN
)	|O
that	|O
appear	|O
to	|O
mediate	|O
removal	|O
of	|O
excess	|O
intracellular	|O
cholesterol	|O
.	|O

After	|O
the	|O
first	|O
28	|O
patients	|O
vincristine	|O
was	|O
replaced	|O
by	|O
teniposide	|O
(	|O
VM	|O
-	|O
26	|O
)	|O
due	|O
to	|O
neurotoxicity	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
an	|O
internal	|O
short	|O
element	|O
located	|O
at	|O
the	|O
very	|O
5'	|O
terminal	|O
of	|O
L1	|B-PROTEIN
sequence	|O
and	|O
the	|O
nuclear	|O
factor	|O
binding	|O
to	|O
the	|O
element	|O
play	|O
a	|O
crucial	|O
role	|O
in	|O
the	|O
transcription	|O
of	|O
human	|O
L1	|B-PROTEIN
.	|O

Tumor	|O
cells	|O
were	|O
focally	|O
immunoreactive	|O
for	|O
neuron	|O
-	|O
specific	|O
enolase	|B-PROTEIN
,	|O
insulin	|B-PROTEIN
,	|O
glucagon	|B-PROTEIN
and	|O
VIP	|B-PROTEIN
.	|O

A	|O
recombinant	|O
with	|O
a	|O
5'	|O
end	|O
from	|O
src	|B-PROTEIN
and	|O
a	|O
3'	|O
end	|O
from	|O
ros	|B-PROTEIN
,	|O
called	|O
SRC	|B-PROTEIN
x	|O
ROS	|B-PROTEIN
,	|O
transformed	|O
chicken	|O
embryo	|O
fibroblasts	|O
(	|O
CEF	|O
)	|O
to	|O
a	|O
spindle	|O
shape	|O
morphology	|O
,	|O
mimicking	|O
that	|O
of	|O
UR2	|B-PROTEIN
.	|O

ROS	|B-PROTEIN
x	|O
SRC	|B-PROTEIN
(	|O
R	|B-PROTEIN
)	|O
contains	|O
a	|O
16	|O
-	|O
amino	|O
-	|O
acid	|O
deletion	|O
that	|O
includes	|O
the	|O
3'	|O
half	|O
of	|O
the	|O
transmembrane	|O
domain	|O
of	|O
ros	|B-PROTEIN
.	|O

To	|O
define	|O
the	|O
number	|O
and	|O
nature	|O
of	|O
the	|O
E6	|B-PROTEIN
and	|O
E7	|B-PROTEIN
gene	|O
products	|O
expressed	|O
in	|O
BPV	|O
-	|O
1	|O
-	|O
transformed	|O
cells	|O
,	|O
we	|O
performed	|O
immunoprecipitation	|O
experiments	|O
with	|O
antisera	|O
raised	|O
to	|O
bacterially	|O
expressed	|O
BPV	|O
-	|O
1	|O
E6	|B-PROTEIN
and	|O
E7	|B-PROTEIN
fusion	|O
proteins	|O
.	|O

Transient	|O
transfection	|O
assays	|O
showed	|O
that	|O
site	|O
A	|O
is	|O
necessary	|O
and	|O
sufficient	|O
for	|O
RXR	|B-PROTEIN
alpha	|I-PROTEIN
-	|O
mediated	|O
transactivation	|O
of	|O
the	|O
apoAI	|B-PROTEIN
gene	|O
basal	|O
promoter	|O
in	|O
human	|O
hepatoma	|O
HepG2	|O
cells	|O
in	|O
the	|O
presence	|O
of	|O
RA	|O
and	|O
that	|O
this	|O
transactivation	|O
is	|O
abolished	|O
by	|O
increasing	|O
amounts	|O
of	|O
cotransfected	|O
ARP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
enhancer	|O
region	|O
of	|O
Akv	|O
murine	|O
leukemia	|O
virus	|O
contains	|O
the	|O
sequence	|O
motif	|O
ACAGATGG	|O
.	|O

Two	|O
splice	|O
variants	|O
of	|O
ALF1	|B-PROTEIN
cDNA	|O
have	|O
been	|O
found	|O
,	|O
differing	|O
by	|O
a	|O
72	|O
-	|O
bp	|O
insertion	|O
,	|O
coding	|O
for	|O
putative	|O
proteins	|O
of	|O
682	|O
and	|O
706	|O
amino	|O
acids	|O
.	|O

A	|O
third	|O
prominent	|O
component	|O
of	|O
apparent	|O
molecular	|O
mass	|O
16	|O
kDa	|O
displayed	|O
several	|O
properties	|O
,	|O
including	|O
ability	|O
to	|O
bind	|O
45Ca2	|O
+	|O
,	|O
that	|O
are	|O
characteristic	|O
of	|O
the	|O
regulatory	|O
(	|O
B	|O
)	|O
subunit	|O
of	|O
mammalian	|O
calcineurin	|B-PROTEIN
and	|O
was	|O
recognized	|O
by	|O
an	|O
antiserum	|O
raised	|O
against	|O
bovine	|O
calcineurin	|B-PROTEIN
.	|O

As	|O
was	|O
observed	|O
previously	|O
for	|O
MATa	|B-PROTEIN
cna1	|O
cna2	|O
double	|O
mutants	|O
,	|O
MATa	|B-PROTEIN
cnb1	|O
mutants	|O
were	|O
defective	|O
in	|O
their	|O
ability	|O
to	|O
recover	|O
from	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
-	|O
induced	|O
growth	|O
arrest	|O
.	|O

Antibodies	|O
against	|O
this	|O
purified	|O
protein	|O
localize	|O
RIM1	|B-PROTEIN
to	|O
mitochondria	|O
.	|O

METHODS	|O
:	|O
IgG	|B-PROTEIN
antibodies	|O
vs	|O
HHV	|O
-	|O
6	|O
(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HHV	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
IgG	|I-PROTEIN
)	|O
were	|O
determined	|O
by	|O
indirect	|O
immunofluorescence	|O
in	|O
100	|O
IVDA	|O
(	|O
29	|O
seronegative	|O
and	|O
71	|O
seropositive	|O
for	|O
HIV	|O
-	|O
1	|O
of	|O
which	|O
45	|O
were	|O
in	|O
stage	|O
II	|O
and	|O
26	|O
in	|O
IV	|O
-	|O
C1	|O
of	|O
CDC	|O
)	|O
as	|O
well	|O
as	|O
in	|O
100	|O
healthy	|O
subjects	|O
of	|O
a	|O
similar	|O
age	|O
(	|O
control	|O
group	|O
)	|O
.	|O

A	|O
position	|O
-	|O
independent	|O
activation	|O
domain	|O
which	|O
contained	|O
conserved	|O
regions	|O
II	|O
and	|O
III	|O
was	|O
identified	|O
at	|O
the	|O
carboxyl	|O
terminus	|O
of	|O
the	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
protein	|O
(	|O
amino	|O
acids	|O
361	|O
to	|O
458	|O
)	|O
.	|O

HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
amino	|O
-	|O
terminal	|O
sequences	|O
defined	|O
by	|O
conserved	|O
region	|O
IV	|O
also	|O
contributed	|O
to	|O
transactivation	|O
,	|O
but	|O
region	|O
IV	|O
activity	|O
required	|O
the	|O
participation	|O
of	|O
the	|O
region	|O
II	|O
-	|O
III	|O
domain	|O
.	|O

Possible	|O
roles	|O
of	|O
RAD5	|B-PROTEIN
putative	|O
ATPase	|B-PROTEIN
/	|O
DNA	|B-PROTEIN
helicase	|I-PROTEIN
activity	|O
in	|O
DNA	|O
repair	|O
and	|O
in	|O
the	|O
maintenance	|O
of	|O
wild	|O
-	|O
type	|O
rates	|O
of	|O
instability	|O
of	|O
simple	|O
repetitive	|O
sequences	|O
are	|O
discussed	|O
.	|O

Susceptibilities	|O
of	|O
540	|O
anaerobic	|O
gram	|O
-	|O
negative	|O
bacilli	|O
to	|O
amoxicillin	|O
,	|O
amoxicillin	|O
-	|O
BRL	|O
42715	|O
,	|O
amoxicillin	|O
-	|O
clavulanate	|O
,	|O
temafloxacin	|O
,	|O
and	|O
clindamycin	|O
.	|O

Nocodazole	|O
arrest	|O
of	|O
DU249	|O
cells	|O
was	|O
exploited	|O
for	|O
the	|O
detection	|O
of	|O
an	|O
M	|O
-	|O
phase	|O
-	|O
activated	|O
MBP	|B-PROTEIN
kinase	|I-PROTEIN
that	|O
was	|O
resolved	|O
from	|O
p41	|B-PROTEIN
MAP	|O
kinase	|O
by	|O
phenyl	|O
-	|O
Superose	|O
chromatography	|O
.	|O

The	|O
hit1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutation	|O
caused	|O
a	|O
defect	|O
in	|O
synthesis	|O
of	|O
a	|O
74	|O
-	|O
kD	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
protein	|I-PROTEIN
.	|O

The	|O
319	|O
base	|O
pair	|O
region	|O
immediately	|O
upstream	|O
of	|O
the	|O
CAP	|O
site	|O
is	|O
characterized	|O
by	|O
the	|O
lack	|O
of	|O
a	|O
proximal	|O
TATA	|O
box	|O
and	|O
the	|O
presence	|O
of	|O
sequences	|O
similar	|O
to	|O
GC	|O
boxes	|O
,	|O
CACCC	|O
boxes	|O
,	|O
CCAAT	|O
boxes	|O
,	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
(	|O
Ap	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
sites	|O
,	|O
partial	|O
glucocorticoid	|O
response	|O
elements	|O
(	|O
GREs	|O
)	|O
,	|O
and	|O
partial	|O
cyclic	|O
AMP	|O
response	|O
elements	|O
(	|O
CREs	|O
)	|O
.	|O

Cloning	|O
and	|O
primary	|O
structure	|O
of	|O
neurocan	|O
,	|O
a	|O
developmentally	|O
regulated	|O
,	|O
aggregating	|O
chondroitin	|O
sulfate	|O
proteoglycan	|O
of	|O
brain	|O
.	|O

In	|O
rats	|O
anaesthetized	|O
with	|O
+	|O
-	|O
chloralose	|O
the	|O
changes	|O
in	|O
extracellular	|O
pH	|O
and	|O
K+	|O
in	|O
spinal	|O
cord	|O
dorsal	|O
horn	|O
were	|O
studied	|O
using	|O
pH	|O
and	|O
K+	|O
ion	|O
-	|O
selective	|O
electrodes	|O
.	|O

Replication	|O
of	|O
bovine	|O
papillomavirus	|O
-	|O
1	|O
(	|O
BPV	|O
-	|O
1	|O
)	|O
DNA	|O
requires	|O
two	|O
viral	|O
gene	|O
products	|O
,	|O
the	|O
E1	|B-PROTEIN
protein	|O
and	|O
the	|O
full	|O
-	|O
length	|O
E2	|B-PROTEIN
protein	|O
.	|O

Insertional	|O
inactivation	|O
of	|O
sms	|B-PROTEIN
led	|O
to	|O
increased	|O
sensitivity	|O
to	|O
the	|O
alkylating	|O
agent	|O
methylmethane	|O
sulfonate	|O
,	|O
but	|O
not	|O
to	|O
a	|O
requirement	|O
for	|O
serine	|O
or	|O
other	|O
metabolites	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
the	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
activator	|I-PROTEIN
/	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
system	|O
may	|O
be	|O
the	|O
downstream	|O
components	|O
of	|O
ras	|B-PROTEIN
signal	|O
transduction	|O
pathways	|O
.	|O

NSCL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
expressed	|O
in	|O
a	|O
larger	|O
number	|O
of	|O
these	|O
cell	|O
lines	|O
.	|O

Labile	|O
LTR	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
appear	|O
to	|O
be	|O
essential	|O
for	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
hyperexpression	|O
,	|O
since	|O
both	|O
LTR	|O
-	|O
enhanced	|O
transcription	|O
and	|O
the	|O
activities	|O
of	|O
LTR	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
are	|O
specifically	|O
decreased	|O
after	|O
inhibition	|O
of	|O
protein	|O
synthesis	|O
(	|O
A.	|O

Ruddell	|O
,	|O
M.	|O

A	|O
single	|O
MEF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
site	|O
is	|O
a	|O
major	|O
positive	|O
regulatory	|O
element	|O
required	|O
for	|O
transcription	|O
of	|O
the	|O
muscle	|O
-	|O
specific	|O
subunit	|O
of	|O
the	|O
human	|O
phosphoglycerate	|B-PROTEIN
mutase	|I-PROTEIN
gene	|O
in	|O
skeletal	|O
and	|O
cardiac	|O
muscle	|O
cells	|O
.	|O

Truncation	|O
variants	|O
of	|O
peptides	|O
isolated	|O
from	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
II	|I-PROTEIN
molecules	|O
suggest	|O
sequence	|O
motifs	|O
.	|O

Although	|O
the	|O
E	|O
-	|O
box	|O
consensus	|O
is	|O
minimally	|O
defined	|O
as	|O
CANNTG	|O
,	|O
the	|O
adjacent	|O
nucleotides	|O
of	|O
functional	|O
E	|O
-	|O
boxes	|O
are	|O
variable	|O
for	|O
genes	|O
regulated	|O
by	|O
the	|O
bHLH	|B-PROTEIN
proteins	|I-PROTEIN
.	|O

Intermediate	|O
levels	|O
of	|O
gene	|O
activity	|O
were	|O
observed	|O
for	|O
TnI	|B-PROTEIN
enhancers	|O
containing	|O
E	|O
-	|O
boxes	|O
derived	|O
from	|O
the	|O
MCK	|B-PROTEIN
left	|O
E	|O
-	|O
box	|O
site	|O
or	|O
from	|O
the	|O
Ig	|B-PROTEIN
kappa	|I-PROTEIN
E2	|I-PROTEIN
E	|O
-	|O
box	|O
.	|O

T	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
beta	|I-PROTEIN
(	|O
TCR	|B-PROTEIN
beta	|I-PROTEIN
)	|O
gene	|O
rearrangements	|O
occur	|O
in	|O
a	|O
third	|O
of	|O
early	|O
B	|O
-	|O
cell	|O
acute	|O
lymphoblastic	|O
leukemias	|O
(	|O
ALLs	|O
)	|O
.	|O

The	|O
CANNTG	|O
motifs	|O
were	|O
found	|O
to	|O
bind	|O
MyoD	|B-PROTEIN
and	|O
myogenin	|B-PROTEIN
fusion	|O
proteins	|O
and	|O
to	|O
interact	|O
with	|O
proteins	|O
in	|O
nuclear	|O
extracts	|O
from	|O
cultured	|O
myotubes	|O
.	|O

Peripheral	|O
polyneuropathy	|O
associated	|O
with	|O
multiple	|O
myeloma	|O
.	|O

We	|O
have	|O
cloned	|O
and	|O
sequenced	|O
COX12	|B-PROTEIN
,	|O
the	|O
nuclear	|O
gene	|O
for	|O
subunit	|O
VIb	|B-PROTEIN
of	|O
Saccharomyces	|O
cerevisiae	|O
cytochrome	|B-PROTEIN
c	|I-PROTEIN
oxidase	|I-PROTEIN
.	|O

The	|O
structure	|O
of	|O
the	|O
calcineurin	|B-PROTEIN
A	|I-PROTEIN
gene	|O
was	|O
determined	|O
by	|O
comparison	|O
of	|O
the	|O
genomic	|O
and	|O
cDNA	|O
sequences	|O
.	|O

The	|O
basal	|O
promoter	|O
elements	|O
of	|O
murine	|O
cytochrome	|B-PROTEIN
c	|I-PROTEIN
oxidase	|I-PROTEIN
subunit	|I-PROTEIN
IV	|I-PROTEIN
gene	|O
consist	|O
of	|O
tandemly	|O
duplicated	|O
ets	|B-PROTEIN
motifs	|O
that	|O
bind	|O
to	|O
GABP	|B-PROTEIN
-	|O
related	|O
transcription	|O
factors	|O
.	|O

Lastly	|O
,	|O
there	|O
are	|O
multiple	|O
instances	|O
in	|O
which	|O
short	|O
oligonucleotide	|O
direct	|O
repeats	|O
flank	|O
a	|O
region	|O
absent	|O
from	|O
either	|O
variola	|O
or	|O
vaccinia	|O
virus	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
short	|O
synthetic	|O
peptides	|O
containing	|O
the	|O
pRB	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
sequences	|I-PROTEIN
of	|O
E1A	|B-PROTEIN
are	|O
sufficient	|O
for	|O
interaction	|O
with	|O
p107	|B-PROTEIN
,	|O
cyclin	|B-PROTEIN
A	|I-PROTEIN
,	|O
and	|O
p130	|B-PROTEIN
.	|O

These	|O
mutants	|O
grow	|O
normally	|O
in	|O
3T6	|O
mouse	|O
fibroblast	|O
cells	|O
,	|O
and	|O
they	|O
do	|O
not	|O
complement	|O
the	|O
wild	|O
-	|O
type	|O
virus	|O
in	|O
coinfection	|O
experiments	|O
of	|O
C2	|O
myoblasts	|O
.	|O

The	|O
MICs	|O
of	|O
this	|O
compound	|O
against	|O
90%	|O
of	|O
these	|O
organisms	|O
,	|O
except	|O
for	|O
methicillin	|O
-	|O
resistant	|O
S.	|O
aureus	|O
,	|O
ranged	|O
from	|O
less	|O
than	|O
or	|O
equal	|O
to	|O
0.006	|O
to	|O
3.13	|O
micrograms	|O
/	|O
ml	|O
.	|O

The	|O
minimal	|O
promoter	|O
of	|O
the	|O
RII	|B-PROTEIN
beta	|I-PROTEIN
gene	|O
was	|O
composed	|O
of	|O
two	|O
adjacent	|O
functional	|O
elements	|O
.	|O

Mapping	|O
the	|O
cAMP	|B-PROTEIN
receptor	|I-PROTEIN
protein	|O
contact	|O
site	|O
on	|O
the	|O
alpha	|O
subunit	|O
of	|O
Escherichia	|O
coli	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
.	|O

Here	|O
we	|O
show	|O
that	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
or	|O
platelet	|B-PROTEIN
-	|I-PROTEIN
derived	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
stimulation	|O
of	|O
intact	|O
human	|O
or	|O
murine	|O
cells	|O
leads	|O
to	|O
phosphorylation	|O
of	|O
Nck	|B-PROTEIN
protein	|O
on	|O
tyrosine	|O
,	|O
serine	|O
,	|O
and	|O
threonine	|O
residues	|O
.	|O

A	|O
major	|O
mechanism	|O
whereby	|O
steroid	|B-PROTEIN
hydroxylase	|I-PROTEIN
gene	|O
transcription	|O
is	|O
regulated	|O
in	|O
the	|O
adrenal	|O
cortex	|O
requires	|O
the	|O
pituitary	|O
peptide	|O
hormone	|O
,	|O
ACTH	|B-PROTEIN
,	|O
which	|O
acts	|O
via	|O
cAMP	|O
.	|O

A	|O
combination	|O
of	|O
comparative	|O
sequence	|O
analysis	|O
and	|O
thermodynamic	|O
methods	|O
reveals	|O
the	|O
conservation	|O
of	|O
tertiary	|O
structure	|O
elements	|O
in	|O
the	|O
5'	|O
untranslated	|O
region	|O
(	|O
UTR	|O
)	|O
of	|O
human	|O
enteroviruses	|O
and	|O
rhinoviruses	|O
.	|O

The	|O
-	|O
64	|O
/	|O
-	|O
37	|O
region	|O
interacted	|O
with	|O
purified	|O
Sp1	|B-PROTEIN
and	|O
an	|O
unidentified	|O
protein	|O
(	|O
s	|O
)	|O
,	|O
proximal	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
(	|I-PROTEIN
s	|I-PROTEIN
)	|I-PROTEIN
I	|I-PROTEIN
(	|O
PRF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
)	|O
.	|O

Km	|O
and	|O
Vmax	|O
for	|O
two	|O
substrates	|O
,	|O
src	|B-PROTEIN
-	|O
related	|O
peptide	|O
and	|O
poly	|O
(	|O
Glu	|O
,	|O
Tyr	|O
)	|O
(	|O
4	|O
:	|O
1	|O
)	|O
,	|O
were	|O
2.4	|O
mM	|O
and	|O
2.5	|O
mumol	|O
min	|O
-	|O
1	|O
mg	|O
-	|O
1	|O
and	|O
0.26	|O
mM	|O
and	|O
1.2	|O
mumol	|O
min	|O
-	|O
1	|O
mg	|O
-	|O
1	|O
,	|O
respectively	|O
.	|O

This	|O
soluble	|O
form	|O
of	|O
the	|O
HGFr	|B-PROTEIN
(	|O
sHGFr	|B-PROTEIN
)	|O
bound	|O
HGF	|B-PROTEIN
with	|O
an	|O
affinity	|O
similar	|O
to	|O
that	|O
of	|O
the	|O
authentic	|O
,	|O
membrane	|O
-	|O
associated	|O
receptor	|O
.	|O

Strategies	|O
for	|O
blood	|O
screening	|O
for	|O
the	|O
hepatitis	|O
C	|O
virus	|O
and	|O
for	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
in	|O
high	|O
risk	|O
groups	|O
.	|O

Also	|O
,	|O
the	|O
human	|O
glycoprotein	|B-PROTEIN
alpha	|I-PROTEIN
-	|O
subunit	|O
promoter	|O
was	|O
induced	|O
10	|O
-	|O
fold	|O
by	|O
FSK	|B-PROTEIN
in	|O
GH4	|O
rat	|O
pituitary	|O
cells	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

Comparison	|O
of	|O
data	|O
obtained	|O
with	|O
the	|O
results	|O
of	|O
chronic	|O
treatment	|O
with	|O
the	|O
opioid	|O
antagonist	|O
permits	|O
to	|O
conclude	|O
that	|O
the	|O
chronic	|O
blockade	|O
increases	|O
the	|O
fatiguability	|O
to	|O
a	|O
great	|O
extent	|O
than	|O
chronic	|O
activation	|O
of	|O
opioid	|O
system	|O
.	|O

Laboratory	|O
studies	|O
using	|O
Ca45	|O
labeled	|O
teeth	|O
and	|O
biologically	|O
stained	|O
teeth	|O
confirmed	|O
that	|O
the	|O
dentifrice	|O
did	|O
not	|O
decalcify	|O
enamel	|O
or	|O
bleach	|O
teeth	|O
.	|O

Structure	|O
and	|O
expression	|O
of	|O
a	|O
gene	|O
from	|O
Arabidopsis	|O
thaliana	|O
encoding	|O
a	|O
protein	|O
related	|O
to	|O
SNF1	|B-PROTEIN
protein	|O
kinase	|O
.	|O

We	|O
have	|O
cloned	|O
and	|O
characterized	|O
a	|O
55	|O
-	|O
kb	|O
region	|O
of	|O
DNA	|O
surrounding	|O
HRAS1	|B-PROTEIN
.	|O

The	|O
ORF1	|O
protein	|O
was	|O
found	|O
to	|O
be	|O
highly	|O
homologous	|O
to	|O
the	|O
putative	|O
potexvirus	|O
RNA	|B-PROTEIN
replicases	|I-PROTEIN
;	|O
ORF2	|O
,	|O
-	|O
3	|O
,	|O
-	|O
5	|O
and	|O
-	|O
6	|O
proteins	|O
also	|O
have	|O
analogues	|O
among	|O
the	|O
potex	|O
-	|O
and	|O
/	|O
or	|O
carlavirus	|O
-	|O
encoded	|O
proteins	|O
.	|O

A	|O
total	|O
of	|O
281	|O
patients	|O
were	|O
divided	|O
into	|O
groups	|O
according	|O
to	|O
their	|O
clinical	|O
diagnosis	|O
and	|O
were	|O
examined	|O
using	|O
capnography	|O
,	|O
spirometry	|O
and	|O
blood	|O
-	|O
gas	|O
analysis	|O
.	|O

The	|O
relationships	|O
between	|O
the	|O
partial	|O
pressures	|O
of	|O
O2	|O
and	|O
CO2	|O
as	|O
well	|O
as	|O
between	|O
their	|O
gradients	|O
,	|O
become	|O
stronger	|O
with	|O
the	|O
increase	|O
of	|O
the	|O
ventilation	|O
-	|O
perfusion	|O
ratio	|O
.	|O

No	|O
significant	|O
correlations	|O
of	|O
peak	|O
VO2	|O
were	|O
observed	|O
between	|O
the	|O
3	|O
tests	|O
.	|O

An	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
gene	|O
(	|O
rbp1	|B-PROTEIN
)	|O
from	|O
Drosophila	|O
melanogaster	|O
,	|O
encoding	|O
an	|O
RNA	|O
recognition	|O
motif	|O
and	|O
an	|O
Arg	|O
-	|O
Ser	|O
rich	|O
(	|O
RS	|O
)	|O
domain	|O
,	|O
has	|O
been	|O
characterized	|O
.	|O

Some	|O
research	|O
studies	|O
have	|O
related	|O
this	|O
kind	|O
of	|O
tumors	|O
with	|O
prolonged	|O
ingestion	|O
of	|O
H2	|O
inhibitors	|O
and	|O
others	|O
antacid	|O
.	|O

A	|O
comparative	|O
study	|O
of	|O
the	|O
total	|O
protein	|O
profiles	|O
of	|O
wild	|O
-	|O
type	|O
S.	|O
entomophila	|O
UC9	|O
and	|O
mutant	|O
UC21	|O
revealed	|O
that	|O
the	|O
mutant	|O
lacked	|O
an	|O
approximately	|O
44	|O
-	|O
kDa	|O
protein	|O
and	|O
overexpressed	|O
an	|O
approximately	|O
20	|O
-	|O
kDa	|O
protein	|O
.	|O

Characterization	|O
of	|O
the	|O
regulon	|O
controlled	|O
by	|O
the	|O
leucine	|B-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
regulatory	|I-PROTEIN
protein	|I-PROTEIN
in	|O
Escherichia	|O
coli	|O
.	|O

Mapping	|O
of	|O
the	|O
mouse	|O
ornithine	|B-PROTEIN
decarboxylase	|I-PROTEIN
-	|O
related	|O
sequence	|O
family	|O
.	|O

This	|O
mutation	|O
also	|O
results	|O
in	|O
markedly	|O
decreased	|O
levels	|O
of	|O
CAD	|B-PROTEIN
mRNA	|O
and	|O
protein	|O
in	|O
the	|O
mutant	|O
.	|O

The	|O
rationale	|O
for	|O
continuous	|O
dopaminergic	|O
stimulation	|O
in	|O
patients	|O
with	|O
Parkinson	|O
's	|O
disease	|O
.	|O

Mutational	|O
studies	|O
revealed	|O
that	|O
it	|O
was	|O
the	|O
homeodomain	|B-PROTEIN
binding	|O
site	|O
II	|O
sequence	|O
that	|O
was	|O
required	|O
for	|O
this	|O
regulation	|O
.	|O

Thus	|O
,	|O
the	|O
pol	|B-PROTEIN
alpha	|I-PROTEIN
-	|O
primase	|B-PROTEIN
complex	|O
appears	|O
to	|O
act	|O
processively	|O
for	|O
only	|O
a	|O
short	|O
distance	|O
.	|O

Interestingly	|O
,	|O
the	|O
positions	|O
of	|O
these	|O
introns	|O
have	|O
been	|O
conserved	|O
in	|O
comparison	|O
with	|O
the	|O
genes	|O
of	|O
two	|O
other	|O
transglutaminase	|O
-	|O
like	|O
activities	|O
described	|O
in	|O
the	|O
literature	|O
,	|O
but	|O
the	|O
TGM1	|B-PROTEIN
gene	|O
is	|O
by	|O
far	|O
the	|O
smallest	|O
characterized	|O
to	|O
date	|O
because	|O
its	|O
introns	|O
are	|O
relatively	|O
smaller	|O
.	|O

In	|O
a	|O
retrospective	|O
analysis	|O
of	|O
data	|O
from	|O
35	|O
cases	|O
with	|O
malignant	|O
lymphoma	|O
from	|O
a	|O
cohort	|O
of	|O
2017	|O
HIV	|O
-	|O
infected	|O
patients	|O
,	|O
the	|O
stage	|O
of	|O
HIV	|O
-	|O
disease	|O
,	|O
the	|O
CD4	|B-PROTEIN
counts	|O
at	|O
the	|O
time	|O
of	|O
diagnosis	|O
,	|O
and	|O
the	|O
use	|O
of	|O
antineoplastic	|O
agents	|O
or	|O
radiotherapy	|O
were	|O
correlated	|O
with	|O
outcome	|O
.	|O

1	|O
.	|O

Effects	|O
of	|O
dioxins	|O
on	|O
thyroid	|O
function	|O
in	|O
newborn	|O
babies	|O
.	|O

cDNA	|O
clones	|O
encoding	|O
Arabidopsis	|O
thaliana	|O
and	|O
Zea	|O
mays	|O
mitochondrial	|O
chaperonin	|B-PROTEIN
HSP60	|O
and	|O
gene	|O
expression	|O
during	|O
seed	|O
germination	|O
and	|O
heat	|O
shock	|O
.	|O

Amino	|O
acid	|O
sequence	|O
comparison	|O
revealed	|O
significant	|O
homology	|O
between	|O
the	|O
yeast	|O
and	|O
Escherichia	|O
coli	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
glutamyl	|I-PROTEIN
kinases	|I-PROTEIN
throughout	|O
their	|O
lengths	|O
.	|O

The	|O
single	|O
site	|O
of	|O
glycosylation	|O
is	|O
located	|O
near	|O
the	|O
C	|O
-	|O
terminus	|O
in	|O
the	|O
N	|O
-	|O
glycosylation	|O
sequon	|O
-	|O
Asn	|O
-	|O
Cys	|O
-	|O
Ser	|O
-	|O
in	|O
which	|O
Cys	|O
forms	|O
part	|O
of	|O
a	|O
disulphide	|O
bridge	|O
.	|O

The	|O
pulmonary	|O
toxic	|O
events	|O
induced	|O
by	|O
acute	|O
nitrogen	|O
dioxide	|O
(	|O
NO	|O
)	|O
2	|O
exposure	|O
were	|O
studied	|O
in	|O
the	|O
rat	|O
to	|O
develop	|O
an	|O
inhalation	|O
model	|O
to	|O
investigate	|O
therapeutic	|O
measures	|O
.	|O

The	|O
pulmonary	|O
effects	|O
observed	|O
,	|O
became	|O
more	|O
pronounced	|O
with	|O
increasing	|O
NO2	|O
concentrations	|O
(	|O
0	|O
,	|O
25	|O
,	|O
75	|O
,	|O
125	|O
,	|O
175	|O
or	|O
200	|O
ppm	|O
,	|O
1	|O
ppm	|O
NO2	|O
=	|O
1.88	|O
mg	|O
m	|O
-	|O
3	|O
NO2	|O
)	|O
and	|O
exposure	|O
times	|O
(	|O
5	|O
,	|O
10	|O
,	|O
20	|O
or	|O
30	|O
min	|O
)	|O
.	|O

Interaction	|O
of	|O
H	|B-PROTEIN
-	|I-PROTEIN
2Eb	|I-PROTEIN
with	|O
an	|O
IAP	|B-PROTEIN
retrotransposon	|O
in	|O
the	|O
A20/2	|O
J	|O
B	|O
cell	|O
lymphoma	|O
.	|O

Gestational	|O
trophoblastic	|O
diseases	|O
:	|O
recent	|O
advances	|O
in	|O
the	|O
understanding	|O
of	|O
cytogenetics	|O
,	|O
histopathology	|O
,	|O
and	|O
natural	|O
history	|O
.	|O

With	|O
the	|O
exception	|O
of	|O
mutants	|O
that	|O
remove	|O
the	|O
membrane	|O
anchor	|O
domain	|O
,	|O
all	|O
of	|O
the	|O
mutant	|O
glycoproteins	|O
retained	|O
the	|O
ability	|O
to	|O
cause	|O
fusion	|O
of	|O
CD4	|B-PROTEIN
-	|O
bearing	|O
cells	|O
.	|O

The	|O
subunit	|O
protein	|O
of	|O
curli	|B-PROTEIN
was	|O
highly	|O
homologous	|O
at	|O
its	|O
amino	|O
terminus	|O
to	|O
SEF	|B-PROTEIN
-	|I-PROTEIN
17	|I-PROTEIN
,	|O
the	|O
subunit	|O
protein	|O
of	|O
thin	|O
,	|O
aggregative	|O
fimbriae	|O
of	|O
Salmonella	|O
enteritidis	|O
27655	|O
strain	|O
3b	|O
,	|O
suggesting	|O
that	|O
these	|O
fibres	|O
form	|O
a	|O
novel	|O
class	|O
of	|O
surface	|O
organelles	|O
on	|O
enterobacteria	|O
.	|O

Substitution	|O
of	|O
the	|O
DR1	|B-PROTEIN
beta	|O
chain	|O
with	|O
H	|B-PROTEIN
-	|I-PROTEIN
2E	|I-PROTEIN
beta	|I-PROTEIN
k	|I-PROTEIN
led	|O
to	|O
a	|O
dramatic	|O
loss	|O
of	|O
recognition	|O
;	|O
alpha	|O
chain	|O
substitution	|O
had	|O
a	|O
less	|O
marked	|O
effect	|O
.	|O

This	|O
negative	|O
regulatory	|O
pathway	|O
may	|O
be	|O
important	|O
for	|O
determining	|O
cell	|O
fate	|O
or	|O
maintaining	|O
an	|O
inducible	|O
state	|O
in	|O
the	|O
ventroposterior	|O
region	|O
of	|O
the	|O
embryo	|O
.	|O

The	|O
distal	|O
portion	|O
of	|O
the	|O
rat	|O
insulin	|B-PROTEIN
I	|I-PROTEIN
gene	|O
5'	|O
-	|O
flanking	|O
DNA	|O
contains	|O
two	|O
sequence	|O
elements	|O
,	|O
the	|O
Far	|O
and	|O
FLAT	|O
elements	|O
,	|O
that	|O
can	|O
function	|O
in	|O
combination	|O
,	|O
but	|O
not	|O
separately	|O
,	|O
as	|O
a	|O
beta	|O
-	|O
cell	|O
-	|O
specific	|O
transcriptional	|O
enhancer	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
exhibited	|O
98%	|O
identity	|O
to	|O
the	|O
human	|O
cellular	|B-PROTEIN
transglutaminase	|I-PROTEIN
sequence	|O
.	|O

This	|O
computation	|O
is	|O
performed	|O
by	|O
a	|O
parallel	|O
network	|O
of	|O
locally	|O
connected	|O
neuron	|O
-	|O
like	|O
elements	|O
.	|O

Repeated	|O
efforts	|O
to	|O
isolate	|O
recombinant	|O
baculoviruses	|O
containing	|O
a	|O
wild	|O
-	|O
type	|O
kinase	|O
failed	|O
,	|O
whereas	|O
recombinants	|O
expressing	|O
a	|O
nonfunctional	|O
kinase	|O
with	|O
a	|O
catalytic	|O
domain	|O
II	|O
mutation	|O
were	|O
readily	|O
isolated	|O
.	|O

Finally	|O
,	|O
we	|O
determined	|O
that	|O
the	|O
P68	|B-PROTEIN
amino	|O
terminus	|O
was	|O
both	|O
necessary	|O
and	|O
sufficient	|O
for	|O
binding	|O
dsRNA	|O
as	|O
we	|O
were	|O
able	|O
to	|O
transfer	|O
dsRNA	|O
-	|O
binding	|O
properties	|O
to	|O
a	|O
reporter	|O
gene	|O
product	|O
previously	|O
unable	|O
to	|O
bind	|O
RNA	|O
.	|O

From	|O
August	|O
1989	|O
to	|O
October	|O
1990	|O
,	|O
83	|O
pregnant	|O
Chinese	|O
women	|O
were	|O
the	|O
subjects	|O
for	|O
measuring	|O
the	|O
levels	|O
of	|O
plasma	|O
functional	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
(	|O
AT	|B-PROTEIN
III	|I-PROTEIN
)	|O
activity	|O
.	|O

Visual	|O
acuity	|O
may	|O
be	|O
decreased	|O
by	|O
transient	|O
changes	|O
in	|O
refractive	|O
error	|O
caused	|O
by	|O
sulfonamides	|O
,	|O
the	|O
antifungal	|O
agent	|O
metronidazole	|O
,	|O
thiazide	|O
diuretics	|O
,	|O
and	|O
carbonic	|B-PROTEIN
anhydrase	|I-PROTEIN
inhibitors	|O
.	|O

Currents	|O
aspects	|O
of	|O
H2	|B-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
in	|O
the	|O
treatment	|O
of	|O
ulcers	|O

In	|O
addition	|O
,	|O
a	|O
21	|O
-	|O
mer	|O
subrepeat	|O
structure	|O
is	|O
also	|O
present	|O
in	|O
each	|O
unit	|O
.	|O

Sequencing	|O
revealed	|O
one	|O
large	|O
open	|O
reading	|O
frame	|O
encoding	|O
a	|O
39	|O
-	|O
kDa	|O
protein	|O
.	|O

These	|O
sites	|O
are	|O
also	|O
potential	|O
keratan	|O
sulfate	|O
attachment	|O
sites	|O
.	|O

We	|O
propose	|O
that	|O
plasmids	|O
of	|O
the	|O
pLS1	|O
family	|O
(	|O
pE194	|O
,	|O
pADB201	|O
,	|O
and	|O
pLB4	|O
)	|O
share	|O
functional	|O
and	|O
structural	|O
characteristics	|O
for	|O
the	|O
regulation	|O
of	|O
their	|O
copy	|O
numbers	|O
.	|O

Perturbation	|O
of	|O
dNTP	|O
pools	|O
also	|O
affected	|O
the	|O
frameshift	|O
fidelity	|O
of	|O
the	|O
replicative	|O
yeast	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|I-PROTEIN
.	|O

Differential	|O
expression	|O
of	|O
the	|O
"	|O
B	|O
"	|O
subunit	|O
of	|O
the	|O
vacuolar	|O
H	|B-PROTEIN
(	|I-PROTEIN
+	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
in	|O
bovine	|O
tissues	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
hGCSFR	|B-PROTEIN
gene	|O
was	|O
chromosomally	|O
localized	|O
by	|O
Southern	|O
blot	|O
analysis	|O
of	|O
its	|O
segregation	|O
pattern	|O
in	|O
a	|O
panel	|O
of	|O
rodent	|O
-	|O
human	|O
hybrid	|O
DNAs	|O
using	|O
the	|O
radiolabeled	|O
cDNA	|O
probe	|O
.	|O

We	|O
have	|O
isolated	|O
and	|O
characterised	|O
a	|O
differentially	|O
-	|O
regulated	|O
gene	|O
family	|O
in	|O
the	|O
protozoan	|O
parasite	|O
Leishmania	|O
major	|O
.	|O

At	|O
some	|O
sites	|O
,	|O
%	|O
T	|O
is	|O
greatly	|O
increased	|O
by	|O
Cl	|O
-	|O
concentrations	|O
up	|O
to	|O
1	|O
M	|O
,	|O
while	|O
at	|O
other	|O
sites	|O
%	|O
T	|O
is	|O
reduced	|O
or	|O
unaffected	|O
by	|O
these	|O
conditions	|O
.	|O

Necrosis	|O
appears	|O
6	|O
h	|O
after	|O
TA	|O
infusion	|O
,	|O
being	|O
5.77%	|O
in	|O
extent	|O
after	|O
12	|O
h	|O
,	|O
14.9%	|O
after	|O
24	|O
h	|O
and	|O
animals	|O
die	|O
with	|O
an	|O
area	|O
of	|O
29.5%	|O
necrosis	|O
.	|O

In	|O
summary	|O
,	|O
the	|O
segments	|O
of	|O
C3	|B-PROTEIN
represented	|O
by	|O
amino	|O
acid	|O
residues	|O
1082-1118	|O
,	|O
1117-1155	|O
,	|O
1234-1294	|O
and	|O
1312-1404	|O
accommodate	|O
C3	|B-PROTEIN
(	|O
D	|O
)	|O
epitopes	|O
that	|O
are	|O
expressed	|O
by	|O
erythrocyte	|O
-	|O
bound	|O
C3	|B-PROTEIN
fragments	|O
,	|O
but	|O
not	|O
by	|O
the	|O
corresponding	|O
fluid	|O
-	|O
phase	|O
fragment	|O
,	|O
whereas	|O
the	|O
segments	|O
spanning	|O
residues	|O
973-1026	|O
and	|O
1477-1510	|O
contain	|O
C3	|B-PROTEIN
(	|O
D	|O
)	|O
epitopes	|O
that	|O
are	|O
exposed	|O
exclusively	|O
in	|O
denatured	|O
C3	|B-PROTEIN
and	|O
therefore	|O
hidden	|O
in	|O
physiological	|O
fragments	|O
of	|O
the	|O
protein	|O
.	|O

These	|O
exons	|O
,	|O
further	|O
identified	|O
as	|O
exons	|O
9	|O
,	|O
10	|O
,	|O
and	|O
11	|O
,	|O
together	|O
encode	|O
the	|O
37	|O
amino	|O
acid	|O
residues	|O
present	|O
in	|O
alpha	|B-PROTEIN
s1	|I-PROTEIN
-	|I-PROTEIN
casein	|I-PROTEIN
variant	|O
A	|O
but	|O
missing	|O
in	|O
variant	|O
F.	|O

We	|O
also	|O
report	|O
here	|O
the	|O
complete	|O
structural	|O
organization	|O
of	|O
the	|O
goat	|O
alpha	|B-PROTEIN
s1	|I-PROTEIN
-	|I-PROTEIN
casein	|I-PROTEIN
transcription	|O
unit	|O
,	|O
deduced	|O
from	|O
polymerase	|O
chain	|O
reaction	|O
experiments	|O
.	|O

Homodimers	|O
of	|O
the	|O
three	|O
proteins	|O
specifically	|O
recognize	|O
the	|O
G	|O
-	|O
box	|O
motif	|O
,	|O
with	|O
GBF1	|B-PROTEIN
and	|O
GBF3	|B-PROTEIN
binding	|O
symmetrically	|O
to	|O
this	|O
palindromic	|O
sequence	|O
.	|O

Neither	|O
gene	|O
possesses	|O
a	|O
distinct	|O
transcriptional	|O
start	|O
site	|O
as	|O
shown	|O
by	|O
nuclease	|O
S1	|B-PROTEIN
analysis	|O
.	|O

The	|O
hydrophobicity	|O
plot	|O
of	|O
NHE	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
is	|O
very	|O
similar	|O
to	|O
that	|O
of	|O
NHE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
NHE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

The	|O
initial	|O
translation	|O
protein	|O
encoded	|O
by	|O
the	|O
cDNA	|O
is	|O
53,932	|O
kDa	|O
and	|O
possesses	|O
a	|O
hydrophilic	|O
amino	|O
acid	|O
composition	|O
with	|O
glutamic	|O
acid	|O
comprising	|O
22%	|O
of	|O
the	|O
total	|O
amino	|O
acid	|O
residues	|O
.	|O

Each	|O
group	|O
received	|O
15	|O
ml	|O
/	|O
kg	|O
of	|O
either	|O
6%	|O
pentafraction	|O
,	|O
6%	|O
pentastarch	|O
,	|O
or	|O
plasma	|O
followed	|O
two	|O
hours	|O
later	|O
by	|O
1.5	|O
micrograms	|O
/	|O
kg	|O
/	|O
0.5	|O
hr	|O
E.	|O

Genetic	|O
and	|O
biochemical	|O
evidence	|O
suggests	|O
that	|O
v	|B-PROTEIN
-	|I-PROTEIN
Crk	|I-PROTEIN
can	|O
induce	|O
transformation	|O
of	|O
chicken	|O
embryo	|O
fibroblasts	|O
by	|O
influencing	|O
the	|O
activity	|O
of	|O
cellular	|O
proteins	|O
involved	|O
in	|O
growth	|O
regulation	|O
.	|O

We	|O
have	|O
constructed	|O
,	|O
using	|O
synthetic	|O
DNA	|O
oligonucleotides	|O
,	|O
a	|O
U14	|B-PROTEIN
snRNA	|O
gene	|O
which	|O
has	|O
been	|O
positioned	|O
behind	|O
a	|O
T7	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
promoter	|O
site	|O
and	|O
then	|O
inserted	|O
into	|O
a	|O
plasmid	|O
.	|O

Gene	|O
and	|O
pseudogene	|O
of	|O
the	|O
mouse	|O
cation	|O
-	|O
dependent	|O
mannose	|B-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

The	|O
chick	|O
axon	|O
-	|O
associated	|O
surface	|O
glycoprotein	|O
neurofascin	|B-PROTEIN
is	|O
implicated	|O
in	|O
axonal	|O
growth	|O
and	|O
fasciculation	|O
as	|O
revealed	|O
by	|O
antibody	|O
perturbation	|O
experiments	|O
.	|O

The	|O
carcinoma	|O
was	|O
restricted	|O
within	|O
the	|O
epithelium	|O
in	|O
one	|O
,	|O
the	|O
mucosal	|O
layer	|O
in	|O
five	|O
,	|O
and	|O
the	|O
submucosal	|O
layer	|O
in	|O
two	|O
.	|O

In	|O
addition	|O
,	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
gamma	|I-PROTEIN
readily	|O
heterodimerize	|O
with	|O
each	|O
other	|O
as	|O
well	|O
as	|O
with	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|I-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
tobacco	|O
GS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
composed	|O
of	|O
subunits	|O
of	|O
identical	|O
size	|O
in	|O
all	|O
organs	|O
examined	|O
.	|O

Between	|O
acoR	|B-PROTEIN
and	|O
acoXABC	|B-PROTEIN
,	|O
two	|O
different	|O
types	|O
of	|O
sequences	|O
with	|O
dual	|O
rotational	|O
symmetry	|O
[	|O
CAC	|O
-	|O
(	|O
N11	|O
to	|O
N18	|O
)	|O
-	|O
GTG	|O
and	|O
TGT	|O
-	|O
(	|O
N10	|O
to	|O
N14	|O
)	|O
-	|O
ACA	|O
]	|O
were	|O
found	|O
;	|O
these	|O
sequences	|O
are	|O
similar	|O
to	|O
NtrC	|B-PROTEIN
and	|O
NifA	|B-PROTEIN
upstream	|O
activator	|O
sequences	|O
,	|O
respectively	|O
.	|O

Although	|O
the	|O
effects	|O
of	|O
the	|O
calcium	|O
supplement	|O
or	|O
calcium	|O
antagonist	|O
alone	|O
were	|O
significant	|O
,	|O
such	|O
hypotensive	|O
responses	|O
were	|O
not	|O
optimal	|O
or	|O
predictable	|O
or	|O
clearly	|O
dose	|O
-	|O
dependent	|O
.	|O

C.	|O
,	|O
Sun	|O
,	|O
J.	|O
,	|O
Hsu	|O
,	|O
M.	|O
-	|O
Y.	|O
,	|O
Vallejo	|O
-	|O
Ramirez	|O
,	|O
J.	|O
,	|O
Inouye	|O
,	|O
S.	|O
,	|O
and	|O
Inouye	|O
,	|O
M.	|O

Surprisingly	|O
,	|O
the	|O
full	|O
-	|O
deletion	|O
mutant	|O
showed	|O
a	|O
strong	|O
block	|O
in	|O
virus	|O
release	|O
,	|O
suggesting	|O
that	|O
NC	|B-PROTEIN
is	|O
involved	|O
in	|O
virus	|O
assembly	|O
.	|O

Furthermore	|O
it	|O
was	|O
suggested	|O
that	|O
FK506	|O
plasma	|O
levels	|O
were	|O
concerned	|O
with	|O
the	|O
appearance	|O
of	|O
side	|O
effect	|O
.	|O

Thirty	|O
percent	|O
of	|O
patients	|O
were	|O
tapered	|O
off	|O
all	|O
steroids	|O
,	|O
and	|O
the	|O
average	|O
steroid	|O
dose	|O
in	|O
the	|O
group	|O
who	|O
received	|O
steroids	|O
was	|O
8.6	|O
mg	|O
of	|O
prednisone	|O
per	|O
day	|O
.	|O

Thus	|O
,	|O
cibenzoline	|O
is	|O
an	|O
effective	|O
antiarrhythmic	|O
agent	|O
with	|O
a	|O
favourable	|O
pharmacokinetic	|O
profile	|O
that	|O
may	|O
be	|O
considered	|O
with	|O
other	|O
class	|O
I	|O
drugs	|O
in	|O
patients	|O
requiring	|O
therapy	|O
for	|O
high	|O
risk	|O
arrhythmias	|O
.	|O

T	|B-PROTEIN
antigen	|I-PROTEIN
contains	|O
four	|O
H	|O
-	|O
2Db	|O
-	|O
restricted	|O
cytotoxic	|O
T	|O
lymphocyte	|O
(	|O
CTL	|O
)	|O
recognition	|O
epitopes	|O
that	|O
are	|O
targets	|O
for	|O
CTL	|O
clones	|O
Y	|O
-	|O
1	|O
,	|O
Y	|O
-	|O
2	|O
,	|O
Y	|O
-	|O
3	|O
,	|O
and	|O
Y	|O
-	|O
5	|O
.	|O

The	|O
method	|O
requires	|O
a	|O
reversed	|O
-	|O
phase	|O
column	|O
and	|O
a	|O
paired	|O
-	|O
ion	|O
technique	|O
to	|O
separate	|O
docusate	|O
sodium	|O
from	|O
other	|O
components	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
the	|O
protein	|O
product	|O
of	|O
the	|O
ref	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
stimulates	|O
the	|O
DNA	|O
binding	|O
activity	|O
of	|O
Fos	|B-PROTEIN
-	|O
Jun	|B-PROTEIN
heterodimers	|O
,	|O
Jun	|B-PROTEIN
-	|O
Jun	|B-PROTEIN
homodimers	|O
and	|O
Hela	|O
cell	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
proteins	|O
as	|O
well	|O
as	|O
that	|O
of	|O
several	|O
other	|O
transcription	|O
factors	|O
including	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
,	|O
Myb	|B-PROTEIN
and	|O
members	|O
of	|O
the	|O
ATF	|B-PROTEIN
/	|O
CREB	|B-PROTEIN
family	|O
.	|O

The	|O
pulpal	|O
tissues	|O
of	|O
the	|O
permanent	|O
mandibular	|O
molars	|O
were	|O
amputated	|O
and	|O
then	|O
dressed	|O
with	|O
calcium	|O
hydrate	|O
.	|O

Northern	|O
blot	|O
analyses	|O
demonstrate	|O
that	|O
3.9	|O
-	|O
and	|O
5	|O
-	|O
kilobase	|O
mRNAs	|O
corresponding	|O
to	|O
the	|O
cDNA	|O
were	|O
present	|O
in	|O
all	|O
tissues	|O
examined	|O
,	|O
suggesting	|O
that	|O
the	|O
protein	|O
it	|O
encodes	|O
performs	|O
a	|O
housekeeping	|O
function	|O
.	|O

The	|O
ARG	|B-PROTEIN
SH2	|O
domain	|O
exhibited	|O
relatively	|O
weak	|O
affinity	|O
for	|O
BCR	|B-PROTEIN
and	|O
was	|O
determined	|O
to	|O
bind	|O
about	|O
10	|O
-	|O
fold	|O
less	|O
strongly	|O
than	|O
the	|O
ABL	|B-PROTEIN
SH2	|O
domain	|O
.	|O

We	|O
analyzed	|O
an	|O
EBV	|O
B	|O
-	|O
cell	|O
clone	|O
,	|O
E29.1	|O
,	|O
derived	|O
from	|O
an	|O
11	|O
week	|O
-	|O
old	|O
embryo	|O
,	|O
and	|O
secreting	|O
both	|O
IgM	|B-PROTEIN
kappa	|I-PROTEIN
and	|O
IgM	|B-PROTEIN
lambda	|I-PROTEIN
.	|O

Interestingly	|O
,	|O
this	|O
activation	|O
occurred	|O
only	|O
when	|O
the	|O
regions	|O
were	|O
cloned	|O
in	|O
the	|O
same	|O
relative	|O
orientation	|O
in	|O
which	|O
they	|O
exist	|O
on	|O
wild	|O
-	|O
type	|O
pCF10	|O
.	|O

In	|O
rats	|O
,	|O
we	|O
examined	|O
the	|O
effect	|O
of	|O
an	|O
omentum	|O
wrapping	|O
on	|O
the	|O
vascularization	|O
of	|O
the	|O
trachea	|O
and	|O
on	|O
regeneration	|O
of	|O
the	|O
mucosal	|O
epithelium	|O
in	|O
the	|O
very	|O
early	|O
stage	|O
after	|O
free	|O
tracheal	|O
grafting	|O
.	|O

To	|O
study	|O
a	|O
possible	|O
functional	|O
role	|O
of	|O
this	|O
putative	|O
chicken	|O
ICS	|B-PROTEIN
,	|O
an	|O
oligonucleotide	|O
spanning	|O
the	|O
upstream	|O
sequences	|O
of	|O
the	|O
BF	|B-PROTEIN
-	|I-PROTEIN
IV	|I-PROTEIN
gene	|O
(	|O
-	|O
174	|O
/	|O
-	|O
194	|O
)	|O
was	|O
cloned	|O
singly	|O
or	|O
in	|O
multiple	|O
copies	|O
before	|O
the	|O
herpes	|O
TK	|B-PROTEIN
promoter	|O
controlling	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyl	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
gene	|O
(	|O
pBLCAT2	|B-PROTEIN
)	|O
.	|O

In	|O
general	|O
,	|O
two	|O
separate	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatographic	|O
runs	|O
were	|O
performed	|O
,	|O
one	|O
for	|O
the	|O
gamma	|O
-	|O
aminobutyric	|O
acid	|O
determination	|O
and	|O
one	|O
for	|O
the	|O
determination	|O
of	|O
the	|O
monoamines	|O
.	|O

We	|O
report	|O
the	|O
successful	|O
use	|O
of	|O
electroconvulsive	|O
therapy	|O
for	|O
treatment	|O
of	|O
severe	|O
depression	|O
in	|O
a	|O
young	|O
man	|O
with	|O
adult	|O
GM2	|O
gangliosidosis	|O
.	|O

Entry	|O
of	|O
yeast	|O
cells	|O
into	|O
the	|O
mitotic	|O
cell	|O
cycle	|O
(	|O
Start	|O
)	|O
involves	|O
a	|O
form	|O
of	|O
the	|O
CDC28	|B-PROTEIN
kinase	|I-PROTEIN
that	|O
associates	|O
with	|O
G1	|O
-	|O
specific	|O
cyclins	|B-PROTEIN
encoded	|O
by	|O
CLN1	|B-PROTEIN
and	|O
CLN2	|B-PROTEIN
(	|O
ref	|O
.	|O

Through	|O
Southern	|O
blot	|O
analyses	|O
of	|O
DNA	|O
from	|O
backcross	|O
and	|O
cogenic	|O
mice	|O
,	|O
recombinant	|O
inbred	|O
strains	|O
,	|O
and	|O
somatic	|O
cell	|O
hybrids	|O
,	|O
the	|O
genetic	|O
loci	|O
that	|O
produce	|O
the	|O
cyclin	|B-PROTEIN
B1	|I-PROTEIN
-	|O
related	|O
sequences	|O
(	|O
designated	|O
loci	|O
Cycb1	|B-PROTEIN
-	|I-PROTEIN
rs1	|I-PROTEIN
to	|O
Cycb1	|B-PROTEIN
-	|I-PROTEIN
rs9	|I-PROTEIN
)	|O
were	|O
mapped	|O
on	|O
mouse	|O
chromosomes	|O
5	|O
,	|O
1	|O
,	|O
17	|O
,	|O
4	|O
,	|O
14	|O
,	|O
13	|O
,	|O
7	|O
,	|O
X	|O
,	|O
and	|O
8	|O
,	|O
respectively	|O
.	|O

Again	|O
residue	|O
Glu	|O
-	|O
381	|O
of	|O
beta	|O
was	|O
notably	|O
reduced	|O
and	|O
no	|O
missing	|O
residue	|O
from	|O
the	|O
epsilon	|O
peptide	|O
could	|O
be	|O
identified	|O
,	|O
but	|O
the	|O
peptide	|O
sequence	|O
limited	|O
the	|O
possible	|O
choices	|O
to	|O
Ser	|O
-	|O
106	|O
,	|O
Ser	|O
-	|O
107	|O
,	|O
or	|O
Ser	|O
-	|O
108	|O
.	|O

Porcelain	|O
to	|O
dentin	|O
bond	|O
strength	|O
with	|O
a	|O
dentin	|O
adhesive	|O
.	|O

TBPf	|O
is	|O
defined	|O
as	|O
a	|O
quotient	|O
of	|O
the	|O
difference	|O
of	|O
the	|O
first	|O
and	|O
the	|O
second	|O
measurement	|O
:	|O
TBPf	|O
=	|O
(	|O
P1	|O
-	|O
P2	|O
)	|O
/	|O
(	|O
A1	|O
-	|O
A2	|O
)	|O
.	|O

It	|O
was	|O
concluded	|O
that	|O
Scotchbond	|O
2	|O
and	|O
Prisma	|O
Universal	|O
Bond	|O
2	|O
are	|O
effective	|O
and	|O
are	|O
the	|O
dentine	|O
bonding	|O
agents	|O
of	|O
choice	|O
.	|O

From	|O
all	|O
clinically	|O
important	|O
yeasts	|O
species	|O
,	|O
a	|O
total	|O
of	|O
96%	|O
were	|O
identified	|O
by	|O
ATB	|O
method	|O
according	|O
to	|O
conventional	|O
methods	|O
.	|O

The	|O
neurohypophysial	|O
vasopressin	|B-PROTEIN
and	|O
oxytocin	|B-PROTEIN
content	|O
was	|O
bioassayed	|O
by	|O
pressor	|O
effect	|O
following	|O
Dekanski	|O
or	|O
milk	|O
-	|O
ejection	|O
activity	|O
in	|O
vitro	|O
following	|O
van	|O
Dongen	|O
and	|O
Hays	|O
,	|O
respectively	|O
.	|O

Comments	|O
are	|O
given	|O
on	|O
the	|O
present	|O
status	|O
of	|O
regulations	|O
concerning	|O
water	|O
in	|O
swimming	|O
pools	|O
and	|O
baths	|O
-	|O
-	|O
1991	|O
-	|O
-	|O
(	|O
in	|O
connection	|O
with	|O
the	|O
KOK	|O
regulations	|O
-	|O
-	|O
1972	|O
-	|O
-	|O
and	|O
the	|O
Federal	|O
German	|O
standard	|O
[	|O
DIN	|O
]	|O
No	|O
.	|O

If	|O
no	|O
reply	|O
was	|O
received	|O
,	|O
telephone	|O
contact	|O
or	|O
home	|O
visits	|O
were	|O
made	|O
.	|O

The	|O
treatment	|O
group	|O
also	|O
showed	|O
in	|O
vivo	|O
T	|O
-	|O
cell	|O
activation	|O
with	|O
an	|O
initial	|O
lymphopenia	|O
followed	|O
by	|O
a	|O
rebound	|O
lymphocytosis	|O
and	|O
upregulation	|O
of	|O
the	|O
subset	|O
markers	|O
CD25	|B-PROTEIN
(	|O
interleukin	|B-PROTEIN
2	|I-PROTEIN
receptor	|I-PROTEIN
)	|O
and	|O
CD45RO	|B-PROTEIN
(	|O
T	|O
-	|O
memory	|O
cells	|O
)	|O
.	|O

Urease	|B-PROTEIN
activity	|O
,	|O
judged	|O
as	|O
the	|O
amount	|O
of	|O
ammonia	|O
production	|O
from	|O
urea	|O
,	|O
could	|O
be	|O
measured	|O
at	|O
25	|O
ng	|O
per	|O
tube	|O
(	|O
S	|O
/	|O
N	|O
=	|O
1.5	|O
)	|O
with	|O
Jack	|O
bean	|O
meal	|O
urease	|B-PROTEIN
.	|O

Consequently	|O
,	|O
significant	|O
differences	|O
between	|O
the	|O
measured	|O
and	|O
calculated	|O
methods	|O
were	|O
noted	|O
in	|O
oxygen	|O
uptake	|O
(	|O
213	|O
+	|O
/	|O
-	|O
41	|O
ml	|O
/	|O
min	|O
vs	|O
193	|O
+	|O
/	|O
-	|O
25	|O
ml	|O
/	|O
min	|O
,	|O
p	|O
<	|O
0.001	|O
)	|O
,	|O
oxygen	|O
delivery	|O
(	|O
780	|O
+	|O
/	|O
-	|O
297	|O
ml	|O
/	|O
min	|O
vs	|O
716	|O
+	|O
/	|O
-	|O
296	|O
ml	|O
/	|O
min	|O
,	|O
p	|O
<	|O
0.001	|O
)	|O
,	|O
and	|O
cardiac	|O
output	|O
(	|O
5.8	|O
+	|O
/	|O
-	|O
2.2	|O
L	|O
/	|O
min	|O
vs	|O
5.3	|O
+	|O
/	|O
-	|O
1.8	|O
L	|O
/	|O
min	|O
,	|O
p	|O
<	|O
0.001	|O
)	|O
.	|O

Although	|O
a	|O
wide	|O
range	|O
of	|O
cognitive	|O
functions	|O
had	|O
been	|O
tested	|O
,	|O
all	|O
but	|O
one	|O
seizure	|O
occurred	|O
during	|O
assessment	|O
of	|O
memory	|O
performance	|O
.	|O

The	|O
experiments	|O
show	|O
that	|O
it	|O
is	|O
the	|O
micromilieu	|O
of	|O
the	|O
alveoli	|O
and	|O
the	|O
condition	|O
of	|O
the	|O
AM	|O
(	|O
certain	|O
physiological	|O
activation	|O
states	|O
,	|O
such	|O
as	|O
phagocytic	|O
activity	|O
)	|O
that	|O
essentially	|O
determine	|O
the	|O
degree	|O
of	|O
recovery	|O
.	|O

Negatively	|O
supercoiled	|O
plasmid	|O
pUC19	|O
did	|O
not	|O
compete	|O
,	|O
whereas	|O
an	|O
otherwise	|O
identical	|O
plasmid	|O
pUC19	|O
(	|O
CG	|O
)	|O
,	|O
which	|O
contained	|O
a	|O
(	|O
dG	|O
-	|O
dC	|O
)	|O
7	|O
segment	|O
in	|O
the	|O
Z	|O
-	|O
form	|O
was	|O
an	|O
excellent	|O
competitor	|O
.	|O

A	|O
cDNA	|O
library	|O
of	|O
tumour	|O
cells	|O
was	|O
screened	|O
with	|O
an	|O
interleukin	|B-PROTEIN
2	|I-PROTEIN
gene	|O
-	|O
specific	|O
probe	|O
.	|O

Our	|O
experiments	|O
suggest	|O
that	|O
the	|O
SCL	|B-PROTEIN
gene	|O
can	|O
be	|O
a	|O
target	|O
for	|O
the	|O
erythroid	|O
transcription	|O
factor	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
that	|O
the	|O
SCL	|B-PROTEIN
gene	|O
product	|O
serves	|O
as	|O
a	|O
positive	|O
regulator	|O
of	|O
erythroid	|O
differentiation	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
lumenal	|O
domains	|O
of	|O
Sec12p	|B-PROTEIN
,	|O
Stl1p	|B-PROTEIN
and	|O
Stl2p	|B-PROTEIN
are	|O
very	|O
different	|O
in	|O
size	|O
and	|O
do	|O
not	|O
show	|O
any	|O
appreciable	|O
homology	|O
.	|O

Complexes	|O
containing	|O
wild	|O
-	|O
type	|O
and	|O
either	|O
his175	|O
or	|O
his273	|O
mutant	|O
p53	|B-PROTEIN
proteins	|O
are	|O
completely	|O
unable	|O
to	|O
bind	|O
to	|O
the	|O
RGC	|B-PROTEIN
DNA	|O
sequence	|O
.	|O

These	|O
temperature	|O
-	|O
and	|O
cold	|O
-	|O
sensitive	|O
strains	|O
were	|O
used	|O
to	|O
prepare	|O
extracts	|O
deficient	|O
in	|O
BRF1	|B-PROTEIN
activity	|O
and	|O
were	|O
tested	|O
for	|O
transcriptional	|O
activity	|O
by	|O
RNA	|B-PROTEIN
polymerases	|I-PROTEIN
I	|I-PROTEIN
,	|I-PROTEIN
II	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
III	|I-PROTEIN
in	|O
vitro	|O
.	|O

These	|O
results	|O
lead	|O
us	|O
to	|O
hypothesize	|O
that	|O
a	|O
single	|O
multisubunit	|O
TFIID	|B-PROTEIN
protein	|O
supports	|O
transcriptional	|O
stimulation	|O
by	|O
diverse	|O
activation	|O
domains	|O
and	|O
from	|O
a	|O
TATA	|O
-	|O
less	|O
promoter	|O
.	|O

The	|O
gene	|O
sequence	|O
also	|O
identified	|O
a	|O
340	|O
-	|O
nucleotide	|O
RNA	|O
in	|O
total	|O
yeast	|O
RNA	|O
and	|O
in	|O
purified	|O
RNase	|O
MRP	|B-PROTEIN
enzyme	|O
preparations	|O
.	|O

The	|O
RNase	|O
MRP	|B-PROTEIN
RNA	|O
gene	|O
was	|O
deleted	|O
by	|O
insertional	|O
replacement	|O
and	|O
found	|O
to	|O
be	|O
essential	|O
for	|O
cellular	|O
viability	|O
,	|O
indicating	|O
a	|O
critical	|O
nuclear	|O
role	|O
for	|O
RNase	|O
MRP	|B-PROTEIN
.	|O

Clone	|O
pSRc200	|O
hybrid	|O
selected	|O
an	|O
mRNA	|O
that	|O
on	|O
cell	|O
-	|O
free	|O
translation	|O
produced	|O
a	|O
38	|O
-	|O
kDa	|O
polypeptide	|O
.	|O

From	|O
these	|O
results	|O
,	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
is	|O
a	|O
novel	|O
CArG	|O
box	|O
-	|O
,	|O
ssDNA	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
RNA	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
as	|O
well	|O
as	|O
a	|O
repressive	|O
transcriptional	|O
factor	|O
.	|O

Cleavage	|O
by	|O
the	|O
intron	|O
-	|O
encoded	|O
enzyme	|O
(	|O
I	|B-PROTEIN
-	|I-PROTEIN
CreI	|I-PROTEIN
)	|O
occurs	|O
5	|O
bp	|O
and	|O
1	|O
bp	|O
3'	|O
to	|O
the	|O
intron	|O
insertion	|O
site	|O
(	|O
in	|O
the	|O
3'	|O
-	|O
exon	|O
)	|O
in	|O
the	|O
top	|O
(	|O
/	|O
)	|O
and	|O
bottom	|O
(	|O
,	|O
)	|O
strands	|O
,	|O
respectively	|O
,	|O
resulting	|O
in	|O
4	|O
-	|O
nt	|O
single	|O
-	|O
stranded	|O
overhangs	|O
with	|O
3'	|O
-	|O
OH	|O
termini	|O
.	|O

Surprisingly	|O
,	|O
the	|O
Xenopus	|O
U7	|B-PROTEIN
gene	|O
contains	|O
two	|O
adjacent	|O
octamer	|O
-	|O
binding	|O
motifs	|O
located	|O
only	|O
12	|O
and	|O
24	|O
bp	|O
upstream	|O
from	|O
the	|O
PSE	|B-PROTEIN
,	|O
instead	|O
of	|O
the	|O
usual	|O
location	|O
around	|O
150-200	|O
bp	|O
upstream	|O
.	|O

The	|O
results	|O
support	|O
earlier	|O
reports	|O
that	|O
collagenase	|B-PROTEIN
inhibitors	|O
are	|O
useful	|O
in	|O
controlling	|O
blister	|O
formation	|O
in	|O
recessive	|O
dystrophic	|O
epidermolysis	|O
bullosa	|O
.	|O

Mutational	|O
analysis	|O
of	|O
essential	|O
IncP	|O
alpha	|O
plasmid	|O
transfer	|O
genes	|O
traF	|B-PROTEIN
and	|O
traG	|O
and	|O
involvement	|O
of	|O
traF	|B-PROTEIN
in	|O
phage	|O
sensitivity	|O
.	|O

The	|O
promoter	|O
was	|O
stimulated	|O
8-20	|O
-	|O
fold	|O
by	|O
phorbol	|O
esters	|O
accounting	|O
for	|O
the	|O
previously	|O
observed	|O
transcriptional	|O
activation	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
beta	|I-PROTEIN
.	|O

In	|O
humans	|O
,	|O
four	|O
AMP	|B-PROTEIN
deaminase	|I-PROTEIN
variants	|O
,	|O
termed	|O
M	|B-PROTEIN
(	|O
muscle	|O
)	|O
,	|O
L	|B-PROTEIN
(	|O
liver	|O
)	|O
,	|O
E1	|B-PROTEIN
,	|O
and	|O
E2	|B-PROTEIN
(	|O
erythrocyte	|O
)	|O
can	|O
be	|O
distinguished	|O
by	|O
a	|O
variety	|O
of	|O
biochemical	|O
and	|O
immunological	|O
criteria	|O
.	|O

Western	|O
blot	|O
analyses	|O
detect	|O
anti	|B-PROTEIN
-	|I-PROTEIN
E	|I-PROTEIN
-	|O
specific	|O
immunoreactivity	|O
in	|O
affinity	|O
-	|O
purified	|O
extracts	|O
derived	|O
from	|O
the	|O
bacterial	|O
expression	|O
of	|O
a	|O
truncated	|O
AMPD3	|B-PROTEIN
cDNA	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
endogenous	|O
N	|O
-	|O
methylation	|O
of	|O
salsolinol	|O
into	|O
N	|O
-	|O
methylsalsolinol	|O
occurs	|O
in	|O
the	|O
brain	|O
in	|O
vivo	|O
.	|O

DR1	|B-PROTEIN
molecules	|O
purified	|O
from	|O
human	|O
lymphoblastoid	|O
cell	|O
lines	|O
could	|O
specifically	|O
bind	|O
to	|O
these	|O
peptide	|O
sequences	|O
expressed	|O
on	|O
the	|O
phage	|O
surface	|O
.	|O

This	|O
article	|O
describes	|O
the	|O
collaborative	|O
care	|O
of	|O
the	|O
woman	|O
participating	|O
in	|O
maternal	|O
blood	|O
donation	|O
for	|O
intrauterine	|O
transfusion	|O
.	|O

Chronic	|O
hepatitis	|O
B	|O
in	|O
adopted	|O
Romanian	|O
children	|O
.	|O

Behind	|O
the	|O
ATPase	|B-PROTEIN
cluster	|O
,	|O
two	|O
open	|O
reading	|O
frames	|O
were	|O
detected	|O
that	|O
are	|O
not	|O
homologous	|O
to	|O
any	|O
known	|O
chloroplast	|O
gene	|O
.	|O

Therefore	|O
,	|O
recombinant	|O
human	|O
Ads	|O
that	|O
express	|O
noninfectious	|O
HIV	|O
or	|O
other	|O
microbial	|O
proteins	|O
are	|O
attractive	|O
vaccine	|O
candidates	|O
.	|O

Alignment	|O
of	|O
the	|O
selected	|O
sequences	|O
allowed	|O
us	|O
to	|O
predict	|O
a	|O
consensus	|O
sequence	|O
for	|O
binding	|O
of	|O
the	|O
individual	|O
homodimeric	|O
Rel	|B-PROTEIN
-	|O
related	|O
proteins	|O
,	|O
and	|O
DNA	|O
-	|O
protein	|O
binding	|O
analysis	|O
of	|O
the	|O
selected	|O
DNA	|O
sequences	|O
revealed	|O
sequence	|O
specificity	|O
of	|O
the	|O
proteins	|O
.	|O

Using	|O
either	|O
a	|O
p50	|B-PROTEIN
-	|O
or	|O
p65	|B-PROTEIN
-	|O
selected	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
motif	|O
,	|O
which	|O
displayed	|O
differential	|O
binding	|O
with	|O
respect	|O
to	|O
the	|O
other	|O
protein	|O
,	|O
little	|O
to	|O
no	|O
binding	|O
was	|O
observed	|O
with	|O
the	|O
heterodimeric	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
complex	|O
.	|O

However	|O
,	|O
a	|O
cosmid	|O
clone	|O
containing	|O
the	|O
entire	|O
mouse	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
gene	|O
,	|O
including	|O
3.7	|O
kb	|O
of	|O
5'	|O
-	|O
and	|O
4	|O
kb	|O
of	|O
3'	|O
-	|O
flanking	|O
DNA	|O
,	|O
was	|O
expressed	|O
at	|O
reduced	|O
levels	|O
in	|O
fibroblasts	|O
overexpressing	|O
oncogenic	|O
ras	|B-PROTEIN
.	|O

To	|O
define	|O
transcriptional	|O
control	|O
elements	|O
responsible	|O
for	|O
muscle	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
human	|O
myoglobin	|B-PROTEIN
gene	|O
,	|O
we	|O
performed	|O
mutational	|O
analysis	|O
of	|O
upstream	|O
sequences	|O
(	|O
nucleotide	|O
positions	|O
-	|O
373	|O
to	|O
+	|O
7	|O
relative	|O
to	|O
the	|O
transcriptional	|O
start	|O
site	|O
)	|O
linked	|O
to	|O
a	|O
firefly	|O
luciferase	|B-PROTEIN
gene	|O
.	|O

Sequencing	|O
analysis	|O
has	|O
shown	|O
that	|O
each	|O
rap1t	|B-PROTEIN
allele	|O
contains	|O
a	|O
nonsense	|O
mutation	|O
within	|O
a	|O
discrete	|O
region	|O
between	|O
amino	|O
acids	|O
663	|O
and	|O
684	|O
.	|O

By	|O
screening	|O
a	|O
Y1	|O
cell	|O
cDNA	|O
library	|O
with	|O
the	|O
DNA	|O
-	|O
binding	|O
region	|O
of	|O
the	|O
H	|B-PROTEIN
-	|I-PROTEIN
2RIIBP	|I-PROTEIN
nuclear	|O
hormone	|O
receptor	|O
cDNA	|O
,	|O
we	|O
isolated	|O
a	|O
cDNA	|O
that	|O
is	|O
selectively	|O
expressed	|O
in	|O
steroidogenic	|O
cells	|O
.	|O

Autopsy	|O
demonstrated	|O
good	|O
survival	|O
of	|O
the	|O
transplanted	|O
cells	|O
with	|O
good	|O
integration	|O
with	|O
the	|O
brain	|O
of	|O
the	|O
recipient	|O
and	|O
traces	|O
of	|O
positive	|O
immunocytochemical	|O
reaction	|O
for	|O
tyrosine	|B-PROTEIN
hydroxylase	|I-PROTEIN
.	|O

The	|O
technique	|O
of	|O
the	|O
TEE	|O
visualization	|O
of	|O
the	|O
proximal	|O
coronary	|O
arteries	|O
is	|O
described	|O
.	|O

The	|O
sequence	|O
of	|O
this	|O
region	|O
shows	|O
high	|O
G+	|O
C	|O
content	|O
(	|O
62%	|O
)	|O
,	|O
which	|O
is	|O
particularly	|O
emphasized	|O
in	|O
the	|O
200	|O
bp	|O
upstream	|O
from	|O
the	|O
mRNA	|O
start	|O
(	|O
80%	|O
G+	|O
C	|O
)	|O
.	|O

In	|O
the	|O
eight	|O
patients	|O
with	|O
persistent	|O
generalized	|O
lymph	|O
-	|O
adenopathy	|O
(	|O
PGL	|O
)	|O
and	|O
nontender	|O
,	|O
nonenlarging	|O
nodes	|O
,	|O
pathologic	|O
analysis	|O
revealed	|O
lymphoid	|O
hyperplasia	|O
.	|O

PaO2	|O
threshold	|O
was	|O
determined	|O
through	|O
an	|O
indwelling	|O
O2	|O
sensor	|O
catheter	|O
.	|O

We	|O
found	|O
that	|O
both	|O
the	|O
E26	|O
virus	|O
-	|O
encoded	|O
v	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
and	|O
the	|O
myeloid	|O
/	|O
B	|O
-	|O
cell	|O
-	|O
specific	|O
factor	|O
PU.1	|B-PROTEIN
bind	|O
efficiently	|O
to	|O
this	|O
site	|O
in	|O
vitro	|O
.	|O

By	|O
using	|O
lambda	|O
gt11	|O
expression	|O
cloning	|O
with	|O
oligonucleotides	|O
corresponding	|O
to	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
1	|O
TATA	|O
element	|O
,	|O
we	|O
report	|O
the	|O
identification	|O
of	|O
a	|O
cellular	|O
protein	|O
with	|O
a	|O
calculated	|O
molecular	|O
mass	|O
of	|O
123	|O
kDa	|O
that	|O
we	|O
designate	|O
TATA	|B-PROTEIN
element	|I-PROTEIN
modulatory	|I-PROTEIN
factor	|I-PROTEIN
(	|O
TMF	|B-PROTEIN
)	|O
.	|O

Blood	|O
levels	|O
of	|O
melatonin	|O
,	|O
serotonin	|O
,	|O
cortisol	|O
,	|O
and	|O
prolactin	|B-PROTEIN
in	|O
relation	|O
to	|O
the	|O
circadian	|O
rhythm	|O
of	|O
platelet	|O
serotonin	|O
uptake	|O
.	|O

We	|O
couldn	|O
't	|O
detect	|O
any	|O
effect	|O
of	|O
n	|O
-	|O
3	|O
FA	|O
supplementation	|O
on	|O
total	|O
cholesterol	|O
,	|O
HDL	|B-PROTEIN
cholesterol	|I-PROTEIN
,	|O
LDL	|B-PROTEIN
cholesterol	|I-PROTEIN
,	|O
apo	|B-PROTEIN
A1	|I-PROTEIN
,	|O
Lp	|B-PROTEIN
(	|I-PROTEIN
a	|I-PROTEIN
)	|I-PROTEIN
,	|O
HbA1C	|B-PROTEIN
,	|O
glucose	|O
,	|O
fibrinogen	|B-PROTEIN
,	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
,	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
,	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
inhibitor	|I-PROTEIN
,	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
and	|O
von	|B-PROTEIN
Willebrand	|I-PROTEIN
factor	|I-PROTEIN
concentration	|O
,	|O
on	|O
bleeding	|O
time	|O
or	|O
on	|O
systolic	|O
or	|O
diastolic	|O
blood	|O
pressure	|O
.	|O

In	|O
8	|O
healthy	|O
volunteers	|O
there	|O
were	|O
no	|O
significant	|O
differences	|O
in	|O
AUC	|O
,	|O
peak	|O
plasma	|O
concentrations	|O
or	|O
time	|O
to	|O
peak	|O
concentration	|O
when	|O
OXC	|O
was	|O
administered	|O
either	|O
with	|O
or	|O
without	|O
ERY	|O
.	|O

Using	|O
5	|O
ng	|O
/	|O
mL	|O
as	|O
the	|O
cutoff	|O
,	|O
the	|O
sensitivity	|O
of	|O
CEA	|B-PROTEIN
was	|O
68%	|O
.	|O

Rolandic	|O
spikes	|O
and	|O
cognitive	|O
function	|O
.	|O

The	|O
effect	|O
of	|O
sodium	|O
18	|O
beta	|O
-	|O
glycyrrhetate	|O
(	|O
SGA	|O
)	|O
on	|O
experimental	|O
arrhythmia	|O
was	|O
investigated	|O
.	|O

Thus	|O
,	|O
chronic	|O
hematocrit	|O
decrease	|O
induced	|O
by	|O
H	|O
or	|O
P	|O
resulted	|O
in	|O
a	|O
significant	|O
fall	|O
in	|O
blood	|O
pressure	|O
compared	|O
to	|O
control	|O
(	|O
201	|O
+	|O
/	|O
-	|O
3	|O
v	|O
175	|O
+	|O
/	|O
-	|O
4	|O
,	|O
167	|O
+	|O
/	|O
-	|O
4	|O
mm	|O
Hg	|O
,	|O
respectively	|O
;	|O
P	|O
<	|O
.05	|O
)	|O
.	|O

The	|O
effects	|O
of	|O
diltiazem	|O
were	|O
stereoselective	|O
,	|O
thus	|O
the	|O
potentiation	|O
induced	|O
by	|O
d	|O
-	|O
cis	|O
diltiazem	|O
was	|O
significantly	|O
greater	|O
in	|O
all	|O
cases	|O
than	|O
that	|O
induced	|O
by	|O
l	|O
-	|O
cis	|O
diltiazem	|O
,	|O
which	|O
suggests	|O
that	|O
calcium	|O
channel	|O
blockade	|O
plays	|O
a	|O
role	|O
in	|O
these	|O
interactions	|O
.	|O

Localization	|O
of	|O
the	|O
brachial	|O
plexus	|O
with	|O
the	|O
nerve	|O
stimulator	|O
is	|O
equally	|O
effective	|O
at	|O
the	|O
interscalene	|O
,	|O
supraclavicular	|O
,	|O
and	|O
axillary	|O
sites	|O
.	|O

Substitution	|O
of	|O
either	|O
Val33	|O
(	|O
by	|O
Gly	|O
)	|O
or	|O
Gly28	|O
(	|O
by	|O
Ser	|O
)	|O
,	|O
two	|O
of	|O
the	|O
most	|O
conserved	|O
residues	|O
in	|O
all	|O
protein	|O
kinases	|O
,	|O
resulted	|O
in	|O
enzyme	|O
with	|O
marginally	|O
detectable	|O
activity	|O
.	|O

Significance	|O
of	|O
the	|O
biopsy	|O
site	|O
of	|O
the	|O
latissimus	|O
dorsi	|O
muscle	|O
for	|O
fiber	|O
typing	|O
.	|O

The	|O
TIMP	|B-PROTEIN
(	|O
-	|O
59	|O
/	|O
-	|O
53	|O
)	|O
AP1	|B-PROTEIN
site	|O
is	|O
a	|O
promiscuous	|O
motif	|O
that	|O
binds	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
AP1	|O
translated	|O
in	|O
vitro	|O
and	|O
is	|O
an	|O
effective	|O
competitor	|O
for	|O
binding	|O
of	|O
nuclear	|O
AP1	|B-PROTEIN
factors	|O
to	|O
the	|O
consensus	|O
TRE	|O
,	|O
but	|O
in	|O
addition	|O
it	|O
binds	|O
factors	|O
that	|O
do	|O
not	|O
associate	|O
with	|O
the	|O
consensus	|O
TRE	|O
.	|O

Involvement	|O
of	|O
AP1	|B-PROTEIN
and	|O
PEA3	|B-PROTEIN
binding	|O
sites	|O
in	|O
the	|O
regulation	|O
of	|O
murine	|O
tissue	|B-PROTEIN
inhibitor	|I-PROTEIN
of	|I-PROTEIN
metalloproteinases	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
TIMP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
transcription	|O
.	|O

Of	|O
the	|O
serum	|O
neutralizing	|O
(	|O
SN	|B-PROTEIN
)	|O
antibody	|O
negative	|O
calves	|O
89.7%	|O
(	|O
26/29	|O
)	|O
and	|O
92.8%	|O
(	|O
90/97	|O
)	|O
developed	|O
SN	|B-PROTEIN
antibody	|O
1	|O
month	|O
after	|O
intranasal	|O
and	|O
intramuscular	|O
vaccination	|O
,	|O
respectively	|O
.	|O

Fractionation	|O
of	|O
crude	|O
nuclear	|O
extracts	|O
by	|O
heparin	|O
-	|O
agarose	|O
chromatography	|O
indicates	|O
that	|O
PCAT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
more	|O
prevalent	|O
in	|O
extracts	|O
prepared	|O
from	|O
salt	|O
-	|O
stressed	|O
leaf	|O
tissue	|O
.	|O

A	|O
controlled	|O
trial	|O
of	|O
recombinant	|O
human	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
after	|O
total	|O
body	|O
irradiation	|O
,	|O
high	|O
-	|O
dose	|O
chemotherapy	|O
,	|O
and	|O
autologous	|O
bone	|O
marrow	|O
transplantation	|O
for	|O
acute	|O
lymphoblastic	|O
leukemia	|O
or	|O
malignant	|O
lymphoma	|O
.	|O

These	|O
data	|O
demonstrate	|O
that	|O
DMVA	|O
does	|O
not	|O
cause	|O
more	|O
myocardial	|O
trauma	|O
than	|O
CPB	|O
when	|O
used	|O
to	|O
provide	|O
resuscitative	|O
circulatory	|O
support	|O
.	|O

The	|O
IgG	|B-PROTEIN
subclass	|O
profile	|O
of	|O
untreated	|O
coeliac	|O
disease	|O
was	|O
found	|O
to	|O
be	|O
the	|O
same	|O
as	|O
in	|O
healthy	|O
controls	|O
(	|O
IgG1	|B-PROTEIN
approximately	|O
IgG2	|B-PROTEIN
>	|O
IgG3	|B-PROTEIN
>	|O
IgG4	|B-PROTEIN
)	|O
,	|O
with	|O
only	|O
the	|O
magnitude	|O
of	|O
the	|O
individual	|O
subclass	|O
responses	|O
being	|O
increased	|O
in	|O
coeliac	|O
patients	|O
.	|O

Examination	|O
of	|O
ANCA	|B-PROTEIN
is	|O
not	|O
only	|O
a	|O
significant	|O
contribution	|O
towards	|O
a	|O
more	|O
accurate	|O
diagnosis	|O
of	|O
renal	|O
vasculitis	|O
,	|O
but	|O
also	|O
an	|O
indicator	|O
of	|O
the	|O
activity	|O
of	|O
the	|O
disease	|O
and	|O
thus	|O
of	|O
the	|O
effectiveness	|O
of	|O
immunosuppressive	|O
treatment	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
total	|O
pinealectomy	|O
in	|O
these	|O
already	|O
sympathectomized	|O
blinded	|O
rabbits	|O
always	|O
resulted	|O
in	|O
a	|O
substantial	|O
deceleration	|O
of	|O
the	|O
rhythms	|O
(	|O
mean	|O
delta	|O
tau	|O
=	|O
+	|O
0.23	|O
h	|O
)	|O
.	|O

Cicatricial	|O
pemphigoid	|O
is	|O
an	|O
autoimmune	|O
systemic	|O
disease	|O
characterized	|O
by	|O
chronic	|O
conjunctival	|O
cicatrization	|O
.	|O

The	|O
effects	|O
of	|O
two	|O
levels	|O
of	|O
caffeine	|O
ingestion	|O
on	|O
excess	|O
postexercise	|O
oxygen	|O
consumption	|O
in	|O
untrained	|O
women	|O
.	|O

The	|O
distinguishing	|O
features	|O
involved	|O
eight	|O
amino	|O
acid	|O
changes	|O
,	|O
including	|O
a	|O
single	|O
lysine	|O
deletion	|O
relative	|O
to	|O
a	|O
primate	|O
consensus	|O
sequence	|O
in	|O
the	|O
first	|O
complementary	|O
-	|O
determing	|O
region	|O
of	|O
V1J1	|B-PROTEIN
.	|O

4	|O
.	|O

The	|O
in	|O
vivo	|O
profile	|O
of	|O
ZFH	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
in	|O
the	|O
larval	|O
CNS	|O
shows	|O
intriguing	|O
overlap	|O
with	|O
DDC	|B-PROTEIN
in	|O
specific	|O
serotonin	|O
and	|O
dopamine	|O
neurons	|O
.	|O

Unlike	|O
the	|O
introns	|O
of	|O
other	|O
duplicated	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
genes	|O
which	|O
are	|O
highly	|O
diverged	|O
,	|O
the	|O
duplicated	|O
S13	|B-PROTEIN
genes	|O
have	|O
two	|O
nearly	|O
identical	|O
DNA	|O
sequences	|O
of	|O
25	|O
and	|O
31	|O
bp	|O
in	|O
length	|O
within	|O
their	|O
introns	|O
.	|O

In	|O
a	|O
prospective	|O
,	|O
randomized	|O
clinical	|O
trial	|O
we	|O
compared	|O
the	|O
efficacy	|O
of	|O
subcutaneously	|O
(	|O
SC	|O
)	|O
administered	|O
(	|O
every	|O
8	|O
h	|O
)	|O
calcium	|O
heparin	|O
to	|O
intravenous	|O
(	|O
IV	|O
)	|O
sodium	|O
heparin	|O
in	|O
the	|O
treatment	|O
of	|O
proximal	|O
deep	|O
-	|O
vein	|O
thrombosis	|O
(	|O
DVT	|O
)	|O
.	|O

The	|O
highest	|O
prevalence	|O
of	|O
reported	|O
pet	|O
allergy	|O
,	|O
chronic	|O
cough	|O
,	|O
wheeze	|O
,	|O
attacks	|O
of	|O
shortness	|O
of	|O
breath	|O
with	|O
wheezing	|O
,	|O
and	|O
doctor	|O
-	|O
diagnosed	|O
asthma	|O
was	|O
found	|O
in	|O
children	|O
who	|O
had	|O
pets	|O
in	|O
the	|O
past	|O
but	|O
not	|O
anymore	|O
.	|O

Therefore	|O
,	|O
it	|O
would	|O
be	|O
advantageous	|O
to	|O
identify	|O
such	|O
persons	|O
and	|O
treat	|O
them	|O
preferentially	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
these	|O
unique	|O
properties	|O
,	|O
the	|O
newly	|O
characterized	|O
hemagglutinin	|B-PROTEIN
has	|O
been	|O
termed	|O
Limulus	|B-PROTEIN
18K	|I-PROTEIN
agglutination	|I-PROTEIN
-	|I-PROTEIN
aggregation	|I-PROTEIN
factor	|I-PROTEIN
(	|O
18K	|B-PROTEIN
-	|I-PROTEIN
LAF	|I-PROTEIN
)	|O
.	|O

The	|O
shift	|O
to	|O
the	|O
nonpermissive	|O
temperature	|O
is	|O
accompanied	|O
by	|O
the	|O
loss	|O
of	|O
guanyl	|O
nucleotide	|O
-	|O
dependent	|O
activity	|O
of	|O
adenylylcyclase	|B-PROTEIN
in	|O
vitro	|O
.	|O

Clin	|O
.	|O

The	|O
data	|O
indicate	|O
that	|O
the	|O
minimal	|O
catalytic	|O
domain	|O
of	|O
Nmt1p	|B-PROTEIN
is	|O
located	|O
between	|O
Ile59	|O
-	|O
-	|O
>	|O
Phe96	|O
and	|O
Gly451	|O
-	|O
-	|O
>	|O
Leu455	|O
.	|O

It	|O
corresponds	|O
to	|O
the	|O
complete	|O
mitochondrial	|O
presequence	|O
and	|O
the	|O
lipoyl	|O
-	|O
bearing	|O
domain	|O
that	|O
are	|O
encoded	|O
by	|O
exons	|O
I	|O
through	|O
IV	|O
of	|O
the	|O
functional	|O
E2	|B-PROTEIN
gene	|O
.	|O

Human	|O
neutrophil	|O
response	|O
to	|O
short	|O
-	|O
term	|O
exposure	|O
to	|O
F	|O
-	|O
75	|O
cobalt	|O
-	|O
based	|O
alloy	|O
.	|O

Disruption	|O
of	|O
microtubules	|O
did	|O
not	|O
affect	|O
the	|O
fidelity	|O
or	|O
kinetics	|O
of	|O
vacuolar	|O
protein	|O
sorting	|O
,	|O
indicating	|O
that	|O
Vps1p	|B-PROTEIN
function	|O
is	|O
not	|O
dependent	|O
on	|O
microtubules	|O
.	|O

A	|O
mutant	|O
form	|O
of	|O
Vps1p	|B-PROTEIN
lacking	|O
the	|O
entire	|O
GTP	|O
-	|O
binding	|O
domain	|O
interfered	|O
with	|O
vacuolar	|O
protein	|O
sorting	|O
in	|O
wild	|O
-	|O
type	|O
cells	|O
.	|O

According	|O
to	|O
out	|O
field	|O
research	|O
,	|O
the	|O
tick	|O
fauna	|O
was	|O
very	|O
rich	|O
throughout	|O
that	|O
area	|O
,	|O
and	|O
it	|O
was	|O
permissible	|O
enough	|O
to	|O
determine	|O
ticks	|O
as	|O
the	|O
vectors	|O
,	|O
based	|O
on	|O
arising	|O
of	|O
anti	|B-PROTEIN
-	|I-PROTEIN
SF	|I-PROTEIN
group	|I-PROTEIN
rickettsiae	|I-PROTEIN
(	|O
SFGR	|B-PROTEIN
)	|O
antibody	|O
in	|O
mice	|O
inoculated	|O
with	|O
some	|O
tick	|O
emulsions	|O
,	|O
findings	|O
of	|O
rickettsiae	|O
reactive	|O
to	|O
patient	|O
sera	|O
or	|O
a	|O
species	|O
-	|O
specific	|O
monoclonal	|O
antibody	|O
to	|O
JSFR	|B-PROTEIN
in	|O
the	|O
hemolymph	|O
cells	|O
of	|O
some	|O
ticks	|O
,	|O
and	|O
electron	|O
microscopical	|O
observations	|O
of	|O
SFGR	|B-PROTEIN
in	|O
various	|O
internal	|O
organs	|O
including	|O
the	|O
salivary	|O
gland	|O
of	|O
ticks	|O
.	|O

The	|O
second	|O
method	|O
,	|O
the	|O
"	|O
macro	|O
"	|O
assay	|O
,	|O
has	|O
a	|O
sensitivity	|O
range	|O
of	|O
0.03-5.0	|O
micrograms	|O
phosphorus	|O
with	|O
100-500	|O
microliters	|O
HClO4	|O
.	|O

Nucleotide	|O
sequence	|O
and	|O
transcriptional	|O
analysis	|O
of	|O
the	|O
polyhedrin	|B-PROTEIN
gene	|O
of	|O
Spodoptera	|O
exigua	|O
nuclear	|O
polyhedrosis	|O
virus	|O
.	|O

Validation	|O
of	|O
automated	|O
systems	|O
-	|O
-	|O
system	|O
definition	|O
.	|O

As	|O
a	|O
consequence	|O
of	|O
dark	|O
rearing	|O
,	|O
the	|O
numerical	|O
density	|O
of	|O
cortical	|O
neurons	|O
in	|O
area	|O
17	|O
amounted	|O
to	|O
about	|O
double	|O
of	|O
the	|O
value	|O
observed	|O
in	|O
normally	|O
reared	|O
kittens	|O
and	|O
was	|O
also	|O
significantly	|O
higher	|O
in	|O
area	|O
18	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
decreased	|O
class	|O
I	|O
enhancer	|O
activity	|O
in	|O
Ad12	|O
-	|O
transformed	|O
cells	|O
may	|O
,	|O
at	|O
least	|O
in	|O
part	|O
,	|O
be	|O
due	|O
to	|O
the	|O
higher	|O
levels	|O
of	|O
an	|O
enhancer	|O
-	|O
specific	|O
factor	|O
,	|O
possibly	|O
acting	|O
as	|O
a	|O
repressor	|O
.	|O

A	|O
second	|O
domain	|O
,	|O
located	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
437	|O
amino	|O
acids	|O
of	|O
IE1	|B-PROTEIN
,	|O
is	|O
required	|O
for	|O
inhibitory	|O
and	|O
DNA	|O
-	|O
binding	|O
activities	|O
.	|O

In	|O
order	|O
to	|O
investigate	|O
the	|O
blood	|O
compatibility	|O
of	|O
autogenous	|O
vein	|O
graft	|O
(	|O
AVG	|O
)	|O
,	|O
changes	|O
in	|O
prostacyclin	|O
(	|O
PGI2	|O
)	|O
production	|O
following	|O
harvesting	|O
and	|O
arterial	|O
implantation	|O
were	|O
studied	|O
experimentally	|O
.	|O

Subcutaneous	|O
administration	|O
of	|O
the	|O
somatostatin	|B-PROTEIN
analogue	|O
,	|O
octreotide	|O
,	|O
100	|O
micrograms	|O
thrice	|O
daily	|O
,	|O
resulted	|O
in	|O
a	|O
sustained	|O
improvement	|O
in	|O
diarrhoea	|O
and	|O
disappearance	|O
of	|O
faecal	|O
incontinence	|O
without	|O
reducing	|O
calcitonin	|B-PROTEIN
levels	|O
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
CRK	|I-PROTEIN
antibodies	|O
detect	|O
a	|O
53kDa	|O
protein	|O
in	|O
extracts	|O
of	|O
C.f	|O
asciculata	|O
in	|O
agreement	|O
with	|O
the	|O
size	|O
predicted	|O
from	|O
the	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
cloned	|O
gene	|O
.	|O

205	|O
,	|O
285-290	|O
]	|O
and	|O
was	|O
subsequently	|O
cloned	|O
and	|O
sequenced	|O
[	|O
J.	|O

Nonreplicating	|O
vaccinia	|O
vector	|O
efficiently	|O
expresses	|O
recombinant	|O
genes	|O
.	|O

Use	|O
of	|O
free	|O
-	|O
access	|O
minerals	|O
.	|O

Interferon	|B-PROTEIN
type	|I-PROTEIN
I	|I-PROTEIN
in	|O
protective	|O
body	|O
reactions	|O
in	|O
an	|O
experimental	|O
Klebsiella	|O
infection	|O

No	|O
other	|O
changes	|O
in	|O
hematopoietic	|O
differentiation	|O
status	|O
were	|O
observed	|O
in	|O
association	|O
with	|O
Id	|B-PROTEIN
-	|I-PROTEIN
SCL	|I-PROTEIN
expression	|O
.	|O

Respiratory	|O
interaction	|O
after	|O
spinal	|O
anesthesia	|O
and	|O
sedation	|O
with	|O
midazolam	|O
.	|O

For	|O
pressure	|O
greater	|O
than	|O
121	|O
atm	|O
abs	|O
,	|O
an	|O
increased	|O
excitability	|O
of	|O
the	|O
tadpoles	|O
made	|O
it	|O
difficult	|O
to	|O
distinguish	|O
the	|O
righting	|O
reflex	|O
from	|O
involuntary	|O
movements	|O
.	|O

One	|O
air	|O
embolism	|O
occurred	|O
;	|O
this	|O
was	|O
the	|O
only	|O
filter	|O
-	|O
or	|O
retrieval	|O
-	|O
related	|O
complication	|O
.	|O

The	|O
5'	|O
region	|O
of	|O
ADH5	|B-PROTEIN
contains	|O
consensus	|O
binding	|O
sites	|O
for	|O
the	|O
transcriptional	|O
regulatory	|O
proteins	|O
,	|O
Sp1	|B-PROTEIN
,	|O
AP2	|B-PROTEIN
,	|O
LF	|B-PROTEIN
-	|I-PROTEIN
A1	|I-PROTEIN
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
A2	|I-PROTEIN
,	|O
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
E1	|I-PROTEIN
.	|O

V.	|O

These	|O
data	|O
indicate	|O
that	|O
RNK	|B-PROTEIN
-	|I-PROTEIN
Met	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
a	|O
serine	|B-PROTEIN
protease	|I-PROTEIN
with	|O
unique	|O
activity	|O
that	|O
is	|O
expressed	|O
in	|O
the	|O
granules	|O
of	|O
large	|O
granular	|O
lymphocytes	|O
.	|O

Purification	|O
and	|O
cloning	|O
of	|O
a	|O
novel	|O
serine	|B-PROTEIN
protease	|I-PROTEIN
,	|O
RNK	|B-PROTEIN
-	|I-PROTEIN
Met	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
from	|O
the	|O
granules	|O
of	|O
a	|O
rat	|O
natural	|O
killer	|O
cell	|O
leukemia	|O
.	|O

We	|O
describe	|O
here	|O
17	|O
dominant	|O
GCN2	|B-PROTEIN
mutations	|O
that	|O
lead	|O
to	|O
derepression	|O
of	|O
GCN4	|B-PROTEIN
expression	|O
in	|O
the	|O
absence	|O
of	|O
amino	|O
acid	|O
starvation	|O
.	|O

Administration	|O
of	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
leads	|O
to	|O
faster	|O
growth	|O
,	|O
but	|O
also	|O
faster	|O
bone	|O
maturation	|O
.	|O

Comparisons	|O
with	|O
the	|O
available	|O
amino	|O
acid	|O
residue	|O
(	|O
aa	|O
)	|O
sequence	|O
information	|O
from	|O
the	|O
complete	|O
CPMV	|O
RNA	|B-PROTEIN
1	|I-PROTEIN
sequence	|O
and	|O
the	|O
partial	|O
sequence	|O
of	|O
red	|O
clover	|O
mottle	|O
virus	|O
RNA	|B-PROTEIN
1	|I-PROTEIN
suggest	|O
that	|O
CPSMV	|O
RNA	|B-PROTEIN
1	|I-PROTEIN
specifies	|O
the	|O
expected	|O
set	|O
of	|O
five	|O
mature	|O
proteins	|O
:	|O
32K	|B-PROTEIN
proteinase	|I-PROTEIN
cofactor	|I-PROTEIN
,	|O
58K	|O
presumed	|O
helicase	|B-PROTEIN
,	|O
VPg	|B-PROTEIN
5'	|O
-	|O
linked	|O
protein	|O
of	|O
the	|O
genomic	|O
RNAs	|O
,	|O
24K	|B-PROTEIN
proteinase	|I-PROTEIN
,	|O
and	|O
87K	|B-PROTEIN
presumed	|I-PROTEIN
polymerase	|I-PROTEIN
,	|O
separated	|O
by	|O
four	|O
cleavage	|O
sites	|O
.	|O

Rice	|O
dwarf	|O
phytoreovirus	|O
segment	|O
S12	|B-PROTEIN
transcript	|O
is	|O
tricistronic	|O
in	|O
vitro	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
utility	|O
of	|O
beta	|B-PROTEIN
2	|I-PROTEIN
transferrin	|I-PROTEIN
assay	|O
in	|O
the	|O
diagnosis	|O
of	|O
cerebrospinal	|O
fluid	|O
otorrhea	|O
is	|O
presented	|O
.	|O

Cold	|O
cardioplegia	|O
was	|O
administered	|O
at	|O
45	|O
mm	|O
Hg	|O
every	|O
20	|O
minutes	|O
for	|O
2	|O
hours	|O
.	|O

The	|O
addition	|O
of	|O
diatrizoate	|O
to	|O
the	|O
IPRK	|O
led	|O
to	|O
a	|O
dose	|O
-	|O
dependent	|O
biphasic	|O
change	|O
in	|O
RPF	|O
and	|O
GFR	|O
characterized	|O
by	|O
an	|O
initial	|O
transient	|O
increase	|O
followed	|O
by	|O
a	|O
marked	|O
and	|O
sustained	|O
decrease	|O
.	|O

To	|O
prepare	|O
for	|O
analyses	|O
with	|O
the	|O
family	|O
variables	|O
,	|O
we	|O
next	|O
present	|O
descriptive	|O
data	|O
based	|O
on	|O
separate	|O
principal	|O
components	|O
analysis	|O
(	|O
PCA	|O
)	|O
and	|O
multidimensional	|O
scaling	|O
analysis	|O
(	|O
MDS	|O
)	|O
of	|O
14	|O
self	|O
-	|O
reported	|O
health	|O
scores	|O
for	|O
husbands	|O
and	|O
for	|O
wives	|O
.	|O

The	|O
structural	|O
genes	|O
encoding	|O
glyceraldehyde	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
dehydrogenase	|I-PROTEIN
(	|O
GAPDH	|B-PROTEIN
)	|O
,	|O
3	|B-PROTEIN
-	|I-PROTEIN
phosphoglycerate	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PGK	|B-PROTEIN
)	|O
and	|O
the	|O
N	|O
-	|O
terminal	|O
part	|O
of	|O
triosephosphate	|B-PROTEIN
isomerase	|I-PROTEIN
(	|O
TIM	|B-PROTEIN
)	|O
from	|O
mesophilic	|O
Bacillus	|O
megaterium	|O
DSM319	|O
have	|O
been	|O
cloned	|O
as	|O
a	|O
gene	|O
cluster	|O
(	|O
gap	|B-PROTEIN
operon	|O
)	|O
by	|O
complementation	|O
of	|O
an	|O
Escherichia	|O
coli	|O
gap	|B-PROTEIN
amber	|O
mutant	|O
.	|O

Pseudomonas	|O
aeruginosa	|O
exotoxin	|B-PROTEIN
A	|I-PROTEIN
:	|O
its	|O
role	|O
in	|O
retardation	|O
of	|O
wound	|O
healing	|O
:	|O
the	|O
1992	|O
Lindberg	|O
Award	|O
.	|O

Laboratory	|O
studies	|O
showed	|O
that	|O
the	|O
direct	|O
fluorescent	|O
-	|O
antibody	|O
kits	|O
were	|O
the	|O
least	|O
sensitive	|O
in	|O
this	|O
case	|O
and	|O
did	|O
not	|O
detect	|O
fewer	|O
than	|O
10	|O
(	|O
4	|O
)	|O
elementary	|O
bodies	|O
per	|O
ml	|O
,	|O
while	|O
most	|O
ELISA	|O
kits	|O
detected	|O
between	|O
130	|O
and	|O
600	|O
elementary	|O
bodies	|O
per	|O
ml	|O
.	|O

To	|O
study	|O
the	|O
significance	|O
of	|O
these	|O
domains	|O
and	|O
the	|O
overall	|O
evolutionary	|O
conservation	|O
of	|O
the	|O
gene	|O
,	|O
the	|O
homolog	|O
from	|O
Drosophila	|O
melanogaster	|O
was	|O
isolated	|O
by	|O
low	|O
stringency	|O
hybridizations	|O
using	|O
two	|O
flanking	|O
probes	|O
of	|O
the	|O
human	|O
ERCC3	|B-PROTEIN
cDNA	|O
.	|O

Mono	|O
-	|O
ADP	|O
-	|O
ribosylation	|O
is	|O
a	|O
reversible	|O
modification	|O
of	|O
proteins	|O
,	|O
with	|O
NAD	|O
:	|O
arginine	|B-PROTEIN
ADP	|I-PROTEIN
-	|I-PROTEIN
ribosyltransferases	|I-PROTEIN
(	|O
EC	|B-PROTEIN
2.4.2.31	|I-PROTEIN
)	|O
and	|O
ADP	|B-PROTEIN
-	|I-PROTEIN
ribosylarginine	|I-PROTEIN
hydrolases	|I-PROTEIN
(	|O
EC	|B-PROTEIN
3.2.2.19	|I-PROTEIN
)	|O
catalyzing	|O
the	|O
opposing	|O
reactions	|O
in	|O
an	|O
ADP	|O
-	|O
ribosylation	|O
cycle	|O
.	|O

For	|O
this	|O
reason	|O
,	|O
the	|O
particle	|O
forming	|O
capacity	|O
of	|O
derivatives	|O
of	|O
the	|O
HIV	|O
-	|O
1	|O
group	|O
specific	|O
core	|O
antigen	|O
p55	|B-PROTEIN
gag	|O
was	|O
assayed	|O
and	|O
compared	|O
dependent	|O
on	|O
various	|O
expression	|O
systems	|O
:	|O
recombinant	|O
bacteria	|O
,	|O
vaccinia	|O
-	|O
and	|O
baculoviruses	|O
were	|O
established	|O
encoding	|O
the	|O
entire	|O
core	|O
protein	|O
p55	|B-PROTEIN
either	|O
in	|O
its	|O
authentic	|O
sequence	|O
or	|O
lacking	|O
the	|O
myristylation	|O
consensus	|O
signal	|O
.	|O

The	|O
tramtrack	|B-PROTEIN
(	|O
ttk	|B-PROTEIN
)	|O
gene	|O
of	|O
Drosophila	|O
encodes	|O
69	|O
-	|O
kDa	|O
and	|O
88	|O
-	|O
kDa	|O
proteins	|O
through	|O
alternative	|O
splicing	|O
of	|O
the	|O
primary	|O
ttk	|B-PROTEIN
transcript	|O
.	|O

Removal	|O
of	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
by	|O
hemodialysis	|O
and	|O
hemofiltration	|O
:	|O
a	|O
four	|O
year	|O
follow	|O
up	|O
.	|O

Removal	|O
of	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
by	|O
hemodialysis	|O
and	|O
hemofiltration	|O
:	|O
a	|O
four	|O
year	|O
follow	|O
up	|O
.	|O

Adapromine	|O
was	|O
established	|O
to	|O
evoke	|O
a	|O
decrease	|O
of	|O
the	|O
amplitude	|O
of	|O
the	|O
dominant	|O
peak	|O
and	|O
dominant	|O
theta	|O
-	|O
activity	|O
in	|O
power	|O
spectra	|O
of	|O
the	|O
EEG	|O
in	|O
the	|O
cortex	|O
and	|O
hippocamp	|O
,	|O
with	|O
an	|O
increase	|O
of	|O
rapid	|O
wave	|O
activity	|O
in	|O
the	|O
beta	|O
2	|O
range	|O
in	|O
the	|O
right	|O
cortex	|O
and	|O
hippocamp	|O
.	|O

These	|O
sequences	|O
were	|O
then	|O
used	|O
to	|O
clone	|O
the	|O
full	|O
-	|O
length	|O
genes	|O
from	|O
a	|O
yeast	|O
genomic	|O
library	|O
.	|O

GAL4	|B-PROTEIN
-	|O
VP16	|B-PROTEIN
-	|O
mediated	|O
antirepression	|O
required	|O
an	|O
auxiliary	|O
factor	|O
,	|O
denoted	|O
as	|O
a	|O
co	|O
-	|O
antirepressor	|O
,	|O
which	|O
was	|O
partially	|O
purified	|O
from	|O
Drosophila	|O
embryos	|O
.	|O

After	|O
28	|O
days	|O
of	|O
haloperidol	|O
treatment	|O
,	|O
similar	|O
changes	|O
were	|O
observed	|O
for	|O
delta	|O
,	|O
together	|O
with	|O
an	|O
increase	|O
of	|O
alpha	|O
1	|O
,	|O
and	|O
a	|O
decrease	|O
of	|O
fast	|O
beta	|O
.	|O

Four	|O
ruminally	|O
and	|O
duodenally	|O
cannulated	|O
Hampshire	|O
wethers	|O
were	|O
used	|O
in	|O
a	|O
4	|O
x	|O
4	|O
Latin	|O
square	|O
experiment	|O
to	|O
determine	|O
whether	|O
linoleoyl	|O
methionine	|O
and	|O
calcium	|O
linoleate	|O
would	|O
increase	|O
duodenal	|O
flow	|O
of	|O
unsaturated	|O
fatty	|O
acids	|O
(	|O
C18	|O
:	|O
2	|O
+	|O
cis	|O
C18	|O
:	|O
1	|O
)	|O
.	|O

Truncated	|O
ICSBP	|B-PROTEIN
lacking	|O
the	|O
first	|O
33	|O
amino	|O
-	|O
terminal	|O
amino	|O
acids	|O
fails	|O
to	|O
bind	|O
to	|O
the	|O
ICS	|B-PROTEIN
,	|O
indicating	|O
that	|O
at	|O
least	|O
part	|O
of	|O
the	|O
DNA	|O
binding	|O
domain	|O
is	|O
located	|O
within	|O
the	|O
well	|O
conserved	|O
amino	|O
terminus	|O
.	|O

Therefore	|O
,	|O
ICSBP	|B-PROTEIN
may	|O
be	|O
involved	|O
in	|O
maintaining	|O
submaximal	|O
transcriptional	|O
activity	|O
of	|O
IFN	|B-PROTEIN
-	|O
inducible	|O
genes	|O
in	|O
hematopoietic	|O
cells	|O
.	|O

A	|O
case	|O
of	|O
chronic	|O
hepatitis	|O
C	|O
with	|O
primary	|O
hypothyroidism	|O
manifested	|O
during	|O
interferon	|B-PROTEIN
treatment	|O

Dynamic	|O
decision	|O
making	|O
:	|O
human	|O
control	|O
of	|O
complex	|O
systems	|O
.	|O

A	|O
coiled	|B-PROTEIN
-	|I-PROTEIN
coil	|I-PROTEIN
related	|I-PROTEIN
protein	|O
specific	|O
for	|O
synapsed	|O
regions	|O
of	|O
meiotic	|O
prophase	|O
chromosomes	|O
.	|O

Comparable	|O
amounts	|O
of	|O
alpha	|B-PROTEIN
5	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
integrin	|I-PROTEIN
were	|O
isolated	|O
from	|O
these	|O
cells	|O
by	|O
chromatography	|O
of	|O
detergent	|O
extracts	|O
on	|O
a	|O
fibronectin	|B-PROTEIN
cell	|O
-	|O
binding	|O
fragment	|O
affinity	|O
column	|O
and	|O
elution	|O
with	|O
EDTA	|O
.	|O

Abstracts	|O
.	|O

These	|O
results	|O
indicate	|O
a	|O
possible	|O
involvement	|O
of	|O
endogenous	|O
opioid	|O
peptides	|O
in	|O
the	|O
cardiac	|O
effects	|O
due	|O
to	|O
myocardial	|O
ischaemia	|O
and	|O
reperfusion	|O
,	|O
mediated	|O
by	|O
opiate	|B-PROTEIN
receptors	|I-PROTEIN
through	|O
opiate	|O
antagonism	|O
.	|O

From	|O
this	|O
library	|O
,	|O
LEU2	|B-PROTEIN
and	|O
HIS3	|B-PROTEIN
cDNAs	|O
were	|O
recovered	|O
at	|O
a	|O
frequency	|O
of	|O
about	|O
1	|O
in	|O
10	|O
(	|O
4	|O
)	|O
and	|O
in	|O
12	|O
out	|O
of	|O
13	|O
cases	|O
these	|O
were	|O
expressed	|O
in	|O
a	|O
galactose	|O
-	|O
dependent	|O
manner	|O
.	|O

Among	|O
these	|O
,	|O
ACT1	|B-PROTEIN
was	|O
isolated	|O
four	|O
times	|O
,	|O
and	|O
NSR1	|B-PROTEIN
three	|O
times	|O
.	|O

Since	|O
CENP	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
gene	|O
is	|O
conserved	|O
in	|O
mammalian	|O
species	|O
and	|O
CENP	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
boxes	|O
are	|O
found	|O
also	|O
in	|O
mouse	|O
centromere	|O
satellite	|O
DNA	|O
(	|O
minor	|O
satellite	|O
)	|O
,	|O
this	|O
sequence	|O
-	|O
specific	|O
DNA	|O
-	|O
protein	|O
interaction	|O
may	|O
be	|O
important	|O
for	|O
some	|O
kind	|O
of	|O
common	|O
centromere	|O
function	|O
.	|O

Interestingly	|O
,	|O
a	|O
portion	|O
of	|O
the	|O
tail	|O
domain	|O
(	|O
aa	|O
,	|O
1,094-1,830	|O
)	|O
shares	|O
58%	|O
amino	|O
acid	|O
sequence	|O
identity	|O
with	|O
a	|O
723	|O
-	|O
aa	|O
protein	|O
from	|O
mouse	|O
brain	|O
reported	|O
to	|O
be	|O
a	|O
glutamic	|B-PROTEIN
acid	|I-PROTEIN
decarboxylase	|I-PROTEIN
.	|O

However	|O
,	|O
in	|O
the	|O
subgroup	|O
with	|O
normal	|O
Ht	|O
(	|O
<	|O
0.45	|O
l	|O
/	|O
l	|O
;	|O
n	|O
=	|O
201	|O
)	|O
there	|O
was	|O
a	|O
significant	|O
reduction	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
of	|O
the	|O
mortality	|O
after	|O
3	|O
months	|O
(	|O
27%	|O
and	|O
16%	|O
,	|O
respectively	|O
)	|O
and	|O
an	|O
increase	|O
of	|O
independence	|O
at	|O
home	|O
(	|O
35%	|O
and	|O
48%	|O
,	|O
respectively	|O
)	|O
due	|O
to	|O
a	|O
reduction	|O
of	|O
the	|O
viscosity	|O
by	|O
means	|O
of	|O
haemodilution	|O
with	|O
albumin	|B-PROTEIN
(	|O
a	|O
specific	|O
viscosity	|O
effect	|O
in	|O
the	|O
normovolaemic	|O
group	|O
)	|O
.	|O

Distribution	|O
and	|O
changing	|O
morphological	|O
course	|O

The	|O
appropriate	|O
use	|O
and	|O
benefits	|O
of	|O
bile	|O
acid	|O
sequestrants	|O
,	|O
nicotinic	|O
acid	|O
,	|O
fibric	|O
acids	|O
,	|O
3	|O
-	|O
hydroxy	|O
-	|O
3	|O
-	|O
methylglutaryl	|O
coenzyme	|O
A	|O
(	|B-PROTEIN
HMG	|I-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
)	|I-PROTEIN
reductase	|I-PROTEIN
inhibitors	|O
,	|O
and	|O
probucol	|O
are	|O
individually	|O
discussed	|O
,	|O
whereas	|O
nonpharmacologic	|O
approaches	|O
used	|O
in	|O
conjunction	|O
with	|O
the	|O
drugs	|O
are	|O
recommended	|O
emphatically	|O
.	|O

This	|O
may	|O
result	|O
in	|O
more	|O
reabsorption	|O
and	|O
hence	|O
reduced	|O
renal	|O
clearance	|O
.	|O

The	|O
major	|O
pathological	|O
findings	|O
of	|O
the	|O
placenta	|O
were	|O
prematuration	|O
and	|O
hypoplasia	|O
.	|O

Green	|O
pepper	|O
significantly	|O
inhibited	|O
N	|O
-	|O
nitrosothiazolidine	|O
-	|O
carboxylic	|O
acid	|O
formation	|O
relative	|O
to	|O
ascorbic	|O
acid	|O
alone	|O
.	|O

A	|O
genomic	|O
clone	|O
,	|O
pTt21	|O
,	|O
containing	|O
DNA	|O
apparently	|O
transcribed	|O
specifically	|O
in	|O
Trypanosoma	|O
cruzi	|O
trypomastigotes	|O
,	|O
was	|O
obtained	|O
by	|O
differentially	|O
screening	|O
a	|O
genomic	|O
library	|O
with	|O
trypomastigote	|O
and	|O
epimastigote	|O
cDNA	|O
.	|O

Brucellosis	|O
-	|O
-	|O
1990	|O

Assay	|O
of	|O
urea	|O
by	|O
immobilized	|O
urease	|B-PROTEIN
coupled	|O
to	|O
a	|O
differential	|O
pH	|O
-	|O
meter	|O
.	|O

RESULTS	|O
:	|O
In	|O
the	|O
AGA	|O
group	|O
,	|O
both	|O
fetal	|O
and	|O
maternal	|O
serum	|O
prolactin	|B-PROTEIN
concentration	|O
increased	|O
significantly	|O
with	|O
gestation	|O
(	|O
P	|O
<	|O
0.001	|O
and	|O
P	|O
<	|O
0.01	|O
,	|O
respectively	|O
)	|O
.	|O

One	|O
phage	|O
clone	|O
contains	|O
a	|O
junction	|O
between	|O
alpha	|O
satellite	|O
DNA	|O
and	|O
a	|O
novel	|O
low	|O
-	|O
copy	|O
repeated	|O
sequence	|O
.	|O

The	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
lactoferrin	|B-PROTEIN
gene	|O
was	|O
isolated	|O
from	|O
a	|O
human	|O
placental	|O
genomic	|O
library	|O
.	|O

Therefore	|O
,	|O
the	|O
molecular	|O
mechanisms	|O
of	|O
the	|O
estrogen	|O
action	|O
that	|O
govern	|O
the	|O
lactoferrin	|B-PROTEIN
gene	|O
expression	|O
differ	|O
between	|O
mouse	|O
and	|O
human	|O
.	|O

BiP670	|B-PROTEIN
retains	|O
basal	|O
and	|O
Ca2+	|O
ionophore	|O
A23187	|O
-	|O
inducible	|O
activities	|O
.	|O

The	|O
CEM	|O
receives	|O
registration	|O
updates	|O
via	|O
an	|O
HL7	|O
message	|O
and	|O
evaluates	|O
data	|O
dependencies	|O
in	|O
rules	|O
via	|O
an	|O
interface	|O
to	|O
the	|O
relational	|O
database	|O
.	|O

Magnetic	|O
resonance	|O
spectroscopy	|O
(	|O
MRS	|O
)	|O
and	|O
imaging	|O
(	|O
MRI	|O
)	|O
are	|O
now	|O
well	|O
established	|O
techniques	|O
for	|O
the	|O
study	|O
of	|O
cellular	|O
metabolism	|O
and	|O
gross	|O
structure	|O
of	|O
muscle	|O
.	|O

Simultaneously	|O
a	|O
greater	|O
NA	|O
was	|O
found	|O
with	|O
no	|O
change	|O
in	|O
plasma	|O
epinephrine	|O
response	|O
.	|O

We	|O
investigated	|O
the	|O
diagnostic	|O
value	|O
of	|O
a	|O
new	|O
in	|O
vitro	|O
test	|O
,	|O
Pharmacia	|O
CAP	|O
System	|O
(	|O
Pharmacia	|O
Diagnostics	|O
AB	|O
,	|O
Uppsala	|O
,	|O
Sweden	|O
)	|O
,	|O
for	|O
the	|O
quantitative	|O
measurement	|O
of	|O
allergen	|O
-	|O
specific	|O
IgE	|B-PROTEIN
antibodies	|O
by	|O
comparison	|O
with	|O
RAST	|O
in	|O
2	|O
groups	|O
of	|O
patients	|O
,	|O
71	|O
atopic	|O
and	|O
48	|O
non	|O
-	|O
atopic	|O
.	|O

Patients	|O
receiving	|O
VPA	|O
showed	|O
differences	|O
in	|O
attention	|O
,	|O
visuomotor	|O
performance	|O
,	|O
verbal	|O
span	|O
and	|O
sensory	|O
discrimination	|O
tasks	|O
at	|O
T1	|O
,	|O
in	|O
visuomotor	|O
performance	|O
at	|O
T2	|O
and	|O
in	|O
spatial	|O
span	|O
at	|O
T3	|O
,	|O
whereas	|O
no	|O
differences	|O
were	|O
detected	|O
at	|O
T4	|O
.	|O

We	|O
found	|O
that	|O
the	|O
gene	|O
segment	|O
containing	|O
the	|O
mu	|O
m	|O
poly	|O
(	|O
A	|O
)	|O
signals	|O
,	|O
along	|O
with	|O
536	|O
bp	|O
of	|O
downstream	|O
flanking	|O
sequence	|O
,	|O
acted	|O
as	|O
a	|O
transcription	|O
terminator	|O
in	|O
both	|O
myeloma	|O
cells	|O
and	|O
L	|O
cell	|O
fibroblasts	|O
.	|O

As	|O
a	|O
part	|O
of	|O
a	|O
large	|O
examination	|O
,	|O
total	|O
and	|O
free	|O
serum	|O
cholesterol	|O
,	|O
total	|O
lipid	|O
and	|O
triglyceride	|O
levels	|O
were	|O
determined	|O
.	|O

Alena	|O
is	|O
a	|O
nurse	|O
in	|O
Prague	|O
-	|O
-	|O
she	|O
dreams	|O
of	|O
higher	|O
wages	|O
and	|O
a	|O
trip	|O
across	|O
the	|O
ocean	|O

Dopamine	|O
neurons	|O
in	|O
subjects	|O
that	|O
received	|O
6	|O
-	|O
OHDA	|O
were	|O
protected	|O
by	|O
pre	|O
-	|O
treatment	|O
with	|O
GBR	|O
-	|O
12909	|O
.	|O

DIBA	|O
was	|O
more	|O
sensitive	|O
and	|O
had	|O
a	|O
better	|O
negative	|O
predictive	|O
value	|O
and	|O
a	|O
lower	|O
false	|O
negative	|O
percentage	|O
than	|O
DFAT	|O
.	|O

Caries	|O
and	|O
parodontitis	|O
have	|O
been	|O
one	|O
of	|O
the	|O
most	|O
spread	|O
diseases	|O
of	|O
mankind	|O
.	|O

The	|O
results	|O
of	|O
this	|O
study	|O
demonstrate	|O
that	|O
strongyloidiasis	|O
was	|O
the	|O
cause	|O
of	|O
sudden	|O
death	|O
.	|O

A	|O
second	|O
large	|O
group	|O
of	|O
disorders	|O
in	|O
pregnancy	|O
is	|O
caused	|O
by	|O
effects	|O
of	|O
infections	|O
of	|O
the	|O
mother	|O
without	|O
pathogens	|O
being	|O
transmitted	|O
to	|O
the	|O
embryo	|O
or	|O
the	|O
placenta	|O
.	|O

Four	|O
short	|O
nucleotide	|O
sequences	|O
(	|O
boxes	|O
I	|O
to	|O
IV	|O
)	|O
contribute	|O
to	|O
the	|O
light	|O
responsiveness	|O
of	|O
the	|O
parsley	|O
chalcone	|B-PROTEIN
synthase	|I-PROTEIN
promoter	|O
.	|O

The	|O
case	|O
described	|O
is	|O
that	|O
of	|O
a	|O
72	|O
-	|O
year	|O
-	|O
old	|O
man	|O
with	|O
ochronosis	|O
who	|O
suffered	|O
a	|O
hyperextension	|O
injury	|O
to	|O
his	|O
spine	|O
in	|O
a	|O
fall	|O
,	|O
resulting	|O
in	|O
a	|O
fracture	|O
through	|O
an	|O
ankylosed	|O
L2	|O
-	|O
L3	|O
disk	|O
space	|O
.	|O

The	|O
mean	|O
blood	|O
flow	|O
in	|O
the	|O
penile	|O
foreskin	|O
was	|O
estimated	|O
to	|O
be	|O
15	|O
ml	|O
/	|O
min	|O
/	|O
100	|O
g	|O
and	|O
it	|O
increased	|O
to	|O
150-200%	|O
after	|O
the	|O
induction	|O
of	|O
anesthesia	|O
,	|O
and	|O
then	|O
decreased	|O
to	|O
72%	|O
at	|O
the	|O
tip	|O
of	|O
the	|O
created	|O
parameatal	|O
foreskin	|O
flap	|O
.	|O

ME1a1	|B-PROTEIN
,	|O
a	|O
16	|O
-	|O
base	|O
-	|O
pair	|O
nuclear	|O
factor	|O
binding	|O
site	|O
residing	|O
between	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
MYC	|I-PROTEIN
P1	|O
and	|O
P2	|O
transcription	|O
initiation	|O
sites	|O
,	|O
is	|O
required	|O
for	|O
P2	|O
activity	|O
.	|O

The	|O
next	|O
twenty	|O
years	|O
of	|O
prevention	|O
in	|O
Indian	|O
country	|O
:	|O
visionary	|O
,	|O
complex	|O
,	|O
and	|O
practical	|O
.	|O

Exogenous	|O
LHRH	|B-PROTEIN
is	|O
also	|O
known	|O
to	|O
facilitate	|O
mating	|O
behavior	|O
in	|O
several	|O
species	|O
.	|O

The	|O
first	|O
146	|O
consecutive	|O
patients	|O
treated	|O
with	|O
EVL	|O
during	|O
the	|O
period	|O
from	|O
August	|O
,	|O
1986	|O
to	|O
July	|O
,	|O
1989	|O
are	|O
reported	|O
.	|O

Replacing	|O
the	|O
aspartic	|O
acid	|O
with	|O
a	|O
lysine	|O
but	|O
not	|O
with	|O
an	|O
alanine	|O
or	|O
valine	|O
residue	|O
allowed	|O
formation	|O
of	|O
disulfide	|O
-	|O
linked	|O
dimers	|O
.	|O

During	|O
V	|O
-	|O
A	|O
bypass	|O
,	|O
hemodynamics	|O
were	|O
stable	|O
.	|O

Greater	|O
rupture	|O
force	|O
was	|O
required	|O
in	|O
the	|O
adult	|O
pigs	|O
than	|O
in	|O
the	|O
young	|O
pigs	|O
.	|O

At	|O
rest	|O
AFF	|O
was	|O
significantly	|O
higher	|O
in	|O
UT	|O
(	|O
29%	|O
)	|O
as	|O
compared	|O
to	|O
AT	|O
(	|O
25%	|O
)	|O
and	|O
UEA	|O
(	|O
25%	|O
)	|O
.	|O

We	|O
investigated	|O
the	|O
smoking	|O
habits	|O
of	|O
relapsers	|O
1	|O
year	|O
after	|O
quitting	|O
in	|O
a	|O
smoking	|O
cessation	|O
trial	|O
using	|O
nicotine	|O
or	|O
placebo	|O
patches	|O
.	|O

Exposure	|O
to	|O
hepatitis	|O
B	|O
virus	|O
in	|O
the	|O
general	|O
population	|O
of	|O
Hisayama	|O
,	|O
Japan	|O
:	|O
significance	|O
of	|O
isolated	|O
antibody	|O
to	|O
hepatitis	|B-PROTEIN
B	|I-PROTEIN
surface	|I-PROTEIN
antigen	|I-PROTEIN
in	|O
general	|O
population	|O
.	|O

Because	|O
of	|O
this	|O
latter	|O
phenomenon	|O
,	|O
we	|O
were	|O
able	|O
to	|O
identify	|O
a	|O
particular	|O
cysteine	|O
motif	|O
that	|O
was	|O
repeated	|O
multiple	|O
times	|O
in	|O
Dfurin2	|B-PROTEIN
but	|O
present	|O
only	|O
twice	|O
in	|O
mammalian	|O
furin	|B-PROTEIN
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
neither	|O
phosphate	|O
buffered	|O
saline	|O
injection	|O
into	|O
the	|O
ES	|O
nor	|O
primary	|O
KLH	|B-PROTEIN
challenges	|O
of	|O
the	|O
ES	|O
were	|O
capable	|O
of	|O
elevating	|O
the	|O
threshold	|O
level	|O
and	|O
changing	|O
the	|O
latency	|O
.	|O

A	|O
newly	|O
developed	|O
broad	|O
-	|O
spectrum	|O
fluoroquinolone	|O
,	|O
levofloxacin	|O
(	|O
LVFX	|O
,	|O
DR	|O
-	|O
3355	|O
)	|O
,	|O
was	|O
evaluated	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
in	|O
comparison	|O
with	|O
ciprofloxacin	|O
(	|O
CPFX	|O
)	|O
,	|O
ofloxacin	|O
(	|O
OFLX	|O
)	|O
and	|O
norfloxacin	|O
(	|O
NFLX	|O
)	|O
.	|O

The	|O
mean	|O
serum	|O
creatinine	|O
levels	|O
were	|O
similar	|O
at	|O
one	|O
year	|O
(	|O
SPK	|O
1.8	|O
,	|O
KTA	|O
1.9	|O
mg	|O
/	|O
d	|O
)	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Model	|O
predictions	|O
were	|O
in	|O
accord	|O
with	|O
the	|O
nine	|O
-	|O
year	|O
survival	|O
experience	|O
of	|O
women	|O
in	|O
the	|O
HIP	|O
trial	|O
,	|O
and	|O
,	|O
with	|O
the	|O
exception	|O
of	|O
women	|O
40-44	|O
years	|O
old	|O
,	|O
with	|O
HIP	|O
data	|O
on	|O
18	|O
-	|O
year	|O
survival	|O
.	|O

High	|O
-	|O
resolution	|O
computed	|O
tomography	|O
in	|O
the	|O
diagnosis	|O
of	|O
miliary	|O
tuberculosis	|O
.	|O

Previously	|O
,	|O
we	|O
showed	|O
that	|O
SNF2	|B-PROTEIN
,	|O
SNF5	|B-PROTEIN
,	|O
and	|O
SNF6	|B-PROTEIN
function	|O
interdependently	|O
in	|O
transcriptional	|O
activation	|O
,	|O
possibly	|O
forming	|O
a	|O
heteromeric	|O
complex	|O
.	|O

We	|O
show	|O
that	|O
LexA	|B-PROTEIN
-	|O
GAL4	|B-PROTEIN
and	|O
LexA	|B-PROTEIN
-	|O
Bicoid	|B-PROTEIN
fusion	|O
proteins	|O
are	|O
both	|O
dependent	|O
on	|O
SNF2	|B-PROTEIN
,	|O
SNF5	|B-PROTEIN
,	|O
and	|O
SNF6	|B-PROTEIN
for	|O
activation	|O
of	|O
target	|O
genes	|O
containing	|O
one	|O
or	|O
multiple	|O
lexA	|B-PROTEIN
operators	|O
.	|O

George	|O
T.	|O

A	|O
lambda	|O
gt10	|O
cDNA	|O
library	|O
was	|O
constructed	|O
from	|O
poly	|O
(	|O
A	|O
)	|O
+	|O
RNA	|O
of	|O
young	|O
green	|O
leaves	|O
of	|O
spinach	|O
.	|O

NE	|B-PROTEIN
and	|O
PR3	|B-PROTEIN
assist	|O
in	|O
the	|O
destruction	|O
of	|O
phagocytosed	|O
microorganisms	|O
,	|O
cleave	|O
the	|O
important	|O
connective	|O
-	|O
tissue	|O
protein	|O
elastin	|B-PROTEIN
,	|O
and	|O
generate	|O
chemotactic	|O
activities	|O
by	|O
forming	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
proteinase	|I-PROTEIN
inhibitor	|O
complexes	|O
and	|O
elastin	|B-PROTEIN
peptides	|O
.	|O

Selected	|O
topics	|O
in	|O
pediatric	|O
ultrasonography	|O
-	|O
-	|O
1992	|O
.	|O

Methods	|O
included	|O
24	|O
-	|O
hour	|O
dietary	|O
recall	|O
,	|O
menu	|O
weights	|O
,	|O
and	|O
recipe	|O
analysis	|O
.	|O

Factors	|O
associated	|O
with	|O
afterdrop	|O
included	|O
age	|O
,	|O
end	|O
-	|O
of	|O
-	|O
surgery	|O
temperature	|O
(	|O
both	|O
positively	|O
)	|O
and	|O
body	|O
mass	|O
(	|O
negatively	|O
)	|O
.	|O

Both	|O
GH	|B-PROTEIN
deficiency	|O
and	|O
impaired	|O
spinal	|O
growth	|O
may	|O
result	|O
in	|O
short	|O
stature	|O
,	|O
whereas	|O
the	|O
occurrence	|O
of	|O
early	|O
puberty	|O
in	|O
association	|O
with	|O
GH	|B-PROTEIN
deficiency	|O
reduces	|O
the	|O
time	|O
available	|O
for	|O
GH	|B-PROTEIN
therapy	|O
.	|O

By	|O
contrast	|O
,	|O
d	|B-PROTEIN
(	|I-PROTEIN
T2AG3T	|I-PROTEIN
)	|I-PROTEIN
and	|O
d	|B-PROTEIN
(	|I-PROTEIN
T2G4T	|I-PROTEIN
)	|I-PROTEIN
form	|O
only	|O
the	|O
G	|O
-	|O
quadruplex	|O
monomer	|O
structures	|O
independent	|O
of	|O
K	|O
cation	|O
concentration	|O
as	|O
reported	|O
previously	|O
[	|O
Sen	|O
,	|O
D.	|O
,	|O
&	|O
Gilbert	|O
,	|O
W.	|O

Differentiating	|O
among	|O
renal	|O
stones	|O
.	|O

IFI	|B-PROTEIN
16	|I-PROTEIN
mRNA	|O
was	|O
found	|O
to	|O
be	|O
constitutively	|O
expressed	|O
in	|O
lymphoid	|O
cells	|O
and	|O
in	|O
cell	|O
lines	|O
of	|O
both	|O
the	|O
T	|O
and	|O
B	|O
lineages	|O
.	|O

Mitochondria	|O
-	|O
lytic	|O
action	|O
of	|O
warfarin	|O
in	|O
lymphocytes	|O
.	|O

Exon	|O
-	|O
intron	|O
junctions	|O
in	|O
the	|O
human	|O
and	|O
rat	|O
AdoMet	|B-PROTEIN
decarboxylase	|I-PROTEIN
genes	|O
were	|O
in	|O
identical	|O
positions	|O
except	|O
that	|O
exons	|O
6	|O
and	|O
7	|O
of	|O
the	|O
human	|O
gene	|O
formed	|O
a	|O
single	|O
exon	|O
in	|O
the	|O
rat	|O
gene	|O
.	|O

Interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
induced	|O
gene	|O
expression	|O
:	|O
evidence	|O
for	|O
a	|O
selective	|O
effect	|O
of	|O
ouabain	|O
on	|O
activation	|O
of	|O
the	|O
ISGF3	|B-PROTEIN
transcription	|O
complex	|O
.	|O

The	|O
cDNA	|O
has	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
900	|O
amino	|O
acids	|O
capable	|O
of	|O
encoding	|O
a	|O
97	|O
-	|O
kDa	|O
protein	|O
.	|O

Moreover	|O
,	|O
LD50	|O
in	|O
mice	|O
of	|O
RP	|O
-	|O
170	|O
(	|O
4.3	|O
g	|O
/	|O
kg	|O
on	|O
i.v	|O
.	|O
)	|O
was	|O
increased	|O
to	|O
5.2	|O
g	|O
/	|O
kg	|O
by	|O
oral	|O
administration	|O
.	|O

Among	|O
the	|O
few	|O
proteins	|O
of	|O
the	|O
eukaryotic	|O
nucleolus	|O
that	|O
have	|O
been	|O
characterized	|O
,	|O
four	|O
proteins	|O
,	|O
nucleolin	|B-PROTEIN
,	|O
fibrillarin	|B-PROTEIN
,	|O
SSB1	|B-PROTEIN
and	|O
NSR1	|B-PROTEIN
,	|O
possess	|O
a	|O
common	|O
structural	|O
motif	|O
,	|O
the	|O
GAR	|O
domain	|O
,	|O
which	|O
is	|O
rich	|O
in	|O
glycine	|O
and	|O
arginine	|O
residues	|O
.	|O

Thus	|O
,	|O
this	|O
study	|O
provides	|O
evidence	|O
that	|O
a	|O
novel	|O
,	|O
ubiquitous	|O
factor	|O
(	|O
HF	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
)	|O
and	|O
a	|O
muscle	|O
factor	|O
(	|O
HF	|B-PROTEIN
-	|I-PROTEIN
1b	|I-PROTEIN
/	|O
MEF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
can	|O
form	|O
a	|O
novel	|O
,	|O
E	|O
-	|O
box	|O
-	|O
independent	|O
pathway	|O
for	|O
muscle	|O
-	|O
specific	|O
expression	|O
in	|O
ventricular	|O
cardiac	|O
muscle	|O
cells	|O
.	|O

Mutations	|O
in	|O
either	|O
gene	|O
block	|O
some	|O
crucial	|O
late	|O
step	|O
in	|O
assembly	|O
of	|O
F1	|B-PROTEIN
,	|O
causing	|O
the	|O
alpha	|O
and	|O
beta	|O
subunits	|O
to	|O
accumulate	|O
in	|O
mitochondria	|O
as	|O
inactive	|O
aggregates	|O
(	|O
Ackerman	|O
,	|O
S.	|O

Expense	|O
limits	|O
the	|O
use	|O
of	|O
hepatitis	|O
B	|O
vaccines	|O
,	|O
but	|O
low	|O
-	|O
dose	|O
intradermal	|O
immunization	|O
has	|O
been	|O
evaluated	|O
as	|O
a	|O
cost	|O
-	|O
saving	|O
strategy	|O
in	|O
numerous	|O
studies	|O
.	|O

Estrogen	|O
replacement	|O
therapy	|O
and	|O
risk	|O
of	|O
breast	|O
cancer	|O
:	|O
results	|O
of	|O
two	|O
meta	|O
-	|O
analyses	|O
.	|O

Switching	|O
FDC	|O
-	|O
P1	|O
/	|O
MAC	|O
cells	|O
from	|O
growth	|O
in	|O
M	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
to	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
caused	|O
the	|O
selective	|O
degradation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fms	|I-PROTEIN
mRNA	|O
within	|O
6	|O
h	|O
after	|O
factor	|O
switching	|O
.	|O

There	|O
was	|O
however	|O
,	|O
no	|O
significant	|O
difference	|O
in	|O
the	|O
prevalence	|O
of	|O
chronic	|O
respiratory	|O
symptoms	|O
between	|O
animal	|O
food	|O
workers	|O
with	|O
positive	|O
and	|O
negative	|O
skin	|O
tests	|O
to	|O
house	|O
dust	|O
or	|O
to	|O
fish	|O
flour	|O
or	|O
among	|O
those	|O
with	|O
increased	|O
or	|O
normal	|O
IgE	|B-PROTEIN
(	|O
except	|O
for	|O
dyspnea	|O
)	|O
.	|O

An	|O
unexpected	|O
finding	|O
was	|O
the	|O
presence	|O
at	|O
position	|O
-	|O
403	|O
to	|O
-	|O
385	|O
of	|O
a	|O
putative	|O
dioxin	|O
responsive	|O
element	|O
,	|O
a	|O
sequence	|O
found	|O
to	|O
be	|O
responsible	|O
for	|O
the	|O
induction	|O
of	|O
transcription	|O
of	|O
the	|O
cytochrome	|B-PROTEIN
P450IA1	|I-PROTEIN
gene	|O
(	|O
CYPIA1	|B-PROTEIN
)	|O
and	|O
other	|O
genes	|O
involved	|O
in	|O
detoxification	|O
/	|O
activation	|O
of	|O
polycyclic	|O
aromatic	|O
hydrocarbons	|O
.	|O

The	|O
gene	|O
encoding	|O
TRP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
maps	|O
to	|O
mouse	|O
chromosome	|O
14	|O
,	|O
in	|O
the	|O
region	|O
of	|O
the	|O
coat	|O
colour	|O
mutation	|O
slaty	|B-PROTEIN
.	|O

Using	|O
bovine	|O
and	|O
murine	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
clones	|O
,	|O
no	|O
change	|O
in	|O
the	|O
rate	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
gene	|O
transcription	|O
or	|O
mRNA	|O
stability	|O
was	|O
detected	|O
during	|O
the	|O
cell	|O
cycle	|O
.	|O

A	|O
13	|O
base	|O
-	|O
pair	|O
oligonucleotide	|O
spanning	|O
nucleotides	|O
+	|O
80	|O
to	|O
+	|O
92	|O
of	|O
the	|O
5	|B-PROTEIN
S	|I-PROTEIN
RNA	|O
gene	|O
retained	|O
specific	|O
and	|O
high	|O
-	|O
affinity	|O
binding	|O
,	|O
although	|O
the	|O
latter	|O
was	|O
reduced	|O
sixfold	|O
relative	|O
to	|O
longer	|O
DNA	|O
fragments	|O
.	|O

Moreover	|O
,	|O
the	|O
reconstitution	|O
of	|O
eUSF	|B-PROTEIN
and	|O
TFIID	|B-PROTEIN
-	|O
depleted	|O
transcription	|O
complexes	|O
with	|O
purified	|O
protein	|O
fractions	|O
demonstrate	|O
that	|O
not	|O
only	|O
TFIID	|B-PROTEIN
but	|O
also	|O
eUSF	|B-PROTEIN
essentially	|O
participates	|O
in	|O
complex	|O
formation	|O
even	|O
on	|O
H5	|B-PROTEIN
promoter	|O
mutations	|O
lacking	|O
the	|O
TATA	|O
-	|O
box	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
T.	|O
thermophilus	|O
enzyme	|O
with	|O
that	|O
of	|O
the	|O
Escherichia	|O
coli	|O
enzyme	|O
showed	|O
(	|O
i	|O
)	|O
a	|O
37%	|O
overall	|O
similarity	|O
;	|O
(	|O
ii	|O
)	|O
the	|O
conservation	|O
of	|O
the	|O
Ser	|O
residue	|O
,	|O
which	|O
is	|O
known	|O
to	|O
be	|O
phosphorylated	|O
in	|O
the	|O
E.	|O
coli	|O
enzyme	|O
,	|O
and	|O
of	|O
the	|O
surrounding	|O
sequence	|O
;	|O
and	|O
(	|O
iii	|O
)	|O
the	|O
presence	|O
of	|O
141	|O
extra	|O
residues	|O
at	|O
the	|O
C	|O
terminus	|O
of	|O
the	|O
T.	|O
thermophilus	|O
enzyme	|O
.	|O

Radiolabelled	|O
palmitate	|O
was	|O
not	|O
incorporated	|O
into	|O
the	|O
mutated	|O
protein	|O
,	|O
showing	|O
that	|O
lipid	|O
modification	|O
occurs	|O
at	|O
the	|O
Cys	|O
-	|O
22	|O
residue	|O
.	|O

17	|O
volunteer	|O
deaf	|O
Ss	|O
were	|O
compared	|O
with	|O
18	|O
volunteer	|O
hearing	|O
Ss	|O
on	|O
the	|O
Stanford	|O
Hypnotic	|O
Clinical	|O
Scale	|O
(	|O
SHCS	|O
)	|O
of	|O
Morgan	|O
and	|O
J.	|O

Mature	|O
tobacco	|O
L12	|B-PROTEIN
protein	|O
has	|O
44%	|O
amino	|O
acid	|O
identity	|O
with	|O
ribosomal	|O
protein	|O
L7	|B-PROTEIN
/	|O
L12	|B-PROTEIN
of	|O
Escherichia	|O
coli	|O
.	|O

Nuclear	|O
-	|O
encoded	|O
chloroplast	|O
ribosomal	|O
protein	|O
L12	|B-PROTEIN
of	|O
Nicotiana	|O
tabacum	|O
:	|O
characterization	|O
of	|O
mature	|O
protein	|O
and	|O
isolation	|O
and	|O
sequence	|O
analysis	|O
of	|O
cDNA	|O
clones	|O
encoding	|O
its	|O
cytoplasmic	|O
precursor	|O
.	|O

The	|O
gene	|O
encoding	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
was	|O
previously	|O
found	|O
to	|O
contain	|O
an	|O
intronic	|O
enhancer	|O
element	|O
that	|O
was	|O
not	|O
tissue	|O
-	|O
specific	|O
in	|O
its	|O
activity	|O
,	|O
despite	|O
the	|O
restricted	|O
expression	|O
of	|O
the	|O
intact	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
-	|O
encoding	|O
gene	|O
.	|O

Molecular	|O
cloning	|O
of	|O
the	|O
polypeptide	|O
component	|O
of	|O
the	|O
Rel	|B-PROTEIN
-	|O
related	|O
human	|O
p75	|B-PROTEIN
nucleoprotein	|O
complex	|O
has	|O
revealed	|O
its	|O
identity	|O
with	|O
the	|O
65	|O
-	|O
kDa	|O
(	|O
p65	|B-PROTEIN
)	|O
subunit	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B.	|I-PROTEIN

Because	|O
single	|O
-	|O
chamber	|O
rate	|O
-	|O
adaptive	|O
atrial	|O
pacing	|O
leaves	|O
the	|O
patient	|O
exposed	|O
to	|O
the	|O
risk	|O
of	|O
future	|O
development	|O
of	|O
AV	|O
block	|O
and	|O
DDD	|O
pacing	|O
does	|O
not	|O
provide	|O
chronotropic	|O
support	|O
,	|O
it	|O
is	|O
likely	|O
that	|O
the	|O
new	|O
rate	|O
-	|O
adaptive	|O
dual	|O
-	|O
chamber	|O
(	|O
DDDR	|O
)	|O
devices	|O
will	|O
be	|O
used	|O
in	|O
a	|O
significant	|O
number	|O
of	|O
these	|O
patients	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

When	|O
transiently	|O
transfected	|O
into	|O
K562	|O
cells	|O
,	|O
this	|O
Lg	|B-PROTEIN
genomic	|O
clone	|O
is	|O
actively	|O
transcribed	|O
,	|O
suggesting	|O
that	|O
,	|O
although	|O
it	|O
possesses	|O
the	|O
characteristics	|O
of	|O
a	|O
processed	|O
pseudogene	|O
,	|O
it	|O
is	|O
likely	|O
to	|O
correspond	|O
to	|O
the	|O
gene	|O
encoding	|O
this	|O
new	|O
ferritin	|B-PROTEIN
subunit	|O
.	|O

Of	|O
the	|O
drugs	|O
orally	|O
administered	|O
,	|O
WR	|O
-	|O
168643	|O
was	|O
the	|O
best	|O
protector	|O
with	|O
a	|O
DMF	|O
of	|O
1.51	|O
.	|O

Characterization	|O
of	|O
these	|O
R	|O
subunits	|O
by	|O
their	|O
8	|O
-	|O
azido	|O
-	|O
cAMP	|O
photoaffinity	|O
labeling	|O
and	|O
immunoreactivity	|O
,	|O
as	|O
well	|O
as	|O
by	|O
a	|O
phosphorylation	|O
-	|O
dependent	|O
mobility	|O
shift	|O
on	|O
sodium	|O
dodecyl	|O
sulfate	|O
-	|O
polyacrylamide	|O
gel	|O
electrophoresis	|O
(	|O
SDS	|O
-	|O
PAGE	|O
)	|O
,	|O
indicated	|O
subunit	|O
sizes	|O
of	|O
RII	|B-PROTEIN
beta	|I-PROTEIN
(	|O
53	|O
kDa	|O
)	|O
greater	|O
than	|O
RII	|B-PROTEIN
alpha	|I-PROTEIN
dephosphoform	|O
(	|O
51	|O
kDa	|O
)	|O
greater	|O
than	|O
RI	|B-PROTEIN
alpha	|I-PROTEIN
(	|O
49	|O
kDa	|O
)	|O
.	|O

Comparison	|O
of	|O
the	|O
genomic	|O
DNA	|O
sequence	|O
with	|O
that	|O
of	|O
the	|O
four	|O
different	|O
mRNAs	|O
indicates	|O
that	|O
these	|O
transcripts	|O
are	|O
produced	|O
by	|O
alternative	|O
splicing	|O
of	|O
the	|O
murine	|O
pre	|O
-	|O
mRNA	|O
according	|O
to	|O
a	|O
cassette	|O
model	|O
.	|O

During	|O
the	|O
1980	|O
's	|O
,	|O
quantifications	|O
of	|O
immunoserological	|O
testings	|O
,	|O
especially	|O
C	|B-PROTEIN
reactive	|I-PROTEIN
protein	|I-PROTEIN
,	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
and	|O
antistreptolysin	|B-PROTEIN
O	|I-PROTEIN
,	|O
progressed	|O
rapidly	|O
.	|O

Within	|O
the	|O
human	|O
enhancer	|O
,	|O
these	|O
two	|O
sites	|O
are	|O
located	|O
within	|O
the	|O
previously	|O
defined	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprints	|O
,	|O
NFAT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
NFIL	|B-PROTEIN
-	|I-PROTEIN
2B	|I-PROTEIN
,	|O
respectively	|O
.	|O

The	|O
cardiac	|O
myosin	|B-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
MLC	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
gene	|O
promoter	|O
contains	|O
several	|O
positive	|O
and	|O
negative	|O
cis	|O
-	|O
acting	|O
sequences	|O
that	|O
are	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
its	|O
expression	|O
.	|O

Deletion	|O
mutagenesis	|O
demonstrated	|O
that	|O
these	|O
two	|O
elements	|O
are	|O
involved	|O
in	|O
the	|O
positive	|O
regulation	|O
of	|O
MLC	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
transcription	|O
.	|O

Disruption	|O
mutations	|O
have	|O
been	|O
constructed	|O
in	|O
the	|O
SLK1	|B-PROTEIN
gene	|O
.	|O
slk1	|B-PROTEIN
null	|O
mutants	|O
cannot	|O
grow	|O
at	|O
37	|O
degrees	|O
C	|O
,	|O
but	|O
many	|O
cells	|O
can	|O
grow	|O
at	|O
30	|O
,	|O
24	|O
,	|O
and	|O
17	|O
degrees	|O
C.	|O

Molecular	|O
and	|O
genetic	|O
analysis	|O
of	|O
the	|O
yeast	|O
early	|O
meiotic	|O
recombination	|O
genes	|O
REC102	|B-PROTEIN
and	|O
REC107	|B-PROTEIN
/	|O
MER2	|B-PROTEIN
.	|O

The	|O
p130	|B-PROTEIN
and	|O
p62	|B-PROTEIN
tyrosine	|O
-	|O
phosphorylated	|O
proteins	|O
that	|O
complexed	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
SH2	|O
in	|O
vitro	|O
also	|O
associated	|O
with	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
in	|O
v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
-	|O
transformed	|O
Rat	|O
-	|O
2	|O
cells	|O
;	|O
this	|O
in	|O
vivo	|O
binding	|O
was	|O
dependent	|O
on	|O
the	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
SH2	|O
domain	|O
.	|O

Probable	|O
progressive	|O
multifocal	|O
leukoencephalopathy	|O
(	|O
PML	|O
)	|O
was	|O
diagnosed	|O
on	|O
the	|O
basis	|O
of	|O
clinical	|O
picture	|O
and	|O
magnetic	|O
resonance	|O
imaging	|O
in	|O
a	|O
63	|O
-	|O
year	|O
-	|O
old	|O
man	|O
with	|O
a	|O
complete	|O
remission	|O
of	|O
a	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O
.	|O

These	|O
data	|O
support	|O
a	|O
possible	|O
biological	|O
significance	|O
of	|O
the	|O
frameshift	|O
to	|O
occur	|O
at	|O
this	|O
position	|O
of	|O
the	|O
large	|O
overlap	|O
by	|O
including	|O
the	|O
putative	|O
RNA	|O
template	|O
-	|O
binding	|O
site	|O
of	|O
the	|O
PLRV	|O
replicase	|B-PROTEIN
in	|O
the	|O
ORF2a	|B-PROTEIN
/	|I-PROTEIN
ORF2b	|I-PROTEIN
transframe	|O
protein	|O
.	|O

Proprotein	|O
processing	|O
occurs	|O
intracellularly	|O
.	|O

A	|O
32P	|O
-	|O
labeled	|O
LAP	|B-PROTEIN
DNA	|O
-	|O
binding	|O
and	|O
dimerization	|O
domain	|O
"	|O
zipper	|O
probe	|O
"	|O
was	|O
used	|O
to	|O
isolate	|O
a	|O
clone	|O
that	|O
encodes	|O
a	|O
new	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
-	|O
homologous	|O
protein	|O
:	|O
CHOP	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
.	|O

Using	|O
a	|O
degenerate	|O
oligodeoxyribonucleotide	|O
(	|O
oligo	|O
)	|O
based	|O
on	|O
the	|O
N	|O
-	|O
terminal	|O
aa	|O
sequence	|O
,	|O
plus	|O
an	|O
internal	|O
oligo	|O
homologous	|O
to	|O
a	|O
conserved	|O
region	|O
within	|O
the	|O
portion	|O
of	|O
CYP1	|B-PROTEIN
and	|O
CYP2	|B-PROTEIN
that	|O
had	|O
been	|O
deleted	|O
in	|O
the	|O
genome	|O
,	|O
a	|O
CYP3	|B-PROTEIN
-	|O
specific	|O
DNA	|O
fragment	|O
was	|O
generated	|O
by	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
(	|O
PCR	|O
)	|O
using	|O
GL81	|O
genomic	|O
DNA	|O
as	|O
a	|O
substrate	|O
.	|O

Stringent	|O
hybridization	|O
of	|O
EHS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
back	|O
to	|O
primate	|O
genomic	|O
DNA	|O
indicates	|O
two	|O
distinct	|O
EHS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
loci	|O
in	|O
normal	|O
human	|O
DNA	|O
,	|O
an	|O
identical	|O
band	|O
pattern	|O
in	|O
chimpanzee	|O
DNA	|O
,	|O
and	|O
a	|O
single	|O
locus	|O
in	|O
rhesus	|O
monkey	|O
DNA	|O
.	|O

The	|O
level	|O
of	|O
carboxyl	|O
-	|O
terminal	|O
parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
in	|O
the	|O
patients	|O
with	|O
thyroid	|O
carcinoma	|O
was	|O
higher	|O
than	|O
that	|O
in	|O
the	|O
patients	|O
without	|O
thyroid	|O
carcinoma	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

The	|O
Caenorhabditis	|O
elegans	|O
vitellogenin	|B-PROTEIN
genes	|O
are	|O
subject	|O
to	|O
sex	|O
-	|O
,	|O
stage	|O
-	|O
,	|O
and	|O
tissue	|O
-	|O
specific	|O
regulation	|O
:	|O
they	|O
are	|O
expressed	|O
solely	|O
in	|O
the	|O
adult	|O
hermaphrodite	|O
intestine	|O
.	|O

The	|O
MET4	|B-PROTEIN
gene	|O
was	|O
cloned	|O
,	|O
and	|O
its	|O
sequence	|O
reveals	|O
that	|O
it	|O
encodes	|O
a	|O
protein	|O
related	|O
to	|O
the	|O
family	|O
of	|O
the	|O
bZIP	|B-PROTEIN
transcriptional	|I-PROTEIN
activators	|I-PROTEIN
.	|O

The	|O
functions	|O
of	|O
isolated	|O
portions	|O
of	|O
the	|O
insulin	|B-PROTEIN
,	|O
IAPP	|B-PROTEIN
,	|O
and	|O
beta	|B-PROTEIN
GK	|I-PROTEIN
promoters	|O
were	|O
studied	|O
by	|O
using	|O
transient	|O
expression	|O
and	|O
DNA	|O
binding	|O
assays	|O
.	|O

It	|O
is	|O
believed	|O
that	|O
these	|O
domains	|O
are	|O
important	|O
for	|O
directing	|O
specific	|O
protein	|O
-	|O
protein	|O
interactions	|O
necessary	|O
for	|O
the	|O
proper	|O
functioning	|O
of	|O
Src	|B-PROTEIN
.	|O

The	|O
c	|B-PROTEIN
-	|I-PROTEIN
Ets	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
oncoprotein	|O
is	|O
a	|O
transcription	|O
activator	|O
that	|O
specifically	|O
binds	|O
to	|O
DNA	|O
.	|O

Previous	|O
transactivation	|O
experiments	|O
indicated	|O
that	|O
three	|O
amino	|O
acids	|O
residing	|O
in	|O
this	|O
region	|O
,	|O
Gly	|O
,	|O
Ser	|O
and	|O
Val	|O
,	|O
appear	|O
to	|O
be	|O
critical	|O
for	|O
target	|O
-	|O
site	|O
discrimination	|O
.	|O

GR63178A	|O
is	|O
a	|O
water	|O
-	|O
soluble	|O
analogue	|O
of	|O
mitoquidone	|O
,	|O
a	|O
pentacyclic	|O
pyrroloquinone	|O
.	|O

Marker	|O
rescue	|O
analysis	|O
has	|O
localized	|O
ts8	|B-PROTEIN
to	|O
a	|O
910	|O
-	|O
bp	|O
internal	|O
segment	|O
of	|O
rpoB	|B-PROTEIN
that	|O
encodes	|O
the	|O
Rif	|B-PROTEIN
domain	|O
.	|O

This	|O
vector	|O
transfected	|O
into	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
directs	|O
expression	|O
of	|O
a	|O
secreted	|O
mature	|O
protein	|O
at	|O
levels	|O
up	|O
to	|O
200	|O
mg	|O
of	|O
LAPP	|O
/	|O
liter	|O
of	|O
culture	|O
medium	|O
.	|O

Competition	|O
analysis	|O
by	|O
gel	|O
mobility	|O
shift	|O
electrophoresis	|O
indicates	|O
that	|O
this	|O
DNA	|O
-	|O
protein	|O
interaction	|O
is	|O
novel	|O
and	|O
not	|O
related	|O
to	|O
many	|O
transcription	|O
factors	|O
previously	|O
reported	|O
.	|O

This	|O
DNA	|O
motif	|O
represents	|O
a	|O
novel	|O
protein	|O
-	|O
binding	|O
sequence	|O
.	|O

OBJECTIVE	|O
:	|O
The	|O
study	|O
was	|O
designed	|O
to	|O
investigate	|O
the	|O
frequency	|O
of	|O
alterations	|O
in	|O
serum	|O
creatinine	|O
in	|O
patients	|O
with	|O
psoriasis	|O
receiving	|O
5	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
of	|O
cyclosporine	|O
.	|O

Intrapocket	|O
chemotherapy	|O
in	|O
adult	|O
periodontitis	|O
using	|O
a	|O
new	|O
controlled	|O
-	|O
release	|O
insert	|O
containing	|O
ofloxacin	|O
(	|O
PT	|O
-	|O
01	|O
)	|O
.	|O

Electromagnetic	|O
blood	|O
flow	|O
(	|O
BF	|O
)	|O
probe	|O
was	|O
applied	|O
on	|O
the	|O
left	|O
anterior	|O
descending	|O
artery	|O
(	|O
LAD	|O
)	|O
.	|O

Hence	|O
temperature	|O
and	|O
virF	|B-PROTEIN
are	|O
both	|O
required	|O
for	|O
the	|O
induction	|O
of	|O
the	|O
yop	|B-PROTEIN
regulon	|O
.	|O

Problems	|O
remain	|O
to	|O
be	|O
resolved	|O
in	|O
the	|O
area	|O
of	|O
quantitative	|O
risk	|O
assessment	|O
.	|O

The	|O
recently	|O
developed	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
interferon	|I-PROTEIN
(	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
)	|O
assay	|O
system	|O
for	|O
the	|O
diagnosis	|O
of	|O
bovine	|O
tuberculosis	|O
in	|O
cattle	|O
has	|O
been	|O
accredited	|O
by	|O
the	|O
Standing	|O
Committee	|O
on	|O
Agriculture	|O
for	|O
use	|O
in	|O
Australia	|O
.	|O

Control	|O
Tmuscle	|O
was	|O
35.8	|O
+	|O
/	|O
-	|O
0.7	|O
degrees	|O
C	|O
,	|O
with	|O
control	|O
Wi	|O
,	|O
max	|O
being	|O
51.6	|O
(	|O
SD	|O
8.7	|O
)	|O
W.k	|O
g	|O
-	|O
1	|O
.	|O

The	|O
Klebsiella	|O
aerogenes	|O
gene	|O
maoA	|B-PROTEIN
,	|O
which	|O
is	|O
involved	|O
in	|O
the	|O
synthesis	|O
of	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
,	|O
was	|O
induced	|O
by	|O
tyramine	|O
and	|O
the	|O
related	|O
compounds	|O
,	|O
subjected	|O
to	|O
catabolite	|O
and	|O
ammonium	|O
ion	|O
repression	|O
,	|O
and	|O
cloned	|O
.	|O

However	|O
,	|O
other	|O
regions	|O
of	|O
the	|O
plasmid	|O
are	|O
also	|O
efficiently	|O
repaired	|O
.	|O

Eight	|O
of	|O
14	|O
infectious	|O
or	|O
inflammatory	|O
lesions	|O
could	|O
be	|O
detected	|O
in	|O
the	|O
early	|O
scan	|O
(	|O
4-6	|O
h	|O
p.i	|O
.	|O
)	|O
.	|O

Thus	|O
,	|O
the	|O
human	|O
D1A	|B-PROTEIN
gene	|O
belongs	|O
to	|O
the	|O
category	|O
of	|O
tissue	|O
-	|O
specific	|O
,	|O
regulated	|O
genes	|O
that	|O
have	|O
housekeeping	|O
-	|O
type	|O
promoters	|O
.	|O

Similar	|O
observations	|O
have	|O
been	|O
made	|O
previously	|O
for	|O
other	|O
genes	|O
.	|O

Preceptorship	|O
of	|O
CNS	|O
students	|O
:	|O
an	|O
exploratory	|O
study	|O
.	|O

To	|O
determine	|O
the	|O
genetic	|O
basis	|O
for	|O
the	|O
differences	|O
between	|O
the	|O
cardiac	|O
and	|O
brain	|O
AE3	|B-PROTEIN
variants	|O
,	|O
we	|O
isolated	|O
and	|O
characterized	|O
the	|O
rat	|O
gene	|O
.	|O

The	|O
1.7	|O
kb	|O
cloned	|O
fragment	|O
was	|O
sequenced	|O
and	|O
shown	|O
to	|O
contain	|O
the	|O
entire	|O
fliA	|B-PROTEIN
gene	|O
.	|O

Institution	|O
of	|O
both	|O
intravenous	|O
and	|O
intracisternal	|O
administration	|O
of	|O
amphotericin	|O
B	|O
and	|O
possibly	|O
concomitant	|O
intravenous	|O
administration	|O
of	|O
dexamethasone	|O
may	|O
be	|O
warranted	|O
in	|O
situations	|O
in	|O
which	|O
the	|O
association	|O
of	|O
C.	|O
immitis	|O
with	|O
CNS	|O
vasculitis	|O
or	|O
encephalitis	|O
appears	|O
likely	|O
before	|O
serologic	|O
or	|O
cultural	|O
confirmation	|O
of	|O
C.	|O
immitis	|O
infection	|O
involving	|O
the	|O
CNS	|O
is	|O
available	|O
.	|O

Lac	|B-PROTEIN
operators	|O
were	|O
introduced	|O
into	|O
several	|O
positions	|O
within	|O
the	|O
CAB	|B-PROTEIN
promoter	|O
and	|O
operator	|O
-	|O
free	|O
plasmid	|O
was	|O
used	|O
as	|O
control	|O
.	|O

Overproduction	|O
,	|O
purification	|O
and	|O
characterization	|O
of	|O
M.H	|O
infI	|O
methyltransferase	|B-PROTEIN
and	|O
its	|O
deletion	|O
mutant	|O
.	|O

Various	|O
companies	|O
produce	|O
this	|O
type	|O
of	|O
lens	|O
.	|O

From	|O
March	|O
5	|O
through	|O
October	|O
26	|O
,	|O
1991	|O
,	|O
eight	|O
persons	|O
were	|O
diagnosed	|O
with	|O
elevated	|O
blood	|O
lead	|O
levels	|O
(	|O
BLLs	|O
)	|O
at	|O
a	|O
local	|O
hospital	|O
and	|O
were	|O
reported	|O
to	|O
the	|O
notifiable	|O
disease	|O
surveillance	|O
system	|O
maintained	|O
by	|O
the	|O
Alabama	|O
Department	|O
of	|O
Public	|O
Health	|O
(	|O
ADPH	|O
)	|O
.	|O

According	|O
to	|O
the	|O
changes	|O
of	|O
perfusion	|O
defects	|O
between	|O
Ex	|O
,	|O
RD	|O
and	|O
ReI	|O
images	|O
,	|O
they	|O
were	|O
classified	|O
into	|O
3	|O
types	|O
:	|O
Type	|O
I	|O
;	|O
perfusion	|O
defect	|O
on	|O
the	|O
RD	|O
image	|O
was	|O
identical	|O
to	|O
ReI	|O
image	|O
(	|O
75%	|O
)	|O
Type	|O
I	|O
was	|O
divided	|O
into	|O
2	|O
subgroups	|O
whether	|O
perfusion	|O
defect	|O
at	|O
Ex	|O
was	|O
unchanged	|O
(	|O
Ia	|O
,	|O
42%	|O
)	|O
or	|O
improved	|O
(	|O
Ib	|O
,	|O
33%	|O
)	|O
on	|O
the	|O
RD	|O
image	|O
.	|O

Keck	|O
,	|O
C.J.	|O

Twenty	|O
-	|O
eight	|O
(	|O
7.0%	|O
)	|O
infants	|O
without	|O
periventricular	|O
hemorrhage	|O
were	|O
revealed	|O
as	|O
having	|O
spastic	|O
cerebral	|O
palsy	|O
by	|O
neurodevelopmental	|O
evaluation	|O
in	|O
later	|O
infancy	|O
.	|O

A	|O
possible	|O
mechanism	|O
is	|O
that	|O
elevated	|O
alveolar	|O
pressure	|O
and	|O
decreased	|O
cardiac	|O
output	|O
eliminate	|O
blood	|O
flow	|O
from	|O
corner	|O
vessels	|O
in	|O
nondependent	|O
high	|O
VA	|O
/	|O
Q	|O
regions	|O
.	|O

Computer	|O
-	|O
aided	|O
"	|O
FRAME	|O
"	|O
analysis	|O
revealed	|O
four	|O
possible	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
,	|O
three	|O
in	|O
one	|O
direction	|O
and	|O
one	|O
in	|O
the	|O
opposite	|O
direction	|O
.	|O

Domain	|O
II	|O
is	|O
highly	|O
homologous	|O
to	|O
the	|O
LDL	|B-PROTEIN
receptor	|I-PROTEIN
and	|O
contains	|O
four	|O
repeats	|O
with	|O
perfect	|O
conservation	|O
of	|O
all	|O
6	|O
consecutive	|O
cysteines	|O
.	|O

In	|O
both	|O
cities	|O
,	|O
HTLV	|O
-	|O
I	|O
/	|O
II	|O
prevalence	|O
increased	|O
significantly	|O
with	|O
age	|O
,	|O
and	|O
the	|O
New	|O
Orleans	|O
age	|O
-	|O
and	|O
sex	|O
-	|O
adjusted	|O
HTLV	|O
-	|O
I	|O
/	|O
II	|O
prevalence	|O
was	|O
significantly	|O
higher	|O
than	|O
that	|O
of	|O
Baltimore	|O
(	|O
P	|O
less	|O
than	|O
.001	|O
)	|O
.	|O

Here	|O
,	|O
we	|O
present	|O
evidence	|O
for	|O
a	|O
model	|O
in	|O
which	|O
mRNA	|O
sequences	|O
up	|O
to	|O
around	|O
100	|O
nucleotides	|O
downstream	|O
from	|O
the	|O
start	|O
codon	|O
of	|O
21K	|O
fold	|O
back	|O
and	|O
base	|O
-	|O
pair	|O
to	|O
the	|O
21K	|O
translation	|O
initiation	|O
region	|O
,	|O
thereby	|O
decreasing	|O
the	|O
translation	|O
initiation	|O
frequency	|O
.	|O

Hybridization	|O
data	|O
indicate	|O
that	|O
6F6.2	|B-PROTEIN
corresponds	|O
to	|O
the	|O
previously	|O
characterized	|O
m6F6	|B-PROTEIN
cDNA	|O
clone	|O
and	|O
that	|O
6F6.1	|B-PROTEIN
and	|O
6F6.3	|B-PROTEIN
,	|O
but	|O
not	|O
6F6.2	|B-PROTEIN
,	|O
are	|O
adjacent	|O
to	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
genes	|I-PROTEIN
.	|O

The	|O
SEN1	|B-PROTEIN
gene	|O
corresponds	|O
to	|O
a	|O
6,336	|O
-	|O
bp	|O
open	|O
reading	|O
frame	|O
coding	|O
for	|O
a	|O
2,112	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
(	|O
molecular	|O
mass	|O
,	|O
239	|O
kDa	|O
)	|O
.	|O

Protein	|B-PROTEIN
tyrosine	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
PTKs	|B-PROTEIN
)	|O
are	|O
implicated	|O
in	|O
the	|O
control	|O
of	|O
cell	|O
growth	|O
by	|O
virtue	|O
of	|O
their	|O
frequent	|O
appearance	|O
as	|O
products	|O
of	|O
retroviral	|O
oncogenes	|O
,	|O
as	|O
intracellular	|O
signal	|O
transducers	|O
,	|O
and	|O
as	|O
growth	|B-PROTEIN
factor	|I-PROTEIN
receptors	|I-PROTEIN
or	|O
components	|O
thereof	|O
.	|O

The	|O
IA4	|B-PROTEIN
mAb	|O
was	|O
identified	|O
among	|O
a	|O
series	|O
of	|O
antibodies	|O
raised	|O
in	|O
BALB	|O
/	|O
c	|O
mice	|O
after	|O
immunization	|O
against	|O
a	|O
HLA	|B-PROTEIN
class	|O
I	|O
-	|O
deficient	|O
,	|O
lymphokine	|O
-	|O
activated	|O
killer	|O
(	|O
LAK	|O
)	|O
-	|O
susceptible	|O
EBV	|O
-	|O
B	|O
lymphocyte	|O
line	|O
.	|O

In	|O
a	|O
randomized	|O
double	|O
-	|O
blind	|O
cross	|O
-	|O
over	|O
study	|O
,	|O
the	|O
subjects	|O
received	|O
theophylline	|O
5	|O
mg.k	|O
g	|O
-	|O
1	|O
per	|O
day	|O
with	|O
omeprazole	|O
20	|O
mg	|O
per	|O
day	|O
or	|O
identical	|O
placebo	|O
during	|O
two	|O
periods	|O
,	|O
each	|O
of	|O
7	|O
days	|O
,	|O
separated	|O
by	|O
a	|O
washout	|O
period	|O
of	|O
7	|O
days	|O
.	|O

Primer	|O
extension	|O
and	|O
mung	|O
bean	|O
and	|O
S1	|B-PROTEIN
nuclease	|O
mapping	|O
indicated	|O
multiple	|O
transcription	|O
initiation	|O
sites	|O
and	|O
were	|O
consistent	|O
with	|O
Northern	|O
analyses	|O
.	|O

Two	|O
variant	|O
PRP	|B-PROTEIN
-	|O
precursor	|O
alleles	|O
occur	|O
which	|O
slightly	|O
differ	|O
in	|O
the	|O
number	|O
of	|O
repeats	|O
in	|O
domain	|O
C.	|O

Unlike	|O
the	|O
typical	|O
enhancer	|O
element	|O
,	|O
this	|O
region	|O
functions	|O
in	|O
an	|O
orientation	|O
-	|O
dependent	|O
manner	|O
.	|O

In	|O
the	|O
last	|O
20	|O
years	|O
,	|O
the	|O
therapeutic	|O
uses	|O
of	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
,	|O
a	|O
potent	|O
neurotoxin	|O
,	|O
have	|O
been	|O
investigated	|O
.	|O

Allagille	|O
's	|O
syndrome	|O
associated	|O
with	|O
antenatal	|O
ascites	|O

Sensitivity	|O
and	|O
specificity	|O
was	|O
established	|O
for	|O
the	|O
Pharmacia	|O
CAP	|O
System	|O
and	|O
the	|O
DPC	|O
AlaSTAT	|O
System	|O
by	|O
comparison	|O
with	|O
results	|O
of	|O
the	|O
skin	|O
prick	|O
test	|O
.	|O

PSI	|B-PROTEIN
-	|I-PROTEIN
G	|I-PROTEIN
and	|O
PSI	|B-PROTEIN
-	|I-PROTEIN
K	|I-PROTEIN
probably	|O
have	|O
evolved	|O
from	|O
a	|O
gene	|O
duplication	|O
of	|O
an	|O
ancestral	|O
gene	|O
.	|O

At	|O
the	|O
C	|O
-	|O
terminus	|O
of	|O
the	|O
protein	|O
is	|O
a	|O
domain	|O
that	|O
contains	|O
sequences	|O
very	|O
similar	|O
to	|O
those	|O
found	|O
in	|O
the	|O
breakpoint	|O
cluster	|O
region	|O
gene	|O
product	|O
,	|O
n	|B-PROTEIN
-	|I-PROTEIN
chimerin	|I-PROTEIN
,	|O
and	|O
rho	|B-PROTEIN
GAP	|O
,	|O
all	|O
of	|O
which	|O
have	|O
been	|O
shown	|O
to	|O
possess	|O
intrinsic	|O
GAP	|B-PROTEIN
activity	|O
on	|O
small	|O
GTPases	|B-PROTEIN
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
revealed	|O
that	|O
two	|O
clusters	|O
of	|O
basic	|O
amino	|O
acids	|O
within	|O
a	|O
conserved	|O
basic	|O
region	|O
and	|O
two	|O
amphipathic	|O
helices	|O
within	|O
the	|O
adjacent	|O
HLH	|O
domain	|O
are	|O
essential	|O
for	|O
sequence	|O
-	|O
specific	|O
DNA	|O
binding	|O
and	|O
hetero	|O
-	|O
oligomerization	|O
,	|O
respectively	|O
.	|O

Dimerization	|O
of	|O
Myf	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
with	|O
the	|O
ubiquitously	|O
expressed	|O
bHLH	|O
protein	|O
E12	|B-PROTEIN
not	|O
only	|O
increases	|O
the	|O
affinity	|O
for	|O
DNA	|O
but	|O
also	|O
stimulates	|O
transactivation	|O
independently	|O
of	|O
DNA	|O
binding	|O
.	|O

The	|O
circadian	|O
rhythmicity	|O
of	|O
sleep	|O
was	|O
pronounced	|O
.	|O

SEA	|O
was	|O
recorded	|O
with	|O
bidirectional	|O
filters	|O
at	|O
25-250	|O
HZ	|O
and	|O
40-250	|O
Hz	|O
using	|O
Simson	|O
method	|O
.	|O

Neural	|O
-	|O
specific	|O
expression	|O
,	|O
genomic	|O
structure	|O
,	|O
and	|O
chromosomal	|O
localization	|O
of	|O
the	|O
gene	|O
encoding	|O
the	|O
zinc	|O
-	|O
finger	|O
transcription	|O
factor	|O
NGFI	|B-PROTEIN
-	|I-PROTEIN
C.	|I-PROTEIN

An	|O
experiment	|O
examined	|O
the	|O
effects	|O
of	|O
treatment	|O
with	|O
gonadotrophin	|B-PROTEIN
releasing	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
100	|O
micrograms	|O
GnRH	|B-PROTEIN
injected	|O
24	|O
h	|O
after	|O
progestagen	|O
sponge	|O
removal	|O
)	|O
,	|O
season	|O
of	|O
treatment	|O
(	|O
autumn	|O
v	|O
.	|O
spring	|O
)	|O
,	|O
the	|O
effect	|O
of	|O
supplementary	|O
feeding	|O
with	|O
lupin	|O
grain	|O
(	|O
in	|O
autumn	|O
only	|O
,	|O
from	|O
12	|O
days	|O
before	|O
until	|O
8	|O
days	|O
after	|O
sponge	|O
removal	|O
)	|O
on	|O
the	|O
time	|O
of	|O
ovulation	|O
in	|O
182	|O
mature	|O
Merino	|O
ewes	|O
superovulated	|O
with	|O
a	|O
combination	|O
of	|O
400	|O
I.U.	|O
pregnant	|B-PROTEIN
mare	|I-PROTEIN
serum	|I-PROTEIN
gonadotrophin	|I-PROTEIN
(	|O
PMSG	|B-PROTEIN
)	|O
and	|O
12	|O
mg	|O
follicle	|B-PROTEIN
stimulating	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
FSH	|B-PROTEIN
-	|I-PROTEIN
P	|I-PROTEIN
)	|O
.	|O

Drug	|O
-	|O
drug	|O
interactions	|O
are	|O
most	|O
likely	|O
to	|O
occur	|O
in	|O
patients	|O
receiving	|O
multiple	|O
medications	|O
and	|O
with	|O
drugs	|O
that	|O
have	|O
a	|O
narrow	|O
therapeutic	|O
window	|O
.	|O

The	|O
sequence	|O
data	|O
now	|O
permit	|O
a	|O
detailed	|O
interpretation	|O
of	|O
the	|O
X	|O
-	|O
ray	|O
crystallographic	|O
structure	|O
of	|O
the	|O
enzyme	|O
and	|O
the	|O
cloning	|O
and	|O
expression	|O
of	|O
the	|O
clostridial	|O
gene	|O
will	|O
facilitate	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
.	|O

Total	|O
body	|O
irradiation	|O
was	|O
delivered	|O
according	|O
to	|O
a	|O
hyperfractionated	|O
scheme	|O
of	|O
12	|O
fractions	|O
given	|O
three	|O
per	|O
day	|O
5	|O
hr	|O
apart	|O
for	|O
4	|O
days	|O
.	|O

A	|O
reduction	|O
in	|O
blood	|O
pressure	|O
was	|O
only	|O
observed	|O
at	|O
the	|O
end	|O
of	|O
the	|O
study	|O
,	|O
from	|O
142	|O
+	|O
/	|O
-	|O
17/86.6	|O
+	|O
/	|O
-	|O
9.1	|O
to	|O
139	|O
+	|O
/	|O
-	|O
13/82.9	|O
+	|O
/	|O
-	|O
8.9	|O
mmHg	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
for	|O
DBP	|O
)	|O
.	|O

AgMNPV	|O
and	|O
Orgyia	|O
pseudotsugata	|O
MNPV	|O
(	|O
OpMNPV	|O
)	|O
are	|O
similar	|O
in	|O
terms	|O
of	|O
promoter	|O
structure	|O
and	|O
polyhedrin	|B-PROTEIN
primary	|O
sequence	|O
,	|O
and	|O
the	|O
polyhedrin	|B-PROTEIN
gene	|O
of	|O
both	|O
viruses	|O
is	|O
transcribed	|O
in	|O
the	|O
anti	|O
-	|O
clockwise	|O
direction	|O
in	|O
relation	|O
to	|O
their	|O
physical	|O
maps	|O
.	|O

A	|O
gene	|O
homologous	|O
to	|O
the	|O
Escherichia	|O
coli	|O
dnaA	|B-PROTEIN
gene	|O
was	|O
isolated	|O
from	|O
Pseudomonas	|O
putida	|O
and	|O
its	|O
transcription	|O
was	|O
investigated	|O
in	|O
E.	|O
coli	|O
as	|O
well	|O
as	|O
in	|O
P.	|O
putida	|O
.	|O

STP1	|B-PROTEIN
is	|O
an	|O
unessential	|O
yeast	|O
gene	|O
involved	|O
in	|O
the	|O
removal	|O
of	|O
intervening	|O
sequences	|O
from	|O
some	|O
,	|O
but	|O
not	|O
all	|O
,	|O
families	|O
of	|O
intervening	|O
sequence	|O
-	|O
containing	|O
pre	|O
-	|O
tRNAs	|O
.	|O

Using	|O
these	|O
antibodies	|O
,	|O
we	|O
were	|O
able	|O
to	|O
define	|O
the	|O
conditions	|O
to	|O
completely	|O
solubilize	|O
the	|O
Cdc25	|B-PROTEIN
protein	|O
.	|O

GCR1	|B-PROTEIN
gene	|O
function	|O
is	|O
required	|O
for	|O
high	|O
-	|O
level	|O
glycolytic	|O
gene	|O
expression	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

The	|O
decay	|O
curves	|O
of	|O
chlorophyll	|O
fluorescence	|O
showed	|O
a	|O
superposition	|O
of	|O
three	|O
exponentially	|O
decaying	|O
components	|O
with	|O
time	|O
constants	|O
of	|O
T1	|O
=	|O
100-200	|O
ps	|O
,	|O
T2	|O
=	|O
300-500	|O
ps	|O
and	|O
T3	|O
=	|O
2.0-3.5	|O
ns	|O
.	|O

After	|O
tilting	|O
,	|O
systolic	|O
blood	|O
pressure	|O
fell	|O
an	|O
average	|O
of	|O
17%	|O
in	|O
patients	|O
who	|O
cramped	|O
infrequently	|O
(	|O
p	|O
=	|O
0.0031	|O
)	|O
but	|O
only	|O
10%	|O
in	|O
frequently	|O
cramping	|O
patients	|O
.	|O

These	|O
results	|O
are	|O
consistent	|O
with	|O
the	|O
roles	|O
that	|O
CCK	|B-PROTEIN
and	|O
trypsin	|B-PROTEIN
inhibitors	|O
are	|O
believed	|O
to	|O
play	|O
in	|O
the	|O
negative	|O
feedback	|O
control	|O
of	|O
pancreatic	|O
exocrine	|O
function	|O
.	|O

Most	|O
apneic	|O
events	|O
occurred	|O
during	|O
Stages	|O
I	|O
and	|O
II	|O
,	|O
and	|O
REM	|O
,	|O
but	|O
this	|O
proportion	|O
was	|O
less	|O
during	|O
the	|O
gamma	|O
OH	|O
study	|O
(	|O
77.9	|O
+	|O
/	|O
-	|O
8.9%	|O
)	|O
than	|O
during	|O
the	|O
control	|O
studies	|O
(	|O
92.3	|O
+	|O
/	|O
-	|O
1.9	|O
and	|O
95.9	|O
+	|O
/	|O
-	|O
2.2%	|O
)	|O
,	|O
apneas	|O
occurring	|O
even	|O
during	|O
SWS	|O
with	|O
gamma	|O
OH	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Eight	|O
rabbits	|O
were	|O
exposed	|O
to	|O
0.7	|O
+	|O
/	|O
-	|O
0.4	|O
mg	|O
/	|O
m3	|O
Co2+	|O
as	|O
CoCl2	|O
and	|O
1.2	|O
+	|O
/	|O
-	|O
0.7	|O
mg	|O
/	|O
m3	|O
Cr3+	|O
as	|O
Cr	|O
(	|O
NO3	|O
)	|O
3	|O
(	|O
group	|O
Co	|O
+	|O
Cr	|O
)	|O
,	|O
eight	|O
to	|O
0.6	|O
+	|O
/	|O
-	|O
0.5	|O
mg	|O
/	|O
m3	|O
Co2+	|O
(	|O
group	|O
Co	|O
)	|O
,	|O
and	|O
eight	|O
to	|O
filtered	|O
air	|O
(	|O
control	|O
group	|O
)	|O
,	|O
for	|O
4	|O
months	|O
,	|O
5	|O
days	|O
/	|O
week	|O
,	|O
and	|O
6	|O
hr	|O
/	|O
day	|O
.	|O

16	|O
women	|O
were	|O
treated	|O
with	|O
methadone	|O
to	|O
prevent	|O
withdrawal	|O
symptoms	|O
.	|O

Disruption	|O
demonstrates	|O
that	|O
CDC14	|B-PROTEIN
is	|O
an	|O
essential	|O
gene	|O
.	|O

Coronary	|O
flow	|O
was	|O
reduced	|O
by	|O
10%	|O
in	|O
the	|O
phosphocreatine	|O
and	|O
by	|O
18%	|O
in	|O
the	|O
control	|O
group	|O
.	|O

The	|O
60A	|B-PROTEIN
transcripts	|O
and	|O
protein	|O
are	|O
first	|O
detected	|O
at	|O
the	|O
onset	|O
of	|O
gastrulation	|O
,	|O
primarily	|O
in	|O
the	|O
mesoderm	|O
of	|O
the	|O
extending	|O
germ	|O
band	|O
.	|O

A	|O
724	|O
-	|O
bp	|O
segment	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
consisting	|O
of	|O
the	|O
proximal	|O
E	|O
-	|O
box	|O
flanked	|O
upstream	|O
by	|O
a	|O
mammalian	|O
-	|O
specific	|O
352	|O
-	|O
bp	|O
region	|O
was	|O
sufficient	|O
for	|O
maximal	|O
transcriptional	|O
activation	|O
in	|O
postconfluent	|O
BC3H1	|O
myoblasts	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
baculovirus	|O
-	|O
expressed	|O
TR	|B-PROTEIN
mediates	|O
transcriptional	|O
activation	|O
and	|O
repression	|O
in	|O
a	|O
promoter	|O
-	|O
specific	|O
manner	|O
in	|O
vitro	|O
.	|O

Influence	|O
of	|O
neural	|O
regulation	|O
on	|O
anti	|O
-	|O
arrhythmic	|O
effects	|O
of	|O
GABA	|O
in	|O
rats	|O

Recent	|O
investigations	|O
have	|O
detailed	|O
a	|O
selective	|O
dye	|O
release	|O
technique	|O
in	|O
which	|O
a	|O
pulse	|O
of	|O
laser	|O
light	|O
induces	|O
the	|O
release	|O
of	|O
a	|O
fluorescent	|O
dye	|O
from	|O
temperature	|O
-	|O
sensitive	|O
liposomes	|O
circulating	|O
in	|O
the	|O
retinal	|O
vasculature	|O
.	|O

And	|O
the	|O
natural	|O
barriers	|O
?	|O

Three	|O
pyridoxine	|O
derivatives	|O
have	|O
been	|O
isolated	|O
from	|O
the	|O
fresh	|O
stem	|O
bark	|O
of	|O
Albizzia	|O
julibrissin	|O
DURAZZ	|O
..	|O

The	|O
serum	|O
erythropoietin	|B-PROTEIN
(	|O
EPO	|B-PROTEIN
)	|O
concentrations	|O
of	|O
15	|O
male	|O
triathletes	|O
(	|O
26.3	|O
U.m	|O
l	|O
-	|O
1	|O
)	|O
were	|O
significantly	|O
lower	|O
than	|O
those	|O
of	|O
45	|O
male	|O
distance	|O
runners	|O
(	|O
31.6	|O
U.m	|O
l	|O
-	|O
1	|O
;	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

The	|O
coating	|O
materials	|O
were	|O
poloxamine	|O
904	|O
,	|O
poloxamine	|O
908	|O
,	|O
poloxamine	|O
1508	|O
,	|O
poloxamer	|O
338	|O
,	|O
and	|O
Brij	|O
35	|O
.	|O

The	|O
eating	|O
and	|O
drinking	|O
patterns	|O
of	|O
pygmy	|O
goats	|O
fed	|O
ad	|O
lib	|O
and	|O
kept	|O
on	|O
a	|O
12	|O
h	|O
light	|O
/	|O
12	|O
h	|O
dark	|O
cycle	|O
were	|O
recorded	|O
and	|O
analyzed	|O
.	|O

The	|O
present	|O
study	|O
highlights	|O
the	|O
improvement	|O
in	|O
sputum	|O
amoxycillin	|O
(	|O
amoxy	|O
)	|O
levels	|O
when	|O
a	|O
combination	|O
tablet	|O
,	|O
amoxy	|O
500	|O
mg	|O
plus	|O
bromhexeine	|O
8	|O
mg	|O
,	|O
is	|O
administered	|O
as	|O
compared	|O
to	|O
plain	|O
amoxy	|O
500	|O
mg	|O
.	|O

His	|O
HC	|B-PROTEIN
II	|I-PROTEIN
activity	|O
and	|O
antigen	|O
levels	|O
were	|O
49%	|O
and	|O
50%	|O
,	|O
respectively	|O
,	|O
and	|O
his	|O
daughter	|O
also	|O
showed	|O
similar	|O
low	|O
levels	|O
.	|O

Argatroban	|O
may	|O
be	|O
more	|O
effective	|O
under	|O
low	|O
HC	|B-PROTEIN
II	|I-PROTEIN
conditions	|O
because	|O
of	|O
its	|O
potent	|O
inhibition	|O
of	|O
thrombin	|B-PROTEIN
activity	|O
at	|O
sites	|O
of	|O
vascular	|O
wall	|O
damage	|O
.	|O

These	|O
results	|O
support	|O
the	|O
diagnostic	|O
validity	|O
of	|O
NFPD	|O
in	|O
CP	|O
/	|O
NCA	|O
patients	|O
,	|O
because	|O
such	|O
patients	|O
had	|O
a	|O
family	|O
history	|O
of	|O
panic	|O
disorder	|O
similar	|O
to	|O
patients	|O
with	|O
a	|O
more	|O
classical	|O
panic	|O
disorder	|O
presentation	|O
.	|O

FDA	|O
regulations	|O
for	|O
growth	|O
factors	|O
and	|O
related	|O
products	|O
.	|O

Because	|O
the	|O
adrenergic	|O
nervous	|O
system	|O
influences	|O
cardiac	|O
arrhythmias	|O
and	|O
myocardial	|O
infarction	|O
can	|O
directly	|O
affect	|O
sympathetic	|O
innervation	|O
in	|O
the	|O
heart	|O
,	|O
we	|O
investigated	|O
the	|O
role	|O
of	|O
the	|O
sympathetic	|O
nervous	|O
system	|O
on	|O
reentry	|O
in	|O
the	|O
canine	|O
heart	|O
4	|O
days	|O
after	|O
infarction	|O
.	|O

DESIGN	|O
:	|O
Serum	|O
aldosterone	|O
and	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
were	|O
measured	|O
supine	|O
prior	|O
to	|O
and	|O
60	|O
,	|O
90	|O
,	|O
120	|O
minutes	|O
after	|O
oral	|O
captopril	|O
,	|O
25	|O
mg	|O
.	|O

Furthermore	|O
,	|O
no	|O
transcripts	|O
of	|O
the	|O
same	|O
size	|O
and	|O
having	|O
the	|O
same	|O
developmental	|O
profile	|O
as	|O
those	|O
generated	|O
by	|O
the	|O
wild	|O
-	|O
type	|O
E10	|B-PROTEIN
fragment	|O
were	|O
identified	|O
by	|O
probes	|O
covering	|O
the	|O
remainder	|O
of	|O
the	|O
cloned	|O
region	|O
.	|O

Intravenous	|O
amine	|O
pressor	|O
tests	|O
in	|O
healthy	|O
volunteers	|O
.	|O

The	|O
mean	|O
minimum	|O
steady	|O
-	|O
state	|O
concentration	|O
after	|O
the	|O
oral	|O
regimen	|O
(	|O
23	|O
micrograms.l	|O
-	|O
1	|O
)	|O
was	|O
78%	|O
of	|O
that	|O
after	|O
the	|O
intramuscular	|O
regime	|O
(	|O
29	|O
micrograms.l	|O
-	|O
1	|O
)	|O
.	|O

In	|O
an	|O
ongoing	|O
study	|O
the	|O
performance	|O
of	|O
the	|O
SMSP	|O
is	|O
being	|O
compared	|O
with	|O
that	|O
of	|O
the	|O
Mini	|O
Speech	|O
Processor	|O
(	|O
MSP	|O
)	|O
.	|O

Both	|O
parents	|O
are	|O
clinically	|O
normal	|O
and	|O
unrelated	|O
.	|O

These	|O
mutant	|O
proteins	|O
retained	|O
the	|O
ability	|O
to	|O
competitively	|O
inhibit	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
-	|O
mediated	|O
transcriptional	|O
activation	|O
of	|O
the	|O
human	|B-PROTEIN
immunodeficiency	|I-PROTEIN
virus	|I-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeat	|I-PROTEIN
but	|O
failed	|O
to	|O
efficiently	|O
transform	|O
chicken	|O
lymphoid	|O
cells	|O
both	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

The	|O
sequence	|O
-	|O
specific	|O
interaction	|O
of	|O
nuclear	|O
factor	|O
HiNF	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
with	|O
this	|O
key	|O
proximal	|O
promoter	|O
element	|O
of	|O
the	|O
H4	|B-PROTEIN
-	|I-PROTEIN
FO108	|I-PROTEIN
gene	|O
is	|O
cell	|O
cycle	|O
regulated	|O
in	|O
normal	|O
diploid	|O
cells	|O
(	|O
J.	|O

In	|O
conclusion	|O
,	|O
to	|O
study	|O
and	|O
overcome	|O
TI	|O
region	|O
-	|O
based	|O
expression	|O
problems	|O
it	|O
is	|O
worthwhile	|O
to	|O
start	|O
out	|O
with	|O
a	|O
versatile	|O
vector	|O
containing	|O
exhaustive	|O
mutations	|O
in	|O
the	|O
periShine	|O
-	|O
Dalgarno	|O
sequences	|O
;	|O
as	|O
a	|O
rule	|O
the	|O
coding	|O
MTI	|O
subregion	|O
can	|O
be	|O
kept	|O
unchanged	|O
.	|O

Four	|O
of	|O
these	|O
five	|O
subjects	|O
also	|O
performed	|O
mixed	|O
sequences	|O
under	|O
conditional	|O
control	|O
of	|O
the	|O
words	|O
(	|O
e.g.	|O
,	|O
A1	|O
-	|O
-	|O
-	|O
-	|O
B2	|O
-	|O
-	|O
-	|O
-	|O
A3	|O
-	|O
-	|O
-	|O
-	|O
B4	|O
-	|O
-	|O
-	|O
-	|O
A5	|O
and	|O
its	|O
reversal	|O
)	|O
,	|O
verifying	|O
that	|O
the	|O
stimuli	|O
which	|O
occupied	|O
the	|O
same	|O
position	|O
in	|O
each	|O
sequence	|O
were	|O
members	|O
of	|O
the	|O
same	|O
class	|O
.	|O

UF	|O
-	|O
021	|O
ophthalmic	|O
solution	|O
(	|O
0.03	|O
to	|O
0.24%	|O
)	|O
,	|O
when	|O
topically	|O
applied	|O
to	|O
the	|O
eyes	|O
of	|O
rabbits	|O
,	|O
caused	|O
dose	|O
-	|O
dependent	|O
IOP	|O
reduction	|O
(	|O
2.8	|O
to	|O
5.2	|O
mmHg	|O
)	|O
,	|O
without	|O
transient	|O
IOP	|O
rise	|O
.	|O

While	|O
blood	|O
pressure	|O
and	|O
noradrenergic	|O
activity	|O
,	|O
assessed	|O
as	|O
changes	|O
in	|O
the	|O
plasma	|O
levels	|O
and	|O
urinary	|O
excretion	|O
of	|O
norepinephrine	|O
,	|O
remained	|O
unaffected	|O
in	|O
the	|O
Pl	|O
group	|O
,	|O
a	|O
significant	|O
drop	|O
in	|O
the	|O
supine	|O
systolic	|O
and	|O
diastolic	|O
blood	|O
pressures	|O
,	|O
as	|O
well	|O
as	|O
in	|O
the	|O
resting	|O
venous	|O
norepinephrine	|O
level	|O
and	|O
in	|O
urinary	|O
norepinephrine	|O
excretion	|O
was	|O
found	|O
after	|O
the	|O
first	|O
month	|O
of	|O
dF	|O
administration	|O
.	|O

Wild	|O
-	|O
type	|O
protein	|O
bound	|O
azido	|O
-	|O
ATP	|O
well	|O
,	|O
but	|O
mutants	|O
with	|O
substitutions	|O
in	|O
the	|O
consensus	|O
amino	|O
acids	|O
were	|O
unable	|O
to	|O
bind	|O
azido	|O
-	|O
ATP	|O
.	|O

Therefore	|O
,	|O
with	|O
a	|O
biopsy	|O
from	|O
the	|O
stoma	|O
site	|O
there	|O
is	|O
a	|O
risk	|O
of	|O
missing	|O
early	|O
rejection	|O
.	|O

Whole	|O
blood	|O
serotonin	|O
levels	|O
were	|O
investigated	|O
in	|O
a	|O
control	|O
group	|O
(	|O
n	|O
=	|O
35	|O
)	|O
and	|O
in	|O
a	|O
group	|O
of	|O
chronic	|O
renal	|O
failure	|O
patients	|O
(	|O
n	|O
=	|O
127	|O
)	|O
on	|O
various	|O
treatment	|O
regimen	|O
i.e.	|O
conservative	|O
treatment	|O
(	|O
n	|O
=	|O
39	|O
)	|O
,	|O
maintenance	|O
haemodialysis	|O
(	|O
n	|O
=	|O
35	|O
)	|O
and	|O
after	|O
renal	|O
transplantation	|O
(	|O
n	|O
=	|O
53	|O
)	|O
.	|O

Tissues	|O
and	|O
exudates	|O
contain	|O
sufficient	|O
thymidine	|O
for	|O
growth	|O
of	|O
anaerobic	|O
bacteria	|O
in	|O
the	|O
presence	|O
of	|O
inhibitory	|O
levels	|O
of	|O
trimethoprim	|O
-	|O
sulfamethoxazole	|O
.	|O

The	|O
homologies	|O
between	|O
RAD16	|B-PROTEIN
,	|O
RAD54	|B-PROTEIN
and	|O
SNF2	|B-PROTEIN
are	|O
also	|O
shared	|O
by	|O
several	|O
additional	|O
,	|O
recently	|O
isolated	|O
yeast	|O
and	|O
Drosophila	|O
genes	|O
.	|O

But	|O
the	|O
application	|O
solutions	|O
of	|O
instrument	|O
disinfectants	|O
should	|O
not	|O
be	|O
used	|O
longer	|O
than	|O
one	|O
day	|O
.	|O

In	|O
the	|O
Rett	|O
syndrome	|O
we	|O
,	|O
therefore	|O
,	|O
suspect	|O
there	|O
are	|O
disturbances	|O
in	|O
the	|O
brain	|O
stem	|O
functions	|O
especially	|O
in	|O
the	|O
ascending	|O
reticular	|O
activating	|O
system	|O
which	|O
is	|O
related	|O
to	|O
elevation	|O
of	|O
the	|O
conscious	|O
level	|O
.	|O

In	|O
a	|O
similar	|O
experiment	|O
,	|O
simultaneous	|O
nitrofurazone	|O
administration	|O
and	|O
S.	|O
enteritidis	|O
challenge	|O
resulted	|O
in	|O
no	|O
significant	|O
differences	|O
in	|O
S.	|O
enteritidis	|O
isolation	|O
frequency	|O
.	|O

In	|O
agreement	|O
with	|O
this	|O
southern	|O
blotting	|O
of	|O
mouse	|O
DNA	|O
with	|O
SmN	|B-PROTEIN
probes	|O
reveals	|O
bands	|O
,	|O
additional	|O
to	|O
those	|O
derived	|O
from	|O
the	|O
pseudogene	|O
,	|O
which	|O
are	|O
characteristic	|O
of	|O
an	|O
intron	|O
-	|O
containing	|O
SmN	|B-PROTEIN
gene	|O
.	|O

Two	|O
cDNAs	|O
encoding	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
have	|O
been	|O
isolated	|O
from	|O
a	|O
yeast	|O
cDNA	|O
library	|O
and	|O
termed	|O
CKI1	|B-PROTEIN
and	|O
CKI2	|B-PROTEIN
.	|O

Incidence	|O
rate	|O
ranging	|O
between	|O
122/100,000	|O
/	|O
year	|O
and	|O
190/100,000	|O
/	|O
year	|O
were	|O
found	|O
(	|O
minimum	|O
,	|O
estimated	|O
and	|O
raw	|O
datasets	|O
)	|O
.	|O

The	|O
observed	|O
sequence	|O
variation	|O
disrupts	|O
the	|O
first	|O
ORF	|O
in	|O
many	|O
Y'	|B-PROTEIN
s	|I-PROTEIN
while	|O
most	|O
of	|O
the	|O
second	|O
ORF	|O
including	|O
the	|O
putative	|O
helicase	|B-PROTEIN
region	|O
is	|O
unaffected	|O
.	|O

The	|O
final	|O
screening	|O
yielded	|O
a	|O
clone	|O
containing	|O
a	|O
2	|O
kilobase	|O
(	|O
kb	|O
)	|O
insert	|O
.	|O

Lesions	|O
were	|O
made	|O
by	|O
pressure	|O
injection	|O
of	|O
kainic	|O
acid	|O
into	|O
the	|O
SOC	|O
through	|O
a	|O
stereotaxically	|O
positioned	|O
glass	|O
micropipette	|O
.	|O

A	|O
38	|O
-	|O
bp	|O
poly	|O
(	|O
dA	|O
-	|O
dT	|O
)	|O
region	|O
was	|O
found	|O
to	|O
be	|O
a	|O
positive	|O
regulator	|O
of	|O
Act1	|B-PROTEIN
promoter	|O
activity	|O
.	|O

We	|O
identified	|O
a	|O
protein	|O
,	|O
termed	|O
NFIL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
A	|I-PROTEIN
(	|O
NF	|B-PROTEIN
beta	|I-PROTEIN
A	|I-PROTEIN
)	|O
,	|O
that	|O
binds	|O
to	|O
a	|O
highly	|O
conserved	|O
12	|O
-	|O
bp	|O
DNA	|O
sequence	|O
(	|O
-	|O
49	|O
to	|O
-	|O
38	|O
)	|O
located	|O
upstream	|O
of	|O
the	|O
TATA	|O
box	|O
motif	|O
in	|O
both	|O
the	|O
human	|O
and	|O
murine	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
genes	|O
.	|O

We	|O
tried	|O
amphotericin	|O
B	|O
(	|O
AmB	|O
)	|O
,	|O
and	|O
remission	|O
of	|O
the	|O
tumor	|O
was	|O
obtained	|O
.	|O

Cutis	|O
aplasia	|O
.	|O

The	|O
DRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
nuclear	|O
protein	|O
has	|O
characteristics	|O
similar	|O
to	|O
those	|O
of	|O
the	|O
muscle	|O
-	|O
specific	|O
regulatory	|O
factor	|O
,	|O
MEF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
Buskin	|O
and	|O
Hauschka	|O
1989	|O
;	|O
Gossett	|O
et	|O
al.	|O
,	|O
1989	|O
)	|O
.	|O

From	|O
the	|O
15	|O
-	|O
kb	|O
clone	|O
a	|O
4	|O
-	|O
kb	|O
EcoRI	|B-PROTEIN
fragment	|O
containing	|O
the	|O
first	|O
two	|O
exons	|O
and	|O
2.6	|O
kb	|O
of	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
opn	|B-PROTEIN
gene	|O
was	|O
sequenced	|O
,	|O
and	|O
the	|O
transcriptional	|O
start	|O
site	|O
determined	|O
by	|O
primer	|O
extension	|O
analysis	|O
and	|O
S1	|B-PROTEIN
nuclease	|O
mapping	|O
.	|O

Cardiovascular	|O
risk	|O
factors	|O
were	|O
measured	|O
by	|O
standardized	|O
techniques	|O
.	|O

Production	|O
costs	|O
included	|O
feed	|O
,	|O
non	|O
-	|O
feed	|O
operating	|O
,	|O
fixed	|O
,	|O
and	|O
replacement	|O
stock	|O
costs	|O
.	|O

We	|O
report	|O
a	|O
patient	|O
developing	|O
factor	|B-PROTEIN
VII	|I-PROTEIN
inhibitor	|O
possibly	|O
as	|O
a	|O
reaction	|O
to	|O
penicillin	|O
administration	|O
;	|O
it	|O
gave	|O
rise	|O
to	|O
fatal	|O
haemorrhage	|O
.	|O

This	|O
is	|O
in	|O
contrast	|O
with	|O
the	|O
classical	|O
'	|O
oxygen	|O
debt	|O
hypothesis	|O
'	|O
,	|O
which	|O
states	|O
that	|O
the	|O
oxygen	|O
debt	|O
and	|O
lactate	|O
clearance	|O
are	|O
linked	|O
.	|O

Account	|O
was	|O
taken	|O
of	|O
noncellular	|O
and	|O
nonhuman	|O
elements	|O
in	|O
the	|O
smears	|O
;	|O
they	|O
included	|O
mucus	|O
,	|O
Charcot	|O
-	|O
Layden	|O
crystals	|O
,	|O
pollen	|O
grains	|O
,	|O
vegetal	|O
fragments	|O
and	|O
fungi	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
the	|O
carbon	|O
-	|O
perfused	|O
areas	|O
and	|O
MBF	|O
in	|O
the	|O
liver	|O
,	|O
renal	|O
cortex	|O
,	|O
spleen	|O
,	|O
and	|O
small	|O
intestinal	|O
serosa	|O
(	|O
only	|O
MBF	|O
)	|O
increased	|O
significantly	|O
5	|O
h	|O
after	|O
CLP	|O
.	|O

In	|O
addition	|O
a	|O
greater	|O
proportion	|O
of	|O
women	|O
in	|O
the	|O
sweeping	|O
group	|O
had	|O
a	|O
cervical	|O
dilatation	|O
of	|O
4	|O
cm	|O
or	|O
more	|O
at	|O
the	|O
first	|O
vaginal	|O
examination	|O
in	|O
the	|O
labour	|O
ward	|O
(	|O
16/33	|O
(	|O
49%	|O
)	|O
vs	|O
5/32	|O
(	|O
16%	|O
)	|O
;	|O
OR	|O
4.39	|O
;	|O
95%	|O
CI	|O
1.56	|O
to	|O
12.32	|O
;	|O
P	|O
=	|O
0.005	|O
)	|O
.	|O

Lewis	|O
,	|O
N.	|O

A	|O
control	|O
group	|O
of	|O
nine	|O
women	|O
(	|O
age	|O
23-40	|O
years	|O
)	|O
on	|O
oral	|O
contraceptives	|O
(	|O
Nordette	|O
-	|O
28	|O
)	|O
was	|O
also	|O
studied	|O
four	|O
times	|O
during	|O
a	|O
pill	|O
cycle	|O
.	|O

This	|O
accurate	|O
and	|O
rapid	|O
method	|O
makes	|O
the	|O
MLPA	|O
test	|O
logistically	|O
feasible	|O
for	|O
large	|O
-	|O
scale	|O
screening	|O
.	|O

The	|O
modalities	|O
for	|O
using	|O
reference	|O
values	|O
for	|O
individual	|O
subjects	|O
as	|O
well	|O
as	|O
for	|O
groups	|O
are	|O
then	|O
discussed	|O
and	|O
the	|O
main	|O
points	|O
of	|O
research	|O
which	|O
must	|O
be	|O
faced	|O
in	|O
the	|O
near	|O
future	|O
regarding	|O
reference	|O
values	|O
are	|O
highlighted	|O
.	|O

The	|O
clinical	|O
application	|O
of	|O
the	|O
antibody	|O
-	|O
targeted	|O
Phthalocyanine	|O
was	|O
performed	|O
in	|O
3	|O
patients	|O
suffering	|O
from	|O
an	|O
advanced	|O
ovarian	|O
carcinoma	|O
(	|O
FIGO	|O
III	|O
)	|O
.	|O

We	|O
found	|O
that	|O
lung	|O
cancer	|O
tissues	|O
of	|O
positive	|O
67Ga	|O
scan	|O
expressed	|O
TFR	|B-PROTEIN
,	|O
but	|O
those	|O
of	|O
a	|O
negative	|O
scan	|O
did	|O
not	|O
.	|O

This	|O
open	|O
reading	|O
frame	|O
was	|O
confirmed	|O
the	|O
correct	|O
one	|O
by	|O
direct	|O
amino	|O
-	|O
terminal	|O
sequence	|O
analysis	|O
of	|O
the	|O
overproduced	|O
msgB	|B-PROTEIN
gene	|O
product	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
purified	|O
and	|O
characterized	|O
the	|O
recombinant	|O
furin	|B-PROTEIN
from	|O
the	|O
conditioned	|O
medium	|O
of	|O
these	|O
cells	|O
.	|O

The	|O
virus	|O
encodes	|O
a	|O
40	|O
-	|O
kDa	|O
protein	|O
,	|O
tax	|B-PROTEIN
,	|O
that	|O
is	|O
important	|O
for	|O
the	|O
immortalization	|O
of	|O
T	|O
cells	|O
.	|O

However	|O
,	|O
butyrate	|O
was	|O
at	|O
least	|O
2	|O
-	|O
fold	|O
more	|O
effective	|O
in	|O
stimulating	|O
CAT	|B-PROTEIN
activity	|O
of	|O
fusion	|O
genes	|O
containing	|O
upstream	|O
sequences	|O
(	|O
-	|O
834	|O
to	|O
-	|O
576	|O
)	|O
than	|O
those	|O
containing	|O
proximal	|O
sequences	|O
(	|O
-	|O
456	|O
to	|O
-	|O
172	|O
)	|O
,	|O
suggesting	|O
two	|O
regions	|O
in	|O
the	|O
PSG1	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
gene	|O
that	|O
mediate	|O
the	|O
butyrate	|O
response	|O
.	|O

An	|O
examination	|O
of	|O
the	|O
role	|O
of	|O
the	|O
carboxyl	|O
terminus	|O
in	|O
regulating	|O
NGFI	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
transcriptional	|O
activity	|O
revealed	|O
that	|O
,	|O
in	|O
accordance	|O
with	|O
other	|O
nuclear	|O
receptors	|O
,	|O
mutants	|O
lacking	|O
portions	|O
of	|O
the	|O
carboxyl	|O
terminus	|O
had	|O
greatly	|O
decreased	|O
activity	|O
.	|O

Altogether	|O
these	|O
results	|O
indicate	|O
that	|O
the	|O
Syn	|B-PROTEIN
5	|I-PROTEIN
locus	|O
segregates	|O
from	|O
the	|O
gene	|O
specifying	|O
gH	|B-PROTEIN
,	|O
to	|O
a	|O
region	|O
encompassing	|O
portions	|O
of	|O
the	|O
TK	|B-PROTEIN
and	|O
UL	|B-PROTEIN
24	|I-PROTEIN
genes	|O
,	|O
and	|O
that	|O
the	|O
syn	|B-PROTEIN
mutation	|O
does	|O
not	|O
affect	|O
the	|O
expression	|O
or	|O
activity	|O
of	|O
TK	|B-PROTEIN
.	|O

Nucleoprotein	|O
(	|O
N	|O
)	|O
expressed	|O
by	|O
both	|O
recombinant	|O
vaccinia	|O
virus	|O
and	|O
TGEV	|O
had	|O
a	|O
relative	|O
molecular	|O
mass	|O
(	|O
Mr	|O
)	|O
of	|O
47,000	|O
and	|O
was	|O
susceptible	|O
to	|O
degradation	|O
at	|O
the	|O
C	|O
-	|O
terminus	|O
yielding	|O
discrete	|O
breakdown	|O
products	|O
.	|O

Recently	|O
,	|O
the	|O
3.6	|O
-	|O
kb	|O
full	|O
-	|O
length	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
GalNAc	|I-PROTEIN
cDNA	|O
sequence	|O
was	|O
isolated	|O
and	|O
found	|O
to	|O
have	|O
remarkable	|O
nucleotide	|O
and	|O
predicted	|O
amino	|O
acid	|O
homology	|O
(	|O
55.8	|O
and	|O
46.9%	|O
,	|O
respectively	|O
)	|O
with	|O
the	|O
human	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
A	|I-PROTEIN
(	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
Gal	|I-PROTEIN
A	|I-PROTEIN
)	|O
cDNA	|O
.	|O

Patients	|O
with	|O
an	|O
enzymatic	|O
activity	|O
below	|O
X	|O
-	|O
-	|O
1	|O
manifested	|O
a	|O
decrease	|O
of	|O
the	|O
content	|O
of	|O
IgA	|B-PROTEIN
,	|O
IgG	|B-PROTEIN
,	|O
IgM	|B-PROTEIN
,	|O
T	|O
and	|O
B	|O
lymphocytes	|O
,	|O
and	|O
of	|O
phagocytic	|O
activity	|O
of	|O
neutrophils	|O
as	|O
compared	|O
to	|O
patients	|O
exhibiting	|O
a	|O
high	|O
enzymatic	|O
activity	|O
.	|O

The	|O
reason	|O
that	|O
nitrous	|O
oxide	|O
does	|O
not	|O
produce	|O
hydroxyl	|O
radicals	|O
readily	|O
might	|O
be	|O
that	|O
the	|O
one	|O
-	|O
electron	|O
reduction	|O
proceeds	|O
through	|O
an	|O
N2O	|O
-	|O
intermediate	|O
which	|O
is	|O
energetically	|O
very	|O
unfavourable	|O
:	|O
EO	|O
(	|O
N2O	|O
/	|O
N2O	|O
-	|O
)	|O
=	|O
-	|O
1.1	|O
V.	|O

All	|O
mutant	|O
JCV	|O
T	|B-PROTEIN
antigens	|I-PROTEIN
bound	|O
to	|O
JCV	|O
and	|O
SV40	|O
origins	|O
of	|O
DNA	|O
replication	|O
.	|O

The	|O
relation	|O
between	|O
myocardial	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptor	|I-PROTEIN
and	|O
left	|O
ventricular	|O
(	|O
LV	|O
)	|O
function	|O
was	|O
studied	|O
in	|O
10	|O
patients	|O
,	|O
aged	|O
41	|O
to	|O
61	|O
years	|O
(	|O
average	|O
51	|O
)	|O
,	|O
with	|O
LV	|O
volume	|O
overload	|O
mainly	|O
due	|O
to	|O
chronic	|O
mitral	|O
regurgitation	|O
.	|O

Since	|O
each	|O
transcript	|O
appears	|O
to	|O
encode	|O
the	|O
same	|O
protein	|O
,	|O
this	|O
complexity	|O
may	|O
reflect	|O
the	|O
need	|O
for	|O
lineage	|O
-	|O
specific	|O
or	|O
differentiation	|O
-	|O
dependent	|O
control	|O
of	|O
expression	|O
.	|O

In	|O
patients	|O
with	|O
limited	|O
disease	|O
,	|O
the	|O
survival	|O
in	|O
the	|O
alternating	|O
arm	|O
was	|O
significantly	|O
superior	|O
to	|O
the	|O
survival	|O
in	|O
the	|O
CAV	|O
arm	|O
(	|O
P	|O
=	|O
.014	|O
)	|O
or	|O
the	|O
survival	|O
in	|O
the	|O
PE	|O
arm	|O
(	|O
P	|O
=	|O
.023	|O
)	|O
.	|O

We	|O
identify	|O
the	|O
"	|O
M	|O
region	|O
"	|O
of	|O
the	|O
muscle	|O
-	|O
specific	|O
Xenopus	|O
cardiac	|O
actin	|B-PROTEIN
gene	|I-PROTEIN
promoter	|O
from	|O
-	|O
282	|O
to	|O
-	|O
348	|O
as	|O
necessary	|O
for	|O
the	|O
embryonic	|O
expression	|O
of	|O
a	|O
cardiac	|O
actin	|B-PROTEIN
-	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
reporter	|O
gene	|O
injected	|O
into	|O
fertilized	|O
eggs	|O
.	|O

In	|O
addition	|O
to	|O
the	|O
previously	|O
identified	|O
and	|O
characterized	|O
attenuator	|B-PROTEIN
1	|I-PROTEIN
situated	|O
93	|O
nucleotides	|O
downstream	|O
from	|O
the	|O
major	|O
late	|O
transcription	|O
start	|O
site	|O
,	|O
a	|O
second	|O
attenuator	|O
,	|O
attenuator	|B-PROTEIN
2	|I-PROTEIN
,	|O
situated	|O
55	|O
nucleotides	|O
downstream	|O
from	|O
it	|O
,	|O
has	|O
been	|O
identified	|O
.	|O

EBNA	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
the	|O
cis	|O
-	|O
acting	|O
CD23	|B-PROTEIN
element	|O
increased	|O
TK	|B-PROTEIN
-	|O
promoted	|O
mRNA	|O
and	|O
did	|O
not	|O
alter	|O
the	|O
herpes	|O
simplex	|O
virus	|O
TK	|B-PROTEIN
promoter	|O
transcription	|O
start	|O
site	|O
.	|O

These	|O
experiments	|O
delineate	|O
a	|O
186	|O
-	|O
bp	|O
,	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
responsive	|O
cell	|O
DNA	|O
fragment	|O
and	|O
provide	|O
firm	|O
evidence	|O
that	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
transactivates	|O
transcription	|O
of	|O
cell	|O
genes	|O
.	|O

Plasma	|O
vitamin	|O
E	|O
,	|O
total	|O
lipids	|O
and	|O
myeloperoxidase	|B-PROTEIN
levels	|O
during	|O
spinal	|O
surgery	|O
.	|O

Transfecting	|O
the	|O
cloned	|O
bovine	|O
PBR	|B-PROTEIN
/	|O
IBP	|B-PROTEIN
cDNA	|O
into	|O
COS	|O
-	|O
7	|O
cells	|O
resulted	|O
in	|O
an	|O
11	|O
-	|O
fold	|O
increase	|O
in	|O
the	|O
density	|O
of	|O
high	|O
affinity	|O
[	|O
3H	|O
]	|O
PK	|O
11195	|O
binding	|O
sites	|O
which	|O
had	|O
only	|O
low	|O
affinity	|O
for	|O
Ro5	|O
-	|O
4864	|O
.	|O

The	|O
initial	|O
phase	|O
of	|O
increased	|O
vascular	|O
permeability	|O
in	|O
the	|O
peritoneal	|O
cavity	|O
and	|O
LTB4	|O
production	|O
was	|O
dose	|O
dependently	|O
inhibited	|O
by	|O
the	|O
5	|O
-	|O
LO	|O
inhibitors	|O
phenidone	|O
,	|O
BW	|O
A4C	|O
,	|O
A63162	|O
,	|O
and	|O
ICI	|O
207	|O
968	|O
but	|O
not	|O
by	|O
dexamethasone	|O
or	|O
colchicine	|O
.	|O

Discrepant	|O
results	|O
with	|O
a	|O
latex	|O
agglutination	|O
test	|O
in	|O
the	|O
assessment	|O
of	|O
cytomegalovirus	|O
antibody	|O
status	|O
of	|O
cardiac	|O
transplant	|O
donors	|O
.	|O

Each	|O
mRNA	|O
contained	|O
five	|O
or	|O
six	|O
internal	|O
uridine	|O
residues	|O
,	|O
which	|O
were	|O
transcribed	|O
using	|O
a	|O
mixture	|O
of	|O
UTP	|O
and	|O
thio	|O
-	|O
UTP	|O
.	|O

We	|O
have	|O
isolated	|O
and	|O
sequenced	|O
two	|O
overlapping	|O
cDNA	|O
fragments	|O
which	|O
could	|O
encode	|O
the	|O
complete	|O
amino	|O
acid	|O
sequence	|O
of	|O
rat	|O
testis	|B-PROTEIN
fructose	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
:	|O
fructose	|B-PROTEIN
-	|I-PROTEIN
2,6	|I-PROTEIN
-	|I-PROTEIN
bisphosphatase	|I-PROTEIN
.	|O

We	|O
have	|O
identified	|O
SWI5	|B-PROTEIN
's	|O
nuclear	|O
localization	|O
signal	|O
(	|O
NLS	|O
)	|O
and	|O
show	|O
that	|O
it	|O
can	|O
confer	|O
cell	|O
cycle	|O
-	|O
dependent	|O
nuclear	|O
entry	|O
to	|O
a	|O
heterologous	|O
protein	|O
.	|O

In	|O
contrast	|O
to	|O
behavioral	|O
deviation	|O
(	|O
the	|O
avoidance	|O
conditioning	|O
lost	|O
)	|O
,	|O
the	|O
haloperidol	|O
intrastriatal	|O
microinjections	|O
did	|O
not	|O
affect	|O
the	|O
DA	|O
synaptic	|O
level	|O
in	|O
rostral	|O
neostriatum	|O
.	|O

In	|O
similar	|O
transient	|O
transfection	|O
experiments	|O
in	|O
HeLa	|O
cells	|O
,	|O
overexpression	|O
of	|O
the	|O
wt	|O
human	|O
retinoblastoma	|B-PROTEIN
susceptibility	|I-PROTEIN
gene	|I-PROTEIN
product	|O
,	|O
RB	|B-PROTEIN
,	|O
was	|O
found	|O
to	|O
repress	|O
the	|O
serum	|O
-	|O
induced	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
-	|O
225	|O
to	|O
+	|O
13	|O
)	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
(	|O
-	|O
711	|O
to	|O
+	|O
42	|O
)	|O
,	|O
and	|O
beta	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
(	|O
-	|O
3400	|O
to	|O
+	|O
912	|O
)	|O
promoters	|O
but	|O
not	|O
the	|O
PRV	|O
-	|O
induced	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
-	|O
110	|O
to	|O
+	|O
13	|O
)	|O
or	|O
the	|O
serum	|O
-	|O
induced	|O
MHC	|B-PROTEIN
(	|O
-	|O
528	|O
to	|O
-	|O
38	|O
)	|O
promoters	|O
.	|O

This	|O
repression	|O
was	|O
mediated	|O
through	|O
binding	|O
to	|O
the	|O
E2	|B-PROTEIN
DNA	|O
-	|O
binding	|O
site	|O
immediately	|O
upstream	|O
of	|O
the	|O
P105	|B-PROTEIN
promoter	|O
TATA	|O
box	|O
and	|O
could	|O
be	|O
abrogated	|O
by	|O
preincubation	|O
of	|O
the	|O
HPV	|O
-	|O
18	|O
P105	|B-PROTEIN
promoter	|O
template	|O
with	|O
the	|O
nuclear	|O
extract	|O
allowing	|O
the	|O
formation	|O
of	|O
the	|O
preinitiation	|O
complex	|O
.	|O

We	|O
did	|O
not	|O
detect	|O
p50	|B-PROTEIN
in	|O
association	|O
with	|O
native	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
in	|O
L	|O
cells	|O
or	|O
with	|O
the	|O
overexpressed	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
in	|O
Chinese	|O
hamster	|O
ovary	|O
cells	|O
.	|O

Two	|O
putative	|O
12	|O
-	|O
O	|O
-	|O
tetradecanoyl	|O
-	|O
phorbol	|O
-	|O
13	|O
-	|O
acetate	|O
(	|O
TPA	|O
)	|O
response	|O
elements	|O
,	|O
that	|O
might	|O
serve	|O
as	|O
binding	|O
sites	|O
for	|O
the	|O
transcription	|O
factor	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
a	|O
consensus	|O
sequence	|O
of	|O
a	|O
transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
(	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
)	|O
inhibitory	|O
element	|O
were	|O
found	|O
in	|O
the	|O
promoter	|O
region	|O
.	|O

TPA	|O
and	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
did	|O
not	|O
markedly	|O
affect	|O
the	|O
activities	|O
of	|O
the	|O
72	|O
-	|O
kDa	|O
enzyme	|O
.	|O

They	|O
were	|O
almost	|O
regularly	|O
excited	|O
by	|O
pressure	|O
to	|O
the	|O
ipsilateral	|O
cornea	|O
or	|O
to	|O
both	|O
corneas	|O
at	|O
a	|O
strength	|O
well	|O
above	|O
the	|O
human	|O
corneal	|O
pain	|O
threshold	|O
.	|O

Feed	|O
intake	|O
was	|O
not	|O
affected	|O
by	|O
dietary	|O
KCl	|O
or	|O
NaHCO3	|O
supplementation	|O
,	|O
but	|O
average	|O
daily	|O
gain	|O
increased	|O
with	|O
increased	|O
K	|O
and	|O
tended	|O
to	|O
be	|O
reduced	|O
by	|O
dietary	|O
NaHCO3	|O
.	|O

Extraction	|O
procedure	|O
for	|O
the	|O
measurement	|O
of	|O
butyltin	|O
compounds	|O
in	|O
biological	|O
tissues	|O
using	|O
toluene	|O
,	|O
HBr	|O
,	|O
and	|O
tropolone	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
have	|O
cloned	|O
a	|O
region	|O
that	|O
complements	|O
the	|O
exoenzyme	|B-PROTEIN
S	|B-PROTEIN
-	|O
deficient	|O
phenotype	|O
of	|O
strain	|O
388	|O
exs1	|B-PROTEIN
::	|O
Tn1	|B-PROTEIN
,	|O
a	|O
chromosomal	|O
Tn1	|B-PROTEIN
insertional	|O
mutation	|O
.	|O

axl	|O
,	|O
a	|O
transforming	|O
gene	|O
isolated	|O
from	|O
primary	|O
human	|O
myeloid	|O
leukemia	|O
cells	|O
,	|O
encodes	|O
a	|O
novel	|O
receptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Alignment	|O
of	|O
the	|O
amino	|O
acid	|O
sequences	|O
surrounding	|O
Tyr	|O
-	|O
766	|O
with	|O
corresponding	|O
regions	|O
of	|O
other	|O
FGFRs	|B-PROTEIN
revealed	|O
conserved	|O
tyrosine	|O
residues	|O
in	|O
all	|O
known	|O
members	|O
of	|O
the	|O
FGFR	|B-PROTEIN
family	|O
.	|O

The	|O
single	|O
most	|O
important	|O
element	|O
,	|O
by	|O
linker	|O
-	|O
scanning	|O
analysis	|O
,	|O
is	|O
a	|O
10	|O
-	|O
bp	|O
region	|O
that	|O
contains	|O
a	|O
CCAAT	|O
motif	|O
.	|O

Capnography	|O
curves	|O
of	|O
40	|O
HVS	|O
patients	|O
,	|O
40	|O
non	|O
-	|O
HVS	|O
patients	|O
with	|O
psycho	|O
-	|O
somatic	|O
complaints	|O
and	|O
26	|O
healthy	|O
controls	|O
were	|O
analyzed	|O
.	|O

The	|O
transcription	|O
initiation	|O
site	|O
was	|O
determined	|O
to	|O
occur	|O
66	|O
bp	|O
upstream	|O
of	|O
the	|O
initiating	|O
Met	|O
.	|O

All	|O
anti	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
and	|O
anti	|B-PROTEIN
-	|I-PROTEIN
i	|I-PROTEIN
CA	|I-PROTEIN
were	|O
shown	|O
to	|O
express	|O
VH4	|B-PROTEIN
heavy	|I-PROTEIN
chains	|I-PROTEIN
,	|O
and	|O
14	|O
of	|O
17	|O
CA	|B-PROTEIN
expressed	|O
a	|O
previously	|O
described	|O
VH4	|B-PROTEIN
second	|O
hypervariable	|O
region	|O
determinant	|O
,	|O
termed	|O
VH4	|B-PROTEIN
-	|I-PROTEIN
HV2a	|I-PROTEIN
.	|O

Intron	|O
K1	|B-PROTEIN
cox1.2	|I-PROTEIN
is	|O
not	|O
found	|O
in	|O
S.	|O
cerevisiae	|O
and	|O
appears	|O
at	|O
an	|O
unique	|O
location	|O
in	|O
K.	|O
lactis	|O
.	|O

We	|O
have	|O
determined	|O
that	|O
the	|O
mutants	|O
define	|O
two	|O
complementation	|O
groups	|O
,	|O
designated	|O
cgs1+	|B-PROTEIN
and	|O
cgs2+	|B-PROTEIN
(	|O
continues	|O
to	|O
grow	|O
in	|O
stationary	|O
)	|O
.	|O

However	|O
,	|O
alterations	|O
in	|O
electrostatic	|O
and	|O
hydrophobic	|O
interactions	|O
created	|O
by	|O
the	|O
three	|O
amino	|O
acid	|O
substitutions	|O
prevent	|O
the	|O
conformational	|O
change	|O
in	|O
the	|O
enzyme	|O
usually	|O
produced	|O
by	|O
calmodulin	|B-PROTEIN
binding	|O
.	|O

The	|O
results	|O
of	|O
induced	|O
coexpression	|O
were	|O
also	|O
supported	|O
by	|O
rapid	|O
generation	|O
of	|O
FeLV	|O
recombinants	|O
when	|O
FeLV	|O
-	|O
C	|O
was	|O
used	|O
to	|O
infect	|O
the	|O
feline	|O
3201B	|O
cell	|O
line	|O
that	|O
constitutively	|O
expresses	|O
high	|O
levels	|O
of	|O
endogenous	|O
FeLV	|O
-	|O
specific	|O
mRNAs	|O
.	|O

Recombination	|O
between	|O
feline	|O
leukemia	|O
virus	|O
subgroup	|O
B	|O
or	|O
C	|O
and	|O
endogenous	|O
env	|B-PROTEIN
elements	|O
alters	|O
the	|O
in	|O
vitro	|O
biological	|O
activities	|O
of	|O
the	|O
viruses	|O
.	|O

The	|O
nucleotide	|O
sequences	|O
at	|O
the	|O
5'	|O
and	|O
3'	|O
ends	|O
of	|O
these	|O
introns	|O
are	|O
characteristic	|O
of	|O
spliced	|O
transcripts	|O
from	|O
eukaryotic	|O
protein	|O
-	|O
encoding	|O
genes	|O
,	|O
with	|O
one	|O
significant	|O
difference	|O
;	|O
i.e.	|O
,	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
LAT	|B-PROTEIN
intron	|O
is	|O
GC	|O
instead	|O
of	|O
the	|O
consensus	|O
sequence	|O
GT	|O
.	|O

At	|O
1	|O
,	|O
5	|O
,	|O
and	|O
9	|O
months	|O
after	|O
initial	|O
isolation	|O
of	|O
C.	|O
kutscheri	|O
from	|O
the	|O
oral	|O
cavity	|O
,	|O
hamsters	|O
were	|O
euthanatized	|O
,	|O
and	|O
attempts	|O
were	|O
made	|O
to	|O
culture	|O
C.	|O
kutscheri	|O
from	|O
13	|O
additional	|O
sites	|O
.	|O

The	|O
strategy	|O
has	|O
been	|O
used	|O
to	|O
determine	|O
2.6	|O
kilobases	|O
of	|O
nucleotide	|O
sequence	|O
in	|O
the	|O
Saccharomyces	|O
cerevisiae	|O
ADE	|B-PROTEIN
1	|I-PROTEIN
locus	|O
.	|O

Two	|O
independent	|O
promoters	|O
as	|O
well	|O
as	|O
5'	|O
untranslated	|O
regions	|O
regulate	|O
Dd	|O
ras	|B-PROTEIN
expression	|O
in	|O
Dictyostelium	|O
.	|O

The	|O
results	|O
suggested	|O
that	|O
,	|O
depending	|O
upon	|O
the	|O
cell	|O
type	|O
,	|O
gene	|O
cotransfer	|O
using	|O
aminoglycoside	|O
resistance	|O
as	|O
a	|O
selectable	|O
marker	|O
may	|O
seriously	|O
perturb	|O
important	|O
cellular	|O
control	|O
mechanisms	|O
such	|O
as	|O
the	|O
PKC	|B-PROTEIN
pathway	|O
leading	|O
to	|O
activation	|O
of	|O
gene	|O
expression	|O
.	|O

Transfer	|O
RNA	|O
genes	|O
from	|O
Dictyostelium	|O
discoideum	|O
are	|O
frequently	|O
associated	|O
with	|O
repetitive	|O
elements	|O
and	|O
contain	|O
consensus	|O
boxes	|O
in	|O
their	|O
5'	|O
and	|O
3'	|O
-	|O
flanking	|O
regions	|O
.	|O

Therefore	|O
,	|O
the	|O
strD	|B-PROTEIN
and	|O
strE	|B-PROTEIN
genes	|O
could	|O
serve	|O
as	|O
universal	|O
probes	|O
indicative	|O
of	|O
the	|O
presence	|O
of	|O
biosynthetic	|O
capacity	|O
for	|O
6	|O
-	|O
deoxyhexose	|O
moieties	|O
.	|O

The	|O
two	|O
genes	|O
code	|O
for	|O
polypeptides	|O
of	|O
420	|O
amino	|O
acids	|O
(	|O
M.H	|B-PROTEIN
giCI	|I-PROTEIN
)	|O
and	|O
345	|O
amino	|O
acids	|O
(	|O
R.H	|B-PROTEIN
giCI	|I-PROTEIN
)	|O
.	|O

Expression	|O
of	|O
the	|O
wt1	|B-PROTEIN
gene	|O
via	|O
transient	|O
transfection	|O
in	|O
COS	|O
-	|O
1	|O
cells	|O
revealed	|O
a	|O
52	|O
kDa	|O
protein	|O
which	|O
was	|O
immunoprecipitated	|O
by	|O
both	|O
the	|O
N	|O
-	|O
terminal	|O
-	|O
and	|O
C	|O
-	|O
terminal	|O
-	|O
specific	|O
antisera	|O
.	|O

The	|O
factor	|O
which	|O
binds	|O
to	|O
the	|O
TR	|B-PROTEIN
promoter	|O
co	|O
-	|O
sedimented	|O
with	|O
SV40	|O
chromosomes	|O
extracted	|O
late	|O
in	|O
infection	|O
.	|O

Temafloxacin	|O
400	|O
mg	|O
b.i.d	|O
.	|O
administered	|O
orally	|O
for	|O
28	|O
days	|O
represents	|O
a	|O
safe	|O
and	|O
effective	|O
treatment	|O
for	|O
chronic	|O
bacterial	|O
prostatitis	|O
.	|O

Its	|O
neuromuscular	|O
effects	|O
are	|O
similar	|O
to	|O
a	|O
single	|O
ED90	|O
dose	|O
of	|O
vecuronium	|O
.	|O

The	|O
patient	|O
with	|O
a	|O
prolonged	|O
fever	|O
caused	|O
by	|O
dissecting	|O
aneurysm	|O
of	|O
the	|O
aorta	|O
in	|O
whom	|O
pleuropneumonia	|O
masked	|O
the	|O
real	|O
diseases	|O
has	|O
been	|O
presented	|O
.	|O

The	|O
resulting	|O
clone	|O
pKB11	|B-PROTEIN
,	|O
which	|O
has	|O
a	|O
1369	|O
-	|O
base	|O
pair	|O
(	|O
bp	|O
)	|O
cDNA	|O
insert	|O
,	|O
overlapping	|O
pCAD142	|B-PROTEIN
by	|O
781	|O
bp	|O
,	|O
was	|O
identified	|O
by	|O
hybridization	|O
methods	|O
and	|O
sequence	|O
analysis	|O
and	|O
found	|O
to	|O
contain	|O
the	|O
entire	|O
cDNA	|O
sequence	|O
for	|O
the	|O
amino	|O
end	|O
of	|O
the	|O
CAD	|B-PROTEIN
polypeptide	|O
.	|O

This	|O
conclusion	|O
was	|O
confirmed	|O
by	|O
Northern	|O
blotting	|O
analysis	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
CAD	|B-PROTEIN
gene	|O
.	|O

We	|O
report	|O
the	|O
isolation	|O
of	|O
genomic	|O
and	|O
cDNA	|O
clones	|O
of	|O
the	|O
light	|O
-	|O
independent	|O
Sn	|B-PROTEIN
:	|O
bol3	|B-PROTEIN
allele	|O
.	|O

Histamine	|O
-	|O
2	|O
blockade	|O
in	|O
psoriasis	|O

Its	|O
clearance	|O
has	|O
been	|O
found	|O
to	|O
be	|O
decreased	|O
(	|O
typically	|O
by	|O
around	|O
25%	|O
,	|O
but	|O
often	|O
by	|O
far	|O
more	|O
)	|O
by	|O
erythromycin	|O
,	|O
troleandomycin	|O
(	|O
triacetyloleandomycin	|O
)	|O
,	|O
roxithromycin	|O
,	|O
enoxacin	|O
,	|O
ciprofloxacin	|O
,	|O
pefloxacin	|O
,	|O
norfloxacin	|O
,	|O
ofloxacin	|O
,	|O
fluoroquinolone	|O
T	|O
-	|O
3262	|O
,	|O
pipemidic	|O
acid	|O
,	|O
cimetidine	|O
,	|O
etintidine	|O
,	|O
propranolol	|O
,	|O
verapamil	|O
,	|O
diltiazem	|O
,	|O
nifedipine	|O
,	|O
furosemide	|O
(	|O
frusemide	|O
)	|O
,	|O
at	|O
least	|O
some	|O
anovulent	|O
agents	|O
,	|O
viloxazine	|O
,	|O
allopurinol	|O
,	|O
ticlopidine	|O
,	|O
idrocilamide	|O
,	|O
thiabendazole	|O
,	|O
disulfiram	|O
,	|O
influenza	|O
-	|O
and	|O
BCG	|O
-	|O
vaccination	|O
,	|O
interferon	|B-PROTEIN
,	|O
and	|O
caffeine	|O
(	|O
half	|O
-	|O
life	|O
increase	|O
)	|O
.	|O

A	|O
third	|O
is	|O
a	|O
partial	|O
element	|O
terminating	|O
at	|O
a	|O
probable	|O
internal	|O
restriction	|O
site	|O
used	|O
for	|O
cloning	|O
.	|O

We	|O
enrolled	|O
253	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
antibody	|I-PROTEIN
positive	|O
heroin	|O
addicts	|O
without	|O
HIV	|O
-	|O
related	|O
disease	|O
(	|O
n	|O
=	|O
81	|O
)	|O
or	|O
with	|O
persistent	|O
generalized	|O
lymphadenopathy	|O
(	|O
n	|O
=	|O
172	|O
)	|O
in	|O
a	|O
prospective	|O
study	|O
to	|O
evaluate	|O
clinical	|O
progression	|O
to	|O
AIDS	|O
related	|O
complex	|O
(	|O
ARC	|O
)	|O
or	|O
AIDS	|O
and	|O
to	|O
identify	|O
factors	|O
of	|O
possible	|O
prognostic	|O
relevance	|O
.	|O

No	|O
homology	|O
was	|O
found	|O
between	|O
RNA14	|B-PROTEIN
and	|O
RNA15	|B-PROTEIN
or	|O
between	|O
RNA14	|B-PROTEIN
and	|O
other	|O
proteins	|O
contained	|O
in	|O
data	|O
banks	|O
.	|O

Mutations	|O
in	|O
the	|O
yeast	|O
RNA14	|B-PROTEIN
and	|O
RNA15	|B-PROTEIN
genes	|O
result	|O
in	|O
an	|O
abnormal	|O
mRNA	|O
decay	|O
rate	|O
;	|O
sequence	|O
analysis	|O
reveals	|O
an	|O
RNA	|O
-	|O
binding	|O
domain	|O
in	|O
the	|O
RNA15	|B-PROTEIN
protein	|O
.	|O

Myocardial	|O
infarction	|O
in	|O
patients	|O
with	|O
previous	|O
bypass	|O
surgery	|O
.	|O

The	|O
most	|O
striking	|O
difference	|O
in	|O
the	|O
birch	|O
NAD	|B-PROTEIN
(	|I-PROTEIN
P	|I-PROTEIN
)	|I-PROTEIN
H	|I-PROTEIN
-	|I-PROTEIN
NR	|I-PROTEIN
sequence	|O
in	|O
comparison	|O
to	|O
NADH	|B-PROTEIN
-	|I-PROTEIN
NR	|I-PROTEIN
sequences	|O
was	|O
found	|O
at	|O
the	|O
putative	|O
pyridine	|O
nucleotide	|O
binding	|O
site	|O
.	|O

A	|O
single	|O
amino	|O
acid	|O
difference	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
influences	|O
dominant	|O
negative	|O
activity	|O
and	|O
receptor	|O
dimer	|O
formation	|O
.	|O

No	|O
such	|O
benefits	|O
were	|O
seen	|O
for	|O
children	|O
with	|O
CD4+	|B-PROTEIN
counts	|O
below	|O
0.2	|O
x	|O
10	|O
(	|O
9	|O
)	|O
per	|O
liter	|O
at	|O
entry	|O
.	|O

Because	|O
the	|O
human	|O
Antp	|B-PROTEIN
TATAA	|O
binding	|O
protein	|O
is	|O
expressed	|O
in	|O
both	|O
lymphoid	|O
and	|O
non	|O
-	|O
lymphoid	|O
cells	|O
,	|O
we	|O
suggest	|O
that	|O
this	|O
homeobox	|B-PROTEIN
gene	|I-PROTEIN
has	|O
evolved	|O
a	|O
more	|O
general	|O
transcriptional	|O
regulatory	|O
function	|O
in	|O
higher	|O
eukaryotic	|O
cells	|O
.	|O

The	|O
95%	|O
confidence	|O
values	|O
(	|O
2SD	|O
)	|O
for	|O
the	|O
change	|O
in	|O
Ros	|O
required	|O
to	|O
exclude	|O
natural	|O
variability	|O
were	|O
0.39	|O
,	|O
0.50	|O
and	|O
0.53	|O
cmH2O	|O
l	|O
-	|O
1	|O
s	|O
,	|O
respectively	|O
.	|O

Among	|O
953	|O
infants	|O
in	|O
22	|O
neonatal	|O
care	|O
units	|O
studied	|O
,	|O
23%	|O
(	|O
median	|O
value	|O
,	|O
range	|O
0-78	|O
)	|O
were	|O
found	|O
to	|O
be	|O
faecally	|O
colonized	|O
with	|O
one	|O
of	|O
21	|O
distinct	|O
nosocomial	|O
strains	|O
of	|O
Escherichia	|O
coli	|O
,	|O
Klebsiella	|O
or	|O
Enterobacter	|O
spp	|O
.	|O

Biochemical	|O
studies	|O
revealed	|O
the	|O
expected	|O
loss	|O
of	|O
ChAT	|B-PROTEIN
activity	|O
in	|O
the	|O
dorsal	|O
and	|O
ventral	|O
hippocampi	|O
of	|O
lesioned	|O
animals	|O
along	|O
with	|O
elevated	|O
levels	|O
of	|O
norepinephrine	|O
(	|O
NE	|O
)	|O
in	|O
the	|O
dorsal	|O
hippocampus	|O
of	|O
MS	|O
/	|O
HSI	|O
animals	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

The	|O
localization	|O
of	|O
this	|O
proteoglycan	|O
locus	|O
in	|O
the	|O
human	|O
genome	|O
and	|O
the	|O
availability	|O
of	|O
new	|O
RFLPs	|O
provide	|O
the	|O
tools	|O
for	|O
future	|O
studies	|O
of	|O
human	|O
diseases	|O
where	|O
the	|O
HSPG2	|B-PROTEIN
proteoglycan	|O
gene	|O
is	|O
suspected	|O
to	|O
be	|O
involved	|O
.	|O

After	|O
2	|O
min	|O
of	|O
dobutamine	|O
injection	|O
,	|O
or	|O
after	|O
20	|O
min	|O
of	|O
pimobendan	|O
injection	|O
,	|O
the	|O
myocardium	|O
was	|O
removed	|O
,	|O
and	|O
used	|O
for	|O
determination	|O
of	|O
the	|O
tissue	|O
levels	|O
of	|O
metabolites	|O
of	|O
energy	|O
and	|O
carbohydrate	|O
metabolism	|O
.	|O

During	|O
coronary	|O
stenosis	|O
,	|O
on	|O
the	|O
contrary	|O
,	|O
intracoronary	|O
procaterol	|O
at	|O
the	|O
same	|O
dose	|O
significantly	|O
deteriorated	|O
regional	|O
myocardial	|O
dysfunction	|O
without	|O
changing	|O
LCX	|O
flow	|O
,	|O
global	|O
hemodynamics	|O
and	|O
cardiac	|O
lactate	|O
metabolism	|O
.	|O

Here	|O
we	|O
present	|O
evidence	|O
that	|O
major	|O
IE	|B-PROTEIN
proteins	|O
IE86	|B-PROTEIN
,	|O
IE72	|B-PROTEIN
,	|O
and	|O
IE55	|B-PROTEIN
are	|O
capable	|O
of	|O
trans	|O
-	|O
activating	|O
the	|O
HIV	|B-PROTEIN
LTR	|I-PROTEIN
in	|O
a	|O
T	|O
-	|O
cell	|O
line	|O
,	|O
HUT	|O
-	|O
78	|O
.	|O

In	|O
a	|O
country	|O
where	|O
general	|O
HIV	|O
prevalence	|O
is	|O
low	|O
,	|O
the	|O
strategy	|O
is	|O
cost	|O
-	|O
effective	|O
for	|O
location	|O
and	|O
counselling	|O
of	|O
unknowingly	|O
seropositive	|O
individuals	|O
.	|O

The	|O
cis	|O
-	|O
acting	|O
element	|O
mediating	|O
glucocorticoid	|O
inducibility	|O
of	|O
the	|O
chicken	|O
glutamine	|B-PROTEIN
synthetase	|I-PROTEIN
gene	|O
has	|O
been	|O
identified	|O
.	|O

However	|O
,	|O
the	|O
increase	|O
in	|O
biliary	|O
excretion	|O
did	|O
not	|O
compensate	|O
for	|O
the	|O
reduced	|O
elimination	|O
of	|O
bretylium	|O
and	|O
hexylsalicylic	|O
acid	|O
via	|O
the	|O
kidney	|O
.	|O

Diagnostic	|O
value	|O
of	|O
cerebrospinal	|O
fluid	|O
immunoglobulin	|B-PROTEIN
G	|I-PROTEIN
(	|O
IgG	|O
)	|O
in	|O
pediatric	|O
neurological	|O
diseases	|O
.	|O

Expression	|O
of	|O
six	|O
genes	|O
,	|O
ipaB	|B-PROTEIN
,	|O
ipaC	|B-PROTEIN
,	|O
invE	|B-PROTEIN
,	|O
invG	|B-PROTEIN
,	|O
invJ	|B-PROTEIN
,	|O
and	|O
invK	|B-PROTEIN
,	|O
was	|O
apparently	|O
regulated	|O
by	|O
the	|O
positive	|O
regulator	|O
virF	|B-PROTEIN
.	|O

Inducible	|O
VT	|O
was	|O
suppressed	|O
entirely	|O
in	|O
one	|O
patient	|O
.	|O

Venkatesan	|O
,	|O
and	|O
D.	|O

The	|O
presence	|O
of	|O
the	|O
corresponding	|O
mature	|O
mRNA	|O
transcripts	|O
(	|O
3.2-3.5	|O
kilobase	|O
pairs	|O
(	|O
kb	|O
]	|O
in	|O
human	|O
fibroblasts	|O
was	|O
shown	|O
by	|O
Northern	|O
blot	|O
hybridization	|O
,	|O
S1	|B-PROTEIN
nuclease	|I-PROTEIN
protection	|O
assay	|O
,	|O
and	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
.	|O

Approximately	|O
50%	|O
of	|O
the	|O
ribosomal	|O
DNA	|O
(	|O
rDNA	|O
)	|O
units	|O
of	|O
Drosophila	|O
melanogaster	|O
are	|O
inactivated	|O
by	|O
two	|O
different	|O
28	|B-PROTEIN
S	|I-PROTEIN
RNA	|O
ribosomal	|O
gene	|O
insertions	|O
(	|O
type	|O
I	|O
and	|O
type	|O
II	|O
)	|O
.	|O

Gap	|B-PROTEIN
b3	|I-PROTEIN
consists	|O
of	|O
two	|O
polypeptide	|O
chains	|O
(	|O
Mr	|O
=	|O
110,000	|O
and	|O
30,000	|O
)	|O
,	|O
which	|O
seem	|O
to	|O
be	|O
proteolytic	|O
cleavage	|O
products	|O
connected	|O
by	|O
disulfide	|O
bonds	|O
from	|O
a	|O
precursor	|O
protein	|O
.	|O

However	|O
,	|O
the	|O
rtFc	|B-PROTEIN
gamma	|I-PROTEIN
R	|I-PROTEIN
alpha	|I-PROTEIN
cDNA	|O
clone	|O
is	|O
complementary	|O
to	|O
at	|O
least	|O
two	|O
different	|O
-	|O
sized	|O
mRNAs	|O
expressed	|O
by	|O
CRNK	|O
-	|O
16	|O
cells	|O
,	|O
contrasting	|O
the	|O
single	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
R	|I-PROTEIN
-	|O
related	|O
mRNA	|O
species	|O
expressed	|O
by	|O
human	|O
and	|O
mouse	|O
natural	|O
killer	|O
cells	|O
.	|O

Both	|O
genes	|O
comprise	|O
three	|O
exons	|O
,	|O
two	|O
introns	|O
and	|O
an	|O
unusually	|O
long	|O
3'	|O
-	|O
untranslated	|O
region	|O
(	|O
3.2	|O
kilobase	|O
pairs	|O
)	|O
,	|O
specificying	|O
a	|O
mRNA	|O
of	|O
approximately	|O
4.1	|O
kilobases	|O
.	|O

Stable	|O
expression	|O
of	|O
the	|O
chimeric	|O
alpha	|B-PROTEIN
i	|I-PROTEIN
(	|I-PROTEIN
54	|I-PROTEIN
)	|I-PROTEIN
/	|I-PROTEIN
s	|I-PROTEIN
polypeptide	|O
in	|O
Chinese	|O
hamster	|O
ovary	|O
(	|O
CHO	|O
)	|O
cells	|O
constitutively	|O
increased	|O
both	|O
cAMP	|O
synthesis	|O
and	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
.	|O

This	|O
exon	|O
,	|O
here	|O
named	|O
exon	|O
0	|O
,	|O
contained	|O
the	|O
entire	|O
5'	|O
untranslated	|O
region	|O
and	|O
the	|O
N	|O
-	|O
terminal	|O
signal	|O
sequence	|O
of	|O
the	|O
polypeptide	|O
.	|O

Treatment	|O
of	|O
human	|O
myeloid	|O
cell	|O
lines	|O
HL	|O
-	|O
60	|O
and	|O
U937	|O
with	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
(	|O
PMA	|O
)	|O
increased	|O
within	|O
2	|O
h	|O
cellular	|O
levels	|O
of	|O
the	|O
RNA	|O
hybridizable	|O
to	|O
LD78	|B-PROTEIN
cDNA	|O
.	|O

A	|O
new	|O
,	|O
flexible	|O
fiberoptic	|O
ventriculoscope	|O
for	|O
observation	|O
of	|O
the	|O
ventricles	|O
and	|O
major	|O
cisterns	|O
is	|O
reported	|O
.	|O

Isopenicillin	|B-PROTEIN
N	|I-PROTEIN
isomerase	|I-PROTEIN
(	|O
epimerase	|B-PROTEIN
)	|O
has	|O
been	|O
purified	|O
from	|O
Streptomyces	|O
clavuligerus	|O
,	|O
and	|O
the	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
N	|O
-	|O
terminus	|O
has	|O
been	|O
determined	|O
.	|O

Serum	|O
IgG	|B-PROTEIN
was	|O
initially	|O
elevated	|O
in	|O
6	|O
patients	|O
.	|O

The	|O
patient	|O
initially	|O
attained	|O
complete	|O
remission	|O
(	|O
CR1	|O
)	|O
with	|O
conventional	|O
chemotherapy	|O
and	|O
then	|O
relapsed	|O
14	|O
months	|O
later	|O
.	|O

157	|O
+	|O
/	|O
-	|O
16	|O
mg	|O
/	|O
dl	|O
;	|O
NS	|O
)	|O
,	|O
glucose	|O
levels	|O
,	|O
and	|O
basal	|O
(	|O
17	|O
+	|O
/	|O
-	|O
4	|O
vs.	|O

Platelet	|O
aggregation	|O
and	|O
metabolic	|O
control	|O
are	|O
not	|O
affected	|O
by	|O
calcium	|O
antagonist	|O
treatment	|O
in	|O
type	|O
II	|O
diabetes	|O
mellitus	|O
.	|O

Wnt	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
int	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
is	|O
a	|O
cellular	|O
oncogene	|O
often	|O
activated	|O
by	|O
insertion	|O
of	|O
proviral	|O
DNA	|O
of	|O
the	|O
mouse	|O
mammary	|O
tumor	|O
virus	|O
.	|O

Induction	|O
of	|O
Jurkat	|O
leukemic	|O
T	|O
cells	|O
with	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
and	|O
ionomycin	|O
did	|O
not	|O
affect	|O
the	|O
level	|O
of	|O
FKBP	|B-PROTEIN
mRNA	|O
.	|O

GLUT5	|B-PROTEIN
mRNA	|O
is	|O
expressed	|O
at	|O
highest	|O
levels	|O
in	|O
small	|O
intestine	|O
and	|O
at	|O
much	|O
lower	|O
levels	|O
in	|O
kidney	|O
,	|O
skeletal	|O
muscle	|O
,	|O
and	|O
adipose	|O
tissue	|O
.	|O

e	|O
.	|O

We	|O
speculate	|O
that	|O
these	|O
tumors	|O
may	|O
represent	|O
congenital	|O
hamartomatous	|O
growths	|O
.	|O

Identification	|O
and	|O
characterization	|O
of	|O
the	|O
promoter	|O
for	|O
the	|O
cytotactin	|B-PROTEIN
gene	|O
.	|O

Surprisingly	|O
,	|O
there	|O
is	|O
no	|O
sequence	|O
homology	|O
between	|O
this	|O
region	|O
of	|O
Ly	|B-PROTEIN
-	|I-PROTEIN
6E	|I-PROTEIN
and	|O
the	|O
established	|O
consensus	|O
for	|O
the	|O
interferon	|B-PROTEIN
-	|O
stimulated	|O
response	|O
element	|O
,	|O
which	|O
has	|O
been	|O
shown	|O
functionally	|O
important	|O
to	|O
all	|O
previously	|O
characterized	|O
alpha	|B-PROTEIN
/	|I-PROTEIN
beta	|I-PROTEIN
interferon	|I-PROTEIN
-	|O
inducible	|O
promoters	|O
.	|O

Relatively	|O
large	|O
DNA	|O
rearrangements	|O
spanning	|O
the	|O
region	|O
with	|O
tandem	|O
direct	|O
repeats	|O
encoding	|O
the	|O
carboxy	|O
-	|O
terminal	|O
histone	|O
H1	|B-PROTEIN
-	|O
like	|O
structure	|O
of	|O
AlgP	|B-PROTEIN
were	|O
detected	|O
in	|O
several	|O
strains	|O
upon	|O
conversion	|O
from	|O
the	|O
mucoid	|O
to	|O
the	|O
nonmucoid	|O
phenotype	|O
.	|O

(	|O
1988	|O
)	|O
J.	|O

These	|O
results	|O
strongly	|O
suggested	|O
that	|O
similar	|O
,	|O
if	|O
not	|O
identical	|O
,	|O
the	|O
CArG	|B-PROTEIN
box	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
interact	|O
with	|O
the	|O
functionally	|O
different	|O
promoter	|O
element	|O
in	|O
the	|O
VLC1	|B-PROTEIN
,	|O
cardiac	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
,	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
genes	|O
.	|O

Polyadenylation	|O
of	|O
B4	|B-PROTEIN
RNA	|O
,	|O
which	|O
occurs	|O
very	|O
early	|O
during	|O
maturation	|O
,	|O
is	|O
limited	|O
to	|O
150	|O
residues	|O
,	|O
and	|O
it	|O
is	|O
this	|O
number	|O
that	|O
is	|O
required	|O
for	|O
polysomal	|O
recruitment	|O
.	|O

Co	|O
-	|O
existence	|O
of	|O
these	|O
regulatory	|O
elements	|O
with	|O
other	|O
elements	|O
,	|O
such	|O
as	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
element	|O
or	|O
CCAAT	|O
box	|O
,	|O
was	|O
also	|O
found	|O
.	|O

Recently	|O
,	|O
studies	|O
of	|O
agents	|O
that	|O
disrupt	|O
collagen	|B-PROTEIN
synthesis	|O
and	|O
deposition	|O
have	|O
yielded	|O
several	|O
new	|O
angiogenesis	|O
inhibitors	|O
.	|O

Since	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
this	|O
gene	|O
is	|O
likely	|O
involved	|O
in	|O
hormonal	|O
regulation	|O
of	|O
its	|O
expression	|O
,	|O
we	|O
have	|O
isolated	|O
and	|O
partially	|O
characterized	|O
an	|O
avian	|O
fatty	|B-PROTEIN
acid	|I-PROTEIN
synthase	|I-PROTEIN
gene	|O
.	|O

A	|O
new	|O
set	|O
of	|O
cDNA	|O
clones	|O
spanning	|O
approximately	|O
3.2	|O
kb	|O
was	|O
isolated	|O
from	|O
a	|O
lambda	|O
-	|O
ZAP	|O
goose	|O
liver	|O
cDNA	|O
library	|O
using	|O
the	|O
5'	|O
-	|O
most	|O
exon	|O
-	|O
containing	|O
fragment	|O
of	|O
the	|O
5'	|O
-	|O
most	|O
genomic	|O
DNA	|O
clone	|O
.	|O

Northern	|O
blotting	|O
analysis	|O
indicates	|O
that	|O
expression	|O
of	|O
the	|O
genes	|O
corresponding	|O
to	|O
these	|O
clones	|O
is	|O
confined	|O
to	|O
pollen	|O
tissue	|O
.	|O

Whereas	|O
cDNA	|O
hybridization	|O
to	|O
genomic	|O
DNA	|O
blots	|O
indicated	|O
a	|O
small	|O
subfamily	|O
of	|O
G0S19	|B-PROTEIN
genes	|O
,	|O
simple	|O
patterns	|O
of	|O
bands	|O
indicated	|O
that	|O
most	|O
cDNAs	|O
,	|O
including	|O
G0S30	|B-PROTEIN
cDNA	|O
,	|O
corresponded	|O
to	|O
single	|O
-	|O
copy	|O
genes	|O
.	|O

Lymphoproliferative	|O
disorders	|O
arising	|O
under	|O
immunosuppression	|O
with	|O
FK	|O
506	|O
:	|O
initial	|O
observations	|O
in	|O
a	|O
large	|O
transplant	|O
population	|O
.	|O

The	|O
Drosophila	|O
suppressor	|B-PROTEIN
of	|I-PROTEIN
sable	|I-PROTEIN
gene	|O
encodes	|O
a	|O
polypeptide	|O
with	|O
regions	|O
similar	|O
to	|O
those	|O
of	|O
RNA	|O
-	|O
binding	|O
proteins	|O
.	|O

2	|O
:	|O
121-133	|O
,	|O
1988	|O
)	|O
.	|O

It	|O
is	|O
,	|O
however	|O
,	|O
extremely	|O
homologous	|O
to	|O
a	|O
third	|O
'	|O
non	|O
-	|O
classical	|O
'	|O
gene	|O
,	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
5.4	|I-PROTEIN
,	|O
and	|O
to	|O
the	|O
chimpanzee	|O
gene	|O
,	|O
Ch28	|B-PROTEIN
.	|O

Although	|O
the	|O
N13	|O
-	|O
N20	|O
interpeak	|O
interval	|O
remained	|O
stable	|O
because	|O
of	|O
the	|O
parallel	|O
shift	|O
of	|O
the	|O
2	|O
peaks	|O
,	|O
the	|O
central	|O
conduction	|O
time	|O
measured	|O
from	|O
onset	|O
latencies	|O
of	|O
N11	|O
and	|O
N20	|O
significantly	|O
increased	|O
.	|O

Using	|O
avidin	|B-PROTEIN
-	|I-PROTEIN
biotin	|I-PROTEIN
complex	|O
DNA	|O
binding	|O
assays	|O
,	|O
a	|O
series	|O
of	|O
overlapping	|O
alpha	|B-PROTEIN
promoter	|I-PROTEIN
DNA	|O
sequences	|O
between	|O
-	|O
170	|O
to	|O
29	|O
basepairs	|O
were	|O
tested	|O
,	|O
but	|O
each	|O
failed	|O
to	|O
bind	|O
GR	|B-PROTEIN
,	|O
whereas	|O
a	|O
control	|O
GRE	|O
avidly	|O
bound	|O
receptor	|O
.	|O

Sequence	|O
determination	|O
of	|O
isolated	|O
peptides	|O
suggested	|O
that	|O
Asn120	|O
is	|O
glycosylated	|O
,	|O
Asn65	|O
and	|O
Asn109	|O
glycosylated	|O
in	|O
some	|O
molecules	|O
but	|O
not	|O
in	|O
others	|O
,	|O
and	|O
Asn72	|O
not	|O
glycosylated	|O
.	|O

The	|O
DNA	|O
sequence	|O
conferring	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activity	|O
was	|O
located	|O
in	|O
the	|O
proximal	|O
promoter	|O
region	|O
.	|O

The	|O
murine	|O
mutation	|O
dominant	|B-PROTEIN
white	|I-PROTEIN
spotting	|I-PROTEIN
(	|O
W	|B-PROTEIN
)	|O
is	|O
in	|O
the	|O
proto	|O
-	|O
oncogene	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
.	|O

Isolation	|O
and	|O
characterization	|O
of	|O
the	|O
rat	|O
chromosomal	|O
gene	|O
for	|O
a	|O
polypeptide	|O
(	|O
pS1	|B-PROTEIN
)	|O
antigenically	|O
related	|O
to	|O
statin	|B-PROTEIN
.	|O

The	|O
proteins	|O
differ	|O
in	|O
the	|O
presence	|O
or	|O
absence	|O
of	|O
a	|O
21	|O
-	|O
amino	|O
-	|O
acid	|O
sequence	|O
located	|O
24	|O
amino	|O
acids	|O
C	|O
terminal	|O
of	|O
the	|O
translational	|O
initiation	|O
codon	|O
.	|O

Our	|O
results	|O
also	|O
indicate	|O
the	|O
existence	|O
of	|O
sequences	|O
downstream	|O
of	|O
-	|O
0.11	|O
kb	|O
which	|O
can	|O
influence	|O
the	|O
pattern	|O
of	|O
tissue	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
B7	|I-PROTEIN
gene	|O
and	|O
the	|O
ability	|O
of	|O
this	|O
gene	|O
to	|O
respond	|O
to	|O
gamma	|B-PROTEIN
interferon	|I-PROTEIN
.	|O

The	|O
SH2	|B-PROTEIN
and	|O
SH3	|B-PROTEIN
domains	|O
of	|O
pp60src	|B-PROTEIN
direct	|O
stable	|O
association	|O
with	|O
tyrosine	|O
phosphorylated	|O
proteins	|O
p130	|B-PROTEIN
and	|O
p110	|B-PROTEIN
.	|O

Chem.	|O

These	|O
clones	|O
overlapped	|O
and	|O
contained	|O
the	|O
structural	|O
gene	|O
encoding	|O
the	|O
complete	|O
C5	|B-PROTEIN
alpha	|I-PROTEIN
-	|O
chain	|O
and	|O
90%	|O
of	|O
the	|O
beta	|O
-	|O
chain	|O
.	|O

The	|O
C5	|B-PROTEIN
alpha	|O
-	|O
chain	|O
was	|O
encoded	|O
by	|O
49	|O
kilobases	|O
containing	|O
26	|O
exons	|O
;	|O
the	|O
beta	|O
-	|O
chain	|O
was	|O
encoded	|O
by	|O
29	|O
kilobases	|O
containing	|O
16	|O
exons	|O
.	|O

Heterozygous	|O
mutation	|O
in	|O
the	|O
G+	|O
5	|O
position	|O
of	|O
intron	|O
33	|O
of	|O
the	|O
pro	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
2	|I-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
gene	|O
(	|O
COL1A2	|B-PROTEIN
)	|O
that	|O
causes	|O
aberrant	|O
RNA	|O
splicing	|O
and	|O
lethal	|O
osteogenesis	|O
imperfecta	|O
.	|O

The	|O
nucleotide	|O
sequences	|O
of	|O
these	|O
genes	|O
differ	|O
at	|O
only	|O
nine	|O
positions	|O
,	|O
resulting	|O
in	|O
three	|O
amino	|O
acid	|O
differences	|O
.	|O

The	|O
protein	|O
predicted	|O
by	|O
the	|O
sequence	|O
of	|O
the	|O
human	|O
pim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
shares	|O
extensive	|O
homology	|O
with	|O
known	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
and	|O
yet	|O
the	|O
human	|O
Pim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
enzyme	|O
has	|O
previously	|O
been	|O
reported	|O
to	|O
exhibit	|O
protein	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
both	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

A	|O
full	|O
-	|O
length	|O
human	|O
pim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cDNA	|O
was	|O
subcloned	|O
into	|O
the	|O
bacterial	|O
vector	|O
pGEX	|O
-	|O
2T	|O
and	|O
the	|O
Pim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
expressed	|O
as	|O
a	|O
fusion	|O
product	|O
with	|O
bacterial	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
.	|O

This	|O
report	|O
substantiates	|O
that	|O
at	|O
least	|O
two	|O
of	|O
the	|O
18	|O
kDa	|O
hsps	|B-PROTEIN
in	|O
maize	|O
are	|O
products	|O
of	|O
different	|O
but	|O
related	|O
genes	|O
.	|O

The	|O
10	|O
kDa	|O
polypeptide	|O
was	|O
phosphorylated	|O
in	|O
vitro	|O
by	|O
incubating	|O
wheat	|O
etioplast	|O
membranes	|O
with	|O
[	|O
gamma	|O
32P	|O
]	|O
ATP	|O
.	|O

Homology	|O
with	|O
the	|O
human	|O
protein	|O
is	|O
only	|O
34%	|O
in	|O
the	|O
tandem	|O
repeat	|O
domain	|O
,	|O
mainly	|O
showing	|O
conservation	|O
of	|O
serines	|O
and	|O
threonines	|O
,	|O
presumed	|O
sites	|O
of	|O
O	|O
-	|O
linked	|O
carbohydrate	|O
attachment	|O
.	|O

In	|O
addition	|O
to	|O
targeting	|O
partially	|O
assembled	|O
Ti	|B-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
CD3	|O
gamma	|O
delta	|O
epsilon	|O
TCR	|O
complexes	|O
to	|O
the	|O
cell	|O
surface	|O
,	|O
CD3	|B-PROTEIN
zeta	|I-PROTEIN
appears	|O
to	|O
be	|O
essential	|O
for	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
production	|O
after	|O
TCR	|B-PROTEIN
stimulation	|O
with	|O
antigen	|O
/	|O
major	|B-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
.	|O

When	|O
desipramine	|O
was	|O
injected	|O
16	|O
hrs	|O
after	|O
fluoxetine	|O
injection	|O
,	|O
brain	|O
levels	|O
of	|O
desipramine	|O
were	|O
no	|O
longer	|O
elevated	|O
.	|O

Opposite	|O
effects	|O
of	|O
CYP1	|B-PROTEIN
are	|O
observed	|O
in	|O
aerobic	|O
,	|O
heme	|O
-	|O
sufficient	|O
cells	|O
.	|O

A	|O
segmental	|O
analysis	|O
of	|O
the	|O
key	|O
regions	|O
of	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DR1	|I-PROTEIN
that	|O
control	|O
T	|O
cell	|O
allorecognition	|O
was	|O
performed	|O
by	|O
using	|O
a	|O
series	|O
of	|O
transfected	|O
cell	|O
lines	|O
expressing	|O
the	|O
products	|O
of	|O
recombinant	|O
DRB	|B-PROTEIN
/	|O
H	|B-PROTEIN
-	|I-PROTEIN
2Eb	|I-PROTEIN
genes	|O
,	|O
paired	|O
with	|O
either	|O
DR	|B-PROTEIN
alpha	|I-PROTEIN
or	|O
H	|B-PROTEIN
-	|I-PROTEIN
2E	|I-PROTEIN
alpha	|I-PROTEIN
.	|O

We	|O
characterized	|O
cDNA	|O
clones	|O
specific	|O
for	|O
the	|O
extracellular	|O
matrix	|O
glycoprotein	|O
undulin	|B-PROTEIN
.	|O

Finally	|O
,	|O
some	|O
point	|O
mutations	|O
in	|O
the	|O
Gag	|B-PROTEIN
-	|O
Pol	|B-PROTEIN
PR	|O
domain	|O
inhibited	|O
activation	|O
of	|O
RT	|B-PROTEIN
in	|O
trans	|O
by	|O
a	|O
wild	|O
-	|O
type	|O
PR	|B-PROTEIN
,	|O
suggesting	|O
that	|O
the	|O
correct	|O
conformation	|O
of	|O
the	|O
PR	|B-PROTEIN
domain	|O
in	|O
Gag	|B-PROTEIN
-	|O
Pol	|B-PROTEIN
is	|O
prerequisite	|O
for	|O
activation	|O
of	|O
RT	|B-PROTEIN
.	|O

The	|O
alpha	|B-PROTEIN
inhibin	|I-PROTEIN
promoter	|O
containing	|O
a	|O
mutated	|O
CRE	|O
was	|O
not	|O
regulated	|O
by	|O
forskolin	|O
in	|O
granulosa	|O
cells	|O
and	|O
did	|O
not	|O
bind	|O
the	|O
CREB	|B-PROTEIN
protein	|O
.	|O

Regulation	|O
of	|O
the	|O
alpha	|B-PROTEIN
inhibin	|I-PROTEIN
gene	|O
by	|O
cyclic	|O
adenosine	|O
3'	|O
,	|O
5'	|O
-	|O
monophosphate	|O
after	|O
transfection	|O
into	|O
rat	|O
granulosa	|O
cells	|O
.	|O

Comparison	|O
of	|O
the	|O
nucleotide	|O
sequences	|O
between	|O
the	|O
human	|O
and	|O
bovine	|O
DNA	|O
showed	|O
that	|O
the	|O
sequence	|O
similarity	|O
extended	|O
2400	|O
bp	|O
downstream	|O
from	|O
the	|O
coding	|O
region	|O
.	|O

Cloning	|O
of	|O
a	|O
human	|O
cDNA	|O
encoding	|O
a	|O
CDC2	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
kinase	|I-PROTEIN
by	|O
complementation	|O
of	|O
a	|O
budding	|O
yeast	|O
cdc28	|B-PROTEIN
mutation	|O
.	|O

In	|O
patients	|O
with	|O
osteomyelitis	|O
and	|O
joint	|O
empyema	|O
(	|O
n	|O
=	|O
48	|O
)	|O
PMN	|B-PROTEIN
elastase	|I-PROTEIN
had	|O
a	|O
sensitivity	|O
of	|O
77%	|O
,	|O
which	|O
was	|O
only	|O
exceeded	|O
by	|O
that	|O
of	|O
the	|O
unspecific	|O
erythrocyte	|O
sedimentation	|O
rate	|O
(	|O
sensitivity	|O
89%	|O
)	|O
.	|O

E.	|O
,	|O
Hession	|O
,	|O
C.	|O
,	|O
Goff	|O
,	|O
D.	|O
,	|O
Griffiths	|O
,	|O
B.	|O
,	|O
Tizard	|O
,	|O
R.	|O
,	|O
Newman	|O
,	|O
B.	|O
,	|O
Chi	|O
-	|O
Rosso	|O
,	|O
G.	|O
,	|O
and	|O
Lobb	|O
,	|O
R.	|O
,	|O
(	|O
1990	|O
)	|O
Cell	|O
63	|O
,	|O
1349-1356	|O
)	|O
.	|O

The	|O
above	|O
results	|O
mean	|O
that	|O
the	|O
increase	|O
in	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptors	|I-PROTEIN
makes	|O
the	|O
prostate	|O
,	|O
which	|O
has	|O
been	|O
already	|O
hypertrophied	|O
,	|O
less	|O
elastic	|O
,	|O
inhibiting	|O
external	|O
urinary	|O
sphincter	|O
function	|O
.	|O

An	|O
approximately	|O
2	|O
-	|O
kilobase	|O
B2	|B-PROTEIN
transcript	|O
was	|O
expressed	|O
in	|O
all	|O
alfalfa	|O
organs	|O
tested	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
the	|O
sulfhydryl	|O
group	|O
of	|O
certain	|O
angiotensin	|B-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
inhibitors	|O
can	|O
potentiate	|O
their	|O
effect	|O
on	|O
the	|O
endogenous	|O
nitrovasodilator	|O
EDRF	|B-PROTEIN
.	|O

Pharmacokinetics	|O
of	|O
FK	|O
506	|O
in	|O
transplant	|O
patients	|O
.	|O

A	|O
second	|O
even	|O
more	|O
significant	|O
match	|O
to	|O
this	|O
E.	|O
coli	|O
region	|O
was	|O
found	|O
in	|O
the	|O
retroviral	|O
ribonuclease	|B-PROTEIN
H	|I-PROTEIN
(	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
)	|O
domain	|O
,	|O
and	|O
corresponds	|O
precisely	|O
to	|O
a	|O
region	|O
that	|O
has	|O
been	|O
aligned	|O
by	|O
previous	|O
investigators	|O
with	|O
the	|O
E.	|O
coli	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
,	|O
suggesting	|O
that	|O
Pol	|B-PROTEIN
I	|I-PROTEIN
helices	|O
O	|O
and	|O
P	|O
are	|O
homologous	|O
to	|O
helices	|O
A	|O
and	|O
D	|O
of	|O
the	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
crystal	|O
structure	|O
,	|O
respectively	|O
.	|O

Analysis	|O
of	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
suggests	|O
that	|O
CHIP28	|B-PROTEIN
protein	|O
contains	|O
six	|O
bilayer	|O
-	|O
spanning	|O
domains	|O
,	|O
two	|O
exofacial	|O
potential	|O
N	|O
-	|O
glycosylation	|O
sites	|O
,	|O
and	|O
intracellular	|O
N	|O
and	|O
C	|O
termini	|O
.	|O

The	|O
qualitative	|O
concentrations	|O
of	|O
HCG	|B-PROTEIN
had	|O
a	|O
sensitivity	|O
of	|O
37.5%	|O
and	|O
a	|O
specificity	|O
of	|O
100%	|O
.	|O

The	|O
reduced	|O
rate	|O
of	|O
F	|O
absorption	|O
and	|O
slower	|O
rise	|O
in	|O
plasma	|O
F	|O
concentration	|O
accompanying	|O
delayed	|O
gastric	|O
emptying	|O
indicate	|O
that	|O
passage	|O
of	|O
F	|O
into	|O
the	|O
small	|O
intestine	|O
is	|O
the	|O
major	|O
factor	|O
in	|O
rapid	|O
F	|O
absorption	|O
.	|O

The	|O
activity	|O
of	|O
serum	|O
lipase	|B-PROTEIN
and	|O
amylase	|B-PROTEIN
distinctly	|O
increased	|O
at	|O
3	|O
h	|O
and	|O
went	|O
up	|O
to	|O
the	|O
maximum	|O
at	|O
12	|O
h	|O
after	|O
injection	|O
of	|O
Na	|O
-	|O
Tc	|O
.	|O

They	|O
were	|O
checked	|O
for	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HCV	|I-PROTEIN
(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
C100	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
with	|O
HCV	|O
EIA	|O
kit	|O
(	|O
Abbott	|O
Lab	|O
.	|O
,	|O
North	|O
Chicago	|O
,	|O
IL	|O
)	|O
.	|O

Diltiazem	|O
resulted	|O
in	|O
a	|O
significant	|O
increase	|O
in	|O
epicardial	|O
diameter	|O
(	|O
+	|O
10%	|O
;	|O
p	|O
=	|O
0.001	|O
)	|O
and	|O
in	|O
coronary	|O
blood	|O
flow	|O
(	|O
CBF	|O
)	|O
(	|O
+	|O
30%	|O
;	|O
p	|O
=	|O
0.0001	|O
)	|O
.	|O

The	|O
first	|O
transfusion	|O
resulted	|O
in	|O
a	|O
platelet	|O
increment	|O
to	|O
32	|O
Gpt	|O
/	|O
l	|O
(	|O
CCI	|O
11	|O
)	|O
.	|O

These	|O
risk	|O
factors	|O
can	|O
be	|O
divided	|O
into	|O
2	|O
groups	|O
:	|O
local	|O
vessel	|O
wall	|O
-	|O
related	|O
factors	|O
,	|O
and	|O
local	|O
(	|O
focal	|O
action	|O
)	|O
systemic	|O
factors	|O
.	|O

Epidemiology	|O
and	|O
prevention	|O
of	|O
hospital	|O
infections	|O
in	|O
the	|O
Local	|O
Health	|O
Unit	|O
of	|O
Sassari	|O
:	|O
profile	|O
of	|O
bacterial	|O
resistance	|O
and	|O
antimicrobial	|O
agents	|O
of	|O
large	|O
usage	|O
.	|O

PRDII	|B-PROTEIN
-	|I-PROTEIN
BF1	|I-PROTEIN
-	|O
derived	|O
cDNAs	|O
did	|O
not	|O
result	|O
in	|O
stimulation	|O
of	|O
either	|O
basal	|O
or	|O
tat	|B-PROTEIN
-	|O
induced	|O
activated	|O
gene	|O
expression	|O
.	|O

Vaccinia	|O
virus	|O
(	|O
VV	|O
)	|O
is	|O
a	|O
potent	|O
immunogen	|O
,	|O
but	|O
the	|O
nature	|O
of	|O
VV	|O
proteins	|O
involved	|O
in	|O
the	|O
activation	|O
of	|O
the	|O
immune	|O
response	|O
of	|O
the	|O
host	|O
is	|O
not	|O
yet	|O
known	|O
.	|O

Max	|B-PROTEIN
:	|O
functional	|O
domains	|O
and	|O
interaction	|O
with	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
.	|O

86	|O
:	|O
3199-3203	|O
)	|O
or	|O
G1	|O
to	|O
S	|O
phase	|O
(	|O
Reilly	|O
,	|O
C.	|O

Substitutions	|O
introduced	|O
at	|O
bases	|O
surrounding	|O
the	|O
ICR2	|B-PROTEIN
motif	|O
yielded	|O
levels	|O
of	|O
pRNA	|O
replication	|O
that	|O
differed	|O
,	|O
depending	|O
on	|O
the	|O
maintenance	|O
of	|O
a	|O
putative	|O
5'	|O
stem	|O
-	|O
loop	|O
structure	|O
in	|O
the	|O
positive	|O
strand	|O
of	|O
the	|O
viral	|O
genome	|O
.	|O

Zn	|O
(	|O
II	|O
)	|O
coordination	|O
domain	|O
mutants	|O
of	|O
T4	|O
gene	|B-PROTEIN
32	|I-PROTEIN
protein	|O
.	|O

Zn	|O
(	|O
II	|O
)	|O
coordination	|O
domain	|O
mutants	|O
of	|O
T4	|O
gene	|B-PROTEIN
32	|I-PROTEIN
protein	|O
.	|O

The	|O
tissue	|O
specificity	|O
of	|O
gene	|O
expression	|O
was	|O
identical	|O
to	|O
that	|O
described	|O
previously	|O
for	|O
the	|O
CaMV	|O
35S	|B-PROTEIN
domain	|O
B	|B-PROTEIN
enhancer	|I-PROTEIN
element	|O
.	|O

The	|O
pathophysiology	|O
and	|O
clinical	|O
management	|O
of	|O
acute	|O
brain	|O
injury	|O
in	|O
infancy	|O
and	|O
childhood	|O
are	|O
presented	|O
using	|O
acute	|O
traumatic	|O
brain	|O
injury	|O
as	|O
a	|O
model	|O
.	|O

Transcripts	|O
from	|O
a	|O
second	|O
POU	|B-PROTEIN
-	|O
domain	|O
gene	|O
,	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
25	|I-PROTEIN
,	|O
were	|O
present	|O
at	|O
low	|O
levels	|O
in	|O
oocytes	|O
and	|O
early	|O
embryos	|O
and	|O
were	|O
dramatically	|O
upregulated	|O
during	|O
early	|O
gastrulation	|O
.	|O

In	|O
some	|O
early	|O
B	|O
cells	|O
and	|O
Abelson	|O
murine	|O
leukemia	|O
virus	|O
-	|O
transformed	|O
pre	|O
-	|O
B	|O
-	|O
cell	|O
lines	|O
,	|O
LT	|B-PROTEIN
mRNA	|O
is	|O
constitutively	|O
expressed	|O
.	|O

The	|O
genome	|O
of	|O
Thogoto	|O
virus	|O
comprises	|O
six	|O
segments	|O
of	|O
single	|O
-	|O
stranded	|O
,	|O
negative	|O
sense	|O
RNA	|O
.	|O

These	|O
tumors	|O
were	|O
classified	|O
into	|O
three	|O
broad	|O
groups	|O
:	|O
I	|O
,	|O
cystadenoma	|O
;	|O
II	|O
,	|O
cystadenocarcinoma	|O
;	|O
and	|O
III	|O
,	|O
adenocarcinoma	|O
with	|O
mucin	|B-PROTEIN
production	|O
or	|O
an	|O
associated	|O
cyst	|O
.	|O

Immunostaining	|O
of	|O
cells	|O
transfected	|O
with	|O
these	|O
constructs	|O
revealed	|O
that	|O
both	|O
the	|O
myristoylated	|O
and	|O
nonmyristoylated	|O
mutants	|O
were	|O
localized	|O
in	|O
nuclei	|O
,	|O
whereas	|O
wild	|O
-	|O
type	|O
PKC	|B-PROTEIN
alpha	|I-PROTEIN
was	|O
primarily	|O
cytoplasmic	|O
and	|O
perinuclear	|O
.	|O

We	|O
have	|O
partially	|O
sequenced	|O
the	|O
RAP74	|B-PROTEIN
protein	|O
from	|O
purified	|O
HeLa	|O
cells	|O
,	|O
cloned	|O
its	|O
complementary	|O
DNA	|O
and	|O
shown	|O
that	|O
its	|O
translation	|O
product	|O
can	|O
interact	|O
with	|O
RAP30	|B-PROTEIN
in	|O
vitro	|O
as	|O
well	|O
as	|O
in	|O
vivo	|O
.	|O

Effects	|O
of	|O
thromboxane	|B-PROTEIN
synthetase	|I-PROTEIN
inhibition	|O
on	|O
postburn	|O
mesenteric	|O
vascular	|O
resistance	|O
and	|O
the	|O
rate	|O
of	|O
bacterial	|O
translocation	|O
in	|O
a	|O
chronic	|O
porcine	|O
model	|O
.	|O

The	|O
primary	|O
pancreatic	|O
insult	|O
seemed	|O
to	|O
be	|O
unaffected	|O
by	|O
the	|O
treatment	|O
,	|O
because	|O
neither	|O
the	|O
rise	|O
in	|O
plasma	|O
lipase	|B-PROTEIN
nor	|O
the	|O
development	|O
of	|O
ascites	|O
or	|O
the	|O
extension	|O
of	|O
the	|O
pancreatic	|O
necrosis	|O
were	|O
diminished	|O
.	|O

The	|O
size	|O
of	|O
the	|O
mutant	|O
molecule	|O
corresponds	|O
to	|O
the	|O
unprocessed	|O
cytoplasmic	|O
precursor	|O
(	|O
pre	|O
-	|O
super	|O
-	|O
pro	|O
-	|O
PrB	|B-PROTEIN
)	|O
,	|O
as	|O
detected	|O
in	|O
sec61	|B-PROTEIN
mutants	|O
,	|O
when	|O
translocation	|O
into	|O
the	|O
endoplasmic	|O
reticulum	|O
is	|O
blocked	|O
.	|O

Thus	|O
,	|O
the	|O
active	|O
-	|O
site	|O
mutation	|O
prevents	|O
the	|O
wild	|O
-	|O
type	|O
processing	|O
of	|O
the	|O
N	|O
-	|O
glycosylated	|O
73	|O
-	|O
kDa	|O
precursor	|O
of	|O
PrB	|B-PROTEIN
to	|O
the	|O
41.5	|O
kDa	|O
pro	|O
-	|O
PrB	|B-PROTEIN
in	|O
the	|O
endoplasmic	|O
reticulum	|O
.	|O

The	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
exhibited	|O
70%	|O
identity	|O
to	|O
that	|O
of	|O
Bacillus	|O
stearothermophilus	|O
TyrTS	|B-PROTEIN
and	|O
55%	|O
identity	|O
to	|O
that	|O
of	|O
E.	|O
coli	|O
TyrTS	|B-PROTEIN
,	|O
while	|O
identity	|O
to	|O
a	|O
second	|O
cryptic	|O
B.	|O
subtilis	|O
TyrTS	|B-PROTEIN
gene	|O
,	|O
designated	|O
tyrZ	|B-PROTEIN
,	|O
was	|O
only	|O
27%	|O
.	|O

Heat	|O
-	|O
inducible	|O
CAT	|B-PROTEIN
activity	|O
was	|O
detectable	|O
when	|O
additional	|O
sequences	|O
from	|O
the	|O
native	|O
promoter	|O
containing	|O
three	|O
CCAAT	|O
boxes	|O
and	|O
a	|O
single	|O
HSE	|O
were	|O
present	|O
in	|O
the	|O
constructions	|O
.	|O

SETTING	|O
-	|O
-	|O
Women	|O
,	|O
Infants	|O
,	|O
and	|O
Children	|O
clinics	|O
in	|O
Minneapolis	|O
,	|O
Minn	|O
.	|O

Testosterone	|O
,	|O
free	|O
testosterone	|O
,	|O
non	|B-PROTEIN
-	|I-PROTEIN
sex	|I-PROTEIN
hormone	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
globulin	|I-PROTEIN
-	|O
bound	|O
testosterone	|O
,	|O
and	|O
free	|O
androgen	|O
index	|O
:	|O
which	|O
testosterone	|O
measurement	|O
is	|O
most	|O
relevant	|O
to	|O
reproductive	|O
and	|O
sexual	|O
function	|O
in	|O
men	|O
with	|O
epilepsy	|O
?	|O

BACKGROUND	|O
:	|O
The	|O
effectiveness	|O
of	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
inhibitors	|O
(	|O
MAOIs	|O
)	|O
in	|O
tricyclic	|O
resistant	|O
depression	|O
has	|O
received	|O
surprisingly	|O
little	|O
systematic	|O
study	|O
.	|O

The	|O
upstream	|O
delta	|O
-	|O
alpha	|O
breakpoint	|O
is	|O
flanked	|O
by	|O
the	|O
direct	|O
repeats	|O
of	|O
the	|O
acceptor	|O
splice	|O
site	|O
,	|O
whereas	|O
the	|O
down	|O
-	|O
stream	|O
alpha	|O
-	|O
delta	|O
breakpoint	|O
is	|O
located	|O
in	|O
the	|O
adjacent	|O
intron	|O
.	|O

Patients	|O
with	|O
moderate	|O
PDDAT	|O
were	|O
impaired	|O
on	|O
all	|O
serial	|O
positions	|O
for	|O
both	|O
spatial	|O
order	|O
and	|O
spatial	|O
recognition	|O
memory	|O
.	|O

Bone	|O
and	|O
bones	|O
.	|O

One	|O
patients	|O
had	|O
plasma	|B-PROTEIN
C	|I-PROTEIN
-	|O
peptide	|O
greater	|O
than	|O
3	|O
pM	|O
and	|O
was	|O
therefore	|O
excluded	|O
from	|O
analysis	|O
.	|O

Complex	|O
repetitive	|O
discharges	|O
were	|O
observed	|O
in	|O
muscles	|O
of	|O
mdx	|O
mice	|O
but	|O
no	|O
complex	|O
repetitive	|O
discharges	|O
or	|O
other	|O
abnormalities	|O
were	|O
observed	|O
in	|O
muscles	|O
of	|O
normal	|O
control	|O
mice	|O
.	|O

Management	|O
often	|O
involves	|O
beta	|O
-	|O
and	|O
calcium	|O
channel	|O
blocking	|O
drugs	|O
or	|O
type	|O
IC	|O
antiarrhythmic	|O
drugs	|O
.	|O

To	|O
overcome	|O
this	|O
problem	|O
,	|O
we	|O
have	|O
overexpressed	|O
Kex2p	|B-PROTEIN
using	|O
the	|O
baculovirus	|O
/	|O
insect	|O
cell	|O
expression	|O
system	|O
.	|O

J.	|O

The	|O
major	|O
49	|O
-	|O
kDa	|O
core	|B-PROTEIN
protein	|O
in	|O
the	|O
liver	|O
HSPG	|B-PROTEIN
preparation	|O
was	|O
found	|O
to	|O
be	|O
reactive	|O
to	|O
an	|O
antibody	|O
that	|O
specifically	|O
recognizes	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
fibroglycan	|B-PROTEIN
.	|O

While	|O
no	|O
obvious	|O
transmembrane	|O
regions	|O
were	|O
identified	|O
,	|O
several	|O
short	|O
hydrophobic	|O
amino	|O
acid	|O
stretches	|O
were	|O
found	|O
to	|O
be	|O
localized	|O
in	|O
and	|O
around	|O
the	|O
Pro	|O
II	|O
region	|O
,	|O
and	|O
these	|O
may	|O
be	|O
responsible	|O
for	|O
attachment	|O
of	|O
precursors	|O
to	|O
membranes	|O
.	|O

Toxicity	|O
was	|O
mild	|O
,	|O
mainly	|O
consisting	|O
of	|O
emesis	|O
(	|O
81%	|O
of	|O
the	|O
patients	|O
;	|O
66%	|O
of	|O
the	|O
courses	|O
)	|O
,	|O
leukopenia	|O
of	|O
World	|O
Health	|O
Organization	|O
(	|O
WHO	|O
)	|O
grade	|O
1	|O
to	|O
2	|O
(	|O
47%	|O
of	|O
the	|O
patients	|O
;	|O
18%	|O
of	|O
the	|O
courses	|O
)	|O
,	|O
and	|O
thrombocytopenia	|O
(	|O
12%	|O
of	|O
the	|O
patients	|O
;	|O
3%	|O
of	|O
the	|O
courses	|O
)	|O
.	|O

W.G.	|O

This	|O
study	|O
confirms	|O
,	|O
although	|O
individual	|O
reaction	|O
is	|O
remarkably	|O
different	|O
,	|O
transportation	|O
as	|O
a	|O
potent	|O
stressor	|O
for	|O
Beagle	|O
dogs	|O
.	|O

A	|O
mouse	|O
brain	|O
beta	|B-PROTEIN
-	|I-PROTEIN
spectrin	|I-PROTEIN
of	|O
cDNA	|O
was	|O
identified	|O
within	|O
a	|O
lambda	|O
Gt11	|O
expression	|O
library	|O
using	|O
an	|O
antibody	|O
which	|O
specifically	|O
binds	|O
with	|O
the	|O
235	|O
kDa	|O
spectrin	|B-PROTEIN
beta	|O
-	|O
subunit	|O
.	|O

RESULTS	|O
:	|O
Plasma	|O
AVP	|B-PROTEIN
responses	|O
to	|O
osmotic	|O
stimulation	|O
,	|O
and	|O
non	|O
-	|O
osmotic	|O
inhibition	|O
by	|O
drinking	|O
,	|O
were	|O
normal	|O
in	|O
patients	|O
with	|O
compulsive	|O
water	|O
drinking	|O
.	|O

The	|O
fragments	|O
of	|O
each	|O
region	|O
were	|O
amplified	|O
by	|O
polymerase	|O
chain	|O
reaction	|O
and	|O
analyzed	|O
by	|O
gel	|O
electrophoresis	|O
to	|O
detect	|O
single	|O
-	|O
strand	|O
conformation	|O
polymorphism	|O
.	|O

The	|O
csbA	|B-PROTEIN
fusion	|O
was	|O
maximally	|O
expressed	|O
during	|O
early	|O
stationary	|O
phase	|O
in	|O
cells	|O
grown	|O
in	|O
Luria	|O
broth	|O
containing	|O
5%	|O
glucose	|O
and	|O
0.2%	|O
glutamine	|O
.	|O

The	|O
constraints	|O
of	|O
primase	|B-PROTEIN
recognition	|O
sequences	|O
,	|O
nucleotide	|O
substrate	|O
requirements	|O
,	|O
and	|O
the	|O
effects	|O
of	|O
additional	|O
proteins	|O
on	|O
oligoribonucleotide	|O
synthesis	|O
by	|O
the	|O
63	|O
-	|O
kDa	|O
gene	|B-PROTEIN
4	|I-PROTEIN
protein	|O
have	|O
been	|O
examined	|O
using	|O
templates	|O
of	|O
defined	|O
sequence	|O
.	|O

Thrombolytic	|O
therapy	|O
in	|O
spontaneous	|O
coronary	|O
artery	|O
dissection	|O
.	|O

A	|O
prospective	|O
trial	|O
was	|O
carried	|O
out	|O
in	|O
156	|O
unselected	|O
patients	|O
(	|O
41	|O
men	|O
,	|O
mean	|O
age	|O
67.5	|O
years	|O
,	|O
115	|O
women	|O
,	|O
mean	|O
age	|O
71.4	|O
years	|O
)	|O
who	|O
had	|O
undergone	|O
total	|O
hip	|O
joint	|O
replacement	|O
because	|O
of	|O
degenerative	|O
or	|O
inflammatory	|O
arthritis	|O
or	|O
fracture	|O
of	|O
the	|O
neck	|O
of	|O
the	|O
femur	|O
.	|O

When	|O
both	|O
lesions	|O
were	|O
complete	|O
lateral	|O
hemisections	|O
in	|O
weanling	|O
operates	|O
,	|O
little	|O
behavioral	|O
recovery	|O
was	|O
observed	|O
,	|O
similar	|O
to	|O
complete	|O
spinal	|O
cord	|O
transection	|O
(	|O
N	|O
=	|O
3	|O
)	|O
.	|O

Human	|O
SRF	|B-PROTEIN
-	|O
related	|O
proteins	|O
:	|O
DNA	|O
-	|O
binding	|O
properties	|O
and	|O
potential	|O
regulatory	|O
targets	|O
.	|O

We	|O
have	|O
isolated	|O
cDNAs	|O
for	|O
a	|O
gene	|O
coding	|O
for	|O
a	|O
G	|B-PROTEIN
protein	|I-PROTEIN
alpha	|O
subunit	|O
from	|O
tomato	|O
(	|O
Lycopersicon	|O
esculentum	|O
,	|O
cv	|O
.	|O

Growth	|O
factor	|O
stimulation	|O
of	|O
cells	|O
causes	|O
the	|O
phosphorylation	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
transcriptional	|O
activation	|O
domain	|O
at	|O
Ser62	|O
within	|O
a	|O
proline	|O
-	|O
rich	|O
region	|O
that	|O
is	|O
highly	|O
conserved	|O
among	|O
members	|O
of	|O
the	|O
Myc	|B-PROTEIN
family	|O
(	|O
Alvarez	|O
,	|O
E.	|O
,	|O
Northwood	|O
,	|O
I.C.	|O
,	|O
Gonzalez	|O
,	|O
F.	|O

The	|O
authors	|O
evaluated	|O
the	|O
potential	|O
for	|O
thrombotic	|O
complications	|O
arising	|O
from	|O
implantation	|O
of	|O
a	|O
ventricular	|O
assist	|O
device	|O
(	|O
Sarns	|O
/	|O
3M	|O
-	|O
VAD	|O
)	|O
in	|O
four	|O
calves	|O
.	|O

Cardiac	|O
output	|O
(	|O
CO	|O
)	|O
was	|O
significantly	|O
higher	|O
(	|O
p	|O
less	|O
than	|O
0.0005	|O
)	|O
in	|O
the	|O
MBBF	|O
group	|O
.	|O

Amino	|O
acid	|O
residues	|O
147-167	|O
of	|O
the	|O
previously	|O
reported	|O
sequence	|O
are	|O
replaced	|O
by	|O
new	|O
residues	|O
147	|O
to	|O
150	|O
.	|O

Transcriptional	|O
activation	|O
by	|O
the	|O
HIV	|O
-	|O
1	|O
Tat	|B-PROTEIN
protein	|O
requires	|O
specific	|O
residues	|O
in	|O
the	|O
hexanucleotide	|O
loop	|O
and	|O
trinucleotide	|O
bulge	|O
of	|O
the	|O
TAR	|B-PROTEIN
RNA	|O
stem	|O
-	|O
loop	|O
structure	|O
found	|O
in	|O
the	|O
5'	|O
-	|O
untranslated	|O
leader	|O
of	|O
all	|O
viral	|O
transcripts	|O
.	|O

We	|O
obtained	|O
quantitative	|O
evidence	|O
on	|O
the	|O
coding	|O
of	|O
interaural	|O
time	|O
differences	|O
(	|O
ITDs	|O
)	|O
of	|O
click	|O
stimuli	|O
by	|O
40	|O
single	|O
neurons	|O
in	|O
the	|O
auditory	|O
cortex	|O
of	|O
anesthetized	|O
albino	|O
rats	|O
.	|O

These	|O
results	|O
strongly	|O
suggest	|O
that	|O
locally	|O
-	|O
applied	|O
TTC	|O
in	|O
combination	|O
with	|O
FDBA	|O
enhances	|O
new	|O
bone	|O
formation	|O
in	|O
experimental	|O
alveolar	|O
bone	|O
defects	|O
.	|O

As	|O
an	|O
initial	|O
step	|O
towards	|O
the	|O
characterization	|O
of	|O
replicative	|O
DNA	|B-PROTEIN
polymerases	|I-PROTEIN
of	|O
trypanosomes	|O
,	|O
we	|O
have	|O
cloned	|O
,	|O
sequenced	|O
and	|O
examined	|O
the	|O
expression	|O
of	|O
the	|O
Trypanosoma	|O
(	|O
Trypanozoon	|O
)	|O
brucei	|O
brucei	|O
gene	|O
that	|O
encodes	|O
the	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|I-PROTEIN
catalytic	|O
core	|O
(	|O
pol	|B-PROTEIN
alpha	|I-PROTEIN
)	|O
.	|O

In	|O
addition	|O
,	|O
there	|O
was	|O
a	|O
significant	|O
increase	|O
in	|O
postdexamethasone	|O
cortical	|O
concentrations	|O
with	|O
age	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
;	|O
r	|O
=	|O
0.31	|O
)	|O
.	|O

Pulmonary	|O
hypertension	|O
,	|O
with	|O
or	|O
without	|O
coronary	|O
arterial	|O
narrowing	|O
,	|O
is	|O
the	|O
major	|O
condition	|O
leading	|O
to	|O
isolated	|O
atrial	|O
infarction	|O
.	|O

The	|O
volume	|O
fraction	|O
(	|O
Vv	|O
)	|O
and	|O
number	|O
/	|O
mm2	|O
(	|O
Na	|O
)	|O
of	|O
all	|O
capillaries	|O
(	|O
perfused	|O
and	|O
nonperfused	|O
)	|O
in	|O
a	|O
given	|O
area	|O
of	|O
brain	|O
were	|O
determined	|O
after	|O
staining	|O
for	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
.	|O

Airway	|O
pressure	|O
and	|O
air	|O
flow	|O
were	|O
measured	|O
at	|O
the	|O
endotracheal	|O
tube	|O
in	|O
13	|O
children	|O
on	|O
a	|O
variety	|O
of	|O
ventilators	|O
.	|O

Appl	|O
.	|O

Issues	|O
of	|O
distribution	|O
of	|O
kinetic	|O
energy	|O
of	|O
traumatizing	|O
object	|O
in	|O
direct	|O
contact	|O
interaction	|O
with	|O
head	|O
during	|O
impact	|O
are	|O
discussed	|O
from	|O
position	|O
of	|O
biomechanics	|O
.	|O

CONCLUSION	|O
:	|O
Monitoring	|O
SpO2	|O
at	|O
the	|O
nasal	|O
septum	|O
site	|O
is	|O
more	|O
reliable	|O
than	|O
monitoring	|O
it	|O
at	|O
the	|O
finger	|O
site	|O
in	|O
hypothermic	|O
patients	|O
.	|O

Diltiazem	|O
decreased	|O
the	|O
total	|O
body	|O
clearance	|O
from	|O
34.0	|O
+	|O
/	|O
-	|O
8.0	|O
to	|O
28.6	|O
+	|O
/	|O
-	|O
6.1	|O
mL	|O
/	|O
min	|O
(	|O
P	|O
less	|O
than	|O
.01	|O
)	|O
,	|O
and	|O
prolonged	|O
the	|O
elimination	|O
half	|O
-	|O
life	|O
from	|O
12.6	|O
+	|O
/	|O
-	|O
3.0	|O
to	|O
14.3	|O
+	|O
/	|O
-	|O
2.5	|O
hours	|O
(	|O
P	|O
less	|O
than	|O
.01	|O
)	|O
of	|O
antipyrine	|O
without	|O
any	|O
changes	|O
in	|O
volume	|O
of	|O
distribution	|O
.	|O

The	|O
granules	|O
grew	|O
as	|O
the	|O
melted	|O
material	|O
immersed	|O
into	|O
the	|O
void	|O
space	|O
among	|O
the	|O
adhered	|O
particles	|O
.	|O

Hence	|O
,	|O
the	|O
uPA	|B-PROTEIN
promoter	|O
contains	|O
multiple	|O
weak	|O
cis	|O
-	|O
acting	|O
elements	|O
distributed	|O
over	|O
7.0	|O
kb	|O
5'	|O
to	|O
the	|O
translation	|O
start	|O
site	|O
.	|O

Substituting	|O
a	|O
Ser	|O
for	|O
Gly69	|O
or	|O
a	|O
Glu	|O
for	|O
Lys	|O
71	|O
in	|O
the	|O
conserved	|O
TGEK	|B-PROTEIN
tetrapeptide	|O
in	|O
finger	|O
II	|O
of	|O
TFIIIA	|B-PROTEIN
resulted	|O
in	|O
the	|O
loss	|O
of	|O
DNA	|O
binding	|O
.	|O

P.	|O

In	|O
one	|O
,	|O
exploratory	|O
behavior	|O
(	|O
assessed	|O
by	|O
hole	|O
pokes	|O
)	|O
and	|O
locomotion	|O
were	|O
assessed	|O
during	|O
a	|O
10	|O
-	|O
min	|O
test	|O
session	|O
.	|O

The	|O
model	|O
is	|O
able	|O
to	|O
anticipate	|O
why	|O
the	|O
effect	|O
of	|O
water	|O
fluoridation	|O
on	|O
caries	|O
prevalence	|O
is	|O
most	|O
pronounced	|O
when	|O
caries	|O
is	|O
diagnosed	|O
at	|O
cavity	|O
level	|O
.	|O

12	|O
-	|O
O	|O
-	|O
Tetradecanoylphorbol	|O
13	|O
-	|O
acetate	|O
was	|O
found	|O
to	|O
inhibit	|O
rapidly	|O
and	|O
potently	|O
the	|O
expression	|O
of	|O
mRNAs	|O
coding	|O
for	|O
the	|O
myogenic	|O
regulators	|O
CMD1	|B-PROTEIN
and	|O
myogenin	|B-PROTEIN
.	|O

In	|O
Xenopus	|O
laevis	|O
,	|O
the	|O
gene	|O
encoding	|O
the	|O
elongation	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
variant	|O
EF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
O	|I-PROTEIN
,	|O
where	|O
O	|O
stands	|O
for	|O
oocyte	|O
,	|O
is	|O
expressed	|O
in	|O
oocytes	|O
and	|O
early	|O
embryos	|O
.	|O

These	|O
introns	|O
belong	|O
to	|O
the	|O
class	|O
of	|O
nuclear	|O
pre	|O
-	|O
mRNA	|O
introns	|O
and	|O
contain	|O
typical	|O
5'	|O
-	|O
and	|O
3'	|O
-	|O
consensus	|O
sequences	|O
,	|O
as	|O
well	|O
as	|O
unique	|O
features	|O
.	|O

The	|O
mRNA	|O
identified	|O
in	|O
both	|O
human	|O
and	|O
rat	|O
cells	|O
with	|O
the	|O
human	|O
clathrin	|B-PROTEIN
clone	|O
revealed	|O
transcripts	|O
of	|O
approximately	|O
6.5	|O
kb	|O
,	|O
which	|O
is	|O
consistent	|O
with	|O
the	|O
predicted	|O
180	|O
kDa	|O
molecular	|O
weight	|O
of	|O
the	|O
clathrin	|B-PROTEIN
heavy	|O
chain	|O
.	|O

In	|O
this	|O
report	|O
,	|O
almost	|O
6	|O
kb	|O
of	|O
DNA	|O
sequence	|O
is	|O
presented	|O
,	|O
including	|O
1251	|O
bp	|O
5'	|O
to	|O
the	|O
gene	|O
,	|O
over	|O
4	|O
kb	|O
of	|O
exon	|O
and	|O
exon	|O
-	|O
intron	|O
junctions	|O
,	|O
and	|O
583	|O
bp	|O
3'	|O
to	|O
the	|O
gene	|O
.	|O

An	|O
8	|O
-	|O
h	|O
exposure	|O
to	|O
10	|O
mg	|O
DMEA	|O
/	|O
m3	|O
corresponds	|O
to	|O
a	|O
postexposure	|O
plasma	|O
concentration	|O
and	|O
2	|O
-	|O
h	|O
postexposure	|O
urinary	|O
excretion	|O
of	|O
4.9	|O
mumol	|O
/	|O
l	|O
and	|O
75	|O
mmol	|O
/	|O
mol	|O
creatinine	|O
,	|O
respectively	|O
.	|O

Antibodies	|O
specific	|O
to	|O
rE12	|B-PROTEIN
and	|O
rNFIL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
disrupt	|O
nucleoprotein	|O
complexes	|O
with	|O
these	|O
DNA	|O
-	|O
binding	|O
sites	|O
,	|O
confirming	|O
the	|O
interaction	|O
of	|O
native	|O
in	|O
vivo	|O
factors	|O
.	|O

A	|O
method	|O
is	|O
described	|O
for	|O
detecting	|O
targeted	|O
events	|O
at	|O
the	|O
mu	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
gene	|O
which	|O
relies	|O
on	|O
co	|O
-	|O
conversion	|O
(	|O
or	|O
co	|O
-	|O
exchange	|O
)	|O
of	|O
a	|O
point	|O
mutation	|O
with	|O
a	|O
selectable	|O
marker	|O
contained	|O
on	|O
a	|O
replacement	|O
vector	|O
.	|O

Allergenic	|O
activity	|O
of	|O
allergen	|O
extract	|O
Ambrosia	|O
elatior	|O
(	|O
AE	|O
)	|O
was	|O
tested	|O
in	|O
fifteen	|O
volunteers	|O
extremely	|O
sensitive	|O
to	|O
the	|O
allergen	|O
.	|O

This	|O
study	|O
was	|O
aimed	|O
at	|O
assessing	|O
whether	|O
c	|O
-	|O
DDP	|O
administration	|O
immediately	|O
before	|O
radiotherapy	|O
could	|O
increase	|O
frequency	|O
and	|O
duration	|O
of	|O
objective	|O
responses	|O
,	|O
as	|O
well	|O
as	|O
survival	|O
,	|O
in	|O
patients	|O
affected	|O
with	|O
locally	|O
advanced	|O
stages	|O
of	|O
squamous	|O
carcinomas	|O
of	|O
the	|O
head	|O
and	|O
neck	|O
.	|O

Two	|O
potential	|O
regulatory	|O
sequences	|O
for	|O
DNA	|O
binding	|O
proteins	|O
were	|O
found	|O
in	|O
the	|O
non	|O
-	|O
coding	|O
5'	|O
region	|O
:	|O
a	|O
HAP2	|B-PROTEIN
/	|O
HAP3	|B-PROTEIN
consensus	|O
recognition	|O
sequence	|O
at	|O
nucleotide	|O
-	|O
154	|O
and	|O
a	|O
BAF1	|B-PROTEIN
consensus	|O
recognition	|O
sequence	|O
at	|O
nucleotide	|O
-	|O
136	|O
.	|O

Marked	|O
thrombocytopenia	|O
,	|O
depletion	|O
of	|O
serum	|O
fibrinogen	|B-PROTEIN
and	|O
prolonged	|O
prothrombin	|B-PROTEIN
and	|O
activated	|O
partial	|O
thromboplastin	|B-PROTEIN
time	|O
,	|O
were	|O
recorded	|O
at	|O
5	|O
to	|O
10	|O
and	|O
30	|O
to	|O
40	|O
minutes	|O
after	|O
intravenous	|O
envenomation	|O
.	|O

We	|O
exploit	|O
the	|O
properties	|O
of	|O
LexA	|B-PROTEIN
fusion	|O
proteins	|O
to	|O
study	|O
the	|O
dimerization	|O
and	|O
DNA	|O
-	|O
contacting	|O
domains	|O
of	|O
cRel	|B-PROTEIN
.	|O

Plasma	|O
lipid	|O
and	|O
lipoprotein	|O
profiles	|O
were	|O
compared	|O
in	|O
elderly	|O
female	|O
runners	|O
(	|O
RU	|O
:	|O
n	|O
=	|O
15	|O
,	|O
aged	|O
66	|O
+	|O
/	|O
-	|O
5	|O
years	|O
,	|O
body	|O
fat	|O
20	|O
+	|O
/	|O
-	|O
4%	|O
,	|O
training	|O
distance	|O
35	|O
+	|O
/	|O
-	|O
15	|O
km	|O
week	|O
-	|O
1	|O
,	|O
VO2max	|O
36	|O
+	|O
/	|O
-	|O
4	|O
ml	|O
kg	|O
-	|O
1	|O
min	|O
-	|O
1	|O
,	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
and	|O
age	|O
-	|O
matched	|O
untrained	|O
women	|O
(	|O
UT	|O
:	|O
n	|O
=	|O
28	|O
,	|O
66	|O
+	|O
/	|O
-	|O
4	|O
years	|O
,	|O
body	|O
fat	|O
26	|O
+	|O
/	|O
-	|O
6%	|O
,	|O
VO2max	|O
26	|O
+	|O
/	|O
-	|O
3	|O
ml	|O
kg	|O
-	|O
1	|O
min	|O
-	|O
1	|O
)	|O
.	|O

Auditory	|O
threshold	|O
shifts	|O
,	|O
as	|O
measured	|O
by	|O
the	|O
auditory	|O
evoked	|O
brainstem	|O
response	|O
,	|O
were	|O
measured	|O
at	|O
2,4,8,12,16	|O
,	|O
20	|O
and	|O
24	|O
kHz	|O
.	|O

Fundamental	|O
and	|O
clinical	|O
evaluation	|O
of	|O
equilibrium	|O
dialysis	|O
-	|O
-	|O
radioimmunoassay	|O
system	|O
for	|O
measurement	|O
of	|O
serum	|O
free	|O
thyroxine	|O

We	|O
conclude	|O
that	|O
TA	|O
caused	|O
a	|O
specific	|O
decrease	|O
in	|O
AGD	|O
on	|O
GD	|O
20	|O
that	|O
was	|O
largely	|O
reversed	|O
by	|O
PCD	|O
23	|O
.	|O

When	|O
examined	|O
as	|O
adults	|O
(	|O
8	|O
weeks	|O
old	|O
)	|O
,	|O
the	|O
external	|O
genitalia	|O
of	|O
TA	|O
-	|O
exposed	|O
offspring	|O
were	|O
normal	|O
.	|O

After	|O
PTCA	|O
,	|O
ejection	|O
fraction	|O
increased	|O
from	|O
54	|O
+	|O
/	|O
-	|O
8%	|O
to	|O
59	|O
+	|O
/	|O
-	|O
8%	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
and	|O
regional	|O
function	|O
improved	|O
significantly	|O
(	|O
maximal	|O
standard	|O
deviation	|O
before	|O
PTCA	|O
:	|O
2.8	|O
+	|O
/	|O
-	|O
0.8	|O
;	|O
after	|O
PTCA	|O
:	|O
1.9	|O
+	|O
/	|O
-	|O
0.9	|O
-	|O
segments	|O
below	|O
the	|O
first	|O
standard	|O
deviation	|O
before	|O
PTCA	|O
:	|O
31	|O
+	|O
/	|O
-	|O
16	|O
;	|O
after	|O
PTCA	|O
:	|O
19	|O
+	|O
/	|O
-	|O
17	|O
)	|O
.	|O

The	|O
alcoholic	|O
patient	|O
,	|O
his	|O
work	|O
and	|O
the	|O
subjectivity	|O
of	|O
the	|O
period	|O

These	|O
data	|O
suggest	|O
that	|O
the	|O
combined	|O
treatment	|O
with	|O
a	|O
thromboxane	|B-PROTEIN
synthetase	|I-PROTEIN
inhibitor	|O
and	|O
a	|O
thromboxane	|B-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
provides	|O
a	|O
better	|O
protection	|O
against	|O
digoxin	|O
intoxication	|O
than	|O
with	|O
either	|O
agent	|O
alone	|O
.	|O

A	|O
330	|O
-	|O
kb	|O
YAC	|O
,	|O
A148A7	|O
,	|O
spanned	|O
from	|O
the	|O
HLA	|B-PROTEIN
-	|O
DQA1	|B-PROTEIN
locus	|O
through	|O
the	|O
Y3	|B-PROTEIN
/	|O
Ring	|B-PROTEIN
4	|I-PROTEIN
locus	|O
and	|O
extended	|O
at	|O
least	|O
130	|O
kb	|O
centromeric	|O
of	|O
YAC	|O
B1D12	|O
.	|O

Interspecific	|O
backcross	|O
analysis	|O
using	|O
progeny	|O
derived	|O
from	|O
matings	|O
of	|O
(	|O
C57BL	|O
/	|O
6J	|O
x	|O
Mus	|O
spretus	|O
)	|O
F1	|O
x	|O
C57BL	|O
/	|O
6J	|O
mice	|O
indicates	|O
that	|O
the	|O
thrombospondin	|B-PROTEIN
gene	|O
is	|O
tightly	|O
linked	|O
to	|O
the	|O
Fshb	|B-PROTEIN
,	|O
Actcl	|B-PROTEIN
,	|O
Ltk	|B-PROTEIN
,	|O
and	|O
B2M	|B-PROTEIN
loci	|O
on	|O
murine	|O
chromosome	|O
2	|O
.	|O

Adverse	|O
foetal	|O
outcome	|O
in	|O
specific	|O
IgM	|B-PROTEIN
positive	|O
Chlamydia	|O
trachomatis	|O
infection	|O
in	|O
pregnancy	|O
.	|O

Using	|O
an	|O
image	|O
-	|O
processing	|O
computer	|O
,	|O
regional	|O
LV	|O
time	|O
-	|O
density	|O
curves	|O
were	|O
constructed	|O
for	|O
one	|O
cardiac	|O
cycle	|O
.	|O

In	|O
a	|O
second	|O
patient	|O
the	|O
VT	|O
became	|O
nonsustained	|O
.	|O

If	|O
delay	|O
has	|O
occurred	|O
between	|O
centrifugation	|O
and	|O
the	|O
measurement	|O
,	|O
causing	|O
substantial	|O
loss	|O
of	|O
CO2	|O
,	|O
equilibration	|O
of	|O
the	|O
sample	|O
with	|O
a	|O
gas	|O
mixture	|O
corresponding	|O
to	|O
PCO2	|O
=	|O
5.3	|O
kPa	|O
prior	|O
to	|O
the	|O
measurement	|O
is	|O
recommended	|O
.	|O

The	|O
possible	|O
mechanisms	|O
underlying	|O
differences	|O
in	|O
post	|O
-	|O
tetanic	|O
effects	|O
from	|O
muscle	|O
and	|O
cutaneous	|O
afferents	|O
in	|O
adults	|O
and	|O
neonates	|O
are	|O
discussed	|O
.	|O

We	|O
examined	|O
behavioral	|O
alterations	|O
in	|O
the	|O
brown	|O
cockroach	|O
,	|O
Periplaneta	|O
brunnea	|O
,	|O
infected	|O
with	|O
the	|O
acanthocephalan	|O
,	|O
Moniliformis	|O
moniliformis	|O
.	|O

First	|O
,	|O
the	|O
finding	|O
of	|O
a	|O
monomeric	|O
Alu	|B-PROTEIN
family	|O
repeat	|O
at	|O
the	|O
junction	|O
between	|O
nonhomology	|O
block	|O
I	|O
and	|O
homology	|O
block	|O
Y	|O
of	|O
the	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
gene	|O
-	|O
containing	|O
unit	|O
in	|O
rhesus	|O
macaque	|O
suggests	|O
that	|O
the	|O
dimeric	|O
Alu	|B-PROTEIN
family	|O
repeat	|O
,	|O
Alu	|B-PROTEIN
3	|I-PROTEIN
,	|O
at	|O
the	|O
orthologous	|O
position	|O
in	|O
human	|O
was	|O
generated	|O
by	|O
insertion	|O
of	|O
a	|O
monomeric	|O
Alu	|B-PROTEIN
family	|O
repeat	|O
into	|O
the	|O
3'	|O
end	|O
of	|O
another	|O
preexisting	|O
Alu	|B-PROTEIN
family	|O
repeat	|O
.	|O

The	|O
sequence	|O
of	|O
the	|O
repressor	|O
locus	|O
,	|O
c	|O
,	|O
of	|O
the	|O
Streptomyces	|O
temperate	|O
phage	|O
,	|O
phi	|O
C31	|O
,	|O
was	|O
shown	|O
previously	|O
to	|O
contain	|O
an	|O
open	|O
reading	|O
frame	|O
encoding	|O
a	|O
74	|O
kDa	|O
protein	|O
.	|O

The	|O
EPO	|B-PROTEIN
levels	|O
were	|O
distinctly	|O
increased	|O
before	|O
transfusion	|O
;	|O
they	|O
did	|O
not	|O
significantly	|O
change	|O
just	|O
after	|O
transfusion	|O
,	|O
but	|O
subsequently	|O
decreased	|O
.	|O

This	|O
differential	|O
sensitivity	|O
to	|O
DB	|O
,	|O
as	|O
measured	|O
by	|O
a	|O
lower	|O
concentration	|O
of	|O
DB	|O
which	|O
caused	|O
loss	|O
of	|O
righting	|O
in	|O
LS	|O
,	|O
was	|O
accompanied	|O
by	|O
an	|O
equal	|O
rate	|O
of	|O
water	|O
-	|O
soluble	|O
barbiturate	|O
brain	|O
distribution	|O
and	|O
elimination	|O
in	|O
the	|O
two	|O
lines	|O
.	|O

The	|O
existence	|O
of	|O
threshold	|O
concentrations	|O
,	|O
above	|O
which	|O
certain	|O
phenomena	|O
may	|O
occur	|O
,	|O
strengthens	|O
the	|O
role	|O
of	|O
sentinels	|O
.	|O

However	|O
,	|O
it	|O
was	|O
synthesized	|O
at	|O
both	|O
temperatures	|O
after	|O
addition	|O
of	|O
A23187	|O
.	|O

Felodipine	|O
did	|O
not	|O
alter	|O
the	|O
baseline	|O
FEV1	|O
,	|O
but	|O
showed	|O
a	|O
small	|O
significant	|O
inhibitory	|O
effect	|O
upon	|O
histamine	|O
and	|O
AMP	|O
induced	|O
bronchoconstriction	|O
.	|O

Ten	|O
out	|O
of	|O
10	|O
patients	|O
with	|O
progressive	|O
disease	|O
had	|O
mast	|O
cells	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
0.5%	|O
,	|O
hyaluronan	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
50	|O
micrograms.l	|O
-	|O
1	|O
and	|O
fibronectin	|B-PROTEIN
greater	|O
than	|O
or	|O
equal	|O
to	|O
350	|O
micrograms.l	|O
-	|O
1	|O
compared	|O
to	|O
eight	|O
out	|O
of	|O
41	|O
patients	|O
with	|O
stable	|O
or	|O
regressive	|O
disease	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Our	|O
mapping	|O
results	|O
did	|O
not	|O
suggest	|O
involvement	|O
of	|O
this	|O
gene	|O
in	|O
previously	|O
mapped	|O
genetic	|O
disorders	|O
or	|O
in	|O
known	|O
neoplasia	|O
-	|O
associated	|O
translocation	|O
breakpoints	|O
.	|O

Relatively	|O
little	|O
is	|O
known	|O
regarding	|O
the	|O
role	|O
of	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT2	|I-PROTEIN
receptor	|I-PROTEIN
activity	|O
in	|O
male	|O
rat	|O
sexual	|O
behavior	|O
.	|O

These	|O
changes	|O
weren	|O
't	|O
so	|O
significant	|O
in	|O
the	|O
group	|O
of	|O
obese	|O
children	|O
who	|O
didn	|O
't	|O
lose	|O
weight	|O
.	|O

Arsenic	|O
contents	|O
in	|O
native	|O
copper	|O

In	|O
ten	|O
other	|O
experiments	|O
(	|O
5	|O
experimental	|O
and	|O
5	|O
control	|O
rats	|O
)	|O
99mTc	|O
-	|O
sulfur	|O
colloid	|O
was	|O
injected	|O
intravenously	|O
.	|O

Magnetotherapy	|O
of	|O
hepatitis	|O
A	|O
and	|O
B	|O
in	|O
children	|O

These	|O
results	|O
were	|O
superior	|O
to	|O
those	|O
in	|O
24	|O
patients	|O
with	|O
conventional	|O
end	|O
-	|O
to	|O
-	|O
end	|O
sutures	|O
on	|O
clinical	|O
testing	|O
.	|O

Mutational	|O
analysis	|O
supports	|O
a	|O
role	|O
for	|O
multiple	|O
structural	|O
features	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
secretion	|O
signal	|O
of	|O
Escherichia	|O
coli	|O
haemolysin	|B-PROTEIN
.	|O

Among	|O
blood	|O
donors	|O
in	|O
the	|O
Republic	|O
of	|O
Serbia	|O
,	|O
regardless	|O
the	|O
number	|O
of	|O
blood	|O
donations	|O
,	|O
the	|O
percentage	|O
of	|O
female	|O
donors	|O
is	|O
significantly	|O
lower	|O
compared	|O
to	|O
the	|O
percentage	|O
of	|O
male	|O
blood	|O
donors	|O
.	|O

Extramedullary	|O
relapse	|O
in	|O
childhood	|O
leukemia	|O
.	|O

Mycoplasma	|O
pneumoniae	|O
was	|O
isolated	|O
from	|O
the	|O
pleural	|O
fluid	|O
of	|O
this	|O
patient	|O
.	|O

RU486	|O
and	|O
ONO	|O
802	|O
in	|O
combination	|O
have	|O
been	|O
shown	|O
to	|O
be	|O
effective	|O
in	|O
early	|O
termination	|O
of	|O
pregnancy	|O
.	|O

The	|O
presence	|O
of	|O
local	|O
abnormalities	|O
in	|O
both	|O
patients	|O
can	|O
support	|O
the	|O
hypothesis	|O
that	|O
the	|O
cortex	|O
,	|O
especially	|O
of	|O
the	|O
temporal	|O
anterior	|O
lobe	|O
,	|O
is	|O
involved	|O
in	|O
the	|O
origin	|O
of	|O
the	|O
laughing	|O
seizures	|O
.	|O

In	|O
line	|O
with	|O
the	|O
small	|O
values	|O
for	|O
QS	|O
/	|O
QC	|O
,	|O
our	|O
results	|O
further	|O
indicate	|O
that	|O
even	|O
large	|O
,	|O
well	|O
-	|O
perfused	|O
,	|O
occluded	|O
air	|O
spaces	|O
in	|O
the	|O
lung	|O
will	|O
hardly	|O
affect	|O
the	|O
recovered	|O
ventilation	|O
/	|O
perfusion	|O
distribution	|O
obtained	|O
from	|O
inert	|O
gas	|O
data	|O
when	|O
CDCSF6	|O
exceeds	|O
0.1	|O
ml.m	|O
in	|O
-	|O
1.m	|O
mHg	|O
-	|O
1	|O
.	|O

Many	|O
cells	|O
were	|O
negative	|O
for	|O
endothelial	|O
-	|O
cell	|O
markers	|O
,	|O
and	|O
they	|O
reacted	|O
with	|O
a	|O
monoclonal	|O
antibody	|O
against	|O
muscle	|O
actin	|B-PROTEIN
.	|O

CT	|O
abnormalities	|O
noted	|O
in	|O
term	|O
babies	|O
included	|O
hemorrhage	|O
(	|O
subarachnoid	|O
5.8%	|O
,	|O
intracerebral	|O
11.6%	|O
)	|O
,	|O
hypodensity	|O
(	|O
mild	|O
23.2%	|O
,	|O
moderate	|O
11.6%	|O
severe	|O
5.8%	|O
)	|O
;	|O
hypodensity	|O
with	|O
hemorrhage	|O
5.8%	|O
and	|O
cerebral	|O
atrophy	|O
5.8%	|O
.	|O

The	|O
effects	|O
of	|O
contrast	|O
media	|O
on	|O
coagulation	|O
factor	|B-PROTEIN
XII	|I-PROTEIN
.	|O

Pigs	|O
were	|O
switched	|O
from	|O
the	|O
growing	|O
to	|O
the	|O
finishing	|O
diet	|O
at	|O
57	|O
and	|O
61	|O
kg	|O
in	|O
Exp.	|O

In	|O
sixteen	|O
patients	|O
with	|O
moderate	|O
essential	|O
hypertension	|O
the	|O
effects	|O
of	|O
10	|O
-	|O
day	|O
nifedipine	|O
treatment	|O
on	|O
serum	|O
uric	|O
acid	|O
and	|O
renal	|O
excretion	|O
of	|O
uric	|O
acid	|O
were	|O
evaluated	|O
.	|O

TPTA	|O
produced	|O
brain	|O
congestion	|O
,	|O
and	|O
hepatic	|O
and	|O
pulmonary	|O
petechial	|O
and	|O
generalized	|O
hemorrhages	|O
.	|O

Examples	|O
are	|O
using	|O
more	|O
subjects	|O
or	|O
an	|O
improved	|O
research	|O
design	|O
,	|O
developing	|O
consensus	|O
statements	|O
or	|O
using	|O
meta	|O
-	|O
analysis	|O
.	|O

A	|O
two	|O
phase	|O
slug	|O
flow	|O
tubular	|O
heat	|O
exchanger	|O
was	|O
used	|O
for	|O
the	|O
thermal	|O
inactivation	|O
of	|O
Listeria	|O
monocytogenes	|O
in	|O
natural	|O
infected	|O
milk	|O
from	|O
seven	|O
cows	|O
.	|O

So	|O
far	|O
15	|O
children	|O
have	|O
been	|O
studied	|O
.	|O

Regional	|O
cerebral	|O
blood	|O
flow	|O
(	|O
rCBF	|O
)	|O
measurements	|O
and	|O
psychiatric	|O
ratings	|O
were	|O
performed	|O
on	|O
seven	|O
schizophrenic	|O
patients	|O
(	|O
mean	|O
age	|O
=	|O
41.4	|O
years	|O
)	|O
who	|O
had	|O
been	|O
examined	|O
18	|O
years	|O
previously	|O
in	|O
a	|O
study	|O
that	|O
used	|O
similar	|O
psychiatric	|O
ratings	|O
and	|O
a	|O
comparable	|O
rCBF	|O
technique	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
identified	|O
a	|O
strong	|O
positive	|O
cis	|O
-	|O
regulatory	|O
element	|O
at	|O
-	|O
70	|O
bp	|O
to	|O
-	|O
75	|O
bp	|O
in	|O
the	|O
LpS1	|B-PROTEIN
beta	|I-PROTEIN
promoter	|O
with	|O
the	|O
sequence	|O
(	|O
G	|O
)	|O
6	|O
and	|O
a	|O
similar	|O
,	|O
more	|O
distal	|O
cis	|O
-	|O
element	|O
at	|O
-	|O
721	|O
bp	|O
to	|O
-	|O
726	|O
bp	|O
.	|O

The	|O
present	|O
study	|O
reports	|O
visual	|O
evoked	|O
potential	|O
responses	|O
to	|O
pattern	|O
reversal	|O
(	|O
VEP	|O
-	|O
P	|O
)	|O
in	|O
ten	|O
third	|O
trimester	|O
pregnant	|O
women	|O
and	|O
changes	|O
in	|O
latency	|O
of	|O
NPN	|O
complex	|O
when	|O
compared	|O
with	|O
these	|O
responses	|O
in	|O
the	|O
non	|O
pregnant	|O
state	|O
.	|O

No	|O
case	|O
of	|O
SMF	|O
demonstrated	|O
expansive	|O
tumorous	|O
growth	|O
.	|O

Different	|O
doses	|O
of	|O
15	|O
-	|O
methyl	|O
-	|O
PGF2	|O
alpha	|O
(	|O
0.125-10	|O
mg	|O
)	|O
were	|O
used	|O
to	|O
induce	|O
luteolysis	|O
and	|O
oestrus	|O
in	|O
7	|O
heifers	|O
with	|O
28	|O
treatments	|O
on	|O
day	|O
8-12	|O
of	|O
the	|O
oestrous	|O
cycle	|O
.	|O

Review	|O
of	|O
the	|O
literature	|O
and	|O
report	|O
of	|O
a	|O
case	|O
of	|O
a	|O
dermoid	|O
cyst	|O
.	|O

Resolution	|O
of	|O
thermographic	|O
asymmetry	|O
and	|O
/	|O
or	|O
decrease	|O
in	|O
Delta	|O
T	|O
was	|O
demonstrated	|O
in	|O
approximately	|O
81%	|O
of	|O
the	|O
post	|O
-	|O
treatment	|O
population	|O
.	|O

In	|O
all	|O
instances	|O
the	|O
apparent	|O
alcohol	|O
responses	|O
were	|O
very	|O
small	|O
and	|O
never	|O
exceeded	|O
a	|O
reading	|O
of	|O
1	|O
microgram	|O
/	|O
100ml	|O
for	|O
breath	|O
samples	|O
more	|O
than	|O
10min	|O
post	|O
-	|O
exposure	|O
.	|O

Maize	|O
rbcS	|B-PROTEIN
promoter	|O
activity	|O
depends	|O
on	|O
sequence	|O
elements	|O
not	|O
found	|O
in	|O
dicot	|O
rbcS	|B-PROTEIN
promoters	|O
.	|O

Measurements	|O
were	|O
done	|O
with	|O
a	|O
commercial	|O
haematofluorometer	|O
Buchler	|O
ZF	|O
which	|O
was	|O
calibrated	|O
to	|O
the	|O
average	|O
haematocrit	|O
value	|O
of	|O
0.42	|O
.	|O

The	|O
relatively	|O
scanty	|O
number	|O
of	|O
examples	|O
,	|O
which	|O
could	|O
be	|O
justified	|O
by	|O
the	|O
variety	|O
and	|O
complexity	|O
of	|O
combined	|O
exposure	|O
,	|O
allows	|O
to	|O
conclude	|O
that	|O
life	|O
-	|O
style	|O
factors	|O
have	|O
considerable	|O
influence	|O
on	|O
interindividual	|O
differences	|O
in	|O
susceptibility	|O
to	|O
xenobiotics	|O
toxicity	|O
.	|O

The	|O
12S	|O
E1A	|B-PROTEIN
product	|O
does	|O
not	|O
activate	|O
a	|O
TRE	|O
sequence	|O
,	|O
but	|O
cotransfection	|O
with	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
circumvents	|O
this	|O
lack	|O
of	|O
stimulation	|O
.	|O

After	|O
treatment	|O
with	|O
tunicamycin	|O
,	|O
the	|O
transfectants	|O
secreted	|O
unglycosylated	|O
18	|O
-	|O
kDa	|O
polypeptides	|O
which	|O
could	|O
also	|O
bind	|O
IgE	|B-PROTEIN
.	|O

PAS1	|B-PROTEIN
,	|O
a	|O
yeast	|O
gene	|O
required	|O
for	|O
peroxisome	|O
biogenesis	|O
,	|O
encodes	|O
a	|O
member	|O
of	|O
a	|O
novel	|O
family	|O
of	|O
putative	|O
ATPases	|B-PROTEIN
.	|O

The	|O
gene	|O
is	|O
1,139	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
long	|O
,	|O
and	|O
,	|O
like	|O
other	|O
members	|O
of	|O
the	|O
SIG	|B-PROTEIN
family	|O
,	|O
the	|O
beta	|B-PROTEIN
TG	|I-PROTEIN
gene	|O
is	|O
divided	|O
into	|O
3	|O
exons	|O
.	|O

The	|O
pp90rsk	|B-PROTEIN
-	|O
protein	|O
kinase	|O
activity	|O
(	|O
referred	|O
to	|O
as	|O
rsk	|B-PROTEIN
-	|O
kinase	|O
)	|O
is	|O
also	|O
not	|O
related	|O
to	|O
cofactor	|O
-	|O
dependent	|O
signal	|O
transducing	|O
protein	|O
kinases	|O
such	|O
as	|O
the	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
members	|O
of	|O
the	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
family	|O
,	|O
or	|O
other	|O
Ca2	|B-PROTEIN
(	|I-PROTEIN
+	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

Human	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
:	|O
a	|O
lineage	|O
-	|O
restricted	|O
transcription	|O
factor	|O
that	|O
regulates	|O
the	|O
expression	|O
of	|O
the	|O
T	|B-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
alpha	|O
gene	|O
.	|O

Like	|O
many	|O
eukaryotic	|O
transcription	|O
factors	|O
,	|O
these	|O
proteins	|O
bind	|O
to	|O
DNA	|O
as	|O
dimers	|O
.	|O

Furthermore	|O
,	|O
the	|O
UvrA	|B-PROTEIN
protein	|O
interacts	|O
with	|O
the	|O
UvrB	|B-PROTEIN
protein	|O
to	|O
modulate	|O
its	|O
activities	|O
,	|O
both	|O
in	|O
solution	|O
and	|O
in	|O
association	|O
with	|O
DNA	|O
,	|O
where	|O
the	|O
UvrAB	|B-PROTEIN
complex	|O
possesses	|O
a	|O
helicase	|B-PROTEIN
activity	|O
.	|O

The	|O
ED30	|O
values	|O
were	|O
2.4	|O
and	|O
2.2	|O
mg	|O
/	|O
kg	|O
and	|O
similar	|O
to	|O
the	|O
respective	|O
values	|O
of	|O
nifedipine	|O
(	|O
ED	|O
30	|O
:	|O
2.4,2.1	|O
mg	|O
/	|O
kg	|O
)	|O
.	|O

Southwestern	|O
blot	|O
analysis	|O
demonstrated	|O
that	|O
this	|O
phosphoprotein	|O
can	|O
bind	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
element	|O
directly	|O
and	|O
specifically	|O
.	|O

Thus	|O
,	|O
the	|O
positive	|O
effect	|O
of	|O
NS1	|B-PROTEIN
on	|O
the	|O
steady	|O
-	|O
state	|O
levels	|O
of	|O
P4	|B-PROTEIN
transcripts	|O
depends	|O
on	|O
the	|O
amplification	|O
of	|O
gene	|O
copy	|O
number	|O
and	|O
the	|O
integrity	|O
of	|O
the	|O
terminal	|O
repeats	|O
.	|O

The	|O
minus	|O
-	|O
end	|O
-	|O
directed	|O
microtubule	|O
motors	|O
,	|O
the	|O
dyneins	|B-PROTEIN
,	|O
may	|O
also	|O
constitute	|O
a	|O
superfamily	|O
of	|O
force	|O
-	|O
generating	|O
proteins	|O
with	|O
distinct	|O
attachment	|O
domains	|O
.	|O

It	|O
is	|O
transparent	|O
,	|O
cheap	|O
to	|O
be	|O
made	|O
,	|O
and	|O
easy	|O
to	|O
empty	|O
and	|O
was	|O
tested	|O
in	|O
118	|O
animals	|O
for	|O
two	|O
and	|O
four	|O
weeks	|O
.	|O

The	|O
incompatibility	|O
group	|O
W	|O
plasmid	|O
pSa	|O
suppresses	|O
Agrobacterium	|O
tumefaciens	|O
oncogenicity	|O
(	|O
J.	|O

Potential	|O
translational	|O
start	|O
signals	|O
are	|O
upstream	|O
of	|O
ORF1	|O
and	|O
ORF2	|O
.	|O

Imaging	|O
of	|O
D2	|B-PROTEIN
dopamine	|I-PROTEIN
receptor	|I-PROTEIN

The	|O
Thr161Val	|O
mutation	|O
causes	|O
a	|O
lethal	|O
phenotype	|O
in	|O
the	|O
fission	|O
yeast	|O
Schizosaccharomyces	|O
pombe	|O
,	|O
while	|O
replacement	|O
of	|O
Thr161	|O
with	|O
glutamic	|O
acid	|O
,	|O
potentially	|O
mimicking	|O
phosphorylation	|O
,	|O
causes	|O
uncoordination	|O
of	|O
mitosis	|O
and	|O
multiple	|O
cytokinesis	|O
.	|O

The	|O
abundance	|O
of	|O
transcripts	|O
from	|O
several	|O
unrelated	|O
genes	|O
is	|O
decreased	|O
in	|O
cdc68	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
cells	|O
after	|O
transfer	|O
to	|O
the	|O
restrictive	|O
temperature	|O
,	|O
while	|O
at	|O
least	|O
one	|O
transcript	|O
,	|O
from	|O
the	|O
HSP82	|B-PROTEIN
gene	|O
,	|O
persists	|O
in	|O
an	|O
aberrant	|O
fashion	|O
.	|O

Deregulation	|O
of	|O
their	|O
expression	|O
may	|O
contribute	|O
to	|O
malignant	|O
transformation	|O
associated	|O
with	|O
HTLV	|O
-	|O
1	|O
infection	|O
.	|O

The	|O
murine	|O
Mov	|B-PROTEIN
-	|I-PROTEIN
34	|I-PROTEIN
gene	|O
:	|O
full	|O
-	|O
length	|O
cDNA	|O
and	|O
genomic	|O
organization	|O
.	|O

CREB	|B-PROTEIN
was	|O
identified	|O
as	|O
one	|O
of	|O
the	|O
protein	|O
components	|O
in	|O
several	|O
of	|O
the	|O
gel	|O
shift	|O
complexes	|O
formed	|O
with	|O
the	|O
variant	|O
CRE	|O
.	|O

The	|O
spectrum	|O
of	|O
histologically	|O
diagnosed	|O
malignant	|O
neoplasms	|O
in	|O
Sabah	|O
,	|O
1983-1988	|O
.	|O

When	|O
transfected	|O
into	|O
Drosophila	|O
SL	|O
-	|O
2	|O
cells	|O
,	|O
pCAT	|O
plasmid	|O
containing	|O
2,090	|O
bp	|O
of	|O
5'	|O
-	|O
flanking	|O
region	|O
shows	|O
a	|O
3.0	|O
-	|O
to	|O
3.5	|O
-	|O
fold	|O
increase	|O
in	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
activity	|O
after	|O
induction	|O
with	|O
retinoic	|O
acid	|O
and	|O
/	|O
or	|O
8	|O
-	|O
bromo	|O
-	|O
cAMP	|O
.	|O

Two	|O
alternatively	|O
spliced	|O
5'	|O
UTRs	|O
,	|O
designated	|O
type	|O
I	|O
and	|O
type	|O
II	|O
,	|O
of	|O
222	|O
and	|O
115	|O
bp	|O
,	|O
respectively	|O
,	|O
were	|O
found	|O
associated	|O
with	|O
PFP	|B-PROTEIN
.	|O

The	|O
N	|O
-	|O
terminus	|O
of	|O
another	|O
open	|O
reading	|O
frame	|O
was	|O
found	|O
3'	|O
from	|O
nifA	|B-PROTEIN
and	|O
tentatively	|O
identified	|O
as	|O
nifB	|B-PROTEIN
by	|O
amino	|O
acid	|O
sequence	|O
comparison	|O
.	|O

The	|O
RNA	|O
genome	|O
of	|O
rabbit	|O
hemorrhagic	|O
disease	|O
virus	|O
(	|O
RHDV	|O
)	|O
was	|O
molecularly	|O
cloned	|O
.	|O

Therefore	|O
,	|O
we	|O
have	|O
developed	|O
a	|O
system	|O
to	|O
study	|O
nuclear	|O
targeting	|O
in	|O
plants	|O
and	|O
have	|O
established	|O
that	|O
the	|O
nuclear	|O
transport	|O
machinery	|O
is	|O
similar	|O
in	|O
monocots	|O
and	|O
dicots	|O
.	|O

A	|O
novel	|O
cDNA	|O
clone	|O
termed	|O
R2	|O
was	|O
isolated	|O
by	|O
subtractive	|O
hybridization	|O
of	|O
a	|O
cDNA	|O
library	|O
of	|O
phytohemagglutinin	|B-PROTEIN
(	|O
PHA	|B-PROTEIN
)	|O
/	|O
phorbol	|O
myristate	|O
acetate	|O
-	|O
stimulated	|O
Jurkat	|O
cells	|O
and	|O
by	|O
rescreening	|O
a	|O
cDNA	|O
library	|O
of	|O
PHA	|B-PROTEIN
-	|O
stimulated	|O
peripheral	|O
blood	|O
lymphocytes	|O
.	|O

In	|O
conclusion	|O
,	|O
we	|O
observed	|O
a	|O
great	|O
regeneration	|O
ability	|O
following	|O
mechanical	|O
injury	|O
in	|O
the	|O
nasal	|O
mucosa	|O
.	|O

There	|O
occurred	|O
a	|O
linear	|O
relationship	|O
between	|O
the	|O
drop	|O
in	|O
glucose	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphatase	|I-PROTEIN
dehydrogenase	|I-PROTEIN
activity	|O
and	|O
in	|O
vitamin	|O
E	|O
level	|O
,	|O
on	|O
one	|O
hand	|O
,	|O
and	|O
the	|O
duration	|O
of	|O
poisoning	|O
with	|O
sodium	|O
nitrite	|O
.	|O

A	|O
vector	|O
containing	|O
a	|O
transcriptionally	|O
inactive	|O
neomycin	|B-PROTEIN
phosphotransferase	|I-PROTEIN
II	|I-PROTEIN
gene	|O
was	|O
used	|O
to	|O
select	|O
promoter	|O
sequences	|O
from	|O
a	|O
pool	|O
of	|O
random	|O
genomic	|O
DNA	|O
fragments	|O
.	|O

Chagas	|O
'	|O
disease	|O
,	|O
visceral	|O
leishmaniasis	|O
,	|O
anti	|B-PROTEIN
-	|I-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
,	|O
schistosomiasis	|O
,	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
and	|O
normal	|O
controls	|O
.	|O

Previous	|O
analysis	|O
of	|O
the	|O
98	|O
-	|O
bp	|O
sequence	|O
has	|O
delineated	|O
several	|O
protein	|O
-	|O
binding	|O
domains	|O
that	|O
are	|O
recognized	|O
by	|O
nuclear	|O
factors	|O
present	|O
in	|O
human	|O
brain	|O
cells	|O
.	|O

The	|O
second	|O
transcriptional	|O
unit	|O
,	|O
designated	|O
UL26.5	|B-PROTEIN
,	|O
predicted	|O
to	|O
specify	|O
a	|O
protein	|O
of	|O
329	|O
amino	|O
acids	|O
,	|O
encodes	|O
the	|O
family	|B-PROTEIN
35	|I-PROTEIN
proteins	|O
;	|O
it	|O
is	|O
transcribed	|O
by	|O
an	|O
mRNA	|O
which	|O
initiates	|O
at	|O
approximately	|O
nucleotide	|O
+	|O
1000	|O
of	|O
the	|O
UL26	|B-PROTEIN
transcription	|O
initiation	|O
site	|O
and	|O
is	|O
translated	|O
from	|O
the	|O
methionine	|O
initiation	|O
codon	|O
located	|O
at	|O
position	|O
+	|O
1099	|O
of	|O
the	|O
UL26	|B-PROTEIN
transcriptional	|O
unit	|O
.	|O

The	|O
adeno	|O
-	|O
associated	|O
virus	|O
(	|O
AAV	|O
)	|O
rep	|B-PROTEIN
gene	|O
encodes	|O
four	|O
proteins	|O
(	|O
Rep78	|B-PROTEIN
,	|O
Rep68	|B-PROTEIN
,	|O
Rep52	|B-PROTEIN
,	|O
and	|O
Rep40	|B-PROTEIN
)	|O
required	|O
for	|O
AAV	|O
DNA	|O
replication	|O
and	|O
AAV	|O
gene	|O
regulation	|O
.	|O

A	|O
larger	|O
region	|O
upstream	|O
of	|O
human	|O
CMV	|O
dbp	|B-PROTEIN
also	|O
mediated	|O
replication	|O
in	|O
transient	|O
assays	|O
.	|O

It	|O
also	|O
contains	|O
a	|O
picornaviral	|O
3C	|B-PROTEIN
-	|O
like	|O
protease	|O
domain	|O
and	|O
two	|O
papain	|B-PROTEIN
-	|O
like	|O
protease	|O
domains	|O
.	|O

However	|O
,	|O
the	|O
relative	|O
positions	|O
of	|O
the	|O
VV	|O
genes	|O
(	|O
genus	|O
Orthopoxvirus	|O
)	|O
are	|O
different	|O
than	|O
those	|O
of	|O
the	|O
corresponding	|O
ORFs	|O
in	|O
SFV	|O
(	|O
genus	|O
Leporipoxvirus	|O
)	|O
,	|O
indicating	|O
complex	|O
rearrangements	|O
of	|O
DNA	|O
in	|O
the	|O
genome	|O
of	|O
one	|O
or	|O
both	|O
of	|O
these	|O
viruses	|O
subsequent	|O
to	|O
their	|O
divergence	|O
from	|O
a	|O
common	|O
ancestor	|O
.	|O

This	|O
result	|O
suggests	|O
that	|O
phosphorylation	|O
of	|O
Thr	|O
14	|O
and	|O
/	|O
or	|O
Tyr	|O
15	|O
inhibits	|O
p34cdc2	|B-PROTEIN
kinase	|O
activity	|O
,	|O
in	|O
line	|O
with	|O
the	|O
location	|O
of	|O
these	|O
residues	|O
within	|O
the	|O
putative	|O
ATP	|O
binding	|O
site	|O
of	|O
the	|O
kinase	|O
.	|O

In	|O
short	|O
-	|O
term	|O
cotransfections	|O
,	|O
a	|O
pFRTK	|B-PROTEIN
-	|O
CAT	|B-PROTEIN
target	|O
containing	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
sites	|I-PROTEIN
from	|O
the	|O
EBV	|O
origin	|O
of	|O
plasmid	|O
replication	|O
,	|O
ori	|B-PROTEIN
-	|I-PROTEIN
P	|I-PROTEIN
,	|O
was	|O
transactivated	|O
by	|O
a	|O
carboxy	|O
-	|O
terminal	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
construction	|O
(	|O
amino	|O
acids	|O
450	|O
to	|O
641	|O
)	|O
that	|O
also	|O
carried	|O
a	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
nuclear	|O
localization	|O
signal	|O
.	|O

The	|O
findings	|O
are	|O
compatible	|O
with	|O
the	|O
idea	|O
that	|O
the	|O
genes	|O
encoding	|O
PDGF	|B-PROTEIN
receptors	|I-PROTEIN
in	|O
glioma	|O
cells	|O
are	|O
regulated	|O
in	|O
concert	|O
with	|O
other	|O
genes	|O
,	|O
the	|O
expression	|O
of	|O
which	|O
may	|O
reflect	|O
the	|O
developmental	|O
program	|O
of	|O
normal	|O
glia	|O
cell	|O
lineages	|O
.	|O

Suggestive	|O
evidence	|O
was	|O
obtained	|O
that	|O
cstA	|B-PROTEIN
is	|O
involved	|O
in	|O
peptide	|O
utilization	|O
.	|O

This	|O
study	|O
tested	|O
the	|O
hypothesis	|O
that	|O
sodium	|O
channel	|O
blocking	|O
drugs	|O
selectively	|O
prolong	|O
the	|O
late	|O
potential	|O
,	|O
or	|O
terminal	|O
low	|O
amplitude	|O
signal	|O
,	|O
portion	|O
of	|O
the	|O
signal	|O
-	|O
averaged	|O
QRS	|O
complex	|O
and	|O
that	|O
prolongation	|O
of	|O
the	|O
late	|O
potential	|O
would	|O
correlate	|O
with	|O
slowing	|O
of	|O
ventricular	|O
tachycardia	|O
.	|O

Identification	|O
and	|O
nucleotide	|O
sequence	|O
of	|O
Rhizobium	|O
meliloti	|O
insertion	|O
sequence	|O
ISRm3	|B-PROTEIN
:	|O
similarity	|O
between	|O
the	|O
putative	|O
transposase	|B-PROTEIN
encoded	|O
by	|O
ISRm3	|B-PROTEIN
and	|O
those	|O
encoded	|O
by	|O
Staphylococcus	|O
aureus	|O
IS256	|B-PROTEIN
and	|O
Thiobacillus	|O
ferrooxidans	|O
IST2	|B-PROTEIN
.	|O

To	|O
determine	|O
the	|O
relationship	|O
of	|O
these	|O
viruses	|O
,	|O
the	|O
complete	|O
DNA	|O
sequence	|O
of	|O
KV	|O
consisting	|O
of	|O
4754	|O
bp	|O
was	|O
determined	|O
.	|O

Whereas	|O
a	|O
PR55	|B-PROTEIN
beta	|O
transcript	|O
of	|O
about	|O
2.3	|O
kb	|O
was	|O
detected	|O
at	|O
high	|O
levels	|O
in	|O
the	|O
neuroblastoma	|O
derived	|O
cell	|O
line	|O
LA	|O
-	|O
N	|O
-	|O
1	|O
,	|O
the	|O
level	|O
of	|O
the	|O
mRNA	|O
was	|O
very	|O
low	|O
in	|O
the	|O
other	|O
human	|O
cell	|O
lines	|O
analyzed	|O
.	|O

Heterodimers	|O
of	|O
myogenin	|B-PROTEIN
and	|O
E12	|B-PROTEIN
(	|O
or	|O
MyoD	|B-PROTEIN
and	|O
E12	|B-PROTEIN
)	|O
specifically	|O
bound	|O
a	|O
restriction	|O
fragment	|O
extending	|O
from	|O
-	|O
200	|O
to	|O
-	|O
103	|O
relative	|O
to	|O
the	|O
start	|O
of	|O
cardiac	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
transcription	|O
.	|O

The	|O
effects	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
were	|O
further	|O
dissected	|O
by	|O
showing	|O
that	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
can	|O
inhibit	|O
differentiation	|O
independently	|O
of	|O
Id	|B-PROTEIN
,	|O
a	|O
negative	|O
regulator	|O
of	|O
muscle	|O
differentiation	|O
.	|O

Stable	|O
association	|O
of	|O
U2	|B-PROTEIN
snRNP	|O
with	|O
the	|O
branchpoint	|O
sequence	|O
of	|O
mammalian	|O
pre	|O
-	|O
mRNAs	|O
requires	|O
binding	|O
of	|O
a	|O
non	|O
-	|O
snRNP	|O
protein	|O
to	|O
the	|O
polypyrimidine	|O
tract	|O
.	|O

Naturally	|O
acquired	|O
antibodies	|O
were	|O
demonstrated	|O
in	|O
some	|O
rabbits	|O
kept	|O
on	|O
commercial	|O
farms	|O
.	|O

The	|O
Italian	|O
Lung	|O
Cancer	|O
Task	|O
Force	|O
(	|O
FONICAP	|O
)	|O
.	|O

The	|O
promoter	|O
activity	|O
of	|O
the	|O
gene	|O
encoding	|O
Alzheimer	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
amyloid	|I-PROTEIN
precursor	|I-PROTEIN
protein	|O
(	|O
APP	|B-PROTEIN
)	|O
is	|O
regulated	|O
by	|O
two	|O
blocks	|O
of	|O
upstream	|O
sequences	|O
.	|O

Biol.	|O

Nucleotide	|O
sequences	|O
between	|O
the	|O
env	|B-PROTEIN
gene	|O
and	|O
the	|O
LTR	|B-PROTEIN
of	|I-PROTEIN
SFV	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
were	|O
determined	|O
.	|O

This	|O
element	|O
was	|O
used	|O
to	|O
screen	|O
an	|O
EMBL3	|O
mouse	|O
genomic	|O
library	|O
.	|O

The	|O
MVV	|O
-	|O
value	|O
is	|O
under	|O
the	|O
predicted	|O
level	|O
in	|O
the	|O
case	|O
of	|O
67-76	|O
percent	|O
.	|O

The	|O
rad9.1	|B-PROTEIN
92	|O
DNA	|O
repair	|O
mutant	|O
from	|O
the	|O
fission	|O
yeast	|O
,	|O
Schizosaccharomyces	|O
pombe	|O
,	|O
is	|O
sensitive	|O
to	|O
both	|O
UV	|O
and	|O
ionising	|O
radiation	|O
.	|O

Review	|O
:	|O
deterioration	|O
of	|O
glucose	|O
tolerance	|O
with	|O
age	|O
:	|O
the	|O
role	|O
of	|O
insulin	|B-PROTEIN
resistance	|O
.	|O

The	|O
5'	|O
region	|O
shows	|O
strong	|O
sequence	|O
similarity	|O
to	|O
Escherichia	|O
coli	|O
consensus	|O
promoters	|O
and	|O
ribosome	|O
-	|O
binding	|O
sequences	|O
and	|O
allows	|O
high	|O
levels	|O
of	|O
expression	|O
in	|O
E.	|O
coli	|O
.	|O

Premature	|O
initiation	|O
of	|O
mitosis	|O
in	|O
yeast	|O
lacking	|O
RCC1	|B-PROTEIN
or	|O
an	|O
interacting	|O
GTPase	|B-PROTEIN
.	|O

The	|O
method	|O
has	|O
been	|O
routinely	|O
used	|O
in	|O
our	|O
laboratory	|O
for	|O
1	|O
year	|O
and	|O
has	|O
proven	|O
to	|O
be	|O
a	|O
reliable	|O
procedure	|O
for	|O
the	|O
biological	|O
control	|O
of	|O
occupational	|O
exposure	|O
to	|O
toluene	|O
and	|O
/	|O
or	|O
xylene	|O
.	|O

The	|O
patient	|O
was	|O
a	|O
78	|O
-	|O
year	|O
-	|O
old	|O
male	|O
in	|O
whom	|O
skin	|O
lesions	|O
preceded	|O
the	|O
diagnosis	|O
of	|O
myelofibrosis	|O
.	|O

Oculus	|O
-	|O
500	|O
is	|O
a	|O
group	|O
of	|O
high	|O
resolution	|O
imaging	|O
boards	|O
for	|O
use	|O
with	|O
IBM	|O
-	|O
AT	|O
and	|O
compatible	|O
computers	|O
.	|O

The	|O
human	|O
cDNA	|O
was	|O
used	|O
to	|O
demonstrate	|O
that	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
could	|O
rapidly	|O
stimulate	|O
MARCKS	|B-PROTEIN
gene	|O
transcription	|O
in	|O
the	|O
human	|O
promyelocytic	|O
leukemia	|O
cell	|O
line	|O
HL60	|O
.	|O

After	|O
resection	|O
of	|O
the	|O
proximal	|O
fragment	|O
,	|O
all	|O
scaphoid	|O
contact	|O
area	|O
and	|O
pressure	|O
was	|O
born	|O
by	|O
the	|O
distal	|O
scaphoid	|O
fragment	|O
.	|O

Plate	|O
luting	|O
,	|O
a	|O
technique	|O
that	|O
uses	|O
polymethylmethacrylate	|O
(	|O
PMMA	|O
)	|O
interposed	|O
between	|O
the	|O
plate	|O
and	|O
the	|O
bone	|O
,	|O
as	|O
well	|O
as	|O
between	|O
the	|O
screw	|O
heads	|O
and	|O
the	|O
plate	|O
,	|O
to	|O
improve	|O
the	|O
stability	|O
of	|O
internal	|O
fixation	|O
was	|O
tested	|O
in	|O
vitro	|O
using	|O
20	|O
paired	|O
equine	|O
third	|O
metacarpal	|O
bones	|O
with	|O
mid	|O
-	|O
diaphyseal	|O
osteotomies	|O
plated	|O
with	|O
six	|O
-	|O
hole	|O
broad	|O
ASIF	|O
compression	|O
plates	|O
.	|O

These	|O
features	|O
were	|O
considered	|O
consistent	|O
with	|O
a	|O
diagnosis	|O
of	|O
Rothmund	|O
-	|O
Thomson	|O
syndrome	|O
.	|O

Thyroid	|O
lymphoma	|O
and	|O
its	|O
management	|O
.	|O

The	|O
protein	|O
encoded	|O
by	|O
ORF113	|B-PROTEIN
contains	|O
a	|O
transmembrane	|O
domain	|O
.	|O

Space	|O
limitations	|O
prevent	|O
an	|O
exhaustive	|O
review	|O
of	|O
all	|O
biologic	|O
pharmaceuticals	|O
,	|O
such	|O
as	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activating	|I-PROTEIN
substance	|I-PROTEIN
,	|O
hormones	|O
(	|O
e.g.	|O
,	|O
thyroid	|O
,	|O
insulin	|B-PROTEIN
,	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
,	|O
erythropoietin	|B-PROTEIN
)	|O
,	|O
clotting	|O
factors	|O
,	|O
and	|O
blood	|O
products	|O
.	|O

Dd	|O
PK1	|B-PROTEIN
RNA	|O
decreases	|O
after	|O
6	|O
h	|O
of	|O
starvation	|O
to	|O
re	|O
-	|O
accumulate	|O
once	|O
the	|O
cells	|O
have	|O
aggregated	|O
.	|O

The	|O
various	|O
forms	|O
of	|O
sickle	|O
cell	|O
disease	|O
share	|O
the	|O
common	|O
feature	|O
of	|O
an	|O
abnormal	|O
globin	|B-PROTEIN
chain	|O
that	|O
,	|O
under	|O
certain	|O
conditions	|O
such	|O
as	|O
hypoxia	|O
,	|O
results	|O
in	|O
the	|O
sickling	|O
of	|O
red	|O
blood	|O
cells	|O
and	|O
obstruction	|O
of	|O
blood	|O
vessels	|O
.	|O

The	|O
primary	|O
structure	|O
of	|O
each	|O
of	|O
the	|O
three	|O
proteins	|O
has	|O
about	|O
70%	|O
homology	|O
with	|O
that	|O
of	|O
mouse	|O
contrapsin	|B-PROTEIN
,	|O
in	|O
contrast	|O
to	|O
43-46%	|O
homology	|O
with	|O
that	|O
of	|O
rat	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
protease	|I-PROTEIN
inhibitor	|O
.	|O

Patterns	|O
of	|O
connections	|O
underlying	|O
cross	|O
-	|O
modality	|O
integration	|O
were	|O
studied	|O
by	|O
injecting	|O
distinguishable	|O
,	|O
retrograde	|O
tracers	|O
(	|O
Fluoro	|O
-	|O
Gold	|O
and	|O
diamidino	|O
yellow	|O
)	|O
in	|O
pairwise	|O
manner	|O
into	|O
different	|O
sensory	|O
representations	|O
(	|O
visual	|O
,	|O
somatosensory	|O
,	|O
and	|O
auditory	|O
)	|O
in	|O
the	|O
cerebral	|O
cortex	|O
of	|O
the	|O
rat	|O
.	|O

Young	|O
CD	|O
-	|O
1	|O
mice	|O
,	|O
4	|O
days	|O
old	|O
,	|O
exposed	|O
to	|O
0.1%	|O
nicotine	|O
sulfate	|O
on	|O
gestational	|O
days	|O
6-20	|O
were	|O
compared	|O
with	|O
untreated	|O
pups	|O
of	|O
the	|O
same	|O
age	|O
to	|O
determine	|O
its	|O
effect	|O
on	|O
the	|O
development	|O
of	|O
mandibular	|O
first	|O
molars	|O
.	|O

USF	|B-PROTEIN
synthesized	|O
in	|O
an	|O
in	|O
vitro	|O
transcription	|O
and	|O
translation	|O
system	|O
also	|O
binds	|O
to	|O
the	|O
ADH	|B-PROTEIN
promoter	|O
as	|O
well	|O
as	|O
to	|O
the	|O
MLP	|O
.	|O

The	|O
across	|O
-	|O
fiber	|O
pattern	|O
of	|O
the	|O
responses	|O
to	|O
hypotonic	|O
NaCl	|O
solutions	|O
correlated	|O
strongly	|O
to	|O
that	|O
elicited	|O
by	|O
distilled	|O
H2O	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

Arterial	|O
radioactivity	|O
content	|O
after	|O
the	|O
intravenous	|O
administration	|O
of	|O
HMPAO	|O
in	|O
seven	|O
human	|O
subjects	|O
was	|O
analyzed	|O
.	|O

Linear	|O
regression	|O
analysis	|O
was	|O
performed	|O
and	|O
the	|O
following	|O
result	|O
was	|O
obtained	|O
:	|O
clearance	|O
(	|O
HMPAO	|O
)	|O
=	|O
0.07	|O
+	|O
0.43	|O
.	|O
rCBF	|O
with	|O
a	|O
high	|O
significance	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

Human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
IN	|B-PROTEIN
,	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
,	|O
was	|O
purified	|O
to	|O
near	|O
homogeneity	|O
.	|O

Thigh	|O
girth	|O
correlated	|O
positively	|O
with	|O
HDL	|B-PROTEIN
and	|O
HDL2	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
and	|O
mass	|O
,	|O
and	|O
with	|O
LDL	|B-PROTEIN
particle	|O
size	|O
among	|O
women	|O
.	|O

Contributions	|O
from	|O
pairs	|O
of	|O
source	|O
and	|O
target	|O
volume	|O
elements	|O
are	|O
summed	|O
for	|O
the	|O
S	|O
values	|O
between	|O
the	|O
tumor	|O
and	|O
itself	|O
,	|O
between	|O
the	|O
remaining	|O
healthy	|O
host	|O
organ	|O
and	|O
itself	|O
,	|O
and	|O
between	|O
the	|O
tumor	|O
and	|O
the	|O
remaining	|O
healthy	|O
host	|O
organ	|O
,	|O
with	|O
the	|O
reciprocity	|O
theorem	|O
assumed	|O
for	|O
the	|O
last	|O
.	|O

Tests	|O
showed	|O
that	|O
an	|O
overall	|O
impression	|O
of	|O
the	|O
force	|O
applied	|O
could	|O
be	|O
obtained	|O
from	|O
a	|O
laboratory	|O
simulation	|O
,	|O
but	|O
that	|O
clearing	|O
cement	|O
and	|O
testing	|O
cement	|O
were	|O
not	|O
modelled	|O
by	|O
this	|O
method	|O
.	|O

The	|O
cDNA	|O
contained	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
1392	|O
bp	|O
that	|O
predicted	|O
a	|O
protein	|O
of	|O
464	|O
amino	|O
acids	|O
and	|O
a	|O
molecular	|O
mass	|O
of	|O
52	|O
kDa	|O
;	|O
this	|O
protein	|O
has	|O
97%	|O
identity	|O
to	|O
rat	|O
liver	|O
glucokinase	|B-PROTEIN
.	|O

Analysis	|O
of	|O
viral	|O
mutants	|O
in	|O
vivo	|O
demonstrated	|O
that	|O
the	|O
NFIII	|B-PROTEIN
/	|O
OCT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
site	|O
and	|O
a	|O
conserved	|O
ATF	|B-PROTEIN
motif	|O
were	|O
important	|O
for	|O
efficient	|O
viral	|O
growth	|O
.	|O

Recovery	|O
of	|O
radiolabelled	|O
BA	|O
through	|O
urine	|O
(	|O
28%	|O
)	|O
and	|O
faeces	|O
(	|O
22%	|O
)	|O
up	|O
to	|O
96	|O
hrs	|O
averaged	|O
50%	|O
,	|O
whereas	|O
residual	|O
radioactivity	|O
in	|O
liver	|O
and	|O
testis	|O
experienced	|O
a	|O
recovery	|O
of	|O
29%	|O
in	|O
scorbutic	|O
animals	|O
.	|O

Saccharomyces	|O
cerevisiae	|O
has	|O
been	|O
used	|O
widely	|O
both	|O
as	|O
a	|O
model	|O
system	|O
for	|O
unraveling	|O
the	|O
biochemical	|O
,	|O
genetic	|O
,	|O
and	|O
molecular	|O
details	|O
of	|O
gene	|O
expression	|O
and	|O
the	|O
secretion	|O
process	|O
,	|O
and	|O
as	|O
a	|O
host	|O
for	|O
the	|O
production	|O
of	|O
heterologous	|O
proteins	|O
of	|O
biotechnological	|O
interest	|O
.	|O

Paradoxically	|O
,	|O
however	|O
,	|O
the	|O
GH	|B-PROTEIN
receptor	|I-PROTEIN
cloned	|O
from	|O
liver	|O
exhibits	|O
no	|O
sequence	|O
similarity	|O
to	|O
receptors	|O
with	|O
known	|O
signal	|O
transduction	|O
mechanisms	|O
,	|O
including	|O
those	|O
exhibiting	|O
ligand	|O
-	|O
activated	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
.	|O

This	|O
indicates	|O
that	|O
under	|O
certain	|O
experimental	|O
conditions	|O
cdc2	|B-PROTEIN
/	|O
p58	|B-PROTEIN
and	|O
cdc2	|B-PROTEIN
/	|O
p62	|B-PROTEIN
may	|O
express	|O
some	|O
differences	|O
in	|O
their	|O
catalytic	|O
activity	|O
.	|O

Mutation	|O
analysis	|O
implicated	|O
multiple	|O
segments	|O
of	|O
the	|O
5'	|O
untranslated	|O
region	|O
as	|O
contributing	|O
to	|O
the	|O
inhibitory	|O
effect	|O
.	|O

Identification	|O
of	|O
Ets	|B-PROTEIN
-	|O
and	|O
notch	|B-PROTEIN
-	|O
related	|O
subunits	|O
in	|O
GA	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

The	|O
enzymatic	|O
response	|O
of	|O
neutrophils	|O
and	|O
monocytes	|O
was	|O
similar	|O
although	|O
the	|O
magnitude	|O
of	|O
the	|O
NADPH	|B-PROTEIN
oxidase	|I-PROTEIN
activity	|O
was	|O
significantly	|O
higher	|O
in	|O
neutrophils	|O
than	|O
in	|O
monocytes	|O
.	|O

In	|O
the	|O
ileum	|O
,	|O
enterotoxin	|O
increased	|O
the	|O
luminal	|O
disappearance	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
and	|O
peripheral	|O
blood	|O
appearance	|O
(	|O
P	|O
less	|O
than	|O
0.001	|O
)	|O
of	|O
chloroquine	|O
.	|O

Formalin	|O
activated	|O
both	|O
SNO	|O
NS	|O
and	|O
NnS	|O
neurones	|O
,	|O
but	|O
,	|O
when	|O
they	|O
responded	|O
,	|O
NS	|O
neurones	|O
(	|O
n	|O
=	|O
5	|O
)	|O
showed	|O
only	|O
the	|O
first	|O
phase	|O
of	|O
activity	|O
while	|O
NnS	|O
neurones	|O
showed	|O
either	|O
one	|O
(	|O
n	|O
=	|O
13	|O
)	|O
or	|O
two	|O
phases	|O
(	|O
n	|O
=	|O
6	|O
)	|O
.	|O

Uptake	|O
of	|O
ofloxacin	|O
by	|O
Escherichia	|O
coli	|O

It	|O
is	|O
concluded	|O
that	|O
attention	|O
to	|O
these	|O
issues	|O
can	|O
substantially	|O
improve	|O
the	|O
quality	|O
of	|O
research	|O
on	|O
AIDS	|O
related	|O
behaviors	|O
on	|O
Black	|O
communities	|O
.	|O

The	|O
effectiveness	|O
of	|O
alpha	|O
-	|O
mercapto	|O
-	|O
beta	|O
-	|O
(	|O
2	|O
-	|O
furyl	|O
)	|O
acrylic	|O
acid	|O
(	|O
MFA	|O
)	|O
and	|O
N	|O
-	|O
benzyl	|O
-	|O
N	|O
-	|O
dithiocarboxy	|O
-	|O
D	|O
-	|O
glucamine	|O
(	|O
NaB	|O
)	|O
,	|O
used	|O
in	|O
combination	|O
,	|O
in	|O
the	|O
mobilization	|O
and	|O
excretion	|O
of	|O
lead	|O
was	|O
investigated	|O
in	|O
rats	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
beta	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
may	|O
act	|O
as	|O
a	|O
tissue	|O
-	|O
specific	|O
,	|O
trans	|O
-	|O
acting	|O
regulator	|O
of	|O
the	|O
expression	|O
of	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
zein	|I-PROTEIN
gene	|O
in	|O
developing	|O
maize	|O
endosperm	|O
.	|O

This	|O
study	|O
examines	|O
the	|O
effects	|O
of	|O
hypovolemia	|O
on	|O
the	|O
extracellular	|O
ptO2	|O
and	|O
ptH	|O
distributions	|O
at	|O
multiple	|O
tissue	|O
sites	|O
using	|O
a	|O
recently	|O
developed	|O
multipoint	|O
microelectrode	|O
,	|O
that	|O
provides	|O
simultaneous	|O
measurements	|O
of	|O
ptO2	|O
and	|O
ptH	|O
.	|O

All	|O
members	|O
are	|O
also	|O
capable	|O
of	|O
activating	|O
in	|O
vivo	|O
transcription	|O
from	|O
promoters	|O
that	|O
contain	|O
a	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
-	|O
binding	|O
site	|O
.	|O

The	|O
domains	|O
involved	|O
in	|O
superactivation	|O
appear	|O
to	|O
be	|O
a	|O
subset	|O
of	|O
those	|O
necessary	|O
to	|O
achieve	|O
synergistic	|O
activation	|O
.	|O

Information	|O
on	|O
conserved	|O
noncoding	|O
sequences	|O
will	|O
help	|O
in	|O
studies	|O
on	|O
the	|O
regulation	|O
of	|O
the	|O
pro	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
collagen	|I-PROTEIN
gene	|O
.	|O

Chlamydia	|O
trachomatis	|O
and	|O
Chlamydia	|O
psittaci	|O
were	|O
not	|O
affected	|O
by	|O
methanol	|O
fixation	|O
.	|O

Although	|O
human	|O
infections	|O
with	|O
bacteraemia	|O
due	|O
to	|O
Pasteurella	|O
multocida	|O
are	|O
not	|O
uncommon	|O
,	|O
endocarditis	|O
associated	|O
with	|O
P.	|O
haemolytica	|O
is	|O
rare	|O
.	|O

For	|O
SMX	|O
at	|O
pH	|O
7.0	|O
,	|O
a	|O
1	|O
:	|O
1	|O
complex	|O
is	|O
formed	|O
,	|O
but	|O
at	|O
pH	|O
7.5	|O
HPCD	|O
has	|O
little	|O
effect	|O
on	|O
the	|O
solubility	|O
of	|O
the	|O
highly	|O
ionized	|O
SMX	|O
,	|O
presumably	|O
since	|O
only	|O
un	|O
-	|O
ionized	|O
molecules	|O
can	|O
form	|O
inclusion	|O
complexes	|O
with	|O
the	|O
HPCD	|O
.	|O

PO2	|O
measurements	|O
using	|O
a	|O
double	|O
barrelled	|O
recess	|O
type	|O
microelectrodes	|O
were	|O
measured	|O
in	|O
the	|O
optic	|O
nerve	|O
head	|O
of	|O
miniature	|O
pigs	|O
in	|O
normoxia	|O
and	|O
hyperoxia	|O
.	|O

POU	|B-PROTEIN
-	|O
specific	|O
and	|O
POU	|B-PROTEIN
-	|O
homeo	|O
domains	|O
of	|O
Oct3	|B-PROTEIN
were	|O
produced	|O
in	|O
Echerichia	|O
coli	|O
for	|O
characterization	|O
of	|O
DNA	|O
binding	|O
to	|O
the	|O
octamer	|O
sequence	|O
.	|O

A	|O
deletion	|O
series	|O
of	|O
the	|O
5'	|O
flanking	|O
region	|O
was	|O
created	|O
from	|O
position	|O
-	|O
1329	|O
to	|O
-	|O
74	|O
relative	|O
to	|O
the	|O
transcriptional	|O
initiation	|O
site	|O
and	|O
similarly	|O
examined	|O
in	|O
transgenic	|O
tobacco	|O
.	|O

The	|O
nucleotide	|O
(	|O
nt	|O
)	|O
sequences	|O
of	|O
the	|O
exons	|O
,	|O
exon	|O
/	|O
intron	|O
boundaries	|O
and	|O
5'	|O
-	|O
and	|O
3'	|O
-	|O
untranslated	|O
regions	|O
were	|O
determined	|O
.	|O

Out	|O
of	|O
40	|O
patients	|O
,	|O
who	|O
initially	|O
did	|O
not	|O
show	|O
eye	|O
complications	|O
due	|O
to	|O
leprosy	|O
,	|O
37	|O
patients	|O
were	|O
essentially	|O
the	|O
same	|O
10	|O
years	|O
later	|O
.	|O

Thus	|O
,	|O
two	|O
very	|O
different	|O
regulatory	|O
elements	|O
are	|O
used	|O
to	|O
mediate	|O
estrogen	|O
induction	|O
of	|O
related	|O
genes	|O
in	|O
chickens	|O
and	|O
amphibians	|O
.	|O

Toxicity	|O
was	|O
very	|O
mild	|O
with	|O
both	|O
regimens	|O
,	|O
although	|O
sedation	|O
was	|O
significantly	|O
higher	|O
in	|O
arm	|O
B	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

Experimentally	|O
in	|O
green	|O
monkeys	|O
,	|O
Syrian	|O
hamsters	|O
and	|O
white	|O
mice	|O
the	|O
authors	|O
studied	|O
the	|O
pathogenic	|O
properties	|O
of	|O
a	|O
new	|O
virus	|O
Issyk	|O
-	|O
Kul	|O
.	|O

Increasing	|O
mean	|O
arterial	|O
pressure	|O
by	|O
phenylephrine	|O
infusion	|O
to	|O
levels	|O
much	|O
greater	|O
than	|O
produced	|O
by	|O
NMA	|O
and	|O
NNA	|O
caused	|O
only	|O
small	|O
reductions	|O
in	|O
cardiac	|O
output	|O
.	|O

J.	|O

Limits	|O
of	|O
energy	|O
turnover	|O
in	|O
relation	|O
to	|O
physical	|O
performance	|O
were	|O
addressed	|O
in	|O
terms	|O
of	|O
upper	|O
and	|O
lower	|O
limit	|O
,	|O
changes	|O
during	|O
a	|O
training	|O
programme	|O
and	|O
how	|O
to	|O
regulate	|O
energy	|O
balance	|O
at	|O
a	|O
changing	|O
energy	|O
turnover	|O
.	|O

With	|O
stepwise	|O
reductions	|O
in	|O
flow	|O
,	|O
the	|O
peak	|O
(	|O
S	|O
)	|O
and	|O
trough	|O
(	|O
D	|O
)	|O
points	|O
of	|O
the	|O
maximum	|O
shifted	|O
-	|O
frequency	|O
envelope	|O
fell	|O
in	|O
parallel	|O
in	|O
a	|O
linear	|O
fashion	|O
until	|O
D	|O
reached	|O
zero	|O
.	|O

The	|O
IE0	|B-PROTEIN
gene	|O
product	|O
also	|O
transactivated	|O
the	|O
IE1	|B-PROTEIN
promoter	|O
but	|O
did	|O
not	|O
affect	|O
expression	|O
from	|O
its	|O
own	|O
promoter	|O
.	|O

Moreover	|O
,	|O
promoters	|O
containing	|O
a	|O
TATA	|O
box	|O
in	|O
the	|O
absence	|O
of	|O
Sp1	|B-PROTEIN
sites	|O
or	|O
Sp1	|B-PROTEIN
sites	|O
in	|O
the	|O
absence	|O
of	|O
a	|O
TATA	|O
box	|O
were	|O
equally	|O
inducible	|O
in	|O
vitro	|O
,	|O
as	|O
was	|O
an	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
III	|I-PROTEIN
promoter	|O
.	|O

Evaluation	|O
of	|O
left	|O
ventricular	|O
function	|O
using	|O
gated	|O
planar	|O
myocardial	|O
imaging	|O
with	|O
Tc	|O
-	|O
99m	|O
-	|O
MIBI	|O

Ivermectin	|O
uptake	|O
and	|O
distribution	|O
in	|O
the	|O
plasma	|O
and	|O
tissue	|O
of	|O
Sudanese	|O
and	|O
Mexican	|O
patients	|O
infected	|O
with	|O
Onchocerca	|O
volvulus	|O
.	|O

Bone	|O
marrow	|O
abnormalities	|O
in	|O
Hodgkin	|O
's	|O
disease	|O
are	|O
reviewed	|O
and	|O
the	|O
current	|O
understanding	|O
of	|O
the	|O
pathological	|O
mechanisms	|O
leading	|O
to	|O
aplastic	|O
anemia	|O
is	|O
discussed	|O
.	|O

The	|O
smaller	|O
uptake	|O
rate	|O
and	|O
faster	|O
clearance	|O
rate	|O
resulted	|O
in	|O
the	|O
lower	|O
BCF	|O
for	|O
SWA	|O
killifish	|O
.	|O

The	|O
currently	|O
proposed	|O
extended	|O
arch	|O
repair	|O
should	|O
be	|O
reserved	|O
for	|O
the	|O
small	|O
group	|O
of	|O
infants	|O
with	|O
transverse	|O
aortic	|O
arch	|O
to	|O
ascending	|O
aorta	|O
diameter	|O
ratios	|O
(	|O
arch	|O
indices	|O
)	|O
of	|O
less	|O
than	|O
0.25	|O
.	|O

DNA	|O
hybridization	|O
analysis	|O
revealed	|O
that	|O
both	|O
pigmented	|O
and	|O
nonpigmented	|O
cells	|O
of	|O
Y.	|O
pestis	|O
possess	|O
a	|O
DNA	|O
locus	|O
homologous	|O
to	|O
the	|O
Escherichia	|O
coli	|O
fur	|B-PROTEIN
gene	|O
.	|O

Increases	|O
in	|O
the	|O
perfusate	|O
PCO2	|O
but	|O
not	|O
in	|O
the	|O
perfusate	|O
H+	|O
were	|O
highly	|O
correlated	|O
with	|O
decreases	|O
in	|O
both	|O
myocardial	|O
contractility	|O
and	|O
oxygen	|O
consumption	|O
(	|O
r2	|O
=	|O
.88	|O
)	|O
.	|O

Expression	|O
was	|O
cell	|O
cycle	|O
controlled	|O
,	|O
with	|O
steady	|O
-	|O
state	|O
RNA	|O
levels	|O
significantly	|O
higher	|O
in	|O
growth	|O
-	|O
arrested	|O
than	|O
in	|O
growth	|O
-	|O
stimulated	|O
cells	|O
.	|O

Determinants	|O
of	|O
recurrent	|O
ischaemia	|O
and	|O
revascularisation	|O
procedures	|O
after	|O
thrombolysis	|O
with	|O
recombinant	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
in	|O
primary	|O
coronary	|O
occlusion	|O
.	|O

Therefore	|O
,	|O
the	|O
rbcL	|B-PROTEIN
-	|O
rbcS	|B-PROTEIN
locus	|O
seems	|O
to	|O
be	|O
barely	|O
expressed	|O
under	|O
a	|O
standard	|O
condition	|O
for	|O
photoautotrophic	|O
growth	|O
.	|O

Relationship	|O
between	|O
mitochondrial	|O
NADH	|B-PROTEIN
-	|I-PROTEIN
ubiquinone	|I-PROTEIN
reductase	|I-PROTEIN
and	|O
a	|O
bacterial	|O
NAD	|B-PROTEIN
-	|I-PROTEIN
reducing	|I-PROTEIN
hydrogenase	|I-PROTEIN
.	|O

Analysis	|O
of	|O
mRNA	|O
expression	|O
shows	|O
that	|O
AT	|B-PROTEIN
-	|I-PROTEIN
BP1	|I-PROTEIN
and	|O
AT	|B-PROTEIN
-	|I-PROTEIN
BP2	|I-PROTEIN
are	|O
expressed	|O
in	|O
all	|O
the	|O
tissues	|O
examined	|O
.	|O

We	|O
report	|O
two	|O
patients	|O
receiving	|O
maintenance	|O
valproate	|O
,	|O
one	|O
with	|O
resolving	|O
acute	|O
hepatitis	|O
C	|O
and	|O
the	|O
other	|O
with	|O
chronic	|O
persistent	|O
hepatitis	|O
C	|O
,	|O
with	|O
incidental	|O
microvesicular	|O
steatosis	|O
demonstrated	|O
on	|O
oil	|O
-	|O
red	|O
O	|O
stains	|O
.	|O

3	|O
cases	|O

UDP	|B-PROTEIN
-	|I-PROTEIN
Gal	|I-PROTEIN
:	|I-PROTEIN
Gal	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
4GlcNAc	|I-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
galactosyltransferase	|I-PROTEIN
is	|O
a	|O
terminal	|O
glycosyltransferase	|B-PROTEIN
that	|O
is	|O
widely	|O
expressed	|O
in	|O
a	|O
variety	|O
of	|O
mammalian	|O
species	|O
,	|O
with	|O
the	|O
notable	|O
exception	|O
of	|O
man	|O
,	|O
apes	|O
,	|O
and	|O
Old	|O
World	|O
monkeys	|O
.	|O

A	|O
synthetic	|O
oligonucleotide	|O
containing	|O
the	|O
SRE	|O
sequence	|O
from	|O
the	|O
mouse	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
gene	|O
promoter	|O
(	|O
-	|O
299	|O
to	|O
-	|O
322	|O
)	|O
was	|O
radioactively	|O
labeled	|O
,	|O
used	|O
as	|O
a	|O
probe	|O
for	|O
the	|O
mobility	|O
shift	|O
assay	|O
and	|O
Southwestern	|O
(	|O
DNA	|O
-	|O
protein	|O
)	|O
blotting	|O
,	|O
and	|O
also	|O
used	|O
for	|O
sequence	|O
-	|O
specific	|O
affinity	|O
chromatography	|O
.	|O

Sequence	|O
requirements	|O
for	|O
premature	|O
transcription	|O
arrest	|O
within	|O
the	|O
first	|O
intron	|O
of	|O
the	|O
mouse	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
gene	|O
.	|O

Infarct	|O
regional	|O
ejection	|O
fraction	|O
improved	|O
by	|O
10.1	|O
+	|O
/	|O
-	|O
2.1%	|O
between	|O
early	|O
and	|O
late	|O
studies	|O
when	|O
the	|O
infarct	|O
-	|O
related	|O
artery	|O
was	|O
patent	|O
and	|O
by	|O
4.8	|O
+	|O
/	|O
-	|O
1.4%	|O
if	|O
it	|O
was	|O
occluded	|O
(	|O
p	|O
=	|O
0.048	|O
)	|O
;	|O
changes	|O
in	|O
global	|O
and	|O
noninfarct	|O
regional	|O
ejection	|O
fraction	|O
were	|O
similar	|O
irrespective	|O
of	|O
perfusion	|O
status	|O
.	|O

One	|O
of	|O
its	|O
lysine	|O
residues	|O
is	|O
modified	|O
by	|O
spermidine	|O
to	|O
form	|O
hypusine	|O
,	|O
a	|O
posttranslational	|O
modification	|O
unique	|O
to	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5A	|I-PROTEIN
.	|O

The	|O
plasmid	|O
shuffle	|O
technique	|O
was	|O
used	|O
to	|O
replace	|O
the	|O
wild	|O
-	|O
type	|O
gene	|O
with	|O
the	|O
mutant	|O
form	|O
,	|O
resulting	|O
in	|O
failure	|O
of	|O
the	|O
yeast	|O
cells	|O
to	|O
grow	|O
.	|O

If	|O
this	|O
is	|O
the	|O
case	|O
,	|O
identification	|O
and	|O
characterization	|O
of	|O
transcripts	|O
from	|O
the	|O
Ig	|B-PROTEIN
loci	|O
should	|O
permit	|O
a	|O
better	|O
understanding	|O
of	|O
the	|O
gene	|O
rearrangement	|O
process	|O
.	|O

Transcription	|O
of	|O
the	|O
metH	|B-PROTEIN
gene	|O
in	|O
Salmonella	|O
typhimurium	|O
and	|O
Escherichia	|O
coli	|O
is	|O
positively	|O
regulated	|O
by	|O
the	|O
metR	|B-PROTEIN
gene	|O
product	|O
,	|O
a	|O
DNA	|O
binding	|O
protein	|O
.	|O

Disruption	|O
of	|O
the	|O
chromosomal	|O
AAR1	|B-PROTEIN
gene	|O
in	|O
alpha	|O
and	|O
a	|O
/	|O
alpha	|O
cells	|O
conferred	|O
the	|O
nonmating	|O
phenotype	|O
,	|O
and	|O
the	|O
a	|O
/	|O
alpha	|O
diploids	|O
could	|O
not	|O
sporulate	|O
.	|O

The	|O
effect	|O
of	|O
ICRF	|O
-	|O
187	|O
on	|O
the	|O
antitumor	|O
response	|O
induced	|O
by	|O
the	|O
combination	|O
of	|O
ADR	|O
and	|O
WBH	|O
was	|O
also	|O
investigated	|O
in	|O
order	|O
to	|O
assess	|O
alterations	|O
in	|O
the	|O
therapeutic	|O
index	|O
of	|O
this	|O
combined	|O
therapeutic	|O
modality	|O
treatment	|O
.	|O

The	|O
ORF	|O
was	|O
analyzed	|O
for	|O
secondary	|O
structural	|O
features	|O
,	|O
and	|O
the	|O
sequence	|O
data	|O
bases	|O
were	|O
searched	|O
for	|O
homologies	|O
.	|O

This	|O
study	|O
indicates	|O
that	|O
this	|O
dose	|O
-	|O
intense	|O
regimen	|O
can	|O
be	|O
safely	|O
administered	|O
,	|O
even	|O
with	|O
the	|O
use	|O
of	|O
purged	|O
marrow	|O
,	|O
with	|O
an	|O
acceptable	|O
toxicity	|O
profile	|O
.	|O

Mitomycin	|O
-	|O
C	|O
can	|O
cause	|O
severe	|O
necrosis	|O
and	|O
ulceration	|O
when	|O
extravasated	|O
inadvertently	|O
into	|O
skin	|O
and	|O
soft	|O
tissues	|O
following	|O
IV	|O
drug	|O
administration	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
have	|O
cloned	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
nidogen	|B-PROTEIN
gene	|O
.	|O

INTERVENTIONS	|O
:	|O
Patients	|O
received	|O
rt	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
,	|O
heparin	|O
,	|O
and	|O
aspirin	|O
.	|O

Consistent	|O
with	|O
the	|O
in	|O
vivo	|O
result	|O
,	|O
the	|O
pseudorevertant	|O
endonucleases	|O
in	|O
the	|O
crude	|O
cell	|O
extract	|O
display	|O
site	|O
-	|O
specific	|O
partial	|O
DNA	|O
cleavage	|O
activity	|O
.	|O

Additionally	|O
,	|O
I	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
beta	|O
,	|O
but	|O
not	|O
I	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
alpha	|O
,	|O
also	|O
prevented	|O
the	|O
binding	|O
of	|O
Rel	|B-PROTEIN
to	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
site	|O
.	|O

Sequence	|O
analysis	|O
reveals	|O
that	|O
the	|O
DNA	|O
binding	|O
domain	|O
of	|O
ILF	|B-PROTEIN
has	|O
strong	|O
homology	|O
to	|O
the	|O
recently	|O
described	|O
fork	|B-PROTEIN
head	|I-PROTEIN
DNA	|O
binding	|O
domain	|O
found	|O
in	|O
the	|O
Drosophila	|O
homeotic	|O
protein	|O
fork	|B-PROTEIN
head	|I-PROTEIN
and	|O
a	|O
family	|O
of	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factors	|I-PROTEIN
,	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
.	|O

Lengthy	|O
and	|O
repeated	|O
hemodialyses	|O
were	|O
required	|O
to	|O
lower	|O
lithemia	|O
to	|O
nontoxic	|O
ranges	|O
.	|O

A	|O
single	|O
i.p	|O
.	|O
injection	|O
of	|O
d	|O
,	|O
l	|O
-	|O
baclofen	|O
10	|O
mg	|O
/	|O
kg	|O
both	|O
reduced	|O
noradrenaline	|O
(	|O
NA	|O
)	|O
biosynthesis	|O
in	|O
vivo	|O
(	|O
31%	|O
)	|O
and	|O
the	|O
endogenous	|O
concentration	|O
of	|O
normetanephrine	|O
(	|O
NMN	|O
)	|O
(	|O
32%	|O
)	|O
and	|O
increased	|O
NA	|O
levels	|O
(	|O
28%	|O
)	|O
.	|O

Fufang	|O
wuzi	|O
yanzong	|O
pills	|O
have	|O
strong	|O
leukogenic	|O
effect	|O
on	|O
cyclophosphamide	|O
induced	|O
leukopenia	|O
in	|O
mice	|O
.	|O

Mutations	|O
in	|O
the	|O
small	|O
subunit	|O
of	|O
ribulosebisphosphate	|B-PROTEIN
carboxylase	|I-PROTEIN
affect	|O
subunit	|O
binding	|O
and	|O
catalysis	|O
.	|O

The	|O
structural	|O
changes	|O
in	|O
intra	|O
-	|O
acinar	|O
artery	|O
manifested	|O
mainly	|O
by	|O
an	|O
increase	|O
in	|O
number	|O
of	|O
muscular	|O
artery	|O
resulting	|O
from	|O
muscularization	|O
of	|O
precursor	|O
cells	|O
(	|O
pericytes	|O
and	|O
intermediate	|O
cells	|O
)	|O
located	|O
within	|O
partially	|O
muscular	|O
and	|O
nonmuscular	|O
arterial	|O
wall	|O
to	|O
smooth	|O
muscle	|O
cell	|O
,	|O
and	|O
by	|O
the	|O
medial	|O
wall	|O
thickened	|O
due	|O
to	|O
hypertrophy	|O
and	|O
hyperplasia	|O
of	|O
smooth	|O
muscle	|O
cells	|O
as	|O
well	|O
as	|O
accumulation	|O
of	|O
a	|O
large	|O
amount	|O
of	|O
collagen	|B-PROTEIN
,	|O
especially	|O
the	|O
type	|B-PROTEIN
1	|I-PROTEIN
collagen	|I-PROTEIN
.	|O

These	|O
results	|O
suggest	|O
that	|O
NZ	|O
-	|O
107	|O
may	|O
be	|O
a	|O
useful	|O
drug	|O
for	|O
the	|O
treatment	|O
of	|O
bronchial	|O
asthma	|O
by	|O
reducing	|O
late	|O
-	|O
phase	|O
airway	|O
responses	|O
and	|O
airway	|O
hyperreactivity	|O
.	|O

In	|O
study	|O
2	|O
,	|O
the	|O
correlation	|O
coefficients	|O
between	|O
the	|O
ISO2	|O
measurements	|O
obtained	|O
at	|O
the	|O
ulcer	|O
margin	|O
and	|O
at	|O
the	|O
adjacent	|O
normal	|O
mucosa	|O
,	|O
and	|O
delta	|O
ISO2	|O
obtained	|O
by	|O
the	|O
experienced	|O
observer	|O
and	|O
one	|O
of	|O
the	|O
three	|O
learners	|O
were	|O
0.94	|O
,	|O
0.97	|O
,	|O
and	|O
0.94	|O
,	|O
respectively	|O
.	|O

Bronchial	|O
mucosa	|O
tattooing	|O
in	|O
persons	|O
exposed	|O
to	|O
different	|O
industrial	|O
aerosols	|O
did	|O
not	|O
depend	|O
on	|O
the	|O
forms	|O
of	|O
PC	|O
,	|O
DB	|O
and	|O
the	|O
diseases	|O
'	|O
stages	|O
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
HBc	|I-PROTEIN
production	|O
of	|O
PBMC	|O
was	|O
enhanced	|O
remarkably	|O
in	|O
this	|O
case	|O
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
sMtCK	|B-PROTEIN
genomic	|O
upstream	|O
sequences	|O
reveals	|O
a	|O
typical	|O
TATAA	|O
box	|O
within	|O
the	|O
80	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
that	|O
,	|O
by	|O
transfection	|O
experiments	|O
,	|O
are	|O
sufficient	|O
to	|O
promote	|O
expression	|O
of	|O
chimeric	|O
plasmids	|O
with	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
sMtCK	|B-PROTEIN
genomic	|O
upstream	|O
sequences	|O
reveals	|O
a	|O
typical	|O
TATAA	|O
box	|O
within	|O
the	|O
80	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
that	|O
,	|O
by	|O
transfection	|O
experiments	|O
,	|O
are	|O
sufficient	|O
to	|O
promote	|O
expression	|O
of	|O
chimeric	|O
plasmids	|O
with	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
.	|O

The	|O
cDNA	|O
segment	|O
is	|O
flanked	|O
by	|O
the	|O
immunoglobulin	|B-PROTEIN
gene	|O
recombination	|O
signal	|O
sequences	|O
so	|O
that	|O
the	|O
cDNA	|O
segment	|O
can	|O
invert	|O
and	|O
the	|O
human	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
L	|O
chain	|O
is	|O
subsequently	|O
expressed	|O
under	|O
the	|O
control	|O
of	|O
the	|O
SV40	|B-PROTEIN
promoter	|I-PROTEIN
.	|O

Lipoprotein	|B-PROTEIN
lipase	|I-PROTEIN
(	|O
LPL	|B-PROTEIN
)	|O
,	|O
a	|O
key	|O
enzyme	|O
in	|O
normal	|O
lipoprotein	|O
metabolism	|O
,	|O
has	|O
a	|O
complex	|O
pattern	|O
of	|O
regulation	|O
and	|O
tissue	|O
-	|O
specific	|O
expression	|O
.	|O

Deletion	|O
of	|O
the	|O
proximal	|O
octanucleotide	|O
motif	|O
from	|O
the	|O
plasmid	|O
containing	|O
the	|O
-	|O
461	|O
fragment	|O
of	|O
the	|O
LPL	|B-PROTEIN
promoter	|O
,	|O
resulted	|O
in	|O
a	|O
79	|O
and	|O
76%	|O
decrease	|O
in	|O
the	|O
level	|O
of	|O
expression	|O
in	|O
transfected	|O
3T3	|O
-	|O
L1	|O
adipocytes	|O
and	|O
HepG2	|O
hepatocytes	|O
,	|O
respectively	|O
.	|O

We	|O
examined	|O
the	|O
binding	|O
of	|O
purified	|O
T3	|B-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
T3R	|B-PROTEIN
alpha	|I-PROTEIN
)	|O
,	|O
overexpressed	|O
in	|O
Escherichia	|O
coli	|O
,	|O
to	|O
wild	|O
-	|O
type	|O
and	|O
up	|O
and	|O
down	|O
mutations	|O
of	|O
the	|O
rGH	|B-PROTEIN
T3RE	|O
to	|O
evaluate	|O
whether	|O
transcriptional	|O
potency	|O
correlates	|O
with	|O
changes	|O
in	|O
T3R	|B-PROTEIN
binding	|O
.	|O

Comparison	|O
of	|O
the	|O
cDNA	|O
-	|O
predicted	|O
avian	|O
TnIcardiac	|B-PROTEIN
amino	|O
acid	|O
sequences	|O
with	|O
known	|O
TnI	|B-PROTEIN
sequences	|O
indicated	|O
1	|O
)	|O
that	|O
the	|O
presence	|O
of	|O
an	|O
N	|O
-	|O
terminal	|O
extension	|O
sequence	|O
carrying	|O
a	|O
dual	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
phosphorylation	|O
target	|O
site	|O
and	|O
an	|O
adjacent	|O
proline	|O
-	|O
rich	|O
segment	|O
is	|O
an	|O
ancient	|O
cardiac	|O
-	|O
specific	|O
feature	|O
of	|O
TnI	|B-PROTEIN
which	|O
has	|O
been	|O
conserved	|O
since	|O
the	|O
bird	|O
/	|O
mammal	|O
divergence	|O
,	|O
2	|O
)	|O
that	|O
features	|O
of	|O
the	|O
near	|O
-	|O
N	|O
-	|O
terminal	|O
troponin	|B-PROTEIN
C	|I-PROTEIN
(	|O
TnC	|B-PROTEIN
)	|O
-	|O
binding	|O
site	|O
sequence	|O
suggest	|O
isoform	|O
-	|O
specific	|O
adaptation	|O
of	|O
TnI	|B-PROTEIN
and	|O
TnC	|B-PROTEIN
,	|O
and	|O
3	|O
)	|O
that	|O
the	|O
avian	|O
TnIcardiac	|B-PROTEIN
internal	|O
actin	|B-PROTEIN
/	|I-PROTEIN
TnC	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
,	|I-PROTEIN
actomyosin	|I-PROTEIN
-	|I-PROTEIN
inhibitory	|I-PROTEIN
,	|I-PROTEIN
domain	|I-PROTEIN
shows	|O
significant	|O
sequence	|O
divergence	|O
from	|O
mammalian	|O
TnIcardiac	|B-PROTEIN
sequences	|O
,	|O
including	|O
the	|O
absence	|O
of	|O
a	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
target	|O
site	|O
which	|O
is	|O
a	|O
cardiac	|O
-	|O
specific	|O
feature	|O
of	|O
TnI	|B-PROTEIN
in	|O
mammals	|O
.	|O

Ventilatory	|O
management	|O
casebook	|O
.	|O

An	|O
ASSEMBLER	|O
routine	|O
for	|O
on	|O
-	|O
line	|O
graphic	|O
display	|O
and	|O
averaging	|O
of	|O
data	|O
acquired	|O
on	|O
a	|O
personal	|O
microcomputer	|O
.	|O

Expression	|O
of	|O
the	|O
mouse	|O
TSH	|B-PROTEIN
beta	|I-PROTEIN
gene	|O
,	|O
therefore	|O
,	|O
gives	|O
rise	|O
to	|O
multiple	|O
mRNAs	|O
,	|O
each	|O
with	|O
a	|O
unique	|O
5'	|O
-	|O
untranslated	|O
region	|O
.	|O

Habituation	|O
of	|O
completely	|O
isolated	|O
neurons	|O
of	|O
the	|O
edible	|O
snail	|O
to	|O
electrical	|O
stimulation	|O
.	|O

It	|O
was	|O
found	|O
that	|O
the	|O
ROSP	|O
undergoes	|O
a	|O
number	|O
of	|O
fluctuations	|O
in	|O
the	|O
negative	|O
and	|O
positive	|O
directions	|O
with	|O
a	|O
gradually	|O
decreasing	|O
amplitude	|O
in	|O
the	|O
course	|O
of	|O
5-25	|O
days	|O
following	|O
the	|O
operation	|O
,	|O
after	|O
which	|O
relatively	|O
stable	|O
negative	|O
values	|O
of	|O
the	|O
ROSP	|O
are	|O
established	|O
on	|O
the	|O
average	|O
in	|O
electrodes	|O
implanted	|O
to	|O
the	|O
level	|O
of	|O
the	|O
dura	|O
mater	|O
,	|O
and	|O
positive	|O
values	|O
in	|O
electrodes	|O
implanted	|O
to	|O
the	|O
level	|O
of	|O
the	|O
pia	|O
mater	|O
.	|O

Blood	|O
flow	|O
velocity	|O
waveforms	|O
were	|O
recorded	|O
by	|O
pulsed	|O
Doppler	|O
examination	|O
of	|O
the	|O
fetal	|O
internal	|O
carotid	|O
and	|O
middle	|O
cerebral	|O
arteries	|O
using	|O
the	|O
established	|O
transabdominal	|O
route	|O
as	|O
well	|O
as	|O
a	|O
new	|O
transvaginal	|O
approach	|O
.	|O

Quantitative	|O
analysis	|O
of	|O
DNA	|O
using	|O
flow	|O
cytometry	|O
and	|O
immunocytochemical	|O
findings	|O
in	|O
16	|O
cases	|O
of	|O
cardiac	|O
myxomas	|O

Sequence	|O
analysis	|O
revealed	|O
that	|O
in	|O
addition	|O
to	|O
the	|O
non	|O
-	|O
spliced	|O
variant	|O
,	|O
multiple	|O
mRNA	|O
species	|O
were	|O
generated	|O
by	|O
alternative	|O
splicing	|O
resulting	|O
in	|O
the	|O
exclusion	|O
of	|O
92	|O
,	|O
166	|O
,	|O
170	|O
,	|O
174	|O
and	|O
263	|O
nucleotides	|O
(	|O
nt	|O
)	|O
,	|O
respectively	|O
,	|O
from	|O
exon	|O
1	|O
.	|O

Position	|O
22	|O
is	|O
an	|O
isoleucine	|O
in	|O
the	|O
complete	|O
SsoL12	|B-PROTEIN
protein	|O
sequence	|O
,	|O
coded	|O
by	|O
an	|O
AUA	|O
codon	|O
.	|O

Symptoms	|O
due	|O
to	|O
the	|O
action	|O
of	|O
mastocyte	|O
mediators	|O
were	|O
observed	|O
.	|O

In	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
copper	|O
levels	|O
exert	|O
some	|O
control	|O
over	|O
the	|O
level	|O
of	|O
SOD1	|B-PROTEIN
expression	|O
.	|O

Of	|O
these	|O
179	|O
samples	|O
,	|O
Mobiluncus	|O
SP	|O
was	|O
observed	|O
in	|O
35	|O
(	|O
19.6%	|O
)	|O
using	|O
Gram	|O
staining	|O
and	|O
in	|O
18	|O
(	|O
10.1%	|O
)	|O
this	|O
microorganism	|O
was	|O
isolated	|O
in	|O
agar	|O
RLK	|O
and	|O
anaerobic	|O
atmosphere	|O
.	|O

Previous	|O
investigators	|O
have	|O
suggested	|O
that	|O
subretinal	|O
blood	|O
damages	|O
the	|O
retina	|O
in	|O
part	|O
because	|O
of	|O
its	|O
solid	|O
fibrin	|B-PROTEIN
meshwork	|O
.	|O

Twenty	|O
-	|O
four	|O
hours	|O
later	|O
,	|O
the	|O
animals	|O
were	|O
randomized	|O
to	|O
subretinal	|O
treatment	|O
with	|O
2.5	|O
micrograms	|O
of	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
or	|O
a	|O
similar	|O
volume	|O
of	|O
physiologic	|O
saline	|O
.	|O

Neuro	|O
-	|O
otological	|O
examinations	|O
revealed	|O
spontaneous	|O
downbeat	|O
nystagmus	|O
,	|O
bilateral	|O
gaze	|O
nystagmus	|O
and	|O
rebound	|O
nystagmus	|O
.	|O

Since	|O
the	|O
morphology	|O
of	|O
the	|O
lesions	|O
can	|O
mimic	|O
that	|O
of	|O
other	|O
cutaneous	|O
disorders	|O
,	|O
Bowen	|O
's	|O
disease	|O
is	|O
often	|O
not	|O
recognized	|O
initially	|O
.	|O

Equine	|O
amnion	|O
and	|O
live	|O
yeast	|O
cell	|O
derivative	|O
were	|O
evaluated	|O
as	|O
a	|O
biological	|O
dressing	|O
and	|O
as	|O
a	|O
topical	|O
wound	|O
medicament	|O
respectively	|O
,	|O
in	|O
the	|O
treatment	|O
of	|O
granulating	|O
wounds	|O
of	|O
the	|O
distal	|O
portion	|O
of	|O
the	|O
limbs	|O
of	|O
horses	|O
.	|O

To	|O
lower	|O
the	|O
current	|O
high	|O
incidence	|O
of	|O
NANB	|O
-	|O
induced	|O
PTH	|O
,	|O
in	|O
1986	|O
,	|O
the	|O
American	|O
Association	|O
of	|O
Blood	|O
Banks	|O
(	|O
AABB	|O
)	|O
recommended	|O
testing	|O
for	|O
these	|O
PTH	|O
-	|O
associated	|O
"	|O
surrogate	|O
"	|O
markers	|O
on	|O
all	|O
donated	|O
units	|O
of	|O
blood	|O
.	|O

Insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
in	|O
burn	|O
patients	|O
.	|O

Fusion	|O
of	|O
ubiquitin	|B-PROTEIN
to	|O
pADPRP	|B-PROTEIN
increased	|O
the	|O
yield	|O
of	|O
pADPRP	|B-PROTEIN
approximately	|O
10	|O
-	|O
fold	|O
compared	|O
to	|O
that	|O
of	|O
the	|O
unfused	|O
enzyme	|O
.	|O

In	|O
group	|O
III	|O
,	|O
patients	|O
also	|O
received	|O
their	|O
own	|O
mediastinal	|O
drainage	|O
blood	|O
,	|O
shed	|O
for	|O
6	|O
hours	|O
after	|O
operation	|O
,	|O
after	|O
concentration	|O
and	|O
washing	|O
in	|O
a	|O
MBRS	|O
.	|O

The	|O
suppression	|O
was	|O
also	|O
demonstrated	|O
in	|O
a	|O
transient	|O
expression	|O
assay	|O
in	|O
vivo	|O
using	|O
isolated	|O
barley	|O
endosperms	|O
.	|O

The	|O
effect	|O
of	|O
salmon	|O
calcitonin	|B-PROTEIN
nasal	|O
spray	|O
in	|O
women	|O
with	|O
established	|O
osteoporosis	|O
has	|O
also	|O
been	|O
studied	|O
.	|O

Skeletal	|O
muscle	|O
metaboreceptor	|O
responses	|O
are	|O
impaired	|O
in	|O
heart	|O
failure	|O
.	|O

Skeletal	|O
muscle	|O
metaboreceptor	|O
exercise	|O
responses	|O
are	|O
attenuated	|O
in	|O
heart	|O
failure	|O
.	|O

Evaluation	|O
of	|O
antiepileptic	|O
drug	|O
effect	|O
on	|O
membrane	|O
fluidity	|O
.	|O

The	|O
examinations	|O
were	|O
performed	|O
on	|O
two	|O
groups	|O
of	|O
20	|O
(	|O
using	|O
AmF	|O
/	|O
SnF2	|O
)	|O
-	|O
,	|O
resp	|O
.	|O

RNA	|O
gel	|O
retardation	|O
and	|O
competition	|O
analyses	|O
indicate	|O
that	|O
TRP	|B-PROTEIN
-	|I-PROTEIN
185	|I-PROTEIN
binding	|O
is	|O
strongly	|O
dependent	|O
on	|O
the	|O
TAR	|O
RNA	|O
loop	|O
sequences	|O
.	|O

The	|O
vaccine	|O
used	|O
was	|O
known	|O
to	|O
be	|O
immunogenic	|O
for	|O
older	|O
children	|O
and	|O
adults	|O
.	|O

Both	|O
groups	|O
then	|O
underwent	|O
hypnotic	|O
induction	|O
,	|O
and	|O
completed	|O
the	|O
test	|O
again	|O
(	|O
R2	|O
)	|O
.	|O

Applications	|O
of	|O
three	|O
-	|O
dimensional	|O
analysis	|O
to	|O
the	|O
auditory	|O
P300	|O
.	|O

The	|O
construct	|O
was	|O
introduced	|O
into	|O
BW2001	|O
(	|O
xth	|O
-	|O
11	|O
,	|O
nfo	|O
-	|O
2	|O
)	|O
strain	|O
cells	|O
of	|O
Escherichia	|O
coli	|O
.	|O

Recombinant	|O
human	|O
TFIID	|B-PROTEIN
supported	|O
weak	|O
basal	|O
transcription	|O
in	|O
heat	|O
-	|O
treated	|O
nuclear	|O
extracts	|O
whereas	|O
a	|O
partially	|O
purified	|O
TFIID	|B-PROTEIN
fraction	|O
from	|O
HeLa	|O
cells	|O
reconstituted	|O
a	|O
maximal	|O
level	|O
of	|O
transcription	|O
.	|O

Only	|O
after	|O
a	|O
pretreatment	|O
aimed	|O
at	|O
increasing	|O
its	|O
oxide	|O
surface	|O
layer	|O
was	|O
titanium	|O
powder	|O
found	|O
to	|O
accelerate	|O
the	|O
precipitation	|O
from	|O
solutions	|O
containing	|O
2	|O
mmol	|O
/	|O
L	|O
CaCl2	|O
,	|O
2	|O
mmol	|O
/	|O
L	|O
KH2PO4	|O
,	|O
50	|O
mmol	|O
/	|O
L	|O
Hepes	|O
,	|O
pH	|O
7.2	|O
,	|O
and	|O
to	|O
induce	|O
precipitation	|O
from	|O
metastable	|O
solutions	|O
containing	|O
1.2	|O
mmol	|O
/	|O
L	|O
CaCl2	|O
,	|O
1.2	|O
mmol	|O
/	|O
L	|O
KH2PO4	|O
,	|O
50	|O
mmol	|O
/	|O
L	|O
Hepes	|O
,	|O
pH	|O
7.2	|O
,	|O
at	|O
37	|O
degrees	|O
C.	|O

We	|O
conclude	|O
that	|O
solidification	|O
could	|O
occur	|O
in	|O
all	|O
feeds	|O
containing	|O
casein	|B-PROTEIN
and	|O
that	|O
alternative	|O
feeds	|O
should	|O
be	|O
considered	|O
in	|O
patients	|O
with	|O
increased	|O
gastric	|O
acidity	|O
.	|O

Neither	|O
model	|O
,	|O
as	|O
applied	|O
,	|O
provided	|O
a	|O
satisfactory	|O
account	|O
of	|O
the	|O
effects	|O
of	|O
the	|O
main	|O
variables	|O
of	|O
number	|O
of	|O
tones	|O
and	|O
amount	|O
of	|O
perturbation	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

This	|O
generalization	|O
of	|O
MFP	|O
involves	|O
defining	|O
an	|O
appropriate	|O
high	|O
-	|O
resolution	|O
cost	|O
function	|O
,	|O
parametrizing	|O
the	|O
search	|O
space	|O
of	|O
the	|O
environment	|O
and	|O
source	|O
,	|O
constructing	|O
solutions	|O
of	|O
the	|O
wave	|O
equation	|O
,	|O
and	|O
utilizing	|O
a	|O
nonlinear	|O
optimization	|O
method	|O
to	|O
search	|O
the	|O
parameter	|O
landscape	|O
for	|O
the	|O
global	|O
minimum	|O
of	|O
the	|O
cost	|O
function	|O
.	|O

Determination	|O
of	|O
an	|O
RNA	|O
structure	|O
involved	|O
in	|O
splicing	|O
inhibition	|O
of	|O
a	|O
muscle	|O
-	|O
specific	|O
exon	|O
.	|O

Endothelial	|O
cells	|O
stored	|O
with	|O
University	|O
of	|O
Wisconsin	|O
solution	|O
excluded	|O
trypan	|O
blue	|O
better	|O
(	|O
1.0%	|O
+	|O
/	|O
-	|O
0.5%	|O
cells	|O
stained	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
.	|O

The	|O
original	|O
technique	|O
was	|O
developed	|O
in	|O
the	|O
1960	|O
's	|O
to	|O
analyze	|O
the	|O
inner	|O
ear	|O
fluid	|O
as	|O
a	|O
diagnostic	|O
procedure	|O
(	|O
i.e.	|O
,	|O
diagnostic	|O
labyrinthotomy	|O
)	|O
in	|O
acoustic	|O
neuroma	|O
suspects	|O
.	|O

The	|O
effect	|O
of	|O
diffusion	|O
limitation	|O
was	|O
quantified	|O
in	|O
terms	|O
of	|O
the	|O
ratio	|O
O2	|O
uptake	|O
/	|O
O2	|O
requirement	|O
(	|O
=	|O
fraction	|O
of	|O
cross	|O
-	|O
sectional	|O
area	|O
supplied	|O
with	|O
O2	|O
)	|O
,	|O
assuming	|O
local	|O
O2	|O
requirement	|O
per	|O
unit	|O
volume	|O
to	|O
be	|O
constant	|O
and	|O
independent	|O
of	|O
PO2	|O
at	|O
PO2	|O
greater	|O
than	|O
0	|O
.	|O

(	|O
2	|O
)	|O
Diffusion	|O
limitation	|O
in	|O
the	|O
heterogeneous	|O
model	|O
sets	|O
in	|O
at	|O
a	|O
lower	|O
O2	|O
requirement	|O
value	|O
,	|O
and	|O
increases	|O
more	|O
gradually	|O
with	|O
increasing	|O
O2	|O
requirement	|O
,	|O
than	|O
in	|O
the	|O
corresponding	|O
homogeneous	|O
models	|O
with	|O
the	|O
same	|O
average	|O
cylinder	|O
diameter	|O
.	|O

The	|O
antihypertensive	|O
effect	|O
of	|O
Estulic	|O
has	|O
been	|O
examined	|O
over	|O
a	|O
12	|O
-	|O
month	|O
period	|O
in	|O
101	|O
hypertensive	|O
patients	|O
.	|O

At	|O
the	|O
time	|O
of	|O
the	|O
seizure	|O
,	|O
the	|O
patient	|O
was	|O
asked	|O
to	|O
read	|O
a	|O
test	|O
phrase	|O
aloud	|O
until	|O
it	|O
was	|O
read	|O
correctly	|O
and	|O
clearly	|O
.	|O

Monitoring	|O
patients	|O
with	|O
acute	|O
leukemia	|O
for	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
TNF	|B-PROTEIN
levels	|O
throughout	|O
the	|O
clinical	|O
course	|O
of	|O
disease	|O
may	|O
help	|O
clarify	|O
the	|O
causes	|O
of	|O
febrile	|O
episodes	|O
.	|O

Echinococcus	|O
granulosus	|O
was	|O
diagnosed	|O
by	|O
fine	|O
-	|O
needle	|O
aspiration	|O
cytology	|O
of	|O
a	|O
lung	|O
cyst	|O
in	|O
a	|O
6	|O
-	|O
yr	|O
-	|O
old	|O
white	|O
female	|O
in	|O
central	|O
Missouri	|O
.	|O

The	|O
sequence	|O
was	|O
determined	|O
of	|O
6493	|O
nucleotides	|O
encompassing	|O
the	|O
bet	|B-PROTEIN
genes	|O
of	|O
Escherichia	|O
coli	|O
which	|O
encode	|O
the	|O
osmoregulatory	|O
choline	|O
-	|O
glycine	|O
betaine	|O
pathway	|O
.	|O

A	|O
7	|O
-	|O
day	|O
treatment	|O
of	|O
amphotericin	|O
B	|O
(	|O
5	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
i.p	|O
.	|O
)	|O
significantly	|O
reduced	|O
the	|O
glomerular	|O
filtration	|O
rate	|O
(	|O
GFR	|O
)	|O
measured	|O
as	|O
inuline	|O
clearance	|O
and	|O
creatinine	|O
clearance	|O
(	|O
0.74	|O
+	|O
/	|O
-	|O
0.29	|O
and	|O
0.16	|O
+	|O
/	|O
-	|O
0.04	|O
ml	|O
/	|O
min	|O
,	|O
respectively	|O
)	|O
in	|O
comparison	|O
to	|O
vehicle	|O
-	|O
treated	|O
rats	|O
(	|O
2.04	|O
+	|O
/	|O
-	|O
0.23	|O
and	|O
1.29	|O
+	|O
/	|O
-	|O
0.19	|O
ml	|O
/	|O
min	|O
,	|O
respectively	|O
)	|O
.	|O

Evolution	|O
of	|O
lesions	|O
did	|O
not	|O
necessarily	|O
follow	|O
a	|O
regular	|O
progression	|O
through	|O
the	|O
later	|O
stages	|O
of	|O
the	|O
vitelliform	|O
classification	|O
.	|O

Confocal	|O
fluorescence	|O
microscopy	|O
in	|O
modern	|O
cell	|O
biology	|O
.	|O

Toluene	|O
is	|O
the	|O
chemical	|O
most	|O
frequently	|O
present	|O
in	|O
cases	|O
involving	|O
volatile	|O
solvents	|O
.	|O

Fortunately	|O
DDT	|O
-	|O
,	|O
HCH	|O
-	|O
and	|O
HCB	|O
-	|O
levels	|O
decreased	|O
in	|O
breast	|O
milk	|O
during	|O
the	|O
last	|O
years	|O
.	|O

A	|O
herpesvirus	|O
proteinase	|O
activity	|O
has	|O
been	|O
identified	|O
and	|O
partially	|O
characterized	|O
by	|O
using	|O
the	|O
cloned	|O
enzyme	|O
and	|O
substrate	|O
genes	|O
in	|O
transient	|O
transfection	|O
assays	|O
.	|O

Adult	|O
H	|O
,	|O
but	|O
not	|O
R	|O
,	|O
manifested	|O
the	|O
burrowing	|O
preference	|O
whenever	|O
offered	|O
the	|O
opportunity	|O
.	|O

The	|O
rear	|O
silver	|O
liquid	|O
chamber	|O
was	|O
threefold	|O
thick	|O
to	|O
17	|O
MeV	|O
protons	|O
in	|O
water	|O
and	|O
it	|O
efficiently	|O
produced	|O
either	|O
13N	|O
by	|O
the	|O
16O	|O
(	|O
p	|O
,	|O
alpha	|O
)	|O
13N	|O
reaction	|O
or	|O
[	|O
18F	|O
]	|O
fluoride	|O
ion	|O
by	|O
the	|O
18O	|O
(	|O
p	|O
,	|O
n	|O
)	|O
18F	|O
reaction	|O
.	|O

Heterogeneous	|O
electron	|O
transfer	|O
of	|O
cytochrome	|B-PROTEIN
c	|I-PROTEIN
facilitated	|O
by	|O
polypyrrole	|O
and	|O
methylene	|O
blue	|O
polypyrrole	|O
film	|O
modified	|O
electrodes	|O
.	|O

Selective	|O
activation	|O
of	|O
adrenaline	|O
secretion	|O
by	|O
the	|O
rat	|O
adrenal	|O
in	|O
neuroglycopenia	|O
detected	|O
via	|O
microdialysis	|O

Urine	|O
specimens	|O
containing	|O
either	|O
phencyclidine	|O
(	|O
PCP	|O
)	|O
or	|O
11	|O
-	|O
nor	|O
-	|O
delta	|O
9	|O
-	|O
tetrahydrocannabinol	|O
-	|O
9	|O
-	|O
carboxylic	|O
acid	|O
(	|O
9	|O
-	|O
THC	|O
-	|O
COOH	|O
)	|O
were	|O
adulterated	|O
with	|O
sodium	|O
chloride	|O
,	|O
bleach	|O
,	|O
vinegar	|O
,	|O
potassium	|O
hydroxide	|O
,	|O
liquid	|O
soap	|O
,	|O
2	|O
-	|O
propanol	|O
,	|O
and	|O
ammonia	|O
.	|O

The	|O
1489	|O
-	|O
base	|O
pair	|O
EFIA	|B-PROTEIN
cDNA	|O
encodes	|O
a	|O
322	|O
-	|O
amino	|O
acid	|O
protein	|O
which	|O
is	|O
nearly	|O
identical	|O
to	|O
two	|O
previously	|O
described	|O
human	|O
DNA	|O
binding	|O
proteins	|O
.	|O

Four	|O
putative	|O
positive	|O
cDNA	|O
clones	|O
were	|O
isolated	|O
,	|O
and	|O
the	|O
largest	|O
insert	|O
(	|O
pASB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
was	|O
sequenced	|O
in	|O
both	|O
orientations	|O
.	|O

Sci	|O
.	|O

Dose	|O
standardisation	|O
of	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
.	|O

The	|O
coding	|O
sequence	|O
for	|O
a	|O
260	|O
-	|O
amino	|O
-	|O
acid	|O
residue	|O
polypeptide	|O
was	|O
interrupted	|O
by	|O
a	|O
single	|O
short	|O
intron	|O
of	|O
60	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
,	|O
and	|O
about	|O
70%	|O
of	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
Drosophila	|O
PCNA	|B-PROTEIN
was	|O
identical	|O
to	|O
the	|O
rat	|O
and	|O
human	|O
PCNA	|B-PROTEIN
polypeptides	|O
,	|O
with	|O
conserved	|O
unique	|O
repeats	|O
of	|O
leucine	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
.	|O

Translational	|O
fusions	|O
of	|O
the	|O
aroF	|B-PROTEIN
regulatory	|O
regions	|O
to	|O
lacZ	|B-PROTEIN
were	|O
constructed	|O
and	|O
then	|O
introduced	|O
in	|O
single	|O
copy	|O
into	|O
the	|O
E.	|O
coli	|O
chromosome	|O
.	|O
beta	|B-PROTEIN
-	|I-PROTEIN
Galactosidase	|I-PROTEIN
assays	|O
for	|O
tyrR	|O
-	|O
mediated	|O
regulation	|O
of	|O
aroF	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
expression	|O
revealed	|O
that	|O
the	|O
E.	|O
coli	|O
TyrR	|B-PROTEIN
repressor	|I-PROTEIN
apparently	|O
recognizes	|O
the	|O
operators	|O
of	|O
both	|O
organisms	|O
with	|O
about	|O
equal	|O
efficiency	|O
.	|O

Along	|O
with	|O
previously	|O
mapped	|O
genes	|O
including	|O
Ly	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
CD20	|B-PROTEIN
,	|O
OSBP	|B-PROTEIN
defines	|O
a	|O
new	|O
conserved	|O
syntenic	|O
group	|O
on	|O
the	|O
long	|O
arm	|O
of	|O
chromosome	|O
11	|O
in	|O
the	|O
human	|O
and	|O
the	|O
proximal	|O
end	|O
of	|O
chromosome	|O
19	|O
in	|O
the	|O
mouse	|O
.	|O

During	|O
exercise	|O
K+	|O
is	|O
released	|O
from	|O
contracting	|O
muscle	|O
and	|O
plasma	|O
K+	|O
concentration	|O
rises	|O
.	|O

Following	|O
treatment	|O
,	|O
serum	|O
estradiol	|O
levels	|O
were	|O
higher	|O
in	|O
groups	|O
E	|O
+	|O
T	|O
and	|O
E	|O
than	|O
in	|O
group	|O
C.	|O

We	|O
conclude	|O
that	|O
the	|O
beta	|O
-	|O
adrenergic	|O
agonist	|O
,	|O
isoproterenol	|O
,	|O
has	|O
little	|O
influence	|O
on	|O
vascular	|O
capacitance	|O
or	|O
liver	|O
volume	|O
of	|O
dogs	|O
,	|O
unless	|O
the	|O
hepatic	|O
outflow	|O
resistance	|O
is	|O
elevated	|O
by	|O
agents	|O
such	|O
as	|O
histamine	|O
.	|O

DNA	|O
sequence	|O
and	|O
evolution	|O
of	|O
the	|O
CPS	|B-PROTEIN
domain	|O
of	|O
the	|O
Syrian	|O
hamster	|O
multifunctional	|O
protein	|O
CAD	|B-PROTEIN
.	|O

Here	|O
we	|O
show	|O
that	|O
these	|O
synthetic	|O
binding	|O
sites	|O
have	|O
a	|O
more	|O
restricted	|O
and	|O
specific	|O
ability	|O
to	|O
enhance	|O
transcription	|O
when	|O
assayed	|O
in	|O
transformed	|O
embryos	|O
.	|O

After	|O
base	|O
-	|O
line	|O
CBF	|O
was	|O
established	|O
,	|O
hexamethonium	|O
bromide	|O
(	|O
2	|O
mg	|O
/	|O
kg	|O
iv	|O
)	|O
,	|O
ipratropium	|O
bromide	|O
(	|O
0.5	|O
microgram	|O
/	|O
kg	|O
iv	|O
)	|O
,	|O
indomethacin	|O
(	|O
2	|O
mg	|O
/	|O
kg	|O
iv	|O
)	|O
,	|O
or	|O
intravenous	|O
0.9%	|O
saline	|O
was	|O
administered	|O
.	|O

A	|O
high	|O
-	|O
frequency	|O
restriction	|O
fragment	|O
length	|O
polymorphism	|O
was	|O
evident	|O
in	|O
the	|O
DNA	|O
from	|O
29	|O
unrelated	|O
individuals	|O
using	|O
the	|O
enzyme	|O
BglII	|B-PROTEIN
.	|O

The	|O
antilog	|O
transformation	|O
of	|O
pH	|O
did	|O
not	|O
improve	|O
the	|O
results	|O
.	|O

Telomeres	|O
prevent	|O
end	|O
-	|O
to	|O
-	|O
end	|O
fusions	|O
and	|O
exonucleolytic	|O
degradation	|O
,	|O
enable	|O
the	|O
end	|O
of	|O
the	|O
linear	|O
DNA	|O
molecule	|O
to	|O
replicate	|O
,	|O
and	|O
function	|O
in	|O
cell	|O
division	|O
.	|O

One	|O
of	|O
these	|O
is	|O
located	|O
in	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
,	|O
and	|O
may	|O
encode	|O
regulatory	|O
sequences	|O
.	|O

The	|O
native	|O
enzyme	|O
purified	|O
from	|O
protease	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
-	|O
deficient	|O
URA2	|B-PROTEIN
-	|O
transformed	|O
cells	|O
,	|O
was	|O
phosphorylated	|O
in	|O
vitro	|O
using	|O
catalytic	|O
subunits	|O
of	|O
pure	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

This	|O
study	|O
suggests	|O
that	|O
BSPMs	|O
are	|O
useful	|O
in	|O
the	|O
assessment	|O
of	|O
AMI	|O
in	|O
terms	|O
of	|O
diagnosis	|O
,	|O
location	|O
and	|O
extent	|O
of	|O
myocardial	|O
infarct	|O
.	|O

A	|O
bovine	|O
abomasum	|O
lambda	|O
gt11	|O
cDNA	|O
library	|O
was	|O
screened	|O
with	|O
a	|O
monoclonal	|O
antibody	|O
raised	|O
against	|O
the	|O
rabbit	|O
H	|B-PROTEIN
,	|I-PROTEIN
K	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
beta	|O
subunit	|O
.	|O

Judicious	|O
use	|O
of	|O
laboratory	|O
testing	|O
,	|O
including	|O
monitoring	|O
of	|O
CD4	|B-PROTEIN
cell	|O
counts	|O
,	|O
is	|O
recommended	|O
.	|O

There	|O
is	|O
no	|O
TATA	|O
box	|O
appropriately	|O
spaced	|O
upstream	|O
from	|O
the	|O
transcription	|O
initiation	|O
site	|O
.	|O

Characterization	|O
of	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
growth	|O
-	|O
regulated	|O
Syrian	|O
hamster	|O
CAD	|B-PROTEIN
gene	|O
.	|O

Early	|O
cirrhosis	|O
,	|O
an	|O
early	|O
modality	|O
of	|O
the	|O
evolution	|O
of	|O
acute	|O
hepatitis	|O
.	|O

Examination	|O
of	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
expression	|O
during	|O
the	|O
MDI	|O
regimen	|O
revealed	|O
that	|O
RA	|O
mediated	|O
an	|O
elevated	|O
,	|O
prolonged	|O
expression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
mRNA	|O
accompanied	|O
by	|O
diminished	|O
expression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
and	|O
Jun	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
mRNAs	|O
.	|O

Although	|O
heart	|O
rate	|O
and	|O
diastolic	|O
pressure	|O
rose	|O
in	|O
some	|O
degree	|O
1	|O
min	|O
after	|O
intubation	|O
,	|O
free	|O
and	|O
total	|O
CA	|O
concentrations	|O
did	|O
not	|O
increase	|O
during	|O
study	|O
period	|O
.	|O

Processing	|O
,	|O
secretion	|O
,	|O
and	|O
immunoreactivity	|O
of	|O
carboxy	|O
terminally	|O
truncated	|O
dengue	|O
-	|O
2	|O
virus	|O
envelope	|B-PROTEIN
proteins	|O
expressed	|O
in	|O
insect	|O
cells	|O
by	|O
recombinant	|O
baculoviruses	|O
.	|O

Combined	|O
therapy	|O
with	|O
MK	|O
-	|O
801	|O
and	|O
nimodipine	|O
for	|O
protection	|O
of	|O
ischemic	|O
brain	|O
damage	|O
.	|O

Initial	|O
screening	|O
of	|O
a	|O
rat	|O
liver	|O
cDNA	|O
library	|O
with	|O
an	|O
oligonucleotide	|O
probe	|O
derived	|O
from	|O
the	|O
rat	|O
SCP2	|B-PROTEIN
protein	|O
sequence	|O
revealed	|O
an	|O
825	|O
-	|O
base	|O
pair	|O
cDNA	|O
clone	|O
coding	|O
for	|O
the	|O
complete	|O
SCP2	|B-PROTEIN
protein	|O
sequence	|O
.	|O

Cloning	|O
,	|O
expression	|O
,	|O
and	|O
nucleotide	|O
sequence	|O
of	|O
rat	|O
liver	|O
sterol	|B-PROTEIN
carrier	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
cDNAs	|O
.	|O

The	|O
addition	|O
of	|O
an	|O
equimolar	|O
complex	|O
of	|O
the	|O
fourth	|O
and	|O
seventh	|O
largest	|O
subunits	|O
,	|O
purified	|O
from	|O
pol	|B-PROTEIN
II	|I-PROTEIN
holoenzyme	|O
by	|O
ion	|O
-	|O
exchange	|O
chromatography	|O
in	|O
the	|O
presence	|O
of	|O
urea	|O
,	|O
restored	|O
promoter	|O
-	|O
directed	|O
initiation	|O
activity	|O
to	|O
pol	|B-PROTEIN
II	|I-PROTEIN
delta	|O
4/7	|O
.	|O

We	|O
report	|O
here	|O
the	|O
identification	|O
of	|O
HSF	|B-PROTEIN
in	|O
the	|O
fission	|O
yeast	|O
Schizosaccharomyces	|O
pombe	|O
.	|O

Induction	|O
requires	|O
the	|O
ACE1	|B-PROTEIN
gene	|O
product	|O
,	|O
which	|O
binds	|O
to	|O
specific	|O
sites	|O
in	|O
the	|O
promoter	|O
region	|O
of	|O
the	|O
CUP1	|B-PROTEIN
gene	|O
.	|O

Gel	|O
mobility	|O
shift	|O
assays	|O
using	|O
a	|O
synthetic	|O
E6	|B-PROTEIN
motif	|O
detected	|O
a	|O
B	|O
-	|O
cell	|O
-	|O
specific	|O
complex	|O
in	|O
addition	|O
to	|O
a	|O
ubiquitous	|O
band	|O
found	|O
also	|O
in	|O
T	|O
cells	|O
and	|O
HeLa	|O
cells	|O
.	|O

Seven	|O
clones	|O
encoding	|O
interferon	|B-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
factors	|I-PROTEIN
have	|O
been	|O
isolated	|O
from	|O
a	|O
mouse	|O
fibroblast	|O
lambda	|O
gt11	|O
cDNA	|O
library	|O
by	|O
using	|O
a	|O
32P	|O
end	|O
-	|O
labeled	|O
tandem	|O
trimer	|O
of	|O
the	|O
mouse	|O
(	|B-PROTEIN
2'	|I-PROTEIN
-	|I-PROTEIN
5'	|I-PROTEIN
)	|I-PROTEIN
oligoadenylate	|I-PROTEIN
synthetase	|I-PROTEIN
gene	|O
interferon	|O
response	|O
element	|O
as	|O
a	|O
probe	|O
.	|O

The	|O
sequence	|O
of	|O
four	|O
clones	|O
was	|O
sufficient	|O
to	|O
construct	|O
a	|O
3018	|O
-	|O
bp	|O
BAL	|B-PROTEIN
cDNA	|O
structure	|O
.	|O

The	|O
application	|O
of	|O
these	|O
instruments	|O
allows	|O
occlusion	|O
of	|O
the	|O
ascending	|O
aorta	|O
traversed	|O
by	|O
the	|O
perfusion	|O
cannula	|O
inserted	|O
directly	|O
or	|O
through	|O
the	|O
apex	|O
of	|O
the	|O
heart	|O
as	|O
well	|O
as	|O
simultaneous	|O
left	|O
ventricular	|O
venting	|O
.	|O

Adenylosuccinate	|B-PROTEIN
synthetase	|I-PROTEIN
(	|O
IMP	|O
:	|O
L	|B-PROTEIN
-	|I-PROTEIN
aspartate	|I-PROTEIN
ligase	|I-PROTEIN
(	|O
GDP	|O
)	|O
,	|O
EC	|B-PROTEIN
6.3.4.4	|I-PROTEIN
)	|O
plays	|O
an	|O
important	|O
role	|O
in	|O
purine	|O
biosynthesis	|O
catalyzing	|O
the	|O
GTP	|O
-	|O
dependent	|O
conversion	|O
of	|O
IMP	|O
to	|O
AMP	|O
.	|O

Immunophenotyping	|O
in	|O
four	|O
cases	|O
,	|O
demonstrated	|O
non	|O
-	|O
B	|O
,	|O
non	|O
-	|O
T	|O
cell	|O
origin	|O
in	|O
three	|O
and	|O
pre	|O
-	|O
B	|O
cell	|O
origin	|O
in	|O
one	|O
.	|O

DNA	|O
-	|O
protein	|O
UV	|O
cross	|O
-	|O
linking	|O
studies	|O
indicated	|O
that	|O
UHF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
has	|O
an	|O
electrophoretic	|O
mobility	|O
on	|O
sodium	|O
dodecyl	|O
sulfate	|O
-	|O
acrylamide	|O
gels	|O
of	|O
approximately	|O
85	|O
kDa	|O
and	|O
suggested	|O
that	|O
additional	|O
proteins	|O
,	|O
specific	|O
to	|O
each	|O
promoter	|O
,	|O
bind	|O
to	|O
each	|O
site	|O
.	|O

The	|O
results	|O
strengthen	|O
the	|O
conclusion	|O
that	|O
predominantly	|O
dynamic	|O
activity	|O
increases	|O
the	|O
G4	|B-PROTEIN
content	|O
of	|O
mature	|O
innervated	|O
fast	|O
muscles	|O
.	|O

The	|O
specific	|O
interaction	|O
between	|O
a	|O
defined	|O
structural	|O
element	|O
of	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
mRNA	|O
(	|O
RRE	|B-PROTEIN
,	|O
the	|O
Rev	|B-PROTEIN
response	|O
element	|O
)	|O
and	|O
the	|O
virus	|O
-	|O
encoded	|O
protein	|O
Rev	|B-PROTEIN
has	|O
been	|O
implicated	|O
in	|O
the	|O
regulation	|O
of	|O
the	|O
export	|O
of	|O
unspliced	|O
or	|O
singly	|O
spliced	|O
mRNA	|O
from	|O
the	|O
nucleus	|O
to	|O
the	|O
cytoplasm	|O
.	|O

We	|O
reviewed	|O
the	|O
records	|O
of	|O
151	|O
patients	|O
with	|O
optic	|O
neuritis	|O
examined	|O
over	|O
an	|O
eight	|O
-	|O
year	|O
period	|O
.	|O

Cut	|O
-	|O
off	|O
levels	|O
that	|O
define	|O
abnormality	|O
are	|O
rather	|O
arbitrary	|O
and	|O
this	|O
decreases	|O
the	|O
specificity	|O
of	|O
the	|O
test	|O
in	|O
apparently	|O
healthy	|O
patients	|O
.	|O

Alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
in	|O
clinical	|O
practice	|O
.	|O

Nucleotide	|O
sequence	|O
analysis	|O
of	|O
the	|O
Pseudomonas	|O
putida	|O
PpG7	|O
salicylate	|B-PROTEIN
hydroxylase	|I-PROTEIN
gene	|O
(	|O
nahG	|B-PROTEIN
)	|O
and	|O
its	|O
3'	|O
-	|O
flanking	|O
region	|O
.	|O

All	|O
six	|O
ARF	|B-PROTEIN
cDNAs	|O
are	|O
more	|O
similar	|O
to	|O
each	|O
other	|O
than	|O
to	|O
other	|O
approximately	|O
20	|O
-	|O
kDa	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

The	|O
long	|O
terminal	|O
repeat	|O
(	|O
LTR	|O
)	|O
of	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
(	|O
HIV	|O
)	|O
contains	|O
three	|O
binding	|O
sites	|O
for	|O
the	|O
transcriptional	|O
factor	|O
Sp1	|B-PROTEIN
.	|O

DNA	|O
from	|O
PCR	|O
was	|O
labeled	|O
and	|O
used	|O
to	|O
isolate	|O
several	|O
lambda	|O
gt11	|O
cDNA	|O
clones	|O
,	|O
including	|O
one	|O
full	|O
-	|O
length	|O
one	|O
(	|O
Dd	|B-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
.	|O

Radiation	|O
-	|O
induced	|O
changes	|O
in	|O
the	|O
area	|O
of	|O
alveoli	|O
and	|O
septa	|O
as	|O
well	|O
as	|O
collagen	|B-PROTEIN
content	|O
were	|O
seen	|O
11	|O
weeks	|O
after	|O
irradiation	|O
.	|O

The	|O
first	|O
follow	|O
-	|O
up	|O
was	|O
at	|O
a	|O
nearly	|O
constant	|O
interval	|O
of	|O
5.1	|O
years	|O
in	|O
Caerphilly	|O
and	|O
3.2	|O
years	|O
in	|O
Speedwell	|O
;	|O
251	|O
major	|O
IHD	|O
events	|O
had	|O
occurred	|O
.	|O

A.	|O

Perilunar	|O
luxation	|O
-	|O
-	|O
an	|O
unusual	|O
injury	|O
demanding	|O
immediate	|O
and	|O
correct	|O
treatment	|O

Landsberg	|O
(	|O
La	|O
-	|O
O	|O
)	|O
and	|O
cv	|O
.	|O

In	|O
summary	|O
,	|O
at	|O
equianesthetic	|O
concentrations	|O
,	|O
desflurane	|O
and	|O
isoflurane	|O
produced	|O
similar	|O
hemodynamic	|O
effects	|O
;	|O
however	|O
,	|O
in	|O
the	|O
absence	|O
of	|O
drugs	|O
that	|O
inhibit	|O
autonomic	|O
reflexes	|O
,	|O
desflurane	|O
had	|O
less	|O
negative	|O
inotropic	|O
activity	|O
and	|O
produced	|O
less	|O
decrease	|O
in	|O
arterial	|O
pressure	|O
.	|O

We	|O
report	|O
here	|O
the	|O
isolation	|O
of	|O
a	|O
full	|O
-	|O
length	|O
cDNA	|O
clone	|O
coding	|O
for	|O
a	|O
hitherto	|O
undiscovered	|O
isoform	|O
of	|O
the	|O
bovine	|O
C	|B-PROTEIN
-	|I-PROTEIN
subunit	|I-PROTEIN
.	|O

Isoform	|B-PROTEIN
C	|I-PROTEIN
beta	|I-PROTEIN
2	|I-PROTEIN
,	|O
an	|O
unusual	|O
form	|O
of	|O
the	|O
bovine	|O
catalytic	|O
subunit	|O
of	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Salient	|O
applications	|O
of	|O
PB	|O
-	|O
PK	|O
modeling	|O
to	|O
toxicological	|O
problems	|O
are	|O
illustrated	|O
with	|O
examples	|O
.	|O

Patients	|O
with	|O
apparently	|O
minor	|O
CT	|O
abnormalities	|O
may	|O
have	|O
significant	|O
epidural	|O
disease	|O
.	|O

The	|O
cdr1	|B-PROTEIN
sequence	|O
includes	|O
an	|O
additional	|O
237	|O
amino	|O
acids	|O
of	|O
the	|O
contiguous	|O
fragment	|O
and	|O
encodes	|O
a	|O
product	|O
of	|O
predicted	|O
Mr	|O
67,000	|O
.	|O

Armed	|O
with	|O
a	|O
clear	|O
understanding	|O
of	|O
the	|O
pathophysiologic	|O
pathways	|O
that	|O
may	|O
cause	|O
and	|O
/	|O
or	|O
contribute	|O
to	|O
the	|O
development	|O
of	|O
unconjugated	|O
hyperbilirubinemia	|O
and	|O
the	|O
associated	|O
jaundice	|O
,	|O
the	|O
practitioner	|O
will	|O
be	|O
successful	|O
in	|O
helping	|O
the	|O
family	|O
understand	|O
their	|O
child	|O
's	|O
illness	|O
.	|O

Displacement	|O
thresholds	|O
of	|O
peripheral	|O
sites	|O
in	|O
monocular	|O
human	|O
vision	|O
were	|O
obtained	|O
.	|O

The	|O
authors	|O
report	|O
a	|O
case	|O
in	|O
which	|O
stereotactic	|O
irrigation	|O
of	|O
a	|O
brain	|O
cyst	|O
was	|O
temporally	|O
associated	|O
with	|O
respiratory	|O
distress	|O
.	|O

ELISA	|O
was	|O
found	|O
to	|O
make	|O
a	|O
contribution	|O
to	|O
the	|O
diagnosis	|O
of	|O
tuberculosis	|O
similar	|O
to	|O
that	|O
of	|O
sputum	|O
smear	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
we	|O
report	|O
a	|O
detailed	|O
study	|O
of	|O
the	|O
structure	|O
and	|O
the	|O
functional	|O
role	|O
of	|O
the	|O
MalT	|B-PROTEIN
binding	|O
sites	|O
located	|O
in	|O
the	|O
adjacent	|O
and	|O
divergent	|O
pulAp	|B-PROTEIN
and	|O
pulCp	|B-PROTEIN
promoters	|O
.	|O

Despite	|O
the	|O
small	|O
number	|O
of	|O
patients	|O
,	|O
on	|O
the	|O
basis	|O
of	|O
this	|O
report	|O
,	|O
we	|O
can	|O
confirm	|O
that	|O
1.5	|O
MU	|O
/	|O
day	|O
of	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
IFN	|I-PROTEIN
is	|O
an	|O
adequate	|O
treatment	|O
for	|O
patients	|O
with	|O
hairy	|O
cell	|O
leukemia	|O
.	|O

Paroxysmal	|O
fluctuations	|O
in	|O
observed	|O
parasitemia	|O
in	|O
Plasmodium	|O
falciparum	|O
malaria	|O
.	|O

No	|O
positive	|O
family	|O
history	|O
was	|O
obtained	|O
.	|O

Occupational	|O
asthma	|O
and	|O
rhinoconjunctivitis	|O
from	|O
inhalation	|O
of	|O
crystalline	|O
bovine	|O
serum	|O
albumin	|B-PROTEIN
powder	|O
.	|O

A	|O
further	|O
subdivision	|O
of	|O
Category	|O
pN1	|O
into	|O
pN1a	|O
(	|O
metastasis	|O
in	|O
single	|O
node	|O
)	|O
and	|O
pN1b	|O
(	|O
two	|O
or	|O
more	|O
nodes	|O
)	|O
is	|O
recommended	|O
.	|O

Amino	|O
acid	|O
sequence	|O
comparisons	|O
of	|O
the	|O
E74A	|B-PROTEIN
protein	|O
reveal	|O
a	|O
highly	|O
conserved	|O
C	|O
-	|O
terminal	|O
region	|O
that	|O
is	|O
rich	|O
in	|O
basic	|O
amino	|O
acid	|O
residues	|O
and	|O
which	|O
has	|O
been	|O
proposed	|O
to	|O
possess	|O
sequence	|O
-	|O
specific	|O
DNA	|O
binding	|O
activity	|O
.	|O

We	|O
found	|O
that	|O
the	|O
relative	|O
strengths	|O
of	|O
the	|O
promoters	|O
were	|O
similar	|O
in	|O
different	|O
contexts	|O
.	|O

Grasso	|O
,	|O
and	|O
A.	|O

After	|O
6	|O
months	|O
,	|O
definite	|O
improvement	|O
in	|O
strength	|O
occurred	|O
in	|O
4	|O
of	|O
7	|O
carnitine	|O
-	|O
treated	|O
patients	|O
and	|O
in	|O
none	|O
of	|O
7	|O
controls	|O
.	|O

Age	|O
at	|O
POI	|O
and	|O
asymptote	|O
were	|O
achieved	|O
later	|O
for	|O
Line	|O
RBC2	|O
than	|O
for	|O
Line	|O
F.	|O

To	|O
identify	|O
the	|O
DNA	|O
sequences	|O
that	|O
cis	|O
-	|O
regulate	|O
the	|O
expression	|O
of	|O
the	|O
rat	|O
liver	|O
pyruvate	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
L	|B-PROTEIN
-	|I-PROTEIN
PK	|I-PROTEIN
)	|O
genes	|O
,	|O
a	|O
series	|O
of	|O
constructs	|O
in	|O
which	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
genes	|O
is	|O
driven	|O
by	|O
various	|O
deleted	|O
fragments	|O
of	|O
the	|O
3200	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
upstream	|O
of	|O
the	|O
L	|B-PROTEIN
-	|I-PROTEIN
PK	|I-PROTEIN
gene	|O
cap	|O
site	|O
have	|O
been	|O
assayed	|O
for	|O
transient	|O
expression	|O
after	|O
introduction	|O
into	|O
hepatoma	|O
HepG2	|O
cells	|O
,	|O
rat	|O
hepatocytes	|O
in	|O
primary	|O
culture	|O
,	|O
fibroblast	|O
LTK	|O
-	|O
cells	|O
,	|O
myogenic	|O
C2C12	|O
cells	|O
,	|O
and	|O
CHO	|O
cells	|O
.	|O

The	|O
disturbance	|O
of	|O
pulmonary	|O
gas	|O
exchange	|O
,	|O
as	|O
revealed	|O
by	|O
the	|O
high	|O
value	|O
of	|O
AaDO2	|O
,	|O
existed	|O
without	|O
left	|O
ventricular	|O
dysfunction	|O
,	|O
and	|O
AaDO2	|O
had	|O
no	|O
significant	|O
relationship	|O
with	|O
any	|O
of	|O
the	|O
hemodynamic	|O
parameters	|O
including	|O
the	|O
difference	|O
between	|O
plasma	|O
colloid	|O
osmotic	|O
pressure	|O
and	|O
PCW	|O
.	|O

A	|O
dose	|O
of	|O
3	|O
and	|O
6	|O
micrograms	|O
/	|O
kg	|O
/	|O
day	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
reduces	|O
the	|O
severity	|O
of	|O
neutropenia	|O
and	|O
thrombocytopenia	|O
after	|O
carboplatin	|O
-	|O
cyclophosphamide	|O
chemotherapy	|O
,	|O
which	|O
may	|O
lead	|O
to	|O
more	|O
effective	|O
chemotherapy	|O
for	|O
ovarian	|O
cancer	|O
in	|O
the	|O
future	|O
.	|O

These	|O
differences	|O
involve	|O
specific	|O
hydrogen	|O
-	|O
bonding	|O
interactions	|O
between	|O
the	|O
protein	|O
and	|O
DNA	|O
,	|O
including	|O
guanine	|O
N7	|O
sites	|O
in	|O
the	|O
major	|O
groove	|O
of	|O
DNA	|O
,	|O
and	|O
alterations	|O
in	|O
DNA	|O
phosphodiester	|O
conformation	|O
induced	|O
by	|O
protein	|O
binding	|O
.	|O

Biochemical	|O
analysis	|O
demonstrates	|O
that	|O
the	|O
BJ1	|B-PROTEIN
protein	|O
is	|O
associated	|O
with	|O
nucleosomes	|O
and	|O
is	|O
released	|O
from	|O
chromatin	|O
by	|O
agents	|O
which	|O
intercalate	|O
into	|O
DNA	|O
,	|O
as	|O
previously	|O
shown	|O
for	|O
the	|O
high	|B-PROTEIN
mobility	|I-PROTEIN
group	|I-PROTEIN
proteins	|O
(	|O
HMGs	|B-PROTEIN
)	|O
.	|O

I	|O
propose	|O
that	|O
their	|O
gene	|O
products	|O
bind	|O
to	|O
the	|O
chromatin	|O
to	|O
establish	|O
or	|O
maintain	|O
a	|O
proper	|O
higher	|O
order	|O
structure	|O
as	|O
a	|O
prerequisite	|O
for	|O
a	|O
regulated	|O
gene	|O
expression	|O
.	|O

The	|O
C4BP	|B-PROTEIN
alpha	|O
gene	|O
is	|O
organized	|O
as	|O
follows	|O
:	|O
the	|O
first	|O
exon	|O
codes	|O
for	|O
the	|O
first	|O
198	|O
nucleotides	|O
of	|O
the	|O
5'	|O
UTR	|O
.	|O

The	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
Rev	|B-PROTEIN
protein	|O
is	|O
a	|O
positive	|O
posttranscriptional	|O
regulator	|O
of	|O
viral	|O
structural	|O
gene	|O
expression	|O
and	|O
essential	|O
for	|O
virus	|O
replication	|O
.	|O

Once	|O
the	|O
proliferation	|O
of	|O
fibroblasts	|O
and	|O
collagen	|B-PROTEIN
synthesis	|O
had	|O
led	|O
to	|O
an	|O
increase	|O
of	|O
mechanical	|O
strength	|O
,	|O
no	|O
negative	|O
effect	|O
on	|O
wound	|O
healing	|O
could	|O
be	|O
detected	|O
applying	|O
the	|O
same	|O
chemotherapeutic	|O
agents	|O
.	|O

The	|O
CDC7	|B-PROTEIN
gene	|O
has	|O
two	|O
in	|O
-	|O
frame	|O
AUG	|O
codons	|O
as	|O
possible	|O
translation	|O
start	|O
sites	|O
,	|O
which	|O
would	|O
produce	|O
58	|O
-	|O
and	|O
56	|O
-	|O
kDa	|O
proteins	|O
,	|O
respectively	|O
.	|O

During	|O
the	|O
years	|O
1980-87	|O
a	|O
total	|O
of	|O
287	|O
persons	|O
received	|O
disability	|O
pensions	|O
in	|O
the	|O
municipality	|O
of	|O
Nordreisa	|O
in	|O
northern	|O
Norway	|O
.	|O

HeLa	|O
and	|O
Jurkat	|O
cell	|O
lines	|O
carrying	|O
the	|O
nef	|B-PROTEIN
gene	|O
linked	|O
to	|O
the	|O
CMV	|O
promoter	|O
or	|O
the	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
were	|O
isolated	|O
by	|O
coselection	|O
for	|O
neomycin	|O
resistance	|O
.	|O

Differences	|O
in	|O
the	|O
clinical	|O
presentation	|O
and	|O
the	|O
gross	|O
appearance	|O
of	|O
the	|O
two	|O
cases	|O
are	|O
described	|O
,	|O
and	|O
similarities	|O
in	|O
the	|O
microscopic	|O
features	|O
are	|O
discussed	|O
.	|O

MEASUREMENTS	|O
AND	|O
MAIN	|O
RESULTS	|O
:	|O
The	|O
two	|O
groups	|O
were	|O
similar	|O
on	|O
entry	|O
into	|O
the	|O
study	|O
,	|O
including	|O
mean	|O
FEV1	|O
measurements	|O
(	|O
0.70	|O
L	|O
atropine	|O
/	|O
0.60	|O
L	|O
metaproterenol	|O
,	|O
P	|O
greater	|O
than	|O
.05	|O
)	|O
.	|O

Using	|O
an	|O
ELISA	|O
,	|O
we	|O
found	|O
that	|O
surfactant	|B-PROTEIN
protein	|I-PROTEIN
A	|I-PROTEIN
(	|O
SP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
)	|O
was	|O
markedly	|O
elevated	|O
in	|O
the	|O
pneumonia	|O
patients	|O
.	|O

In	|O
view	|O
of	|O
the	|O
short	|O
t1/2	|O
,	|O
we	|O
used	|O
three	|O
doses	|O
/	|O
day	|O
.	|O

Temporal	|O
control	|O
of	|O
GUS	|B-PROTEIN
expression	|O
was	|O
found	|O
to	|O
involve	|O
two	|O
negative	|O
regulatory	|O
sequences	|O
,	|O
NRS1	|O
(	|O
-	|O
391	|O
to	|O
-	|O
295	|O
)	|O
and	|O
NRS2	|O
(	|O
-	|O
518	|O
to	|O
-	|O
418	|O
)	|O
,	|O
as	|O
well	|O
as	|O
the	|O
positive	|O
domain	|O
UAS1	|O
.	|O

We	|O
purified	|O
a	|O
Ca2+	|O
/	|O
calmodulin	|O
(	|B-PROTEIN
CaM	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
CaM	|B-PROTEIN
kinase	|I-PROTEIN
)	|O
from	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
with	|O
properties	|O
similar	|O
to	|O
mammalian	|O
type	|O
II	|O
CaM	|B-PROTEIN
kinases	|I-PROTEIN
.	|O

In	|O
most	|O
cases	|O
,	|O
DR4	|B-PROTEIN
-	|O
homozygous	|O
,	|O
DRB1	|B-PROTEIN
-	|O
heterozygous	|O
individuals	|O
could	|O
be	|O
genotyped	|O
with	|O
the	|O
panel	|O
of	|O
probes	|O
.	|O

Two	|O
patients	|O
had	|O
immediate	|O
adverse	|O
effects	|O
from	|O
NMF	|O
;	|O
one	|O
had	|O
a	|O
grand	|O
mal	|O
seizure	|O
and	|O
the	|O
other	|O
developed	|O
severe	|O
abdominal	|O
pain	|O
.	|O

The	|O
muscles	|O
from	|O
the	|O
ischemic	|O
group	|O
had	|O
significantly	|O
lower	|O
(	|O
P	|O
less	|O
than	|O
.05	|O
)	|O
values	|O
for	|O
capillary	|O
density	|O
and	|O
capillary	|O
to	|O
fiber	|O
ratio	|O
and	|O
significantly	|O
higher	|O
intercapillary	|O
distance	|O
than	|O
those	|O
from	|O
the	|O
normal	|O
group	|O
.	|O

The	|O
prevalence	|O
of	|O
opportunistic	|O
infection	|O
among	|O
surviving	|O
AIDS	|O
patients	|O
and	|O
the	|O
probability	|O
of	|O
being	|O
in	|O
tumour	|O
response	|O
following	|O
cancer	|O
therapy	|O
conditional	|O
on	|O
being	|O
alive	|O
are	|O
two	|O
examples	|O
of	|O
such	|O
functions	|O
.	|O

Serum	|O
TNF	|B-PROTEIN
concentrations	|O
were	|O
elevated	|O
at	|O
diagnosis	|O
and	|O
gradually	|O
decreased	|O
toward	|O
the	|O
reference	|O
limits	|O
by	|O
week	|O
16	|O
.	|O

Genomic	|O
clones	|O
encompassing	|O
the	|O
human	|O
ETS1	|B-PROTEIN
gene	|O
were	|O
isolated	|O
and	|O
utilized	|O
to	|O
define	|O
its	|O
molecular	|O
organization	|O
.	|O

Polymerase	|O
chain	|O
reaction	|O
analysis	|O
of	|O
ETS1	|B-PROTEIN
cDNA	|O
identified	|O
several	|O
amplified	|O
products	|O
,	|O
indicating	|O
alternative	|O
splicing	|O
.	|O

Most	|O
of	|O
the	|O
expressed	|O
human	|O
E3	|B-PROTEIN
polypeptides	|O
(	|O
five	|O
bands	|O
)	|O
were	|O
found	|O
in	|O
the	|O
insoluble	|O
pellet	|O
while	|O
primarily	|O
full	|O
-	|O
length	|O
mature	|O
E3	|B-PROTEIN
was	|O
found	|O
in	|O
the	|O
soluble	|O
fraction	|O
.	|O

To	|O
test	|O
promotor	|O
function	|O
,	|O
chimeric	|O
genes	|O
were	|O
constructed	|O
linking	|O
fragments	|O
of	|O
chicken	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
5'	|O
-	|O
flanking	|O
DNA	|O
to	|O
a	|O
promoterless	|O
reporter	|O
plasmid	|O
.	|O

The	|O
alpha	|B-PROTEIN
4	|I-PROTEIN
gene	|O
5'	|O
flanking	|O
region	|O
acted	|O
as	|O
a	|O
promoter	|O
in	|O
transfection	|O
assays	|O
.	|O

Characterization	|O
of	|O
the	|O
alpha	|B-PROTEIN
4	|I-PROTEIN
integrin	|I-PROTEIN
gene	|O
promoter	|O
.	|O

Only	|O
the	|O
3.0	|O
-	|O
kb	|O
transcript	|O
was	|O
detected	|O
in	|O
adult	|O
tissues	|O
,	|O
where	|O
its	|O
expression	|O
was	|O
restricted	|O
almost	|O
exclusively	|O
to	|O
the	|O
central	|O
nervous	|O
system	|O
.	|O

Two	|O
homologues	|O
of	|O
the	|O
rhombotin	|B-PROTEIN
gene	|O
have	|O
now	|O
been	|O
isolated	|O
.	|O

Angina	|O
haemorrhagica	|O
bullosa	|O
causing	|O
respiratory	|O
obstruction	|O
postoperatively	|O
.	|O

We	|O
examined	|O
the	|O
effects	|O
of	|O
long	|O
-	|O
term	|O
perfusion	|O
with	|O
pyridoxalated	|O
hemoglobin	|B-PROTEIN
polyoxyethylene	|O
conjugate	|O
(	|O
PHP	|O
)	|O
solution	|O
on	|O
cardiac	|O
function	|O
of	|O
isolated	|O
rat	|O
hearts	|O
.	|O

Conclusion	|O
:	|O
inlet	|O
type	|O
VSD	|O
and	|O
perimembranous	|O
type	|O
TOF	|O
have	|O
anatomic	|O
features	|O
in	|O
which	|O
the	|O
proximal	|O
His	|O
bundle	|O
tends	|O
to	|O
be	|O
jeopardized	|O
by	|O
suturing	|O
for	|O
VSD	|O
closure	|O
.	|O

The	|O
gcd2	|B-PROTEIN
-	|O
503	|O
mutation	|O
also	|O
results	|O
in	|O
polysome	|O
runoff	|O
,	|O
accumulation	|O
of	|O
inactive	|O
80S	|B-PROTEIN
ribosomal	|O
couples	|O
,	|O
and	|O
accumulation	|O
of	|O
at	|O
least	|O
one	|O
of	|O
the	|O
subunits	|O
of	|O
the	|O
general	|B-PROTEIN
translation	|I-PROTEIN
initiation	|I-PROTEIN
factor	|I-PROTEIN
2	|I-PROTEIN
(	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
in	|O
43S	|B-PROTEIN
-	|O
48S	|B-PROTEIN
particles	|O
following	|O
a	|O
shift	|O
to	|O
the	|O
restrictive	|O
temperature	|O
.	|O

Eight	|O
patients	|O
with	|O
ARC	|O
and	|O
renal	|O
failure	|O
were	|O
recently	|O
evaluated	|O
.	|O

To	|O
measure	|O
the	|O
enhancer	|O
activity	|O
of	|O
DR60	|B-PROTEIN
,	|O
a	|O
reporter	|O
plasmid	|O
was	|O
constructed	|O
that	|O
contained	|O
DR60	|B-PROTEIN
cloned	|O
upstream	|O
of	|O
the	|O
reporter	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
gene	|O
under	|O
the	|O
control	|O
of	|O
the	|O
delayed	|O
-	|O
early	|O
39K	|O
promoter	|O
.	|O

A	|O
single	|O
case	|O
of	|O
an	|O
adenocarcinoma	|O
,	|O
arising	|O
in	|O
a	|O
retroperitoneal	|O
enterogenous	|O
cyst	|O
and	|O
which	|O
presented	|O
as	|O
a	|O
left	|O
renal	|O
cyst	|O
,	|O
is	|O
reported	|O
.	|O

Using	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
,	|O
we	|O
analyzed	|O
the	|O
U6	|B-PROTEIN
RNA	|O
genes	|O
of	|O
52	|O
organisms	|O
.	|O

Both	|O
tear	|O
volume	|O
and	|O
tear	|O
flow	|O
were	|O
found	|O
to	|O
be	|O
significantly	|O
(	|O
P	|O
less	|O
than	|O
0.001	|O
)	|O
decreased	|O
up	|O
to	|O
6	|O
h	|O
after	|O
instillation	|O
,	|O
reaching	|O
a	|O
minimum	|O
90	|O
min	|O
after	|O
application	|O
(	|O
tear	|O
volume	|O
:	|O
-	|O
63%	|O
;	|O
tear	|O
flow	|O
:	|O
-	|O
71%	|O
)	|O
.	|O

Hydrophobicity	|O
analysis	|O
indicated	|O
that	|O
the	|O
KlaA	|B-PROTEIN
and	|O
KlaB	|B-PROTEIN
polypeptides	|O
are	|O
likely	|O
to	|O
be	|O
soluble	|O
,	|O
whereas	|O
the	|O
KlaC	|B-PROTEIN
polypeptide	|O
was	|O
predicted	|O
to	|O
have	|O
four	|O
potential	|O
membrane	|O
-	|O
spanning	|O
domains	|O
.	|O

To	|O
facilitate	|O
the	|O
availability	|O
of	|O
important	|O
new	|O
therapeutic	|O
agents	|O
,	|O
the	|O
Food	|O
and	|O
Drug	|O
Administration	|O
(	|O
FDA	|O
)	|O
in	|O
the	|O
mid	|O
-	|O
1970s	|O
began	|O
assigning	|O
therapeutic	|O
ratings	|O
to	|O
investigational	|O
new	|O
drugs	|O
and	|O
holding	|O
end	|O
-	|O
of	|O
-	|O
phase	|O
II	|O
conferences	|O
with	|O
drug	|O
sponsors	|O
.	|O

In	|O
contrast	|O
,	|O
similar	|O
rates	|O
of	|O
B.	|O
sphaericus	|O
products	|O
,	|O
ABG	|O
-	|O
6184	|O
technical	|O
powder	|O
and	|O
BSP	|O
-	|O
2	|O
flowable	|O
concentrate	|O
,	|O
produced	|O
no	|O
significant	|O
reduction	|O
.	|O

The	|O
remainder	|O
(	|O
18.4%	|O
)	|O
was	|O
with	|O
IgA	|B-PROTEIN
nephropathy	|O
,	|O
which	|O
was	|O
histologically	|O
mild	|O
.	|O

Grossly	|O
,	|O
the	|O
experimental	|O
vulvitis	|O
was	|O
identical	|O
to	|O
the	|O
field	|O
condition	|O
,	|O
and	|O
bacteria	|O
indistinguishable	|O
from	|O
the	|O
inoculated	|O
strains	|O
were	|O
reisolated	|O
.	|O

3	|O
.	|O

Furthermore	|O
,	|O
the	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
complex	|O
was	|O
difficult	|O
to	|O
obtain	|O
from	|O
dpb2	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
cells	|O
,	|O
suggesting	|O
that	|O
a	|O
stable	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
complex	|O
requires	|O
DPB2	|B-PROTEIN
and	|O
is	|O
essential	|O
for	|O
chromosomal	|O
replication	|O
.	|O

To	|O
determine	|O
whether	|O
mononuclear	|O
cell	|O
secretory	|O
products	|O
contribute	|O
to	|O
the	|O
changes	|O
in	|O
bone	|O
turnover	|O
that	|O
characterize	|O
the	|O
development	|O
of	|O
postmenopausal	|O
osteoporosis	|O
,	|O
we	|O
evaluated	|O
the	|O
effects	|O
of	|O
oophorectomy	|O
and	|O
subsequent	|O
estrogen	|O
replacement	|O
on	|O
the	|O
spontaneous	|O
secretion	|O
of	|O
interleukin	|B-PROTEIN
1	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
and	|O
on	|O
the	|O
phytohemagglutinin	|B-PROTEIN
A	|I-PROTEIN
-	|O
induced	|O
secretion	|O
of	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
from	|O
peripheral	|O
blood	|O
mononuclear	|O
cells	|O
.	|O

There	|O
were	|O
45	|O
to	|O
56	|O
nt	|O
differences	|O
between	|O
the	|O
virulent	|O
and	|O
avirulent	|O
groups	|O
while	|O
there	|O
were	|O
6	|O
to	|O
14	|O
nt	|O
differences	|O
among	|O
four	|O
avirulent	|O
strains	|O
.	|O

The	|O
standard	|O
principles	|O
of	|O
surgical	|O
management	|O
must	|O
be	|O
adhered	|O
to	|O
when	|O
using	|O
Sandostatin	|O
to	|O
treat	|O
patients	|O
with	|O
these	|O
disorders	|O
.	|O

Some	|O
of	|O
the	|O
PCR	|O
products	|O
contained	|O
mutations	|O
in	|O
ATG1	|B-PROTEIN
and	|O
/	|O
or	|O
ATG2	|B-PROTEIN
.	|O

Hemorrhagic	|O
shock	|O
and	|O
bacterial	|O
translocation	|O
in	|O
a	|O
swine	|O
model	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
the	|O
levels	|O
of	|O
oxygen	|O
free	|O
radicals	|O
were	|O
increased	|O
in	|O
hepatocytes	|O
and	|O
mitochondria	|O
.	|O

The	|O
sequence	|O
of	|O
the	|O
pMxL1	|O
plasmid	|O
containing	|O
the	|O
invertible	|O
region	|O
contains	|O
a	|O
perfect	|O
tandem	|O
repeat	|O
of	|O
19	|O
bp	|O
in	|O
the	|O
orientation	|O
1	|O
nonexpressed	|O
pilin	|B-PROTEIN
gene	|O
at	|O
the	|O
middle	|O
of	|O
the	|O
recombination	|O
junction	|O
site	|O
.	|O

No	|O
evidence	|O
for	|O
the	|O
presence	|O
of	|O
introns	|O
within	|O
the	|O
acvA	|B-PROTEIN
gene	|O
has	|O
been	|O
found	|O
.	|O

These	|O
observations	|O
,	|O
together	|O
with	|O
the	|O
occurrence	|O
of	|O
putative	|O
4'	|O
-	|O
phosphopantetheine	|O
-	|O
attachment	|O
sites	|O
and	|O
a	|O
putative	|O
thioesterase	|B-PROTEIN
site	|O
,	|O
are	|O
discussed	|O
with	|O
reference	|O
to	|O
the	|O
reaction	|O
sequence	|O
leading	|O
to	|O
production	|O
of	|O
the	|O
ACV	|B-PROTEIN
tripeptide	|O
.	|O

Pargyline	|O
,	|O
a	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
inhibitor	|O
,	|O
reduces	|O
peak	|O
3	|O
transiently	|O
(	|O
max	|O
.	|O

When	|O
given	|O
the	|O
choice	|O
between	|O
an	|O
estrous	|O
female	|O
and	|O
a	|O
sexually	|O
active	|O
male	|O
in	|O
the	|O
AOF	|O
,	|O
flutamide	|O
females	|O
,	|O
as	|O
well	|O
as	|O
controls	|O
,	|O
preferred	|O
the	|O
male	|O
partner	|O
.	|O

Hypoxic	|O
ventilatory	|O
responses	|O
were	|O
-	|O
1.99	|O
+	|O
/	|O
-	|O
0.37	|O
L	|O
/	|O
min	|O
/	|O
%	|O
SaO2	|O
in	|O
the	|O
relatives	|O
and	|O
-	|O
1.54	|O
+	|O
/	|O
-	|O
0.25	|O
L	|O
/	|O
min	|O
/	|O
%	|O
SaO2	|O
in	|O
the	|O
control	|O
subjects	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Very	|O
small	|O
deletions	|O
within	|O
the	|O
conserved	|O
region	|O
completely	|O
abolished	|O
transforming	|O
activity	|O
of	|O
dbl	|B-PROTEIN
,	|O
while	|O
extensive	|O
deletion	|O
outside	|O
of	|O
this	|O
region	|O
had	|O
no	|O
effect	|O
.	|O

This	|O
computerized	|O
list	|O
was	|O
linked	|O
to	|O
the	|O
central	|O
files	|O
of	|O
the	|O
Massachusetts	|O
Cancer	|O
Registry	|O
and	|O
cases	|O
diagnosed	|O
between	|O
1982	|O
and	|O
1988	|O
were	|O
identified	|O
.	|O

We	|O
also	|O
present	|O
evidence	|O
for	|O
a	|O
negative	|O
regulatory	|O
element	|O
in	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
Mlu	|B-PROTEIN
I	|I-PROTEIN
upstream	|O
activation	|O
sequence	|O
.	|O

A	|O
method	|O
for	|O
establishing	|O
stimulus	|O
control	|O
of	|O
ethanol	|O
responding	|O
was	|O
developed	|O
.	|O

Mechanism	|O
of	|O
activation	|O
of	|O
the	|O
vav	|B-PROTEIN
protooncogene	|O
.	|O
vav	|B-PROTEIN
is	|O
a	|O
human	|O
locus	|O
that	|O
appears	|O
to	|O
be	|O
specifically	|O
expressed	|O
in	|O
cells	|O
of	|O
hematopoietic	|O
origin	|O
regardless	|O
of	|O
their	|O
differentiation	|O
lineage	|O
.	|O

Endothelial	|O
cell	|O
seeding	|O
.	|O

Menetrier	|O
disease	|O
in	|O
a	|O
child	|O
.	|O

After	|O
hemodynamic	|O
stabilization	|O
,	|O
the	|O
goal	|O
of	|O
therapy	|O
is	|O
to	|O
diminish	|O
the	|O
chance	|O
that	|O
an	|O
ulcer	|O
will	|O
continue	|O
to	|O
bleed	|O
or	|O
will	|O
rebleed	|O
.	|O

Thirty	|O
seven	|O
patients	|O
(	|O
amitriptyline	|O
n	|O
=	|O
16	|O
,	|O
moclobemide	|O
n	|O
=	|O
21	|O
)	|O
completed	|O
the	|O
six	|O
week	|O
protocol	|O
,	|O
which	|O
was	|O
conducted	|O
under	|O
double	|O
blind	|O
conditions	|O
.	|O

The	|O
stimulus	|O
threshold	|O
for	|O
EER	|O
showed	|O
a	|O
less	|O
individual	|O
variation	|O
than	|O
amplitude	|O
.	|O

Analysis	|O
of	|O
electrically	|O
evoked	|O
response	|O
(	|O
EER	|O
)	|O
in	|O
relation	|O
to	|O
the	|O
central	|O
visual	|O
pathway	|O
of	|O
the	|O
cat	|O
(	|O
1	|O
)	|O
.	|O

Furthermore	|O
,	|O
plasma	|O
fibrinogen	|B-PROTEIN
levels	|O
increased	|O
by	|O
a	|O
mean	|O
of	|O
17.6%	|O
,	|O
a	|O
potentially	|O
adverse	|O
effect	|O
of	|O
gemfibrozil	|O
that	|O
has	|O
not	|O
been	|O
previously	|O
reported	|O
.	|O

Gemfibrozil	|O
in	|O
hyperlipidaemic	|O
patients	|O
with	|O
peripheral	|O
arterial	|O
disease	|O
:	|O
some	|O
undiscovered	|O
actions	|O
.	|O

An	|O
RME1	|B-PROTEIN
-	|O
independent	|O
pathway	|O
for	|O
sporulation	|O
control	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
acts	|O
through	|O
IME1	|B-PROTEIN
transcript	|O
accumulation	|O
.	|O

The	|O
role	|O
of	|O
pharmacological	|O
profiling	|O
in	|O
safety	|O
assessment	|O
.	|O

Its	|O
application	|O
in	|O
Madagascar	|O
:	|O
advantages	|O
and	|O
disadvantages	|O

In	|O
all	|O
cases	|O
,	|O
high	|O
-	|O
level	|O
expression	|O
of	|O
the	|O
truncated	|O
avian	|O
integrins	|B-PROTEIN
was	|O
obtained	|O
.	|O

The	|O
authors	|O
evaluate	|O
the	|O
clinical	|O
efficacy	|O
of	|O
EMB	|O
AZS	|O
in	|O
recurrent	|O
ulcer	|O
after	|O
operation	|O
on	|O
the	|O
stomach	|O
caused	|O
by	|O
a	|O
high	|O
level	|O
of	|O
acid	|O
production	|O
and	|O
ulcerative	|O
gastroduodenal	|O
bleeding	|O
.	|O

In	|O
adulthood	|O
these	|O
rats	|O
were	|O
hyperactive	|O
and	|O
learned	|O
the	|O
active	|O
avoidance	|O
response	|O
later	|O
than	|O
the	|O
controls	|O
.	|O

To	|O
investigate	|O
the	|O
regulation	|O
of	|O
Spec	|B-PROTEIN
gene	|O
activity	|O
,	|O
the	|O
region	|O
around	|O
the	|O
Spec1	|B-PROTEIN
transcriptional	|O
initiation	|O
site	|O
was	|O
analyzed	|O
for	|O
sites	|O
of	|O
protein	|O
-	|O
DNA	|O
interaction	|O
.	|O

Phosphopeptide	|O
mapping	|O
revealed	|O
the	|O
same	|O
autophosphorylation	|O
sites	|O
utilized	|O
by	|O
EGFR	|B-PROTEIN
-	|I-PROTEIN
IC	|I-PROTEIN
as	|O
those	|O
identified	|O
in	|O
wild	|O
-	|O
type	|O
EGFR	|B-PROTEIN
.	|O

The	|O
encoded	|O
sequence	|O
revealed	|O
a	|O
typical	|O
signal	|O
peptide	|O
,	|O
a	|O
predominantly	|O
hydrophilic	|O
707	|O
amino	|O
acid	|O
residue	|O
domain	|O
with	|O
8	|O
N	|O
-	|O
glycosylation	|O
sites	|O
,	|O
a	|O
transmembrane	|O
domain	|O
,	|O
and	|O
a	|O
C	|O
-	|O
terminal	|O
domain	|O
of	|O
52	|O
amino	|O
acids	|O
.	|O

The	|O
TCF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
binding	|O
site	|O
was	|O
also	|O
required	|O
for	|O
TCR	|B-PROTEIN
alpha	|I-PROTEIN
enhancer	|O
activity	|O
in	|O
transcriptionally	|O
active	|O
extracts	|O
from	|O
Jurkat	|O
but	|O
not	|O
HeLa	|O
cells	|O
,	|O
confirming	|O
that	|O
TCF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
is	|O
a	|O
T	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
.	|O

A	|O
new	|O
semi	|O
-	|O
automatic	|O
method	|O
for	|O
quantifying	|O
regional	|O
cerebral	|O
uptake	|O
of	|O
99m	|O
technetium	|O
-	|O
hexamethylpropylene	|O
amine	|O
oxime	|O
(	|O
99mTc	|O
-	|O
HMPAO	|O
)	|O
was	|O
used	|O
to	|O
assess	|O
single	|O
photon	|O
emission	|O
tomograms	|O
from	|O
5	|O
normal	|O
subjects	|O
,	|O
14	|O
patients	|O
with	|O
Alzheimer	|O
's	|O
disease	|O
,	|O
14	|O
patients	|O
with	|O
dementia	|O
of	|O
frontal	|O
lobe	|O
type	|O
and	|O
4	|O
patients	|O
with	|O
dementia	|O
with	|O
motor	|O
neurone	|O
disease	|O
.	|O

The	|O
results	|O
showed	|O
that	|O
fog	|O
,	|O
up	|O
to	|O
a	|O
level	|O
of	|O
base	|O
plus	|O
fog	|O
of	|O
0.6	|O
optical	|O
density	|O
units	|O
,	|O
had	|O
no	|O
influence	|O
on	|O
the	|O
diagnostic	|O
accuracy	|O
in	|O
the	|O
absence	|O
of	|O
any	|O
compensation	|O
.	|O

IdB	|O
1031	|O
was	|O
first	|O
extracted	|O
by	|O
liquid	|O
-	|O
solid	|O
partition	|O
and	|O
the	|O
extracts	|O
were	|O
evaporated	|O
and	|O
analysed	|O
on	|O
a	|O
reversed	|O
-	|O
phase	|O
column	|O
under	|O
isocratic	|O
conditions	|O
,	|O
using	|O
either	|O
an	|O
electrochemical	|O
or	|O
a	|O
UV	|O
detector	|O
.	|O

In	|O
this	|O
model	|O
,	|O
eltoprazine	|O
has	|O
a	|O
very	|O
specific	|O
anti	|O
-	|O
aggressive	|O
(	|O
serenic	|O
)	|O
profile	|O
,	|O
inhibiting	|O
aggression	|O
while	|O
social	|O
interaction	|O
and	|O
exploration	|O
are	|O
not	|O
decreased	|O
but	|O
even	|O
enhanced	|O
;	|O
inactivity	|O
,	|O
a	|O
measure	|O
for	|O
sedation	|O
,	|O
is	|O
not	|O
affected	|O
.	|O

A	|O
new	|O
method	|O
for	|O
the	|O
in	|O
vitro	|O
transfer	|O
of	|O
delayed	|O
hypersensitivity	|O
by	|O
dialysed	|O
transfer	|B-PROTEIN
factor	|I-PROTEIN
.	|O

Effect	|O
of	|O
separate	|O
and	|O
combined	|O
effects	|O
of	|O
plutonium	|O
-	|O
239	|O
,	|O
hexachlorobutadiene	|O
and	|O
tributyl	|O
phosphate	|O
on	|O
the	|O
thymus	|O
gland	|O
of	|O
rats	|O

Data	|O
collection	|O
was	|O
made	|O
with	|O
a	|O
query	|O
language	|O
,	|O
and	|O
data	|O
analysis	|O
performed	|O
with	|O
an	|O
interactive	|O
knowledge	|O
-	|O
based	|O
statistical	|O
tool	|O
,	|O
MAXITAB	|O
,	|O
employing	|O
a	|O
multivariate	|O
tabular	|O
analysis	|O
technique	|O
.	|O

ARPIA	|O
has	|O
been	|O
implemented	|O
by	|O
using	|O
a	|O
relational	|O
DBMS	|O
,	|O
very	|O
cheap	|O
and	|O
highly	|O
diffused	|O
on	|O
personal	|O
computers	|O
.	|O

Diuresis	|O
was	|O
induced	|O
by	|O
scheduled	|O
drinking	|O
of	|O
tea	|O
(	|O
150	|O
ml	|O
/	|O
h	|O
)	|O
.	|O

Diagnostic	|O
value	|O
of	|O
adenosine	|B-PROTEIN
deaminase	|I-PROTEIN
activity	|O
in	|O
tuberculous	|O
effusions	|O
.	|O

Femoral	|O
strain	|O
adaptation	|O
after	|O
total	|O
hip	|O
replacement	|O
:	|O
a	|O
comparison	|O
of	|O
cemented	|O
and	|O
porous	|O
ingrowth	|O
components	|O
in	|O
canines	|O
.	|O

Immuno	|O
-	|O
cytochemistry	|O
,	|O
using	|O
antisera	|O
against	|O
Campylobacter	|O
jejuni	|O
,	|O
showed	|O
that	|O
the	|O
positive	|O
staining	|O
in	|O
altered	|O
epithelial	|O
cells	|O
were	|O
restricted	|O
to	|O
intracellular	|O
organisms	|O
having	|O
a	|O
structure	|O
resembling	|O
Campylobacter	|O
spp	|O
.	|O

Promoter	|O
activities	|O
were	|O
estimated	|O
using	|O
beta	|B-PROTEIN
-	|I-PROTEIN
glucuronidase	|I-PROTEIN
and	|O
neomycin	|B-PROTEIN
phosphotransferase	|I-PROTEIN
II	|I-PROTEIN
reporter	|O
gene	|O
systems	|O
.	|O

The	|O
5'	|O
regions	|O
of	|O
these	|O
two	|O
soybean	|O
actin	|B-PROTEIN
genes	|O
contain	|O
many	|O
unusual	|O
features	|O
including	|O
(	|O
CT	|O
)	|O
repeats	|O
and	|O
long	|O
stretches	|O
of	|O
pyrimidine	|O
-	|O
rich	|O
DNA	|O
.	|O

All	|O
8	|O
(	|O
100%	|O
)	|O
patients	|O
with	|O
fulminant	|O
hepatic	|O
failure	|O
who	|O
received	|O
grafts	|O
survived	|O
,	|O
including	|O
3	|O
who	|O
received	|O
ABO	|O
-	|O
incompatible	|O
grafts	|O
,	|O
though	|O
2	|O
of	|O
these	|O
subsequently	|O
required	|O
retransplantation	|O
.	|O

No	|O
patient	|O
had	|O
a	|O
history	|O
of	|O
excess	|O
alcohol	|O
intake	|O
,	|O
or	|O
prolonged	|O
intake	|O
of	|O
hepatotoxic	|O
drugs	|O
and	|O
steroids	|O
,	|O
and	|O
were	|O
not	|O
obese	|O
or	|O
malnourished	|O
.	|O

An	|O
evolutionary	|O
comparison	|O
of	|O
amino	|O
acid	|O
sequences	|O
of	|O
34	|O
HSP70	|B-PROTEIN
proteins	|O
from	|O
17	|O
species	|O
suggests	|O
that	|O
BiP	|B-PROTEIN
genes	|O
share	|O
a	|O
common	|O
ancestor	|O
,	|O
which	|O
diverged	|O
from	|O
other	|O
HSP70	|B-PROTEIN
genes	|O
near	|O
the	|O
time	|O
when	|O
eukaryotes	|O
first	|O
appeared	|O
.	|O

Spore	|O
inocula	|O
(	|O
approximately	|O
10	|O
(	|O
6	|O
)	|O
/	|O
coupon	|O
)	|O
were	|O
dried	|O
onto	|O
0.5	|O
-	|O
in	|O
.	|O

However	|O
,	|O
overexpression	|O
of	|O
both	|O
the	|O
STE4	|B-PROTEIN
and	|O
STE18	|B-PROTEIN
proteins	|O
did	|O
not	|O
generate	|O
a	|O
stronger	|O
pheromone	|O
response	|O
than	|O
overexpression	|O
of	|O
STE4	|B-PROTEIN
in	|O
the	|O
presence	|O
of	|O
wild	|O
-	|O
type	|O
levels	|O
of	|O
STE18	|B-PROTEIN
.	|O

Reverse	|O
transcription	|O
-	|O
PCR	|O
was	|O
then	|O
used	|O
to	|O
clone	|O
from	|O
human	|O
poly	|O
(	|O
A	|O
)	|O
+	|O
RNA	|O
the	|O
cDNA	|O
corresponding	|O
to	|O
the	|O
expressed	|O
homolog	|O
of	|O
psi	|O
ARF	|B-PROTEIN
4	|I-PROTEIN
,	|O
referred	|O
to	|O
as	|O
human	|O
ARF	|B-PROTEIN
4	|I-PROTEIN
.	|O

To	|O
evaluate	|O
the	|O
cost	|O
and	|O
benefits	|O
of	|O
screening	|O
tests	|O
for	|O
Chlamydia	|O
trachomatis	|O
in	|O
adolescent	|O
males	|O
,	|O
we	|O
developed	|O
a	|O
decision	|O
analysis	|O
model	|O
and	|O
compared	|O
the	|O
leukocyte	|O
esterase	|B-PROTEIN
urine	|O
dipstick	|O
test	|O
with	|O
culture	|O
,	|O
with	|O
direct	|O
-	|O
smear	|O
fluorescent	|O
antibody	|O
(	|O
DFA	|O
)	|O
,	|O
and	|O
with	|O
the	|O
option	|O
of	|O
no	|O
screening	|O
(	|O
no	|O
treatment	|O
)	|O
.	|O

Sequencing	|O
the	|O
gene	|O
for	|O
an	|O
imipenem	|O
-	|O
cefoxitin	|O
-	|O
hydrolyzing	|O
enzyme	|O
(	|O
CfiA	|B-PROTEIN
)	|O
from	|O
Bacteroides	|O
fragilis	|O
TAL2480	|O
reveals	|O
strong	|O
similarity	|O
between	|O
CfiA	|B-PROTEIN
and	|O
Bacillus	|O
cereus	|O
beta	|B-PROTEIN
-	|I-PROTEIN
lactamase	|I-PROTEIN
II	|I-PROTEIN
.	|O

The	|O
cloned	|O
HindIII	|B-PROTEIN
fragment	|O
,	|O
which	|O
was	|O
shown	|O
by	|O
DNA	|O
sequence	|O
analysis	|O
to	|O
encode	|O
the	|O
N	|O
-	|O
terminal	|O
half	|O
of	|O
the	|O
B.	|O
subtilis	|O
IF2	|B-PROTEIN
protein	|O
and	|O
0.2	|O
kb	|O
of	|O
upstream	|O
flanking	|O
sequence	|O
,	|O
was	|O
utilized	|O
as	|O
a	|O
homologous	|O
probe	|O
to	|O
clone	|O
an	|O
overlapping	|O
2.76	|O
-	|O
kb	|O
ClaI	|B-PROTEIN
chromosomal	|O
fragment	|O
containing	|O
the	|O
entire	|O
IF2	|B-PROTEIN
structural	|O
gene	|O
.	|O

The	|O
N	|O
-	|O
terminal	|O
115	|O
amino	|O
acids	|O
correspond	|O
to	|O
a	|O
putative	|O
DNA	|O
-	|O
binding	|O
domain	|O
and	|O
show	|O
significant	|O
sequence	|O
similarity	|O
with	|O
other	|O
cloned	|O
IFN	|B-PROTEIN
response	|O
factors	|O
(	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
.	|O

Maternal	|O
seizures	|O
had	|O
occurred	|O
during	|O
pregnancy	|O
in	|O
52	|O
per	|O
cent	|O
.	|O

It	|O
encodes	|O
a	|O
protein	|O
with	|O
three	|O
zinc	|O
fingers	|O
similar	|O
to	|O
those	|O
of	|O
the	|O
transcription	|O
factor	|O
Sp1	|B-PROTEIN
.	|O

Krox	|B-PROTEIN
-	|I-PROTEIN
24	|I-PROTEIN
is	|O
therefore	|O
a	|O
sequence	|O
-	|O
specific	|O
transcriptional	|O
activator	|O
.	|O

The	|O
interindividual	|O
variability	|O
of	|O
the	|O
parameters	|O
is	|O
taken	|O
into	|O
consideration	|O
by	|O
interactively	|O
determining	|O
the	|O
threshold	|O
levels	|O
.	|O

The	|O
patients	|O
were	|O
divided	|O
into	|O
3	|O
subgroups	|O
:	|O
1	|O
)	|O
13	|O
N+	|O
patients	|O
with	|O
multiple	|O
hot	|O
spots	|O
(	|O
greater	|O
than	|O
2	|O
)	|O
(	|O
N+	|O
IM	|O
)	|O
;	|O
2	|O
)	|O
24	|O
N+	|O
patients	|O
with	|O
single	|O
hot	|O
spots	|O
(	|O
less	|O
than	|O
or	|O
equal	|O
to	|O
2	|O
)	|O
(	|O
N+	|O
IS	|O
)	|O
;	|O
3	|O
)	|O
12	|O
N	|O
-	|O
patients	|O
with	|O
single	|O
hot	|O
spots	|O
(	|O
less	|O
than	|O
or	|O
equal	|O
to	|O
2	|O
)	|O
(	|O
N	|O
-	|O
IS	|O
)	|O
.	|O

Inspired	|O
CO2	|O
causing	|O
changes	|O
from	|O
hypo	|O
-	|O
to	|O
normocapnia	|O
has	|O
previously	|O
been	|O
shown	|O
to	|O
improve	|O
arterial	|O
O2	|O
tension	|O
(	|O
PaO2	|O
)	|O
and	|O
to	|O
reduce	|O
alveolar	|O
-	|O
arterial	|O
O2	|O
difference	|O
.	|O

Expression	|O
,	|O
nucleotide	|O
sequence	|O
and	|O
mutational	|O
analysis	|O
of	|O
two	|O
open	|O
reading	|O
frames	|O
in	|O
the	|O
nif	|B-PROTEIN
gene	|O
region	|O
of	|O
Anabaena	|O
sp	|O
.	|O
strain	|O
PCC7120	|O
.	|O

Further	|O
,	|O
they	|O
are	|O
consistent	|O
with	|O
the	|O
suggestion	|O
that	|O
sites	|O
homologous	|O
to	|O
the	|O
CAR1	|B-PROTEIN
URS	|O
may	|O
be	|O
situated	|O
in	|O
the	|O
5'	|O
-	|O
flanking	|O
regions	|O
of	|O
multiple	|O
unrelated	|O
yeast	|O
genes	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
a	|O
sequence	|O
match	|O
between	|O
enhancers	|O
and	|O
certain	|O
promoter	|O
elements	|O
is	|O
critical	|O
.	|O

This	|O
Mr	|O
is	|O
similar	|O
to	|O
those	|O
of	|O
the	|O
purified	|O
smg	|B-PROTEIN
p25A	|I-PROTEIN
GDI	|I-PROTEIN
estimated	|O
by	|O
sodium	|O
dodecyl	|O
sulfate	|O
-	|O
polyacrylamide	|O
gel	|O
electrophoresis	|O
and	|O
sucrose	|O
density	|O
gradient	|O
ultracentrifugation	|O
,	|O
which	|O
are	|O
about	|O
54,000	|O
and	|O
65,000	|O
,	|O
respectively	|O
.	|O

Yeast	|O
mutants	|O
assigned	|O
to	|O
the	|O
pet	|B-PROTEIN
complementation	|O
group	|O
G104	|O
were	|O
found	|O
to	|O
lack	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
ketoglutarate	|I-PROTEIN
dehydrogenase	|I-PROTEIN
activity	|O
as	|O
a	|O
result	|O
of	|O
mutations	|O
in	|O
the	|O
dihydrolipoyl	|B-PROTEIN
transsuccinylase	|I-PROTEIN
(	|O
KE2	|B-PROTEIN
)	|O
component	|O
of	|O
the	|O
complex	|O
.	|O

Critical	|O
residues	|O
required	|O
for	|O
repression	|O
are	|O
located	|O
within	|O
the	|O
C	|O
-	|O
terminal	|O
27	|O
amino	|O
acids	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
,	|O
since	|O
v	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
and	|O
C	|O
-	|O
terminal	|O
truncations	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
did	|O
not	|O
down	|O
regulate	|O
.	|O

We	|O
also	|O
discovered	|O
a	|O
V	|B-PROTEIN
lambda	|I-PROTEIN
pseudogene	|O
,	|O
called	|O
psi	|O
V	|B-PROTEIN
lambda	|I-PROTEIN
1	|I-PROTEIN
,	|O
3	|O
kb	|O
upstream	|O
of	|O
the	|O
U266	|B-PROTEIN
lambda	|I-PROTEIN
gene	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
we	|O
have	|O
analyzed	|O
the	|O
structure	|O
of	|O
human	|O
gene	|O
for	|O
Gx	|B-PROTEIN
alpha	|I-PROTEIN
,	|O
which	|O
spans	|O
more	|O
than	|O
60	|O
kilobases	|O
.	|O

A	|O
long	|O
follow	|O
-	|O
up	|O
study	|O
revealed	|O
that	|O
convalescent	|O
stage	|O
children	|O
still	|O
have	|O
the	|O
potency	|O
to	|O
have	|O
an	|O
immediate	|O
type	|O
hypersensitivity	|O
reaction	|O
on	|O
exposure	|O
to	|O
mite	|O
antigen	|O
,	|O
with	|O
a	|O
high	|O
titer	|O
of	|O
mite	|O
specific	|O
IgE	|B-PROTEIN
in	|O
their	|O
sera	|O
,	|O
but	|O
they	|O
are	|O
free	|O
from	|O
asthmatic	|O
attacks	|O
because	|O
of	|O
the	|O
reduction	|O
in	|O
the	|O
amount	|O
of	|O
mite	|O
antigen	|O
in	|O
the	|O
body	|O
,	|O
as	|O
shown	|O
by	|O
the	|O
reduction	|O
in	|O
the	|O
amount	|O
of	|O
mite	|O
specific	|O
IgG	|B-PROTEIN
.	|O

But	|O
no	|O
influence	|O
was	|O
observed	|O
at	|O
lower	|O
concentrations	|O
than	|O
1/4	|O
MIC	|O
of	|O
AMK	|O
.	|O

Uses	|O
of	|O
orthoclone	|O
OKT3	|B-PROTEIN
for	|O
prophylaxis	|O
of	|O
rejection	|O
and	|O
induction	|O
in	|O
initial	|O
nonfunction	|O
in	|O
kidney	|O
transplantation	|O
.	|O

Uses	|O
of	|O
orthoclone	|O
OKT3	|O
for	|O
prophylaxis	|O
of	|O
rejection	|O
and	|O
induction	|O
in	|O
initial	|O
nonfunction	|O
in	|O
kidney	|O
transplantation	|O
.	|O

Furthermore	|O
,	|O
we	|O
notice	|O
two	|O
potential	|O
consensus	|O
motifs	|O
which	|O
are	|O
also	|O
found	|O
in	|O
corresponding	|O
positions	|O
in	|O
the	|O
genes	|O
for	|O
the	|O
nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
and	|O
the	|O
68	|B-PROTEIN
-	|I-PROTEIN
kDa	|I-PROTEIN
neurofilament	|I-PROTEIN
protein	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
-	|O
119	|O
to	|O
-	|O
81	|O
fragment	|O
of	|O
the	|O
CCK	|B-PROTEIN
promoter	|O
contains	|O
a	|O
transcriptional	|O
enhancer	|O
that	|O
potentiates	|O
the	|O
transcription	|O
from	|O
the	|O
herpes	|O
simplex	|O
virus	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
promoter	|O
in	|O
a	|O
position	|O
-	|O
and	|O
orientation	|O
-	|O
independent	|O
manner	|O
.	|O

Thirty	|O
minutes	|O
of	|O
supine	|O
restraint	|O
decreased	|O
DOPAC	|O
concentrations	|O
in	|O
the	|O
median	|O
eminence	|O
of	|O
female	|O
rats	|O
that	|O
were	|O
not	|O
exposed	|O
to	|O
ether	|O
,	|O
and	|O
brief	|O
exposure	|O
to	|O
ether	|O
enhanced	|O
this	|O
effect	|O
.	|O

Influence	|O
of	|O
metoprolol	|O
treatment	|O
on	|O
sympatho	|O
-	|O
adrenal	|O
activation	|O
of	|O
fibrinolysis	|O
.	|O

Five	|O
of	|O
10	|O
scars	|O
studied	|O
decreased	|O
at	|O
least	|O
50%	|O
in	|O
linear	|O
dimensions	|O
.	|O

Managing	|O
dysphagia	|O
in	|O
a	|O
chronic	|O
care	|O
setting	|O
:	|O
an	|O
introduction	|O
.	|O

Gel	|O
-	|O
mobility	|O
-	|O
shift	|O
assays	|O
confirmed	|O
that	|O
the	|O
Raji	|O
nuclear	|O
proteins	|O
that	|O
bound	|O
to	|O
W	|O
and	|O
V	|O
elements	|O
were	|O
competed	|O
with	|O
by	|O
an	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DRA	|I-PROTEIN
X	|O
-	|O
box	|O
oligonucleotide	|O
.	|O

In	|O
Denmark	|O
only	|O
1-3	|O
cases	|O
of	|O
transfusion	|O
-	|O
associated	|O
hepatitis	|O
NANB	|O
(	|O
TAH	|O
-	|O
NANB	|O
)	|O
are	|O
registered	|O
annually	|O
or	|O
about	|O
1	|O
case	|O
per	|O
100,000	|O
units	|O
transfused	|O
.	|O

The	|O
NF1	|B-PROTEIN
locus	|O
encodes	|O
a	|O
protein	|O
functionally	|O
related	|O
to	|O
mammalian	|O
GAP	|B-PROTEIN
and	|O
yeast	|O
IRA	|B-PROTEIN
proteins	|O
.	|O

Hence	|O
,	|O
the	|O
replacement	|O
of	|O
Phe	|O
-	|O
62	|O
with	|O
Ser	|O
specifically	|O
affects	|O
a	|O
determinant	|O
on	|O
the	|O
lambda	|B-PROTEIN
I	|I-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
that	|O
is	|O
necessary	|O
for	|O
the	|O
intracellular	|O
transport	|O
of	|O
this	|O
molecule	|O
.	|O

A	|O
second	|O
isotype	|O
of	|O
Raja	|O
immunoglobulin	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
genes	|O
has	|O
been	|O
detected	|O
by	|O
screening	|O
a	|O
spleen	|O
cDNA	|O
library	|O
with	|O
homologous	|O
Raja	|O
VH	|B-PROTEIN
-	|O
and	|O
CH1	|B-PROTEIN
-	|O
specific	|O
probes	|O
complementing	|O
the	|O
respective	|O
regions	|O
of	|O
the	|O
mu	|B-PROTEIN
-	|O
like	|O
isotype	|O
.	|O

Petko	|O
,	|O
and	|O
S.	|O

Disruption	|O
of	|O
ARF2	|B-PROTEIN
causes	|O
no	|O
detectable	|O
phenotype	|O
.	|O

Human	|O
recombinant	|O
DNA	|O
-	|O
derived	|O
antihemophilic	|B-PROTEIN
factor	|I-PROTEIN
(	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
)	|O
in	|O
the	|O
treatment	|O
of	|O
hemophilia	|O
A.	|O
recombinant	|O
Factor	|B-PROTEIN
VIII	|I-PROTEIN
Study	|O
Group	|O
.	|O

Like	|O
other	|O
members	|O
of	|O
this	|O
family	|O
,	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
HLH	|O
motif	|O
and	|O
the	|O
adjacent	|O
basic	|O
domain	|O
are	|O
necessary	|O
and	|O
sufficient	|O
to	|O
confer	|O
site	|O
-	|O
specific	|O
DNA	|O
binding	|O
.	|O

Furthermore	|O
,	|O
expression	|O
of	|O
the	|O
promoter	|O
in	|O
embryonic	|O
Drosophila	|O
melanogaster	|O
cells	|O
that	|O
lack	|O
MyoD1	|B-PROTEIN
and	|O
Sp1	|B-PROTEIN
is	|O
strictly	|O
dependent	|O
on	|O
all	|O
three	|O
sites	|O
remaining	|O
intact	|O
and	|O
on	|O
the	|O
presence	|O
of	|O
exogenously	|O
supplied	|O
Sp1	|B-PROTEIN
and	|O
MyoD1	|B-PROTEIN
.	|O

Effects	|O
of	|O
a	|O
selective	|O
monoamine	|O
oxidase	|O
(	|B-PROTEIN
MAO	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
inhibitor	|O
,	|O
clorgyline	|O
,	|O
a	|O
selective	|O
MAO	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
inhibitor	|O
,	|O
deprenyl	|O
,	|O
and	|O
a	|O
non	|O
-	|O
selective	|O
MAO	|B-PROTEIN
inhibitor	|O
,	|O
nialamide	|O
,	|O
were	|O
investigated	|O
on	|O
footshock	|O
-	|O
induced	|O
aggression	|O
(	|O
FIA	|O
)	|O
in	|O
paired	|O
rats	|O
.	|O

To	|O
identify	|O
structural	|O
features	|O
of	|O
residues	|O
flanking	|O
the	|O
c	|O
-	|O
region	|O
that	|O
influence	|O
the	|O
fidelity	|O
and	|O
efficiency	|O
of	|O
signal	|O
peptidase	|O
cleavage	|O
as	|O
well	|O
as	|O
co	|O
-	|O
translational	|O
translocation	|O
,	|O
we	|O
introduced	|O
six	|O
amino	|O
acid	|O
substitutions	|O
into	|O
the	|O
COOH	|O
terminus	|O
of	|O
the	|O
hydrophobic	|O
core	|O
and	|O
seven	|O
substitutions	|O
at	|O
the	|O
NH2	|O
terminus	|O
of	|O
the	|O
mature	|O
region	|O
(	|O
the	|O
+	|O
1	|O
position	|O
)	|O
of	|O
a	|O
model	|O
eukaryotic	|O
preprotein	|O
-	|O
human	|O
pre	|B-PROTEIN
(	|I-PROTEIN
delta	|I-PROTEIN
pro	|I-PROTEIN
)	|I-PROTEIN
apoA	|I-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
.	|O

Additionally	|O
,	|O
although	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
and	|O
egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNAs	|O
are	|O
expressed	|O
at	|O
elevated	|O
levels	|O
in	|O
stimulated	|O
liver	|O
cells	|O
,	|O
fos	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
,	|O
fra	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
egr	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
are	|O
not	|O
,	|O
which	|O
suggests	|O
that	|O
factors	|O
in	|O
addition	|O
to	|O
the	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
participate	|O
in	|O
the	|O
regulation	|O
of	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
gene	|I-PROTEIN
induction	|O
.	|O

Of	|O
848	|O
patients	|O
,	|O
819	|O
cases	|O
with	|O
complete	|O
description	|O
of	|O
patient	|O
's	|O
background	|O
were	|O
evaluable	|O
:	|O
Group	|O
A	|O
(	|O
surgery	|O
+	|O
MMC	|O
+	|O
5	|O
-	|O
FU	|O
:	|O
chemotherapy	|O
)	|O
253	|O
cases	|O
,	|O
group	|O
B	|O
(	|O
surgery	|O
+	|O
MMC	|O
+	|O
5	|O
-	|O
FU	|O
+	|O
OK	|O
-	|O
432	|O
or	|O
PSK	|O
:	|O
immunochemotherapy	|O
)	|O
282	|O
and	|O
group	|O
C	|O
(	|O
surgery	|O
alone	|O
)	|O
284	|O
.	|O

The	|O
nuclear	|O
proteins	|O
encoded	|O
by	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
protooncogenes	|O
are	|O
expressed	|O
during	|O
the	|O
proliferation	|O
period	|O
of	|O
osteoblast	|O
phenotype	|O
development	|O
.	|O

This	|O
model	|O
is	|O
further	|O
supported	|O
by	|O
binding	|O
of	|O
the	|O
Fos	|B-PROTEIN
-	|O
Jun	|B-PROTEIN
complex	|O
at	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
in	|O
the	|O
type	|O
alpha	|B-PROTEIN
I	|I-PROTEIN
collagen	|I-PROTEIN
promoter	|O
that	|O
is	|O
contiguous	|O
with	|O
,	|O
but	|O
not	|O
overlapping	|O
,	|O
the	|O
VDRE	|O
.	|O

PBSX	|B-PROTEIN
is	|O
induced	|O
by	|O
agents	|O
which	|O
elicit	|O
the	|O
SOS	|O
response	|O
.	|O

A	|O
bacteriological	|O
relapse	|O
requiring	|O
treatment	|O
occurred	|O
by	|O
5	|O
years	|O
in	|O
16.8%	|O
of	|O
113	|O
R3	|O
,	|O
5.2%	|O
of	|O
97	|O
R5	|O
,	|O
and	|O
20.0%	|O
of	|O
115	|O
Z5	|O
patients	|O
with	|O
organisms	|O
sensitive	|O
to	|O
streptomycin	|O
and	|O
isoniazid	|O
initially	|O
.	|O

In	|O
the	|O
controls	|O
,	|O
it	|O
was	|O
found	|O
that	|O
all	|O
right	|O
-	|O
handed	|O
and	|O
10	|O
out	|O
of	|O
14	|O
left	|O
-	|O
handed	|O
control	|O
subjects	|O
showed	|O
a	|O
right	|O
VHF	|O
(	|O
i.e.	|O
,	|O
left	|O
hemisphere	|O
)	|O
advantage	|O
.	|O

Although	|O
no	|O
Rh	|B-PROTEIN
-	|I-PROTEIN
antibodies	|I-PROTEIN
were	|O
demonstrable	|O
,	|O
a	|O
similar	|O
mechanism	|O
can	|O
be	|O
postulated	|O
for	|O
the	|O
Rh	|O
-	|O
system	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
has	|O
the	|O
greatest	|O
homology	|O
(	|O
61%	|O
)	|O
to	|O
the	|O
green	|O
alga	|O
Scenedemus	|O
obliquus	|O
plastocyanin	|B-PROTEIN
.	|O

Higher	|O
fasting	|O
serum	|O
gastrin	|B-PROTEIN
concentration	|O
(	|O
102.0	|O
+	|O
/	|O
-	|O
21.1	|O
vs	|O
63.3	|O
+	|O
/	|O
-	|O
8.3	|O
ng.l	|O
-	|O
1	|O
)	|O
,	|O
and	|O
greater	|O
postprandial	|O
gastrin	|B-PROTEIN
release	|O
(	|O
AUC0	|O
-	|O
120	|O
:	|O
16690	|O
+	|O
/	|O
-	|O
2648	|O
vs	|O
10654	|O
+	|O
/	|O
-	|O
1283	|O
ng.l	|O
-	|O
1	|O
min	|O
)	|O
were	|O
observed	|O
after	|O
VTP	|O
-	|O
HM	|O
than	|O
after	|O
VTP	|O
-	|O
Cas	|O
.	|O

The	|O
experimental	|O
group	|O
consisted	|O
of	|O
61	|O
examinees	|O
class	|O
II	|O
/	|O
2	|O
orthodontic	|O
anomalies	|O
.	|O

This	|O
study	|O
was	|O
performed	|O
to	|O
clarify	|O
the	|O
location	|O
of	|O
a	|O
transesophageal	|O
echocardiographic	|O
(	|O
TEE	|O
)	|O
transducer	|O
when	|O
obtaining	|O
the	|O
short	|O
-	|O
axis	|O
view	|O
of	|O
the	|O
left	|O
ventricle	|O
(	|O
S	|O
-	|O
LV	|O
)	|O
.	|O

Subjects	|O
were	|O
16	|O
male	|O
chronic	|O
schizophrenics	|O
consisting	|O
of	|O
8	|O
DST	|O
suppressors	|O
and	|O
8	|O
nonsuppressors	|O
.	|O

From	|O
S3	|O
(	|O
CBF	|O
:	|O
79-60%	|O
)	|O
to	|O
S5	|O
(	|O
CBF	|O
:	|O
39-0%	|O
)	|O
,	|O
%	|O
WTh	|O
,	|O
1	|O
/	|O
TPC	|O
and	|O
1	|O
/	|O
T	|O
were	|O
significantly	|O
decreased	|O
from	|O
those	|O
of	|O
the	|O
control	|O
levels	|O
(	|O
all	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

In	|O
this	|O
article	|O
we	|O
propose	|O
to	|O
find	|O
out	|O
the	|O
percentage	|O
of	|O
normal	|O
occlusion	|O
and	|O
the	|O
distribution	|O
of	|O
maloclusions	|O
,	|O
according	|O
to	|O
the	|O
anteroposterior	|O
relationship	|O
between	|O
the	|O
dental	|O
archs	|O
(	|O
following	|O
the	|O
ANGLE3	|O
classification	|O
)	|O
.	|O

In	|O
that	|O
case	|O
,	|O
the	|O
ratio	|O
of	|O
brush	|O
abrasion	|O
was	|O
0.268	|O
,	|O
compressive	|O
and	|O
transverse	|O
strength	|O
,	|O
124.3	|O
and	|O
86.3	|O
MPa	|O
respectively	|O
,	|O
hardness	|O
,	|O
43.2	|O
Hk	|O
,	|O
water	|O
absorption	|O
14.2	|O
micrograms	|O
/	|O
mm3	|O
and	|O
thermal	|O
expansion	|O
coefficient	|O
,	|O
47.4	|O
x	|O
10	|O
(	|O
-	|O
6	|O
)	|O
/	|O
degrees	|O
C.	|O

9	|O
,	|O
1498-1506	|O
)	|O
.	|O

In	|O
a	|O
highly	|O
select	|O
group	|O
of	|O
stable	|O
hypertensive	|O
patients	|O
,	|O
we	|O
have	|O
assessed	|O
the	|O
strength	|O
of	|O
association	|O
between	|O
various	|O
blood	|O
pressure	|O
measurements	|O
(	|O
24	|O
h	|O
average	|O
automated	|O
ambulatory	|O
blood	|O
pressure	|O
,	|O
4	|O
h	|O
automated	|O
ambulatory	|O
morning	|O
average	|O
blood	|O
pressure	|O
,	|O
multiple	|O
office	|O
visit	|O
average	|O
blood	|O
pressure	|O
,	|O
and	|O
a	|O
single	|O
office	|O
visit	|O
average	|O
blood	|O
pressure	|O
)	|O
and	|O
various	|O
echocardiographic	|O
indices	|O
of	|O
hypertensive	|O
cardiac	|O
target	|O
organ	|O
damage	|O
(	|O
left	|O
atrial	|O
diameter	|O
,	|O
left	|O
ventricular	|O
end	|O
diastolic	|O
diameter	|O
,	|O
posterior	|O
wall	|O
thickness	|O
,	|O
combined	|O
wall	|O
thickness	|O
,	|O
relative	|O
wall	|O
thickness	|O
,	|O
left	|O
ventricular	|O
mass	|O
and	|O
mass	|O
index	|O
,	|O
and	|O
combined	|O
wall	|O
thickness	|O
/	|O
left	|O
ventricular	|O
diastolic	|O
diameter	|O
ratio	|O
)	|O
.	|O

We	|O
have	|O
previously	|O
identified	|O
,	|O
by	|O
screening	|O
a	|O
lambda	|O
gt11	|O
expression	|O
library	|O
,	|O
murine	|O
protein	|O
mXBP	|B-PROTEIN
,	|O
which	|O
binds	|O
to	|O
a	|O
sequence	|O
which	|O
overlaps	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
murine	|O
class	|O
II	|O
major	|B-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
A	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
X	|O
box	|O
,	|O
a	|O
conserved	|O
transcription	|O
element	|O
found	|O
upstream	|O
of	|O
all	|O
class	|O
II	|O
genes	|O
.	|O

The	|O
p36	|B-PROTEIN
gene	|O
is	|O
at	|O
least	|O
22	|O
kb	|O
in	|O
length	|O
and	|O
has	|O
a	|O
coding	|O
sequence	|O
of	|O
approximately	|O
1	|O
kb	|O
,	|O
representing	|O
only	|O
4.5%	|O
of	|O
the	|O
gene	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

This	|O
multimodality	|O
treatment	|O
for	|O
locally	|O
advanced	|O
gynecologic	|O
tumors	|O
appears	|O
feasible	|O
with	|O
modification	|O
,	|O
and	|O
continued	|O
work	|O
exploring	|O
this	|O
approach	|O
is	|O
encouraged	|O
.	|O

A	|O
contiguous	|O
and	|O
sequentially	|O
occupied	|O
secondary	|O
Fur	|B-PROTEIN
-	|O
binding	|O
site	|O
in	|O
entC	|B-PROTEIN
was	|O
protected	|O
at	|O
higher	|O
Fur	|B-PROTEIN
concentrations	|O
,	|O
extending	|O
the	|O
protected	|O
region	|O
to	|O
+	|O
49	|O
,	|O
and	|O
sequestering	|O
the	|O
putative	|O
Shine	|O
-	|O
Dalgarno	|O
sequence	|O
.	|O

The	|O
major	|O
promoter	|O
responds	|O
strongly	|O
to	|O
virus	|O
-	|O
encoded	|O
trans	|O
activators	|O
EIA	|B-PROTEIN
and	|O
EIV	|B-PROTEIN
and	|O
contains	|O
four	|O
elements	|O
:	|O
a	|O
TAGA	|O
motif	|O
analogous	|O
to	|O
the	|O
TATA	|O
box	|O
,	|O
two	|O
EIIF	|B-PROTEIN
sites	|O
present	|O
in	|O
an	|O
inverted	|O
orientation	|O
,	|O
and	|O
an	|O
ATF	|B-PROTEIN
/	|O
CREB	|B-PROTEIN
site	|O
.	|O

With	|O
the	|O
modified	|O
fingertip	|O
-	|O
to	|O
-	|O
floor	|O
(	|O
MFTF	|O
)	|O
method	|O
,	|O
patients	|O
stand	|O
on	|O
a	|O
stool	|O
and	|O
forward	|O
bend	|O
so	|O
that	|O
measurements	|O
can	|O
be	|O
taken	|O
on	|O
patients	|O
who	|O
are	|O
able	|O
to	|O
touch	|O
the	|O
floor	|O
or	|O
reach	|O
beyond	|O
the	|O
level	|O
of	|O
the	|O
floor	|O
.	|O

No	|O
significant	|O
differences	|O
could	|O
be	|O
seen	|O
in	|O
response	|O
rates	|O
according	|O
to	|O
the	|O
concentration	|O
of	|O
estrogen	|B-PROTEIN
receptors	|I-PROTEIN
or	|O
presence	|O
of	|O
progesteron	|B-PROTEIN
receptors	|I-PROTEIN
in	|O
this	|O
group	|O
of	|O
patients	|O
.	|O

Teicoplanin	|O
was	|O
given	|O
most	|O
often	|O
because	|O
of	|O
persistent	|O
fever	|O
or	|O
initial	|O
Gram	|O
-	|O
positive	|O
bacteraemia	|O
and	|O
only	|O
one	|O
-	|O
third	|O
of	|O
these	|O
cases	|O
responded	|O
.	|O

Luteinizing	|B-PROTEIN
hormone	|I-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
hormone	|I-PROTEIN
analog	|O
therapy	|O
of	|O
uterine	|O
fibroid	|O
:	|O
analysis	|O
of	|O
results	|O
obtained	|O
with	|O
buserelin	|O
administered	|O
intranasally	|O
and	|O
goserelin	|O
administered	|O
subcutaneously	|O
as	|O
a	|O
monthly	|O
depot	|O
.	|O

In	|O
Experiments	|O
1	|O
and	|O
2	|O
,	|O
infants	|O
,	|O
like	|O
adults	|O
,	|O
initially	|O
categorized	|O
novel	|O
objects	|O
on	|O
the	|O
basis	|O
of	|O
physical	|O
appearance	|O
,	|O
but	|O
only	|O
if	|O
trained	|O
with	|O
multiple	|O
exemplars	|O
,	|O
after	|O
delays	|O
of	|O
1	|O
and	|O
7	|O
days	|O
.	|O

The	|O
clinical	|O
picture	|O
of	|O
the	|O
disease	|O
was	|O
significantly	|O
different	|O
from	|O
anthropogenic	|O
cutaneous	|O
leishmaniasis	|O
caused	|O
by	|O
L.	|O
tropica	|O
but	|O
similar	|O
to	|O
cutaneous	|O
patterns	|O
caused	|O
by	|O
L.	|O
infantum	|O
which	|O
was	|O
a	|O
prevalent	|O
pattern	|O
in	|O
the	|O
southern	|O
France	|O
.	|O

Although	|O
there	|O
are	|O
no	|O
octamer	|O
elements	|O
in	|O
the	|O
adenovirus	|O
genome	|O
that	|O
are	|O
known	|O
to	|O
be	|O
important	|O
for	|O
transcription	|O
,	|O
there	|O
are	|O
octamer	|O
elements	|O
in	|O
the	|O
viral	|O
terminal	|O
repeat	|O
sequences	|O
.	|O

In	|O
comparison	|O
with	|O
the	|O
16	|O
introns	|O
reported	|O
in	|O
AHA3	|B-PROTEIN
,	|O
AHA2	|B-PROTEIN
is	|O
missing	|O
one	|O
intron	|O
in	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
and	|O
a	|O
second	|O
intron	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
coding	|O
region	|O
.	|O

Northern	|O
blot	|O
analysis	|O
indicates	|O
that	|O
AHA2	|B-PROTEIN
mRNA	|O
relative	|O
to	|O
total	|O
cellular	|O
RNA	|O
is	|O
expressed	|O
at	|O
significantly	|O
higher	|O
levels	|O
in	|O
root	|O
tissue	|O
as	|O
compared	|O
with	|O
shoot	|O
tissue	|O
.	|O

Impaction	|O
of	|O
gastrostomy	|O
tube	|O
in	|O
the	|O
abdominal	|O
wall	|O
.	|O

Both	|O
antidepressants	|O
elevated	|O
the	|O
pain	|O
threshold	|O
acutely	|O
,	|O
while	|O
pretreatment	|O
with	|O
pCPA	|O
largely	|O
blocked	|O
the	|O
analgesia	|O
.	|O

Sci	|O
.	|O

A	|O
needs	|O
assessment	|O
of	|O
these	|O
families	|O
was	|O
also	|O
done	|O
.	|O

TCR	|B-PROTEIN
alpha	|I-PROTEIN
and	|I-PROTEIN
beta	|I-PROTEIN
gene	|O
expression	|O
may	|O
be	|O
regulated	|O
by	|O
a	|O
common	|O
set	|O
of	|O
T	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
nuclear	|I-PROTEIN
proteins	|I-PROTEIN
in	|O
that	|O
the	|O
T	|B-PROTEIN
beta	|I-PROTEIN
2	|I-PROTEIN
element	|O
binding	|O
a	|O
set	|O
of	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
that	|O
are	|O
also	|O
bound	|O
by	|O
the	|O
T	|B-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
element	|O
of	|O
the	|O
human	|O
TCR	|B-PROTEIN
alpha	|I-PROTEIN
enhancer	|O
and	|O
the	|O
decamer	|O
element	|O
present	|O
in	|O
a	|O
large	|O
number	|O
of	|O
human	|O
and	|O
murine	|O
TCR	|B-PROTEIN
beta	|I-PROTEIN
promoters	|O
.	|O

The	|O
3'	|O
stem	|O
-	|O
loop	|O
is	|O
highly	|O
divergent	|O
in	|O
structure	|O
among	|O
species	|O
and	|O
lies	|O
immediately	|O
upstream	|O
of	|O
the	|O
binding	|O
site	|O
for	|O
Sm	|B-PROTEIN
proteins	|O
.	|O

The	|O
deleted	|O
nucleotide	|O
sequence	|O
corresponded	|O
to	|O
sequences	|O
that	|O
,	|O
by	|O
analogy	|O
to	|O
the	|O
organization	|O
of	|O
the	|O
type	|B-PROTEIN
I	|I-PROTEIN
collagen	|I-PROTEIN
genes	|O
,	|O
should	|O
be	|O
precisely	|O
encoded	|O
by	|O
exon	|O
41	|O
of	|O
the	|O
COL3A1	|B-PROTEIN
gene	|O
.	|O

These	|O
losses	|O
account	|O
for	|O
the	|O
resistance	|O
of	|O
EDS	|O
-	|O
IV	|O
collagen	|B-PROTEIN
to	|O
cyanogen	|O
bromide	|O
and	|O
mammalian	|O
collagenase	|B-PROTEIN
digestion	|O
.	|O

A	|O
4.8	|O
-	|O
kilobase	|O
BamHI	|B-PROTEIN
-	|O
HindIII	|B-PROTEIN
fragment	|O
encoding	|O
the	|O
entire	|O
Neurospora	|O
crassa	|O
CuZn	|B-PROTEIN
superoxide	|I-PROTEIN
dismutase	|I-PROTEIN
gene	|O
(	|O
herein	|O
designated	|O
sod	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
was	|O
isolated	|O
from	|O
a	|O
genomic	|O
library	|O
using	|O
two	|O
60	|O
-	|O
base	|O
deoxyoligonucleotide	|O
probes	|O
corresponding	|O
to	|O
the	|O
published	|O
N.	|O
crassa	|O
amino	|O
acid	|O
sequence	|O
.	|O

Two	|O
other	|O
peptides	|O
,	|O
either	|O
partially	|O
or	|O
totally	|O
lacking	|O
the	|O
basic	|O
region	|O
,	|O
but	|O
containing	|O
the	|O
intact	|O
leucine	|O
zipper	|O
domain	|O
,	|O
readily	|O
form	|O
dimers	|O
but	|O
do	|O
not	|O
bind	|O
to	|O
the	|O
CRE	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
CRE	|O
of	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
promoter	|O
located	|O
at	|O
-	|O
60	|O
was	|O
weakly	|O
induced	|O
by	|O
cAMP	|O
and	|O
E1a	|B-PROTEIN
in	|O
both	|O
HeLa	|O
and	|O
PC12	|O
cells	|O
.	|O

We	|O
have	|O
isolated	|O
and	|O
sequenced	|O
the	|O
gene	|O
encoding	|O
the	|O
human	|O
U1	|B-PROTEIN
-	|O
70K	|O
snRNP	|O
protein	|O
.	|O

Although	|O
popular	|O
this	|O
hypothesis	|O
is	|O
far	|O
from	|O
explaining	|O
all	|O
the	|O
clinical	|O
facts	|O
,	|O
namely	|O
that	|O
rigidity	|O
is	|O
equal	|O
in	|O
extensor	|O
and	|O
flexor	|O
,	|O
proximal	|O
and	|O
distal	|O
muscles	|O
.	|O

Using	|O
appropriate	|O
synthetic	|O
HSE	|O
oligonucleotides	|O
,	|O
three	|O
types	|O
of	|O
clones	|O
with	|O
potential	|O
HSE	|O
binding	|O
domains	|O
were	|O
isolated	|O
from	|O
a	|O
tomato	|O
lambda	|O
gt11	|O
expression	|O
library	|O
by	|O
DNA	|O
-	|O
ligand	|O
screening	|O
.	|O

Fluid	|O
(	|O
AVLF	|O
)	|O
31	|O
.	|O

The	|O
results	|O
supported	|O
the	|O
therapeutic	|O
principle	|O
of	|O
TCM	|O
:	|O
Treating	|O
patients	|O
according	|O
to	|O
their	|O
pathophysiological	|O
patterns	|O
.	|O

The	|O
nmr	|B-PROTEIN
gene	|O
is	|O
the	|O
major	|O
negative	|O
regulatory	|O
gene	|O
in	|O
the	|O
nitrogen	|O
control	|O
circuit	|O
of	|O
Neurospora	|O
crassa	|O
,	|O
which	|O
,	|O
together	|O
with	|O
positive	|O
regulatory	|O
genes	|O
,	|O
governs	|O
the	|O
expression	|O
of	|O
multiple	|O
unlinked	|O
structural	|O
genes	|O
of	|O
the	|O
circuit	|O
.	|O

The	|O
4	|O
days	|O
dexamethasone	|O
suppression	|O
test	|O
showed	|O
more	|O
than	|O
80%	|O
suppression	|O
of	|O
dehydroepiandrosterone	|O
-	|O
sulphate	|O
and	|O
a	|O
variable	|O
(	|O
40-60%	|O
)	|O
reduction	|O
of	|O
testosterone	|O
and	|O
androstenedione	|O
levels	|O
.	|O

The	|O
ratio	|O
of	|O
P	|O
-	|O
31	|O
NMR	|O
-	|O
S	|O
derived	|O
inorganic	|O
phosphates	|O
[	|O
Pi	|O
]	|O
to	|O
phosphocreatine	|O
[	|O
PCr	|O
]	|O
was	|O
significantly	|O
greater	|O
at	|O
rest	|O
in	|O
LVH	|O
baboons	|O
[	|O
0.53	|O
+	|O
/	|O
-	|O
0.06	|O
versus	|O
controls	|O
=	|O
0.41	|O
+	|O
/	|O
-	|O
0.17	|O
;	|O
P	|O
less	|O
than	|O
0.05	|O
]	|O
.	|O

Cutaneous	|O
necrosis	|O
associated	|O
with	|O
protein	|B-PROTEIN
S	|I-PROTEIN
deficiency	|O
.	|O

Critical	|O
study	|O

Regional	|O
cerebral	|O
blood	|O
flow	|O
was	|O
measured	|O
using	|O
N	|O
-	|O
isopropyl	|O
-	|O
123I	|O
-	|O
iodoamphetamine	|O
with	|O
single	|O
-	|O
photon	|O
emission	|O
computed	|O
tomography	|O
(	|O
CT	|O
)	|O
in	|O
16	|O
aged	|O
patients	|O
with	|O
noninsulin	|O
-	|O
dependent	|O
diabetes	|O
mellitus	|O
(	|O
NIDDM	|O
,	|O
average	|O
age	|O
72.8	|O
years	|O
,	|O
average	|O
fasting	|O
plasma	|O
glucose	|O
7.7	|O
mmol	|O
/	|O
L	|O
)	|O
,	|O
and	|O
12	|O
nondiabetic	|O
subjects	|O
(	|O
71.6	|O
years	|O
,	|O
5.3	|O
mmol	|O
/	|O
L	|O
)	|O
.	|O

Mean	|O
ROI	|O
-	|O
A	|O
/	|O
B	|O
ratio	|O
was	|O
49.6	|O
+	|O
/	|O
-	|O
1.7%	|O
in	|O
the	|O
diabetic	|O
group	|O
,	|O
significantly	|O
lower	|O
than	|O
the	|O
57.9	|O
+	|O
/	|O
-	|O
1.6%	|O
at	|O
the	|O
nondiabetic	|O
group	|O
(	|O
p	|O
less	|O
than	|O
0.005	|O
)	|O
.	|O

These	|O
data	|O
strongly	|O
implicate	|O
the	|O
normal	|O
product	|O
of	|O
the	|O
int	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
,	|O
which	|O
is	|O
related	|O
to	|O
the	|O
fibroblast	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
family	|O
,	|O
as	|O
a	|O
contributory	|O
factor	|O
in	|O
virally	|O
induced	|O
mammary	|O
tumors	|O
.	|O

This	|O
result	|O
indicates	|O
that	|O
separate	|O
complexes	|O
exist	|O
containing	|O
ankyrin	|B-PROTEIN
and	|O
fodrin	|B-PROTEIN
with	|O
either	|O
uvomorulin	|B-PROTEIN
or	|O
Na+	|B-PROTEIN
,	|I-PROTEIN
K+	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
.	|O

These	|O
genes	|O
are	|O
expressed	|O
within	|O
a	|O
few	|O
hours	|O
of	|O
the	|O
initiation	|O
of	|O
development	|O
;	|O
their	|O
mRNAs	|O
accumulate	|O
to	|O
a	|O
peak	|O
at	|O
12	|O
hr	|O
and	|O
persist	|O
until	|O
culmination	|O
.	|O

The	|O
PC2	|B-PROTEIN
protein	|O
also	|O
shows	|O
great	|O
similarity	|O
to	|O
the	|O
incomplete	|O
NH2	|O
-	|O
terminal	|O
sequence	|O
of	|O
the	|O
human	|O
furin	|B-PROTEIN
gene	|O
product	|O
,	|O
a	|O
putative	|O
membrane	|O
-	|O
inserted	|O
receptor	|O
-	|O
like	|O
molecule	|O
.	|O

Whether	|O
or	|O
not	|O
there	|O
are	|O
sequences	|O
conferring	|O
cAMP	|O
responsiveness	|O
which	|O
are	|O
common	|O
both	|O
to	|O
P	|B-PROTEIN
-	|I-PROTEIN
450scc	|I-PROTEIN
and	|O
the	|O
other	|O
steroidogenic	|O
P	|B-PROTEIN
-	|I-PROTEIN
450	|I-PROTEIN
genes	|O
remains	|O
to	|O
be	|O
established	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
used	|O
footprinting	|O
and	|O
gel	|O
mobility	|O
retardation	|O
assays	|O
to	|O
reveal	|O
that	|O
bacterially	|O
synthesized	|O
Zta	|B-PROTEIN
fusion	|O
proteins	|O
bound	|O
directly	|O
to	|O
six	|O
TGTGCAA	|O
-	|O
like	|O
motifs	|O
within	|O
DSL	|B-PROTEIN
.	|O

The	|O
zta	|B-PROTEIN
transactivator	|O
involved	|O
in	|O
induction	|O
of	|O
lytic	|O
cycle	|O
gene	|O
expression	|O
in	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
-	|O
infected	|O
lymphocytes	|O
binds	|O
to	|O
both	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
ZRE	|B-PROTEIN
sites	|O
in	|O
target	|O
promoter	|O
and	|O
enhancer	|O
regions	|O
.	|O

It	|O
is	|O
the	|O
human	|O
homolog	|O
of	|O
the	|O
mouse	|O
Mx	|B-PROTEIN
protein	|O
involved	|O
in	|O
resistance	|O
to	|O
influenza	|O
virus	|O
.	|O

Fragments	|O
containing	|O
the	|O
21	|O
-	|O
base	|O
-	|O
pair	|O
repeat	|O
region	|O
,	|O
the	|O
enhancer	|B-PROTEIN
of	|I-PROTEIN
simian	|I-PROTEIN
virus	|I-PROTEIN
40	|I-PROTEIN
or	|O
both	|O
strongly	|O
stimulated	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
synthesis	|O
,	|O
and	|O
three	|O
fragments	|O
from	|O
the	|O
polyomavirus	|B-PROTEIN
enhancer	|I-PROTEIN
region	|O
stimulated	|O
moderate	|O
levels	|O
.	|O

The	|O
sites	|O
targeted	|O
for	|O
mutagenesis	|O
,	|O
residues	|O
60	|O
,	|O
61	|O
,	|O
and	|O
66	|O
,	|O
are	|O
located	|O
within	|O
a	|O
putative	|O
helical	|O
loop	|O
structure	|O
which	|O
may	|O
be	|O
involved	|O
in	|O
substrate	|O
recognition	|O
by	|O
the	|O
enzyme	|O
.	|O

The	|O
possible	|O
benefits	|O
of	|O
LMW	|O
heparin	|O
(	|O
reduced	|O
frequency	|O
of	|O
bleeding	|O
,	|O
alleviation	|O
of	|O
hypertriglyceridemia	|O
)	|O
were	|O
not	|O
,	|O
however	|O
,	|O
apparent	|O
,	|O
possibly	|O
because	|O
of	|O
the	|O
short	|O
observation	|O
period	|O
and	|O
the	|O
low	|O
incidence	|O
of	|O
hemorrhagic	|O
complications	|O
in	|O
routine	|O
dialyses	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
destrin	|B-PROTEIN
is	|O
165	|O
residues	|O
long	|O
and	|O
is	|O
very	|O
similar	|O
(	|O
71%	|O
identical	|O
)	|O
to	|O
that	|O
of	|O
cofilin	|B-PROTEIN
,	|O
a	|O
widely	|O
distributed	|O
,	|O
pH	|O
-	|O
sensitive	|O
actin	|B-PROTEIN
-	|O
modulating	|O
protein	|O
.	|O

Summers	|O
,	|O
Virology	|O
89	|O
:	|O
517-527	|O
,	|O
1978	|O
)	|O
.	|O

With	|O
only	|O
purified	|O
T	|B-PROTEIN
antigen	|I-PROTEIN
in	|O
the	|O
presence	|O
of	|O
topoisomerase	|B-PROTEIN
I	|I-PROTEIN
to	|O
unwind	|O
purified	|O
DNA	|O
,	|O
ori	|O
-	|O
auxiliary	|O
sequences	|O
strongly	|O
facilitated	|O
T	|B-PROTEIN
-	|I-PROTEIN
antigen	|I-PROTEIN
-	|O
dependent	|O
DNA	|O
conformational	|O
changes	|O
consistent	|O
with	|O
melting	|O
the	|O
first	|O
50	|O
base	|O
pairs	|O
.	|O

A	|O
rabbit	|O
antiserum	|O
was	|O
raised	|O
against	|O
a	|O
synthetic	|O
peptide	|O
corresponding	|O
to	|O
a	|O
hydrophilic	|O
portion	|O
of	|O
the	|O
translated	|O
murine	|O
cDNA	|O
sequence	|O
.	|O

Conservation	|O
of	|O
function	|O
of	|O
Drosophila	|O
melanogaster	|O
abl	|B-PROTEIN
and	|O
murine	|O
v	|B-PROTEIN
-	|I-PROTEIN
abl	|I-PROTEIN
proteins	|O
in	|O
transformation	|O
of	|O
mammalian	|O
cells	|O
.	|O

In	|O
transient	|O
cotransfection	|O
assays	|O
using	|O
Chang	|O
liver	|O
cells	|O
(	|O
CCL	|O
13	|O
)	|O
,	|O
pM1	|O
DNA	|O
exerts	|O
a	|O
6	|O
-	|O
to	|O
10	|O
-	|O
fold	|O
trans	|O
-	|O
activating	|O
effect	|O
on	|O
the	|O
expression	|O
of	|O
the	|O
pSV2CAT	|O
reporter	|O
plasmid	|O
.	|O

We	|O
have	|O
determined	|O
the	|O
nucleotide	|O
(	|O
nt	|O
)	|O
sequence	|O
of	|O
the	|O
7.5	|O
-	|O
kb	|O
COR	|B-PROTEIN
segment	|O
that	|O
encompasses	|O
a	|O
cluster	|O
of	|O
six	|O
genes	|O
(	|O
CYC1	|B-PROTEIN
,	|O
UTR1	|B-PROTEIN
,	|O
UTR3	|B-PROTEIN
,	|O
OSM1	|B-PROTEIN
,	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
Gly	|I-PROTEIN
)	|I-PROTEIN
and	|O
RAD7	|B-PROTEIN
)	|O
located	|O
on	|O
chromosome	|O
X	|O
of	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Specific	|O
binding	|O
of	|O
the	|O
protein	|O
factors	|O
to	|O
the	|O
sites	|O
,	|O
possibly	|O
to	|O
the	|O
three	|O
Mt	|O
sequences	|O
,	|O
may	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
coordinate	|O
regulation	|O
of	|O
the	|O
transcription	|O
of	|O
nuclear	|O
genes	|O
encoding	|O
subunits	|O
responsible	|O
for	|O
mitochondrial	|O
oxidative	|O
phosphorylation	|O
.	|O

This	|O
points	|O
to	|O
a	|O
specific	|O
interference	|O
with	|O
HSV	|O
-	|O
induced	|O
DNA	|O
amplification	|O
.	|O

No	|O
recombination	|O
signal	|O
sequences	|O
have	|O
been	|O
found	|O
contiguous	|O
to	|O
the	|O
recombination	|O
point	|O
.	|O

The	|O
antinociceptive	|O
properties	|O
,	|O
as	|O
measured	|O
by	|O
the	|O
tail	|O
-	|O
flick	|O
and	|O
hot	|O
-	|O
plate	|O
tests	|O
,	|O
and	|O
the	|O
motor	|O
effects	|O
of	|O
an	|O
intrathecally	|O
-	|O
administered	|O
benzodiazepine	|O
agonist	|O
midazolam	|O
,	|O
alone	|O
,	|O
and	|O
in	|O
combination	|O
with	|O
morphine	|O
,	|O
was	|O
examined	|O
in	|O
rats	|O
.	|O

Constructs	|O
were	|O
made	|O
in	|O
which	|O
an	|O
AATAAA	|O
and	|O
the	|O
GT	|O
-	|O
rich	|O
region	|O
were	|O
separated	|O
by	|O
various	|O
distances	|O
ranging	|O
from	|O
7	|O
to	|O
43	|O
bp	|O
.	|O

To	|O
address	|O
this	|O
issue	|O
,	|O
the	|O
gene	|O
for	|O
factor	|B-PROTEIN
Y	|I-PROTEIN
has	|O
been	|O
cloned	|O
molecularly	|O
and	|O
its	|O
DNA	|O
sequence	|O
has	|O
been	|O
determined	|O
.	|O

We	|O
cloned	|O
and	|O
sequenced	|O
the	|O
cDNAs	|O
against	|O
genomic	|O
RNA	|O
and	|O
mRNA	|O
for	|O
phosphoprotein	|B-PROTEIN
(	|I-PROTEIN
P	|I-PROTEIN
)	|I-PROTEIN
of	|O
human	|O
parainfluenza	|O
type	|O
2	|O
virus	|O
(	|O
PIV	|O
-	|O
2	|O
)	|O
.	|O
cDNA	|O
clone	|O
from	|O
genomic	|O
RNA	|O
was	|O
1439	|O
nucleotides	|O
in	|O
length	|O
excluding	|O
poly	|O
(	|O
A	|O
)	|O
and	|O
was	|O
found	|O
to	|O
have	|O
two	|O
small	|O
open	|O
reading	|O
frames	|O
encoding	|O
proteins	|O
of	|O
233	|O
and	|O
249	|O
amino	|O
acids	|O
.	|O

We	|O
show	|O
that	|O
cytR	|B-PROTEIN
expression	|O
is	|O
negatively	|O
controlled	|O
by	|O
the	|O
CytR	|B-PROTEIN
protein	|O
and	|O
positively	|O
affected	|O
by	|O
the	|O
cAMP	|O
/	|O
CAP	|B-PROTEIN
complex	|O
.	|O

To	|O
identify	|O
these	|O
sites	|O
,	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
3T3	|O
-	|O
L1	|O
adipocyte	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
of	|O
the	|O
mouse	|O
was	|O
determined	|O
.	|O

PAO	|O
blocks	|O
turnover	|O
of	|O
the	|O
phosphoryl	|O
group	|O
of	|O
pp15	|B-PROTEIN
,	|O
causing	|O
its	|O
accumulation	|O
,	|O
and	|O
thereby	|O
appears	|O
to	|O
interrupt	|O
signal	|O
transmission	|O
from	|O
the	|O
receptor	|O
to	|O
the	|O
glucose	|O
-	|O
transport	|O
system	|O
.	|O

It	|O
is	|O
likely	|O
that	|O
the	|O
sequence	|O
similarities	|O
reflect	|O
a	|O
common	|O
molecular	|O
architecture	|O
of	|O
the	|O
two	|O
heme	|O
binding	|O
sites	|O
and	|O
of	|O
a	|O
copper	|O
binding	|O
site	|O
in	|O
these	|O
enzymes	|O
.	|O

The	|O
cDNA	|O
sequence	|O
has	|O
an	|O
813	|O
-	|O
bp	|O
open	|O
reading	|O
frame	|O
(	|O
ORF	|O
)	|O
whose	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
is	|O
97.6%	|O
identical	|O
to	|O
the	|O
272	|O
carboxy	|O
-	|O
terminal	|O
amino	|O
acids	|O
of	|O
the	|O
human	|O
ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
.	|O

To	|O
characterize	|O
the	|O
O7	|B-PROTEIN
-	|I-PROTEIN
LPS	|I-PROTEIN
region	|O
,	|O
the	|O
recombinant	|O
cosmids	|O
pJHCV31	|O
and	|O
pJHCV32	|O
were	|O
mutagenized	|O
by	|O
transposon	|O
mutagenesis	|O
with	|O
Tn3HoHo1	|B-PROTEIN
,	|O
which	|O
carries	|O
a	|O
promoterless	|O
lac	|B-PROTEIN
operon	|O
and	|O
can	|O
therefore	|O
generate	|O
lacZ	|B-PROTEIN
transcriptional	|O
fusions	|O
with	|O
target	|O
DNA	|O
sequences	|O
.	|O

The	|O
sacT	|B-PROTEIN
gene	|O
regulating	|O
the	|O
sacPA	|B-PROTEIN
operon	|O
in	|O
Bacillus	|O
subtilis	|O
shares	|O
strong	|O
homology	|O
with	|O
transcriptional	|O
antiterminators	|O
.	|O

The	|O
TraD	|B-PROTEIN
protein	|O
(	|O
83,899	|O
Da	|O
)	|O
contains	|O
three	|O
hydrophobic	|O
regions	|O
,	|O
of	|O
which	|O
two	|O
are	|O
located	|O
near	|O
the	|O
amino	|O
-	|O
terminal	|O
region	|O
.	|O

The	|O
protein	|O
product	|O
of	|O
orfD	|B-PROTEIN
,	|O
which	|O
is	|O
probably	|O
a	|O
new	|O
tra	|B-PROTEIN
gene	|O
(	|O
named	|O
traX	|B-PROTEIN
)	|O
,	|O
contains	|O
65%	|O
hydrophobic	|O
amino	|O
acids	|O
,	|O
especially	|O
rich	|O
in	|O
alanine	|O
and	|O
leucine	|O
.	|O

Various	|O
mutant	|O
HN	|B-PROTEIN
genes	|O
were	|O
constructed	|O
to	|O
examine	|O
the	|O
role	|O
of	|O
residues	|O
flanking	|O
the	|O
signal	|O
-	|O
anchor	|O
domain	|O
,	|O
including	|O
the	|O
cytoplasmic	|O
tail	|O
,	|O
on	|O
assembly	|O
and	|O
intracellular	|O
transport	|O
of	|O
the	|O
HN	|B-PROTEIN
glycoprotein	|O
.	|O

Our	|O
studies	|O
extend	|O
these	|O
findings	|O
and	|O
show	|O
that	|O
the	|O
E2	|B-PROTEIN
transactivation	|O
gene	|O
is	|O
expressed	|O
from	|O
multiple	|O
promoters	|O
.	|O

Furthermore	|O
,	|O
analysis	|O
of	|O
the	|O
E2	|B-PROTEIN
proteins	|O
present	|O
in	|O
various	|O
cell	|O
lines	|O
harboring	|O
specific	|O
BPV	|O
-	|O
1	|O
mutants	|O
,	|O
including	|O
the	|O
2558	|O
acceptor	|O
mutant	|O
,	|O
proves	|O
that	|O
alternate	|O
modes	|O
of	|O
E2	|B-PROTEIN
expression	|O
exist	|O
.	|O

Disruption	|O
of	|O
the	|O
IRA2	|B-PROTEIN
gene	|O
resulted	|O
in	|O
(	|O
i	|O
)	|O
increased	|O
sensitivity	|O
to	|O
heat	|O
shock	|O
and	|O
nitrogen	|O
starvation	|O
,	|O
(	|O
ii	|O
)	|O
sporulation	|O
defects	|O
,	|O
and	|O
(	|O
iii	|O
)	|O
suppression	|O
of	|O
the	|O
lethality	|O
of	|O
the	|O
cdc25	|B-PROTEIN
mutant	|O
.	|O

This	|O
cohort	|O
of	|O
patients	|O
was	|O
selected	|O
on	|O
the	|O
basis	|O
of	|O
clinical	|O
stage	|O
.	|O

A	|O
gene	|O
in	|O
Drosophila	|O
melanogaster	|O
that	|O
maps	|O
cytologically	|O
to	|O
2C1	|O
-	|O
3	|O
on	|O
the	|O
distal	|O
portion	|O
of	|O
the	|O
X	|O
-	|O
chromosome	|O
encodes	|O
a	|O
member	|O
of	|O
the	|O
steroid	|B-PROTEIN
/	|I-PROTEIN
thyroid	|I-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
superfamily	|O
.	|O

A	|O
portion	|O
of	|O
Region	|O
II	|O
also	|O
resembles	|O
part	|O
of	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
oncoprotein	|O
's	|O
leucine	|O
zipper	|O
,	|O
which	|O
in	|O
turn	|O
,	|O
has	|O
been	|O
demonstrated	|O
to	|O
be	|O
the	|O
heterodimerization	|O
site	|O
between	|O
the	|O
jun	|B-PROTEIN
and	|O
fos	|B-PROTEIN
oncoproteins	|O
.	|O

To	|O
determine	|O
whether	|O
vanadate	|O
could	|O
inhibit	|O
PEPCK	|B-PROTEIN
gene	|O
transcription	|O
,	|O
a	|O
series	|O
of	|O
chimeric	|O
genes	|O
containing	|O
several	|O
deletions	|O
in	|O
the	|O
P	|B-PROTEIN
-	|I-PROTEIN
enolypyruvate	|I-PROTEIN
carboxykinase	|I-PROTEIN
promoter	|O
between	|O
-	|O
550	|O
and	|O
-	|O
68	|O
was	|O
linked	|O
to	|O
the	|O
structural	|O
genes	|O
for	|O
either	|O
amino	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
glycosyl	|I-PROTEIN
phosphotransferase	|I-PROTEIN
(	|O
neo	|B-PROTEIN
)	|O
or	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
and	|O
introduced	|O
into	|O
hepatoma	|O
cells	|O
using	|O
three	|O
methods	|O
:	|O
(	|O
a	|O
)	|O
infection	|O
with	|O
a	|O
Moloney	|O
murine	|O
leukemia	|O
virus	|O
-	|O
based	|O
retrovirus	|O
,	|O
(	|O
b	|O
)	|O
transfection	|O
and	|O
stable	|O
selection	|O
for	|O
neo	|B-PROTEIN
expression	|O
,	|O
or	|O
(	|O
c	|O
)	|O
transient	|O
expression	|O
of	|O
chloroamphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
.	|O

The	|O
diagnosis	|O
of	|O
miliary	|O
tuberculosis	|O
should	|O
be	|O
systematically	|O
considered	|O
in	|O
ARDS	|O
of	|O
unknown	|O
origin	|O
.	|O

In	|O
order	|O
to	|O
characterize	|O
the	|O
functional	|O
elements	|O
of	|O
the	|O
promoter	|O
that	|O
in	|O
some	|O
way	|O
must	|O
respond	|O
to	|O
these	|O
regulatory	|O
signals	|O
,	|O
a	|O
number	|O
of	|O
promoter	|O
mutations	|O
were	|O
constructed	|O
,	|O
including	|O
a	|O
set	|O
of	|O
linker	|O
-	|O
scanning	|O
mutations	|O
across	|O
the	|O
entire	|O
promoter	|O
region	|O
.	|O

A	|O
DNA	|O
motif	|O
related	|O
to	|O
the	|O
cAMP	|O
-	|O
responsive	|O
element	|O
and	|O
an	|O
exon	|O
-	|O
located	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
binding	|O
site	|O
in	|O
the	|O
human	|O
tissue	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
gene	|O
promoter	|O
cooperate	|O
in	|O
basal	|O
expression	|O
and	|O
convey	|O
activation	|O
by	|O
phorbol	|O
ester	|O
and	|O
cAMP	|O
.	|O

The	|O
26S	|B-PROTEIN
rRNA	|O
binding	|O
ribosomal	|O
protein	|O
equivalent	|O
to	|O
bacterial	|O
protein	|O
L11	|B-PROTEIN
is	|O
encoded	|O
by	|O
unspliced	|O
duplicated	|O
genes	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Five	|O
healthy	|O
male	|O
subjects	|O
inspired	|O
air	|O
for	|O
20	|O
min	|O
and	|O
then	|O
5%	|O
CO2/95	|O
%	|O
O2	|O
for	|O
30	|O
min	|O
,	|O
of	|O
which	|O
the	|O
first	|O
10	|O
min	|O
was	|O
used	|O
to	|O
achieve	|O
a	|O
steady	|O
-	|O
state	|O
end	|O
-	|O
tidal	|O
CO2	|O
measurement	|O
.	|O

Significant	|O
correlations	|O
were	|O
obtained	|O
between	|O
changes	|O
in	|O
SSEP	|O
in	|O
response	|O
to	|O
AS	|O
and	|O
the	|O
presence	|O
of	|O
not	|O
deep	|O
residual	|O
-	|O
organic	|O
disturbances	|O
,	|O
so	|O
-	|O
called	|O
"	|O
ground	|O
"	|O
in	|O
psychogenic	|O
disorders	|O
.	|O

The	|O
transcripts	|O
were	|O
equally	|O
active	|O
with	|O
or	|O
without	|O
a	|O
5'	|O
methylated	|O
capstructure	|O
as	|O
expected	|O
,	|O
since	|O
EMCV	|O
-	|O
RNA	|O
is	|O
one	|O
of	|O
the	|O
mRNAs	|O
capable	|O
of	|O
internal	|O
initiation	|O
.	|O

The	|O
E6	|B-PROTEIN
/	|O
E7	|B-PROTEIN
promoter	|O
of	|O
all	|O
genital	|O
human	|O
papillomaviruses	|O
is	|O
responsible	|O
for	|O
expression	|O
of	|O
the	|O
viral	|O
transforming	|O
genes	|O
.	|O

A	|O
case	|O
of	|O
Goodpasture	|O
's	|O
syndrome	|O
.	|O

Seventy	|O
-	|O
two	|O
of	|O
73	|O
negative	|O
controls	|O
and	|O
all	|O
positive	|O
blocks	|O
as	|O
seen	|O
on	|O
soft	|O
tissue	|O
radiographs	|O
(	|O
STRs	|O
)	|O
were	|O
correctly	|O
coded	|O
(	|O
specificity	|O
98.6%	|O
,	|O
sensitivity	|O
100%	|O
)	|O
.	|O

No	|O
symptomatic	|O
abnormality	|O
has	|O
been	|O
noted	|O
in	|O
the	|O
neonatal	|O
period	|O
except	|O
periventricular	|O
calcifications	|O
.	|O

Immunohistochemical	|O
analysis	|O
of	|O
several	|O
rat	|O
organs	|O
also	|O
showed	|O
staining	|O
in	|O
epithelial	|O
cells	|O
.	|O

Both	|O
strains	|O
grew	|O
very	|O
poorly	|O
,	|O
or	|O
not	|O
at	|O
all	|O
,	|O
on	|O
nonfermentable	|O
carbon	|O
sources	|O
and	|O
exhibited	|O
,	|O
at	|O
most	|O
,	|O
only	|O
5%	|O
of	|O
wild	|O
-	|O
type	|O
ubiquinol	|B-PROTEIN
-	|I-PROTEIN
cytochrome	|I-PROTEIN
c	|I-PROTEIN
oxidoreductase	|I-PROTEIN
activity	|O
.	|O

Regulation	|O
of	|O
irgA	|B-PROTEIN
by	|O
iron	|O
in	|O
V.	|O
cholerae	|O
occurs	|O
at	|O
the	|O
transcriptional	|O
level	|O
,	|O
and	|O
there	|O
is	|O
an	|O
interrupted	|O
dyad	|O
symmetric	|O
sequence	|O
in	|O
the	|O
vicinity	|O
of	|O
the	|O
promoter	|O
that	|O
is	|O
homologous	|O
to	|O
Fur	|B-PROTEIN
binding	|O
sites	|O
of	|O
E.	|O
coli	|O
.	|O

Transcription	|O
of	|O
the	|O
first	|O
operon	|O
coding	|O
for	|O
m	|O
-	|O
xylene	|O
-	|O
degrading	|O
enzymes	|O
on	|O
the	|O
TOL	|O
plasmid	|O
of	|O
Pseudomonas	|O
putida	|O
is	|O
activated	|O
by	|O
the	|O
xylR	|B-PROTEIN
gene	|O
product	|O
in	|O
the	|O
presence	|O
of	|O
m	|O
-	|O
xylene	|O
.	|O

The	|O
recombinant	|O
contains	|O
the	|O
normal	|O
beta	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
gene	|O
,	|O
the	|O
mutant	|O
gene	|O
and	|O
Ylp	|O
vector	|O
sequences	|O
between	|O
the	|O
two	|O
copies	|O
.	|O

Some	|O
of	|O
the	|O
mutations	|O
obtained	|O
do	|O
not	|O
contain	|O
a	|O
copy	|O
of	|O
the	|O
Ulysses	|B-PROTEIN
element	|O
at	|O
the	|O
mutant	|O
locus	|O
,	|O
suggesting	|O
that	|O
a	|O
different	|O
transposable	|O
element	|O
may	|O
be	|O
responsible	|O
for	|O
the	|O
mutation	|O
.	|O

Determination	|O
of	|O
diquat	|O
in	|O
biological	|O
materials	|O
by	|O
electron	|O
spin	|O
resonance	|O
spectroscopy	|O
.	|O

We	|O
show	|O
also	|O
that	|O
RA	|O
represses	|O
the	|O
transcriptional	|O
activity	|O
of	|O
a	|O
reporter	|O
gene	|O
containing	|O
a	|O
TPA	|O
responding	|O
AP1	|B-PROTEIN
binding	|O
site	|O
driving	|O
the	|O
HSV	|O
tk	|B-PROTEIN
promoter	|O
.	|O

Moreover	|O
,	|O
radiolabeled	|O
EFI	|B-PROTEIN
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
,	|O
or	|O
CBF	|B-PROTEIN
DNAs	|O
give	|O
rise	|O
to	|O
identical	|O
gel	|O
retardation	|O
patterns	|O
in	|O
extracts	|O
from	|O
a	|O
variety	|O
of	|O
different	|O
cell	|O
types	|O
.	|O

Risk	|O
factors	|O
influencing	|O
lymph	|O
nodes	|O
metastasis	|O
in	|O
lung	|O
cancer	|O
with	|O
stage	|O
I	|O
,	|O
II	|O
or	|O
IIIA	|O

Multifunctional	|B-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MFPK	|B-PROTEIN
)	|O
phosphorylates	|O
ATP	|B-PROTEIN
-	|I-PROTEIN
citrate	|I-PROTEIN
lyase	|I-PROTEIN
on	|O
peptide	|B-PROTEIN
B	|I-PROTEIN
on	|O
two	|O
sites	|O
,	|O
BT	|O
and	|O
BS	|O
,	|O
on	|O
threonine	|O
and	|O
serine	|O
,	|O
respectively	|O
,	|O
inhibitor	|B-PROTEIN
2	|I-PROTEIN
on	|O
a	|O
threonyl	|O
residue	|O
,	|O
and	|O
glycogen	|B-PROTEIN
synthase	|I-PROTEIN
at	|O
sites	|O
2	|O
and	|O
3	|O
.	|O

The	|O
characterized	|O
Y'	|B-PROTEIN
repeated	|I-PROTEIN
sequence	|I-PROTEIN
families	|I-PROTEIN
provide	|O
an	|O
experimental	|O
system	|O
in	|O
which	|O
repeated	|O
sequence	|O
interactions	|O
and	|O
subsequent	|O
evolution	|O
can	|O
be	|O
studied	|O
.	|O

The	|O
electrically	|O
induced	|O
motile	|O
responses	|O
were	|O
not	|O
suppressed	|O
in	|O
the	|O
presence	|O
of	|O
dinitrophenol	|O
or	|O
cytochalasin	|O
B.	|O

Unlike	|O
p59v	|B-PROTEIN
-	|O
rel	|B-PROTEIN
,	|O
which	|O
is	|O
a	|O
nuclear	|O
protein	|O
in	|O
CEF	|O
,	|O
indirect	|O
immunofluorescence	|O
showed	|O
that	|O
p68c	|B-PROTEIN
-	|O
rel	|B-PROTEIN
in	|O
JD214c	|O
-	|O
rel	|O
infected	|O
CEF	|O
is	|O
located	|O
exclusively	|O
in	|O
the	|O
cytoplasm	|O
of	|O
these	|O
cells	|O
,	|O
even	|O
though	|O
the	|O
sequence	|O
of	|O
p68c	|B-PROTEIN
-	|O
rel	|B-PROTEIN
showed	|O
that	|O
it	|O
contains	|O
a	|O
nuclear	|O
localizing	|O
sequence	|O
identical	|O
to	|O
the	|O
one	|O
previously	|O
identified	|O
in	|O
p59v	|B-PROTEIN
-	|O
rel	|B-PROTEIN
.	|O

Kinetic	|O
experiments	|O
revealed	|O
that	|O
within	|O
10	|O
min	|O
this	|O
radiolabeled	|O
precursor	|O
protein	|O
was	|O
converted	|O
in	|O
HL	|O
-	|O
60	|O
cells	|O
into	|O
an	|O
Mr	|O
approximately	|O
150,000	|O
chondroitin	|O
sulfate	|O
proteoglycan	|O
intermediate	|O
.	|O

Blood	|O
flow	|O
and	|O
velocity	|O
(	|O
measured	|O
using	|O
Doppler	|O
ultrasound	|O
)	|O
gradually	|O
decreased	|O
during	|O
diastole	|O
and	|O
ultimately	|O
reversed	|O
in	|O
direction	|O
as	|O
cotyledon	|O
resistance	|O
was	|O
increased	|O
up	|O
to	|O
14	|O
fold	|O
.	|O

A	|O
total	|O
of	|O
112	|O
patients	|O
received	|O
anistreplase	|O
and	|O
119	|O
received	|O
heparin	|O
within	|O
a	|O
mean	|O
period	|O
of	|O
188	|O
+	|O
/	|O
-	|O
62	|O
min	|O
following	|O
the	|O
onset	|O
of	|O
symptoms	|O
.	|O

However	|O
,	|O
primary	|O
transcripts	|O
of	|O
a	|O
variant	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
Val	|I-PROTEIN
)	|I-PROTEIN
(	|I-PROTEIN
UAC	|I-PROTEIN
)	|I-PROTEIN
gene	|O
are	|O
processing	|O
deficient	|O
under	|O
standard	|O
growth	|O
conditions	|O
(	|O
30	|O
degrees	|O
C	|O
)	|O
,	|O
due	|O
to	|O
a	|O
slightly	|O
altered	|O
5'	|O
flanking	|O
region	|O
.	|O

The	|O
promoter	|O
activity	|O
was	|O
measured	|O
by	|O
a	|O
transient	|O
expression	|O
of	|O
a	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
gene	|O
connected	|O
with	|O
various	|O
5'	|O
-	|O
deletion	|O
mutants	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
.	|O

Three	|O
of	|O
the	|O
short	|O
ORFs	|O
in	|O
the	|O
central	|O
region	|O
of	|O
BIV	|O
have	|O
been	|O
identified	|O
by	|O
location	|O
and	|O
structural	|O
similarity	|O
to	|O
the	|O
nonstructural	|O
/	|O
regulatory	|O
genes	|O
(	|O
vif	|B-PROTEIN
,	|O
tat	|B-PROTEIN
,	|O
and	|O
rev	|B-PROTEIN
)	|O
of	|O
other	|O
lentiviruses	|O
;	|O
we	|O
also	|O
discovered	|O
two	|O
unique	|O
ORFs	|O
,	|O
termed	|O
W	|O
and	|O
Y	|O
,	|O
which	|O
may	|O
serve	|O
as	|O
exons	|O
for	|O
novel	|O
genes	|O
.	|O

The	|O
Saccharomyces	|O
cerevisiae	|O
14DM	|B-PROTEIN
gene	|O
,	|O
encoding	|O
cytochrome	|B-PROTEIN
P450	|I-PROTEIN
lanosterol	|I-PROTEIN
14	|I-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
demethylase	|I-PROTEIN
(	|O
14DM	|B-PROTEIN
)	|O
,	|O
was	|O
overexpressed	|O
in	|O
various	|O
S.	|O
cerevisiae	|O
strains	|O
under	|O
the	|O
control	|O
of	|O
three	|O
strong	|O
heterologous	|O
yeast	|O
transcription	|O
promoters	|O
(	|O
pADC1	|B-PROTEIN
,	|O
pGPD	|B-PROTEIN
,	|O
pPHO5	|B-PROTEIN
)	|O
and	|O
under	|O
the	|O
control	|O
of	|O
its	|O
own	|O
promoter	|O
.	|O

Truncations	|O
composed	|O
of	|O
78	|O
and	|O
64	|O
amino	|O
acids	|O
were	|O
translocated	|O
across	|O
the	|O
endoplasmic	|O
reticulum	|O
membrane	|O
,	|O
and	|O
translocation	|O
was	|O
found	|O
to	|O
be	|O
strictly	|O
co	|O
-	|O
translational	|O
and	|O
SRP	|B-PROTEIN
-	|O
dependent	|O
.	|O

Pulmonary	|O
vascular	|O
resistance	|O
was	|O
not	|O
altered	|O
,	|O
ejection	|O
fraction	|O
remained	|O
unchanged	|O
and	|O
isovolumic	|O
relaxation	|O
period	|O
was	|O
lengthened	|O
(	|O
119	|O
+	|O
/	|O
-	|O
20.1	|O
to	|O
147.39	|O
+	|O
/	|O
-	|O
21.15	|O
,	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

The	|O
ANB1	|B-PROTEIN
locus	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
encodes	|O
the	|O
protein	|O
synthesis	|O
initiation	|O
factor	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
4D	|I-PROTEIN
.	|O

The	|O
contribution	|O
that	|O
alternative	|O
splicing	|O
events	|O
in	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
expression	|O
may	|O
make	|O
on	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
function	|O
remains	|O
to	|O
be	|O
elucidated	|O
.	|O

Serum	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
levels	|O
(	|O
beta	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
M	|I-PROTEIN
)	|O
were	|O
studied	|O
in	|O
150	|O
drug	|O
addicts	|O
,	|O
50	|O
of	|O
them	|O
asymptomatic	|O
carriers	|O
of	|O
anti	|B-PROTEIN
HIV	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
antibodies	|O
,	|O
50	|O
symptomatic	|O
carriers	|O
with	|O
persistent	|O
generalized	|O
lymphadenopathy	|O
(	|O
P.G.L.	|O
)	|O
and	|O
50	|O
serum	|O
negative	|O
patients	|O
who	|O
had	|O
been	|O
living	|O
in	|O
a	|O
closed	|O
community	|O
for	|O
at	|O
least	|O
2	|O
years	|O
.	|O

This	|O
emancipation	|O
of	|O
the	|O
ability	|O
to	|O
copulate	|O
from	|O
hormonal	|O
influence	|O
makes	|O
female	|O
sexual	|O
motivation	|O
the	|O
primary	|O
regulator	|O
of	|O
mating	|O
in	|O
primates	|O
.	|O

No	|O
therapy	|O
exists	|O
for	|O
halting	|O
the	|O
progression	|O
of	|O
the	|O
disease	|O
with	|O
the	|O
possible	|O
exception	|O
of	|O
laser	|O
photocoagulation	|O
treatment	|O
used	|O
to	|O
ablate	|O
subretinal	|O
neovascular	|O
membranes	|O
in	|O
an	|O
attempt	|O
to	|O
avoid	|O
complications	|O
of	|O
subretinal	|O
hemorrhages	|O
.	|O

R.	|O

Specific	|O
hyperimmune	|B-PROTEIN
globulins	|I-PROTEIN
to	|O
pathogens	|O
such	|O
as	|O
Haemophilus	|O
influenzae	|O
and	|O
Streptococcus	|O
pneumoniae	|O
have	|O
also	|O
been	|O
studied	|O
.	|O

Therapeutic	|O
effects	|O
of	|O
cefpirome	|O
(	|O
HR	|O
810	|O
)	|O
on	|O
experimental	|O
mixed	|O
infections	|O
with	|O
Enterococcus	|O
faecalis	|O
and	|O
Escherichia	|O
coli	|O
in	|O
mice	|O
.	|O

Regulation	|O
of	|O
yeast	|O
LEU2	|B-PROTEIN
.	|O

Homozygous	|O
individuals	|O
usually	|O
develop	|O
purpura	|O
fulminans	|O
as	|O
newborns	|O
;	|O
heterozygous	|O
protein	|B-PROTEIN
C	|I-PROTEIN
-	|O
deficient	|O
individuals	|O
are	|O
at	|O
increased	|O
risk	|O
for	|O
venous	|O
thrombosis	|O
and	|O
pulmonary	|O
embolism	|O
.	|O

Ischemic	|O
stroke	|O
due	|O
to	|O
protein	|B-PROTEIN
C	|I-PROTEIN
deficiency	|O
.	|O

TREB7	|B-PROTEIN
and	|O
TREB36	|B-PROTEIN
protected	|O
all	|O
three	|O
repeats	|O
of	|O
the	|O
21	|O
bp	|O
,	|O
but	|O
TREB5	|B-PROTEIN
protected	|O
only	|O
the	|O
second	|O
repeat	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
5	|O
KE	|O
X	|O
3	|O
/	|O
W	|O
may	|O
be	|O
the	|O
optimal	|O
regimen	|O
to	|O
augment	|O
the	|O
antitumor	|O
immunity	|O
of	|O
RNL	|O
.	|O

Analysis	|O
of	|O
various	|O
deletion	|O
mutants	|O
indicates	|O
that	|O
the	|O
sequence	|O
requirements	|O
for	|O
binding	|O
by	|O
QBP	|B-PROTEIN
in	|O
vitro	|O
are	|O
indistinguishable	|O
from	|O
those	|O
necessary	|O
for	|O
Q	|O
activity	|O
in	|O
vivo	|O
,	|O
strongly	|O
suggesting	|O
that	|O
QBP	|B-PROTEIN
is	|O
required	|O
for	|O
the	|O
function	|O
of	|O
this	|O
TATA	|O
-	|O
independent	|O
promoter	|O
.	|O

Since	|O
general	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
(	|O
GRFI	|B-PROTEIN
)	|O
/	|O
repressor	|B-PROTEIN
/	|I-PROTEIN
activator	|I-PROTEIN
site	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
RAP1	|B-PROTEIN
)	|O
/	|O
translation	|B-PROTEIN
upstream	|I-PROTEIN
factor	|I-PROTEIN
(	|O
TUF	|B-PROTEIN
)	|O
is	|O
believed	|O
to	|O
be	|O
an	|O
activator	|O
of	|O
MAT	|B-PROTEIN
alpha	|I-PROTEIN
expression	|O
,	|O
we	|O
examined	|O
whether	|O
PYK1	|B-PROTEIN
,	|O
which	|O
is	|O
known	|O
to	|O
be	|O
regulated	|O
by	|O
GRFI	|B-PROTEIN
/	|O
RAP1	|B-PROTEIN
/	|O
TUF	|B-PROTEIN
,	|O
is	|O
also	|O
affected	|O
by	|O
the	|O
gal11	|B-PROTEIN
mutation	|O
.	|O

Yeast	|O
Gal11	|B-PROTEIN
protein	|O
mediates	|O
the	|O
transcriptional	|O
activation	|O
signal	|O
of	|O
two	|O
different	|O
transacting	|O
factors	|O
,	|O
Gal4	|B-PROTEIN
and	|O
general	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
/	|O
repressor	|B-PROTEIN
/	|I-PROTEIN
activator	|I-PROTEIN
site	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
/	|O
translation	|O
upstream	|O
factor	|O
.	|O

Deletion	|O
from	|O
either	|O
the	|O
N	|O
-	|O
or	|O
C	|O
-	|O
terminal	|O
ends	|O
of	|O
repA	|B-PROTEIN
(	|O
28	|O
and	|O
69	|O
codons	|O
,	|O
respectively	|O
,	|O
out	|O
of	|O
the	|O
286	|O
-	|O
codon	|O
open	|O
reading	|O
frame	|O
)	|O
affected	|O
the	|O
initiator	|O
but	|O
not	|O
the	|O
inhibitory	|O
activity	|O
.	|O

The	|O
two	|O
larger	|O
peptides	|O
,	|O
one	|O
containing	|O
amino	|O
acids	|O
1-228	|O
and	|O
the	|O
other	|O
containing	|O
amino	|O
acids	|O
85-228	|O
,	|O
formed	|O
dimers	|O
in	|O
solution	|O
and	|O
bound	|O
DNA	|O
specifically	|O
as	|O
a	|O
dimer	|O
.	|O

In	|O
vitro	|O
transcription	|O
extracts	|O
from	|O
ret1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cells	|O
terminate	|O
less	|O
efficiently	|O
at	|O
weak	|O
transcription	|O
termination	|O
signals	|O
than	|O
those	|O
from	|O
RET1	|B-PROTEIN
cells	|O
,	|O
using	|O
a	|O
variety	|O
of	|O
tRNA	|O
templates	|O
.	|O

Guiding	|O
patients	|O
in	|O
the	|O
decision	|O
should	|O
involve	|O
a	|O
multidisciplinary	|O
team	|O
composed	|O
of	|O
a	|O
surgical	|O
oncologist	|O
,	|O
geneticist	|O
,	|O
pathologist	|O
,	|O
psychotherapist	|O
and	|O
plastic	|O
surgeon	|O
.	|O

IgG	|B-PROTEIN
and	|O
IgM	|B-PROTEIN
antibody	|O
activity	|O
was	|O
determined	|O
by	|O
adding	|O
a	|O
1	|O
:	|O
100	|O
dilution	|O
of	|O
serum	|O
to	|O
plates	|O
coated	|O
with	|O
A60	|B-PROTEIN
antigen	|I-PROTEIN
.	|O

These	|O
factors	|O
belong	|O
to	|O
a	|O
set	|O
of	|O
genetically	|O
distinct	|O
molecules	|O
,	|O
including	|O
AP	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
and	|O
MLTF	|B-PROTEIN
,	|O
that	|O
bind	|O
to	|O
the	|O
CACCTGTC	|O
motif	|O
or	|O
related	|O
sequences	|O
.	|O

Among	|O
known	|O
flea	|O
larvae	|O
,	|O
the	|O
genus	|O
Anomiopsyllus	|O
(	|O
Anomiopsyllinae	|O
,	|O
Anomiopsyllini	|O
)	|O
is	|O
as	|O
distinctive	|O
in	|O
larval	|O
form	|O
as	|O
are	|O
the	|O
adults	|O
.	|O

Here	|O
,	|O
we	|O
have	|O
used	|O
specific	|O
antibody	|O
to	|O
identify	|O
and	|O
characterize	|O
the	|O
SSN6	|B-PROTEIN
protein	|O
.	|O

These	|O
latter	|O
results	|O
showed	|O
that	|O
the	|O
ABFI	|B-PROTEIN
protein	|O
,	|O
like	|O
the	|O
RAP1	|B-PROTEIN
protein	|O
,	|O
bound	|O
sequences	|O
required	|O
for	|O
positive	|O
as	|O
well	|O
as	|O
negative	|O
regulation	|O
of	|O
gene	|O
expression	|O
.	|O

Clinical	|O
nutrition	|O
of	|O
adult	|O
horses	|O
.	|O

The	|O
computer	|O
-	|O
programmed	|O
cytocentrifuge	|O
is	|O
currently	|O
most	|O
popular	|O
.	|O

RNase	|B-PROTEIN
protection	|O
assays	|O
reveal	|O
that	|O
this	|O
gene	|O
,	|O
unr	|B-PROTEIN
,	|O
is	|O
transcribed	|O
in	|O
the	|O
same	|O
direction	|O
as	|O
N	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
and	|O
that	|O
its	|O
3'	|O
end	|O
is	|O
located	|O
just	|O
130	|O
base	|O
pairs	|O
away	|O
from	|O
the	|O
point	|O
at	|O
which	|O
N	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
transcription	|O
begins	|O
.	|O

Isolation	|O
of	|O
a	|O
temperature	|O
-	|O
sensitive	|O
mutant	|O
with	|O
an	|O
altered	|O
tRNA	|B-PROTEIN
nucleotidyltransferase	|I-PROTEIN
and	|O
cloning	|O
of	|O
the	|O
gene	|O
encoding	|O
tRNA	|B-PROTEIN
nucleotidyltransferase	|I-PROTEIN
in	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

The	|O
juxtamembrane	|O
region	|O
of	|O
the	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
IR	|B-PROTEIN
)	|O
beta	|O
-	|O
subunit	|O
contains	|O
an	|O
unphosphorylated	|O
tyrosyl	|O
residue	|O
(	|O
Tyr960	|O
)	|O
that	|O
is	|O
essential	|O
for	|O
insulin	|B-PROTEIN
-	|O
stimulated	|O
tyrosyl	|O
phosphorylation	|O
of	|O
some	|O
endogenous	|O
substrates	|O
and	|O
certain	|O
biological	|O
responses	|O
(	|O
White	|O
,	|O
M.F.	|O
,	|O
Livingston	|O
,	|O
J.N.	|O
,	|O
Backer	|O
,	|O
J.M.	|O
,	|O
Lauris	|O
,	|O
V.	|O
,	|O
Dull	|O
,	|O
T.J.	|O
,	|O
Ullrich	|O
,	|O
A.	|O
,	|O
and	|O
Kahn	|O
,	|O
C.R.	|O

This	|O
gene	|O
joins	|O
the	|O
group	|O
of	|O
genes	|O
whose	|O
members	|O
are	|O
rapidly	|O
transcribed	|O
in	|O
response	|O
to	|O
insulin	|B-PROTEIN
and	|O
other	|O
mitogens	|O
.	|O

The	|O
3'	|O
region	|O
,	|O
GA2	|B-PROTEIN
,	|O
is	|O
necessary	|O
for	|O
maximal	|O
expression	|O
.	|O

1	|O
,	|O
among	|O
which	|O
nine	|O
have	|O
been	|O
cloned	|O
and	|O
two	|O
(	|O
potentially	|O
functional	|O
)	|O
sequenced	|O
.	|O

Pups	|O
placed	|O
into	|O
the	|O
novel	|O
environment	|O
with	|O
their	|O
mothers	|O
exhibited	|O
an	|O
intermediate	|O
level	|O
of	|O
DA	|O
turnover	|O
.	|O

The	|O
efficacy	|O
and	|O
safety	|O
of	|O
a	|O
novel	|O
percutaneous	|O
anaesthetic	|O
preparation	|O
based	|O
on	|O
amethocaine	|O
has	|O
been	|O
investigated	|O
in	|O
the	|O
paediatric	|O
clinical	|O
environment	|O
.	|O

Homozygous	|O
protein	|B-PROTEIN
C	|I-PROTEIN
(	|O
PC	|B-PROTEIN
)	|O
deficiency	|O
is	|O
reported	|O
in	|O
two	|O
siblings	|O
(	|O
girl	|O
and	|O
boy	|O
)	|O
who	|O
received	|O
their	|O
proper	|O
diagnoses	|O
at	|O
the	|O
ages	|O
of	|O
7	|O
4/12	|O
and	|O
1	|O
3/12	|O
years	|O
respectively	|O
.	|O

The	|O
grandfather	|O
and	|O
the	|O
granddaughter	|O
both	|O
had	|O
microtia	|O
and	|O
meatal	|O
atresia	|O
,	|O
whereas	|O
the	|O
daughter	|O
had	|O
a	|O
normal	|O
outer	|O
ear	|O
except	|O
for	|O
a	|O
narrow	|O
meatus	|O
and	|O
auricular	|O
appendages	|O
.	|O

Abnormal	|O
intrapulmonary	|O
shunting	|O
(	|O
IPS	|O
)	|O
,	|O
which	|O
was	|O
proved	|O
in	|O
4	|O
cases	|O
by	|O
whole	|O
-	|O
body	|O
radionuclide	|O
scanning	|O
with	|O
99mTc	|O
-	|O
MAA	|O
,	|O
is	|O
suggested	|O
as	|O
the	|O
major	|O
cause	|O
of	|O
cyanosis	|O
in	|O
liver	|O
cirrhosis	|O
.	|O

The	|O
urinary	|O
protein	|O
,	|O
serum	|O
albumin	|B-PROTEIN
,	|O
BUN	|O
and	|O
SCr	|O
all	|O
had	|O
very	|O
significant	|O
improvement	|O
.	|O

More	|O
generally	|O
,	|O
Ets1	|B-PROTEIN
and	|O
Ets2	|B-PROTEIN
could	|O
regulate	|O
transcription	|O
of	|O
cellular	|O
genes	|O
.	|O

Within	|O
this	|O
sequence	|O
the	|O
MSAS	|B-PROTEIN
gene	|O
was	|O
identified	|O
as	|O
a	|O
5322	|O
-	|O
bp	|O
-	|O
long	|O
open	|O
reading	|O
frame	|O
coding	|O
for	|O
a	|O
protein	|O
of	|O
1774	|O
amino	|O
acids	|O
and	|O
190,731	|O
Da	|O
molecular	|O
mass	|O
.	|O

Horseradish	|B-PROTEIN
peroxidase	|I-PROTEIN
as	|O
a	|O
permeability	|O
marker	|O
in	|O
injured	|O
rat	|O
caudal	|O
and	|O
iliac	|O
arteries	|O
.	|O

Standardized	|O
gastric	|O
wall	|O
specimens	|O
from	|O
the	|O
area	|O
of	|O
grossly	|O
healed	|O
ulcers	|O
were	|O
obtained	|O
,	|O
processed	|O
,	|O
and	|O
evaluated	|O
by	|O
light	|O
microscopy	|O
and	|O
by	|O
transmission	|O
electron	|O
microscopy	|O
.	|O

2	|O
.	|O

The	|O
effects	|O
of	|O
coenzyme	|O
Q10	|O
(	|O
CoQ	|O
)	|O
and	|O
captopril	|O
on	|O
functional	|O
capacity	|O
,	|O
hemodynamics	|O
and	|O
survival	|O
were	|O
studied	|O
in	|O
154	|O
rats	|O
that	|O
recovered	|O
after	|O
experimental	|O
myocardial	|O
infarction	|O
.	|O

Evidence	|O
that	|O
therapeutic	|O
alterations	|O
of	|O
a	|O
circadian	|O
rhythm	|O
for	|O
gastric	|O
emptying	|O
response	|O
may	|O
be	|O
possible	|O
.	|O

The	|O
interrelation	|O
of	|O
the	|O
levels	|O
of	|O
glucocorticoids	|O
and	|O
insulin	|B-PROTEIN
in	|O
the	|O
blood	|O
of	|O
irradiated	|O
animals	|O

This	|O
last	|O
includes	|O
tissue	|O
O2	|O
transfer	|O
(	|O
Ft	|O
'	|O
)	|O
and	|O
mitochondrial	|O
O2	|O
utilization	|O
(	|O
Fm	|O
'	|O
)	|O
.	|O

Foveating	|O
saccades	|O
,	|O
therefore	|O
,	|O
can	|O
be	|O
distinguished	|O
from	|O
other	|O
FEMs	|O
on	|O
the	|O
basis	|O
of	|O
speed	|O
.	|O

Incidence	|O
correlated	|O
with	|O
the	|O
grade	|O
of	|O
oral	|O
hygiene	|O
und	|O
periodontal	|O
disease	|O
.	|O

Our	|O
study	|O
shows	|O
that	|O
the	|O
area	|O
of	|O
Alcoy	|O
is	|O
a	|O
medium	|O
MS	|O
risk	|O
region	|O
according	|O
to	|O
the	|O
thesis	|O
of	|O
Kurzke	|O
,	|O
although	|O
high	|O
MS	|O
areas	|O
may	|O
be	|O
found	|O
,	|O
thus	|O
confirming	|O
that	|O
MS	|O
distribution	|O
in	|O
southern	|O
Europe	|O
is	|O
not	|O
uniform	|O
.	|O

On	|O
an	|O
antithrombin	|B-PROTEIN
unit	|O
basis	|O
,	|O
CY	|O
216	|O
and	|O
CY	|O
222	|O
were	|O
equivalent	|O
and	|O
more	|O
potent	|O
than	|O
UH	|O
.	|O

Chick	|O
brain	|O
actin	|B-PROTEIN
depolymerizing	|O
factor	|O
(	|O
ADF	|B-PROTEIN
)	|O
is	|O
a	|O
19	|O
-	|O
kDa	|O
protein	|O
that	|O
severs	|O
actin	|B-PROTEIN
filaments	|O
and	|O
binds	|O
actin	|B-PROTEIN
monomers	|O
.	|O

Initial	|O
experience	|O
with	|O
a	|O
serotonin	|O
agonist	|O
.	|O

Comprehensive	|O
care	|O
of	|O
the	|O
patient	|O
exposed	|O
to	|O
a	|O
human	|O
teratogen	|O
may	|O
also	|O
include	|O
discussion	|O
of	|O
prenatal	|O
diagnostic	|O
procedures	|O
and	|O
other	|O
pregnancy	|O
management	|O
options	|O
.	|O

Primer	|O
extension	|O
analysis	|O
and	|O
RNA	|O
sequencing	|O
demonstrates	|O
that	|O
the	|O
transcription	|O
start	|O
point	|O
of	|O
rat	|O
ODC	|B-PROTEIN
mRNA	|O
is	|O
located	|O
303	|O
nt	|O
upstream	|O
from	|O
the	|O
A	|O
residue	|O
in	|O
the	|O
start	|O
codon	|O
.	|O

For	|O
85Sr	|O
,	|O
larger	|O
-	|O
than	|O
-	|O
expected	|O
distribution	|O
coefficients	|O
were	|O
obtained	|O
in	|O
the	|O
desorption	|O
experiments	|O
,	|O
an	|O
indication	|O
of	|O
the	|O
irreversible	|O
formation	|O
of	|O
metal	|O
-	|O
oxyhydroxides	|O
during	|O
a	|O
slow	|O
reaction	|O
.	|O

Gene	|O
constructs	|O
possessing	|O
the	|O
complete	|O
tat	|B-PROTEIN
,	|O
rev	|B-PROTEIN
(	|O
tat+	|B-PROTEIN
rev+	|B-PROTEIN
)	|O
and	|O
env	|B-PROTEIN
genes	|O
were	|O
transiently	|O
expressed	|O
in	|O
COS	|O
-	|O
1	|O
cells	|O
as	|O
precursor	|B-PROTEIN
SU	|I-PROTEIN
-	|I-PROTEIN
TM	|I-PROTEIN
(	|O
gp160	|B-PROTEIN
)	|O
,	|O
SU.T	|B-PROTEIN
M	|I-PROTEIN
(	|O
gp120	|B-PROTEIN
x	|O
41	|O
)	|O
,	|O
and	|O
nucleolar	|O
rev	|B-PROTEIN
protein	|O
.	|O

This	|O
growth	|O
arrest	|O
is	|O
partly	|O
suppressed	|O
on	|O
minimal	|O
medium	|O
or	|O
under	|O
conditions	|O
in	|O
which	|O
the	|O
cells	|O
are	|O
less	|O
dependent	|O
on	|O
mitochondrial	|O
metabolism	|O
.	|O

Patients	|O
with	|O
detectable	|O
serum	|O
TNF	|B-PROTEIN
levels	|O
had	|O
significantly	|O
lower	|O
serum	|O
T3	|O
concentrations	|O
compared	|O
to	|O
those	|O
with	|O
undetectable	|O
levels	|O
[	|O
1.072	|O
+	|O
/	|O
-	|O
0.588	|O
vs.	|O

Giant	|O
pilomatrix	|O
carcinoma	|O
:	|O
report	|O
and	|O
review	|O
of	|O
the	|O
literature	|O
.	|O

Further	|O
studies	|O
of	|O
mandibular	|O
movement	|O
at	|O
initial	|O
tooth	|O
contact	|O
.	|O

Each	|O
parent	|O
interacted	|O
with	|O
their	|O
4	|O
-	|O
or	|O
5	|O
-	|O
year	|O
-	|O
old	|O
son	|O
or	|O
daughter	|O
in	|O
each	|O
of	|O
two	|O
conversations	|O
-	|O
-	|O
unstructured	|O
(	|O
social	|O
conversation	|O
)	|O
and	|O
structured	|O
(	|O
task	|O
activity	|O
)	|O
.	|O

Droperidol	|O
-	|O
induced	|O
extrapyramidal	|O
symptoms	|O
in	|O
an	|O
adolescent	|O
following	|O
strabismus	|O
surgery	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
the	|O
cis	|O
-	|O
regulatory	|O
elements	|O
required	|O
for	|O
developmental	|O
control	|O
of	|O
the	|O
HaG3	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
helianthinin	|O
gene	|O
are	|O
located	|O
in	|O
a	|O
2.4	|O
kb	|O
upstream	|O
region	|O
of	|O
this	|O
gene	|O
.	|O

The	|O
induction	|O
by	|O
pseudorabies	|O
virus	|O
of	|O
an	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
construct	|O
containing	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
TATA	|O
box	|O
and	|O
the	|O
RNA	|O
start	|O
site	|O
(	|O
"	|O
initiator	|O
"	|O
or	|O
Inr	|O
element	|O
)	|O
but	|O
not	|O
the	|O
MRE	|O
region	|O
was	|O
also	|O
repressed	|O
by	|O
Dex	|O
in	|O
the	|O
presence	|O
of	|O
wild	|O
-	|O
type	|O
GR	|B-PROTEIN
.	|O

Some	|O
mutations	|O
affected	|O
Dhfr	|B-PROTEIN
in	|O
a	|O
qualitative	|O
manner	|O
,	|O
such	|O
as	|O
by	|O
changing	|O
the	|O
startpoint	|O
of	|O
one	|O
of	|O
the	|O
major	|O
Dhfr	|B-PROTEIN
transcripts	|O
or	|O
changing	|O
the	|O
relative	|O
abundance	|O
of	|O
the	|O
two	|O
major	|O
Dhfr	|B-PROTEIN
transcripts	|O
.	|O

The	|O
glial	|O
cyst	|O
wall	|O
was	|O
lined	|O
in	|O
part	|O
by	|O
flattened	|O
or	|O
cuboidal	|O
epithelium	|O
.	|O

We	|O
conclude	|O
that	|O
class	|O
I	|O
cytologic	|O
smears	|O
with	|O
moderate	|O
to	|O
severe	|O
inflammation	|O
may	|O
be	|O
associated	|O
with	|O
findings	|O
of	|O
condylomata	|O
and	|O
cervical	|O
dysplasia	|O
.	|O

As	|O
in	|O
mammals	|O
,	|O
considerable	|O
nucleotide	|O
diversity	|O
was	|O
observed	|O
at	|O
the	|O
junctions	|O
of	|O
the	|O
variable	|O
,	|O
diversity	|O
,	|O
and	|O
joining	|O
elements	|O
in	|O
chicken	|O
TCR	|B-PROTEIN
beta	|I-PROTEIN
cDNAs	|O
.	|O

The	|O
protooncogene	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
encodes	|O
a	|O
nuclear	|O
transcription	|O
factor	|O
that	|O
binds	|O
to	|O
DNA	|O
in	|O
a	|O
sequence	|O
-	|O
specific	|O
manner	|O
and	|O
transactivates	|O
transcription	|O
of	|O
several	|O
viral	|O
and	|O
cellular	|O
genes	|O
.	|O

Modification	|O
by	|O
this	|O
latter	|O
compound	|O
was	|O
so	|O
extensive	|O
that	|O
the	|O
amount	|O
of	|O
membrane	|O
-	|O
associated	|O
N	|O
-	|O
myristoylated	|O
protein	|O
was	|O
decreased	|O
.	|O

S6	|B-PROTEIN
kinase	|I-PROTEIN
activation	|O
requires	|O
displacement	|O
of	|O
this	|O
inhibitory	|O
segment	|O
,	|O
which	|O
is	|O
proposed	|O
to	|O
occur	|O
consequent	|O
to	|O
its	|O
multiple	|O
phosphorylation	|O
.	|O

Rats	|O
with	|O
one	|O
olfactory	|O
bulb	|O
removed	|O
and	|O
the	|O
contralateral	|O
naris	|O
closed	|O
can	|O
detect	|O
odors	|O
.	|O

Expression	|O
of	|O
the	|O
human	|O
T	|O
cell	|O
receptor	|O
(	|B-PROTEIN
TCR	|I-PROTEIN
)	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
is	|O
regulated	|O
by	|O
a	|O
T	|O
cell	|O
-	|O
specific	|O
transcriptional	|O
enhancer	|O
that	|O
is	|O
located	|O
4.5	|O
kilobases	|O
(	|O
kb	|O
)	|O
3'	|O
to	|O
the	|O
C	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
segment	|O
.	|O

The	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
site	|O
was	|O
localized	|O
to	|O
a	|O
17	|O
-	|O
base	|O
pair	|O
(	|O
bp	|O
)	|O
region	|O
from	|O
the	|O
3'	|O
end	|O
of	|O
T	|B-PROTEIN
alpha	|I-PROTEIN
2	|I-PROTEIN
.	|O

Cerebral	|O
flow	|O
and	|O
resistance	|O
showed	|O
minor	|O
reductions	|O
with	|O
HD	|O
.	|O

Utilization	|O
of	|O
alternative	|O
polyadenylation	|O
signals	|O
was	|O
previously	|O
shown	|O
to	|O
generate	|O
two	|O
sialophorin	|B-PROTEIN
mRNAs	|O
of	|O
1.9	|O
and	|O
4.3	|O
kb	|O
,	|O
which	|O
differ	|O
in	|O
the	|O
length	|O
of	|O
their	|O
3'	|O
untranslated	|O
regions	|O
.	|O

Presidential	|O
address	|O
1990	|O
-	|O
-	|O
coming	|O
in	|O
from	|O
the	|O
cold	|O
.	|O

Human	|O
T	|O
-	|O
cell	|O
leukemia	|O
virus	|O
type	|O
I	|O
(	|O
HTLV	|O
-	|O
I	|O
)	|O
encodes	|O
a	|O
40	|O
-	|O
kDa	|O
nuclear	|O
protein	|O
,	|O
Tax	|B-PROTEIN
,	|O
which	|O
stimulates	|O
transcription	|O
from	|O
three	|O
21	|O
-	|O
base	|O
pair	|O
(	|O
bp	|O
)	|O
repeats	|O
in	|O
its	|O
U3	|O
region	|O
.	|O

We	|O
have	|O
now	|O
identified	|O
,	|O
after	|O
21	|O
serial	|O
undiluted	|O
passages	|O
of	|O
MHV	|O
,	|O
a	|O
small	|O
DI	|B-PROTEIN
RNA	|O
,	|O
DIssF	|B-PROTEIN
,	|O
which	|O
is	|O
efficiently	|O
packaged	|O
into	|O
virions	|O
.	|O

The	|O
Jenkins	|O
Activity	|O
Survey	|O
and	|O
the	|O
CPI	|O
-	|O
revised	|O
:	|O
further	|O
evidence	|O
of	|O
adaptive	|O
and	|O
maladaptive	|O
type	|O
A	|O
traits	|O
.	|O

There	|O
was	|O
evidence	|O
of	|O
attenuated	|O
regression	|O
slopes	|O
relating	|O
recalled	|O
to	|O
observed	|O
portion	|O
sizes	|O
for	|O
4	|O
of	|O
the	|O
10	|O
food	|O
groups	|O
;	|O
adjusted	|O
r2	|O
values	|O
for	|O
the	|O
recalled	|O
portion	|O
sizes	|O
ranged	|O
from	|O
0.02	|O
to	|O
0.94	|O
.	|O

The	|O
result	|O
suggests	|O
that	|O
this	|O
non	|O
-	|O
invasive	|O
TTD	|O
method	|O
is	|O
easily	|O
available	|O
and	|O
useful	|O
in	|O
monitoring	|O
the	|O
intraoperative	|O
cardiac	|O
output	|O
.	|O

The	|O
TUP1	|B-PROTEIN
gene	|O
was	|O
isolated	|O
in	|O
a	|O
screen	|O
for	|O
genes	|O
that	|O
regulate	|O
mating	|O
type	|O
(	|O
V.L.	|O

The	|O
SUP44	|B-PROTEIN
suppressor	|O
mutation	|O
occurs	|O
near	|O
a	|O
region	|O
of	|O
the	|O
protein	|O
that	|O
corresponds	|O
to	|O
the	|O
known	|O
positions	|O
of	|O
alterations	|O
in	|O
E.	|O
coli	|O
S5	|O
ram	|B-PROTEIN
mutations	|O
.	|O

Interestingly	|O
,	|O
disruption	|O
of	|O
the	|O
VPS34	|B-PROTEIN
locus	|O
resulted	|O
in	|O
a	|O
temperature	|O
-	|O
sensitive	|O
growth	|O
defect	|O
,	|O
indicating	|O
that	|O
the	|O
VPS34	|B-PROTEIN
gene	|O
is	|O
essential	|O
for	|O
vegetative	|O
growth	|O
only	|O
at	|O
elevated	|O
growth	|O
temperatures	|O
.	|O

We	|O
describe	|O
a	|O
case	|O
of	|O
a	|O
perinephric	|O
abscess	|O
treated	|O
with	|O
amphotericin	|O
B	|O
and	|O
nephrectomy	|O
.	|O

This	|O
,	|O
together	|O
with	|O
the	|O
data	|O
obtained	|O
with	|O
haloperidol	|O
,	|O
suggests	|O
that	|O
a	|O
minimal	|O
increase	|O
in	|O
the	|O
firing	|O
rate	|O
of	|O
LC	|O
cells	|O
(	|O
+	|O
140%	|O
)	|O
is	|O
required	|O
before	|O
it	|O
could	|O
influence	|O
the	|O
turnover	|O
of	|O
NA	|O
,	|O
as	|O
measured	|O
by	|O
DOPAC	|O
changes	|O
.	|O

This	|O
interaction	|O
occurs	|O
over	|O
a	|O
wide	|O
range	|O
of	|O
both	|O
parameters	|O
;	|O
for	|O
charge	|O
density	|O
from	|O
at	|O
least	|O
10	|O
to	|O
800	|O
microC	|O
/	|O
cm2	|O
and	|O
,	|O
for	|O
charge	|O
per	|O
phase	|O
,	|O
from	|O
at	|O
least	|O
0.05	|O
to	|O
5.0	|O
microC	|O
per	|O
phase	|O
.	|O

Perceptions	|O
of	|O
illness	|O
intrusiveness	|O
were	|O
significantly	|O
higher	|O
when	|O
both	|O
muscle	|O
cramp	|O
and	|O
headache	|O
symptoms	|O
occurred	|O
during	|O
one	|O
or	|O
more	|O
assessment	|O
intervals	|O
as	|O
compared	|O
to	|O
when	|O
muscle	|O
cramps	|O
or	|O
headaches	|O
,	|O
only	|O
,	|O
occurred	|O
.	|O

Results	|O
have	|O
surprisingly	|O
revealed	|O
the	|O
presence	|O
of	|O
three	|O
U14	|B-PROTEIN
snRNA	|O
-	|O
homologous	|O
regions	|O
positioned	|O
within	|O
introns	|O
5	|O
,	|O
6	|O
,	|O
and	|O
8	|O
of	|O
the	|O
mouse	|O
cognate	|O
hsc70	|B-PROTEIN
heat	|O
shock	|O
gene	|O
.	|O

65	|O
-	|O
kilodalton	|O
protein	|O
phosphorylated	|O
by	|O
interleukin	|B-PROTEIN
2	|I-PROTEIN
stimulation	|O
bears	|O
two	|O
putative	|O
actin	|B-PROTEIN
-	|O
binding	|O
sites	|O
and	|O
two	|O
calcium	|O
-	|O
binding	|O
sites	|O
.	|O

The	|O
highly	|O
restrained	|O
girls	|O
had	|O
a	|O
significantly	|O
higher	|O
EAT	|O
score	|O
than	|O
the	|O
low	|O
-	|O
restrained	|O
girls	|O
,	|O
and	|O
shared	|O
with	|O
their	|O
mothers	|O
a	|O
susceptibility	|O
to	|O
the	|O
disinhibitory	|O
effects	|O
of	|O
negative	|O
mood	|O
states	|O
on	|O
their	|O
eating	|O
behaviour	|O
.	|O

The	|O
Mauriceville	|O
and	|O
Varkud	|O
mitochondrial	|O
plasmids	|O
are	|O
closely	|O
related	|O
,	|O
closed	|O
-	|O
circular	|O
DNAs	|O
(	|O
3.6	|O
and	|O
3.7	|O
kb	|O
,	|O
respectively	|O
)	|O
that	|O
have	|O
characteristics	|O
of	|O
mtDNA	|O
introns	|O
and	|O
retroid	|O
elements	|O
.	|O

The	|O
circadian	|O
rhythm	|O
,	|O
however	|O
,	|O
was	|O
not	|O
affected	|O
and	|O
the	|O
difference	|O
between	|O
minimum	|O
(	|O
12.00	|O
h	|O
)	|O
and	|O
maximum	|O
(	|O
18.50	|O
h	|O
)	|O
serum	|O
concentrations	|O
was	|O
31.3%	|O
.	|O

Sequence	|O
and	|O
genetic	|O
organization	|O
of	|O
a	|O
Zymomonas	|O
mobilis	|O
gene	|O
cluster	|O
that	|O
encodes	|O
several	|O
enzymes	|O
of	|O
glucose	|O
metabolism	|O
.	|O

Most	|O
strains	|O
(	|O
95%	|O
)	|O
of	|O
S.	|O
lugdunensis	|O
produced	|O
a	|O
delta	|B-PROTEIN
hemolysin	|I-PROTEIN
like	|O
that	|O
seen	|O
with	|O
nine	|O
other	|O
species	|O
of	|O
CNS	|O
.	|O

For	|O
this	|O
,	|O
cDNAs	|O
containing	|O
the	|O
60K	|O
,	|O
87K	|O
,	|O
110K	|O
and	|O
170K	|O
protein	|O
coding	|O
sequences	|O
were	|O
each	|O
provided	|O
with	|O
an	|O
ATG	|O
start	|O
codon	|O
and	|O
the	|O
cDNA	|O
containing	|O
the	|O
60K	|O
coding	|O
sequence	|O
with	|O
a	|O
TAA	|O
stop	|O
codon	|O
immediately	|O
downstream	|O
of	|O
the	|O
coding	|O
sequence	|O
.	|O

Finally	|O
,	|O
a	|O
complementary	|O
footprinting	|O
analysis	|O
of	|O
the	|O
upstream	|O
region	|O
of	|O
the	|O
constitutively	|O
expressed	|O
HSC82	|B-PROTEIN
gene	|O
reveals	|O
the	|O
presence	|O
of	|O
three	|O
discrete	|O
protein	|O
complexes	|O
.	|O

Pathophysiology	|O
of	|O
bone	|O
loss	|O
in	|O
castrated	|O
animals	|O
.	|O

Auditory	|O
-	|O
visual	|O
interaction	|O
in	|O
the	|O
generation	|O
of	|O
saccades	|O
in	|O
man	|O
.	|O

First	|O
,	|O
each	|O
lung	|O
was	|O
cut	|O
into	|O
slices	|O
,	|O
from	|O
which	|O
primary	|O
disectors	|O
were	|O
sampled	|O
systematically	|O
with	|O
a	|O
known	|O
sampling	|O
fraction	|O
.	|O

The	|O
upstream	|O
promoter	|O
is	|O
located	|O
within	|O
the	|O
coding	|O
sequence	|O
of	|O
a	|O
divergent	|O
gene	|O
expressing	|O
a	|O
protein	|O
of	|O
Mr	|O
39	|O
kDa	|O
of	|O
unknown	|O
function	|O
.	|O

Assuming	|O
O2	|O
consumption	|O
of	|O
the	|O
isolated	|O
skin	|O
to	|O
be	|O
same	|O
as	|O
in	|O
situ	|O
,	|O
calculations	|O
showed	|O
that	|O
when	|O
water	|O
PO2	|O
was	|O
high	|O
(	|O
150	|O
mm	|O
Hg	|O
)	|O
,	|O
about	|O
40%	|O
of	|O
total	|O
cutaneous	|O
O2	|O
uptake	|O
was	|O
consumed	|O
by	|O
the	|O
skin	|O
.	|O

Experiments	|O
showed	|O
that	|O
temporary	|O
arrest	|O
of	|O
pulmonary	|O
circulation	|O
under	|O
conditions	|O
of	|O
extracorporeal	|O
circulation	|O
is	|O
attended	|O
by	|O
the	|O
development	|O
of	|O
ischemia	|O
of	|O
the	|O
respiratory	|O
pulmonary	|O
tissue	|O
.	|O

MCh	|O
infusion	|O
caused	|O
a	|O
concentration	|O
-	|O
dependent	|O
increase	|O
in	|O
airway	|O
resistance	|O
at	|O
constant	|O
QBA	|O
.	|O

Taste	|O
reactivity	|O
tests	|O
were	|O
used	|O
to	|O
examine	|O
the	|O
orofacial	|O
responses	|O
of	|O
alcohol	|O
preferring	|O
(	|O
P	|O
)	|O
rats	|O
and	|O
alcohol	|O
nonpreferring	|O
(	|O
NP	|O
)	|O
rats	|O
to	|O
the	|O
taste	|O
of	|O
alcohol	|O
.	|O

Plasma	|O
concentrations	|O
of	|O
atracurium	|O
and	|O
laudanosine	|O
were	|O
0.73-3.11	|O
micrograms	|O
ml	|O
-	|O
1	|O
and	|O
0.48-8.65	|O
micrograms	|O
ml	|O
-	|O
1	|O
,	|O
respectively	|O
;	|O
CSF	|O
concentration	|O
of	|O
laudanosine	|O
was	|O
70-440	|O
ng	|O
ml	|O
-	|O
1	|O
.	|O

Plasma	|O
Al	|O
was	|O
obtained	|O
during	|O
each	|O
baseline	|O
and	|O
drug	|O
course	|O
.	|O

The	|O
survival	|O
in	|O
the	|O
case	|O
of	|O
these	|O
patients	|O
was	|O
studied	|O
five	|O
years	|O
later	|O
.	|O

The	|O
occurrence	|O
,	|O
maintenance	|O
and	|O
possible	|O
involvement	|O
of	|O
these	|O
repeated	|O
sequences	|O
,	|O
capable	|O
of	|O
forming	|O
stable	|O
secondary	|O
structures	|O
,	|O
are	|O
discussed	|O
in	|O
relation	|O
to	|O
their	|O
location	|O
in	|O
the	|O
region	|O
of	|O
control	|O
signals	|O
.	|O

IST	|B-PROTEIN
is	|O
not	|O
the	|O
RNA	|O
target	|O
(	|O
TAR	|O
)	|O
for	|O
Tat	|B-PROTEIN
trans	|O
-	|O
activation	|O
;	|O
however	|O
,	|O
because	|O
it	|O
relies	|O
entirely	|O
on	|O
cellular	|O
factors	|O
for	|O
activity	|O
,	|O
IST	|B-PROTEIN
may	|O
serve	|O
to	|O
provide	|O
abundant	|O
RNA	|O
targets	|O
for	|O
Tat	|B-PROTEIN
trans	|O
-	|O
activation	|O
without	|O
a	|O
requirement	|O
for	|O
full	|O
-	|O
length	|O
viral	|O
mRNA	|O
expression	|O
.	|O

Genotoxic	|O
activity	|O
of	|O
a	|O
tobacco	|O
-	|O
specific	|O
nitrosamine	|O
.	|O

The	|O
endodontal	|O
treatment	|O
need	|O
has	|O
been	|O
forming	|O
a	|O
clinical	|O
order	|O
of	|O
magnitude	|O
.	|O

1	|O
(	|O
"	|O
long	|O
method	|O
"	|O
)	|O
and	|O
the	|O
HML	|O
method	|O
.	|O

These	|O
results	|O
may	|O
suggest	|O
involvement	|O
of	|O
peripheral	|O
enkephalins	|O
in	|O
pain	|O
modulation	|O
in	|O
patients	|O
with	|O
episodic	|O
cluster	|O
headache	|O
.	|O

Effects	|O
of	|O
cisapride	|O
on	|O
upper	|O
-	|O
gastrointestinal	|O
motility	|O
and	|O
digestive	|O
hormones	|O

Common	|O
foot	|O
pathologies	|O
are	|O
heel	|O
pain	|O
,	|O
metatarsalgia	|O
,	|O
hammertoes	|O
and	|O
clawtoes	|O
,	|O
bunions	|O
,	|O
hallux	|O
rigidus	|O
,	|O
corns	|O
and	|O
calluses	|O
,	|O
nail	|O
pathologies	|O
,	|O
arthritis	|O
,	|O
and	|O
neuropathies	|O
.	|O

Liver	|O
dysfunction	|O
in	|O
the	|O
presence	|O
of	|O
different	|O
adverse	|O
reactions	|O
presented	|O
with	|O
a	|O
higher	|O
activity	|O
in	|O
the	|O
blood	|O
serum	|O
of	|O
indicator	|O
liver	|O
enzymes	|O
and	|O
its	|O
impaired	|O
protein	|O
-	|O
forming	|O
function	|O
.	|O

Coenzyme	|O
Q10	|O
:	|O
blood	|O
levels	|O
and	|O
metabolic	|O
demand	|O
.	|O

The	|O
CT	|O
characteristics	|O
are	|O
discussed	|O
and	|O
the	|O
recent	|O
literature	|O
is	|O
reviewed	|O
.	|O

Unfortunately	|O
,	|O
these	|O
preservatives	|O
may	|O
also	|O
interfere	|O
with	|O
microbiological	|O
assays	|O
used	|O
to	|O
determine	|O
product	|O
sterility	|O
or	|O
bioburden	|O
levels	|O
.	|O

In	|O
26	|O
patients	|O
with	|O
angina	|O
pectoris	|O
,	|O
the	|O
changes	|O
of	|O
LVEF	|O
,	|O
LVESV	|O
and	|O
PSP	|O
/	|O
LVESV	|O
were	|O
more	|O
sensitive	|O
for	|O
the	|O
detection	|O
of	|O
exercise	|O
-	|O
induced	|O
ischemia	|O
than	|O
the	|O
appearance	|O
of	|O
chest	|O
pain	|O
and	|O
the	|O
changes	|O
of	|O
ECG	|O
.	|O

In	|O
both	|O
groups	|O
there	|O
were	|O
5	|O
management	|O
failure	|O
of	|O
therapy	|O
,	|O
so	|O
that	|O
alternative	|O
medication	|O
or	|O
a	|O
cesarean	|O
section	|O
lead	|O
to	|O
delivery	|O
.	|O

Serum	|O
Fibrin	|B-PROTEIN
Degradation	|I-PROTEIN
Products	|I-PROTEIN
(	|O
FDP	|B-PROTEIN
)	|O
were	|O
determined	|O
in	|O
50	|O
oral	|O
cancer	|O
patients	|O
and	|O
50	|O
normal	|O
individuals	|O
prior	|O
to	|O
any	|O
kind	|O
of	|O
treatment	|O
.	|O

The	|O
uteroglobin	|B-PROTEIN
promoter	|O
contains	|O
a	|O
noncanonical	|O
estrogen	|O
responsive	|O
element	|O
.	|O

Prostaglandin	|O
synthesis	|O
inhibitors	|O
have	|O
been	|O
shown	|O
to	|O
delay	|O
healing	|O
of	|O
bone	|O
and	|O
this	|O
has	|O
led	|O
to	|O
limitations	|O
on	|O
their	|O
use	|O
clinically	|O
in	|O
some	|O
situations	|O
.	|O

The	|O
inspiratory	|O
oxygen	|O
concentration	|O
needed	|O
(	|O
FiO2	|O
)	|O
and	|O
the	|O
Horowitz	|O
quotient	|O
differed	|O
in	|O
a	|O
highly	|O
significant	|O
manner	|O
beginning	|O
on	|O
the	|O
1st	|O
day	|O
after	|O
trauma	|O
.	|O

The	|O
corn	|O
and	|O
mineral	|O
oil	|O
emulsions	|O
were	|O
almost	|O
as	|O
effective	|O
as	|O
milk	|O
but	|O
less	|O
effective	|O
than	|O
sucrose	|O
(	|O
0.3	|O
M	|O
)	|O
in	|O
stimulating	|O
ingestion	|O
.	|O

Significance	|O
of	|O
thin	|O
glomerular	|O
basement	|O
membranes	|O
in	|O
hematuric	|O
children	|O
.	|O

Significance	|O
of	|O
cytokine	|O
production	|O
and	|O
adhesion	|O
molecules	|O
in	|O
malarial	|O
immunopathology	|O
.	|O

The	|O
former	|O
procedure	|O
is	|O
economical	|O
but	|O
complicated	|O
,	|O
whereas	|O
the	|O
latter	|O
is	|O
simple	|O
and	|O
labour	|O
-	|O
saving	|O
,	|O
but	|O
a	|O
special	|O
ultrafiltration	|O
tube	|O
is	|O
required	|O
.	|O

Simple	|O
method	|O
for	|O
determination	|O
of	|O
the	|O
cephalosporin	|O
DQ	|O
-	|O
2556	|O
in	|O
biological	|O
fluids	|O
by	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatography	|O
.	|O

Since	|O
one	|O
group	|O
of	|O
adolescents	|O
more	|O
difficult	|O
to	|O
influence	|O
are	|O
those	|O
whose	|O
parents	|O
smoke	|O
,	|O
parental	|O
involvement	|O
in	|O
smoking	|O
prevention	|O
may	|O
be	|O
a	|O
powerful	|O
enhancer	|O
.	|O

Further	|O
research	|O
is	|O
recommended	|O
to	|O
identify	|O
the	|O
coping	|O
styles	|O
associated	|O
with	|O
the	|O
high	|O
EE	|O
/	|O
low	|O
EE	|O
research	|O
classification	|O
.	|O

Staining	|O
with	|O
IF	|O
MoAB	|O
alone	|O
of	|O
BAL	|O
fluid	|O
only	|O
seemed	|O
to	|O
be	|O
even	|O
more	|O
sensitive	|O
than	|O
silver	|O
methenamine	|O
staining	|O
of	|O
BAL	|O
,	|O
TBB	|O
and	|O
brushing	|O
material	|O
.	|O

Ultrastructural	|O
and	|O
morphometric	|O
study	|O
of	|O
the	|O
myeloid	|O
parenchyma	|O
cells	|O
of	|O
mice	|O
prior	|O
and	|O
after	|O
X	|O
-	|O
ray	|O
exposure	|O

Using	|O
an	|O
audiotape	|O
cassette	|O
and	|O
headphones	|O
the	|O
duration	|O
of	|O
the	|O
hallucinations	|O
decreased	|O
significantly	|O
.	|O

The	|O
mean	|O
change	|O
in	|O
HbA1	|B-PROTEIN
,	|O
adjusted	|O
for	|O
the	|O
initial	|O
value	|O
,	|O
was	|O
-	|O
0.4%	|O
in	|O
the	|O
experimental	|O
and	|O
+	|O
0.5%	|O
in	|O
the	|O
control	|O
group	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Effect	|O
of	|O
biliary	|O
obstruction	|O
and	|O
cholangitis	|O
on	|O
serum	|O
SPan	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
level	|O

Very	|O
good	|O
accuracy	|O
(	|O
r	|O
greater	|O
than	|O
0.9	|O
)	|O
was	|O
found	|O
when	|O
except	|O
comparing	|O
H	|O
*	|O
2	|O
with	|O
the	|O
other	|O
machine	|O
and	|O
the	|O
reference	|O
methods	|O
,	|O
except	|O
for	|O
MCHCH	|O
and	|O
basophil	|O
count	|O
.	|O

The	|O
second	|O
part	|O
of	|O
this	|O
paper	|O
shows	|O
some	|O
medical	|O
applications	|O
of	|O
these	|O
two	|O
aspects	|O
of	|O
NMR	|O
,	|O
with	|O
help	|O
of	|O
some	|O
examples	|O
,	|O
taken	|O
from	|O
the	|O
literature	|O
,	|O
according	|O
to	|O
what	|O
is	|O
concerned	|O
with	|O
endocrinology	|O
.	|O

Interlimb	|O
coordination	|O
during	|O
fictive	|O
locomotion	|O
in	|O
the	|O
thalamic	|O
cat	|O
.	|O

Antileukoproteinase	|B-PROTEIN
(	|O
ALP	|B-PROTEIN
)	|O
is	|O
a	|O
low	|O
mol	|O
wt	|O
mucosal	|O
secretory	|O
protein	|O
which	|O
,	|O
in	|O
human	|O
tissues	|O
,	|O
inhibits	|O
the	|O
activities	|O
of	|O
the	|O
neutral	|O
serine	|B-PROTEIN
lysosomal	|I-PROTEIN
proteinases	|I-PROTEIN
elastase	|O
and	|O
cathepsin	|B-PROTEIN
-	|I-PROTEIN
G.	|I-PROTEIN

By	|O
introducing	|O
a	|O
series	|O
of	|O
deletions	|O
in	|O
the	|O
vimentin	|B-PROTEIN
promoter	|O
,	|O
we	|O
further	|O
restrict	|O
these	|O
sequences	|O
to	|O
30	|O
base	|O
pairs	|O
,	|O
located	|O
between	|O
241	|O
and	|O
210	|O
base	|O
pairs	|O
upstream	|O
of	|O
the	|O
mRNA	|O
cap	|O
site	|O
.	|O

In	|O
particular	|O
,	|O
71	|O
and	|O
69%	|O
amino	|O
acid	|O
sequence	|O
similarities	|O
were	|O
identified	|O
with	|O
hsp70	|B-PROTEIN
of	|O
Escherichia	|O
coli	|O
and	|O
Bacillus	|O
megaterium	|O
,	|O
respectively	|O
.	|O

No	|O
causal	|O
relations	|O
may	|O
be	|O
inferred	|O
from	|O
the	|O
correlation	|O
between	|O
the	|O
level	|O
of	|O
trapezius	|O
activity	|O
and	|O
complaints	|O
,	|O
though	|O
it	|O
indicates	|O
that	|O
individual	|O
,	|O
inexpedient	|O
muscle	|O
activity	|O
patterns	|O
may	|O
constitute	|O
an	|O
important	|O
risk	|O
factor	|O
for	|O
development	|O
of	|O
musculo	|O
-	|O
skeletal	|O
complaints	|O
.	|O

All	|O
89	|O
participating	|O
household	|O
members	|O
were	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HIV	|I-PROTEIN
seronegative	|O
,	|O
and	|O
78	|O
who	|O
were	|O
tested	|O
were	|O
serum	|O
p24	|B-PROTEIN
antigen	|O
negative	|O
.	|O

Analysis	|O
with	|O
additional	|O
anti	|O
-	|O
peptide	|O
antibodies	|O
specific	|O
for	|O
alpha	|O
,	|O
beta	|O
,	|O
or	|O
gamma	|O
PKC	|B-PROTEIN
indicated	|O
that	|O
all	|O
three	|O
types	|O
of	|O
PKC	|B-PROTEIN
are	|O
expressed	|O
in	|O
JK	|O
cells	|O
;	|O
however	|O
,	|O
JKPE	|O
cells	|O
lost	|O
a	|O
major	|O
approximately	|O
82	|O
kDa	|O
immunoreactive	|O
cytosolic	|O
protein	|O
detectable	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
PKC	|I-PROTEIN
alpha	|O
antibody	|O
.	|O

To	|O
those	|O
of	|O
us	|O
who	|O
are	|O
not	|O
satisfied	|O
with	|O
the	|O
present	|O
outlook	|O
there	|O
is	|O
much	|O
to	|O
be	|O
investigated	|O
and	|O
much	|O
to	|O
be	|O
contributed	|O
.	|O

To	|O
determine	|O
the	|O
effects	|O
on	|O
the	|O
pulmonary	|O
barrier	|O
of	|O
several	|O
surface	|O
active	|O
agents	|O
,	|O
a	|O
series	|O
of	|O
metered	|O
dose	|O
inhalers	|O
(	|O
MDIs	|O
)	|O
was	|O
prepared	|O
and	|O
used	|O
to	|O
dose	|O
aerosolized	|O
surfactant	|O
to	|O
the	|O
airways	|O
of	|O
isolated	|O
perfused	|O
rat	|O
lungs	|O
.	|O

The	|O
beta	|O
chain	|O
contains	|O
five	|O
potential	|O
N	|O
-	|O
linked	|O
glycosylation	|O
sites	|O
,	|O
and	|O
endoglycosidase	|B-PROTEIN
digestion	|O
suggested	|O
that	|O
the	|O
beta	|O
chain	|O
contained	|O
multiple	|O
complex	|O
carbohydrate	|O
side	|O
chains	|O
.	|O

The	|O
therapeutic	|O
protocole	|O
used	|O
at	|O
the	|O
Gustave	|O
Roussy	|O
Institute	|O
for	|O
invasive	|O
epithelioma	|O
of	|O
the	|O
uterine	|O
cervix	|O
rests	|O
,	|O
for	|O
limited	|O
forms	|O
(	|O
T1B	|O
-	|O
T2	|O
proximal	|O
)	|O
,	|O
on	|O
combined	|O
radiology	|O
and	|O
surgery	|O
.	|O

Thyrotropin	|B-PROTEIN
-	|O
induced	|O
expression	|O
of	|O
a	|O
gene	|O
for	|O
a	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
related	|O
to	|O
the	|O
trk	|B-PROTEIN
oncogene	|O
.	|O

The	|O
introns	|O
are	|O
1.6-1.9	|O
kbp	|O
long	|O
.	|O

After	|O
an	|O
initial	|O
titration	|O
period	|O
and	|O
adjustment	|O
of	|O
the	|O
therapeutic	|O
dose	|O
,	|O
the	|O
individual	|O
doses	|O
were	|O
from	|O
21	|O
to	|O
500	|O
micrograms	|O
/	|O
24	|O
hrs	|O
(	|O
mean	|O
160	|O
micrograms	|O
/	|O
24	|O
hrs	|O
)	|O
.	|O

In	|O
the	|O
first	|O
series	|O
of	|O
experiments	|O
,	|O
Sprague	|O
-	|O
Dawley	|O
male	|O
rats	|O
were	|O
implanted	|O
unilaterally	|O
with	|O
guide	|O
cannulas	|O
aimed	|O
at	|O
the	|O
lateral	|O
ventricle	|O
.	|O

Use	|O
of	|O
Selenastrum	|O
capricornutum	|O
and	|O
Microfeast	|O
as	|O
food	|O
for	|O
Daphnia	|O
pulex	|O
.	|O

The	|O
persistence	|O
of	|O
members	|O
of	|O
the	|O
prostigmatid	|O
families	|O
Tydeidae	|O
,	|O
Nanorchestidae	|O
and	|O
Tarsonemidae	|O
in	|O
the	|O
moisture	|O
-	|O
deficient	|O
90%	|O
-	|O
concentration	|O
treatments	|O
supports	|O
previous	|O
evidence	|O
of	|O
adaptations	|O
to	|O
low	|O
-	|O
water	|O
-	|O
content	|O
habitats	|O
.	|O

To	|O
define	|O
the	|O
mechanism	|O
responsible	|O
for	|O
the	|O
loss	|O
of	|O
transcription	|O
elongation	|O
blockage	|O
and	|O
resulting	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
deregulation	|O
in	|O
Burkitt	|O
's	|O
lymphoma	|O
,	|O
we	|O
analyzed	|O
transcription	|O
patterns	|O
after	|O
transfer	|O
of	|O
normal	|O
and	|O
Burkitt	|O
's	|O
lymphoma	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
alleles	|O
into	|O
murine	|O
cells	|O
and	|O
Xenopus	|O
oocyte	|O
germinal	|O
vesicles	|O
.	|O

Erythrocyte	|O
protoporphyrin	|O
concentration	|O
increased	|O
significantly	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
by	|O
14	|O
days	|O
in	|O
dogs	|O
fed	|O
the	|O
basal	|O
diet	|O
,	|O
and	|O
remained	|O
significantly	|O
high	|O
relative	|O
to	|O
that	|O
in	|O
dogs	|O
of	|O
the	|O
other	|O
dietary	|O
groups	|O
for	|O
the	|O
remainder	|O
of	|O
the	|O
study	|O
.	|O

The	|O
coding	|O
sequences	|O
of	|O
the	|O
Crry	|B-PROTEIN
gene	|O
encompass	|O
over	|O
25	|O
kb	|O
of	|O
DNA	|O
,	|O
whereas	|O
the	|O
Crry	|B-PROTEIN
-	|O
ps	|B-PROTEIN
sequences	|O
are	|O
included	|O
within	|O
a	|O
single	|O
5.6	|O
-	|O
kb	|O
Eco	|B-PROTEIN
-	|I-PROTEIN
R1	|I-PROTEIN
fragment	|O
.	|O

The	|O
genomic	|O
and	|O
transcriptional	|O
complexity	|O
of	|O
the	|O
Crry	|B-PROTEIN
and	|O
Crry	|B-PROTEIN
-	|O
ps	|B-PROTEIN
genes	|O
.	|O

From	|O
an	|O
RNK	|O
-	|O
16	|O
lambda	|O
-	|O
gt11	|O
library	|O
,	|O
we	|O
have	|O
isolated	|O
and	|O
sequenced	|O
a	|O
novel	|O
cDNA	|O
rat	|O
NK	|B-PROTEIN
cell	|I-PROTEIN
protease	|I-PROTEIN
1	|I-PROTEIN
(	|O
RNKP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
that	|O
has	|O
characteristics	|O
unique	|O
to	|O
serine	|B-PROTEIN
proteases	|I-PROTEIN
.	|O

The	|O
induction	|O
of	|O
RNKP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
in	|O
the	|O
Con	|B-PROTEIN
A	|I-PROTEIN
-	|O
cultured	|O
spleen	|O
cells	|O
is	|O
accompanied	|O
by	|O
increases	|O
in	|O
both	|O
NK	|O
and	|O
lymphokine	|O
-	|O
activated	|O
killer	|O
lymphocyte	|O
activities	|O
.	|O

The	|O
paper	|O
is	|O
concerned	|O
with	|O
the	|O
data	|O
on	|O
change	|O
in	|O
the	|O
blood	|O
level	|O
of	|O
ACTH	|B-PROTEIN
,	|O
STH	|B-PROTEIN
,	|O
TSH	|B-PROTEIN
,	|O
cortisol	|O
,	|O
T3	|O
,	|O
insulin	|B-PROTEIN
,	|O
C	|B-PROTEIN
-	|I-PROTEIN
peptide	|I-PROTEIN
during	|O
a	|O
25	|O
-	|O
minute	|O
session	|O
of	|O
respiration	|O
using	|O
a	|O
gaseous	|O
hypoxic	|O
mixture	|O
with	|O
10%	|O
oxygen	|O
(	|O
GHM	|O
-	|O
10	|O
)	|O
.	|O

The	|O
abscess	|O
was	|O
debrided	|O
and	|O
the	|O
septum	|O
was	|O
patched	|O
with	|O
a	|O
single	|O
layer	|O
of	|O
autologous	|O
pericardium	|O
.	|O

In	|O
18%	|O
lymphography	|O
was	|O
clearly	|O
positive	|O
and	|O
CT	|O
negative	|O
.	|O

The	|O
present	|O
study	|O
examined	|O
the	|O
effect	|O
of	|O
intensity	|O
,	|O
rate	|O
,	|O
and	|O
polarity	|O
on	|O
the	|O
spectral	|O
content	|O
of	|O
ABRs	|O
of	|O
15	|O
normal	|O
-	|O
hearing	|O
subjects	|O
.	|O

Similar	|O
memory	|O
impairments	|O
found	|O
in	|O
medial	|O
septal	|O
-	|O
vertical	|O
diagonal	|O
band	|O
of	|O
Broca	|O
and	|O
nucleus	|O
basalis	|O
lesioned	|O
rats	|O
:	|O
are	|O
memory	|O
defects	|O
induced	|O
by	|O
nucleus	|O
basalis	|O
lesions	|O
related	|O
to	|O
the	|O
degree	|O
of	|O
non	|O
-	|O
specific	|O
subcortical	|O
cell	|O
loss	|O
?	|O
The	|O
function	|O
of	|O
nucleus	|O
basalis	|O
(	|O
NB	|O
)	|O
and	|O
medial	|O
septal	|O
-	|O
vertical	|O
diagonal	|O
band	|O
of	|O
Broca	|O
(	|O
MS	|O
-	|O
VDBB	|O
)	|O
in	|O
a	|O
place	|O
navigation	|O
task	|O
requiring	|O
reference	|O
memory	|O
was	|O
investigated	|O
.	|O

Studies	|O
also	|O
have	|O
alluded	|O
to	|O
a	|O
relationship	|O
between	|O
the	|O
MSMR	|O
cyst	|O
and	|O
certain	|O
signs	|O
or	|O
symptoms	|O
of	|O
disease	|O
.	|O

The	|O
BAL	|O
-	|O
to	|O
-	|O
plasma	|O
specific	|O
activity	|O
of	|O
urea	|O
was	|O
about	|O
twice	|O
that	|O
of	|O
Na+	|O
,	|O
indicating	|O
that	|O
urea	|O
diffused	|O
into	|O
the	|O
ELF	|O
more	|O
rapidly	|O
than	|O
Na+	|O
during	|O
the	|O
70	|O
s	|O
that	|O
elapsed	|O
between	|O
the	|O
time	|O
the	|O
radioactive	|O
urea	|O
and	|O
Na+	|O
were	|O
injected	|O
into	|O
the	|O
circulation	|O
and	|O
the	|O
time	|O
when	|O
lavage	|O
was	|O
complete	|O
.	|O

The	|O
kappa	|O
coefficient	|O
of	|O
agreement	|O
between	|O
the	|O
Patho	|O
Dx	|O
Kit	|O
and	|O
the	|O
standard	|O
method	|O
was	|O
0.958	|O
.	|O

Senior	|O
systems	|O
-	|O
-	|O
45	|O
;	|O
Mental	|O
health	|O
and	|O
illness	|O
in	|O
old	|O
age	|O
-	|O
-	|O
3	|O
.	|O

When	|O
normalized	|O
for	|O
imaging	|O
time	|O
,	|O
all	|O
parameters	|O
are	|O
significantly	|O
higher	|O
with	|O
RASE	|O
,	|O
with	|O
a	|O
C	|O
/	|O
A	|O
per	|O
unit	|O
time	|O
that	|O
was	|O
338%	|O
higher	|O
.	|O

Patients	|O
with	|O
acute	|O
myocardial	|O
infarction	|O
had	|O
higher	|O
plasma	|O
concentrations	|O
of	|O
neutrophil	|O
elastase	|B-PROTEIN
and	|O
the	|O
non	|O
-	|O
peroxide	|O
diene	|O
conjugated	|O
isomer	|O
of	|O
linoleic	|O
acid	|O
than	|O
normal	|O
volunteers	|O
or	|O
patients	|O
with	|O
stable	|O
ischaemic	|O
heart	|O
disease	|O
.	|O

Determination	|O
of	|O
three	|O
-	|O
dimensional	|O
imaging	|O
properties	|O
of	|O
a	|O
light	|O
microscope	|O
system	|O
.	|O

The	|O
cis	|O
-	|O
acting	|O
element	|O
,	|O
identified	|O
as	|O
CACGTGACCCG	|O
,	|O
is	|O
located	|O
34	|O
bp	|O
upstream	|O
from	|O
the	|O
transcription	|O
initiation	|O
site	|O
,	|O
and	|O
contains	|O
the	|O
core	|O
sequence	|O
of	|O
the	|O
upstream	|O
promoter	|O
sequence	|O
of	|O
Ad2MLP	|B-PROTEIN
.	|O

The	|O
clinical	|O
relevance	|O
of	|O
these	|O
findings	|O
is	|O
strengthened	|O
by	|O
the	|O
observation	|O
that	|O
similar	|O
results	|O
were	|O
obtained	|O
when	|O
P.H	|O
Cl	|O
was	|O
given	|O
by	|O
the	|O
intravenous	|O
route	|O
.	|O

TMBr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
identical	|O
to	|O
striated	|O
muscle	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
tropomyosin	|I-PROTEIN
from	|O
amino	|O
acids	|O
1	|O
through	|O
258	|O
but	|O
contains	|O
a	|O
novel	|O
COOH	|O
-	|O
terminal	|O
region	|O
from	|O
amino	|O
acids	|O
259	|O
through	|O
281	|O
.	|O

The	|O
procedure	|O
has	|O
been	|O
applied	|O
to	|O
three	|O
materials	|O
:	|O
particle	|O
board	|O
with	|O
carpet	|O
;	|O
gypsum	|O
board	|O
with	|O
wallpaper	|O
;	|O
and	|O
plywood	|O
with	|O
polyurethane	|O
lacquer	|O
,	|O
for	|O
which	|O
the	|O
steady	|O
-	|O
state	|O
emission	|O
factors	|O
(	|O
mg	|O
m	|O
-	|O
2	|O
h	|O
-	|O
1	|O
)	|O
of	|O
several	|O
compounds	|O
are	|O
given	|O
.	|O

Intron	|O
1	|O
is	|O
6.5	|O
kb	|O
long	|O
,	|O
and	|O
the	|O
minimal	|O
sizes	|O
of	|O
introns	|O
2	|O
and	|O
3	|O
are	|O
estimated	|O
to	|O
be	|O
32	|O
kb	|O
each	|O
.	|O

After	|O
4	|O
h	|O
,	|O
lesions	|O
in	|O
the	|O
secretory	|O
part	|O
of	|O
the	|O
stomach	|O
were	|O
scored	|O
and	|O
mucosal	|O
prostaglandin	|O
E2	|O
synthesis	|O
was	|O
determined	|O
by	|O
the	|O
ex	|O
vivo	|O
prostaglandin	|O
generation	|O
technique	|O
.	|O

Comparison	|O
of	|O
transmembrane	|O
and	|O
cytoplasmic	|O
domains	|O
to	|O
a	|O
third	|O
cell	|O
-	|O
surface	|O
proteoglycan	|O
,	|O
48K5	|B-PROTEIN
from	|O
human	|O
lung	|O
fibroblasts	|O
(	|O
Marynen	|O
,	|O
P.	|O
,	|O
Zhang	|O
,	|O
J.	|O
,	|O
Cassiman	|O
,	|O
J.	|O
,	|O
Vanden	|O
Berghe	|O
,	|O
H.	|O
,	|O
and	|O
David	|O
,	|O
C.	|O

Approximately	|O
65%	|O
of	|O
the	|O
total	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
phosphotransferase	|I-PROTEIN
activity	|O
is	|O
recovered	|O
in	|O
particulate	|O
fractions	|O
of	|O
homogenates	|O
prepared	|O
from	|O
asynchronous	|O
populations	|O
of	|O
C.	|O
elegans	|O
.	|O

High	|O
levels	|O
of	|O
C	|B-PROTEIN
subunits	|I-PROTEIN
are	|O
observed	|O
in	|O
several	|O
subsequent	|O
larval	|O
and	|O
adult	|O
stages	|O
of	|O
development	|O
.	|O

A	|O
second	|O
,	|O
novel	|O
C	|O
subunit	|O
(	|O
CeCAT	|B-PROTEIN
alpha	|I-PROTEIN
'	|I-PROTEIN
,	|O
374	|O
residues	|O
)	|O
has	|O
a	|O
unique	|O
56	|O
-	|O
residue	|O
carboxyl	|O
-	|O
terminal	|O
region	|O
that	|O
is	|O
generated	|O
by	|O
the	|O
alternative	|O
splicing	|O
of	|O
the	|O
C	|B-PROTEIN
pre	|O
-	|O
mRNA	|O
.	|O

The	|O
alternative	|O
exon	|O
introduces	|O
the	|O
novel	|O
carboxyl	|O
terminus	|O
and	|O
a	|O
new	|O
translation	|O
stop	|O
signal	|O
,	|O
while	|O
simultaneously	|O
converting	|O
the	|O
coding	|O
sequence	|O
for	|O
40	|O
carboxyl	|O
-	|O
terminal	|O
residues	|O
in	|O
CeCAT	|B-PROTEIN
alpha	|I-PROTEIN
into	|O
3'	|O
-	|O
untranslated	|O
nucleotides	|O
.	|O

French	|O
,	|O
M.	|O

Slowly	|O
adapting	|O
type	|O
I	|O
mechanoreceptor	|O
discharge	|O
as	|O
a	|O
function	|O
of	|O
dynamic	|O
force	|O
versus	|O
dynamic	|O
displacement	|O
of	|O
glabrous	|O
skin	|O
of	|O
raccoon	|O
and	|O
squirrel	|O
monkey	|O
hand	|O
.	|O

Methods	|O
used	|O
include	|O
Cobb	|O
angle	|O
and	|O
a	|O
segmental	|O
evaluation	|O
(	|O
T7	|O
-	|O
T12	|O
)	|O
of	|O
each	|O
of	|O
convex	|O
and	|O
concave	|O
rib	|O
-	|O
vertebra	|O
angles	|O
(	|O
RVAs	|O
)	|O
,	|O
rib	|O
-	|O
vertebra	|O
angle	|O
differences	|O
(	|O
RVADs	|O
)	|O
,	|O
vertebral	|O
rotation	|O
,	|O
tilt	|O
and	|O
displacement	|O
.	|O

Plasma	|O
lecithin	|B-PROTEIN
/	|I-PROTEIN
cholesterol	|I-PROTEIN
acyltransferase	|I-PROTEIN
(	|O
LCAT	|B-PROTEIN
)	|O
activity	|O
in	|O
multiple	|O
-	|O
organ	|O
donors	|O
:	|O
a	|O
predictor	|O
of	|O
allograft	|O
viability	|O
in	|O
clinical	|O
liver	|O
transplantation	|O
.	|O

Lars	|O
has	|O
AIDS	|O
-	|O
-	|O
a	|O
more	|O
dignified	|O
life	|O
with	|O
care	|O
at	|O
home	|O
.	|O

Axillary	|O
nodal	|O
status	|O
,	|O
tumour	|O
progesterone	|B-PROTEIN
receptor	|I-PROTEIN
status	|O
,	|O
and	|O
season	|O
of	|O
tumour	|O
detection	|O
significantly	|O
influenced	|O
survival	|O
in	|O
both	|O
older	|O
(	|O
greater	|O
than	|O
50	|O
yrs	|O
)	|O
and	|O
younger	|O
(	|O
less	|O
than	|O
50	|O
yrs	|O
)	|O
patients	|O
.	|O

The	|O
application	|O
of	|O
these	|O
microelectrodes	|O
to	|O
the	|O
measurement	|O
of	|O
rapid	|O
,	|O
transient	|O
changes	|O
in	|O
retinal	|O
[	|O
K+	|O
]	|O
o	|O
is	|O
presented	|O
.	|O

Expression	|O
,	|O
cellular	|O
localization	|O
and	|O
in	|O
vitro	|O
transcription	|O
studies	|O
establish	|O
that	|O
cloned	|O
hUBF	|B-PROTEIN
encodes	|O
a	|O
nucleolar	|O
factor	|O
that	|O
binds	|O
specifically	|O
to	|O
the	|O
upstream	|O
control	|O
element	|O
and	|O
core	|O
of	|O
the	|O
rRNA	|O
gene	|O
promoter	|O
to	|O
activate	|O
transcription	|O
in	|O
a	|O
binding	|O
site	|O
-	|O
dependent	|O
manner	|O
.	|O

Combining	|O
multiple	|O
laboratory	|O
studies	|O
may	|O
be	|O
of	|O
value	|O
in	|O
predetermining	|O
the	|O
eventual	|O
outcome	|O
in	|O
near	|O
-	|O
drowning	|O
.	|O

Accumulations	|O
of	|O
Tl+	|O
1	|O
(	|O
202Tl	|O
label	|O
)	|O
were	|O
6	|O
times	|O
those	|O
for	|O
Ga	|O
or	|O
In	|O
in	|O
the	|O
brain	|O
and	|O
muscles	|O
,	|O
and	|O
.1	|O
times	|O
in	|O
plasma	|O
.	|O

There	|O
was	|O
a	|O
gradual	|O
increase	|O
in	|O
the	|O
myocyte	|O
diameter	|O
according	|O
to	|O
age	|O
in	|O
the	|O
biopsy	|O
and	|O
autopsy	|O
specimens	|O
.	|O

Despite	|O
the	|O
absence	|O
of	|O
exercise	|O
-	|O
induced	|O
asthma	|O
(	|O
EIA	|O
)	|O
while	|O
breathing	|O
WH	|O
air	|O
,	|O
asthmatic	|O
patients	|O
still	|O
had	|O
significantly	|O
higher	|O
mean	|O
GH	|O
increments	|O
than	|O
normal	|O
subjects	|O
(	|O
9.2	|O
vs	|O
2.3	|O
ng	|O
/	|O
ml	|O
,	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

The	|O
afferents	|O
'	|O
phase	|O
of	|O
response	|O
was	|O
unmodified	|O
by	|O
electrical	|O
EVS	|O
stimulation	|O
.	|O

Solving	|O
an	|O
age	|O
old	|O
problem	|O
.	|O

The	|O
distribution	|O
of	|O
their	|O
fibrinogen	|B-PROTEIN
levels	|O
was	|O
Gaussian	|O
,	|O
but	|O
more	|O
wide	|O
-	|O
based	|O
than	|O
the	|O
distribution	|O
of	|O
our	|O
normal	|O
controls	|O
.	|O

In	|O
a	|O
stepwise	|O
logistic	|O
regression	|O
analysis	|O
of	|O
SPT	|O
and	|O
RAST	|O
data	|O
,	|O
the	|O
occurrence	|O
of	|O
serum	|O
IgE	|B-PROTEIN
antibodies	|O
to	|O
P.	|O
orbiculare	|O
had	|O
the	|O
highest	|O
explanatory	|O
value	|O
for	|O
current	|O
eczema	|O
.	|O

The	|O
examination	|O
was	|O
focused	|O
on	|O
assessment	|O
of	|O
different	|O
types	|O
of	|O
drusen	|O
,	|O
on	|O
evaluation	|O
of	|O
the	|O
development	|O
and	|O
incidence	|O
of	|O
risk	|O
factors	|O
leading	|O
to	|O
complications	|O
and	|O
loss	|O
of	|O
central	|O
vision	|O
.	|O

They	|O
were	|O
then	|O
subjected	|O
to	|O
whole	|O
-	|O
body	|O
heat	|O
stress	|O
(	|O
water	|O
-	|O
perfused	|O
suits	|O
)	|O
,	|O
and	|O
the	|O
3	|O
minutes	|O
of	|O
LBNP	|O
was	|O
repeated	|O
.	|O

An	|O
NF1	|B-PROTEIN
-	|O
related	|O
vitellogenin	|B-PROTEIN
activator	|O
element	|O
mediates	|O
transcription	|O
from	|O
the	|O
estrogen	|O
-	|O
regulated	|O
Xenopus	|O
laevis	|O
vitellogenin	|B-PROTEIN
promoter	|O
.	|O

A	|O
poor	|O
correlation	|O
was	|O
also	|O
observed	|O
between	|O
PbB	|O
and	|O
ALAD	|B-PROTEIN
activity	|O
of	|O
the	|O
stearate	|O
workers	|O
.	|O

At	|O
the	|O
carboxyl	|O
terminus	|O
,	|O
deletion	|O
as	|O
far	|O
as	|O
residue	|O
388	|O
did	|O
not	|O
affect	|O
in	|O
vitro	|O
TRF.C	|B-PROTEIN
assembly	|O
,	|O
although	|O
trans	|O
-	|O
activating	|O
activity	|O
was	|O
abolished	|O
.	|O

The	|O
effects	|O
of	|O
mean	|O
luminance	|O
were	|O
also	|O
measured	|O
and	|O
a	|O
general	|O
expression	|O
that	|O
would	|O
take	|O
them	|O
into	|O
account	|O
was	|O
derived	|O
.	|O

Effect	|O
of	|O
hyperglycemia	|O
on	|O
pain	|O
threshold	|O
in	|O
alloxan	|O
-	|O
diabetic	|O
rats	|O
.	|O

We	|O
have	|O
synthesized	|O
[	|O
7,7-2	|O
H2	|O
]	|O
-	|O
19	|O
-	|O
OHA	|O
with	|O
high	|O
deuterium	|O
content	|O
and	|O
,	|O
together	|O
with	|O
[	|O
7,7-2	|O
H2	|O
]	|O
A	|O
and	|O
[	|O
9,11-2	|O
H2	|O
]	|O
estrone	|O
(	|O
E1	|O
)	|O
,	|O
have	|O
developed	|O
a	|O
quantitative	|O
assay	|O
of	|O
serum	|O
level	|O
19	|O
-	|O
OHA	|O
,	|O
A	|O
,	|O
and	|O
E1	|O
using	|O
the	|O
gas	|O
chromatography	|O
/	|O
mass	|O
spectrometry	|O
-	|O
mass	|O
fragmentography	|O
method	|O
to	|O
monitor	|O
individual	|O
subjects	|O
throughout	|O
pregnancy	|O
.	|O

Sequence	|O
analysis	|O
of	|O
these	|O
genes	|O
and	|O
their	|O
surrounding	|O
sequences	|O
are	|O
presented	|O
and	|O
compared	|O
with	|O
other	|O
known	|O
tRNA	|O
genes	|O
from	|O
plant	|O
mitochondria	|O
.	|O

Experiments	|O
were	|O
performed	|O
in	|O
which	|O
brain	|O
-	|O
stem	|O
auditory	|O
-	|O
evoked	|O
responses	|O
(	|O
BAERs	|O
)	|O
were	|O
elicited	|O
by	|O
two	|O
types	|O
of	|O
pseudorandom	|O
pulse	|O
trains	|O
:	|O
maximum	|O
length	|O
sequences	|O
(	|O
MLS	|O
)	|O
and	|O
Legendre	|O
sequences	|O
(	|O
LGS	|O
)	|O
.	|O

Since	|O
the	|O
UfAP	|B-PROTEIN
and	|O
UTMP	|B-PROTEIN
share	|O
many	|O
biosynthetic	|O
and	|O
structural	|O
features	|O
that	|O
include	|O
site	|O
of	|O
biosynthesis	|O
in	|O
the	|O
endometrium	|O
,	|O
P4	|O
-	|O
responsiveness	|O
,	|O
the	|O
presence	|O
of	|O
the	|O
mannose	|B-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
lysosomal	|I-PROTEIN
recognition	|I-PROTEIN
marker	|I-PROTEIN
,	|O
and	|O
considerable	|O
sequence	|O
similarity	|O
,	|O
the	|O
UfAP	|B-PROTEIN
and	|O
the	|O
UTMP	|B-PROTEIN
may	|O
have	|O
homologous	|O
function	|O
which	|O
for	|O
both	|O
still	|O
remains	|O
obscure	|O
.	|O

Fifteen	|O
light	|O
for	|O
dates	|O
infants	|O
and	|O
their	|O
placentae	|O
were	|O
compared	|O
to	|O
15	|O
well	|O
-	|O
grown	|O
infants	|O
and	|O
their	|O
placentae	|O
.	|O

Treating	|O
renal	|O
anaemia	|O
with	|O
recombinant	|O
human	|O
erythropoietin	|B-PROTEIN
.	|O

The	|O
pseudolymphoma	|O
syndrome	|O
is	|O
a	|O
reversible	|O
reactive	|O
condition	|O
consisting	|O
of	|O
fever	|O
,	|O
lymphadenopathy	|O
and	|O
generalized	|O
rash	|O
.	|O

In	|O
the	|O
local	|O
geomagnetic	|O
field	|O
,	|O
the	|O
animals	|O
preferred	|O
the	|O
SE	|O
-	|O
sector	|O
.	|O

In	|O
the	|O
artificial	|O
lung	|O
,	|O
like	|O
in	|O
the	|O
natural	|O
lung	|O
and	|O
peripheral	|O
tissues	|O
,	|O
gas	|O
exchanges	|O
depend	|O
on	|O
several	|O
parameters	|O
:	|O
blood	|O
inlet	|O
conditions	|O
,	|O
blood	|O
flow	|O
rate	|O
,	|O
temperature	|O
,	|O
composition	|O
of	|O
the	|O
gas	|O
mixture	|O
used	|O
for	|O
ventilation	|O
,	|O
blood	|O
tissue	|O
perfusion	|O
,	|O
O2	|O
consumption	|O
,	|O
etc	|O
.	|O

Mean	|O
(	|O
+	|O
/	|O
-	|O
SE	|O
)	|O
measurements	|O
of	|O
clearance	|O
(	|O
24.5	|O
+	|O
/	|O
-	|O
2.06	|O
v	|O
26.5	|O
+	|O
/	|O
-	|O
2.05	|O
mL	|O
/	|O
min	|O
/	|O
m2	|O
)	|O
,	|O
half	|O
-	|O
life	|O
(	|O
5.7	|O
+	|O
/	|O
-	|O
0.5	|O
v	|O
6.4	|O
+	|O
/	|O
-	|O
0.5	|O
hours	|O
)	|O
,	|O
and	|O
volume	|O
of	|O
distribution	|O
(	|O
12.4	|O
+	|O
/	|O
-	|O
1.1	|O
v	|O
13.7	|O
+	|O
/	|O
-	|O
1.6	|O
L	|O
/	|O
m2	|O
)	|O
were	|O
not	|O
significantly	|O
different	|O
in	|O
patients	|O
with	|O
jaundice	|O
when	|O
compared	|O
with	|O
controls	|O
.	|O

Attitudes	|O
were	|O
found	|O
to	|O
be	|O
multidimensional	|O
,	|O
with	|O
similar	|O
dimensions	|O
being	|O
identified	|O
in	|O
both	|O
samples	|O
.	|O

We	|O
conclude	|O
that	|O
DNA	|O
ploidy	|O
is	|O
a	|O
major	|O
objective	|O
prognostic	|O
factor	|O
and	|O
therapeutic	|O
determinant	|O
for	|O
endometrial	|O
carcinoma	|O
.	|O

A	|O
semiautomatic	|O
digital	|O
system	|O
(	|O
Videoplan	|O
2	|O
)	|O
was	|O
used	|O
.	|O

Environmental	|O
factors	|O
were	|O
more	|O
important	|O
in	|O
the	|O
older	|O
cohorts	|O
(	|O
perhaps	|O
because	|O
of	|O
less	|O
reliable	|O
recall	|O
)	|O
.	|O

Dopamine	|O
SERS	|O
spectra	|O
from	|O
these	|O
electrodes	|O
are	|O
similar	|O
to	|O
those	|O
obtained	|O
at	|O
uncoated	|O
electrodes	|O
.	|O

These	|O
findings	|O
indicate	|O
that	|O
hypergastrinemia	|O
induced	|O
by	|O
surgical	|O
removal	|O
of	|O
acid	|O
-	|O
producing	|O
mucosa	|O
in	|O
the	|O
rat	|O
has	|O
the	|O
same	|O
effects	|O
on	|O
oxyntical	|O
mucosal	|O
HDC	|B-PROTEIN
activity	|O
,	|O
histamine	|O
concentration	|O
and	|O
ECL	|O
cell	|O
density	|O
as	|O
hypergastrinemia	|O
induced	|O
by	|O
continuous	|O
gastrin	|B-PROTEIN
infusion	|O
or	|O
by	|O
long	|O
-	|O
term	|O
treatment	|O
with	|O
effective	|O
antisecretagogues	|O
.	|O

Basing	|O
on	|O
experimental	|O
toxicity	|O
research	|O
it	|O
was	|O
established	|O
that	|O
,	|O
out	|O
of	|O
50	|O
atmosphere	|O
metal	|O
corrosion	|O
inhibitors	|O
,	|O
some	|O
14	|O
per	|O
cent	|O
were	|O
found	|O
extremely	|O
hazardous	|O
,	|O
42	|O
per	|O
cent	|O
-	|O
-	|O
of	|O
high	|O
level	|O
hazardous	|O
,	|O
33	|O
percent	|O
-	|O
-	|O
of	|O
moderate	|O
and	|O
11	|O
per	|O
cent	|O
-	|O
-	|O
of	|O
low	|O
hazardous	|O
.	|O

The	|O
order	|O
of	|O
the	|O
helicase	|B-PROTEIN
motif	|O
and	|O
the	|O
nsP3	|B-PROTEIN
homology	|O
region	|O
in	|O
the	|O
RUB	|O
genome	|O
is	|O
reversed	|O
with	|O
respect	|O
to	|O
the	|O
alphavirus	|O
genome	|O
indicating	|O
that	|O
a	|O
genetic	|O
rearrangement	|O
has	|O
occurred	|O
during	|O
the	|O
evolution	|O
of	|O
these	|O
viruses	|O
.	|O

The	|O
results	|O
suggest	|O
followings	|O
-	|O
-	|O
1	|O
)	|O
both	|O
eosinophils	|O
and	|O
neutrophils	|O
participate	|O
in	|O
hypersecretion	|O
of	|O
type	|O
Ib	|O
in	|O
atopic	|O
cases	|O
,	|O
and	|O
only	|O
eosinophils	|O
in	|O
non	|O
-	|O
atopic	|O
cases	|O
.	|O

There	|O
were	|O
5	|O
treatments	|O
:	|O
control	|O
(	|O
C	|O
)	|O
;	|O
a	|O
wooden	|O
surround	|O
in	|O
one	|O
rear	|O
corner	|O
of	|O
the	|O
cage	|O
(	|O
S	|O
)	|O
;	|O
a	|O
fiberglass	|O
rollaway	|O
hollow	|O
in	|O
one	|O
rear	|O
corner	|O
of	|O
the	|O
cage	|O
(	|O
H	|O
)	|O
;	|O
a	|O
hollow	|O
and	|O
a	|O
surround	|O
(	|O
H	|O
/	|O
S	|O
)	|O
;	|O
a	|O
nest	|O
box	|O
attached	|O
to	|O
the	|O
back	|O
of	|O
the	|O
cage	|O
,	|O
containing	|O
a	|O
hollow	|O
(	|O
N	|O
)	|O
.	|O

While	|O
no	|O
significant	|O
differences	|O
in	|O
the	|O
tensile	|O
responses	|O
or	|O
failure	|O
characteristics	|O
were	|O
noted	|O
for	|O
irradiated	|O
and	|O
nonirradiated	|O
grafts	|O
in	|O
the	|O
drip	|O
,	|O
in	|O
the	|O
bath	|O
environment	|O
the	|O
nonirradiated	|O
tissues	|O
had	|O
greater	|O
strength	|O
and	|O
modulus	|O
.	|O

The	|O
patient	|O
was	|O
treated	|O
with	|O
benzathine	|O
penicillin	|O
,	|O
2,400,000	|O
U	|O
weekly	|O
for	|O
three	|O
weeks	|O
.	|O

A	|O
consensus	|O
binding	|O
site	|O
for	|O
the	|O
transcription	|O
factor	|O
SP1	|B-PROTEIN
was	|O
identified	|O
in	|O
intron	|O
As	|O
downstream	|O
of	|O
the	|O
proenkephalin	|B-PROTEIN
germ	|O
cell	|O
cap	|O
site	|O
region	|O
.	|O

This	|O
proposed	|O
method	|O
is	|O
similar	|O
in	|O
principle	|O
to	|O
the	|O
sets	|O
technique	|O
but	|O
is	|O
shown	|O
to	|O
have	|O
much	|O
better	|O
expected	|O
time	|O
to	|O
alarm	|O
properties	|O
.	|O

The	|O
effects	|O
on	|O
reflex	|O
latencies	|O
but	|O
not	|O
on	|O
paCO2	|O
or	|O
pHa	|O
were	|O
blocked	|O
by	|O
naloxone	|O
(	|O
2	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
and	|O
were	|O
not	|O
present	|O
in	|O
morphine	|O
-	|O
tolerant	|O
animals	|O
.	|O

Of	|O
the	|O
remaining	|O
seven	|O
,	|O
five	|O
reacted	|O
either	|O
with	|O
immediate	|O
and	|O
strong	|O
symptoms	|O
or	|O
had	|O
spontaneously	|O
reduced	|O
gluten	|B-PROTEIN
intake	|O
,	|O
or	|O
had	|O
an	|O
acquired	|O
IgA	|B-PROTEIN
deficiency	|O
.	|O

Drug	|O
and	|O
personnel	|O
costs	|O
were	|O
reduced	|O
when	|O
batch	|O
manufacturing	|O
with	|O
40	|O
-	|O
mL	|O
multidose	|O
vials	|O
was	|O
compared	|O
with	|O
extemporaneous	|O
compounding	|O
with	|O
unit	|O
-	|O
dose	|O
vials	|O
.	|O

Changes	|O
in	|O
prognosis	|O
of	|O
twin	|O
births	|O
over	|O
20	|O
years	|O
.	|O

Dermal	|O
toxicity	|O
and	|O
carcinogenicity	|O
of	|O
4	|O
-	|O
vinyl	|O
-	|O
1	|O
-	|O
cyclohexene	|O
diepoxide	|O
in	|O
Fischer	|O
rats	|O
and	|O
B6C3F1	|O
mice	|O
.	|O

Per	|O
kg	|O
FFM	|O
SMR	|O
was	|O
almost	|O
restored	|O
to	|O
baseline	|O
values	|O
for	|O
the	|O
EX	|O
group	|O
,	|O
whereas	|O
the	|O
non	|O
-	|O
exercising	|O
subjects	|O
still	|O
showed	|O
depressed	|O
values	|O
(	|O
EX	|O
3.7	|O
per	|O
cent	|O
and	|O
D	|O
+	|O
DE	|O
15.8	|O
per	|O
cent	|O
lower	|O
than	|O
before	|O
treatment	|O
;	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

MK	|O
-	|O
927	|O
:	|O
a	|O
topically	|O
active	|O
ocular	|O
hypotensive	|O
carbonic	|B-PROTEIN
anhydrase	|I-PROTEIN
inhibitor	|O
.	|O

PCR	|O
-	|O
derived	|O
fragments	|O
were	|O
used	|O
as	|O
probes	|O
for	|O
the	|O
isolation	|O
of	|O
the	|O
U3	|B-PROTEIN
snRNA	|O
genes	|O
from	|O
a	|O
genomic	|O
library	|O
of	|O
Arabidopsis	|O
.	|O

In	|O
addition	|O
serum	|O
IgE	|B-PROTEIN
concentrations	|O
were	|O
not	|O
statistically	|O
different	|O
.	|O

The	|O
findings	|O
suggest	|O
that	|O
,	|O
although	|O
iodine	|O
deficiency	|O
is	|O
the	|O
most	|O
probable	|O
cause	|O
of	|O
goiter	|O
among	|O
immigrants	|O
of	|O
the	|O
1928	|O
cohort	|O
,	|O
where	|O
the	|O
native	|O
population	|O
is	|O
concerned	|O
(	|O
both	|O
men	|O
and	|O
women	|O
)	|O
,	|O
some	|O
other	|O
goitrogenic	|O
factor	|O
(	|O
s	|O
)	|O
must	|O
be	|O
involved	|O
.	|O

The	|O
transcriptional	|O
unit	|O
spans	|O
a	|O
chromosomal	|O
region	|O
of	|O
about	|O
55	|O
kilobase	|O
pairs	|O
(	|O
kbp	|O
)	|O
.	|O

100	|O
of	|O
the	|O
patients	|O
who	|O
would	|O
have	|O
died	|O
survive	|O
.	|O

Co	|O
-	|O
administration	|O
of	|O
5FU	|O
,	|O
angiotensin	|B-PROTEIN
II	|I-PROTEIN
and	|O
microspheres	|O
via	|O
the	|O
hepatic	|O
artery	|O
may	|O
reduce	|O
drug	|O
exposure	|O
in	|O
the	|O
systemic	|O
compartment	|O
and	|O
therefore	|O
may	|O
increase	|O
the	|O
therapeutic	|O
ratio	|O
of	|O
5FU	|O
administration	|O
via	|O
the	|O
hepatic	|O
artery	|O
.	|O

The	|O
effects	|O
of	|O
tap	|O
(	|O
TW	|O
)	|O
or	|O
carbonated	|O
(	|O
CW	|O
)	|O
water	|O
on	|O
arterial	|O
pH	|O
,	|O
partial	|O
pressure	|O
of	|O
carbon	|O
dioxide	|O
(	|O
PCO2	|O
)	|O
and	|O
plasma	|O
lactate	|O
were	|O
determined	|O
in	|O
heat	|O
-	|O
stressed	|O
broilers	|O
.	|O

Transient	|O
expression	|O
of	|O
human	|O
and	|O
chicken	|O
progesterone	|B-PROTEIN
receptors	|I-PROTEIN
does	|O
not	|O
support	|O
alternative	|O
translational	|O
initiation	|O
from	|O
a	|O
single	|O
mRNA	|O
as	|O
the	|O
mechanism	|O
generating	|O
two	|O
receptor	|O
isoforms	|O
.	|O

In	|O
contrast	|O
,	|O
2,397	|O
(	|O
74%	|O
)	|O
had	|O
one	|O
or	|O
more	|O
risk	|O
factors	|O
(	|O
not	|O
low	|O
risk	|O
)	|O
;	|O
of	|O
these	|O
,	|O
5.3%	|O
died	|O
in	|O
6	|O
weeks	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

The	|O
Community	|O
Adjustment	|O
Scale	|O
provided	|O
outcome	|O
data	|O
related	|O
to	|O
the	|O
subjects	|O
'	|O
degree	|O
of	|O
productivity	|O
,	|O
ability	|O
to	|O
maintain	|O
close	|O
relationships	|O
,	|O
and	|O
presence	|O
/	|O
absence	|O
of	|O
symptomatology	|O
an	|O
average	|O
of	|O
32	|O
years	|O
after	|O
initial	|O
admission	|O
.	|O

However	|O
,	|O
at	|O
18	|O
months	|O
of	|O
age	|O
,	|O
significantly	|O
higher	|O
levels	|O
of	|O
IgG1	|B-PROTEIN
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
and	|O
of	|O
IgG4	|B-PROTEIN
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
were	|O
found	|O
in	|O
infants	|O
with	|O
an	|O
elevated	|O
IgE	|B-PROTEIN
(	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
8.0	|O
kU	|O
/	|O
l	|O
)	|O
than	|O
in	|O
those	|O
with	|O
a	|O
lower	|O
level	|O
.	|O

The	|O
protein	|O
sequence	|O
contains	|O
seven	|O
potential	|O
N	|O
-	|O
linked	|O
glycosylation	|O
sites	|O
and	|O
a	|O
threonine	|O
/	|O
serine	|O
-	|O
rich	|O
region	|O
which	|O
is	|O
a	|O
potential	|O
site	|O
for	|O
attachment	|O
of	|O
O	|O
-	|O
linked	|O
carbohydrate	|O
.	|O

Thus	|O
adaptation	|O
to	|O
continuous	|O
mild	|O
stress	|O
has	|O
a	|O
potent	|O
antiarrhythmic	|O
effect	|O
which	|O
occurs	|O
due	|O
to	|O
the	|O
increased	|O
vagal	|O
tone	|O
.	|O

The	|O
eluent	|O
from	|O
the	|O
column	|O
was	|O
mixed	|O
with	|O
the	|O
chemiluminescent	|O
solution	|O
containing	|O
lucigenin	|B-PROTEIN
and	|O
Triton	|O
X	|O
-	|O
100	|O
and	|O
a	|O
0.28	|O
M	|O
KOH	|O
solution	|O
by	|O
pumps	|O
and	|O
monitored	|O
by	|O
a	|O
chemiluminescence	|O
detector	|O
.	|O

On	|O
histologic	|O
examination	|O
the	|O
cuboidal	|O
epithelium	|O
of	|O
the	|O
mucous	|O
membrane	|O
was	|O
found	|O
to	|O
be	|O
changed	|O
into	|O
columnar	|O
epithelium	|O
,	|O
with	|O
uneven	|O
distribution	|O
of	|O
enlarged	|O
nuclei	|O
in	|O
the	|O
vacuolized	|O
cytoplasm	|O
.	|O

These	|O
results	|O
suggest	|O
an	|O
increased	|O
risk	|O
of	|O
developing	|O
cancer	|O
among	|O
polyp	|O
patients	|O
and	|O
the	|O
possibility	|O
of	|O
prophylactic	|O
effect	|O
of	|O
polypectomy	|O
against	|O
subsequent	|O
cancer	|O
.	|O

The	|O
same	|O
trend	|O
was	|O
noted	|O
between	|O
YG	|O
4.5	|O
heifers	|O
and	|O
YG	|O
5.5	|O
steers	|O
,	|O
indicating	|O
a	|O
sex	|O
-	|O
related	|O
deposition	|O
of	|O
seam	|O
fat	|O
in	|O
fed	|O
cattle	|O
.	|O

The	|O
nucleotide	|O
sequence	|O
consists	|O
of	|O
48	|O
bp	|O
of	|O
5'	|O
-	|O
end	|O
non	|O
-	|O
coding	|O
region	|O
,	|O
1695	|O
bp	|O
of	|O
coding	|O
region	|O
and	|O
212	|O
bp	|O
of	|O
3'	|O
-	|O
end	|O
non	|O
-	|O
coding	|O
region	|O
including	|O
a	|O
20	|O
bp	|O
poly	|O
(	|O
A	|O
)	|O
tail	|O
.	|O

Toxicities	|O
included	|O
:	|O
nausea	|O
/	|O
vomiting	|O
(	|O
69%	|O
)	|O
,	|O
headache	|O
(	|O
25%	|O
)	|O
,	|O
chills	|O
(	|O
69%	|O
)	|O
,	|O
pain	|O
at	|O
tumor	|O
sites	|O
(	|O
63%	|O
)	|O
,	|O
hypotension	|O
(	|O
31%	|O
)	|O
,	|O
and	|O
hypertension	|O
(	|O
38%	|O
)	|O
.	|O

The	|O
results	|O
also	|O
showed	|O
that	|O
although	|O
oyster	|O
shell	|O
supplementation	|O
generally	|O
increased	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
,	|O
bone	|O
mineralization	|O
was	|O
relatively	|O
uninfluenced	|O
as	|O
judged	|O
by	|O
the	|O
low	|O
coefficients	|O
of	|O
variation	|O
(	|O
CV	|O
)	|O
of	|O
3.14-3.51%	|O
and	|O
3.39-4.82%	|O
for	|O
calcium	|O
and	|O
phosphorus	|O
content	|O
in	|O
the	|O
femur	|O
and	|O
tibia	|O
respectively	|O
.	|O

In	|O
6	|O
of	|O
24	|O
infants	|O
studied	|O
(	|O
27th	|O
-	|O
40th	|O
weeks	|O
of	|O
gestation	|O
)	|O
,	|O
acquired	|O
and	|O
congenital	|O
structural	|O
anomalies	|O
of	|O
the	|O
airways	|O
were	|O
detected	|O
with	|O
an	|O
ultrathin	|O
flexible	|O
fiberscope	|O
(	|O
Olympus	|O
PF18	|O
S	|O
,	|O
1.8	|O
mm	|O
)	|O
.	|O

Fatal	|O
encephalitis	|O
in	|O
a	|O
patient	|O
with	|O
chronic	|O
graft	|O
-	|O
versus	|O
-	|O
host	|O
disease	|O
.	|O

Compared	|O
to	|O
its	|O
counterpart	|O
in	|O
the	|O
GPB	|B-PROTEIN
gene	|O
,	|O
exon	|O
3	|O
of	|O
the	|O
GPE	|B-PROTEIN
gene	|O
contains	|O
several	|O
point	|O
mutations	|O
,	|O
an	|O
insertion	|O
of	|O
24	|O
bp	|O
,	|O
and	|O
a	|O
stop	|O
codon	|O
which	|O
shortens	|O
the	|O
reading	|O
frame	|O
.	|O

Molecular	|O
cloning	|O
of	|O
a	|O
cDNA	|O
encoding	|O
rat	|O
NADH	|B-PROTEIN
-	|I-PROTEIN
cytochrome	|I-PROTEIN
b5	|I-PROTEIN
reductase	|I-PROTEIN
and	|O
the	|O
corresponding	|O
gene	|O
.	|O

The	|O
results	|O
corroborate	|O
the	|O
idea	|O
that	|O
the	|O
structure	|O
of	|O
relaxation	|O
curves	|O
contains	|O
information	|O
on	|O
the	|O
distance	|O
scale	|O
and	|O
on	|O
the	|O
architecture	|O
of	|O
the	|O
pore	|O
space	|O
,	|O
even	|O
if	|O
it	|O
is	|O
difficult	|O
to	|O
extract	|O
it	|O
without	|O
ambiguities	|O
.	|O

Serotonin	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT2	|I-PROTEIN
receptor	|I-PROTEIN
binding	|O
on	|O
blood	|O
platelets	|O
as	|O
a	|O
state	|O
dependent	|O
marker	|O
in	|O
major	|O
affective	|O
disorder	|O
.	|O

Although	|O
%	|O
BF	|O
was	|O
correlated	|O
with	|O
all	|O
the	|O
BMIs	|O
(	|O
r	|O
=	|O
0.60-0.82	|O
)	|O
,	|O
applying	|O
objective	|O
definitions	|O
of	|O
obesity	|O
based	|O
on	|O
BMIs	|O
or	|O
%	|O
BF	|O
by	|O
densitometry	|O
often	|O
produced	|O
conflicting	|O
results	|O
.	|O

The	|O
RF	|O
values	|O
correlated	|O
well	|O
with	|O
the	|O
angiographic	|O
semiquantitative	|O
scale	|O
of	|O
severity	|O
of	|O
aortal	|O
insufficiency	|O
(	|O
r	|O
=	|O
0.805	|O
;	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
,	|O
although	|O
they	|O
enabled	|O
the	|O
authors	|O
only	|O
to	|O
make	|O
a	|O
partial	|O
differentiation	|O
of	|O
haemodynamically	|O
severe	|O
regurgitations	|O
and	|O
mild	|O
or	|O
insignificant	|O
ones	|O
.	|O

Promoter	|O
elements	|O
include	|O
an	|O
atypical	|O
TATA	|O
box	|O
(	|O
GTTA	|O
)	|O
,	|O
one	|O
CCAAT	|O
box	|O
much	|O
further	|O
from	|O
the	|O
initiation	|O
site	|O
,	|O
three	|O
reverse	|O
compliments	|O
of	|O
CCAAT	|O
(	|O
ATTGG	|O
)	|O
,	|O
and	|O
two	|O
pyrimidine	|O
-	|O
rich	|O
nucleotide	|O
stretches	|O
.	|O

The	|O
cloned	|O
genes	|O
were	|O
identified	|O
in	|O
genetic	|O
libraries	|O
by	|O
hybridization	|O
screening	|O
using	|O
four	|O
deoxyoligonucleotide	|O
probes	|O
which	|O
corresponded	|O
to	|O
the	|O
partial	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
purified	|O
enzyme	|O
.	|O

The	|O
pattern	|O
for	|O
catalytic	|O
zinc	|O
sites	|O
included	|O
two	|O
ligands	|O
close	|O
in	|O
sequence	|O
,	|O
a	|O
sequence	|O
-	|O
distant	|O
ligand	|O
,	|O
and	|O
a	|O
main	|O
-	|O
chain	|O
hydrogen	|O
bond	|O
joining	|O
two	|O
ligands	|O
.	|O

Results	|O
of	|O
the	|O
long	|O
-	|O
term	|O
observation	|O
and	|O
treatment	|O
of	|O
patients	|O
with	|O
arterial	|O
hypertension	|O

Eucaryotic	|O
transcription	|O
factors	|O
that	|O
stimulate	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
by	|O
increasing	|O
the	|O
efficiency	|O
of	|O
elongation	|O
of	|O
specifically	|O
or	|O
randomly	|O
initiated	|O
RNA	|O
chains	|O
have	|O
been	|O
isolated	|O
and	|O
characterized	|O
.	|O

Sprague	|O
-	|O
Dawley	|O
newborn	|O
rats	|O
(	|O
n	|O
=	|O
85	|O
)	|O
breathed	|O
100%	|O
oxygen	|O
(	|O
O2	|O
)	|O
or	|O
room	|O
air	|O
(	|O
RA	|O
)	|O
during	|O
the	|O
first	|O
8	|O
days	|O
of	|O
life	|O
,	|O
and	|O
then	|O
RA	|O
.	|O

The	|O
Lm	|O
increased	|O
and	|O
the	|O
alveoli	|O
/	|O
mm2	|O
and	|O
elastic	|O
recoil	|O
pressure	|O
decreased	|O
.	|O

Comparison	|O
of	|O
propofol	|O
and	|O
thiopentone	|O
as	|O
anaesthetic	|O
agents	|O
for	|O
electroconvulsive	|O
therapy	|O
.	|O

In	|O
Experiment	|O
II	|O
,	|O
as	|O
performing	|O
moderate	|O
supine	|O
cycling	|O
(	|O
55%	|O
VO2	|O
max	|O
)	|O
for	|O
50	|O
minutes	|O
under	|O
several	|O
LBNP	|O
conditions	|O
in	|O
5	|O
sedentary	|O
women	|O
,	|O
there	|O
were	|O
correspondingly	|O
similar	|O
changing	|O
manners	|O
of	|O
the	|O
cardiovascular	|O
adjustments	|O
to	|O
each	|O
of	|O
the	|O
phases	|O
given	|O
in	|O
Experiment	|O
I.	|O

Commercially	|O
available	|O
formulations	|O
of	|O
2.5%	|O
and	|O
5%	|O
lambdacyhalothrin	|O
can	|O
be	|O
diluted	|O
either	|O
with	|O
water	|O
for	|O
ULV	|O
cold	|O
aerosol	|O
space	|O
-	|O
spraying	|O
or	|O
with	|O
diesel	|O
/	|O
kerosene	|O
for	|O
thermal	|O
fogging	|O
at	|O
recommended	|O
application	|O
rates	|O
of	|O
0.5-1	|O
g	|O
ai	|O
/	|O
ha	|O
for	|O
mosquito	|O
control	|O
and	|O
2	|O
g	|O
ai	|O
/	|O
ha	|O
for	|O
housefly	|O
control	|O
.	|O

Thus	|O
,	|O
this	|O
reading	|O
frame	|O
was	|O
concluded	|O
to	|O
encode	|O
the	|O
precursor	|O
of	|O
mitochondrial	|O
fumarase	|B-PROTEIN
.	|O

Sequence	|O
analysis	|O
indicates	|O
that	|O
in	|O
addition	|O
to	|O
an	|O
ATA	|O
and	|O
GC	|O
box	|O
,	|O
this	|O
region	|O
contains	|O
domains	|O
that	|O
have	|O
been	|O
implicated	|O
in	|O
the	|O
regulation	|O
of	|O
other	|O
muscle	|O
-	|O
specific	|O
genes	|O
:	|O
a	|O
CArG	|O
box	|O
at	|O
-	|O
91	|O
bp	|O
;	|O
myocyte	|O
-	|O
specific	|O
enhancer	|O
-	|O
binding	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
binding	|O
site	|O
homologies	|O
at	|O
-	|O
58	|O
,	|O
-	|O
535	|O
,	|O
and	|O
-	|O
583	|O
bp	|O
;	|O
and	|O
a	|O
muscle	|O
-	|O
CAAT	|O
consensus	|O
sequence	|O
at	|O
-	|O
394	|O
bp	|O
relative	|O
to	|O
the	|O
cap	|O
site	|O
.	|O

The	|O
trk	|B-PROTEIN
-	|I-PROTEIN
2h	|I-PROTEIN
oncogene	|O
,	|O
isolated	|O
from	|O
the	|O
human	|O
breast	|O
carcinoma	|O
cell	|O
line	|O
MDA	|O
-	|O
MB	|O
231	|O
by	|O
genomic	|O
DNA	|O
-	|O
transfection	|O
into	|O
NIH3T3	|O
cells	|O
,	|O
consists	|O
of	|O
the	|O
trk	|B-PROTEIN
proto	|O
-	|O
oncogene	|O
receptor	|O
kinase	|O
domain	|O
fused	|O
to	|O
a	|O
N	|O
-	|O
terminal	|O
41	|O
amino	|O
acid	|O
activating	|O
sequence	|O
(	|O
Kozma	|O
,	|O
S.C.	|O
,	|O
Redmond	|O
,	|O
S.M.S.	|O
,	|O
Xiao	|O
-	|O
Chang	|O
,	|O
F.	|O
,	|O
Saurer	|O
,	|O
S.M.	|O
,	|O
Groner	|O
,	|O
B.	|O
and	|O
Hynes	|O
,	|O
N.E.	|O

Antibodies	|O
raised	|O
against	|O
a	|O
bacterially	|O
produced	|O
beta	|B-PROTEIN
gal	|I-PROTEIN
-	|O
trk	|B-PROTEIN
receptor	|O
kinase	|O
fusion	|O
protein	|O
recognized	|O
a	|O
44	|O
kd	|O
phosphoprotein	|O
phosphorylated	|O
on	|O
serine	|O
,	|O
threonine	|O
and	|O
tyrosine	|O
in	|O
extracts	|O
of	|O
trk	|B-PROTEIN
-	|I-PROTEIN
2h	|I-PROTEIN
transformed	|O
NIH3T3	|O
cells	|O
.	|O

Since	|O
very	|O
recent	|O
scanning	|O
-	|O
deletion	|O
analysis	|O
indicates	|O
that	|O
there	|O
is	|O
a	|O
critical	|O
region	|O
for	|O
activity	|O
near	|O
Cys	|O
-	|O
118	|O
and	|O
that	|O
Cys	|O
-	|O
118	|O
is	|O
necessary	|O
for	|O
maximal	|O
activity	|O
,	|O
we	|O
conclude	|O
that	|O
the	|O
Cys	|O
-	|O
118	|O
residue	|O
is	|O
necessary	|O
for	|O
proper	|O
glycosylation	|O
and	|O
maximal	|O
biologic	|O
activity	|O
of	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
.	|O

Molecular	|O
and	|O
functional	|O
characterization	|O
of	|O
the	|O
promoter	|O
of	|O
ETS2	|B-PROTEIN
,	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
.	|O

Information	|O
about	|O
immunologic	|O
drug	|O
interactions	|O
is	|O
needed	|O
by	|O
pharmacists	|O
to	|O
make	|O
rational	|O
drug	|O
-	|O
use	|O
decisions	|O
.	|O

Branch	|O
occlusion	|O
of	|O
Heubner	|O
's	|O
artery	|O
,	|O
or	|O
perforators	|O
from	|O
the	|O
proximal	|O
anterior	|O
or	|O
middle	|O
cerebral	|O
arteries	|O
were	|O
the	|O
posited	|O
mechanism	|O
of	|O
infarction	|O
.	|O

All	|O
ABFI	|B-PROTEIN
-	|O
binding	|O
sites	|O
,	|O
regardless	|O
of	|O
origin	|O
,	|O
provided	|O
weak	|O
UAS	|O
function	|O
in	|O
vivo	|O
when	|O
examined	|O
in	|O
test	|O
plasmids	|O
.	|O

An	|O
examination	|O
of	|O
the	|O
properties	|O
of	|O
sequences	|O
surrounding	|O
ARS1	|O
left	|O
open	|O
the	|O
possibility	|O
that	|O
ABFI	|B-PROTEIN
enhances	|O
the	|O
initiation	|O
of	|O
DNA	|O
replication	|O
at	|O
ARS1	|O
by	|O
transcriptional	|O
activation	|O
.	|O

Nonvascular	|O
ophthalmic	|O
and	|O
neurologic	|O
disorders	|O
that	|O
can	|O
be	|O
confused	|O
with	|O
amaurosis	|O
fugax	|O
are	|O
listed	|O
,	|O
and	|O
an	|O
algorithm	|O
for	|O
evaluation	|O
(	|O
which	|O
includes	|O
ophthalmic	|O
examination	|O
,	|O
laboratory	|O
studies	|O
,	|O
and	|O
noninvasive	|O
carotid	|O
artery	|O
studies	|O
)	|O
is	|O
given	|O
.	|O

Likewise	|O
,	|O
whether	|O
or	|O
not	|O
the	|O
hypotensive	|O
action	|O
of	|O
converting	|O
enzyme	|O
inhibitors	|O
is	|O
age	|O
-	|O
related	|O
is	|O
as	|O
yet	|O
unknown	|O
.	|O

Polyclonal	|O
antiserum	|O
generated	|O
to	|O
the	|O
fusion	|O
protein	|O
was	|O
capable	|O
of	|O
detecting	|O
42	|O
-	|O
and	|O
46	|O
-	|O
kilodalton	|O
polypeptides	|O
from	|O
virus	|O
particles	|O
;	|O
both	|O
polypeptides	|O
were	|O
also	|O
shown	|O
to	|O
contain	|O
HBsAg	|B-PROTEIN
determinants	|O
.	|O

These	|O
characteristics	|O
of	|O
N22	|O
/	|O
P22	|O
indicate	|O
that	|O
it	|O
is	|O
a	|O
localized	|O
synaptically	|O
dependent	|O
event	|O
conforming	|O
to	|O
a	|O
transverse	|O
dipole	|O
with	|O
dorsal	|O
negativity	|O
and	|O
a	|O
simultaneous	|O
anterior	|O
positivity	|O
.	|O

Role	|O
of	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
in	|O
cellular	|O
oxidative	|O
processes	|O
and	|O
method	|O
of	|O
its	|O
determination	|O
in	|O
biological	|O
materials	|O

At	|O
maximum	|O
photosensitivity	|O
the	|O
inhibitory	|O
amino	|O
acids	|O
gamma	|O
-	|O
aminobutyric	|O
acid	|O
and	|O
taurine	|O
were	|O
lower	|O
,	|O
and	|O
those	|O
of	|O
asparagine	|O
(	|O
metabolite	|O
of	|O
the	|O
excitatory	|O
amino	|O
acid	|O
aspartate	|O
)	|O
were	|O
higher	|O
,	|O
than	|O
when	|O
the	|O
animals	|O
were	|O
not	|O
photosensitive	|O
.	|O

We	|O
evaluated	|O
the	|O
likelihood	|O
of	|O
tissues	|O
to	|O
be	|O
positive	|O
for	|O
carcinoembryonic	|B-PROTEIN
antigen	|I-PROTEIN
and	|O
the	|O
intensity	|O
of	|O
carcinoembryonic	|B-PROTEIN
antigen	|I-PROTEIN
staining	|O
in	|O
specimens	|O
of	|O
villous	|O
adenomas	|O
,	|O
mixed	|O
polypoid	|O
villous	|O
adenomas	|O
,	|O
polypoid	|O
adenomas	|O
,	|O
and	|O
diverticulitis	|O
using	|O
the	|O
peroxidase	|B-PROTEIN
-	|O
antiperoxidase	|B-PROTEIN
technique	|O
.	|O

The	|O
priming	|O
activity	|O
of	|O
DNA	|O
incised	|O
by	|O
either	|O
of	|O
the	|O
Drosophila	|O
enzymes	|O
can	|O
be	|O
enhanced	|O
,	|O
however	|O
,	|O
by	|O
an	|O
additional	|O
incubation	|O
with	|O
E.	|O
coli	|O
endonuclease	|B-PROTEIN
IV	|I-PROTEIN
,	|O
which	|O
is	|O
known	|O
to	|O
cleave	|O
depurinated	|O
DNA	|O
on	|O
the	|O
5'	|O
-	|O
side	|O
of	|O
an	|O
apurinic	|O
site	|O
.	|O

A.	|O

Therefore	|O
,	|O
in	|O
conjunction	|O
with	|O
a	|O
positive	|O
pregnancy	|O
test	|O
and	|O
the	|O
patient	|O
's	|O
clinical	|O
history	|O
,	|O
a	|O
severely	|O
depressed	|O
or	|O
absent	|O
serum	|O
PAPP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
level	|O
may	|O
aid	|O
in	|O
the	|O
diagnosis	|O
of	|O
extrauterine	|O
pregnancy	|O
.	|O

The	|O
levels	|O
of	|O
both	|O
MAP1	|B-PROTEIN
-	|O
specific	|O
and	|O
MAP2	|B-PROTEIN
-	|O
specific	|O
mRNAs	|O
decline	|O
in	|O
the	|O
postnatal	|O
developing	|O
brain	|O
;	|O
the	|O
level	|O
of	|O
MAP1	|B-PROTEIN
-	|O
specific	|O
mRNA	|O
also	|O
increases	|O
slightly	|O
in	|O
rat	|O
PC12	|O
cells	|O
upon	|O
exposure	|O
to	|O
nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
.	|O

The	|O
cDNAs	|O
cross	|O
-	|O
hybridize	|O
with	|O
genomic	|O
sequences	|O
in	|O
rat	|O
,	|O
human	|O
,	|O
and	|O
chicken	|O
DNA	|O
,	|O
but	|O
not	|O
with	|O
DNA	|O
from	|O
frog	|O
,	|O
Drosophila	|O
,	|O
or	|O
sea	|O
urchin	|O
.	|O

Colorimetric	|O
method	|O
of	|O
determining	|O
glycerin	|O
in	|O
the	|O
blood	|O

Deletion	|O
analysis	|O
was	|O
carried	|O
out	|O
within	|O
a	|O
part	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
showing	|O
homology	|O
to	|O
the	|O
upstream	|O
region	|O
of	|O
the	|O
yeast	|O
CYC1	|B-PROTEIN
gene	|O
.	|O

The	|O
N1	|O
and	|O
P2	|O
were	|O
comparable	|O
in	|O
amplitude	|O
and	|O
both	|O
had	|O
prolonged	|O
refractory	|O
periods	|O
.	|O

Tolerance	|O
to	|O
fenfluramine	|O
anorexia	|O
:	|O
fact	|O
or	|O
fiction	|O
?	|O
Recent	|O
findings	|O
in	|O
this	|O
laboratory	|O
with	|O
regard	|O
to	|O
tolerance	|O
to	|O
fenfluramine	|O
anorexia	|O
are	|O
reviewed	|O
with	|O
respect	|O
to	|O
generality	|O
of	|O
the	|O
behavioural	|O
phenomenon	|O
.	|O

In	|O
30	|O
dogs	|O
the	|O
left	|O
limb	|O
(	|O
tail	|O
)	|O
of	|O
the	|O
pancreas	|O
was	|O
removed	|O
but	|O
left	|O
in	|O
the	|O
abdominal	|O
cavity	|O
after	|O
cessation	|O
of	|O
blood	|O
flow	|O
to	|O
produce	|O
warm	|O
ischemia	|O
for	|O
30	|O
,	|O
60	|O
,	|O
and	|O
120	|O
min	|O
(	|O
10	|O
dogs	|O
at	|O
each	|O
time	|O
point	|O
)	|O
,	|O
and	|O
then	|O
was	|O
flushed	|O
with	|O
cold	|O
Ringers	|O
'	|O
lactate	|O
and	|O
transplanted	|O
to	|O
the	|O
iliac	|O
vessels	|O
.	|O

These	|O
results	|O
support	|O
the	|O
view	|O
that	|O
clonidine	|O
and	|O
6	|O
-	|O
OHDA	|O
,	|O
but	|O
not	|O
alpha	|O
-	|O
MD	|O
,	|O
have	|O
central	|O
pressor	|O
actions	|O
in	|O
the	|O
rat	|O
that	|O
oppose	|O
their	|O
antihypertensive	|O
action	|O
.	|O

Furthermore	|O
,	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
sensitivity	|O
appears	|O
to	|O
be	|O
unaltered	|O
in	|O
BHT	|O
.	|O

We	|O
conclude	|O
that	|O
Hansel	|O
's	|O
stain	|O
substantially	|O
improves	|O
the	|O
recognition	|O
of	|O
eosinophiluria	|O
as	|O
compared	|O
with	|O
Wright	|O
's	|O
stain	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
the	|O
negative	|O
inotropic	|O
action	|O
of	|O
nicorandil	|O
is	|O
caused	|O
by	|O
inhibition	|O
of	|O
Ca	|O
influx	|O
and	|O
intracellular	|O
mobilization	|O
of	|O
Ca	|O
.	|O

The	|O
study	|O
included	|O
139	|O
eyes	|O
with	|O
presumed	|O
ocular	|O
histoplasmosis	|O
syndrome	|O
(	|O
POHS	|O
)	|O
and	|O
age	|O
-	|O
related	|O
macular	|O
degeneration	|O
(	|O
AMD	|O
)	|O
.	|O

Comparison	|O
of	|O
elastase	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
with	|O
amylase	|B-PROTEIN
,	|O
lipase	|B-PROTEIN
,	|O
and	|O
trypsin	|B-PROTEIN
-	|O
like	|O
immunoreactivity	|O
in	|O
the	|O
diagnosis	|O
of	|O
acute	|O
pancreatitis	|O
.	|O

A	|O
probe	|O
evoked	|O
potentials	|O
procedure	|O
was	|O
used	|O
to	|O
assess	|O
the	|O
relative	|O
engagement	|O
of	|O
both	|O
cerebral	|O
hemispheres	|O
during	|O
a	|O
language	|O
task	|O
in	|O
the	|O
following	|O
four	|O
groups	|O
of	|O
dextral	|O
adults	|O
:	|O
left	|O
hemisphere	|O
(	|O
LH	|O
)	|O
-	|O
damaged	|O
aphasics	|O
recovering	|O
from	|O
stroke	|O
,	|O
dysarthrics	|O
,	|O
right	|O
hemisphere	|O
(	|O
RH	|O
)	|O
-	|O
damaged	|O
nonaphasic	|O
patients	|O
,	|O
and	|O
normal	|O
control	|O
subjects	|O
.	|O

Mucolipidosis	|O
type	|O
IV	|O
:	|O
clinical	|O
spectrum	|O
and	|O
natural	|O
history	|O
.	|O

Two	|O
of	|O
the	|O
three	|O
groups	|O
were	|O
administered	|O
dauricine	|O
,	|O
as	|O
a	|O
new	|O
calcium	|O
channel	|O
blocker	|O
,	|O
and	|O
verapamil	|O
,	|O
as	|O
a	|O
generally	|O
recognized	|O
calcium	|O
channel	|O
blocker	|O
,	|O
respectively	|O
,	|O
from	|O
15	|O
minutes	|O
pre	|O
-	|O
bypass	|O
to	|O
the	|O
end	|O
of	|O
the	|O
bypass	|O
procedure	|O
(	|O
a	|O
period	|O
of	|O
95	|O
minutes	|O
)	|O
.	|O

No	|O
reflow	|O
occurred	|O
in	|O
approximately	|O
30	|O
percent	|O
of	|O
the	|O
muscle	|O
microvasculature	|O
upon	|O
reperfusion	|O
.	|O

Rarely	|O
,	|O
patients	|O
with	|O
locally	|O
advanced	|O
,	|O
uncontrollable	|O
,	|O
non	|O
-	|O
metastatic	|O
prostatic	|O
cancer	|O
enjoy	|O
prolonged	|O
survival	|O
.	|O

Lysozyme	|B-PROTEIN
activity	|O
was	|O
evidently	|O
increased	|O
as	|O
well	|O
in	|O
undiluted	|O
as	|O
in	|O
diluted	|O
sera	|O
in	|O
all	|O
our	|O
tested	|O
patients	|O
.	|O

The	|O
first	|O
involved	|O
measurements	|O
of	|O
the	|O
steady	|O
state	|O
levels	|O
of	|O
mRNAs	|O
for	|O
subunit	|O
5	|O
of	|O
cytochrome	|B-PROTEIN
oxidase	|I-PROTEIN
and	|O
the	|O
beta	|O
subunit	|O
of	|O
F1	|B-PROTEIN
ATPase	|I-PROTEIN
in	|O
wild	|O
type	|O
and	|O
in	|O
a	|O
hem2	|B-PROTEIN
mutant	|O
.	|O

A	|O
5.8	|B-PROTEIN
S	|I-PROTEIN
-	|O
like	|O
structure	|O
is	|O
present	|O
within	|O
the	|O
5'	|O
-	|O
terminal	|O
region	|O
of	|O
all	|O
three	|O
fungal	|O
mitochondrial	|O
LSU	|B-PROTEIN
rRNAs	|O
;	|O
in	|O
contrast	|O
,	|O
no	|O
4.5	|B-PROTEIN
S	|I-PROTEIN
-	|O
like	|O
structure	|O
is	|O
evident	|O
at	|O
the	|O
3'	|O
end	|O
of	|O
these	|O
molecules	|O
.	|O

ATP	|O
gamma	|O
S	|O
inhibition	|O
can	|O
be	|O
overcome	|O
by	|O
high	|O
concentrations	|O
of	|O
ATP	|O
,	|O
dATP	|O
,	|O
araATP	|O
,	|O
or	|O
ddATP	|O
.	|O

The	|O
recovery	|O
of	|O
labelled	|O
methoxydextrane	|O
is	|O
98	|O
+	|O
/	|O
-	|O
7%	|O
.	|O

ASL	|O
-	|O
8123	|O
demonstrated	|O
weak	|O
competitive	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenoreceptor	|I-PROTEIN
blocking	|O
activity	|O
in	|O
isolated	|O
guinea	|O
pig	|O
right	|O
atria	|O
with	|O
a	|O
pA2	|O
of	|O
3.73	|O
+	|O
/	|O
-	|O
0.07	|O
;	|O
no	|O
agonist	|O
-	|O
like	|O
activity	|O
was	|O
observed	|O
in	|O
this	|O
tissue	|O
at	|O
concentrations	|O
of	|O
ASL	|O
-	|O
8123	|O
from	|O
3	|O
X	|O
10	|O
(	|O
-	|O
5	|O
)	|O
to	|O
1	|O
X	|O
10	|O
(	|O
-	|O
2	|O
)	|O
M.	|O

Enhancer	|O
and	|O
promoter	|O
elements	|O
directing	|O
activation	|O
and	|O
glucocorticoid	|O
repression	|O
of	|O
the	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
fetoprotein	|I-PROTEIN
gene	|O
in	|O
hepatocytes	|O
.	|O

We	|O
discuss	|O
the	|O
results	|O
in	|O
relation	|O
to	|O
previous	|O
systems	|O
for	|O
parcellating	|O
the	|O
posterior	|O
ectosylvian	|O
gyrus	|O
of	|O
the	|O
cat	|O
and	|O
consider	|O
the	|O
possibility	|O
that	|O
divisions	|O
of	|O
the	|O
feline	|O
posterior	|O
ectosylvian	|O
gyrus	|O
correspond	|O
directly	|O
to	|O
areas	|O
making	|O
up	|O
the	|O
superior	|O
temporal	|O
gyrus	|O
in	|O
primates	|O
.	|O

The	|O
gene	|O
is	|O
contained	|O
within	|O
a	|O
1.8	|O
-	|O
kilobase	|O
AccI	|B-PROTEIN
-	|O
EcoRI	|B-PROTEIN
restriction	|O
fragment	|O
mapping	|O
at	|O
map	|O
coordinates	|O
0.136	|O
to	|O
0.148	|O
in	|O
the	|O
UL	|O
region	|O
of	|O
the	|O
EHV	|O
-	|O
1	|O
genome	|O
and	|O
is	|O
transcribed	|O
from	|O
right	|O
to	|O
left	|O
.	|O

The	|O
4	|O
-	|O
AP	|O
(	|O
4-20	|O
mM	|O
)	|O
effect	|O
resulted	|O
in	|O
a	|O
decrease	|O
of	|O
the	|O
sensory	|O
activity	|O
,	|O
which	|O
was	|O
fully	|O
restored	|O
by	|O
TEA	|O
or	|O
Ba2+	|O
.	|O

Hybridization	|O
of	|O
a	|O
probe	|O
from	|O
this	|O
region	|O
to	|O
electrophoretic	|O
blots	|O
of	|O
RNAs	|O
from	|O
different	|O
human	|O
tissues	|O
showed	|O
a	|O
predominant	|O
2.8	|O
-	|O
kilobase	|O
(	|O
kb	|O
)	|O
message	|O
accompanied	|O
by	|O
weaker	|O
bands	|O
4.1	|O
and	|O
2.1	|O
kb	|O
in	|O
size	|O
.	|O

Prognosis	|O
of	|O
asymptomatic	|O
multiple	|O
myeloma	|O
.	|O

A	|O
new	|O
method	|O
for	|O
the	|O
quantitative	|O
analysis	|O
of	|O
sleep	|O
spindles	|O
during	|O
continuous	|O
overnight	|O
EEG	|O
recordings	|O
.	|O

Svensson	|O
et	|O
al.	|O

Endogenous	|O
release	|O
of	|O
neuronal	|O
serotonin	|O
and	|O
5	|O
-	|O
hydroxyindoleacetic	|O
acid	|O
in	|O
the	|O
caudate	|O
-	|O
putamen	|O
of	|O
the	|O
rat	|O
as	|O
revealed	|O
by	|O
intracerebral	|O
dialysis	|O
coupled	|O
to	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatography	|O
with	|O
fluorimetric	|O
detection	|O
.	|O

In	|O
this	|O
report	|O
we	|O
describe	|O
for	|O
the	|O
first	|O
time	|O
the	|O
complete	|O
primary	|O
structure	|O
of	|O
type	|B-PROTEIN
X	|I-PROTEIN
collagen	|I-PROTEIN
,	|O
based	|O
on	|O
cloning	|O
and	|O
sequencing	|O
of	|O
cDNA	|O
and	|O
genomic	|O
DNA	|O
.	|O

Viable	|O
flap	|O
areas	|O
were	|O
established	|O
following	|O
vascular	|O
pedicle	|O
ligation	|O
(	|O
both	|O
vessels	|O
or	|O
only	|O
artery	|O
or	|O
vein	|O
)	|O
,	|O
on	|O
the	|O
third	|O
day	|O
after	|O
flap	|O
replantation	|O
in	|O
both	|O
island	|O
and	|O
free	|O
flaps	|O
.	|O

The	|O
size	|O
discrepancy	|O
is	|O
not	|O
due	|O
to	|O
glycosylation	|O
or	|O
phosphorylation	|O
of	|O
Ag35	|B-PROTEIN
but	|O
may	|O
result	|O
from	|O
a	|O
proline	|O
-	|O
rich	|O
sequence	|O
which	|O
occurs	|O
in	|O
this	|O
polypeptide	|O
.	|O

A	|O
9.5	|O
-	|O
kb	|O
KpnI	|B-PROTEIN
-	|O
SalI	|B-PROTEIN
fragment	|O
,	|O
where	|O
all	|O
the	|O
DNA	|O
changes	|O
associated	|O
with	|O
su	|B-PROTEIN
(	|I-PROTEIN
Hw	|I-PROTEIN
)	|I-PROTEIN
mutations	|O
were	|O
mapped	|O
,	|O
was	|O
able	|O
to	|O
rescue	|O
the	|O
su	|B-PROTEIN
(	|I-PROTEIN
Hw	|I-PROTEIN
)	|I-PROTEIN
mutant	|O
phenotype	|O
after	|O
P	|B-PROTEIN
-	|I-PROTEIN
element	|I-PROTEIN
-	|O
mediated	|O
germ	|O
-	|O
line	|O
transformation	|O
.	|O

The	|O
corticosterone	|O
synthesis	|O
inhibitor	|O
metyrapone	|O
(	|O
75	|O
mg	|O
/	|O
kg	|O
i.p	|O
.	|O
)	|O
was	|O
given	|O
to	|O
attenuate	|O
the	|O
rise	|O
of	|O
corticosterone	|O
to	|O
a	|O
level	|O
typical	|O
of	|O
stressed	|O
males	|O
.	|O

The	|O
effects	|O
of	|O
L655	|O
,	|O
240	|O
,	|O
a	|O
selective	|O
thromboxane	|O
and	|O
prostaglandin	|O
endoperoxide	|O
antagonist	|O
,	|O
on	|O
ischemia	|O
-	|O
and	|O
reperfusion	|O
-	|O
induced	|O
cardiac	|O
arrhythmias	|O
.	|O

In	|O
10	|O
pentobarbitalized	|O
dogs	|O
,	|O
plasma	|O
viscosity	|O
(	|O
Ep	|O
)	|O
was	|O
raised	|O
fourfold	|O
while	|O
apparent	|O
blood	|O
viscosity	|O
(	|O
Ea	|O
)	|O
increased	|O
about	|O
twofold	|O
by	|O
two	|O
steps	|O
of	|O
exchange	|O
transfusion	|O
of	|O
200	|O
ml	|O
of	|O
plasma	|O
with	|O
plasma	|O
containing	|O
high	|O
molecular	|O
weight	|O
dextran	|O
(	|O
mol	|O
wt	|O
500,000	|O
,	|O
20%	|O
wt	|O
/	|O
vol	|O
)	|O
.	|O

The	|O
small	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
is	|O
abundant	|O
in	|O
human	|O
amniotic	|O
fluid	|O
.	|O

Serum	|O
prostatic	|B-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
levels	|O
showed	|O
a	|O
significantly	|O
weaker	|O
correlation	|O
with	|O
cancer	|O
volume	|O
(	|O
r	|O
equals	|O
0.51	|O
)	|O
and	|O
every	|O
other	|O
pathological	|O
parameter	|O
.	|O

The	|O
investigation	|O
was	|O
thereafter	|O
continued	|O
in	|O
an	|O
open	|O
fashion	|O
by	|O
administering	|O
a	|O
single	|O
10	|O
mg	|O
dose	|O
of	|O
the	|O
MAO	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
inhibitor	|O
deprenyl	|O
to	|O
the	|O
same	|O
subjects	|O
.	|O

Their	|O
studies	|O
have	|O
revealed	|O
a	|O
considerable	|O
increase	|O
of	|O
CSF	|O
AP	|B-PROTEIN
activity	|O
in	|O
purulent	|O
meningitides	|O
whereas	|O
in	|O
serous	|O
meningitides	|O
it	|O
grows	|O
negligibly	|O
.	|O

A	|O
cDNA	|O
encoding	|O
a	|O
new	|O
human	|O
lymphocyte	|O
cell	|O
surface	|O
molecule	|O
has	|O
been	|O
isolated	|O
and	|O
shown	|O
to	|O
identify	|O
a	|O
fourth	|O
member	|O
of	|O
a	|O
recently	|O
discovered	|O
family	|O
of	|O
adhesion	|O
proteins	|O
.	|O

Dopamine	|O
caused	|O
a	|O
prominent	|O
potassium	|O
efflux	|O
measured	|O
as	|O
86Rb	|O
+	|O
efflux	|O
from	|O
control	|O
glands	|O
,	|O
but	|O
was	|O
without	|O
effect	|O
in	|O
denervated	|O
glands	|O
.	|O

Spontaneous	|O
sensitization	|O
to	|O
cross	|O
-	|O
reacting	|O
chemicals	|O
in	|O
a	|O
proportion	|O
of	|O
control	|O
animals	|O
is	|O
strongly	|O
suggested	|O
,	|O
somewhat	|O
akin	|O
to	|O
spontaneous	|O
sensitization	|O
in	|O
patients	|O
with	|O
anaphylactoid	|O
reactions	|O
to	|O
neuromuscular	|O
blockers	|O
on	|O
first	|O
exposure	|O
,	|O
and	|O
in	|O
whom	|O
IgE	|B-PROTEIN
antibodies	|O
are	|O
detected	|O
.	|O

This	|O
approach	|O
was	|O
examined	|O
utilizing	|O
the	|O
fetal	|O
protein	|O
,	|O
HGB	|B-PROTEIN
F.	|I-PROTEIN

The	|O
investigation	|O
was	|O
apt	|O
at	|O
studying	|O
the	|O
relationship	|O
between	|O
urinary	|O
metabolites	|O
of	|O
serotonin	|O
and	|O
catecholamine	|O
(	|O
5	|O
-	|O
HIAA	|O
and	|O
VMA	|O
)	|O
,	|O
T	|O
-	|O
cells	|O
(	|O
OKT3+	|B-PROTEIN
)	|O
,	|O
T	|O
-	|O
helper	|O
(	|O
OKT4+	|B-PROTEIN
)	|O
,	|O
T	|O
-	|O
suppressor	|O
(	|O
OKT8+	|B-PROTEIN
)	|O
and	|O
B	|O
-	|O
cells	|O
(	|O
EAC	|O
-	|O
rosette	|O
forming	|O
cells	|O
)	|O
in	|O
normal	|O
(	|O
10	|O
subjects	|O
,	|O
1	|O
female	|O
,	|O
9	|O
male	|O
,	|O
age	|O
21	|O
+	|O
/	|O
-	|O
5	|O
years	|O
)	|O
and	|O
stress	|O
administered	|O
subjects	|O
(	|O
20	|O
subjects	|O
,	|O
3	|O
female	|O
,	|O
17	|O
male	|O
,	|O
age	|O
20	|O
+	|O
/	|O
-	|O
4	|O
years	|O
)	|O
.	|O

The	|O
84.1	|B-PROTEIN
C	|I-PROTEIN
mAb	|O
recognizes	|O
a	|O
site	|O
on	|O
IgE	|B-PROTEIN
which	|O
is	|O
identical	|O
or	|O
very	|O
close	|O
to	|O
the	|O
Fc	|B-PROTEIN
epsilon	|I-PROTEIN
R	|I-PROTEIN
binding	|O
site	|O
,	|O
and	|O
95.3	|O
recognizes	|O
a	|O
site	|O
on	|O
IgE	|B-PROTEIN
which	|O
is	|O
related	|O
,	|O
but	|O
not	|O
identical	|O
to	|O
the	|O
Fc	|B-PROTEIN
epsilon	|I-PROTEIN
R	|I-PROTEIN
binding	|O
site	|O
.	|O

Their	|O
hydropathic	|O
plots	|O
are	|O
very	|O
similar	|O
and	|O
both	|O
possess	|O
three	|O
hydrophobic	|O
segments	|O
that	|O
are	|O
likely	|O
alpha	|O
-	|O
helical	|O
transmembrane	|O
segments	|O
.	|O

Angiotensin	|B-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
inhibitors	|O
enhance	|O
the	|O
antihypertensive	|O
efficacy	|O
of	|O
diuretics	|O
and	|O
blunt	|O
or	|O
prevent	|O
adverse	|O
metabolic	|O
effects	|O
.	|O

In	|O
addition	|O
to	|O
the	|O
significant	|O
reduction	|O
in	|O
blood	|O
pressure	|O
,	|O
the	|O
angiotensin	|B-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
(	|O
ACE	|B-PROTEIN
)	|O
inhibitor	|O
ramipril	|O
caused	|O
a	|O
significant	|O
regression	|O
of	|O
pathologic	|O
left	|O
ventricular	|O
hypertrophy	|O
demonstrated	|O
by	|O
magnetic	|O
resonance	|O
imaging	|O
and	|O
echocardiography	|O
.	|O

Endocrine	|O
cells	|O
were	|O
studied	|O
by	|O
means	|O
of	|O
Grimelius	|O
'	|O
silver	|O
staining	|O
and	|O
immunostaining	|O
for	|O
chromogranin	|B-PROTEIN
,	|O
a	|O
general	|O
marker	|O
of	|O
endocrine	|O
cells	|O
.	|O

The	|O
ratio	|O
of	|O
radioactivity	|O
in	|O
tumour	|O
compared	|O
with	|O
normal	|O
tissue	|O
(	|O
T	|O
:	|O
N	|O
ratio	|O
)	|O
was	|O
determined	|O
after	|O
simultaneously	|O
injecting	|O
microspheres	|O
into	|O
the	|O
portal	|O
and	|O
arterial	|O
circulation	|O
of	|O
each	|O
animal	|O
.	|O

The	|O
mRNA	|O
was	|O
converted	|O
to	|O
cDNA	|O
and	|O
amplified	|O
by	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
technique	|O
.	|O

Tissue	|O
necrosis	|O
was	|O
evaluated	|O
using	|O
triphenyltetrazolium	|O
staining	|O
and	|O
was	|O
related	|O
to	|O
two	|O
major	|O
baseline	|O
predictors	|O
of	|O
infarct	|O
size	|O
:	|O
anatomic	|O
risk	|O
zone	|O
size	|O
and	|O
coronary	|O
collateral	|O
flow	|O
.	|O

To	|O
study	|O
the	|O
retinal	|O
surface	|O
in	|O
the	|O
human	|O
eye	|O
in	|O
normal	|O
and	|O
diseased	|O
states	|O
we	|O
used	|O
laser	|O
scanning	|O
tomography	|O
.	|O

Previously	|O
,	|O
we	|O
reported	|O
the	|O
sequence	|O
of	|O
the	|O
gene	|O
encoding	|O
human	|O
K14	|B-PROTEIN
(	|O
D.	|O

A	|O
potential	|O
TATA	|O
box	|O
is	|O
located	|O
29	|O
base	|O
pairs	|O
upstream	|O
of	|O
the	|O
first	|O
transcription	|O
initiation	|O
site	|O
.	|O

Cotransfection	|O
of	|O
either	|O
construct	|O
with	|O
plasmids	|O
encoding	|O
PKI	|B-PROTEIN
(	|O
1-31	|O
)	|O
inhibits	|O
cAMP	|O
-	|O
stimulated	|O
but	|O
not	|O
basal	|O
-	|O
or	|O
phorbol	|O
ester	|O
-	|O
stimulated	|O
expression	|O
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
5'	|O
flanking	|O
region	|O
revealed	|O
several	|O
GC	|O
boxes	|O
but	|O
no	|O
identifiable	|O
TATA	|O
box	|O
.	|O

The	|O
underlying	|O
cirrhosis	|O
was	|O
alcoholic	|O
in	|O
11	|O
(	|O
53.3%	|O
)	|O
,	|O
cryptogenic	|O
in	|O
5	|O
(	|O
23.8%	|O
)	|O
,	|O
and	|O
hepatitis	|O
B	|O
chronic	|O
infection	|O
related	|O
in	|O
5	|O
(	|O
23.8%	|O
)	|O
.	|O

Once	|O
P	|B-PROTEIN
-	|I-PROTEIN
450scc	|I-PROTEIN
mRNA	|O
is	|O
induced	|O
as	|O
a	|O
consequence	|O
of	|O
the	|O
LH	|B-PROTEIN
/	|O
hCG	|B-PROTEIN
surge	|O
it	|O
is	|O
constitutively	|O
maintained	|O
by	|O
luteinized	|O
cells	|O
in	|O
vivo	|O
(	|O
0-4	|O
days	|O
)	|O
and	|O
in	|O
vitro	|O
(	|O
0-9	|O
days	|O
)	|O
in	|O
the	|O
absence	|O
of	|O
gonadotropins	|B-PROTEIN
,	|O
is	|O
susceptible	|O
to	|O
modulation	|O
by	|O
prolactin	|B-PROTEIN
and	|O
is	|O
no	|O
longer	|O
regulated	|O
by	|O
cAMP	|O
.	|O

Similarly	|O
,	|O
a	|O
human	|O
but	|O
not	|O
a	|O
bovine	|O
alpha	|B-PROTEIN
transgene	|I-PROTEIN
was	|O
expressed	|O
in	|O
placenta	|O
in	|O
transgenic	|O
mice	|O
.	|O

A	|O
rapid	|O
staining	|O
technique	|O
for	|O
Leishmania	|O
parasites	|O
in	|O
splenic	|O
aspirate	|O
smears	|O
.	|O

NIK	|O
-	|O
244	|O
suppressed	|O
coronary	|O
ligation	|O
-	|O
and	|O
digitalis	|O
-	|O
induced	|O
arrhythmias	|O
,	|O
and	|O
the	|O
minimum	|O
effective	|O
plasma	|O
concentrations	|O
for	|O
arrhythmias	|O
induced	|O
by	|O
24	|O
-	|O
h	|O
and	|O
48	|O
-	|O
h	|O
coronary	|O
ligation	|O
and	|O
digitalis	|O
were	|O
0.41	|O
+	|O
/	|O
-	|O
0.10	|O
(	|O
by	|O
1	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
)	|O
,	|O
0.70	|O
+	|O
/	|O
-	|O
0.13	|O
(	|O
by	|O
1	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
)	|O
,	|O
and	|O
0.21	|O
+	|O
/	|O
-	|O
0.08	|O
(	|O
by	|O
0.5	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
)	|O
microgram	|O
/	|O
ml	|O
,	|O
respectively	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
of	|O
the	|O
mean	|O
,	|O
n	|O
=	|O
6	|O
)	|O
.	|O

In	|O
TNF	|B-PROTEIN
-	|O
resistant	|O
T24	|O
bladder	|O
carcinoma	|O
cells	|O
,	|O
TNF	|B-PROTEIN
failed	|O
to	|O
alter	|O
EGF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
tyrosine	|O
protein	|O
kinase	|O
activity	|O
although	|O
both	|O
EGF	|B-PROTEIN
and	|O
phorbol	|O
ester	|O
were	|O
shown	|O
to	|O
modulate	|O
the	|O
enzymatic	|O
activity	|O
of	|O
the	|O
receptor	|O
in	|O
these	|O
cells	|O
.	|O

Thus	|O
,	|O
phosphodiesterase	|O
inhibitors	|O
that	|O
produce	|O
an	|O
opiate	|O
quasi	|O
-	|O
withdrawal	|O
syndrome	|O
potentiate	|O
interoceptive	|O
stimuli	|O
and	|O
weight	|O
loss	|O
associated	|O
with	|O
the	|O
withdrawal	|O
syndrome	|O
precipitated	|O
by	|O
naltrexone	|O
in	|O
morphine	|O
-	|O
dependent	|O
rats	|O
.	|O

The	|O
diagnostic	|O
value	|O
of	|O
blood	|O
serum	|O
and	|O
urinary	|O
amylase	|B-PROTEIN
,	|O
lipase	|B-PROTEIN
,	|O
and	|O
trypsin	|B-PROTEIN
in	|O
exacerbations	|O
of	|O
chronic	|O
relapsing	|O
pancreatitis	|O
is	|O
discussed	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
the	|O
mechanism	|O
of	|O
action	|O
,	|O
two	|O
groups	|O
of	|O
inodilators	|O
are	|O
distinguished	|O
,	|O
the	|O
phosphodiesterase	|O
inhibitors	|O
and	|O
the	|O
dopaminergic	|O
agents	|O
.	|O

Structural	|O
organization	|O
and	|O
expression	|O
of	|O
the	|O
mouse	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
.	|O

Intravenous	|O
gamma	|B-PROTEIN
globulins	|I-PROTEIN

Following	|O
chondroitinase	|B-PROTEIN
AC	|I-PROTEIN
and	|I-PROTEIN
ABC	|I-PROTEIN
digestion	|O
,	|O
staining	|O
reactions	|O
suggested	|O
that	|O
the	|O
highest	|O
levels	|O
of	|O
dermatan	|O
sulfate	|O
were	|O
in	|O
the	|O
diabetes	|O
resistant	|O
group	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
compared	|O
to	|O
diabetic	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
compared	|O
to	|O
diabetes	|O
prone	|O
)	|O
and	|O
the	|O
highest	|O
levels	|O
of	|O
chondroitin	|O
sulfates	|O
were	|O
in	|O
the	|O
diabetes	|O
prone	|O
group	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

Myocardial	|O
perfusion	|O
was	|O
evaluated	|O
using	|O
the	|O
enhanced	|O
gray	|O
level	|O
after	|O
contrast	|O
injection	|O
,	|O
and	|O
the	|O
level	|O
was	|O
compared	|O
with	|O
the	|O
morphology	|O
and	|O
degree	|O
of	|O
collateral	|O
development	|O
.	|O

Once	|O
NGF	|B-PROTEIN
administration	|O
is	|O
proven	|O
effective	|O
it	|O
will	|O
be	|O
possible	|O
to	|O
develop	|O
alternative	|O
ways	|O
of	|O
NGF	|B-PROTEIN
administration	|O
.	|O

During	|O
the	|O
program	|O
's	|O
use	|O
at	|O
the	|O
RSNA	|O
meeting	|O
,	|O
the	|O
program	|O
selected	|O
the	|O
correct	|O
diagnosis	|O
in	|O
the	|O
top	|O
five	|O
22%	|O
of	|O
the	|O
time	|O
.	|O

Immunoglobulin	|B-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
(	|O
IgL	|B-PROTEIN
)	|O
diversity	|O
is	|O
generated	|O
in	|O
the	|O
chicken	|O
by	|O
recombination	|O
between	|O
the	|O
single	|O
functional	|O
variable	|O
(	|O
VL	|B-PROTEIN
)	|O
and	|O
joining	|O
(	|O
JL	|B-PROTEIN
)	|O
gene	|O
segments	|O
and	|O
subsequent	|O
somatic	|O
diversification	|O
of	|O
the	|O
rearranged	|O
VL	|B-PROTEIN
region	|O
.	|O

The	|O
results	|O
were	|O
as	|O
follows	|O
:	|O
1	|O
)	|O
Total	|O
integrated	|O
EMG	|O
activity	|O
of	|O
FB	|O
group	|O
was	|O
approximately	|O
equal	|O
in	|O
any	|O
occluded	|O
position	|O
,	|O
whereas	|O
that	|O
of	|O
CG	|O
and	|O
GF	|O
group	|O
varied	|O
from	|O
position	|O
to	|O
position	|O
.	|O

Muscle	|O
action	|O
potential	|O
and	|O
masticatory	|O
rhythm	|O
of	|O
anterior	|O
temporal	|O
and	|O
masseter	|O
muscles	|O
in	|O
children	|O
and	|O
adults	|O

In	|O
76%	|O
of	|O
59	|O
lead	|O
-	|O
toxic	|O
children	|O
,	|O
bone	|O
lead	|O
values	|O
measured	|O
by	|O
LXRF	|O
were	|O
equal	|O
to	|O
or	|O
greater	|O
than	|O
those	|O
measured	|O
in	|O
normal	|O
and	|O
industrially	|O
exposed	|O
adults	|O
.	|O

When	|O
considered	|O
with	|O
the	|O
known	|O
neurotoxic	|O
effects	|O
on	|O
children	|O
of	|O
"	|O
low	|O
levels	|O
"	|O
of	|O
exposure	|O
to	|O
lead	|O
,	|O
these	|O
results	|O
also	|O
suggest	|O
that	|O
either	|O
an	|O
excessively	|O
narrow	|O
margin	|O
of	|O
safety	|O
or	|O
insufficient	|O
safety	|O
is	|O
provided	|O
by	|O
present	|O
U.S.	|O
guidelines	|O
,	|O
which	|O
classify	|O
an	|O
elevated	|O
blood	|O
lead	|O
concentration	|O
as	|O
25	|O
micrograms	|O
/	|O
dl	|O
or	|O
greater	|O
.	|O

In	|O
resting	|O
3T3	|O
cells	|O
,	|O
jun	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
is	|O
expressed	|O
at	|O
a	|O
higher	|O
level	|O
compared	|O
to	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
and	|O
jun	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
,	|O
and	|O
its	|O
transcription	|O
is	|O
stimulated	|O
only	|O
slightly	|O
by	|O
serum	|O
growth	|O
factors	|O
.	|O

The	|O
thrombolytic	|O
effects	|O
of	|O
native	|O
tissue	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
AK	|B-PROTEIN
-	|I-PROTEIN
124	|I-PROTEIN
)	|O
on	|O
experimental	|O
canine	|O
coronary	|O
thrombosis	|O
.	|O

O2	|O
and	|O
CO2	|O
in	|O
the	|O
tracheostomy	|O
tube	|O
were	|O
continuously	|O
monitored	|O
by	|O
mass	|O
spectrometry	|O
using	|O
a	|O
special	|O
sample	|O
-	|O
hold	|O
phase	|O
-	|O
locked	|O
sampling	|O
technique	|O
.	|O

Enzyme	|O
-	|O
linked	|O
immunosorbent	|O
assay	|O
for	|O
screening	|O
aflatoxin	|O
B1	|O
in	|O
cottonseed	|O
products	|O
and	|O
mixed	|O
feed	|O
:	|O
collaborative	|O
study	|O
.	|O

However	|O
,	|O
experiments	|O
with	|O
S1	|B-PROTEIN
mapping	|O
of	|O
in	|O
vivo	|O
transcripts	|O
,	|O
gene	|O
disruptions	|O
in	|O
the	|O
alpha	|O
region	|O
,	|O
and	|O
a	|O
single	|O
-	|O
copy	|O
transcriptional	|O
fusion	|O
vector	|O
all	|O
suggested	|O
that	|O
these	|O
possible	|O
promoters	|O
were	|O
largely	|O
inactive	|O
during	|O
logarithmic	|O
growth	|O
,	|O
that	|O
the	|O
major	|O
promoter	|O
for	|O
the	|O
alpha	|O
operon	|O
lay	|O
upstream	|O
from	|O
the	|O
region	|O
cloned	|O
,	|O
and	|O
that	|O
the	|O
genes	|O
in	|O
the	|O
IF1	|B-PROTEIN
to	|O
L17	|B-PROTEIN
interval	|O
were	|O
cotranscribed	|O
.	|O

Functional	|O
rearranged	|O
antibody	|O
genes	|O
were	|O
detected	|O
with	|O
JH	|B-PROTEIN
and	|O
VH	|B-PROTEIN
heavy	|O
chain	|O
probes	|O
and	|O
with	|O
Jk	|B-PROTEIN
and	|O
Vk	|B-PROTEIN
light	|O
chain	|O
probes	|O
.	|O

Two	|O
specific	|O
DNA	|O
-	|O
protein	|O
complexes	|O
were	|O
identified	|O
in	|O
gel	|O
retardation	|O
assays	|O
using	|O
HeLa	|O
cell	|O
nuclear	|O
extracts	|O
and	|O
an	|O
oligonucleotide	|O
probe	|O
spanning	|O
the	|O
footprinted	|O
region	|O
.	|O

After	|O
transfection	|O
,	|O
specific	|O
TSH	|B-PROTEIN
beta	|I-PROTEIN
promoter	|O
activity	|O
was	|O
evident	|O
in	|O
both	|O
TRH	|B-PROTEIN
-	|O
responsive	|O
pituitary	|O
-	|O
derived	|O
GH3	|O
and	|O
primary	|O
pituitary	|O
cell	|O
cultures	|O
.	|O

In	|O
transformed	|O
E.	|O
coli	|O
,	|O
constitutive	|O
CAT	|B-PROTEIN
expression	|O
is	|O
maintained	|O
when	|O
as	|O
little	|O
as	|O
0.3	|O
kilobase	|O
of	|O
DNA	|O
from	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
1.6	|O
-	|O
kilobase	|O
segment	|O
is	|O
inserted	|O
in	|O
the	|O
correct	|O
orientation	|O
in	|O
front	|O
of	|O
the	|O
CAT	|B-PROTEIN
gene	|O
.	|O

Lowering	|O
of	|O
the	|O
renal	|O
blood	|O
flow	|O
alters	|O
the	|O
glomerular	|O
and	|O
tubular	|O
excretion	|O
processes	|O
.	|O

Tonometry	|O
of	|O
blood	|O
samples	|O
from	|O
patients	|O
may	|O
also	|O
be	|O
used	|O
in	|O
the	|O
determination	|O
of	|O
acid	|O
-	|O
base	|O
quantities	|O
and	|O
hemoglobin	|B-PROTEIN
-	|O
oxygen	|O
affinity	|O
e.g.	|O
p50	|O
.	|O

100	|O
and	|O
14	|O
p	|O
.	|O

Isolation	|O
of	|O
Weeksella	|O
virosa	|O
(	|O
formerly	|O
CDC	|O
group	|O
IIf	|O
)	|O
from	|O
a	|O
vaginal	|O
sample	|O
.	|O

Here	|O
,	|O
we	|O
alter	|O
the	|O
dimerization	|O
specificity	|O
of	|O
Fos	|B-PROTEIN
by	|O
precisely	|O
replacing	|O
its	|O
leucine	|O
zipper	|O
with	|O
that	|O
from	|O
GCN4	|B-PROTEIN
.	|O

Growth	|O
of	|O
tracheal	|O
anastomoses	|O
in	|O
growing	|O
animals	|O

Fourth	|O
,	|O
sometime	|O
between	|O
4	|O
and	|O
24	|O
hours	|O
of	|O
recovery	|O
is	|O
necessary	|O
to	|O
reverse	|O
the	|O
effect	|O
of	|O
chronic	|O
hypoxia	|O
on	|O
cerebral	|O
blood	|O
flow	|O
.	|O

The	|O
ORF1	|O
product	|O
was	|O
required	|O
for	|O
competence	|O
,	|O
while	|O
ORF2	|O
,	|O
which	|O
was	|O
cotranscribed	|O
with	|O
ORF1	|O
and	|O
encoded	|O
a	|O
predicted	|O
protein	|O
of	|O
126	|O
amino	|O
acids	|O
,	|O
was	|O
not	|O
.	|O

Kindling	|O
of	|O
the	|O
primary	|O
visual	|O
cortex	|O
(	|O
VC	|O
)	|O
was	|O
compared	|O
with	|O
that	|O
of	|O
the	|O
amygdala	|O
in	|O
cats	|O
.	|O

Abundant	|O
infiltration	|O
of	|O
lymphocytes	|O
and	|O
plasma	|O
cells	|O
was	|O
also	|O
wide	|O
-	|O
spread	|O
beneath	|O
the	|O
carcinoma	|O
in	|O
situ	|O
,	|O
together	|O
with	|O
the	|O
lymphoid	|O
follicles	|O
.	|O

These	|O
case	|O
reports	|O
provide	|O
further	|O
evidence	|O
that	|O
LiCO3	|O
can	|O
be	|O
a	|O
useful	|O
medication	|O
in	|O
the	|O
treatment	|O
of	|O
aggressive	|O
behavior	|O
and	|O
affective	|O
instability	|O
after	|O
brain	|O
injury	|O
,	|O
but	|O
that	|O
it	|O
has	|O
significant	|O
potential	|O
for	|O
neurotoxicity	|O
in	|O
this	|O
population	|O
,	|O
particularly	|O
when	|O
used	|O
in	|O
conjunction	|O
with	|O
neuroleptic	|O
agents	|O
.	|O

In	|O
all	|O
sessions	|O
under	|O
IFN	|B-PROTEIN
,	|O
the	|O
latency	|O
of	|O
the	|O
P100	|O
component	|O
of	|O
the	|O
VEP	|O
was	|O
shortened	|O
as	|O
compared	|O
to	|O
baseline	|O
conditions	|O
.	|O

Among	|O
100	|O
cases	|O
of	|O
post	|O
-	|O
transfusion	|O
hepatitis	|O
,	|O
10	|O
are	|O
due	|O
to	|O
the	|O
hepatitis	|O
B	|O
virus	|O
(	|O
despite	|O
systematic	|O
search	|O
for	|O
HBs	|B-PROTEIN
Ag	|I-PROTEIN
)	|O
,	|O
89	|O
are	|O
due	|O
to	|O
one	|O
of	|O
the	|O
non	|O
-	|O
A	|O
non	|O
-	|O
B	|O
viruses	|O
(	|O
not	|O
detectable	|O
by	|O
specific	|O
serological	|O
tests	|O
)	|O
and	|O
1	|O
to	|O
several	|O
viruses	|O
,	|O
specially	|O
CMV	|O
.	|O

Recessive	|O
lethal	|O
mutations	|O
were	|O
isolated	|O
based	|O
upon	|O
failure	|O
to	|O
complement	|O
the	|O
recessive	|O
lethality	|O
of	|O
Df	|O
(	|O
3L	|O
)	|O
RR2	|O
,	|O
a	|O
deletion	|O
of	|O
the	|O
DRE	|O
region	|O
that	|O
removes	|O
16-18	|O
polytene	|O
chromosome	|O
bands	|O
.	|O

Current	|O
status	|O
and	|O
future	|O
perspectives	|O

K.	|O

A	|O
215	|O
-	|O
base	|O
-	|O
pair	|O
(	|O
bp	|O
)	|O
region	|O
of	|O
the	|O
mouse	|O
MOPC	|B-PROTEIN
41	|I-PROTEIN
kappa	|I-PROTEIN
light	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
immunoglobulin	|I-PROTEIN
gene	|O
enhancer	|O
has	|O
been	|O
analyzed	|O
for	|O
specific	|O
binding	|O
of	|O
lymphoid	|O
and	|O
nonlymphoid	|O
nuclear	|O
factors	|O
.	|O

This	|O
paper	|O
presents	|O
the	|O
reasons	|O
why	|O
countries	|O
to	|O
which	|O
Chagas	|O
disease	|O
is	|O
endemic	|O
should	|O
carry	|O
out	|O
the	|O
relevant	|O
research	|O
themselves	|O
.	|O

The	|O
PETCO2	|O
measurement	|O
during	|O
precordial	|O
compression	|O
predicted	|O
the	|O
success	|O
of	|O
defibrillation	|O
with	|O
return	|O
of	|O
spontaneous	|O
circulation	|O
.	|O

Gastric	|O
CO2	|O
/	|O
HCO3	|O
was	|O
determined	|O
in	|O
absence	|O
of	|O
simultaneous	|O
inhibition	|O
of	|O
acid	|O
secretion	|O
by	|O
intra	|O
-	|O
and	|O
extragastric	|O
pCO2	|O
/	|O
pH	|O
measurements	|O
in	|O
23	|O
persons	|O
and	|O
calculated	|O
using	|O
the	|O
equation	|O
of	|O
Henderson	|O
-	|O
Hasselbalch	|O
.	|O
pCO2	|O
was	|O
measured	|O
with	|O
use	|O
of	|O
a	|O
new	|O
electrode	|O
.	|O

Follow	|O
-	|O
up	|O
study	|O
showed	|O
85%	|O
of	|O
these	|O
patients	|O
with	|O
effectiveness	|O
.	|O

The	|O
other	|O
patients	|O
continued	|O
the	|O
trial	|O
with	|O
single	|O
daily	|O
doses	|O
of	|O
monotherapy	|O
.	|O

Neonatal	|O
Chagas	|O
disease	|O
:	|O
laboratory	|O
diagnosis	|O
during	|O
the	|O
first	|O
year	|O
of	|O
life	|O

Using	|O
mutated	|O
IL2R	|B-PROTEIN
alpha	|I-PROTEIN
promoter	|O
constructs	|O
in	|O
transient	|O
transfection	|O
and	|O
DNA	|O
binding	|O
assays	|O
,	|O
we	|O
now	|O
demonstrate	|O
that	|O
sequences	|O
located	|O
immediately	|O
upstream	|O
and	|O
downstream	|O
of	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
enhancer	|O
also	|O
contribute	|O
to	|O
the	|O
regulation	|O
of	|O
IL2R	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
expression	|O
.	|O

Palindromic	|O
rheumatism	|O

Inefficacy	|O
of	|O
phosphine	|O
fumigation	|O
against	|O
ticks	|O
.	|O

Forty	|O
patients	|O
,	|O
divided	|O
according	|O
to	|O
their	|O
initial	|O
total	|O
gastrointestinal	|O
transit	|O
times	|O
and	|O
presenting	|O
symptoms	|O
,	|O
were	|O
treated	|O
with	|O
cimetropium	|O
bromide	|O
50	|O
mg	|O
t.d.s	|O
.	|O
or	|O
placebo	|O
for	|O
1	|O
month	|O
according	|O
to	|O
a	|O
double	|O
-	|O
blind	|O
,	|O
parallel	|O
group	|O
design	|O
.	|O

An	|O
immunologically	|O
related	|O
protein	|O
was	|O
detected	|O
in	|O
ribosome	|O
and	|O
membrane	|O
fractions	|O
of	|O
mitochondria	|O
from	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Mapping	|O
of	|O
RNA	|O
-	|O
temperature	|O
-	|O
sensitive	|O
mutants	|O
of	|O
Sindbis	|O
virus	|O
:	|O
complementation	|B-PROTEIN
group	|I-PROTEIN
F	|I-PROTEIN
mutants	|O
have	|O
lesions	|O
in	|O
nsP4	|B-PROTEIN
.	|O

The	|O
effect	|O
of	|O
the	|O
thromboxane	|O
A2	|O
(	|B-PROTEIN
TXA2	|I-PROTEIN
)	|I-PROTEIN
/	|I-PROTEIN
prostaglandin	|I-PROTEIN
endoperoxide	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
,	|O
SQ	|O
29,548	|O
on	|O
pacing	|O
-	|O
induced	|O
ischemia	|O
was	|O
determined	|O
in	|O
anesthetized	|O
open	|O
-	|O
chest	|O
dogs	|O
.	|O

According	|O
to	|O
the	|O
published	|O
sequence	|O
of	|O
the	|O
CHS1	|B-PROTEIN
gene	|O
,	|O
this	|O
fragment	|O
contains	|O
four	|O
repeats	|O
of	|O
a	|O
TGAAACA	|O
consensus	|O
sequence	|O
previously	|O
identified	|O
in	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
-	|O
inducible	|O
BAR1	|B-PROTEIN
promoter	|O
[	|O
Kronstad	|O
,	|O
J.	|O

The	|O
recovery	|O
index	|O
(	|O
T25	|O
-	|O
T75	|O
)	|O
after	|O
the	|O
infusion	|O
stopped	|O
was	|O
similar	|O
in	|O
patients	|O
who	|O
received	|O
mivacurium	|O
and	|O
those	|O
who	|O
received	|O
suxamethonium	|O
.	|O

The	|O
sign	|O
of	|O
Leser	|O
-	|O
Trelat	|O
:	|O
does	|O
it	|O
exist	|O
?	|O
The	|O
sign	|O
of	|O
Leser	|O
-	|O
Trelat	|O
is	|O
usually	|O
regarded	|O
as	|O
a	|O
reliable	|O
cutaneous	|O
marker	|O
of	|O
internal	|O
malignancy	|O
.	|O

Xenopus	|O
homolog	|O
of	|O
the	|O
mos	|B-PROTEIN
protooncogene	|O
transforms	|O
mammalian	|O
fibroblasts	|O
and	|O
induces	|O
maturation	|O
of	|O
Xenopus	|O
oocytes	|O
.	|O

Southern	|O
blot	|O
analyses	|O
demonstrated	|O
a	|O
low	|O
,	|O
if	|O
not	|O
single	|O
,	|O
copy	|O
number	|O
for	|O
this	|O
gene	|O
and	|O
conservation	|O
of	|O
this	|O
domain	|O
in	|O
other	|O
vertebrates	|O
.	|O

Three	|O
missense	|O
mutants	|O
in	|O
subunit	|O
a	|O
of	|O
the	|O
Escherichia	|O
coli	|O
F1F0	|B-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
were	|O
isolated	|O
and	|O
characterized	|O
after	|O
hydroxylamine	|O
mutagenesis	|O
of	|O
a	|O
plasmid	|O
carrying	|O
the	|O
uncB	|B-PROTEIN
(	|O
subunit	|O
a	|O
)	|O
gene	|O
.	|O

Moreover	|O
,	|O
exons	|O
2a	|O
and	|O
2b	|O
share	|O
the	|O
same	|O
5'	|O
sequence	|O
but	|O
differ	|O
from	|O
each	|O
other	|O
by	|O
the	|O
use	|O
of	|O
two	|O
distinct	|O
donor	|O
splice	|O
sites	|O
171	|O
bp	|O
apart	|O
in	|O
the	|O
gene	|O
.	|O

S1	|B-PROTEIN
nuclease	|I-PROTEIN
analysis	|O
of	|O
RNA	|O
prepared	|O
after	|O
transfection	|O
of	|O
these	|O
HIV	|O
constructs	|O
into	|O
HeLa	|O
cells	|O
infected	|O
with	|O
wild	|O
-	|O
type	|O
adenovirus	|O
indicated	|O
that	|O
the	|O
enhancer	|O
,	|O
SP1	|B-PROTEIN
,	|O
TATA	|O
,	|O
and	|O
a	|O
portion	|O
of	|O
the	|O
transactivation	|O
-	|O
responsive	|O
element	|O
were	|O
each	|O
required	|O
for	|O
complete	|O
E1A	|B-PROTEIN
/	|O
E1B	|B-PROTEIN
-	|O
mediated	|O
activation	|O
of	|O
the	|O
HIV	|B-PROTEIN
LTR	|I-PROTEIN
.	|O

In	|O
supine	|O
position	|O
,	|O
plasma	|O
ANP	|B-PROTEIN
levels	|O
ranged	|O
from	|O
12	|O
pg	|O
/	|O
ml	|O
to	|O
51.5	|O
pg	|O
/	|O
ml	|O
,	|O
with	|O
an	|O
average	|O
level	|O
of	|O
35.3	|O
+	|O
/	|O
-	|O
11.5	|O
pg	|O
/	|O
ml	|O
.	|O

The	|O
overall	|O
prevalence	|O
of	|O
HBV	|O
markers	|O
was	|O
higher	|O
among	|O
staff	|O
members	|O
than	|O
in	|O
the	|O
blood	|O
donors	|O
of	|O
our	|O
area	|O
.	|O

Quantitative	|O
predictions	|O
are	|O
confirmed	|O
for	|O
the	|O
positive	|O
responses	|O
,	|O
but	|O
not	|O
for	|O
the	|O
negatives	|O
,	|O
suggesting	|O
that	|O
the	|O
SSTS	|O
model	|O
is	|O
incorrect	|O
.	|O

Plasma	|O
concentrations	|O
of	|O
ANF	|B-PROTEIN
(	|O
pANF	|B-PROTEIN
)	|O
,	|O
aldosterone	|O
(	|O
PAC	|O
)	|O
and	|O
renin	|B-PROTEIN
(	|O
PRC	|B-PROTEIN
)	|O
were	|O
measured	|O
daily	|O
,	|O
as	|O
were	|O
hemodynamic	|O
parameters	|O
.	|O

The	|O
adenovirus	|O
E1A	|B-PROTEIN
gene	|O
encodes	|O
a	|O
protein	|O
that	|O
transcriptionally	|O
activates	|O
viral	|O
early	|B-PROTEIN
genes	|I-PROTEIN
.	|O

Administration	|O
of	|O
dexamethasone	|O
was	|O
associated	|O
with	|O
progressive	|O
rises	|O
in	|O
plasma	|O
17	|O
alpha	|O
OH	|O
progesterone	|O
,	|O
11	|O
beta	|O
-	|O
desoxycortisol	|O
,	|O
DHEA	|O
sulphate	|O
,	|O
androstenedione	|O
and	|O
testosterone	|O
,	|O
together	|O
with	|O
increased	|O
urinary	|O
excretion	|O
of	|O
androsterone	|O
,	|O
11	|O
beta	|O
OH	|O
androsterone	|O
,	|O
etiocholanolone	|O
,	|O
DHEA	|O
,	|O
and	|O
16	|O
alpha	|O
OH	|O
DHEA	|O
.	|O

RNA	|O
transcripts	|O
that	|O
hybridize	|O
to	|O
the	|O
introduced	|O
foreign	|O
gene	|O
have	|O
been	|O
identified	|O
.	|O

In	|O
HeLa	|O
cells	|O
,	|O
it	|O
activated	|O
transcription	|O
from	|O
the	|O
herpes	|O
simplex	|O
virus	|O
type	|O
1	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
promoter	|O
linked	|O
to	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
gene	|O
when	|O
located	|O
in	|O
inverted	|O
orientation	|O
upstream	|O
of	|O
the	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
promoter	|O
or	|O
downstream	|O
of	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
gene	|O
coding	|O
sequence	|O
.	|O

At	|O
the	|O
basal	|O
unstimulated	|O
condition	|O
,	|O
Ren1d	|B-PROTEIN
5'	|O
flanking	|O
sequence	|O
in	|O
the	|O
sense	|O
orientation	|O
inhibited	|O
basal	|O
CAT	|B-PROTEIN
expression	|O
from	|O
the	|O
TK	|B-PROTEIN
promoter	|O
of	|O
pUTKAT1	|O
,	|O
whereas	|O
the	|O
same	|O
sequence	|O
in	|O
the	|O
antisense	|O
orientation	|O
did	|O
not	|O
.	|O

None	|O
were	|O
restricted	|O
from	|O
clinical	|O
duties	|O
,	|O
were	|O
given	|O
varicella	|O
-	|O
zoster	|O
immune	|B-PROTEIN
globulin	|I-PROTEIN
,	|O
or	|O
developed	|O
disease	|O
.	|O

In	|O
the	|O
formalin	|O
test	|O
,	|O
however	|O
,	|O
naloxone	|O
attenuated	|O
morphine	|O
analgesia	|O
at	|O
the	|O
lower	|O
doses	|O
(	|O
0.1	|O
and	|O
0.3	|O
mg	|O
/	|O
kg	|O
)	|O
and	|O
potentiated	|O
morphine	|O
analgesia	|O
at	|O
the	|O
highest	|O
dose	|O
(	|O
10	|O
mg	|O
/	|O
kg	|O
)	|O
.	|O

We	|O
have	|O
isolated	|O
cDNA	|O
clones	|O
from	|O
rat	|O
brain	|O
and	|O
human	|O
liver	|O
encoding	|O
a	|O
putative	|O
isoform	|O
of	|O
the	|O
Na	|B-PROTEIN
,	|I-PROTEIN
K	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
beta	|O
subunit	|O
.	|O

We	|O
have	|O
determined	|O
that	|O
several	|O
E1	|B-PROTEIN
mutants	|O
mapping	|O
in	|O
both	|O
the	|O
M	|O
and	|O
R	|O
regions	|O
and	|O
a	|O
single	|O
mutant	|O
of	|O
the	|O
upstream	|O
regulatory	|O
region	|O
have	|O
a	|O
higher	|O
transforming	|O
activity	|O
on	|O
mouse	|O
C127	|O
cells	|O
than	|O
the	|O
wild	|O
-	|O
type	|O
genome	|O
does	|O
.	|O

UbiA	|B-PROTEIN
is	|O
also	|O
unique	|O
among	|O
known	|O
polyubiquitin	|B-PROTEIN
genes	|O
in	|O
containing	|O
four	|O
cis	|O
-	|O
spliced	|O
introns	|O
within	|O
its	|O
coding	|O
sequence	|O
.	|O

That	|O
of	|O
the	|O
T2	|B-PROTEIN
gene	|O
contains	|O
numerous	|O
potential	|O
sites	|O
for	|O
binding	|O
the	|O
mammalian	|O
transcription	|O
factor	|O
SP1	|B-PROTEIN
,	|O
but	|O
no	|O
TATA	|O
or	|O
CCAAT	|O
sequences	|O
are	|O
evident	|O
near	|O
to	|O
its	|O
5'	|O
end	|O
,	|O
although	|O
these	|O
latter	|O
features	|O
are	|O
associated	|O
with	|O
the	|O
human	|O
T1	|B-PROTEIN
gene	|O
.	|O

Radiation	|O
therapy	|O
was	|O
effective	|O
in	|O
controlling	|O
symptomatic	|O
metastasis	|O
in	|O
all	|O
three	|O
patients	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
patients	|O
who	|O
undergo	|O
postoperative	|O
irradiation	|O
for	|O
low	|O
grade	|O
spinal	|O
astrocytomas	|O
and	|O
localized	|O
spinal	|O
ependymomas	|O
achieve	|O
excellent	|O
survival	|O
.	|O

The	|O
methylation	|O
of	|O
nuclear	|O
and	|O
chloroplast	|O
DNAs	|O
has	|O
been	|O
examined	|O
in	|O
relation	|O
to	|O
the	|O
known	|O
differential	|O
expression	|O
of	|O
C4	|B-PROTEIN
photosynthesis	|O
genes	|O
in	|O
the	|O
bundle	|O
sheath	|O
and	|O
mesophyll	|O
cells	|O
of	|O
etiolated	|O
,	|O
greening	|O
,	|O
and	|O
fully	|O
green	|O
maize	|O
leaves	|O
.	|O

S1	|B-PROTEIN
nuclease	|O
analysis	|O
of	|O
RNA	|O
from	|O
chemically	|O
induced	|O
B95	|O
-	|O
8	|O
cells	|O
and	|O
from	|O
Vero	|O
cells	|O
cotransfected	|O
with	|O
NotI	|B-PROTEIN
repeat	|O
promoter	|O
-	|O
CAT	|B-PROTEIN
and	|O
Z	|B-PROTEIN
showed	|O
that	|O
Z	|B-PROTEIN
transactivation	|O
increased	|O
the	|O
level	|O
of	|O
correctly	|O
initiated	|O
,	|O
stable	|O
RNA	|O
transcripts	|O
.	|O

We	|O
conclude	|O
that	|O
(	|O
a	|O
)	|O
the	|O
likelihood	|O
of	|O
detecting	|O
carcinoma	|O
or	|O
atypical	|O
hyperplasia	|O
exclusively	|O
in	|O
the	|O
adipose	|O
tissue	|O
component	|O
of	|O
grossly	|O
benign	|O
breast	|O
biopsies	|O
is	|O
extremely	|O
low	|O
,	|O
and	|O
(	|O
b	|O
)	|O
a	|O
possible	|O
cost	|O
-	|O
effective	|O
method	|O
of	|O
sampling	|O
grossly	|O
benign	|O
breast	|O
biopsies	|O
consists	|O
of	|O
initially	|O
submitting	|O
a	|O
maximum	|O
of	|O
10	|O
blocks	|O
of	|O
fibrous	|O
parenchyma	|O
for	|O
each	|O
case	|O
,	|O
then	|O
examining	|O
the	|O
remaining	|O
tissue	|O
histologically	|O
only	|O
if	|O
carcinoma	|O
or	|O
atypical	|O
hyperplasia	|O
is	|O
found	|O
among	|O
these	|O
blocks	|O
.	|O

Analysis	|O
of	|O
the	|O
DNA	|O
from	|O
15	|O
cases	|O
of	|O
sporadic	|O
and	|O
familial	|O
Wilms	|O
'	|O
tumor	|O
did	|O
not	|O
reveal	|O
any	|O
changes	|O
,	|O
indicating	|O
that	|O
the	|O
translocation	|O
breakpoint	|O
does	|O
not	|O
reside	|O
in	|O
this	|O
gene	|O
.	|O

We	|O
also	|O
provide	|O
evidence	|O
that	|O
neither	|O
the	|O
lambda	|B-PROTEIN
O	|I-PROTEIN
and	|O
P	|B-PROTEIN
initiators	|I-PROTEIN
nor	|O
the	|O
E.	|O
coli	|O
DnaJ	|B-PROTEIN
and	|O
DnaK	|B-PROTEIN
heat	|O
shock	|O
proteins	|O
play	|O
a	|O
direct	|O
role	|O
in	|O
the	|O
propagation	|O
of	|O
lambda	|O
replication	|O
forks	|O
in	|O
vitro	|O
.	|O

Synthetic	|O
oligonucleotides	|O
representing	|O
the	|O
19	|O
bp	|O
repeat	|O
unit	|O
strongly	|O
reduced	|O
the	|O
activity	|O
of	|O
the	|O
IE1/2	|B-PROTEIN
enhancer	|O
/	|O
promoter	|O
in	|O
cotransfection	|O
assays	|O
after	|O
transient	|O
expression	|O
.	|O

Effects	|O
of	|O
nitrogen	|O
(	|O
PN2	|O
:	|O
5	|O
and	|O
14	|O
MPa	|O
)	|O
and	|O
helium	|O
(	|O
PHe	|O
:	|O
13	|O
and	|O
14	|O
MPa	|O
)	|O
were	|O
also	|O
tested	|O
.	|O

The	|O
mustard	|O
chloroplast	|O
gene	|O
rps16	|B-PROTEIN
is	|O
split	|O
by	|O
an	|O
887	|O
bp	|O
group	|O
II	|O
(	|O
or	|O
III	|O
)	|O
intron	|O
.	|O

Antibodies	|O
raised	|O
to	|O
the	|O
expressed	|O
NS3	|B-PROTEIN
by	|O
immunization	|O
of	|O
mice	|O
detected	|O
both	|O
NS3	|B-PROTEIN
and	|O
NS3A	|B-PROTEIN
in	|O
BTV	|O
-	|O
10	|O
-	|O
infected	|O
BHK	|O
cells	|O
but	|O
not	|O
in	|O
purified	|O
BTV	|O
-	|O
10	|O
virus	|O
particles	|O
.	|O

Similarly	|O
,	|O
supraventricular	|O
tachycaydia	|O
following	|O
resuscitative	|O
efforts	|O
appeared	|O
to	|O
be	|O
associated	|O
with	|O
a	|O
negative	|O
outcome	|O
.	|O

The	|O
negative	|O
calcium	|O
balance	|O
with	|O
hyperparathyroidemia	|O
occurred	|O
after	|O
continuous	|O
oral	|O
administration	|O
of	|O
Cd	|O
and	|O
developed	|O
via	|O
increased	|O
urinary	|O
excretion	|O
of	|O
calcium	|O
.	|O

Clone	|O
4c	|O
(	|O
2681	|O
bp	|O
)	|O
had	|O
a	|O
coding	|O
region	|O
identical	|O
to	|O
that	|O
of	|O
clone	|O
22c	|O
but	|O
it	|O
included	|O
a	|O
putative	|O
intron	|O
of	|O
959	|O
bp	|O
.	|O

The	|O
application	|O
of	|O
ISH	|O
and	|O
IHC	|O
did	|O
not	|O
change	|O
significantly	|O
the	|O
routine	|O
histologic	|O
classification	|O
of	|O
pneumonias	|O
into	|O
CMV	|O
-	|O
IP	|O
and	|O
IIP	|O
.	|O

Validity	|O
of	|O
immunohistology	|O
and	|O
in	|O
situ	|O
hybridization	|O
in	|O
the	|O
differential	|O
diagnosis	|O
of	|O
cytomegalovirus	|O
pneumonia	|O
and	|O
idiopathic	|O
interstitial	|O
pneumonia	|O
after	|O
allogenic	|O
bone	|O
marrow	|O
transplantation	|O

The	|O
unique	|O
nature	|O
and	|O
arrangement	|O
of	|O
the	|O
ANT1	|B-PROTEIN
transcriptional	|O
control	|O
elements	|O
may	|O
account	|O
for	|O
this	|O
differential	|O
expression	|O
.	|O

A	|O
brief	|O
account	|O
of	|O
the	|O
1988	|O
seminar	|O
in	|O
Shanghai	|O
on	|O
viral	|O
hepatitis	|O
A	|O

The	|O
Bacillus	|O
subtilis	|O
phage	|O
phi	|B-PROTEIN
105	|I-PROTEIN
repressor	|O
,	|O
a	|O
lambda	|B-PROTEIN
repressor	|I-PROTEIN
-	|O
like	|O
transcriptional	|O
regulatory	|O
protein	|O
,	|O
was	|O
overproduced	|O
in	|O
Escherichia	|O
coli	|O
and	|O
purified	|O
to	|O
near	|O
homogeneity	|O
in	|O
order	|O
to	|O
examine	|O
its	|O
in	|O
vitro	|O
DNA	|O
-	|O
binding	|O
properties	|O
.	|O

In	|O
consequence	|O
,	|O
the	|O
gpI	|B-PROTEIN
derived	|O
from	|O
cells	|O
infected	|O
with	|O
mO74	|O
showed	|O
antigenic	|O
characteristics	|O
similar	|O
to	|O
those	|O
of	|O
gpI	|B-PROTEIN
from	|O
VZV	|O
-	|O
infected	|O
cells	|O
as	|O
determined	|O
from	|O
the	|O
immunoprecipitation	|O
pattern	|O
,	|O
although	|O
the	|O
molecular	|O
weight	|O
of	|O
each	|O
polypeptide	|O
was	|O
different	|O
,	|O
and	|O
antibody	|O
produced	|O
in	|O
rabbits	|O
infected	|O
with	|O
recombinant	|O
virus	|O
had	|O
a	|O
high	|O
neutralizing	|O
activity	|O
,	|O
when	|O
the	|O
reaction	|O
was	|O
performed	|O
with	|O
complement	|O
.	|O

Erythrocytic	|O
stages	|O
of	|O
mammalian	|O
malarial	|O
parasites	|O
contain	|O
acristate	|O
mitochondria	|O
whose	|O
functions	|O
are	|O
not	|O
well	|O
understood	|O
.	|O

However	|O
,	|O
bilateral	|O
diffuse	|O
pulmonary	|O
infiltrations	|O
developed	|O
21	|O
days	|O
later	|O
.	|O

Grossly	|O
,	|O
the	|O
incidence	|O
of	|O
a	|O
type	|O
IIc	|O
carcinoma	|O
was	|O
46.5%	|O
and	|O
that	|O
of	|O
a	|O
IIc	|O
+	|O
III	|O
type	|O
was	|O
20.5%	|O
,	|O
respectively	|O
.	|O

Restriction	|O
maps	|O
of	|O
the	|O
cloned	|O
plasmids	|O
revealed	|O
that	|O
their	|O
chromosomal	|O
inserts	|O
consisted	|O
of	|O
overlapping	|O
fragments	|O
.	|O

VP5	|B-PROTEIN
,	|O
which	|O
encodes	|O
the	|O
major	|B-PROTEIN
capsid	|I-PROTEIN
protein	|O
,	|O
each	|O
fused	|O
to	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
gene	|O
.	|O

Of	|O
202	|O
initially	|O
seronegative	|O
caretakers	|O
(	|O
observed	|O
for	|O
an	|O
average	|O
of	|O
305	|O
days	|O
per	|O
woman	|O
)	|O
,	|O
19	|O
seroconverted	|O
,	|O
for	|O
an	|O
annual	|O
seroconversion	|O
rate	|O
of	|O
11	|O
percent	|O
.	|O

In	|O
contrast	|O
,	|O
a	|O
similar	|O
fragment	|O
lacking	|O
the	|O
38	|O
-	|O
base	|O
-	|O
pair	|O
region	|O
had	|O
no	|O
such	|O
stabilizing	|O
effect	|O
.	|O

First	|O
,	|O
a	|O
pet54	|B-PROTEIN
::	|O
LEU2	|B-PROTEIN
cytoductant	|O
bearing	|O
the	|O
's	|O
hort	|O
'	|O
mitochondrial	|O
genome	|O
that	|O
lacks	|O
both	|O
COX1	|B-PROTEIN
introns	|O
aI5	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
aI5	|B-PROTEIN
beta	|I-PROTEIN
is	|O
defective	|O
only	|O
in	|O
COX3	|B-PROTEIN
gene	|O
expression	|O
and	|O
not	|O
in	|O
COX1	|B-PROTEIN
mRNA	|O
splicing	|O
or	|O
mRNA	|O
translation	|O
.	|O

Insert2	|O
contains	|O
repetitive	|O
non	|O
-	|O
Ig	|B-PROTEIN
-	|O
related	|O
sequences	|O
and	|O
a	|O
small	|O
Ig	|B-PROTEIN
-	|O
related	|O
sequence	|O
.	|O

Since	|O
considerable	|O
variations	|O
in	|O
length	|O
and	|O
primary	|O
sequence	|O
in	|O
the	|O
CDR3	|B-PROTEIN
(	|O
complementarity	|B-PROTEIN
determining	|I-PROTEIN
region	|I-PROTEIN
)	|O
peptides	|O
of	|O
all	|O
the	|O
H	|B-PROTEIN
-	|I-PROTEIN
chains	|I-PROTEIN
are	|O
evident	|O
,	|O
conservation	|O
of	|O
the	|O
D	|B-PROTEIN
-	|I-PROTEIN
region	|I-PROTEIN
structure	|O
does	|O
not	|O
appear	|O
to	|O
be	|O
necessary	|O
for	|O
effective	|O
hapten	|O
binding	|O
.	|O

Tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
oncogenes	|O
abrogate	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
dependence	|O
of	|O
murine	|O
myeloid	|O
cells	|O
through	|O
signaling	|O
pathways	|O
involving	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
:	|O
conditional	|O
regulation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
transcription	|O
by	|O
temperature	|O
-	|O
sensitive	|O
v	|B-PROTEIN
-	|I-PROTEIN
abl	|I-PROTEIN
.	|O

This	|O
TC	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
enhanson	|O
,	|O
which	|O
is	|O
identical	|O
to	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
motif	|O
from	|O
the	|O
kappa	|B-PROTEIN
chain	|I-PROTEIN
enhancer	|O
,	|O
was	|O
active	|O
in	|O
both	|O
lymphoid	|O
and	|O
non	|O
-	|O
lymphoid	|O
cells	|O
,	|O
which	|O
contrasts	|O
with	|O
the	|O
previously	|O
reported	|O
lymphoid	|O
cell	|O
specificity	|O
of	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
motif	|O
.	|O

The	|O
DNA	|O
helix	|O
at	|O
the	|O
tandemly	|O
repeated	|O
,	|O
13mer	|O
sequence	|O
is	|O
thermodynamically	|O
unstable	|O
,	|O
as	|O
evidenced	|O
by	|O
hypersensitivity	|O
to	|O
single	|B-PROTEIN
-	|I-PROTEIN
strand	|I-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
nuclease	|I-PROTEIN
in	|O
a	|O
negatively	|O
supercoiled	|O
plasmid	|O
,	|O
and	|O
demonstrated	|O
by	|O
stable	|O
DNA	|O
unwinding	|O
seen	|O
after	|O
two	|O
-	|O
dimensional	|O
gel	|O
electrophoresis	|O
of	|O
topoisomers	|O
.	|O

There	|O
has	|O
been	|O
similar	|O
improvement	|O
in	|O
treating	|O
ampullary	|O
and	|O
periampullary	|O
cancer	|O
,	|O
gallbladder	|O
cancer	|O
,	|O
or	|O
extrahepatic	|O
bile	|O
duct	|O
cancer	|O
.	|O

Beta	|B-PROTEIN
-	|I-PROTEIN
endorphin	|I-PROTEIN
,	|O
ACTH	|B-PROTEIN
and	|O
cortisol	|O
secretion	|O
were	|O
measured	|O
in	|O
twelve	|O
healthy	|O
adult	|O
males	|O
after	|O
nasal	|O
spray	|O
administration	|O
200	|O
IU	|O
salmon	|O
calcitonin	|B-PROTEIN
.	|O

The	|O
data	|O
indicate	|O
that	|O
calcitonin	|B-PROTEIN
induced	|O
a	|O
beta	|B-PROTEIN
-	|I-PROTEIN
endorphin	|I-PROTEIN
increase	|O
independent	|O
of	|O
enhanced	|O
corticotrophin	|B-PROTEIN
-	|O
cortisol	|O
release	|O
.	|O

The	|O
DNA	|O
sequences	|O
predict	|O
proteins	|O
for	|O
SRP54sc	|B-PROTEIN
and	|O
SRP54sp	|B-PROTEIN
that	|O
are	|O
47%	|O
and	|O
52%	|O
identical	|O
to	|O
SRP54mam	|B-PROTEIN
,	|O
respectively	|O
.	|O

Other	|O
hemostatic	|O
values	|O
evaluated	|O
were	|O
activated	|O
partial	|O
thromboplastin	|B-PROTEIN
times	|O
,	|O
prothrombin	|B-PROTEIN
times	|O
,	|O
thrombin	|B-PROTEIN
times	|O
,	|O
fibrinogen	|B-PROTEIN
,	|O
platelet	|O
counts	|O
,	|O
and	|O
fibrin	|O
/	|O
fibrinogen	|B-PROTEIN
degradation	|O
products	|O
.	|O

Rare	|O
neurogenic	|O
tumor	|O
with	|O
metastasis	|O
to	|O
mouth	|O
,	|O
jaw	|O
and	|O
face	|O
regions	|O

We	|O
have	|O
designated	|O
the	|O
protein	|O
"	|B-PROTEIN
cellular	|I-PROTEIN
NBP	|I-PROTEIN
"	|I-PROTEIN
(	|O
CNBP	|B-PROTEIN
)	|O
.	|O

Responsiveness	|O
to	|O
beta	|O
-	|O
2	|O
agonist	|O
therapy	|O
was	|O
retained	|O
with	|O
both	|O
agents	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Drug	|O
use	|O
in	|O
trauma	|O
victims	|O
.	|O

A	|O
critical	|O
heart	|O
rate	|O
and	|O
/	|O
or	|O
appropriate	|O
sympathetic	|O
state	|O
was	|O
found	|O
to	|O
provoke	|O
all	|O
instances	|O
of	|O
reentrant	|O
or	|O
automatic	|O
atrial	|O
tachycardia	|O
and	|O
atypical	|O
junctional	|O
tachycardia	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
neu	|B-PROTEIN
proto	|O
-	|O
oncogene	|O
did	|O
not	|O
show	|O
kinase	|O
activity	|O
or	|O
transforming	|O
properties	|O
when	|O
expressed	|O
at	|O
similar	|O
levels	|O
in	|O
NIH	|O
3T3	|O
cells	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

The	|O
65	|O
-	|O
bp	|O
sequence	|O
contains	|O
the	|O
octameric	|O
cAMP	|O
-	|O
responsive	|O
enhancer	|O
(	|O
CRE	|O
)	|O
TGACGTCA	|O
(	|O
nucleotides	|O
-	|O
48	|O
to	|O
-	|O
41	|O
)	|O
.	|O

Somatostatin	|B-PROTEIN
gene	|O
expression	|O
in	|O
pancreatic	|O
islet	|O
cells	|O
is	|O
directed	|O
by	|O
cell	|O
-	|O
specific	|O
DNA	|O
control	|O
elements	|O
and	|O
DNA	|O
-	|O
binding	|O
proteins	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
full	|O
mu	|O
-	|O
opioid	|O
agonists	|O
fentanyl	|O
,	|O
morphine	|O
,	|O
I	|O
-	|O
methadone	|O
and	|O
levorphanol	|O
produced	|O
50%	|O
fentanyl	|O
-	|O
appropriate	|O
responding	|O
at	|O
doses	|O
only	|O
1.3	|O
to	|O
10.9	|O
times	|O
smaller	|O
than	|O
those	|O
required	|O
to	|O
decrease	|O
response	|O
rates	|O
by	|O
50%	|O
.	|O

After	|O
overtraining	|O
on	|O
the	|O
original	|O
discrimination	|O
,	|O
the	|O
controls	|O
showed	|O
the	|O
normal	|O
difficulty	|O
in	|O
learning	|O
the	|O
first	|O
reversal	|O
.	|O

Isolation	|O
and	|O
characterization	|O
of	|O
a	|O
cDNA	|O
encoding	|O
a	|O
putative	|O
cytokine	|O
which	|O
is	|O
induced	|O
by	|O
stimulation	|O
via	|O
the	|O
CD2	|B-PROTEIN
structure	|O
on	|O
human	|O
T	|O
lymphocytes	|O
.	|O

After	|O
termination	|O
of	|O
medication	|O
the	|O
animals	|O
were	|O
kindled	|O
electrically	|O
in	|O
the	|O
nucleus	|O
amygdala	|O
.	|O

Haploid	|O
cells	|O
of	|O
mating	|O
type	|O
A	|O
of	|O
the	|O
basidiomycetous	|O
yeast	|O
Rhodosporidium	|O
toruloides	|O
secrete	|O
a	|O
mating	|O
pheromone	|O
,	|O
rhodotorucine	|B-PROTEIN
A	|I-PROTEIN
,	|O
which	|O
is	|O
an	|O
undecapeptide	|O
containing	|O
S	|O
-	|O
farnesyl	|O
cysteine	|O
at	|O
its	|O
carboxy	|O
terminus	|O
.	|O

Tumour	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
and	|O
adult	|O
respiratory	|O
distress	|O
syndrome	|O
.	|O

Monitoring	|O
of	|O
rheumatoid	|O
arthritis	|O
.	|O

The	|O
decrease	|O
in	|O
left	|O
ventricular	|O
(	|O
LV	|O
)	|O
stroke	|O
volume	|O
during	|O
positive	|O
end	|O
-	|O
expiratory	|O
pressure	|O
(	|O
PEEP	|O
)	|O
has	|O
been	|O
attributed	|O
to	|O
reduced	|O
LV	|O
filling	|O
and	|O
a	|O
decreased	|O
contractile	|O
state	|O
.	|O

An	|O
experiment	|O
on	|O
the	|O
return	|O
-	|O
of	|O
-	|O
fear	|O
(	|O
ROF	|O
)	|O
was	|O
carried	|O
out	|O
on	|O
40	|O
snake	|O
-	|O
or	|O
spider	|O
-	|O
phobic	|O
subjects	|O
in	|O
order	|O
to	|O
determine	|O
whether	|O
an	|O
arousing	|O
event	|O
that	|O
occurs	|O
shortly	|O
before	|O
retest	|O
influences	|O
the	|O
magnitude	|O
of	|O
the	|O
ROF	|O
.	|O

Evolutionary	|O
conservation	|O
of	|O
homeodomain	|B-PROTEIN
-	|O
binding	|O
sites	|O
and	|O
other	|O
sequences	|O
upstream	|O
and	|O
within	|O
the	|O
major	|O
transcription	|O
unit	|O
of	|O
the	|O
Drosophila	|O
segmentation	|O
gene	|O
engrailed	|B-PROTEIN
.	|O

To	|O
assess	|O
the	|O
functional	|O
importance	|O
of	|O
these	|O
NBS	|O
in	|O
the	|O
overall	|O
drug	|O
resistance	|O
phenotype	|O
conferred	|O
by	|O
mdr1	|B-PROTEIN
,	|O
we	|O
introduced	|O
amino	|O
acid	|O
substitutions	|O
in	|O
the	|O
core	|O
consensus	|O
sequence	|O
for	|O
nucleotide	|O
binding	|O
,	|O
GXGKST	|O
.	|O

When	|O
the	|O
first	|O
twitch	|O
of	|O
TOF	|O
spontaneously	|O
recovered	|O
to	|O
10%	|O
of	|O
control	|O
value	|O
,	|O
neostigmine	|O
was	|O
injected	|O
(	|O
40	|O
micrograms	|O
/	|O
kg	|O
in	|O
adults	|O
,	|O
30	|O
micrograms	|O
/	|O
kg	|O
in	|O
infants	|O
and	|O
children	|O
)	|O
.	|O

No	|O
significant	|O
differences	|O
were	|O
found	|O
in	|O
relation	|O
to	|O
Type	|O
A	|O
behaviour	|O
and	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
blockade	|O
.	|O

Selection	|O
of	|O
the	|O
22	|O
items	|O
of	|O
the	|O
Clinical	|O
Institute	|O
Withdrawal	|O
Assessment	|O
-	|O
Benzodiazepines	|O
(	|O
CIWA	|O
-	|O
B	|O
)	|O
was	|O
based	|O
on	|O
statistically	|O
significant	|O
differences	|O
between	|O
baseline	|O
and	|O
critical	|O
withdrawal	|O
periods	|O
in	|O
high	|O
-	|O
dose	|O
subjects	|O
and	|O
between	|O
symptoms	|O
associated	|O
with	|O
placebo	|O
and	|O
diazepam	|O
in	|O
low	|O
-	|O
dose	|O
subjects	|O
,	|O
using	|O
contingency	|O
tables	|O
and	|O
logistic	|O
regression	|O
analysis	|O
.	|O

Antihistamines	|O
in	|O
asthma	|O
.	|O

We	|O
have	|O
therefore	|O
evaluated	|O
the	|O
efficacy	|O
and	|O
safety	|O
of	|O
doxazosin	|O
,	|O
a	|O
new	|O
orally	|O
active	|O
selective	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
blocker	|O
,	|O
in	|O
patients	|O
with	|O
systemic	|O
hypertension	|O
with	|O
concomitant	|O
airflow	|O
limitation	|O
.	|O

Northern	|O
blot	|O
analysis	|O
revealed	|O
multiple	|O
oIGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
transcripts	|O
in	|O
a	|O
broad	|O
band	|O
at	|O
800-1,100	|O
nucleotides	|O
and	|O
other	|O
transcripts	|O
of	|O
higher	|O
molecular	|O
weight	|O
in	|O
liver	|O
.	|O

Materials	|O
science	|O
studies	|O
on	|O
the	|O
soldering	|O
of	|O
different	|O
orthodontic	|O
wires	|O

The	|O
latency	|O
time	|O
for	|O
the	|O
lactate	|O
concentration	|O
to	|O
reach	|O
the	|O
top	|O
values	|O
was	|O
reduced	|O
by	|O
aerobic	|O
training	|O
(	|O
T2	|O
)	|O
.	|O

In	|O
patients	|O
resistant	|O
to	|O
VAD	|O
,	|O
high	|O
-	|O
dose	|O
therapies	|O
with	|O
intravenous	|O
melphalan	|O
,	|O
a	|O
CBV	|O
combination	|O
(	|O
cyclophosphamide	|O
-	|O
BCNU	|O
-	|O
VP	|O
-	|O
16	|O
)	|O
or	|O
an	|O
EDAP	|O
regimen	|O
(	|O
VP	|O
-	|O
16	|O
-	|O
platinum	|O
)	|O
produced	|O
responses	|O
in	|O
about	|O
40%	|O
of	|O
patients	|O
.	|O

The	|O
discussion	|O
focuses	|O
primarily	|O
on	|O
the	|O
newer	|O
drugs	|O
like	|O
angiotensin	|B-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
inhibitors	|O
,	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptor	|I-PROTEIN
blockers	|O
,	|O
and	|O
calcium	|O
antagonists	|O
.	|O

The	|O
avian	|O
cellular	|O
homolog	|O
of	|O
the	|O
oncogene	|O
jun	|B-PROTEIN
.	|O

A	|O
736	|O
-	|O
bp	|O
sequence	|O
of	|O
the	|O
5'	|O
flanking	|O
region	|O
adjacent	|O
to	|O
the	|O
cap	|O
site	|O
of	|O
the	|O
human	|O
AFP	|B-PROTEIN
gene	|O
shows	|O
a	|O
61%	|O
similarity	|O
with	|O
the	|O
corresponding	|O
region	|O
of	|O
the	|O
mouse	|O
AFP	|B-PROTEIN
gene	|O
.	|O

High	|O
ATP	|O
/	|O
GTP	|O
ratios	|O
promoted	|O
initiation	|O
of	|O
RNA	|O
primer	|O
synthesis	|O
at	|O
3'	|O
-	|O
dCTTT	|O
sites	|O
,	|O
whereas	|O
low	|O
ATP	|O
/	|O
GTP	|O
ratios	|O
promoted	|O
initiation	|O
at	|O
3'	|O
-	|O
dCCC	|O
sites	|O
.	|O

After	|O
hepatitis	|O
B	|O
vaccine	|O
immunization	|O
,	|O
serum	|O
antibody	|O
response	|O
was	|O
of	|O
primary	|O
type	|O
in	|O
33	|O
cases	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBs	|I-PROTEIN
less	|O
than	|O
2.1	|O
S	|O
/	|O
N	|O
(	|O
S	|O
/	|O
N	|O
Ratio	|O
Unit	|O
)	|O
at	|O
T0	|O
,	|O
the	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBs	|I-PROTEIN
positive	|O
rate	|O
was	|O
39.4%	|O
,	|O
84.8%	|O
,	|O
96.7%	|O
and	|O
96.7%	|O
in	|O
T1	|O
,	|O
T2	|O
,	|O
T0	|O
and	|O
T12	|O
respectively	|O
.	|O

The	|O
experimental	|O
design	|O
incorporated	|O
a	|O
multiple	|O
regression	|O
model	|O
,	|O
sequential	|O
treatments	|O
and	|O
a	|O
proportional	|O
end	|O
point	|O
(	|O
95%	|O
)	|O
for	|O
protection	|O
time	|O
.	|O

Interspecific	|O
complementation	|O
tests	|O
showed	|O
that	|O
the	|O
P7	|B-PROTEIN
proteins	|O
are	|O
unable	|O
to	|O
complement	|O
P1	|B-PROTEIN
parA	|O
or	|O
parB	|B-PROTEIN
mutants	|O
,	|O
and	|O
the	|O
P1	|B-PROTEIN
proteins	|O
fail	|O
to	|O
complement	|O
the	|O
P7	|B-PROTEIN
mutations	|O
.	|O

GN101	|O
,	|O
YC819	|O
-	|O
9	|O
,	|O
and	|O
SB3	|O
.	|O

Analysis	|O
of	|O
the	|O
inferred	|O
1,859	|O
-	|O
residue	|O
ama	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
product	|O
showed	|O
considerable	|O
identity	|O
with	|O
the	|O
largest	|O
subunit	|O
of	|O
RNAP	|B-PROTEIN
II	|I-PROTEIN
from	|O
other	|O
organisms	|O
,	|O
including	|O
the	|O
presence	|O
of	|O
a	|O
zinc	|O
finger	|O
motif	|O
near	|O
the	|O
amino	|O
terminus	|O
,	|O
and	|O
a	|O
carboxyl	|O
-	|O
terminal	|O
domain	|O
of	|O
42	|O
tandemly	|O
reiterated	|O
heptamers	|O
with	|O
the	|O
consensus	|O
Tyr	|O
Ser	|O
Pro	|O
Thr	|O
Ser	|O
Pro	|O
Ser	|O
.	|O

Nodular	|O
involvement	|O
of	|O
the	|O
left	|O
lung	|O
and	|O
infiltration	|O
of	|O
the	|O
mucosa	|O
of	|O
the	|O
left	|O
lower	|O
lobe	|O
bronchus	|O
followed	|O
very	|O
gradually	|O
and	|O
a	|O
monoclonal	|O
gammopathy	|O
(	|O
IgA	|B-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
Type	|I-PROTEIN
Kappa	|I-PROTEIN
)	|O
was	|O
demonstrated	|O
.	|O

5	|O
.	|O

None	|O
of	|O
the	|O
measured	|O
parameters	|O
(	|O
heart	|O
contents	|O
of	|O
neutral	|O
lipids	|O
,	|O
total	|O
phospholipids	|O
,	|O
phosphatidylcholine	|O
,	|O
phosphatidylethanolamine	|O
,	|O
diphosphatidylglycerol	|O
,	|O
sphingomyelin	|O
and	|O
fatty	|O
acid	|O
composition	|O
of	|O
each	|O
phospholipid	|O
class	|O
)	|O
appeared	|O
to	|O
be	|O
related	|O
with	|O
the	|O
grading	|O
of	|O
the	|O
lesions	|O
.	|O

Of	|O
165	|O
women	|O
with	|O
non	|O
-	|O
malignant	|O
diagnoses	|O
26	|O
(	|O
16%	|O
)	|O
had	|O
CA	|B-PROTEIN
125	|I-PROTEIN
levels	|O
in	|O
excess	|O
of	|O
35	|O
U	|O
/	|O
ml	|O
and	|O
8	|O
(	|O
5%	|O
)	|O
greater	|O
than	|O
65	|O
U	|O
/	|O
ml	|O
.	|O

We	|O
conclude	|O
that	|O
at	|O
steady	|O
state	|O
the	|O
timing	|O
of	|O
a	|O
light	|O
meal	|O
is	|O
unlikely	|O
to	|O
alter	|O
in	|O
any	|O
clinically	|O
important	|O
manner	|O
the	|O
pharmacokinetics	|O
of	|O
nifedipine	|O
released	|O
from	|O
'	|O
biphasic	|O
'	|O
tablets	|O
.	|O

The	|O
GALT	|O
-	|O
primed	|O
calves	|O
had	|O
increased	|O
serum	|O
IgG	|B-PROTEIN
,	|O
lavage	|O
IgG	|B-PROTEIN
and	|O
IgA	|B-PROTEIN
and	|O
increased	|O
LNA	|B-PROTEIN
titers	|O
in	|O
both	|O
lavage	|O
fluids	|O
and	|O
serum	|O
following	|O
the	|O
SC	|O
dose	|O
of	|O
killed	|O
bacteria	|O
.	|O

Recent	|O
investigations	|O
have	|O
shown	|O
that	|O
Grenz	|O
rays	|O
can	|O
suppress	|O
the	|O
allergic	|O
contact	|O
dermatitis	|O
reaction	|O
completely	|O
and	|O
that	|O
Langerhans	|O
cells	|O
,	|O
identified	|O
by	|O
OKT6	|B-PROTEIN
antibodies	|O
and	|O
electron	|O
microscopy	|O
,	|O
disappear	|O
from	|O
the	|O
epidermis	|O
at	|O
the	|O
same	|O
time	|O
.	|O

The	|O
elements	|O
responsible	|O
for	|O
glucocorticoid	|O
stimulation	|O
of	|O
ADH	|B-PROTEIN
gene	|O
transcription	|O
appear	|O
to	|O
reside	|O
outside	|O
of	|O
this	|O
region	|O
.	|O

1	|O
.	|O

The	|O
present	|O
studies	|O
compare	|O
the	|O
biochemical	|O
characteristics	|O
,	|O
Kanagawa	|O
hemolysin	|B-PROTEIN
reactions	|O
,	|O
and	|O
plasmid	|O
profiles	|O
of	|O
13	|O
patient	|O
and	|O
221	|O
environmental	|O
isolates	|O
of	|O
the	|O
organism	|O
.	|O

High	|O
values	|O
of	|O
both	|O
retinol	|O
and	|O
beta	|O
-	|O
carotene	|O
were	|O
found	|O
in	|O
full	|O
fat	|O
cheeses	|O
and	|O
whipping	|O
cream	|O
:	|O
from	|O
179.0	|O
(	|O
cheese	|O
,	|O
Edam	|O
-	|O
type	|O
)	|O
to	|O
318.7	|O
micrograms	|O
/	|O
100	|O
g	|O
(	|O
whipping	|O
cream	|O
)	|O
and	|O
from	|O
86.7	|O
(	|O
cheese	|O
,	|O
Edam	|O
-	|O
type	|O
)	|O
to	|O
186.5	|O
micrograms	|O
/	|O
100	|O
g	|O
(	|O
whipping	|O
cream	|O
)	|O
for	|O
all	|O
-	|O
trans	|O
retinol	|O
and	|O
total	|O
beta	|O
-	|O
carotene	|O
,	|O
respectively	|O
.	|O

COGLAB	|O
includes	|O
measures	|O
of	|O
preattentional	|O
,	|O
attentional	|O
,	|O
conceptual	|O
,	|O
and	|O
psychomotor	|O
performance	|O
.	|O

These	|O
data	|O
locate	|O
the	|O
aniridia	|B-PROTEIN
gene	|O
(	|O
AN2	|B-PROTEIN
)	|O
and	|O
a	|O
recurrent	|O
T	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
leukemia	|I-PROTEIN
breakpoint	|I-PROTEIN
(	|O
TCL2	|B-PROTEIN
)	|O
in	|O
the	|O
marker	|O
sequence	|O
,	|O
on	|O
opposite	|O
sides	|O
of	|O
MIC1	|B-PROTEIN
.	|O

A	|O
fine	|O
-	|O
structure	|O
deletion	|O
map	|O
of	|O
human	|O
chromosome	|O
11p	|O
:	|O
analysis	|O
of	|O
J1	|O
series	|O
hybrids	|O
.	|O

With	|O
respect	|O
to	|O
effective	|O
diffusivity	|O
of	|O
platelets	|O
(	|O
De	|O
)	|O
and	|O
the	|O
surface	|O
reactivity	|O
constant	|O
(	|O
K	|O
)	|O
,	|O
less	|O
significant	|O
differences	|O
were	|O
found	|O
among	|O
artificial	|O
materials	|O
.	|O

The	|O
two	|O
most	|O
recent	|O
patients	|O
(	|O
35	|O
and	|O
132	|O
days	|O
)	|O
received	|O
only	|O
oral	|O
dipyridamole	|O
(	|O
75	|O
mg	|O
X	|O
3	|O
/	|O
day	|O
)	|O
and	|O
aspirin	|O
(	|O
80	|O
mg	|O
/	|O
day	|O
)	|O
after	|O
the	|O
early	|O
recovery	|O
period	|O
(	|O
four	|O
-	|O
six	|O
days	|O
)	|O
,	|O
resulting	|O
in	|O
normal	|O
prothrombin	|B-PROTEIN
and	|O
partial	|O
thromboplastin	|B-PROTEIN
times	|O
.	|O

Middle	|O
-	|O
latency	|O
auditory	|O
evoked	|O
potentials	|O
(	|O
MAEPs	|O
)	|O
were	|O
recorded	|O
in	|O
controls	|O
and	|O
patients	|O
with	|O
focal	|O
lesions	|O
in	|O
dorsolateral	|O
prefrontal	|O
cortex	|O
.	|O

Most	|O
of	|O
them	|O
were	|O
situated	|O
at	|O
Sylvius	|O
fissure	|O
(	|O
13	|O
cases	|O
)	|O
.	|O

Intracellular	|O
activity	|O
studies	|O
indicated	|O
that	|O
,	|O
at	|O
ten	|O
times	|O
MBC	|O
,	|O
only	|O
penicillin	|O
had	|O
any	|O
significant	|O
activity	|O
against	|O
intracellular	|O
staphylococci	|O
,	|O
reducing	|O
survival	|O
by	|O
28%	|O
.	|O

Specifically	|O
,	|O
they	|O
were	|O
performed	|O
to	|O
determine	|O
whether	|O
detection	|O
of	|O
envelope	|O
phase	|O
disparity	|O
was	|O
consistent	|O
with	|O
processing	|O
within	|O
a	|O
single	|O
channel	|O
in	|O
which	|O
the	|O
AM	|O
tones	|O
were	|O
simply	|O
added	|O
.	|O

Gel	|O
retardation	|O
assays	|O
combined	|O
with	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
and	|O
diethyl	|O
pyrocarbonate	|O
interference	|O
showed	|O
that	|O
a	|O
nuclear	|O
factor	|O
from	|O
differentiated	|O
C2	|O
myotubes	|O
and	|O
BC3H1	|O
myocytes	|O
recognized	|O
a	|O
conserved	|O
A	|O
+	|O
T	|O
-	|O
rich	|O
sequence	|O
within	|O
the	|O
peripheral	|O
activating	|O
region	|O
.	|O

Such	|O
transgenic	|O
plants	|O
should	|O
enable	|O
not	|O
only	|O
the	|O
mutational	|O
analysis	|O
of	|O
sequence	|O
elements	|O
within	|O
the	|O
replication	|O
origin	|O
region	|O
,	|O
but	|O
also	|O
the	|O
construction	|O
of	|O
a	|O
new	|O
generation	|O
of	|O
vectors	|O
for	|O
gene	|O
amplification	|O
in	|O
plants	|O
,	|O
based	|O
on	|O
a	|O
minimal	|O
virus	|O
replicon	|O
.	|O

Ventral	|O
rhinotomy	|O
is	|O
no	|O
more	|O
difficult	|O
than	|O
dorsal	|O
rhinotomy	|O
,	|O
has	|O
less	|O
patient	|O
morbidity	|O
and	|O
fewer	|O
postoperative	|O
complications	|O
,	|O
and	|O
is	|O
more	|O
cosmetically	|O
acceptable	|O
.	|O

Four	|O
full	|O
-	|O
thickness	|O
skin	|O
incisions	|O
were	|O
made	|O
in	|O
the	|O
back	|O
of	|O
10	|O
female	|O
pigs	|O
that	|O
treated	|O
twice	|O
a	|O
day	|O
for	|O
14	|O
days	|O
with	|O
2	|O
ml	|O
of	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
300	|O
ng	|O
/	|O
ml	|O
)	|O
or	|O
2	|O
ml	|O
of	|O
Ringer	|O
's	|O
lactate	|O
solution	|O
in	|O
a	|O
single	|O
-	|O
blind	|O
,	|O
randomized	|O
fashion	|O
.	|O

During	|O
challenge	|O
,	|O
rebiopsy	|O
was	|O
done	|O
when	|O
reticulin	|B-PROTEIN
antibodies	|O
turned	|O
positive	|O
(	|O
mean	|O
0.6	|O
years	|O
,	|O
range	|O
0.2-2.0	|O
)	|O
or	|O
at	|O
the	|O
end	|O
of	|O
the	|O
two	|O
year	|O
study	|O
.	|O

The	|O
effect	|O
of	|O
iron	|O
intake	|O
on	|O
59Fe	|O
absorption	|O
throughout	|O
pregnancy	|O
,	|O
and	|O
on	|O
maternal	|O
and	|O
fetal	|O
Fe	|O
status	|O
towards	|O
the	|O
end	|O
of	|O
pregnancy	|O
,	|O
was	|O
investigated	|O
in	|O
rats	|O
.	|O

The	|O
deduced	|O
protein	|O
sequence	|O
is	|O
characterized	|O
by	|O
a	|O
putative	|O
16	|O
-	|O
residue	|O
amino	|O
-	|O
terminal	|O
signal	|O
peptide	|O
that	|O
is	|O
cleaved	|O
,	|O
resulting	|O
in	|O
a	|O
239	|O
-	|O
residue	|O
polypeptide	|O
.	|O

Analysis	|O
of	|O
the	|O
rate	|O
constants	|O
indicated	|O
that	|O
the	|O
isomerization	|O
rate	|O
k12	|O
was	|O
approximately	|O
equal	|O
to	|O
the	|O
apparent	|O
degradation	|O
rate	|O
of	|O
the	|O
delta	|O
3	|O
ester	|O
kdeg	|O
,	|O
and	|O
slower	|O
than	|O
the	|O
hydrolysis	|O
rate	|O
of	|O
the	|O
delta	|O
2	|O
ester	|O
k24	|O
.	|O

A	|O
protocol	|O
is	|O
elaborated	|O
for	|O
the	|O
preparation	|O
and	|O
characterization	|O
of	|O
a	|O
quality	|O
control	|O
material	|O
(	|O
QCM	|O
)	|O
containing	|O
intrinsic	|O
concentration	|O
of	|O
cadmium	|O
(	|O
Cd	|O
)	|O
(	|O
0.8	|O
microgram	|O
/	|O
L	|O
)	|O
and	|O
lead	|O
(	|O
Pb	|O
)	|O
(	|O
13.4	|O
micrograms	|O
/	|O
dL	|O
)	|O
from	|O
bovine	|O
blood	|O
and	|O
an	|O
elevated	|O
QCM	|O
containing	|O
Cd	|O
(	|O
5.0	|O
micrograms	|O
/	|O
L	|O
)	|O
,	|O
mercury	|O
(	|O
Hg	|O
)	|O
(	|O
11.2	|O
micrograms	|O
/	|O
L	|O
)	|O
,	|O
and	|O
Pb	|O
(	|O
34.5	|O
micrograms	|O
/	|O
dL	|O
)	|O
from	|O
bovine	|O
blood	|O
spiked	|O
with	|O
aqueous	|O
spiking	|O
-	|O
solutions	|O
prepared	|O
with	|O
salts	|O
of	|O
Cd	|O
,	|O
Hg	|O
,	|O
and	|O
Pb	|O
.	|O

Reagent	|O
strips	|O
are	|O
frequently	|O
used	|O
in	|O
the	|O
practice	|O
of	|O
laboratory	|O
medicine	|O
as	|O
well	|O
as	|O
outside	|O
the	|O
professional	|O
laboratories	|O
.	|O

The	|O
lowest	|O
detectable	|O
concentration	|O
was	|O
1.0	|O
ng	|O
/	|O
ml	|O
in	|O
the	|O
serum	|O
.	|O

Precipitating	|O
antibodies	|O
for	|O
Thermophilic	|O
actinomycetes	|O
and	|O
M.f	|O
.	|O
were	|O
negative	|O
.	|O

LON	|O
-	|O
72	|O
(	|O
34	|O
isolates	|O
)	|O
,	|O
LON	|O
-	|O
73	|O
(	|O
1	|O
)	|O
,	|O
LON	|O
-	|O
71	|O
(	|O
2	|O
)	|O
and	|O
LON	|O
-	|O
10	|O
(	|O
2	|O
)	|O
were	|O
found	|O
at	|O
altitudes	|O
around	|O
2000	|O
m	|O
,	|O
3	|O
of	|O
them	|O
in	|O
a	|O
single	|O
village	|O
.	|O

Animal	|O
experimental	|O
and	|O
clinical	|O
applications	|O
of	|O
plates	|O
,	|O
screws	|O
and	|O
spinal	|O
segmental	|O
replacement	|O
implants	|O
made	|O
of	|O
this	|O
composite	|O
material	|O
have	|O
shown	|O
good	|O
results	|O
so	|O
far	|O
.	|O

Significance	|O
of	|O
delta	|O
-	|O
aminolevulinic	|O
acid	|O
analysis	|O
in	|O
clinical	|O
tests	|O

No	|O
changes	|O
were	|O
evident	|O
in	|O
the	|O
FR	|O
-	|O
task	|O
performance	|O
of	|O
controls	|O
that	|O
received	|O
daily	|O
saline	|O
injections	|O
.	|O

The	|O
antigen	|O
-	|O
specific	|O
IgG4	|B-PROTEIN
antibody	|O
seems	|O
to	|O
be	|O
an	|O
index	|O
in	|O
evaluating	|O
immunotherapy	|O
objectively	|O
.	|O

Although	|O
the	|O
fertility	|O
decline	|O
in	|O
the	|O
black	|O
population	|O
in	|O
the	|O
Mississippi	|O
Delta	|O
between	|O
the	|O
late	|O
1870	|O
's	|O
and	|O
early	|O
1930	|O
's	|O
closely	|O
paralleled	|O
that	|O
of	|O
the	|O
national	|O
black	|O
population	|O
,	|O
it	|O
rose	|O
much	|O
more	|O
dramatically	|O
in	|O
the	|O
1940	|O
's	|O
and	|O
1950	|O
's	|O
to	|O
almost	|O
1880	|O
levels	|O
.	|O

According	|O
to	|O
their	|O
staining	|O
affinity	|O
for	|O
anti	|B-PROTEIN
-	|I-PROTEIN
T	|I-PROTEIN
antibodies	|O
,	|O
the	|O
glandular	|O
tissue	|O
cells	|O
were	|O
classified	|O
as	|O
T	|B-PROTEIN
-	|O
,	|O
T+	|B-PROTEIN
,	|O
T+	|B-PROTEIN
+	|I-PROTEIN
,	|O
and	|O
T	|B-PROTEIN
and	|O
the	|O
annual	|O
changes	|O
in	|O
the	|O
numbers	|O
of	|O
these	|O
cell	|O
populations	|O
,	|O
as	|O
well	|O
as	|O
in	|O
the	|O
volume	|O
occupied	|O
by	|O
the	|O
glandular	|O
tissue	|O
,	|O
were	|O
calculated	|O
.	|O

Ampicillin	|O
(	|O
AMP	|O
)	|O
alone	|O
or	|O
with	|O
an	|O
aminoglycoside	|O
(	|O
AMI	|O
)	|O
was	|O
the	|O
treatment	|O
in	|O
9	|O
and	|O
16	|O
cases	|O
,	|O
respectively	|O
.	|O

Alkoxymetgyl	|O
-	|O
3,4	|O
-	|O
dimethylpyridinium	|O
chlorides	|O
were	|O
synthetized	|O
by	|O
reacting	|O
3,4	|O
-	|O
dimethylpyridine	|O
with	|O
chloromethyl	|O
alkyl	|O
ethers	|O
,	|O
while	|O
1	|O
-	|O
ethyloxymethyl	|O
-	|O
3	|O
-	|O
alkylthiomethylimidazolium	|O
chlorides	|O
were	|O
obtained	|O
in	|O
reactions	|O
of	|O
1	|O
-	|O
ethyloxymethylimidazol	|O
with	|O
chloromethyl	|O
alkyl	|O
sulfides	|O
.	|O

We	|O
investigated	|O
the	|O
incidence	|O
of	|O
congenital	|O
color	|O
deficiency	|O
among	|O
Koreans	|O
by	|O
the	|O
use	|O
of	|O
H	|O
-	|O
R	|O
-	|O
R	|O
pseudoisochromatic	|O
plates	|O
.	|O

Eighty	|O
patients	|O
presenting	|O
to	|O
HGGM	|O
with	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphomas	|O
between	|O
1962	|O
and	|O
1986	|O
,	|O
were	|O
reviewed	|O
.	|O

The	|O
relation	|O
between	|O
VE	|O
/	|O
VO2	|O
and	|O
Q	|O
/	|O
VO2	|O
showed	|O
a	|O
significant	|O
negative	|O
correlation	|O
(	|O
r	|O
=	|O
-	|O
0.93	|O
,	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

The	|O
differential	|O
diagnosis	|O
of	|O
both	|O
affections	|O
is	|O
based	|O
on	|O
the	|O
clinical	|O
course	|O
,	|O
sialography	|O
and	|O
CT	|O
examination	|O
which	|O
along	|O
with	|O
modern	|O
ATB	|O
treatment	|O
significantly	|O
modify	|O
hitherto	|O
used	|O
surgical	|O
therapy	|O
.	|O

Retrograde	|O
filling	|O
consists	|O
in	|O
sealing	|O
endodontics	|O
system	|O
directly	|O
at	|O
the	|O
apical	|O
zone	|O
after	|O
surgical	|O
approach	|O
.	|O

Collaborative	|O
study	|O
of	|O
Japanese	|O
Pharmacopoeia	|O
Heparin	|O
Sodium	|O
Reference	|O
Standard	|O

Serological	|O
studies	|O
at	|O
the	|O
early	|O
relapse	|O
stage	|O
of	|O
this	|O
disease	|O
showed	|O
increased	|O
serum	|O
ANA	|B-PROTEIN
,	|O
IgA	|B-PROTEIN
and	|O
IgM	|B-PROTEIN
level	|O
with	|O
normal	|O
IgG	|B-PROTEIN
and	|O
decrease	|O
of	|O
C3	|B-PROTEIN
and	|O
C4	|B-PROTEIN
.	|O

The	|O
maximum	|O
stress	|O
due	|O
to	|O
the	|O
hygroscopic	|O
examination	|O
of	|O
the	|O
composite	|O
was	|O
0.74	|O
kg	|O
/	|O
mm2	|O
at	|O
equilibrium	|O
of	|O
the	|O
water	|O
absorbed	|O
of	|O
the	|O
composite	|O
.	|O

Ischemic	|O
heart	|O
disease	|O
evaluated	|O
by	|O
exercise	|O
stress	|O
thallium	|O
-	|O
201	|O
myocardial	|O
scintigraphy	|O
:	|O
a	|O
comparison	|O
of	|O
SPECT	|O
and	|O
bull	|O
's	|O
eye	|O
display	|O

Sequence	|O
analysis	|O
of	|O
the	|O
47	|O
-	|O
kilodalton	|O
major	|B-PROTEIN
integral	|I-PROTEIN
membrane	|I-PROTEIN
immunogen	|I-PROTEIN
of	|O
Treponema	|O
pallidum	|O
.	|O

Potential	|O
consensus	|O
sequences	|O
for	|O
early	|O
and	|O
late	|O
regulatory	|O
elements	|O
were	|O
identified	|O
.	|O

An	|O
FP	|B-PROTEIN
mutant	|O
,	|O
AcFP875	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
had	|O
a	|O
1.6	|O
-	|O
kbp	|O
insertion	|O
of	|O
S.	|O
frugiperda	|O
DNA	|O
near	|O
the	|O
5'	|O
end	|O
of	|O
these	|O
transcripts	|O
which	|O
by	|O
S1	|B-PROTEIN
analysis	|O
were	|O
shown	|O
to	|O
initiate	|O
within	|O
the	|O
host	|O
cell	|O
sequence	|O
.	|O

Construction	|O
of	|O
a	|O
RIP1	|B-PROTEIN
deletion	|O
strain	|O
and	|O
isolation	|O
of	|O
temperature	|O
-	|O
sensitive	|O
mutants	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
hypocitraturia	|O
in	|O
type	|O
I	|O
renal	|O
tubular	|O
acidosis	|O
may	|O
be	|O
due	|O
to	|O
a	|O
defect	|O
in	|O
proximal	|O
tubule	|O
function	|O
.	|O

Concomitant	|O
chronic	|O
lymphocytic	|O
leukemia	|O
,	|O
acute	|O
myeloid	|O
leukemia	|O
,	|O
and	|O
thrombosis	|O
with	|O
protein	|B-PROTEIN
C	|I-PROTEIN
deficiency	|O
.	|O

Vivid	|O
visual	|O
hallucinations	|O
without	|O
other	|O
psychopathology	|O
have	|O
been	|O
reported	|O
for	|O
several	|O
hundred	|O
years	|O
.	|O

In	|O
the	|O
whole	|O
group	|O
,	|O
basal	|O
GH	|B-PROTEIN
and	|O
somatomedin	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
levels	|O
decreased	|O
from	|O
a	|O
mean	|O
(	|O
+	|O
/	|O
-	|O
standard	|O
error	|O
of	|O
the	|O
mean	|O
)	|O
of	|O
52.3	|O
+	|O
/	|O
-	|O
12.7	|O
to	|O
11.1	|O
+	|O
/	|O
-	|O
6.3	|O
ng	|O
/	|O
ml	|O
and	|O
from	|O
7.6	|O
+	|O
/	|O
-	|O
0.7	|O
to	|O
2.5	|O
+	|O
/	|O
-	|O
0.5	|O
U	|O
/	|O
ml	|O
,	|O
respectively	|O
.	|O

Application	|O
of	|O
different	|O
criteria	|O
of	|O
cure	|O
revealed	|O
that	|O
19	|O
patients	|O
(	|O
66%	|O
)	|O
had	|O
basal	|O
GH	|B-PROTEIN
levels	|O
below	|O
5	|O
ng	|O
/	|O
ml	|O
,	|O
17	|O
patients	|O
(	|O
59%	|O
)	|O
had	|O
normal	|O
somatomedin	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
values	|O
,	|O
16	|O
patients	|O
(	|O
55%	|O
)	|O
had	|O
complete	|O
GH	|B-PROTEIN
suppression	|O
(	|O
less	|O
than	|O
1	|O
ng	|O
/	|O
ml	|O
)	|O
during	|O
OGTT	|O
,	|O
and	|O
13	|O
patients	|O
(	|O
45%	|O
)	|O
met	|O
the	|O
above	|O
-	|O
mentioned	|O
criteria	|O
with	|O
disappearance	|O
of	|O
the	|O
paradoxical	|O
GH	|B-PROTEIN
response	|O
to	|O
TRH	|B-PROTEIN
/	|O
GnRH	|B-PROTEIN
test	|O
.	|O

It	|O
suggests	|O
a	|O
sequence	|O
of	|O
surgical	|O
planning	|O
that	|O
can	|O
prevent	|O
them	|O
and	|O
also	|O
offers	|O
ways	|O
of	|O
dealing	|O
with	|O
the	|O
problems	|O
should	|O
they	|O
occur	|O
.	|O

In	|O
Rat	|O
-	|O
1a	|O
cells	|O
the	|O
expression	|O
of	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
mRNA	|O
was	|O
associated	|O
with	|O
the	|O
ability	|O
to	|O
clone	|O
in	|O
soft	|O
agarose	|O
and	|O
form	|O
tumors	|O
in	|O
nude	|O
mice	|O
.	|O

Furthermore	|O
,	|O
formation	|O
of	|O
foci	|O
of	|O
transformed	|O
RECs	|O
by	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
/	|O
ras	|B-PROTEIN
combination	|O
was	|O
augmented	|O
3	|O
-	|O
fold	|O
by	|O
the	|O
tumor	|O
promoter	|O
phorbol	|O
12	|O
-	|O
tetradecanoate	|O
13	|O
-	|O
acetate	|O
.	|O

Platelet	|B-PROTEIN
activating	|I-PROTEIN
factor	|I-PROTEIN
was	|O
given	|O
in	|O
six	|O
doses	|O
at	|O
15	|O
minute	|O
intervals	|O
and	|O
airway	|O
response	|O
measured	|O
as	|O
change	|O
in	|O
partial	|O
expiratory	|O
flow	|O
at	|O
30%	|O
of	|O
vital	|O
capacity	|O
(	|O
Vp30	|O
)	|O
.	|O

There	|O
was	|O
no	|O
significant	|O
correlation	|O
between	|O
baseline	|O
PC40	|O
methacholine	|O
and	|O
the	|O
maximal	|O
fall	|O
in	|O
Vp30	|O
after	|O
either	|O
the	|O
first	|O
(	|O
12	|O
micrograms	|O
)	|O
or	|O
the	|O
second	|O
dose	|O
(	|O
24	|O
micrograms	|O
)	|O
of	|O
platelet	|B-PROTEIN
activating	|I-PROTEIN
factor	|I-PROTEIN
.	|O

Both	|O
BG	|O
and	|O
IRI	|B-PROTEIN
concentrations	|O
during	|O
the	|O
OGTT	|O
were	|O
the	|O
lowest	|O
in	|O
body	|O
builders	|O
,	|O
medium	|O
in	|O
controls	|O
,	|O
and	|O
the	|O
highest	|O
in	|O
obese	|O
men	|O
.	|O

Postcoital	|O
contraception	|O
:	|O
a	|O
family	|O
planning	|O
study	|O
.	|O

A	|O
0.5	|O
rating	|O
was	|O
intended	|O
to	|O
characterize	|O
subjects	|O
in	|O
whom	|O
mild	|O
cognitive	|O
impairment	|O
due	|O
to	|O
senile	|O
dementia	|O
of	|O
the	|O
Alzheimer	|O
type	|O
was	|O
suspected	|O
but	|O
was	|O
insufficient	|O
in	|O
degree	|O
to	|O
warrant	|O
a	|O
diagnosis	|O
of	|O
definite	|O
dementia	|O
.	|O

An	|O
implant	|O
may	|O
release	|O
a	|O
drug	|O
either	|O
by	|O
diffusion	|O
concurrent	|O
with	|O
dissolution	|O
of	|O
the	|O
polymeric	|O
implant	|O
material	|O
without	|O
depolymerization	|O
(	|O
Type	|O
A	|O
)	|O
or	|O
by	|O
bioerosion	|O
involving	|O
depolymerization	|O
(	|O
Type	|O
B	|O
)	|O
.	|O

Although	|O
it	|O
is	|O
well	|O
known	|O
that	|O
calcium	|O
channel	|O
blockers	|O
can	|O
influence	|O
contraction	|O
of	|O
vascular	|O
smooth	|O
muscle	|O
,	|O
there	|O
is	|O
less	|O
knowledge	|O
on	|O
its	|O
effect	|O
on	|O
excitation	|O
contraction	|O
coupling	|O
in	|O
the	|O
endocrine	|O
glands	|O
and	|O
more	|O
specifically	|O
on	|O
insulin	|B-PROTEIN
and	|O
glucagon	|B-PROTEIN
release	|O
.	|O

Many	|O
studies	|O
have	|O
pointed	|O
out	|O
the	|O
possibility	|O
of	|O
"	|O
masked	|O
"	|O
organic	|O
factors	|O
in	|O
erectile	|O
impotence	|O
,	|O
detectable	|O
only	|O
by	|O
means	|O
of	|O
laboratory	|O
investigations	|O
:	|O
mild	|O
hypogonadism	|O
,	|O
hyperprolactinemia	|O
,	|O
occlusions	|O
selectively	|O
located	|O
at	|O
the	|O
site	|O
of	|O
the	|O
sexual	|O
arteries	|O
,	|O
venous	|O
incompetence	|O
,	|O
subclinical	|O
neuropathies	|O
.	|O

The	|O
site	|O
-	|O
specific	|O
DNA	|O
inversion	|O
system	|O
Cin	|B-PROTEIN
encoded	|O
by	|O
the	|O
bacteriophage	|O
P1	|O
consists	|O
of	|O
a	|O
recombinase	|B-PROTEIN
,	|O
two	|O
inverted	|O
crossing	|O
-	|O
over	|O
sites	|O
and	|O
a	|O
recombinational	|O
enhancer	|O
.	|O

The	|O
terminator	|O
region	|O
supported	|O
termination	|O
of	|O
transcripts	|O
initiated	|O
by	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
I	|I-PROTEIN
in	|O
vivo	|O
.	|O

US	|O
-	|O
Doppler	|O
has	|O
recently	|O
gained	|O
attention	|O
as	|O
a	|O
noninvasive	|O
method	|O
for	|O
the	|O
functional	|O
evaluation	|O
of	|O
arteriovenous	|O
fistulas	|O
(	|O
FAV	|O
)	|O
.	|O

Doppler	|O
echo	|O
in	|O
evaluating	|O
arteriovenous	|O
fistulae	|O
for	|O
dialysis	|O

Improved	|O
cosmesis	|O
,	|O
extension	|O
of	|O
the	|O
scope	|O
of	|O
the	|O
problems	|O
that	|O
can	|O
be	|O
addressed	|O
with	|O
this	|O
repair	|O
(	|O
including	|O
treatment	|O
of	|O
a	|O
distal	|O
urethrocutaneous	|O
fistula	|O
)	|O
and	|O
the	|O
ease	|O
with	|O
which	|O
the	|O
Arap	|O
procedure	|O
can	|O
be	|O
performed	|O
are	|O
the	|O
advantages	|O
that	|O
this	|O
operation	|O
has	|O
over	|O
other	|O
1	|O
-	|O
stage	|O
distal	|O
hypospadias	|O
repairs	|O
.	|O

Following	|O
the	|O
patients	|O
during	|O
a	|O
course	|O
of	|O
therapy	|O
with	|O
a	|O
selective	|O
vasodilator	|O
calcium	|O
antagonist	|O
,	|O
the	|O
beta	|O
-	|O
adrenergic	|O
reflex	|O
vasodilation	|O
became	|O
substantially	|O
attenuated	|O
but	|O
was	|O
preserved	|O
during	|O
a	|O
placebo	|O
course	|O
of	|O
therapy	|O
.	|O

The	|O
galactose	|B-PROTEIN
transporter	|I-PROTEIN
shows	|O
both	|O
sequence	|O
and	|O
structural	|O
homology	|O
with	|O
a	|O
superfamily	|O
of	|O
sugar	|B-PROTEIN
transporters	|I-PROTEIN
which	|O
includes	|O
the	|O
human	|O
HepG2	|B-PROTEIN
-	|I-PROTEIN
erythrocyte	|I-PROTEIN
and	|I-PROTEIN
fetal	|I-PROTEIN
muscle	|I-PROTEIN
glucose	|I-PROTEIN
transporters	|I-PROTEIN
,	|O
the	|O
rat	|O
brain	|O
and	|O
liver	|O
glucose	|B-PROTEIN
transporters	|I-PROTEIN
,	|O
the	|O
Escherichia	|O
coli	|O
xylose	|B-PROTEIN
and	|I-PROTEIN
arabinose	|I-PROTEIN
permeases	|I-PROTEIN
,	|O
and	|O
the	|O
S.	|O
cerevisiae	|O
glucose	|B-PROTEIN
,	|I-PROTEIN
maltose	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
galactose	|I-PROTEIN
transporters	|I-PROTEIN
.	|O

Of	|O
110	|O
previously	|O
untreated	|O
patients	|O
who	|O
had	|O
entered	|O
the	|O
study	|O
of	|O
protocol	|O
TCL821	|O
,	|O
96	|O
were	|O
evaluable	|O
.	|O

There	|O
were	|O
3/32	|O
(	|O
9.4	|O
per	|O
cent	|O
)	|O
adverse	|O
reactions	|O
(	|O
ADRs	|O
)	|O
,	|O
and	|O
one	|O
case	|O
each	|O
of	|O
nausea	|O
,	|O
dizziness	|O
and	|O
increased	|O
menstrual	|O
flow	|O
.	|O

More	|O
mRNA	|O
corresponding	|O
to	|O
nagB	|B-PROTEIN
and	|O
nagA	|B-PROTEIN
is	|O
detected	|O
than	|O
that	|O
corresponding	|O
to	|O
the	|O
distal	|O
genes	|O
,	|O
nagC	|B-PROTEIN
and	|O
nagD	|B-PROTEIN
.	|O

Tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
)	|O
is	|O
reported	|O
to	|O
cause	|O
a	|O
shock	|O
syndrome	|O
similar	|O
to	|O
that	|O
produced	|O
by	|O
endotoxin	|O
(	|O
LPS	|O
)	|O
.	|O

The	|O
calcium	|O
requirement	|O
for	|O
hypothermic	|O
storage	|O
of	|O
the	|O
cardiac	|O
explant	|O
.	|O

The	|O
seventh	|O
cysteine	|O
residue	|O
of	|O
CTSE	|B-PROTEIN
is	|O
located	|O
within	|O
the	|O
activation	|O
peptide	|O
region	|O
of	|O
the	|O
proenzyme	|O
.	|O

The	|O
p34.8	|B-PROTEIN
gene	|O
has	|O
a	|O
strong	|O
codon	|O
usage	|O
bias	|O
which	|O
is	|O
strikingly	|O
different	|O
from	|O
that	|O
of	|O
the	|O
polyhedrin	|B-PROTEIN
gene	|O
.	|O

Of	|O
the	|O
single	|O
-	|O
stranded	|O
DNA	|O
transformants	|O
,	|O
65%	|O
resulted	|O
from	|O
replacement	|O
of	|O
the	|O
resident	|O
met2	|B-PROTEIN
mutation	|O
by	|O
the	|O
exogenous	|O
wild	|O
-	|O
type	|O
allele	|O
.	|O

The	|O
results	|O
strongly	|O
support	|O
the	|O
notion	|O
that	|O
the	|O
OBF1	|B-PROTEIN
-	|O
binding	|O
sites	|O
and	|O
the	|O
OBF1	|B-PROTEIN
protein	|O
are	|O
important	|O
for	|O
normal	|O
ARS	|O
function	|O
as	|O
an	|O
origin	|O
of	|O
replication	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
S1	|B-PROTEIN
nuclease	|O
protection	|O
analysis	|O
of	|O
RNA	|O
preparations	|O
from	|O
several	|O
mouse	|O
tissues	|O
,	|O
both	|O
dhfr	|B-PROTEIN
and	|O
divergent	|O
genes	|O
showed	|O
similar	|O
levels	|O
of	|O
expression	|O
but	|O
did	|O
show	|O
some	|O
specificity	|O
in	|O
start	|O
site	|O
utilization	|O
.	|O

Four	|O
out	|O
of	|O
10	|O
patients	|O
showed	|O
clinical	|O
improvement	|O
according	|O
to	|O
Ritchie	|O
-	|O
Index	|O
,	|O
pain	|O
score	|O
,	|O
ESR	|O
and	|O
CRP	|B-PROTEIN
.	|O

62	|O
:	|O
2491-2499	|O
,	|O
1987	|O
)	|O
.	|O

With	|O
both	|O
wild	|O
-	|O
type	|O
and	|O
the	|O
mutant	|O
enzymes	|O
,	|O
ATP	|O
activates	|O
both	|O
[	|O
14C	|O
]	|O
Asp	|O
in	|O
equilibrium	|O
N	|O
-	|O
carbamyl	|O
-	|O
L	|O
-	|O
aspartate	|O
(	|O
C	|O
-	|O
Asp	|O
)	|O
and	|O
the	|O
[	|O
32P	|O
]	|O
carbamyl	|O
phosphate	|O
(	|O
C	|O
-	|O
P	|O
)	|O
in	|O
equilibrium	|O
Pi	|O
exchanges	|O
.	|O

Survival	|O
rates	|O
for	|O
the	|O
original	|O
treatment	|O
group	|O
were	|O
84.5%	|O
and	|O
57.6%	|O
at	|O
12	|O
and	|O
21	|O
months	|O
,	|O
respectively	|O
;	|O
for	|O
the	|O
delayed	|O
treatment	|O
group	|O
,	|O
78.8%	|O
and	|O
64.6%	|O
at	|O
12	|O
and	|O
21	|O
months	|O
,	|O
respectively	|O
,	|O
and	|O
78.8%	|O
and	|O
47.5%	|O
at	|O
12	|O
and	|O
21	|O
months	|O
,	|O
respectively	|O
,	|O
for	|O
77	|O
subjects	|O
with	|O
AIDS	|O
and	|O
93.0%	|O
and	|O
71.8%	|O
,	|O
respectively	|O
,	|O
for	|O
50	|O
subjects	|O
with	|O
AIDS	|O
-	|O
related	|O
complex	|O
in	|O
the	|O
original	|O
treatment	|O
group	|O
.	|O

Mapping	|O
results	|O
suggested	|O
that	|O
the	|O
complementation	|O
group	|O
identified	|O
by	|O
these	|O
mutants	|O
is	|O
allelic	|O
to	|O
the	|O
ag	|B-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
mutation	|O
identified	|O
previously	|O
.	|O

The	|O
products	|O
of	|O
genes	|O
ura10	|B-PROTEIN
and	|O
ura3	|B-PROTEIN
are	|O
proposed	|O
to	|O
participate	|O
in	|O
the	|O
channeling	|O
of	|O
orotidine	|O
monophosphate	|O
.	|O

After	|O
the	|O
application	|O
of	|O
RS	|O
86	|O
,	|O
REM	|O
latency	|O
was	|O
shortened	|O
in	|O
all	|O
groups	|O
under	|O
investigation	|O
.	|O

Hybridization	|O
analysis	|O
showed	|O
that	|O
the	|O
size	|O
of	|O
the	|O
mRNA	|O
is	|O
about	|O
1.4	|O
kilobases	|O
.	|O

Agranulocytosis	|O
treatment	|O
with	|O
rhGM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN

The	|O
R.	|O
meliloti	|O
nifH	|B-PROTEIN
promoter	|O
but	|O
not	|O
the	|O
K.	|O
pneumoniae	|O
nifH	|B-PROTEIN
promoter	|O
showed	|O
sigma	|B-PROTEIN
54	|I-PROTEIN
-	|O
dependent	|O
methylation	|O
protection	|O
of	|O
guanine	|O
residues	|O
at	|O
-	|O
14	|O
,	|O
-	|O
25	|O
and	|O
-	|O
26	|O
,	|O
the	|O
most	|O
conserved	|O
nucleotides	|O
characteristic	|O
of	|O
sigma	|B-PROTEIN
54	|I-PROTEIN
-	|O
dependent	|O
promoters	|O
.	|O

Major	|O
clinical	|O
symptoms	|O
of	|O
the	|O
disease	|O
were	|O
defined	|O
in	|O
this	|O
group	|O
of	|O
patients	|O
.	|O

Recently	|O
,	|O
an	|O
alternatively	|O
spliced	|O
form	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
-	|O
encoded	|O
mRNA	|O
has	|O
been	|O
identified	|O
in	|O
murine	|O
cells	|O
containing	|O
either	|O
normal	|O
or	|O
rearranged	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
genes	|O
.	|O

Routine	|O
clinical	|O
analysis	|O
revealed	|O
lower	|O
hematocrit	|O
and	|O
hemoglobin	|B-PROTEIN
,	|O
and	|O
elevated	|O
BUN	|O
and	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
in	|O
the	|O
treated	|O
group	|O
.	|O

To	|O
assess	|O
the	|O
health	|O
significance	|O
of	|O
the	|O
early	|O
renal	|O
changes	|O
after	|O
chronic	|O
exposure	|O
to	|O
cadmium	|O
,	|O
23	|O
workers	|O
removed	|O
from	|O
exposure	|O
because	|O
of	|O
the	|O
discovery	|O
of	|O
an	|O
increased	|O
urinary	|O
excretion	|O
of	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
or	|O
retinol	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
or	|O
both	|O
,	|O
have	|O
been	|O
examined	|O
once	|O
a	|O
year	|O
for	|O
five	|O
years	|O
.	|O

In	|O
order	|O
to	|O
study	|O
the	|O
structural	|O
and	|O
functional	|O
organization	|O
of	|O
the	|O
eukaryotic	|O
nucleolus	|O
,	|O
we	|O
have	|O
started	|O
to	|O
isolate	|O
and	|O
characterize	|O
nucleolar	|O
components	|O
of	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

A	|O
transcription	|O
factor	|O
exclusion	|O
assay	|O
was	|O
used	|O
to	|O
show	|O
that	|O
the	|O
PCF1	|B-PROTEIN
mutation	|O
affects	|O
two	|O
distinct	|O
stages	|O
in	|O
transcription	|O
:	|O
one	|O
prior	|O
to	|O
and	|O
one	|O
after	|O
stable	|O
complex	|O
formation	|O
;	|O
and	|O
that	|O
these	|O
effects	|O
are	|O
mediated	|O
by	|O
a	|O
component	|O
of	|O
the	|O
stable	|O
complex	|O
.	|O

Psychiatry	|O
and	|O
the	|O
skin	|O
.	|O

These	|O
adverse	|O
effects	|O
usually	|O
abate	|O
with	|O
time	|O
.	|O

The	|O
cytosolic	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferases	|I-PROTEIN
(	|O
GSTs	|B-PROTEIN
,	|O
EC	|B-PROTEIN
2.5.1.18	|I-PROTEIN
)	|O
are	|O
a	|O
superfamily	|O
of	|O
dimeric	|O
isoenzymes	|O
which	|O
catalyze	|O
the	|O
conjugation	|O
of	|O
electrophilic	|O
substrates	|O
with	|O
glutathione	|O
.	|O

Furthermore	|O
,	|O
the	|O
3'	|O
-	|O
untranslated	|O
regions	|O
of	|O
pmGT10	|B-PROTEIN
display	|O
a	|O
marked	|O
degree	|O
of	|O
homology	|O
to	|O
the	|O
3'	|O
region	|O
of	|O
the	|O
rat	|O
Yb1	|B-PROTEIN
gene	|O
,	|O
while	|O
this	|O
region	|O
of	|O
pmGT2	|B-PROTEIN
displays	|O
marked	|O
homology	|O
to	|O
the	|O
corresponding	|O
region	|O
of	|O
the	|O
rat	|O
Yb2	|B-PROTEIN
gene	|O
.	|O

Model	|O
IV	|O
:	|O
primary	|O
abutments	|O
with	|O
the	|O
lateral	|O
incisor	|O
and	|O
the	|O
second	|O
molar	|O
as	|O
secondary	|O
abutments	|O
.	|O

The	|O
incidence	|O
of	|O
fetal	|O
breathing	|O
movements	|O
(	|O
06.00-10.00	|O
h	|O
)	|O
decreased	|O
with	|O
increasing	|O
gestational	|O
age	|O
while	|O
fetal	|O
arterial	|O
concentrations	|O
of	|O
plasma	|O
PGE	|O
increased	|O
significantly	|O
over	|O
the	|O
same	|O
period	|O
of	|O
gestation	|O
.	|O

During	|O
the	|O
first	|O
3	|O
min	|O
of	|O
recovery	|O
,	|O
plasma	|O
potassium	|O
fell	|O
rapidly	|O
in	|O
spite	|O
of	|O
nearly	|O
unchanged	|O
blood	|O
acidosis	|O
and	|O
significantly	|O
decreasing	|O
bicarbonate	|O
concentration	|O
.	|O

The	|O
present	|O
data	|O
also	|O
suggest	|O
that	|O
when	|O
compared	|O
to	|O
the	|O
systemic	|O
vascular	|O
bed	|O
,	|O
the	|O
pulmonary	|O
vascular	|O
bed	|O
is	|O
less	|O
responsive	|O
to	|O
bolus	|O
administration	|O
of	|O
ET	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

In	|O
comparison	|O
with	|O
normal	|O
pregnant	|O
women	|O
and	|O
normal	|O
non	|O
-	|O
pregnant	|O
women	|O
,	|O
women	|O
with	|O
PIH	|O
showed	|O
an	|O
increase	|O
in	|O
heart	|O
rate	|O
,	|O
suggesting	|O
an	|O
increased	|O
peripheral	|O
sympathetic	|O
tone	|O
,	|O
and	|O
an	|O
initial	|O
derangement	|O
in	|O
renal	|O
function	|O
as	|O
shown	|O
by	|O
the	|O
increase	|O
in	|O
serum	|O
uric	|O
acid	|O
and	|O
reduction	|O
in	|O
sodium	|O
excretion	|O
and	|O
total	|O
and	|O
fractional	|O
calcium	|O
excretion	|O
at	|O
any	|O
given	|O
level	|O
of	|O
sodium	|O
excretion	|O
.	|O

We	|O
have	|O
examined	|O
the	|O
role	|O
of	|O
two	|O
recombination	|O
-	|O
and	|O
repair	|O
-	|O
defective	|O
mutations	|O
,	|O
rad1	|B-PROTEIN
and	|O
rad52	|B-PROTEIN
,	|O
on	|O
direct	|O
repeat	|O
recombination	|O
in	|O
transcriptionally	|O
active	|O
and	|O
inactive	|O
sequences	|O
.	|O

The	|O
encoded	|O
protein	|O
has	|O
a	|O
leader	|O
sequence	|O
of	|O
27	|O
amino	|O
acids	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
knowledge	|O
of	|O
the	|O
epidemiology	|O
of	|O
Parkinson	|O
's	|O
disease	|O
is	|O
necessary	|O
in	|O
creating	|O
etiological	|O
hypotheses	|O
,	|O
since	|O
only	|O
hypotheses	|O
consistent	|O
with	|O
the	|O
epidemiological	|O
profile	|O
deserve	|O
careful	|O
testing	|O
.	|O

The	|O
stereoselectivity	|O
of	|O
drug	|O
action	|O
.	|O

Scotchbond	|O
2	|O
showed	|O
the	|O
least	|O
dye	|O
penetration	|O
but	|O
not	|O
statistically	|O
less	|O
than	|O
the	|O
XR	|O
bond	|O
/	|O
Silus	|O
Plus	|O
combination	|O
.	|O

A	|O
combination	|O
of	|O
cisplatin	|O
and	|O
5	|O
-	|O
fluorouracil	|O
,	|O
both	|O
administered	|O
4	|O
days	|O
continuously	|O
as	|O
infusion	|O
,	|O
was	|O
assessed	|O
in	|O
advanced	|O
head	|O
and	|O
neck	|O
cancer	|O
.	|O

Metformin	|O
plasma	|O
concentrations	|O
remained	|O
unchanged	|O
except	|O
for	|O
patients	|O
transferred	|O
from	|O
1.5	|O
to	|O
2.0	|O
g	|O
daily	|O
to	|O
850	|O
mg	|O
twice	|O
daily	|O
;	|O
in	|O
these	|O
patients	|O
plasma	|O
concentrations	|O
increased	|O
from	|O
1.83	|O
+	|O
/	|O
-	|O
0.87	|O
to	|O
2.50	|O
+	|O
/	|O
-	|O
0.89	|O
micrograms	|O
/	|O
l	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

Diagnosis	|O
of	|O
primary	|O
sclerosing	|O
cholangitis	|O
in	|O
a	|O
blood	|O
donor	|O
with	|O
elevated	|O
serum	|O
alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
.	|O

When	|O
statistically	|O
analyzed	|O
in	|O
various	|O
subgroupings	|O
,	|O
the	|O
obtained	|O
average	|O
sedimentation	|O
coefficients	|O
and	|O
polydispersity	|O
profiles	|O
supported	|O
the	|O
following	|O
conclusions	|O
:	|O
(	|O
a	|O
)	|O
loss	|O
of	|O
proteoglycan	|O
aggregation	|O
and	|O
sedimentability	|O
is	|O
confirmed	|O
to	|O
be	|O
a	|O
primary	|O
sign	|O
of	|O
cartilage	|O
matrix	|O
degradation	|O
;	|O
(	|O
b	|O
)	|O
higher	|O
S	|O
values	|O
for	|O
proteoglycans	|O
of	|O
the	|O
high	|O
weight	|O
(	|O
HW	|O
)	|O
-	|O
bearing	|O
areas	|O
and	|O
lower	|O
values	|O
for	|O
those	|O
of	|O
the	|O
low	|O
weight	|O
(	|O
LW	|O
)	|O
-	|O
bearing	|O
areas	|O
were	|O
a	|O
typical	|O
finding	|O
in	|O
normal	|O
cartilage	|O
samples	|O
;	|O
(	|O
c	|O
)	|O
inversion	|O
of	|O
this	|O
pattern	|O
was	|O
indicative	|O
of	|O
matrix	|O
degradation	|O
,	|O
suggesting	|O
that	|O
the	|O
HW	|O
regions	|O
are	|O
more	|O
affected	|O
than	|O
the	|O
LW	|O
-	|O
bearing	|O
areas	|O
;	|O
(	|O
d	|O
)	|O
the	|O
average	|O
S	|O
value	|O
distribution	|O
across	|O
cartilage	|O
thickness	|O
tended	|O
to	|O
resemble	|O
the	|O
corresponding	|O
proteoglycan	|O
content	|O
versus	|O
distance	|O
from	|O
articular	|O
surface	|O
;	|O
and	|O
(	|O
e	|O
)	|O
the	|O
deepest	|O
cartilage	|O
layer	|O
had	|O
,	|O
in	|O
most	|O
cases	|O
,	|O
the	|O
smallest	|O
amount	|O
of	|O
aggregates	|O
while	|O
the	|O
highest	|O
average	|O
sedimentability	|O
was	|O
observed	|O
at	|O
the	|O
middle	|O
zone	|O
of	|O
the	|O
normal	|O
samples	|O
.	|O

A	|O
significant	|O
relationship	|O
existed	|O
during	|O
the	|O
evolution	|O
of	|O
the	|O
disease	|O
between	|O
CRS	|O
/	|O
BW	|O
and	|O
gas	|O
exchange	|O
parameters	|O
(	|O
FIO2	|O
and	|O
a	|O
/	|O
AO2	|O
ratio	|O
)	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
,	|O
but	|O
gas	|O
exchange	|O
improved	|O
earlier	|O
than	|O
lung	|O
mechanics	|O
.	|O

End	|O
points	|O
measured	|O
were	|O
perioperative	|O
(	|O
30	|O
-	|O
day	|O
)	|O
myocardial	|O
infarction	|O
(	|O
MI	|O
)	|O
rate	|O
and	|O
death	|O
.	|O

The	|O
predicted	|O
molecular	|O
weight	|O
of	|O
the	|O
polyprotein	|O
encoded	|O
by	|O
ORF1	|O
is	|O
33	|O
kilodaltons	|O
(	|O
kDa	|O
)	|O
.	|O

Thus	|O
RV	|O
O2	|O
demand	|O
fell	|O
when	|O
RC	|O
O2	|O
supply	|O
was	|O
reduced	|O
,	|O
although	|O
a	|O
flow	|O
reserve	|O
was	|O
available	|O
.	|O

An	|O
alternative	|O
method	|O
of	|O
UKM	|O
is	|O
proposed	|O
based	|O
on	|O
collecting	|O
a	|O
small	|O
fraction	|O
of	|O
spent	|O
dialysate	|O
flow	|O
for	|O
3	|O
consecutive	|O
dialyses	|O
.	|O

Liquid	|O
chromatography	|O
with	|O
amperometric	|O
detection	|O
(	|O
LC	|O
/	|O
AD	|O
)	|O
is	|O
used	|O
to	|O
determine	|O
fluazifop	|O
acid	|O
produced	|O
from	|O
the	|O
metabolism	|O
or	|O
base	|O
hydrolysis	|O
of	|O
fluazifop	|O
-	|O
butyl	|O
in	|O
soybeans	|O
and	|O
soybean	|O
oil	|O
.	|O

The	|O
dichloromethane	|O
is	|O
removed	|O
,	|O
mobile	|O
phase	|O
solvent	|O
is	|O
added	|O
,	|O
and	|O
aliquots	|O
are	|O
injected	|O
onto	|O
a	|O
PRP	|O
-	|O
1	|O
liquid	|O
chromatographic	|O
column	|O
;	|O
fluazifop	|O
acid	|O
is	|O
separated	|O
from	|O
coextracted	|O
compounds	|O
and	|O
detected	|O
at	|O
an	|O
applied	|O
potential	|O
of	|O
+	|O
1.25	|O
V	|O
,	|O
using	|O
an	|O
amperometric	|O
electrochemical	|O
detector	|O
in	|O
the	|O
oxidation	|O
mode	|O
.	|O

Primer	|O
extension	|O
experiments	|O
indicated	|O
that	|O
the	|O
transcription	|O
initiation	|O
site	|O
mapped	|O
to	|O
a	|O
position	|O
on	|O
gene	|B-PROTEIN
IV	|I-PROTEIN
that	|O
was	|O
analogous	|O
to	|O
that	|O
reported	|O
for	|O
the	|O
structurally	|O
similar	|O
P	|B-PROTEIN
-	|I-PROTEIN
450e	|I-PROTEIN
gene	|O
.	|O

Significantly	|O
,	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
results	|O
demonstrated	|O
that	|O
gene	|B-PROTEIN
IV	|I-PROTEIN
transcripts	|O
were	|O
associated	|O
with	|O
hepatic	|O
polysome	|O
fractions	|O
,	|O
indicating	|O
their	|O
active	|O
utilization	|O
in	|O
this	|O
tissue	|O
.	|O

Validation	|O
of	|O
the	|O
survey	|O
of	|O
work	|O
styles	|O
:	|O
a	|O
profile	|O
measure	|O
of	|O
the	|O
type	|O
A	|O
behaviour	|O
pattern	|O
.	|O

Only	|O
one	|O
ADR	|O
was	|O
related	|O
definitely	|O
to	|O
ciprofloxacin	|O
therapy	|O
.	|O

HIV	|O
infectiousness	|O
and	|O
the	|O
AIDS	|O
epidemic	|O
.	|O

From	|O
day	|O
30	|O
after	|O
turnout	|O
,	|O
the	|O
PFB	|O
-	|O
group	|O
had	|O
significantly	|O
lower	|O
serum	|O
pepsinogen	|B-PROTEIN
levels	|O
,	|O
which	|O
reflects	|O
the	|O
low	|O
degree	|O
of	|O
abomasal	|O
damage	|O
in	|O
these	|O
animals	|O
.	|O

The	|O
corresponding	|O
inhibition	|O
of	|O
acid	|B-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
in	|O
control	|O
male	|O
and	|O
female	|O
guinea	|O
pigs	|O
was	|O
15.91%	|O
and	|O
20.33%	|O
respectively	|O
.	|O

Its	|O
clinical	|O
and	|O
histopathologic	|O
characteristics	|O
.	|O

Normocapnic	|O
(	|O
PACO2	|O
=	|O
40	|O
mm	|O
Hg	|O
)	|O
ventilatory	|O
drive	|O
increased	|O
significantly	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
in	|O
six	|O
subjects	|O
(	|O
Type	|O
1	|O
response	|O
)	|O
and	|O
decreased	|O
substantially	|O
in	|O
the	|O
others	|O
(	|O
Type	|O
2	|O
response	|O
)	|O
;	|O
with	|O
hypercapnia	|O
,	|O
the	|O
changes	|O
in	|O
drive	|O
were	|O
attenuated	|O
in	|O
both	|O
groups	|O
.	|O

Fundus	|O
changes	|O
in	|O
(	|O
type	|O
II	|O
)	|O
mesangiocapillary	|O
glomerulonephritis	|O
simulating	|O
drusen	|O
:	|O
a	|O
histopathological	|O
report	|O
.	|O

Chronic	|O
dose	|O
effects	|O
of	|O
methyl	|O
parathion	|O
on	|O
nuthatches	|O
:	|O
cholinesterase	|B-PROTEIN
and	|O
ptilochronology	|O
.	|O

The	|O
titer	|O
of	|O
anti	|B-PROTEIN
HSV	|I-PROTEIN
type	|I-PROTEIN
1	|I-PROTEIN
and	|O
anti	|B-PROTEIN
HSV	|I-PROTEIN
type	|I-PROTEIN
2	|I-PROTEIN
antibodies	|O
in	|O
the	|O
mothers	|O
'	|O
and	|O
cord	|O
blood	|O
was	|O
determined	|O
and	|O
compared	|O
.	|O

Kidney	|O
weight	|O
and	|O
kidney	|O
-	|O
to	|O
-	|O
body	|O
weight	|O
ratio	|O
were	|O
significantly	|O
elevated	|O
at	|O
the	|O
highest	|O
dose	|O
level	|O
after	|O
10	|O
weeks	|O
and	|O
at	|O
the	|O
two	|O
higher	|O
dose	|O
levels	|O
after	|O
15	|O
weeks	|O
of	|O
exposure	|O
.	|O

Allelic	|O
variation	|O
in	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
and	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
sequences	|O
and	|O
the	|O
evolution	|O
of	|O
the	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
alleles	|O
.	|O

A	|O
method	|O
for	|O
determining	|O
optimal	|O
development	|O
conditions	|O
by	|O
summary	|O
oxygen	|O
consumption	|O

Men	|O
were	|O
more	|O
positive	|O
about	|O
their	|O
physical	|O
fitness	|O
than	|O
women	|O
.	|O

Handgrip	|O
dynamometry	|O
was	|O
also	|O
carried	|O
out	|O
in	|O
249	|O
of	|O
the	|O
patients	|O
.	|O

In	|O
cerebrospinal	|O
fluid	|O
,	|O
an	|O
ADA	|B-PROTEIN
catalytic	|O
concentration	|O
above	|O
0.15	|O
mu	|O
kat	|O
/	|O
L	|O
strongly	|O
suggests	|O
tuberculous	|O
meningitis	|O
in	|O
patients	|O
older	|O
than	|O
7	|O
years	|O
(	|O
sensitivity	|O
1.00	|O
,	|O
specificity	|O
0.99	|O
and	|O
efficiency	|O
0.99	|O
)	|O
.	|O

NERVTRACK	|O
contains	|O
4000	|O
anatomical	|O
data	|O
items	|O
arranged	|O
in	|O
a	|O
tree	|O
-	|O
like	|O
manner	|O
reflecting	|O
structural	|O
and	|O
functional	|O
relationships	|O
.	|O

Swim	|O
-	|O
over	|O
:	|O
an	|O
alternative	|O
method	|O
for	|O
harvesting	|O
motile	|O
spermatozoa	|O
.	|O

Perfusion	|O
washout	|O
:	|O
increasing	|O
a	|O
microvascular	|O
free	|O
flap	|O
tolerance	|O
to	|O
ischemia	|O
.	|O

Similarly	|O
,	|O
the	|O
sequence	|O
of	|O
the	|O
U2	|B-PROTEIN
RNA	|O
region	|O
shown	|O
to	|O
be	|O
involved	|O
in	|O
pre	|O
-	|O
mRNA	|O
branchpoint	|O
recognition	|O
in	|O
yeast	|O
,	|O
and	|O
exactly	|O
conserved	|O
in	|O
metazoan	|O
U2	|B-PROTEIN
RNAs	|O
,	|O
was	|O
totally	|O
divergent	|O
in	|O
trypanosomes	|O
.	|O

It	|O
is	|O
striking	|O
that	|O
the	|O
active	|O
CHO	|O
spacer	|O
promoter	|O
violated	|O
the	|O
otherwise	|O
universal	|O
rule	|O
that	|O
metazoan	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
I	|I-PROTEIN
promoters	|O
all	|O
have	|O
a	|O
G	|O
residue	|O
at	|O
position	|O
-	|O
16	|O
.	|O

A	|O
raised	|O
amplitude	|O
of	|O
the	|O
aggregation	|O
of	|O
plates	|O
and	|O
a	|O
decrease	|O
in	|O
the	|O
threshold	|O
of	|O
their	|O
sensitivity	|O
to	|O
ADP	|O
were	|O
established	|O
in	|O
the	|O
persons	|O
with	|O
types	|O
IIa	|O
and	|O
IIb	|O
HLP	|O
and	|O
in	|O
CHD	|O
without	|O
HLP	|O
.	|O

Significant	|O
intergroup	|O
differences	|O
are	|O
highlighted	|O
for	|O
both	|O
selected	|O
dentoskeletal	|O
and	|O
soft	|O
tissue	|O
profile	|O
variables	|O
.	|O

The	|O
author	|O
provides	|O
a	|O
rationale	|O
for	|O
an	|O
interactional	|O
view	|O
and	|O
presents	|O
a	|O
case	|O
in	|O
which	|O
post	|O
-	|O
surgical	|O
hiccups	|O
were	|O
successfully	|O
treated	|O
,	|O
using	|O
principles	|O
developed	|O
by	|O
the	|O
Mental	|O
Research	|O
Institute	|O
.	|O

The	|O
relative	|O
toxicity	|O
of	|O
nickel	|O
oxide	|O
(	|O
NiO	|O
)	|O
,	|O
nickel	|O
sulfate	|O
hexahydrate	|O
(	|O
NiSO4.6	|O
H2O	|O
)	|O
,	|O
and	|O
nickel	|O
subsulfide	|O
(	|O
Ni3S2	|O
)	|O
was	|O
studied	|O
in	|O
F344	|O
/	|O
N	|O
rats	|O
and	|O
B6C3F1	|O
mice	|O
after	|O
inhalation	|O
exposure	|O
for	|O
6	|O
hr	|O
/	|O
day	|O
,	|O
5	|O
days	|O
/	|O
week	|O
,	|O
for	|O
13	|O
weeks	|O
.	|O

Light	|O
microscopical	|O
and	|O
routine	|O
immunohistochemical	|O
studies	|O
of	|O
a	|O
cervical	|O
neoplasm	|O
in	|O
a	|O
32	|O
year	|O
old	|O
woman	|O
initially	|O
suggested	|O
a	|O
histiocytic	|O
lymphoma	|O
,	|O
but	|O
histochemical	|O
staining	|O
for	|O
chloroacetate	|B-PROTEIN
esterase	|I-PROTEIN
established	|O
the	|O
correct	|O
diagnosis	|O
.	|O

From	|O
the	|O
National	|O
Institutes	|O
of	|O
Health	|O
.	|O

Molecular	|O
cloning	|O
and	|O
characterisation	|O
of	|O
the	|O
two	|O
homologous	|O
genes	|O
coding	|O
for	|O
nitrate	|B-PROTEIN
reductase	|I-PROTEIN
in	|O
tobacco	|O
.	|O

In	|O
the	|O
final	|O
model	|O
,	|O
grade	|O
(	|O
p	|O
=	|O
0.0002	|O
)	|O
,	|O
peritoneal	|O
cytologic	|O
results	|O
(	|O
p	|O
=	|O
0.0002	|O
)	|O
,	|O
progesterone	|B-PROTEIN
receptor	|I-PROTEIN
status	|O
(	|O
p	|O
=	|O
0.004	|O
)	|O
,	|O
and	|O
age	|O
as	|O
a	|O
continuous	|O
variable	|O
(	|O
p	|O
=	|O
0.008	|O
)	|O
were	|O
most	|O
closely	|O
associated	|O
with	|O
disease	|O
-	|O
free	|O
survival	|O
.	|O

In	|O
contrast	|O
,	|O
despite	|O
external	|O
radiation	|O
therapy	|O
,	|O
brain	|O
metastases	|O
proved	|O
fatal	|O
.	|O

COUP	|B-PROTEIN
transcription	|O
factor	|O
is	|O
a	|O
member	|O
of	|O
the	|O
steroid	|B-PROTEIN
receptor	|I-PROTEIN
superfamily	|O
.	|O

In	|O
Experiment	|O
2	|O
,	|O
we	|O
again	|O
used	|O
classification	|O
,	|O
but	|O
the	|O
fixed	|O
standard	|O
75	|O
was	|O
not	|O
at	|O
the	|O
center	|O
of	|O
the	|O
range	|O
of	|O
target	|O
numbers	|O
(	|O
20	|O
,	|O
21	|O
,	|O
...	|O

Cosmid	|O
clones	|O
containing	|O
both	|O
VNTR	|O
sequences	|O
were	|O
identified	|O
,	|O
and	|O
restriction	|O
mapping	|O
showed	|O
them	|O
to	|O
be	|O
less	|O
than	|O
15	|O
kb	|O
apart	|O
.	|O

The	|O
oxygen	|O
uptake	|O
(	|O
VO2	|O
)	|O
,	|O
carbon	|O
dioxide	|O
output	|O
(	|O
VCO2	|O
)	|O
,	|O
respiratory	|O
rate	|O
(	|O
fR	|O
)	|O
,	|O
minute	|O
ventilation	|O
(	|O
VE	|O
)	|O
,	|O
alveolar	|O
ventilation	|O
(	|O
VA	|O
)	|O
,	|O
alveolar	|O
oxygen	|O
pressure	|O
(	|O
PAO2	|O
)	|O
,	|O
and	|O
VE	|O
/	|O
VO2	|O
ratio	|O
were	|O
higher	|O
in	|O
the	|O
cows	|O
,	|O
while	|O
the	|O
tidal	|O
volume	|O
(	|O
VT	|O
)	|O
and	|O
physiological	|O
dead	|O
space	|O
(	|O
VD	|O
)	|O
were	|O
larger	|O
in	|O
the	|O
horses	|O
.	|O

Epithelial	|O
damage	|O
was	|O
not	|O
observed	|O
in	|O
any	|O
controls	|O
but	|O
was	|O
in	|O
all	|O
tissues	|O
exposed	|O
to	|O
SO2	|O
.	|O

Among	|O
booked	|O
patients	|O
the	|O
maternal	|O
mortality	|O
rate	|O
was	|O
0.32	|O
and	|O
among	|O
unbooked	|O
patients	|O
11.13	|O
per	|O
1000	|O
deliveries	|O
.	|O

The	|O
present	|O
study	|O
investigates	|O
whether	|O
prostaglandins	|O
"	|O
cytoprotect	|O
"	|O
the	|O
gastric	|O
mucosa	|O
against	|O
hemorrhage	|O
-	|O
induced	|O
stress	|O
ulceration	|O
by	|O
assessing	|O
the	|O
influence	|O
of	|O
16,16	|O
-	|O
dimethyl	|O
prostaglandin	|O
E2	|O
(	|O
16,16	|O
-	|O
dm	|O
PGE2	|O
)	|O
on	|O
gross	|O
and	|O
microscopic	|O
lesion	|O
formation	|O
,	|O
intramucosal	|O
tissue	|O
pH	|O
,	|O
H+	|O
back	|O
-	|O
diffusion	|O
,	|O
and	|O
mucosal	|O
blood	|O
flow	|O
in	|O
rat	|O
gastric	|O
mucosa	|O
exposed	|O
to	|O
luminal	|O
acid	|O
(	|O
100	|O
mM	|O
HCl	|O
)	|O
during	|O
hemorrhagic	|O
shock	|O
(	|O
13	|O
ml	|O
/	|O
kg	|O
for	|O
20	|O
min	|O
)	|O
.	|O

Transcripts	|O
characterized	|O
include	|O
(	|O
i	|O
)	|O
abundant	|O
monocistronic	|O
L11e	|B-PROTEIN
and	|O
tricistronic	|O
L1e	|O
-	|O
L10e	|O
-	|O
L12e	|B-PROTEIN
transcripts	|O
;	|O
(	|O
ii	|O
)	|O
less	|O
abundant	|O
bicistronic	|O
NAB	|B-PROTEIN
-	|O
L11e	|B-PROTEIN
and	|O
monocistronic	|O
NAB	|B-PROTEIN
transcripts	|O
and	|O
(	|O
iii	|O
)	|O
a	|O
very	|O
rare	|O
ORF	|O
monocistronic	|O
transcript	|O
.	|O

Qualitatively	|O
,	|O
the	|O
results	|O
are	|O
similar	|O
for	|O
the	|O
two	|O
species	|O
:	|O
Both	|O
rhesus	|O
monkey	|O
and	|O
man	|O
have	|O
photopic	|O
and	|O
scotopic	|O
branches	|O
,	|O
which	|O
cross	|O
at	|O
approximately	|O
the	|O
same	|O
time	|O
in	|O
the	|O
dark	|O
and	|O
at	|O
approximately	|O
the	|O
same	|O
background	|O
luminance	|O
.	|O

Evidence	|O
from	|O
the	|O
structure	|O
of	|O
a	|O
number	|O
of	|O
cDNA	|O
clones	|O
,	|O
as	|O
well	|O
as	|O
S1	|B-PROTEIN
nuclease	|O
and	|O
primer	|O
extension	|O
studies	|O
supports	|O
the	|O
hypothesis	|O
that	|O
the	|O
PTHrP	|B-PROTEIN
gene	|O
contains	|O
at	|O
least	|O
two	|O
mRNA	|O
transcription	|O
start	|O
points	|O
that	|O
define	|O
two	|O
putative	|O
regulatory	|O
domains	|O
.	|O

At	|O
each	|O
level	|O
of	|O
PaO2	|O
we	|O
obtained	|O
simultaneous	|O
measures	|O
of	|O
arterial	|O
and	|O
venous	|O
blood	|O
gases	|O
,	|O
venous	|O
lactate	|O
concentration	|O
,	|O
and	|O
changes	|O
in	|O
the	|O
relative	|O
concentrations	|O
of	|O
inorganic	|O
phosphate	|O
,	|O
phosphocreatine	|O
,	|O
and	|O
ATP	|O
measured	|O
with	|O
31P	|O
magnetic	|O
resonance	|O
spectroscopy	|O
.	|O

The	|O
transcription	|O
initiation	|O
site	|O
was	|O
determined	|O
by	|O
S1	|B-PROTEIN
nuclease	|O
mapping	|O
.	|O

Endometrial	|O
biopsies	|O
and	|O
plasma	|O
oestradiol	|O
(	|O
E2	|O
)	|O
and	|O
progesterone	|O
(	|O
P4	|O
)	|O
levels	|O
in	|O
23	|O
patients	|O
were	|O
evaluated	|O
during	|O
26	|O
replacement	|O
therapy	|O
cycles	|O
for	|O
premature	|O
ovarian	|O
failure	|O
.	|O

The	|O
mobility	|O
of	|O
the	|O
upper	|O
and	|O
lower	|O
premolars	|O
under	|O
load	|O
was	|O
investigated	|O
in	|O
relation	|O
to	|O
the	|O
interproximal	|O
contact	|O
and	|O
occlusal	|O
facets	|O
.	|O

A	|O
larval	|O
albumin	|B-PROTEIN
-	|O
like	|O
protein	|O
was	|O
not	|O
detectable	|O
by	|O
silver	|O
staining	|O
in	|O
serum	|O
of	|O
tadpoles	|O
before	|O
the	|O
beginning	|O
of	|O
metamorphosis	|O
at	|O
stage	|O
48	|O
.	|O

Behaviorally	|O
,	|O
a	|O
pain	|O
-	|O
tolerant	|O
group	|O
(	|O
PT	|O
=	|O
29	|O
Ss	|O
)	|O
tolerated	|O
the	|O
entire	|O
3	|O
-	|O
min	|O
test	|O
(	|O
means	|O
=	|O
180	|O
+	|O
/	|O
-	|O
0	|O
sec	|O
)	|O
,	|O
while	|O
a	|O
pain	|O
-	|O
sensitive	|O
group	|O
(	|O
PS	|O
=	|O
13	|O
Ss	|O
)	|O
averaged	|O
only	|O
50.31	|O
+	|O
/	|O
-	|O
20.81	|O
sec	|O
of	|O
the	|O
cold	|O
-	|O
pressor	|O
test	|O
(	|O
t	|O
=	|O
16.75	|O
,	|O
P	|O
less	|O
than	|O
0.0001	|O
)	|O
,	|O
replicating	|O
our	|O
earlier	|O
studies	|O
.	|O

This	|O
suggested	|O
that	|O
baboon	|O
liver	|O
class	|O
I	|O
ADH	|B-PROTEIN
is	|O
of	|O
the	|O
same	|O
ancestral	|O
lineage	|O
as	|O
the	|O
human	|O
ADH	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
.	|O

Isolated	|O
proteinuria	|O
(	|O
i.e.	|O
without	|O
hematuria	|O
and	|O
/	|O
or	|O
pyuria	|O
)	|O
is	|O
a	|O
frequent	|O
finding	|O
.	|O

Each	|O
individual	|O
shot	|O
25	|O
bullets	|O
in	|O
about	|O
5	|O
minutes	|O
,	|O
at	|O
an	|O
intensity	|O
level	|O
calculated	|O
at	|O
163	|O
dB	|O
.	|O

Lithium	|O
delays	|O
the	|O
circadian	|O
rhythm	|O
of	|O
wheel	|O
-	|O
running	|O
in	|O
Syrian	|O
hamsters	|O
at	|O
plasma	|O
concentrations	|O
(	|O
0.59-0.74	|O
mM	|O
)	|O
that	|O
also	|O
cause	|O
toxic	|O
weight	|O
loss	|O
.	|O

Dynamic	|O
and	|O
static	|O
scintigrams	|O
,	|O
using	|O
99mtechnetium	|O
methylene	|O
diphosphonate	|O
,	|O
were	|O
obtained	|O
at	|O
zero	|O
,	|O
six	|O
,	|O
and	|O
12	|O
weeks	|O
after	|O
fracture	|O
.	|O

On	|O
admission	|O
to	|O
our	|O
department	|O
in	|O
September	|O
,	|O
1987	|O
,	|O
the	|O
patient	|O
was	|O
alert	|O
and	|O
had	|O
spastic	|O
paraparesis	|O
,	|O
the	|O
impairment	|O
of	|O
all	|O
sensory	|O
modalities	|O
below	|O
the	|O
level	|O
of	|O
Th	|O
10	|O
and	|O
urinary	|O
disturbance	|O
.	|O

Prostaglandins	|O
and	|O
gallstones	|O

The	|O
nature	|O
of	|O
the	|O
process	|O
formed	|O
by	|O
the	|O
successive	|O
occurrences	|O
of	|O
this	|O
arrhythmia	|O
was	|O
studied	|O
in	|O
8	|O
patients	|O
with	|O
a	|O
history	|O
of	|O
symptomatic	|O
paroxysmal	|O
AF	|O
.	|O

This	|O
would	|O
have	|O
had	|O
the	|O
effect	|O
of	|O
positioning	|O
the	|O
genes	|O
currently	|O
on	|O
the	|O
long	|O
arm	|O
adjacent	|O
to	|O
the	|O
centromeric	|O
heterochromatin	|O
,	|O
perhaps	|O
resulting	|O
in	|O
a	|O
"	|O
position	|O
effect	|O
"	|O
on	|O
transcription	|O
of	|O
these	|O
genes	|O
.	|O

Initial	|O
experience	|O
with	|O
a	|O
microprocessor	|O
controlled	|O
current	|O
based	|O
defibrillator	|O
.	|O

Obesity	|O
was	|O
strongly	|O
associated	|O
with	|O
the	|O
proportions	|O
of	|O
nonprotein	|O
-	|O
bound	|O
and	|O
albumin	|B-PROTEIN
-	|O
bound	|O
estradiol	|O
,	|O
and	|O
inversely	|O
associated	|O
with	|O
sex	|B-PROTEIN
hormone	|I-PROTEIN
binding	|I-PROTEIN
globulin	|I-PROTEIN
(	|O
SHBG	|B-PROTEIN
)	|O
levels	|O
and	|O
the	|O
proportion	|O
of	|O
SHBG	|B-PROTEIN
-	|O
bound	|O
estradiol	|O
.	|O

Heterogeneous	|O
nuclear	|O
ribonucleoprotein	|O
(	|O
hnRNP	|O
)	|O
core	|O
protein	|O
A1	|B-PROTEIN
is	|O
a	|O
major	|O
component	|O
of	|O
mammalian	|O
hnRNP	|O
40	|B-PROTEIN
S	|I-PROTEIN
particles	|O
.	|O

Brain	|O
cholinesterase	|B-PROTEIN
activity	|O
of	|O
nestling	|O
great	|O
egrets	|O
,	|O
snowy	|O
egrets	|O
and	|O
black	|O
-	|O
crowned	|O
night	|O
-	|O
herons	|O
.	|O
inhibition	|O
of	|O
brain	|O
cholinesterase	|B-PROTEIN
(	|O
ChE	|B-PROTEIN
)	|O
activity	|O
in	|O
birds	|O
is	|O
often	|O
used	|O
to	|O
diagnose	|O
exposure	|O
or	|O
death	|O
from	|O
organophosphorus	|O
or	|O
carbamate	|O
pesticides	|O
.	|O

The	|O
effect	|O
of	|O
zinc	|O
deficiency	|O
on	|O
trace	|O
metals	|O
in	|O
the	|O
liver	|O
,	|O
spleen	|O
,	|O
kidney	|O
,	|O
pancreas	|O
and	|O
duodenum	|O
was	|O
investigated	|O
in	|O
the	|O
control	|O
and	|O
zinc	|O
-	|O
deficient	|O
rats	|O
at	|O
17	|O
days	|O
and	|O
20	|O
days	|O
of	|O
pregnancy	|O
.	|O

Our	|O
findings	|O
support	|O
the	|O
view	|O
of	|O
a	|O
multifactorial	|O
genesis	|O
of	|O
the	|O
cardiac	|O
involvement	|O
in	|O
uremic	|O
patients	|O
.	|O

Heating	|O
cells	|O
to	|O
43	|O
degrees	|O
C	|O
decreased	|O
the	|O
amount	|O
of	|O
newly	|O
synthesized	|O
rRNA	|O
to	|O
less	|O
than	|O
5%	|O
of	|O
the	|O
control	|O
level	|O
and	|O
led	|O
to	|O
greater	|O
than	|O
95%	|O
inhibition	|O
of	|O
transcription	|O
termination	|O
at	|O
a	|O
region	|O
355	|O
to	|O
362	|O
nucleotides	|O
downstream	|O
of	|O
the	|O
3'	|O
end	|O
of	|O
28S	|B-PROTEIN
rRNA	|O
,	|O
with	|O
readthrough	|O
continuing	|O
into	|O
the	|O
next	|O
transcription	|O
unit	|O
.	|O

Deletion	|O
analysis	|O
showed	|O
that	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
4FA	|I-PROTEIN
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
4FB	|I-PROTEIN
,	|O
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
sequences	|O
are	|O
each	|O
necessary	|O
for	|O
full	|O
enhancer	|O
activity	|O
.	|O

Cord	|O
swelling	|O
was	|O
observed	|O
in	|O
2	|O
patients	|O
who	|O
developed	|O
complete	|O
lesions	|O
.	|O

Reye	|O
's	|O
syndrome	|O
:	|O
reports	|O
of	|O
7	|O
cases	|O
in	|O
the	|O
period	|O
1982-1987	|O

When	|O
two	|O
-	|O
dimensional	|O
polyacrylamide	|O
gel	|O
electrophoretic	|O
patterns	|O
of	|O
[	|O
35S	|O
]	|O
methionine	|O
-	|O
labeled	|O
proteins	|O
secreted	|O
from	|O
cells	|O
infected	|O
with	|O
parental	|O
and	|O
recombinant	|O
viruses	|O
were	|O
compared	|O
,	|O
a	|O
spot	|O
missing	|O
from	|O
the	|O
latter	|O
corresponded	|O
in	|O
molecular	|O
weigh	|O
and	|O
isoelectric	|O
point	|O
with	|O
that	|O
predicted	|O
from	|O
the	|O
N1L	|B-PROTEIN
ORF	|O
.	|O

PULSE	|O
is	|O
used	|O
to	|O
set	|O
such	|O
NMR	|O
spectroscopic	|O
parameters	|O
as	|O
the	|O
delay	|O
and	|O
duration	|O
of	|O
rf	|O
transmit	|O
and	|O
receive	|O
gates	|O
,	|O
rf	|O
phase	|O
,	|O
sampling	|O
times	|O
,	|O
and	|O
such	|O
imaging	|O
parameters	|O
as	|O
rf	|O
pulse	|O
shape	|O
and	|O
gradient	|O
waveforms	|O
.	|O

Definite	|O
JPsA	|O
(	|O
24	|O
patients	|O
)	|O
was	|O
defined	|O
as	|O
arthritis	|O
associated	|O
,	|O
but	|O
not	|O
necessarily	|O
coincident	|O
,	|O
with	|O
a	|O
typical	|O
psoriatic	|O
rash	|O
,	|O
or	|O
arthritis	|O
plus	|O
at	|O
least	|O
3	|O
of	|O
4	|O
minor	|O
criteria	|O
:	|O
dactylitis	|O
,	|O
nail	|O
pitting	|O
,	|O
psoriasis	|O
-	|O
like	|O
rash	|O
,	|O
or	|O
family	|O
history	|O
of	|O
psoriasis	|O
.	|O

Hence	|O
follows	|O
Kurti	|O
's	|O
demand	|O
to	|O
mete	|O
out	|O
appropriate	|O
importance	|O
to	|O
the	|O
arguments	|O
.	|O

The	|O
author	|O
gives	|O
an	|O
account	|O
of	|O
antipsychotic	|O
,	|O
analgetic	|O
,	|O
myorelaxing	|O
and	|O
vasodilatating	|O
effects	|O
of	|O
some	|O
calcium	|O
antagonists	|O
,	|O
and	|O
their	|O
clinical	|O
application	|O
is	|O
discussed	|O
.	|O

A	|O
correlation	|O
coefficient	|O
was	|O
used	|O
for	|O
assessing	|O
the	|O
similarity	|O
of	|O
each	|O
map	|O
pattern	|O
with	|O
the	|O
normal	|O
mean	|O
IQRST	|O
map	|O
.	|O

A	|O
hospital	|O
-	|O
based	|O
study	|O
of	|O
the	|O
relationship	|O
between	|O
retained	|O
placenta	|O
and	|O
mastitis	|O
in	|O
dairy	|O
cows	|O
.	|O

This	|O
indicates	|O
that	|O
lipid	|O
peroxidation	|O
may	|O
be	|O
involved	|O
in	|O
the	|O
development	|O
of	|O
senile	|O
cataract	|O
and	|O
,	|O
as	|O
a	|O
direct	|O
consequence	|O
of	|O
retinal	|O
damage	|O
,	|O
also	|O
in	|O
the	|O
pathogenesis	|O
of	|O
cataract	|O
in	|O
diabetes	|O
and	|O
in	|O
severe	|O
myopia	|O
.	|O

The	|O
histological	|O
grading	|O
was	|O
certified	|O
in	|O
68	|O
cases	|O
:	|O
12	|O
G1	|O
,	|O
39	|O
G2	|O
,	|O
17	|O
G3	|O
;	|O
extracapsular	|O
spread	|O
was	|O
found	|O
in	|O
20/54	|O
cases	|O
(	|O
37%	|O
)	|O
.	|O

Asthma	|O
was	|O
significantly	|O
more	|O
often	|O
associated	|O
with	|O
ASA	|O
group	|O
(	|O
91%	|O
)	|O
vs	|O
46%	|O
at	|O
AT	|O
and	|O
in	|O
only	|O
16%	|O
at	|O
INTR	|O
group	|O
.	|O

A	|O
value	|O
of	|O
1.1	|O
l	|O
/	|O
kg	|O
was	|O
used	|O
for	|O
V	|O
in	|O
calculating	|O
all	|O
single	|O
sample	|O
estimates	|O
of	|O
clearance	|O
(	|O
CL	|O
)	|O
,	|O
and	|O
a	|O
value	|O
of	|O
4.3	|O
l	|O
/	|O
kg	|O
was	|O
used	|O
to	|O
calculate	|O
single	|O
sample	|O
estimates	|O
of	|O
clearance	|O
of	|O
plasma	|O
unbound	|O
drug	|O
(	|O
CLunb	|O
)	|O
.	|O

The	|O
solitary	|O
kidney	|O
:	|O
a	|O
model	|O
of	|O
chronic	|O
hyperfiltration	|O
in	|O
humans	|O
.	|O

Halothane	|O
is	|O
metabolized	|O
by	|O
an	|O
oxidative	|O
pathway	|O
to	|O
stable	|O
,	|O
nonvolatile	|O
end	|O
products	|O
,	|O
trifluoroacetic	|O
acid	|O
(	|O
TFAA	|O
)	|O
and	|O
bromide	|O
(	|O
Br	|O
-	|O
)	|O
,	|O
and	|O
by	|O
reductive	|O
pathways	|O
to	|O
Br	|O
-	|O
and	|O
inorganic	|O
fluoride	|O
(	|O
F	|O
-	|O
)	|O
.	|O

The	|O
values	|O
were	|O
consistently	|O
lower	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
during	|O
summer	|O
(	|O
3.79	|O
+	|O
/	|O
-	|O
0.13	|O
micrograms	|O
/	|O
100	|O
ml	|O
)	|O
,	|O
as	|O
compared	|O
to	|O
winter	|O
(	|O
5.06	|O
+	|O
/	|O
-	|O
0.27	|O
)	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
HAPE	|O
-	|O
S	|O
-	|O
S	|O
are	|O
prone	|O
to	|O
irregular	|O
nocturnal	|O
breathing	|O
patterns	|O
at	|O
high	|O
altitude	|O
,	|O
which	|O
is	|O
associated	|O
with	|O
the	|O
development	|O
of	|O
AMS	|O
,	|O
but	|O
it	|O
was	|O
not	|O
possible	|O
to	|O
determine	|O
whether	|O
these	|O
abnormal	|O
breathing	|O
patterns	|O
are	|O
a	|O
cause	|O
or	|O
an	|O
effect	|O
of	|O
AMS	|O
.	|O

Buflomedil	|O
(	|O
i.v	|O
.	|O
)	|O
induced	|O
a	|O
dose	|O
-	|O
dependent	|O
increase	|O
of	|O
cardiac	|O
output	|O
at	|O
0.16-0.64	|O
mg	|O
/	|O
kg	|O
,	|O
biphasic	|O
changes	|O
at	|O
1.28	|O
and	|O
2.56	|O
mg	|O
/	|O
kg	|O
and	|O
a	|O
marked	|O
decrease	|O
and	|O
subsequent	|O
slight	|O
increase	|O
at	|O
a	|O
large	|O
dose	|O
of	|O
5.12	|O
mg	|O
/	|O
kg	|O
.	|O

It	|O
was	|O
possible	|O
to	|O
classify	|O
the	|O
animals	|O
into	|O
high	|O
and	|O
low	|O
responders	|O
according	|O
to	|O
the	|O
pattern	|O
of	|O
humoral	|O
immune	|O
response	|O
.	|O

Heart	|O
rate	|O
(	|O
HR	|O
)	|O
,	|O
rectal	|O
temperature	|O
(	|O
Tre	|O
)	|O
,	|O
blood	|O
pressure	|O
,	|O
temperature	|O
and	|O
relative	|O
humidity	|O
changes	|O
inside	|O
clothing	|O
were	|O
measured	|O
on	|O
18	|O
professional	|O
firemen	|O
(	|O
mean	|O
age	|O
29.4	|O
+	|O
/	|O
-	|O
7.4	|O
yr	|O
,	|O
VO2	|O
max	|O
41.4	|O
+	|O
8.8	|O
ml	|O
kg	|O
-	|O
1	|O
min	|O
-	|O
1	|O
)	|O
wearing	|O
fire	|O
fighter	|O
's	|O
uniforms	|O
(	|O
SU	|O
)	|O
or	|O
aluminized	|O
,	|O
fire	|O
resistant	|O
,	|O
impermeable	|O
clothing	|O
with	|O
self	|O
contained	|O
breathing	|O
apparatus	|O
(	|O
FE	|O
)	|O
.	|O

The	|O
clinical	|O
tolerance	|O
and	|O
pharmacokinetics	|O
of	|O
FCE	|O
22101	|O
(	|O
sodium	|O
(	|O
5R	|O
,	|O
6S	|O
)	|O
-	|O
6	|O
-	|O
[	|O
(	|O
1R	|O
)	|O
-	|O
hydroxyethyl	|O
]	|O
-	|O
2	|O
-	|O
carbamoyloxymethyl	|O
-	|O
2	|O
-	|O
penem	|O
-	|O
3	|O
-	|O
carboxylate	|O
)	|O
,	|O
a	|O
new	|O
penem	|O
antibiotic	|O
,	|O
have	|O
been	|O
studied	|O
after	|O
giving	|O
a	|O
single	|O
i.v	|O
.	|O
dose	|O
of	|O
4	|O
mg.k	|O
g	|O
-	|O
1	|O
to	|O
ten	|O
healthy	|O
male	|O
volunteers	|O
.	|O

DNA	|O
blot	|O
hybridization	|O
suggests	|O
that	|O
the	|O
rat	|O
genome	|O
may	|O
contain	|O
more	|O
than	|O
one	|O
gene	|O
encoding	|O
PtdIns	|B-PROTEIN
transfer	|O
protein	|O
.	|O

We	|O
use	|O
the	|O
term	|O
corticosteroid	|O
-	|O
dependent	|O
IA	|O
to	|O
refer	|O
to	|O
the	|O
serious	|O
problem	|O
of	|O
chronic	|O
IA	|O
requiring	|O
maintenance	|O
prednisone	|O
therapy	|O
.	|O

Another	|O
segment	|O
of	|O
CRL3	|B-PROTEIN
(	|O
-	|O
296	|O
to	|O
-	|O
184	|O
)	|O
,	|O
also	|O
displaying	|O
enhancer	|O
function	|O
,	|O
contained	|O
tandem	|O
repeated	|O
sequences	|O
(	|O
DR	|O
-	|O
A1	|O
and	|O
DR	|O
-	|O
A2	|O
)	|O
.	|O

1	|O
-	|O
(	|O
1	|O
-	|O
Naphthyl	|O
)	|O
piperazine	|O
(	|O
1	|O
-	|O
NP	|O
)	|O
has	|O
been	|O
reported	|O
to	|O
have	|O
serotonin	|O
antagonist	|O
properties	|O
at	|O
the	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT2	|I-PROTEIN
subtype	|O
of	|O
receptor	|O
,	|O
and	|O
it	|O
has	|O
been	|O
suggested	|O
that	|O
it	|O
may	|O
have	|O
agonist	|O
actions	|O
at	|O
the	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT1	|I-PROTEIN
site	|O
.	|O

1	|O
-	|O
(	|O
m	|O
-	|O
Chlorophenyl	|O
)	|O
piperazine	|O
(	|O
mCPP	|O
,	|O
0.1-3.0	|O
mg	|O
/	|O
kg	|O
)	|O
and	|O
1	|O
-	|O
(	|O
m	|O
-	|O
trifluoromethylphenyl	|O
)	|O
piperazine	|O
(	|O
TFMPP	|O
,	|O
0.1-3.0	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
both	|O
thought	|O
to	|O
act	|O
primarily	|O
at	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT1	|I-PROTEIN
sites	|O
,	|O
also	|O
decreased	|O
responding	|O
and	|O
this	|O
effect	|O
was	|O
blocked	|O
by	|O
methysergide	|O
and	|O
by	|O
1	|O
-	|O
NP	|O
,	|O
but	|O
not	|O
by	|O
ketanserin	|O
.	|O

The	|O
characteristic	|O
feature	|O
of	|O
liver	|O
and	|O
spleen	|O
MP	|O
function	|O
in	|O
patients	|O
with	|O
VHA	|O
associated	|O
with	|O
HBsAg	|B-PROTEIN
carriership	|O
consisted	|O
in	|O
the	|O
lack	|O
of	|O
the	|O
compensatory	|O
reaction	|O
on	|O
the	|O
part	|O
of	|O
spleen	|O
MP	|O
,	|O
which	|O
was	|O
likely	|O
to	|O
be	|O
connected	|O
with	|O
overstrain	|O
of	|O
long	|O
standing	|O
and	|O
depletion	|O
of	|O
the	|O
MP	|O
system	|O
due	|O
to	|O
permanent	|O
antigenic	|O
stimulation	|O
of	|O
HBsAg	|B-PROTEIN
.	|O

Changes	|O
in	|O
xanthine	|B-PROTEIN
oxidase	|I-PROTEIN
activity	|O
in	|O
patients	|O
with	|O
circulatory	|O
failure	|O

A	|O
soap	|O
and	|O
water	|O
(	|O
1	|O
:	|O
1	|O
,	|O
v	|O
/	|O
v	|O
)	|O
solution	|O
effectively	|O
decontaminated	|O
powdered	|O
stratum	|O
corneum	|O
.	|O

The	|O
cytoprotective	|O
and	|O
antiulcer	|O
activities	|O
of	|O
the	|O
antacid	|O
magaldrate	|O
(	|O
ES	|O
Riopan	|O
)	|O
as	|O
well	|O
as	|O
its	|O
effects	|O
on	|O
gastric	|O
mucosal	|O
blood	|O
flow	|O
and	|O
mucus	|O
secretions	|O
,	|O
were	|O
determined	|O
in	|O
the	|O
rat	|O
.	|O

The	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
preferentially	|O
infects	|O
CD4+	|B-PROTEIN
T	|O
lymphocytes	|O
and	|O
may	|O
exist	|O
as	|O
a	|O
latent	|O
provirus	|O
within	|O
these	|O
cells	|O
for	|O
extended	|O
periods	|O
.	|O

Histiocytic	|O
panniculitis	|O
was	|O
observed	|O
in	|O
biopsy	|O
specimens	|O
with	|O
cytophagocytosis	|O
.	|O

We	|O
have	|O
utilized	|O
the	|O
human	|B-PROTEIN
4F2	|I-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
(	|O
4F2HC	|B-PROTEIN
)	|O
gene	|O
as	|O
a	|O
model	|O
system	|O
in	|O
studies	|O
designed	|O
to	|O
elucidate	|O
the	|O
molecular	|O
events	|O
involved	|O
in	|O
regulating	|O
inducible	|O
gene	|O
expression	|O
during	|O
normal	|O
human	|O
T	|O
-	|O
cell	|O
activation	|O
.	|O

A	|O
cDNA	|O
encoding	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
4FB	|I-PROTEIN
enhancer	|O
binding	|O
protein	|O
has	|O
been	|O
cloned	|O
by	|O
screening	|O
a	|O
lambda	|O
gt11	|O
cDNA	|O
library	|O
with	|O
a	|O
rabiolabelled	|O
oligonucleotide	|O
corresponding	|O
to	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
4FB	|I-PROTEIN
recognition	|O
sequence	|O
.	|O

Electrocardiographic	|O
right	|O
ventricular	|O
hypertrophy	|O
was	|O
seen	|O
in	|O
4	|O
,	|O
and	|O
biventricular	|O
hypertrophy	|O
in	|O
5	|O
patients	|O
.	|O

The	|O
two	|O
IL6	|B-PROTEIN
mRNA	|O
species	|O
are	|O
generated	|O
by	|O
alternative	|O
polyadenylation	|O
at	|O
sites	|O
separated	|O
by	|O
a	|O
distance	|O
of	|O
1.2	|O
kilobases	|O
.	|O

Sequencing	|O
analysis	|O
revealed	|O
that	|O
the	|O
0.54	|O
-	|O
and	|O
0.4	|O
-	|O
kb	|O
fragments	|O
are	|O
identical	|O
except	|O
for	|O
150	|O
nucleotides	|O
missing	|O
at	|O
the	|O
5'	|O
region	|O
of	|O
the	|O
0.4	|O
-	|O
kb	|O
fragment	|O
.	|O

The	|O
mature	|O
protein	|O
also	|O
contains	|O
a	|O
cysteine	|O
-	|O
rich	|O
,	|O
highly	|O
hydrophilic	|O
region	|O
homologous	|O
to	|O
the	|O
ovomucoid	|B-PROTEIN
serine	|I-PROTEIN
protease	|I-PROTEIN
inhibitors	|I-PROTEIN
(	|O
residues	|O
76-132	|O
)	|O
.	|O

Oligosynaptic	|O
EPSP	|O
components	|O
were	|O
consistently	|O
modulated	|O
only	|O
in	|O
the	|O
superficial	|O
peroneal	|O
responses	|O
in	|O
flexor	|O
motoneurons	|O
,	|O
which	|O
exhibited	|O
enhanced	|O
amplitude	|O
during	|O
the	|O
flexion	|O
phase	|O
.	|O

Experiments	|O
on	|O
23	|O
white	|O
rats	|O
and	|O
10	|O
guinea	|O
pigs	|O
have	|O
shown	|O
that	|O
preliminarily	|O
indomethacin	|O
-	|O
induced	|O
inhibition	|O
of	|O
prostaglandins	|O
synthesis	|O
prevented	|O
development	|O
of	|O
pulmonary	|O
oedema	|O
,	|O
evoked	|O
by	|O
heterologous	|O
serum	|O
in	|O
rats	|O
and	|O
by	|O
vagotomy	|O
in	|O
guinea	|O
pigs	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
lack	|O
of	|O
conservation	|O
of	|O
the	|O
membrane	|O
attachment	|O
sequence	|O
arginine	|O
-	|O
glycine	|O
-	|O
aspartic	|O
acid	|O
argues	|O
against	|O
its	|O
functional	|O
importance	|O
in	|O
CgA	|B-PROTEIN
.	|O

Third	|O
-	|O
and	|O
later	|O
-	|O
parity	|O
cows	|O
were	|O
randomly	|O
assigned	|O
after	|O
each	|O
parturition	|O
to	|O
Charolais	|O
and	|O
Red	|O
Poll	|O
bulls	|O
in	|O
multiple	|O
-	|O
sire	|O
pastures	|O
.	|O

Within	|O
each	|O
lobe	|O
,	|O
the	|O
PA	|O
dispersion	|O
was	|O
up	|O
to	|O
10	|O
cmH2O	|O
at	|O
CFV	|O
of	|O
90	|O
l	|O
/	|O
min	|O
;	|O
when	|O
flow	|O
decreased	|O
,	|O
PA	|O
at	|O
all	|O
sites	|O
decreased	|O
,	|O
as	|O
did	|O
the	|O
intralobar	|O
dispersion	|O
.	|O

The	|O
system	|O
consisted	|O
of	|O
the	|O
intact	|O
canine	|O
heart	|O
connected	|O
to	|O
a	|O
microcomputer	|O
that	|O
operated	|O
as	|O
the	|O
modulated	|O
parasystolic	|O
pacemaker	|O
.	|O

In	|O
order	|O
to	|O
identify	|O
and	|O
classify	|O
the	|O
basic	|O
CT	|O
appearances	|O
of	|O
interstitial	|O
pneumonia	|O
,	|O
radiologic	|O
-	|O
pathologic	|O
correlative	|O
study	|O
was	|O
performed	|O
using	|O
inflated	|O
and	|O
fixed	|O
lungs	|O
from	|O
autopsy	|O
and	|O
surgery	|O
.	|O

The	|O
disease	|O
ran	|O
an	|O
atypical	|O
course	|O
;	|O
with	|O
early	|O
jaundice	|O
syndrome	|O
,	|O
severe	|O
enterorrhagia	|O
and	|O
late	|O
appearance	|O
of	|O
roseola	|O
.	|O

The	|O
transcription	|O
factor	|O
Sp1	|B-PROTEIN
bound	|O
to	|O
eight	|O
sites	|O
,	|O
as	|O
demonstrated	|O
by	|O
footprinting	|O
assays	|O
and	|O
gel	|O
shift	|O
analysis	|O
with	|O
purified	|O
Sp1	|B-PROTEIN
.	|O

The	|O
combination	|O
PIP	|O
64	|O
micrograms	|O
-	|O
PEF	|O
4	|O
micrograms	|O
prevents	|O
the	|O
frequent	|O
secondary	|O
regrowth	|O
seen	|O
after	|O
6	|O
hours	|O
with	|O
the	|O
antibiotics	|O
used	|O
alone	|O
.	|O

With	|O
a	|O
sample	|O
of	|O
mothers	|O
of	|O
healthy	|O
infants	|O
,	|O
all	|O
three	|O
subscales	|O
of	|O
the	|O
revised	|O
instrument	|O
,	|O
WPL	|O
-	|O
R	|O
,	|O
had	|O
acceptable	|O
levels	|O
of	|O
internal	|O
consistency	|O
at	|O
7	|O
,	|O
30	|O
,	|O
and	|O
90	|O
days	|O
postpartum	|O
,	|O
and	|O
stability	|O
across	|O
administrations	|O
.	|O

Since	|O
1948	|O
,	|O
the	|O
use	|O
of	|O
saline	|O
-	|O
washed	|O
red	|O
cells	|O
(	|O
WRBCs	|O
)	|O
has	|O
been	|O
advocated	|O
to	|O
minimize	|O
hemolysis	|O
after	|O
transfusion	|O
to	|O
patients	|O
with	|O
PNH	|O
.	|O

In	|O
the	|O
group	|O
of	|O
asthmatics	|O
statistically	|O
significant	|O
correlation	|O
was	|O
found	|O
between	|O
PC20	|O
PGF2	|O
alpha	|O
and	|O
histamine	|O
values	|O
(	|O
r	|O
=	|O
0.538	|O
,	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Acute	|O
experiments	|O
on	|O
nembutal	|O
-	|O
anesthetized	|O
cats	|O
(	|O
50	|O
mg	|O
/	|O
kg	|O
)	|O
were	|O
employed	|O
to	|O
investigate	|O
the	|O
effect	|O
of	|O
1	|O
T	|O
pulsating	|O
magnetic	|O
field	|O
(	|O
PMF	|O
)	|O
on	|O
neuromuscular	|O
system	|O
of	|O
the	|O
leg	|O
.	|O

No	|O
significant	|O
differences	|O
were	|O
found	|O
between	|O
the	|O
TS	|O
and	|O
the	|O
PTS	|O
.	|O

The	|O
percentages	|O
of	|O
formed	|O
cysts	|O
and	|O
growth	|O
rates	|O
were	|O
monthly	|O
estimated	|O
and	|O
analyzed	|O
rhythmometrically	|O
by	|O
cosinor	|O
for	|O
5	|O
clonal	|O
cultures	|O
of	|O
Scripsiella	|O
trochoidea	|O
Stein	|O
grown	|O
for	|O
2	|O
years	|O
under	|O
laboratory	|O
conditions	|O
,	|O
rended	|O
as	|O
constant	|O
as	|O
possible	|O
from	|O
the	|O
view	|O
point	|O
of	|O
environmental	|O
temperature	|O
(	|O
24	|O
+	|O
/	|O
-	|O
1	|O
degree	|O
C	|O
)	|O
,	|O
lighting	|O
(	|O
25	|O
microEin	|O
m	|O
-	|O
2	|O
s	|O
-	|O
1	|O
)	|O
,	|O
and	|O
artificial	|O
seawater	|O
.	|O

A	|O
genomic	|O
DNA	|O
clone	|O
encoding	|O
oryzacystatin	|B-PROTEIN
(	|O
Oc	|B-PROTEIN
)	|O
,	|O
a	|O
cysteine	|B-PROTEIN
proteinase	|I-PROTEIN
inhibitor	|O
(	|O
cystatin	|B-PROTEIN
)	|O
of	|O
rice	|O
,	|O
was	|O
isolated	|O
from	|O
a	|O
lambda	|O
EMBL3	|O
phage	|O
library	|O
constructed	|O
with	|O
Sau3AI	|B-PROTEIN
partial	|O
digests	|O
of	|O
rice	|O
chromosomal	|O
DNA	|O
,	|O
by	|O
screening	|O
with	|O
an	|O
oc	|B-PROTEIN
cDNA	|O
as	|O
a	|O
probe	|O
.	|O

The	|O
use	|O
of	|O
an	|O
appropriate	|O
solution	|O
of	|O
methylene	|O
blue	|O
(	|O
0.2%	|O
in	|O
0.9	|O
M	|O
NaCl	|O
for	|O
15	|O
min	|O
)	|O
permits	|O
the	|O
staining	|O
of	|O
premalignant	|O
areas	|O
and	|O
CIS	|O
,	|O
and	|O
their	|O
early	|O
diagnosis	|O
.	|O

Lower	|O
limits	|O
(	|O
to	|O
10	|O
micrograms	|O
/	|O
kg	|O
)	|O
were	|O
detectable	|O
,	|O
but	|O
with	|O
lower	|O
reliability	|O
(	|O
60%	|O
)	|O
.	|O

Instead	|O
,	|O
some	|O
small	|O
negative	|O
effects	|O
are	|O
observed	|O
,	|O
particularly	|O
involving	|O
effects	|O
of	|O
husbands	|O
'	|O
retirement	|O
on	|O
the	|O
marital	|O
satisfaction	|O
of	|O
employed	|O
wives	|O
.	|O

This	|O
in	|O
turn	|O
will	|O
further	|O
enhance	|O
the	|O
role	|O
of	|O
meta	|O
-	|O
analysis	|O
in	|O
helping	|O
clinicians	|O
and	|O
policy	|O
makers	|O
answer	|O
clinical	|O
questions	|O
.	|O

In	|O
one	|O
acromegalic	|O
patient	|O
visual	|O
improvement	|O
was	|O
obtained	|O
while	|O
the	|O
abnormal	|O
GH	|B-PROTEIN
secretion	|O
remained	|O
unaltered	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
PPSF	|O
+	|O
DBP	|O
side	|O
showed	|O
large	|O
amounts	|O
of	|O
bone	|O
formation	|O
,	|O
and	|O
bone	|O
almost	|O
covered	|O
the	|O
implant	|O
.	|O

The	|O
accuracies	|O
of	|O
presence	|O
or	|O
absence	|O
of	|O
neuroblastoma	|O
were	|O
compared	|O
between	|O
131I	|O
-	|O
MIBG	|O
imaging	|O
and	|O
several	|O
tumor	|O
markers	|O
.	|O

The	|O
congenital	|O
forms	|O
(	|O
7	|O
cases	|O
)	|O
all	|O
occurred	|O
in	|O
female	|O
infants	|O
and	|O
involved	|O
the	|O
mucosa	|O
overlying	|O
either	|O
the	|O
anterior	|O
ridge	|O
of	|O
the	|O
maxilla	|O
or	|O
the	|O
mandible	|O
.	|O

Immunohistochemical	|O
studies	|O
revealed	|O
positive	|O
staining	|O
for	|O
S100	|B-PROTEIN
protein	|O
in	|O
all	|O
the	|O
granular	|O
cell	|O
tumors	|O
of	|O
the	|O
adult	|O
but	|O
in	|O
none	|O
of	|O
the	|O
congenital	|O
granular	|O
cell	|O
epulides	|O
.	|O

We	|O
also	|O
found	|O
that	|O
the	|O
same	|O
males	|O
,	|O
breeding	|O
in	|O
different	|O
years	|O
on	|O
the	|O
same	|O
territories	|O
,	|O
had	|O
significantly	|O
larger	|O
harems	|O
in	|O
the	|O
years	|O
they	|O
had	|O
familiar	|O
neighbors	|O
.	|O

Male	|B-PROTEIN
-	|I-PROTEIN
enhanced	|I-PROTEIN
antigen	|I-PROTEIN
gene	|O
is	|O
phylogenetically	|O
conserved	|O
and	|O
expressed	|O
at	|O
late	|O
stages	|O
of	|O
spermatogenesis	|O
.	|O

In	|O
rats	|O
bearing	|O
Walker	|O
-	|O
256	|O
-	|O
carcinosarcoma	|O
4	|O
-	|O
EPI	|O
was	|O
effective	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Pacing	|O
the	|O
Roux	|O
limb	|O
abolished	|O
the	|O
ectopic	|O
pacemakers	|O
,	|O
restored	|O
the	|O
slow	|O
emptying	|O
of	|O
liquids	|O
to	|O
the	|O
more	|O
rapid	|O
rate	|O
found	|O
in	|O
the	|O
Billroth	|O
dogs	|O
(	|O
t1/2	|O
:	|O
paced	|O
Roux	|O
,	|O
72	|O
+	|O
/	|O
-	|O
15	|O
minutes	|O
;	|O
Billroth	|O
,	|O
43	|O
+	|O
/	|O
-	|O
9	|O
minutes	|O
;	|O
p	|O
greater	|O
than	|O
0.05	|O
)	|O
and	|O
did	|O
not	|O
change	|O
emptying	|O
of	|O
solids	|O
.	|O

The	|O
treatments	|O
were	|O
60	|O
mg	|O
t.i.d	|O
.	|O
and	|O
120	|O
mg	|O
t.i.d	|O
.	|O
during	|O
14	|O
days	|O
'	|O
treatment	|O
,	|O
with	|O
the	|O
last	|O
dose	|O
pulsed	|O
with	|O
1.85	|O
MBq	|O
[	|O
14C	|O
]	|O
diltiazem	|O
.	|O

The	|O
subepicardial	|O
lymphatic	|O
capillaries	|O
were	|O
ramified	|O
and	|O
anastomosed	|O
with	|O
each	|O
other	|O
to	|O
form	|O
a	|O
relatively	|O
dense	|O
network	|O
which	|O
extended	|O
over	|O
the	|O
entire	|O
surface	|O
of	|O
both	|O
ventricles	|O
.	|O

The	|O
examination	|O
must	|O
include	|O
T1	|O
and	|O
T2	|O
sequences	|O
and	|O
scans	|O
in	|O
three	|O
planes	|O
.	|O

A	|O
great	|O
deal	|O
of	|O
information	|O
is	|O
available	|O
on	|O
the	|O
morphology	|O
of	|O
the	|O
claustrum	|O
in	|O
various	|O
animal	|O
species	|O
,	|O
as	|O
well	|O
as	|O
on	|O
its	|O
neuronal	|O
distribution	|O
and	|O
relationships	|O
with	|O
the	|O
cerebral	|O
cortex	|O
and	|O
other	|O
nuclei	|O
.	|O

Low	|O
-	|O
grade	|O
glioma	|O
.	|O

In	|O
terms	|O
of	|O
sequence	|O
repetitions	|O
,	|O
seven	|O
tandemly	|O
repeated	|O
copies	|O
of	|O
the	|O
hexanucleotide	|O
ATTGTT	|O
and	|O
three	|O
flanking	|O
regions	|O
of	|O
dyad	|O
symmetry	|O
were	|O
detected	|O
,	|O
all	|O
in	|O
ORF	|O
T3C	|O
.	|O

The	|O
significance	|O
of	|O
these	|O
palindromic	|O
domains	|O
in	|O
this	|O
ORF	|O
is	|O
unclear	|O
but	|O
the	|O
coincidence	|O
of	|O
the	|O
end	|O
of	|O
one	|O
larger	|O
palindrome	|O
with	|O
the	|O
end	|O
of	|O
the	|O
translated	|O
protein	|O
sequence	|O
that	|O
has	|O
homology	|O
with	|O
the	|O
B	|O
chain	|O
of	|O
insulin	|B-PROTEIN
suggests	|O
that	|O
the	|O
palindromes	|O
may	|O
divide	|O
the	|O
T2	|B-PROTEIN
protein	|O
into	|O
several	|O
functional	|O
units	|O
.	|O

During	|O
sub	|O
-	|O
maximal	|O
exercise	|O
,	|O
DCR	|O
in	|O
the	|O
UT	|O
dogs	|O
decreased	|O
from	|O
a	|O
resting	|O
value	|O
of	|O
4.08	|O
+	|O
/	|O
-	|O
0.18	|O
mm	|O
Hg	|O
X	|O
ml	|O
-	|O
1	|O
X	|O
min	|O
-	|O
1	|O
to	|O
1.91	|O
+	|O
/	|O
-	|O
0.17	|O
mm	|O
Hg	|O
X	|O
ml	|O
-	|O
1	|O
X	|O
min	|O
-	|O
1	|O
at	|O
a	|O
workload	|O
of	|O
6.4	|O
kph	|O
(	|O
speed	|O
)	|O
/	|O
16%	|O
(	|O
grade	|O
)	|O
.	|O

7	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
the	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
gene	|O
family	|O
may	|O
be	|O
distributed	|O
over	|O
at	|O
least	|O
two	|O
human	|O
chromosomes	|O
.	|O

The	|O
major	|O
inserted	|O
DNA	|O
has	|O
no	|O
significant	|O
homology	|O
to	|O
published	|O
human	|O
nucleic	|O
acid	|O
sequences	|O
.	|O

In	|O
44	|O
evaluable	|O
patients	|O
the	|O
response	|O
rate	|O
was	|O
50%	|O
,	|O
with	|O
one	|O
complete	|O
response	|O
.	|O

We	|O
have	|O
also	|O
found	|O
that	|O
the	|O
in	|O
vitro	|O
interaction	|O
between	|O
the	|O
SV40	|O
octamer	|O
motif	|O
and	|O
the	|O
lymphoid	|O
cell	|O
-	|O
specific	|O
protein	|O
oct	|B-PROTEIN
-	|I-PROTEIN
B2	|I-PROTEIN
was	|O
negatively	|O
modulated	|O
by	|O
a	|O
component	|O
present	|O
in	|O
the	|O
nuclear	|O
extracts	|O
from	|O
several	|O
lymphoid	|O
cell	|O
lines	|O
.	|O

Anoxia	|O
was	|O
introduced	|O
by	|O
perfusing	|O
the	|O
gill	|O
with	|O
water	|O
deprived	|O
of	|O
oxygen	|O
or	|O
by	|O
halting	|O
the	|O
water	|O
flow	|O
to	|O
the	|O
gill	|O
.	|O

Growth	|O
,	|O
4	|O
-	|O
PA	|O
and	|O
14C	|O
turnover	|O
data	|O
indicated	|O
that	|O
WB	|O
contributed	|O
to	|O
B	|O
-	|O
6	|O
intake	|O
of	|O
these	|O
rats	|O
.	|O

Thus	|O
,	|O
multiple	|O
myogenic	|O
factors	|O
that	|O
vary	|O
qualitatively	|O
and	|O
quantitatively	|O
may	|O
be	|O
responsible	|O
for	|O
the	|O
different	|O
and	|O
complex	|O
modulatory	|O
programs	|O
of	|O
actin	|B-PROTEIN
gene	|O
expression	|O
observed	|O
during	|O
in	|O
vivo	|O
muscle	|O
differentiation	|O
.	|O

DNA	|O
sequence	|O
analysis	|O
revealed	|O
that	|O
these	|O
clones	|O
encode	|O
two	|O
distinct	|O
forms	|O
of	|O
translocase	|B-PROTEIN
.	|O

The	|O
effect	|O
of	|O
acetazolamide	|O
(	|O
ACZ	|O
)	|O
on	|O
HCO3	|O
-	|O
and	|O
Cl	|O
-	|O
activities	|O
in	|O
inner	|O
ear	|O
fluid	|O
was	|O
investigated	|O
by	|O
ion	|O
-	|O
selective	|O
microelectrode	|O
methods	|O
.	|O

RPA190	|B-PROTEIN
encodes	|O
a	|O
polypeptide	|O
chain	|O
of	|O
186,270	|O
daltons	|O
in	|O
a	|O
large	|O
uninterrupted	|O
reading	|O
frame	|O
.	|O

Both	|O
the	|O
intact	|O
A1	|B-PROTEIN
protein	|O
and	|O
its	|O
proteolytic	|O
fragment	|O
,	|O
the	|O
UP1	|B-PROTEIN
protein	|O
,	|O
can	|O
be	|O
cleaved	|O
by	|O
Staphylococcus	|O
aureus	|O
V	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
protease	|O
to	|O
produce	|O
two	|O
polypeptides	|O
of	|O
92	|O
amino	|O
acids	|O
.	|O

Irmiere	|O
,	|O
and	|O
W.	|O

These	|O
offspring	|O
of	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
MSH	|I-PROTEIN
treated	|O
mothers	|O
were	|O
less	|O
sensitive	|O
to	|O
pain	|O
and	|O
as	|O
adults	|O
showed	|O
a	|O
reduced	|O
analgesic	|O
response	|O
to	|O
morphine	|O
.	|O

Simian	|O
immunodeficiency	|O
virus	|O
(	|O
SIV	|O
)	|O
is	|O
a	|O
lentivirus	|O
with	|O
morphological	|O
and	|O
antigenic	|O
similarities	|O
to	|O
human	|O
immunodeficiency	|O
virus	|O
,	|O
the	|O
causative	|O
agent	|O
of	|O
acquired	|O
immunodeficiency	|O
syndrome	|O
(	|O
AIDS	|O
)	|O
of	|O
humans	|O
.	|O

The	|O
lack	|O
of	|O
change	|O
in	|O
the	|O
ratio	|O
of	|O
the	|O
two	|O
spliced	|O
products	|O
expressed	|O
from	|O
either	|O
the	|O
normal	|O
or	|O
the	|O
5'	|O
-	|O
rearranged	|O
myb	|B-PROTEIN
further	|O
indicates	|O
that	|O
the	|O
insertion	|O
of	|O
the	|O
unique	|O
121	|O
amino	|O
acids	|O
in	|O
the	|O
larger	|O
myb	|B-PROTEIN
transcripts	|O
is	|O
not	|O
a	|O
consequence	|O
of	|O
tumor	|O
-	|O
specific	|O
activation	|O
of	|O
the	|O
mouse	|O
myb	|B-PROTEIN
oncogene	|O
.	|O

The	|O
use	|O
of	|O
CRF	|B-PROTEIN
-	|I-PROTEIN
41	|I-PROTEIN
in	|O
the	|O
differential	|O
diagnosis	|O
of	|O
Cushing	|O
's	|O
syndrome	|O
and	|O
obesity	|O
.	|O

We	|O
detected	|O
mos	|B-PROTEIN
transcripts	|O
by	|O
Northern	|O
(	|O
RNA	|O
)	|O
analyses	|O
in	|O
RNA	|O
prepared	|O
from	|O
chicken	|O
and	|O
quail	|O
ovaries	|O
and	|O
testes	|O
.	|O

The	|O
predicted	|O
L	|B-PROTEIN
mRNA	|O
was	|O
6398	|O
nucleotides	|O
long	|O
and	|O
contained	|O
a	|O
single	|O
open	|O
reading	|O
frame	|O
corresponding	|O
to	|O
an	|O
L	|B-PROTEIN
protein	|O
encompassing	|O
2109	|O
amino	|O
acids	|O
with	|O
a	|O
MW	|O
of	|O
241,546	|O
.	|O

The	|O
results	|O
suggest	|O
that	|O
the	|O
organization	|O
of	|O
functional	|O
units	|O
of	|O
the	|O
72	|O
-	|O
bp	|O
repeat	|O
required	|O
for	|O
transcriptional	|O
enhancement	|O
of	|O
the	|O
early	|O
promoter	|O
is	|O
different	|O
from	|O
that	|O
required	|O
for	|O
late	|O
promoter	|O
function	|O
.	|O

Variations	|O
in	|O
the	|O
5'	|O
half	|O
of	|O
U3	|O
were	|O
primarily	|O
due	|O
to	|O
insertions	|O
and	|O
deletions	|O
.	|O

An	|O
analysis	|O
of	|O
the	|O
steady	|O
state	|O
RNA	|O
levels	|O
in	|O
T	|O
-	|O
lymphoid	|O
cell	|O
lines	|O
showed	|O
that	|O
at	|O
least	|O
three	|O
different	|O
incomplete	|O
proviral	|O
transcripts	|O
and	|O
their	|O
spliced	|O
products	|O
made	|O
up	|O
the	|O
majority	|O
of	|O
expressed	|O
RD	|B-PROTEIN
-	|I-PROTEIN
114	|I-PROTEIN
mRNA	|O
,	|O
and	|O
further	|O
demonstrated	|O
that	|O
partially	|O
deleted	|O
proviral	|O
loci	|O
have	|O
the	|O
potential	|O
to	|O
be	|O
transcriptionally	|O
vigorous	|O
in	|O
certain	|O
feline	|O
cell	|O
types	|O
.	|O

Aplastic	|O
crisis	|O
in	|O
sickle	|O
cell	|O
disorders	|O
:	|O
bone	|O
marrow	|O
necrosis	|O
and	|O
human	|O
parvovirus	|O
infection	|O
.	|O

Either	|O
two	|O
or	|O
more	|O
different	|O
sequences	|O
can	|O
promote	|O
cleavage	|O
,	|O
or	|O
a	|O
single	|O
element	|O
exists	|O
which	|O
is	|O
long	|O
and	|O
diffuse	|O
.	|O

Low	|O
molecular	|O
weight	|O
heparins	|O
have	|O
stimulated	|O
much	|O
interest	|O
because	|O
of	|O
their	|O
supposedly	|O
more	|O
selective	|O
action	|O
on	|O
Xa	|B-PROTEIN
factor	|I-PROTEIN
.	|O

The	|O
bactericidal	|O
activity	|O
of	|O
six	|O
new	|O
rifamycin	|O
derivatives	|O
-	|O
-	|O
rifabutin	|O
(	|O
RBU	|O
)	|O
,	|O
FCE	|O
22250	|O
(	|O
F22	|O
)	|O
,	|O
rifapentine	|O
(	|O
RPE	|O
)	|O
,	|O
CGP	|O
29861	|O
(	|O
C29	|O
)	|O
,	|O
CGP	|O
7040	|O
(	|O
C70	|O
)	|O
and	|O
CGP	|O
27557	|O
(	|O
C27	|O
)	|O
and	|O
rifampicin	|O
(	|O
RMP	|O
)	|O
-	|O
-	|O
have	|O
been	|O
measured	|O
against	|O
log	|O
phase	|O
and	|O
,	|O
as	|O
a	|O
better	|O
test	|O
of	|O
sterilising	|O
activity	|O
,	|O
against	|O
stationary	|O
phase	|O
cultures	|O
of	|O
Mycobacterium	|O
tuberculosis	|O
,	|O
H37Rv	|O
.	|O

Mo	|O
+	|O
SV	|O
M	|O
-	|O
MuLV	|O
-	|O
inoculated	|O
animals	|O
became	|O
moribund	|O
at	|O
3	|O
to	|O
13	|O
months	|O
postinoculation	|O
,	|O
whereas	|O
delta	|O
Mo	|O
+	|O
SV	|O
M	|O
-	|O
MuLV	|O
-	|O
inoculated	|O
animals	|O
became	|O
moribund	|O
at	|O
6	|O
to	|O
24	|O
months	|O
postinoculation	|O
.	|O

Sodium	|O
dodecyl	|O
sulphate	|O
-	|O
induced	|O
cleavage	|O
by	|O
eukaryotic	|O
topoisomerase	|B-PROTEIN
I	|I-PROTEIN
is	|O
known	|O
to	|O
yield	|O
enzyme	|O
covalently	|O
attached	|O
to	|O
the	|O
3'	|O
cut	|O
end	|O
of	|O
the	|O
DNA	|O
.	|O

Amino	|O
acid	|O
sequence	|O
of	|O
one	|O
human	|O
liver	|O
clone	|O
(	|O
HL	|O
-	|O
14	|O
)	|O
was	|O
identical	|O
to	|O
the	|O
rabbit	|O
skeletal	|O
muscle	|O
phosphatase	|B-PROTEIN
2A	|I-PROTEIN
cDNA	|O
(	|O
with	|O
97%	|O
nucleotide	|O
identity	|O
)	|O
.	|O

Herpes	|O
virus	|O
infection	|O
was	|O
characterized	|O
by	|O
inversion	|O
of	|O
the	|O
T4	|O
/	|O
T8	|O
ratio	|O
below	|O
1.0	|O
(	|O
sensitivity	|O
90%	|O
,	|O
specificity	|O
88%	|O
)	|O
,	|O
caused	|O
by	|O
proliferation	|O
of	|O
the	|O
T8	|O
subpopulation	|O
,	|O
which	|O
-	|O
-	|O
compared	|O
with	|O
the	|O
findings	|O
in	|O
patients	|O
with	|O
rejection	|O
crises	|O
-	|O
-	|O
was	|O
significantly	|O
raised	|O
(	|O
P	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

RVEF	|O
and	|O
LVEF	|O
both	|O
increased	|O
by	|O
about	|O
14%	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
and	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

The	|O
levels	|O
of	|O
NPY	|B-PROTEIN
-	|O
ir	|O
in	|O
the	|O
rat	|O
vas	|O
deferens	|O
were	|O
not	|O
affected	|O
by	|O
either	|O
surgical	|O
or	|O
pharmacological	|O
treatment	|O
.	|O

Quantitative	|O
assays	|O
in	|O
which	|O
the	|O
activity	|O
of	|O
the	|O
synthetic	|O
alpha	|B-PROTEIN
s	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
compared	|O
to	|O
that	|O
of	|O
native	|O
purified	|O
human	|O
erythrocyte	|O
type	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
Gs	|I-PROTEIN
,	|O
indicated	|O
that	|O
the	|O
two	|O
products	|O
are	|O
equipotent	|O
within	|O
a	|O
2	|O
-	|O
fold	|O
margin	|O
of	|O
error	|O
.	|O

In	|O
these	|O
cells	|O
,	|O
E2	|B-PROTEIN
proteins	|O
had	|O
little	|O
or	|O
no	|O
stimulatory	|O
effect	|O
on	|O
the	|O
transcriptional	|O
activity	|O
of	|O
the	|O
HPV	|B-PROTEIN
-	|I-PROTEIN
11	|I-PROTEIN
enhancer	|I-PROTEIN
-	|O
SV40	|B-PROTEIN
promoter	|I-PROTEIN
.	|O

The	|O
mechanism	|O
by	|O
which	|O
E2	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
represses	|O
E2	|B-PROTEIN
-	|I-PROTEIN
dependent	|O
enhancer	|O
activity	|O
most	|O
likely	|O
involves	|O
competition	|O
with	|O
E2	|B-PROTEIN
for	|O
binding	|O
to	|O
a	|O
common	|O
transcriptional	|O
regulatory	|O
site	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

Accurate	|O
evaluation	|O
of	|O
the	|O
treatment	|O
results	|O
in	|O
unresectable	|O
lung	|O
cancer	|O
patients	|O
must	|O
take	|O
the	|O
strong	|O
prognostic	|O
factors	|O
into	|O
account	|O
.	|O

(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
IIa	|I-PROTEIN
)	|O
and	|O
Holmer	|O
et	|O
al.	|O

Introduction	|O
of	|O
v	|B-PROTEIN
-	|I-PROTEIN
fms	|I-PROTEIN
into	|O
a	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
dependent	|O
murine	|O
macrophage	|O
cell	|O
line	|O
induced	|O
factor	|O
independence	|O
and	|O
tumorigenicity	|O
by	|O
a	|O
nonautocrine	|O
mechanism	|O
.	|O

Chronic	|O
E	|O
-	|O
B	|O
virus	|O
infection	|O
terminated	|O
in	|O
malignant	|O
lymphoma	|O
:	|O
a	|O
case	|O
report	|O

The	|O
primary	|O
structure	|O
and	|O
cotranscription	|O
of	|O
the	|O
petCA	|B-PROTEIN
genes	|O
encoding	|O
the	|O
Rieske	|B-PROTEIN
-	|I-PROTEIN
FeS	|I-PROTEIN
(	|O
nuclear	|B-PROTEIN
encoded	|I-PROTEIN
in	|I-PROTEIN
plants	|I-PROTEIN
)	|O
and	|O
apocytochrome	|B-PROTEIN
f	|I-PROTEIN
proteins	|O
has	|O
been	|O
described	|O
previously	|O
(	|O
Kallas	|O
,	|O
T.	|O
,	|O
Spiller	|O
,	|O
S.	|O
,	|O
and	|O
Malkin	|O
,	|O
R.	|O

The	|O
Nostoc	|O
petBD	|B-PROTEIN
genes	|O
are	|O
not	|O
closely	|O
linked	|O
to	|O
the	|O
psbB	|B-PROTEIN
gene	|O
(	|O
encoding	|O
the	|O
51	|O
-	|O
kDa	|O
photosystem	|B-PROTEIN
II	|I-PROTEIN
polypeptide	|O
)	|O
and	|O
do	|O
not	|O
contain	|O
introns	|O
as	|O
do	|O
the	|O
closely	|O
related	|O
chloroplast	|O
genes	|O
.	|O

RNA	|O
blot	|O
hybridizations	|O
identified	|O
an	|O
1.8	|O
-	|O
kb	|O
mRNA	|O
common	|O
to	|O
cytochrome	|B-PROTEIN
b6	|I-PROTEIN
and	|O
subunit	|O
IV	|O
,	|O
and	|O
an	|O
intensely	|O
hybridizing	|O
0.8	|O
-	|O
kb	|O
mRNA	|O
specific	|O
to	|O
the	|O
subunit	|O
IV	|O
gene	|O
probe	|O
.	|O

Whereas	|O
the	|O
muscle	|O
isoform	|O
consists	|O
of	|O
997	|O
amino	|O
acids	|O
and	|O
terminates	|O
with	|O
the	|O
sequence	|O
Ala	|O
-	|O
Ile	|O
-	|O
Leu	|O
-	|O
Glu	|O
,	|O
the	|O
second	|O
isoform	|O
is	|O
1043	|O
amino	|O
acids	|O
in	|O
length	|O
due	|O
to	|O
the	|O
replacement	|O
of	|O
these	|O
last	|O
4	|O
amino	|O
acids	|O
with	|O
a	|O
50	|O
-	|O
amino	|O
acid	|O
sequence	|O
that	|O
contains	|O
a	|O
potential	|O
transmembrane	|O
domain	|O
followed	|O
by	|O
a	|O
consensus	|O
sequence	|O
for	|O
an	|O
N	|O
-	|O
linked	|O
glycosylation	|O
site	|O
.	|O

Substitution	|O
of	|O
a	|O
threonine	|O
residue	|O
by	|O
an	|O
alanine	|O
residue	|O
at	|O
position	|O
-	|O
2	|O
(	|O
P2	|O
)	|O
of	|O
this	|O
cleavage	|O
site	|O
abolished	|O
cleavage	|O
,	|O
whereas	|O
substitution	|O
of	|O
a	|O
tyrosine	|O
residue	|O
by	|O
a	|O
phenylalanine	|O
residue	|O
at	|O
amino	|O
acid	|O
position	|O
-	|O
1	|O
(	|O
P1	|O
)	|O
of	|O
the	|O
cleavage	|O
site	|O
did	|O
not	|O
influence	|O
processing	|O
.	|O

All	|O
of	|O
the	|O
indigo	|O
-	|O
producing	|O
bacteria	|O
had	|O
an	|O
indoxyl	|B-PROTEIN
phosphatase	|I-PROTEIN
with	|O
a	|O
pI	|O
of	|O
6.4	|O
.	|O

The	|O
number	|O
of	|O
polymerases	|O
active	|O
in	|O
vitro	|O
at	|O
the	|O
E	|O
strand	|O
promoter	|O
was	|O
similar	|O
to	|O
the	|O
number	|O
of	|O
polymerases	|O
at	|O
the	|O
L	|O
strand	|O
promoter	|O
.	|O

A	|O
family	|O
of	|O
RNA	|O
molecules	|O
in	|O
the	|O
2.0-2.2	|O
-	|O
kilobase	|O
range	|O
identified	|O
with	|O
a	|O
probe	|O
from	|O
this	|O
gene	|O
was	|O
overexpressed	|O
in	|O
the	|O
resistant	|O
cells	|O
.	|O

A	|O
highly	|O
hydrophobic	|O
sequence	|O
located	|O
near	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
extremity	|O
of	|O
the	|O
molecule	|O
most	|O
likely	|O
constitutes	|O
the	|O
anchor	|O
to	|O
the	|O
plasma	|O
membrane	|O
.	|O

The	|O
SV40	|B-PROTEIN
enhancer	|I-PROTEIN
augmented	|O
replication	|O
1.5-10	|O
fold	|O
.	|O

One	|O
of	|O
these	|O
,	|O
the	|O
origin	|O
core	|O
,	|O
is	|O
required	|O
only	|O
for	|O
DNA	|O
replication	|O
.	|O

Induction	|O
of	|O
proto	|O
-	|O
oncogene	|O
fos	|B-PROTEIN
transcription	|O
through	|O
the	|O
adenylate	|B-PROTEIN
cyclase	|I-PROTEIN
pathway	|O
:	|O
characterization	|O
of	|O
a	|O
cAMP	|O
-	|O
responsive	|O
element	|O
.	|O

A	|O
17	|O
-	|O
mer	|O
oligodeoxynucleotide	|O
,	|O
corresponding	|O
to	|O
a	|O
region	|O
of	|O
the	|O
VtHb	|B-PROTEIN
amino	|O
acid	|O
sequence	|O
was	|O
used	|O
as	|O
a	|O
hybridization	|O
probe	|O
to	|O
screen	|O
a	|O
Vitreoscilla	|O
genomic	|O
library	|O
constructed	|O
in	|O
broad	|O
-	|O
host	|O
-	|O
range	|O
cosmid	|O
vector	|O
pVK102	|O
.	|O

(	|O
total	|O
soluble	|O
solids	|O
)	|O
and	|O
organoleptic	|O
characteristics	|O
under	|O
the	|O
influence	|O
of	|O
different	|O
treatments	|O
.	|O

Causes	|O
of	|O
death	|O
found	|O
in	|O
an	|O
epidemiological	|O
study	|O
of	|O
native	|O
chickens	|O
in	|O
Thai	|O
villages	|O
.	|O

The	|O
progression	|O
of	|O
non	|O
-	|O
A	|O
,	|O
non	|O
-	|O
B	|O
hepatitis	|O
to	|O
chronic	|O
diseases	|O
,	|O
and	|O
the	|O
transformation	|O
to	|O
hepatocellular	|O
carcinoma	|O

Elevated	|O
IOP	|O
developed	|O
in	|O
35	|O
patients	|O
(	|O
44	|O
eyes	|O
)	|O
during	|O
the	|O
study	|O
.	|O

Use	|O
of	|O
serum	|O
thyroglobulin	|B-PROTEIN
determination	|O
in	|O
the	|O
follow	|O
-	|O
up	|O
of	|O
differentiated	|O
carcinomas	|O
of	|O
the	|O
thyroid	|O

Poor	|O
response	|O
when	|O
laboratory	|O
recommended	|O
range	|O
for	|O
serum	|O
lithium	|O
is	|O
changed	|O
.	|O

The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
investigate	|O
the	|O
effects	|O
of	|O
nebulized	|O
ipratropium	|O
in	|O
patients	|O
with	|O
acute	|O
asthma	|O
in	|O
order	|O
to	|O
determine	|O
whether	|O
it	|O
augments	|O
the	|O
bronchodilator	|O
effect	|O
of	|O
a	|O
beta	|O
agonist	|O
drug	|O
.	|O

Further	|O
analysis	|O
of	|O
this	|O
DNA	|O
fragment	|O
showed	|O
that	|O
four	|O
genes	|O
are	|O
present	|O
encoding	|O
proteins	|O
of	|O
16	|O
,	|O
18.5	|O
,	|O
21	|O
and	|O
89	|O
kDal	|O
.	|O

Hantaan	|O
virus	|O
.	|O

Changes	|O
in	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
sensitivity	|O
in	|O
humans	|O
after	|O
heavy	|O
alcohol	|O
intake	|O
.	|O

No	|O
significant	|O
differences	|O
between	|O
the	|O
two	|O
treatment	|O
groups	|O
were	|O
found	|O
,	|O
but	|O
rapid	|O
responders	|O
had	|O
a	|O
smaller	|O
mean	|O
initial	|O
platelet	|O
-	|O
associated	|O
IgG	|B-PROTEIN
index	|O
which	|O
returned	|O
more	|O
rapidly	|O
and	|O
more	|O
permanently	|O
to	|O
normal	|O
than	|O
that	|O
of	|O
slow	|O
responders	|O
.	|O

Replacement	|O
variant	|O
histone	|B-PROTEIN
genes	|O
contain	|O
intervening	|O
sequences	|O
.	|O

Double	|O
-	|O
blind	|O
randomised	|O
trial	|O
of	|O
intravenous	|O
tissue	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
versus	|O
placebo	|O
in	|O
acute	|O
myocardial	|O
infarction	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
domains	|O
(	|O
CTDs	|O
)	|O
of	|O
the	|O
RPase	|B-PROTEIN
beta	|I-PROTEIN
subunit	|O
and	|O
DNA	|B-PROTEIN
primase	|I-PROTEIN
(	|O
dnaG	|B-PROTEIN
protein	|O
)	|O
were	|O
not	|O
only	|O
strongly	|O
homologous	|O
to	|O
each	|O
other	|O
but	|O
also	|O
considerably	|O
homologous	|O
to	|O
the	|O
RPase	|B-PROTEIN
alpha	|I-PROTEIN
,	|O
suggesting	|O
that	|O
an	|O
alpha	|O
subunit	|O
-	|O
like	|O
enzyme	|O
must	|O
have	|O
been	|O
commonly	|O
ancestral	|O
to	|O
core	|B-PROTEIN
enzyme	|O
subunits	|O
and	|O
primase	|B-PROTEIN
.	|O

However	|O
,	|O
vancomycin	|O
and	|O
fosfomycin	|O
,	|O
which	|O
revealed	|O
suboptimal	|O
in	|O
vitro	|O
bactericidal	|O
activity	|O
,	|O
proved	|O
as	|O
efficacious	|O
as	|O
penicillin	|O
G	|O
and	|O
imipenem	|O
in	|O
an	|O
experimental	|O
mode	|O
of	|O
murine	|O
gas	|O
gangrene	|O
.	|O

Fentanyl	|O
,	|O
a	|O
prototypic	|O
mu	|B-PROTEIN
-	|I-PROTEIN
opiate	|I-PROTEIN
receptor	|I-PROTEIN
agonist	|O
,	|O
has	|O
been	|O
previously	|O
shown	|O
to	|O
produce	|O
a	|O
syndrome	|O
characterized	|O
by	|O
marked	|O
analgesia	|O
and	|O
locomotor	|O
stimulation	|O
as	|O
well	|O
as	|O
tachycardia	|O
,	|O
tachypnoea	|O
and	|O
behavioural	|O
arousal	|O
.	|O

Intravesical	|O
chemotherapy	|O
.	|O

Bisoprolol	|O
was	|O
found	|O
to	|O
be	|O
an	|O
effective	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
antagonist	|O
,	|O
the	|O
pA2	|O
values	|O
determined	|O
against	|O
isoprenaline	|O
in	|O
guinea	|O
pig	|O
atria	|O
and	|O
tracheal	|O
muscle	|O
being	|O
7.45	|O
and	|O
6.41	|O
,	|O
respectively	|O
.	|O

Output	|O
of	|O
99mTcO	|O
-	|O
4	|O
by	|O
the	|O
parotid	|O
gland	|O
closely	|O
mimicked	|O
fluctuations	|O
in	|O
parotid	|O
saliva	|O
flow	|O
rate	|O
.	|O

The	|O
Hagen	|O
-	|O
Poiseuille	|O
equation	|O
is	|O
used	|O
to	|O
assess	|O
the	|O
effects	|O
of	|O
attached	|O
parasites	|O
in	|O
the	|O
foregut	|O
of	|O
Leishmania	|O
-	|O
infected	|O
sandflies	|O
on	|O
blood	|O
flow	|O
.	|O

Moreover	|O
,	|O
in	|O
rats	|O
allowed	|O
to	|O
choose	|O
in	|O
a	|O
T	|O
-	|O
maze	|O
between	|O
immediate	|O
-	|O
but	|O
-	|O
small	|O
vs.	|O
delayed	|O
-	|O
but	|O
-	|O
large	|O
reward	|O
,	|O
BZP	|O
significantly	|O
decreased	|O
the	|O
frequency	|O
with	|O
which	|O
the	|O
delayed	|O
reward	|O
was	|O
chosen	|O
,	|O
with	|O
5	|O
-	|O
HT	|O
uptake	|O
blockers	|O
producing	|O
opposite	|O
effects	|O
.	|O

An	|O
endometrial	|O
luteal	|O
phase	|O
deficiency	|O
was	|O
detected	|O
in	|O
15	|O
(	|O
30%	|O
)	|O
of	|O
aborting	|O
patients	|O
.	|O

Prenatal	|O
exposure	|O
to	|O
the	|O
fungicide	|O
dinocap	|O
causes	|O
behavioral	|O
torticollis	|O
,	|O
ballooning	|O
and	|O
cleft	|O
palate	|O
in	|O
mice	|O
,	|O
but	|O
not	|O
rats	|O
or	|O
hamsters	|O
.	|O

Reperfusion	|O
with	|O
normal	|O
blood	|O
in	|O
the	|O
beating	|O
,	|O
working	|O
hearts	|O
caused	|O
extensive	|O
structural	|O
damage	|O
,	|O
reduced	|O
reflow	|O
,	|O
and	|O
failed	|O
to	|O
restore	|O
contractility	|O
in	|O
any	|O
instance	|O
(	|O
-	|O
27%	|O
systolic	|O
shortening	|O
,	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

The	|O
sensitivity	|O
of	|O
the	|O
vas	|O
deferens	|O
to	|O
adrenaline	|O
was	|O
also	|O
reduced	|O
in	|O
scorbutic	|O
guinea	|O
pigs	|O
,	|O
thus	|O
decreasing	|O
their	|O
fertility	|O
rate	|O
.	|O

In	|O
metabolic	|O
acidosis	|O
there	|O
was	|O
a	|O
marked	|O
stimulation	|O
when	|O
clamped	|O
at	|O
-	|O
10	|O
to	|O
-	|O
100	|O
mV	|O
.	|O

On	|O
Days	|O
1	|O
and	|O
14	|O
,	|O
most	|O
young	|O
and	|O
elderly	|O
subjects	|O
exhibited	|O
monoexponential	|O
decline	|O
in	|O
bevantolol	|O
plasma	|O
concentrations	|O
after	|O
absorption	|O
phase	|O
.	|O

Mature	|O
and	|O
old	|O
B6AF1	|O
and	|O
B6D2F1	|O
mice	|O
were	|O
given	|O
acidified	|O
tap	|O
water	|O
or	|O
promethazine	|O
HCl	|O
(	|O
a	|O
phenothiazine	|O
with	|O
H1	|B-PROTEIN
receptor	|O
blocking	|O
activity	|O
)	|O
,	|O
chlorpheniramine	|O
(	|O
an	|O
H1	|B-PROTEIN
blocker	|O
)	|O
or	|O
trifluoperazine	|O
(	|O
a	|O
phenothiazine	|O
with	|O
no	|O
H1	|B-PROTEIN
blocking	|O
activity	|O
)	|O
in	|O
their	|O
drinking	|O
water	|O
,	|O
and	|O
the	|O
effects	|O
of	|O
these	|O
agents	|O
on	|O
bone	|O
mineral	|O
content	|O
were	|O
assessed	|O
by	|O
intermittently	|O
measuring	|O
the	|O
24	|O
-	|O
h	|O
whole	|O
body	|O
retention	|O
of	|O
Tc	|O
99m	|O
methylene	|O
diphosphonate	|O
(	|O
Tc	|O
99m	|O
MDP	|O
,	|O
an	|O
indicator	|O
of	|O
bone	|O
metabolism	|O
)	|O
and	|O
at	|O
the	|O
end	|O
of	|O
the	|O
studies	|O
by	|O
determining	|O
ash	|O
weights	|O
of	|O
femur	|O
,	|O
ilium	|O
and	|O
sacrum	|O
.	|O

Present	|O
results	|O
reveal	|O
a	|O
frequency	|O
-	|O
dependent	|O
inhibition	|O
of	|O
ganglionic	|O
transmission	|O
by	|O
diltiazem	|O
,	|O
and	|O
suggest	|O
that	|O
diltiazem	|O
may	|O
depress	|O
excessive	|O
sympathetic	|O
activity	|O
without	|O
affecting	|O
normal	|O
ganglionic	|O
transmission	|O
.	|O

Studies	|O
were	|O
performed	|O
on	|O
several	|O
superficial	|O
veins	|O
from	|O
the	|O
rabbit	|O
face	|O
to	|O
examine	|O
the	|O
relationship	|O
between	|O
beta	|B-PROTEIN
adrenoceptor	|I-PROTEIN
subtype	|O
distribution	|O
,	|O
intrinsic	|O
myogenic	|O
tone	|O
and	|O
sympathetic	|O
nerve	|O
innervation	|O
.	|O

Effects	|O
of	|O
a	|O
new	|O
antihypertensive	|O
agent	|O
,	|O
SGB	|O
-	|O
1534	|O
,	|O
on	|O
rat	|O
platelet	|O
aggregation	|O
.	|O

Since	|O
the	|O
stability	|O
of	|O
TF1	|B-PROTEIN
resides	|O
in	|O
its	|O
primary	|O
structure	|O
,	|O
we	|O
cloned	|O
a	|O
gene	|O
coding	|O
for	|O
TF1	|B-PROTEIN
,	|O
and	|O
the	|O
primary	|O
structure	|O
of	|O
the	|O
beta	|O
subunit	|O
was	|O
deduced	|O
from	|O
the	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
gene	|O
to	|O
compare	|O
the	|O
sequence	|O
with	|O
those	|O
of	|O
beta	|O
's	|O
of	|O
three	|O
major	|O
categories	|O
of	|O
F1	|B-PROTEIN
's	|O
;	|O
prokaryotic	|O
membranes	|O
,	|O
chloroplasts	|O
,	|O
and	|O
mitochondria	|O
.	|O

Body	|O
temperature	|O
and	|O
overall	|O
conductance	|O
in	|O
the	|O
cold	|O
appear	|O
to	|O
be	|O
more	|O
variable	|O
in	|O
P.	|O
s	|O
.	|O
campbelli	|O
than	|O
in	|O
nominative	|O
sp	|O
.	|O

Two	|O
polyadenylation	|O
sites	|O
were	|O
used	|O
,	|O
one	|O
at	|O
the	|O
end	|O
of	|O
the	|O
early	|O
(	|B-PROTEIN
E	|I-PROTEIN
)	|I-PROTEIN
region	|I-PROTEIN
of	|O
the	|O
viral	|O
DNA	|O
,	|O
the	|O
other	|O
at	|O
the	|O
end	|O
of	|O
the	|O
late	|O
(	|B-PROTEIN
L	|I-PROTEIN
)	|I-PROTEIN
region	|I-PROTEIN
.	|O

A	|O
drug	|O
with	|O
ISA	|O
"	|O
down	|O
regulates	|O
"	|O
beta	|B-PROTEIN
receptors	|I-PROTEIN
;	|O
thus	|O
,	|O
when	|O
the	|O
drug	|O
is	|O
withdrawn	|O
there	|O
is	|O
no	|O
post	|O
-	|O
beta	|O
-	|O
blocking	|O
drug	|O
hypersensitivity	|O
in	|O
contrast	|O
to	|O
agents	|O
without	|O
ISA	|O
.	|O

Six	|O
patients	|O
with	|O
human	|O
T	|O
-	|O
cell	|O
lymphotropic	|O
virus	|O
type	|O
I	|O
(	|O
HTLV	|O
-	|O
I	|O
)	|O
-	|O
associated	|O
myelopathy	|O
(	|O
HAM	|O
)	|O
were	|O
studied	|O
by	|O
electrophysiologic	|O
methods	|O
.	|O

Terazosin	|O
,	|O
a	|O
structural	|O
analog	|O
of	|O
prazosin	|O
,	|O
also	|O
inhibits	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
adrenoceptors	|I-PROTEIN
and	|O
is	|O
recommended	|O
as	|O
once	|O
or	|O
twice	|O
-	|O
daily	|O
therapy	|O
.	|O

Testing	|O
blood	|O
donors	|O
for	|O
non	|O
-	|O
A	|O
,	|O
non	|O
-	|O
B	|O
hepatitis	|O
:	|O
irrational	|O
,	|O
perhaps	|O
,	|O
but	|O
inescapable	|O
.	|O

Most	|O
patients	|O
with	|O
high	|O
blood	|O
pressure	|O
(	|O
BP	|O
)	|O
can	|O
be	|O
managed	|O
by	|O
using	|O
one	|O
of	|O
4	|O
classes	|O
of	|O
compounds	|O
:	|O
a	|O
diuretic	|O
,	|O
beta	|O
blocker	|O
,	|O
converting	|O
enzyme	|O
inhibitor	|O
or	|O
calcium	|O
antagonist	|O
.	|O

In	|O
a	|O
randomised	|O
double	|O
-	|O
blind	|O
study	|O
,	|O
46	|O
first	|O
episode	|O
schizophrenics	|O
were	|O
given	|O
pimozide	|O
or	|O
flupenthixol	|O
for	|O
up	|O
to	|O
5	|O
weeks	|O
;	|O
the	|O
mean	|O
daily	|O
dose	|O
at	|O
the	|O
end	|O
was	|O
18.8	|O
mg	|O
pimozide	|O
and	|O
20	|O
mg	|O
flupenthixol	|O
.	|O

Somatostatin	|B-PROTEIN
-	|O
producing	|O
endocrine	|O
pancreatic	|O
tumor	|O
in	|O
Recklinghausen	|O
's	|O
neurofibromatosis	|O
.	|O

Direct	|O
and	|O
inverted	|O
repeat	|O
elements	|O
of	|O
10	|O
,	|O
11	|O
,	|O
16	|O
,	|O
19	|O
,	|O
and	|O
22	|O
nucleotides	|O
(	|O
nt	|O
)	|O
flank	|O
the	|O
promoter	|O
site	|O
.	|O

We	|O
have	|O
been	|O
able	|O
to	|O
map	|O
specific	|O
DNA	|O
fragments	|O
at	|O
the	|O
bases	|O
of	|O
chromatin	|O
loops	|O
with	|O
the	|O
help	|O
of	|O
a	|O
novel	|O
extraction	|O
procedure	|O
by	|O
using	|O
lithium	|O
-	|O
3'	|O
,	|O
5'	|O
-	|O
diiodosalicylate	|O
.	|O

Seventy	|O
-	|O
one	|O
supplementary	|O
doses	|O
of	|O
vecuronium	|O
were	|O
used	|O
for	|O
muscle	|O
relaxation	|O
during	|O
a	|O
22	|O
-	|O
h	|O
-	|O
long	|O
NLA	|O
II	|O
anaesthesia	|O
.	|O

Finally	|O
,	|O
the	|O
recovery	|O
indexes	|O
represented	|O
by	|O
the	|O
times	|O
required	|O
for	|O
T1	|O
/	|O
T0	|O
and	|O
T4	|O
/	|O
T1	|O
to	|O
rise	|O
from	|O
25%	|O
to	|O
75%	|O
respectively	|O
were	|O
studied	|O
.	|O

Transformed	|O
bacterial	|O
colonies	|O
were	|O
screened	|O
for	|O
recombinant	|O
plasmids	|O
containing	|O
cDNA	|O
coding	|O
for	|O
BiP	|B-PROTEIN
by	|O
hybrid	|O
-	|O
selected	|O
mRNA	|O
translation	|O
.	|O

DPA	|O
attenuated	|O
the	|O
increase	|O
of	|O
the	|O
intensity	|O
of	|O
the	|O
ischemic	|O
and	|O
pressure	|O
pain	|O
components	|O
with	|O
increasing	|O
ischemia	|O
duration	|O
,	|O
but	|O
only	|O
the	|O
effect	|O
on	|O
the	|O
pressure	|O
pain	|O
component	|O
was	|O
significant	|O
.	|O

Topical	|O
1	|O
percent	|O
isoproterenol	|O
in	|O
the	|O
presence	|O
of	|O
the	|O
phosphodiesterase	|O
inhibitor	|O
theophylline	|O
was	|O
tested	|O
for	|O
its	|O
ability	|O
to	|O
stimulate	|O
the	|O
rate	|O
of	|O
aqueous	|O
humor	|O
flow	|O
through	|O
the	|O
anterior	|O
chamber	|O
of	|O
the	|O
normal	|O
and	|O
the	|O
partially	|O
adrenergically	|O
denervated	|O
human	|O
eye	|O
(	|O
Horner	|O
's	|O
syndrome	|O
)	|O
.	|O

Hyperthyroidism	|O
is	|O
one	|O
of	|O
the	|O
numerous	|O
causes	|O
of	|O
infertility	|O
and	|O
recurrent	|O
abortion	|O
.	|O

A	|O
strong	|O
correlation	|O
exists	|O
between	|O
the	|O
numbers	|O
of	|O
CFU	|O
-	|O
GM	|O
transfused	|O
and	|O
the	|O
rate	|O
of	|O
granulocytes	|O
and	|O
platelets	|O
recovery	|O
.	|O

We	|O
propose	|O
that	|O
the	|O
technique	|O
of	|O
low	|O
-	|O
frequency	|O
kindling	|O
is	|O
a	|O
useful	|O
experimental	|O
model	|O
in	|O
assessing	|O
the	|O
effects	|O
of	|O
antipsychotic	|O
or	|O
antiepileptic	|O
drugs	|O
on	|O
the	|O
excitability	|O
of	|O
the	|O
limbic	|O
regions	|O
.	|O

Oestrogen	|O
implant	|O
overdose	|O
.	|O

Three	|O
sequence	|O
elements	|O
are	|O
shown	|O
to	|O
be	|O
required	|O
for	|O
accurate	|O
and	|O
efficient	|O
transcription	|O
termination	|O
by	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
I	|I-PROTEIN
(	|O
pol	|B-PROTEIN
I	|I-PROTEIN
)	|O
assayed	|O
both	|O
in	|O
a	|O
cell	|O
-	|O
free	|O
transcription	|O
system	|O
and	|O
in	|O
vivo	|O
after	|O
transfection	|O
of	|O
rDNA	|O
minigene	|O
constructs	|O
into	|O
3T6	|O
cells	|O
.	|O

The	|O
biosynthesis	|O
and	|O
stability	|O
of	|O
the	|O
three	|O
mutant	|O
proteins	|O
were	|O
similar	|O
to	|O
those	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
erbB	|B-PROTEIN
protein	|O
,	|O
and	|O
all	|O
three	|O
retained	|O
the	|O
ability	|O
to	|O
transform	|O
chicken	|O
embryo	|O
fibroblasts	|O
.	|O

Codon	|O
usage	|O
in	|O
C.	|O
reinhardtii	|O
mitochondria	|O
is	|O
highly	|O
biased	|O
,	|O
with	|O
eight	|O
codons	|O
entirely	|O
absent	|O
from	|O
all	|O
protein	|O
-	|O
coding	|O
genes	|O
;	|O
however	|O
,	|O
even	|O
though	|O
codon	|O
usage	|O
is	|O
restricted	|O
,	|O
it	|O
appears	|O
that	|O
C.	|O
reinhardtii	|O
mtDNA	|O
cannot	|O
encode	|O
the	|O
minimum	|O
number	|O
of	|O
tRNAs	|O
needed	|O
to	|O
support	|O
mitochondrial	|O
protein	|O
synthesis	|O
.	|O

A	|O
new	|O
physiopathological	|O
treatment	|O
of	|O
HBV	|O
-	|O
related	|O
polyarteritis	|O
inspired	|O
by	|O
advances	|O
in	|O
the	|O
treatment	|O
of	|O
chronic	|O
active	|O
hepatitis	|O
B	|O
was	|O
tested	|O
in	|O
7	|O
patients	|O
.	|O

Like	|O
scrotal	|O
testes	|O
,	|O
undescended	|O
testes	|O
were	|O
hypointense	|O
to	|O
fat	|O
on	|O
sequences	|O
with	|O
a	|O
short	|O
repetition	|O
time	|O
(	|O
TR	|O
)	|O
and	|O
echo	|O
time	|O
(	|O
TE	|O
)	|O
in	|O
all	|O
cases	|O
,	|O
and	|O
hyperintense	|O
or	|O
isointense	|O
to	|O
fat	|O
on	|O
long	|O
TR	|O
/	|O
TE	|O
sequences	|O
in	|O
all	|O
but	|O
two	|O
cases	|O
.	|O

The	|O
subunit	|B-PROTEIN
-	|I-PROTEIN
a	|I-PROTEIN
gene	|O
is	|O
preceded	|O
by	|O
a	|O
gene	|O
coding	|O
for	|O
a	|O
small	|O
hydrophobic	|O
protein	|O
,	|O
as	|O
has	|O
been	|O
observed	|O
previously	|O
in	|O
the	|O
atp	|B-PROTEIN
operons	|O
in	|O
E.	|O
coli	|O
,	|O
bacterium	|O
PS3	|O
and	|O
cyanobacteria	|O
.	|O

Here	|O
,	|O
we	|O
describe	|O
the	|O
isolation	|O
of	|O
bovine	|O
and	|O
rat	|O
GHF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cDNA	|O
clones	|O
.	|O

To	|O
explore	|O
the	|O
functional	|O
properties	|O
of	|O
the	|O
protein	|O
encoded	|O
by	|O
neu	|B-PROTEIN
,	|O
we	|O
created	|O
a	|O
fusion	|O
gene	|O
that	|O
joins	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
neu	|B-PROTEIN
to	|O
the	|O
extracellular	|O
portion	|O
of	|O
an	|O
immunoglobulin	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
.	|O

The	|O
East	|O
African	|O
dik	|O
-	|O
dik	|O
antelope	|O
represents	|O
a	|O
miniature	|O
model	|O
ruminant	|O
for	|O
comparative	|O
studies	|O
.	|O

By	|O
sequence	|O
comparison	|O
,	|O
42	|O
blocks	|O
of	|O
homology	|O
are	|O
defined	|O
in	|O
the	|O
5'	|O
-	|O
terminal	|O
region	|O
,	|O
of	|O
which	|O
36	|O
appear	|O
in	|O
the	|O
CpG	|O
island	|O
and	|O
contain	|O
numerous	|O
conserved	|O
CpG	|O
dinucleotides	|O
.	|O

Among	|O
unusual	|O
features	|O
,	|O
we	|O
report	|O
numerous	|O
large	|O
G	|O
+	|O
C	|O
-	|O
rich	|O
conserved	|O
sequences	|O
located	|O
in	|O
the	|O
first	|O
intron	|O
.	|O

In	|O
the	|O
first	|O
group	|O
,	|O
0.02%	|O
Prazosin	|O
(	|O
0.5	|O
mg	|O
/	|O
kg	|O
)	|O
was	|O
administered	|O
intravenously	|O
for	|O
1.5	|O
hours	|O
before	|O
the	|O
application	|O
of	|O
Oxy	|O
-	|O
Hb	|O
or	|O
PGF2	|O
alpha	|O
.	|O

Efficacy	|O
and	|O
field	|O
evaluation	|O
of	|O
Bacillus	|O
thuringiensis	|O
(	|O
H	|O
-	|O
14	|O
)	|O
and	|O
B.	|O
sphaericus	|O
against	|O
floodwater	|O
mosquitoes	|O
in	|O
California	|O
.	|O

2	|O
cases	|O
of	|O
type	|O
II	|O
tyrosinosis	|O
(	|O
Richner	|O
-	|O
Hanhart	|O
syndrome	|O
)	|O

This	|O
loss	|O
was	|O
independent	|O
of	|O
drug	|O
concentration	|O
and	|O
a	|O
correction	|O
factor	|O
was	|O
employed	|O
to	|O
calculate	|O
the	|O
true	|O
free	|O
diazepam	|O
concentration	|O
.	|O

Effects	|O
of	|O
a	|O
perfluorochemical	|O
blood	|O
substitute	|O
on	|O
diazepam	|O
binding	|O
by	|O
human	|O
albumin	|B-PROTEIN
.	|O

A	|O
second	|O
promoter	|O
activity	|O
was	|O
identified	|O
in	|O
the	|O
region	|O
between	|O
the	|O
two	|O
major	|O
transcriptional	|O
start	|O
sites	|O
.	|O

A	|O
decamer	|O
sequence	|O
,	|O
5'	|O
-	|O
CGA	|O
-	|O
CCCCUCC	|O
-	|O
3'	|O
,	|O
complementary	|O
to	|O
a	|O
conserved	|O
sequence	|O
adjacent	|O
to	|O
the	|O
enzymatic	|O
cleavage	|O
site	|O
on	|O
the	|O
mitochondrial	|O
RNA	|O
substrate	|O
,	|O
is	|O
present	|O
in	|O
the	|O
RNAase	|O
MRP	|B-PROTEIN
RNA	|O
.	|O

Effects	|O
of	|O
aging	|O
and	|O
beta	|O
-	|O
adrenergic	|O
-	|O
blockade	|O
on	|O
standing	|O
-	|O
induced	|O
QT	|O
/	|O
QS2	|O
changes	|O
.	|O

A	|O
patient	|O
with	|O
an	|O
infected	|O
wound	|O
or	|O
one	|O
on	|O
a	|O
primary	|O
area	|O
(	|O
hands	|O
,	|O
feet	|O
,	|O
face	|O
,	|O
or	|O
perineum	|O
)	|O
may	|O
have	|O
to	|O
be	|O
hospitalized	|O
to	|O
ensure	|O
proper	|O
care	|O
.	|O

Pharmacology	|O
studies	|O
with	|O
potassium	|O
chloride	|O
and	|O
acetylcholine	|O
suggest	|O
that	|O
raveron	|O
acts	|O
as	|O
a	|O
calcium	|O
antagonist	|O
by	|O
blocking	|O
the	|O
influx	|O
of	|O
extracellular	|O
calcium	|O
.	|O

Computer	|O
analysis	|O
included	|O
digital	|O
averaging	|O
,	|O
followed	|O
by	|O
digital	|O
filtering	|O
in	|O
different	|O
frequency	|O
bands	|O
in	|O
order	|O
to	|O
determine	|O
the	|O
frequency	|O
range	|O
corresponding	|O
to	|O
notches	|O
and	|O
slurs	|O
.	|O

On	|O
admission	|O
to	|O
the	|O
ICU	|O
,	|O
117	|O
patients	|O
(	|O
61	|O
percent	|O
)	|O
had	|O
hypomagnesemia	|O
(	|O
serum	|O
Mg	|O
less	|O
than	|O
1.5	|O
mEq	|O
/	|O
dl	|O
)	|O
,	|O
66	|O
patients	|O
(	|O
34	|O
percent	|O
)	|O
had	|O
normomagnesemia	|O
(	|O
1.5	|O
to	|O
2.0	|O
mEq	|O
/	|O
dl	|O
)	|O
,	|O
and	|O
ten	|O
patients	|O
(	|O
5	|O
percent	|O
)	|O
had	|O
hypermagnesemia	|O
(	|O
greater	|O
than	|O
2.0	|O
mEq	|O
/	|O
dl	|O
)	|O
.	|O

The	|O
risk	|O
factors	|O
studied	|O
were	|O
male	|O
sex	|O
,	|O
hypertension	|O
,	|O
diabetes	|O
mellitus	|O
,	|O
hypercholesterolemia	|O
,	|O
cigarette	|O
smoking	|O
,	|O
sedentary	|O
life	|O
-	|O
style	|O
,	|O
and	|O
family	|O
history	|O
.	|O

Neither	|O
verapamil	|O
nor	|O
nifedipine	|O
changed	|O
collateral	|O
myocardial	|O
blood	|O
flow	|O
from	|O
0.10	|O
+	|O
/	|O
-	|O
0.02	|O
in	|O
the	|O
subendocardium	|O
and	|O
0.17	|O
+	|O
/	|O
-	|O
0.03	|O
ml	|O
/	|O
min	|O
/	|O
g	|O
in	|O
the	|O
subepicardium	|O
.	|O

There	|O
were	|O
35	|O
boys	|O
and	|O
15	|O
girls	|O
,	|O
with	|O
a	|O
mean	|O
age	|O
of	|O
five	|O
and	|O
a	|O
half	|O
years	|O
.	|O

Controlled	|O
versus	|O
uncontrolled	|O
reperfusion	|O
of	|O
ischemic	|O
myocardium	|O
after	|O
experimental	|O
coronary	|O
artery	|O
occlusion	|O
was	|O
studied	|O
to	|O
determine	|O
the	|O
effect	|O
on	|O
regional	|O
ventricular	|O
wall	|O
motion	|O
and	|O
associated	|O
biochemical	|O
alterations	|O
.	|O

Cardiac	|O
disease	|O
was	|O
not	|O
detected	|O
with	|O
M	|O
-	|O
mode	|O
,	|O
2	|O
-	|O
dimensional	|O
real	|O
-	|O
time	|O
or	|O
pulsed	|O
-	|O
wave	|O
Doppler	|O
echocardiography	|O
.	|O

Hemodynamic	|O
assessment	|O
was	|O
obtained	|O
before	|O
and	|O
following	|O
administration	|O
of	|O
digoxin	|O
10	|O
micrograms	|O
/	|O
kg	|O
IV	|O
or	|O
dopamine	|O
,	|O
5	|O
to	|O
12	|O
micrograms	|O
/	|O
kg	|O
/	|O
min	|O
IV	|O
.	|O

We	|O
also	|O
examined	|O
the	|O
relationship	|O
between	|O
the	|O
side	|O
of	|O
sinusitis	|O
and	|O
the	|O
cleft	|O
side	|O
in	|O
patients	|O
with	|O
unilateral	|O
cleft	|O
palate	|O
.	|O

We	|O
conclude	|O
that	|O
at	|O
these	|O
low	|O
levels	|O
studied	|O
,	|O
aluminum	|O
accumulates	|O
in	|O
intestinal	|O
tissue	|O
,	|O
and	|O
that	|O
this	|O
accumulation	|O
is	|O
enhanced	|O
by	|O
citrate	|O
ligand	|O
.	|O

Thus	|O
,	|O
the	|O
effects	|O
of	|O
father	|O
absence	|O
under	|O
routine	|O
conditions	|O
in	|O
relatively	|O
healthy	|O
samples	|O
may	|O
exert	|O
no	|O
significant	|O
effects	|O
independent	|O
of	|O
intervening	|O
family	|O
stressors	|O
or	|O
maternal	|O
psychopathology	|O
.	|O

Recently	|O
,	|O
an	|O
electrical	|O
-	|O
mechanical	|O
analog	|O
model	|O
of	|O
heat	|O
flow	|O
within	|O
the	|O
brain	|O
has	|O
been	|O
developed	|O
from	|O
which	|O
an	|O
expression	|O
for	|O
CBF	|O
has	|O
been	|O
derived	|O
:	|O
CBF	|O
=	|O
Cb	|O
/	|O
(	|O
tau	|O
rho	|O
c	|O
)	|O
where	|O
tau	|O
is	|O
the	|O
thermal	|O
decay	|O
constant	|O
,	|O
rho	|O
is	|O
the	|O
density	|O
of	|O
blood	|O
,	|O
and	|O
c	|O
is	|O
its	|O
specific	|O
heat	|O
.	|O

All	|O
of	|O
the	|O
newly	|O
acquired	|O
proviruses	|O
identified	|O
in	|O
mosaic	|O
founder	|O
SWR	|O
/	|O
J	|O
-	|O
RF	|O
/	|O
J	|O
mice	|O
that	|O
could	|O
be	|O
transmitted	|O
through	|O
the	|O
germ	|O
line	|O
were	|O
also	|O
present	|O
in	|O
somatic	|O
tissues	|O
,	|O
demonstrating	|O
that	|O
viral	|O
integration	|O
occurred	|O
before	|O
the	|O
germ	|O
line	|O
was	|O
set	|O
aside	|O
from	|O
the	|O
somatic	|O
lineages	|O
.	|O

Molecular	|O
cloning	|O
of	|O
the	|O
cDNA	|O
for	|O
the	|O
human	|O
U2	|O
snRNA	|O
-	|O
specific	|O
A'	|B-PROTEIN
protein	|O
.	|O

For	|O
the	|O
present	|O
work	|O
we	|O
used	|O
water	|O
saturated	|O
with	|O
a	|O
50/50	|O
mixture	|O
of	|O
H2	|O
and	|O
O2	|O
gases	|O
,	|O
for	|O
which	|O
the	|O
heat	|O
defect	|O
is	|O
calculated	|O
to	|O
be	|O
-	|O
2.1%	|O
.	|O

Successful	|O
use	|O
of	|O
transureteroureterostomy	|O
to	|O
salvage	|O
ureterosigmoidostomy	|O
after	|O
anastomotic	|O
failure	|O
.	|O

During	|O
flexion	|O
whiplash	|O
,	|O
the	|O
torque	|O
at	|O
the	|O
occipital	|O
condyle	|O
reverses	|O
its	|O
direction	|O
at	|O
about	|O
25	|O
ms	|O
after	|O
impact	|O
.	|O

The	|O
data	|O
indicates	|O
the	|O
presence	|O
of	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT2	|I-PROTEIN
serotonergic	|I-PROTEIN
receptors	|I-PROTEIN
in	|O
the	|O
bronchial	|O
artery	|O
of	|O
these	|O
species	|O
.	|O

Oxfendazole	|O
,	|O
which	|O
was	|O
active	|O
for	|O
the	|O
shortest	|O
time	|O
(	|O
about	|O
65	|O
days	|O
)	|O
from	|O
the	|O
start	|O
of	|O
grazing	|O
(	|O
May	|O
1	|O
)	|O
,	|O
produced	|O
a	|O
78.1	|O
per	|O
cent	|O
reduction	|O
in	|O
Ostertagia	|O
species	|O
and	|O
an	|O
84.4	|O
per	|O
cent	|O
reduction	|O
in	|O
D	|O
viviparus	|O
.	|O

By	|O
adapting	|O
a	|O
method	|O
for	|O
DNA	|O
-	|O
footprinting	|O
using	|O
impure	|O
extracts	|O
of	|O
ner	|B-PROTEIN
overproducing	|O
cells	|O
,	|O
we	|O
were	|O
able	|O
to	|O
determine	|O
that	|O
the	|O
ner	|B-PROTEIN
-	|O
binding	|O
sites	|O
are	|O
located	|O
between	|O
nucleotides	|O
1026	|O
and	|O
1058	|O
from	|O
the	|O
Mu	|O
left	|O
end	|O
.	|O

We	|O
have	|O
identified	|O
and	|O
characterized	|O
the	|O
structure	|O
of	|O
the	|O
Spec1	|B-PROTEIN
gene	|O
in	|O
the	|O
sea	|O
urchin	|O
Strongylocentrotus	|O
purpuratus	|O
.	|O

Platelet	|O
function	|O
and	|O
platelet	|O
-	|O
polymorphonuclear	|O
-	|O
neutrophil	|O
interaction	|O
in	|O
patients	|O
with	|O
deficient	|O
platelet	|O
lipoxygenase	|B-PROTEIN
activity	|O
.	|O

Spontaneous	|O
degradation	|O
of	|O
atracurium	|O
in	|O
plasma	|O
is	|O
the	|O
major	|O
route	|O
of	|O
elimination	|O
in	|O
man	|O
and	|O
contributes	|O
to	|O
a	|O
short	|O
elimination	|O
half	|O
-	|O
life	|O
(	|O
approximatively	|O
20	|O
min	|O
)	|O
.	|O

Transformed	|O
cell	|O
lines	|O
expressing	|O
solely	|O
E1a	|B-PROTEIN
or	|O
E1a	|B-PROTEIN
and	|O
E1b	|B-PROTEIN
gene	|O
products	|O
derived	|O
from	|O
these	|O
viruses	|O
display	|O
enhanced	|O
anchorage	|O
-	|O
independent	|O
growth	|O
at	|O
37	|O
degrees	|O
C	|O
versus	|O
32	|O
degrees	|O
C	|O
and	|O
display	|O
a	|O
cytoskeletal	|O
architecture	|O
resembling	|O
untransformed	|O
fibroblastic	|O
CREF	|O
cells	|O
.	|O

Partial	|O
N	|O
-	|O
terminal	|O
amino	|O
acid	|O
sequence	|O
analysis	|O
showed	|O
that	|O
the	|O
43K	|O
and	|O
42K	|O
T	|B-PROTEIN
antigens	|I-PROTEIN
contain	|O
methionine	|O
at	|O
residues	|O
1	|O
and	|O
5	|O
,	|O
as	|O
predicted	|O
from	|O
the	|O
DNA	|O
sequence	|O
,	|O
whereas	|O
no	|O
methionine	|O
was	|O
released	|O
from	|O
the	|O
39K	|O
T	|B-PROTEIN
antigen	|I-PROTEIN
during	|O
the	|O
first	|O
six	|O
cycles	|O
of	|O
Edman	|O
degradation	|O
.	|O

Group	|O
A	|O
was	|O
treated	|O
with	|O
three	|O
or	|O
four	|O
doses	|O
of	|O
hepatitis	|B-PROTEIN
B	|I-PROTEIN
immune	|I-PROTEIN
globulin	|I-PROTEIN
(	|O
HBIG	|B-PROTEIN
)	|O
in	|O
one	|O
of	|O
three	|O
different	|O
schedules	|O
.	|O

In	|O
the	|O
former	|O
instance	|O
,	|O
in	|O
addition	|O
to	|O
serum	|O
calcium	|O
and	|O
phosphorous	|O
ion	|O
concentrations	|O
,	|O
tissue	|O
pH	|O
,	|O
blood	|O
supply	|O
,	|O
hormones	|O
,	|O
i.e.	|O
,	|O
vitamin	|O
D	|O
,	|O
vitamin	|O
A	|O
,	|O
and	|O
various	|O
enzymes	|O
(	|O
e.g.	|O
,	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
and	|O
pyrophosphatase	|B-PROTEIN
)	|O
may	|O
all	|O
play	|O
significant	|O
,	|O
ancillary	|O
,	|O
time	|O
-	|O
dependent	|O
,	|O
but	|O
as	|O
yet	|O
undetermined	|O
roles	|O
.	|O

Penicillinase	|B-PROTEIN
production	|O
in	|O
Staphylococcus	|O
aureus	|O
strains	|O
of	|O
clinical	|O
importance	|O
.	|O

Thus	|O
,	|O
quantitative	|O
analysis	|O
of	|O
thallium	|O
-	|O
201	|O
uptake	|O
and	|O
washout	|O
provided	|O
objective	|O
evidence	|O
for	|O
improved	|O
myocardial	|O
perfusion	|O
after	|O
coronary	|O
angioplasty	|O
.	|O

This	|O
study	|O
reports	|O
the	|O
effects	|O
of	|O
a	|O
preparation	|O
with	|O
50	|O
micrograms	|O
ethinyl	|O
estradiol	|O
and	|O
2	|O
mg	|O
cyproterone	|O
acetate	|O
on	|O
gonadotropins	|B-PROTEIN
,	|O
prolactin	|B-PROTEIN
,	|O
testosterone	|O
,	|O
sex	|B-PROTEIN
hormone	|I-PROTEIN
binding	|I-PROTEIN
globulin	|I-PROTEIN
(	|O
SHBG	|B-PROTEIN
)	|O
,	|O
androstenedione	|O
,	|O
and	|O
calculated	|O
free	|O
testosterone	|O
index	|O
before	|O
and	|O
after	|O
six	|O
months	|O
of	|O
treatment	|O
.	|O

Functional	|O
flow	|O
was	|O
evaluated	|O
using	|O
laser	|O
Doppler	|O
flowmetry	|O
(	|O
LDF	|O
)	|O
,	|O
for	|O
which	|O
the	|O
output	|O
signal	|O
,	|O
blood	|O
cell	|O
flux	|O
(	|O
BCF	|O
)	|O
,	|O
is	|O
expressed	|O
in	|O
terms	|O
of	|O
volts	|O
.	|O

In	|O
nine	|O
patients	|O
with	|O
renal	|O
failure	|O
routine	|O
haemodialysis	|O
was	|O
accompanied	|O
by	|O
a	|O
30	|O
per	|O
cent	|O
reduction	|O
in	|O
plasma	|O
ANP	|B-PROTEIN
concentration	|O
.	|O

To	|O
investigate	|O
the	|O
effects	|O
of	|O
isotretinoin	|O
on	|O
HDL	|B-PROTEIN
,	|O
we	|O
measured	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
,	|O
HDL	|B-PROTEIN
phospholipids	|O
(	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
PL	|I-PROTEIN
)	|O
,	|O
apoprotein	|B-PROTEIN
A1	|I-PROTEIN
(	|O
apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
and	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
subfractions	|O
(	|O
HDL2	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
and	|O
HDL3	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
)	|O
in	|O
24	|O
healthy	|O
,	|O
male	|O
patients	|O
receiving	|O
a	|O
16	|O
-	|O
week	|O
course	|O
of	|O
isotretinoin	|O
(	|O
1.0	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
)	|O
for	|O
treatment	|O
of	|O
severe	|O
acne	|O
vulgaris	|O
.	|O

The	|O
clinical	|O
picture	|O
and	|O
laboratory	|O
parameters	|O
were	|O
consistent	|O
with	|O
a	|O
serum	|O
sickness	|O
reaction	|O
.	|O

Our	|O
data	|O
,	|O
however	|O
,	|O
did	|O
not	|O
suggest	|O
the	|O
existence	|O
of	|O
a	|O
conversion	|O
factor	|O
for	|O
LDF	|O
signal	|O
to	|O
absolute	|O
flow	|O
values	|O
from	|O
experiment	|O
to	|O
experiment	|O
.	|O

Preventive	|O
effect	|O
of	|O
ONO	|O
-	|O
3708	|O
on	|O
thrombosis	|O
and	|O
vasospasms	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

The	|O
frequency	|O
of	|O
PPNG	|O
strains	|O
increased	|O
from	|O
1.7%	|O
in	|O
1981	|O
to	|O
6.7%	|O
in	|O
1985	|O
.	|O

Monospecific	|O
antibodies	|O
,	|O
eluted	|O
from	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
fusion	|O
protein	|O
of	|O
either	|O
clone	|O
reacted	|O
with	|O
the	|O
U1	|B-PROTEIN
snRNP	|I-PROTEIN
-	|O
specific	|O
A	|B-PROTEIN
antigen	|I-PROTEIN
.	|O

Quantitative	|O
analysis	|O
of	|O
the	|O
coronary	|O
stenosis	|O
was	|O
assessed	|O
before	|O
and	|O
after	|O
PTCA	|O
,	|O
and	|O
the	|O
dilatation	|O
resulted	|O
in	|O
an	|O
increase	|O
in	|O
minimal	|O
luminal	|O
cross	|O
-	|O
sectional	|O
area	|O
from	|O
1.1	|O
+	|O
/	|O
-	|O
0.8	|O
to	|O
2.7	|O
+	|O
/	|O
-	|O
1.2	|O
mm2	|O
.	|O

The	|O
pathogenesis	|O
of	|O
Limited	|O
Joint	|O
Mobility	|O
(	|O
LJM	|O
)	|O
in	|O
diabetes	|O
is	|O
unknown	|O
,	|O
but	|O
the	|O
abnormality	|O
is	|O
said	|O
to	|O
be	|O
associated	|O
with	|O
an	|O
increased	|O
incidence	|O
of	|O
microangiopathy	|O
.	|O

In	|O
a	|O
previous	|O
study	|O
(	|O
Brandl	|O
,	|O
C.	|O

The	|O
experimental	|O
end	|O
points	|O
were	|O
the	|O
time	|O
required	|O
for	|O
treated	|O
tumors	|O
to	|O
reach	|O
3	|O
times	|O
their	|O
treatment	|O
size	|O
,	|O
the	|O
survival	|O
of	|O
stem	|O
cells	|O
in	|O
the	|O
duodenal	|O
crypts	|O
,	|O
and	|O
the	|O
breathing	|O
rate	|O
measured	|O
early	|O
(	|O
19-23	|O
weeks	|O
)	|O
and	|O
late	|O
(	|O
41-46	|O
weeks	|O
)	|O
after	|O
treatment	|O
.	|O

Schedule	|O
2	|O
,	|O
in	|O
which	|O
2.4	|O
mg	|O
/	|O
kg	|O
c	|O
-	|O
DDP	|O
was	|O
administered	|O
immediately	|O
before	|O
X	|O
-	|O
ray	|O
on	|O
5	|O
consecutive	|O
days	|O
produced	|O
the	|O
highest	|O
degree	|O
of	|O
enhancement	|O
of	|O
radiation	|O
effect	|O
(	|O
expressed	|O
as	|O
dose	|O
-	|O
effect	|O
factor	|O
)	|O
;	|O
and	|O
the	|O
next	|O
greatest	|O
enhancement	|O
was	|O
produced	|O
by	|O
12	|O
mg	|O
/	|O
kg	|O
c	|O
-	|O
DDP	|O
administered	|O
24	|O
h	|O
before	|O
the	|O
start	|O
of	|O
fractionated	|O
daily	|O
radiotherapy	|O
.	|O

The	|O
cpc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
encoded	|O
transcript	|O
contains	|O
three	|O
open	|O
reading	|O
frames	|O
,	|O
two	|O
of	|O
which	|O
are	|O
located	|O
in	|O
the	|O
720	|O
-	|O
nucleotide	|O
leader	|O
segment	|O
preceding	|O
the	|O
cpc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
coding	|O
region	|O
.	|O

The	|O
seco	|O
-	|O
steroid	|O
hormone	|O
1,25	|O
-	|O
dihydroxyvitamin	|O
D3	|O
is	|O
known	|O
to	|O
induce	|O
the	|O
expression	|O
of	|O
a	|O
calcium	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
termed	|O
calbindin	|B-PROTEIN
-	|I-PROTEIN
D28K	|I-PROTEIN
in	|O
a	|O
variety	|O
of	|O
target	|O
tissues	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
calbindin	|B-PROTEIN
-	|I-PROTEIN
D28K	|I-PROTEIN
promoter	|O
is	|O
composed	|O
of	|O
a	|O
variety	|O
of	|O
simple	|O
repeated	|O
sequences	|O
,	|O
some	|O
of	|O
which	|O
are	|O
components	|O
of	|O
putative	|O
regulatory	|O
signals	|O
.	|O

The	|O
HOI	|O
induced	|O
a	|O
nearly	|O
fourfold	|O
increase	|O
in	|O
ANF	|B-PROTEIN
in	|O
the	|O
elderly	|O
,	|O
whereas	|O
that	|O
for	|O
the	|O
young	|O
was	|O
threefold	|O
.	|O

To	|O
assess	|O
the	|O
ability	|O
of	|O
the	|O
atria	|O
to	|O
maintain	|O
elevated	|O
plasma	|O
concentrations	|O
of	|O
atrial	|B-PROTEIN
natriuretic	|I-PROTEIN
peptide	|I-PROTEIN
(	|O
ANP	|B-PROTEIN
)	|O
,	|O
the	|O
temporal	|O
changes	|O
in	|O
plasma	|O
ANP	|B-PROTEIN
concentrations	|O
were	|O
studied	|O
in	|O
seven	|O
chloralose	|O
-	|O
anaesthetized	|O
dogs	|O
during	|O
4	|O
h	|O
of	|O
sustained	|O
rapid	|O
cardiac	|O
pacing	|O
.	|O

Ig	|B-PROTEIN
D	|I-PROTEIN
-	|O
JH	|B-PROTEIN
recombinations	|O
may	|O
precede	|O
TcR	|B-PROTEIN
gene	|O
recombination	|O
in	|O
these	|O
early	|O
T	|O
cell	|O
lines	|O
,	|O
and	|O
some	|O
but	|O
not	|O
all	|O
express	|O
sterile	|O
Cmu	|B-PROTEIN
transcripts	|O
.	|O

The	|O
RAD18	|B-PROTEIN
gene	|O
open	|O
reading	|O
frame	|O
encodes	|O
a	|O
protein	|O
of	|O
487	|O
amino	|O
acids	|O
,	|O
with	|O
a	|O
calculated	|O
molecular	|O
weight	|O
of	|O
55,512	|O
.	|O

Atomic	|O
absorption	|O
spectrophotometry	|O
applied	|O
to	|O
bacterially	|O
expressed	|O
E1A	|B-PROTEIN
proteins	|O
revealed	|O
that	|O
the	|O
289	|O
-	|O
amino	|O
acid	|O
protein	|O
binds	|O
one	|O
zinc	|O
ion	|O
,	|O
whereas	|O
the	|O
243	|O
-	|O
amino	|O
acid	|O
protein	|O
binds	|O
no	|O
zinc	|O
.	|O

Most	|O
patients	|O
preferred	|O
tablets	|O
to	|O
injection	|O
both	|O
on	|O
day	|O
1	|O
(	|O
313	|O
v	|O
200	|O
)	|O
and	|O
at	|O
follow	|O
up	|O
(	|O
373	|O
v	|O
104	|O
)	|O
.	|O

Plots	|O
of	|O
RV	|O
,	|O
LV	|O
+	|O
S	|O
and	|O
2A	|O
weight	|O
vs	|O
real	|O
hematocrit	|O
showed	|O
sharp	|O
upward	|O
inflections	|O
at	|O
real	|O
hematocrit	|O
65%	|O
,	|O
suggesting	|O
a	|O
possible	|O
role	|O
of	|O
increased	|O
viscosity	|O
in	|O
CO	|O
cardiomegaly	|O
at	|O
the	|O
higher	|O
hematocrit	|O
.	|O

The	|O
absorbable	|O
perisplenic	|O
mesh	|O
is	|O
an	|O
important	|O
improvement	|O
,	|O
and	|O
in	|O
some	|O
cases	|O
it	|O
may	|O
replace	|O
other	|O
techniques	|O
for	|O
arresting	|O
splenic	|O
bleeding	|O
.	|O

A	|O
rare	|O
chronic	|O
course	|O
of	|O
Budd	|O
-	|O
Chiari	|O
syndrome	|O
associated	|O
with	|O
thrombosis	|O
of	|O
the	|O
portal	|O
vein	|O
was	|O
observed	|O
in	|O
a	|O
30	|O
-	|O
year	|O
-	|O
old	|O
male	|O
patient	|O
suffering	|O
from	|O
postmyocarditic	|O
cardiosclerosis	|O
.	|O

After	|O
one	|O
accommodation	|O
night	|O
,	|O
sleep	|O
EEG	|O
recordings	|O
were	|O
performed	|O
during	|O
three	|O
consecutive	|O
nights	|O
in	|O
ten	|O
drug	|O
-	|O
free	|O
inpatients	|O
presenting	|O
generalized	|O
anxiety	|O
disorder	|O
(	|O
GAD	|O
)	|O
with	|O
significant	|O
depression	|O
,	|O
compared	|O
with	|O
a	|O
age	|O
-	|O
and	|O
sex	|O
-	|O
matched	|O
group	|O
of	|O
patients	|O
with	|O
GAD	|O
and	|O
a	|O
group	|O
of	|O
primary	|O
major	|O
depressive	|O
disorder	|O
(	|O
MDD	|O
)	|O
patients	|O
.	|O

Oligonucleotide	|O
mutagenesis	|O
of	|O
these	|O
binding	|O
domains	|O
indicated	|O
their	|O
importance	|O
in	|O
the	|O
transcriptional	|O
regulation	|O
of	|O
the	|O
E3	|B-PROTEIN
promoter	|O
in	|O
yeast	|O
cells	|O
.	|O

The	|O
concentration	|O
of	|O
PGI2	|O
on	|O
the	|O
newly	|O
-	|O
formed	|O
luminal	|O
surface	|O
remained	|O
low	|O
.	|O

Organ	|O
transplantation	|O
in	|O
Denmark	|O
.	|O

Effects	|O
of	|O
single	|O
and	|O
combined	|O
maltose	|O
tetrapalmitate	|O
immunotherapy	|O
,	|O
cyclophosphamide	|O
chemotherapy	|O
and	|O
radiotherapy	|O
on	|O
ethyl	|O
carbamate	|O
accelerated	|O
primary	|O
lung	|O
cancer	|O
in	|O
A	|O
/	|O
J	|O
mice	|O
.	|O

D.	|O

A	|O
114	|O
-	|O
base	|O
pair	|O
sequence	|O
of	|O
predominantly	|O
repeating	|O
purine	|O
-	|O
pyrimidine	|O
nucleotides	|O
separates	|O
these	|O
two	|O
d	|O
(	|O
AC	|O
)	|O
repeats	|O
.	|O

Phase	|O
II	|O
study	|O
of	|O
VP	|O
-	|O
16	|O
(	|O
capsule	|O
)	|O
in	|O
solid	|O
tumors	|O
.	|O

When	|O
the	|O
coding	|O
segments	|O
,	|O
including	|O
both	|O
framework	|O
and	|O
complementarity	|O
-	|O
determining	|O
regions	|O
,	|O
of	|O
these	|O
genes	|O
and	|O
the	|O
murine	|O
probe	|O
sequences	|O
are	|O
compared	|O
by	|O
metric	|O
analysis	|O
,	|O
it	|O
is	|O
apparent	|O
that	|O
the	|O
caiman	|O
genes	|O
are	|O
only	|O
slightly	|O
more	|O
related	|O
to	|O
each	|O
other	|O
than	|O
to	|O
the	|O
mammalian	|O
sequence	|O
,	|O
consistent	|O
with	|O
significant	|O
preservation	|O
of	|O
nucleotide	|O
sequence	|O
over	|O
an	|O
extended	|O
period	|O
of	|O
phylogenetic	|O
time	|O
.	|O

Evidence	|O
for	|O
a	|O
role	|O
of	|O
endogenous	|O
corticotropin	|B-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
factor	|I-PROTEIN
in	|O
cold	|O
,	|O
ether	|O
,	|O
immobilization	|O
,	|O
and	|O
traumatic	|O
stress	|O
.	|O

An	|O
unusual	|O
feature	|O
of	|O
these	|O
replicative	|O
genes	|O
is	|O
that	|O
the	|O
smaller	|O
mRNA	|O
begins	|O
within	|O
a	|O
long	|O
open	|O
reading	|O
frame	|O
of	|O
the	|O
larger	|O
mRNA	|O
.	|O

Different	|O
sequence	|O
elements	|O
of	|O
both	|O
the	|O
retroviral	|O
vectors	|O
and	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
gene	|O
recombined	|O
during	|O
genesis	|O
of	|O
highly	|O
oncogenic	|O
retroviruses	|O
CMII	|O
,	|O
MC29	|O
,	|O
or	|O
MH2	|O
.	|O

81	|O
milk	|O
samples	|O
collected	|O
from	|O
35	|O
donors	|O
3	|O
days	|O
to	|O
7	|O
months	|O
after	|O
delivery	|O
were	|O
examined	|O
for	|O
the	|O
occurrence	|O
of	|O
cytomegalovirus	|O
(	|O
CMV	|O
)	|O
.	|O

Subcloning	|O
of	|O
DNA	|O
fragments	|O
from	|O
the	|O
8.5	|O
-	|O
kilobase	|O
(	|O
kb	|O
)	|O
insert	|O
of	|O
pAVO4	|O
defined	|O
a	|O
4	|O
-	|O
kb	|O
DNA	|O
fragment	|O
which	|O
contained	|O
the	|O
functional	|O
FBP+	|B-PROTEIN
gene	|O
and	|O
its	|O
regulatory	|O
region	|O
.	|O

Three	|O
cases	|O
of	|O
primary	|O
signet	|O
-	|O
ring	|O
cell	|O
carcinoma	|O
of	|O
the	|O
rectum	|O
are	|O
described	|O
.	|O

The	|O
data	|O
obtained	|O
up	|O
to	|O
now	|O
only	|O
suggest	|O
the	|O
future	|O
potentiality	|O
of	|O
Bestatin	|O
treatment	|O
for	|O
these	|O
types	|O
of	|O
malignancy	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
dopaminergic	|O
regulation	|O
of	|O
adrenal	|O
zona	|O
glomerulosa	|O
corticosteroid	|O
and	|O
renal	|O
renin	|B-PROTEIN
secretion	|O
is	|O
absent	|O
in	|O
patients	|O
with	|O
high	|O
spinal	|O
cord	|O
transections	|O
,	|O
suggesting	|O
that	|O
intact	|O
neural	|O
pathways	|O
from	|O
the	|O
central	|O
nervous	|O
system	|O
are	|O
necessary	|O
for	|O
metoclopramide	|O
stimulation	|O
of	|O
aldosterone	|O
and	|O
renin	|B-PROTEIN
secretion	|O
in	|O
men	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
enhancer	|O
sequences	|O
,	|O
the	|O
adenovirus	|O
E1A	|B-PROTEIN
gene	|O
can	|O
not	|O
stimulate	|O
CATase	|B-PROTEIN
synthesis	|O
.	|O

These	|O
IgG	|B-PROTEIN
antibodies	|O
in	|O
the	|O
babies	|O
diminished	|O
rapidly	|O
after	|O
delivery	|O
,	|O
and	|O
were	|O
detectable	|O
only	|O
in	|O
3	|O
cases	|O
at	|O
2	|O
,	|O
3	|O
,	|O
and	|O
5	|O
months	|O
of	|O
ages	|O
out	|O
of	|O
38	|O
babies	|O
up	|O
to	|O
21	|O
months	|O
.	|O

Fine	|O
analysis	|O
at	|O
the	|O
nucleotide	|O
level	|O
of	|O
the	|O
early	|O
events	|O
in	|O
the	|O
digestion	|O
with	|O
nuclease	|O
S1	|B-PROTEIN
shows	|O
that	|O
the	|O
enzyme	|O
attacks	|O
preferentially	|O
the	|O
sequence	|O
(	|O
G	|O
-	|O
A	|O
)	|O
12	|O
on	|O
the	|O
message	|O
complementary	|O
strand	|O
.	|O

Those	|O
dosages	|O
that	|O
inhibited	|O
mean	|O
NTE	|B-PROTEIN
activity	|O
in	|O
spinal	|O
cord	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
72%	|O
and	|O
brain	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
66%	|O
of	|O
control	|O
values	|O
within	|O
44	|O
hr	|O
postexposure	|O
produced	|O
marked	|O
spinal	|O
cord	|O
pathology	|O
14	|O
days	|O
postexposure	|O
in	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
90%	|O
of	|O
similarly	|O
dosed	|O
animals	|O
.	|O

FK	|O
33-824	|O
,	|O
a	|O
methionine	|O
-	|O
enkephalin	|B-PROTEIN
analogue	|O
,	|O
suppressed	|O
plasma	|O
ACTH	|B-PROTEIN
to	|O
85%	|O
of	|O
basal	|O
level	|O
,	|O
while	|O
bromocriptine	|O
(	|O
CB	|O
-	|O
154	|O
)	|O
caused	|O
no	|O
significant	|O
change	|O
.	|O

A	|O
v	|B-PROTEIN
-	|I-PROTEIN
erbB	|I-PROTEIN
-	|O
related	|O
protooncogene	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
erbB	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
is	|O
distinct	|O
from	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
erbB	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
gene	|O
and	|O
is	|O
amplified	|O
in	|O
a	|O
human	|O
salivary	|O
gland	|O
adenocarcinoma	|O
.	|O

The	|O
sequence	|O
analysis	|O
of	|O
both	|O
products	|O
of	|O
individual	|O
phi	|O
80	|O
site	|O
-	|O
specific	|O
recombination	|O
events	|O
in	|O
vivo	|O
shows	|O
that	|O
recombination	|O
with	|O
a	|O
secondary	|O
attachment	|O
(	|O
att	|O
)	|O
site	|O
generates	|O
several	|O
different	|O
novel	|O
joints	|O
at	|O
the	|O
mismatched	|O
position	|O
:	|O
one	|O
recombination	|O
event	|O
resulted	|O
in	|O
a	|O
single	|O
base	|O
-	|O
pair	|O
deletion	|O
and	|O
two	|O
other	|O
recombination	|O
events	|O
resulted	|O
in	|O
two	|O
different	|O
single	|O
base	|O
-	|O
pair	|O
substitutions	|O
.	|O

This	|O
L	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
sequence	|O
is	|O
amplified	|O
10-20	|O
-	|O
fold	|O
in	|O
four	|O
SCLC	|O
cell	|O
line	|O
DNAs	|O
and	|O
in	|O
one	|O
SCLC	|O
tumour	|O
specimen	|O
taken	|O
directly	|O
from	|O
a	|O
patient	|O
.	|O

Temperature	|O
-	|O
shift	|O
experiments	|O
using	|O
synchronously	|O
grown	|O
cells	|O
of	|O
a	|O
delta	|B-PROTEIN
top1	|I-PROTEIN
top2	|O
temperature	|O
-	|O
sensitive	|O
(	|O
ts	|O
)	|O
double	|O
mutant	|O
and	|O
its	|O
isogenic	|O
top2	|B-PROTEIN
ts	|O
strain	|O
show	|O
that	|O
,	|O
whereas	|O
mitotic	|O
blocks	|O
can	|O
prevent	|O
killing	|O
of	|O
the	|O
top2	|B-PROTEIN
ts	|O
mutant	|O
at	|O
a	|O
nonpermissive	|O
temperature	|O
,	|O
the	|O
same	|O
treatments	|O
are	|O
ineffective	|O
in	|O
preventing	|O
cell	|O
death	|O
of	|O
the	|O
delta	|B-PROTEIN
top1	|I-PROTEIN
top2	|O
ts	|O
double	|O
mutant	|O
.	|O

The	|O
homology	|O
to	|O
v	|B-PROTEIN
-	|I-PROTEIN
mil	|I-PROTEIN
starts	|O
within	|O
the	|O
coding	|O
sequence	|O
of	|O
exon	|O
1	|O
and	|O
ends	|O
within	|O
the	|O
3'	|O
untranslated	|O
region	|O
of	|O
exon	|O
11	|O
,	|O
12	|O
nucleotides	|O
downstream	|O
from	|O
the	|O
nonsense	|O
codon	|O
terminating	|O
the	|O
large	|O
open	|O
reading	|O
frame	|O
shared	|O
between	|O
c	|B-PROTEIN
-	|I-PROTEIN
mil	|I-PROTEIN
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
mil	|I-PROTEIN
.	|O

Examination	|O
of	|O
the	|O
sequence	|O
of	|O
the	|O
Punta	|O
Toro	|O
M	|B-PROTEIN
gene	|I-PROTEIN
product	|O
reveals	|O
the	|O
presence	|O
of	|O
multiple	|O
hydrophobic	|O
sequences	|O
including	|O
a	|O
19	|O
-	|O
amino	|O
acid	|O
,	|O
carboxy	|O
-	|O
proximal	|O
,	|O
hydrophobic	|O
region	|O
(	|O
G2	|O
)	|O
.	|O

Six	|O
(	|O
four	|O
FAP	|O
;	|O
two	|O
primary	|O
amyloidosis	|O
)	|O
also	|O
had	|O
diffusely	|O
positive	|O
myocardial	|O
uptakes	|O
,	|O
but	|O
the	|O
intensity	|O
was	|O
less	|O
than	|O
that	|O
of	|O
the	|O
sternum	|O
.	|O

The	|O
intensity	|O
of	|O
myocardial	|O
uptake	|O
of	|O
Tc	|O
-	|O
99m	|O
-	|O
PYP	|O
in	|O
patients	|O
with	|O
echocardiographic	|O
left	|O
ventricular	|O
hypertrophy	|O
and	|O
/	|O
or	|O
highly	|O
refractile	|O
myocardial	|O
echoes	|O
,	|O
so	|O
-	|O
called	|O
granular	|O
sparkling	|O
appearance	|O
(	|O
GS	|O
)	|O
was	|O
slightly	|O
greater	|O
than	|O
that	|O
in	|O
patients	|O
with	|O
neither	|O
myocardial	|O
hypertrophy	|O
nor	|O
GS	|O
.	|O

The	|O
210	|O
kDa	|O
precursor	|O
is	|O
converted	|O
slowly	|O
(	|O
t	|O
1/2	|O
=	|O
2	|O
h	|O
)	|O
by	|O
proteolytic	|O
processing	|O
into	|O
a	|O
125	|O
kDa	|O
(	|O
alpha	|O
'	|O
)	|O
and	|O
83	|O
kDa	|O
(	|O
beta	|O
'	|O
)	|O
species	|O
.	|O

Alveolar	|O
lymphocytes	|O
were	|O
surprisingly	|O
increased	|O
in	|O
most	|O
patients	|O
with	|O
AIDS	|O
(	|O
mean	|O
26.1	|O
+	|O
/	|O
-	|O
21.9%	|O
;	|O
range	|O
1-76%	|O
)	|O
and	|O
CGL	|O
(	|O
mean	|O
26.6	|O
+	|O
/	|O
-	|O
22.6%	|O
;	|O
range	|O
3-76%	|O
)	|O
with	|O
criteria	|O
of	|O
activation	|O
contrasting	|O
with	|O
the	|O
blood	|O
lymphopenia	|O
.	|O

We	|O
have	|O
determined	|O
that	|O
these	|O
nicks	|O
occur	|O
in	|O
both	|O
the	|O
wild	|O
-	|O
type	|O
and	|O
the	|O
mutant	|O
sites	|O
.	|O

The	|O
sequence	|O
was	|O
determined	|O
for	|O
a	|O
4024	|O
-	|O
base	|O
pair	|O
(	|O
bp	|O
)	|O
segment	|O
that	|O
extends	|O
from	|O
149	|O
bp	|O
5'	|O
to	|O
the	|O
cap	|O
site	|O
of	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
to	|O
207	|O
bp	|O
3'	|O
to	|O
psi	|B-PROTEIN
alpha	|I-PROTEIN
.	|O

Its	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
shows	|O
extensive	|O
homology	|O
to	|O
those	|O
of	|O
Drosophila	|O
hsp70	|B-PROTEIN
,	|O
trout	|O
hsp70	|B-PROTEIN
,	|O
Xenopus	|O
hsp70	|B-PROTEIN
,	|O
yeast	|O
hsp70	|B-PROTEIN
,	|O
and	|O
some	|O
homology	|O
to	|O
the	|O
heat	|O
-	|O
inducible	|O
dnaK	|B-PROTEIN
gene	|O
product	|O
of	|O
Escherichia	|O
coli	|O
.	|O

When	|O
phosphorylation	|O
of	|O
exogenous	|O
peptide	|O
substrates	|O
was	|O
measured	|O
as	|O
a	|O
function	|O
of	|O
receptor	|O
self	|O
-	|O
phosphorylation	|O
,	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
was	|O
found	|O
to	|O
be	|O
enhanced	|O
two	|O
to	|O
threefold	|O
at	|O
1-2	|O
mol	|O
of	|O
phosphate	|O
per	|O
mol	|O
of	|O
receptor	|O
.	|O

At	|O
temperatures	|O
permissive	|O
for	|O
transformation	|O
,	|O
6m2	|O
cells	|O
contain	|O
P58gag	|B-PROTEIN
produced	|O
from	|O
the	|O
4.0	|O
-	|O
kilobase	|O
(	|O
kb	|O
)	|O
viral	|O
RNA	|O
genome	|O
and	|O
P85gag	|B-PROTEIN
-	|O
mos	|B-PROTEIN
translated	|O
from	|O
a	|O
3.5	|O
-	|O
kb	|O
spliced	|O
mRNA	|O
.	|O

The	|O
pet56	|B-PROTEIN
and	|O
his3	|B-PROTEIN
genes	|O
are	|O
transcribed	|O
divergently	|O
from	|O
initiation	|O
sites	|O
that	|O
are	|O
separated	|O
by	|O
only	|O
192	|O
bp	|O
.	|O

Multistep	|O
transformation	|O
by	|O
defined	|O
fragments	|O
of	|O
herpes	|O
simplex	|O
virus	|O
type	|O
2	|O
DNA	|O
:	|O
oncogenic	|O
region	|O
and	|O
its	|O
gene	|O
product	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
in	|O
patients	|O
with	|O
first	|O
-	|O
attack	|O
genital	|O
herpes	|O
,	|O
the	|O
type	|O
of	|O
HSV	|O
is	|O
the	|O
most	|O
important	|O
determinant	|O
of	|O
subsequent	|O
recurrences	|O
and	|O
that	|O
intravenous	|O
acyclovir	|O
has	|O
little	|O
effect	|O
on	|O
subsequent	|O
recurrences	|O
.	|O

Comparison	|O
of	|O
sequences	|O
of	|O
ovine	|O
and	|O
bovine	|O
,	|O
rat	|O
and	|O
guinea	|O
-	|O
pig	|O
alpha	|B-PROTEIN
s1	|I-PROTEIN
-	|I-PROTEIN
casein	|I-PROTEIN
mRNAs	|O
has	|O
revealed	|O
a	|O
greater	|O
homology	|O
in	|O
the	|O
3'	|O
and	|O
especially	|O
5'	|O
non	|O
coding	|O
regions	|O
.	|O

One	|O
group	|O
(	|O
n	|O
=	|O
9	|O
)	|O
was	|O
premedicated	|O
with	|O
midazolam	|O
,	|O
0.1	|O
mg	|O
kg	|O
-	|O
1	|O
,	|O
and	|O
atropine	|O
0.2-0.4	|O
mg	|O
i.m	|O
.	|O

Comparison	|O
with	|O
a	|O
recently	|O
described	|O
c	|B-PROTEIN
-	|I-PROTEIN
sis	|I-PROTEIN
cDNA	|O
clone	|O
(	|O
Collins	|O
et	|O
al.	|O
,	|O
Nature	|O
316	|O
,	|O
748-750	|O
(	|O
1985	|O
)	|O
)	|O
revealed	|O
that	|O
the	|O
1.9	|O
kbp	|O
DNA	|O
region	|O
contained	|O
a	|O
large	|O
5'	|O
c	|B-PROTEIN
-	|I-PROTEIN
sis	|I-PROTEIN
exon	|O
of	|O
at	|O
least	|O
1050	|O
bp	|O
.	|O

It	|O
was	|O
also	|O
suggested	|O
that	|O
the	|O
biological	|O
activities	|O
of	|O
5	|O
-	|O
FU	|O
,	|O
ADM	|O
and	|O
MMC	|O
in	|O
FAMLIP	|O
were	|O
stable	|O
in	|O
FULIP	|O
,	|O
ADRLIP	|O
and	|O
MMCLIP	|O
.	|O

Surprisingly	|O
,	|O
a	|O
C	|O
to	|O
G	|O
transversion	|O
at	|O
the	|O
first	|O
residue	|O
of	|O
the	|O
CAT	|B-PROTEIN
pentanucleotide	|O
,	|O
which	|O
severely	|O
impairs	|O
the	|O
activity	|O
of	|O
both	|O
promoters	|O
,	|O
appears	|O
to	|O
increase	|O
affinity	|O
of	|O
the	|O
CAT	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

The	|O
nucleotide	|O
sequence	|O
of	|O
3874	|O
bp	|O
of	|O
cloned	|O
R.	|O
sphaeroides	|O
chromosomal	|O
DNA	|O
,	|O
including	|O
the	|O
three	|O
structural	|O
genes	|O
fbcF	|B-PROTEIN
,	|O
fbcB	|B-PROTEIN
and	|O
fbcC	|B-PROTEIN
has	|O
been	|O
determined	|O
.	|O

The	|O
N	|O
-	|O
terminal	|O
sequence	|O
of	|O
one	|O
hydrophilic	|O
peptide	|O
of	|O
the	|O
FeS	|B-PROTEIN
protein	|O
has	|O
been	|O
also	|O
obtained	|O
confirming	|O
the	|O
fbcF	|B-PROTEIN
reading	|O
frame	|O
.	|O

The	|O
5'	|O
and	|O
3'	|O
untranslated	|O
sequences	|O
contain	|O
characteristic	|O
sequences	|O
that	|O
are	|O
involved	|O
in	|O
the	|O
initiation	|O
and	|O
termination	|O
of	|O
transcription	|O
,	|O
including	|O
two	|O
possible	|O
promoters	|O
,	|O
one	|O
of	|O
which	|O
may	|O
contain	|O
two	|O
overlapping	|O
-	|O
10	|O
sequences	|O
.	|O

Unlike	|O
P135gag	|B-PROTEIN
-	|O
myb	|B-PROTEIN
-	|O
ets	|B-PROTEIN
and	|O
the	|O
Mr	|O
75,000	|O
translation	|O
product	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
(	|O
P75c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
)	|O
,	|O
which	|O
are	|O
nuclear	|O
proteins	|O
,	|O
P54c	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
was	|O
found	|O
to	|O
be	|O
predominantly	|O
cytoplasmic	|O
.	|O

The	|O
Dox	|B-PROTEIN
-	|I-PROTEIN
A2	|I-PROTEIN
locus	|O
is	|O
within	|O
3.4	|O
to	|O
4.4	|O
kb	|O
of	|O
the	|O
Df	|B-PROTEIN
(	|I-PROTEIN
2L	|I-PROTEIN
)	|I-PROTEIN
OD15	|I-PROTEIN
breakpoint	|O
,	|O
placing	|O
four	|O
of	|O
the	|O
vital	|O
loci	|O
within	|O
a	|O
maximum	|O
of	|O
15.5	|O
kb	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
end	|O
of	|O
this	|O
polypeptide	|O
harbors	|O
three	|O
types	|O
of	|O
repeated	|O
sequences	|O
.	|O

Further	|O
outbreaks	|O
of	|O
ocular	|O
disease	|O
in	|O
farmed	|O
red	|O
deer	|O
calves	|O
caused	|O
by	|O
HVC	|O
-	|O
1	|O
were	|O
investigated	|O
.	|O

From	|O
our	|O
ultrastructural	|O
and	|O
biochemical	|O
studies	|O
,	|O
it	|O
is	|O
evident	|O
that	|O
Type	|O
II	|O
pneumocytes	|O
are	|O
an	|O
early	|O
target	|O
of	|O
radiation	|O
and	|O
the	|O
release	|O
of	|O
surfactant	|O
into	|O
the	|O
alveolus	|O
shortly	|O
after	|O
exposure	|O
persists	|O
for	|O
days	|O
and	|O
weeks	|O
.	|O

Thirty	|O
of	|O
the	|O
clones	|O
contained	|O
a	|O
complete	|O
340	|O
base	|O
-	|O
pair	|O
dimer	|O
unit	|O
of	|O
the	|O
repeat	|O
.	|O

Two	|O
copies	|O
of	|O
the	|O
72	|O
-	|O
bp	|O
repeat	|O
provided	|O
efficient	|O
activation	|O
of	|O
gene	|O
expression	|O
.	|O

The	|O
open	|O
reading	|O
frames	|O
of	|O
rbsD	|B-PROTEIN
,	|O
rbsA	|B-PROTEIN
,	|O
and	|O
rbsC	|B-PROTEIN
encode	|O
proteins	|O
of	|O
139	|O
,	|O
501	|O
,	|O
and	|O
321	|O
amino	|O
acid	|O
residues	|O
,	|O
respectively	|O
.	|O

In	|O
order	|O
to	|O
study	|O
the	|O
influence	|O
of	|O
iron	|O
overload	|O
on	|O
the	|O
polymorphonuclear	|O
leucocyte	|O
(	|O
PMN	|O
)	|O
metabolism	|O
of	|O
patients	|O
on	|O
chronic	|O
hemodialysis	|O
,	|O
generation	|O
of	|O
superoxide	|O
anion	|O
(	|O
O2	|O
-	|O
)	|O
by	|O
PMN	|O
in	|O
whole	|O
blood	|O
was	|O
compared	|O
in	|O
two	|O
groups	|O
of	|O
hemodialyzed	|O
patients	|O
:	|O
group	|O
A	|O
consisted	|O
of	|O
twenty	|O
-	|O
one	|O
individuals	|O
with	|O
serum	|O
ferritin	|B-PROTEIN
levels	|O
above	|O
1000	|O
ng	|O
/	|O
ml	|O
and	|O
group	|O
B	|O
of	|O
nineteen	|O
individuals	|O
with	|O
serum	|O
ferritin	|B-PROTEIN
levels	|O
below	|O
1000	|O
ng	|O
/	|O
ml	|O
.	|O

Cattaneo	|O
,	|O
and	|O
J.	|O

Human	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
A	|I-PROTEIN
:	|O
nucleotide	|O
sequence	|O
of	|O
a	|O
cDNA	|O
clone	|O
encoding	|O
the	|O
mature	|O
enzyme	|O
.	|O

Diazepam	|O
(	|O
3	|O
mg	|O
/	|O
kg	|O
)	|O
generalized	|O
to	|O
Ro	|O
11-6896	|O
whereas	|O
the	|O
structurally	|O
related	|O
Ro	|O
5-4864	|O
(	|O
3	|O
mg	|O
/	|O
kg	|O
and	|O
30	|O
mg	|O
/	|O
kg	|O
)	|O
did	|O
not	|O
.	|O

The	|O
amino	|O
acid	|O
sequence	|O
was	|O
determined	|O
to	|O
be	|O
residues	|O
716-724	|O
and	|O
hence	|O
lysine	|O
residue	|O
721	|O
is	|O
located	|O
within	|O
the	|O
ATP	|O
-	|O
binding	|O
site	|O
.	|O

Osteocalcin	|B-PROTEIN
(	|O
and	|O
urinary	|O
hydroxyproline	|O
)	|O
were	|O
not	|O
elevated	|O
in	|O
isolated	|O
hyperphosphatasaemia	|O
,	|O
indicating	|O
that	|O
mechanisms	|O
other	|O
than	|O
increased	|O
bone	|O
turnover	|O
may	|O
account	|O
for	|O
the	|O
markedly	|O
elevated	|O
serum	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
in	|O
these	|O
subjects	|O
.	|O

Analysis	|O
of	|O
glucocorticoid	|O
unresponsive	|O
cell	|O
variants	|O
using	|O
a	|O
mouse	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
complementary	|O
DNA	|O
clone	|O
.	|O

Among	|O
the	|O
v	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
codons	|O
,	|O
the	|O
first	|O
5	|O
are	|O
derived	|O
from	|O
the	|O
noncoding	|O
5'	|O
terminus	|O
of	|O
the	|O
second	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
exon	|O
,	|O
and	|O
412	|O
codons	|O
correspond	|O
to	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
coding	|O
region	|O
.	|O

A	|O
recombinant	|O
vector	|O
,	|O
p410+	|O
,	|O
was	|O
constructed	|O
which	|O
carried	|O
the	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
K	|I-PROTEIN
fragment	|O
(	|O
nucleotides	|O
107565	|O
to	|O
112625	|O
of	|O
the	|O
B95	|O
-	|O
8	|O
strain	|O
,	|O
encoding	|O
the	|O
EBV	|O
-	|O
associated	|O
nuclear	|O
antigen	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
the	|O
cis	|O
-	|O
acting	|O
sequence	|O
from	|O
the	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
fragment	|O
,	|O
and	|O
a	|O
dominant	|O
selectable	|O
marker	|O
gene	|O
encoding	|O
G	|O
-	|O
418	|O
resistance	|O
in	|O
animal	|O
cells	|O
.	|O

13	|O
men	|O
with	|O
a	|O
history	|O
of	|O
recurrent	|O
genital	|O
herpes	|O
simplex	|O
virus	|O
type	|O
2	|O
(	|O
HSV	|O
-	|O
2	|O
)	|O
infection	|O
were	|O
followed	|O
daily	|O
for	|O
4	|O
weeks	|O
with	|O
samples	|O
taken	|O
from	|O
the	|O
urethra	|O
for	|O
virus	|O
isolation	|O
.	|O

Next	|O
,	|O
with	|O
carcinoma	|O
presenting	|O
a	|O
leather	|O
bottle	|O
(	|O
linitis	|O
plastica	|O
type	|O
)	|O
of	|O
the	|O
stomach	|O
itself	|O
,	|O
the	|O
II	|O
c	|O
portion	|O
of	|O
the	|O
stomach	|O
consisted	|O
of	|O
fundic	|O
glands	|O
(	|O
undifferentiated	|O
carcinoma	|O
)	|O
shall	|O
become	|O
the	|O
primary	|O
focus	|O
supporting	|O
Nakamura	|O
's	|O
theory	|O
.	|O

During	|O
the	|O
biosynthesis	|O
of	|O
all	|O
three	|O
mutant	|O
polypeptides	|O
,	|O
the	|O
signal	|O
peptide	|O
is	|O
efficiently	|O
and	|O
accurately	|O
cleaved	|O
from	|O
the	|O
nascent	|O
protein	|O
,	|O
even	|O
though	|O
in	|O
mutants	|O
X2	|O
and	|O
X3	|O
the	|O
cleavage	|O
site	|O
itself	|O
has	|O
been	|O
altered	|O
.	|O

The	|O
hexanucleotide	|O
5'	|O
-	|O
TGTCCT	|O
-	|O
3'	|O
,	|O
thought	|O
to	|O
be	|O
important	|O
for	|O
GRE	|O
activity	|O
,	|O
not	|O
only	|O
was	|O
found	|O
in	|O
this	|O
sequence	|O
and	|O
in	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
,	|O
but	|O
also	|O
was	|O
present	|O
twice	|O
in	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
gene	|O
that	|O
did	|O
not	|O
show	|O
specific	|O
receptor	|O
binding	|O
.	|O

Five	|O
patients	|O
developed	|O
metastatic	|O
spread	|O
,	|O
and	|O
all	|O
of	|O
them	|O
died	|O
of	|O
tumor	|O
.	|O

The	|O
smallest	|O
of	|O
the	|O
mini	|O
-	|O
Mu	|O
elements	|O
is	|O
only	|O
7.9	|O
kilobase	|O
pairs	|O
long	|O
,	|O
allowing	|O
the	|O
cloning	|O
of	|O
DNA	|O
fragments	|O
of	|O
up	|O
to	|O
31.1	|O
kilobase	|O
pairs	|O
,	|O
and	|O
the	|O
largest	|O
of	|O
them	|O
is	|O
21.7	|O
kilobase	|O
pairs	|O
,	|O
requiring	|O
that	|O
clones	|O
carry	|O
insertions	|O
of	|O
less	|O
than	|O
17.3	|O
kilobase	|O
pairs	|O
.	|O

The	|O
52	|O
-	|O
protein	|O
subunit	|O
of	|O
T4	|O
DNA	|B-PROTEIN
topoisomerase	|I-PROTEIN
is	|O
homologous	|O
to	|O
the	|O
gyrA	|B-PROTEIN
-	|O
protein	|O
of	|O
gyrase	|B-PROTEIN
.	|O

There	|O
were	|O
no	|O
interfering	|O
peaks	|O
in	|O
the	|O
quantitation	|O
of	|O
sulbactam	|O
.	|O

The	|O
latent	|O
periods	|O
from	|O
the	|O
antral	|O
exclusion	|O
to	|O
the	|O
occurrence	|O
of	|O
anastomotic	|O
ulcers	|O
after	|O
a	|O
subtotal	|O
gastrectomy	|O
with	|O
Billroth	|O
's	|O
type	|O
II	|O
reconstruction	|O
varied	|O
from	|O
a	|O
few	|O
days	|O
to	|O
19	|O
years	|O
,	|O
with	|O
an	|O
average	|O
of	|O
2.8	|O
years	|O
.	|O

The	|O
nucleosomal	|O
arrays	|O
detected	|O
by	|O
MPE	|O
X	|O
Fe	|O
(	|O
II	|O
)	|O
were	|O
characterized	|O
by	|O
a	|O
considerable	|O
loss	|O
of	|O
detail	|O
and	|O
significantly	|O
enhanced	|O
accessibility	|O
,	|O
the	|O
extent	|O
of	|O
which	|O
probably	|O
reflected	|O
the	|O
relative	|O
transcription	|O
rate	|O
of	|O
each	|O
gene	|O
.	|O

Translation	|O
of	|O
specific	|O
cellular	|O
genes	|O
from	|O
the	|O
chimeric	|O
viral	|O
-	|O
cellular	|O
transcripts	|O
seems	|O
to	|O
be	|O
unlikely	|O
.	|O

The	|O
molecular	|O
weight	|O
of	|O
in	|O
vivo	|O
-	|O
labeled	|O
proteins	|O
was	|O
increased	|O
relative	|O
to	|O
that	|O
of	|O
in	|O
vitro	|O
-	|O
translated	|O
proteins	|O
,	|O
indicating	|O
that	|O
a	|O
posttranslational	|O
modification	|O
had	|O
occurred	|O
.	|O

Insertion	|O
of	|O
4	|O
bp	|O
reduced	|O
SV40	|B-PROTEIN
early	|I-PROTEIN
promoter	|I-PROTEIN
-	|O
dependent	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
expression	|O
by	|O
six	|O
-	|O
to	|O
eightfold	|O
.	|O

In	|O
the	|O
DNAs	|O
of	|O
all	|O
Ph1	|O
-	|O
positive	|O
chronic	|O
myelocytic	|O
leukemia	|O
patients	|O
studied	|O
to	|O
date	|O
,	|O
a	|O
breakpoint	|O
on	|O
chromosome	|O
22	|O
(	|O
the	|O
Ph1	|O
chromosome	|O
)	|O
can	|O
be	|O
demonstrated	|O
with	|O
a	|O
probe	|O
from	|O
the	|O
bcr	|B-PROTEIN
(	|O
breakpoint	|B-PROTEIN
cluster	|I-PROTEIN
region	|I-PROTEIN
)	|O
.	|O

Nuclease	|O
footprinting	|O
revealed	|O
that	|O
purified	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
bound	|O
at	|O
multiple	|O
discrete	|O
sites	|O
within	|O
and	|O
at	|O
the	|O
borders	|O
of	|O
the	|O
tandemly	|O
repeated	|O
sequence	|O
motif	|O
that	|O
defines	|O
Sa	|B-PROTEIN
.	|O

The	|O
96	|O
-	|O
bp	|O
insert	|O
contained	|O
a	|O
termination	|O
signal	|O
which	|O
caused	|O
the	|O
premature	|O
termination	|O
of	|O
the	|O
protein	|O
,	|O
leading	|O
to	|O
the	|O
generation	|O
of	|O
a	|O
p53	|B-PROTEIN
product	|O
9	|O
amino	|O
acids	|O
shorter	|O
than	|O
usual	|O
.	|O

All	|O
tumors	|O
proved	|O
histologically	|O
to	|O
be	|O
neuroendocrine	|O
in	|O
origin	|O
.	|O

The	|O
coding	|O
region	|O
of	|O
2385	|O
nucleotides	|O
corresponds	|O
to	|O
a	|O
polypeptide	|O
chain	|O
of	|O
795	|O
amino	|O
acids	|O
,	|O
giving	|O
a	|O
molecular	|O
weight	|O
of	|O
91,555	|O
for	|O
the	|O
hsp108	|B-PROTEIN
protein	|O
.	|O

Transcriptional	|O
control	|O
signals	|O
of	|O
a	|O
herpes	|O
simplex	|O
virus	|O
type	|O
1	|O
late	|O
(	|O
gamma	|B-PROTEIN
2	|I-PROTEIN
)	|O
gene	|O
lie	|O
within	|O
bases	|O
-	|O
34	|O
to	|O
+	|O
124	|O
relative	|O
to	|O
the	|O
5'	|O
terminus	|O
of	|O
the	|O
mRNA	|O
.	|O

A	|O
noncatalytic	|O
domain	|O
conserved	|O
among	|O
cytoplasmic	|O
protein	|O
-	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
modifies	|O
the	|O
kinase	|O
function	|O
and	|O
transforming	|O
activity	|O
of	|O
Fujinami	|B-PROTEIN
sarcoma	|I-PROTEIN
virus	|I-PROTEIN
P130gag	|I-PROTEIN
-	|O
fps	|B-PROTEIN
.	|O

Gluzman	|O
,	|O
EMBO	|O
J.	|O

A	|O
single	|O
exon	|O
encodes	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
26	|O
amino	|O
acids	|O
of	|O
the	|O
ssd	|B-PROTEIN
chain	|O
and	|O
the	|O
3'	|O
untranslated	|O
region	|O
of	|O
its	|O
mRNA	|O
,	|O
ending	|O
with	|O
a	|O
poly	|O
(	|O
A	|O
)	|O
-	|O
addition	|O
site	|O
.	|O

The	|O
5'	|O
-	|O
nontranslated	|O
sequences	|O
and	|O
parts	|O
of	|O
the	|O
coding	|O
sequences	|O
of	|O
various	|O
yeast	|O
genes	|O
have	|O
been	|O
cloned	|O
into	|O
representative	|O
lacZ	|B-PROTEIN
fusion	|O
vectors	|O
.	|O

Two	|O
activities	|O
of	|O
the	|O
D	|B-PROTEIN
protein	|I-PROTEIN
of	|O
the	|O
miniF	|O
plasmid	|O
have	|O
been	|O
found	|O
.	|O

SPECT	|O
examination	|O
of	|O
the	|O
TMJ	|O
using	|O
99m	|O
Tc	|O
-	|O
MDP	|O
was	|O
performed	|O
in	|O
43	|O
patients	|O
with	|O
arthrographically	|O
proven	|O
anterior	|O
dislocation	|O
of	|O
the	|O
disc	|O
and	|O
in	|O
30	|O
normals	|O
.	|O

Plasma	|O
renin	|B-PROTEIN
activity	|O
rose	|O
and	|O
the	|O
plasma	|O
aldosterone	|O
level	|O
fell	|O
after	|O
taking	|O
lisinopril	|O
.	|O

Two	|O
mutants	|O
,	|O
each	|O
representative	|O
of	|O
a	|O
separate	|O
pet	|B-PROTEIN
complementation	|O
group	|O
,	|O
have	|O
been	|O
analyzed	|O
.	|O

The	|O
second	|O
group	|O
of	|O
homologous	|O
elements	|O
is	|O
present	|O
in	|O
the	|O
upstream	|O
region	|O
of	|O
both	|O
genes	|O
.	|O

A	|O
centromere	|O
in	|O
S.	|O
cerevisiae	|O
consists	|O
of	|O
a	|O
region	|O
of	|O
DNA	|O
,	|O
approximately	|O
150	|O
bp	|O
in	|O
length	|O
,	|O
containing	|O
three	|O
important	|O
sequence	|O
elements	|O
,	|O
which	|O
are	|O
folded	|O
with	|O
proteins	|O
into	|O
a	|O
specific	|O
conformation	|O
in	|O
the	|O
chromatin	|O
(	|O
the	|O
yeast	|O
kinetochore	|O
)	|O
.	|O

Constitutive	|O
function	|O
of	|O
a	|O
positively	|O
regulated	|O
promoter	|O
reveals	|O
new	|O
sequences	|O
essential	|O
for	|O
activity	|O
.	|O

Two	|O
separate	|O
NF1	|B-PROTEIN
-	|O
binding	|O
loci	|O
were	|O
also	|O
found	|O
in	|O
the	|O
equivalent	|O
IE68	|B-PROTEIN
gene	|O
of	|O
HCMV	|O
(	|O
Towne	|O
)	|O
DNA	|O
,	|O
but	|O
in	|O
this	|O
case	|O
the	|O
DNA	|O
sequence	|O
and	|O
competition	|O
filter	|O
binding	|O
experiments	|O
indicated	|O
a	|O
maximum	|O
of	|O
only	|O
four	|O
to	|O
five	|O
consensus	|O
binding	|O
sites	|O
encompassing	|O
the	|O
promoter	|O
-	|O
enhancer	|O
region	|O
.	|O

The	|O
previously	|O
described	|O
four	|O
sets	|O
of	|O
13	|O
-	|O
to	|O
18	|O
-	|O
base	|O
-	|O
pair	|O
interspersed	|O
repeat	|O
elements	|O
between	|O
-	|O
55	|O
and	|O
-	|O
580	|O
provide	|O
most	|O
of	|O
the	|O
high	|O
basal	|O
transcriptional	|O
strength	|O
,	|O
whereas	|O
the	|O
arrangement	|O
of	|O
further	|O
upstream	|O
tandemly	|O
repeated	|O
NF1	|B-PROTEIN
-	|O
binding	|O
sites	|O
may	|O
contribute	|O
significantly	|O
to	|O
the	|O
expanded	|O
biological	|O
host	|O
range	|O
for	|O
expression	|O
of	|O
SCMV	|O
IE94	|B-PROTEIN
compared	|O
with	|O
HCMV	|O
IE68	|B-PROTEIN
.	|O

We	|O
inserted	|O
genes	|O
or	|O
gene	|O
segments	|O
,	|O
that	|O
code	|O
for	|O
the	|O
bacterial	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
,	|O
the	|O
bacterial	|O
gene	|O
conferring	|O
resistance	|O
against	|O
hygromycin	|O
,	|O
and	|O
the	|O
ORF	|O
E7	|B-PROTEIN
of	|O
the	|O
human	|O
papillomavirus	|O
type	|O
18	|O
into	|O
these	|O
vectors	|O
.	|O

By	|O
contrast	|O
,	|O
their	|O
basal	|O
adrenal	|O
androgen	|O
levels	|O
were	|O
significantly	|O
decreased	|O
compared	|O
to	|O
those	|O
in	|O
normal	|O
subjects	|O
on	|O
both	|O
the	|O
day	|O
on	|O
and	|O
the	|O
day	|O
off	|O
prednisone	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Active	|O
lambda	|B-PROTEIN
and	|I-PROTEIN
kappa	|I-PROTEIN
antibody	|I-PROTEIN
gene	|O
rearrangement	|O
in	|O
Abelson	|O
murine	|O
leukemia	|O
virus	|O
-	|O
transformed	|O
pre	|O
-	|O
B	|O
cell	|O
lines	|O
.	|O

Identification	|O
of	|O
p40x	|O
-	|O
responsive	|O
regulatory	|O
sequences	|O
within	|O
the	|O
human	|O
T	|O
-	|O
cell	|O
leukemia	|O
virus	|O
type	|O
I	|O
long	|O
terminal	|O
repeat	|O
.	|O

During	|O
pentobarbital	|O
anesthesia	|O
,	|O
the	|O
basal	|O
VO2	|O
was	|O
5.26	|O
ml	|O
/	|O
kg	|O
/	|O
min	|O
and	|O
was	|O
increased	|O
by	|O
epinephrine	|O
in	|O
a	|O
dose	|O
dependent	|O
manner	|O
at	|O
plasma	|O
concentrations	|O
between	|O
3.9	|O
ng	|O
/	|O
ml	|O
(	|O
VO2	|O
=	|O
5.68	|O
ml	|O
/	|O
kg	|O
/	|O
min	|O
)	|O
and	|O
36.5	|O
ng	|O
/	|O
ml	|O
(	|O
VO2	|O
=	|O
6.47	|O
ml	|O
/	|O
kg	|O
/	|O
min	|O
)	|O
.	|O

Influence	|O
of	|O
cyclo	|B-PROTEIN
-	|I-PROTEIN
oxygenase	|I-PROTEIN
inhibition	|O
and	|O
of	|O
leukotriene	|B-PROTEIN
receptor	|I-PROTEIN
blockade	|O
on	|O
pulmonary	|O
vascular	|O
pressure	|O
/	|O
cardiac	|O
index	|O
relationships	|O
in	|O
hyperoxic	|O
and	|O
in	|O
hypoxic	|O
dogs	|O
.	|O

Oligonucleotide	|O
-	|O
directed	|O
mutagenesis	|O
was	|O
used	|O
to	|O
create	|O
an	|O
NdeI	|B-PROTEIN
restriction	|O
site	|O
at	|O
the	|O
natural	|O
ATG	|O
of	|O
the	|O
yeast	|O
R.	|O

ACTH	|B-PROTEIN
release	|O
is	|O
transiently	|O
suppressed	|O
in	|O
some	|O
children	|O
after	|O
exogenous	|O
ACTH	|B-PROTEIN
treatment	|O
.	|O

We	|O
previously	|O
showed	|O
that	|O
the	|O
upstream	|O
promoter	|O
element	|O
of	|O
the	|O
yeast	|O
RP39A	|B-PROTEIN
gene	|O
consists	|O
of	|O
these	|O
identical	|O
sequence	|O
motifs	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
mammalian	|O
erythroid	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
spectrin	|I-PROTEIN
evolved	|O
by	|O
duplication	|O
and	|O
rapid	|O
divergence	|O
from	|O
an	|O
ancestral	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
fodrin	|I-PROTEIN
-	|O
like	|O
gene	|O
.	|O

Northern	|O
analyses	|O
of	|O
RNAs	|O
from	|O
mouse	|O
tissues	|O
and	|O
cell	|O
lines	|O
indicated	|O
that	|O
p11	|B-PROTEIN
mRNA	|O
levels	|O
vary	|O
widely	|O
.	|O

One	|O
group	|O
of	|O
six	|O
cDNA	|O
clones	|O
was	|O
derived	|O
from	|O
a	|O
2.9	|O
-	|O
kilobase	|O
early	|O
transcript	|O
encoded	|O
by	|O
the	|O
IR2	|O
repeat	|O
element	|O
and	|O
showed	|O
restriction	|O
site	|O
polymorphism	|O
for	|O
the	|O
enzyme	|O
SmaI	|B-PROTEIN
.	|O

Combined	|O
immunochemotherapy	|O
with	|O
cyclophosphamide	|O
plus	|O
BCG	|O
gave	|O
a	|O
better	|O
enhancement	|O
of	|O
the	|O
antitumor	|O
effect	|O
of	|O
the	|O
cytostatic	|O
than	|O
that	|O
of	|O
the	|O
combination	|O
of	|O
methotrexate	|O
plus	|O
BCG	|O
and	|O
cyclophosphamide	|O
plus	|O
levamisole	|O
.	|O

Morphine	|O
produced	|O
a	|O
dose	|O
-	|O
dependent	|O
bradycardia	|O
followed	|O
by	|O
tachycardia	|O
.	|O

The	|O
PSS	|B-PROTEIN
gene	|O
was	|O
subcloned	|O
into	|O
a	|O
1.1	|O
-	|O
kb	|O
fragment	|O
of	|O
the	|O
yeast	|O
DNA	|O
on	|O
the	|O
YEp13	|O
vector	|O
.	|O

Indeed	|O
,	|O
A	|O
-	|O
MuLV	|O
pseudotyped	|O
with	|O
some	|O
viruses	|O
,	|O
such	|O
as	|O
the	|O
Moloney	|O
MuLV	|O
,	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
highly	|O
lymphogenic	|O
,	|O
whereas	|O
A	|O
-	|O
MuLV	|O
pseudotyped	|O
with	|O
other	|O
viruses	|O
,	|O
such	|O
as	|O
the	|O
BALB	|O
/	|O
c	|O
endogenous	|O
N	|O
-	|O
tropic	|O
MuLV	|O
,	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
devoid	|O
of	|O
lymphogenic	|O
potential	|O
(	|O
N.	|O

The	|O
presence	|O
of	|O
circulating	|O
platelet	|O
aggregates	|O
and	|O
elevated	|O
levels	|O
of	|O
fibrinopeptide	|B-PROTEIN
A	|I-PROTEIN
(	|O
a	|O
cleavage	|O
product	|O
of	|O
fibrin	|B-PROTEIN
)	|O
suggests	|O
that	|O
platelet	|O
activation	|O
and	|O
fibrin	|B-PROTEIN
deposition	|O
may	|O
play	|O
a	|O
role	|O
in	|O
the	|O
pathogenesis	|O
of	|O
this	|O
disorder	|O
.	|O

The	|O
gene	|O
is	|O
essential	|O
for	|O
yeast	|O
vegetative	|O
growth	|O
.	|O

4	|O
.	|O

In	|O
general	|O
,	|O
the	|O
values	|O
obtained	|O
by	|O
the	|O
two	|O
methods	|O
were	|O
in	|O
agreement	|O
for	|O
each	|O
species	|O
of	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
and	|O
followed	|O
the	|O
order	|O
:	|O
wild	|O
type	|O
greater	|O
than	|O
Glu24	|O
-	|O
-	|O
-	|O
-	|O
Gly	|O
greater	|O
than	|O
Asp27	|O
-	|O
-	|O
-	|O
-	|O
Gly	|O
much	|O
greater	|O
than	|O
Pro7	|O
-	|O
-	|O
-	|O
-	|O
Thr	|O
greater	|O
than	|O
Tyr29	|O
-	|O
-	|O
-	|O
-	|O
Gly	|O
greater	|O
than	|O
Leu47	|O
-	|O
-	|O
-	|O
-	|O
His	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
suppression	|O
of	|O
elevated	|O
prolactin	|B-PROTEIN
levels	|O
in	|O
progressive	|O
metastatic	|O
breast	|O
cancer	|O
patients	|O
is	|O
not	|O
effective	|O
in	|O
restoring	|O
tumor	|O
sensitivity	|O
to	|O
chemotherapy	|O
.	|O

We	|O
report	|O
a	|O
prevalence	|O
study	|O
of	|O
the	|O
best	|O
visual	|O
acuity	|O
in	|O
the	|O
affected	|O
eye	|O
of	|O
100	|O
selected	|O
patients	|O
with	|O
herpetic	|O
keratitis	|O
seen	|O
during	|O
a	|O
two	|O
-	|O
year	|O
period	|O
.	|O

We	|O
also	|O
found	|O
an	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
4A	|I-PROTEIN
intronless	|O
retroposon	|O
which	|O
,	|O
when	|O
compared	|O
to	|O
the	|O
cDNA	|O
,	|O
contains	|O
a	|O
single	|O
nucleotide	|O
difference	|O
.	|O

Bacteriologic	|O
culture	|O
of	|O
pancreatic	|O
tissue	|O
was	|O
positive	|O
in	|O
6/8	|O
IB	|O
and	|O
3/17	|O
NIB	|O
rats	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

These	|O
similarities	|O
suggest	|O
that	|O
these	|O
E2	|B-PROTEIN
proteins	|O
are	|O
structurally	|O
and	|O
evolutionarily	|O
related	|O
.	|O

After	|O
infection	|O
of	|O
293	|O
cells	|O
(	|O
which	|O
provide	|O
complementary	|O
E1a	|B-PROTEIN
-	|O
E1b	|B-PROTEIN
functions	|O
)	|O
,	|O
both	|O
viruses	|O
directed	|O
equal	|O
amounts	|O
of	|O
P	|B-PROTEIN
/	|I-PROTEIN
C	|I-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
mRNA	|I-PROTEIN
transcription	|O
.	|O

This	|O
observation	|O
cannot	|O
be	|O
explained	|O
by	|O
the	|O
scanning	|O
model	|O
for	|O
ribosomal	|O
initiation	|O
and	|O
suggests	|O
that	|O
ribosomes	|O
may	|O
be	|O
binding	|O
directly	|O
at	|O
an	|O
internal	|O
mRNA	|O
site	|O
at	|O
or	|O
near	|O
the	|O
initiator	|O
AUG	|O
codon	|O
for	|O
the	|O
C	|B-PROTEIN
protein	|I-PROTEIN
.	|O

In	|O
view	|O
of	|O
these	|O
results	|O
,	|O
simultaneous	|O
pancreas	|O
-	|O
kidney	|O
transplantation	|O
appears	|O
to	|O
be	|O
the	|O
treatment	|O
of	|O
choice	|O
for	|O
Type	|O
I	|O
diabetic	|O
patients	|O
.	|O

This	|O
makes	|O
these	|O
compounds	|O
attractive	|O
as	|O
vehicles	|O
for	|O
these	|O
and	|O
other	|O
gases	|O
in	|O
-	|O
vivo	|O
and	|O
in	|O
-	|O
vitro	|O
.	|O

DNA	|O
sequencing	|O
of	|O
the	|O
DPM1	|B-PROTEIN
gene	|O
revealed	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
801	|O
bases	|O
.	|O

The	|O
relationship	|O
between	|O
primary	|O
malignant	|O
lymphoma	|O
of	|O
the	|O
thyroid	|O
and	|O
chronic	|O
thyroiditis	|O
is	|O
discussed	|O
.	|O

Administration	|O
of	|O
anticoagulants	|O
,	|O
i.e.	|O
,	|O
heparin	|O
,	|O
prostaglandin	|O
E1	|O
and	|O
ticlopidine	|O
seems	|O
to	|O
be	|O
effective	|O
in	|O
alleviating	|O
symptoms	|O
and	|O
might	|O
prevent	|O
further	|O
deterioration	|O
.	|O

Mutational	|O
analysis	|O
of	|O
the	|O
L1	|B-PROTEIN
binding	|O
site	|O
of	|O
23S	|B-PROTEIN
rRNA	|I-PROTEIN
in	|O
Escherichia	|O
coli	|O
.	|O

Animals	|O
may	|O
be	|O
immunized	|O
by	|O
oral	|O
vaccination	|O
,	|O
but	|O
natural	|O
mechanisms	|O
that	|O
also	|O
can	|O
terminate	|O
outbreaks	|O
are	|O
discussed	|O
.	|O

Prostacyclin	|O
formation	|O
,	|O
reflected	|O
by	|O
the	|O
excretion	|O
rate	|O
of	|O
its	|O
stable	|O
metabolite	|O
6	|O
-	|O
keto	|O
-	|O
prostaglandin	|O
F1	|O
alpha	|O
,	|O
was	|O
measured	|O
by	|O
means	|O
of	|O
radioimmunoassay	|O
in	|O
4	|O
-	|O
hour	|O
urine	|O
specimens	|O
obtained	|O
during	|O
a	|O
smoking	|O
-	|O
free	|O
period	|O
and	|O
after	|O
participants	|O
had	|O
inhaled	|O
smoke	|O
from	|O
four	|O
high	|O
-	|O
nicotine	|O
cigarettes	|O
.	|O

However	|O
,	|O
excretion	|O
of	|O
6	|O
-	|O
keto	|O
-	|O
prostaglandin	|O
F1	|O
alpha	|O
was	|O
further	|O
reduced	|O
in	|O
the	|O
smokers	|O
who	|O
used	|O
oral	|O
contraceptives	|O
(	|O
133	|O
+	|O
/	|O
-	|O
20	|O
to	|O
86	|O
+	|O
/	|O
-	|O
9	|O
ng	|O
/	|O
gm	|O
of	|O
creatinine	|O
,	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

The	|O
in	|O
vitro	|O
activity	|O
of	|O
mecillinam	|O
and	|O
amoxicillin	|O
/	|O
clavulanic	|O
acid	|O
against	|O
Escherichia	|O
coli	|O
strains	|O
producing	|O
beta	|B-PROTEIN
-	|I-PROTEIN
lactamases	|I-PROTEIN
of	|O
the	|O
TEM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
Oxa	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
chromosomal	|O
type	|O
were	|O
studied	|O
using	|O
the	|O
broth	|O
and	|O
agar	|O
dilution	|O
technique	|O
.	|O

GCN4	|B-PROTEIN
encodes	|O
a	|O
transcriptional	|O
activator	|O
of	|O
amino	|O
acid	|O
biosynthetic	|O
genes	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

These	|O
results	|O
imply	|O
that	|O
the	|O
GCN3	|B-PROTEIN
product	|O
can	|O
promote	|O
either	|O
repression	|O
or	|O
activation	|O
of	|O
GCN4	|B-PROTEIN
expression	|O
depending	|O
on	|O
amino	|O
acid	|O
availability	|O
.	|O

The	|O
efficacy	|O
of	|O
these	|O
immunosuppressive	|O
drugs	|O
is	|O
clinical	|O
proven	|O
.	|O

The	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
S.	|O
aureus	|O
peptide	|O
carrying	|O
the	|O
phosphoryl	|O
group	|O
was	|O
found	|O
to	|O
be	|O
Gln	|O
-	|O
Val	|O
-	|O
Val	|O
-	|O
Ser	|O
-	|O
Thr	|O
-	|O
Phe	|O
-	|O
Met	|O
-	|O
Gly	|O
-	|O
Asn	|O
-	|O
Gly	|O
-	|O
Leu	|O
-	|O
Ala	|O
-	|O
Ile	|O
-	|O
Pro	|O
-	|O
His	|O
-	|O
Gly	|O
-	|O
Thr	|O
-	|O
Asp	|O
-	|O
Asp	|O
.	|O

These	|O
mutations	|O
alter	|O
two	|O
regions	|O
of	|O
GAL4	|B-PROTEIN
protein	|O
:	|O
the	|O
DNA	|O
binding	|O
domain	|O
,	|O
and	|O
the	|O
transcription	|O
activation	|O
domain	|O
.	|O

The	|O
results	|O
indicated	|O
that	|O
two	|O
genes	|O
(	|O
citA	|B-PROTEIN
and	|O
citB	|B-PROTEIN
)	|O
have	|O
separate	|O
promoters	|O
,	|O
and	|O
the	|O
location	|O
of	|O
the	|O
promoter	|O
for	|O
the	|O
citB	|B-PROTEIN
gene	|O
in	|O
the	|O
Tn3411	|B-PROTEIN
nucleotide	|O
sequence	|O
was	|O
different	|O
from	|O
that	|O
in	|O
pMS185	|O
.	|O

The	|O
rci	|B-PROTEIN
gene	|O
was	|O
fused	|O
with	|O
lacZ	|B-PROTEIN
and	|O
its	|O
gene	|O
product	|O
was	|O
identified	|O
by	|O
Western	|O
blot	|O
analysis	|O
.	|O

Structure	|O
and	|O
regulation	|O
of	|O
a	|O
nuclear	|O
gene	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
that	|O
specifies	|O
MRP13	|B-PROTEIN
,	|O
a	|O
protein	|O
of	|O
the	|O
small	|O
subunit	|O
of	|O
the	|O
mitochondrial	|O
ribosome	|O
.	|O

After	|O
a	|O
survey	|O
of	|O
the	|O
anatomical	|O
and	|O
physiological	|O
basis	|O
of	|O
operative	|O
treatment	|O
of	|O
behaviour	|O
disorders	|O
by	|O
stereotactic	|O
lesions	|O
in	|O
the	|O
amygdala	|O
and	|O
the	|O
posterior	|O
medial	|O
hypothalamus	|O
the	|O
author	|O
describes	|O
his	|O
own	|O
experiences	|O
with	|O
603	|O
operations	|O
for	|O
control	|O
of	|O
conservatively	|O
untreatable	|O
aggressiveness	|O
.	|O

Histological	|O
examination	|O
revealed	|O
a	|O
small	|O
simple	|O
renal	|O
cyst	|O
associated	|O
with	|O
renal	|O
cell	|O
carcinoma	|O
.	|O

Although	|O
large	|O
epidemiologic	|O
studies	|O
are	|O
best	|O
able	|O
to	|O
identify	|O
the	|O
relative	|O
contributions	|O
of	|O
specific	|O
risk	|O
factors	|O
while	|O
controlling	|O
for	|O
other	|O
risk	|O
factors	|O
,	|O
new	|O
studies	|O
need	|O
to	|O
focus	|O
on	|O
important	|O
unresolved	|O
questions	|O
.	|O

Thus	|O
,	|O
prostacyclin	|O
enhanced	|O
the	|O
autoregulative	|O
property	|O
of	|O
the	|O
inner	|O
ear	|O
vessels	|O
.	|O

The	|O
method	|O
is	|O
accurate	|O
,	|O
with	|O
good	|O
precision	|O
and	|O
adequate	|O
sensitivity	|O
.	|O

Factors	|O
influencing	|O
the	|O
bond	|O
strength	|O
between	|O
glass	|O
polyalkenoate	|O
(	|O
ionomer	|O
)	|O
cements	|O
and	|O
dentine	|O
.	|O

The	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
yeast	|O
and	|O
mammalian	|O
mitochondrial	|O
targeting	|O
sequences	|O
are	|O
similar	|O
but	|O
less	|O
related	|O
than	|O
the	|O
mature	|O
polypeptides	|O
.	|O

Van	|O
der	|O
Ende	|O
,	|O
R.	|O

During	|O
insulin	|B-PROTEIN
infusion	|O
,	|O
a	|O
20%	|O
dextrose	|O
solution	|O
was	|O
infused	|O
by	|O
a	|O
Biostator	|O
in	|O
order	|O
to	|O
maintain	|O
the	|O
patient	|O
's	|O
glycemia	|O
at	|O
90	|O
mg	|O
/	|O
dl	|O
.	|O

Amounts	|O
of	|O
glucose	|O
infused	|O
during	|O
the	|O
last	|O
20	|O
min	|O
of	|O
each	|O
2	|O
hour	|O
insulin	|B-PROTEIN
infusion	|O
were	|O
(	|O
at	|O
1	|O
and	|O
10	|O
m	|O
/	|O
kg	|O
/	|O
min	|O
respectively	|O
)	|O
:	|O
before	|O
treatment	|O
(	|O
K+	|O
=	|O
2.7	|O
mmol	|O
/	|O
l	|O
)	|O
:	|O
2.4	|O
and	|O
8.4	|O
mg	|O
/	|O
kg	|O
/	|O
min	|O
;	|O
after	|O
spironolactone	|O
(	|O
K+	|O
=	|O
3.9	|O
mmol	|O
/	|O
l	|O
)	|O
:	|O
3.3	|O
and	|O
15.4	|O
mg	|O
/	|O
kg	|O
/	|O
min	|O
;	|O
after	|O
indomethacine	|O
(	|O
K+	|O
=	|O
3.7	|O
mmol	|O
/	|O
l	|O
)	|O
:	|O
5	|O
and	|O
19	|O
mg	|O
/	|O
kg	|O
/	|O
min	|O
after	|O
stopping	|O
drugs	|O
(	|O
K+	|O
=	|O
2.9	|O
mmol	|O
/	|O
l	|O
)	|O
:	|O
2.5	|O
and	|O
5.3	|O
mg	|O
/	|O
kg	|O
/	|O
min	|O
.	|O

Mycobacterium	|O
avium	|O
-	|O
intracellulare	|O
complex	|O
infections	|O
in	|O
the	|O
acquired	|O
immunodeficiency	|O
syndrome	|O
.	|O

Recurrence	|O
of	|O
oxalate	|O
deposition	|O
in	|O
a	|O
renal	|O
transplant	|O
during	|O
ciclosporin	|O
A	|O
therapy	|O
.	|O

The	|O
bile	|O
acid	|O
sequestrants	|O
(	|O
cholestyramine	|O
and	|O
colestipol	|O
)	|O
,	|O
nicotinic	|O
acid	|O
,	|O
fenofibrate	|O
and	|O
inhibitors	|O
of	|O
hydroxymethylglutaryl	|O
coenzyme	|O
A	|O
(	|B-PROTEIN
HMG	|I-PROTEIN
CoA	|I-PROTEIN
)	|I-PROTEIN
reductase	|I-PROTEIN
(	|O
e.g.	|O
lovastatin	|O
or	|O
simvastatin	|O
)	|O
are	|O
the	|O
most	|O
effective	|O
drugs	|O
for	|O
use	|O
in	|O
patients	|O
with	|O
primary	|O
hypercholesterolaemia	|O
;	|O
these	|O
agents	|O
reduce	|O
plasma	|O
concentrations	|O
of	|O
total	|O
and	|O
LDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
by	|O
15	|O
to	|O
45%	|O
.	|O

Finally	|O
,	|O
the	|O
pathophysiological	|O
aspects	|O
of	|O
urinary	|O
acidification	|O
are	|O
discussed	|O
,	|O
focusing	|O
on	|O
renal	|O
tubular	|O
acidosis	|O
models	|O
(	|O
induced	|O
by	|O
maleate	|O
and	|O
amphotericin	|O
B	|O
treatment	|O
)	|O
and	|O
their	|O
cellular	|O
mechanisms	|O
,	|O
as	|O
well	|O
as	|O
the	|O
role	|O
of	|O
adrenal	|O
steroids	|O
in	|O
urinary	|O
acidification	|O
.	|O

Analysis	|O
in	|O
3	|O
groups	|O
of	|O
patients	|O
suffering	|O
from	|O
simple	|O
acute	|O
and	|O
pernicious	|O
malarial	|O
flare	|O
-	|O
ups	|O

Statement	|O
on	|O
the	|O
development	|O
of	|O
guidelines	|O
for	|O
the	|O
prevention	|O
of	|O
AIDS	|O
transmission	|O
in	|O
the	|O
workplace	|O
.	|O

Modifications	|O
of	|O
the	|O
involuntary	|O
postcontraction	|O
in	|O
diseased	|O
people	|O
.	|O

Cocaine	|O
-	|O
treated	|O
rats	|O
acquired	|O
a	|O
preference	|O
for	|O
cocaine	|O
-	|O
associated	|O
contextual	|O
stimuli	|O
(	|O
CS	|O
)	|O
relative	|O
to	|O
saline	|O
-	|O
injected	|O
control	|O
rats	|O
.	|O

Under	|O
these	|O
schedules	|O
,	|O
a	|O
reinforced	|O
response	|O
run	|O
consisted	|O
of	|O
responding	|O
between	|O
eight	|O
and	|O
12	|O
times	|O
on	|O
one	|O
response	|O
key	|O
(	|O
work	|O
key	|O
)	|O
and	|O
then	|O
responding	|O
once	|O
on	|O
a	|O
second	|O
response	|O
key	|O
(	|O
reinforced	|O
key	|O
)	|O
.	|O

Intravenous	|O
glucose	|O
tolerance	|O
tests	|O
were	|O
performed	|O
before	|O
operation	|O
,	|O
before	|O
starting	|O
CyA	|O
and	|O
after	|O
3	|O
weeks	|O
.	|O

The	|O
effects	|O
of	|O
glutaraldehyde	|O
on	|O
dimensions	|O
and	|O
ultrastructure	|O
of	|O
microvascular	|O
beds	|O
in	|O
rat	|O
mesentery	|O
were	|O
studied	|O
in	|O
two	|O
kinds	|O
of	|O
experiment	|O
,	|O
administering	|O
the	|O
fixative	|O
by	|O
intra	|O
-	|O
arterial	|O
perfusion	|O
at	|O
a	|O
pressure	|O
of	|O
80	|O
mm	|O
Hg	|O
and	|O
by	|O
superfusion	|O
of	|O
the	|O
exteriorized	|O
mesenteric	|O
membrane	|O
.	|O

This	|O
gave	|O
rise	|O
to	|O
RNA	|O
molecules	|O
with	|O
3'	|O
-	|O
untranslated	|O
regions	|O
of	|O
roughly	|O
375	|O
,	|O
655	|O
,	|O
and	|O
945	|O
base	|O
pairs	|O
.	|O

Also	|O
,	|O
the	|O
BALB	|B-PROTEIN
/	|I-PROTEIN
c	|I-PROTEIN
gene	|O
contains	|O
a	|O
single	|O
substitution	|O
in	|O
a	|O
conserved	|O
octamer	|O
sequence	|O
approximately	|O
equal	|O
to	|O
100	|O
nucleotides	|O
upstream	|O
of	|O
the	|O
coding	|O
region	|O
,	|O
which	|O
could	|O
affect	|O
its	|O
expression	|O
.	|O

Clinical	|O
findings	|O
were	|O
:	|O
height	|O
183	|O
cm	|O
,	|O
weight	|O
62	|O
kg	|O
,	|O
increased	|O
length	|O
of	|O
lower	|O
limbs	|O
,	|O
P2	|O
-	|O
A2	|O
pilosity	|O
and	|O
micropenis	|O
.	|O

Our	|O
data	|O
suggest	|O
that	|O
it	|O
may	|O
be	|O
possible	|O
to	|O
individualize	|O
hCG	|B-PROTEIN
administration	|O
at	|O
midcycle	|O
by	|O
determining	|O
the	|O
number	|O
of	|O
follicles	|O
greater	|O
than	|O
1	|O
cm	|O
by	|O
ultrasound	|O
on	|O
cycle	|O
day	|O
12	|O
or	|O
13	|O
and	|O
giving	|O
hCG	|B-PROTEIN
when	|O
serum	|O
E2	|O
levels	|O
reach	|O
1100	|O
to	|O
1200	|O
pmol	|O
/	|O
l	|O
per	|O
follicle	|O
.	|O

The	|O
8	|O
patients	|O
receiving	|O
Ir192	|O
implant	|O
in	|O
addition	|O
to	|O
external	|O
radiation	|O
showed	|O
improved	|O
(	|O
p	|O
=	|O
0.06	|O
)	|O
survival	|O
compared	|O
to	|O
the	|O
9	|O
receiving	|O
external	|O
only	|O
:	|O
median	|O
15	|O
months	|O
(	|O
range	|O
1.5-34	|O
+	|O
months	|O
)	|O
versus	|O
7	|O
months	|O
(	|O
range	|O
2.5-21	|O
months	|O
)	|O
.	|O

Within	|O
Stage	|O
IA	|O
,	|O
141	|O
patients	|O
had	|O
well	|O
differentiated	|O
tumor	|O
(	|O
G1	|O
)	|O
,	|O
20	|O
had	|O
moderately	|O
well	|O
differentiated	|O
tumor	|O
(	|O
G2	|O
)	|O
,	|O
and	|O
12	|O
patients	|O
had	|O
poorly	|O
differentiated	|O
(	|O
G3	|O
)	|O
.	|O

Mechanism	|O
of	|O
the	|O
t	|O
(	|O
14	|O
;	|O
18	|O
)	|O
chromosomal	|O
translocation	|O
:	|O
structural	|O
analysis	|O
of	|O
both	|O
derivative	|O
14	|O
and	|O
18	|O
reciprocal	|O
partners	|O
.	|O

After	|O
age	|O
30	|O
,	|O
mean	|O
hemoglobin	|B-PROTEIN
levels	|O
for	|O
men	|O
gradually	|O
declined	|O
,	|O
while	|O
those	|O
in	|O
women	|O
rose	|O
,	|O
so	|O
that	|O
the	|O
sex	|O
difference	|O
diminished	|O
after	|O
60	|O
years	|O
of	|O
age	|O
.	|O

Ritanserin	|O
is	|O
a	|O
new	|O
substance	|O
with	|O
highly	|O
selective	|O
blocking	|O
activity	|O
on	|O
S2	|B-PROTEIN
receptors	|I-PROTEIN
for	|O
5	|O
-	|O
HT	|O
in	|O
the	|O
central	|O
nervous	|O
system	|O
.	|O

Ethylene	|O
glycol	|O
and	|O
diethylene	|O
glycol	|O
were	|O
each	|O
administered	|O
once	|O
weekly	|O
subcutaneously	|O
to	|O
groups	|O
of	|O
100	|O
female	|O
NMRI	|O
mice	|O
at	|O
3	|O
dosages	|O
(	|O
30	|O
;	|O
10	|O
und	|O
3	|O
mg	|O
single	|O
dose	|O
per	|O
mouse	|O
)	|O
.	|O

Research	|O
on	|O
ethylene	|O
glycol	|O
and	|O
diethylene	|O
glycol	|O
for	|O
carcinogenic	|O
effects	|O

The	|O
results	|O
suggest	|O
that	|O
the	|O
greater	|O
estrogenic	|O
influence	|O
associated	|O
with	|O
the	|O
ethinyl	|O
estradiol	|O
-	|O
containing	|O
OC	|O
resulted	|O
in	|O
inhibition	|O
of	|O
coronary	|O
artery	|O
atherosclerosis	|O
despite	|O
a	|O
pronounced	|O
progestin	|O
-	|O
induced	|O
lowering	|O
of	|O
plasma	|O
HDL	|B-PROTEIN
cholesterol	|I-PROTEIN
concentration	|O
and	|O
,	|O
further	|O
,	|O
that	|O
hormonal	|O
balance	|O
may	|O
have	|O
a	|O
marked	|O
influence	|O
on	|O
the	|O
relationship	|O
between	|O
plasma	|O
lipids	|O
and	|O
atherogenesis	|O
.	|O

During	|O
BH	|O
the	|O
ventilator	|O
was	|O
disconnected	|O
and	|O
a	|O
bias	|O
flow	|O
of	|O
50%	|O
O2	|O
at	|O
4-5	|O
l	|O
/	|O
min	|O
was	|O
delivered	|O
through	|O
the	|O
side	|O
ports	|O
of	|O
a	|O
small	|O
catheter	|O
whose	|O
tip	|O
was	|O
positioned	|O
1	|O
cm	|O
cephalad	|O
of	|O
the	|O
carina	|O
.	|O

Comparison	|O
of	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
removal	|O
using	|O
the	|O
same	|O
polysulphone	|O
membrane	|O
for	|O
haemodialysis	|O
and	|O
haemofiltration	|O
shows	|O
that	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
is	|O
more	|O
effectively	|O
removed	|O
by	|O
convection	|O
than	|O
by	|O
diffusion	|O
when	|O
both	|O
treatment	|O
modes	|O
are	|O
matched	|O
for	|O
blood	|O
flow	|O
and	|O
urea	|O
clearance	|O
.	|O

40.3	|O
+	|O
/	|O
-	|O
10.1	|O
mg	|O
/	|O
l	|O
(	|O
SD	|O
)	|O
vs	|O
31.2	|O
+	|O
/	|O
-	|O
8.0	|O
,	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O
beta	|B-PROTEIN
2m	|I-PROTEIN
was	|O
not	|O
significantly	|O
higher	|O
in	|O
patients	|O
with	|O
bone	|O
cysts	|O
(	|O
37.7	|O
+	|O
/	|O
-	|O
11.4	|O
mg	|O
/	|O
l	|O
vs	|O
37.0	|O
+	|O
/	|O
-	|O
10.0	|O
)	|O
,	|O
but	|O
median	|O
duration	|O
of	|O
dialysis	|O
was	|O
significantly	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
longer	|O
in	|O
patients	|O
with	|O
bone	|O
cysts	|O
(	|O
90	|O
vs	|O
57	|O
months	|O
)	|O
.	|O
beta	|B-PROTEIN
2m	|I-PROTEIN
was	|O
lower	|O
in	|O
patients	|O
maintained	|O
on	|O
dialysis	|O
for	|O
less	|O
than	|O
1	|O
year	|O
and	|O
whose	|O
residual	|O
urine	|O
volume	|O
was	|O
greater	|O
than	|O
0.1	|O
litre	|O
per	|O
day	|O
.	|O

The	|O
mean	|O
percentage	|O
of	|O
linoleic	|O
acid	|O
in	|O
the	|O
triglycerides	|O
of	|O
the	|O
subcutaneous	|O
adipose	|O
tissue	|O
(	|O
PLASAT	|O
)	|O
of	|O
these	|O
subjects	|O
was	|O
substantially	|O
higher	|O
than	|O
that	|O
in	|O
a	|O
similar	|O
group	|O
examined	|O
in	|O
1975-1976	|O
.	|O

In	|O
overdoses	|O
up	|O
to	|O
2	|O
g	|O
fluvoxamine	|O
no	|O
lasting	|O
toxic	|O
effects	|O
were	|O
observed	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
the	|O
plasma	|O
prolactin	|B-PROTEIN
response	|O
to	|O
12.5	|O
micrograms	|O
i.v	|O
.	|O

No	|O
effect	|O
was	|O
found	|O
on	|O
grooming	|O
behavior	|O
.	|O

The	|O
remaining	|O
six	|O
patients	|O
had	|O
slightly	|O
decreased	|O
(	|O
n	|O
=	|O
3	|O
)	|O
or	|O
normal	|O
(	|O
n	|O
=	|O
3	|O
)	|O
seminal	|O
parameters	|O
.	|O

In	|O
addition	|O
,	|O
a	|O
wild	|O
-	|O
type	|O
strain	|O
containing	|O
a	|O
temperature	|O
-	|O
sensitive	|O
threonyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
mutation	|O
showed	|O
increased	|O
thr	|B-PROTEIN
operon	|O
expression	|O
at	|O
the	|O
non	|O
-	|O
permissive	|O
temperature	|O
,	|O
whereas	|O
none	|O
of	|O
the	|O
mutants	|O
showed	|O
any	|O
change	|O
.	|O

Significant	|O
treatment	|O
-	|O
related	|O
problems	|O
appeared	|O
during	|O
the	|O
second	|O
decade	|O
in	|O
5	|O
patients	|O
,	|O
including	|O
one	|O
chest	|O
wall	|O
sarcoma	|O
;	|O
all	|O
of	|O
these	|O
patients	|O
had	|O
received	|O
at	|O
least	|O
60	|O
Gy	|O
to	|O
breast	|O
and	|O
regional	|O
nodal	|O
areas	|O
.	|O

Clinical	|O
and	|O
biological	|O
correlates	|O
of	|O
panic	|O
states	|O
.	|O

Effects	|O
of	|O
long	|O
-	|O
term	|O
parenteral	|O
nutrition	|O
on	|O
gastrin	|B-PROTEIN
release	|O
in	|O
dogs	|O
.	|O

The	|O
mean	|O
weight	|O
and	|O
height	|O
velocities	|O
were	|O
148%	|O
and	|O
122%	|O
of	|O
the	|O
standard	|O
,	|O
respectively	|O
.	|O

Of	|O
7	|O
patients	|O
treated	|O
with	|O
cyclophosphamide	|O
,	|O
hexamethylmelamine	|O
,	|O
adriamycin	|O
and	|O
cisplatin	|O
(	|O
CHAP	|O
-	|O
5	|O
)	|O
,	|O
6	|O
had	|O
measurable	|O
disease	|O
,	|O
of	|O
whom	|O
5	|O
yielded	|O
a	|O
response	|O
(	|O
2	|O
complete	|O
responses	|O
for	|O
19	|O
+	|O
and	|O
40	|O
months	|O
and	|O
3	|O
partial	|O
responses	|O
for	|O
4	|O
,	|O
7	|O
and	|O
8	|O
months	|O
)	|O
.	|O

Isolation	|O
and	|O
characterization	|O
of	|O
a	|O
vinculin	|B-PROTEIN
cDNA	|O
from	|O
chick	|O
-	|O
embryo	|O
fibroblasts	|O
.	|O

A	|O
complementary	|O
study	|O
,	|O
showing	|O
a	|O
good	|O
agreement	|O
between	|O
surface	|O
and	|O
oesophageal	|O
EMGd	|O
seems	|O
to	|O
confirm	|O
that	|O
surface	|O
EMGd	|O
is	|O
a	|O
useful	|O
and	|O
promising	|O
tool	|O
for	|O
clinical	|O
investigation	|O
.	|O

No	|O
differences	|O
in	|O
fixation	|O
quality	|O
were	|O
observed	|O
between	|O
cochleas	|O
fixed	|O
by	|O
intravascular	|O
perfusion	|O
and	|O
cochleas	|O
fixed	|O
by	|O
intralabyrinthine	|O
perfusion	|O
.	|O

The	|O
DNA	|O
sequence	|O
encodes	|O
a	|O
protein	|O
of	|O
1520	|O
amino	|O
acids	|O
with	|O
sequence	|O
homology	|O
to	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
abl	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
product	|O
,	|O
beginning	|O
at	|O
the	|O
amino	|O
terminus	|O
and	|O
extending	|O
656	|O
amino	|O
acids	|O
through	|O
the	|O
region	|O
essential	|O
for	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
.	|O

The	|O
requirement	|O
of	|O
different	|O
essential	|O
fatty	|O
acids	|O
in	|O
patients	|O
with	|O
total	|O
parenteral	|O
nutrition	|O
after	|O
heavy	|O
injury	|O
is	|O
of	|O
special	|O
interest	|O
with	|O
respect	|O
to	|O
the	|O
development	|O
and	|O
prognosis	|O
of	|O
shock	|O
,	|O
sepsis	|O
or	|O
adult	|O
respiratory	|O
distress	|O
syndrome	|O
.	|O

In	|O
64%	|O
a	|O
small	|O
cardiac	|O
vein	|O
does	|O
not	|O
exist	|O
,	|O
but	|O
its	|O
origin	|O
,	|O
the	|O
right	|O
marginal	|O
vein	|O
,	|O
joins	|O
the	|O
system	|O
of	|O
anterior	|O
cardiac	|O
veins	|O
.	|O

The	|O
Drosophila	|O
melanogaster	|O
Gart	|B-PROTEIN
gene	|O
encodes	|O
three	|O
enzymatic	|O
activities	|O
in	|O
the	|O
pathway	|O
for	|O
purine	|O
de	|O
novo	|O
synthesis	|O
.	|O

The	|O
role	|O
of	|O
neuroplasticity	|O
in	|O
the	|O
response	|O
to	|O
drugs	|O
.	|O

Biol.	|O

The	|O
results	|O
of	|O
these	|O
experiments	|O
indicate	|O
that	|O
at	|O
least	|O
two	|O
upstream	|O
activator	|O
sequences	|O
(	|O
UAS	|O
)	|O
mediate	|O
maximum	|O
induction	|O
by	|O
galactose	|O
.	|O

Reversal	|O
of	|O
the	|O
increase	|O
in	|O
apomorphine	|O
-	|O
induced	|O
stereotypy	|O
and	|O
aggression	|O
in	|O
REM	|O
sleep	|O
deprived	|O
rats	|O
by	|O
dopamine	|O
agonist	|O
pretreatments	|O
.	|O

The	|O
heart	|O
rate	|O
,	|O
respiratory	|O
rate	|O
,	|O
arterial	|O
O2	|O
and	|O
systemic	|O
vascular	|O
resistance	|O
were	|O
not	|O
significantly	|O
altered	|O
.	|O

Human	|O
rIL	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
expressed	|O
in	|O
COS7	|O
cells	|O
has	|O
multipotential	|O
CSF	|B-PROTEIN
activity	|O
in	|O
semisolid	|O
cultures	|O
of	|O
bone	|O
marrow	|O
cells	|O
,	|O
and	|O
selectively	|O
induced	|O
the	|O
proliferation	|O
of	|O
My	|O
-	|O
10	|O
+	|O
marrow	|O
or	|O
cord	|O
blood	|O
cells	|O
in	|O
liquid	|O
cultures	|O
.	|O

In	|O
14	|O
patients	|O
whose	|O
PaCO2	|O
was	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
39	|O
torr	|O
(	|O
range	|O
39	|O
to	|O
58	|O
torr	|O
)	|O
and	|O
clinical	|O
asthma	|O
score	|O
was	|O
6	|O
or	|O
greater	|O
,	|O
PaCO2	|O
decreased	|O
a	|O
mean	|O
of	|O
11.7	|O
torr	|O
during	|O
a	|O
mean	|O
of	|O
8.1	|O
hours	|O
.	|O

A	|O
randomized	|O
,	|O
prospective	|O
study	|O
was	|O
conducted	|O
to	|O
compare	|O
ovarian	|O
stimulation	|O
with	|O
human	|B-PROTEIN
menopausal	|I-PROTEIN
gonadotropin	|I-PROTEIN
(	|O
hMG	|B-PROTEIN
)	|O
and	|O
human	|B-PROTEIN
follicle	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
hFSH	|B-PROTEIN
)	|O
in	|O
an	|O
in	|O
vitro	|O
fertilization	|O
and	|O
embryo	|O
transfer	|O
(	|O
IVF	|O
-	|O
ET	|O
)	|O
program	|O
.	|O

Our	|O
findings	|O
suggest	|O
that	|O
the	|O
mtr	|B-PROTEIN
product	|O
causes	|O
both	|O
transcription	|O
attenuation	|O
and	|O
inhibition	|O
of	|O
translation	|O
of	|O
trpE	|B-PROTEIN
mRNA	|O
.	|O

Apropos	|O
of	|O
a	|O
case	|O

A	|O
prostaglandin	|O
analogue	|O
given	|O
in	|O
early	|O
pregnancy	|O
and	|O
human	|O
chorionic	|B-PROTEIN
gonadotropin	|I-PROTEIN
given	|O
near	|O
the	|O
end	|O
of	|O
the	|O
ensuing	|O
follicular	|O
phase	|O
were	|O
used	|O
for	|O
controlling	|O
the	|O
reproductive	|O
cycle	|O
,	|O
timing	|O
oocyte	|O
collection	|O
,	|O
and	|O
synchronizing	|O
the	|O
cycles	|O
of	|O
oocyte	|O
donors	|O
and	|O
embryo	|O
recipients	|O
.	|O

The	|O
nucleolin	|B-PROTEIN
gene	|O
extends	|O
over	|O
9000	|O
base	|O
-	|O
pairs	|O
and	|O
is	|O
split	|O
into	|O
14	|O
exons	|O
that	|O
encode	|O
the	|O
706	|O
amino	|O
acid	|O
residues	|O
of	|O
the	|O
protein	|O
.	|O

Although	|O
L	|O
-	|O
threo	|O
-	|O
dihydroxyphenylserine	|O
(	|O
DOPS	|O
)	|O
,	|O
an	|O
artificial	|O
norepinephrine	|O
(	|O
NE	|O
)	|O
precursor	|O
,	|O
did	|O
not	|O
change	|O
immobility	|O
in	|O
intact	|O
mice	|O
,	|O
DOPS	|O
significantly	|O
reduced	|O
immobility	|O
in	|O
mice	|O
pretreated	|O
with	|O
the	|O
selective	|O
NE	|O
neurotoxin	|O
DSP4	|O
.	|O

Substantial	|O
amounts	|O
of	|O
liposomal	|O
ampicillin	|O
were	|O
recovered	|O
from	|O
isolated	|O
Kupffer	|O
cells	|O
,	|O
the	|O
target	|O
cells	|O
of	|O
L.	|O
monocytogenes	|O
after	|O
intravenous	|O
inoculation	|O
.	|O

This	|O
suggested	|O
that	|O
delta	|O
6	|O
and	|O
delta	|O
5	|O
desaturation	|O
activities	|O
are	|O
normal	|O
in	|O
these	|O
conditions	|O
with	|O
this	|O
C18	|O
:	|O
2w6	|O
supply	|O
.	|O

The	|O
genetic	|O
basis	|O
for	|O
the	|O
expression	|O
of	|O
a	|O
latent	|O
VH	|B-PROTEIN
allotype	|O
in	|O
the	|O
rabbit	|O
was	|O
investigated	|O
.	|O

Here	|O
we	|O
report	|O
the	|O
complete	|O
6	|O
-	|O
kilobase	|O
cDNA	|O
sequence	|O
coding	|O
for	|O
a	|O
chain	|O
of	|O
1775	|O
amino	|O
acids	|O
,	|O
as	|O
well	|O
as	|O
the	|O
genomic	|O
structure	|O
.	|O

HDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
(	|O
+	|O
6%	|O
,	|O
P	|O
less	|O
than	|O
.01	|O
)	|O
and	|O
apolipoprotein	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
(	|O
+	|O
6%	|O
,	|O
P	|O
less	|O
than	|O
.01	|O
)	|O
concentrations	|O
increased	|O
significantly	|O
only	|O
in	|O
the	|O
young	|O
.	|O

The	|O
Euglena	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
gene	|O
cluster	|O
resembles	|O
the	|O
S	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
ribosomal	|O
protein	|O
operon	|O
of	|O
Escherichia	|O
coli	|O
in	|O
gene	|O
organization	|O
and	|O
follows	|O
the	|O
exact	|O
linear	|O
order	|O
of	|O
the	|O
analogous	|O
genes	|O
in	|O
the	|O
tobacco	|O
and	|O
liverwort	|O
chloroplast	|O
genomes	|O
.	|O

The	|O
distribution	|O
of	|O
the	|O
sites	|O
of	|O
recombinational	|O
resolution	|O
is	|O
inversely	|O
correlated	|O
with	|O
that	|O
of	|O
the	|O
gradient	|O
of	|O
sequence	|O
divergence	|O
,	|O
with	|O
only	|O
approximately	|O
7%	|O
of	|O
the	|O
X	|O
recombinants	|O
resolved	|O
within	|O
the	|O
3'	|O
third	|O
of	|O
the	|O
X	|O
blocks	|O
where	|O
two	|O
diverged	|O
Alu	|B-PROTEIN
family	|O
repeats	|O
reside	|O
.	|O

The	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
region	|O
upstream	|O
from	|O
M.	|O
voltae	|O
ORFtrpA	|B-PROTEIN
was	|O
determined	|O
and	|O
revealed	|O
the	|O
presence	|O
of	|O
an	|O
ORF	|O
of	|O
1227	|O
nucleotides	|O
(	|O
ORFtrpB	|B-PROTEIN
)	|O
encoding	|O
a	|O
409	|O
amino	|O
acid	|O
polypeptide	|O
of	|O
mol	|O
.	|O
wt	|O
.	|O

Potentiation	|O
of	|O
the	|O
thrombolytic	|O
efficacy	|O
of	|O
single	|O
-	|O
chain	|O
urokinase	|B-PROTEIN
(	|O
Pro	|B-PROTEIN
-	|I-PROTEIN
urokinase	|I-PROTEIN
)	|O
by	|O
heparin	|O
.	|O

Of	|O
49	|O
receptors	|O
which	|O
fired	|O
in	|O
phase	|O
with	|O
ventilation	|O
,	|O
13	|O
behaved	|O
like	|O
mammalian	|O
rapidly	|O
adapting	|O
pulmonary	|O
stretch	|O
receptors	|O
,	|O
19	|O
like	|O
mammalian	|O
slowly	|O
adapting	|O
pulmonary	|O
stretch	|O
receptors	|O
(	|O
PSR	|O
)	|O
,	|O
and	|O
17	|O
like	|O
avian	|O
intrapulmonary	|O
CO2	|O
-	|O
sensitive	|O
chemoreceptors	|O
(	|O
IPC	|O
)	|O
.	|O

Symptomatic	|O
hyperventilators	|O
had	|O
a	|O
larger	|O
number	|O
of	|O
sighs	|O
and	|O
abnormally	|O
wide	|O
fluctuations	|O
in	|O
baseline	|O
for	|O
inspiratory	|O
time	|O
,	|O
expiratory	|O
time	|O
,	|O
and	|O
PETCO2	|O
.	|O

In	|O
the	|O
IA	|O
task	|O
,	|O
post	|O
-	|O
training	|O
intraperitoneal	|O
injections	|O
of	|O
picrotoxin	|O
and	|O
bicuculline	|O
induced	|O
a	|O
dose	|O
-	|O
dependent	|O
enhancement	|O
of	|O
retention	|O
measured	|O
24	|O
h	|O
after	|O
the	|O
training	|O
,	|O
while	|O
retention	|O
was	|O
not	|O
affected	|O
by	|O
bicuculline	|O
methiodide	|O
(	|O
a	|O
GABA	|B-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
that	|O
does	|O
not	|O
readily	|O
cross	|O
the	|O
blood	|O
-	|O
brain	|O
barrier	|O
)	|O
.	|O

Clinical	|O
research	|O
of	|O
non	|O
-	|O
A	|O
,	|O
non	|O
-	|O
B	|O
post	|O
-	|O
transfusion	|O
hepatitis	|O

It	|O
is	|O
suggested	|O
that	|O
the	|O
use	|O
of	|O
endogenous	|O
creatinine	|O
clearance	|O
to	|O
estimate	|O
the	|O
glomerular	|O
filtration	|O
rate	|O
(	|O
GFR	|O
)	|O
requires	|O
caution	|O
and	|O
the	|O
recognition	|O
of	|O
the	|O
limitations	|O
of	|O
the	|O
method	|O
,	|O
and	|O
that	|O
simpler	|O
techniques	|O
(	|O
serum	|O
creatinine	|O
or	|O
estimated	|O
endogenous	|O
creatinine	|O
clearance	|O
)	|O
are	|O
preferable	|O
in	|O
routine	|O
practice	|O
.	|O

The	|O
protein	|O
mixtures	|O
of	|O
sesame	|O
flour	|O
and	|O
soybean	|O
flour	|O
were	|O
well	|O
accepted	|O
.	|O

The	|O
5'	|O
end	|O
of	|O
the	|O
coding	|O
region	|O
was	|O
located	|O
precisely	|O
by	|O
comparing	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
to	|O
the	|O
actual	|O
N	|O
-	|O
terminal	|O
amino	|O
acid	|O
sequence	|O
of	|O
IHF	|B-PROTEIN
.	|O

A	|O
protein	|O
footprint	|O
also	|O
was	|O
identified	|O
for	|O
a	|O
GC	|O
box	|O
element	|O
at	|O
nucleotides	|O
-	|O
59	|O
to	|O
-	|O
45	|O
.	|O

Insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
II	|I-PROTEIN
(	|O
IGFII	|B-PROTEIN
)	|O
is	|O
a	|O
mitogenic	|O
polypeptide	|O
,	|O
the	|O
mRNAs	|O
of	|O
which	|O
are	|O
present	|O
in	|O
multiple	|O
forms	|O
,	|O
despite	|O
derivation	|O
from	|O
a	|O
single	|O
gene	|O
.	|O

The	|O
central	|O
visual	|O
fields	|O
of	|O
2165	|O
normal	|O
and	|O
106	|O
glaucoma	|O
eyes	|O
were	|O
measured	|O
using	|O
a	|O
threshold	|O
related	|O
suprathreshold	|O
strategy	|O
.	|O

The	|O
variability	|O
is	|O
most	|O
likely	|O
a	|O
result	|O
of	|O
alternative	|O
splicing	|O
of	|O
exons	|O
from	|O
the	|O
primary	|O
elastin	|B-PROTEIN
transcripts	|O
.	|O

This	|O
led	|O
to	|O
the	|O
conclusion	|O
that	|O
the	|O
metatarsal	|O
artery	|O
should	|O
be	|O
used	|O
for	|O
toe	|O
MP	|O
joint	|O
grafts	|O
,	|O
while	|O
the	|O
unilateral	|O
proper	|O
digital	|O
artery	|O
is	|O
suitable	|O
for	|O
toe	|O
PIP	|O
joint	|O
grafts	|O
,	|O
together	|O
with	|O
concomitant	|O
or	|O
dorsal	|O
cutaneous	|O
vein	|O
.	|O

Effect	|O
of	|O
chronic	|O
undernutrition	|O
on	|O
susceptibility	|O
to	|O
cold	|O
stress	|O
in	|O
young	|O
adult	|O
and	|O
aged	|O
rats	|O
.	|O

This	|O
effect	|O
and	|O
the	|O
fact	|O
that	|O
all	|O
three	|O
doses	|O
were	|O
toxic	|O
to	|O
the	|O
dams	|O
dictated	|O
that	|O
a	|O
second	|O
experiment	|O
be	|O
carried	|O
out	|O
at	|O
lower	|O
doses	|O
.	|O

The	|O
CHARGE	|O
association	|O
is	|O
a	|O
collection	|O
of	|O
multisystem	|O
congenital	|O
anomalies	|O
including	|O
choanal	|O
atresia	|O
.	|O

Esophageal	|O
brush	|O
cytological	|O
screening	|O
was	|O
undertaken	|O
and	|O
blood	|O
concentrations	|O
of	|O
micronutrients	|O
(	|O
vitamin	|O
A	|O
,	|O
E	|O
,	|O
B12	|O
,	|O
folic	|O
acid	|O
and	|O
methionine	|O
)	|O
determined	|O
from	|O
adults	|O
at	|O
risk	|O
for	|O
esophageal	|O
carcinoma	|O
(	|O
EC	|O
)	|O
in	|O
Transkei	|O
and	|O
Ciskei	|O
,	|O
Southern	|O
Africa	|O
.	|O

Aviators	|O
from	|O
the	|O
Light	|O
Attack	|O
Wing	|O
,	|O
Pacific	|O
were	|O
surveyed	|O
and	|O
the	|O
results	|O
were	|O
categorized	|O
by	|O
aircraft	|O
type	|O
.	|O

Evaluation	|O
of	|O
human	|O
and	|O
bovine	|O
modified	|O
-	|O
hemoglobin	|B-PROTEIN
solution	|O
as	|O
oxygen	|O
-	|O
carrying	|O
fluid	|O
for	|O
blood	|O
volume	|O
replacement	|O
.	|O

Delayed	|O
gallbladder	|O
visualization	|O
and	|O
reduction	|O
in	|O
ejection	|O
fraction	|O
were	|O
sensitive	|O
but	|O
nonspecific	|O
indicators	|O
of	|O
biliary	|O
disease	|O
.	|O

26	|O
micrograms	|O
PAF	|B-PROTEIN
or	|O
placebo	|O
was	|O
sprayed	|O
into	|O
each	|O
nasal	|O
cavity	|O
8	|O
h	|O
and	|O
1	|O
h	|O
before	|O
a	|O
nasal	|O
allergen	|O
challenge	|O
.	|O

Sci	|O
.	|O

Chem.	|O

Sequential	|O
MR	|O
examinations	|O
of	|O
the	|O
nasal	|O
cavity	|O
and	|O
paranasal	|O
sinuses	|O
were	|O
performed	|O
within	|O
a	|O
6-8	|O
h	|O
period	|O
in	|O
five	|O
normal	|O
volunteers	|O
.	|O

Comparison	|O
was	|O
made	|O
with	|O
other	|O
neuroradiological	|O
imaging	|O
modalities	|O
including	|O
CT	|O
,	|O
myelography	|O
,	|O
CT	|O
ventriculography	|O
,	|O
and	|O
CT	|O
myelocisternography	|O
.	|O

The	|O
feed	|O
given	|O
to	|O
young	|O
broiler	|O
chickens	|O
was	|O
contaminated	|O
artificially	|O
with	|O
Salmonella	|O
kedougou	|O
,	|O
a	|O
serotype	|O
associated	|O
with	|O
both	|O
subclinical	|O
infections	|O
in	|O
commercially	|O
reared	|O
chickens	|O
and	|O
food	|O
poisoning	|O
in	|O
humans	|O
.	|O

A	|O
poor	|O
correlation	|O
was	|O
found	|O
between	|O
a	|O
mildly	|O
-	|O
atypical	|O
(	|O
inflammatory	|O
)	|O
cytological	|O
result	|O
(	|O
class	|O
2	|O
)	|O
and	|O
a	|O
benign	|O
histological	|O
diagnosis	|O
:	|O
48%	|O
of	|O
class	|O
-	|O
2	|O
smears	|O
were	|O
diagnosed	|O
histologically	|O
as	|O
dysplasia	|O
or	|O
worse	|O
.	|O

Factors	|O
involved	|O
in	|O
specific	|O
transcription	|O
by	|O
mammalian	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
:	|O
purification	|O
,	|O
genetic	|O
specificity	|O
,	|O
and	|O
TATA	|O
box	|O
-	|O
promoter	|O
interactions	|O
of	|O
TFIID	|B-PROTEIN
.	|O

Change	|O
in	|O
plasma	|O
cystyl	|B-PROTEIN
aminopeptidase	|I-PROTEIN
(	|O
oxytocinase	|B-PROTEIN
)	|O
between	|O
30-34	|O
weeks	|O
'	|O
gestation	|O
as	|O
a	|O
predictor	|O
of	|O
pregnancy	|O
-	|O
induced	|O
hypertension	|O
.	|O

You	|O
make	|O
the	|O
diagnosis	|O
.	|O

The	|O
test	|O
for	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
naphthyl	|I-PROTEIN
esterase	|I-PROTEIN
and	|O
quantitation	|O
of	|O
macrophages	|O
(	|O
absolute	|O
number	|O
)	|O
per	|O
infiltration	|O
area	|O
unit	|O
adjacent	|O
to	|O
the	|O
abscess	|O
suggest	|O
a	|O
direct	|O
correlation	|O
between	|O
the	|O
absolute	|O
number	|O
of	|O
macrophages	|O
and	|O
the	|O
width	|O
of	|O
the	|O
capsule	|O
.	|O

Determined	|O
as	|O
migration	|O
differentials	|O
,	|O
chemotactic	|O
and	|O
chemokinetic	|O
responsiveness	|O
tended	|O
to	|O
be	|O
higher	|O
in	|O
the	|O
neutropenic	|O
group	|O
.	|O

The	|O
deduced	|O
96	|O
-	|O
residue	|O
amino	|O
acid	|O
coding	|O
sequence	|O
of	|O
the	|O
murine	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
(	|I-PROTEIN
Y	|I-PROTEIN
)	|I-PROTEIN
cDNA	|O
is	|O
very	|O
similar	|O
to	|O
the	|O
reported	|O
amino	|O
acid	|O
sequence	|O
of	|O
human	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
,	|O
except	|O
that	|O
it	|O
lacks	|O
11	|O
internal	|O
amino	|O
acids	|O
reported	|O
in	|O
the	|O
human	|O
protein	|O
.	|O

Interpersonal	|O
style	|O
differences	|O
among	|O
drug	|O
abusers	|O
were	|O
explored	|O
using	|O
Ryan	|O
's	|O
(	|O
1977	|O
)	|O
typological	|O
system	|O
of	|O
FIRO	|O
-	|O
B	|O
interpretation	|O
.	|O

Statement	|O
of	|O
the	|O
American	|O
Academy	|O
of	|O
Implant	|O
Dentistry	|O
.	|O

Sera	|O
from	|O
euthyroid	|O
post	|O
-	|O
menopausal	|O
or	|O
pregnant	|O
women	|O
yielded	|O
TSH	|B-PROTEIN
levels	|O
within	|O
the	|O
normal	|O
range	|O
.	|O

No	|O
UOxase	|B-PROTEIN
mRNA	|O
was	|O
detected	|O
in	|O
11	|O
nonhepatic	|O
tissues	|O
of	|O
rat	|O
,	|O
suggesting	|O
tissue	|O
specificity	|O
of	|O
expression	|O
of	|O
this	|O
UOxase	|B-PROTEIN
gene	|O
.	|O

The	|O
platelet	|O
adhesion	|O
rate	|O
on	|O
these	|O
layers	|O
were	|O
tested	|O
concerning	|O
the	|O
valuation	|O
of	|O
the	|O
haemocompatibility	|O
of	|O
the	|O
basic	|O
-	|O
polymers	|O
polyurethane	|O
(	|O
PUR	|O
)	|O
,	|O
polyvinylchloride	|O
(	|O
PVC	|O
)	|O
,	|O
and	|O
polystyrene	|O
(	|O
PS	|O
)	|O
in	|O
two	|O
different	|O
worked	|O
test	|O
chambers	|O
.	|O

Conservative	|O
treatment	|O
of	|O
bladder	|O
carcinoma	|O
by	|O
partial	|O
cystectomy	|O
and	|O
interstitial	|O
iridium	|O
192	|O
.	|O

In	|O
a	|O
112	|O
-	|O
d	|O
feedlot	|O
trial	|O
,	|O
105	|O
heifers	|O
were	|O
assigned	|O
to	|O
light	|O
,	|O
medium	|O
and	|O
heavy	|O
weight	|O
blocks	|O
on	|O
five	|O
treatments	|O
:	|O
dietary	|O
MGA	|O
(	|O
.5	|O
mg.h	|O
d	|O
-	|O
1.d	|O
-	|O
1	|O
)	|O
,	|O
control	|O
(	|O
no	|O
MGA	|O
)	|O
or	|O
DEPO	|O
-	|O
MGA	|O
on	|O
d	|O
1	|O
at	|O
.5	|O
,	|O
1.0	|O
or	|O
1.5	|O
ml	|O
/	|O
hd	|O
(	|O
30	|O
,	|O
60	|O
or	|O
90	|O
mg	|O
MGA	|O
/	|O
hd	|O
,	|O
respectively	|O
)	|O
.	|O

Existence	|O
and	|O
uniqueness	|O
of	|O
solutions	|O
of	|O
the	|O
appropriate	|O
boundary	|O
value	|O
problems	|O
are	|O
established	|O
,	|O
in	|O
the	|O
case	|O
of	|O
small	|O
permeability	|O
coefficients	|O
and	|O
transport	|O
rates	|O
,	|O
or	|O
large	|O
diffusion	|O
coefficients	|O
and	|O
small	|O
resistance	|O
to	|O
flow	|O
constants	|O
.	|O

There	|O
were	|O
gene	|O
clusters	|O
encoding	|O
photosynthesis	|O
components	|O
such	|O
as	|O
the	|O
psbB	|B-PROTEIN
-	|O
psbH	|B-PROTEIN
-	|O
petB	|B-PROTEIN
-	|O
petD	|B-PROTEIN
and	|O
the	|O
psbE	|B-PROTEIN
-	|I-PROTEIN
psbF	|I-PROTEIN
clusters	|O
.	|O

The	|O
results	|O
presented	|O
suggest	|O
that	|O
TIQ	|O
reduces	|O
the	|O
turnover	|O
rate	|O
of	|O
the	|O
nigrostriatal	|O
dopamine	|O
neurons	|O
after	|O
repeated	|O
administration	|O
for	|O
a	|O
long	|O
period	|O
in	|O
mice	|O
.	|O

The	|O
partial	|O
sequence	|O
of	|O
the	|O
62	|B-PROTEIN
-	|I-PROTEIN
kDa	|I-PROTEIN
nuclear	|I-PROTEIN
pore	|I-PROTEIN
glycoprotein	|I-PROTEIN
shows	|O
little	|O
similarity	|O
to	|O
other	|O
characterized	|O
proteins	|O
and	|O
elucidates	|O
structural	|O
features	|O
of	|O
a	|O
member	|O
of	|O
the	|O
family	|O
of	|O
nuclear	|B-PROTEIN
pore	|I-PROTEIN
glycoproteins	|I-PROTEIN
.	|O

Seventy	|O
-	|O
two	|O
hours	|O
after	|O
administration	|O
of	|O
vitamin	|O
K1	|O
,	|O
plasma	|O
concentrations	|O
of	|O
the	|O
vitamin	|O
were	|O
not	|O
different	|O
from	|O
normal	|O
.	|O

The	|O
glomerular	|O
filtration	|O
rate	|O
did	|O
not	|O
change	|O
but	|O
lithium	|O
clearance	|O
fell	|O
by	|O
30%	|O
.	|O

During	|O
a	|O
28	|O
-	|O
week	|O
promotion	|O
bioassay	|O
,	|O
groups	|O
of	|O
30	|O
male	|O
CD	|O
-	|O
1	|O
mice	|O
were	|O
treated	|O
once	|O
with	|O
50	|O
microliter	|O
of	|O
either	|O
DMBA	|O
(	|O
1.0	|O
mg	|O
/	|O
ml	|O
)	|O
or	|O
acetone	|O
,	|O
rested	|O
for	|O
2	|O
weeks	|O
,	|O
and	|O
then	|O
treated	|O
twice	|O
per	|O
week	|O
with	|O
test	|O
material	|O
for	|O
the	|O
remaining	|O
25	|O
weeks	|O
.	|O

The	|O
pathogenesis	|O
of	|O
Dupuytren	|O
's	|O
contracture	|O

An	|O
ELISA	|O
procedure	|O
was	|O
developed	|O
for	|O
monitoring	|O
the	|O
specific	|O
IgE	|B-PROTEIN
response	|O
in	|O
dogs	|O
to	|O
Dirofilaria	|O
immitis	|O
infection	|O
.	|O

Fifty	|O
min	|O
after	|O
release	|O
from	|O
stress	|O
,	|O
increases	|O
in	|O
plasma	|O
corticosterone	|O
levels	|O
induced	|O
by	|O
stress	|O
recovered	|O
in	|O
the	|O
biting	|O
group	|O
but	|O
remained	|O
high	|O
in	|O
the	|O
non	|O
-	|O
biting	|O
group	|O
.	|O

The	|O
only	|O
isolate	|O
of	|O
Aeromonas	|O
hydrophila	|O
produced	|O
cytotoxic	|O
enterotoxin	|O
and	|O
was	|O
invasive	|O
.	|O

An	|O
11	|O
-	|O
month	|O
-	|O
old	|O
girl	|O
suffering	|O
from	|O
Dandy	|O
-	|O
Walker	|O
malformation	|O
(	|O
DWM	|O
)	|O
associated	|O
with	|O
tetralogy	|O
of	|O
Fallot	|O
(	|O
TOF	|O
)	|O
is	|O
presented	|O
.	|O

The	|O
incidence	|O
of	|O
early	|O
neonatal	|O
convulsions	|O
for	|O
inborn	|O
babies	|O
was	|O
3.0/1000	|O
live	|O
births	|O
.	|O

The	|O
median	|O
survival	|O
is	|O
not	|O
reached	|O
with	|O
a	|O
median	|O
follow	|O
-	|O
up	|O
time	|O
of	|O
9.6	|O
years	|O
.	|O

Critical	|O
evaluation	|O
of	|O
various	|O
methods	|O
of	|O
determining	|O
markers	|O
of	|O
fetal	|O
maturity	|O
in	|O
amniotic	|O
fluid	|O

Of	|O
the	|O
43	|O
infants	|O
with	|O
a	|O
(	|O
probable	|O
)	|O
loss	|O
18	|O
were	|O
examined	|O
again	|O
at	|O
3	|O
months	|O
corrected	|O
age	|O
.	|O

Variety	|O
of	|O
cows	|O
and	|O
sires	|O
according	|O
to	|O
types	|O
of	|O
dermatoglyphics	|O
(	|O
patterns	|O
)	|O
of	|O
the	|O
nose	|O
-	|O
labial	|O
mirror	|O
of	|O
cattle	|O

Although	|O
not	|O
consistently	|O
identified	|O
in	|O
all	|O
samples	|O
,	|O
secondary	|O
Academic	|O
,	|O
Personal	|O
Responsibility	|O
,	|O
and	|O
Community	|O
/	|O
Vocational	|O
dimensions	|O
were	|O
also	|O
identified	|O
.	|O

Recovery	|O
was	|O
characterized	|O
by	|O
rapid	|O
improvement	|O
such	|O
that	|O
all	|O
measured	|O
parameters	|O
normalized	|O
by	|O
1	|O
week	|O
,	|O
except	|O
for	|O
cross	|O
-	|O
sectional	|O
cardiac	|O
area	|O
which	|O
remained	|O
dilated	|O
up	|O
to	|O
4	|O
weeks	|O
(	|O
14	|O
+	|O
/	|O
-	|O
3	|O
cm2	|O
,	|O
p	|O
less	|O
than	|O
0.05	|O
versus	|O
control	|O
)	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Not	|O
even	|O
extensive	|O
pancreatic	|O
resection	|O
could	|O
prevent	|O
pancreatic	|O
remnant	|O
infection	|O
.	|O

It	|O
has	|O
been	|O
calculated	|O
that	|O
600,000	|O
new	|O
cases	|O
of	|O
lung	|O
cancer	|O
occur	|O
worldwide	|O
every	|O
year	|O
,	|O
most	|O
of	|O
them	|O
due	|O
to	|O
smoking	|O
.	|O

Neuromyelitis	|O
optica	|O
(	|O
Devic	|O
's	|O
syndrome	|O
)	|O
:	|O
not	|O
always	|O
multiple	|O
sclerosis	|O
.	|O

Effect	|O
of	|O
the	|O
methods	|O
of	|O
cutaneous	|O
administration	|O
of	|O
methyl	|O
isobutyl	|O
ketone	|O
on	|O
its	|O
toxicity	|O

Incorporation	|O
of	|O
0.1	|O
or	|O
0.2	|O
M	|O
sodium	|O
dihydrogen	|O
phosphate	|O
in	|O
the	|O
sugar	|O
solutions	|O
resulted	|O
in	|O
a	|O
decrease	|O
in	|O
the	|O
shelf	|O
-	|O
life	|O
of	|O
diltiazem	|O
.	|O

None	|O
had	|O
a	|O
past	|O
history	|O
of	|O
opportunistic	|O
infections	|O
;	|O
neither	|O
did	|O
any	|O
have	|O
lymphopenia	|O
.	|O

Increasing	|O
the	|O
phosphorus	|O
content	|O
of	|O
the	|O
diet	|O
improved	|O
the	|O
reabsorption	|O
of	|O
calcium	|O
and	|O
magnesium	|O
.	|O

Post	|O
-	|O
transcriptional	|O
regulation	|O
of	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
gene	|O
expression	|O
during	|O
development	|O
in	|O
Dictyostelium	|O
discoideum	|O
.	|O

The	|O
temporal	|O
and	|O
static	|O
plasma	|O
concentration	|O
-	|O
effect	|O
relationships	|O
were	|O
evaluated	|O
by	|O
pharmacodynamic	|O
modeling	|O
and	|O
linear	|O
regression	|O
.	|O

The	|O
increase	|O
in	|O
amplitudes	|O
of	|O
the	|O
b	|O
-	|O
wave	|O
during	|O
the	|O
adaptation	|O
period	|O
was	|O
more	|O
prominent	|O
in	|O
lead	|O
-	|O
exposed	|O
subjects	|O
than	|O
in	|O
controls	|O
.	|O

Possible	|O
factors	|O
for	|O
the	|O
development	|O
of	|O
psychotic	|O
symptomatology	|O
during	|O
group	|O
activities	|O
and	|O
the	|O
role	|O
of	|O
group	|O
dynamics	|O
acting	|O
as	|O
stress	|O
factors	|O
precipitating	|O
functional	|O
psychoses	|O
,	|O
especially	|O
bipolar	|O
manifestations	|O
,	|O
are	|O
discussed	|O
.	|O

Baseline	|O
measurements	|O
of	|O
forced	|O
expiratory	|O
volume	|O
in	|O
1	|O
s	|O
(	|O
FEV1	|O
)	|O
,	|O
specific	|O
airway	|O
conductance	|O
(	|O
SGaw	|O
)	|O
and	|O
the	|O
provocative	|O
dose	|O
of	|O
carbachol	|O
causing	|O
a	|O
35%	|O
reduction	|O
in	|O
SGaw	|O
(	|O
PD35	|O
)	|O
,	|O
and	|O
a	|O
20%	|O
reduction	|O
in	|O
FEV1	|O
(	|O
PD20	|O
)	|O
were	|O
established	|O
on	|O
entry	|O
while	|O
each	|O
subject	|O
was	|O
still	|O
smoking	|O
.	|O

Many	|O
children	|O
with	|O
BGC	|O
are	|O
delayed	|O
in	|O
their	|O
development	|O
,	|O
but	|O
calcifications	|O
are	|O
not	|O
directly	|O
related	|O
to	|O
specific	|O
forms	|O
of	|O
neurologic	|O
dysfunction	|O
.	|O

R	|O
-	|O
wave	|O
voltage	|O
in	|O
the	|O
right	|O
precordial	|O
leads	|O
in	|O
anthracycline	|O
cardiomyopathy	|O
:	|O
a	|O
clinical	|O
study	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
the	|O
pooling	|O
requirements	|O
are	|O
task	|O
dependent	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
CSFHU	|B-PROTEIN
can	|O
increase	|O
neutrophil	|O
counts	|O
by	|O
increasing	|O
the	|O
number	|O
and	|O
maturity	|O
of	|O
the	|O
marrow	|O
neutrophil	|O
precursors	|O
in	|O
some	|O
types	|O
of	|O
childhood	|O
chronic	|O
neutropenia	|O
.	|O

The	|O
purposes	|O
of	|O
this	|O
study	|O
were	|O
1	|O
)	|O
to	|O
examine	|O
the	|O
effect	|O
of	|O
high	|O
intensity	|O
,	|O
low	|O
frequency	|O
transcutaneous	|O
electrical	|O
nerve	|O
stimulation	|O
at	|O
auricular	|O
acupuncture	|O
points	|O
on	|O
experimental	|O
pain	|O
threshold	|O
measured	|O
at	|O
the	|O
wrist	|O
and	|O
2	|O
)	|O
to	|O
determine	|O
the	|O
changes	|O
in	|O
effect	|O
over	|O
time	|O
.	|O

In	|O
the	|O
infected	|O
neonates	|O
serum	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
amylase	|I-PROTEIN
value	|O
,	|O
as	|O
determined	|O
by	|O
the	|O
blue	|O
starch	|O
method	|O
,	|O
was	|O
only	|O
40%	|O
that	|O
of	|O
healthy	|O
controls	|O
;	|O
the	|O
mean	|O
value	|O
of	|O
175.1	|O
+	|O
/	|O
-	|O
64.9	|O
IU	|O
/	|O
l	|O
for	|O
healthy	|O
neonates	|O
was	|O
significantly	|O
higher	|O
(	|O
p	|O
less	|O
than	|O
0.0010	|O
)	|O
than	|O
the	|O
value	|O
of	|O
82.8	|O
+	|O
/	|O
-	|O
44.4	|O
IU	|O
/	|O
l	|O
for	|O
the	|O
infected	|O
neonates	|O
.	|O

Records	|O
of	|O
31	|O
children	|O
with	|O
AIDS	|O
or	|O
AIDS	|O
-	|O
related	|O
complex	|O
admitted	|O
to	|O
the	|O
pediatric	|O
intensive	|O
care	|O
unit	|O
for	|O
acute	|O
respiratory	|O
failure	|O
throughout	|O
a	|O
46	|O
-	|O
month	|O
period	|O
were	|O
reviewed	|O
.	|O

Fourteen	|O
patients	|O
were	|O
in	|O
the	|O
multifocal	|O
disease	|O
group	|O
;	|O
13	|O
were	|O
detected	|O
by	|O
SPECT	|O
and	|O
10	|O
by	|O
TCT	|O
.	|O

SPECT	|O
is	|O
an	|O
important	|O
aid	|O
in	|O
the	|O
diagnosis	|O
of	|O
AIDS	|O
dementia	|O
complex	|O
and	|O
contributes	|O
to	|O
the	|O
understanding	|O
of	|O
the	|O
pathophysiological	|O
mechanisms	|O
of	|O
this	|O
disorder	|O
.	|O

We	|O
were	|O
interested	|O
in	|O
studying	|O
the	|O
relationship	|O
between	|O
the	|O
circadian	|O
rhythm	|O
in	|O
body	|O
temperature	|O
and	|O
24	|O
-	|O
h	|O
variations	|O
in	|O
plasma	|O
concentrations	|O
of	|O
iron	|O
,	|O
zinc	|O
,	|O
circulating	|O
leukocyte	|O
counts	|O
,	|O
and	|O
plasma	|O
interleukin	|B-PROTEIN
1	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
activity	|O
.	|O

The	|O
murine	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
I	|I-PROTEIN
genes	|O
,	|O
H	|B-PROTEIN
-	|I-PROTEIN
2Dq	|I-PROTEIN
and	|O
H	|B-PROTEIN
-	|I-PROTEIN
2Lq	|I-PROTEIN
,	|O
are	|O
strikingly	|O
homologous	|O
to	|O
each	|O
other	|O
,	|O
H	|B-PROTEIN
-	|I-PROTEIN
2Ld	|I-PROTEIN
,	|O
and	|O
two	|O
genes	|O
reported	|O
to	|O
encode	|O
tumor	|O
-	|O
specific	|O
antigens	|O
.	|O

The	|O
active	|O
derivatives	|O
of	|O
the	|O
present	|O
series	|O
were	|O
also	|O
tested	|O
for	|O
their	|O
analgesic	|O
activity	|O
against	|O
aconitine	|O
-	|O
induced	|O
writhing	|O
in	|O
albino	|O
mice	|O
and	|O
ulcerogenic	|O
activity	|O
in	|O
albino	|O
rats	|O
.	|O

In	|O
untreated	|O
mice	|O
,	|O
bactericidal	|O
activity	|O
of	|O
peritoneal	|O
macrophages	|O
decreased	|O
from	|O
one	|O
day	|O
to	|O
3	|O
days	|O
after	|O
ip	|O
injection	|O
of	|O
killed	|O
L.	|O
monocytogenes	|O
.	|O

Among	|O
a	|O
population	|O
of	|O
18,175	|O
children	|O
below	|O
7	|O
years	|O
of	|O
age	|O
in	|O
medium	|O
sized	|O
towns	|O
and	|O
rural	|O
areas	|O
in	|O
south	|O
-	|O
western	|O
Germany	|O
552	|O
(	|O
3.03%	|O
)	|O
cases	|O
of	|O
croup	|O
were	|O
registered	|O
during	|O
a	|O
12	|O
months	|O
period	|O
in	|O
1984-85	|O
by	|O
their	|O
physicians	|O
.	|O

We	|O
concluded	|O
that	|O
Ga	|O
-	|O
fbg	|O
scintigraphy	|O
is	|O
a	|O
very	|O
simple	|O
method	|O
and	|O
sufficiently	|O
useful	|O
for	|O
detecting	|O
active	|O
left	|O
ventricular	|O
thrombi	|O
and	|O
for	|O
monitoring	|O
the	|O
effect	|O
of	|O
anticoagulant	|O
therapy	|O
.	|O

In	|O
vitro	|O
assessment	|O
of	|O
the	|O
biocompatibility	|O
of	|O
dental	|O
materials	|O
-	|O
-	|O
the	|O
millipore	|O
filter	|O
method	|O
.	|O

Hypomagnesemia	|O
was	|O
due	|O
to	|O
magnesium	|O
wasting	|O
by	|O
the	|O
kidney	|O
.	|O

Dentalplaque	|O
was	|O
controlled	|O
by	|O
the	|O
oral	|O
higienic	|O
index	|O
of	|O
the	|O
whole	|O
dentition	|O
daily	|O
,	|O
after	|O
staining	|O
with	|O
1	|O
per	|O
cent	|O
alkaline	|O
fuxin	|O
.	|O

GRFI	|B-PROTEIN
bound	|O
to	|O
sequences	|O
at	|O
the	|O
negative	|O
regulatory	|O
elements	|O
(	|O
silencers	|O
)	|O
of	|O
the	|O
silent	|B-PROTEIN
mating	|I-PROTEIN
type	|I-PROTEIN
loci	|I-PROTEIN
HML	|O
E	|O
and	|O
HMR	|B-PROTEIN
E	|I-PROTEIN
and	|O
to	|O
the	|O
upstream	|O
activating	|O
sequence	|O
(	|O
UAS	|O
)	|O
required	|O
for	|O
transcription	|O
of	|O
the	|O
MAT	|B-PROTEIN
alpha	|I-PROTEIN
genes	|O
.	|O

The	|O
effects	|O
of	|O
these	|O
mutations	|O
on	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
activity	|O
were	|O
assayed	|O
by	|O
measuring	|O
the	|O
ability	|O
of	|O
mutant	|O
genes	|O
to	|O
confer	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
amanitin	|I-PROTEIN
resistance	|O
after	|O
transfection	|O
of	|O
susceptible	|O
rodent	|O
cells	|O
.	|O

We	|O
report	|O
the	|O
use	|O
of	|O
a	|O
new	|O
technetium	|O
-	|O
99m	|O
-	|O
albumin	|B-PROTEIN
colloid	|O
white	|O
blood	|O
cell	|O
(	|O
TAC	|O
-	|O
WBC	|O
)	|O
scan	|O
in	|O
the	|O
evaluation	|O
of	|O
appendicitis	|O
.	|O

In	|O
one	|O
of	|O
these	|O
tumors	|O
the	|O
observed	|O
rearrangement	|O
was	|O
not	|O
due	|O
to	|O
the	|O
insertion	|O
of	|O
an	|O
intact	|O
MoMuLV	|O
provirus	|O
.	|O

The	|O
indications	|O
for	|O
its	|O
use	|O
include	|O
every	|O
primary	|O
and	|O
secondary	|O
rhinoplasty	|O
candidate	|O
unless	|O
tip	|O
grafts	|O
are	|O
going	|O
to	|O
be	|O
under	|O
tension	|O
or	|O
if	|O
the	|O
deformity	|O
is	|O
minor	|O
.	|O

The	|O
SSB	|B-PROTEIN
-	|O
poly	|O
(	|O
dT	|O
)	|O
affinity	|O
is	|O
too	|O
high	|O
to	|O
measure	|O
in	|O
buffers	|O
containing	|O
even	|O
5	|O
M	|O
NaCl	|O
;	|O
however	|O
,	|O
in	|O
1.8-2.5	|O
M	|O
NaBr	|O
,	|O
we	|O
measure	|O
alpha	|O
log	|O
Kobsd	|O
/	|O
alpha	|O
log	|O
[	|O
NaBr	|O
]	|O
=	|O
-	|O
5.7	|O
+	|O
/	|O
-	|O
0.7	|O
,	|O
with	|O
a	|O
lower	|O
value	|O
of	|O
omega	|O
T	|O
/	|O
O	|O
=	|O
130	|O
+	|O
/	|O
-	|O
70	|O
.	|O

Mutations	|O
at	|O
the	|O
suf12	|B-PROTEIN
locus	|O
were	|O
isolated	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
as	|O
extragenic	|O
suppressors	|O
of	|O
+	|O
1	|O
frameshift	|O
mutations	|O
in	|O
glycine	|O
(	|O
GGX	|O
)	|O
and	|O
proline	|O
(	|O
CCX	|O
)	|O
codons	|O
,	|O
as	|O
well	|O
as	|O
UGA	|O
and	|O
UAG	|O
nonsense	|O
mutations	|O
.	|O

The	|O
behavior	|O
of	|O
suf12	|B-PROTEIN
-	|O
null	|O
/	|O
SUF12+	|B-PROTEIN
heterozygotes	|O
indicates	|O
that	|O
suf12	|B-PROTEIN
is	|O
co	|O
-	|O
dominantly	|O
expressed	|O
and	|O
suggests	|O
that	|O
suf12	|B-PROTEIN
allele	|O
-	|O
specific	|O
suppression	|O
may	|O
result	|O
from	|O
functionally	|O
distinct	|O
mutant	|O
proteins	|O
rather	|O
than	|O
variation	|O
in	|O
residual	|O
wild	|O
-	|O
type	|O
SUF12+	|B-PROTEIN
activity	|O
.	|O

Antituberculosis	|O
agents	|O
.	|O

The	|O
putative	|O
immunity	|O
protein	|O
was	|O
detected	|O
among	|O
the	|O
[	|O
35S	|O
]	|O
methionine	|O
-	|O
labelled	|O
proteins	|O
produced	|O
by	|O
minicells	|O
carrying	|O
cni	|B-PROTEIN
cloned	|O
under	|O
lac	|B-PROTEIN
promoter	|O
control	|O
,	|O
and	|O
when	|O
the	|O
gene	|O
was	|O
subcloned	|O
into	|O
expression	|O
vectors	|O
under	|O
the	|O
control	|O
of	|O
a	|O
bacteriophage	|O
T7	|O
promoter	|O
.	|O

Antibodies	|O
made	|O
against	|O
fusion	|O
protein	|O
produced	|O
by	|O
the	|O
DP1A	|B-PROTEIN
clone	|O
reacted	|O
specifically	|O
with	|O
DP	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
on	|O
immunoblots	|O
.	|O

Finally	|O
,	|O
over	|O
a	|O
similar	|O
range	|O
of	|O
QO2	|O
,	|O
oxygen	|O
extraction	|O
was	|O
greater	|O
in	|O
patients	|O
with	|O
ARDS	|O
compared	|O
to	|O
patients	|O
with	|O
non	|O
-	|O
ARDS	|O
respiratory	|O
failure	|O
(	|O
r	|O
=	|O
-	|O
0.67	|O
and	|O
slope	|O
=	|O
-	|O
0.62	|O
vs	|O
r	|O
=	|O
-	|O
0.45	|O
and	|O
slope	|O
=	|O
-	|O
0.35	|O
;	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Stable	|O
patients	|O
have	|O
mucous	|O
hypersecretion	|O
and	|O
little	|O
evidence	|O
of	|O
acute	|O
inflammation	|O
.	|O

Hyperprolactinaemia	|O
,	|O
moderate	|O
hypogonadism	|O
,	|O
infraclinical	|O
neuropathies	|O
,	|O
arterial	|O
stenoses	|O
and	|O
moderate	|O
venous	|O
leakages	|O
seem	|O
to	|O
play	|O
a	|O
partial	|O
role	|O
of	|O
organic	|O
starter	|O
or	|O
cofactor	|O
,	|O
the	|O
sexual	|O
consequences	|O
of	|O
which	|O
are	|O
amplified	|O
by	|O
psychological	|O
factors	|O
,	|O
partly	|O
secondary	|O
to	|O
the	|O
initial	|O
sexual	|O
failures	|O
.	|O

Yang	|O
and	|O
H.	|O

Secretory	|O
function	|O
of	|O
the	|O
prostate	|O
gland	|O
.	|O

Chronic	|O
endotoxemia	|O
appears	|O
to	|O
be	|O
associated	|O
with	|O
an	|O
elevated	|O
pulmonary	|O
microvascular	|O
permeability	|O
and	|O
a	|O
tendency	|O
toward	|O
a	|O
hyperdynamic	|O
circulation	|O
but	|O
with	|O
an	|O
appreciable	|O
degree	|O
of	|O
refractoriness	|O
associated	|O
with	|O
regional	|O
hemodynamics	|O
and	|O
eicosanoid	|O
biosynthesis	|O
.	|O

In	|O
contrast	|O
,	|O
we	|O
observed	|O
high	|O
concentrations	|O
in	|O
29	|O
of	|O
75	|O
patients	|O
with	|O
tumors	|O
of	|O
the	|O
central	|O
nervous	|O
system	|O
,	|O
especially	|O
in	|O
meningioma	|O
(	|O
6/9	|O
)	|O
,	|O
glioblastoma	|O
(	|O
9/23	|O
)	|O
,	|O
and	|O
neurinoma	|O
(	|O
5/5	|O
)	|O
.	|O

Diet	|O
and	|O
atopic	|O
eczema	|O
.	|O

Time	|O
delay	|O
effects	|O
on	|O
the	|O
tensile	|O
bond	|O
strength	|O
developed	|O
by	|O
the	|O
Silicoater	|O
.	|O

The	|O
future	|O
of	|O
research	|O
with	|O
interferon	|B-PROTEIN
may	|O
be	|O
divided	|O
into	|O
three	|O
areas	|O
:	|O
Efforts	|O
must	|O
be	|O
made	|O
to	|O
determine	|O
how	|O
best	|O
to	|O
translate	|O
the	|O
in	|O
vitro	|O
synergy	|O
into	|O
clinically	|O
meaningful	|O
terms	|O
;	|O
in	|O
order	|O
to	|O
exploit	|O
the	|O
fullest	|O
potential	|O
of	|O
IFN	|B-PROTEIN
,	|O
research	|O
is	|O
moving	|O
toward	|O
using	|O
this	|O
agent	|O
earlier	|O
in	|O
disease	|O
either	|O
as	|O
an	|O
adjuvant	|O
after	|O
tumor	|O
debulking	|O
or	|O
after	|O
initial	|O
diagnosis	|O
;	|O
the	|O
medical	|O
community	|O
must	|O
rethink	|O
the	|O
natural	|O
history	|O
of	|O
some	|O
diseases	|O
,	|O
because	|O
the	|O
fullest	|O
potential	|O
of	|O
the	|O
biologic	|O
agents	|O
will	|O
most	|O
likely	|O
manifest	|O
itself	|O
when	|O
these	|O
agents	|O
are	|O
used	|O
together	|O
.	|O

Minor	|O
differences	|O
were	|O
noted	|O
with	|O
latamoxef	|O
producing	|O
mild	|O
persistant	|O
elevation	|O
of	|O
prothrombin	|B-PROTEIN
time	|O
(	|O
0.7	|O
second	|O
)	|O
associated	|O
with	|O
depression	|O
of	|O
factor	|B-PROTEIN
II	|I-PROTEIN
and	|O
factor	|B-PROTEIN
VII	|I-PROTEIN
.	|O

Six	|O
healthy	|O
male	|O
subjects	|O
received	|O
single	|O
oral	|O
doses	|O
of	|O
regular	|O
release	|O
(	|O
RR	|O
)	|O
quinidine	|O
sulfate	|O
,	|O
sustained	|O
release	|O
(	|O
SR	|O
)	|O
quinidine	|O
bisulfate	|O
and	|O
the	|O
same	|O
dose	|O
of	|O
the	|O
SR	|O
product	|O
with	|O
food	|O
(	|O
SR	|O
-	|O
F	|O
)	|O
.	|O

This	|O
report	|O
expands	|O
on	|O
previous	|O
work	|O
with	|O
interferon	|B-PROTEIN
alfa	|I-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
(	|O
Intron	|O
A	|O
;	|O
Schering	|O
-	|O
Plough	|O
)	|O
in	|O
the	|O
treatment	|O
of	|O
hairy	|O
cell	|O
leukemia	|O
(	|O
HCL	|O
)	|O
.	|O

Oxygen	|O
delivery	|O
and	|O
base	|O
excess	|O
decreased	|O
significantly	|O
and	|O
four	|O
pigs	|O
died	|O
.	|O

Clinical	|O
chemistry	|O
.	|O

Revascularization	|O
after	|O
anterior	|O
maxillary	|O
and	|O
mandibular	|O
osteotomy	|O

Static	|O
orthoses	|O
for	|O
the	|O
management	|O
of	|O
microstomia	|O
.	|O

The	|O
intrapancreatic	|O
spread	|O
of	|O
the	|O
carcinoma	|O
correlated	|O
with	|O
portal	|O
invasion	|O
of	|O
carcinoma	|O
,	|O
hardness	|O
of	|O
the	|O
body	|O
and	|O
tail	|O
,	|O
obstruction	|O
of	|O
main	|O
pancreatic	|O
duct	|O
and	|O
irregular	|O
pancreaticogram	|O
.	|O

Lysosomal	|O
enzymes	|O
that	|O
degrade	|O
cartilage	|O
are	|O
released	|O
.	|O

Contrary	|O
to	|O
the	|O
observation	|O
made	|O
with	|O
other	|O
S.	|O
pombe	|O
genes	|O
transcribed	|O
in	|O
the	|O
budding	|O
yeast	|O
,	|O
the	|O
heterologous	|O
actin	|B-PROTEIN
gene	|O
transcript	|O
is	|O
initiated	|O
39	|O
nucleotides	|O
upstream	|O
of	|O
the	|O
initiation	|O
start	|O
site	|O
used	|O
in	|O
the	|O
homologous	|O
yeast	|O
.	|O

A	|O
multicentre	|O
study	|O
involving	|O
9	|O
Italian	|O
institutions	|O
was	|O
carried	|O
out	|O
to	|O
compare	|O
the	|O
efficacy	|O
and	|O
safety	|O
of	|O
ranitidine	|O
150	|O
mg	|O
b.i.d	|O
.	|O
and	|O
ranitidine	|O
300	|O
mg	|O
nocte	|O
in	|O
the	|O
treatment	|O
of	|O
reflux	|O
oesophagitis	|O
.	|O

Monotherapy	|O
with	|O
ceftazidime	|O
was	|O
clinically	|O
and	|O
bacteriologically	|O
as	|O
effective	|O
as	|O
a	|O
combination	|O
therapy	|O
with	|O
cefazolin	|O
and	|O
tobramycin	|O
.	|O

The	|O
N3	|O
wave	|O
of	|O
the	|O
SSEP	|O
's	|O
,	|O
which	|O
has	|O
been	|O
found	|O
to	|O
correlate	|O
best	|O
with	|O
neurological	|O
recovery	|O
,	|O
returned	|O
to	|O
65%	|O
+	|O
/	|O
-	|O
48%	|O
of	|O
the	|O
preischemia	|O
amplitude	|O
in	|O
the	|O
insulin	|B-PROTEIN
-	|O
treated	|O
animals	|O
,	|O
compared	|O
to	|O
40%	|O
+	|O
/	|O
-	|O
34%	|O
in	|O
the	|O
fasted	|O
group	|O
and	|O
26%	|O
+	|O
/	|O
-	|O
24%	|O
in	|O
the	|O
control	|O
animals	|O
.	|O

Proctoscopy	|O
and	|O
roentgenographic	|O
studies	|O
may	|O
be	|O
an	|O
important	|O
part	|O
of	|O
evaluation	|O
,	|O
especially	|O
in	|O
patients	|O
who	|O
present	|O
with	|O
perianal	|O
suppuration	|O
,	|O
masses	|O
,	|O
or	|O
anal	|O
fissures	|O
.	|O

In	|O
the	|O
control	|O
group	|O
the	|O
histological	|O
picture	|O
resembled	|O
osteoarthritis	|O
.	|O

In	|O
contrast	|O
to	|O
this	|O
mRNA	|O
,	|O
90%	|O
of	|O
alpha	|B-PROTEIN
and	|I-PROTEIN
beta	|I-PROTEIN
actin	|I-PROTEIN
mRNAs	|O
were	|O
translated	|O
in	|O
both	|O
myoblasts	|O
and	|O
myotubes	|O
.	|O

Plasma	|O
renin	|B-PROTEIN
activity	|O
does	|O
not	|O
predict	|O
the	|O
antihypertensive	|O
efficacy	|O
of	|O
chlorthalidone	|O
.	|O

Cephradine	|O
250	|O
mg	|O
at	|O
night	|O
for	|O
12	|O
months	|O
was	|O
given	|O
as	|O
a	|O
prophylactic	|O
measure	|O
to	|O
33	|O
female	|O
patients	|O
of	|O
mean	|O
age	|O
41.6	|O
years	|O
,	|O
who	|O
had	|O
a	|O
history	|O
in	|O
the	|O
preceding	|O
12	|O
months	|O
of	|O
between	|O
three	|O
and	|O
24	|O
(	|O
median	|O
=	|O
7	|O
)	|O
episodes	|O
of	|O
frequency	|O
and	|O
/	|O
or	|O
dysuria	|O
.	|O

If	|O
this	|O
is	|O
unavailable	|O
,	|O
then	|O
Supramid	|O
has	|O
a	|O
proven	|O
record	|O
for	|O
good	|O
tissue	|O
compatibility	|O
and	|O
resistance	|O
to	|O
infection	|O
.	|O

The	|O
size	|O
of	|O
the	|O
group	|O
allocated	|O
to	|O
the	|O
good	|O
compliance	|O
category	|O
by	|O
the	|O
use	|O
of	|O
the	|O
digoxin	|O
marker	|O
was	|O
equivalent	|O
in	|O
size	|O
to	|O
a	|O
group	|O
of	|O
patients	|O
who	|O
had	|O
returned	|O
less	|O
than	|O
15%	|O
of	|O
their	|O
prescribed	|O
dose	|O
or	|O
reported	|O
a	|O
deviation	|O
of	|O
less	|O
than	|O
6%	|O
from	|O
their	|O
prescription	|O
.	|O

Bullous	|O
keratopathy	|O
was	|O
usually	|O
aphakic	|O
in	|O
origin	|O
in	|O
1982	|O
,	|O
but	|O
after	|O
1983	|O
pseudophakic	|O
bullous	|O
keratopathy	|O
(	|O
PBK	|O
)	|O
was	|O
the	|O
most	|O
common	|O
cause	|O
of	|O
bullous	|O
keratopathy	|O
.	|O

The	|O
ultrastructural	|O
findings	|O
,	|O
as	|O
well	|O
as	|O
the	|O
urinary	|O
C	|B-PROTEIN
-	|I-PROTEIN
peptide	|I-PROTEIN
excretion	|O
,	|O
confirmed	|O
that	|O
the	|O
glycemic	|O
effects	|O
should	|O
not	|O
be	|O
thought	|O
to	|O
be	|O
due	|O
to	|O
a	|O
direct	|O
action	|O
of	|O
the	|O
drugs	|O
used	|O
on	|O
the	|O
endocrine	|O
pancreas	|O
.	|O

The	|O
activity	|O
of	|O
the	|O
EGF	|B-PROTEIN
receptor	|I-PROTEIN
promoter	|O
can	|O
be	|O
modulated	|O
by	|O
E1A	|B-PROTEIN
protein	|O
and	|O
receptor	|O
RNA	|O
levels	|O
increased	|O
by	|O
stimulation	|O
with	|O
phorbol	|O
ester	|O
or	|O
fetal	|O
calf	|O
serum	|O
.	|O

In	|O
vitro	|O
antimalarial	|O
activity	|O
of	|O
neem	|O
(	|O
Azadirachta	|O
indica	|O
A.	|O

"	|O
In	|O
vitro	|O
"	|O
study	|O
of	|O
dentin	|O
adhesion	|O
to	|O
adhesives	|O
made	|O
from	|O
urethane	|O
molecules	|O
with	|O
free	|O
groups	|O
of	|O
isocyanate	|O

By	|O
Felix	|O
Lagrange	|O
,	|O
1918	|O
.	|O

There	|O
is	|O
a	|O
cysteine	|O
clustering	|O
region	|O
in	|O
an	|O
N	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
raf	|I-PROTEIN
(	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|I-PROTEIN
product	|O
deduced	|O
from	|O
the	|O
nucleotide	|O
sequence	|O
,	|O
and	|O
this	|O
cysteine	|O
clustering	|O
region	|O
was	|O
found	|O
to	|O
be	|O
highly	|O
homologous	|O
to	|O
that	|O
present	|O
in	|O
an	|O
N	|O
-	|O
terminal	|O
region	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
,	|O
although	|O
,	|O
in	|O
the	|O
latter	|O
cysteine	|O
clusters	|O
are	|O
present	|O
in	|O
duplicate	|O
.	|O

Hand	|O
-	|O
held	|O
,	|O
continuous	|O
-	|O
wave	|O
Doppler	|O
probes	|O
,	|O
coupled	|O
with	|O
sound	|O
spectral	|O
analysis	|O
,	|O
can	|O
successfully	|O
predict	|O
carotid	|O
artery	|O
stenosis	|O
.	|O

The	|O
German	|O
Society	|O
of	|O
Pediatric	|O
Oncology	|O
in	|O
1981	|O
initiated	|O
the	|O
Cooperative	|O
Ewing	|O
's	|O
Sarcoma	|O
Study	|O
(	|O
CESS	|O
81	|O
)	|O
using	|O
a	|O
four	|O
-	|O
drug	|O
combination	|O
of	|O
chemotherapy	|O
prior	|O
to	|O
definitive	|O
local	|O
control	|O
with	|O
surgery	|O
and	|O
/	|O
or	|O
radiation	|O
.	|O

The	|O
program	|O
has	|O
been	|O
written	|O
in	|O
a	|O
generic	|O
BASIC	|O
in	|O
order	|O
to	|O
make	|O
the	|O
procedure	|O
user	|O
-	|O
friendly	|O
.	|O

Since	|O
high	|O
levels	|O
of	|O
immunoglobulin	|B-PROTEIN
G	|I-PROTEIN
were	|O
demonstrated	|O
against	|O
the	|O
surface	|O
of	|O
the	|O
NVS	|O
after	|O
immunization	|O
,	|O
passive	|O
transfer	|O
experiments	|O
were	|O
initiated	|O
.	|O

A	|O
study	|O
was	|O
conducted	|O
of	|O
a	|O
human	|O
male	|O
who	|O
had	|O
inhaled	|O
a	|O
mixture	|O
of	|O
241Am	|O
and	|O
Pu	|O
.	|O

An	|O
analytic	|O
method	|O
for	|O
comparative	|O
parameter	|O
weighting	|O
in	|O
magnetic	|O
resonance	|O
(	|O
MR	|O
)	|O
imaging	|O
has	|O
been	|O
developed	|O
using	|O
the	|O
concept	|O
of	|O
"	|O
fractional	|O
sensitivity	|O
.	|O
"	|O
This	|O
new	|O
approach	|O
results	|O
in	|O
easily	|O
calculated	|O
indexes	|O
for	|O
T1	|O
,	|O
T2	|O
,	|O
and	|O
hydrogen	|O
weighting	|O
.	|O

Fifty	|O
-	|O
four	|O
patients	|O
were	|O
divided	|O
into	|O
groups	|O
according	|O
to	|O
their	|O
clinical	|O
presentation	|O
;	|O
seven	|O
asymptomatic	|O
volunteers	|O
,	|O
20	|O
patients	|O
with	|O
duodenal	|O
-	|O
gastric	|O
reflux	|O
gastropathy	|O
(	|O
DRG	|O
)	|O
,	|O
16	|O
patients	|O
with	|O
recurrent	|O
ulcers	|O
of	|O
the	|O
duodenal	|O
bulb	|O
(	|O
RUD	|O
)	|O
,	|O
and	|O
11	|O
patients	|O
with	|O
Moynihan	|O
's	|O
disease	|O
.	|O

No	|O
previous	|O
studies	|O
have	|O
determined	|O
the	|O
pharmaco	|O
-	|O
dynamics	|O
of	|O
intravenous	|O
procainamide	|O
when	|O
administered	|O
in	|O
a	|O
dose	|O
of	|O
15	|O
mg	|O
/	|O
kg	|O
and	|O
at	|O
a	|O
rate	|O
of	|O
50	|O
mg	|O
/	|O
min	|O
,	|O
as	|O
is	|O
common	|O
practice	|O
during	|O
electropharmacologic	|O
testing	|O
.	|O

High	|O
concentrations	|O
of	|O
tumor	|O
-	|O
associated	|O
trypsin	|B-PROTEIN
inhibitor	|O
in	|O
hemodialyzed	|O
patients	|O
.	|O

In	|O
the	|O
chicken	|O
liver	|O
,	|O
levels	|O
of	|O
chicken	|O
MT	|B-PROTEIN
mRNA	|O
were	|O
rapidly	|O
induced	|O
by	|O
metals	|O
(	|O
Cd2+	|O
,	|O
Zn2+	|O
,	|O
Cu2+	|O
)	|O
,	|O
glucocorticoids	|O
and	|O
lipopolysaccharide	|O
.	|O

With	|O
histology	|O
and	|O
Evans	|O
blue	|O
injections	|O
,	|O
blood	|O
-	|O
brain	|O
barrier	|O
alterations	|O
were	|O
seen	|O
as	|O
early	|O
as	|O
4	|O
days	|O
after	|O
a	|O
dose	|O
of	|O
50	|O
Gy	|O
.	|O

Dosimetric	|O
estimates	|O
for	|O
these	|O
organs	|O
were	|O
2.3	|O
+	|O
/	|O
-	|O
1.1	|O
and	|O
2.3	|O
+	|O
/	|O
-	|O
1.4	|O
rad	|O
(	|O
.02	|O
+	|O
/	|O
-	|O
.01	|O
Gy	|O
)	|O
,	|O
respectively	|O
,	|O
with	|O
a	|O
whole	|O
-	|O
body	|O
estimate	|O
of	|O
0.28	|O
rad	|O
(	|O
.003	|O
Gy	|O
)	|O
.	|O

A	|O
significant	|O
association	|O
between	|O
a	|O
family	|O
history	|O
and	|O
a	|O
higher	|O
urinary	|O
pH	|O
was	|O
observed	|O
among	|O
the	|O
female	|O
calcium	|O
stone	|O
patients	|O
.	|O

New	|O
technologies	|O
in	|O
diagnosis	|O
and	|O
classification	|O
of	|O
malignancy	|O
.	|O

Thus	|O
the	|O
present	|O
data	|O
also	|O
suggest	|O
that	|O
BP	|O
and	|O
HR	|O
measurements	|O
are	|O
influenced	|O
not	|O
only	|O
by	|O
state	|O
-	|O
dependent	|O
factors	|O
but	|O
also	|O
by	|O
at	|O
least	|O
three	|O
different	|O
factors	|O
that	|O
are	|O
each	|O
independent	|O
of	|O
the	|O
state	|O
:	|O
one	|O
leads	|O
to	|O
BP	|O
and	|O
HR	|O
values	|O
that	|O
are	|O
influenced	|O
by	|O
the	|O
cycle	|O
the	|O
animal	|O
is	|O
in	|O
and	|O
the	|O
other	|O
two	|O
influence	|O
,	|O
respectively	|O
,	|O
the	|O
ranking	|O
of	|O
the	|O
individual	|O
's	|O
BP	|O
and	|O
HR	|O
levels	|O
within	|O
the	|O
population	|O
.	|O

The	|O
correlation	|O
between	|O
PaCO2	|O
and	|O
PtcO2	|O
in	|O
RDS	|O
was	|O
insufficient	|O
to	|O
make	|O
clinical	|O
judgement	|O
.	|O

Since	|O
1967	|O
at	|O
the	|O
times	|O
of	|O
their	|O
biennial	|O
ABCC	|O
/	|O
RERF	|O
radiological	|O
examinations	|O
,	|O
all	|O
Adult	|O
Health	|O
Study	|O
(	|O
AHS	|O
)	|O
subjects	|O
have	|O
been	|O
interviewed	|O
to	|O
determine	|O
the	|O
exposures	|O
to	|O
medical	|O
x	|O
-	|O
rays	|O
they	|O
experienced	|O
in	|O
institutions	|O
other	|O
than	|O
RERF	|O
in	|O
order	|O
to	|O
estimate	|O
the	|O
numbers	|O
of	|O
examinations	|O
and	|O
corresponding	|O
doses	|O
which	|O
they	|O
received	|O
.	|O

The	|O
epidermal	|O
growth	|O
factor	|O
(	|B-PROTEIN
EGF	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
which	|O
exhibits	|O
intrinsic	|O
protein	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
,	|O
undergoes	|O
a	|O
rapid	|O
,	|O
intramolecular	|O
self	|O
-	|O
phosphorylation	|O
reaction	|O
following	|O
EGF	|B-PROTEIN
activation	|O
.	|O

One	|O
millimolar	|O
ouabain	|O
completely	|O
inhibited	|O
net	|O
HCO3	|O
-	|O
secretion	|O
.	|O

There	|O
are	|O
regions	|O
with	|O
long	|O
runs	|O
of	|O
up	|O
to	|O
45%	|O
C	|O
or	|O
35%	|O
G	|O
residues	|O
.	|O

The	|O
same	|O
rhythmic	|O
structure	|O
enables	|O
a	|O
prediction	|O
to	|O
be	|O
made	|O
concerning	|O
when	|O
vowels	|O
of	|O
stressed	|O
syllables	|O
will	|O
be	|O
auditorily	|O
perceived	|O
.	|O

Vocal	|O
cord	|O
abduction	|O
rehabilitation	|O
by	|O
nervous	|O
selective	|O
anastomosis	|O
.	|O

UK	|O
's	|O
biotechnology	|O
lacking	|O
specialists	|O
.	|O

A	|O
case	|O
of	|O
AIDS	|O
-	|O
related	|O
complex	|O
(	|O
ARC	|O
/	|O
LAS	|O
)	|O
in	|O
a	|O
health	|O
worker	|O

Distant	|O
spread	|O
was	|O
found	|O
in	|O
46	|O
patients	|O
(	|O
34%	|O
)	|O
,	|O
42	|O
of	|O
whom	|O
had	|O
serum	|O
Tg	|B-PROTEIN
greater	|O
than	|O
10	|O
micrograms	|O
/	|O
l	|O
.	|O

The	|O
glomerular	|O
filtration	|O
rate	|O
and	|O
effective	|O
renal	|O
plasma	|O
flow	|O
were	|O
determined	|O
by	|O
a	|O
standard	|O
clearance	|O
method	|O
,	|O
employing	|O
continuous	|O
infusion	|O
of	|O
inulin	|O
and	|O
para	|O
-	|O
aminohippuric	|O
acid	|O
.	|O

After	|O
the	|O
meal	|O
containing	|O
potato	|O
,	|O
plasma	|O
glucose	|O
levels	|O
rose	|O
sharply	|O
,	|O
peaked	|O
at	|O
30-45	|O
min	|O
and	|O
fell	|O
below	|O
initial	|O
levels	|O
2	|O
to	|O
3	|O
h	|O
later	|O
.	|O

The	|O
relations	|O
among	|O
various	|O
negative	|O
emotional	|O
and	|O
behavioral	|O
characteristics	|O
(	|O
e.g.	|O
,	|O
aggression	|O
,	|O
anxiety	|O
,	|O
undercompliance	|O
,	|O
depressive	|O
mood	|O
)	|O
and	|O
adjustment	|O
were	|O
examined	|O
through	|O
use	|O
of	|O
data	|O
from	|O
the	|O
31	|O
-	|O
year	|O
-	|O
old	|O
New	|O
York	|O
Longitudinal	|O
Study	|O
.	|O

To	|O
evaluate	|O
the	|O
effect	|O
of	|O
altitude	|O
on	|O
adolescent	|O
growth	|O
and	|O
development	|O
,	|O
three	|O
groups	|O
of	|O
healthy	|O
,	|O
well	|O
-	|O
nourished	|O
youth	|O
of	|O
similar	|O
socioeconomic	|O
status	|O
and	|O
ethnic	|O
grouping	|O
who	|O
resided	|O
at	|O
sea	|O
level	|O
(	|O
n	|O
=	|O
1262	|O
subjects	|O
)	|O
,	|O
mid	|O
-	|O
altitude	|O
(	|O
n	|O
=	|O
1743	|O
subjects	|O
)	|O
,	|O
and	|O
high	|O
altitude	|O
(	|O
n	|O
=	|O
1137	|O
subjects	|O
)	|O
were	|O
studied	|O
.	|O

Because	|O
the	|O
CAP	|O
measures	|O
variables	|O
predictive	|O
of	|O
abusive	|O
behavior	|O
,	|O
a	|O
substantial	|O
relationship	|O
was	|O
expected	|O
between	|O
the	|O
CAP	|O
and	|O
the	|O
MHI	|O
Loss	|O
of	|O
Behavioral	|O
/	|O
Emotional	|O
Control	|O
scale	|O
.	|O

We	|O
have	|O
improved	|O
our	|O
system	|O
for	|O
nuclear	|O
contour	|O
digitization	|O
and	|O
determined	|O
its	|O
theoretical	|O
limitations	|O
by	|O
digitizing	|O
standardized	|O
objects	|O
.	|O

Such	|O
a	|O
change	|O
may	|O
involve	|O
increased	|O
mammary	|O
utilization	|O
of	|O
pre	|O
-	|O
formed	|O
long	|O
-	|O
chain	|O
fatty	|O
acid	|O
and	|O
increased	|O
metabolism	|O
of	|O
glucose	|O
via	|O
glycolysis	|O
.	|O

The	|O
skin	|O
site	|O
,	|O
6	|O
-	|O
cm	|O
-	|O
distal	|O
and	|O
-	|O
proximal	|O
subcutaneous	|O
segments	|O
of	|O
the	|O
catheter	|O
,	|O
exudates	|O
,	|O
and	|O
blood	|O
were	|O
cultured	|O
.	|O

Because	|O
of	|O
its	|O
great	|O
reliability	|O
,	|O
conventional	|O
arteriography	|O
occupies	|O
a	|O
place	|O
of	|O
choice	|O
among	|O
the	|O
medical	|O
imaging	|O
techniques	|O
.	|O

Rapid	|O
detection	|O
of	|O
radioisotopically	|O
contaminated	|O
test	|O
serum	|O
before	|O
radioassay	|O
of	|O
vitamin	|O
B12	|O
.	|O

The	|O
former	|O
group	|O
did	|O
excrete	|O
less	|O
dry	|O
fecal	|O
material	|O
compared	|O
to	|O
both	|O
other	|O
groups	|O
.	|O

Electronic	|O
data	|O
processing	|O
(	|O
EDP	|O
)	|O
latex	|O
immunoassay	|O
using	|O
anti	|B-PROTEIN
-	|I-PROTEIN
human	|I-PROTEIN
seminal	|I-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HSAP	|I-PROTEIN
)	|O
immune	|O
serum	|O
was	|O
applied	|O
for	|O
the	|O
species	|O
and	|O
organ	|O
identification	|O
of	|O
human	|O
seminal	|O
stains	|O
.	|O

Vimentin	|B-PROTEIN
positivity	|O
was	|O
noted	|O
in	|O
the	|O
undifferentiated	|O
and	|O
fibroblastic	|O
components	|O
.	|O

The	|O
maximum	|O
deflections	|O
of	|O
phase	|O
IV	|O
for	|O
Ar	|O
and	|O
N2	|O
from	|O
extrapolated	|O
phase	|O
III	|O
slopes	|O
were	|O
smaller	|O
in	|O
the	|O
prone	|O
position	|O
,	|O
suggesting	|O
more	|O
uniform	|O
tracer	|O
gas	|O
concentrations	|O
across	|O
the	|O
lungs	|O
.	|O

Recent	|O
developments	|O
in	|O
drugs	|O
antagonistic	|O
to	|O
factors	|O
causing	|O
peptic	|O
ulcer	|O
-	|O
-	|O
clinical	|O
efficacy	|O
and	|O
problems	|O
;	|O
gastrin	|B-PROTEIN
receptor	|I-PROTEIN
blockaders	|O

The	|O
spermicide	|O
nonoxynol	|O
-	|O
9	|O
is	|O
a	|O
member	|O
of	|O
a	|O
homologous	|O
series	|O
of	|O
alkylphenol	|O
-	|O
ethoxylates	|O
(	|O
polyethoxyethanols	|O
)	|O
of	|O
general	|O
formula	|O
C9H19	|O
-	|O
C6H6	|O
-	|O
O	|O
-	|O
(	|O
CH2CH2O	|O
)	|O
n	|O
-	|O
1	|O
CH2CH2OH	|O
.	|O

Static	|O
magnetic	|O
fields	|O
affect	|O
the	|O
diffusion	|O
of	|O
biological	|O
particles	|O
in	|O
solutions	|O
through	|O
the	|O
Lorentz	|O
force	|O
and	|O
Maxwell	|O
stress	|O
.	|O

Psychological	|O
disturbance	|O
was	|O
greater	|O
in	|O
the	|O
high	|O
life	|O
stress	|O
group	|O
as	|O
indicated	|O
by	|O
significant	|O
elevations	|O
on	|O
the	|O
global	|O
severity	|O
index	|O
of	|O
the	|O
Symptom	|O
Checklist	|O
-	|O
90	|O
and	|O
elevations	|O
on	|O
somatization	|O
,	|O
obsessive	|O
compulsive	|O
,	|O
interpersonal	|O
sensitivity	|O
,	|O
depression	|O
,	|O
anxiety	|O
and	|O
psychoticism	|O
subscales	|O
.	|O

Chronic	|O
administration	|O
of	|O
sodium	|O
cyanate	|O
decreases	|O
O2	|O
extraction	|O
ratio	|O
in	|O
dogs	|O
.	|O

Nucleotide	|O
sequencing	|O
indicates	|O
that	|O
this	|O
E1	|B-PROTEIN
alpha	|I-PROTEIN
cDNA	|O
clone	|O
is	|O
1821	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
in	|O
length	|O
with	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
1365	|O
bp	|O
and	|O
a	|O
3'	|O
-	|O
untranslated	|O
region	|O
of	|O
356	|O
bp	|O
.	|O

SPA	|O
from	|O
PAG	|O
sites	|O
was	|O
associated	|O
with	|O
aversion	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
MAN	|O
showed	|O
a	|O
unimodal	|O
,	|O
skewed	|O
distribution	|O
,	|O
with	|O
a	|O
range	|O
from	|O
approximately	|O
1	|O
to	|O
14	|O
micron	|O
and	|O
a	|O
maximum	|O
at	|O
3-4	|O
micron	|O
.	|O

Abnormal	|O
technetium	|O
Tc	|O
99m	|O
medronate	|O
scans	|O
in	|O
patients	|O
with	|O
previously	|O
undiagnosed	|O
polyarthralgias	|O
suggested	|O
inflammatory	|O
arthropathy	|O
and	|O
influenced	|O
management	|O
decisions	|O
with	|O
favorable	|O
therapeutic	|O
outcomes	|O
.	|O

Practical	|O
interest	|O
of	|O
such	|O
studies	|O
is	|O
limited	|O
since	|O
the	|O
pharmacokinetic	|O
parameters	|O
are	|O
systematically	|O
evaluated	|O
in	|O
man	|O
during	|O
phase	|O
I	|O
trials	|O
.	|O

The	|O
artery	|O
cuff	|O
was	|O
slightly	|O
superior	|O
to	|O
the	|O
fat	|O
wrap	|O
,	|O
particularly	|O
in	|O
having	|O
fewer	|O
adhesions	|O
and	|O
a	|O
better	|O
histological	|O
picture	|O
.	|O

Lithium	|O
-	|O
carbonate	|O
action	|O
during	|O
radiation	|O
therapy	|O
has	|O
been	|O
studied	|O
,	|O
valuing	|O
the	|O
positive	|O
effect	|O
on	|O
leukopoiesis	|O
and	|O
the	|O
consequent	|O
better	|O
clinical	|O
conditions	|O
of	|O
the	|O
patients	|O
in	|O
course	|O
of	|O
treatment	|O
.	|O

Of	|O
the	|O
53	|O
units	|O
tested	|O
during	|O
sinusoidal	|O
motion	|O
at	|O
0.05	|O
Hz	|O
(	|O
9.1	|O
cm	|O
/	|O
s	|O
)	|O
,	|O
1	|O
(	|O
1.9%	|O
)	|O
was	|O
responsive	|O
to	|O
the	|O
otolith	|O
input	|O
only	|O
,	|O
13	|O
(	|O
24.5%	|O
)	|O
were	|O
influenced	|O
by	|O
the	|O
visual	|O
input	|O
only	|O
and	|O
23	|O
(	|O
43.4%	|O
)	|O
responded	|O
to	|O
both	|O
modalities	|O
.	|O

Depending	|O
on	|O
the	|O
location	|O
and	|O
size	|O
of	|O
the	|O
mass	|O
,	|O
a	|O
wide	|O
range	|O
of	|O
clinical	|O
presentations	|O
is	|O
associated	|O
with	|O
the	|O
lesion	|O
.	|O

The	|O
development	|O
and	|O
distribution	|O
of	|O
Trypanosoma	|O
congolense	|O
,	|O
T	|O
vivax	|O
and	|O
T	|O
brucei	|O
in	|O
the	|O
skin	|O
of	|O
goats	|O
was	|O
examined	|O
after	|O
the	|O
animals	|O
were	|O
bitten	|O
by	|O
infected	|O
Glossina	|O
morsitans	|O
centralis	|O
.	|O

Electroglottography	|O
is	|O
a	|O
useful	|O
,	|O
non	|O
-	|O
invasive	|O
technique	|O
that	|O
can	|O
assist	|O
in	|O
the	|O
assessment	|O
of	|O
vocal	|O
fold	|O
dysfunction	|O
.	|O

Statistical	|O
analysis	|O
of	|O
the	|O
degrees	|O
of	|O
secondary	|O
spinal	|O
cord	|O
compression	|O
was	|O
performed	|O
in	|O
group	|O
-	|O
1	|O
dogs	|O
by	|O
measuring	|O
and	|O
comparing	|O
ratios	|O
of	|O
the	|O
vertical	|O
to	|O
the	|O
horizontal	|O
diameters	|O
of	|O
the	|O
transverse	|O
spinal	|O
cord	|O
sections	|O
from	|O
locations	|O
within	|O
(	|O
T12	|O
to	|O
L1	|O
)	|O
and	|O
out	|O
of	|O
(	|O
T11	|O
,	|O
T11	|O
-	|O
12	|O
,	|O
L1	|O
-	|O
2	|O
,	|O
and	|O
L2	|O
)	|O
the	|O
region	|O
of	|O
surgical	|O
intervention	|O
.	|O

The	|O
pharmacological	|O
effects	|O
of	|O
the	|O
novel	|O
compound	|O
WEB	|O
1881	|O
FU	|O
(	|O
4	|O
-	|O
amino	|O
-	|O
methyl	|O
-	|O
1	|O
-	|O
benzyl	|O
-	|O
pyrrolidine	|O
-	|O
2	|O
-	|O
one	|O
-	|O
fumarate	|O
)	|O
were	|O
investigated	|O
.	|O

Histopathological	|O
examination	|O
revealed	|O
dose	|O
-	|O
related	|O
proliferation	|O
of	|O
type	|O
II	|O
pneumocytes	|O
in	|O
dams	|O
and	|O
proliferation	|O
of	|O
interstitial	|O
cells	|O
and	|O
delayed	|O
septal	|O
/	|O
capillary	|O
development	|O
in	|O
neonates	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

So	|O
far	|O
no	|O
problems	|O
with	|O
multiply	|O
resistant	|O
strains	|O
have	|O
developed	|O
.	|O

During	|O
the	|O
observation	|O
period	|O
of	|O
0.4-30	|O
weeks	|O
,	|O
cardiac	|O
white	|O
spots	|O
on	|O
the	|O
right	|O
ventricle	|O
of	|O
BALB	|O
/	|O
c	|O
mice	|O
were	|O
first	|O
detected	|O
at	|O
three	|O
weeks	|O
(	|O
6	|O
of	|O
20	|O
mice	|O
;	|O
30%	|O
)	|O
,	|O
and	|O
the	|O
maximal	|O
incidence	|O
of	|O
cardiac	|O
white	|O
spots	|O
was	|O
obtained	|O
at	|O
nine	|O
weeks	|O
(	|O
39	|O
of	|O
44	|O
mice	|O
;	|O
88%	|O
)	|O
.	|O

The	|O
state	|O
of	|O
the	|O
liver	|O
in	|O
generalized	|O
forms	|O
of	|O
meningococcal	|O
infection	|O

Increasing	|O
the	|O
RH	|O
beyond	|O
32%	|O
resulted	|O
in	|O
solvation	|O
of	|O
the	|O
peroxy	|O
radical	|O
,	|O
sterically	|O
hindering	|O
the	|O
radical	|O
from	|O
entering	|O
the	|O
propagation	|O
transition	|O
state	|O
.	|O

The	|O
effects	|O
produced	|O
by	|O
oral	|O
administration	|O
of	|O
500	|O
mg	|O
/	|O
kg	|O
p	|O
-	|O
xylene	|O
or	|O
toluene	|O
lasted	|O
at	|O
least	|O
8	|O
hr	|O
,	|O
while	|O
the	|O
effect	|O
of	|O
inhaled	|O
p	|O
-	|O
xylene	|O
dissipated	|O
within	|O
75	|O
min	|O
of	|O
removal	|O
from	|O
the	|O
exposure	|O
.	|O

PATIENTS	|O
and	|O
METHODS	|O
:	|O
Thallium	|O
-	|O
201	|O
myocardial	|O
scintigraphy	|O
was	|O
performed	|O
at	|O
rest	|O
and	|O
after	|O
0.56	|O
mg	|O
/	|O
kg	|O
intravenous	|O
dipyridamole	|O
during	|O
four	|O
minutes	|O
in	|O
16	|O
patients	|O
with	|O
sarcoidosis	|O
.	|O

Thin	|O
melanomas	|O
can	|O
metastasize	|O
and	|O
be	|O
lethal	|O
.	|O

The	|O
TA	|O
muscle	|O
was	|O
fatigued	|O
by	|O
four	|O
forms	|O
of	|O
repeated	|O
isometric	|O
contractions	|O
:	|O
(	|O
1	|O
)	|O
maximal	|O
voluntary	|O
contractions	|O
(	|O
MVC	|O
)	|O
,	|O
(	|O
2	|O
)	|O
MVC	|O
with	|O
circulation	|O
occluded	|O
,	|O
(	|O
3	|O
)	|O
electrically	|O
evoked	|O
contractions	|O
with	|O
20	|O
Hz	|O
supramaximal	|O
voltage	|O
stimulation	|O
and	|O
(	|O
4	|O
)	|O
electrically	|O
evoked	|O
contractions	|O
with	|O
circulation	|O
occluded	|O
.	|O

The	|O
actuarial	|O
local	|O
control	|O
rates	|O
at	|O
10	|O
years	|O
for	|O
the	|O
three	|O
treatment	|O
groups	|O
were	|O
as	|O
follows	|O
:	|O
subtotal	|O
excision	|O
alone	|O
,	|O
18%	|O
;	|O
subtotal	|O
excision	|O
plus	|O
postoperative	|O
radiation	|O
therapy	|O
,	|O
82%	|O
;	|O
and	|O
total	|O
excision	|O
alone	|O
,	|O
77%	|O
.	|O

The	|O
effects	|O
of	|O
anabolic	|O
implants	|O
on	|O
rate	|O
,	|O
composition	|O
and	|O
energetic	|O
efficiency	|O
of	|O
growth	|O
were	|O
determined	|O
in	|O
steers	|O
fed	|O
diets	|O
varying	|O
in	|O
forage	|O
and	|O
grain	|O
content	|O
.	|O

Prolonged	|O
suspension	|O
induced	|O
a	|O
significant	|O
change	|O
in	|O
the	|O
geometric	|O
configuration	|O
of	|O
the	|O
femur	|O
middiaphysis	|O
by	|O
increasing	|O
the	|O
minimum	|O
diameter	|O
(	|O
12%	|O
)	|O
without	|O
any	|O
significant	|O
alterations	|O
in	|O
cortical	|O
area	|O
,	|O
density	|O
,	|O
mineral	|O
,	|O
and	|O
collagen	|B-PROTEIN
concentrations	|O
.	|O

Which	|O
cineangiographically	|O
assessed	|O
anatomic	|O
variable	|O
correlates	|O
best	|O
with	|O
functional	|O
measurements	|O
of	|O
stenosis	|O
severity	|O
?	|O
A	|O
comparison	|O
of	|O
quantitative	|O
analysis	|O
of	|O
the	|O
coronary	|O
cineangiogram	|O
with	|O
measured	|O
coronary	|O
flow	|O
reserve	|O
and	|O
exercise	|O
/	|O
redistribution	|O
thallium	|O
-	|O
201	|O
scintigraphy	|O
.	|O

Water	|O
content	|O
and	|O
equilibrium	|O
water	|O
partition	|O
in	|O
immature	|O
cartilage	|O
.	|O

Thyroid	|O
function	|O
tests	|O
were	|O
performed	|O
on	|O
300	|O
admissions	|O
,	|O
leaving	|O
707	|O
untested	|O
.	|O

Data	|O
on	|O
the	|O
line	|O
spread	|O
function	|O
(	|O
LSF	|O
)	|O
were	|O
obtained	|O
from	|O
the	|O
image	|O
of	|O
a	|O
0.2	|O
mm	|O
wide	|O
slit	|O
between	|O
tungsten	|O
blocks	|O
that	|O
were	|O
positioned	|O
at	|O
the	|O
isocentre	|O
in	|O
front	|O
of	|O
a	|O
polystyrene	|O
phantom	|O
.	|O

Primary	|O
infection	|O
is	|O
usually	|O
managed	|O
conservatively	|O
.	|O

Papers	|O
of	|O
the	|O
Society	|O
for	|O
Clinical	|O
Vascular	|O
Surgery	|O
.	|O

Ischemic	|O
heart	|O
disease	|O
,	|O
age	|O
of	|O
more	|O
than	|O
75	|O
years	|O
,	|O
and	|O
the	|O
fact	|O
that	|O
the	|O
patient	|O
was	|O
a	|O
woman	|O
were	|O
independent	|O
predictors	|O
of	|O
poor	|O
cardiac	|O
function	|O
.	|O

Prognosis	|O
in	|O
Bowen	|O
's	|O
disease	|O
localized	|O
to	|O
the	|O
ano	|O
-	|O
genital	|O
region	|O
.	|O

Taken	|O
together	|O
,	|O
the	|O
results	|O
suggest	|O
that	|O
chlorphentermine	|O
may	|O
be	|O
capable	|O
of	|O
producing	|O
dual	|O
stimulus	|O
effects	|O
in	|O
animals	|O
.	|O

Liquid	|O
chromatographic	|O
method	|O
for	|O
determination	|O
of	|O
citreoviridin	|O
in	|O
corn	|O
and	|O
rice	|O
.	|O

These	|O
findings	|O
indicate	|O
that	|O
autophosphorylation	|O
of	|O
Thr286	|O
(	|O
alpha	|O
subunit	|O
)	|O
and	|O
Thr287	|O
(	|O
beta	|O
subunit	|O
)	|O
is	|O
responsible	|O
for	|O
transition	|O
of	|O
CaM	|B-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
II	|I-PROTEIN
to	|O
the	|O
Ca2+	|O
-	|O
independent	|O
form	|O
.	|O

This	|O
rapid	|O
and	|O
extensive	|O
penetration	|O
of	|O
intrathecally	|O
administered	|O
chemotherapy	|O
may	|O
offer	|O
insight	|O
into	|O
the	|O
myelopathy	|O
observed	|O
with	|O
these	|O
treatments	|O
.	|O

The	|O
interaction	|O
of	|O
radiation	|O
and	|O
hyperthermia	|O
was	|O
systematically	|O
studied	|O
in	|O
the	|O
Dunning	|O
R3327G	|O
prostatic	|O
adenocarcinoma	|O
,	|O
the	|O
preeminent	|O
animal	|O
model	|O
for	|O
human	|O
prostatic	|O
cancer	|O
.	|O

Pregnant	|O
rats	|O
were	|O
exposed	|O
to	|O
one	|O
of	|O
the	|O
following	|O
:	|O
(	|O
1	|O
)	|O
10%	|O
O2	|O
in	|O
N2	|O
or	|O
100%	|O
O2	|O
for	|O
2	|O
days	|O
beginning	|O
at	|O
day	|O
7	|O
,	|O
11	|O
,	|O
14	|O
,	|O
or	|O
18	|O
of	|O
pregnancy	|O
;	|O
(	|O
2	|O
)	|O
10%	|O
O2	|O
in	|O
N2	|O
or	|O
100%	|O
O2	|O
for	|O
10	|O
h	|O
/	|O
day	|O
beginning	|O
at	|O
day	|O
7	|O
;	|O
or	|O
(	|O
3	|O
)	|O
14-11%	|O
O2	|O
in	|O
N2	|O
continuously	|O
beginning	|O
at	|O
day	|O
14	|O
till	|O
day	|O
21	|O
when	|O
they	|O
were	|O
sacrificed	|O
.	|O

The	|O
incidence	|O
of	|O
cryptosporidiosis	|O
in	|O
young	|O
children	|O
was	|O
determined	|O
by	|O
staining	|O
of	|O
faecal	|O
specimens	|O
with	|O
a	|O
modified	|O
Kinyoun	|O
stain	|O
.	|O

Seven	|O
patients	|O
(	|O
8.3	|O
percent	|O
)	|O
had	|O
latent	|O
hypothyroidism	|O
only	|O
discovered	|O
by	|O
hormonal	|O
determinations	|O
.	|O

Addition	|O
of	|O
sucralfate	|O
or	|O
De	|O
-	|O
Nol	|O
resulted	|O
in	|O
increments	|O
of	|O
gastric	|O
HCO3	|O
secretion	|O
,	|O
reaching	|O
about	|O
45%	|O
and	|O
59%	|O
,	|O
respectively	|O
,	|O
of	|O
the	|O
maximal	|O
HCO3	|O
response	|O
to	|O
16,16	|O
-	|O
dimethyl	|O
PGE2	|O
(	|O
dmPGE2	|O
)	|O
.	|O

Moreover	|O
,	|O
unlike	|O
control	|O
rats	|O
operated	|O
animals	|O
did	|O
not	|O
show	|O
aversion	|O
to	|O
the	|O
highest	|O
concentrations	|O
of	|O
saccharin	|O
solutions	|O
.	|O

In	|O
Salmo	|O
gairdneri	|O
,	|O
no	|O
specialized	|O
system	|O
of	|O
portal	|O
vessels	|O
appears	|O
to	|O
exist	|O
between	|O
the	|O
pineal	|O
organ	|O
and	|O
other	|O
portions	|O
of	|O
the	|O
brain	|O
.	|O

The	|O
4	|O
degrees	|O
stimuli	|O
were	|O
found	|O
to	|O
elicit	|O
scalp	|O
distributions	|O
for	|O
the	|O
pattern	|O
reversal	|O
P100	|O
and	|O
the	|O
pattern	|O
onset	|O
C1	|O
consistent	|O
with	|O
striate	|O
and	|O
extrastriate	|O
visual	|O
cortical	|O
origins	|O
respectively	|O
.	|O

Nuclear	|B-PROTEIN
factor	|I-PROTEIN
III	|I-PROTEIN
(	|O
NFIII	|B-PROTEIN
)	|O
is	|O
a	|O
protein	|O
from	|O
HeLa	|O
cells	|O
that	|O
stimulates	|O
the	|O
initiation	|O
of	|O
adenovirus	|O
type	|O
2	|O
(	|O
Ad2	|O
)	|O
DNA	|O
replication	|O
by	|O
binding	|O
to	|O
a	|O
specific	|O
nucleotide	|O
sequence	|O
in	|O
the	|O
origin	|O
,	|O
adjacent	|O
to	|O
the	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
recognition	|O
site	|O
.	|O

A	|O
Golgi	|O
study	|O
of	|O
the	|O
sixth	|O
layer	|O
of	|O
the	|O
cerebral	|O
cortex	|O
.	|O

We	|O
conclude	|O
that	|O
cephalothin	|O
clearance	|O
of	|O
S.	|O
aureus	|O
from	|O
a	|O
site	|O
accessible	|O
to	|O
phagocytes	|O
was	|O
delayed	|O
when	|O
compared	|O
to	|O
a	|O
phagocyte	|O
-	|O
inaccessible	|O
site	|O
.	|O

The	|O
findings	|O
are	|O
discussed	|O
in	|O
the	|O
context	|O
of	|O
known	|O
properties	|O
of	|O
cortical	|O
-	|O
bar	|O
detectors	|O
.	|O

Mean	|O
rCBF	|O
increased	|O
in	|O
some	|O
patients	|O
4-8	|O
weeks	|O
after	|O
surgery	|O
on	|O
the	|O
ipsilateral	|O
side	|O
.	|O

Quantitative	|O
computed	|O
tomography	|O
for	|O
measuring	|O
vertebral	|O
bone	|O
mineral	|O
content	|O
offers	|O
high	|O
sensitivity	|O
and	|O
reproducibility	|O
.	|O

The	|O
structure	|O
of	|O
the	|O
enhancer	|O
was	|O
also	|O
probed	|O
by	|O
inserting	|O
a	|O
pair	|O
of	|O
complementary	|O
synthetic	|O
oligodeoxynucleotides	|O
which	|O
represented	|O
the	|O
region	|O
between	|O
nt	|O
positions	|O
-	|O
235	|O
and	|O
-	|O
215	|O
into	|O
a	|O
truncated	|O
template	|O
which	|O
lacked	|O
the	|O
enhancer	|O
.	|O

Kf	|O
,	|O
c	|O
and	|O
CT	|O
(	|O
referenced	|O
to	|O
the	|O
initial	|O
lung	|O
mass	|O
)	|O
decreased	|O
linearly	|O
with	|O
reductions	|O
in	|O
lung	|O
mass	|O
%	|O
delta	|O
Kf	|O
,	|O
c	|O
=	|O
1.26-0.98%	|O
mass	|O
removed	|O
(	|O
r	|O
=	|O
0.90	|O
,	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
and	|O
%	|O
delta	|O
CT	|O
=	|O
-	|O
3.99-0.98%	|O
mass	|O
removed	|O
(	|O
r	|O
=	|O
0.82	|O
,	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
relationships	|O
that	|O
were	|O
not	|O
altered	|O
by	|O
blocker	|O
pretreatment	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Two	|O
scintigraphic	|O
methods	|O
,	|O
resting	|O
dipyridamole	|O
and	|O
exercise	|O
thallium	|O
-	|O
201	|O
myocardial	|O
perfusion	|O
imaging	|O
,	|O
to	|O
detect	|O
and	|O
localize	|O
coronary	|O
artery	|O
stenosis	|O
were	|O
compared	|O
in	|O
32	|O
patients	|O
suffering	|O
from	|O
coronary	|O
artery	|O
disease	|O
.	|O

From	|O
these	|O
results	|O
,	|O
it	|O
is	|O
concluded	|O
that	|O
EDLF	|O
has	|O
clear	|O
vasoconstrictor	|O
properties	|O
which	|O
are	|O
not	|O
due	|O
to	|O
adrenergic	|O
or	|O
calcium	|O
entry	|O
mechanisms	|O
and	|O
that	|O
there	|O
are	|O
differences	|O
in	|O
the	|O
vasoconstrictor	|O
effects	|O
of	|O
EDLFs	|O
with	|O
respect	|O
to	|O
different	|O
vascular	|O
beds	|O
.	|O

Research	|O
was	|O
carried	|O
out	|O
on	|O
the	|O
rheumatoid	|B-PROTEIN
factors	|I-PROTEIN
in	|O
the	|O
serum	|O
of	|O
917	|O
patients	|O
by	|O
means	|O
of	|O
two	|O
tests	|O
(	|O
one	|O
using	|O
polystyrene	|O
and	|O
one	|O
with	|O
erythrocytes	|O
)	|O
and	|O
the	|O
results	|O
obtained	|O
were	|O
compared	|O
using	|O
a	|O
method	|O
of	|O
reference	|O
.	|O

A	|O
low	|O
aspirin	|B-PROTEIN
esterase	|I-PROTEIN
activity	|O
may	|O
be	|O
a	|O
contributory	|O
factor	|O
in	|O
precipitating	|O
these	|O
aspirin	|O
sensitive	|O
reactions	|O
.	|O

In	|O
both	|O
experiments	|O
,	|O
average	|O
daily	|O
gain	|O
and	|O
gain	|O
-	|O
to	|O
-	|O
feed	|O
ratio	|O
were	|O
similar	|O
for	|O
TR	|O
and	|O
CR	|O
.	|O

Overall	|O
least	|O
-	|O
squares	|O
means	|O
for	|O
uncooked	|O
and	|O
cooked	|O
longissimus	|O
muscle	|O
and	|O
subcutaneous	|O
fat	|O
were	|O
63.32	|O
,	|O
80.27	|O
and	|O
98.90	|O
mg	|O
of	|O
cholesterol	|O
/	|O
100	|O
g	|O
of	|O
tissue	|O
,	|O
respectively	|O
.	|O

The	|O
role	|O
of	|O
supercritical	|O
fluid	|O
chromatography	|O
(	|O
SFC	|O
)	|O
as	|O
a	|O
viable	|O
technique	|O
for	|O
analyzing	|O
agricultural	|O
products	|O
has	|O
been	|O
investigated	|O
using	|O
packed	|O
and	|O
capillary	|O
column	|O
methodology	|O
.	|O

Nitrofurazone	|O
significantly	|O
reduced	|O
the	|O
rise	|O
in	|O
LH	|B-PROTEIN
induced	|O
by	|O
LHRH	|B-PROTEIN
.	|O

Ovarian	|O
tumors	|O
in	|O
pregnancy	|O
.	|O

Ultrastructural	|O
study	|O
of	|O
polyarteritis	|O

X2	|O
test	|O
,	|O
with	|O
Yates	|O
correction	|O
if	|O
need	|O
,	|O
was	|O
used	|O
as	|O
statistical	|O
.	|O
method	|O
.	|O

After	|O
a	|O
baseline	|O
study	|O
,	|O
WPW	|O
syndrome	|O
was	|O
simulated	|O
by	|O
stimulation	|O
at	|O
seven	|O
different	|O
sites	|O
around	|O
the	|O
base	|O
of	|O
the	|O
ventricles	|O
,	|O
and	|O
RNV	|O
's	|O
were	|O
obtained	|O
.	|O

Man	|O
and	|O
insect	|O
,	|O
past	|O
,	|O
present	|O
,	|O
future	|O

All	|O
patients	|O
had	|O
the	|O
CA	|B-PROTEIN
125	|I-PROTEIN
assay	|O
performed	|O
within	|O
one	|O
week	|O
before	|O
their	|O
second	|O
-	|O
look	|O
operation	|O
.	|O

Allergy	|O
and	|O
Tourette	|O
's	|O
syndrome	|O
.	|O

The	|O
criterion	|O
was	|O
reached	|O
after	|O
two	|O
sessions	|O
and	|O
generalization	|O
to	|O
a	|O
variety	|O
of	|O
pills	|O
and	|O
capsules	|O
occurred	|O
.	|O

Clinical	|O
method	|O
for	|O
the	|O
treatment	|O
of	|O
Class	|O
II	|O
occlusal	|O
anomalies	|O
with	|O
open	|O
bite	|O

Enoxacin	|O
appears	|O
to	|O
be	|O
well	|O
suited	|O
for	|O
the	|O
treatment	|O
of	|O
complicated	|O
UTI	|O
.	|O

Mean	|O
fluorosis	|O
scores	|O
,	|O
however	|O
,	|O
were	|O
similar	|O
.	|O

Autonomic	|O
dysfunctions	|O
were	|O
restricted	|O
to	|O
tonic	|O
pupils	|O
.	|O

An	|O
industry	|O
-	|O
wide	|O
retrospective	|O
cohort	|O
mortality	|O
study	|O
was	|O
conducted	|O
on	|O
6,152	|O
chemical	|O
workers	|O
(	|O
2,460	|O
exposed	|O
and	|O
3,692	|O
nonexposed	|O
)	|O
engaged	|O
in	|O
chloromethyl	|O
ether	|O
manufacture	|O
at	|O
7	|O
major	|O
U.S.	|O
companies	|O
between	|O
1948	|O
and	|O
1980	|O
.	|O

The	|O
diagnosis	|O
of	|O
amyloidosis	|O
was	|O
determined	|O
from	|O
a	|O
labial	|O
salivary	|O
gland	|O
biopsy	|O
.	|O

Hair	|O
and	|O
blood	|O
samples	|O
were	|O
taken	|O
before	|O
vitamin	|O
C	|O
or	|O
placebo	|O
supplementation	|O
was	|O
started	|O
and	|O
at	|O
monthly	|O
intervals	|O
thereafter	|O
for	|O
three	|O
months	|O
.	|O

In	|O
treated	|O
herds	|O
,	|O
cows	|O
more	|O
than	|O
40	|O
d	|O
postpartum	|O
with	|O
a	|O
corpus	|O
luteum	|O
received	|O
prostaglandin	|O
F2	|O
alpha	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
if	|O
the	|O
measured	|O
angle	|O
ANB	|O
is	|O
smaller	|O
than	|O
the	|O
calculated	|O
angle	|O
,	|O
the	|O
skeletal	|O
relation	|O
is	|O
Class	|O
III	|O
.	|O

Emergency	|O
treatment	|O
of	|O
facial	|O
and	|O
maxillary	|O
/	|O
mandibular	|O
injuries	|O

In	|O
14	|O
cases	|O
,	|O
isolates	|O
were	|O
biotyped	|O
yielding	|O
eight	|O
with	|O
biotype	|O
II	|O
,	|O
four	|O
with	|O
biotype	|O
III	|O
,	|O
and	|O
one	|O
each	|O
with	|O
biotypes	|O
IV	|O
and	|O
V.	|O

A	|O
total	|O
of	|O
117	|O
EVS	|O
treatments	|O
were	|O
performed	|O
on	|O
34	|O
patients	|O
.	|O

Most	|O
of	|O
the	|O
prepeptide	|O
portion	|O
of	|O
the	|O
precursor	|O
polypeptide	|O
is	|O
encoded	|O
by	|O
the	|O
next	|O
three	|O
exons	|O
,	|O
and	|O
the	|O
mature	|O
form	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
is	|O
encoded	|O
by	|O
the	|O
remaining	|O
three	|O
exons	|O
.	|O

A	|O
stochastic	|O
version	|O
of	|O
Kernell	|O
's	|O
(	|O
1968	|O
,	|O
1972	|O
)	|O
model	|O
with	|O
cumulative	|O
afterhyperpolarization	|O
(	|O
AHP	|O
)	|O
was	|O
simulated	|O
.	|O

In	|O
a	|O
previous	|O
interim	|O
report	|O
we	|O
noted	|O
more	|O
prompt	|O
resolution	|O
of	|O
dermatomal	|O
signs	|O
and	|O
symptoms	|O
with	|O
acyclovir	|O
treatment	|O
.	|O

The	|O
detectability	|O
of	|O
the	|O
defects	|O
in	|O
RCA	|O
or	|O
LAD	|O
region	|O
was	|O
80%	|O
in	|O
single	|O
-	|O
position	|O
scans	|O
in	|O
stress	|O
studies	|O
.	|O

Pharmacologic	|O
properties	|O
of	|O
serotonergic	|O
agents	|O
and	|O
antidepressant	|O
drugs	|O
.	|O

This	|O
brief	|O
hypercapnic	|O
challenge	|O
induced	|O
a	|O
rapid	|O
increase	|O
in	|O
CBF	|O
in	|O
the	|O
absence	|O
of	|O
any	|O
change	|O
in	|O
MABP	|O
.	|O

These	|O
data	|O
should	|O
be	|O
useful	|O
in	|O
developing	|O
reagents	|O
for	|O
heterozygote	|O
detection	|O
and	|O
prenatal	|O
diagnosis	|O
of	|O
11	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
hydroxylase	|I-PROTEIN
deficiency	|O
,	|O
the	|O
second	|O
most	|O
frequent	|O
cause	|O
of	|O
congenital	|O
adrenal	|O
hyperplasia	|O
.	|O

Osteocalcin	|B-PROTEIN
(	|O
serum	|B-PROTEIN
bone	|I-PROTEIN
-	|I-PROTEIN
Gla	|I-PROTEIN
protein	|I-PROTEIN
,	|O
sBGP	|B-PROTEIN
)	|O
,	|O
serum	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
(	|O
sAP	|B-PROTEIN
)	|O
and	|O
urinary	|O
hydroxyproline	|O
/	|O
creatinine	|O
ratio	|O
(	|O
uOH	|O
-	|O
Prol	|O
/	|O
creatinine	|O
)	|O
have	|O
been	|O
measured	|O
in	|O
21	|O
patients	|O
with	|O
primary	|O
hyperparathyroidism	|O
(	|O
PHPT	|O
)	|O
and	|O
in	|O
nine	|O
patients	|O
with	|O
hypercalcaemia	|O
of	|O
malignancy	|O
(	|O
HM	|O
)	|O
.	|O

Multivariate	|O
logistic	|O
regression	|O
analysis	|O
indicated	|O
that	|O
seropositivity	|O
was	|O
strongly	|O
associated	|O
with	|O
the	|O
prevalence	|O
of	|O
hepatitis	|O
B	|O
in	|O
an	|O
employee	|O
's	|O
country	|O
of	|O
birth	|O
and	|O
with	|O
age	|O
.	|O

Hexsyn	|O
is	|O
the	|O
Goodyear	|O
Tire	|O
and	|O
Rubber	|O
Company	|O
tradename	|O
for	|O
a	|O
polyolefin	|O
rubber	|O
synthesized	|O
from	|O
1	|O
-	|O
hexene	|O
with	|O
3-5%	|O
methylhexadiene	|O
as	|O
the	|O
source	|O
of	|O
residual	|O
double	|O
bonds	|O
for	|O
vulcanization	|O
.	|O

Chimeric	|O
phage	|O
-	|O
plasmid	|O
expression	|O
vectors	|O
were	|O
constructed	|O
from	|O
pUC18/19	|O
plasmids	|O
by	|O
cloning	|O
a	|O
single	|O
-	|O
stranded	|O
DNA	|O
(	|O
ssDNA	|O
)	|O
origin	|O
of	|O
replication	|O
from	|O
bacteriophage	|O
f1	|O
and	|O
inserting	|O
a	|O
bacteriophage	|O
T7	|O
promoter	|O
within	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
gene	|O
.	|O

By	|O
order	|O
of	|O
decreasing	|O
rate	|O
,	|O
finger	|O
flexors	|O
,	|O
jaw	|O
,	|O
crossed	|O
adductors	|O
,	|O
and	|O
triceps	|O
reflexes	|O
were	|O
less	|O
frequently	|O
elicited	|O
in	|O
both	|O
groups	|O
.	|O

Natl	|O
.	|O

Neither	|O
ethanol	|O
nor	|O
estrogen	|O
has	|O
been	|O
shown	|O
to	|O
cause	|O
UROD	|B-PROTEIN
-	|O
deficiency	|O
in	|O
animals	|O
.	|O

Although	|O
not	|O
common	|O
,	|O
the	|O
disorder	|O
is	|O
the	|O
most	|O
frequently	|O
diagnosed	|O
disturbance	|O
of	|O
porphyrin	|O
metabolism	|O
in	|O
many	|O
countries	|O
,	|O
and	|O
further	|O
insight	|O
into	|O
its	|O
unusual	|O
pathogenesis	|O
may	|O
clarify	|O
the	|O
hepatotoxic	|O
effects	|O
of	|O
the	|O
4	|O
etiologic	|O
agents	|O
.	|O

Five	|O
out	|O
of	|O
eight	|O
consecutive	|O
cases	|O
with	|O
initial	|O
symptoms	|O
of	|O
a	|O
'm	|O
idline	|O
granuloma	|O
'	|O
were	|O
identified	|O
as	|O
malignant	|O
histiocytosis	|O
(	|O
histiocytic	|O
sarcoma	|O
)	|O
which	|O
within	|O
5	|O
months	|O
to	|O
4	|O
years	|O
led	|O
to	|O
generalization	|O
and	|O
death	|O
.	|O

All	|O
patients	|O
then	|O
received	|O
suxamethonium	|O
1.5	|O
mg	|O
kg	|O
-	|O
1	|O
i.v	|O
.	|O

The	|O
highest	|O
postoperative	|O
CK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
level	|O
was	|O
less	|O
after	|O
BC	|O
(	|O
BC	|O
,	|O
31	|O
+	|O
/	|O
-	|O
17	|O
U	|O
/	|O
L	|O
;	|O
CC	|O
,	|O
56	|O
+	|O
/	|O
-	|O
13	|O
U	|O
/	|O
L	|O
;	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

No	|O
relevant	|O
changes	|O
in	|O
heart	|O
rate	|O
,	|O
body	|O
weight	|O
,	|O
and	|O
plasma	|O
levels	|O
of	|O
renin	|B-PROTEIN
activity	|O
and	|O
aldosterone	|O
concentration	|O
were	|O
observed	|O
.	|O

High	|O
trough	|O
serum	|O
TOB	|O
concentrations	|O
were	|O
associated	|O
with	|O
death	|O
and	|O
very	|O
low	|O
levels	|O
with	|O
recovery	|O
.	|O

State	|O
-	|O
approved	|O
schools	|O
of	|O
nursing	|O
R.N.	|O

In	|O
a	|O
maxicell	|O
system	|O
a	|O
protein	|O
with	|O
an	|O
approximate	|O
molecular	|O
weight	|O
of	|O
36,000	|O
was	|O
synthesized	|O
.	|O

This	|O
means	|O
that	|O
the	|O
loss	|O
of	|O
recessives	|O
must	|O
be	|O
calculated	|O
by	|O
using	|O
a	|O
hypergeometric	|O
and	|O
not	|O
a	|O
binomial	|O
model	|O
as	|O
Fisher	|O
did	|O
.	|O

The	|O
incidence	|O
of	|O
second	|O
malignant	|O
neoplasms	|O
was	|O
lower	|O
(	|O
1.3%	|O
)	|O
in	|O
the	|O
group	|O
treated	|O
with	|O
5	|O
-	|O
fluorouracil	|O
,	|O
doxorubicin	|O
,	|O
and	|O
cyclophosphamide	|O
than	|O
in	|O
the	|O
historical	|O
control	|O
group	|O
(	|O
4.8%	|O
)	|O
.	|O

Ovulation	|O
was	|O
induced	|O
in	|O
8	|O
(	|O
56.7%	|O
)	|O
patients	|O
who	|O
conceived	|O
.	|O

In	|O
previous	|O
work	|O
(	|O
E.	|O

The	|O
small	|O
size	|O
and	|O
placement	|O
of	|O
the	|O
mutagenesis	|O
marker	|O
(	|O
the	|O
supF	|B-PROTEIN
suppressor	|O
tRNA	|O
gene	|O
from	|O
Escherichia	|O
coli	|O
)	|O
within	|O
the	|O
vector	|O
substantially	|O
reduced	|O
the	|O
frequency	|O
of	|O
spontaneous	|O
mutations	|O
normally	|O
observed	|O
after	|O
transfection	|O
of	|O
mammalian	|O
cells	|O
with	|O
plasmid	|O
DNA	|O
;	|O
hence	|O
,	|O
UV	|O
-	|O
induced	|O
mutations	|O
were	|O
easily	|O
identified	|O
above	|O
the	|O
spontaneous	|O
background	|O
.	|O

W.	|O

Tetrad	|O
analysis	|O
and	|O
mitotic	|O
recombination	|O
experiments	|O
localized	|O
the	|O
PEP4	|B-PROTEIN
gene	|O
proximal	|O
to	|O
GAL4	|B-PROTEIN
on	|O
chromosome	|O
XVI	|O
.	|O

Based	|O
on	|O
our	|O
observations	|O
,	|O
we	|O
propose	|O
a	|O
model	|O
whereby	|O
inactive	|O
precursor	|O
molecules	|O
produced	|O
from	|O
the	|O
PEP4	|B-PROTEIN
gene	|O
self	|O
-	|O
activate	|O
within	|O
the	|O
yeast	|O
vacuole	|O
and	|O
subsequently	|O
activate	|O
other	|O
vacuolar	|B-PROTEIN
hydrolases	|I-PROTEIN
.	|O

The	|O
poly	|O
(	|O
A	|O
)	|O
segment	|O
of	|O
the	|O
RNA	|O
was	|O
selectively	|O
cross	|O
-	|O
linked	|O
to	|O
the	|O
72,000	|O
-	|O
molecular	|O
-	|O
weight	|O
protein	|O
(	|O
72K	|O
protein	|O
)	|O
.	|O

In	|O
vitro	|O
translation	|O
of	|O
RNA	|O
synthesized	|O
from	|O
the	|O
cloned	|O
cDNAs	|O
predicts	|O
that	|O
P0	|B-PROTEIN
transcripts	|O
are	|O
translated	|O
into	|O
a	|O
novel	|O
12.5	|O
-	|O
kilodalton	|O
protein	|O
corresponding	|O
to	|O
the	|O
first	|O
open	|O
reading	|O
frame	|O
.	|O

The	|O
N	|O
-	|O
terminal	|O
amino	|O
acid	|O
sequence	|O
of	|O
Mop	|B-PROTEIN
has	|O
sequence	|O
homology	|O
with	|O
DNA	|O
binding	|O
proteins	|O
.	|O

Several	|O
new	|O
techniques	|O
are	|O
available	|O
for	|O
monitoring	|O
control	|O
of	|O
diabetes	|O
.	|O

Ciprofloxacin	|O
:	|O
an	|O
overview	|O
of	|O
adverse	|O
experiences	|O
.	|O

Possible	|O
pathogenetic	|O
mechanisms	|O
of	|O
hemopoietic	|O
changes	|O
in	|O
response	|O
to	|O
space	|O
flight	|O
effects	|O
are	|O
described	|O
.	|O

The	|O
rho	|B-PROTEIN
genes	|O
comprise	|O
an	|O
evolutionarily	|O
conserved	|O
family	|O
with	|O
significant	|O
homology	|O
to	|O
the	|O
ras	|B-PROTEIN
oncogene	|O
family	|O
.	|O

Also	|O
,	|O
component	|O
I	|O
significantly	|O
correlated	|O
with	|O
fasting	|O
insulin	|B-PROTEIN
and	|O
VO2	|O
max	|O
for	|O
both	|O
sexes	|O
and	|O
with	|O
basal	|O
metabolism	|O
and	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
for	|O
females	|O
and	|O
males	|O
,	|O
respectively	|O
.	|O

The	|O
glucose	|O
areas	|O
following	|O
the	|O
ingestion	|O
of	|O
the	|O
foods	|O
were	|O
:	|O
Study	|O
1	|O
:	|O
glucose	|O
11.7	|O
,	|O
orange	|O
juice	|O
7.3	|O
,	|O
sucrose	|O
5.2	|O
,	|O
glucose	|O
+	|O
fructose	|O
6.3	|O
,	|O
and	|O
fructose	|O
0.7	|O
mmol	|O
X	|O
h	|O
/	|O
l	|O
;	|O
Study	|O
2	|O
:	|O
glucose	|O
14.6	|O
,	|O
orange	|O
juice	|O
7.3	|O
,	|O
apples	|O
5.5	|O
,	|O
and	|O
apple	|O
juice	|O
4.7	|O
mmol	|O
X	|O
h	|O
/	|O
l	|O
;	|O
Study	|O
3	|O
:	|O
glucose	|O
12.6	|O
,	|O
ice	|O
cream	|O
8.1	|O
,	|O
milk	|O
3.7	|O
,	|O
and	|O
lactose	|O
4.1	|O
mmol	|O
X	|O
h	|O
/	|O
l	|O
.	|O

The	|O
serum	|O
insulin	|B-PROTEIN
response	|O
cannot	|O
.	|O

SCL	|O
prolonged	|O
promptly	|O
after	|O
verapamil	|O
,	|O
and	|O
sinus	|O
arrest	|O
developed	|O
in	|O
two	|O
of	|O
10	|O
group	|O
2	|O
and	|O
two	|O
of	|O
five	|O
group	|O
3	|O
animals	|O
.	|O

Development	|O
of	|O
a	|O
yeast	|O
system	|O
to	|O
assay	|O
mutational	|O
specificity	|O
.	|O

Postglucose	|O
serum	|O
insulin	|B-PROTEIN
levels	|O
showed	|O
no	|O
significant	|O
correlations	|O
with	|O
systolic	|O
or	|O
diastolic	|O
blood	|O
pressure	|O
levels	|O
in	|O
men	|O
,	|O
but	|O
in	|O
female	|O
diabetic	|O
and	|O
non	|O
-	|O
diabetic	|O
subjects	|O
significant	|O
correlations	|O
were	|O
found	|O
in	|O
particular	|O
with	|O
systolic	|O
blood	|O
pressure	|O
level	|O
.	|O

We	|O
used	|O
oligonucleotide	|O
-	|O
directed	|O
mutagenesis	|O
to	|O
alter	|O
a	|O
site	|O
in	|O
MucA	|B-PROTEIN
homologous	|O
to	|O
the	|O
Ala	|O
-	|O
Gly	|O
cleavage	|O
site	|O
of	|O
LexA	|B-PROTEIN
.	|O

The	|O
latter	|O
was	|O
determined	|O
as	|O
follows	|O
:	|O
Type	|O
I	|O
-	|O
solid	|O
tumor	|O
tissue	|O
without	|O
significant	|O
peripheral	|O
isolated	|O
tumor	|O
cells	|O
;	|O
Type	|O
II	|O
-	|O
solid	|O
tumor	|O
tissue	|O
associated	|O
with	|O
peripheral	|O
isolated	|O
tumor	|O
cells	|O
;	|O
Type	|O
III	|O
-	|O
isolated	|O
tumor	|O
cells	|O
only	|O
.	|O

The	|O
pharmacology	|O
of	|O
carnitine	|O
.	|O

Acute	|O
inhalation	|O
toxicity	|O
of	|O
T	|O
-	|O
2	|O
mycotoxin	|O
in	|O
mice	|O
.	|O

The	|O
present	|O
investigation	|O
sought	|O
to	|O
identify	|O
the	|O
principal	|O
dimensions	|O
of	|O
the	|O
Framingham	|O
Type	|O
A	|O
scale	|O
(	|O
FTAS	|O
)	|O
and	|O
then	|O
to	|O
examine	|O
their	|O
physiological	|O
and	|O
psychological	|O
correlates	|O
.	|O

A	|O
preliminary	|O
study	|O
on	|O
pyogenic	|O
arthritis	|O
.	|O

Legionella	|O
,	|O
microbial	|O
ecology	|O
,	|O
and	|O
inconspicuous	|O
consumption	|O
.	|O

Lymphatics	|O
in	|O
the	|O
aorta	|O
of	|O
rats	|O
treated	|O
with	|O
a	|O
soy	|O
-	|O
bean	|O
oil	|O
extract	|O
(	|O
lipofundin	|O
)	|O
.	|O

As	|O
a	|O
last	|O
resort	|O
,	|O
it	|O
may	|O
be	|O
possible	|O
to	|O
maintain	|O
a	|O
patient	|O
on	|O
dialysis	|O
in	|O
reasonable	|O
health	|O
with	|O
a	|O
DiaTAP	|O
button	|O
graft	|O
complex	|O
infected	|O
with	|O
Staphylococcus	|O
epidermidis	|O
and	|O
intermittent	|O
positive	|O
blood	|O
cultures	|O
using	|O
long	|O
term	|O
vancomycin	|O
therapy	|O
.	|O

For	|O
signal	|O
durations	|O
less	|O
than	|O
10	|O
ms	|O
,	|O
however	|O
,	|O
the	|O
SoNo	|O
and	|O
S	|O
pi	|O
No	|O
threshold	|O
functions	|O
converged	|O
and	|O
the	|O
masking	|O
-	|O
level	|O
difference	|O
decreased	|O
.	|O

The	|O
spleen	|O
rate	|O
of	|O
about	|O
600	|O
villagers	|O
of	|O
RK	|O
I	|O
examined	|O
was	|O
54.3%	|O
and	|O
the	|O
parasite	|O
rate	|O
13.2%	|O
before	|O
the	|O
drug	|O
intervention	|O
.	|O

Multiple	|O
dosing	|O
four	|O
times	|O
daily	|O
for	|O
7	|O
days	|O
of	|O
indoprofen	|O
200	|O
mg	|O
,	|O
a	|O
non	|O
-	|O
steroidal	|O
anti	|O
-	|O
inflammatory	|O
drug	|O
with	|O
a	|O
short	|O
half	|O
-	|O
life	|O
(	|O
t1/2	|O
)	|O
,	|O
revealed	|O
drug	|O
accumulation	|O
in	|O
eight	|O
elderly	|O
subjects	|O
.	|O

In	|O
10	|O
patients	|O
with	|O
subacute	|O
cardiac	|O
tamponade	|O
,	|O
pulmonary	|O
wedge	|O
pressure	|O
(	|O
PWP	|O
)	|O
,	|O
RAP	|O
,	|O
and	|O
IPP	|O
were	|O
measured	|O
along	|O
with	|O
indexes	|O
of	|O
systolic	|O
function	|O
.	|O

Encompassing	|O
tamponade	|O
and	|O
pericardiocentesis	|O
data	|O
,	|O
left	|O
ventricular	|O
stroke	|O
work	|O
index	|O
showed	|O
positive	|O
correlation	|O
with	|O
TMFP1	|O
(	|O
r	|O
=	|O
.59	|O
)	|O
and	|O
TMFP2	|O
(	|O
r	|O
=	|O
.52	|O
)	|O
but	|O
not	|O
with	|O
TMFP3	|O
.	|O

Rabbits	|O
developed	|O
profound	|O
hypocalcemia	|O
,	|O
with	|O
levels	|O
falling	|O
from	|O
15.5	|O
+	|O
/	|O
-	|O
0.2	|O
to	|O
7.6	|O
+	|O
/	|O
-	|O
0.4	|O
mg	|O
/	|O
dl	|O
under	|O
the	|O
influence	|O
of	|O
TSST	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Reward	|O
value	|O
of	|O
prosodic	|O
features	|O
of	|O
language	|O
for	|O
autistic	|O
,	|O
mentally	|O
retarded	|O
,	|O
and	|O
normal	|O
children	|O
.	|O

Similarly	|O
,	|O
actuarial	|O
interpretations	|O
for	|O
the	|O
second	|O
protocols	|O
were	|O
not	|O
more	|O
frequently	|O
selected	|O
by	|O
therapists	|O
as	|O
more	|O
valid	|O
,	|O
regardless	|O
of	|O
treatment	|O
condition	|O
and	|O
elevation	|O
of	|O
the	|O
F	|O
and	|O
F	|O
-	|O
K	|O
indices	|O
on	|O
the	|O
first	|O
MMPI	|O
profile	|O
.	|O

Due	|O
to	|O
its	|O
relatively	|O
soluble	|O
chemical	|O
form	|O
,	|O
90Sr	|O
was	|O
rapidly	|O
translocated	|O
from	|O
lung	|O
to	|O
bone	|O
where	|O
a	|O
substantial	|O
portion	|O
was	|O
retained	|O
for	|O
a	|O
long	|O
period	|O
of	|O
time	|O
.	|O

The	|O
study	|O
disclosed	|O
generalized	|O
atrophy	|O
and	|O
diffuse	|O
symmetric	|O
white	|O
matter	|O
hypodensities	|O
.	|O

The	|O
diagnosis	|O
of	|O
metachromatic	|O
leukodystrophy	|O
(	|O
MLD	|O
)	|O
was	|O
confirmed	|O
by	|O
the	|O
finding	|O
of	|O
low	|O
arylsulfatase	|B-PROTEIN
A	|I-PROTEIN
(	|O
ASA	|B-PROTEIN
)	|O
levels	|O
in	|O
cultured	|O
fibroblasts	|O
in	|O
both	|O
sisters	|O
.	|O

Artificial	|O
ventilation	|O
was	|O
conducted	|O
using	|O
a	|O
tidal	|O
volume	|O
of	|O
10	|O
ml	|O
X	|O
kg	|O
-	|O
1	|O
and	|O
a	|O
rate	|O
of	|O
10	|O
to	|O
12	|O
c	|O
X	|O
min	|O
-	|O
1	|O
.	|O

Significantly	|O
lower	|O
heart	|O
rate	|O
reactivity	|O
and	|O
significantly	|O
less	|O
pronounced	|O
left	|O
temporal	|O
artery	|O
pulse	|O
amplitude	|O
responses	|O
were	|O
found	|O
in	|O
non	|O
-	|O
medicated	|O
TH	|O
subjects	|O
than	|O
in	|O
controls	|O
.	|O

An	|O
epidemiological	|O
survey	|O
of	|O
rheumatic	|O
valve	|O
disease	|O
and	|O
rheumatic	|O
fever	|O
in	|O
primary	|O
and	|O
secondary	|O
school	|O
students	|O
in	|O
Jiangxi	|O
Province	|O

Drugs	|O
that	|O
are	|O
transformed	|O
via	|O
phase	|O
II	|O
reactions	|O
usually	|O
do	|O
not	|O
require	|O
dosage	|O
adjustment	|O
.	|O

A	|O
study	|O
of	|O
human	|O
genes	|O
coding	|O
for	|O
U4	|B-PROTEIN
small	|O
nuclear	|O
RNA	|O
is	|O
presented	|O
.	|O

Using	|O
the	|O
balloon	|O
-	|O
gas	|O
procedure	|O
with	|O
a	|O
single	|O
gas	|O
injection	|O
,	|O
a	|O
bubble	|O
was	|O
obtained	|O
that	|O
was	|O
large	|O
enough	|O
to	|O
tamponade	|O
a	|O
giant	|O
tear	|O
without	|O
prior	|O
drainage	|O
of	|O
subretinal	|O
fluid	|O
or	|O
vitrectomy	|O
.	|O

Heat	|B-PROTEIN
-	|I-PROTEIN
labile	|I-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
enterotoxin	|I-PROTEIN
(	|O
LT	|B-PROTEIN
)	|O
was	|O
produced	|O
by	|O
26	|O
of	|O
42	|O
stool	|O
isolates	|O
(	|O
62%	|O
)	|O
,	|O
while	|O
only	|O
1	|O
of	|O
the	|O
42	|O
isolates	|O
(	|O
2%	|O
)	|O
produced	|O
enterotoxinlike	|O
activity	|O
in	|O
suckling	|O
mice	|O
;	|O
65%	|O
of	|O
the	|O
cytotoxin	|O
-	|O
producing	|O
strains	|O
also	|O
produced	|O
an	|O
LT	|B-PROTEIN
-	|O
like	|O
material	|O
.	|O

Development	|O
of	|O
a	|O
provisional	|O
information	|O
-	|O
retrieval	|O
descriptor	|O
language	|O
for	|O
"	|O
Roentgenology	|O
and	|O
Medical	|O
Radiology	|O
"	|O
for	|O
use	|O
in	|O
the	|O
Medinform	|O
system	|O

Persistent	|O
acantholytic	|O
dermatosis	|O
with	|O
increased	|O
light	|O
sensitivity	|O

Thus	|O
,	|O
a	|O
negative	|O
test	|O
is	|O
compatible	|O
with	|O
low	|O
disease	|O
activity	|O
and	|O
/	|O
or	|O
efficacy	|O
of	|O
calcium	|O
antagonist	|O
treatment	|O
.	|O

Thus	|O
,	|O
a	|O
negative	|O
test	|O
is	|O
compatible	|O
with	|O
low	|O
disease	|O
activity	|O
and	|O
/	|O
or	|O
efficacy	|O
of	|O
calcium	|O
antagonist	|O
treatment	|O
.	|O

Dorsal	|O
foot	|O
TcpO2	|O
was	|O
measured	|O
by	|O
using	|O
oxygen	|O
-	|O
sensing	|O
electrodes	|O
with	|O
surface	|O
temperatures	|O
of	|O
42	|O
degrees	|O
C	|O
and	|O
45	|O
degrees	|O
C	|O
;	|O
in	|O
theory	|O
,	|O
changes	|O
in	|O
sympathetic	|O
activity	|O
should	|O
affect	|O
vasomotor	|O
tone	|O
and	|O
TcpO2	|O
in	|O
skin	|O
beneath	|O
an	|O
electrode	|O
at	|O
42	|O
degrees	|O
C	|O
(	|O
submaximal	|O
vasodilation	|O
)	|O
,	|O
but	|O
not	|O
at	|O
45	|O
degrees	|O
C	|O
(	|O
maximal	|O
vasodilation	|O
)	|O
.	|O

In	|O
subjects	|O
(	|O
n	|O
=	|O
5	|O
)	|O
with	|O
quadriplegia	|O
and	|O
reduced	|O
sympathetic	|O
tone	|O
secondary	|O
to	|O
cervical	|O
cord	|O
trauma	|O
,	|O
TcpO2	|O
at	|O
42	|O
degrees	|O
C	|O
and	|O
vasodilation	|O
index	|O
were	|O
increased	|O
(	|O
45.0	|O
mmHg	|O
and	|O
0.61	|O
)	|O
;	|O
TcpO2	|O
at	|O
45	|O
degrees	|O
C	|O
did	|O
not	|O
change	|O
.	|O

The	|O
nucleotide	|O
sequences	|O
of	|O
the	|O
human	|O
and	|O
murine	|O
ornithine	|B-PROTEIN
decarboxylase	|I-PROTEIN
mRNAs	|O
share	|O
an	|O
85%	|O
homology	|O
,	|O
even	|O
in	|O
their	|O
3'	|O
-	|O
noncoding	|O
regions	|O
.	|O

The	|O
absolute	|O
concentrations	|O
of	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
plasmin	|I-PROTEIN
inhibitor	|O
,	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
macroglobulin	|I-PROTEIN
,	|O
and	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
increased	|O
with	|O
exercise	|O
(	|O
all	|O
P	|O
less	|O
than	|O
0.005	|O
)	|O
,	|O
but	|O
when	|O
concentrations	|O
were	|O
corrected	|O
for	|O
acute	|O
shifts	|O
of	|O
plasma	|O
water	|O
during	|O
exercise	|O
,	|O
the	|O
quantity	|O
of	|O
these	|O
inhibitors	|O
actually	|O
decreased	|O
(	|O
all	|O
P	|O
less	|O
than	|O
0.005	|O
)	|O
.	|O

The	|O
other	|O
model	|O
was	|O
a	|O
continuous	|O
exponential	|O
plus	|O
constant	|O
of	|O
the	|O
form	|O
La	|O
-	|O
=	|O
a	|O
+	|O
b	|O
[	|O
exp	|O
(	|O
cVO2	|O
)	|O
]	|O
.	|O

Cell.	|O

Timing	|O
of	|O
symptoms	|O
and	|O
oocyst	|O
excretion	|O
in	|O
human	|O
cryptosporidiosis	|O
.	|O

After	|O
dopamine	|O
infusion	|O
in	|O
women	|O
with	|O
polycystic	|O
ovary	|O
syndrome	|O
and	|O
in	|O
matched	|O
controls	|O
,	|O
steady	|O
state	|O
levels	|O
of	|O
plasma	|O
dopamine	|O
,	|O
norepinephrine	|O
,	|O
and	|O
the	|O
ratio	|O
of	|O
dopamine	|O
/	|O
norepinephrine	|O
were	|O
similar	|O
in	|O
the	|O
two	|O
groups	|O
.	|O

Diagnostic	|O
importance	|O
of	|O
determining	|O
the	|O
complement	|O
constituents	|O
in	|O
children	|O
with	|O
autoimmune	|O
thyroiditis	|O

In	|O
the	|O
normal	|O
,	|O
basal	|O
(	|O
unstimulated	|O
)	|O
condition	|O
there	|O
were	|O
no	|O
significant	|O
correlations	|O
(	|O
p	|O
greater	|O
than	|O
0.05	|O
)	|O
between	|O
the	|O
systolic	|O
blood	|O
pressure	|O
and	|O
dopamine	|O
(	|O
r	|O
=	|O
0.09	|O
)	|O
,	|O
norepinephrine	|O
(	|O
r	|O
=	|O
0.26	|O
)	|O
,	|O
or	|O
epinephrine	|O
(	|O
r	|O
=	|O
0.27	|O
)	|O
,	|O
nor	|O
were	|O
there	|O
significant	|O
correlations	|O
between	|O
melatonin	|O
and	|O
dopamine	|O
(	|O
r	|O
=	|O
-	|O
0.01	|O
)	|O
,	|O
norepinephrine	|O
(	|O
r	|O
=	|O
-	|O
0.26	|O
)	|O
,	|O
or	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
(	|O
r	|O
=	|O
0.17	|O
)	|O
.	|O

The	|O
4	|O
patients	|O
with	|O
carboxyhemoglobin	|B-PROTEIN
levels	|O
in	|O
excess	|O
of	|O
10%	|O
may	|O
represent	|O
occult	|O
carbon	|O
monoxide	|O
poisoning	|O
in	|O
this	|O
population	|O
.	|O

All	|O
these	|O
processes	|O
were	|O
fully	|O
developed	|O
during	|O
the	|O
last	|O
month	|O
of	|O
pregnancy	|O
,	|O
offering	|O
the	|O
same	|O
picture	|O
as	|O
the	|O
controls	|O
.	|O

Hypoglycemic	|O
action	|O
of	|O
"	|O
he	|O
xiang	|O
zhuang	|O
qi	|O
gong	|O
"	|O
and	|O
its	|O
mechanism	|O
on	|O
diabetes	|O
mellitus	|O

In	|O
cases	|O
of	|O
1	|O
degrees	|O
HPT	|O
,	|O
the	|O
plasma	|O
1,25	|O
-	|O
(	|O
OH	|O
)	|O
2D	|O
level	|O
rose	|O
significantly	|O
in	|O
all	|O
cases	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
,	|O
although	|O
the	|O
pattern	|O
of	|O
the	|O
increase	|O
was	|O
not	|O
uniform	|O
.	|O

This	|O
region	|O
of	|O
60	|O
amino	|O
acids	|O
may	|O
be	|O
involved	|O
in	|O
coiled	|O
-	|O
coil	|O
interactions	|O
similar	|O
to	|O
those	|O
that	|O
facilitate	|O
the	|O
filament	|O
formation	|O
in	|O
the	|O
rod	|O
region	|O
.	|O

This	|O
approach	|O
enables	|O
the	|O
sources	|O
of	|O
error	|O
in	|O
the	|O
calculation	|O
of	|O
nutrient	|O
utilization	|O
to	|O
be	|O
readily	|O
identified	|O
,	|O
and	|O
their	|O
effect	|O
on	|O
precision	|O
to	|O
be	|O
assessed	|O
in	|O
different	|O
nutritional	|O
and	|O
metabolic	|O
states	|O
.	|O

The	|O
effect	|O
of	|O
dietary	|O
zinc	|O
deficiency	|O
on	|O
the	|O
mossy	|O
fiber	|O
zinc	|O
content	|O
of	|O
the	|O
rat	|O
hippocampus	|O
.	|O

Weaned	|O
rats	|O
were	|O
fed	|O
a	|O
normal	|O
diet	|O
or	|O
a	|O
low	|O
-	|O
protein	|O
,	|O
low	|O
-	|O
energy	|O
diet	|O
,	|O
and	|O
injected	|O
with	|O
saline	|O
or	|O
thyroxine	|O
(	|O
5	|O
micrograms	|O
/	|O
100	|O
g	|O
BW	|O
)	|O
for	|O
22	|O
days	|O
.	|O

It	|O
is	|O
largely	|O
predicted	|O
by	|O
lupus	|O
anticoagulant	|O
(	|O
estimated	|O
by	|O
activated	|O
partial	|O
thromboplastin	|B-PROTEIN
time	|O
)	|O
and	|O
/	|O
or	|O
antibody	|O
to	|O
cardiolipin	|O
.	|O

The	|O
effects	|O
of	|O
several	|O
opioid	|O
agonists	|O
and	|O
the	|O
opioid	|O
antagonist	|O
naloxone	|O
were	|O
examined	|O
in	|O
rats	|O
responding	|O
under	|O
a	|O
fixed	|O
-	|O
consecutive	|O
-	|O
number	|O
(	|O
FCN	|O
)	|O
schedule	|O
.	|O

The	|O
rate	|O
-	|O
decreasing	|O
effects	|O
of	|O
morphine	|O
and	|O
U50488	|O
were	|O
reversed	|O
completely	|O
by	|O
a	|O
0.01	|O
and	|O
1.0	|O
mg	|O
/	|O
kg	|O
dose	|O
of	|O
naloxone	|O
,	|O
respectively	|O
.	|O

Data	|O
from	|O
119	|O
men	|O
and	|O
40	|O
women	|O
undergoing	|O
coronary	|O
angiography	|O
provide	|O
an	|O
opportunity	|O
to	|O
compare	|O
these	|O
associations	|O
in	|O
relation	|O
to	|O
a	|O
direct	|O
and	|O
continuous	|O
measure	|O
of	|O
atherosclerosis	|O
while	|O
controlling	|O
for	|O
age	|O
,	|O
sex	|O
,	|O
income	|O
,	|O
hypertension	|O
,	|O
serum	|O
cholesterol	|O
,	|O
smoking	|O
,	|O
angina	|O
,	|O
diabetes	|O
,	|O
family	|O
history	|O
of	|O
heart	|O
disease	|O
,	|O
Type	|O
A	|O
behavior	|O
pattern	|O
,	|O
and	|O
hostility	|O
.	|O

An	|O
intralobar	|O
change	|O
in	|O
temperature	|O
above	|O
or	|O
below	|O
36	|O
degrees	|O
C	|O
decreases	|O
only	|O
the	|O
lobar	|O
bronchial	|O
blood	|O
flow	|O
and	|O
does	|O
not	|O
influence	|O
blood	|O
flow	|O
to	|O
other	|O
nearby	|O
tissues	|O
including	|O
those	|O
vascularized	|O
by	|O
the	|O
bronchial	|O
circulation	|O
.	|O

Convulsive	|O
status	|O
epilepticus	|O
after	|O
infusion	|O
of	|O
cisplatin	|O

The	|O
presence	|O
in	|O
such	|O
patients	|O
of	|O
antibodies	|O
to	|O
adrenaline	|O
and	|O
noradrenaline	|O
is	|O
indicative	|O
of	|O
considerable	|O
disruption	|O
of	|O
catecholamine	|O
biotransformation	|O
.	|O

The	|O
following	|O
markers	|O
were	|O
looked	|O
for	|O
in	|O
the	|O
serum	|O
,	|O
skin	|O
and	|O
liver	|O
of	|O
all	|O
patients	|O
with	|O
chronic	|O
hepatitis	|O
:	|O
HBV	|O
(	|O
HBs	|B-PROTEIN
Ag	|I-PROTEIN
and	|O
HBe	|B-PROTEIN
Ag	|I-PROTEIN
,	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBs	|I-PROTEIN
,	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBe	|I-PROTEIN
and	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBc	|I-PROTEIN
in	|O
the	|O
serum	|O
,	|O
HBs	|B-PROTEIN
and	|I-PROTEIN
HBc	|I-PROTEIN
Ag	|I-PROTEIN
in	|O
the	|O
liver	|O
)	|O
;	|O
non	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
non	|I-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
(	|O
non	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|I-PROTEIN
non	|I-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
Ag	|I-PROTEIN
and	|I-PROTEIN
antibody	|I-PROTEIN
,	|O
anti	|B-PROTEIN
non	|I-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
non	|I-PROTEIN
-	|I-PROTEIN
Bc	|I-PROTEIN
in	|O
the	|O
serum	|O
,	|O
non	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|I-PROTEIN
non	|I-PROTEIN
-	|I-PROTEIN
Bc	|I-PROTEIN
Ag	|I-PROTEIN
in	|O
the	|O
liver	|O
)	|O
.	|O

Groups	|O
of	|O
male	|O
and	|O
female	|O
Fischer	|O
344	|O
rats	|O
,	|O
B6C3F1	|O
mice	|O
,	|O
and	|O
Hartley	|O
guinea	|O
pigs	|O
were	|O
exposed	|O
once	|O
for	|O
6	|O
hr	|O
to	|O
mean	|O
concentrations	|O
of	|O
10.5	|O
,	|O
5.4	|O
,	|O
2.4	|O
,	|O
1.0	|O
,	|O
or	|O
0	|O
(	|O
control	|O
)	|O
ppm	|O
of	|O
methyl	|O
isocyanate	|O
(	|O
MIC	|O
)	|O
vapor	|O
.	|O

Radionuclide	|O
study	|O
and	|O
endomyocardial	|O
biopsy	|O
revealed	|O
remarkable	|O
degeneration	|O
of	|O
myocardium	|O
.	|O

Immobilization	|O
of	|O
the	|O
fracture	|O
in	|O
a	|O
collar	|O
and	|O
cuff	|O
sling	|O
was	|O
as	|O
effective	|O
as	|O
more	|O
elaborate	|O
methods	|O
.	|O

Comparison	|O
of	|O
patients	|O
receiving	|O
phenytoin	|O
and	|O
those	|O
who	|O
were	|O
not	|O
showed	|O
significantly	|O
lower	|O
serum	|O
folate	|O
in	|O
the	|O
sub	|O
-	|O
group	|O
receiving	|O
phenytoin	|O
,	|O
but	|O
there	|O
was	|O
no	|O
significant	|O
difference	|O
between	|O
the	|O
sub	|O
-	|O
groups	|O
with	|O
respect	|O
to	|O
vitamin	|O
B12	|O
or	|O
behaviour	|O
problem	|O
rating	|O
.	|O

Effects	|O
of	|O
a	|O
low	|O
-	|O
energy	|O
laser	|O
beam	|O
on	|O
the	|O
cells	|O
of	|O
the	|O
newt	|O
embryo	|O

Typical	|O
and	|O
atypical	|O
clinical	|O
features	|O
of	|O
this	|O
lacrimal	|O
sac	|O
cyst	|O
are	|O
emphasized	|O
.	|O

The	|O
role	|O
of	|O
saliva	|O
in	|O
sour	|O
taste	|O
perception	|O
was	|O
investigated	|O
in	|O
a	|O
series	|O
of	|O
4	|O
experiments	|O
.	|O

Samples	|O
from	|O
1415	|O
neurological	|O
patients	|O
were	|O
used	|O
to	|O
study	|O
the	|O
diagnostic	|O
value	|O
of	|O
acid	|B-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
glycoprotein	|I-PROTEIN
in	|O
the	|O
lumbar	|O
cerebrospinal	|O
fluid	|O
.	|O

Separate	|O
experiments	|O
measured	|O
AIB	|O
and	|O
86RbCl	|O
uptake	|O
in	|O
36B	|O
-	|O
10	|O
cells	|O
in	|O
vitro	|O
1	|O
and	|O
2	|O
days	|O
following	|O
20	|O
Gy	|O
irradiation	|O
to	|O
assess	|O
whether	|O
this	|O
radiation	|O
dose	|O
reduced	|O
the	|O
capacity	|O
of	|O
tumor	|O
cells	|O
to	|O
trap	|O
AIB	|O
or	|O
Rb+	|O
.	|O

For	|O
patients	|O
with	|O
recurrent	|O
or	|O
metastatic	|O
disease	|O
,	|O
the	|O
data	|O
suggest	|O
that	|O
I	|O
-	|O
131	|O
MIBG	|O
scintigraphy	|O
is	|O
the	|O
examination	|O
of	|O
choice	|O
.	|O

W.	|O

Comparison	|O
of	|O
the	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
M	|B-PROTEIN
RNA	|I-PROTEIN
product	|O
of	|O
Uukuniemi	|O
virus	|O
with	|O
that	|O
of	|O
Punta	|O
Toro	|O
and	|O
Rift	|O
Valley	|O
fever	|O
viruses	|O
showed	|O
in	|O
both	|O
cases	|O
a	|O
weak	|O
homology	|O
that	|O
was	|O
more	|O
pronounced	|O
for	|O
the	|O
proteins	|O
located	|O
at	|O
the	|O
COOH	|O
-	|O
terminal	|O
end	|O
of	|O
the	|O
precursor	|O
.	|O

Cyclosporine	|O
treatment	|O
for	|O
intractable	|O
polymyositis	|O
.	|O

In	|O
addition	|O
,	|O
on	|O
the	|O
Cohler	|O
's	|O
maternal	|O
scale	|O
,	|O
Korean	|O
mothers	|O
were	|O
found	|O
to	|O
view	|O
their	|O
infants	|O
as	|O
more	|O
passive	|O
and	|O
dependent	|O
than	|O
American	|O
mothers	|O
did	|O
(	|O
P	|O
less	|O
than	|O
0.00	|O
)	|O
.	|O

A	|O
preoperative	|O
teaching	|O
booklet	|O
for	|O
pediatric	|O
patients	|O
.	|O

Hyperthyroidism	|O

We	|O
conclude	|O
that	|O
for	|O
mono	|O
-	|O
intronic	|O
precursors	|O
in	|O
which	|O
there	|O
is	|O
only	|O
one	|O
choice	|O
of	|O
splice	|O
sites	|O
,	|O
most	|O
of	|O
the	|O
exon	|O
sequences	|O
are	|O
not	|O
mechanistically	|O
involved	|O
in	|O
the	|O
splicing	|O
process	|O
.	|O

UVA	|O
-	|O
induced	|O
melanocytic	|O
lesions	|O
.	|O

Ex	|O
vivo	|O
MAO	|B-PROTEIN
inhibition	|O
data	|O
indicated	|O
DPGPEA	|O
to	|O
be	|O
an	|O
inhibitor	|O
of	|O
MAO	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
,	|O
although	|O
the	|O
effect	|O
was	|O
much	|O
weaker	|O
than	|O
seen	|O
with	|O
tranylcypromine	|O
or	|O
pargyline	|O
.	|O

Thus	|O
in	|O
this	|O
region	|O
of	|O
the	|O
vessel	|O
pyridinoline	|O
represents	|O
the	|O
major	|O
stabilising	|O
crosslink	|O
of	|O
collagen	|B-PROTEIN
.	|O

A	|O
careful	|O
,	|O
radiolabelled	|O
tissue	|O
-	|O
distribution	|O
study	|O
is	|O
warranted	|O
to	|O
elucidate	|O
the	|O
complicated	|O
metabolic	|O
fate	|O
of	|O
perhexiline	|O
.	|O

Systemic	|O
lupus	|O
erythematosus	|O
was	|O
diagnosed	|O
.	|O

In	|O
the	|O
evening	|O
,	|O
the	|O
amplitude	|O
of	|O
the	|O
responses	|O
to	|O
both	|O
O2	|O
and	|O
CO2	|O
increased	|O
but	|O
the	|O
increase	|O
in	|O
CO2	|O
sensitivity	|O
was	|O
proportionally	|O
more	|O
important	|O
.	|O

The	|O
statistical	|O
significance	|O
of	|O
the	|O
prognosis	|O
factors	|O
was	|O
studied	|O
by	|O
uni	|O
-	|O
and	|O
multivariative	|O
methods	|O
,	|O
according	|O
to	|O
the	|O
model	|O
of	|O
Cox	|O
,	|O
with	|O
the	|O
help	|O
of	|O
an	|O
IMB	|O
computer	|O
.	|O

These	|O
changes	|O
at	|O
the	|O
site	|O
of	|O
injection	|O
consist	|O
of	|O
a	|O
focal	|O
abnormality	|O
characterized	|O
by	|O
a	|O
slight	|O
increase	|O
in	|O
signal	|O
intensity	|O
on	|O
T1	|O
weighted	|O
images	|O
and	|O
markedly	|O
increased	|O
signal	|O
intensity	|O
on	|O
T2	|O
weighted	|O
images	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
less	|O
antidopaminergic	|O
activity	|O
of	|O
RHAL	|O
in	|O
this	|O
neuroleptic	|O
test	|O
might	|O
be	|O
explained	|O
by	|O
the	|O
lesser	|O
conversion	|O
of	|O
RHAL	|O
to	|O
HAL	|O
.	|O

The	|O
purpose	|O
of	|O
this	|O
study	|O
is	|O
twofold	|O
:	|O
(	|O
1	|O
)	|O
to	|O
present	|O
a	|O
parallel	|O
form	|O
of	|O
the	|O
Gudjonsson	|O
Suggestibility	|O
Scale	|O
(	|O
GSS	|O
,	|O
Form	|O
1	|O
)	|O
;	|O
(	|O
2	|O
)	|O
to	|O
study	|O
test	|O
-	|O
retest	|O
reliabilities	|O
of	|O
interrogative	|O
suggestibility	|O
.	|O

Organisms	|O
were	|O
recovered	|O
from	|O
the	|O
conjunctiva	|O
for	|O
several	|O
weeks	|O
,	|O
and	|O
persistent	|O
genital	|O
and	|O
gastrointestinal	|O
infection	|O
also	|O
resulted	|O
from	|O
the	|O
ocular	|O
infection	|O
in	|O
some	|O
cats	|O
.	|O

In	|O
vivo	|O
epiluminescence	|O
microscopy	|O
of	|O
pigmented	|O
skin	|O
lesions	|O
.	|O

These	|O
equilibrium	|O
solutions	|O
are	|O
then	|O
shown	|O
to	|O
arise	|O
from	|O
the	|O
vertices	|O
of	|O
a	|O
particular	|O
convex	|O
polyhedron	|O
.	|O

The	|O
average	|O
deviations	|O
in	|O
the	|O
X	|O
-	|O
ray	|O
counts	|O
of	|O
the	|O
constant	|O
elements	|O
from	|O
the	|O
series	|O
means	|O
were	|O
used	|O
to	|O
correct	|O
the	|O
recorded	|O
count	|O
of	|O
the	|O
variable	|O
element	|O
in	|O
each	|O
block	|O
.	|O

Statistically	|O
significant	|O
effects	|O
were	|O
noted	|O
at	|O
doses	|O
which	|O
did	|O
not	|O
appear	|O
to	|O
be	|O
maternally	|O
toxic	|O
.	|O

Low	|O
MAO	|B-PROTEIN
subjects	|O
showed	|O
a	|O
pattern	|O
of	|O
higher	|O
scores	|O
in	|O
KSP	|O
Impulsiveness	|O
,	|O
EPQ	|O
Neuroticism	|O
,	|O
and	|O
KSP	|O
Somatic	|O
Anxiety	|O
and	|O
Irritability	|O
and	|O
lower	|O
scores	|O
in	|O
KSP	|O
Socialization	|O
,	|O
in	|O
line	|O
with	|O
personality	|O
profiles	|O
found	|O
in	|O
alcoholics	|O
,	|O
psychopaths	|O
,	|O
and	|O
suicide	|O
attempters	|O
who	|O
also	|O
tend	|O
to	|O
have	|O
low	|O
platelet	|O
MAO	|B-PROTEIN
activity	|O
.	|O

To	|O
evaluate	|O
the	|O
relative	|O
accuracy	|O
of	|O
continuous	|O
wave	|O
(	|O
CW	|O
)	|O
and	|O
high	|O
pulse	|O
repetition	|O
frequency	|O
(	|O
HPRF	|O
)	|O
Doppler	|O
for	|O
estimating	|O
aortic	|O
transvalvular	|O
pressure	|O
gradients	|O
,	|O
Doppler	|O
examinations	|O
with	|O
both	|O
devices	|O
were	|O
obtained	|O
in	|O
87	|O
consecutive	|O
patients	|O
with	|O
aortic	|O
valve	|O
disease	|O
.	|O

In	|O
group	|O
I	|O
,	|O
Paw	|O
,	|O
delta	|O
V	|O
,	|O
PaO2	|O
,	|O
Vinj	|O
and	|O
VT	|O
significantly	|O
decreased	|O
whereas	|O
operating	|O
pressure	|O
and	|O
E	|O
significantly	|O
increased	|O
when	|O
the	|O
internal	|O
diameter	|O
of	|O
the	|O
injector	|O
cannula	|O
was	|O
reduced	|O
.	|O

In	|O
calves	|O
receiving	|O
milk	|O
-	|O
substitute	|O
diets	|O
containing	|O
80-260	|O
g	|O
DM	|O
/	|O
kg	|O
,	|O
milk	|O
intakes	|O
were	|O
reduced	|O
by	|O
up	|O
to	|O
30%	|O
on	|O
the	|O
1st	|O
day	|O
that	|O
calves	|O
were	|O
fed	|O
once	|O
daily	|O
instead	|O
of	|O
twice	|O
daily	|O
.	|O

Today	|O
there	|O
is	|O
no	|O
doubt	|O
that	|O
elevated	|O
plasma	|O
cholesterol	|O
levels	|O
should	|O
be	|O
lowered	|O
first	|O
by	|O
dietary	|O
modification	|O
even	|O
in	|O
early	|O
childhood	|O
,	|O
beginning	|O
at	|O
the	|O
age	|O
of	|O
two	|O
years	|O
.	|O

The	|O
number	|O
of	|O
fecal	|O
pellets	|O
ingested	|O
peaked	|O
at	|O
5	|O
to	|O
6	|O
weeks	|O
old	|O
(	|O
13	|O
pellets	|O
/	|O
day	|O
)	|O
and	|O
gradually	|O
decreased	|O
,	|O
thereafter	|O
(	|O
2.1	|O
pellets	|O
at	|O
78	|O
weeks	|O
old	|O
,	|O
1.5	|O
pellets	|O
at	|O
104	|O
weeks	|O
old	|O
)	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
N	|O
-	|O
nitroso	|O
compounds	|O
can	|O
be	|O
formed	|O
in	|O
vivo	|O
in	|O
the	|O
infected	|O
bladder	|O
,	|O
which	|O
could	|O
explain	|O
the	|O
association	|O
between	|O
urinary	|O
-	|O
tract	|O
infections	|O
and	|O
increased	|O
risk	|O
for	|O
bladder	|O
cancer	|O
.	|O

Epithelial	|O
nerve	|O
fiber	|O
defects	|O
included	|O
absence	|O
or	|O
distorted	|O
architecture	|O
of	|O
the	|O
basal	|O
epithelial	|O
plexus	|O
and	|O
intra	|O
-	|O
epithelial	|O
terminals	|O
.	|O

The	|O
histologic	|O
grade	|O
for	|O
the	|O
same	|O
anatomic	|O
site	|O
varied	|O
among	|O
hearts	|O
and	|O
among	|O
different	|O
anatomic	|O
sites	|O
in	|O
the	|O
same	|O
heart	|O
.	|O

Serum	|O
levels	|O
of	|O
albumin	|B-PROTEIN
,	|O
globulin	|B-PROTEIN
,	|O
and	|O
coagulation	|B-PROTEIN
protein	|I-PROTEIN
activity	|O
were	|O
measured	|O
preshock	|O
,	|O
postshock	|O
,	|O
and	|O
daily	|O
for	|O
3	|O
days	|O
;	|O
skin	|O
lymph	|O
levels	|O
were	|O
measured	|O
on	|O
Day	|O
3	|O
.	|O

For	|O
colostral	|O
milk	|O
there	|O
was	|O
a	|O
significant	|O
correlation	|O
of	|O
vitamin	|O
K1	|O
to	|O
cholesterol	|O
(	|O
r	|O
=	|O
0.62	|O
)	|O
but	|O
not	|O
to	|O
total	|O
lipid	|O
or	|O
phospholipid	|O
suggesting	|O
a	|O
role	|O
for	|O
cholesterol	|O
in	|O
the	|O
secretion	|O
of	|O
vitamin	|O
K1	|O
into	|O
colostral	|O
milk	|O
.	|O

Endurance	|O
training	|O
resulted	|O
in	|O
an	|O
increase	|O
of	|O
stiffness	|O
associated	|O
with	|O
a	|O
decrease	|O
of	|O
type	|O
II	|O
fibers	|O
.	|O

A	|O
rate	|O
-	|O
decreasing	|O
dose	|O
of	|O
physostigmine	|O
,	|O
an	|O
acetylcholinesterase	|B-PROTEIN
inhibitor	|O
,	|O
was	|O
studied	|O
in	|O
combination	|O
with	|O
the	|O
range	|O
of	|O
atropine	|O
doses	|O
.	|O

References	|O
for	|O
occupational	|O
fitness	|O
of	|O
adolescents	|O
with	|O
diseases	|O
of	|O
the	|O
respiratory	|O
tract	|O
and	|O
lungs	|O

Salzburg	|O
,	|O
9-12	|O
September	|O
1987	|O
.	|O

Two	|O
new	|O
glucosidase	|B-PROTEIN
inhibitors	|O
(	|O
BAY	|O
m	|O
1099	|O
and	|O
BAY	|O
o	|O
1248	|O
)	|O
were	|O
studied	|O
in	|O
volunteers	|O
and	|O
type	|O
II	|O
diabetics	|O
under	|O
various	|O
conditions	|O
.	|O

The	|O
models	|O
accurately	|O
localized	|O
the	|O
common	|O
boundaries	|O
between	|O
the	|O
PBB	|O
and	|O
CN	|O
.	|O

Two	|O
of	|O
these	|O
six	|O
cases	|O
showed	|O
mucosal	|O
spread	|O
without	|O
stromal	|O
invasion	|O
(	|O
type	|O
A	|O
)	|O
;	|O
the	|O
remaining	|O
four	|O
cases	|O
presented	|O
a	|O
direct	|O
extension	|O
(	|O
type	|O
B	|O
)	|O
from	|O
muscle	|O
-	|O
invasive	|O
carcinomas	|O
of	|O
the	|O
bladder	|O
.	|O

However	|O
,	|O
conversions	|O
of	|O
12	|O
mm	|O
or	|O
more	|O
from	|O
a	|O
documented	|O
negative	|O
result	|O
indicated	|O
spread	|O
of	|O
infection	|O
.	|O

The	|O
maximum	|O
amplitude	|O
of	|O
evoked	|O
responses	|O
in	|O
the	|O
cervical	|O
sympathetic	|O
trunk	|O
was	|O
obtained	|O
when	|O
the	|O
T2	|O
white	|O
ramus	|O
was	|O
stimulated	|O
and	|O
decreased	|O
gradually	|O
when	|O
followed	|O
by	|O
the	|O
stimulation	|O
of	|O
T1	|O
,	|O
T3	|O
,	|O
T4	|O
and	|O
T5	|O
white	|O
rami	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
contact	|O
allergy	|O
to	|O
K	|O
-	|O
CG	|O
is	|O
common	|O
.	|O

The	|O
effect	|O
of	|O
a	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
antagonist	|O
,	|O
pindolol	|O
,	|O
on	|O
uterine	|O
smooth	|O
muscle	|O
in	|O
term	|O
pregnant	|O
women	|O
was	|O
studied	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
(	|O
in	|O
hypertensive	|O
women	|O
)	|O
.	|O

The	|O
less	|O
-	|O
polar	|O
mycolic	|O
acid	|O
-	|O
containing	|O
Rhodococcus	|O
species	|O
showed	|O
chromatographic	|O
patterns	|O
that	|O
partially	|O
overlapped	|O
(	|O
in	|O
elution	|O
times	|O
)	|O
the	|O
patterns	|O
of	|O
Nocardia	|O
asteroides	|O
,	|O
N.	|O
otitidiscaviarum	|O
,	|O
and	|O
N.	|O
brasiliensis	|O
,	|O
but	|O
the	|O
larger	|O
number	|O
of	|O
peaks	|O
in	|O
the	|O
last	|O
species	|O
made	|O
separation	|O
between	|O
the	|O
genera	|O
possible	|O
.	|O

The	|O
development	|O
of	|O
a	|O
data	|O
base	|O
is	|O
described	|O
which	|O
can	|O
be	|O
used	|O
as	|O
common	|O
reference	|O
for	|O
ECG	|O
computer	|O
programs	|O
analyzing	|O
12	|O
or	|O
15	|O
simultaneously	|O
recorded	|O
leads	|O
.	|O

Blood	|O
serum	|O
erythropoietin	|B-PROTEIN
level	|O
and	|O
basic	|O
hematological	|O
indices	|O
during	|O
the	|O
adaptation	|O
of	|O
healthy	|O
newborn	|O
infants	|O

49	|O
,	|O
XXXXY	|O
chromosome	|O
anomaly	|O
:	|O
an	|O
unusual	|O
variant	|O
of	|O
Klinefelter	|O
's	|O
syndrome	|O
.	|O

Contraction	|O
of	|O
the	|O
tracheal	|O
muscle	|O
and	|O
the	|O
activity	|O
of	|O
stretch	|O
receptors	|O
in	|O
the	|O
trachea	|O

The	|O
selenium	|O
level	|O
and	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
activity	|O
in	|O
the	|O
blood	|O
,	|O
liver	|O
,	|O
and	|O
stomach	|O
mucosa	|O
were	|O
significantly	|O
higher	|O
in	|O
the	|O
high	|O
-	|O
selenium	|O
diet	|O
group	|O
than	|O
in	|O
the	|O
low	|O
-	|O
selenium	|O
diet	|O
group	|O
.	|O

Oxygen	|O
delivery	|O
and	|O
consumption	|O
and	|O
P50	|O
in	|O
patients	|O
with	|O
acute	|O
myocardial	|O
infarction	|O
.	|O

Infants	|O
of	|O
this	|O
sample	|O
had	|O
monocular	|O
PL	|O
visual	|O
acuities	|O
similar	|O
to	|O
those	|O
established	|O
by	|O
McDonald	|O
et	|O
al.	|O
in	|O
a	|O
laboratory	|O
setting	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
the	|O
effect	|O
of	|O
the	|O
isomers	|O
of	|O
pentobarbital	|O
and	|O
secobarbital	|O
on	|O
mult	|O
FR30	|O
FI600	|O
responding	|O
and	|O
on	|O
suppressed	|O
responding	|O
are	|O
qualitatively	|O
similar	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

The	|O
number	|O
of	|O
crystalline	|O
deposits	|O
is	|O
less	|O
in	|O
the	|O
advanced	|O
atrophic	|O
areas	|O
of	|O
the	|O
RPE	|O
-	|O
choriocapillaris	|O
complex	|O
.	|O

All	|O
33	|O
subjects	|O
were	|O
given	|O
psychometric	|O
instruments	|O
for	|O
measuring	|O
various	|O
components	|O
of	|O
anger	|O
and	|O
anxiety	|O
:	|O
Spielberger	|O
's	|O
State	|O
-	|O
Trait	|O
Personality	|O
Inventory	|O
,	|O
the	|O
Anger	|O
Expression	|O
Scale	|O
,	|O
and	|O
the	|O
State	|O
Anger	|O
Reaction	|O
Scale	|O
.	|O

It	|O
was	|O
found	|O
that	|O
the	|O
primary	|O
visual	|O
cortex	|O
of	|O
the	|O
rat	|O
is	|O
asymmetrical	|O
in	|O
volume	|O
,	|O
and	|O
that	|O
the	|O
asymmetry	|O
reflects	|O
side	|O
differences	|O
in	|O
the	|O
number	|O
of	|O
neurons	|O
.	|O

The	|O
subjects	|O
received	|O
a	|O
single	|O
500	|O
mg	|O
dose	|O
of	|O
acetaminophen	|O
i.v	|O
.	|O
and	|O
concentrations	|O
in	|O
plasma	|O
were	|O
measured	|O
for	|O
360	|O
minutes	|O
and	|O
in	|O
urine	|O
for	|O
24	|O
h	|O
in	|O
order	|O
to	|O
estimate	|O
the	|O
production	|O
of	|O
metabolites	|O
.	|O

Mean	|O
weighted	|O
skin	|O
temperature	|O
(	|O
Tsk	|O
)	|O
was	|O
lower	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
following	|O
acclimation	|O
than	|O
before	|O
,	|O
and	|O
acclimation	|O
resulted	|O
in	|O
a	|O
larger	|O
(	|O
P	|O
less	|O
than	|O
0.02	|O
)	|O
Tre	|O
-	|O
to	|O
-	|O
Tsk	|O
gradient	|O
.	|O

Indium	|O
-	|O
111	|O
leukocyte	|O
imaging	|O
in	|O
patients	|O
with	|O
rheumatoid	|O
arthritis	|O
.	|O

The	|O
effect	|O
of	|O
L	|O
-	|O
methionine	|O
supplementation	|O
on	|O
the	|O
utilization	|O
of	|O
a	|O
soy	|O
protein	|O
isolate	|O
(	|O
SPI	|O
)	|O
was	|O
evaluated	|O
by	|O
short	|O
-	|O
term	|O
nitrogen	|O
balance	|O
studies	|O
in	|O
young	|O
women	|O
.	|O

Primary	|O
invasive	|O
Haemophilus	|O
influenzae	|O
type	|O
b	|O
disease	|O
:	|O
a	|O
population	|O
-	|O
based	|O
assessment	|O
of	|O
risk	|O
factors	|O
.	|O

Overall	|O
,	|O
lesions	|O
infiltrating	|O
the	|O
deep	|O
lamina	|O
propria	|O
do	|O
not	|O
exhibit	|O
a	|O
reduced	|O
frequency	|O
of	|O
occurrence	|O
compared	|O
to	|O
lesions	|O
infiltrating	|O
the	|O
skeletal	|O
muscle	|O
;	|O
however	|O
,	|O
carcinomas	|O
affecting	|O
other	|O
oral	|O
sites	|O
showed	|O
a	|O
reduced	|O
frequency	|O
of	|O
deeply	|O
infiltrating	|O
lesions	|O
in	|O
comparison	|O
to	|O
more	|O
superficial	|O
lesions	|O
.	|O

Factors	|O
that	|O
showed	|O
significant	|O
correlation	|O
to	|O
elevated	|O
CIC	|O
's	|O
in	|O
the	|O
highly	|O
elevated	|O
portion	|O
of	|O
our	|O
CIC	|O
population	|O
were	|O
poor	|O
NIH	|O
score	|O
,	|O
increased	|O
patient	|O
age	|O
,	|O
low	|O
peak	|O
expiratory	|O
flow	|O
rate	|O
,	|O
and	|O
elevated	|O
total	|O
serum	|O
IgG	|B-PROTEIN
.	|O

Induction	|O
of	|O
both	|O
potential	|O
transcripts	|O
follows	|O
heat	|O
shock	|O
in	|O
vivo	|O
.	|O

New	|O
and	|O
successful	|O
steps	|O
have	|O
been	|O
made	|O
in	|O
immunodiagnostics	|O
,	|O
immunotherapy	|O
,	|O
and	|O
immunoprophylaxis	|O
of	|O
immunologically	|O
conditioned	|O
infertility	|O
.	|O

Amikacin	|O
was	|O
the	|O
most	|O
stable	|O
and	|O
tobramycin	|O
was	|O
the	|O
least	|O
stable	|O
aminoglycoside	|O
under	|O
the	|O
conditions	|O
tested	|O
.	|O

This	|O
may	|O
explain	|O
in	|O
part	|O
a	|O
secular	|O
trend	|O
towards	|O
reduced	|O
birthweight	|O
for	|O
gestation	|O
in	|O
preterm	|O
infants	|O
.	|O

Estimated	|O
nucleic	|O
acid	|O
N	|O
absorption	|O
is	|O
7-8%	|O
of	|O
N	|O
intake	|O
.	|O

Adhesion	|O
,	|O
phagocytosis	|O
,	|O
chemotactic	|O
and	|O
random	|O
migration	|O
,	|O
nitroblue	|O
tetrazolium	|O
dye	|O
reduction	|O
of	|O
peritoneal	|O
exudate	|O
neutrophils	|O
and	|O
macrophages	|O
,	|O
fibrinogen	|B-PROTEIN
level	|O
,	|O
gelation	|O
of	|O
soluble	|O
fibrin	|B-PROTEIN
and	|O
serial	|O
dilution	|O
protamine	|O
sulfate	|O
test	|O
were	|O
investigated	|O
in	|O
115	|O
New	|O
Zealand	|O
white	|O
rabbits	|O
with	|O
experimentally	|O
induced	|O
Shwartzman	|O
phenomenon	|O
in	|O
the	|O
colon	|O
,	|O
and	|O
in	|O
control	|O
animals	|O
.	|O

Nickel	|O
is	|O
the	|O
most	|O
common	|O
cause	|O
of	|O
allergic	|O
contact	|O
dermatitis	|O
in	|O
Singapore	|O
,	|O
resulting	|O
in	|O
positive	|O
reactions	|O
in	|O
patch	|O
tests	|O
between	|O
7	|O
and	|O
14%	|O
.	|O

The	|O
FFA	|O
levels	|O
were	|O
not	|O
affected	|O
(	|O
P	|O
greater	|O
than	|O
.1	|O
)	|O
by	|O
meal	|O
interval	|O
.	|O

He	|O
visited	|O
our	|O
hospital	|O
and	|O
left	|O
solitary	|O
renal	|O
cyst	|O
was	|O
suspected	|O
.	|O

However	|O
,	|O
further	|O
analyses	|O
of	|O
the	|O
data	|O
indicate	|O
that	|O
increasing	|O
VO2	|O
AT	|O
(	|O
r	|O
=	|O
-	|O
0.63	|O
,	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
rather	|O
than	|O
VO2max	|O
(	|O
r	|O
=	|O
-	|O
0.15	|O
)	|O
could	|O
result	|O
in	|O
improving	|O
the	|O
10,000	|O
m	|O
race	|O
performance	|O
to	|O
a	|O
larger	|O
extent	|O
,	|O
and	|O
that	|O
the	|O
absolute	|O
amount	|O
of	|O
change	|O
(	|O
delta	|O
)	|O
in	|O
the	|O
10,000	|O
m	|O
run	|O
time	|O
is	|O
best	|O
accounted	|O
for	|O
by	|O
a	|O
combination	|O
of	|O
delta	|O
VO2	|O
AT	|O
and	|O
delta	|O
5,000	|O
m	|O
run	|O
time	|O
.	|O

A	|O
significant	|O
herd	|O
X	|O
period	|O
interaction	|O
existed	|O
for	|O
liver	|O
TG	|O
and	|O
serum	|O
dextran	|O
precipitable	|O
cholesterol	|O
concentrations	|O
.	|O

Liver	|O
TG	|O
and	|O
serum	|O
NEFA	|O
concentrations	|O
were	|O
positively	|O
correlated	|O
.	|O

The	|O
results	|O
show	|O
that	|O
nerve	|O
and	|O
roots	|O
differ	|O
considerably	|O
both	|O
in	|O
the	|O
force	|O
they	|O
sustain	|O
before	|O
failure	|O
and	|O
in	|O
the	|O
other	|O
biomechanics	|O
they	|O
exhibit	|O
.	|O

When	|O
the	|O
coronary	|O
sinus	|O
pressure	|O
reached	|O
15	|O
torr	|O
,	|O
there	|O
was	|O
a	|O
significant	|O
decrease	|O
in	|O
cardiac	|O
index	|O
(	|O
3.60	|O
+	|O
/	|O
-	|O
0.5	|O
to	|O
2.70	|O
+	|O
/	|O
-	|O
0.6	|O
L	|O
/	|O
min	|O
/	|O
m2	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
,	|O
coronary	|O
blood	|O
flow	|O
(	|O
13.7	|O
+	|O
/	|O
-	|O
3.1	|O
to	|O
7.0	|O
+	|O
/	|O
-	|O
2.1	|O
ml	|O
/	|O
min	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
,	|O
rate	|O
of	|O
rise	|O
of	|O
left	|O
ventricular	|O
pressure	|O
(	|O
1,567	|O
+	|O
/	|O
-	|O
275	|O
to	|O
1,331	|O
+	|O
/	|O
-	|O
314	|O
,	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
,	|O
and	|O
an	|O
increase	|O
in	|O
coronary	|O
arteriovenous	|O
difference	|O
(	|O
62.8%	|O
+	|O
/	|O
-	|O
9.3%	|O
to	|O
70.5%	|O
+	|O
/	|O
-	|O
5.4%	|O
saturation	|O
,	|O
p	|O
less	|O
than	|O
0.03	|O
)	|O
.	|O

Calcifications	|O
in	|O
the	|O
thoracic	|O
aorta	|O
at	|O
the	|O
level	|O
of	|O
the	|O
11th	|O
and	|O
the	|O
12th	|O
thoracic	|O
vertebrae	|O
in	|O
592	|O
men	|O
and	|O
333	|O
women	|O
were	|O
studied	|O
using	|O
computed	|O
tomography	|O
.	|O

In	|O
a	|O
series	|O
of	|O
402	|O
consecutive	|O
autopsies	|O
,	|O
parietal	|O
pleural	|O
plaques	|O
(	|O
PP	|O
)	|O
were	|O
found	|O
in	|O
68	|O
individuals	|O
above	|O
40	|O
years	|O
of	|O
age	|O
.	|O

Approximately	|O
60%	|O
of	|O
cell	|O
bodies	|O
of	|O
primary	|O
neurons	|O
innervating	|O
the	|O
intra	|O
and	|O
perioral	|O
structures	|O
through	|O
the	|O
inferior	|O
alveolar	|O
,	|O
lingual	|O
,	|O
mental	|O
,	|O
and	|O
buccal	|O
nerves	|O
were	|O
in	|O
the	|O
range	|O
between	|O
300	|O
and	|O
600	|O
micron	|O
2	|O
in	|O
cross	|O
-	|O
sectional	|O
area	|O
:	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
509	|O
+	|O
/	|O
-	|O
243	|O
micron	|O
2	|O
,	|O
420	|O
+	|O
/	|O
-	|O
181	|O
micron	|O
2	|O
,	|O
469	|O
+	|O
/	|O
-	|O
200	|O
micron	|O
2	|O
,	|O
and	|O
444	|O
+	|O
/	|O
-	|O
186	|O
micron	|O
2	|O
,	|O
respectively	|O
.	|O

Pharmacological	|O
action	|O
of	|O
eptazocine	|O
(	|O
l	|O
-	|O
1,4	|O
-	|O
dimethyl	|O
-	|O
10	|O
-	|O
hydroxy	|O
-	|O
2,3,4,5,6,7	|O
-	|O
hexahydro	|O
-	|O
1,6	|O
-	|O
methano	|O
-	|O
1H	|O
-	|O
4	|O
-	|O
benz	|O
azonine	|O
)	|O
.	|O

On	|O
transition	|O
from	|O
high	|O
to	|O
low	|O
voltage	|O
there	|O
was	|O
a	|O
significant	|O
fall	|O
in	|O
arterial	|O
pressure	|O
(	|O
7%	|O
)	|O
and	|O
an	|O
increase	|O
in	|O
flow	|O
(	|O
19-38%	|O
)	|O
to	|O
areas	|O
of	|O
the	|O
brain	|O
corresponding	|O
to	|O
the	|O
arborization	|O
of	|O
the	|O
reticular	|O
formation	|O
,	|O
i.e.	|O
excluding	|O
the	|O
cerebrum	|O
and	|O
cerebellum	|O
.	|O

Findings	|O
of	|O
positive	|O
potentials	|O
showed	|O
that	|O
N1	|O
originated	|O
in	|O
the	|O
area	|O
of	|O
ventral	|O
gray	|O
matter	|O
through	|O
the	|O
ventro	|O
-	|O
lateral	|O
column	|O
and	|O
N2	|O
through	|O
the	|O
dorsal	|O
column	|O
.	|O

One	|O
hundred	|O
and	|O
four	|O
(	|O
14	|O
per	|O
cent	|O
)	|O
second	|O
primary	|O
tumours	|O
were	|O
reported	|O
.	|O

Failures	|O
of	|O
colorimetric	|O
additivity	|O
under	|O
these	|O
experimental	|O
conditions	|O
are	|O
discussed	|O
.	|O

There	|O
have	|O
been	|O
five	|O
problems	|O
(	|O
extravasation	|O
2	|O
,	|O
suspected	|O
sepsis	|O
1	|O
,	|O
and	|O
hematoma	|O
2	|O
)	|O
during	|O
a	|O
total	|O
of	|O
2,927	|O
days	|O
of	|O
exposure	|O
.	|O

It	|O
is	|O
suggested	|O
that	|O
these	|O
results	|O
may	|O
raise	|O
the	|O
interesting	|O
possibility	|O
of	|O
providing	|O
a	|O
means	|O
of	|O
identifying	|O
greater	|O
or	|O
lesser	|O
susceptibility	|O
to	|O
the	|O
coronary	|O
effects	|O
of	|O
Type	|O
A	|O
behavior	|O
.	|O

Two	|O
studies	|O
assessed	|O
two	|O
types	|O
of	|O
reliability	|O
of	|O
the	|O
student	|O
Jenkins	|O
Activity	|O
Survey	|O
(	|O
JAS	|O
;	|O
a	|O
questionnaire	|O
measure	|O
of	|O
Type	|O
A	|O
behavior	|O
)	|O
.	|O

Splenectomized	|O
patients	|O
are	|O
predisposed	|O
toward	|O
developing	|O
overwhelming	|O
bacterial	|O
infections	|O
.	|O

When	|O
phencyclidine	|O
was	|O
administered	|O
alone	|O
,	|O
overall	|O
response	|O
rate	|O
decreased	|O
and	|O
percent	|O
errors	|O
increased	|O
with	|O
increasing	|O
doses	|O
.	|O

Possibilities	|O
and	|O
outlook	|O
for	|O
wrist	|O
joint	|O
endoprosthesis	|O

Study	|O
of	|O
the	|O
energy	|O
metabolism	|O
of	|O
the	|O
sensomotor	|O
cortex	|O
and	|O
hippocampus	|O
by	|O
the	|O
(	|O
14C	|O
)	|O
2	|O
-	|O
deoxyglucose	|O
method	|O
during	|O
the	|O
development	|O
of	|O
dissociated	|O
states	|O

Malignant	|O
lymphoma	|O
is	|O
very	|O
heterogeneous	|O
in	|O
terms	|O
of	|O
its	|O
biological	|O
behavior	|O
.	|O

Further	|O
investigations	|O
are	|O
necessary	|O
to	|O
elucidate	|O
the	|O
biochemical	|O
and	|O
physiological	|O
properties	|O
of	|O
DLIS	|O
.	|O

Among	|O
them	|O
,	|O
26	|O
cases	|O
were	|O
benign	|O
and	|O
34	|O
malignant	|O
.	|O

Of	|O
the	|O
cases	|O
with	|O
PLD	|O
,	|O
50%	|O
had	|O
associated	|O
renal	|O
cysts	|O
and	|O
10%	|O
of	|O
the	|O
cases	|O
with	|O
APCD	|O
had	|O
associated	|O
liver	|O
cysts	|O
.	|O

Fast	|O
goal	|O
-	|O
directed	|O
voluntary	|O
movements	|O
of	|O
the	|O
human	|O
upper	|O
extremity	|O
are	|O
known	|O
to	|O
be	|O
associated	|O
with	|O
three	|O
distinct	|O
bursts	|O
of	|O
EMG	|O
activity	|O
in	|O
antagonistic	|O
muscles	|O
.	|O

The	|O
combination	|O
of	|O
F1	|O
and	|O
F2	|O
which	|O
was	|O
the	|O
best	|O
predictor	|O
of	|O
CHD	|O
in	|O
this	|O
population	|O
(	|O
G1	|O
)	|O
might	|O
be	|O
interpreted	|O
as	|O
reflecting	|O
trunk	|O
adiposity	|O
mainly	|O
abdominal	|O
.	|O

Renal	|O
clearance	|O
fell	|O
from	|O
19.0	|O
+	|O
/	|O
-	|O
4.9	|O
ml	|O
/	|O
min	|O
/	|O
1.73	|O
m2	|O
(	|O
group	|O
I	|O
)	|O
to	|O
1.0	|O
+	|O
/	|O
-	|O
0.4	|O
ml	|O
/	|O
min	|O
/	|O
1.73	|O
m2	|O
(	|O
group	|O
IV	|O
)	|O
.	|O

The	|O
relations	|O
between	|O
type	|O
A	|O
behavior	|O
,	|O
clinically	|O
relevant	|O
behavior	|O
,	|O
academic	|O
achievement	|O
,	|O
and	|O
IQ	|O
in	|O
children	|O
.	|O

The	|O
rats	|O
were	|O
used	|O
for	|O
the	|O
study	|O
of	|O
the	|O
effects	|O
of	|O
sepsis	|O
on	|O
the	|O
utilization	|O
of	|O
exogenous	|O
fat	|O
emulsion	|O
.	|O

She	|O
also	|O
had	|O
slight	|O
weakness	|O
of	|O
the	|O
upper	|O
extremities	|O
.	|O

Results	|O
of	|O
electron	|O
therapy	|O
of	|O
tumors	|O
in	|O
different	|O
sites	|O

The	|O
mechanism	|O
of	|O
action	|O
is	|O
explored	|O
in	|O
some	|O
detail	|O
,	|O
specifically	|O
as	|O
it	|O
relates	|O
to	|O
reticuloendothelial	|O
system	|O
(	|O
RES	|O
)	|O
Fc	|B-PROTEIN
receptor	|I-PROTEIN
blockade	|O
and	|O
suppression	|O
of	|O
antiplatelet	|O
antibody	|O
synthesis	|O
.	|O

Incidences	|O
of	|O
nonfatal	|O
stroke	|O
,	|O
myocardial	|O
infarction	|O
,	|O
angina	|O
pectoris	|O
und	|O
left	|O
ventricular	|O
hypertrophy	|O
could	|O
also	|O
be	|O
lowered	|O
.	|O

High	|O
radial	|O
r	|O
values	|O
with	|O
small	|O
standard	|O
deviations	|O
were	|O
observed	|O
in	|O
normal	|O
LV	|O
(	|O
0.972	|O
+	|O
/	|O
-	|O
0.016	|O
)	|O
and	|O
in	|O
non	|O
-	|O
MI	|O
regions	|O
(	|O
0.964	|O
+	|O
/	|O
-	|O
0.018	|O
)	|O
,	|O
indicating	|O
temporally	|O
homogeneous	|O
radial	|O
shortening	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
during	|O
pregnancy	|O
there	|O
are	|O
increases	|O
in	|O
bone	|O
formation	|O
rates	|O
contributing	|O
to	|O
the	|O
increases	|O
in	|O
skeletal	|O
mass	|O
.	|O

We	|O
analyzed	|O
data	|O
from	|O
56	|O
patients	|O
with	|O
Systemic	|O
Lupus	|O
Erythematosus	|O
(	|O
SLE	|O
)	|O
in	|O
whom	|O
renal	|O
biopsies	|O
were	|O
done	|O
systematically	|O
.	|O

The	|O
possibility	|O
of	|O
a	|O
hereditary	|O
disorder	|O
leading	|O
to	|O
a	|O
minor	|O
defect	|O
in	|O
elastic	|O
fibre	|O
structure	|O
which	|O
could	|O
be	|O
responsible	|O
for	|O
the	|O
spontaneous	|O
lesions	|O
is	|O
discussed	|O
.	|O

Prevention	|O
by	|O
a	|O
heparin	|O
-	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
combination	|O

N	|O
-	|O
Substituted	|O
trimethylsilylcarbamates	|O
were	|O
tested	|O
as	|O
derivatizing	|O
reagents	|O
for	|O
gas	|O
chromatographic	|O
analysis	|O
.	|O

MICs	|O
of	|O
four	|O
antifungal	|O
agents	|O
(	|O
5	|O
-	|O
fluorocytosine	|O
,	|O
miconazole	|O
,	|O
ketoconazole	|O
,	|O
and	|O
amphotericin	|O
B	|O
)	|O
for	|O
84	|O
clinical	|O
isolates	|O
of	|O
various	|O
Candida	|O
species	|O
were	|O
then	|O
determined	|O
with	|O
both	|O
media	|O
in	|O
agar	|O
dilution	|O
and	|O
microtiter	|O
broth	|O
dilution	|O
systems	|O
.	|O

There	|O
were	|O
18	|O
patients	|O
with	|O
Group	|O
II	|O
(	|O
a	|O
)	|O
tumors	|O
;	|O
although	|O
tumor	|O
biopsy	|O
was	|O
attempted	|O
on	|O
eight	|O
of	|O
these	|O
,	|O
pathological	|O
diagnosis	|O
at	|O
the	|O
time	|O
of	|O
surgery	|O
was	|O
made	|O
in	|O
only	|O
one	|O
case	|O
.	|O

Evidence	|O
that	|O
opiate	|O
addiction	|O
is	|O
in	|O
part	|O
an	|O
immune	|O
response	|O
.	|O

Parasitological	|O
post	|O
-	|O
mortem	|O
examination	|O
of	|O
all	|O
seropositive	|O
animals	|O
showed	|O
five	|O
and	|O
seven	|O
false	|O
-	|O
positive	|O
animals	|O
when	|O
E	|B-PROTEIN
/	|I-PROTEIN
S	|I-PROTEIN
and	|I-PROTEIN
CWE	|I-PROTEIN
antigens	|I-PROTEIN
were	|O
used	|O
,	|O
respectively	|O
.	|O

Glucocorticoid	|O
induced	|O
hypertension	|O
has	|O
been	|O
regarded	|O
as	|O
independent	|O
of	|O
sodium	|O
(	|O
Na	|O
)	|O
,	|O
in	|O
contrast	|O
to	|O
mineralocorticoid	|O
induced	|O
hypertension	|O
,	|O
which	|O
is	|O
Na+	|O
-	|O
dependent	|O
.	|O

Seventeen	|O
of	|O
them	|O
were	|O
on	|O
treatment	|O
with	|O
systemic	|O
steroids	|O
.	|O

Examples	|O
of	|O
its	|O
use	|O
in	|O
the	|O
intensive	|O
therapy	|O
unit	|O
are	|O
described	|O
.	|O

The	|O
growing	|O
drug	|O
problem	|O
is	|O
also	|O
reflected	|O
in	|O
the	|O
increasing	|O
number	|O
of	|O
cases	|O
of	|O
hepatitis	|O
B	|O
and	|O
of	|O
drug	|O
-	|O
related	|O
deaths	|O
.	|O

Only	|O
seven	|O
patients	|O
,	|O
five	|O
of	|O
whom	|O
have	|O
metastatic	|O
disease	|O
,	|O
survive	|O
more	|O
than	|O
10	|O
years	|O
after	|O
first	|O
presentation	|O
;	|O
nine	|O
patients	|O
,	|O
one	|O
of	|O
whom	|O
has	|O
secondaries	|O
,	|O
survive	|O
for	|O
5	|O
years	|O
or	|O
less	|O
.	|O

Although	|O
differences	|O
were	|O
not	|O
significant	|O
,	|O
infants	|O
in	|O
the	|O
experimental	|O
group	|O
had	|O
more	|O
changes	|O
in	|O
the	|O
intermittent	|O
mandatory	|O
ventilation	|O
(	|O
IMV	|O
)	|O
settings	|O
during	|O
transport	|O
,	|O
and	|O
more	|O
such	|O
infants	|O
arrived	|O
at	|O
the	|O
receiving	|O
hospital	|O
with	|O
acceptable	|O
pH	|O
and	|O
PCO2	|O
values	|O
.	|O

Repetitive	|O
sequences	|O
are	|O
present	|O
in	|O
at	|O
least	|O
three	|O
introns	|O
of	|O
the	|O
cytochrome	|B-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
450PBc2	|I-PROTEIN
gene	|O
,	|O
but	|O
not	|O
in	|O
exons	|O
or	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
.	|O

A	|O
large	|O
increase	|O
of	|O
serum	|O
ketones	|O
occurred	|O
under	|O
all	|O
conditions	|O
,	|O
and	|O
the	|O
exercise	|O
respiratory	|O
quotient	|O
suggested	|O
some	|O
increase	|O
of	|O
fat	|O
utilization	|O
,	|O
WW	|O
(	|O
0.85	|O
)	|O
through	|O
CW	|O
(	|O
0.84	|O
)	|O
to	|O
CC	|O
(	|O
0.83	|O
)	|O
.	|O

This	|O
lack	|O
of	|O
correlation	|O
may	|O
be	|O
due	|O
to	|O
variations	|O
in	|O
the	|O
metabolic	|O
activity	|O
of	|O
the	|O
endometriotic	|O
implants	|O
present	|O
at	|O
different	|O
stages	|O
of	|O
the	|O
disease	|O
.	|O

Respiratory	|O
adaptation	|O
to	|O
chronic	|O
hypoxia	|O
in	|O
newborn	|O
rats	|O
.	|O

Compound	|O
1	|O
is	|O
either	|O
21	|O
-	|O
O	|O
-	|O
angeloyl	|O
,	|O
22	|O
-	|O
O	|O
-	|O
tigloyl	|O
R1	|O
-	|O
barrigenol	|O
,	|O
or	|O
21	|O
-	|O
O	|O
-	|O
tigloyl	|O
,	|O
22	|O
-	|O
O	|O
-	|O
angeloyl	|O
R1	|O
-	|O
barrigenol	|O
.	|O

Human	|O
and	|O
Chinese	|O
hamster	|O
S14	|B-PROTEIN
protein	|O
sequences	|O
deduced	|O
from	|O
the	|O
cDNAs	|O
are	|O
identical	|O
.	|O

RPS14	|B-PROTEIN
introns	|O
3	|O
and	|O
4	|O
both	|O
contain	|O
Alu	|B-PROTEIN
sequences	|O
.	|O

One	|O
of	|O
the	|O
most	|O
relevant	|O
aspects	|O
in	|O
achieving	|O
the	|O
consistent	|O
survival	|O
of	|O
an	|O
animal	|O
undergoing	|O
the	|O
experimental	|O
implantation	|O
of	|O
a	|O
total	|O
artificial	|O
heart	|O
is	|O
obviously	|O
related	|O
to	|O
the	|O
correct	|O
anatomic	|O
placement	|O
of	|O
prosthetic	|O
ventricles	|O
inside	|O
the	|O
chest	|O
.	|O

An	|O
exaggerated	|O
tissue	|O
response	|O
adjacent	|O
to	|O
the	|O
cyanoacrylate	|O
site	|O
suggested	|O
a	|O
potential	|O
toxic	|O
chemical	|O
or	|O
thermal	|O
reaction	|O
,	|O
or	|O
both	|O
,	|O
to	|O
the	|O
tissue	|O
adhesive	|O
,	|O
but	|O
there	|O
was	|O
no	|O
evidence	|O
of	|O
any	|O
distant	|O
ocular	|O
effects	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
there	|O
may	|O
be	|O
a	|O
relationship	|O
between	|O
the	|O
pathogenesis	|O
of	|O
MAL	|O
,	|O
narcolepsy	|O
,	|O
and	|O
OSA	|O
.	|O

Among	|O
82	|O
superficial	|O
lesions	|O
34	|O
were	|O
classified	|O
as	|O
showing	|O
CR	|O
and	|O
another	|O
23	|O
as	|O
showing	|O
PR	|O
,	|O
with	|O
a	|O
response	|O
rate	|O
of	|O
69.5%	|O
.	|O

Under	|O
the	|O
same	|O
hematocrit	|O
and	|O
flow	|O
conditions	|O
,	|O
the	|O
rate	|O
of	|O
oxygen	|O
saturation	|O
decrease	|O
was	|O
significantly	|O
higher	|O
for	|O
the	|O
sickle	|O
cells	|O
than	|O
for	|O
normal	|O
cells	|O
.	|O

While	|O
the	|O
examiner	|O
observed	|O
the	|O
interior	|O
of	|O
the	|O
eye	|O
with	|O
indirect	|O
ophthalmoscopy	|O
,	|O
the	|O
point	|O
source	|O
of	|O
light	|O
from	|O
the	|O
fiberoptic	|O
light	|O
pipe	|O
was	|O
moved	|O
along	|O
the	|O
margins	|O
of	|O
the	|O
episcleral	|O
plaque	|O
.	|O

These	|O
fusion	|O
proteins	|O
also	|O
allowed	|O
the	|O
localization	|O
of	|O
the	|O
transcriptional	|O
activation	|O
and	|O
DNA	|O
binding	|O
domains	|O
of	|O
the	|O
ToxR	|B-PROTEIN
protein	|O
to	|O
its	|O
cytoplasmically	|O
located	|O
N	|O
-	|O
terminal	|O
portion	|O
.	|O

From	|O
life	|O
-	|O
table	|O
analyses	|O
of	|O
these	|O
patients	|O
,	|O
we	|O
estimated	|O
that	|O
the	|O
incidence	|O
of	|O
secondary	|O
chondrosarcoma	|O
in	|O
patients	|O
who	|O
have	|O
Ollier	|O
disease	|O
is	|O
about	|O
25	|O
per	|O
cent	|O
at	|O
the	|O
age	|O
of	|O
forty	|O
years	|O
,	|O
and	|O
that	|O
malignant	|O
degeneration	|O
is	|O
almost	|O
a	|O
certainty	|O
in	|O
patients	|O
who	|O
have	|O
Maffucci	|O
syndrome	|O
.	|O

The	|O
lethal	|O
toxicity	|O
of	|O
inorganic	|O
(	|O
HgCl2	|O
)	|O
and	|O
organic	|O
(	|O
CH3HgCl	|O
)	|O
mercury	|O
chloride	|O
was	|O
compared	|O
for	|O
Coturnix	|O
(	|O
Japanese	|O
quail	|O
,	|O
Coturnix	|O
japonica	|O
)	|O
of	|O
different	|O
ages	|O
from	|O
hatch	|O
through	|O
adulthood	|O
by	|O
single	|O
-	|O
dose	|O
acute	|O
oral	|O
and	|O
intramuscular	|O
injections	|O
and	|O
by	|O
a	|O
5	|O
-	|O
d	|O
dietary	|O
trial	|O
.	|O

Since	|O
the	|O
integrated	|O
13h00	|O
-	|O
16h00	|O
plasma	|O
cortisol	|O
estimation	|O
is	|O
cheaper	|O
and	|O
simpler	|O
than	|O
the	|O
mean	|O
13h00	|O
-	|O
16h00	|O
plasma	|O
cortisol	|O
estimation	|O
,	|O
we	|O
recommend	|O
it	|O
as	|O
an	|O
adjunct	|O
in	|O
the	|O
diagnosis	|O
of	|O
Cushing	|O
's	|O
syndrome	|O
.	|O

Most	|O
of	|O
the	|O
patients	|O
had	|O
locally	|O
advanced	|O
lesions	|O
(	|O
63	|O
T3	|O
-	|O
4	|O
:	|O
91.5%	|O
)	|O
according	|O
to	|O
the	|O
adopted	|O
TNM	|O
system	|O
(	|O
Lederman	|O
-	|O
Gadeberg	|O
,	|O
Sisson	|O
-	|O
Jesse	|O
)	|O
.	|O

The	|O
risk	|O
for	|O
these	|O
complications	|O
is	|O
increased	|O
by	|O
the	|O
following	|O
factors	|O
:	|O
multiple	|O
gestation	|O
,	|O
the	|O
combination	|O
of	|O
magnesium	|O
sulfate	|O
and	|O
beta	|O
-	|O
adrenergic	|O
agonist	|O
,	|O
and	|O
the	|O
use	|O
of	|O
adrenocortico	|O
-	|O
steroids	|O
to	|O
hasten	|O
fetal	|O
pulmonary	|O
maturity	|O
.	|O

Chlorambucil	|O
and	|O
interferon	|B-PROTEIN
for	|O
low	|O
grade	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O
.	|O

Selenium	|O
(	|O
.1	|O
ppm	|O
)	|O
and	|O
E	|O
(	|O
50	|O
IU	|O
/	|O
kg	|O
)	|O
supplementation	|O
of	|O
the	|O
diet	|O
of	|O
the	|O
sow	|O
increased	|O
plasma	|O
tocopherol	|O
and	|O
Se	|O
concentrations	|O
,	|O
but	|O
did	|O
not	|O
increase	|O
plasma	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
(	|O
GSH	|B-PROTEIN
-	|I-PROTEIN
Px	|I-PROTEIN
)	|O
activity	|O
.	|O

Framingham	|O
Type	|O
A	|O
behavior	|O
was	|O
positively	|O
associated	|O
with	|O
diastolic	|O
blood	|O
pressure	|O
(	|O
r	|O
=	|O
0.17	|O
,	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
among	|O
the	|O
women	|O
.	|O

The	|O
in	|O
vitro	|O
antibacterial	|O
potency	|O
is	|O
greatest	|O
when	|O
the	|O
1	|O
-	|O
substituent	|O
is	|O
2,4	|O
-	|O
difluorophenyl	|O
and	|O
the	|O
7	|O
-	|O
substituent	|O
is	|O
a	|O
3	|O
-	|O
amino	|O
-	|O
1	|O
-	|O
pyrrolidinyl	|O
group	|O
.	|O

The	|O
M	|B-PROTEIN
reading	|O
frame	|O
differed	|O
from	|O
the	|O
reported	|O
sequence	|O
by	|O
a	|O
single	|O
nucleotide	|O
corresponding	|O
to	|O
a	|O
conservative	|O
lysine	|O
to	|O
arginine	|O
amino	|O
acid	|O
substitution	|O
near	|O
the	|O
carboxy	|O
-	|O
terminus	|O
conserved	|O
among	|O
the	|O
M	|B-PROTEIN
proteins	|O
of	|O
paramyxoviruses	|O
.	|O

An	|O
ion	|O
chromatographic	|O
method	|O
was	|O
used	|O
to	|O
determine	|O
Br	|O
ion	|O
in	|O
the	|O
urine	|O
of	|O
Greyhounds	|O
.	|O

II	|O
.	|O

Laryngographic	|O
changes	|O
following	|O
endotracheal	|O
intubation	|O
in	|O
adults	|O
.	|O

Intensification	|O
of	|O
human	|O
myocardial	|O
contractile	|O
activity	|O
as	|O
affected	|O
by	|O
blood	|O
serum	|O

Autotransplantation	|O
of	|O
a	|O
vein	|O
segment	|O
with	|O
valve	|O
in	|O
the	|O
treatment	|O
of	|O
deep	|O
vein	|O
valvular	|O
insufficiency	|O
of	|O
the	|O
lower	|O
extremity	|O

The	|O
relationships	|O
among	|O
four	|O
descriptors	|O
of	|O
lactate	|O
increase	|O
:	|O
lactate	|O
threshold	|O
(	|O
LT	|O
)	|O
(	|O
the	|O
VO2	|O
at	|O
which	|O
blood	|O
lactate	|O
concentration	|O
begins	|O
to	|O
increase	|O
above	|O
the	|O
resting	|O
level	|O
during	|O
an	|O
incremental	|O
exercise	|O
test	|O
)	|O
,	|O
LT1	|O
(	|O
the	|O
VO2	|O
at	|O
which	|O
blood	|O
lactate	|O
increases	|O
1	|O
mM	|O
above	|O
the	|O
resting	|O
level	|O
)	|O
,	|O
LT2	|O
(	|O
the	|O
VO2	|O
at	|O
which	|O
blood	|O
lactate	|O
concentration	|O
reaches	|O
a	|O
fixed	|O
value	|O
of	|O
2	|O
mM	|O
)	|O
,	|O
onset	|O
of	|O
blood	|O
lactate	|O
accumulation	|O
(	|O
OBLA	|O
;	|O
the	|O
VO2	|O
at	|O
which	|O
blood	|O
lactate	|O
reaches	|O
a	|O
concentration	|O
of	|O
4	|O
mM	|O
)	|O
,	|O
were	|O
compared	|O
with	|O
aerobic	|O
capacity	|O
(	|O
VO2max	|O
)	|O
and	|O
12	|O
min	|O
running	|O
performance	|O
in	|O
19	|O
untrained	|O
female	|O
students	|O
.	|O

This	|O
is	|O
based	|O
on	|O
partitioning	|O
an	|O
underlying	|O
multivariate	|O
normal	|O
distribution	|O
.	|O

The	|O
observation	|O
of	|O
late	|O
effects	|O
after	|O
irradiations	|O
or	|O
after	|O
space	|O
flights	|O
show	|O
the	|O
difficulties	|O
encountered	|O
in	|O
assessing	|O
radiative	|O
risks	|O
during	|O
long	|O
duration	|O
space	|O
flights	|O
.	|O

Practical	|O
use	|O
and	|O
interpretation	|O
of	|O
viral	|O
hepatitis	|O
B	|O
markers	|O
and	|O
hepatic	|O
biopsy	|O
in	|O
HBs	|B-PROTEIN
Ag	|I-PROTEIN
carriers	|O
and	|O
at	|O
the	|O
chronic	|O
hepatitis	|O
stage	|O

The	|O
1	|O
,	|O
2	|O
,	|O
3	|O
and	|O
4	|O
year	|O
survival	|O
rates	|O
were	|O
94%	|O
,	|O
84%	|O
,	|O
76%	|O
and	|O
63%	|O
,	|O
respectively	|O
.	|O

Inhibition	|O
of	|O
histalog	|O
-	|O
stimulated	|O
gastric	|O
secretion	|O
by	|O
40	|O
749	|O
RP	|O
,	|O
a	|O
new	|O
long	|O
-	|O
acting	|O
gastric	|O
antisecretory	|O
agent	|O
.	|O

Five	|O
-	|O
year	|O
prospective	|O
study	|O
of	|O
peripheral	|O
white	|O
blood	|O
cells	|O
in	|O
infectious	|O
mononucleosis	|O
.	|O

Northern	|O
blotting	|O
with	|O
a	|O
unique	|O
17	|O
-	|O
mer	|O
oligonucleotide	|O
demonstrated	|O
the	|O
absence	|O
of	|O
the	|O
mutant	|O
sequence	|O
in	|O
the	|O
mRNA	|O
from	|O
which	|O
the	|O
cDNA	|O
library	|O
giving	|O
rise	|O
to	|O
the	|O
mutant	|O
cDNA	|O
was	|O
constructed	|O
.	|O

Novel	|O
multigene	|O
families	|O
encoding	|O
highly	|O
repetitive	|O
peptide	|O
sequences	|O
.	|O

Chemotherapy	|O
of	|O
metastasizing	|O
breast	|O
cancer	|O

In	|O
recent	|O
years	|O
,	|O
successful	|O
physiological	|O
models	|O
have	|O
been	|O
developed	|O
for	|O
a	|O
variety	|O
of	|O
volatile	|O
and	|O
nonvolatile	|O
chemicals	|O
,	|O
and	|O
their	|O
ability	|O
to	|O
perform	|O
the	|O
extrapolations	|O
needed	|O
in	|O
risk	|O
assessment	|O
has	|O
been	|O
demonstrated	|O
.	|O

Linear	|O
extrapolation	|O
is	|O
used	|O
below	|O
the	|O
experimental	|O
data	|O
range	|O
to	|O
establish	|O
an	|O
upper	|O
bound	|O
on	|O
carcinogenic	|O
risk	|O
at	|O
low	|O
doses	|O
.	|O

Hisako	|O
Minowa	|O
who	|O
has	|O
worked	|O
as	|O
a	|O
psychiatric	|O
counsellor	|O
in	|O
industry	|O
for	|O
the	|O
past	|O
20	|O
years	|O

Deletion	|O
mapping	|O
studies	|O
revealed	|O
that	|O
the	|O
upstream	|O
DNA	|O
sequences	|O
up	|O
to	|O
-	|O
86	|O
were	|O
sufficient	|O
for	|O
the	|O
optimal	|O
basal	|O
level	|O
transcription	|O
in	|O
HeLa	|O
cells	|O
and	|O
also	|O
for	|O
the	|O
EIA	|B-PROTEIN
-	|O
induced	|O
transcription	|O
.	|O

Incorporation	|O
of	|O
the	|O
polyene	|O
antibiotic	|O
amphotericin	|O
B	|O
(	|O
AMB	|O
)	|O
in	|O
liposomes	|O
results	|O
in	|O
a	|O
marked	|O
reduction	|O
in	|O
drug	|O
toxicity	|O
with	|O
no	|O
loss	|O
of	|O
antifungal	|O
potency	|O
.	|O

Eleven	|O
healthy	|O
,	|O
normotensive	|O
males	|O
undergoing	|O
routine	|O
restorative	|O
dental	|O
care	|O
were	|O
evaluated	|O
during	|O
treatment	|O
for	|O
possible	|O
hemodynamic	|O
alterations	|O
in	|O
response	|O
to	|O
potential	|O
sympathetic	|O
nervous	|O
system	|O
stimulation	|O
.	|O

Serum	|O
IgM	|B-PROTEIN
and	|O
IgE	|B-PROTEIN
concentrations	|O
,	|O
allergen	|O
-	|O
specific	|O
IgE	|B-PROTEIN
scores	|O
,	|O
and	|O
the	|O
tumor	|O
E2R	|B-PROTEIN
status	|O
were	|O
combined	|O
to	|O
construct	|O
a	|O
three	|O
-	|O
level	|O
risk	|O
classification	|O
that	|O
was	|O
more	|O
prognostic	|O
than	|O
any	|O
of	|O
the	|O
individual	|O
components	|O
.	|O

The	|O
M	|O
-	|O
3	|O
subtype	|O
was	|O
an	|O
adverse	|O
prognostic	|O
factor	|O
.	|O

Within	|O
the	|O
Strep	|O
.	|O
mutans	|O
group	|O
there	|O
was	|O
a	|O
highly	|O
-	|O
significant	|O
difference	|O
between	|O
Strep	|O
.	|O
mutans	|O
/	|O
Strep	|O
.	|O
cricetus	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
with	|O
respect	|O
to	|O
mean	|O
clump	|O
size	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
T.C.	|O
,	|O
LDL	|B-PROTEIN
-	|I-PROTEIN
C.	|I-PROTEIN
,	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
C.	|I-PROTEIN
,	|O
HDL2	|B-PROTEIN
-	|I-PROTEIN
C.	|I-PROTEIN
,	|O
apo	|B-PROTEIN
B	|I-PROTEIN
,	|O
apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
/	|I-PROTEIN
B	|I-PROTEIN
ratio	|O
and	|O
apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
/	|I-PROTEIN
B	|I-PROTEIN
ratio	|O
are	|O
predictive	|O
risk	|O
factors	|O
of	|O
the	|O
coronary	|O
heart	|O
disease	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
the	|O
unique	|O
suppository	|O
formulation	|O
of	|O
CZX	|O
-	|O
S	|O
is	|O
useful	|O
in	|O
the	|O
treatment	|O
of	|O
infections	|O
in	|O
children	|O
with	|O
heavy	|O
psychophysiologic	|O
disorders	|O
and	|O
in	|O
children	|O
who	|O
cannot	|O
take	|O
oral	|O
drugs	|O
because	|O
of	|O
severe	|O
vomiting	|O
.	|O

In	|O
addition	|O
,	|O
marked	|O
hypertension	|O
accompanied	|O
this	|O
disorder	|O
and	|O
all	|O
abnormalities	|O
,	|O
including	|O
the	|O
hypertension	|O
,	|O
responded	|O
to	|O
1	|B-PROTEIN
-	|I-PROTEIN
desamino	|I-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
arginine	|I-PROTEIN
vasopressin	|I-PROTEIN
therapy	|O
.	|O

Single	|O
photon	|O
emission	|O
computerized	|O
tomography	|O
(	|O
SPECT	|O
)	|O
,	|O
by	|O
providing	|O
three	|O
-	|O
dimensional	|O
representation	|O
of	|O
myocardial	|O
Tl	|O
-	|O
201	|O
,	|O
offers	|O
promise	|O
for	|O
improved	|O
localization	|O
of	|O
CAD	|O
.	|O

Computer	|O
assisted	|O
mapping	|O
in	|O
quantitative	|O
analysis	|O
of	|O
cerebral	|O
positron	|O
emission	|O
tomograms	|O
.	|O

In	|O
19	|O
patients	|O
vagotomy	|O
not	|O
only	|O
curbed	|O
the	|O
bleeding	|O
but	|O
provided	|O
definitive	|O
therapy	|O
(	|O
Visick	|O
I	|O
-	|O
II	|O
)	|O
;	|O
4	|O
patients	|O
died	|O
(	|O
mortality	|O
rate	|O
16%	|O
)	|O
.	|O

Documentation	|O
of	|O
a	|O
successful	|O
intrauterine	|O
fertilization	|O
with	|O
delivery	|O
of	|O
a	|O
term	|O
baby	|O
supports	|O
the	|O
theoretical	|O
feasibility	|O
of	|O
the	|O
EP	|O
;	|O
however	|O
,	|O
anovulation	|O
incurred	|O
by	|O
our	|O
procedure	|O
appears	|O
to	|O
be	|O
the	|O
major	|O
drawback	|O
.	|O

MRI	|O
disclosed	|O
one	|O
or	|O
more	|O
of	|O
the	|O
following	|O
abnormalities	|O
in	|O
24	|O
(	|O
63%	|O
)	|O
of	|O
38	|O
treated	|O
kidneys	|O
:	|O
(	|O
1	|O
)	|O
loss	|O
of	|O
corticomedullary	|O
differentiation	|O
,	|O
(	|O
2	|O
)	|O
perirenal	|O
fluid	|O
,	|O
(	|O
3	|O
)	|O
subcapsular	|O
hematoma	|O
,	|O
(	|O
4	|O
)	|O
hemorrhage	|O
into	|O
a	|O
renal	|O
cyst	|O
,	|O
and	|O
(	|O
5	|O
)	|O
unexplained	|O
abnormalities	|O
.	|O

The	|O
results	|O
obtained	|O
are	|O
similar	|O
to	|O
those	|O
described	|O
with	|O
the	|O
previous	|O
Cremophor	|O
formulation	|O
although	|O
greater	|O
variability	|O
in	|O
induction	|O
and	|O
recovery	|O
times	|O
was	|O
noted	|O
with	|O
the	|O
emulsion	|O
formulation	|O
.	|O

The	|O
percentage	|O
RFR	|O
reduction	|O
at	|O
the	|O
end	|O
of	|O
CPB	|O
showed	|O
significant	|O
correlation	|O
with	|O
1	|O
)	|O
CPB	|O
duration	|O
(	|O
r	|O
=	|O
0.49	|O
)	|O
,	|O
2	|O
)	|O
oxygen	|O
flow	|O
rate	|O
index	|O
(	|O
OFRI	|O
)	|O
,	|O
i.e.	|O
flow	|O
/	|O
min	|O
in	|O
the	|O
bubble	|O
oxygenator	|O
/	|O
m2	|O
bsa	|O
(	|O
r	|O
=	|O
0.38	|O
)	|O
,	|O
and	|O
3	|O
)	|O
blood	|O
flow	|O
rate	|O
index	|O
(	|O
BFRI	|O
)	|O
,	|O
i.e.	|O
average	|O
volume	|O
of	|O
blood	|O
pumped	|O
through	|O
the	|O
heart	|O
-	|O
lung	|O
machine	|O
/	|O
min	|O
CPB	|O
time	|O
/	|O
m2	|O
bsa	|O
(	|O
r	|O
=	|O
0.51	|O
)	|O
.	|O

Diagnosis	|O
of	|O
unilateral	|O
renal	|O
artery	|O
lesions	|O
after	|O
captopril	|O
administration	|O
.	|O

A	|O
yeast	|O
DNA	|O
fragment	|O
carrying	|O
the	|O
gene	|O
CP	|B-PROTEIN
A1	|I-PROTEIN
encoding	|O
the	|O
small	|O
subunit	|O
of	|O
the	|O
arginine	|O
pathway	|O
carbamoyl	|B-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
synthetase	|I-PROTEIN
has	|O
been	|O
sequenced	|O
.	|O

A	|O
retrospective	|O
study	|O
of	|O
banked	|O
sera	|O
from	|O
19	|O
cats	|O
with	|O
the	|O
eosinophilic	|O
granuloma	|O
complex	|O
revealed	|O
that	|O
68%	|O
of	|O
affected	|O
cats	|O
had	|O
circulating	|O
antibodies	|O
to	|O
components	|O
of	|O
normal	|O
cat	|O
epithelium	|O
.	|O

In	|O
memory	|O
of	|O
Magdelaine	|O
Comtesse	|O

The	|O
H2	|B-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
and	|O
sucralfate	|O
cost	|O
about	|O
the	|O
same	|O
and	|O
have	|O
few	|O
side	|O
effects	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
indoramin	|O
may	|O
have	|O
Class	|O
III	|O
antiarrhythmic	|O
activity	|O
.	|O

A	|O
high	|O
efficacy	|O
of	|O
the	|O
combined	|O
use	|O
of	|O
nontoxic	|O
doses	|O
of	|O
two	|O
pharmaceuticals	|O
:	|O
cystamine	|O
(	|O
50	|O
mg	|O
/	|O
kg	|O
)	|O
and	|O
mexamine	|O
(	|O
25	|O
mg	|O
/	|O
kg	|O
)	|O
under	|O
the	|O
conditions	|O
of	|O
short	|O
-	|O
term	|O
exogenous	|O
hypoxia	|O
(	|O
7.5%	|O
O2	|O
)	|O
was	|O
found	|O
in	|O
(	|O
CBA	|O
X	|O
C57Bl	|O
)	|O
F1	|O
mice	|O
.	|O

The	|O
Mean	|O
was	|O
74,3	|O
+	|O
/	|O
-	|O
53,6	|O
micrograms	|O
J	|O
/	|O
g	|O
Cr	|O
,	|O
the	|O
Median	|O
61	|O
micrograms	|O
J	|O
/	|O
g	|O
Cr	|O
.	|O

In	|O
the	|O
region	|O
Walgau	|O
with	|O
mixed	|O
industrial	|O
-	|O
rural	|O
population	|O
an	|O
iodine	|O
deficiency	|O
I	|O
was	|O
found	|O
in	|O
81%	|O
and	|O
an	|O
iodine	|O
deficiency	|O
II	|O
in	|O
45%	|O
.	|O

The	|O
structural	|O
gene	|O
for	|O
hydrogenase	|B-PROTEIN
encodes	|O
a	|O
protein	|O
product	|O
of	|O
molecular	|O
mass	|O
45820	|O
Da	|O
.	|O

Pancreaticoduodenal	|O
lymph	|O
node	|O
enlargement	|O
,	|O
regardless	|O
of	|O
cause	|O
,	|O
has	|O
been	|O
a	|O
source	|O
of	|O
imaging	|O
confusion	|O
because	|O
of	|O
its	|O
propensity	|O
to	|O
mimic	|O
pancreatic	|O
malignancy	|O
yet	|O
not	|O
cause	|O
biliary	|O
obstruction	|O
.	|O

Interference	|O
with	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
was	|O
only	|O
observed	|O
in	|O
the	|O
ELISA	|O
enzygnost	|O
if	|O
sera	|O
were	|O
not	|O
pretreated	|O
with	|O
latex	|O
adsorbents	|O
.	|O

All	|O
patients	|O
had	|O
elevated	|O
levels	|O
of	|O
serum	|O
IgE	|B-PROTEIN
antibodies	|O
to	|O
the	|O
crude	|O
soybean	|O
extract	|O
;	|O
binding	|O
values	|O
ranged	|O
from	|O
2.3	|O
to	|O
28.1	|O
times	|O
that	|O
of	|O
a	|O
negative	|O
control	|O
serum	|O
.	|O

New	|O
techniques	|O
for	|O
the	|O
mass	|O
spectrometry	|O
of	|O
natural	|O
products	|O
.	|O

Dual	|O
radionuclide	|O
subtraction	|O
imaging	|O
of	|O
the	|O
spleen	|O
using	|O
67Ga	|O
citrate	|O
and	|O
99mTc	|O
is	|O
useful	|O
in	|O
further	|O
delineating	|O
lesions	|O
that	|O
are	|O
identified	|O
on	|O
either	|O
a	|O
routine	|O
radiogallium	|O
survey	|O
or	|O
on	|O
a	|O
conventional	|O
sulfur	|O
colloid	|O
liver	|O
-	|O
spleen	|O
image	|O
.	|O

Such	|O
studied	|O
acquired	|O
with	|O
low	|O
energy	|O
or	|O
medium	|O
energy	|O
collimation	|O
and	|O
a	|O
window	|O
centered	|O
on	|O
the	|O
159	|O
keV	|O
123I	|O
photopeak	|O
contain	|O
appreciable	|O
septal	|O
breakthrough	|O
signals	|O
originating	|O
from	|O
Compton	|O
scatter	|O
of	|O
high	|O
energy	|O
photons	|O
primarily	|O
from	|O
124I	|O
.	|O

Nursing	|O
education	|O
-	|O
-	|O
the	|O
computer	|O
obligation	|O
.	|O

Shear	|O
bond	|O
strength	|O
of	|O
a	|O
composite	|O
resin	|O
to	|O
an	|O
etched	|O
glass	|O
ionomer	|O
.	|O

An	|O
additional	|O
advantage	|O
is	|O
that	|O
the	|O
resin	|O
can	|O
be	|O
removed	|O
and	|O
the	|O
immunoperoxidase	|B-PROTEIN
technique	|O
carried	|O
out	|O
on	|O
thin	|O
sections	|O
.	|O

Such	|O
a	|O
concept	|O
is	|O
crucial	|O
to	|O
our	|O
understanding	|O
of	|O
the	|O
pathology	|O
of	|O
ageing	|O
in	|O
general	|O
.	|O

We	|O
consider	|O
that	|O
DIL	|O
-	|O
CP	|O
is	|O
a	|O
safe	|O
and	|O
excellent	|O
CP	|O
in	|O
CABG	|O
surgery	|O
and	|O
we	|O
are	|O
now	|O
utilizing	|O
this	|O
CP	|O
in	|O
all	|O
patients	|O
requiring	|O
CABG	|O
surgery	|O
.	|O

We	|O
have	|O
earlier	|O
evolved	|O
an	|O
experimental	|O
model	|O
by	|O
means	|O
of	|O
which	|O
changes	|O
identical	|O
to	|O
the	|O
microembolism	|O
syndrome	|O
can	|O
be	|O
induced	|O
from	|O
a	|O
reproducible	|O
musculo	|O
-	|O
skeletal	|O
trauma	|O
in	|O
pigs	|O
observed	|O
under	|O
long	|O
-	|O
term	|O
anesthesia	|O
under	|O
standardized	|O
conditions	|O
.	|O

Although	|O
no	|O
statistical	|O
significance	|O
was	|O
achieved	|O
,	|O
it	|O
is	|O
remarkable	|O
that	|O
there	|O
was	|O
a	|O
clear	|O
trend	|O
for	|O
the	|O
superiority	|O
of	|O
Galphimia	|O
D6	|O
while	|O
the	|O
Galphimia	|O
dilution	|O
10	|O
(	|O
-	|O
6	|O
)	|O
was	|O
about	|O
equally	|O
effective	|O
compared	|O
with	|O
placebo	|O
.	|O

The	|O
volume	|O
of	|O
blood	|O
to	|O
the	|O
flap	|O
ranges	|O
from	|O
1	|O
to	|O
2	|O
ml	|O
/	|O
min	|O
,	|O
collateral	|O
circulation	|O
to	|O
the	|O
flap	|O
exists	|O
,	|O
but	|O
is	|O
negligible	|O
,	|O
and	|O
there	|O
is	|O
little	|O
change	|O
in	|O
the	|O
capillary	|O
blood	|O
flow	|O
as	|O
the	|O
flap	|O
ages	|O
.	|O

With	|O
aging	|O
,	|O
many	|O
aspects	|O
of	|O
immune	|O
function	|O
change	|O
.	|O

Oral	|O
candidiasis	|O

In	|O
addition	|O
,	|O
the	|O
gcd1	|B-PROTEIN
-	|O
101	|O
mutation	|O
suppressed	|O
the	|O
low	|O
translational	|O
efficiency	|O
of	|O
GCN4	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
mRNA	|O
observed	|O
in	|O
gcn2	|B-PROTEIN
-	|O
and	|O
gcn3	|B-PROTEIN
-	|O
cells	|O
.	|O

This	|O
suggests	|O
that	|O
alaproclate	|O
acutely	|O
increases	|O
the	|O
responsiveness	|O
of	|O
postsynaptic	|O
muscarinic	|B-PROTEIN
and	|I-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
adrenoceptors	|I-PROTEIN
.	|O

The	|O
concentrations	|O
of	|O
apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
and	|O
apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
of	|O
abstainers	|O
decreased	|O
significantly	|O
compared	|O
with	|O
the	|O
corresponding	|O
changes	|O
in	|O
controls	|O
.	|O

The	|O
distribution	|O
of	|O
patients	|O
was	|O
as	|O
follows	|O
:	|O
group	|O
1	|O
-	|O
-	|O
complex	|O
gamma	|O
-	|O
therapy	|O
(	|O
55	|O
cases	|O
)	|O
,	|O
group	|O
2	|O
-	|O
-	|O
complex	|O
gamma	|O
-	|O
therapy	|O
plus	|O
iliac	|O
lymphadenectomy	|O
(	|O
50	|O
cases	|O
)	|O
and	|O
group	|O
3	|O
-	|O
-	|O
complex	|O
radiation	|O
treatment	|O
with	|O
megavolt	|O
bremsstrahlung	|O
beam	|O
from	|O
the	|O
luc	|O
type	|O
installation	|O
and	|O
iliac	|O
lymphadenectomy	|O
(	|O
50	|O
cases	|O
)	|O
.	|O

The	|O
availability	|O
of	|O
cryoprecipitate	|O
and	|O
DDAVP	|O
offers	|O
an	|O
alternative	|O
and	|O
effective	|O
treatment	|O
for	|O
the	|O
temporary	|O
reversal	|O
of	|O
uremic	|O
bleeding	|O
in	|O
patients	|O
who	|O
require	|O
urgent	|O
invasive	|O
procedures	|O
.	|O

Thrombophlebitis	|O
and	|O
pulmonary	|O
embolism	|O
in	|O
congenital	|O
factor	|B-PROTEIN
XII	|I-PROTEIN
deficiency	|O

Biopsies	|O
of	|O
the	|O
jejunal	|O
mucosa	|O
have	|O
shown	|O
abnormal	|O
enzyme	|O
activity	|O
or	|O
deficiencies	|O
in	|O
transport	|O
mechanisms	|O
.	|O

Laboratory	|O
pyrolyses	|O
have	|O
indeed	|O
shown	|O
that	|O
PCBs	|O
give	|O
significant	|O
yields	|O
of	|O
PCDFs	|O
,	|O
and	|O
chlorobenzenes	|O
give	|O
both	|O
PCDFs	|O
and	|O
PCDDs	|O
.	|O

A	|O
significant	|O
degree	|O
of	|O
homology	|O
was	|O
also	|O
found	|O
among	|O
these	|O
genes	|O
and	|O
the	|O
Mtase	|B-PROTEIN
gene	|O
of	|O
related	|O
phage	|O
SPR	|O
,	|O
which	|O
codes	|O
for	|O
an	|O
enzyme	|O
with	|O
different	|O
modification	|O
specificity	|O
.	|O

Thyrotropin	|B-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
hormone	|I-PROTEIN
-	|O
induced	|O
contraction	|O
of	|O
urethral	|O
and	|O
vaginal	|O
muscle	|O
.	|O

In	|O
a	|O
blind	|O
controlled	|O
trial	|O
,	|O
15	|O
patients	|O
with	|O
COCM	|O
(	|O
NYHA	|O
II	|O
-	|O
III	|O
)	|O
with	|O
sinus	|O
rhythm	|O
and	|O
a	|O
left	|O
ventricular	|O
ejection	|O
fraction	|O
(	|O
LV	|O
-	|O
EF	|O
)	|O
of	|O
34.5	|O
+	|O
/	|O
-	|O
2.6%	|O
received	|O
consecutively	|O
D	|O
(	|O
0.25-0.5	|O
mg	|O
/	|O
d	|O
)	|O
,	|O
placebo	|O
(	|O
PLAC	|O
)	|O
,	|O
P	|O
(	|O
slow	|O
releases	|O
=	|O
SR	|O
)	|O
(	|O
80	|O
mg	|O
/	|O
d	|O
SR	|O
)	|O
and	|O
both	|O
drugs	|O
combined	|O
in	|O
respective	|O
doses	|O
.	|O

Mild	|O
orbital	|O
discomfort	|O
occurred	|O
in	|O
some	|O
patients	|O
.	|O

The	|O
sample	|O
is	|O
deproteinized	|O
and	|O
after	|O
centrifugation	|O
valproic	|O
acid	|O
in	|O
the	|O
supernatant	|O
is	|O
measured	|O
in	|O
the	|O
free	|O
form	|O
by	|O
direct	|O
injection	|O
into	|O
the	|O
gas	|O
chromatograph	|O
.	|O

Changes	|O
in	|O
muscarinic	|B-PROTEIN
acetylcholine	|I-PROTEIN
receptors	|I-PROTEIN
in	|O
guinea	|O
-	|O
pig	|O
lung	|O
:	|O
effects	|O
of	|O
aging	|O
,	|O
inhalation	|O
of	|O
an	|O
allergen	|O
,	|O
administration	|O
of	|O
drugs	|O
,	|O
and	|O
vagotomy	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
other	|O
stabilizers	|O
,	|O
increased	|O
sucrose	|O
can	|O
provide	|O
increased	|O
thermoresistance	|O
to	|O
the	|O
virus	|O
in	|O
2.5%	|O
albumin	|B-PROTEIN
.	|O

The	|O
overall	|O
prevalence	|O
of	|O
psoriasis	|O
was	|O
4.79%	|O
in	|O
men	|O
and	|O
4.85%	|O
in	|O
women	|O
.	|O

Greek	|O
classicism	|O
in	|O
living	|O
structure	|O
?	|O
Some	|O
deductive	|O
pathways	|O
in	|O
animal	|O
morphology	|O
.	|O

The	|O
possible	|O
origin	|O
and	|O
role	|O
of	|O
CSF	|O
prolactin	|B-PROTEIN
are	|O
discussed	|O
.	|O

Three	|O
chromosomal	|O
crsA	|B-PROTEIN
mutations	|O
,	|O
crsA1	|B-PROTEIN
,	|O
crsA4	|B-PROTEIN
,	|O
and	|O
crsA47	|B-PROTEIN
,	|O
were	|O
transferred	|O
by	|O
the	|O
"	|O
gene	|O
conversion	|O
"	|O
process	|O
to	|O
B.	|O
subtilis	|O
plasmid	|O
pRPD11	|O
,	|O
which	|O
consists	|O
of	|O
the	|O
entire	|O
wild	|O
-	|O
type	|O
rpoD	|B-PROTEIN
coding	|O
sequence	|O
,	|O
encoding	|O
the	|O
major	|O
sigma	|B-PROTEIN
43	|I-PROTEIN
factor	|O
of	|O
B.	|O
subtilis	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
,	|O
and	|O
pUB110	|O
.	|O

Selective	|O
effect	|O
of	|O
pulmonary	|O
oedema	|O
on	|O
prostaglandin	|O
E2	|O
pharmacokinetics	|O
in	|O
rat	|O
lung	|O
.	|O

This	|O
article	|O
will	|O
briefly	|O
review	|O
the	|O
published	|O
data	|O
on	|O
the	|O
morphology	|O
,	|O
function	|O
,	|O
and	|O
biochemistry	|O
of	|O
the	|O
normal	|O
renal	|O
medulla	|O
and	|O
the	|O
pathology	|O
associated	|O
with	|O
RPN	|O
,	|O
together	|O
with	|O
the	|O
secondary	|O
changes	|O
which	|O
give	|O
rise	|O
to	|O
cortical	|O
degeneration	|O
or	|O
epithelial	|O
carcinoma	|O
.	|O

The	|O
data	|O
indicate	|O
that	|O
the	|O
five	|O
different	|O
(	|O
and	|O
partially	|O
overlapping	|O
)	|O
sry	|B-PROTEIN
messenger	|O
RNAs	|O
detectable	|O
in	|O
early	|O
embryos	|O
are	|O
initiated	|O
at	|O
three	|O
separate	|O
sites	|O
,	|O
each	|O
directly	|O
upstream	|O
from	|O
one	|O
of	|O
the	|O
three	|O
protein	|O
-	|O
coding	|O
regions	|O
,	|O
designated	|O
(	|O
in	|O
5'	|O
to	|O
3'	|O
order	|O
)	|O
beta	|O
,	|O
alpha	|O
and	|O
delta	|O
.	|O

Chronic	|O
thyroiditis	|O
as	|O
a	|O
risk	|O
factor	|O
of	|O
B	|O
-	|O
cell	|O
lymphoma	|O
in	|O
the	|O
thyroid	|O
gland	|O
.	|O

Plasma	|O
secretin	|B-PROTEIN
levels	|O
also	|O
augmented	|O
after	|O
the	|O
administration	|O
of	|O
ethanol	|O
solutions	|O
,	|O
with	|O
a	|O
delay	|O
of	|O
about	|O
one	|O
hour	|O
after	|O
the	|O
onset	|O
of	|O
acid	|O
secretion	|O
.	|O

Spectrophotometric	|O
microanalysis	|O
of	|O
ethylenediaminotetracetic	|O
acid	|O
in	|O
pharmaceutical	|O
preparations	|O

A	|O
comparison	|O
among	|O
the	|O
5'	|O
flanking	|O
regions	|O
encompassing	|O
the	|O
presumptive	|O
HS	|B-PROTEIN
promoter	|O
of	|O
the	|O
soybean	|O
HS	|B-PROTEIN
-	|O
protein	|O
genes	|O
demonstrated	|O
this	|O
region	|O
to	|O
be	|O
extremely	|O
homologous	|O
.	|O

Results	|O
of	|O
this	|O
study	|O
indicate	|O
that	|O
GLC	|O
of	|O
short	|O
chain	|O
fatty	|O
acids	|O
produced	|O
on	|O
agar	|O
medium	|O
by	|O
anaerobes	|O
,	|O
combined	|O
with	|O
simple	|O
tests	|O
such	|O
as	|O
Gram	|O
's	|O
stain	|O
and	|O
colonial	|O
morphology	|O
,	|O
may	|O
allow	|O
fir	|O
direct	|O
presumptive	|O
genus	|O
identification	|O
from	|O
an	|O
initial	|O
pure	|O
agar	|O
culture	|O
.	|O

Using	|O
this	|O
method	|O
,	|O
we	|O
measured	|O
absorption	|O
of	|O
low	|O
doses	|O
of	|O
vitamin	|O
A	|O
,	|O
which	|O
may	|O
provide	|O
a	|O
more	|O
physiological	|O
approach	|O
to	|O
assessment	|O
of	|O
fat	|O
malabsorption	|O
.	|O

Fulminant	|O
hepatitis	|O
A	|O
in	|O
chronic	|O
HBV	|O
carrier	|O
.	|O

Tissue	|O
pressure	|O
,	|O
rCBF	|O
,	|O
and	|O
water	|O
content	|O
were	|O
measured	|O
from	|O
gray	|O
matter	|O
in	|O
the	|O
central	|O
core	|O
and	|O
the	|O
peripheral	|O
margin	|O
of	|O
the	|O
MCA	|O
territory	|O
over	|O
6	|O
h	|O
after	|O
MCAO	|O
.	|O

During	|O
this	|O
time	|O
,	|O
the	|O
patients	|O
all	|O
had	|O
the	|O
characteristic	|O
plasma	|O
thyroid	|O
hormone	|O
changes	|O
associated	|O
with	|O
amiodarone	|O
therapy	|O
,	|O
i.e.	|O
increased	|O
T4	|O
,	|O
free	|O
T4	|O
,	|O
and	|O
rT3	|O
and	|O
decreased	|O
T3	|O
,	|O
while	|O
remaining	|O
clinically	|O
euthyroid	|O
.	|O

Drug	|O
and	|O
nutrient	|O
interactions	|O
.	|O

In	|O
each	|O
compartment	|O
O2	|O
is	|O
removed	|O
by	|O
the	|O
tissues	|O
as	|O
a	|O
chemical	|O
reaction	|O
takes	|O
place	|O
between	|O
O2	|O
and	|O
oxyhemoglobin	|B-PROTEIN
(	|O
HbO2	|B-PROTEIN
)	|O
.	|O

To	|O
evaluate	|O
the	|O
effects	|O
of	|O
propranolol	|O
on	|O
myocardial	|O
metabolism	|O
after	|O
coronary	|O
reperfusion	|O
,	|O
serial	|O
measurements	|O
of	|O
myocardial	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
CK	|B-PROTEIN
)	|O
and	|O
calcium	|O
(	|O
Ca	|O
)	|O
contents	|O
and	|O
CK	|B-PROTEIN
and	|O
lactic	|O
acid	|O
(	|O
LA	|O
)	|O
concentrations	|O
in	|O
coronary	|O
sinus	|O
blood	|O
were	|O
carried	|O
out	|O
in	|O
33	|O
open	|O
-	|O
chest	|O
dogs	|O
.	|O

Dissolution	|O
of	|O
the	|O
Pt	|O
-	|O
30%	|O
Ir	|O
microelectrode	|O
tip	|O
was	|O
observed	|O
by	|O
scanning	|O
electron	|O
microscopy	|O
at	|O
charge	|O
densities	|O
as	|O
low	|O
as	|O
200	|O
microC	|O
/	|O
cm2	|O
X	|O
ph	|O
(	|O
1	|O
A	|O
/	|O
cm2	|O
)	|O
,	|O
whereas	|O
erosion	|O
of	|O
activated	|O
iridium	|O
microelectrodes	|O
occurred	|O
only	|O
at	|O
the	|O
highest	|O
charge	|O
and	|O
current	|O
densities	|O
(	|O
3200	|O
microC	|O
/	|O
cm2	|O
X	|O
ph	|O
,	|O
16	|O
A	|O
/	|O
cm2	|O
)	|O
.	|O

Cortisol	|O
excretion	|O
,	|O
appeared	|O
to	|O
be	|O
markedly	|O
affected	|O
by	|O
the	|O
season	|O
although	|O
other	|O
factors	|O
such	|O
as	|O
social	|O
and	|O
environmental	|O
stress	|O
cannot	|O
be	|O
discounted	|O
.	|O

Two	|O
studies	|O
on	|O
the	|O
relationship	|O
between	|O
taking	|O
a	|O
commercial	|O
coaching	|O
course	|O
and	|O
performance	|O
on	|O
the	|O
Medical	|O
College	|O
Admission	|O
Test	|O
(	|O
MCAT	|O
)	|O
are	|O
reported	|O
.	|O

A	|O
total	|O
of	|O
90	|O
patients	|O
were	|O
randomly	|O
allocated	|O
either	|O
to	|O
an	|O
MY	|O
-	|O
1	|O
treated	|O
or	|O
an	|O
untreated	|O
group	|O
.	|O

Below	|O
50%	|O
decrease	|O
of	|O
PaO2	|O
,	|O
NADH	|O
was	|O
reduced	|O
largely	|O
.	|O

Angiography	|O
was	|O
performed	|O
following	|O
the	|O
rCBF	|O
study	|O
and	|O
the	|O
degree	|O
of	|O
vasospasm	|O
was	|O
measured	|O
on	|O
the	|O
angiograms	|O
.	|O

The	|O
results	|O
from	|O
the	|O
first	|O
five	|O
years	|O
of	|O
follow	|O
up	|O
in	|O
1972	|O
showed	|O
a	|O
4.7	|O
-	|O
fold	|O
excess	|O
mortality	|O
for	|O
ischaemic	|O
and	|O
other	|O
heart	|O
diseases	|O
(	|O
ICD	|O
A83	|O
-	|O
A84	|O
)	|O
compared	|O
with	|O
a	|O
comparable	|O
reference	|O
cohort	|O
of	|O
paper	|O
mill	|O
workers	|O
.	|O

The	|O
financial	|O
impact	|O
of	|O
childhood	|O
asthma	|O
has	|O
not	|O
been	|O
assessed	|O
since	|O
Vance	|O
and	|O
Taylor	|O
reported	|O
their	|O
data	|O
in	|O
Annals	|O
of	|O
Allergy	|O
13	|O
years	|O
ago	|O
.	|O

Hypersplenism	|O

Electrical	|O
activity	|O
was	|O
evaluated	|O
by	|O
monitoring	|O
the	|O
general	|O
electrocorticogram	|O
(	|O
ECoG	|O
)	|O
as	|O
well	|O
as	|O
local	|O
DC	|O
steady	|O
potential	|O
(	|O
two	|O
sites	|O
)	|O
.	|O

The	|O
topography	|O
and	|O
trajectories	|O
of	|O
the	|O
commissural	|O
fibers	|O
of	|O
the	|O
superior	|O
temporal	|O
region	|O
(	|O
STR	|O
)	|O
are	|O
studied	|O
using	|O
the	|O
autoradiographic	|O
technique	|O
.	|O

The	|O
diabetic	|O
state	|O
was	|O
characterized	|O
by	|O
mild	|O
insulin	|B-PROTEIN
deficiency	|O
,	|O
plasma	|O
levels	|O
being	|O
73%	|O
of	|O
controls	|O
,	|O
and	|O
mild	|O
hyperglycemia	|O
,	|O
with	|O
nonfasting	|O
plasma	|O
glucose	|O
levels	|O
of	|O
1.5	|O
times	|O
normal	|O
.	|O

The	|O
primary	|O
CT	|O
findings	|O
were	|O
misinterpreted	|O
as	|O
a	|O
brain	|O
infarct	|O
or	|O
possibly	|O
a	|O
tumour	|O
.	|O

No	|O
consistent	|O
correlation	|O
between	|O
blood	|O
pressure	|O
change	|O
and	|O
SCR	|O
-	|O
change	|O
was	|O
seen	|O
.	|O

Shoulder	|O
forearm	|O
support	|O
for	|O
the	|O
subluxed	|O
shoulder	|O
.	|O

Piroxicam	|O
produced	|O
a	|O
lower	|O
incidence	|O
of	|O
gastric	|O
ulcers	|O
than	|O
equivalent	|O
doses	|O
of	|O
indomethacin	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
both	|O
in	|O
the	|O
early	|O
stages	|O
(	|O
0T	|O
,	|O
0N	|O
)	|O
and	|O
in	|O
more	|O
severe	|O
stages	|O
of	|O
VWF	|O
(	|O
stages	|O
1-2	|O
)	|O
cold	|O
induced	|O
hyperreactivity	|O
in	|O
the	|O
digital	|O
vessels	|O
and	|O
Raynaud	|O
's	|O
syndrome	|O
are	|O
vascular	|O
disorders	|O
of	|O
functional	|O
origin	|O
occurring	|O
without	|O
any	|O
prethrombotic	|O
alterations	|O
.	|O

In	|O
MCCP	|O
functions	|O
of	|O
the	|O
source	|O
emission	|O
,	|O
surface	|O
reflection	|O
,	|O
photoacceptor	|O
sensitivity	|O
are	|O
approximated	|O
by	|O
the	|O
normal	|O
distribution	|O
curves	|O
.	|O

However	|O
,	|O
kidneys	|O
perfused	|O
for	|O
72	|O
hr	|O
demonstrated	|O
more	|O
similar	|O
renal	|O
functions	|O
when	|O
tested	|O
by	|O
either	|O
IMPK	|O
or	|O
IBPK	|O
.	|O

To	|O
assess	|O
the	|O
effects	|O
of	|O
alveolar	|O
hypoxia	|O
and	|O
angiotensin	|B-PROTEIN
II	|I-PROTEIN
infusion	|O
on	|O
distribution	|O
of	|O
blood	|O
flow	|O
to	|O
the	|O
lung	|O
we	|O
performed	|O
perfusion	|O
lung	|O
scans	|O
on	|O
anesthetized	|O
mechanically	|O
ventilated	|O
lambs	|O
.	|O

A	|O
flow	|O
rate	|O
of	|O
at	|O
least	|O
5	|O
mL	|O
/	|O
h	|O
is	|O
required	|O
through	|O
the	|O
receptor	|O
(	|O
volume	|O
,	|O
0.4	|O
mL	|O
)	|O
for	|O
accurate	|O
results	|O
.	|O

We	|O
have	|O
now	|O
located	|O
the	|O
5'	|O
ends	|O
of	|O
the	|O
two	|O
remaining	|O
late	|O
mRNAs	|O
.	|O

The	|O
efficacy	|O
of	|O
quantitative	|O
and	|O
qualitative	|O
chloride	|O
titrators	|O
in	|O
the	|O
estimation	|O
of	|O
human	|O
salt	|O
intake	|O
.	|O

Doctor	|O
Berglund	|O
warns	|O
members	|O
of	|O
union	|O
pitfalls	|O
.	|O

Acute	|O
appearance	|O
of	|O
hemiparesis	|O
or	|O
hemiplegia	|O
with	|O
initial	|O
marked	|O
spasticity	|O
was	|O
observed	|O
in	|O
8	|O
stroke	|O
patients	|O
.	|O

Recurrent	|O
acute	|O
rhinosinusitis	|O
was	|O
common	|O
in	|O
both	|O
groups	|O
of	|O
patients	|O
,	|O
but	|O
the	|O
development	|O
of	|O
chronic	|O
rhinosinusitis	|O
was	|O
only	|O
found	|O
in	|O
patients	|O
with	|O
CVID	|O
,	|O
indicating	|O
the	|O
more	|O
severe	|O
nature	|O
of	|O
this	|O
condition	|O
compared	|O
with	|O
selective	|O
IgA	|B-PROTEIN
deficiency	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
AP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
may	|O
be	|O
potentially	|O
useful	|O
in	|O
the	|O
management	|O
of	|O
heart	|O
failure	|O
.	|O

The	|O
various	|O
muscles	|O
of	|O
the	|O
pelvic	|O
floor	|O
region	|O
could	|O
be	|O
reflexly	|O
activated	|O
either	|O
individually	|O
or	|O
as	|O
a	|O
mass	|O
unit	|O
depending	|O
on	|O
the	|O
intensity	|O
of	|O
stimulation	|O
.	|O

It	|O
has	|O
been	|O
reported	|O
that	|O
rat	|O
blood	|O
chloroform	|O
levels	|O
were	|O
significantly	|O
decreased	|O
after	|O
treatment	|O
with	|O
ClO2	|O
.	|O

The	|O
frequency	|O
of	|O
lactase	|B-PROTEIN
phenotypes	|O
in	|O
Aymara	|O
children	|O
.	|O

Activities	|O
of	|O
hepatic	|O
cytochrome	|B-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
450	|I-PROTEIN
-	|O
dependent	|O
metabolizing	|O
enzymes	|O
such	|O
as	|O
aminopyrine	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
TMO	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
demethylase	|I-PROTEIN
and	|O
aniline	|B-PROTEIN
hydroxylase	|I-PROTEIN
activity	|O
were	|O
decreased	|O
by	|O
pretreatment	|O
of	|O
rats	|O
with	|O
cimetidine	|O
,	|O
whereas	|O
in	|O
the	|O
rats	|O
pretreated	|O
with	|O
ranitidine	|O
,	|O
these	|O
enzyme	|O
activities	|O
were	|O
not	|O
changed	|O
.	|O

Doxorubicin	|O
,	|O
dacarbazine	|O
,	|O
vincristine	|O
,	|O
and	|O
cyclophosphamide	|O
in	|O
the	|O
treatment	|O
of	|O
advanced	|O
gastrointestinal	|O
leiomyosarcoma	|O
.	|O

The	|O
effect	|O
of	|O
the	|O
opiate	|O
antagonist	|O
naloxone	|O
was	|O
evaluated	|O
in	|O
11	|O
unselected	|O
patients	|O
with	|O
cerebral	|O
ischemia	|O
.	|O

Electrochemical	|O
detection	|O
of	|O
depressed	|O
circulating	|O
levels	|O
of	|O
vitamin	|O
K1	|O
in	|O
osteoporosis	|O
.	|O

In	|O
the	|O
present	|O
experiments	|O
,	|O
we	|O
investigate	|O
the	|O
role	|O
played	|O
by	|O
the	|O
temporal	|O
pattern	|O
of	|O
neural	|O
activity	|O
during	|O
the	|O
ontogeny	|O
of	|O
frequency	|O
tuning	|O
in	|O
the	|O
mouse	|O
central	|O
auditory	|O
system	|O
.	|O

Ultrastructure	|O
of	|O
the	|O
tumor	|O
in	|O
1	|O
patient	|O
in	|O
whom	|O
transurethral	|O
resection	|O
was	|O
performed	|O
2	|O
weeks	|O
after	|O
alum	|O
irrigation	|O
revealed	|O
well	|O
preserved	|O
nuclear	|O
chromatin	|O
,	|O
thus	|O
,	|O
suggesting	|O
that	|O
whatever	|O
changes	|O
occur	|O
after	|O
alum	|O
irrigation	|O
are	|O
short	|O
-	|O
lived	|O
.	|O

The	|O
generally	|O
adopted	|O
criteria	|O
enabling	|O
to	|O
classify	|O
the	|O
examined	|O
persons	|O
into	|O
the	|O
following	|O
3	|O
groups	|O
have	|O
been	|O
used	|O
:	|O
(	|O
a	|O
)	|O
diseased	|O
of	|O
BEN	|O
;	|O
(	|O
b	|O
)	|O
suspect	|O
to	|O
be	|O
diseased	|O
of	|O
BEN	|O
,	|O
and	|O
(	|O
c	|O
)	|O
individuals	|O
without	|O
signs	|O
of	|O
a	|O
renal	|O
disease	|O
.	|O

For	|O
this	|O
purpose	|O
,	|O
a	|O
simple	|O
respiration	|O
-	|O
control	|O
device	|O
has	|O
been	|O
developed	|O
that	|O
enables	|O
the	|O
patient	|O
to	|O
monitor	|O
breath	|O
-	|O
holding	|O
during	|O
successive	|O
scans	|O
.	|O

The	|O
POEMS	|O
syndrome	|O
(	|O
Polyneuropathy	|O
,	|O
Organomegaly	|O
,	|O
Endocrinopathy	|O
,	|O
Monoclonal	|O
component	|O
,	|O
Skin	|O
)	|O
.	|O

During	|O
a	|O
disease	|O
remission	|O
there	|O
was	|O
an	|O
increase	|O
in	|O
GAG	|O
secretion	|O
with	|O
urine	|O
,	|O
linked	|O
with	|O
hyperheparinuria	|O
(	|O
13.1	|O
-	|O
fold	|O
,	|O
P	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

In	|O
metastasis	|O
-	|O
free	|O
patients	|O
,	|O
the	|O
best	|O
results	|O
were	|O
obtained	|O
with	|O
tumor	|O
diameters	|O
under	|O
2	|O
cm	|O
regardless	|O
of	|O
their	|O
localization	|O
in	|O
lung	|O
tissue	|O
and	|O
with	|O
2	|O
-	|O
-	|O
4.9	|O
cm	|O
tumors	|O
embedded	|O
in	|O
lung	|O
parenchyma	|O
.	|O

Two	|O
siblings	|O
with	|O
hemolytic	|O
anemia	|O
caused	|O
by	|O
triosephosphate	|B-PROTEIN
isomerase	|I-PROTEIN
deficiency	|O
developed	|O
a	|O
progressive	|O
neurological	|O
syndrome	|O
featuring	|O
dystonic	|O
movements	|O
,	|O
tremor	|O
,	|O
pyramidal	|O
tract	|O
signs	|O
,	|O
and	|O
evidence	|O
of	|O
spinal	|O
motor	|O
neuron	|O
involvement	|O
.	|O

One	|O
extract	|O
with	|O
the	|O
lowest	|O
PCA	|O
content	|O
was	|O
non	|O
-	|O
carcinogenic	|O
.	|O

In	|O
the	|O
10	|O
patients	|O
with	|O
a	|O
more	|O
severe	|O
degree	|O
of	|O
steatorrhea	|O
the	|O
decrease	|O
in	|O
fat	|O
loss	|O
approached	|O
20%	|O
and	|O
a	|O
close	|O
relationship	|O
was	|O
found	|O
(	|O
r	|O
=	|O
0.84	|O
,	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
between	|O
the	|O
extent	|O
of	|O
the	|O
fatty	|O
acid	|O
loss	|O
on	|O
placebo	|O
and	|O
the	|O
decrease	|O
of	|O
this	|O
loss	|O
on	|O
taurine	|O
.	|O

Aortic	|O
diameters	|O
in	|O
infants	|O
and	|O
young	|O
children	|O
:	|O
normative	|O
angiographic	|O
data	|O
.	|O

The	|O
present	|O
investigation	|O
has	|O
revealed	|O
that	|O
the	|O
distribution	|O
of	|O
the	|O
main	|O
fatty	|O
acids	|O
in	|O
Leptospira	|O
phospholipids	|O
is	|O
similar	|O
to	|O
their	|O
distribution	|O
in	|O
Leptospira	|O
neutral	|O
lipids	|O
with	|O
the	|O
exception	|O
of	|O
unsaturated	|O
fatty	|O
acid	|O
with	|O
14	|O
carbon	|O
atoms	|O
,	|O
occurring	|O
mainly	|O
in	|O
phospholipids	|O
.	|O

Since	|O
1970	|O
the	|O
frequency	|O
of	|O
potassium	|O
-	|O
induced	|O
ulceration	|O
has	|O
been	|O
low	|O
-	|O
-	|O
3	|O
cases	|O
per	|O
100	|O
000	|O
patient	|O
-	|O
years	|O
of	|O
slow	|O
-	|O
release	|O
tablet	|O
use	|O
.	|O

Hydrocortisone	|O
caused	|O
lymphopenia	|O
and	|O
inhibited	|O
the	|O
blastogenic	|O
response	|O
of	|O
peripheral	|O
blood	|O
lymphocytes	|O
to	|O
phytohemagglutinin	|B-PROTEIN
and	|O
concanavalin	|B-PROTEIN
A	|I-PROTEIN
mitogens	|O
.	|O

To	|O
test	|O
the	|O
feasibility	|O
of	|O
using	|O
liposomes	|O
to	|O
deliver	|O
therapeutic	|O
agents	|O
to	|O
the	|O
lungs	|O
,	|O
the	|O
effect	|O
of	|O
liposome	|O
-	|O
encapsulated	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
(	|O
SOD	|B-PROTEIN
)	|O
or	|O
catalase	|B-PROTEIN
on	|O
pulmonary	|O
oxygen	|O
toxicity	|O
was	|O
studied	|O
in	|O
rats	|O
.	|O

Marrow	|O
cell	|O
necrosis	|O
in	|O
anorexia	|O
nervosa	|O
and	|O
involuntary	|O
starvation	|O
.	|O

For	|O
comparison	|O
conventional	|O
heparin	|O
was	|O
used	|O
during	|O
18	|O
dialyses	|O
in	|O
the	|O
same	|O
patients	|O
.	|O

Chenodeoxycholic	|O
acid	|O
(	|O
cheno	|O
)	|O
and	|O
ursodeoxycholic	|O
acid	|O
(	|O
urso	|O
)	|O
dissolve	|O
cholesterol	|O
gallstones	|O
in	|O
man	|O
.	|O

Sensory	|O
evoked	|O
field	|O
potentials	|O
were	|O
recorded	|O
from	|O
the	|O
mesencephalic	|O
reticular	|O
formation	|O
(	|O
MRF	|O
)	|O
,	|O
central	|O
gray	|O
(	|O
CG	|O
)	|O
and	|O
somatosensory	|O
cortex	|O
(	|O
SCX	|O
)	|O
,	|O
following	|O
incremental	|O
doses	|O
of	|O
halothane	|O
in	|O
freely	|O
-	|O
moving	|O
rats	|O
.	|O

Ultrastructure	|O
of	|O
the	|O
heart	|O
muscle	|O
in	|O
experimental	|O
myocardial	|O
infarct	|O
following	|O
physical	|O
training	|O

Pharmacological	|O
desympathization	|O
leads	|O
to	|O
the	|O
development	|O
of	|O
hyper	|O
-	|O
reactivity	|O
of	|O
the	|O
true	|O
pacemakers	|O
to	|O
noradrenaline	|O
and	|O
dopamine	|O
and	|O
triggers	|O
off	|O
changes	|O
in	|O
the	|O
regulation	|O
of	|O
the	|O
electric	|O
activity	|O
of	|O
these	|O
cells	|O
by	|O
catecholamines	|O
.	|O

OODG	|O
is	|O
a	|O
diagnostic	|O
method	|O
permitting	|O
assessment	|O
of	|O
ocular	|O
pulse	|O
curves	|O
and	|O
objective	|O
determination	|O
of	|O
blood	|O
pressures	|O
in	|O
the	|O
ophthalmic	|O
circulatory	|O
system	|O
(	|O
retinal	|O
and	|O
ciliary	|O
arterial	|O
blood	|O
pressures	|O
)	|O
simultaneously	|O
for	|O
both	|O
eyes	|O
,	|O
without	|O
dilatation	|O
of	|O
the	|O
pupils	|O
.	|O

Viral	|O
infections	|O
have	|O
long	|O
been	|O
suspected	|O
to	|O
be	|O
causative	|O
agents	|O
in	|O
a	|O
number	|O
of	|O
inner	|O
ear	|O
dysfunctions	|O
.	|O

55	|O
+	|O
/	|O
-	|O
11%	|O
)	|O
,	|O
all	|O
other	|O
parameters	|O
showed	|O
a	|O
significant	|O
increase	|O
:	|O
RS	|O
index	|O
5.4	|O
+	|O
/	|O
-	|O
1.4	|O
mVolt	|O
to	|O
6.0	|O
+	|O
/	|O
-	|O
1.7	|O
mVolt	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
;	|O
EDD	|O
6.3	|O
+	|O
/	|O
-	|O
0.7	|O
to	|O
6.8	|O
+	|O
/	|O
-	|O
0.9	|O
cm	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
;	|O
HV	|O
1017	|O
+	|O
/	|O
-	|O
151	|O
ml	|O
to	|O
1099	|O
+	|O
/	|O
-	|O
261	|O
ml	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
;	|O
EDV	|O
371	|O
+	|O
/	|O
-	|O
131	|O
ml	|O
to	|O
441	|O
+	|O
/	|O
-	|O
175	|O
ml	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
;	|O
RBV	|O
117	|O
+	|O
/	|O
-	|O
57	|O
ml	|O
to	|O
151	|O
+	|O
/	|O
-	|O
77	|O
ml	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

Retrospective	|O
analyses	|O
of	|O
this	|O
death	|O
revealed	|O
a	|O
significant	|O
decrease	|O
of	|O
the	|O
left	|O
ventricular	|O
(	|O
LV	|O
)	|O
end	|O
-	|O
diastolic	|O
volume	|O
index	|O
(	|O
EDVI	|O
)	|O
of	|O
21	|O
ml	|O
/	|O
m2	|O
(	|O
36%	|O
of	|O
normal	|O
)	|O
.	|O

In	|O
group	|O
I	|O
adults	|O
both	|O
of	|O
these	|O
variables	|O
increased	|O
.	|O

Polysorbate	|O
80	|O
did	|O
not	|O
have	|O
a	|O
direct	|O
stimulant	|O
or	|O
relaxant	|O
effect	|O
on	|O
either	|O
guinea	|O
pig	|O
ileum	|O
or	|O
rat	|O
uterus	|O
,	|O
however	|O
,	|O
it	|O
antagonised	|O
the	|O
contractions	|O
induced	|O
by	|O
acetylcholine	|O
,	|O
histamine	|O
,	|O
barium	|O
,	|O
5	|O
-	|O
hydroxytryptamine	|O
and	|O
carbachol	|O
in	|O
a	|O
dose	|O
-	|O
dependent	|O
manner	|O
.	|O

Individual	|O
alcohol	|O
reaction	|O
profiles	|O
.	|O

Vitiligo	|O
in	|O
diabetes	|O
mellitus	|O
.	|O

The	|O
pharmacokinetics	|O
of	|O
each	|O
tetracycline	|O
in	|O
serum	|O
and	|O
dermal	|O
,	|O
suction	|O
blister	|O
fluid	|O
were	|O
determined	|O
after	|O
oral	|O
doses	|O
of	|O
300	|O
mg	|O
lymecycline	|O
or	|O
100	|O
mg	|O
doxycycline	|O
on	|O
the	|O
3rd	|O
day	|O
.	|O

A	|O
high	|O
degree	|O
of	|O
correlation	|O
in	|O
the	|O
sense	|O
of	|O
the	|O
classic	|O
conception	|O
of	|O
brain	|O
localization	|O
of	|O
neuropsychological	|O
syndromes	|O
was	|O
found	|O
.	|O

Either	|O
a	|O
UV	|O
detector	|O
set	|O
at	|O
268	|O
nm	|O
or	|O
an	|O
electrochemical	|O
(	|O
EC	|O
)	|O
detector	|O
set	|O
at	|O
a	|O
potential	|O
of	|O
+	|O
0.9	|O
V	|O
(	|O
versus	|O
Ag	|O
/	|O
AgCl	|O
/	|O
3	|O
M	|O
NaCl	|O
)	|O
was	|O
used	|O
to	|O
monitor	|O
the	|O
drug	|O
.	|O

35	|O
patients	|O
with	|O
acute	|O
arterial	|O
occlusions	|O
[	|O
27	|O
]	|O
and	|O
graft	|O
thromboses	|O
[	|O
8	|O
]	|O
,	|O
responsible	|O
for	|O
severe	|O
and	|O
recent	|O
ischemia	|O
,	|O
were	|O
treated	|O
by	|O
fibrinolytic	|O
therapy	|O
(	|O
Urokinase	|B-PROTEIN
:	|O
1	|O
000	|O
units	|O
/	|O
kg	|O
/	|O
hour	|O
,	|O
and	|O
Lys	|O
Plasminogen	|B-PROTEIN
)	|O
.	|O

The	|O
mean	|O
transfer	|O
ratios	|O
of	|O
the	|O
drug	|O
into	|O
the	|O
genital	|O
tissues	|O
to	|O
the	|O
concentration	|O
in	|O
the	|O
uterine	|O
arterial	|O
blood	|O
were	|O
such	|O
that	|O
the	|O
transfer	|O
ratio	|O
into	|O
the	|O
portio	|O
vaginalis	|O
was	|O
the	|O
highest	|O
,	|O
followed	|O
by	|O
the	|O
uterine	|O
cervix	|O
and	|O
the	|O
myometrium	|O
,	|O
and	|O
that	|O
into	|O
the	|O
oviduct	|O
was	|O
the	|O
lowest	|O
with	|O
about	|O
1/2	|O
that	|O
into	|O
the	|O
portio	|O
vaginalis	|O
.	|O

We	|O
conclude	|O
that	|O
androgenic	|O
hormones	|O
reduce	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
concentrations	|O
and	|O
the	|O
HDL2	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
subfraction	|O
,	|O
possibly	|O
by	|O
enhancing	|O
hepatic	|O
triglyceride	|B-PROTEIN
lipase	|I-PROTEIN
activity	|O
.	|O

Because	|O
of	|O
its	|O
wide	|O
spectrum	|O
of	|O
activity	|O
particularly	|O
against	|O
ampicillin	|O
resistant	|O
strains	|O
of	|O
H.	|O
influenzae	|O
and	|O
because	|O
of	|O
its	|O
good	|O
tolerance	|O
Cefaclor	|O
is	|O
very	|O
useful	|O
in	|O
treatment	|O
of	|O
respiratory	|O
tract	|O
infections	|O
in	|O
children	|O
.	|O

Lower	|O
extremity	|O
weight	|O
bearing	|O
under	|O
various	|O
standing	|O
conditions	|O
in	|O
independently	|O
ambulatory	|O
patients	|O
with	|O
hemiparesis	|O
.	|O

Shape	|O
factor	|O
correlated	|O
well	|O
with	|O
hemodynamic	|O
data	|O
for	|O
RV	|O
/	|O
LV	|O
systolic	|O
pressure	|O
ratios	|O
(	|O
r	|O
=	|O
0.93	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
for	|O
normalized	|O
interventricular	|O
pressure	|O
differences	|O
(	|O
r	|O
=	|O
-	|O
0.95	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

The	|O
effective	|O
and	|O
low	|O
toxic	|O
dose	|O
schedules	|O
of	|O
KW	|O
-	|O
2083	|O
should	|O
be	|O
investigated	|O
further	|O
.	|O

Furthermore	|O
,	|O
the	|O
initial	|O
plasma	|O
retinol	|O
level	|O
in	|O
conjunction	|O
with	|O
RBP	|B-PROTEIN
was	|O
found	|O
to	|O
be	|O
even	|O
lower	|O
in	|O
12	|O
patients	|O
(	|O
35.1	|O
micrograms	|O
dl	|O
-	|O
1	|O
,	|O
3.7	|O
mg	|O
dl	|O
-	|O
1	|O
)	|O
who	|O
subsequently	|O
had	|O
cancer	|O
recurrence	|O
than	|O
in	|O
those	|O
who	|O
remained	|O
free	|O
of	|O
apparent	|O
cancer	|O
(	|O
44.5	|O
micrograms	|O
dl	|O
-	|O
1	|O
,	|O
4.6	|O
mg	|O
dl	|O
-	|O
1	|O
)	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
:	|O
1	|O
)	|O
the	|O
initial	|O
response	|O
to	|O
tethering	|O
varies	|O
according	|O
to	|O
previous	|O
penning	|O
and	|O
handling	|O
experience	|O
,	|O
2	|O
)	|O
although	|O
the	|O
circadian	|O
rhythm	|O
of	|O
cortisol	|O
was	|O
either	|O
altered	|O
or	|O
disrupted	|O
during	|O
estrus	|O
,	|O
such	|O
disruptions	|O
were	|O
not	|O
influenced	|O
by	|O
type	|O
of	|O
penning	|O
and	|O
3	|O
)	|O
tether	|O
stalls	|O
may	|O
chronically	|O
increase	|O
cortisol	|O
concentrations	|O
in	|O
gilts	|O
.	|O

This	|O
laser	|O
provided	|O
sufficient	|O
power	|O
in	|O
an	|O
amniotic	|O
fluid	|O
medium	|O
to	|O
occlude	|O
placental	|O
vessels	|O
as	|O
large	|O
as	|O
7	|O
mm	|O
in	|O
diameter	|O
within	|O
6	|O
seconds	|O
at	|O
a	|O
power	|O
density	|O
of	|O
2000	|O
W	|O
/	|O
cm2	|O
.	|O

On	|O
d	|O
112	|O
,	|O
progesterone	|O
was	|O
higher	|O
(	|O
P	|O
less	|O
than	|O
.05	|O
)	|O
in	|O
hysterectomized	|O
heifers	|O
than	|O
in	|O
other	|O
treatment	|O
groups	|O
.	|O

Male	|O
Japanese	|O
quail	|O
were	|O
chronically	|O
exposed	|O
to	|O
5000	|O
ppm	|O
manganese	|O
(	|O
Mn	|O
)	|O
as	|O
particulate	|O
manganese	|O
oxide	|O
(	|O
Mn3O4	|O
)	|O
in	|O
their	|O
diet	|O
from	|O
hatching	|O
to	|O
75	|O
days	|O
of	|O
age	|O
.	|O

This	|O
study	|O
indicated	|O
that	|O
the	|O
Japanese	|O
quail	|O
was	|O
less	|O
sensitive	|O
to	|O
particulate	|O
Mn3O4	|O
exposure	|O
than	|O
rodents	|O
treated	|O
comparably	|O
.	|O

Plasma	|O
and	|O
bladder	|O
platinum	|O
concentration	|O
were	|O
measured	|O
following	|O
intravesical	|O
DDP	|O
,	|O
and	|O
also	|O
histopathological	|O
examination	|O
,	|O
urinalysis	|O
,	|O
complete	|O
blood	|O
count	|O
and	|O
blood	|O
chemistry	|O
were	|O
performed	|O
in	|O
order	|O
to	|O
know	|O
the	|O
toxicity	|O
of	|O
intravesical	|O
DDP	|O
.	|O

Scintigraphic	|O
visualisation	|O
of	|O
Walker	|O
carcinoma	|O
-	|O
256	|O
in	|O
Sprague	|O
-	|O
Dawley	|O
rats	|O
by	|O
means	|O
of	|O
99mTc	|O
-	|O
labelled	|O
monocytes	|O
.	|O

These	|O
results	|O
were	|O
compared	|O
with	|O
those	|O
obtained	|O
in	|O
-	|O
D	|O
mothers	|O
and	|O
pups	|O
,	|O
after	|O
giving	|O
the	|O
mothers	|O
an	|O
oral	|O
supplement	|O
(	|O
10	|O
i.u	|O
.	|O
vitamin	|O
D3	|O
/	|O
day	|O
)	|O
during	|O
the	|O
period	|O
of	|O
lactation	|O
(	|O
20	|O
days	|O
)	|O
.	|O

Rabbit	|O
eyes	|O
were	|O
removed	|O
and	|O
held	|O
in	|O
temperature	|O
-	|O
regulated	|O
chambers	|O
and	|O
irrigated	|O
with	|O
saline	|O
.	|O

Before	|O
birth	|O
,	|O
there	|O
were	|O
a	|O
few	|O
perivascular	|O
adrenergic	|O
nerves	|O
and	|O
correspondingly	|O
low	|O
ovarian	|O
NE	|O
levels	|O
.	|O

Monitoring	|O
changes	|O
in	|O
the	|O
heart	|O
rate	|O
of	|O
the	|O
premature	|O
fetus	|O
during	|O
tocolysis	|O
with	|O
the	|O
beta	|O
-	|O
adrenomimetics	|O
partusisten	|O
and	|O
Pre	|O
-	|O
par	|O

Since	|O
September	|O
1980	|O
to	|O
June	|O
1983	|O
we	|O
have	|O
treated	|O
32	|O
patients	|O
with	|O
ovarian	|O
cancer	|O
.	|O

The	|O
results	|O
suggest	|O
that	|O
the	|O
calcium	|O
antagonist	|O
,	|O
diltiazem	|O
,	|O
may	|O
modify	|O
the	|O
effects	|O
of	|O
isoflurane	|O
on	|O
myocardial	|O
function	|O
.	|O

Supraventricular	|O
arrhythmias	|O
-	|O
-	|O
digoxin	|O
and	|O
quinidine	|O
revisited	|O
.	|O

Visidex	|O
I	|O
is	|O
unsuitable	|O
for	|O
storage	|O
and	|O
re	|O
-	|O
reading	|O
.	|O

Treatment	|O
with	|O
oxyphenylbutazone	|O
and	|O
hydrocortisone	|O
failed	|O
to	|O
inhibit	|O
the	|O
raised	|O
serum	|O
CPN	|B-PROTEIN
levels	|O
.	|O

40,000	|O
)	|O
.	|O

The	|O
Cox	|O
proportional	|O
hazards	|O
model	|O
was	|O
applied	|O
to	|O
the	|O
data	|O
in	|O
order	|O
to	|O
determine	|O
the	|O
prognostic	|O
factors	|O
for	|O
long	|O
-	|O
term	|O
survival	|O
.	|O

This	|O
suggests	|O
that	|O
mechanisms	|O
other	|O
than	|O
an	|O
excessive	|O
increase	|O
in	|O
myocardial	|O
oxygen	|O
demand	|O
may	|O
be	|O
responsible	|O
for	|O
the	|O
many	|O
episodes	|O
occurring	|O
outside	|O
the	|O
hospital	|O
.	|O

Duration	|O
of	|O
remission	|O
in	|O
advanced	|O
gastric	|O
cancer	|O
patients	|O
responding	|O
to	|O
sequential	|O
dose	|O
of	|O
MTX	|O
and	|O
5	|O
-	|O
FU	|O

These	|O
data	|O
showed	|O
:	|O
that	|O
progesterone	|O
secretion	|O
is	|O
pulsatile	|O
throughout	|O
the	|O
human	|O
luteal	|O
phase	|O
,	|O
with	|O
maximum	|O
frequency	|O
in	|O
the	|O
mid	|O
-	|O
luteal	|O
phase	|O
;	|O
that	|O
during	|O
the	|O
mid	|O
-	|O
luteal	|O
phase	|O
most	|O
subjects	|O
had	|O
progesterone	|O
levels	|O
both	|O
above	|O
and	|O
below	|O
currently	|O
accepted	|O
ovulatory	|O
thresholds	|O
;	|O
the	|O
use	|O
of	|O
a	|O
single	|O
measurement	|O
of	|O
progesterone	|O
in	|O
the	|O
mid	|O
-	|O
luteal	|O
phase	|O
is	|O
not	|O
always	|O
a	|O
reliable	|O
indicator	|O
of	|O
ovulation	|O
;	|O
a	|O
threshold	|O
greater	|O
than	|O
20	|O
nmol	|O
/	|O
l	|O
may	|O
yield	|O
an	|O
unacceptable	|O
number	|O
of	|O
false	|O
negative	|O
results	|O
.	|O

The	|O
fast	|O
real	|O
-	|O
time	|O
digital	|O
processing	|O
of	|O
the	|O
N2	|O
and	|O
flow	|O
signals	|O
incorporated	|O
filtering	|O
,	|O
delay	|O
compensation	|O
,	|O
and	|O
corrections	|O
for	|O
the	|O
effects	|O
of	|O
changes	|O
in	|O
gas	|O
composition	|O
and	|O
temperature	|O
.	|O

This	|O
slope	|O
tended	|O
to	|O
be	|O
higher	|O
(	|O
approximately	|O
1.6	|O
dB	|O
/	|O
dB	|O
)	|O
for	|O
L1	|O
=	|O
L2	|O
greater	|O
than	|O
80	|O
dB	|O
.	|O

Histamine	|O
reactivity	|O
was	|O
significantly	|O
reduced	|O
after	|O
the	|O
nifedipine	|O
aerosol	|O
,	|O
the	|O
geometric	|O
mean	|O
provocative	|O
concentration	|O
causing	|O
a	|O
35%	|O
fall	|O
in	|O
specific	|O
airway	|O
conductance	|O
,	|O
rising	|O
from	|O
5.0	|O
to	|O
10.9	|O
mg	|O
/	|O
ml	|O
of	|O
histamine	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Pharmacologic	|O
doses	|O
of	|O
vitamin	|O
B6	|O
administered	|O
to	|O
lactating	|O
women	|O
have	|O
been	|O
reported	|O
to	|O
suppress	|O
plasma	|O
prolactin	|B-PROTEIN
.	|O

There	|O
was	|O
a	|O
significant	|O
but	|O
similar	|O
elevation	|O
of	|O
mean	|O
O2	|O
uptake	|O
during	|O
40	|O
min	|O
postexercise	|O
by	|O
13.6%	|O
in	|O
both	|O
the	|O
fasted	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
and	|O
fed	|O
state	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

National	|O
Institutes	|O
of	|O
Health	|O
Consensus	|O
Development	|O
Conference	|O
Statement	|O
.	|O

In	|O
controls	|O
,	|O
most	|O
of	|O
the	|O
output	|O
from	|O
the	|O
conduit	|O
occurred	|O
during	|O
type	|O
I	|O
activity	|O
(	|O
73	|O
+	|O
/	|O
-	|O
14%	|O
)	|O
.	|O

Greater	|O
attenuation	|O
of	|O
the	|O
N1	|O
-	|O
P2	|O
and	|O
baseline	|O
-	|O
P2	|O
amplitude	|O
of	|O
the	|O
probe	|O
EPs	|O
was	|O
observed	|O
when	|O
the	|O
probe	|O
stimulus	|O
was	|O
presented	|O
to	|O
the	|O
right	|O
ear	|O
and	|O
the	|O
verbal	|O
material	|O
presented	|O
to	|O
the	|O
left	|O
ear	|O
than	|O
when	|O
the	|O
opposite	|O
stimulation	|O
arrangement	|O
was	|O
used	|O
.	|O

Twenty	|O
-	|O
five	|O
patients	|O
(	|O
80,6%	|O
)	|O
with	|O
mixed	|O
neoplasms	|O
were	|O
operated	|O
on	|O
by	|O
total	|O
conservative	|O
parotidectomy	|O
(	|O
T.C.P.	|O
)	|O
,	|O
3	|O
(	|O
9,7%	|O
)	|O
by	|O
S.P.	|O
and	|O
3	|O
(	|O
9,7%	|O
)	|O
by	|O
En	|O
.	|O

The	|O
comparisons	|O
revealed	|O
that	|O
female	|O
homicide	|O
-	|O
suicide	|O
perpetrators	|O
were	|O
more	|O
likely	|O
than	|O
female	|O
homicide	|O
-	|O
suicide	|O
victims	|O
to	|O
live	|O
in	|O
mobile	|O
homes	|O
,	|O
kill	|O
their	|O
lover	|O
or	|O
ex	|O
-	|O
lover	|O
,	|O
have	|O
their	|O
crime	|O
accidentally	|O
discovered	|O
,	|O
leave	|O
a	|O
suicide	|O
note	|O
,	|O
kill	|O
on	|O
a	|O
weekend	|O
,	|O
and	|O
be	|O
depressed	|O
,	|O
but	|O
are	|O
less	|O
likely	|O
than	|O
female	|O
homicide	|O
-	|O
suicide	|O
victims	|O
to	|O
live	|O
with	|O
a	|O
spouse	|O
.	|O

Germ	|O
-	|O
free	|O
rabbits	|O
given	|O
mouse	|O
CRF	|O
-	|O
flora	|O
showed	|O
values	|O
quite	|O
different	|O
from	|O
control	|O
animals	|O
for	|O
most	|O
parameters	|O
,	|O
indicating	|O
unsuitability	|O
of	|O
mouse	|O
CRF	|O
flora	|O
to	|O
'	|O
normalize	|O
'	|O
rabbits	|O
.	|O

The	|O
weak	|O
relationships	|O
between	|O
F	|O
and	|O
Zn	|O
to	|O
Mg	|O
clearly	|O
have	|O
no	|O
significant	|O
effect	|O
on	|O
the	|O
contents	|O
of	|O
these	|O
elements	|O
in	|O
bone	|O
.	|O

L3	|O
-	|O
L4	|O
compressive	|O
load	|O
was	|O
calculated	|O
using	|O
a	|O
model	|O
of	|O
the	|O
anatomy	|O
of	|O
the	|O
trunk	|O
musculoskeletal	|O
system	|O
.	|O

Diagnosis	|O
:	|O
progressive	|O
multifocal	|O
leukoencephalopathy	|O
.	|O

Component	|O
P100	|O
was	|O
associated	|O
with	|O
a	|O
frontal	|O
negativity	|O
of	|O
similar	|O
latency	|O
favoring	|O
the	|O
hypothesis	|O
of	|O
a	|O
dipolar	|O
occipital	|O
generator	|O
.	|O

Although	|O
no	|O
differences	|O
were	|O
noted	|O
in	|O
the	|O
decrease	|O
in	|O
platelet	|O
counts	|O
between	|O
the	|O
two	|O
groups	|O
,	|O
fibrinogen	|B-PROTEIN
levels	|O
and	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
antiplasmin	|I-PROTEIN
levels	|O
declined	|O
less	|O
drastically	|O
in	|O
the	|O
antithrombin	|B-PROTEIN
-	|O
treated	|O
group	|O
.	|O

Failure	|O
of	|O
stapedius	|O
reflexometry	|O
in	|O
the	|O
diagnosis	|O
of	|O
myasthenia	|O
gravis	|O
.	|O

Factors	|O
influencing	|O
semen	|O
characteristics	|O
in	|O
young	|O
boars	|O
reared	|O
in	|O
a	|O
subtropical	|O
environment	|O
were	|O
studied	|O
.	|O

[	|O
14C	|O
]	|O
-	|O
beta	|O
-	|O
phenethylamine	|O
,	|O
its	|O
distribution	|O
after	|O
administration	|O
by	|O
various	|O
routes	|O
to	|O
cats	|O
,	|O
and	|O
the	|O
effects	|O
of	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
inhibitors	|O
.	|O

All	|O
runners	|O
drank	|O
a	|O
total	|O
of	|O
1.4	|O
L	|O
of	|O
water	|O
during	|O
the	|O
race	|O
.	|O

The	|O
rates	|O
of	|O
total	|O
energy	|O
use	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
=	|O
39.3	|O
+	|O
/	|O
-	|O
1.2	|O
vs	|O
35.7	|O
+	|O
/	|O
-	|O
1.3	|O
kJ	|O
X	|O
min	|O
-	|O
1	|O
;	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
were	|O
significantly	|O
higher	|O
at	|O
-	|O
10	|O
degrees	|O
C	|O
than	|O
at	|O
22	|O
degrees	|O
C.	|O

Clinical	|O
aspects	|O
and	|O
therapy	|O

Following	|O
seven	|O
days	|O
'	|O
incubation	|O
both	|O
at	|O
20	|O
degrees	|O
C	|O
and	|O
28	|O
degrees	|O
C	|O
,	|O
Ae	|O
.	|O
vexans	|O
nip	|O
.	|O
was	|O
capable	|O
of	|O
transmitting	|O
the	|O
virus	|O
.	|O

Blood	|O
eosinophils	|O
in	|O
patients	|O
with	|O
Taenia	|O
saginata	|O
taeniasis	|O
.	|O

The	|O
imino	|O
proton	|O
of	|O
T3	|O
in	|O
the	|O
O6meG.T	|O
12	|O
-	|O
mer	|O
and	|O
G3	|O
in	|O
the	|O
O6meG.N	|O
12	|O
-	|O
mer	|O
helix	|O
,	|O
which	|O
are	|O
associated	|O
with	|O
the	|O
modification	|O
site	|O
,	|O
resonate	|O
at	|O
unusually	|O
high	|O
field	|O
(	|O
8.5	|O
to	|O
9.0	|O
ppm	|O
)	|O
compared	|O
to	|O
imino	|O
protons	|O
in	|O
Watson	|O
-	|O
Crick	|O
base	|O
pairs	|O
(	|O
12.5	|O
to	|O
14.5	|O
ppm	|O
)	|O
.	|O

The	|O
recommendation	|O
is	|O
made	|O
that	|O
specific	|O
sub	|O
-	|O
groups	|O
of	|O
attempters	|O
need	|O
to	|O
be	|O
identified	|O
and	|O
may	|O
warrant	|O
specialized	|O
intervention	|O
strategies	|O
.	|O

There	|O
was	|O
no	|O
correlation	|O
between	|O
secretor	|O
status	|O
and	|O
clinical	|O
status	|O
,	|O
spirometry	|O
measurements	|O
,	|O
salivary	|O
and	|O
serum	|O
lysozyme	|B-PROTEIN
levels	|O
or	|O
rates	|O
of	|O
respiratory	|O
tract	|O
colonization	|O
with	|O
P.	|O
aeruginosa	|O
and	|O
S.	|O
aureus	|O
.	|O

There	|O
was	|O
no	|O
correlation	|O
between	|O
secretor	|O
status	|O
and	|O
clinical	|O
status	|O
,	|O
spirometry	|O
measurements	|O
,	|O
salivary	|O
and	|O
serum	|O
lysozyme	|B-PROTEIN
levels	|O
or	|O
rates	|O
of	|O
respiratory	|O
tract	|O
colonization	|O
with	|O
P.	|O
aeruginosa	|O
and	|O
S.	|O
aureus	|O
.	|O

Gains	|O
increased	|O
3.5%	|O
(	|O
P	|O
less	|O
than	|O
.10	|O
)	|O
and	|O
feed	|O
conversion	|O
improved	|O
5.9%	|O
(	|O
P	|O
less	|O
than	|O
.07	|O
)	|O
in	|O
steers	|O
fed	|O
.28	|O
%	|O
AS	|O
-	|O
VFA	|O
compared	|O
with	|O
gain	|O
and	|O
feed	|O
conversion	|O
of	|O
the	|O
control	|O
steers	|O
.	|O

Postnatal	|O
volumetric	|O
development	|O
of	|O
the	|O
prefrontal	|O
cortex	|O
in	|O
the	|O
rat	|O
.	|O

Daily	|O
and	|O
seasonal	|O
rhythmicity	|O
in	|O
the	|O
methylation	|O
of	|O
pineal	|O
indolic	|O
compounds	|O
in	|O
adult	|O
male	|O
golden	|O
hamsters	|O
,	|O
kept	|O
under	|O
natural	|O
conditions	|O
.	|O

The	|O
transit	|O
time	|O
was	|O
significantly	|O
shortened	|O
.	|O

Among	|O
the	|O
patients	|O
grades	|O
1-2-3	|O
,	|O
81%	|O
had	|O
a	|O
good	|O
out	|O
come	|O
without	|O
any	|O
neurological	|O
abnormality	|O
,	|O
among	|O
the	|O
patients	|O
graded	|O
4-5	|O
,	|O
only	|O
27%	|O
had	|O
a	|O
fair	|O
out	|O
come	|O
.	|O

Activity	|O
of	|O
acid	|B-PROTEIN
hydrolases	|I-PROTEIN
of	|O
peripheral	|O
blood	|O
leukocytes	|O
in	|O
focal	|O
and	|O
segmental	|O
pneumonia	|O
in	|O
children	|O

Comparative	|O
studies	|O
of	|O
the	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
level	|O
and	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
activity	|O
in	|O
patients	|O
with	|O
thrombophlebitis	|O

We	|O
also	|O
observed	|O
that	|O
the	|O
predictive	|O
ability	|O
of	|O
the	|O
selected	|O
attitudes	|O
and	|O
orientations	|O
increased	|O
considerably	|O
from	|O
1975	|O
to	|O
1982	|O
.	|O

Relations	|O
between	|O
cellular	|O
electrical	|O
activity	|O
and	|O
cardiac	|O
mechanical	|O
activity	|O
in	|O
man	|O
,	|O
the	|O
dog	|O
and	|O
the	|O
rabbit	|O

Treatment	|O
of	|O
Paget	|O
's	|O
disease	|O
.	|O

Improvement	|O
of	|O
the	|O
CRT	|O
display	|O
of	|O
an	|O
averager	|O
.	|O

Is	|O
desensitization	|O
'	|O
for	|O
ragweed	|O
hay	|O
fever	|O
immunologically	|O
specific	|O
?	|O

Renal	|O
excretion	|O
of	|O
sulphadimidine	|O
in	|O
normal	|O
and	|O
uraemic	|O
subjects	|O
.	|O

Experiences	|O
with	|O
the	|O
clinical	|O
and	|O
experimental	|O
use	|O
of	|O
Urat	|O
-	|O
I	|O
lithotriptor	|O
.	|O

Formation	|O
of	|O
hyphae	|O
and	|O
chlamydospores	|O
by	|O
Cryptococcus	|O
laurentii	|O
.	|O

Evaluation	|O
of	|O
thyroid	|O
function	|O
.	|O

The	|O
effect	|O
of	|O
a	|O
tissue	|O
emulsion	|O
,	|O
vitamin	|O
A	|O
and	|O
nonspecific	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
globulin	|I-PROTEIN
on	|O
the	|O
blood	|O
clearance	|O
in	|O
rabbits	|O

HL	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
antibodies	|O
in	|O
polytransfused	|O
patients	|O

Demonstration	|O
of	|O
fine	|O
structure	|O
of	|O
the	|O
guinea	|O
pig	|O
organ	|O
of	|O
Corti	|O
after	|O
electron	|O
microscopic	|O
silver	|O
staining	|O

Histamine	|O
metabolism	|O
in	|O
hemorrhagic	|O
-	|O
hypotensive	|O
shock	|O

They	|O
also	|O
discuss	|O
the	|O
existing	|O
nomenclature	|O
.	|O

Relaxation	|O
of	|O
catch	|O
in	|O
a	|O
molluscan	|O
smooth	|O
muscle	|O
.	|O

Studies	|O
on	|O
alcoholic	|O
liver	|O
injury	|O
.	|O

Hypothalamic	|O
control	|O
of	|O
coronary	|O
circulation	|O
in	|O
the	|O
dog	|O
.	|O

Evidence	|O
for	|O
two	|O
distinctive	|O
clinical	|O
,	|O
epidemiological	|O
,	|O
and	|O
immunological	|O
types	|O
of	|O
infection	|O
.	|O

Ultraviolet	|O
light	|O
-	|O
induced	|O
kinin	|B-PROTEIN
formation	|O
in	|O
human	|O
skin	|O
.	|O

Poliomyelitis	|O
from	|O
a	|O
vaccine	|O
.	|O

To	|O
the	|O
problem	|O
of	|O
the	|O
stimulation	|O
of	|O
the	|O
growth	|O
of	|O
transplantable	|O
tumors	|O
of	|O
animals	|O
previously	|O
treated	|O
with	|O
antineoplastic	|O
antibiotics	|O

Assessment	|O
of	|O
nutrient	|O
media	|O
in	|O
the	|O
diagnosis	|O
of	|O
diptheria	|O

Aluminium	|O
resin	|O
for	|O
the	|O
treatment	|O
of	|O
the	|O
hyperkalamia	|O
of	|O
renal	|O
failure	|O
.	|O

Value	|O
of	|O
the	|O
EMG	|O
in	|O
the	|O
diagnosis	|O
of	|O
a	|O
cardiomyopathy	|O
associated	|O
with	|O
a	|O
myotonic	|O
myopathy	|O
.	|O

D.	|O

Prevention	|O
of	|O
maternal	|O
Rh	|O
sensitization	|O
:	|O
anti	|B-PROTEIN
-	|I-PROTEIN
Rh	|I-PROTEIN
immune	|I-PROTEIN
globulin	|I-PROTEIN
.	|O

Serotonin	|O
levels	|O
in	|O
infant	|O
hypothyroidism	|O
.	|O

Cerebrospinal	|O
fluid	|O
transferrin	|B-PROTEIN
II	|I-PROTEIN
studies	|O
in	|O
ischemic	|O
disorders	|O
of	|O
the	|O
central	|O
nervous	|O
system	|O
.	|O

High	|O
dosages	|O
of	|O
D	|O
-	|O
penicillamine	|O
in	|O
pulmonary	|O
fibroses	|O

Inverse	|O
relation	|O
between	|O
serum	|O
IgG	|B-PROTEIN
concentration	|O
and	|O
glucose	|O
and	|O
xylose	|O
absorption	|O
in	|O
Zambian	|O
African	|O
adults	|O
.	|O

Disorders	|O
of	|O
platelet	|O
function	|O
in	|O
chronic	|O
myeloid	|O
leukemias	|O

The	|O
effect	|O
of	|O
anticonvulsants	|O
on	|O
sodium	|O
-	|O
potassium	|O
-	|O
activated	|O
ATPase	|B-PROTEIN
,	|O
sodium	|O
,	|O
and	|O
potassim	|O
in	|O
cortex	|O
.	|O

Effect	|O
of	|O
immune	|O
lymphocytes	|O
and	|O
of	|O
rabbit	|B-PROTEIN
-	|I-PROTEIN
anti	|I-PROTEIN
-	|I-PROTEIN
lymphocyte	|I-PROTEIN
globulin	|I-PROTEIN
(	|O
RAMLG	|B-PROTEIN
)	|O
on	|O
infected	|O
macrophages	|O
exposed	|O
to	|O
increased	|O
incubation	|O
temperature	|O
in	|O
vitro	|O
.	|O

Estral	|O
cycle	|O
in	|O
white	|O
rats	|O
in	|O
the	|O
low	|O
and	|O
high	|O
mountains	|O
of	|O
Kirghizia	|O

Lactation	|O
of	|O
baboons	|O
fed	|O
a	|O
low	|O
protein	|O
maintenance	|O
diet	|O
.	|O

Studies	|O
on	|O
the	|O
organic	|O
matrix	|O
of	|O
human	|O
ear	|O
ossicles	|O

A	|O
medical	|O
-	|O
geographical	|O
review	|O

Age	|O
and	|O
sex	|O
structure	|O
of	|O
the	|O
natural	|O
population	|O
of	|O
Ornithodoros	|O
tatarovski	|O
Ol	|O
.	|O

Sensitization	|O
to	|O
hyperlactatemia	|O
induced	|O
by	|O
phenformin	|O
after	|O
subtotal	|O
ablation	|O
of	|O
the	|O
pancreas	|O
.	|O

Vitamin	|O
D3	|O
and	|O
calcium	|O
absorption	|O
in	|O
the	|O
chick	|O
.	|O

The	|O
incidence	|O
of	|O
tumours	|O
in	|O
young	|O
chickens	|O
.	|O

Laboratory	|O
aspects	|O
with	|O
particular	|O
reference	|O
to	|O
chemotherapy	|O
and	|O
control	|O
.	|O

Their	|O
effect	|O
on	|O
the	|O
guinea	|O
pig	|O
vas	|O
deferens	|O
.	|O

Androgens	|O
and	|O
growth	|O
.	|O

Effect	|O
of	|O
variations	|O
in	|O
time	|O
interval	|O
between	|O
treatment	|O
with	|O
BCG	|O
and	|O
quartz	|O
dust	|O
on	|O
translocation	|O
of	|O
quartz	|O
dust	|O
from	|O
the	|O
lungs	|O
to	|O
their	|O
regional	|O
lymph	|O
nodes	|O
.	|O

Therapeutic	|O
action	|O
of	|O
a	|O
new	|O
antibiotic	|O
-	|O
corticoid	|O
association	|O
used	|O
for	|O
instillations	|O
in	|O
otology	|O

Clinico	|O
-	|O
physiological	|O
experiment	|O

Enzyme	|O
histochemical	|O
findings	|O
in	|O
the	|O
ultimobranchial	|O
body	|O
of	|O
the	|O
horse	|O

Familial	|O
glutathione	|B-PROTEIN
reductase	|I-PROTEIN
deficiency	|O
and	|O
disorder	|O
of	|O
glutathione	|O
synthesis	|O
in	|O
the	|O
erythrocyte	|O

Studies	|O
on	|O
swine	|O
enteroviruses	|O
.	|O

Serodiagnosis	|O
of	|O
ectromelia	|O
in	|O
laboratory	|O
mice	|O

Ultrasound	|O
effect	|O
on	|O
the	|O
cytochrome	|B-PROTEIN
oxidase	|I-PROTEIN
activity	|O

Metastasis	|O
of	|O
colon	|O
carcinoma	|O
to	|O
the	|O
lip	|O
.	|O

Genesis	|O
of	|O
foam	|O
cells	|O
:	|O
study	|O
in	|O
rats	|O
after	|O
administration	|O
of	|O
Cloforex	|O
.	|O

Pre	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
lipoprotein	|O
and	|O
early	|O
detection	|O
of	|O
risk	|O
factors	|O
for	|O
coronary	|O
heart	|O
disease	|O
.	|O

Conditions	|O
influencing	|O
inhibitors	|O
of	|O
the	|O
colony	|B-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
CSF	|B-PROTEIN
)	|O
.	|O

Absence	|O
of	|O
action	|O
potentials	|O
in	|O
frog	|O
slow	|O
muscle	|O
fibres	|O
paralysed	|O
by	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
.	|O

An	|O
automated	|O
method	|O
for	|O
the	|O
quantitative	|O
analysis	|O
of	|O
the	|O
polyamines	|O
putrescine	|O
,	|O
spermidine	|O
and	|O
spermine	|O
in	|O
cerebrospinal	|O
fluid	|O
(	|O
CSF	|O
)	|O
was	|O
used	|O
to	|O
analyze	|O
CSF	|O
samples	|O
from	|O
37	|O
patients	|O
with	|O
central	|O
nervous	|O
system	|O
(	|O
CNS	|O
)	|O
tumors	|O
and	|O
from	|O
13	|O
patients	|O
without	|O
tumors	|O
.	|O

I.	|O

Disulfiram	|O
and	|O
the	|O
drug	|O
-	|O
induced	|O
effects	|O
on	|O
motility	|O
.	|O

Particles	|O
resembling	|O
microbodies	|O
in	|O
normal	|O
and	|O
neoplastic	|O
perianal	|O
glands	|O
of	|O
dogs	|O
.	|O

Natural	|O
and	|O
induced	|O
malarias	|O
in	|O
western	|O
hemisphere	|O
monkeys	|O
.	|O

A	|O
study	|O
in	|O
vivo	|O
of	|O
adrenergic	|B-PROTEIN
receptors	|I-PROTEIN
in	|O
the	|O
rectum	|O
and	|O
in	|O
the	|O
internal	|O
and	|O
sphincter	|O
of	|O
the	|O
cat	|O
.	|O

Intracranial	|O
arachnoid	|O
cyst	|O
of	|O
the	|O
middle	|O
fossa	|O
demonstrated	|O
by	|O
positive	|O
99mTc	|O
brainscintigraphy	|O
.	|O

Effects	|O
of	|O
estrogen	|O
and	|O
glucocorticoids	|O
on	|O
the	|O
adrenal	|O
development	|O
of	|O
the	|O
fetus	|O
.	|O

Copper	|O
and	|O
ceruloplasmin	|B-PROTEIN
content	|O
in	|O
pregnant	|O
women	|O
and	|O
in	|O
women	|O
with	|O
certain	|O
gynecological	|O
diseases	|O

Effect	|O
of	|O
noise	|O
on	|O
CO	|O
-	|O
induced	|O
increases	|O
of	|O
LAP	|B-PROTEIN
and	|O
GPT	|B-PROTEIN
activity	|O
in	|O
the	|O
plasma	|O
of	|O
rats	|O

Kinetics	|O
of	|O
calcium	|O
metabolism	|O
.	|O

On	|O
the	|O
transport	|O
of	|O
mucus	|O
and	|O
its	|O
rheologic	|O
simulants	|O
in	|O
ciliated	|O
systems	|O
.	|O

A	|O
hydrodynamic	|O
description	|O
of	|O
the	|O
osmotic	|O
reflection	|O
coefficient	|O
with	|O
application	|O
to	|O
the	|O
pore	|O
theory	|O
of	|O
transcapillary	|O
exchange	|O
.	|O

Pathology	|O
of	|O
neuritis	|O
caudae	|O
equinae	|O
in	|O
the	|O
horse	|O

Abnormal	|O
characteristics	|O
and	|O
verticillation	|O
in	|O
Platynothrus	|O
peltifer	|O

Selected	|O
topics	|O
in	|O
laboratory	|O
animal	|O
medicine	|O
.	|O

Problems	|O
common	|O
to	|O
pediatrics	|O
and	|O
anesthesiology	|O

Clinical	|O
course	|O
and	|O
nursing	|O
care	|O
of	|O
patients	|O
with	|O
decubitus	|O
ulcer	|O
-	|O
-	|O
use	|O
of	|O
pillows	|O
stuffed	|O
with	|O
buckwheat	|O
chaff	|O

On	|O
parents	|O

From	|O
the	|O
Icelandic	|O
Red	|O
Cross	|O
activities	|O

Effects	|O
of	|O
alcoholism	|O
on	|O
the	|O
family	|O

Treatment	|O
and	|O
care	|O
of	|O
adult	|O
diabetes	|O
mellitus	|O
without	|O
coma	|O

Re	|O
-	|O
examining	|O
methylbenzene	|O
(	|O
toluene	|O
)	|O
as	|O
a	|O
treatment	|O
for	|O
Ancylostomum	|O
caninum	|O
.	|O

Junctions	|O
between	|O
cells	|O
of	|O
the	|O
human	|O
enamel	|O
organ	|O
.	|O

Electrocardiograms	|O
of	|O
the	|O
month	|O
.	|O

Composites	|O
as	|O
restoration	|O
materials	|O

Hodgkin	|O
's	|O
disease	|O
.	|O

Value	|O
of	|O
Normotest	|O
and	|O
antithrombin	|B-PROTEIN
3	|I-PROTEIN
in	|O
the	|O
assessment	|O
of	|O
liver	|O
function	|O
.	|O

Glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
in	|O
human	|O
red	|O
cells	|O
in	|O
health	|O
and	|O
disease	|O
.	|O

Histopathologic	|O
response	|O
of	|O
gingival	|O
tissues	|O
to	|O
hemodent	|O
and	|O
aluminum	|O
chloride	|O
solutions	|O
as	|O
tissue	|O
displacement	|O
materials	|O
.	|O

Changes	|O
following	|O
periodontal	|O
surgery	|O
.	|O

Intracellular	|O
pH	|O
,	|O
H	|O
ion	|O
flux	|O
and	|O
H	|O
ion	|O
permeability	|O
coefficient	|O
in	|O
bullfrog	|O
toe	|O
muscle	|O
.	|O

Teratological	|O
studies	|O
on	|O
SF	|O
-	|O
837	|O
.	|O

Directives	|O
concerning	|O
medical	|O
care	|O

Proceedings	|O
:	|O
Reversible	|O
complete	|O
heart	|O
block	|O
following	|O
surgery	|O
of	|O
congenital	|O
heart	|O
defects	|O

Method	|O
of	|O
synthesis	|O
of	|O
the	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
in	|O
clinico	|O
-	|O
immunological	|O
studies	|O

Variations	|O
of	|O
the	|O
timing	|O
of	|O
deflections	|O
in	|O
the	|O
His	|O
bundle	|O
recordings	|O
.	|O

Extracellular	|O
fibril	|O
formation	|O
by	|O
neuroglial	|O
cells	|O
at	|O
the	|O
vitreoretinal	|O
junction	|O
of	|O
the	|O
human	|O
eye	|O
.	|O

Blood	|O
platelets	|O
,	|O
coagulation	|O
factors	|O
and	|O
morphologic	|O
organ	|O
changes	|O
following	|O
scalding	|O
shock	|O
in	|O
rhesus	|O
monkeys	|O

Cell	|O
viability	|O
and	|O
lysosomal	|B-PROTEIN
enzymes	|I-PROTEIN

State	|O
-	|O
approved	|O
schools	|O
of	|O
nursing	|O
-	|O
-	|O
R.N.	|O
,	|O
1972	|O
.	|O

Further	|O
investigation	|O
on	|O
the	|O
chemotactic	|O
influence	|O
of	|O
thymic	|B-PROTEIN
hormone	|I-PROTEIN
on	|O
lymphocytes	|O

1,3	|O
-	|O
bis	|O
(	|O
2	|O
-	|O
chloroethyl	|O
)	|O
-	|O
1	|O
-	|O
nitrosourea	|O
(	|O
bcnu	|O
)	|O
and	|O
other	|O
nitrosoureas	|O
in	|O
cancer	|O
treatment	|O
:	|O
a	|O
review	|O
.	|O

Pneumothorax	|O
following	|O
lung	|O
abscess	|O
in	|O
the	|O
renal	|O
transplant	|O
patient	|O
.	|O

Taxonomically	|O
significant	|O
colour	|O
changes	|O
in	|O
Brevibacterium	|O
linens	|O
probably	|O
associated	|O
with	|O
a	|O
carotenoid	|O
-	|O
like	|O
pigment	|O
.	|O

Temporal	|O
relationships	|O
and	|O
the	|O
development	|O
phase	|O
affected	|O
.	|O

A	|O
short	|O
history	|O
of	|O
dermatology	|O
in	|O
Lagos	|O
,	|O
Nigeria	|O
.	|O

Local	|O
graft	|O
irradiation	|O
as	|O
an	|O
adjunct	|O
to	|O
pharmacologic	|O
immunosuppression	|O
.	|O

Letter	|O
:	|O
Salmonella	|O
detection	|O

Role	|O
of	|O
biocenosis	|O
in	|O
the	|O
manifestation	|O
of	|O
Shigella	|O
virulence	|O

The	|O
effect	|O
of	|O
antilymphocyte	|O
sera	|O
on	|O
formation	|O
of	|O
transplantation	|O
and	|O
anti	|O
-	|O
infection	|O
immunity	|O
in	|O
mice	|O

60th	|O
birthday	|O
of	|O
colonel	|O
prof	|O
.	|O
e.c	|O
erny	|O
m.d	|O
.	|O

Morphology	|O
of	|O
bacteriophages	|O
of	|O
Klebsiella	|O
bacilli	|O
.	|O

Cortical	|O
afferents	|O
to	|O
the	|O
entorhinal	|O
cortex	|O
of	|O
the	|O
Rhesus	|O
monkey	|O
.	|O

Mechanism	|O
of	|O
immunogenesis	|O
in	|O
vaccination	|O
with	|O
streptomycin	|O
-	|O
dependent	|O
mutants	|O
of	|O
salmonellae	|O
and	|O
shigellae	|O
.	|O

Resistance	|O
pattern	|O
of	|O
Mycobacterium	|O
tuberculosis	|O
(	|O
H	|O
37	|O
Rv	|O
)	|O
to	|O
a	|O
new	|O
antibiotic	|O
,	|O
lividomycin	|O

Pulmonary	|O
arterial	|O
pressure	|O
and	|O
structure	|O
in	|O
the	|O
patas	|O
monkey	|O
after	|O
prolonged	|O
administration	|O
of	|O
aminorex	|O
fumarate	|O
.	|O

Effect	|O
of	|O
triftazin	|O
and	|O
aminazin	|O
on	|O
hippocampal	|O
bioelectric	|O
activity	|O

Sex	|O
ratio	|O
at	|O
birth	|O
.	|O

Pathological	|O
processes	|O
in	|O
the	|O
cervix	|O
uteri	|O

Benign	|O
intramural	|O
tumors	|O
of	|O
the	|O
esophagus	|O

General	|O
formulae	|O
for	|O
estimating	|O
heritability	|O
in	|O
a	|O
population	|O
with	|O
related	|O
parents	|O
.	|O

Measurement	|O
of	|O
open	|O
-	|O
loop	|O
responses	|O
to	|O
electrical	|O
stimulation	|O
in	|O
olfactory	|O
bulb	|O
of	|O
cat	|O
.	|O

Glucose	|O
disappearance	|O
rate	|O
and	|O
changes	|O
in	|O
plasma	|O
nutrients	|O
after	|O
intravenouly	|O
injected	|O
glucose	|O
in	|O
normoglycaemic	|O
and	|O
hypoglycaemic	|O
underweight	|O
newborns	|O
.	|O

Normal	|O
values	|O
for	|O
the	|O
peripheral	|O
blood	|O
and	|O
bone	|O
marrow	|O
of	|O
the	|O
grey	|O
(	|O
Armenian	|O
)	|O
hamster	|O

The	|O
relationship	|O
of	|O
human	|O
umbilical	|O
arterial	|O
and	|O
venous	|O
plasma	|O
levels	|O
of	|O
corticosteroids	|O
to	|O
gestational	|O
age	|O
.	|O

Antibiotic	|O
effect	|O
of	|O
the	|O
mud	|O
from	|O
heviz	|O

Sulfuric	|O
acid	|O
concentration	|O
in	|O
the	|O
catalyzed	|O
breathalyzer	|O
ampules	|O
.	|O

Role	|O
of	|O
histoclinical	|O
studies	|O
in	|O
the	|O
prophylaxis	|O
of	|O
spontaneous	|O
abortions	|O

Range	|O
behavior	|O
of	|O
Hereford	|O
,	|O
Hereford	|O
x	|O
Holstein	|O
and	|O
Holstein	|O
non	|O
-	|O
lactating	|O
heifers	|O
.	|O

Chemical	|O
constituents	|O
of	|O
the	|O
gentianaceae	|O
V	|O
:	|O
tetraoxygenated	|O
xanthones	|O
of	|O
Swertia	|O
chirata	|O
Buch	|O
.	|O
-	|O
Ham	|O
.	|O

Methyl	|O
mercury	|O
intoxication	|O
in	|O
rat	|O
kidneys	|O
.	|O

Microdetermination	|O
of	|O
adrenocortical	|O
steroids	|O
by	|O
double	|O
isotope	|O
method	|O
.	|O

Compensative	|O
justice	|O
and	|O
moral	|O
investment	|O
among	|O
Japanese	|O
,	|O
Chinese	|O
,	|O
and	|O
Koreans	|O
.	|O

Effects	|O
of	|O
cortisone	|O
,	|O
starvation	|O
,	|O
and	|O
rickets	|O
on	|O
oxidative	|O
enzyme	|O
activities	|O
of	|O
epiphyseal	|O
cartilage	|O
from	|O
rats	|O
.	|O

Metal	|O
coordination	|O
compounds	|O
of	|O
thiabendazole	|O
.	|O

Estimation	|O
of	|O
renin	|B-PROTEIN
secretion	|O
rate	|O
and	|O
renal	|O
plasma	|O
flow	|O
from	|O
peripheral	|O
and	|O
renal	|O
vein	|O
renin	|B-PROTEIN
levels	|O
.	|O

Disability	|O
insurance	|O
under	|O
social	|O
security	|O
.	|O

Choice	|O
of	|O
vessel	|O
.	|O

Suppression	|O
of	|O
food	|O
intake	|O
in	|O
the	|O
rat	|O
by	|O
tung	|O
oil	|O
.	|O

Studies	|O
of	|O
lipoprotein	|B-PROTEIN
-	|I-PROTEIN
X	|I-PROTEIN
(	|O
LP	|B-PROTEIN
-	|I-PROTEIN
X	|I-PROTEIN
)	|O
and	|O
bile	|O
acids	|O
in	|O
familial	|O
LCAT	|B-PROTEIN
deficiency	|O
.	|O

Pneumothorax	|O
complicated	|O
by	|O
chronic	|O
steroid	|O
treatment	|O
.	|O

Polycythemia	|O
-	|O
1973	|O
.	|O

Manifest	|O
anxiety	|O
of	|O
Vietnam	|O
returnees	|O
and	|O
undergraduates	|O
.	|O

Familial	|O
juvenile	|O
nephronophthisis	|O

Early	|O
heparin	|O
therapy	|O
in	|O
60	|O
children	|O
with	|O
acute	|O
meningococcemia	|O
.	|O

9,11	|O
-	|O
Seco	|O
steroids	|O
derived	|O
from	|O
estradiol	|O
3	|O
-	|O
methyl	|O
ether	|O
.	|O

Psychological	|O
examinations	|O
in	|O
patients	|O
with	|O
chronic	|O
kidney	|O
insufficiency	|O

Possibilities	|O
of	|O
needleless	|O
administration	|O
of	|O
various	|O
substances	|O
to	|O
animals	|O

Change	|O
in	|O
the	|O
makeup	|O
of	|O
the	|O
blood	|O
following	|O
a	|O
short	|O
-	|O
term	|O
local	|O
action	|O
of	|O
a	|O
permanent	|O
magnetic	|O
field	|O
on	|O
the	|O
human	|O
body	|O

Observations	|O
on	|O
the	|O
flight	|O
activities	|O
of	|O
Chrysops	|O
caecutiens	|O
L.	|O

Combination	|O
of	|O
3	|O
multiple	|O
primary	|O
malignant	|O
and	|O
benign	|O
tumors	|O
of	|O
the	|O
breasts	|O
and	|O
uterus	|O

Analysis	|O
of	|O
clearance	|O
curve	|O
of	|O
rose	|O
bengal	|O
-	|O
I	|O
-	|O
131	|O

Proceedings	|O
:	|O
Barrels	|O
and	|O
somatotopy	|O
in	|O
S	|O
I	|O
neocortex	|O
of	|O
the	|O
brush	|O
-	|O
tailed	|O
possum	|O
.	|O

Antivitamin	|O
K	|O
agents	|O

Canine	|O
reproduction	|O
:	|O
effects	|O
of	|O
a	|O
single	|O
injection	|O
of	|O
medroxyprogesterone	|O
acetate	|O
on	|O
the	|O
reproductive	|O
organs	|O
of	|O
the	|O
bitch	|O
.	|O

3	|O
.	|O

Hypoglycemic	|O
and	|O
antidiabetic	|O
properties	|O

Hematopoietic	|O
system	|O
in	|O
streptococcal	|O
allergy	|O
.	|O

Letter	|O
:	|O
Aryl	|B-PROTEIN
hydrocarbon	|I-PROTEIN
hydroxylase	|I-PROTEIN
and	|O
smoking	|O
.	|O

Evaluation	|O
of	|O
1,10	|O
-	|O
phenanthroline	|O
as	|O
a	|O
reagent	|O
for	|O
sialic	|O
acid	|O
determinations	|O
.	|O

Delta	|O
-	|O
aminolevulinic	|O
acid	|O
in	|O
physiological	|O
conditions	|O
and	|O
some	|O
diseases	|O
in	|O
children	|O

Nonteratogenicity	|O
in	|O
rats	|O
of	|O
blighted	|O
potatoes	|O
and	|O
compounds	|O
contained	|O
in	|O
them	|O
.	|O

VII	|O
.	|O

Isolation	|O
of	|O
tha	|O
avian	|O
reticuloendothelial	|O
virus	|O
(	|O
strain	|O
T	|O
)	|O
.	|O

Observations	|O
on	|O
saccules	|O
of	|O
rats	|O
exposed	|O
to	|O
long	|O
-	|O
term	|O
hypergravity	|O
.	|O

Effect	|O
of	|O
a	|O
high	|O
-	|O
intensity	|O
SHF	|O
field	|O
on	|O
the	|O
blood	|O
coagulation	|O
system	|O

The	|O
levels	|O
of	|O
galactosyltransferase	|B-PROTEIN
activity	|O
in	|O
sera	|O
from	|O
normal	|O
children	|O
and	|O
patients	|O
with	|O
cystic	|O
fibrosis	|O
.	|O

Lack	|O
of	|O
effect	|O
of	|O
the	|O
appetite	|O
stimulant	|O
pizotifen	|O
(	|O
BC	|O
105	|O
)	|O
on	|O
the	|O
absorption	|O
of	|O
isonicotinylhydrazine	|O
.	|O

Relationship	|O
between	|O
gross	|O
lesions	|O
and	|O
Escherichia	|O
coli	|O
serotypes	|O
in	|O
chronic	|O
respiratory	|O
disease	|O
(	|O
CRD	|O
)	|O
of	|O
poultry	|O
.	|O

Plastic	|O
solution	|O
of	|O
elbow	|O
joint	|O
ankylosis	|O
with	|O
a	|O
decorticated	|O
cylindrical	|O
flap	|O

Effects	|O
of	|O
ionizing	|O
radiation	|O
in	|O
the	|O
human	|O
oral	|O
cavity	|O
and	|O
oropharynx	|O
:	|O
results	|O
of	|O
a	|O
survey	|O
.	|O

The	|O
Twentieth	|O
Anniversary	|O
of	|O
the	|O
Pomeranian	|O
Medical	|O
Academy	|O
.	|O

Immunelectrophoretic	|O
pattern	|O
of	|O
Wassermann	|O
reagin	|O
and	|O
comparison	|O
of	|O
the	|O
appearance	|O
time	|O
between	|O
RPCF	|B-PROTEIN
and	|O
FTA	|B-PROTEIN
antibodies	|O

Motile	|O
nocardoid	|O
Actinomycetales	|O
.	|O

Electrocardiographic	|O
QRS	|O
complexes	|O
and	|O
vectorcardiographic	|O
QRS	|O
loop	|O

Study	|O
of	|O
antinuclear	|O
autoantibodies	|O
by	|O
immunofluorescence	|O
technic	|O
in	|O
collagen	|B-PROTEIN
diseases	|O

Cardiac	|O
preservation	|O
.	|O

Labial	|O
bar	|O
.	|O

Yusuf	|O
Dawood	|O
Docrat	|O
L.R.C.P.	|O

Dr.	|O

The	|O
metabolism	|O
and	|O
pharmacology	|O
of	|O
5	|O
-	|O
fluorouracil	|O
.	|O

Spleen	|O
weight	|O
in	|O
rats	|O
during	|O
tumour	|O
growth	|O
and	|O
in	|O
homograft	|O
rejection	|O
.	|O

Isolation	|O
of	|O
Proteus	|O
vulgaris	|O
MC	|O
-	|O
63	|O
from	|O
carcinoma	|O
63	|O
and	|O
its	|O
antitumor	|O
effect	|O
on	|O
Crocker	|O
sarcoma	|O
180	|O
and	|O
Ehrlich	|O
carcinoma	|O
.	|O

Human	|O
synovial	|O
fluid	|O
:	|O
detection	|O
of	|O
a	|O
new	|O
component	|O
.	|O

Effects	|O
of	|O
temperature	|O
and	|O
moulting	|O
cycle	|O
on	|O
melanin	|O
synthesis	|O
in	|O
the	|O
newt	|O
,	|O
Triturus	|O
cristatus	|O
.	|O

Some	|O
reflexions	|O
apropos	|O
of	|O
a	|O
personal	|O
statistical	|O
study	|O
of	|O
513	|O
arterial	|O
embolisms	|O

LA	|O
-	|O
3848	|O
-	|O
MS	|O
.	|O

Immunochemical	|O
studies	|O
with	|O
filarial	|O
antigens	|O
.	|O

Morphological	|O
and	|O
functional	|O
alterations	|O
noted	|O
after	|O
baboon	|O
renal	|O
allotransplantation	|O
.	|O

Heterogeneity	|O
of	|O
human	|O
serum	|O
albumin	|B-PROTEIN
.	|O

Analysis	|O
of	|O
corticosteroids	|O
.	|O

Reactivities	|O
to	|O
horse	|O
anti	|B-PROTEIN
-	|I-PROTEIN
lymphocyte	|I-PROTEIN
globulin	|I-PROTEIN
.	|O

Plasma	|O
histaminase	|B-PROTEIN
in	|O
patients	|O
of	|O
bronchial	|O
asthma	|O
and	|O
the	|O
effect	|O
of	|O
prednisolone	|O
administration	|O
on	|O
it	|O
.	|O

A	|O
comparative	|O
study	|O
of	|O
the	|O
cortical	|O
end	|O
of	|O
the	|O
auditory	|O
analyzer	|O
during	|O
postnatal	|O
ontogenesis	|O
in	|O
lower	|O
monkeys	|O
and	|O
man	|O

The	|O
effect	|O
of	|O
osmotic	|O
flow	|O
on	|O
the	|O
distribution	|O
of	|O
horseradish	|B-PROTEIN
peroxidase	|I-PROTEIN
within	|O
the	|O
intercellular	|O
spaces	|O
of	|O
toad	|O
bladder	|O
epithelium	|O
.	|O

Immunogenicity	|O
of	|O
various	|O
mycobacteria	|O
and	|O
the	|O
corresponding	|O
levels	|O
of	|O
cross	|O
-	|O
protection	|O
developed	|O
between	|O
species	|O
.	|O

Ten	|O
-	|O
year	|O
experience	|O
with	|O
one	|O
-	|O
stage	|O
proctocolectomy	|O
and	|O
anal	|O
ileostomy	|O
.	|O

Nitrogen	|O
-	|O
hydrogen	|O
tautomerism	|O
in	|O
porphyrins	|O
and	|O
chlorins	|O
.	|O

Factors	|O
affecting	|O
the	|O
inhibition	|O
of	|O
phagocytosis	|O
by	|O
chlorpromazine	|O
.	|O

Photopic	|O
spectral	|O
sensitivity	|O
determined	|O
electroretinographically	|O
for	|O
the	|O
pigeon	|O
eye	|O
.	|O

Angiography	|O
of	|O
aneurysmal	|O
bone	|O
cyst	|O
.	|O

Cholinesterase	|B-PROTEIN

Sodium	|O
restriction	|O
in	|O
cardiac	|O
failure	|O
.	|O

Clinical	|O
and	|O
angiographic	|O
examinations	|O
in	|O
occlusion	|O
disease	|O
of	|O
the	|O
great	|O
intestinal	|O
arteries	|O

Serum	|O
lipid	|O
changes	|O
during	|O
pregnancy	|O
due	|O
to	|O
oral	|O
calcium	|O
administration	|O

Successful	|O
treatment	|O
of	|O
candidiasis	|O
with	|O
transfer	|B-PROTEIN
factor	|I-PROTEIN
.	|O

A	|O
possible	|O
role	|O
for	|O
the	|O
mixed	|O
function	|O
oxidase	|B-PROTEIN
enzyme	|O
system	|O
in	|O
the	|O
requirement	|O
for	|O
selenium	|O
in	|O
the	|O
rat	|O
.	|O

Periodic	|O
breathing	|O
and	|O
apnea	|O
in	|O
preterm	|O
infants	|O
.	|O

Working	|O
session	|O
report	|O
:	|O
in	|O
vivo	|O
-	|O
in	|O
vitro	|O
screening	|O
.	|O

Clinicopathologic	|O
studies	|O
in	|O
feminizing	|O
tumors	|O
of	|O
the	|O
ovary	|O
.	|O

On	|O
the	|O
constituents	|O
of	|O
Dryopteris	|O
polylepis	|O

Relation	|O
between	|O
mixing	|O
ratio	|O
of	|O
raw	|O
materials	|O
and	|O
composition	|O
of	|O
products	|O
in	|O
the	|O
synthesis	|O
of	|O
aluminosilicates	|O

Influence	|O
of	|O
diet	|O
on	|O
urinary	|O
VMA	|O
excretion	|O
.	|O

Oscilloscope	|O
triggering	|O
circuit	|O
for	|O
recording	|O
long	|O
transients	|O
at	|O
fast	|O
sweep	|O
speeds	|O
.	|O

Derivatives	|O
of	|O
boswellic	|O
acids	|O
.	|O

The	|O
status	|O
of	|O
education	|O
and	|O
training	|O
programs	|O
in	|O
speech	|O
pathology	|O
and	|O
audiology	|O
-	|O
-	|O
1971-72	|O
.	|O

Coronary	|O
arteries	|O
-	|O
-	|O
old	|O
and	|O
new	|O
.	|O

Antiviral	|O
agents	|O
.	|O

Separation	|O
of	|O
ninhydrin	|O
-	|O
positive	|O
compounds	|O
in	|O
urine	|O
by	|O
the	|O
combined	|O
methods	|O
of	|O
medium	|O
-	|O
tension	|O
intophoresis	|O
and	|O
partition	|O
chromatography	|O

Conservative	|O
treatment	|O
of	|O
central	|O
nervous	|O
system	|O
injuries	|O

Spasmus	|O
nutans	|O
:	|O
a	|O
syndrome	|O
of	|O
auto	|O
-	|O
arousal	|O
.	|O

6	|O
.	|O

1st	|O
data	|O
on	|O
the	|O
immunosuppressive	|O
therapy	|O
of	|O
scleroderma	|O

Slowed	|O
lysosomal	|B-PROTEIN
enzyme	|I-PROTEIN
release	|O
and	|O
its	|O
normalization	|O
by	|O
drugs	|O
in	|O
adjuvant	|O
-	|O
induced	|O
polyarthritis	|O
.	|O

Treatment	|O
of	|O
ovarian	|O
neoplasms	|O

Experimental	|O
pancreatitis	|O
in	|O
pigs	|O
.	|O

Bacterial	|O
metabolism	|O
of	|O
4	|O
-	|O
chlorophenoxyacetate	|O
.	|O

Dynamics	|O
of	|O
hospital	|O
stay	|O
in	|O
peptic	|O
ulcer	|O
patients	|O

I.	|O

Surgical	|O
treatment	|O
of	|O
pathologic	|O
scars	|O
of	|O
myocardial	|O
infarct	|O

The	|O
interaction	|O
of	|O
caffeine	|O
,	|O
theophylline	|O
and	|O
theobromine	|O
with	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
inhibitors	|O
.	|O

Effect	|O
of	|O
phenformin	|O
on	|O
gluconeogenesis	|O
in	|O
perfused	|O
rat	|O
liver	|O
.	|O

New	|O
alkaloids	|O
from	|O
bark	|O
of	|O
Erythrophleum	|O
ivorense	|O
.	|O

A	|O
case	|O
of	|O
M	|O
hemoglobinosis	|O

Radiosensitive	|O
nature	|O
of	|O
paravascular	|O
infiltrate	|O
-	|O
producing	|O
potential	|O
of	|O
parental	|O
spleen	|O
cells	|O
.	|O

Sinusoidal	|O
oscillations	|O
of	|O
a	|O
gas	|O
dilution	|O
indicator	|O

The	|O
value	|O
of	|O
different	|O
sources	|O
of	|O
nitrogen	|O
in	|O
diets	|O
for	|O
the	|O
early	|O
-	|O
weaned	|O
calf	|O
.	|O

1	|O
.	|O

Abdominal	|O
tumors	|O
in	|O
childhood	|O
.	|O

Results	|O
of	|O
the	|O
official	|O
inspection	|O
of	|O
the	|O
commercial	|O
anti	|O
-	|O
inflammatory	|O
enzyme	|O
preparations	|O
containing	|O
chymotrypsin	|B-PROTEIN
and	|O
trypsin	|B-PROTEIN
by	|O
means	|O
of	|O
modified	|O
NF	|O
13	|O
methods	|O

Studies	|O
on	|O
the	|O
hereditary	|O
nature	|O
of	|O
sole	|O
prints	|O
-	|O
-	|O
with	|O
special	|O
reference	|O
to	|O
interdigital	|O
and	|O
triradii	|O

The	|O
problem	|O
of	|O
disablement	|O
due	|O
to	|O
pulmonary	|O
tuberculosis	|O
,	|O
on	|O
the	|O
basis	|O
of	|O
an	|O
analysis	|O
of	|O
the	|O
history	|O
of	|O
395	|O
cases	|O
as	|O
observed	|O
in	|O
Gdansk	|O
in	|O
the	|O
years	|O
1946-1965	|O

Cleidocranial	|O
dysostosis	|O

Proposals	|O
on	|O
authorization	|O
;	|O
by	|O
a	|O
group	|O
of	|O
nurses	|O
from	|O
psychiatric	|O
hospitals	|O

Successive	|O
abdominal	|O
scintillation	|O
with	|O
131	|O
-	|O
I	|O
-	|O
tagged	|O
BSP	|O
-	|O
-	|O
description	|O
of	|O
the	|O
thyroid	|O
gland	|O
,	|O
kidney	|O
and	|O
spleen	|O
(	|O
comparison	|O
with	|O
131	|O
-	|O
I	|O
-	|O
RB	|O
)	|O

Pneumonia	|O
in	|O
children	|O

Osteosarcoma	|O
caused	|O
by	|O
3,4	|O
-	|O
benzopyrene	|O

The	|O
content	|O
of	|O
glucosamine	|O
and	|O
galactosamine	|O
in	|O
tartar	|O

Relapse	|O
of	|O
leukemia	|O
after	|O
prolonged	|O
remission	|O
.	|O

Influence	|O
of	|O
cigarette	|O
smoking	|O
on	|O
some	|O
blood	|O
coagulation	|O
tests	|O
.	|O

The	|O
non	|O
-	|O
role	|O
of	|O
fluoride	|O
in	|O
the	|O
control	|O
of	|O
plasma	|O
calcium	|O
in	|O
the	|O
parathyroidectomized	|O
rat	|O
.	|O

Second	|O
report	|O
of	|O
the	|O
Norwegian	|O
Cancer	|O
Society	|O
.	|O

Modification	|O
of	|O
the	|O
growth	|O
of	|O
Tetrahymena	|O
by	|O
compounds	|O
which	|O
affect	|O
the	|O
adrenergic	|O
mechanism	|O
.	|O

SAM	|O
-	|O
TR	|O
-	|O
68-54	|O
.	|O

A	|O
brief	|O
discussion	|O
of	|O
color	|O
deficiencies	|O
.	|O

BIM	|O
130	|O
.	|O

Problems	|O
in	|O
the	|O
determination	|O
of	|O
the	|O
antigenic	|O
content	|O
of	|O
influenza	|O
vaccines	|O
.	|O

Aedes	|O
aegypti	|O
(	|O
L.	|O
)	|O
and	|O
Aedes	|O
albopictus	|O
(	|O
Skuse	|O
)	|O
in	|O
Singapore	|O
City	|O
.	|O

Homograft	|O
response	|O
and	|O
hemagglutinin	|B-PROTEIN
production	|O
by	|O
sensitized	|O
thymectomized	|O
irradiated	|O
adult	|O
mice	|O
.	|O

Comparative	|O
study	|O
on	|O
acute	|O
oral	|O
overload	|O
using	|O
tolbutamide	|O
and	|O
tolazamide	|O
in	|O
normal	|O
and	|O
diabetic	|O
subjects	|O
.	|O

Mycotoxins	|O
in	|O
feeds	|O
and	|O
foods	|O
.	|O

Factors	|O
influencing	|O
in	|O
vitro	|O
skin	|B-PROTEIN
permeability	|I-PROTEIN
factor	|I-PROTEIN
production	|O
by	|O
Vibrio	|O
cholerae	|O
.	|O

Spinal	|O
cord	|O
representation	|O
of	|O
the	|O
micturition	|O
reflex	|O
.	|O

Biological	|O
action	|O
and	|O
kinetics	|O
of	|O
the	|O
elimination	|O
of	|O
tritium	|O
oxide	|O
in	|O
dogs	|O

Auto	|O
-	|O
and	|O
isotopy	|O
of	|O
the	|O
conjunctiva	|O

IX	|O
.	|O

Pitfalls	|O
in	|O
the	|O
use	|O
of	|O
chromosome	|O
aberration	|O
analysis	|O
for	|O
biological	|O
radiation	|O
dosimetry	|O
.	|O

Renin	|B-PROTEIN
secretion	|O
in	|O
essential	|O
and	|O
accelerated	|O
hypertension	|O
.	|O

The	|O
need	|O
for	|O
including	|O
forensic	|O
medical	|O
expertise	|O
in	|O
the	|O
list	|O
of	|O
urgent	|O
criminal	|O
investigative	|O
actions	|O

Histopathology	|O
and	|O
pathogenesis	|O
of	|O
exanthematous	|O
viroses	|O

CNS	|O
effects	|O
of	|O
local	|O
anesthetics	|O
only	|O
partially	|O
dependent	|O
on	|O
biogenic	|O
amine	|O
mechanisms	|O
.	|O

Diethylene	|O
benzene	|O

Midge	|O
control	|O
in	|O
flood	|O
channels	|O
.	|O

The	|O
effects	|O
of	|O
taloximine	|O
and	|O
aminophylline	|O
on	|O
isolated	|O
human	|O
smooth	|O
muscle	|O
.	|O

The	|O
exploratory	|O
behaviour	|O
in	|O
normal	|O
and	|O
aggressive	|O
mice	|O
.	|O

Genitography	|O
in	|O
intersexual	|O
states	|O
.	|O

Tolerance	|O
test	|O
of	|O
HB	|O
419	|O
in	|O
animal	|O
experiments	|O

The	|O
role	|O
of	|O
ascorbic	|O
acid	|O
in	|O
the	|O
prevention	|O
of	|O
bladder	|O
tumor	|O
formation	|O
.	|O

The	|O
"	|O
28	|O
percent	|O
"	|O
Venturi	|O
mask	|O
in	|O
obstructive	|O
airway	|O
disease	|O
.	|O

3'	|O
-	|O
Methyl	|O
,	|O
8	|O
-	|O
methyl	|O
,	|O
and	|O
8	|O
-	|O
phenyl	|O
derivatives	|O
of	|O
5,9	|O
-	|O
dimethyl	|O
-	|O
6,7	|O
-	|O
benzomorphans	|O
.	|O

Antidromic	|O
invasion	|O
of	|O
impulses	|O
and	|O
recurrent	|O
collateral	|O
inhibition	|O
in	|O
pyramidal	|O
tract	|O
neurones	|O
.	|O

The	|O
distribution	|O
of	|O
body	|O
fluids	|O
following	|O
hemorrhage	|O
and	|O
resuscitation	|O
in	|O
combat	|O
casualties	|O
.	|O

Once	|O
more	|O
Hong	|O
Kong	|O
influenza	|O
in	|O
the	|O
Netherlands	|O

Early	|O
disagnosis	|O
of	|O
cancer	|O
-	|O
-	|O
50	|O
per	|O
cent	|O
of	|O
all	|O
patients	|O
could	|O
be	|O
cured	|O

Difficulties	|O
bound	|O
to	|O
measuring	|O
of	|O
sputum	|O
viscosity	|O

Lipid	|O
concentration	|O
and	|O
lipase	|B-PROTEIN
activity	|O
in	|O
the	|O
epiphysis	|O
of	|O
adrenalectomized	|O
rats	|O
consuming	|O
food	|O
with	|O
different	|O
sodium	|O
content	|O

Behavior	|O
of	|O
aspartate	|B-PROTEIN
aminotransferase	|I-PROTEIN
(	|O
EC	|B-PROTEIN
2.6.1.1	|I-PROTEIN
)	|O
and	|O
alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
(	|O
EC	|B-PROTEIN
2.6.1.2	|I-PROTEIN
)	|O
in	|O
rat	|O
serum	|O
during	|O
the	|O
course	|O
of	|O
acute	|O
radiation	|O
syndrome	|O
following	|O
whole	|O
body	|O
X	|O
-	|O
irradiation	|O

Diminished	|O
forearm	|O
arteriolar	|O
dilator	|O
capacity	|O
produced	|O
by	|O
mineralocorticoid	|O
-	|O
induced	|O
salt	|O
retention	|O
in	|O
man	|O
.	|O

Studies	|O
on	|O
the	|O
pathogenicity	|O
of	|O
ECHO	|O
9	|O
(	|O
HILL	|O
)	|O
virus	|O
and	|O
its	|O
mutants	|O
for	|O
suckling	|O
mice	|O

Counter	|O
-	|O
current	|O
heat	|O
exchange	|O
in	|O
the	|O
respiratory	|O
passages	|O
:	|O
effect	|O
on	|O
water	|O
and	|O
heat	|O
balance	|O
.	|O

Calibration	|O
and	|O
a	|O
correction	|O
of	|O
blood	|O
O2	|O
content	|O
measured	|O
by	|O
Po2	|O
and	|O
CO	|O
saturation	|O
.	|O

Mae	|O
West	|O
and	|O
the	|O
doctor	|O
shortage	|O
.	|O

Elimination	|O
of	|O
gamma	|O
-	|O
irradiation	|O
induced	|O
oxidation	|O
in	|O
aqueous	|O
drug	|O
preparations	|O

The	|O
absolute	|O
configuration	|O
at	|O
C	|O
-	|O
2	|O
in	|O
monocrotalic	|O
acid	|O
.	|O

Teratogenic	|O
effects	|O
of	|O
actinomycin	|O
D	|O
in	|O
rats	|O

The	|O
plasma	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
concentration	|O
of	|O
the	|O
foetal	|O
lamb	|O
.	|O

Bimodal	|O
cochlear	|O
response	|O
curves	|O
in	|O
rodents	|O
.	|O

A	|O
new	|O
hemagglutination	|O
test	|O
for	|O
the	|O
on	|O
-	|O
slide	|O
assay	|O
of	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN

CO2	|O
assimilation	|O
by	|O
chloroplasts	|O
illuminated	|O
on	|O
filter	|O
paper	|O
.	|O

The	|O
biology	|O
of	|O
Hyostrongylus	|O
ruidus	|O
.	|O

Foreign	|O
profiles	|O
in	|O
air	|O
pollution	|O
control	|O
activities	|O
.	|O

Effects	|O
of	|O
chronic	|O
metaraminol	|O
treatment	|O
on	|O
the	|O
sympathetic	|O
activity	|O
of	|O
intact	|O
and	|O
adrenal	|O
demedullated	|O
rats	|O
kept	|O
in	|O
warm	|O
or	|O
cold	|O
environments	|O
.	|O

The	|O
association	|O
of	|O
clopamide	|O
and	|O
hydergine	|O
(	|O
Brinedine	|O
)	|O
in	|O
the	|O
treatment	|O
of	|O
the	|O
vasculo	|O
-	|O
renal	|O
syndromes	|O
of	|O
pregnancy	|O

The	|O
effect	|O
of	|O
low	|O
dosage	|O
radiation	|O
on	|O
metabolism	|O
and	|O
function	|O
of	|O
the	|O
rat	|O
kidney	|O
damaged	|O
by	|O
ischemia	|O

Leukemia	|O
in	|O
twins	|O
:	|O
world	|O
-	|O
wide	|O
review	|O
of	|O
clinical	|O
cases	|O
.	|O

Preliminary	|O
report	|O
.	|O

Quantitation	|O
of	|O
exocrine	|O
IgA	|B-PROTEIN
in	|O
human	|O
serum	|O
in	|O
health	|O
and	|O
disease	|O
.	|O

Gastrointestinal	|O
manifestations	|O
of	|O
systemic	|O
sclerosis	|O

Iodine	|O
metabolism	|O
in	|O
chronic	|O
thyroiditis	|O
.	|O

Total	|O
body	|O
water	|O
,	|O
rhodanide	|O
space	|O
and	|O
I	|O
-	|O
131	|O
-	|O
albumin	|B-PROTEIN
space	|O
under	|O
the	|O
acute	|O
effect	|O
of	|O
furosemide	|O

V.	|O

18F	|O
and	|O
85Sr	|O
scintimetry	|O
in	|O
the	|O
study	|O
of	|O
primary	|O
arthropathies	|O
.	|O

Propagation	|O
and	|O
hormone	|O
production	|O
by	|O
human	|O
normal	|O
and	|O
malignant	|O
trophoblast	|O
in	|O
rats	|O
.	|O

Health	|O
:	|O
an	|O
integrative	|O
reticulum	|O
.	|O

Sensitive	|O
fluorometric	|O
method	|O
of	|O
determining	|O
SH	|O
-	|O
and	|O
S	|O
-	|O
S	|O
-	|O
groups	|O
when	|O
jointly	|O
present	|O

Morphogenesis	|O
of	|O
the	|O
trochanter	|O
produced	|O
by	|O
femoral	|O
regeneration	|O
in	|O
the	|O
phasmid	|O
Carausius	|O
morosus	|O
Br	|O

Behavioral	|O
and	|O
electrographic	|O
expression	|O
of	|O
natural	|O
sleep	|O
and	|O
wakefulness	|O
in	|O
reptiles	|O

Sensitivities	|O
of	|O
thromboplastins	|B-PROTEIN
to	|O
factor	|B-PROTEIN
VII	|I-PROTEIN
deficiency	|O
.	|O

3	|O
.	|O

Central	|O
venous	|O
catheter	|O
used	|O
for	|O
recording	|O
intracardiac	|O
electrocardiogram	|O
.	|O

Two	|O
Lab	|O
8	|O
computer	|O
programmes	|O
for	|O
use	|O
in	|O
the	|O
study	|O
of	|O
the	|O
isometric	|O
and	|O
isotonic	|O
contractile	|O
characteristics	|O
of	|O
skeletal	|O
muscle	|O
.	|O

Open	|O
head	|O
-	|O
brain	|O
injuries	|O

The	|O
modification	|O
of	|O
P32	|O
uptake	|O
into	|O
the	|O
Jensen	|O
sarcoma	|O
in	|O
vitro	|O
by	|O
adding	|O
of	|O
peroxide	|O
to	|O
the	|O
nutritive	|O
medium	|O

Students	|O
,	|O
parents	|O
,	|O
teachers	|O
and	|O
hearing	|O
disorders	|O

Changing	|O
and	|O
predicting	|O
doses	|O
of	|O
Cs137	|O
irradiation	|O

Positive	|O
shifts	|O
of	|O
basal	|O
skin	|O
potentials	|O
during	|O
human	|O
sleep	|O
.	|O

Evaluating	|O
dietary	|O
department	|O
management	|O
.	|O

5	|O
-	|O
(	|O
Dimethylaminopropyl	|O
)	|O
-	|O
19,11	|O
-	|O
dihydro	|O
-	|O
5H	|O
-	|O
benzo	|O
[	|O
2,3	|O
]	|O
pyrido	|O
[	|O
6,7	|O
-	|O
b	|O
]	|O
azepine	|O
.	|O

Osteogenesis	|O
imperfecta	|O

Investigation	|O
on	|O
the	|O
exchange	|O
of	|O
Ca45	|O
in	|O
intact	|O
and	|O
burned	|O
rats	|O
by	|O
the	|O
kinetic	|O
analysis	|O
method	|O

Effect	|O
of	|O
thrombotic	|O
and	|O
antithrombotic	|O
drugs	|O
on	|O
the	|O
surface	|O
charge	|O
characteristics	|O
of	|O
canine	|O
blood	|O
vessels	|O
:	|O
in	|O
vivo	|O
and	|O
in	|O
vitro	|O
studies	|O
.	|O

Measurements	|O
of	|O
activity	|O
with	|O
the	|O
radioprotective	|O
chamber	|O
VA	|O
-	|O
K	|O
-	|O
254	|O
of	|O
the	|O
osimeter	|O
VA	|O
-	|O
J18	|O

3	|O
-	|O
(	|O
N	|O
-	|O
Alkyl	|O
-	|O
N	|O
-	|O
2	|O
-	|O
chloroethylaminomethyl	|O
)	|O
-	|O
5	|O
-	|O
or	|O
7	|O
-	|O
halogenobenzo	|O
[	|O
b	|O
]	|O
thiophen	|O
hydrochlorides	|O
.	|O

Nephrectomy	|O
applied	|O
to	|O
cattle	|O

Evaluation	|O
of	|O
automatic	|O
blood	|O
cell	|O
counters	|O
.	|O

Determination	|O
of	|O
transaminases	|O
with	|O
an	|O
autoanalyzer	|O

Sterols	|O
in	|O
pollen	|O
.	|O

Dermoid	|O
cyst	|O
in	|O
a	|O
free	|O
skin	|O
flap	|O
as	|O
the	|O
complication	|O
after	|O
treatment	|O
of	|O
recurring	|O
hernia	|O

Histological	|O
observations	|O
on	|O
the	|O
decidua	|O
in	|O
the	|O
second	|O
half	|O
of	|O
pregnancy	|O

Endocardial	|O
fibro	|O
-	|O
elastosis	|O
,	|O
mitral	|O
incompetence	|O
,	|O
and	|O
coarctation	|O
of	|O
abdominal	|O
aorta	|O
.	|O

Studies	|O
on	|O
the	|O
method	|O
of	|O
size	|O
reduction	|O
of	|O
medicinal	|O
compounds	|O
.	|O

Children	|O
with	|O
defective	|O
vision	|O

Identification	|O
and	|O
estimation	|O
of	|O
monosaccharides	|O
and	|O
disaccharides	|O
in	|O
urine	|O
by	|O
gas	|O
-	|O
liquid	|O
chromatography	|O
.	|O

Steroids	|O
in	|O
germfree	|O
and	|O
conventional	|O
rats	|O
.	|O

The	|O
effects	|O
of	|O
loading	|O
the	|O
respiratory	|O
pumps	|O
on	|O
the	|O
oxygen	|O
consumption	|O
of	|O
Callionymus	|O
lyra	|O
.	|O

Trials	|O
of	|O
sevine	|O
activity	|O
against	|O
mosquito	|O
larvae	|O

The	|O
significance	|O
of	|O
structural	|O
integrity	|O
of	|O
lymphoid	|O
tissue	|O
for	|O
antibody	|O
production	|O
in	|O
culture	|O
in	|O
vivo	|O

The	|O
effect	|O
of	|O
a	|O
constant	|O
magnetic	|O
field	|O
on	|O
the	|O
phagocytic	|O
activity	|O
of	|O
Paramecia	|O

Studies	|O
carried	|O
out	|O
with	|O
the	|O
Glossina	|O
morsitans	|O
colony	|O
of	|O
Lisbon	|O
.	|O

Relations	|O
between	|O
adrenergic	|O
mechanisms	|O
and	|O
analgesic	|O
effects	|O

Transformations	|O
in	|O
the	|O
morphine	|O
series	|O
.	|O

Dissociative	|O
anesthetics	|O
2	|O
-	|O
(	|O
o	|O
-	|O
chlorophenyl	|O
)	|O
-	|O
2	|O
-	|O
methyl	|O
-	|O
amino	|O
cyclohexane	|O
HCL	|O
(	|O
CI	|O
-	|O
581	|O
)	|O

Estrus	|O
and	|O
copulative	|O
abilities	|O
of	|O
androgen	|O
-	|O
sterilized	|O
rats	|O

The	|O
bearing	|O
of	|O
season	|O
and	|O
sequence	|O
of	|O
calving	|O
on	|O
frequency	|O
of	|O
male	|O
,	|O
female	|O
and	|O
total	|O
calvings	|O
in	|O
Hariana	|O
cows	|O
.	|O

Hemodynamics	|O
changes	|O
in	|O
man	|O
during	|O
flight	|O

Caries	|O
prevention	|O
in	|O
the	|O
dental	|O
office	|O
.	|O

I.	|O

Clinical	|O
applications	|O
of	|O
inhibition	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptors	|I-PROTEIN
with	|O
propranolol	|O
.	|O

Automatic	|O
view	|O
box	|O
.	|O

Measurement	|O
of	|O
gastric	|O
acid	|O
secretion	|O
by	|O
conductivity	|O
.	|O

Effect	|O
of	|O
castration	|O
on	|O
pituitary	|O
and	|O
serum	|O
LH	|B-PROTEIN
and	|O
FSH	|B-PROTEIN
in	|O
testosterone	|O
-	|O
sterilized	|O
rats	|O
.	|O

The	|O
significance	|O
of	|O
the	|O
phenolphthalein	|B-PROTEIN
sulphatase	|I-PROTEIN
test	|O
for	|O
the	|O
differentiation	|O
and	|O
identification	|O
of	|O
Nocardia	|O
species	|O
.	|O

Relationship	|O
of	|O
mast	|O
cells	|O
to	|O
sarcoidosis	|O
granuloma	|O
of	|O
the	|O
skin	|O

Long	|O
-	|O
term	|O
effects	|O
of	|O
clofibrate	|O
(	|O
Atromid	|O
-	|O
S	|O
)	|O
on	|O
serum	|O
lipids	|O
in	|O
man	|O
.	|O

Phosphate	|B-PROTEIN
glucose	|I-PROTEIN
dehydrogenase	|I-PROTEIN
deficiency	|O
causing	|O
hyperbilirubinemia	|O
in	|O
the	|O
newborn	|O

Evidence	|O
forthe	|O
electroosmosis	|O
theory	|O
of	|O
transport	|O
in	|O
the	|O
phloem	|O
.	|O

Effects	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptor	|I-PROTEIN
blockade	|O
on	|O
airway	|O
conductance	|O
and	|O
lung	|O
volume	|O
in	|O
normal	|O
and	|O
asthmatic	|O
subjects	|O
.	|O

Effect	|O
of	|O
heparin	|O
on	|O
the	|O
inactivation	|O
of	|O
serum	|O
lipoprotein	|O
lipase	|B-PROTEIN
by	|O
the	|O
liver	|O
in	|O
unanesthetized	|O
dogs	|O
.	|O

Experimental	|O
chlorpromazine	|O
cataracts	|O
.	|O

I.	|O

Specialist	|O
in	|O
family	|O
practice	|O
-	|O
-	|O
prototype	|O
of	|O
a	|O
doctor	|O
.	|O

The	|O
possibility	|O
of	|O
selective	|O
chemotherapy	|O
of	|O
progressive	|O
recurring	|O
ovarian	|O
carcinoma	|O
with	|O
the	|O
aid	|O
of	|O
cytodiagnosis	|O
and	|O
incorporation	|O
of	|O
tagged	|O
idoxuridine	|O

Variation	|O
in	|O
the	|O
temporal	|O
-	|O
spatial	|O
distribution	|O
of	|O
228Ra	|O
and	|O
224Ra	|O
in	|O
the	|O
RES	|O
and	|O
marrow	|O
-	|O
free	|O
skeleton	|O
after	|O
incorporation	|O
of	|O
colloidal	|O
ThO2	|O

Oxidative	|O
degradation	|O
of	|O
adrenaline	|O
solutions	|O
:	|O
study	|O
of	|O
the	|O
intermediate	|O
stages	|O
and	|O
their	|O
analytic	|O
value	|O
for	|O
the	|O
control	|O
of	|O
this	|O
solute	|O

Absorption	|O
of	|O
electrolytes	|O
from	|O
the	|O
colon	|O
in	|O
cases	|O
of	|O
ulcerative	|O
colitis	|O
and	|O
in	|O
control	|O
subjects	|O
.	|O

Ion	|O
injection	|O
.	|O

Polyvinyl	|O
alcohol	|O
as	|O
a	|O
solution	|O
mediator	|O

Mining	|O
the	|O
diagnostic	|O
iron	|O
ore	|O
.	|O

The	|O
structure	|O
of	|O
digiprogenin	|O
.	|O

The	|O
need	|O
in	|O
the	|O
small	|O
hospital	|O
.	|O

I.	|O

On	|O
the	|O
character	|O
of	|O
changes	|O
in	|O
the	|O
enzyme	|O
activity	|O
in	|O
the	|O
brain	|O
tissue	|O
during	|O
reflex	|O
epilepsy	|O

A	|O
malignant	|O
true	|O
teratoma	|O
of	|O
liver	|O
in	|O
childhood	|O
.	|O

Methoxyflurane	|O
and	|O
renal	|O
function	|O

Histochemistry	|O
and	|O
electron	|O
microscopy	|O
of	|O
acute	|O
liver	|O
lesions	|O
induced	|O
by	|O
Aflatoxin	|O
B1	|O
in	|O
ducklings	|O
.	|O

Functional	|O
disorders	|O
of	|O
the	|O
ureter	|O
following	|O
gynecologic	|O
surgery	|O

Study	|O
of	|O
the	|O
alterations	|O
of	|O
intestinal	|O
absorption	|O
,	|O
by	|O
means	|O
of	|O
I	|O
-	|O
131	|O
-	|O
triolein	|O
,	|O
in	|O
the	|O
whole	|O
body	|O
irradiated	|O
rat	|O

Chemical	|O
histologic	|O
and	|O
immunologic	|O
responses	|O
in	|O
rats	|O
to	|O
CC1	|O
-	|O
4	|O
by	|O
different	|O
routes	|O
of	|O
administration	|O
.	|O

Clinical	|O
trials	|O
with	|O
1,3	|O
-	|O
bis	|O
(	|O
2	|O
-	|O
chloroethyl	|O
)	|O
-	|O
1	|O
-	|O
nitrosourea	|O
,	|O
NSC	|O
-	|O
409962	|O
.	|O

Hydroxypropyl	|O
methacrylate	|O
,	|O
a	|O
new	|O
water	|O
-	|O
miscible	|O
embedding	|O
medium	|O
for	|O
electron	|O
microscopy	|O
.	|O

Statistics	|O
of	|O
the	|O
past	|O
5	|O
years	|O

On	|O
the	|O
diagnosis	|O
of	|O
bovine	|O
leucosis	|O
and	|O
its	|O
control	|O
in	|O
southern	|O
Lower	|O
Saxony	|O

Experience	|O
with	|O
the	|O
restoration	|O
of	|O
agglutination	|O
properties	|O
of	|O
non	|O
-	|O
agglutinating	|O
dysenterial	|O
cultures	|O
with	|O
the	|O
use	|O
of	|O
Rzhaninov	|O
's	|O
method	|O

Study	|O
on	|O
micromelias	|O
in	|O
the	|O
mouse	|O
fetus	|O
caused	|O
by	|O
x	|O
-	|O
radiation	|O
,	|O
hypoxia	|O
,	|O
trypan	|O
blue	|O
injection	|O
of	|O
hypervitaminosis	|O
-	|O
A	|O
upon	|O
mother	|O
animals	|O
during	|O
pregnancy	|O
.	|O

Human	|O
antitetanus	|O
serum	|O
:	|O
an	|O
unused	|O
wealth	|O

(	|O
3	|O
)	|O
.	|O

Studies	|O
on	|O
the	|O
intracutaneous	|O
infection	|O
of	|O
rabbits	|O
by	|O
Staphylococcus	|O
aureus	|O
.	|O

On	|O
catabolism	|O
of	|O
aminoketones	|O
in	|O
climacteric	|O
age	|O

The	|O
effect	|O
of	|O
feeding	|O
patterns	|O
on	|O
fat	|O
deposition	|O
in	|O
mice	|O
.	|O

Naphthalene	|O
and	|O
paradichlorobenzene	|O
in	|O
clinical	|O
toxicology	|O

IV	|O
.	|O

Studies	|O
on	|O
powdered	|O
preparations	|O
.	|O

A	|O
case	|O
report	|O
with	|O
angiographic	|O
follow	|O
-	|O
up	|O
study	|O
.	|O

Interactions	|O
between	|O
adrenergics	|O
,	|O
adrenolytics	|O
and	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
inhibitors	|O

Further	|O
studies	|O
on	|O
a	|O
"	|O
new	|O
"	|O
human	|O
isoprecipitin	|B-PROTEIN
system	|O
(	|O
Australia	|O
antigen	|O
)	|O
.	|O

Pigmentary	|O
rhythms	|O
as	|O
indicators	|O
of	|O
neurosecretion	|O
.	|O

Story	|O
of	|O
a	|O
hospital	|O
that	|O
filmed	|O
its	|O
employee	|O
orientation	|O
program	|O
.	|O

When	|O
the	|O
cervical	|O
Pap	|O
smear	|O
is	|O
positive	|O
.	|O

I.	|O

The	|O
3	|O
-	|O
hour	|O
test	|O
iodine	|O
(	|O
I	|O
-	|O
132	|O
)	|O
uptake	|O
by	|O
the	|O
thyroid	|O
in	|O
children	|O
with	|O
growth	|O
deficiency	|O

Persistence	|O
of	|O
toxaphene	|O
in	|O
treated	|O
lakes	|O
.	|O

Studies	|O
on	|O
Coxsackie	|O
B	|O
Type	|O
5	|O
virus	|O
infections	|O
.	|O

Value	|O
of	|O
the	|O
method	|O
of	|O
passive	|O
hemagglutination	|O
with	|O
polysaccharide	|O
C	|O
in	|O
detecting	|O
C	|B-PROTEIN
-	|I-PROTEIN
reactive	|I-PROTEIN
protein	|I-PROTEIN
as	|O
compared	|O
to	|O
precipitation	|O
in	|O
capillaries	|O
and	|O
slide	|O
latex	|O
test	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
CRP	|I-PROTEIN
serum	|O

Adrenergic	|O
nerve	|O
function	|O
,	|O
noradrenaline	|O
level	|O
and	|O
noradrenaline	|O
uptake	|O
in	|O
cat	|O
nictitating	|O
membrane	|O
after	|O
reserpine	|O
treatment	|O
.	|O

Concussion	|O
of	|O
the	|O
spinal	|O
cord	|O

Study	|O
on	|O
the	|O
evagination	|O
of	|O
Cysticercus	|O
pisiformis	|O
.	|O

Antimicrobial	|O
substance	|O
isolated	|O
from	|O
an	|O
acorn	|O
extract	|O
.	|O

The	|O
pathogenicity	|O
of	|O
Achromobacter	|O
puntatum	|O
for	|O
cold	|O
blooded	|O
and	|O
warm	|O
blooded	|O
animals	|O

Consanguinity	|O
and	|O
migration	|O
in	|O
the	|O
marriages	|O
of	|O
the	|O
region	|O
of	|O
Nunoa	|O
,	|O
Santiago	|O
,	|O
1850-1960	|O

On	|O
the	|O
amount	|O
and	|O
significance	|O
of	|O
the	|O
effective	|O
glucose	|O
level	|O
in	|O
tumors	|O
.	|O

Studies	|O
of	|O
lipogenesis	|O
by	|O
labelled	|O
precursors	|O
in	|O
the	|O
pregnant	|O
rat	|O
.	|O

Pharmacodynamic	|O
studies	|O
on	|O
the	|O
cardiovascular	|O
system	|O
of	|O
spontaneously	|O
hypertensive	|O
rats	|O
.	|O

Nuclear	|O
spin	|O
of	|O
249Bk	|O
from	|O
the	|O
hyperfine	|O
structure	|O
in	|O
its	|O
emission	|O
spectrum	|O
.	|O

Further	|O
observations	|O
on	|O
resorption	|O
in	|O
guinea	|O
pigs	|O
following	|O
injections	|O
of	|O
trypan	|O
blue	|O
.	|O

Derivatives	|O
of	|O
fluorene	|O
.	|O

Note	|O
on	|O
Slot	|O
's	|O
method	|O
for	|O
the	|O
specific	|O
determination	|O
of	|O
creatinine	|O
.	|O

Retention	|O
behavior	|O
of	|O
steroids	|O
in	|O
gas	|O
chromatography	|O
with	|O
a	|O
series	|O
of	|O
combination	|O
columns	|O
.	|O

Compensatory	|O
renal	|O
hypertrophy	|O
in	|O
parabiotic	|O
rats	|O
.	|O

(	|O
3	|O
)	|O
.	|O

XXI	|O
.	|O

In	|O
vitro	|O
evaluation	|O
of	|O
the	|O
mucolytic	|O
action	|O
of	|O
urea	|O
.	|O

Electrophoretic	|O
characteriaztion	|O
of	|O
virus	|O
-	|O
induced	|O
interferon	|B-PROTEIN
of	|O
the	|O
blood	|O
and	|O
urine	|O
in	|O
rabbits	|O

Iron	|O
and	|O
folate	|O
deficiency	|O
in	|O
pregnancy	|O

Symposium	|O
on	|O
presenile	|O
spongy	|O
encephalopathies	|O
.	|O

Twenty	|O
-	|O
two	|O
of	|O
the	|O
24	|O
patients	|O
had	|O
a	|O
rise	|O
in	|O
the	|O
total	|O
serum	|O
amylase	|B-PROTEIN
following	|O
ERCP	|O
.	|O

The	|O
immuno	|O
-	|O
purified	|O
mRNA	|O
in	|O
the	|O
polysome	|O
complex	|O
was	|O
used	|O
to	|O
prepare	|O
cDNA	|O
with	|O
which	|O
to	|O
probe	|O
a	|O
D.	|O
melanogaster	|O
genomic	|O
library	|O
.	|O

Elevated	|O
maternal	|O
alpha	|B-PROTEIN
fetoproteins	|I-PROTEIN
and	|O
oligoamnios	|O
:	|O
fetal	|O
prognosis	|O

Also	|O
discussed	|O
is	|O
the	|O
possibility	|O
of	|O
a	|O
combined	|O
genetic	|O
and	|O
environmental	|O
etiology	|O
.	|O

Courses	|O
were	|O
repeated	|O
monthly	|O
upon	|O
recovery	|O
of	|O
myelosuppression	|O
.	|O

Stimulation	|O
with	|O
MCh	|O
produced	|O
a	|O
Ca	|O
-	|O
dependent	|O
transient	|O
elevation	|O
of	|O
cGMP	|O
level	|O
from	|O
10	|O
to	|O
80	|O
fmol	|O
/	|O
gland	|O
,	|O
peaking	|O
at	|O
1-2	|O
min	|O
but	|O
returning	|O
to	|O
the	|O
basal	|O
level	|O
by	|O
5	|O
min	|O
.	|O

Two	|O
hundred	|O
forty	|O
-	|O
three	|O
patients	|O
have	|O
received	|O
WR	|O
-	|O
2721	|O
in	|O
Phase	|O
I	|O
-	|O
II	|O
studies	|O
.	|O

The	|O
PEPCK	|B-PROTEIN
promoter	|O
fragment	|O
was	|O
introduced	|O
either	|O
in	|O
the	|O
proper	|O
orientation	|O
for	|O
transcription	|O
of	|O
the	|O
TK	|B-PROTEIN
gene	|O
or	|O
in	|O
the	|O
opposite	|O
orientation	|O
.	|O

Many	|O
mammary	|O
tumors	|O
induced	|O
by	|O
mouse	|O
mammary	|O
tumor	|O
virus	|O
(	|O
MMTV	|O
)	|O
contain	|O
a	|O
provirus	|O
in	|O
the	|O
same	|O
region	|O
of	|O
the	|O
host	|O
-	|O
cell	|O
genome	|O
,	|O
leading	|O
to	|O
expression	|O
of	|O
a	|O
putative	|O
cellular	|O
oncogene	|O
called	|O
int	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

In	|O
these	|O
cases	|O
,	|O
asbestos	|O
or	|O
erionite	|O
-	|O
tissue	|O
burden	|O
followed	|O
by	|O
fibrosis	|O
was	|O
frequently	|O
observed	|O
.	|O

Hepatitis	|O
B	|O
virus	|O
and	|O
hepatoma	|O
.	|O

Eight	|O
recombinant	|O
DNA	|O
clones	|O
of	|O
endogenous	|O
murine	|O
leukemia	|O
virus	|O
(	|O
MuLV	|O
)	|O
-	|O
related	|O
DNA	|O
sequences	|O
have	|O
been	|O
isolated	|O
from	|O
a	|O
lambdaphage	|O
genomic	|O
library	|O
of	|O
Balb	|O
/	|O
c	|O
mouse	|O
DNA	|O
.	|O

USA	|O
80	|O
,	|O
3618-3622	|O
)	|O
The	|O
two	|O
proteins	|O
show	|O
36%	|O
identities	|O
in	|O
their	|O
amino	|O
acid	|O
sequence	|O
,	|O
in	|O
an	|O
alignment	|O
requiring	|O
six	|O
gaps	|O
.	|O

The	|O
envelope	|B-PROTEIN
glycoproteins	|O
of	|O
Rous	|O
sarcoma	|O
virus	|O
(	|O
RSV	|O
)	|O
,	|O
gp85	|B-PROTEIN
and	|O
gp37	|B-PROTEIN
,	|O
are	|O
anchored	|O
in	|O
the	|O
membrane	|O
by	|O
a	|O
27	|O
-	|O
amino	|O
acid	|O
,	|O
hydrophobic	|O
domain	|O
that	|O
lies	|O
adjacent	|O
to	|O
a	|O
22	|O
-	|O
amino	|O
acid	|O
,	|O
cytoplasmic	|O
domain	|O
at	|O
the	|O
carboxy	|O
terminus	|O
of	|O
gp37	|B-PROTEIN
.	|O

The	|O
drug	|O
was	|O
given	|O
in	|O
a	|O
daily	|O
oral	|O
dose	|O
of	|O
0.5	|O
g	|O
/	|O
m2	|O
,	|O
3.5	|O
h	|O
prior	|O
to	|O
each	|O
radiation	|O
treatment	|O
.	|O

Histogenetic	|O
aspects	|O
of	|O
mesoblastic	|O
nephroma	|O
.	|O

Effect	|O
of	|O
acute	|O
and	|O
chronic	|O
psychogenic	|O
stress	|O
on	|O
corticoadrenal	|O
and	|O
pituitary	|B-PROTEIN
-	|I-PROTEIN
thyroid	|I-PROTEIN
hormones	|I-PROTEIN
in	|O
male	|O
rats	|O
.	|O

Mature	|O
mRNA	|O
for	|O
cytosolic	|O
phosphoenolpyruvate	|B-PROTEIN
carboxykinase	|I-PROTEIN
of	|O
the	|O
chicken	|O
is	|O
2.8	|O
kilobases	|O
in	|O
length	|O
,	|O
similar	|O
to	|O
that	|O
previously	|O
noted	|O
for	|O
mRNA	|O
coding	|O
for	|O
the	|O
same	|O
enzyme	|O
in	|O
the	|O
rat	|O
.	|O

Upstream	|O
activation	|O
sites	|O
of	|O
the	|O
CYC1	|B-PROTEIN
gene	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
are	|O
active	|O
when	|O
inverted	|O
but	|O
not	|O
when	|O
placed	|O
downstream	|O
of	|O
the	|O
"	|O
TATA	|O
box	|O
"	|O
.	|O

An	|O
intact	|O
5.7	|O
-	|O
kb	|O
provirus	|O
of	|O
the	|O
avian	|O
erythroblastosis	|O
virus	|O
E26	|O
has	|O
been	|O
molecularly	|O
cloned	|O
for	|O
comparisons	|O
with	|O
avian	|O
myeloblastosis	|O
virus	|O
(	|O
AMV	|O
)	|O
and	|O
other	|O
avian	|O
tumor	|O
viruses	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
haloperidol	|O
selectively	|O
reduced	|O
the	|O
animal	|O
's	|O
capacity	|O
to	|O
'	|O
programme	|O
non	|O
-	|O
stimulus	|O
directed	|O
motor	|O
behaviour	|O
'	|O
.	|O

Neither	|O
side	|O
effect	|O
nor	|O
abnormal	|O
laboratory	|O
findings	|O
due	|O
to	|O
this	|O
drug	|O
were	|O
observed	|O
.	|O

The	|O
results	|O
presented	|O
in	|O
this	|O
report	|O
suggest	|O
that	|O
the	|O
SV40	|O
G	|O
-	|O
C	|O
-	|O
rich	|O
sequences	|O
can	|O
function	|O
as	|O
independent	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
transcriptional	|O
-	|O
control	|O
elements	|O
.	|O

Construction	|O
of	|O
human	|O
cell	|O
lines	|O
which	|O
contain	|O
and	|O
express	|O
the	|O
adenovirus	|O
DNA	|O
binding	|O
protein	|O
gene	|O
by	|O
cotransformation	|O
with	|O
the	|O
HSV	|O
-	|O
1	|O
tk	|B-PROTEIN
gene	|O
.	|O

Diagnosis	|O
and	|O
treatment	|O
of	|O
insulin	|B-PROTEIN
-	|O
secreting	|O
tumours	|O
.	|O

Theories	|O
proffered	|O
to	|O
account	|O
for	|O
the	|O
modality	|O
shift	|O
effect	|O
are	|O
critically	|O
evaluated	|O
.	|O

The	|O
effects	|O
of	|O
cardioselective	|O
beta	|O
-	|O
1	|O
adrenergic	|O
agonist	|O
,	|O
1	|O
-	|O
(	|O
4	|O
-	|O
hydroxyphenoxy	|O
)	|O
-	|O
isopropylamino	|O
-	|O
2	|O
-	|O
propanol	|O
)	|O
,	|O
i.e.	|O
,	|O
prenalterol	|O
,	|O
were	|O
examined	|O
on	|O
direct	|O
and	|O
continuous	|O
measurements	|O
of	|O
left	|O
ventricular	|O
(	|O
LV	|O
)	|O
pressure	|O
,	|O
diameter	|O
,	|O
dP	|O
/	|O
dt	|O
,	|O
velocity	|O
of	|O
shortening	|O
,	|O
arterial	|O
pressure	|O
,	|O
iliac	|O
blood	|O
flow	|O
and	|O
heart	|O
rate	|O
in	|O
10	|O
conscious	|O
dogs	|O
.	|O

Endorphins	|B-PROTEIN
at	|O
the	|O
approach	|O
of	|O
death	|O
.	|O

Trial	|O
treatment	|O
of	|O
schizophrenia	|O
with	|O
des	|B-PROTEIN
-	|I-PROTEIN
Tyr	|I-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
-	|I-PROTEIN
endorphin	|I-PROTEIN

Cardiac	|O
taurine	|O
levels	|O
and	|O
sarcolemmal	|O
calcium	|O
binding	|O
activity	|O
in	|O
furazolidone	|O
-	|O
induced	|O
cardiomyopathy	|O
.	|O

Separation	|O
of	|O
malaria	|O
-	|O
infected	|O
erythrocytes	|O
from	|O
whole	|O
blood	|O
:	|O
use	|O
of	|O
a	|O
selective	|O
high	|O
-	|O
gradient	|O
magnetic	|O
separation	|O
technique	|O
.	|O

The	|O
roll	|O
-	|O
over	|O
test	|O
to	|O
predict	|O
toxemia	|O
in	|O
pregnancy	|O
.	|O

Can	|O
thyroglobulin	|B-PROTEIN
assay	|O
really	|O
supplant	|O
radioiodine	|O
scans	|O
in	|O
patients	|O
with	|O
differentiated	|O
thyroid	|O
cancer	|O
?	|O

3	|O
Significant	|O
reductions	|O
in	|O
lying	|O
mean	|O
arterial	|O
blood	|O
pressure	|O
were	|O
observed	|O
with	|O
daily	|O
doses	|O
of	|O
200	|O
mg	|O
(	|O
-	|O
9%	|O
)	|O
,	|O
400	|O
mg	|O
(	|O
-	|O
10%	|O
)	|O
and	|O
800	|O
mg	|O
(	|O
-	|O
14%	|O
)	|O
,	|O
and	|O
were	|O
associated	|O
with	|O
significant	|O
decreases	|O
in	|O
heart	|O
rate	|O
and	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
.	|O

Isolation	|O
of	|O
Aeromonas	|O
from	|O
faeces	|O
.	|O

Plasma	|O
and	|O
erthrocyte	|O
lipid	|O
profile	|O
and	|O
lipoprotein	|O
lipase	|B-PROTEIN
activity	|O
in	|O
postheparin	|O
plasma	|O
on	|O
vasectomized	|O
rabbits	|O
were	|O
studied	|O
and	|O
also	|O
the	|O
incidence	|O
of	|O
atherosclerosis	|O
in	|O
different	|O
arterial	|O
beds	|O
.	|O

(	|O
iii	|O
)	|O
The	|O
mRNA	|O
is	|O
not	|O
efficiently	|O
polyadenylated	|O
at	|O
sequences	|O
in	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
DHFR	|B-PROTEIN
cDNA	|O
but	|O
rather	|O
uses	|O
polyadenylation	|O
signals	|O
downstream	|O
from	|O
the	|O
DHFR	|B-PROTEIN
cDNA	|O
.	|O

At	|O
both	|O
water	|O
temperatures	|O
,	|O
VO2	|O
increased	|O
linearly	|O
with	|O
increasing	|O
swimming	|O
velocity	|O
.	|O

Propranolol	|O
also	|O
effectively	|O
controlled	|O
her	|O
familial	|O
tremor	|O
.	|O

Brief	|O
report	|O
.	|O

The	|O
distribution	|O
phase	|O
is	|O
followed	|O
by	|O
an	|O
elimination	|O
phase	|O
with	|O
a	|O
much	|O
longer	|O
half	|O
-	|O
life	|O
(	|O
mean	|O
value	|O
375	|O
min	|O
)	|O
and	|O
a	|O
volume	|O
of	|O
distribution	|O
of	|O
approximately	|O
200-400	|O
l	|O
.	|O

Hybrid	|O
-	|O
selection	|O
experiments	|O
against	|O
total	|O
PB	|O
-	|O
inducible	|O
RNA	|O
were	|O
performed	|O
with	|O
plasmid	|O
DNA	|O
derived	|O
from	|O
clones	|O
enriched	|O
in	|O
PB	|O
-	|O
inducible	|O
information	|O
.	|O

Risk	|O
of	|O
HTLV	|O
infection	|O
in	|O
patients	|O
on	|O
haemodialysis	|O
.	|O

In	|O
vitro	|O
metabolism	|O
of	|O
progesterone	|O
by	|O
the	|O
human	|O
undescended	|O
testis	|O
.	|O

Two	|O
patients	|O
withdrew	|O
from	|O
therapy	|O
,	|O
one	|O
for	|O
personal	|O
reasons	|O
and	|O
one	|O
because	|O
a	|O
paraspinal	|O
mass	|O
developed	|O
.	|O

All	|O
patients	|O
received	|O
VCR	|O
1.0	|O
mg	|O
/	|O
m2	|O
weekly	|O
for	|O
6	|O
weeks	|O
with	|O
dose	|O
modification	|O
for	|O
neurotoxicity	|O
.	|O

Glutamic	|O
acid	|O
in	|O
a	|O
dose	|O
of	|O
1/100	|O
of	|O
the	|O
LD50	|O
was	|O
injected	|O
in	|O
the	|O
form	|O
of	|O
sodium	|O
salt	|O
into	|O
male	|O
and	|O
female	|O
Wistar	|O
rats	|O
for	|O
7	|O
days	|O
after	|O
8	|O
-	|O
and	|O
12	|O
-	|O
day	|O
injections	|O
of	|O
dexazone	|O
.	|O

Serum	|O
ascorbic	|O
acid	|O
had	|O
an	|O
inverse	|O
and	|O
the	|O
strongest	|O
association	|O
with	|O
systolic	|O
blood	|O
pressure	|O
among	|O
the	|O
risk	|O
factors	|O
including	|O
blood	|O
pressure	|O
,	|O
total	|O
cholesterol	|O
,	|O
triglyceride	|O
,	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
GTP	|I-PROTEIN
and	|O
obesity	|O
.	|O

Plasma	|O
secretin	|B-PROTEIN
,	|O
pancreozymin	|B-PROTEIN
,	|O
and	|O
somatostatin	|B-PROTEIN
-	|O
like	|O
hormone	|O
in	|O
chronic	|O
renal	|O
failure	|O
patients	|O
.	|O

Effect	|O
of	|O
bromazepam	|O
on	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
and	|O
prolactin	|B-PROTEIN
secretion	|O
in	|O
normal	|O
subjects	|O
.	|O

In	|O
several	|O
cases	|O
of	|O
definite	|O
SjS	|O
,	|O
labial	|O
salivary	|O
gland	|O
examinations	|O
after	|O
more	|O
than	|O
a	|O
one	|O
year	|O
interval	|O
were	|O
performed	|O
on	|O
two	|O
occasions	|O
,	|O
and	|O
the	|O
clinical	|O
and	|O
histopathological	|O
changes	|O
were	|O
investigated	|O
.	|O

All	|O
radiologists	|O
using	|O
the	|O
machine	|O
found	|O
that	|O
the	|O
reporting	|O
terminal	|O
was	|O
simple	|O
to	|O
operate	|O
,	|O
but	|O
found	|O
that	|O
reporting	|O
abnormalities	|O
caused	|O
an	|O
increased	|O
effort	|O
and	|O
took	|O
a	|O
longer	|O
time	|O
.	|O

Thalamotomy	|O
aiming	|O
at	|O
the	|O
CM	|O
-	|O
Pf	|O
complex	|O
and	|O
using	|O
stereotactic	|O
gamma	|O
irradiation	|O
has	|O
been	|O
performed	|O
in	|O
a	|O
series	|O
of	|O
52	|O
patients	|O
with	|O
severe	|O
pain	|O
due	|O
to	|O
malignancy	|O
.	|O

2	|O
Silastic	|O
capsules	|O
,	|O
each	|O
containing	|O
22-23	|O
mg	|O
of	|O
ethinyl	|O
estradiol	|O
,	|O
were	|O
inserted	|O
subcutaneously	|O
in	|O
5	|O
men	|O
with	|O
benign	|O
prostatic	|O
hypertrophy	|O
.	|O

When	|O
used	|O
subcutaneously	|O
or	|O
intravenously	|O
in	|O
maximum	|O
tolerated	|O
doses	|O
the	|O
antibiotic	|O
inhibited	|O
the	|O
development	|O
of	|O
lymphadenosis	|O
NK	|O
/	|O
Li	|O
by	|O
90	|O
and	|O
70	|O
per	|O
cent	|O
respectively	|O
.	|O

Effect	|O
of	|O
2	|O
-	|O
(	|O
p	|O
-	|O
chlorophenyl	|O
)	|O
cyclopropylamine	|O
on	|O
5	|O
-	|O
hydroxyindole	|O
concentration	|O
and	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
activity	|O
in	|O
rat	|O
brain	|O
.	|O

Then	|O
,	|O
pure	|O
pancreatic	|O
juice	|O
was	|O
infused	|O
into	|O
the	|O
duodenum	|O
.	|O

An	|O
experiment	|O
was	|O
carried	|O
on	|O
133	|O
grown	|O
up	|O
fowls	|O
and	|O
broilers	|O
from	|O
4	|O
industrial	|O
farms	|O
,	|O
vaccinated	|O
with	|O
spray	|O
lento	|O
and	|O
mesogenic	|O
vaccines	|O
for	|O
straining	|O
the	|O
immunity	|O
against	|O
pseodopest	|O
through	|O
RIHA	|O
and	|O
provoking	|O
pseudoplague	|O
with	|O
a	|O
pathogenic	|O
virus	|O
.	|O

(	|O
2	|O
)	|O
The	|O
inappropriateness	|O
of	|O
adaptive	|O
segmentation	|O
for	|O
the	|O
isolation	|O
of	|O
spikes	|O
and	|O
sharp	|O
waves	|O
,	|O
which	|O
had	|O
been	|O
anticipated	|O
in	|O
view	|O
of	|O
the	|O
short	|O
duration	|O
of	|O
such	|O
transients	|O
in	|O
relation	|O
to	|O
the	|O
length	|O
of	|O
the	|O
window	|O
(	|O
1.2	|O
sec	|O
)	|O
used	|O
for	|O
the	|O
autocorrelation	|O
functions	|O
employed	|O
in	|O
the	|O
segmentation	|O
algorithm	|O
,	|O
was	|O
confirmed	|O
.	|O

The	|O
ability	|O
of	|O
chronic	|O
UM	|O
-	|O
272	|O
(	|O
dimethylpropranolol	|O
)	|O
treatment	|O
to	|O
prevent	|O
the	|O
induction	|O
of	|O
reentrant	|O
ventricular	|O
tachyarrhythmias	|O
was	|O
assessed	|O
in	|O
the	|O
conscious	|O
dog	|O
subjected	|O
to	|O
serial	|O
programmed	|O
electrical	|O
stimulation	|O
on	|O
days	|O
3	|O
-	|O
-	|O
5	|O
after	|O
myocardial	|O
infarction	|O
.	|O

The	|O
effect	|O
of	|O
echothiophate	|O
on	|O
the	|O
biphasic	|O
response	|O
of	|O
rabbit	|O
ocular	|O
pressure	|O
to	|O
dipivefrin	|O
.	|O

In	|O
most	|O
cases	|O
of	|O
acute	|O
transmural	|O
infarction	|O
,	|O
the	|O
reciprocal	|O
ST	|O
segment	|O
depressions	|O
observed	|O
in	|O
contralateral	|O
leads	|O
are	|O
less	|O
marked	|O
than	|O
the	|O
primary	|O
ST	|O
segment	|O
elevations	|O
.	|O

Bacillus	|O
cereus	|O
cross	|O
-	|O
infection	|O
in	|O
a	|O
maternity	|O
-	|O
unit	|O
.	|O

We	|O
have	|O
followed	|O
37	|O
phenytoin	|O
-	|O
treated	|O
patients	|O
with	|O
reduced	|O
serum	|O
IgA	|B-PROTEIN
concentrations	|O
for	|O
2-7	|O
years	|O
.	|O

In	|O
the	|O
latter	|O
category	|O
particular	|O
emphasis	|O
is	|O
being	|O
placed	|O
on	|O
new	|O
anthracycline	|O
analogues	|O
of	|O
doxorubicin	|O
and	|O
analogues	|O
of	|O
cisplatinum	|O
diammine	|O
dichloride	|O
.	|O

Unusual	|O
course	|O
of	|O
plasmocytosis	|O
.	|O

Late	|O
mRNA	|O
selected	|O
by	|O
a	|O
cDNA	|O
homologous	|O
to	|O
the	|O
HindIII	|B-PROTEIN
-	|I-PROTEIN
P	|I-PROTEIN
/	|O
EcoRI	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
region	|O
of	|O
the	|O
AcNPV	|O
map	|O
directed	|O
the	|O
synthesis	|O
of	|O
31K	|O
and	|O
30K	|O
proteins	|O
which	|O
comigrated	|O
with	|O
the	|O
31K	|O
and	|O
30K	|O
proteins	|O
translated	|O
from	|O
RNA	|O
selected	|O
by	|O
the	|O
HindIII	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
/	|O
EcoRI	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
/	|O
SstI	|B-PROTEIN
-	|I-PROTEIN
G	|I-PROTEIN
cDNA	|O
.	|O

Intraoperatively	|O
the	|O
complement	|O
factor	|O
C3c	|B-PROTEIN
decreased	|O
by	|O
20%	|O
,	|O
while	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
antitrypsin	|I-PROTEIN
showed	|O
postoperatively	|O
an	|O
increase	|O
by	|O
30%	|O
.	|O

A	|O
polypeptide	|O
chain	|O
of	|O
34	|O
residues	|O
of	|O
the	|O
deduced	|O
yeast	|O
amino	|O
acid	|O
sequence	|O
closely	|O
resembles	|O
a	|O
peptide	|O
sequence	|O
at	|O
the	|O
ADP	|O
binding	|O
site	|O
of	|O
bovine	|O
muscle	|O
pyruvate	|B-PROTEIN
kinase	|I-PROTEIN
.	|O

The	|O
P165	|O
component	|O
,	|O
however	|O
,	|O
could	|O
be	|O
differentiated	|O
from	|O
the	|O
two	|O
later	|O
components	|O
since	|O
it	|O
increased	|O
in	|O
amplitude	|O
with	|O
increased	|O
task	|O
demands	|O
while	|O
the	|O
N2	|O
and	|O
P3	|O
amplitudes	|O
remained	|O
constant	|O
.	|O

Differential	|O
drawing	|O
size	|O
associated	|O
with	|O
unilateral	|O
brain	|O
damage	|O
.	|O

The	|O
intracoronary	|O
administration	|O
of	|O
both	|O
drugs	|O
markedly	|O
reduced	|O
the	|O
incidence	|O
of	|O
VF	|O
induced	|O
by	|O
the	|O
release	|O
of	|O
a	|O
40	|O
-	|O
min	|O
coronary	|O
artery	|O
occlusion	|O
.	|O

These	|O
fusions	|O
are	|O
contained	|O
on	|O
plasmids	|O
which	|O
have	|O
both	|O
yeast	|O
and	|O
E.	|O
coli	|O
replication	|O
origins	|O
and	|O
selectable	|O
markers	|O
and	|O
,	|O
therefore	|O
,	|O
can	|O
be	|O
used	|O
to	|O
transform	|O
either	|O
yeast	|O
or	|O
E.	|O
coli	|O
cells	|O
.	|O

Therefore	|O
,	|O
it	|O
was	|O
concluded	|O
that	|O
thrombotic	|O
tendency	|O
certainly	|O
existed	|O
in	|O
patients	|O
with	|O
MS	|O
compared	|O
to	|O
those	|O
with	|O
non	|O
RHD	|O
and	|O
that	|O
it	|O
was	|O
one	|O
of	|O
the	|O
causes	|O
of	|O
the	|O
significantly	|O
high	|O
incidence	|O
of	|O
thromboembolism	|O
in	|O
comparison	|O
with	|O
non	|O
RHD	|O
.	|O

Toxicity	|O
was	|O
significant	|O
in	|O
selected	|O
cases	|O
;	|O
three	|O
patients	|O
developed	|O
WBC	|O
counts	|O
less	|O
than	|O
1,000	|O
/	|O
mm3	|O
and	|O
one	|O
of	|O
these	|O
patients	|O
died	|O
with	|O
sepsis	|O
.	|O

Subdural	|O
electrodes	|O
may	|O
yield	|O
larger	|O
VEP	|O
amplitudes	|O
than	|O
skull	|O
or	|O
scalp	|O
electrodes	|O
.	|O

Products	|O
of	|O
immune	|O
cells	|O
such	|O
as	|O
transfer	|B-PROTEIN
factor	|I-PROTEIN
and	|O
lymphokines	|O
form	|O
the	|O
third	|O
and	|O
possibly	|O
most	|O
important	|O
group	|O
of	|O
immune	|O
-	|O
stimulating	|O
agents	|O
.	|O

Use	|O
of	|O
the	|O
immunofluorescence	|O
method	|O
for	|O
identification	|O
of	|O
enteroviruses	|O
in	|O
cell	|O
cultures	|O

This	|O
fraction	|O
is	|O
resistant	|O
to	|O
digestions	|O
by	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
and	|O
RNase	|B-PROTEIN
T1	|I-PROTEIN
and	|O
disappears	|O
completely	|O
upon	|O
alkali	|O
hydrolysis	|O
.	|O

The	|O
construction	|O
of	|O
a	|O
small	|O
library	|O
of	|O
mouse	|O
repetitive	|O
DNA	|O
has	|O
been	|O
previously	|O
reported	|O
(	|O
Pietras	|O
et	|O
al.	|O
,	|O
Nucleic	|O
Acids	|O
Res.	|O

No	|O
direct	|O
repeats	|O
flank	|O
the	|O
pseudogene	|O
in	|O
the	|O
U2/4	|B-PROTEIN
locus	|O
.	|O

The	|O
direct	|O
effects	|O
of	|O
transmitter	|O
release	|O
were	|O
(	|O
a	|O
)	|O
an	|O
early	|O
fall	|O
in	|O
MAP	|O
followed	|O
by	|O
a	|O
late	|O
pressor	|O
effect	|O
;	|O
and	|O
(	|O
b	|O
)	|O
an	|O
early	|O
bradycardia	|O
followed	|O
by	|O
a	|O
late	|O
tachycardia	|O
.	|O

At	|O
Cabras	|O
(	|O
Oristano	|O
)	|O
,	|O
a	|O
town	|O
characterized	|O
by	|O
a	|O
high	|O
incidence	|O
of	|O
thalassaemia	|O
and	|O
G6PD	|B-PROTEIN
deficiency	|O
less	|O
than	|O
half	|O
the	|O
people	|O
between	|O
18	|O
and	|O
35	|O
have	|O
a	|O
fair	|O
knowledge	|O
of	|O
genetic	|O
diseases	|O
and	|O
of	|O
their	|O
prevention	|O
.	|O

The	|O
number	|O
of	|O
elements	|O
and	|O
their	|O
sizes	|O
relative	|O
to	|O
the	|O
configuration	|O
were	|O
varied	|O
in	|O
a	|O
series	|O
of	|O
five	|O
experiments	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
overall	|O
chance	|O
that	|O
a	|O
patient	|O
would	|O
undergo	|O
ET	|O
was	|O
greater	|O
in	|O
a	|O
cycle	|O
in	|O
which	|O
more	|O
than	|O
one	|O
follicle	|O
20	|O
mm	|O
or	|O
larger	|O
was	|O
developing	|O
than	|O
in	|O
a	|O
cycle	|O
in	|O
which	|O
a	|O
single	|O
large	|O
follicle	|O
was	|O
developing	|O
.	|O

Experience	|O
with	|O
the	|O
tensor	|O
fasciae	|O
latae	|O
free	|O
flap	|O
.	|O

Five	|O
of	|O
the	|O
patients	|O
with	|O
increased	|O
L	|O
-	|O
L	|O
size	|O
had	|O
a	|O
normal	|O
A	|O
-	|O
P	|O
diameter	|O
.	|O

Immunochemotherapy	|O
with	|O
schizophyllan	|O
(	|O
SPG	|O
)	|O
combined	|O
with	|O
chemotherapeutic	|O
agents	|O
was	|O
evaluated	|O
in	|O
two	|O
syngeneic	|O
tumor	|O
-	|O
C3H	|O
/	|O
He	|O
mouse	|O
systems	|O
.	|O

However	|O
,	|O
when	|O
combined	|O
with	|O
mitomycin	|O
C	|O
given	|O
with	|O
1	|O
to	|O
5	|O
-	|O
days	|O
interval	|O
,	|O
the	|O
concurrent	|O
administration	|O
of	|O
SPG	|O
prolonged	|O
significantly	|O
the	|O
life	|O
-	|O
span	|O
of	|O
the	|O
tumor	|O
-	|O
bearing	|O
mice	|O
.	|O

Data	|O
are	|O
presented	|O
hinting	|O
that	|O
the	|O
15	|O
beta	|O
-	|O
hydroxy	|O
-	|O
,	|O
metabolite	|O
of	|O
CPA	|O
may	|O
actually	|O
be	|O
the	|O
biologically	|O
active	|O
agent	|O
.	|O

The	|O
abluminal	|O
surface	|O
is	|O
often	|O
almost	|O
entirely	|O
encircled	|O
by	|O
a	|O
thick	|O
layer	|O
of	|O
fibrillary	|O
connective	|O
tissue	|O
.	|O

In	|O
contrast	|O
,	|O
in	|O
LL	|O
patients	|O
during	|O
ENL	|O
the	|O
ConA	|B-PROTEIN
-	|O
induced	|O
suppressor	|O
response	|O
was	|O
markedly	|O
reduced	|O
.	|O

Functional	|O
characterization	|O
of	|O
a	|O
fraction	|O
identified	|O
by	|O
its	|O
activity	|O
in	|O
a	|O
second	|O
template	|O
rescue	|O
assay	|O
.	|O

It	|O
has	|O
been	|O
established	|O
that	|O
preoperative	|O
irradiation	|O
in	|O
the	|O
form	|O
of	|O
the	|O
fractionation	|O
of	|O
a	|O
single	|O
focal	|O
dose	|O
of	|O
6	|O
Gy	|O
every	|O
other	|O
day	|O
,	|O
the	|O
summary	|O
dose	|O
of	|O
24	|O
Gy	|O
within	|O
8-10	|O
days	|O
followed	|O
by	|O
surgery	|O
1-3	|O
days	|O
after	|O
irradiation	|O
does	|O
not	|O
either	|O
complicate	|O
its	|O
performance	|O
or	|O
the	|O
course	|O
of	|O
the	|O
postoperative	|O
period	|O
,	|O
and	|O
by	|O
the	|O
short	|O
-	|O
and	|O
long	|O
-	|O
term	|O
results	|O
it	|O
is	|O
no	|O
worse	|O
than	|O
the	|O
routine	|O
dose	|O
fractionation	|O
.	|O

Fibrin	|B-PROTEIN
gels	|O
and	|O
their	|O
possible	|O
implication	|O
for	|O
surface	|O
hemorheology	|O
in	|O
health	|O
and	|O
disease	|O
.	|O

Hepatitis	|O
-	|O
B	|O
vaccination	|O
in	|O
the	|O
elderly	|O
.	|O

Radiogallium	|O
imaging	|O
is	|O
thus	|O
of	|O
limited	|O
use	|O
in	|O
evaluation	|O
of	|O
suspected	|O
giant	|O
cell	|O
tumors	|O
of	|O
bone	|O
.	|O

The	|O
customary	|O
coupling	|O
reagent	|O
sulfanilic	|O
acid	|O
has	|O
been	|O
replaced	|O
by	|O
1,3	|O
-	|O
dimethylbarbituric	|O
acid	|O
;	|O
CNCl	|O
is	|O
produced	|O
in	|O
the	|O
flow	|O
through	|O
system	|O
directly	|O
from	|O
KCN	|O
and	|O
chloramine	|O
T.	|O

Ventricular	|O
volume	|O
stiffness	|O
vs.	|O
the	|O
mean	|O
wall	|O
stress	|O
relationship	|O
of	|O
LVH	|O
shifted	|O
upward	|O
,	|O
whereas	|O
the	|O
normalized	|O
wall	|O
muscle	|O
stiffness	|O
vs.	|O
the	|O
mean	|O
wall	|O
stress	|O
relationship	|O
of	|O
LVH	|O
showed	|O
a	|O
smaller	|O
slope	|O
.	|O

Synthesis	|O
of	|O
(	|O
+	|O
)	|O
-	|O
lysergic	|O
acid	|O
diethylamide	|O
tartrate	|O

Weight	|O
loss	|O
reduces	|O
arterial	|O
pressure	|O
by	|O
a	|O
decrease	|O
in	|O
intravascular	|O
volume	|O
and	|O
cardiac	|O
output	|O
associated	|O
with	|O
a	|O
fall	|O
in	|O
sympathetic	|O
activity	|O
.	|O

The	|O
effect	|O
of	|O
treatment	|O
may	|O
thus	|O
be	|O
divided	|O
into	|O
two	|O
main	|O
phases	|O
-	|O
-	|O
an	|O
initial	|O
phase	|O
with	|O
a	|O
reduction	|O
in	|O
LV	|O
mass	|O
and	|O
a	|O
reduction	|O
in	|O
cardiac	|O
output	|O
and	|O
no	|O
change	|O
in	|O
total	|O
peripheral	|O
resistance	|O
-	|O
-	|O
and	|O
a	|O
second	|O
phase	|O
with	|O
a	|O
constant	|O
LV	|O
mass	|O
but	|O
an	|O
increase	|O
in	|O
cardiac	|O
output	|O
to	|O
the	|O
pretreatment	|O
level	|O
again	|O
and	|O
a	|O
concomitant	|O
decrease	|O
in	|O
total	|O
peripheral	|O
resistance	|O
.	|O

This	|O
study	|O
was	|O
undertaken	|O
to	|O
assess	|O
the	|O
effects	|O
of	|O
hypothermia	|O
and	|O
chemical	|O
cardioplegia	|O
on	|O
the	|O
functional	|O
recovery	|O
of	|O
hypertrophied	|O
non	|O
-	|O
failing	|O
rat	|O
hearts	|O
subjected	|O
to	|O
an	|O
extended	|O
period	|O
of	|O
global	|O
ischaemia	|O
.	|O

Oxygen	|O
profiles	|O
calculated	|O
for	|O
the	|O
Krogh	|O
model	|O
with	|O
excentric	|O
diffusion	|O
were	|O
similar	|O
to	|O
those	|O
derived	|O
for	|O
the	|O
two	|O
models	|O
of	|O
concentric	|O
diffusion	|O
.	|O

Cultivation	|O
technics	|O
for	|O
Codonopsis	|O
pilosula	|O

Radioimmunoassay	|O
of	|O
serum	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
B	|I-PROTEIN
isoenzyme	|O
in	|O
the	|O
diagnosis	|O
of	|O
acute	|O
myocardial	|O
infarction	|O
.	|O

Selective	|O
macrophage	|O
inhibition	|O
abolishes	|O
warfarin	|O
-	|O
induced	|O
reduction	|O
of	|O
metastasis	|O
.	|O

Restriction	|O
enzyme	|O
and	|O
heteroduplex	|O
analyses	|O
confirmed	|O
that	|O
sequences	|O
unique	|O
to	|O
FeSV	|O
(	|O
src	|B-PROTEIN
sequences	|O
)	|O
are	|O
located	|O
at	|O
the	|O
center	|O
of	|O
the	|O
FeSV	|O
genome	|O
and	|O
are	|O
approximately	|O
1.5	|O
kilobase	|O
pairs	|O
in	|O
length	|O
.	|O

Among	|O
six	|O
different	|O
library	|O
isolates	|O
containing	|O
6.5	|O
-	|O
to	|O
7	|O
-	|O
kb	|O
IAP	|B-PROTEIN
units	|O
,	|O
some	|O
restriction	|O
sites	|O
were	|O
highly	|O
conserved	|O
whereas	|O
others	|O
varied	|O
in	|O
both	|O
occurrence	|O
and	|O
position	|O
.	|O

Catecholamines	|O
and	|O
aversive	|O
learning	|O
:	|O
a	|O
review	|O
.	|O

A	|O
haemolytic	|O
enterotoxigenic	|O
strain	|O
of	|O
E.	|O
coli	|O
(	|O
O149	|O
:	|O
K88	|O
:	|O
H10	|O
)	|O
was	|O
regularly	|O
recovered	|O
from	|O
piglets	|O
with	|O
PWD	|O
while	|O
rotavirus	|O
was	|O
demonstrated	|O
on	|O
a	|O
number	|O
of	|O
occasions	|O
.	|O

The	|O
antibody	|O
titer	|O
of	|O
202	|O
chickens	|O
to	|O
SA	|O
-	|O
11	|O
rotavirus	|O
was	|O
determined	|O
by	|O
enzyme	|O
-	|O
linked	|O
immunosorbent	|O
blocking	|O
assay	|O
.	|O

Poly	|O
(	|O
dT	|O
)	|O
and	|O
denatured	|O
calf	|O
thymus	|O
DNA	|O
were	|O
more	|O
effective	|O
than	|O
were	|O
other	|O
polynucleotides	|O
tested	|O
in	|O
promoting	|O
accumulation	|O
of	|O
19	|O
HDP	|B-PROTEIN
*	|I-PROTEIN
;	|O
(	|O
dT	|O
)	|O
8	|O
was	|O
as	|O
effective	|O
as	|O
were	|O
longer	|O
molecules	|O
of	|O
(	|O
dT	|O
)	|O
n	|O
,	|O
but	|O
(	|O
dT	|O
)	|O
4	|O
and	|O
(	|O
dT	|O
)	|O
6	|O
were	|O
much	|O
less	|O
effective	|O
,	|O
indicating	|O
that	|O
the	|O
binding	|O
site	|O
involved	|O
in	|O
19	|O
HDP	|B-PROTEIN
*	|I-PROTEIN
accumulation	|O
covered	|O
between	|O
6	|O
and	|O
8	|O
residues	|O
of	|O
(	|O
dT	|O
)	|O
n	|O
.	|O

A	|O
double	|O
-	|O
blind	|O
trial	|O
of	|O
half	|O
-	|O
strength	|O
Polybactrin	|O
Soluble	|O
GU	|O
bladder	|O
irrigation	|O
in	|O
cystoscopy	|O
.	|O

Thus	|O
it	|O
appears	|O
that	|O
insertion	|O
of	|O
a	|O
transposable	|O
element	|O
near	|O
the	|O
5'	|O
terminus	|O
of	|O
the	|O
structural	|O
gene	|O
can	|O
produce	|O
constitutive	|O
expression	|O
of	|O
a	|O
normally	|O
glucose	|O
-	|O
repressed	|O
enzyme	|O
.	|O

Five	|O
experiments	|O
examined	|O
the	|O
influence	|O
of	|O
opiate	|O
antagonists	|O
on	|O
both	|O
the	|O
short	|O
-	|O
term	|O
analgesic	|O
reaction	|O
resulting	|O
30	|O
min	|O
after	|O
exposure	|O
to	|O
inescapable	|O
shock	|O
and	|O
the	|O
long	|O
-	|O
term	|O
analgesic	|O
reaction	|O
resulting	|O
after	|O
reexposure	|O
to	|O
shock	|O
24	|O
hr	|O
after	|O
inescapable	|O
shock	|O
exposure	|O
.	|O

Experiment	|O
3	|O
showed	|O
that	|O
the	|O
long	|O
-	|O
term	|O
analgesic	|O
reaction	|O
could	|O
also	|O
be	|O
reduced	|O
by	|O
administration	|O
of	|O
naltrexone	|O
prior	|O
to	|O
reexposure	|O
to	|O
shock	|O
.	|O

During	|O
the	|O
period	|O
from	|O
May	|O
to	|O
August	|O
,	|O
1978	|O
,	|O
an	|O
epidemic	|O
of	|O
hand	|O
,	|O
foot	|O
and	|O
mouth	|O
disease	|O
(	|O
HFMD	|O
)	|O
occurred	|O
in	|O
Gifu	|O
prefecture	|O
.	|O

A	|O
22K	|O
polypeptide	|O
was	|O
detected	|O
as	|O
a	|O
translation	|O
product	|O
of	|O
late	|O
RNA	|O
that	|O
hybridized	|O
to	|O
this	|O
DNA	|O
fragment	|O
.	|O

Replicating	|O
simian	|O
virus	|O
40	|O
(	|O
SV40	|O
)	|O
chromosomes	|O
were	|O
found	|O
to	|O
be	|O
similar	|O
to	|O
other	|O
eukaryotic	|O
chromosomes	|O
in	|O
that	|O
the	|O
rate	|O
and	|O
extent	|O
of	|O
micrococcal	|B-PROTEIN
nuclease	|I-PROTEIN
(	|O
MNase	|B-PROTEIN
)	|O
digestion	|O
were	|O
greater	|O
with	|O
replicating	|O
than	|O
with	|O
nonreplicating	|O
mature	|O
SV40	|O
chromatin	|O
.	|O

A	|O
hypothesis	|O
.	|O

We	|O
have	|O
investigated	|O
the	|O
requirements	|O
of	|O
the	|O
CH	|B-PROTEIN
gene	|O
switch	|O
by	|O
characterizing	|O
two	|O
rearranged	|O
gamma	|B-PROTEIN
2b	|I-PROTEIN
genes	|O
from	|O
a	|O
gamma	|B-PROTEIN
2b	|I-PROTEIN
producing	|O
mouse	|O
myeloma	|O
(	|O
MPC	|O
-	|O
11	|O
)	|O
.	|O

Physiology	|O
and	|O
Physiopathology	|O

The	|O
genome	|O
of	|O
avian	|O
erythroblastosis	|O
virus	|O
contains	|O
two	|O
independently	|O
expressed	|O
genetic	|O
loci	|O
(	|O
v	|B-PROTEIN
-	|I-PROTEIN
erbA	|I-PROTEIN
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
erbB	|I-PROTEIN
)	|O
whose	|O
activities	|O
are	|O
probably	|O
responsible	|O
for	|O
oncogenesis	|O
by	|O
the	|O
virus	|O
.	|O

Because	|O
RNase	|B-PROTEIN
III	|I-PROTEIN
host	|O
mutants	|O
are	|O
defective	|O
in	|O
sib	|B-PROTEIN
regulation	|O
,	|O
processing	|O
of	|O
the	|O
PL	|B-PROTEIN
mRNA	|O
at	|O
sib	|B-PROTEIN
by	|O
this	|O
endoribonuclease	|O
may	|O
cause	|O
int	|B-PROTEIN
mRNA	|O
decay	|O
and	|O
decrease	|O
int	|B-PROTEIN
synthesis	|O
.	|O

At	|O
least	|O
one	|O
clone	|O
,	|O
lambda	|O
HHG	|O
41	|O
,	|O
contains	|O
,	|O
in	|O
addition	|O
to	|O
the	|O
histone	|B-PROTEIN
genes	|O
,	|O
a	|O
region	|O
that	|O
hybridizes	|O
with	|O
a	|O
cytoplasmic	|O
RNA	|O
approximately	|O
330	|O
nucleotides	|O
in	|O
length	|O
.	|O

Both	|O
neural	|O
and	|O
hormonal	|O
pathways	|O
and	|O
both	|O
opiate	|O
and	|O
nonopiate	|O
substances	|O
play	|O
roles	|O
in	|O
the	|O
complex	|O
modulation	|O
of	|O
pain	|O
transmission	|O
.	|O

Restoration	|O
of	|O
impaired	|O
immune	|O
functions	|O
in	|O
aging	|O
animals	|O
.	|O

Postoperative	|O
serum	|O
ACTH	|B-PROTEIN
levels	|O
were	|O
normal	|O
.	|O

WR	|O
-	|O
2721	|O
(	|O
S	|O
-	|O
2	|O
-	|O
(	|O
3	|O
aminopropylamino	|O
)	|O
ethylphosphorothioic	|O
acid	|O
)	|O
has	|O
been	|O
investigated	|O
for	|O
its	|O
ability	|O
to	|O
protect	|O
gut	|O
,	|O
lung	|O
,	|O
and	|O
testis	|O
,	|O
as	|O
well	|O
as	|O
fibrosarcoma	|O
(	|O
FSa	|O
)	|O
tumor	|O
nodules	|O
,	|O
in	|O
the	|O
lungs	|O
of	|O
mice	|O
from	|O
gamma	|O
-	|O
radiation	|O
injury	|O
.	|O

In	|O
fact	|O
,	|O
families	|O
of	|O
polypeptides	|O
were	|O
produced	|O
by	|O
initiation	|O
of	|O
translation	|O
at	|O
AUG	|O
codons	|O
within	|O
sequences	|O
coding	|O
for	|O
VP1	|B-PROTEIN
and	|O
T	|B-PROTEIN
,	|O
presumably	|O
as	|O
a	|O
result	|O
of	|O
transcription	|O
initiation	|O
events	|O
that	|O
generated	|O
5'	|O
ends	|O
immediately	|O
upstream	|O
from	|O
these	|O
AUGs	|O
.	|O

In	|O
addition	|O
,	|O
TRP1	|B-PROTEIN
RI	|O
Circle	|O
DNA	|O
is	|O
organized	|O
into	|O
nucleosomes	|O
whose	|O
size	|O
and	|O
spacing	|O
are	|O
indistinguishable	|O
from	|O
that	|O
of	|O
bulk	|O
yeast	|O
chromatin	|O
.	|O

The	|O
frequency	|O
of	|O
previous	|O
transfusion	|O
in	|O
chronic	|O
hepatitis	|O
,	|O
cirrhosis	|O
and	|O
hepatocellular	|O
carcinoma	|O
of	|O
type	|O
NANB	|O
was	|O
42.8	|O
,	|O
37.1	|O
and	|O
15.1%	|O
,	|O
respectively	|O
,	|O
whereas	|O
the	|O
incidence	|O
of	|O
early	|O
posttransfusion	|O
hepatitis	|O
was	|O
8.5	|O
,	|O
8.6	|O
and	|O
7.5%	|O
,	|O
respectively	|O
.	|O
in	|O
chronic	|O
liver	|O
diseases	|O
with	|O
a	|O
history	|O
of	|O
jaundice	|O
and	|O
/	|O
or	|O
hepatitis	|O
,	|O
previous	|O
transfusions	|O
are	|O
more	|O
frequently	|O
associated	|O
with	|O
type	|O
NANB	|O
than	|O
with	|O
type	|O
B	|O
disease	|O
.	|O

Of	|O
115	|O
hepatitis	|O
B	|O
patients	|O
seen	|O
at	|O
12	|O
months	|O
,	|O
6%	|O
had	|O
chronic	|O
hepatitis	|O
Bs	|O
antigenaemia	|O
,	|O
60%	|O
had	|O
developed	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HBs	|I-PROTEIN
antibodies	|O
,	|O
and	|O
7.3%	|O
still	|O
had	|O
abnormal	|O
liver	|O
function	|O
.	|O

Survey	|O
on	|O
antibody	|O
against	|O
egg	|O
drop	|O
syndrome	|O
-	|O
1976	|O
virus	|O
among	|O
chicken	|O
flocks	|O
in	|O
Japan	|O
.	|O

In	|O
49	|O
patients	|O
in	|O
whom	|O
gated	|O
equilibrium	|O
ventriculography	|O
and	|O
cardiac	|O
catheterization	|O
were	|O
performed	|O
within	|O
a	|O
6	|O
day	|O
interval	|O
,	|O
total	|O
and	|O
fractional	|O
portions	|O
of	|O
global	|O
and	|O
regional	|O
right	|O
ventricular	|O
ejection	|O
fraction	|O
(	|O
RVEF	|O
)	|O
were	|O
correlated	|O
with	|O
pulmonary	|O
arterial	|O
systolic	|O
pressure	|O
.	|O

74	|O
,	|O
193-197	|O
)	|O
.	|O

The	|O
combination	|O
of	|O
MISO	|O
and	|O
WR	|O
-	|O
2721	|O
gave	|O
an	|O
intermediate	|O
response	|O
compared	|O
with	|O
either	|O
drug	|O
used	|O
alone	|O
,	|O
resulting	|O
in	|O
some	|O
sensitization	|O
with	|O
single	|O
doses	|O
and	|O
an	|O
overall	|O
protection	|O
with	|O
repeated	|O
small	|O
doses	|O
.	|O

Two	|O
mutations	|O
that	|O
affect	|O
larval	|O
cuticle	|B-PROTEIN
protein	|O
gene	|O
expression	|O
in	|O
the	|O
2/3	|O
variant	|O
Drosophila	|O
melanogaster	|O
strain	|O
were	|O
investigated	|O
.	|O

The	|O
ensembles	|O
are	|O
considered	|O
to	|O
be	|O
one	|O
of	|O
the	|O
forms	|O
of	|O
activity	|O
of	|O
the	|O
structured	|O
morphofunctional	|O
cortical	|O
units	|O
,	|O
i.e.	|O
the	|O
columns	|O
.	|O

The	|O
strong	|O
conservation	|O
of	|O
the	|O
inverted	|O
terminal	|O
repeat	|O
sequence	|O
may	|O
reflect	|O
a	|O
common	|O
integration	|O
mechanism	|O
for	|O
VL30	|B-PROTEIN
elements	|O
and	|O
MuLV	|O
proviruses	|O
.	|O

A	|O
cDNA	|O
cloning	|O
vector	|O
that	|O
permits	|O
expression	|O
of	|O
cDNA	|O
inserts	|O
in	|O
mammalian	|O
cells	|O
.	|O

Hybridization	|O
of	|O
plasmid	|O
-	|O
transformed	|O
Escherichia	|O
coli	|O
RR1	|O
colonies	|O
with	|O
32P	|O
-	|O
labeled	|O
viral	|O
genome	|O
RNAs	|O
demonstrated	|O
the	|O
presence	|O
of	|O
DNA	|O
clones	|O
representative	|O
of	|O
each	|O
of	|O
the	|O
10	|O
reovirus	|O
RNAs	|O
and	|O
10	|O
of	|O
the	|O
11	|O
constituent	|O
segments	|O
of	|O
the	|O
rotavirus	|O
genome	|O
.	|O

Another	|O
sequence	|O
,	|O
GGGXGGAG	|O
,	|O
which	|O
is	|O
repeated	|O
several	|O
times	|O
in	|O
many	|O
polyomaviruses	|O
and	|O
adenoviruses	|O
,	|O
and	|O
which	|O
is	|O
thought	|O
to	|O
play	|O
a	|O
role	|O
in	|O
DNA	|O
replication	|O
and	|O
/	|O
or	|O
transcription	|O
,	|O
is	|O
not	|O
found	|O
in	|O
the	|O
JCV	|O
sequence	|O
presented	|O
.	|O

In	|O
conclusion	|O
,	|O
these	|O
studies	|O
indicate	|O
that	|O
LiCl	|O
(	|O
1	|O
)	|O
decreases	|O
histamine	|O
-	|O
stimulated	|O
gastric	|O
acid	|O
secretion	|O
,	|O
and	|O
(	|O
2	|O
)	|O
diminishes	|O
bile	|O
-	|O
induced	|O
disruption	|O
of	|O
the	|O
gastric	|O
mucosal	|O
barrier	|O
in	|O
the	|O
canine	|O
Heidenhain	|O
pouch	|O
.	|O

Lung	|O
density	|O
increased	|O
in	|O
quartz	|O
-	|O
exposed	|O
,	|O
but	|O
not	|O
in	|O
volcanic	|O
-	|O
ash	|O
-	|O
exposed	|O
animals	|O
.	|O

The	|O
hepatitis	|B-PROTEIN
A	|I-PROTEIN
virus	|I-PROTEIN
antibody	|I-PROTEIN
(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HAV	|I-PROTEIN
)	|O
in	|O
chronic	|O
diffuse	|O
liver	|O
diseases	|O

The	|O
junctions	|O
between	|O
viral	|O
and	|O
cellular	|O
sequences	|O
were	|O
determined	|O
by	|O
DNA	|O
sequence	|O
analysis	|O
to	|O
be	|O
517	|O
nucleotides	|O
into	|O
the	|O
p30	|B-PROTEIN
sequence	|O
and	|O
1,920	|O
nucleotides	|O
into	|O
the	|O
polymerase	|O
sequence	|O
.	|O

Naloxone	|O
(	|O
2	|O
mg	|O
/	|O
kg	|O
bolus	|O
+	|O
2	|O
mg	|O
X	|O
kg	|O
-	|O
1	|O
X	|O
h	|O
-	|O
1	|O
)	|O
was	|O
given	|O
with	|O
one	|O
of	|O
the	|O
two	|O
doses	|O
of	|O
the	|O
lipopolysaccharide	|O
.	|O

Gel	|O
route	|O
preparation	|O
of	|O
low	|O
fusing	|O
dental	|O
porcelain	|O
frit	|O
.	|O

I.	|O

Viral	|O
RNA	|O
,	|O
molecularly	|O
cloned	|O
proviral	|O
DNA	|O
,	|O
and	|O
virus	|O
-	|O
specific	|O
protein	|O
of	|O
avian	|O
retrovirus	|O
MH2	|O
were	|O
analyzed	|O
.	|O

Intracellular	|O
recordings	|O
were	|O
performed	|O
on	|O
the	|O
optic	|O
tectum	|O
of	|O
the	|O
carp	|O
in	|O
vitro	|O
.	|O

Molecular	|O
structure	|O
and	|O
evolutionary	|O
origin	|O
of	|O
human	|O
cardiac	|O
muscle	|O
actin	|B-PROTEIN
gene	|O
.	|O

The	|O
mutants	|O
were	|O
obtained	|O
by	|O
substitution	|O
into	|O
a	|O
molecular	|O
clone	|O
of	|O
M	|O
-	|O
MuLV	|O
DNA	|O
by	|O
DNA	|O
from	|O
two	|O
acutely	|O
transforming	|O
viruses	|O
,	|O
Ableson	|O
MuLV	|O
(	|O
Ab	|O
-	|O
MuLV	|O
)	|O
and	|O
Moloney	|O
murine	|O
sarcoma	|O
virus	|O
(	|O
M	|O
-	|O
MSV	|O
)	|O
.	|O

Plasmids	|O
for	|O
the	|O
cloning	|O
and	|O
expression	|O
of	|O
full	|O
-	|O
length	|O
double	|O
-	|O
stranded	|O
cDNAs	|O
under	|O
control	|O
of	|O
the	|O
SV40	|O
early	|B-PROTEIN
or	|O
late	|B-PROTEIN
gene	|O
promoter	|O
.	|O

Supplementing	|O
a	|O
soybean	|O
protein	|O
and	|O
sucrose	|O
-	|O
based	|O
diet	|O
with	|O
levels	|O
of	|O
2.2	|O
,	|O
11	|O
,	|O
and	|O
55	|O
ppm	|O
of	|O
the	|O
antibiotic	|O
,	|O
from	|O
the	|O
two	|O
sources	|O
each	|O
with	|O
two	|O
different	|O
purities	|O
,	|O
improved	|O
weight	|O
gain	|O
of	|O
chicks	|O
an	|O
average	|O
of	|O
23%	|O
and	|O
improved	|O
feed	|O
efficiency	|O
an	|O
average	|O
of	|O
13%	|O
at	|O
the	|O
higher	|O
levels	|O
(	|O
all	|O
P	|O
less	|O
than	|O
.01	|O
)	|O
.	|O

The	|O
dnaQ	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
and	|O
the	|O
rnh	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
fused	|O
genes	|O
were	|O
constructed	|O
and	|O
hybrid	|O
proteins	|O
with	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
activity	|O
were	|O
produced	|O
.	|O

Overall	|O
prevalences	|O
of	|O
antibody	|O
were	|O
70	|O
per	|O
cent	|O
in	|O
cattle	|O
,	|O
67	|O
per	|O
cent	|O
in	|O
sheep	|O
and	|O
76	|O
per	|O
cent	|O
in	|O
goats	|O
as	|O
assessed	|O
by	|O
an	|O
immunodiffusion	|O
test	|O
.	|O

Expression	|O
of	|O
herpes	|O
simplex	|O
virus	|O
beta	|O
and	|O
gamma	|O
genes	|O
integrated	|O
in	|O
mammalian	|O
cells	|O
and	|O
their	|O
induction	|O
by	|O
an	|O
alpha	|O
gene	|O
product	|O
.	|O

The	|O
splice	|O
acceptor	|O
site	|O
is	|O
ca.	|O

This	|O
is	|O
consistent	|O
with	|O
a	|O
model	|O
proposing	|O
that	|O
SSV	|O
was	|O
generated	|O
by	|O
recombination	|O
between	|O
proviral	|O
DNA	|O
of	|O
a	|O
simian	|O
sarcoma	|O
associated	|O
virus	|O
and	|O
proto	|B-PROTEIN
-	|I-PROTEIN
sis	|I-PROTEIN
and	|O
that	|O
introns	|O
were	|O
spliced	|O
out	|O
subsequently	|O
from	|O
a	|O
fused	|O
viral	|B-PROTEIN
-	|I-PROTEIN
sis	|I-PROTEIN
messenger	|O
RNA	|O
.	|O

We	|O
conclude	|O
that	|O
,	|O
with	|O
autonomic	|O
nervous	|O
system	|O
activity	|O
intact	|O
,	|O
carotid	|O
chemoreceptor	|O
reflex	|O
activation	|O
can	|O
elicit	|O
an	|O
absolute	|O
reflexly	|O
mediated	|O
reduction	|O
in	|O
coronary	|O
blood	|O
flow	|O
in	|O
the	|O
normal	|O
,	|O
conscious	|O
dog	|O
,	|O
despite	|O
an	|O
increase	|O
in	|O
arterial	|O
pressure	|O
.	|O

Female	|O
subjects	|O
,	|O
including	|O
both	|O
normal	|O
subjects	|O
and	|O
idiopathic	|O
calcium	|O
stone	|O
-	|O
formers	|O
,	|O
have	|O
higher	|O
urinary	|O
cyclic	|O
AMP	|O
levels	|O
than	|O
their	|O
male	|O
counterparts	|O
,	|O
and	|O
this	|O
difference	|O
is	|O
significant	|O
when	|O
urinary	|O
cyclic	|O
AMP	|O
is	|O
expressed	|O
in	|O
the	|O
units	|O
mumol	|O
/	|O
g	|O
of	|O
creatinine	|O
.	|O

We	|O
conclude	|O
that	|O
the	|O
'm	|O
orning	|O
dip	|O
'	|O
observed	|O
in	|O
asthmatic	|O
patients	|O
cannot	|O
simply	|O
be	|O
explained	|O
by	|O
changes	|O
in	|O
cell	|O
receptor	|O
number	|O
or	|O
affinity	|O
,	|O
as	|O
our	|O
results	|O
suggest	|O
that	|O
both	|O
groups	|O
have	|O
intact	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
function	|O
.	|O

The	|O
effect	|O
of	|O
desipramine	|O
probably	|O
represents	|O
inhibition	|O
of	|O
neuronal	|O
uptake	|O
and	|O
that	|O
of	|O
amitriptyline	|O
and	|O
mianserin	|O
blockade	|O
of	|O
neuronal	|O
uptake	|O
and	|O
prejunctional	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
adrenoreceptors	|I-PROTEIN
.	|O

We	|O
conclude	|O
that	|O
the	|O
gp54	|B-PROTEIN
structural	|O
gene	|O
is	|O
required	|O
for	|O
initiation	|O
or	|O
amplification	|O
of	|O
the	|O
splenic	|O
erythroblast	|O
hyperplasia	|O
which	|O
characterizes	|O
the	|O
preleukemic	|O
phase	|O
of	|O
Rauscher	|O
disease	|O
.	|O

Surgical	|O
treatment	|O
of	|O
pulmonary	|O
metastases	|O
.	|O

A	|O
promoter	|O
sequence	|O
(	|O
Goldberg	|O
-	|O
Hogness	|O
or	|O
TATA	|O
box	|O
)	|O
is	|O
situated	|O
28	|O
base	|O
pairs	|O
upstream	|O
from	|O
the	|O
point	|O
of	|O
initiation	|O
of	|O
transcription	|O
which	|O
was	|O
found	|O
by	|O
S1	|B-PROTEIN
nuclease	|O
mapping	|O
and	|O
by	|O
oligonucleotide	|O
-	|O
primed	|O
reverse	|O
transcription	|O
of	|O
rat	|O
PTH	|B-PROTEIN
mRNA	|O
.	|O

Each	|O
of	|O
these	|O
spliced	|O
mRNAs	|O
has	|O
an	|O
untranslated	|O
leader	|O
sequence	|O
of	|O
249	|O
bases	|O
and	|O
a	|O
single	|O
intron	|O
of	|O
approximately	|O
540	|O
bases	|O
which	|O
are	|O
contained	|O
entirely	|O
within	|O
TRs	|O
/	|O
IRs	|O
sequences	|O
.	|O

The	|O
expression	|O
of	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
was	|O
detected	|O
within	|O
1	|O
h	|O
after	|O
infection	|O
of	|O
cells	|O
with	|O
recombinant	|O
virus	|O
,	|O
reflecting	|O
the	|O
early	|O
nature	|O
of	|O
the	|O
promoters	|O
used	|O
.	|O

NPT	|B-PROTEIN
II	|I-PROTEIN
synthesis	|O
,	|O
measured	|O
by	|O
agar	|O
plate	|O
assays	|O
of	|O
kanamycin	|O
resistance	|O
and	|O
by	|O
immunoprecipitation	|O
of	|O
the	|O
NPT	|B-PROTEIN
II	|I-PROTEIN
protein	|O
,	|O
was	|O
repressed	|O
in	|O
the	|O
presence	|O
of	|O
cysteine	|O
and	|O
derepressed	|O
in	|O
its	|O
absence	|O
.	|O

A	|O
computed	|O
tomographic	|O
scan	|O
obtained	|O
after	|O
EOE	|O
-	|O
13	|O
infusion	|O
accurately	|O
showed	|O
the	|O
perfusion	|O
pattern	|O
of	|O
the	|O
implanted	|O
catheter	|O
.	|O

The	|O
primary	|O
structure	|O
of	|O
the	|O
GAL7	|B-PROTEIN
5'	|O
flanking	|O
region	|O
has	|O
many	|O
features	|O
common	|O
to	|O
those	|O
of	|O
multicellular	|O
eukaryotic	|O
genes	|O
.	|O

The	|O
12,000	|O
MW	|O
(	|O
12K	|O
)	|O
IE	|B-PROTEIN
polypeptide	|O
encoded	|O
by	|O
IEmRNA	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
is	|O
translated	|O
from	|O
an	|O
88	|O
codon	|O
open	|O
reading	|O
frame	|O
,	|O
leaving	|O
a	|O
1200	|O
base	|O
3'	|O
non	|O
-	|O
translated	|O
region	|O
.	|O

The	|O
greatest	|O
difference	|O
between	|O
the	|O
Ad7	|O
and	|O
Ad5	|O
DBPs	|B-PROTEIN
is	|O
the	|O
absence	|O
,	|O
in	|O
the	|O
Ad7	|O
protein	|O
,	|O
of	|O
12	|O
amino	|O
acids	|O
located	|O
between	|O
the	|O
two	|O
functional	|O
domains	|O
in	|O
the	|O
Ad5	|O
protein	|O
(	|O
amino	|O
acids	|O
151-162	|O
)	|O
.	|O

No	|O
significant	|O
correlation	|O
was	|O
found	|O
between	|O
LVM	|O
or	|O
wall	|O
thickness	|O
and	|O
body	|O
surface	|O
area	|O
,	|O
age	|O
,	|O
blood	|O
pressure	|O
,	|O
heart	|O
rate	|O
,	|O
cardiac	|O
output	|O
,	|O
total	|O
peripheral	|O
resistance	|O
and	|O
left	|O
ventricular	|O
systolic	|O
wall	|O
stress	|O
,	|O
whereas	|O
CD25	|O
was	|O
correlated	|O
with	|O
urinary	|O
catecholamines	|O
only	|O
in	|O
hypertensive	|O
patients	|O
(	|O
r	|O
=	|O
0.606	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

Furthermore	|O
,	|O
no	|O
Shine	|O
-	|O
Dalgarno	|O
sequences	|O
are	|O
present	|O
upstream	|O
of	|O
the	|O
presumed	|O
translational	|O
start	|O
codons	|O
.	|O

The	|O
gene	|O
cat	|B-PROTEIN
-	|I-PROTEIN
86	|I-PROTEIN
,	|O
specifying	|O
chloramphenicol	|O
-	|O
inducible	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
,	|O
is	|O
located	|O
on	|O
the	|O
1.1	|O
-	|O
kilobase	|O
cloned	|O
DNA	|O
.	|O

The	|O
myeloproliferative	|O
sarcoma	|O
virus	|O
(	|O
MPSV	|O
)	|O
was	|O
derived	|O
by	|O
passage	|O
of	|O
Moloney	|O
sarcoma	|O
virus	|O
(	|O
Mo	|O
-	|O
MuSV	|O
)	|O
in	|O
adult	|O
mice	|O
.	|O

The	|O
same	|O
-	|O
sized	|O
EBNA	|B-PROTEIN
protein	|O
(	|O
approximately	|O
78,000	|O
)	|O
was	|O
made	|O
after	|O
transfection	|O
with	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
K	|I-PROTEIN
(	|O
5.2	|O
kilobase	|O
pairs	|O
[	|O
kbp	|O
]	|O
)	|O
or	|O
the	|O
I1f	|O
subfragment	|O
(	|O
2.9	|O
kbp	|O
)	|O
.	|O

They	|O
generated	|O
ca.	|O

Here	|O
we	|O
have	|O
determined	|O
the	|O
nucleotide	|O
sequence	|O
of	|O
3.5	|O
kb	|O
from	|O
the	|O
3'	|O
end	|O
of	|O
delta	|B-PROTEIN
gag	|I-PROTEIN
to	|O
the	|O
3'	|O
end	|O
of	|O
molecularly	|O
cloned	|O
proviral	|O
MH2	|O
DNA	|O
,	|O
in	|O
order	|O
to	|O
elucidate	|O
the	|O
genetic	|O
structure	|O
of	|O
the	|O
virus	|O
and	|O
to	|O
compare	|O
it	|O
with	|O
other	|O
mht	|B-PROTEIN
-	|O
and	|O
myc	|B-PROTEIN
-	|O
containing	|O
oncogenic	|O
viruses	|O
as	|O
well	|O
as	|O
with	|O
the	|O
chicken	|O
proto	|O
-	|O
myc	|B-PROTEIN
gene	|O
.	|O

USA	|O
80	|O
,	|O
802-806	|O
]	|O
was	|O
used	|O
to	|O
isolate	|O
a	|O
genomic	|O
clone	|O
lambda	|O
PGK	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
containing	|O
a	|O
portion	|O
of	|O
an	|O
autosomal	|O
locus	|O
for	|O
phosphoglycerate	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
PGK	|B-PROTEIN
)	|O
.	|O

A.	|O

188	|O
patients	|O
received	|O
cimetidine	|O
400	|O
mg	|O
q.i.d	|O
.	|O
intravenously	|O
and	|O
1,000	|O
mg	|O
daily	|O
orally	|O
in	|O
divided	|O
doses	|O
.	|O

An	|O
immunologic	|O
test	|O
using	|O
stomach	|O
and	|O
tumor	|O
antigens	|O
for	|O
screening	|O
of	|O
those	|O
at	|O
high	|O
risk	|O
for	|O
stomach	|O
cancer	|O
is	|O
suggested	|O
.	|O

Thirty	|O
isolates	|O
of	|O
Haemophilus	|O
influenzae	|O
type	|O
b	|O
were	|O
obtained	|O
during	|O
an	|O
outbreak	|O
of	|O
invasive	|O
H.	|O
influenzae	|O
type	|O
b	|O
disease	|O
and	|O
were	|O
classified	|O
by	|O
the	|O
electrophoretic	|O
profile	|O
of	|O
their	|O
lipopolysaccharide	|O
(	|O
LPS	|O
)	|O
.	|O

Tiaprofenic	|O
acid	|O
overdose	|O
.	|O

Frog	|O
type	|O
I	|O
(	|O
Ft	|O
I	|O
)	|O
and	|O
frog	|O
type	|O
II	|O
(	|O
Ft	|O
II	|O
)	|O
slowly	|O
adapting	|O
(	|O
SA	|O
)	|O
units	|O
produced	|O
spikes	|O
only	|O
at	|O
the	|O
indentation	|O
phase	|O
,	|O
and	|O
the	|O
threshold	|O
response	|O
phase	|O
(	|O
TRP	|O
)	|O
,	|O
i.e.	|O
.	|O
the	|O
phase	|O
of	|O
the	|O
first	|O
spike	|O
was	|O
for	|O
ca.	|O

Frog	|O
type	|O
I	|O
(	|O
Ft	|O
I	|O
)	|O
and	|O
frog	|O
type	|O
II	|O
(	|O
Ft	|O
II	|O
)	|O
slowly	|O
adapting	|O
(	|O
SA	|O
)	|O
units	|O
produced	|O
spikes	|O
only	|O
at	|O
the	|O
indentation	|O
phase	|O
,	|O
and	|O
the	|O
threshold	|O
response	|O
phase	|O
(	|O
TRP	|O
)	|O
,	|O
i.e.	|O
.	|O
the	|O
phase	|O
of	|O
the	|O
first	|O
spike	|O
was	|O
for	|O
ca.	|O

DMCM	|O
also	|O
permits	|O
extension	|O
of	|O
the	|O
possibilities	|O
of	|O
obtaining	|O
and	|O
transplanting	|O
donor	|O
organs	|O
.	|O

Grimelius	|O
stain	|O
was	|O
positive	|O
,	|O
Masson	|O
Fontana	|O
stain	|O
negative	|O
.	|O

Blood	|O
glucose	|O
and	|O
plasma	|O
insulin	|B-PROTEIN
were	|O
measured	|O
at	|O
zero	|O
time	|O
and	|O
then	|O
at	|O
15	|O
,	|O
30	|O
,	|O
60	|O
,	|O
90	|O
and	|O
120	|O
min	|O
after	|O
ingestion	|O
of	|O
25	|O
g	|O
glucose	|O
,	|O
fructose	|O
or	|O
lactose	|O
,	|O
or	|O
30	|O
g	|O
honey	|O
,	|O
50	|O
g	|O
white	|O
bread	|O
,	|O
125	|O
g	|O
white	|O
rice	|O
or	|O
potatoes	|O
,	|O
150	|O
g	|O
apples	|O
or	|O
260	|O
g	|O
carrots	|O
.	|O

Clinical	|O
use	|O
of	|O
absorbable	|O
polyglycolic	|O
acid	|O
suture	|O
in	|O
Blalock	|O
-	|O
Taussig	|O
's	|O
operation	|O

Among	|O
these	|O
are	|O
:	|O
(	|O
1	|O
)	|O
Is	|O
there	|O
sufficient	|O
understanding	|O
of	|O
family	|O
pathophysiology	|O
,	|O
of	|O
the	|O
sensitivity	|O
and	|O
specificity	|O
of	|O
diagnostic	|O
techniques	|O
and	|O
of	|O
the	|O
safety	|O
and	|O
efficacy	|O
of	|O
therapeutic	|O
modalities	|O
to	|O
make	|O
true	|O
family	|O
health	|O
care	|O
possible	|O
?	|O
(	|O
2	|O
)	|O
If	|O
this	|O
type	|O
of	|O
care	|O
is	|O
possible	|O
,	|O
how	|O
are	|O
the	|O
needs	|O
of	|O
the	|O
family	|O
and	|O
its	|O
individual	|O
members	|O
met	|O
,	|O
or	|O
value	|O
judgements	|O
made	|O
about	|O
their	|O
relative	|O
importance	|O
?	|O
and	|O
(	|O
3	|O
)	|O
What	|O
are	|O
the	|O
consequences	|O
for	|O
the	|O
health	|O
care	|O
delivery	|O
system	|O
of	|O
this	|O
type	|O
of	|O
care	|O
?	|O
An	|O
extensive	|O
literature	|O
review	|O
is	|O
used	|O
in	|O
an	|O
attempt	|O
to	|O
answer	|O
these	|O
queries	|O
,	|O
from	|O
which	|O
questions	|O
for	|O
further	|O
study	|O
are	|O
posed	|O
.	|O

In	|O
patients	|O
in	|O
group	|O
A	|O
(	|O
"	|O
normal	|O
"	|O
CI	|O
)	|O
,	|O
the	|O
CI	|O
,	|O
heart	|O
rate	|O
and	|O
the	|O
mean	|O
circumferential	|O
fiber	|O
shortening	|O
velocity	|O
(	|O
mVCF	|O
)	|O
were	|O
normal	|O
,	|O
but	|O
the	|O
TPR	|O
was	|O
increased	|O
significantly	|O
.	|O

Immunologically	|O
reactive	|O
insulin	|B-PROTEIN
levels	|O
were	|O
determined	|O
in	|O
freely	|O
-	|O
moving	|O
normal	|O
rats	|O
offered	|O
three	|O
different	|O
test	|O
-	|O
meals	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
both	|O
naturally	|O
acquired	|O
and	|O
passive	|O
(	|O
modified	|O
immune	|B-PROTEIN
serum	|I-PROTEIN
globulin	|I-PROTEIN
)	|O
antibodies	|O
to	|O
type	|B-PROTEIN
III	|I-PROTEIN
group	|I-PROTEIN
B	|I-PROTEIN
Streptococcus	|I-PROTEIN
antigen	|I-PROTEIN
are	|O
partially	|O
protective	|O
against	|O
intra	|O
-	|O
amniotic	|O
infection	|O
.	|O

In	|O
the	|O
posthospital	|O
phase	|O
of	|O
AMI	|O
,	|O
as	|O
well	|O
as	|O
in	|O
CCHD	|O
,	|O
the	|O
occurrence	|O
of	|O
high	|O
-	|O
grade	|O
VPBs	|O
usually	|O
indicates	|O
more	|O
advanced	|O
degrees	|O
of	|O
both	|O
coronary	|O
and	|O
left	|O
ventricular	|O
disease	|O
as	|O
well	|O
as	|O
the	|O
possibility	|O
of	|O
cardiac	|O
and	|O
/	|O
or	|O
sudden	|O
death	|O
.	|O

Sweet	|O
oranges	|O
,	|O
mandarin	|O
,	|O
grapefruit	|O
,	|O
lemon	|O
,	|O
and	|O
lime	|O
are	|O
generally	|O
used	|O
for	|O
processing	|O
.	|O

The	|O
genes	|O
at	|O
each	|O
locus	|O
are	|O
divergently	|O
transcribed	|O
and	|O
the	|O
coding	|O
sequences	|O
are	|O
separated	|O
by	|O
646	|O
base	|O
-	|O
pairs	|O
at	|O
one	|O
locus	|O
and	|O
676	|O
base	|O
-	|O
pairs	|O
at	|O
the	|O
other	|O
.	|O

The	|O
enzymic	|O
hydrolysis	|O
of	|O
urea	|O
produces	|O
ammonia	|O
which	|O
causes	|O
a	|O
vivid	|O
yellow	|O
to	|O
purple	|O
colour	|O
change	|O
in	|O
the	|O
pH	|O
indicator	|O
.	|O

The	|O
clinical	|O
efficacy	|O
rates	|O
evaluated	|O
in	|O
151	|O
cases	|O
(	|O
KS	|O
-	|O
R1	|O
group	|O
in	|O
77	|O
cases	|O
,	|O
oral	|O
group	|O
in	|O
74	|O
cases	|O
)	|O
on	|O
standard	|O
criteria	|O
of	|O
committee	|O
members	|O
were	|O
88.3%	|O
for	|O
the	|O
KS	|O
-	|O
R1	|O
group	|O
and	|O
86.5%	|O
for	|O
the	|O
oral	|O
group	|O
,	|O
respectively	|O
.	|O

Side	|O
effect	|O
including	|O
subjective	|O
and	|O
objective	|O
symptoms	|O
were	|O
strictly	|O
evaluated	|O
in	|O
163	|O
cases	|O
(	|O
KS	|O
-	|O
R1	|O
group	|O
in	|O
83	|O
cases	|O
,	|O
oral	|O
group	|O
in	|O
80	|O
cases	|O
)	|O
,	|O
but	|O
the	|O
incidence	|O
rate	|O
which	|O
was	|O
22.9%	|O
for	|O
the	|O
KS	|O
-	|O
R1	|O
group	|O
and	|O
23.8%	|O
for	|O
the	|O
oral	|O
group	|O
showed	|O
no	|O
significant	|O
difference	|O
.	|O

Plasma	|O
renin	|B-PROTEIN
activity	|O
did	|O
not	|O
change	|O
in	|O
response	|O
to	|O
head	|O
-	|O
up	|O
tilt	|O
or	|O
isoprenaline	|O
infusion	|O
in	|O
the	|O
patients	|O
.	|O

Martin	|O
Luther	|O
and	|O
his	|O
physicians	|O
.	|O

Enhancement	|O
of	|O
the	|O
immune	|O
response	|O
by	|O
aspecific	|O
action	|O
of	|O
vaccine	|O
additives	|O
in	|O
the	|O
aerogenic	|O
immunization	|O
of	|O
swine	|O
against	|O
swine	|O
plague	|O

Induced	|O
gamma	|O
-	|O
ray	|O
spectroscopy	|O

Bepridil	|O
,	|O
a	|O
calcium	|O
antagonist	|O
with	|O
a	|O
half	|O
-	|O
life	|O
of	|O
approximately	|O
42	|O
hours	|O
,	|O
was	|O
compared	|O
with	|O
placebo	|O
in	|O
a	|O
double	|O
-	|O
blind	|O
,	|O
randomized	|O
,	|O
crossover	|O
trial	|O
.	|O

Analysis	|O
of	|O
proteins	|O
synthesized	|O
by	|O
plasmids	|O
containing	|O
deleted	|O
forms	|O
of	|O
the	|O
trfA	|B-PROTEIN
region	|O
indicates	|O
that	|O
the	|O
A2	|B-PROTEIN
protein	|O
is	|O
the	|O
essential	|O
trfA	|B-PROTEIN
-	|O
encoded	|O
replication	|O
protein	|O
of	|O
plasmid	|O
RK2	|O
.	|O

Effects	|O
of	|O
negative	|O
pleural	|O
pressure	|O
on	|O
left	|O
ventricular	|O
hemodynamics	|O
.	|O

Resting	|O
plasma	|O
norepinephrine	|O
(	|O
NE	|O
)	|O
and	|O
epinephrine	|O
(	|O
E	|O
)	|O
levels	|O
were	|O
lower	|O
during	|O
active	|O
therapy	|O
than	|O
2	|O
wk	|O
after	|O
withdrawal	|O
(	|O
guanfacine	|O
and	|O
control	|O
:	|O
plasma	|O
NE	|O
,	|O
0.27	|O
+	|O
/	|O
-	|O
0.03/0.64	|O
+	|O
/	|O
-	|O
0.13	|O
ng	|O
/	|O
ml	|O
;	|O
plasma	|O
E	|O
,	|O
0.09	|O
+	|O
/	|O
-	|O
0.02/0.17	|O
+	|O
/	|O
-	|O
0.05	|O
ng	|O
/	|O
ml	|O
)	|O
.	|O

Renal	|O
response	|O
to	|O
captopril	|O
in	|O
severe	|O
heart	|O
failure	|O
:	|O
role	|O
of	|O
furosemide	|O
in	|O
natriuresis	|O
and	|O
reversal	|O
of	|O
hyponatremia	|O
.	|O

Lauciello	|O
describes	|O
a	|O
technique	|O
for	|O
the	|O
placement	|O
of	|O
functionally	|O
generated	|O
amalgam	|O
stops	|O
as	|O
restorations	|O
within	|O
mandibular	|O
acrylic	|O
teeth	|O
.	|O

Eleven	|O
biopsy	|O
specimens	|O
(	|O
five	|O
papules	|O
and	|O
six	|O
dusky	|O
or	|O
crusted	|O
lesions	|O
)	|O
from	|O
four	|O
patients	|O
with	|O
pityriasis	|O
lichenoides	|O
et	|O
varioliformis	|O
acuta	|O
(	|O
PLEVA	|O
)	|O
were	|O
studied	|O
by	|O
direct	|O
immunofluorescence	|O
and	|O
immunoperoxidase	|B-PROTEIN
technics	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
a	|O
major	|O
part	|O
of	|O
the	|O
reduction	|O
in	|O
food	|O
intake	|O
in	|O
hyperphagic	|O
rats	|O
eating	|O
a	|O
quinine	|O
-	|O
adulterated	|O
diet	|O
is	|O
due	|O
to	|O
postingestional	|O
events	|O
.	|O

The	|O
aspirate	|O
from	|O
a	|O
parathyroid	|O
cyst	|O
was	|O
watery	|O
clear	|O
and	|O
contained	|O
high	|O
amount	|O
of	|O
parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
.	|O

EGV	|O
had	|O
no	|O
detectable	|O
effect	|O
on	|O
PP	|B-PROTEIN
secretion	|O
under	|O
basal	|O
or	|O
stimulated	|O
conditions	|O
.	|O

The	|O
numerous	|O
tests	|O
demonstrate	|O
that	|O
the	|O
HDL	|O
-	|O
2M	|O
can	|O
be	|O
extensively	|O
and	|O
successfully	|O
used	|O
for	|O
therapy	|O
of	|O
insulin	|B-PROTEIN
-	|O
dependent	|O
diabetes	|O
mellitus	|O
in	|O
clinical	|O
practice	|O
.	|O

Lung	|O
prostacyclin	|O
production	|O
may	|O
be	|O
related	|O
to	|O
flow	|O
.	|O

For	|O
the	|O
first	|O
30	|O
min	|O
following	|O
insulin	|B-PROTEIN
administration	|O
,	|O
the	|O
rate	|O
of	|O
change	|O
in	|O
glucose	|O
levels	|O
was	|O
significantly	|O
less	|O
among	|O
the	|O
patients	|O
with	|O
major	|O
depressive	|O
disorder	|O
than	|O
among	|O
either	|O
the	|O
patients	|O
with	|O
dysthymic	|O
disorder	|O
or	|O
the	|O
normal	|O
control	|O
subjects	|O
.	|O

Management	|O
of	|O
hypertension	|O
in	|O
the	|O
elderly	|O
.	|O

Climatic	|O
treatment	|O
of	|O
children	|O
with	|O
respiratory	|O
allergy	|O

Transplantation	|O
of	|O
kidneys	|O
of	|O
juvenile	|O
donors	|O
in	|O
adult	|O
recipients	|O
.	|O

Ten	|O
patients	|O
with	|O
advanced	|O
,	|O
diffuse	|O
Hodgkin	|O
's	|O
and	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphomas	|O
responding	|O
poorly	|O
to	|O
the	|O
most	|O
widely	|O
employed	|O
primary	|O
chemotherapy	|O
regimens	|O
were	|O
treated	|O
with	|O
a	|O
high	|O
-	|O
dose	|O
chemotherapy	|O
(	|O
HDC	|O
)	|O
followed	|O
by	|O
rescue	|O
with	|O
non	|O
-	|O
frozen	|O
autologous	|O
bone	|O
marrow	|O
infusion	|O
(	|O
ABMT	|O
)	|O
.	|O

Effect	|O
of	|O
proteolytic	|O
enzymes	|O
and	|O
polypeptides	|O
on	|O
the	|O
antacid	|O
activity	|O
of	|O
almagate	|O
and	|O
other	|O
antacids	|O
.	|O

Results	|O
of	|O
a	|O
controlled	|O
study	|O

Hydrallazine	|O
also	|O
caused	|O
a	|O
slight	|O
increase	|O
in	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
and	|O
urinary	|O
excretion	|O
of	|O
noradrenaline	|O
.	|O

Urease	|B-PROTEIN
activity	|O
of	|O
97%	|O
of	|O
these	|O
organisms	|O
became	|O
evident	|O
within	|O
30	|O
min	|O
.	|O

After	|O
description	|O
of	|O
his	|O
short	|O
life	|O
and	|O
an	|O
explanation	|O
of	|O
the	|O
light	|O
conductor	|O
Bozzini	|O
's	|O
merit	|O
is	|O
emphasized	|O
,	|O
by	|O
his	|O
invention	|O
as	|O
first	|O
physician	|O
to	|O
have	|O
made	|O
accessible	|O
to	|O
medicine	|O
endoscopic	|O
diagnostic	|O
possibilities	|O
.	|O

The	|O
effect	|O
of	|O
lithium	|O
on	|O
the	|O
osmoregulation	|O
of	|O
arginine	|O
vasopressin	|B-PROTEIN
secretion	|O
.	|O

The	|O
susceptibility	|O
of	|O
the	|O
PPNG	|O
strains	|O
to	|O
clinically	|O
relevant	|O
antibiotics	|O
varied	|O
with	|O
the	|O
plasmid	|O
pattern	|O
;	|O
this	|O
stresses	|O
the	|O
necessity	|O
of	|O
permanent	|O
surveillance	|O
of	|O
gonococcal	|O
infections	|O
and	|O
of	|O
regular	|O
evaluation	|O
of	|O
the	|O
recommendations	|O
for	|O
antimicrobial	|O
treatment	|O
.	|O

Antithrombin	|B-PROTEIN
III	|I-PROTEIN
(	|O
AT	|B-PROTEIN
III	|I-PROTEIN
)	|O
is	|O
a	|O
plasma	|O
protein	|O
which	|O
acts	|O
as	|O
the	|O
principal	|O
inhibitor	|O
of	|O
thrombin	|B-PROTEIN
and	|O
is	|O
a	|O
major	|O
modulator	|O
of	|O
intravascular	|O
coagulation	|O
.	|O

Eighteen	|O
patients	|O
were	|O
untreated	|O
,	|O
and	|O
8	|O
had	|O
been	|O
given	|O
previous	|O
treatment	|O
with	|O
depot	|O
testosterone	|O
100	|O
mg	|O
intramuscularly	|O
every	|O
2-3	|O
weeks	|O
for	|O
an	|O
average	|O
duration	|O
of	|O
4.7	|O
years	|O
.	|O

195mPt	|O
-	|O
labeled	|O
cisplatin	|O
was	|O
administered	|O
iv	|O
and	|O
ip	|O
to	|O
control	|O
mice	|O
and	|O
to	|O
mice	|O
bearing	|O
Sarcoma	|O
180	|O
.	|O

New	|O
beta	|O
-	|O
blocking	|O
drugs	|O
have	|O
been	|O
introduced	|O
which	|O
may	|O
prove	|O
beneficial	|O
in	|O
certain	|O
clinical	|O
situations	|O
since	|O
they	|O
exert	|O
more	|O
selective	|O
blockade	|O
of	|O
the	|O
cardiac	|B-PROTEIN
receptors	|I-PROTEIN
(	|O
beta1	|B-PROTEIN
)	|O
as	|O
opposed	|O
to	|O
smooth	|B-PROTEIN
muscle	|I-PROTEIN
receptors	|I-PROTEIN
(	|O
beta2	|B-PROTEIN
)	|O
.	|O

If	|O
facilities	|O
for	|O
measurements	|O
of	|O
O2	|O
consumption	|O
and	|O
hence	|O
metabolic	|O
rate	|O
are	|O
available	|O
,	|O
these	|O
should	|O
be	|O
utilized	|O
.	|O

This	|O
generally	|O
means	|O
an	|O
energy	|O
intake	|O
of	|O
1.4	|O
to	|O
1.6	|O
times	|O
the	|O
energy	|O
expenditure	|O
,	|O
with	|O
a	|O
N	|O
intake	|O
of	|O
250	|O
to	|O
400	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
.	|O

In	|O
the	|O
37	|O
patients	|O
without	|O
lung	|O
disease	|O
respiratory	|O
muscle	|O
weakness	|O
was	|O
accompanied	|O
by	|O
significant	|O
decreases	|O
in	|O
vital	|O
capacity	|O
,	|O
total	|O
lung	|O
capacity	|O
,	|O
and	|O
maximum	|O
voluntary	|O
ventilation	|O
;	|O
by	|O
significant	|O
increases	|O
in	|O
residual	|O
volume	|O
and	|O
arterial	|O
carbon	|O
dioxide	|O
tension	|O
(	|O
PaCO2	|O
)	|O
;	|O
and	|O
greater	|O
likelihood	|O
of	|O
dependence	|O
on	|O
ventilators	|O
,	|O
atelectasis	|O
,	|O
and	|O
pneumonia	|O
.	|O

Commun	|O
.	|O

The	|O
statistical	|O
analysis	|O
of	|O
data	|O
of	|O
TRH	|B-PROTEIN
test	|O
on	|O
a	|O
sample	|O
of	|O
57	|O
healthy	|O
volunteers	|O
has	|O
permitted	|O
an	|O
evaluation	|O
of	|O
the	|O
upper	|O
limits	|O
of	|O
the	|O
normal	|O
thyrotropin	|B-PROTEIN
response	|O
;	|O
the	|O
secretory	|O
area	|O
(	|O
As	|O
)	|O
was	|O
shown	|O
to	|O
be	|O
more	|O
discriminating	|O
.	|O

Total	|O
cumulative	|O
doses	|O
of	|O
doxorubicin	|O
ranged	|O
from	|O
145	|O
to	|O
625	|O
mg	|O
.	|O
/	|O
m.2	|O
.	|O

Movement	|O
programming	|O
depends	|O
on	|O
understanding	|O
of	|O
behavioral	|O
requirements	|O
.	|O

Following	|O
20	|O
min	|O
of	|O
steady	|O
state	|O
anaesthesia	|O
during	|O
which	|O
measurements	|O
of	|O
IOP	|O
,	|O
arterial	|O
pressure	|O
,	|O
heart	|O
rate	|O
,	|O
FIO2	|O
,	|O
FE	|O
'	|O
CO2	|O
and	|O
CVP	|O
were	|O
recorded	|O
,	|O
one	|O
group	|O
of	|O
patients	|O
received	|O
atracurium	|O
0.45	|O
mg	|O
kg	|O
-	|O
1	|O
and	|O
the	|O
other	|O
pancuronium	|O
0.1	|O
mg	|O
kg	|O
-	|O
1	|O
.	|O

Transitory	|O
subclinical	|O
and	|O
permanent	|O
hypothyroidism	|O
in	|O
the	|O
course	|O
of	|O
subacute	|O
thyroiditis	|O
(	|O
de	|O
Quervain	|O
)	|O
.	|O

Gonadotropin	|B-PROTEIN
levels	|O
in	|O
mothers	|O
who	|O
have	|O
had	|O
two	|O
sets	|O
of	|O
DZ	|O
twins	|O
.	|O

Freezing	|O
of	|O
plasma	|O
to	|O
obtain	|O
better	|O
yield	|O
of	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
:	|O
C.	|O

These	|O
children	|O
were	|O
grouped	|O
into	|O
four	|O
diagnostic	|O
categories	|O
:	|O
1	|O
)	|O
idiopathic	|O
GH	|B-PROTEIN
deficiency	|O
(	|O
n	|O
=	|O
10	|O
)	|O
;	|O
2	|O
)	|O
organic	|O
hypopituitarism	|O
(	|O
n	|O
=	|O
7	|O
)	|O
;	|O
3	|O
)	|O
intrauterine	|O
growth	|O
retardation	|O
(	|O
n	|O
=	|O
5	|O
)	|O
;	|O
and	|O
4	|O
)	|O
constitutional	|O
delay	|O
of	|O
growth	|O
and	|O
/	|O
or	|O
familial	|O
short	|O
stature	|O
(	|O
n	|O
=	|O
18	|O
)	|O
,	|O
by	|O
standard	|O
clinical	|O
criteria	|O
and	|O
physiological	|O
and	|O
pharmacological	|O
tests	|O
of	|O
GH	|B-PROTEIN
reserve	|O
.	|O

Each	|O
patient	|O
had	|O
measurable	|O
LH	|B-PROTEIN
and	|O
FSH	|B-PROTEIN
levels	|O
,	|O
with	|O
pulsed	|O
nocturnal	|O
secretion	|O
,	|O
and	|O
pubertal	|O
LH	|B-PROTEIN
and	|O
FSH	|B-PROTEIN
responses	|O
to	|O
LRH	|B-PROTEIN
.	|O

These	|O
changes	|O
were	|O
the	|O
result	|O
of	|O
a	|O
decrease	|O
in	|O
afterload	|O
:	|O
mean	|O
aortic	|O
pressure	|O
fell	|O
from	|O
85	|O
+	|O
/	|O
-	|O
11.8	|O
to	|O
68	|O
+	|O
/	|O
-	|O
19.6	|O
mmHg	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
and	|O
systemic	|O
arterial	|O
resistance	|O
fell	|O
from	|O
2	|O
886	|O
+	|O
/	|O
-	|O
745	|O
to	|O
2	|O
010	|O
+	|O
/	|O
-	|O
610	|O
dynes	|O
/	|O
cm	|O
-	|O
5	|O
/	|O
sec	|O
/	|O
m	|O
-	|O
2	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

Cimetidine	|O
800	|O
mg	|O
given	|O
at	|O
night	|O
is	|O
as	|O
effective	|O
as	|O
400	|O
mg	|O
twice	|O
daily	|O
;	|O
the	|O
single	|O
dose	|O
regimen	|O
may	|O
improve	|O
patient	|O
compliance	|O
,	|O
thus	|O
facilitating	|O
treatment	|O
.	|O

Ceftazidime	|O
shows	|O
promise	|O
as	|O
single	|O
-	|O
agent	|O
therapy	|O
for	|O
serious	|O
gram	|O
-	|O
negative	|O
bacillary	|O
infections	|O
.	|O

Regional	|O
CBF	|O
was	|O
determined	|O
by	|O
clearance	|O
of	|O
xenon	|O
133	|O
in	|O
67	|O
patients	|O
undergoing	|O
coronary	|O
bypass	|O
grafting	|O
procedures	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
serum	|O
BGP	|B-PROTEIN
is	|O
a	|O
valuable	|O
measurement	|O
of	|O
bone	|O
metabolism	|O
.	|O

The	|O
management	|O
of	|O
the	|O
"	|O
chronic	|O
"	|O
patient	|O
.	|O

Study	|O
of	|O
bacterial	|O
motility	|O
and	|O
rate	|O
of	|O
movement	|O
using	|O
a	|O
closed	|O
circuit	|O
television	|O

Finding	|O
of	|O
Rhodnius	|O
prolixus	|O
Stal	|O
,	|O
1859	|O
,	|O
in	|O
babassu	|O
palm	|O
trees	|O

Each	|O
causative	|O
organism	|O
has	|O
a	|O
species	|O
-	|O
specific	|O
preference	|O
and	|O
requirement	|O
for	|O
temperature	|O
,	|O
salinity	|O
,	|O
pH	|O
,	|O
the	|O
basic	|O
nutrients	|O
,	|O
and	|O
growth	|O
factors	|O
,	|O
and	|O
the	|O
toxin	|O
formation	|O
is	|O
affected	|O
by	|O
these	|O
environmental	|O
factors	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
axillo	|O
-	|O
axillary	|O
by	|O
-	|O
pass	|O
is	|O
a	|O
simple	|O
solution	|O
for	|O
a	|O
complex	|O
haemodynamic	|O
,	|O
clinical	|O
and	|O
therapeutic	|O
problem	|O
.	|O

Deformities	|O
of	|O
the	|O
tip	|O
of	|O
the	|O
olecranon	|O
and	|O
of	|O
the	|O
coronoid	|O
process	|O
are	|O
also	|O
described	|O
(	|O
De	|O
Palma	|O
1956	|O
,	|O
Jordan	|O
1958	|O
,	|O
Ahlberg	|O
1965	|O
,	|O
Weseloh	|O
1973	|O
)	|O
.	|O

There	|O
was	|O
significant	|O
correlation	|O
of	|O
LVM	|O
/	|O
M2	|O
and	|O
PWVn	|O
for	|O
pre	|O
-	|O
AVR	|O
and	|O
post	|O
AVR	|O
studies	|O
.	|O

Statokinesimetric	|O
recording	|O
in	|O
Huntington	|O
choreas	|O

The	|O
development	|O
and	|O
histostructural	|O
organization	|O
of	|O
intrahepatic	|O
biliary	|O
ducts	|O
were	|O
studied	|O
on	|O
a	|O
human	|O
embryofetal	|O
material	|O
6	|O
to	|O
32	|O
weeks	|O
old	|O
.	|O

It	|O
has	|O
been	|O
shown	|O
in	|O
an	|O
animal	|O
experiment	|O
that	|O
alterations	|O
of	|O
the	|O
renal	|O
vasculature	|O
and	|O
parenchyma	|O
after	|O
hemostasis	|O
performed	|O
by	|O
Infrared	|O
-	|O
Contact	|O
-	|O
Coagulation	|O
are	|O
best	|O
shown	|O
by	|O
intravital	|O
magnification	|O
angiography	|O
(	|O
magnification	|O
factor	|O
2.22	|O
)	|O
.	|O

Cardiovascular	|O
and	|O
adrenal	|O
medullo	|O
-	|O
sympathetic	|O
reactions	|O
to	|O
acute	|O
tobacco	|O
poisoning	|O

Intravenous	|O
injections	|O
of	|O
SG	|O
-	|O
75	|O
(	|O
0.03-1	|O
mg	|O
/	|O
kg	|O
)	|O
decreased	|O
systemic	|O
blood	|O
pressure	|O
(	|O
SBP	|O
)	|O
and	|O
increased	|O
peripheral	|O
(	|O
coronary	|O
,	|O
renal	|O
,	|O
mesenteric	|O
and	|O
femoral	|O
)	|O
blood	|O
flow	|O
(	|O
PBF	|O
)	|O
dose	|O
-	|O
dependently	|O
.	|O

In	|O
doses	|O
of	|O
0.03-0.3	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
,	|O
SG	|O
-	|O
75	|O
did	|O
not	|O
significantly	|O
affect	|O
pulse	|O
pressure	|O
,	|O
heart	|O
rate	|O
,	|O
aortic	|O
blood	|O
flow	|O
,	|O
left	|O
ventricular	|O
pressure	|O
(	|O
LVP	|O
)	|O
and	|O
LVdP	|O
/	|O
dt	|O
max	|O
.	|O

Resting	|O
VE	|O
in	|O
the	|O
luteal	|O
phase	|O
was	|O
7.8%	|O
greater	|O
than	|O
that	|O
in	|O
the	|O
follicular	|O
phase	|O
.	|O

Exposure	|O
of	|O
endothelium	|O
to	|O
pulsatile	|O
shear	|O
stresses	|O
that	|O
followed	|O
a	|O
tape	|O
recording	|O
of	|O
physiological	|O
flow	|O
waveforms	|O
(	|O
electromagnetic	|O
flowmeter	|O
)	|O
did	|O
not	|O
cause	|O
gross	|O
injury	|O
or	|O
denudation	|O
even	|O
when	|O
peak	|O
shear	|O
exceeded	|O
1500	|O
dyne	|O
/	|O
cm2	|O
.	|O

Modern	|O
cancer	|O
therapy	|O
has	|O
included	|O
surgery	|O
,	|O
radiotherapy	|O
,	|O
chemotherapy	|O
,	|O
and	|O
most	|O
recently	|O
,	|O
immunotherapy	|O
and	|O
hyperthermia	|O
.	|O

There	|O
was	|O
a	|O
close	|O
correlation	|O
between	|O
plasma	|O
clearance	|O
of	|O
NT	|O
by	|O
10	|O
-	|O
hydroxylation	|O
and	|O
the	|O
D	|O
metabolic	|O
ratio	|O
(	|O
D	|O
/	|O
4	|O
-	|O
OH	|O
-	|O
D	|O
in	|O
urine	|O
)	|O
in	|O
the	|O
Ghanaians	|O
(	|O
rs	|O
=	|O
-	|O
0.95	|O
;	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
and	|O
Swedes	|O
(	|O
rs	|O
=	|O
-	|O
0.84	|O
;	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

The	|O
response	|O
properties	|O
of	|O
cat	|O
horizontal	|O
canal	|O
afferents	|O
(	|O
N	|O
=	|O
81	|O
)	|O
were	|O
characterized	|O
by	|O
three	|O
parameters	|O
:	|O
their	|O
long	|O
time	|O
constants	|O
(	|O
tau	|O
)	|O
,	|O
low	|O
frequency	|O
gain	|O
constants	|O
(	|O
G1	|O
)	|O
,	|O
and	|O
middle	|O
frequency	|O
gain	|O
constants	|O
(	|O
Gm	|O
)	|O
.	|O

Endothelium	|O
of	|O
the	|O
central	|O
ear	|O
artery	|O
of	|O
an	|O
anesthetized	|O
rabbit	|O
is	|O
damaged	|O
by	|O
placing	|O
artery	|O
forceps	|O
on	|O
the	|O
ear	|O
directly	|O
over	|O
the	|O
vessel	|O
.	|O

Despite	|O
supraphysiologic	|O
E2	|O
concentrations	|O
,	|O
however	|O
,	|O
cervical	|O
mucus	|O
scores	|O
were	|O
significantly	|O
reduced	|O
in	|O
the	|O
CC	|O
-	|O
treated	|O
group	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

Stimulation	|O
of	|O
the	|O
caudate	|O
nucleus	|O
'	|O
dophamine	|O
-	|O
reactive	|O
system	|O
in	|O
dogs	|O
by	|O
means	|O
of	|O
administration	|O
of	|O
dophamine	|O
(	|O
60	|O
micrograms	|O
)	|O
and	|O
phenamine	|O
led	|O
to	|O
deterioration	|O
of	|O
conditioned	|O
and	|O
unconditioned	|O
components	|O
of	|O
feeding	|O
behaviour	|O
.	|O

Value	|O
of	|O
urine	|O
glucose	|O
tests	|O
in	|O
the	|O
management	|O
of	|O
type	|O
II	|O
diabetes	|O
mellitus	|O
.	|O

This	|O
experiment	|O
was	|O
conducted	|O
to	|O
determine	|O
if	|O
the	|O
sex	|O
or	|O
actual	|O
egg	|O
production	|O
was	|O
the	|O
important	|O
factor	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Hydrocortisone	|O
seems	|O
to	|O
be	|O
unable	|O
to	|O
hinder	|O
the	|O
postdenervation	|O
changes	|O
in	|O
the	|O
muscle	|O
membrane	|O
whereas	|O
high	|O
doses	|O
of	|O
the	|O
hormone	|O
are	|O
able	|O
to	|O
induce	|O
changes	|O
in	|O
the	|O
muscle	|O
membrane	|O
.	|O

Significant	|O
clinical	|O
differences	|O
between	|O
the	|O
patients	|O
treated	|O
with	|O
and	|O
without	|O
AMB	|O
were	|O
longer	|O
survival	|O
time	|O
following	|O
diagnosis	|O
of	|O
illness	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
and	|O
more	|O
frequent	|O
cranial	|O
nerve	|O
signs	|O
in	|O
the	|O
treated	|O
patients	|O
(	|O
P	|O
=	|O
0.089	|O
)	|O
.	|O

A	|O
pharmacokinetic	|O
study	|O
of	|O
apalcillin	|O
was	|O
performed	|O
in	|O
12	|O
patients	|O
in	|O
an	|O
intensive	|O
-	|O
care	|O
unit	|O
.	|O

Catch	|O
-	|O
up	|O
growth	|O
was	|O
observed	|O
only	|O
for	|O
a	|O
12	|O
-	|O
month	|O
period	|O
in	|O
4	|O
children	|O
with	|O
a	|O
bone	|O
age	|O
of	|O
7	|O
to	|O
8	|O
years	|O
.	|O

Thrombocyte	|O
function	|O
was	|O
impaired	|O
in	|O
all	|O
patients	|O
,	|O
characterized	|O
by	|O
a	|O
diminished	|O
platelet	|O
shape	|O
change	|O
.	|O

The	|O
findings	|O
demonstrate	|O
that	|O
AMPH	|O
administration	|O
induces	|O
a	|O
significant	|O
increase	|O
in	|O
the	|O
height	|O
of	|O
a	|O
major	|O
electroactive	|O
peak	|O
in	|O
the	|O
caudate	|O
nucleus	|O
of	|O
pigtail	|O
monkeys	|O
,	|O
and	|O
further	|O
that	|O
such	|O
amphetamine	|O
-	|O
induced	|O
increases	|O
can	|O
be	|O
manipulated	|O
by	|O
altering	|O
the	|O
affective	|O
and	|O
/	|O
or	|O
emotional	|O
state	|O
of	|O
the	|O
animal	|O
.	|O

In	|O
two	|O
experiments	|O
,	|O
neonatal	|O
female	|O
BALB	|O
/	|O
cCrgl	|O
or	|O
BALB	|O
/	|O
cfC3HCrgl	|O
mice	|O
were	|O
given	|O
subcutaneous	|O
injections	|O
of	|O
5	|O
micrograms	|O
17	|O
beta	|O
-	|O
estradiol	|O
or	|O
sesame	|O
oil	|O
for	|O
the	|O
first	|O
3	|O
days	|O
of	|O
life	|O
and	|O
were	|O
ovariectomized	|O
at	|O
60	|O
days	|O
of	|O
age	|O
,	|O
at	|O
which	|O
time	|O
vaginal	|O
concretions	|O
(	|O
Experiments	|O
I	|O
and	|O
II	|O
)	|O
or	|O
silica	|O
(	|O
Experiment	|O
II	|O
)	|O
were	|O
implanted	|O
intravaginally	|O
.	|O

For	|O
228	|O
of	|O
425	|O
deaths	|O
(	|O
54%	|O
)	|O
occurring	|O
among	|O
26	|O
100	|O
people	|O
of	|O
known	|O
age	|O
in	|O
the	|O
Malumfashi	|O
area	|O
of	|O
northern	|O
Nigeria	|O
,	|O
data	|O
were	|O
collected	|O
on	|O
symptoms	|O
present	|O
prior	|O
to	|O
death	|O
.	|O

Salivary	|O
estradiol	|O
17	|O
beta	|O
(	|O
E2	|O
-	|O
17	|O
beta	|O
)	|O
and	|O
progesterone	|O
(	|O
P	|O
)	|O
were	|O
determined	|O
by	|O
using	|O
radioimmunoassay	|O
techniques	|O
in	|O
30	|O
pregnant	|O
females	|O
in	|O
the	|O
first	|O
,	|O
second	|O
and	|O
third	|O
trimesters	|O
as	|O
well	|O
as	|O
in	|O
10	|O
non	|O
-	|O
pregnant	|O
controls	|O
during	|O
the	|O
luteal	|O
phase	|O
of	|O
the	|O
menstrual	|O
cycle	|O
.	|O

Other	|O
than	|O
d	|O
7	|O
,	|O
there	|O
was	|O
no	|O
significant	|O
effect	|O
on	|O
the	|O
number	|O
of	|O
implants	|O
.	|O

Variable	|O
FHR	|O
decelerations	|O
or	|O
bradycardias	|O
were	|O
encountered	|O
on	|O
95	|O
nonstress	|O
tests	|O
(	|O
18.8%	|O
)	|O
in	|O
80	|O
(	|O
33.5%	|O
)	|O
postdate	|O
patients	|O
.	|O

The	|O
response	|O
chain	|O
in	|O
each	|O
component	|O
was	|O
maintained	|O
by	|O
food	|O
presentation	|O
under	|O
a	|O
fixed	|O
-	|O
ratio	|O
schedule	|O
.	|O

The	|O
results	|O
imply	|O
that	|O
kindling	|O
does	|O
not	|O
produce	|O
its	|O
facilitating	|O
effect	|O
on	|O
acquisition	|O
of	|O
HPC	|O
SS	|O
by	|O
removing	|O
a	|O
disruptive	|O
effect	|O
of	|O
the	|O
stimulation	|O
.	|O

The	|O
persistent	|O
fetal	|O
dispersion	|O
of	|O
nodal	|O
and	|O
Hiss	|O
bundle	|O
fragments	|O
within	|O
the	|O
ventricular	|O
septum	|O
is	|O
proposed	|O
as	|O
a	|O
possible	|O
explanation	|O
.	|O

According	|O
to	|O
the	|O
biochemical	|O
tests	|O
,	|O
high	|O
activity	|O
(	|O
over	|O
200	|O
U	|O
/	|O
l	|O
)	|O
of	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
was	|O
recorded	|O
exclusively	|O
in	|O
patients	|O
with	|O
the	|O
lymphogranulomatosis	|O
-	|O
induced	|O
liver	|O
damage	|O
.	|O

Changes	|O
of	|O
plasma	|O
cortisol	|O
level	|O
in	|O
late	|O
asthmatic	|O
responses	|O

Significant	|O
alterations	|O
in	|O
the	|O
vasectomized	|O
rats	|O
from	|O
sham	|O
rats	|O
included	|O
:	|O
testicular	|O
and	|O
epididymal	|O
hypertrophy	|O
,	|O
formation	|O
of	|O
pathologic	|O
vas	|O
deferens	|O
granulomas	|O
,	|O
decreased	|O
total	|O
serum	|O
protein	|O
,	|O
lowered	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
globulin	|I-PROTEIN
levels	|O
as	|O
shown	|O
by	|O
serum	|O
electrophoresis	|O
,	|O
and	|O
increased	|O
sperm	|O
agglutinin	|B-PROTEIN
antibody	|O
titers	|O
.	|O

SFP	|O
was	|O
significantly	|O
elevated	|O
in	|O
Hn	|O
(	|O
s	|O
)	|O
.	|O

The	|O
average	|O
birth	|O
mass	|O
of	|O
these	|O
newborns	|O
was	|O
3491.9	|O
+	|O
/	|O
-	|O
2	|O
SD	|O
780.5	|O
g	|O
and	|O
that	|O
in	|O
the	|O
control	|O
group	|O
3,767.5	|O
+	|O
/	|O
-	|O
2	|O
SD	|O
824.2	|O
g	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

This	|O
machine	|O
drift	|O
,	|O
which	|O
was	|O
not	|O
associated	|O
with	|O
a	|O
rise	|O
in	|O
water	|O
phantom	|O
temperature	|O
and	|O
did	|O
not	|O
consistently	|O
correlate	|O
with	|O
estimated	|O
x	|O
-	|O
ray	|O
tube	|O
heat	|O
,	|O
could	|O
result	|O
in	|O
a	|O
significant	|O
overestimation	|O
of	|O
regional	|O
cerebral	|O
blood	|O
flow	|O
(	|O
rCBF	|O
)	|O
for	|O
a	|O
xenon	|O
/	|O
CT	|O
rCBF	|O
protocol	|O
involving	|O
5-7	|O
sequential	|O
scans	|O
obtained	|O
at	|O
1	|O
-	|O
min	|O
interscan	|O
intervals	|O
.	|O

Other	|O
uncertainties	|O
in	|O
the	|O
dosimetry	|O
at	|O
Y	|O
-	|O
12	|O
and	|O
Vinca	|O
are	|O
unaltered	|O
.	|O

E2	|O
treatments	|O
elevated	|O
hen	|O
plasma	|O
TG	|O
7.2	|O
X	|O
,	|O
PL	|O
5.1	|O
X	|O
,	|O
and	|O
C	|O
7.2	|O
X	|O
;	|O
and	|O
pullet	|O
plasma	|O
TG	|O
6.8	|O
X	|O
,	|O
PL	|O
3.7	|O
X	|O
,	|O
and	|O
C	|O
2.5	|O
X.	|O

By	|O
contrast	|O
,	|O
kidneys	|O
from	|O
rats	|O
with	|O
chronic	|O
metabolic	|O
acidosis	|O
produced	|O
significantly	|O
more	|O
NH3	|O
than	|O
both	|O
these	|O
groups	|O
(	|O
2.73	|O
+	|O
/	|O
-	|O
0.29	|O
mumol	|O
X	|O
min	|O
-	|O
1	|O
X	|O
g	|O
-	|O
1	|O
)	|O
.	|O

Serodiagnosis	|O
of	|O
trypanosomiasis	|O
in	|O
dromedary	|O
camels	|O
using	|O
a	|O
card	|O
agglutination	|O
test	|O
set	|O
(	|O
Testryp	|O
CATT	|O
)	|O
.	|O

Adenyl	|B-PROTEIN
cyclase	|I-PROTEIN
activity	|O
of	|O
gastric	|O
mucosa	|O
in	|O
patients	|O
with	|O
duodenal	|O
ulcer	|O
before	|O
and	|O
after	|O
treatment	|O

Proteinuria	|O
-	|O
-	|O
selected	|O
physiopathological	|O
and	|O
clinical	|O
problems	|O

However	|O
,	|O
subcutaneously	|O
administered	|O
pneumococci	|O
gave	|O
a	|O
lower	|O
mortality	|O
than	|O
pneumococci	|O
given	|O
intravenously	|O
or	|O
intraperitoneally	|O
.	|O

Reaction	|O
of	|O
human	|O
organism	|O
to	|O
exercise	|O
.	|O

HA	|O
resulted	|O
in	|O
decreased	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
Tre	|O
(	|O
0.4	|O
degrees	|O
C	|O
)	|O
and	|O
HR	|O
(	|O
17	|O
b	|O
X	|O
min	|O
-	|O
1	|O
)	|O
,	|O
and	|O
increased	|O
(	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
Msw	|O
(	|O
16	|O
g	|O
X	|O
m	|O
-	|O
2	|O
X	|O
h	|O
-	|O
1	|O
)	|O
during	|O
the	|O
saline	|O
experiments	|O
.	|O

The	|O
results	|O
obtained	|O
were	|O
as	|O
follows	|O
:	|O
The	|O
mitral	|O
valve	|O
orifice	|O
area	|O
(	|O
MVA	|O
)	|O
was	|O
significantly	|O
smaller	|O
in	|O
patients	|O
with	|O
type	|O
III	|O
of	|O
the	|O
LVIT	|O
flow	|O
velocity	|O
pattern	|O
than	|O
in	|O
patients	|O
with	|O
type	|O
I	|O
(	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

Scientific	|O
cooperation	|O
of	|O
CMEA	|O
member	|O
countries	|O
has	|O
been	|O
carried	|O
out	|O
since	|O
1974	|O
under	|O
the	|O
sponsorship	|O
of	|O
the	|O
Cancer	|O
Research	|O
Institute	|O
,	|O
Slovak	|O
Academy	|O
of	|O
Sciences	|O
(	|O
Czechoslovakia	|O
)	|O
within	|O
the	|O
framework	|O
of	|O
CMEA	|O
.	|O

This	|O
compares	|O
favorably	|O
to	|O
results	|O
of	|O
similarly	|O
sized	|O
melanomas	|O
treated	|O
by	|O
enucleation	|O
.	|O

A	|O
new	|O
variant	|O
of	|O
the	|O
EMG	|O
-	|O
BFB	|O
method	|O
(	|O
multichannel	|O
)	|O
is	|O
offered	|O
which	|O
has	|O
made	|O
it	|O
possible	|O
to	|O
use	|O
the	|O
method	|O
not	|O
only	|O
for	|O
training	|O
weakened	|O
muscles	|O
and	|O
reducing	|O
spasticity	|O
in	|O
their	|O
antagonists	|O
but	|O
also	|O
for	|O
improving	|O
motor	|O
coordination	|O
.	|O

Lymphocytes	|O
from	|O
all	|O
3	|O
species	|O
yielded	|O
maximum	|O
responses	|O
with	|O
a	|O
48	|O
-	|O
hour	|O
prelabel	|O
and	|O
12	|O
-	|O
to	|O
-	|O
16	|O
hour	|O
postlabel	|O
incubation	|O
period	|O
at	|O
41	|O
C	|O
and	|O
1	|O
:	|O
20	|O
blood	|O
dilution	|O
.	|O

However	|O
,	|O
there	|O
was	|O
a	|O
difference	|O
in	|O
the	|O
quality	|O
of	|O
immunity	|O
:	|O
fever	|O
and	|O
body	|O
weight	|O
loss	|O
were	|O
seen	|O
in	|O
hamsters	|O
vaccinated	|O
with	|O
the	|O
killed	|O
-	|O
toxoplasma	|O
vaccine	|O
after	|O
they	|O
were	|O
challenge	|O
exposed	|O
with	|O
T	|O
-	|O
1	|O
strain	|O
,	|O
whereas	|O
these	|O
changes	|O
were	|O
rarely	|O
seen	|O
in	|O
hamsters	|O
given	|O
the	|O
live	|O
-	|O
toxoplasma	|O
vaccine	|O
and	|O
then	|O
challenge	|O
exposed	|O
with	|O
RH	|O
strain	|O
.	|O

Alternating	|O
proline	|O
/	|O
alanine	|O
sequence	|O
of	|O
beta	|B-PROTEIN
B1	|I-PROTEIN
subunit	|O
originates	|O
from	|O
a	|O
repetitive	|O
DNA	|O
sequence	|O
.	|O

The	|O
segmental	|O
and	|O
regional	|O
projections	|O
of	|O
the	|O
sciatic	|O
,	|O
tibial	|O
and	|O
common	|O
peroneal	|O
nerves	|O
to	|O
the	|O
substantia	|O
gelatinosa	|O
of	|O
the	|O
spinal	|O
cord	|O
in	|O
rats	|O
-	|O
-	|O
an	|O
experimental	|O
study	|O
by	|O
means	|O
of	|O
an	|O
acid	|B-PROTEIN
phosphatase	|I-PROTEIN
(	|O
ACP	|B-PROTEIN
)	|O
method	|O
.	|O

Removal	|O
of	|O
lipid	|O
fractions	|O
of	|O
plant	|O
extractions	|O
with	|O
hexane	|O
is	|O
recommended	|O
to	|O
avoid	|O
damage	|O
to	|O
the	|O
HPLC	|O
column	|O
.	|O

In	|O
the	|O
Arithmetic	|O
subtest	|O
one	|O
of	|O
the	|O
items	|O
would	|O
not	|O
meet	|O
the	|O
difficulty	|O
grading	|O
shown	|O
while	|O
the	|O
last	|O
two	|O
items	|O
offer	|O
very	|O
little	|O
possibility	|O
of	|O
success	|O
for	|O
all	|O
subjects	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

The	|O
toxicological	|O
evaluation	|O
of	|O
chlorofluorocarbon	|O
22	|O
(	|O
CFC	|O
22	|O
)	|O
.	|O

All	|O
patients	|O
were	|O
evaluable	|O
for	|O
toxicity	|O
and	|O
9	|O
for	|O
response	|O
.	|O

Methods	|O
of	|O
clinical	|O
and	|O
experimental	|O
algesimetry	|O
are	|O
described	|O
that	|O
have	|O
been	|O
used	|O
to	|O
evaluate	|O
effects	|O
of	|O
peripherally	|O
and	|O
centrally	|O
acting	|O
analgesics	|O
.	|O

The	|O
present	|O
paper	|O
elucidates	|O
the	|O
existing	|O
discrepancies	|O
,	|O
and	|O
offers	|O
a	|O
consistent	|O
terminology	|O
incorporating	|O
also	|O
such	|O
terms	|O
as	|O
"	|O
additivity	|O
"	|O
,	|O
"	|O
potentiation	|O
"	|O
,	|O
and	|O
"	|O
simple	|O
similarity	|O
"	|O
.	|O

We	|O
propose	|O
that	|O
the	|O
ambiguous	|O
discrimination	|O
required	|O
a	|O
greater	|O
time	|O
for	|O
simulus	|O
evaluation	|O
and	|O
that	|O
this	|O
was	|O
reflected	|O
in	|O
the	|O
delayed	|O
P3	|O
latencies	|O
.	|O

Ammonia	|O
concentration	|O
dropped	|O
significantly	|O
in	|O
all	|O
treatments	|O
,	|O
a	|O
finding	|O
which	|O
suggests	|O
a	|O
protective	|O
effect	|O
on	|O
protein	|O
nitrogen	|O
degradation	|O
to	|O
non	|O
-	|O
protein	|O
nitrogen	|O
(	|O
NH3	|O
)	|O
.	|O

In	|O
this	|O
respect	|O
C	|B-PROTEIN
reactive	|I-PROTEIN
protein	|I-PROTEIN
concentrations	|O
are	|O
superior	|O
to	|O
white	|O
cell	|O
count	|O
,	|O
erythrocyte	|O
sedimentation	|O
rate	|O
,	|O
and	|O
temperature	|O
and	|O
the	|O
concentrations	|O
of	|O
antiproteases	|O
.	|O

Human	|B-PROTEIN
thyroid	|I-PROTEIN
stimulator	|I-PROTEIN
(	|O
HTS	|B-PROTEIN
)	|O
in	|O
thyroid	|O
diseases	|O

We	|O
conclude	|O
that	|O
administration	|O
of	|O
the	|O
calcium	|O
antagonist	|O
Verapamil	|O
is	|O
of	|O
no	|O
additional	|O
value	|O
in	|O
tocolytic	|O
treatment	|O
with	|O
beta	|O
-	|O
mimetics	|O
.	|O

Brainstem	|O
auditory	|O
evoked	|O
responses	|O
(	|O
BAERs	|O
)	|O
and	|O
quantitative	|O
saccadic	|O
eye	|O
movement	|O
studies	|O
provide	|O
information	|O
on	|O
the	|O
integrity	|O
of	|O
pathways	|O
traversing	|O
the	|O
brainstem	|O
.	|O

Effects	|O
of	|O
ketamine	|O
on	|O
the	|O
circulatory	|O
functions	|O
and	|O
body	|O
tissue	|O
oxygenation	|O
in	|O
dogs	|O
under	|O
normal	|O
and	|O
hypovolemic	|O
conditions	|O
.	|O

The	|O
salient	|O
clinical	|O
features	|O
,	|O
the	|O
problems	|O
of	|O
management	|O
and	|O
the	|O
modern	|O
approaches	|O
to	|O
the	|O
reconstruction	|O
of	|O
facial	|O
deformities	|O
seen	|O
in	|O
this	|O
disease	|O
are	|O
described	|O
.	|O

Besides	|O
,	|O
it	|O
was	|O
considered	|O
that	|O
the	|O
NPF	|O
was	|O
a	|O
useful	|O
tool	|O
for	|O
activation	|O
of	|O
velopharyngeal	|O
activity	|O
by	|O
way	|O
of	|O
visual	|O
feed	|O
-	|O
back	|O
control	|O
.	|O

To	|O
evaluate	|O
the	|O
comparative	|O
safety	|O
of	|O
U	|O
-	|O
P	|O
and	|O
D	|O
&	|O
E	|O
,	|O
we	|O
analyzed	|O
2,805	|O
U	|O
-	|O
P	|O
and	|O
9,572	|O
D	|O
&	|O
E	|O
abortions	|O
at	|O
13	|O
to	|O
24	|O
menstrual	|O
weeks	|O
'	|O
gestation	|O
.	|O

Three	|O
radiologists	|O
without	|O
knowledge	|O
of	|O
patients	|O
'	|O
data	|O
and	|O
treatment	|O
analyzed	|O
30	|O
angiograms	|O
with	|O
and	|O
30	|O
examinations	|O
without	|O
PGF	|O
.	|O

In	|O
a	|O
man	|O
with	|O
myelomonocytic	|O
leukemia	|O
,	|O
the	|O
association	|O
of	|O
increased	|O
prostatic	|B-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
in	|O
serum	|O
and	|O
the	|O
presence	|O
of	|O
typical	|O
bone	|O
lesions	|O
on	|O
roentgenography	|O
suggested	|O
the	|O
existence	|O
of	|O
disseminated	|O
prostatic	|O
carcinoma	|O
.	|O

The	|O
rational	|O
for	|O
the	|O
prophylactic	|O
treatment	|O
,	|O
the	|O
therapy	|O
of	|O
the	|O
meningopathy	|O
and	|O
AIL	|O
-	|O
AIEOP	|O
protocols	|O
are	|O
exposed	|O
.	|O

An	|O
experimental	|O
long	|O
-	|O
term	|O
study	|O
.	|O

No	|O
anisotropism	|O
was	|O
recorded	|O
in	|O
a	|O
tetrahydrofuran	|O
solution	|O
.	|O

Hepatitis	|O
B	|O
vaccine	|O

The	|O
calculated	|O
values	|O
of	|O
lambda	|O
tb	|O
at	|O
37	|O
degrees	|O
C	|O
and	|O
50	|O
per	|O
cent	|O
haematocrit	|O
were	|O
0.650	|O
for	|O
the	|O
pulp	|O
,	|O
0.674	|O
for	|O
the	|O
tongue	|O
,	|O
0.828	|O
for	|O
the	|O
submandibular	|O
gland	|O
and	|O
0.881	|O
for	|O
the	|O
gingiva	|O
of	|O
the	|O
dog	|O
.	|O
lambda	|O
cp	|O
increased	|O
and	|O
lambda	|O
tp	|O
decreased	|O
as	|O
the	|O
temperature	|O
was	|O
reduced	|O
from	|O
37	|O
to	|O
4	|O
degrees	|O
C.	|O

As	|O
pleural	|O
thickening	|O
is	|O
seen	|O
commonly	|O
in	|O
asbestosis	|O
and	|O
may	|O
influence	|O
lung	|O
volumes	|O
and	|O
the	|O
ratio	|O
of	|O
transfer	|B-PROTEIN
factor	|I-PROTEIN
to	|O
effective	|O
alveolar	|O
volume	|O
,	|O
the	|O
results	|O
of	|O
these	|O
measurements	|O
were	|O
compared	|O
only	|O
in	|O
the	|O
cases	|O
showing	|O
absent	|O
or	|O
minimal	|O
pleural	|O
thickening	|O
.	|O

The	|O
invasive	|O
pattern	|O
of	|O
squamous	|O
cell	|O
carcinoma	|O
in	|O
the	|O
mandibular	|O
gingiva	|O

Azygos	|O
vein	|O
abutting	|O
the	|O
posterior	|O
wall	|O
of	|O
the	|O
right	|O
main	|O
and	|O
upper	|O
lobe	|O
bronchi	|O
:	|O
a	|O
normal	|O
CT	|O
variant	|O
.	|O

However	|O
,	|O
the	|O
history	|O
of	|O
acute	|O
severe	|O
complications	|O
from	|O
otitis	|O
media	|O
revealed	|O
a	|O
higher	|O
frequency	|O
in	|O
those	|O
individuals	|O
with	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
antitrypsin	|I-PROTEIN
deficiency	|O
as	|O
compared	|O
to	|O
normals	|O
.	|O

The	|O
Sarns	|O
51F	|O
cavoatrial	|O
cannula	|O
decompressed	|O
the	|O
venous	|O
system	|O
as	|O
efficiently	|O
as	|O
the	|O
double	|O
caval	|O
cannulas	|O
.	|O

All	|O
other	|O
changes	|O
at	|O
the	|O
3	|O
-	|O
,	|O
5	|O
-	|O
,	|O
and	|O
6	|O
-	|O
positions	|O
,	|O
as	|O
well	|O
as	|O
the	|O
replacement	|O
of	|O
the	|O
phenyl	|O
group	|O
at	|O
position	|O
2	|O
,	|O
caused	|O
a	|O
marked	|O
decrease	|O
of	|O
activity	|O
.	|O

Three	|O
experiments	|O
contrasted	|O
the	|O
effects	|O
of	|O
6	|O
-	|O
hydroxydopamine	|O
-	|O
induced	|O
lesions	|O
of	|O
the	|O
ventral	|O
noradrenergic	|O
and	|O
dorsal	|O
noradrenergic	|O
projections	|O
,	|O
predominantly	|O
to	|O
hypothalamus	|O
and	|O
cortex	|O
,	|O
respectively	|O
,	|O
upon	|O
body	|O
weight	|O
changes	|O
and	|O
food	|O
-	|O
related	|O
behaviour	|O
in	|O
the	|O
rat	|O
.	|O

Limb	|O
allografts	|O
in	|O
rats	|O
immunosuppressed	|O
with	|O
cyclosporin	|O
A.	|O

The	|O
method	|O
involved	|O
deproteinizing	|O
samples	|O
with	|O
two	|O
volumes	|O
of	|O
acetonitrile	|O
followed	|O
by	|O
injection	|O
of	|O
5	|O
microliters	|O
of	|O
deproteinized	|O
supernatant	|O
onto	|O
a	|O
C18	|O
reversed	|O
-	|O
phase	|O
column	|O
.	|O

Refractory	|O
periods	|O
of	|O
the	|O
AV	|O
junction	|O
were	|O
altered	|O
in	|O
a	|O
comparable	|O
fashion	|O
to	|O
conduction	|O
through	|O
the	|O
AV	|O
node	|O
.	|O

This	|O
paper	|O
brings	|O
together	|O
data	|O
,	|O
obtained	|O
from	|O
a	|O
variety	|O
of	|O
sources	|O
,	|O
on	|O
the	|O
extent	|O
of	|O
prescription	|O
and	|O
use	|O
of	|O
psychotropic	|O
drugs	|O
in	|O
the	|O
late	|O
1960s	|O
and	|O
early	|O
1970s	|O
.	|O

Sixteen	|O
patients	|O
were	|O
studied	|O
within	|O
24	|O
hours	|O
of	|O
resuscitation	|O
and	|O
all	|O
showed	|O
depressed	|O
right	|O
ventricular	|O
ejection	|O
(	|O
RVEF	|O
)	|O
and	|O
/	|O
or	|O
an	|O
increased	|O
end	|O
-	|O
diastolic	|O
volume	|O
(	|O
RVEDVI	|O
)	|O
.	|O

During	|O
a	|O
single	|O
LAD	|O
occlusion	|O
lasting	|O
35	|O
minutes	|O
(	|O
series	|O
I	|O
,	|O
n	|O
=	|O
10	|O
)	|O
9	|O
microns	|O
TMs	|O
were	|O
infused	|O
immediately	|O
and	|O
30	|O
minutes	|O
after	|O
ligation	|O
,	|O
15	|O
microns	|O
TMs	|O
being	|O
infused	|O
after	|O
15-20	|O
minutes	|O
.	|O

The	|O
population	|O
of	|O
between	|O
75,000	|O
and	|O
100,000	|O
was	|O
largely	|O
unstable	|O
,	|O
and	|O
cost	|O
per	|O
capita	|O
was	|O
$	|O
0.95	|O
to	|O
$	|O
1.21	|O
.	|O

Female	|O
Wistar	|O
rats	|O
were	|O
fed	|O
a	|O
liquid	|O
diet	|O
,	|O
Sustacal	|O
,	|O
which	|O
contained	|O
ethanol	|O
(	|O
40%	|O
of	|O
calories	|O
)	|O
or	|O
isocaloric	|O
sucrose	|O
.	|O

HL	|O
02	|O
type	|O
oculomotor	|O
stimulator	|O
.	|O

Four	|O
patients	|O
(	|O
group	|O
1	|O
)	|O
had	|O
type	|O
I	|O
basement	|O
membrane	|O
nephropathy	|O
,	|O
characterized	|O
by	|O
marked	|O
thickening	|O
and	|O
lamellation	|O
of	|O
the	|O
basement	|O
membrane	|O
in	|O
a	|O
pattern	|O
resembling	|O
that	|O
of	|O
Alport	|O
's	|O
syndrome	|O
.	|O

Brain	|O
pH	|O
following	|O
3	|O
h	|O
of	|O
cerebral	|O
focal	|O
ischemia	|O
changed	|O
from	|O
a	|O
normal	|O
value	|O
of	|O
7.0	|O
to	|O
6.5	|O
and	|O
6.2	|O
in	|O
animals	|O
studied	|O
under	|O
barbiturate	|O
and	|O
halothane	|O
anesthesia	|O
,	|O
respectively	|O
.	|O

Our	|O
results	|O
demonstrate	|O
the	|O
importance	|O
of	|O
phosphate	|O
and	|O
calcium	|O
in	|O
influencing	|O
the	|O
secretion	|O
of	|O
PTH	|B-PROTEIN
and	|O
CT	|B-PROTEIN
in	|O
uremia	|O
.	|O

Thin	|O
-	|O
layer	|O
chromatographic	|O
methods	|O
were	|O
up	|O
-	|O
dated	|O
for	|O
pharmacokinetic	|O
studies	|O
of	|O
imipramine	|O
in	|O
plasma	|O
and	|O
urine	|O
.	|O

Introductory	|O
remarks	|O
.	|O

Increasing	|O
the	|O
cut	|O
-	|O
off	|O
point	|O
to	|O
3	|O
positive	|O
responses	|O
decreased	|O
the	|O
sensitivity	|O
to	|O
81%	|O
and	|O
increased	|O
the	|O
specificity	|O
to	|O
94%	|O
.	|O

After	|O
clofelin	|O
administration	|O
the	|O
autoregulation	|O
borders	|O
shifted	|O
to	|O
the	|O
right	|O
i	|O
.	|O
e	|O
.	|O
towards	|O
higher	|O
AP	|O
levels	|O
.	|O

This	|O
phenomenon	|O
may	|O
be	|O
regarded	|O
as	|O
a	|O
variant	|O
of	|O
selective	|O
individual	|O
cell	|O
death	|O
,	|O
currently	|O
referred	|O
to	|O
as	|O
apoptosis	|O
,	|O
which	|O
has	|O
not	|O
been	|O
previously	|O
reported	|O
in	|O
a	|O
case	|O
of	|O
embryonal	|O
rhabdomyosarcoma	|O
.	|O

Combination	|O
of	|O
a	|O
Shwachman	|O
syndrome	|O
and	|O
a	|O
complex	|O
granulocyte	|O
function	|O
disorder	|O
in	|O
a	|O
girl	|O

A	|O
combined	|O
series	|O
of	|O
patients	|O
experienced	|O
a	|O
TOL	|O
after	|O
two	|O
or	|O
more	|O
previous	|O
cesarean	|O
deliveries	|O
;	|O
the	|O
rate	|O
of	|O
vaginal	|O
delivery	|O
was	|O
66%	|O
,	|O
and	|O
there	|O
was	|O
virtually	|O
no	|O
morbidity	|O
.	|O

Nursing	|O
home	|O
discharges	|O
in	|O
clinical	|O
practice	|O
.	|O

Trial	|O
3	|O
broiler	|O
chickens	|O
were	|O
maintained	|O
on	|O
control	|O
feed	|O
until	|O
they	|O
reached	|O
3	|O
weeks	|O
of	|O
age	|O
at	|O
which	|O
time	|O
they	|O
were	|O
taken	|O
off	|O
of	|O
feed	|O
for	|O
2.5	|O
hr	|O
and	|O
then	|O
placed	|O
on	|O
either	|O
control	|O
feed	|O
or	|O
feed	|O
containing	|O
4.0	|O
ppm	|O
ochratoxin	|O
A	|O
,	|O
and	|O
heart	|O
rate	|O
and	|O
blood	|O
pressure	|O
were	|O
measured	|O
every	|O
half	|O
hour	|O
through	|O
7	|O
hr	|O
.	|O

The	|O
carcinogen	|O
bioassay	|O
therefore	|O
is	|O
a	|O
very	|O
important	|O
component	|O
of	|O
the	|O
battery	|O
of	|O
toxicological	|O
tests	|O
used	|O
in	|O
hazard	|O
evaluation	|O
.	|O

Harmful	|O
effects	|O
in	|O
animals	|O
and	|O
man	|O
may	|O
result	|O
from	|O
both	|O
deficient	|O
or	|O
excessive	|O
amounts	|O
of	|O
intake	|O
.	|O

Angionephroscintigraphy	|O
in	|O
the	|O
diagnosis	|O
of	|O
diseases	|O
of	|O
the	|O
kidney	|O

The	|O
analysis	|O
of	|O
the	|O
structure	|O
of	|O
the	|O
sleep	|O
period	|O
as	|O
a	|O
whole	|O
reveals	|O
that	|O
with	|O
increasing	|O
of	|O
the	|O
age	|O
the	|O
delta	|O
-	|O
wave	|O
stage	|O
(	|O
DS	|O
)	|O
of	|O
the	|O
QS	|O
(	|O
determined	|O
by	|O
defined	|O
polygraphic	|O
parameters	|O
)	|O
increases	|O
,	|O
while	|O
the	|O
paradoxical	|O
phase	|O
of	|O
sleep	|O
(	|O
PS	|O
)	|O
decreases	|O
,	|O
this	|O
change	|O
being	|O
more	|O
pronounced	|O
during	|O
the	|O
first	|O
six	|O
months	|O
than	|O
during	|O
the	|O
second	|O
ones	|O
of	|O
the	|O
first	|O
year	|O
of	|O
the	|O
life	|O
.	|O

[	|O
82Br	|O
]	|O
MISO	|O
was	|O
prepared	|O
by	|O
irradiating	|O
samples	|O
of	|O
Br	|O
-	|O
MISO	|O
in	|O
a	|O
SLOWPOKE	|O
reactor	|O
for	|O
2	|O
h	|O
at	|O
a	|O
thermal	|O
neutron	|O
flux	|O
of	|O
10	|O
(	|O
12	|O
)	|O
n	|O
cm	|O
-	|O
2	|O
s	|O
-	|O
1	|O
.	|O

While	|O
these	|O
findings	|O
may	|O
reflect	|O
the	|O
sensitivity	|O
of	|O
a	|O
thick	|O
myocardial	|O
wall	|O
to	|O
ischaemia	|O
during	|O
surgery	|O
,	|O
the	|O
postoperative	|O
recovery	|O
was	|O
not	|O
related	|O
to	|O
the	|O
serum	|O
CK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
level	|O
.	|O

Morphofunctional	|O
status	|O
of	|O
the	|O
formed	|O
elements	|O
of	|O
the	|O
blood	|O
in	|O
rats	|O
subjected	|O
to	|O
different	|O
variants	|O
of	|O
combined	|O
and	|O
isolated	|O
exposure	|O
to	|O
BR	|O
-	|O
1	|O
benzene	|O

Using	|O
a	|O
MOS	|O
-	|O
Hypersil	|O
reversed	|O
-	|O
phase	|O
column	|O
with	|O
a	|O
phosphate	|O
buffer	|O
-	|O
-	|O
acetonitrile	|O
mobile	|O
phase	|O
,	|O
baseline	|O
separation	|O
of	|O
antipyrine	|O
,	|O
its	|O
metabolites	|O
3	|O
-	|O
hydroxymethylantipyrine	|O
,	|O
norantipyrine	|O
and	|O
4	|O
-	|O
hydroxyantipyrine	|O
,	|O
and	|O
the	|O
internal	|O
standard	|O
,	|O
phenacetin	|O
,	|O
was	|O
achieved	|O
within	|O
6	|O
min	|O
.	|O

The	|O
liver	|O
in	|O
the	|O
severely	|O
ill	|O

In	|O
a	|O
randomized	|O
study	|O
on	|O
150	|O
patients	|O
(	|O
ASA	|O
1	|O
)	|O
undergoing	|O
induction	|O
of	|O
anaesthesia	|O
,	|O
the	|O
effects	|O
of	|O
Fentanyl	|O
(	|O
0.1	|O
mg	|O
)	|O
,	|O
the	|O
combination	|O
of	|O
Fentanyl	|O
(	|O
0.1	|O
mg	|O
)	|O
and	|O
Droperidol	|O
(	|O
5	|O
mg	|O
)	|O
(	|O
Innovar	|O
,	|O
Thalamonal	|O
)	|O
and	|O
Atropine	|O
(	|O
0.01	|O
mg	|O
/	|O
kg	|O
b.w	|O
.	|O
)	|O
alone	|O
on	|O
cardiocirculatory	|O
parameters	|O
were	|O
studied	|O
.	|O

These	|O
results	|O
confirming	|O
the	|O
high	|O
validity	|O
of	|O
NOM	|O
inhibiting	|O
test	|O
in	|O
the	|O
diagnosis	|O
of	|O
tumoural	|O
hyperprolactinemic	|O
states	|O
,	|O
reveal	|O
contradictory	|O
responses	|O
to	|O
CD	|O
/	|O
LD	|O
,	|O
LD	|O
and	|O
DOM	|O
,	|O
with	|O
sustain	|O
the	|O
existence	|O
of	|O
2	|O
sub	|O
-	|O
group	|O
of	|O
Prolactinomas	|O
:	|O
with	|O
or	|O
without	|O
a	|O
maintained	|O
DA	|O
central	|O
tonus	|O
supporting	|O
the	|O
possibility	|O
of	|O
different	|O
etiopathogenetical	|O
factors	|O
in	|O
inducing	|O
a	|O
tumoural	|O
hyperprolactinemic	|O
states	|O
.	|O

Serum	|O
lipids	|O
and	|O
lipoproteins	|O
of	|O
29	|O
insulin	|B-PROTEIN
dependent	|O
diabetic	|O
children	|O
have	|O
been	|O
determined	|O
and	|O
related	|O
to	|O
the	|O
metabolic	|O
status	|O
of	|O
the	|O
patients	|O
.	|O

Low	|O
NA	|O
and	|O
A	|O
may	|O
participate	|O
in	|O
lowering	|O
the	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
which	|O
in	|O
PA	|O
in	|O
suppressed	|O
,	|O
sometimes	|O
disproportionately	|O
to	|O
the	|O
actual	|O
body	|O
sodium	|O
content	|O
.	|O

Amikacin	|O
concentrations	|O
in	|O
serum	|O
and	|O
blister	|O
fluid	|O
in	|O
healthy	|O
volunteers	|O
and	|O
in	|O
patients	|O
with	|O
renal	|O
impairment	|O
.	|O

The	|O
subgroup	|O
innervating	|O
the	|O
medial	|O
rectus	|O
lies	|O
exclusively	|O
along	|O
the	|O
medial	|O
face	|O
of	|O
the	|O
oculomotor	|O
nucleus	|O
,	|O
with	|O
no	|O
aberrant	|O
neurons	|O
in	|O
the	|O
medial	|O
longitudinal	|O
fasciculus	|O
,	|O
as	|O
have	|O
been	|O
found	|O
in	|O
other	|O
mammals	|O
.	|O

Hepatitis	|O
B	|O
vaccination	|O
strategy	|O
for	|O
health	|O
-	|O
care	|O
workers	|O
in	|O
a	|O
country	|O
of	|O
intermediate	|O
hepatitis	|O
B	|O
endemicity	|O
.	|O

An	|O
intravenous	|O
drip	|O
infusion	|O
of	|O
AMK	|O
in	|O
adequate	|O
dosage	|O
would	|O
be	|O
beneficial	|O
to	|O
use	|O
against	|O
some	|O
infectious	|O
diseases	|O
of	|O
otorhinolaryngologic	|O
field	|O
.	|O

Out	|O
of	|O
these	|O
families	|O
74,3%	|O
planned	|O
next	|O
pregnancy	|O
(	|O
table	|O
IX	|O
)	|O
,	|O
57,6%	|O
wanted	|O
to	|O
have	|O
prenatal	|O
diagnosis	|O
(	|O
table	|O
VI	|O
)	|O
.	|O

The	|O
authors	|O
have	|O
tested	|O
the	|O
interference	|O
of	|O
the	|O
hemoglobin	|B-PROTEIN
by	|O
two	|O
routine	|O
methods	|O
(	|O
Berthelot	|O
classic	|O
and	|O
Berthelot	|O
modified	|O
)	|O
for	|O
the	|O
determination	|O
of	|O
plasmatic	|O
urea	|O
.	|O

Parkinsonian	|O
patients	|O
had	|O
a	|O
significantly	|O
lower	|O
prevalence	|O
of	|O
alcohol	|O
use	|O
.	|O

These	|O
cells	|O
averaged	|O
17	|O
microns	|O
in	|O
diameter	|O
and	|O
reproduced	|O
by	|O
fission	|O
,	|O
forming	|O
clusters	|O
of	|O
two	|O
or	|O
four	|O
daughter	|O
cells	|O
.	|O

Female	|O
but	|O
not	|O
male	|O
mortalities	|O
were	|O
significantly	|O
higher	|O
for	|O
cake	|O
-	|O
fed	|O
rats	|O
than	|O
for	|O
those	|O
fed	|O
diet	|O
41B	|O
.	|O

Urinary	|O
N	|B-PROTEIN
-	|I-PROTEIN
acetylglucosaminidase	|I-PROTEIN
activity	|O
per	|O
mg	|O
creatinine	|O
did	|O
not	|O
differ	|O
significantly	|O
between	|O
groups	|O
.	|O

The	|O
associations	|O
between	|O
sex	|B-PROTEIN
-	|I-PROTEIN
hormone	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
globulin	|I-PROTEIN
capacity	|O
(	|O
SHBG	|B-PROTEIN
)	|O
,	|O
age	|O
,	|O
body	|O
mass	|O
index	|O
(	|O
BMI	|O
)	|O
,	|O
and	|O
physical	|O
fitness	|O
have	|O
been	|O
studied	|O
in	|O
34	|O
men	|O
and	|O
36	|O
women	|O
.	|O

Dipetalonema	|O
(	|O
Alafilaria	|O
)	|O
hydrochoerus	|O
subgen	|O
.	|O
et	|O
sp	|O
.	|O
n	|O
.	|O

After	|O
1.5	|O
years	|O
of	|O
such	|O
photoperiodic	|O
control	|O
,	|O
all	|O
ewes	|O
were	|O
blinded	|O
by	|O
bilateral	|O
orbital	|O
enucleation	|O
.	|O

The	|O
concentrations	|O
of	|O
C4	|B-PROTEIN
and	|O
C1	|B-PROTEIN
-	|I-PROTEIN
INH	|I-PROTEIN
increased	|O
with	|O
advancing	|O
stage	|O
of	|O
disease	|O
and	|O
were	|O
above	|O
normal	|O
mean	|O
values	|O
in	|O
all	|O
stages	|O
.	|O

Less	|O
antibacterial	|O
activity	|O
was	|O
shown	|O
toward	|O
the	|O
Gram	|O
-	|O
negative	|O
bacilli	|O
,	|O
i.e.	|O
,	|O
Pseudomonas	|O
,	|O
Klebsiella	|O
-	|O
Enterobacter	|O
,	|O
Shigella	|O
,	|O
Escherichia	|O
coli	|O
,	|O
Serratia	|O
marcescens	|O
and	|O
Proteus	|O
.	|O

The	|O
mucosal	|O
defence	|O
capacity	|O
against	|O
proteolytic	|O
leukocyte	|O
enzymes	|O
.	|O

The	|O
apparatus	|O
consists	|O
of	|O
an	|O
Am	|O
-	|O
241	|O
exciting	|O
source	|O
(	|O
300	|O
mCi	|O
)	|O
and	|O
pure	|O
Ge	|O
detector	|O
(	|O
50	|O
mm2	|O
X	|O
5	|O
mm	|O
)	|O
for	|O
measuring	|O
K	|O
alpha	|O
fluorescent	|O
x	|O
-	|O
rays	|O
(	|O
28.3	|O
and	|O
28.6	|O
KeV	|O
)	|O
emitted	|O
from	|O
exited	|O
iodine	|O
.	|O

Ultrastructural	|O
studies	|O
of	|O
retinopathy	|O
of	|O
premature	|O
infants	|O

The	|O
range	|O
of	|O
serum	|O
concentrations	|O
,	|O
mean	|O
values	|O
,	|O
median	|O
values	|O
,	|O
and	|O
standard	|O
deviations	|O
for	|O
each	|O
analyte	|O
are	|O
reported	|O
for	|O
males	|O
and	|O
females	|O
and	|O
for	|O
three	|O
age	|O
groups	|O
(	|O
25-44	|O
,	|O
45-59	|O
,	|O
60-70	|O
)	|O
.	|O

The	|O
effects	|O
of	|O
antithrombotic	|O
drugs	|O
in	|O
patients	|O
with	|O
left	|O
ventricular	|O
thrombi	|O
:	|O
assessment	|O
with	|O
indium	|O
-	|O
111	|O
platelet	|O
imaging	|O
and	|O
two	|O
-	|O
dimensional	|O
echocardiography	|O
.	|O

A	|O
stable	|O
interface	|O
depends	|O
on	|O
overall	|O
stress	|O
and	|O
microstress	|O
distribution	|O
on	|O
the	|O
bone	|O
,	|O
particularly	|O
trabecular	|O
bone	|O
.	|O

Plasma	|O
NE	|O
was	|O
also	|O
low	|O
in	|O
the	|O
anephric	|O
group	|O
(	|O
289	|O
mg	|O
/	|O
liter	|O
+	|O
/	|O
-	|O
126	|O
(	|O
1	|O
SD	|O
)	|O
vs	|O
612	|O
+	|O
/	|O
-	|O
189	|O
,	|O
P	|O
=	|O
0.033	|O
,	|O
resting	|O
)	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

10	|O
long	|O
-	|O
term	|O
hemodialysis	|O
patients	|O
had	|O
immediate	|O
and	|O
redistribution	|O
thallium	|O
-	|O
201	|O
myocardial	|O
imaging	|O
performed	|O
after	|O
a	|O
course	|O
of	|O
hemodialysis	|O
.	|O

The	|O
Prolactin	|B-PROTEIN
levels	|O
were	|O
within	|O
the	|O
physiological	|O
norms	|O
;	|O
the	|O
responses	|O
to	|O
TRH	|B-PROTEIN
were	|O
normal	|O
,	|O
and	|O
elevated	|O
only	|O
in	|O
a	|O
few	|O
cases	|O
.	|O

Despite	|O
total	|O
tumor	|O
resection	|O
,	|O
multiple	|O
intraperitoneal	|O
tumor	|O
nodules	|O
of	|O
varying	|O
sizes	|O
were	|O
found	|O
and	|O
resected	|O
six	|O
months	|O
and	|O
one	|O
year	|O
later	|O
.	|O

Private	|O
hospital	|O
accreditation	|O
.	|O

Antithrombin	|B-PROTEIN
III	|I-PROTEIN
in	|O
hip	|O
surgery	|O

In	|O
14	|O
of	|O
21	|O
infant	|O
hearts	|O
(	|O
66%	|O
)	|O
with	|O
aortic	|O
arch	|O
interruption	|O
between	|O
the	|O
left	|O
common	|O
carotid	|O
and	|O
left	|O
subclavian	|O
arteries	|O
(	|O
type	|O
B	|O
of	|O
Celoria	|O
and	|O
Patton	|O
)	|O
,	|O
the	|O
right	|O
subclavian	|O
artery	|O
(	|O
SA	|O
)	|O
arose	|O
anomalously	|O
.	|O

We	|O
suggest	|O
that	|O
sensitivity	|O
to	|O
photoperiod	|O
in	|O
pallid	|O
bats	|O
,	|O
as	|O
in	|O
several	|O
other	|O
mammals	|O
,	|O
is	|O
mediated	|O
by	|O
the	|O
pineal	|O
gland	|O
.	|O

Absorption	|O
was	|O
rapid	|O
,	|O
with	|O
a	|O
mean	|O
time	|O
to	|O
peak	|O
of	|O
39	|O
min	|O
.	|O

Additionally	|O
,	|O
observations	|O
that	|O
patients	|O
with	|O
mitral	|O
versus	|O
aortic	|O
regurgitation	|O
respond	|O
differently	|O
to	|O
valve	|O
replacement	|O
suggest	|O
that	|O
differences	|O
exist	|O
preoperatively	|O
between	|O
these	|O
two	|O
types	|O
of	|O
volume	|O
overload	|O
.	|O

A	|O
case	|O
of	|O
manifest	|O
latent	|O
nystagmus	|O
of	|O
late	|O
onset	|O
in	|O
a	|O
13	|O
-	|O
year	|O
-	|O
old	|O
girl	|O
is	|O
reported	|O
.	|O

Within	|O
the	|O
compartment	|O
or	|O
dimension	|O
of	|O
severity	|O
of	|O
depression	|O
a	|O
subscale	|O
of	|O
the	|O
Hamilton	|O
Depression	|O
Scale	|O
(	|O
or	|O
the	|O
Melancholia	|O
Scale	|O
)	|O
was	|O
shown	|O
to	|O
have	|O
reached	|O
an	|O
instrumental	|O
perfection	|O
,	|O
e.g.	|O
as	|O
an	|O
outcome	|O
measure	|O
of	|O
antidepressant	|O
treatment	|O
.	|O

Significant	|O
immunoglobulinuria	|O
developed	|O
prior	|O
to	|O
the	|O
development	|O
of	|O
azotemia	|O
,	|O
significantly	|O
decreased	|O
creatinine	|O
clearance	|O
,	|O
significant	|O
proteinuria	|O
(	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
3+	|O
dipstick	|O
or	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
5	|O
gm	|O
per	|O
24	|O
-	|O
hour	|O
urine	|O
collection	|O
)	|O
,	|O
or	|O
oliguria	|O
.	|O

A	|O
total	|O
number	|O
of	|O
1628	|O
cases	|O
were	|O
collected	|O
from	|O
135	|O
medical	|O
institutions	|O
.	|O

Epileptiform	|O
activity	|O
recorded	|O
from	|O
superficial	|O
laminae	|O
bordering	|O
layer	|O
4	|O
,	|O
and	|O
into	|O
which	|O
layer	|O
4'	|O
s	|O
primary	|O
projections	|O
terminate	|O
,	|O
is	|O
suppressed	|O
preferentially	|O
by	|O
phenytoin	|O
.	|O

The	|O
AD	|O
components	|O
were	|O
markedly	|O
more	|O
dependent	|O
on	|O
the	|O
affective	|O
state	|O
of	|O
the	|O
rat	|O
then	|O
was	|O
the	|O
V1	|O
component	|O
.	|O

Is	|O
nisoldipine	|O
capable	|O
of	|O
reducing	|O
left	|O
ventricular	|O
preload	|O
?	|O
In	|O
ten	|O
anesthetized	|O
pigs	|O
,	|O
nisoldipine	|O
(	|O
2-4	|O
micrograms	|O
X	|O
kg	|O
-	|O
1	|O
X	|O
min	|O
-	|O
1	|O
)	|O
,	|O
a	|O
calcium	|O
channel	|O
blocker	|O
structurally	|O
related	|O
to	|O
nifedipine	|O
,	|O
reduced	|O
left	|O
ventricular	|O
systolic	|O
pressure	|O
(	|O
40%	|O
)	|O
and	|O
systemic	|O
vascular	|O
resistance	|O
(	|O
35%	|O
)	|O
,	|O
whereas	|O
maxLVdP	|O
/	|O
dt	|O
decreased	|O
by	|O
20%	|O
and	|O
cardiac	|O
output	|O
was	|O
unchanged	|O
.	|O

Monkeys	|O
were	|O
evaluated	|O
before	|O
and	|O
after	|O
unilateral	|O
and	|O
serial	|O
bilateral	|O
removal	|O
of	|O
superior	|O
temporal	|O
cortex	|O
.	|O

HBB	|O
concentration	|O
in	|O
the	|O
fetuses	|O
indicated	|O
little	|O
,	|O
if	|O
any	|O
accumulation	|O
.	|O

All	|O
samples	|O
exhibited	|O
a	|O
decline	|O
in	|O
ethanol	|O
concentration	|O
,	|O
with	|O
most	|O
losses	|O
falling	|O
within	|O
the	|O
expected	|O
20	|O
to	|O
40	|O
mg	|O
%	|O
range	|O
.	|O

Plasma	|O
lactoferrin	|B-PROTEIN
and	|O
the	|O
blood	|O
count	|O
of	|O
polynuclear	|O
neutrophils	|O

The	|O
importance	|O
of	|O
selective	|O
renal	|O
vein	|O
phlebography	|O
in	|O
the	|O
evaluation	|O
of	|O
unexplained	|O
hematuria	|O
and	|O
filing	|O
defects	|O
in	|O
the	|O
excretory	|O
urogram	|O
is	|O
illustrated	|O
.	|O

Pilot	|O
study	|O
of	|O
blood	|O
coagulation	|O
in	|O
gout	|O
patients	|O
.	|O

The	|O
statistical	|O
analysis	|O
consist	|O
of	|O
the	|O
F	|O
test	|O
followed	|O
by	|O
Snedecor	|O
's	|O
contrast	|O
test	|O
.	|O

The	|O
pyramidal	|O
tract	|O
and	|O
Mesencephalic	|O
Reticular	|O
Formation	|O
(	|O
MRF	|O
)	|O
were	|O
stimulated	|O
before	|O
and	|O
after	|O
the	|O
transection	|O
.	|O

Further	|O
,	|O
the	|O
reduction	|O
in	|O
5	|O
-	|O
hydroxytryptophan	|O
(	|O
5	|O
-	|O
HTP	|O
)	|O
accumulation	|O
by	|O
LSD	|O
showed	|O
regional	|O
differences	|O
in	|O
inhibition	|O
by	|O
methiothepin	|O
(	|O
hypothalamus	|O
greater	|O
than	|O
cortex	|O
greater	|O
than	|O
striatum	|O
)	|O
which	|O
paralleled	|O
the	|O
autoreceptor	|O
antagonist	|O
activity	|O
of	|O
methiothepin	|O
in	|O
vitro	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Effects	|O
of	|O
methiothepin	|O
and	|O
lysergic	|O
acid	|O
diethylamide	|O
on	|O
serotonin	|O
release	|O
in	|O
vitro	|O
and	|O
serotonin	|O
synthesis	|O
in	|O
vivo	|O
:	|O
possible	|O
relation	|O
to	|O
serotonin	|B-PROTEIN
autoreceptor	|I-PROTEIN
function	|O
.	|O

In	|O
a	|O
recent	|O
measles	|O
epidemic	|O
in	|O
El	|O
Paso	|O
,	|O
TX	|O
,	|O
120,000	|O
records	|O
were	|O
screened	|O
using	|O
these	|O
criteria	|O
,	|O
and	|O
as	|O
a	|O
result	|O
13,000	|O
students	|O
were	|O
vaccinated	|O
.	|O

No	|O
patient	|O
with	|O
bradyarrhythmia	|O
-	|O
related	|O
SCD	|O
had	|O
manifest	|O
atrioventricular	|O
block	|O
or	|O
bundle	|O
branch	|O
block	|O
.	|O

The	|O
measurement	|O
of	|O
the	|O
areas	|O
of	|O
fibrin	|B-PROTEIN
,	|O
of	|O
tissue	|O
and	|O
fibrinolysis	|O
,	|O
at	|O
the	|O
above	|O
mentioned	|O
times	|O
,	|O
has	|O
been	|O
effected	|O
at	|O
standard	|O
magnification	|O
(	|O
15	|O
X	|O
)	|O
by	|O
an	|O
image	|O
analyser	|O
(	|O
Videoplan	|O
)	|O
scale	|O
1	|O
:	|O
8	|O
.	|O

Diclofenac	|O
sodium	|O
-	|O
chlormezanone	|O
poisoning	|O
.	|O

Postprandial	|O
plasma	|O
enteroglucagon	|B-PROTEIN
concentration	|O
after	|O
90	|O
minutes	|O
in	|O
untreated	|O
patients	|O
correlated	|O
positively	|O
to	|O
the	|O
faecal	|O
fat	|O
excretion	|O
(	|O
r	|O
=	|O
0.58	|O
,	|O
p	|O
less	|O
than	|O
0.02	|O
)	|O
.	|O

Blood	|O
pressure	|O
in	|O
children	|O
.	|O

In	|O
this	|O
study	|O
the	|O
splenectomized	|O
captive	|O
born	|O
cynomolgus	|O
appeared	|O
to	|O
be	|O
capable	|O
of	|O
supplementing	|O
rhesus	|O
as	|O
an	|O
antimalarial	|O
drug	|O
testing	|O
model	|O
.	|O

The	|O
results	|O
showed	|O
that	|O
the	|O
sensitivity	|O
of	|O
the	|O
3	|O
given	|O
guinea	|O
pig	|O
strains	|O
was	|O
comparable	|O
.	|O

Adult	|O
Amblyomma	|O
lepidum	|O
ticks	|O
fed	|O
as	|O
nymphs	|O
on	|O
this	|O
goat	|O
transmitted	|O
heartwater	|O
to	|O
a	|O
Friesian	|O
(	|O
Bos	|O
taurus	|O
)	|O
calf	|O
.	|O

Twenty	|O
-	|O
one	|O
percent	|O
of	|O
these	|O
patients	|O
had	|O
neurologic	|O
disease	|O
that	|O
appeared	|O
to	|O
be	|O
responsible	|O
for	|O
the	|O
tinnitus	|O
.	|O

Morphine	|O
injected	|O
into	|O
the	|O
lateral	|O
ventricle	|O
of	|O
the	|O
rat	|O
produced	|O
unilateral	|O
analgesia	|O
in	|O
the	|O
formalin	|O
test	|O
,	|O
which	|O
involves	|O
continuous	|O
,	|O
moderate	|O
pain	|O
.	|O

The	|O
maps	|O
of	|O
Case	|O
2	|O
showed	|O
that	|O
a	|O
maximum	|O
first	|O
appeared	|O
on	|O
the	|O
upper	|O
right	|O
back	|O
and	|O
then	|O
moved	|O
down	|O
the	|O
right	|O
side	|O
of	|O
the	|O
posterior	|O
thorax	|O
.	|O

Urinary	|O
urate	|O
excretion	|O
,	|O
urate	|O
clearance	|O
,	|O
and	|O
fractional	|O
excretion	|O
of	|O
urate	|O
all	|O
increased	|O
significantly	|O
during	|O
water	|O
immersion	|O
,	|O
and	|O
decreased	|O
in	|O
the	|O
hour	|O
following	|O
water	|O
immersion	|O
.	|O

Mutations	|O
in	|O
seven	|O
other	|O
lts	|B-PROTEIN
genes	|O
do	|O
not	|O
result	|O
in	|O
the	|O
mak	|B-PROTEIN
-	|O
phenotype	|O
.	|O

Twenty	|O
-	|O
eight	|O
were	|O
excluded	|O
as	|O
gallstones	|O
were	|O
not	|O
proved	|O
:	|O
of	|O
the	|O
remainder	|O
,	|O
21	|O
patients	|O
received	|O
glucagon	|B-PROTEIN
and	|O
22	|O
placebo	|O
.	|O

4	|O
Five	|O
patients	|O
died	|O
within	|O
one	|O
month	|O
of	|O
captopril	|O
and	|O
five	|O
between	|O
four	|O
and	|O
seven	|O
months	|O
,	|O
three	|O
of	|O
whom	|O
had	|O
improved	|O
to	|O
class	|O
IIM	|O
and	|O
one	|O
to	|O
IIS	|O
before	|O
death	|O
.	|O

Bullous	|O
angiolymphoid	|O
hyperplasia	|O
with	|O
eosinophilia	|O

Regions	|O
of	|O
the	|O
translated	|O
open	|O
reading	|O
frames	|O
of	|O
cobA	|B-PROTEIN
and	|O
the	|O
third	|O
intron	|O
of	|O
the	|O
cob	|B-PROTEIN
gene	|O
in	|O
yeast	|O
show	|O
high	|O
amino	|O
acid	|O
homology	|O
.	|O

Multiresistant	|O
strains	|O
isolated	|O
from	|O
humans	|O
in	|O
enteral	|O
toxico	|O
-	|O
infections	|O
kill	|O
orally	|O
infected	|O
mice	|O
more	|O
frequently	|O
than	|O
strains	|O
isolated	|O
in	|O
hospital	|O
infections	|O
.	|O

Single	|O
tooth	|O
replacement	|O
with	|O
the	|O
aid	|O
of	|O
the	|O
ITI	|O
(	|O
International	|O
Team	|O
fur	|O
Implantologie	|O
)	|O
type	|O
F	|O
hollow	|O
-	|O
cylinder	|O
implant	|O

The	|O
13,14	|O
-	|O
dihydro	|O
-	|O
15	|O
-	|O
keto	|O
-	|O
metabolites	|O
of	|O
PGE2	|O
and	|O
PGF2	|O
alpha	|O
had	|O
no	|O
statistically	|O
significant	|O
antiarrhythmic	|O
effect	|O
.	|O

Nucleotide	|O
sequence	|O
of	|O
DNA	|O
controlling	|O
expression	|O
of	|O
genes	|O
for	|O
maltosaccharide	|O
utilization	|O
in	|O
Streptococcus	|O
pneumoniae	|O
.	|O

The	|O
hypertension	|O
with	|O
elevated	|O
PRA	|O
,	|O
however	|O
,	|O
was	|O
resistant	|O
to	|O
the	|O
angiotensin	|B-PROTEIN
II	|I-PROTEIN
(	|O
AII	|B-PROTEIN
)	|O
analog	|O
[	|O
Sar1	|O
,	|O
Ile8	|O
]	|O
ALL	|O
.	|O

Colorimetric	|O
determination	|O
of	|O
urinary	|O
iron	|O
,	|O
chelated	|O
with	|O
deferoxamine	|O
B	|O
,	|O
using	|O
a	|O
single	|O
reagent	|O

Measurements	|O
of	|O
perfusion	|O
also	|O
showed	|O
significantly	|O
higher	|O
values	|O
under	|O
active	|O
therapy	|O
.	|O

Volume	|O
of	|O
distribution	|O
of	|O
total	|O
DMDZ	|O
(	|O
range	|O
,	|O
1.33	|O
to	|O
6.30	|O
l	|O
/	|O
kg	|O
)	|O
and	|O
of	|O
unbound	|O
DMDZ	|O
after	|O
correction	|O
for	|O
protein	|O
binding	|O
(	|O
range	|O
,	|O
43	|O
to	|O
243	|O
l	|O
/	|O
kg	|O
)	|O
was	|O
larger	|O
in	|O
women	|O
than	|O
in	|O
men	|O
of	|O
all	|O
ages	|O
,	|O
and	|O
in	|O
the	|O
elderly	|O
as	|O
opposed	|O
to	|O
the	|O
young	|O
.	|O

Effects	|O
of	|O
dopamine	|O
and	|O
of	|O
a	|O
dopaminergic	|O
blocker	|O
,	|O
haloperidol	|O
,	|O
on	|O
the	|O
responses	|O
of	|O
carotid	|O
body	|O
chemoreceptors	|O
to	|O
hypoxia	|O
and	|O
hypercapnia	|O
were	|O
investigated	|O
in	|O
16	|O
anesthetized	|O
cats	|O
.	|O

HLA	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
and	|I-PROTEIN
B	|I-PROTEIN
phenotypes	|O
of	|O
105	|O
patients	|O
suffering	|O
from	|O
malignant	|O
melanomas	|O
were	|O
determined	|O
,	|O
with	|O
special	|O
regard	|O
for	|O
metastatic	|O
form	|O
or	|O
relapse	|O
.	|O

Trypanosoma	|O
cruzi	|O
.	|O

The	|O
subjects	|O
of	|O
the	|O
study	|O
were	|O
10	|O
normal	|O
subjects	|O
and	|O
64	|O
patients	|O
with	|O
gastroduodenal	|O
disease	|O
.	|O

1	|O
.	|O

This	|O
study	|O
represents	|O
the	|O
first	|O
published	|O
long	|O
-	|O
term	|O
follow	|O
-	|O
up	|O
regarding	|O
this	|O
mode	|O
of	|O
treatment	|O
in	|O
patients	|O
with	|O
alveolar	|O
hypoventilation	|O
.	|O

The	|O
alterations	|O
in	|O
differentiation	|O
of	|O
osteoprogenitor	|O
cells	|O
,	|O
together	|O
with	|O
the	|O
failure	|O
of	|O
mineralization	|O
,	|O
resulted	|O
in	|O
significantly	|O
lower	|O
rates	|O
of	|O
bone	|O
formation	|O
(	|O
as	|O
measured	|O
by	|O
fluorochrome	|O
labeling	|O
)	|O
in	|O
the	|O
magnesium	|O
-	|O
deficient	|O
rats	|O
.	|O

A	|O
convenient	|O
measure	|O
of	|O
this	|O
impairment	|O
may	|O
be	|O
obtained	|O
using	|O
the	|O
ratio	|O
of	|O
urine	|O
volume	|O
(	|O
V	|O
)	|O
divided	|O
by	|O
lithium	|O
clearance	|O
(	|O
CLi	|O
)	|O
.	|O

Nitrogen	|O
balance	|O
was	|O
compared	|O
,	|O
and	|O
metabolic	|O
complications	|O
were	|O
monitored	|O
by	|O
evaluating	|O
BUN	|O
,	|O
serum	|O
creatinine	|O
,	|O
creatinine	|O
clearance	|O
,	|O
serum	|O
CO2	|O
,	|O
SGOT	|B-PROTEIN
,	|O
SGPT	|B-PROTEIN
,	|O
serum	|O
LDH	|B-PROTEIN
,	|O
and	|O
serum	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
.	|O

Production	|O
of	|O
C	|O
mu	|B-PROTEIN
RNAs	|O
,	|O
unlike	|O
mu	|B-PROTEIN
mRNAs	|O
,	|O
does	|O
not	|O
require	|O
recombination	|O
with	|O
the	|O
joining	|B-PROTEIN
region	|I-PROTEIN
(	|O
JH	|B-PROTEIN
)	|O
locus	|O
.	|O

The	|O
1.9	|O
-	|O
kb	|O
C	|B-PROTEIN
mu	|I-PROTEIN
RNA	|O
contains	|O
the	|O
3'	|O
sequence	|O
characteristic	|O
of	|O
secreted	|O
mu	|B-PROTEIN
chain	|I-PROTEIN
,	|O
whereas	|O
the	|O
longer	|O
species	|O
bear	|O
that	|O
of	|O
membrane	|O
-	|O
bound	|O
mu	|B-PROTEIN
chin	|O
.	|O

Transcripts	|O
of	|O
the	|O
immunoglobulin	|B-PROTEIN
C	|I-PROTEIN
mu	|I-PROTEIN
gene	|O
vary	|O
in	|O
structure	|O
and	|O
splicing	|O
during	|O
lymphoid	|O
development	|O
.	|O

Non	|O
-	|O
complement	|O
-	|O
dependent	|O
sperm	|O
-	|O
immobilizing	|O
activity	|O
was	|O
also	|O
detected	|O
in	|O
the	|O
cervical	|O
mucus	|O
of	|O
several	|O
patients	|O
.	|O

The	|O
role	|O
of	|O
DNA	|O
rearrangement	|O
and	|O
alternative	|O
RNA	|O
processing	|O
in	|O
the	|O
expression	|O
of	|O
immunoglobulin	|B-PROTEIN
delta	|I-PROTEIN
genes	|O
.	|O

Although	|O
the	|O
mechanism	|O
of	|O
action	|O
of	|O
ICRF	|O
-	|O
159	|O
and	|O
187	|O
has	|O
not	|O
been	|O
clearly	|O
defined	|O
,	|O
it	|O
is	|O
evident	|O
from	|O
both	|O
preclinical	|O
and	|O
early	|O
clinical	|O
studies	|O
that	|O
these	|O
compounds	|O
are	|O
of	|O
interest	|O
.	|O

All	|O
62	|O
isolates	|O
were	|O
resistant	|O
to	|O
lincomycin	|O
,	|O
colistin	|O
,	|O
nystatin	|O
,	|O
amphotericin	|O
B	|O
,	|O
trimethoprim	|O
lactate	|O
,	|O
polymyxin	|O
B	|O
,	|O
and	|O
anisomycin	|O
.	|O

The	|O
evaluation	|O
of	|O
amniotic	|O
fluid	|O
delta	|O
OD450	|O
is	|O
considered	|O
to	|O
be	|O
the	|O
cornerstone	|O
of	|O
clinical	|O
management	|O
.	|O

Host	|O
lipids	|O
in	|O
tuberculous	|O
infection	|O
.	|O

There	|O
is	|O
now	|O
a	|O
significative	|O
difference	|O
between	|O
age	|O
group	|O
1-5	|O
and	|O
the	|O
others	|O
(	|O
p	|O
Less	|O
Than	|O
0,02	|O
)	|O
.	|O

The	|O
sympathetic	|O
neuroeffector	|O
influence	|O
on	|O
the	|O
myocardium	|O
with	|O
ATCI	|O
depends	|O
to	|O
a	|O
large	|O
measure	|O
on	|O
the	|O
intensity	|O
of	|O
the	|O
neurotransmitter	|O
biosynthesis	|O
and	|O
function	|O
of	|O
cardiomyocyte	|O
adrenoreceptors	|O
.	|O

Lens	|O
aldose	|B-PROTEIN
reductase	|I-PROTEIN
in	|O
diabetic	|O
and	|O
galactosemic	|O
cataracts	|O
.	|O

Fenfluramine	|O
(	|O
in	|O
doses	|O
ranging	|O
from	|O
0.0625-4.0	|O
mg	|O
/	|O
kg	|O
/	|O
infusion	|O
)	|O
did	|O
not	|O
maintain	|O
self	|O
-	|O
administration	|O
behavior	|O
at	|O
or	|O
above	|O
the	|O
minimum	|O
requirement	|O
(	|O
FR	|O
30	|O
)	|O
.	|O

In	|O
the	|O
course	|O
of	|O
Hepatitis	|O
A	|O
HBs	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
HBe	|I-PROTEIN
-	|I-PROTEIN
antigen	|I-PROTEIN
as	|O
well	|O
as	|O
HBc	|B-PROTEIN
(	|I-PROTEIN
IgM	|I-PROTEIN
and	|I-PROTEIN
IgG	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
,	|I-PROTEIN
HBs	|I-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
HBe	|I-PROTEIN
-	|I-PROTEIN
antibodies	|I-PROTEIN
can	|O
be	|O
detected	|O
.	|O

The	|O
effect	|O
of	|O
the	|O
fatty	|O
acid	|O
cyclo	|B-PROTEIN
-	|I-PROTEIN
oxygenase	|I-PROTEIN
inhibitor	|O
indomethacin	|O
on	|O
cerebral	|O
blood	|O
flow	|O
(	|O
CBF	|O
)	|O
and	|O
the	|O
metabolic	|O
rate	|O
for	|O
oxygen	|O
(	|O
CMRO2	|O
)	|O
was	|O
studied	|O
in	|O
paralyzed	|O
and	|O
artificially	|O
ventilated	|O
rats	|O
.	|O

The	|O
rat	|O
incisor	|O
is	|O
an	|O
excellent	|O
model	|O
system	|O
in	|O
which	|O
to	|O
study	|O
amelgenesis	|O
.	|O

The	|O
already	|O
elevated	|O
prolactin	|B-PROTEIN
levels	|O
in	|O
nursing	|O
women	|O
were	|O
not	|O
influenced	|O
by	|O
chronic	|O
oestradiol	|O
administration	|O
.	|O

Factor	|B-PROTEIN
VIII	|I-PROTEIN
procoagulant	|O
activity	|O
,	|O
antigen	|O
concentration	|O
and	|O
von	|B-PROTEIN
Willebrand	|I-PROTEIN
activity	|O
as	|O
ristocetin	|B-PROTEIN
cofactor	|I-PROTEIN
were	|O
determined	|O
several	|O
times	|O
in	|O
10	|O
patients	|O
with	|O
DIC	|O
.	|O

Morphine	|O
-	|O
dependent	|O
and	|O
control	|O
rats	|O
in	|O
an	|O
oral	|O
free	|O
-	|O
choice	|O
protocol	|O
were	|O
treated	|O
with	|O
gamma	|O
-	|O
vinyl	|O
GABA	|O
(	|O
GVG	|O
)	|O
,	|O
60	|O
,	|O
120	|O
and	|O
240	|O
mg	|O
/	|O
kg	|O
IP	|O
,	|O
for	|O
3	|O
days	|O
over	|O
three	|O
successive	|O
periods	|O
.	|O

Significance	|O
of	|O
the	|O
pulmonary	|O
gas	|O
exchange	|O
reaction	|O
to	|O
physical	|O
loading	|O
in	|O
evaluating	|O
the	|O
effectiveness	|O
of	|O
mitral	|O
commissurotomy	|O

Thyreoliberin	|B-PROTEIN
VUFB	|O
in	|O
thyroid	|O
gammagraphy	|O

In	|O
silicosis	|O
,	|O
significant	|O
relationships	|O
between	|O
patients	|O
and	|O
sons	|O
were	|O
not	|O
seen	|O
with	|O
respect	|O
to	|O
arterial	|O
blood	|O
gas	|O
determinations	|O
and	|O
ventilatory	|O
responses	|O
except	|O
for	|O
Paco2	|O
of	|O
patients	|O
and	|O
hypercapnic	|O
ventilatory	|O
responses	|O
of	|O
sons	|O
.	|O

For	|O
steers	|O
the	|O
urinary	|O
N	|O
values	|O
were	|O
403	|O
and	|O
295	|O
mg	|O
/	|O
kg	|O
W0.7	|O
5	|O
at	|O
200	|O
and	|O
350	|O
kg	|O
live	|O
weight	|O
respectively	|O
and	|O
total	|O
N	|O
excretion	|O
including	|O
faecal	|O
N	|O
was	|O
408	|O
and	|O
320	|O
mg	|O
/	|O
kg	|O
W0.7	|O
5	|O
.	|O

Advances	|O
in	|O
hemophilia	|O
treatment	|O
:	|O
a	|O
hepatitis	|O
-	|O
safe	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
concentrate	|O

This	|O
study	|O
was	|O
designed	|O
to	|O
assess	|O
and	|O
compare	|O
the	|O
ability	|O
of	|O
three	|O
different	|O
forms	|O
of	|O
DSG	|O
to	|O
block	|O
EIB	|O
.	|O

Comparison	|O
of	|O
three	|O
different	|O
preparations	|O
of	|O
disodium	|O
cromoglycate	|O
in	|O
the	|O
prevention	|O
of	|O
exercise	|O
-	|O
induced	|O
bronchospasm	|O
:	|O
a	|O
double	|O
-	|O
blind	|O
study	|O
.	|O

LCBF	|O
in	|O
normal	|O
and	|O
hypoxic	|O
puppies	|O
was	|O
correlated	|O
with	|O
local	|O
cerebral	|O
glucose	|O
utilization	|O
(	|O
LCGU	|O
)	|O
obtained	|O
under	|O
the	|O
same	|O
experimental	|O
conditions	|O
(	|O
Duffy	|O
et	|O
al	|O
,	|O
1982	|O
)	|O
.	|O

Phagocytosis	|O
of	|O
tubercle	|O
bacilli	|O
by	|O
macrophages	|O
.	|O

Detection	|O
of	|O
hemophilia	|O
A	|O
carriers	|O
.	|O

The	|O
stability	|O
of	|O
isoniazid	|O
solutions	|O
increases	|O
markedly	|O
with	|O
increasing	|O
NTA	|O
or	|O
EDTA	|O
concentration	|O
up	|O
to	|O
1	|O
mmol	|O
/	|O
l	|O
.	|O

Bile	|O
bilirubin	|O
did	|O
not	|O
rise	|O
within	|O
12	|O
h	|O
after	|O
haem	|O
infusion	|O
a	|O
finding	|O
which	|O
warrants	|O
further	|O
investigation	|O
.	|O

Autoimmune	|O
manipulation	|O
aids	|O
juvenile	|O
diabetes	|O
management	|O
.	|O

Other	|O
properties	|O
of	|O
Hg	|O
-	|O
and	|O
Cd	|O
-	|O
spores	|O
were	|O
similar	|O
to	|O
those	|O
of	|O
control	|O
spores	|O
.	|O

The	|O
decrease	|O
in	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
with	|O
increasing	|O
VLDL	|B-PROTEIN
-	|I-PROTEIN
triglycerides	|I-PROTEIN
was	|O
relatively	|O
much	|O
larger	|O
than	|O
the	|O
concomitant	|O
decrease	|O
in	|O
apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I.	|I-PROTEIN

Apo	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
level	|O
was	|O
unrelated	|O
to	|O
age	|O
,	|O
but	|O
increased	|O
with	|O
ethanol	|O
consumption	|O
and	|O
decreased	|O
with	|O
adiposity	|O
.	|O

TEMTU	|O
and	|O
DPTU	|O
were	|O
the	|O
most	|O
potent	|O
teratogens	|O
.	|O

The	|O
osmotic	|O
diuretic	|O
mannitol	|O
was	|O
administered	|O
to	|O
21	|O
patients	|O
.	|O

Of	|O
270	|O
patients	|O
with	|O
well	|O
-	|O
defined	|O
drug	|O
reactions	|O
,	|O
190	|O
(	|O
70	|O
per	|O
cent	|O
)	|O
gave	|O
a	|O
positive	|O
response	|O
to	|O
the	|O
mast	|O
cell	|O
test	|O
.	|O

Selenium	|O
,	|O
as	|O
a	|O
constituent	|O
of	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
,	|O
plays	|O
a	|O
role	|O
in	|O
the	|O
antioxidant	|O
defense	|O
systems	|O
of	|O
the	|O
body	|O
,	|O
but	|O
other	|O
metabolic	|O
roles	|O
for	|O
selenium	|O
may	|O
yet	|O
be	|O
discovered	|O
.	|O

Diagnostic	|O
value	|O
of	|O
serum	|O
myoglobin	|B-PROTEIN
in	|O
cases	|O
of	|O
neuromuscular	|O
disease	|O

At	|O
43%	|O
blood	|O
pressure	|O
reduction	|O
,	|O
PCO2	|O
fell	|O
by	|O
0.53	|O
kPa	|O
,	|O
a	|O
decrease	|O
which	|O
could	|O
not	|O
explain	|O
the	|O
observed	|O
CBF	|O
fall	|O
of	|O
27%	|O
.	|O

During	|O
the	|O
last	|O
6	|O
months	|O
of	|O
the	|O
study	|O
a	|O
striking	|O
change	|O
in	|O
epidemiology	|O
concerning	|O
hepatitis	|O
A	|O
was	|O
seen	|O
,	|O
apparently	|O
caused	|O
by	|O
a	|O
steep	|O
increase	|O
in	|O
the	|O
incidence	|O
of	|O
this	|O
type	|O
of	|O
hepatitis	|O
among	|O
drug	|O
addicts	|O
.	|O

Asthmatic	|O
patients	|O
showed	|O
greater	|O
responses	|O
of	|O
both	|O
parameters	|O
to	|O
adrenaline	|O
than	|O
controls	|O
indicating	|O
that	|O
long	|O
-	|O
term	|O
corticosteroid	|O
treatment	|O
enhances	|O
the	|O
acute	|O
responses	|O
of	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
and	|O
clotting	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
to	|O
adrenaline	|O
infusion	|O
.	|O

Sulphur	|O
amino	|O
acids	|O
(	|O
g	|O
/	|O
16	|O
g	|O
N	|O
)	|O
were	|O
higher	|O
in	|O
the	|O
isolates	|O
than	|O
in	|O
the	|O
flours	|O
.	|O

Time	|O
shifts	|O
increase	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
release	|O
.	|O

It	|O
then	|O
merged	|O
with	|O
right	|O
ventricular	|O
wavefronts	|O
ending	|O
along	|O
the	|O
right	|O
ventricular	|O
anterior	|O
atrioventricular	|O
groove	|O
and	|O
outflow	|O
tract	|O
.	|O

Many	|O
of	|O
these	|O
landfill	|O
operations	|O
were	|O
undertaken	|O
in	|O
the	|O
early	|O
1950s	|O
and	|O
1960s	|O
,	|O
when	|O
knowledge	|O
regarding	|O
the	|O
safe	|O
and	|O
prolonged	|O
containment	|O
of	|O
the	|O
waste	|O
buried	|O
was	|O
nonexistent	|O
or	|O
minimal	|O
at	|O
best	|O
.	|O

Vesicles	|O
could	|O
be	|O
induced	|O
only	|O
with	|O
multiple	|O
exposures	|O
to	|O
UVA	|O
.	|O

The	|O
level	|O
of	|O
contamination	|O
in	|O
the	|O
wound	|O
can	|O
be	|O
determined	|O
with	|O
the	|O
rapid	|O
biopsy	|O
fixation	|O
technique	|O
.	|O

Self	|O
-	|O
heating	|O
after	|O
deep	|O
hypothermia	|O
(	|O
20	|O
degrees	|O
C	|O
)	|O
causes	|O
a	|O
considerable	|O
increase	|O
in	|O
the	|O
brain	|O
tissues	|O
glutaminase	|B-PROTEIN
activity	|O
at	|O
all	|O
studied	|O
incubation	|O
temperatures	|O
(	|O
37	|O
,	|O
30	|O
,	|O
20	|O
and	|O
10	|O
degrees	|O
C	|O
)	|O
as	|O
compared	|O
to	|O
control	|O
rats	|O
and	|O
rats	|O
under	|O
hypothermia	|O
.	|O

Similar	|O
observations	|O
were	|O
made	|O
with	|O
unilateral	|O
pneumothorax	|O
of	|O
15	|O
cmH2O	|O
for	|O
30	|O
min	|O
.	|O

According	|O
to	|O
Sugiura	|O
's	|O
classification	|O
,	|O
they	|O
consisted	|O
of	|O
Type	|O
Ia	|O
in	|O
63%	|O
,	|O
Type	|O
Ib	|O
in	|O
11%	|O
,	|O
Type	|O
II	|O
in	|O
11%	|O
,	|O
and	|O
Type	|O
III	|O
in	|O
16%	|O
.	|O

This	|O
study	|O
was	|O
undertaken	|O
to	|O
define	|O
the	|O
mechanism	|O
for	|O
the	|O
respiratory	|O
inhibition	|O
observed	|O
during	|O
high	|O
-	|O
frequency	|O
oscillatory	|O
ventilation	|O
(	|O
HFOV	|O
)	|O
.	|O

Determination	|O
of	|O
20	|O
alpha	|O
-	|O
hydroxy	|O
-	|O
9	|O
beta	|O
,	|O
10	|O
alpha	|O
-	|O
pregna	|O
-	|O
4,6	|O
-	|O
dien	|O
-	|O
3	|O
-	|O
one	|O
in	|O
plasma	|O
by	|O
selected	|O
ion	|O
monitoring	|O
.	|O

A	|O
case	|O
of	|O
a	|O
dense	|O
epidermoid	|O
cyst	|O
of	|O
the	|O
suprasellar	|O
cistern	|O
is	|O
presented	|O
.	|O

Copper	|O
treatments	|O
were	|O
assigned	|O
to	|O
simulate	|O
the	|O
different	|O
levels	|O
of	|O
copper	|O
intake	|O
that	|O
might	|O
result	|O
from	|O
differences	|O
in	|O
daily	|O
feed	|O
intake	|O
similar	|O
to	|O
the	|O
practice	|O
followed	|O
with	|O
commercial	|O
industry	|O
.	|O

Fibromuscular	|O
intimal	|O
thickening	|O
was	|O
seen	|O
in	|O
the	|O
ascending	|O
and	|O
thoracic	|O
aorta	|O
of	|O
the	|O
swine	|O
fed	|O
62,500	|O
IU	|O
of	|O
vitamin	|O
D3	|O
/	|O
kg	|O
of	|O
diet	|O
for	|O
three	|O
months	|O
duration	|O
;	|O
and	|O
after	|O
3	|O
months	|O
of	|O
vitamin	|O
D3	|O
withdrawal	|O
,	|O
atherosclerotic	|O
lesions	|O
were	|O
found	|O
.	|O

Because	|O
of	|O
a	|O
rapid	|O
development	|O
of	|O
the	|O
connective	|O
tissue	|O
scars	|O
,	|O
however	|O
,	|O
at	|O
the	|O
place	|O
of	|O
the	|O
destroyed	|O
glandular	|O
parenchyma	|O
areas	|O
,	|O
there	|O
is	|O
no	|O
normalization	|O
of	|O
the	|O
organ	|O
's	|O
structure	|O
and	|O
function	|O
by	|O
the	|O
42d	|O
day	|O
.	|O

Histological	|O
signs	|O
of	|O
the	|O
flare	|O
-	|O
up	|O
reaction	|O
were	|O
already	|O
present	|O
at	|O
6	|O
hr	|O
after	|O
i.v	|O
.	|O
challenge	|O
and	|O
lasted	|O
for	|O
at	|O
least	|O
4	|O
days	|O
.	|O

Significant	|O
GMBF	|O
reductions	|O
occurred	|O
in	|O
early	|O
shock	|O
in	|O
both	|O
treatment	|O
groups	|O
.	|O

Of	|O
254	|O
children	|O
with	|O
neuroblastoma	|O
treated	|O
at	|O
St	|O
.	|O

Penicillin	|O
-	|O
G	|O
degradation	|O
products	|O
inhibit	|O
in	|O
vitro	|O
granulopoiesis	|O
.	|O

Plasma	|O
fibrinogen	|B-PROTEIN
was	|O
measured	|O
by	|O
the	|O
turbidimetric	|O
method	|O
in	|O
timol	|O
turbidimetric	|O
units	|O
.	|O

Five	|O
patients	|O
with	|O
type	|O
III	|O
musculoskeletal	|O
infection	|O
from	|O
nongonococcal	|O
Neisseria	|O
species	|O
were	|O
examined	|O
during	|O
a	|O
13	|O
-	|O
month	|O
period	|O
.	|O

Distal	|O
tubular	|O
acidification	|O
and	|O
the	|O
threshold	|O
for	|O
proximal	|O
tubular	|O
bicarbonate	|O
reabsorption	|O
were	|O
normal	|O
,	|O
as	|O
was	|O
urine	|O
concentrating	|O
capacity	|O
.	|O

Detection	|O
of	|O
exercise	|O
-	|O
induced	|O
asynergy	|O
by	|O
M	|O
-	|O
mode	|O
echocardiography	|O
.	|O

The	|O
Tullio	|O
phenomenon	|O
,	|O
fistula	|O
test	|O
,	|O
and	|O
Hennebert	|O
's	|O
sign	|O
:	|O
clinical	|O
significance	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
significant	|O
pulmonary	|O
metabolism	|O
of	|O
5	|O
-	|O
HT	|O
followed	|O
by	|O
efflux	|O
of	|O
5	|O
-	|O
HIAA	|O
into	|O
venous	|O
output	|O
occurs	|O
during	|O
single	|O
-	|O
pass	|O
circulation	|O
.	|O

Disturbances	|O
of	|O
placental	|O
maturation	|O
,	|O
2	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
histopathological	|O
findings	|O
,	|O
the	|O
origin	|O
of	|O
amyloid	|O
appeared	|O
to	|O
be	|O
closely	|O
related	|O
to	|O
the	|O
fibroblasts	|O
.	|O

Both	|O
groups	|O
were	|O
subjected	|O
to	|O
tests	|O
of	|O
delayed	|O
hypersensitivity	|O
with	|O
Candidin	|B-PROTEIN
,	|O
Trycophytin	|B-PROTEIN
and	|O
Tuberculin	|B-PROTEIN
.	|O

Serum	|O
lactate	|B-PROTEIN
dehydrogenase	|I-PROTEIN
and	|O
haptoglobin	|B-PROTEIN
levels	|O
were	|O
normal	|O
,	|O
and	|O
total	|O
bilirubin	|O
was	|O
only	|O
slightly	|O
elevated	|O
.	|O

Low	|O
-	|O
dose	|O
D	|O
(	|O
0.4-0.8	|O
mg	|O
)	|O
and	|O
DB	|O
(	|O
1.0-5.0	|O
mg	|O
)	|O
did	|O
not	|O
significantly	|O
alter	|O
any	|O
parameter	|O
from	|O
control	|O
.	|O

Efficacy	|O
of	|O
cervical	|O
spine	|O
immobilization	|O
methods	|O
.	|O

Leads	|O
from	|O
the	|O
MMWR	|O
.	|O

The	|O
presence	|O
of	|O
visna	|O
-	|O
maedi	|O
in	|O
Italy	|O
is	|O
reported	|O
for	|O
the	|O
first	|O
time	|O
.	|O

High	|O
levels	|O
of	|O
IC	|O
coincided	|O
with	|O
relative	|O
hypocomplementemia	|O
.	|O

Circulating	|O
platelets	|O
may	|O
be	|O
activated	|O
by	|O
exposed	|O
triple	|O
-	|O
helical	|O
collagen	|B-PROTEIN
in	|O
atherosclerotic	|O
lesions	|O
in	|O
Mg	|O
-	|O
deficient	|O
ruminants	|O
.	|O

Acute	|O
type	|O
A	|O
hepatitis	|O
in	|O
three	|O
patients	|O
with	|O
chronic	|O
HBV	|O
infection	|O
.	|O

Pathogenetic	|O
relationships	|O
between	|O
renal	|O
tubular	|O
acidosis	|O
and	|O
sodium	|O
metabolism	|O
alterations	|O
in	|O
liver	|O
cirrhosis	|O
.	|O

5	|O
microU	|O
/	|O
l	|O
thyrotropin	|B-PROTEIN
:	|O
75%	|O
(	|O
1974	|O
)	|O
,	|O
45%	|O
(	|O
1977	|O
)	|O
and	|O
20%	|O
(	|O
1980	|O
)	|O
.	|O

Echosismography	|O
enables	|O
to	|O
improve	|O
the	|O
diagnosis	|O
when	|O
compared	|O
with	|O
classical	|O
sonography	|O
in	|O
about	|O
20%	|O
of	|O
cases	|O
.	|O

Relationships	|O
with	|O
the	|O
acquired	|O
immune	|O
deficiency	|O
syndrome	|O
.	|O

The	|O
prevalence	|O
of	|O
CPAF	|O
was	|O
similar	|O
in	|O
type	|O
1	|O
and	|O
type	|O
2	|O
diabetes	|O
,	|O
was	|O
greater	|O
in	|O
women	|O
than	|O
in	|O
men	|O
,	|O
and	|O
was	|O
significantly	|O
greater	|O
after	|O
repeated	|O
administrations	|O
than	|O
after	|O
one	|O
single	|O
administration	|O
of	|O
chlorpropamide	|O
.	|O

A	|O
reassessment	|O
of	|O
the	|O
prevalence	|O
data	|O
was	|O
carried	|O
out	|O
in	|O
the	|O
southern	|O
province	|O
of	|O
Uusimaa	|O
and	|O
in	|O
the	|O
western	|O
province	|O
of	|O
Vaasa	|O
,	|O
the	|O
prevalence	|O
day	|O
being	|O
January	|O
1	|O
,	|O
1979	|O
.	|O

The	|O
results	|O
confirm	|O
and	|O
extend	|O
previous	|O
work	|O
by	|O
other	|O
researchers	|O
.	|O

In	|O
the	|O
ultramarathon	|O
runner	|O
the	|O
testosterone	|O
levels	|O
sharply	|O
rose	|O
at	|O
the	|O
beginning	|O
of	|O
the	|O
training	|O
session	|O
(	|O
from	|O
the	|O
7,20	|O
ng	|O
/	|O
ml	|O
to	|O
11,50	|O
ng	|O
/	|O
ml	|O
after	|O
20	|O
'	|O
training	|O
)	|O
,	|O
and	|O
subsequently	|O
decrease	|O
after	|O
3	|O
hours	|O
(	|O
9,20	|O
ng	|O
/	|O
ml	|O
)	|O
and	|O
at	|O
the	|O
end	|O
of	|O
the	|O
6	|O
hours	|O
training	|O
(	|O
4,60	|O
ng	|O
/	|O
ml	|O
)	|O
.	|O

In	|O
patients	|O
with	|O
complete	|O
or	|O
partial	|O
remission	|O
of	|O
the	|O
tumor	|O
,	|O
the	|O
neopterine	|O
excretion	|O
dropped	|O
to	|O
normal	|O
values	|O
.	|O

In	|O
visible	|O
tumours	|O
the	|O
best	|O
results	|O
were	|O
obtained	|O
with	|O
FB	|O
(	|O
85%	|O
)	|O
while	|O
TBN	|O
was	|O
positive	|O
in	|O
65%	|O
.	|O

Total	|O
PGE	|O
levels	|O
in	|O
synovial	|O
fluid	|O
remained	|O
significantly	|O
depressed	|O
in	|O
the	|O
patient	|O
group	|O
for	|O
24	|O
hours	|O
after	|O
the	|O
400	|O
-	|O
mg	|O
test	|O
dose	|O
of	|O
tolmetin	|O
on	|O
day	|O
8	|O
.	|O

Normal	|O
rates	|O
of	|O
weight	|O
gain	|O
were	|O
seen	|O
once	|O
absorbed	|O
energy	|O
intakes	|O
reached	|O
100-110%	|O
of	|O
requirements	|O
.	|O

Its	|O
vasodilatory	|O
,	|O
anti	|O
-	|O
vasopressor	|O
,	|O
and	|O
platelet	|O
stabilizing	|O
effects	|O
could	|O
be	|O
expected	|O
to	|O
counteract	|O
the	|O
placental	|O
ischemia	|O
,	|O
hypertension	|O
and	|O
excessive	|O
coagulation	|O
that	|O
are	|O
seen	|O
in	|O
pre	|O
-	|O
eclampsia	|O
.	|O

Behcet	|O
's	|O
syndrome	|O

Survival	|O
of	|O
111	|O
Indium	|O
-	|O
labelled	|O
autologous	|O
platelets	|O
was	|O
studied	|O
in	|O
2	|O
patients	|O
after	|O
correction	|O
of	|O
platelet	|O
count	|O
and	|O
was	|O
still	|O
found	|O
shortened	|O
.	|O

The	|O
effect	|O
of	|O
emotional	|O
-	|O
painful	|O
stress	|O
(	|O
EPS	|O
)	|O
on	|O
myocardial	|O
extensibility	|O
and	|O
contractility	|O
was	|O
studied	|O
on	|O
an	|O
isolated	|O
rat	|O
atrium	|O
.	|O

Terbutaline	|O
;	|O
a	|O
beta2	|O
-	|O
adrenergic	|O
agonist	|O
,	|O
and	|O
aminophyllin	|O
,	|O
a	|O
phosphodiesterase	|O
inhibitor	|O
,	|O
were	|O
given	|O
separately	|O
,	|O
or	|O
in	|O
combination	|O
,	|O
to	|O
rabbit	|O
fetuses	|O
on	|O
the	|O
28th	|O
day	|O
of	|O
gestation	|O
.	|O

When	|O
O2	|O
therapy	|O
was	|O
controlled	|O
for	|O
,	|O
the	|O
association	|O
between	|O
RBT	|O
and	|O
RLF	|O
did	|O
not	|O
achieve	|O
statistical	|O
significance	|O
(	|O
P	|O
=	|O
.07	|O
)	|O
.	|O

This	|O
two	|O
-	|O
helix	|O
motif	|O
is	|O
thought	|O
to	|O
be	|O
involved	|O
in	|O
specific	|O
DNA	|O
sequence	|O
recognition	|O
by	|O
CAP	|B-PROTEIN
.	|O

The	|O
hyperacute	|O
phase	|O
of	|O
posterolateral	|O
myocardial	|O
infarction	|O
.	|O

Statistics	|O
for	|O
nurse	|O
managers	|O
-	|O
-	|O
3	|O
.	|O

The	|O
infection	|O
rate	|O
was	|O
five	|O
times	|O
greater	|O
in	|O
patients	|O
with	|O
Hickman	|O
catheters	|O
than	|O
in	|O
those	|O
with	|O
Broviac	|O
catheters	|O
(	|O
p	|O
=	|O
0.01	|O
)	|O
.	|O

After	|O
a	|O
year	|O
of	|O
planning	|O
in	|O
the	|O
Laboratory	|O
Assistants	|O
'	|O
School	|O
in	|O
Stockholm	|O
:	|O
new	|O
education	|O
for	|O
laboratory	|O
assistants	|O
is	|O
now	|O
arranged	|O

The	|O
electrocardiogram	|O
.	|O

Setting	|O
takes	|O
place	|O
through	|O
complex	|O
formation	|O
of	|O
(	|O
NH4Mg	|O
PO4.6	|O
H2O	|O
)	|O
n	|O
,	|O
excess	|O
reactants	|O
,	|O
and	|O
water	|O
.	|O

The	|O
Authors	|O
have	|O
proposed	|O
to	|O
develop	|O
this	|O
research	|O
employing	|O
a	|O
preparation	|O
containing	|O
exclusively	|O
a	|O
cortisonic	|O
,	|O
the	|O
desametazone	|O
,	|O
in	|O
order	|O
to	|O
evaluate	|O
the	|O
alterations	|O
of	|O
the	|O
dentinogenesis	|O
to	|O
be	|O
attributed	|O
to	|O
such	|O
component	|O
.	|O

Secretory	|O
IgA	|B-PROTEIN
and	|O
serum	|O
immunoglobulins	|B-PROTEIN
as	|O
indices	|O
of	|O
the	|O
local	|O
immunity	|O
of	|O
the	|O
intestinal	|O
mucosa	|O
in	|O
acute	|O
leukemias	|O

Serum	|O
IgE	|B-PROTEIN
levels	|O
in	|O
Tauranga	|O
children	|O
.	|O

Use	|O
of	|O
prostaglandin	|O
F2	|O
alpha	|O
(	|O
PGF2	|O
alpha	|O
)	|O
in	|O
cattle	|O
breeding	|O
.	|O

Thus	|O
it	|O
appears	|O
that	|O
the	|O
management	|O
of	|O
blood	|O
,	|O
including	|O
washing	|O
is	|O
of	|O
great	|O
importance	|O
.	|O

Range	|O
,	|O
variations	|O
and	|O
neoplastic	|O
potential	|O
.	|O

The	|O
scores	|O
are	|O
dependent	|O
in	|O
part	|O
on	|O
the	|O
reliability	|O
of	|O
faculty	|O
evaluations	|O
.	|O

Study	|O
on	|O
distribution	|O
of	|O
metal	|O
in	|O
the	|O
teeth	|O
treated	|O
by	|O
iontophoresis	|O
with	|O
transparent	|O
specimens	|O

Whereas	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
declined	|O
exponentially	|O
from	|O
a	|O
single	|O
peak	|O
,	|O
myoglobin	|B-PROTEIN
appeared	|O
in	|O
multiple	|O
episodes	|O
inadequately	|O
represented	|O
by	|O
a	|O
single	|O
peak	|O
value	|O
and	|O
having	|O
no	|O
clear	|O
clinical	|O
correlation	|O
.	|O

Utero	|O
-	|O
placental	|O
blood	|O
flow	|O
and	|O
the	|O
effect	|O
of	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
stimulating	|O
drugs	|O
.	|O

Development	|O
of	|O
basophilic	|O
leukemia	|O
with	|O
trisomy	|O
8	|O
and	|O
atypical	|O
erythroblastosis	|O
in	|O
a	|O
patient	|O
with	|O
a	|O
history	|O
of	|O
aplastic	|O
anemia	|O
22	|O
years	|O
earlier	|O

The	|O
arginyl	|O
peptide	|O
bonds	|O
that	|O
are	|O
cleaved	|O
in	|O
the	|O
conversion	|O
of	|O
human	|O
factor	|B-PROTEIN
IX	|I-PROTEIN
to	|O
factor	|B-PROTEIN
IXa	|I-PROTEIN
by	|O
factor	|B-PROTEIN
XIa	|I-PROTEIN
were	|O
identified	|O
as	|O
Arg145	|O
-	|O
Ala146	|O
and	|O
Arg180	|O
-	|O
Val181	|O
.	|O

Alveolar	|O
growth	|O
,	|O
contemporary	|O
with	|O
dental	|O
eruption	|O
,	|O
is	|O
sufficient	|O
to	|O
compensate	|O
possible	|O
hypotrophy	|O
of	|O
maxillary	|O
bone	|O
bases	|O
.	|O

Fluorometric	|O
methods	|O
can	|O
also	|O
provide	|O
information	|O
about	|O
porphyrin	|O
binding	|O
sites	|O
that	|O
is	|O
useful	|O
in	|O
understanding	|O
porphyrin	|O
transport	|O
and	|O
clearance	|O
.	|O

Renal	|O
and	|O
extrarenal	|O
arterial	|O
fibromuscular	|O
hyperplasia	|O
with	|O
hypertension	|O
.	|O

The	|O
monoexponential	|O
rate	|O
of	|O
clearance	|O
of	|O
tracer	|O
-	|O
-	|O
obtained	|O
from	|O
the	|O
portion	|O
of	|O
the	|O
residue	|O
-	|O
detection	|O
curve	|O
reflecting	|O
metabolism	|O
of	|O
fatty	|O
acid	|O
incorporated	|O
into	|O
neutral	|O
lipids	|O
-	|O
-	|O
correlated	|O
directly	|O
with	|O
induced	|O
changes	|O
in	|O
tension	|O
-	|O
time	|O
index	|O
after	|O
injections	|O
into	|O
the	|O
left	|O
atrium	|O
(	|O
r	|O
=	|O
0.96	|O
,	|O
n	|O
=	|O
12	|O
)	|O
,	|O
right	|O
atrium	|O
(	|O
r	|O
=	|O
0.86	|O
,	|O
n	|O
=	|O
14	|O
)	|O
,	|O
and	|O
ear	|O
vein	|O
(	|O
r	|O
=	|O
0.93	|O
,	|O
n	|O
=	|O
14	|O
)	|O
.	|O

Both	|O
examinations	|O
are	|O
sensitive	|O
indicators	|O
of	|O
CNS	|O
abnormalities	|O
associated	|O
with	|O
bacterial	|O
meningeal	|O
infections	|O
and	|O
are	|O
important	|O
determinants	|O
of	|O
the	|O
therapy	|O
and	|O
ultimate	|O
prognosis	|O
of	|O
such	|O
complications	|O
.	|O

Specific	|O
IgE	|B-PROTEIN
levels	|O
decreased	|O
slightly	|O
,	|O
but	|O
always	|O
remained	|O
within	|O
the	|O
pathological	|O
range	|O
.	|O

Similar	|O
clinical	|O
evaluation	|O
of	|O
an	|O
obligate	|O
carrier	|O
revealed	|O
no	|O
ocular	|O
abnormalities	|O
.	|O

Correlation	|O
between	|O
intraocular	|O
involvement	|O
and	|O
systemic	|O
outcome	|O
was	|O
poor	|O
.	|O

A	|O
case	|O
of	|O
anterior	|O
cleavage	|O
syndrome	|O
in	|O
a	|O
27	|O
-	|O
year	|O
-	|O
old	|O
female	|O
patient	|O
is	|O
described	|O
.	|O

The	|O
daily	|O
administration	|O
of	|O
betamethasone	|O
for	|O
three	|O
weeks	|O
markedly	|O
reduced	|O
the	|O
absorption	|O
of	|O
calcium	|O
and	|O
phosphate	|O
as	|O
well	|O
as	|O
the	|O
growth	|O
rate	|O
.	|O

Endorphins	|B-PROTEIN
and	|O
legal	|O
issues	|O
.	|O

At	|O
necropsy	|O
28	|O
days	|O
post	|O
-	|O
inoculation	|O
,	|O
F344	|O
rats	|O
had	|O
no	|O
gross	|O
lung	|O
lesions	|O
,	|O
even	|O
those	|O
given	|O
the	|O
maximum	|O
dose	|O
of	|O
1.4	|O
X	|O
10	|O
(	|O
9	|O
)	|O
colony	|O
-	|O
forming	|O
units	|O
of	|O
M.	|O
pulmonis	|O
.	|O

Aneurysmectomy	|O
and	|O
the	|O
performance	|O
of	|O
CABG	|O
were	|O
not	|O
significantly	|O
associated	|O
with	|O
postoperative	|O
ECG	|O
changes	|O
,	|O
but	|O
more	|O
bypass	|O
grafts	|O
per	|O
patient	|O
grafted	|O
appeared	|O
in	|O
the	|O
group	|O
with	|O
postoperative	|O
ECG	|O
changes	|O
,	|O
suggesting	|O
that	|O
coronary	|O
artery	|O
disease	|O
may	|O
be	|O
more	|O
severe	|O
in	|O
that	|O
group	|O
.	|O

REV	|O
I	|O
:	|O
All	|O
vessels	|O
up	|O
to	|O
50%	|O
stenosed	|O
have	|O
a	|O
patent	|O
graft	|O
.	|O

Complete	|O
sequences	|O
were	|O
obtained	|O
for	|O
the	|O
three	|O
large	|O
thrombic	|O
peptides	|O
,	|O
and	|O
these	|O
were	|O
aligned	|O
by	|O
using	|O
peptides	|O
from	|O
the	|O
V8	|B-PROTEIN
protease	|I-PROTEIN
digest	|O
.	|O

The	|O
extraction	|O
measurements	|O
were	|O
used	|O
to	|O
test	|O
for	|O
extracerebral	|O
contamination	|O
of	|O
venous	|O
outflow	|O
.	|O

Contractile	|O
responses	|O
to	|O
norepinephrine	|O
,	|O
serotonin	|O
and	|O
potassium	|O
(	|O
K+	|O
)	|O
and	|O
relaxant	|O
responses	|O
to	|O
isoproterenol	|O
and	|O
papaverine	|O
were	|O
studied	|O
in	|O
vitro	|O
with	|O
spirally	|O
cut	|O
thoracic	|O
aortic	|O
strips	|O
from	|O
aortic	|O
coarcted	|O
hypertensive	|O
rats	|O
(	|O
AHR	|O
)	|O
2	|O
,	|O
6	|O
,	|O
14	|O
and	|O
28	|O
days	|O
postoperatively	|O
and	|O
compared	|O
to	|O
time	|O
-	|O
matched	|O
,	|O
sham	|O
-	|O
operated	|O
normotensive	|O
controls	|O
.	|O

On	|O
line	|O
calculation	|O
of	|O
steroid	|O
concentrations	|O
by	|O
radioimmunoassay	|O

Detection	|O
of	|O
congenital	|O
hypothyroidism	|O
in	|O
26,282	|O
newborn	|O
infants	|O

In	|O
rubella	|O
patients	|O
with	|O
serologic	|O
confirmation	|O
by	|O
HI	|O
,	|O
the	|O
IF	|O
test	|O
detected	|O
significant	|O
rises	|O
in	|O
219	|O
(	|O
99.1%	|O
)	|O
of	|O
221	|O
patients	|O
and	|O
the	|O
PHA	|B-PROTEIN
test	|O
detected	|O
antibody	|O
conversion	|O
in	|O
68	|O
(	|O
93%	|O
)	|O
of	|O
73	|O
patients	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
folate	|O
compounds	|O
decrease	|O
formate	|O
accumulation	|O
after	|O
methanol	|O
by	|O
stimulating	|O
formate	|O
oxidation	|O
or	|O
utilization	|O
and	|O
suggest	|O
a	|O
possible	|O
use	|O
for	|O
folates	|O
in	|O
the	|O
treatment	|O
of	|O
certain	|O
cases	|O
of	|O
human	|O
methanol	|O
poisoning	|O
.	|O

The	|O
effect	|O
of	|O
sodium	|O
saccharin	|O
in	|O
the	|O
diet	|O
on	|O
caecal	|O
microflora	|O
.	|O

The	|O
residue	|O
functions	|O
,	|O
R	|O
(	|O
t	|O
)	|O
,	|O
for	|O
C	|O
-	|O
11	|O
CPZ	|O
and	|O
In	|O
-	|O
113m	|O
transferrin	|B-PROTEIN
were	|O
plotted	|O
against	|O
time	|O
for	|O
selected	|O
areas	|O
of	|O
interest	|O
,	|O
and	|O
the	|O
CPZ	|O
area	|O
-	|O
weighted	|O
extraction	|O
,	|O
E	|O
(	|O
t	|O
)	|O
,	|O
was	|O
computed	|O
for	|O
the	|O
same	|O
areas	|O
every	|O
250	|O
msec	|O
using	|O
the	|O
formula	|O
:	|O
E	|O
(	|O
t	|O
)	|O
=	|O
[	|O
RT	|O
(	|O
t	|O
)	|O
-	|O
RR	|O
(	|O
t	|O
)	|O
]	|O
/	|O
[	|O
1	|O
-	|O
RR	|O
(	|O
t	|O
)	|O
]	|O
,	|O
where	|O
RT	|O
and	|O
RR	|O
are	|O
the	|O
normalized	|O
residue	|O
functions	|O
for	|O
CPZ	|O
and	|O
transferrin	|B-PROTEIN
,	|O
respectively	|O
.	|O

Synchronous	|O
extracts	|O
showed	|O
no	|O
significant	|O
migration	|O
inhibition	|O
in	|O
allogeneic	|O
assays	|O
.	|O

Ten	|O
days	|O
of	|O
cefadroxil	|O
therapy	|O
was	|O
used	|O
to	|O
treat	|O
44	|O
children	|O
with	|O
urinary	|O
tract	|O
infection	|O
and	|O
CRP	|B-PROTEIN
values	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
28	|O
microgram	|O
/	|O
ml	|O
(	|O
CRP	|B-PROTEIN
-	|O
positive	|O
group	|O
)	|O
.	|O

Both	|O
resting	|O
blood	|O
flow	|O
(	|O
RBF	|O
)	|O
and	|O
maximal	|O
blood	|O
flow	|O
(	|O
NBF	|O
)	|O
were	|O
studied	|O
by	|O
Xenon	|O
133	|O
clearance	|O
.	|O

Plasma	|O
renin	|B-PROTEIN
concentration	|O
is	|O
significantly	|O
higher	|O
in	|O
the	|O
subcapsular	|O
venous	|O
outflow	|O
,	|O
which	|O
drains	|O
the	|O
superficial	|O
cortex	|O
,	|O
than	|O
in	|O
the	|O
deep	|O
venous	|O
outflow	|O
,	|O
which	|O
drains	|O
the	|O
inner	|O
half	|O
of	|O
the	|O
cortex	|O
and	|O
medulla	|O
of	|O
the	|O
cat	|O
kidney	|O
.	|O

After	|O
acclimation	|O
,	|O
resting	|O
supine	|O
and	|O
sitting	|O
DPB	|O
decreased	|O
(	|O
P	|O
less	|O
than	|O
0.05	|O
)	|O
by	|O
6	|O
and	|O
9	|O
mmHg	|O
,	|O
respectively	|O
.	|O

In	|O
the	|O
diabetics	|O
,	|O
Ca2+	|O
infusions	|O
induced	|O
a	|O
rise	|O
of	|O
plasma	|O
Ca2+	|O
up	|O
to	|O
3.2	|O
+	|O
/	|O
-	|O
0.1	|O
mmol	|O
/	|O
1	|O
and	|O
a	|O
fall	|O
of	|O
circulating	|O
glucagon	|B-PROTEIN
(	|O
-	|O
26.4	|O
+	|O
/	|O
-	|O
5.7%	|O
;	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
and	|O
glucose	|O
(	|O
-	|O
23.3	|O
+	|O
/	|O
-	|O
3.6%	|O
;	|O
p	|O
less	|O
than	|O
0.05	|O
)	|O
.	|O

Fifty	|O
-	|O
eight	|O
RMI	|O
's	|O
occurred	|O
in	|O
the	|O
placebo	|O
group	|O
as	|O
compared	|O
to	|O
only	|O
twenty	|O
in	|O
the	|O
AC	|O
group	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

The	|O
"	|O
cracked	|O
-	|O
tooth	|O
"	|O
syndrome	|O
.	|O

The	|O
foregoing	|O
results	|O
show	|O
that	|O
CXD	|O
has	|O
high	|O
efficacy	|O
and	|O
safety	|O
and	|O
it	|O
can	|O
be	|O
said	|O
that	|O
it	|O
is	|O
a	|O
drug	|O
required	|O
in	|O
the	|O
pediatric	|O
field	|O
.	|O

Based	|O
on	|O
peptide	|O
map	|O
similarities	|O
,	|O
partial	|O
amino	|O
-	|O
terminal	|O
sequence	|O
data	|O
,	|O
and	|O
common	|O
genetic	|O
origin	|O
,	|O
it	|O
is	|O
suggested	|O
that	|O
p60	|B-PROTEIN
and	|O
p62	|B-PROTEIN
have	|O
identical	|O
amino	|O
acid	|O
sequences	|O
carboxy	|O
-	|O
terminal	|O
to	|O
the	|O
p60	|B-PROTEIN
initiator	|O
methionine	|O
(	|O
residue	|O
21	|O
of	|O
p62	|B-PROTEIN
)	|O
.	|O

All	|O
patients	|O
in	|O
the	|O
control	|O
group	|O
showed	|O
a	|O
significant	|O
improvement	|O
in	|O
their	|O
PEFR	|O
while	|O
only	|O
3	|O
patients	|O
in	|O
the	|O
treated	|O
group	|O
showed	|O
an	|O
improvement	|O
.	|O

Facts	|O
on	|O
the	|O
Economic	|O
Recovery	|O
Tax	|O
Act	|O
of	|O
1981	|O
for	|O
speech	|O
-	|O
language	|O
pathologists	|O
and	|O
audiologists	|O
.	|O

From	|O
Pap	|O
to	|O
ApUp	|O
.	|O

The	|O
relationship	|O
between	|O
the	|O
rare	|O
complications	|O
mentioned	|O
above	|O
and	|O
the	|O
pathophysiology	|O
of	|O
Bartter	|O
's	|O
syndrome	|O
is	|O
still	|O
obscure	|O
.	|O

Using	|O
an	|O
opsonophagocytic	|O
bacterial	|O
assay	|O
and	|O
a	|O
suckling	|O
rat	|O
model	|O
of	|O
GBS	|O
sepsis	|O
,	|O
we	|O
analyzed	|O
a	|O
modified	|O
human	|O
immunoglobulin	|B-PROTEIN
for	|O
opsonic	|O
and	|O
protective	|O
antibody	|O
.	|O

Glomerular	|O
lesions	|O
in	|O
renal	|O
allografts	|O
.	|O

Commonly	|O
observed	|O
systemic	|O
toxic	|O
effects	|O
(	|O
bone	|O
marrow	|O
,	|O
gastrointestinal	|O
tract	|O
,	|O
and	|O
heart	|O
)	|O
were	|O
not	|O
seen	|O
in	|O
this	|O
study	|O
.	|O

2	|O
.	|O

When	|O
vascular	|O
pressure	|O
(	|O
Pvas	|O
)	|O
was	|O
raised	|O
abruptly	|O
from	|O
-	|O
5	|O
to	|O
+	|O
25	|O
cmH2O	|O
by	|O
air	|O
inflation	|O
for	|O
60	|O
min	|O
,	|O
Px	|O
(	|O
f	|O
)	|O
became	|O
abruptly	|O
less	|O
negative	|O
,	|O
then	|O
remained	|O
stable	|O
.	|O

(	|O
1980	|O
)	|O
:	|O
Science	|O
210	|O
,	|O
77-72	|O
)	|O
that	|O
stimulating	|O
the	|O
crossed	|O
olivocochlear	|O
bundle	|O
(	|O
COCB	|O
)	|O
can	|O
change	|O
the	|O
magnitude	|O
of	|O
the	|O
distortion	|O
product	|O
(	|O
f2	|O
-	|O
f1	|O
)	|O
in	|O
the	|O
ear	|O
-	|O
canal	|O
sound	|O
pressure	|O
.	|O

Rats	|O
underwent	|O
either	|O
a	|O
90-95%	|O
JIB	|O
or	|O
a	|O
sham	|O
operation	|O
.	|O

When	|O
the	|O
l	|O
-	|O
methadone	|O
-	|O
sensitive	|O
,	|O
opioid	|B-PROTEIN
receptor	|I-PROTEIN
is	|O
blocked	|O
by	|O
naloxone	|O
or	|O
tolerance	|O
has	|O
developed	|O
,	|O
than	|O
l	|O
-	|O
methadone	|O
can	|O
produce	|O
behavioral	|O
effects	|O
by	|O
a	|O
nonopioid	|O
mechanism	|O
.	|O

Microwave	|O
hyperthermia	|O
-	|O
induced	|O
blood	|O
-	|O
brain	|O
barrier	|O
alterations	|O
.	|O

Large	|O
and	|O
small	|O
medullary	|O
lesions	|O
inhibited	|O
the	|O
occurrence	|O
of	|O
target	|O
fibres	|O
in	|O
the	|O
tenotomized	|O
muscles	|O
,	|O
the	|O
smallest	|O
one	|O
being	|O
neurolysis	|O
of	|O
the	|O
dorsal	|O
roots	|O
.	|O

Diagnosis	|O
of	|O
phenylalanine	|B-PROTEIN
hydroxylase	|I-PROTEIN
deficiency	|O
(	|O
phenylketonuria	|O
)	|O
.	|O

In	|O
10	|O
control	|O
sheep	|O
mean	|O
plasma	|O
TXB2	|O
concentration	|O
increased	|O
from	|O
0.39	|O
ng	|O
/	|O
ml	|O
prebypass	|O
to	|O
about	|O
1.1	|O
ng	|O
/	|O
ml	|O
at	|O
8	|O
and	|O
16	|O
min	|O
of	|O
bypass	|O
.	|O

The	|O
respiratory	|O
rate	|O
was	|O
13	|O
+	|O
/	|O
-	|O
1	|O
breaths	|O
/	|O
min	|O
with	|O
52	|O
+	|O
/	|O
-	|O
4%	|O
of	|O
the	|O
respiratory	|O
cycle	|O
spent	|O
in	|O
inspiration	|O
;	|O
end	|O
-	|O
tidal	|O
CO2	|O
pressure	|O
increased	|O
by	|O
3.3	|O
+	|O
/	|O
-	|O
1.0	|O
Torr	|O
during	|O
runs	|O
at	|O
SIP	|O
.	|O

There	|O
was	|O
no	|O
further	|O
increase	|O
in	|O
oxygen	|O
consumption	|O
when	|O
these	|O
subjects	|O
breathed	|O
with	|O
inspiratory	|O
pressures	|O
above	|O
SIP	|O
.	|O

We	|O
compared	|O
the	|O
volume	|O
of	|O
the	|O
pulmonary	|O
extravascular	|O
,	|O
extracellular	|O
water	|O
space	|O
using	|O
sodium	|O
and	|O
sucrose	|O
indicators	|O
in	|O
8	|O
normal	|O
and	|O
11	|O
edematous	|O
rabbit	|O
lungs	|O
by	|O
steady	|O
-	|O
state	|O
techniques	|O
.	|O

Investigated	|O
the	|O
reliability	|O
,	|O
validity	|O
and	|O
dimensionality	|O
of	|O
scores	|O
obtained	|O
by	|O
acute	|O
psychiatric	|O
inpatients	|O
(	|O
N	|O
=	|O
120	|O
)	|O
on	|O
the	|O
Michigan	|O
Alcoholism	|O
Screening	|O
Test	|O
adapted	|O
to	|O
assess	|O
lifetime	|O
and	|O
current	|O
symptomatology	|O
.	|O

A	|O
simple	|O
method	|O
for	|O
measuring	|O
urinary	|O
iron	|O
following	|O
the	|O
administration	|O
of	|O
desferrioxamine	|O
(	|O
DF	|O
)	|O
is	|O
described	|O
.	|O

During	|O
conventional	|O
hemofiltration	|O
using	|O
substitution	|O
fluid	|O
with	|O
a	|O
Na+	|O
concentration	|O
of	|O
140	|O
mEq	|O
/	|O
L	|O
,	|O
a	|O
decrease	|O
in	|O
extracellular	|O
fluid	|O
volume	|O
was	|O
noted	|O
whereas	|O
the	|O
intracellular	|O
fluid	|O
volume	|O
was	|O
unaltered	|O
.	|O

The	|O
uncomplicated	|O
cases	|O
of	|O
typhoid	|O
fever	|O
were	|O
found	|O
to	|O
have	|O
an	|O
intact	|O
CMIR	|O
as	|O
compared	|O
to	|O
the	|O
complicated	|O
cases	|O
.	|O

Transvenous	|O
serial	|O
xeroradiography	|O
.	|O

Recommendations	|O
to	|O
deal	|O
with	|O
these	|O
and	|O
related	|O
issues	|O
are	|O
presented	|O
.	|O

Use	|O
of	|O
subcutaneous	|O
deferoxamine	|O
in	|O
a	|O
child	|O
with	|O
hemochromatosis	|O
associated	|O
with	|O
congenital	|O
dyserythropoietic	|O
anemia	|O
,	|O
type	|O
I.	|O

There	|O
was	|O
a	|O
significant	|O
correlation	|O
between	|O
tubular	|O
diameter	|O
and	|O
spg	|O
(	|O
r	|O
=	|O
0.68	|O
,	|O
P	|O
less	|O
than	|O
0.001	|O
)	|O
suggesting	|O
that	|O
tubular	|O
diameter	|O
measurements	|O
in	|O
histological	|O
sections	|O
could	|O
be	|O
used	|O
to	|O
predict	|O
sperm	|O
production	|O
.	|O

The	|O
differential	|O
investigation	|O
of	|O
lipoproteins	|O
,	|O
however	|O
,	|O
showed	|O
that	|O
the	|O
high	|B-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
(	|O
HDL	|B-PROTEIN
)	|O
fractions	|O
are	|O
absolutely	|O
or	|O
relatively	|O
decreased	|O
with	|O
respect	|O
to	|O
low	|B-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoproteins	|I-PROTEIN
(	|O
LDL	|B-PROTEIN
)	|O
in	|O
cerebral	|O
infarcts	|O
and	|O
in	|O
transient	|O
ischaemic	|O
attacks	|O
.	|O

Although	|O
noninhibitory	|O
fluid	|O
had	|O
higher	|O
mean	|O
concentrations	|O
of	|O
phosphorus	|O
and	|O
zinc	|O
,	|O
these	|O
differences	|O
did	|O
not	|O
hold	|O
after	|O
meconium	|O
-	|O
stained	|O
samples	|O
were	|O
excluded	|O
.	|O

Selenium	|O
status	|O
of	|O
thoroughbreds	|O
in	|O
the	|O
United	|O
Kingdom	|O
.	|O

During	|O
an	|O
8	|O
-	|O
wk	|O
follow	|O
-	|O
up	|O
,	|O
parasites	|O
reappeared	|O
in	|O
10	|O
patients	|O
,	|O
5	|O
after	|O
each	|O
drug	|O
,	|O
between	|O
1	|O
and	|O
7	|O
wk	|O
after	|O
treatment	|O
.	|O

Preparation	|O
of	|O
a	|O
stable	|O
phospholipid	|O
reagent	|O
for	|O
coagulation	|O
assays	|O
.	|O

A	|O
note	|O
on	|O
some	|O
consequences	|O
of	|O
UV	|O
vision	|O
in	|O
birds	|O
.	|O

Before	|O
turnout	|O
,	|O
a	|O
morantel	|O
sustained	|O
release	|O
bolus	|O
(	|O
MSRB	|O
)	|O
was	|O
administered	|O
to	|O
each	|O
animal	|O
in	|O
the	|O
"	|O
treated	|O
"	|O
category	|O
.	|O

In	|O
a	|O
longitudinal	|O
study	|O
,	|O
14	|O
low	|O
-	|O
risk	|O
fetuses	|O
were	|O
studied	|O
at	|O
2	|O
-	|O
week	|O
intervals	|O
from	|O
32	|O
weeks	|O
of	|O
gestation	|O
onward	|O
.	|O

Further	|O
,	|O
intracerebroventricular	|O
injections	|O
of	|O
KA	|O
resulted	|O
in	|O
the	|O
substantial	|O
loss	|O
of	|O
pyramidal	|O
cells	|O
in	|O
the	|O
whole	|O
CA3	|O
field	|O
of	|O
the	|O
hippocampus	|O
.	|O

Seventeen	|O
of	|O
the	|O
35	|O
patients	|O
were	|O
randomly	|O
chosen	|O
to	|O
receive	|O
a	|O
training	|O
program	|O
(	|O
lasting	|O
approximately	|O
1	|O
month	|O
)	|O
designed	|O
to	|O
establish	|O
a	|O
systematic	|O
strategy	|O
of	|O
organizing	|O
complex	|O
visual	|O
material	|O
.	|O

The	|O
duration	|O
and	|O
the	|O
amplitude	|O
of	|O
the	|O
negative	|O
potential	|O
were	|O
greatest	|O
for	|O
completely	|O
regenerating	|O
ears	|O
with	|O
overgrowth	|O
,	|O
smaller	|O
for	|O
partially	|O
regenerating	|O
ears	|O
,	|O
and	|O
smallest	|O
for	|O
the	|O
nonregenerating	|O
ears	|O
.	|O

Samples	|O
obtained	|O
from	|O
normal	|O
volunteers	|O
and	|O
from	|O
the	|O
great	|O
majority	|O
of	|O
the	|O
patients	|O
,	|O
excluding	|O
those	|O
with	|O
asthma	|O
,	|O
had	|O
no	|O
effect	|O
on	|O
ciliary	|O
beating	|O
.	|O

These	|O
results	|O
suggested	|O
the	|O
possibility	|O
that	|O
the	|O
fetus	|O
played	|O
some	|O
role	|O
in	|O
the	|O
production	|O
of	|O
E3	|O
-	|O
16	|O
-	|O
G	|O
in	|O
early	|O
pregnancy	|O
.	|O

In	|O
this	|O
way	|O
it	|O
is	|O
possible	|O
to	|O
simulate	|O
the	|O
growth	|O
function	|O
of	|O
the	|O
embryofetal	|O
curve	|O
of	|O
the	|O
length	|O
'	|O
increase	|O
of	|O
man	|O
and	|O
the	|O
curve	|O
of	|O
the	|O
mass	|O
'	|O
increase	|O
of	|O
rat	|O
.	|O

The	|O
highest	|O
doses	|O
were	|O
found	|O
for	|O
drivers	|O
who	|O
transported	|O
large	|O
numbers	|O
of	|O
99Mo	|O
generators	|O
.	|O

The	|O
steepness	|O
of	|O
the	|O
standard	|O
O2	|O
dissociation	|O
curve	|O
becomes	|O
greater	|O
during	|O
the	|O
training	|O
period	|O
(	|O
increase	|O
in	|O
Hill	|O
's	|O
n	|O
from	|O
2.68	|O
+	|O
/	|O
-	|O
0.10	|O
to	|O
2.96	|O
+	|O
/	|O
-	|O
0.15	|O
)	|O
.	|O

Conjugated	|O
and	|O
unconjugated	|O
phenylacetic	|O
acid	|O
and	|O
m	|O
-	|O
and	|O
p	|O
-	|O
hydroxyphenylacetic	|O
acid	|O
have	|O
been	|O
determined	|O
in	|O
the	|O
plasma	|O
of	|O
normal	|O
,	|O
healthy	|O
subjects	|O
after	|O
fasting	|O
,	|O
consumption	|O
of	|O
a	|O
meal	|O
and	|O
ingestion	|O
of	|O
deuterium	|O
labelled	|O
amine	|O
precursors	|O
,	|O
by	|O
high	|O
-	|O
resolution	|O
gas	|O
chromatography	|O
-	|O
-	|O
high	|O
resolution	|O
mass	|O
spectrometry	|O
with	|O
selected	|O
ion	|O
monitoring	|O
of	|O
their	|O
trifluoroethyl	|O
-	|O
pentafluoropropionyl	|O
derivatives	|O
.	|O

In	|O
concept	|O
II	|O
62	|O
patients	|O
were	|O
treated	|O
with	|O
selective	|O
vagotomy	|O
and	|O
pyloroplasty	|O
.	|O

They	|O
consisted	|O
of	|O
behavioural	|O
disorders	|O
,	|O
tetraparesis	|O
,	|O
incontinence	|O
and	|O
oculomotor	|O
paralysis	|O
.	|O

CSF	|O
adenosine	|B-PROTEIN
deaminase	|I-PROTEIN
activity	|O
(	|O
ADA	|O
)	|O
was	|O
measured	|O
at	|O
the	|O
same	|O
time	|O
.	|O

Histamine	|O
reactivity	|O
had	|O
returned	|O
to	|O
normal	|O
in	|O
half	|O
the	|O
workers	|O
who	|O
had	|O
left	|O
their	|O
original	|O
factories	|O
,	|O
but	|O
in	|O
only	|O
one	|O
worker	|O
who	|O
had	|O
moved	|O
within	|O
her	|O
original	|O
factory	|O
.	|O

It	|O
was	|O
also	|O
found	|O
that	|O
there	|O
is	|O
no	|O
significant	|O
difference	|O
between	|O
the	|O
prevalence	|O
of	|O
nasal	|O
carriage	|O
of	|O
S.	|O
aureus	|O
amongst	|O
the	|O
hospital	|O
staff	|O
and	|O
the	|O
patients	|O
.	|O

Ficat	|O
and	|O
Bizou	|O
's	|O
condylar	|O
depth	|O
index	|O
and	|O
the	|O
condylar	|O
-	|O
joint	|O
surface	|O
angle	|O
of	|O
Brattstrom	|O
are	|O
recommended	|O
as	|O
especially	|O
suitable	|O
methods	|O
of	|O
measurement	|O
.	|O

There	|O
were	|O
no	|O
significant	|O
differences	|O
in	|O
EF	|O
between	|O
the	|O
two	|O
studies	|O
,	|O
both	|O
at	|O
rest	|O
(	|O
56.0	|O
+	|O
/	|O
-	|O
13.8%	|O
vs	|O
58.2	|O
+	|O
/	|O
-	|O
11.7%	|O
,	|O
p	|O
=	|O
NS	|O
)	|O
and	|O
with	|O
exercise	|O
(	|O
51.1	|O
+	|O
/	|O
-	|O
17.6%	|O
vs	|O
54.3	|O
+	|O
/	|O
-	|O
17.6%	|O
,	|O
p	|O
=	|O
NS	|O
)	|O
and	|O
a	|O
highly	|O
significant	|O
correlation	|O
was	|O
shown	|O
between	|O
the	|O
two	|O
groups	|O
of	|O
values	|O
(	|O
rest	|O
r	|O
=	|O
0.90	|O
,	|O
exercise	|O
r	|O
=	|O
0.93	|O
,	|O
p	|O
less	|O
than	|O
0.001	|O
)	|O
.	|O

After	|O
MOPP	|O
therapy	|O
,	|O
complete	|O
remission	|O
of	|O
Hodgkin	|O
's	|O
disease	|O
was	|O
accompanied	|O
by	|O
normalization	|O
of	|O
the	|O
glucocerebrosidase	|B-PROTEIN
level	|O
and	|O
disappearance	|O
of	|O
Gaucher	|O
's	|O
cells	|O
.	|O

Specifically	|O
,	|O
by	|O
the	|O
type	|O
of	|O
adjuvant	|O
therapy	|O
,	|O
the	|O
median	|O
disease	|O
-	|O
free	|O
interval	|O
and	|O
survival	|O
from	|O
stage	|O
IVA	|O
for	|O
23	|O
patients	|O
receiving	|O
Corynebacterium	|O
parvum	|O
were	|O
6.9	|O
and	|O
19	|O
months	|O
;	|O
for	|O
39	|O
patients	|O
receiving	|O
BCG	|O
,	|O
eight	|O
months	|O
and	|O
26	|O
months	|O
;	|O
for	|O
24	|O
patients	|O
receiving	|O
BCG	|O
+	|O
DTIC	|O
,	|O
eight	|O
and	|O
17.4	|O
months	|O
;	|O
and	|O
for	|O
all	|O
51	|O
DTIC	|O
treated	|O
patients	|O
6.3	|O
and	|O
17.8	|O
months	|O
,	|O
respectively	|O
.	|O

The	|O
COP	|O
-	|O
PAWP	|O
gradient	|O
was	|O
markedly	|O
decreased	|O
in	|O
both	|O
shock	|O
and	|O
non	|O
-	|O
shock	|O
patients	|O
with	|O
pulmonary	|O
edema	|O
.	|O

Re	|O
:	|O
A	|O
modified	|O
method	|O
for	|O
the	|O
in	|O
vivo	|O
labeling	|O
of	|O
red	|O
blood	|O
cells	|O
with	|O
Tc	|O
-	|O
99m	|O
.	|O

A	|O
limited	|O
study	|O
in	|O
a	|O
glassware	|O
factory	|O
(	|O
As2O3	|O
exposure	|O
)	|O
involving	|O
the	|O
measurement	|O
of	|O
total	|O
airborne	|O
arsenic	|O
,	|O
the	|O
determination	|O
of	|O
urinary	|O
arsenic	|O
,	|O
and	|O
the	|O
evaluation	|O
of	|O
hand	|O
and	|O
mouth	|O
contamination	|O
by	|O
arsenic	|O
before	|O
and	|O
after	|O
the	|O
workshift	|O
suggests	|O
that	|O
the	|O
high	|O
urinary	|O
arsenic	|O
levels	|O
(	|O
300	|O
microgram	|O
/	|O
g	|O
creatinine	|O
)	|O
are	|O
likely	|O
to	|O
be	|O
more	|O
related	|O
to	|O
an	|O
increased	|O
oral	|O
intake	|O
from	|O
contaminated	|O
hands	|O
than	|O
to	|O
an	|O
increased	|O
absorption	|O
from	|O
the	|O
lungs	|O
.	|O

Parasitological	|O
and	|O
pathological	|O
findings	|O
in	|O
capuchin	|O
monkeys	|O
infected	|O
with	|O
Schistosoma	|O
japonicum	|O
or	|O
Schistosoma	|O
mansoni	|O
.	|O

The	|O
pia	|O
mater	|O
at	|O
the	|O
site	|O
of	|O
the	|O
entry	|O
of	|O
blood	|O
vessels	|O
into	|O
the	|O
central	|O
nervous	|O
system	|O
.	|O

Experimental	|O
reproduction	|O
of	|O
malignant	|O
catarrhal	|O
fever	|O
in	|O
Bali	|O
cattle	|O

1	|O
A	|O
colonic	|O
delivery	|O
system	|O
is	|O
described	|O
to	|O
deliver	|O
orally	|O
ingested	|O
drugs	|O
to	|O
the	|O
colon	|O
and	|O
release	|O
them	|O
at	|O
that	|O
site	|O
by	|O
coating	|O
with	|O
an	|O
acrylic	|O
based	|O
resin	|O
(	|O
Eudragit	|O
S	|O
)	|O
.	|O

Administration	|O
of	|O
the	|O
dopamine	|O
agonist	|O
bromocriptine	|O
(	|O
2.5	|O
mg	|O
three	|O
times	|O
a	|O
day	|O
for	|O
4	|O
days	|O
)	|O
suppressed	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
mean	|O
24	|O
-	|O
h	|O
plasma	|O
18	|O
-	|O
OHB	|O
levels	|O
from	|O
21.9	|O
+	|O
/	|O
-	|O
2.0	|O
to	|O
14.8	|O
+	|O
/	|O
-	|O
1.4	|O
ng	|O
/	|O
dl	|O
.	|O

Restarting	|O
time	|O
was	|O
not	|O
affected	|O
by	|O
magnesium	|O
cardioplegia	|O
.	|O

The	|O
most	|O
common	|O
types	|O
of	|O
malformations	|O
were	|O
eye	|O
defects	|O
and	|O
open	|O
coeloms	|O
.	|O

Repair	|O
of	|O
a	|O
cosmetic	|O
defect	|O
of	|O
the	|O
lower	|O
leg	|O
with	|O
a	|O
myocutaneous	|O
free	|O
flap	|O
.	|O

According	|O
to	|O
the	|O
literature	|O
,	|O
second	|O
malignant	|O
epithelial	|O
tumours	|O
are	|O
,	|O
in	|O
contrast	|O
to	|O
mesenchymal	|O
tumours	|O
such	|O
as	|O
osteosarcoma	|O
,	|O
very	|O
rare	|O
in	|O
retinoblastoma	|O
survivors	|O
.	|O

In	|O
Malmo	|O
,	|O
Sweden	|O
,	|O
17,181	|O
school	|O
children	|O
born	|O
in	|O
the	|O
years	|O
1961-1965	|O
were	|O
screened	|O
for	|O
scoliosis	|O
once	|O
a	|O
year	|O
between	|O
the	|O
ages	|O
of	|O
7	|O
and	|O
16	|O
years	|O
,	|O
during	|O
1971-1980	|O
.	|O

In	|O
the	|O
past	|O
,	|O
immunology	|O
in	|O
Singapore	|O
was	|O
mainly	|O
confined	|O
to	|O
serology	|O
for	|O
the	|O
diagnosis	|O
of	|O
certain	|O
infectious	|O
diseases	|O
.	|O

Intra	|O
-	|O
articular	|O
dislocation	|O
of	|O
the	|O
patella	|O
.	|O

This	|O
study	|O
demonstrates	|O
secretion	|O
of	|O
bicarbonate	|O
by	|O
the	|O
human	|O
stomach	|O
in	|O
vivo	|O
at	|O
a	|O
rate	|O
equivalent	|O
to	|O
10	|O
-	|O
-	|O
20%	|O
of	|O
basal	|O
acid	|O
secretion	|O
.	|O

Histological	|O
evaluation	|O
revealed	|O
a	|O
more	|O
than	|O
twofold	|O
increase	|O
in	|O
the	|O
number	|O
of	|O
interepithelial	|O
mononuclear	|O
cells	|O
(	|O
p	|O
less	|O
than	|O
0.005	|O
)	|O
,	|O
while	|O
the	|O
number	|O
of	|O
epithelial	|O
cells	|O
/	|O
100	|O
microns	|O
of	|O
villous	|O
mucosa	|O
and	|O
the	|O
mean	|O
height	|O
of	|O
the	|O
epithelial	|O
cells	|O
were	|O
comparable	|O
in	|O
both	|O
groups	|O
.	|O

Cramps	|O
in	|O
extrapyramidal	|O
disorders	|O
.	|O

A	|O
suspected	|O
new	|O
storage	|O
disease	|O
in	|O
cattle	|O
.	|O

For	|O
various	|O
dog	|O
vessels	|O
in	|O
vivo	|O
,	|O
Q	|O
/	|O
Dk	|O
ranged	|O
from	|O
0.15	|O
to	|O
47	|O
X	|O
10	|O
(	|O
5	|O
)	|O
Torr	|O
/	|O
cm2	|O
.	|O

The	|O
tetraphasic	|O
action	|O
of	|O
lidocaine	|O
on	|O
CNS	|O
electrical	|O
activity	|O
and	|O
behavior	|O
in	|O
cats	|O
.	|O

Modification	|O
of	|O
enteral	|O
resorption	|O
by	|O
cytostatic	|O
therapy	|O

Asymptomatic	|O
bacteriospermia	|O
and	|O
fertility	|O

Triumph	|O
of	|O
Leninist	|O
national	|O
policy	|O

The	|O
favourable	|O
effect	|O
of	|O
thymic	|O
shielding	|O
was	|O
also	|O
reflected	|O
in	|O
a	|O
significant	|O
increase	|O
of	|O
LD50/30	|O
,	|O
and	|O
the	|O
dose	|O
reduction	|O
factor	|O
was	|O
equal	|O
to	|O
2	|O
.	|O

The	|O
application	|O
of	|O
ultrafiltration	|O
to	|O
sample	|O
preparation	|O
in	|O
the	|O
detection	|O
and	|O
quantification	|O
of	|O
ethylene	|O
glycol	|O
in	|O
plasma	|O
by	|O
gas	|O
chromatography	|O
is	|O
described	|O
.	|O

Mastocytosis	|O
.	|O

A	|O
new	|O
Onchocerca	|O
species	|O
,	|O
a	|O
parasite	|O
of	|O
domestic	|O
cattle	|O
,	|O
in	|O
Senegal	|O

It	|O
was	|O
suggested	|O
that	|O
the	|O
absence	|O
of	|O
pronounced	|O
differences	|O
between	|O
conditions	|O
may	|O
have	|O
been	|O
due	|O
to	|O
the	|O
complexity	|O
of	|O
the	|O
task	|O
or	|O
the	|O
type	|O
of	|O
prompts	|O
employed	|O
.	|O

A	|O
limiting	|O
factor	|O
were	|O
disturbances	|O
in	|O
the	|O
system	|O
of	|O
energy	|O
transport	|O
(	|O
creatine	|O
phosphate	|O
,	|O
creatine	|B-PROTEIN
phosphokinase	|I-PROTEIN
)	|O
and	|O
of	|O
the	|O
calcium	|O
pump	|O
(	|O
Ca+	|B-PROTEIN
+	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
of	|O
the	|O
sarcoplasmic	|O
reticulum	|O
,	|O
SPR	|O
)	|O
,	|O
which	|O
evidently	|O
led	|O
to	|O
a	|O
decrease	|O
of	|O
the	|O
inotropic	|O
properties	|O
of	|O
the	|O
myocardium	|O
at	|O
70%	|O
restriction	|O
of	|O
coronary	|O
blood	|O
flow	|O
.	|O

In	|O
vitro	|O
penetration	|O
tests	|O
of	|O
human	|O
sperm	|O
into	|O
cervical	|O
mucus	|O
were	|O
introduced	|O
in	|O
order	|O
to	|O
study	|O
the	|O
interaction	|O
between	|O
sperm	|O
and	|O
cervical	|O
mucus	|O
.	|O

Vibrio	|O
fluvialis	|O
(	|O
group	|O
F	|O
vibrio	|O
)	|O
in	|O
Maharashtra	|O
.	|O

Serum	|B-PROTEIN
creatine	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
SCK	|B-PROTEIN
)	|O
was	|O
measured	|O
in	|O
ten	|O
subjects	|O
in	|O
the	|O
laboratory	|O
before	|O
and	|O
after	|O
the	|O
performance	|O
of	|O
bicycle	|O
ergometry	|O
and	|O
a	|O
lifting	|O
task	|O
.	|O

Organisms	|O
were	|O
not	|O
observed	|O
in	|O
the	|O
5	|O
bobcats	|O
trapped	|O
in	|O
2	|O
other	|O
counties	|O
.	|O

The	|O
cause	|O
of	|O
death	|O
is	|O
often	|O
quite	|O
apparent	|O
from	|O
the	|O
pathological	|O
and	|O
toxicological	|O
findings	|O
;	|O
however	|O
,	|O
the	|O
manner	|O
of	|O
death	|O
often	|O
gives	|O
the	|O
examining	|O
official	|O
some	|O
difficulty	|O
.	|O

The	|O
average	|O
annual	|O
cost	|O
per	|O
head	|O
of	|O
population	|O
was	|O
US+	|O
0	|O
X	|O
46	|O
.	|O

It	|O
is	|O
postulated	|O
that	|O
altered	|O
blood	|O
flow	|O
,	|O
mediated	|O
through	|O
the	|O
well	|O
-	|O
known	|O
prostaglandin	|B-PROTEIN
synthetase	|I-PROTEIN
inhibitory	|O
effects	|O
of	|O
ibuprofen	|O
,	|O
resulted	|O
in	|O
tubular	|O
necrosis	|O
.	|O

Either	|O
20	|O
mg	|O
mitomycin	|O
/	|O
20	|O
ml	|O
distilled	|O
water	|O
or	|O
40	|O
mg	|O
/	|O
40	|O
ml	|O
distilled	|O
water	|O
was	|O
locally	|O
instilled	|O
into	|O
the	|O
bladder	|O
with	|O
a	|O
catheter	|O
after	|O
emptying	|O
it	|O
and	|O
was	|O
left	|O
for	|O
about	|O
25	|O
-	|O
l20	|O
min	|O
.	|O

Both	|O
groups	|O
rejected	|O
pops	|O
with	|O
added	|O
SOA	|O
,	|O
decreasing	|O
mouthing	|O
times	|O
as	|O
SOA	|O
concentration	|O
increased	|O
.	|O

The	|O
mean	|O
extracted	|O
concentration	|O
of	|O
flucloxacillin	|O
obtained	|O
at	|O
operation	|O
was	|O
12.9	|O
micrograms	|O
/	|O
ml	|O
(	|O
SD	|O
5.25	|O
)	|O
in	|O
synovial	|O
fluid	|O
;	|O
2.9	|O
micrograms	|O
/	|O
g	|O
(	|O
SD	|O
3.59	|O
)	|O
in	|O
synovium	|O
;	|O
2.0	|O
micrograms	|O
/	|O
g	|O
(	|O
SD	|O
1.48	|O
)	|O
in	|O
cancellous	|O
bone	|O
and	|O
1.3	|O
micrograms	|O
/	|O
g	|O
(	|O
SD	|O
1.25	|O
)	|O
in	|O
cortical	|O
bone	|O
.	|O

A	|O
preliminary	|O
study	|O
of	|O
vincristine	|O
,	|O
methotrexate	|O
,	|O
and	|O
prednisolone	|O
(	|O
VM	|O
*	|O
P	|O
)	|O
combination	|O
chemotherapy	|O
for	|O
advanced	|O
adult	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O

Lacrimal	|O
secretion	|O
in	|O
hyperthyroidism	|O

Re	|O
-	|O
examination	|O
of	|O
the	|O
ED01	|O
study	|O
.	|O

Based	|O
on	|O
213	|O
determinations	|O
,	|O
the	|O
control	|O
mean	|O
serum	|O
CPK	|B-PROTEIN
activity	|O
was	|O
262	|O
+	|O
/	|O
-	|O
113	|O
I.U.	|O
/	|O
liter	|O
.	|O

A	|O
further	|O
study	|O
on	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
release	|O
by	|O
vasoactive	|O
agents	|O
in	|O
the	|O
isolated	|O
perfused	|O
dog	|O
leg	|O
.	|O

CDDP	|O
is	|O
active	|O
as	|O
a	|O
single	|O
agent	|O
in	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O
.	|O

Treatment	|O
of	|O
meat	|O
muscle	|O
800	|O
V	|O
for	|O
45	|O
s	|O
reduced	|O
weeping	|O
but	|O
increased	|O
slightly	|O
the	|O
rate	|O
of	|O
autoxidation	|O
of	|O
lipids	|O
.	|O

The	|O
hormonal	|O
response	|O
to	|O
a	|O
standardized	|O
bicycle	|O
exercise	|O
test	|O
was	|O
studied	|O
in	|O
11	|O
male	|O
cadets	|O
exposed	|O
to	|O
a	|O
course	|O
of	|O
107	|O
h	|O
of	|O
continuous	|O
activity	|O
with	|O
less	|O
than	|O
2	|O
h	|O
sleep	|O
.	|O

At	|O
an	|O
ambient	|O
temperature	|O
of	|O
25	|O
degrees	|O
C	|O
,	|O
the	|O
responses	|O
to	|O
spinal	|O
cooling	|O
are	|O
reduced	|O
during	|O
the	|O
dark	|O
phase	|O
.	|O

A	|O
method	|O
for	|O
determining	|O
cumulative	|O
behavioral	|O
toxicity	|O
after	|O
chronic	|O
oral	|O
administration	|O
of	|O
l	|O
-	|O
alpha	|O
-	|O
acetylmethadol	|O
to	|O
female	|O
rats	|O
.	|O

After	|O
successful	|O
subtotal	|O
parathyroidectomy	|O
,	|O
evident	|O
by	|O
the	|O
decrease	|O
of	|O
serum	|O
iPTH	|B-PROTEIN
levels	|O
,	|O
both	|O
the	|O
CL	|O
of	|O
group	|O
2	|O
PMNs	|O
and	|O
the	|O
ability	|O
of	|O
group	|O
2	|O
sera	|O
to	|O
induce	|O
augmented	|O
CL	|O
in	|O
normal	|O
PMNs	|O
decreased	|O
(	|O
p	|O
<	|O
0.025	|O
)	|O
.	|O

TCZ	|O
provides	|O
quick	|O
,	|O
inexpensive	|O
,	|O
noninvasive	|O
indication	|O
of	|O
tissue	|O
necrosis	|O
,	|O
moderate	|O
-	|O
to	|O
-	|O
severe	|O
intracranial	|O
hemorrhage	|O
,	|O
and	|O
delayed	|O
brain	|O
maturation	|O
.	|O

The	|O
number	|O
of	|O
muricidal	|O
rats	|O
increased	|O
with	|O
increase	|O
in	|O
the	|O
duration	|O
of	|O
Cd	|O
administration	|O
in	|O
association	|O
with	|O
greater	|O
accumulation	|O
of	|O
Cd	|O
in	|O
the	|O
olfactory	|O
bulb	|O
than	|O
in	|O
any	|O
other	|O
region	|O
of	|O
the	|O
brain	|O
.	|O

This	|O
test	|O
should	|O
provide	|O
another	|O
practical	|O
means	|O
to	|O
study	|O
leprosy	|O
.	|O

The	|O
preferences	|O
were	|O
for	|O
intact	|O
vis	|O
-	|O
a	|O
-	|O
vis	|O
castrated	|O
males	|O
,	|O
though	|O
injections	|O
of	|O
TP	|O
restored	|O
the	|O
castrates	|O
'	|O
attractiveness	|O
to	|O
the	|O
females	|O
.	|O

Each	|O
trial	|O
consisted	|O
of	|O
light	|O
and	|O
buzzer	|O
for	|O
five	|O
seconds	|O
as	|O
conditioned	|O
stimuli	|O
and	|O
electric	|O
shock	|O
for	|O
five	|O
seconds	|O
as	|O
an	|O
unconditioned	|O
stimulus	|O
.	|O

Ulcer	|O
appeared	|O
on	|O
the	|O
angulus	|O
of	|O
the	|O
stomach	|O
at	|O
the	|O
28th	|O
week	|O
and	|O
resulted	|O
in	|O
ulcer	|O
scar	|O
at	|O
the	|O
42nd	|O
week	|O
.	|O

Family	|O
visits	|O
and	|O
involvement	|O
in	|O
treatment	|O
of	|O
patients	|O
at	|O
a	|O
state	|O
hospital	|O
.	|O

A	|O
transparent	|O
overlay	|O
for	|O
assessing	|O
amplitude	|O
of	|O
ECG	|O
wave	|O
forms	|O
.	|O

Adverse	|O
reaction	|O
of	|O
the	|O
apparently	|O
healthy	|O
partner	|O
in	|O
response	|O
to	|O
improvement	|O
in	|O
the	|O
overtly	|O
dysfunctional	|O
partner	|O
.	|O

Brain	|O
scan	|O
with	|O
99mTc	|O
-	|O
labelled	|O
macroaggregated	|B-PROTEIN
albumin	|I-PROTEIN
(	|O
MAA	|B-PROTEIN
brain	|O
scan	|O
)	|O
and	|O
computed	|O
tomography	|O
studies	|O
(	|O
CT	|O
)	|O
were	|O
performed	|O
on	|O
78	|O
patients	|O
with	|O
intracranial	|O
diseases	|O
.	|O

Inhibition	|O
of	|O
Fusarium	|O
moniliforme	|O
var	|O
.	|O
subglutinans	|O
,	|O
the	|O
causal	|O
agent	|O
of	|O
pine	|O
pitch	|O
canker	|O
,	|O
by	|O
the	|O
soil	|O
bacterium	|O
Arthrobacter	|O
sp	|O
.	|O

The	|O
five	|O
-	|O
drug	|O
combination	|O
of	|O
fluorouracil	|O
imidazole	|O
carboxamide	|O
dimethyl	|O
triazeno	|O
,	|O
vincristine	|O
,	|O
bis	|O
-	|O
chloroethyl	|O
nitrosourea	|O
,	|O
and	|O
prednisone	|O
(	|O
FIVB	|O
+	|O
P	|O
)	|O
was	|O
given	|O
to	|O
120	|O
women	|O
with	|O
metastatic	|O
breast	|O
cancer	|O
.	|O

A	|O
method	|O
is	|O
described	|O
for	|O
the	|O
simultaneous	|O
determination	|O
of	|O
1	|O
,	|O
alpha	|O
-	|O
acetylmethadol	|O
(	|O
LAAM	|O
)	|O
and	|O
five	|O
active	|O
metabolites	|O
-	|O
-	|O
noracetylmethadol	|O
,	|O
dinoracetylmethadol	|O
,	|O
methadol	|O
,	|O
normethadol	|O
,	|O
and	|O
dinormethadol	|O
-	|O
-	|O
in	|O
biofluids	|O
by	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatography	|O
using	|O
a	|O
normal	|O
-	|O
phase	|O
column	|O
and	|O
a	|O
UV	|O
detector	|O
at	|O
218	|O
nm	|O
.	|O

Results	|O
of	|O
the	|O
recognition	|O
task	|O
revealed	|O
significant	|O
effects	|O
of	|O
consonant	|O
voicing	|O
,	|O
position	|O
and	|O
vowel	|O
context	|O
on	|O
syllable	|O
recognition	|O
.	|O

Visual	|O
response	|O
properties	|O
of	|O
neurons	|O
in	|O
four	|O
extrastriate	|O
visual	|O
areas	|O
of	|O
the	|O
owl	|O
monkey	|O
(	|O
Aotus	|O
trivirgatus	|O
)	|O
:	|O
a	|O
quantitative	|O
comparison	|O
of	|O
medial	|O
,	|O
dorsomedial	|O
,	|O
dorsolateral	|O
,	|O
and	|O
middle	|O
temporal	|O
areas	|O
.	|O

A	|O
unified	|O
approach	|O
to	|O
the	|O
standardization	|O
of	|O
allergens	|O
.	|O

Clinical	|O
and	|O
anatomical	|O
considerations	|O

A	|O
dose	|O
-	|O
dependent	|O
fall	|O
in	|O
GABA	|O
content	|O
was	|O
observed	|O
;	|O
GABA	|O
decrease	|O
was	|O
evident	|O
15	|O
min	|O
after	|O
the	|O
administration	|O
,	|O
reached	|O
its	|O
nadir	|O
at	|O
60	|O
min	|O
and	|O
disappeared	|O
at	|O
120	|O
minutes	|O
.	|O

Theory	|O
and	|O
applications	|O
of	|O
pulse	|O
dosing	|O
:	|O
a	|O
summary	|O
of	|O
the	|O
symposium	|O
.	|O

These	|O
results	|O
show	|O
that	|O
the	|O
neonate	|O
differs	|O
from	|O
the	|O
adult	|O
in	|O
respect	|O
of	|O
both	|O
the	|O
nature	|O
of	|O
effects	|O
of	|O
the	|O
drug	|O
and	|O
sensitivity	|O
to	|O
it	|O
.	|O

To	|O
evaluate	|O
the	|O
gas	|O
chromatographic	|O
electron	|O
capture	|O
detection	|O
method	|O
described	|O
earlier	|O
,	|O
23	|O
plasma	|O
samples	|O
have	|O
been	|O
analysed	|O
by	|O
both	|O
techniques	|O
.	|O

The	|O
hemodynamics	|O
of	|O
isoproterenol	|O
-	|O
induced	|O
cardiac	|O
failure	|O
in	|O
the	|O
rat	|O
.	|O

Several	|O
authors	|O
have	|O
recently	|O
reported	|O
interference	|O
in	|O
theophylline	|O
analysis	|O
by	|O
paraxanthine	|O
(	|O
1,7	|O
-	|O
dimethylxanthine	|O
)	|O
,	|O
an	|O
important	|O
metabolite	|O
of	|O
caffeine	|O
.	|O

Multi	|O
drug	|O
regimens	|O
like	|O
C	|O
-	|O
MOPP	|O
,	|O
CHOP	|O
and	|O
BACOP	|O
led	|O
to	|O
high	|O
remission	|O
rates	|O
and	|O
in	|O
some	|O
cases	|O
probably	|O
also	|O
to	|O
a	|O
cure	|O
of	|O
the	|O
disease	|O
.	|O

For	|O
monocytes	|O
,	|O
as	|O
measured	|O
on	|O
the	|O
Hematrak	|O
,	|O
it	|O
was	|O
13.4%	|O
.	|O

Morphological	|O
features	|O
of	|O
Jat	|O
dentition	|O
.	|O

Clinical	|O
accuracy	|O
of	|O
updated	|O
version	|O
of	|O
the	|O
Phadebas	|O
RAST	|O
test	|O
.	|O

Five	|O
control	|O
subjects	|O
with	|O
COPD	|O
,	|O
who	|O
performed	|O
the	|O
same	|O
sequence	|O
of	|O
tests	|O
without	|O
breathing	|O
30%	|O
O2	|O
,	|O
showed	|O
no	|O
change	|O
in	|O
flow	|O
rates	|O
or	|O
density	|O
dependence	|O
.	|O

Following	|O
extended	|O
recovery	|O
hippocampal	|O
EEG	|O
was	|O
normal	|O
despite	|O
extensive	|O
cellular	|O
loss	|O
in	|O
areas	|O
CA3	|O
and	|O
CA4	|O
.	|O

Evoked	|O
potential	|O
and	|O
single	|O
unit	|O
responses	|O
to	|O
olfactory	|O
nerve	|O
volleys	|O
in	|O
the	|O
isolated	|O
turtle	|O
olfactory	|O
bulb	|O
.	|O

While	|O
all	|O
deletions	|O
within	|O
the	|O
sequence	|O
coding	|O
for	|O
the	|O
mature	|O
tRNA	|O
led	|O
to	|O
inactivity	|O
of	|O
the	|O
mutated	|O
genes	|O
,	|O
substitution	|O
of	|O
the	|O
central	|O
portion	|O
by	|O
concatenated	|O
Hind	|B-PROTEIN
III	|I-PROTEIN
linkers	|O
produced	|O
gene	|O
units	|O
active	|O
in	|O
transcription	|O
.	|O

Cross	|O
reactivity	|O
in	|O
theophylline	|O
RIA	|O
kit	|O
decreased	|O
.	|O

Strontium	|O
-	|O
90	|O
was	|O
inject	|O
i.v	|O
.	|O
into	|O
pregnant	|O
rats	|O
on	|O
day	|O
18	|O
post	|O
conception	|O
(	|O
p.c	|O
.	|O
)	|O
.	|O

Recording	|O
of	|O
the	|O
digital	|O
sphygmic	|O
activity	|O
in	|O
the	|O
lower	|O
extremities	|O
with	|O
the	|O
photoplethysmographic	|O
and	|O
strain	|O
-	|O
gauge	|O
methods	|O
.	|O

Eight	|O
hr	|O
of	|O
acidosis	|O
caused	|O
a	|O
significant	|O
(	|O
P	|O
less	|O
than	|O
0.01	|O
)	|O
decrease	|O
in	|O
P50	|O
in	|O
vitro	|O
which	|O
fell	|O
from	|O
29.0	|O
to	|O
24.4	|O
torr	|O
.	|O

Catheter	|O
transit	|O
slows	|O
the	|O
response	|O
to	|O
a	|O
step	|O
increase	|O
in	|O
concentration	|O
by	|O
about	|O
0.13	|O
s	|O
(	|O
from	|O
10	|O
per	|O
cent	|O
-	|O
90	|O
per	|O
cent	|O
)	|O
and	|O
prolongs	|O
the	|O
transit	|O
time	|O
through	|O
the	|O
catheter	|O
for	|O
a	|O
volatile	|O
anesthetic	|O
by	|O
about	|O
0.04	|O
s	|O
more	|O
than	|O
N2	|O
.	|O

These	|O
women	|O
should	|O
not	|O
be	|O
given	|O
the	|O
current	|O
estrogen	|O
PPI	|O
,	|O
which	|O
was	|O
designed	|O
to	|O
warn	|O
women	|O
of	|O
the	|O
risks	|O
of	|O
long	|O
-	|O
term	|O
estrogen	|O
use	|O
;	|O
a	|O
PPI	|O
should	|O
be	|O
written	|O
specifically	|O
for	|O
patients	|O
receiving	|O
short	|O
courses	|O
.	|O

The	|O
oral	|O
temperature	|O
rose	|O
and	|O
the	|O
serum	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
levels	|O
fell	|O
only	|O
in	|O
those	|O
patients	|O
who	|O
were	|O
actively	|O
warmed	|O
.	|O

Determination	|O
of	|O
aortic	|O
distensibility	|O
and	|O
its	|O
variations	|O
in	|O
arterial	|O
hypertension	|O
.	|O

We	|O
studied	|O
the	|O
role	|O
of	|O
prostaglandins	|O
in	|O
acid	|O
-	|O
induced	|O
esophagitis	|O
and	|O
the	|O
associated	|O
LES	|O
hypotension	|O
by	|O
simultaneous	|O
treatment	|O
of	|O
some	|O
animals	|O
with	|O
indomethacin	|O
(	|O
150	|O
micrograms	|O
/	|O
kg	|O
intravenous	|O
)	|O
,	|O
a	|O
specific	|O
inhibitor	|O
of	|O
prostaglandin	|O
synthesis	|O
,	|O
either	|O
during	|O
production	|O
of	|O
esophagitis	|O
or	|O
during	|O
recovery	|O
.	|O

Since	|O
only	|O
58%	|O
of	|O
our	|O
sample	|O
could	|O
be	|O
adequately	|O
classified	|O
with	|O
one	|O
diagnosis	|O
,	|O
we	|O
expect	|O
that	|O
the	|O
ASDC	|O
nosology	|O
will	|O
need	|O
to	|O
evolve	|O
further	|O
.	|O

A	|O
surgical	|O
technique	|O
for	|O
correcting	|O
this	|O
problem	|O
is	|O
described	|O
.	|O

Effects	|O
of	|O
prostaglandin	|O
inhibitors	|O
on	|O
the	|O
onset	|O
of	|O
proteinuria	|O
and	|O
stroke	|O
in	|O
stroke	|O
-	|O
prone	|O
spontaneously	|O
hypertensive	|O
rats	|O
.	|O

In	|O
this	|O
study	|O
,	|O
the	|O
general	|O
clinical	|O
criteria	|O
for	|O
inhalation	|O
injury	|O
-	|O
-	|O
presence	|O
of	|O
facial	|O
or	|O
oropharyngeal	|O
burns	|O
,	|O
carboxyhemoglobin	|B-PROTEIN
levels	|O
,	|O
carbonaceous	|O
sputum	|O
,	|O
or	|O
closed	|O
space	|O
injury	|O
-	|O
-	|O
did	|O
not	|O
differentiate	|O
patients	|O
with	|O
airway	|O
injury	|O
only	|O
from	|O
those	|O
with	|O
parenchymal	|O
injury	|O
.	|O

Survival	|O
was	|O
calculated	|O
both	|O
from	|O
the	|O
date	|O
of	|O
onset	|O
and	|O
from	|O
the	|O
date	|O
of	|O
diagnosis	|O
.	|O

Methisergide	|O
(	|O
0.5	|O
mg	|O
/	|O
kg	|O
,	|O
i.p	|O
.	|O
)	|O
,	|O
a	|O
blocker	|O
of	|O
serotonin	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
prevented	|O
the	|O
development	|O
of	|O
the	|O
antinociceptive	|O
effect	|O
of	|O
serotonin	|O
.	|O

The	|O
plasma	|O
half	|O
-	|O
life	|O
of	|O
slow	|O
disposition	|O
phase	|O
t1/2	|O
beta	|O
,	|O
increases	|O
from	|O
0.26	|O
hour	|O
in	|O
rabbits	|O
with	|O
normal	|O
renal	|O
function	|O
to	|O
5.41	|O
hours	|O
in	|O
rabbits	|O
with	|O
severe	|O
renal	|O
impairment	|O
.	|O

Effects	|O
of	|O
early	|O
monocular	|O
deprivation	|O
on	|O
development	|O
of	|O
cortico	|O
-	|O
geniculate	|O
projections	|O
in	|O
the	|O
cat	|O
.	|O

Corticosteroid	|O
therapy	|O
is	|O
known	|O
to	|O
be	|O
hazardous	|O
in	|O
patients	|O
with	|O
occult	|O
infection	|O
but	|O
the	|O
mechanism	|O
by	|O
which	|O
the	|O
host	|O
parasite	|O
relationship	|O
is	|O
altered	|O
by	|O
steroids	|O
is	|O
not	|O
known.W	|O
e	|O
have	|O
used	|O
an	|O
intestinal	|O
protozoal	|O
parasite	|O
,	|O
Giardia	|O
muris	|O
,	|O
to	|O
examine	|O
the	|O
effects	|O
of	|O
corticosteroids	|O
on	|O
the	|O
number	|O
of	|O
parasites	|O
in	|O
the	|O
intestine	|O
in	|O
the	|O
course	|O
of	|O
a	|O
primary	|O
infection	|O
.	|O

Static	|O
lung	|O
function	|O
in	|O
puppies	|O
after	|O
pneumonectomy	|O
.	|O

With	|O
Sair	|O
and	|O
So2	|O
,	|O
mean	|O
vital	|O
capacity	|O
was	|O
reduced	|O
by	|O
44%	|O
from	|O
control	|O
.	|O

Bilateral	|O
Charnley	|O
arthroplasty	|O
as	|O
a	|O
single	|O
procedure	|O
.	|O

Of	|O
the	|O
117	|O
patients	|O
(	|O
out	|O
of	|O
the	|O
136	|O
)	|O
with	|O
serologic	|O
evidence	|O
of	|O
chronic	|O
thyroiditis	|O
who	|O
could	|O
be	|O
studied	|O
,	|O
eight	|O
(	|O
7%	|O
)	|O
had	|O
hyperthyroidism	|O
and	|O
45	|O
(	|O
38%	|O
)	|O
were	|O
hypothyroid	|O
.	|O

The	|O
relationship	|O
between	|O
estrogenic	|O
properties	|O
of	|O
Tamoxifen	|O
and	|O
breast	|O
cancer	|O
management	|O
is	|O
discussed	|O
.	|O

The	|O
new	|O
semi	|O
-	|O
synthetic	|O
oral	|O
cephalosporin	|O
,	|O
CGP	|O
9,000	|O
,	|O
has	|O
been	|O
evaluated	|O
in	|O
a	|O
large	|O
number	|O
of	|O
hospitalized	|O
patients	|O
with	|O
urinary	|O
infections	|O
.	|O

A	|O
fluoroimmunoassay	|O
for	|O
the	|O
determination	|O
of	|O
serum	|O
of	|O
plasma	|O
levels	|O
of	|O
propranolol	|O
was	|O
developed	|O
using	|O
antibodies	|O
to	|O
propranolol	|O
coupled	|O
to	|O
magnetizable	|O
solid	|O
-	|O
phase	|O
particles	|O
and	|O
fluorescein	|O
-	|O
labeled	|O
propranolol	|O
as	|O
tracer	|O
.	|O

The	|O
syncytial	|O
microvillous	|O
projections	|O
seemed	|O
to	|O
be	|O
more	|O
numerous	|O
and	|O
longer	|O
in	|O
CNF	|O
,	|O
otherwise	|O
the	|O
structure	|O
of	|O
the	|O
trophoblastic	|O
layer	|O
of	|O
the	|O
villi	|O
and	|O
the	|O
lining	|O
of	|O
the	|O
subtrophoblastic	|O
vessels	|O
were	|O
identical	|O
in	|O
CNF	|O
and	|O
controls	|O
.	|O

When	|O
pollen	|O
allergen	|O
from	|O
three	|O
grass	|O
species	|O
were	|O
used	|O
,	|O
The	|O
RAST	|O
-	|O
test	|O
results	|O
did	|O
not	|O
differ	|O
from	|O
duplicate	|O
values	|O
either	|O
.	|O

DMI	|O
and	|O
2	|O
-	|O
OH	|O
-	|O
DMI	|O
concentrations	|O
were	|O
determined	|O
in	|O
a	|O
similar	|O
group	|O
of	|O
61	|O
DMI	|O
-	|O
treated	|O
patients	|O
.	|O

It	|O
has	|O
been	|O
shown	|O
in	|O
experiments	|O
in	|O
vitro	|O
that	|O
the	|O
hepatotrophic	|O
organic	|O
anions	|O
,	|O
the	|O
radiographic	|O
contrast	|O
agent	|O
(	|O
RCA	|O
)	|O
bilignost	|O
used	|O
in	|O
cholecystography	|O
and	|O
Bengal	|O
pink	|O
,	|O
have	|O
an	|O
affinity	|O
,	|O
unlike	|O
the	|O
urographic	|O
RCA	|O
triombrin	|O
and	|O
renotrophic	|O
dye	|O
indigo	|O
-	|O
carmine	|O
,	|O
for	|O
the	|O
plasmatic	|O
membranes	|O
(	|O
PM	|O
)	|O
of	|O
liver	|O
cells	|O
.	|O

33	|O
out	|O
of	|O
90	|O
neurons	|O
of	|O
the	|O
cat	|O
medial	|O
geniculate	|O
body	|O
revealed	|O
the	|O
selectivity	|O
of	|O
their	|O
afterdischarges	|O
to	|O
movement	|O
of	|O
sound	|O
when	|O
velocity	|O
of	|O
the	|O
movement	|O
changed	|O
from	|O
30	|O
to	|O
180	|O
deg	|O
/	|O
s	|O
.	|O

In	|O
controls	|O
,	|O
only	|O
modest	|O
differences	|O
were	|O
observed	|O
.	|O

Assay	|O
of	|O
serum	|O
immunoreactive	|O
trypsin	|B-PROTEIN
in	|O
dried	|O
blood	|O
spots	|O
and	|O
the	|O
early	|O
detection	|O
of	|O
cystic	|O
fibrosis	|O
.	|O

Similar	|O
waves	|O
were	|O
seen	|O
on	|O
cross	|O
-	|O
correlating	|O
a	|O
motor	|O
unit	|O
with	|O
an	|O
electronic	|O
oscillator	|O
,	|O
confirming	|O
that	|O
their	|O
occurrence	|O
does	|O
not	|O
necessarily	|O
demonstrate	|O
the	|O
existence	|O
of	|O
active	|O
neural	|O
interactions	|O
.	|O

Leukocyte	|O
enzyme	|O
activity	|O
and	|O
blood	|O
lymphocyte	|O
blast	|O
transformation	|O
in	|O
chronic	|O
bronchitis	|O

Current	|O
status	|O
of	|O
chemotherapy	|O
for	|O
Hodgkin	|O
's	|O
disease	|O

In	|O
literature	|O
,	|O
the	|O
HBE	|O
has	|O
been	|O
displayed	|O
by	|O
application	|O
of	|O
the	|O
averaging	|O
method	|O
.	|O

Forty	|O
-	|O
five	|O
cases	|O
were	|O
surgically	|O
by	|O
direct	|O
approach	|O
to	|O
the	|O
tumour	|O
,	|O
while	|O
two	|O
cases	|O
were	|O
treated	|O
only	|O
with	|O
a	|O
shunt	|O
.	|O

In	|O
Group	|O
V	|O
,	|O
the	|O
salvaged	|O
tissue	|O
was	|O
primarily	|O
subepicardial	|O
with	|O
virtually	|O
no	|O
lateral	|O
zone	|O
of	|O
salvaged	|O
tissue	|O
(	|O
ratio	|O
of	|O
salvaged	|O
subepicardium	|O
to	|O
salvaged	|O
subendocardium	|O
14.8	|O
+	|O
/	|O
-	|O
1.9	|O
to	|O
1	|O
)	|O
.	|O

Progressive	|O
100	|O
-	|O
mmHg	|O
stepwise	|O
decreases	|O
in	|O
superfusate	|O
oxygen	|O
partial	|O
pressure	|O
(	|O
PO2	|O
)	|O
from	|O
control	|O
(	|O
95%	|O
O2	|O
aeration	|O
,	|O
PO2	|O
,	|O
620-650	|O
mmHg	|O
)	|O
were	|O
produced	|O
,	|O
and	|O
subsequent	|O
changes	|O
in	|O
isometric	|O
active	|O
and	|O
resting	|O
tension	|O
were	|O
measured	|O
.	|O

The	|O
known	|O
B1	|O
-	|O
deficiency	|O
reaches	|O
excessive	|O
high	|O
values	|O
with	|O
light	|O
exercise	|O
.	|O

Based	|O
on	|O
AUC	|O
infinity	|O
analyses	|O
,	|O
the	|O
pharmacokinetics	|O
of	|O
buflomedil	|O
were	|O
found	|O
to	|O
be	|O
linear	|O
within	|O
the	|O
dose	|O
ranges	|O
studied	|O
(	|O
50	|O
to	|O
200	|O
mg	|O
for	|O
i	|O
.	|O
v	|O
.	|O
injection	|O
and	|O
150	|O
to	|O
450	|O
mg	|O
for	|O
oral	|O
administration	|O
)	|O
.	|O

Gastrin	|B-PROTEIN
secretion	|O
during	|O
food	|O
stimulation	|O
in	|O
digestive	|O
system	|O
diseases	|O

Fibrinogen	|B-PROTEIN
determination	|O
using	|O
the	|O
KZM	|O
-	|O
1	|O
meter	|O

Over	|O
a	|O
period	|O
of	|O
15	|O
days	|O
16%	|O
of	|O
the	|O
dose	|O
administered	|O
was	|O
excreted	|O
with	|O
faeces	|O
and	|O
0.9%	|O
in	|O
the	|O
urine	|O
.	|O

Delayed	|O
or	|O
paradoxically	|O
emptying	|O
regions	|O
of	|O
the	|O
left	|O
ventricle	|O
were	|O
detected	|O
by	|O
a	|O
relatively	|O
new	|O
nuclear	|O
technique	|O
-	|O
-	|O
phase	|O
imaging	|O
.	|O

Responses	|O
to	|O
brainstem	|O
of	|O
nuclei	|O
medialis	|O
dorsalis	|O
,	|O
lateralis	|O
posterior	|O
were	|O
of	|O
considerably	|O
longer	|O
latency	|O
.	|O

Nineteen	|O
patients	|O
with	|O
non	|O
-	|O
visualized	|O
gallbladder	|O
with	|O
OCG	|O
subsequently	|O
had	|O
Tc	|O
-	|O
99m	|O
-	|O
PyG	|O
cholescintigraphy	|O
performed	|O
.	|O

One	|O
was	|O
allowed	|O
fresh	|O
drinking	|O
water	|O
ad	|O
libitum	|O
whilst	|O
the	|O
other	|O
received	|O
Aludrox	|O
in	|O
their	|O
drinking	|O
water	|O
.	|O

Anamnestic	|O
data	|O
were	|O
obtained	|O
from	|O
case	|O
history	|O
,	|O
smoking	|O
habits	|O
were	|O
not	|O
known	|O
in	|O
collective	|O
A	|O
and	|O
C.	|O

The	|O
determination	|O
of	|O
physical	|O
performance	|O
capacity	|O
was	|O
based	|O
on	|O
W170	|O
,	|O
W85	|O
%	|O
and	|O
on	|O
predicted	|O
VO2	|O
max	|O
measured	|O
with	|O
continuously	|O
increasing	|O
work	|O
load	|O
on	|O
a	|O
bicycle	|O
ergometer	|O
.	|O

Determination	|O
of	|O
lead	|O
in	|O
blood	|O
.	|O

Effect	|O
of	|O
indomethacin	|O
and	|O
prostaglandin	|O
F2	|O
alpha	|O
on	|O
parturition	|O
in	|O
swine	|O
.	|O

LD50	|O
values	|O
of	|O
terms	|O
of	|O
KP	|O
were	|O
84	|O
mg	|O
/	|O
kg	|O
in	|O
male	|O
rats	|O
and	|O
122	|O
mg	|O
/	|O
kg	|O
in	|O
female	|O
rats	|O
when	|O
KP	|O
-	|O
CMC	|O
was	|O
administered	|O
intrarectally	|O
,	|O
and	|O
117	|O
mg	|O
/	|O
kg	|O
in	|O
male	|O
and	|O
92	|O
mg	|O
/	|O
kg	|O
in	|O
female	|O
when	|O
KP	|O
-	|O
T10	|O
was	|O
administered	|O
intrarectally	|O
.	|O
,	|O
while	|O
peroral	|O
administration	|O
of	|O
KP	|O
-	|O
CMC	|O
showed	|O
LD50	|O
values	|O
of	|O
68	|O
mg	|O
/	|O
kg	|O
in	|O
males	|O
and	|O
78	|O
mg	|O
/	|O
kg	|O
in	|O
females	|O
in	|O
terms	|O
of	|O
KP	|O
.	|O

Autotransfusion	|O
was	|O
performed	|O
as	|O
follows	|O
:	|O
Heparin	|O
-	|O
ACD	|O
-	|O
B	|O
-	|O
Heparin	|O
-	|O
DPD	|O
-	|O
Heparin	|O
-	|O
ACD	|O
-	|O
B	|O
etc	|O
.	|O

Electron	|O
microscopic	|O
picture	|O
of	|O
the	|O
cerebral	|O
cortex	|O
in	|O
rats	|O
cooled	|O
to	|O
22	|O
degrees	|O
C	|O

Generally	|O
the	|O
differences	|O
between	|O
short	|O
gut	|O
and	|O
sham	|O
operation	|O
animals	|O
disappeared	|O
when	|O
the	|O
data	|O
were	|O
normalised	|O
for	|O
mucosal	|O
weight	|O
.	|O

A	|O
simplified	|O
thin	|O
-	|O
layer	|O
chromatographic	|O
determination	|O
of	|O
hippuric	|O
acid	|O
and	|O
methylhippuric	|O
acids	|O
.	|O

The	|O
architecture	|O
of	|O
microvasculature	|O
in	|O
these	|O
two	|O
regions	|O
was	|O
also	|O
examined	|O
by	|O
scanning	|O
electron	|O
microscopy	|O
,	|O
using	|O
the	|O
resin	|O
casting	|O
method	|O
.	|O

MSMS	|O
Council	|O
hears	|O
new	|O
public	|O
health	|O
director	|O
.	|O

Chordoma	|O
of	|O
the	|O
spinal	|O
cord	|O
in	|O
a	|O
F344	|O
rat	|O
.	|O

Micro	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatographic	|O
system	|O
with	|O
micro	|O
precolumn	|O
and	|O
dual	|O
electrochemical	|O
detector	|O
for	|O
direct	|O
injection	|O
analysis	|O
of	|O
catecholamines	|O
in	|O
body	|O
fluids	|O
.	|O

Thirty	|O
-	|O
one	|O
age	|O
-	|O
matched	|O
,	|O
conscious	|O
,	|O
virgin	|O
,	|O
male	|O
Sprague	|O
-	|O
Dawley	|O
rats	|O
and	|O
spontaneously	|O
hypertensive	|O
rats	|O
(	|O
SHRs	|O
)	|O
were	|O
individually	|O
injected	|O
with	|O
a	|O
single	|O
subcutaneous	|O
dose	|O
of	|O
85	|O
mg	|O
/	|O
kg	|O
dl	|O
-	|O
isoproterenol	|O
to	|O
determine	|O
the	|O
degree	|O
and	|O
time	|O
course	|O
of	|O
drug	|O
-	|O
induced	|O
cardiac	|O
failure	|O
and	|O
functional	|O
recovery	|O
.	|O

A	|O
narrow	|O
zone	|O
of	|O
myelin	|O
-	|O
axonal	|O
dissociation	|O
was	|O
also	|O
observed	|O
.	|O

The	|O
IgA	|B-PROTEIN
deficiency	|O
is	|O
combined	|O
with	|O
the	|O
IgE	|B-PROTEIN
one	|O
.	|O

In	|O
PB	|O
mice	|O
,	|O
there	|O
was	|O
only	|O
a	|O
small	|O
deficit	|O
in	|O
the	|O
number	|O
of	|O
the	|O
hippocampal	|O
pyramidal	|O
neurons	|O
compared	|O
to	|O
controls	|O
(	|O
15%	|O
,	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
,	|O
and	|O
no	|O
deficit	|O
in	|O
the	|O
granule	|O
cells	|O
.	|O

Nutritional	|O
cataracts	|O
in	|O
timber	|O
wolves	|O
.	|O

Prevention	|O
of	|O
transfusion	|O
reactions	|O
by	|O
the	|O
use	|O
of	|O
saline	|O
washed	|O
red	|O
blood	|O
cells	|O
.	|O

The	|O
geometric	|O
mean	|O
hemagglutination	|O
-	|O
inhibition	|O
antibody	|O
titers	|O
(	|O
GMT	|O
)	|O
of	|O
non	|O
-	|O
immunized	|O
,	|O
once	|O
-	|O
immunized	|O
,	|O
and	|O
twice	|O
-	|O
immunized	|O
chickens	|O
were	|O
compared	|O
at	|O
2	|O
-	|O
week	|O
intervals	|O
following	|O
primary	|O
immunization	|O
,	|O
secondary	|O
immunization	|O
,	|O
and	|O
challenge	|O
.	|O

The	|O
quantitative	|O
determination	|O
of	|O
HBSAG	|B-PROTEIN
-	|O
-	|O
a	|O
valuable	|O
aid	|O
in	|O
evaluating	|O
the	|O
infectiousness	|O
of	|O
hepatitis	|O
B	|O
virus	|O
carriers	|O

2	|O
.	|O
numerous	|O
narrow	|O
shunt	|O
vessels	|O
departing	|O
continuously	|O
from	|O
the	|O
primary	|O
arteries	|O
to	|O
feed	|O
a	|O
secondary	|O
arterial	|O
system	|O
which	|O
parallels	|O
the	|O
primary	|O
one	|O
.	|O

Urological	|O
complications	|O
are	|O
frequent	|O
during	|O
and	|O
after	|O
the	|O
treatment	|O
of	|O
gynecological	|O
malignancy	|O
.	|O

Arachnoid	|O
cyst	|O
.	|O

100	|O
more	|O
than	|O
in	|O
the	|O
summer	|O
coat	|O
)	|O
.	|O

Hypotension	|O
was	|O
produced	|O
by	|O
head	|O
up	|O
tilt	|O
.	|O

Therefore	|O
the	|O
procedure	|O
of	|O
Lich	|O
-	|O
Gregoir	|O
is	|O
not	|O
to	|O
be	|O
recommended	|O
in	|O
adults	|O
.	|O

Mucoepidermoid	|O
and	|O
acinous	|O
cell	|O
carcinomas	|O
of	|O
salivary	|O
tissues	|O
.	|O

Twenty	|O
patients	|O
aged	|O
45	|O
or	|O
older	|O
with	|O
the	|O
diagnosis	|O
of	|O
endogenous	|O
depression	|O
were	|O
evaluated	|O
in	|O
terms	|O
of	|O
safety	|O
and	|O
efficacy	|O
in	|O
their	|O
response	|O
to	|O
multiple	|O
monitored	|O
electroconvulsive	|O
therapy	|O
(	|O
MMECT	|O
)	|O
versus	|O
single	|O
electroconvulsive	|O
therapy	|O
(	|O
SECT	|O
)	|O
.	|O

Two	|O
new	|O
artifacts	|O
in	|O
automated	|O
coagulation	|O
testing	|O
.	|O

This	|O
relatively	|O
simple	|O
and	|O
easily	|O
performed	|O
technique	|O
of	|O
measuring	|O
deep	|O
muscle	|O
temperature	|O
appears	|O
to	|O
be	|O
a	|O
useful	|O
adjunct	|O
in	|O
choosing	|O
the	|O
amputation	|O
level	|O
.	|O

Longitudinal	|O
force	|O
-	|O
length	|O
relationships	|O
of	|O
guinea	|O
pig	|O
ureter	|O
were	|O
studied	|O
in	|O
vitro	|O
in	|O
animals	|O
3	|O
weeks	|O
,	|O
3	|O
months	|O
,	|O
and	|O
3	|O
years	|O
of	|O
age	|O
.	|O

Tests	|O
of	|O
the	|O
method	|O
indicate	|O
(	|O
1	|O
)	|O
the	|O
Mossbauer	|O
source	|O
can	|O
be	|O
placed	|O
on	|O
the	|O
basilar	|O
membrane	|O
without	|O
altering	|O
the	|O
signal	|O
-	|O
transmission	|O
properties	|O
of	|O
the	|O
cochlea	|O
,	|O
and	|O
(	|O
2	|O
)	|O
the	|O
source	|O
adheres	|O
to	|O
the	|O
basilar	|O
membrane	|O
.	|O

Angiographic	|O
work	|O
-	|O
up	|O
in	|O
a	|O
patient	|O
with	|O
late	|O
vaginal	|O
metastasis	|O
from	|O
a	|O
renal	|O
carcinoma	|O
.	|O

The	|O
authors	|O
conclude	|O
that	|O
nonspecificity	|O
of	|O
low	|O
platelet	|O
MAO	|B-PROTEIN
as	|O
a	|O
possible	|O
correlate	|O
of	|O
bipolar	|O
affective	|O
disorder	|O
,	|O
as	|O
well	|O
as	|O
schizophrenia	|O
,	|O
increases	|O
the	|O
burden	|O
of	|O
proof	|O
necessary	|O
before	|O
findings	|O
of	|O
low	|O
platelet	|O
MAO	|B-PROTEIN
can	|O
be	|O
accepted	|O
as	|O
primary	|O
.	|O

Ecthyma	|O
,	|O
a	|O
known	|O
disease	|O
,	|O
of	|O
which	|O
little	|O
is	|O
known	|O

Estrogen	|O
replacement	|O
,	|O
either	|O
as	|O
17	|O
beta	|O
-	|O
estradiol	|O
or	|O
beta	|O
-	|O
estradiol	|O
-	|O
3	|O
-	|O
benzoate	|O
via	|O
subcutaneous	|O
Silastic	|O
capsules	|O
,	|O
was	|O
associated	|O
with	|O
elevated	|O
rates	|O
of	|O
heat	|O
production	|O
and	|O
dry	|O
heat	|O
loss	|O
relative	|O
to	|O
untreated	|O
ovariectomized	|O
controls	|O
.	|O

The	|O
following	|O
aspects	|O
were	|O
assessed	|O
:	|O
(	|O
1	|O
)	|O
The	|O
effect	|O
on	|O
the	|O
cardiovascular	|O
system	|O
in	|O
terms	|O
of	|O
brachial	|O
arterial	|O
pressure	|O
,	|O
pulse	|O
rate	|O
,	|O
and	|O
oxygen	|O
consumption	|O
(	|O
VO2	|O
)	|O
during	|O
exercise	|O
in	|O
5	|O
health	|O
volunteers	|O
;	|O
(	|O
2	|O
)	|O
emg	|O
activity	|O
of	|O
the	|O
tibialis	|O
anterior	|O
and	|O
gastrocnemius	|O
muscles	|O
during	|O
exercise	|O
in	|O
the	|O
same	|O
5	|O
volunteers	|O
;	|O
and	|O
(	|O
3	|O
)	|O
postexercise	|O
ankle	|O
pressure	|O
changes	|O
in	|O
10	|O
subjects	|O
with	|O
angiographically	|O
proven	|O
occlusive	|O
arterial	|O
diseases	|O
of	|O
the	|O
lower	|O
extremities	|O
.	|O

Changes	|O
in	|O
immunologic	|O
reactivity	|O
in	|O
subjects	|O
receiving	|O
transfer	|B-PROTEIN
factor	|I-PROTEIN
could	|O
not	|O
be	|O
distinguished	|O
from	|O
those	|O
in	|O
subjects	|O
receiving	|O
placebo	|O
.	|O

It	|O
was	|O
argued	|O
that	|O
this	|O
arose	|O
from	|O
the	|O
possibility	|O
that	|O
the	|O
nature	|O
of	|O
blue	|O
collar	|O
jobs	|O
was	|O
physical	|O
,	|O
and	|O
that	|O
loss	|O
of	|O
myocardial	|O
tissue	|O
might	|O
be	|O
expected	|O
to	|O
more	|O
markedly	|O
interfere	|O
with	|O
their	|O
work	|O
efficiency	|O
(	|O
on	|O
returning	|O
to	|O
work	|O
)	|O
than	|O
it	|O
would	|O
the	|O
efficiency	|O
of	|O
the	|O
more	|O
sedentary	|O
jobs	|O
of	|O
white	|O
collar	|O
workers	|O
.	|O

Importance	|O
of	|O
determining	|O
the	|O
blood	|O
sulfhydryl	|O
groups	|O
in	|O
fractures	|O
of	|O
the	|O
long	|O
tubular	|O
bones	|O
complicated	|O
by	|O
infection	|O

The	|O
results	|O
revealed	|O
increased	|O
blood	|O
lead	|O
level	|O
associated	|O
with	|O
decreased	|O
blood	|O
haemoglobin	|B-PROTEIN
and	|O
increased	|O
urinary	|O
excretion	|O
of	|O
delta	|O
amino	|O
levulinic	|O
acid	|O
.	|O

Following	|O
iv	|O
injection	|O
of	|O
0.5	|O
g	|O
galactose	|O
per	|O
kg	|O
body	|O
weight	|O
,	|O
together	|O
with	|O
2	|O
mu	|O
Ci	|O
generally	|O
14C	|O
-	|O
labelled	|O
galactose	|O
,	|O
14CO2	|O
is	|O
collected	|O
in	|O
regular	|O
intervals	|O
during	|O
one	|O
hour	|O
.	|O

Specific	|O
clotting	|O
factor	|O
assays	|O
showed	|O
an	|O
isolated	|O
deficiency	|O
of	|O
factor	|B-PROTEIN
X	|I-PROTEIN
ranging	|O
from	|O
7	|O
to	|O
12	|O
per	|O
cent	|O
on	|O
three	|O
determinations	|O
.	|O

Charcoal	|O
-	|O
facilitated	|O
dialysis	|O
.	|O

Blood	|O
variables	|O
measured	|O
at	|O
eight	|O
intervals	|O
before	|O
,	|O
during	|O
,	|O
and	|O
after	|O
operation	|O
were	|O
as	|O
follows	|O
:	|O
seven	|O
plasma	|O
proteins	|O
,	|O
free	|O
hemoglobin	|B-PROTEIN
,	|O
formed	|O
elements	|O
,	|O
and	|O
clotting	|O
functions	|O
.	|O

Retinal	|O
changes	|O
in	|O
pigmentary	|O
retinopathy	|O
in	|O
children	|O

As	|O
a	|O
result	|O
,	|O
beta	|O
-	|O
apo	|O
-	|O
8'	|O
-	|O
carotenoic	|O
acid	|O
ethyl	|O
ester	|O
(	|O
apo	|O
-	|O
EE	|O
)	|O
was	|O
used	|O
as	|O
a	|O
reference	|O
standard	|O
in	|O
Experiments	|O
4	|O
to	|O
6	|O
.	|O

The	|O
ability	|O
of	|O
sodium	|O
phenobarbital	|O
(	|O
60	|O
mg	|O
/	|O
kg	|O
)	|O
and	|O
sodium	|O
barbital	|O
(	|O
80	|O
mg	|O
/	|O
kg	|O
)	|O
to	|O
produce	|O
a	|O
taste	|O
aversion	|O
in	|O
23	|O
hr	|O
fluid	|O
deprived	|O
rats	|O
was	|O
examined	|O
using	|O
a	|O
discrimination	|O
or	|O
two	|O
bottle	|O
taste	|O
aversion	|O
task	|O
(	|O
0.125%	|O
sodium	|O
saccharin	|O
solution	|O
or	|O
water	|O
)	|O
.	|O

It	|O
appears	|O
that	|O
the	|O
pulmonary	|O
gas	|O
exchange	|O
parenchyma	|O
of	|O
these	|O
smallest	|O
mammals	|O
is	|O
well	|O
suited	|O
to	|O
supply	|O
the	|O
organism	|O
with	|O
the	|O
comparatively	|O
high	|O
levels	|O
of	|O
O2	|O
required	|O
by	|O
the	|O
high	|O
metabolic	|O
rates	|O
,	|O
exhibiting	|O
a	|O
structural	|O
adaptation	|O
of	|O
the	|O
lung	|O
to	|O
higher	|O
VO2	|O
.	|O

Underestimations	|O
by	|O
as	|O
much	|O
as	|O
35%	|O
may	|O
occur	|O
due	|O
to	|O
the	|O
problems	|O
in	|O
the	|O
existing	|O
methodologies	|O
.	|O

Chemotherapy	|O
was	|O
administered	|O
without	|O
altering	|O
the	|O
course	|O
of	|O
the	|O
disorder	|O
.	|O

Drug	|O
inhibition	|O
of	|O
whole	|O
blood	|O
aspirin	|B-PROTEIN
esterase	|I-PROTEIN
.	|O

However	|O
,	|O
at	|O
lower	|O
temperature	|O
the	|O
positive	|O
staircase	|O
was	|O
not	|O
clear	|O
and	|O
rather	|O
negative	|O
staircase	|O
appeared	|O
(	|O
1	|O
-	|O
-	|O
3	|O
Hz	|O
)	|O
.	|O

Visual	|O
averaged	|O
evoked	|O
responses	|O
and	|O
platelet	|O
monoamine	|B-PROTEIN
oxidase	|I-PROTEIN
in	|O
patients	|O
suffering	|O
from	|O
alcoholism	|O
.	|O

At	|O
the	|O
end	|O
of	|O
the	|O
experiment	|O
the	|O
urinary	|O
porphyrin	|O
excretion	|O
and	|O
the	|O
porphyrin	|O
content	|O
in	|O
lijver	|O
and	|O
skin	|O
were	|O
diminished	|O
in	|O
HCB	|O
-	|O
CQ	|O
-	|O
treated	|O
animals	|O
by	|O
about	|O
50%	|O
compared	|O
to	|O
the	|O
HCB	|O
controls	|O
.	|O

Six	|O
hours	|O
after	|O
the	|O
last	|O
administration	|O
,	|O
uterus	|O
of	|O
Gf	|O
and	|O
Cv	|O
mice	|O
were	|O
weight	|O
337.6	|O
mg	|O
%	|O
and	|O
423.5	|O
mg	|O
%	|O
respectively	|O
,	|O
the	|O
difference	|O
was	|O
statistically	|O
significant	|O
(	|O
p	|O
less	|O
than	|O
0.01	|O
)	|O
.	|O

Although	|O
stone	|O
-	|O
formers	|O
were	|O
not	|O
found	|O
to	|O
display	|O
any	|O
features	|O
of	|O
magnesium	|O
metabolism	|O
that	|O
were	|O
different	|O
from	|O
those	|O
in	|O
the	|O
control	|O
group	|O
,	|O
their	|O
lower	|O
urinary	|O
excretion	|O
of	|O
magnesium	|O
in	|O
relation	|O
to	|O
calcium	|O
may	|O
be	|O
a	|O
factor	|O
in	|O
their	|O
increased	|O
stone	|O
-	|O
forming	|O
propensity	|O
.	|O

Analysis	|O
of	|O
an	|O
autopsy	|O
population	|O
.	|O

A	|O
16	|O
-	|O
year	|O
follow	|O
-	|O
up	|O
study	|O
of	|O
69	|O
paraplegics	|O
with	|O
complete	|O
lesions	|O
from	|O
T1	|O
-	|O
L3	|O
is	|O
presented	|O
.	|O

Autoradiographic	|O
localisation	|O
of	|O
its	|O
cellular	|O
distribution	|O
in	|O
the	|O
kidney	|O
.	|O

Hippocampal	|O
stimulation	|O
overlapping	|O
conditioned	|O
stimulus	|O
preexposure	|O
produced	|O
attenuation	|O
of	|O
latent	|O
inhibition	|O
,	|O
as	|O
did	|O
stimulation	|O
presented	|O
during	|O
conditioning	|O
after	|O
preexposure	|O
.	|O

The	|O
centromedial	|O
amygdala	|O
and	|O
gastric	|O
pathology	|O
in	|O
rats	|O
.	|O

Cataract	|O
extraction	|O
in	|O
primary	|O
glaucoma	|O

Number	|O
and	|O
size	|O
of	|O
the	|O
myelin	|O
structures	|O
in	|O
the	|O
pneumocytes	|O
typ	|O
II	|O
increased	|O
simultaneously	|O
.	|O

In	|O
the	|O
intact	|O
animal	|O
,	|O
postextrasystolic	|O
potentiation	|O
depended	|O
on	|O
the	|O
basic	|O
pacing	|O
interval	|O
,	|O
t0	|O
,	|O
and	|O
the	|O
timing	|O
of	|O
the	|O
extrasystole	|O
,	|O
t1	|O
:	|O
when	|O
t0	|O
was	|O
held	|O
constant	|O
and	|O
t1	|O
was	|O
increased	|O
,	|O
potentiation	|O
decreased	|O
;	|O
when	|O
t1	|O
was	|O
held	|O
constant	|O
and	|O
t0	|O
was	|O
increased	|O
,	|O
potentiation	|O
increased	|O
.	|O

In	|O
spite	|O
of	|O
this	|O
and	|O
other	|O
complications	|O
of	|O
corticosteroids	|O
,	|O
she	|O
made	|O
a	|O
full	|O
recovery	|O
from	|O
the	|O
fungal	|O
infection	|O
following	|O
treatment	|O
with	|O
amphotericin	|O
B	|O
and	|O
surgical	|O
excision	|O
of	|O
the	|O
lung	|O
abscess	|O
.	|O

Implications	|O
of	|O
this	|O
observation	|O
for	|O
pediatrics	|O
are	|O
discussed	|O
.	|O

For	|O
the	|O
study	|O
of	|O
the	|O
transition	|O
of	|O
long	|O
to	|O
short	|O
waves	|O
(	|O
deep	|O
-	|O
water	|O
waves	|O
)	|O
a	|O
closed	|O
-	|O
form	|O
solution	|O
is	|O
advantageous	|O
;	|O
this	|O
can	|O
,	|O
however	|O
,	|O
only	|O
be	|O
obtained	|O
at	|O
the	|O
cost	|O
of	|O
further	|O
simplification	|O
.	|O

Treatment	|O
of	|O
suppurative	|O
peritonitis	|O

We	|O
report	|O
a	|O
case	|O
of	|O
pheochromocytoma	|O
manifesting	|O
during	|O
the	|O
third	|O
trimester	|O
of	|O
pregnancy	|O
.	|O

Fasting	|O
plasma	|O
and	|O
lipoprotein	|O
lipid	|O
concentrations	|O
,	|O
adipose	|O
tissue	|O
lipoprotein	|O
lipase	|B-PROTEIN
activity	|O
,	|O
anthropometric	|O
data	|O
,	|O
alcohol	|O
consumption	|O
,	|O
smoking	|O
habits	|O
,	|O
weekly	|O
mileage	|O
run	|O
and	|O
performance	|O
on	|O
a	|O
bicycle	|O
ergometer	|O
were	|O
recorded	|O
before	|O
and	|O
after	|O
the	|O
training	|O
period	|O
.	|O

The	|O
C18	|O
:	|O
1	|O
:	|O
C10	|O
value	|O
is	|O
a	|O
convenient	|O
measure	|O
of	|O
these	|O
changes	|O
and	|O
can	|O
be	|O
determined	|O
more	|O
rapidly	|O
than	|O
determining	|O
all	|O
the	|O
lower	|O
fatty	|O
acids	|O
.	|O

A	|O
progressive	|O
growth	|O
of	|O
blood	|O
erythrocyte	|O
membrane	|O
injury	|O
has	|O
been	|O
demonstrated	|O
after	|O
rats	|O
were	|O
exposed	|O
to	|O
gamma	|O
-	|O
irradiaton	|O
at	|O
a	|O
dose	|O
of	|O
100	|O
to	|O
500	|O
Gy	|O
.	|O

Within	|O
the	|O
3'	|O
terminal	|O
50	|O
nucleotides	|O
,	|O
the	|O
mouse	|O
mt	|O
12S	|B-PROTEIN
rRNA	|I-PROTEIN
contains	|O
a	|O
potential	|O
10	|O
bp	|O
hairpin	|O
structure	|O
and	|O
a	|O
sequence	|O
of	|O
15	|O
consecutive	|O
nucleotides	|O
common	|O
to	|O
the	|O
RNA	|O
of	|O
the	|O
small	|O
ribosomal	|O
subunit	|O
in	|O
all	|O
systems	|O
,	|O
but	|O
does	|O
not	|O
contain	|O
the	|O
mRNA	|O
binding	|O
site	|O
(	|O
ACCUCC	|O
)	|O
found	|O
in	|O
E.	|O
coli	|O
and	|O
corn	|O
chloroplast	|O
rRNAs	|O
.	|O

Microscopic	|O
anatomy	|O
and	|O
cell	|O
population	|O
dynamics	|O
.	|O

Thirty	|O
cadaver	|O
brains	|O
were	|O
examined	|O
under	|O
X	|O
6	|O
to	|O
16	|O
magnification	|O
in	|O
order	|O
to	|O
define	|O
the	|O
microsurgical	|O
anatomy	|O
of	|O
the	|O
pineal	|O
region	|O
,	|O
particularly	|O
the	|O
relationship	|O
of	|O
the	|O
pineal	|O
body	|O
,	|O
posterior	|O
cerebral	|O
artery	|O
,	|O
superior	|O
cerebellar	|O
artery	|O
,	|O
vein	|O
of	|O
Galen	|O
,	|O
basal	|O
vein	|O
of	|O
Rosenthal	|O
,	|O
internal	|O
cerebral	|O
vein	|O
,	|O
straight	|O
sinus	|O
,	|O
bridging	|O
vein	|O
,	|O
the	|O
size	|O
of	|O
the	|O
tentorial	|O
notch	|O
,	|O
and	|O
the	|O
third	|O
and	|O
the	|O
fourth	|O
cranial	|O
nerves	|O
.	|O

Serum	|O
antibody	|O
titre	|O
was	|O
not	|O
significantly	|O
associated	|O
with	|O
the	|O
recurrence	|O
rate	|O
or	|O
the	|O
duration	|O
of	|O
infection	|O
.	|O

We	|O
propose	|O
that	|O
refeeding	|O
may	|O
be	|O
an	|O
important	|O
mechanism	|O
for	|O
activation	|O
of	|O
certain	|O
viral	|O
infections	|O
previously	|O
suppressed	|O
by	|O
famine	|O
.	|O

One	|O
hundred	|O
twenty	|O
units	|O
of	|O
deglycerolized	|O
red	|O
blood	|O
cells	|O
,	|O
some	|O
with	|O
glycerol	|O
added	|O
so	|O
as	|O
to	|O
exceed	|O
an	|O
acceptable	|O
1%	|O
glycerol	|O
content	|O
,	|O
had	|O
measurements	|O
made	|O
of	|O
the	|O
post	|O
-	|O
wash	|O
supernatant	|O
fluid	|O
by	|O
refractive	|O
index	|O
and	|O
osmometry	|O
.	|O

The	|O
symptoms	|O
and	|O
objective	|O
findings	|O
were	|O
caused	|O
by	|O
a	|O
malignant	|O
lymphoma	|O
,	|O
and	|O
the	|O
diagnosis	|O
was	|O
established	|O
from	|O
a	|O
drill	|O
biopsy	|O
.	|O

Our	|O
study	|O
differs	|O
from	|O
previous	|O
studies	|O
in	|O
that	|O
it	|O
is	|O
limited	|O
to	|O
one	|O
diagnostic	|O
entity	|O
,	|O
yet	|O
at	|O
the	|O
same	|O
time	|O
evaluates	|O
a	|O
broad	|O
range	|O
of	|O
social	|O
and	|O
work	|O
-	|O
related	|O
factors	|O
in	|O
disability	|O
.	|O

It	|O
is	|O
suggested	|O
that	|O
a	|O
raised	|O
hydroxykynurenine	|O
/	|O
hydroxyanthranilic	|O
acid	|O
ratio	|O
does	|O
not	|O
necessarily	|O
indicate	|O
vitamin	|O
B6	|O
deficiency	|O
but	|O
may	|O
represent	|O
a	|O
nonspecific	|O
response	|O
of	|O
tryptophan	|O
metabolism	|O
to	|O
stress	|O
.	|O

All	|O
control	|O
persons	|O
had	|O
a	|O
normal	|O
reaction	|O
to	|O
DNFB	|O
.	|O

In	|O
a	|O
control	|O
group	|O
both	|O
common	|O
carotid	|O
arteries	|O
(	|O
CCA	|O
)	|O
were	|O
ligated	|O
.	|O

At	|O
pH	|O
6.9	|O
,	|O
the	|O
same	|O
lidocaine	|O
concentrations	|O
significantly	|O
reduced	|O
resting	|O
potential	|O
(	|O
3-10%	|O
)	|O
,	|O
action	|O
potential	|O
amplitude	|O
(	|O
3-8%	|O
)	|O
and	|O
Vmax	|O
(	|O
14-22%	|O
)	|O
.	|O

Simultaneous	|O
right	|O
and	|O
left	|O
adrenal	|O
and	|O
peripheral	|O
blood	|O
samples	|O
were	|O
collected	|O
for	|O
determination	|O
of	|O
oestrone	|O
(	|O
E1	|O
)	|O
and	|O
oestradiol	|O
(	|O
E2	|O
)	|O
.	|O

Arm	|O
function	|O
tests	|O
.	|O

All	|O
lambs	|O
with	|O
B	|O
breeding	|O
had	|O
significantly	|O
higher	|O
Hb	|B-PROTEIN
levels	|O
at	|O
the	|O
end	|O
of	|O
the	|O
experiment	|O
than	|O
did	|O
NB	|O
lambs	|O
.	|O
b	|O
and	|O
S	|O
x	|O
B	|O
lambs	|O
had	|O
higher	|O
(	|O
P	|O
<	|O
.05	|O
)	|O
Hb	|B-PROTEIN
levels	|O
than	|O
the	|O
D	|O
x	|O
B	|O
lambs	|O
,	|O
and	|O
B	|O
lambs	|O
had	|O
the	|O
highest	|O
(	|O
P	|O
<	|O
.05	|O
)	|O
mean	|O
corpuscular	|O
hemoglobin	|B-PROTEIN
concentrations	|O
.	|O

The	|O
same	|O
response	|O
occurs	|O
whether	|O
acrylamide	|O
is	|O
given	|O
immediately	|O
after	|O
nerve	|O
ligation	|O
or	|O
1	|O
week	|O
later	|O
.	|O

The	|O
operation	|O
recommended	|O
is	|O
excision	|O
of	|O
3	|O
mm	|O
of	|O
central	|O
slip	|O
followed	|O
by	|O
end	|O
-	|O
to	|O
-	|O
end	|O
repair	|O
of	|O
the	|O
tendon	|O
.	|O

In	|O
the	|O
unclipped	|O
group	|O
arterial	|O
pressure	|O
decreased	|O
50	|O
mmHg	|O
to	|O
normal	|O
by	|O
24	|O
h	|O
and	|O
was	|O
associated	|O
with	|O
increased	|O
diuresis	|O
and	|O
a	|O
small	|O
decrease	|O
in	|O
blood	|O
volume	|O
(	|O
9.8%	|O
)	|O
.	|O

Marked	|O
sedative	|O
activity	|O
was	|O
observed	|O
with	|O
9	|O
-	|O
methoxy	|O
-	|O
5	|O
-	|O
phenylpyrrolo	|O
[	|O
2,1	|O
-	|O
d	|O
]	|O
[	|O
1,5	|O
]	|O
benzothiazepin	|O
-	|O
6,6	|O
-	|O
dioxide	|O
(	|O
NF19	|O
)	|O
and	|O
9	|O
-	|O
chloro	|O
-	|O
5	|O
-	|O
p	|O
-	|O
nitrophenylpyrrolo	|O
[	|O
2,1	|O
-	|O
d	|O
]	|O
[	|O
1,5	|O
]	|O
benzothiazepin	|O
-	|O
6,6	|O
-	|O
dioxide	|O
(	|O
NF20	|O
)	|O
.	|O

In	|O
patients	|O
,	|O
the	|O
effect	|O
of	|O
CCK	|B-PROTEIN
-	|O
PZ	|B-PROTEIN
on	|O
the	|O
movement	|O
of	|O
the	|O
terminal	|O
part	|O
of	|O
the	|O
bile	|O
duct	|O
was	|O
measured	|O
with	|O
a	|O
pressure	|O
sensor	|O
using	|O
a	|O
duodenofiberscope	|O
.	|O

In	|O
11	|O
patients	|O
with	|O
Horton	|O
's	|O
headache	|O
morphological	|O
investigations	|O
(	|O
differential	|O
white	|O
blood	|O
cell	|O
count	|O
)	|O
,	|O
cytoenzymatic	|O
determinations	|O
(	|O
alkaline	|B-PROTEIN
and	|I-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
,	|O
non	|O
-	|O
specific	|O
esterase	|B-PROTEIN
)	|O
and	|O
cytoimmunological	|O
tests	|O
(	|O
IgM	|B-PROTEIN
and	|O
IgG	|B-PROTEIN
binding	|O
)	|O
were	|O
carried	|O
out	|O
on	|O
capillary	|O
blood	|O
neutrophils	|O
obtained	|O
from	|O
the	|O
area	|O
of	|O
pain	|O
,	|O
non	|O
-	|O
painful	|O
area	|O
of	|O
the	|O
skin	|O
on	|O
the	|O
head	|O
on	|O
the	|O
contralateral	|O
side	|O
,	|O
and	|O
from	|O
the	|O
finger	|O
.	|O

As	|O
high	|O
-	|O
speed	|O
,	|O
volumetric	|O
imaging	|O
,	|O
computed	|O
tomographic	|O
scan	|O
machines	|O
such	|O
as	|O
the	|O
Dynamic	|O
Spatial	|O
Reconstructor	|O
become	|O
available	|O
with	|O
higher	|O
density	|O
resolution	|O
,	|O
perhaps	|O
a	|O
single	|O
injection	|O
of	|O
contrast	|O
agent	|O
into	|O
the	|O
right	|O
atrium	|O
or	|O
even	|O
a	|O
peripheral	|O
vein	|O
may	|O
be	|O
adequate	|O
to	|O
obtain	|O
all	|O
these	|O
measurements	|O
.	|O

The	|O
ESEG	|O
's	|O
are	|O
a	|O
direct	|O
result	|O
of	|O
the	|O
NEXT	|O
study	|O
.	|O

The	|O
potentially	|O
SLE	|O
-	|O
inducing	|O
drugs	|O
are	|O
reviewed	|O
.	|O

A	|O
third	|O
series	|O
of	|O
mice	|O
were	|O
given	|O
a	|O
single	|O
injection	|O
of	|O
5	|O
-	|O
OH	|O
-	|O
DA	|O
,	|O
sacrificed	|O
,	|O
and	|O
prepared	|O
for	|O
ultrastructural	|O
study	|O
.	|O

Fourteen	|O
different	|O
species	|O
(	|O
eight	|O
Platyhelmintha	|O
,	|O
one	|O
Nematoda	|O
and	|O
five	|O
Crustacea	|O
)	|O
have	|O
been	|O
inventorized	|O
.	|O

No	|O
symptoms	|O
other	|O
than	|O
hot	|O
flush	|O
showed	|O
such	|O
significant	|O
correlation	|O
with	|O
plasma	|O
epinephrine	|O
or	|O
norepinephrine	|O
levels	|O
.	|O

The	|O
mean	|O
values	|O
of	|O
the	|O
concentrations	|O
of	|O
the	|O
components	|O
due	|O
to	|O
tobacco	|O
smoke	|O
are	|O
:	|O
CO	|O
=	|O
1.1	|O
ppm	|O
,	|O
NO	|O
=	|O
32	|O
ppb	|O
,	|O
NO2	|O
=	|O
24	|O
ppb	|O
,	|O
nicotine	|O
=	|O
0.9	|O
micrograms	|O
/	|O
m3	|O
,	|O
particulate	|O
matter	|O
=	|O
133	|O
micrograms	|O
/	|O
m3	|O
.	|O

The	|O
average	|O
backscatter	|O
coefficient	|O
was	|O
six	|O
time	|O
larger	|O
in	|O
regions	|O
of	|O
infarct	|O
studied	|O
8	|O
-	|O
-	|O
10	|O
weeks	|O
after	|O
occlusion	|O
than	|O
that	|O
in	|O
regions	|O
of	|O
infarct	|O
studied	|O
5	|O
-	|O
-	|O
6	|O
weeks	|O
after	|O
occlusion	|O
.	|O

At	|O
4	|O
wk	|O
however	|O
,	|O
tumor	|O
relapse	|O
was	|O
noted	|O
in	|O
6	|O
of	|O
7	|O
group	|O
4	|O
responders	|O
,	|O
10	|O
of	|O
12	|O
in	|O
group	|O
5	|O
,	|O
13	|O
of	|O
16	|O
in	|O
group	|O
7	|O
,	|O
but	|O
only	|O
4	|O
of	|O
19	|O
group	|O
8	|O
responders	|O
(	|O
p	|O
less	|O
than	|O
.001	|O
group	|O
8	|O
versus	|O
4	|O
,	|O
5	|O
,	|O
7	|O
)	|O
.	|O

Early	|O
infection	|O
was	|O
detected	|O
in	|O
one	|O
of	|O
50	|O
control	|O
women	|O
who	|O
gave	|O
birth	|O
to	|O
a	|O
healthy	|O
infant	|O
.	|O

Pentachlorophenol	|O
accelerates	|O
the	|O
onset	|O
of	|O
HCB	|O
porphyria	|O
,	|O
in	|O
other	|O
words	|O
it	|O
increases	|O
the	|O
total	|O
urinary	|O
porphyrin	|O
excretion	|O
and	|O
causes	|O
an	|O
earlier	|O
disturbance	|O
of	|O
the	|O
porphyrin	|O
pattern	|O
.	|O

Family	|O
planning	|O
continues	|O
to	|O
play	|O
a	|O
minor	|O
role	|O
,	|O
and	|O
only	|O
25.3	|O
per	|O
cent	|O
of	|O
all	|O
patients	|O
reviewed	|O
took	|O
to	|O
oral	|O
contraceptives	|O
for	|O
shorter	|O
or	|O
longer	|O
periods	|O
of	|O
time	|O
.	|O
-	|O
The	|O
percentages	|O
of	|O
primiparae	|O
and	|O
secundiparae	|O
in	|O
all	|O
births	|O
as	|O
well	|O
as	|O
the	|O
high	|O
percentage	|O
of	|O
multigravidity	|O
are	|O
parameters	|O
by	|O
which	|O
the	|O
approach	|O
to	|O
reproduction	|O
differs	|O
substantively	|O
from	|O
behaviour	|O
patterns	|O
in	|O
Europe	|O
.	|O

The	|O
term	|O
osteomesopycnosis	|O
is	|O
proposed	|O
for	|O
a	|O
sclerosing	|O
bone	|O
disease	|O
with	|O
dominant	|O
inheritance	|O
that	|O
has	|O
been	|O
discovered	|O
in	|O
five	|O
members	|O
of	|O
four	|O
different	|O
families	|O
.	|O

The	|O
87K	|O
protein	|O
,	|O
together	|O
with	|O
proteins	|O
of	|O
105,000	|O
and	|O
75,000	|O
daltons	|O
,	|O
are	|O
translated	|O
from	|O
leftward	|O
transcribed	|O
(	|O
1	|O
-	|O
strand	|O
)	|O
messenger	|O
RNAs	|O
that	|O
are	|O
complementary	|O
to	|O
the	|O
viral	|O
genome	|O
between	|O
positions	|O
11.2	|O
and	|O
31.5	|O
.	|O

The	|O
identification	|O
of	|O
viable	|O
myocardium	|O
with	|O
both	|O
99mTc	|O
-	|O
tetrofosmin	|O
and	|O
201Tl	|O
can	|O
be	|O
greatly	|O
enhanced	|O
to	|O
a	|O
similar	|O
degree	|O
if	|O
the	|O
severity	|O
of	|O
reduction	|O
in	|O
activity	|O
within	|O
nonreversible	|O
defects	|O
is	|O
considered	|O
.	|O

The	|O
temporal	|O
component	|O
lacked	|O
a	|O
mandibular	|O
fossa	|O
as	|O
well	|O
as	|O
articular	|O
eminence	|O
.	|O

EUK	|O
-	|O
8	|O
is	|O
a	|O
novel	|O
,	|O
synthetic	|O
,	|O
low	|O
-	|O
molecular	|O
-	|O
weight	|O
salen	|O
-	|O
manganese	|O
complex	|O
that	|O
exhibits	|O
both	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
and	|O
catalase	|B-PROTEIN
activities	|O
in	|O
vitro	|O
.	|O

The	|O
protein	|O
ELT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
encoded	|O
by	|O
a	|O
single	|O
-	|O
copy	|O
gene	|O
homologous	|O
to	|O
the	|O
GATA	|B-PROTEIN
family	|O
of	|O
vertebrate	|O
transcription	|O
factors	|O
,	|O
is	|O
potentially	|O
capable	|O
of	|O
interacting	|O
with	|O
this	|O
element	|O
.	|O

However	|O
,	|O
in	|O
contrast	|O
with	|O
previous	|O
in	|O
vitro	|O
cell	|O
-	|O
free	|O
integration	|O
studies	|O
,	|O
alteration	|O
of	|O
the	|O
highly	|O
conserved	|O
CA	|O
dinucleotide	|O
resulted	|O
in	|O
a	|O
mutant	|O
which	|O
still	|O
retained	|O
40%	|O
of	|O
wild	|O
-	|O
type	|O
integration	|O
activity	|O
.	|O

The	|O
resulting	|O
R	|B-PROTEIN
protein	|O
terminates	|O
five	|O
codons	|O
downstream	|O
of	|O
the	|O
frameshift	|O
site	|O
at	|O
the	|O
V	|B-PROTEIN
protein	|O
stop	|O
codon	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
although	|O
PI2	|O
and	|O
PI3	|O
viruses	|O
belong	|O
to	|O
the	|O
same	|O
parainfluenza	|O
virus	|O
genus	|O
,	|O
these	|O
viruses	|O
show	|O
marked	|O
differences	|O
with	|O
respect	|O
to	|O
functional	|O
requirements	|O
for	|O
the	|O
cytoplasmic	|O
tail	|O
of	|O
the	|O
F	|B-PROTEIN
glycoprotein	|O
.	|O

By	|O
site	|O
-	|O
specific	|O
mutagenesis	|O
,	|O
we	|O
also	|O
show	|O
that	|O
individual	|O
ICP27	|B-PROTEIN
C	|O
-	|O
terminal	|O
amino	|O
acid	|O
residues	|O
that	|O
are	|O
positionally	|O
conserved	|O
in	|O
ICP27	|B-PROTEIN
homologs	|O
in	|O
other	|O
herpesviruses	|O
(	|O
D	|O
-	|O
357	|O
,	|O
E	|O
-	|O
358	|O
,	|O
H	|O
-	|O
479	|O
,	|O
C	|O
-	|O
400	|O
,	|O
C	|O
-	|O
483	|O
,	|O
and	|O
C	|O
-	|O
488	|O
)	|O
are	|O
critical	|O
for	|O
trans	|O
-	|O
regulatory	|O
activity	|O
.	|O

Magnetic	|O
resonance	|O
imaging	|O
(	|O
MRI	|O
)	|O
has	|O
enabled	|O
us	|O
to	|O
see	|O
the	|O
spinal	|O
intramedullary	|O
pathology	|O
as	|O
differences	|O
in	|O
signal	|O
intensity	|O
.	|O

Patients	|O
with	|O
psychotropic	|O
drugs	|O
showed	|O
significantly	|O
higher	|O
PRL	|B-PROTEIN
levels	|O
.	|O

The	|O
Laser	|O
Scanning	|O
Ophthalmoscope	|O
enables	|O
a	|O
fundus	|O
-	|O
based	|O
examination	|O
and	|O
therefore	|O
allows	|O
exact	|O
comparison	|O
between	|O
morphologic	|O
appearance	|O
and	|O
corresponding	|O
function	|O
.	|O

Malaria	|O
,	|O
anaemia	|O
,	|O
and	|O
HIV	|O
-	|O
1	|O
transmission	|O
in	|O
central	|O
Africa	|O
.	|O

BSE	|O
and	|O
farmworkers	|O
.	|O

In	|O
addition	|O
,	|O
two	|O
-	|O
dimensional	|O
nuclear	|O
magnetic	|O
resonance	|O
studies	|O
with	|O
F17A	|O
,	|O
K13Q	|O
,	|O
F15Y	|O
and	|O
F27Y	|O
revealed	|O
that	|O
the	|O
mutants	|O
have	|O
the	|O
same	|O
overall	|O
structure	|O
as	|O
the	|O
wild	|O
-	|O
type	|O
CspB	|B-PROTEIN
protein	|O
.	|O

Considerably	|O
high	|O
levels	|O
of	|O
IgE	|B-PROTEIN
antibodies	|O
was	|O
also	|O
established	|O
while	|O
other	|O
pollens	|O
did	|O
not	|O
show	|O
such	|O
correspondence	|O
.	|O

Peroxisome	|B-PROTEIN
proliferator	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
receptors	|I-PROTEIN
(	|O
PPARs	|B-PROTEIN
)	|O
and	|O
retinoid	|B-PROTEIN
X	|I-PROTEIN
receptors	|I-PROTEIN
(	|O
RXRs	|B-PROTEIN
)	|O
are	|O
nuclear	|B-PROTEIN
hormone	|I-PROTEIN
receptors	|I-PROTEIN
that	|O
are	|O
activated	|O
by	|O
fatty	|O
acids	|O
and	|O
9	|O
-	|O
cis	|O
-	|O
retinoic	|O
acid	|O
,	|O
respectively	|O
.	|O

This	|O
is	|O
particularly	|O
intriguing	|O
because	|O
SKUT	|O
-	|O
1B	|O
-	|O
20	|O
cells	|O
lack	|O
the	|O
transcription	|O
factor	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
number	|O
of	|O
lactotropes	|O
,	|O
somatotropes	|O
,	|O
thyrotropes	|O
,	|O
and	|O
gonadotropes	|O
was	|O
not	|O
altered	|O
compared	|O
with	|O
controls	|O
,	|O
indicating	|O
that	|O
in	|O
the	|O
adult	|O
pituitary	|O
,	|O
POMC	|B-PROTEIN
products	|O
are	|O
not	|O
required	|O
to	|O
maintain	|O
the	|O
distribution	|O
of	|O
cell	|O
types	|O
.	|O

Some	|O
strains	|O
of	|O
A.	|O
parasiticus	|O
produced	|O
all	|O
four	|O
aflatoxins	|O
B1	|O
B2	|O
G1	|O
G2	|O
,	|O
while	|O
the	|O
other	|O
ones	|O
produced	|O
AF	|O
B1	|O
+	|O
G1	|O
only	|O
,	|O
with	|O
concentrations	|O
of	|O
aflatoxins	|O
from	|O
0.1	|O
to	|O
450	|O
mg	|O
/	|O
kg	|O
.	|O

We	|O
have	|O
isolated	|O
a	|O
new	|O
,	|O
larger	|O
rat	|O
B	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
genomic	|O
clone	|O
.	|O

In	|O
addition	|O
to	|O
the	|O
nine	|O
and	|O
51	|O
terminal	|O
amino	|O
acid	|O
forms	|O
already	|O
known	|O
,	|O
we	|O
identified	|O
a	|O
third	|O
with	|O
43	|O
terminal	|O
amino	|O
acids	|O
predicted	|O
to	|O
encode	|O
a	|O
novel	|O
RET	|B-PROTEIN
protein	|O
isoform	|O
.	|O

Both	|O
classes	|O
of	|O
MHBst	|B-PROTEIN
proteins	|O
were	|O
found	|O
to	|O
form	|O
dimers	|O
;	|O
an	|O
which	|O
is	|O
involved	|O
in	|O
mediating	|O
the	|O
dimerization	|O
.	|O

In	|O
electrophoretic	|O
mobility	|O
shift	|O
assays	|O
,	|O
the	|O
PERE	|B-PROTEIN
formed	|O
three	|O
major	|O
complexes	|O
(	|O
P1	|O
,	|O
P2	|O
and	|O
P3	|O
)	|O
with	|O
proteins	|O
in	|O
nuclear	|O
extracts	|O
from	|O
HeLa	|O
or	|O
293	|O
cells	|O
.	|O

She	|O
had	|O
been	|O
receiving	|O
MTX	|O
7.5	|O
mg	|O
/	|O
week	|O
for	|O
2.5	|O
months	|O
because	|O
of	|O
her	|O
vasculitis	|O
symptoms	|O
.	|O

Analysis	|O
of	|O
the	|O
sequence	|O
identified	|O
four	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
which	|O
are	|O
designated	|O
UL1	|B-PROTEIN
,	|O
UL2	|B-PROTEIN
,	|O
UL3	|B-PROTEIN
,	|O
and	|O
UL3.5	|B-PROTEIN
based	|O
on	|O
their	|O
homology	|O
with	|O
proteins	|O
of	|O
herpes	|O
simplex	|O
virus	|O
-	|O
1	|O
(	|O
HSV	|O
-	|O
1	|O
)	|O
,	|O
pseudorabies	|O
virus	|O
(	|O
PRV	|O
)	|O
,	|O
equine	|O
herpesvirus	|O
-	|O
1	|O
,	|O
and	|O
varicella	|O
-	|O
zoster	|O
virus	|O
.	|O

These	|O
HPV16	|O
E6	|B-PROTEIN
/	|O
E7	|B-PROTEIN
cDNAs	|O
were	|O
cloned	|O
under	|O
the	|O
SV40	|B-PROTEIN
enhancer	|I-PROTEIN
/	|I-PROTEIN
promoter	|I-PROTEIN
and	|O
the	|O
MMTV	|B-PROTEIN
LTR	|I-PROTEIN
to	|O
examine	|O
the	|O
activities	|O
of	|O
ras	|B-PROTEIN
-	|O
collaborative	|O
transformation	|O
and	|O
induction	|O
of	|O
cellular	|O
DNA	|O
synthesis	|O
,	|O
both	|O
of	|O
which	|O
depend	|O
on	|O
the	|O
E7	|B-PROTEIN
gene	|O
product	|O
.	|O

Correlation	|O
coefficients	|O
between	|O
the	|O
reference	|O
methods	|O
and	|O
NIT	|O
were	|O
>	|O
or	|O
=	|O
0.95	|O
for	|O
water	|O
,	|O
fat	|O
,	|O
crude	|O
protein	|O
and	|O
connective	|O
-	|O
tissue	|O
-	|O
protein	|O
frei	|O
meat	|O
protein	|O
,	|O
and	|O
>	|O
or	|O
=	|O
0.86	|O
for	|O
connective	|O
-	|O
tissue	|O
-	|O
protein	|O
.	|O

The	|O
translation	|O
products	|O
of	|O
both	|O
clones	|O
are	|O
highly	|O
homologous	|O
to	|O
APS1	|B-PROTEIN
(	|O
66	|O
and	|O
86%	|O
identity	|O
,	|O
respectively	|O
)	|O
over	|O
their	|O
entire	|O
lengths	|O
,	|O
including	|O
amino	|O
terminal	|O
sequences	|O
resembling	|O
transit	|O
peptides	|O
for	|O
plastid	|O
localization	|O
.	|O

The	|O
serum	|O
levels	|O
of	|O
IgE	|B-PROTEIN
,	|O
and	|O
asIgE	|B-PROTEIN
and	|O
IgG	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
against	|O
14	|O
common	|O
food	|O
allergens	|O
were	|O
determined	|O
.	|O

Two	|O
experiments	|O
investigating	|O
the	|O
effects	|O
of	|O
short	|O
-	|O
term	|O
spaceflight	|O
on	|O
cancellous	|O
bone	|O
turnover	|O
were	|O
carried	|O
out	|O
:	|O
Physiological	|O
Systems	|O
Experiment	|O
-	|O
1	|O
(	|O
PSE	|O
-	|O
1	|O
)	|O
(	|O
a	|O
4	|O
-	|O
d	|O
orbital	|O
spaceflight	|O
)	|O
and	|O
PSE	|O
-	|O
2	|O
(	|O
a	|O
10	|O
-	|O
d	|O
flight	|O
)	|O
.	|O

That	|O
sequence	|O
strongly	|O
promoted	|O
the	|O
transcription	|O
of	|O
the	|O
promotorless	|O
chloramphenicol	|B-PROTEIN
acetyltranferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
gene	|O
in	|O
cells	|O
of	|O
pancreatic	|O
origin	|O
(	|O
AR	|O
-	|O
42J	|O
)	|O
but	|O
not	|O
in	|O
cells	|O
of	|O
non	|O
-	|O
pancreatic	|O
origin	|O
(	|O
Rat	|O
2	|O
and	|O
IEC	|O
6	|O
)	|O
.	|O

Functional	|O
analysis	|O
of	|O
aryl	|B-PROTEIN
hydrocarbon	|I-PROTEIN
receptor	|I-PROTEIN
nuclear	|O
translocator	|O
interactions	|O
with	|O
aryl	|B-PROTEIN
hydrocarbon	|I-PROTEIN
receptor	|I-PROTEIN
in	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
system	|O
.	|O

Histopathologic	|O
observations	|O
showed	|O
that	|O
both	|O
somatostatin	|B-PROTEIN
and	|O
triamcinolone	|O
acetonide	|O
reduced	|O
the	|O
inflammatory	|O
signs	|O
in	|O
the	|O
joint	|O
structures	|O
,	|O
although	|O
triamcinolone	|O
acetonide	|O
appeared	|O
to	|O
be	|O
more	|O
effective	|O
.	|O

An	|O
approach	|O
to	|O
a	|O
biomathematical	|O
model	|O
of	|O
lymphocytopoiesis	|O
.	|O

The	|O
influenza	|O
virus	|O
NS1	|B-PROTEIN
protein	|O
is	|O
a	|O
unique	|O
posttranscriptional	|O
regulator	|O
that	|O
has	|O
two	|O
activities	|O
:	|O
inhibition	|O
of	|O
the	|O
nuclear	|O
export	|O
of	|O
poly	|O
A	|O
-	|O
containing	|O
mRNAs	|O
and	|O
inhibition	|O
of	|O
pre	|O
-	|O
mRNA	|O
splicing	|O
.	|O

These	|O
are	|O
two	|O
regions	|O
of	|O
known	|O
conserved	|O
synteny	|O
,	|O
providing	|O
further	|O
evidence	|O
that	|O
the	|O
human	|O
STEP	|B-PROTEIN
is	|O
a	|O
true	|O
homolog	|O
of	|O
the	|O
murine	|O
STEP	|B-PROTEIN
gene	|O
.	|O

Molecular	|O
cloning	|O
of	|O
the	|O
human	|O
homolog	|O
of	|O
a	|O
striatum	|B-PROTEIN
-	|I-PROTEIN
enriched	|I-PROTEIN
phosphatase	|I-PROTEIN
(	|O
STEP	|B-PROTEIN
)	|O
gene	|O
and	|O
chromosomal	|O
mapping	|O
of	|O
the	|O
human	|O
and	|O
murine	|O
loci	|O
.	|O

Carbonic	|B-PROTEIN
anhydrase	|I-PROTEIN
V	|I-PROTEIN
(	|O
CA	|B-PROTEIN
V	|I-PROTEIN
)	|O
is	|O
expressed	|O
in	|O
mitochondrial	|O
matrix	|O
in	|O
liver	|O
and	|O
several	|O
other	|O
tissues	|O
.	|O

Vitamin	|O
D3	|O
plus	|O
nicotine	|O
treatment	|O
produced	|O
parallel	|O
increases	|O
in	|O
cardiac	|O
mass	|O
and	|O
elastic	|O
modulus	|O
,	|O
with	|O
a	|O
significant	|O
correlation	|O
between	|O
the	|O
two	|O
.	|O

The	|O
latter	|O
domain	|O
appears	|O
to	|O
be	|O
involved	|O
in	|O
targeting	|O
Num1p	|B-PROTEIN
to	|O
the	|O
mother	|O
cell	|O
cortex	|O
.	|O

This	|O
finding	|O
is	|O
consistent	|O
with	|O
the	|O
notion	|O
that	|O
the	|O
dsRNA	|O
binding	|O
domains	|O
may	|O
be	|O
composed	|O
of	|O
two	|O
separate	|O
functional	|O
subdomains	|O
.	|O

Preferential	|O
heterodimeric	|O
parallel	|O
coiled	|O
-	|O
coil	|O
formation	|O
by	|O
synthetic	|O
Max	|B-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
leucine	|O
zippers	|O
:	|O
a	|O
description	|O
of	|O
putative	|O
electrostatic	|O
interactions	|O
responsible	|O
for	|O
the	|O
specificity	|O
of	|O
heterodimerization	|O
.	|O

Comparison	|O
to	|O
other	|O
coxI	|B-PROTEIN
genes	|O
revealed	|O
a	|O
966	|O
-	|O
bp	|O
group	|O
I	|O
intron	|O
,	|O
which	|O
,	|O
based	|O
on	|O
homology	|O
with	|O
the	|O
related	|O
yeast	|O
coxI	|B-PROTEIN
intron	|O
aI4	|O
,	|O
potentially	|O
encodes	|O
a	|O
279	|O
-	|O
amino	|O
-	|O
acid	|O
site	|O
-	|O
specific	|O
DNA	|B-PROTEIN
endonuclease	|I-PROTEIN
.	|O

We	|O
studied	|O
the	|O
GR	|B-PROTEIN
in	|O
DMS	|O
-	|O
79	|O
cells	|O
derived	|O
from	|O
a	|O
human	|O
ACTH	|B-PROTEIN
-	|O
secreting	|O
small	|O
cell	|O
lung	|O
cancer	|O
.	|O

This	|O
study	|O
analyzed	|O
whether	|O
the	|O
localization	|O
of	|O
an	|O
accessory	|O
pathway	|O
could	|O
be	|O
predicted	|O
by	|O
using	|O
the	|O
polarity	|O
of	|O
the	|O
QRS	|O
complex	|O
during	|O
sinus	|O
rhythm	|O
on	|O
the	|O
surface	|O
ECG	|O
,	|O
instead	|O
of	|O
the	|O
delta	|O
wave	|O
polarity	|O
as	|O
used	|O
in	|O
many	|O
reports	|O
.	|O

The	|O
promoter	|O
mutation	|O
is	|O
complemented	|O
in	|O
trans	|O
by	|O
E1A	|B-PROTEIN
products	|O
of	|O
the	|O
heterologous	|O
helper	|O
adenovirus	|O
type	|O
5	|O
(	|O
Ad5	|O
)	|O
.	|O

Thus	|O
,	|O
as	|O
expected	|O
,	|O
trans	|O
-	|O
splicing	|O
depends	|O
on	|O
the	|O
integrity	|O
of	|O
U2	|B-PROTEIN
,	|O
U4	|B-PROTEIN
,	|O
and	|O
U6	|B-PROTEIN
snRNAs	|O
.	|O

Treatment	|O
of	|O
PCC4.a	|O
za1R	|O
cells	|O
with	|O
an	|O
RAR	|B-PROTEIN
-	|O
selective	|O
agonist	|O
also	|O
repressed	|O
the	|O
expression	|O
of	|O
EC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
while	|O
treatment	|O
with	|O
an	|O
RXR	|B-PROTEIN
-	|O
selective	|O
agonist	|O
reduced	|O
EC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
slightly	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
E1A243	|B-PROTEIN
,	|O
YY1	|B-PROTEIN
represses	|O
CRE	|O
-	|O
dependent	|O
transcription	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
by	|O
physically	|O
interacting	|O
with	|O
ATF	|B-PROTEIN
/	|O
CREB	|B-PROTEIN
proteins	|O
bound	|O
to	|O
the	|O
-	|O
67	|O
CRE	|O
.	|O

Shift	|O
-	|O
down	|O
experiments	|O
indicated	|O
that	|O
the	|O
10	|O
(	|O
4	|O
)	|O
-	|O
to	|O
10	|O
(	|O
5	|O
)	|O
-	|O
fold	|O
reduction	|O
in	|O
virus	|O
yield	|O
at	|O
the	|O
nonpermissive	|O
temperature	|O
was	|O
due	|O
to	|O
the	|O
disfunction	|O
of	|O
alpha	|B-PROTEIN
TIF	|I-PROTEIN
late	|O
in	|O
infection	|O
,	|O
presumably	|O
in	|O
virion	|O
maturation	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
tip	|B-PROTEIN
acts	|O
at	|O
an	|O
early	|O
stage	|O
of	|O
the	|O
T	|O
-	|O
cell	|O
signal	|O
transduction	|O
cascade	|O
by	|O
associating	|O
with	|O
Lck	|B-PROTEIN
and	|O
downregulating	|O
Lck	|O
-	|O
mediated	|O
activation	|O
.	|O

Human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
Vpr	|B-PROTEIN
is	|O
a	|O
virion	|O
-	|O
associated	|O
,	|O
regulatory	|O
protein	|O
that	|O
is	|O
required	|O
for	|O
efficient	|O
viral	|O
replication	|O
in	|O
monocytes	|O
/	|O
macrophages	|O
.	|O

Here	|O
we	|O
examine	|O
the	|O
potential	|O
for	|O
VP16	|B-PROTEIN
protein	|O
-	|O
protein	|O
interactions	|O
specific	|O
to	|O
virus	|O
-	|O
infected	|O
cells	|O
and	|O
show	|O
that	|O
VP16	|B-PROTEIN
copurifies	|O
in	|O
a	|O
highly	|O
enriched	|O
fraction	|O
with	|O
a	|O
single	|O
major	|O
polypeptide	|O
which	|O
we	|O
identify	|O
as	|O
the	|O
virus	|O
-	|O
encoded	|O
structural	|O
protein	|O
VP22	|B-PROTEIN
.	|O

Thus	|O
,	|O
transcriptional	|O
regulation	|O
,	|O
splicing	|O
,	|O
kinase	|O
interaction	|O
sites	|O
,	|O
and	|O
tyrosine	|O
phosphorylation	|O
of	|O
the	|O
LMP2A	|B-PROTEIN
homologs	|O
have	|O
been	|O
conserved	|O
despite	|O
significant	|O
sequences	|O
heterogeneity	|O
in	|O
the	|O
preterminal	|O
repeat	|O
regions	|O
of	|O
these	|O
human	|O
and	|O
nonhuman	|O
primate	|O
EBVs	|O
.	|O

Results	|O
of	|O
the	|O
ECAT	|O
Angina	|O
Pectoris	|O
Study	|O
Group	|O
.	|O

Therefore	|O
,	|O
a	|O
prospective	|O
Phase	|O
II	|O
trial	|O
was	|O
conducted	|O
to	|O
determine	|O
the	|O
safety	|O
and	|O
efficacy	|O
of	|O
cryosurgery	|O
following	|O
radiation	|O
therapy	|O
in	|O
men	|O
with	|O
local	|O
recurrence	|O
.	|O

These	|O
motifs	|O
include	|O
a	|O
Chi	|O
motif	|O
and	|O
a	|O
Chi	|O
-	|O
like	|O
element	|O
previously	|O
found	|O
in	|O
the	|O
recombination	|O
hotspot	|O
region	|O
of	|O
the	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
and	|O
close	|O
to	|O
chromosomal	|O
breakpoints	|O
in	|O
T	|O
-	|O
ALL	|O
lines	|O
.	|O

Common	|O
history	|O
and	|O
prospects	|O
in	|O
surgical	|O
gynecology	|O
of	|O
the	|O
Charite	|O
and	|O
the	|O
Vienna	|O
University	|O
Clinic	|O

In	|O
contrast	|O
with	|O
the	|O
previously	|O
reported	|O
HMGR1	|B-PROTEIN
mRNA	|O
(	|O
HMGR1S	|B-PROTEIN
mRNA	|O
)	|O
,	|O
which	|O
is	|O
detected	|O
at	|O
high	|O
levels	|O
in	|O
all	|O
tissues	|O
of	|O
the	|O
plant	|O
,	|O
HMGR1L	|B-PROTEIN
mRNA	|O
is	|O
present	|O
at	|O
relatively	|O
low	|O
levels	|O
and	|O
its	|O
expression	|O
is	|O
restricted	|O
mostly	|O
to	|O
seedlings	|O
,	|O
roots	|O
and	|O
inflorescences	|O
.	|O

However	|O
,	|O
the	|O
requirement	|O
of	|O
rev3	|B-PROTEIN
for	|O
the	|O
production	|O
of	|O
G.C	|O
-	|O
-	|O
>	|O
T.A	|O
transversions	|O
by	|O
the	|O
rad18	|B-PROTEIN
mutator	|O
,	|O
which	|O
induces	|O
only	|O
these	|O
substitutions	|O
,	|O
was	|O
similar	|O
to	|O
that	|O
for	|O
rad6	|B-PROTEIN
-	|O
mediated	|O
G.C	|O
-	|O
-	|O
>	|O
T.A	|O
transversion	|O
.	|O

The	|O
second	|O
mutation	|O
present	|O
in	|O
the	|O
original	|O
mutant	|O
proved	|O
to	|O
be	|O
an	|O
allele	|O
of	|O
a	|O
known	|O
gene	|O
,	|O
PBS2	|B-PROTEIN
,	|O
which	|O
encodes	|O
a	|O
putative	|O
protein	|O
kinase	|O
that	|O
functions	|O
in	|O
the	|O
high	|O
osmolarity	|O
stress	|O
pathway	|O
.	|O

In	|O
adult	|O
tissues	|O
,	|O
it	|O
was	|O
less	|O
restricted	|O
,	|O
indicating	|O
that	|O
RAFTK	|B-PROTEIN
expression	|O
is	|O
developmentally	|O
up	|O
-	|O
regulated	|O
.	|O

As	|O
hGM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
hGMR	|B-PROTEIN
)	|O
does	|O
not	|O
contain	|O
a	|O
consensus	|O
sequence	|O
for	|O
binding	|O
of	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
hGMR	|B-PROTEIN
must	|O
use	|O
a	|O
distinct	|O
mechanism	|O
for	|O
its	|O
association	|O
with	|O
and	|O
activation	|O
of	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

J.	|O

The	|O
identity	|O
between	|O
hnRNPs	|B-PROTEIN
H	|B-PROTEIN
and	|O
H'	|B-PROTEIN
is	|O
96%	|O
,	|O
between	|O
H	|B-PROTEIN
and	|O
F	|B-PROTEIN
78%	|O
,	|O
and	|O
between	|O
H'	|B-PROTEIN
and	|O
F	|B-PROTEIN
75%	|O
,	|O
respectively	|O
.	|O

TPBF	|B-PROTEIN
has	|O
two	|O
potential	|O
coiled	|O
-	|O
coil	|O
regions	|O
,	|O
a	|O
basic	|O
region	|O
,	|O
a	|O
proline	|O
-	|O
rich	|O
region	|O
,	|O
a	|O
histidine	|O
-	|O
rich	|O
N	|O
terminus	|O
,	|O
and	|O
a	|O
nuclear	|O
targeting	|O
sequence	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
transiently	|O
expressed	|O
in	|O
primary	|O
cultures	|O
of	|O
rat	|O
hepatocytes	|O
plasmids	|O
consisting	|O
of	|O
CYP3A1	|B-PROTEIN
5'	|O
-	|O
flanking	|O
sequences	|O
fused	|O
to	|O
a	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
plasmid	|O
.	|O

We	|O
show	|O
that	|O
stimulation	|O
of	|O
resting	|O
splenic	|O
B	|O
cells	|O
with	|O
CD40L	|B-PROTEIN
-	|O
expressing	|O
Sf9	|O
cells	|O
induces	|O
germ	|O
-	|O
line	|O
gamma	|O
1	|O
and	|O
epsilon	|O
transcripts	|O
independently	|O
of	|O
cytokines	|O
.	|O

To	|O
confirm	|O
the	|O
GapIII	|B-PROTEIN
protein	|O
activity	|O
,	|O
constructs	|O
containing	|O
different	|O
GapIII	|B-PROTEIN
-	|O
GRD	|B-PROTEIN
domains	|O
were	|O
transformed	|O
into	|O
iral	|B-PROTEIN
mutant	|O
yeast	|O
to	|O
determine	|O
their	|O
relative	|O
ability	|O
to	|O
replace	|O
IRA1	|B-PROTEIN
functionally	|O
.	|O

At	|O
the	|O
time	|O
of	|O
the	|O
13	|O
latest	|O
BPVs	|O
,	|O
age	|O
ranged	|O
from	|O
three	|O
days	|O
to	|O
13.1	|O
years	|O
(	|O
mean	|O
5.7	|O
+	|O
/	|O
-	|O
SD	|O
4.8	|O
years	|O
)	|O
.	|O

A	|O
tobacco	|O
homologue	|O
(	|O
trolC	|B-PROTEIN
)	|O
of	|O
the	|O
rolC	|B-PROTEIN
gene	|O
of	|O
the	|O
Agrobacterium	|O
rhizogenes	|O
Ri	|O
-	|O
plasmid	|O
was	|O
cloned	|O
and	|O
sequenced	|O
from	|O
Nicotiana	|O
tabacum	|O
L.	|O
cv	|O
.	|O

High	|O
ADR1	|B-PROTEIN
gene	|O
dosage	|O
increased	|O
the	|O
transcription	|O
of	|O
genes	|O
encoding	|O
peroxisomal	|O
proteins	|O
as	|O
compared	|O
to	|O
one	|O
copy	|O
of	|O
the	|O
ADR1	|B-PROTEIN
gene	|O
.	|O

A	|O
water	|O
-	|O
vapour	|O
giga	|O
-	|O
maser	|O
in	|O
the	|O
active	|O
galaxy	|O
TXFS2226	|O
-	|O
184	|O
.	|O

Of	|O
the	|O
three	|O
known	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
family	|O
inhibitors	|O
,	|O
Ig	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
,	|O
LIP	|B-PROTEIN
and	|O
CHOP	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
,	|O
only	|O
Ig	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
is	|O
ubiquitously	|O
expressed	|O
.	|O

The	|O
effects	|O
of	|O
a	|O
1	|O
-	|O
or	|O
24	|O
-	|O
hour	|O
pretreatment	|O
regimen	|O
with	|O
monophosphoryl	|O
lipid	|O
A	|O
(	|O
MLA	|O
,	|O
35	|O
micrograms	|O
/	|O
kg	|O
i.v	|O
.	|O
)	|O
on	|O
myocardial	|O
stunning	|O
produced	|O
by	|O
repetitive	|O
coronary	|O
occlusions	|O
were	|O
studied	|O
in	|O
barbital	|O
-	|O
anesthetized	|O
dogs	|O
.	|O

These	|O
incisors	|O
were	|O
studied	|O
by	|O
scanning	|O
electron	|O
microscopy	|O
-	|O
energy	|O
dispersive	|O
spectroscopy	|O
analysis	|O
(	|O
SEM	|O
-	|O
EDS	|O
)	|O
and	|O
light	|O
microscopy	|O
to	|O
examine	|O
the	|O
calciotraumatic	|O
lines	|O
of	|O
strontium	|O
in	|O
the	|O
rat	|O
incisor	|O
labial	|O
dentin	|O
.	|O

A	|O
platelet	|B-PROTEIN
-	|I-PROTEIN
derived	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
phosphopeptide	|O
containing	|O
Tyr	|O
-	|O
857	|O
does	|O
not	|O
bind	|O
appreciably	|O
to	|O
the	|O
Src	|B-PROTEIN
SH2	|O
domain	|O
,	|O
suggesting	|O
it	|O
is	|O
not	|O
the	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
binding	|O
site	|O
for	|O
Src	|B-PROTEIN
as	|O
previously	|O
reported	|O
.	|O

We	|O
have	|O
also	|O
tested	|O
Src	|B-PROTEIN
SH2	|O
mutants	|O
for	|O
their	|O
binding	|O
properties	|O
and	|O
have	|O
interpreted	|O
our	|O
results	|O
in	|O
light	|O
of	|O
the	|O
recent	|O
crystal	|O
structure	|O
solution	|O
for	|O
the	|O
Src	|B-PROTEIN
SH2	|O
domain	|O
.	|O

These	|O
observations	|O
link	|O
actin	|B-PROTEIN
plaque	|O
assembly	|O
to	|O
increased	|O
cell	|O
substrate	|O
adhesion	|O
.	|O

The	|O
early	|O
lethality	|O
of	|O
the	|O
left	|O
-	|O
sided	|O
resectio	|O
was	|O
0%	|O
and	|O
the	|O
postoperative	|O
survival	|O
-	|O
-	|O
5-10	|O
months	|O
.	|O

There	|O
are	|O
two	|O
immunogenic	|O
sites	|O
on	|O
the	|O
type	|O
A	|O
influenza	|O
A	|O
/	|O
Japan	|O
/	|O
57	|O
(	|O
H2N2	|O
)	|O
hemagglutinin	|B-PROTEIN
(	|O
HA	|B-PROTEIN
)	|O
that	|O
can	|O
be	|O
recognized	|O
by	|O
class	|B-PROTEIN
I	|I-PROTEIN
major	|I-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
(	|O
MHC	|B-PROTEIN
)	|O
,	|O
H	|B-PROTEIN
-	|I-PROTEIN
2Kd	|I-PROTEIN
-	|O
restricted	|O
cytolytic	|O
T	|O
lymphocytes	|O
(	|O
CTLs	|O
)	|O
.	|O

This	|O
enhancer	|O
activates	|O
both	|O
the	|O
K19	|B-PROTEIN
and	|O
TK	|B-PROTEIN
basal	|O
promoters	|O
in	|O
HeLa	|O
cells	|O
.	|O

Mechanism	|O
of	|O
enhancement	|O
of	|O
DNA	|O
expression	|O
consequent	|O
to	|O
cointernalization	|O
of	|O
a	|O
replication	|O
-	|O
deficient	|O
adenovirus	|O
and	|O
unmodified	|O
plasmid	|O
DNA	|O
.	|O

Interestingly	|O
,	|O
one	|O
IRF	|B-PROTEIN
binding	|O
site	|O
was	|O
found	|O
within	|O
the	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
promoter	|O
,	|O
and	|O
expression	|O
of	|O
the	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
was	|O
affected	|O
by	|O
both	|O
transient	|O
and	|O
stable	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
.	|O

Therefore	|O
,	|O
we	|O
studied	|O
ninety	|O
coagulopathic	|O
patients	|O
with	|O
the	|O
aim	|O
of	|O
determining	|O
the	|O
prevalence	|O
of	|O
hepatitis	|O
C	|O
virus	|O
(	|B-PROTEIN
HCV	|I-PROTEIN
)	|I-PROTEIN
antibodies	|I-PROTEIN
using	|O
the	|O
ELISA	|O
and	|O
RIBA	|O
methods	|O
.	|O

The	|O
highest	|O
decrease	|O
in	|O
mutagenic	|O
activity	|O
was	|O
observed	|O
when	|O
enzymatic	|O
bleaching	|O
was	|O
used	|O
together	|O
with	|O
chlorine	|O
.	|O

Hepatitis	|B-PROTEIN
B	|I-PROTEIN
surface	|I-PROTEIN
antigen	|I-PROTEIN
was	|O
detected	|O
in	|O
2	|O
patients	|O
,	|O
with	|O
negative	|O
hepatitis	|B-PROTEIN
C	|I-PROTEIN
virus	|I-PROTEIN
antibody	|I-PROTEIN
.	|O

There	|O
was	|O
also	|O
a	|O
highly	|O
significant	|O
correlation	|O
between	|O
total	|O
selenium	|O
intake	|O
and	|O
liver	|O
selenium	|O
concentration	|O
(	|O
r	|O
=	|O
0.99	|O
,	|O
p	|O
<	|O
0.01	|O
)	|O
after	|O
1	|O
mo	|O
of	|O
treatment	|O
,	|O
but	|O
this	|O
time	|O
liver	|O
selenium	|O
did	|O
not	|O
change	|O
with	|O
time	|O
,	|O
and	|O
the	|O
correlation	|O
remained	|O
highly	|O
significant	|O
throughout	|O
the	|O
investigation	|O
.	|O

Antibodies	|O
affinity	|O
-	|O
purified	|O
using	|O
the	|O
bacterially	|O
expressed	|O
recombinant	|O
protein	|O
recognized	|O
the	|O
56K	|B-PROTEIN
autoantigen	|I-PROTEIN
in	|O
a	|O
HeLa	|O
cell	|O
extract	|O
.	|O
cDNA	|O
sequencing	|O
revealed	|O
that	|O
the	|O
56K	|B-PROTEIN
cDNA	|I-PROTEIN
shares	|O
a	|O
high	|O
degree	|O
of	|O
homology	|O
in	|O
both	|O
nucleotide	|O
(	|O
87%	|O
)	|O
and	|O
amino	|O
acid	|O
sequence	|O
(	|O
92.5%	|O
)	|O
with	|O
bovine	|O
annexin	|B-PROTEIN
XI	|I-PROTEIN
,	|O
indicating	|O
that	|O
the	|O
56K	|B-PROTEIN
cDNA	|I-PROTEIN
encodes	|O
the	|O
human	|O
homologue	|O
of	|O
annexin	|B-PROTEIN
XI	|I-PROTEIN
,	|O
a	|O
member	|O
of	|O
the	|O
Ca	|B-PROTEIN
(	|I-PROTEIN
2+	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
phospholipid	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
family	|O
.	|O

The	|O
avidin	|B-PROTEIN
-	|I-PROTEIN
biotin	|I-PROTEIN
complex	|I-PROTEIN
peroxidase	|I-PROTEIN
(	|O
ABC	|B-PROTEIN
-	|I-PROTEIN
P	|I-PROTEIN
)	|O
method	|O
was	|O
used	|O
to	|O
detect	|O
Mycobacterium	|O
bovis	|O
,	|O
and	|O
the	|O
results	|O
were	|O
compared	|O
with	|O
those	|O
obtained	|O
by	|O
the	|O
Ziehl	|O
-	|O
Neelsen	|O
(	|O
ZN	|O
)	|O
technique	|O
.	|O

Its	|O
role	|O
in	|O
these	|O
processes	|O
suggests	|O
that	|O
the	|O
function	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
may	|O
be	|O
important	|O
early	|O
in	|O
the	|O
establishment	|O
of	|O
the	|O
hematopoietic	|O
lineage	|O
.	|O

The	|O
transforming	|O
gene	|O
of	|O
the	|O
avian	|O
sarcoma	|O
virus	|O
CT10	|B-PROTEIN
encodes	|O
a	|O
fusion	|O
protein	|O
(	|O
p47gag	|B-PROTEIN
-	|O
crk	|B-PROTEIN
or	|O
v	|B-PROTEIN
-	|I-PROTEIN
Crk	|I-PROTEIN
)	|O
containing	|O
viral	|O
Gag	|B-PROTEIN
sequences	|O
fused	|O
to	|O
cellular	|O
sequences	|O
consisting	|O
primarily	|O
of	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
regions	|I-PROTEIN
2	|I-PROTEIN
and	|I-PROTEIN
3	|I-PROTEIN
(	|O
SH2	|B-PROTEIN
and	|O
SH3	|B-PROTEIN
sequences	|O
)	|O
.	|O

This	|O
specific	|O
methylation	|O
pattern	|O
caused	|O
inactivation	|O
of	|O
the	|O
HSV	|O
tk	|B-PROTEIN
gene	|O
,	|O
while	|O
methylation	|O
of	|O
the	|O
cytosine	|O
residues	|O
within	|O
the	|O
nucleotide	|O
sequence	|O
from	|O
+	|O
811	|O
to	|O
+	|O
1309	|O
had	|O
no	|O
effect	|O
on	|O
HSV	|O
tk	|B-PROTEIN
gene	|O
activity	|O
.	|O

CONCLUSION	|O
:	|O
This	|O
study	|O
documents	|O
that	|O
regression	|O
of	|O
choroidal	|O
neovascularization	|O
that	|O
occurred	|O
with	|O
alpha	|B-PROTEIN
interferon	|I-PROTEIN
treatment	|O
was	|O
minimal	|O
.	|O

Long	|O
-	|O
range	|O
mapping	|O
of	|O
the	|O
11q23	|O
region	|O
involved	|O
in	|O
chromosome	|O
aberrations	|O
in	|O
human	|O
tumors	|O
by	|O
pulsed	|O
-	|O
field	|O
gel	|O
electrophoresis	|O
with	|O
a	|O
yeast	|O
artificial	|O
chromosome	|O
.	|O

GTRE	|O
,	|O
TRE	|O
,	|O
and	|O
CRE	|O
oligonucleotides	|O
all	|O
compete	|O
more	|O
efficiently	|O
for	|O
protein	|O
binding	|O
to	|O
their	|O
labeled	|O
congeners	|O
than	|O
for	|O
protein	|O
binding	|O
to	|O
either	|O
of	|O
the	|O
other	|O
labeled	|O
oligonucleotides	|O
,	|O
suggesting	|O
that	|O
the	|O
GTRE	|O
,	|O
TRE	|O
,	|O
and	|O
CRE	|O
oligonucleotides	|O
,	|O
suggesting	|O
that	|O
the	|O
GTRE	|O
,	|O
TRE	|O
,	|O
and	|O
CRE	|O
oligonucleotides	|O
each	|O
bind	|O
unique	|O
as	|O
well	|O
as	|O
common	|O
proteins	|O
,	|O
likely	|O
to	|O
be	|O
members	|O
of	|O
the	|O
Jun	|B-PROTEIN
/	|O
Fos	|B-PROTEIN
and	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
/	|O
activating	|B-PROTEIN
transcription	|I-PROTEIN
factors	|I-PROTEIN
(	|O
CREB	|B-PROTEIN
/	|O
ATF	|B-PROTEIN
)	|O
families	|O
of	|O
transcription	|O
factors	|O
,	|O
in	|O
chromaffin	|O
cells	|O
.	|O

One	|O
patient	|O
only	|O
had	|O
any	|O
test	|O
abnormalities	|O
.	|O

One	|O
antibody	|O
,	|O
mAb1C2	|B-PROTEIN
,	|O
and	|O
a	|O
synthetic	|O
peptide	|O
comprising	|O
its	|O
epitope	|O
selectively	|O
inhibited	|O
in	|O
vitro	|O
transcription	|O
from	|O
TATA	|O
-	|O
containing	|O
,	|O
but	|O
not	|O
from	|O
TATA	|O
-	|O
less	|O
promoters	|O
,	|O
irrespective	|O
of	|O
whether	|O
they	|O
were	|O
transcribed	|O
by	|O
Pol	|B-PROTEIN
II	|I-PROTEIN
or	|O
Pol	|B-PROTEIN
III	|I-PROTEIN
.	|O

The	|O
lymph	|O
nodes	|O
from	|O
two	|O
of	|O
the	|O
patients	|O
with	|O
rheumatoid	|O
arthritis	|O
contained	|O
numerous	|O
sarcoid	|O
like	|O
granulomata	|O
,	|O
further	|O
indicating	|O
a	|O
possible	|O
association	|O
between	|O
sarcoidosis	|O
and	|O
rheumatoid	|O
arthritis	|O
.	|O

HCV	|O
infection	|O
acquired	|O
during	|O
or	|O
after	|O
BMT	|O
caused	|O
only	|O
mild	|O
acute	|O
hepatitis	|O
C	|O
,	|O
which	|O
progressed	|O
to	|O
chronic	|O
hepatitis	|O
C	|O
in	|O
one	|O
patient	|O
surviving	|O
10	|O
years	|O
after	|O
BMT	|O
.	|O

Hepatitis	|O
C	|O
virus	|O
infection	|O
is	|O
a	|O
risk	|O
factor	|O
for	|O
liver	|O
failure	|O
from	|O
veno	|O
-	|O
occlusive	|O
disease	|O
after	|O
bone	|O
marrow	|O
transplantation	|O
.	|O

High	|O
plasma	|O
concentrations	|O
of	|O
soluble	|O
E	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
were	|O
closely	|O
associated	|O
with	|O
multiple	|O
-	|O
organ	|O
dysfunction	|O
and	|O
death	|O
.	|O

These	|O
human	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|O
transformed	|O
cell	|O
populations	|O
have	|O
acquired	|O
a	|O
low	|O
,	|O
constitutive	|O
production	|O
of	|O
human	|O
IFN	|B-PROTEIN
,	|O
while	|O
replicating	|O
at	|O
a	|O
rate	|O
similar	|O
to	|O
that	|O
of	|O
untransformed	|O
cells	|O
and	|O
of	|O
cells	|O
transformed	|O
with	|O
the	|O
control	|O
vector	|O
carrying	|O
a	|O
human	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
sequence	|O
encoding	|O
an	|O
inactive	|O
,	|O
mutated	|O
protein	|O
.	|O

Improvement	|O
of	|O
the	|O
polypyrimidine	|O
tract	|O
also	|O
increased	|O
the	|O
splicing	|O
efficiency	|O
,	|O
but	|O
to	|O
a	|O
degree	|O
slightly	|O
less	|O
than	|O
that	|O
obtained	|O
with	|O
the	|O
branchpoint	|O
mutation	|O
.	|O

Liver	|O
transplantation	|O
in	|O
one	|O
patient	|O
resolved	|O
metabolic	|O
complications	|O
but	|O
did	|O
not	|O
improve	|O
PMN	|O
count	|O
or	|O
the	|O
infectious	|O
status	|O
,	|O
while	|O
neutropenia	|O
was	|O
corrected	|O
by	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
.	|O

Joys	|O
and	|O
F.	|O

Activation	|O
of	|O
the	|O
SH2	|B-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
protein	|I-PROTEIN
tyrosine	|I-PROTEIN
phosphatase	|I-PROTEIN
,	|O
SH	|B-PROTEIN
-	|I-PROTEIN
PTP2	|I-PROTEIN
,	|O
by	|O
phosphotyrosine	|O
-	|O
containing	|O
peptides	|O
derived	|O
from	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrate	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Tyrosine	|O
phosphorylation	|O
of	|O
cellular	|O
proteins	|O
is	|O
the	|O
earliest	|O
identifiable	|O
event	|O
following	|O
T	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
antigen	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
TCR	|B-PROTEIN
)	|O
stimulation	|O
and	|O
is	|O
essential	|O
for	|O
activating	|O
downstream	|O
signaling	|O
machinery	|O
.	|O

The	|O
interferon	|B-PROTEIN
-	|O
induced	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PKR	|B-PROTEIN
)	|O
is	|O
considered	|O
to	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
cellular	|O
defense	|O
against	|O
viral	|O
infection	|O
and	|O
,	|O
in	|O
addition	|O
,	|O
has	|O
been	|O
suggested	|O
to	|O
be	|O
a	|O
tumor	|O
suppressor	|O
gene	|O
because	|O
of	|O
its	|O
growth	|O
-	|O
suppressive	|O
properties	|O
.	|O

Moreover	|O
,	|O
Lck	|B-PROTEIN
was	|O
reversibly	|O
co	|O
-	|O
immunoprecipitated	|O
with	|O
p95Vav	|B-PROTEIN
,	|O
and	|O
the	|O
stoichiometry	|O
of	|O
binding	|O
increased	|O
in	|O
anti	|B-PROTEIN
-	|I-PROTEIN
CD3	|I-PROTEIN
-	|O
treated	|O
Jurkat	|O
cells	|O
.	|O

In	|O
contrast	|O
,	|O
injection	|O
of	|O
a	|O
plasmid	|O
encoding	|O
simian	|O
virus	|O
40	|O
small	|B-PROTEIN
t	|I-PROTEIN
antigen	|I-PROTEIN
,	|O
which	|O
interacts	|O
with	|O
PP2A	|B-PROTEIN
to	|O
inhibit	|O
its	|O
activity	|O
towards	|O
several	|O
phosphoprotein	|O
substrates	|O
,	|O
had	|O
no	|O
effect	|O
on	|O
the	|O
phosphorylation	|O
state	|O
of	|O
CREB	|B-PROTEIN
in	|O
stimulated	|O
or	|O
unstimulated	|O
NIH	|O
3T3	|O
cells	|O
.	|O

Several	|O
Src	|B-PROTEIN
SH3	|O
-	|O
binding	|O
proteins	|O
were	|O
phosphorylated	|O
in	|O
Src	|B-PROTEIN
-	|O
transformed	|O
cells	|O
.	|O

We	|O
also	|O
examined	|O
the	|O
effect	|O
of	|O
proteolytic	|O
processing	|O
in	|O
the	|O
MVE	|O
nonstructural	|O
polyprotein	|O
segment	|O
mediated	|O
by	|O
the	|O
viral	|O
proteinase	|O
NS3	|B-PROTEIN
on	|O
antigen	|O
processing	|O
and	|O
presentation	|O
of	|O
the	|O
MVE	|O
H	|O
-	|O
2Kk	|O
-	|O
restricted	|O
T	|O
cell	|O
determinant	|O
.	|O

A	|O
full	|O
-	|O
length	|O
PRL	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
PRLR	|B-PROTEIN
)	|O
complementary	|O
DNA	|O
from	|O
pigeons	|O
was	|O
obtained	|O
by	|O
screening	|O
pigeon	|O
crop	|O
sac	|O
libraries	|O
and	|O
by	|O
reverse	|O
transcription	|O
coupled	|O
with	|O
polymerase	|O
chain	|O
reaction	|O
.	|O

After	|O
7	|O
days	|O
,	|O
a	|O
spontaneous	|O
regression	|O
of	|O
the	|O
morphologic	|O
alterations	|O
caused	|O
by	|O
caerulein	|O
-	|O
induced	|O
acute	|O
pancreatitis	|O
occurs	|O
;	|O
however	|O
,	|O
recovery	|O
of	|O
the	|O
secretory	|O
function	|O
of	|O
the	|O
pancreas	|O
was	|O
only	|O
reached	|O
after	|O
this	|O
period	|O
of	|O
time	|O
when	|O
L	|O
-	|O
364,718	|O
was	|O
administered	|O
therapeutically	|O
(	|O
0.1	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
)	|O
.	|O

We	|O
observed	|O
that	|O
dephosphorylation	|O
severely	|O
inhibits	|O
the	|O
DNA	|O
-	|O
binding	|O
ability	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
-	|I-PROTEIN
delta	|I-PROTEIN
and	|O
its	|O
transactivating	|O
potential	|O
increases	|O
in	|O
the	|O
presence	|O
of	|O
cellular	|O
phosphatase	|O
inhibitors	|O
,	|O
such	|O
as	|O
okadaic	|O
acid	|O
and	|O
sodium	|O
orthovanadate	|O
.	|O

Two	|O
promoters	|O
were	|O
identified	|O
by	|O
S1	|B-PROTEIN
nuclease	|O
mapping	|O
:	|O
P1	|O
,	|O
which	|O
lies	|O
about	|O
72	|O
bp	|O
upstream	|O
from	|O
the	|O
structural	|O
gene	|O
;	|O
and	|O
P2	|O
,	|O
which	|O
lies	|O
about	|O
35	|O
bp	|O
upstream	|O
.	|O

Interleukin	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
)	|O
is	|O
a	|O
potent	|O
inflammatory	|O
mediator	|O
that	|O
belongs	|O
to	|O
the	|O
family	|O
of	|O
C	|B-PROTEIN
-	|I-PROTEIN
X	|I-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
chemokines	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
cells	|O
containing	|O
a	|O
PTP1C	|B-PROTEIN
in	|O
which	|O
the	|O
catalytic	|O
site	|O
had	|O
been	|O
inactivated	|O
through	|O
mutagenesis	|O
,	|O
stably	|O
phosphorylated	|O
the	|O
phosphatase	|O
.	|O

We	|O
recently	|O
found	|O
that	|O
the	|O
p72syk	|B-PROTEIN
protein	|O
tyrosine	|O
kinase	|O
is	|O
physically	|O
associated	|O
with	|O
the	|O
TCR	|B-PROTEIN
/	|O
CD3	|B-PROTEIN
complex	|O
and	|O
is	|O
rapidly	|O
tyrosine	|O
phosphorylated	|O
and	|O
activated	|O
by	|O
receptor	|O
triggering	|O
also	|O
in	|O
T	|O
cells	|O
lacking	|O
p56lck	|B-PROTEIN
.	|O

The	|O
transforming	|O
protein	|O
of	|O
Rous	|O
sarcoma	|O
virus	|O
,	|O
pp60v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
,	|O
and	|O
its	|O
normal	|O
cellular	|O
homolog	|O
,	|O
pp60c	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
,	|O
differ	|O
not	|O
only	|O
in	|O
oncogenic	|O
potential	|O
but	|O
also	|O
in	|O
their	|O
subcellular	|O
localization	|O
and	|O
cytoskeletal	|O
binding	|O
ability	|O
.	|O
pp60v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
has	|O
been	|O
shown	|O
to	|O
stably	|O
associate	|O
with	|O
a	|O
detergent	|O
-	|O
insoluble	|O
cytoskeletal	|O
matrix	|O
,	|O
whereas	|O
pp60c	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
does	|O
not	|O
.	|O

Organization	|O
of	|O
the	|O
bovine	|O
gene	|O
encoding	|O
the	|O
endothelial	|O
nitric	|B-PROTEIN
oxide	|I-PROTEIN
synthase	|I-PROTEIN
.	|O

We	|O
determined	|O
whether	|O
regional	|O
myocardial	|O
work	|O
efficiency	|O
(	|O
segment	|O
work	|O
/	|O
regional	|O
O2	|O
consumption	|O
)	|O
would	|O
be	|O
elevated	|O
by	|O
surgically	|O
-	|O
augmented	|O
inflow	|O
.	|O

In	|O
female	|O
Sl	|B-PROTEIN
(	|I-PROTEIN
pan	|I-PROTEIN
)	|I-PROTEIN
/	|I-PROTEIN
Sl	|I-PROTEIN
(	|I-PROTEIN
pan	|I-PROTEIN
)	|I-PROTEIN
mice	|O
,	|O
ovarian	|O
follicle	|O
development	|O
is	|O
arrested	|O
at	|O
the	|O
one	|O
layered	|O
cuboidal	|O
stage	|O
as	|O
a	|O
result	|O
of	|O
reduced	|O
KL	|B-PROTEIN
expression	|O
in	|O
follicle	|O
cells	|O
,	|O
indicating	|O
a	|O
role	|O
for	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
in	|O
oocyte	|O
growth	|O
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
NPROSP	|I-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
also	|O
exclusively	|O
detected	|O
time	|O
-	|O
dependent	|O
appearances	|O
of	|O
5-10	|O
-	|O
kDa	|O
proSP	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
forms	|O
in	|O
lamellar	|O
bodies	|O
and	|O
homogenates	|O
.	|O

In	|O
the	|O
B6	|O
-	|O
derived	|O
Db	|B-PROTEIN
mutant	|O
B6.C	|O
H	|O
-	|O
2bm13	|O
(	|O
bm13	|O
)	|O
strain	|O
,	|O
part	|O
of	|O
the	|O
class	|O
I	|O
Db	|B-PROTEIN
antigen	|O
-	|O
presenting	|O
groove	|O
is	|O
shaped	|O
by	|O
a	|O
class	|B-PROTEIN
I	|I-PROTEIN
Kb	|I-PROTEIN
-	|O
encoded	|O
sequence	|O
.	|O

Three	|O
mutants	|O
(	|O
pms1	|B-PROTEIN
,	|O
pms2	|B-PROTEIN
and	|O
pms3	|B-PROTEIN
)	|O
isolated	|O
earlier	|O
from	|O
MW104	|O
-	|O
1B	|O
were	|O
shown	|O
to	|O
correct	|O
in	|O
vitro	|O
constructed	|O
plasmids	|O
with	|O
defined	|O
DNA	|O
mismatches	|O
(	|O
G	|O
/	|O
T	|O
,	|O
A	|O
/	|O
C	|O
,	|O
G	|O
/	|O
G	|O
,	|O
etc	|O
.	|O
)	|O
poorly	|O
(	|O
Kramer	|O
et	|O
al.	|O
,	|O
1989a	|O
)	|O
.	|O

Our	|O
findings	|O
confirm	|O
the	|O
high	|O
frequency	|O
of	|O
proximal	|O
nerve	|O
lesions	|O
in	|O
early	|O
GBS	|O
and	|O
CIDP	|O
,	|O
not	|O
all	|O
of	|O
which	|O
are	|O
associated	|O
with	|O
distal	|O
motor	|O
conduction	|O
abnormalities	|O
,	|O
and	|O
suggest	|O
that	|O
assessment	|O
of	|O
multiple	|O
F	|O
wave	|O
parameters	|O
,	|O
in	|O
particular	|O
chronodispersion	|O
,	|O
mean	|O
latency	|O
and	|O
mean	|O
amplitude	|O
(	|O
in	|O
addition	|O
to	|O
absence	|O
and	|O
minimum	|O
latency	|O
)	|O
,	|O
increases	|O
the	|O
yield	|O
of	|O
F	|O
wave	|O
studies	|O
.	|O

Hematopoietic	|B-PROTEIN
growth	|I-PROTEIN
factors	|I-PROTEIN
are	|O
being	|O
used	|O
to	|O
accelerate	|O
the	|O
recovery	|O
of	|O
myelopoiesis	|O
following	|O
high	|O
-	|O
dose	|O
chemotherapy	|O
in	|O
cancer	|O
patients	|O
.	|O

Effects	|O
of	|O
alterations	|O
of	|O
primer	|O
-	|O
binding	|O
site	|O
sequences	|O
on	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
replication	|O
.	|O

Presentation	|O
of	|O
a	|O
horse	|O
cytochrome	|B-PROTEIN
c	|I-PROTEIN
peptide	|O
by	|O
multiple	|O
H	|O
-	|O
2b	|O
class	|O
I	|O
major	|B-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
(	|I-PROTEIN
MHC	|I-PROTEIN
)	|I-PROTEIN
molecules	|O
to	|O
C57BL	|O
/	|O
6	|O
-	|O
and	|O
bm1	|O
-	|O
derived	|O
cytotoxic	|O
T	|O
lymphocytes	|O
:	|O
presence	|O
of	|O
a	|O
single	|O
MHC	|B-PROTEIN
anchor	|O
residue	|O
may	|O
confer	|O
efficient	|O
peptide	|O
-	|O
specific	|O
CTL	|O
recognition	|O
.	|O

A	|O
particularly	|O
striking	|O
HpaII	|B-PROTEIN
tiny	|O
fragment	|O
island	|O
,	|O
extending	|O
over	|O
nearly	|O
2,000	|O
base	|O
pairs	|O
,	|O
surrounds	|O
the	|O
USF2	|B-PROTEIN
translation	|O
initiation	|O
site	|O
.	|O

Diagnosis	|O
of	|O
prostatic	|O
carcinoma	|O
:	|O
the	|O
yield	|O
of	|O
serum	|O
prostate	|B-PROTEIN
specific	|I-PROTEIN
antigen	|I-PROTEIN
,	|O
digital	|O
rectal	|O
examination	|O
and	|O
transrectal	|O
ultrasonography	|O
.	|O

Increased	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
colony	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
levels	|O
in	|O
neonates	|O
with	|O
perinatal	|O
complications	|O
.	|O

The	|O
results	|O
revealed	|O
a	|O
hierarchy	|O
of	|O
ligand	|O
affinities	|O
that	|O
mirrored	|O
their	|O
adhesive	|O
activity	|O
(	|O
rsVCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
>	|O
fibronectin	|B-PROTEIN
variants	|O
containing	|O
CS1	|B-PROTEIN
>	|O
>	|O
other	|O
fibronectin	|B-PROTEIN
variants	|O
)	|O
.	|O

When	|O
expressed	|O
in	|O
and	|O
purified	|O
from	|O
Escherichia	|O
coli	|O
,	|O
both	|O
full	|O
-	|O
length	|O
Fpr3	|B-PROTEIN
and	|O
its	|O
isolated	|O
COOH	|O
-	|O
terminal	|O
domain	|O
exhibit	|O
readily	|O
detectable	|O
PPIase	|B-PROTEIN
activity	|O
.	|O

Dilutions	|O
of	|O
H	|B-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
or	|I-PROTEIN
H	|I-PROTEIN
-	|I-PROTEIN
2d	|I-PROTEIN
NP	|I-PROTEIN
peptides	|O
indicated	|O
that	|O
3-4	|O
logs	|O
less	|O
H	|B-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
NP	|I-PROTEIN
peptide	|O
was	|O
required	|O
to	|O
sensitize	|O
syngeneic	|O
target	|O
cells	|O
for	|O
CTL	|O
-	|O
specific	|O
lysis	|O
,	|O
suggesting	|O
that	|O
the	|O
differing	|O
affinities	|O
of	|O
H	|O
-	|O
2b	|O
and	|O
H	|O
-	|O
2d	|O
major	|B-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
molecules	|O
for	|O
their	|O
peptides	|O
likely	|O
account	|O
for	|O
the	|O
total	|O
removal	|O
of	|O
NP	|O
CTL	|O
in	|O
the	|O
H	|O
-	|O
2b	|O
mice	|O
but	|O
only	|O
partial	|O
removal	|O
in	|O
H	|O
-	|O
2d	|O
mice	|O
made	|O
to	|O
express	|O
thymic	|O
NP	|O
.	|O

However	|O
,	|O
expression	|O
of	|O
sigma	|B-PROTEIN
3	|I-PROTEIN
from	|O
S4	|B-PROTEIN
(	|O
3'	|B-PROTEIN
UTR	|I-PROTEIN
/	|I-PROTEIN
S1	|I-PROTEIN
)	|O
,	|O
which	|O
included	|O
the	|O
PKR	|B-PROTEIN
activator	|O
sequence	|O
from	|O
S1	|B-PROTEIN
within	|O
the	|O
3'	|O
-	|O
UTR	|O
of	|O
S4	|B-PROTEIN
,	|O
was	|O
comparable	|O
to	|O
that	|O
from	|O
wild	|O
-	|O
type	|O
S4	|B-PROTEIN
.	|O

Microvessels	|O
were	|O
counted	|O
in	|O
a	|O
x200	|O
field	|O
(	|O
0.754	|O
mm2	|O
)	|O
in	|O
the	|O
area	|O
of	|O
maximal	|O
angiogenesis	|O
.	|O

Although	|O
both	|O
transfected	|O
cell	|O
lines	|O
contain	|O
FGF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cell	|I-PROTEIN
surface	|I-PROTEIN
receptors	|I-PROTEIN
as	|O
judged	|O
by	|O
crosslinking	|O
studies	|O
,	|O
the	|O
wild	|O
-	|O
type	|O
transfectants	|O
are	|O
refractory	|O
to	|O
exogenous	|O
FGF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
whereas	|O
the	|O
mutant	|O
transfectants	|O
respond	|O
normally	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Recent	|O
studies	|O
have	|O
demonstrated	|O
that	|O
the	|O
activated	|O
GH	|B-PROTEIN
receptor	|I-PROTEIN
can	|O
stimulate	|O
Stat1	|B-PROTEIN
,	|O
a	|O
cytoplasmic	|O
transcription	|O
factor	|O
that	|O
becomes	|O
tyrosine	|O
phosphorylated	|O
and	|O
translocates	|O
to	|O
the	|O
nucleus	|O
,	|O
where	|O
it	|O
can	|O
interact	|O
with	|O
specific	|O
DNA	|O
sequences	|O
to	|O
modulate	|O
gene	|O
expression	|O
.	|O

In	|O
viral	|O
infections	|O
,	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
was	|O
correlated	|O
with	|O
mononuclear	|O
cells	|O
(	|O
rs	|O
=	|O
0.41	|O
,	|O
P	|O
<	|O
0.05	|O
)	|O
,	|O
white	|O
blood	|O
cell	|O
counts	|O
(	|O
rs	|O
=	|O
0.56	|O
,	|O
P	|O
<	|O
0.01	|O
)	|O
,	|O
neutrophils	|O
(	|O
rs	|O
=	|O
0.41	|O
,	|O
P	|O
<	|O
0.05	|O
)	|O
and	|O
CRP	|B-PROTEIN
(	|O
rs	|O
=	|O
0.47	|O
,	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

Minor	|O
initiation	|O
sites	|O
were	|O
found	|O
at	|O
positions	|O
-	|O
128	|O
,	|O
-	|O
111	|O
,	|O
-	|O
91	|O
,	|O
and	|O
-	|O
74	|O
.	|O

Phosphoamino	|O
acid	|O
analysis	|O
of	|O
radiolabeled	|O
ASGPR	|B-PROTEIN
subunits	|O
identified	|O
Ser	|O
(	|O
P	|O
)	|O
as	|O
the	|O
predominant	|O
(	|O
approximately	|O
95%	|O
)	|O
and	|O
Thr	|O
(	|O
P	|O
)	|O
as	|O
a	|O
minor	|O
(	|O
approximately	|O
5%	|O
)	|O
phosphoamino	|O
acid	|O
in	|O
each	|O
polypeptide	|O
and	|O
confirmed	|O
the	|O
presence	|O
of	|O
Tyr	|O
(	|O
P	|O
)	|O
(	|O
approximately	|O
1%	|O
)	|O
in	|O
RHL1	|B-PROTEIN
.	|O

To	|O
further	|O
define	|O
the	|O
structural	|O
requirements	|O
for	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
interaction	|O
with	|O
the	|O
TCR	|B-PROTEIN
,	|O
we	|O
developed	|O
a	|O
binding	|O
assay	|O
using	|O
immobilized	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
fusion	|O
proteins	|O
containing	|O
the	|O
NH2	|O
-	|O
and	|O
/	|O
or	|O
COOH	|O
-	|O
terminal	|O
SH2	|B-PROTEIN
domains	|O
of	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
,	|O
and	|O
soluble	|O
synthetic	|O
peptides	|O
with	|O
the	|O
sequence	|O
of	|O
the	|O
cytoplasmic	|O
region	|O
of	|O
the	|O
TCR	|B-PROTEIN
zeta	|I-PROTEIN
chain	|I-PROTEIN
(	|O
TCR	|B-PROTEIN
zeta	|I-PROTEIN
cyt	|I-PROTEIN
)	|O
or	|O
individual	|O
TCR	|B-PROTEIN
zeta	|I-PROTEIN
and	|O
CD3	|B-PROTEIN
epsilon	|I-PROTEIN
TAM	|O
motifs	|O
.	|O

All	|O
four	|O
doubly	|O
tyrosine	|O
phosphorylated	|O
TAM	|O
peptides	|O
cross	|O
-	|O
compete	|O
with	|O
each	|O
other	|O
for	|O
binding	|O
to	|O
the	|O
tandem	|O
SH2	|B-PROTEIN
domains	|O
of	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
.	|O

The	|O
three	|O
-	|O
dimensional	|O
structure	|O
of	|O
RT	|B-PROTEIN
shows	|O
that	|O
it	|O
is	|O
a	|O
strikingly	|O
asymmetric	|O
heterodimer	|O
consisting	|O
of	|O
two	|O
differently	|O
folded	|O
subunits	|O
(	|O
molecular	|O
weights	|O
66	|O
kDa	|O
and	|O
51	|O
kDa	|O
)	|O
with	|O
identical	|O
amino	|O
-	|O
terminal	|O
amino	|O
acid	|O
sequences	|O
(	|O
residues	|O
1-428	|O
)	|O
.	|O

Pharmacological	|O
and	|O
pharmacokinetic	|O
characteristics	|O
of	|O
the	|O
non	|O
-	|O
ionic	|O
monomeric	|O
X	|O
-	|O
ray	|O
contrast	|O
agent	|O
iopromide	|O
(	|O
Ultravist	|O
,	|O
CAS	|O
73334-07-3	|O
)	|O
were	|O
evaluated	|O
in	|O
preclinical	|O
studies	|O
.	|O

All	|O
subsequent	|O
patients	|O
were	|O
treated	|O
at	|O
the	|O
maximal	|O
tolerated	|O
dose	|O
of	|O
EDXR	|O
(	|O
35	|O
mg	|O
/	|O
m2	|O
/	|O
day	|O
)	|O
.	|O

The	|O
median	|O
post	|O
-	|O
treatment	|O
,	|O
pre	|O
-	|O
operative	|O
serum	|O
PSA	|B-PROTEIN
was	|O
0.4	|O
ng	|O
/	|O
ml	|O
.	|O

Addition	|O
of	|O
soluble	|O
recombinant	|O
human	|O
SLF	|B-PROTEIN
to	|O
SI4	|O
-	|O
h220	|O
cultures	|O
enhanced	|O
reduction	|O
of	|O
cell	|O
-	|O
surface	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
expression	|O
and	|O
its	|O
protein	|O
degradation	|O
.	|O

Membrane	|O
-	|O
bound	|O
Steel	|B-PROTEIN
factor	|I-PROTEIN
induces	|O
more	|O
persistent	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activation	|O
and	|O
longer	|O
life	|O
span	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
gene	|O
-	|O
encoded	|O
protein	|O
than	|O
its	|O
soluble	|O
form	|O
.	|O

Analysis	|O
of	|O
the	|O
sequences	|O
with	|O
the	|O
BLAST	|O
and	|O
GRAIL	|O
programs	|O
provided	|O
additional	|O
independent	|O
evidence	|O
that	|O
15	|O
of	|O
these	|O
17	|O
clones	|O
contain	|O
coding	|O
sequences	|O
and	|O
that	|O
nine	|O
other	|O
clones	|O
are	|O
likely	|O
to	|O
contain	|O
sequences	|O
coding	|O
for	|O
portions	|O
of	|O
new	|O
genes	|O
.	|O

Patients	|O
with	|O
more	|O
than	|O
250	|O
PVC	|O
/	|O
24	|O
hours	|O
were	|O
selected	|O
for	|O
distribution	|O
of	|O
PVC	|O
and	|O
CI	|O
evaluation	|O
.	|O

Horvath	|O
,	|O
I.	|O

Cell	|O
lines	|O
derived	|O
from	|O
the	|O
tumors	|O
were	|O
examined	|O
by	|O
fluorescent	|O
in	|O
situ	|O
hybridization	|O
for	|O
the	|O
status	|O
of	|O
the	|O
transferred	|O
human	|O
chromosome	|O
and	|O
by	|O
PCR	|O
for	|O
marker	|O
loss	|O
.	|O

The	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
predicted	|O
RfbA	|B-PROTEIN
and	|O
RfbB	|B-PROTEIN
homologs	|O
showed	|O
identities	|O
of	|O
75.7%	|O
(	|O
87.9%	|O
total	|O
similarity	|O
)	|O
and	|O
78.0%	|O
(	|O
86.5%	|O
total	|O
similarity	|O
)	|O
,	|O
respectively	|O
.	|O

However	|O
,	|O
multiple	|O
alanine	|O
substitutions	|O
or	|O
proline	|O
(	|O
helix	|O
-	|O
destabilizing	|O
)	|O
substitutions	|O
disrupted	|O
both	|O
oligomerization	|O
and	|O
transport	|O
of	|O
GP64	|O
EFP	|B-PROTEIN
.	|O

The	|O
FinO	|B-PROTEIN
protein	|O
of	|O
IncF	|O
plasmids	|O
binds	|O
FinP	|B-PROTEIN
antisense	|O
RNA	|O
and	|O
its	|O
target	|O
,	|O
traJ	|B-PROTEIN
mRNA	|O
,	|O
and	|O
promotes	|O
duplex	|O
formation	|O
.	|O

In	|O
this	|O
paper	|O
we	|O
report	|O
that	|O
ligand	|O
binding	|O
induced	|O
tyrosine	|O
phosphorylation	|O
in	|O
BaF3	|O
cells	|O
engineered	|O
to	|O
express	|O
the	|O
murine	|B-PROTEIN
Mpl	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
BaF3	|O
/	|O
mMpl	|B-PROTEIN
)	|O
.	|O

A	|O
chicken	|O
paxillin	|B-PROTEIN
cDNA	|O
was	|O
also	|O
cloned	|O
and	|O
is	|O
predicted	|O
to	|O
encode	|O
a	|O
protein	|O
approximately	|O
90%	|O
identical	|O
to	|O
human	|O
paxil	|B-PROTEIN
-	|I-PROTEIN
lin	|I-PROTEIN
.	|O

We	|O
linked	|O
a	|O
4.1	|O
-	|O
kilobase	|O
pair	|O
HindIII	|B-PROTEIN
DNA	|O
fragment	|O
from	|O
the	|O
region	|O
upstream	|O
of	|O
the	|O
human	|O
AP	|B-PROTEIN
endonuclease	|I-PROTEIN
gene	|O
(	|O
APE	|O
)	|O
to	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
gene	|O
.	|O

The	|O
overexpressed	|O
His6	|O
-	|O
tagged	|O
GrsA	|B-PROTEIN
derivatives	|O
were	|O
affinity	|O
-	|O
purified	|O
,	|O
and	|O
the	|O
catalytic	|O
properties	|O
of	|O
the	|O
deletion	|O
mutants	|O
were	|O
examined	|O
by	|O
biochemical	|O
studies	|O
including	|O
ATP	|O
-	|O
dependent	|O
amino	|O
acid	|O
activation	|O
,	|O
carboxyl	|O
thioester	|O
formation	|O
,	|O
and	|O
the	|O
ability	|O
to	|O
racemize	|O
the	|O
covalently	|O
bound	|O
phenylalanine	|O
from	|O
L	|O
-	|O
to	|O
the	|O
D	|O
-	|O
isomer	|O
.	|O

CD7+	|B-PROTEIN
/	|O
CD3	|B-PROTEIN
-	|O
T	|O
-	|O
cell	|O
precursors	|O
exhibit	|O
V	|B-PROTEIN
delta	|I-PROTEIN
2D	|I-PROTEIN
delta	|O
3	|O
rearrangements	|O
.	|O

HVH2	|B-PROTEIN
mRNA	|O
showed	|O
an	|O
expression	|O
pattern	|O
distinct	|O
from	|O
CL100	|B-PROTEIN
(	|O
human	|O
homologue	|O
of	|O
mouse	|O
MKP1	|B-PROTEIN
)	|O
and	|O
PAC1	|B-PROTEIN
,	|O
two	|O
previously	|O
identified	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
phosphatases	|I-PROTEIN
.	|O

These	|O
data	|O
suggest	|O
that	|O
these	|O
sequences	|O
located	|O
immediately	|O
3'	|O
to	|O
the	|O
breakpoint	|O
of	|O
the	|O
HPFH	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
deletion	|O
,	|O
exhibit	|O
both	|O
the	|O
structure	|O
and	|O
the	|O
function	|O
of	|O
an	|O
enhancer	|O
,	|O
and	|O
can	|O
modify	|O
the	|O
developmental	|O
specificity	|O
of	|O
the	|O
fetal	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
genes	|O
,	|O
resulting	|O
in	|O
their	|O
continued	|O
expression	|O
during	|O
adult	|O
life	|O
.	|O

In	|O
vivo	|O
association	|O
between	|O
Shb	|B-PROTEIN
-	|O
SH3	|B-PROTEIN
domain	|O
proteins	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
and	|O
Eps8	|B-PROTEIN
was	|O
detected	|O
by	|O
coimmunoprecipitation	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
interaction	|O
between	|O
Jak2	|B-PROTEIN
and	|O
PRLR	|B-PROTEIN
requires	|O
a	|O
proline	|O
-	|O
rich	|O
sequence	|O
in	|O
the	|O
membrane	|O
proximal	|O
region	|O
of	|O
the	|O
receptor	|O
,	|O
which	|O
is	|O
conserved	|O
among	|O
the	|O
different	|O
members	|O
of	|O
the	|O
cytokine	|B-PROTEIN
receptor	|I-PROTEIN
superfamily	|O
.	|O

Transcription	|O
of	|O
the	|O
vascular	|B-PROTEIN
cell	|I-PROTEIN
adhesion	|I-PROTEIN
molecule	|I-PROTEIN
1	|I-PROTEIN
(	|O
VCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
gene	|O
in	|O
endothelial	|O
cells	|O
is	|O
induced	|O
by	|O
lipopolysaccharide	|O
and	|O
the	|O
inflammatory	|O
cytokines	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
and	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
.	|O

Experiments	|O
with	|O
recombinant	|O
proteins	|O
showed	|O
that	|O
p50	|B-PROTEIN
/	|O
p65	|B-PROTEIN
and	|O
high	|B-PROTEIN
-	|I-PROTEIN
mobility	|I-PROTEIN
-	|I-PROTEIN
group	|I-PROTEIN
I	|I-PROTEIN
(	|I-PROTEIN
Y	|I-PROTEIN
)	|I-PROTEIN
protein	|O
cooperatively	|O
facilitated	|O
the	|O
binding	|O
of	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
to	|O
the	|O
VCAM1	|B-PROTEIN
IRF	|O
binding	|O
site	|O
and	|O
that	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
physically	|O
interacted	|O
with	|O
p50	|B-PROTEIN
and	|O
with	|O
high	|B-PROTEIN
-	|I-PROTEIN
mobility	|I-PROTEIN
-	|I-PROTEIN
group	|I-PROTEIN
I	|I-PROTEIN
(	|I-PROTEIN
Y	|I-PROTEIN
)	|I-PROTEIN
protein	|O
.	|O

Based	|O
on	|O
these	|O
results	|O
the	|O
minimal	|O
control	|O
element	|O
(	|O
AX	|O
470	|O
)	|O
specifying	|O
the	|O
anterior	|O
boundary	|O
of	|O
Hox	|B-PROTEIN
expression	|O
was	|O
designated	|O
as	|O
Hoxa	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
enhancer	|O
.	|O

In	|O
this	|O
report	|O
we	|O
describe	|O
the	|O
isolation	|O
of	|O
a	|O
Fab	|B-PROTEIN
fragment	|O
(	|O
Fab	|B-PROTEIN
A8	|O
)	|O
showing	|O
a	|O
high	|O
relative	|O
affinity	|O
for	|O
the	|O
receptor	|O
(	|O
0.5	|O
nM	|O
)	|O
.	|O

MBP	|B-PROTEIN
-	|O
Rep68	|B-PROTEIN
delta	|I-PROTEIN
-	|O
mediated	|O
DNA	|B-PROTEIN
-	|I-PROTEIN
RNA	|I-PROTEIN
helicase	|I-PROTEIN
activity	|O
required	|O
ATP	|O
hydrolysis	|O
and	|O
the	|O
presence	|O
of	|O
Mg2+	|O
ions	|O
and	|O
was	|O
inhibited	|O
by	|O
high	|O
ionic	|O
strength	|O
.	|O

To	|O
identify	|O
critical	|O
regions	|O
mediating	|O
growth	|O
signal	|O
transduction	|O
by	|O
hG	|B-PROTEIN
-	|I-PROTEIN
CSFR	|I-PROTEIN
,	|O
deletions	|O
or	|O
site	|O
-	|O
directed	|O
amino	|O
acid	|O
substitutions	|O
were	|O
introduced	|O
into	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
hG	|B-PROTEIN
-	|I-PROTEIN
CSFR	|I-PROTEIN
,	|O
and	|O
the	|O
mutant	|O
cDNAs	|O
were	|O
transfected	|O
into	|O
the	|O
murine	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
-	|O
dependent	|O
Ba	|O
/	|O
F3	|O
and	|O
FDCP	|O
cell	|O
lines	|O
.	|O

When	|O
combined	|O
with	|O
independent	|O
activating	|O
mutations	|O
in	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
abl	|I-PROTEIN
kinase	|O
domain	|O
or	|O
NH2	|O
-	|O
terminus	|O
,	|O
the	|O
G128R	|B-PROTEIN
mutation	|O
blocked	|O
transformation	|O
by	|O
the	|O
double	|O
mutant	|O
,	|O
suggesting	|O
that	|O
the	|O
G128R	|B-PROTEIN
mutant	|O
was	|O
unable	|O
to	|O
transform	|O
cells	|O
for	|O
trivial	|O
reasons	|O
.	|O

Both	|O
mutations	|O
completely	|O
abolished	|O
binding	|O
of	|O
the	|O
Abl	|O
SH3	|B-PROTEIN
domain	|O
to	|O
proline	|O
-	|O
rich	|O
target	|O
proteins	|O
in	|O
a	|O
filter	|O
-	|O
binding	|O
assay	|O
.	|O

Changes	|O
induced	|O
in	|O
the	|O
gills	|O
of	|O
milkfish	|O
(	|O
Chanos	|O
chanos	|O
Forsskal	|O
)	|O
fingerlings	|O
after	|O
acute	|O
exposure	|O
to	|O
nifurpirinol	|O
(	|O
Furanace	|O
;	|O
P	|O
-	|O
7138	|O
)	|O
.	|O

Retreatment	|O
of	|O
these	|O
2	|O
dogs	|O
resulted	|O
in	|O
a	|O
similar	|O
,	|O
but	|O
blunted	|O
,	|O
response	|O
to	|O
human	|O
immunoglobulin	|B-PROTEIN
.	|O

The	|O
levels	|O
of	|O
NSE	|B-PROTEIN
and	|O
MBP	|B-PROTEIN
in	|O
the	|O
IJVB	|O
were	|O
compared	|O
to	|O
those	|O
in	|O
the	|O
PVB	|O
.	|O

As	|O
expected	|O
,	|O
the	|O
insulin	|B-PROTEIN
effect	|O
to	|O
increase	|O
ras	|B-PROTEIN
GTP	|O
formation	|O
and	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
was	|O
negligible	|O
in	|O
A	|O
/	|O
K1018	|O
cells	|O
but	|O
normal	|O
,	|O
or	|O
supernormal	|O
,	|O
in	|O
Y	|O
/	|O
F2	|O
cells	|O
.	|O

Morphologic	|O
variables	|O
included	|O
cancer	|O
volume	|O
,	|O
histologic	|O
grade	|O
,	|O
capsular	|O
penetration	|O
,	|O
seminal	|O
vesicle	|O
invasion	|O
,	|O
and	|O
lymph	|O
node	|O
metastasis	|O
.	|O

Sequence	|O
analysis	|O
of	|O
these	|O
regions	|O
showed	|O
a	|O
CAAT	|O
box	|O
upstream	|O
of	|O
exon	|O
1a	|O
and	|O
high	|O
G	|O
-	|O
C	|O
content	|O
regions	|O
within	|O
both	|O
P1	|O
and	|O
P2	|O
.	|O

The	|O
fusion	|O
proteins	|O
were	|O
tested	|O
by	|O
ELISA	|O
for	|O
reactivity	|O
with	|O
a	|O
panel	|O
of	|O
human	|O
anti	|B-PROTEIN
-	|I-PROTEIN
La	|I-PROTEIN
sera	|O
in	|O
order	|O
to	|O
define	|O
the	|O
nature	|O
of	|O
the	|O
epitopes	|O
.	|O

GCD10	|B-PROTEIN
was	|O
first	|O
identified	|O
genetically	|O
as	|O
a	|O
translational	|O
repressor	|O
of	|O
GCN4	|B-PROTEIN
.	|O

GCD10	|B-PROTEIN
binds	|O
RNA	|O
in	|O
vitro	|O
and	|O
we	|O
present	|O
strong	|O
biochemical	|O
evidence	|O
that	|O
it	|O
is	|O
identical	|O
to	|O
the	|O
RNA	|O
-	|O
binding	|O
subunit	|O
of	|O
yeast	|B-PROTEIN
initiation	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
(	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
.	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
is	|O
a	|O
multisubunit	|O
complex	|O
that	|O
stimulates	|O
translation	|O
initiation	|O
in	|O
vitro	|O
at	|O
several	|O
different	|O
steps	|O
.	|O

Sources	|O
of	|O
noise	|O
in	|O
these	|O
signals	|O
were	|O
evaluated	|O
in	|O
preparations	|O
stained	|O
with	|O
the	|O
potentiometric	|O
probe	|O
RH	|O
-	|O
414	|O
.	|O

1993	|O
.	|O

A	|O
transformation	|O
-	|O
competent	|O
mutant	|O
,	|O
like	|O
the	|O
wild	|O
-	|O
type	|O
E5	|B-PROTEIN
protein	|O
,	|O
bound	|O
the	|O
receptor	|O
and	|O
induced	|O
receptor	|O
tyrosine	|O
phosphorylation	|O
and	|O
down	|O
-	|O
regulation	|O
.	|O

We	|O
conclude	|O
that	|O
cAMP	|O
,	|O
acting	|O
through	|O
PKA	|B-PROTEIN
,	|O
is	|O
an	|O
essential	|O
regulator	|O
of	|O
basal	|O
CFTR	|B-PROTEIN
gene	|O
expression	|O
and	|O
may	|O
mediate	|O
an	|O
induction	|O
of	|O
CFTR	|B-PROTEIN
in	|O
responsive	|O
cell	|O
types	|O
.	|O

Appropriate	|O
restriction	|O
sites	|O
allow	|O
one	|O
to	|O
insert	|O
virtually	|O
any	|O
desired	|O
cDNA	|O
fragment	|O
directly	|O
behind	|O
the	|O
epitope	|O
-	|O
specific	|O
sequence	|O
and	|O
before	|O
a	|O
long	|O
poly	|O
(	|O
A	|O
)	|O
tail	|O
.	|O

Both	|O
PPC	|O
-	|O
1	|O
and	|O
ALVA	|O
-	|O
31	|O
cells	|O
display	|O
tumorigenesis	|O
and	|O
invasiveness	|O
in	|O
nude	|O
mice	|O
,	|O
whereas	|O
LNCap	|O
cells	|O
exhibit	|O
a	|O
less	|O
malignant	|O
phenotype	|O
,	|O
suggesting	|O
a	|O
correlation	|O
between	|O
CD44	|B-PROTEIN
variant	|O
(	|O
CD44v	|B-PROTEIN
)	|O
expression	|O
and	|O
aggressive	|O
prostate	|O
tumor	|O
behavior	|O
.	|O

The	|O
gene	|O
product	|O
of	|O
cotS	|B-PROTEIN
was	|O
confirmed	|O
to	|O
be	|O
identical	|O
to	|O
Cot40	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
by	|O
SDS	|O
-	|O
PAGE	|O
and	|O
immunoblotting	|O
from	|O
Escherichia	|O
coli	|O
transformed	|O
with	|O
a	|O
plasmid	|O
containing	|O
the	|O
cotS	|B-PROTEIN
region	|O
.	|O

Two	|O
such	|O
genes	|O
,	|O
designated	|O
hsiggll150	|B-PROTEIN
and	|O
hsiggll295	|B-PROTEIN
,	|O
were	|O
cloned	|O
and	|O
sequenced	|O
from	|O
genomic	|O
DNA	|O
.	|O

A	|O
retrospective	|O
epidemiological	|O
study	|O
is	|O
reported	|O
concerning	|O
burn	|O
injuries	|O
in	|O
775	|O
children	|O
hospitalized	|O
at	|O
the	|O
unit	|O
of	|O
burn	|O
care	|O
of	|O
Casablanca	|O
between	|O
1985	|O
and	|O
1993	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
protein	|O
binding	|O
to	|O
the	|O
E2F	|B-PROTEIN
-	|O
like	|O
sequences	|O
may	|O
act	|O
to	|O
reduce	|O
expression	|O
.	|O

The	|O
RAD6	|B-PROTEIN
/	|O
UBC2	|B-PROTEIN
gene	|O
from	|O
Saccharomyces	|O
cerevisiae	|O
encodes	|O
a	|O
ubiquitin	|B-PROTEIN
-	|O
conjugating	|O
enzyme	|O
involved	|O
in	|O
DNA	|O
repair	|O
,	|O
induced	|O
mutagenesis	|O
,	|O
and	|O
sporulation	|O
.	|O

Echocardiography	|O
revealed	|O
right	|O
ventricular	|O
diastolic	|O
collapse	|O
(	|O
RVDC	|O
)	|O
without	|O
physical	|O
signs	|O
of	|O
cardiac	|O
tamponade	|O
.	|O

In	|O
on	|O
-	|O
going	|O
screening	|O
programmes	|O
,	|O
the	|O
Haemoccult	|O
test	|O
consists	|O
of	|O
six	|O
slides	|O
and	|O
a	|O
test	|O
is	|O
considered	|O
positive	|O
if	|O
at	|O
least	|O
one	|O
slide	|O
is	|O
coloured	|O
.	|O

We	|O
showed	|O
previously	|O
that	|O
a	|O
fusion	|O
protein	|O
(	|O
GAL4	|B-PROTEIN
-	|O
p40	|B-PROTEIN
)	|O
containing	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
GAL4	|B-PROTEIN
and	|O
sequences	|O
of	|O
chicken	|O
l	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
p40	|B-PROTEIN
)	|O
inhibits	|O
growth	|O
in	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

We	|O
have	|O
demonstrated	|O
previously	|O
that	|O
two	|O
binding	|O
sites	|O
in	|O
the	|O
-	|O
184	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
promoter	|O
are	|O
recognized	|O
by	|O
widely	|O
distributed	|O
factors	|O
and	|O
that	|O
there	|O
is	|O
also	|O
a	|O
critical	|O
autoregulatory	|O
site	|O
,	|O
we	|O
identified	|O
a	|O
binding	|O
site	|O
for	|O
a	|O
cell	|O
-	|O
specific	|O
factor	|O
,	|O
LF	|B-PROTEIN
-	|I-PROTEIN
H3	|I-PROTEIN
beta	|I-PROTEIN
,	|O
that	|O
may	|O
function	|O
in	|O
restricting	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
gene	|O
expression	|O
to	|O
hepatocytes	|O
.	|O

In	|O
4	|O
spinalized	|O
cats	|O
,	|O
the	|O
effects	|O
of	|O
afferent	|O
inputs	|O
from	|O
hindlimb	|O
cutaneous	|O
nerves	|O
(	|O
sural	|O
cutaneous	|O
nerve	|O
:	|O
Sur	|O
)	|O
on	|O
mono	|O
-	|O
and	|O
poly	|O
-	|O
synaptic	|O
reflex	|O
recorded	|O
from	|O
tail	|O
muscle	|O
motoneurons	|O
were	|O
studied	|O
before	|O
and	|O
after	|O
spinal	|O
lesioning	|O
at	|O
S2	|O
-	|O
3	|O
level	|O
.	|O

The	|O
flow	|O
rate	|O
of	|O
phosphate	|O
buffered	|O
saline	|O
through	|O
dermis	|O
was	|O
measured	|O
as	|O
a	|O
function	|O
of	|O
applied	|O
pressure	|O
.	|O

However	|O
,	|O
parallax	|O
measurements	|O
showed	|O
that	|O
at	|O
150K	|O
,	|O
collapse	|O
of	|O
Epon	|O
sections	|O
does	|O
not	|O
take	|O
place	|O
.	|O

Although	|O
within	|O
normal	|O
limits	|O
,	|O
latency	|O
was	|O
high	|O
.	|O

The	|O
outcome	|O
of	|O
the	|O
optimization	|O
of	|O
the	|O
seven	|O
-	|O
field	|O
plan	|O
prompted	|O
an	|O
investigation	|O
into	|O
the	|O
best	|O
results	|O
that	|O
could	|O
be	|O
achieved	|O
by	|O
an	|O
"	|O
ideal	|O
"	|O
conformal	|O
radiotherapy	|O
technique	|O
.	|O

Specific	|O
requirements	|O
for	|O
branched	|O
-	|O
chain	|O
amino	|O
acids	|O
,	|O
glutamine	|O
,	|O
and	|O
arginine	|O
are	|O
evaluated	|O
.	|O

The	|O
pea	|O
rps10	|B-PROTEIN
intron	|O
is	|O
homologous	|O
to	|O
introns	|O
in	|O
rrn26	|B-PROTEIN
and	|O
cox3	|B-PROTEIN
in	|O
the	|O
Marchantia	|O
mitochondrial	|O
genome	|O
,	|O
while	|O
the	|O
Marchantia	|O
rps10	|B-PROTEIN
gene	|O
lacks	|O
an	|O
intron	|O
.	|O

The	|O
optimal	|O
care	|O
of	|O
CHF	|O
patient	|O
includes	|O
the	|O
recognition	|O
and	|O
management	|O
of	|O
these	|O
electrolyte	|O
disturbances	|O
.	|O

Serum	|O
magnesium	|O
in	|O
79	|O
patients	|O
of	|O
gynecologic	|O
neoplasms	|O
treated	|O
with	|O
cisplatin	|O
and	|O
their	|O
controls	|O
was	|O
measured	|O
.	|O

METHODS	|O
:	|O
rHb1.1	|B-PROTEIN
or	|O
human	|O
serum	|O
albumin	|B-PROTEIN
was	|O
administered	|O
intravenously	|O
to	|O
fasting	|O
male	|O
volunteers	|O
.	|O

Alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
(	|O
ALT	|B-PROTEIN
)	|O
levels	|O
had	|O
been	|O
elevated	|O
for	|O
six	|O
months	|O
in	|O
all	|O
patients	|O
and	|O
hepatitis	|O
B	|O
viral	|O
infection	|O
was	|O
replicative	|O
.	|O

In	|O
this	|O
study	|O
we	|O
have	|O
investigated	|O
the	|O
role	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
in	|O
initiating	|O
the	|O
adipogenic	|O
program	|O
by	|O
overexpressing	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
in	|O
multipotential	|O
NIH	|O
-	|O
3T3	|O
fibroblasts	|O
.	|O

XYL1	|B-PROTEIN
was	|O
isolated	|O
as	|O
a	|O
highly	|O
expressed	|O
fusion	|O
clone	|O
from	|O
a	|O
'	|B-PROTEIN
lacZ	|I-PROTEIN
translational	|O
fusion	|O
library	|O
.	|O

Various	|O
transcripts	|O
are	|O
generated	|O
from	|O
the	|O
VCSA1	|B-PROTEIN
gene	|O
by	|O
alternative	|O
splicing	|O
and	|O
poly	|O
(	|O
A	|O
)	|O
processing	|O
in	|O
the	|O
rat	|O
submandibular	|O
gland	|O
.	|O

However	|O
,	|O
division	|O
of	|O
the	|O
chest	|O
wall	|O
muscles	|O
,	|O
usually	|O
with	|O
diathermy	|O
,	|O
contributes	|O
to	|O
prolonged	|O
pain	|O
and	|O
morbidity	|O
.	|O

Closure	|O
of	|O
an	|O
open	|O
high	|O
below	|O
-	|O
knee	|O
guillotine	|O
amputation	|O
wound	|O
using	|O
a	|O
skin	|O
-	|O
stretching	|O
device	|O
.	|O

Our	|O
study	|O
was	|O
addressed	|O
to	|O
the	|O
synthesis	|O
of	|O
some	|O
derivatives	|O
of	|O
this	|O
sequence	|O
in	|O
order	|O
to	|O
obtain	|O
both	|O
peptide	|O
substrates	|O
suitable	|O
for	|O
the	|O
detection	|O
of	|O
the	|O
Src	|B-PROTEIN
-	|O
like	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
and	|O
active	|O
site	|O
-	|O
directed	|O
inhibitors	|O
specific	|O
for	|O
this	|O
class	|O
of	|O
enzymes	|O
.	|O

Citrate	|B-PROTEIN
synthase	|I-PROTEIN
activity	|O
was	|O
increased	|O
in	|O
the	|O
medial	|O
head	|O
(	|O
81%	|O
,	|O
P	|O
<	|O
0.001	|O
)	|O
and	|O
the	|O
red	|O
long	|O
head	|O
(	|O
88%	|O
,	|O
P	|O
<	|O
0.001	|O
)	|O
of	|O
the	|O
triceps	|O
brachii	|O
muscle	|O
in	|O
R	|O
rats	|O
but	|O
not	|O
in	|O
the	|O
white	|O
long	|O
head	|O
(	|O
25%	|O
,	|O
P	|O
=	|O
0.06	|O
)	|O
.	|O

The	|O
expression	|O
of	|O
the	|O
putative	|O
operon	|O
bglPH	|B-PROTEIN
of	|O
Bacillus	|O
subtilis	|O
was	|O
studied	|O
by	|O
using	|O
bglP	|B-PROTEIN
'	|I-PROTEIN
-	|O
lacZ	|B-PROTEIN
transcriptional	|O
fusions	|O
.	|O

Although	|O
eight	|O
contiguous	|O
genes	|O
necessary	|O
for	|O
urease	|B-PROTEIN
activity	|O
have	|O
been	|O
cloned	|O
and	|O
sequenced	|O
,	|O
the	|O
transcriptional	|O
organization	|O
and	|O
regulation	|O
of	|O
specific	|O
genes	|O
within	|O
the	|O
Proteus	|B-PROTEIN
gene	|O
cluster	|O
has	|O
not	|O
been	|O
investigated	|O
in	|O
detail	|O
.	|O

The	|O
hypBFCDE	|B-PROTEIN
operon	|O
from	|O
Rhizobium	|O
leguminosarum	|O
biovar	|O
viciae	|O
is	|O
expressed	|O
from	|O
an	|O
Fnr	|B-PROTEIN
-	|O
type	|O
promoter	|O
that	|O
escapes	|O
mutagenesis	|O
of	|O
the	|O
fnrN	|B-PROTEIN
gene	|O
.	|O

We	|O
demonstrate	|O
that	|O
a	|O
VT+	|O
peptide	|O
was	|O
specifically	|O
phosphorylated	|O
by	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
(	|O
PKC	|B-PROTEIN
)	|O
in	|O
vitro	|O
,	|O
but	|O
not	|O
by	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
(	|O
PKA	|B-PROTEIN
)	|O
.	|O

R.	|O

15	|O
,	|O
2500-2508	|O
;	|O
O'	|O
Neill	|O
,	|O
T.	|O

Control	|O
experiments	|O
showed	|O
that	|O
each	|O
fusion	|O
protein	|O
had	|O
a	|O
high	|O
affinity	|O
binding	|O
site	|O
for	|O
estradiol	|O
-	|O
17	|O
beta	|O
and	|O
could	|O
transactivate	|O
an	|O
ERE	|O
-	|O
LacZ	|B-PROTEIN
reporter	|O
gene	|O
in	|O
yeast	|O
similar	|O
to	|O
the	|O
wild	|O
type	|O
ER	|B-PROTEIN
.	|O

Although	|O
Micrococcus	|O
luteus	|O
UV	|B-PROTEIN
endonuclease	|I-PROTEIN
has	|O
been	|O
reported	|O
to	|O
be	|O
an	|O
18	|O
-	|O
kDa	|O
enzyme	|O
with	|O
possible	|O
homology	|O
to	|O
the	|O
16	|O
-	|O
kDa	|O
endonuclease	|B-PROTEIN
V	|I-PROTEIN
from	|O
bacteriophage	|O
T4	|O
(	|O
Gordon	|O
,	|O
L.	|O

Several	|O
different	|O
oncogenes	|O
and	|O
growth	|O
factors	|O
promote	|O
G1	|O
phase	|O
progression	|O
.	|O

Cyclin	|B-PROTEIN
D1	|I-PROTEIN
promoter	|O
activity	|O
was	|O
stimulated	|O
by	|O
overexpression	|O
of	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
p41MAPK	|B-PROTEIN
)	|O
or	|O
c	|B-PROTEIN
-	|I-PROTEIN
Ets	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
through	|O
the	|O
proximal	|O
22	|O
base	|O
pairs	|O
.	|O

Indeed	|O
,	|O
ERM	|B-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
synergistically	|O
activated	|O
the	|O
EBS	|O
-	|O
CRE	|O
without	|O
making	|O
an	|O
apparent	|O
ternary	|O
complex	|O
.	|O

A	|O
mutant	|O
(	|O
residues	|O
1-332	|O
)	|O
showed	|O
complete	|O
Ca2+	|O
/	|O
CaM	|B-PROTEIN
-	|O
dependent	|O
activity	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
R206S	|O
HSF	|B-PROTEIN
substitution	|O
exhibits	|O
constitutive	|O
transcriptional	|O
activation	|O
from	|O
a	|O
consensus	|O
HSE	|O
(	|O
HSE2	|O
)	|O
.	|O

The	|O
two	|O
bases	|O
immediately	|O
flanking	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
element	|O
proved	|O
to	|O
be	|O
very	|O
important	|O
to	|O
its	|O
function	|O
as	|O
a	|O
UAS	|O
element	|O
as	|O
did	|O
the	|O
two	|O
bases	|O
immediately	|O
3'	|O
of	|O
the	|O
bHLH	|O
core	|O
motif	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
the	|O
PCNA	|B-PROTEIN
gene	|O
is	|O
a	|O
likely	|O
target	|O
gene	|O
of	|O
E2F	|B-PROTEIN
.	|O

Differential	|O
sensitivity	|O
of	|O
the	|O
MMPI	|O
-	|O
2	|O
depression	|O
scales	|O
and	|O
subscales	|O
.	|O

After	|O
recovery	|O
,	|O
a	|O
hypertonic	|O
saline	|O
challenge	|O
was	|O
performed	|O
.	|O

The	|O
range	|O
of	|O
eosinophils	|O
was	|O
22-56%	|O
of	|O
the	|O
number	|O
of	|O
peripheral	|O
white	|O
blood	|O
cells	|O
(	|O
mean	|O
nadir	|O
33%	|O
)	|O
.	|O

Comparisons	|O
of	|O
rrnB	|B-PROTEIN
P1	|O
-	|O
lacZ	|B-PROTEIN
expression	|O
at	|O
different	|O
ppGpp	|O
levels	|O
is	|O
interpreted	|O
for	|O
the	|O
rpoD	|B-PROTEIN
(	|O
P504L	|O
)	|O
mutant	|O
as	|O
resulting	|O
from	|O
a	|O
hypersensitivity	|O
to	|O
ppGpp	|O
.	|O

These	|O
intron	|O
chimeras	|O
show	|O
that	|O
peripheral	|O
sequences	|O
and	|O
the	|O
elements	|O
that	|O
define	|O
the	|O
splice	|O
sites	|O
are	|O
adequate	|O
for	|O
self	|O
-	|O
splicing	|O
activity	|O
but	|O
that	|O
the	|O
central	|O
portions	|O
containing	|O
the	|O
catalytic	|O
cores	|O
of	|O
ai4	|B-PROTEIN
and	|O
bi4	|B-PROTEIN
are	|O
deficient	|O
;	|O
these	|O
cores	|O
are	|O
the	|O
likely	|O
targets	|O
of	|O
the	|O
splicing	|O
proteins	|O
.	|O

Here	|O
we	|O
demonstrate	|O
genetically	|O
that	|O
plus	|O
-	|O
strand	|O
DNA	|O
synthesis	|O
of	|O
the	|O
yeast	|B-PROTEIN
Ty1	|I-PROTEIN
element	|O
is	|O
initiated	|O
at	|O
two	|O
sites	|O
located	|O
at	|O
the	|O
5'	|O
boundary	|O
of	|O
the	|O
3'	|O
long	|O
terminal	|O
repeat	|O
(	|O
PPT1	|B-PROTEIN
)	|O
and	|O
near	|O
the	|O
middle	|O
of	|O
the	|O
pol	|B-PROTEIN
gene	|O
in	|O
the	|O
integrase	|B-PROTEIN
coding	|O
sequence	|O
(	|O
PPT2	|B-PROTEIN
)	|O
.	|O

Characterization	|O
of	|O
the	|O
3'	|O
ends	|O
of	|O
the	|O
plus	|O
-	|O
strand	|O
DNA	|O
fragments	|O
reveals	|O
(	|O
1	|O
)	|O
that	|O
the	|O
upstream	|O
fragment	|O
is	|O
elongated	|O
beyond	|O
PPT2	|B-PROTEIN
creating	|O
a	|O
plus	|O
-	|O
strand	|O
overlap	|O
and	|O
(	|O
2	|O
)	|O
that	|O
the	|O
majority	|O
of	|O
plus	|O
-	|O
strand	|O
strong	|O
-	|O
stop	|O
DNA	|O
fragments	|O
bear	|O
a	|O
copy	|O
of	|O
the	|O
minus	|O
-	|O
strand	|O
primer	|O
binding	|O
site	|O
in	|O
agreement	|O
with	|O
the	|O
accepted	|O
model	|O
of	|O
retroviral	|O
genomic	|O
RNA	|O
reverse	|O
transcription	|O
.	|O

The	|O
patients	|O
undergoing	|O
VTLB	|O
had	|O
significantly	|O
shorter	|O
operative	|O
times	|O
(	|O
VTLB	|O
,	|O
100.2	|O
+	|O
/	|O
-	|O
27.2	|O
min	|O
.	|O
vs	|O
OLB	|O
,	|O
119.8	|O
+	|O
/	|O
-	|O
42.6	|O
min	|O
;	|O
p	|O
<	|O
0.01	|O
)	|O
and	|O
less	|O
blood	|O
loss	|O
(	|O
VTLB	|O
,	|O
4.7	|O
+	|O
/	|O
-	|O
14.6	|O
ml	|O
vs	|O
OLB	|O
,	|O
65.7	|O
+	|O
/	|O
-	|O
77.0	|O
ml	|O
;	|O
p	|O
<	|O
0.001	|O
)	|O
.	|O

By	|O
150	|O
minutes	|O
after	|O
Cr2O3	|O
inhalation	|O
,	|O
FEV1.0	|O
had	|O
decreased	|O
by	|O
32%	|O
.	|O

This	|O
combined	|O
intravenous	|O
anaesthetic	|O
regimen	|O
gave	|O
good	|O
anaesthesia	|O
and	|O
analgesia	|O
to	|O
pigs	|O
for	|O
up	|O
to	|O
2	|O
h	|O
as	|O
monitored	|O
by	|O
clinical	|O
signs	|O
.	|O

Twenty	|O
food	|O
products	|O
were	|O
contaminated	|O
with	|O
V.	|O
cholerae	|O
O1	|O
,	|O
Ogawa	|O
,	|O
toxigenic	|O
and	|O
not	|O
toxigenic	|O
strains	|O
:	|O
yoghurt	|O
,	|O
cream	|O
cheese	|O
,	|O
apricot	|O
marmelade	|O
,	|O
hip	|O
rose	|O
marmelade	|O
,	|O
mayonnaise	|O
,	|O
italian	|O
pasta	|O
for	|O
"	|O
empanadas	|O
"	|O
,	|O
"	|O
dulce	|O
de	|O
leche	|O
"	|O
,	|O
meat	|O
sausage	|O
,	|O
meat	|O
and	|O
spinach	|O
ravioli	|O
,	|O
margarine	|O
,	|O
milk	|O
dessert	|O
(	|O
made	|O
with	|O
cocoa	|O
,	|O
milk	|O
confiture	|O
,	|O
starch	|O
and	|O
additives	|O
)	|O
,	|O
lettuce	|O
,	|O
tuna	|O
fish	|O
,	|O
ricotta	|O
and	|O
sterilized	|O
milk	|O
.	|O

It	|O
is	|O
impossible	|O
to	|O
define	|O
only	|O
one	|O
clinical	|O
outline	|O
because	|O
both	|O
symptomatic	|O
and	|O
asymptomatic	|O
infected	|O
NB	|O
may	|O
be	|O
found	|O
with	|O
gestational	|O
age	|O
at	|O
term	|O
and	|O
pre	|O
-	|O
term	|O
and	|O
when	|O
born	|O
with	|O
a	|O
weight	|O
above	|O
or	|O
below	|O
2000	|O
g	|O
.	|O

The	|O
expression	|O
of	|O
the	|O
pilin	|B-PROTEIN
gene	|O
,	|O
tcpA	|B-PROTEIN
,	|O
is	|O
dependent	|O
upon	|O
ToxR	|B-PROTEIN
and	|O
upon	|O
ToxT	|B-PROTEIN
.	|O

The	|O
chloramphenicol	|B-PROTEIN
-	|I-PROTEIN
resistance	|I-PROTEIN
transposon	|I-PROTEIN
Tn4451	|O
undergoes	|O
precise	|O
conjugative	|O
deletion	|O
from	|O
its	|O
parent	|O
plasmid	|O
plP401	|O
in	|O
Clostridium	|O
perfringens	|O
and	|O
precise	|O
spontaneous	|O
excision	|O
from	|O
multicopy	|O
plasmids	|O
in	|O
Escherichia	|O
coli	|O
.	|O

Ras	|B-PROTEIN
p21Val	|I-PROTEIN
inhibits	|O
myogenesis	|O
without	|O
altering	|O
the	|O
DNA	|O
binding	|O
or	|O
transcriptional	|O
activities	|O
of	|O
the	|O
myogenic	|O
basic	|B-PROTEIN
helix	|I-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
factors	|I-PROTEIN
.	|O

In	|O
cells	|O
limited	|O
for	|O
His	|O
,	|O
increased	|O
expression	|O
of	|O
arg	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
cpc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
decreased	|O
expression	|O
of	|O
cox	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
,	|O
also	|O
had	|O
translational	|O
and	|O
transcriptional	|O
components	|O
.	|O

The	|O
peptide	|O
sequences	|O
reveal	|O
that	|O
the	|O
factor	|O
consists	|O
of	|O
GABP	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
GABP	|B-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
with	|O
Ets	|B-PROTEIN
and	|O
Notch	|B-PROTEIN
motifs	|O
,	|O
respectively	|O
.	|O

Immunofluorescence	|O
microscopy	|O
and	|O
cell	|O
fractionation	|O
analyses	|O
showed	|O
that	|O
the	|O
110	|O
-	|O
kDa	|O
protein	|O
was	|O
exclusively	|O
nuclear	|O
,	|O
whereas	|O
the	|O
150	|O
-	|O
kDa	|O
protein	|O
was	|O
present	|O
in	|O
both	|O
the	|O
cytoplasm	|O
and	|O
nucleus	|O
of	|O
human	|O
cells	|O
.	|O

Expression	|O
and	|O
regulation	|O
by	|O
interferon	|B-PROTEIN
of	|O
a	|O
double	|O
-	|O
stranded	|O
-	|O
RNA	|O
-	|O
specific	|O
adenosine	|B-PROTEIN
deaminase	|I-PROTEIN
from	|O
human	|O
cells	|O
:	|O
evidence	|O
for	|O
two	|O
forms	|O
of	|O
the	|O
deaminase	|O
.	|O

T	|O
-	|O
cell	|O
hybridomas	|O
,	|O
thymocytes	|O
,	|O
and	|O
T	|O
cells	|O
can	|O
be	|O
induced	|O
to	|O
undergo	|O
apoptotic	|O
cell	|O
death	|O
by	|O
activation	|O
through	|O
the	|O
T	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

Deletions	|O
were	|O
examined	|O
in	|O
the	|O
LYS2	|B-PROTEIN
gene	|O
,	|O
using	|O
a	|O
set	|O
of	|O
31	|O
-	|O
to	|O
156	|O
-	|O
bp	|O
inserts	|O
that	|O
included	|O
inserts	|O
with	|O
no	|O
apparent	|O
potential	|O
for	|O
secondary	|O
structure	|O
as	|O
well	|O
as	|O
two	|O
quasipalindromes	|O
.	|O

Overexpression	|O
of	|O
SCS1	|B-PROTEIN
could	|O
not	|O
complement	|O
an	|O
HSP60	|B-PROTEIN
-	|O
null	|O
allele	|O
,	|O
indicating	|O
that	|O
suppression	|O
was	|O
not	|O
due	|O
to	|O
the	|O
bypassing	|O
of	|O
Hsp60	|B-PROTEIN
activity	|O
.	|O

The	|O
DNA	|O
binding	|O
domain	|O
of	|O
NirA	|B-PROTEIN
was	|O
expressed	|O
as	|O
a	|O
fusion	|O
protein	|O
with	|O
the	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
of	|O
Schistosoma	|O
japonicum	|O
.	|O

The	|O
kinase	|O
is	|O
essential	|O
in	|O
vivo	|O
for	|O
normal	|O
phosphorylation	|O
of	|O
the	|O
CTD	|O
and	|O
for	|O
normal	|O
growth	|O
and	|O
differentiation	|O
.	|O

A	|O
general	|O
model	|O
for	|O
ARE	|O
-	|O
mediated	|O
mRNA	|O
degradation	|O
involving	|O
a	|O
potential	|O
role	|O
for	|O
certain	|O
heterogeneous	|O
nuclear	|O
ribonucleoproteins	|O
and	|O
ARE	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
is	|O
proposed	|O
.	|O

Finally	|O
,	|O
we	|O
demonstrate	|O
that	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|I-PROTEIN
can	|O
also	|O
active	|O
the	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
promoter	|O
in	|O
nonmyeloid	|O
cells	|O
.	|O

Endocytosis	|O
and	|O
vacuolar	|O
degradation	|O
of	|O
the	|O
plasma	|O
membrane	|O
-	|O
localized	|O
Pdr5	|B-PROTEIN
ATP	|O
-	|O
binding	|O
cassette	|O
multidrug	|O
transporter	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Individual	|O
mutations	|O
in	|O
motifs	|O
III	|O
,	|O
IV	|O
,	|O
and	|O
V	|O
had	|O
distinctive	|O
effects	|O
on	|O
the	|O
affinity	|O
of	|O
enzyme	|O
for	|O
GTP	|O
,	|O
the	|O
rate	|O
of	|O
covalent	|O
catalysis	|O
(	|O
EpG	|O
formation	|O
)	|O
,	|O
or	|O
the	|O
transfer	|O
of	|O
GMP	|O
from	|O
enzyme	|O
to	|O
RNA	|O
.	|O

Mutational	|O
analysis	|O
of	|O
mRNA	|O
capping	|B-PROTEIN
enzyme	|I-PROTEIN
identifies	|O
amino	|O
acids	|O
involved	|O
in	|O
GTP	|O
binding	|O
,	|O
enzyme	|O
-	|O
guanylate	|O
formation	|O
,	|O
and	|O
GMP	|O
transfer	|O
to	|O
RNA	|O
.	|O

Disruption	|O
of	|O
the	|O
HOG1	|B-PROTEIN
and	|O
PBS2	|B-PROTEIN
genes	|O
leads	|O
to	|O
a	|O
dramatic	|O
decrease	|O
of	|O
the	|O
HSP12	|B-PROTEIN
inducibility	|O
in	|O
osmostressed	|O
cells	|O
,	|O
whereas	|O
overproduction	|O
of	|O
Hog1	|B-PROTEIN
produces	|O
a	|O
fivefold	|O
increase	|O
in	|O
wild	|O
-	|O
type	|O
induced	|O
levels	|O
upon	|O
a	|O
shift	|O
to	|O
a	|O
high	|O
salt	|O
concentration	|O
.	|O

Deletion	|O
or	|O
inactivation	|O
of	|O
CRY1	|B-PROTEIN
leads	|O
to	|O
5	|O
-	|O
to	|O
10	|O
-	|O
fold	|O
-	|O
increased	|O
levels	|O
of	|O
CRY2	|B-PROTEIN
mRNA	|O
.	|O

(	|O
1986	|O
)	|O
method	|O
of	|O
separation	|O
of	|O
Cryptosporidium	|O
spp	|O
.	|O
oocysts	|O
from	|O
feces	|O
by	|O
using	|O
a	|O
percoll	|O
discontinuous	|O
density	|O
gradient	|O
appeared	|O
a	|O
method	|O
of	|O
choice	|O
for	|O
obtaining	|O
large	|O
numbers	|O
of	|O
oocysts	|O
of	|O
C.	|O
parvum	|O
free	|O
of	|O
fecal	|O
contamination	|O
.	|O

Staphylococcal	|O
enterotoxin	|B-PROTEIN
A	|I-PROTEIN
involvement	|O
in	|O
the	|O
illness	|O
of	|O
a	|O
20	|O
-	|O
month	|O
-	|O
old	|O
burn	|O
patient	|O
.	|O

METHODS	|O
:	|O
We	|O
obtained	|O
maximal	|O
inspiratory	|O
and	|O
expiratory	|O
flow	|O
-	|O
volume	|O
curves	|O
in	|O
41	|O
unselected	|O
patients	|O
with	|O
essential	|O
tremor	|O
(	|O
14	|O
males	|O
,	|O
27	|O
females	|O
,	|O
age	|O
61.7	|O
+	|O
/	|O
-	|O
2.14	|O
years	|O
)	|O
.	|O

Our	|O
findings	|O
also	|O
provide	|O
the	|O
basis	|O
for	|O
the	|O
development	|O
of	|O
assays	|O
to	|O
screen	|O
for	|O
the	|O
ligands	|O
to	|O
testis	|B-PROTEIN
receptor	|I-PROTEIN
2	|I-PROTEIN
and	|O
hERR1	|B-PROTEIN
.	|O

Four	|O
p53	|B-PROTEIN
DNA	|O
-	|O
binding	|O
domain	|O
peptides	|O
bind	|O
natural	|O
p53	|B-PROTEIN
-	|O
response	|O
elements	|O
and	|O
bend	|O
the	|O
DNA	|O
.	|O

The	|O
Stat5b	|B-PROTEIN
mRNA	|O
has	|O
a	|O
size	|O
of	|O
5.6	|O
kb	|O
and	|O
encodes	|O
a	|O
protein	|O
of	|O
786	|O
amino	|O
acids	|O
.	|O

The	|O
hydropathy	|O
plot	|O
revealed	|O
a	|O
rather	|O
hydrophilic	|O
N	|O
-	|O
terminal	|O
region	|O
and	|O
the	|O
absence	|O
of	|O
a	|O
hydrophobic	|O
signal	|O
peptide	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
G	|B-PROTEIN
beta	|I-PROTEIN
gamma	|I-PROTEIN
-	|O
stimulated	|O
Shc	|B-PROTEIN
phosphorylation	|O
represents	|O
an	|O
early	|O
step	|O
in	|O
the	|O
pathway	|O
leading	|O
to	|O
p21ras	|B-PROTEIN
activation	|O
,	|O
similar	|O
to	|O
the	|O
mechanism	|O
utilized	|O
by	|O
growth	|B-PROTEIN
factor	|I-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

This	|O
report	|O
focused	|O
on	|O
the	|O
relationship	|O
between	|O
Type	|O
A	|O
behavior	|O
and	|O
eight	|O
basic	|O
emotion	|O
dimensions	|O
.	|O

All	|O
carcasses	|O
resulted	|O
in	|O
contamination	|O
with	|O
aerobic	|O
mesophilic	|O
bacteria	|O
in	|O
the	|O
range	|O
from	|O
6	|O
x	|O
10	|O
(	|O
3	|O
)	|O
to	|O
1.2	|O
x	|O
10	|O
(	|O
6	|O
)	|O
CFU	|O
/	|O
ml	|O
liquid	|O
washed	|O
,	|O
and	|O
94%	|O
them	|O
with	|O
sporulate	|O
bacteria	|O
,	|O
the	|O
threshold	|O
being	|O
under	|O
100	|O
CFU	|O
/	|O
ml	|O
(	|O
Figure	|O
1	|O
)	|O
.	|O

As	|O
for	|O
31	|O
stage	|O
I	|O
-	|O
II	|O
lung	|O
cancer	|O
patients	|O
,	|O
CR	|O
has	|O
been	|O
observed	|O
in	|O
82.8%	|O
of	|O
them	|O
and	|O
PR	|O
in	|O
13.8%	|O
;	|O
the	|O
response	|O
was	|O
always	|O
assessed	|O
with	|O
chest	|O
radiography	|O
,	|O
CT	|O
,	|O
FBS	|O
,	|O
cytology	|O
and	|O
/	|O
or	|O
histology	|O
.	|O

Pediatric	|O
medical	|O
emergencies	|O
in	|O
a	|O
regional	|O
hospital	|O
:	|O
appropriate	|O
locale	|O
?	|O

Protein	|O
electrophoresis	|O
showed	|O
decreased	|O
albumin	|B-PROTEIN
levels	|O
in	|O
both	|O
groups	|O
,	|O
with	|O
lower	|O
values	|O
in	|O
G2	|O
.	|O

METHODS	|O
:	|O
All	|O
these	|O
30	|O
non	|O
-	|O
responders	|O
received	|O
an	|O
extra	|O
dose	|O
of	|O
the	|O
same	|O
vaccine	|O
2	|O
months	|O
after	|O
primary	|O
immunization	|O
and	|O
a	|O
booster	|O
dose	|O
with	|O
a	|O
yeast	|O
-	|O
derived	|O
vaccine	|O
6	|O
years	|O
later	|O
.	|O

An	|O
abnormally	|O
high	|O
percentage	|O
of	|O
hypertensive	|O
patients	|O
(	|O
approximately	|O
30%	|O
)	|O
undergoing	|O
cardiac	|O
catheterization	|O
because	|O
of	|O
anginal	|O
pain	|O
and	|O
/	|O
or	|O
exercise	|O
-	|O
induced	|O
ST	|O
-	|O
segment	|O
depressions	|O
has	|O
angiographically	|O
normal	|O
coronary	|O
arteries	|O
.	|O

Negative	|O
-	|O
staining	|O
,	|O
refractile	|O
mycobacteria	|O
in	|O
Romanowsky	|O
-	|O
stained	|O
smears	|O
.	|O

Mibefradil	|O
(	|O
Ro	|O
40-5967	|O
)	|O
is	|O
a	|O
novel	|O
calcium	|O
antagonist	|O
from	|O
a	|O
new	|O
chemical	|O
class	|O
and	|O
is	|O
the	|O
first	|O
that	|O
selectively	|O
blocks	|O
the	|O
T	|O
-	|O
type	|O
calcium	|O
channel	|O
.	|O

However	|O
,	|O
2	|O
minimum	|O
alveolar	|O
concentration	|O
anesthesia	|O
did	|O
significantly	|O
decrease	|O
the	|O
calculated	|O
VE	|O
at	|O
a	|O
PCO2	|O
of	|O
60	|O
mmHg	|O
(	|O
from	|O
7.4	|O
+	|O
/	|O
-	|O
1.2	|O
to	|O
4.0	|O
+	|O
/	|O
-	|O
0.6	|O
l.m	|O
in	|O
-	|O
1	|O
)	|O
,	|O
indicating	|O
a	|O
rightward	|O
shift	|O
in	|O
the	|O
response	|O
relationship	|O
.	|O

cDNA	|O
encoding	|O
a	|O
functional	|O
feline	|O
liver	|O
/	|O
bone	|O
/	|O
kidney	|O
-	|O
type	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
.	|O

Protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
(	|O
PKC	|B-PROTEIN
)	|O
,	|O
a	|O
widely	|O
-	|O
distributed	|O
enzyme	|O
implicated	|O
in	|O
the	|O
regulation	|O
of	|O
many	|O
physiological	|O
processes	|O
,	|O
consists	|O
of	|O
a	|O
family	|O
of	|O
at	|O
least	|O
twelve	|O
isoenzymes	|O
which	|O
differ	|O
in	|O
tissue	|O
distribution	|O
,	|O
subcellular	|O
localization	|O
,	|O
regulatory	|O
properties	|O
,	|O
etc	|O
.	|O

This	|O
work	|O
,	|O
therefore	|O
,	|O
also	|O
emphasizes	|O
the	|O
importance	|O
of	|O
careful	|O
choice	|O
of	|O
oligonucleotide	|O
and	|O
cDNA	|O
probes	|O
to	|O
study	|O
PKC	|B-PROTEIN
zeta	|I-PROTEIN
mRNA	|O
.	|O

This	|O
action	|O
is	|O
dependent	|O
on	|O
helix	|B-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
factors	|I-PROTEIN
bound	|O
to	|O
the	|O
E1	|B-PROTEIN
element	|O
.	|O

The	|O
debate	|O
over	|O
electives	|O
-	|O
-	|O
1899	|O
.	|O

Polypeptide	|O
growth	|O
factors	|O
and	|O
cytokines	|O
mediate	|O
their	|O
biochemical	|O
functions	|O
through	|O
their	|O
responsive	|O
receptors	|O
.	|O

However	|O
,	|O
a	|O
strongly	|O
increased	|O
frequency	|O
of	|O
CpG	|O
dinucleotides	|O
was	|O
found	|O
.	|O

Here	|O
we	|O
focused	|O
on	|O
the	|O
role	|O
of	|O
the	|O
5'	|O
proximal	|O
regulatory	|O
cassette	|O
(	|O
-	|O
190	|O
;	|O
+	|O
53	|O
bp	|O
)	|O
of	|O
the	|O
rat	|B-PROTEIN
enkephalin	|I-PROTEIN
(	|O
rENK	|B-PROTEIN
)	|O
gene	|O
in	|O
the	|O
developmental	|O
regulation	|O
of	|O
the	|O
enkephalin	|B-PROTEIN
phenotype	|O
.	|O

Unexpectedly	|O
,	|O
all	|O
ENK	|B-PROTEIN
-	|O
specific	|O
motifs	|O
formed	|O
specific	|O
and	|O
highly	|O
abundant	|O
protein	|O
-	|O
DNA	|O
complexes	|O
when	|O
nuclear	|O
extracts	|O
from	|O
the	|O
human	|O
tumor	|O
cell	|O
line	|O
(	|O
HeLa	|O
)	|O
,	|O
which	|O
does	|O
not	|O
express	|O
ENK	|B-PROTEIN
,	|O
were	|O
used	|O
.	|O

Infant	|O
aged	|O
3.5	|O
years	|O
presents	|O
persistence	|O
of	|O
primordial	|O
vitreous	|O
body	|O
with	|O
crystalline	|O
dislocation	|O
in	|O
the	|O
camera	|O
aquosa	|O
and	|O
secondary	|O
buphthalmos	|O
of	|O
the	|O
left	|O
eye	|O
and	|O
microphthalmos	|O
with	|O
dislocation	|O
of	|O
the	|O
crystalline	|O
in	|O
the	|O
vitreous	|O
body	|O
of	|O
the	|O
right	|O
eye	|O
.	|O

During	|O
the	|O
dose	|O
-	|O
finding	|O
,	|O
two	|O
patients	|O
were	|O
temporarily	|O
withdrawn	|O
from	|O
medication	|O
and	|O
one	|O
patient	|O
was	|O
excluded	|O
because	|O
of	|O
elevated	|O
levels	|O
of	|O
liver	|O
enzymes	|O
.	|O

In	|O
comparison	|O
of	|O
cDNA	|O
and	|O
genomic	|O
sequences	|O
four	|O
RNA	|O
editing	|O
events	|O
were	|O
found	|O
in	|O
both	|O
atp9	|B-PROTEIN
genes	|O
.	|O

MZF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
represses	|O
CAT	|B-PROTEIN
reporter	|O
gene	|O
expression	|O
via	|O
GAL4	|B-PROTEIN
binding	|O
sites	|O
in	|O
the	|O
nonhematopoietic	|O
cell	|O
lines	|O
NIH	|O
3T3	|O
and	|O
293	|O
.	|O

As	|O
with	|O
the	|O
heterologous	|O
DNA	|O
binding	|O
domain	|O
,	|O
MZF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
represses	|O
reporter	|O
gene	|O
expression	|O
in	|O
nonhematopoietic	|O
cell	|O
lines	|O
and	|O
activates	|O
expression	|O
in	|O
hematopoietic	|O
cell	|O
lines	|O
.	|O

Analyses	|O
of	|O
hGMR	|B-PROTEIN
beta	|I-PROTEIN
subunit	|I-PROTEIN
mutants	|O
revealed	|O
two	|O
cytoplasmic	|O
regions	|O
involved	|O
in	|O
activation	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
promoter	|O
,	|O
one	|O
is	|O
essential	|O
and	|O
the	|O
other	|O
is	|O
dispensable	|O
but	|O
enhances	|O
the	|O
activity	|O
.	|O

Similarly	|O
,	|O
we	|O
observed	|O
synthetic	|O
phenotypes	|O
between	|O
mutations	|O
in	|O
MIF2	|B-PROTEIN
and	|O
trans	|O
-	|O
acting	|O
mutations	|O
in	|O
three	|O
known	|O
yeast	|O
centromere	|O
protein	|O
genes	|O
-	|O
CEP1	|B-PROTEIN
/	|O
CBF1	|B-PROTEIN
/	|O
CPF1	|B-PROTEIN
,	|O
NDC10	|B-PROTEIN
/	|O
CBF2	|B-PROTEIN
,	|O
and	|O
CEP3	|B-PROTEIN
/	|O
CBF3B	|B-PROTEIN
.	|O

Taken	|O
together	|O
,	|O
these	|O
data	|O
suggest	|O
that	|O
the	|O
Mif2	|B-PROTEIN
protein	|O
interacts	|O
with	|O
Cep1p	|B-PROTEIN
at	|O
the	|O
centromere	|O
and	|O
that	|O
the	|O
yeast	|O
centromere	|O
indeed	|O
exists	|O
as	|O
a	|O
higher	|O
order	|O
protein	|O
-	|O
DNA	|O
complex	|O
.	|O

To	|O
accomplish	|O
this	|O
,	|O
actin	|B-PROTEIN
cables	|O
and	|O
patches	|O
are	|O
redistributed	|O
during	|O
the	|O
cell	|O
cycle	|O
to	|O
direct	|O
secretory	|O
components	|O
to	|O
appropriate	|O
sites	|O
for	|O
cell	|O
growth	|O
.	|O

The	|O
effects	|O
of	|O
Codonopsis	|O
pilosula	|O
oral	|O
liquor	|O
(	|O
CPOL	|O
)	|O
on	|O
tissue	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
t	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
)	|O
and	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
inhibitor	|I-PROTEIN
(	|O
PAI	|B-PROTEIN
)	|O
in	|O
the	|O
plasma	|O
of	|O
25	|O
patients	|O
of	|O
coronary	|O
heart	|O
disease	|O
with	|O
blood	|O
stasis	|O
were	|O
studied	|O
.	|O

Estimated	|O
daily	|O
intakes	|O
(	|O
EDIs	|O
)	|O
per	|O
person	|O
were	|O
0.56	|O
microgram	|O
for	|O
total	|O
HCH	|O
,	|O
0.20	|O
microgram	|O
for	|O
gamma	|O
-	|O
HCH	|O
,	|O
0.09	|O
microgram	|O
for	|O
dieldrin	|O
,	|O
1.42	|O
micrograms	|O
for	|O
total	|O
DDT	|O
,	|O
and	|O
0.15	|O
microgram	|O
for	|O
HCB	|O
.	|O

Imaging	|O
features	|O
of	|O
splenic	|O
epidermoid	|O
cyst	|O
with	|O
pathologic	|O
correlation	|O
.	|O

In	|O
two	|O
further	|O
cases	|O
(	|O
one	|O
type	|O
I	|O
and	|O
one	|O
type	|O
III	|O
SMA	|O
)	|O
,	|O
de	|O
novo	|O
deletions	|O
of	|O
only	|O
one	|O
copy	|O
of	|O
Ag1	|B-PROTEIN
-	|I-PROTEIN
CA	|I-PROTEIN
and	|O
C212	|B-PROTEIN
were	|O
found	|O
.	|O

With	|O
each	|O
of	|O
the	|O
three	|O
pairs	|O
of	|O
isolates	|O
(	|O
case	|O
and	|O
suspicious	|O
case	|O
)	|O
,	|O
identical	|O
IS6110	|O
banding	|O
patterns	|O
were	|O
found	|O
suggesting	|O
identical	|O
MTB	|O
strains	|O
.	|O

HRES	|O
has	|O
been	|O
found	|O
to	|O
be	|O
clinically	|O
useful	|O
in	|O
assessing	|O
histologic	|O
damage	|O
following	|O
pneumatic	|O
dilatation	|O
and	|O
in	|O
localizing	|O
the	|O
LES	|O
during	|O
the	|O
administration	|O
of	|O
intrasphincter	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
injection	|O
in	|O
the	|O
treatment	|O
of	|O
achalasia	|O
.	|O

These	|O
early	|O
structural	|O
processes	|O
are	|O
assumed	|O
to	|O
be	|O
subserved	|O
by	|O
the	|O
anterior	|O
parts	|O
of	|O
the	|O
left	|O
hemisphere	|O
,	|O
as	|O
event	|O
-	|O
related	|O
brain	|O
potentials	|O
show	|O
this	|O
area	|O
to	|O
be	|O
maximally	|O
activated	|O
when	|O
phrase	|O
structure	|O
violations	|O
are	|O
processed	|O
and	|O
as	|O
circumscribed	|O
lesions	|O
in	|O
this	|O
area	|O
lead	|O
to	|O
an	|O
impairment	|O
of	|O
the	|O
on	|O
-	|O
line	|O
structural	|O
assignment	|O
.	|O

In	|O
men	|O
with	|O
BMI	|O
<	|O
30	|O
,	|O
the	|O
OR	|O
was	|O
1.83	|O
for	|O
postprandial	|O
TG	|O
(	|O
P	|O
=	|O
.041	|O
)	|O
and	|O
2.77	|O
for	|O
postprandial	|O
RP	|O
(	|O
P	|O
=	|O
.032	|O
)	|O
in	|O
models	|O
that	|O
included	|O
fasting	|O
TG	|O
,	|O
LDL	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
,	|O
and	|O
hypertension	|O
.	|O

SL1	|B-PROTEIN
trans	|O
-	|O
splicing	|O
specified	|O
by	|O
AU	|O
-	|O
rich	|O
synthetic	|O
RNA	|O
inserted	|O
at	|O
the	|O
5'	|O
end	|O
of	|O
Caenorhabditis	|O
elegans	|O
pre	|O
-	|O
mRNA	|O
.	|O

A	|O
pyrazolo	|O
-	|O
quinoline	|O
compound	|O
,	|O
6	|O
-	|O
methoxy	|O
-	|O
4	|O
-	|O
[	|O
2	|O
-	|O
[	|O
(	|O
2	|O
-	|O
hydroxyethoxyl	|O
)	|O
-	|O
ethyl	|O
]	|O
amino	|O
]	|O
-	|O
3	|O
-	|O
methyl	|O
-	|O
1M	|O
-	|O
pyrazo	|O
lo	|O
[	|O
3,4	|O
-	|O
b	|O
]	|O
quinoline	|O
(	|O
SCH	|O
51344	|O
)	|O
,	|O
was	|O
identified	|O
based	|O
on	|O
its	|O
ability	|O
to	|O
derepress	|O
human	|O
smooth	|O
muscle	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
promoter	|O
activity	|O
in	|O
ras	|B-PROTEIN
-	|O
transformed	|O
cells	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
these	|O
relations	|O
,	|O
a	|O
risk	|O
factor	|O
-	|O
selection	|O
scale	|O
(	|O
RFSS	|O
)	|O
(	|O
range	|O
,	|O
0	|O
to	|O
10	|O
)	|O
was	|O
developed	|O
by	|O
computing	|O
appropriate	|O
weights	|O
for	|O
each	|O
risk	|O
factor	|O
.	|O

The	|O
Caenorhabditis	|O
elegans	|O
death	|B-PROTEIN
susceptibility	|I-PROTEIN
gene	|I-PROTEIN
,	|O
ced	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
has	|O
a	|O
number	|O
of	|O
homologs	|O
in	|O
vertebrate	|O
species	|O
,	|O
including	|O
interleukin	|O
-	|O
1	|O
beta	|O
(	|B-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
(	|O
ICE	|B-PROTEIN
)	|O
,	|O
Ich	|B-PROTEIN
-	|I-PROTEIN
1long	|I-PROTEIN
,	|O
and	|O
CPP32	|B-PROTEIN
.	|O

Repression	|O
of	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
-	|O
mediated	|O
transcriptional	|O
activation	|O
by	|O
unliganded	|O
thyroid	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
TR	|B-PROTEIN
)	|O
is	|O
TR	|B-PROTEIN
isoform	|O
-	|O
specific	|O
.	|O

The	|O
results	|O
indicate	|O
considerable	|O
flexibility	|O
in	|O
the	|O
spacing	|O
between	|O
DH	|B-PROTEIN
regulatory	|O
sites	|O
.	|O

Obstruction	|O
of	|O
the	|O
ERF	|B-PROTEIN
repressor	|O
function	|O
by	|O
the	|O
transactivating	|O
members	|O
of	|O
the	|O
ets	|B-PROTEIN
family	|O
of	|O
genes	|O
(	|O
i.e.g	|O
ag	|O
-	|O
myb	|B-PROTEIN
-	|O
ets	|B-PROTEIN
)	|O
may	|O
be	|O
essential	|O
for	|O
the	|O
control	|O
of	|O
genes	|O
involved	|O
in	|O
cell	|O
proliferation	|O
and	|O
may	|O
also	|O
underlie	|O
their	|O
tumorigenic	|O
effects	|O
.	|O

Overexpression	|O
of	|O
wild	|O
-	|O
type	|O
p53	|B-PROTEIN
also	|O
induces	|O
apoptosis	|O
in	|O
an	|O
LCL	|O
.	|O

We	|O
show	|O
that	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
(	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
protooncogene	|O
product	|O
)	|O
,	|O
which	|O
is	|O
an	|O
intrinsically	|O
unstable	|O
nuclear	|O
protein	|O
,	|O
is	|O
metabolically	|O
highly	|O
stabilized	|O
,	|O
and	|O
greatly	|O
enhances	|O
the	|O
transforming	|O
efficiency	|O
of	|O
NIH	|O
3T3	|O
cells	|O
,	|O
by	|O
Mos	|B-PROTEIN
.	|O

Cloning	|O
,	|O
sequencing	|O
and	|O
expression	|O
of	|O
the	|O
3	|B-PROTEIN
-	|I-PROTEIN
phosphoglycerate	|I-PROTEIN
kinase	|I-PROTEIN
gene	|O
of	|O
Pyrococcus	|O
woesei	|O
in	|O
Escherichia	|O
coli	|O
and	|O
characterization	|O
of	|O
the	|O
protein	|O
.	|O

These	|O
observations	|O
lead	|O
to	|O
the	|O
proposal	|O
that	|O
the	|O
RNAP	|B-PROTEIN
II	|I-PROTEIN
CTD	|O
might	|O
be	|O
an	|O
in	|O
vivo	|O
target	|O
for	|O
the	|O
activated	|O
p42mapk	|B-PROTEIN
and	|O
p44mapk	|B-PROTEIN
MAP	|O
kinases	|O
.	|O

We	|O
also	|O
isolated	|O
two	|O
alternatively	|O
spliced	|O
forms	|O
of	|O
human	|O
CD6	|B-PROTEIN
cDNA	|O
lacking	|O
sequences	|O
encoding	|O
membrane	|O
-	|O
proximal	|O
regions	|O
of	|O
the	|O
cytoplasmic	|O
domain	|O
which	|O
maintain	|O
the	|O
same	|O
reading	|O
frame	|O
as	|O
CD6	|B-PROTEIN
-	|O
PB1	|B-PROTEIN
.	|O

We	|O
sought	|O
to	|O
determine	|O
whether	|O
such	|O
differences	|O
in	|O
polyadenylation	|O
affect	|O
the	|O
steady	|O
-	|O
state	|O
levels	|O
of	|O
DHFR	|B-PROTEIN
and	|O
mRNAs	|O
expressed	|O
from	|O
either	|O
allele	|O
and	|O
,	|O
in	|O
a	|O
more	|O
general	|O
sense	|O
,	|O
to	|O
ask	|O
whether	|O
differences	|O
in	|O
3'	|O
end	|O
RNA	|O
processing	|O
in	|O
a	|O
gene	|O
containing	|O
multiple	|O
poly	|O
(	|O
A	|O
)	|O
sites	|O
affects	|O
the	|O
final	|O
level	|O
of	|O
gene	|O
expression	|O
.	|O

We	|O
have	|O
isolated	|O
a	|O
Drosophila	|O
melanogaster	|O
(	|O
Dm	|O
)	|O
cDNA	|O
encoding	|O
a	|O
polypeptide	|O
that	|O
has	|O
extensive	|O
sequence	|O
similarity	|O
to	|O
the	|O
mammalian	|O
MAPKAPK	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

A	|O
2.4	|O
-	|O
kb	|O
MAPKAPK	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
message	|O
is	|O
expressed	|O
throughout	|O
development	|O
,	|O
while	|O
two	|O
shorter	|O
transcripts	|O
of	|O
2.3	|O
and	|O
1.8	|O
kb	|O
appear	|O
to	|O
be	|O
specifically	|O
expressed	|O
in	|O
the	|O
germline	|O
.	|O

The	|O
finding	|O
that	|O
the	|O
chimeric	|O
TdT	|B-PROTEIN
::	|O
Pol	|B-PROTEIN
beta	|I-PROTEIN
protein	|O
possessed	|O
significant	|O
template	|O
-	|O
dependent	|O
polymerase	|O
activity	|O
suggests	|O
that	|O
aa	|O
1-60	|O
of	|O
Pol	|B-PROTEIN
beta	|I-PROTEIN
are	|O
involved	|O
in	|O
template	|O
utilization	|O
during	|O
the	|O
polymerization	|O
reaction	|O
,	|O
as	|O
suggested	|O
by	|O
the	|O
previous	|O
finding	|O
that	|O
the	|O
8	|O
-	|O
kDa	|O
N	|O
-	|O
terminal	|O
domain	|O
of	|O
Pol	|B-PROTEIN
beta	|I-PROTEIN
possesses	|O
ssDNA	|O
-	|O
binding	|O
activity	|O
[	|O
Kumar	|O
et	|O
al.	|O
,	|O
J.	|O

The	|O
average	|O
values	|O
were	|O
199	|O
and	|O
424	|O
revertants	|O
/	|O
g	|O
for	|O
the	|O
hamburgers	|O
and	|O
hot	|O
dogs	|O
,	|O
respectively	|O
.	|O

Cholangiography	|O
was	|O
performed	|O
in	|O
all	|O
cases	|O
and	|O
classified	|O
by	|O
a	|O
scoring	|O
system	|O
specifically	|O
developed	|O
for	|O
pediatric	|O
patients	|O
.	|O

The	|O
integrity	|O
of	|O
the	|O
cDNA	|O
sequence	|O
was	|O
confirmed	|O
by	|O
analysis	|O
of	|O
several	|O
overlapping	|O
genomic	|O
clones	|O
that	|O
span	|O
the	|O
GAR1	|B-PROTEIN
gene	|O
.	|O

In	|O
Trial	|O
1	|O
,	|O
eight	|O
sows	|O
were	|O
allowed	|O
to	|O
farrow	|O
naturally	|O
(	|O
d	|O
114	|O
,	|O
NF	|O
sows	|O
)	|O
and	|O
eight	|O
sows	|O
were	|O
induced	|O
to	|O
farrow	|O
(	|O
IF	|O
sows	|O
)	|O
prematurely	|O
by	|O
injection	|O
of	|O
prostaglandin	|O
F2	|O
alpha	|O
on	|O
d	|O
112	|O
of	|O
gestation	|O
.	|O

End	|O
-	|O
tidal	|O
PO2	|O
and	|O
the	|O
ratio	|O
of	|O
minute	|O
ventilation	|O
to	|O
oxygen	|O
consumption	|O
(	|O
VE	|O
/	|O
VO2	|O
)	|O
were	|O
lower	|O
while	|O
PETCO2	|O
was	|O
higher	|O
for	|O
Hyp	|O
(	|O
P	|O
<	|O
or	|O
=	|O
0.01	|O
)	|O
.	|O

These	|O
results	|O
suggested	|O
that	|O
NfxB	|B-PROTEIN
negatively	|O
autoregulates	|O
the	|O
expression	|O
of	|O
nfxB	|B-PROTEIN
itself	|O
.	|O

A511	|O
is	|O
a	|O
broad	|O
-	|O
host	|O
-	|O
range	|O
,	|O
virulent	|O
myovirus	|O
for	|O
Listeria	|O
monocytogenes	|O
.	|O

The	|O
mechanism	|O
of	|O
peroxisome	|O
proliferation	|O
is	|O
poorly	|O
understood	|O
.	|O

If	|O
NCR	|O
-	|O
sensitive	|O
gene	|O
expression	|O
occurs	|O
exclusively	|O
by	|O
this	|O
pathway	|O
,	|O
as	|O
has	|O
been	|O
thought	|O
to	|O
be	|O
the	|O
case	|O
,	|O
then	|O
the	|O
NCR	|O
sensitivity	|O
of	|O
a	|O
gene	|O
's	|O
expression	|O
should	|O
be	|O
abolished	|O
by	|O
a	|O
ure2	|B-PROTEIN
delta	|O
mutation	|O
.	|O

The	|O
single	|O
-	|O
stranded	|O
DNA	|O
Pur	|B-PROTEIN
alpha	|I-PROTEIN
recognition	|O
element	|O
disrupts	|O
these	|O
complexes	|O
.	|O

Association	|O
of	|O
human	|O
Pur	|B-PROTEIN
alpha	|I-PROTEIN
with	|O
the	|O
retinoblastoma	|B-PROTEIN
protein	|I-PROTEIN
,	|O
Rb	|B-PROTEIN
,	|O
regulates	|O
binding	|O
to	|O
the	|O
single	|O
-	|O
stranded	|O
DNA	|O
Pur	|B-PROTEIN
alpha	|I-PROTEIN
recognition	|O
element	|O
.	|O

The	|O
insulin	|B-PROTEIN
-	|O
induced	|O
DNA	|O
-	|O
binding	|O
complex	|O
was	|O
identified	|O
as	|O
the	|O
p50	|B-PROTEIN
/	|O
p65	|B-PROTEIN
heterodimer	|O
.	|O

Using	|O
varying	|O
conditions	|O
,	|O
three	|O
distinct	|O
complexes	|O
were	|O
shown	|O
to	|O
interact	|O
specifically	|O
with	|O
the	|O
NIP	|B-PROTEIN
region	|O
,	|O
although	|O
only	|O
one	|O
correlates	|O
with	|O
repressor	|O
activity	|O
.	|O

Exchange	|O
of	|O
the	|O
LPL	|B-PROTEIN
and	|O
HL	|B-PROTEIN
lids	|O
resulted	|O
in	|O
a	|O
reversal	|O
of	|O
the	|O
phospholipase	|B-PROTEIN
/	|O
neutral	|O
lipase	|B-PROTEIN
ratio	|O
,	|O
establishing	|O
the	|O
important	|O
role	|O
of	|O
this	|O
region	|O
in	|O
mediating	|O
substrate	|O
specificity	|O
.	|O

The	|O
interferon	|B-PROTEIN
-	|O
inducible	|O
protein	|O
kinase	|O
PKR	|B-PROTEIN
modulates	|O
the	|O
transcriptional	|O
activation	|O
of	|O
immunoglobulin	|B-PROTEIN
kappa	|I-PROTEIN
gene	|O
.	|O

Truncated	|O
forms	|O
of	|O
a	|O
novel	|O
yeast	|O
protein	|O
suppress	|O
the	|O
lethality	|O
of	|O
a	|O
G	|B-PROTEIN
protein	|I-PROTEIN
alpha	|O
subunit	|O
deficiency	|O
by	|O
interacting	|O
with	|O
the	|O
beta	|O
subunit	|O
.	|O

Another	|O
common	|O
mutation	|O
involved	|O
amino	|O
acids	|O
that	|O
are	|O
thought	|O
to	|O
make	|O
specific	|O
contacts	|O
with	|O
DNA	|O
.	|O

Phorbol	|O
esters	|O
stimulated	|O
phosphorylation	|O
of	|O
CSK	|B-PROTEIN
35H	|I-PROTEIN
proteins	|O
,	|O
thus	|O
emphasizing	|O
that	|O
sequences	|O
isolated	|O
according	|O
to	|O
PKC	|B-PROTEIN
binding	|O
activity	|O
in	|O
vitro	|O
are	|O
also	|O
PKC	|B-PROTEIN
substrates	|O
in	|O
vivo	|O
.	|O

Levels	|O
of	|O
TSG	|B-PROTEIN
-	|I-PROTEIN
14	|I-PROTEIN
protein	|O
(	|O
also	|O
termed	|O
PTX	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
become	|O
elevated	|O
in	|O
the	|O
serum	|O
of	|O
mice	|O
and	|O
humans	|O
after	|O
injection	|O
with	|O
bacterial	|O
lipopolysaccharide	|O
,	|O
but	|O
in	|O
contrast	|O
to	|O
conventional	|O
acute	|O
phase	|O
proteins	|O
,	|O
the	|O
bulk	|O
of	|O
TSG	|B-PROTEIN
-	|I-PROTEIN
14	|I-PROTEIN
synthesis	|O
in	|O
the	|O
intact	|O
organism	|O
occurs	|O
outside	|O
the	|O
liver	|O
.	|O

The	|O
mouse	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
syntrophin	|I-PROTEIN
gene	|O
(	|O
>	|O
33	|O
kilobases	|O
)	|O
contains	|O
seven	|O
exons	|O
,	|O
all	|O
of	|O
which	|O
have	|O
homologues	|O
at	|O
the	|O
corresponding	|O
position	|O
in	|O
the	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
syntrophin	|I-PROTEIN
gene	|O
.	|O

Altogether	|O
our	|O
data	|O
indicate	|O
that	|O
PEDF	|B-PROTEIN
belongs	|O
to	|O
the	|O
subgroup	|O
of	|O
noninhibitory	|O
serpins	|B-PROTEIN
and	|O
that	|O
its	|O
N	|O
-	|O
terminal	|O
region	|O
confers	|O
a	|O
neurite	|O
-	|O
promoting	|O
activity	|O
to	|O
the	|O
protein	|O
.	|O

We	|O
report	|O
here	|O
the	|O
cloning	|O
of	|O
the	|O
murine	|O
p44	|B-PROTEIN
MAP	|O
kinase	|O
(	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
1	|I-PROTEIN
)	|O
gene	|O
,	|O
the	|O
determination	|O
of	|O
its	|O
intron	|O
/	|O
exon	|O
boundaries	|O
,	|O
and	|O
the	|O
characterization	|O
of	|O
its	|O
promoter	|O
.	|O

It	|O
contains	|O
three	|O
putative	|O
TATA	|O
boxes	|O
far	|O
upstream	|O
of	|O
the	|O
main	|O
start	|O
sites	|O
region	|O
,	|O
one	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
box	|O
,	|O
one	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
box	|O
,	|O
one	|O
Malt	|B-PROTEIN
box	|O
,	|O
one	|O
GAGA	|O
box	|O
,	|O
one	|O
half	|O
serum	|O
-	|O
responsive	|O
element	|O
,	|O
and	|O
putative	|O
binding	|O
sites	|O
for	|O
Sp1	|B-PROTEIN
(	|O
five	|O
)	|O
,	|O
GC	|B-PROTEIN
-	|I-PROTEIN
rich	|I-PROTEIN
binding	|I-PROTEIN
factor	|I-PROTEIN
(	|O
five	|O
)	|O
,	|O
CTF	|B-PROTEIN
-	|I-PROTEIN
NF1	|I-PROTEIN
(	|O
one	|O
)	|O
,	|O
Myb	|B-PROTEIN
(	|O
one	|O
)	|O
,	|O
p53	|B-PROTEIN
(	|O
two	|O
)	|O
,	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
one	|O
)	|O
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
(	|O
two	|O
)	|O
,	|O
MyoD	|B-PROTEIN
(	|O
two	|O
)	|O
,	|O
Zeste	|B-PROTEIN
(	|O
one	|O
)	|O
,	|O
and	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
(	|O
one	|O
)	|O
.	|O

One	|O
of	|O
these	|O
is	|O
surrounded	|O
by	|O
an	|O
adenine	|O
-	|O
uridine	|O
rich	|O
region	|O
that	|O
can	|O
form	|O
an	|O
11	|O
-	|O
base	|O
pair	|O
stem	|O
structure	|O
.	|O

We	|O
conclude	|O
that	|O
this	|O
new	|O
measurement	|O
technique	|O
provides	|O
an	|O
easy	|O
and	|O
accurate	|O
P0.1	|O
measurement	|O
using	|O
standard	|O
respiratory	|O
equipment	|O
when	|O
tested	|O
in	|O
a	|O
lung	|O
model	|O
.	|O

Effects	|O
of	|O
verapamil	|O
and	|O
propranolol	|O
on	|O
early	|O
afterdepolarizations	|O
and	|O
ventricular	|O
arrhythmias	|O
induced	|O
by	|O
epinephrine	|O
in	|O
congenital	|O
long	|O
QT	|O
syndrome	|O
.	|O

Deletion	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
beta	|I-PROTEIN
leucine	|O
zipper	|O
domain	|O
also	|O
greatly	|O
diminished	|O
the	|O
interaction	|O
between	|O
these	|O
two	|O
proteins	|O
.	|O

After	|O
cells	|O
were	|O
stably	|O
transfected	|O
with	|O
CIITA	|B-PROTEIN
,	|O
endogenous	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
II	|I-PROTEIN
genes	|O
were	|O
constitutively	|O
expressed	|O
,	|O
and	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
II	|I-PROTEIN
promoters	|O
,	|O
delivered	|O
by	|O
transfection	|O
,	|O
were	|O
actively	|O
transcribed	|O
in	|O
CIITA	|B-PROTEIN
-	|O
expressing	|O
cells	|O
.	|O

Two	|O
domains	|O
of	|O
EBNA2	|B-PROTEIN
defined	|O
by	|O
deletion	|O
of	|O
amino	|O
acids	|O
247-337	|O
and	|O
437-476	|O
were	|O
found	|O
to	|O
be	|O
important	|O
for	|O
the	|O
activation	|O
of	|O
both	|O
promoters	|O
,	|O
while	|O
two	|O
different	|O
domains	|O
corresponding	|O
to	|O
residues	|O
4-18	|O
and	|O
118-198	|O
were	|O
required	|O
solely	|O
for	|O
the	|O
LMP1	|B-PROTEIN
promoter	|O
.	|O

The	|O
peak	|O
velocities	|O
of	|O
the	|O
atrial	|O
systolic	|O
waves	|O
of	|O
the	|O
transmitral	|O
and	|O
pulmonary	|O
venous	|O
flow	|O
velocities	|O
(	|O
A	|O
and	|O
PVA	|O
,	|O
respectively	|O
)	|O
and	|O
first	|O
systolic	|O
wave	|O
(	|O
PVS1	|O
)	|O
of	|O
pulmonary	|O
venous	|O
flow	|O
,	|O
durations	|O
of	|O
both	|O
atrial	|O
systolic	|O
waves	|O
,	|O
and	|O
amplitude	|O
of	|O
interatrial	|O
septal	|O
motion	|O
during	|O
atrial	|O
systole	|O
increased	|O
significantly	|O
ten	|O
days	|O
after	|O
cardioversion	|O
compared	|O
with	|O
those	|O
measured	|O
within	|O
a	|O
day	|O
of	|O
cardioversion	|O
in	|O
all	|O
patients	|O
except	|O
the	|O
5	|O
patients	|O
with	|O
dilated	|O
cardiomyopathy	|O
.	|O

Additionally	|O
,	|O
the	|O
enzyme	|O
shows	|O
activity	|O
towards	|O
triglycerides	|O
such	|O
as	|O
olive	|O
oil	|O
and	|O
tributyrin	|O
and	|O
towards	|O
egg	|O
-	|O
yolk	|O
emulsions	|O
.	|O

The	|O
nucleotide	|O
sequence	|O
directly	|O
upstream	|O
of	|O
fimA	|B-PROTEIN
contains	|O
two	|O
open	|O
reading	|O
frames	|O
,	|O
ORF5	|O
and	|O
ORF1	|O
,	|O
whose	|O
deduced	|O
protein	|O
products	|O
are	|O
homologous	|O
to	|O
members	|O
of	|O
a	|O
superfamily	|O
of	|O
ATP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
cassette	|I-PROTEIN
membrane	|O
transport	|O
proteins	|O
,	|O
including	|O
both	|O
prokaryotic	|O
and	|O
eukaryotic	|O
uptake	|O
and	|O
export	|O
systems	|O
.	|O

The	|O
ORF3	|O
probe	|O
also	|O
hybridized	|O
to	|O
a	|O
540	|O
bp	|O
transcript	|O
consistent	|O
with	|O
the	|O
size	|O
of	|O
ORF3	|O
alone	|O
and	|O
supportive	|O
of	|O
the	|O
mutagenesis	|O
data	|O
of	|O
non	|O
-	|O
linkage	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
low	|O
concentrations	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
may	|O
be	|O
useful	|O
for	|O
nonsurgical	|O
treatment	|O
of	|O
human	|O
vitreous	|O
hemorrhage	|O
.	|O

We	|O
conclude	|O
that	|O
pancreatic	|O
polypeptide	|O
and	|O
motilin	|B-PROTEIN
responses	|O
to	|O
a	|O
meal	|O
are	|O
different	|O
in	|O
encopretic	|O
children	|O
than	|O
in	|O
children	|O
in	|O
the	|O
control	|O
group	|O
.	|O

Here	|O
we	|O
report	|O
the	|O
cloning	|O
,	|O
expression	|O
,	|O
and	|O
biochemical	|O
characterization	|O
of	|O
the	|O
32	|O
-	|O
kDa	|O
subunit	|O
of	|O
human	|O
(	|O
h	|O
)	|O
TFIID	|B-PROTEIN
,	|O
termed	|O
hTAFII32	|B-PROTEIN
.	|O

Hemolytic	|O
jaundice	|O
due	|O
to	|O
G6PD	|B-PROTEIN
deficiency	|O
causing	|O
kernicterus	|O
in	|O
a	|O
female	|O
newborn	|O
.	|O

Two	|O
transcripts	|O
of	|O
1.6	|O
kb	|O
and	|O
5.8	|O
kb	|O
are	|O
5'	|O
coterminal	|O
and	|O
may	|O
both	|O
encode	|O
the	|O
novel	|O
glycoprotein	|O
gene	|O
EUS4	|B-PROTEIN
.	|O

Mean	|O
growth	|O
changes	|O
in	|O
this	|O
Class	|O
II	|O
sample	|O
were	|O
comparable	|O
to	|O
those	|O
previously	|O
reported	|O
for	|O
male	|O
subjects	|O
with	|O
Class	|O
I	|O
malocclusions	|O
over	|O
the	|O
same	|O
age	|O
period	|O
,	|O
suggesting	|O
a	|O
similarity	|O
in	|O
postpubertal	|O
development	|O
between	|O
these	|O
two	|O
groups	|O
.	|O

However	|O
,	|O
the	|O
few	|O
studies	|O
that	|O
address	|O
antimicrobial	|O
prophylaxis	|O
in	|O
bone	|O
marrow	|O
transplantation	|O
have	|O
not	|O
always	|O
shown	|O
a	|O
survival	|O
benefit	|O
.	|O

The	|O
fracture	|O
groups	|O
were	|O
significantly	|O
older	|O
and	|O
had	|O
more	|O
years	|O
since	|O
menopause	|O
than	|O
the	|O
control	|O
groups	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
found	|O
differences	|O
in	|O
the	|O
binding	|O
of	|O
nuclear	|O
factors	|O
from	|O
shoots	|O
versus	|O
from	|O
roots	|O
,	|O
in	|O
agreement	|O
with	|O
the	|O
different	|O
activities	|O
of	|O
the	|O
promoter	|O
in	|O
these	|O
two	|O
organs	|O
.	|O

The	|O
prevalence	|O
and	|O
incidence	|O
of	|O
human	|O
immunodeficiency	|O
virus	|O
types	|O
1	|O
and	|O
2	|O
(	|O
HIV	|O
-	|O
1	|O
,	|O
HIV	|O
-	|O
2	|O
)	|O
,	|O
human	|O
T	|O
-	|O
lymphotropic	|O
virus	|O
types	|O
I	|O
and	|O
II	|O
(	|O
HTLV	|O
-	|O
I	|O
/	|O
II	|O
)	|O
,	|O
and	|O
syphilitic	|O
infections	|O
and	|O
the	|O
association	|O
between	|O
these	|O
infections	|O
were	|O
determined	|O
in	|O
a	|O
cohort	|O
of	|O
police	|O
officers	|O
in	|O
Guinea	|O
-	|O
Bissau	|O
.	|O

By	|O
in	|O
vitro	|O
immunoprecipitations	|O
and	|O
gel	|O
shift	|O
assays	|O
,	|O
we	|O
identified	|O
two	|O
classes	|O
of	|O
high	|O
affinity	|O
Engrailed	|B-PROTEIN
-	|O
binding	|O
sites	|O
upstream	|O
of	|O
each	|O
of	|O
the	|O
two	|O
polyhomeotic	|O
transcription	|O
units	|O
.	|O

Subjects	|O
with	|O
a	|O
short	|O
postexposure	|O
time	|O
and	|O
a	|O
dioxin	|O
burden	|O
>	|O
0.6	|O
pg	|O
/	|O
m3	|O
had	|O
a	|O
significantly	|O
higher	|O
risk	|O
of	|O
hypoergy	|O
than	|O
unexposed	|O
subjects	|O
(	|O
hypoergy	|O
I	|O
:	|O
OR	|O
=	|O
9.51	|O
,	|O
95%	|O
CI	|O
=	|O
1.96-42.02	|O
;	|O
hypoergy	|O
II	|O
:	|O
OR	|O
=	|O
2.92	|O
,	|O
95%	|O
CI	|O
=	|O
1.14-7.5	|O
)	|O
.	|O

Analysis	|O
of	|O
this	|O
sequence	|O
combined	|O
with	|O
that	|O
previously	|O
reported	|O
for	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
directly	|O
proximal	|O
to	|O
the	|O
start	|O
of	|O
transcription	|O
revealed	|O
several	|O
putative	|O
regulatory	|O
sequences	|O
.	|O

We	|O
now	|O
show	|O
that	|O
the	|O
BAT1	|B-PROTEIN
translation	|O
product	|O
is	|O
the	|O
homolog	|O
of	|O
the	|O
rat	|O
p47	|B-PROTEIN
nuclear	|O
protein	|O
,	|O
the	|O
WM6	|B-PROTEIN
Drosophila	|O
gene	|O
product	|O
,	|O
and	|O
probably	|O
also	|O
Ce08102	|B-PROTEIN
of	|O
Caenorhabditis	|O
elegans	|O
,	|O
all	|O
members	|O
of	|O
the	|O
DEAD	|B-PROTEIN
protein	|O
family	|O
of	|O
ATP	|O
-	|O
dependent	|O
RNA	|B-PROTEIN
helicases	|I-PROTEIN
.	|O

By	|O
using	|O
lacZ	|B-PROTEIN
fusions	|O
,	|O
it	|O
was	|O
possible	|O
to	|O
localize	|O
the	|O
DNA	|O
sequences	|O
required	|O
to	|O
mediate	|O
nitrate	|O
repression	|O
to	|O
the	|O
pfl	|B-PROTEIN
promoter	|O
-	|O
regulatory	|O
region	|O
.	|O

In	|O
this	|O
report	|O
,	|O
we	|O
describe	|O
the	|O
characterization	|O
of	|O
two	|O
early	|O
class	|B-PROTEIN
II	|I-PROTEIN
flagellar	|I-PROTEIN
genes	|I-PROTEIN
contained	|O
in	|O
the	|O
orfX	|O
-	|O
fliP	|B-PROTEIN
locus	|O
.	|O

Vestibular	|O
adaptation	|O
exercises	|O
and	|O
recovery	|O
:	|O
acute	|O
stage	|O
after	|O
acoustic	|O
neuroma	|O
resection	|O
.	|O

The	|O
experimental	|O
design	|O
represents	|O
a	|O
2	|O
x	|O
3	|O
factorial	|O
arrangement	|O
of	|O
treatments	|O
with	|O
three	|O
dietary	|O
levels	|O
of	|O
incorporation	|O
of	|O
RSB	|O
(	|O
0	|O
,	|O
50	|O
,	|O
and	|O
100%	|O
)	|O
,	|O
and	|O
chickens	|O
either	|O
infected	|O
or	|O
uninfected	|O
.	|O

A	|O
cDNA	|O
clone	|O
corresponding	|O
to	|O
the	|O
putative	|O
GA	|B-PROTEIN
20	|I-PROTEIN
-	|O
oxidase	|B-PROTEIN
genomic	|O
sequence	|O
was	|O
constructed	|O
with	|O
the	|O
reverse	|O
transcription	|O
-	|O
PCR	|O
method	|O
,	|O
and	|O
the	|O
identity	|O
of	|O
the	|O
cDNA	|O
clone	|O
was	|O
confirmed	|O
by	|O
analyzing	|O
the	|O
capability	|O
of	|O
the	|O
fusion	|O
protein	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
to	|O
convert	|O
GA53	|B-PROTEIN
to	|O
GA44	|B-PROTEIN
and	|O
GA19	|B-PROTEIN
to	|O
GA20	|B-PROTEIN
.	|O

There	|O
were	|O
no	|O
significant	|O
changes	|O
in	|O
either	|O
the	|O
fatty	|O
acid	|O
composition	|O
of	|O
biliary	|O
lecithin	|O
or	|O
in	|O
the	|O
bile	|O
acid	|O
composition	|O
of	|O
bile	|O
.	|O

Total	|O
cholesterol	|O
was	|O
also	|O
reduced	|O
at	|O
week	|O
12	|O
by	|O
17.0%	|O
(	|O
20	|O
mg	|O
/	|O
day	|O
)	|O
and	|O
15.7%	|O
(	|O
20-30	|O
mg	|O
/	|O
day	|O
)	|O
,	|O
and	|O
at	|O
week	|O
52	|O
by	|O
20.4%	|O
(	|O
<	|O
or	|O
=	|O
20	|O
mg	|O
/	|O
day	|O
)	|O
and	|O
19.2%	|O
(	|O
>	|O
or	|O
=	|O
30	|O
mg	|O
/	|O
day	|O
)	|O
.	|O

Although	|O
further	|O
studies	|O
are	|O
required	|O
to	|O
determine	|O
the	|O
precise	|O
role	|O
of	|O
PEBP2	|B-PROTEIN
in	|O
the	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
promoter	|O
activity	|O
,	|O
the	|O
present	|O
findings	|O
suggested	|O
the	|O
importance	|O
of	|O
the	|O
relative	|O
ratio	|O
of	|O
different	|O
PEBP2	|B-PROTEIN
isoforms	|O
in	|O
regulating	|O
the	|O
levels	|O
of	|O
the	|O
promoter	|O
activity	|O
.	|O

Benefits	|O
of	|O
obtaining	|O
board	|O
certification	|O
in	|O
pharmacotherapy	|O
.	|O

Piperacillin	|O
-	|O
tazobactam	|O
can	|O
be	|O
used	|O
for	|O
the	|O
treatment	|O
of	|O
infections	|O
caused	|O
by	|O
gram	|O
-	|O
negative	|O
,	|O
gram	|O
-	|O
positive	|O
,	|O
aerobic	|O
,	|O
and	|O
anaerobic	|O
bacteria	|O
.	|O

Basal	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
(	|O
PRA	|O
)	|O
was	|O
slightly	|O
raised	|O
prior	|O
to	|O
training	|O
(	|O
P	|O
<	|O
0.07	|O
)	|O
compared	|O
to	|O
the	|O
controls	|O
and	|O
post	|O
-	|O
training	|O
.	|O

This	|O
apparently	|O
anomalous	|O
structure	|O
/	|O
activity	|O
relationship	|O
raises	|O
important	|O
issues	|O
for	|O
understanding	|O
the	|O
evolution	|O
of	|O
regulatory	|O
peptides	|O
and	|O
the	|O
mechanisms	|O
that	|O
control	|O
their	|O
expression	|O
.	|O

The	|O
structural	|O
gene	|O
encoding	|O
the	|O
novel	|O
lantibiotic	|O
epilancin	|B-PROTEIN
K7	|I-PROTEIN
from	|O
Staphylococcus	|O
epidermidis	|O
K7	|O
was	|O
cloned	|O
and	|O
its	|O
nucleotide	|O
sequence	|O
was	|O
determined	|O
.	|O

This	|O
paper	|O
summarises	|O
the	|O
experimental	|O
evidence	|O
upon	|O
which	|O
the	|O
clinical	|O
trials	|O
of	|O
aldose	|B-PROTEIN
reductase	|I-PROTEIN
inhibitors	|O
in	|O
diabetic	|O
patients	|O
have	|O
been	|O
initiated	|O
and	|O
the	|O
results	|O
of	|O
published	|O
drug	|O
trials	|O
in	|O
these	|O
patients	|O
.	|O

The	|O
spectrum	|O
of	|O
phenotypes	|O
caused	|O
by	|O
these	|O
mutations	|O
was	|O
strikingly	|O
different	|O
than	|O
mutations	|O
in	|O
the	|O
adaptor	|O
for	|O
the	|O
VP16	|B-PROTEIN
activation	|O
domain	|O
.	|O

Increase	|O
in	|O
urinary	|O
calcium	|O
and	|O
oxalate	|O
after	|O
fructose	|O
infusion	|O
.	|O

The	|O
5'	|O
flanking	|O
region	|O
is	|O
highly	|O
GC	|O
rich	|O
,	|O
with	|O
multiple	|O
CpG	|O
doublets	|O
,	|O
and	|O
contains	|O
multiple	|O
binding	|O
sites	|O
for	|O
Sp1	|B-PROTEIN
.	|O

To	|O
discern	|O
whether	|O
these	|O
disorders	|O
of	|O
GnRH	|B-PROTEIN
deficiency	|O
are	|O
associated	|O
with	|O
altered	|O
melatonin	|O
secretion	|O
profiles	|O
,	|O
we	|O
compared	|O
untreated	|O
young	|O
males	|O
IGD	|O
(	|O
n	|O
=	|O
7	|O
)	|O
and	|O
DP	|O
(	|O
n	|O
=	|O
7	|O
)	|O
to	|O
normal	|O
pubertal	|O
male	|O
controls	|O
(	|O
n	|O
=	|O
6	|O
)	|O
.	|O

Increased	|O
blood	|O
pressure	|O
during	|O
CyA	|O
treatment	|O
was	|O
independent	|O
of	|O
circulating	|O
ET	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
levels	|O
.	|O

Analysis	|O
of	|O
several	|O
Tat	|B-PROTEIN
mutants	|O
indicated	|O
that	|O
both	|O
the	|O
cysteine	|O
-	|O
rich	|O
and	|O
the	|O
core	|O
domains	|O
of	|O
this	|O
transactivator	|O
are	|O
necessary	|O
and	|O
sufficient	|O
to	|O
activate	|O
transcription	|O
when	|O
TBP	|B-PROTEIN
is	|O
overexpressed	|O
.	|O

In	|O
addition	|O
,	|O
depletion	|O
of	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
from	|O
the	|O
nuclear	|O
extract	|O
by	|O
using	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
specific	|O
antiserum	|O
or	|O
a	|O
sequence	|O
-	|O
specific	|O
DNA	|O
affinity	|O
resin	|O
decreased	|O
in	|O
vitro	|O
transcription	|O
from	|O
the	|O
wild	|O
-	|O
type	|O
MMTV	|O
promoter	|O
to	|O
a	|O
level	|O
identical	|O
to	|O
that	|O
obtained	|O
from	|O
a	|O
promoter	|O
in	|O
which	|O
all	|O
three	|O
octamer	|O
-	|O
related	|O
sequences	|O
were	|O
mutated	|O
.	|O

Transactivation	|O
of	|O
the	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
by	|O
T3R	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
several	|O
receptor	|O
mutants	|O
revealed	|O
that	|O
the	|O
50	|O
-	|O
amino	|O
-	|O
acid	|O
N	|B-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
A	|I-PROTEIN
/	|I-PROTEIN
B	|I-PROTEIN
region	|I-PROTEIN
of	|O
T3R	|B-PROTEIN
alpha	|I-PROTEIN
,	|O
known	|O
to	|O
interact	|O
with	|O
the	|O
basal	|O
transcription	|O
factor	|O
TFIIB	|B-PROTEIN
,	|O
is	|O
critical	|O
for	|O
activation	|O
of	|O
both	|O
Tat	|B-PROTEIN
-	|O
dependent	|O
and	|O
Tat	|B-PROTEIN
-	|O
independent	|O
responsive	|O
sequences	|O
of	|O
the	|O
LTR	|O
.	|O

M.M.C.	|O
was	|O
used	|O
for	|O
2.5	|O
minutes	|O
in	|O
44	|O
cases	|O
(	|O
20	|O
HR	|O
patients	|O
,	|O
24	|O
LR	|O
patients	|O
)	|O
,	|O
and	|O
for	|O
5	|O
minutes	|O
in	|O
66	|O
cases	|O
(	|O
46	|O
HR	|O
patients	|O
,	|O
20	|O
LR	|O
patients	|O
)	|O
.	|O

Finally	|O
,	|O
we	|O
show	|O
that	|O
complexes	|O
similar	|O
to	|O
the	|O
C25	|B-PROTEIN
,	|O
C30	|B-PROTEIN
and	|O
C35	|B-PROTEIN
complexes	|O
are	|O
formed	|O
by	|O
rat	|O
cortex	|O
nuclear	|O
extracts	|O
and	|O
the	|O
SAA	|O
element	|O
in	|O
EMSA	|O
experiments	|O
,	|O
suggesting	|O
the	|O
relevance	|O
of	|O
our	|O
in	|O
vitro	|O
observations	|O
to	|O
the	|O
in	|O
vivo	|O
functioning	|O
of	|O
the	|O
rat	|O
APP	|B-PROTEIN
promoter	|O
.	|O

Oncological	|O
,	|O
clinical	|O
and	|O
psychological	|O
aspects	|O
are	|O
evaluated	|O
according	|O
to	|O
experience	|O
accumulated	|O
in	|O
recent	|O
years	|O
,	|O
with	|O
immediate	|O
and	|O
delayed	|O
reconstruction	|O
,	|O
carried	|O
out	|O
in	|O
the	|O
most	|O
diverse	|O
specialized	|O
centers	|O
.	|O

The	|O
analysis	|O
of	|O
the	|O
prevalence	|O
values	|O
shows	|O
clearly	|O
that	|O
the	|O
global	|O
MS	|O
-	|O
frequency	|O
is	|O
closer	|O
related	|O
to	|O
the	|O
geomagnetic	|O
than	|O
to	|O
the	|O
geographic	|O
latitude	|O
.	|O

Diltiazem	|O
caused	|O
significant	|O
decrease	|O
in	|O
the	|O
ventricular	|O
response	|O
without	|O
conversion	|O
to	|O
sinus	|O
rhythm	|O
.	|O

Subhuman	|O
primates	|O
appear	|O
to	|O
be	|O
more	|O
sensitive	|O
to	|O
reproductive	|O
and	|O
other	|O
adverse	|O
effects	|O
of	|O
PCBs	|O
than	|O
humans	|O
.	|O

When	|O
excluding	|O
children	|O
with	|O
ocular	|O
and	|O
cerebral	|O
pathology	|O
,	|O
32	|O
matched	|O
pairs	|O
of	|O
premature	|O
and	|O
control	|O
children	|O
remained	|O
.	|O

The	|O
cryptococcal	|B-PROTEIN
antigen	|I-PROTEIN
test	|O
was	|O
positive	|O
at	|O
1	|O
:	|O
125	|O
by	|O
latex	|O
agglutination	|O
.	|O

Functional	|O
analysis	|O
of	|O
DNase	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
hypersensitive	|O
sites	|O
at	|O
the	|O
mouse	|O
porphobilinogen	|B-PROTEIN
deaminase	|I-PROTEIN
gene	|O
locus	|O
.	|O

These	|O
transcripts	|O
have	|O
a	|O
unique	|O
5'	|O
untranslated	|O
region	|O
and	|O
NH2	|O
-	|O
terminal	|O
sequence	|O
and	|O
encode	|O
a	|O
predicted	|O
protein	|O
of	|O
121	|O
kD	|O
.	|O

Both	|O
mu	|B-PROTEIN
and	|I-PROTEIN
gamma	|I-PROTEIN
2b	|I-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
genes	|O
cause	|O
this	|O
feedback	|O
inhibition	|O
of	|O
heavy	|O
chain	|O
gene	|O
rearrangement	|O
.	|O

Purified	|O
CarP	|B-PROTEIN
binds	|O
in	|O
vitro	|O
to	|O
the	|O
carAB	|B-PROTEIN
control	|O
region	|O
and	|O
protects	|O
against	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
two	|O
approximately	|O
25	|O
bp	|O
long	|O
stretches	|O
,	|O
one	|O
of	|O
which	|O
is	|O
located	|O
just	|O
downstream	|O
of	|O
the	|O
GATC	|O
sequence	|O
.	|O

They	|O
include	|O
genes	|O
encoding	|O
three	|O
subunits	|O
of	|O
the	|O
cytochrome	|B-PROTEIN
oxidase	|I-PROTEIN
(	|O
cox1	|O
to	|O
3	|O
)	|O
,	|O
apocytochrome	|B-PROTEIN
b	|I-PROTEIN
(	|O
cob	|B-PROTEIN
)	|O
,	|O
seven	|O
subunits	|O
of	|O
the	|O
NADH	|B-PROTEIN
dehydrogenase	|I-PROTEIN
complex	|O
(	|O
nad1	|B-PROTEIN
to	|I-PROTEIN
6	|I-PROTEIN
,	|O
nad4L	|B-PROTEIN
)	|O
,	|O
two	|O
ATPase	|B-PROTEIN
subunits	|O
(	|O
atp6	|B-PROTEIN
and	|O
atp9	|B-PROTEIN
)	|O
,	|O
three	|O
ribosomal	|O
RNAs	|O
(	|O
rrn5	|B-PROTEIN
,	|O
srn	|B-PROTEIN
and	|O
lrn	|B-PROTEIN
)	|O
,	|O
23	|O
tRNAs	|O
and	|O
four	|O
ribosomal	|O
proteins	|O
(	|O
rps3	|B-PROTEIN
,	|O
rps11	|B-PROTEIN
,	|O
rps12	|B-PROTEIN
and	|O
rpl16	|B-PROTEIN
)	|O
.	|O

From	|O
day	|O
10	|O
,	|O
a	|O
significant	|O
increase	|O
in	|O
platelet	|O
count	|O
was	|O
observed	|O
in	|O
eight	|O
of	|O
the	|O
ten	|O
patients	|O
treated	|O
with	|O
heparin	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
,	|O
with	|O
return	|O
to	|O
the	|O
initial	|O
value	|O
after	|O
heparin	|O
cessation	|O
in	|O
six	|O
of	|O
the	|O
responders	|O
.	|O

These	|O
"	|O
nucleocapsid	|O
-	|O
like	|O
"	|O
structures	|O
were	|O
readily	|O
purified	|O
by	|O
density	|O
gradient	|O
centrifugation	|O
.	|O

The	|O
Babcock	|O
Surgical	|O
Clinic	|O
.	|O

Resources	|O
for	|O
helping	|O
patients	|O
to	|O
quit	|O
smoking	|O
.	|O

The	|O
PEBP2	|B-PROTEIN
alpha	|I-PROTEIN
proteins	|O
contain	|O
a	|O
128	|O
-	|O
amino	|O
-	|O
acid	|O
(	|O
aa	|O
)	|O
region	|O
highly	|O
homologous	|O
to	|O
the	|O
Drosophila	|O
melanogaster	|O
segmentation	|O
gene	|O
runt	|B-PROTEIN
.	|O

In	|O
human	|O
proliferative	|O
cells	|O
,	|O
the	|O
NADP	|O
-	|O
dependent	|O
ME	|B-PROTEIN
activity	|O
is	|O
poorly	|O
expressed	|O
and	|O
barely	|O
inducible	|O
by	|O
thyroid	|O
hormones	|O
.	|O

Based	|O
on	|O
previous	|O
mapping	|O
of	|O
the	|O
G	|B-PROTEIN
beta	|I-PROTEIN
gamma	|I-PROTEIN
binding	|O
region	|O
of	|O
beta	|B-PROTEIN
ARK	|I-PROTEIN
,	|O
and	|O
conserved	|O
residues	|O
within	|O
the	|O
PH	|B-PROTEIN
domain	|O
,	|O
we	|O
have	|O
constructed	|O
a	|O
series	|O
of	|O
mutants	|O
in	|O
the	|O
carboxyl	|O
terminus	|O
of	|O
beta	|B-PROTEIN
ARK	|I-PROTEIN
in	|O
order	|O
to	|O
determine	|O
important	|O
residues	|O
involved	|O
in	|O
G	|B-PROTEIN
beta	|I-PROTEIN
gamma	|I-PROTEIN
and	|O
PIP2	|O
binding	|O
.	|O

Histopathological	|O
features	|O
of	|O
relapsed	|O
leprosy	|O
.	|O

To	|O
dissect	|O
these	|O
mechanisms	|O
,	|O
wild	|O
-	|O
type	|O
and	|O
mutant	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
proteins	|O
were	|O
studied	|O
in	|O
an	|O
in	|O
vitro	|O
system	|O
with	|O
purified	|O
plasma	|O
membranes	|O
from	|O
v	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
-	|O
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
-	|O
transformed	|O
cells	|O
(	|O
transformed	|O
membranes	|O
)	|O
.	|O

In	|O
CV	|O
-	|O
1	|O
cells	|O
,	|O
cotransfection	|O
of	|O
the	|O
retinoid	|B-PROTEIN
and	|I-PROTEIN
estrogen	|I-PROTEIN
receptors	|I-PROTEIN
led	|O
to	|O
mutual	|O
inhibition	|O
of	|O
the	|O
other	|O
's	|O
activity	|O
,	|O
while	|O
an	|O
RA	|O
-	|O
dependent	|O
inhibition	|O
of	|O
ER	|B-PROTEIN
activity	|O
was	|O
observed	|O
in	|O
breast	|O
cancer	|O
cells	|O
.	|O

One	|O
of	|O
these	|O
factors	|O
,	|O
HRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
recognizes	|O
a	|O
cis	|O
element	|O
consisting	|O
of	|O
an	|O
inverted	|O
palindromic	|O
motif	|O
.	|O

Regulation	|O
of	|O
Gax	|B-PROTEIN
homeobox	|O
gene	|O
transcription	|O
by	|O
a	|O
combination	|O
of	|O
positive	|O
factors	|O
including	|O
myocyte	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
enhancer	|I-PROTEIN
factor	|I-PROTEIN
2	|I-PROTEIN
.	|O

The	|O
carboxyl	|O
-	|O
terminal	|O
transactivation	|O
domain	|O
of	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
is	|O
negatively	|O
regulated	|O
and	|O
stress	|O
responsive	|O
.	|O

D.	|O

It	|O
was	|O
proposed	|O
that	|O
the	|O
synthetase	|O
-	|O
related	|O
sequences	|O
of	|O
GCN2	|B-PROTEIN
stimulate	|O
the	|O
activity	|O
of	|O
the	|O
kinase	|O
by	|O
interacting	|O
directly	|O
with	|O
uncharged	|O
tRNA	|O
that	|O
accumulates	|O
during	|O
amino	|O
acid	|O
limitation	|O
.	|O

However	|O
,	|O
unlike	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
the	|O
E1B	|B-PROTEIN
19K	|O
proteins	|O
,	|O
which	|O
completely	|O
block	|O
apoptosis	|O
but	|O
not	|O
p53	|B-PROTEIN
-	|O
dependent	|O
growth	|O
arrest	|O
,	|O
H	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
expression	|O
permitted	|O
DNA	|O
synthesis	|O
and	|O
cell	|O
proliferation	|O
in	|O
the	|O
presence	|O
of	|O
high	|O
levels	|O
of	|O
wild	|O
-	|O
type	|O
p53	|B-PROTEIN
.	|O

To	|O
compare	|O
the	|O
PAX3	|B-PROTEIN
and	|O
putative	|O
PAX3	|B-PROTEIN
-	|O
FKHR	|B-PROTEIN
transactivation	|O
domains	|O
,	|O
we	|O
fused	|O
C	|O
-	|O
terminal	|O
test	|O
fragments	|O
to	|O
the	|O
heterologous	|O
GAL4	|B-PROTEIN
DNA	|O
-	|O
binding	|O
domain	|O
and	|O
tested	|O
activation	|O
of	|O
a	|O
reporter	|O
gene	|O
co	|O
-	|O
transfected	|O
into	|O
four	|O
cell	|O
types	|O
.	|O

All	|O
subjects	|O
were	|O
submitted	|O
to	|O
ECG	|O
and	|O
arterial	|O
blood	|O
pressure	|O
determination	|O
and	|O
were	|O
assayed	|O
for	|O
TSH	|B-PROTEIN
,	|O
thyroid	|O
hormone	|O
,	|O
PRL	|B-PROTEIN
,	|O
glucose	|O
,	|O
creatinine	|O
,	|O
nitrogen	|O
,	|O
glutamine	|B-PROTEIN
transaminase	|I-PROTEIN
,	|O
cholesterol	|O
and	|O
triglycerides	|O
plasma	|O
levels	|O
before	|O
therapy	|O
(	|O
T0	|O
)	|O
,	|O
after	|O
30	|O
treatment	|O
days	|O
(	|O
T30	|O
)	|O
and	|O
after	|O
a	|O
15	|O
days	|O
washout	|O
(	|O
T45	|O
)	|O
.	|O

Acute	|O
decrease	|O
in	|O
body	|O
temperature	|O
(	|O
TB	|O
)	|O
lowered	|O
PaCO2	|O
(	|O
32.5	|O
to	|O
14.5	|O
mmHg	|O
)	|O
and	|O
[	|O
HCO3	|O
-	|O
]	|O
a	|O
(	|O
24.20	|O
mEq	|O
/	|O
L	|O
to	|O
17.56	|O
mEq	|O
/	|O
L	|O
)	|O
,	|O
increased	|O
pHa	|O
(	|O
7.481	|O
to	|O
7.608	|O
)	|O
and	|O
diminished	|O
the	|O
[	|O
OH	|O
-	|O
]	|O
/	|O
[	|O
H+	|O
]	|O
ratio	|O
,	|O
but	|O
had	|O
no	|O
significant	|O
effect	|O
on	|O
[	|O
SID	|O
]	|O
or	|O
[	|O
Atot	|O
]	|O
,	|O
although	|O
both	|O
total	|O
phosphorus	|O
[	|O
PT	|O
]	|O
and	|O
inorganic	|O
phosphate	|O
[	|O
Pi	|O
]	|O
increased	|O
.	|O

Hepatitis	|O
B	|O
vaccine	|O
:	|O
still	|O
has	|O
its	|O
problems	|O
.	|O

Basal	|O
promoter	|O
activity	|O
is	|O
enhanced	|O
by	|O
a	|O
functional	|O
M1	|O
domain	|O
in	|O
LHR	|B-PROTEIN
-	|O
expressing	|O
mouse	|O
Leydig	|O
tumor	|O
cells	|O
(	|O
MLTC	|O
)	|O
but	|O
not	|O
in	|O
non	|O
-	|O
expressing	|O
CHO	|O
cells	|O
.	|O

The	|O
RAT3	|B-PROTEIN
gene	|O
encodes	|O
an	|O
1157	|O
-	|O
amino	|O
acid	|O
protein	|O
without	|O
similarity	|O
to	|O
other	|O
known	|O
proteins	|O
.	|O

For	|O
Al	|O
,	|O
the	|O
exposure	|O
to	|O
1.36	|O
mg	|O
/	|O
m3	|O
during	|O
the	|O
shift	|O
corresponded	|O
to	|O
a	|O
urinary	|O
concentration	|O
at	|O
the	|O
end	|O
of	|O
the	|O
shift	|O
of	|O
200	|O
microgram	|O
/	|O
g	|O
creatinine	|O
.	|O

Tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
alpha	|I-PROTEIN
)	|O
,	|O
a	|O
proinflammatory	|O
cytokine	|O
,	|O
inhibits	|O
cAMP	|O
-	|O
stimulated	|O
testosterone	|O
production	|O
in	|O
mouse	|O
Leydig	|O
cells	|O
.	|O

The	|O
Drosophila	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
homolog	|O
:	|O
a	|O
gene	|O
essential	|O
for	|O
embryonic	|O
development	|O
encodes	|O
two	|O
receptor	|O
isoforms	|O
with	|O
different	|O
signaling	|O
potential	|O
.	|O

We	|O
show	|O
here	|O
that	|O
RA	|O
and	|O
E1A	|B-PROTEIN
induce	|O
phosphorylation	|O
of	|O
the	|O
E1A	|O
-	|O
associated	|O
300	|B-PROTEIN
kDa	|I-PROTEIN
protein	|I-PROTEIN
(	|I-PROTEIN
p300	|I-PROTEIN
)	|I-PROTEIN
during	|O
the	|O
differentiation	|O
of	|O
F9	|O
cells	|O
.	|O

The	|O
double	|O
-	|O
stranded	|O
RNA	|O
binding	|O
domain	|O
(	|O
dsRBD	|O
)	|O
is	|O
an	|O
approximately	|O
65	|O
amino	|O
acid	|O
motif	|O
that	|O
is	|O
found	|O
in	|O
a	|O
variety	|O
of	|O
proteins	|O
that	|O
interact	|O
with	|O
double	|O
-	|O
stranded	|O
(	|O
ds	|O
)	|O
RNA	|O
,	|O
such	|O
as	|O
Escherichia	|O
coli	|O
RNase	|B-PROTEIN
III	|I-PROTEIN
and	|O
the	|O
dsRNA	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
PKR	|B-PROTEIN
.	|O

CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
isoforms	|O
beta	|O
and	|O
delta	|O
are	|O
expressed	|O
in	|O
mammary	|O
epithelial	|O
cells	|O
and	|O
bind	|O
to	|O
multiple	|O
sites	|O
in	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
casein	|I-PROTEIN
gene	|O
promoter	|O
.	|O

SCA	|B-PROTEIN
was	|O
resistant	|O
to	|O
inhibitors	|O
of	|O
serine	|O
,	|O
aspartyl	|O
,	|O
and	|O
metalloproteases	|B-PROTEIN
,	|O
but	|O
it	|O
was	|O
sensitive	|O
to	|O
N	|O
-	|O
ethylmaleimide	|O
.	|O

Mutational	|O
analysis	|O
of	|O
potential	|O
activating	|O
phosphorylation	|O
sites	|O
found	|O
in	|O
NIMA	|B-PROTEIN
,	|O
NIM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
related	|O
protein	|O
kinases	|O
was	|O
performed	|O
on	|O
NIMA	|B-PROTEIN
.	|O

However	|O
,	|O
a	|O
similar	|O
mutation	|O
of	|O
a	|O
leucine	|O
residue	|O
to	|O
arginine	|O
at	|O
position	|O
422	|O
showed	|O
no	|O
alteration	|O
of	|O
heterodimerization	|O
,	|O
DNA	|O
binding	|O
,	|O
or	|O
transcriptional	|O
activation	|O
.	|O

Expression	|O
of	|O
the	|O
CYP11A1	|B-PROTEIN
gene	|O
is	|O
increased	|O
by	|O
hormones	|O
,	|O
such	|O
as	|O
adrenocorticotropin	|B-PROTEIN
and	|O
luteinizing	|B-PROTEIN
hormone	|I-PROTEIN
,	|O
as	|O
well	|O
as	|O
by	|O
a	|O
number	|O
of	|O
growth	|O
factors	|O
,	|O
suggesting	|O
that	|O
its	|O
promoter	|O
may	|O
contain	|O
regulatory	|O
elements	|O
that	|O
respond	|O
to	|O
multiple	|O
signal	|O
transduction	|O
pathways	|O
.	|O

NH2	|O
-	|O
and	|O
COOH	|O
-	|O
terminal	|O
deletion	|O
analysis	|O
revealed	|O
that	|O
both	|O
the	|O
PH	|B-PROTEIN
and	|O
putative	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
domains	|O
are	|O
required	|O
,	|O
but	|O
the	|O
zinc	|O
butterfly	|O
is	|O
dispensable	|O
,	|O
for	|O
transformation	|O
.	|O

We	|O
have	|O
found	|O
that	|O
the	|O
expression	|O
of	|O
GTPase	|B-PROTEIN
-	|O
deficient	|O
mutants	|O
of	|O
alpha	|B-PROTEIN
12	|I-PROTEIN
(	|O
alpha	|B-PROTEIN
12Q229L	|I-PROTEIN
)	|O
or	|O
alpha	|B-PROTEIN
13	|I-PROTEIN
(	|O
alpha	|B-PROTEIN
13Q226L	|I-PROTEIN
)	|O
leads	|O
to	|O
robust	|O
activation	|O
of	|O
the	|O
Jun	|B-PROTEIN
kinase	|O
/	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
/	|O
SAPK	|B-PROTEIN
)	|O
pathway	|O
.	|O

The	|O
objective	|O
of	|O
our	|O
study	|O
was	|O
to	|O
evaluate	|O
the	|O
age	|O
,	|O
sex	|O
,	|O
clinical	|O
conditions	|O
,	|O
family	|O
history	|O
,	|O
site	|O
,	|O
catheter	|O
association	|O
,	|O
means	|O
of	|O
radiologic	|O
evaluation	|O
,	|O
development	|O
of	|O
pulmonary	|O
involvement	|O
,	|O
prevalence	|O
of	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
,	|O
protein	|B-PROTEIN
C	|I-PROTEIN
and	|O
protein	|B-PROTEIN
S	|I-PROTEIN
deficiencies	|O
,	|O
and	|O
lupus	|O
anticoagulants	|O
in	|O
children	|O
who	|O
suffered	|O
a	|O
thrombotic	|O
event	|O
.	|O

Harel	|O
,	|O
E.M.	|O

Radiotherapy	|O
and	|O
early	|O
orchiectomy	|O
in	|O
stage	|O
D1	|O
prostatic	|O
carcinoma	|O

Structural	|O
organization	|O
and	|O
developmental	|O
expression	|O
pattern	|O
of	|O
the	|O
mouse	|O
WD	|O
-	|O
repeat	|O
gene	|O
DMR	|B-PROTEIN
-	|I-PROTEIN
N9	|I-PROTEIN
immediately	|O
upstream	|O
of	|O
the	|O
myotonic	|B-PROTEIN
dystrophy	|I-PROTEIN
locus	|I-PROTEIN
.	|O

The	|O
ARX2	|O
procedure	|O
models	|O
the	|O
recorded	|O
signal	|O
as	|O
the	|O
sum	|O
of	|O
three	|O
signals	|O
:	|O
(	|O
a	|O
)	|O
the	|O
background	|O
EEG	|O
activity	|O
,	|O
modelled	|O
as	|O
an	|O
autoregressive	|O
process	|O
driven	|O
by	|O
a	|O
white	|O
noise	|O
;	|O
(	|O
b	|O
)	|O
a	|O
filtered	|O
version	|O
of	|O
a	|O
reference	|O
signal	|O
carrying	|O
the	|O
average	|O
information	|O
contained	|O
in	|O
each	|O
sweep	|O
;	|O
(	|O
c	|O
)	|O
a	|O
signal	|O
due	|O
to	|O
the	|O
ocular	|O
artefact	|O
propagation	|O
.	|O

The	|O
expression	|O
of	|O
the	|O
gene	|O
encoding	|O
the	|O
enzyme	|O
(	|O
CYP19	|B-PROTEIN
)	|O
is	|O
regulated	|O
,	|O
in	|O
part	|O
,	|O
by	|O
tissue	|O
-	|O
specific	|O
promoters	|O
through	|O
the	|O
use	|O
of	|O
alternative	|O
-	|O
splicing	|O
mechanisms	|O
.	|O

Using	|O
mutagenesis	|O
,	|O
we	|O
have	|O
identified	|O
two	|O
mutations	|O
of	|O
the	|O
second	|O
actin	|B-PROTEIN
-	|O
binding	|O
domain	|O
that	|O
can	|O
also	|O
suppress	|O
the	|O
act1	|B-PROTEIN
mutations	|O
of	|O
interest	|O
.	|O

CIITA	|B-PROTEIN
mRNA	|O
is	|O
normally	|O
inducible	|O
by	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
in	|O
class	|O
II	|O
non	|O
-	|O
inducible	|O
,	|O
RB	|O
-	|O
defective	|O
lines	|O
,	|O
and	|O
in	|O
one	|O
line	|O
,	|O
re	|O
-	|O
expression	|O
of	|O
RB	|B-PROTEIN
has	|O
no	|O
effect	|O
on	|O
CIITA	|B-PROTEIN
mRNA	|O
induction	|O
levels	|O
.	|O

The	|O
normal	|O
cell	|O
cycle	|O
is	|O
regulated	|O
by	|O
several	|O
molecules	|O
,	|O
such	|O
as	|O
the	|O
tumor	|O
-	|O
suppressor	|O
protein	|O
pRb	|B-PROTEIN
,	|O
the	|O
G1	|B-PROTEIN
cyclins	|I-PROTEIN
,	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
and	|O
their	|O
inhibitors	|O
.	|O

Consistent	|O
with	|O
the	|O
protein	|O
expression	|O
data	|O
,	|O
V	|B-PROTEIN
beta	|I-PROTEIN
8.3	|I-PROTEIN
gene	|O
transcripts	|O
were	|O
found	|O
only	|O
in	|O
the	|O
transgenic	|O
lines	|O
with	|O
the	|O
wild	|O
-	|O
type	|O
promoter	|O
.	|O

These	|O
results	|O
are	|O
very	|O
useful	|O
for	|O
deciding	|O
on	|O
the	|O
doses	|O
of	|O
hormones	|O
and	|O
the	|O
expected	|O
serum	|O
estradiol	|O
level	|O
in	|O
HRT	|O
for	|O
Japanese	|O
women	|O
.	|O

Comparison	|O
of	|O
1.5	|O
Tesla	|O
and	|O
0.35	|O
Tesla	|O
field	|O
strength	|O
magnetic	|O
resonance	|O
imaging	|O
scans	|O
in	|O
the	|O
morphometric	|O
evaluation	|O
of	|O
the	|O
lumbar	|O
intervertebral	|O
foramina	|O
.	|O

One	|O
month	|O
after	|O
the	|O
DTaP	|O
booster	|O
vaccination	|O
,	|O
both	|O
groups	|O
had	|O
6	|O
-	|O
to	|O
40	|O
-	|O
fold	|O
increases	|O
in	|O
serum	|O
antibody	|O
concentrations	|O
to	|O
all	|O
antigens	|O
tested	|O
;	|O
the	|O
concentrations	|O
against	|O
the	|O
three	|O
pertussis	|B-PROTEIN
antigens	|I-PROTEIN
were	|O
higher	|O
in	|O
the	|O
DTaP	|O
-	|O
primed	|O
children	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

Interestingly	|O
,	|O
this	|O
amino	|O
-	|O
terminal	|O
determinant	|O
appears	|O
not	|O
to	|O
reside	|O
in	|O
the	|O
HSV	|O
-	|O
alpha	|B-PROTEIN
TIF	|I-PROTEIN
,	|O
which	|O
displays	|O
no	|O
independent	|O
amino	|O
-	|O
terminal	|O
activity	|O
.	|O

We	|O
also	|O
show	|O
that	|O
in	|O
fusions	|O
with	|O
the	|O
DNA	|O
binding	|O
domain	|O
of	|O
GAL4	|B-PROTEIN
,	|O
full	|O
activity	|O
requires	|O
the	|O
entire	|O
BHV	|O
-	|O
alpha	|B-PROTEIN
TIF	|I-PROTEIN
,	|O
although	|O
both	|O
amino	|O
and	|O
carboxyl	|O
termini	|O
display	|O
some	|O
activity	|O
on	|O
their	|O
own	|O
.	|O

To	|O
investigate	|O
the	|O
potential	|O
role	|O
of	|O
SP1	|B-PROTEIN
,	|O
we	|O
examined	|O
nuclear	|O
extracts	|O
from	|O
HCMV	|O
-	|O
infected	|O
cells	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
messenger	|O
RNAs	|O
encoding	|O
trans	|O
-	|O
sialidases	|O
containing	|O
the	|O
repeats	|O
are	|O
not	|O
present	|O
in	|O
epimastigotes	|O
but	|O
are	|O
abundant	|O
in	|O
trypomastigotes	|O
.	|O

From	|O
May	|O
1985	|O
to	|O
May	|O
1989	|O
,	|O
126	|O
necropsies	|O
were	|O
performed	|O
at	|O
the	|O
Sao	|O
Paulo	|O
City	|O
Morgue	|O
on	|O
cadavers	|O
of	|O
individuals	|O
AIDS	|O
victims	|O
whose	|O
unnatural	|O
deaths	|O
had	|O
prompted	|O
police	|O
investigations	|O
.	|O

A	|O
model	|O
with	|O
age	|O
and	|O
weight	|O
described	|O
the	|O
best	|O
fit	|O
for	|O
TBBMD	|O
,	|O
whereas	|O
age	|O
,	|O
weight	|O
,	|O
and	|O
height	|O
described	|O
the	|O
best	|O
fit	|O
for	|O
total	|O
body	|O
TBBMC	|O
.	|O

As	|O
retinoic	|O
acid	|O
and	|O
thyroid	|O
hormone	|O
are	|O
frequently	|O
involved	|O
in	|O
developmental	|O
regulatory	|O
processes	|O
,	|O
it	|O
is	|O
possible	|O
that	|O
this	|O
element	|O
may	|O
be	|O
important	|O
in	|O
the	|O
process	|O
of	|O
islet	|O
cell	|O
differentiation	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
peptide	|O
sequences	|O
of	|O
the	|O
human	|O
lymphocyte	|O
-	|O
specific	|O
high	|O
mobility	|O
group	|O
(	|O
HMG	|O
)	|O
-	|O
box	|O
transcription	|O
factor	|O
TCF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
are	|O
determined	|O
by	|O
alternative	|O
splice	|O
mechanisms	|O
affecting	|O
the	|O
exons	|O
VIII	|O
to	|O
X.	|O

Thromboxane	|O
B2	|O
increased	|O
(	|O
97	|O
+	|O
/	|O
-	|O
105	|O
versus	|O
40	|O
+	|O
/	|O
-	|O
26	|O
pg	|O
/	|O
ml	|O
)	|O
and	|O
was	|O
significantly	|O
higher	|O
during	|O
heparin	|O
free	|O
hemodialysis	|O
than	|O
during	|O
hemodialysis	|O
with	|O
heparin	|O
(	|O
p	|O
=	|O
0.01	|O
,	|O
Wilcoxon	|O
matched	|O
pairs	|O
signed	|O
rank	|O
test	|O
)	|O
.	|O

A	|O
new	|O
vector	|O
,	|O
pHBK280	|O
,	|O
was	|O
designed	|O
to	|O
facilitate	|O
this	|O
analysis	|O
.	|O

To	|O
explore	|O
the	|O
mechanism	|O
of	|O
RSK	|B-PROTEIN
activation	|O
,	|O
a	|O
cloned	|O
human	|O
RSK	|B-PROTEIN
cDNA	|O
(	|O
RSK3	|B-PROTEIN
)	|O
was	|O
used	|O
to	|O
generate	|O
and	|O
characterize	|O
several	|O
site	|O
-	|O
directed	|O
RSK	|B-PROTEIN
mutants	|I-PROTEIN
;	|O
K91A	|O
(	|O
N	|O
-	|O
Lys	|O
,	|O
NH2	|O
-	|O
terminal	|O
ATP	|O
-	|O
binding	|O
mutant	|O
)	|O
,	|O
K444A	|O
(	|O
C	|O
-	|O
Lys	|O
,	|O
COOH	|O
-	|O
terminal	|O
ATP	|O
-	|O
binding	|O
mutant	|O
)	|O
,	|O
N	|O
/	|O
C	|O
-	|O
Lys	|O
(	|O
double	|O
ATP	|O
-	|O
binding	|O
mutant	|O
)	|O
T570A	|O
(	|O
C	|O
-	|O
Thr	|O
,	|O
mutant	|O
of	|O
the	|O
putative	|O
MAPK	|B-PROTEIN
phosphorylation	|O
site	|O
in	|O
subdomain	|O
VIII	|O
of	|O
the	|O
C	|O
-	|O
domain	|O
)	|O
,	|O
S218A	|O
(	|O
N	|O
-	|O
Ser	|O
,	|O
mutant	|O
of	|O
the	|O
corresponding	|O
NH2	|O
-	|O
terminal	|O
residue	|O
)	|O
.	|O

In	|O
contrast	|O
,	|O
both	|O
C	|O
-	|O
Lys	|O
and	|O
C	|O
-	|O
Thr	|O
retained	|O
high	|O
levels	|O
of	|O
kinase	|O
activity	|O
and	|O
were	|O
capable	|O
of	|O
responding	|O
to	|O
stimulation	|O
.	|O

Conversely	|O
,	|O
treatment	|O
of	|O
human	|O
protein	|B-PROTEIN
-	|I-PROTEIN
tyrosine	|I-PROTEIN
phosphatase	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
overexpressing	|O
cells	|O
with	|O
phenylarsine	|O
oxide	|O
led	|O
to	|O
a	|O
loss	|O
of	|O
the	|O
constitutive	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
activity	|O
.	|O

A	|O
TATA	|O
-	|O
less	|O
promoter	|O
containing	|O
binding	|O
sites	|O
for	|O
ubiquitous	|O
transcription	|O
factors	|O
mediates	|O
cell	|O
type	|O
-	|O
specific	|O
regulation	|O
of	|O
the	|O
gene	|O
for	|O
transcription	|B-PROTEIN
enhancer	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

Since	|O
electrical	|O
stimulation	|O
of	|O
neurones	|O
may	|O
activate	|O
not	|O
only	|O
cell	|O
bodies	|O
but	|O
also	|O
neuronal	|O
fibres	|O
,	|O
this	|O
study	|O
aimed	|O
to	|O
test	|O
a	|O
selectively	|O
cholinergic	|O
neurochemical	|O
stimulation	|O
of	|O
the	|O
rat	|O
substantia	|O
innominata	|O
(	|O
SI	|O
)	|O
by	|O
the	|O
local	|O
microinjection	|O
of	|O
carbachol	|O
;	|O
the	|O
effects	|O
of	|O
this	|O
acetylcholine	|O
agonist	|O
were	|O
compared	|O
with	|O
glutamate	|O
.	|O

Here	|O
we	|O
describe	|O
an	|O
in	|O
vitro	|O
assay	|O
where	|O
the	|O
NS3	|B-PROTEIN
-	|I-PROTEIN
4A	|I-PROTEIN
polyprotein	|O
,	|O
NS3	|B-PROTEIN
,	|O
the	|O
serine	|B-PROTEIN
proteinase	|I-PROTEIN
domain	|O
(	|O
the	|O
N	|O
-	|O
terminal	|O
181	|O
residues	|O
of	|O
NS3	|B-PROTEIN
)	|O
,	|O
and	|O
the	|O
NS4A	|B-PROTEIN
cofactor	|O
were	|O
produced	|O
by	|O
cell	|O
-	|O
free	|O
translation	|O
and	|O
tested	|O
for	|O
trans	|O
-	|O
processing	|O
of	|O
radiolabeled	|O
substrates	|O
.	|O

In	|O
contrast	|O
,	|O
over	|O
-	|O
expression	|O
of	|O
RAR	|B-PROTEIN
beta	|I-PROTEIN
only	|O
poorly	|O
restored	|O
differentiation	|O
,	|O
although	|O
it	|O
could	|O
replace	|O
RAR	|B-PROTEIN
gamma	|I-PROTEIN
for	|O
the	|O
activation	|O
of	|O
target	|O
genes	|O
.	|O

We	|O
purified	|O
both	|O
proteins	|O
from	|O
human	|O
platelet	|O
membranes	|O
using	|O
DEAE	|O
-	|O
Sepharose	|O
chromatography	|O
followed	|O
by	|O
mAb	|O
F11	|B-PROTEIN
affinity	|O
chromatography	|O
.	|O

The	|O
homeobox	|O
gene	|O
ATK1	|B-PROTEIN
of	|O
Arabidopsis	|O
thaliana	|O
is	|O
expressed	|O
in	|O
the	|O
shoot	|O
apex	|O
of	|O
the	|O
seedling	|O
and	|O
in	|O
flowers	|O
and	|O
inflorescence	|O
stems	|O
of	|O
mature	|O
plants	|O
.	|O

The	|O
most	|O
likely	|O
explanation	|O
for	|O
this	|O
is	|O
that	|O
gold	|O
principally	|O
accumulates	|O
in	|O
the	|O
Kupffer	|O
cells	|O
and	|O
renal	|O
cortex	|O
and	|O
these	|O
cells	|O
do	|O
not	|O
express	|O
Type	|B-PROTEIN
I	|I-PROTEIN
deiodinase	|I-PROTEIN
.	|O

These	|O
results	|O
suggest	|O
that	|O
different	|O
models	|O
of	|O
intestinal	|O
ischemia	|O
have	|O
different	|O
cytokine	|O
profiles	|O
and	|O
that	|O
the	|O
early	|O
TNF	|B-PROTEIN
response	|O
associated	|O
with	|O
SMA	|O
occlusion	|O
model	|O
is	|O
primarily	|O
due	|O
to	|O
the	|O
laparotomy	|O
.	|O

Our	|O
evidence	|O
derives	|O
from	|O
three	|O
principal	|O
observations	|O
:	|O
1	|O
)	|O
a	|O
transfection	|O
construct	|O
containing	|O
only	|O
122	|O
nucleotides	|O
(	|O
nt	|O
)	|O
of	|O
promoter	|O
1	|O
and	|O
328	|O
nt	|O
of	|O
the	|O
5'	|O
-	|O
UTR	|O
retained	|O
full	|O
PGE2	|O
-	|O
stimulated	|O
reporter	|O
expression	|O
;	|O
2	|O
)	|O
maximal	|O
PGE2	|O
-	|O
driven	|O
reporter	|O
expression	|O
required	|O
the	|O
presence	|O
of	|O
nt	|O
196	|O
to	|O
328	|O
of	|O
exon	|O
1	|O
when	|O
tested	|O
within	|O
the	|O
context	|O
of	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
promoter	|O
1	|O
;	|O
3	|O
)	|O
cotransfection	|O
of	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
promoter	|O
-	|O
luciferase	|B-PROTEIN
-	|O
reporter	|O
constructs	|O
with	|O
a	|O
plasmid	|O
encoding	|O
the	|O
alpha	|O
-	|O
isoform	|O
of	|O
the	|O
catalytic	|O
subunit	|O
of	|O
murine	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PKA	|B-PROTEIN
)	|O
produced	|O
results	|O
comparable	|O
to	|O
those	|O
seen	|O
with	|O
PGE2	|O
treatment	|O
,	|O
whereas	|O
cotransfection	|O
with	|O
a	|O
plasmid	|O
encoding	|O
a	|O
mutant	|O
regulatory	|O
subunit	|O
of	|O
PKA	|B-PROTEIN
that	|O
cannot	|O
bind	|O
cAMP	|O
blocked	|O
PGE2	|O
-	|O
induced	|O
reporter	|O
expression	|O
.	|O

The	|O
changes	|O
after	|O
treatment	|O
were	|O
observed	|O
chiefly	|O
by	|O
electromyography	|O
while	|O
sensory	|O
and	|O
motor	|O
improvement	|O
were	|O
also	|O
recorded	|O
as	|O
auxiliary	|O
indicators	|O
.	|O

Band	|O
-	|O
shift	|O
assays	|O
and	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
experiments	|O
using	|O
purified	|O
42	|O
kDa	|O
repressor	|O
isoform	|O
confirmed	|O
that	|O
CIRs	|B-PROTEIN
5	|I-PROTEIN
and	|I-PROTEIN
6	|I-PROTEIN
were	|O
indeed	|O
the	|O
targets	|O
for	|O
binding	|O
of	|O
this	|O
protein	|O
.	|O

The	|O
5'	|O
-	|O
terminus	|O
of	|O
the	|O
p	|B-PROTEIN
-	|I-PROTEIN
gvpF	|I-PROTEIN
-	|I-PROTEIN
M	|I-PROTEIN
mRNA	|O
was	|O
located	|O
169	|O
nucleotides	|O
upstream	|O
of	|O
p	|B-PROTEIN
-	|I-PROTEIN
gvpF	|I-PROTEIN
within	|O
p	|B-PROTEIN
-	|I-PROTEIN
gvpE	|I-PROTEIN
.	|O

Retransformation	|O
of	|O
uvsH77	|B-PROTEIN
mutants	|O
with	|O
the	|O
rescued	|O
cosmids	|O
from	|O
the	|O
MMS	|O
-	|O
resistant	|O
transformants	|O
resulted	|O
in	|O
restoration	|O
of	|O
both	|O
UV	|O
and	|O
MMS	|O
resistance	|O
to	|O
wild	|O
-	|O
type	|O
levels	|O
.	|O

Furthermore	|O
,	|O
this	|O
element	|O
confers	|O
p53	|B-PROTEIN
induction	|O
to	|O
the	|O
otherwise	|O
nonresponsive	|O
adenovirus	|O
major	|O
late	|O
promoter	|O
.	|O

In	|O
flies	|O
,	|O
the	|O
dShc	|B-PROTEIN
protein	|O
physically	|O
associates	|O
with	|O
the	|O
activated	|O
Drosophila	|B-PROTEIN
epidermal	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
homolog	|O
(	|O
DER	|B-PROTEIN
)	|O
and	|O
is	|O
inducibly	|O
phosphorylated	|O
on	|O
tyrosine	|O
by	|O
DER	|B-PROTEIN
.	|O

A	|O
potential	|O
binding	|O
site	|O
for	|O
the	|O
dShc	|B-PROTEIN
PTB	|O
domain	|O
is	|O
located	|O
at	|O
Tyr	|O
-	|O
1228	|O
of	|O
DER	|B-PROTEIN
.	|O

A	|O
Drosophila	|O
shc	|B-PROTEIN
gene	|O
product	|O
is	|O
implicated	|O
in	|O
signaling	|O
by	|O
the	|O
DER	|B-PROTEIN
receptor	|I-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

This	|O
inhibition	|O
can	|O
be	|O
overcome	|O
by	|O
mutating	|O
either	|O
the	|O
exon	|O
's	|O
5'	|O
or	|O
3'	|O
splice	|O
site	|O
to	|O
make	|O
it	|O
correspond	|O
more	|O
closely	|O
to	|O
the	|O
relevant	|O
consensus	|O
sequence	|O
.	|O

Biochemical	|O
analysis	|O
shows	|O
that	|O
Ssm1p	|B-PROTEIN
is	|O
a	|O
structural	|O
protein	|O
that	|O
forms	|O
part	|O
of	|O
the	|O
largest	|O
60S	|B-PROTEIN
ribosomal	|O
subunit	|O
,	|O
which	|O
does	|O
not	|O
exist	|O
in	|O
a	|O
pool	|O
of	|O
free	|O
proteins	|O
.	|O

In	|O
wild	|O
-	|O
type	|O
cells	|O
,	|O
SSM1b	|B-PROTEIN
transcripts	|O
accumulate	|O
to	|O
twice	|O
the	|O
level	|O
of	|O
SSM1a	|B-PROTEIN
transcripts	|O
,	|O
suggesting	|O
that	|O
SSM1b	|B-PROTEIN
is	|O
responsible	|O
for	|O
the	|O
majority	|O
of	|O
the	|O
Ssm1p	|B-PROTEIN
pool	|O
.	|O

Northern	|O
blot	|O
analysis	|O
revealed	|O
the	|O
expression	|O
of	|O
LIMK	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
predominantly	|O
in	|O
the	|O
brain	|O
and	|O
the	|O
expression	|O
of	|O
LIMK	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
mRNA	|O
in	|O
various	|O
tissues	|O
in	|O
the	|O
rat	|O
.	|O

However	|O
,	|O
the	|O
relative	|O
binding	|O
affinity	|O
for	|O
the	|O
motifs	|O
is	|O
different	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
this	|O
anatomic	|O
concept	|O
,	|O
the	|O
brachioplasty	|O
procedure	|O
was	|O
modified	|O
to	|O
provide	|O
secure	|O
anchoring	|O
of	|O
the	|O
arm	|O
flap	|O
to	|O
the	|O
axillary	|O
fascia	|O
along	|O
with	|O
strong	|O
superficial	|O
fascial	|O
system	|O
repair	|O
of	|O
incisions	|O
,	|O
reducing	|O
the	|O
risk	|O
of	|O
widening	|O
or	|O
migration	|O
of	|O
scars	|O
and	|O
unnatural	|O
contours	|O
.	|O

Furthermore	|O
,	|O
microinjection	|O
of	|O
dominant	|O
negative	|O
forms	|O
of	|O
Rac	|B-PROTEIN
and	|O
Cdc42	|B-PROTEIN
or	|O
of	|O
the	|O
Rho	|B-PROTEIN
inhibitor	|O
C3	|B-PROTEIN
transferase	|I-PROTEIN
blocked	|O
serum	|O
-	|O
induced	|O
DNA	|O
synthesis	|O
.	|O

INF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
therapy	|O
has	|O
been	|O
a	|O
major	|O
development	|O
in	|O
the	|O
treatment	|O
of	|O
CML	|O
.	|O

A	|O
series	|O
of	|O
amino	|O
terminal	|O
deletion	|O
mutants	|O
(	|O
d10	|O
,	|O
d20	|O
,	|O
d27	|O
,	|O
d31	|O
,	|O
d40	|O
,	|O
d44	|O
,	|O
and	|O
d73	|O
)	|O
were	|O
compared	|O
for	|O
processing	|O
,	|O
cell	|O
surface	|O
expression	|O
,	|O
and	|O
maintenance	|O
of	|O
their	|O
biological	|O
attributes	|O
by	|O
recombinant	|O
expression	|O
of	|O
mutant	|O
genes	|O
using	|O
a	|O
plasmid	|O
vector	|O
(	|O
pcDL	|O
-	|O
SR	|O
alpha	|O
-	|O
296	|O
)	|O
in	|O
CV	|O
-	|O
1	|O
and	|O
HeLa	|O
cells	|O
.	|O

Intrathecal	|O
acetyl	|B-PROTEIN
cholinesterase	|I-PROTEIN
inhibitors	|O
produce	|O
analgesia	|O
that	|O
is	|O
synergistic	|O
with	|O
morphine	|O
and	|O
clonidine	|O
in	|O
rats	|O
.	|O

After	|O
determining	|O
isoflurane	|O
MAC	|O
in	|O
triplicate	|O
,	|O
birds	|O
were	|O
given	|O
a	|O
mu	|O
-	|O
opioid	|O
agonist	|O
(	|O
morphine	|O
,	|O
n	|O
=	|O
9	|O
)	|O
or	|O
a	|O
kappa	|O
-	|O
opioid	|O
agonist	|O
(	|O
U50488H	|O
,	|O
n	|O
=	|O
9	|O
)	|O
.	|O

Max	|B-PROTEIN
was	|O
constantly	|O
transcribed	|O
at	|O
a	|O
relatively	|O
low	|O
level	|O
during	|O
cell	|O
cycle	|O
progression	|O
.	|O

The	|O
yeast	|O
enzyme	|O
was	|O
6	|O
-	|O
fold	|O
slower	|O
than	|O
the	|O
mammalian	|O
enzymes	|O
,	|O
which	|O
made	|O
it	|O
amenable	|O
to	|O
pre	|O
-	|O
steady	|O
-	|O
state	|O
stopped	|O
-	|O
flow	|O
spectroscopic	|O
kinetic	|O
analysis	|O
at	|O
30	|O
degrees	|O
C	|O
and	|O
pH	|O
6.0	|O
.	|O

Key	|O
areas	|O
of	|O
the	|O
selection	|O
process	|O
including	|O
medical	|O
and	|O
surgical	|O
alternatives	|O
to	|O
transplantation	|O
,	|O
the	|O
composition	|O
of	|O
the	|O
transplant	|O
work	|O
-	|O
up	|O
,	|O
specific	|O
inclusion	|O
criteria	|O
as	|O
well	|O
as	|O
specific	|O
psychosocial	|O
factors	|O
and	|O
specific	|O
disease	|O
etiologies	|O
and	|O
co	|O
-	|O
morbidities	|O
that	|O
might	|O
represent	|O
contraindications	|O
were	|O
extensively	|O
reviewed	|O
.	|O

The	|O
transport	|O
of	|O
a	|O
genetically	|O
engineered	|O
chimeric	|O
transmembrane	|O
protein	|O
connected	|O
to	|O
this	|O
ER	|O
leader	|O
sequence	|O
was	|O
as	|O
efficient	|O
as	|O
that	|O
of	|O
the	|O
original	|O
protein	|O
from	|O
which	|O
the	|O
ER	|O
sequence	|O
has	|O
been	|O
derived	|O
.	|O

In	|O
both	|O
shoots	|O
and	|O
roots	|O
,	|O
GT	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
is	|O
undetectable	|O
in	|O
meristematic	|O
tissue	|O
but	|O
becomes	|O
expressed	|O
at	|O
later	|O
stages	|O
of	|O
cellular	|O
development	|O
,	|O
consistent	|O
with	|O
a	|O
role	|O
in	|O
contributing	|O
to	|O
the	|O
pattern	|O
of	|O
phytochrome	|B-PROTEIN
A	|I-PROTEIN
gene	|O
expression	|O
.	|O

A	|O
polymorphic	|O
bipartite	|O
motif	|O
signals	|O
nuclear	|O
targeting	|O
of	|O
early	|O
auxin	|O
-	|O
inducible	|O
proteins	|O
related	|O
to	|O
PS	|B-PROTEIN
-	|I-PROTEIN
IAA4	|I-PROTEIN
from	|O
pea	|O
(	|O
Pisum	|O
sativum	|O
)	|O
.	|O

Comparative	|O
DNA	|O
sequence	|O
analysis	|O
showed	|O
the	|O
Genethon	|O
microsatellite	|O
D19S596	|B-PROTEIN
lies	|O
2.2	|O
kb	|O
downstream	|O
of	|O
the	|O
coding	|O
region	|O
of	|O
FUT1	|B-PROTEIN
,	|O
indicating	|O
that	|O
the	|O
cluster	|O
comprising	|O
the	|O
closely	|O
linked	|O
FUT1	|B-PROTEIN
and	|O
FUT2	|B-PROTEIN
genes	|O
is	|O
located	|O
4	|O
cM	|O
distal	|O
to	|O
D19S412	|B-PROTEIN
(	|O
lod	|O
score	|O
13.7	|O
)	|O
and	|O
9	|O
cM	|O
proximal	|O
to	|O
D19S571	|B-PROTEIN
(	|O
lod	|O
score	|O
11.7	|O
)	|O
.	|O

We	|O
conclude	|O
that	|O
transcription	|O
activation	|O
by	|O
LEF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
vitro	|O
is	|O
a	|O
chromatin	|O
-	|O
dependent	|O
process	|O
that	|O
requires	|O
a	|O
functional	|O
trans	|O
-	|O
activation	|O
domain	|O
in	|O
addition	|O
to	|O
the	|O
HMG	|B-PROTEIN
domain	|O
.	|O

TH	|B-PROTEIN
-	|O
SH3	|B-PROTEIN
binding	|O
in	|O
vitro	|O
is	|O
abolished	|O
by	|O
specific	|O
,	|O
single	|O
amino	|O
acid	|O
substitutions	|O
within	|O
the	|O
Btk	|O
TH	|B-PROTEIN
domain	|O
or	|O
the	|O
Fyn	|O
SH3	|B-PROTEIN
domain	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
K	|B-PROTEIN
-	|I-PROTEIN
glypican	|I-PROTEIN
is	|O
a	|O
novel	|O
GPI	|O
-	|O
anchored	|O
HSPG	|B-PROTEIN
involved	|O
in	|O
embryonic	|O
development	|O
.	|O

Protein	|B-PROTEIN
S	|I-PROTEIN
levels	|O
were	|O
virtually	|O
undetectable	|O
at	|O
the	|O
time	|O
of	|O
admission	|O
and	|O
failed	|O
to	|O
respond	|O
to	|O
infusions	|O
of	|O
fresh	|O
frozen	|O
plasma	|O
,	|O
despite	|O
correction	|O
of	|O
other	|O
procoagulant	|O
and	|O
anticoagulant	|O
factors	|O
.	|O

The	|O
plant	|O
hormone	|O
auxin	|O
transcriptionally	|O
activates	|O
early	|B-PROTEIN
genes	|I-PROTEIN
.	|O

The	|O
test	|O
was	|O
not	|O
performed	|O
in	|O
3923	|O
patients	|O
because	|O
of	|O
contraindications	|O
.	|O

The	|O
ubiquitous	|O
transcription	|O
factor	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
forms	|O
complexes	|O
with	|O
an	|O
octamer	|O
motif	|O
present	|O
within	|O
FPIV	|O
by	|O
gel	|O
shift	|O
analysis	|O
with	|O
liver	|O
and	|O
kidney	|O
extracts	|O
,	|O
making	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
an	|O
intriguing	|O
candidate	|O
for	|O
partnership	|O
in	|O
androgen	|O
regulation	|O
.	|O

A	|O
new	|O
non	|O
-	|O
LTR	|O
retrotransposon	|O
provides	|O
evidence	|O
for	|O
multiple	|O
distinct	|O
site	|O
-	|O
specific	|O
elements	|O
in	|O
Crithidia	|O
fasciculata	|O
miniexon	|O
arrays	|O
.	|O

We	|O
used	|O
deletion	|O
analysis	|O
and	|O
transfection	|O
assays	|O
with	|O
reporter	|O
gene	|O
constructs	|O
to	|O
examine	|O
the	|O
transcription	|O
control	|O
elements	|O
in	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
EpoR	|B-PROTEIN
gene	|O
.	|O

The	|O
CVA16.4	|B-PROTEIN
proteolipid	|O
transcript	|O
is	|O
the	|O
most	|O
prevalent	|O
of	|O
the	|O
two	|O
proteolipid	|O
messages	|O
in	|O
expanding	|O
ovules	|O
harvested	|O
10	|O
d	|O
post	|O
-	|O
anthesis	|O
.	|O

Incubation	|O
of	|O
the	|O
purified	|O
fusion	|O
proteins	|O
with	|O
[	|O
gamma	|O
-	|O
32P	|O
]	|O
ATP	|O
in	|O
an	|O
in	|O
vitro	|O
assay	|O
showed	|O
that	|O
both	|O
proteins	|O
were	|O
capable	|O
of	|O
autophosphorylation	|O
.	|O

The	|O
character	|O
of	|O
specific	|O
immune	|O
response	|O
in	|O
101	|O
immunized	|O
children	|O
and	|O
in	|O
12	|O
adults	|O
belonging	|O
to	|O
a	|O
high	|O
risk	|O
group	|O
with	|O
respect	|O
to	|O
VHB	|O
.	|O

After	|O
nadolol	|O
,	|O
heart	|O
rate	|O
decreased	|O
(	|O
-	|O
22	|O
+	|O
/	|O
-	|O
8%	|O
)	|O
,	|O
and	|O
so	|O
did	|O
PBV	|O
and	|O
PBF	|O
(	|O
8.8	|O
+	|O
/	|O
-	|O
3.4	|O
vs.	|O

The	|O
synthetic	|O
DNA	|O
sequence	|O
was	|O
constructed	|O
to	|O
achieve	|O
efficient	|O
base	|O
pairing	|O
with	|O
Escherichia	|O
coli	|O
16S	|B-PROTEIN
ribosomal	|O
RNA	|O
,	|O
avoidance	|O
of	|O
internal	|O
secondary	|O
structure	|O
,	|O
and	|O
optimal	|O
codon	|O
usage	|O
for	|O
high	|O
-	|O
level	|O
protein	|O
expression	|O
in	|O
accord	|O
with	|O
the	|O
known	|O
preferences	|O
in	|O
E.	|O
coli	|O
.	|O

Adrenergic	|O
system	|O
activation	|O
,	|O
indicated	|O
by	|O
metanephrine	|O
/	|O
epinephrine	|O
ratio	|O
,	|O
increased	|O
with	|O
time	|O
in	|O
losing	|O
males	|O
,	|O
except	|O
that	|O
after	|O
one	|O
month	|O
of	|O
cohabitation	|O
,	|O
turnover	|O
returned	|O
to	|O
levels	|O
that	|O
equaled	|O
those	|O
of	|O
control	|O
animals	|O
.	|O

Transabdominal	|O
repair	|O
of	|O
type	|O
IV	|O
thoraco	|O
-	|O
abdominal	|O
aortic	|O
aneurysms	|O
.	|O

A.	|O

Transcription	|O
factors	|O
containing	|O
a	|O
basic	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
(	|O
bHLH	|O
)	|O
motif	|O
regulate	|O
the	|O
expression	|O
of	|O
tissue	|O
-	|O
specific	|O
genes	|O
in	|O
a	|O
number	|O
of	|O
mammalian	|O
and	|O
insect	|O
systems	|O
.	|O

Primer	|O
extension	|O
and	|O
cDNA	|O
cloning	|O
were	|O
used	|O
to	|O
isolate	|O
the	|O
complete	|O
5'	|O
end	|O
of	|O
the	|O
Nramp1	|B-PROTEIN
mRNA	|O
.	|O

Primer	|O
extension	|O
and	|O
S1	|B-PROTEIN
nuclease	|O
mapping	|O
experiments	|O
were	|O
used	|O
to	|O
locate	|O
the	|O
transcription	|O
initiation	|O
site	|O
of	|O
Nramp1	|B-PROTEIN
and	|O
revealed	|O
the	|O
presence	|O
of	|O
one	|O
major	|O
and	|O
several	|O
minor	|O
initiation	|O
sites	|O
.	|O

EsaR	|B-PROTEIN
can	|O
repress	|O
its	|O
own	|O
expression	|O
but	|O
seems	|O
not	|O
to	|O
regulate	|O
the	|O
expression	|O
of	|O
esaI	|B-PROTEIN
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
CD69	|B-PROTEIN
gene	|O
revealed	|O
the	|O
presence	|O
of	|O
a	|O
potential	|O
TATA	|O
element	|O
30	|O
base	|O
pairs	|O
upstream	|O
of	|O
the	|O
major	|O
transcription	|O
initiation	|O
site	|O
and	|O
several	|O
putative	|O
binding	|O
sequences	|O
for	|O
inducible	|O
transcription	|O
factors	|O
(	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
,	|O
Egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
which	|O
might	|O
mediate	|O
the	|O
inducible	|O
expression	|O
of	|O
this	|O
gene	|O
.	|O

The	|O
plasmin	|B-PROTEIN
-	|O
derived	|O
D	|O
(	|O
approximately	|O
105	|O
-	|O
kDa	|O
)	|O
product	|O
,	|O
however	|O
,	|O
could	|O
be	|O
cross	|O
-	|O
linked	|O
into	|O
DD	|O
dimers	|O
.	|O

All	|O
clinical	|O
isolates	|O
were	|O
concomitantly	|O
tested	|O
by	|O
disk	|O
diffusion	|O
and	|O
agar	|O
dilution	|O
procedures	|O
as	|O
outlined	|O
by	|O
the	|O
National	|O
Committee	|O
for	|O
Clinical	|O
Laboratory	|O
Standards	|O
.	|O

IgE	|B-PROTEIN
levels	|O
showed	|O
higher	|O
values	|O
compared	|O
to	|O
normal	|O
individuals	|O
and	|O
IgE	|B-PROTEIN
levels	|O
were	|O
higher	|O
in	|O
children	|O
groups	|O
than	|O
in	|O
adults	|O
regardless	|O
of	|O
the	|O
intensity	|O
of	|O
infection	|O
.	|O

Tissue	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
tmy	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
was	|O
determined	|O
by	|O
microinjection	|O
of	|O
a	|O
promoter	|O
/	|O
lacZ	|B-PROTEIN
fusion	|O
gene	|O
and	|O
with	|O
immunohistochemistry	|O
by	|O
using	|O
affinity	|O
-	|O
purified	|O
tissue	|O
-	|O
specific	|O
anti	|B-PROTEIN
-	|I-PROTEIN
tropomyosins	|I-PROTEIN
.	|O

The	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
chloroplast	|O
(	|O
cp	|O
)	|O
DNA	|O
from	|O
maize	|O
(	|O
Zea	|O
mays	|O
)	|O
has	|O
been	|O
completed	|O
.	|O

Investigation	|O
of	|O
the	|O
control	|O
of	|O
coronavirus	|O
subgenomic	|O
mRNA	|O
transcription	|O
by	|O
using	|O
T7	|O
-	|O
generated	|O
negative	|O
-	|O
sense	|O
RNA	|O
transcripts	|O
.	|O

Initiation	|O
of	|O
translation	|O
of	|O
the	|O
human	|O
hepatitis	|O
C	|O
virus	|O
(	|O
HCV	|O
)	|O
RNA	|O
genome	|O
occurs	|O
by	|O
internal	|O
ribosome	|O
entry	|O
into	|O
the	|O
5'	|O
noncoding	|O
region	|O
(	|O
5'	|O
NCR	|O
)	|O
in	|O
a	|O
cap	|O
-	|O
independent	|O
manner	|O
.	|O

Mean	|O
longitudinal	|O
extension	|O
of	|O
the	|O
epidural	|O
lesion	|O
was	|O
2.6	|O
vertebral	|O
segments	|O
.	|O

The	|O
association	|O
of	|O
p255	|B-PROTEIN
with	|O
splicing	|O
complexes	|O
is	|O
suggested	|O
by	|O
the	|O
finding	|O
that	|O
mAb	|O
CC3	|B-PROTEIN
can	|O
inhibit	|O
in	|O
vitro	|O
splicing	|O
and	|O
immunoprecipitate	|O
pre	|O
-	|O
messenger	|O
RNA	|O
and	|O
splicing	|O
products	|O
.	|O

L	|O
-	|O
735,524	|O
free	|O
base	|O
or	|O
sulfate	|O
salt	|O
was	|O
administered	|O
orally	|O
as	|O
suspension	|O
,	|O
solution	|O
or	|O
in	|O
solid	|O
dosage	|O
forms	|O
to	|O
fasted	|O
or	|O
fed	|O
Beagle	|O
dogs	|O
.	|O

Doppler	|O
ultrasound	|O
studies	|O
of	|O
long	|O
-	|O
term	|O
follow	|O
-	|O
up	|O
of	|O
children	|O
with	|O
hemolytic	|O
-	|O
uremic	|O
syndrome	|O

Thus	|O
,	|O
endemic	|O
cumlations	|O
of	|O
hepatitis	|O
A	|O
diseases	|O
are	|O
possible	|O
.	|O

(	|O
1991	|O
)	|O
.	|O

The	|O
properties	|O
of	|O
the	|O
phi	|O
29	|O
SSB	|B-PROTEIN
-	|O
ssDNA	|O
complex	|O
are	|O
described	|O
.	|O

This	|O
shows	|O
that	|O
the	|O
characteristically	|O
diffuse	|O
banding	|O
pattern	|O
of	|O
plant	|O
nuclear	|O
proteins	|O
interacting	|O
with	|O
the	|O
G	|O
-	|O
box	|O
is	|O
also	|O
observed	|O
in	|O
a	|O
binding	|O
assay	|O
using	|O
only	|O
one	|O
recombinant	|O
GBF	|B-PROTEIN
.	|O

We	|O
studied	|O
120	|O
male	|O
and	|O
42	|O
female	|O
patients	|O
with	|O
early	|O
CAD	|O
who	|O
were	|O
unrelated	|O
to	|O
each	|O
other	|O
but	|O
were	|O
from	|O
families	|O
in	|O
which	|O
at	|O
least	|O
one	|O
other	|O
sibling	|O
had	|O
early	|O
CAD	|O
.	|O

The	|O
physical	|O
linkage	|O
of	|O
the	|O
FHR2	|B-PROTEIN
and	|O
the	|O
factor	|B-PROTEIN
H	|I-PROTEIN
genes	|O
provides	|O
additional	|O
evidence	|O
for	|O
a	|O
close	|O
relatedness	|O
of	|O
complement	|O
factor	|B-PROTEIN
H	|I-PROTEIN
and	|O
the	|O
factor	|B-PROTEIN
H	|I-PROTEIN
-	|O
related	|O
proteins	|O
.	|O

Genomic	|O
structure	|O
and	|O
chromosomal	|O
location	|O
of	|O
the	|O
mouse	|O
pre	|B-PROTEIN
-	|I-PROTEIN
T	|I-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
.	|O

The	|O
third	|O
domain	|O
had	|O
the	|O
motif	|O
of	|O
a	|O
cAMP	|O
response	|O
element	|O
(	|O
CRE	|O
)	|O
.	|O

The	|O
tyrosine	|O
-	|O
phosphorylated	|O
state	|O
of	|O
CAK	|B-PROTEIN
beta	|I-PROTEIN
was	|O
not	|O
reduced	|O
on	|O
trypsinization	|O
,	|O
nor	|O
enhanced	|O
in	|O
response	|O
to	|O
plating	|O
3Y1	|O
cells	|O
onto	|O
fibronectin	|B-PROTEIN
.	|O

Our	|O
results	|O
suggest	|O
that	|O
while	|O
many	|O
muscle	|O
gene	|O
E	|O
-	|O
boxes	|O
are	|O
capable	|O
of	|O
binding	|O
the	|O
previously	|O
characterized	|O
spectrum	|O
of	|O
MDF	|B-PROTEIN
/	|O
bH	|O
-	|O
L	|O
-	|O
H	|O
heterodimers	|O
in	|O
vitro	|O
,	|O
MCK	|B-PROTEIN
-	|I-PROTEIN
L	|I-PROTEIN
type	|O
E	|O
-	|O
boxes	|O
probably	|O
bind	|O
qualitatively	|O
different	|O
factors	|O
in	|O
vivo	|O
.	|O

A	|O
single	|O
-	|O
case	|O
experimental	|O
ABAB	|O
multiple	|O
baseline	|O
design	|O
was	|O
employed	|O
to	|O
test	|O
for	|O
treatment	|O
effectiveness	|O
.	|O

These	|O
clones	|O
were	|O
found	|O
to	|O
share	|O
a	|O
common	|O
domain	|O
encoded	|O
by	|O
p	|O
(	|O
CA	|O
)	|O
n	|O
repeats	|O
;	|O
a	|O
simple	|O
sequence	|O
length	|O
polymorphism	|O
(	|O
SSLP	|O
)	|O
.	|O

In	|O
one	|O
glioblastoma	|O
cell	|O
line	|O
,	|O
a	|O
Shc	|B-PROTEIN
-	|O
associated	|O
p190	|B-PROTEIN
was	|O
identified	|O
as	|O
the	|O
activated	|O
PDGFR	|B-PROTEIN
.	|O

We	|O
conclude	|O
that	|O
,	|O
in	|O
comparison	|O
to	|O
reports	|O
from	|O
other	|O
regions	|O
,	|O
Scandinavian	|O
renal	|O
transplant	|O
recipients	|O
are	|O
at	|O
high	|O
risk	|O
of	|O
dying	|O
of	|O
IHD	|O
.	|O

Veterinary	|O
certification	|O
for	|O
livestock	|O
export	|O
.	|O

The	|O
serum	|O
concentration	|O
of	|O
iP	|O
before	|O
dialysis	|O
(	|O
HD	|O
)	|O
was	|O
on	|O
average	|O
3.06	|O
(	|O
+	|O
/	|O
-	|O
0.81	|O
)	|O
mmol	|O
/	|O
l	|O
and	|O
D	|O
was	|O
on	|O
average	|O
55.6	|O
(	|O
+	|O
/	|O
-	|O
10.0	|O
)	|O
mmol	|O
.	|O

A	|O
significant	|O
correlation	|O
between	|O
a	|O
number	|O
of	|O
functional	|O
parameters	|O
of	|O
gastric	|O
secretion	|O
,	|O
incretion	|O
and	|O
histological	|O
changes	|O
of	|O
gastric	|O
mucosa	|O
was	|O
found	|O
in	|O
patients	|O
with	|O
chronic	|O
gastritis	|O
.	|O

The	|O
TAF	|O
factor	|O
appears	|O
to	|O
be	|O
particularly	|O
significant	|O
in	|O
OCD	|O
.	|O

Diffuse	|O
white	|O
matter	|O
injury	|O
can	|O
be	|O
attributed	|O
to	|O
radiation	|O
and	|O
associated	|O
with	|O
neurological	|O
deficits	|O
,	|O
but	|O
leukoencephalopathy	|O
is	|O
rarely	|O
observed	|O
in	|O
the	|O
absence	|O
of	|O
chemotherapy	|O
.	|O

RNase	|B-PROTEIN
protection	|O
analyses	|O
indicate	|O
that	|O
either	|O
61	|O
-	|O
kDa	|O
CaM	|B-PROTEIN
PDE	|I-PROTEIN
mRNA	|O
or	|O
structurally	|O
related	|O
transcripts	|O
encoding	|O
different	|O
CaM	|B-PROTEIN
PDE	|I-PROTEIN
isoforms	|O
are	|O
expressed	|O
in	|O
a	|O
tissue	|O
-	|O
specific	|O
manner	|O
.	|O

Little	|O
or	|O
no	|O
protection	|O
was	|O
detected	|O
using	|O
adrenal	|O
cortex	|O
,	|O
adrenal	|O
medulla	|O
,	|O
liver	|O
,	|O
kidney	|O
cortex	|O
,	|O
spleen	|O
,	|O
or	|O
T	|O
-	|O
lymphocyte	|O
total	|O
RNA	|O
.	|O

The	|O
PDGFR	|B-PROTEIN
mutants	|O
that	|O
failed	|O
to	|O
associate	|O
with	|O
PLC	|B-PROTEIN
gamma	|I-PROTEIN
were	|O
not	|O
able	|O
to	|O
mediate	|O
the	|O
PDGF	|B-PROTEIN
-	|O
dependent	|O
production	|O
of	|O
inositol	|O
phosphates	|O
.	|O

We	|O
found	|O
a	|O
direct	|O
correlation	|O
between	|O
the	|O
levels	|O
of	|O
transcription	|O
of	|O
the	|O
acc	|B-PROTEIN
genes	|O
and	|O
the	|O
rate	|O
of	|O
cellular	|O
growth	|O
.	|O

The	|O
hybridizing	|O
clone	|O
of	|O
V.	|O
vulnificus	|O
chromosomal	|O
DNA	|O
complemented	|O
a	|O
V.	|O
cholerae	|O
fur	|B-PROTEIN
mutant	|O
.	|O

We	|O
generated	|O
transformed	|O
B	|O
lymphoblast	|O
cell	|O
lines	|O
from	|O
controls	|O
,	|O
from	|O
four	|O
patients	|O
with	|O
p47	|B-PROTEIN
-	|O
phox	|B-PROTEIN
-	|O
deficient	|O
chronic	|O
granulomatous	|O
disease	|O
,	|O
and	|O
from	|O
three	|O
parents	|O
.	|O

The	|O
ectopic	|O
expression	|O
of	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
3/4	|I-PROTEIN
in	|O
hybrid	|O
cells	|O
under	|O
a	|O
constitutive	|O
promoter	|O
is	|O
sufficient	|O
for	|O
transcriptional	|O
activation	|O
of	|O
an	|O
octamer	|O
-	|O
dependent	|O
promoter	|O
.	|O

RNase	|B-PROTEIN
protection	|O
and	|O
primer	|O
extension	|O
assays	|O
confirmed	|O
that	|O
the	|O
5'	|O
non	|O
-	|O
coding	|O
exon	|O
is	|O
included	|O
in	|O
the	|O
DDT1	|O
aFGF	|B-PROTEIN
mRNA	|O
and	|O
that	|O
a	|O
major	|O
transcription	|O
start	|O
site	|O
is	|O
approximately	|O
136	|O
bp	|O
upstream	|O
of	|O
the	|O
5'	|O
non	|O
-	|O
coding	|O
splice	|O
junction	|O
of	|O
this	|O
exon	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
FK	|O
506	|O
is	|O
a	|O
useful	|O
immunosuppressive	|O
agent	|O
in	|O
kidney	|O
transplantation	|O
.	|O

The	|O
roles	|O
of	|O
phorbol	|O
esters	|O
and	|O
cyclic	|O
AMP	|O
in	|O
mediating	|O
the	|O
GnRH	|B-PROTEIN
response	|O
were	|O
also	|O
investigated	|O
.	|O

RT	|O
-	|O
PCR	|O
using	|O
1.D	|O
-	|O
specific	|O
primers	|O
showed	|O
that	|O
kidney	|O
,	|O
brain	|O
and	|O
prostate	|O
do	|O
not	|O
express	|O
1.D	|O
mRNA	|O
even	|O
though	|O
kidney	|O
and	|O
brain	|O
are	|O
the	|O
most	|O
abundant	|O
source	|O
for	|O
aFGF	|B-PROTEIN
protein	|O
.	|O

Molecular	|O
cloning	|O
and	|O
characterization	|O
of	|O
two	|O
genes	|O
encoding	|O
gp138	|B-PROTEIN
,	|O
a	|O
cell	|O
surface	|O
glycoprotein	|O
involved	|O
in	|O
the	|O
sexual	|O
cell	|O
fusion	|O
of	|O
Dictyostelium	|O
discoideum	|O
.	|O

Two	|O
-	|O
dimensional	|O
phosphotryptic	|O
analyses	|O
indicate	|O
that	|O
phosphorylation	|O
on	|O
Ser	|O
-	|O
12	|O
and	|O
Ser	|O
-	|O
48	|O
in	|O
unstimulated	|O
cells	|O
is	|O
associated	|O
with	|O
the	|O
ability	|O
of	|O
overexpressed	|O
pp60c	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
to	|O
potentiate	|O
beta	|O
-	|O
adrenergic	|O
signalling	|O
.	|O

Piroximone	|O
is	|O
a	|O
new	|O
phosphodiesterase	|B-PROTEIN
III	|I-PROTEIN
inhibitor	|O
that	|O
combines	|O
inotropic	|O
and	|O
vasodilator	|O
properties	|O
.	|O

Cytogenetic	|O
studies	|O
were	|O
performed	|O
in	|O
lymphocytes	|O
from	|O
hospital	|O
workers	|O
exposed	|O
to	|O
low	|O
doses	|O
of	|O
radiation	|O
(	|O
1.6-42.71	|O
mSv	|O
)	|O
.	|O

To	|O
study	|O
the	|O
origin	|O
of	|O
different	|O
fMLF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
transcripts	|O
,	|O
the	|O
genetic	|O
linkage	|O
of	|O
chemotactic	|O
receptor	|O
genes	|O
,	|O
and	|O
the	|O
regulation	|O
of	|O
fMLF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
gene	|O
expression	|O
,	|O
we	|O
determined	|O
the	|O
copy	|O
number	|O
,	|O
chromosomal	|O
location	|O
,	|O
structural	|O
organization	|O
,	|O
and	|O
5'	|O
-	|O
flanking	|O
sequence	|O
of	|O
the	|O
human	|O
fMLF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
gene	|O
.	|O

The	|O
first	|O
exon	|O
encodes	|O
66	|O
bp	|O
of	|O
the	|O
5'	|O
-	|O
untranslated	|O
sequence	|O
,	|O
while	|O
exon	|O
2	|O
encodes	|O
the	|O
coding	|O
and	|O
3'	|O
-	|O
untranslated	|O
sequences	|O
.	|O

The	|O
genomic	|O
structure	|O
of	|O
four	|O
members	|O
of	|O
the	|O
SRC	|B-PROTEIN
-	|O
family	|O
revealed	|O
nearly	|O
identical	|O
exon	|O
/	|O
intron	|O
boundaries	|O
within	|O
the	|O
catalytic	|O
domain	|O
of	|O
this	|O
family	|O
.	|O

Since	|O
we	|O
have	|O
observed	|O
effects	|O
of	|O
growth	|O
factors	|O
and	|O
cAMP	|O
as	|O
well	|O
as	|O
estradiol	|O
(	|O
E2	|O
)	|O
on	|O
regulation	|O
of	|O
expression	|O
of	|O
some	|O
genes	|O
stimulated	|O
by	|O
the	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
ER	|B-PROTEIN
)	|O
,	|O
we	|O
have	|O
undertaken	|O
studies	|O
to	|O
examine	|O
directly	|O
whether	|O
activators	|O
of	|O
protein	|O
kinases	|O
can	|O
modulate	|O
transcriptional	|O
activity	|O
of	|O
the	|O
ER	|B-PROTEIN
.	|O

Using	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
,	|O
Whipple	|O
-	|O
specific	|O
DNA	|O
fragments	|O
of	|O
284	|O
base	|O
pairs	|O
from	|O
the	|O
genome	|O
of	|O
the	|O
Whipple	|O
bacterium	|O
(	|O
Tropheryma	|O
whippelii	|O
)	|O
were	|O
demonstrated	|O
.	|O

RNA	|B-PROTEIN
polymerase	|I-PROTEIN
bound	|O
to	|O
the	|O
+	|O
10A	|O
promoter	|O
partially	|O
protects	|O
a	|O
20	|O
base	|O
-	|O
pair	|O
sequence	|O
from	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
digestion	|O
upstream	|O
of	|O
the	|O
start	|O
site	|O
.	|O

Salivary	|O
sodium	|O
,	|O
calcium	|O
,	|O
and	|O
magnesium	|O
concentrations	|O
were	|O
significantly	|O
higher	|O
in	|O
the	|O
SLE	|O
patients	|O
with	|O
systemic	|O
lupus	|O
erythematosus	|O
,	|O
whereas	|O
potassium	|O
and	|O
total	|O
protein	|O
concentrations	|O
and	|O
amylase	|B-PROTEIN
activity	|O
did	|O
not	|O
differ	|O
significantly	|O
from	|O
the	|O
controls	|O
.	|O

Chem.	|O

Recombinant	|O
plasmid	|O
pFV100	|O
was	|O
subsequently	|O
isolated	|O
by	|O
its	|O
ability	|O
to	|O
complement	|O
B	|O
-	|O
band	|O
expression	|O
in	|O
ge6	|B-PROTEIN
.	|O

We	|O
here	|O
demonstrate	|O
that	|O
a	|O
temperature	|O
-	|O
sensitive	|O
fission	|O
yeast	|O
mutant	|O
which	|O
has	|O
a	|O
mutation	|O
in	|O
a	|O
homologous	|O
gene	|O
,	|O
and	|O
two	|O
of	|O
three	|O
additional	|O
(	|O
mtr1	|B-PROTEIN
/	|O
prp20	|B-PROTEIN
/	|O
srm1	|B-PROTEIN
)	|O
mutants	|O
accumulate	|O
nuclear	|O
poly	|O
(	|O
A	|O
)	|O
+	|O
RNA	|O
at	|O
37	|O
degrees	|O
C.	|O

Since	|O
RCC1p	|B-PROTEIN
acts	|O
as	|O
GNRP	|B-PROTEIN
for	|O
Ran	|B-PROTEIN
,	|O
a	|O
small	|O
nuclear	|O
GTPase	|B-PROTEIN
of	|O
the	|O
ras	|B-PROTEIN
superfamily	|O
,	|O
we	|O
have	|O
identified	|O
two	|O
homologs	|O
of	|O
Ran	|B-PROTEIN
in	|O
S.c	|O
erevisiae	|O
(	|O
CNR1	|B-PROTEIN
and	|O
CNR2	|B-PROTEIN
)	|O
.	|O

The	|O
immunosuppressant	|O
FK506	|O
inhibits	|O
amino	|O
acid	|O
import	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Prostate	|B-PROTEIN
specific	|I-PROTEIN
antigen	|I-PROTEIN
shows	|O
the	|O
metastatic	|O
cases	|O
better	|O
[	|O
correction	|O
of	|O
worse	|O
]	|O
than	|O
prostatic	|B-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
.	|O

Protein	|O
phosphorylation	|O
appears	|O
to	|O
play	|O
a	|O
critical	|O
role	|O
in	|O
uPA	|B-PROTEIN
gene	|O
expression	|O
in	|O
these	|O
cells	|O
;	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
-	|O
activating	|O
phorbol	|O
esters	|O
cooperate	|O
with	|O
pp60v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
to	|O
synergistically	|O
increase	|O
uPA	|B-PROTEIN
mRNA	|O
,	|O
whereas	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
(	|I-PROTEIN
cAMP	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
-	|O
activating	|O
agents	|O
(	|O
e.g.	|O
,	|O
8	|O
-	|O
bromo	|O
cAMP	|O
)	|O
repress	|O
uPA	|B-PROTEIN
mRNA	|O
levels	|O
.	|O

Of	|O
these	|O
carriers	|O
149	|O
were	|O
diagnosed	|O
to	|O
be	|O
asymptomatic	|O
clinically	|O
,	|O
biochemically	|O
and	|O
echographically	|O
.	|O

This	|O
300	|O
bp	|O
5'	|O
-	|O
upstream	|O
sequence	|O
of	|O
K3	|B-PROTEIN
keratin	|I-PROTEIN
gene	|O
,	|O
which	|O
can	|O
function	|O
in	|O
vitro	|O
as	|O
a	|O
keratinocyte	|O
-	|O
specific	|O
promoter	|O
,	|O
contains	|O
two	|O
clusters	|O
of	|O
partially	|O
overlapping	|O
motifs	|O
,	|O
one	|O
with	|O
an	|O
NFkB	|B-PROTEIN
consensus	|O
sequence	|O
and	|O
another	|O
with	|O
a	|O
GC	|O
box	|O
.	|O

Identification	|O
of	|O
mutations	|O
in	|O
the	|O
coding	|O
sequence	|O
of	|O
the	|O
proto	|O
-	|O
oncogene	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
in	|O
a	|O
human	|O
mast	|O
cell	|O
leukemia	|O
cell	|O
line	|O
causing	|O
ligand	|O
-	|O
independent	|O
activation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
product	|O
.	|O

BACKGROUND	|O
:	|O
Delineation	|O
of	|O
the	|O
morphologic	|O
aspects	|O
of	|O
age	|O
-	|O
related	|O
macular	|O
degeneration	|O
(	|O
ARMD	|O
)	|O
is	|O
helpful	|O
in	|O
correlation	|O
with	|O
the	|O
clinical	|O
features	|O
and	|O
may	|O
contribute	|O
to	|O
understanding	|O
the	|O
pathogenesis	|O
.	|O

An	|O
abundant	|O
1.1	|O
-	|O
kb	|O
virion	|O
-	|O
sense	|O
polyadenylated	|O
RNA	|O
and	|O
four	|O
complementary	|O
-	|O
sense	|O
polyadenylated	|O
RNAs	|O
of	|O
1.7	|O
,	|O
1.5	|O
,	|O
1.3	|O
,	|O
and	|O
0.7	|O
kb	|O
have	|O
been	|O
identified	|O
by	|O
northern	|O
blot	|O
hybridization	|O
,	|O
confirming	|O
the	|O
bidirectional	|O
transcription	|O
strategy	|O
implied	|O
by	|O
the	|O
arrangement	|O
of	|O
ORFs	|O
.	|O

Risk	|O
factors	|O
associated	|O
with	|O
a	|O
high	|O
seroprevalence	|O
of	|O
hepatitis	|O
C	|O
virus	|O
infection	|O
in	|O
Egyptian	|O
blood	|O
donors	|O
.	|O

Here	|O
the	|O
cloning	|O
and	|O
molecular	|O
analysis	|O
of	|O
the	|O
Zm	|B-PROTEIN
-	|I-PROTEIN
ERabp1	|I-PROTEIN
,	|O
Zm	|B-PROTEIN
-	|I-PROTEIN
ERabp4	|I-PROTEIN
,	|O
and	|O
Zm	|B-PROTEIN
-	|I-PROTEIN
ERabp5	|I-PROTEIN
genes	|O
is	|O
presented	|O
.	|O

This	|O
agent	|O
,	|O
isolated	|O
from	|O
the	|O
fungus	|O
Streptomyces	|O
tsukubaensis	|O
,	|O
has	|O
a	|O
mechanism	|O
of	|O
action	|O
similar	|O
to	|O
that	|O
of	|O
cyclosporine	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
of	|O
the	|O
proximal	|O
promoter	|O
revealed	|O
four	|O
regions	|O
of	|O
protection	|O
.	|O

Finally	|O
,	|O
the	|O
stability	|O
of	|O
the	|O
nucleotide	|O
binding	|O
function	|O
of	|O
the	|O
two	|O
proteins	|O
is	|O
similar	|O
as	|O
assessed	|O
by	|O
sensitivity	|O
to	|O
urea	|O
.	|O

Insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
BP	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
transcription	|O
in	|O
rat	|O
liver	|O
varies	|O
with	|O
developmental	|O
age	|O
and	|O
fasting	|O
.	|O

The	|O
presence	|O
of	|O
the	|O
RV	|O
5'	|O
(	|O
+	|O
)	|O
SL	|O
sequence	|O
had	|O
the	|O
primary	|O
enhancing	|O
effect	|O
on	|O
translation	|O
.	|O

By	|O
contrast	|O
,	|O
all	|O
proteins	|O
initiated	|O
with	|O
a	|O
methionine	|O
placed	|O
one	|O
residue	|O
upstream	|O
of	|O
the	|O
natural	|O
N	|O
terminus	|O
of	|O
PR	|B-PROTEIN
failed	|O
to	|O
show	|O
specific	|O
proteolysis	|O
.	|O

Reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
and	|O
protease	|O
activities	|O
of	|O
avian	|O
leukosis	|O
virus	|O
Gag	|B-PROTEIN
-	|O
Pol	|B-PROTEIN
fusion	|O
proteins	|O
expressed	|O
in	|O
insect	|O
cells	|O
.	|O

In	|O
addition	|O
,	|O
an	|O
mck1	|B-PROTEIN
mds1	|O
mrk1	|O
triple	|O
disruptant	|O
was	|O
viable	|O
.	|O

However	|O
,	|O
there	|O
were	|O
some	|O
properties	|O
of	|O
Rak	|B-PROTEIN
that	|O
are	|O
distinct	|O
from	|O
Src	|B-PROTEIN
-	|O
like	|O
kinases	|O
:	|O
(	|O
a	|O
)	|O
expression	|O
of	|O
Rak	|B-PROTEIN
was	|O
predominantly	|O
in	|O
epithelial	|O
-	|O
derived	|O
cell	|O
lines	|O
and	|O
tissues	|O
,	|O
especially	|O
normal	|O
liver	|O
and	|O
kidney	|O
,	|O
and	|O
cell	|O
lines	|O
of	|O
breast	|O
and	|O
colon	|O
origin	|O
;	|O
(	|O
b	|O
)	|O
Rak	|B-PROTEIN
does	|O
not	|O
harbor	|O
the	|O
NH2	|O
-	|O
terminal	|O
glycine	|O
essential	|O
for	|O
myristylation	|O
and	|O
membrane	|O
localization	|O
;	|O
and	|O
(	|O
c	|O
)	|O
Rak	|B-PROTEIN
possesses	|O
a	|O
putative	|O
bipartite	|O
nuclear	|O
localization	|O
signal	|O
in	|O
the	|O
SH2	|B-PROTEIN
domain	|O
,	|O
and	|O
subcellular	|O
fractionation	|O
studies	|O
revealed	|O
that	|O
p54rak	|B-PROTEIN
resides	|O
predominantly	|O
in	|O
the	|O
nucleus	|O
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
We	|O
report	|O
our	|O
experience	|O
with	|O
seven	|O
children	|O
with	|O
active	|O
small	|O
bowel	|O
Crohn	|O
's	|O
disease	|O
given	|O
a	|O
casein	|B-PROTEIN
-	|O
based	|O
,	|O
polymeric	|O
feed	|O
rich	|O
in	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
2	|I-PROTEIN
(	|O
Specific	|O
Polymeric	|O
Diet	|O
;	|O
Nestle	|O
-	|O
Clintec	|O
;	|O
Vevey	|O
,	|O
Switzerland	|O
)	|O
as	|O
complete	|O
nutrition	|O
for	|O
8	|O
weeks	|O
.	|O

The	|O
leader	|O
sequence	|O
of	|O
the	|O
isolated	|O
cDNA	|O
clone	|O
contains	|O
several	|O
small	|O
open	|O
reading	|O
frames	|O
upstream	|O
of	|O
the	|O
initiation	|O
codon	|O
of	|O
the	|O
largest	|O
open	|O
reading	|O
frame	|O
coding	|O
for	|O
the	|O
homeodomain	|B-PROTEIN
protein	|O
.	|O

A	|O
small	|O
amount	|O
of	|O
HSP81	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
was	|O
detected	|O
only	|O
in	|O
roots	|O
.	|O

Cell	|O
adhesion	|O
and	|O
migration	|O
assays	|O
demonstrate	|O
that	|O
alpha	|B-PROTEIN
6	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
is	|O
the	|O
major	|O
laminin	|B-PROTEIN
receptor	|I-PROTEIN
in	|O
undifferentiated	|O
F9	|O
cells	|O
as	|O
well	|O
as	|O
F9	|O
-	|O
derived	|O
PE	|O
cells	|O
.	|O

No	|O
local	|O
destruction	|O
by	|O
tumor	|O
or	|O
infection	|O
could	|O
be	|O
demonstrated	|O
apart	|O
from	|O
HIV	|O
infection	|O
.	|O

Among	|O
the	|O
mixed	|O
race	|O
persons	|O
one	|O
Chukcha	|O
-	|O
Eskimo	|O
had	|O
AS	|O
,	|O
one	|O
Eskimo	|O
-	|O
Russian	|O
had	|O
psoriatic	|O
arthritis	|O
(	|O
PsA	|O
)	|O
.	|O

Our	|O
data	|O
complement	|O
other	|O
studies	|O
of	|O
circumpolar	|O
populations	|O
and	|O
reinforce	|O
the	|O
reported	|O
high	|O
prevalences	|O
of	|O
SPA	|O
and	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
B27	|I-PROTEIN
among	|O
those	|O
populations	|O
.	|O

Clinical	|O
studies	|O
SY5555	|O
was	|O
administered	|O
to	|O
45	|O
patients	|O
with	|O
various	|O
infectious	|O
diseases	|O
(	|O
2	|O
with	|O
acute	|O
pharyngitis	|O
,	|O
8	|O
with	|O
acute	|O
tonsillitis	|O
,	|O
4	|O
with	|O
lacunar	|O
tonsillitis	|O
,	|O
3	|O
each	|O
with	|O
acute	|O
bronchitis	|O
,	|O
pneumonia	|O
and	|O
pertussis	|O
,	|O
7	|O
with	|O
scarlet	|O
fever	|O
,	|O
3	|O
with	|O
impetigo	|O
contagiosa	|O
,	|O
6	|O
with	|O
acute	|O
urinary	|O
tract	|O
infections	|O
,	|O
2	|O
with	|O
balanoposthitis	|O
and	|O
1	|O
each	|O
with	|O
cervical	|O
lymphadenitis	|O
,	|O
S.S.S.S.	|O
,	|O
vulvitis	|O
and	|O
acute	|O
colitis	|O
)	|O
at	|O
daily	|O
doses	|O
between	|O
3.4-10	|O
mg	|O
/	|O
kg	|O
,	|O
t.i.d	|O
.	|O
,	|O
for	|O
3-14	|O
days	|O
.	|O

Although	|O
most	|O
SH2	|B-PROTEIN
-	|O
pTyr	|B-PROTEIN
interactions	|O
occur	|O
between	|O
two	|O
different	|O
types	|O
of	|O
molecules	|O
,	|O
some	|O
appear	|O
to	|O
involve	|O
only	|O
a	|O
single	|O
molecular	|O
type	|O
.	|O

RESULTS	|O
:	|O
Closure	|O
time	|O
of	|O
fistulas	|O
in	|O
patients	|O
receiving	|O
TPN	|O
+	|O
somatostatin	|B-PROTEIN
was	|O
significantly	|O
shorter	|O
(	|O
13.86	|O
+	|O
/	|O
-	|O
1.84	|O
versus	|O
20.4	|O
+	|O
/	|O
-	|O
2.89	|O
days	|O
)	|O
than	|O
in	|O
those	|O
receiving	|O
TPN	|O
alone	|O
.	|O

Experimental	|O
adhesion	|O
prophylaxis	|O
with	|O
recombinant	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
.	|O

Scratching	|O
during	|O
sleep	|O
in	|O
children	|O
with	|O
atopic	|O
dermatitis	|O
is	|O
associated	|O
with	|O
increased	|O
VO2	|O
.	|O

To	|O
determine	|O
which	|O
sequences	|O
in	|O
the	|O
rat	|O
P450c17	|B-PROTEIN
promoter	|O
may	|O
be	|O
responsible	|O
for	|O
basal	|O
and	|O
cAMP	|O
-	|O
stimulated	|O
gene	|O
transcription	|O
,	|O
deletion	|O
constructs	|O
containing	|O
between	|O
-	|O
1,560	|O
and	|O
-	|O
53	|O
base	|O
pairs	|O
of	|O
5'	|O
-	|O
flanking	|O
DNA	|O
from	|O
the	|O
rat	|O
P450c17	|B-PROTEIN
gene	|O
were	|O
ligated	|O
to	|O
plasmids	|O
expressing	|O
the	|O
reporter	|O
gene	|O
luciferase	|B-PROTEIN
and	|O
transfected	|O
into	|O
two	|O
mouse	|O
cell	|O
lines	|O
,	|O
adrenal	|O
Y	|O
-	|O
1	|O
cells	|O
,	|O
and	|O
testicular	|O
Leydig	|O
MA	|O
-	|O
10	|O
cells	|O
.	|O

Within	|O
-	|O
subject	|O
BP	|O
differences	|O
between	|O
fish	|O
oil	|O
and	|O
corn	|O
oil	|O
treatment	|O
were	|O
similar	|O
for	|O
Dinamap	|O
(	|O
3.2	|O
+	|O
/	|O
-	|O
1.8/2.5	|O
+	|O
/	|O
-	|O
1.0	|O
mm	|O
Hg	|O
)	|O
and	|O
for	|O
24	|O
-	|O
h	|O
ABP	|O
(	|O
2.5	|O
+	|O
/	|O
-	|O
1.0/2.3	|O
+	|O
/	|O
-	|O
0.8	|O
mm	|O
Hg	|O
)	|O
,	|O
but	|O
were	|O
more	|O
significant	|O
with	|O
the	|O
latter	|O
.	|O

We	|O
have	|O
cloned	|O
and	|O
sequenced	|O
the	|O
mouse	|O
NMO1	|B-PROTEIN
cDNA	|O
,	|O
which	|O
encodes	|O
the	|O
NAD	|B-PROTEIN
(	|I-PROTEIN
P	|I-PROTEIN
)	|I-PROTEIN
H	|I-PROTEIN
:	|I-PROTEIN
menadione	|I-PROTEIN
oxidoreductase	|I-PROTEIN
[	|O
also	|O
called	|O
NAD	|B-PROTEIN
(	|I-PROTEIN
P	|I-PROTEIN
)	|I-PROTEIN
H	|I-PROTEIN
:	|I-PROTEIN
(	|I-PROTEIN
quinone	|I-PROTEIN
acceptor	|I-PROTEIN
)	|I-PROTEIN
oxidoreductase	|I-PROTEIN
;	|O
quinone	|B-PROTEIN
reductase	|I-PROTEIN
;	|O
azo	|B-PROTEIN
dye	|I-PROTEIN
reductase	|I-PROTEIN
;	|O
DT	|B-PROTEIN
diaphorase	|I-PROTEIN
;	|O
EC	|B-PROTEIN
1.6.99.2	|I-PROTEIN
]	|O
.	|O

Escherichia	|O
coli	|O
JRG582	|O
is	|O
an	|O
ampD	|B-PROTEIN
ampE	|O
deletion	|O
derivative	|O
of	|O
strain	|O
HfrH	|O
and	|O
accordingly	|O
it	|O
is	|O
derepressed	|O
for	|O
expression	|O
of	|O
the	|O
cloned	|O
inducible	|O
beta	|B-PROTEIN
-	|I-PROTEIN
lactamase	|I-PROTEIN
gene	|O
of	|O
Citrobacter	|O
freundii	|O
,	|O
carried	|O
on	|O
plasmid	|O
pNU305	|O
.	|O

Such	|O
a	|O
mechanism	|O
may	|O
allow	|O
acceleration	|O
of	|O
degenerative	|O
joint	|O
conditions	|O
,	|O
and	|O
may	|O
account	|O
for	|O
the	|O
increased	|O
prevalence	|O
of	|O
such	|O
conditions	|O
seen	|O
with	|O
HMS	|O
subjects	|O
.	|O

Solitary	|O
thyroid	|O
nodule	|O
.	|O

Male	|O
contraception	|O
:	|O
ideas	|O
for	|O
the	|O
future	|O
.	|O

While	|O
daily	|O
food	|O
intake	|O
was	|O
almost	|O
constant	|O
regardless	|O
of	|O
the	|O
dietary	|O
protein	|O
level	|O
,	|O
water	|O
intake	|O
and	|O
urine	|O
volume	|O
increased	|O
with	|O
increasing	|O
the	|O
dietary	|O
protein	|O
.	|O

We	|O
propose	|O
that	|O
Mad	|B-PROTEIN
and	|O
Medea	|B-PROTEIN
encode	|O
rate	|O
-	|O
limiting	|O
components	|O
integral	|O
to	|O
dpp	|B-PROTEIN
pathways	|O
throughout	|O
development	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
the	|O
vacuolar	|O
H	|B-PROTEIN
(	|I-PROTEIN
+	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
B2	|O
subunit	|O
gene	|O
in	|O
differentiating	|O
THP	|O
-	|O
1	|O
cells	|O
.	|O

However	|O
,	|O
the	|O
inability	|O
to	|O
export	|O
RNA	|O
from	|O
the	|O
nucleus	|O
to	|O
the	|O
cytoplasm	|O
was	|O
not	|O
limited	|O
to	|O
a	|O
particular	|O
phase	|O
of	|O
the	|O
cell	|O
division	|O
cycle	|O
.	|O

An	|O
E	|O
box	|O
element	|O
is	|O
required	|O
for	|O
the	|O
expression	|O
of	|O
the	|O
ad4bp	|B-PROTEIN
gene	|O
,	|O
a	|O
mammalian	|O
homologue	|O
of	|O
ftz	|B-PROTEIN
-	|I-PROTEIN
f1	|I-PROTEIN
gene	|O
,	|O
which	|O
is	|O
essential	|O
for	|O
adrenal	|O
and	|O
gonadal	|O
development	|O
.	|O

Inhibition	|O
assays	|O
performed	|O
with	|O
over	|O
30	|O
different	|O
natural	|O
and	|O
synthetic	|O
sialylated	|O
and	|O
/	|O
or	|O
sulfated	|O
compounds	|O
are	|O
utilized	|O
to	|O
define	|O
in	|O
greater	|O
detail	|O
specific	|O
structural	|O
features	|O
involved	|O
in	|O
oligosaccharide	|O
-	|O
protein	|O
binding	|O
.	|O

The	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
protein	|O
in	|O
the	|O
region	|O
of	|O
the	|O
specificity	|O
pocket	|O
is	|O
similar	|O
to	|O
that	|O
of	|O
S.	|O
griseus	|O
proteases	|B-PROTEIN
A	|I-PROTEIN
,	|I-PROTEIN
B	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
C.	|I-PROTEIN

Mutations	|O
in	|O
the	|O
VPS45	|B-PROTEIN
gene	|I-PROTEIN
,	|O
a	|O
SEC1	|B-PROTEIN
homologue	|O
,	|O
result	|O
in	|O
vacuolar	|O
protein	|O
sorting	|O
defects	|O
and	|O
accumulation	|O
of	|O
membrane	|O
vesicles	|O
.	|O

In	|O
293	|O
cells	|O
,	|O
expression	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
inhibitor	|O
,	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
reduced	|O
the	|O
stimulatory	|O
activity	|O
of	|O
LMP	|B-PROTEIN
.	|O

This	|O
experimental	|O
design	|O
was	|O
used	|O
to	|O
determine	|O
the	|O
effect	|O
of	|O
displacement	|O
of	|O
the	|O
alpha	|B-PROTEIN
4-2	|I-PROTEIN
binding	|O
site	|O
on	|O
the	|O
repression	|O
of	|O
alpha	|B-PROTEIN
4	|I-PROTEIN
gene	|O
transcription	|O
by	|O
ICP4	|B-PROTEIN
.	|O

Immediate	|O
-	|O
early	|O
transcription	|O
from	|O
the	|O
channel	|O
catfish	|O
virus	|O
genome	|O
:	|O
characterization	|O
of	|O
two	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
transcripts	|I-PROTEIN
.	|O

The	|O
GRE	|O
at	|O
nucleotide	|O
7640	|O
is	|O
a	|O
composite	|O
GRE	|O
(	|O
cGRE	|O
)	|O
containing	|O
an	|O
overlapping	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
motif	|O
for	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
homodimer	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
heterodimer	|O
.	|O

In	|O
contrast	|O
to	|O
some	|O
results	|O
previously	|O
published	|O
for	|O
a	|O
very	|O
close	|O
sequence	|O
variant	|O
(	|O
see	|O
ref	|O
.	|O

Transcriptional	|O
activation	|O
by	|O
thyroid	|O
hormone	|O
(	|O
T3	|O
)	|O
requires	|O
interactions	|O
between	|O
the	|O
T3	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
TR	|B-PROTEIN
)	|O
and	|O
T3	|O
response	|O
elements	|O
(	|O
TREs	|O
)	|O
composed	|O
of	|O
two	|O
copies	|O
of	|O
sequences	|O
related	|O
to	|O
AGGTCA	|O
.	|O

A	|O
multivariate	|O
analysis	|O
of	|O
risk	|O
factors	|O
for	|O
relapse	|O
examined	|O
age	|O
,	|O
WBC	|O
at	|O
diagnosis	|O
,	|O
blast	|O
count	|O
at	|O
diagnosis	|O
,	|O
percentage	|O
of	|O
marrow	|O
blasts	|O
,	|O
FAB	|B-PROTEIN
subtype	|O
,	|O
the	|O
number	|O
of	|O
remission	|O
induction	|O
courses	|O
to	|O
achieve	|O
a	|O
remission	|O
,	|O
maintenance	|O
therapy	|O
,	|O
consolidation	|O
therapy	|O
,	|O
marrow	|O
cell	|O
dose	|O
,	|O
donor	|O
-	|O
recipient	|O
sex	|O
,	|O
GVHD	|O
prophylaxis	|O
regimen	|O
and	|O
isolation	|O
and	|O
decontamination	|O
in	|O
laminar	|O
airflow	|O
rooms	|O
.	|O

Carnitine	|O
palmitoyltransferase	|O
(	|B-PROTEIN
CPT	|I-PROTEIN
)	|I-PROTEIN
II	|I-PROTEIN
deficiency	|O
is	|O
the	|O
most	|O
common	|O
inherited	|O
disorder	|O
of	|O
lipid	|O
metabolism	|O
affecting	|O
skeletal	|O
muscle	|O
.	|O

We	|O
show	|O
that	|O
these	|O
three	|O
gain	|O
-	|O
of	|O
-	|O
function	|O
mutants	|O
differ	|O
considerably	|O
in	|O
their	|O
ability	|O
to	|O
bypass	|O
the	|O
sex	|O
determination	|O
signal	|O
,	|O
with	|O
SxlM4	|B-PROTEIN
being	|O
the	|O
strongest	|O
and	|O
SxlM1	|B-PROTEIN
the	|O
weakest	|O
.	|O

We	|O
show	|O
that	|O
these	|O
three	|O
gain	|O
-	|O
of	|O
-	|O
function	|O
mutants	|O
differ	|O
considerably	|O
in	|O
their	|O
ability	|O
to	|O
bypass	|O
the	|O
sex	|O
determination	|O
signal	|O
,	|O
with	|O
SxlM4	|B-PROTEIN
being	|O
the	|O
strongest	|O
and	|O
SxlM1	|B-PROTEIN
the	|O
weakest	|O
.	|O

Binding	|O
of	|O
meAda	|B-PROTEIN
is	|O
necessary	|O
to	|O
activate	|O
transcription	|O
of	|O
the	|O
adaptive	|O
response	|O
genes	|O
;	|O
accordingly	|O
,	|O
in	|O
vitro	|O
transcription	|O
of	|O
aidB	|B-PROTEIN
is	|O
dependent	|O
on	|O
the	|O
presence	|O
of	|O
meAda	|B-PROTEIN
.	|O

No	|O
significant	|O
differences	|O
were	|O
identified	|O
between	|O
groups	|O
for	|O
pH	|O
,	|O
PaCO2	|O
,	|O
intracranial	|O
pressure	|O
,	|O
heart	|O
rate	|O
,	|O
brain	|O
temperature	|O
,	|O
or	|O
glucose	|O
levels	|O
.	|O

Blood	|O
pressure	|O
also	|O
was	|O
increased	|O
by	|O
lidocaine	|O
(	|O
6	|O
mg	|O
kg	|O
-	|O
1	|O
)	|O
.	|O

Anesthesiologists	|O
often	|O
use	|O
more	|O
than	|O
one	|O
drug	|O
in	|O
a	|O
patient	|O
to	|O
achieve	|O
a	|O
target	|O
response	|O
,	|O
such	|O
as	|O
a	|O
desired	|O
blood	|O
pressure	|O
.	|O

We	|O
suggest	|O
that	|O
this	|O
gene	|O
cluster	|O
codes	|O
for	|O
(	|O
parts	|O
of	|O
)	|O
a	|O
multisubunit	|O
cytochrome	|B-PROTEIN
c	|I-PROTEIN
haem	|I-PROTEIN
lyase	|I-PROTEIN
.	|O

In	|O
this	|O
paper	|O
,	|O
a	|O
comparison	|O
between	|O
the	|O
number	|O
and	|O
shape	|O
of	|O
corneal	|O
endothelial	|O
cells	|O
has	|O
been	|O
performed	|O
in	|O
25	|O
patients	|O
before	|O
and	|O
6	|O
months	|O
after	|O
PRK	|O
.	|O

Standard	|O
reference	|O
sources	|O
indicate	|O
that	|O
an	|O
able	|O
-	|O
bodied	|O
11	|O
-	|O
year	|O
-	|O
old	|O
child	|O
of	|O
comparable	|O
height	|O
requires	|O
1,493	|O
kcal	|O
/	|O
d	|O
for	|O
support	|O
of	|O
basal	|O
metabolic	|O
functions	|O
.	|O

Weak	|O
allergenicity	|O
of	|O
recombinant	|O
hirudin	|B-PROTEIN
CGP	|O
39393	|O
(	|O
REVASC	|O
)	|O
in	|O
immunocompetent	|O
volunteers	|O
.	|O

In	|O
contrast	|O
to	|O
the	|O
myoD	|B-PROTEIN
promoter	|O
,	|O
the	|O
myoD	|B-PROTEIN
enhancer	|O
shows	|O
striking	|O
conservation	|O
between	|O
humans	|O
and	|O
mice	|O
both	|O
in	|O
its	|O
sequence	|O
and	|O
its	|O
distal	|O
position	|O
.	|O

However	|O
,	|O
a	|O
clear	|O
difference	|O
exists	|O
between	|O
myoblasts	|O
and	|O
10T1	|O
/	|O
2	|O
cells	|O
(	|O
and	|O
other	|O
non	|O
-	|O
muscle	|O
cell	|O
types	|O
)	|O
in	|O
the	|O
chromatin	|O
structure	|O
of	|O
the	|O
chromosomal	|O
myoD	|B-PROTEIN
core	|O
enhancer	|O
,	|O
suggesting	|O
that	|O
the	|O
myoD	|B-PROTEIN
enhancer	|O
is	|O
repressed	|O
by	|O
epigenetic	|O
mechanisms	|O
in	|O
10T1	|O
/	|O
2	|O
cells	|O
.	|O

Using	|O
Ki	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
-	|O
transformed	|O
3T3	|O
cells	|O
as	|O
a	|O
model	|O
system	|O
,	|O
we	|O
show	|O
that	|O
both	|O
RA	|O
and	|O
the	|O
'	|O
dissociating	|O
'	|O
retinoids	|O
inhibit	|O
anchorage	|O
-	|O
independent	|O
cell	|O
proliferation	|O
,	|O
suggesting	|O
that	|O
retinoid	|O
-	|O
induced	|O
growth	|O
inhibition	|O
may	|O
be	|O
related	|O
to	|O
AP1	|B-PROTEIN
transrepression	|O
.	|O

The	|O
Oct	|B-PROTEIN
and	|O
HMG2	|B-PROTEIN
proteins	|O
also	|O
interact	|O
in	|O
vivo	|O
.	|O

Atopic	|O
dermatitis	|O
is	|O
an	|O
"	|O
itch	|O
which	|O
rashes	|O
and	|O
not	|O
a	|O
rash	|O
which	|O
itches	|O
"	|O
and	|O
therefore	|O
,	|O
any	|O
patient	|O
treatment	|O
program	|O
should	|O
address	|O
the	|O
multiplicity	|O
of	|O
potential	|O
trigger	|O
factors	|O
that	|O
provoke	|O
this	|O
itching	|O
.	|O

Primer	|O
extension	|O
experiments	|O
showed	|O
that	|O
there	|O
are	|O
two	|O
transcription	|O
initiation	|O
sites	|O
16	|O
bp	|O
apart	|O
in	|O
the	|O
mouse	|O
type	|B-PROTEIN
2	|I-PROTEIN
receptor	|I-PROTEIN
gene	|O
.	|O

The	|O
beta	|O
subunit	|O
of	|O
the	|O
Fc	|B-PROTEIN
epsilon	|I-PROTEIN
R1	|I-PROTEIN
is	|O
a	|O
33	|O
-	|O
kDa	|O
tyrosine	|O
phosphoprotein	|O
,	|O
but	|O
the	|O
p33	|B-PROTEIN
Grb2	|O
-	|O
binding	|O
protein	|O
described	|O
in	|O
the	|O
present	|O
report	|O
is	|O
not	|O
the	|O
Fc	|B-PROTEIN
epsilon	|I-PROTEIN
R1	|I-PROTEIN
beta	|O
chain	|O
and	|O
its	|O
identity	|O
is	|O
unknown	|O
.	|O

To	|O
study	|O
the	|O
mechanisms	|O
as	|O
well	|O
as	|O
magnitude	|O
of	|O
the	|O
transmembrane	|O
transfer	|O
of	|O
bacterial	|O
products	|O
from	|O
the	|O
dialysate	|O
,	|O
we	|O
developed	|O
a	|O
computerized	|O
in	|O
vitro	|O
dialysis	|O
model	|O
which	|O
provides	|O
continuous	|O
pressure	|O
recording	|O
from	|O
the	|O
arterial	|O
,	|O
venous	|O
,	|O
dialysate	|O
inflow	|O
and	|O
outflow	|O
ports	|O
.	|O

After	|O
24	|O
hour	|O
incubation	|O
,	|O
total	|O
cell	|O
-	|O
associated	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1Ra	|I-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
were	|O
measured	|O
by	|O
specific	|O
radioimmunoassay	|O
.	|O

Each	|O
dietary	|O
treatment	|O
was	|O
fed	|O
to	|O
six	|O
pen	|O
replicates	|O
of	|O
five	|O
chicks	|O
per	|O
pen	|O
for	|O
21	|O
d	|O
.	|O

1972	|O
.	|O

In	|O
contrast	|O
,	|O
recent	|O
evidence	|O
suggests	|O
that	|O
children	|O
with	|O
sickle	|B-PROTEIN
-	|I-PROTEIN
hemoglobin	|I-PROTEIN
C	|I-PROTEIN
disease	|O
do	|O
not	|O
develop	|O
functional	|O
asplenia	|O
before	|O
3	|O
to	|O
4	|O
years	|O
of	|O
age	|O
and	|O
thus	|O
may	|O
not	|O
benefit	|O
from	|O
penicillin	|O
prophylaxis	|O
.	|O

Deletion	|O
analysis	|O
indicates	|O
that	|O
TBP	|B-PROTEIN
and	|O
hTAFII18	|B-PROTEIN
bind	|O
to	|O
distinct	|O
domains	|O
of	|O
hTAFII28	|B-PROTEIN
.	|O
hTAFII18	|B-PROTEIN
also	|O
interacts	|O
with	|O
TBP	|B-PROTEIN
,	|O
but	|O
it	|O
interacts	|O
more	|O
strongly	|O
with	|O
hTAFII28	|B-PROTEIN
and	|O
hTAFII30	|B-PROTEIN
.	|O

The	|O
NarX	|B-PROTEIN
and	|O
NarQ	|B-PROTEIN
proteins	|O
with	|O
amino	|O
acid	|O
substitutions	|O
at	|O
the	|O
first	|O
conserved	|O
histidine	|O
position	|O
were	|O
also	|O
unable	|O
to	|O
dephosphorylate	|O
NarL	|B-PROTEIN
-	|O
phosphate	|O
in	|O
vitro	|O
.	|O

Vascular	|O
endothelial	|O
cells	|O
undergo	|O
profound	|O
changes	|O
upon	|O
cellular	|O
activation	|O
including	|O
expression	|O
of	|O
a	|O
spectrum	|O
of	|O
cell	|O
activation	|O
-	|O
associated	|O
genes	|O
.	|O

Because	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
CREM	|B-PROTEIN
are	|O
known	|O
to	|O
bind	|O
to	|O
cAMP	|O
response	|O
elements	|O
(	|O
CRE	|O
)	|O
,	|O
this	|O
functional	|O
sequence	|O
was	|O
named	|O
the	|O
kappa	|B-PROTEIN
E3	|I-PROTEIN
'	|I-PROTEIN
-	|O
CRE	|O
.	|O

The	|O
Ng	|B-PROTEIN
/	|I-PROTEIN
RC3	|I-PROTEIN
and	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
genes	|O
have	|O
a	|O
similar	|O
expression	|O
pattern	|O
in	|O
the	|O
brain	|O
during	|O
development	|O
.	|O

Structure	|O
and	|O
regulation	|O
of	|O
the	|O
gene	|O
encoding	|O
the	|O
neuron	|O
-	|O
specific	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
substrate	|O
neurogranin	|B-PROTEIN
(	|O
RC3	|B-PROTEIN
protein	|O
)	|O
.	|O

The	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
known	|O
largest	|O
subunits	|O
of	|O
DdRPs	|B-PROTEIN
from	|O
different	|O
species	|O
contain	|O
highly	|O
conserved	|O
regions	|O
.	|O

The	|O
TTG	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
has	|O
been	|O
identified	|O
at	|O
the	|O
site	|O
of	|O
chromosomal	|O
translocations	|O
in	|O
acute	|O
T	|O
-	|O
cell	|O
leukemia	|O
's	|O
(	|O
T	|O
-	|O
ALL	|O
)	|O
.	|O

In	|O
vitro	|O
studies	|O
with	|O
blood	|O
cells	|O
incubated	|O
with	|O
acetate	|O
or	|O
bicarbonate	|O
ions	|O
in	|O
concentrations	|O
,	|O
which	|O
are	|O
observed	|O
in	|O
vivo	|O
during	|O
hemodialysis	|O
,	|O
suggest	|O
that	|O
probably	|O
these	|O
ions	|O
do	|O
not	|O
directly	|O
affect	|O
superoxide	|O
anions	|O
generation	|O
,	|O
erythrocyte	|O
SOD	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
catalase	|B-PROTEIN
activities	|O
and	|O
erythrocyte	|O
membrane	|O
lipid	|O
peroxidation	|O
.	|O

Short	|O
therapy	|O
with	|O
omeprazole	|O
20	|O
mg	|O
/	|O
b.i.d	|O
.	|O
,	|O
clarithromycin	|O
500	|O
mg	|O
/	|O
b.i.d	|O
.	|O
,	|O
and	|O
CBS	|O
120	|O
mg	|O
/	|O
q.i.d	|O
.	|O
is	|O
a	|O
safe	|O
,	|O
well	|O
tolerated	|O
combination	|O
that	|O
achieves	|O
a	|O
80.6%	|O
eradication	|O
rate	|O
of	|O
H.	|O
pylori	|O
and	|O
duodenal	|O
ulcer	|O
healing	|O
rates	|O
as	|O
good	|O
as	|O
those	|O
achieved	|O
by	|O
omeprazole	|O
20	|O
mg	|O
/	|O
d	|O
when	|O
given	|O
for	|O
4	|O
wk	|O
.	|O

The	|O
concentration	|O
of	|O
mite	|O
allergen	|O
was	|O
very	|O
low	|O
(	|O
mean	|O
0.18	|O
micrograms	|O
Der	|O
p	|O
milligrams	|O
sieved	|O
house	|O
dust	|O
)	|O
,	|O
whereas	|O
that	|O
of	|O
cat	|O
allergen	|O
was	|O
high	|O
in	|O
homes	|O
with	|O
a	|O
cat	|O
(	|O
80.8	|O
micrograms	|O
Fel	|O
d	|O
milligrams	|O
)	|O
but	|O
also	|O
in	|O
homes	|O
with	|O
no	|O
cat	|O
(	|O
3.2	|O
micrograms	|O
Fel	|O
d	|O
milligrams	|O
)	|O
.	|O

CONCLUSIONS	|O
:	|O
A	|O
comparison	|O
of	|O
the	|O
LysU	|B-PROTEIN
crystal	|O
structure	|O
with	|O
the	|O
structures	|O
of	|O
seryl	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
aspartyl	|I-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetases	|I-PROTEIN
enables	|O
a	|O
conserved	|O
core	|O
to	|O
be	|O
identified	|O
.	|O

Whole	|O
bowel	|O
irrigation	|O
is	|O
a	|O
recently	|O
described	|O
technique	|O
to	|O
enhance	|O
the	|O
passage	|O
of	|O
drugs	|O
already	|O
beyond	|O
the	|O
pylorus	|O
.	|O

The	|O
MPS1	|B-PROTEIN
open	|O
reading	|O
frame	|O
has	|O
been	|O
fused	|O
to	|O
those	|O
that	|O
encode	|O
the	|O
LexA	|B-PROTEIN
protein	|O
or	|O
the	|O
GST	|B-PROTEIN
protein	|O
and	|O
both	|O
of	|O
these	|O
constructs	|O
function	|O
in	|O
yeast	|O
.	|O

As	|O
in	|O
Tb	|O
,	|O
U6	|B-PROTEIN
is	|O
a	|O
single	|O
-	|O
copy	|O
gene	|O
and	|O
two	|O
tRNA	|O
genes	|O
,	|O
tRNAGln	|B-PROTEIN
and	|O
tRNAIle	|B-PROTEIN
,	|O
are	|O
found	|O
upstream	|O
to	|O
the	|O
gene	|O
.	|O

Hematopoietic	|B-PROTEIN
growth	|I-PROTEIN
factors	|I-PROTEIN
have	|O
already	|O
had	|O
an	|O
enormous	|O
impact	|O
on	|O
transfusion	|O
practice	|O
by	|O
eliminating	|O
or	|O
reducing	|O
the	|O
need	|O
for	|O
red	|O
blood	|O
cell	|O
transfusions	|O
in	|O
a	|O
variety	|O
of	|O
anemic	|O
states	|O
characterized	|O
by	|O
an	|O
absolute	|O
or	|O
relative	|O
decrease	|O
in	|O
erythropoietin	|B-PROTEIN
.	|O

However	|O
,	|O
the	|O
mouse	|O
has	|O
previously	|O
been	|O
shown	|O
to	|O
possess	|O
only	|O
three	|O
forms	|O
of	|O
ADH	|B-PROTEIN
.	|O

During	|O
IC	|O
breaths	|O
and	|O
following	|O
EC	|O
and	|O
VC	|O
breaths	|O
at	|O
rest	|O
,	|O
end	|O
-	|O
tidal	|O
CO2	|O
pressure	|O
(	|O
PET	|O
,	|O
CO2	|O
)	|O
fell	|O
by	|O
7.5	|O
,	|O
8.5	|O
and	|O
9.5	|O
mmHg	|O
,	|O
respectively	|O
.	|O

2	|O
.	|O

Phylogenetic	|O
analyses	|O
of	|O
19	|O
amino	|O
acid	|O
sequences	|O
of	|O
6	|O
related	|O
protein	|O
types	|O
indicate	|O
that	|O
actin	|B-PROTEIN
-	|O
associated	|O
proteins	|O
related	|O
to	|O
gelsolin	|B-PROTEIN
are	|O
monophyletic	|O
to	|O
a	|O
common	|O
ancestor	|O
and	|O
include	|O
flightless	|B-PROTEIN
proteins	|O
.	|O

No	|O
homologs	|O
of	|O
other	|O
members	|O
of	|O
the	|O
Surfeit	|B-PROTEIN
gene	|O
cluster	|O
were	|O
detected	|O
in	|O
close	|O
proximity	|O
to	|O
the	|O
D.	|O
melanogaster	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
/	|O
rpL7a	|B-PROTEIN
gene	|O
.	|O

Moreover	|O
,	|O
we	|O
found	|O
that	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
,	|O
in	|O
contrast	|O
to	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
,	|O
was	|O
required	|O
for	|O
the	|O
G1	|O
/	|O
S	|O
transition	|O
even	|O
in	|O
cells	|O
lacking	|O
retinoblastoma	|B-PROTEIN
protein	|I-PROTEIN
function	|O
.	|O

The	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
SGC1	|B-PROTEIN
gene	|O
product	|O
includes	|O
a	|O
region	|O
with	|O
substantial	|O
similarity	|O
to	|O
the	|O
basic	|O
-	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
domain	|O
of	|O
the	|O
Myc	|B-PROTEIN
family	|O
of	|O
DNA	|O
-	|O
binding	|O
proteins	|O
.	|O

By	|O
creating	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|O
BSAP	|B-PROTEIN
fusion	|O
proteins	|O
,	|O
we	|O
were	|O
able	|O
to	|O
identify	|O
a	|O
short	|O
amino	|O
acid	|O
stretch	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
part	|O
of	|O
the	|O
paired	|B-PROTEIN
domain	|O
which	|O
is	|O
responsible	|O
for	|O
these	|O
differences	|O
in	|O
DNA	|O
-	|O
binding	|O
specificity	|O
.	|O

To	|O
establish	|O
a	|O
possible	|O
association	|O
between	|O
familial	|O
dysfibrinogenemia	|O
and	|O
thrombophilia	|O
,	|O
data	|O
on	|O
cases	|O
with	|O
both	|O
affections	|O
were	|O
collected	|O
in	|O
a	|O
study	|O
within	|O
the	|O
framework	|O
of	|O
the	|O
SSC	|O
Subcommittee	|O
on	|O
Fibrinogen	|B-PROTEIN
of	|O
the	|O
International	|O
Society	|O
on	|O
Thrombosis	|O
and	|O
Haemostasis	|O
.	|O

Conjugated	|O
estrogens	|O
shorten	|O
bleeding	|O
time	|O
in	|O
uraemia	|O
:	|O
a	|O
possible	|O
role	|O
of	|O
serotonin	|O
?	|O

These	|O
six	|O
districts	|O
have	|O
an	|O
area	|O
of	|O
34,000	|O
km2	|O
and	|O
hold	|O
a	|O
population	|O
of	|O
30	|O
million	|O
.	|O

According	|O
to	|O
symptoms	|O
,	|O
signs	|O
,	|O
imaging	|O
features	|O
,	|O
operation	|O
findings	|O
,	|O
the	|O
original	|O
places	|O
and	|O
the	|O
expansive	|O
directions	|O
of	|O
the	|O
tumor	|O
,	|O
they	|O
were	|O
divided	|O
into	|O
four	|O
clinical	|O
types	|O
:	|O
sellar	|O
,	|O
clival	|O
,	|O
occipito	|O
-	|O
temporal	|O
and	|O
extent	|O
.	|O

Two	|O
mammalian	|O
enzymes	|O
,	|O
the	|O
haem	|B-PROTEIN
-	|I-PROTEIN
controlled	|I-PROTEIN
repressor	|I-PROTEIN
(	|O
HCR	|B-PROTEIN
)	|O
and	|O
the	|O
double	|B-PROTEIN
-	|I-PROTEIN
stranded	|I-PROTEIN
RNA	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
inhibitor	|I-PROTEIN
(	|O
dsI	|B-PROTEIN
)	|O
,	|O
phosphorylate	|O
Ser	|O
-	|O
51	|O
of	|O
the	|O
alpha	|O
subunit	|O
,	|O
thereby	|O
inhibiting	|O
the	|O
exchange	|O
of	|O
bound	|O
nucleotides	|O
on	|O
,	|O
and	|O
thus	|O
the	|O
recycling	|O
of	|O
,	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

A	|O
triple	|O
Ser	|O
-	|O
-	|O
>	|O
Ala	|O
mutant	|O
form	|O
of	|O
yeast	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
was	|O
found	|O
to	|O
be	|O
no	|O
longer	|O
phosphorylated	|O
by	|O
either	|O
of	|O
the	|O
yeast	|O
(	|O
or	|O
mammalian	|O
)	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
activities	|O
in	|O
vitro	|O
.	|O

The	|O
cases	|O
included	|O
35	|O
de	|O
novo	|O
diffuse	|O
aggressive	|O
lymphomas	|O
(	|O
DAL	|O
;	|O
19	|O
large	|O
-	|O
cell	|O
,	|O
4	|O
mixed	|O
-	|O
cell	|O
,	|O
and	|O
12	|O
large	|O
-	|O
cell	|O
immunoblastic	|O
)	|O
,	|O
52	|O
transformed	|O
aggressive	|O
lymphomas	|O
derived	|O
from	|O
follicular	|O
lymphomas	|O
(	|O
TFL	|O
)	|O
,	|O
42	|O
indolent	|O
follicular	|O
lymphomas	|O
(	|O
FL	|O
)	|O
,	|O
14	|O
mantle	|O
cell	|O
lymphomas	|O
(	|O
MCL	|O
)	|O
,	|O
and	|O
27	|O
small	|O
noncleaved	|O
cell	|O
lymphomas	|O
(	|O
SNCL	|O
)	|O
.	|O

Icterus	|O
and	|O
beta	|O
-	|O
thalassemia	|O
in	|O
Congolese	|O
children	|O
in	|O
Brazzaville	|O

Female	|O
patients	|O
with	|O
breast	|O
cancer	|O
diagnosed	|O
between	|O
1982	|O
and	|O
1991	|O
at	|O
Roswell	|O
Park	|O
Cancer	|O
Institute	|O
(	|O
RPCI	|O
)	|O
in	|O
Buffalo	|O
,	|O
New	|O
York	|O
,	|O
who	|O
provided	|O
information	|O
on	|O
their	|O
cigarette	|O
smoking	|O
history	|O
at	|O
the	|O
time	|O
of	|O
their	|O
diagnosis	|O
were	|O
included	|O
.	|O

Upon	|O
analysis	|O
of	|O
the	|O
tissue	|O
distribution	|O
of	|O
AAMP	|B-PROTEIN
,	|O
it	|O
was	|O
found	|O
to	|O
be	|O
expressed	|O
strongly	|O
in	|O
endothelial	|O
cells	|O
,	|O
cytotrophoblasts	|O
,	|O
and	|O
poorly	|O
differentiated	|O
colon	|O
adenocarcinoma	|O
cells	|O
found	|O
in	|O
lymphatics	|O
.	|O

Data	|O
from	|O
the	|O
V	|O
-	|O
HeFT	|O
II	|O
show	|O
that	|O
at	|O
2	|O
-	|O
year	|O
follow	|O
-	|O
up	|O
,	|O
a	|O
progressive	|O
rise	|O
of	|O
plasma	|O
norepinephrine	|O
was	|O
observed	|O
in	|O
both	|O
treatment	|O
arms	|O
,	|O
suggesting	|O
that	|O
disease	|O
progresses	|O
despite	|O
treatment	|O
with	|O
either	|O
an	|O
angiotensin	|B-PROTEIN
-	|I-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
inhibitor	|O
,	|O
enalapril	|O
,	|O
or	|O
vasodilator	|O
therapy	|O
with	|O
hydralazine	|O
/	|O
isosorbide	|O
dinitrate	|O
.	|O

Binding	|O
activity	|O
in	|O
rat	|O
liver	|O
nuclear	|O
extracts	|O
includes	|O
these	|O
orphan	|O
receptors	|O
as	|O
judged	|O
from	|O
electromobility	|O
supershift	|O
experiments	|O
and	|O
from	|O
results	|O
obtained	|O
with	|O
expressed	|O
receptors	|O
,	|O
although	|O
the	|O
element	|O
in	|O
CYP2C11	|B-PROTEIN
did	|O
not	|O
bind	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
.	|O

Transcript	|O
analysis	|O
reveals	|O
that	|O
lethal	|O
B	|B-PROTEIN
block	|I-PROTEIN
substitutions	|O
reduce	|O
U6	|B-PROTEIN
RNA	|O
synthesis	|O
at	|O
least	|O
10	|O
-	|O
fold	|O
in	|O
vivo	|O
and	|O
20	|O
-	|O
fold	|O
in	|O
vitro	|O
.	|O

Analysis	|O
of	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
/	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
homodimerization	|O
using	|O
both	|O
in	|O
vitro	|O
binding	|O
assays	|O
as	|O
well	|O
as	|O
a	|O
yeast	|O
two	|O
-	|O
hybrid	|O
method	|O
provided	|O
evidence	|O
in	|O
support	|O
of	|O
a	|O
head	|O
-	|O
to	|O
-	|O
tail	|O
model	|O
for	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
/	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
homodimerization	|O
and	|O
revealed	|O
that	|O
sequences	|O
within	|O
the	|O
NH2	|O
-	|O
terminal	|O
A	|O
domain	|O
interact	|O
with	|O
a	|O
structure	|O
that	|O
requires	|O
the	|O
presence	|O
of	|O
both	|O
the	|O
carboxyl	|O
B	|O
and	|O
C	|O
domains	|O
in	|O
combination	|O
.	|O

The	|O
protein	|O
is	|O
composed	|O
of	|O
a	|O
central	|O
alpha	|O
-	|O
helical	|O
portion	|O
with	|O
globular	|O
domains	|O
at	|O
both	|O
NH2	|O
and	|O
COOH	|O
termini	|O
,	|O
and	|O
the	|O
epitope	|O
to	|O
the	|O
monoclonal	|O
antibody	|O
resides	|O
in	|O
the	|O
central	|O
alpha	|O
-	|O
helical	|O
stalk	|O
.	|O

Radioligand	|O
binding	|O
was	|O
indistinguishable	|O
for	|O
both	|O
transiently	|O
expressed	|O
constructs	|O
.	|O

Diagnosis	|O
of	|O
FHCS	|O
has	|O
been	|O
weighed	|O
upon	|O
laparoscopic	|O
findings	|O
.	|O

Human	|O
papillomavirus	|O
type	|O
31b	|O
late	|B-PROTEIN
gene	|I-PROTEIN
expression	|O
is	|O
regulated	|O
through	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
-	|O
mediated	|O
changes	|O
in	|O
RNA	|O
processing	|O
.	|O

Interestingly	|O
,	|O
virions	|O
also	|O
contained	|O
smaller	|O
proteins	|O
that	|O
reacted	|O
with	|O
antibodies	|O
specific	|O
for	|O
the	|O
accessory	|O
proteins	|O
as	|O
well	|O
as	|O
SN	|B-PROTEIN
and	|O
CAT	|B-PROTEIN
fusion	|O
partners	|O
.	|O

Studies	|O
using	|O
an	|O
inhibitor	|O
or	|O
a	|O
mutant	|O
Lb	|B-PROTEIN
proteinase	|I-PROTEIN
indicated	|O
that	|O
stimulation	|O
of	|O
IRES	|O
-	|O
driven	|O
translation	|O
is	|O
mediated	|O
via	|O
proteolysis	|O
of	|O
some	|O
cellular	|O
component	|O
(	|O
s	|O
)	|O
.	|O

Restriction	|O
mapping	|O
analysis	|O
localized	|O
this	|O
cDNA	|O
to	|O
the	|O
HHV	|O
-	|O
6A	|O
(	|O
U1102	|O
)	|O
genomic	|O
BamHI	|B-PROTEIN
G	|O
fragment	|O
,	|O
at	|O
the	|O
right	|O
end	|O
of	|O
the	|O
unique	|O
long	|O
segment	|O
of	|O
the	|O
genome	|O
and	|O
to	|O
the	|O
SalI	|B-PROTEIN
L	|I-PROTEIN
and	|O
SalI	|B-PROTEIN
O	|I-PROTEIN
fragments	|O
within	|O
the	|O
left	|O
and	|O
right	|O
terminal	|O
direct	|O
repeat	|O
regions	|O
,	|O
respectively	|O
.	|O

For	|O
replication	|O
reporter	|O
constructs	|O
where	|O
E1	|B-PROTEIN
and	|O
E2	|B-PROTEIN
are	|O
supplied	|O
in	|O
trans	|O
by	|O
the	|O
respective	|O
expression	|O
vectors	|O
,	|O
distance	|O
between	|O
the	|O
half	|O
sites	|O
seems	|O
to	|O
play	|O
a	|O
major	|O
role	|O
,	|O
yet	|O
the	|O
phasing	|O
relationships	|O
are	|O
measurable	|O
.	|O

As	|O
it	|O
had	|O
been	|O
previously	|O
reported	|O
that	|O
the	|O
18	|O
-	|O
bp	|O
palindrome	|O
contains	|O
sufficient	|O
nucleotide	|O
sequence	|O
information	|O
for	|O
E1	|B-PROTEIN
binding	|O
,	|O
we	|O
speculate	|O
that	|O
a	|O
minimal	|O
E1	|B-PROTEIN
recognition	|O
motif	|O
is	|O
presented	|O
in	|O
each	|O
half	|O
site	|O
.	|O

METHODS	|O
:	|O
Out	|O
of	|O
171	|O
patients	|O
receiving	|O
anticoagulation	|O
between	|O
July	|O
1992	|O
and	|O
December	|O
1993	|O
,	|O
83	|O
patients	|O
with	|O
hemispheric	|O
embolisms	|O
received	|O
heparin	|O
within	|O
72	|O
hours	|O
from	|O
onset	|O
(	|O
activated	|O
partial	|O
thromboplastin	|B-PROTEIN
time	|O
[	|O
aPTT	|O
]	|O
1.5	|O
times	|O
control	|O
value	|O
)	|O
.	|O

In	|O
the	|O
commercially	|O
available	|O
intravenous	|O
formulation	|O
of	|O
Cyclosporin	|O
A	|O
(	|O
Sandimmun	|O
)	|O
,	|O
polyoxyethylated	|O
castor	|O
oil	|O
(	|O
Cremophor	|O
EL	|O
)	|O
is	|O
used	|O
as	|O
a	|O
solubilizing	|O
agent	|O
.	|O

Lung	|O
function	|O
tests	|O
(	|O
EFR	|O
)	|O
were	|O
performed	|O
on	|O
these	|O
patients	|O
for	|O
a	|O
period	|O
of	|O
19.2	|O
+	|O
/	|O
-	|O
3.4	|O
months	|O
.	|O

Sequence	|O
comparisons	|O
of	|O
prokaryotic	|O
RCR	|B-PROTEIN
initiators	|I-PROTEIN
has	|O
revealed	|O
a	|O
set	|O
of	|O
three	|O
common	|O
motifs	|O
,	|O
two	|O
of	|O
which	|O
,	|O
a	|O
putative	|O
metal	|O
coordination	|O
site	|O
and	|O
a	|O
downstream	|O
active	|O
-	|O
site	|O
tyrosine	|O
motif	|O
,	|O
could	|O
be	|O
tentatively	|O
identified	|O
in	|O
parvoviral	|O
replicator	|B-PROTEIN
proteins	|O
.	|O

The	|O
mean	|O
marginal	|O
discrepancy	|O
of	|O
provisional	|O
restorations	|O
was	|O
compared	|O
for	|O
restorations	|O
fabricated	|O
from	|O
stone	|O
,	|O
low	|O
-	|O
viscosity	|O
poly	|O
(	|O
vinyl	|O
siloxane	|O
)	|O
,	|O
and	|O
medium	|O
-	|O
viscosity	|O
poly	|O
(	|O
vinyl	|O
siloxane	|O
)	|O
.	|O

The	|O
characterized	|O
Aplysia	|O
Afurin2	|B-PROTEIN
is	|O
a	|O
candidate	|O
PC	|B-PROTEIN
that	|O
may	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
processing	|O
of	|O
egg	|B-PROTEIN
-	|I-PROTEIN
laying	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
ELH	|B-PROTEIN
)	|O
-	|O
related	|O
precursors	|O
in	|O
the	|O
secretory	|O
cells	|O
of	|O
the	|O
atrial	|O
gland	|O
.	|O

Rats	|O
treated	|O
with	|O
8	|O
-	|O
OH	|O
-	|O
DPAT	|O
were	|O
not	|O
impaired	|O
in	|O
their	|O
ability	|O
to	|O
learn	|O
a	|O
visual	|O
discrimination	|O
in	|O
a	|O
water	|O
maze	|O
.	|O

The	|O
term	|O
endovascular	|O
papillary	|O
haemangioma	|O
is	|O
suggested	|O
.	|O

In	|O
addition	|O
,	|O
two	|O
internal	|O
promoters	|O
,	|O
PmiaA	|B-PROTEIN
and	|O
P1hfq	|B-PROTEIN
were	|O
identified	|O
and	|O
mapped	|O
to	|O
201	|O
and	|O
837	|O
nucleotides	|O
upstream	|O
from	|O
the	|O
respective	|O
translation	|O
start	|O
sites	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
mutL	|B-PROTEIN
,	|O
miaA	|B-PROTEIN
,	|O
and	|O
hfq	|B-PROTEIN
expression	|O
could	|O
be	|O
regulated	|O
by	|O
multiple	|O
mechanisms	|O
,	|O
including	|O
degree	|O
of	|O
cotranscription	|O
from	|O
upstream	|O
genes	|O
,	|O
modulation	|O
of	|O
internal	|O
promoter	|O
strength	|O
,	|O
and	|O
by	|O
RNase	|B-PROTEIN
E	|I-PROTEIN
activity	|O
.	|O

Coronary	|O
T1	|O
and	|O
T2	|O
weighted	|O
images	|O
were	|O
obtained	|O
.	|O

The	|O
2	|O
kb	|O
of	|O
5'	|O
-	|O
flanking	|O
region	|O
and	|O
the	|O
1.1	|O
kb	|O
of	|O
the	|O
entire	|O
sGTH	|B-PROTEIN
alpha	|O
subunit	|O
coding	|O
region	|O
were	|O
sequenced	|O
from	|O
the	|O
genomic	|O
clone	|O
,	|O
sGTH	|B-PROTEIN
alpha	|O
-	|O
G1	|O
.	|O

Functional	|O
analysis	|O
of	|O
the	|O
sGTH	|B-PROTEIN
alpha	|I-PROTEIN
subunit	|O
promoter	|O
by	|O
the	|O
transient	|O
transfection	|O
of	|O
several	|O
sGTH	|B-PROTEIN
alpha	|I-PROTEIN
/	|O
CAT	|B-PROTEIN
chimeric	|O
plasmids	|O
into	|O
rainbow	|O
trout	|O
pituitary	|O
cells	|O
suggests	|O
that	|O
its	|O
pituitary	|O
-	|O
specific	|O
expression	|O
is	|O
GSE	|B-PROTEIN
-	|O
dependent	|O
.	|O

Indium	|O
-	|O
111	|O
OncoScint	|O
CR	|O
/	|O
OV	|O
and	|O
F	|O
-	|O
18	|O
FDG	|O
in	|O
colorectal	|O
and	|O
ovarian	|O
carcinoma	|O
recurrences	|O
.	|O

His	|O
carnitine	|O
palmitoyltransferase	|O
(	|B-PROTEIN
CPT	|I-PROTEIN
)	|I-PROTEIN
I	|I-PROTEIN
and	|I-PROTEIN
II	|I-PROTEIN
activities	|O
were	|O
0.06	|O
and	|O
0.12	|O
nmol	|O
/	|O
min	|O
/	|O
mg	|O
protein	|O
,	|O
as	|O
compared	|O
with	|O
a	|O
mean	|O
value	|O
of	|O
0.22	|O
+	|O
/	|O
-	|O
0.14	|O
and	|O
0.27	|O
+	|O
/	|O
-	|O
0.07	|O
nmol	|O
/	|O
min	|O
/	|O
mg	|O
protein	|O
,	|O
respectively	|O
,	|O
in	|O
control	|O
subjects	|O
.	|O

The	|O
Myc	|B-PROTEIN
LZ	|O
was	|O
found	|O
to	|O
prevent	|O
homodimeric	|O
interactions	|O
,	|O
thus	|O
explaining	|O
Myc	|B-PROTEIN
inability	|O
to	|O
homodimerize	|O
efficiently	|O
.	|O

Staphylococcus	|O
aureus	|O
and	|O
CNS	|O
showed	|O
high	|O
or	|O
moderate	|O
resistance	|O
rates	|O
to	|O
methicillin	|O
(	|O
DMPPC	|O
)	|O
.	|O

Thus	|O
,	|O
VF	|O
resistant	|O
to	|O
defibrillation	|O
is	|O
not	|O
necessarily	|O
associated	|O
with	|O
both	|O
toxic	|O
plasma	|O
drug	|O
level	|O
and	|O
remarkably	|O
decreased	|O
conduction	|O
.	|O

The	|O
smallest	|O
active	|O
FecR	|B-PROTEIN
derivative	|O
contained	|O
59	|O
amino	|O
acid	|O
residues	|O
as	|O
compared	|O
to	|O
the	|O
317	|O
residues	|O
of	|O
wild	|O
-	|O
type	|O
FecR	|B-PROTEIN
.	|O

The	|O
gene	|O
pairs	|O
psbB	|B-PROTEIN
-	|O
psbT	|B-PROTEIN
and	|O
psbH	|B-PROTEIN
-	|O
psbN	|B-PROTEIN
are	|O
cotranscribed	|O
from	|O
opposite	|O
strands	|O
.	|O

Hybridization	|O
signals	|O
were	|O
also	|O
detected	|O
with	|O
total	|O
DNAs	|O
of	|O
Rhizobium	|O
leguminosarum	|O
bv	|O
.	|O
phaseoli	|O
,	|O
Rhodobacter	|O
capsulatus	|O
and	|O
Escherichia	|O
coli	|O
,	|O
but	|O
not	|O
those	|O
of	|O
Xanthomonas	|O
campestris	|O
pv	|O
.	|O
campestris	|O
and	|O
Pseudomonas	|O
putida	|O
.	|O

The	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
contains	|O
regions	|O
identical	|O
to	|O
the	|O
sequences	|O
of	|O
peptides	|O
derived	|O
from	|O
bovine	|O
liver	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2B	|I-PROTEIN
alpha	|I-PROTEIN
subunit	|O
.	|O

Expression	|O
of	|O
this	|O
cDNA	|O
in	|O
vitro	|O
yields	|O
a	|O
peptide	|O
which	|O
comigrates	|O
with	|O
natural	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2B	|I-PROTEIN
alpha	|I-PROTEIN
in	|O
SDS	|O
/	|O
polyacrylamide	|O
gels	|O
.	|O

When	|O
RNA	|O
encoding	|O
the	|O
tail	|O
domain	|O
of	|O
desmoglein	|B-PROTEIN
was	|O
coinjected	|O
with	|O
plakoglobin	|B-PROTEIN
RNA	|O
,	|O
both	|O
the	|O
dorsalizing	|O
effect	|O
and	|O
nuclear	|O
accumulation	|O
of	|O
plakoglobin	|B-PROTEIN
were	|O
suppressed	|O
.	|O

Six	|O
of	|O
them	|O
,	|O
NUC1	|B-PROTEIN
,	|O
PRP21	|B-PROTEIN
(	|O
also	|O
called	|O
SPP91	|B-PROTEIN
)	|O
,	|O
CDC6	|B-PROTEIN
,	|O
CRY2	|B-PROTEIN
,	|O
the	|O
gene	|O
encoding	|O
the	|O
ribosomal	|O
protein	|O
S24	|B-PROTEIN
and	|O
the	|O
gene	|O
coding	|O
for	|O
a	|O
hypothetical	|O
protein	|O
of	|O
599	|O
amino	|O
acids	|O
,	|O
have	|O
been	|O
sequenced	|O
previously	|O
.	|O

Intrastriatal	|O
grafts	|O
of	|O
nigral	|O
and	|O
adrenal	|O
tissues	|O
have	|O
been	|O
found	|O
to	|O
be	|O
effective	|O
in	|O
alleviating	|O
many	|O
of	|O
the	|O
simple	|O
motor	|O
and	|O
sensorimotor	|O
deficits	|O
associated	|O
with	|O
lesions	|O
of	|O
the	|O
nigrostriatal	|O
dopamine	|O
system	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
determine	|O
the	|O
impact	|O
of	|O
the	|O
introduction	|O
of	|O
clarithromycin	|O
and	|O
azithromycin	|O
on	|O
the	|O
treatment	|O
and	|O
survival	|O
of	|O
patients	|O
with	|O
AIDS	|O
and	|O
disseminated	|O
Mycobacterium	|O
avium	|O
complex	|O
(	|O
DMAC	|O
)	|O
.	|O

Thereafter	|O
,	|O
the	|O
aggregation	|O
rose	|O
to	|O
the	|O
initial	|O
100%	|O
value	|O
4	|O
h	|O
after	|O
drug	|O
application	|O
and	|O
remained	|O
at	|O
this	|O
level	|O
during	|O
the	|O
observation	|O
period	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Growth	|O
curves	|O
indicated	|O
that	|O
proliferation	|O
of	|O
clone	|O
CA9	|O
in	|O
the	|O
presence	|O
of	|O
10%	|O
serum	|O
was	|O
reduced	|O
by	|O
60%	|O
compared	|O
with	|O
clone	|O
ME10	|O
.	|O

The	|O
protein	|O
coding	|O
region	|O
,	|O
1,696	|O
bps	|O
long	|O
,	|O
is	|O
divided	|O
by	|O
an	|O
intron	|O
into	|O
two	|O
exons	|O
.	|O

The	|O
UAS	|O
of	|O
the	|O
AAC2	|B-PROTEIN
gene	|O
contains	|O
at	|O
least	|O
two	|O
distinct	|O
motifs	|O
for	|O
DNA	|O
-	|O
binding	|O
transcriptional	|O
activators	|O
,	|O
including	|O
one	|O
which	|O
is	|O
identical	|O
with	|O
the	|O
core	|O
HAP2/3	|B-PROTEIN
/	|I-PROTEIN
4	|I-PROTEIN
binding	|O
motif	|O
,	|O
and	|O
a	|O
second	|O
one	|O
with	|O
the	|O
ABF1	|B-PROTEIN
consensus	|O
binding	|O
sequence	|O
.	|O

The	|O
emerging	|O
complexity	|O
of	|O
the	|O
5'	|O
regulatory	|O
region	|O
of	|O
the	|O
GH	|B-PROTEIN
receptor	|I-PROTEIN
gene	|O
was	|O
emphasised	|O
by	|O
the	|O
observation	|O
that	|O
probes	|O
derived	|O
from	|O
exon	|O
1B	|O
and	|O
the	|O
distal	|O
3'	|O
intron	|O
boundary	|O
do	|O
not	|O
hybridise	|O
with	|O
previously	|O
cloned	|O
genomic	|O
sequences	|O
that	|O
span	|O
the	|O
liver	|O
-	|O
specific	|O
P1	|O
promoter	|O
and	|O
exon	|O
2	|O
.	|O

A	|O
polymorphic	|O
dinucleotide	|O
(	|O
GT	|O
/	|O
CA	|O
)	|O
n	|O
repeat	|O
contained	|O
in	|O
the	|O
NHE5	|O
cosmid	|O
was	|O
identified	|O
and	|O
developed	|O
into	|O
a	|O
microsatellite	|O
PCR	|O
marker	|O
.	|O

The	|O
proteins	|O
are	|O
more	|O
than	|O
90%	|O
identical	|O
to	|O
each	|O
other	|O
within	|O
the	|O
protein	|O
kinase	|O
domain	|O
but	|O
only	|O
51-59%	|O
identical	|O
to	|O
other	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
I	|I-PROTEIN
isoforms	|O
within	|O
this	|O
region	|O
.	|O

We	|O
used	|O
two	|O
approaches	|O
to	|O
ascertain	|O
whether	|O
CDP	|B-PROTEIN
/	|O
cut	|B-PROTEIN
serves	|O
as	|O
a	|O
repressor	|O
of	|O
gp91	|B-PROTEIN
-	|O
phox	|B-PROTEIN
gene	|O
expression	|O
.	|O

Serum	|O
induction	|O
of	|O
a	|O
MEF2	|B-PROTEIN
reporter	|O
gene	|O
was	|O
not	|O
observed	|O
in	|O
a	|O
line	|O
of	|O
NIH	|O
3T3	|O
cells	|O
which	|O
contain	|O
low	|O
MEF2	|B-PROTEIN
site	|O
binding	|O
activity	|O
.	|O

Despite	|O
the	|O
activation	|O
of	|O
these	|O
intracellular	|O
signaling	|O
molecules	|O
,	|O
PDGF	|B-PROTEIN
beta	|I-PROTEIN
receptor	|I-PROTEIN
activation	|O
elicited	|O
no	|O
detectable	|O
effect	|O
on	|O
cell	|O
proliferation	|O
or	|O
differentiation	|O
.	|O

UAS1	|O
is	|O
the	|O
binding	|O
site	|O
for	|O
the	|O
transcriptional	|O
regulator	|O
Adr1p	|B-PROTEIN
.	|O

In	|O
the	|O
context	|O
of	|O
the	|O
ADH2	|B-PROTEIN
upstream	|O
regulatory	|O
region	|O
,	|O
including	|O
UAS1	|O
,	|O
working	|O
in	|O
concert	|O
with	|O
the	|O
ADH2	|B-PROTEIN
basal	|O
promoter	|O
elements	|O
,	|O
UAS2	|O
-	|O
dependent	|O
gene	|O
activation	|O
was	|O
dependent	|O
on	|O
orientation	|O
,	|O
copy	|O
number	|O
,	|O
and	|O
helix	|O
phase	|O
.	|O

Induction	|O
in	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
DNA	|O
binding	|O
correlates	|O
with	|O
a	|O
concomitant	|O
GH	|B-PROTEIN
trans	|O
-	|O
activation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
genes	|O
described	|O
previously	|O
.	|O

Inactivation	|O
of	|O
MAP	|B-PROTEIN
kinases	|I-PROTEIN
occurs	|O
via	|O
a	|O
specific	|O
phosphatase	|O
,	|O
MKP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Short	|O
-	|O
course	|O
amphotericin	|O
B	|O
therapy	|O
for	|O
candidemia	|O
in	|O
pediatric	|O
patients	|O
.	|O

Furthermore	|O
,	|O
45Ca	|O
-	|O
binding	|O
assays	|O
revealed	|O
that	|O
CCaMK	|B-PROTEIN
directly	|O
binds	|O
Ca2+	|O
.	|O

Since	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
an	|O
important	|O
mediator	|O
of	|O
tumor	|O
promoter	|O
action	|O
,	|O
these	|O
findings	|O
may	|O
explain	|O
the	|O
anti	|O
-	|O
tumor	|O
-	|O
promoting	|O
activity	|O
of	|O
phenolic	|O
antioxidants	|O
.	|O

The	|O
second	|O
complex	|O
,	|O
when	|O
purified	|O
,	|O
contained	|O
four	|O
protein	|O
components	|O
including	|O
the	|O
36	|O
-	|O
kDa	|O
protein	|O
.	|O

The	|O
protein	|O
expressed	|O
from	|O
the	|O
cloned	|O
cDNA	|O
is	|O
secreted	|O
into	|O
the	|O
culture	|O
medium	|O
and	|O
yields	|O
of	|O
up	|O
to	|O
40	|O
mg	|O
per	|O
litre	|O
have	|O
been	|O
obtained	|O
.	|O

The	|O
study	|O
was	|O
repeated	|O
after	|O
administration	|O
of	|O
oral	|O
amiodarone	|O
,	|O
50	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
for	|O
2	|O
days	|O
in	|O
8	|O
divided	|O
doses	|O
(	|O
mean	|O
dose	|O
6.9	|O
+	|O
/	|O
-	|O
0.4	|O
g	|O
)	|O
.	|O

Plasmids	|O
pAMS12	|O
,	|O
pAMS13	|O
and	|O
pAMS14	|O
were	|O
transformed	|O
into	|O
a	|O
laboratory	|O
strain	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
whereas	|O
pAMS15	|O
was	|O
stably	|O
introduced	|O
into	|O
two	|O
commercial	|O
wine	|O
yeast	|O
strains	|O
.	|O

The	|O
maximum	|O
induction	|O
of	|O
ACC	|B-PROTEIN
-	|I-PROTEIN
oxidase	|I-PROTEIN
transcripts	|O
occurred	|O
at	|O
about	|O
6	|O
h	|O
after	|O
excision	|O
,	|O
while	|O
the	|O
maximum	|O
enzyme	|O
activity	|O
was	|O
observed	|O
at	|O
24	|O
h	|O
.	|O

Within	|O
their	|O
polypeptide	|O
chain	|O
,	|O
they	|O
all	|O
contain	|O
those	|O
conserved	|O
features	|O
that	|O
define	|O
a	|O
plant	|O
CDPK	|B-PROTEIN
;	|O
kinase	|O
catalytic	|O
sequences	|O
are	|O
linked	|O
to	|O
a	|O
calmodulin	|B-PROTEIN
-	|O
like	|O
regulatory	|O
domain	|O
through	|O
a	|O
junction	|O
region	|O
.	|O

Repair	|O
of	|O
this	|O
insertion	|O
by	|O
homologous	|O
recombination	|O
restores	|O
the	|O
activity	|O
of	|O
the	|O
hprt	|B-PROTEIN
locus	|O
,	|O
thus	|O
confirming	|O
the	|O
site	|O
of	|O
mutation	|O
.	|O

The	|O
timing	|O
of	|O
fla	|B-PROTEIN
gene	|O
expression	|O
in	|O
the	|O
cell	|O
cycle	|O
is	|O
determined	|O
by	|O
specialized	|O
forms	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
and	|O
the	|O
appearance	|O
and	|O
/	|O
or	|O
activation	|O
of	|O
regulatory	|O
proteins	|O
.	|O

Primer	|O
extension	|O
experiments	|O
revealed	|O
a	|O
strong	|O
transcription	|O
initiation	|O
site	|O
102	|O
bp	|O
upstream	|O
of	|O
the	|O
translational	|O
start	|O
site	|O
.	|O

Polypeptides	|O
of	|O
the	|O
same	|O
apparent	|O
sizes	|O
are	|O
detected	|O
in	|O
spores	|O
of	|O
a	|O
cotE	|B-PROTEIN
null	|O
mutant	|O
,	|O
on	|O
which	|O
basis	|O
we	|O
infer	|O
that	|O
the	|O
products	|O
of	|O
the	|O
cotJ	|B-PROTEIN
operon	|O
are	|O
required	|O
for	|O
the	|O
normal	|O
formation	|O
of	|O
the	|O
inner	|O
layers	|O
of	|O
the	|O
coat	|O
or	|O
are	|O
themselves	|O
structural	|O
components	|O
of	|O
the	|O
coat	|O
.	|O

Based	|O
on	|O
the	|O
estimated	|O
values	|O
of	|O
divergence	|O
of	|O
apobec1	|B-PROTEIN
sequences	|O
in	|O
terms	|O
of	|O
the	|O
numbers	|O
of	|O
synonymous	|O
and	|O
non	|O
-	|O
synonymous	|O
suhstitutions	|O
per	|O
site	|O
,	|O
we	|O
found	|O
that	|O
apobec1	|B-PROTEIN
is	|O
a	|O
fairly	|O
rapidly	|O
evolving	|O
protein	|O
.	|O

EEA1	|B-PROTEIN
is	|O
a	|O
conserved	|O
alpha	|O
-	|O
helical	|O
peripheral	|O
membrane	|O
protein	|O
flanked	|O
by	|O
cysteine	|O
"	|O
fingers	|O
"	|O
and	|O
contains	|O
a	|O
calmodulin	|B-PROTEIN
-	|O
binding	|O
IQ	|O
motif	|O
.	|O

Nucleotide	|O
sequences	|O
of	|O
the	|O
clones	|O
revealed	|O
that	|O
one	|O
clone	|O
,	|O
cap3	|B-PROTEIN
,	|O
contained	|O
an	|O
open	|O
reading	|O
frame	|O
(	|O
ORF	|O
)	|O
that	|O
would	|O
code	|O
for	|O
a	|O
26	|O
-	|O
amino	|O
acid	|O
,	|O
cysteine	|O
-	|O
rich	|O
peptide	|O
with	|O
significant	|O
homology	|O
to	|O
Neurospora	|O
crassa	|O
copper	|B-PROTEIN
metallothionein	|I-PROTEIN
.	|O

Sensing	|O
with	|O
chemically	|O
and	|O
biologically	|O
modified	|O
carbon	|O
electrodes	|O
.	|O

Elevation	|O
of	|O
the	|O
tissues	|O
of	|O
the	|O
face	|O
is	|O
essentially	|O
vertical	|O
and	|O
acts	|O
on	|O
the	|O
forehead	|O
,	|O
temporal	|O
region	|O
,	|O
gaze	|O
and	|O
cheekbones	|O
.	|O

This	|O
region	|O
binds	|O
two	|O
ubiquitous	|O
nuclear	|O
factors	|O
,	|O
USF	|B-PROTEIN
/	|O
MLTF	|B-PROTEIN
and	|O
the	|O
CAAT	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
/	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
CTF	|B-PROTEIN
/	|O
NF1	|B-PROTEIN
)	|O
.	|O

The	|O
potential	|O
impact	|O
of	|O
using	|O
a	|O
rapid	|O
diagnostic	|O
test	|O
(	|O
Strep	|O
A	|O
OIA	|O
)	|O
on	|O
detection	|O
and	|O
treatment	|O
of	|O
group	|O
A	|O
beta	|O
-	|O
hemolytic	|O
streptococcal	|O
(	|O
GABHS	|O
)	|O
pharyngitis	|O
in	|O
a	|O
large	|O
-	|O
volume	|O
pediatric	|O
and	|O
adolescent	|O
clinic	|O
was	|O
examined	|O
.	|O

The	|O
bHLH	|B-PROTEIN
proteins	|I-PROTEIN
function	|O
as	|O
potent	|O
transcriptional	|O
activators	|O
of	|O
tissue	|O
-	|O
specific	|O
genes	|O
by	|O
forming	|O
heterodimers	|O
between	|O
ubiquitous	|O
and	|O
cell	|O
-	|O
restricted	|O
family	|O
members	|O
.	|O

YAC	|O
and	|O
cosmid	|O
contigs	|O
spanning	|O
the	|O
BRCA1	|B-PROTEIN
region	|O
were	|O
used	|O
to	|O
select	|O
cDNA	|O
clones	|O
from	|O
pools	|O
of	|O
cDNAs	|O
derived	|O
from	|O
human	|O
placenta	|O
,	|O
HeLa	|O
cells	|O
,	|O
activated	|O
T	|O
cells	|O
,	|O
and	|O
fetal	|O
head	|O
.	|O

The	|O
other	|O
two	|O
clones	|O
,	|O
Ash	|B-PROTEIN
-	|I-PROTEIN
m	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
s	|I-PROTEIN
,	|O
had	|O
nucleotide	|O
sequences	|O
identical	|O
with	|O
Ash	|B-PROTEIN
-	|I-PROTEIN
l	|I-PROTEIN
cDNA	|O
in	|O
the	|O
amino	|O
-	|O
terminal	|O
region	|O
.	|O

This	|O
study	|O
assesses	|O
the	|O
feasibility	|O
and	|O
toxicity	|O
of	|O
adoptive	|O
immunotherapy	|O
with	|O
tumor	|O
infiltrating	|O
lymphocytes	|O
and	|O
recombinant	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
in	|O
29	|O
patients	|O
who	|O
underwent	|O
resection	|O
for	|O
stage	|O
III	|O
non	|O
-	|O
small	|O
-	|O
cell	|O
lung	|O
cancer	|O
.	|O

MATERIAL	|O
AND	|O
METHODS	|O
:	|O
Of	|O
the	|O
17	|O
men	|O
and	|O
17	|O
women	|O
,	|O
who	|O
were	|O
21	|O
to	|O
80	|O
years	|O
of	|O
age	|O
,	|O
27	|O
had	|O
hereditary	|O
motor	|O
and	|O
sensory	|O
neuropathy	|O
type	|O
I	|O
and	|O
7	|O
had	|O
acquired	|O
demyelinating	|O
polyneuropathy	|O
.	|O

The	|O
present	|O
study	|O
describes	|O
the	|O
cell	|O
volume	|O
dynamics	|O
in	|O
intact	|O
rat	|O
hearts	|O
,	|O
during	|O
ischemia	|O
and	|O
after	|O
reperfusion	|O
.	|O

In	|O
contrast	|O
,	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
alone	|O
had	|O
no	|O
effect	|O
on	|O
repCRS2	|O
-	|O
dependent	|O
reporter	|O
gene	|O
activity	|O
.	|O

DNA	|O
sequencing	|O
and	|O
Southern	|O
blot	|O
analyses	|O
established	|O
that	|O
the	|O
cDNA	|O
clones	|O
are	|O
derived	|O
from	|O
two	|O
different	|O
genes	|O
.	|O

Muscle	|O
GSH	|B-PROTEIN
-	|I-PROTEIN
Px	|I-PROTEIN
activity	|O
after	|O
prolonged	|O
exercise	|O
,	|O
training	|O
,	|O
and	|O
selenium	|O
supplementation	|O
.	|O

Mutation	|O
of	|O
the	|O
Sp1	|B-PROTEIN
element	|O
,	|O
which	|O
abolishes	|O
Sp1	|B-PROTEIN
binding	|O
,	|O
results	|O
in	|O
a	|O
6-10	|O
-	|O
fold	|O
reduction	|O
in	|O
reporter	|O
activity	|O
.	|O

The	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
gene	|O
is	|O
overexpressed	|O
in	|O
a	|O
variety	|O
of	|O
tumor	|O
types	|O
and	|O
appears	|O
to	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
abnormal	|O
growth	|O
of	|O
a	|O
number	|O
of	|O
cell	|O
types	|O
.	|O

We	|O
found	|O
that	|O
PML	|B-PROTEIN
was	|O
expressed	|O
at	|O
a	|O
lower	|O
level	|O
in	|O
S	|O
,	|O
G2	|O
,	|O
and	|O
M	|O
phases	|O
and	|O
at	|O
a	|O
significantly	|O
higher	|O
level	|O
in	|O
G1	|O
phase	|O
.	|O

Schooling	|O
is	|O
found	|O
to	|O
be	|O
related	|O
to	|O
good	|O
health	|O
even	|O
after	|O
controlling	|O
for	|O
differences	|O
in	|O
observable	|O
health	|O
inputs	|O
.	|O

With	|O
this	|O
bisected	|O
diastolic	|O
driving	|O
,	|O
the	|O
abnormal	|O
echo	|O
disappeared	|O
completely	|O
.	|O

It	|O
acts	|O
on	|O
Cdks	|B-PROTEIN
in	|O
the	|O
G1	|O
and	|O
S	|O
phases	|O
of	|O
the	|O
cell	|O
cycle	|O
,	|O
and	|O
also	|O
binds	|O
to	|O
proliferating	|B-PROTEIN
cell	|I-PROTEIN
nuclear	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
PCNA	|B-PROTEIN
)	|O
,	|O
blocking	|O
DNA	|O
replication	|O
in	|O
vitro	|O
.	|O

Two	|O
major	|O
and	|O
one	|O
minor	|O
transcription	|O
initiation	|O
sites	|O
were	|O
assigned	|O
to	|O
positions	|O
+	|O
1	|O
and	|O
+	|O
24	|O
and	|O
position	|O
+	|O
14	|O
,	|O
respectively	|O
,	|O
by	|O
a	|O
combination	|O
of	|O
ribonuclease	|O
protection	|O
,	|O
primer	|O
extension	|O
,	|O
and	|O
5'	|O
RACE	|O
analyses	|O
.	|O

The	|O
roxithromycin	|O
doses	|O
that	|O
were	|O
chosen	|O
for	|O
these	|O
studies	|O
were	|O
less	|O
than	|O
achievable	|O
blood	|O
levels	|O
.	|O

We	|O
demonstrate	|O
here	|O
that	|O
the	|O
-	|O
DEDDDL	|O
sequence	|O
stabilizes	|O
GDP	|O
binding	|O
to	|O
Ran	|B-PROTEIN
,	|O
and	|O
that	|O
the	|O
domain	|O
is	|O
required	|O
for	|O
high	|O
affinity	|O
interaction	|O
with	|O
a	|O
Ran	|B-PROTEIN
-	|O
binding	|O
protein	|O
,	|O
HTF9A	|B-PROTEIN
/	|O
RanBP1	|B-PROTEIN
.	|O

Further	|O
,	|O
the	|O
ORFs	|O
of	|O
components	|O
3	|O
and	|O
5	|O
potentially	|O
encoded	|O
proteins	|O
of	|O
about	|O
20	|O
kDa	|O
,	|O
the	|O
size	|O
of	|O
the	|O
BBTV	|O
coat	|B-PROTEIN
protein	|O
.	|O

Serial	|O
followup	|O
strength	|O
data	|O
for	|O
2	|O
patients	|O
were	|O
compared	|O
to	|O
change	|O
in	|O
creatinine	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
CK	|B-PROTEIN
)	|O
levels	|O
.	|O

CodY	|B-PROTEIN
does	|O
not	|O
have	|O
any	|O
homologues	|O
in	|O
the	|O
data	|O
-	|O
bases	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
investigate	|O
the	|O
incidence	|O
and	|O
presentation	|O
of	|O
acute	|O
pernicious	|O
or	|O
fulminating	|O
beriberi	|O
in	|O
a	|O
general	|O
district	|O
hospital	|O
.	|O

Unlike	|O
most	|O
other	|O
small	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
which	|O
are	|O
expressed	|O
ubiquitously	|O
,	|O
TTF	|B-PROTEIN
was	|O
transcribed	|O
only	|O
in	|O
hemopoietic	|O
cells	|O
as	|O
a	|O
2.2	|O
kb	|O
transcript	|O
.	|O

An	|O
explanation	|O
explored	|O
for	|O
this	|O
lack	|O
of	|O
gene	|O
expression	|O
was	|O
that	|O
increased	|O
levels	|O
of	|O
RAR	|B-PROTEIN
alpha	|I-PROTEIN
or	|O
PML	|B-PROTEIN
might	|O
suppress	|O
APL	|O
cell	|O
growth	|O
.	|O

Transfection	|O
of	|O
non	|O
-	|O
deleted	|O
expression	|O
vector	|O
into	|O
NIH3T3	|O
cells	|O
results	|O
in	|O
acquisition	|O
of	|O
focus	|O
-	|O
forming	|O
activity	|O
while	|O
a	|O
deleted	|O
form	|O
of	|O
expression	|O
vector	|O
fails	|O
to	|O
show	|O
this	|O
activity	|O
even	|O
in	|O
the	|O
presence	|O
of	|O
basic	|B-PROTEIN
FGF	|I-PROTEIN
.	|O

Cytosolic	|O
extracts	|O
from	|O
a	|O
variety	|O
of	|O
mammalian	|O
cell	|O
lines	|O
(	|O
monkey	|O
Cos7	|O
,	|O
several	|O
mouse	|O
fibrosarcomas	|O
and	|O
human	|O
HeLa	|O
S3	|O
)	|O
demonstrated	|O
similar	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
dependent	|O
RNA	|O
-	|O
protein	|O
band	|O
shifts	|O
as	|O
cell	|O
extract	|O
from	|O
BALB	|O
/	|O
c	|O
3T3	|O
mouse	|O
fibroblasts	|O
.	|O

All	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
(	|O
rp	|B-PROTEIN
)	|O
gene	|O
promoters	|O
from	|O
Saccharomyces	|O
cerevisiae	|O
studied	|O
so	|O
far	|O
contain	|O
either	|O
(	|O
usually	|O
two	|O
)	|O
binding	|O
sites	|O
for	|O
the	|O
global	|O
gene	|O
regulator	|O
Rap1p	|B-PROTEIN
or	|O
one	|O
binding	|O
site	|O
for	|O
another	|O
global	|O
factor	|O
,	|O
Abf1p	|B-PROTEIN
.	|O

The	|O
provisional	|O
reports	|O
are	|O
based	|O
mainly	|O
upon	|O
macroscopic	|O
findings	|O
,	|O
whereas	|O
the	|O
final	|O
reports	|O
include	|O
the	|O
information	|O
provided	|O
by	|O
supplementary	|O
investigations	|O
such	|O
as	|O
microscopy	|O
,	|O
histochemistry	|O
,	|O
more	|O
rarely	|O
electron	|O
microscopy	|O
,	|O
immunohistochemistry	|O
and	|O
/	|O
or	|O
microbiology	|O
.	|O

Circulating	|O
thrombomodulin	|B-PROTEIN
:	|O
current	|O
knowledge	|O
and	|O
future	|O
prospects	|O

CPT	|O
-	|O
11	|O
was	|O
administered	|O
as	|O
a	|O
30	|O
-	|O
minute	|O
i.v	|O
.	|O
infusion	|O
at	|O
a	|O
dose	|O
of	|O
350	|O
mg	|O
/	|O
m2	|O
diluted	|O
in	|O
250	|O
ml	|O
normal	|O
saline	|O
every	|O
3	|O
weeks	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
MTD	|O
for	|O
CPT	|O
-	|O
11	|O
administered	|O
in	|O
a	|O
3	|O
consecutive	|O
-	|O
days	|O
-	|O
every	|O
-	|O
3	|O
weeks	|O
schedule	|O
in	|O
this	|O
patient	|O
population	|O
is	|O
115	|O
mg	|O
/	|O
m2	|O
/	|O
day	|O
.	|O

A	|O
73	|O
bp	|O
fragment	|O
(	|O
X1	|O
region	|O
)	|O
of	|O
the	|O
PRB	|B-PROTEIN
-	|I-PROTEIN
1b	|I-PROTEIN
promoter	|O
,	|O
located	|O
between	|O
positions	|O
-	|O
213	|O
and	|O
-	|O
141	|O
,	|O
was	|O
sufficient	|O
to	|O
confer	|O
ethylene	|O
responsiveness	|O
to	|O
the	|O
reporter	|O
gene	|O
.	|O

To	|O
assess	|O
the	|O
function	|O
(	|O
s	|O
)	|O
of	|O
E74	|B-PROTEIN
during	|O
metamorphosis	|O
,	|O
we	|O
have	|O
isolated	|O
and	|O
characterized	|O
recessive	|O
loss	|O
-	|O
of	|O
-	|O
function	|O
mutations	|O
specific	|O
to	|O
each	|O
transcription	|O
unit	|O
.	|O

Although	|O
the	|O
extracellular	|O
domain	|O
of	|O
the	|O
TSH	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
is	|O
sufficient	|O
for	|O
high	|O
affinity	|O
binding	|O
of	|O
TSH	|B-PROTEIN
,	|O
we	|O
conclude	|O
that	|O
the	|O
hyt	|O
mutation	|O
in	|O
the	|O
fourth	|O
transmembrane	|O
domain	|O
eliminates	|O
TSH	|B-PROTEIN
binding	|O
.	|O

Lipiodol	|O
was	|O
covalently	|O
conjugated	|O
with	|O
EDTB	|O
.	|O

Moreover	|O
,	|O
Western	|O
blots	|O
demonstrated	|O
at	|O
least	|O
six	|O
types	|O
of	|O
Ypt	|B-PROTEIN
in	|O
both	|O
Cr	|O
and	|O
Vc	|O
,	|O
suggesting	|O
that	|O
these	|O
Ypt	|B-PROTEIN
are	|O
used	|O
for	|O
household	|O
functions	|O
responsible	|O
for	|O
vesicle	|O
transport	|O
rather	|O
than	|O
for	|O
cellular	|O
differentiation	|O
.	|O

The	|O
absence	|O
of	|O
other	|O
regions	|O
of	|O
hybridization	|O
suggests	|O
that	|O
there	|O
are	|O
no	|O
closely	|O
related	|O
sequences	|O
(	|O
e.g.	|O
,	|O
reverse	|O
transcribed	|O
pseudogenes	|O
)	|O
scattered	|O
throughout	|O
the	|O
genome	|O
and	|O
that	|O
if	|O
there	|O
are	|O
closely	|O
related	|O
genes	|O
,	|O
they	|O
must	|O
be	|O
clustered	|O
near	|O
GSTT2	|B-PROTEIN
.	|O

However	|O
,	|O
the	|O
lens	|O
dose	|O
(	|O
3.6	|O
Gy	|O
/	|O
25	|O
fractions	|O
)	|O
was	|O
higher	|O
compared	|O
to	|O
the	|O
other	|O
techniques	|O
.	|O

Antibodies	|O
to	|O
the	|O
human	|O
PTS1R	|B-PROTEIN
recognize	|O
this	|O
protein	|O
in	|O
human	|O
,	|O
monkey	|O
,	|O
rat	|O
,	|O
and	|O
hamster	|O
cells	|O
.	|O

There	|O
is	|O
a	|O
national	|O
effort	|O
to	|O
begin	|O
to	|O
ask	|O
all	|O
female	|O
patients	|O
about	|O
family	|O
violence	|O
.	|O

GnRH	|B-PROTEIN
treatment	|O
was	|O
found	|O
to	|O
increase	|O
the	|O
phosphorylation	|O
of	|O
tyrosine	|O
residues	|O
of	|O
MAPK	|B-PROTEIN
and	|O
to	|O
increase	|O
MAPK	|B-PROTEIN
activity	|O
,	|O
as	|O
determined	|O
by	|O
an	|O
immune	|O
complex	|O
kinase	|O
assay	|O
.	|O

Molecular	|O
cloning	|O
of	|O
an	|O
amphibian	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrate	|I-PROTEIN
1	|I-PROTEIN
-	|O
like	|O
cDNA	|O
and	|O
involvement	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
in	|O
insulin	|B-PROTEIN
-	|O
induced	|O
Xenopus	|O
oocyte	|O
maturation	|O
.	|O

We	|O
report	|O
here	|O
that	|O
in	|O
cultured	|O
Jurkat	|O
T	|O
cells	|O
,	|O
Cbl	|B-PROTEIN
is	|O
coprecipitated	|O
with	|O
antibody	|O
against	|O
the	|O
adapter	|O
protein	|O
Grb2	|B-PROTEIN
.	|O

The	|O
effect	|O
of	|O
these	|O
cell	|O
cycle	|O
regulators	|O
is	|O
not	|O
specific	|O
to	|O
the	|O
rap1s	|B-PROTEIN
or	|O
hmr	|B-PROTEIN
delta	|I-PROTEIN
A	|I-PROTEIN
mutation	|O
,	|O
since	|O
swi6	|B-PROTEIN
,	|O
swi4	|B-PROTEIN
,	|O
and	|O
clb5	|B-PROTEIN
mutations	|O
also	|O
suppress	|O
mutations	|O
in	|O
SIR1	|B-PROTEIN
,	|O
another	|O
gene	|O
implicated	|O
in	|O
the	|O
establishment	|O
of	|O
silencing	|O
.	|O

ICP4	|B-PROTEIN
has	|O
been	|O
shown	|O
to	|O
form	|O
tripartite	|O
complexes	|O
cooperatively	|O
with	|O
the	|O
TATA	|B-PROTEIN
box	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
and	|O
TFIIB	|B-PROTEIN
on	|O
DNA	|O
containing	|O
an	|O
ICP4	|B-PROTEIN
binding	|O
site	|O
and	|O
a	|O
TATA	|O
box	|O
(	|O
C.	|O

Otte	|O
,	|O
Mol.	|O

Characterization	|O
of	|O
fus1	|B-PROTEIN
of	|O
Schizosaccharomyces	|O
pombe	|O
:	|O
a	|O
developmentally	|O
controlled	|O
function	|O
needed	|O
for	|O
conjugation	|O
.	|O

SRY	|B-PROTEIN
-	|O
related	|O
cDNA	|O
encoding	|O
a	|O
protein	|O
with	|O
a	|O
high	|B-PROTEIN
-	|I-PROTEIN
mobility	|I-PROTEIN
-	|I-PROTEIN
group	|I-PROTEIN
(	|O
HMG	|B-PROTEIN
)	|O
box	|O
and	|O
a	|O
leucine	|O
zipper	|O
motif	|O
,	|O
which	|O
was	|O
designated	|O
SOX	|B-PROTEIN
-	|I-PROTEIN
LZ	|I-PROTEIN
,	|O
was	|O
isolated	|O
from	|O
a	|O
rainbow	|O
trout	|O
testis	|O
cDNA	|O
library	|O
.	|O

Scalp	|O
flaps	|O
can	|O
be	|O
expanded	|O
just	|O
to	|O
the	|O
point	|O
of	|O
becoming	|O
noticeable	|O
over	|O
4	|O
to	|O
6	|O
weeks	|O
followed	|O
by	|O
scalp	|O
flap	|O
transposition	|O
and	|O
easy	|O
closure	|O
of	|O
the	|O
donor	|O
site	|O
.	|O

In	|O
the	|O
Center	|O
for	|O
Human	|O
Genetics	|O
in	|O
Leuven	|O
,	|O
predictive	|O
DNA	|O
-	|O
testing	|O
for	|O
Huntington	|O
's	|O
disease	|O
is	|O
available	|O
as	|O
a	|O
clinical	|O
service	|O
since	|O
November	|O
1987	|O
,	|O
initially	|O
by	|O
DNA	|O
-	|O
linkage	|O
and	|O
since	|O
mid	|O
1993	|O
by	|O
direct	|O
mutation	|O
analysis	|O
.	|O

Risks	|O
of	|O
chronicity	|O
following	|O
acute	|O
hepatitis	|O
B	|O
virus	|O
infection	|O
:	|O
a	|O
review	|O
.	|O

Examination	|O
of	|O
neurohumoral	|O
factors	|O
revealed	|O
a	|O
hyperactive	|O
sympathetic	|O
nervous	|O
system	|O
and	|O
an	|O
increase	|O
in	|O
plasma	|O
renin	|B-PROTEIN
activity	|O
.	|O

We	|O
compared	|O
the	|O
inhibitory	|O
effect	|O
of	|O
naturally	|O
occurring	|O
mutant	|O
hTR	|B-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
,	|O
artificially	|O
created	|O
hTR	|B-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
mutants	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
erbA	|I-PROTEIN
alpha	|I-PROTEIN
2	|I-PROTEIN
and	|O
the	|O
human	|O
peroxisome	|B-PROTEIN
proliferator	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
hPPAR	|B-PROTEIN
)	|O
on	|O
three	|O
prototypic	|O
T3	|O
-	|O
response	|O
elements	|O
(	|O
TREs	|O
)	|O
,	|O
TRE	|O
-	|O
PAL	|O
,	|O
DR	|O
+	|O
4	|O
and	|O
TRE	|O
-	|O
LAP	|O
.	|O

The	|O
amino	|O
-	|O
terminal	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
Pip	|B-PROTEIN
exhibits	|O
a	|O
high	|O
degree	|O
of	|O
homology	|O
to	|O
the	|O
DNA	|O
-	|O
binding	|O
domains	|O
of	|O
members	|O
of	|O
the	|O
interferon	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
(	|O
IRF	|B-PROTEIN
)	|O
family	|O
,	|O
which	|O
includes	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
ICSBP	|B-PROTEIN
,	|O
and	|O
ISGF3	|B-PROTEIN
gamma	|I-PROTEIN
.	|O

An	|O
outbreak	|O
of	|O
hepatitis	|O
A	|O
among	|O
homosexual	|O
men	|O
in	|O
Amsterdam	|O
,	|O
1991-1993	|O
.	|O

The	|O
RAP74	|B-PROTEIN
subunit	|O
of	|O
TFIIF	|B-PROTEIN
alone	|O
contained	|O
the	|O
stimulatory	|O
activity	|O
and	|O
the	|O
minimal	|O
region	|O
sufficient	|O
for	|O
stimulation	|O
corresponds	|O
to	|O
COOH	|O
-	|O
terminal	|O
residues	|O
358-517	|O
.	|O

We	|O
have	|O
generated	|O
various	|O
base	|O
substitutions	|O
and	|O
internal	|O
deletions	|O
in	|O
and	|O
around	|O
DRE	|O
(	|O
nucleotide	|O
positions	|O
-	|O
93	|O
to	|O
-	|O
100	|O
with	|O
respect	|O
to	|O
the	|O
transcription	|O
initiation	|O
site	|O
)	|O
of	|O
the	|O
PCNA	|B-PROTEIN
gene	|O
in	|O
vitro	|O
and	|O
subsequently	|O
examined	|O
their	|O
effects	|O
on	|O
the	|O
binding	|O
to	|O
DREF	|B-PROTEIN
(	|O
DRE	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
factor	|I-PROTEIN
)	|O
and	|O
PCNA	|B-PROTEIN
gene	|O
promote	|O
activity	|O
in	|O
cultured	|O
Drosophila	|O
Kc	|O
cells	|O
as	|O
well	|O
as	|O
in	|O
living	|O
flies	|O
.	|O

The	|O
hsp70	|B-PROTEIN
gene	|O
family	|O
of	|O
Neurospora	|O
crassa	|O
:	|O
cloning	|O
,	|O
sequence	|O
analysis	|O
,	|O
expression	|O
,	|O
and	|O
genetic	|O
mapping	|O
of	|O
the	|O
major	|O
stress	|O
-	|O
inducible	|O
member	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequences	|O
of	|O
each	|O
of	|O
the	|O
W3A1	|O
ETF	|B-PROTEIN
subunits	|O
exhibit	|O
only	|O
approximately	|O
30%	|O
identity	|O
with	|O
the	|O
corresponding	|O
subunits	|O
of	|O
the	|O
ETF	|B-PROTEIN
from	|O
human	|O
,	|O
rat	|O
,	|O
and	|O
Paracoccus	|O
denitrificans	|O
,	|O
which	|O
as	|O
a	|O
group	|O
are	|O
greater	|O
than	|O
50%	|O
identical	|O
.	|O

A	|O
secondary	|O
phosphorylation	|O
of	|O
CREB341	|B-PROTEIN
at	|O
Ser129	|O
is	|O
required	|O
for	|O
the	|O
cAMP	|O
-	|O
mediated	|O
control	|O
of	|O
gene	|O
expression	|O
.	|O

A	|O
role	|O
for	|O
glycogen	|B-PROTEIN
synthase	|I-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
in	|O
the	|O
control	|O
of	|O
gene	|O
expression	|O
.	|O

This	|O
last	|O
region	|O
contains	|O
two	|O
sites	|O
that	|O
bind	|O
Ets	|B-PROTEIN
-	|O
related	|O
proteins	|O
present	|O
in	|O
liver	|O
nuclear	|O
extracts	|O
as	|O
well	|O
as	|O
recombinant	|O
purified	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
.	|O

Other	|O
assays	|O
also	|O
distinguished	|O
the	|O
processive	|O
replication	|O
of	|O
pNeo.M	|O
yc	|O
-	|O
2.4	|O
from	|O
the	|O
dispersive	|O
labeling	|O
of	|O
control	|O
plasmids	|O
.	|O

Reconstitution	|O
of	|O
complexes	|O
containing	|O
p62	|B-PROTEIN
and	|O
the	|O
src	|B-PROTEIN
family	|O
kinase	|O
p59fyn	|B-PROTEIN
in	|O
HeLa	|O
cells	|O
demonstrated	|O
that	|O
complex	|O
formation	|O
resulted	|O
in	|O
tyrosine	|O
phosphorylation	|O
of	|O
p62	|B-PROTEIN
and	|O
was	|O
mediated	|O
by	|O
both	|O
the	|O
SH3	|B-PROTEIN
and	|O
SH2	|B-PROTEIN
domains	|O
of	|O
p59fyn	|B-PROTEIN
.	|O

Therefore	|O
,	|O
it	|O
is	|O
hoped	|O
that	|O
by	|O
defining	|O
the	|O
transcriptional	|O
control	|O
of	|O
the	|O
L7	|B-PROTEIN
gene	|O
insights	|O
into	|O
the	|O
mechanisms	|O
that	|O
control	|O
functional	|O
fate	|O
and	|O
organization	|O
in	|O
the	|O
nervous	|O
system	|O
can	|O
be	|O
gained	|O
.	|O

In	|O
contrast	|O
,	|O
a	|O
Maf	|B-PROTEIN
-	|O
related	|O
protein	|O
,	|O
Nrl	|B-PROTEIN
,	|O
completely	|O
mimicked	|O
c	|B-PROTEIN
-	|I-PROTEIN
Maf	|I-PROTEIN
actions	|O
.	|O

The	|O
27	|O
-	|O
base	|O
element	|O
interacts	|O
with	|O
a	|O
PDGF	|B-PROTEIN
-	|O
activated	|O
serine	|O
/	|O
threonine	|O
phosphoprotein	|O
that	|O
is	|O
detected	|O
only	|O
within	|O
the	|O
nucleus	|O
of	|O
PDGF	|O
-	|O
treated	|O
3T3	|O
cells	|O
.	|O

By	|O
contrast	|O
,	|O
deletion	|O
of	|O
this	|O
Ras	|B-PROTEIN
-	|O
binding	|O
site	|O
did	|O
not	|O
diminish	|O
activation	|O
of	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
kinase	|I-PROTEIN
by	|O
Src	|B-PROTEIN
,	|O
implying	|O
that	|O
Src	|B-PROTEIN
and	|O
Ras	|B-PROTEIN
can	|O
activate	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
through	|O
independent	|O
mechanisms	|O
.	|O

In	|O
studies	|O
of	|O
many	|O
different	|O
phenotypically	|O
distinct	|O
cells	|O
,	|O
the	|O
CRE	|O
of	|O
the	|O
somatostatin	|B-PROTEIN
gene	|O
promoter	|O
is	|O
a	|O
prototype	|O
of	|O
a	|O
highly	|O
cAMP	|O
-	|O
responsive	|O
element	|O
regulated	|O
by	|O
CREB	|B-PROTEIN
.	|O

The	|O
first	|O
gene	|O
,	|O
NSR1	|B-PROTEIN
,	|O
a	|O
previously	|O
identified	|O
gene	|O
,	|O
encodes	|O
a	|O
protein	|O
involved	|O
in	|O
ribosomal	|O
RNA	|O
maturation	|O
and	|O
possibly	|O
in	|O
transport	|O
of	|O
proteins	|O
into	|O
the	|O
nucleus	|O
.	|O

Characterization	|O
of	|O
the	|O
promoter	|O
for	|O
the	|O
human	|O
85	|O
kDa	|O
cytosolic	|O
phospholipase	|B-PROTEIN
A2	|I-PROTEIN
gene	|O
.	|O

This	|O
paper	|O
describes	|O
the	|O
advantages	|O
and	|O
limitations	|O
of	|O
the	|O
main	|O
study	|O
approaches	|O
used	|O
.	|O

Comparative	|O
study	|O
of	|O
the	|O
differential	|O
white	|O
blood	|O
cell	|O
count	|O
using	|O
three	|O
automated	|O
analyzers	|O
:	|O
Coulter	|O
STKS	|O
,	|O
Sysmex	|O
NE	|O
8000	|O
and	|O
Technicon	|O
H	|O
-	|O
1	|O
.	|O

Characterization	|O
of	|O
FIII	|B-PROTEIN
/	|O
YY1	|B-PROTEIN
,	|O
a	|O
Xenopus	|O
laevis	|O
conserved	|O
zinc	|B-PROTEIN
-	|I-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
binding	|O
to	|O
the	|O
first	|O
exon	|O
of	|O
L1	|B-PROTEIN
and	|O
L14	|B-PROTEIN
ribosomal	|O
protein	|O
genes	|O
.	|O

Further	|O
studies	|O
established	|O
that	|O
the	|O
Ep	|B-PROTEIN
-	|O
induced	|O
increase	|O
in	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
mRNA	|O
could	|O
be	|O
inhibited	|O
by	|O
the	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
inhibitor	|O
genistein	|O
and	|O
the	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
inhibitor	|O
Compound	|O
3	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

This	|O
structure	|O
of	|O
cucumisin	|B-PROTEIN
suggests	|O
that	|O
it	|O
is	|O
probably	|O
synthesized	|O
as	|O
an	|O
inactive	|O
precursor	|O
.	|O

Molecular	|O
dissection	|O
of	|O
the	|O
multimeric	|O
CD3	|B-PROTEIN
-	|O
TCR	|B-PROTEIN
complex	|O
revealed	|O
that	|O
at	|O
least	|O
two	|O
associated	|O
polypeptides	|O
,	|O
CD3	|B-PROTEIN
zeta	|I-PROTEIN
and	|O
CD3	|B-PROTEIN
epsilon	|I-PROTEIN
,	|O
autonomously	|O
couple	|O
antigenic	|O
recognition	|O
event	|O
to	|O
early	|O
and	|O
late	|O
events	|O
of	|O
the	|O
intracytoplasmic	|O
activation	|O
cascade	|O
.	|O

Protein	|O
cHMGI	|B-PROTEIN
binds	|O
preferentially	|O
to	|O
AT	|O
-	|O
rich	|O
DNA	|O
with	|O
a	|O
half	|O
-	|O
saturation	|O
value	|O
of	|O
1.1	|O
nM	|O
.	|O

This	|O
study	|O
investigated	|O
the	|O
degree	|O
to	|O
which	|O
racial	|O
identity	|O
influences	|O
Mexican	|O
-	|O
Americans	|O
'	|O
performance	|O
on	|O
the	|O
L	|O
,	|O
K	|O
,	|O
and	|O
MF	|O
scales	|O
of	|O
the	|O
MMPI	|O
-	|O
2	|O
.	|O

Both	|O
can	|O
be	|O
elevated	|O
on	|O
a	|O
single	|O
vascular	|O
pedicle	|O
based	|O
on	|O
the	|O
superficial	|O
temporal	|O
artery	|O
,	|O
the	|O
double	|O
-	|O
layered	|O
temporal	|O
fascia	|O
flap	|O
.	|O

To	|O
do	|O
this	|O
,	|O
segments	|O
of	|O
DNA	|O
from	|O
the	|O
5'	|O
flank	|O
of	|O
the	|O
initiation	|O
sites	|O
for	|O
germline	|O
epsilon	|O
RNA	|O
were	|O
ligated	|O
to	|O
a	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
and	|O
transfected	|O
into	|O
two	|O
mouse	|O
B	|O
cell	|O
lines	|O
,	|O
one	|O
of	|O
which	|O
can	|O
be	|O
induced	|O
to	|O
switch	|O
to	|O
IgE	|B-PROTEIN
.	|O

The	|O
negative	|O
predictive	|O
value	|O
is	|O
92%	|O
,	|O
vs	|O
80%	|O
for	|O
the	|O
NCEP	|O
I.	|O

Oncogenic	|O
capacity	|O
of	|O
the	|O
E2F1	|B-PROTEIN
gene	|O
.	|O

In	|O
some	|O
of	|O
the	|O
cases	|O
of	|O
solitary	|O
lesion	|O
,	|O
serum	|O
TSH	|B-PROTEIN
levels	|O
,	|O
serum	|O
thyroglobulin	|B-PROTEIN
values	|O
,	|O
and	|O
131I	|O
protein	|O
bounded	|O
iodine	|O
(	|O
131I	|O
-	|O
PBI	|O
)	|O
were	|O
measured	|O
,	|O
but	|O
there	|O
were	|O
no	|O
significant	|O
differences	|O
between	|O
successful	|O
and	|O
unsuccessful	|O
therapy	|O
.	|O

Endo16	|B-PROTEIN
transcripts	|O
are	|O
confined	|O
to	|O
the	|O
definitive	|O
vegetal	|O
plate	|O
in	|O
blastula	|O
stage	|O
embryos	|O
;	|O
at	|O
gastrula	|O
stage	|O
this	|O
gene	|O
is	|O
expressed	|O
throughout	|O
the	|O
archenteron	|O
,	|O
but	|O
later	|O
only	|O
in	|O
the	|O
midgut	|O
.	|O

A	|O
unique	|O
leucine	|O
-	|O
proline	|O
repeat	|O
element	|O
found	|O
N	|O
-	|O
terminal	|O
to	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
EmBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
does	|O
not	|O
appear	|O
to	|O
play	|O
a	|O
role	|O
in	|O
DNA	|O
-	|O
binding	|O
or	|O
dimerization	|O
.	|O

Another	|O
full	|O
ORF	|O
was	|O
found	|O
on	|O
the	|O
opposite	|O
strand	|O
downstream	|O
from	|O
the	|O
nspC	|B-PROTEIN
gene	|O
.	|O

The	|O
U14	|B-PROTEIN
genes	|O
of	|O
mouse	|O
as	|O
well	|O
as	|O
rat	|O
,	|O
hamster	|O
,	|O
human	|O
,	|O
Xenopus	|O
and	|O
trout	|O
are	|O
encoded	|O
within	|O
introns	|O
of	|O
the	|O
constitutively	|O
expressed	|O
70	|B-PROTEIN
-	|I-PROTEIN
kDa	|I-PROTEIN
-	|I-PROTEIN
cognate	|I-PROTEIN
-	|I-PROTEIN
heat	|I-PROTEIN
-	|I-PROTEIN
shock	|I-PROTEIN
protein	|O
gene	|O
(	|O
hsc70	|B-PROTEIN
)	|O
.	|O

Two	|O
related	|O
cDNAs	|O
were	|O
isolated	|O
that	|O
encode	|O
proteins	|O
that	|O
recognize	|O
the	|O
XMyoDa	|B-PROTEIN
TATA	|O
motif	|O
.	|O

Deletion	|O
of	|O
both	|O
prfA	|B-PROTEIN
and	|O
ponA	|B-PROTEIN
resulted	|O
in	|O
extremely	|O
slow	|O
growth	|O
and	|O
a	|O
reduction	|O
in	|O
sporulation	|O
efficiency	|O
.	|O

Inclusion	|O
in	|O
this	|O
family	|O
of	|O
proteins	|O
suggests	|O
that	|O
FliQ	|B-PROTEIN
and	|O
FliR	|B-PROTEIN
may	|O
participate	|O
in	|O
an	|O
export	|O
pathway	|O
required	|O
for	|O
flagellum	|O
assembly	|O
.	|O

In	|O
broken	|O
L	|O
-	|O
cell	|O
membranes	|O
expressing	|O
wild	|O
type	|O
or	|O
mutant	|O
M6P	|B-PROTEIN
/	|I-PROTEIN
IGF	|I-PROTEIN
II	|I-PROTEIN
receptors	|I-PROTEIN
,	|O
30	|O
nM	|O
IGF	|B-PROTEIN
II	|I-PROTEIN
also	|O
failed	|O
to	|O
affect	|O
the	|O
pertussis	|B-PROTEIN
toxin	|I-PROTEIN
substrate	|O
activity	|O
.	|O

Chem.	|O

For	|O
the	|O
first	|O
time	|O
we	|O
describe	|O
deletion	|O
and	|O
point	|O
mutations	|O
within	|O
the	|O
plasma	|O
membrane	|O
family	|O
of	|O
guanylyl	|B-PROTEIN
cyclase	|I-PROTEIN
receptors	|I-PROTEIN
that	|O
result	|O
in	|O
the	|O
formation	|O
of	|O
effective	|O
dominant	|O
negative	|O
proteins	|O
.	|O

Increase	|O
in	|O
blood	|O
NEFA	|O
was	|O
further	|O
augmented	|O
by	|O
fat	|O
plus	|O
AA	|O
supplementation	|O
,	|O
but	|O
no	|O
changes	|O
in	|O
concentrations	|O
of	|O
Lys	|O
or	|O
Met	|O
in	|O
blood	|O
were	|O
found	|O
.	|O

Virol.	|O

Coronary	|O
vasoconstriction	|O
caused	|O
by	|O
endothelin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
enhanced	|O
by	|O
ischemia	|O
-	|O
reperfusion	|O
and	|O
by	|O
norepinephrine	|O
present	|O
in	|O
concentrations	|O
typically	|O
observed	|O
after	|O
neonatal	|O
cardiopulmonary	|O
bypass	|O
.	|O

Comparison	|O
of	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
kafirin	|I-PROTEIN
with	|O
the	|O
published	|O
sequences	|O
of	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
prolamins	|I-PROTEIN
of	|O
maize	|O
,	|O
and	|O
Coix	|O
revealed	|O
highly	|O
conserved	|O
domains	|O
.	|O

Atcys1	|B-PROTEIN
,	|O
Athyp1	|B-PROTEIN
,	|O
AKin10	|B-PROTEIN
and	|O
the	|O
ORF	|O
are	|O
very	|O
close	|O
to	|O
each	|O
other	|O
and	|O
organized	|O
in	|O
the	|O
same	|O
polarity	|O
;	|O
hence	|O
,	|O
the	|O
intergenic	|O
regions	|O
probably	|O
contain	|O
,	|O
within	|O
less	|O
than	|O
0.5	|O
kb	|O
,	|O
all	|O
the	|O
regulatory	|O
elements	|O
necessary	|O
to	|O
govern	|O
initiation	|O
and	|O
termination	|O
of	|O
transcription	|O
.	|O

Southern	|O
blot	|O
hybridization	|O
experiments	|O
suggest	|O
the	|O
presence	|O
of	|O
one	|O
copy	|O
of	|O
Atcys1	|B-PROTEIN
,	|O
Athyp1	|B-PROTEIN
and	|O
AKin10	|B-PROTEIN
per	|O
haploid	|O
genome	|O
,	|O
and	|O
Northern	|O
blot	|O
analysis	|O
demonstrates	|O
that	|O
the	|O
three	|O
genes	|O
are	|O
differentially	|O
expressed	|O
in	|O
roots	|O
,	|O
shoots	|O
and	|O
leaves	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
HAC1	|B-PROTEIN
may	|O
also	|O
be	|O
one	|O
of	|O
the	|O
meiotic	|O
genes	|O
.	|O

We	|O
characterized	|O
three	|O
Arabidopsis	|O
thaliana	|O
cDNA	|O
clones	|O
that	|O
could	|O
rescue	|O
the	|O
sterile	|O
phenotype	|O
of	|O
the	|O
Schizosaccharomyces	|O
pombe	|O
pde1	|B-PROTEIN
mutant	|I-PROTEIN
,	|O
which	|O
is	|O
defective	|O
in	|O
cAMP	|B-PROTEIN
phosphodiesterase	|I-PROTEIN
.	|O

Furthermore	|O
,	|O
the	|O
identification	|O
of	|O
a	|O
Dr1	|B-PROTEIN
-	|O
like	|O
protein	|O
in	|O
A.t	|O
haliana	|O
strongly	|O
argues	|O
for	|O
the	|O
ubiquity	|O
of	|O
this	|O
protein	|O
among	|O
eukaryotic	|O
genera	|O
and	|O
for	|O
a	|O
conserved	|O
mechanism	|O
to	|O
regulate	|O
transcription	|O
initiation	|O
that	|O
involves	|O
Dr1	|B-PROTEIN
.	|O

Similarly	|O
approximately	|O
300	|O
bp	|O
of	|O
sequence	|O
downstream	|O
of	|O
the	|O
translation	|O
terminator	|O
TGA	|O
of	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
tubulin	|I-PROTEIN
2	|I-PROTEIN
(	|O
BTU2	|B-PROTEIN
)	|O
gene	|O
could	|O
substitute	|O
for	|O
the	|O
3'	|O
region	|O
of	|O
the	|O
H4	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
gene	|O
.	|O

These	|O
data	|O
demonstrate	|O
that	|O
the	|O
STR	|B-PROTEIN
family	|O
of	|O
genes	|O
is	|O
represented	|O
in	|O
a	|O
nematode	|O
whose	|O
ancestor	|O
appeared	|O
well	|O
before	|O
the	|O
branching	|O
that	|O
gave	|O
rise	|O
to	|O
the	|O
Arthropoda	|O
and	|O
Chordata	|O
.	|O

The	|O
pre	|O
-	|O
and	|O
postoperative	|O
haemoglobin	|B-PROTEIN
concentrations	|O
in	|O
the	|O
autologous	|O
group	|O
were	|O
lower	|O
by	|O
15	|O
and	|O
10	|O
g	|O
/	|O
L	|O
,	|O
respectively	|O
,	|O
after	|O
primary	|O
THR	|O
and	|O
by	|O
10	|O
g	|O
/	|O
L	|O
in	|O
both	|O
instances	|O
after	|O
revision	|O
THR	|O
.	|O

The	|O
introduction	|O
of	|O
an	|O
acidic	|O
residue	|O
at	|O
the	|O
second	|O
site	|O
was	|O
essential	|O
for	|O
suppression	|O
of	|O
the	|O
Asn	|O
-	|O
285	|O
mutation	|O
because	|O
Lys	|O
-	|O
220	|O
and	|O
Gln	|O
-	|O
220	|O
second	|O
-	|O
site	|O
mutants	|O
of	|O
the	|O
Asn	|O
-	|O
285	|O
mutant	|O
showed	|O
very	|O
low	|O
tetracycline	|O
resistance	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
the	|O
cytokine	|O
that	|O
participates	|O
in	|O
the	|O
autocrine	|O
growth	|O
control	|O
of	|O
hairy	|O
cell	|O
leukemia	|O
has	|O
strong	|O
bone	|O
resorptive	|O
properties	|O
.	|O

(	|O
iv	|O
)	|O
Although	|O
UCRBP	|B-PROTEIN
has	|O
been	|O
previously	|O
shown	|O
to	|O
act	|O
as	|O
a	|O
transcriptional	|O
repressor	|O
,	|O
we	|O
show	|O
here	|O
that	|O
UCRBP	|B-PROTEIN
can	|O
also	|O
act	|O
as	|O
a	|O
positive	|O
transactivator	|O
of	|O
a	|O
reporter	|O
driven	|O
by	|O
UCR	|O
elements	|O
when	|O
used	|O
in	|O
co	|O
-	|O
transfection	|O
assays	|O
.	|O

The	|O
sequence	|O
of	|O
monkey	|O
opsin	|B-PROTEIN
closely	|O
resembles	|O
the	|O
human	|O
sequence	|O
at	|O
the	|O
nucleotide	|O
and	|O
the	|O
amino	|O
acid	|O
levels	|O
,	|O
with	|O
the	|O
latter	|O
having	|O
only	|O
7	|O
differences	|O
out	|O
of	|O
348	|O
residues	|O
.	|O

One	|O
complex	|O
appears	|O
to	|O
be	|O
ubiquitous	|O
but	|O
enriched	|O
in	|O
lymphoid	|O
cells	|O
and	|O
represents	|O
the	|O
binding	|O
of	|O
a	|O
potentially	|O
novel	|O
factor	|O
with	|O
an	|O
apparent	|O
molecular	|O
mass	|O
of	|O
approximately	|O
50	|O
kDa	|O
.	|O

Chem.	|O

Conversely	|O
,	|O
activation	|O
of	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
3/4	|I-PROTEIN
promoter	|O
by	|O
RAR	|B-PROTEIN
:	|O
RXR	|B-PROTEIN
heterodimers	|O
was	|O
completely	|O
abolished	|O
by	|O
EAR	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
/	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFI	|I-PROTEIN
and	|O
by	|O
ARP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFII	|I-PROTEIN
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
EKLF	|B-PROTEIN
provides	|O
a	|O
crucial	|O
transactivation	|O
function	|O
for	|O
globin	|B-PROTEIN
expression	|O
and	|O
further	|O
reinforce	|O
the	|O
idea	|O
that	|O
EKLF	|B-PROTEIN
is	|O
an	|O
important	|O
regulator	|O
of	|O
CACCC	|O
element	|O
-	|O
directed	|O
transcription	|O
in	|O
erythroid	|O
cells	|O
.	|O

Using	|O
a	|O
battery	|O
of	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
mutants	|O
,	|O
we	|O
show	|O
that	|O
(	|O
i	|O
)	|O
a	|O
dimer	|O
binds	|O
a	|O
single	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
molecule	|O
,	|O
(	|O
ii	|O
)	|O
the	|O
acidic	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
is	|O
not	|O
required	|O
for	|O
protein	|O
-	|O
protein	|O
binding	|O
and	|O
does	|O
not	|O
mask	|O
the	|O
nuclear	|O
localization	|O
signal	|O
of	|O
the	|O
dimer	|O
,	|O
(	|O
iii	|O
)	|O
the	|O
same	|O
C	|O
-	|O
terminal	|O
region	|O
is	|O
required	|O
for	|O
inhibition	|O
of	|O
DNA	|O
binding	|O
,	|O
and	|O
(	|O
iv	|O
)	|O
this	|O
inhibition	|O
may	|O
be	|O
accomplished	|O
by	|O
direct	|O
interaction	|O
between	|O
the	|O
PEST	|O
-	|O
like	|O
region	|O
and	|O
the	|O
DNA	|O
-	|O
binding	|O
region	|O
of	|O
one	|O
of	|O
the	|O
subunits	|O
of	|O
the	|O
dimer	|O
.	|O

The	|O
negative	|O
regulatory	|O
activity	|O
of	|O
the	|O
N	|O
-	|O
terminal	|O
domain	|O
was	|O
antagonized	|O
by	|O
a	|O
C	|O
-	|O
terminal	|O
segment	|O
of	|O
Pho81p	|B-PROTEIN
supplied	|O
in	|O
trans	|O
.	|O

At	|O
different	|O
times	|O
of	|O
the	|O
surgical	|O
procedures	|O
(	|O
thorax	|O
opening	|O
and	|O
closure	|O
,	|O
period	|O
of	|O
cardiopulmonary	|O
bypass	|O
)	|O
67	|O
to	|O
100%	|O
of	|O
the	|O
patients	|O
in	|O
group	|O
1	|O
had	|O
vancomycin	|O
concentrations	|O
in	|O
the	|O
studied	|O
tissues	|O
above	|O
the	|O
MIC	|O
90	|O
for	|O
Staphylococcus	|O
aureus	|O
(	|O
1	|O
microgram	|O
/	|O
g	|O
)	|O
and	|O
Staphylococcus	|O
epidermidis	|O
(	|O
2	|O
micrograms	|O
/	|O
g	|O
)	|O
.	|O

On	|O
-	|O
line	|O
angioscopic	|O
images	|O
of	|O
tissue	|O
flaps	|O
floating	|O
in	|O
the	|O
lumen	|O
,	|O
recent	|O
or	|O
structured	|O
thrombi	|O
,	|O
artery	|O
wall	|O
dissections	|O
,	|O
plaque	|O
ruptures	|O
,	|O
deep	|O
fissurations	|O
and	|O
sub	|O
-	|O
intimal	|O
haemorrhages	|O
demonstrate	|O
,	|O
in	|O
live	|O
colour	|O
,	|O
the	|O
pathophysiological	|O
mechanisms	|O
of	|O
coronary	|O
artery	|O
stenosis	|O
.	|O

The	|O
enhanced	|O
cysteine	|O
formation	|O
in	|O
a	|O
pCSK4F	|O
plant	|O
responding	|O
to	|O
sulfite	|O
was	|O
also	|O
observed	|O
in	|O
leaf	|O
discs	|O
.	|O

Each	|O
type	|O
was	|O
divided	|O
into	|O
two	|O
subgroups	|O
on	|O
the	|O
basis	|O
of	|O
whether	|O
the	|O
body	|O
and	|O
tail	|O
of	|O
the	|O
pancreas	|O
showed	|O
intense	|O
fatty	|O
replacement	|O
(	|O
type	|O
a	|O
=	|O
negative	|O
for	|O
intense	|O
fatty	|O
replacement	|O
,	|O
type	|O
b	|O
=	|O
positive	|O
for	|O
intense	|O
fatty	|O
replacement	|O
)	|O
.	|O

Between	|O
the	|O
subgroups	|O
of	|O
dementia	|O
disorders	|O
there	|O
were	|O
no	|O
significant	|O
differences	|O
in	|O
basal	|O
cortisol	|O
levels	|O
.	|O

A	|O
new	|O
hypothesis	|O
on	|O
mechanisms	|O
for	|O
inhibiting	|O
catalytic	|O
subunits	|O
by	|O
gamma	|O
-	|O
subunits	|O
and	|O
activation	|O
of	|O
a	|O
holoenzyme	|O
by	|O
transducin	|B-PROTEIN

Basal	|O
components	|O
of	|O
the	|O
transcription	|O
apparatus	|O
(	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
,	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
)	|O
contain	|O
activation	|O
domains	|O
:	|O
is	|O
the	|O
repetitive	|O
C	|O
-	|O
terminal	|O
domain	|O
(	|O
CTD	|O
)	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
a	|O
"	|O
portable	|O
enhancer	|O
domain	|O
"	|O
?	|O
Regions	|O
rich	|O
in	|O
serine	|O
,	|O
threonine	|O
,	|O
and	|O
proline	|O
residues	|O
can	|O
be	|O
found	|O
in	|O
transcriptional	|O
activation	|O
domains	|O
,	|O
as	|O
well	|O
as	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
parts	|O
of	|O
mammalian	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
,	|O
where	|O
they	|O
are	|O
interrupted	|O
by	|O
polyglutamine	|O
stretches	|O
.	|O

Mutagenesis	|O
of	|O
IM1	|B-PROTEIN
enhances	|O
the	|O
ability	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
to	|O
activate	|O
an	|O
AP1	|B-PROTEIN
bearing	|O
promoter	|O
.	|O

Binding	|O
of	|O
SSP	|B-PROTEIN
to	|O
the	|O
stage	|B-PROTEIN
selector	|I-PROTEIN
element	|I-PROTEIN
(	|O
SSE	|B-PROTEIN
)	|O
in	|O
the	|O
proximal	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
promoter	|O
is	|O
integral	|O
to	|O
the	|O
competitive	|O
silencing	|O
of	|O
a	|O
linked	|O
beta	|B-PROTEIN
-	|I-PROTEIN
promoter	|I-PROTEIN
in	|O
embryonic	|O
/	|O
fetal	|O
stage	|O
erythroleukemia	|O
(	|O
K562	|O
)	|O
cells	|O
.	|O

This	|O
failure	|O
to	|O
execute	|O
regulated	|O
G1	|O
/	|O
S	|O
arrest	|O
is	|O
correlated	|O
with	|O
enhanced	|O
thermosensitivity	|O
of	|O
colony	|O
-	|O
forming	|O
ability	|O
.	|O

Mutations	|O
that	|O
alter	|O
photoreceptor	|O
cell	|O
structure	|O
and	|O
development	|O
were	|O
isolated	|O
that	|O
fail	|O
to	|O
complement	|O
these	|O
deletions	|O
.	|O

It	|O
is	|O
possible	|O
that	|O
the	|O
telomeres	|O
of	|O
the	|O
two	|O
nuclei	|O
have	|O
different	|O
functions	|O
.	|O

The	|O
marker	|O
orders	|O
from	|O
the	|O
genetic	|O
and	|O
RH	|O
maps	|O
were	|O
consistent	|O
.	|O

Integrated	|O
mapping	|O
analysis	|O
of	|O
the	|O
Werner	|O
syndrome	|O
region	|O
of	|O
chromosome	|O
8	|O
.	|O

The	|O
region	|O
between	|O
DXS52	|B-PROTEIN
and	|O
Factor	|B-PROTEIN
VIII	|I-PROTEIN
gene	|O
in	|O
the	|O
human	|O
Xq28	|O
chromosomal	|O
band	|O
contains	|O
a	|O
G+	|O
C	|O
-	|O
rich	|O
isochore	|O
to	|O
which	|O
many	|O
genes	|O
have	|O
been	|O
mapped	|O
.	|O

Haplotype	|O
mapping	|O
and	|O
sequence	|O
analysis	|O
of	|O
the	|O
mouse	|O
Nramp	|B-PROTEIN
gene	|O
predict	|O
susceptibility	|O
to	|O
infection	|O
with	|O
intracellular	|O
parasites	|O
.	|O

This	|O
utilization	|O
of	|O
an	|O
intronic	|O
polyadenylation	|O
site	|O
without	|O
alternative	|O
exon	|O
usage	|O
is	|O
comparable	|O
to	|O
the	|O
mechanism	|O
whereby	|O
both	|O
secreted	|O
and	|O
membrane	|O
-	|O
bound	|O
forms	|O
of	|O
the	|O
immunoglobulin	|B-PROTEIN
mu	|I-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
are	|O
made	|O
from	|O
a	|O
single	|O
genetic	|O
locus	|O
.	|O

To	|O
further	|O
our	|O
knowledge	|O
about	|O
the	|O
systemic	|O
humoral	|O
immune	|O
system	|O
response	|O
to	|O
weak	|O
hapten	|O
-	|O
syngeneic	|O
or	|O
allogeneic	|O
protein	|O
conjugates	|O
(	|O
corrosion	|O
and	|O
wear	|O
products	|O
of	|O
metallic	|O
orthopedic	|O
devices	|O
)	|O
,	|O
a	|O
sensitive	|O
enzyme	|O
-	|O
linked	|O
immunosorbent	|O
assay	|O
(	|O
ELISA	|O
)	|O
method	|O
for	|O
testing	|O
for	|O
antibody	|O
(	|O
humoral	|O
immunity	|O
)	|O
to	|O
metals	|O
was	|O
developed	|O
.	|O

In	|O
contrast	|O
,	|O
peak	|O
filling	|O
rate	|O
(	|O
PFR	|O
)	|O
,	|O
normalized	|O
to	|O
end	|O
diastolic	|O
volume	|O
(	|O
EDV	|O
)	|O
,	|O
or	|O
stroke	|O
volume	|O
(	|O
SV	|O
)	|O
,	|O
or	|O
expressed	|O
as	|O
the	|O
ratio	|O
of	|O
PFR	|O
-	|O
to	|O
-	|O
PER	|O
was	|O
reduced	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
time	|O
to	|O
PFR	|O
(	|O
TPFR	|O
)	|O
was	|O
prolonged	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
and	|O
echocardiographic	|O
left	|O
ventricular	|O
mass	|O
index	|O
was	|O
higher	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
in	|O
patients	|O
with	|O
acromegaly	|O
compared	|O
to	|O
normals	|O
.	|O

A	|O
genetic	|O
complementation	|O
system	|O
was	|O
developed	|O
in	|O
which	|O
tobacco	|O
etch	|O
virus	|O
(	|O
TEV	|B-PROTEIN
)	|O
polymerase	|O
(	|O
NIb	|B-PROTEIN
)	|O
-	|O
expressing	|O
transgenic	|O
plants	|O
or	|O
protoplasts	|O
were	|O
inoculated	|O
with	|O
NIb	|B-PROTEIN
-	|O
defective	|O
TEV	|B-PROTEIN
mutants	|O
.	|O

Nucleotide	|O
sequence	|O
and	|O
transcriptional	|O
analysis	|O
of	|O
the	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
gene	|O
of	|O
Bombyx	|O
mori	|O
nuclear	|O
polyhedrosis	|O
virus	|O
.	|O

Comparison	|O
of	|O
the	|O
genomes	|O
of	|O
PMTV	|O
,	|O
BNYVV	|O
,	|O
and	|O
SBWMV	|O
shows	|O
that	|O
furoviruses	|O
exhibit	|O
considerable	|O
heterogeneity	|O
in	|O
genome	|O
organization	|O
.	|O

The	|O
drug	|O
sensitivity	|O
was	|O
100%	|O
for	|O
vancomycin	|O
(	|O
VCM	|O
)	|O
,	|O
30%	|O
for	|O
imipenam	|O
(	|O
IMP	|O
)	|O
,	|O
31%	|O
for	|O
minomycin	|O
(	|O
MINO	|O
)	|O
,	|O
31%	|O
for	|O
amikacin	|O
(	|O
AMK	|O
)	|O
,	|O
and	|O
7%	|O
for	|O
fosfomycin	|O
(	|O
FOM	|O
)	|O
.	|O

Deglycosylation	|O
with	|O
endoglycosidase	|B-PROTEIN
H	|I-PROTEIN
showed	|O
that	|O
the	|O
mutant	|O
receptors	|O
had	|O
mainly	|O
high	|O
-	|O
mannose	|O
oligosaccharide	|O
chains	|O
.	|O

Dietary	|O
supplement	|O
with	|O
fish	|O
oil	|O
and	|O
related	|O
n	|O
-	|O
3	|O
EFAs	|O
has	|O
been	|O
used	|O
to	|O
study	|O
their	|O
antihypertensive	|O
property	|O
in	|O
animals	|O
and	|O
humans	|O
with	|O
borderline	|O
and	|O
essential	|O
hypertension	|O
.	|O

The	|O
HSD3B1	|B-PROTEIN
and	|O
HSD3B2	|B-PROTEIN
genes	|O
encoding	|O
the	|O
types	|O
I	|O
and	|O
II	|O
3	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
HSD	|I-PROTEIN
isoenzymes	|O
,	|O
respectively	|O
,	|O
have	|O
been	|O
previously	|O
assigned	|O
by	|O
in	|O
situ	|O
hybridization	|O
to	|O
the	|O
chromosome	|O
1p13.1	|O
region	|O
.	|O

Therefore	|O
the	|O
prevalences	|O
of	|O
total	|O
diabetes	|O
and	|O
GDM	|O
were	|O
1.19%	|O
and	|O
0.56%	|O
,	|O
respectively	|O
.	|O

Insulin	|B-PROTEIN
-	|O
stimulated	|O
glucose	|O
transport	|O
in	|O
adipocytes	|O
is	|O
mediated	|O
by	|O
the	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
.	|O

After	|O
selection	|O
and	|O
conversion	|O
to	|O
adipocytes	|O
,	|O
the	|O
level	|O
of	|O
EGFR	|B-PROTEIN
expression	|O
was	|O
retained	|O
in	|O
infectant	|O
adipocytes	|O
(	|O
150,000	|O
and	|O
250,000	|O
/	|O
cell	|O
,	|O
respectively	|O
)	|O
,	|O
but	|O
not	|O
in	|O
the	|O
parental	|O
3T3	|O
-	|O
L1	|O
adipocytes	|O
(	|O
<	|O
5000	|O
/	|O
cell	|O
)	|O
.	|O

Intron	|O
-	|O
exon	|O
structure	|O
of	|O
the	|O
porcine	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
encoding	|O
gene	|O
.	|O

Fraction	|O
2	|O
contains	|O
1,25	|O
(	|O
OH	|O
)	|O
2	|O
-	|O
vitamin	|O
D3	|O
,	|O
vitamin	|O
D3	|O
,	|O
25	|O
(	|O
OH	|O
)	|O
-	|O
vitamin	|O
D3	|O
and	|O
1,24,25	|O
(	|O
OH	|O
)	|O
3	|O
-	|O
vitamin	|O
D3	|O
.	|O

The	|O
kallistatin	|B-PROTEIN
gene	|O
was	|O
localized	|O
by	|O
in	|O
situ	|O
hybridization	|O
to	|O
human	|O
chromosome	|O
14q31	|O
-	|O
q32.1	|O
,	|O
close	|O
to	|O
the	|O
serpin	|B-PROTEIN
genes	|O
encoding	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
antichymotrypsin	|I-PROTEIN
,	|O
protein	|B-PROTEIN
C	|I-PROTEIN
inhibitor	|I-PROTEIN
,	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
antitrypsin	|I-PROTEIN
,	|O
and	|O
corticosteroid	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
globulin	|I-PROTEIN
.	|O

The	|O
locus	|O
encoding	|O
the	|O
XD	|B-PROTEIN
gene	|O
(	|O
designated	|O
Xd	|B-PROTEIN
)	|O
was	|O
mapped	|O
to	|O
the	|O
distal	|O
part	|O
of	|O
mouse	|O
chromosome	|O
17	|O
by	|O
haplotype	|O
analysis	|O
of	|O
114	|O
interspecific	|O
backcross	|O
mice	|O
.	|O

Some	|O
studies	|O
of	|O
exercise	|O
have	|O
associated	|O
beta	|B-PROTEIN
-	|I-PROTEIN
endorphin	|I-PROTEIN
release	|O
with	|O
increased	|O
exertion	|O
levels	|O
,	|O
but	|O
other	|O
evidence	|O
suggests	|O
that	|O
acidosis	|O
may	|O
stimulate	|O
the	|O
release	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
endorphin	|I-PROTEIN
.	|O

An	|O
interatrial	|O
communication	|O
mitigates	|O
the	|O
impairment	|O
of	|O
LV	|O
function	|O
after	|O
an	|O
acute	|O
and	|O
sustained	|O
drop	|O
of	|O
intrathoracic	|O
pressure	|O
.	|O

Self	|O
or	|O
foreign	|O
cellular	|O
proteins	|O
provide	|O
peptides	|O
for	|O
presentation	|O
by	|O
major	|O
histocompatibility	|O
complex	|O
(	|B-PROTEIN
MHC	|I-PROTEIN
)	|I-PROTEIN
class	|I-PROTEIN
I	|I-PROTEIN
molecules	|O
on	|O
the	|O
surface	|O
of	|O
antigen	|O
presenting	|O
cells	|O
(	|O
APC	|O
)	|O
.	|O

The	|O
characteristics	|O
of	|O
the	|O
VirD1	|B-PROTEIN
/	|O
VirD2	|B-PROTEIN
-	|O
mediated	|O
cleavage	|O
reaction	|O
strongly	|O
resemble	|O
those	|O
observed	|O
with	|O
relaxosomes	|O
of	|O
IncP	|O
plasmids	|O
involved	|O
in	|O
initiation	|O
of	|O
transfer	|O
DNA	|O
replication	|O
during	|O
bacterial	|O
conjugation	|O
.	|O

Isoelectric	|O
focusing	|O
of	|O
tryptic	|O
peptides	|O
generated	|O
from	|O
MHC	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
phosphorylated	|O
with	|O
cdc2	|B-PROTEIN
kinase	|I-PROTEIN
revealed	|O
one	|O
major	|O
phosphopeptide	|O
that	|O
was	|O
purified	|O
by	|O
reverse	|O
-	|O
phase	|O
high	|O
performance	|O
liquid	|O
chromatography	|O
and	|O
sequenced	|O
.	|O

The	|O
deduced	|O
protein	|O
sequence	|O
was	|O
88%	|O
homologous	|O
to	|O
that	|O
of	|O
hNUC	|B-PROTEIN
I	|I-PROTEIN
,	|O
isolated	|O
from	|O
human	|O
osteosarcoma	|O
cells	|O
.	|O

However	|O
,	|O
cotransfection	|O
studies	|O
indicate	|O
that	|O
RVR	|B-PROTEIN
does	|O
not	|O
activate	|O
transcription	|O
when	|O
this	|O
hormone	|O
response	|O
element	|O
is	|O
linked	|O
to	|O
a	|O
reporter	|O
gene	|O
but	|O
rather	|O
acts	|O
as	|O
a	|O
potent	|O
competitive	|O
repressor	|O
of	|O
ROR	|B-PROTEIN
alpha	|I-PROTEIN
function	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
Flavobacterium	|O
glycosylasparaginase	|B-PROTEIN
with	|O
a	|O
mammalian	|O
glycosylasparaginase	|B-PROTEIN
revealed	|O
30%	|O
structural	|O
identity	|O
and	|O
60%	|O
overall	|O
similarity	|O
between	|O
the	|O
prokaryotic	|O
and	|O
eukaryotic	|O
forms	|O
of	|O
the	|O
enzyme	|O
.	|O

Dissociation	|O
and	|O
complexation	|O
of	|O
the	|O
fluoroquinolone	|O
antimicrobials	|O
-	|O
-	|O
an	|O
update	|O
.	|O

Superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
(	|O
SOD	|B-PROTEIN
)	|O
activity	|O
decreased	|O
significantly	|O
in	|O
sperm	|O
subjected	|O
to	|O
direct	|O
electric	|O
current	|O
in	|O
comparison	|O
to	|O
the	|O
control	|O
or	|O
the	|O
sample	|O
incubated	|O
with	|O
electrolyzed	|O
medium	|O
.	|O

These	|O
studies	|O
indicate	|O
that	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
electrical	|O
stimulation	|O
generate	|O
reactive	|O
oxygen	|O
species	|O
and	|O
affect	|O
SOD	|B-PROTEIN
activity	|O
,	|O
which	|O
in	|O
part	|O
are	|O
responsible	|O
for	|O
decreased	|O
sperm	|O
motion	|O
and	|O
viability	|O
.	|O

Molecular	|O
cloning	|O
and	|O
sequencing	|O
of	|O
a	|O
cDNA	|O
encoding	|O
SR	|B-PROTEIN
beta	|I-PROTEIN
revealed	|O
that	|O
SR	|B-PROTEIN
beta	|I-PROTEIN
is	|O
a	|O
transmembrane	|O
protein	|O
and	|O
,	|O
like	|O
SR	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
SRP54	|B-PROTEIN
,	|O
is	|O
a	|O
member	|O
of	|O
the	|O
GTPase	|B-PROTEIN
superfamily	|O
.	|O

To	|O
understand	|O
the	|O
function	|O
of	|O
receptor	|O
-	|O
linked	|O
tyrosine	|B-PROTEIN
phosphatases	|I-PROTEIN
in	|O
neural	|O
development	|O
,	|O
we	|O
sought	|O
to	|O
identify	|O
LAR	|B-PROTEIN
isoforms	|O
preferentially	|O
expressed	|O
in	|O
the	|O
nervous	|O
system	|O
and	|O
cellular	|O
processes	|O
regulating	|O
LAR	|B-PROTEIN
alternative	|O
splicing	|O
.	|O

Sex	|O
selection	|O
via	|O
albumin	|B-PROTEIN
columns	|O
:	|O
20	|O
years	|O
of	|O
results	|O
.	|O

135	|O
students	|O
had	|O
a	|O
count	|O
of	|O
less	|O
than	|O
50	|O
eggs	|O
/	|O
10	|O
ml	|O
.	|O
urine	|O
and	|O
56	|O
had	|O
more	|O
than	|O
50	|O
eggs	|O
/	|O
10ml	|O
.	|O

They	|O
also	|O
reported	|O
that	|O
E	|B-PROTEIN
mu	|I-PROTEIN
pim	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
transgenic	|O
mice	|O
show	|O
greatly	|O
accelerated	|O
lymphoma	|O
development	|O
when	|O
infected	|O
with	|O
wild	|O
-	|O
type	|O
M	|O
-	|O
MuLV	|O
at	|O
birth	|O
.	|O

Comparison	|O
of	|O
human	|O
and	|O
murine	|O
blk	|B-PROTEIN
sequences	|O
indicated	|O
that	|O
they	|O
share	|O
86%	|O
amino	|O
acid	|O
identity	|O
,	|O
the	|O
most	|O
conserved	|O
region	|O
being	|O
the	|O
catalytic	|O
domain	|O
(	|O
93%	|O
identity	|O
)	|O
.	|O

Chrispeels	|O
[	|O
1993	|O
]	|O
EMBO	|O
J	|O
12	|O
:	|O
2241-2247	|O
)	|O
.	|O

The	|O
mRNAs	|O
of	|O
the	|O
GRF	|B-PROTEIN
genes	|O
are	|O
encoded	|O
by	|O
six	|O
exons	|O
interrupted	|O
by	|O
five	|O
introns	|O
.	|O

The	|O
effect	|O
of	|O
ethanol	|O
on	|O
human	|O
sensorimotor	|O
reactivity	|O
was	|O
assessed	|O
by	|O
examining	|O
the	|O
acoustic	|O
startle	|O
response	|O
.	|O

Digitalis	|O
glycosides	|O
or	|O
beta	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
are	|O
not	|O
helpful	|O
in	|O
the	|O
therapy	|O
of	|O
this	|O
form	|O
of	|O
atrial	|O
fibrillation	|O
whereas	|O
class	|O
I	|O
antiarrhythmic	|O
drugs	|O
have	|O
been	|O
shown	|O
to	|O
be	|O
more	|O
effective	|O
.	|O

Atrial	|O
fibrillation	|O
and	|O
the	|O
autonomic	|O
nervous	|O
system	|O

VIII	|O
in	|O
doses	|O
2-3	|O
times	|O
higher	|O
than	|O
usually	|O
used	|O
in	|O
haemophiliacs	|O
without	|O
inhibitor	|O
were	|O
successful	|O
.	|O

A	|O
reduction	|O
of	|O
the	|O
aspartate	|B-PROTEIN
aminotransferase	|I-PROTEIN
activity	|O
was	|O
observed	|O
from	|O
800	|O
mg	|O
/	|O
kg	|O
b.w	|O
.	|O
/	|O
d	|O
onwards	|O
.	|O

Thus	|O
,	|O
these	|O
studies	|O
indicate	|O
that	|O
the	|O
104	|O
-	|O
kDa	|O
isoform	|O
is	|O
required	|O
for	|O
normal	|O
proliferation	|O
of	|O
female	|O
germline	|O
cells	|O
and	|O
perhaps	|O
for	|O
oocyte	|O
differentiation	|O
.	|O

Physical	|O
analysis	|O
maps	|O
SAL6	|B-PROTEIN
to	|O
chromosome	|O
XVI	|O
between	|O
TPK2	|B-PROTEIN
and	|O
spt14	|B-PROTEIN
.	|O

The	|O
newly	|O
devised	|O
DCT	|O
method	|O
yields	|O
reliable	|O
data	|O
in	|O
measuring	|O
TBF	|O
.	|O

Removal	|O
of	|O
PDMP	|O
from	|O
the	|O
cell	|O
medium	|O
resulted	|O
in	|O
reversal	|O
of	|O
the	|O
cell	|O
cycle	|O
changes	|O
,	|O
with	|O
cells	|O
re	|O
-	|O
entering	|O
the	|O
S	|O
phase	|O
.	|O

Rho	|B-PROTEIN
GDP	|I-PROTEIN
/	|I-PROTEIN
GTP	|I-PROTEIN
exchange	|I-PROTEIN
inhibitor	|I-PROTEIN
,	|O
Rho	|B-PROTEIN
GDI	|I-PROTEIN
,	|O
comigrated	|O
with	|O
Rac2	|B-PROTEIN
and	|O
RhoA	|B-PROTEIN
,	|O
but	|O
not	|O
Rac1	|B-PROTEIN
.	|O

A	|O
major	|O
task	|O
for	|O
sports	|O
scientists	|O
may	|O
be	|O
to	|O
verify	|O
empirically	|O
the	|O
nature	|O
of	|O
an	|O
integrated	|O
model	|O
of	|O
the	|O
sport	|O
performer	|O
.	|O

Schnell	|O
,	|O
J.	|O

Encapsidation	|O
of	|O
poliovirus	|O
replicons	|O
encoding	|O
the	|O
complete	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
gag	|B-PROTEIN
gene	|O
by	|O
using	|O
a	|O
complementation	|O
system	|O
which	|O
provides	|O
the	|O
P1	|B-PROTEIN
capsid	|O
protein	|O
in	|O
trans	|O
.	|O

Removal	|O
of	|O
the	|O
GST	|B-PROTEIN
domain	|O
from	|O
GST	|B-PROTEIN
-	|O
Tax	|B-PROTEIN
by	|O
thrombin	|B-PROTEIN
restores	|O
Tax	|B-PROTEIN
's	|O
ability	|O
to	|O
assemble	|O
a	|O
ternary	|O
Tax	|B-PROTEIN
-	|O
CREB	|B-PROTEIN
-	|O
21	|O
-	|O
bp	|O
-	|O
repeat	|O
complex	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

The	|O
requirement	|O
of	|O
PilE	|B-PROTEIN
in	|O
pilus	|O
biogenesis	|O
was	|O
confirmed	|O
by	|O
demonstrating	|O
that	|O
chromosomal	|O
pilE	|B-PROTEIN
insertion	|O
mutants	|O
were	|O
pilus	|O
-	|O
and	|O
twitching	|O
-	|O
motility	|O
deficient	|O
.	|O

The	|O
pilE	|B-PROTEIN
gene	|O
product	|O
of	|O
Pseudomonas	|O
aeruginosa	|O
,	|O
required	|O
for	|O
pilus	|O
biogenesis	|O
,	|O
shares	|O
amino	|O
acid	|O
sequence	|O
identity	|O
with	|O
the	|O
N	|O
-	|O
termini	|O
of	|O
type	|O
4	|O
prepilin	|B-PROTEIN
proteins	|O
.	|O

Because	|O
of	|O
the	|O
functional	|O
conservation	|O
of	|O
cell	|O
cycle	|O
control	|O
elements	|O
,	|O
the	|O
expression	|O
of	|O
a	|O
vertebrate	|O
wee1	|B-PROTEIN
or	|O
mik1	|B-PROTEIN
homolog	|O
would	|O
be	|O
expected	|O
to	|O
rescue	|O
such	|O
lethal	|O
mutations	|O
in	|O
yeast	|O
.	|O

The	|O
expression	|O
of	|O
this	|O
clone	|O
in	|O
a	|O
wee1	|B-PROTEIN
/	|O
mik1	|B-PROTEIN
-	|O
deficient	|O
mutant	|O
causes	|O
an	|O
elongated	|O
cell	|O
phenotype	|O
under	|O
non	|O
-	|O
permissive	|O
growth	|O
conditions	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
phosphorylation	|O
of	|O
M	|B-PROTEIN
protein	|O
at	|O
the	|O
major	|O
in	|O
vivo	|O
sites	|O
is	|O
not	|O
essential	|O
for	|O
virus	|O
assembly	|O
.	|O

Near	|O
a	|O
third	|O
(	|O
31.6%	|O
)	|O
of	|O
Insulin	|B-PROTEIN
Dependent	|O
and	|O
a	|O
third	|O
(	|O
33.41%	|O
)	|O
for	|O
Non	|O
Insulin	|B-PROTEIN
Dependent	|O
were	|O
of	|O
D	|O
,	|O
F	|O
,	|O
H	|O
White	|O
's	|O
Class	|O
.	|O

The	|O
activity	|O
of	|O
6	|O
-	|O
fluoroquinolones	|O
and	|O
their	|O
nonfluorinated	|O
derivatives	|O
is	|O
compared	|O
in	|O
general	|O
.	|O

As	|O
the	|O
half	|O
-	|O
life	|O
of	|O
the	|O
compound	|O
did	|O
never	|O
exceed	|O
8-9	|O
h	|O
,	|O
the	|O
data	|O
do	|O
not	|O
support	|O
any	|O
change	|O
of	|O
pidotimod	|O
administration	|O
schedule	|O
(	|O
every	|O
24-12	|O
h	|O
)	|O
.	|O

The	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
cascade	|O
is	|O
highly	|O
conserved	|O
in	|O
all	|O
eukaryotes	|O
and	|O
involved	|O
in	|O
numerous	|O
cellular	|O
responses	|O
.	|O

A	|O
comparative	|O
study	|O
by	|O
holographic	|O
interferometry	|O
of	|O
ten	|O
porcine	|O
bioprosthetic	|O
valves	|O
(	|O
seven	|O
Carpentier	|O
-	|O
Edwards	|O
SAV	|O
,	|O
two	|O
BioImplant	|O
and	|O
one	|O
Valcor	|O
)	|O
with	|O
five	|O
human	|O
aortic	|O
valves	|O
before	|O
and	|O
after	|O
glutaraldehyde	|O
treatment	|O
is	|O
presented	|O
.	|O

No	|O
serious	|O
side	|O
effects	|O
were	|O
observed	|O
.	|O

This	|O
region	|O
constitutes	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
with	|O
basic	|O
-	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
and	|O
leucine	|O
-	|O
zipper	|O
motifs	|O
,	|O
features	|O
common	|O
to	|O
the	|O
myc	|B-PROTEIN
-	|O
related	|O
transcription	|O
factor	|O
family	|O
.	|O

Specific	|O
binding	|O
was	|O
not	|O
observed	|O
with	|O
either	|O
the	|O
orthologous	|O
rat	|O
or	|O
mouse	|O
fragments	|O
using	|O
human	|O
or	|O
rodent	|O
extracts	|O
.	|O

The	|O
mean	|O
jitter	|O
and	|O
the	|O
fiber	|O
density	|O
did	|O
not	|O
change	|O
significantly	|O
from	|O
day	|O
0	|O
(	|O
30.1	|O
+	|O
/	|O
-	|O
3.6	|O
microseconds	|O
;	|O
1.4	|O
+	|O
/	|O
-	|O
0.07	|O
)	|O
to	|O
day	|O
30	|O
(	|O
34.5	|O
+	|O
/	|O
-	|O
2.7	|O
microseconds	|O
;	|O
1.6	|O
+	|O
/	|O
-	|O
0.13	|O
)	|O
.	|O

Lack	|O
of	|O
cyclin	|B-PROTEIN
D	|I-PROTEIN
-	|O
Cdk	|B-PROTEIN
complexes	|O
in	|O
Rb	|B-PROTEIN
-	|O
negative	|O
cells	|O
correlates	|O
with	|O
high	|O
levels	|O
of	|O
p16INK4	|B-PROTEIN
/	|O
MTS1	|B-PROTEIN
tumour	|O
suppressor	|O
gene	|O
product	|O
.	|O

Recombinant	|B-PROTEIN
human	|I-PROTEIN
serum	|I-PROTEIN
albumin	|I-PROTEIN
(	|O
rHSA	|B-PROTEIN
)	|O
produced	|O
by	|O
cultured	|O
fermentation	|O
has	|O
been	|O
prepared	|O
in	|O
the	|O
form	|O
of	|O
microcapsules	|O
nominally	|O
3-5	|O
microns	|O
in	|O
diameter	|O
and	|O
radiolabelled	|O
with	|O
technetium	|O
-	|O
99m	|O
following	|O
reduction	|O
with	|O
stannous	|O
chloride	|O
.	|O

We	|O
have	|O
measured	|O
the	|O
release	|O
of	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
tumour	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
)	|O
by	|O
unstimulated	|O
monocytes	|O
and	|O
monocytes	|O
stimulated	|O
with	|O
lipopolysaccharide	|O
(	|O
LPS	|O
)	|O
isolated	|O
from	|O
the	|O
peripheral	|O
blood	|O
of	|O
two	|O
patients	|O
with	|O
acute	|O
poststreptococcal	|O
glomerulonephritis	|O
(	|O
AGN	|O
)	|O
and	|O
16	|O
healthy	|O
controls	|O
.	|O

Such	|O
an	|O
intervention	|O
may	|O
be	|O
of	|O
considerable	|O
use	|O
for	|O
the	|O
treatment	|O
of	|O
angiogenesis	|O
-	|O
dependent	|O
diseases	|O
involving	|O
FGF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

We	|O
have	|O
attempted	|O
to	|O
clone	|O
two	|O
recessive	|O
extragenic	|O
suppressors	|O
of	|O
such	|O
ts	|O
mutants	|O
(	|O
sdp1	|B-PROTEIN
for	|O
mutation	|O
pol3	|B-PROTEIN
-	|O
14	|O
and	|O
sdp5	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
for	|O
mutation	|O
pol3	|B-PROTEIN
-	|O
11	|O
)	|O
by	|O
transforming	|O
thermoresistant	|O
haploid	|O
strains	|O
pol3	|B-PROTEIN
-	|O
14	|O
sdp1	|O
and	|O
pol3	|B-PROTEIN
-	|O
11	|O
sdp5	|O
-	|O
1	|O
with	|O
wild	|O
-	|O
type	|O
genomic	|O
libraries	|O
in	|O
singlecopy	|O
or	|O
multicopy	|O
vectors	|O
.	|O

UV	|O
cross	|O
-	|O
linking	|O
experiments	|O
show	|O
that	|O
TEP	|B-PROTEIN
has	|O
an	|O
apparent	|O
molecular	|O
mass	|O
of	|O
approximately	|O
65	|O
kDa	|O
.	|O

In	|O
acute	|O
-	|O
phase	|O
livers	|O
,	|O
we	|O
observed	|O
a	|O
dramatic	|O
reduction	|O
in	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
alpha	|I-PROTEIN
expression	|O
which	|O
correlates	|O
with	|O
a	|O
decrease	|O
in	|O
the	|O
expression	|O
of	|O
its	|O
target	|O
gene	|O
,	|O
the	|O
TTR	|B-PROTEIN
gene	|O
.	|O

Alternatively	|O
,	|O
loss	|O
-	|O
of	|O
-	|O
function	|O
alleles	|O
of	|O
genes	|O
that	|O
inhibit	|O
cAPK	|B-PROTEIN
lead	|O
to	|O
the	|O
inability	|O
to	|O
undergo	|O
sexual	|O
differentiation	|O
.	|O

One	|O
member	|O
of	|O
this	|O
family	|O
,	|O
RFX1	|B-PROTEIN
,	|O
is	|O
a	|O
transcription	|O
factor	|O
for	|O
a	|O
variety	|O
of	|O
viral	|O
and	|O
cellular	|O
genes	|O
.	|O

This	|O
mutant	|O
was	|O
identified	|O
by	|O
screening	|O
with	|O
a	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|O
inducible	|O
vector	|O
a	|O
series	|O
of	|O
mink	|O
lung	|O
epithelial	|O
cell	|O
clones	|O
that	|O
have	|O
normal	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
binding	|O
activity	|O
but	|O
have	|O
lost	|O
antiproliferative	|O
and	|O
transcriptional	|O
responses	|O
to	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
.	|O

Cloning	|O
by	|O
complementation	|O
and	|O
subsequent	|O
physical	|O
and	|O
genetic	|O
analysis	|O
revealed	|O
that	|O
it	|O
maps	|O
to	|O
RAF1	|B-PROTEIN
.	|O

In	|O
the	|O
presence	|O
of	|O
inositol	|O
and	|O
choline	|O
(	|O
repressing	|O
)	|O
,	|O
the	|O
product	|O
of	|O
the	|O
OPI1	|B-PROTEIN
gene	|O
represses	|O
transcription	|O
dictated	|O
by	|O
the	|O
UASINO	|O
element	|O
.	|O

By	|O
treating	|O
monkey	|O
COS	|O
cells	|O
with	|O
oligonucleotides	|O
linked	|O
to	|O
psoralen	|O
,	|O
we	|O
have	|O
generated	|O
targeted	|O
mutations	|O
in	|O
a	|O
simian	|O
virus	|O
40	|O
(	|O
SV40	|O
)	|O
vector	|O
contained	|O
within	|O
the	|O
cells	|O
via	|O
intracellular	|O
triple	|O
helix	|O
formation	|O
.	|O

The	|O
interleukin	|B-PROTEIN
2	|I-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
gene	|O
is	|O
rapidly	|O
and	|O
potently	|O
induced	|O
in	|O
T	|O
cells	|O
in	|O
response	|O
to	|O
mitogenic	|O
stimuli	|O
.	|O

The	|O
Wilms	|B-PROTEIN
'	|I-PROTEIN
tumour	|I-PROTEIN
suppressor	|I-PROTEIN
protein	|I-PROTEIN
(	|O
WT1	|B-PROTEIN
)	|O
is	|O
a	|O
putative	|O
transcriptional	|O
regulatory	|O
protein	|O
with	|O
four	|O
zinc	|O
fingers	|O
,	|O
the	|O
last	|O
three	|O
of	|O
which	|O
have	|O
extensive	|O
sequence	|O
homology	|O
to	|O
the	|O
early	|B-PROTEIN
growth	|I-PROTEIN
response	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
EGR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
protein	|O
.	|O

OBJECTIVES	|O
:	|O
1	|O
)	|O
to	|O
determine	|O
serum	|O
ACE	|B-PROTEIN
activity	|O
in	|O
patients	|O
with	|O
COPD	|O
treated	|O
with	|O
and	|O
without	|O
continuous	|O
ambulatory	|O
oxygen	|O
therapy	|O
(	|O
CAOT	|O
)	|O
;	|O
2	|O
)	|O
to	|O
verify	|O
whether	|O
there	|O
is	|O
a	|O
correlation	|O
between	|O
ACE	|B-PROTEIN
and	|O
any	|O
hematological	|O
,	|O
spirometric	|O
or	|O
gasometric	|O
parameter	|O
.	|O

In	|O
order	|O
to	|O
infer	|O
shape	|O
from	|O
contour	|O
,	|O
the	|O
human	|O
visual	|O
system	|O
must	|O
selectively	|O
integrate	|O
fragments	|O
projecting	|O
from	|O
a	|O
common	|O
object	|O
while	|O
keeping	|O
fragments	|O
from	|O
different	|O
objects	|O
separate	|O
.	|O

Among	|O
9	|O
group	|O
I	|O
patients	|O
with	|O
a	|O
positive	|O
result	|O
on	|O
head	|O
-	|O
up	|O
tilt	|O
-	|O
table	|O
testing	|O
and	|O
no	|O
evidence	|O
of	|O
structural	|O
heart	|O
disease	|O
(	|O
mean	|O
follow	|O
-	|O
up	|O
4.3	|O
years	|O
)	|O
,	|O
7	|O
are	|O
without	|O
further	|O
episodes	|O
of	|O
syncope	|O
;	|O
3	|O
have	|O
discontinued	|O
medication	|O
and	|O
5	|O
have	|O
resumed	|O
at	|O
least	|O
limited	|O
exercise	|O
.	|O

Constructs	|O
designed	|O
and	|O
expressed	|O
were	|O
E2L1	|B-PROTEIN
(	|O
1-98	|O
)	|O
,	|O
E2L1.H	|B-PROTEIN
1	|I-PROTEIN
(	|O
1-128	|O
)	|O
,	|O
E2L2	|B-PROTEIN
(	|O
120-233	|O
)	|O
,	|O
E2H1.L	|B-PROTEIN
2	|I-PROTEIN
(	|O
98-233	|O
)	|O
,	|O
and	|O
E2L1.H	|B-PROTEIN
1.L	|I-PROTEIN
2	|I-PROTEIN
(	|O
1-233	|O
)	|O
,	|O
where	|O
numbers	|O
in	|O
parentheses	|O
give	|O
the	|O
amino	|O
acid	|O
sequence	|O
for	|O
the	|O
portions	|O
of	|O
the	|O
E2	|B-PROTEIN
component	|O
incorporated	|O
into	|O
a	|O
construct	|O
.	|O

Thus	|O
,	|O
we	|O
have	|O
produced	|O
lipoyl	|O
domain	|O
constructs	|O
that	|O
can	|O
be	|O
employed	|O
in	|O
sorting	|O
the	|O
specific	|O
roles	|O
of	|O
E2L1	|B-PROTEIN
and	|O
E2L2	|B-PROTEIN
in	|O
facilitating	|O
catalytic	|O
and	|O
regulatory	|O
processes	|O
.	|O

METHODS	|O
:	|O
Ten	|O
influenza	|O
A	|O
(	|O
H3N2	|O
)	|O
viruses	|O
isolated	|O
during	|O
the	|O
outbreaks	|O
were	|O
examined	|O
for	|O
resistance	|O
to	|O
amantadine	|O
and	|O
rimantadine	|O
by	|O
means	|O
of	|O
an	|O
enzyme	|O
immunoassay	|O
and	|O
by	|O
sequencing	|O
of	|O
the	|O
viral	|O
nucleic	|O
acid	|O
that	|O
encodes	|O
the	|O
transmembrane	|O
domain	|O
of	|O
the	|O
M2	|B-PROTEIN
protein	|O
.	|O

The	|O
first	|O
contains	|O
ATF	|B-PROTEIN
/	|O
CRE	|O
and	|O
TBP	|B-PROTEIN
/	|O
TATA	|O
sequence	|O
motifs	|O
within	|O
an	|O
87	|O
-	|O
bp	|O
region	|O
.	|O

Gene	|O
expression	|O
occurs	|O
in	|O
a	|O
circadian	|O
rhythm	|O
and	|O
induced	|O
by	|O
light	|O
in	|O
leaves	|O
of	|O
dark	|O
-	|O
adapted	|O
plants	|O
.	|O

Our	|O
results	|O
suggested	|O
that	|O
the	|O
hexamer	|O
and	|O
the	|O
octamer	|O
motifs	|O
may	|O
play	|O
important	|O
role	|O
(	|O
s	|O
)	|O
in	|O
regulation	|O
of	|O
replication	|O
-	|O
dependent	|O
but	|O
not	|O
of	|O
replication	|O
-	|O
independent	|O
expression	|O
of	|O
the	|O
wheat	|O
histone	|O
H3	|B-PROTEIN
gene	|O
.	|O

The	|O
tissue	|O
-	|O
specific	|O
expression	|O
of	|O
DP	|B-PROTEIN
family	|O
members	|O
suggests	|O
that	|O
the	|O
combination	|O
of	|O
DP	|B-PROTEIN
/	|O
E2F	|B-PROTEIN
heterodimers	|O
that	|O
constitute	|O
DRTF1	|B-PROTEIN
/	|O
E2F	|B-PROTEIN
is	|O
influenced	|O
by	|O
the	|O
phenotype	|O
of	|O
the	|O
cell	|O
.	|O

Similarly	|O
,	|O
in	|O
mammalian	|O
cells	|O
PBP74	|B-PROTEIN
is	|O
synthesized	|O
as	|O
a	|O
pre	|O
-	|O
protein	|O
that	|O
requires	|O
membrane	|O
potential	|O
-	|O
dependent	|O
import	|O
into	|O
mitochondria	|O
for	|O
its	|O
maturation	|O
.	|O

In	|O
a	|O
second	|O
experiment	|O
involving	|O
an	|O
18	|O
-	|O
h	|O
lung	|O
clearance	|O
assay	|O
,	|O
we	|O
used	|O
the	|O
mAb	|O
3.2.3	|B-PROTEIN
to	|O
deplete	|O
rats	|O
of	|O
LGL	|O
/	|O
NK	|O
cells	|O
with	|O
the	|O
following	|O
rationale	|O
:	|O
if	|O
LGL	|O
/	|O
NK	|O
cells	|O
are	|O
necessary	|O
to	|O
mediate	|O
an	|O
event	|O
,	|O
then	|O
in	|O
their	|O
absence	|O
,	|O
that	|O
event	|O
should	|O
not	|O
occur	|O
.	|O

Treatment	|O
of	|O
recurrent	|O
FSGS	|O
has	|O
included	|O
high	|O
-	|O
dose	|O
steroids	|O
,	|O
high	|O
-	|O
dose	|O
cyclosporine	|O
(	|O
CSA	|O
)	|O
,	|O
plasmapheresis	|O
,	|O
and	|O
ACE	|B-PROTEIN
inhibitors	|O
with	|O
mixed	|O
results	|O
.	|O

Our	|O
results	|O
concluded	|O
that	|O
1	|O
)	|O
the	|O
two	|O
inhibin	|B-PROTEIN
/	|O
activin	|B-PROTEIN
beta	|O
B	|O
-	|O
subunit	|O
mRNAs	|O
were	|O
transcribed	|O
from	|O
different	|O
initiation	|O
sites	|O
;	|O
2	|O
)	|O
both	|O
promoters	|O
may	|O
be	|O
controlled	|O
by	|O
up	|O
-	|O
stream	|O
negative	|O
regulatory	|O
elements	|O
;	|O
and	|O
3	|O
)	|O
neither	|O
of	|O
these	|O
promoters	|O
is	|O
responsive	|O
to	|O
cAMP	|O
and	|O
/	|O
or	|O
phorbol	|O
esters	|O
under	|O
the	|O
conditions	|O
employed	|O
.	|O

Promoter	|O
region	|O
of	|O
the	|O
transcriptional	|O
unit	|O
for	|O
human	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
chimaerin	|I-PROTEIN
,	|O
a	|O
neuron	|O
-	|O
specific	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
for	|O
p21rac	|B-PROTEIN
.	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
chimaerin	|I-PROTEIN
is	|O
a	|O
neuron	|O
-	|O
specific	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
for	|O
p21rac	|B-PROTEIN
,	|O
a	|O
protein	|O
involved	|O
in	|O
morphological	|O
events	|O
.	|O

Upstream	|O
from	|O
the	|O
transcription	|O
start	|O
point	|O
(	|O
tsp	|O
)	|O
,	|O
a	|O
nucleotide	|O
sequence	|O
highly	|O
homologous	|O
to	|O
the	|O
consensus	|O
sequence	|O
motif	|O
for	|O
the	|O
sigma	|B-PROTEIN
35	|I-PROTEIN
-	|O
recognized	|O
promoters	|O
was	|O
found	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
an	|O
analysis	|O
of	|O
the	|O
dynamics	|O
in	|O
the	|O
closing	|O
phase	|O
of	|O
the	|O
occluder	|O
of	|O
a	|O
mechanical	|O
monoleaflet	|O
heart	|O
valve	|O
prosthesis	|O
is	|O
presented	|O
.	|O

During	|O
ISO+	|O
AT	|O
infusion	|O
,	|O
abdominal	|O
fat	|O
blood	|O
flow	|O
was	|O
still	|O
significantly	|O
increased	|O
as	|O
compared	|O
with	|O
control	|O
values	|O
in	|O
lean	|O
and	|O
obese	|O
subjects	|O
.	|O

When	|O
expressed	|O
per	|O
kilogram	|O
body	|O
weight	|O
,	|O
mean	|O
GIT	|O
increased	|O
in	|O
the	|O
dF	|O
group	|O
from	|O
0.14%	|O
to	|O
0.16%	|O
above	|O
RMR	|O
,	|O
with	|O
a	|O
significant	|O
decrease	|O
from	|O
0.15%	|O
to	|O
0.13%	|O
in	|O
the	|O
P	|O
group	|O
.	|O

In	|O
nucleus	|O
ventralis	|O
anterior	|O
thalami	|O
-	|O
nucleus	|O
ventralis	|O
lateralis	|O
thalami	|O
neurons	|O
with	|O
an	|O
inhibitory	|O
input	|O
from	|O
nucleus	|O
entopeduncularis	|O
,	|O
a	|O
shortening	|O
of	|O
inhibition	|O
from	|O
17.5	|O
+	|O
/	|O
-	|O
3.6	|O
to	|O
9.1	|O
+	|O
/	|O
-	|O
1.8	|O
ms	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
under	|O
the	|O
haloperidol	|O
influence	|O
was	|O
evident	|O
.	|O

However	|O
,	|O
inclusion	|O
of	|O
the	|O
neighboring	|O
CGGAAR	|O
motifs	|O
from	|O
the	|O
ICP4	|B-PROTEIN
promoter	|O
,	|O
which	|O
bind	|O
factors	|O
GABP	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
beta	|O
,	|O
results	|O
in	|O
a	|O
strong	|O
synergistic	|O
activation	|O
.	|O

The	|O
first	|O
open	|O
reading	|O
frame	|O
of	|O
the	|O
blueberry	|O
scorch	|O
carlavirus	|O
(	|O
BBScV	|O
)	|O
genome	|O
encodes	|O
a	|O
putative	|O
replication	|O
-	|O
associated	|O
protein	|O
of	|O
223	|O
kDa	|O
(	|O
p223	|B-PROTEIN
)	|O
.	|O

From	|O
sequence	|O
alignments	|O
with	|O
phylogenetically	|O
related	|O
viruses	|O
,	|O
including	|O
tymoviruses	|O
,	|O
we	|O
predicted	|O
that	|O
p223	|B-PROTEIN
contained	|O
a	|O
papain	|B-PROTEIN
-	|O
like	|O
proteinase	|O
domain	|O
with	|O
a	|O
putative	|O
catalytic	|O
cysteine994	|O
and	|O
histidine1075	|O
.	|O

This	|O
finding	|O
represents	|O
both	|O
a	|O
potentially	|O
important	|O
mechanism	|O
by	|O
which	|O
HPV	|O
gene	|O
expression	|O
can	|O
be	|O
regulated	|O
and	|O
an	|O
interesting	|O
model	|O
for	|O
the	|O
study	|O
of	|O
transcriptional	|O
cooperativity	|O
.	|O

Using	|O
this	|O
method	|O
,	|O
VLPs	|O
were	|O
obtained	|O
in	|O
quantities	|O
sufficient	|O
for	|O
further	|O
characterization	|O
.	|O

Analysis	|O
of	|O
the	|O
sequence	|O
upstream	|O
of	|O
this	|O
initiation	|O
codon	|O
reveals	|O
the	|O
presence	|O
of	|O
a	|O
promotor	|O
sequence	|O
.	|O

SUP46	|B-PROTEIN
is	|O
implicated	|O
in	|O
translation	|O
fidelity	|O
and	|O
encodes	|O
the	|O
ribosomal	|O
protein	|O
S13	|B-PROTEIN
.	|O

To	|O
explore	|O
the	|O
functional	|O
relationship	|O
between	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
and	|O
Rb	|B-PROTEIN
,	|O
a	|O
eukaryotic	|O
expression	|O
plasmid	|O
was	|O
constructed	|O
containing	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
gene	|O
under	|O
control	|O
of	|O
the	|O
SV40	|B-PROTEIN
promoter	|I-PROTEIN
complex	|O
.	|O

The	|O
high	|O
degree	|O
of	|O
sequence	|O
identity	|O
(	|O
96%	|O
)	|O
between	|O
hydrolase	|B-PROTEIN
B	|I-PROTEIN
and	|I-PROTEIN
C	|I-PROTEIN
,	|O
particularly	|O
in	|O
the	|O
3'	|O
untranslated	|O
region	|O
,	|O
suggests	|O
that	|O
the	|O
genes	|O
encoding	|O
these	|O
two	|O
carboxylesterases	|B-PROTEIN
evolved	|O
by	|O
duplication	|O
and	|O
divergence	|O
of	|O
a	|O
common	|O
ancestral	|O
gene	|O
.	|O

The	|O
regions	|O
of	|O
the	|O
tooth	|O
fracture	|O
are	|O
determined	|O
.	|O

Secondary	|O
pancreatic	|O
involvement	|O
of	|O
mycosis	|O
fungoides	|O
detected	|O
by	|O
a	|O
clinically	|O
palpable	|O
mass	|O
.	|O

The	|O
NR2	|O
hybrid	|O
is	|O
a	|O
powerful	|O
tool	|O
for	|O
the	|O
mapping	|O
of	|O
new	|O
probes	|O
of	|O
this	|O
region	|O
,	|O
as	|O
well	|O
as	|O
for	|O
obtaining	|O
new	|O
informative	|O
probes	|O
specific	|O
for	|O
the	|O
deletion	|O
by	|O
subtractive	|O
cloning	|O
of	|O
the	|O
region	|O
.	|O

TDEYA	|O
at	|O
doses	|O
of	|O
200	|O
to	|O
500	|O
mg	|O
/	|O
kg	|O
significantly	|O
suppressed	|O
xanthine	|B-PROTEIN
oxidase	|I-PROTEIN
(	|O
XO	|B-PROTEIN
)	|O
activity	|O
in	|O
the	|O
stomach	|O
tissue	|O
following	|O
its	|O
oral	|O
administration	|O
.	|O

Like	|O
humans	|O
,	|O
the	|O
PITSLRE	|B-PROTEIN
PK	|I-PROTEIN
genes	|O
in	|O
chickens	|O
must	|O
be	|O
closely	|O
linked	|O
,	|O
based	|O
on	|O
fluorescent	|O
in	|O
situ	|O
hybridization	|O
(	|O
FISH	|O
)	|O
localization	|O
of	|O
these	|O
genes	|O
to	|O
a	|O
single	|O
chicken	|O
microchromosome	|O
.	|O

Here	|O
,	|O
we	|O
report	|O
the	|O
characterization	|O
of	|O
an	|O
alternatively	|O
processed	|O
form	|O
of	|O
AFAP	|B-PROTEIN
-	|I-PROTEIN
110	|I-PROTEIN
that	|O
encodes	|O
an	|O
additional	|O
258	|O
base	|O
pair	|O
(	|O
bp	|O
)	|O
of	|O
open	|O
reading	|O
frame	|O
.	|O

Expression	|O
of	|O
class	|B-PROTEIN
IV	|I-PROTEIN
ADH	|I-PROTEIN
mRNA	|O
was	|O
detected	|O
in	|O
human	|O
stomach	|O
but	|O
not	|O
liver	|O
.	|O

In	|O
ICE	|B-PROTEIN
gamma	|I-PROTEIN
,	|O
most	|O
of	|O
the	|O
propeptide	|O
(	|O
amino	|O
acids	|O
20-112	|O
)	|O
is	|O
deleted	|O
,	|O
which	|O
suggests	|O
that	|O
it	|O
may	|O
function	|O
as	|O
a	|O
catalyst	|O
for	|O
ICE	|B-PROTEIN
autoprocessing	|O
in	|O
vivo	|O
.	|O

Endocytosis	|O
and	|O
lysosomal	|O
targeting	|O
of	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptors	|I-PROTEIN
are	|O
mediated	|O
by	|O
distinct	|O
sequences	|O
independent	|O
of	|O
the	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
domain	|O
.	|O

It	|O
is	|O
now	|O
recognized	|O
that	|O
essentially	|O
all	|O
eukaryotic	|O
and	|O
prokaryotic	|O
genes	|O
whose	|O
5'	|O
-	|O
flanking	|O
regions	|O
are	|O
known	|O
and	|O
that	|O
encode	|O
barbiturate	|O
-	|O
inducible	|O
proteins	|O
contain	|O
the	|O
Barbie	|O
box	|O
element	|O
.	|O

Mutation	|O
of	|O
the	|O
P450BM	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
Barbie	|O
box	|O
significantly	|O
increased	|O
the	|O
expression	|O
of	|O
both	|O
P450BM	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
and	|O
Bm3P1	|B-PROTEIN
(	|O
another	|O
small	|O
gene	|O
located	|O
upstream	|O
of	|O
the	|O
P450BM	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
gene	|O
that	|O
encodes	|O
a	|O
second	|O
putative	|O
regulatory	|O
protein	|O
)	|O
in	|O
response	|O
to	|O
pentobarbital	|O
induction	|O
but	|O
left	|O
the	|O
basal	|O
levels	|O
unaffected	|O
.	|O

The	|O
p97	|B-PROTEIN
-	|O
depleted	|O
nuclei	|O
remained	|O
largely	|O
competent	|O
for	|O
nuclear	|O
protein	|O
import	|O
.	|O

A	|O
potential	|O
outcome	|O
of	|O
these	|O
biochemical	|O
effects	|O
may	|O
include	|O
the	|O
limited	|O
responsiveness	|O
of	|O
infected	|O
T	|O
cells	|O
to	|O
antigenic	|O
stimulation	|O
observed	|O
during	|O
HIV	|O
-	|O
1	|O
infection	|O
.	|O

The	|O
full	|O
protocol	|O
was	|O
completed	|O
by	|O
33	|O
patients	|O
(	|O
45%	|O
of	|O
original	|O
cohort	|O
)	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
found	|O
that	|O
cell	|O
-	|O
specific	|O
suppression	|O
of	|O
RA	|O
-	|O
stimulated	|O
zif268	|B-PROTEIN
gene	|O
expression	|O
can	|O
be	|O
attributed	|O
to	|O
a	|O
29	|O
base	|O
pair	|O
nucleotide	|O
sequence	|O
,	|O
located	|O
downstream	|O
of	|O
the	|O
RA	|O
-	|O
responsive	|O
region	|O
in	|O
the	|O
zif268	|B-PROTEIN
gene	|O
.	|O

We	|O
show	|O
that	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
and	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
interact	|O
with	|O
each	|O
other	|O
to	|O
form	|O
a	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
-	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
complex	|O
and	|O
that	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
does	|O
not	|O
interact	|O
with	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
or	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
individually	|O
but	|O
that	|O
it	|O
associates	|O
with	|O
the	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
-	|O
CBF	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
complex	|O
.	|O

In	|O
the	|O
first	|O
,	|O
homologous	|O
sequences	|O
were	|O
deleted	|O
from	|O
a	|O
mouse	|O
enhancer	|O
,	|O
resulting	|O
in	|O
a	|O
tissue	|O
-	|O
specific	|O
loss	|O
of	|O
activity	|O
when	|O
assayed	|O
in	|O
transgenic	|O
mice	|O
.	|O

OKT3	|B-PROTEIN
prophylaxis	|O
improves	|O
long	|O
-	|O
term	|O
renal	|O
graft	|O
survival	|O
in	|O
high	|O
-	|O
risk	|O
patients	|O
as	|O
compared	|O
to	|O
cyclosporine	|O
:	|O
combined	|O
results	|O
from	|O
the	|O
prospective	|O
,	|O
randomized	|O
Belgian	|O
and	|O
US	|O
studies	|O
.	|O

The	|O
major	|O
PKC	|B-PROTEIN
beta	|I-PROTEIN
transcription	|O
initiation	|O
site	|O
was	|O
identified	|O
by	|O
primer	|O
extension	|O
and	|O
S1	|B-PROTEIN
nuclease	|O
protection	|O
.	|O

In	|O
the	|O
course	|O
of	|O
a	|O
study	|O
of	|O
low	|O
dose	|O
X	|O
-	|O
rays	|O
effects	|O
,	|O
we	|O
found	|O
that	|O
male	|O
ICR	|O
white	|O
Swiss	|O
mice	|O
showed	|O
remarkable	|O
suppression	|O
of	|O
mounting	|O
behavior	|O
after	|O
whole	|O
body	|O
irradiation	|O
by	|O
5	|O
to	|O
15	|O
cGy	|O
X	|O
-	|O
rays	|O
.	|O

A	|O
quantitative	|O
analysis	|O
of	|O
the	|O
diffraction	|O
intensity	|O
as	|O
function	|O
of	|O
the	|O
accumulated	|O
electron	|O
dose	|O
suggests	|O
the	|O
possibility	|O
of	|O
recording	|O
up	|O
to	|O
250	|O
diffraction	|O
patterns	|O
with	|O
3.5	|O
A	|O
resolution	|O
from	|O
a	|O
single	|O
crotoxin	|O
complex	|O
crystal	|O
128	|O
A	|O
thick	|O
.	|O

Supplementary	|O
Phase	|O
Contraste	|O
RSE	|O
(	|O
"	|O
Rapid	|O
Sequential	|O
Excitation	|O
"	|O
)	|O
sequences	|O
were	|O
carried	|O
out	|O
in	|O
29	|O
patients	|O
.	|O

In	|O
yeast	|O
,	|O
the	|O
products	|O
of	|O
the	|O
UPF1	|B-PROTEIN
and	|O
UPF3	|B-PROTEIN
genes	|O
are	|O
required	|O
for	|O
this	|O
decay	|O
pathway	|O
,	|O
and	|O
in	|O
this	|O
report	|O
we	|O
focus	|O
on	|O
the	|O
identification	|O
and	|O
characterization	|O
of	|O
additional	|O
factors	|O
required	|O
for	|O
rapid	|O
decay	|O
of	|O
nonsense	|O
-	|O
containing	|O
mRNAs	|O
.	|O

Mutations	|O
in	|O
UPF1	|B-PROTEIN
lead	|O
to	|O
the	|O
selective	|O
stabilization	|O
of	|O
mRNAs	|O
containing	|O
early	|O
nonsense	|O
mutations	|O
without	|O
affecting	|O
the	|O
decay	|O
rates	|O
of	|O
most	|O
other	|O
mRNAs	|O
.	|O

A	|O
DNA	|O
fragment	|O
encoding	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
(	|O
amino	|O
acids	|O
1-60	|O
)	|O
of	|O
the	|O
Escherichia	|O
coli	|O
fru	|B-PROTEIN
transcriptional	|O
regulator	|O
was	|O
cloned	|O
into	|O
the	|O
pGEX	|O
-	|O
KT	|O
vector	|O
and	|O
expressed	|O
in	|O
frame	|O
with	|O
the	|O
fused	|O
gene	|O
encoding	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
.	|O

Using	|O
gel	|O
retardation	|O
assays	|O
with	|O
HepG2	|O
nuclear	|O
extract	|O
,	|O
we	|O
demonstrated	|O
the	|O
presence	|O
of	|O
a	|O
specific	|O
protein	|O
which	|O
bound	|O
to	|O
the	|O
NRE	|O
fragment	|O
.	|O

0.61	|O
+	|O
/	|O
-	|O
0.04	|O
)	|O
.	|O

Several	|O
nuclear	|O
factors	|O
that	|O
interact	|O
with	|O
sequences	|O
in	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
mouse	|O
tyrosinase	|B-PROTEIN
gene	|O
were	|O
identified	|O
using	|O
band	|O
shift	|O
and	|O
methylation	|O
interference	|O
assays	|O
.	|O

With	|O
a	|O
population	|O
of	|O
853	|O
million	|O
there	|O
should	|O
be	|O
51,204	|O
patients	|O
with	|O
hemophilia	|O
A	|O
in	|O
India	|O
assuming	|O
a	|O
prevalence	|O
of	|O
6/100,000	|O
population	|O
.	|O

When	|O
combined	|O
with	|O
serum	|O
ferritin	|B-PROTEIN
and	|O
hemoglobin	|B-PROTEIN
determinations	|O
,	|O
the	|O
serum	|O
transferrin	|B-PROTEIN
receptor	|I-PROTEIN
assay	|O
is	|O
a	|O
valuable	|O
addition	|O
in	|O
epidemiologic	|O
surveys	|O
because	|O
it	|O
provides	|O
a	|O
quantitative	|O
measure	|O
of	|O
functional	|O
iron	|O
deficiency	|O
and	|O
it	|O
distinguishes	|O
true	|O
IDA	|O
from	|O
the	|O
anemia	|O
of	|O
chronic	|O
disease	|O
.	|O

Twenty	|O
-	|O
two	|O
consecutive	|O
patients	|O
with	|O
ischaemic	|O
ulcers	|O
had	|O
tcPO2	|O
measured	|O
and	|O
the	|O
ankle	|O
/	|O
brachial	|O
(	|O
ABI	|O
)	|O
and	|O
toe	|O
/	|O
brachial	|O
(	|O
TBI	|O
)	|O
indices	|O
calculated	|O
.	|O

TcPO2	|O
measurement	|O
appears	|O
to	|O
be	|O
a	|O
reliable	|O
technique	|O
that	|O
can	|O
influence	|O
ischaemic	|O
ulcer	|O
management	|O
.	|O

Since	|O
1990	|O
the	|O
University	|O
Hospital	|O
of	|O
Tromso	|O
has	|O
provided	|O
local	|O
hospitals	|O
in	|O
northern	|O
Norway	|O
with	|O
a	|O
remote	|O
frozen	|O
section	|O
service	|O
and	|O
with	|O
access	|O
to	|O
video	|O
conferences	|O
for	|O
the	|O
review	|O
of	|O
microscopic	|O
findings	|O
and	|O
for	|O
the	|O
discussion	|O
of	|O
major	|O
diagnostic	|O
issues	|O
.	|O

Current	|O
status	|O
of	|O
telepathology	|O
.	|O

Expression	|O
of	|O
h6.1	|O
in	|O
COS	|O
-	|O
1	|O
cells	|O
led	|O
to	|O
the	|O
production	|O
of	|O
a	|O
typical	|O
type	|B-PROTEIN
IV	|I-PROTEIN
PDE	|I-PROTEIN
activity	|O
in	|O
that	|O
cAMP	|O
,	|O
but	|O
not	|O
cGMP	|O
,	|O
served	|O
as	|O
substrate	|O
and	|O
its	|O
activity	|O
was	|O
insensitive	|O
to	|O
either	|O
Ca2+	|O
/	|O
CaM	|B-PROTEIN
or	|O
cGMP	|O
but	|O
was	|O
inhibited	|O
by	|O
low	|O
concentrations	|O
of	|O
rolipram	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

PMEK1	|B-PROTEIN
displays	|O
96	|O
and	|O
80%	|O
identity	|O
respectively	|O
with	|O
the	|O
tobacco	|O
NTF3	|B-PROTEIN
and	|O
Arabidopsis	|O
ATMPK1	|B-PROTEIN
kinases	|O
,	|O
and	|O
only	|O
50%	|O
to	|O
the	|O
more	|O
distantly	|O
related	|O
plant	|O
MAP	|O
kinase	|O
MsERK1	|B-PROTEIN
from	|O
alfalfa	|O
.	|O

Translation	|O
of	|O
the	|O
coding	|O
segment	|O
,	|O
which	|O
was	|O
designated	|O
MsPRP2	|B-PROTEIN
,	|O
suggested	|O
it	|O
encodes	|O
a	|O
chimeric	|O
40,569	|O
Da	|O
cell	|O
wall	|O
protein	|O
with	|O
an	|O
amino	|O
-	|O
terminal	|O
signal	|O
sequence	|O
,	|O
a	|O
repetitive	|O
proline	|O
-	|O
rich	|O
sequence	|O
,	|O
and	|O
a	|O
cysteine	|O
-	|O
rich	|O
carboxyl	|O
-	|O
terminal	|O
sequence	|O
homologous	|O
to	|O
nonspecific	|O
lipid	|O
transfer	|O
proteins	|O
.	|O

The	|O
presence	|O
of	|O
type	|O
I	|O
hypersensitivity	|O
in	|O
a	|O
subgroup	|O
of	|O
aspergillomas	|O
suggests	|O
an	|O
immunoallergic	|O
component	|O
to	|O
this	|O
disease	|O
which	|O
could	|O
contribute	|O
to	|O
a	|O
chronic	|O
inflammatory	|O
response	|O
to	|O
Aspergillus	|O
in	|O
some	|O
aspergillomas	|O
.	|O

This	|O
concept	|O
is	|O
supported	|O
by	|O
the	|O
identification	|O
of	|O
RH	|B-PROTEIN
-	|O
like	|O
genes	|O
in	|O
non	|O
human	|O
primates	|O
.	|O

With	|O
steady	|O
illumination	|O
,	|O
outer	|O
retinal	|O
(	|O
photoreceptor	|O
)	|O
QO2	|O
decreased	|O
to	|O
1.4	|O
+	|O
/	|O
-	|O
0.9	|O
ml	|O
O2	|O
/	|O
(	|O
100	|O
g.m	|O
in	|O
)	|O
,	|O
but	|O
inner	|O
retinal	|O
QO2	|O
remained	|O
unchanged	|O
at	|O
3.7	|O
+	|O
/	|O
-	|O
1.5	|O
ml	|O
O2	|O
/	|O
(	|O
100	|O
g.m	|O
in	|O
)	|O
(	|O
5	|O
cats	|O
)	|O
.	|O

We	|O
have	|O
screened	|O
the	|O
mouse	|O
cDNA	|O
library	|O
of	|O
an	|O
MIN6	|O
cell	|O
line	|O
,	|O
derived	|O
from	|O
pancreatic	|O
beta	|O
cells	|O
,	|O
for	|O
its	|O
novel	|O
isoform	|O
and	|O
have	|O
identified	|O
a	|O
cDNA	|O
encoding	|O
a	|O
593	|O
-	|O
amino	|O
acid	|O
protein	|O
having	|O
63	|O
,	|O
53	|O
,	|O
and	|O
30%	|O
identity	|O
with	|O
munc	|B-PROTEIN
-	|I-PROTEIN
18	|I-PROTEIN
/	|I-PROTEIN
n	|I-PROTEIN
-	|I-PROTEIN
Sec1	|I-PROTEIN
/	|I-PROTEIN
rbSec1	|I-PROTEIN
,	|O
Caenorhabditis	|O
elegans	|O
unc18	|B-PROTEIN
,	|O
and	|O
Saccharomyces	|O
cerevisiae	|O
Sec1p	|B-PROTEIN
,	|O
respectively	|O
.	|O

The	|O
catenins	|B-PROTEIN
bind	|O
to	|O
APC	|B-PROTEIN
and	|O
E	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
in	|O
a	|O
similar	|O
fashion	|O
,	|O
but	|O
APC	|B-PROTEIN
and	|O
E	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
do	|O
not	|O
associate	|O
with	|O
each	|O
other	|O
either	|O
in	|O
the	|O
presence	|O
or	|O
absence	|O
of	|O
catenins	|B-PROTEIN
.	|O

However	|O
,	|O
addition	|O
of	|O
core	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
III	|I-PROTEIN
to	|O
preinitiation	|O
complex	|O
,	|O
fully	|O
reconstituting	|O
holoenzyme	|O
resulted	|O
in	|O
replacement	|O
of	|O
gamma	|O
by	|O
alpha	|O
at	|O
the	|O
primer	|O
terminus	|O
.	|O

The	|O
PSD2	|B-PROTEIN
gene	|O
was	|O
heterologously	|O
expressed	|O
by	|O
infection	|O
of	|O
Sf	|O
-	|O
9	|O
insect	|O
cells	|O
with	|O
recombinant	|O
baculovirus	|O
,	|O
resulting	|O
in	|O
a	|O
10	|O
-	|O
fold	|O
increase	|O
in	|O
PSD	|B-PROTEIN
activity	|O
.	|O

Computerized	|O
detection	|O
of	|O
abnormal	|O
asymmetry	|O
in	|O
digital	|O
chest	|O
radiographs	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
gluconeogenic	|O
genes	|O
are	|O
derepressed	|O
upon	|O
binding	|O
of	|O
Cat8p	|B-PROTEIN
,	|O
whose	|O
synthesis	|O
depends	|O
on	|O
the	|O
release	|O
of	|O
Cat4p	|B-PROTEIN
(	|O
Mig1p	|B-PROTEIN
)	|O
from	|O
the	|O
CAT8	|B-PROTEIN
promoter	|O
.	|O

Like	|O
Epo	|B-PROTEIN
,	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
is	|O
expressed	|O
in	|O
kidney	|O
,	|O
liver	|O
,	|O
and	|O
Hep3B	|O
cells	|O
but	|O
not	|O
in	|O
HeLa	|O
cells	|O
.	|O

Moreover	|O
,	|O
the	|O
hypoxia	|O
-	|O
induced	|O
expression	|O
of	|O
the	|O
endogenous	|O
Epo	|B-PROTEIN
gene	|O
was	|O
significantly	|O
inhibited	|O
in	|O
Hep3B	|O
cells	|O
stably	|O
transfected	|O
with	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
delta	|I-PROTEIN
C.	|I-PROTEIN

These	|O
observations	|O
indicate	|O
that	|O
there	|O
are	|O
multiple	|O
mechanisms	|O
by	|O
which	|O
an	|O
individual	|O
transcript	|O
can	|O
be	|O
degraded	|O
following	|O
deadenylation	|O
.	|O

Small	|O
Maf	|B-PROTEIN
proteins	|O
heterodimerize	|O
with	|O
Fos	|B-PROTEIN
and	|O
may	|O
act	|O
as	|O
competitive	|O
repressors	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
E2	|I-PROTEIN
transcription	|O
factor	|O
.	|O

We	|O
show	|O
here	|O
that	|O
the	|O
binding	|O
of	|O
C1F	|B-PROTEIN
in	|O
vitro	|O
is	|O
sensitive	|O
to	|O
the	|O
concentration	|O
of	|O
calcium	|O
ions	|O
.	|O

Survival	|O
after	|O
development	|O
of	|O
symptomatic	|O
infection	|O
(	|O
P	|O
-	|O
2	|O
)	|O
did	|O
not	|O
differ	|O
by	|O
transmission	|O
mode	|O
.	|O

Both	|O
factors	|O
demonstrated	|O
significant	|O
correlations	|O
with	|O
rCBF	|O
in	|O
the	|O
medial	|O
prefrontal	|O
cortex	|O
and	|O
frontal	|O
polar	|O
cortex	|O
while	|O
for	|O
each	|O
factor	|O
there	|O
were	|O
also	|O
unique	|O
patterns	|O
of	|O
correlations	|O
with	|O
posterior	|O
brain	|O
regions	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
the	|O
function	|O
of	|O
the	|O
DS2	|B-PROTEIN
may	|O
be	|O
the	|O
protection	|O
of	|O
the	|O
nuclear	|O
DNA	|O
from	|O
desiccation	|O
.	|O

Glomerular	|O
hemodynamics	|O
during	|O
abortion	|O
induced	|O
by	|O
RU	|O
486	|O
and	|O
sepsis	|O
in	|O
rats	|O
.	|O

The	|O
aim	|O
of	|O
this	|O
retrospective	|O
study	|O
was	|O
to	|O
demonstrate	|O
that	|O
in	|O
certain	|O
cases	|O
of	|O
expulsive	|O
choroidal	|O
hemorrhage	|O
(	|O
ECH	|O
)	|O
anatomical	|O
success	|O
and	|O
useful	|O
vision	|O
can	|O
be	|O
obtained	|O
with	|O
repeated	|O
vitreoretinal	|O
surgery	|O
.	|O

The	|O
function	|O
of	|O
the	|O
C	|O
-	|O
terminal	|O
tail	|O
in	|O
telomere	|O
maintenance	|O
is	|O
not	|O
mediated	|O
through	|O
the	|O
RAP1	|B-PROTEIN
interacting	|I-PROTEIN
factor	|I-PROTEIN
RIF1	|O
:	|O
rap1	|B-PROTEIN
alleles	|O
defective	|O
in	|O
both	|O
the	|O
C	|O
-	|O
terminal	|O
tail	|O
and	|O
RIF1	|B-PROTEIN
interaction	|O
domains	|O
have	|O
additive	|O
effects	|O
on	|O
telomere	|O
length	|O
.	|O

The	|O
resulting	|O
integrated	|O
physical	|O
,	|O
genetic	|O
,	|O
and	|O
cytogenetic	|O
map	|O
constitutes	|O
a	|O
resource	|O
for	|O
the	|O
characterization	|O
of	|O
genes	|O
that	|O
may	|O
be	|O
involved	|O
in	|O
the	|O
WAGR	|O
syndrome	|O
.	|O

The	|O
contribution	|O
of	|O
skin	|O
flow	|O
to	|O
the	|O
changes	|O
in	|O
760-800	|O
nm	|O
absorption	|O
was	|O
investigated	|O
by	|O
simultaneous	|O
measurement	|O
of	|O
skin	|O
flow	|O
by	|O
laser	|O
flow	|O
Doppler	|O
and	|O
NIR	|O
recordings	|O
during	|O
hot	|O
water	|O
immersion	|O
.	|O

Proteins	|O
immunoprecipitated	|O
from	|O
lysates	|O
of	|O
control	|O
-	|O
and	|O
VEGF	|B-PROTEIN
-	|O
stimulated	|O
BAEC	|O
with	|O
antisera	|O
to	|O
phospholipase	|B-PROTEIN
C	|I-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
(	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
)	|O
were	|O
fractionated	|O
by	|O
SDS	|O
-	|O
polyacrylamide	|O
gel	|O
electrophoresis	|O
and	|O
transferred	|O
to	|O
Immobilon	|O
-	|O
P.	|O

Alternatively	|O
processed	|O
isoforms	|O
of	|O
cellular	|O
nucleic	|B-PROTEIN
acid	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
interact	|O
with	|O
a	|O
suppressor	|O
region	|O
of	|O
the	|O
human	|O
beta	|B-PROTEIN
-	|I-PROTEIN
myosin	|I-PROTEIN
heavy	|O
chain	|O
gene	|O
.	|O

Involvement	|O
of	|O
early	|O
growth	|O
response	|O
factor	|O
Egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
apolipoprotein	|B-PROTEIN
AI	|I-PROTEIN
gene	|O
transcription	|O
.	|O

The	|O
wild	|O
-	|O
type	|O
and	|O
altered	|O
forms	|O
of	|O
the	|O
F	|B-PROTEIN
protein	|I-PROTEIN
were	|O
expressed	|O
in	|O
BHK	|O
-	|O
21	|O
and	|O
HeLa	|O
T4	|O
cells	|O
by	|O
use	|O
of	|O
the	|O
recombinant	|O
vaccinia	|O
virus	|O
-	|O
encoding	|O
T7	|B-PROTEIN
polymerase	|I-PROTEIN
system	|O
.	|O

Erythrocyte	|O
delta	|B-PROTEIN
-	|I-PROTEIN
aminolevulinic	|I-PROTEIN
acid	|I-PROTEIN
dehydratase	|I-PROTEIN
(	|O
ALAD	|B-PROTEIN
)	|O
activity	|O
,	|O
erythrocyte	|O
zinc	|O
protoporphyrin	|O
(	|O
ZPP	|O
)	|O
/	|O
heme	|O
ratio	|O
,	|O
and	|O
urinary	|O
coproporphyrin	|O
(	|O
UC	|O
)	|O
concentration	|O
have	|O
been	|O
employed	|O
as	|O
biological	|O
indicators	|O
of	|O
moderate	|O
-	|O
to	|O
high	|O
-	|O
level	|O
lead	|O
exposure	|O
,	|O
corresponding	|O
to	|O
blood	|O
levels	|O
in	|O
excess	|O
of	|O
50	|O
micrograms	|O
/	|O
dl	|O
,	|O
in	|O
human	|O
subjects	|O
.	|O

The	|O
relative	|O
risk	|O
of	|O
graft	|O
loss	|O
after	|O
conversion	|O
to	|O
azathioprine	|O
compared	|O
with	|O
graft	|O
loss	|O
after	|O
conversion	|O
to	|O
azathioprine	|O
compared	|O
with	|O
cyclosporin	|O
maintenance	|O
was	|O
0.71	|O
(	|O
0.37-1.38	|O
)	|O
and	|O
the	|O
relative	|O
risk	|O
of	|O
patient	|O
death	|O
was	|O
0.57	|O
(	|O
0.23-1.41	|O
)	|O
.	|O

Three	|O
classes	|O
of	|O
test	|O
objects	|O
were	|O
considered	|O
:	|O
(	|O
1	|O
)	|O
a	|O
multicompartment	|O
test	|O
object	|O
for	|O
31P	|O
MRS	|O
measurements	|O
performed	|O
with	|O
slice	|O
-	|O
selective	|O
sequences	|O
;	|O
(	|O
2	|O
)	|O
a	|O
two	|O
-	|O
compartment	|O
test	|O
object	|O
for	|O
volume	|O
-	|O
selection	|O
1H	|O
MRS	|O
;	|O
and	|O
(	|O
3	|O
)	|O
two	|O
-	|O
compartment	|O
test	|O
objects	|O
for	|O
assessing	|O
the	|O
performance	|O
of	|O
experimental	|O
systems	|O
using	|O
ISIS	|O
as	|O
volume	|O
localization	|O
sequence	|O
in	|O
31P	|O
MRS	|O
.	|O

The	|O
"	|O
tobacco	|O
issue	|O
"	|O
.	|O

Pregnancy	|O
screening	|O
by	|O
uterine	|O
artery	|O
Doppler	|O
velocimetry	|O
-	|O
-	|O
which	|O
criterion	|O
performs	|O
best	|O
?	|O
OBJECTIVE	|O
:	|O
To	|O
test	|O
whether	|O
repeating	|O
Doppler	|O
studies	|O
of	|O
the	|O
uteroplacental	|O
circulation	|O
late	|O
in	|O
gestation	|O
will	|O
improve	|O
the	|O
test	|O
's	|O
power	|O
for	|O
predicting	|O
pregnancy	|O
-	|O
induced	|O
hypertension	|O
and	|O
fetal	|O
growth	|O
restriction	|O
(	|O
FGR	|O
)	|O
,	|O
and	|O
whether	|O
analysis	|O
based	|O
on	|O
a	|O
combination	|O
of	|O
quantitative	|O
and	|O
qualitative	|O
assessments	|O
of	|O
the	|O
uterine	|O
arterial	|O
waveforms	|O
will	|O
yield	|O
better	|O
results	|O
than	|O
analysis	|O
based	|O
on	|O
either	|O
alone	|O
.	|O

The	|O
effect	|O
of	|O
the	|O
Ca	|O
entry	|O
blocker	|O
nitrendipine	|O
,	|O
the	|O
antioxidant	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
(	|O
SOD	|B-PROTEIN
)	|O
,	|O
and	|O
a	|O
combination	|O
of	|O
nitrendipine	|O
and	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
on	|O
postischemic	|O
renal	|O
function	|O
was	|O
studied	|O
in	|O
four	|O
groups	|O
(	|O
n	|O
=	|O
24	|O
)	|O
of	|O
rats	|O
.	|O

PURPOSE	|O
:	|O
The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
evaluate	|O
the	|O
bony	|O
anchorage	|O
of	|O
a	|O
new	|O
implant	|O
(	|O
orderly	|O
wired	|O
surface	|O
effect	|O
with	|O
alloy	|O
Ti	|O
Al	|O
Va	|O
and	|O
ordered	|O
pores	|O
of	|O
488	|O
mu	|O
)	|O
.	|O

To	|O
determine	|O
whether	|O
food	|O
and	|O
/	|O
or	|O
water	|O
in	|O
the	|O
gastrointestinal	|O
tract	|O
affects	|O
restitution	|O
of	|O
blood	|O
volume	|O
and	|O
plasma	|O
protein	|O
after	|O
hemorrhage	|O
,	|O
fed	|O
and	|O
24	|O
-	|O
h	|O
-	|O
fasted	|O
awake	|O
rats	|O
received	|O
a	|O
20	|O
ml.k	|O
g	|O
-	|O
1	|O
x	|O
3	|O
min	|O
-	|O
1	|O
hemorrhage	|O
,	|O
and	|O
restitution	|O
of	|O
blood	|O
volume	|O
was	|O
measured	|O
by	|O
Evans	|O
blue	|O
dye	|O
and	|O
dilution	|O
of	|O
hematocrit	|O
.	|O

Cooperative	|O
dimerization	|O
of	|O
paired	|B-PROTEIN
class	|O
homeo	|O
domains	|O
on	|O
DNA	|O
.	|O

We	|O
took	|O
advantage	|O
of	|O
the	|O
high	|O
degree	|O
of	|O
aa	|O
sequence	|O
homology	|O
between	|O
DAHPSs	|B-PROTEIN
from	|O
several	|O
species	|O
to	|O
isolate	|O
ARO3	|B-PROTEIN
homologues	|O
from	|O
the	|O
pathogenic	|O
yeast	|O
Candida	|O
albicans	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
demonstrate	|O
that	|O
BOX	|O
DNA	|O
enhances	|O
transcription	|O
from	|O
the	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
TK	|B-PROTEIN
)	|O
promoter	|O
in	|O
various	|O
EC	|O
cells	|O
.	|O

Deletion	|O
analyses	|O
of	|O
the	|O
construct	|O
revealed	|O
that	|O
the	|O
transcription	|O
of	|O
BOXF1	|B-PROTEIN
gene	|O
is	|O
regulated	|O
by	|O
BOX	|O
DNA	|O
,	|O
preferentially	|O
in	|O
undifferentiated	|O
EC	|O
cells	|O
versus	|O
differentiated	|O
cells	|O
.	|O

Analysis	|O
of	|O
disassociation	|O
rates	|O
indicates	|O
that	|O
the	|O
Grf10	|B-PROTEIN
-	|O
Swi5	|B-PROTEIN
-	|O
DNA	|O
complex	|O
has	|O
a	|O
longer	|O
half	|O
-	|O
life	|O
than	|O
protein	|O
-	|O
DNA	|O
complexes	|O
that	|O
contain	|O
only	|O
Swi5	|B-PROTEIN
or	|O
Grf10	|B-PROTEIN
.	|O

The	|O
presence	|O
of	|O
an	|O
unusual	|O
transcript	|O
possessing	|O
IVS2C	|B-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
at	|O
the	|O
5'	|O
terminus	|O
suggests	|O
that	|O
cleavage	|O
of	|O
its	|O
splice	|O
acceptor	|O
is	|O
inefficient	|O
or	|O
negatively	|O
regulated	|O
.	|O

The	|O
mutant	|O
allele	|O
of	|O
the	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
tubulin	|I-PROTEIN
gene	|O
was	|O
designated	|O
tua1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

During	|O
chronic	|O
treatment	|O
,	|O
when	|O
plasma	|O
concentrations	|O
fluctuated	|O
between	|O
23.5	|O
ng.m	|O
l	|O
-	|O
1	|O
at	|O
8	|O
h	|O
and	|O
14	|O
ng.m	|O
l	|O
-	|O
1	|O
at	|O
24	|O
h	|O
post	|O
-	|O
dosing	|O
,	|O
ST	|O
segment	|O
depression	|O
at	|O
an	|O
individually	|O
comparable	|O
workload	|O
was	|O
significantly	|O
decreased	|O
by	|O
28%	|O
compared	|O
with	|O
placebo	|O
(	|O
P	|O
<	|O
0.005	|O
)	|O
at	|O
both	|O
points	|O
in	|O
time	|O
.	|O

Results	|O
from	|O
in	|O
vitro	|O
transcription	|O
-	|O
translation	|O
analysis	|O
and	|O
maxicell	|O
experiments	|O
suggested	|O
that	|O
the	|O
447	|O
-	|O
bp	|O
ORF	|O
was	|O
the	|O
one	|O
being	|O
actively	|O
expressed	|O
.	|O

Preliminary	|O
experiments	|O
demonstrated	|O
that	|O
it	|O
was	|O
possible	|O
to	|O
produce	|O
fasD	|B-PROTEIN
mutants	|O
,	|O
whose	|O
products	|O
remain	|O
functional	|O
for	|O
fimbrial	|O
export	|O
and	|O
assembly	|O
.	|O

Evoked	|O
electromyographic	|O
response	|O
to	|O
indirect	|O
supramaximal	|O
stimulation	|O
at	|O
1	|O
Hz	|O
was	|O
monitored	|O
in	|O
ten	|O
adult	|O
goats	|O
under	|O
thiopentone	|O
-	|O
halothane	|O
anaesthesia	|O
.	|O

313	|O
,	|O
98-102	|O
)	|O
.	|O

Group	|O
6	|O
was	|O
given	|O
physostigmine	|O
,	|O
0.1	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
,	|O
known	|O
to	|O
inhibit	|O
cholinesterase	|B-PROTEIN
degradation	|O
,	|O
5	|O
min	|O
before	|O
bupivacaine	|O
administration	|O
,	|O
and	|O
Group	|O
7	|O
received	|O
a	|O
combination	|O
of	|O
physostigmine	|O
pretreatment	|O
and	|O
electrical	|O
vagal	|O
stimulation	|O
.	|O

To	|O
examine	|O
the	|O
possibility	|O
that	|O
LNNB	|O
performance	|O
of	|O
the	|O
schizophrenic	|O
groups	|O
may	|O
have	|O
been	|O
related	|O
to	|O
neuroleptic	|O
medication	|O
,	|O
analyses	|O
were	|O
completed	|O
on	|O
the	|O
relationship	|O
between	|O
medication	|O
levels	|O
and	|O
LNNB	|O
scores	|O
.	|O

ISIS	|O
5	|O
possibilities	|O
.	|O

The	|O
use	|O
of	|O
specific	|O
antibodies	|O
allowed	|O
the	|O
identification	|O
of	|O
at	|O
least	|O
RAR	|B-PROTEIN
beta	|I-PROTEIN
in	|O
some	|O
of	|O
the	|O
DNA	|O
-	|O
protein	|O
complexes	|O
,	|O
although	|O
the	|O
four	|O
sequences	|O
bind	|O
single	|O
RARs	|B-PROTEIN
transfected	|O
in	|O
COS	|O
cells	|O
much	|O
less	|O
efficiently	|O
,	|O
or	|O
not	|O
at	|O
all	|O
,	|O
when	|O
compared	|O
to	|O
a	|O
canonical	|O
RAR	|B-PROTEIN
responsive	|O
element	|O
.	|O

The	|O
present	|O
treatment	|O
strategy	|O
in	|O
progressive	|O
disorders	|O
is	|O
mainly	|O
based	|O
on	|O
the	|O
complementary	|O
effect	|O
of	|O
intensive	|O
radiochemotherapy	|O
,	|O
autologous	|O
stem	|O
-	|O
cell	|O
transplantation	|O
and	|O
the	|O
rational	|O
use	|O
of	|O
cytokines	|O
,	|O
mostly	|O
colony	|B-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factors	|I-PROTEIN
.	|O

Our	|O
study	|O
cohorts	|O
consisted	|O
of	|O
15	|O
patients	|O
who	|O
received	|O
SC	|O
rIL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
at	|O
doses	|O
of	|O
4.8-14.4	|O
million	|O
IU	|O
/	|O
m2	|O
/	|O
day	|O
on	|O
5	|O
days	|O
per	|O
week	|O
for	|O
a	|O
total	|O
of	|O
8	|O
weeks	|O
,	|O
20	|O
patients	|O
who	|O
received	|O
rIFN	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
2b	|I-PROTEIN
at	|O
3.0-6.0	|O
million	|O
U	|O
/	|O
m2	|O
/	|O
day	|O
thrice	|O
weekly	|O
for	|O
a	|O
total	|O
of	|O
6	|O
weeks	|O
,	|O
and	|O
72	|O
patients	|O
who	|O
were	|O
given	|O
SC	|O
rIFN	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
2b	|I-PROTEIN
at	|O
6.0	|O
million	|O
U	|O
/	|O
m2	|O
/	|O
day	|O
thrice	|O
weekly	|O
plus	|O
SC	|O
rIL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
at	|O
14.4-18.0	|O
million	|O
IU	|O
/	|O
m2	|O
/	|O
day	|O
on	|O
days	|O
1	|O
and	|O
2	|O
,	|O
followed	|O
by	|O
4.8	|O
million	|O
IU	|O
/	|O
m2	|O
/	|O
day	|O
,	|O
5	|O
days	|O
per	|O
week	|O
for	|O
6	|O
consecutive	|O
weeks	|O
.	|O

Analysis	|O
of	|O
a	|O
set	|O
of	|O
deletion	|O
constructs	|O
in	|O
transient	|O
transfection	|O
assays	|O
measuring	|O
heterologous	|O
reporter	|O
gene	|O
(	|O
luciferase	|B-PROTEIN
)	|O
activity	|O
demonstrated	|O
that	|O
the	|O
182	|O
-	|O
bp	|O
5'	|O
-	|O
flanking	|O
region	|O
provides	|O
full	|O
promoter	|O
activity	|O
in	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
stimulated	|O
L2	|O
cells	|O
.	|O

At	|O
the	|O
MTD	|O
(	|O
8	|O
mg	|O
/	|O
m2	|O
/	|O
day	|O
)	|O
,	|O
the	|O
dose	|O
-	|O
limiting	|O
toxicity	|O
of	|O
this	|O
agent	|O
is	|O
myelosuppression	|O
.	|O

Mitogen	|O
-	|O
induced	|O
lymphocyte	|O
proliferation	|O
was	|O
diminished	|O
.	|O

A	|O
decanucleotide	|O
promoter	|O
sequence	|O
homologous	|O
to	|O
those	|O
found	|O
in	|O
humans	|O
and	|O
mice	|O
was	|O
located	|O
in	|O
the	|O
5'	|O
untranslated	|O
region	|O
of	|O
one	|O
horse	|O
gene	|O
.	|O

Some	|O
of	|O
these	|O
targets	|O
were	|O
reported	|O
to	|O
code	|O
for	|O
molecules	|O
involved	|O
in	|O
cell	|O
-	|O
cell	|O
interactions	|O
,	|O
whereas	|O
no	|O
relationship	|O
has	|O
yet	|O
been	|O
demonstrated	|O
between	|O
Hox	|B-PROTEIN
genes	|O
and	|O
other	|O
transcription	|O
factors	|O
involved	|O
in	|O
determining	|O
and	|O
/	|O
or	|O
maintaining	|O
tissue	|O
specificity	|O
.	|O

Northern	|O
analysis	|O
of	|O
RNA	|O
samples	|O
isolated	|O
from	|O
ammonium	|O
-	|O
grown	|O
cultures	|O
of	|O
the	|O
ntcA	|B-PROTEIN
mutant	|O
showed	|O
reduced	|O
amounts	|O
of	|O
glnA	|B-PROTEIN
message	|O
and	|O
the	|O
absence	|O
of	|O
a	|O
1.7	|O
-	|O
kb	|O
transcript	|O
.	|O

HER2	|B-PROTEIN
overexpressing	|O
cells	|O
showed	|O
a	|O
single	|O
prominent	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
hypersensitive	|O
site	|O
near	|O
a	|O
conserved	|O
and	|O
hitherto	|O
unrecognized	|O
ets	|B-PROTEIN
response	|O
element	|O
(	|O
GAGGAA	|O
)	|O
,	|O
located	|O
38	|O
bases	|O
down	|O
-	|O
stream	|O
from	|O
the	|O
CAAT	|O
box	|O
and	|O
directly	|O
5'	|O
of	|O
the	|O
TATA	|O
box	|O
in	|O
the	|O
human	|O
HER2	|B-PROTEIN
promoter	|O
.	|O

Gel	|O
-	|O
shift	|O
assays	|O
with	|O
nuclear	|O
extracts	|O
and	|O
oligonucleotide	|O
sequences	|O
spanning	|O
the	|O
0.125	|O
-	|O
kb	|O
promoter	|O
region	|O
detected	|O
an	|O
ETS	|B-PROTEIN
-	|O
immunoreactive	|O
complex	|O
,	|O
present	|O
most	|O
abundantly	|O
in	|O
cells	|O
overexpressing	|O
HER2	|B-PROTEIN
,	|O
whose	|O
high	|O
-	|O
affinity	|O
binding	|O
depended	|O
on	|O
the	|O
GAGGAA	|O
response	|O
element	|O
.	|O

Comparison	|O
of	|O
cDNA	|O
sequences	|O
revealed	|O
that	|O
the	|O
two	|O
mRNA	|O
species	|O
arise	|O
as	|O
a	|O
result	|O
of	|O
alternate	|O
use	|O
of	|O
poly	|O
(	|O
A	|O
)	|O
-	|O
addition	|O
sites	|O
.	|O

The	|O
gene	|O
for	|O
the	|O
RNA	|O
-	|O
dependent	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PKR	|B-PROTEIN
)	|O
was	|O
isolated	|O
from	|O
mouse	|O
genomic	|O
DNA	|O
and	|O
characterized	|O
.	|O

High	|O
-	|O
frequency	|O
electrical	|O
stimulation	|O
in	|O
the	|O
hippocampus	|O
leads	|O
to	|O
an	|O
increase	|O
in	|O
synaptic	|O
efficacy	|O
that	|O
lasts	|O
for	|O
many	|O
hours	|O
.	|O

Similar	|O
to	|O
the	|O
mouse	|O
gene	|O
,	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
human	|O
CD79	|B-PROTEIN
alpha	|I-PROTEIN
lacks	|O
a	|O
TATA	|O
box	|O
;	|O
however	|O
,	|O
unlike	|O
mouse	|O
CD79	|B-PROTEIN
alpha	|I-PROTEIN
,	|O
a	|O
classical	|O
octamer	|O
motif	|O
could	|O
not	|O
be	|O
identified	|O
in	|O
the	|O
human	|O
gene	|O
.	|O

Detailed	|O
molecular	|O
organization	|O
of	|O
the	|O
coding	|O
and	|O
upstream	|O
regulatory	|O
regions	|O
of	|O
the	|O
murine	|O
homeodomain	|B-PROTEIN
-	|O
containing	|O
gene	|O
,	|O
Msx	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
is	|O
reported	|O
.	|O

We	|O
report	|O
here	|O
the	|O
cloning	|O
of	|O
the	|O
human	|O
goosecoid	|B-PROTEIN
gene	|O
(	|O
GSC	|B-PROTEIN
)	|O
from	|O
a	|O
genomic	|O
library	|O
and	|O
the	|O
sequence	|O
of	|O
its	|O
encoded	|O
protein	|O
.	|O

In	|O
order	|O
to	|O
define	|O
potential	|O
candidate	|O
genes	|O
for	|O
inherited	|O
disorders	|O
characterized	|O
by	|O
aberrant	|O
gene	|O
expression	|O
,	|O
we	|O
utilized	|O
Kruppel	|B-PROTEIN
-	|O
related	|O
sequences	|O
to	|O
isolate	|O
zinc	|O
finger	|O
-	|O
containing	|O
cDNAs	|O
.	|O

This	|O
virus	|O
is	|O
not	|O
merely	|O
a	|O
South	|O
African	|O
strain	|O
of	|O
passion	|O
fruit	|O
woodiness	|O
virus	|O
(	|O
PWV	|O
)	|O
:	|O
the	|O
deduced	|O
CP	|B-PROTEIN
sequence	|O
is	|O
only	|O
distantly	|O
related	|O
to	|O
CPs	|B-PROTEIN
of	|O
other	|O
sequenced	|O
strains	|O
of	|O
PWV	|O
,	|O
although	|O
it	|O
is	|O
part	|O
of	|O
a	|O
distinct	|O
subgroup	|O
of	|O
potyviruses	|O
related	|O
to	|O
PWV	|O
.	|O

The	|O
ratio	|O
of	|O
the	|O
activity	|O
of	|O
arogenate	|B-PROTEIN
dehydrogenase	|I-PROTEIN
to	|O
that	|O
of	|O
prephenate	|B-PROTEIN
dehydrogenase	|I-PROTEIN
(	|O
approximately	|O
3	|O
:	|O
1	|O
)	|O
remained	|O
constant	|O
throughout	|O
purification	|O
,	|O
and	|O
the	|O
two	|O
activities	|O
were	|O
therefore	|O
inseparable	|O
.	|O

The	|O
isolated	|O
POT1	|B-PROTEIN
clones	|O
hybridized	|O
to	|O
a	|O
1.4	|O
kb	|O
RNA	|O
species	|O
,	|O
which	|O
was	|O
induced	|O
approximately	|O
30	|O
-	|O
fold	|O
when	|O
oleate	|O
was	|O
the	|O
carbon	|O
source	|O
.	|O

The	|O
Y.	|O
lipolytica	|O
genomic	|O
POT1	|B-PROTEIN
gene	|O
was	|O
disrupted	|O
by	|O
replacing	|O
120	|O
bp	|O
of	|O
its	|O
coding	|O
sequence	|O
with	|O
2.7	|O
kbp	|O
of	|O
DNA	|O
including	|O
the	|O
Y.	|O
lipolytica	|O
LEU2	|B-PROTEIN
gene	|O
.	|O

A	|O
leucine	|O
zipper	|O
domain	|O
of	|O
the	|O
suppressor	|O
of	|O
Hairy	|B-PROTEIN
-	|I-PROTEIN
wing	|I-PROTEIN
protein	|O
mediates	|O
its	|O
repressive	|O
effect	|O
on	|O
enhancer	|O
function	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
CT	|O
should	|O
be	|O
routinely	|O
employed	|O
in	|O
patients	|O
with	|O
N1	|O
-	|O
N3	|O
neck	|O
disease	|O
to	|O
determine	|O
the	|O
proper	|O
electron	|O
-	|O
energy	|O
prescription	|O
.	|O

The	|O
predicted	|O
DNA	|O
-	|O
binding	|O
,	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
domain	|I-PROTEIN
protein	|I-PROTEIN
sequence	|O
was	|O
strictly	|O
conserved	|O
.	|O

60	|O
patients	|O
were	|O
entered	|O
into	|O
a	|O
randomised	|O
study	|O
comparing	|O
vindesine	|O
(	|O
3	|O
mg	|O
/	|O
m2	|O
/	|O
week	|O
)	|O
plus	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
2b	|I-PROTEIN
(	|O
6	|O
U	|O
/	|O
m2	|O
3	|O
times	|O
per	|O
week	|O
)	|O
to	|O
vindesine	|O
alone	|O
or	|O
to	|O
interferon	|B-PROTEIN
alone	|O
for	|O
the	|O
treatment	|O
of	|O
metastatic	|O
malignant	|O
melanoma	|O
.	|O

The	|O
novel	|O
Notch	|B-PROTEIN
homologue	|O
mouse	|O
Notch	|B-PROTEIN
3	|O
lacks	|O
specific	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|O
repeats	|O
and	|O
is	|O
expressed	|O
in	|O
proliferating	|O
neuroepithelium	|O
.	|O

BACKGROUND	|O
:	|O
We	|O
conducted	|O
a	|O
phase	|O
I	|O
study	|O
with	|O
MDL	|O
73,147	|O
EF	|O
,	|O
a	|O
new	|O
5	|O
hydroxytryptamine	|O
3	|O
(	|B-PROTEIN
5	|I-PROTEIN
-	|I-PROTEIN
HT3	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
,	|O
in	|O
25	|O
patients	|O
requiring	|O
emetogenic	|O
chemotherapy	|O
.	|O

In	|O
the	|O
presence	|O
of	|O
the	|O
in	|O
vivo	|O
reducing	|O
system	|O
(	|O
thioredoxin	|B-PROTEIN
,	|O
thioredoxin	|B-PROTEIN
reductase	|I-PROTEIN
,	|O
and	|O
NADPH	|O
)	|O
,	|O
however	|O
,	|O
each	|O
of	|O
these	|O
mutants	|O
catalyzed	|O
the	|O
formation	|O
of	|O
only	|O
0.6-0.8	|O
dCTPs	|O
per	|O
mole	|O
of	|O
enzyme	|O
.	|O

These	|O
genetic	|O
alterations	|O
do	|O
not	|O
affect	|O
synthesis	|O
of	|O
the	|O
major	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
protein	|O
,	|O
p64	|B-PROTEIN
,	|O
which	|O
is	|O
initiated	|O
from	|O
the	|O
first	|O
AUG	|O
codon	|O
in	|O
exon	|O
2	|O
.	|O

In	|O
addition	|O
,	|O
both	|O
the	|O
exon	|O
1	|O
-	|O
and	|O
exon	|O
2	|O
-	|O
initiated	|O
forms	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
protein	|O
stimulated	|O
transcription	|O
of	|O
a	|O
Myc	|B-PROTEIN
/	|O
Max	|B-PROTEIN
-	|O
responsive	|O
reporter	|O
construct	|O
to	|O
a	|O
similar	|O
level	|O
.	|O

Biological	|O
activities	|O
of	|O
hematopoietic	|B-PROTEIN
growth	|I-PROTEIN
factors	|I-PROTEIN
that	|O
lead	|O
to	|O
future	|O
clinical	|O
application	|O
.	|O

Expression	|O
is	|O
exclusively	|O
limited	|O
to	|O
the	|O
CNS	|O
at	|O
this	|O
and	|O
later	|O
stages	|O
.	|O

Immunoreactive	|O
AR	|B-PROTEIN
content	|O
in	|O
transfected	|O
COS	|O
-	|O
1	|O
cells	|O
was	|O
not	|O
influenced	|O
by	|O
exposure	|O
to	|O
8	|O
-	|O
Br	|O
-	|O
cAMP	|O
.	|O

Disruption	|O
of	|O
any	|O
one	|O
of	|O
the	|O
four	|O
genes	|O
encoding	|O
the	|O
newly	|O
identified	|O
SRP	|B-PROTEIN
proteins	|O
results	|O
in	|O
slow	|O
cell	|O
growth	|O
and	|O
inefficient	|O
protein	|O
translocation	|O
across	|O
the	|O
ER	|O
membrane	|O
.	|O

Genetic	|O
alterations	|O
in	|O
elements	|O
of	|O
normal	|O
signal	|O
transduction	|O
mechanisms	|O
are	|O
known	|O
to	|O
be	|O
oncogenic	|O
events	|O
often	|O
resulting	|O
in	|O
aberrant	|O
activation	|O
of	|O
programs	|O
of	|O
gene	|O
transcription	|O
.	|O

The	|O
expression	|O
pattern	|O
of	|O
GL2	|B-PROTEIN
,	|O
as	|O
demonstrated	|O
by	|O
in	|O
situ	|O
hybridization	|O
,	|O
indicated	|O
that	|O
the	|O
gene	|O
is	|O
expressed	|O
in	|O
trichome	|O
progenitor	|O
cells	|O
and	|O
at	|O
stages	|O
associated	|O
with	|O
trichome	|O
development	|O
.	|O

NOT4	|B-PROTEIN
interacts	|O
with	|O
NOT1	|B-PROTEIN
and	|O
NOT3	|B-PROTEIN
in	|O
the	|O
two	|O
-	|O
hybrid	|O
assay	|O
,	|O
and	|O
overexpression	|O
of	|O
NOT3	|B-PROTEIN
or	|O
NOT4	|B-PROTEIN
suppresses	|O
not1	|B-PROTEIN
and	|O
not2	|B-PROTEIN
mutations	|O
.	|O

Binding	|O
site	|O
selection	|O
using	|O
in	|O
vitro	|O
-	|O
synthesized	|O
proteins	|O
reveals	|O
that	|O
the	|O
ROR	|B-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
and	|O
ROR	|B-PROTEIN
alpha	|I-PROTEIN
2	|I-PROTEIN
isoforms	|O
bind	|O
DNA	|O
as	|O
monomers	|O
to	|O
hormone	|O
response	|O
elements	|O
composed	|O
of	|O
a	|O
6	|O
-	|O
bp	|O
AT	|O
-	|O
rich	|O
sequence	|O
preceding	|O
a	|O
half	|O
-	|O
site	|O
core	|O
motif	|O
PuGGTCA	|O
(	|O
RORE	|B-PROTEIN
)	|O
.	|O

The	|O
p73pct1	|B-PROTEIN
/	|O
p85cdc10	|B-PROTEIN
complex	|O
binds	|O
both	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
to	|O
MCB	|B-PROTEIN
but	|O
not	|O
SCB	|B-PROTEIN
or	|O
E2F	|B-PROTEIN
sites	|O
.	|O

We	|O
show	|O
that	|O
the	|O
en	|B-PROTEIN
stripes	|O
expand	|O
anteriorly	|O
in	|O
slp	|B-PROTEIN
mutant	|O
embryos	|O
and	|O
that	|O
slp	|B-PROTEIN
activity	|O
is	|O
an	|O
absolute	|O
requirement	|O
for	|O
maintenance	|O
of	|O
wg	|B-PROTEIN
expression	|O
at	|O
the	|O
same	|O
time	|O
that	|O
wg	|B-PROTEIN
transcription	|O
is	|O
dependent	|O
on	|O
hh	|B-PROTEIN
.	|O

The	|O
DNA	|O
sequence	|O
adjacent	|O
to	|O
the	|O
lacZ	|B-PROTEIN
gene	|O
has	|O
been	|O
determined	|O
for	|O
91	|O
vegetative	|O
fusion	|O
genes	|O
whose	|O
products	|O
have	|O
been	|O
localized	|O
and	|O
for	|O
43	|O
meiotically	|O
induced	|O
fusions	|O
.	|O

CMV	|O
hyperimmunoglobulin	|B-PROTEIN
treatment	|O
(	|O
Cytotect	|O
,	|O
Biotest	|O
)	|O
was	|O
started	|O
(	|O
2	|O
ml	|O
/	|O
kg	|O
bw	|O
on	|O
day	|O
1	|O
and	|O
3	|O
,	|O
and	|O
1	|O
ml	|O
/	|O
kg	|O
on	|O
days	|O
5	|O
,	|O
7	|O
and	|O
9	|O
)	|O
,	|O
which	|O
led	|O
to	|O
the	|O
eradication	|O
of	|O
the	|O
residual	|O
infiltrate	|O
and	|O
CMV	|O
-	|O
DNA	|O
in	|O
the	|O
myocardium	|O
.	|O

Internal	|O
biliary	|O
drainage	|O
,	|O
unlike	|O
external	|O
drainage	|O
,	|O
does	|O
not	|O
suppress	|O
the	|O
regeneration	|O
of	|O
cholestatic	|O
rat	|O
liver	|O
after	|O
partial	|O
hepatectomy	|O
.	|O

ORF	|O
2	|O
potentially	|O
encoded	|O
a	|O
hydrophobic	|O
protein	|O
of	|O
29,705	|O
Da	|O
with	|O
six	|O
potential	|O
membrane	|O
-	|O
spanning	|O
regions	|O
.	|O

In	|O
eight	|O
groups	|O
of	|O
subjects	|O
operating	|O
various	|O
hand	|O
-	|O
held	|O
vibrating	|O
tools	|O
and	|O
aged	|O
from	|O
30	|O
to	|O
59	|O
years	|O
,	|O
the	|O
prevalence	|O
rates	|O
of	|O
vibration	|O
-	|O
induced	|O
white	|O
finger	|O
(	|O
VWF	|O
)	|O
and	|O
numbness	|O
,	|O
pain	|O
,	|O
or	|O
stiffness	|O
in	|O
the	|O
upper	|O
and	|O
lower	|O
extremities	|O
were	|O
investigated	|O
.	|O

DNA	|O
sequence	|O
analysis	|O
showed	|O
that	|O
the	|O
gene	|O
was	|O
525	|O
bp	|O
long	|O
and	|O
encoded	|O
a	|O
175	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
with	|O
a	|O
molecular	|O
weight	|O
of	|O
19,094	|O
containing	|O
a	|O
21	|O
-	|O
residue	|O
typical	|O
lipoprotein	|O
signal	|O
peptide	|O
and	|O
consensus	|O
prolipoprotein	|O
processing	|O
site	|O
.	|O

DNA	|O
sequence	|O
and	|O
functions	|O
of	|O
the	|O
actVI	|B-PROTEIN
region	|O
of	|O
the	|O
actinorhodin	|B-PROTEIN
biosynthetic	|O
gene	|O
cluster	|O
of	|O
Streptomyces	|O
coelicolor	|O
A3	|O
(	|O
2	|O
)	|O
.	|O

(	|O
1992	|O
)	|O
Genomics	|O
12	|O
,	|O
58-62	|O
)	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
predicted	|O
polypeptide	|O
sequence	|O
of	|O
the	|O
Drosophila	|O
protein	|O
with	|O
the	|O
equivalent	|O
subunits	|O
from	|O
mouse	|O
and	|O
yeast	|O
suggests	|O
that	|O
they	|O
are	|O
closely	|O
related	|O
and	|O
defines	|O
three	|O
conserved	|O
regions	|O
which	|O
are	|O
likely	|O
to	|O
be	|O
important	|O
for	|O
enzyme	|O
activity	|O
.	|O

Plasmids	|O
were	|O
constructed	|O
with	|O
the	|O
mouse	|O
promoter	|O
region	|O
linked	|O
to	|O
the	|O
reporter	|O
gene	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
,	|O
and	|O
transiently	|O
and	|O
stably	|O
transfected	|O
in	|O
the	|O
INS	|O
-	|O
1	|O
cells	|O
.	|O

Cytoplasmic	|O
dynein	|B-PROTEIN
is	|O
a	|O
multisubunit	|O
,	|O
microtubule	|O
-	|O
dependent	|O
mechanochemical	|O
enzyme	|O
that	|O
has	|O
been	|O
proposed	|O
to	|O
function	|O
in	|O
a	|O
variety	|O
of	|O
intracellular	|O
movements	|O
,	|O
including	|O
minus	|O
-	|O
end	|O
-	|O
directed	|O
transport	|O
of	|O
organelles	|O
.	|O

Identification	|O
of	|O
the	|O
plakoglobin	|B-PROTEIN
-	|O
binding	|O
domain	|O
in	|O
desmoglein	|B-PROTEIN
and	|O
its	|O
role	|O
in	|O
plaque	|O
assembly	|O
and	|O
intermediate	|O
filament	|O
anchorage	|O
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
One	|O
hundred	|O
eighty	|O
-	|O
four	|O
chemotherapy	|O
-	|O
naive	|O
patients	|O
receiving	|O
high	|O
-	|O
dose	|O
cisplatin	|O
(	|O
81	|O
to	|O
120	|O
mg	|O
/	|O
m2	|O
)	|O
were	|O
randomized	|O
to	|O
receive	|O
one	|O
of	|O
four	|O
granisetron	|O
doses	|O
(	|O
5	|O
,	|O
10	|O
,	|O
20	|O
,	|O
or	|O
40	|O
micrograms	|O
/	|O
kg	|O
)	|O
administered	|O
before	|O
chemotherapy	|O
.	|O

Nine	|O
new	|O
naphthalene	|O
related	|O
compounds	|O
(	|O
I	|O
,	|O
IV	|O
,	|O
V	|O
,	|O
VII	|O
-	|O
XII	|O
)	|O
together	|O
with	|O
four	|O
known	|O
compounds	|O
(	|O
II	|O
,	|O
III	|O
,	|O
VI	|O
,	|O
XIII	|O
)	|O
were	|O
isolated	|O
from	|O
the	|O
root	|O
bark	|O
of	|O
Oroxylum	|O
indicum	|O
Vent	|O
.	|O

Specifically	|O
,	|O
this	|O
study	|O
determined	|O
the	|O
influence	|O
of	|O
:	|O
(	|O
1	|O
)	|O
an	|O
awareness	|O
strategy	|O
,	|O
(	|O
2	|O
)	|O
a	|O
non	|O
-	|O
awareness	|O
strategy	|O
,	|O
(	|O
3	|O
)	|O
a	|O
Five	|O
-	|O
Step	|O
Approach	|O
strategy	|O
and	|O
(	|O
4	|O
)	|O
a	|O
control	|O
condition	|O
.	|O

Mutually	|O
exclusive	|O
interaction	|O
of	|O
the	|O
adenovirus	|O
E4	|B-PROTEIN
-	|I-PROTEIN
6/7	|I-PROTEIN
protein	|O
and	|O
the	|O
retinoblastoma	|B-PROTEIN
gene	|I-PROTEIN
product	|O
with	|O
internal	|O
domains	|O
of	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
DP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

As	|O
shown	|O
previously	|O
,	|O
EBNA2	|B-PROTEIN
transactivates	|O
the	|O
promoters	|O
of	|O
the	|O
viral	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

We	|O
previously	|O
showed	|O
that	|O
v	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
,	|O
the	|O
oncoprotein	|O
of	|O
the	|O
avian	|O
retrovirus	|O
Rev	|O
-	|O
T	|O
,	|O
can	|O
increase	|O
expression	|O
from	|O
promoters	|O
containing	|O
binding	|O
sites	|O
for	|O
the	|O
cellular	|O
transcription	|O
factor	|O
Sp1	|B-PROTEIN
in	|O
chicken	|O
embryo	|O
fibroblasts	|O
(	|O
S.	|O

Previous	|O
studies	|O
have	|O
demonstrated	|O
that	|O
the	|O
TATA	|O
element	|O
is	|O
critical	|O
for	|O
basal	|O
and	|O
Tat	|B-PROTEIN
-	|O
induced	|O
HIV	|O
-	|O
1	|O
gene	|O
expression	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
p54	|B-PROTEIN
gene	|O
carried	|O
by	|O
two	|O
virulent	|O
ASFV	|O
strains	|O
(	|O
E70	|O
and	|O
E75	|O
)	|O
with	|O
that	|O
obtained	|O
from	|O
virus	|O
Ba71V	|O
showed	|O
100%	|O
similarity	|O
.	|O

The	|O
p55	|B-PROTEIN
mRNA	|O
is	|O
undetectable	|O
in	|O
non	|O
-	|O
EBV	|O
-	|O
infected	|O
B	|O
-	|O
and	|O
T	|O
-	|O
cell	|O
lines	|O
or	|O
in	|O
a	|O
myelomonocytic	|O
cell	|O
line	|O
(	|O
U937	|O
)	|O
.	|O

A	|O
simple	|O
registration	|O
as	|O
an	|O
incentive	|O
for	|O
improvement	|O

The	|O
transverse	|O
magnetization	|O
decays	|O
mentioned	|O
above	|O
exhibited	|O
two	|O
components	|O
,	|O
a	|O
T2	|O
fast	|O
(	|O
T2f	|O
)	|O
and	|O
a	|O
T2	|O
slow	|O
(	|O
T2s	|O
)	|O
component	|O
.	|O

RESULTS	|O
:	|O
The	|O
diagnostic	|O
quality	|O
of	|O
FDG	|O
images	|O
was	|O
at	|O
least	|O
as	|O
good	|O
as	|O
that	|O
of	|O
their	|O
Tl	|O
-	|O
201	|O
counterparts	|O
,	|O
with	|O
less	|O
liver	|O
background	|O
in	|O
all	|O
but	|O
one	|O
FDG	|O
study	|O
.	|O

The	|O
coordinated	|O
expression	|O
of	|O
CD4	|B-PROTEIN
and	|O
CD8	|B-PROTEIN
during	|O
T	|O
-	|O
cell	|O
development	|O
is	|O
tightly	|O
coupled	|O
with	|O
the	|O
maturation	|O
state	|O
of	|O
the	|O
T	|O
cell	|O
.	|O

Expression	|O
of	|O
a	|O
dominant	|O
-	|O
negative	|O
ras	|B-PROTEIN
gene	|O
also	|O
blocks	|O
TIS10	|B-PROTEIN
/	|O
PGS2	|B-PROTEIN
induction	|O
by	|O
v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
.	|O

The	|O
dying	|O
tTG	|B-PROTEIN
-	|O
transfected	|O
cells	|O
exhibit	|O
both	|O
cytoplasmic	|O
and	|O
nuclear	|O
changes	|O
characteristic	|O
of	|O
cells	|O
undergoing	|O
apoptosis	|O
.	|O

Using	|O
an	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
-	|O
mediated	|O
mapping	|O
technique	|O
,	|O
we	|O
show	|O
that	|O
the	|O
64	|O
-	|O
kDa	|O
subunit	|O
of	|O
CstF	|B-PROTEIN
can	|O
be	|O
photo	|O
cross	|O
-	|O
linked	|O
to	|O
pre	|O
-	|O
mRNAs	|O
at	|O
U	|O
-	|O
rich	|O
regions	|O
located	|O
downstream	|O
of	|O
the	|O
cleavage	|O
site	|O
of	|O
the	|O
simian	|O
virus	|O
40	|O
late	|O
and	|O
adenovirus	|O
L3	|B-PROTEIN
pre	|O
-	|O
mRNAs	|O
.	|O

The	|O
protein	|O
encoded	|O
is	|O
114	|O
kDa	|O
and	|O
contains	|O
eight	|O
zinc	|O
finger	|O
motifs	|O
,	|O
seven	|O
of	|O
which	|O
are	|O
present	|O
in	|O
two	|O
clusters	|O
at	|O
opposite	|O
ends	|O
of	|O
the	|O
molecule	|O
.	|O

Tissue	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
diazepam	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
inhibitor	|I-PROTEIN
in	|O
Drosophila	|O
melanogaster	|O
:	|O
cloning	|O
,	|O
structure	|O
,	|O
and	|O
localization	|O
of	|O
the	|O
gene	|O
.	|O

Using	|O
a	|O
v	|B-PROTEIN
-	|I-PROTEIN
erbA	|I-PROTEIN
probe	|O
,	|O
we	|O
obtained	|O
a	|O
cDNA	|O
which	|O
encodes	|O
a	|O
novel	|O
445	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
,	|O
RLD	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
that	|O
contains	|O
the	|O
characteristic	|O
domains	|O
of	|O
nuclear	|O
receptors	|O
.	|O

Only	|O
two	|O
of	|O
the	|O
isoforms	|O
possess	|O
the	|O
N	|O
-	|O
terminal	|O
zinc	|O
finger	|O
domain	|O
that	|O
is	|O
necessary	|O
and	|O
sufficient	|O
for	|O
TdT	|B-PROTEIN
promoter	|O
binding	|O
.	|O

This	|O
study	|O
provides	|O
direct	|O
evidence	|O
that	|O
USF	|B-PROTEIN
,	|O
a	|O
member	|O
of	|O
the	|O
basic	|B-PROTEIN
helix	|I-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
leucine	|I-PROTEIN
zipper	|I-PROTEIN
family	|I-PROTEIN
,	|O
binds	|O
to	|O
MLE1	|B-PROTEIN
,	|O
HF	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
,	|O
and	|O
PRE	|B-PROTEIN
B	|I-PROTEIN
sites	|O
and	|O
suggests	|O
that	|O
it	|O
is	|O
a	|O
component	|O
of	|O
protein	|O
complexes	|O
that	|O
may	|O
coordinately	|O
control	|O
the	|O
expression	|O
of	|O
MLC	|B-PROTEIN
-	|I-PROTEIN
2v	|I-PROTEIN
and	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
myosin	|I-PROTEIN
heavy	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
genes	|O
.	|O

Human	|O
T	|O
-	|O
cell	|O
leukemia	|O
virus	|O
type	|O
I	|O
Tax	|B-PROTEIN
activation	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
/	|O
Rel	|B-PROTEIN
involves	|O
phosphorylation	|O
and	|O
degradation	|O
of	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
RelA	|B-PROTEIN
(	|I-PROTEIN
p65	|I-PROTEIN
)	|I-PROTEIN
-	|O
mediated	|O
induction	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
rel	|I-PROTEIN
gene	|O
.	|O

Activation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
gene	|O
expression	|O
by	|O
a	|O
kinase	|O
-	|O
deficient	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

Because	|O
endogenous	|O
HSF	|B-PROTEIN
DNA	|O
-	|O
binding	|O
activity	|O
is	|O
low	|O
and	|O
anti	|B-PROTEIN
-	|I-PROTEIN
hHSF1	|I-PROTEIN
antibody	|O
does	|O
not	|O
recognize	|O
Xenopus	|O
HSF	|B-PROTEIN
,	|O
we	|O
employed	|O
this	|O
system	|O
for	|O
mapping	|O
regions	|O
in	|O
hHSF1	|B-PROTEIN
that	|O
are	|O
required	|O
for	|O
the	|O
maintenance	|O
of	|O
the	|O
monomeric	|O
state	|O
.	|O

Enhancers	|O
containing	|O
disrupted	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
sites	|O
were	|O
tested	|O
in	|O
transient	|O
expression	|O
assays	|O
in	|O
the	|O
murine	|O
T	|O
-	|O
cell	|O
line	|O
EL4.E	|O
1	|O
;	|O
alterations	|O
in	|O
the	|O
LVb	|O
element	|O
affected	|O
constitutive	|O
enhancer	|O
activity	|O
,	|O
while	|O
mutation	|O
of	|O
either	|O
the	|O
LVb	|O
or	|O
LVc	|O
element	|O
disrupted	|O
phorbol	|O
ester	|O
-	|O
induced	|O
enhancer	|O
activity	|O
.	|O

The	|O
predominant	|O
binding	|O
activity	|O
was	|O
not	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
but	|O
rather	|O
two	|O
independent	|O
DNA	|O
-	|O
protein	|O
complexes	|O
that	|O
comigrated	|O
in	|O
mobility	|O
shift	|O
assays	|O
.	|O

These	|O
RZR	|B-PROTEIN
subtypes	|O
represent	|O
members	|O
of	|O
a	|O
new	|O
family	|O
of	|O
orphan	|B-PROTEIN
nuclear	|I-PROTEIN
receptors	|I-PROTEIN
that	|O
most	|O
likely	|O
regulate	|O
specific	|O
gene	|O
expression	|O
.	|O

Interestingly	|O
,	|O
these	|O
response	|O
elements	|O
display	|O
dramatically	|O
reduced	|O
affinity	|O
for	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
-	|O
retinoid	|B-PROTEIN
-	|I-PROTEIN
X	|I-PROTEIN
receptor	|I-PROTEIN
heterodimers	|O
.	|O

Treatment	|O
with	|O
amphotericin	|O
B	|O
and	|O
flucytosine	|O
led	|O
to	|O
improvement	|O
of	|O
the	|O
symptoms	|O
but	|O
did	|O
not	|O
eradicate	|O
the	|O
micro	|O
-	|O
organisms	|O
from	|O
the	|O
cerebrospinal	|O
fluid	|O
(	|O
CSF	|O
)	|O
.	|O

The	|O
unexpected	|O
presence	|O
of	|O
the	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
trp	|I-PROTEIN
)	|I-PROTEIN
(	|I-PROTEIN
CCA	|I-PROTEIN
)	|I-PROTEIN
-	|O
gene	|O
transcript	|O
in	|O
mitochondria	|O
is	|O
also	|O
reported	|O
.	|O

The	|O
parameters	|O
of	|O
nonspecific	|O
humoral	|O
immunity	|O
-	|O
-	|O
serum	|O
immunoglobulins	|B-PROTEIN
and	|O
immune	|O
complexes	|O
-	|O
-	|O
were	|O
evaluated	|O
in	|O
irradiated	|O
group	|O
of	|O
patients	|O
with	|O
uterine	|O
cervix	|O
carcinoma	|O
(	|O
Stages	|O
IIB	|O
and	|O
IIIB	|O
)	|O
,	|O
during	|O
one	|O
year	|O
follow	|O
up	|O
.	|O

Mutation	|O
of	|O
KRKR	|O
to	|O
NGER	|O
retains	|O
MO15	|B-PROTEIN
in	|O
the	|O
cytoplasmic	|O
compartment	|O
,	|O
whilst	|O
the	|O
wild	|O
-	|O
type	|O
protein	|O
is	|O
detected	|O
exclusively	|O
in	|O
the	|O
nucleus	|O
.	|O

To	|O
confirm	|O
the	|O
binding	|O
of	|O
protein	|O
to	|O
these	|O
sites	|O
in	|O
cells	|O
,	|O
we	|O
carried	|O
out	|O
an	|O
in	|O
vivo	|O
genomic	|O
footprinting	|O
analysis	|O
of	|O
this	|O
portion	|O
of	|O
the	|O
TGF	|B-PROTEIN
alpha	|I-PROTEIN
promoter	|O
in	|O
normal	|O
and	|O
transformed	|O
rat	|O
liver	|O
epithelial	|O
cell	|O
lines	|O
that	|O
express	|O
the	|O
endogenous	|O
gene	|O
at	|O
varying	|O
levels	|O
.	|O

Strikingly	|O
,	|O
this	|O
subdomain	|O
is	|O
also	|O
present	|O
in	|O
the	|O
otherwise	|O
unrelated	|O
N	|O
-	|O
terminal	|O
activating	|O
region	|O
of	|O
p58c	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
was	|O
thus	|O
named	|O
BEC	|B-PROTEIN
for	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
/	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
Conserved	|O
sequence	|O
.	|O

This	|O
work	|O
unravels	|O
a	|O
new	|O
model	|O
for	|O
the	|O
ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
's	|O
evolution	|O
,	|O
based	|O
for	|O
the	|O
first	|O
time	|O
on	|O
both	|O
structural	|O
and	|O
functional	|O
evidences	|O
.	|O

The	|O
v	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
oncogene	|O
of	|O
the	|O
avian	|O
retrovirus	|O
E26	|O
differs	|O
from	|O
its	|O
cellular	|O
progenitor	|O
p68c	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
by	|O
two	|O
amino	|O
acid	|O
substitutions	|O
(	|O
alanine	|O
285	|O
and	|O
isoleucine	|O
445	|O
in	|O
c	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
both	|O
substituted	|O
by	|O
valine	|O
in	|O
v	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
,	|O
mutations	|O
A	|O
and	|O
B	|O
respectively	|O
)	|O
and	|O
its	|O
carboxy	|O
-	|O
terminal	|O
end	|O
(	|O
mutation	|O
C	|O
)	|O
.	|O

Consequently	|O
functional	|O
mRNAs	|O
can	|O
be	|O
produced	|O
by	|O
endogenous	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
I.	|I-PROTEIN

The	|O
individual	|O
subunits	|O
of	|O
Ku	|B-PROTEIN
have	|O
been	|O
difficult	|O
to	|O
isolate	|O
from	|O
human	|O
cells	|O
without	|O
denaturation	|O
and	|O
attempts	|O
to	|O
produce	|O
functional	|O
recombinant	|O
Ku	|B-PROTEIN
have	|O
been	|O
largely	|O
unsuccessful	|O
.	|O

Using	|O
this	|O
method	|O
,	|O
we	|O
were	|O
able	|O
to	|O
select	|O
strong	|O
enhancer	|O
-	|O
type	|O
activation	|O
domains	|O
from	|O
the	|O
immediate	|B-PROTEIN
early	|I-PROTEIN
regions	|I-PROTEIN
of	|O
two	|O
herpesviruses	|O
,	|O
namely	|O
pseudorabies	|O
virus	|O
and	|O
bovine	|O
herpesvirus	|O
1	|O
.	|O

Remarkably	|O
,	|O
U21	|B-PROTEIN
contains	|O
a	|O
long	|O
stretch	|O
(	|O
13	|O
nt	|O
.	|O
)	|O
of	|O
complementarity	|O
to	|O
a	|O
highly	|O
conserved	|O
sequence	|O
in	|O
28S	|B-PROTEIN
rRNA	|O
.	|O

A	|O
genetic	|O
system	|O
was	|O
devised	|O
to	|O
select	|O
for	|O
pi	|B-PROTEIN
protein	|O
mutants	|O
which	|O
discriminate	|O
between	|O
IR	|O
and	|O
DR	|O
(	|O
York	|O
et	|O
al.	|O
,	|O
Gene	|O
(	|O
Amst	|O
.	|O
)	|O
116	|O
,	|O
7-12	|O
,	|O
1992	|O
;	|O
York	|O
and	|O
Filutowicz	|O
,	|O
J.	|O

Univariate	|O
statistical	|O
analysis	|O
based	|O
on	|O
Kaplan	|O
-	|O
Meier	|O
-	|O
estimates	|O
and	|O
Log	|O
-	|O
Rank	|O
-	|O
Test	|O
showed	|O
the	|O
following	|O
prognostically	|O
beneficial	|O
factors	|O
:	|O
Limited	|O
disease	|O
stage	|O
(	|O
p	|O
=	|O
0.009	|O
)	|O
,	|O
NSE	|B-PROTEIN
serum	|O
level	|O
less	|O
than	|O
25	|O
micrograms	|O
/	|O
l	|O
(	|O
p	|O
=	|O
0.016	|O
)	|O
,	|O
serum	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
less	|O
than	|O
200	|O
U	|O
/	|O
l	|O
(	|O
p	|O
=	|O
0.035	|O
)	|O
,	|O
normal	|O
serum	|O
albumin	|B-PROTEIN
(	|O
p	|O
=	|O
0.003	|O
)	|O
and	|O
activity	|O
index	|O
of	|O
minimum	|O
of	|O
70	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
.	|O

These	|O
results	|O
provide	|O
evidence	|O
of	|O
a	|O
bypass	|O
of	|O
p53	|B-PROTEIN
-	|O
induced	|O
Waf1	|B-PROTEIN
/	|O
Cip1	|B-PROTEIN
-	|O
mediated	|O
cell	|O
cycle	|O
regulatory	|O
pathways	|O
by	|O
a	|O
member	|O
of	|O
the	|O
myb	|B-PROTEIN
oncogene	|O
family	|O
.	|O

HBx	|B-PROTEIN
strongly	|O
elevates	|O
levels	|O
of	|O
GTP	|O
-	|O
bound	|O
Ras	|B-PROTEIN
,	|O
activated	|O
and	|O
phosphorylated	|O
Raf	|B-PROTEIN
,	|O
and	|O
tyrosine	|O
-	|O
phosphorylated	|O
and	|O
activated	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
.	|O

Role	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
in	|O
simian	|B-PROTEIN
virus	|I-PROTEIN
40	|I-PROTEIN
large	|I-PROTEIN
tumor	|I-PROTEIN
antigen	|I-PROTEIN
-	|O
induced	|O
DNA	|O
synthesis	|O
in	|O
quiescent	|O
3T3	|O
-	|O
L1	|O
mouse	|O
fibroblasts	|O
.	|O

All	|O
groups	|O
were	|O
challenged	|O
subsequently	|O
with	|O
naloxone	|O
(	|O
0.4	|O
mg	|O
/	|O
kg	|O
)	|O
in	|O
the	|O
distinctive	|O
environment	|O
and	|O
then	|O
observed	|O
for	|O
signs	|O
of	|O
opiate	|O
withdrawal	|O
.	|O

Laser	|O
therapy	|O
of	|O
penile	|O
carcinoma	|O

A	|O
15.1	|O
kb	|O
fragment	|O
of	|O
the	|O
yeast	|O
genome	|O
was	|O
allocated	|O
to	|O
the	|O
centromeric	|O
region	|O
of	|O
chromosome	|O
XIV	|O
by	|O
genetic	|O
mapping	|O
.	|O

A	|O
third	|O
one	|O
is	|O
homologous	|O
in	|O
half	|O
of	|O
its	|O
length	|O
to	|O
the	|O
prokaryotic	|O
hydantoinase	|B-PROTEIN
HyuA	|O
and	|O
in	|O
the	|O
other	|O
half	|O
to	|O
hydatoinase	|B-PROTEIN
HyuB	|O
.	|O

It	|O
was	|O
shown	|O
that	|O
estradiol	|O
concentrations	|O
obtained	|O
after	|O
estradiol	|O
valerate	|O
and	|O
micronized	|O
estradiol	|O
ingestion	|O
were	|O
dependent	|O
on	|O
the	|O
patient	|O
's	|O
age	|O
as	|O
well	|O
as	|O
on	|O
the	|O
constitutional	|O
type	|O
.	|O

There	|O
were	|O
9	|O
patients	|O
in	|O
NYHA	|O
class	|O
III	|O
and	|O
8	|O
in	|O
class	|O
IV	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Constipation	|O
is	|O
not	|O
a	|O
risk	|O
factor	|O
for	|O
hemorrhoids	|O
:	|O
a	|O
case	|O
-	|O
control	|O
study	|O
of	|O
potential	|O
etiological	|O
agents	|O
.	|O

Of	|O
419	|O
persons	|O
surveyed	|O
,	|O
207	|O
(	|O
49.4%	|O
)	|O
were	|O
antigen	|O
-	|O
positive	|O
with	|O
the	|O
Og4C3	|B-PROTEIN
assay	|O
.	|O

TG	|O
-	|O
day	|O
and	|O
TG	|O
-	|O
night	|O
were	|O
19.4	|O
+	|O
/	|O
-	|O
6.1%	|O
,	|O
26.6	|O
+	|O
/	|O
-	|O
5.3%	|O
,	|O
(	|O
750	|O
mm3	|O
<	|O
T.	|O

Vibrio	|O
cholerae	|O
O139	|O
in	|O
Calcutta	|O
.	|O

Ten	|O
volunteers	|O
were	|O
tested	|O
at	|O
18,000	|O
ft	|O
(	|O
5,486	|O
m	|O
)	|O
,	|O
and	|O
through	|O
12,000	|O
,	|O
8,000	|O
,	|O
and	|O
5,000	|O
ft	|O
(	|O
3,657	|O
,	|O
2,438	|O
,	|O
and	|O
1,524	|O
m	|O
)	|O
with	|O
directional	|O
sounds	|O
recorded	|O
via	|O
a	|O
dummy	|O
head	|O
microphone	|O
and	|O
presented	|O
binaurally	|O
.	|O

Upon	|O
differentiation	|O
with	|O
retinoic	|O
acid	|O
(	|O
RA	|O
)	|O
,	|O
transcription	|O
of	|O
the	|O
Rex	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
decreases	|O
rapidly	|O
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
zebrafish	|O
egr1	|B-PROTEIN
coding	|O
region	|O
revealed	|O
a	|O
high	|O
level	|O
of	|O
homology	|O
to	|O
the	|O
mouse	|O
,	|O
rat	|O
,	|O
and	|O
human	|O
Egr1	|B-PROTEIN
genes	|O
with	|O
the	|O
notable	|O
exception	|O
of	|O
a	|O
polymorphic	|O
,	|O
triplet	|O
nucleotide	|O
repeat	|O
sequence	|O
in	|O
the	|O
region	|O
coding	|O
for	|O
the	|O
amino	|O
terminus	|O
of	|O
the	|O
Egr1	|B-PROTEIN
protein	|O
.	|O

The	|O
fibrinogen	|B-PROTEIN
,	|O
serum	|O
proteins	|O
,	|O
sodium	|O
heparin	|O
and	|O
membrane	|O
contributed	|O
to	|O
Cm	|O
by	|O
20%	|O
,	|O
14%	|O
,	|O
2%	|O
and	|O
64%	|O
,	|O
respectively	|O
.	|O

In	|O
these	|O
vectors	|O
the	|O
chimeric	|B-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeat	|I-PROTEIN
(	|O
chLTR	|B-PROTEIN
)	|O
drives	|O
the	|O
expression	|O
of	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyl	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
reporter	|O
gene	|O
that	|O
is	|O
followed	|O
by	|O
an	|O
internal	|O
SV40	|B-PROTEIN
virus	|I-PROTEIN
early	|I-PROTEIN
region	|I-PROTEIN
promoter	|I-PROTEIN
linked	|O
to	|O
the	|O
neomycin	|B-PROTEIN
phosphotransferase	|I-PROTEIN
II	|I-PROTEIN
(	|O
NEO	|B-PROTEIN
)	|O
gene	|O
.	|O

Optima	|O
)	|O
genomic	|O
library	|O
by	|O
hybridizing	|O
with	|O
elicitor	|O
-	|O
induced	|O
stilbene	|B-PROTEIN
synthase	|I-PROTEIN
cDNA	|O
as	|O
a	|O
probe	|O
.	|O

A	|O
total	|O
of	|O
125	|O
acute	|O
leukemia	|O
adult	|O
patients	|O
were	|O
autografted	|O
with	|O
bone	|O
marrow	|O
(	|O
BM	|O
)	|O
purged	|O
by	|O
mafosfamide	|O
(	|O
ASTA	|O
Z	|O
)	|O
during	|O
the	|O
period	|O
of	|O
January	|O
1983	|O
to	|O
January	|O
1993	|O
.	|O

The	|O
pretransplant	|O
regimen	|O
consisted	|O
of	|O
cyclophosphamide	|O
(	|O
120	|O
mg	|O
/	|O
kg	|O
)	|O
and	|O
total	|O
body	|O
irradiation	|O
.	|O

The	|O
site	|O
-	|O
directed	|O
mutation	|O
of	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
motif	|O
in	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
/	|O
CAT	|B-PROTEIN
plasmid	|O
resulted	|O
in	|O
the	|O
complete	|O
abrogation	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
promoter	|O
activity	|O
in	|O
these	|O
cells	|O
.	|O

Curiously	|O
,	|O
testololactone	|O
was	|O
earlier	|O
and	|O
more	|O
widely	|O
used	|O
than	|O
aminoglutethimide	|O
in	|O
treating	|O
advanced	|O
breast	|O
carcinoma	|O
.	|O

Use	|O
of	|O
the	|O
vena	|O
cava	|O
to	|O
extend	|O
the	|O
right	|O
renal	|O
vein	|O
for	|O
cadaver	|O
transplantation	|O
is	|O
controversial	|O
.	|O

Enhanced	|O
hepatic	|O
portal	|O
blood	|O
flow	|O
induced	|O
by	|O
prostaglandin	|O
E1	|O
following	|O
liver	|O
transplantation	|O
in	|O
pigs	|O
.	|O

One	|O
gene	|O
appears	|O
ubiquitously	|O
expressed	|O
while	|O
the	|O
other	|O
is	|O
prominently	|O
expressed	|O
in	|O
muscle	|O
.	|O

For	|O
HeLa	|O
,	|O
293	|O
,	|O
U937	|O
,	|O
and	|O
A549	|O
cells	|O
,	|O
participation	|O
of	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
DP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
cyclin	|B-PROTEIN
A	|I-PROTEIN
,	|O
and	|O
RB	|B-PROTEIN
was	|O
involved	|O
in	|O
formation	|O
of	|O
some	|O
complexes	|O
only	|O
,	|O
assuming	|O
participation	|O
of	|O
factors	|O
different	|O
from	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
DP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
others	|O
.	|O

E1A	|B-PROTEIN
autoactivation	|O
mediated	|O
by	|O
these	|O
sites	|O
was	|O
about	|O
twofold	|O
compared	|O
with	|O
a	|O
ninefold	|O
activation	|O
described	|O
for	|O
the	|O
complete	|O
E1A	|B-PROTEIN
promoter	|O
.	|O

Cestode	|O
invasion	|O
in	|O
irradiated	|O
host	|O
organism	|O
increases	|O
the	|O
negative	|O
effect	|O
of	|O
ionizing	|O
radiation	|O
on	|O
the	|O
hamster	|O
immune	|O
system	|O
.	|O

During	|O
heat	|O
exposure	|O
,	|O
chicks	|O
that	|O
had	|O
been	|O
subjected	|O
to	|O
early	|O
60%	|O
restriction	|O
with	|O
non	|O
-	|O
metyrapone	|O
-	|O
treated	|O
food	|O
had	|O
lower	|O
H	|O
/	|O
L	|O
ratios	|O
and	|O
improved	|O
resistance	|O
to	|O
marble	|O
spleen	|O
disease	|O
infection	|O
.	|O

Analyses	|O
of	|O
additional	|O
tumors	|O
induced	|O
in	|O
mice	|O
from	|O
two	|O
reciprocal	|O
crosses	|O
,	|O
A	|O
/	|O
J	|O
x	|O
C3H	|O
/	|O
HeJ	|O
F1	|O
(	|O
hereafter	|O
called	|O
AC3F1	|O
)	|O
and	|O
C3H	|O
/	|O
HeJ	|O
x	|O
A	|O
/	|O
J	|O
F1	|O
(	|O
hereafter	|O
called	|O
C3AF1	|O
)	|O
,	|O
provided	|O
evidence	|O
for	|O
the	|O
inactivation	|O
of	|O
one	|O
allele	|O
of	|O
the	|O
putative	|O
chromosome	|O
4	|O
tumor	|O
suppressor	|O
gene	|O
by	|O
parental	|O
imprinting	|O
.	|O

ERV1	|B-PROTEIN
is	|O
involved	|O
in	|O
the	|O
cell	|O
-	|O
division	|O
cycle	|O
and	|O
the	|O
maintenance	|O
of	|O
mitochondrial	|O
genomes	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Lesion	|O
diameters	|O
of	|O
greater	|O
than	|O
20	|O
mm	|O
and	|O
the	|O
large	|O
sessile	|O
-	|O
type	|O
configurations	|O
were	|O
factors	|O
that	|O
were	|O
associated	|O
with	|O
incomplete	|O
removal	|O
.	|O

Routinely	|O
collected	|O
,	|O
processed	|O
and	|O
stored	|O
breast	|O
cancer	|O
tissue	|O
blocks	|O
recovered	|O
from	|O
the	|O
archives	|O
of	|O
the	|O
Pathology	|O
laboratory	|O
in	|O
Dar	|O
es	|O
Salaam	|O
after	|O
storage	|O
of	|O
up	|O
to	|O
3	|O
years	|O
were	|O
analysed	|O
by	|O
a	|O
flow	|O
cytometry	|O
for	|O
DNA	|O
ploidy	|O
and	|O
S	|O
-	|O
phase	|O
fraction	|O
.	|O

Cbf3	|B-PROTEIN
contains	|O
three	|O
proteins	|O
,	|O
Cbf3a	|B-PROTEIN
,	|O
Cbf3b	|B-PROTEIN
and	|O
Cbf3c	|B-PROTEIN
.	|O

Such	|O
an	|O
interaction	|O
could	|O
be	|O
detected	|O
using	|O
a	|O
GST	|B-PROTEIN
-	|O
POU	|B-PROTEIN
fusion	|O
protein	|O
bound	|O
to	|O
glutathione	|O
-	|O
agarose	|O
beads	|O
.	|O

These	|O
mutations	|O
are	|O
localized	|O
in	|O
the	|O
same	|O
region	|O
where	|O
the	|O
HSV	|O
transactivator	|O
VP16	|B-PROTEIN
binds	|O
,	|O
but	|O
did	|O
not	|O
coincide	|O
with	|O
the	|O
VP16	|B-PROTEIN
contacts	|O
.	|O

In	|O
general	|O
,	|O
the	|O
filtration	|O
rate	|O
in	|O
relevant	|O
areas	|O
appears	|O
to	|O
be	|O
an	|O
integrative	|O
and	|O
easily	|O
determined	|O
parameter	|O
,	|O
reflecting	|O
hormonal	|O
and	|O
neurogenic	|O
vascular	|O
as	|O
well	|O
as	|O
local	|O
interstitial	|O
control	|O
of	|O
the	|O
Starling	|O
forces	|O
.	|O

Notably	|O
,	|O
these	|O
residues	|O
are	|O
located	|O
in	|O
different	|O
domains	|O
.	|O

However	|O
,	|O
rapamycin	|O
inhibited	|O
proliferation	|O
of	|O
Ba	|O
/	|O
F3	|O
-	|O
EpoRgp55	|O
but	|O
not	|O
of	|O
MEL	|O
cells	|O
despite	|O
inhibition	|O
of	|O
p70	|B-PROTEIN
S6	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
in	|O
both	|O
cells	|O
.	|O

Intraventricular	|O
injection	|O
of	|O
(	|O
2S	|O
,	|O
1'	|O
R	|O
,	|O
2'	|O
R	|O
,	|O
3'	|O
R	|O
)	|O
-	|O
2	|O
-	|O
(	|O
2,3	|O
-	|O
dicarboxycyclopropyl	|O
)	|O
glycine	|O
(	|O
DCG	|O
-	|O
IV	|O
)	|O
,	|O
a	|O
potent	|O
agonist	|O
for	|O
metabotropic	|O
glutamate	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
to	|O
rats	|O
retarded	|O
dose	|O
-	|O
dependently	|O
the	|O
recovery	|O
from	|O
halothane	|O
anesthesia	|O
at	|O
a	|O
dose	|O
range	|O
from	|O
30	|O
to	|O
300	|O
pmol	|O
/	|O
rat	|O
.	|O

The	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
(	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
/	|O
forkhead	|B-PROTEIN
(	|O
fkh	|B-PROTEIN
)	|O
proteins	|O
consist	|O
of	|O
an	|O
extensive	|O
family	|O
of	|O
tissue	|O
-	|O
specific	|O
and	|O
developmental	|O
gene	|O
regulators	|O
which	|O
share	|O
homology	|O
within	|O
the	|O
winged	|O
helix	|O
DNA	|O
binding	|O
motif	|O
.	|O

Homozygous	|O
null	|O
embryos	|O
also	|O
displayed	|O
abnormalities	|O
in	|O
heart	|O
development	|O
,	|O
consistent	|O
with	|O
the	|O
conclusion	|O
that	|O
Tek	|B-PROTEIN
is	|O
necessary	|O
for	|O
endocardial	|O
/	|O
myocardial	|O
interactions	|O
during	|O
development	|O
.	|O

Interestingly	|O
,	|O
dTFIIA	|B-PROTEIN
-	|I-PROTEIN
L	|I-PROTEIN
/	|I-PROTEIN
S	|I-PROTEIN
is	|O
also	|O
able	|O
to	|O
significantly	|O
enhance	|O
transcriptional	|O
activation	|O
by	|O
upstream	|O
transcription	|O
factors	|O
including	|O
Sp1	|B-PROTEIN
,	|O
VP16	|B-PROTEIN
,	|O
and	|O
NTF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

A	|O
strong	|O
trithorax	|B-PROTEIN
binding	|O
site	|O
was	|O
found	|O
at	|O
the	|O
cytological	|O
location	|O
of	|O
the	|O
fork	|B-PROTEIN
head	|I-PROTEIN
gene	|O
,	|O
a	|O
region	|O
-	|O
specific	|O
homeotic	|B-PROTEIN
gene	|I-PROTEIN
not	|O
located	|O
within	|O
a	|O
homeotic	|B-PROTEIN
complex	|I-PROTEIN
.	|O

In	|O
particular	|O
,	|O
changes	|O
in	|O
intracellular	|O
Ca2+	|O
have	|O
the	|O
potential	|O
to	|O
either	|O
inhibit	|O
or	|O
augment	|O
the	|O
ability	|O
of	|O
cAMP	|O
to	|O
stimulate	|O
transcription	|O
,	|O
depending	|O
on	|O
the	|O
presence	|O
of	|O
specific	|O
forms	|O
of	|O
Ca2+	|B-PROTEIN
/	|I-PROTEIN
calmodulin	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

Antibodies	|O
directed	|O
against	|O
the	|O
SNM1	|B-PROTEIN
protein	|O
immunoprecipitated	|O
RNase	|O
MRP	|B-PROTEIN
RNA	|O
from	|O
whole	|O
-	|O
cell	|O
extracts	|O
without	|O
precipitating	|O
the	|O
structurally	|O
and	|O
functionally	|O
related	|O
RNase	|B-PROTEIN
P	|I-PROTEIN
RNA	|O
.	|O

C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|I-PROTEIN
also	|O
activates	|O
the	|O
promoter	|O
of	|O
the	|O
rat	|O
class	|O
-	|O
I	|O
ADH	|B-PROTEIN
gene	|O
in	|O
a	|O
sequence	|O
-	|O
specific	|O
manner	|O
[	|O
Potter	|O
et	|O
al.	|O
,	|O
Arch	|O
.	|O

C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|I-PROTEIN
also	|O
activates	|O
the	|O
promoter	|O
of	|O
the	|O
rat	|O
class	|O
-	|O
I	|O
ADH	|B-PROTEIN
gene	|O
in	|O
a	|O
sequence	|O
-	|O
specific	|O
manner	|O
[	|O
Potter	|O
et	|O
al.	|O
,	|O
Arch	|O
.	|O

Our	|O
results	|O
show	|O
that	|O
the	|O
ORF	|O
of	|O
hAMPK	|B-PROTEIN
encodes	|O
552	|O
amino	|O
acids	|O
(	|O
aa	|O
)	|O
(	|O
62.250	|O
kDa	|O
)	|O
and	|O
is	|O
highly	|O
conserved	|O
with	|O
rAMPK	|B-PROTEIN
with	|O
identities	|O
of	|O
97.3	|O
and	|O
90%	|O
at	|O
the	|O
aa	|O
and	|O
nt	|O
levels	|O
,	|O
respectively	|O
.	|O

In	|O
human	|O
brain	|O
,	|O
contactin	|B-PROTEIN
was	|O
first	|O
identified	|O
by	|O
amino	|O
terminal	|O
and	|O
peptide	|O
sequencing	|O
of	|O
the	|O
lentil	|O
-	|O
lectin	|O
-	|O
binding	|O
glycoprotein	|O
Gp135	|B-PROTEIN
.	|O

The	|O
centromeric	|O
YAC	|O
contig	|O
,	|O
which	|O
consists	|O
of	|O
23	|O
overlapping	|O
YACs	|O
and	|O
orders	|O
19	|O
sequence	|O
-	|O
tagged	|O
sites	|O
(	|O
STSs	|O
)	|O
,	|O
covers	|O
a	|O
minimum	|O
of	|O
2.2	|O
Mb	|O
and	|O
spans	|O
the	|O
Ewing	|O
sarcoma	|O
breakpoint	|O
.	|O
c	|B-PROTEIN
-	|I-PROTEIN
ets	|I-PROTEIN
1	|I-PROTEIN
and	|O
Fli	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
two	|O
members	|O
of	|O
the	|O
ets	|B-PROTEIN
family	|O
,	|O
have	|O
been	|O
linked	|O
within	|O
400	|O
kb	|O
of	|O
intervening	|O
DNA	|O
within	|O
this	|O
contig	|O
,	|O
which	|O
also	|O
comprises	|O
a	|O
polymorphic	|O
microsatellite	|O
,	|O
D11S912	|B-PROTEIN
(	|O
CA	|O
)	|O
n	|O
,	|O
which	|O
we	|O
have	|O
localized	|O
within	|O
the	|O
Fli	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
.	|O

A	|O
cDNA	|O
for	|O
a	|O
newly	|O
discovered	|O
pseudogene	|O
,	|O
closely	|O
related	|O
to	|O
the	|O
mouse	|O
mast	|O
cell	|O
chymases	|B-PROTEIN
was	|O
isolated	|O
by	|O
polymerase	|O
chain	|O
reaction	|O
amplification	|O
from	|O
a	|O
mouse	|O
connective	|O
tissue	|O
-	|O
like	|O
mast	|O
cell	|O
line	|O
.	|O

IFI16	|B-PROTEIN
consists	|O
of	|O
ten	|O
exons	|O
and	|O
nine	|O
intervening	|O
introns	|O
spanning	|O
at	|O
least	|O
28	|O
kilobases	|O
(	|O
kb	|O
)	|O
of	|O
DNA	|O
.	|O

Courses	|O
were	|O
repeated	|O
every	|O
four	|O
weeks	|O
.	|O

Peter	|O
Elfer	|O
explores	|O
the	|O
implications	|O
of	|O
the	|O
ruling	|O
.	|O

Other	|O
adverse	|O
events	|O
with	|O
incidences	|O
significantly	|O
higher	|O
than	|O
with	|O
placebo	|O
were	|O
dizziness	|O
,	|O
constipation	|O
,	|O
sweating	|O
,	|O
nervousness	|O
,	|O
and	|O
abnormal	|O
ejaculation	|O
.	|O

Homology	|O
was	|O
also	|O
detected	|O
between	|O
the	|O
putative	|O
transit	|O
peptide	|O
sequence	|O
of	|O
cysteine	|B-PROTEIN
synthase	|I-PROTEIN
C	|I-PROTEIN
and	|O
other	|O
mitochondrion	|O
-	|O
targeting	|O
leader	|O
sequences	|O
.	|O

Furthermore	|O
,	|O
our	|O
data	|O
also	|O
show	|O
that	|O
,	|O
in	|O
addition	|O
to	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
another	|O
HF	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
-	|O
related	|O
factor	|O
may	|O
be	|O
recognized	|O
by	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
MHC	|I-PROTEIN
gene	|O
EM	|O
element	|O
.	|O

Rat	|O
kidney	|O
carboxylesterase	|B-PROTEIN
.	|O

Recombinant	|O
I	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
inhibited	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
motif	|O
binding	|O
by	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B1	|I-PROTEIN
,	|O
RelA	|B-PROTEIN
,	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
as	|O
indicated	|O
by	|O
studies	|O
using	|O
UV	|O
radiation	|O
-	|O
induced	|O
covalent	|O
cross	|O
-	|O
linking	|O
to	|O
a	|O
bromodeoxyuridine	|O
-	|O
substituted	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
oligonucleotide	|O
.	|O

The	|O
physical	|O
and	|O
chemical	|O
stability	|O
of	|O
a	|O
combination	|O
of	|O
drugs	|O
commonly	|O
administered	|O
into	|O
the	|O
epidural	|O
or	|O
intrathecal	|O
space	|O
for	|O
the	|O
treatment	|O
of	|O
chronic	|O
pain	|O
was	|O
investigated	|O
.	|O

Therefore	|O
,	|O
mechanisms	|O
that	|O
control	|O
activation	|O
of	|O
the	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
cascade	|O
temporally	|O
and	|O
spatially	|O
may	|O
be	|O
important	|O
for	|O
specification	|O
of	|O
cellular	|O
responses	|O
.	|O

A	|O
candidate	|O
gene	|O
for	|O
Bcg	|B-PROTEIN
,	|O
designated	|O
natural	|B-PROTEIN
resistance	|I-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
macrophage	|I-PROTEIN
protein	|I-PROTEIN
(	|O
Nramp	|B-PROTEIN
)	|O
,	|O
has	|O
been	|O
isolated	|O
and	|O
shown	|O
to	|O
encode	|O
a	|O
novel	|O
macrophage	|O
-	|O
specific	|O
membrane	|O
protein	|O
,	|O
which	|O
is	|O
altered	|O
in	|O
susceptible	|O
animals	|O
.	|O

This	|O
motif	|O
is	|O
similar	|O
to	|O
but	|O
distinct	|O
from	|O
the	|O
LIM	|B-PROTEIN
domain	|O
and	|O
the	|O
RING	|B-PROTEIN
finger	|I-PROTEIN
family	|I-PROTEIN
,	|O
and	|O
is	|O
reminiscent	|O
of	|O
known	|O
metal	|O
-	|O
binding	|O
regions	|O
.	|O

The	|O
P131	|O
ORF	|O
is	|O
followed	|O
in	|O
-	|O
frame	|O
by	|O
a	|O
second	|O
ORF	|O
which	|O
is	|O
probably	|O
expressed	|O
by	|O
partial	|O
readthrough	|O
of	|O
the	|O
UGA	|O
termination	|O
codon	|O
of	|O
the	|O
P131	|O
ORF	|O
to	|O
produce	|O
a	|O
polypeptide	|O
of	|O
M	|O
(	|O
r	|O
)	|O
191044	|O
(	|O
P191	|O
)	|O
.	|O

One	|O
hundred	|O
fifty	|O
patients	|O
were	|O
reviewed	|O
at	|O
1	|O
year	|O
after	|O
arthroplasty	|O
.	|O

Elementary	|O
visual	|O
hallucinations	|O
in	|O
migraine	|O
and	|O
epilepsy	|O
.	|O

The	|O
influence	|O
of	|O
patient	|O
-	|O
related	|O
factors	|O
on	|O
inter	|O
-	|O
observer	|O
variability	|O
in	|O
the	|O
evaluation	|O
of	|O
neurological	|O
signs	|O
was	|O
investigated	|O
.	|O

Segments	|O
with	|O
more	|O
reduced	|O
BMIPP	|O
uptake	|O
than	|O
MIBI	|O
uptake	|O
(	|O
mismatching	|O
)	|O
showed	|O
either	|O
normal	|O
wall	|O
motion	|O
or	|O
demonstrated	|O
inotropic	|O
reserve	|O
during	|O
dobutamine	|O
stimulation	|O
.	|O

The	|O
defined	|O
length	|O
of	|O
the	|O
mRNA	|O
,	|O
1,838	|O
nucleotides	|O
,	|O
was	|O
in	|O
agreement	|O
with	|O
that	|O
of	|O
a	|O
1.9	|O
-	|O
kb	|O
RNA	|O
expressed	|O
throughout	|O
the	|O
replication	|O
cycle	|O
,	|O
starting	|O
at	|O
the	|O
early	|O
stages	|O
of	|O
infection	|O
.	|O

Infect	|O
.	|O

Transient	|O
transfections	|O
of	|O
a	|O
construct	|O
expressing	|O
the	|O
RNA	|O
transcript	|O
defined	|O
by	|O
clone	|O
B1.1	|O
into	|O
D17	|O
cells	|O
led	|O
to	|O
the	|O
expression	|O
of	|O
an	|O
Env	|B-PROTEIN
/	|O
Mlvi	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
fusion	|O
protein	|O
with	|O
an	|O
apparent	|O
molecular	|O
mass	|O
of	|O
33	|O
kDa	|O
.	|O

Roizman	|O
,	|O
J.	|O

Articles	|O
addressing	|O
valvular	|O
heart	|O
disease	|O
or	|O
heart	|O
failure	|O
secondary	|O
to	|O
acute	|O
myocardial	|O
infarction	|O
or	|O
Chagas	|O
'	|O
disease	|O
were	|O
excluded	|O
.	|O

The	|O
present	|O
data	|O
also	|O
indicate	|O
that	|O
patients	|O
with	|O
TGBM	|O
nephropathy	|O
often	|O
have	|O
concomitant	|O
IgA	|B-PROTEIN
nephropathy	|O
and	|O
mesangial	|O
proliferative	|O
glomerulonephritis	|O
.	|O

All	|O
nuclear	|O
receptors	|O
have	|O
several	|O
well	|O
-	|O
characterized	|O
structural	|O
domains	|O
,	|O
including	|O
a	|O
conserved	|O
DNA	|O
-	|O
binding	|O
domain	|O
,	|O
and	|O
a	|O
ligand	|O
binding	|O
domain	|O
at	|O
the	|O
carboxyl	|O
terminus	|O
of	|O
the	|O
receptor	|O
.	|O

The	|O
sample	|O
includes	|O
all	|O
the	|O
HIV	|O
-	|O
infected	|O
-	|O
patients	|O
continuously	|O
referred	|O
to	|O
the	|O
Outpatient	|O
Service	|O
of	|O
the	|O
Infectious	|O
Diseases	|O
dept	|O
.	|O
of	|O
Bologna	|O
's	|O
"	|O
Ospedale	|O
Maggiore	|O
"	|O
General	|O
Hospital	|O
during	|O
some	|O
five	|O
days	|O
(	|O
19-23	|O
rd	|O
,	|O
July	|O
1993	|O
)	|O
.	|O

Using	|O
in	|O
organello	|O
footprint	|O
analysis	|O
,	|O
we	|O
demonstrate	|O
that	|O
within	|O
human	|O
placental	|O
mitochondria	|O
there	|O
is	|O
a	|O
high	|O
level	|O
of	|O
protein	|O
-	|O
DNA	|O
binding	|O
at	|O
regularly	|O
phased	|O
intervals	|O
throughout	|O
a	|O
500	|O
-	|O
bp	|O
region	|O
encompassing	|O
the	|O
D	|O
-	|O
loop	|O
DNA	|O
origins	|O
and	|O
two	|O
promoter	|O
regions	|O
.	|O

The	|O
Nur77	|B-PROTEIN
protein	|O
can	|O
act	|O
as	|O
a	|O
potent	|O
transcription	|O
activator	|O
and	|O
may	|O
function	|O
to	|O
regulate	|O
the	|O
expression	|O
of	|O
downstream	|O
genes	|O
in	|O
response	|O
to	|O
extracellular	|O
stimuli	|O
.	|O

One	|O
class	|O
of	|O
plasmids	|O
contained	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
His	|I-PROTEIN
)	|I-PROTEIN
genes	|O
and	|O
conferred	|O
efficient	|O
suppression	|O
only	|O
when	|O
cells	|O
were	|O
starved	|O
for	|O
histidine	|O
;	|O
these	|O
plasmids	|O
suppressed	|O
a	|O
gcn2	|B-PROTEIN
deletion	|O
much	|O
less	|O
efficiently	|O
than	|O
they	|O
suppressed	|O
gcn2	|B-PROTEIN
-	|I-PROTEIN
507	|I-PROTEIN
.	|O

Thus	|O
,	|O
the	|O
presence	|O
of	|O
the	|O
Cln2	|B-PROTEIN
PEST	|O
domain	|O
was	|O
sufficient	|O
to	|O
destabilize	|O
a	|O
heterologous	|O
protein	|O
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
with	|O
each	|O
of	|O
these	|O
sequences	|O
demonstrated	|O
complexes	|O
with	|O
mobilities	|O
identical	|O
to	|O
those	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
site	|O
from	|O
the	|O
kappa	|B-PROTEIN
light	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
gene	|O
.	|O

Although	|O
a	|O
carboxyl	|O
-	|O
terminal	|O
HSF	|B-PROTEIN
transcriptional	|O
activation	|O
domain	|O
is	|O
critical	|O
for	|O
the	|O
activation	|O
of	|O
CUP1	|B-PROTEIN
transcription	|O
in	|O
response	|O
to	|O
both	|O
heat	|O
shock	|O
stress	|O
and	|O
glucose	|O
starvation	|O
,	|O
this	|O
region	|O
is	|O
dispensable	|O
for	|O
transient	|O
heat	|O
shock	|O
activation	|O
of	|O
at	|O
least	|O
two	|O
genes	|O
encoding	|O
members	|O
of	|O
the	|O
S.	|O
cerevisiae	|O
hsp70	|B-PROTEIN
family	|O
.	|O

We	|O
have	|O
recently	|O
detected	|O
high	|O
levels	|O
of	|O
CKB	|B-PROTEIN
mRNA	|O
in	|O
HeLa	|O
cells	|O
and	|O
,	|O
in	|O
this	|O
study	|O
,	|O
have	|O
tested	|O
whether	|O
this	|O
may	|O
be	|O
due	|O
to	|O
the	|O
extremely	|O
low	|O
amounts	|O
of	|O
p53	|B-PROTEIN
protein	|O
present	|O
in	|O
HeLa	|O
cells	|O
.	|O

Distal	|O
lower	|O
motor	|O
neuron	|O
syndrome	|O
with	|O
high	|O
-	|O
titer	|O
serum	|O
IgM	|B-PROTEIN
anti	|I-PROTEIN
-	|I-PROTEIN
GM1	|I-PROTEIN
antibodies	|O
:	|O
improvement	|O
following	|O
immunotherapy	|O
with	|O
monthly	|O
plasma	|O
exchange	|O
and	|O
intravenous	|O
cyclophosphamide	|O
.	|O

Regulators	|O
responsible	|O
for	|O
the	|O
pervasive	|O
,	|O
nonsex	|O
-	|O
specific	|O
alternative	|O
pre	|O
-	|O
mRNA	|O
splicing	|O
characteristic	|O
of	|O
metazoans	|O
are	|O
almost	|O
entirely	|O
unknown	|O
or	|O
uncertain	|O
.	|O

A	|O
normal	|O
systemic	|O
response	|O
was	|O
obtained	|O
after	|O
IF	|O
,	|O
indicating	|O
that	|O
rhG	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
retains	|O
activity	|O
in	|O
the	|O
solid	|O
state	|O
.	|O

A	|O
full	|O
-	|O
length	|O
cDNA	|O
clone	|O
isolated	|O
from	|O
a	|O
rat	|O
lung	|O
library	|O
was	|O
predicted	|O
to	|O
encode	|O
a	|O
55	|O
-	|O
kDa	|O
protein	|O
containing	|O
at	|O
its	|O
amino	|O
terminus	|O
a	|O
targeting	|O
domain	|O
that	|O
binds	|O
to	|O
the	|O
ANP	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
domain	|O
and	|O
containing	|O
at	|O
its	|O
carboxyl	|O
terminus	|O
a	|O
putative	|O
protein	|B-PROTEIN
-	|I-PROTEIN
serine	|I-PROTEIN
phosphatase	|I-PROTEIN
domain	|O
.	|O

A	|O
high	|O
-	|O
resolution	|O
restriction	|O
map	|O
of	|O
over	|O
200	|O
kb	|O
of	|O
contiguous	|O
DNA	|O
containing	|O
N	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
has	|O
been	|O
generated	|O
by	|O
subcloning	|O
YACs	|O
into	|O
cosmids	|O
.	|O

PAI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
levels	|O
increased	|O
significantly	|O
in	|O
patients	|O
who	|O
received	|O
iohexol	|O
but	|O
not	|O
in	|O
those	|O
who	|O
received	|O
ioxaglate	|O
.	|O

In	|O
the	|O
present	|O
article	|O
,	|O
the	|O
causes	|O
of	|O
death	|O
or	|O
ill	|O
-	|O
being	|O
as	|O
found	|O
in	|O
10	|O
consecutive	|O
carcinogenicity	|O
studies	|O
-	|O
-	|O
5	|O
studies	|O
with	|O
2400	|O
OFA	|O
(	|O
Sprague	|O
-	|O
Dawley	|O
-	|O
derived	|O
)	|O
and	|O
Wistar	|O
rats	|O
and	|O
5	|O
studies	|O
with	|O
2400	|O
OF1	|O
and	|O
NMRI	|O
mice	|O
-	|O
-	|O
were	|O
re	|O
-	|O
examined	|O
.	|O

Determination	|O
of	|O
potassium	|O
iodide	|O
in	|O
Polish	|O
edible	|O
salt	|O

The	|O
recovery	|O
value	|O
of	|O
systolic	|O
pressure	|O
was	|O
higher	|O
than	|O
diastolic	|O
pressure	|O
and	|O
pulse	|O
pressure	|O
increased	|O
.	|O

The	|O
importance	|O
of	|O
hepatitis	|O
C	|O
virus	|O
(	|O
HCV	|O
)	|O
infection	|O
as	|O
a	|O
cause	|O
of	|O
chronic	|O
liver	|O
disease	|O
has	|O
become	|O
clear	|O
with	|O
the	|O
introduction	|O
of	|O
serologic	|O
detection	|O
methods	|O
.	|O

Human	|O
adenovirus	|O
type	|O
41	|O
contains	|O
two	|O
fibers	|O
.	|O

Outflow	|O
obstruction	|O
of	|O
pancreatic	|O
juice	|O
,	|O
i.e.	|O
,	|O
"	|O
relative	|O
stenosis	|O
of	|O
the	|O
minor	|O
papilla	|O
,	|O
"	|O
was	|O
considered	|O
to	|O
be	|O
present	|O
in	|O
the	|O
patients	|O
with	|O
type	|O
II	|O
papilla	|O
,	|O
and	|O
,	|O
therefore	|O
,	|O
the	|O
patients	|O
with	|O
type	|O
II	|O
papilla	|O
might	|O
suffer	|O
from	|O
acute	|O
pancreatitis	|O
resulting	|O
from	|O
poor	|O
drainage	|O
of	|O
pancreatic	|O
juice	|O
and	|O
excessive	|O
pressure	|O
in	|O
the	|O
dorsal	|O
duct	|O
.	|O

Sequencing	|O
of	|O
the	|O
TP53	|B-PROTEIN
transcripts	|O
from	|O
exons	|O
2	|O
to	|O
10	|O
,	|O
however	|O
,	|O
did	|O
not	|O
reveal	|O
mutations	|O
of	|O
the	|O
remaining	|O
allele	|O
in	|O
any	|O
of	|O
these	|O
tumors	|O
.	|O

An	|O
unusual	|O
complication	|O
in	|O
an	|O
unsuitable	|O
patient	|O
.	|O

In	|O
the	|O
ISO	|O
group	|O
,	|O
at	|O
pre	|O
-	|O
DEX	|O
,	|O
CBF	|O
increased	|O
from	|O
86	|O
+	|O
/	|O
-	|O
8	|O
to	|O
166	|O
+	|O
/	|O
-	|O
19	|O
mL.m	|O
in	|O
-	|O
1.100	|O
g	|O
-	|O
1	|O
in	|O
response	|O
to	|O
hypercapnia	|O
(	|O
PCO2	|O
approximately	|O
90	|O
mmHg	|O
)	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

All	|O
other	|O
ejaculate	|O
parameters	|O
(	|O
density	|O
,	|O
motility	|O
,	|O
swelling	|O
test	|O
,	|O
penetration	|O
test	|O
)	|O
remained	|O
unchanged	|O
,	|O
and	|O
there	|O
was	|O
only	|O
one	|O
post	|O
-	|O
therapeutic	|O
pregnancy	|O
.	|O

KRN2391	|O
and	|O
cromakalim	|O
produced	|O
a	|O
dose	|O
-	|O
dependent	|O
increase	|O
in	|O
aortic	|O
and	|O
coronary	|O
blood	|O
flow	|O
.	|O

In	|O
H4IIE	|O
rat	|O
hepatoma	|O
cells	|O
,	|O
glucocorticoids	|O
,	|O
retinoic	|O
acid	|O
and	|O
cyclic	|O
AMP	|O
(	|O
cAMP	|O
)	|O
increase	|O
PEPCK	|B-PROTEIN
gene	|O
transcription	|O
whereas	|O
insulin	|B-PROTEIN
and	|O
phorbol	|O
esters	|O
have	|O
the	|O
opposite	|O
effect	|O
.	|O

Acta	|O
572	|O
,	|O
113-120	|O
]	|O
.	|O

Basal	|O
plasma	|O
AVP	|B-PROTEIN
levels	|O
and	|O
AVP	|B-PROTEIN
release	|O
after	|O
postural	|O
change	|O
were	|O
assessed	|O
,	|O
and	|O
plasma	|O
NPY	|B-PROTEIN
levels	|O
were	|O
measured	|O
in	|O
the	|O
same	|O
samples	|O
.	|O

A	|O
stretch	|O
of	|O
16	|O
nucleotides	|O
just	|O
upstream	|O
of	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4RE	|I-PROTEIN
contributed	|O
to	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
inducibility	|O
and	|O
formed	|O
nucleoprotein	|O
complexes	|O
with	|O
constitutive	|O
factors	|O
.	|O

Our	|O
previous	|O
study	|O
suggested	|O
that	|O
pertussis	|B-PROTEIN
toxin	|I-PROTEIN
(	|O
IAP	|B-PROTEIN
)	|O
-	|O
sensitive	|O
GTP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
s	|O
)	|O
(	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
)	|O
is	|O
involved	|O
in	|O
the	|O
process	|O
of	|O
differentiation	|O
by	|O
hormones	|O
/	|O
IBMX	|O
,	|O
accompanied	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
induction	|O
.	|O

ATX	|B-PROTEIN
,	|O
like	|O
PC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
was	|O
found	|O
to	|O
hydrolyze	|O
the	|O
type	|B-PROTEIN
I	|I-PROTEIN
phosphodiesterase	|I-PROTEIN
substrate	|O
p	|O
-	|O
nitrophenyl	|O
thymidine	|O
-	|O
5'	|O
-	|O
monophosphate	|O
.	|O

The	|O
effect	|O
of	|O
site	|O
-	|O
specific	|O
mutations	|O
in	|O
the	|O
mouse	|O
platelet	|O
-	|O
derived	|O
growth	|O
factor	|O
(	|B-PROTEIN
PDGF	|I-PROTEIN
)	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
on	|O
activation	|O
of	|O
the	|O
Na+	|B-PROTEIN
/	|I-PROTEIN
H+	|I-PROTEIN
exchanger	|I-PROTEIN
was	|O
examined	|O
in	|O
normal	|O
murine	|O
mammary	|O
gland	|O
epithelial	|O
(	|O
NMuMG	|O
)	|O
and	|O
Chinese	|O
hamster	|O
ovary	|O
(	|O
CHO	|O
)	|O
cells	|O
.	|O

Sequence	|O
analysis	|O
revealed	|O
:	|O
1	|O
)	|O
a	|O
kinase	|O
catalytic	|O
domain	|O
most	|O
characteristic	|O
of	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
kinases	|I-PROTEIN
but	|O
hybrid	|O
between	|O
members	|O
of	|O
the	|O
family	|O
of	|O
microtubule	|B-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
kinases	|I-PROTEIN
and	|O
the	|O
fibroblast	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
family	|O
;	|O
2	|O
)	|O
two	|O
putative	|O
alpha	|O
-	|O
helical	|O
leucine	|O
zipper	|O
motifs	|O
separated	|O
by	|O
a	|O
25	|O
-	|O
amino	|O
acid	|O
charged	|O
intermediate	|O
segment	|O
but	|O
lacking	|O
an	|O
NH2	|O
-	|O
terminal	|O
basic	|O
domain	|O
;	|O
and	|O
3	|O
)	|O
COOH	|O
-	|O
terminal	|O
and	|O
NH2	|O
-	|O
terminal	|O
proline	|O
-	|O
rich	|O
domains	|O
suggestive	|O
of	|O
src	|B-PROTEIN
homology	|I-PROTEIN
3	|I-PROTEIN
(	|O
SH3	|B-PROTEIN
)	|O
domain	|O
binding	|O
regions	|O
.	|O

Type	|O
2	|O
genomes	|O
containing	|O
this	|O
sequence	|O
presumably	|O
more	|O
closely	|O
reflect	|O
the	|O
structure	|O
of	|O
the	|O
infectious	|O
,	|O
replication	|O
-	|O
competent	|O
retrovirus	|O
ancestors	|O
of	|O
the	|O
HERV	|O
-	|O
K	|O
family	|O
than	|O
do	|O
type	|O
1	|O
genomes	|O
that	|O
lack	|O
the	|O
sequence	|O
.	|O

However	|O
,	|O
when	|O
domain	|O
I	|O
and	|O
domain	|O
II	|O
were	|O
linked	|O
on	|O
the	|O
same	|O
plasmid	|O
,	|O
high	|O
levels	|O
of	|O
replication	|O
were	|O
observed	|O
.	|O

Point	|O
mutations	|O
that	|O
suppressed	|O
the	|O
in	|O
vitro	|O
binding	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
to	|O
the	|O
internal	|O
palindromic	|O
arm	|O
reduced	|O
the	|O
activity	|O
of	|O
the	|O
resident	|O
P4	|O
promoter	|O
,	|O
while	|O
those	|O
preventing	|O
complex	|O
formation	|O
with	|O
USF	|B-PROTEIN
did	|O
not	|O
,	|O
as	|O
determined	|O
by	|O
transient	|O
expression	|O
assays	|O
using	|O
the	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
.	|O

Surprisingly	|O
,	|O
Northern	|O
(	|O
RNA	|O
)	|O
blot	|O
analysis	|O
and	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
-	|O
PCRs	|O
performed	|O
after	|O
transfection	|O
of	|O
COS	|O
-	|O
7	|O
or	|O
HeLa	|O
cells	|O
with	|O
these	|O
viral	|O
RNAs	|O
revealed	|O
that	|O
Y88S	|B-PROTEIN
and	|O
Y88L	|B-PROTEIN
RNAs	|I-PROTEIN
replicated	|O
at	|O
only	|O
very	|O
low	|O
levels	|O
.	|O

Surprisingly	|O
,	|O
nuclear	|O
forms	|O
of	|O
IE110	|B-PROTEIN
were	|O
found	|O
to	|O
move	|O
a	|O
cytoplasmic	|O
form	|O
of	|O
IE175	|B-PROTEIN
into	|O
nuclear	|O
punctate	|O
structures	|O
,	|O
and	|O
a	|O
cytoplasmic	|O
form	|O
of	|O
IE110	|B-PROTEIN
was	|O
able	|O
to	|O
retain	|O
nuclear	|O
forms	|O
of	|O
IE175	|B-PROTEIN
in	|O
cytoplasmic	|O
punctate	|O
structures	|O
.	|O

Transcription	|O
of	|O
the	|O
gene	|O
for	|O
ivanolysin	|B-PROTEIN
O	|I-PROTEIN
and	|O
expression	|O
of	|O
other	|O
genes	|O
of	|O
the	|O
virulence	|B-PROTEIN
gene	|I-PROTEIN
cluster	|O
in	|O
L.	|O
ivanovii	|O
were	|O
dependent	|O
on	|O
PrfA	|B-PROTEIN
.	|O

Moreover	|O
,	|O
by	|O
complementation	|O
of	|O
the	|O
WA	|O
fyuA	|B-PROTEIN
mutant	|O
by	|O
the	|O
cloned	|O
fyuA	|B-PROTEIN
gene	|O
,	|O
yersiniabactin	|O
uptake	|O
and	|O
mouse	|O
virulence	|O
were	|O
restored	|O
.	|O

The	|O
ICBF	|O
in	|O
the	|O
ischaemic	|O
cortex	|O
revealed	|O
a	|O
graded	|O
reduction	|O
from	|O
the	|O
ischaemic	|O
centre	|O
to	|O
the	|O
surrounding	|O
tissues	|O
.	|O

The	|O
treatment	|O
of	|O
hydronephrosis	|O
in	|O
children	|O

The	|O
inflation	|O
hub	|O
of	|O
the	|O
probe	|O
is	|O
recreated	|O
by	|O
modifying	|O
a	|O
standard	|O
USCI	|O
Tuohy	|O
-	|O
Borst	|O
Y	|O
adaptor	|O
and	|O
attaching	|O
this	|O
to	|O
the	|O
transected	|O
probe	|O
hypotube	|O
.	|O

The	|O
other	|O
element	|O
bound	|O
RBP	|B-PROTEIN
-	|I-PROTEIN
J	|I-PROTEIN
kappa	|I-PROTEIN
with	|O
low	|O
affinity	|O
.	|O

The	|O
basal	|O
promoter	|O
strength	|O
of	|O
constructs	|O
that	|O
contained	|O
deletions	|O
in	|O
the	|O
U5	|B-PROTEIN
region	|O
of	|O
the	|O
LTR	|O
was	|O
analyzed	|O
by	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
assays	|O
following	|O
transfection	|O
of	|O
HeLa	|O
cells	|O
or	|O
Jurkat	|O
T	|O
-	|O
cells	|O
in	|O
the	|O
presence	|O
or	|O
absence	|O
of	|O
viral	|O
transactivator	|O
tax	|B-PROTEIN
protein	|O
.	|O

In	|O
reviewing	|O
a	|O
number	|O
of	|O
the	|O
most	|O
intensely	|O
studied	|O
environmentally	|O
inducible	|O
promoters	|O
it	|O
becomes	|O
clear	|O
that	|O
the	|O
presence	|O
of	|O
two	|O
cis	|O
-	|O
acting	|O
elements	|O
are	|O
critical	|O
for	|O
promoter	|O
activity	|O
,	|O
one	|O
of	|O
which	|O
is	|O
the	|O
G	|O
-	|O
box	|O
(	|O
CCACGTGG	|O
)	|O
.	|O

Recently	|O
,	|O
a	|O
protein	|O
designated	|O
GF14	|B-PROTEIN
has	|O
been	|O
isolated	|O
that	|O
is	|O
associated	|O
with	|O
the	|O
GBF	|B-PROTEIN
protein	|O
complex	|O
.	|O

New	|O
diagnostic	|O
strategies	|O
for	|O
lupus	|O
anticoagulants	|O
and	|O
antiphospholipid	|O
antibodies	|O
.	|O

Moreover	|O
,	|O
the	|O
ability	|O
to	|O
selectivity	|O
arrest	|O
elongation	|O
by	|O
polIII	|B-PROTEIN
at	|O
defined	|O
positions	|O
within	|O
the	|O
tRNA	|O
gene	|O
transcription	|O
unit	|O
has	|O
permitted	|O
the	|O
identification	|O
of	|O
discrete	|O
functional	|O
properties	|O
of	|O
paused	|O
mammalian	|O
polIII	|B-PROTEIN
ternary	|O
complexes	|O
.	|O

Propafenone	|O
is	|O
well	|O
tolerated	|O
in	|O
the	|O
majority	|O
of	|O
young	|O
patients	|O
.	|O

Mutational	|O
analysis	|O
of	|O
yeast	|O
CEG1	|B-PROTEIN
demonstrated	|O
that	|O
four	|O
of	|O
the	|O
five	|O
conserved	|O
motifs	|O
are	|O
essential	|O
for	|O
capping	|B-PROTEIN
enzyme	|I-PROTEIN
function	|O
in	|O
vivo	|O
.	|O

2	|O
patients	|O
(	|O
11%	|O
)	|O
had	|O
significant	|O
morbidity	|O
502	|O
and	|O
529	|O
days	|O
respectively	|O
after	|O
transplantation	|O
.	|O

A	|O
recent	|O
index	|O
(	|O
Fluorosis	|O
Risk	|O
Index	|O
)	|O
developed	|O
by	|O
Pendrys	|O
(	|O
1990	|O
)	|O
is	|O
also	|O
included	|O
in	|O
this	|O
review	|O
.	|O

Alternative	|O
splicing	|O
of	|O
the	|O
cytoplasmic	|O
tail	|O
appears	|O
to	|O
generate	|O
multiple	|O
PECAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
isoforms	|O
that	|O
may	|O
regulate	|O
phosphorylation	|O
,	|O
cytoskeletal	|O
association	|O
,	|O
and	|O
affinity	|O
modulation	|O
of	|O
the	|O
mature	|O
protein	|O
.	|O

Transfer	|O
also	|O
correlated	|O
inversely	|O
with	|O
gastric	|O
juice	|O
pH	|O
(	|O
r	|O
=	|O
-	|O
0.619	|O
,	|O
P	|O
<	|O
0.02	|O
)	|O
.	|O

This	|O
technique	|O
has	|O
a	|O
sensitivity	|O
and	|O
a	|O
specificity	|O
of	|O
almost	|O
100%	|O
,	|O
and	|O
is	|O
currently	|O
the	|O
best	|O
way	|O
to	|O
diagnose	|O
nodal	|O
involvement	|O
,	|O
apart	|O
from	|O
laparotomy	|O
.	|O

The	|O
data	|O
show	|O
conclusively	|O
that	|O
phosphorylation	|O
of	|O
His	|O
-	|O
304	|O
is	|O
not	|O
essential	|O
for	|O
any	|O
of	|O
the	|O
known	|O
functions	|O
of	|O
A.	|O
vinelandii	|O
NifL	|B-PROTEIN
.	|O

The	|O
role	|O
of	|O
HIV	|O
tat	|B-PROTEIN
,	|O
which	|O
is	|O
the	|O
main	|O
enhancing	|O
factor	|O
for	|O
viral	|B-PROTEIN
LTR	|I-PROTEIN
,	|O
in	|O
the	|O
regulation	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
transcription	|O
has	|O
been	|O
studied	|O
following	|O
transient	|O
expression	|O
of	|O
the	|O
tat	|B-PROTEIN
gene	|O
in	|O
phorbol	|O
ester	|O
and	|O
calcium	|O
ionophore	|O
-	|O
activated	|O
Jurkat	|O
cells	|O
transfected	|O
with	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
promoter	|O
-	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
constructs	|O
.	|O

Splice	|O
variations	|O
in	|O
genes	|O
coding	|O
for	|O
the	|O
transmembrane	|O
FGF	|B-PROTEIN
receptor	|I-PROTEIN
(	|I-PROTEIN
FGFR	|I-PROTEIN
)	|I-PROTEIN
result	|O
in	|O
isoforms	|O
that	|O
vary	|O
in	|O
the	|O
ectodomain	|O
,	|O
intracellular	|O
juxtamembrane	|O
domain	|O
,	|O
and	|O
the	|O
intracellular	|O
kinase	|O
domain	|O
.	|O

If	|O
this	|O
is	|O
present	|O
,	|O
such	|O
patients	|O
should	|O
be	|O
closely	|O
monitored	|O
,	|O
and	|O
any	|O
atypical	|O
lesions	|O
biopsied	|O
.	|O

Cumulated	|O
maximum	|O
lod	|O
scores	|O
between	|O
FRDA	|B-PROTEIN
and	|O
D9S5	|B-PROTEIN
and	|O
between	|O
FRDA	|B-PROTEIN
and	|O
D9S15	|B-PROTEIN
are	|O
above	|O
36	|O
and	|O
61	|O
,	|O
respectively	|O
,	|O
at	|O
a	|O
recombination	|O
fraction	|O
of	|O
0	|O
,	|O
indicating	|O
that	|O
recombination	|O
events	|O
needed	|O
to	|O
orient	|O
the	|O
search	|O
of	|O
the	|O
gene	|O
are	|O
very	|O
difficult	|O
to	|O
identify	|O
and	|O
ascertain	|O
.	|O

A	|O
receptor	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
OsPK10	|B-PROTEIN
,	|O
has	|O
been	|O
cloned	|O
from	|O
rice	|O
(	|O
Oryza	|O
sativa	|O
)	|O
.	|O

A	|O
sequence	|O
representing	|O
about	|O
50%	|O
of	|O
the	|O
expected	|O
complete	|O
sequence	|O
was	|O
obtained	|O
by	|O
translation	|O
of	|O
the	|O
two	|O
open	|O
reading	|O
frames	|O
present	|O
on	|O
a	|O
1.6	|O
kb	|O
DNA	|O
genomic	|O
fragment	|O
.	|O

Goodpasture	|O
's	|O
-	|O
like	|O
syndrome	|O
and	|O
effect	|O
of	|O
extracorporeal	|O
membrane	|O
oxygenator	|O
support	|O
.	|O

A	|O
cDNA	|O
clone	|O
pCZ1	|O
,	|O
with	|O
a	|O
1.1	|O
kb	|O
insert	|O
,	|O
was	|O
isolated	|O
from	|O
a	|O
NaCl	|O
-	|O
adapted	|O
tobacco	|O
cell	|O
cDNA	|O
library	|O
that	|O
encodes	|O
an	|O
apparently	|O
full	|O
-	|O
length	|O
29	|O
kDa	|O
protein	|O
(	|O
251	|O
amino	|O
acids	|O
)	|O
with	|O
a	|O
calculated	|O
pI	|O
of	|O
5.7	|O
.	|O

METHODS	|O
-	|O
-	|O
16	|O
volunteered	|O
for	|O
spirometry	|O
with	|O
methacholine	|O
provocation	|O
test	|O
including	|O
a	|O
test	|O
for	|O
small	|O
airways	|O
function	|O
by	|O
volume	|O
of	|O
trapped	|O
gas	|O
(	|O
VTG	|O
)	|O
.	|O

Relationship	|O
of	|O
CDK	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
kinase	|I-PROTEIN
and	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
CTD	|O
kinase	|O
TFIIH	|B-PROTEIN
/	|O
TFIIK	|B-PROTEIN
.	|O

The	|O
git1	|B-PROTEIN
,	|O
git3	|B-PROTEIN
,	|O
git5	|B-PROTEIN
,	|O
git7	|B-PROTEIN
,	|O
git8	|B-PROTEIN
and	|O
git10	|B-PROTEIN
genes	|O
act	|O
upstream	|O
of	|O
adenylate	|B-PROTEIN
cyclase	|I-PROTEIN
,	|O
presumably	|O
encoding	|O
an	|O
adenylate	|B-PROTEIN
cyclase	|I-PROTEIN
activation	|O
pathway	|O
.	|O

These	|O
same	|O
regions	|O
showed	|O
remarkable	|O
homology	|O
to	|O
two	|O
invertebrate	|O
proteins	|O
,	|O
CNC	|B-PROTEIN
and	|O
skin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
postulated	|O
to	|O
regulate	|O
embryonic	|O
development	|O
in	|O
Drosophila	|O
melanogaster	|O
and	|O
Caenorhabditis	|O
elegans	|O
,	|O
respectively	|O
.	|O

DNA	|O
sequence	|O
analysis	|O
has	|O
confirmed	|O
that	|O
this	|O
mutation	|O
affects	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
alpha	|O
subunit	|O
,	|O
changing	|O
a	|O
leucine	|O
residue	|O
at	|O
position	|O
290	|O
to	|O
a	|O
histidine	|O
(	|O
rpoAL290H	|B-PROTEIN
)	|O
.	|O

CONCLUSIONS	|O
:	|O
These	|O
findings	|O
indicate	|O
a	|O
physical	|O
barrier	|O
of	|O
oesophageal	|O
surfactant	|O
which	|O
could	|O
offer	|O
some	|O
degree	|O
of	|O
protection	|O
against	|O
gastro	|O
-	|O
oesophageal	|O
reflux	|O
but	|O
one	|O
which	|O
is	|O
particularly	|O
prone	|O
to	|O
attack	|O
by	|O
bile	|O
.	|O

Differential	|O
screening	|O
of	|O
mitochondrial	|O
cDNA	|O
libraries	|O
from	|O
male	|O
-	|O
fertile	|O
and	|O
cytoplasmic	|O
male	|O
-	|O
sterile	|O
sugar	|O
-	|O
beet	|O
reveals	|O
genome	|O
rearrangements	|O
at	|O
atp6	|B-PROTEIN
and	|O
atpA	|B-PROTEIN
loci	|O
.	|O

The	|O
effects	|O
of	|O
social	|O
isolation	|O
on	|O
morphine	|O
-	|O
induced	|O
locomotor	|O
activity	|O
were	|O
compared	|O
in	|O
:	|O
(	|O
i	|O
)	|O
animals	|O
with	|O
an	|O
intact	|O
hypothalamo	|O
-	|O
pituitary	|O
-	|O
adrenal	|O
(	|O
HPA	|O
)	|O
axis	|O
;	|O
(	|O
ii	|O
)	|O
animals	|O
in	|O
which	|O
stress	|O
-	|O
induced	|O
corticosterone	|O
secretion	|O
was	|O
blocked	|O
by	|O
adrenalectomy	|O
.	|O

Using	|O
this	|O
reporter	|O
gene	|O
system	|O
,	|O
we	|O
previously	|O
showed	|O
that	|O
EPO	|B-PROTEIN
-	|O
induced	|O
activation	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
promoter	|O
can	|O
be	|O
detected	|O
rapidly	|O
and	|O
sensitively	|O
as	|O
an	|O
elevation	|O
of	|O
cellular	|O
luciferase	|B-PROTEIN
activity	|O
.	|O

I	|O
hypothesize	|O
that	|O
white	|B-PROTEIN
gene	|O
expression	|O
from	|O
P	|B-PROTEIN
[	|I-PROTEIN
en	|I-PROTEIN
]	|I-PROTEIN
is	|O
repressed	|O
by	|O
the	|O
formation	|O
of	|O
a	|O
protein	|O
complex	|O
which	|O
is	|O
initiated	|O
at	|O
the	|O
engrailed	|B-PROTEIN
PS	|O
sites	|O
and	|O
also	|O
requires	|O
interactions	|O
with	|O
flanking	|O
genomic	|O
DNA	|O
.	|O

SPP41	|B-PROTEIN
was	|O
cloned	|O
and	|O
sequenced	|O
and	|O
found	|O
to	|O
be	|O
essential	|O
.	|O
spp43	|B-PROTEIN
is	|O
allelic	|O
to	|O
the	|O
previously	|O
identified	|O
suppressor	|O
srn1	|B-PROTEIN
,	|O
which	|O
encodes	|O
a	|O
negative	|O
regulator	|O
of	|O
gene	|O
expression	|O
.	|O

Standard	|O
curve	|O
correlation	|O
coefficients	|O
of	|O
0.995	|O
or	|O
greater	|O
were	|O
obtained	|O
during	|O
validation	|O
experiments	|O
and	|O
analysis	|O
of	|O
study	|O
samples	|O
.	|O

To	|O
see	|O
if	|O
a	|O
pulse	|O
oximeter	|O
can	|O
monitor	|O
the	|O
fetus	|O
during	|O
labour	|O
we	|O
recruited	|O
100	|O
Caucasian	|O
women	|O
in	|O
normal	|O
uncomplicated	|O
labour	|O
.	|O

There	|O
was	|O
no	|O
difference	|O
in	|O
plasma	|O
concentrations	|O
of	|O
PGI2	|O
(	|O
figure	|O
4	|O
)	|O
and	|O
TxA2	|O
in	|O
patients	|O
with	|O
normal	|O
blood	|O
pressure	|O
,	|O
mild	|O
preeclampsia	|O
and	|O
hypotension	|O
,	|O
whereas	|O
in	|O
severe	|O
preeclampsia	|O
,	|O
the	|O
plasma	|O
concentration	|O
of	|O
PGI2	|O
was	|O
significantly	|O
lower	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
and	|O
of	|O
TxA2	|O
significantly	|O
higher	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
.	|O

A	|O
causal	|O
analysis	|O
of	|O
secondary	|O
variables	|O
showed	|O
that	|O
the	|O
formation	|O
of	|O
FB	|O
memories	|O
was	|O
primarily	|O
associated	|O
with	|O
the	|O
level	|O
of	|O
importance	|O
attached	|O
to	|O
the	|O
event	|O
and	|O
level	|O
of	|O
affective	|O
response	|O
to	|O
the	|O
news	|O
.	|O

Deletion	|O
studies	|O
identified	|O
a	|O
distal	|O
response	|O
element	|O
that	|O
is	|O
responsible	|O
for	|O
the	|O
cytokine	|O
response	|O
and	|O
has	|O
properties	|O
of	|O
an	|O
inducible	|O
transcriptional	|O
enhancer	|O
.	|O

The	|O
IPL1	|B-PROTEIN
gene	|O
is	|O
required	|O
for	|O
high	|O
-	|O
fidelity	|O
chromosome	|O
segregation	|O
in	|O
the	|O
budding	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

2	|O
.	|O

No	|O
drop	|O
in	|O
oxygen	|O
saturation	|O
(	|O
SaO2	|O
)	|O
or	|O
visual	|O
evidence	|O
of	|O
transient	|O
electroencephalographic	|O
(	|O
EEG	|O
)	|O
arousals	|O
can	|O
be	|O
found	|O
at	|O
repeat	|O
polysomnography	|O
.	|O

The	|O
complete	|O
gene	|O
organization	|O
was	|O
obtained	|O
by	|O
combining	|O
the	|O
results	|O
of	|O
the	|O
sequence	|O
of	|O
these	|O
clones	|O
and	|O
those	|O
of	|O
the	|O
characterization	|O
of	|O
polymerase	|O
chain	|O
reaction	|O
-	|O
amplified	|O
genomic	|O
segments	|O
.	|O

INO2	|B-PROTEIN
,	|O
a	|O
regulatory	|O
gene	|O
in	|O
yeast	|O
phospholipid	|O
biosynthesis	|O
,	|O
affects	|O
nuclear	|O
segregation	|O
and	|O
bud	|O
pattern	|O
formation	|O
.	|O

The	|O
pentafluorobenzyl	|O
derivative	|O
of	|O
clonidine	|O
yields	|O
an	|O
intense	|O
ion	|O
fragment	|O
at	|O
m	|O
/	|O
z	|O
354	|O
,	|O
and	|O
the	|O
lower	|O
limit	|O
of	|O
detection	|O
is	|O
0.025	|O
ng	|O
/	|O
ml	|O
for	|O
a	|O
1	|O
-	|O
ml	|O
plasma	|O
sample	|O
.	|O

Mammalian	|O
ABPs	|B-PROTEIN
and	|O
SHBGs	|B-PROTEIN
bind	|O
sex	|O
steroids	|O
with	|O
high	|O
affinity	|O
,	|O
but	|O
some	|O
binding	|O
properties	|O
differ	|O
among	|O
species	|O
.	|O

Src	|B-PROTEIN
homology	|I-PROTEIN
(	|O
SH	|B-PROTEIN
)	|O
domain	|O
dependent	|O
protein	|O
-	|O
protein	|O
interactions	|O
are	|O
important	|O
to	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
receptor	|I-PROTEIN
signal	|O
transduction	|O
.	|O

Sample	|O
treatment	|O
was	|O
optimized	|O
in	|O
order	|O
to	|O
achieve	|O
a	|O
complete	|O
extraction	|O
of	|O
labetalol	|O
diastereoisomers	|O
and	|O
to	|O
avoid	|O
racemization	|O
during	|O
extraction	|O
.	|O

Under	|O
resting	|O
conditions	|O
,	|O
activity	|O
levels	|O
of	|O
cardiac	|O
vagal	|O
and	|O
sympathetic	|O
outflows	|O
are	|O
not	|O
related	|O
across	|O
young	|O
,	|O
healthy	|O
human	|O
subjects	|O
and	|O
peripheral	|O
interaction	|O
is	|O
not	|O
manifest	|O
between	|O
the	|O
autonomic	|O
divisions	|O
.	|O

Both	|O
proprioceptive	|O
and	|O
electroreceptive	|O
units	|O
showed	|O
a	|O
progression	|O
of	|O
receptive	|O
fields	|O
from	|O
anterior	|O
to	|O
posterior	|O
body	|O
in	|O
the	|O
rostral	|O
to	|O
caudal	|O
direction	|O
along	|O
the	|O
length	|O
of	|O
DGR	|O
.	|O

In	|O
control	|O
patients	|O
,	|O
baseline	|O
images	|O
presented	|O
Type	|O
I	|O
in	|O
25	|O
,	|O
Type	|O
II	|O
in	|O
7	|O
,	|O
and	|O
the	|O
Type	|O
III	|O
&	|O
IV	|O
in	|O
0	|O
,	|O
and	|O
the	|O
Type	|O
after	|O
loading	|O
was	|O
the	|O
same	|O
as	|O
the	|O
Type	|O
at	|O
baseline	|O
.	|O

A	|O
more	|O
complete	|O
analysis	|O
of	|O
dose	|O
response	|O
,	|O
time	|O
and	|O
mode	|O
of	|O
Ga	|O
administration	|O
(	|O
preinjury	|O
or	|O
postinjury	|O
)	|O
,	|O
and	|O
availability	|O
of	|O
Ga	|O
across	|O
the	|O
blood	|O
-	|O
brain	|O
barrier	|O
is	|O
needed	|O
to	|O
further	|O
evaluate	|O
the	|O
efficacy	|O
of	|O
this	|O
compound	|O
.	|O

The	|O
presence	|O
of	|O
regulatory	|O
sequences	|O
for	|O
the	|O
binding	|O
of	|O
transcription	|O
factors	|O
such	|O
as	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
whose	|O
activation	|O
is	|O
associated	|O
with	|O
the	|O
immediate	|O
response	|O
of	|O
the	|O
cell	|O
to	|O
an	|O
injury	|O
,	|O
may	|O
be	|O
an	|O
indication	|O
of	|O
the	|O
important	|O
role	|O
which	|O
HO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
may	|O
play	|O
in	|O
defense	|O
mechanisms	|O
against	|O
tissue	|O
injury	|O
.	|O

Granisetron	|O
,	|O
but	|O
not	|O
saline	|O
,	|O
abolished	|O
vomiting	|O
and	|O
nausea	|O
when	|O
given	|O
as	|O
intervention	|O
after	|O
this	|O
combined	|O
emetic	|O
regimen	|O
.	|O

The	|O
femoroarterial	|O
coronary	|O
sinus	|O
difference	|O
in	|O
lactate	|O
turned	|O
negative	|O
,	|O
and	|O
pH	|O
,	|O
PCO2	|O
and	|O
potassium	|O
differences	|O
increased	|O
in	|O
group	|O
2	|O
during	|O
pacing	|O
.	|O

This	|O
was	|O
obtained	|O
with	|O
the	|O
thermal	|O
neutron	|O
fluency	|O
2.0	|O
x	|O
10	|O
(	|O
10	|O
)	|O
n	|O
/	|O
cm2	|O
.	|O

Endotoxemia	|O
induced	|O
by	|O
gram	|O
-	|O
negative	|O
bacteria	|O
leads	|O
to	|O
endotoxic	|O
shock	|O
pathogenetically	|O
stemming	|O
from	|O
the	|O
integral	|O
component	|O
of	|O
the	|O
bacterial	|O
wall	|O
-	|O
-	|O
lipid	|O
A.	|O

The	|O
study	|O
made	|O
to	|O
define	|O
the	|O
ability	|O
of	|O
lipid	|B-PROTEIN
A	|I-PROTEIN
monoclonal	|I-PROTEIN
antibodies	|I-PROTEIN
to	|O
correct	|O
hemodynamic	|O
disturbances	|O
due	|O
to	|O
endotoxemia	|O
in	|O
dog	|O
experiments	|O
showed	|O
the	|O
efficacy	|O
of	|O
the	|O
antibodies	|O
administration	|O
.	|O

A	|O
randomised	|O
,	|O
controlled	|O
trial	|O
was	|O
undertaken	|O
in	|O
40	|O
patients	|O
with	|O
active	|O
Crohn	|O
's	|O
disease	|O
to	|O
evaluate	|O
clinical	|O
and	|O
nutritional	|O
outcomes	|O
after	|O
an	|O
amino	|O
acid	|O
based	|O
diet	|O
containing	|O
3%	|O
fat	|O
was	|O
given	|O
by	|O
a	|O
feeding	|O
tube	|O
compared	|O
with	|O
a	|O
peptide	|O
based	|O
diet	|O
containing	|O
33%	|O
fat	|O
.	|O

This	|O
sequenced	|O
region	|O
of	|O
the	|O
V	|O
beta	|O
locus	|O
contains	|O
an	|O
average	|O
number	|O
of	|O
repetitive	|O
DNA	|O
elements	|O
(	|O
21	|O
Alu	|B-PROTEIN
,	|O
three	|O
L1	|B-PROTEIN
,	|O
three	|O
MER	|O
,	|O
and	|O
three	|O
retrovirus	|O
-	|O
related	|O
elements	|O
.	|O

The	|O
sequenced	|O
genomic	|O
region	|O
thus	|O
accounts	|O
for	|O
essentially	|O
all	|O
of	|O
the	|O
longest	|O
known	|O
transcript	|O
(	|O
4.5	|O
kb	|O
)	|O
,	|O
although	|O
the	|O
precise	|O
ends	|O
of	|O
this	|O
transcript	|O
have	|O
not	|O
been	|O
defined	|O
.	|O

The	|O
pexB	|B-PROTEIN
upstream	|O
region	|O
contained	|O
245	|O
nucleotides	|O
within	|O
which	|O
sequences	|O
approximating	|O
the	|O
consensus	|O
for	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
receptor	|I-PROTEIN
protein	|O
and	|O
integration	|B-PROTEIN
host	|I-PROTEIN
factor	|I-PROTEIN
binding	|O
sites	|O
were	|O
discernible	|O
.	|O

The	|O
fepA	|B-PROTEIN
-	|O
entD	|B-PROTEIN
and	|O
fes	|B-PROTEIN
-	|O
entF	|B-PROTEIN
operons	|O
in	|O
the	|O
enterobactin	|O
synthesis	|O
and	|O
transport	|O
system	|O
are	|O
divergently	|O
transcribed	|O
from	|O
overlapping	|O
promoters	|O
,	|O
and	|O
both	|O
are	|O
inhibited	|O
by	|O
the	|O
Fur	|B-PROTEIN
repressor	|O
protein	|O
under	|O
iron	|O
-	|O
replete	|O
conditions	|O
.	|O

Sequence	|O
analysis	|O
of	|O
a	|O
6.3	|O
-	|O
kbp	|O
genomic	|O
EcoRI	|B-PROTEIN
-	|O
fragment	|O
of	|O
Alcaligenes	|O
eutrophus	|O
,	|O
which	|O
was	|O
recently	|O
identified	|O
by	|O
using	|O
a	|O
dihydrolipoamide	|B-PROTEIN
dehydrogenase	|I-PROTEIN
-	|O
specific	|O
DNA	|O
probe	|O
(	|O
A.	|O

Using	|O
a	|O
previously	|O
published	|O
two	|O
-	|O
frequency	|O
(	|O
AC	|O
excitation	|O
)	|O
three	|O
-	|O
electrode	|O
method	|O
,	|O
the	|O
admittance	|O
locus	|O
plot	|O
(	|O
ALP	|O
)	|O
in	|O
the	|O
low	|O
-	|O
frequency	|O
region	|O
(	|O
<	|O
1000	|O
Hz	|O
)	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
very	|O
well	|O
approximated	|O
by	|O
a	|O
straight	|O
line	|O
and	|O
can	|O
be	|O
described	|O
with	|O
frequency	|O
-	|O
independent	|O
parameters	|O
;	|O
phase	|O
angle	|O
alpha	|O
pi	|O
/	|O
2	|O
,	|O
conductance	|O
at	|O
extrapolated	|O
zero	|O
frequency	|O
G0	|O
=	|O
1	|O
/	|O
R0	|O
,	|O
and	|O
ion	|O
relaxation	|O
time	|O
tau	|O
.	|O

Intraoperative	|O
measurement	|O
of	|O
activated	|O
partial	|O
thromboplastin	|B-PROTEIN
time	|O
and	|O
prothrombin	|B-PROTEIN
time	|O
with	|O
a	|O
new	|O
compact	|O
monitor	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
sought	|O
to	|O
test	|O
the	|O
hypothesis	|O
that	|O
,	|O
when	|O
equal	|O
volumes	|O
are	|O
administered	|O
intrathecally	|O
,	|O
significant	|O
differences	|O
exist	|O
in	|O
the	|O
potential	|O
to	|O
three	|O
commonly	|O
used	|O
anesthetic	|O
solutions	|O
to	|O
induce	|O
sensory	|O
impairment	|O
.	|O

In	|O
an	|O
in	|O
vitro	|O
study	|O
,	|O
10/0	|O
nylon	|O
was	|O
found	|O
to	|O
require	|O
a	|O
significantly	|O
lower	|O
laser	|O
energy	|O
density	|O
to	|O
produce	|O
suture	|O
lysis	|O
following	|O
a	|O
single	|O
shot	|O
than	|O
either	|O
10/0	|O
Dacron	|O
or	|O
10/0	|O
prolene	|O
.	|O

The	|O
proteins	|O
encoded	|O
downstream	|O
of	|O
rpoN	|B-PROTEIN
are	|O
known	|O
to	|O
negatively	|O
regulate	|O
sigma	|B-PROTEIN
54	|I-PROTEIN
activity	|O
.	|O

We	|O
report	|O
here	|O
that	|O
microinjection	|O
of	|O
an	|O
anti	|B-PROTEIN
-	|I-PROTEIN
CBP	|I-PROTEIN
antiserum	|O
into	|O
fibroblasts	|O
can	|O
inhibit	|O
transcription	|O
from	|O
a	|O
cAMP	|O
responsive	|O
promoter	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
a	|O
class	|O
of	|O
proline	|O
-	|O
rich	|O
activator	|O
proteins	|O
and	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
possess	|O
a	|O
common	|O
structural	|O
and	|O
functional	|O
component	|O
which	|O
can	|O
interact	|O
with	|O
the	|O
same	|O
target	|O
in	|O
the	|O
general	|O
transcription	|O
machinery	|O
.	|O

Cloning	|O
of	|O
higher	|O
plant	|O
omega	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
fatty	|I-PROTEIN
acid	|I-PROTEIN
desaturases	|I-PROTEIN
.	|O

65	|O
,	|O
3829-3838	|O
,	|O
1991	|O
)	|O
,	|O
a	|O
truncated	|O
form	|O
of	|O
the	|O
IE	|B-PROTEIN
polypeptide	|O
lacking	|O
IE	|B-PROTEIN
amino	|O
acid	|O
residues	|O
1-322	|O
(	|O
and	|O
,	|O
therefore	|O
lacks	|O
the	|O
deduced	|O
transcriptional	|O
activation	|O
domain	|O
)	|O
,	|O
fails	|O
to	|O
transactivate	|O
the	|O
EHV	|O
-	|O
1	|O
tk	|B-PROTEIN
promoter	|O
,	|O
but	|O
retains	|O
the	|O
ability	|O
to	|O
down	|O
-	|O
regulate	|O
the	|O
EHV	|O
-	|O
1	|O
IE	|B-PROTEIN
promoter	|O
.	|O

However	|O
,	|O
by	|O
an	|O
NS35	|B-PROTEIN
-	|O
specific	|O
RNA	|O
capture	|O
assay	|O
,	|O
the	|O
multimers	|O
were	|O
shown	|O
to	|O
possess	|O
the	|O
RNA	|O
-	|O
binding	|O
activity	|O
previously	|O
demonstrated	|O
for	|O
NS35	|B-PROTEIN
.	|O

CONCLUSION	|O
:	|O
Human	|O
preterm	|O
birth	|O
is	|O
associated	|O
with	|O
significantly	|O
lower	|O
progesterone	|O
/	|O
17	|O
beta	|O
-	|O
estradiol	|O
ratios	|O
than	|O
those	|O
of	|O
women	|O
with	|O
preterm	|O
labor	|O
delivered	|O
at	|O
term	|O
.	|O

Ketamine	|O
in	|O
the	|O
treatment	|O
of	|O
bronchospasm	|O
during	|O
mechanical	|O
ventilation	|O
.	|O

In	|O
conclusion	|O
,	|O
the	|O
disposition	|O
of	|O
venlafaxine	|O
and	|O
O	|O
-	|O
desmethylvenlafaxine	|O
is	|O
markedly	|O
altered	|O
in	|O
renal	|O
disease	|O
;	|O
therefore	|O
dosage	|O
adjustment	|O
is	|O
warranted	|O
for	|O
patients	|O
with	|O
creatinine	|O
clearance	|O
values	|O
below	|O
30	|O
ml	|O
/	|O
min	|O
.	|O

The	|O
availability	|O
of	|O
sequence	|O
from	|O
multiple	|O
species	|O
has	|O
permitted	|O
us	|O
to	|O
determine	|O
that	|O
the	|O
UBE	|O
site	|O
has	|O
close	|O
similarity	|O
to	|O
motifs	|O
that	|O
bind	|O
members	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
family	|O
of	|O
transcription	|O
factors	|O
.	|O

The	|O
incidence	|O
of	|O
HSV	|O
-	|O
2	|O
positive	|O
subjects	|O
(	|O
HSV	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
/	|I-PROTEIN
HSV	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
antibody	|I-PROTEIN
ratio	|O
>	|O
or	|O
=	|O
1	|O
)	|O
was	|O
low	|O
in	|O
the	|O
Jewish	|O
Israeli	|O
population	|O
,	|O
compared	|O
to	|O
other	|O
demographic	|O
areas	|O
.	|O

The	|O
mechanism	|O
whereby	|O
zeta	|B-PROTEIN
PKC	|I-PROTEIN
regulates	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
most	|O
probably	|O
involves	|O
the	|O
activation	|O
of	|O
a	|O
putative	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
kinase	|I-PROTEIN
of	|O
molecular	|O
mass	|O
approximately	|O
50	|O
kDa	|O
,	|O
which	|O
phosphorylates	|O
and	|O
inactivates	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B.	|I-PROTEIN

Stable	|O
expression	|O
of	|O
truncated	|O
inositol	|B-PROTEIN
1,4,5	|I-PROTEIN
-	|I-PROTEIN
trisphosphate	|I-PROTEIN
receptor	|I-PROTEIN
subunits	|O
in	|O
3T3	|O
fibroblasts	|O
.	|O

The	|O
molecular	|O
basis	|O
for	|O
commitment	|O
of	|O
progenitors	|O
to	|O
the	|O
eosinophil	|O
lineage	|O
and	|O
mechanisms	|O
by	|O
which	|O
eosinophil	|O
-	|O
specific	|O
genes	|O
are	|O
expressed	|O
and	|O
regulated	|O
during	|O
differentiation	|O
is	|O
unknown	|O
.	|O

We	|O
report	|O
the	|O
identification	|O
and	|O
characterization	|O
of	|O
myr	|B-PROTEIN
4	|I-PROTEIN
(	|O
myosin	|B-PROTEIN
from	|I-PROTEIN
rat	|I-PROTEIN
)	|O
,	|O
the	|O
first	|O
mammalian	|O
myosin	|B-PROTEIN
I	|I-PROTEIN
that	|O
is	|O
not	|O
closely	|O
related	|O
to	|O
brush	|O
border	|O
myosin	|B-PROTEIN
I.	|I-PROTEIN

M.	|O
,	|O
and	|O
D.	|O

In	|O
addition	|O
,	|O
computer	|O
analysis	|O
suggests	|O
that	|O
sequences	|O
similar	|O
to	|O
the	|O
A	|O
stem	|O
element	|O
are	|O
present	|O
within	|O
the	|O
three	|O
AAV	|B-PROTEIN
promoter	|I-PROTEIN
regions	|O
.	|O

At	|O
least	|O
some	|O
of	|O
the	|O
difference	|O
in	|O
stability	|O
of	|O
the	|O
two	|O
kinds	|O
of	|O
complexes	|O
was	|O
due	|O
to	|O
the	|O
fact	|O
that	|O
the	|O
dissociation	|O
rate	|O
of	|O
the	|O
A	|O
stem	|O
substrate	|O
from	|O
the	|O
protein	|O
-	|O
DNA	|O
complexes	|O
was	|O
approximately	|O
fourfold	|O
faster	|O
than	|O
that	|O
of	|O
the	|O
complete	|O
TR	|B-PROTEIN
.	|O

Processing	|O
of	|O
the	|O
NS3	|B-PROTEIN
'	|I-PROTEIN
-	|O
5B	|B-PROTEIN
polyprotein	|O
was	|O
complex	|O
and	|O
occurred	|O
rapidly	|O
.	|O

However	|O
,	|O
each	|O
promoter	|O
activated	|O
by	|O
IEP86	|B-PROTEIN
was	|O
synergistically	|O
affected	|O
by	|O
the	|O
addition	|O
of	|O
IEP72	|B-PROTEIN
.	|O

32Pi	|O
labeling	|O
or	|O
isoelectric	|O
focusing	|O
analysis	|O
of	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
from	|O
conditional	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
II	|I-PROTEIN
mutants	|O
indicated	|O
that	|O
phosphorylation	|O
of	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
is	|O
abolished	|O
or	|O
dephosphorylated	|O
forms	|O
of	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
are	|O
detected	|O
when	|O
these	|O
strains	|O
are	|O
grown	|O
at	|O
the	|O
restrictive	|O
growth	|O
conditions	|O
.	|O

Thus	|O
,	|O
YMIP	|B-PROTEIN
is	|O
a	|O
functional	|O
homolog	|O
of	|O
RMIP	|B-PROTEIN
and	|O
represents	|O
a	|O
new	|O
component	|O
of	|O
the	|O
yeast	|O
mitochondrial	|O
import	|O
machinery	|O
.	|O

The	|O
R2	|O
region	|O
within	|O
the	|O
class	|O
I	|O
enhancer	|O
acts	|O
as	|O
a	|O
negative	|O
element	|O
in	|O
Ad12	|O
-	|O
transformed	|O
cells	|O
and	|O
exhibits	|O
a	|O
stronger	|O
binding	|O
activity	|O
than	|O
is	|O
observed	|O
in	|O
nontumorigenic	|O
Ad5	|O
-	|O
transformed	|O
cells	|O
,	|O
which	|O
are	|O
not	|O
reduced	|O
in	|O
class	|O
I	|O
expression	|O
.	|O

PURPOSE	|O
:	|O
To	|O
evaluate	|O
the	|O
kinetics	|O
of	|O
erythropoietin	|B-PROTEIN
(	|O
EPO	|B-PROTEIN
)	|O
production	|O
and	|O
address	|O
the	|O
pathogenesis	|O
of	|O
anemia	|O
of	|O
prematurity	|O
,	|O
we	|O
measured	|O
EPO	|B-PROTEIN
levels	|O
in	|O
infants	|O
during	|O
the	|O
first	|O
year	|O
of	|O
life	|O
.	|O

The	|O
nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
beta	|I-PROTEIN
gene	|O
(	|O
NGFB	|B-PROTEIN
)	|O
belongs	|O
to	|O
a	|O
conserved	|O
syntenic	|O
group	|O
on	|O
human	|O
chromosome	|O
1	|O
and	|O
mouse	|O
Chromosome	|O
3	|O
.	|O

Furthermore	|O
,	|O
an	|O
upstream	|O
element	|O
,	|O
collagen	|B-PROTEIN
element	|O
I	|O
(	|O
-	|O
370	|O
/	|O
-	|O
344	|O
)	|O
,	|O
which	|O
shares	|O
homology	|O
with	|O
the	|O
LAP	|B-PROTEIN
binding	|O
cis	|O
-	|O
element	|O
of	|O
the	|O
albumin	|B-PROTEIN
promoter	|O
(	|O
9	|O
of	|O
13	|O
bp	|O
)	|O
is	|O
described	|O
.	|O

Number	|O
and	|O
size	|O
of	|O
silver	|O
-	|O
stained	|O
nucleoli	|O
(	|O
Ag	|O
-	|O
NOR	|O
clusters	|O
)	|O
in	|O
canine	|O
seminomas	|O
:	|O
correlation	|O
with	|O
histological	|O
features	|O
and	|O
tumour	|O
behaviour	|O
.	|O

We	|O
speculate	|O
that	|O
mast	|O
cell	|O
degranulation	|O
may	|O
be	|O
involved	|O
in	|O
the	|O
pathogenesis	|O
of	|O
necrobiosis	|O
by	|O
altering	|O
fibroblast	|O
enzyme	|O
activity	|O
and	|O
/	|O
or	|O
producing	|O
prolonged	|O
inflammatory	|O
reactions	|O
.	|O

Molecular	|O
cloning	|O
of	|O
a	|O
cysteine	|B-PROTEIN
synthase	|I-PROTEIN
cDNA	|O
from	|O
Citrullus	|O
vulgaris	|O
(	|O
watermelon	|O
)	|O
by	|O
genetic	|O
complementation	|O
in	|O
an	|O
Escherichia	|O
coli	|O
Cys	|O
-	|O
auxotroph	|O
.	|O

In	|O
earlier	|O
studies	|O
we	|O
identified	|O
several	|O
regulatory	|O
elements	|O
that	|O
control	|O
transcriptional	|O
activation	|O
and	|O
aerobic	|O
repression	|O
of	|O
one	|O
of	|O
these	|O
genes	|O
,	|O
COX5b	|B-PROTEIN
.	|O

Although	|O
elevated	|O
serum	|O
levels	|O
of	|O
antibodies	|O
to	|O
the	|O
nicotinic	|B-PROTEIN
acetylcholine	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
nAChR	|B-PROTEIN
)	|O
have	|O
been	|O
reported	|O
in	|O
neuroleptic	|O
treated	|O
patients	|O
with	|O
tardive	|O
dyskinesia	|O
,	|O
such	|O
antibodies	|O
have	|O
not	|O
been	|O
determined	|O
in	|O
comparable	|O
nondyskinetic	|O
patients	|O
.	|O

The	|O
tumor	|O
suppressor	|O
and	|O
transcriptional	|O
factor	|O
p53	|B-PROTEIN
is	|O
a	|O
phosphorylated	|O
protein	|O
.	|O

This	|O
DNA	|O
containing	|O
promoter	|O
activity	|O
has	|O
been	|O
sequenced	|O
in	|O
its	|O
entirety	|O
and	|O
found	|O
to	|O
contain	|O
multiple	|O
putative	|O
regulatory	|O
sites	|O
.	|O

However	|O
,	|O
Southern	|O
blot	|O
and	|O
karyotype	|O
analyses	|O
did	|O
not	|O
reveal	|O
any	|O
significant	|O
changes	|O
in	|O
copy	|O
number	|O
or	|O
gross	|O
rearrangements	|O
of	|O
the	|O
p53	|B-PROTEIN
gene	|O
in	|O
any	|O
of	|O
the	|O
p53	|B-PROTEIN
-	|O
cell	|O
lines	|O
.	|O

HupI	|B-PROTEIN
showed	|O
strong	|O
identity	|O
to	|O
rubredoxin	|B-PROTEIN
and	|O
rubredoxin	|B-PROTEIN
-	|O
like	|O
proteins	|O
from	|O
many	|O
other	|O
bacteria	|O
.	|O

The	|O
PCr	|O
resynthesis	|O
rate	|O
(	|O
P	|O
<	|O
0.01	|O
)	|O
and	|O
the	|O
effective	|O
maximal	|O
rate	|O
of	|O
mitochondrial	|O
ATP	|O
synthesis	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
also	|O
improved	|O
.	|O

An	|O
examination	|O
was	|O
performed	|O
in	|O
15	|O
patients	|O
who	|O
had	|O
developed	|O
pronounced	|O
osteomalacia	|O
following	|O
gastric	|O
resection	|O
.	|O

However	|O
,	|O
regional	|O
MVO2	|O
increased	|O
to	|O
about	|O
the	|O
same	|O
extent	|O
in	|O
the	|O
CFX	|O
(	|O
from	|O
6.0	|O
+	|O
/	|O
-	|O
0.7	|O
to	|O
12.4	|O
+	|O
/	|O
-	|O
0.9	|O
ml	|O
O2.m	|O
in	|O
-	|O
1	|O
times	|O
100	|O
g	|O
-	|O
1	|O
)	|O
and	|O
the	|O
LAD	|O
region	|O
(	|O
from	|O
7.0	|O
+	|O
/	|O
-	|O
0.6	|O
to	|O
14.5	|O
+	|O
/	|O
-	|O
1.3	|O
ml	|O
O2.m	|O
in	|O
-	|O
1	|O
times	|O
100	|O
g	|O
-	|O
1	|O
)	|O
.	|O

IGF	|B-PROTEIN
I	|I-PROTEIN
and	|O
insulin	|B-PROTEIN
receptors	|I-PROTEIN
are	|O
homologous	|O
proteins	|O
that	|O
function	|O
in	|O
distinct	|O
physiological	|O
pathways	|O
.	|O

Immunodepression	|O
was	|O
combined	|O
with	|O
the	|O
increase	|O
of	|O
glucocorticoid	|O
activity	|O
of	|O
adrenal	|O
cortex	|O
,	|O
while	|O
no	|O
significant	|O
changes	|O
in	|O
thyroid	|O
hormones	|O
were	|O
registered	|O
.	|O

Tryptic	|O
cleavage	|O
and	|O
peptide	|O
sequence	|O
analysis	|O
demonstrated	|O
that	|O
the	|O
98	|O
-	|O
kD	|O
protein	|O
is	|O
identical	|O
to	|O
a	|O
recently	|O
cloned	|O
protein	|O
,	|O
special	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
T	|I-PROTEIN
-	|I-PROTEIN
rich	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
SATB1	|B-PROTEIN
)	|O
,	|O
that	|O
binds	|O
selectively	|O
to	|O
nuclear	|O
matrix	|O
/	|O
scaffold	|O
-	|O
associated	|O
regions	|O
of	|O
DNA	|O
(	|O
MARs	|O
/	|O
SARs	|O
)	|O
.	|O

Aberrant	|O
protein	|O
phosphorylation	|O
at	|O
tyrosine	|O
is	|O
responsible	|O
for	|O
the	|O
growth	|O
-	|O
inhibitory	|O
action	|O
of	|O
pp60v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
expressed	|O
in	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Acute	|O
pancreatitis	|O
:	|O
a	|O
multisystem	|O
disease	|O
.	|O

Alginate	|O
biosynthesis	|O
is	|O
controlled	|O
by	|O
a	|O
complex	|O
regulatory	|O
mechanism	|O
.	|O

The	|O
sequence	|O
upstream	|O
of	|O
the	|O
rhlA	|B-PROTEIN
promoter	|O
contains	|O
two	|O
inverted	|O
repeats	|O
which	|O
define	|O
putative	|O
binding	|O
sites	|O
for	|O
the	|O
RhlR	|B-PROTEIN
regulator	|O
.	|O

We	|O
have	|O
examined	|O
by	|O
in	|O
vitro	|O
footprinting	|O
a	|O
region	|O
located	|O
downstream	|O
of	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
,	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
promoter	|O
found	|O
to	|O
be	|O
hypersensitive	|O
to	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
digestion	|O
in	|O
vivo	|O
.	|O

Heparin	|O
had	|O
no	|O
effect	|O
on	|O
rAC	|O
-	|O
st	|O
myosin	|B-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
,	|O
while	|O
the	|O
B	|O
subunit	|O
-	|O
containing	|O
forms	|O
were	|O
stimulated	|O
2-3	|O
-	|O
fold	|O
.	|O

The	|O
relative	|O
abundance	|O
of	|O
each	|O
alternatively	|O
spliced	|O
mRNA	|O
was	|O
determined	|O
by	|O
reverse	|O
transcription	|O
-	|O
polymerase	|O
chain	|O
reaction	|O
in	|O
various	|O
human	|O
tissues	|O
and	|O
cell	|O
lines	|O
.	|O

BACKGROUND	|O
AND	|O
DESIGN	|O
:	|O
Fifty	|O
-	|O
nine	|O
melanocytic	|O
nevi	|O
with	|O
eccentric	|O
foci	|O
of	|O
hyperpigmentation	|O
(	|O
"	|O
small	|O
dark	|O
dots	|O
"	|O
)	|O
that	|O
measured	|O
primarily	|O
1	|O
to	|O
2	|O
mm	|O
in	|O
diameter	|O
were	|O
prospectively	|O
examined	|O
to	|O
determine	|O
the	|O
histologic	|O
correlates	|O
of	|O
the	|O
dark	|O
dots	|O
.	|O

The	|O
retention	|O
index	|O
of	|O
201Tl	|O
SPECT	|O
is	|O
a	|O
useful	|O
indicator	|O
of	|O
metastatic	|O
potential	|O
,	|O
thereby	|O
facilitating	|O
the	|O
prediction	|O
of	|O
prognosis	|O
,	|O
and	|O
provides	|O
insight	|O
into	|O
the	|O
relationship	|O
between	|O
201Tl	|O
uptake	|O
and	|O
malignancy	|O
.	|O

The	|O
central	|O
globular	|O
domain	|O
is	|O
highly	|O
similar	|O
to	|O
those	|O
regions	|O
from	|O
other	|O
H1	|B-PROTEIN
molecules	|O
,	|O
and	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
domain	|O
contains	|O
a	|O
repeating	|O
hexapeptide	|O
motif	|O
,	|O
variants	|O
of	|O
which	|O
are	|O
conserved	|O
among	|O
H1	|B-PROTEIN
molecules	|O
.	|O

The	|O
location	|O
and	|O
approximate	|O
length	|O
of	|O
the	|O
intron	|O
are	|O
conserved	|O
in	|O
both	|O
the	|O
tomato	|O
and	|O
Arabidopsis	|O
genes	|O
,	|O
with	|O
the	|O
intron	|O
separating	|O
the	|O
'	|O
nose	|O
'	|O
region	|O
(	|O
encoded	|O
by	|O
exon	|O
1	|O
)	|O
from	|O
the	|O
central	|O
globular	|O
domain	|O
(	|O
exon	|O
2	|O
)	|O
.	|O

The	|O
topology	|O
and	|O
chain	|O
folding	|O
of	|O
the	|O
beta	|O
subunits	|O
in	|O
the	|O
artifactual	|O
beta	|O
60	|O
capsid	|O
are	|O
similar	|O
to	|O
the	|O
native	|O
alpha	|B-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
60	|I-PROTEIN
enzyme	|O
.	|O

A	|O
single	|O
NMSC	|O
was	|O
present	|O
in	|O
69.4%	|O
,	|O
two	|O
in	|O
16%	|O
,	|O
three	|O
in	|O
6.4%	|O
,	|O
four	|O
in	|O
3.5%	|O
,	|O
five	|O
to	|O
nine	|O
in	|O
4.2%	|O
,	|O
and	|O
0.5%	|O
had	|O
ten	|O
or	|O
more	|O
.	|O

A	|O
constitutive	|O
mutant	|O
form	|O
with	|O
a	|O
single	|O
substitution	|O
(	|O
V88A	|O
)	|O
in	|O
the	|O
amino	|O
-	|O
terminal	|O
(	|O
response	|O
regulator	|O
)	|O
region	|O
was	|O
used	|O
.	|O

Comparisons	|O
of	|O
the	|O
four	|O
operon	|O
control	|O
regions	|O
studied	|O
indicate	|O
that	|O
the	|O
NarL	|B-PROTEIN
heptamers	|O
are	|O
arranged	|O
with	|O
diverse	|O
orientations	|O
and	|O
spacing	|O
.	|O

Direct	|O
binding	|O
and	|O
competition	|O
assays	|O
using	|O
30	|O
-	|O
mer	|O
oligonucleotide	|O
probes	|O
representing	|O
the	|O
individual	|O
CBF1	|B-PROTEIN
binding	|O
sites	|O
indicated	|O
that	|O
CBF1	|B-PROTEIN
bound	|O
less	|O
efficiently	|O
to	|O
the	|O
CD23	|B-PROTEIN
promoter	|O
and	|O
the	|O
EBV	|O
LMP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
sites	|O
than	|O
to	|O
the	|O
Cp	|B-PROTEIN
site	|O
.	|O

We	|O
have	|O
found	|O
a	|O
satisfactory	|O
reproducibility	|O
in	|O
vitro	|O
(	|O
T1	|O
:	|O
1.9%	|O
;	|O
T2	|O
:	|O
6.2%	|O
)	|O
,	|O
while	|O
the	|O
reproducibility	|O
was	|O
less	|O
satisfactory	|O
in	|O
vivo	|O
(	|O
T1	|O
:	|O
16.4%	|O
;	|O
T2	|O
:	|O
13.4%	|O
)	|O
.	|O

The	|O
two	|O
ParA	|B-PROTEIN
proteins	|O
that	|O
are	|O
produced	|O
as	|O
a	|O
result	|O
of	|O
independent	|O
translation	|O
initiation	|O
at	|O
two	|O
different	|O
start	|O
codons	|O
within	|O
the	|O
same	|O
open	|O
reading	|O
frame	|O
were	|O
overexpressed	|O
in	|O
Escherichia	|O
coli	|O
and	|O
partially	|O
purified	|O
.	|O

To	|O
get	|O
further	|O
insights	|O
into	|O
the	|O
molecular	|O
mechanisms	|O
that	|O
control	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
,	|O
we	|O
have	|O
isolated	|O
5'	|O
sequences	|O
of	|O
the	|O
murine	|O
gene	|O
and	|O
compared	|O
them	|O
to	|O
their	|O
human	|O
counterparts	|O
.	|O

CONCLUSION	|O
:	|O
Sonographic	|O
angiography	|O
has	|O
a	|O
possible	|O
role	|O
in	|O
the	|O
detection	|O
of	|O
small	|O
nodules	|O
in	|O
patients	|O
with	|O
CRF	|O
.	|O

Each	|O
expressed	|O
domain	|O
,	|O
as	|O
well	|O
as	|O
FKBP	|B-PROTEIN
-	|I-PROTEIN
33	|I-PROTEIN
itself	|O
,	|O
possesses	|O
peptidyl	|B-PROTEIN
-	|I-PROTEIN
prolyl	|I-PROTEIN
cis	|I-PROTEIN
-	|I-PROTEIN
trans	|I-PROTEIN
isomerase	|I-PROTEIN
activity	|O
,	|O
though	|O
with	|O
much	|O
lower	|O
specific	|O
activities	|O
than	|O
FKBP	|B-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
.	|O

The	|O
first	|O
85	|O
nt	|O
upstream	|O
of	|O
the	|O
transcription	|O
initiation	|O
site	|O
of	|O
the	|O
mouse	|O
desmin	|B-PROTEIN
gene	|O
,	|O
which	|O
contain	|O
an	|O
E	|O
box	|O
(	|O
E1	|O
)	|O
,	|O
the	|O
binding	|O
site	|O
of	|O
the	|O
helix	|B-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
myogenic	|I-PROTEIN
regulators	|I-PROTEIN
,	|O
are	|O
sufficient	|O
to	|O
confer	|O
low	|O
level	|O
muscle	|O
-	|O
specific	|O
expression	|O
.	|O

The	|O
acfD	|B-PROTEIN
gene	|O
encompasses	|O
254	|O
nt	|O
that	|O
are	|O
predicted	|O
to	|O
encode	|O
an	|O
88	|O
-	|O
amino	|O
-	|O
acid	|O
(	|O
aa	|O
)	|O
protein	|O
.	|O

We	|O
find	|O
that	|O
beta	|B-PROTEIN
II	|I-PROTEIN
PKC	|I-PROTEIN
phosphorylates	|O
nuclear	|O
envelope	|O
lamin	|B-PROTEIN
B	|I-PROTEIN
at	|O
10-20	|O
times	|O
the	|O
rate	|O
of	|O
alpha	|B-PROTEIN
PKC	|I-PROTEIN
,	|O
whereas	|O
both	|O
kinases	|O
phosphorylate	|O
soluble	|O
lamin	|B-PROTEIN
B	|I-PROTEIN
at	|O
similar	|O
rates	|O
.	|O

Regulation	|O
of	|O
parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
protein	|I-PROTEIN
(	|O
PTHrP	|B-PROTEIN
)	|O
gene	|O
expression	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
a	|O
diverse	|O
set	|O
of	|O
carboxyl	|O
-	|O
terminal	|O
sequence	|O
motifs	|O
and	|O
posttranslational	|O
modifications	|O
lead	|O
to	|O
functional	|O
Ras	|B-PROTEIN
proteins	|O
in	|O
yeast	|O
.	|O

We	|O
conclude	|O
that	|O
c	|B-PROTEIN
-	|I-PROTEIN
Abl	|I-PROTEIN
activates	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
transcription	|O
indirectly	|O
with	|O
no	|O
requirement	|O
for	|O
DNA	|O
binding	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
Abl	|I-PROTEIN
.	|O

Long	|O
-	|O
latency	|O
:	|O
locked	|O
units	|O
responded	|O
to	|O
shocks	|O
with	|O
little	|O
jitter	|O
and	|O
long	|O
latency	|O
(	|O
4-11	|O
ms	|O
)	|O
.	|O

The	|O
highly	|O
conserved	|O
ninth	|O
heptad	|O
,	|O
which	|O
is	|O
involved	|O
in	|O
heterodimerization	|O
,	|O
appears	|O
to	|O
participate	|O
in	|O
the	|O
receptor	|O
-	|O
inhibitor	|O
interaction	|O
,	|O
suggesting	|O
that	|O
the	|O
inhibitor	|O
is	|O
a	|O
related	|O
member	|O
of	|O
the	|O
receptor	|O
gene	|O
family	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
for	|O
expression	|O
of	|O
snRNA	|O
genes	|O
in	|O
maize	|O
,	|O
a	|O
monocotyledonous	|O
plant	|O
,	|O
the	|O
USE	|O
and	|O
TATA	|O
elements	|O
are	|O
essential	|O
,	|O
but	|O
not	|O
sufficient	|O
,	|O
for	|O
transcription	|O
.	|O

Extensive	|O
DNA	|O
rearrangement	|O
occurs	|O
during	|O
the	|O
development	|O
of	|O
the	|O
somatic	|O
macronucleus	|O
from	|O
the	|O
germ	|O
line	|O
micronucleus	|O
in	|O
ciliated	|O
protozoans	|O
.	|O

An	|O
in	|O
vitro	|O
binding	|O
site	|O
selection	|O
procedure	|O
was	|O
used	|O
to	|O
determine	|O
DNA	|O
sequences	|O
preferentially	|O
bound	|O
by	|O
wild	|O
-	|O
type	|O
HLF	|B-PROTEIN
and	|O
chimeric	|O
E2A	|B-PROTEIN
-	|O
HLF	|B-PROTEIN
proteins	|O
isolated	|O
from	|O
various	|O
t	|O
(	|O
17	|O
;	|O
19	|O
)	|O
-	|O
bearing	|O
leukemias	|O
.	|O

The	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
glutamine	|O
-	|O
rich	|O
and	|O
proline	|O
-	|O
rich	|O
activation	|O
domains	|O
can	|O
synergize	|O
with	|O
each	|O
other	|O
or	|O
duplicates	|O
of	|O
themselves	|O
to	|O
activate	|O
transcription	|O
.	|O

Binding	|O
of	|O
U2	|B-PROTEIN
small	|O
nuclear	|O
ribonucleoprotein	|O
(	|O
snRNP	|O
)	|O
to	|O
the	|O
pre	|O
-	|O
mRNA	|O
is	|O
an	|O
early	|O
and	|O
important	|O
step	|O
in	|O
spliceosome	|O
assembly	|O
.	|O

Taken	|O
together	|O
,	|O
our	|O
data	|O
suggest	|O
that	|O
Dbf8p	|B-PROTEIN
plays	|O
an	|O
essential	|O
role	|O
in	|O
chromosome	|O
segregation	|O
.	|O

Ariga	|O
,	|O
Biochem	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
the	|O
KRAB	|B-PROTEIN
domain	|O
present	|O
in	|O
the	|O
non	|O
-	|O
finger	|O
region	|O
of	|O
many	|O
ZFP	|B-PROTEIN
genes	|O
quenches	|O
transcription	|O
possibly	|O
due	|O
to	|O
specific	|O
protein	|O
-	|O
protein	|O
interactions	|O
between	|O
the	|O
KRAB	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
domain	|O
and	|O
components	|O
of	|O
the	|O
proximal	|O
transcriptional	|O
apparatus	|O
.	|O

Marine	|O
oils	|O
and	|O
cardiovascular	|O
reactivity	|O
.	|O

The	|O
diagnostic	|O
significance	|O
of	|O
creatine	|B-PROTEIN
phosphokinase	|I-PROTEIN
antibodies	|O
in	|O
the	|O
cardiac	|O
muscle	|O
in	|O
non	|O
-	|O
coronarogenic	|O
myocardial	|O
diseases	|O

According	|O
to	|O
the	|O
results	|O
of	|O
assays	|O
obtained	|O
with	|O
the	|O
use	|O
of	|O
assay	|O
systems	|O
ORTHO	|O
ELISA	|O
and	|O
ABBOTT	|O
HCV	|O
EIA	|O
(	|O
USA	|O
)	|O
,	|O
the	|O
detection	|O
rate	|O
of	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HCV	|I-PROTEIN
-	|I-PROTEIN
C100	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
among	|O
primary	|O
blood	|O
donors	|O
in	|O
Moscow	|O
was	|O
1.37%	|O
and	|O
was	|O
not	|O
different	|O
from	|O
that	|O
among	|O
HBsAg	|B-PROTEIN
carriers	|O
(	|O
1.8%	|O
)	|O
and	|O
among	|O
donors	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HCV	|I-PROTEIN
-	|I-PROTEIN
C100	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
in	|O
the	|O
blood	|O
(	|O
1.6%	|O
)	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
.	|O

We	|O
examined	|O
the	|O
hypothesis	|O
that	|O
the	|O
coronary	|O
vasomotor	|O
responses	|O
to	|O
etomidate	|O
(	|O
ETO	|O
)	|O
,	|O
propofol	|O
(	|O
PRO	|O
)	|O
,	|O
and	|O
sodium	|O
thiopental	|O
(	|O
STP	|O
)	|O
are	|O
mediated	|O
through	|O
contrasting	|O
effects	|O
on	|O
the	|O
resting	|O
nitric	|O
oxide	|O
(	|O
NO	|O
)	|O
-	|O
dependent	|O
vasodilator	|O
tone	|O
that	|O
opposes	|O
adrenergic	|O
vasoconstrictor	|O
activity	|O
in	|O
the	|O
intact	|O
dog	|O
.	|O

Significant	|O
alterations	|O
in	|O
CBC	|O
results	|O
and	|O
serum	|O
CRP	|B-PROTEIN
concentration	|O
,	|O
compared	|O
with	|O
baseline	|O
values	|O
,	|O
were	|O
lacking	|O
in	|O
dogs	|O
of	|O
the	|O
control	|O
group	|O
.	|O

These	|O
alternative	|O
splice	|O
variants	|O
were	|O
detected	|O
in	|O
RNA	|O
isolated	|O
from	|O
several	|O
sources	|O
,	|O
including	|O
primary	|O
leptomeningeal	|O
tissue	|O
and	|O
an	|O
established	|O
line	|O
of	|O
leptomeningeal	|O
cells	|O
(	|O
LMC	|O
)	|O
.	|O

Roux	|O
-	|O
en	|O
-	|O
Y	|O
gastroenterostomy	|O
severely	|O
disturbs	|O
emptying	|O
of	|O
the	|O
gallbladder	|O
.	|O

Surface	|O
-	|O
coil	|O
experiments	|O
on	|O
phantoms	|O
and	|O
on	|O
human	|O
calf	|O
muscles	|O
in	|O
vivo	|O
are	|O
presented	|O
.	|O

Large	|O
interpatient	|O
variation	|O
in	|O
peak	|O
PCZ	|O
plasma	|O
levels	|O
(	|O
91-3215	|O
ng	|O
/	|O
ml	|O
)	|O
was	|O
seen	|O
,	|O
with	|O
the	|O
plasma	|O
half	|O
-	|O
life	|O
(	|O
t1/2	|O
alpha	|O
)	|O
being	|O
approximately	|O
57	|O
min	|O
in	|O
patients	|O
given	|O
135-180	|O
mg	|O
/	|O
m2	|O
PCZ	|O
.	|O

The	|O
maximal	|O
effect	|O
was	|O
seen	|O
at	|O
100	|O
ng	|O
/	|O
ml	|O
EGF	|B-PROTEIN
,	|O
with	|O
a	|O
time	|O
lag	|O
of	|O
about	|O
5	|O
h	|O
.	|O

KAR1	|B-PROTEIN
encodes	|O
an	|O
essential	|O
component	|O
of	|O
the	|O
yeast	|O
spindle	|O
pole	|O
body	|O
(	|O
SPB	|O
)	|O
that	|O
is	|O
required	|O
for	|O
karyogamy	|O
and	|O
SPB	|O
duplication	|O
.	|O

CDC31	|B-PROTEIN
is	|O
required	|O
for	|O
SPB	|O
duplication	|O
and	|O
encodes	|O
a	|O
calmodulin	|B-PROTEIN
-	|O
like	|O
protein	|O
that	|O
is	|O
most	|O
closely	|O
related	|O
to	|O
caltractin	|B-PROTEIN
/	|O
centrin	|B-PROTEIN
,	|O
a	|O
protein	|O
associated	|O
with	|O
the	|O
Chlamydomonas	|O
basal	|O
body	|O
.	|O

During	|O
transcript	|O
elongation	|O
,	|O
the	|O
sizes	|O
of	|O
the	|O
DNA	|O
footprint	|O
and	|O
the	|O
single	|O
-	|O
stranded	|O
transcription	|O
bubble	|O
vary	|O
markedly	|O
among	|O
transcription	|O
complexes	|O
halted	|O
at	|O
different	|O
template	|O
positions	|O
.	|O

The	|O
newly	|O
recognised	|O
skeletogenital	|O
syndrome	|O
.	|O

All	|O
our	|O
patients	|O
had	|O
polyps	|O
,	|O
23	|O
(	|O
54%	|O
)	|O
had	|O
asthma	|O
,	|O
12	|O
(	|O
27%	|O
)	|O
had	|O
aspirin	|O
sensitivity	|O
,	|O
20	|O
(	|O
65%	|O
)	|O
had	|O
eosinophilia	|O
,	|O
and	|O
9	|O
(	|O
69%	|O
)	|O
had	|O
increased	|O
total	|O
IgE	|B-PROTEIN
levels	|O
.	|O

Ras	|O
-	|O
and	|O
ultra	|B-PROTEIN
-	|I-PROTEIN
violet	|I-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
that	|O
phosphorylate	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
on	|O
serine	|O
residues	|O
at	|O
positions	|O
63	|O
and	|O
73	|O
and	|O
stimulate	|O
its	|O
transcriptional	|O
activity	|O
have	|O
been	|O
identified	|O
.	|O

A	|O
short	|O
sequence	|O
surrounding	|O
the	|O
major	|O
JNK	|B-PROTEIN
phosphorylation	|O
site	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
is	|O
conserved	|O
in	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
and	|O
is	|O
part	|O
of	|O
its	|O
activation	|O
domain	|O
,	|O
suggesting	|O
that	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
may	|O
be	|O
similarly	|O
regulated	|O
.	|O

c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
transcriptional	|O
activity	|O
stimulated	|O
by	|O
H	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
-	|O
activated	|O
protein	|O
kinase	|O
distinct	|O
from	|O
JNK	|B-PROTEIN
and	|O
ERK	|B-PROTEIN
.	|O

A	|O
new	|O
generation	|O
of	|O
information	|O
retrieval	|O
tools	|O
for	|O
biologists	|O
:	|O
the	|O
example	|O
of	|O
the	|O
ExPASy	|O
WWW	|O
server	|O
.	|O

Essential	|O
features	|O
of	|O
this	|O
model	|O
are	|O
bending	|O
of	|O
the	|O
DNA	|O
double	|O
helix	|O
and	|O
contact	|O
of	|O
operator	|O
sites	|O
with	|O
repressor	|O
domains	|O
bearing	|O
sequence	|O
homologies	|O
with	|O
the	|O
helix	|O
-	|O
turn	|O
-	|O
helix	|O
(	|O
HTH	|O
)	|O
motifs	|O
of	|O
other	|O
DNA	|O
-	|O
binding	|O
proteins	|O
.	|O

The	|O
partial	|O
ORF	|O
was	|O
found	|O
to	|O
be	|O
identical	|O
to	|O
the	|O
C	|O
terminus	|O
of	|O
HrpJ2	|B-PROTEIN
.	|O

The	|O
partial	|O
ORF	|O
was	|O
found	|O
to	|O
be	|O
identical	|O
to	|O
the	|O
C	|O
terminus	|O
of	|O
HrpJ2	|B-PROTEIN
.	|O

The	|O
binding	|O
of	|O
transcription	|O
factor	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
vitamin	|B-PROTEIN
D	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
VDR	|B-PROTEIN
)	|O
to	|O
the	|O
composite	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
plus	|I-PROTEIN
vitamin	|I-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
promoter	|I-PROTEIN
region	|O
(	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
+	|I-PROTEIN
VDRE	|I-PROTEIN
)	|O
of	|O
the	|O
human	|O
osteocalcin	|B-PROTEIN
gene	|O
was	|O
characterized	|O
in	|O
osteocalcin	|B-PROTEIN
-	|O
producing	|O
(	|O
MG	|O
-	|O
63	|O
)	|O
and	|O
non	|O
-	|O
producing	|O
(	|O
U2	|O
-	|O
Os	|O
,	|O
SaOs	|O
-	|O
2	|O
)	|O
human	|O
osteosarcoma	|O
cell	|O
lines	|O
.	|O

Rapid	|O
detection	|O
of	|O
this	|O
mutation	|O
is	|O
achieved	|O
by	|O
restriction	|O
digestion	|O
of	|O
PCR	|O
-	|O
amplified	|O
genomic	|O
DNA	|O
;	|O
a	|O
mismatch	|O
primer	|O
combined	|O
with	|O
the	|O
point	|O
mutation	|O
creates	|O
a	|O
Tru9I	|B-PROTEIN
restriction	|O
site	|O
.	|O

Wild	|O
type	|O
and	|O
mutant	|O
Epo	|B-PROTEIN
cDNAs	|O
were	|O
transiently	|O
expressed	|O
at	|O
high	|O
levels	|O
in	|O
COS1	|O
and	|O
COS7	|O
cells	|O
.	|O

OBJECTIVE	|O
-	|O
-	|O
To	|O
assess	|O
the	|O
risk	|O
of	|O
hepatitis	|O
A	|O
in	|O
international	|O
travelers	|O
and	|O
to	|O
recommend	|O
preventive	|O
measures	|O
.	|O

The	|O
bactericidal	|O
effect	|O
of	|O
disinfectants	|O
against	|O
biofilm	|O
cells	|O
was	|O
found	|O
to	|O
be	|O
considerably	|O
enhanced	|O
by	|O
increasing	|O
the	|O
concentrations	|O
of	|O
the	|O
disinfectants	|O
.	|O

Expression	|O
of	|O
ME31B	|B-PROTEIN
cDNA	|O
in	|O
S.	|O
pombe	|O
suppresses	|O
the	|O
ste13	|B-PROTEIN
mutation	|O
.	|O

Use	|O
of	|O
Medi	|O
-	|O
Jector	|O
EZ	|O
dermojet	|O
for	|O
anesthesia	|O
in	|O
minor	|O
surgery	|O

2	|O
.	|O

The	|O
immune	|O
response	|O
of	|O
past	|O
-	|O
infection	|O
of	|O
cytomegalovirus	|O
in	|O
the	|O
patients	|O
of	|O
RTID	|O
is	|O
rather	|O
remarkable	|O
.	|O

Acupuncture	|O
effect	|O
on	|O
deep	|O
receptors	|O
was	|O
not	|O
limited	|O
to	|O
one	|O
point	|O
but	|O
within	|O
a	|O
certain	|O
area	|O
,	|O
namely	|O
distant	|O
effect	|O
existed	|O
.	|O

Reduced	|O
NK	|O
activity	|O
correlates	|O
with	|O
active	|O
disease	|O
in	|O
HIV	|O
-	|O
patients	|O
with	|O
multidrug	|O
-	|O
resistant	|O
pulmonary	|O
tuberculosis	|O
.	|O

Smoking	|O
history	|O
and	|O
awake	|O
oxygen	|O
saturation	|O
(	|O
SaO2	|O
)	|O
was	|O
recorded	|O
in	|O
all	|O
of	|O
them	|O
.	|O

(	|O
LH	|B-PROTEIN
P	|O
<	|O
0.05	|O
,	|O
LH	|B-PROTEIN
/	|O
FSH	|B-PROTEIN
P	|O
<	|O
0.01	|O
)	|O
.	|O

The	|O
relative	|O
R	|O
-	|O
and	|O
L	|O
-	|O
brain	|O
weights	|O
were	|O
found	|O
to	|O
be	|O
inversely	|O
related	|O
to	|O
the	|O
relative	|O
R	|O
-	|O
L	|O
brain	|O
weight	|O
only	|O
in	|O
the	|O
RH	|O
female	|O
cats	|O
with	|O
R	|O
-	|O
L	|O
brain	|O
weight	|O
smaller	|O
than	|O
zero	|O
(	|O
testosterone	|O
in	|O
males	|O
,	|O
estrogen	|O
in	|O
females	|O
)	|O
.	|O

This	|O
mode	|O
of	|O
ternary	|O
complex	|O
formation	|O
is	|O
in	|O
contrast	|O
to	|O
the	|O
one	|O
seen	|O
in	|O
the	|O
promoter	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
protooncogene	|O
,	|O
where	|O
formation	|O
of	|O
the	|O
ternary	|O
complex	|O
is	|O
dependent	|O
on	|O
the	|O
prior	|O
assembly	|O
of	|O
the	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
-	|O
DNA	|O
binary	|O
complex	|O
.	|O

The	|O
LTR	|O
-	|O
binding	|O
activities	|O
of	|O
VBP	|B-PROTEIN
,	|O
a1	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
,	|O
and	|O
B	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
nuclear	|I-PROTEIN
extract	|I-PROTEIN
protein	|I-PROTEIN
were	|O
compared	|O
and	|O
mapped	|O
by	|O
gel	|O
shift	|O
,	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
,	|O
and	|O
methylation	|O
interference	|O
assays	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
leader	|O
-	|O
mRNA	|O
fusion	|O
in	|O
coronavirus	|O
transcription	|O
does	|O
not	|O
require	|O
direct	|O
RNA	|O
-	|O
RNA	|O
interaction	|O
between	|O
complementary	|O
sequences	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
leader	|O
-	|O
mRNA	|O
fusion	|O
in	|O
coronavirus	|O
transcription	|O
does	|O
not	|O
require	|O
direct	|O
RNA	|O
-	|O
RNA	|O
interaction	|O
between	|O
complementary	|O
sequences	|O
.	|O

Vaccinia	|O
virus	|O
-	|O
expressed	|O
,	|O
purified	|O
full	|O
-	|O
length	|O
HPV	|O
-	|O
16	|O
and	|O
BPV	|O
-	|O
1	|O
E2	|B-PROTEIN
proteins	|O
bound	|O
a	|O
consensus	|O
E2	|B-PROTEIN
site	|O
with	|O
high	|O
specific	|O
affinities	|O
(	|O
Kd	|O
=	|O
approximately	|O
10	|O
(	|O
-	|O
9	|O
)	|O
M	|O
)	|O
and	|O
stimulated	|O
in	|O
vitro	|O
transcription	|O
up	|O
to	|O
six	|O
-	|O
to	|O
eightfold	|O
.	|O

This	|O
alternatively	|O
spliced	|O
transcript	|O
contained	|O
an	|O
open	|O
reading	|O
frame	|O
extending	|O
from	|O
the	|O
upstream	|O
J	|O
alpha	|O
11-2	|O
region	|O
to	|O
82	|O
nucleotides	|O
downstream	|O
of	|O
the	|O
beginning	|O
of	|O
the	|O
TCR	|B-PROTEIN
C	|I-PROTEIN
alpha	|O
region	|O
,	|O
and	|O
potentially	|O
encoded	|O
a	|O
36	|O
amino	|O
acid	|O
polypeptide	|O
.	|O

In	|O
HeLa	|O
x	|O
fibroblast	|O
cell	|O
hybrids	|O
its	|O
expression	|O
correlates	|O
with	|O
tumorigenicity	|O
.	|O

Demographic	|O
characteristics	|O
and	|O
risk	|O
factor	|O
data	|O
for	|O
76,672	|O
clients	|O
were	|O
studied	|O
to	|O
characterize	|O
the	|O
distribution	|O
of	|O
infection	|O
with	|O
human	|O
immunodeficiency	|O
virus	|O
(	|O
HIV	|O
)	|O
and	|O
the	|O
use	|O
of	|O
counseling	|O
and	|O
testing	|O
facilities	|O
in	|O
Houston	|O
,	|O
Tex	|O
.	|O

Results	|O
indicate	|O
that	|O
KNM	|O
-	|O
LU	|O
335	|O
differs	|O
from	|O
both	|O
human	|O
and	|O
chimpanzee	|O
M1s	|O
in	|O
relative	|O
distances	|O
(	|O
measured	|O
in	|O
three	|O
dimensions	|O
)	|O
between	|O
crown	|O
fissure	|O
termini	|O
.	|O

We	|O
describe	|O
49	|O
cases	|O
with	|O
papillary	|O
tumor	|O
<	|O
1	|O
cm	|O
.	|O

Comparison	|O
with	|O
the	|O
bovine	|O
gene	|O
showed	|O
that	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
hATP1	|B-PROTEIN
gene	|O
has	|O
an	|O
unconserved	|O
guanine	|O
-	|O
cytosine	|O
(	|O
GC	|O
)	|O
rich	|O
region	|O
,	|O
including	|O
several	|O
binding	|O
motifs	|O
of	|O
transcriptional	|O
factors	|O
,	|O
such	|O
as	|O
Sp1	|B-PROTEIN
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
and	|O
GCF	|B-PROTEIN
.	|O

Structure	|O
,	|O
promoter	|O
analysis	|O
and	|O
chromosomal	|O
assignment	|O
of	|O
the	|O
human	|O
APEX	|B-PROTEIN
gene	|O
.	|O

The	|O
polyubiquitin	|B-PROTEIN
gene	|O
was	|O
transcribed	|O
throughout	|O
the	|O
Volvox	|O
life	|O
cycle	|O
with	|O
peaks	|O
in	|O
the	|O
1.6	|O
-	|O
kb	|O
mRNA	|O
levels	|O
during	|O
pre	|O
-	|O
cleavage	|O
,	|O
cleavage	|O
,	|O
and	|O
post	|O
-	|O
inversion	|O
.	|O

Thus	|O
,	|O
in	|O
stress	|O
-	|O
induced	|O
arrhythmic	|O
disease	|O
as	|O
well	|O
as	|O
in	|O
ischemic	|O
heart	|O
disease	|O
,	|O
the	|O
main	|O
pathogenetic	|O
links	|O
are	|O
outside	|O
the	|O
heart	|O
,	|O
but	|O
they	|O
differ	|O
from	|O
those	|O
observed	|O
in	|O
ischemia	|O
.	|O

Here	|O
,	|O
we	|O
present	|O
genetic	|O
evidence	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
for	|O
a	|O
functional	|O
interaction	|O
between	|O
the	|O
DEAH	|B-PROTEIN
protein	|O
Prp16	|B-PROTEIN
,	|O
and	|O
the	|O
U6	|B-PROTEIN
and	|O
U2	|B-PROTEIN
spliceosomal	|O
snRNAs	|O
.	|O

The	|O
consensus	|O
gene	|O
order	|O
deduced	|O
by	|O
combining	|O
data	|O
from	|O
both	|O
crosses	|O
is	|O
D2Mit1	|B-PROTEIN
-	|O
(	|O
Dbh	|B-PROTEIN
,	|O
Notch1	|B-PROTEIN
)	|O
-	|O
(	|O
Col5a1	|B-PROTEIN
,	|O
Rxra	|B-PROTEIN
)	|O
-	|O
Spna2	|B-PROTEIN
-	|O
Ab	|B-PROTEIN
l	|I-PROTEIN
-	|O
(	|O
Ak1	|B-PROTEIN
,	|O
Fpgs	|B-PROTEIN
)	|O
-	|O
(	|O
Grp78	|B-PROTEIN
,	|O
Pbx3	|B-PROTEIN
)	|O
-	|O
(	|O
Epb7.2	|B-PROTEIN
,	|I-PROTEIN
Hc	|I-PROTEIN
,	|I-PROTEIN
Gsn	|I-PROTEIN
)	|O
-	|O
Acra	|B-PROTEIN
.	|O

The	|O
high	|O
level	|O
of	|O
transformation	|O
-	|O
associated	|O
deletions	|O
in	|O
the	|O
human	|O
YACs	|O
was	|O
reduced	|O
over	|O
10	|O
-	|O
fold	|O
when	|O
the	|O
host	|O
was	|O
a	|O
recombination	|O
-	|O
deficient	|O
strain	|O
deleted	|O
for	|O
the	|O
RAD52	|B-PROTEIN
gene	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
megabase	|O
region	|O
surrounding	|O
the	|O
dagA	|B-PROTEIN
locus	|O
was	|O
mapped	|O
.	|O

These	|O
mutants	|O
had	|O
deletions	|O
of	|O
the	|O
extreme	|O
amino	|O
-	|O
terminal	|O
residues	|O
as	|O
far	|O
as	|O
amino	|O
acid	|O
residue	|O
30	|O
.	|O

SECONDARY	|O
OUTCOME	|O
MEASURE	|O
-	|O
-	|O
Double	|O
-	|O
blind	|O
caffeine	|O
-	|O
withdrawal	|O
evaluation	|O
.	|O

Elimination	|O
of	|O
natural	|O
antibodies	|O
in	|O
discordant	|O
xenografts	|O

An	|O
8	|O
-	|O
bp	|O
sequence	|O
(	|O
ATTTCAAA	|O
)	|O
within	|O
the	|O
protected	|O
region	|O
shares	|O
significant	|O
homology	|O
with	|O
promoter	|O
sequences	|O
required	|O
for	|O
ethylene	|O
responsiveness	|O
from	|O
the	|O
tomato	|O
fruit	|O
-	|O
ripening	|O
E4	|B-PROTEIN
gene	|O
.	|O

We	|O
present	|O
evidence	|O
that	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
delta	|I-PROTEIN
of	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
an	|O
enzyme	|O
that	|O
is	|O
essential	|O
for	|O
viability	|O
and	|O
chromosomal	|O
replication	|O
,	|O
is	|O
also	|O
required	|O
for	|O
base	|O
excision	|O
repair	|O
of	|O
exogenous	|O
DNA	|O
methylation	|O
damage	|O
.	|O

We	|O
have	|O
identified	|O
two	|O
Marek	|O
's	|O
Disease	|O
Virus	|O
(	|O
MDV	|O
)	|O
genes	|O
within	|O
the	|O
EcoRI	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
fragment	|O
of	|O
MDV	|O
-	|O
GA	|O
genomic	|O
DNA	|O
.	|O

Cowpox	|O
virus	|O
contains	|O
two	|O
copies	|O
of	|O
an	|O
early	|B-PROTEIN
gene	|I-PROTEIN
encoding	|O
a	|O
soluble	|O
secreted	|O
form	|O
of	|O
the	|O
type	|O
II	|O
TNF	|B-PROTEIN
receptor	|I-PROTEIN
.	|O

To	|O
determine	|O
whether	|O
P35	|B-PROTEIN
could	|O
activate	|O
the	|O
39k	|O
promoter	|O
in	|O
the	|O
absence	|O
of	|O
IE1	|B-PROTEIN
,	|O
the	|O
p35	|B-PROTEIN
open	|O
reading	|O
frame	|O
was	|O
cloned	|O
under	|O
the	|O
control	|O
of	|O
the	|O
ie1	|B-PROTEIN
promoter	|O
.	|O

Mutagenesis	|O
of	|O
each	|O
NRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
motif	|O
in	|O
the	|O
ALAS	|B-PROTEIN
promoter	|O
gave	|O
substantially	|O
lowered	|O
levels	|O
of	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
expression	|O
,	|O
whereas	|O
mutagenesis	|O
of	|O
both	|O
NRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
motifs	|O
resulted	|O
in	|O
the	|O
almost	|O
complete	|O
loss	|O
of	|O
expression	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
analysis	|O
indicated	|O
that	|O
DREF	|B-PROTEIN
binds	|O
to	|O
the	|O
24	|O
-	|O
bp	|O
DRE	|O
region	|O
of	|O
the	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
in	|O
which	|O
8	|O
-	|O
bp	|O
palindromic	|O
sequences	|O
are	|O
centered	|O
.	|O

Novel	|O
8	|O
-	|O
base	|O
pair	|O
sequence	|O
(	|O
Drosophila	|O
DNA	|O
replication	|O
-	|O
related	|O
element	|O
)	|O
and	|O
specific	|O
binding	|O
factor	|O
involved	|O
in	|O
the	|O
expression	|O
of	|O
Drosophila	|O
genes	|O
for	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
proliferating	|B-PROTEIN
cell	|I-PROTEIN
nuclear	|I-PROTEIN
antigen	|I-PROTEIN
.	|O

In	|O
addition	|O
,	|O
a	|O
microsatellite	|O
repeat	|O
polymorphism	|O
with	|O
a	|O
heterozygosity	|O
of	|O
71%	|O
at	|O
the	|O
RET	|B-PROTEIN
locus	|O
and	|O
a	|O
restriction	|O
fragment	|O
length	|O
polymorphism	|O
with	|O
a	|O
heterozygosity	|O
of	|O
42%	|O
detected	|O
by	|O
a	|O
lambda	|O
clone	|O
from	|O
the	|O
D10S94	|B-PROTEIN
locus	|O
have	|O
been	|O
developed	|O
for	|O
high	|O
-	|O
resolution	|O
genetic	|O
linkage	|O
mapping	|O
and	|O
predictive	|O
diagnostic	|O
testing	|O
.	|O

However	|O
,	|O
tyrA	|B-PROTEIN
can	|O
be	|O
expressed	|O
efficiently	|O
from	|O
an	|O
internal	|O
promoter	|O
which	|O
appears	|O
to	|O
lie	|O
within	|O
the	|O
3'	|O
portion	|O
of	|O
aroF	|B-PROTEIN
.	|O

Within	|O
the	|O
span	|O
of	|O
attenuator	|O
region	|O
encoding	|O
the	|O
three	|O
stem	|O
-	|O
loop	|O
structures	|O
of	|O
mRNA	|O
secondary	|O
configuration	|O
,	|O
hot	|O
spots	|O
of	|O
base	|O
-	|O
residue	|O
divergence	|O
were	|O
localized	|O
to	|O
looped	|O
-	|O
out	|O
regions	|O
.	|O

Most	|O
,	|O
however	|O
,	|O
would	|O
tell	|O
the	|O
spouse	|O
the	|O
full	|O
truth	|O
about	|O
both	|O
diagnosis	|O
and	|O
prognosis	|O
.	|O

Previous	|O
studies	|O
showed	|O
that	|O
mutations	|O
in	|O
the	|O
6K	|O
protein	|O
led	|O
to	|O
the	|O
slow	|O
release	|O
of	|O
aberrant	|O
,	|O
multi	|O
-	|O
cored	|O
infectious	|O
virions	|O
.	|O

Metabolism	|O
of	|O
calcium	|O
and	|O
vitamin	|O
D3	|O
in	|O
patients	|O
with	|O
acute	|O
tubulointerstitial	|O
nephritis	|O
:	|O
a	|O
study	|O
of	|O
41	|O
patients	|O
with	|O
nephropathia	|O
epidemica	|O
.	|O

Furthermore	|O
,	|O
this	|O
study	|O
demonstrates	|O
that	|O
reduced	|O
inotropy	|O
with	|O
timolol	|O
helped	|O
uniform	|O
local	|O
contraction	|O
as	|O
estimated	|O
by	|O
the	|O
increased	|O
LONG	|O
/	|O
CIRC	|O
ratio	|O
,	|O
a	|O
transition	|O
that	|O
could	|O
improve	|O
contraction	|O
efficacy	|O
.	|O

Effects	|O
of	|O
moderate	|O
hypercapnia	|O
on	|O
hypothermia	|O
induced	|O
by	|O
cold	|O
He	|O
-	|O
O2	|O
in	|O
rats	|O
.	|O

The	|O
RFLP	|O
patterns	|O
of	|O
the	|O
isolates	|O
from	|O
six	|O
of	|O
these	|O
patients	|O
remained	|O
essentially	|O
unchanged	|O
(	|O
two	|O
strains	|O
showed	|O
one	|O
additional	|O
band	|O
)	|O
despite	|O
the	|O
development	|O
of	|O
drug	|O
resistance	|O
.	|O

We	|O
recommend	|O
that	|O
ovarian	|O
stimulation	|O
is	|O
done	|O
only	|O
if	|O
there	|O
is	|O
a	|O
valid	|O
indication	|O
after	|O
proper	|O
assessment	|O
of	|O
the	|O
ovaries	|O
,	|O
and	|O
that	|O
women	|O
who	|O
have	|O
had	|O
ovarian	|O
stimulation	|O
are	|O
followed	|O
for	|O
longer	|O
than	|O
at	|O
present	|O
.	|O

A23187	|O
did	|O
not	|O
induce	|O
any	|O
modifications	|O
of	|O
the	|O
endolymphatic	|O
potential	|O
,	|O
the	|O
ampullar	|O
direct	|O
current	|O
or	|O
the	|O
frequency	|O
of	|O
the	|O
evoked	|O
afferent	|O
spikes	|O
.	|O

Activation	|O
of	|O
the	|O
aboral	|O
ectoderm	|O
-	|O
specific	|O
Spec2a	|B-PROTEIN
gene	|O
in	|O
blastula	|O
-	|O
stage	|O
sea	|O
urchin	|O
embryos	|O
requires	|O
an	|O
upstream	|O
regulatory	|O
region	|O
that	|O
is	|O
part	|O
of	|O
a	|O
repetitive	|O
sequence	|O
element	|O
(	|O
RSR	|O
)	|O
associated	|O
with	|O
all	|O
Spec1	|B-PROTEIN
/	|O
Spec2	|B-PROTEIN
genes	|O
.	|O

A	|O
transcript	|O
of	|O
about	|O
2	|O
kb	|O
is	|O
expected	|O
for	|O
each	|O
PPO	|B-PROTEIN
.	|O

Mutations	|O
in	|O
a	|O
region	|O
located	|O
15	|O
to	|O
30	|O
bp	|O
downstream	|O
from	|O
the	|O
major	|O
transcription	|O
start	|O
site	|O
that	|O
shows	|O
good	|O
homology	|O
to	|O
a	|O
sequence	|O
in	|O
the	|O
first	|O
exon	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
implicated	|O
as	|O
a	|O
negative	|O
regulatory	|O
element	|O
resulted	|O
in	|O
a	|O
significant	|O
increase	|O
in	|O
basal	|O
gene	|O
expression	|O
but	|O
did	|O
not	|O
affect	|O
regulation	|O
.	|O

Salazopyrine	|O
desensitization	|O

During	|O
exercise	|O
,	|O
the	|O
Pes	|O
-	|O
Ves	|O
relation	|O
was	|O
shifted	|O
toward	|O
the	|O
left	|O
and	|O
the	|O
slope	|O
[	|O
end	|O
-	|O
systolic	|O
elastance	|O
(	|O
Ees	|O
)	|O
]	|O
increased	|O
from	|O
7.7	|O
+	|O
/	|O
-	|O
2.8	|O
to	|O
12.7	|O
+	|O
/	|O
-	|O
4.2	|O
(	|O
SD	|O
)	|O
mmHg	|O
/	|O
ml	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

We	|O
show	|O
that	|O
HRI	|B-PROTEIN
and	|O
dsRNA	|B-PROTEIN
-	|I-PROTEIN
PK	|I-PROTEIN
phosphorylate	|O
yeast	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
and	|O
functionally	|O
substitute	|O
for	|O
GCN2	|B-PROTEIN
protein	|O
to	|O
stimulate	|O
GCN4	|B-PROTEIN
translation	|O
in	|O
yeast	|O
.	|O

Double	|O
-	|O
staining	|O
confirmed	|O
that	|O
there	|O
were	|O
separate	|O
populations	|O
of	|O
CD68	|B-PROTEIN
-	|O
positive	|O
macrophages	|O
and	|O
XIIIa	|B-PROTEIN
-	|O
positive	|O
dendrocytes	|O
.	|O

Interestingly	|O
,	|O
in	|O
the	|O
adult	|O
,	|O
transgene	|O
expression	|O
patterns	|O
within	|O
the	|O
cerebellum	|O
in	|O
two	|O
lines	|O
appeared	|O
to	|O
mark	|O
distinct	|O
anterior	|O
-	|O
posterior	|O
compartments	|O
.	|O

Southern	|O
analysis	|O
on	|O
genomic	|O
DNA	|O
isolated	|O
from	|O
tissues	|O
and	|O
cell	|O
lines	|O
from	|O
several	|O
mouse	|O
strains	|O
using	|O
mCD22	|B-PROTEIN
cDNA	|O
demonstrated	|O
that	|O
the	|O
Cd22	|B-PROTEIN
locus	|O
encoding	|O
mCD22	|B-PROTEIN
is	|O
a	|O
single	|O
copy	|O
gene	|O
of	|O
<	|O
or	|O
=	|O
30	|O
kb	|O
.	|O

The	|O
concentrations	|O
of	|O
plasma	|O
ACTH	|B-PROTEIN
and	|O
cortisol	|O
increased	|O
by	|O
40%	|O
and	|O
60%	|O
after	|O
MPTP	|O
treatment	|O
,	|O
respectively	|O
.	|O

Instead	|O
,	|O
the	|O
results	|O
support	|O
the	|O
idea	|O
that	|O
Pc	|B-PROTEIN
group	|O
products	|O
provide	|O
stable	|O
memory	|O
or	|O
imprinting	|O
of	|O
boundaries	|O
which	|O
are	|O
initially	|O
specified	|O
by	|O
gap	|O
and	|O
pair	|O
-	|O
rule	|O
regulators	|O
.	|O

To	|O
investigate	|O
the	|O
regulation	|O
of	|O
expression	|O
of	|O
the	|O
human	|O
mdr1	|B-PROTEIN
gene	|O
,	|O
the	|O
response	|O
of	|O
the	|O
mdr1	|B-PROTEIN
promoter	|O
to	|O
signals	|O
involved	|O
in	|O
cell	|O
proliferation	|O
was	|O
examined	|O
.	|O

The	|O
tyrosine	|B-PROTEIN
hydroxylase	|I-PROTEIN
gene	|O
(	|O
TH	|B-PROTEIN
)	|O
contains	|O
a	|O
single	|O
copy	|O
of	|O
a	|O
consensus	|O
CRE	|O
at	|O
-	|O
45	|O
to	|O
-	|O
38	|O
base	|O
pair	|O
(	|O
bp	|O
)	|O
upstream	|O
of	|O
the	|O
transcription	|O
initiation	|O
site	|O
.	|O

Tobacco	|O
mosaic	|O
virus	|O
-	|O
infected	|O
tobacco	|O
(	|O
Nicotiana	|O
tabacum	|O
var	|O
.	|O

Through	|O
a	|O
stretch	|O
of	|O
56	|O
amino	|O
acids	|O
,	|O
constituting	|O
the	|O
MADS	|B-PROTEIN
domain	|O
,	|O
the	|O
two	|O
proteins	|O
are	|O
identical	|O
except	|O
for	|O
two	|O
conservative	|O
amino	|O
acid	|O
substitutions	|O
.	|O

Isolation	|O
and	|O
characterization	|O
of	|O
SRF	|B-PROTEIN
accessory	|O
proteins	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
:	|O
(	|O
a	|O
)	|O
proSRIF	|B-PROTEIN
cleavage	|O
is	|O
initiated	|O
in	|O
the	|O
TGN	|O
,	|O
and	|O
(	|O
b	|O
)	|O
this	|O
reaction	|O
requires	|O
an	|O
acidic	|O
pH	|O
which	|O
is	|O
facilitated	|O
by	|O
a	|O
Golgi	|O
-	|O
associated	|O
vacuolar	|O
-	|O
type	|O
ATPase	|B-PROTEIN
.	|O

Fenoldopam	|O
,	|O
a	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
agonist	|O
,	|O
has	|O
been	|O
shown	|O
,	|O
in	|O
animal	|O
experiments	|O
,	|O
to	|O
improve	|O
renal	|O
perfusion	|O
.	|O

Clinical	|O
aspects	|O
of	|O
early	|O
increase	|O
in	|O
serum	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
glutamyl	|I-PROTEIN
transferase	|I-PROTEIN
in	|O
cerebral	|O
infarction	|O
.	|O

In	|O
the	|O
3'	|O
flanking	|O
region	|O
of	|O
the	|O
27	|O
kDa	|O
zein	|B-PROTEIN
gene	|O
,	|O
several	|O
AATAAA	|O
-	|O
like	|O
sequences	|O
and	|O
a	|O
sequence	|O
resembling	|O
the	|O
mammalian	|O
GT	|O
-	|O
rich	|O
sequence	|O
are	|O
present	|O
around	|O
the	|O
polyadenylation	|O
sites	|O
.	|O

The	|O
indoor	|O
radon	|O
concentration	|O
in	|O
the	|O
summer	|O
(	|O
1990	|O
)	|O
period	|O
ranged	|O
between	|O
8	|O
and	|O
81	|O
Bq	|O
m	|O
-	|O
3	|O
,	|O
while	|O
in	|O
the	|O
winter	|O
(	|O
1989-1990	|O
)	|O
it	|O
ranged	|O
between	|O
20	|O
and	|O
143	|O
Bq	|O
m	|O
-	|O
3	|O
for	|O
the	|O
first	|O
year	|O
of	|O
measurements	|O
or	|O
between	|O
8	|O
and	|O
92	|O
Bq	|O
m	|O
-	|O
3	|O
in	|O
the	|O
summer	|O
(	|O
1991	|O
)	|O
period	|O
and	|O
between	|O
12	|O
and	|O
119	|O
Bq	|O
m	|O
-	|O
3	|O
in	|O
the	|O
winter	|O
(	|O
1990-1991	|O
)	|O
for	|O
the	|O
second	|O
year	|O
of	|O
measurements	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
hrpRS	|B-PROTEIN
and	|O
hrpL	|B-PROTEIN
are	|O
part	|O
of	|O
a	|O
regulatory	|O
cascade	|O
in	|O
which	|O
HrpR	|B-PROTEIN
and	|O
HrpS	|B-PROTEIN
activate	|O
expression	|O
of	|O
hrpL	|B-PROTEIN
and	|O
HrpL	|B-PROTEIN
,	|O
a	|O
putative	|O
sigma	|B-PROTEIN
factor	|I-PROTEIN
,	|O
induces	|O
expression	|O
of	|O
HrpL	|B-PROTEIN
-	|O
responsive	|O
genes	|O
.	|O

DtxR	|B-PROTEIN
is	|O
an	|O
iron	|O
-	|O
dependent	|O
sequence	|O
-	|O
specific	|O
DNA	|O
-	|O
binding	|O
protein	|O
that	|O
binds	|O
to	|O
the	|O
tox	|B-PROTEIN
operator	|O
,	|O
an	|O
inverted	|O
-	|O
repeat	|O
nucleotide	|O
sequence	|O
located	|O
upstream	|O
from	|O
the	|O
diphtheria	|B-PROTEIN
toxin	|I-PROTEIN
gene	|O
.	|O

Vasopressin	|B-PROTEIN
(	|O
AVP	|B-PROTEIN
)	|O
,	|O
the	|O
antidiuretic	|O
hormone	|O
,	|O
is	|O
a	|O
cyclic	|O
nonapeptide	|O
that	|O
acts	|O
through	|O
binding	|O
to	|O
G	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
specific	|I-PROTEIN
membrane	|I-PROTEIN
receptors	|I-PROTEIN
pharmacologically	|O
divided	|O
into	|O
three	|O
subtypes	|O
(	|O
V1a	|B-PROTEIN
,	|O
V1b	|B-PROTEIN
,	|O
and	|O
V2	|B-PROTEIN
)	|O
linked	|O
to	|O
distinct	|O
second	|O
messengers	|O
.	|O

These	|O
results	|O
confirmed	|O
that	|O
cleavage	|O
of	|O
the	|O
leader	|O
peptide	|O
is	|O
the	|O
last	|O
step	|O
in	|O
nisin	|B-PROTEIN
maturation	|O
and	|O
is	|O
necessary	|O
to	|O
generate	|O
a	|O
biologically	|O
active	|O
peptide	|O
.	|O

When	|O
the	|O
promoter	|O
region	|O
was	|O
linked	|O
with	|O
a	|O
heterologous	|O
reporter	|O
gene	|O
,	|O
we	|O
found	|O
that	|O
the	|O
promoter	|O
region	|O
is	|O
inducible	|O
by	|O
both	|O
interferons	|B-PROTEIN
(	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
)	|O
and	|O
interferon	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
B.	|I-PROTEIN
burgdorferi	|I-PROTEIN
,	|O
anti	|B-PROTEIN
-	|I-PROTEIN
B.	|I-PROTEIN
turicatae	|I-PROTEIN
and	|O
anti	|B-PROTEIN
-	|I-PROTEIN
B.	|I-PROTEIN
parkeri	|I-PROTEIN
antibodies	|O
,	|O
tested	|O
by	|O
the	|O
indirect	|O
immunofluorescent	|O
assay	|O
(	|O
IFA	|O
)	|O
,	|O
were	|O
detected	|O
in	|O
10.8	|O
,	|O
16.1	|O
and	|O
8.2%	|O
of	|O
the	|O
serum	|O
samples	|O
tested	|O
,	|O
and	|O
confirmed	|O
by	|O
IFA	|O
-	|O
ABS	|O
in	|O
1.3	|O
,	|O
1.3	|O
and	|O
1.0%	|O
,	|O
respectively	|O
.	|O

The	|O
approach	|O
derives	|O
from	|O
a	|O
recently	|O
described	|O
strategy	|O
for	|O
making	|O
recombinants	|O
from	|O
five	|O
overlapping	|O
EBV	|O
cosmid	|O
-	|O
cloned	|O
DNAs	|O
(	|O
B.	|O

Evaluation	|O
of	|O
desmopressin	|O
for	|O
dental	|O
extractions	|O
in	|O
patients	|O
with	|O
hemostatic	|O
disorders	|O
.	|O

Comparative	|O
analysis	|O
with	|O
an	|O
antiandrogen	|O
niftolid	|O
and	|O
synthetic	|O
GnRH	|B-PROTEIN
was	|O
carried	|O
out	|O
in	|O
22	|O
normal	|O
subjects	|O
,	|O
14	|O
patients	|O
with	|O
primary	|O
and	|O
20	|O
ones	|O
with	|O
secondary	|O
hypogonadism	|O
,	|O
and	|O
in	|O
5	|O
patients	|O
with	|O
clinical	|O
signs	|O
of	|O
gonadal	|O
insufficiency	|O
and	|O
obscure	|O
diagnosis	|O
in	|O
order	|O
to	|O
elucidate	|O
the	|O
pituitary	|O
gonadotropin	|B-PROTEIN
reserves	|O
.	|O

All	|O
other	|O
normal	|O
and	|O
transformed	|O
lymphoid	|O
and	|O
nonlymphoid	|O
cell	|O
lines	|O
and	|O
normal	|O
tissues	|O
were	|O
negative	|O
for	|O
PANG	|B-PROTEIN
expression	|O
except	|O
for	|O
the	|O
brain	|O
,	|O
wherein	|O
unique	|O
4.0	|O
-	|O
and	|O
6.1	|O
-	|O
kb	|O
transcripts	|O
were	|O
detected	|O
.	|O

The	|O
cis	|O
-	|O
acting	|O
regulatory	|O
properties	|O
of	|O
an	|O
872	|O
bp	|O
promoter	|O
fragment	|O
of	|O
a	|O
B.	|O
napus	|O
oleosin	|B-PROTEIN
gene	|O
were	|O
examined	|O
by	|O
analysis	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
glucuronidase	|I-PROTEIN
(	|O
GUS	|B-PROTEIN
)	|O
expression	|O
in	|O
transgenic	|O
tobacco	|O
plants	|O
containing	|O
an	|O
oleosin	|B-PROTEIN
promoter	|O
-	|O
GUS	|B-PROTEIN
transcriptional	|O
fusion	|O
.	|O

This	|O
indicates	|O
that	|O
the	|O
mechanism	|O
by	|O
which	|O
CX	|O
blocks	|O
rapid	|O
degradation	|O
of	|O
tubulin	|B-PROTEIN
mRNA	|O
in	|O
vivo	|O
is	|O
not	|O
simply	|O
by	|O
preventing	|O
its	|O
translation	|O
and	|O
suggests	|O
the	|O
involvement	|O
of	|O
an	|O
altered	|O
trans	|O
-	|O
factor	|O
.	|O

L.	|O
,	|O
Greer	|O
,	|O
J.	|O
&	|O
Carter	|O
,	|O
G.	|O

Increasing	|O
the	|O
extracellular	|O
calcium	|O
concentration	|O
enhanced	|O
detrusor	|O
contractility	|O
in	|O
a	|O
dose	|O
-	|O
dependent	|O
manner	|O
in	|O
both	|O
control	|O
and	|O
obstructed	|O
bladders	|O
.	|O

Structural	|O
organization	|O
of	|O
the	|O
gene	|O
encoding	|O
the	|O
human	|O
lipocalin	|O
tear	|O
prealbumin	|B-PROTEIN
and	|O
synthesis	|O
of	|O
the	|O
recombinant	|O
protein	|O
in	|O
Escherichia	|O
coli	|O
.	|O

The	|O
sequence	|O
has	|O
a	|O
1092	|O
-	|O
bp	|O
open	|O
reading	|O
frame	|O
encoding	|O
a	|O
protein	|O
of	|O
364	|O
amino	|O
acids	|O
.	|O

Western	|O
blotting	|O
(	|O
immunoblotting	|O
)	|O
with	|O
an	|O
antiserum	|O
to	|O
a	|O
partial	|O
SOD	|B-PROTEIN
expressed	|O
in	|O
Escherichia	|O
coli	|O
revealed	|O
two	|O
proteins	|O
with	|O
estimated	|O
molecular	|O
masses	|O
of	|O
19	|O
and	|O
29	|O
kDa	|O
.	|O

The	|O
gene	|O
organization	|O
of	|O
CRSV	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
similar	|O
to	|O
those	|O
of	|O
red	|O
clover	|O
necrotic	|O
mosaic	|O
(	|O
RCNMV	|O
)	|O
and	|O
sweet	|O
clover	|O
necrotic	|O
mosaic	|O
(	|O
SCNMV	|O
)	|O
dianthoviruses	|O
with	|O
the	|O
exception	|O
that	|O
CRSV	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
contains	|O
the	|O
additional	|O
3'	|O
-	|O
terminal	|O
ORF	|O
.	|O

Members	|O
of	|O
the	|O
myocyte	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
factor	|I-PROTEIN
2	|I-PROTEIN
(	|O
MEF2	|B-PROTEIN
)	|O
family	|O
of	|O
transcription	|O
factors	|O
bind	|O
a	|O
conserved	|O
A	|O
/	|O
T	|O
-	|O
rich	|O
sequence	|O
in	|O
the	|O
control	|O
regions	|O
of	|O
numerous	|O
muscle	|O
-	|O
specific	|O
genes	|O
.	|O

We	|O
have	|O
previously	|O
shown	|O
that	|O
LBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
represses	|O
HIV	|O
-	|O
1	|O
transcription	|O
by	|O
inhibiting	|O
the	|O
binding	|O
of	|O
TFIID	|B-PROTEIN
to	|O
the	|O
TATA	|O
box	|O
.	|O

These	|O
results	|O
illustrate	|O
an	|O
important	|O
role	|O
for	|O
La	|B-PROTEIN
in	|O
RNA	|O
production	|O
by	|O
demonstrating	|O
its	|O
ability	|O
to	|O
clear	|O
the	|O
termination	|O
sites	|O
of	|O
class	|O
III	|O
templates	|O
,	|O
thereby	|O
promoting	|O
efficient	|O
use	|O
of	|O
transcription	|O
complexes	|O
by	|O
pol	|B-PROTEIN
III	|I-PROTEIN
.	|O

The	|O
films	|O
were	|O
analyzed	|O
using	|O
a	|O
scanning	|O
helium	|O
-	|O
neon	|O
laser	|O
densitometer	|O
with	|O
a	|O
small	|O
aperture	|O
of	|O
5-10	|O
microns	|O
.	|O

The	|O
GafChromic	|O
method	|O
has	|O
proven	|O
to	|O
be	|O
an	|O
accurate	|O
and	|O
rapid	|O
method	|O
of	|O
analysis	|O
and	|O
could	|O
be	|O
easily	|O
incorporated	|O
into	|O
a	|O
quality	|O
assurance	|O
program	|O
.	|O

Viral	|O
genomic	|O
RNA	|O
for	|O
these	|O
reactions	|O
was	|O
obtained	|O
directly	|O
from	|O
fecal	|O
specimens	|O
of	|O
infected	|O
infant	|O
rats	|O
.	|O

GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
was	|O
present	|O
in	|O
equivalent	|O
levels	|O
in	|O
both	|O
erythroid	|O
cell	|O
lines	|O
,	|O
but	|O
at	|O
a	|O
low	|O
level	|O
in	|O
FDC	|O
-	|O
P1	|O
cells	|O
.	|O

Tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
alpha	|I-PROTEIN
)	|O
is	|O
one	|O
of	|O
several	|O
autocrine	|O
/	|O
paracrine	|O
factors	|O
known	|O
to	|O
exert	|O
potent	|O
inhibitory	|O
effects	|O
on	|O
bone	|O
.	|O

We	|O
have	|O
investigated	|O
the	|O
role	|O
of	|O
cellular	|O
p21ras	|B-PROTEIN
protein	|O
in	|O
insulin	|B-PROTEIN
and	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
)	|O
signaling	|O
pathways	|O
.	|O

The	|O
lack	|O
of	|O
the	|O
C2	|B-PROTEIN
domain	|O
of	|O
the	|O
Ca	|O
(	|O
2+	|O
)	|O
-	|O
dependent	|O
PKCs	|B-PROTEIN
and	|O
the	|O
presence	|O
of	|O
a	|O
unique	|O
NH2	|O
-	|O
terminal	|O
sequence	|O
with	|O
a	|O
potential	|O
signal	|O
peptide	|O
and	|O
a	|O
transmembrane	|O
domain	|O
suggest	|O
that	|O
PKC	|B-PROTEIN
mu	|I-PROTEIN
is	|O
a	|O
novel	|O
member	|O
of	|O
the	|O
subgroup	|O
of	|O
atypical	|O
PKCs	|B-PROTEIN
.	|O

Moreover	|O
,	|O
we	|O
observed	|O
that	|O
the	|O
function	|O
of	|O
T3R	|B-PROTEIN
-	|O
RXR	|B-PROTEIN
heterodimers	|O
on	|O
response	|O
elements	|O
composed	|O
of	|O
two	|O
half	|O
-	|O
sites	|O
in	|O
a	|O
directly	|O
repeated	|O
orientation	|O
spaced	|O
by	|O
4	|O
nucleotides	|O
is	|O
determined	|O
in	|O
major	|O
parts	|O
by	|O
the	|O
5'	|O
-	|O
flanking	|O
sequence	|O
of	|O
the	|O
upstream	|O
half	|O
-	|O
site	|O
.	|O

However	|O
,	|O
three	|O
Hm1	|B-PROTEIN
mutants	|O
that	|O
were	|O
moderately	|O
deficient	|O
in	|O
stimulating	|O
PI	|O
turnover	|O
displayed	|O
normal	|O
sequestration	|O
,	|O
suggesting	|O
distinct	|O
mechanisms	|O
.	|O

Furthermore	|O
,	|O
in	|O
vitro	|O
decay	|O
reaction	|O
mixtures	|O
supplemented	|O
with	|O
the	|O
20	|O
-	|O
nt	|O
sense	|O
RNA	|O
transcript	|O
resulted	|O
in	|O
stabilization	|O
of	|O
R2	|B-PROTEIN
message	|O
.	|O

Deletion	|O
analyses	|O
of	|O
the	|O
pCD41	|B-PROTEIN
ORF	|O
-	|O
A	|O
and	|O
the	|O
use	|O
of	|O
promoter	|O
constructs	|O
further	|O
mapped	|O
an	|O
internal	|O
functional	|O
promoter	|O
within	|O
the	|O
pCD41	|B-PROTEIN
sequence	|O
that	|O
can	|O
direct	|O
the	|O
synthesis	|O
of	|O
the	|O
trans	|O
-	|O
activating	|O
protein	|O
.	|O

Seven	|O
of	|O
these	|O
had	|O
counterparts	|O
in	|O
the	|O
US	|O
of	|O
herpes	|O
simplex	|O
type	|O
1	|O
(	|O
HSV	|O
-	|O
1	|O
)	|O
,	|O
pseudorabies	|O
virus	|O
(	|O
PRV	|O
)	|O
,	|O
and	|O
equine	|O
herpesvirus	|O
type	|O
1	|O
(	|O
EHV	|O
-	|O
1	|O
)	|O
.	|O

The	|O
inferred	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
cyanobacterial	|O
HemB	|B-PROTEIN
protein	|O
indicates	|O
a	|O
significant	|O
difference	|O
in	|O
the	|O
metal	|O
cofactor	|O
requirement	|O
from	|O
the	|O
higher	|O
-	|O
plant	|O
enzymes	|O
,	|O
which	|O
was	|O
confirmed	|O
by	|O
overexpression	|O
and	|O
biochemical	|O
analysis	|O
.	|O

METHODS	|O
AND	|O
RESULTS	|O
:	|O
In	|O
25	|O
open	|O
-	|O
chest	|O
,	|O
anesthetized	|O
dogs	|O
,	|O
progressive	|O
circumflex	|O
artery	|O
stenosis	|O
led	|O
to	|O
a	|O
concordant	|O
decrease	|O
of	|O
circumflex	|O
artery	|O
resting	|O
and	|O
hyperemic	|O
flow	|O
,	|O
coronary	|O
flow	|O
reserve	|O
,	|O
and	|O
inverse	|O
angiographic	|O
mean	|O
transit	|O
time	|O
Tmicro	|O
-	|O
1	|O
(	|O
P	|O
<	|O
.01	|O
)	|O
.	|O

However	|O
,	|O
a	|O
correlation	|O
was	|O
observed	|O
between	|O
SF	|O
levels	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
with	|O
those	|O
of	|O
lactate	|O
,	|O
LDH	|B-PROTEIN
,	|O
beta	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
microglobulin	|I-PROTEIN
and	|O
glucose	|O
.	|O

Sodium	|O
-	|O
taurocholate	|O
-	|O
induced	|O
acute	|O
necrotizing	|O
pancreatitis	|O
does	|O
not	|O
affect	|O
jejunal	|O
oxygenation	|O
in	|O
pigs	|O
.	|O

Although	|O
inactive	|O
in	|O
cells	|O
under	|O
normal	|O
conditions	|O
,	|O
the	|O
CHOP	|B-PROTEIN
gene	|O
is	|O
markedly	|O
induced	|O
by	|O
a	|O
variety	|O
of	|O
cellular	|O
stresses	|O
,	|O
including	|O
nutrient	|O
deprivation	|O
and	|O
metabolic	|O
perturbations	|O
.	|O

The	|O
ipiO	|B-PROTEIN
genes	|O
code	|O
for	|O
two	|O
almost	|O
identical	|O
152	|O
-	|O
aa	|O
proteins	|O
which	|O
do	|O
not	|O
have	|O
any	|O
homology	|O
with	|O
sequences	|O
present	|O
in	|O
data	|O
libraries	|O
.	|O

Sterol	|O
analysis	|O
of	|O
the	|O
disrupted	|O
mutant	|O
demonstrated	|O
the	|O
accumulation	|O
of	|O
ignosterol	|O
,	|O
indicating	|O
a	|O
loss	|O
of	|O
Erg24p	|B-PROTEIN
activity	|O
.	|O

The	|O
previously	|O
described	|O
enhanced	|O
translation	|O
of	|O
spinach	|O
L12	|B-PROTEIN
mRNA	|O
from	|O
its	|O
two	|O
tandem	|O
AUG	|O
codons	|O
and	|O
the	|O
two	|O
functional	|O
rpl12	|B-PROTEIN
genes	|O
in	|O
Arabidopsis	|O
probably	|O
provide	|O
two	|O
mechanisms	|O
for	|O
generating	|O
the	|O
four	|O
copies	|O
of	|O
L12	|B-PROTEIN
/	|O
chloroplast	|O
ribosome	|O
,	|O
qualitatively	|O
different	|O
from	|O
those	|O
attempted	|O
in	|O
eubacteria	|O
.	|O

In	|O
these	|O
experiments	|O
we	|O
begin	|O
to	|O
study	|O
the	|O
potential	|O
functions	|O
of	|O
the	|O
alpha	|B-PROTEIN
7	|I-PROTEIN
cytoplasmic	|O
domain	|O
by	|O
analyzing	|O
homologies	|O
between	|O
the	|O
rat	|O
and	|O
human	|O
sequences	|O
,	|O
by	|O
immunologic	|O
studies	|O
using	|O
an	|O
anti	|O
-	|O
cytoplasmic	|O
domain	|O
antiserum	|O
,	|O
and	|O
by	|O
identifying	|O
two	|O
alternate	|O
forms	|O
.	|O

The	|O
alpha	|O
7A	|O
form	|O
RNA	|O
contains	|O
an	|O
additional	|O
113	|O
nucleotides	|O
compared	|O
to	|O
the	|O
B	|O
form	|O
,	|O
and	|O
a	|O
common	|O
coding	|O
region	|O
in	|O
the	|O
A	|O
and	|O
B	|O
form	|O
RNAs	|O
is	|O
used	|O
in	|O
alternate	|O
reading	|O
frames	|O
.	|O

In	|O
order	|O
to	|O
evaluate	|O
the	|O
function	|O
of	|O
the	|O
hypothalamic	|O
-	|O
pituitary	|O
-	|O
thyroid	|O
(	|O
HPT	|O
)	|O
-	|O
axis	|O
in	|O
unipolar	|O
depression	|O
,	|O
the	|O
authors	|O
measured	|O
basal	|O
0800h	|O
plasma	|O
levels	|O
of	|O
free	|O
thyroxine	|O
(	|O
FT4	|O
)	|O
,	|O
free	|O
triiodothyronine	|O
(	|O
FT3	|O
)	|O
,	|O
and	|O
thyroid	|B-PROTEIN
stimulating	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
TSH	|B-PROTEIN
)	|O
by	|O
means	|O
of	|O
the	|O
new	|O
,	|O
ultrasensitive	|O
assays	|O
(	|O
TSH	|O
-	|O
IRMA	|O
)	|O
in	|O
69	|O
healthy	|O
controls	|O
,	|O
62	|O
minor	|O
,	|O
101	|O
simple	|O
major	|O
,	|O
and	|O
57	|O
melancholic	|O
depressed	|O
subjects	|O
.	|O

CRS	|B-PROTEIN
function	|O
in	|O
a	|O
5'	|O
LTR	|O
-	|O
linked	|O
gene	|O
expression	|O
assay	|O
correlates	|O
with	|O
the	|O
ability	|O
of	|O
both	|O
p60CRS	|B-PROTEIN
and	|O
p40CRS	|B-PROTEIN
to	|O
interact	|O
with	|O
5'	|O
LTR	|O
RNA	|O
in	|O
vitro	|O
.	|O

Serial	|O
levels	|O
of	|O
troponin	|B-PROTEIN
T	|I-PROTEIN
and	|O
the	|O
activity	|O
of	|O
CK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
were	|O
measured	|O
6	|O
,	|O
12	|O
,	|O
24	|O
and	|O
48	|O
h	|O
after	|O
aortic	|O
unclamping	|O
.	|O

Regionalization	|O
of	|O
drug	|O
delivery	|O
is	|O
a	|O
potential	|O
method	|O
to	|O
avoid	|O
this	|O
problem	|O
.	|O

The	|O
epidemic	|O
occurred	|O
in	|O
a	|O
group	|O
of	|O
26	|O
community	|O
members	|O
(	|O
23	|O
men	|O
and	|O
3	|O
women	|O
,	|O
mean	|O
age	|O
,	|O
28.9	|O
-	|O
-	|O
3	|O
years	|O
)	|O
living	|O
and	|O
working	|O
together	|O
,	|O
who	|O
underwent	|O
acute	|O
and	|O
convalescent	|O
serologic	|O
tests	|O
for	|O
Mycoplasma	|O
pneumoniae	|O
,	|O
Legionella	|O
pneumophila	|O
,	|O
cytomegalovirus	|O
,	|O
adenovirus	|O
,	|O
Coxiella	|O
burnetii	|O
,	|O
and	|O
Chlamydia	|O
pneumoniae	|O
.	|O

MEK	|B-PROTEIN
itself	|O
is	|O
activated	|O
via	|O
serine	|O
phosphorylation	|O
by	|O
upstream	|B-PROTEIN
activator	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
including	|O
c	|B-PROTEIN
-	|I-PROTEIN
raf	|I-PROTEIN
,	|O
mos	|B-PROTEIN
and	|O
MEK	|B-PROTEIN
kinase	|I-PROTEIN
.	|O

Genomic	|O
DNA	|O
clones	|O
containing	|O
the	|O
T	|O
-	|O
cell	|O
-	|O
specific	|O
human	|O
MAL	|B-PROTEIN
gene	|O
were	|O
isolated	|O
.	|O

Members	|O
of	|O
SVA	|B-PROTEIN
are	|O
also	|O
present	|O
in	|O
the	|O
complement	|O
C2	|B-PROTEIN
gene	|O
located	|O
about	|O
20	|O
kilobases	|O
upstream	|O
of	|O
RP1	|B-PROTEIN
in	|O
the	|O
HLA	|B-PROTEIN
and	|O
in	|O
the	|O
cytochrome	|O
CYP1A1	|B-PROTEIN
gene	|O
.	|O

Expression	|O
of	|O
the	|O
dibasic	|O
proprotein	|O
processing	|O
enzyme	|O
furin	|B-PROTEIN
is	|O
directed	|O
by	|O
multiple	|O
promoters	|O
.	|O

European	|O
Community	|O
Huntington	|O
's	|O
Disease	|O
Collaborative	|O
Study	|O
Group	|O
.	|O

The	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
and	|O
skeletal	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
gene	|O
promoters	|O
contain	|O
YY1	|B-PROTEIN
binding	|O
sites	|O
thought	|O
to	|O
act	|O
either	|O
as	|O
positive	|O
or	|O
negative	|O
cis	|O
-	|O
acting	|O
elements	|O
.	|O

MSSP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
produced	|O
in	|O
E.	|O
coli	|O
as	|O
a	|O
fusion	|O
protein	|O
with	|O
GST	|B-PROTEIN
specifically	|O
interacted	|O
with	|O
single	|O
-	|O
stranded	|O
TCTTAT	|O
(	|O
plus	|O
myc	|B-PROTEIN
(	|O
H	|O
-	|O
P	|O
)	|O
21	|O
)	|O
and	|O
ACT	|O
-	|O
ATT	|O
(	|O
in	|O
minus	|O
myc	|B-PROTEIN
(	|O
H	|O
-	|O
P	|O
)	|O
21	|O
)	|O
,	|O
the	|O
consensus	|O
of	|O
which	|O
can	|O
be	|O
referred	|O
to	|O
as	|O
A	|O
/	|O
TCTA	|O
/	|O
TA	|O
/	|O
TT	|O
.	|O

Within	|O
12	|O
hours	|O
after	|O
MR	|O
tomography	|O
the	|O
patients	|O
were	|O
surgically	|O
explored	|O
,	|O
biopsied	|O
and	|O
if	|O
necessary	|O
orchiectomised	|O
.	|O

Certain	|O
spt10	|B-PROTEIN
spontaneous	|O
alleles	|O
are	|O
good	|O
suppressors	|O
but	|O
have	|O
a	|O
normal	|O
growth	|O
rate	|O
,	|O
suggesting	|O
that	|O
the	|O
SPT10	|B-PROTEIN
protein	|O
may	|O
have	|O
two	|O
distinct	|O
functions	|O
.	|O

Varieties	|O
of	|O
envious	|O
experience	|O
.	|O

The	|O
results	|O
show	|O
that	|O
both	|O
the	|O
amino	|O
and	|O
carboxy	|O
termini	|O
of	|O
the	|O
NS1	|B-PROTEIN
protein	|O
molecule	|O
and	|O
the	|O
cysteines	|O
at	|O
residues	|O
337	|O
and	|O
340	|O
are	|O
essential	|O
for	|O
tubule	|O
formation	|O
.	|O

The	|O
3'	|O
UTR	|O
has	|O
several	|O
stable	|O
hairpins	|O
that	|O
are	|O
flanked	|O
by	|O
single	|O
-	|O
stranded	|O
(	|O
A	|O
/	|O
U	|O
)	|O
UGC	|O
sequences	|O
.	|O

Moreover	|O
,	|O
the	|O
major	|O
site	|O
of	|O
transcriptional	|O
initiation	|O
,	|O
which	|O
was	|O
localized	|O
by	|O
primer	|O
extension	|O
250	|O
bp	|O
upstream	|O
of	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cDNA	|O
clone	|O
,	|O
was	|O
shown	|O
to	|O
be	|O
identical	|O
in	|O
normal	|O
cells	|O
and	|O
tumors	|O
carrying	|O
a	|O
provirus	|O
in	|O
the	|O
Tpl	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
locus	|O
.	|O

Specifically	|O
,	|O
by	|O
oligonucleotide	|O
-	|O
directed	|O
site	|O
-	|O
specific	|O
mutagenesis	|O
,	|O
we	|O
demonstrate	|O
that	|O
of	|O
10	|O
cysteine	|O
residues	|O
in	|O
the	|O
ORF4	|O
polypeptide	|O
,	|O
only	|O
C	|O
-	|O
421	|O
and	|O
C	|O
-	|O
426	|O
are	|O
essential	|O
for	|O
transactivator	|O
function	|O
and	|O
suggest	|O
that	|O
these	|O
cysteine	|O
residues	|O
may	|O
participate	|O
in	|O
critical	|O
protein	|O
-	|O
protein	|O
interactions	|O
rather	|O
than	|O
protein	|O
-	|O
nucleic	|O
acid	|O
interactions	|O
to	|O
mediate	|O
ORF4	|O
inducibility	|O
.	|O

In	|O
Rat	|O
1a	|O
cells	|O
,	|O
m1R	|B-PROTEIN
stimulation	|O
of	|O
phospholipase	|B-PROTEIN
C	|I-PROTEIN
beta	|I-PROTEIN
and	|O
the	|O
marked	|O
rise	|O
in	|O
intracellular	|O
calcium	|O
stimulated	|O
cyclic	|O
AMP	|O
(	|O
cAMP	|O
)	|O
synthesis	|O
,	|O
resulting	|O
in	|O
the	|O
activation	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A.	|I-PROTEIN

The	|O
mutations	|O
did	|O
not	|O
affect	|O
the	|O
repression	|O
of	|O
CPA1	|B-PROTEIN
by	|O
arginine	|O
.	|O

A	|O
segment	|O
of	|O
mRNA	|O
encoding	|O
the	|O
leader	|O
peptide	|O
of	|O
the	|O
CPA1	|B-PROTEIN
gene	|O
confers	|O
repression	|O
by	|O
arginine	|O
on	|O
a	|O
heterologous	|O
yeast	|O
gene	|O
transcript	|O
.	|O

To	|O
search	|O
for	|O
genes	|O
that	|O
interact	|O
with	|O
the	|O
SLK1	|B-PROTEIN
-	|O
SLT2	|B-PROTEIN
pathway	|O
,	|O
a	|O
synthetic	|O
lethal	|O
suppression	|O
screen	|O
was	|O
carried	|O
out	|O
.	|O

Genetic	|O
and	|O
phenotypic	|O
analysis	|O
indicates	|O
that	|O
NHP6A	|B-PROTEIN
and	|O
NHP6B	|B-PROTEIN
function	|O
downstream	|O
of	|O
SLT2	|B-PROTEIN
.	|O

In	|O
this	|O
report	|O
,	|O
we	|O
present	|O
two	|O
lines	|O
of	|O
evidence	|O
that	|O
all	|O
ribosomes	|O
which	|O
synthesize	|O
GCN4	|B-PROTEIN
have	|O
previously	|O
translated	|O
uORF1	|O
,	|O
resumed	|O
scanning	|O
,	|O
and	|O
reinitiated	|O
at	|O
the	|O
GCN4	|B-PROTEIN
start	|O
site	|O
.	|O

Identical	|O
components	|O
of	|O
yeast	|O
transcription	|B-PROTEIN
factor	|I-PROTEIN
IIIB	|I-PROTEIN
are	|O
required	|O
and	|O
sufficient	|O
for	|O
transcription	|O
of	|O
TATA	|O
box	|O
-	|O
containing	|O
and	|O
TATA	|O
-	|O
less	|O
genes	|O
.	|O

Concordantly	|O
,	|O
it	|O
was	|O
shown	|O
that	|O
the	|O
dnHLH	|B-PROTEIN
protein	|O
Id1	|B-PROTEIN
inhibits	|O
differentiation	|O
of	|O
muscle	|O
and	|O
myeloid	|O
cells	|O
in	|O
vitro	|O
.	|O

RNP1	|B-PROTEIN
,	|O
a	|O
new	|O
ribonucleoprotein	|O
gene	|O
of	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Crohn	|O
's	|O
disease	|O
in	|O
prolonged	|O
remission	|O
:	|O
should	|O
one	|O
augment	|O
protein	|O
-	|O
calorie	|O
intake	|O
as	|O
compared	|O
to	|O
healthy	|O
subjects	|O
?	|O
]	|O
The	|O
aim	|O
of	|O
our	|O
two	|O
year	|O
prospective	|O
study	|O
was	|O
to	|O
evaluate	|O
whether	|O
adult	|O
Crohn	|O
's	|O
disease	|O
patients	|O
in	|O
prolonged	|O
remission	|O
(	|O
CDAI	|O
<	|O
150	|O
)	|O
,	|O
in	|O
order	|O
to	|O
maintain	|O
their	|O
body	|O
weight	|O
as	|O
close	|O
as	|O
possible	|O
to	|O
the	|O
ideal	|O
one	|O
,	|O
need	|O
a	|O
protein	|O
-	|O
calorie	|O
intake	|O
higher	|O
than	|O
the	|O
predicted	|O
one	|O
and	|O
that	|O
of	|O
healthy	|O
controls	|O
.	|O

To	|O
achieve	|O
complete	|O
dissection	|O
of	|O
the	|O
anterior	|O
vitreous	|O
,	|O
we	|O
remove	|O
even	|O
a	|O
clear	|O
lens	|O
during	|O
the	|O
first	|O
surgical	|O
intervention	|O
in	|O
selected	|O
cases	|O
.	|O

Restoration	|O
of	|O
opponens	|O
function	|O
with	|O
transplantation	|O
of	|O
free	|O
composites	|O
dorsal	|O
pedal	|O
skin	|O
flap	|O
containing	|O
m	|O
.	|O
extensor	|O
hallucis	|O
brevis	|O

Neither	|O
ethanol	|O
regimen	|O
impaired	|O
spontaneous	|O
alternation	|O
,	|O
but	|O
the	|O
4	|O
g	|O
ethanol.k	|O
g	|O
-	|O
1	|O
x	|O
day	|O
-	|O
1	|O
regimen	|O
increased	|O
the	|O
percent	|O
completed	|O
trials	|O
.	|O

The	|O
mean	|O
(	|O
+	|O
/	|O
-	|O
sd	|O
)	|O
intra	|O
-	|O
vesicular	|O
pressure	|O
(	|O
IVP	|O
)	|O
and	|O
maximal	|O
urethral	|O
closure	|O
pressures	|O
(	|O
MUCP	|O
)	|O
were	|O
10.3	|O
(	|O
+	|O
/	|O
-	|O
1.7	|O
)	|O
and	|O
129.8	|O
(	|O
+	|O
/	|O
-	|O
19.6	|O
)	|O
cmH2O	|O
,	|O
respectively	|O
,	|O
and	|O
the	|O
ratio	|O
between	|O
MUCP	|O
and	|O
IVP	|O
was	|O
13.2	|O
(	|O
+	|O
/	|O
-	|O
2.5	|O
)	|O
.	|O

Several	|O
highly	|O
conserved	|O
regions	|O
were	|O
identified	|O
at	|O
the	|O
near	|O
N	|O
terminus	|O
,	|O
middle	|O
and	|O
C	|O
terminus	|O
.	|O

Thioredoxin	|B-PROTEIN
(	|O
TR	|B-PROTEIN
)	|O
is	|O
a	|O
small	|O
ubiquitous	|O
dithiol	|B-PROTEIN
-	|I-PROTEIN
reductase	|I-PROTEIN
enzyme	|O
first	|O
identified	|O
in	|O
bacteria	|O
and	|O
plants	|O
.	|O

The	|O
mutation	|O
within	|O
the	|O
asgB480	|B-PROTEIN
allele	|O
was	|O
identified	|O
as	|O
an	|O
A	|O
-	|O
to	|O
-	|O
G	|O
transition	|O
that	|O
results	|O
in	|O
a	|O
threonine	|O
-	|O
to	|O
-	|O
alanine	|O
substitution	|O
in	|O
the	|O
predicted	|O
protein	|O
product	|O
.	|O

The	|O
cysteine	|O
-	|O
rich	|O
region	|O
of	|O
raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
kinase	|I-PROTEIN
contains	|O
zinc	|O
,	|O
translocates	|O
to	|O
liposomes	|O
,	|O
and	|O
is	|O
adjacent	|O
to	|O
a	|O
segment	|O
that	|O
binds	|O
GTP	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
.	|O

Kinetic	|O
coupling	|O
and	|O
requirement	|O
for	|O
ATP	|O
hydrolysis	|O
.	|O

ATP	|O
by	|O
itself	|O
also	|O
reduced	|O
polypeptide	|O
binding	|O
to	|O
Ssb1/2	|B-PROTEIN
p	|I-PROTEIN
to	|O
a	|O
level	|O
that	|O
was	|O
intermediate	|O
between	|O
that	|O
observed	|O
for	|O
the	|O
Ssa	|B-PROTEIN
Hsp70	|O
proteins	|O
tested	|O
and	|O
BiP	|B-PROTEIN
and	|O
DnaK	|B-PROTEIN
.	|O

Digestion	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
with	|O
endoprotease	|B-PROTEIN
Asp	|I-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
produced	|O
a	|O
domain	|O
smaller	|O
than	|O
the	|O
TCD	|B-PROTEIN
(	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
bZIP	|O
domains	|O
(	|O
NFBD	|B-PROTEIN
)	|O
(	|O
272-345	|O
)	|O
)	|O
,	|O
a	|O
domain	|O
identified	|O
either	|O
in	|O
the	|O
absence	|O
or	|O
the	|O
presence	|O
of	|O
DNA	|O
.	|O

Signaling	|O
by	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
involves	|O
direct	|O
associations	|O
between	|O
proteins	|O
with	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
2	|I-PROTEIN
(	|O
SH2	|B-PROTEIN
)	|O
domains	|O
and	|O
sites	|O
of	|O
tyrosine	|O
phosphorylation	|O
.	|O

Rather	|O
,	|O
complete	|O
skipping	|O
of	|O
exon	|O
V	|O
and	|O
subsequent	|O
joining	|O
of	|O
exon	|O
IV	|O
to	|O
exon	|O
VI	|O
caused	|O
a	|O
shift	|O
in	|O
the	|O
open	|O
reading	|O
frame	|O
,	|O
which	|O
remodeled	|O
GPHe	|B-PROTEIN
(	|I-PROTEIN
P2	|I-PROTEIN
)	|I-PROTEIN
with	|O
an	|O
elongated	|O
new	|O
hydrophobic	|O
sequence	|O
for	|O
membrane	|O
anchoring	|O
.	|O

The	|O
responses	|O
of	|O
the	|O
"	|O
stress	|O
hormones	|O
"	|O
cortisol	|O
,	|O
11	|O
-	|O
deoxycortisol	|O
,	|O
ACTH	|B-PROTEIN
,	|O
vasopressin	|B-PROTEIN
(	|O
AVP	|B-PROTEIN
)	|O
,	|O
and	|O
corticotropin	|B-PROTEIN
releasing	|I-PROTEIN
factor	|I-PROTEIN
(	|O
CRF	|B-PROTEIN
)	|O
were	|O
studied	|O
in	|O
6	|O
normal	|O
males	|O
in	|O
response	|O
to	|O
acute	|O
cortisol	|O
deficiency	|O
induced	|O
by	|O
the	|O
11	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
hydroxylase	|I-PROTEIN
inhibitor	|O
,	|O
metyrapone	|O
.	|O

Structure	|O
and	|O
expression	|O
of	|O
the	|O
alternative	|O
sigma	|B-PROTEIN
factor	|I-PROTEIN
,	|O
RpoN	|B-PROTEIN
,	|O
in	|O
Rhodobacter	|O
capsulatus	|O
;	|O
physiological	|O
relevance	|O
of	|O
an	|O
autoactivated	|O
nifU2	|B-PROTEIN
-	|O
rpoN	|B-PROTEIN
superoperon	|O
.	|O

Thus	|O
our	|O
observations	|O
establish	|O
a	|O
functional	|O
link	|O
between	|O
the	|O
PKC	|B-PROTEIN
and	|O
retinoid	|O
pathways	|O
,	|O
which	|O
are	|O
generally	|O
considered	|O
to	|O
have	|O
antagonistic	|O
activities	|O
on	|O
differentiation	|O
processes	|O
.	|O

The	|O
colony	|B-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factors	|I-PROTEIN
(	|O
CSFs	|B-PROTEIN
)	|O
principally	|O
involved	|O
in	|O
the	|O
production	|O
of	|O
neutrophils	|O
and	|O
monocytes	|O
are	|O
granulocyte	|B-PROTEIN
CSF	|I-PROTEIN
,	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
CSF	|I-PROTEIN
,	|O
macrophage	|B-PROTEIN
CSF	|I-PROTEIN
,	|O
and	|O
interleukin	|B-PROTEIN
3	|I-PROTEIN
(	|O
sometimes	|O
called	|O
multi	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
.	|O

The	|O
degree	|O
of	|O
lung	|O
destruction	|O
,	|O
reflected	|O
by	|O
interstitial	|O
hemorrhage	|O
was	|O
assessed	|O
by	|O
measuring	|O
hemoglobin	|B-PROTEIN
content	|O
in	|O
the	|O
fluid	|O
of	|O
the	|O
lavaged	|O
lungs	|O
.	|O

Expression	|O
plasmids	|O
harboring	|O
full	|O
-	|O
length	|O
or	|O
kinase	|O
domain	|O
of	|O
PKC	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
PKC	|B-PROTEIN
delta	|I-PROTEIN
(	|O
PKC	|B-PROTEIN
alpha	|I-PROTEIN
K	|I-PROTEIN
and	|O
PKC	|B-PROTEIN
delta	|I-PROTEIN
K	|I-PROTEIN
)	|O
were	|O
constructed	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
both	|O
PKC	|B-PROTEIN
alpha	|I-PROTEIN
(	|O
calcium	|O
dependent	|O
)	|O
and	|O
PKC	|B-PROTEIN
delta	|I-PROTEIN
(	|O
calcium	|O
independent	|O
)	|O
may	|O
mediate	|O
the	|O
transcription	|O
of	|O
TPA	|O
-	|O
inducible	|O
genes	|O
through	|O
both	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
non	|O
-	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
sequences	|O
.	|O

With	|O
a	|O
cutoff	|O
level	|O
for	|O
TSST	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
of	|O
less	|O
than	|O
100	|O
pg	|O
/	|O
ml	|O
,	|O
28	|O
samples	|O
obtained	|O
from	|O
12	|O
patients	|O
were	|O
positive	|O
for	|O
TSST	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Insertion	|O
of	|O
short	|O
oligonucleotides	|O
encoding	|O
the	|O
basic	|O
amino	|O
acid	|O
motifs	|O
726	|O
-	|O
GRKRKSP	|O
-	|O
732	|O
from	|O
IE175	|B-PROTEIN
and	|O
500	|O
-	|O
VRPRKRR	|O
-	|O
506	|O
from	|O
IE110	|B-PROTEIN
into	|O
deleted	|O
cytoplasmic	|O
forms	|O
of	|O
the	|O
two	|O
proteins	|O
restored	|O
the	|O
karyophilic	|O
phenotype	|O
and	|O
confirmed	|O
that	|O
these	|O
motifs	|O
are	|O
both	|O
necessary	|O
and	|O
sufficient	|O
for	|O
proper	|O
nuclear	|O
localization	|O
.	|O

Mapping	|O
of	|O
intracellular	|O
localization	|O
domains	|O
and	|O
evidence	|O
for	|O
colocalization	|O
interactions	|O
between	|O
the	|O
IE110	|B-PROTEIN
and	|O
IE175	|B-PROTEIN
nuclear	|O
transactivator	|O
proteins	|O
of	|O
herpes	|O
simplex	|O
virus	|O
.	|O

The	|O
revertant	|O
TATA	|O
boxes	|O
accelerated	|O
the	|O
kinetics	|O
of	|O
HIV	|O
replication	|O
when	|O
present	|O
in	|O
the	|O
context	|O
of	|O
an	|O
LTR	|O
containing	|O
a	|O
Sp1	|B-PROTEIN
mutation	|O
(	|O
deletion	|O
or	|O
site	|O
specific	|O
)	|O
;	|O
no	|O
effect	|O
was	|O
observed	|O
on	|O
the	|O
infectivity	|O
of	|O
wild	|O
-	|O
type	|O
HIV	|O
.	|O

Panlobular	|O
emphysema	|O

Since	|O
the	|O
ETS	|B-PROTEIN
domain	|O
,	|O
which	|O
is	|O
localized	|O
in	|O
the	|O
carboxy	|O
terminal	|O
region	|O
of	|O
the	|O
encoded	|O
protein	|O
,	|O
is	|O
95%	|O
and	|O
96%	|O
identical	|O
to	|O
that	|O
of	|O
PEA3	|B-PROTEIN
and	|O
ER81	|B-PROTEIN
,	|O
respectively	|O
,	|O
we	|O
named	|O
this	|O
new	|O
member	|O
'	|B-PROTEIN
Ets	|I-PROTEIN
Related	|I-PROTEIN
Molecule	|I-PROTEIN
PEA3	|I-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
'	|I-PROTEIN
(	|O
ERM	|B-PROTEIN
)	|O
.	|O

Gel	|O
shift	|O
analysis	|O
indicates	|O
that	|O
the	|O
full	|O
-	|O
length	|O
ERM	|B-PROTEIN
protein	|O
is	|O
able	|O
to	|O
bind	|O
specifically	|O
to	|O
an	|O
oligonucleotide	|O
containing	|O
the	|O
consensus	|O
nucleotide	|O
core	|O
sequence	|O
GGAA	|O
recognized	|O
by	|O
the	|O
Ets	|B-PROTEIN
proteins	|O
.	|O

Effects	|O
of	|O
estradiol	|O
on	|O
worm	|O
burden	|O
and	|O
peripheral	|O
leukocytes	|O
in	|O
Parastrongylus	|O
malaysiensis	|O
-	|O
infected	|O
rats	|O
.	|O

Dotarizine	|O
produced	|O
arterial	|O
dilation	|O
in	|O
both	|O
systemic	|O
and	|O
pulmonary	|O
circulation	|O
:	|O
the	|O
total	|O
peripheral	|O
resistance	|O
dropped	|O
,	|O
and	|O
femoral	|O
artery	|O
flow	|O
rose	|O
;	|O
aortic	|O
and	|O
pulmonary	|O
artery	|O
mean	|O
and	|O
diastolic	|O
pressures	|O
declined	|O
,	|O
and	|O
systolic	|O
pressures	|O
remained	|O
almost	|O
stable	|O
.	|O

These	|O
issues	|O
include	|O
the	|O
use	|O
of	|O
LMWHs	|O
in	|O
patients	|O
with	|O
arterial	|O
thrombosis	|O
or	|O
myocardial	|O
infarction	|O
(	|O
e.g.	|O
in	|O
conjunction	|O
with	|O
thrombolytic	|O
treatment	|O
)	|O
,	|O
and	|O
in	|O
patients	|O
with	|O
pulmonary	|O
embolism	|O
.	|O

The	|O
usefulness	|O
of	|O
the	|O
lambda	|O
PG15	|O
and	|O
the	|O
lambda	|O
AD5	|O
cloning	|O
vectors	|O
was	|O
demonstrated	|O
by	|O
constructing	|O
large	|O
Neurospora	|O
crassa	|O
cDNA	|O
libraries	|O
.	|O

Endoscopic	|O
transthoracic	|O
sympathectomy	|O
as	|O
adjuvant	|O
treatment	|O
for	|O
critical	|O
upper	|O
-	|O
limb	|O
ischaemia	|O
.	|O

Sequence	|O
comparisons	|O
have	|O
shown	|O
that	|O
Aps1p	|B-PROTEIN
is	|O
more	|O
similar	|O
to	|O
the	|O
sigma	|O
subunit	|O
of	|O
the	|O
Golgi	|O
-	|O
localized	|O
mammalian	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
complex	|O
than	|O
Aps2p	|B-PROTEIN
,	|O
which	|O
is	|O
more	|O
related	|O
to	|O
the	|O
plasma	|O
membrane	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
sigma	|O
subunit	|O
.	|O

The	|O
Saccharomyces	|O
cerevisiae	|O
APS1	|B-PROTEIN
gene	|O
encodes	|O
a	|O
homolog	|O
of	|O
the	|O
small	|O
subunit	|O
of	|O
the	|O
mammalian	|O
clathrin	|B-PROTEIN
AP	|O
-	|O
1	|O
complex	|O
:	|O
evidence	|O
for	|O
functional	|O
interaction	|O
with	|O
clathrin	|B-PROTEIN
at	|O
the	|O
Golgi	|O
complex	|O
.	|O

These	|O
results	|O
are	|O
the	|O
first	|O
to	|O
demonstrate	|O
the	|O
structural	|O
organization	|O
of	|O
a	|O
vertebrate	|O
gene	|O
encoding	|O
an	|O
integral	|O
membrane	|O
protein	|O
of	|O
the	|O
nuclear	|O
envelope	|O
that	|O
may	|O
be	|O
a	|O
member	|O
of	|O
a	|O
family	|O
of	|O
polypeptides	|O
conserved	|O
in	|O
evolution	|O
.	|O

Biochemical	|O
characterization	|O
of	|O
valosin	|B-PROTEIN
-	|O
containing	|O
protein	|O
,	|O
a	|O
protein	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
substrate	|O
in	|O
hematopoietic	|O
cells	|O
.	|O

The	|O
presence	|O
of	|O
the	|O
foreign	|O
gene	|O
was	|O
confirmed	|O
by	|O
Southern	|O
analysis	|O
.	|O

All	|O
patients	|O
with	|O
deterioriation	|O
in	|O
mental	|O
status	|O
showed	|O
a	|O
marked	|O
increase	|O
in	|O
liver	|O
enzymes	|O
(	|O
aspartate	|B-PROTEIN
and	|I-PROTEIN
alanine	|I-PROTEIN
aminotransaminases	|I-PROTEIN
)	|O
and	|O
severe	|O
coagulopathy	|O
.	|O

Functional	|O
postnatal	|O
development	|O
of	|O
the	|O
rat	|O
primary	|O
visual	|O
cortex	|O
and	|O
the	|O
role	|O
of	|O
visual	|O
experience	|O
:	|O
dark	|O
rearing	|O
and	|O
monocular	|O
deprivation	|O
.	|O

Eleven	|O
patients	|O
tested	|O
positive	|O
for	|O
the	|O
hepatitis	|B-PROTEIN
B	|I-PROTEIN
surface	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
HBsAg	|B-PROTEIN
)	|O
.	|O

The	|O
xylose	|B-PROTEIN
isomerase	|I-PROTEIN
-	|O
encoding	|O
gene	|O
(	|O
xylA	|B-PROTEIN
)	|O
of	|O
Clostridium	|O
thermosaccharolyticum	|O
:	|O
cloning	|O
,	|O
sequencing	|O
and	|O
phylogeny	|O
of	|O
XylA	|B-PROTEIN
enzymes	|O
.	|O

Two	|O
phosphopeptides	|O
,	|O
identified	|O
as	|O
RS	|O
-	|O
[	|O
32P	|O
]	|O
SGASGLLTSEHHSR	|O
and	|O
S	|O
-	|O
[	|O
32P	|O
]	|O
SGASGLLTSEHHSR	|O
,	|O
were	|O
obtained	|O
after	|O
stoichiometric	|O
phosphorylation	|O
and	|O
trypsinization	|O
of	|O
the	|O
peptide	|O
.	|O

Mitochondrial	|O
Mas70p	|B-PROTEIN
signal	|O
anchor	|O
sequence	|O
.	|O

Altogether	|O
,	|O
these	|O
data	|O
suggest	|O
that	|O
Ypt51p	|B-PROTEIN
,	|O
Ypt52p	|B-PROTEIN
,	|O
and	|O
Ypt53p	|B-PROTEIN
are	|O
required	|O
for	|O
transport	|O
in	|O
the	|O
endocytic	|O
pathway	|O
and	|O
for	|O
correct	|O
sorting	|O
of	|O
vacuolar	|B-PROTEIN
hydrolases	|I-PROTEIN
suggesting	|O
a	|O
possible	|O
intersection	|O
of	|O
the	|O
endocytic	|O
with	|O
the	|O
vacuolar	|O
sorting	|O
pathway	|O
.	|O

All	|O
of	|O
the	|O
basal	|O
TPN	|O
solutions	|O
were	|O
isonitrogenous	|O
and	|O
identical	|O
in	|O
nutrient	|O
composition	|O
,	|O
except	|O
for	|O
the	|O
difference	|O
in	|O
energy	|O
level	|O
,	|O
which	|O
was	|O
adjusted	|O
with	|O
glucose	|O
.	|O

Surprisingly	|O
,	|O
TFIIIC	|B-PROTEIN
alpha	|O
has	|O
no	|O
homology	|O
to	|O
any	|O
of	|O
the	|O
yeast	|O
TFIIIC	|B-PROTEIN
subunits	|O
already	|O
cloned	|O
,	|O
suggesting	|O
a	|O
significant	|O
degree	|O
of	|O
evolutionary	|O
divergence	|O
for	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
III	|I-PROTEIN
factors	|O
.	|O

Transactivation	|O
domain	|O
is	|O
located	|O
downstream	|O
of	|O
the	|O
128	|O
-	|O
amino	|O
-	|O
acid	|O
runt	|B-PROTEIN
homology	|O
region	|O
,	|O
referred	|O
to	|O
as	|O
the	|O
Runt	|B-PROTEIN
domain	|O
.	|O

We	|O
estimate	|O
that	|O
the	|O
protease	|O
activity	|O
is	|O
at	|O
least	|O
35	|O
-	|O
fold	|O
greater	|O
in	|O
mature	|O
B	|O
cells	|O
than	|O
in	|O
pre	|O
-	|O
B	|O
cells	|O
.	|O

The	|O
ligand	|O
for	|O
RXR	|B-PROTEIN
,	|O
9	|O
-	|O
cis	|O
retinoic	|O
acid	|O
,	|O
has	|O
the	|O
opposite	|O
effect	|O
of	|O
destabilizing	|O
the	|O
heterodimeric	|O
-	|O
DNA	|O
complex	|O
.	|O

Cerebral125	|O
albumin	|B-PROTEIN
was	|O
increased	|O
to	|O
similar	|O
proportions	|O
in	|O
those	|O
groups	|O
submitted	|O
to	|O
hyperosmolality	|O
.	|O

Retrogradely	|O
labelled	|O
neurons	|O
significantly	|O
prevailed	|O
in	|O
the	|O
ipsilateral	|O
substantia	|O
nigra	|O
pars	|O
compacta	|O
.	|O

Response	|O
to	|O
treatment	|O
was	|O
better	|O
in	|O
patients	|O
with	|O
less	|O
pretreatment	|O
(	|O
one	|O
-	|O
two	|O
prior	|O
treatments	|O
)	|O
than	|O
in	|O
heavily	|O
pretreated	|O
ones	|O
(	|O
more	|O
than	|O
three	|O
)	|O
and	|O
this	|O
relation	|O
was	|O
found	|O
to	|O
be	|O
statistically	|O
significant	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

Therefore	|O
,	|O
the	|O
amino	|O
-	|O
terminal	|O
sequence	|O
of	|O
the	|O
purified	|O
carA	|B-PROTEIN
product	|O
is	|O
identical	|O
to	|O
that	|O
derived	|O
from	|O
the	|O
nucleotide	|O
sequence	|O
in	|O
both	|O
organisms	|O
,	|O
P.	|O
stutzeri	|O
having	|O
four	|O
additional	|O
amino	|O
acids	|O
.	|O

Aneurysmal	|O
bone	|O
cyst	|O
of	|O
the	|O
jaws	|O
:	|O
analysis	|O
of	|O
11	|O
cases	|O
.	|O

Location	|O
and	|O
orientation	|O
of	|O
an	|O
activating	|O
region	|O
in	|O
the	|O
Escherichia	|O
coli	|O
transcription	|O
factor	|O
,	|O
FNR	|B-PROTEIN
.	|O

Moxidectin	|O
(	|O
at	|O
3	|O
times	|O
the	|O
therapeutic	|O
dose	|O
)	|O
did	|O
not	|O
have	|O
deleterious	|O
effects	|O
on	|O
cow	|O
reproductive	|O
performance	|O
as	|O
examined	|O
(	|O
eg	|O
,	|O
at	|O
folliculogenesis	|O
,	|O
ovulation	|O
,	|O
and	|O
the	|O
early	|O
embryonic	|O
phase	|O
of	|O
development	|O
)	|O
.	|O

Northern	|O
-	|O
blot	|O
analysis	|O
of	|O
mRNA	|O
from	|O
Avicel	|O
-	|O
grown	|O
N.	|O
patriciarum	|O
showed	|O
that	|O
xynB	|B-PROTEIN
hybridized	|O
to	|O
a	|O
3.4	|O
kb	|O
mRNA	|O
species	|O
.	|O

The	|O
variable	|O
regions	|O
of	|O
vertebrate	|O
striated	|O
TnT	|B-PROTEIN
isoforms	|O
reflect	|O
the	|O
subsequent	|O
addition	|O
and	|O
modification	|O
of	|O
genomic	|O
sequences	|O
to	|O
give	|O
rise	|O
to	|O
members	|O
of	|O
the	|O
TnT	|B-PROTEIN
multigene	|O
family	|O
.	|O

The	|O
class	|O
II	|O
Escherichia	|O
coli	|O
alanine	|B-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
aminoacylates	|O
RNA	|O
miniduplexes	|O
,	|O
which	|O
reconstruct	|O
the	|O
acceptor	|O
end	|O
of	|O
alanine	|B-PROTEIN
tRNA	|I-PROTEIN
with	|O
the	|O
critical	|O
G3	|O
:	|O
U70	|O
base	|O
pair	|O
.	|O

Simple	|O
reaction	|O
time	|O
(	|O
RT	|O
)	|O
to	|O
a	|O
peripheral	|O
visual	|O
target	|O
(	|O
S2	|O
)	|O
is	|O
shortened	|O
when	|O
a	|O
non	|O
-	|O
informative	|O
cue	|O
(	|O
S1	|O
)	|O
is	|O
flashed	|O
at	|O
the	|O
S2	|O
location	|O
100-150	|O
ms	|O
before	|O
target	|O
onset	|O
(	|O
early	|O
facilitation	|O
)	|O
.	|O

A	|O
second	|O
study	|O
group	|O
,	|O
with	|O
intact	|O
cardiac	|O
innervation	|O
,	|O
consisted	|O
of	|O
19	|O
patients	|O
with	|O
stable	|O
angina	|O
pectoris	|O
class	|O
I	|O
to	|O
III	|O
.	|O

These	|O
viruses	|O
depend	|O
on	|O
the	|O
host	|O
cell	|O
machinery	|O
for	|O
their	|O
existence	|O
,	|O
and	|O
interference	|O
with	|O
these	|O
processes	|O
typically	|O
interferes	|O
with	|O
other	|O
important	|O
host	|O
physiology	|O
.	|O

Treatment	|O
was	|O
well	|O
-	|O
tolerated	|O
.	|O

A	|O
concentration	|O
of	|O
12.5	|O
ppm	|O
SO2	|O
induced	|O
a	|O
decrease	|O
from	|O
baseline	|O
values	|O
of	|O
approximately	|O
80%	|O
in	|O
mean	|O
MCA	|O
and	|O
of	|O
roughly	|O
70%	|O
in	|O
mean	|O
CBF	|O
.	|O

We	|O
have	|O
used	|O
these	|O
modified	|O
assay	|O
conditions	|O
to	|O
extend	|O
studies	|O
on	|O
the	|O
transposition	|O
pathway	|O
.	|O

Renal	|O
cell	|O
carcinoma	|O
in	|O
children	|O
:	|O
a	|O
single	|O
institution	|O
's	|O
experience	|O
.	|O

The	|O
data	|O
suggest	|O
that	|O
ICP10	|B-PROTEIN
constitutively	|O
increases	|O
ras	|B-PROTEIN
activity	|O
,	|O
and	|O
its	|O
TM	|O
segment	|O
plays	|O
a	|O
critical	|O
role	|O
in	|O
transformation	|O
-	|O
related	|O
signaling	|O
pathways	|O
.	|O

Thus	|O
,	|O
we	|O
have	|O
separated	|O
the	|O
signal	|O
function	|O
from	|O
the	|O
anchor	|O
function	|O
of	|O
the	|O
6.7	|O
K	|O
SA	|O
domain	|O
.	|O

Five	|O
concensus	|O
poly	|O
A	|O
addition	|O
sites	|O
are	|O
located	|O
in	|O
the	|O
350	|O
base	|O
pairs	|O
immediately	|O
following	|O
the	|O
protein	|B-PROTEIN
IX	|I-PROTEIN
coding	|O
region	|O
.	|O

Factors	|O
associated	|O
with	|O
intrafamilial	|O
transmission	|O
of	|O
hepatitis	|O
B	|O
virus	|O
infection	|O
in	|O
Korea	|O
.	|O

Exposure	|O
to	|O
higher	|O
TPA	|O
concentrations	|O
decreased	|O
the	|O
content	|O
of	|O
these	|O
transcripts	|O
.	|O

Northern	|O
analysis	|O
,	|O
to	|O
search	|O
for	|O
a	|O
pcbAB	|B-PROTEIN
transcript	|O
,	|O
showed	|O
no	|O
distinct	|O
transcript	|O
and	|O
indicated	|O
severely	|O
degraded	|O
mRNA	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
the	|O
minimal	|O
requirements	|O
for	|O
induction	|O
of	|O
PEPCK	|B-PROTEIN
by	|O
PKA	|B-PROTEIN
and	|O
inhibition	|O
by	|O
insulin	|B-PROTEIN
include	|O
:	|O
1	|O
)	|O
the	|O
CREB	|B-PROTEIN
activation	|O
domain	|O
,	|O
2	|O
)	|O
the	|O
PEPCK	|B-PROTEIN
TATA	|O
sequence	|O
,	|O
and	|O
3	|O
)	|O
insulin	|B-PROTEIN
-	|O
responsive	|O
hepatoma	|O
cells	|O
.	|O

The	|O
high	|O
degree	|O
of	|O
conservation	|O
between	|O
NQO2	|B-PROTEIN
and	|O
NQO1	|B-PROTEIN
gene	|O
organization	|O
and	|O
sequence	|O
confirmed	|O
that	|O
NQO2	|B-PROTEIN
gene	|O
encodes	|O
for	|O
a	|O
second	|O
member	|O
of	|O
the	|O
NQO	|B-PROTEIN
gene	|O
family	|O
in	|O
human	|O
.	|O

The	|O
efficacy	|O
of	|O
a	|O
Propionibacterium	|O
acnes	|O
product	|O
for	|O
treatment	|O
of	|O
coliform	|O
mastitis	|O
was	|O
evaluated	|O
following	|O
intramammary	|O
infusion	|O
of	|O
Escherichia	|O
coli	|O
.	|O

The	|O
human	|O
eps15	|B-PROTEIN
gene	|O
,	|O
encoding	|O
a	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
substrate	|O
,	|O
is	|O
conserved	|O
in	|O
evolution	|O
and	|O
maps	|O
to	|O
1p31	|O
-	|O
p32	|O
.	|O

The	|O
gene	|O
encoding	|O
the	|O
105	|O
-	|O
kDa	|O
protein	|O
(	|O
p105	|B-PROTEIN
)	|O
precursor	|O
of	|O
the	|O
p50	|B-PROTEIN
subunit	|O
of	|O
transcription	|O
factor	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
also	|O
encodes	|O
a	|O
p70	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
protein	|O
,	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
gamma	|O
,	|O
which	|O
is	|O
identical	|O
to	|O
the	|O
C	|O
-	|O
terminal	|O
607	|O
amino	|O
acids	|O
of	|O
p105	|B-PROTEIN
.	|O

Alternative	|O
splicing	|O
of	|O
RNA	|O
transcripts	|O
encoded	|O
by	|O
the	|O
murine	|O
p105	|B-PROTEIN
NF	|O
-	|O
kappa	|O
B	|O
gene	|O
generates	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
gamma	|I-PROTEIN
isoforms	|O
with	|O
different	|O
inhibitory	|O
activities	|O
.	|O

Topical	|O
L	|O
-	|O
NNA	|O
attenuated	|O
the	|O
hypercapnic	|O
increase	|O
of	|O
CoBF	|O
by	|O
52	|O
+	|O
/	|O
-	|O
6%	|O
and	|O
CeBF	|O
by	|O
29	|O
+	|O
/	|O
-	|O
5%	|O
after	|O
45	|O
-	|O
min	|O
exposure	|O
.	|O

The	|O
experiment	|O
included	|O
6	|O
male	|O
and	|O
4	|O
female	|O
healthy	|O
subjects	|O
who	|O
,	|O
during	|O
a	|O
24	|O
-	|O
hour	|O
stay	|O
in	|O
the	|O
respiration	|O
chambers	|O
,	|O
performed	|O
,	|O
in	|O
the	|O
morning	|O
and	|O
afternoon	|O
,	|O
15	|O
min	|O
cycling	|O
with	|O
the	|O
total	|O
work	|O
of	|O
6,750	|O
kg	|O
m	|O
.	|O

These	|O
rearrangements	|O
result	|O
in	|O
the	|O
formation	|O
of	|O
chimeric	|O
genes	|O
showing	|O
the	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
domain	|O
of	|O
ret	|B-PROTEIN
fused	|O
with	|O
the	|O
5'	|O
end	|O
sequences	|O
of	|O
different	|O
genes	|O
.	|O

Frequent	|O
loss	|O
of	|O
heterozygosity	|O
(	|O
LOH	|O
)	|O
of	|O
>	|O
30%	|O
of	|O
the	|O
informative	|O
cases	|O
was	|O
observed	|O
on	|O
chromosomes	|O
3p	|O
(	|O
41.1%	|O
)	|O
,	|O
5q	|O
(	|O
52.6%	|O
)	|O
,	|O
6p	|O
(	|O
30.4%	|O
)	|O
,	|O
8p	|O
(	|O
33.3%	|O
)	|O
,	|O
9p	|O
(	|O
35.7%	|O
)	|O
,	|O
9q	|O
(	|O
30.8%	|O
)	|O
,	|O
11p	|O
(	|O
32.4%	|O
)	|O
,	|O
13q	|O
(	|O
52.7%	|O
)	|O
,	|O
17p	|O
(	|O
55.2%	|O
)	|O
,	|O
17q	|O
(	|O
33.3%	|O
)	|O
,	|O
18q	|O
(	|O
45.7%	|O
)	|O
,	|O
and	|O
19q	|O
(	|O
30.4%	|O
)	|O
.	|O

A	|O
single	|O
amino	|O
acid	|O
change	|O
in	|O
the	|O
CPY	|B-PROTEIN
vacuolar	|O
sorting	|O
signal	|O
prevents	|O
this	|O
interaction	|O
.	|O

Glutamyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
and	|O
prolyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
belong	|O
to	|O
different	|O
classes	|O
of	|O
aminoacyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetases	|I-PROTEIN
that	|O
are	|O
thought	|O
to	|O
have	|O
evolved	|O
along	|O
independent	|O
evolutionary	|O
pathways	|O
.	|O

Using	|O
the	|O
sequence	|O
data	|O
obtained	|O
from	|O
the	|O
human	|O
TCRAC	|B-PROTEIN
/	|O
TCRDC	|B-PROTEIN
region	|O
,	|O
we	|O
have	|O
extended	|O
a	|O
polymerase	|O
chain	|O
reaction	|O
-	|O
based	|O
assay	|O
to	|O
test	|O
for	|O
the	|O
expression	|O
of	|O
the	|O
individual	|O
TCRAJ	|B-PROTEIN
gene	|O
segments	|O
.	|O

This	|O
analysis	|O
revealed	|O
an	|O
intact	|O
gene	|O
(	|O
arg4	|B-PROTEIN
)	|O
showing	|O
a	|O
high	|O
degree	|O
of	|O
homology	|O
with	|O
the	|O
Saccharomyces	|O
cerevisiae	|O
CPA2	|B-PROTEIN
gene	|O
encoding	|O
the	|O
large	|O
subunit	|O
of	|O
carbamoyl	|B-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
synthetase	|I-PROTEIN
(	|O
CPS	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
)	|O
.	|O

Restriction	|O
analysis	|O
and	|O
Southern	|O
hybridization	|O
revealed	|O
the	|O
presence	|O
of	|O
Tn5422	|B-PROTEIN
in	|O
all	|O
the	|O
plasmid	|O
-	|O
mediated	|O
cadmium	|O
-	|O
resistant	|O
L.	|O
monocytogenes	|O
strains	|O
tested	|O
but	|O
not	|O
in	|O
strains	|O
encoding	|O
cadmium	|O
resistance	|O
on	|O
the	|O
chromosome	|O
.	|O

The	|O
baroreflex	|O
latency	|O
(	|O
from	|O
the	|O
ECG	|O
R	|O
-	|O
wave	|O
to	|O
the	|O
integrated	|O
MSNA	|O
burst	|O
peak	|O
)	|O
was	|O
constant	|O
at	|O
approximately	|O
1.20	|O
s	|O
during	|O
sleep	|O
,	|O
suggesting	|O
that	|O
pulse	|O
-	|O
synchronicity	|O
was	|O
maintained	|O
.	|O

DESIGN	|O
-	|O
-	|O
A	|O
randomised	|O
study	|O
was	|O
conducted	|O
in	|O
all	|O
women	|O
aged	|O
50-70	|O
years	|O
who	|O
were	|O
eligible	|O
for	|O
breast	|O
cancer	|O
screening	|O
and	|O
living	|O
in	|O
the	|O
city	|O
of	|O
Utrecht	|O
.	|O

Identification	|O
of	|O
an	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
gene	|I-PROTEIN
in	|O
the	|O
Marek	|O
's	|O
disease	|O
virus	|O
long	|O
internal	|O
repeat	|O
region	|O
which	|O
encodes	|O
a	|O
unique	|O
14	|O
-	|O
kilodalton	|O
polypeptide	|O
.	|O

We	|O
have	|O
used	|O
a	|O
full	|O
-	|O
length	|O
cDNA	|O
clone	|O
of	|O
a	|O
mouse	|O
hepatitis	|O
virus	|O
strain	|O
A59	|O
defective	|O
interfering	|O
(	|O
DI	|O
)	|O
RNA	|O
,	|O
pMIDI	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
,	|O
and	|O
cassette	|O
mutagenesis	|O
to	|O
study	|O
the	|O
mechanism	|O
of	|O
coronavirus	|O
subgenomic	|O
mRNA	|O
synthesis	|O
.	|O

To	|O
study	|O
the	|O
structure	|O
-	|O
function	|O
of	|O
the	|O
gene	|B-PROTEIN
5	|I-PROTEIN
product	|O
,	|O
wild	|O
-	|O
type	|O
and	|O
mutant	|O
forms	|O
of	|O
NS53	|B-PROTEIN
were	|O
produced	|O
by	|O
using	|O
a	|O
recombinant	|O
baculovirus	|O
expression	|O
system	|O
and	|O
a	|O
recombinant	|O
vaccinia	|O
virus	|O
/	|O
T7	|O
(	|O
vTF7	|O
-	|O
3	|O
)	|O
expression	|O
system	|O
.	|O

Gel	|O
electrophoresis	|O
and	|O
Western	|O
immunoblot	|O
analyses	|O
of	|O
intracellular	|O
fractions	|O
derived	|O
from	|O
infected	|O
cells	|O
revealed	|O
that	|O
large	|O
amounts	|O
of	|O
NS53	|B-PROTEIN
were	|O
present	|O
in	|O
the	|O
cytosol	|O
and	|O
in	|O
association	|O
with	|O
the	|O
cytoskeletal	|O
matrix	|O
.	|O

The	|O
transcription	|O
factor	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
encoded	|O
by	|O
a	|O
gene	|O
located	|O
on	|O
chromosome	|O
6	|O
near	|O
the	|O
HLA	|B-PROTEIN
locus	|O
.	|O

The	|O
mature	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
mRNA	|O
is	|O
spliced	|O
from	|O
7	|O
exons	|O
distributed	|O
over	|O
a	|O
region	|O
of	|O
18	|O
kb	|O
genomic	|O
DNA	|O
.	|O

San	|O
Martin	|O
's	|O
psychological	|O
traits	|O
coupled	|O
to	|O
his	|O
work	|O
with	|O
masonic	|O
lodges	|O
that	|O
allowed	|O
him	|O
to	|O
display	|O
his	|O
abilities	|O
as	|O
strategist	|O
and	|O
political	|O
ruler	|O
.	|O

The	|O
participants	|O
were	|O
homosexual	|O
men	|O
in	|O
hepatitis	|O
B	|O
vaccine	|O
trials	|O
in	|O
Amsterdam	|O
(	|O
n	|O
=	|O
74	|O
)	|O
,	|O
New	|O
York	|O
City	|O
(	|O
n	|O
=	|O
120	|O
)	|O
,	|O
and	|O
San	|O
Francisco	|O
(	|O
n	|O
=	|O
168	|O
)	|O
.	|O

The	|O
7	|O
-	|O
day	|O
treatment	|O
resulted	|O
in	|O
a	|O
decrease	|O
in	|O
mitochondrial	|O
uptake	|O
of	|O
Rh123	|O
and	|O
an	|O
increase	|O
in	|O
NAO	|O
uptake	|O
.	|O

Thrombotic	|O
thrombocytopenic	|O
purpura	|O
in	|O
systemic	|O
lupus	|O
erythematosus	|O
.	|O

Comparison	|O
with	|O
the	|O
crystal	|O
structure	|O
of	|O
Desulfovibrio	|O
gigas	|O
,	|O
Dg	|O
,	|O
Fd	|B-PROTEIN
(	|O
Kissinger	|O
et	|O
al.	|O
,	|O
1991	|O
)	|O
reveals	|O
a	|O
very	|O
similar	|O
folding	|O
topology	|O
,	|O
although	|O
several	|O
secondary	|O
structural	|O
elements	|O
are	|O
extended	|O
in	|O
Pf	|O
relative	|O
to	|O
Dg	|O
Fd	|B-PROTEIN
.	|O

CONCLUSIONS	|O
:	|O
Serum	|O
prolactin	|B-PROTEIN
concentrations	|O
show	|O
age	|O
related	|O
variations	|O
in	|O
presumably	|O
fertile	|O
men	|O
.	|O

Eight	|O
highly	|O
trained	|O
male	|O
kayakers	|O
were	|O
studied	|O
to	|O
determine	|O
the	|O
relationship	|O
between	|O
critical	|O
power	|O
(	|O
CP	|O
)	|O
and	|O
the	|O
onset	|O
of	|O
blood	|O
lactate	|O
accumulation	|O
(	|O
OBLA	|O
)	|O
.	|O

As	|O
in	|O
S.	|O
cerevisiae	|O
,	|O
the	|O
sequence	|O
of	|O
rhp51+	|B-PROTEIN
showed	|O
two	|O
MluI	|B-PROTEIN
cell	|O
-	|O
cycle	|O
boxes	|O
and	|O
a	|O
putative	|O
DNA	|O
damage	|O
-	|O
responsive	|O
element	|O
in	|O
its	|O
upstream	|O
region	|O
.	|O

Women	|O
's	|O
opportunities	|O
for	|O
paid	|O
work	|O
outside	|O
the	|O
home	|O
are	|O
constrained	|O
by	|O
their	|O
role	|O
as	|O
primary	|O
carer	|O
within	|O
the	|O
family	|O
,	|O
writes	|O
Trudy	|O
Wynne	|O
.	|O

A	|O
partial	|O
cDNA	|O
sequence	|O
indicated	|O
that	|O
the	|O
T	|B-PROTEIN
lymphocyte	|I-PROTEIN
early	|I-PROTEIN
-	|I-PROTEIN
activation	|I-PROTEIN
gene	|I-PROTEIN
(	|O
Tea	|B-PROTEIN
)	|O
encodes	|O
a	|O
protein	|O
related	|O
to	|O
the	|O
dual	|O
-	|O
function	|O
ecotropic	|B-PROTEIN
retrovirus	|I-PROTEIN
receptor	|I-PROTEIN
/	|O
cationic	|B-PROTEIN
amino	|I-PROTEIN
acid	|I-PROTEIN
transporter	|I-PROTEIN
(	|O
ecoR	|B-PROTEIN
/	|O
CAT1	|B-PROTEIN
)	|O
,	|O
and	|O
RNA	|O
blots	|O
suggested	|O
highest	|O
Tea	|B-PROTEIN
expression	|O
in	|O
T	|O
lymphocytes	|O
and	|O
liver	|O
(	|O
MacLeod	|O
,	|O
C.L.	|O
,	|O
Finley	|O
,	|O
K.	|O
,	|O
Kakuda	|O
,	|O
D.	|O

Furthermore	|O
,	|O
unlike	|O
the	|O
case	|O
for	|O
HIS3	|B-PROTEIN
where	|O
only	|O
a	|O
limited	|O
subset	|O
of	|O
TATA	|O
-	|O
like	|O
sequences	|O
can	|O
activate	|O
transcription	|O
in	|O
conjunction	|O
with	|O
GCN4p	|B-PROTEIN
,	|O
many	|O
divergent	|O
TATA	|O
-	|O
like	|O
sequences	|O
allowed	|O
GCN4p	|B-PROTEIN
activation	|O
of	|O
TRP3	|B-PROTEIN
.	|O

Bacterially	|O
expressed	|O
protein	|O
,	|O
as	|O
well	|O
as	|O
the	|O
in	|O
vitro	|O
reticulocyte	|O
lysate	|O
translation	|O
product	|O
,	|O
comigrated	|O
with	|O
the	|O
purified	|O
37	|O
-	|O
kDa	|O
protein	|O
on	|O
sodium	|O
dodecyl	|O
sulfate	|O
-	|O
polyacrylamide	|O
gels	|O
.	|O

In	|O
addition	|O
,	|O
this	|O
kinase	|O
is	|O
well	|O
conserved	|O
evolutionarily	|O
,	|O
ubiquitously	|O
expressed	|O
,	|O
and	|O
its	|O
genes	|O
map	|O
to	|O
a	|O
position	|O
on	|O
human	|O
chromosome	|O
1	|O
frequently	|O
deleted	|O
in	|O
the	|O
late	|O
stages	|O
of	|O
tumorigenesis	|O
.	|O

Deletion	|O
analysis	|O
of	|O
the	|O
ICL1	|B-PROTEIN
promoter	|O
led	|O
to	|O
the	|O
identification	|O
of	|O
an	|O
upstream	|O
activating	|O
sequence	|O
element	|O
,	|O
UASICL1	|O
(	|O
5'	|O
CATTCATCCG	|O
3'	|O
)	|O
,	|O
necessary	|O
and	|O
sufficient	|O
for	|O
conferring	|O
carbon	|O
source	|O
-	|O
dependent	|O
regulation	|O
on	|O
a	|O
heterologous	|O
reporter	|O
gene	|O
.	|O

Interestingly	|O
,	|O
the	|O
interaction	|O
of	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
with	|O
the	|O
motif	|O
was	|O
dependent	|O
on	|O
the	|O
presence	|O
of	|O
both	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
SH2	|O
domains	|O
and	|O
both	|O
of	|O
the	|O
tyrosine	|O
residues	|O
in	|O
the	|O
motif	|O
,	|O
suggesting	|O
that	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
interacts	|O
with	|O
two	|O
phosphotyrosine	|O
residues	|O
and	|O
that	|O
the	|O
binding	|O
of	|O
the	|O
two	|O
SH2	|B-PROTEIN
domains	|O
is	|O
cooperative	|O
.	|O

PRL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
able	|O
to	|O
dephosphorylate	|O
phosphotyrosine	|O
substrates	|O
,	|O
and	|O
mutation	|O
of	|O
the	|O
active	|O
-	|O
site	|O
cysteine	|O
residue	|O
abolishes	|O
this	|O
activity	|O
.	|O

In	|O
Mv1Lu	|O
lung	|O
epithelial	|O
cells	|O
,	|O
ActR	|B-PROTEIN
-	|I-PROTEIN
IB	|I-PROTEIN
and	|O
T	|B-PROTEIN
beta	|I-PROTEIN
R	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
signal	|O
a	|O
common	|O
set	|O
of	|O
growth	|O
-	|O
inhibitory	|O
and	|O
transcriptional	|O
responses	|O
in	|O
association	|O
with	|O
their	|O
corresponding	|O
ligands	|O
and	|O
type	|B-PROTEIN
II	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

50	|O
kDa	|O
and	|O
130-170	|O
kDa	|O
were	|O
detected	|O
.	|O

H	|O
-	|O
7	|O
,	|O
which	|O
specifically	|O
,	|O
although	|O
weakly	|O
,	|O
inhibited	|O
PKC	|B-PROTEIN
activation	|O
,	|O
had	|O
no	|O
effect	|O
on	|O
tyrosine	|O
phosphorylation	|O
and	|O
PtdIns	|O
(	|O
3,4	|O
)	|O
P2	|O
production	|O
.	|O

The	|O
effects	|O
of	|O
systemic	|O
glucose	|O
concentration	|O
on	|O
brain	|O
metabolism	|O
following	|O
repeated	|O
brain	|O
ischemia	|O
.	|O

This	|O
strategy	|O
was	|O
used	|O
to	|O
place	|O
both	|O
the	|O
Tn903	|O
neo	|B-PROTEIN
gene	|O
and	|O
the	|O
Rhodosporidium	|O
toruloides	|O
phenylalanine	|B-PROTEIN
ammonia	|I-PROTEIN
lyase	|I-PROTEIN
(	|O
PAL	|O
)	|O
-	|O
encoding	|O
gene	|O
under	|O
the	|O
transcriptional	|O
control	|O
of	|O
pPGK	|B-PROTEIN
::	|O
REP2	|B-PROTEIN
.	|O

In	|O
the	|O
case	|O
of	|O
congenital	|O
protein	|B-PROTEIN
C	|I-PROTEIN
deficiency	|O
,	|O
vitamin	|O
K	|O
antagonists	|O
must	|O
be	|O
started	|O
cautiously	|O
due	|O
to	|O
the	|O
risk	|O
of	|O
skin	|O
necrosis	|O
.	|O

A	|O
-	|O
69	|O
-	|O
year	|O
-	|O
old	|O
patient	|O
with	|O
postoperative	|O
small	|O
-	|O
bowel	|O
obstruction	|O
underwent	|O
laparotomy	|O
three	|O
times	|O
.	|O

On	|O
physical	|O
examination	|O
a	|O
mild	|O
symmetrical	|O
polyarthritis	|O
of	|O
small	|O
and	|O
large	|O
joints	|O
was	|O
seen	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
observe	|O
that	|O
the	|O
hUBF	|B-PROTEIN
-	|O
promoter	|O
interaction	|O
is	|O
highly	|O
sensitive	|O
to	|O
the	|O
antagonistic	|O
effects	|O
of	|O
cisplatin	|O
-	|O
DNA	|O
adducts	|O
.	|O

We	|O
conclude	|O
that	|O
the	|O
SIMV	|O
is	|O
useful	|O
in	|O
weaning	|O
neonates	|O
from	|O
the	|O
ventilator	|O
.	|O

VP	|O
-	|O
16	|O
,	|O
ifosfamide	|O
and	|O
cisplatin	|O
(	|O
VIP	|O
)	|O
for	|O
extensive	|O
small	|O
cell	|O
lung	|O
cancer	|O
.	|O

A	|O
total	|O
of	|O
7	|O
(	|O
4	|O
males	|O
and	|O
3	|O
females	|O
)	|O
patients	|O
were	|O
included	|O
in	|O
this	|O
retrospective	|O
study	|O
to	|O
determine	|O
the	|O
sensitivity	|O
of	|O
radioimmunoscintigraphy	|O
with	|O
I	|O
-	|O
131	|O
labeled	|O
anti	|B-PROTEIN
CEA	|I-PROTEIN
/	|O
CA	|B-PROTEIN
19-9	|I-PROTEIN
monoclonal	|O
antibodies	|O
.	|O

Simultaneous	|O
,	|O
bilateral	|O
and	|O
permanent	|O
ventilation	|O
with	|O
a	|O
diaphragm	|O
pacing	|O
in	|O
childhood	|O
:	|O
the	|O
implantation	|O
technique	|O
and	|O
indications	|O

A	|O
genomic	|O
clone	|O
for	|O
the	|O
cyc07	|B-PROTEIN
gene	|O
,	|O
which	|O
is	|O
expressed	|O
specifically	|O
at	|O
the	|O
S	|O
phase	|O
during	|O
the	|O
cell	|O
cycle	|O
in	|O
synchronous	|O
cultures	|O
of	|O
periwinkle	|O
(	|O
Catharanthus	|O
roseus	|O
)	|O
cells	|O
,	|O
was	|O
isolated	|O
.	|O

CONCLUSIONS	|O
:	|O
Translocation	|O
of	|O
bacteria	|O
or	|O
endotoxin	|O
from	|O
the	|O
gastrointestinal	|O
tract	|O
into	|O
the	|O
bloodstream	|O
has	|O
been	|O
noted	|O
in	|O
animal	|O
experiments	|O
;	|O
however	|O
,	|O
translocation	|O
was	|O
not	|O
detected	|O
in	|O
our	|O
patients	|O
with	|O
hemorrhagic	|O
shock	|O
.	|O

The	|O
pyrR	|B-PROTEIN
and	|O
pyrP	|B-PROTEIN
genes	|O
encoded	|O
polypeptides	|O
with	|O
calculated	|O
molecular	|O
masses	|O
of	|O
19.9	|O
and	|O
45.2	|O
kDa	|O
,	|O
respectively	|O
.	|O

Southern	|O
blotting	|O
analysis	|O
implied	|O
the	|O
occurrence	|O
of	|O
multiple	|O
COXVb	|B-PROTEIN
genes	|O
in	|O
the	|O
rat	|O
genome	|O
.	|O

Acylation	|O
with	|O
the	|O
palmitate	|O
analog	|O
was	|O
prevented	|O
when	|O
Gly	|O
-	|O
2	|O
was	|O
mutated	|O
to	|O
alanine	|O
,	|O
implying	|O
that	|O
N	|O
-	|O
myristylation	|O
is	|O
required	|O
for	|O
palmitylation	|O
,	|O
and	|O
when	|O
either	|O
Cys	|O
-	|O
3	|O
or	|O
Cys	|O
-	|O
6	|O
was	|O
mutated	|O
to	|O
serine	|O
.	|O

Subunit	|O
composition	|O
and	|O
domain	|O
structure	|O
of	|O
the	|O
Spo0A	|B-PROTEIN
sporulation	|O
transcription	|O
factor	|O
of	|O
Bacillus	|O
subtilis	|O
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
analysis	|O
indicates	|O
that	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
as	|O
well	|O
as	|O
other	|O
related	|O
members	|O
of	|O
this	|O
family	|O
,	|O
bind	|O
specifically	|O
to	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
site	|O
in	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
promoter	|O
.	|O

BYV	|O
,	|O
citrus	|O
tristeza	|O
virus	|O
(	|O
CTV	|O
)	|O
,	|O
beet	|O
yellow	|O
stunt	|O
virus	|O
(	|O
BYSV	|O
)	|O
and	|O
carnation	|O
necrotic	|O
fleck	|O
virus	|O
templates	|O
produced	|O
1	|O
kb	|O
amplification	|O
products	|O
,	|O
which	|O
were	|O
shown	|O
by	|O
sequencing	|O
to	|O
represent	|O
fragments	|O
of	|O
the	|O
respective	|O
HSP70	|B-PROTEIN
genes	|O
.	|O

To	|O
identify	|O
the	|O
precise	|O
location	|O
of	|O
the	|O
phosphorylation	|O
site	|O
on	|O
the	|O
64	|O
-	|O
kDa	|O
protein	|O
,	|O
a	|O
step	|O
-	|O
by	|O
-	|O
step	|O
mutagenesis	|O
procedures	|O
was	|O
followed	|O
.	|O

The	|O
p53	|B-PROTEIN
tumor	|O
suppressor	|O
gene	|O
product	|O
,	|O
a	|O
sequence	|O
-	|O
specific	|O
DNA	|O
-	|O
binding	|O
protein	|O
,	|O
has	|O
been	|O
shown	|O
to	|O
act	|O
as	|O
a	|O
transcriptional	|O
activator	|O
and	|O
repressor	|O
both	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

Mutational	|O
analysis	|O
of	|O
chromosomal	|O
segment	|O
64AB	|O
,	|O
a	|O
region	|O
containing	|O
the	|O
glutamic	|B-PROTEIN
acid	|I-PROTEIN
decarboxylase	|I-PROTEIN
gene	|O
.	|O

Rearrangements	|O
of	|O
the	|O
NFKB2	|B-PROTEIN
gene	|O
are	|O
associated	|O
with	|O
lymphoid	|O
malignancies	|O
,	|O
but	|O
the	|O
functional	|O
significance	|O
of	|O
these	|O
alterations	|O
is	|O
not	|O
known	|O
.	|O

Cloning	|O
and	|O
sequencing	|O
of	|O
the	|O
corresponding	|O
cDNAs	|O
indicates	|O
that	|O
,	|O
via	|O
alternative	|O
splicing	|O
,	|O
the	|O
rearranged	|O
gene	|O
codes	|O
for	|O
two	|O
proteins	|O
of	|O
84	|O
and	|O
85	|O
kD	|O
(	|O
p84/85	|B-PROTEIN
)	|O
which	|O
retain	|O
the	|O
DNA	|O
-	|O
binding	|O
rel	|B-PROTEIN
domain	|O
and	|O
the	|O
first	|O
five	|O
ankyrin	|B-PROTEIN
repeats	|O
,	|O
but	|O
have	|O
lost	|O
their	|O
carboxy	|O
-	|O
terminus	|O
including	|O
the	|O
seventh	|O
ankyrin	|B-PROTEIN
repeat	|O
.	|O

Transient	|O
co	|O
-	|O
transfection	|O
assays	|O
involving	|O
NFKB2	|B-PROTEIN
expression	|O
vectors	|O
and	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
-	|O
driven	|O
reporter	|O
plasmids	|O
indicate	|O
that	|O
NFKB2	|B-PROTEIN
p85	|O
has	|O
lost	|O
the	|O
transcriptional	|O
repressor	|O
functions	|O
typical	|O
of	|O
normal	|O
NFKB2	|B-PROTEIN
p52	|O
.	|O

Also	|O
,	|O
HR21ap	|B-PROTEIN
as	|O
well	|O
as	|O
HR21Xap	|B-PROTEIN
are	|O
specific	|O
in	|O
their	|O
inhibition	|O
of	|O
Sp1	|B-PROTEIN
binding	|O
.	|O

Intravenous	|O
antibiotic	|O
therapy	|O
in	|O
cystic	|O
fibrosis	|O
:	|O
in	|O
hospital	|O
or	|O
at	|O
home	|O
?	|O

Open	|O
reading	|O
frames	|O
in	|O
a	|O
4556	|O
nucleotide	|O
sequence	|O
within	|O
MDV	|O
-	|O
1	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
DNA	|O
fragment	|O
:	|O
evidence	|O
for	|O
splicing	|O
of	|O
mRNA	|O
from	|O
a	|O
new	|O
viral	|O
glycoprotein	|O
gene	|O
.	|O

The	|O
ns2	|B-PROTEIN
gene	|O
comprises	|O
an	|O
open	|O
reading	|O
frame	|O
(	|O
ORF	|O
)	|O
encoding	|O
a	|O
putative	|O
nonstructural	|O
(	|O
ns	|O
)	|O
protein	|O
of	|O
279	|O
amino	|O
acids	|O
with	|O
a	|O
predicted	|O
molecular	|O
mass	|O
of	|O
32	|O
-	|O
kDa	|O
.	|O

Co	|O
-	|O
transfection	|O
of	|O
a	|O
tat	|B-PROTEIN
expressing	|O
plasmid	|O
with	|O
these	|O
viruses	|O
containing	|O
the	|O
tat	|B-PROTEIN
ORF	|O
mutations	|O
resulted	|O
in	|O
higher	|O
levels	|O
of	|O
virus	|O
production	|O
demonstrating	|O
that	|O
the	|O
effects	|O
of	|O
both	|O
mutants	|O
are	|O
tat	|B-PROTEIN
specific	|O
.	|O

Analysis	|O
of	|O
the	|O
gag	|B-PROTEIN
and	|O
rev	|B-PROTEIN
proteins	|O
in	|O
the	|O
transfected	|O
cells	|O
demonstrated	|O
that	|O
these	|O
proteins	|O
were	|O
not	|O
detectable	|O
in	|O
cells	|O
transfected	|O
with	|O
the	|O
tat	|B-PROTEIN
mutants	|O
but	|O
could	|O
be	|O
readily	|O
detected	|O
when	|O
the	|O
mutations	|O
were	|O
complemented	|O
in	|O
trans	|O
with	|O
a	|O
tat	|B-PROTEIN
expression	|O
vector	|O
.	|O

The	|O
hydrophobicity	|O
profile	|O
of	|O
the	|O
methyltransferase	|O
reveals	|O
the	|O
presence	|O
of	|O
at	|O
least	|O
five	|O
potential	|O
transmembrane	|O
domains	|O
.	|O

Measurement	|O
of	|O
SaO2	|O
at	|O
moderate	|O
altitude	|O
can	|O
be	|O
helpful	|O
in	|O
the	|O
care	|O
of	|O
both	|O
healthy	|O
and	|O
ill	|O
newborns	|O
or	|O
infants	|O
.	|O

To	|O
determine	|O
whether	|O
the	|O
excess	|O
prevalence	|O
of	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
infection	|O
in	|O
US	|O
black	|O
and	|O
Hispanic	|O
homosexual	|O
men	|O
relative	|O
to	|O
white	|O
men	|O
can	|O
be	|O
explained	|O
by	|O
differences	|O
in	|O
sociodemographic	|O
factors	|O
,	|O
history	|O
of	|O
sexually	|O
transmitted	|O
diseases	|O
,	|O
or	|O
sexual	|O
and	|O
drug	|O
-	|O
use	|O
behaviors	|O
,	|O
the	|O
authors	|O
conducted	|O
a	|O
cross	|O
-	|O
sectional	|O
analysis	|O
of	|O
baseline	|O
HIV	|O
-	|O
1	|O
seroprevalence	|O
and	|O
HIV	|O
-	|O
1	|O
risk	|O
factors	|O
among	|O
4,475	|O
non	|O
-	|O
Hispanic	|O
white	|O
,	|O
234	|O
Hispanic	|O
white	|O
,	|O
and	|O
194	|O
black	|O
homosexual	|O
men	|O
from	|O
four	|O
centers	|O
in	|O
the	|O
United	|O
States	|O
(	|O
Baltimore	|O
/	|O
Washington	|O
,	|O
DC	|O
,	|O
Pittsburgh	|O
,	|O
Chicago	|O
,	|O
and	|O
Los	|O
Angeles	|O
)	|O
.	|O

The	|O
patients	|O
in	|O
one	|O
group	|O
had	|O
intrauterine	|O
catheters	|O
inserted	|O
and	|O
oxytocin	|B-PROTEIN
was	|O
titrated	|O
to	|O
achieve	|O
the	|O
75th	|O
percentile	|O
of	|O
uterine	|O
activity	|O
observed	|O
in	|O
spontaneous	|O
normal	|O
labour	|O
according	|O
to	|O
parity	|O
.	|O

Continued	|O
development	|O
of	|O
the	|O
rat	|O
conditioning	|O
paradigm	|O
is	|O
especially	|O
warranted	|O
because	|O
of	|O
the	|O
ability	|O
to	|O
record	|O
sympathetic	|O
nerve	|O
activity	|O
in	|O
intact	|O
,	|O
awake	|O
subjects	|O
and	|O
the	|O
large	|O
number	|O
of	|O
readily	|O
available	|O
genetic	|O
strains	|O
,	|O
which	|O
model	|O
human	|O
pathological	|O
states	|O
.	|O

The	|O
ultrastructure	|O
of	|O
retinal	|O
vessels	|O
was	|O
examined	|O
in	|O
three	|O
eyes	|O
from	|O
diabetic	|O
patients	|O
and	|O
two	|O
eyes	|O
from	|O
control	|O
subjects	|O
.	|O

The	|O
regulatory	|O
region	|O
also	|O
has	|O
a	|O
sequence	|O
similar	|O
to	|O
the	|O
binding	|O
site	|O
for	|O
a	|O
liver	|O
-	|O
specific	|O
transcription	|O
factor	|O
,	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
at	|O
positions	|O
-	|O
120	|O
to	|O
-	|O
132	|O
.	|O

Thus	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
GRE	|O
sufficient	|O
to	|O
account	|O
for	|O
full	|O
glucocorticoid	|O
inducibility	|O
and	|O
an	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
close	|O
to	|O
the	|O
promoter	|O
that	|O
are	|O
major	|O
determinants	|O
of	|O
transcriptional	|O
control	|O
of	|O
the	|O
Xenopus	|O
fibrinogen	|B-PROTEIN
B	|I-PROTEIN
beta	|O
subunit	|O
gene	|O
in	|O
cells	|O
from	|O
normal	|O
liver	|O
tissue	|O
.	|O

Acad	|O
.	|O

The	|O
PRB	|B-PROTEIN
-	|I-PROTEIN
1b	|I-PROTEIN
gene	|O
encodes	|O
for	|O
a	|O
basic	|O
-	|O
type	|O
component	|O
of	|O
the	|O
pathogenesis	|O
-	|O
related	|O
PR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
family	|O
.	|O

Replacement	|O
of	|O
the	|O
CRE	|O
with	|O
a	|O
second	|O
copy	|O
of	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
results	|O
in	|O
a	|O
level	|O
of	|O
transcriptional	|O
activity	|O
comparable	|O
with	|O
that	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
sequence	|O
,	|O
but	|O
replacement	|O
of	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
with	|O
a	|O
CRE	|O
abolishes	|O
activity	|O
.	|O

The	|O
T	|B-PROTEIN
-	|I-PROTEIN
cyt	|I-PROTEIN
promoter	|O
,	|O
although	|O
of	|O
bacterial	|O
origin	|O
is	|O
active	|O
in	|O
planta	|O
and	|O
the	|O
30	|O
bp	|O
cyt	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
element	|O
is	|O
located	|O
within	|O
a	|O
region	|O
that	|O
is	|O
essential	|O
for	|O
T	|B-PROTEIN
-	|I-PROTEIN
cyt	|I-PROTEIN
promotor	|O
activity	|O
in	|O
leaf	|O
,	|O
stem	|O
and	|O
root	|O
cells	|O
of	|O
tobacco	|O
plants	|O
.	|O

Reviewing	|O
manuscripts	|O
:	|O
developing	|O
an	|O
efficient	|O
system	|O
.	|O

We	|O
suggest	|O
that	|O
CT	|O
scan	|O
be	|O
preferable	|O
in	|O
diagnosis	|O
of	|O
tumors	|O
in	|O
that	|O
area	|O
.	|O

SIN	|O
-	|O
1	|O
had	|O
no	|O
influence	|O
on	|O
either	|O
the	|O
ischemic	|O
parameters	|O
in	|O
the	|O
surface	|O
electrocardiogram	|O
(	|O
ECG	|O
)	|O
or	|O
the	|O
intracoronary	|O
ECG	|O
.	|O

Effect	|O
of	|O
aging	|O
on	|O
respiratory	|O
skeletal	|O
muscles	|O
.	|O

Two	|O
BASIC	|O
computer	|O
programs	|O
using	|O
logit	|O
transformation	|O
for	|O
the	|O
analysis	|O
of	|O
S	|O
-	|O
shaped	|O
curves	|O
are	|O
presented	|O
.	|O

The	|O
yeast	|O
SSS1	|B-PROTEIN
gene	|O
is	|O
essential	|O
for	|O
secretory	|O
protein	|O
translocation	|O
and	|O
encodes	|O
a	|O
conserved	|O
protein	|O
of	|O
the	|O
endoplasmic	|O
reticulum	|O
.	|O

The	|O
lengths	|O
of	|O
the	|O
complete	|O
polypeptide	|O
chain	|O
of	|O
the	|O
recombinant	|O
enzyme	|O
and	|O
its	|O
transit	|O
peptide	|O
are	|O
388	|O
and	|O
53	|O
residues	|O
,	|O
respectively	|O
.	|O

The	|O
absence	|O
of	|O
H4PteGlun	|O
bound	|O
to	|O
the	|O
T	|B-PROTEIN
protein	|I-PROTEIN
in	|O
our	|O
experimental	|O
conditions	|O
demonstrates	|O
that	|O
H4PteGlun	|O
is	|O
not	|O
covalently	|O
linked	|O
to	|O
the	|O
T	|B-PROTEIN
protein	|I-PROTEIN
.	|O

TATA	|O
and	|O
CCAAT	|O
boxes	|O
are	|O
located	|O
34	|O
-	|O
bp	|O
and	|O
68	|O
-	|O
bp	|O
,	|O
respectively	|O
,	|O
upstream	|O
of	|O
the	|O
transcription	|O
start	|O
site	|O
,	|O
the	|O
5'	|O
-	|O
untranslated	|O
leader	|O
is	|O
78	|O
nucleotides	|O
long	|O
,	|O
and	|O
the	|O
intronless	|O
gene	|O
has	|O
at	|O
least	|O
two	|O
different	|O
polyadenylation	|O
sites	|O
.	|O

GGS1	|B-PROTEIN
is	|O
the	|O
same	|O
gene	|O
as	|O
TPS1	|B-PROTEIN
which	|O
was	|O
identified	|O
as	|O
encoding	|O
a	|O
subunit	|O
of	|O
the	|O
trehalose	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
synthase	|I-PROTEIN
/	|I-PROTEIN
phosphatase	|I-PROTEIN
complex	|O
and	|O
it	|O
is	|O
allelic	|O
to	|O
the	|O
fdp1	|B-PROTEIN
,	|O
byp1	|B-PROTEIN
,	|O
glc6	|B-PROTEIN
and	|O
cif1	|B-PROTEIN
mutations	|O
.	|O

We	|O
also	|O
compared	|O
the	|O
sequence	|O
with	|O
the	|O
partly	|O
homologous	|O
products	|O
of	|O
the	|O
S.	|O
cerevisiae	|O
genes	|O
TPS2	|B-PROTEIN
and	|O
TSL1	|B-PROTEIN
which	|O
code	|O
for	|O
the	|O
larger	|O
subunits	|O
of	|O
the	|O
trehalose	|B-PROTEIN
synthase	|I-PROTEIN
complex	|O
and	|O
with	|O
a	|O
TSL1	|B-PROTEIN
homologue	|O
,	|O
TPS3	|B-PROTEIN
,	|O
of	|O
unknown	|O
function	|O
.	|O

Stroop	|O
interference	|O
:	|O
aging	|O
effects	|O
assessed	|O
with	|O
the	|O
Stroop	|O
Color	|O
-	|O
Word	|O
Test	|O
.	|O

Stimulation	|O
of	|O
[	|O
3H	|O
]	|O
PA	|O
production	|O
upon	|O
CD3	|B-PROTEIN
cross	|O
-	|O
linking	|O
was	|O
77%	|O
lower	|O
in	|O
permeabilized	|O
CD45	|B-PROTEIN
-	|O
cells	|O
than	|O
in	|O
CD45+	|B-PROTEIN
cells	|O
,	|O
consistent	|O
with	|O
the	|O
reduced	|O
activity	|O
of	|O
p59fyn	|B-PROTEIN
in	|O
CD45	|B-PROTEIN
-	|O
cells	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
study	|O
demonstrates	|O
that	|O
transvaginal	|O
ultrasonography	|O
has	|O
an	|O
efficiency	|O
of	|O
88%	|O
in	|O
differentiating	|O
endometriomas	|O
from	|O
other	|O
ovarian	|O
masses	|O
with	|O
a	|O
specificity	|O
of	|O
90%	|O
.	|O

Genomic	|O
Southern	|O
blot	|O
analysis	|O
of	|O
rat	|O
EFIA	|B-PROTEIN
(	|O
gene	|O
encoding	|O
enhancer	|B-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
subunit	|I-PROTEIN
A	|I-PROTEIN
)	|O
reveals	|O
a	|O
complex	|O
band	|O
pattern	|O
when	|O
cDNA	|O
subfragment	|O
probes	|O
are	|O
used	|O
.	|O

The	|O
effect	|O
of	|O
ibopamine	|O
and	|O
furosemide	|O
in	|O
130	|O
patients	|O
with	|O
NYHA	|O
Class	|O
I	|O
and	|O
II	|O
heart	|O
failure	|O
were	|O
studied	|O
in	|O
a	|O
parallel	|O
,	|O
double	|O
-	|O
blind	|O
,	|O
randomized	|O
placebo	|O
-	|O
controlled	|O
multi	|O
-	|O
centre	|O
trial	|O
.	|O

The	|O
nit	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
gene	|O
of	|O
the	|O
filamentous	|O
fungus	|O
Neurospora	|O
crassa	|O
encodes	|O
nitrate	|B-PROTEIN
reductase	|I-PROTEIN
,	|O
the	|O
enzyme	|O
which	|O
catalyzes	|O
the	|O
first	|O
step	|O
in	|O
nitrate	|O
assimilation	|O
.	|O

Unfolding	|O
can	|O
be	|O
described	|O
by	|O
a	|O
two	|O
-	|O
state	|O
process	|O
since	|O
a	|O
ratio	|O
of	|O
delta	|O
Hcalorimetric	|O
to	|O
delta	|O
Hvan	|O
't	|O
Hoff	|O
equals	|O
0.96	|O
.	|O

A	|O
Dictyostelium	|O
transformant	|O
overexpressing	|O
DdPTPa	|B-PROTEIN
does	|O
not	|O
develop	|O
normally	|O
.	|O

This	|O
motif	|O
has	|O
been	|O
shown	|O
to	|O
mediate	|O
protein	|O
interactions	|O
in	|O
the	|O
case	|O
of	|O
ankyrin	|B-PROTEIN
as	|O
well	|O
as	|O
several	|O
other	|O
repeat	|O
-	|O
bearing	|O
proteins	|O
.	|O

[	|B-PROTEIN
Ala85	|I-PROTEIN
]	|I-PROTEIN
Dk	|I-PROTEIN
(	|I-PROTEIN
69-85	|I-PROTEIN
)	|I-PROTEIN
retains	|O
full	|O
biological	|O
activity	|O
.	|O

We	|O
postulate	|O
that	|O
CaM	|B-PROTEIN
binding	|O
by	|O
HIV	|O
envelope	|B-PROTEIN
proteins	|O
is	|O
likely	|O
to	|O
exert	|O
diverse	|O
modulatory	|O
effects	|O
,	|O
and	|O
the	|O
mechanism	|O
for	|O
HIV	|O
-	|O
induced	|O
cytotoxicity	|O
may	|O
involve	|O
,	|O
in	|O
part	|O
,	|O
inhibition	|O
of	|O
CaM	|B-PROTEIN
-	|O
regulated	|O
cellular	|O
functions	|O
.	|O

There	|O
was	|O
no	|O
apparent	|O
effect	|O
of	|O
growth	|O
temperature	|O
on	|O
the	|O
steady	|O
-	|O
state	|O
levels	|O
of	|O
fad7	|B-PROTEIN
mRNA	|O
in	|O
wild	|O
type	|O
plants	|O
.	|O

The	|O
major	|O
myosin	|B-PROTEIN
-	|O
binding	|O
domain	|O
of	|O
skeletal	|O
muscle	|O
MyBP	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
(	|O
C	|O
protein	|O
)	|O
resides	|O
in	|O
the	|O
COOH	|O
-	|O
terminal	|O
,	|O
immunoglobulin	|B-PROTEIN
C2	|O
motif	|O
.	|O

A	|O
second	|O
important	|O
molecule	|O
in	|O
TCR	|B-PROTEIN
signal	|O
transduction	|O
is	|O
the	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
p21ras	|B-PROTEIN
,	|O
which	|O
is	|O
coupled	|O
to	|O
the	|O
TCR	|B-PROTEIN
by	|O
a	|O
protein	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
dependent	|O
mechanism	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
periseizure	|O
lipid	|O
accumulation	|O
is	|O
related	|O
to	|O
cortical	|O
oxygenation	|O
.	|O

We	|O
conclude	|O
that	|O
the	|O
QLMI	|O
questionnaire	|O
has	|O
good	|O
potential	|O
as	|O
an	|O
instrument	|O
for	|O
assessing	|O
QL	|O
in	|O
post	|O
-	|O
AMI	|O
patients	|O
and	|O
that	|O
it	|O
can	|O
be	|O
successfully	|O
self	|O
-	|O
administered	|O
.	|O

Most	|O
smokers	|O
would	|O
prefer	|O
to	|O
quit	|O
smoking	|O
on	|O
their	|O
own	|O
.	|O

The	|O
inhibitory	|O
response	|O
to	|O
taps	|O
is	|O
essentially	|O
a	|O
protective	|O
reflex	|O
which	|O
probably	|O
serves	|O
to	|O
reduce	|O
the	|O
activity	|O
of	|O
the	|O
jaw	|O
-	|O
closing	|O
muscles	|O
when	|O
one	|O
bites	|O
unexpectedly	|O
on	|O
hard	|O
objects	|O
.	|O

The	|O
action	|O
of	|O
nef	|B-PROTEIN
was	|O
specific	|O
to	|O
the	|O
LTR	|O
,	|O
as	|O
expression	|O
of	|O
nef	|B-PROTEIN
had	|O
no	|O
effect	|O
on	|O
the	|O
activity	|O
of	|O
the	|O
simian	|O
virus	|O
40	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
fms	|I-PROTEIN
,	|O
urokinase	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
,	|O
or	|O
type	|B-PROTEIN
5	|I-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
promoter	|O
.	|O
trans	|O
-	|O
activating	|O
activity	|O
was	|O
also	|O
manifested	|O
by	|O
a	|O
frameshift	|O
mutant	|O
expressing	|O
only	|O
the	|O
first	|O
35	|O
amino	|O
acids	|O
of	|O
the	|O
protein	|O
.	|O

The	|O
product	|O
of	|O
the	|O
vpr	|B-PROTEIN
open	|O
reading	|O
frame	|O
of	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
is	|O
a	|O
15	|O
-	|O
kDa	|O
,	|O
arginine	|O
-	|O
rich	|O
protein	|O
that	|O
is	|O
present	|O
in	|O
virions	|O
in	|O
molar	|O
quantities	|O
equivalent	|O
to	|O
that	|O
of	|O
Gag	|B-PROTEIN
.	|O

The	|O
recombinant	|O
vaccinia	|O
virus	|O
-	|O
expressed	|O
mutant	|O
P1	|B-PROTEIN
polyproteins	|O
were	|O
analyzed	|O
for	|O
proteolytic	|O
processing	|O
defects	|O
in	|O
cells	|O
coinfected	|O
with	|O
a	|O
recombinant	|O
vaccinia	|O
virus	|O
(	|O
VVP3	|O
)	|O
that	|O
expresses	|O
the	|O
poliovirus	|O
3CD	|B-PROTEIN
protease	|I-PROTEIN
and	|O
for	|O
processing	|O
and	|O
assembly	|O
defects	|O
by	|O
using	|O
a	|O
trans	|O
complementation	|O
system	|O
in	|O
which	|O
P1	|B-PROTEIN
-	|O
expressing	|O
recombinant	|O
vaccinia	|O
viruses	|O
provide	|O
capsid	|B-PROTEIN
precursor	|I-PROTEIN
to	|O
a	|O
defective	|O
poliovirus	|O
genome	|O
that	|O
does	|O
not	|O
express	|O
functional	|O
capsid	|B-PROTEIN
proteins	|I-PROTEIN
(	|O
D.	|O

In	|O
contrast	|O
,	|O
capsid	|B-PROTEIN
proteins	|I-PROTEIN
derived	|O
from	|O
the	|O
P1	|B-PROTEIN
precursor	|O
with	|O
a	|O
valine	|O
substitution	|O
at	|O
the	|O
amino	|O
terminus	|O
of	|O
VP1	|B-PROTEIN
(	|O
VP1	|B-PROTEIN
-	|I-PROTEIN
G001V	|I-PROTEIN
)	|O
assembled	|O
empty	|O
capsid	|O
particles	|O
but	|O
were	|O
deficient	|O
in	|O
assembling	|O
RNA	|O
-	|O
containing	|O
virions	|O
.	|O

RESULTS	|O
:	|O
In	|O
an	|O
18	|O
moth	|O
period	|O
and	|O
out	|O
of	|O
a	|O
total	|O
of	|O
284	|O
positive	|O
blood	|O
cultures	|O
(	|O
154	|O
significant	|O
isolations	|O
)	|O
14	|O
episodes	|O
of	|O
bacteremia	|O
by	|O
M.	|O
tuberculosis	|O
were	|O
studied	|O
in	|O
12	|O
prison	|O
patients	|O
coinfected	|O
by	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
with	|O
associated	|O
severe	|O
immunosuppression	|O
(	|O
mean	|O
of	|O
CD4	|B-PROTEIN
=	|O
0.068	|O
x	|O
10	|O
(	|O
9	|O
)	|O
/	|O
l	|O
)	|O
.	|O

Acid	|O
instilled	|O
on	|O
the	|O
larynx	|O
of	|O
maturing	|O
rabbits	|O
resulted	|O
in	|O
significant	|O
obstructive	|O
,	|O
central	|O
,	|O
and	|O
mixed	|O
apnea	|O
.	|O

By	|O
using	|O
total	|O
-	|O
protein	|O
extracts	|O
from	|O
mycelia	|O
grown	|O
under	|O
penicillin	|O
producing	|O
conditions	|O
we	|O
have	|O
detected	|O
a	|O
DNA	|O
-	|O
binding	|O
activity	|O
that	|O
specifically	|O
shifts	|O
a	|O
promoter	|O
fragment	|O
located	|O
between	|O
-	|O
654	|O
and	|O
-	|O
455	|O
(	|O
relative	|O
to	|O
IPNS	|B-PROTEIN
tsp	|O
)	|O
.	|O

A	|O
series	|O
of	|O
5'	|O
-	|O
deletions	|O
revealed	|O
that	|O
the	|O
fragment	|O
-	|O
218	|O
to	|O
+	|O
4	|O
from	|O
the	|O
TSS	|O
had	|O
the	|O
highest	|O
promoter	|O
activity	|O
,	|O
nearly	|O
1000	|O
-	|O
fold	|O
greater	|O
than	|O
the	|O
promoterless	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
construct	|O
.	|O

The	|O
lemdr1	|B-PROTEIN
gene	|O
was	|O
cloned	|O
in	|O
the	|O
expression	|O
vector	|O
pALTNEO	|O
and	|O
transfected	|O
into	|O
wild	|O
-	|O
type	|O
L.	|O
enriettii	|O
and	|O
the	|O
resulting	|O
transfected	|O
cells	|O
were	|O
resistant	|O
to	|O
vinblastine	|O
but	|O
at	|O
lower	|O
levels	|O
than	|O
in	|O
the	|O
selected	|O
mutant	|O
cells	|O
.	|O

The	|O
bioavailability	|O
of	|O
etodolac	|O
from	|O
capsules	|O
exposed	|O
to	|O
stressed	|O
conditions	|O
was	|O
compared	|O
in	|O
both	|O
dogs	|O
and	|O
humans	|O
to	|O
capsules	|O
stored	|O
at	|O
RT	|O
conditions	|O
.	|O

Similar	|O
synergistic	|O
activation	|O
was	|O
observed	|O
in	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
promoter	|O
,	|O
which	|O
also	|O
contains	|O
both	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
binding	|O
sites	|O
.	|O

Notice	|O
of	|O
retraction	|O
.	|O

No	|O
homology	|O
was	|O
found	|O
between	|O
the	|O
36K	|O
protein	|O
and	|O
known	|O
structures	|O
of	|O
proteins	|O
.	|O

We	|O
report	|O
an	|O
odd	|O
case	|O
of	|O
marked	|O
enlargement	|O
of	|O
suprapineal	|O
recess	|O
in	|O
a	|O
patient	|O
with	|O
triventricular	|O
hydrocephalus	|O
.	|O

As	|O
regards	|O
lipid	|O
metabolism	|O
,	|O
the	|O
mean	|O
values	|O
for	|O
total	|O
triglycerides	|O
,	|O
cholesterol	|O
,	|O
LDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
and	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
cholesterol	|I-PROTEIN
seen	|O
at	|O
the	|O
end	|O
of	|O
five	|O
years	|O
of	|O
Norplant	|O
-	|O
2	|O
rod	|O
use	|O
and	|O
six	|O
months	|O
postremoval	|O
were	|O
similar	|O
to	|O
the	|O
preinsertion	|O
mean	|O
.	|O

At	|O
a	|O
PaCO2	|O
of	|O
40	|O
mmHg	|O
,	|O
baseline	|O
brain	|O
pHi	|O
measured	|O
7.03	|O
+	|O
/	|O
-	|O
0.04	|O
,	|O
while	|O
regional	|O
cortical	|O
blood	|O
flow	|O
was	|O
47.0	|O
+	|O
/	|O
-	|O
4.3	|O
ml.1	|O
00	|O
g	|O
-	|O
1.m	|O
in	|O
-	|O
1	|O
.	|O

CPAP	|O
reduced	|O
isotime	|O
(	|O
defined	|O
as	|O
the	|O
last	|O
common	|O
minute	|O
of	|O
exercise	|O
)	|O
VO2	|O
and	|O
dyspnea	|O
in	|O
those	|O
patients	|O
with	|O
more	|O
severe	|O
lung	|O
disease	|O
,	|O
but	|O
these	|O
values	|O
tended	|O
to	|O
increase	|O
slightly	|O
in	|O
the	|O
patients	|O
with	|O
only	|O
mild	|O
lung	|O
disease	|O
.	|O

Effects	|O
of	|O
diltiazem	|O
on	|O
netilmicin	|O
-	|O
induced	|O
nephrotoxicity	|O
in	|O
rabbits	|O
.	|O

Four	|O
forms	|O
of	|O
salmonellosis	|O
were	|O
recognised	|O
in	|O
feedlots	|O
and	|O
during	|O
transport	|O
by	|O
sea	|O
:	|O
septicaemic	|O
,	|O
and	|O
acute	|O
,	|O
subacute	|O
and	|O
chronic	|O
enteric	|O
.	|O

About	|O
20%	|O
of	|O
single	|O
-	|O
stranded	|O
DNA	|O
binding	|O
was	|O
observed	|O
in	|O
the	|O
presence	|O
of	|O
MgdTDP	|O
,	|O
but	|O
none	|O
was	|O
detectable	|O
in	|O
the	|O
absence	|O
of	|O
nucleotides	|O
.	|O

To	|O
our	|O
knowledge	|O
this	|O
is	|O
the	|O
first	|O
case	|O
in	|O
which	|O
a	|O
probable	|O
association	|O
between	|O
cholelithiasis	|O
and	|O
Wildervanck	|O
's	|O
syndrome	|O
has	|O
been	|O
recorded	|O
.	|O

Both	|O
4,8	|O
-	|O
DiMeIQx	|O
and	|O
A	|O
alpha	|O
C	|O
were	|O
found	|O
at	|O
<	|O
1	|O
p.p.b	|O
.	|O

Three	|O
cysteine	|O
and	|O
four	|O
tryptophan	|O
residues	|O
,	|O
previously	|O
identified	|O
as	|O
conserved	|O
amongst	|O
nitrous	|B-PROTEIN
-	|I-PROTEIN
oxide	|I-PROTEIN
reductases	|I-PROTEIN
,	|O
are	|O
found	|O
in	|O
the	|O
Paracoccus	|O
enzyme	|O
.	|O

Recombinant	|O
Leishmania	|O
surface	|O
glycoprotein	|O
GP63	|B-PROTEIN
is	|O
secreted	|O
in	|O
the	|O
baculovirus	|O
expression	|O
system	|O
as	|O
a	|O
latent	|O
metalloproteinase	|B-PROTEIN
.	|O

Delineating	|O
the	|O
molecular	|O
basis	|O
for	|O
agonist	|O
-	|O
induced	|O
destabilization	|O
of	|O
mRNA	|O
of	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
linked	|I-PROTEIN
receptors	|I-PROTEIN
that	|O
contributes	|O
to	|O
receptor	|O
down	|O
-	|O
regulation	|O
is	|O
fundamental	|O
to	|O
our	|O
understanding	|O
of	|O
long	|O
-	|O
term	|O
regulation	|O
of	|O
receptors	|O
by	|O
agonist	|O
.	|O

Addition	|O
of	|O
phalloidin	|O
-	|O
stabilized	|O
F	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
nuclei	|O
and	|O
phalloidin	|O
restored	|O
L266D	|O
actin	|B-PROTEIN
's	|O
ability	|O
to	|O
polymerize	|O
at	|O
4	|O
degrees	|O
C.	|O

These	|O
cells	|O
produce	|O
a	|O
low	|O
level	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
when	|O
stimulated	|O
with	|O
PMA	|O
alone	|O
;	|O
however	|O
,	|O
N6	|O
,	|O
O2	|O
-	|O
dibutyryl	|O
cAMP	|O
(	|O
Bt2cAMP	|O
)	|O
,	|O
in	|O
combination	|O
with	|O
PMA	|O
,	|O
augmented	|O
by	|O
more	|O
than	|O
tenfold	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
production	|O
at	|O
the	|O
mRNA	|O
and	|O
the	|O
protein	|O
levels	|O
.	|O

Hu	|B-PROTEIN
-	|I-PROTEIN
Met	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
expression	|O
in	|O
a	|O
small	|O
number	|O
of	|O
human	|O
T	|O
cell	|O
tumor	|O
lines	|O
did	|O
not	|O
correlate	|O
with	|O
any	|O
particular	|O
phenotype	|O
or	|O
stage	|O
of	|O
development	|O
.	|O

Partial	|O
engorgement	|O
was	|O
higher	|O
in	|O
the	|O
treatments	|O
.	|O

Northern	|O
(	|O
RNA	|O
)	|O
analysis	|O
demonstrated	|O
expression	|O
of	|O
human	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
in	|O
all	|O
tissues	|O
and	|O
cell	|O
lines	|O
tested	|O
.	|O

These	|O
results	|O
demonstrate	|O
the	|O
existence	|O
of	|O
different	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
isoforms	|O
and	|O
define	|O
a	|O
family	|O
of	|O
genes	|O
encoding	|O
distinct	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
catalytic	|O
subunits	|O
that	|O
can	|O
associate	|O
with	|O
p85	|B-PROTEIN
.	|O

In	|O
addition	|O
to	|O
the	|O
protein	|O
-	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
domain	|O
,	|O
p56lck	|B-PROTEIN
possesses	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
2	|I-PROTEIN
and	|O
3	|O
(	|O
SH2	|B-PROTEIN
and	|O
SH3	|B-PROTEIN
)	|O
domains	|O
as	|O
well	|O
as	|O
a	|O
unique	|O
N	|O
-	|O
terminal	|O
region	|O
.	|O

Strains	|O
bearing	|O
the	|O
drs2	|B-PROTEIN
mutation	|O
process	|O
the	|O
20S	|B-PROTEIN
precursor	|O
of	|O
the	|O
mature	|O
18S	|B-PROTEIN
rRNA	|O
slowly	|O
and	|O
are	|O
deficient	|O
in	|O
40S	|B-PROTEIN
ribosomal	|O
subunits	|O
.	|O

Hepatitis	|O
B	|O
and	|O
liver	|O
transplantation	|O
.	|O

One	|O
complex	|O
most	|O
likely	|O
contained	|O
Sp1	|B-PROTEIN
,	|O
and	|O
another	|O
complex	|O
showed	|O
S	|O
-	|O
phase	|O
-	|O
specific	|O
binding	|O
,	|O
suggesting	|O
a	|O
direct	|O
role	|O
in	|O
the	|O
cell	|O
-	|O
cycle	|O
-	|O
dependent	|O
R1	|B-PROTEIN
gene	|O
expression	|O
.	|O

These	|O
combined	|O
observations	|O
define	|O
a	|O
promoter	|O
and	|O
an	|O
enhancer	|O
for	|O
the	|O
chicken	|O
L	|B-PROTEIN
-	|I-PROTEIN
CAM	|I-PROTEIN
gene	|O
.	|O

The	|O
rate	|O
of	|O
enzymic	|O
stimulation	|O
induced	|O
by	|O
a	|O
given	|O
nitrate	|O
correlates	|O
closely	|O
with	|O
the	|O
rate	|O
of	|O
measured	|O
NO	|O
production	|O
from	|O
the	|O
nitrate	|O
molecule	|O
.	|O

Clipping	|O
resulted	|O
in	|O
a	|O
serious	|O
mislocalization	|O
of	|O
the	|O
position	|O
of	|O
the	|O
peak	|O
of	|O
the	|O
epicortical	|O
potential	|O
field	|O
.	|O

The	|O
duration	|O
of	|O
diabetes	|O
mellitus	|O
in	|O
these	|O
patients	|O
was	|O
from	|O
5	|O
months	|O
to	|O
6	|O
years	|O
,	|O
and	|O
in	|O
all	|O
patients	|O
this	|O
was	|O
the	|O
first	|O
myocardial	|O
infarction	|O
.	|O

The	|O
247	|O
-	|O
kDa	|O
complex	|O
appears	|O
to	|O
contain	|O
two	|O
distinct	|O
protein	|O
-	|O
DNA	|O
complexes	|O
of	|O
approximately	|O
232	|O
and	|O
256	|O
kDa	|O
and	|O
represents	|O
two	|O
proteins	|O
covalently	|O
cross	|O
-	|O
linked	|O
to	|O
a	|O
single	|O
DRE	|O
oligonucleotide	|O
,	|O
while	|O
the	|O
97	|O
,	|O
105	|O
,	|O
and	|O
115	|O
-	|O
kDa	|O
complexes	|O
represent	|O
single	|O
protein	|O
-	|O
DRE	|O
cross	|O
-	|O
links	|O
.	|O

The	|O
promoter	|O
and	|O
upstream	|O
region	|O
of	|O
the	|O
Brassica	|O
napus	|O
2S	|O
storage	|O
protein	|O
napA	|B-PROTEIN
gene	|O
were	|O
studied	|O
to	|O
identify	|O
cis	|O
-	|O
acting	|O
sequences	|O
involved	|O
in	|O
developmental	|O
seed	|O
-	|O
specific	|O
expression	|O
.	|O

However	|O
,	|O
limited	|O
comparisons	|O
reveal	|O
domains	|O
in	|O
the	|O
NH2	|O
and	|O
COOH	|O
termini	|O
that	|O
have	|O
a	|O
high	|O
degree	|O
of	|O
similarity	|O
suggesting	|O
functional	|O
conservation	|O
.	|O

Rinit	|O
reflects	|O
the	|O
Newtonian	|O
resistances	|O
and	|O
Rdiff	|O
represents	|O
the	|O
viscoelastic	|O
/	|O
inhomogeneous	|O
pressure	|O
dissipations	|O
in	|O
the	|O
system	|O
.	|O

We	|O
have	|O
explored	|O
the	|O
mechanism	|O
of	|O
action	|O
of	|O
the	|O
fibronectin	|B-PROTEIN
splicing	|O
enhancer	|O
and	|O
found	|O
that	|O
the	|O
SE	|O
element	|O
is	|O
required	|O
for	|O
efficient	|O
assembly	|O
of	|O
early	|O
splicing	|O
complexes	|O
,	|O
allowing	|O
a	|O
more	|O
efficient	|O
interaction	|O
of	|O
the	|O
U2	|B-PROTEIN
snRNP	|O
with	|O
branch	|O
site	|O
sequences	|O
.	|O

Inspection	|O
of	|O
enhancer	|O
mutants	|O
suggests	|O
that	|O
trans	|O
-	|O
activation	|O
by	|O
hLEF	|B-PROTEIN
/	|O
GAL4	|B-PROTEIN
is	|O
especially	|O
dependent	|O
on	|O
TCF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
a	|O
distinct	|O
T	|O
-	|O
cell	|O
-	|O
enriched	|O
protein	|O
that	|O
binds	|O
to	|O
sequences	|O
flanking	|O
the	|O
hLEF	|B-PROTEIN
-	|O
binding	|O
site	|O
in	|O
the	|O
enhancer	|O
.	|O

We	|O
conclude	|O
that	|O
sequences	|O
outside	|O
of	|O
the	|O
hLEF	|B-PROTEIN
HMG	|O
box	|O
mediate	|O
cell	|O
-	|O
and	|O
context	|O
-	|O
specific	|O
activation	|O
of	|O
the	|O
TCR	|B-PROTEIN
alpha	|I-PROTEIN
enhancer	|O
and	|O
may	|O
facilitate	|O
interactions	|O
between	|O
hLEF	|B-PROTEIN
and	|O
other	|O
T	|O
-	|O
cell	|O
-	|O
specific	|O
factors	|O
recruited	|O
to	|O
the	|O
enhancer	|O
.	|O

A	|O
cAMP	|O
response	|O
element	|O
(	|O
CRE	|O
)	|O
consensus	|O
signal	|O
was	|O
identified	|O
in	|O
the	|O
5'	|O
-	|O
noncoding	|O
region	|O
.	|O
cAMP	|O
regulates	|O
the	|O
expression	|O
of	|O
Kv1.5	|B-PROTEIN
gene	|O
in	|O
a	|O
cell	|O
-	|O
specific	|O
manner	|O
.	|O

A	|O
number	|O
of	|O
serological	|O
tests	|O
measuring	|O
the	|O
presence	|O
of	|O
Helicobacter	|O
pylori	|O
-	|O
specific	|O
serum	|O
immunoglobulin	|B-PROTEIN
G	|I-PROTEIN
(	|O
IgG	|B-PROTEIN
)	|O
are	|O
now	|O
commercially	|O
available	|O
.	|O

Using	|O
a	|O
series	|O
of	|O
mutant	|O
T	|B-PROTEIN
antigens	|I-PROTEIN
expressed	|O
by	|O
recombinant	|O
baculoviruses	|O
in	|O
Sf9	|O
cells	|O
,	|O
we	|O
find	|O
that	|O
the	|O
origin	|O
unwinding	|O
activities	|O
of	|O
both	|O
TS677	|O
-	|O
-	|O
>	|O
A	|O
and	|O
TS677	|O
,	|O
679	|O
-	|O
-	|O
>	|O
A	|O
are	|O
inhibited	|O
by	|O
the	|O
T	|B-PROTEIN
-	|I-PROTEIN
antigen	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
as	|O
is	|O
wild	|O
-	|O
type	|O
T	|B-PROTEIN
antigen	|I-PROTEIN
.	|O

The	|O
degree	|O
of	|O
hypoperfusion	|O
was	|O
slightly	|O
related	|O
to	|O
decrease	|O
in	|O
FEV1.0	|O
%	|O
,	|O
V25	|O
and	|O
PaO2	|O
and	|O
increase	|O
in	|O
circulating	|O
blood	|O
volume	|O
and	|O
peripheral	|O
red	|O
blood	|O
cell	|O
counts	|O
.	|O

Two	|O
patients	|O
were	|O
treated	|O
successfully	|O
with	|O
a	|O
combination	|O
of	|O
metronidazole	|O
(	|O
a	|O
tissue	|O
amoebicide	|O
)	|O
and	|O
diloxanide	|O
(	|O
a	|O
lumenal	|O
amoebicide	|O
)	|O
.	|O

We	|O
have	|O
identified	|O
in	|O
the	|O
5'	|O
untranslated	|O
region	|O
of	|O
the	|O
Drosophila	|O
copia	|B-PROTEIN
retrotransposon	|O
,	|O
3'	|O
to	|O
the	|O
left	|O
LTR	|O
,	|O
a	|O
sequence	|O
for	|O
transcriptional	|O
regulation	|O
by	|O
homeoproteins	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
lesions	|O
of	|O
the	|O
OPT	|O
complex	|O
(	|O
the	|O
thalamic	|O
source	|O
of	|O
afferents	|O
to	|O
IHA	|O
and	|O
HD	|O
)	|O
were	|O
found	|O
to	|O
have	|O
no	|O
effect	|O
on	|O
color	|O
-	|O
reversal	|O
learning	|O
performance	|O
.	|O

The	|O
fourth	|O
dose	|O
produced	|O
favorable	|O
results	|O
(	|O
66.7%	|O
)	|O
in	|O
individuals	|O
with	|O
HB	|B-PROTEIN
antibodies	|O
between	|O
10	|O
and	|O
100	|O
IU	|O
/	|O
ml	|O
and	|O
unfavorable	|O
ones	|O
(	|O
3.8%	|O
)	|O
where	|O
the	|O
HB	|B-PROTEIN
antibodies	|O
were	|O
below	|O
10	|O
IU	|O
/	|O
ml	|O
.	|O

CONCLUSIONS	|O
:	|O
In	|O
our	|O
patients	|O
and	|O
within	|O
the	|O
range	|O
of	|O
treatment	|O
variables	|O
studied	|O
,	|O
age	|O
,	|O
Karnofsky	|O
index	|O
,	|O
and	|O
graft	|O
-	|O
versus	|O
-	|O
host	|O
disease	|O
are	|O
the	|O
most	|O
important	|O
factors	|O
related	|O
with	|O
early	|O
mortality	|O
.	|O

Nucleotide	|O
sequence	|O
analysis	|O
of	|O
the	|O
HA	|B-PROTEIN
gene	|O
in	|O
these	|O
two	|O
mutants	|O
confirmed	|O
the	|O
HA	|B-PROTEIN
-	|O
phenotype	|O
.	|O

This	|O
intron	|O
occupies	|O
a	|O
conserved	|O
position	|O
corresponding	|O
to	|O
that	|O
of	|O
intron	|O
1	|O
in	|O
the	|O
transit	|O
peptide	|O
region	|O
of	|O
chloroplast	|O
GAPDH	|B-PROTEIN
genes	|O
(	|O
GapA	|B-PROTEIN
and	|O
GapB	|B-PROTEIN
)	|O
of	|O
higher	|O
plants	|O
.	|O

The	|O
drug	|O
-	|O
resistant	|O
cell	|O
lines	|O
P388	|O
/	|O
ADR	|O
/	|O
3	|O
and	|O
P388	|O
/	|O
ADR	|O
/	|O
7	|O
express	|O
a	|O
shortened	|O
topo	|B-PROTEIN
II	|I-PROTEIN
alpha	|I-PROTEIN
mRNA	|O
transcript	|O
in	|O
addition	|O
to	|O
the	|O
native	|O
transcript	|O
present	|O
in	|O
the	|O
drug	|O
-	|O
sensitive	|O
P388/4	|O
cell	|O
line	|O
.	|O

Using	|O
a	|O
3'	|O
-	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
strategy	|O
,	|O
we	|O
have	|O
cloned	|O
cDNAs	|O
representing	|O
the	|O
3'	|O
-	|O
termini	|O
of	|O
both	|O
the	|O
native	|O
and	|O
mutant	|O
transcripts	|O
from	|O
both	|O
P388	|O
/	|O
ADR	|O
/	|O
3	|O
and	|O
P388	|O
/	|O
ADR	|O
/	|O
7	|O
cells	|O
.	|O

The	|O
phi	|B-PROTEIN
AP3	|I-PROTEIN
factor	|I-PROTEIN
is	|O
a	|O
nuclear	|O
phosphoprotein	|O
;	|O
the	|O
extent	|O
of	|O
its	|O
phosphorylation	|O
is	|O
regulated	|O
during	|O
the	|O
cell	|O
cycle	|O
.	|O

Similarly	|O
,	|O
the	|O
N	|O
-	|O
terminal	|O
cytoplasmic	|O
domain	|O
of	|O
the	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
protein	|I-PROTEIN
2A	|I-PROTEIN
(	|O
LMP2A	|B-PROTEIN
)	|O
of	|O
the	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
(	|O
EBV	|O
)	|O
contains	|O
a	|O
single	|O
copy	|O
of	|O
the	|O
Tyr	|O
-	|O
X	|O
-	|O
X	|O
-	|O
Leu	|O
/	|O
Ile	|O
-	|O
containing	|O
motif	|O
which	|O
could	|O
play	|O
a	|O
critical	|O
role	|O
in	|O
B	|O
cell	|O
transformation	|O
.	|O

The	|O
functional	|O
homology	|O
of	|O
Cwg2	|B-PROTEIN
with	|O
Cdc43	|B-PROTEIN
,	|O
which	|O
has	|O
been	|O
implicated	|O
in	|O
the	|O
control	|O
of	|O
cell	|O
polarity	|O
,	|O
suggests	|O
a	|O
link	|O
between	|O
two	|O
morphogenetic	|O
events	|O
such	|O
as	|O
establishment	|O
of	|O
cell	|O
polarity	|O
and	|O
cell	|O
wall	|O
biosynthesis	|O
.	|O

Molecular	|O
cloning	|O
of	|O
a	|O
P	|O
-	|O
type	|O
ATPase	|B-PROTEIN
gene	|O
from	|O
the	|O
cyanobacterium	|O
Synechocystis	|O
sp	|O
.	|O

The	|O
cloning	|O
of	|O
PTR2	|B-PROTEIN
represents	|O
the	|O
first	|O
example	|O
of	|O
the	|O
molecular	|O
genetic	|O
characterization	|O
of	|O
a	|O
eucaryotic	|O
peptide	|O
transport	|O
gene	|O
.	|O

By	|O
using	|O
the	|O
full	|O
-	|O
length	|O
cytoplasmic	|O
domain	|O
and	|O
mutants	|O
with	|O
progressive	|O
carboxy	|O
-	|O
terminal	|O
deletions	|O
,	|O
internal	|O
deletions	|O
,	|O
or	|O
point	|O
mutations	|O
,	|O
we	|O
identified	|O
the	|O
first	|O
150	|O
amino	|O
acid	|O
residues	|O
of	|O
LIFR	|B-PROTEIN
as	|O
the	|O
minimal	|O
region	|O
necessary	|O
for	|O
signaling	|O
.	|O

To	|O
examine	|O
the	|O
biochemical	|O
basis	|O
of	|O
the	|O
end	|O
joining	|O
,	|O
nuclear	|O
extracts	|O
were	|O
prepared	|O
from	|O
a	|O
wide	|O
variety	|O
of	|O
mammalian	|O
cell	|O
lines	|O
and	|O
tested	|O
for	|O
their	|O
ability	|O
to	|O
join	|O
test	|O
plasmid	|O
substrates	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
the	|O
largest	|O
subunit	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
and	|O
TFIIB	|B-PROTEIN
are	|O
important	|O
determinants	|O
of	|O
transcription	|O
start	|O
site	|O
selection	|O
in	|O
S.	|O
cerevisiae	|O
and	|O
suggest	|O
that	|O
this	|O
function	|O
might	|O
be	|O
conferred	|O
by	|O
interaction	|O
between	|O
these	|O
two	|O
proteins	|O
.	|O

Recombinant	|O
expression	|O
of	|O
a	|O
chimeric	|O
EGFR	|B-PROTEIN
/	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
receptor	|I-PROTEIN
in	|O
NIH	|O
3T3	|O
fibroblasts	|O
allowed	|O
us	|O
to	|O
investigate	|O
cytoplasmic	|O
events	|O
associated	|O
with	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
signal	|O
transduction	|O
upon	|O
ligand	|O
activation	|O
.	|O

Oligonucleotide	|O
competitors	|O
were	|O
used	|O
to	|O
evaluate	|O
the	|O
accessibility	|O
of	|O
the	|O
TATA	|O
-	|O
binding	|O
site	|O
in	|O
TIF	|B-PROTEIN
-	|I-PROTEIN
IB	|I-PROTEIN
,	|O
TFIID	|B-PROTEIN
,	|O
and	|O
TFIIIB	|B-PROTEIN
.	|O

The	|O
227	|O
-	|O
to	|O
-	|O
239	|O
region	|O
blocked	|O
ADR1	|B-PROTEIN
activity	|O
independently	|O
of	|O
the	|O
TAD	|B-PROTEIN
present	|O
on	|O
ADR1	|B-PROTEIN
,	|O
ADR1	|B-PROTEIN
DNA	|O
binding	|O
,	|O
and	|O
specific	|O
ADH2	|B-PROTEIN
promoter	|O
sequences	|O
.	|O

Analysis	|O
of	|O
strains	|O
harboring	|O
an	|O
mds1	|B-PROTEIN
null	|O
mutation	|O
demonstrates	|O
that	|O
MDS1	|B-PROTEIN
is	|O
not	|O
essential	|O
during	|O
normal	|O
vegetative	|O
growth	|O
but	|O
appears	|O
to	|O
be	|O
required	|O
for	|O
meiosis	|O
.	|O

TGF	|B-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
expression	|O
is	|O
largely	|O
governed	|O
by	|O
three	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
sites	|O
located	|O
in	|O
two	|O
different	|O
promoters	|O
of	|O
this	|O
gene	|O
.	|O

Val	|O
-	|O
-	|O
>	|O
Ala	|O
mutations	|O
selectively	|O
alter	|O
helix	|O
-	|O
helix	|O
packing	|O
in	|O
the	|O
transmembrane	|O
segment	|O
of	|O
phage	|O
M13	|O
coat	|B-PROTEIN
protein	|O
.	|O

Strategic	|O
change	|O
in	|O
the	|O
NHS	|O
.	|O

A	|O
much	|O
less	|O
expensive	|O
solution	|O
than	|O
UW	|O
,	|O
containing	|O
only	|O
K	|O
(	|O
+	|O
)	|O
-	|O
lactobionate	|O
,	|O
KH2PO4	|O
,	|O
MgSO4	|O
and	|O
raffinose	|O
,	|O
can	|O
be	|O
used	|O
successfully	|O
for	|O
preservation	|O
of	|O
rat	|O
hepatocytes	|O
for	|O
24	|O
hr	|O
for	|O
drug	|O
transport	|O
studies	|O
.	|O

Repeated	|O
administration	|O
of	|O
GRg2	|O
20	|O
mg	|O
/	|O
kg	|O
i.p	|O
.	|O
significantly	|O
improved	|O
the	|O
CYP	|O
-	|O
induced	|O
recognitional	|O
deficits	|O
by	|O
increasing	|O
the	|O
CYP	|O
-	|O
decreased	|O
rate	|O
from	|O
55.8	|O
+	|O
/	|O
-	|O
9.6	|O
to	|O
80.8	|O
+	|O
/	|O
-	|O
4.2	|O
in	|O
d	|O
3	|O
learning	|O
acquisition	|O
(	|O
F	|O
(	|O
1,14	|O
)	|O
=	|O
5.6	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
,	|O
from	|O
53.4	|O
+	|O
/	|O
-	|O
8.4	|O
to	|O
60.0	|O
+	|O
/	|O
-	|O
8.2	|O
in	|O
48	|O
h	|O
memory	|O
acquisition	|O
(	|O
F	|O
(	|O
1,14	|O
)	|O
=	|O
7.5	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
and	|O
from	|O
55.0	|O
+	|O
/	|O
-	|O
5.5	|O
to	|O
88.3	|O
+	|O
/	|O
-	|O
2.5	|O
in	|O
24	|O
h	|O
memory	|O
retention	|O
(	|O
F	|O
(	|O
1,12	|O
)	|O
27.5	|O
,	|O
p	|O
<	|O
0.01	|O
)	|O
as	|O
well	|O
as	|O
from	|O
60.0	|O
+	|O
/	|O
-	|O
6.8	|O
to	|O
85.6	|O
+	|O
/	|O
-	|O
6.9	|O
in	|O
48	|O
h	|O
memory	|O
retrieval	|O
(	|O
F	|O
(	|O
1,12	|O
)	|O
=	|O
5.2	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
,	|O
respectively	|O
.	|O

Human	|O
bcl3	|B-PROTEIN
protein	|O
specifically	|O
displaces	|O
(	|O
p50	|B-PROTEIN
)	|O
2	|O
-	|O
DNA	|O
complexes	|O
.	|O

The	|O
therapeutic	|O
action	|O
of	|O
cyclosporin	|O
A	|O
(	|O
Sandimmun	|O
)	|O
:	|O
its	|O
application	|O
in	|O
rheumatoid	|O
arthritis	|O
.	|O

In	|O
vitro	|O
translation	|O
experiments	|O
show	|O
that	|O
human	|O
cDNA	|O
derived	|O
RNA	|O
translates	|O
into	|O
a	|O
protein	|O
with	|O
a	|O
mobility	|O
of	|O
44-46	|O
kD	|O
on	|O
SDS	|O
polyacrylamide	|O
gels	|O
.	|O

After	|O
peripheral	|O
administration	|O
of	|O
both	|O
CRF	|B-PROTEIN
and	|O
TRH	|B-PROTEIN
,	|O
ACTH	|B-PROTEIN
levels	|O
were	|O
significantly	|O
higher	|O
on	|O
the	|O
tumor	|O
side	|O
in	|O
all	|O
patients	|O
.	|O

Pentazocine	|O
analgesia	|O
:	|O
is	|O
there	|O
a	|O
niche	|O
for	|O
Talwin	|O
Nx	|O
?	|O
Pentazocine	|O
can	|O
be	|O
a	|O
useful	|O
analgesic	|O
agent	|O
for	|O
the	|O
management	|O
of	|O
acute	|O
dental	|O
pain	|O
.	|O

A	|O
sequence	|O
homology	|O
analysis	|O
between	|O
human	|O
nm23	|B-PROTEIN
-	|I-PROTEIN
H1	|I-PROTEIN
and	|O
the	|O
homolog	|O
gene	|O
of	|O
the	|O
rat	|O
(	|O
NDP	|B-PROTEIN
-	|I-PROTEIN
K	|I-PROTEIN
beta	|I-PROTEIN
)	|O
shows	|O
that	|O
exon	|O
-	|O
intron	|O
boundaries	|O
are	|O
well	|O
conserved	|O
between	|O
these	|O
two	|O
species	|O
.	|O

A	|O
favourable	|O
response	|O
was	|O
achieved	|O
with	|O
a	|O
combination	|O
of	|O
amphotericin	|O
B	|O
and	|O
cotrimoxazole	|O
.	|O

Response	|O
durations	|O
were	|O
short	|O
.	|O

RESULTS	|O
:	|O
At	|O
the	|O
beginning	|O
of	|O
the	|O
QA	|O
/	|O
QI	|O
process	|O
,	|O
monitoring	|O
of	|O
blood	|O
administration	|O
practices	|O
revealed	|O
that	|O
a	|O
variance	|O
from	|O
institutional	|O
blood	|O
administration	|O
policy	|O
occurred	|O
during	|O
50	|O
percent	|O
of	|O
blood	|O
and	|O
component	|O
transfusions	|O
.	|O

In	|O
addition	|O
,	|O
REP21	|B-PROTEIN
plants	|O
were	|O
resistant	|O
to	|O
an	|O
unusually	|O
broad	|O
range	|O
of	|O
tobamoviruses	|O
including	|O
tomato	|O
mosaic	|O
virus	|O
,	|O
tobacco	|O
mild	|O
green	|O
mosaic	|O
virus	|O
,	|O
TMV	|O
-	|O
U5	|O
,	|O
green	|O
tomato	|O
atypical	|O
mosaic	|O
virus	|O
,	|O
and	|O
ribgrass	|O
mosaic	|O
virus	|O
.	|O

Drug	|O
effect	|O
,	|O
measured	|O
as	|O
postural	|O
sway	|O
,	|O
was	|O
also	|O
similar	|O
in	|O
the	|O
patients	|O
with	|O
cirrhosis	|O
and	|O
control	|O
subjects	|O
;	|O
therefore	|O
the	|O
ratio	|O
of	|O
effect	|O
area	|O
under	|O
the	|O
curve	|O
to	|O
concentration	|O
area	|O
under	|O
the	|O
curve	|O
,	|O
a	|O
measure	|O
of	|O
sensitivity	|O
,	|O
did	|O
not	|O
differ	|O
significantly	|O
between	|O
the	|O
patients	|O
with	|O
cirrhosis	|O
and	|O
the	|O
control	|O
subjects	|O
.	|O

We	|O
present	|O
evidence	|O
that	|O
YY1	|B-PROTEIN
,	|O
a	|O
ubiquitously	|O
expressed	|O
DNA	|O
-	|O
binding	|O
protein	|O
,	|O
regulates	|O
the	|O
activity	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
promoter	|O
primarily	|O
through	|O
an	|O
effect	|O
on	|O
DNA	|O
structure	|O
.	|O

In	|O
a	|O
retrospective	|O
analysis	|O
of	|O
first	|O
-	|O
time	|O
total	|O
colonoscopies	|O
in	|O
685	|O
patients	|O
,	|O
we	|O
investigated	|O
the	|O
relationship	|O
between	|O
hyperplastic	|O
and	|O
adenomatous	|O
polyps	|O
.	|O

The	|O
rate	|O
of	|O
decrement	|O
in	|O
DPOAE	|O
amplitude	|O
over	|O
a	|O
prescribed	|O
time	|O
period	|O
was	|O
utilized	|O
as	|O
a	|O
measure	|O
of	|O
susceptibility	|O
to	|O
the	|O
acoustic	|O
trauma	|O
.	|O

Effect	|O
of	|O
single	|O
base	|O
substitutions	|O
at	|O
glycine	|O
-	|O
870	|O
codon	|O
of	|O
gramicidin	|B-PROTEIN
S	|I-PROTEIN
synthetase	|I-PROTEIN
2	|I-PROTEIN
gene	|O
on	|O
proline	|O
activation	|O
.	|O

The	|O
predicted	|O
Pay4p	|B-PROTEIN
sequence	|O
contains	|O
two	|O
putative	|O
ATP	|O
-	|O
binding	|O
domains	|O
and	|O
shows	|O
structural	|O
relationships	|O
to	|O
other	|O
potential	|O
ATP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
involved	|O
in	|O
biological	|O
processes	|O
as	|O
diverse	|O
as	|O
peroxisome	|O
biogenesis	|O
,	|O
vesicle	|O
-	|O
mediated	|O
protein	|O
transport	|O
,	|O
cell	|O
cycle	|O
control	|O
,	|O
and	|O
transcriptional	|O
regulation	|O
.	|O

The	|O
results	|O
show	|O
that	|O
the	|O
structure	|O
of	|O
the	|O
decorin	|B-PROTEIN
gene	|O
promoter	|O
is	|O
different	|O
from	|O
that	|O
of	|O
any	|O
other	|O
proteoglycan	|O
promoter	|O
characterized	|O
so	|O
far	|O
and	|O
indicate	|O
that	|O
the	|O
pur	|O
/	|O
pyr	|O
segment	|O
plays	|O
a	|O
role	|O
in	|O
the	|O
regulation	|O
of	|O
gene	|O
transcription	|O
.	|O

The	|O
kinase	|O
inhibitor	|O
staurosporine	|O
(	|O
1	|O
microM	|O
)	|O
blocks	|O
LPA	|O
-	|O
induced	|O
,	|O
but	|O
not	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|O
induced	|O
,	|O
activation	|O
of	|O
p21ras	|B-PROTEIN
and	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
,	|O
consistent	|O
with	|O
an	|O
intermediate	|O
protein	|O
kinase	|O
linking	|O
the	|O
LPA	|B-PROTEIN
receptor	|I-PROTEIN
to	|O
p21ras	|B-PROTEIN
activation	|O
.	|O

267	|O
,	|O
4870-4877	|O
)	|O
)	|O
indicates	|O
an	|O
overall	|O
identity	|O
of	|O
58	|O
and	|O
56%	|O
,	|O
respectively	|O
,	|O
with	|O
a	|O
91	|O
and	|O
92%	|O
identity	|O
in	|O
the	|O
highly	|O
conserved	|O
transmembrane	|O
and	|O
cytoplasmic	|O
domains	|O
.	|O

S.	|O
,	|O
K.	|O

The	|O
survival	|O
rate	|O
at	|O
forty	|O
months	|O
in	|O
15	|O
patients	|O
with	|O
N2	|O
disease	|O
who	|O
underwent	|O
R2b	|O
operation	|O
was	|O
51%	|O
.	|O

Mothers	|O
with	|O
severe	|O
anatomical	|O
abnormalities	|O
,	|O
who	|O
are	|O
HIV	|O
positive	|O
,	|O
have	|O
active	|O
TB	|O
or	|O
whose	|O
children	|O
have	|O
inherited	|O
mono	|O
-	|O
or	|O
disaccharide	|O
intolerances	|O
should	|O
not	|O
breastfeed	|O
.	|O

G.	|O

The	|O
psaD	|B-PROTEIN
,	|O
psaF	|B-PROTEIN
,	|O
psaH	|B-PROTEIN
,	|O
and	|O
psaL	|B-PROTEIN
products	|O
have	|O
two	|O
isoforms	|O
each	|O
that	|O
are	|O
distinguished	|O
by	|O
different	|O
mobilities	|O
in	|O
polyacrylamide	|O
gel	|O
electrophoresis	|O
,	|O
and	|O
the	|O
psaE	|B-PROTEIN
product	|O
has	|O
four	|O
isoforms	|O
.	|O

When	|O
Hy	|O
-	|O
Vac	|O
SPF	|O
type	|O
V	|O
embryos	|O
were	|O
exposed	|O
to	|O
either	|O
0.20	|O
ml	|O
50%	|O
ethanol	|O
in	|O
CRS	|O
or	|O
to	|O
0.20	|O
ml	|O
CRS	|O
(	|O
controls	|O
)	|O
,	|O
ethanol	|O
-	|O
treated	|O
embryos	|O
showed	|O
a	|O
VSD	|O
incidence	|O
of	|O
34.1%	|O
compared	|O
with	|O
a	|O
3.6%	|O
incidence	|O
in	|O
the	|O
controls	|O
(	|O
P	|O
=	|O
0.0017	|O
)	|O
.	|O

Peripheral	|O
vitreochorioretinal	|O
dystrophies	|O
in	|O
myopia	|O
patients	|O

In	|O
our	|O
studies	|O
,	|O
we	|O
utilized	|O
HIV	|O
-	|O
1	|O
HXB2	|B-PROTEIN
and	|O
HIV	|O
-	|O
1	|O
Z2Z6	|B-PROTEIN
core	|I-PROTEIN
enhancers	|O
because	|O
the	|O
Z2Z6	|B-PROTEIN
strain	|O
has	|O
a	|O
single	|O
point	|O
mutation	|O
flanking	|O
the	|O
right	|O
ETS	|B-PROTEIN
-	|O
binding	|O
site	|O
.	|O

The	|O
secondary	|O
,	|O
but	|O
not	|O
the	|O
primary	|O
,	|O
antibody	|O
responses	|O
of	|O
male	|O
C57Bl	|O
/	|O
6	|O
mice	|O
were	|O
higher	|O
among	|O
mice	|O
housed	|O
alone	|O
compared	|O
to	|O
mice	|O
housed	|O
in	|O
groups	|O
;	|O
differences	|O
were	|O
observed	|O
for	|O
both	|O
IgM	|B-PROTEIN
and	|O
IgG	|B-PROTEIN
anti	|I-PROTEIN
-	|I-PROTEIN
KLH	|I-PROTEIN
antibodies	|O
.	|O

However	|O
,	|O
a	|O
surprisingly	|O
high	|O
degree	|O
of	|O
conservation	|O
of	|O
intron	|O
sequences	|O
was	|O
observed	|O
between	|O
both	|O
species	|O
.	|O

Interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
may	|O
possibly	|O
potentiate	|O
metastasis	|O
of	|O
cardiac	|O
myxoma	|O
.	|O

Other	|O
parameters	|O
of	|O
iron	|O
metabolism	|O
,	|O
including	|O
ferritin	|B-PROTEIN
,	|O
were	|O
not	|O
found	|O
to	|O
contribute	|O
to	|O
the	|O
risk	|O
.	|O

Responses	|O
to	|O
the	|O
Plowright	|O
Rinderpest	|O
vaccine	|O
by	|O
43	|O
calves	|O
and	|O
70	|O
adult	|O
cattle	|O
in	|O
Uganda	|O
in	|O
1990	|O
,	|O
through	|O
the	|O
production	|O
of	|O
IgG	|B-PROTEIN
antibodies	|O
,	|O
were	|O
monitored	|O
for	|O
4	|O
weeks	|O
using	|O
the	|O
ELISA	|O
assay	|O
.	|O

Because	|O
of	|O
the	|O
small	|O
number	|O
of	|O
visceral	|O
angiography	|O
procedures	|O
performed	|O
(	|O
38	|O
)	|O
,	|O
no	|O
definitive	|O
conclusions	|O
could	|O
be	|O
drawn	|O
as	|O
to	|O
the	|O
differences	|O
between	|O
ionic	|O
and	|O
nonionic	|O
agents	|O
regarding	|O
grade	|O
-	|O
2	|O
and	|O
grade	|O
-	|O
3	|O
adverse	|O
events	|O
.	|O

Tumours	|O
of	|O
the	|O
cavum	|O
oris	|O
and	|O
oropharynx	|O
of	|O
T1	|O
-	|O
stage	|O
are	|O
possible	|O
only	|O
in	|O
1	|O
of	|O
3	|O
cases	|O
.	|O

Thomas	|O
'	|O
Hospital	|O
solution	|O
(	|O
with	|O
95%	|O
O2	|O
:	|O
5%	|O
CO2	|O
)	|O
can	|O
meet	|O
the	|O
metabolic	|O
demand	|O
of	|O
the	|O
ischaemic	|O
myocardium	|O
and	|O
thus	|O
increase	|O
the	|O
safe	|O
duration	|O
of	|O
cardiac	|O
arrest	|O
.	|O

Plasma	|O
,	|O
LDL	|B-PROTEIN
and	|O
liver	|O
cholesterol	|O
concentrations	|O
were	|O
higher	|O
in	|O
the	|O
hyperlipidemic	|O
control	|O
than	|O
the	|O
nonhyperlipidemic	|O
control	|O
and	|O
lower	|O
in	|O
the	|O
groups	|O
fed	|O
diets	|O
containing	|O
pectin	|B-PROTEIN
or	|O
prune	|O
fiber	|O
than	|O
in	|O
the	|O
hyperlipidemic	|O
control	|O
group	|O
.	|O

The	|O
Stryker	|O
frame	|O
modification	|O
to	|O
the	|O
standard	|O
Dornier	|O
HM3	|O
lithotriptor	|O
allows	|O
for	|O
improved	|O
visualization	|O
and	|O
easier	|O
localization	|O
of	|O
distal	|O
ureteral	|O
calculi	|O
compared	|O
to	|O
the	|O
standard	|O
gantry	|O
.	|O

Glomerular	|O
mesangial	|O
cells	|O
expressed	|O
an	|O
abundant	|O
1.1	|O
kb	|O
mRNA	|O
transcript	|O
for	|O
Id1	|B-PROTEIN
,	|O
but	|O
in	|O
contrast	|O
to	|O
other	|O
cell	|O
types	|O
Id1	|B-PROTEIN
mRNA	|O
was	|O
expressed	|O
in	|O
both	|O
randomly	|O
cycling	|O
cells	|O
and	|O
in	|O
serum	|O
-	|O
deprived	|O
,	|O
quiescent	|O
cultures	|O
.	|O

Routine	|O
psychometric	|O
screening	|O
of	|O
IHD	|O
patients	|O
may	|O
provide	|O
a	|O
cost	|O
-	|O
effective	|O
means	|O
of	|O
alerting	|O
cardiologists	|O
and	|O
internists	|O
to	|O
the	|O
relatively	|O
high	|O
levels	|O
of	|O
distress	|O
among	|O
their	|O
patients	|O
.	|O

A	|O
single	|O
1.8	|O
-	|O
kb	|O
transcript	|O
mRNA	|O
was	|O
detected	|O
by	|O
Northern	|O
(	|O
RNA	|O
)	|O
blot	|O
analysis	|O
,	|O
and	|O
its	|O
5'	|O
end	|O
maps	|O
to	|O
a	|O
position	|O
51	|O
bp	|O
upstream	|O
from	|O
the	|O
site	|O
of	|O
initiation	|O
of	|O
protein	|O
synthesis	|O
.	|O

Employing	|O
this	|O
sequence	|O
information	|O
from	|O
c11/1	|O
,	|O
the	|O
c11/1	|O
-	|O
specific	|O
cDNA	|O
was	|O
generated	|O
from	|O
poly	|O
(	|O
A	|O
)	|O
+	|O
RNA	|O
of	|O
bovine	|O
PMNLs	|O
by	|O
reverse	|O
transcription	|O
and	|O
a	|O
combination	|O
of	|O
polymerase	|O
chain	|O
reaction	|O
(	|O
PCR	|O
)	|O
methods	|O
.	|O

The	|O
sequence	|O
similarity	|O
has	|O
suggested	|O
that	|O
SCG10	|B-PROTEIN
and	|O
stathmin	|B-PROTEIN
have	|O
been	|O
derived	|O
from	|O
structurally	|O
and	|O
evolutionarily	|O
related	|O
genes	|O
.	|O

These	|O
data	|O
are	|O
consistent	|O
with	|O
the	|O
idea	|O
that	|O
the	|O
neuron	|O
-	|O
specific	|O
SCG10	|B-PROTEIN
gene	|O
evolved	|O
by	|O
duplication	|O
and	|O
modification	|O
of	|O
the	|O
more	|O
broadly	|O
expressed	|O
stathmin	|B-PROTEIN
/	|O
Lap18	|B-PROTEIN
gene	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
mouse	|O
HO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
is	|O
identical	|O
to	|O
that	|O
of	|O
p32	|B-PROTEIN
,	|O
initially	|O
identified	|O
as	|O
a	|O
stress	|O
-	|O
induced	|O
protein	|O
in	|O
mouse	|O
BALBc	|O
/	|O
3T3	|O
cells	|O
.	|O

We	|O
found	|O
that	|O
T3	|O
(	|O
10	|O
(	|O
-	|O
8	|O
)	|O
M	|O
)	|O
selectively	|O
stimulates	|O
transcription	|O
from	|O
rGH	|B-PROTEIN
-	|O
TRE	|O
-	|O
and	|O
TREpal	|O
-	|O
,	|O
but	|O
not	|O
ME	|O
-	|O
TRE	|O
-	|O
and	|O
F2	|O
-	|O
TRE	|O
-	|O
,	|O
containing	|O
templates	|O
in	|O
which	|O
these	|O
TREs	|O
are	|O
linked	|O
in	|O
front	|O
of	|O
the	|O
rGH	|B-PROTEIN
minimal	|O
promoter	|O
containing	|O
only	|O
the	|O
TATA	|B-PROTEIN
box	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
but	|O
not	|O
any	|O
other	|O
proximal	|O
binding	|O
protein	|O
,	|O
sequence	|O
.	|O

Using	|O
a	|O
polymerase	|O
chain	|O
reaction	|O
-	|O
based	|O
approach	|O
,	|O
we	|O
cloned	|O
a	|O
150	|O
-	|O
base	|O
pair	|O
fragment	|O
of	|O
a	|O
new	|O
sialymotif	|O
from	|O
human	|O
placenta	|O
mRNA	|O
,	|O
which	|O
was	|O
then	|O
used	|O
as	|O
a	|O
probe	|O
to	|O
clone	|O
the	|O
complete	|O
coding	|O
sequence	|O
of	|O
the	|O
corresponding	|O
gene	|O
from	|O
a	|O
cDNA	|O
library	|O
.	|O

The	|O
structural	|O
analysis	|O
also	|O
demonstrated	|O
that	|O
the	|O
heterogeneity	|O
of	|O
the	|O
HDC	|B-PROTEIN
mRNA	|O
is	|O
caused	|O
by	|O
an	|O
insertion	|O
of	|O
the	|O
seventh	|O
intron	|O
sequence	|O
and	|O
alternative	|O
use	|O
of	|O
the	|O
splicing	|O
acceptor	|O
site	|O
at	|O
the	|O
12th	|O
exon	|O
.	|O

A	|O
complementary	|O
DNA	|O
was	|O
isolated	|O
from	|O
Caenorhabditis	|O
elegans	|O
that	|O
encoded	|O
a	|O
polypeptide	|O
of	|O
1438	|O
amino	|O
acid	|O
residues	|O
,	|O
CeGAP	|B-PROTEIN
,	|O
which	|O
contains	|O
a	|O
domain	|O
with	|O
sequence	|O
similarity	|O
to	|O
the	|O
COOH	|O
-	|O
terminal	|O
segment	|O
(	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
region	|O
)	|O
of	|O
Bcr	|B-PROTEIN
and	|O
other	|O
known	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
proteins	|I-PROTEIN
of	|O
the	|O
Rho	|B-PROTEIN
subfamily	|O
.	|O

Additional	|O
exonuclease	|B-PROTEIN
III	|I-PROTEIN
protection	|O
was	|O
observed	|O
beyond	|O
the	|O
core	|O
region	|O
on	|O
both	|O
the	|O
5'	|O
and	|O
3'	|O
sides	|O
,	|O
suggesting	|O
that	|O
E1	|B-PROTEIN
interacted	|O
with	|O
more	|O
distal	|O
sequences	|O
as	|O
well	|O
.	|O

Repression	|O
is	|O
alleviated	|O
when	|O
the	|O
two	|O
(	|O
for	|O
E2	|B-PROTEIN
)	|O
or	|O
three	|O
(	|O
for	|O
E2	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
)	|O
promoter	|O
-	|O
proximal	|O
copies	|O
of	|O
E2	|B-PROTEIN
-	|O
RS	|O
are	|O
mutated	|O
.	|O

A	|O
mutant	|O
in	|O
the	|O
AAV	|O
terminal	|O
resolution	|O
site	|O
(	|O
trs	|O
)	|O
was	|O
defective	|O
for	|O
DNA	|O
replication	|O
in	|O
the	|O
in	|O
vitro	|O
assay	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
rep	|B-PROTEIN
strongly	|O
enhances	|O
the	|O
function	|O
of	|O
negative	|O
regulatory	|O
elements	|O
of	|O
the	|O
LTR	|O
.	|O

However	|O
,	|O
artificially	|O
ventilated	|O
rats	|O
,	|O
pretreated	|O
with	|O
MK	|O
-	|O
801	|O
,	|O
were	|O
more	|O
sensitive	|O
(	|O
lethal	|O
cocaine	|O
dose	|O
,	|O
76.6	|O
+	|O
/	|O
-	|O
8.0	|O
mg	|O
/	|O
kg	|O
,	|O
n	|O
=	|O
5	|O
)	|O
than	|O
vehicle	|O
pretreated	|O
rats	|O
(	|O
129.4	|O
+	|O
/	|O
-	|O
15.8	|O
mg	|O
/	|O
kg	|O
,	|O
n	|O
=	|O
6	|O
)	|O
,	|O
indicating	|O
that	|O
MK	|O
-	|O
801	|O
may	|O
increase	|O
both	|O
the	|O
respiratory	|O
and	|O
the	|O
cardiac	|O
toxicity	|O
of	|O
cocaine	|O
in	|O
urethane	|O
anesthetized	|O
rats	|O
.	|O

The	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
3/4	|I-PROTEIN
gene	|O
product	|O
,	|O
which	|O
belongs	|O
to	|O
the	|O
POU	|B-PROTEIN
family	|O
of	|O
transcription	|O
factors	|O
,	|O
is	|O
a	|O
good	|O
candidate	|O
for	|O
regulating	|O
initial	|O
differentiation	|O
decisions	|O
.	|O

Using	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
,	|O
we	|O
show	|O
that	|O
the	|O
RAREoct	|B-PROTEIN
contributes	|O
to	|O
the	|O
transcriptional	|O
activation	|O
of	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
3/4	|I-PROTEIN
promoter	|O
in	|O
P19	|O
cells	|O
and	|O
,	|O
most	|O
interestingly	|O
,	|O
mediates	|O
the	|O
RA	|O
-	|O
induced	|O
repression	|O
in	|O
RA	|O
-	|O
differentiated	|O
EC	|O
cells	|O
.	|O

176	|O
:	|O
787-792	|O
,	|O
1992	|O
;	|O
M.	|O

Furthermore	|O
,	|O
the	|O
negative	|O
transcriptional	|O
effect	|O
of	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFs	|I-PROTEIN
is	|O
dominant	|O
over	|O
the	|O
activating	|O
effect	|O
of	|O
the	|O
Oct4	|B-PROTEIN
embryonic	|O
stem	|O
cell	|O
-	|O
specific	|O
enhancer	|O
.	|O

Analysis	|O
of	|O
mig	|B-PROTEIN
/	|O
CAT	|B-PROTEIN
chimeric	|O
constructs	|O
transiently	|O
transfected	|O
into	|O
the	|O
RAW	|O
264.7	|O
mouse	|O
monocytic	|O
cell	|O
line	|O
revealed	|O
a	|O
unique	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
-	|O
responsive	|O
element	|O
(	|O
gamma	|B-PROTEIN
RE	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

When	|O
expressed	|O
alone	|O
in	|O
test	|O
cells	|O
,	|O
Atr	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
is	|O
unable	|O
to	|O
bind	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
,	|O
activin	|B-PROTEIN
,	|O
or	|O
bone	|B-PROTEIN
morphogenetic	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
.	|O

Therefore	|O
,	|O
Mxi1	|B-PROTEIN
and	|O
Mad	|B-PROTEIN
might	|O
antagonize	|O
Myc	|B-PROTEIN
function	|O
and	|O
are	|O
candidate	|O
tumor	|O
suppressor	|O
genes	|O
.	|O

To	|O
our	|O
knowledge	|O
,	|O
type	|O
IV	|O
renal	|O
tubular	|O
acidosis	|O
has	|O
not	|O
been	|O
reported	|O
previously	|O
in	|O
association	|O
with	|O
Alport	|O
's	|O
syndrome	|O
in	|O
an	|O
adult	|O
patient	|O
.	|O

A	|O
cDNA	|O
clone	|O
was	|O
isolated	|O
from	|O
a	|O
chicken	|O
embryo	|O
cDNA	|O
library	|O
employing	|O
a	|O
PCR	|O
-	|O
generated	|O
radiolabeled	|O
probe	|O
specific	|O
for	|O
the	|O
U3	|B-PROTEIN
region	|I-PROTEIN
of	|O
the	|O
Rous	|B-PROTEIN
sarcoma	|I-PROTEIN
virus	|I-PROTEIN
LTR	|I-PROTEIN
.	|O

Two	|O
basic	|O
patterns	|O
of	|O
locomotor	|O
behavior	|O
and	|O
corresponding	|O
torso	|O
morphology	|O
exist	|O
among	|O
extant	|O
anthropoids	|O
.	|O

Animal	|O
age	|O
and	|O
sex	|O
had	|O
no	|O
significant	|O
effects	|O
on	|O
CSF	|O
composition	|O
,	|O
but	|O
serum	|O
IgG	|B-PROTEIN
concentration	|O
increased	|O
with	|O
age	|O
.	|O

Fast	|O
continuous	|O
expansion	|O
.	|O

A	|O
randomized	|O
,	|O
multicenter	|O
study	|O
comparing	|O
the	|O
efficacy	|O
and	|O
tolerability	|O
of	|O
tropisetron	|O
,	|O
a	|O
new	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT3	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
,	|O
with	|O
a	|O
metoclopramide	|O
-	|O
containing	|O
antiemetic	|O
cocktail	|O
in	|O
the	|O
prevention	|O
of	|O
cisplatin	|O
-	|O
induced	|O
emesis	|O
.	|O

Each	|O
repeat	|O
consists	|O
of	|O
12	|O
nt	|O
,	|O
coding	|O
for	|O
the	|O
reiterated	|O
sequence	|O
,	|O
K	|O
/	|O
NPAG	|O
.	|O

ENV	|B-PROTEIN
also	|O
was	|O
secreted	|O
from	|O
P.	|O
pastoris	|O
using	|O
the	|O
S.	|O
cerevisiae	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
prepro	|O
secretion	|O
leader	|O
and	|O
the	|O
S.	|O
cerevisiae	|O
invertase	|B-PROTEIN
signal	|O
sequence	|O
.	|O

BACKGROUND	|O
:	|O
To	|O
determine	|O
the	|O
predictors	|O
of	|O
desipramine	|O
-	|O
refractory	|O
depression	|O
,	|O
the	|O
authors	|O
examined	|O
the	|O
outcome	|O
in	|O
patients	|O
with	|O
major	|O
depression	|O
who	|O
were	|O
admitted	|O
to	|O
a	|O
general	|O
hospital	|O
and	|O
treated	|O
with	|O
desipramine	|O
adjusted	|O
to	|O
an	|O
adequate	|O
blood	|O
level	|O
.	|O

Analysis	|O
of	|O
the	|O
intact	|O
hGH	|B-PROTEIN
gene	|O
or	|O
hGH	|B-PROTEIN
5'	|O
-	|O
flanking	|O
DNA	|O
(	|O
5'	|O
-	|O
FR	|O
)	|O
coupled	|O
to	|O
the	|O
hGh	|B-PROTEIN
cDNA	|O
or	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
or	|O
luciferase	|B-PROTEIN
genes	|O
,	|O
indicated	|O
that	|O
cAMP	|O
primarily	|O
stimulated	|O
hGH	|B-PROTEIN
promoter	|O
activity	|O
.	|O

The	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
SAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cDNA	|O
showed	|O
that	|O
mature	|O
SAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
consisted	|O
of	|O
1093	|O
amino	|O
acids	|O
and	|O
a	|O
transmembrane	|O
-	|O
type	|O
PTP	|B-PROTEIN
,	|O
which	|O
possessed	|O
a	|O
single	|O
PTP	|B-PROTEIN
-	|O
conserved	|O
domain	|O
in	|O
the	|O
cytoplasmic	|O
region	|O
.	|O

The	|O
following	|O
evidence	|O
indicates	|O
that	|O
the	|O
69	|O
-	|O
kD	|O
protein	|O
is	|O
a	|O
common	|O
,	|O
rather	|O
than	|O
a	|O
U1	|B-PROTEIN
-	|O
specific	|O
,	|O
protein	|O
,	|O
possibly	|O
associating	|O
with	|O
the	|O
snRNP	|O
core	|O
particles	|O
by	|O
protein	|O
-	|O
protein	|O
interaction	|O
.	|O

Several	|O
features	|O
of	|O
10.24.6	|O
cells	|O
suggest	|O
that	|O
the	|O
mutation	|O
disrupts	|O
normal	|O
intracellular	|O
formation	|O
of	|O
peptide	|B-PROTEIN
/	|I-PROTEIN
DR	|I-PROTEIN
complexes	|O
.	|O

This	|O
distribution	|O
parallels	|O
that	|O
of	|O
the	|O
neurotransmitters	|O
glutamate	|O
and	|O
aspartate	|O
;	|O
however	|O
,	|O
neither	|O
of	|O
these	|O
excitatory	|O
amino	|O
acids	|O
is	|O
a	|O
substrate	|O
for	|O
transport	|O
.	|O

The	|O
Harleco	|O
apparatus	|O
is	|O
a	|O
simple	|O
,	|O
useful	|O
,	|O
cost	|O
-	|O
effective	|O
adjunct	|O
to	|O
the	|O
diagnosis	|O
and	|O
treatment	|O
of	|O
this	|O
life	|O
-	|O
threatening	|O
condition	|O
.	|O

Co	|O
-	|O
transfection	|O
of	|O
expression	|O
vectors	|O
for	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|I-PROTEIN
C	|I-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
trans	|O
-	|O
activated	|O
the	|O
rat	|O
uncoupling	|B-PROTEIN
protein	|I-PROTEIN
gene	|O
promoter	|O
due	|O
to	|O
sequences	|O
in	|O
the	|O
5'	|O
proximal	|O
region	|O
.	|O

It	|O
was	|O
not	|O
possible	|O
to	|O
study	|O
the	|O
basis	|O
for	|O
tissue	|O
-	|O
specific	|O
expression	|O
of	|O
this	|O
gene	|O
,	|O
because	|O
the	|O
beta	|B-PROTEIN
3	|I-PROTEIN
gene	|O
promoter	|O
had	|O
not	|O
been	|O
isolated	|O
previously	|O
.	|O

Isolation	|O
and	|O
characterization	|O
of	|O
a	|O
TATA	|O
-	|O
less	|O
promoter	|O
for	|O
the	|O
human	|O
beta	|B-PROTEIN
3	|I-PROTEIN
integrin	|I-PROTEIN
gene	|O
.	|O

Subretinal	|O
fluid	|O
was	|O
punctured	|O
on	|O
the	|O
poorer	|O
eye	|O
in	|O
19	|O
eyes	|O
(	|O
52.7%	|O
)	|O
and	|O
on	|O
the	|O
better	|O
eye	|O
in	|O
7	|O
eyes	|O
(	|O
19.4%	|O
)	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
activation	|O
of	|O
these	|O
enzymes	|O
is	|O
not	|O
sufficient	|O
for	|O
the	|O
acute	|O
stimulation	|O
of	|O
glucose	|O
transport	|O
.	|O

The	|O
inserted	|O
region	|O
,	|O
which	|O
represents	|O
an	|O
intron	|O
in	|O
brain	|O
and	|O
muscle	|O
,	|O
is	|O
expressed	|O
in	|O
the	|O
tumor	|O
cell	|O
lines	|O
either	|O
as	|O
a	|O
"	|O
readthrough	|O
"	|O
form	|O
or	|O
with	|O
78	|O
residues	|O
deleted	|O
from	|O
its	|O
5'	|O
end	|O
.	|O

Concordance	|O
of	|O
IBDQ	|O
scores	|O
was	|O
tested	|O
in	|O
280	|O
stable	|O
subjects	|O
.	|O

Regression	|O
line	|O
slopes	|O
of	|O
IBDQ	|O
scores	|O
were	|O
significantly	|O
different	|O
in	|O
patients	|O
who	|O
deteriorated	|O
from	|O
those	|O
who	|O
remained	|O
stable	|O
(	|O
[	|O
b	|O
]	|O
<	|O
0.15	|O
;	|O
P	|O
<	|O
0.0001	|O
)	|O
.	|O

Praziquantel	|O
and	|O
Albendazole	|O
were	|O
found	|O
effective	|O
in	|O
the	|O
treatment	|O
of	|O
neurocysticercosis	|O
,	|O
but	|O
because	|O
of	|O
serious	|O
side	|O
effects	|O
encountered	|O
in	|O
some	|O
cases	|O
,	|O
the	|O
drugs	|O
should	|O
be	|O
used	|O
cautiously	|O
in	|O
selected	|O
cases	|O
only	|O
.	|O

Inhibition	|O
of	|O
erythromycin	|O
synthesis	|O
by	|O
disruption	|O
of	|O
malonyl	|B-PROTEIN
-	|I-PROTEIN
coenzyme	|I-PROTEIN
A	|I-PROTEIN
decarboxylase	|I-PROTEIN
gene	|O
eryM	|O
in	|O
Saccharopolyspora	|O
erythraea	|O
.	|O

This	|O
region	|O
is	|O
required	|O
for	|O
activation	|O
of	|O
DNA	|O
binding	|O
of	|O
MyoD	|B-PROTEIN
and	|O
E12	|B-PROTEIN
homodimers	|O
and	|O
E12	|B-PROTEIN
/	|O
MyoD	|B-PROTEIN
heterodimers	|O
.	|O

Transcriptional	|O
analysis	|O
of	|O
a	|O
series	|O
of	|O
deletion	|O
mutants	|O
of	|O
the	|O
gene	|O
in	|O
the	|O
nuclear	|O
extracts	|O
prepared	|O
from	|O
the	|O
middle	|O
silk	|O
gland	|O
of	|O
2	|O
-	|O
day	|O
-	|O
old	|O
fifth	|O
instar	|O
larvae	|O
revealed	|O
the	|O
presence	|O
of	|O
multiple	|O
cis	|O
-	|O
regulatory	|O
elements	|O
located	|O
both	|O
upstream	|O
and	|O
downstream	|O
of	|O
the	|O
initiation	|O
site	|O
.	|O

One	|O
of	|O
these	|O
elements	|O
,	|O
the	|O
homeodomain	|B-PROTEIN
-	|O
binding	|O
element	|O
,	|O
was	|O
identified	|O
to	|O
mediate	|O
negative	|O
regulation	|O
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
of	|O
the	|O
traI	|B-PROTEIN
structural	|O
gene	|O
and	|O
application	|O
of	|O
purified	|O
mutant	|O
TraI	|B-PROTEIN
proteins	|O
for	|O
in	|O
vitro	|O
assays	|O
served	|O
to	|O
evaluate	|O
the	|O
functional	|O
importance	|O
of	|O
conserved	|O
amino	|O
acid	|O
residues	|O
.	|O

Concerted	|O
action	|O
of	|O
three	|O
distinct	|O
domains	|O
in	|O
the	|O
DNA	|O
cleaving	|O
-	|O
joining	|O
reaction	|O
catalyzed	|O
by	|O
relaxase	|B-PROTEIN
(	|O
TraI	|B-PROTEIN
)	|O
of	|O
conjugative	|O
plasmid	|O
RP4	|O
.	|O

The	|O
COOH	|O
-	|O
terminal	|O
46	|O
codons	|O
of	|O
slyD	|B-PROTEIN
encode	|O
a	|O
remarkable	|O
histidine	|O
-	|O
rich	|O
peptide	|O
sequence	|O
which	|O
is	|O
at	|O
least	|O
partly	|O
dispensable	|O
for	|O
slyD	|B-PROTEIN
function	|O
in	|O
E	|B-PROTEIN
-	|O
mediated	|O
lysis	|O
.	|O

Monospecific	|O
antibodies	|O
raised	|O
against	|O
rat	|O
cytochrome	|B-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
450	|I-PROTEIN
1A1	|I-PROTEIN
recognized	|O
a	|O
protein	|O
in	|O
the	|O
hepatic	|O
microsomes	|O
of	|O
the	|O
double	|O
-	|O
crested	|O
cormorant	|O
,	|O
and	|O
also	|O
in	|O
those	|O
of	|O
the	|O
great	|O
blue	|O
heron	|O
(	|O
Ardea	|O
herodias	|O
)	|O
,	|O
using	|O
immunoblotting	|O
.	|O

We	|O
studied	|O
GSH	|B-PROTEIN
-	|I-PROTEIN
Px	|I-PROTEIN
enzyme	|O
activity	|O
in	|O
serum	|O
after	|O
acute	|O
myocardial	|O
infarction	|O
(	|O
AMI	|O
)	|O
and	|O
unstable	|O
angina	|O
pectoris	|O
(	|O
UAP	|O
)	|O
.	|O

The	|O
HGF	|B-PROTEIN
-	|O
induced	|O
cell	|O
motility	|O
was	|O
mimicked	|O
by	|O
12-0	|O
-	|O
tetradecanoyl	|O
-	|O
phorbol	|O
-	|O
13	|O
-	|O
acetate	|O
,	|O
a	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
-	|O
activating	|O
phorbol	|O
ester	|O
,	|O
but	|O
not	|O
by	|O
Ca2+	|O
ionophore	|O
.	|O

In	|O
addition	|O
,	|O
lexical	|O
priming	|O
was	|O
examined	|O
by	|O
presenting	|O
an	|O
identity	|O
prime	|O
earlier	|O
in	|O
the	|O
text	|O
.	|O

METHODS	|O
:	|O
Forty	|O
-	|O
nine	|O
cases	|O
with	|O
intrahepatic	|O
multiple	|O
nodules	|O
of	|O
HCC	|O
,	|O
by	|O
gross	|O
examination	|O
,	|O
among	|O
184	|O
consecutive	|O
resected	|O
HCCs	|O
were	|O
examined	|O
clinicopathologically	|O
.	|O

In	|O
the	|O
present	|O
report	|O
,	|O
66	|O
hemochromatosis	|O
families	|O
yielding	|O
151	|O
hemochromatosis	|O
chromosomes	|O
and	|O
182	|O
normal	|O
chromosomes	|O
were	|O
RFLP	|O
-	|O
typed	|O
with	|O
a	|O
battery	|O
of	|O
probes	|O
,	|O
including	|O
two	|O
newly	|O
derived	|O
polymorphic	|O
markers	|O
from	|O
the	|O
6.7	|O
and	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
F	|I-PROTEIN
loci	|O
located	|O
150	|O
and	|O
250	|O
kb	|O
telomeric	|O
to	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|O
respectively	|O
.	|O

Pneumothorax	|O
during	|O
laparoscopic	|O
dissection	|O
of	|O
the	|O
diaphragmatic	|O
hiatus	|O
.	|O

Different	|O
cortical	|O
malformations	|O
were	|O
produced	|O
in	|O
rats	|O
by	|O
a	|O
single	|O
dose	|O
of	|O
X	|O
-	|O
rays	|O
(	|O
200	|O
cGy	|O
)	|O
given	|O
on	|O
different	|O
days	|O
during	|O
gestation	|O
.	|O

T2	|O
cancers	|O
should	|O
not	|O
be	|O
excluded	|O
from	|O
the	|O
benefit	|O
of	|O
preoperative	|O
irradiation	|O
.	|O

IFN	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
IFN	|B-PROTEIN
gamma	|I-PROTEIN
inducibility	|O
is	|O
mediated	|O
by	|O
a	|O
single	|O
element	|O
:	|O
a	|O
high	|O
affinity	|O
,	|O
nearly	|O
palindromic	|O
version	|O
of	|O
the	|O
IFN	|B-PROTEIN
gamma	|I-PROTEIN
activation	|I-PROTEIN
site	|I-PROTEIN
(	|O
GAS	|B-PROTEIN
)	|O
.	|O

Mutations	|O
in	|O
the	|O
nuclear	|O
gene	|O
CBP1	|B-PROTEIN
of	|O
Saccharomyces	|O
cerevisiae	|O
result	|O
in	|O
degradation	|O
of	|O
mitochondrially	|O
encoded	|O
cytochrome	|B-PROTEIN
b	|I-PROTEIN
(	|O
cob	|B-PROTEIN
)	|O
RNA	|O
;	|O
thus	|O
,	|O
the	|O
cells	|O
are	|O
unable	|O
to	|O
respire	|O
.	|O

Twenty	|O
-	|O
three	|O
sequence	|O
-	|O
tagged	|O
sites	|O
(	|O
STSs	|O
)	|O
were	|O
mapped	|O
within	|O
the	|O
contig	|O
,	|O
a	|O
density	|O
of	|O
approximately	|O
1	|O
per	|O
200	|O
kb	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
we	|O
demonstrate	|O
that	|O
binding	|O
of	|O
the	|O
GA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
GABP	|B-PROTEIN
)	|O
to	|O
ets	|B-PROTEIN
sequence	|O
motifs	|O
within	|O
each	|O
repeated	|O
unit	|O
is	|O
required	|O
for	|O
transcriptional	|O
activation	|O
of	|O
the	|O
COXIV	|B-PROTEIN
promoter	|O
.	|O

To	|O
gain	|O
further	|O
insight	|O
into	|O
the	|O
pathogenesis	|O
of	|O
the	|O
adult	|O
respiratory	|O
distress	|O
syndrome	|O
(	|O
ARDS	|O
)	|O
,	|O
the	|O
authors	|O
studied	|O
possible	|O
relationships	|O
among	|O
the	|O
activation	|O
status	|O
of	|O
circulating	|O
polymorphonuclear	|O
neutrophils	|O
(	|O
PMN	|O
)	|O
,	|O
cytokine	|O
levels	|O
,	|O
and	|O
the	|O
severity	|O
of	|O
lung	|O
injury	|O
in	|O
31	|O
patients	|O
:	|O
15	|O
with	|O
ARDS	|O
,	|O
9	|O
with	|O
severe	|O
pneumonia	|O
uncomplicated	|O
by	|O
ARDS	|O
,	|O
and	|O
7	|O
mechanically	|O
ventilated	|O
patients	|O
with	|O
neither	|O
ARDS	|O
nor	|O
pneumonia	|O
.	|O

Amiodarone	|O
,	|O
seldom	|O
used	|O
as	|O
first	|O
-	|O
line	|O
treatment	|O
,	|O
appears	|O
to	|O
be	|O
the	|O
most	|O
effective	|O
drug	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
stimulation	|O
by	|O
different	|O
dopamine	|O
agonists	|O
produces	|O
a	|O
different	|O
pattern	|O
of	|O
effects	|O
on	|O
the	|O
characteristics	|O
of	|O
the	|O
reaction	|O
time	|O
response	|O
.	|O

Two	|O
experiments	|O
were	|O
conducted	|O
to	|O
study	|O
the	|O
vacuous	|O
jaw	|O
movements	|O
induced	|O
in	|O
rats	|O
by	|O
acute	|O
administration	|O
of	|O
the	|O
monoamine	|O
-	|O
depleting	|O
agent	|O
reserpine	|O
.	|O

Depletion	|O
of	|O
dopamine	|O
in	|O
the	|O
nucleus	|O
accumbens	|O
led	|O
to	|O
a	|O
dramatic	|O
shift	|O
in	|O
behavior	|O
in	|O
which	|O
there	|O
was	|O
a	|O
significant	|O
decrease	|O
in	|O
lever	|O
pressing	|O
but	|O
a	|O
significant	|O
increase	|O
in	|O
consumption	|O
of	|O
lab	|O
chow	|O
.	|O

We	|O
have	|O
investigated	|O
the	|O
influence	|O
of	|O
NaFe3+	|O
EDTA	|O
,	|O
and	|O
of	|O
increasing	|O
dietary	|O
levels	|O
of	|O
Na2EDTA	|O
,	|O
on	|O
Zn	|O
,	|O
Cu	|O
and	|O
Ca	|O
metabolism	|O
in	|O
rats	|O
fed	|O
on	|O
Zn	|O
-	|O
sufficient	|O
and	|O
Zn	|O
-	|O
deficient	|O
soya	|O
-	|O
bean	|O
-	|O
isolate	|O
-	|O
based	|O
diets	|O
.	|O

Recovery	|O
of	|O
carbimazole	|O
-	|O
induced	|O
agranulocytosis	|O
following	|O
recombinant	|B-PROTEIN
granulocyte	|I-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
colony	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
rhGM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
administration	|O
.	|O

Thus	|O
,	|O
the	|O
system	|O
can	|O
be	|O
used	|O
to	|O
detect	|O
and	|O
study	|O
dynamic	|O
perfusion	|O
changes	|O
from	|O
the	|O
brain	|O
surface	|O
with	|O
minimal	|O
tissue	|O
damage	|O
.	|O

The	|O
neglect	|O
of	|O
Richards	|O
's	|O
theory	|O
demonstrates	|O
the	|O
range	|O
of	|O
factors	|O
,	|O
other	|O
than	|O
the	|O
strictly	|O
scientific	|O
,	|O
which	|O
can	|O
be	|O
important	|O
in	|O
determining	|O
the	|O
influence	|O
or	|O
otherwise	|O
of	|O
a	|O
psychological	|O
theory	|O
.	|O

The	|O
positive	|O
-	|O
acting	|O
global	|O
sulfur	|O
regulatory	|O
protein	|O
,	|O
CYS3	|B-PROTEIN
,	|O
of	|O
Neurospora	|O
crassa	|O
turns	|O
on	|O
the	|O
expression	|O
of	|O
a	|O
family	|O
of	|O
unlinked	|O
structural	|O
genes	|O
that	|O
encode	|O
enzymes	|O
of	|O
sulfur	|O
catabolism	|O
.	|O

Analysis	|O
of	|O
the	|O
upstream	|O
untranslated	|O
region	|O
of	|O
CHL15	|B-PROTEIN
revealed	|O
the	|O
presence	|O
of	|O
the	|O
hexamer	|O
element	|O
,	|O
ACGCGT	|O
(	|O
an	|O
MluI	|B-PROTEIN
restriction	|O
site	|O
)	|O
controlling	|O
both	|O
the	|O
periodic	|O
expression	|O
and	|O
coordinate	|O
regulation	|O
of	|O
the	|O
DNA	|O
synthesis	|O
genes	|O
in	|O
budding	|O
yeast	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
150	|O
-	|O
kDa	|O
protein	|O
contains	|O
an	|O
NTP	|O
-	|O
binding	|O
helicase	|B-PROTEIN
motif	|O
and	|O
the	|O
readthrough	|O
region	|O
,	|O
an	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
motif	|O
,	|O
indicating	|O
that	|O
these	|O
two	|O
overlapping	|O
proteins	|O
may	|O
form	|O
an	|O
RNA	|O
replication	|O
complex	|O
similar	|O
to	|O
those	|O
of	|O
tobamo	|O
-	|O
and	|O
tobraviruses	|O
.	|O

The	|O
5'	|O
ends	|O
of	|O
F3R	|B-PROTEIN
late	|O
transcripts	|O
were	|O
located	|O
to	|O
an	|O
A	|O
within	|O
the	|O
sequence	|O
5'	|O
-	|O
TAAAG	|O
,	|O
41	|O
nt	|O
downstream	|O
from	|O
the	|O
early	|O
promoter	|O
and	|O
17	|O
nt	|O
upstream	|O
from	|O
the	|O
initiation	|O
codon	|O
.	|O

On	|O
T2	|O
weighted	|O
images	|O
,	|O
low	|O
intensity	|O
areas	|O
in	|O
the	|O
thalamus	|O
,	|O
the	|O
striatum	|O
,	|O
the	|O
anterior	|O
limb	|O
of	|O
the	|O
internal	|O
capsule	|O
,	|O
the	|O
tegmentum	|O
of	|O
midbrain	|O
,	|O
high	|O
intensity	|O
areas	|O
in	|O
middle	|O
cerebellar	|O
peduncle	|O
,	|O
the	|O
posterior	|O
limb	|O
of	|O
the	|O
internal	|O
capsule	|O
,	|O
the	|O
lateral	|O
part	|O
of	|O
the	|O
cerebral	|O
peduncle	|O
,	|O
and	|O
the	|O
cerebral	|O
white	|O
matter	|O
were	|O
noted	|O
.	|O

Using	|O
the	|O
rap1t	|B-PROTEIN
alleles	|O
to	|O
generate	|O
wild	|O
-	|O
type	|O
cells	|O
differing	|O
only	|O
in	|O
telomere	|O
tract	|O
lengths	|O
,	|O
we	|O
also	|O
show	|O
that	|O
telomere	|O
position	|O
effects	|O
are	|O
highly	|O
sensitive	|O
to	|O
changes	|O
in	|O
the	|O
size	|O
(	|O
or	|O
structure	|O
)	|O
of	|O
the	|O
telomeric	|O
tract	|O
.	|O

Pronounced	|O
microangiopathy	|O
characterized	|O
by	|O
avascular	|O
fields	|O
,	|O
enlarged	|O
and	|O
tortuous	|O
capillaries	|O
and	|O
increased	|O
transcapillary	|O
diffusion	|O
of	|O
sodium	|O
fluorescein	|O
,	|O
was	|O
clearly	|O
demonstrable	|O
in	|O
the	|O
area	|O
of	|O
the	|O
nodules	|O
.	|O

Epigenetic	|O
switching	|O
of	|O
transcriptional	|O
states	|O
:	|O
cis	|O
-	|O
and	|O
trans	|O
-	|O
acting	|O
factors	|O
affecting	|O
establishment	|O
of	|O
silencing	|O
at	|O
the	|O
HMR	|B-PROTEIN
locus	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
p65	|O
,	|O
p50	|B-PROTEIN
,	|O
and	|O
Rel	|B-PROTEIN
functionally	|O
synergize	|O
with	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
,	|O
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
delta	|I-PROTEIN
.	|O

It	|O
could	|O
be	|O
detected	|O
exclusively	|O
in	|O
the	|O
culture	|O
medium	|O
of	|O
cDNA	|O
-	|O
transfected	|O
COS	|O
cells	|O
.	|O

The	|O
first	|O
group	|O
of	|O
sequential	|O
BMB	|O
showed	|O
a	|O
significant	|O
progress	|O
to	|O
myelofibrosis	|O
in	|O
so	|O
-	|O
called	|O
"	|O
Chronic	|O
Megakaryocytic	|O
-	|O
Granulocytic	|O
Myelosis	|O
"	|O
-	|O
-	|O
CMGM	|O
-	|O
,	|O
which	|O
corresponds	|O
to	|O
Agnogenic	|O
Myeloid	|O
Metaplasia	|O
-	|O
AMM	|O
-	|O
in	|O
72.4%	|O
(	|O
21/29	|O
patients	|O
)	|O
,	|O
as	|O
well	|O
as	|O
in	|O
CML	|O
with	|O
megakaryocytic	|O
increase	|O
-	|O
CML.M	|O
I	|O
-	|O
in	|O
39.2%	|O
(	|O
20/51	|O
)	|O
.	|O

The	|O
two	|O
methods	|O
identify	|O
the	|O
same	|O
patients	|O
only	|O
if	|O
micturitional	|O
pressures	|O
are	|O
normal	|O
(	|O
40	|O
to	|O
60	|O
cmH2O	|O
)	|O
to	|O
high	|O
(	|O
over	|O
60	|O
cmH2O	|O
)	|O
and	|O
the	|O
Sussett	|O
formula	|O
is	|O
used	|O
with	|O
a	|O
higher	|O
(	|O
95th	|O
centile	|O
)	|O
cutoff	|O
.	|O

There	|O
was	|O
no	|O
clear	|O
correlation	|O
between	|O
the	|O
MFA	|O
and	|O
the	|O
severity	|O
of	|O
the	|O
UTS	|O
phenotype	|O
.	|O

Chicken	|O
sterol	|B-PROTEIN
carrier	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
/	|O
sterol	|B-PROTEIN
carrier	|I-PROTEIN
protein	|I-PROTEIN
x	|I-PROTEIN
:	|O
cDNA	|O
cloning	|O
reveals	|O
evolutionary	|O
conservation	|O
of	|O
structure	|O
and	|O
regulated	|O
expression	|O
.	|O

The	|O
plasmatic	|O
albumin	|B-PROTEIN
concentration	|O
(	|O
3.5-4.5	|O
g	|O
/	|O
dl	|O
)	|O
represents	|O
about	|O
60%	|O
of	|O
the	|O
total	|O
plasma	|O
protein	|O
.	|O

These	|O
lesions	|O
were	|O
asymptomatic	|O
,	|O
but	|O
both	|O
were	|O
characterized	|O
clinically	|O
by	|O
central	|O
ulceration	|O
.	|O

A	|O
single	|O
five	|O
minute	|O
period	|O
of	|O
rapid	|O
atrial	|O
pacing	|O
fails	|O
to	|O
limit	|O
infarct	|O
size	|O
in	|O
the	|O
in	|O
situ	|O
rabbit	|O
heart	|O
.	|O

Neither	|O
RD19	|B-PROTEIN
nor	|O
RD21	|B-PROTEIN
mRNA	|O
synthesis	|O
was	|O
responsive	|O
to	|O
cold	|O
or	|O
to	|O
heat	|O
stress	|O
.	|O

Previous	|O
studies	|O
indicated	|O
that	|O
the	|O
20S	|B-PROTEIN
proteasome	|O
is	|O
a	|O
catalytic	|O
core	|O
of	|O
the	|O
26S	|B-PROTEIN
proteolytic	|O
complex	|O
that	|O
possesses	|O
a	|O
latent	|O
multicatalytic	|O
proteinase	|O
activity	|O
and	|O
catalyzes	|O
an	|O
ATP	|O
-	|O
dependent	|O
,	|O
selective	|O
breakdown	|O
of	|O
proteins	|O
ligated	|O
to	|O
ubiquitin	|B-PROTEIN
.	|O

The	|O
O2	|O
deficit	|O
was	|O
not	|O
related	|O
to	|O
blood	|O
lactate	|O
during	|O
submaximal	|O
exercise	|O
,	|O
muscle	|O
enzyme	|O
activity	|O
(	|O
citrate	|B-PROTEIN
synthase	|I-PROTEIN
,	|O
3	|B-PROTEIN
-	|I-PROTEIN
hydroxyacyl	|I-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
-	|I-PROTEIN
dehydrogenase	|I-PROTEIN
,	|O
lactate	|B-PROTEIN
dehydrogenase	|I-PROTEIN
)	|O
,	|O
number	|O
of	|O
muscle	|O
capillaries	|O
,	|O
%	|O
ST	|O
fibres	|O
or	|O
muscle	|O
buffer	|O
capacity	|O
.	|O

The	|O
sequence	|O
of	|O
the	|O
putative	|O
RBP1	|B-PROTEIN
protein	|O
contains	|O
two	|O
copies	|O
of	|O
an	|O
RNA	|O
recognition	|O
motif	|O
,	|O
two	|O
glutamine	|O
stretches	|O
,	|O
an	|O
asparagine	|O
-	|O
rich	|O
region	|O
,	|O
a	|O
methionine	|O
-	|O
rich	|O
region	|O
,	|O
and	|O
two	|O
long	|O
potential	|O
alpha	|O
-	|O
helixes	|O
.	|O

One	|O
defective	|O
RNA	|O
with	|O
a	|O
large	|O
deletion	|O
in	|O
the	|O
p70	|B-PROTEIN
coding	|O
region	|O
was	|O
able	|O
to	|O
replicate	|O
efficiently	|O
,	|O
both	|O
when	|O
inoculated	|O
with	|O
the	|O
helper	|O
genome	|O
and	|O
when	|O
inoculated	|O
with	|O
a	|O
second	|O
complementing	|O
defective	|O
RNA	|O
that	|O
supplied	|O
a	|O
wild	|O
-	|O
type	|O
p70	|B-PROTEIN
.	|O

Release	|O
of	|O
this	|O
selective	|O
pressure	|O
,	|O
however	|O
,	|O
gave	|O
way	|O
to	|O
homologous	|O
resolution	|O
of	|O
the	|O
cointegrate	|O
structures	|O
.	|O

Complete	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
bacteriophage	|O
K1F	|O
tail	|B-PROTEIN
gene	|O
encoding	|O
endo	|B-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
acylneuraminidase	|I-PROTEIN
(	|O
endo	|B-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
)	|O
and	|O
comparison	|O
to	|O
an	|O
endo	|B-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
homolog	|O
in	|O
bacteriophage	|O
PK1E	|O
.	|O

Binding	|O
of	|O
U2	|B-PROTEIN
small	|O
nuclear	|O
ribonucleoprotein	|O
was	|O
partially	|O
inhibited	|O
.	|O

Morphometrical	|O
quantification	|O
of	|O
brain	|O
edema	|O
related	|O
to	|O
experimental	|O
multiple	|O
micro	|O
-	|O
infarcts	|O
in	|O
mice	|O
:	|O
assessment	|O
of	|O
neurotropin	|B-PROTEIN
effect	|O
.	|O

One	|O
member	|O
of	|O
this	|O
multigene	|O
family	|O
,	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
is	|O
most	|O
abundantly	|O
expressed	|O
in	|O
T	|O
lymphocytes	|O
,	|O
a	|O
cellular	|O
target	|O
for	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
infection	|O
and	|O
replication	|O
.	|O

Indeed	|O
,	|O
significant	|O
level	|O
of	|O
CAT	|B-PROTEIN
activity	|O
was	|O
observed	|O
in	|O
human	|O
lung	|O
adenocarcinoma	|O
(	|O
A549	|O
-	|O
1	|O
)	|O
cells	|O
which	|O
had	|O
been	|O
incubated	|O
with	|O
a	|O
complex	|O
of	|O
T7	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
,	|O
pT7	|B-PROTEIN
-	|I-PROTEIN
EMC	|I-PROTEIN
-	|I-PROTEIN
CAT	|I-PROTEIN
DNA	|O
and	|O
DC	|O
-	|O
chol	|O
cationic	|O
liposomes	|O
.	|O

Pneumoscrotum	|O
is	|O
a	|O
rare	|O
condition	|O
that	|O
receives	|O
little	|O
discussion	|O
in	|O
standard	|O
texts	|O
of	|O
urology	|O
.	|O

The	|O
first	|O
gene	|O
codes	|O
for	|O
a	|O
protein	|O
containing	|O
11	|O
cystein	|O
residues	|O
in	|O
an	|O
arrangement	|O
typical	|O
for	|O
Fe	|B-PROTEIN
/	|I-PROTEIN
S	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

Triton	|O
-	|O
disrupted	|O
cells	|O
retained	|O
capacity	|O
for	|O
activation	|O
of	|O
the	|O
pathway	|O
by	|O
both	|O
peptide	|O
growth	|O
factors	|O
and	|O
by	|O
addition	|O
of	|O
GTP	|O
-	|O
loaded	|O
p21	|B-PROTEIN
rasVal12	|O
.	|O

To	|O
begin	|O
to	|O
examine	|O
the	|O
mechanism	|O
controlling	|O
expression	|O
of	|O
this	|O
gene	|O
during	|O
the	|O
cell	|O
-	|O
cycle	|O
,	|O
a	|O
mouse	|O
B	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
5'	|O
flanking	|O
sequence	|O
was	|O
isolated	|O
from	|O
a	|O
cosmid	|O
library	|O
and	|O
shown	|O
to	|O
promote	|O
efficiently	|O
the	|O
transcription	|O
of	|O
a	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
when	|O
transfected	|O
into	|O
NIH3T3	|O
fibroblasts	|O
.	|O

The	|O
influence	|O
of	|O
a	|O
high	|O
ionic	|O
strength	|O
on	|O
the	|O
resolution	|O
was	|O
clearly	|O
shown	|O
.	|O

The	|O
number	|O
of	|O
bacteria	|O
in	|O
the	|O
lung	|O
,	|O
peripheral	|O
white	|O
blood	|O
cell	|O
and	|O
BAL	|O
fluid	|O
cell	|O
also	|O
decreased	|O
by	|O
the	|O
administration	|O
of	|O
FN	|B-PROTEIN
.	|O

In	|O
mice	|O
,	|O
three	|O
major	|O
families	|O
of	|O
L1	|O
elements	|O
,	|O
termed	|O
"	|O
A	|O
,	|O
"	|O
"	|O
F	|O
,	|O
"	|O
and	|O
"	|O
V	|O
,	|O
"	|O
have	|O
been	|O
defined	|O
on	|O
the	|O
basis	|O
of	|O
the	|O
sequence	|O
found	|O
at	|O
the	|O
5'	|O
terminus	|O
.	|O

TFEC	|B-PROTEIN
,	|O
a	|O
basic	|B-PROTEIN
helix	|I-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
protein	|I-PROTEIN
,	|O
forms	|O
heterodimers	|O
with	|O
TFE3	|B-PROTEIN
and	|O
inhibits	|O
TFE3	|B-PROTEIN
-	|O
dependent	|O
transcription	|O
activation	|O
.	|O

The	|O
equivalent	|O
of	|O
the	|O
third	|O
ligand	|O
,	|O
H	|O
-	|O
87	|O
,	|O
is	|O
T	|O
-	|O
47	|O
in	|O
the	|O
PSTAIRE	|O
sequence	|O
motif	|O
.	|O

Similar	|O
results	|O
were	|O
seen	|O
on	|O
Western	|O
blots	|O
of	|O
Autographa	|O
californica	|O
MNPV	|O
(	|O
AcMNPV	|O
)	|O
-	|O
infected	|O
Spodoptera	|O
frugiperda	|O
cells	|O
.	|O

In	|O
infected	|O
mammalian	|O
cells	|O
,	|O
the	|O
ARV	|B-PROTEIN
G	|B-PROTEIN
and	|O
GNS	|B-PROTEIN
genes	|O
are	|O
transcribed	|O
primarily	|O
as	|O
a	|O
polycistronic	|O
mRNA	|O
which	|O
appears	|O
to	|O
extend	|O
from	|O
the	|O
consensus	|O
sequence	|O
(	|O
AACAG	|O
)	|O
at	|O
the	|O
start	|O
of	|O
the	|O
G	|B-PROTEIN
gene	|O
to	|O
the	|O
next	|O
recognized	|O
polyadenylation	|O
signal	|O
(	|O
CATG	|O
[	|O
A	|O
]	|O
7	|O
)	|O
located	|O
697	|O
nucleotides	|O
downstream	|O
of	|O
the	|O
GNS	|B-PROTEIN
protein	|O
termination	|O
codon	|O
.	|O

Molecular	|O
cloning	|O
and	|O
expression	|O
of	|O
RPE65	|B-PROTEIN
,	|O
a	|O
novel	|O
retinal	|O
pigment	|O
epithelium	|O
-	|O
specific	|O
microsomal	|O
protein	|O
that	|O
is	|O
post	|O
-	|O
transcriptionally	|O
regulated	|O
in	|O
vitro	|O
.	|O

The	|O
mean	|O
power	|O
(	|O
in	|O
mu	|O
W	|O
)	|O
required	|O
to	|O
produce	|O
the	|O
observed	|O
flow	|O
rate	|O
was	|O
estimated	|O
at	|O
each	|O
outflow	|O
pressure	|O
as	|O
the	|O
product	|O
of	|O
the	|O
flow	|O
rate	|O
and	|O
the	|O
pressure	|O
across	|O
the	|O
lymphatic	|O
vessel	|O
.	|O

Although	|O
antisperm	|O
antibodies	|O
are	|O
associated	|O
with	|O
infertility	|O
,	|O
many	|O
hospital	|O
laboratories	|O
do	|O
not	|O
test	|O
for	|O
these	|O
antibodies	|O
.	|O

PPD	|B-PROTEIN
-	|O
specific	|O
IgG	|B-PROTEIN
subclass	|O
responses	|O
were	|O
evident	|O
to	|O
all	|O
four	|O
IgG	|B-PROTEIN
subclasses	|O
.	|O

Anterior	|O
body	|O
pattern	|O
in	|O
Drosophila	|O
is	|O
specified	|O
by	|O
the	|O
graded	|O
distribution	|O
of	|O
the	|O
bicoid	|B-PROTEIN
protein	|O
(	|O
bcd	|B-PROTEIN
)	|O
,	|O
which	|O
activates	|O
subordinate	|O
genes	|O
in	|O
distinct	|O
anterior	|O
domains	|O
.	|O

GAP	|B-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
bound	|O
constitutively	|O
to	|O
p190	|B-PROTEIN
in	|O
both	|O
serum	|O
-	|O
deprived	|O
and	|O
growth	|O
factor	|O
-	|O
stimulated	|O
cells	|O
.	|O

The	|O
peptide	|O
sequence	|O
contains	|O
a	|O
region	|O
of	|O
80	|O
amino	|O
acids	|O
that	|O
shows	|O
similarity	|O
to	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
to	|O
the	|O
recently	|O
described	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
related	|O
gene	|O
,	|O
MCL1	|B-PROTEIN
.	|O

The	|O
phosphorylation	|O
efficiency	|O
is	|O
improved	|O
by	|O
increasing	|O
the	|O
number	|O
of	|O
N	|O
-	|O
terminal	|O
arginine	|O
residues	|O
and	|O
by	|O
moving	|O
the	|O
arginyl	|O
cluster	|O
one	|O
residue	|O
further	|O
away	|O
from	|O
the	|O
serine	|O
,	|O
the	|O
nonapeptide	|O
(	|O
Arg	|O
)	|O
4	|O
-	|O
Ala	|O
-	|O
Ala	|O
-	|O
Ser	|O
-	|O
Val	|O
-	|O
Ala	|O
being	|O
the	|O
best	|O
substrate	|O
among	|O
all	|O
the	|O
short	|O
peptides	|O
tested	|O
(	|O
Km	|O
=	|O
15	|O
microM	|O
)	|O
.	|O

Botulinum	|B-PROTEIN
toxin	|I-PROTEIN
:	|O
preferred	|O
treatment	|O
for	|O
hemifacial	|O
spasm	|O
.	|O

The	|O
Saccharomyces	|O
cerevisiae	|O
GAL1	|B-PROTEIN
and	|O
GAL10	|B-PROTEIN
genes	|O
are	|O
controlled	|O
in	|O
response	|O
to	|O
the	|O
availability	|O
of	|O
galactose	|O
and	|O
glucose	|O
by	|O
multiple	|O
activating	|O
and	|O
repressing	|O
proteins	|O
bound	|O
at	|O
adjacent	|O
or	|O
overlapping	|O
sites	|O
in	|O
UASG	|O
.	|O

Surprisingly	|O
,	|O
the	|O
results	|O
of	|O
several	|O
experiments	|O
suggest	|O
that	|O
the	|O
TSF	|B-PROTEIN
genes	|O
encode	|O
global	|O
regulatory	|O
factors	|O
.	|O
tsf1	|B-PROTEIN
to	|O
tsf6	|B-PROTEIN
mutations	|O
derepressed	|O
expression	|O
from	|O
yeast	|O
CYC	|B-PROTEIN
-	|O
GAL	|B-PROTEIN
hybrid	|O
promoters	|O
(	|O
fused	|O
to	|O
lacZ	|B-PROTEIN
)	|O
that	|O
harbor	|O
a	|O
variety	|O
of	|O
operator	|O
sequences	|O
,	|O
and	|O
caused	|O
pleiotropic	|O
defects	|O
in	|O
cell	|O
growth	|O
,	|O
mating	|O
,	|O
and	|O
sporulation	|O
.	|O

Sex	|O
of	|O
calf	|O
(	|O
variate	|O
2	|O
)	|O
was	|O
associated	|O
most	|O
closely	|O
with	|O
width	|O
of	|O
muzzle	|O
and	|O
head	|O
.	|O

Sequence	|O
comparison	|O
indicates	|O
that	|O
exons	|O
5'	|O
/	|O
L	|O
and	|O
L	|O
/	|O
N	|O
in	|O
PSG12	|B-PROTEIN
and	|O
PSG12	|B-PROTEIN
psi	|I-PROTEIN
are	|O
99%	|O
identical	|O
,	|O
except	|O
that	|O
the	|O
L	|O
/	|O
N	|O
exon	|O
in	|O
the	|O
PSG12	|B-PROTEIN
psi	|I-PROTEIN
gene	|O
contains	|O
a	|O
stop	|O
codon	|O
.	|O

The	|O
mechanisms	|O
that	|O
govern	|O
the	|O
activation	|O
or	|O
suppression	|O
of	|O
the	|O
CD8	|B-PROTEIN
gene	|O
are	|O
likely	|O
to	|O
be	|O
central	|O
to	|O
the	|O
T	|O
cell	|O
development	|O
program	|O
.	|O

We	|O
suggest	|O
that	|O
the	|O
ER	|O
lumenal	|O
variable	|O
domain	|O
of	|O
gp19K	|B-PROTEIN
has	|O
a	|O
specific	|O
tertiary	|O
structure	|O
that	|O
is	|O
important	|O
for	|O
binding	|O
to	|O
the	|O
polymorphic	|O
alpha	|O
1	|O
and	|O
alpha	|O
2	|O
domains	|O
of	|O
class	|B-PROTEIN
I	|I-PROTEIN
heavy	|I-PROTEIN
(	|I-PROTEIN
alpha	|I-PROTEIN
)	|I-PROTEIN
chains	|O
.	|O

We	|O
recently	|O
found	|O
that	|O
17	|O
beta	|O
-	|O
estradiol	|O
(	|O
E2	|O
)	|O
not	|O
only	|O
suppresses	|O
bone	|O
resorption	|O
but	|O
also	|O
stimulates	|O
bone	|O
formation	|O
in	|O
the	|O
cancellous	|O
bone	|O
of	|O
female	|O
rats	|O
.	|O

Recombinant	|O
human	|O
erythropoietin	|B-PROTEIN
(	|O
epoetin	|B-PROTEIN
)	|O
is	|O
approved	|O
to	|O
be	|O
administered	|O
by	|O
the	|O
intravenous	|O
(	|O
i.v	|O
.	|O
)	|O
or	|O
subcutaneous	|O
(	|O
SC	|O
)	|O
route	|O
.	|O

Single	|O
-	|O
photon	|O
emission	|O
computed	|O
tomography	|O
(	|O
SPECT	|O
)	|O
with	|O
99mTc	|O
-	|O
hexamethylpropyleneamine	|O
oxime	|O
(	|O
HMPAO	|O
)	|O
was	|O
used	|O
to	|O
investigate	|O
changes	|O
in	|O
cerebral	|O
blood	|O
flow	|O
in	|O
seven	|O
patients	|O
with	|O
cortical	|O
visual	|O
impairment	|O
.	|O

The	|O
rCBF	|O
ratio	|O
was	|O
mainly	|O
reduced	|O
in	|O
frontal	|O
lobes	|O
(	|O
65%	|O
)	|O
.	|O

METHODS	|O
:	|O
Twenty	|O
-	|O
two	|O
patients	|O
were	|O
grouped	|O
according	|O
to	|O
their	|O
etiology	|O
based	|O
on	|O
the	|O
study	|O
of	|O
antiadrenal	|O
antibodies	|O
at	|O
diagnosis	|O
of	|O
the	|O
disease	|O
:	|O
7	|O
were	|O
positive	|O
(	|O
autoimmune	|O
etiology	|O
or	|O
EAA	|O
)	|O
,	|O
11	|O
were	|O
negative	|O
(	|O
tuberculous	|O
etiology	|O
or	|O
EAT	|O
)	|O
and	|O
in	|O
four	|O
serologic	|O
study	|O
was	|O
not	|O
available	|O
(	|O
undetermined	|O
etiology	|O
or	|O
EAI	|O
)	|O
.	|O

2	|O
-	|O
AP	|O
induced	|O
marked	|O
,	|O
steady	|O
rises	|O
in	|O
mRNA	|O
accumulation	|O
from	|O
both	|O
transfected	|O
and	|O
chromosomally	|O
integrated	|O
HIV	|O
-	|O
1	|O
constructs	|O
but	|O
no	|O
increases	|O
from	|O
an	|O
endogenous	|O
gene	|O
encoding	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
or	|O
glucose	|B-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
dehydrogenase	|I-PROTEIN
.	|O

The	|O
UV	|O
induction	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
is	|O
mediated	|O
by	|O
two	|O
UV	|O
response	|O
elements	|O
consisting	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
like	|O
sequences	|O
within	|O
its	|O
5'	|O
control	|O
region	|O
.	|O

Protein	|O
tyrosine	|B-PROTEIN
phosphatases	|I-PROTEIN
(	|O
PTPs	|B-PROTEIN
)	|O
,	|O
together	|O
with	|O
protein	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
(	|O
PTKs	|B-PROTEIN
)	|O
,	|O
are	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
cell	|O
activation	|O
,	|O
growth	|O
,	|O
and	|O
differentiation	|O
.	|O

ST	|O
elevation	|O
occurs	|O
in	|O
5	|O
patients	|O
(	|O
55.5%	|O
)	|O
of	|O
subgroup	|O
A	|O
and	|O
in	|O
no	|O
patient	|O
of	|O
the	|O
subgroup	|O
B.	|O

Furthermore	|O
,	|O
a	|O
p21X	|B-PROTEIN
protein	|O
lacking	|O
the	|O
N	|O
-	|O
terminus	|O
of	|O
Rex1	|B-PROTEIN
was	|O
expressed	|O
at	|O
high	|O
levels	|O
;	|O
our	|O
data	|O
indicate	|O
that	|O
p21X	|B-PROTEIN
is	|O
translated	|O
from	|O
the	|O
1.6	|O
-	|O
kb	|O
mRNA	|O
which	|O
is	|O
derived	|O
primarily	|O
from	|O
deleted	|O
proviruses	|O
.	|O

HTLV	|O
-	|O
1	|O
gene	|O
expression	|O
by	|O
defective	|O
proviruses	|O
in	|O
an	|O
infected	|O
T	|O
-	|O
cell	|O
line	|O
.	|O

Thus	|O
,	|O
it	|O
was	|O
confirmed	|O
that	|O
the	|O
sodium	|O
lauryl	|O
sulfate	|O
method	|O
of	|O
estimating	|O
hemoglobin	|B-PROTEIN
concentration	|O
is	|O
an	|O
appropriate	|O
alternative	|O
to	|O
the	|O
cyanmethemoglobin	|B-PROTEIN
method	|O
and	|O
avoids	|O
the	|O
generation	|O
of	|O
toxic	|O
wastes	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
predicted	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
two	|O
human	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
delta	|I-PROTEIN
clones	|O
with	|O
the	|O
rat	|O
and	|O
mouse	|O
homologues	|O
indicated	|O
a	|O
greater	|O
degree	|O
of	|O
sequence	|O
divergence	|O
(	|O
89-90%	|O
homology	|O
)	|O
compared	|O
to	|O
the	|O
high	|O
degree	|O
of	|O
sequence	|O
conservation	|O
observed	|O
with	|O
other	|O
human	|O
PKC	|B-PROTEIN
family	|O
members	|O
and	|O
their	|O
mammalian	|O
counterparts	|O
.	|O

XII	|O
.	|O

When	|O
comparing	|O
the	|O
barley	|O
PSI	|B-PROTEIN
-	|I-PROTEIN
K	|I-PROTEIN
and	|O
PSI	|B-PROTEIN
-	|I-PROTEIN
G	|I-PROTEIN
with	|O
the	|O
reported	|O
PSI	|B-PROTEIN
-	|I-PROTEIN
K	|I-PROTEIN
sequence	|O
from	|O
Synechococcus	|O
vulcanus	|O
,	|O
the	|O
degree	|O
of	|O
similarity	|O
is	|O
equal	|O
,	|O
suggesting	|O
that	|O
an	|O
ancestral	|O
gene	|O
has	|O
been	|O
duplicated	|O
in	|O
a	|O
chloroplast	|O
progenitor	|O
but	|O
not	|O
in	|O
a	|O
cyanobacterial	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
the	|O
structures	|O
of	|O
the	|O
b	|O
-	|O
Zip	|O
domain	|O
are	|O
well	|O
conserved	|O
among	|O
these	|O
Maf	|B-PROTEIN
-	|O
related	|O
proteins	|O
.	|O

Under	|O
these	|O
conditions	|O
,	|O
transfections	|O
with	|O
cDNAs	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
p50	|O
and	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
(	|O
SRF	|B-PROTEIN
)	|O
produced	|O
a	|O
factor	|O
(	|O
s	|O
)	|O
that	|O
mediated	|O
Tax	|B-PROTEIN
binding	|O
to	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
site	|O
and	|O
the	|O
CArG	|O
box	|O
respectively	|O
.	|O

We	|O
show	|O
here	|O
that	|O
v	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
specifically	|O
increased	|O
expression	|O
from	|O
a	|O
reporter	|O
plasmid	|O
containing	|O
multiple	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
approximately	|O
sixfold	|O
in	|O
chicken	|O
embryo	|O
fibroblasts	|O
(	|O
CEFs	|O
)	|O
,	|O
even	|O
though	|O
v	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
did	|O
not	|O
bind	|O
directly	|O
to	|O
these	|O
sites	|O
.	|O
v	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
also	|O
increased	|O
expression	|O
from	|O
a	|O
reporter	|O
plasmid	|O
containing	|O
a	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|B-PROTEIN
HIV	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|I-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeat	|I-PROTEIN
(	|O
LTR	|O
)	|O
in	|O
which	|O
the	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
binding	|O
sites	|O
were	|O
mutated	|O
but	|O
which	|O
still	|O
contained	|O
intact	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
.	|O

The	|O
simultaneous	|O
recording	|O
of	|O
electrical	|O
activity	|O
from	|O
the	|O
surface	|O
electrocardiogram	|O
,	|O
right	|O
ventricular	|O
apex	|O
,	|O
His	|O
bundle	|O
,	|O
high	|O
right	|O
atrium	|O
,	|O
coronary	|O
sinus	|O
,	|O
with	|O
or	|O
without	|O
a	|O
roving	|O
mapping	|O
catheter	|O
,	|O
enables	|O
us	|O
to	|O
precisely	|O
map	|O
the	|O
electrical	|O
activation	|O
sequence	|O
in	|O
the	|O
heart	|O
.	|O

CONCLUSION	|O
:	|O
This	|O
retrospective	|O
analysis	|O
does	|O
not	|O
confirm	|O
the	|O
efficacy	|O
of	|O
one	|O
course	|O
of	|O
simultaneous	|O
Mitomycin	|O
-	|O
C	|O
and	|O
5	|O
-	|O
fluorouracil	|O
,	|O
at	|O
least	|O
in	|O
association	|O
with	|O
full	|O
-	|O
dose	|O
radiotherapy	|O
incorporating	|O
Iridium	|O
-	|O
192	|O
boost	|O
.	|O

Despite	|O
the	|O
existence	|O
of	|O
30	|O
cysteine	|O
residues	|O
,	|O
carboxymethylation	|O
prevented	|O
the	|O
formation	|O
of	|O
most	|O
if	|O
not	|O
all	|O
disulfide	|O
bonds	|O
that	|O
otherwise	|O
occurred	|O
when	|O
the	|O
cells	|O
were	|O
sonicated	|O
.	|O

Cerebro	|O
-	|O
oculo	|O
-	|O
facioskeletal	|O
syndrome	|O
(	|O
Pena	|O
-	|O
Shokeir	|O
syndrome	|O
II	|O
)	|O

Most	|O
importantly	|O
,	|O
the	|O
addition	|O
of	|O
purified	|O
17S	|O
U2	|B-PROTEIN
snRNPs	|I-PROTEIN
,	|O
but	|O
not	|O
of	|O
12S	|O
U2	|B-PROTEIN
snRNPs	|I-PROTEIN
,	|O
to	|O
HeLa	|O
splicing	|O
extracts	|O
in	|O
which	|O
the	|O
endogeneous	|O
U2	|B-PROTEIN
snRNPs	|I-PROTEIN
have	|O
been	|O
functionally	|O
neutralized	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
PRP9	|I-PROTEIN
antibodies	|O
fully	|O
restores	|O
the	|O
mRNA	|O
-	|O
splicing	|O
activity	|O
of	|O
the	|O
extracts	|O
.	|O

Differences	|O
in	|O
profiles	|O
of	|O
viscosity	|O
variables	|O
between	|O
subgroups	|O
of	|O
EAD	|O
in	|O
RA	|O
patients	|O
were	|O
observed	|O
.	|O

These	|O
contain	|O
a	|O
single	|O
1977	|O
-	|O
bp	|O
exon	|O
that	|O
encodes	|O
900	|O
bp	|O
of	|O
the	|O
5'	|O
and	|O
3'	|O
untranslated	|O
sequences	|O
in	|O
addition	|O
to	|O
a	|O
1077	|O
-	|O
bp	|O
open	|O
reading	|O
frame	|O
identical	|O
to	|O
that	|O
found	|O
in	|O
vascular	|O
smooth	|O
muscle	|O
cell	|O
AT1a	|B-PROTEIN
receptor	|I-PROTEIN
cDNAs	|O
.	|O

Deletion	|O
of	|O
a	|O
53	|O
-	|O
bp	|O
early	|O
promoter	|O
region	|O
containing	|O
the	|O
transcription	|O
start	|O
site	|O
and	|O
a	|O
putative	|O
TATA	|O
box	|O
completely	|O
abolishes	|O
the	|O
ability	|O
of	|O
upstream	|O
elements	|O
to	|O
drive	|O
transcription	|O
of	|O
the	|O
luciferase	|B-PROTEIN
cDNA	|O
.	|O

One	|O
chimpanzee	|O
reliably	|O
selected	|O
the	|O
larger	|O
numeral	|O
4	|O
during	|O
testing	|O
with	|O
a	|O
nonadjacent	|O
pair	|O
(	|O
2-4	|O
)	|O
,	|O
and	|O
2	|O
chimps	|O
showed	|O
no	|O
preference	|O
.	|O

Dissipation	|O
of	|O
claudication	|O
pain	|O
after	|O
walking	|O
:	|O
implications	|O
for	|O
endurance	|O
training	|O
.	|O

Alternative	|O
transcript	|O
of	|O
the	|O
nonselective	|O
-	|O
type	|O
endothelin	|B-PROTEIN
receptor	|I-PROTEIN
from	|O
rat	|O
brain	|O
.	|O

The	|O
Functional	|O
Independence	|O
Measure	|O
:	|O
a	|O
comparative	|O
study	|O
of	|O
clinician	|O
and	|O
self	|O
ratings	|O
.	|O

Polymyxin	|O
B	|O
was	|O
given	|O
intravenously	|O
for	|O
1	|O
week	|O
postburn	|O
in	|O
doses	|O
designed	|O
to	|O
neutralize	|O
circulating	|O
endotoxemia	|O
.	|O

SvO2	|O
can	|O
be	|O
determined	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

The	|O
transverse	|O
relaxation	|O
time	|O
(	|O
T2	|O
)	|O
and	|O
apparent	|O
diffusion	|O
coefficient	|O
of	|O
water	|O
were	|O
determined	|O
.	|O

The	|O
Drosophila	|O
clathrin	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
gene	|O
:	|O
clathrin	|B-PROTEIN
function	|O
is	|O
essential	|O
in	|O
a	|O
multicellular	|O
organism	|O
.	|O

The	|O
binding	|O
specificity	|O
of	|O
this	|O
protein	|O
was	|O
compared	|O
to	|O
that	|O
of	|O
human	|O
E2F	|B-PROTEIN
using	|O
a	|O
number	|O
of	|O
mutant	|O
E2F	|B-PROTEIN
sites	|O
as	|O
competitors	|O
.	|O

To	|O
analyze	|O
the	|O
VH	|O
regions	|O
of	|O
polyreactive	|O
antibodies	|O
,	|O
with	|O
particular	|O
attention	|O
at	|O
their	|O
somatically	|O
mutated	|O
status	|O
,	|O
we	|O
generated	|O
five	|O
IgG	|B-PROTEIN
(	|O
three	|O
IgG1	|B-PROTEIN
and	|O
two	|O
IgG3	|B-PROTEIN
)	|O
mAb	|O
(	|O
using	|O
B	|O
cells	|O
from	|O
a	|O
healthy	|O
subject	|O
,	|O
a	|O
patient	|O
with	|O
insulin	|B-PROTEIN
-	|O
dependent	|O
diabetes	|O
mellitus	|O
and	|O
a	|O
patient	|O
with	|O
SLE	|O
)	|O
,	|O
which	|O
bound	|O
with	|O
various	|O
efficiencies	|O
a	|O
number	|O
of	|O
different	|O
self	|O
and	|O
foreign	|O
Ag	|O
.	|O

It	|O
is	|O
possible	|O
that	|O
the	|O
patch	|O
determines	|O
the	|O
proper	|O
conformation	|O
of	|O
the	|O
site	|O
and	|O
thereby	|O
contributes	|O
to	|O
recognition	|O
indirectly	|O
.	|O

These	|O
findings	|O
suggest	|O
a	|O
functional	|O
cross	|O
-	|O
talk	|O
between	|O
RB	|B-PROTEIN
protein	|O
and	|O
p21ras	|B-PROTEIN
,	|O
which	|O
balances	|O
the	|O
cell	|O
phenotype	|O
between	|O
normal	|O
and	|O
transformed	|O
states	|O
.	|O

The	|O
7	|O
-	|O
kb	|O
mRNA	|O
differs	|O
by	|O
alternative	|O
splicing	|O
such	|O
that	|O
it	|O
encodes	|O
a	|O
protein	|O
with	|O
a	|O
distinct	|O
amino	|O
terminus	|O
.	|O

Kinetics	|O
of	|O
the	|O
inhibition	|O
indicated	|O
that	|O
this	|O
polymerase	|O
domain	|O
can	|O
inhibit	|O
viral	|O
replication	|O
only	|O
during	|O
the	|O
preinitiation	|O
stage	|O
.	|O

The	|O
other	|O
transmembrane	|O
regions	|O
as	|O
well	|O
as	|O
the	|O
nucleoplasmic	|O
domain	|O
are	|O
not	|O
required	|O
for	|O
sorting	|O
.	|O

3	|O
.	|O

McCann	|O
III	|O
,	|O
F.	|O

These	|O
cell	|O
lines	|O
,	|O
selected	|O
for	|O
the	|O
ability	|O
to	|O
support	|O
the	|O
replication	|O
of	|O
a	|O
temperature	|O
-	|O
sensitive	|O
VP5	|B-PROTEIN
mutant	|O
,	|O
were	|O
used	|O
to	|O
isolate	|O
VP5	|B-PROTEIN
and	|O
VP23	|B-PROTEIN
null	|O
mutants	|O
.	|O

The	|O
E1	|B-PROTEIN
nuclear	|O
transport	|O
motif	|O
is	|O
highly	|O
conserved	|O
in	|O
the	|O
animal	|O
and	|O
human	|O
papillomaviruses	|O
and	|O
is	|O
encoded	|O
in	|O
a	|O
similar	|O
region	|O
in	|O
the	|O
related	|O
E1	|B-PROTEIN
genes	|O
.	|O

The	|O
E1	|B-PROTEIN
replication	|O
protein	|O
of	|O
bovine	|O
papillomavirus	|O
type	|O
1	|O
contains	|O
an	|O
extended	|O
nuclear	|O
localization	|O
signal	|O
that	|O
includes	|O
a	|O
p34cdc2	|B-PROTEIN
phosphorylation	|O
site	|O
.	|O

In	|O
order	|O
to	|O
investigate	|O
to	|O
what	|O
extent	|O
this	|O
interaction	|O
might	|O
contribute	|O
to	|O
tumor	|O
induction	|O
by	|O
the	|O
virus	|O
,	|O
we	|O
have	|O
introduced	|O
two	|O
different	|O
point	|O
mutations	|O
within	|O
the	|O
putative	|O
pRb	|B-PROTEIN
-	|O
binding	|O
sequence	|O
of	|O
large	|B-PROTEIN
T	|I-PROTEIN
antigen	|I-PROTEIN
,	|O
and	|O
as	|O
a	|O
preliminary	|O
to	|O
in	|O
vivo	|O
experiments	|O
we	|O
have	|O
studied	|O
their	|O
effects	|O
in	|O
vitro	|O
on	|O
some	|O
biological	|O
activities	|O
relevant	|O
to	|O
tumor	|O
induction	|O
.	|O

We	|O
conclude	|O
that	|O
the	|O
conservation	|O
of	|O
nucleotides	|O
154	|O
to	|O
156	|O
is	|O
likely	|O
to	|O
be	|O
a	|O
consequence	|O
of	|O
their	|O
role	|O
as	|O
a	|O
sequence	|O
-	|O
specific	|O
recognition	|O
element	|O
for	|O
the	|O
SRP54	|B-PROTEIN
protein	|O
.	|O

A	|O
region	|O
of	|O
the	|O
deduced	|O
protein	|O
shares	|O
extensive	|O
homology	|O
with	|O
a	|O
catalytic	|O
region	|O
of	|O
Raf	|B-PROTEIN
kinases	|I-PROTEIN
,	|O
a	|O
feature	|O
shared	|O
only	|O
with	|O
TFIIE	|B-PROTEIN
among	|O
transcription	|O
factors	|O
.	|O

The	|O
low	|O
molecular	|O
mass	|O
polypeptide	|O
complex	|O
is	|O
assumed	|O
to	|O
be	|O
involved	|O
in	|O
antigen	|O
presentation	|O
,	|O
generating	|O
peptides	|O
from	|O
cytosolic	|O
protein	|O
antigens	|O
,	|O
which	|O
are	|O
subsequently	|O
presented	|O
to	|O
cytotoxic	|O
T	|O
-	|O
lymphocytes	|O
on	|O
the	|O
cell	|O
surface	|O
.	|O

Secondary	|O
cleavage	|O
of	|O
RT	|B-PROTEIN
at	|O
Trp	|O
-	|O
595	|O
-	|O
Tyr	|O
-	|O
596	|O
of	|O
Pol	|B-PROTEIN
yields	|O
a	|O
truncated	|O
form	|O
lacking	|O
the	|O
C	|O
-	|O
terminal	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
domain	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
approximately	|O
50	|O
amino	|O
acids	|O
of	|O
Bel	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
are	|O
shown	|O
to	|O
be	|O
essential	|O
for	|O
Bel	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activity	|O
but	|O
can	|O
be	|O
effectively	|O
substituted	|O
by	|O
the	|O
C	|O
-	|O
terminal	|O
activation	|O
domain	|O
of	|O
VP16	|B-PROTEIN
.	|O

Since	|O
the	|O
-	|O
172	|O
/	|O
-	|O
148	|O
element	|O
also	|O
conferred	|O
estrogen	|O
and	|O
thyroid	|O
hormone	|O
responsiveness	|O
,	|O
it	|O
can	|O
be	|O
considered	|O
a	|O
composite	|O
hormone	|O
response	|O
element	|O
.	|O

Optimal	|O
activation	|O
of	|O
T	|O
cells	|O
requires	|O
at	|O
least	|O
two	|O
signals	|O
.	|O

Together	|O
with	|O
a	|O
considerably	|O
shortened	|O
and	|O
interrupted	|O
aromatic	|O
aa	|O
stretch	|O
in	|O
this	|O
region	|O
,	|O
these	|O
differences	|O
are	|O
discussed	|O
in	|O
terms	|O
of	|O
the	|O
peculiar	|O
affinity	|O
of	|O
cyanobacterial	|O
cytochrome	|B-PROTEIN
oxidases	|I-PROTEIN
for	|O
acidic	|O
c	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
cytochromes	|I-PROTEIN
.	|O

All	|O
four	|O
of	|O
the	|O
genes	|O
have	|O
a	|O
similar	|O
structure	|O
,	|O
with	|O
the	|O
receptor	|O
protein	|O
encoded	|O
in	|O
a	|O
single	|O
exon	|O
.	|O

Identity	|O
of	|O
GABP	|B-PROTEIN
with	|O
NRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
a	|O
multisubunit	|O
activator	|O
of	|O
cytochrome	|B-PROTEIN
oxidase	|I-PROTEIN
expression	|O
,	|O
reveals	|O
a	|O
cellular	|O
role	|O
for	|O
an	|O
ETS	|B-PROTEIN
domain	|O
activator	|O
of	|O
viral	|O
promoters	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
beta	|O
-	|O
funaltrexamine	|O
(	|O
beta	|O
-	|O
FNA	|O
)	|O
and	|O
naltrindole	|O
(	|O
NTI	|O
)	|O
(	|O
nonequilibrium	|O
mu	|O
-	|O
and	|O
delta	|O
-	|O
antagonist	|O
,	|O
respectively	|O
)	|O
were	|O
used	|O
to	|O
precipitate	|O
withdrawal	|O
in	|O
butorphanol	|O
-	|O
dependent	|O
rats	|O
.	|O

The	|O
intracellular	|O
basic	|O
region	|O
/	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
(	|O
bHLH	|O
)	|O
dioxin	|B-PROTEIN
receptor	|I-PROTEIN
mediates	|O
signal	|O
transduction	|O
by	|O
dioxin	|O
(	|O
2,3,7,8	|O
-	|O
tetrachlorodibenzo	|O
-	|O
p	|O
-	|O
dioxin	|O
)	|O
and	|O
functions	|O
as	|O
a	|O
ligand	|O
-	|O
activated	|O
DNA	|O
binding	|O
protein	|O
directly	|O
interacting	|O
with	|O
target	|O
genes	|O
by	|O
binding	|O
to	|O
dioxin	|O
response	|O
elements	|O
.	|O

The	|O
alpha	|B-PROTEIN
2A	|I-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
alpha	|B-PROTEIN
2AAR	|I-PROTEIN
)	|O
is	|O
coupled	|O
to	|O
a	|O
variety	|O
of	|O
effectors	|O
via	|O
pertussis	|B-PROTEIN
toxin	|I-PROTEIN
-	|O
sensitive	|O
GTP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

A	|O
sequence	|O
comparison	|O
reveals	|O
two	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|O
consensus	|O
sequences	|O
,	|O
basic	|O
DNA	|O
binding	|O
region	|O
and	|O
leucine	|O
zippers	|O
1	|O
and	|O
2	|O
(	|O
bZIP1	|O
and	|O
bZIP2	|O
)	|O
,	|O
within	|O
this	|O
region	|O
.	|O

One	|O
of	|O
these	|O
genes	|O
,	|O
REC114	|B-PROTEIN
,	|O
is	|O
described	|O
here	|O
,	|O
and	|O
the	|O
data	|O
confirm	|O
that	|O
REC114	|B-PROTEIN
is	|O
a	|O
meiosis	|O
-	|O
specific	|O
recombination	|O
gene	|O
with	|O
no	|O
detectable	|O
function	|O
in	|O
mitosis	|O
.	|O

The	|O
transactivation	|O
function	|O
of	|O
EBNA2	|B-PROTEIN
was	|O
also	|O
observed	|O
in	|O
the	|O
HeLa	|O
epithelial	|O
cell	|O
line	|O
,	|O
which	|O
suggests	|O
that	|O
EBV	|O
and	|O
HIV	|O
-	|O
1	|O
infection	|O
of	|O
non	|O
-	|O
B	|O
cells	|O
may	|O
result	|O
in	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|I-PROTEIN
activation	|O
.	|O

Mutation	|O
of	|O
the	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
binding	|O
sites	|O
in	|O
the	|O
Rous	|B-PROTEIN
sarcoma	|I-PROTEIN
virus	|I-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeat	|I-PROTEIN
and	|O
gag	|B-PROTEIN
enhancers	|O
.	|O

Nuclear	|O
protein	|O
phosphatase	|B-PROTEIN
2A	|I-PROTEIN
dephosphorylates	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
-	|O
phosphorylated	|O
CREB	|B-PROTEIN
and	|O
regulates	|O
CREB	|B-PROTEIN
transcriptional	|O
stimulation	|O
.	|O

We	|O
show	|O
that	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
activates	|O
JRE	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
through	|O
an	|O
H7	|O
-	|O
sensitive	|O
pathway	|O
that	|O
does	|O
not	|O
involve	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
,	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
Ca	|O
(	|O
2+	|O
)	|O
-	|O
or	|O
calmodulin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
Ras	|B-PROTEIN
,	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
or	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
)	|O
.	|O

Mutation	|O
of	|O
the	|O
presumptive	|O
phosphorylated	|O
tyrosine	|O
and	|O
threonine	|O
residues	|O
of	|O
Mpk1p	|B-PROTEIN
individually	|O
to	|O
phenylalanine	|O
and	|O
alanine	|O
,	|O
respectively	|O
,	|O
severely	|O
impaired	|O
Mpk1p	|B-PROTEIN
function	|O
.	|O

Growth	|O
factor	|O
stimulation	|O
rapidly	|O
induces	|O
a	|O
reversible	|O
change	|O
in	|O
the	|O
electrophoretic	|O
mobility	|O
of	|O
the	|O
ternary	|O
complex	|O
,	|O
accompanied	|O
by	|O
increased	|O
phosphorylation	|O
of	|O
the	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
C	|O
-	|O
terminal	|O
region	|O
and	|O
by	|O
the	|O
activation	|O
of	|O
a	|O
42	|O
kd	|O
cellular	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
kinase	|O
.	|O

In	|O
contrast	|O
to	|O
the	|O
situation	|O
in	|O
mammalian	|O
cells	|O
,	|O
prolonged	|O
exposure	|O
of	|O
the	|O
agonist	|O
(	|O
24	|O
h	|O
)	|O
does	|O
not	|O
result	|O
in	|O
down	|O
regulation	|O
of	|O
the	|O
remaining	|O
70%	|O
of	|O
the	|O
receptors	|O
.	|O

This	|O
stimulatory	|O
effect	|O
could	|O
also	|O
be	|O
elicited	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
,	|O
which	|O
interacts	|O
with	|O
topo	|B-PROTEIN
II	|I-PROTEIN
,	|O
but	|O
not	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
,	|O
which	|O
does	|O
not	|O
bind	|O
topo	|B-PROTEIN
II	|I-PROTEIN
in	|O
our	|O
in	|O
vitro	|O
assay	|O
.	|O

The	|O
regulation	|O
of	|O
Myf	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
and	|O
MyoD	|B-PROTEIN
function	|O
by	|O
a	|O
cAMP	|O
-	|O
dependent	|O
pathway	|O
may	|O
partly	|O
explain	|O
how	|O
external	|O
signals	|O
generated	|O
by	|O
serum	|O
and	|O
certain	|O
peptide	|O
growth	|O
factors	|O
can	|O
be	|O
transduced	|O
to	|O
the	|O
nucleus	|O
and	|O
inhibit	|O
dominant	|O
-	|O
acting	|O
factors	|O
that	|O
are	|O
responsible	|O
for	|O
myoblast	|O
differentiation	|O
.	|O

16	|O
,	|O
99-104	|O
)	|O
.	|O

We	|O
have	|O
previously	|O
reported	|O
that	|O
high	|O
level	|O
human	|O
desmin	|B-PROTEIN
expression	|O
depends	|O
on	|O
a	|O
280	|O
-	|O
base	|O
pair	|O
muscle	|O
-	|O
specific	|O
enhancer	|O
which	|O
can	|O
function	|O
not	|O
only	|O
in	|O
myotubes	|O
,	|O
but	|O
can	|O
also	|O
activate	|O
gene	|O
expression	|O
in	|O
myoblasts	|O
.	|O

After	|O
surgery	|O
,	|O
patients	|O
self	|O
administered	|O
one	|O
of	|O
three	|O
possible	|O
postsurgical	|O
medications	|O
,	|O
which	|O
included	|O
placebo	|O
,	|O
codeine	|O
60	|O
mg	|O
,	|O
and	|O
ibuprofen	|O
400	|O
mg	|O
,	|O
when	|O
their	|O
pain	|O
reached	|O
a	|O
moderate	|O
or	|O
severe	|O
intensity	|O
.	|O

Replacement	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
5'	|O
-	|O
regulatory	|O
region	|O
with	|O
either	|O
of	|O
the	|O
mutants	|O
'	|O
cis	|O
-	|O
acting	|O
regulatory	|O
element	|O
resulted	|O
in	|O
the	|O
anaerobic	|O
expression	|O
of	|O
active	|O
Mn	|B-PROTEIN
-	|I-PROTEIN
superoxide	|I-PROTEIN
dismutase	|I-PROTEIN
.	|O

The	|O
orf61	|B-PROTEIN
gene	|O
product	|O
,	|O
when	|O
expressed	|O
from	|O
an	|O
exogenous	|O
promoter	|O
,	|O
inhibited	|O
int	|B-PROTEIN
-	|O
mediated	|O
integration	|O
at	|O
the	|O
chromosomal	|O
attB	|B-PROTEIN
site	|O
.	|O

Expression	|O
in	|O
established	|O
LCLs	|O
,	|O
occurring	|O
irrespective	|O
of	|O
virus	|O
producer	|O
status	|O
,	|O
was	|O
not	|O
a	|O
consequence	|O
of	|O
continued	|O
in	|O
vitro	|O
passage	|O
;	|O
thus	|O
,	|O
appropriately	|O
spliced	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
transcripts	|O
could	|O
be	|O
amplified	|O
from	|O
normal	|O
B	|O
cells	|O
within	|O
1	|O
day	|O
of	|O
their	|O
experimental	|O
infection	|O
in	|O
vitro	|O
,	|O
along	|O
with	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
/	|O
W	|O
promoter	|O
-	|O
initiated	|O
but	|O
not	|O
BamHI	|B-PROTEIN
-	|I-PROTEIN
F	|I-PROTEIN
promoter	|O
-	|O
initiated	|O
mRNAs	|O
.	|O

Analysis	|O
by	|O
cell	|O
surface	|O
immunofluorescence	|O
showed	|O
that	|O
the	|O
UL28	|B-PROTEIN
gene	|O
is	|O
not	|O
required	|O
for	|O
expression	|O
of	|O
viral	|O
glycoproteins	|O
on	|O
the	|O
surface	|O
of	|O
infected	|O
cells	|O
.	|O

Furthermore	|O
,	|O
a	|O
mutant	|O
receptor	|O
(	|O
Y977F	|O
/	|O
Y989F	|O
[	|O
PLC	|B-PROTEIN
gamma	|I-PROTEIN
-	|O
binding	|O
sites	|O
]	|O
)	|O
could	|O
fully	|O
activate	|O
Ras	|B-PROTEIN
,	|O
and	|O
the	|O
direct	|O
activation	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
and	|O
calcium	|O
mobilization	|O
had	|O
almost	|O
no	|O
effect	|O
on	|O
the	|O
GDP	|O
/	|O
GTP	|O
state	|O
of	|O
Ras	|B-PROTEIN
in	|O
this	|O
cell	|O
line	|O
.	|O

Estrogen	|O
treatment	|O
in	|O
high	|O
doses	|O
is	|O
effective	|O
in	|O
reducing	|O
adult	|O
stature	|O
in	|O
constitutionally	|O
tall	|O
girls	|O
.	|O

Mutations	|O
at	|O
the	|O
extreme	|O
C	|O
-	|O
terminus	|O
of	|O
EIAV	|O
Tat	|B-PROTEIN
impaired	|O
both	|O
RNA	|O
binding	|O
and	|O
activation	|O
domain	|O
functions	|O
,	|O
suggesting	|O
effects	|O
on	|O
secondary	|O
or	|O
tertiary	|O
structure	|O
.	|O

This	|O
observation	|O
suggests	|O
that	|O
the	|O
methyl	|O
-	|O
directed	|O
repair	|O
system	|O
utilizes	|O
the	|O
proximal	|O
d	|O
(	|O
GATC	|O
)	|O
sequence	|O
to	|O
direct	|O
correction	|O
.	|O

Uracil	|B-PROTEIN
DNA	|I-PROTEIN
glycosylase	|I-PROTEIN
catalyzes	|O
the	|O
initial	|O
step	|O
in	|O
the	|O
repair	|O
pathway	|O
that	|O
removes	|O
potentially	|O
mutagenic	|O
uracil	|O
from	|O
duplex	|O
DNA	|O
.	|O

Current	|O
clinical	|O
trials	|O
should	|O
answer	|O
the	|O
question	|O
of	|O
which	|O
of	|O
the	|O
therapeutic	|O
options	|O
impairs	|O
quality	|O
of	|O
life	|O
less	|O
.	|O

Lithium	|O
phthalocyanine	|O
(	|O
LiPc	|O
)	|O
is	|O
a	|O
prototype	|O
of	|O
another	|O
generation	|O
of	|O
synthetic	|O
,	|O
metallic	|O
-	|O
organic	|O
,	|O
paramagnetic	|O
crystallites	|O
that	|O
appear	|O
very	|O
useful	|O
for	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
electron	|O
paramagnetic	|O
resonance	|O
oximetry	|O
.	|O

In	|O
this	|O
report	|O
,	|O
we	|O
focus	|O
on	|O
the	|O
genetics	|O
of	|O
the	|O
region	|O
of	|O
the	|O
17	|O
hep	|O
syn	|O
gB	|B-PROTEIN
gene	|O
that	|O
conferred	|O
both	|O
the	|O
syncytial	|O
and	|O
pathogenic	|O
phenotypes	|O
to	|O
17	|B-PROTEIN
syn+	|I-PROTEIN
.	|O

Recipients	|O
with	|O
acute	|O
leukaemia	|O
in	|O
first	|O
remission	|O
or	|O
chronic	|O
myeloid	|O
leukaemia	|O
in	|O
first	|O
chronic	|O
phase	|O
were	|O
analysed	|O
as	|O
good	|O
risk	|O
,	|O
and	|O
those	|O
beyond	|O
these	|O
stages	|O
,	|O
as	|O
poor	|O
risk	|O
patients	|O
.	|O

Elledge	|O
,	|O
P.	|O

Drugs	|O
suppressed	|O
>	|O
or	|O
=	|O
75%	|O
of	|O
the	|O
total	|O
premature	|O
ventricular	|O
contractions	|O
in	|O
all	|O
patients	|O
who	|O
had	|O
both	|O
use	|O
-	|O
dependent	|O
QRS	|O
prolongation	|O
and	|O
reverse	|O
use	|O
-	|O
dependent	|O
QT	|O
prolongation	|O
,	|O
in	|O
79%	|O
of	|O
patients	|O
with	|O
use	|O
-	|O
dependent	|O
QRS	|O
prolongation	|O
alone	|O
,	|O
in	|O
70%	|O
with	|O
reverse	|O
use	|O
-	|O
dependent	|O
QT	|O
prolongation	|O
alone	|O
,	|O
and	|O
in	|O
11%	|O
with	|O
neither	|O
use	|O
-	|O
dependent	|O
QRS	|O
prolongation	|O
nor	|O
reverse	|O
use	|O
-	|O
dependent	|O
QT	|O
prolongation	|O
.	|O

Losses	|O
during	|O
the	|O
complete	|O
procedure	|O
are	|O
corrected	|O
for	|O
using	|O
radioactive	|O
estrogen	|O
conjugates	|O
during	|O
the	|O
first	|O
steps	|O
and	|O
later	|O
by	|O
adding	|O
deuterated	|O
internal	|O
standards	|O
of	|O
all	|O
compounds	|O
measured	|O
(	|O
matairesinol	|O
,	|O
enterodiol	|O
,	|O
enterolactone	|O
,	|O
daidzein	|O
,	|O
O	|O
-	|O
desmethylangolensin	|O
,	|O
equol	|O
,	|O
and	|O
genistein	|O
)	|O
.	|O

IE2	|B-PROTEIN
-	|O
IE2	|B-PROTEIN
interactions	|O
were	|O
mapped	|O
to	|O
a	|O
domain	|O
containing	|O
a	|O
putative	|O
helix	|O
-	|O
turn	|O
-	|O
helix	|O
motif	|O
located	|O
near	|O
the	|O
C	|O
terminus	|O
of	|O
IE2	|B-PROTEIN
,	|O
between	|O
amino	|O
acids	|O
456	|O
and	|O
539	|O
.	|O

The	|O
Sp1	|B-PROTEIN
region	|O
,	|O
however	|O
,	|O
is	|O
converted	|O
to	|O
a	|O
functionally	|O
strong	|O
TRE	|O
by	|O
the	|O
viral	|O
tat	|B-PROTEIN
factor	|O
.	|O

Precipitation	|O
using	|O
GST	|B-PROTEIN
fusion	|O
proteins	|O
containing	|O
Fyn	|B-PROTEIN
SH2	|O
,	|O
SH3	|B-PROTEIN
,	|O
and	|O
SH2	|B-PROTEIN
/	|O
SH3	|B-PROTEIN
domains	|O
revealed	|O
that	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
bound	|O
principally	|O
to	|O
the	|O
SH3	|B-PROTEIN
domain	|O
of	|O
Fyn	|B-PROTEIN
.	|O

A	|O
sheep	|O
testicular	|O
cDNA	|O
library	|O
constructed	|O
in	|O
pcDNA1	|O
vector	|O
was	|O
screened	|O
with	|O
a	|O
probe	|O
generated	|O
by	|O
polymerase	|O
chain	|O
reaction	|O
(	|O
PCR	|O
)	|O
and	|O
corresponding	|O
to	|O
a	|O
1.6	|O
kb	|O
fragment	|O
of	|O
the	|O
rat	|O
luteinizing	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
cDNA	|O
.	|O

Two	|O
putative	|O
Rev	|B-PROTEIN
proteins	|O
with	|O
apparent	|O
molecular	|O
masses	|O
of	|O
18	|O
and	|O
16	|O
kDa	|O
were	|O
expressed	|O
by	|O
p2/2	|B-PROTEIN
and	|O
p176	|B-PROTEIN
,	|O
while	|O
p20	|B-PROTEIN
expressed	|O
only	|O
a	|O
16	|O
-	|O
kDa	|O
species	|O
.	|O

Three	|O
group	|O
1	|O
patients	|O
developed	|O
CMV	|O
disease	|O
;	|O
1	|O
group	|O
2	|O
patient	|O
developed	|O
CMV	|O
hepatitis	|O
.	|O

The	|O
ability	|O
of	|O
spt2	|B-PROTEIN
mutations	|O
to	|O
suppress	|O
the	|O
transcriptional	|O
interference	|O
caused	|O
by	|O
the	|O
delta	|O
promoter	|O
insertion	|O
his	|B-PROTEIN
-	|I-PROTEIN
4-912	|I-PROTEIN
delta	|I-PROTEIN
correlates	|O
with	|O
an	|O
increase	|O
in	|O
wild	|O
-	|O
type	|O
HIS4	|B-PROTEIN
mRNA	|O
levels	|O
.	|O

Nuclear	|O
localization	|O
and	|O
protein	|O
sequence	|O
similarities	|O
suggested	|O
that	|O
the	|O
SPT2	|B-PROTEIN
/	|O
SIN1	|B-PROTEIN
protein	|O
may	|O
be	|O
related	|O
to	|O
the	|O
nonhistone	|O
chromosomal	|O
protein	|O
HMG1	|B-PROTEIN
.	|O

The	|O
conserved	|O
ninth	|O
C	|O
-	|O
terminal	|O
heptad	|O
in	|O
thyroid	|O
hormone	|O
and	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptors	|I-PROTEIN
mediates	|O
diverse	|O
responses	|O
by	|O
affecting	|O
heterodimer	|O
but	|O
not	|O
homodimer	|O
formation	|O
.	|O

Genetic	|O
interactions	|O
between	|O
BCK2	|B-PROTEIN
and	|O
other	|O
pathway	|O
components	|O
suggested	|O
that	|O
BCK2	|B-PROTEIN
functions	|O
on	|O
a	|O
common	|O
pathway	|O
branch	|O
with	|O
PPZ1	|B-PROTEIN
and	|O
PPZ2	|B-PROTEIN
.	|O

Steroidogenic	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
,	|O
an	|O
orphan	|B-PROTEIN
nuclear	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
regulates	|O
the	|O
expression	|O
of	|O
the	|O
rat	|O
aromatase	|B-PROTEIN
gene	|O
in	|O
gonadal	|O
tissues	|O
.	|O

To	|O
study	|O
the	|O
functional	|O
differences	|O
between	|O
cutaneous	|O
HPV5	|O
and	|O
HPV8	|O
E7s	|B-PROTEIN
and	|O
genital	|O
HPV16	|O
E7	|B-PROTEIN
,	|O
we	|O
cloned	|O
each	|O
of	|O
the	|O
E7	|B-PROTEIN
open	|O
reading	|O
frames	|O
and	|O
tested	|O
their	|O
immortalizing	|O
and	|O
transforming	|O
activities	|O
,	|O
the	|O
binding	|O
ability	|O
of	|O
their	|O
products	|O
with	|O
retinoblastoma	|B-PROTEIN
protein	|I-PROTEIN
(	|O
RB	|B-PROTEIN
)	|O
and	|O
their	|O
complementation	|O
activity	|O
of	|O
a	|O
RB	|B-PROTEIN
-	|O
nonbinding	|O
adenovirus	|O
E1A	|B-PROTEIN
mutant	|O
.	|O

The	|O
rhaB	|B-PROTEIN
transcription	|O
start	|O
site	|O
was	|O
mapped	|O
to	|O
-	|O
24	|O
relative	|O
to	|O
the	|O
start	|O
of	|O
translation	|O
.	|O

Several	|O
lines	|O
of	|O
evidence	|O
demonstrate	|O
that	|O
this	|O
growth	|O
inhibition	|O
requires	|O
active	|O
PKA	|B-PROTEIN
subunits	|O
and	|O
cAMP	|O
:	|O
(	|O
i	|O
)	|O
this	|O
phenotype	|O
is	|O
dependent	|O
on	|O
cAMP	|O
since	|O
it	|O
is	|O
not	|O
seen	|O
in	|O
a	|O
strain	|O
lacking	|O
adenylyl	|B-PROTEIN
cyclase	|I-PROTEIN
activity	|O
,	|O
but	|O
the	|O
growth	|O
rate	|O
of	|O
these	|O
transformants	|O
is	|O
slower	|O
when	|O
exogenous	|O
cAMP	|O
is	|O
added	|O
;	|O
(	|O
ii	|O
)	|O
normal	|O
growth	|O
occurs	|O
when	|O
wild	|O
-	|O
type	|O
RI	|B-PROTEIN
cDNA	|O
is	|O
replaced	|O
by	|O
a	|O
mutant	|O
RI	|B-PROTEIN
cDNA	|O
encoding	|O
a	|O
RI	|B-PROTEIN
protein	|O
with	|O
reduced	|O
cAMP	|O
binding	|O
;	|O
and	|O
(	|O
iii	|O
)	|O
the	|O
growth	|O
-	|O
inhibited	|O
phenotype	|O
of	|O
the	|O
transformed	|O
BL21	|O
(	|O
DE3	|O
)	|O
cells	|O
requires	|O
soluble	|O
,	|O
active	|O
C	|B-PROTEIN
alpha	|I-PROTEIN
protein	|O
.	|O

Liu	|O
,	|O
B.	|O

BCR	|B-PROTEIN
-	|O
ABL	|B-PROTEIN
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
abl	|I-PROTEIN
oncogenes	|O
induce	|O
distinct	|O
patterns	|O
of	|O
thymic	|O
lymphoma	|O
involving	|O
different	|O
lymphocyte	|O
subsets	|O
.	|O

These	|O
experiments	|O
confirm	|O
that	|O
the	|O
6	|O
-	|O
S	|O
liganded	|O
form	|O
of	|O
the	|O
receptor	|O
identified	|O
in	|O
nuclear	|O
extracts	|O
of	|O
cells	|O
treated	|O
with	|O
2,3,7,8	|O
-	|O
tetrachlorodibenzo	|O
-	|O
p	|O
-	|O
dioxin	|O
(	|O
TCDD	|O
)	|O
contains	|O
the	|O
Ah	|B-PROTEIN
receptor	|I-PROTEIN
protein	|O
and	|O
ARNT	|B-PROTEIN
but	|O
not	|O
the	|O
90	|O
-	|O
kDa	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
protein	|I-PROTEIN
.	|O

LDL	|B-PROTEIN
cholesterol	|I-PROTEIN
decreased	|O
from	|O
4.74	|O
+	|O
/	|O
-	|O
0.87	|O
to	|O
3.78	|O
+	|O
/	|O
-	|O
0.78	|O
mmol	|O
/	|O
l	|O
after	|O
8	|O
weeks	|O
on	|O
simvastatin	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
,	|O
and	|O
apo	|B-PROTEIN
B	|I-PROTEIN
fell	|O
from	|O
142	|O
+	|O
/	|O
-	|O
31	|O
to	|O
112	|O
+	|O
/	|O
-	|O
22	|O
mg	|O
/	|O
dl	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
.	|O

LDL	|B-PROTEIN
cholesterol	|I-PROTEIN
decreased	|O
from	|O
4.74	|O
+	|O
/	|O
-	|O
0.87	|O
to	|O
3.78	|O
+	|O
/	|O
-	|O
0.78	|O
mmol	|O
/	|O
l	|O
after	|O
8	|O
weeks	|O
on	|O
simvastatin	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
,	|O
and	|O
apo	|B-PROTEIN
B	|I-PROTEIN
fell	|O
from	|O
142	|O
+	|O
/	|O
-	|O
31	|O
to	|O
112	|O
+	|O
/	|O
-	|O
22	|O
mg	|O
/	|O
dl	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
.	|O

This	|O
negative	|O
element	|O
may	|O
,	|O
at	|O
least	|O
in	|O
part	|O
,	|O
be	|O
responsible	|O
for	|O
the	|O
cell	|O
type	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
DGK	|B-PROTEIN
gene	|O
.	|O

Regulated	|O
activity	|O
of	|O
the	|O
distal	|O
promoter	|O
-	|O
like	|O
element	|O
of	|O
the	|O
human	|O
corticotropin	|B-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
hormone	|I-PROTEIN
gene	|O
and	|O
secondary	|O
structural	|O
features	|O
of	|O
its	|O
corresponding	|O
transcripts	|O
.	|O

A	|O
new	|O
bioencapsulation	|O
technology	|O
for	|O
microbial	|O
inoculants	|O
.	|O

We	|O
linked	|O
hypersensitivity	|O
site	|O
2	|O
(	|O
HS2	|O
)	|O
from	|O
the	|O
locus	|O
control	|O
region	|O
(	|O
LCR	|O
)	|O
to	|O
a	|O
A	|B-PROTEIN
gamma	|I-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
gene	|O
(	|O
A	|B-PROTEIN
gamma	|I-PROTEIN
*	|I-PROTEIN
)	|O
mutationally	|O
marked	|O
to	|O
allow	|O
its	|O
transcript	|O
to	|O
be	|O
distinguished	|O
from	|O
endogenous	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
mRNA	|O
.	|O

INTERVENTIONS	|O
-	|O
-	|O
Patients	|O
allocated	|O
to	|O
treatment	|O
with	|O
levodopa	|B-PROTEIN
/	|I-PROTEIN
dopa	|I-PROTEIN
decarboxylase	|I-PROTEIN
inhibitor	|O
alone	|O
(	|O
arm	|O
1	|O
)	|O
,	|O
levodopa	|B-PROTEIN
/	|I-PROTEIN
decarboxylase	|I-PROTEIN
inhibitor	|O
/	|O
selegiline	|O
in	|O
combination	|O
(	|O
arm	|O
2	|O
)	|O
,	|O
or	|O
bromocriptine	|O
(	|O
arm	|O
3	|O
)	|O
.	|O

It	|O
contains	|O
three	|O
putative	|O
binding	|O
sites	|O
for	|O
transcription	|O
factor	|O
Sp1	|B-PROTEIN
as	|O
well	|O
as	|O
several	|O
short	|O
sequences	|O
that	|O
are	|O
similar	|O
to	|O
known	|O
cis	|O
-	|O
acting	|O
enhancers	|O
or	|O
binding	|O
sites	|O
for	|O
transcription	|O
factors	|O
.	|O

French	|O
bean	|O
contains	|O
a	|O
small	|O
family	|O
of	|O
genes	|O
encoding	|O
PAL	|B-PROTEIN
and	|O
two	|O
of	|O
these	|O
genes	|O
,	|O
PAL2	|B-PROTEIN
and	|O
PAL3	|B-PROTEIN
,	|O
have	|O
been	|O
shown	|O
to	|O
be	|O
differentially	|O
expressed	|O
at	|O
the	|O
mRNA	|O
level	|O
in	|O
bean	|O
tissues	|O
.	|O

Plasma	|O
thromboxane	|O
B2	|O
levels	|O
in	|O
the	|O
older	|O
group	|O
were	|O
about	|O
double	|O
those	|O
in	|O
younger	|O
piglets	|O
.	|O

By	|O
stepwise	|O
linear	|O
multiple	|O
regression	|O
analysis	|O
,	|O
ionized	|O
magnesium	|O
was	|O
significantly	|O
related	|O
to	|O
cyclosporin	|O
trough	|O
level	|O
and	|O
total	|O
cholesterol	|O
but	|O
not	|O
to	|O
serum	|O
creatinine	|O
,	|O
time	|O
after	|O
transplant	|O
or	|O
the	|O
dose	|O
of	|O
cyclosporin	|O
.	|O

The	|O
human	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
II	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
)	|O
gene	|O
contains	|O
four	|O
promoters	|O
(	|O
P1	|O
,	|O
P2	|O
,	|O
P3	|O
and	|O
P4	|O
)	|O
.	|O

Moreover	|O
,	|O
in	|O
transient	|O
transfection	|O
assays	|O
,	|O
PU.1	|B-PROTEIN
alone	|O
activated	|O
reporter	|O
constructs	|O
containing	|O
the	|O
JB	|O
cis	|O
-	|O
element	|O
,	|O
and	|O
the	|O
activation	|O
was	|O
shown	|O
to	|O
be	|O
dependent	|O
on	|O
a	|O
glutamine	|O
-	|O
rich	|O
sequence	|O
in	|O
the	|O
amino	|O
-	|O
terminal	|O
portion	|O
of	|O
PU.1	|B-PROTEIN
.	|O

Army	|O
veterans	|O
given	|O
yellow	|O
fever	|O
vaccine	|O
contaminated	|O
with	|O
hepatitis	|O
B	|O
virus	|O
in	|O
1942	|O
and	|O
controls	|O
and	|O
(	|O
b	|O
)	|O
a	|O
case	|O
-	|O
control	|O
study	|O
comparing	|O
veterans	|O
with	|O
hepatocellular	|O
carcinoma	|O
in	|O
Veterans	|O
Affairs	|O
hospitals	|O
with	|O
matched	|O
controls	|O
with	|O
respect	|O
to	|O
receipt	|O
of	|O
contaminated	|O
vaccine	|O
in	|O
1942	|O
.	|O

They	|O
were	|O
found	|O
to	|O
be	|O
seropositive	|O
for	|O
antibodies	|O
to	|O
hepatitis	|O
C	|O
virus	|O
by	|O
second	|O
-	|O
generation	|O
testing	|O
(	|O
RIBA	|O
2	|O
,	|O
Ortho	|O
Diagnostic	|O
Systems	|O
Inc	|O
,	|O
Westwood	|O
,	|O
MA	|O
)	|O
.	|O

Defects	|O
of	|O
fibrillin	|B-PROTEIN
(	|O
FBN1	|B-PROTEIN
)	|O
,	|O
a	|O
glycoprotein	|O
component	|O
of	|O
the	|O
extracellular	|O
microfibril	|O
,	|O
cause	|O
Marfan	|O
syndrome	|O
.	|O

When	|O
introduced	|O
into	|O
recJ+	|B-PROTEIN
strains	|O
,	|O
srjA	|B-PROTEIN
mutations	|O
conferred	|O
hyperrecombinational	|O
and	|O
hyper	|O
-	|O
UVr	|B-PROTEIN
phenotypes	|O
.	|O

Distinguishing	|O
roles	|O
of	|O
the	|O
membrane	|O
-	|O
cytoskeleton	|O
and	|O
cadherin	|B-PROTEIN
mediated	|O
cell	|O
-	|O
cell	|O
adhesion	|O
in	|O
generating	|O
different	|O
Na+	|B-PROTEIN
,	|I-PROTEIN
K	|I-PROTEIN
(	|I-PROTEIN
+	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
ATPase	|I-PROTEIN
distributions	|O
in	|O
polarized	|O
epithelia	|O
.	|O

Neonatal	|O
lupus	|O
erythematosus	|O
is	|O
most	|O
often	|O
associated	|O
with	|O
autoantibodies	|O
against	|O
Ro	|B-PROTEIN
and	|O
La	|B-PROTEIN
antigens	|O
.	|O

Genetic	|O
abnormalities	|O
that	|O
could	|O
lead	|O
to	|O
mutagenesis	|O
include	|O
chromosomal	|O
abnormalities	|O
and	|O
single	|O
-	|O
gene	|O
mutations	|O
.	|O

Hops	|O
,	|O
and	|O
L.	|O

Continued	|O
absorption	|O
of	|O
amino	|O
acids	|O
by	|O
the	|O
NBB	|O
carrier	|O
(	|O
for	|O
neutral	|O
amino	|O
acids	|O
)	|O
,	|O
the	|O
Y+	|O
system	|O
(	|O
for	|O
dibasic	|O
amino	|O
acids	|O
)	|O
,	|O
and	|O
the	|O
PHE	|O
carrier	|O
were	|O
operative	|O
even	|O
during	|O
the	|O
actively	|O
purging	|O
stage	|O
of	|O
watery	|O
diarrhoea	|O
due	|O
to	|O
cholera	|O
.	|O

1	|O
)	|O
CFDN	|O
,	|O
AMPC	|O
and	|O
MNZ	|O
showed	|O
a	|O
potent	|O
antimicrobial	|O
activity	|O
against	|O
H.	|O
pylori	|O
,	|O
and	|O
especially	|O
,	|O
AMPC	|O
showed	|O
a	|O
marked	|O
bactericidal	|O
activity	|O
in	|O
a	|O
short	|O
time	|O
.	|O

Creutzfeldt	|O
-	|O
Jakob	|O
disease	|O
and	|O
lyophilised	|O
dura	|O
mater	|O
grafts	|O
:	|O
report	|O
of	|O
two	|O
cases	|O
.	|O

A	|O
high	|O
mean	|O
intensity	|O
of	|O
CLTPA	|O
(	|O
standardized	|O
multivariate	|O
regression	|O
coefficient	|O
beta	|O
-	|O
0.059	|O
,	|O
p	|O
=	|O
0.020	|O
)	|O
and	|O
a	|O
high	|O
maximal	|O
oxygen	|O
uptake	|O
(	|O
beta	|O
-	|O
0.163	|O
,	|O
p	|O
<	|O
0.001	|O
)	|O
were	|O
associated	|O
with	|O
reduced	|O
plasma	|O
fibrinogen	|B-PROTEIN
when	|O
adjusting	|O
for	|O
the	|O
strongest	|O
covariates	|O
.	|O

What	|O
young	|O
people	|O
think	|O
and	|O
do	|O
when	|O
the	|O
option	|O
for	|O
cystic	|O
fibrosis	|O
carrier	|O
testing	|O
is	|O
available	|O
.	|O

A	|O
patient	|O
matches	|O
a	|O
PIC	|O
patient	|O
if	|O
both	|O
have	|O
the	|O
same	|O
mechanism	|O
of	|O
injury	|O
,	|O
the	|O
same	|O
coding	|O
of	|O
Revised	|O
Trauma	|O
Score	|O
variables	|O
(	|O
Glascow	|O
Coma	|O
Scale	|O
score	|O
,	|O
systolic	|O
blood	|O
pressure	|O
,	|O
respiratory	|O
rate	|O
)	|O
,	|O
the	|O
same	|O
coded	|O
age	|O
per	|O
A	|O
Severity	|O
Characterization	|O
of	|O
Trauma	|O
)	|O
(	|O
ASCOT	|O
)	|O
,	|O
and	|O
if	|O
they	|O
differ	|O
by	|O
no	|O
more	|O
than	|O
0.5	|O
for	|O
A	|O
,	|O
B	|O
,	|O
and	|O
C	|O
(	|O
the	|O
ASCOT	|O
components	|O
for	|O
serious	|O
injuries	|O
)	|O
.	|O

Skin	|O
and	|O
bowel	|O
TPO2	|O
varied	|O
with	|O
DO2	|O
and	|O
each	|O
other	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

A	|O
region	|O
approximately	|O
100	|O
bp	|O
upstream	|O
from	|O
the	|O
transcription	|O
start	|O
point	|O
of	|O
virB	|B-PROTEIN
was	|O
identified	|O
as	|O
being	|O
necessary	|O
for	|O
full	|O
activation	|O
of	|O
this	|O
promoter	|O
by	|O
VirF	|B-PROTEIN
.	|O

We	|O
have	|O
isolated	|O
a	|O
cosmid	|O
containing	|O
DNA	|O
that	|O
corresponds	|O
to	|O
the	|O
site	|O
of	|O
transposon	|O
insertion	|O
in	|O
257DH4	|O
and	|O
have	|O
localized	|O
Tn5	|B-PROTEIN
on	|O
an	|O
8.0	|O
kb	|O
EcoRI	|B-PROTEIN
fragment	|O
.	|O

The	|O
scr	|B-PROTEIN
regulon	|O
of	|O
pUR400	|O
and	|O
the	|O
chromosomally	|O
encoded	|O
scr	|B-PROTEIN
regulon	|O
of	|O
Klebsiella	|O
pneumoniae	|O
KAY2026	|O
are	|O
both	|O
negatively	|O
controlled	|O
by	|O
a	|O
specific	|O
repressor	|O
(	|O
ScrR	|B-PROTEIN
)	|O
.	|O

Although	|O
the	|O
molecular	|O
mechanisms	|O
involved	|O
in	|O
this	|O
regulation	|O
are	|O
currently	|O
being	|O
elucidated	|O
,	|O
very	|O
little	|O
is	|O
known	|O
about	|O
the	|O
trans	|O
-	|O
acting	|O
factors	|O
that	|O
allow	|O
expression	|O
of	|O
the	|O
nitrate	|B-PROTEIN
and	|I-PROTEIN
nitrite	|I-PROTEIN
reductase	|I-PROTEIN
genes	|O
which	|O
code	|O
for	|O
the	|O
first	|O
enzymes	|O
in	|O
the	|O
pathway	|O
.	|O

The	|O
Ntl1	|B-PROTEIN
gene	|O
is	|O
present	|O
as	|O
a	|O
unique	|O
copy	|O
in	|O
the	|O
diploid	|O
N.	|O
plumbaginifolia	|O
species	|O
.	|O

Transient	|O
transfection	|O
experiments	|O
revealed	|O
that	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
isoforms	|O
a	|O
and	|O
b	|O
,	|O
but	|O
not	|O
c	|O
and	|O
d	|O
,	|O
strongly	|O
stimulate	|O
transcription	|O
from	|O
a	|O
promoter	|O
containing	|O
six	|O
copies	|O
of	|O
a	|O
paired	|B-PROTEIN
-	|O
domain	|O
recognition	|O
sequence	|O
.	|O

The	|O
amino	|O
-	|O
terminal	|O
third	|O
of	|O
the	|O
protein	|O
contains	|O
a	|O
high	|B-PROTEIN
-	|I-PROTEIN
mobility	|I-PROTEIN
-	|I-PROTEIN
group	|I-PROTEIN
motif	|O
characteristic	|O
of	|O
DNA	|O
-	|O
binding	|O
proteins	|O
.	|O

We	|O
have	|O
examined	|O
the	|O
ability	|O
of	|O
various	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
subunits	|O
to	|O
bind	|O
to	|O
,	|O
and	|O
activate	|O
transcription	|O
from	|O
,	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
promoter	|O
.	|O

When	|O
multiple	|O
copies	|O
of	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
NF	|O
-	|O
kappa	|O
B	|O
site	|O
were	|O
linked	|O
to	|O
an	|O
enhancerless	|O
simian	|B-PROTEIN
virus	|I-PROTEIN
40	|I-PROTEIN
promoter	|I-PROTEIN
,	|O
this	|O
element	|O
was	|O
able	|O
to	|O
mediate	|O
phorbol	|O
ester	|O
-	|O
or	|O
lipopolysaccharide	|O
-	|O
inducible	|O
gene	|O
expression	|O
.	|O

We	|O
found	|O
that	|O
the	|O
3'	|O
-	|O
end	|O
-	|O
adjacent	|O
sequence	|O
CA	|O
(	|O
N	|O
)	|O
3-10	|O
AGTNNAA	|O
,	|O
conserved	|O
in	|O
plant	|O
Pol	|B-PROTEIN
II	|I-PROTEIN
-	|O
specific	|O
U	|B-PROTEIN
snRNA	|O
genes	|O
,	|O
is	|O
essential	|O
for	|O
the	|O
3'	|O
-	|O
end	|O
formation	|O
of	|O
U2	|B-PROTEIN
transcripts	|O
and	|O
,	|O
similar	|O
to	|O
the	|O
vertebrate	|O
3'	|O
box	|O
,	|O
is	|O
highly	|O
tolerant	|O
to	|O
mutation	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
Rb	|B-PROTEIN
protein	|O
is	|O
interacting	|O
with	|O
some	|O
component	|O
(	|O
s	|O
)	|O
of	|O
the	|O
cell	|O
cycle	|O
-	|O
regulatory	|O
machinery	|O
during	|O
G2	|O
phase	|O
.	|O

MDBP	|B-PROTEIN
from	|O
HeLa	|O
and	|O
Raji	|O
cells	|O
formed	|O
DNA	|O
-	|O
protein	|O
complexes	|O
with	|O
X	|O
-	|O
box	|O
oligonucleotides	|O
that	|O
coelectrophoresed	|O
with	|O
those	|O
containing	|O
standard	|O
MDBP	|B-PROTEIN
sites	|O
.	|O

Transgenic	|O
mice	|O
harboring	|O
the	|O
rat	|O
TnI	|B-PROTEIN
-	|O
CAT	|B-PROTEIN
fusion	|O
gene	|O
expressed	|O
the	|O
reporter	|O
specifically	|O
in	|O
the	|O
skeletal	|O
muscle	|O
.	|O

METHODS	|O
:	|O
Fifty	|O
-	|O
one	|O
healthy	|O
eyes	|O
,	|O
169	|O
ocular	|O
hypertensive	|O
eyes	|O
with	|O
normal	|O
visual	|O
fields	|O
,	|O
and	|O
132	|O
glaucomatous	|O
eyes	|O
with	|O
early	|O
visual	|O
field	|O
defects	|O
were	|O
evaluated	|O
with	|O
qualitative	|O
and	|O
quantitative	|O
measures	|O
of	|O
structural	|O
damage	|O
to	|O
the	|O
optic	|O
nerve	|O
and	|O
nerve	|O
fiber	|O
layer	|O
.	|O

Consistent	|O
with	|O
the	|O
hypothesis	|O
that	|O
it	|O
acts	|O
as	|O
transcriptional	|O
regulator	|O
,	|O
wild	|O
-	|O
type	|O
p53	|B-PROTEIN
protein	|O
binds	|O
DNA	|O
and	|O
activates	|O
transcription	|O
of	|O
several	|O
promoters	|O
.	|O

The	|O
ADP	|B-PROTEIN
-	|I-PROTEIN
ribosylation	|I-PROTEIN
factor	|I-PROTEIN
(	|O
ARF	|B-PROTEIN
)	|O
family	|O
is	|O
one	|O
of	|O
four	|O
subfamilies	|O
of	|O
the	|O
RAS	|B-PROTEIN
superfamily	|O
of	|O
low	|O
molecular	|O
weight	|O
GTP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
)	|O
.	|O

The	|O
E1	|B-PROTEIN
gene	|O
is	|O
located	|O
within	|O
the	|O
first	|O
intron	|O
of	|O
the	|O
gene	|O
for	|O
RCC1	|B-PROTEIN
,	|O
a	|O
protein	|O
that	|O
regulates	|O
onset	|O
of	|O
mitosis	|O
.	|O

Genomic	|O
Southern	|O
blot	|O
analysis	|O
and	|O
chromosome	|O
mapping	|O
showed	|O
that	|O
GPRK6	|B-PROTEIN
hybridizes	|O
to	|O
two	|O
closely	|O
related	|O
genes	|O
located	|O
on	|O
chromosomes	|O
5	|O
and	|O
13	|O
and	|O
are	|O
,	|O
therefore	|O
,	|O
distinct	|O
from	|O
the	|O
GPRK	|B-PROTEIN
located	|O
near	|O
the	|O
Huntington	|B-PROTEIN
disease	|I-PROTEIN
locus	|I-PROTEIN
on	|O
chromosome	|O
4	|O
.	|O

Metabolic	|O
labeling	|O
studies	|O
in	|O
S.	|O
cerevisiae	|O
and	|O
co	|O
-	|O
expression	|O
of	|O
nmt72p	|B-PROTEIN
with	|O
several	|O
protein	|O
substrates	|O
of	|O
Nmt1p	|B-PROTEIN
in	|O
Escherichia	|O
coli	|O
indicate	|O
that	|O
the	|O
Leu99	|O
-	|O
-	|O
>	|O
Pro	|O
substitution	|O
causes	|O
a	|O
reduction	|O
in	|O
the	|O
acylation	|O
of	|O
some	|O
but	|O
not	|O
all	|O
protein	|O
substrates	|O
.	|O

These	|O
CTD	|B-PROTEIN
kinases	|I-PROTEIN
,	|O
designated	|O
CTDK1	|B-PROTEIN
and	|O
CTDK2	|B-PROTEIN
,	|O
are	|O
fractionated	|O
by	|O
chromatography	|O
on	|O
Mono	|O
Q.	|O

Instead	|O
,	|O
mRNA	|O
of	|O
2.0	|O
and	|O
2.8	|O
kb	|O
are	|O
detected	|O
in	|O
varying	|O
abundance	|O
.	|O

Previously	|O
,	|O
we	|O
identified	|O
a	|O
51	|O
-	|O
bp	|O
promoter	|O
fragment	|O
,	|O
oligo31/32	|O
,	|O
which	|O
conferred	|O
heat	|O
shock	|O
inducibility	|O
on	|O
the	|O
heterologous	|O
CYC1	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
reporter	|O
gene	|O
in	|O
S.	|O
cerevisiae	|O
(	|O
N.	|O

The	|O
sequence	|O
of	|O
the	|O
HIR1	|B-PROTEIN
gene	|O
predicts	|O
an	|O
88	|O
-	|O
kDa	|O
protein	|O
with	|O
three	|O
repeats	|O
of	|O
a	|O
motif	|O
found	|O
in	|O
the	|O
G	|B-PROTEIN
beta	|I-PROTEIN
subunit	|O
of	|O
retinal	|O
transducin	|B-PROTEIN
and	|O
in	|O
a	|O
yeast	|O
transcriptional	|O
repressor	|O
,	|O
Tup1	|B-PROTEIN
.	|O

All	|O
of	|O
these	|O
data	|O
suggest	|O
that	|O
replication	|O
of	|O
UV	|O
-	|O
damaged	|O
templates	|O
occurs	|O
in	|O
vitro	|O
as	|O
it	|O
does	|O
in	|O
vivo	|O
and	|O
that	|O
this	|O
replication	|O
results	|O
in	|O
mutation	|O
fixation	|O
.	|O

To	|O
identify	|O
factors	|O
that	|O
may	|O
modify	|O
the	|O
heterosexual	|O
transmission	|O
of	|O
human	|O
T	|O
cell	|O
leukemia	|O
/	|O
lymphoma	|O
virus	|O
type	|O
I	|O
(	|O
HTLV	|O
-	|O
I	|O
)	|O
,	|O
534	|O
married	|O
couples	|O
enrolled	|O
in	|O
the	|O
Miyazaki	|O
Cohort	|O
Study	|O
between	|O
November	|O
1984	|O
and	|O
April	|O
1989	|O
were	|O
studied	|O
:	|O
95	|O
husband	|O
HTLV	|O
-	|O
I	|O
-	|O
seropositive	|O
(	|O
H+	|O
)	|O
/	|O
wife	|O
seropositive	|O
(	|O
W+	|O
)	|O
,	|O
33	|O
H+	|O
/	|O
W	|O
-	|O
,	|O
64	|O
H	|O
-	|O
/	|O
W+	|O
,	|O
and	|O
342	|O
H	|O
-	|O
/	|O
W	|O
-	|O
.	|O

Biol.	|O

To	|O
characterize	|O
the	|O
expression	|O
of	|O
this	|O
DNA	|B-PROTEIN
repair	|I-PROTEIN
enzyme	|I-PROTEIN
,	|O
we	|O
have	|O
isolated	|O
the	|O
corresponding	|O
genomic	|O
clone	|O
.	|O

L.	|O
,	|O
Stange	|O
,	|O
G.	|O
,	|O
Markovich	|O
,	|O
D.	|O
,	|O
Biber	|O
,	|O
J.	|O
,	|O
Testar	|O
,	|O
X.	|O
,	|O
Zorzano	|O
,	|O
A.	|O
,	|O
Palacin	|O
,	|O
M.	|O
,	|O
and	|O
Murer	|O
,	|O
H.	|O

The	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
gene	|O
predicts	|O
a	|O
polypeptide	|O
of	|O
215	|O
amino	|O
acids	|O
(	|O
25.2	|O
kDa	|O
)	|O
with	|O
two	|O
putative	|O
membrane	|O
-	|O
spanning	|O
domains	|O
.	|O

SAECG	|O
,	|O
echocardiography	|O
and	|O
thallium	|O
-	|O
201	|O
imaging	|O
were	|O
performed	|O
before	|O
and	|O
1	|O
month	|O
after	|O
attempted	|O
angioplasty	|O
.	|O

They	|O
were	|O
called	|O
PACE4	|B-PROTEIN
and	|O
PC4	|B-PROTEIN
.	|O

265	|O
,	|O
1102-1110	|O
)	|O
.	|O

Both	|O
fusion	|O
proteins	|O
form	|O
stable	|O
specific	|O
complexes	|O
with	|O
a	|O
short	|O
DNA	|O
duplex	|O
harboring	|O
the	|O
CTGT	|O
(	|O
at	|O
)	|O
4ACAG	|O
consensus	|O
sequence	|O
of	|O
the	|O
LexA	|B-PROTEIN
repressor	|O
.	|O

Ten	|O
selenocysteine	|O
residues	|O
(	|O
deduced	|O
)	|O
are	|O
present	|O
.	|O

CONCLUSIONS	|O
:	|O
Free	|O
protein	|B-PROTEIN
S	|I-PROTEIN
deficiency	|O
is	|O
common	|O
among	|O
hospitalized	|O
patients	|O
,	|O
even	|O
in	|O
the	|O
absence	|O
of	|O
a	|O
recognized	|O
predisposing	|O
condition	|O
.	|O

During	|O
the	|O
past	|O
decade	|O
,	|O
different	|O
types	|O
of	|O
endogenous	|O
retroviral	|O
sequences	|O
have	|O
been	|O
defined	|O
in	|O
the	|O
human	|O
genome	|O
usually	|O
by	|O
low	|O
stringency	|O
hybridization	|O
employing	|O
DNA	|O
probes	|O
of	|O
evolutionary	|O
conserved	|O
animal	|O
retrovirus	|O
genes	|O
.	|O

As	|O
the	|O
components	|O
of	|O
these	|O
complexes	|O
,	|O
at	|O
least	|O
five	|O
TRBPs	|B-PROTEIN
(	|O
p30	|B-PROTEIN
,	|O
p37	|B-PROTEIN
,	|O
p46	|B-PROTEIN
,	|O
p50	|B-PROTEIN
,	|O
and	|O
p56	|B-PROTEIN
)	|O
showing	|O
specific	|O
binding	|O
to	|O
the	|O
TAR	|O
RNA	|O
were	|O
detected	|O
in	|O
the	|O
uv	|O
cross	|O
-	|O
linking	|O
assay	|O
.	|O

The	|O
obvious	|O
functional	|O
necessity	|O
for	|O
editing	|O
in	|O
kinetoplastid	|O
mitochondria	|O
is	|O
the	|O
formation	|O
of	|O
translatable	|O
mRNAs	|O
.	|O

The	|O
use	|O
of	|O
this	|O
model	|O
for	|O
investigating	|O
pathophysiologically	|O
significant	|O
issues	|O
in	|O
denervating	|O
diseases	|O
is	|O
illustrated	|O
with	|O
five	|O
different	|O
sets	|O
of	|O
parameters	|O
.	|O

An	|O
extensive	|O
inverted	|O
repeat	|O
is	|O
present	|O
3'	|O
of	|O
rpeA	|B-PROTEIN
;	|O
inverted	|O
repeats	|O
are	|O
found	|O
downstream	|O
of	|O
all	|O
PE	|B-PROTEIN
operons	|O
sequenced	|O
to	|O
date	|O
,	|O
although	|O
the	|O
sequence	|O
is	|O
not	|O
conserved	|O
.	|O

We	|O
describe	|O
a	|O
novel	|O
cytoplasmic	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
,	|O
termed	|O
BPK	|B-PROTEIN
(	|O
B	|B-PROTEIN
cell	|I-PROTEIN
progenitor	|I-PROTEIN
kinase	|I-PROTEIN
)	|O
,	|O
which	|O
is	|O
expressed	|O
in	|O
all	|O
stages	|O
of	|O
the	|O
B	|O
lineage	|O
and	|O
in	|O
myeloid	|O
cells	|O
.	|O

Large	|O
differences	|O
between	|O
the	|O
groups	|O
were	|O
not	|O
observed	|O
in	|O
HA	|B-PROTEIN
-	|I-PROTEIN
synthesizing	|I-PROTEIN
enzyme	|I-PROTEIN
activity	|O
,	|O
but	|O
degradative	|O
enzyme	|O
activity	|O
was	|O
much	|O
higher	|O
in	|O
aspirin	|O
-	|O
induced	|O
asthma	|O
-	|O
related	|O
polyps	|O
than	|O
in	|O
other	|O
types	|O
of	|O
nasal	|O
polyps	|O
tested	|O
.	|O

In	|O
the	|O
multivariate	|O
analysis	|O
,	|O
six	|O
variables	|O
were	|O
independently	|O
correlated	|O
with	|O
survival	|O
:	|O
blood	|O
urea	|O
nitrogen	|O
level	|O
,	|O
serum	|O
aspartate	|B-PROTEIN
aminotransferase	|I-PROTEIN
level	|O
,	|O
community	|O
-	|O
acquired	|O
vs.	|O
hospital	|O
-	|O
acquired	|O
peritonitis	|O
,	|O
age	|O
,	|O
Child	|O
-	|O
Pugh	|O
score	|O
and	|O
ileus	|O
.	|O

Localization	|O
of	|O
the	|O
intronless	|O
gene	|O
coding	|O
for	|O
calmodulin	|B-PROTEIN
-	|O
like	|O
protein	|O
CLP	|B-PROTEIN
to	|O
human	|O
chromosome	|O
10p13	|O
-	|O
ter	|O
.	|O

In	|O
wandering	|O
stage	|O
larvae	|O
,	|O
the	|O
OBP	|B-PROTEIN
transcript	|O
appeared	|O
to	|O
be	|O
at	|O
least	|O
250	|O
-	|O
fold	|O
less	|O
abundant	|O
than	|O
ribosomal	|O
RNA	|O
.	|O

One	|O
such	|O
mutant	|O
also	|O
affects	|O
the	|O
overlapping	|O
-	|O
10	|O
hexamer	|O
of	|O
PR	|O
and	|O
results	|O
in	|O
reduced	|O
occupancy	|O
by	|O
both	|O
MerR	|B-PROTEIN
and	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
,	|O
likely	|O
as	|O
a	|O
result	|O
of	|O
inefficient	|O
transcriptional	|O
initiation	|O
of	|O
merR	|B-PROTEIN
mRNA	|O
.	|O

However	|O
,	|O
L	|B-PROTEIN
-	|I-PROTEIN
plastin	|I-PROTEIN
has	|O
been	|O
found	|O
in	|O
many	|O
types	|O
of	|O
malignant	|O
human	|O
cells	|O
of	|O
non	|O
-	|O
hemopoietic	|O
origin	|O
suggesting	|O
that	|O
its	|O
expression	|O
is	|O
induced	|O
accompanying	|O
tumorigenesis	|O
in	|O
solid	|O
tissues	|O
.	|O

Finally	|O
,	|O
we	|O
present	|O
evidence	|O
that	|O
fimbrin	|B-PROTEIN
is	|O
a	|O
third	|O
distinct	|O
plastin	|B-PROTEIN
isoform	|O
which	|O
is	|O
specifically	|O
expressed	|O
at	|O
high	|O
levels	|O
in	|O
the	|O
small	|O
intestine	|O
.	|O

This	|O
promoter	|O
could	|O
direct	|O
the	|O
constitutive	|O
expression	|O
of	|O
the	|O
reporter	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
at	|O
high	|O
frequency	|O
in	|O
transfected	|O
colonies	|O
of	|O
transformed	|O
cells	|O
that	|O
express	|O
L	|B-PROTEIN
-	|I-PROTEIN
plastin	|I-PROTEIN
constitutively	|O
;	|O
by	|O
contrast	|O
,	|O
this	|O
promoter	|O
was	|O
virtually	|O
inactive	|O
in	|O
transfected	|O
colonies	|O
of	|O
normal	|O
fibroblasts	|O
and	|O
it	|O
exhibited	|O
a	|O
low	|O
frequency	|O
of	|O
constitutive	|O
activation	|O
in	|O
transfected	|O
colonies	|O
of	|O
in	|O
vitro	|O
SV40	|O
-	|O
transformed	|O
fibroblasts	|O
which	|O
did	|O
not	|O
exhibit	|O
L	|B-PROTEIN
-	|I-PROTEIN
plastin	|I-PROTEIN
expression	|O
.	|O

The	|O
half	|O
-	|O
life	|O
of	|O
the	|O
serum	|O
-	|O
induced	|O
CBP	|B-PROTEIN
/	|O
tk	|B-PROTEIN
binding	|O
activity	|O
was	|O
estimated	|O
to	|O
be	|O
less	|O
than	|O
1	|O
h	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

The	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprint	|O
extended	|O
5'	|O
in	|O
the	|O
silencer	|O
region	|O
to	|O
include	|O
an	|O
inverted	|O
repeat	|O
of	|O
a	|O
six	|O
-	|O
nucleotide	|O
motif	|O
(	|O
epsilon	|O
-	|O
267	|O
to	|O
-	|O
278	|O
bp	|O
)	|O
which	|O
shares	|O
5	|O
of	|O
6	|O
bases	|O
with	|O
the	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
consensus	|O
sequence	|O
.	|O

Furthermore	|O
,	|O
competitor	|O
containing	|O
the	|O
YY1	|B-PROTEIN
consensus	|O
sequence	|O
competed	|O
for	|O
protein	|B-PROTEIN
B	|I-PROTEIN
binding	|O
,	|O
whereas	|O
competitor	|O
containing	|O
a	|O
perfect	|O
yeast	|O
ABF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
consensus	|O
sequence	|O
did	|O
not	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
400	|O
WORDS	|O
)	|O

The	|O
gene	|O
includes	|O
three	|O
exons	|O
and	|O
two	|O
introns	|O
within	|O
1.6	|O
kilobases	|O
of	|O
DNA	|O
,	|O
and	|O
the	|O
entire	|O
open	|O
reading	|O
frame	|O
for	|O
glycoprotein	|B-PROTEIN
IX	|I-PROTEIN
is	|O
included	|O
within	|O
the	|O
third	|O
exon	|O
.	|O

Rhizobium	|O
meliloti	|O
large	|O
plasmid	|O
pRmeGR4b	|O
carries	|O
the	|O
nodulation	|O
competitiveness	|O
locus	|O
nfe	|B-PROTEIN
responsible	|O
for	|O
the	|O
nodulation	|O
efficiency	|O
and	|O
competitive	|O
ability	|O
of	|O
strain	|O
GR4	|O
on	|O
alfalfa	|O
roots	|O
.	|O

Further	|O
,	|O
the	|O
ability	|O
of	|O
recombinant	|O
beta	|O
and	|O
/	|O
or	|O
gamma	|O
chains	|O
to	|O
function	|O
in	|O
defined	|O
biochemical	|O
assays	|O
of	|O
beta	|O
gamma	|O
activity	|O
was	|O
assessed	|O
for	|O
membrane	|O
extracts	|O
and	|O
supernatant	|O
fractions	|O
from	|O
infected	|O
Sf9	|O
cells	|O
.	|O

This	|O
report	|O
describes	|O
the	|O
identification	|O
of	|O
a	|O
gene	|O
of	|O
related	|O
function	|O
,	|O
SMD1	|B-PROTEIN
,	|O
located	|O
immediately	|O
3'	|O
to	|O
PRP38	|B-PROTEIN
.	|O

These	|O
data	|O
establish	|O
Smd1p	|B-PROTEIN
as	|O
a	|O
required	|O
component	|O
of	|O
the	|O
cellular	|O
splicing	|O
apparatus	|O
and	|O
a	|O
factor	|O
in	|O
snRNA	|O
maturation	|O
and	|O
stability	|O
.	|O

This	|O
study	|O
compared	|O
the	|O
gross	|O
and	|O
fine	|O
motor	|O
performance	|O
of	|O
14	|O
traumatically	|O
brain	|O
-	|O
injured	|O
children	|O
(	|O
five	|O
to	|O
15	|O
years	|O
old	|O
,	|O
with	|O
loss	|O
of	|O
consciousness	|O
for	|O
at	|O
least	|O
24	|O
hours	|O
)	|O
to	|O
14	|O
normal	|O
children	|O
group	|O
matched	|O
for	|O
age	|O
and	|O
sex	|O
.	|O

We	|O
compared	|O
the	|O
parameters	|O
pleural	|B-PROTEIN
adenosine	|I-PROTEIN
deaminase	|I-PROTEIN
(	|O
PADA	|B-PROTEIN
,	|O
determined	|O
in	|O
405	|O
patients	|O
)	|O
,	|O
the	|O
PADA	|B-PROTEIN
/	|O
serum	|O
ADA	|B-PROTEIN
ratio	|O
(	|O
P	|B-PROTEIN
/	|O
SADA	|B-PROTEIN
;	|O
276	|O
cases	|O
)	|O
,	|O
pleural	|B-PROTEIN
lysozyme	|I-PROTEIN
(	|O
PLYS	|B-PROTEIN
,	|O
276	|O
cases	|O
)	|O
,	|O
the	|O
PLYS	|B-PROTEIN
/	|O
serum	|B-PROTEIN
LYS	|I-PROTEIN
ratio	|O
(	|O
P	|B-PROTEIN
/	|O
SLYS	|B-PROTEIN
;	|O
276	|O
cases	|O
)	|O
,	|O
and	|O
pleural	|B-PROTEIN
interferon	|I-PROTEIN
gamma	|I-PROTEIN
(	|O
IFN	|B-PROTEIN
,	|O
145	|O
cases	|O
)	|O
regarding	|O
their	|O
ability	|O
to	|O
differentiate	|O
tuberculous	|O
pleural	|O
effusions	|O
from	|O
others	|O
.	|O

These	|O
exons	|O
were	|O
identified	|O
by	|O
cloning	|O
and	|O
sequencing	|O
cDNAs	|O
obtained	|O
by	|O
polymerase	|O
chain	|O
reaction	|O
amplification	|O
of	|O
a	|O
fibroblast	|O
cDNA	|O
library	|O
.	|O

Deletion	|O
of	|O
the	|O
apeA	|B-PROTEIN
gene	|O
,	|O
either	|O
with	|O
or	|O
without	|O
deletion	|O
of	|O
other	|O
proteinases	|O
(	|O
protease	|B-PROTEIN
IV	|I-PROTEIN
and	|O
aminopeptidase	|B-PROTEIN
N	|I-PROTEIN
)	|O
,	|O
did	|O
not	|O
have	|O
any	|O
effect	|O
on	|O
cell	|O
growth	|O
in	|O
the	|O
various	|O
media	|O
tested	|O
.	|O

In	|O
Experiment	|O
2	|O
scopolamine	|O
hydrobromide	|O
,	|O
0.5	|O
and	|O
1.0	|O
mg	|O
/	|O
kg	|O
i.p	|O
.	|O
,	|O
was	|O
administered	|O
1	|O
h	|O
before	|O
each	|O
electrical	|O
stimulation	|O
until	|O
each	|O
rat	|O
showed	|O
the	|O
stage	|O
-	|O
3	|O
seizure	|O
.	|O

PNT	|O
,	|O
ADD	|O
and	|O
BSS	|O
in	|O
the	|O
initial	|O
stage	|O
of	|O
kindling	|O
,	|O
kindling	|O
rate	|O
for	|O
the	|O
stage	|O
-	|O
3	|O
and	|O
-	|O
5	|O
seizures	|O
,	|O
seizure	|O
parameters	|O
at	|O
the	|O
first	|O
stage	|O
-	|O
3	|O
and	|O
-	|O
5	|O
were	|O
recorded	|O
and	|O
compared	|O
to	|O
the	|O
values	|O
of	|O
saline	|O
-	|O
treated	|O
,	|O
control	|O
group	|O
.	|O

CONCLUSIONS	|O
.	|O

There	|O
was	|O
a	|O
positive	|O
correlation	|O
between	|O
pyridinium	|O
cross	|O
-	|O
link	|O
excretion	|O
and	|O
thyroid	|O
hormone	|O
concentrations	|O
.	|O

Mutations	|O
truncating	|O
as	|O
many	|O
as	|O
143	|O
C	|O
-	|O
terminal	|O
residues	|O
from	|O
the	|O
transcriptional	|O
activator	|O
encoded	|O
by	|O
the	|O
areA	|B-PROTEIN
gene	|O
,	|O
mediating	|O
nitrogen	|O
metabolite	|O
repression	|O
in	|O
Aspergillus	|O
nidulans	|O
,	|O
do	|O
not	|O
significantly	|O
reduce	|O
the	|O
ability	|O
of	|O
the	|O
areA	|B-PROTEIN
product	|O
to	|O
activate	|O
expression	|O
of	|O
most	|O
genes	|O
under	|O
areA	|B-PROTEIN
control	|O
.	|O

Naval	|O
personnel	|O
who	|O
exceed	|O
standards	|O
for	|O
%	|O
BF	|O
can	|O
be	|O
separated	|O
from	|O
active	|O
duty	|O
.	|O

Weak	|O
promoter	|O
activity	|O
was	|O
observed	|O
for	|O
the	|O
promoter	|O
of	|O
the	|O
C1	|B-PROTEIN
and	|O
C2	|B-PROTEIN
ORFs	|O
(	|O
C1	|B-PROTEIN
-	|O
C2	|B-PROTEIN
gene	|O
)	|O
and	|O
for	|O
the	|O
promoter	|O
of	|O
the	|O
V1	|B-PROTEIN
ORF	|O
.	|O

The	|O
activity	|O
of	|O
the	|O
coat	|B-PROTEIN
protein	|O
promoter	|O
of	|O
chloris	|O
striate	|O
mosaic	|O
virus	|O
is	|O
enhanced	|O
by	|O
its	|O
own	|O
and	|O
C1	|O
-	|O
C2	|B-PROTEIN
gene	|O
products	|O
.	|O

The	|O
amino	|O
acid	|O
sequence	|O
alignment	|O
of	|O
TC	|B-PROTEIN
II	|I-PROTEIN
with	|O
that	|O
of	|O
other	|O
Cbl	|B-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
rat	|O
intrinsic	|B-PROTEIN
factor	|I-PROTEIN
,	|O
human	|O
transcobalamin	|B-PROTEIN
I	|I-PROTEIN
and	|O
porcine	|O
haptocorrin	|B-PROTEIN
)	|O
revealed	|O
only	|O
33%	|O
overall	|O
homology	|O
.	|O

This	|O
short	|O
communication	|O
compares	|O
a	|O
novel	|O
fluorimetric	|O
microplate	|O
enzyme	|O
immunoassay	|O
(	|O
FEIA	|O
)	|O
with	|O
a	|O
commercial	|O
time	|O
-	|O
resolved	|O
fluoroimmunoassay	|O
for	|O
the	|O
determination	|O
of	|O
thyrotropin	|B-PROTEIN
in	|O
dried	|O
blood	|O
spots	|O
.	|O

The	|O
evaluation	|O
was	|O
performed	|O
using	|O
a	|O
retrospective	|O
study	|O
design	|O
with	|O
newborn	|O
blood	|O
samples	|O
from	|O
three	|O
screening	|O
centres	|O
.	|O

A	|O
region	|O
in	|O
the	|O
C	|O
-	|O
terminus	|O
of	|O
adenovirus	|O
2/5	|O
E1a	|B-PROTEIN
protein	|O
is	|O
required	|O
for	|O
association	|O
with	|O
a	|O
cellular	|O
phosphoprotein	|O
and	|O
important	|O
for	|O
the	|O
negative	|O
modulation	|O
of	|O
T24	|O
-	|O
ras	|B-PROTEIN
mediated	|O
transformation	|O
,	|O
tumorigenesis	|O
and	|O
metastasis	|O
.	|O

These	|O
studies	|O
demonstrate	|O
that	|O
both	|O
G	|B-PROTEIN
alpha	|I-PROTEIN
i	|I-PROTEIN
genes	|O
are	|O
dynamically	|O
regulated	|O
in	|O
LLC	|O
-	|O
PK1	|O
cells	|O
by	|O
both	|O
growth	|O
,	|O
differentiation	|O
,	|O
and	|O
hormone	|O
signals	|O
.	|O

Constructs	|O
containing	|O
the	|O
full	|O
-	|O
length	|O
PfCPK	|B-PROTEIN
cDNA	|O
have	|O
been	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
at	|O
a	|O
high	|O
level	|O
to	|O
generate	|O
a	|O
60	|O
-	|O
kDa	|O
recombinant	|O
protein	|O
.	|O

When	|O
ligated	|O
to	|O
the	|O
proIL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
cap	|O
site	|O
-	|O
proximal	|O
region	|O
(	|O
located	|O
between	|O
-	|O
131	|O
to	|O
+	|O
12	|O
)	|O
,	|O
both	|O
the	|O
proIL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
and	|O
the	|O
simian	|B-PROTEIN
virus	|I-PROTEIN
40	|I-PROTEIN
enhancer	|I-PROTEIN
elements	|O
functioned	|O
more	|O
efficiently	|O
in	|O
monocytes	|O
than	|O
in	|O
HeLa	|O
cells	|O
,	|O
which	|O
are	|O
not	|O
normally	|O
competent	|O
for	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
expression	|O
.	|O

Therefore	|O
,	|O
PC	|B-PROTEIN
-	|I-PROTEIN
PLC	|I-PROTEIN
is	|O
a	|O
component	|O
of	|O
a	|O
signal	|O
transduction	|O
pathway	|O
leading	|O
to	|O
transcription	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
and	|O
junB	|B-PROTEIN
that	|O
collaborates	|O
with	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
and	|O
is	|O
independent	|O
of	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
delta	|I-PROTEIN
and	|O
Ras	|B-PROTEIN
activation	|O
.	|O

In	|O
mitogen	|O
-	|O
stimulated	|O
splenocytes	|O
,	|O
Gfi	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
begins	|O
to	|O
rise	|O
at	|O
12	|O
h	|O
after	|O
stimulation	|O
and	|O
reaches	|O
very	|O
high	|O
levels	|O
after	|O
50	|O
h	|O
,	|O
suggesting	|O
that	|O
it	|O
may	|O
be	|O
functionally	|O
involved	|O
in	|O
events	|O
occurring	|O
after	|O
the	|O
interaction	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
with	|O
its	|O
receptor	|O
,	|O
perhaps	|O
during	|O
the	|O
transition	|O
from	|O
the	|O
G1	|O
to	|O
the	|O
S	|O
phase	|O
of	|O
the	|O
cell	|O
cycle	|O
.	|O

We	|O
have	|O
isolated	|O
and	|O
characterized	|O
the	|O
GCD6	|B-PROTEIN
and	|O
GCD7	|B-PROTEIN
genes	|O
and	|O
shown	|O
that	|O
their	|O
products	|O
are	|O
required	|O
to	|O
repress	|O
GCN4	|B-PROTEIN
translation	|O
under	|O
nonstarvation	|O
conditions	|O
.	|O

The	|O
plateau	|O
MO2	|O
value	|O
was	|O
that	|O
predicted	|O
by	|O
allometric	|O
relation	|O
.	|O

While	|O
the	|O
latter	|O
corresponded	|O
to	|O
a	|O
protein	|O
of	|O
824	|O
amino	|O
acids	|O
,	|O
an	|O
upstream	|O
open	|O
reading	|O
frame	|O
(	|O
uORF	|O
)	|O
within	|O
the	|O
5'	|O
leader	|O
could	|O
potentially	|O
encode	|O
a	|O
54	|O
amino	|O
acid	|O
peptide	|O
.	|O

The	|O
SCH9	|B-PROTEIN
protein	|O
kinase	|O
mRNA	|O
contains	|O
a	|O
long	|O
5'	|O
leader	|O
with	|O
a	|O
small	|O
open	|O
reading	|O
frame	|O
.	|O

In	|O
contrast	|O
to	|O
T	|O
cells	|O
,	|O
in	|O
fibroblasts	|O
PILOT	|B-PROTEIN
gene	|O
expression	|O
requires	|O
only	|O
one	|O
signal	|O
(	|O
PMA	|O
)	|O
and	|O
is	|O
not	|O
affected	|O
by	|O
CyA	|O
.	|O

Histochemical	|O
localization	|O
of	|O
GUS	|B-PROTEIN
revealed	|O
promoter	|O
function	|O
in	|O
leaf	|O
epidermis	|O
,	|O
mesophyll	|O
and	|O
vascular	|O
bundles	|O
,	|O
in	|O
the	|O
cortex	|O
and	|O
vascular	|O
cylinder	|O
of	|O
the	|O
root	|O
.	|O

In	|O
order	|O
to	|O
investigate	|O
how	|O
these	|O
expression	|O
patterns	|O
are	|O
established	|O
,	|O
we	|O
fused	|O
promoter	|O
regions	|O
of	|O
an	|O
acidic	|O
and	|O
a	|O
basic	|O
glucanase	|B-PROTEIN
gene	|O
to	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
glucuronidase	|I-PROTEIN
(	|O
GUS	|B-PROTEIN
)	|O
reporter	|O
gene	|O
and	|O
examined	|O
expression	|O
of	|O
these	|O
constructs	|O
in	|O
transgenic	|O
tobacco	|O
plants	|O
.	|O

Southern	|O
blot	|O
analysis	|O
using	|O
probes	|O
from	|O
the	|O
3'	|O
portions	|O
of	|O
the	|O
genomic	|O
and	|O
B.	|O
napus	|O
MA	|B-PROTEIN
and	|O
MB	|B-PROTEIN
cDNA	|O
clones	|O
showed	|O
that	|O
MA	|B-PROTEIN
type	|O
myrosinases	|B-PROTEIN
are	|O
encoded	|O
by	|O
approximately	|O
4	|O
genes	|O
,	|O
while	|O
MB	|B-PROTEIN
type	|O
myrosinases	|B-PROTEIN
are	|O
encoded	|O
by	|O
more	|O
than	|O
10	|O
genes	|O
in	|O
B.	|O
napus	|O
.	|O

Sudomoina	|O
,	|O
A.	|O

Zinc	|O
fingers	|O
(	|O
Zf	|O
)	|O
are	|O
a	|O
common	|O
structural	|O
motif	|O
found	|O
in	|O
many	|O
nucleic	|O
acid	|O
-	|O
binding	|O
proteins	|O
.	|O

The	|O
deduced	|O
bovine	|O
EFIA	|B-PROTEIN
#	|I-PROTEIN
1	|I-PROTEIN
amino	|O
acid	|O
(	|O
aa	|O
)	|O
sequence	|O
is	|O
98%	|O
identical	|O
to	|O
rat	|O
EFIA	|B-PROTEIN
and	|O
100%	|O
identical	|O
to	|O
human	|O
EFIA	|B-PROTEIN
/	|O
DbpB	|B-PROTEIN
/	|O
YB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
family	|O
member	|O
DNA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
B	|I-PROTEIN
(	|O
DbpB	|B-PROTEIN
)	|O
.	|O

Effect	|O
of	|O
tracheal	|O
insufflation	|O
of	|O
deferoxamine	|O
on	|O
acute	|O
ozone	|O
toxicity	|O
in	|O
rats	|O
.	|O

Localization	|O
of	|O
the	|O
insertion	|O
locus	|O
in	|O
the	|O
yeast	|O
genome	|O
and	|O
complementation	|O
studies	|O
with	|O
the	|O
temperature	|O
-	|O
sensitive	|O
mutant	|O
indicate	|O
that	|O
the	|O
two	|O
mutations	|O
are	|O
allelic	|O
.	|O

Replacement	|O
of	|O
the	|O
spacer	|O
sequence	|O
between	|O
the	|O
two	|O
ARMs	|O
with	|O
a	|O
shorter	|O
stretch	|O
of	|O
sequence	|O
also	|O
reduced	|O
RNA	|O
binding	|O
in	|O
vitro	|O
.	|O

Type	|O
II	|O
could	|O
be	|O
divided	|O
further	|O
into	|O
two	|O
forms	|O
(	|O
IIA	|O
and	|O
IIB	|O
)	|O
that	|O
may	|O
represent	|O
two	|O
underscribed	|O
species	|O
or	|O
developmental	|O
stages	|O
of	|O
the	|O
same	|O
species	|O
.	|O

Second	|O
,	|O
the	|O
transcription	|O
factor	|O
Gal	|B-PROTEIN
-	|I-PROTEIN
ER	|I-PROTEIN
was	|O
rendered	|O
more	|O
potent	|O
and	|O
less	|O
susceptible	|O
to	|O
cell	|O
type	|O
-	|O
specific	|O
variation	|O
by	|O
fusing	|O
the	|O
strong	|O
activating	|O
domain	|O
of	|O
the	|O
herpesvirus	|O
protein	|O
VP16	|B-PROTEIN
onto	|O
its	|O
C	|O
terminus	|O
.	|O

The	|O
exogenous	|O
fos	|B-PROTEIN
gene	|O
was	|O
rapidly	|O
induced	|O
to	|O
maximal	|O
levels	|O
within	|O
1-2	|O
hr	|O
of	|O
estrogen	|O
addition	|O
.	|O

Elimination	|O
of	|O
Haemophilus	|O
influenzae	|O
type	|O
b	|O
meningitis	|O
after	|O
introduction	|O
of	|O
vaccination	|O

Endosonography	|O
accurately	|O
assessed	|O
tumor	|O
extension	|O
in	|O
two	|O
T2	|O
tumors	|O
,	|O
14	|O
T3	|O
tumors	|O
,	|O
and	|O
seven	|O
T4	|O
tumors	|O
.	|O

In	|O
the	|O
present	|O
study	|O
we	|O
demonstrated	|O
a	|O
unique	|O
mechanism	|O
of	|O
action	|O
of	|O
8	|O
-	|O
Cl	|O
-	|O
cAMP	|O
in	|O
the	|O
regulation	|O
of	|O
these	|O
kinase	|O
isozymes	|O
in	|O
HL	|O
-	|O
60	|O
human	|O
promyelocytic	|O
leukemia	|O
cells	|O
.	|O

Analysis	|O
of	|O
cell	|O
cycle	|O
regulation	|O
in	|O
the	|O
budding	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
has	|O
shown	|O
that	|O
a	|O
central	|O
regulatory	|O
protein	|O
kinase	|O
,	|O
Cdc28	|B-PROTEIN
,	|O
undergoes	|O
changes	|O
in	|O
activity	|O
through	|O
the	|O
cell	|O
cycle	|O
by	|O
associating	|O
with	|O
distinct	|O
groups	|O
of	|O
cyclins	|B-PROTEIN
that	|O
accumulate	|O
at	|O
different	|O
times	|O
.	|O

Overlapping	|O
clones	|O
representing	|O
full	|O
-	|O
length	|O
cDNAs	|O
for	|O
MMI	|B-PROTEIN
alpha	|I-PROTEIN
were	|O
obtained	|O
from	|O
mouse	|O
brain	|O
.	|O

The	|O
method	|O
involves	|O
preliminary	|O
isolation	|O
of	|O
oxiracetam	|O
and	|O
internal	|O
standard	|O
from	|O
plasma	|O
by	|O
solid	|O
-	|O
phase	|O
extraction	|O
prior	|O
to	|O
the	|O
formation	|O
of	|O
their	|O
n	|O
-	|O
propyl	|O
carbamate	|O
derivatives	|O
.	|O

There	|O
are	|O
,	|O
however	|O
,	|O
several	|O
differences	|O
between	|O
the	|O
two	|O
new	|O
ars	|O
sequences	|O
.	|O

Pathways	|O
linking	|O
the	|O
olfactory	|O
bulbs	|O
with	|O
the	|O
medial	|O
preoptic	|O
anterior	|O
hypothalamus	|O
are	|O
important	|O
for	|O
intermale	|O
aggression	|O
in	|O
mice	|O
.	|O

Pokeweed	|B-PROTEIN
mitogen	|I-PROTEIN
(	|O
PWM	|B-PROTEIN
)	|O
or	|O
anti	|B-PROTEIN
-	|I-PROTEIN
CD3	|I-PROTEIN
significantly	|O
increases	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
messenger	|O
RNA	|O
(	|O
mRNA	|O
)	|O
levels	|O
in	|O
T	|O
cells	|O
.	|O

Following	|O
seizure	|O
induction	|O
,	|O
MABP	|O
increased	|O
to	|O
105	|O
mm	|O
Hg	|O
and	|O
brain	|O
pHi	|O
fell	|O
to	|O
6.79	|O
+	|O
/	|O
-	|O
0.03	|O
within	|O
15	|O
min	|O
and	|O
remained	|O
at	|O
this	|O
level	|O
for	|O
1	|O
h	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
.	|O

In	|O
contrast	|O
,	|O
rats	|O
receiving	|O
U74500A	|O
(	|O
2	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
infusion	|O
commencing	|O
30	|O
min	|O
prior	|O
to	|O
revascularisation	|O
)	|O
exhibited	|O
enhanced	|O
GMBF	|O
throughout	|O
reperfusion	|O
[	|O
PI	|O
10	|O
min	|O
:	|O
3.26	|O
(	|O
2.56-3.63	|O
)	|O
;	|O
120	|O
min	|O
:	|O
2.03	|O
(	|O
1.73-2.25	|O
)	|O
;	|O
240	|O
min	|O
:	|O
2.13	|O
(	|O
1.75-2.44	|O
)	|O
,	|O
p	|O
<	|O
0.01	|O
vs.	|O
controls	|O
and	|O
normals	|O
]	|O
with	|O
complete	|O
muscle	|O
salvage	|O
[	|O
GMV	|O
100%	|O
in	|O
all	|O
reperfused	|O
muscles	|O
,	|O
p	|O
<	|O
0.01	|O
vs.	|O
controls	|O
,	|O
not	|O
significant	|O
(	|O
NS	|O
)	|O
vs.	|O
normals	|O
and	|O
6	|O
h	|O
ischaemia	|O
]	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

Sequencing	|O
of	|O
a	|O
1.3	|O
-	|O
kilobase	|O
fragment	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
TSG6	|B-PROTEIN
gene	|O
identified	|O
TATA	|O
-	|O
like	|O
and	|O
CAAT	|O
sequences	|O
near	|O
the	|O
transcription	|O
start	|O
site	|O
.	|O

The	|O
region	|O
that	|O
imparts	|O
inducibility	|O
by	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
TNF	|B-PROTEIN
(	|O
positions	|O
-	|O
165	|O
to	|O
-	|O
58	|O
)	|O
contains	|O
potential	|O
binding	|O
sites	|O
for	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
.	|O

Ig	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
Ig	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
contain	|O
extended	|O
cytoplasmic	|O
structure	|O
(	|O
61	|O
and	|O
48	|O
amino	|O
acids	|O
,	|O
respectively	|O
)	|O
and	|O
associate	|O
with	|O
cytoplasmic	|O
effectors	|O
indicating	|O
that	|O
they	|O
are	|O
directly	|O
involved	|O
in	|O
signal	|O
transduction	|O
.	|O

Sterile	|O
mutants	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
were	|O
isolated	|O
from	|O
alpha	|O
*	|O
cells	|O
having	|O
the	|O
a	|B-PROTEIN
/	|I-PROTEIN
alpha	|I-PROTEIN
aar1	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
genotype	|O
(	|O
exhibiting	|O
alpha	|O
mating	|O
ability	|O
and	|O
weak	|O
a	|O
mating	|O
ability	|O
as	|O
a	|O
result	|O
of	|O
a	|O
defect	|O
in	|O
a1	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
2	|I-PROTEIN
repression	|O
)	|O
.	|O

We	|O
studied	|O
the	|O
functional	|O
interaction	|O
between	|O
human	|O
embryonic	|O
zeta	|B-PROTEIN
2	|I-PROTEIN
globin	|I-PROTEIN
promoter	|O
and	|O
the	|O
alpha	|B-PROTEIN
globin	|I-PROTEIN
regulatory	|O
element	|O
(	|O
HS	|B-PROTEIN
-	|I-PROTEIN
40	|I-PROTEIN
)	|O
located	|O
40	|O
kb	|O
upstream	|O
of	|O
the	|O
zeta	|B-PROTEIN
2	|I-PROTEIN
globin	|I-PROTEIN
gene	|O
.	|O

It	|O
was	|O
shown	|O
by	|O
transient	|O
expression	|O
assay	|O
that	|O
HS	|B-PROTEIN
-	|I-PROTEIN
40	|I-PROTEIN
behaved	|O
as	|O
an	|O
authentic	|O
enhancer	|O
for	|O
high	|O
-	|O
level	|O
zeta	|B-PROTEIN
2	|I-PROTEIN
globin	|I-PROTEIN
promoter	|O
activity	|O
in	|O
K562	|O
cells	|O
,	|O
an	|O
erythroid	|O
cell	|O
line	|O
of	|O
embryonic	|O
and	|O
/	|O
or	|O
fetal	|O
origin	|O
.	|O

Initial	|O
results	|O
indicate	|O
that	|O
this	|O
23S	|B-PROTEIN
pre	|I-PROTEIN
-	|I-PROTEIN
rRNA	|I-PROTEIN
is	|O
the	|O
same	|O
as	|O
the	|O
species	|O
detected	|O
on	|O
depletion	|O
of	|O
the	|O
small	|B-PROTEIN
nucleolar	|I-PROTEIN
RNA	|I-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
proteins	|I-PROTEIN
NOP1	|O
and	|O
GAR1	|B-PROTEIN
and	|O
in	|O
an	|O
snr10	|B-PROTEIN
mutant	|O
strain	|O
.	|O

Breitbart	|O
,	|O
L.	|O

This	|O
study	|O
evaluates	|O
the	|O
feasibility	|O
of	|O
indirect	|O
mesenteric	|O
lymphangiography	|O
as	|O
a	|O
colonoscopic	|O
technique	|O
in	|O
a	|O
canine	|O
model	|O
.	|O

OBJECTIVE	|O
:	|O
Our	|O
purpose	|O
was	|O
to	|O
determine	|O
the	|O
simultaneous	|O
concentrations	|O
of	|O
serum	|O
cotinine	|O
in	|O
both	|O
fetal	|O
and	|O
maternal	|O
blood	|O
.	|O

Internal	|O
amino	|O
acid	|O
sequence	|O
has	|O
now	|O
been	|O
obtained	|O
from	|O
this	|O
protein	|O
which	|O
shares	|O
50-100%	|O
sequence	|O
identity	|O
with	|O
sequences	|O
encoded	|O
by	|O
mammalian	|O
G	|B-PROTEIN
alpha	|I-PROTEIN
11	|I-PROTEIN
and	|O
G	|B-PROTEIN
alpha	|I-PROTEIN
q	|I-PROTEIN
cDNAs	|O
.	|O

Estradiol	|O
is	|O
known	|O
to	|O
induce	|O
expression	|O
of	|O
certain	|O
proto	|O
-	|O
oncogenes	|O
,	|O
and	|O
this	|O
led	|O
us	|O
to	|O
examine	|O
potential	|O
regulatory	|O
regions	|O
of	|O
the	|O
cellular	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
oncogene	|O
.	|O

Air	|O
lead	|O
was	|O
not	|O
a	|O
significant	|O
explanatory	|O
variable	|O
.	|O

We	|O
now	|O
show	|O
that	|O
regulation	|O
of	|O
flaN	|B-PROTEIN
transcription	|O
in	|O
vivo	|O
depends	|O
on	|O
a	|O
sigma	|B-PROTEIN
54	|I-PROTEIN
promoter	|O
and	|O
two	|O
ftr	|O
elements	|O
located	|O
downstream	|O
of	|O
the	|O
transcription	|O
start	|O
site	|O
at	|O
+	|O
86	|O
(	|O
ftr2	|O
)	|O
and	|O
+	|O
120	|O
(	|O
ftr3	|O
)	|O
.	|O

5	|O
micrograms	|O
/	|O
l	|O
was	|O
detected	|O
in	|O
urine	|O
from	|O
some	|O
non	|O
-	|O
occupationally	|O
exposed	|O
persons	|O
.	|O

Fibular	|O
dimelia	|O
with	|O
deficiency	|O
of	|O
the	|O
tibia	|O
.	|O

This	|O
prospective	|O
study	|O
compared	|O
the	|O
measured	|O
energy	|O
expenditures	|O
of	|O
30	|O
patients	|O
using	|O
indirect	|O
calorimetry	|O
with	|O
their	|O
predicted	|O
basal	|O
energy	|O
expenditure	|O
according	|O
to	|O
the	|O
Harris	|O
-	|O
Benedict	|O
equation	|O
,	|O
or	|O
their	|O
calculated	|O
energy	|O
expenditure	|O
derived	|O
from	|O
basal	|O
energy	|O
expenditure	|O
times	|O
,	|O
an	|O
activity	|O
factor	|O
,	|O
and	|O
a	|O
stress	|O
factor	|O
.	|O

However	|O
,	|O
after	|O
repeated	|O
infections	|O
,	|O
hypobiotic	|O
larvae	|O
were	|O
numerous	|O
.	|O

This	|O
was	|O
performed	|O
in	|O
a	|O
double	|O
blinded	|O
,	|O
randomized	|O
,	|O
placebo	|O
-	|O
controlled	|O
study	|O
.	|O

Group	|O
I	|O
consisted	|O
of	|O
six	|O
noncholestatic	|O
patients	|O
;	|O
group	|O
II	|O
consisted	|O
of	|O
nine	|O
mildly	|O
cholestatic	|O
patients	|O
with	|O
mild	|O
hepatic	|O
impairment	|O
(	|O
conjugated	|O
bilirubin	|O
,	|O
47	|O
mumol	|O
liter	|O
-	|O
1	|O
;	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
,	|O
280	|O
IU	|O
liter	|O
-	|O
1	|O
;	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
glutamyltranspeptidase	|I-PROTEIN
,	|O
190	|O
IU	|O
liter	|O
-	|O
1	|O
)	|O
;	|O
group	|O
III	|O
consisted	|O
of	|O
six	|O
benign	|O
intrahepatic	|O
cholestatic	|O
patients	|O
with	|O
high	|O
isolated	|O
conjugated	|O
hyperbilirubinemia	|O
(	|O
98.1	|O
mumol	|O
liter	|O
-	|O
1	|O
)	|O
.	|O

There	|O
was	|O
either	|O
no	|O
change	|O
or	|O
an	|O
improvement	|O
in	|O
renographic	|O
findings	|O
(	|O
t1/2	|O
time	|O
and	|O
/	|O
or	|O
split	|O
function	|O
)	|O
in	|O
40	|O
patients	|O
(	|O
93%	|O
)	|O
.	|O

We	|O
discuss	|O
the	|O
need	|O
to	|O
use	|O
animals	|O
older	|O
than	|O
3	|O
months	|O
for	|O
the	|O
study	|O
of	|O
'	|O
adult	|O
'	|O
regeneration	|O
phenomena	|O
since	|O
3	|O
-	|O
month	|O
-	|O
old	|O
rats	|O
may	|O
be	|O
somewhat	|O
immature	|O
.	|O

Nuclear	|O
beta	|B-PROTEIN
II	|I-PROTEIN
PKC	|I-PROTEIN
,	|O
like	|O
p34cdc2	|B-PROTEIN
kinase	|I-PROTEIN
,	|O
may	|O
function	|O
to	|O
regulate	|O
nuclear	|O
lamina	|O
structural	|O
stability	|O
during	|O
cell	|O
cycle	|O
.	|O

In	|O
situ	|O
copper	|O
-	|O
phenanthroline	|O
footprinting	|O
of	|O
individual	|O
gel	|O
shift	|O
assembly	|O
intermediates	|O
shows	|O
that	|O
on	|O
the	|O
302	|O
-	|O
nucleotide	|O
G4oric	|O
,	|O
the	|O
first	|O
two	|O
SSB	|B-PROTEIN
tetramers	|O
assemble	|O
at	|O
random	|O
,	|O
but	|O
the	|O
addition	|O
of	|O
more	|O
SSB	|B-PROTEIN
tetramers	|O
results	|O
in	|O
formation	|O
of	|O
a	|O
unique	|O
structure	|O
.	|O

Effects	|O
of	|O
intramammary	|O
endotoxin	|O
infusion	|O
on	|O
milking	|O
-	|O
induced	|O
oxytocin	|B-PROTEIN
release	|O
.	|O

Finger	|B-PROTEIN
associated	|I-PROTEIN
box	|I-PROTEIN
-	|I-PROTEIN
zinc	|I-PROTEIN
finger	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
FAX	|B-PROTEIN
-	|I-PROTEIN
ZFPs	|I-PROTEIN
)	|O
constitute	|O
a	|O
subfamily	|O
of	|O
the	|O
many	|O
C2H2	|B-PROTEIN
type	|I-PROTEIN
ZFPs	|I-PROTEIN
in	|O
Xenopus	|O
laevis	|O
.	|O

Further	|O
evidence	|O
for	|O
a	|O
clustered	|O
organization	|O
of	|O
FAX	|B-PROTEIN
-	|O
ZFP	|B-PROTEIN
transcription	|O
units	|O
is	|O
provided	|O
by	|O
Southern	|O
blot	|O
analysis	|O
of	|O
large	|O
genomic	|O
restriction	|O
fragments	|O
separated	|O
by	|O
transverse	|O
field	|O
gel	|O
electrophoresis	|O
,	|O
and	|O
by	|O
in	|O
situ	|O
hybridization	|O
on	|O
intact	|O
chromosomes	|O
.	|O

A	|O
rat	|O
cDNA	|O
that	|O
encodes	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
has	|O
been	|O
isolated	|O
and	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
to	|O
yield	|O
a	|O
catalytically	|O
active	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
protein	|O
.	|O

Mutational	|O
analyses	|O
have	|O
demonstrated	|O
the	|O
importance	|O
of	|O
sequences	|O
within	|O
the	|O
327	|O
bp	|O
segment	|O
that	|O
contain	|O
a	|O
putative	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
responsive	|I-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CREB	|B-PROTEIN
)	|O
binding	|O
site	|O
for	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
and	|O
PMA	|O
responsiveness	|O
and	|O
putative	|O
PU	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
for	|O
basal	|O
promoter	|O
activity	|O
.	|O

(	|O
1992	|O
)	|O
J.	|O

In	|O
F42A	|O
-	|O
stimulated	|O
internalization	|O
assays	|O
on	|O
forskolin	|O
-	|O
induced	|O
YT	|O
-	|O
1	|O
cells	|O
,	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
alpha	|I-PROTEIN
chain	|O
is	|O
consistently	|O
endocytosed	|O
together	|O
with	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
beta	|I-PROTEIN
subunit	|O
indicating	|O
that	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
alpha	|I-PROTEIN
is	|O
stably	|O
associated	|O
with	|O
the	|O
F42A	|O
-	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
beta	|I-PROTEIN
complex	|O
even	|O
though	|O
the	|O
alpha	|O
-	|O
subunit	|O
contributes	|O
little	|O
if	|O
any	|O
affinity	|O
to	|O
the	|O
F42A	|O
binding	|O
reaction	|O
.	|O

The	|O
microcirculatory	|O
dynamics	|O
of	|O
prostaglandin	|O
E1	|O
and	|O
/	|O
or	|O
nicardipine	|O
and	|O
their	|O
different	|O
reactions	|O
in	|O
the	|O
hyper	|O
-	|O
and	|O
hypodynamic	|O
state	|O
of	|O
septic	|O
shock	|O
in	|O
a	|O
rat	|O
model	|O

We	|O
obtained	|O
the	|O
prevalence	|O
of	|O
IgG	|B-PROTEIN
antibodies	|O
against	|O
Trypanosoma	|O
cruzi	|O
among	|O
1076	|O
blood	|O
donors	|O
at	|O
the	|O
Instituto	|O
Nacional	|O
de	|O
Cardiologia	|O
"	|O
Ignacio	|O
Chavez	|O
"	|O
in	|O
Mexico	|O
City	|O
.	|O

Examination	|O
of	|O
the	|O
immediate	|O
sequence	|O
5'	|O
to	|O
the	|O
mRNA	|O
start	|O
site	|O
reveals	|O
no	|O
TATA	|O
box	|O
and	|O
multiple	|O
known	|O
enhancer	|O
sequences	|O
.	|O

The	|O
short	|O
-	|O
term	|O
synthesis	|O
and	|O
infant	|O
-	|O
regulated	|O
removal	|O
of	|O
milk	|O
in	|O
lactating	|O
women	|O
.	|O

Pseudosubstrate	|O
(	|O
19-36	|O
)	|O
,	|O
derived	|O
from	|O
the	|O
C	|O
-	|O
terminus	|O
of	|O
Ca	|O
-	|O
dependent	|O
PKC	|B-PROTEIN
isotypes	|O
,	|O
inhibited	|O
beta	|B-PROTEIN
-	|I-PROTEIN
PKC	|I-PROTEIN
but	|O
not	|O
nPKC	|B-PROTEIN
activity	|O
using	|O
either	|O
Histone	|B-PROTEIN
IIIS	|I-PROTEIN
or	|O
peptide	|O
(	|O
19-31	|O
)	|O
as	|O
substrate	|O
.	|O

Based	|O
on	|O
these	|O
results	|O
,	|O
a	|O
new	|O
model	|O
for	|O
the	|O
regulation	|O
of	|O
nif	|B-PROTEIN
/	|O
fix	|B-PROTEIN
gene	|O
expression	|O
in	|O
A.	|O
caulinodans	|O
is	|O
proposed	|O
.	|O

Nitric	|O
oxide	|O
inhalation	|O
selectively	|O
reduces	|O
pulmonary	|O
hypertension	|O
in	|O
porcine	|O
endotoxin	|O
shock	|O
and	|O
improves	|O
arterial	|O
oxygenation	|O
and	|O
pH	|O
with	|O
a	|O
marked	|O
attenuation	|O
of	|O
sympathetic	|O
activation	|O
.	|O

B	|O
cell	|O
-	|O
specific	|O
mb	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
B29	|B-PROTEIN
genes	|O
encode	|O
the	|O
alpha	|O
/	|O
beta	|O
components	|O
of	|O
the	|O
BCR	|B-PROTEIN
-	|O
associated	|O
complex	|O
in	|O
mature	|O
sIgM+	|B-PROTEIN
B	|O
cells	|O
.	|O

Bipolarity	|O
in	|O
Jungian	|O
type	|O
theory	|O
and	|O
the	|O
Myers	|O
-	|O
Briggs	|O
Type	|O
Indicator	|O
.	|O

A	|O
variety	|O
of	|O
nuclear	|O
ribonucleoproteins	|O
are	|O
believed	|O
to	|O
associate	|O
directly	|O
with	|O
nascent	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
transcripts	|O
and	|O
remain	|O
associated	|O
during	|O
subsequent	|O
nuclear	|O
RNA	|O
processing	|O
reactions	|O
,	|O
including	|O
pre	|O
-	|O
mRNA	|O
polyadenylation	|O
and	|O
splicing	|O
as	|O
well	|O
as	|O
nucleocytoplasmic	|O
mRNA	|O
transport	|O
.	|O

Mutations	|O
at	|O
three	|O
sites	|O
have	|O
larger	|O
effects	|O
in	|O
muscle	|O
than	|O
nonmuscle	|O
cells	|O
;	|O
an	|O
A	|O
/	|O
T	|O
-	|O
rich	|O
site	|O
mutation	|O
has	|O
a	|O
pronounced	|O
effect	|O
in	|O
both	|O
striated	|O
muscle	|O
types	|O
,	|O
mutations	|O
at	|O
the	|O
MEF1	|B-PROTEIN
(	|O
Right	|O
E	|O
-	|O
box	|O
)	|O
site	|O
are	|O
relatively	|O
specific	|O
to	|O
expression	|O
in	|O
skeletal	|O
muscle	|O
,	|O
and	|O
mutations	|O
at	|O
the	|O
CArG	|O
site	|O
are	|O
relatively	|O
specific	|O
to	|O
expression	|O
in	|O
cardiac	|O
muscle	|O
.	|O

Transient	|O
transfection	|O
analysis	|O
with	|O
these	|O
mutations	|O
revealed	|O
that	|O
only	|O
a	|O
10	|O
-	|O
bp	|O
region	|O
,	|O
containing	|O
precisely	|O
the	|O
Ets	|B-PROTEIN
and	|O
proximal	|O
LyF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
sites	|O
,	|O
was	|O
needed	|O
for	|O
D'	|O
activity	|O
.	|O

However	|O
,	|O
despite	|O
its	|O
relationship	|O
to	|O
the	|O
TR	|B-PROTEIN
,	|O
Rev	|B-PROTEIN
-	|O
Erb	|B-PROTEIN
bound	|O
poorly	|O
to	|O
TR	|B-PROTEIN
binding	|O
sites	|O
.	|O

We	|O
report	|O
here	|O
that	|O
a	|O
25	|O
-	|O
bp	|O
promoter	|O
element	|O
previously	|O
shown	|O
to	|O
be	|O
important	|O
for	|O
the	|O
G1	|O
-	|O
S	|O
activation	|O
of	|O
the	|O
human	|B-PROTEIN
thymidine	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
htk	|B-PROTEIN
)	|O
promoter	|O
in	|O
growth	|O
-	|O
stimulated	|O
cells	|O
is	|O
a	|O
cellular	|O
target	|O
of	|O
cyclin	|B-PROTEIN
A	|I-PROTEIN
and	|O
the	|O
p33cdk2	|B-PROTEIN
complexes	|O
.	|O

These	|O
protective	|O
influences	|O
were	|O
observed	|O
throughout	|O
the	|O
range	|O
of	|O
filling	|O
pressures	|O
measured	|O
,	|O
from	|O
0	|O
to	|O
30	|O
mmHg	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
with	|O
rat	|O
liver	|O
nuclear	|O
extracts	|O
identified	|O
7	|O
major	|O
protein	|O
-	|O
binding	|O
domains	|O
termed	|O
P1	|O
through	|O
P7	|O
in	|O
a	|O
796	|O
base	|O
pair	|O
DNA	|O
fragment	|O
(	|O
base	|O
pairs	|O
-	|O
763	|O
to	|O
+	|O
33	|O
)	|O
.	|O

This	|O
may	|O
account	|O
,	|O
at	|O
least	|O
in	|O
part	|O
,	|O
for	|O
the	|O
ability	|O
of	|O
excess	|O
wt	|O
p53	|B-PROTEIN
to	|O
inhibit	|O
cell	|O
proliferation	|O
and	|O
to	|O
interfere	|O
with	|O
neoplastic	|O
processes	|O
.	|O

Neither	|O
clone	|O
encoded	|O
the	|O
cognate	|O
endonuclease	|O
.	|O

Northern	|O
blot	|O
analysis	|O
of	|O
total	|O
cellular	|O
RNA	|O
indicated	|O
that	|O
xylP	|B-PROTEIN
encodes	|O
a	|O
1.3	|O
-	|O
kb	|O
transcript	|O
which	|O
is	|O
induced	|O
by	|O
xylan	|O
.	|O

The	|O
nifJ	|B-PROTEIN
and	|O
nifH	|B-PROTEIN
promoters	|O
of	|O
Klebsiella	|O
pneumoniae	|O
are	|O
divergently	|O
transcribed	|O
sigma	|B-PROTEIN
54	|I-PROTEIN
-	|O
dependent	|O
promoters	|O
that	|O
are	|O
positively	|O
activated	|O
by	|O
the	|O
NifA	|B-PROTEIN
protein	|O
.	|O

These	|O
data	|O
show	|O
that	|O
PTH	|B-PROTEIN
and	|O
cAMP	|O
can	|O
repress	|O
collagen	|B-PROTEIN
promoter	|O
activity	|O
in	|O
calvariae	|O
from	|O
transgenic	|O
mice	|O
,	|O
suggesting	|O
that	|O
the	|O
alpha	|O
1	|O
(	|O
I	|O
)	|O
collagen	|B-PROTEIN
promoter	|O
may	|O
contain	|O
cis	|O
elements	|O
down	|O
-	|O
stream	|O
of	|O
-	|O
2.3	|O
kilobases	|O
that	|O
mediate	|O
PTH	|B-PROTEIN
and	|O
cAMP	|O
repression	|O
of	|O
collagen	|B-PROTEIN
gene	|O
expression	|O
in	|O
bone	|O
.	|O

Both	|O
inhaled	|O
and	|O
superfused	|O
isoflurane	|O
dilated	|O
the	|O
baseline	|O
vein	|O
diameter	|O
before	|O
stimulation	|O
.	|O

Prevalence	|O
of	|O
rheumatoid	|O
arthritis	|O
and	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
in	|O
women	|O
:	|O
evidence	|O
for	|O
a	|O
secular	|O
decline	|O
.	|O

Although	|O
olfactory	|O
associative	|O
conditioning	|O
in	|O
newborn	|O
rats	|O
produces	|O
marked	|O
structural	|O
and	|O
functional	|O
changes	|O
in	|O
the	|O
olfactory	|O
bulb	|O
,	|O
recent	|O
evidence	|O
suggests	|O
that	|O
extrabulbar	|O
circuits	|O
must	|O
be	|O
involved	|O
in	|O
storing	|O
these	|O
early	|O
memories	|O
.	|O

The	|O
fission	|O
yeast	|O
dsk1+	|B-PROTEIN
gene	|O
,	|O
a	|O
multicopy	|O
suppressor	|O
for	|O
cold	|O
-	|O
sensitive	|O
dis1	|B-PROTEIN
mutants	|O
,	|O
encodes	|O
a	|O
novel	|O
61	|O
-	|O
kd	|O
protein	|O
kinase	|O
.	|O

Closure	|O
of	|O
the	|O
patent	|O
ductus	|O
arteriosus	|O
with	|O
a	|O
Ligaclip	|O
through	|O
a	|O
minithoracotomy	|O
.	|O

Sequence	|O
comparison	|O
between	|O
the	|O
translated	|O
ORF	|O
and	|O
a	|O
protein	|O
database	|O
reveal	|O
between	|O
26.5	|O
and	|O
23.4%	|O
aa	|O
sequence	|O
homology	|O
to	|O
bacterial	|O
transmembrane	|O
(	|B-PROTEIN
TM	|I-PROTEIN
)	|I-PROTEIN
proteins	|I-PROTEIN
including	|O
those	|O
mediating	|O
chloramphenicol	|O
(	|O
Cm	|O
)	|O
and	|O
tetracycline	|O
(	|O
Tc	|O
)	|O
resistance	|O
and	|O
an	|O
arabinose	|O
-	|O
proton	|O
symport	|O
protein	|O
.	|O

The	|O
yeast	|O
gene	|O
that	|O
encodes	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
,	|O
designated	|O
TIF5	|B-PROTEIN
,	|O
has	|O
been	|O
isolated	|O
and	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
to	|O
yield	|O
a	|O
catalytically	|O
active	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
protein	|O
.	|O

The	|O
strategies	|O
by	|O
which	|O
hepatitis	|O
B	|O
and	|O
hepatitis	|O
D	|O
can	|O
be	|O
diminished	|O
and	|O
eventually	|O
eliminated	|O
are	|O
:	|O
immunization	|O
,	|O
measures	|O
to	|O
prevent	|O
exposure	|O
to	|O
infective	|O
blood	|O
or	|O
blood	|O
derivatives	|O
and	|O
education	|O
(	|O
in	|O
particular	|O
awareness	|O
that	|O
hepatitis	|O
B	|O
is	|O
a	|O
sexually	|O
transmitted	|O
disease	|O
)	|O
.	|O

Xylose	|O
-	|O
and	|O
arabinose	|O
-	|O
containing	|O
polymers	|O
were	|O
better	|O
digested	|O
than	|O
was	|O
cellulose	|O
for	|O
both	|O
breads	|O
.	|O

The	|O
technical	|O
construction	|O
of	|O
the	|O
mouth	|O
protectors	|O
is	|O
illustrated	|O
,	|O
as	|O
is	|O
the	|O
need	|O
for	|O
instrumentation	|O
and	|O
its	|O
costs	|O
and	|O
the	|O
materials	|O
required	|O
to	|O
manufacture	|O
these	|O
mouth	|O
protectors	|O
.	|O

The	|O
alpha	|O
-	|O
subunit	|O
by	|O
itself	|O
binds	|O
to	|O
telomeric	|O
DNA	|O
.	|O

We	|O
conclude	|O
that	|O
the	|O
alpha	|O
-	|O
subunit	|O
of	|O
the	|O
telomere	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
like	|O
many	|O
transcription	|O
factors	|O
,	|O
has	|O
separable	|O
DNA	|O
-	|O
binding	|O
and	|O
protein	|O
-	|O
protein	|O
interaction	|O
domains	|O
.	|O

Three	|O
patients	|O
had	|O
well	|O
-	|O
,	|O
6	|O
patients	|O
had	|O
moderately	|O
-	|O
,	|O
and	|O
5	|O
patients	|O
had	|O
poorly	|O
-	|O
differentiated	|O
adenocarcinoma	|O
of	|O
the	|O
prostate	|O
.	|O

Spontaneous	|O
burst	|O
firing	|O
in	|O
cat	|O
primary	|O
auditory	|O
cortex	|O
:	|O
age	|O
and	|O
depth	|O
dependence	|O
and	|O
its	|O
effect	|O
on	|O
neural	|O
interaction	|O
measures	|O
.	|O

By	|O
applying	|O
the	|O
potentiometric	|O
method	|O
,	|O
in	|O
aqueous	|O
medium	|O
of	|O
ionic	|O
strength	|O
mu	|O
=	|O
0.2	|O
,	|O
the	|O
stability	|O
constants	|O
,	|O
log	|O
beta	|O
1	|O
=	|O
4.42	|O
and	|O
log	|O
beta	|O
2	|O
=	|O
8.57	|O
were	|O
obtained	|O
.	|O

Cryopreservation	|O
straws	|O
filled	|O
with	|O
media	|O
plus	|O
additive	|O
are	|O
emersed	|O
below	|O
the	|O
surface	|O
of	|O
an	|O
unprocessed	|O
donor	|O
ejaculate	|O
.	|O

The	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
can	|O
potentially	|O
encode	|O
26	|O
-	|O
and	|O
22	|O
-	|O
kDa	|O
proteins	|O
that	|O
differ	|O
only	|O
in	|O
their	|O
carboxyl	|O
tails	|O
because	|O
of	|O
an	|O
alternative	|O
splicing	|O
mechanism	|O
.	|O

The	|O
active	|O
open	|O
reading	|O
frame	|O
in	|O
the	|O
clone	|O
maps	|O
at	|O
27	|O
min	|O
on	|O
the	|O
E.	|O
coli	|O
chromosome	|O
and	|O
is	|O
identical	|O
in	|O
sequence	|O
to	|O
a	|O
wild	|O
type	|O
counterpart	|O
.	|O

Subsequent	|O
cloning	|O
and	|O
nucleotide	|O
sequence	|O
analysis	|O
of	|O
the	|O
S.	|O
pombe	|O
adenylate	|B-PROTEIN
kinase	|I-PROTEIN
gene	|O
,	|O
adk1	|B-PROTEIN
,	|O
revealed	|O
a	|O
coding	|O
region	|O
of	|O
660	|O
nucleotides	|O
.	|O

Calcification	|O
of	|O
a	|O
cariogenic	|O
Streptococcus	|O
and	|O
of	|O
Corynebacterium	|O
(	|O
Bacterionema	|O
)	|O
matruchotii	|O
.	|O

As	|O
a	|O
result	|O
of	|O
alternative	|O
splicing	|O
,	|O
the	|O
BGP	|B-PROTEIN
gene	|O
is	|O
transcribed	|O
into	|O
at	|O
least	|O
seven	|O
distinct	|O
mRNA	|O
species	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
promoters	|O
for	|O
muMIP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
and	|O
muMIP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
reveals	|O
a	|O
conserved	|O
CK	|O
-	|O
1	|O
element	|O
,	|O
but	|O
transient	|O
expression	|O
studies	|O
in	|O
RAW	|O
264.7	|O
macrophages	|O
with	|O
proximal	|O
fragments	|O
of	|O
either	|O
the	|O
muMIP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
or	|O
the	|O
muMIP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
5'	|O
promoter	|O
fused	|O
to	|O
a	|O
human	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
reporter	|O
gene	|O
link	|O
LPS	|O
-	|O
inducibility	|O
in	|O
both	|O
to	|O
promoter	|O
segments	|O
near	|O
to	|O
,	|O
but	|O
not	|O
identical	|O
with	|O
,	|O
the	|O
consensus	|O
CK	|O
-	|O
1	|O
sequence	|O
.	|O

However	|O
,	|O
essential	|O
contrast	|O
differences	|O
existing	|O
between	|O
the	|O
FSE	|O
sequences	|O
and	|O
their	|O
routine	|O
asymmetric	|O
dual	|O
SE	|O
counterpart	|O
can	|O
be	|O
identified	|O
.	|O

Sequence	|O
analysis	|O
and	|O
identification	|O
of	|O
two	|O
hyp	|B-PROTEIN
regulatory	|O
mutants	|O
.	|O

The	|O
gene	|O
encoding	|O
the	|O
receptor	|O
for	|O
macrophage	|O
colony	|B-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
CSF	|O
-	|O
1	|O
)	|O
,	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fms	|I-PROTEIN
protooncogene	|O
,	|O
is	|O
selectively	|O
expressed	|O
in	|O
immature	|O
and	|O
mature	|O
mononuclear	|O
phagocytes	|O
and	|O
trophoblasts	|O
.	|O

The	|O
level	|O
of	|O
the	|O
SUP4A53T61	|B-PROTEIN
transcript	|O
was	|O
threefold	|O
higher	|O
in	|O
the	|O
tap1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
than	|O
in	|O
the	|O
wild	|O
type	|O
.	|O

This	|O
sequence	|O
similarity	|O
raises	|O
the	|O
possibility	|O
that	|O
GCN1	|B-PROTEIN
interacts	|O
with	|O
ribosomes	|O
or	|O
tRNA	|O
molecules	|O
and	|O
functions	|O
in	|O
conjunction	|O
with	|O
GCN2	|B-PROTEIN
in	|O
monitoring	|O
uncharged	|O
tRNA	|O
levels	|O
during	|O
the	|O
process	|O
of	|O
translation	|O
elongation	|O
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
HB	|I-PROTEIN
(	|O
BSAP	|B-PROTEIN
)	|O
is	|O
a	|O
repressor	|O
of	|O
the	|O
murine	|O
immunoglobulin	|B-PROTEIN
heavy	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
3'	|I-PROTEIN
alpha	|I-PROTEIN
enhancer	|O
at	|O
early	|O
stages	|O
of	|O
B	|O
-	|O
cell	|O
differentiation	|O
.	|O

Since	|O
the	|O
regulation	|O
of	|O
SWI4	|B-PROTEIN
is	|O
required	|O
for	|O
normal	|O
cell	|O
cycle	|O
progression	|O
,	|O
we	|O
have	|O
characterized	|O
cis	|O
-	|O
and	|O
trans	|O
-	|O
acting	|O
regulators	|O
of	|O
SWI4	|B-PROTEIN
transcription	|O
.	|O

It	|O
also	|O
suggests	|O
that	|O
there	|O
is	|O
another	|O
pathway	|O
which	|O
can	|O
activate	|O
SWI4	|B-PROTEIN
transcription	|O
in	|O
the	|O
absence	|O
of	|O
SWI6	|B-PROTEIN
.	|O

Multiple	|O
SWI6	|B-PROTEIN
-	|O
dependent	|O
cis	|O
-	|O
acting	|O
elements	|O
control	|O
SWI4	|B-PROTEIN
transcription	|O
through	|O
the	|O
cell	|O
cycle	|O
.	|O

In	|O
conclusion	|O
,	|O
changes	|O
in	|O
carotid	|O
sinus	|O
stimulation	|O
alters	|O
blood	|O
flow	|O
to	|O
the	|O
hindlimb	|O
through	|O
changes	|O
in	|O
both	|O
Pcrit	|O
and	|O
Ra	|O
.	|O

Multizone	|O
PRK	|O
has	|O
been	|O
suggested	|O
to	|O
increase	|O
the	|O
predictability	|O
of	|O
higher	|O
myopic	|O
corrections	|O
.	|O

In	|O
17	|O
patients	|O
with	|O
deletions	|O
,	|O
the	|O
parental	|O
origin	|O
of	|O
deletion	|O
was	|O
determined	|O
.	|O

The	|O
COL7A1	|B-PROTEIN
gene	|O
,	|O
which	|O
encodes	|O
type	|B-PROTEIN
VII	|I-PROTEIN
collagen	|I-PROTEIN
,	|O
has	|O
been	|O
implicated	|O
as	|O
a	|O
candidate	|O
gene	|O
for	|O
dominantly	|O
and	|O
recessively	|O
inherited	|O
forms	|O
of	|O
dystrophic	|O
epidermolysis	|O
bullosa	|O
.	|O

However	|O
,	|O
study	|O
of	|O
the	|O
productive	|O
gamma	|O
gene	|O
showed	|O
that	|O
the	|O
skipped	|O
variable	|O
exon	|O
was	|O
bounded	|O
by	|O
normal	|O
splicing	|O
signals	|O
and	|O
that	|O
the	|O
adjacent	|O
intron	|O
organization	|O
was	|O
not	|O
altered	|O
.	|O

We	|O
conclude	|O
that	|O
grade	|O
III	|O
BGCT	|O
can	|O
be	|O
treated	|O
by	|O
modified	|O
intralesional	|O
excision	|O
provided	|O
the	|O
articular	|O
surfaces	|O
and	|O
part	|O
of	|O
the	|O
metaphysis	|O
are	|O
intact	|O
.	|O

Second	|O
,	|O
nitrate	|O
induction	|O
of	|O
aeg	|B-PROTEIN
-	|I-PROTEIN
46.5	|I-PROTEIN
operon	|O
expression	|O
is	|O
substantially	|O
enhanced	|O
in	|O
narL	|B-PROTEIN
null	|O
strains	|O
(	|O
M.H.	|O

This	|O
new	|O
knowledge	|O
has	|O
contributed	|O
to	|O
the	|O
development	|O
of	|O
a	|O
successful	|O
immunoprophylactic	|O
strategy	|O
for	|O
eliminating	|O
Hib	|O
disease	|O
.	|O

The	|O
HMG	|B-PROTEIN
CoA	|I-PROTEIN
reductase	|I-PROTEIN
inhibitors	|O
are	|O
the	|O
most	|O
effective	|O
cholesterol	|O
-	|O
lowering	|O
agents	|O
currently	|O
available	|O
.	|O

The	|O
etiology	|O
,	|O
pathology	|O
,	|O
brain	|O
CT	|O
scan	|O
features	|O
,	|O
clinical	|O
manifestations	|O
and	|O
treatment	|O
of	|O
these	|O
accidents	|O
were	|O
discussed	|O
.	|O

Drosophila	|O
230	|O
-	|O
kD	|O
TFIID	|B-PROTEIN
subunit	|O
,	|O
a	|O
functional	|O
homolog	|O
of	|O
the	|O
human	|O
cell	|O
cycle	|O
gene	|O
product	|O
,	|O
negatively	|O
regulates	|O
DNA	|O
binding	|O
of	|O
the	|O
TATA	|O
box	|O
-	|O
binding	|O
subunit	|O
of	|O
TFIID	|B-PROTEIN
.	|O

One	|O
enigmatic	|O
aspect	|O
of	|O
GATA	|B-PROTEIN
factor	|I-PROTEIN
expression	|O
is	|O
that	|O
several	|O
GATA	|B-PROTEIN
proteins	|O
,	|O
which	|O
ostensibly	|O
share	|O
the	|O
same	|O
DNA	|O
-	|O
binding	|O
site	|O
specificity	|O
,	|O
are	|O
coexpressed	|O
in	|O
erythroid	|O
cells	|O
.	|O

Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
a	|O
tissue	|O
-	|O
specific	|O
POU	|B-PROTEIN
domain	|O
factor	|O
obligatory	|O
for	|O
the	|O
appearance	|O
of	|O
three	|O
cell	|O
phenotypes	|O
in	|O
the	|O
anterior	|O
pituitary	|O
gland	|O
.	|O

Maximum	|O
number	|O
of	|O
strains	|O
(	|O
39.1%	|O
)	|O
were	|O
resistant	|O
in	|O
S.	|O
bareilly	|O
serotype	|O
,	|O
followed	|O
by	|O
S.	|O
typhimurium	|O
(	|O
21.7%	|O
)	|O
and	|O
least	|O
in	|O
S.	|O
typhi	|O
(	|O
17.4%	|O
)	|O
.	|O

Biol.	|O

Characterization	|O
and	|O
hormonal	|O
regulation	|O
of	|O
the	|O
promoter	|O
of	|O
the	|O
rat	|O
prostaglandin	|B-PROTEIN
endoperoxide	|I-PROTEIN
synthase	|I-PROTEIN
2	|I-PROTEIN
gene	|O
in	|O
granulosa	|O
cells	|O
.	|O

The	|O
retention	|O
of	|O
75SeHCAT	|O
was	|O
low	|O
.	|O

Patient	|O
characteristics	|O
associated	|O
with	|O
deep	|O
wounds	|O
as	|O
well	|O
as	|O
patient	|O
and	|O
wound	|O
characteristics	|O
predictive	|O
of	|O
the	|O
extent	|O
of	|O
healing	|O
and	|O
time	|O
required	|O
for	|O
healing	|O
were	|O
identified	|O
.	|O

Members	|O
of	|O
the	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
family	|O
of	|O
basic	|O
-	|O
leucine	|O
zipper	|O
(	|B-PROTEIN
bZip	|I-PROTEIN
)	|I-PROTEIN
transcription	|I-PROTEIN
factors	|I-PROTEIN
form	|O
heterodimers	|O
and	|O
bind	|O
to	|O
the	|O
CAAT	|O
box	|O
and	|O
other	|O
sequence	|O
-	|O
related	|O
enhancer	|O
motifs	|O
.	|O

In	|O
mammalian	|O
cells	|O
,	|O
phosphorylation	|O
of	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
inhibits	|O
the	|O
activity	|O
of	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2B	|I-PROTEIN
,	|O
the	|O
GDP	|B-PROTEIN
-	|I-PROTEIN
GTP	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
for	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

In	|O
conclusion	|O
,	|O
these	|O
observations	|O
demonstrated	|O
that	|O
stratification	|O
of	|O
acute	|O
MI	|O
patients	|O
by	|O
plasma	|O
ANF	|B-PROTEIN
level	|O
is	|O
a	|O
useful	|O
non	|O
-	|O
invasive	|O
method	|O
for	|O
predicting	|O
prognosis	|O
and	|O
for	|O
identifying	|O
individuals	|O
at	|O
high	|O
risk	|O
of	|O
cardiac	|O
death	|O
.	|O

Analysis	|O
of	|O
the	|O
binding	|O
of	|O
Lrp	|B-PROTEIN
to	|O
a	|O
set	|O
of	|O
circularly	|O
permuted	|O
DNA	|O
fragments	|O
from	|O
this	|O
region	|O
indicates	|O
that	|O
Lrp	|B-PROTEIN
induces	|O
DNA	|O
bending	|O
.	|O

Yeast	|O
mutants	|O
lacking	|O
a	|O
functional	|O
NOP1	|B-PROTEIN
gene	|O
can	|O
be	|O
complemented	|O
by	|O
human	|O
fibrillarin	|B-PROTEIN
but	|O
are	|O
temperature	|O
sensitive	|O
for	|O
growth	|O
and	|O
impaired	|O
in	|O
pre	|O
-	|O
rRNA	|O
processing	|O
.	|O

The	|O
patients	|O
were	|O
divided	|O
into	|O
ischaemia	|O
and	|O
non	|O
-	|O
ischaemia	|O
groups	|O
on	|O
the	|O
basis	|O
of	|O
the	|O
change	|O
in	|O
lactate	|O
extraction	|O
ratio	|O
during	|O
balloon	|O
inflation	|O
.	|O

Seven	|O
out	|O
of	|O
34	|O
patients	|O
died	|O
,	|O
giving	|O
a	|O
mortality	|O
rate	|O
of	|O
21%	|O
.	|O

A	|O
36	|O
-	|O
kDa	|O
protein	|O
that	|O
was	|O
localized	|O
to	|O
the	|O
membrane	|O
fraction	|O
was	|O
detected	|O
in	|O
minicells	|O
containing	|O
plasmids	|O
with	|O
the	|O
ftsN	|B-PROTEIN
gene	|O
,	|O
confirming	|O
that	|O
FtsN	|B-PROTEIN
was	|O
a	|O
membrane	|O
protein	|O
.	|O

SSG1	|B-PROTEIN
,	|O
a	|O
gene	|O
encoding	|O
a	|O
sporulation	|O
-	|O
specific	|O
1,3	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
glucanase	|I-PROTEIN
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Expression	|O
of	|O
this	|O
protein	|O
in	|O
E.	|O
coli	|O
demonstrated	|O
that	|O
tyrosine	|O
was	|O
incorporated	|O
during	|O
suppression	|O
and	|O
that	|O
yeast	|O
cytoplasmic	|O
TyrRS	|B-PROTEIN
activity	|O
was	|O
produced	|O
.	|O

The	|O
first	|O
involved	|O
complementation	|O
of	|O
a	|O
nonphotosynthetic	|O
mutant	|O
of	|O
Chlamydomonas	|O
,	|O
CC	|O
-	|O
2341	|O
(	|O
ac	|O
-	|O
u	|O
-	|O
g	|O
-	|O
2.3	|O
)	|O
,	|O
which	|O
has	|O
a	|O
frameshift	|O
mutation	|O
in	|O
the	|O
psaB	|B-PROTEIN
gene	|O
,	|O
and	|O
selection	|O
of	|O
photosynthetic	|O
transformants	|O
on	|O
minimal	|O
medium	|O
.	|O

Against	|O
200	|O
strains	|O
of	|O
methicillin	|O
-	|O
resistant	|O
Staphylococcus	|O
aureus	|O
(	|O
MRSA	|O
)	|O
isolated	|O
from	|O
1990	|O
to	|O
1991	|O
,	|O
minimum	|O
inhibitory	|O
concentrations	|O
(	|O
MICs	|O
)	|O
of	|O
a	|O
total	|O
of	|O
15	|O
antibacterial	|O
agents	|O
including	|O
arbekacin	|O
(	|O
ABK	|O
)	|O
were	|O
determined	|O
.	|O

It	|O
is	|O
reported	|O
that	|O
,	|O
at	|O
present	|O
,	|O
most	|O
of	|O
the	|O
MRSAs	|O
spreading	|O
in	|O
Japan	|O
are	|O
acceleratedly	|O
acquiring	|O
resistance	|O
to	|O
many	|O
drugs	|O
,	|O
and	|O
especially	|O
,	|O
they	|O
are	|O
developing	|O
high	|O
resistance	|O
against	|O
beta	|O
-	|O
lactams	|O
.	|O

Beg2	|B-PROTEIN
and	|O
Beg1	|B-PROTEIN
are	|O
regulated	|O
differently	|O
which	|O
may	|O
indicate	|O
variation	|O
in	|O
storage	|O
or	|O
utilization	|O
properties	|O
among	|O
the	|O
barley	|O
globulins	|B-PROTEIN
.	|O

Here	|O
,	|O
we	|O
have	|O
more	|O
closely	|O
investigated	|O
transactivation	|O
of	|O
the	|O
human	|O
HSP70	|B-PROTEIN
promoter	|O
by	|O
Myb	|B-PROTEIN
proteins	|O
.	|O

We	|O
have	|O
found	|O
out	|O
that	|O
one	|O
-	|O
year	|O
-	|O
old	|O
carps	|O
are	|O
extremely	|O
sensitive	|O
to	|O
ichthiomycin	|O
in	|O
concentrations	|O
between	|O
25-125	|O
micrograms	|O
/	|O
dm3	|O
.	|O

RESULTS	|O
:	|O
Statistically	|O
significant	|O
differences	|O
were	|O
obtained	|O
between	|O
group	|O
I	|O
and	|O
II	|O
concerning	|O
the	|O
number	|O
of	|O
patients	|O
in	|O
whom	|O
induced	|O
atrial	|O
fibrillation	|O
with	|O
conduction	|O
by	|O
the	|O
accessory	|O
pathway	|O
and	|O
RR	|O
<	|O
or	|O
=	|O
250	|O
msec	|O
was	|O
found	|O
(	|O
0	|O
vs	|O
6	|O
,	|O
p	|O
=	|O
0.0045	|O
)	|O
.	|O

We	|O
studied	|O
the	|O
effect	|O
of	|O
skinfold	|O
thickness	|O
on	|O
the	|O
correlation	|O
between	|O
serum	|O
total	|O
bilirubin	|O
level	|O
and	|O
transcutaneous	|O
bilirubin	|O
(	|O
TcB	|O
)	|O
readings	|O
.	|O

Both	|O
immunophilins	|B-PROTEIN
may	|O
have	|O
important	|O
roles	|O
in	|O
receptor	|O
assembly	|O
and	|O
may	|O
represent	|O
a	|O
new	|O
category	|O
of	|O
ligand	|O
-	|O
and	|O
calcium	|O
-	|O
dependent	|O
modulators	|O
of	|O
protein	|O
function	|O
.	|O

The	|O
GTPase	|B-PROTEIN
activity	|O
of	|O
CDC42Ce	|B-PROTEIN
is	|O
moderately	|O
stimulated	|O
by	|O
human	|O
n	|B-PROTEIN
-	|I-PROTEIN
chimaerin	|I-PROTEIN
,	|O
a	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
for	|O
the	|O
related	|O
p21	|B-PROTEIN
rac1	|O
.	|O

Tl	|O
-	|O
201	|O
uptake	|O
ratio	|O
of	|O
the	|O
right	|O
ventricle	|O
,	|O
which	|O
represents	|O
the	|O
ratio	|O
of	|O
total	|O
counts	|O
of	|O
the	|O
right	|O
ventricle	|O
to	|O
counts	|O
of	|O
the	|O
administered	|O
dose	|O
of	|O
Tl	|O
-	|O
201	|O
,	|O
was	|O
higher	|O
in	|O
COPD	|O
,	|O
especially	|O
in	|O
pulmonary	|O
emphysema	|O
and	|O
B	|O
type	|O
COPD	|O
by	|O
Burrows	|O
classification	|O
than	|O
in	|O
controls	|O
.	|O

A	|O
second	|O
hydrophobic	|O
domain	|O
,	|O
bordered	|O
by	|O
two	|O
hydrophilic	|O
regions	|O
strongly	|O
suggests	|O
a	|O
transmembrane	|O
region	|O
.	|O

This	|O
gene	|O
spans	|O
23	|O
kb	|O
and	|O
is	|O
composed	|O
of	|O
five	|O
exons	|O
and	|O
four	|O
introns	|O
.	|O

The	|O
remaining	|O
RAD+	|B-PROTEIN
cells	|O
progressed	|O
to	|O
form	|O
microcolonies	|O
(	|O
<	|O
30	|O
cells	|O
)	|O
containing	|O
aberrantly	|O
shaped	|O
inviable	|O
cells	|O
.	|O

The	|O
11	|O
;	|O
22	|O
chromosomal	|O
translocation	|O
specifically	|O
linked	|O
to	|O
Ewing	|O
sarcoma	|O
and	|O
primitive	|O
neuroectodermal	|O
tumor	|O
results	|O
in	|O
a	|O
chimeric	|O
molecule	|O
fusing	|O
the	|O
amino	|O
-	|O
terminal	|O
-	|O
encoding	|O
portion	|O
of	|O
the	|O
EWS	|B-PROTEIN
gene	|O
to	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
DNA	|O
-	|O
binding	|O
domain	|O
encoded	|O
by	|O
the	|O
FLI1	|B-PROTEIN
gene	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
a	|O
range	|O
of	|O
microenvironmental	|O
conditions	|O
exist	|O
within	|O
purified	|O
water	|O
systems	|O
,	|O
leading	|O
to	|O
variable	|O
populations	|O
of	|O
bacteria	|O
.	|O

X	|O
-	|O
linked	|O
liver	|O
glycogenosis	|O
:	|O
localization	|O
and	|O
isolation	|O
of	|O
a	|O
candidate	|O
gene	|O
.	|O

This	|O
conclusion	|O
is	|O
based	|O
on	|O
the	|O
observations	|O
of	|O
the	|O
immunologic	|O
changes	|O
that	|O
characterize	|O
the	|O
acute	|O
stages	|O
of	|O
illness	|O
as	|O
well	|O
as	|O
on	|O
the	|O
demonstrated	|O
association	|O
with	|O
toxin	|O
-	|O
producing	|O
bacteria	|O
in	|O
the	|O
pharynx	|O
and	|O
gastrointestinal	|O
tract	|O
.	|O

Measurement	|O
of	|O
anti	|O
-	|O
HCV	|O
IgM	|B-PROTEIN
antibodies	|O
with	|O
an	|O
experimental	|O
kit	|O

Embryo	|O
coculture	|O
system	|O
may	|O
contribute	|O
to	|O
understand	|O
the	|O
mechanisms	|O
underlying	|O
the	|O
decrease	|O
of	|O
fertility	|O
with	|O
aging	|O
.	|O

These	|O
cell	|O
lines	|O
displayed	|O
methylation	|O
of	|O
the	|O
CpG	|O
island	|O
surrounding	|O
the	|O
first	|O
exon	|O
of	|O
p16INK4A	|B-PROTEIN
and	|O
expressed	|O
abundant	|O
levels	|O
of	|O
a	|O
nontranslated	|O
mRNA	|O
containing	|O
an	|O
alternative	|O
first	|O
exon	|O
(	|O
E1	|O
beta	|O
)	|O
,	|O
as	|O
did	|O
all	|O
other	|O
cell	|O
lines	|O
in	|O
which	|O
the	|O
p16INK4A	|B-PROTEIN
locus	|O
was	|O
not	|O
deleted	|O
.	|O

An	|O
immunoperoxidase	|B-PROTEIN
reaction	|O
,	|O
PAP	|B-PROTEIN
method	|O
,	|O
with	|O
the	|O
antiserum	|O
of	|O
Factor	|B-PROTEIN
VIII	|I-PROTEIN
as	|O
the	|O
primary	|O
antibody	|O
,	|O
was	|O
carried	|O
out	|O
in	|O
the	|O
endometrial	|O
biopsies	|O
to	|O
detect	|O
the	|O
Factor	|B-PROTEIN
VIII	|I-PROTEIN
activity	|O
in	|O
the	|O
endometrial	|O
endothelium	|O
before	|O
and	|O
after	|O
insertion	|O
of	|O
LNG	|O
-	|O
IUD	|O
-	|O
20	|O
.	|O

Umweltchem	|O
.	|O

Egd1p	|B-PROTEIN
is	|O
homologous	|O
to	|O
human	|O
BTF3b	|B-PROTEIN
,	|O
recently	|O
identified	|O
as	|O
the	|O
beta	|O
subunit	|O
of	|O
the	|O
heterodimeric	|O
nascent	|B-PROTEIN
-	|I-PROTEIN
polypeptide	|I-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
complex	|I-PROTEIN
(	|O
NAC	|B-PROTEIN
)	|O
involved	|O
in	|O
ensuring	|O
signal	|O
-	|O
sequence	|O
-	|O
specific	|O
protein	|O
sorting	|O
and	|O
translocation	|O
[	|O
Wiedmann	|O
et	|O
al.	|O
,	|O
Nature	|O
370	|O
(	|O
1994	|O
)	|O
434-440	|O
]	|O
.	|O

Purified	|O
PLB	|B-PROTEIN
showed	|O
optimal	|O
lyase	|B-PROTEIN
activity	|O
at	|O
pH	|O
10.0	|O
.	|O

The	|O
5'	|O
flanking	|O
regions	|O
of	|O
both	|O
pelA	|B-PROTEIN
and	|O
pelB	|B-PROTEIN
were	|O
translationally	|O
fused	|O
to	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
glucuronidase	|I-PROTEIN
gene	|O
and	|O
introduced	|O
into	|O
F.	|O
solani	|O
f	|O
.	|O
sp	|O
.	|O
pisi	|O
,	|O
and	|O
beta	|B-PROTEIN
-	|I-PROTEIN
glucuronidase	|I-PROTEIN
activities	|O
of	|O
the	|O
transformants	|O
were	|O
measured	|O
.	|O

When	|O
nifA	|B-PROTEIN
mRNA	|O
5'	|O
start	|O
points	|O
were	|O
mapped	|O
by	|O
primer	|O
extension	|O
,	|O
both	|O
a	|O
minor	|O
upstream	|O
transcript	|O
(	|O
s	|O
)	|O
starting	|O
45	|O
bp	|O
distal	|O
to	|O
the	|O
anaerobox	|O
and	|O
a	|O
major	|O
downstream	|O
transcript	|O
starting	|O
10	|O
bp	|O
distal	|O
to	|O
the	|O
sigma	|B-PROTEIN
54	|I-PROTEIN
box	|O
were	|O
observed	|O
.	|O

We	|O
failed	|O
to	|O
find	|O
these	|O
data	|O
to	|O
be	|O
useful	|O
in	|O
predicting	|O
the	|O
time	|O
of	|O
onset	|O
of	|O
initial	|O
seizures	|O
after	|O
acute	|O
ischemic	|O
stroke	|O
and	|O
recurrence	|O
.	|O

The	|O
human	|O
papillomavirus	|O
type	|O
16	|O
E7	|B-PROTEIN
protein	|O
complements	|O
adenovirus	|O
type	|O
5	|O
E1A	|B-PROTEIN
amino	|O
-	|O
terminus	|O
-	|O
dependent	|O
transactivation	|O
of	|O
adenovirus	|O
type	|O
5	|O
early	|B-PROTEIN
genes	|I-PROTEIN
and	|O
increases	|O
ATF	|B-PROTEIN
and	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
DNA	|O
binding	|O
activity	|O
.	|O

A	|O
chaotropic	|O
detergent	|O
,	|O
0.1%	|O
Nonidet	|O
P	|O
-	|O
40	|O
,	|O
also	|O
abolished	|O
the	|O
interaction	|O
,	|O
further	|O
supporting	|O
the	|O
hydrophobic	|O
nature	|O
of	|O
the	|O
interaction	|O
.	|O

Contrary	|O
to	|O
expectations	|O
,	|O
we	|O
find	|O
a	|O
relatively	|O
high	|O
level	|O
of	|O
variation	|O
in	|O
the	|O
stripe	|B-PROTEIN
2	|I-PROTEIN
enhancer	|O
region	|O
,	|O
including	|O
point	|O
substitutions	|O
and	|O
insertion	|O
/	|O
deletions	|O
in	|O
binding	|O
sites	|O
,	|O
and	|O
a	|O
comparable	|O
level	|O
of	|O
variation	|O
in	|O
the	|O
other	|O
noncoding	|O
regions	|O
.	|O

Degradation	|O
of	|O
the	|O
soybean	|O
ribulose	|B-PROTEIN
-	|I-PROTEIN
1,5	|I-PROTEIN
-	|I-PROTEIN
bisphosphate	|I-PROTEIN
carboxylase	|I-PROTEIN
small	|O
-	|O
subunit	|O
mRNA	|O
,	|O
SRS4	|B-PROTEIN
,	|O
initiates	|O
with	|O
endonucleolytic	|O
cleavage	|O
.	|O

Cloning	|O
and	|O
sequencing	|O
revealed	|O
that	|O
dMax	|B-PROTEIN
contains	|O
a	|O
deletion	|O
spanning	|O
the	|O
basic	|O
region	|O
and	|O
helix	|O
1	|O
and	|O
the	|O
loop	|O
of	|O
the	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
region	|O
,	|O
presumably	|O
as	|O
a	|O
result	|O
of	|O
alternative	|O
splicing	|O
of	|O
max	|B-PROTEIN
RNA	|O
.	|O

I	|O
report	|O
here	|O
that	|O
induction	|O
of	|O
HSP82	|B-PROTEIN
is	|O
regulated	|O
by	|O
the	|O
early	|O
meiotic	|O
IME1	|B-PROTEIN
-	|O
IME2	|B-PROTEIN
transcriptional	|O
cascade	|O
.	|O

The	|O
domain	|O
structure	|O
of	|O
bovine	|O
LTBP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
very	|O
similar	|O
to	|O
that	|O
of	|O
the	|O
human	|O
LTBP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
containing	|O
20	|O
examples	|O
of	|O
6	|O
-	|O
cysteine	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|O
like	|O
repeats	|O
,	|O
16	|O
of	|O
which	|O
have	|O
the	|O
consensus	|O
sequence	|O
for	|O
calcium	|O
binding	|O
,	|O
together	|O
with	|O
4	|O
examples	|O
of	|O
8	|O
-	|O
cysteine	|O
motifs	|O
characteristic	|O
of	|O
fibrillins	|B-PROTEIN
and	|O
LTBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Similarly	|O
,	|O
expression	|O
of	|O
a	|O
transiently	|O
transfected	|O
wild	|O
-	|O
type	|O
prothymosin	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
as	|O
the	|O
reporter	|O
was	|O
not	|O
affected	|O
by	|O
a	|O
repertoire	|O
of	|O
myc	|B-PROTEIN
-	|O
derived	|O
genes	|O
,	|O
including	|O
myc	|B-PROTEIN
itself	|O
and	|O
dominant	|O
or	|O
recessive	|O
negative	|O
myc	|B-PROTEIN
mutants	|O
.	|O

Differential	|O
regulation	|O
of	|O
the	|O
alpha	|B-PROTEIN
/	|I-PROTEIN
beta	|I-PROTEIN
interferon	|I-PROTEIN
-	|O
stimulated	|O
Jak	|B-PROTEIN
/	|O
Stat	|B-PROTEIN
pathway	|O
by	|O
the	|O
SH2	|B-PROTEIN
domain	|O
-	|O
containing	|O
tyrosine	|O
phosphatase	|O
SHPTP1	|B-PROTEIN
.	|O

We	|O
now	|O
report	|O
the	|O
isolation	|O
and	|O
expression	|O
of	|O
cDNAs	|O
encoding	|O
PTF	|B-PROTEIN
gamma	|O
and	|O
PTF	|B-PROTEIN
delta	|O
,	|O
as	|O
well	|O
as	|O
functional	|O
studies	|O
with	|O
cognate	|O
antibodies	|O
that	|O
recognize	|O
the	|O
native	|O
PTF	|B-PROTEIN
complex	|O
in	|O
HeLa	|O
extracts	|O
.	|O

Results	|O
from	|O
the	|O
mechanism	|O
study	|O
have	|O
revealed	|O
that	|O
YY1	|B-PROTEIN
is	|O
able	|O
to	|O
inhibit	|O
transactivation	|O
mediated	|O
by	|O
either	|O
AP1	|B-PROTEIN
or	|O
the	|O
Sp1	|B-PROTEIN
-	|O
related	|O
protein	|O
,	|O
and	|O
YY1	|B-PROTEIN
suppressive	|O
activity	|O
is	|O
DNA	|O
binding	|O
dependent	|O
.	|O

The	|O
skp1+	|B-PROTEIN
gene	|O
is	|O
not	|O
essential	|O
.	|O

The	|O
TEA1	|B-PROTEIN
(	|O
Ty	|B-PROTEIN
enhancer	|I-PROTEIN
activator	|I-PROTEIN
)	|O
gene	|O
sequence	|O
predicts	|O
a	|O
protein	|O
of	|O
86.9	|O
kDa	|O
whose	|O
N	|O
terminus	|O
contains	|O
a	|O
zinc	|O
cluster	|O
and	|O
dimerization	|O
motif	|O
typical	|O
of	|O
the	|O
Gal4	|B-PROTEIN
-	|O
type	|O
family	|O
of	|O
DNA	|O
-	|O
binding	|O
proteins	|O
.	|O

Refugees	|O
living	|O
in	|O
Lund	|O
and	|O
repatriated	|O
to	|O
Chile	|O
considered	|O
their	|O
health	|O
as	|O
bad	|O
in	|O
a	|O
higher	|O
proportion	|O
than	|O
their	|O
Swedish	|O
counterparts	|O
,	|O
with	|O
an	|O
odds	|O
ratio	|O
of	|O
3.48	|O
(	|O
2.03-5.66	|O
)	|O
and	|O
4.78	|O
(	|O
2.1-10.25	|O
)	|O
respectively	|O
.	|O

This	|O
study	|O
underlines	|O
the	|O
importance	|O
of	|O
terminal	|O
SC5b	|B-PROTEIN
-	|I-PROTEIN
9	|I-PROTEIN
complement	|I-PROTEIN
complex	|O
as	|O
a	|O
suitable	|O
marker	|O
in	|O
the	|O
evaluation	|O
of	|O
complement	|O
activation	|O
during	|O
cardiopulmonary	|O
bypass	|O
.	|O

Videonystagmoscopy	|O
has	|O
been	|O
used	|O
to	|O
subjectively	|O
observe	|O
the	|O
responses	|O
of	|O
the	|O
vestibular	|O
system	|O
in	|O
a	|O
population	|O
of	|O
patients	|O
with	|O
vestibular	|O
deficits	|O
.	|O

The	|O
MCA	|O
and	|O
UA	|O
PI	|O
values	|O
showed	|O
the	|O
greatest	|O
deviation	|O
for	|O
any	|O
single	|O
-	|O
vessel	|O
parameter	|O
.	|O

Striking	|O
sequence	|O
similarities	|O
(	|O
57	|O
and	|O
53%	|O
)	|O
were	|O
observed	|O
with	|O
yeast	|O
mitochondrial	|O
proteins	|O
,	|O
SMF1	|B-PROTEIN
and	|O
SMF2	|B-PROTEIN
,	|O
especially	|O
within	|O
putative	|O
functional	|O
domains	|O
:	|O
exon	|O
6	|O
encoding	|O
the	|O
second	|O
transmembrane	|O
spanning	|O
domain	|O
,	|O
site	|O
of	|O
the	|O
murine	|B-PROTEIN
susceptibility	|I-PROTEIN
mutation	|O
;	|O
and	|O
exon	|O
11	|O
encoding	|O
a	|O
conserved	|O
transport	|O
motif	|O
.	|O

Stems	|O
contain	|O
distinctly	|O
less	|O
P	|B-PROTEIN
protein	|I-PROTEIN
mRNA	|O
and	|O
the	|O
relative	|O
level	|O
in	|O
roots	|O
is	|O
very	|O
low	|O
but	|O
still	|O
clearly	|O
detectable	|O
.	|O

The	|O
B.	|O
germanica	|O
cyclophilin	|B-PROTEIN
amino	|O
acid	|O
sequence	|O
shares	|O
83%	|O
identity	|O
with	|O
the	|O
cytosolic	|O
cyclophilin	|B-PROTEIN
isoform	|O
from	|O
Drosophila	|O
melanogaster	|O
(	|O
Cyp	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

Furthermore	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
soluble	|O
form	|O
of	|O
ERp57	|B-PROTEIN
/	|O
GRP58	|B-PROTEIN
by	|O
Western	|O
blotting	|O
and	|O
biosynthetic	|O
labeling	|O
.	|O

The	|O
minimal	|O
region	|O
of	|O
overlap	|O
of	|O
Langer	|O
-	|O
Giedion	|O
syndrome	|O
deletions	|O
,	|O
previously	|O
identified	|O
by	|O
analysis	|O
of	|O
15	|O
patients	|O
,	|O
was	|O
placed	|O
on	|O
the	|O
map	|O
by	|O
analysis	|O
of	|O
2	|O
patients	|O
whose	|O
deletions	|O
define	|O
the	|O
endpoints	|O
.	|O

Consistent	|O
with	|O
the	|O
hepatic	|O
and	|O
epidermal	|O
expression	|O
of	|O
histidase	|B-PROTEIN
,	|O
this	|O
finding	|O
suggests	|O
that	|O
histidase	|B-PROTEIN
transcription	|O
may	|O
be	|O
regulated	|O
by	|O
these	|O
factors	|O
.	|O

Comparison	|O
of	|O
promoters	|O
repressed	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
reveals	|O
a	|O
weak	|O
consensus	|O
sequence	|O
of	|O
the	|O
initiator	|O
(	|O
Inr	|O
)	|O
element	|O
:	|O
TCA	|O
(	|O
+	|O
1	|O
)	|O
YYYNY	|O
.	|O

The	|O
human	|O
gp39	|B-PROTEIN
promoter	|O
.	|O

Transfection	|O
analyses	|O
indicate	|O
that	|O
mutation	|O
of	|O
any	|O
one	|O
of	|O
these	|O
TGACCT	|O
motifs	|O
or	|O
truncation	|O
of	|O
the	|O
entire	|O
HD	|B-PROTEIN
PPRE	|O
into	|O
a	|O
separate	|O
DR1	|O
and	|O
DR2	|O
element	|O
significantly	|O
reduced	|O
the	|O
transcriptional	|O
response	|O
of	|O
HD	|B-PROTEIN
PPRE	|O
to	|O
peroxisome	|O
proliferators	|O
.	|O

The	|O
site	|O
of	|O
autophosphorylation	|O
is	|O
Tyr397	|O
which	|O
corresponds	|O
to	|O
the	|O
consensus	|O
autophosphorylation	|O
site	|O
of	|O
other	|O
Src	|B-PROTEIN
family	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
.	|O

This	|O
protein	|O
-	|O
protein	|O
interaction	|O
does	|O
not	|O
require	|O
the	|O
simultaneous	|O
binding	|O
of	|O
Oct	|B-PROTEIN
proteins	|O
to	|O
DNA	|O
,	|O
and	|O
high	|O
resolution	|O
footprinting	|O
of	|O
the	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
DNA	|I-PROTEIN
interaction	|O
reveals	|O
that	|O
binding	|O
of	|O
BOB.1	|B-PROTEIN
/	|O
OBF.1	|B-PROTEIN
to	|O
Oct1	|B-PROTEIN
or	|O
Oct2	|B-PROTEIN
does	|O
not	|O
alter	|O
the	|O
interaction	|O
with	|O
DNA	|O
.	|O

Together	|O
,	|O
our	|O
data	|O
suggest	|O
that	|O
the	|O
TR2	|B-PROTEIN
orphan	|O
receptor	|O
may	|O
be	|O
a	|O
master	|O
regulator	|O
in	|O
modulating	|O
the	|O
activation	|O
of	|O
two	|O
key	|O
HREs	|O
,	|O
RARE	|O
beta	|O
and	|O
CRBPIIp	|O
,	|O
involved	|O
in	|O
the	|O
retinoic	|O
acid	|O
signal	|O
transduction	|O
pathway	|O
.	|O

Using	|O
a	|O
series	|O
of	|O
mutant	|O
proteins	|O
,	|O
we	|O
have	|O
characterized	|O
domains	|O
responsible	|O
for	|O
activation	|O
or	|O
repression	|O
.	|O

Unlike	|O
ARF	|B-PROTEIN
,	|O
the	|O
ARP	|B-PROTEIN
immunoreactivity	|O
was	|O
detected	|O
in	|O
plasma	|O
membranes	|O
but	|O
not	|O
in	|O
cytosol	|O
of	|O
fractionated	|O
3T3	|O
-	|O
L1	|O
cells	|O
.	|O

It	|O
is	|O
considered	|O
that	|O
the	|O
recurrent	|O
annular	|O
erythema	|O
is	|O
a	|O
specific	|O
skin	|O
manifestation	|O
of	|O
SjS	|O
with	|O
anti	|O
SS	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
/	|I-PROTEIN
SS	|I-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
antibodies	|O
.	|O

Competition	|O
needs	|O
to	|O
be	|O
better	|O
studied	|O
,	|O
since	|O
in	|O
Central	|O
America	|O
and	|O
Caribean	|O
islands	|O
this	|O
kind	|O
of	|O
study	|O
has	|O
favored	|O
the	|O
biological	|O
control	|O
of	|O
planorbid	|O
species	|O
.	|O

In	|O
this	|O
paper	|O
we	|O
describe	|O
properties	|O
of	|O
the	|O
cdc10	|B-PROTEIN
-	|O
C4	|O
mutant	|O
of	|O
the	|O
fission	|O
yeast	|O
Schizosaccharomyces	|O
pombe	|O
.	|O

TIEG	|B-PROTEIN
expression	|O
in	|O
hFOB	|O
cells	|O
was	|O
highly	|O
induced	|O
by	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
and	|O
bone	|B-PROTEIN
morphogenetic	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
BMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
,	|O
with	|O
a	|O
moderate	|O
induction	|O
by	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
EGF	|B-PROTEIN
)	|O
,	|O
but	|O
no	|O
induction	|O
by	|O
other	|O
growth	|O
factors	|O
/	|O
cytokines	|O
was	|O
observed	|O
.	|O

An	|O
infectious	|O
origin	|O
should	|O
always	|O
be	|O
excluded	|O
since	|O
specific	|O
etiologic	|O
therapy	|O
may	|O
be	|O
implemented	|O
.	|O

The	|O
predicted	|O
protein	|O
products	|O
of	|O
ORFs	|O
N2417	|B-PROTEIN
and	|O
N2403	|B-PROTEIN
present	|O
similarities	|O
with	|O
domains	|O
from	|O
proteins	|O
of	|O
other	|O
organisms	|O
:	|O
the	|O
Candida	|O
maltosa	|O
cycloheximide	|B-PROTEIN
-	|I-PROTEIN
resistance	|I-PROTEIN
protein	|I-PROTEIN
,	|O
the	|O
human	|O
interleukin	|B-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
factor	|I-PROTEIN
(	|O
ILF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
.	|O

In	|O
particular	|O
,	|O
the	|O
highly	|O
expressed	|O
ADH1	|B-PROTEIN
gene	|O
is	|O
represented	|O
in	|O
this	|O
database	|O
by	|O
no	|O
less	|O
than	|O
20	|O
EST	|O
sequences	|O
.	|O

Five	|O
families	|O
of	|O
Ashkenazi	|O
Jewish	|O
descent	|O
carried	|O
the	|O
185delAG	|O
mutation	|O
and	|O
shared	|O
the	|O
same	|O
haplotype	|O
at	|O
eight	|O
polymorphic	|O
markers	|O
spanning	|O
approximately	|O
850	|O
kb	|O
at	|O
BRCA1	|B-PROTEIN
.	|O

The	|O
subjects	|O
from	|O
the	|O
two	|O
regions	|O
with	|O
a	|O
higher	|O
pollution	|O
level	|O
had	|O
lower	|O
FVC	|O
and	|O
FEV1	|O
values	|O
than	|O
those	|O
from	|O
the	|O
Viskovo	|O
region	|O
.	|O

PTP	|B-PROTEIN
-	|I-PROTEIN
S3	|I-PROTEIN
differs	|O
from	|O
PTP	|B-PROTEIN
-	|I-PROTEIN
S4	|I-PROTEIN
in	|O
having	|O
a	|O
deletion	|O
of	|O
19	|O
amino	|O
acids	|O
corresponding	|O
to	|O
exon	|O
E1	|O
.	|O

All	|O
three	|O
NR	|B-PROTEIN
isoforms	|O
are	|O
expressed	|O
in	|O
cv	|O
.	|O

All	|O
three	|O
NR	|B-PROTEIN
isoforms	|O
are	|O
expressed	|O
in	|O
cv	|O
.	|O

The	|O
Arabidopsis	|O
FAD7	|B-PROTEIN
gene	|O
encodes	|O
a	|O
chloroplast	|O
omega	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
fatty	|I-PROTEIN
acid	|I-PROTEIN
desaturase	|I-PROTEIN
that	|O
catalyzes	|O
the	|O
desaturation	|O
of	|O
lipid	|O
-	|O
linked	|O
dienoic	|O
fatty	|O
acids	|O
(	|O
18	|O
:	|O
2	|O
and	|O
16	|O
:	|O
2	|O
)	|O
.	|O

When	|O
differentiated	|O
G0	|O
-	|O
arrested	|O
leaf	|O
cells	|O
were	|O
induced	|O
to	|O
resume	|O
cell	|O
division	|O
by	|O
treatment	|O
with	|O
plant	|O
hormones	|O
,	|O
cycMs4	|B-PROTEIN
transcription	|O
was	|O
induced	|O
before	|O
the	|O
onset	|O
of	|O
DNA	|O
synthesis	|O
.	|O

A	|O
survey	|O
is	|O
given	|O
of	|O
the	|O
pharmacological	|O
backgrounds	|O
that	|O
are	|O
relevant	|O
for	|O
the	|O
drug	|O
treatment	|O
of	|O
essential	|O
hypertension	|O
in	|O
the	|O
elderly	|O
.	|O

Protein	|O
kinases	|O
play	|O
pivotal	|O
roles	|O
in	|O
the	|O
control	|O
of	|O
many	|O
cellular	|O
processes	|O
.	|O

Interestingly	|O
,	|O
internal	|O
and	|O
5'	|O
deletions	|O
revealed	|O
tha	|O
the	|O
distal	|O
promoter	|O
was	|O
not	|O
required	|O
for	|O
full	|O
transcriptional	|O
activity	|O
and	|O
that	|O
the	|O
first	|O
631	|O
base	|O
pairs	|O
of	|O
WNT	|B-PROTEIN
-	|I-PROTEIN
5A	|I-PROTEIN
harbored	|O
the	|O
strongest	|O
promoter	|O
activity	|O
.	|O

The	|O
protein	|O
kinase	|O
domains	|O
of	|O
LIMK1	|B-PROTEIN
and	|O
LIMK2	|B-PROTEIN
are	|O
unique	|O
in	|O
that	|O
they	|O
contain	|O
an	|O
unusual	|O
sequence	|O
motif	|O
Asp	|O
-	|O
Leu	|O
-	|O
Asn	|O
-	|O
Ser	|O
-	|O
His	|O
-	|O
Asn	|O
in	|O
subdomain	|O
VIB	|O
and	|O
a	|O
highly	|O
basic	|O
insert	|O
between	|O
subdomains	|O
VII	|O
and	|O
VIII	|O
.	|O

A	|O
human	|O
recombinant	|O
cDNA	|O
clone	|O
that	|O
encoded	|O
253	|O
amino	|O
acids	|O
residues	|O
of	|O
a	|O
zinc	|B-PROTEIN
-	|I-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
(	|O
THZif	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
was	|O
cloned	|O
by	|O
screening	|O
a	|O
cDNA	|O
library	|O
prepared	|O
from	|O
human	|O
promyelocytic	|O
leukemia	|O
HL60	|O
cells	|O
with	|O
synthetic	|O
oligodeoxynucleotide	|O
probes	|O
that	|O
corresponded	|O
to	|O
the	|O
amino	|O
acid	|O
sequences	|O
of	|O
tryptic	|O
peptides	|O
derived	|O
from	|O
the	|O
DNA	|O
-	|O
binding	|O
protein	|O
specific	|O
for	|O
the	|O
nuclease	|B-PROTEIN
-	|I-PROTEIN
hypersensitive	|I-PROTEIN
element	|I-PROTEIN
(	|O
NHE	|B-PROTEIN
)	|O
of	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
gene	|O
.	|O

Erythrocyte	|O
AA	|O
in	|O
FO+	|O
EPO	|B-PROTEIN
-	|O
supplemented	|O
infants	|O
remained	|O
low	|O
and	|O
below	|O
breast	|O
-	|O
and	|O
placebo	|O
formula	|O
-	|O
fed	|O
levels	|O
.	|O

Taking	|O
into	|O
consideration	|O
weight	|O
and	|O
seasonal	|O
changes	|O
in	|O
bone	|O
mass	|O
,	|O
total	|O
(	|O
TBBMC	|O
)	|O
and	|O
regional	|O
body	|O
bone	|O
mineral	|O
content	|O
were	|O
measured	|O
in	|O
38	|O
women	|O
treated	|O
with	|O
GnRH	|B-PROTEIN
agonists	|O
for	|O
6	|O
months	|O
for	|O
endometriosis	|O
or	|O
leiomyomata	|O
.	|O

The	|O
encoded	|O
polypeptide	|O
is	|O
similar	|O
in	|O
sequence	|O
to	|O
the	|O
ABA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
allergen	|O
of	|O
Ascaris	|O
,	|O
the	|O
gp15/400	|B-PROTEIN
'	|O
ladder	|O
'	|O
protein	|O
of	|O
Brugia	|O
malayi	|O
,	|O
Brugia	|O
pahangi	|O
and	|O
Wuchereria	|O
bancrofti	|O
,	|O
and	|O
a	|O
15	|B-PROTEIN
-	|I-PROTEIN
kDa	|I-PROTEIN
antigen	|I-PROTEIN
of	|O
Dirofilaria	|O
immitis	|O
.	|O

Certain	|O
transcript	|O
patterns	|O
in	|O
Epifagus	|O
plastids	|O
are	|O
highly	|O
complex	|O
and	|O
similar	|O
to	|O
those	|O
of	|O
tobacco	|O
operons	|O
.	|O

Spontaneous	|O
recovery	|O
occurs	|O
within	|O
30	|O
min	|O
to	|O
2	|O
hrs	|O
.	|O

DAF	|B-PROTEIN
is	|O
a	|O
70	|O
kD	|O
glycoprotein	|O
containing	|O
complement	|O
regulatory	|O
short	|O
consensus	|O
repeats	|O
(	|O
SCRs	|O
)	|O
;	|O
its	|O
gene	|O
is	|O
located	|O
in	|O
the	|O
regulation	|B-PROTEIN
of	|I-PROTEIN
complement	|I-PROTEIN
activation	|I-PROTEIN
(	|O
RCA	|B-PROTEIN
)	|O
gene	|O
cluster	|O
on	|O
chromosome	|O
1	|O
and	|O
is	|O
about	|O
40	|O
kb	|O
in	|O
size	|O
.	|O

The	|O
XS2	|B-PROTEIN
gene	|O
down	|O
-	|O
regulates	|O
but	|O
does	|O
not	|O
abolish	|O
expression	|O
of	|O
LU	|B-PROTEIN
genes	|O
and	|O
does	|O
not	|O
affect	|O
expression	|O
of	|O
CD44	|B-PROTEIN
.	|O

Diabetes	|O
care	|O
:	|O
a	|O
guideline	|O
to	|O
the	|O
facilities	|O
needed	|O
to	|O
support	|O
internationally	|O
endorsed	|O
standards	|O
.	|O

There	|O
is	|O
no	|O
TATA	|O
box	|O
around	|O
the	|O
transcriptional	|O
start	|O
points	|O
(	|O
tsp	|O
)	|O
,	|O
as	|O
determined	|O
by	|O
primer	|O
extension	|O
analysis	|O
.	|O

According	|O
to	|O
the	|O
investigation	|O
,	|O
the	|O
recent	|O
burst	|O
of	|O
pseudoterranovosis	|O
in	|O
this	|O
area	|O
can	|O
be	|O
attributed	|O
to	|O
the	|O
increased	|O
presence	|O
of	|O
sea	|O
lions	|O
,	|O
which	|O
proliferate	|O
in	|O
the	|O
Arctic	|O
region	|O
,	|O
then	|O
migrate	|O
to	|O
the	|O
northern	|O
Japan	|O
Sea	|O
and	|O
eat	|O
the	|O
intermediate	|O
host	|O
fish	|O
.	|O

In	|O
summary	|O
,	|O
the	|O
efficacies	|O
of	|O
adjuvant	|O
carboplatin	|O
and	|O
of	|O
abdominal	|O
radiotherapy	|O
seem	|O
to	|O
be	|O
identical	|O
.	|O

To	|O
identify	|O
some	|O
of	|O
the	|O
genes	|O
expressed	|O
in	|O
LPS	|O
-	|O
activated	|O
coelomocytes	|O
,	|O
we	|O
sequenced	|O
randomly	|O
chosen	|O
clones	|O
from	|O
a	|O
directionally	|O
constructed	|O
cDNA	|O
library	|O
to	|O
produce	|O
a	|O
set	|O
of	|O
expressed	|O
sequence	|O
tags	|O
(	|O
ESTs	|O
)	|O
.	|O

Characterization	|O
of	|O
an	|O
EcR	|B-PROTEIN
/	|O
USP	|B-PROTEIN
heterodimer	|O
target	|O
site	|O
that	|O
mediates	|O
ecdysone	|O
responsiveness	|O
of	|O
the	|O
Drosophila	|O
Lsp	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
.	|O

Thus	|O
,	|O
SPECT	|O
was	|O
not	|O
as	|O
sensitive	|O
as	|O
PET	|O
in	|O
this	|O
activation	|O
task	|O
.	|O

Transcriptional	|O
activation	|O
of	|O
the	|O
chicken	|O
lysozyme	|B-PROTEIN
gene	|O
by	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
Bp65	|I-PROTEIN
(	|O
RelA	|B-PROTEIN
)	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
,	|O
but	|O
not	|O
by	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
Bp50	|I-PROTEIN
.	|O

The	|O
results	|O
indicate	|O
that	|O
the	|O
bradycardic	|O
agents	|O
alinidine	|O
and	|O
zatebradine	|O
do	|O
not	|O
exert	|O
antiarrhythmic	|O
efficacy	|O
against	|O
SVT	|O
induced	|O
during	|O
subacute	|O
myocardial	|O
infarction	|O
in	|O
conscious	|O
dogs	|O
.	|O

In	|O
vivo	|O
,	|O
selective	|O
activation	|O
of	|O
SAPKs	|B-PROTEIN
stimulates	|O
formation	|O
of	|O
the	|O
ternary	|O
complex	|O
containing	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
and	|O
the	|O
serum	|O
response	|O
element	|O
,	|O
and	|O
enhances	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
dependent	|O
transcription	|O
.	|O

An	|O
epidemic	|O
of	|O
hepatitis	|O
B	|O
virus	|O
infection	|O
among	|O
intravenous	|O
drug	|O
users	|O
in	|O
Iceland	|O
.	|O

The	|O
gene	|O
was	|O
uniquely	|O
mapped	|O
with	|O
odds	|O
>	|O
1,000	|O
:	|O
1	|O
on	|O
chromosome	|O
3p	|O
in	|O
Centre	|O
d'	|O
Etude	|O
du	|O
Polymorphisme	|O
Humain	|O
pedigrees	|O
.	|O

Three	|O
of	|O
these	|O
subunits	|O
are	|O
also	|O
homologous	|O
to	|O
the	|O
dimeric	|O
POR	|B-PROTEIN
from	|O
a	|O
mesophilic	|O
archaeon	|O
,	|O
Halobacterium	|O
halobium	|O
(	|O
21%	|O
identity	|O
)	|O
.	|O

The	|O
transposon	|O
-	|O
inactivated	|O
gene	|O
,	|O
designated	|O
pilP	|B-PROTEIN
,	|O
is	|O
525	|O
bp	|O
long	|O
,	|O
potentially	|O
encoding	|O
a	|O
19.1	|O
-	|O
kDa	|O
protein	|O
precursor	|O
that	|O
contains	|O
a	|O
typical	|O
membrane	|O
lipoprotein	|O
leader	|O
sequence	|O
.	|O

Cheung	|O
and	|O
S.	|O

Upstream	|O
of	|O
the	|O
dra	|B-PROTEIN
gene	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
313	|O
amino	|O
acids	|O
was	|O
identified	|O
.	|O

Sucrose	|O
-	|O
specific	|O
regulation	|O
of	|O
scrB	|B-PROTEIN
was	|O
also	|O
lost	|O
upon	|O
deletion	|O
of	|O
4	|O
bp	|O
of	|O
a	|O
palindromic	|O
sequence	|O
(	|O
OB	|O
)	|O
covering	|O
positions	|O
+	|O
6	|O
to	|O
+	|O
21	|O
downstream	|O
of	|O
the	|O
scrB	|B-PROTEIN
transcriptional	|O
start	|O
site	|O
.	|O

In	|O
E.	|O
coli	|O
,	|O
CheW	|B-PROTEIN
mediates	|O
the	|O
physical	|O
coupling	|O
of	|O
the	|O
receptors	|O
to	|O
the	|O
kinase	|O
CheA	|B-PROTEIN
.	|O

The	|O
promoter	|O
of	|O
the	|O
first	|O
gene	|O
,	|O
epiF	|B-PROTEIN
,	|O
responded	|O
to	|O
the	|O
activator	|O
protein	|O
EpiQ	|B-PROTEIN
and	|O
contained	|O
a	|O
palindromic	|O
sequence	|O
similar	|O
to	|O
the	|O
EpiQ	|B-PROTEIN
binding	|O
site	|O
of	|O
the	|O
epiA	|B-PROTEIN
promoter	|O
,	|O
which	|O
is	|O
also	|O
activated	|O
by	|O
EpiQ	|B-PROTEIN
.	|O

CXC	|O
chemokines	|O
bind	|O
to	|O
unique	|O
sets	|O
of	|O
selectivity	|O
determinants	|O
that	|O
can	|O
function	|O
independently	|O
and	|O
are	|O
broadly	|O
distributed	|O
on	|O
multiple	|O
domains	|O
of	|O
human	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
receptor	|I-PROTEIN
B.	|I-PROTEIN

Oligodeoxynucleotides	|O
antisense	|O
to	|O
the	|O
predicted	|O
translation	|O
initiation	|O
regions	|O
of	|O
ICP4	|B-PROTEIN
and	|O
pp38	|B-PROTEIN
mRNAs	|O
inhibited	|O
proliferation	|O
of	|O
MSB1	|O
cells	|O
but	|O
not	|O
MDCC	|O
-	|O
CU91	|O
(	|O
CU91	|O
)	|O
reticuloendotheliosis	|O
virus	|O
-	|O
transformed	|O
cells	|O
.	|O

Retroviral	|O
replication	|O
requires	|O
that	|O
a	|O
portion	|O
of	|O
the	|O
primary	|O
transcripts	|O
generated	|O
from	|O
proviral	|O
DNA	|O
be	|O
spliced	|O
to	|O
serve	|O
as	|O
mRNA	|O
for	|O
the	|O
envelope	|B-PROTEIN
protein	|O
and	|O
in	|O
Rous	|O
sarcoma	|O
virus	|O
as	|O
src	|B-PROTEIN
mRNA	|O
.	|O

In	|O
this	|O
case	|O
the	|O
degree	|O
of	|O
promoter	|O
methylation	|O
,	|O
which	|O
could	|O
extend	|O
beyond	|O
the	|O
T	|O
-	|O
DNA	|O
borders	|O
,	|O
was	|O
not	|O
correlated	|O
with	|O
the	|O
reduction	|O
in	|O
steady	|O
-	|O
state	|O
poly	|O
(	|O
A	|O
)	|O
+	|O
mRNA	|O
levels	|O
,	|O
the	|O
silenced	|O
state	|O
was	|O
transmitted	|O
through	|O
meiosis	|O
and	|O
reactivation	|O
lasted	|O
several	|O
generations	|O
.	|O

Thus	|O
,	|O
the	|O
consensus	|O
sequences	|O
for	|O
phosphatase	|O
regulation	|O
are	|O
5'	|O
-	|O
GCACGTGGG	|O
-	|O
3'	|O
and	|O
5'	|O
-	|O
GCACGTTTT	|O
-	|O
3'	|O
which	|O
differ	|O
from	|O
the	|O
binding	|O
sequences	|O
for	|O
the	|O
Cpflp	|B-PROTEIN
protein	|O
required	|O
for	|O
transcription	|O
of	|O
the	|O
genes	|O
in	|O
methionine	|O
biosynthesis	|O
and	|O
for	|O
centromere	|O
function	|O
.	|O

Here	|O
we	|O
report	|O
that	|O
the	|O
proline	|O
-	|O
rich	|O
region	|O
of	|O
CAP	|B-PROTEIN
is	|O
recognized	|O
by	|O
the	|O
SH3	|B-PROTEIN
domains	|O
of	|O
several	|O
proteins	|O
,	|O
including	|O
the	|O
yeast	|O
actin	|O
-	|O
associated	|O
protein	|O
Abp1p	|B-PROTEIN
.	|O

We	|O
have	|O
identified	|O
and	|O
characterized	|O
a	|O
vitamin	|O
D	|O
response	|O
element	|O
(	|O
VDRE	|O
)	|O
in	|O
the	|O
promoter	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
.	|O

In	|O
addition	|O
to	|O
protein	|O
binding	|O
at	|O
sequences	|O
known	|O
to	|O
be	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
transcription	|O
,	|O
genomic	|O
footprinting	|O
of	|O
the	|O
entire	|O
promoter	|O
region	|O
also	|O
showed	|O
that	|O
a	|O
protein	|O
factor	|O
is	|O
constitutively	|O
bound	|O
to	|O
the	|O
first	|O
intron	|O
of	|O
the	|O
rep3	|B-PROTEIN
gene	|O
.	|O

Differentiation	|O
was	|O
not	|O
observed	|O
after	|O
cellular	|O
expression	|O
of	|O
GTPase	|B-PROTEIN
-	|O
deficient	|O
forms	|O
of	|O
alpha	|B-PROTEIN
i2	|I-PROTEIN
or	|O
alpha	|B-PROTEIN
0	|I-PROTEIN
,	|O
indicating	|O
selectivity	|O
for	|O
the	|O
Gq	|B-PROTEIN
family	|O
of	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
.	|O

Consistent	|O
with	|O
a	|O
possible	|O
role	|O
in	|O
transcription	|O
,	|O
Paf1p	|B-PROTEIN
is	|O
localized	|O
to	|O
the	|O
nucleus	|O
.	|O

By	|O
comparing	|O
the	|O
abundances	|O
of	|O
many	|O
yeast	|O
transcripts	|O
in	|O
isogenic	|O
wild	|O
-	|O
type	|O
and	|O
paf1	|B-PROTEIN
mutant	|O
strains	|O
,	|O
we	|O
have	|O
identified	|O
genes	|O
whose	|O
expression	|O
is	|O
affected	|O
by	|O
PAF1	|B-PROTEIN
.	|O

Paf1p	|B-PROTEIN
may	|O
therefore	|O
be	|O
required	|O
for	|O
both	|O
positive	|O
and	|O
negative	|O
regulation	|O
of	|O
subsets	|O
of	|O
yeast	|O
genes	|O
.	|O

Using	|O
a	|O
high	|O
-	|O
copy	|O
suppression	|O
strategy	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
yeast	|O
gene	|O
(	|O
UBS1	|B-PROTEIN
)	|O
whose	|O
elevated	|O
expression	|O
suppresses	|O
the	|O
conditional	|O
cell	|O
cycle	|O
defects	|O
associated	|O
with	|O
cdc34	|B-PROTEIN
mutations	|O
.	|O

Molecular	|O
characterization	|O
of	|O
malignant	|O
melanoma	|O
of	|O
soft	|O
parts	|O
or	|O
soft	|O
tissue	|O
clear	|O
cell	|O
sarcoma	|O
which	|O
shares	|O
t	|O
(	|O
12	|O
;	|O
22	|O
)	|O
chromosome	|O
translocation	|O
revealed	|O
fusion	|O
of	|O
EWS	|B-PROTEIN
with	|O
a	|O
transcriptional	|O
factor	|O
gene	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Clones	|O
that	|O
expressed	|O
DBD	|O
exhibited	|O
a	|O
dominant	|O
negative	|O
phenotype	|O
and	|O
did	|O
not	|O
elicit	|O
antiviral	|O
activity	|O
against	|O
vesicular	|O
stomatitis	|O
virus	|O
(	|O
VSV	|O
)	|O
infection	|O
upon	|O
IFN	|B-PROTEIN
treatment	|O
.	|O

Abp1	|B-PROTEIN
preferentially	|O
binds	|O
to	|O
multiple	|O
sites	|O
in	|O
ARS	|B-PROTEIN
3002	|I-PROTEIN
and	|O
to	|O
the	|O
DNA	|O
polymer	|O
poly	|O
[	|O
d	|O
(	|O
A.T	|O
)	|O
]	|O
.	|O

Identification	|O
,	|O
purification	|O
,	|O
and	|O
molecular	|O
cloning	|O
of	|O
autonomously	|B-PROTEIN
replicating	|I-PROTEIN
sequence	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
from	|O
fission	|O
yeast	|O
Schizosaccharomyces	|O
pombe	|O
.	|O

A	|O
short	|O
open	|O
reading	|O
frame	|O
(	|O
ORF2	|O
)	|O
,	|O
of	|O
unknown	|O
function	|O
,	|O
is	|O
present	|O
in	|O
all	|O
FIV	|O
isolates	|O
.	|O

The	|O
patient	|O
was	|O
homozygous	|O
for	|O
the	|O
underlying	|O
mutation	|O
,	|O
which	|O
was	|O
found	|O
to	|O
be	|O
a	|O
G	|O
-	|O
-	|O
>	|O
T	|O
transversion	|O
within	|O
the	|O
acceptor	|O
splice	|O
site	|O
between	|O
intron	|O
e	|O
and	|O
exon	|O
6	|O
,	|O
abolishing	|O
normal	|O
RNA	|O
splicing	|O
.	|O

These	|O
regions	|O
overlap	|O
with	|O
the	|O
HIT	|B-PROTEIN
protein	|O
similarity	|O
regions	|O
.	|O

We	|O
tested	|O
10	|O
rats	|O
with	|O
electrophysiologically	|O
guided	|O
,	|O
ibotenic	|O
acid	|O
lesions	|O
of	|O
the	|O
PBN	|O
(	|O
PBNx	|O
)	|O
to	|O
determine	|O
whether	|O
they	|O
could	|O
acquire	|O
a	|O
LiCl	|O
-	|O
induced	|O
CTA	|O
to	|O
l	|O
-	|O
alanine	|O
(	|O
0.3	|O
M	|O
)	|O
or	|O
demonstrate	|O
a	|O
sodium	|O
appetite	|O
following	|O
furosemide	|O
treatment	|O
and	|O
overnight	|O
access	|O
to	|O
sodium	|O
deficient	|O
chow	|O
.	|O

Liposomal	|O
Amphotericin	|O
-	|O
B	|O
failed	|O
in	|O
6/7	|O
patients	|O
with	|O
culture	|O
-	|O
proven	|O
mycosis	|O
who	|O
died	|O
from	|O
infection	|O
with	|O
Aspergillus	|O
(	|O
n	|O
=	|O
2	|O
)	|O
and	|O
Candida	|O
(	|O
n	|O
=	|O
4	|O
)	|O
,	|O
respectively	|O
.	|O

Mg2+	|O
and	|O
Mn2+	|O
compete	|O
for	|O
binding	|O
sites	|O
,	|O
with	|O
the	|O
former	|O
having	|O
lower	|O
affinity	|O
.	|O

Magnetic	|O
storm	|O
indicators	|O
could	|O
be	|O
used	|O
in	|O
medicine	|O
,	|O
in	|O
geophysics	|O
and	|O
for	|O
special	|O
purposes	|O
.	|O

Transgenic	|O
tobacco	|O
plants	|O
(	|O
ppa	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
constitutively	|O
expressing	|O
Escherichia	|O
coli	|O
pyrophosphatase	|B-PROTEIN
behind	|O
the	|O
35S	|B-PROTEIN
CaMV	|O
promoter	|O
accumulate	|O
high	|O
levels	|O
of	|O
soluble	|O
sugars	|O
in	|O
their	|O
leaves	|O
[	|O
27	|O
]	|O
.	|O

Human	|O
LAF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
readily	|O
hybridized	|O
with	|O
genes	|O
in	|O
mouse	|O
and	|O
chicken	|O
,	|O
thus	|O
showing	|O
that	|O
this	|O
gene	|O
family	|O
has	|O
been	|O
highly	|O
conserved	|O
during	|O
vertebrate	|O
evolution	|O
.	|O

Hb	|B-PROTEIN
levels	|O
remained	|O
adequate	|O
(	|O
Hb	|B-PROTEIN
=	|O
10.68	|O
+	|O
/	|O
-	|O
0.77	|O
g	|O
/	|O
dl	|O
)	|O
after	|O
14.6	|O
+	|O
/	|O
-	|O
7.64	|O
months	|O
.	|O

CBT	|O
is	|O
discussed	|O
in	|O
comparison	|O
with	|O
the	|O
Wisconsin	|O
Card	|O
Sorting	|O
Test	|O
as	|O
a	|O
potential	|O
cognitive	|O
activation	|O
task	|O
for	|O
functional	|O
neuroimaging	|O
of	|O
the	|O
frontal	|O
lobes	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
although	|O
218leu	|O
retains	|O
normal	|O
transactivation	|O
activity	|O
on	|O
a	|O
p53	|B-PROTEIN
promoter	|O
in	|O
yeast	|O
at	|O
physiological	|O
temperatures	|O
,	|O
it	|O
is	|O
not	|O
capable	|O
of	|O
normal	|O
p53	|B-PROTEIN
function	|O
in	|O
the	|O
presence	|O
of	|O
a	|O
248trp	|B-PROTEIN
allele	|I-PROTEIN
in	|O
SNU	|O
-	|O
C5	|O
cells	|O
.	|O

Cycles	|O
were	|O
repeated	|O
every	|O
3	|O
weeks	|O
.	|O

Neither	|O
class	|O
II	|O
nor	|O
IV	|O
infections	|O
precluded	|O
transplantation	|O
.	|O

Although	|O
a	|O
great	|O
deal	|O
is	|O
understood	|O
about	|O
how	|O
bHLH	|B-PROTEIN
factors	|I-PROTEIN
activate	|O
gene	|O
transcription	|O
via	|O
E	|O
-	|O
box	|O
DNA	|O
consensus	|O
sequences	|O
,	|O
studies	|O
of	|O
bHLH	|B-PROTEIN
factor	|I-PROTEIN
function	|O
in	|O
higher	|O
eukaryotes	|O
often	|O
have	|O
been	|O
hindered	|O
by	|O
the	|O
presence	|O
of	|O
multiple	|O
family	|O
members	|O
.	|O

Mobility	|O
and	|O
supershift	|O
assays	|O
demonstrated	|O
that	|O
upstream	|B-PROTEIN
stimulatory	|I-PROTEIN
factor	|I-PROTEIN
(	|O
USF	|B-PROTEIN
)	|O
and	|O
Sp1	|B-PROTEIN
bind	|O
to	|O
the	|O
former	|O
elements	|O
and	|O
competition	|O
experiments	|O
confirmed	|O
that	|O
CREB	|B-PROTEIN
/	|O
ATF	|B-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
bind	|O
to	|O
the	|O
CRE	|O
/	|O
TRE	|O
element	|O
.	|O

Upstream	|O
of	|O
-	|O
37	|O
,	|O
the	|O
5'	|O
untranslated	|O
sequences	|O
of	|O
the	|O
isolates	|O
differ	|O
in	|O
both	|O
length	|O
and	|O
sequence	|O
.	|O

In	|O
these	|O
cases	|O
,	|O
greatly	|O
increased	|O
human	|B-PROTEIN
chorionic	|I-PROTEIN
gonadotropin	|I-PROTEIN
(	|O
hCG	|B-PROTEIN
)	|O
levels	|O
and	|O
suppressed	|O
TSH	|B-PROTEIN
levels	|O
suggest	|O
that	|O
hCG	|B-PROTEIN
has	|O
thyrotropic	|O
activity	|O
.	|O

High	|O
fibrinogen	|B-PROTEIN
levels	|O
could	|O
thus	|O
be	|O
a	|O
risk	|O
for	|O
perioperative	|O
thrombosis	|O
.	|O

Strontium	|O
chloride	|O
Sr	|O
89	|O
is	|O
costly	|O
,	|O
but	|O
preliminary	|O
analysis	|O
indicates	|O
that	|O
it	|O
may	|O
reduce	|O
management	|O
expenditures	|O
overall	|O
.	|O
(	|O
ABSTRACT	|O
TRUNCATED	|O
AT	|O
250	|O
WORDS	|O
)	|O

We	|O
propose	|O
that	|O
epigenetic	|O
features	|O
of	|O
tissue	|O
-	|O
specific	|O
control	|O
and	|O
of	|O
the	|O
control	|O
of	|O
allelic	|O
expression	|O
are	|O
intricately	|O
linked	|O
.	|O

This	|O
study	|O
determined	|O
the	|O
arthritogenic	|O
potential	|O
of	|O
silicone	|O
gel	|O
by	|O
either	|O
mixing	|O
it	|O
with	|O
bovine	|B-PROTEIN
collagen	|I-PROTEIN
II	|I-PROTEIN
(	|O
BII	|B-PROTEIN
)	|O
or	|O
by	|O
injecting	|O
silicone	|O
gel	|O
alone	|O
in	|O
DA	|O
rats	|O
.	|O

SBF	|B-PROTEIN
binds	|O
to	|O
the	|O
promoter	|O
prior	|O
to	|O
the	|O
activation	|O
of	|O
transcription	|O
in	|O
late	|O
G1	|O
,	|O
suggesting	|O
that	|O
Cln	|B-PROTEIN
/	|O
Cdc28	|B-PROTEIN
kinase	|O
regulates	|O
the	|O
ability	|O
of	|O
previously	|O
bound	|O
SBF	|B-PROTEIN
to	|O
activate	|O
transcription	|O
.	|O

However	|O
,	|O
it	|O
remains	|O
an	|O
open	|O
question	|O
whether	|O
vertebrate	|O
Hox	|B-PROTEIN
genes	|O
expressed	|O
under	|O
the	|O
control	|O
of	|O
Drosophila	|O
regulatory	|O
sequences	|O
can	|O
substitute	|O
the	|O
function	|O
of	|O
Drosophila	|O
Hox	|B-PROTEIN
genes	|O
.	|O

This	|O
approach	|O
places	|O
gHoxb	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
into	|O
the	|O
normal	|O
embryonic	|O
spatiotemporal	|O
context	|O
in	|O
which	|O
lab	|O
acts	|O
.	|O

This	|O
5'	|O
splice	|O
site	|O
sequence	|O
was	|O
required	|O
for	|O
enhanced	|O
polyadenylation	|O
and	|O
was	|O
recognized	|O
by	|O
both	|O
U1	|B-PROTEIN
small	|O
nuclear	|O
ribonucleoproteins	|O
(	|O
snRNPs	|O
)	|O
and	|O
alternative	|B-PROTEIN
splicing	|I-PROTEIN
factor	|I-PROTEIN
/	|O
splicing	|B-PROTEIN
factor	|I-PROTEIN
2	|I-PROTEIN
(	|O
ASF	|B-PROTEIN
/	|O
SF2	|B-PROTEIN
)	|O
.	|O

This	|O
analysis	|O
revealed	|O
that	|O
SAP	|B-PROTEIN
145	|I-PROTEIN
,	|O
together	|O
with	|O
four	|O
other	|O
SF3a	|B-PROTEIN
/	|O
SF3b	|B-PROTEIN
subunits	|O
,	|O
UV	|O
cross	|O
-	|O
links	|O
to	|O
pre	|O
-	|O
mRNA	|O
in	|O
a	|O
20	|O
-	|O
nucleotide	|O
region	|O
upstream	|O
of	|O
the	|O
BPS	|O
.	|O

We	|O
propose	|O
that	|O
CTS1	|B-PROTEIN
and	|O
CTS2	|B-PROTEIN
of	|O
Ci	|O
are	|O
members	|O
of	|O
two	|O
distinct	|O
classes	|O
of	|O
fungal	|O
chitinases	|B-PROTEIN
,	|O
an	|O
observation	|O
not	|O
previously	|O
reported	|O
for	|O
a	|O
single	|O
fungus	|O
.	|O

Although	|O
the	|O
consumption	|O
of	|O
myoglobin	|B-PROTEIN
-	|O
bound	|O
O2	|O
(	|O
MbO2	|O
)	|O
stores	|O
in	|O
seal	|O
muscles	|O
has	|O
been	|O
demonstrated	|O
in	|O
seal	|O
muscles	|O
during	|O
laboratory	|O
simulations	|O
of	|O
diving	|O
,	|O
this	|O
may	|O
not	|O
be	|O
a	|O
feature	|O
of	|O
normal	|O
field	|O
diving	|O
in	|O
which	|O
measurements	|O
of	|O
heart	|O
rate	|O
and	|O
lactate	|O
production	|O
show	|O
marked	|O
differences	|O
from	|O
the	|O
profound	|O
diving	|O
response	|O
induced	|O
by	|O
forced	|O
immersion	|O
.	|O

The	|O
human	|O
purH	|B-PROTEIN
cDNA	|O
is	|O
1776	|O
base	|O
pairs	|O
in	|O
length	|O
encoding	|O
for	|O
a	|O
591	|O
-	|O
amino	|O
acid	|O
polypeptic	|O
(	|O
Mr	|O
=	|O
64,425	|O
)	|O
.	|O

The	|O
Saccharomyces	|O
cerevisiae	|O
spindle	|O
pole	|O
body	|O
duplication	|O
gene	|O
MPS1	|B-PROTEIN
is	|O
part	|O
of	|O
a	|O
mitotic	|O
checkpoint	|O
.	|O

In	|O
our	|O
opinion	|O
,	|O
the	|O
SM	|O
-	|O
CMA	|O
system	|O
is	|O
,	|O
despite	|O
some	|O
shortcomings	|O
in	|O
its	|O
user	|O
-	|O
interface	|O
,	|O
a	|O
useful	|O
and	|O
versatile	|O
instrument	|O
for	|O
examination	|O
of	|O
human	|O
semen	|O
samples	|O
,	|O
with	|O
desirable	|O
features	|O
.	|O

The	|O
purpose	|O
of	|O
the	|O
study	|O
reported	|O
here	|O
was	|O
to	|O
investigate	|O
whether	|O
differences	|O
in	|O
T1	|O
and	|O
T2	|O
between	|O
tumors	|O
are	|O
mainly	|O
a	|O
consequence	|O
of	|O
differences	|O
in	|O
the	|O
fractional	|O
volume	|O
of	|O
the	|O
extracellular	|O
compartment	|O
.	|O

A	|O
mutant	|O
areA	|B-PROTEIN
product	|O
truncated	|O
immediately	|O
after	|O
the	|O
last	|O
residue	|O
of	|O
the	|O
highly	|O
conserved	|O
GATA	|B-PROTEIN
(	|O
DNA	|O
-	|O
binding	|O
)	|O
domain	|O
retains	|O
partial	|O
function	|O
.	|O

Oligonucleotides	|O
,	|O
designed	|O
on	|O
the	|O
basis	|O
of	|O
conserved	|O
flanking	|O
amino	|O
acid	|O
sequence	|O
segments	|O
within	|O
the	|O
catalytic	|O
domain	|O
of	|O
eukaryotic	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
(	|O
PKC	|B-PROTEIN
)	|O
proteins	|O
,	|O
were	|O
used	|O
as	|O
primers	|O
for	|O
polymerase	|O
chain	|O
reactions	|O
to	|O
amplify	|O
a	|O
427	|O
-	|O
bp	|O
chromosomal	|O
DNA	|O
fragment	|O
from	|O
the	|O
filamentous	|O
fungus	|O
Trichoderma	|O
reesei	|O
.	|O

Disruption	|O
of	|O
RB	|B-PROTEIN
/	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
interaction	|O
by	|O
single	|O
point	|O
mutations	|O
in	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
enhances	|O
S	|O
-	|O
phase	|O
entry	|O
and	|O
apoptosis	|O
.	|O

Apparent	|O
loss	|O
of	|O
differentiation	|O
markers	|O
characterizes	|O
advanced	|O
malignant	|O
neoplasms	|O
.	|O

This	|O
region	|O
contains	|O
a	|O
motif	|O
with	|O
partial	|O
identity	|O
with	|O
the	|O
binding	|O
site	|O
for	|O
the	|O
ubiquitous	|O
transcription	|O
factor	|O
upstream	|B-PROTEIN
stimulatory	|I-PROTEIN
factor	|I-PROTEIN
(	|O
USF	|B-PROTEIN
)	|O
,	|O
which	|O
binds	|O
to	|O
the	|O
human	|O
insulin	|B-PROTEIN
promoter	|O
.	|O

The	|O
method	|O
has	|O
been	|O
satisfactorily	|O
applied	|O
to	|O
the	|O
determination	|O
of	|O
paracetamol	|O
in	|O
pharmaceutical	|O
formulations	|O
and	|O
biological	|O
fluids	|O
.	|O

These	|O
primers	|O
yielded	|O
a	|O
PCR	|O
product	|O
of	|O
a	|O
characteristic	|O
length	|O
within	|O
most	|O
Xanthomonas	|O
species	|O
and	|O
pathovars	|O
tested	|O
.	|O

The	|O
Clb5	|B-PROTEIN
kinase	|I-PROTEIN
,	|O
which	|O
promotes	|O
S	|O
phase	|O
,	|O
remains	|O
active	|O
during	|O
the	|O
G2	|O
-	|O
phase	|O
arrest	|O
of	|O
cells	|O
of	|O
the	|O
parental	|O
strain	|O
,	|O
but	|O
its	|O
activity	|O
declines	|O
rapidly	|O
in	|O
sim	|B-PROTEIN
mutants	|O
.	|O

The	|O
C	|O
/	|O
D	|O
ratio	|O
was	|O
equal	|O
to	|O
or	|O
over	|O
0.6	|O
in	|O
9	|O
cases	|O
(	|O
16	|O
eyes	|O
)	|O
,	|O
and	|O
the	|O
values	|O
were	|O
inconsistent	|O
between	|O
both	|O
eyes	|O
in	|O
55%	|O
of	|O
the	|O
patients	|O
.	|O

Rad6	|B-PROTEIN
mutants	|O
display	|O
a	|O
remarkably	|O
pleiotropic	|O
phenotype	|O
,	|O
implicating	|O
the	|O
protein	|O
in	|O
DNA	|O
damage	|O
-	|O
induced	|O
mutagenesis	|O
,	|O
postreplication	|O
repair	|O
,	|O
repression	|O
of	|O
retrotransposition	|O
,	|O
and	|O
sporulation	|O
.	|O

RNase	|B-PROTEIN
protection	|O
assays	|O
revealed	|O
a	|O
correlation	|O
between	|O
the	|O
levels	|O
of	|O
dorsal	|O
and	|O
ventral	|O
skin	|O
expression	|O
with	|O
pigmentation	|O
/	|O
phaeomelanin	|O
phenotypes	|O
.	|O

Molecular	|O
cloning	|O
,	|O
expression	|O
pattern	|O
,	|O
and	|O
chromosomal	|O
localization	|O
of	|O
human	|O
CDKN2D	|B-PROTEIN
/	|O
INK4d	|B-PROTEIN
,	|O
an	|O
inhibitor	|O
of	|O
cyclin	|B-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

Overproduction	|O
of	|O
HrcA	|B-PROTEIN
protein	|O
from	|O
a	|O
second	|O
copy	|O
of	|O
hrcA	|B-PROTEIN
derived	|O
from	|O
a	|O
plasmid	|O
(	|O
phrcA+	|B-PROTEIN
)	|O
in	|O
B.	|O
subtilis	|O
wild	|O
-	|O
type	|O
and	|O
delta	|O
hrcA	|B-PROTEIN
strains	|O
prevented	|O
heat	|O
shock	|O
induction	|O
of	|O
the	|O
dnaK	|B-PROTEIN
and	|O
groE	|B-PROTEIN
operons	|O
at	|O
the	|O
level	|O
of	|O
transcription	|O
almost	|O
completely	|O
and	|O
strongly	|O
reduced	|O
the	|O
amounts	|O
of	|O
mRNA	|O
at	|O
a	|O
low	|O
temperature	|O
as	|O
well	|O
.	|O

We	|O
report	|O
the	|O
molecular	|O
cloning	|O
and	|O
functional	|O
characterization	|O
of	|O
USF2	|B-PROTEIN
isoforms	|O
,	|O
corresponding	|O
to	|O
a	|O
44	|O
-	|O
kDa	|O
subunit	|O
,	|O
USF2a	|B-PROTEIN
,	|O
and	|O
a	|O
new	|O
38	|O
-	|O
kDa	|O
subunit	|O
,	|O
USF2b	|B-PROTEIN
,	|O
generated	|O
by	|O
differential	|O
splicing	|O
.	|O

The	|O
preferential	|O
heterodimerization	|O
of	|O
USF	|B-PROTEIN
subunits	|O
was	|O
reproduced	|O
ex	|O
vivo	|O
,	|O
while	|O
the	|O
in	|O
vitro	|O
association	|O
of	|O
cotranslated	|O
subunits	|O
,	|O
or	|O
recombinant	|O
USF	|B-PROTEIN
proteins	|O
,	|O
appeared	|O
to	|O
be	|O
random	|O
.	|O

Activated	|O
PKR	|B-PROTEIN
may	|O
exist	|O
as	|O
a	|O
dimer	|O
and	|O
phosphorylates	|O
the	|O
eukaryotic	|O
translation	|B-PROTEIN
initiation	|I-PROTEIN
factor	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
subunit	|O
(	|O
cIF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
to	|O
inhibit	|O
polypeptide	|O
chain	|O
initiation	|O
.	|O

GRP78	|B-PROTEIN
,	|O
a	|O
molecular	|O
chaperone	|O
expressed	|O
in	|O
the	|O
endoplasmic	|O
reticulum	|O
,	|O
is	|O
a	|O
"	|O
glucose	|O
-	|O
regulated	|O
protein	|O
"	|O
induced	|O
by	|O
stress	|O
responses	|O
that	|O
deplete	|O
glucose	|O
or	|O
intracisternal	|O
calcium	|O
or	|O
otherwise	|O
disrupt	|O
glycoprotein	|O
trafficking	|O
.	|O

The	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
receptor	|I-PROTEIN
is	|O
a	|O
seven	|O
-	|O
transmembrane	|O
spanning	|O
receptor	|O
coupled	|O
to	|O
specific	|O
heterotrimeric	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
including	|O
Gi	|B-PROTEIN
and	|O
G16	|B-PROTEIN
.	|O

In	|O
a	|O
second	|O
series	|O
of	|O
experiments	|O
,	|O
the	|O
efficacy	|O
of	|O
PDC	|O
/	|O
HDC	|O
Ac	|O
was	|O
evaluated	|O
in	|O
both	|O
single	|O
and	|O
multiple	|O
dose	|O
regiments	|O
.	|O

To	|O
elucidate	|O
the	|O
functional	|O
significance	|O
of	|O
Fyn	|B-PROTEIN
in	|O
the	|O
expression	|O
of	|O
viral	|O
promoters	|O
,	|O
we	|O
transfected	|O
a	|O
Fyn	|B-PROTEIN
-	|O
expression	|O
vector	|O
together	|O
with	|O
a	|O
reporter	|O
plasmid	|O
containing	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
gene	|O
driven	|O
by	|O
HIV	|B-PROTEIN
LTR	|I-PROTEIN
into	|O
a	|O
human	|O
T	|O
cell	|O
line	|O
,	|O
Jurkat	|O
.	|O

We	|O
conducted	|O
a	|O
prospective	|O
,	|O
randomized	|O
controlled	|O
trial	|O
of	|O
metoprolol	|O
,	|O
a	|O
selective	|O
beta	|O
-	|O
blocker	|O
for	|O
prevention	|O
of	|O
gastrointestinal	|O
bleeding	|O
from	|O
portal	|O
hypertension	|O
in	|O
29	|O
non	|O
-	|O
selected	|O
patients	|O
with	|O
liver	|O
disease	|O
and	|O
previous	|O
gastrointestinal	|O
bleeding	|O
.	|O

A	|O
genetic	|O
and	|O
molecular	|O
analysis	|O
of	|O
non	|O
-	|O
inducible	|O
qutA	|B-PROTEIN
mutants	|O
showed	|O
that	|O
all	|O
23	|O
mutations	|O
analysed	|O
map	|O
within	|O
the	|O
N	|O
-	|O
terminal	|O
half	|O
of	|O
the	|O
encoded	|O
QUTA	|B-PROTEIN
protein	|O
.	|O

These	|O
studies	|O
indicate	|O
that	|O
the	|O
acidimetric	|O
test	|O
was	|O
less	|O
sensitive	|O
than	|O
the	|O
chromogenic	|O
cephalosporin	|O
substrates	|O
and	|O
that	|O
nitrocefin	|O
and	|O
S1	|O
could	|O
be	|O
used	|O
to	|O
screen	|O
for	|O
beta	|B-PROTEIN
-	|I-PROTEIN
lactamase	|I-PROTEIN
production	|O
in	|O
these	|O
tested	|O
species	|O
.	|O

Suppressors	|O
of	|O
defective	|O
silencing	|O
in	|O
yeast	|O
:	|O
effects	|O
on	|O
transcriptional	|O
repression	|O
at	|O
the	|O
HMR	|B-PROTEIN
locus	|O
,	|O
cell	|O
growth	|O
and	|O
telomere	|O
structure	|O
.	|O

Although	|O
ANP	|B-PROTEIN
induced	|O
systemic	|O
capillary	|O
filtration	|O
,	|O
in	|O
the	|O
calf	|O
,	|O
filtration	|O
was	|O
reduced	|O
with	|O
ANP	|B-PROTEIN
.	|O

Recent	|O
literature	|O
has	|O
suggested	|O
that	|O
beta	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
transferrin	|I-PROTEIN
can	|O
also	|O
be	|O
used	|O
as	|O
a	|O
clinical	|O
marker	|O
for	|O
perilymph	|O
.	|O

With	|O
current	|O
methodology	|O
beta	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
transferrin	|I-PROTEIN
does	|O
not	|O
appear	|O
to	|O
be	|O
a	|O
reliable	|O
clinical	|O
marker	|O
for	|O
perilymph	|O
in	|O
the	|O
operative	|O
setting	|O
.	|O

The	|O
hIGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
gene	|O
has	|O
two	|O
promoters	|O
,	|O
P1	|O
and	|O
P2	|O
.	|O

Gel	|O
mobility	|O
shift	|O
assays	|O
indicated	|O
that	|O
at	|O
least	|O
four	|O
nuclear	|O
proteins	|O
with	|O
distinct	|O
biochemical	|O
and	|O
binding	|O
properties	|O
possess	|O
the	|O
ability	|O
to	|O
bind	|O
the	|O
3	|O
beta	|O
I	|O
-	|O
A	|O
element	|O
to	|O
produce	|O
four	|O
DNA	|O
-	|O
protein	|O
complexes	|O
(	|O
R1	|O
to	|O
R4	|O
)	|O
.	|O

Sixty	|O
-	|O
five	|O
patients	|O
(	|O
aged	|O
between	|O
3	|O
years	|O
5	|O
months	|O
and	|O
60	|O
years	|O
)	|O
suffering	|O
from	|O
medically	|O
resistant	|O
temporal	|O
lobe	|O
epilepsy	|O
(	|O
TLE	|O
)	|O
were	|O
operated	|O
on	|O
over	|O
a	|O
period	|O
of	|O
33	|O
months	|O
in	|O
Bethel	|O
Epilepsy	|O
Center	|O
.	|O

Significant	|O
correlations	|O
existed	|O
between	|O
FEV1	|O
and	|O
the	|O
corresponding	|O
values	|O
of	|O
Raw	|O
,	|O
MEF50	|O
and	|O
MEF25	|O
,	|O
although	|O
there	|O
were	|O
considerable	|O
individual	|O
differences	|O
between	|O
test	|O
results	|O
.	|O

(	|O
1989	|O
)	|O
,	|O
which	|O
is	|O
identical	|O
to	|O
the	|O
SSC1	|B-PROTEIN
gene	|O
(	|O
Smith	|O
et	|O
al.	|O
,	|O
1988	|O
)	|O
.	|O

This	|O
region	|O
also	|O
contains	|O
a	|O
gene	|O
specifying	|O
a	|O
Leu	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
precursor	|O
and	|O
a	|O
remnant	|O
of	|O
a	|O
tau	|O
element	|O
.	|O

Occupational	|O
exposure	|O
to	|O
hepatitis	|O
B	|O
virus	|O
and	|O
human	|O
immunodeficiency	|O
virus	|O
:	|O
a	|O
comparative	|O
risk	|O
analysis	|O
.	|O

Hybrid	|O
female	|O
mice	|O
(	|O
C57BL	|O
x	|O
CBA	|O
)	|O
were	|O
paired	|O
with	|O
breeder	|O
males	|O
(	|O
CD	|O
-	|O
1	|O
)	|O
and	|O
LNG	|O
pellets	|O
were	|O
implanted	|O
on	|O
day	|O
0	|O
,	|O
the	|O
day	|O
on	|O
which	|O
copulation	|O
plugs	|O
were	|O
found	|O
,	|O
or	|O
on	|O
day	|O
2	|O
or	|O
day	|O
3	|O
in	|O
the	|O
postcoital	|O
period	|O
.	|O

This	|O
gene	|O
encodes	|O
a	|O
putative	|O
transcription	|O
factor	|O
with	|O
regions	|O
of	|O
homology	|O
to	|O
several	|O
other	|O
proteins	|O
including	|O
the	|O
zinc	|O
fingers	|O
and	|O
other	|O
domains	|O
of	|O
the	|O
Drosophila	|O
trithorax	|B-PROTEIN
gene	|O
product	|O
,	|O
and	|O
the	|O
"	|O
AT	|O
-	|O
hook	|O
"	|O
DNA	|O
-	|O
binding	|O
motif	|O
of	|O
high	|B-PROTEIN
mobility	|I-PROTEIN
group	|I-PROTEIN
proteins	|O
.	|O

Using	|O
reference	|O
probes	|O
as	|O
internal	|O
standards	|O
,	|O
we	|O
show	|O
that	|O
the	|O
ost	|B-PROTEIN
transcription	|O
unit	|O
is	|O
located	|O
within	|O
the	|O
cytogenetic	|O
band	|O
interval	|O
89A1	|O
,	|O
2	|O
on	|O
the	|O
right	|O
arm	|O
of	|O
the	|O
third	|O
chromosome	|O
,	|O
and	|O
that	|O
it	|O
exerts	|O
diagnostic	|O
segmentation	|O
gene	|O
expression	|O
patterns	|O
in	|O
the	|O
embryo	|O
.	|O

The	|O
purified	|O
recombinant	|O
enzyme	|O
catalyzed	|O
specific	|O
phosphoryl	|O
transfer	|O
from	|O
ATP	|O
to	|O
UMP	|O
and	|O
CMP	|O
.	|O

Studies	|O
on	|O
the	|O
life	|O
cycle	|O
of	|O
Haplorchis	|O
pumilio	|O
(	|O
Looss	|O
,	|O
1896	|O
)	|O
Looss	|O
,	|O
1899	|O
with	|O
morphological	|O
redescription	|O
of	|O
larval	|O
and	|O
adult	|O
stages	|O
.	|O

Regressing	|O
microaneurysms	|O
in	|O
5	|O
cases	|O
of	|O
hepatitis	|O
B	|O
virus	|O
related	|O
polyarteritis	|O
nodosa	|O
.	|O

During	|O
the	|O
following	|O
pregnancy	|O
ultrasonographic	|O
studies	|O
of	|O
the	|O
male	|O
fetus	|O
in	|O
the	|O
16th	|O
week	|O
of	|O
gestation	|O
revealed	|O
severe	|O
micrognathia	|O
,	|O
short	|O
and	|O
wide	|O
thumbs	|O
,	|O
and	|O
big	|O
toes	|O
,	|O
and	|O
bowed	|O
tibiae	|O
.	|O

Despite	|O
an	|O
overall	|O
survival	|O
rate	|O
of	|O
43%	|O
,	|O
survival	|O
to	|O
discharge	|O
varied	|O
greatly	|O
(	|O
0	|O
to	|O
100%	|O
)	|O
among	|O
the	|O
24	|O
diagnostic	|O
groups	|O
:	|O
tumor	|O
lysis	|O
syndrome	|O
and	|O
systemic	|O
lupus	|O
erythematosus	|O
(	|O
3/3	|O
patients	|O
each	|O
,	|O
100%	|O
)	|O
,	|O
hemolytic	|O
uremic	|O
syndrome	|O
(	|O
8/9	|O
patients	|O
,	|O
89%	|O
)	|O
.	|O

One	|O
hundred	|O
units	|O
/	|O
kg	|O
of	|O
recombinant	|B-PROTEIN
human	|I-PROTEIN
erythropoietin	|I-PROTEIN
(	|O
rhEPO	|B-PROTEIN
)	|O
was	|O
given	|O
subcutaneously	|O
3	|O
times	|O
a	|O
week	|O
for	|O
3	|O
weeks	|O
.	|O

A	|O
3	|O
-	|O
week	|O
regimen	|O
of	|O
erythropoietin	|B-PROTEIN
may	|O
help	|O
prevent	|O
the	|O
donor	|O
's	|O
need	|O
to	|O
receive	|O
allogeneic	|O
blood	|O
transfusion	|O
,	|O
when	|O
the	|O
initial	|O
Hb	|B-PROTEIN
levels	|O
were	|O
below	|O
130	|O
milligrams	|O
.	|O

In	|O
these	|O
constructs	|O
,	|O
GUS	|B-PROTEIN
expression	|O
was	|O
driven	|O
by	|O
promoter	|O
regions	|O
derived	|O
from	|O
the	|O
Arabidopsis	|O
alcohol	|B-PROTEIN
dehydrogenase	|I-PROTEIN
(	|O
Adh1	|B-PROTEIN
)	|O
,	|O
maize	|O
ubiquitin	|B-PROTEIN
(	|O
Ubi1	|B-PROTEIN
)	|O
,	|O
rice	|O
actin	|B-PROTEIN
(	|O
Act1	|B-PROTEIN
)	|O
and	|O
CaMV	|O
35S	|B-PROTEIN
genes	|O
.	|O

Its	|O
organization	|O
and	|O
regulation	|O
indicate	|O
that	|O
the	|O
S.	|O
pombe	|O
URA1	|B-PROTEIN
gene	|O
product	|O
appears	|O
very	|O
similar	|O
to	|O
the	|O
S.	|O
cerevisiae	|O
URA2	|B-PROTEIN
gene	|O
product	|O
.	|O

The	|O
mean	|O
body	|O
mass	|O
index	|O
(	|O
BMI	|O
)	|O
was	|O
31.8	|O
+	|O
/	|O
-	|O
6.3	|O
kg	|O
/	|O
m2	|O
and	|O
28.5	|O
+	|O
/	|O
-	|O
6.3	|O
kg	|O
/	|O
m2	|O
in	|O
women	|O
and	|O
men	|O
,	|O
respectively	|O
.	|O

These	|O
findings	|O
demonstrate	|O
that	|O
haemodialysis	|O
patients	|O
with	|O
chronic	|O
hepatitis	|O
C	|O
respond	|O
well	|O
to	|O
interferon	|B-PROTEIN
treatment	|O
and	|O
that	|O
a	|O
long	|O
-	|O
term	|O
response	|O
is	|O
achieved	|O
in	|O
a	|O
high	|O
proportion	|O
of	|O
patients	|O
.	|O

Synthetic	|O
enantiomers	|O
of	|O
drugs	|O

Polysome	|O
analysis	|O
further	|O
indicated	|O
that	|O
these	|O
germ	|O
cell	|O
-	|O
specific	|O
Sp1	|B-PROTEIN
mRNAs	|O
are	|O
translated	|O
,	|O
albeit	|O
with	|O
a	|O
lower	|O
efficiency	|O
than	|O
the	|O
somatic	|O
transcript	|O
.	|O

In	|O
nondiabetics	|O
the	|O
response	|O
of	|O
tcPO2	|O
but	|O
not	|O
of	|O
LDF	|O
was	|O
influenced	|O
by	|O
the	|O
values	|O
at	|O
rest	|O
.	|O

This	|O
study	|O
proposes	|O
an	|O
estimator	|O
for	|O
such	|O
global	|O
synchronizing	|O
effects	|O
upon	|O
unit	|O
-	|O
pair	|O
correlations	|O
based	|O
on	|O
local	|O
field	|O
potentials	|O
(	|O
LFPs	|O
)	|O
.	|O

The	|O
assembly	|O
of	|O
sequence	|O
ready	|O
,	|O
high	|O
-	|O
resolution	|O
physical	|O
maps	|O
and	|O
construction	|O
of	|O
minimally	|O
overlapping	|O
contigs	|O
for	|O
the	|O
human	|O
as	|O
well	|O
as	|O
model	|O
genomes	|O
requires	|O
accurate	|O
determination	|O
of	|O
the	|O
extent	|O
of	|O
overlap	|O
between	|O
adjacent	|O
clones	|O
as	|O
well	|O
as	|O
their	|O
relative	|O
orientation	|O
.	|O

(	|O
ii	|O
)	|O
opening	|O
of	|O
KATP	|O
attenuates	|O
,	|O
inhibition	|O
of	|O
the	|O
channel	|O
exacerbates	|O
functional	|O
consequences	|O
of	|O
coronary	|O
occlusion	|O
,	|O
and	|O
(	|O
iii	|O
)	|O
KATP	|O
opening	|O
attenuates	|O
reperfusion	|O
-	|O
induced	|O
VF	|O
,	|O
but	|O
it	|O
triggers	|O
ischemia	|O
-	|O
induced	|O
VF	|O
.	|O

The	|O
DNA	|O
sequences	|O
upstream	|O
of	|O
these	|O
termini	|O
exhibit	|O
homology	|O
to	|O
plant	|O
mitochondrial	|O
-	|O
processing	|O
sites	|O
,	|O
therefore	|O
the	|O
proximal	|O
5'	|O
ends	|O
are	|O
most	|O
probably	|O
generated	|O
by	|O
RNA	|O
processing	|O
.	|O

Curing	|O
shrinkage	|O
and	|O
volumetric	|O
changes	|O
of	|O
resin	|O
-	|O
modified	|O
glass	|O
ionomer	|O
restorative	|O
materials	|O
.	|O

Here	|O
we	|O
present	|O
genetic	|O
evidence	|O
suggesting	|O
that	|O
PP2A	|B-PROTEIN
functions	|O
downstream	|O
of	|O
Ras1	|B-PROTEIN
in	|O
the	|O
Sevenless	|B-PROTEIN
receptor	|O
tyrosine	|O
kinase	|O
(	|O
RTK	|B-PROTEIN
)	|O
signal	|O
transduction	|O
pathway	|O
that	|O
specifies	|O
R7	|O
photoreceptor	|O
cell	|O
fate	|O
in	|O
the	|O
developing	|O
Drosophila	|O
eye	|O
.	|O

QBMDs	|O
for	|O
a	|O
5%	|O
change	|O
in	|O
response	|O
(	|O
QBMD05	|O
)	|O
were	|O
6	|O
-	|O
fold	|O
lower	|O
,	|O
on	|O
average	|O
,	|O
than	|O
the	|O
corresponding	|O
NOAEL	|O
.	|O

Effects	|O
of	|O
repeated	|O
exposures	|O
of	|O
hydrogen	|O
sulphide	|O
on	|O
rat	|O
hippocampal	|O
EEG	|O
.	|O

The	|O
gene	|O
encodes	|O
an	|O
ATP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
cassette	|I-PROTEIN
,	|O
ABC	|B-PROTEIN
transporter	|I-PROTEIN
.	|O

The	|O
T	|O
-	|O
box	|O
motif	|O
is	|O
present	|O
in	|O
a	|O
family	|O
of	|O
genes	|O
whose	|O
structural	|O
features	|O
and	|O
expression	|O
patterns	|O
support	|O
their	|O
involvement	|O
in	|O
developmental	|O
gene	|O
regulation	|O
.	|O

Molecular	|O
analysis	|O
of	|O
a	|O
novel	|O
schizosaccharomyces	|O
pombe	|O
gene	|O
containing	|O
two	|O
RNP	|O
consensus	|O
-	|O
sequence	|O
RNA	|O
-	|O
binding	|O
domains	|O
.	|O

Do	|O
overall	|O
treatment	|O
time	|O
,	|O
field	|O
size	|O
,	|O
and	|O
treatment	|O
energy	|O
influence	|O
local	|O
control	|O
of	|O
T1	|O
-	|O
T2	|O
squamous	|O
cell	|O
carcinomas	|O
of	|O
the	|O
glottic	|O
larynx	|O
?	|O
PURPOSE	|O
:	|O
To	|O
evaluate	|O
treatment	|O
and	|O
patient	|O
related	|O
prognostic	|O
factors	|O
that	|O
may	|O
influence	|O
local	|O
control	|O
in	|O
the	|O
treatment	|O
of	|O
T1	|O
-	|O
T2	|O
squamous	|O
cell	|O
carcinoma	|O
of	|O
the	|O
glottic	|O
larynx	|O
.	|O

In	|O
contrast	|O
to	|O
the	|O
signaling	|O
triggered	|O
by	|O
surface	|O
Ig	|B-PROTEIN
engagement	|O
in	|O
B	|O
lymphocytes	|O
,	|O
CD38	|B-PROTEIN
ligation	|O
did	|O
not	|O
appear	|O
to	|O
induce	|O
tyrosine	|O
phosphorylation	|O
of	|O
the	|O
src	|B-PROTEIN
-	|O
like	|O
protein	|O
tyrosine	|O
kinases	|O
lyn	|B-PROTEIN
,	|O
fyn	|B-PROTEIN
,	|O
and	|O
btk	|B-PROTEIN
,	|O
or	|O
of	|O
vav	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
ras	|I-PROTEIN
-	|I-PROTEIN
GTPase	|I-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
,	|O
nor	|O
did	|O
it	|O
induce	|O
detectable	|O
changes	|O
in	|O
cytosolic	|O
CA2+	|O
concentrations	|O
.	|O

Mutations	|O
in	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
amanitin	|I-PROTEIN
conserved	|O
domain	|O
of	|O
the	|O
largest	|O
subunit	|O
of	|O
yeast	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
III	|I-PROTEIN
affect	|O
pausing	|O
,	|O
RNA	|O
cleavage	|O
and	|O
transcriptional	|O
transitions	|O
.	|O

The	|O
evidence	|O
presented	|O
here	|O
suggests	|O
that	|O
the	|O
p40	|B-PROTEIN
complex	|O
is	|O
a	|O
ribonucleoprotein	|O
complex	|O
containing	|O
L1Hs	|B-PROTEIN
RNA	|O
(	|O
s	|O
)	|O
and	|O
that	|O
protein	|O
-	|O
protein	|O
interactions	|O
in	|O
which	|O
alpha	|O
-	|O
helix	|O
structures	|O
participate	|O
,	|O
for	|O
example	|O
coiled	|O
-	|O
coils	|O
,	|O
may	|O
occur	|O
in	|O
the	|O
complex	|O
.	|O

Our	|O
data	|O
suggest	|O
that	|O
trans	|O
-	|O
activation	|O
from	|O
the	|O
prothymosin	|B-PROTEIN
intron	|O
enhancer	|O
is	|O
a	|O
faithful	|O
reflection	|O
of	|O
the	|O
transforming	|O
properties	|O
of	|O
the	|O
Myc	|B-PROTEIN
protein	|O
.	|O

Pseudomembranous	|O
conjunctivitis	|O
following	|O
bone	|O
marrow	|O
transplantation	|O
:	|O
immunopathological	|O
and	|O
ultrastructural	|O
study	|O
of	|O
one	|O
case	|O
.	|O

In	|O
view	|O
of	|O
the	|O
presence	|O
of	|O
SECIS	|O
elements	|O
in	|O
the	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
of	|O
bacterial	|O
selenoproteins	|B-PROTEIN
,	|O
we	|O
examine	|O
the	|O
effects	|O
in	|O
the	|O
type	|B-PROTEIN
1	|I-PROTEIN
deiodinase	|I-PROTEIN
of	|O
extending	|O
the	|O
ORF	|O
into	|O
the	|O
SECIS	|O
element	|O
,	|O
and	|O
find	|O
that	|O
this	|O
dramatically	|O
inhibits	|O
SECIS	|O
function	|O
.	|O

The	|O
5'	|O
external	|O
transcribed	|O
spacer	|O
(	|O
ETS	|O
)	|O
region	|O
of	|O
the	|O
pre	|O
-	|O
rRNA	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
contains	|O
a	|O
sequence	|O
with	|O
10	|O
bp	|O
of	|O
perfect	|O
complementarity	|O
to	|O
the	|O
U3	|B-PROTEIN
snoRNA	|O
.	|O

These	|O
animals	|O
were	|O
viable	|O
and	|O
fertile	|O
.	|O

This	|O
spindle	|O
defect	|O
of	|O
pds1	|B-PROTEIN
mutants	|O
results	|O
from	|O
a	|O
temperature	|O
-	|O
sensitive	|O
step	|O
that	|O
occurs	|O
around	|O
the	|O
G1	|O
/	|O
S	|O
boundary	|O
about	|O
the	|O
time	|O
of	|O
spindle	|O
assembly	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
RPF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
likely	|O
to	|O
be	|O
involved	|O
in	|O
early	|O
steps	|O
in	|O
the	|O
differentiation	|O
of	|O
amacrine	|O
and	|O
ganglion	|O
cells	|O
.	|O

In	|O
the	|O
point	|O
mutant	|O
we	|O
observed	|O
normal	|O
repair	|O
of	|O
endonuclease	|B-PROTEIN
III	|I-PROTEIN
site	|O
(	|O
i.e.	|O
as	|O
wild	|O
type	|O
)	|O
,	|O
but	|O
no	|O
removal	|O
of	|O
CPDs	|O
at	|O
the	|O
MAT	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
HML	|B-PROTEIN
alpha	|I-PROTEIN
loci	|O
.	|O

However	|O
,	|O
for	|O
the	|O
evaluable	|O
cases	|O
,	|O
the	|O
performances	|O
of	|O
the	|O
CD3500	|O
and	|O
the	|O
STKS	|O
were	|O
broadly	|O
similar	|O
and	|O
generally	|O
correlated	|O
well	|O
with	|O
the	|O
manual	|O
reference	|O
procedure	|O
.	|O

Carboxy	|O
-	|O
terminal	|O
Spc110p	|B-PROTEIN
truncations	|O
lacking	|O
the	|O
calmodulin	|B-PROTEIN
binding	|O
site	|O
can	|O
support	|O
growth	|O
and	|O
are	|O
also	|O
phosphorylated	|O
in	|O
a	|O
cell	|O
cycle	|O
-	|O
specific	|O
manner	|O
.	|O

Both	|O
EWS	|B-PROTEIN
-	|O
FLI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
FLI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
proteins	|O
function	|O
as	|O
transcription	|O
factors	|O
that	|O
bind	|O
specifically	|O
to	|O
ets	|B-PROTEIN
sequences	|O
(	|O
the	|O
ets	|B-PROTEIN
boxes	|O
)	|O
present	|O
in	|O
promoter	|O
elements	|O
.	|O

In	|O
electromobility	|O
shift	|O
assays	|O
,	|O
EWS	|B-PROTEIN
-	|O
FLI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
to	|O
the	|O
SRE	|O
is	|O
detectable	|O
in	|O
the	|O
absence	|O
of	|O
SRF	|B-PROTEIN
whereas	|O
the	|O
binding	|O
of	|O
FLI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
not	|O
,	|O
suggesting	|O
that	|O
the	|O
interaction	|O
with	|O
DNA	|O
is	|O
the	|O
step	|O
which	|O
limits	|O
ternary	|O
complex	|O
formation	|O
by	|O
FLI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Additional	|O
studies	|O
with	|O
new	|O
and	|O
reprocessed	|O
regenerated	|O
cellulose	|O
dialyzers	|O
comparing	|O
450	|O
and	|O
220	|O
mL	|O
/	|O
min	|O
blood	|O
flow	|O
rates	|O
at	|O
10	|O
minutes	|O
showed	|O
no	|O
change	|O
in	|O
BTG	|O
.	|O

DNA	|O
methylation	|O
,	|O
especially	|O
of	|O
either	|O
one	|O
or	|O
both	|O
of	|O
the	|O
deoxyadenosines	|O
at	|O
the	|O
two	|O
GATC	|O
motifs	|O
(	|O
one	|O
in	|O
the	|O
first	|O
exon	|O
and	|O
the	|O
other	|O
in	|O
the	|O
first	|O
intron	|O
of	|O
the	|O
rice	|O
CatA	|B-PROTEIN
gene	|O
)	|O
,	|O
appeared	|O
to	|O
be	|O
responsible	|O
for	|O
the	|O
CatA	|B-PROTEIN
promoter	|O
activity	|O
identified	|O
in	|O
the	|O
transient	|O
assay	|O
.	|O

The	|O
viral	|B-PROTEIN
LTR	|I-PROTEIN
was	|O
used	|O
as	|O
the	|O
promoter	|O
.	|O

Overlapping	|O
cDNA	|O
clones	|O
were	|O
isolated	|O
and	|O
sequenced	|O
.	|O

In	|O
conclusion	|O
,	|O
IgM	|B-PROTEIN
class	|O
CIC	|O
is	|O
the	|O
predominant	|O
CIC	|O
in	|O
acute	|O
hepatitis	|O
A	|O
and	|O
correlated	|O
with	|O
disease	|O
activity	|O
.	|O

Epitope	|O
mapping	|O
revealed	|O
that	|O
these	|O
three	|O
clones	|O
appear	|O
to	|O
recognize	|O
an	|O
identical	|O
epitope	|O
domain	|O
present	|O
on	|O
the	|O
C	|O
-	|O
terminal	|O
RNP	|O
motif	|O
of	|O
the	|O
U1A	|B-PROTEIN
protein	|O
.	|O

Variables	|O
evaluated	|O
were	|O
number	|O
of	|O
weekly	|O
anginal	|O
events	|O
,	|O
data	|O
from	|O
ergometric	|O
exercise	|O
testing	|O
with	|O
simultaneous	|O
electrocardiographic	|O
registration	|O
,	|O
semiquantitative	|O
evaluation	|O
of	|O
Tc	|O
-	|O
99m	|O
2	|O
-	|O
methoxy	|O
isobutyl	|O
isonitrile	|O
(	|O
MIBI	|O
)	|O
scans	|O
and	|O
rheologic	|O
variables	|O
.	|O

As	|O
the	|O
length	|O
of	|O
the	|O
fatty	|O
acid	|O
decreased	|O
,	|O
the	|O
binding	|O
affinity	|O
was	|O
reduced	|O
;	|O
myristic	|O
acid	|O
(	|O
14	|O
:	|O
0	|O
)	|O
bound	|O
with	|O
a	|O
K	|O
(	|O
d	|O
)	|O
of	|O
1409	|O
+	|O
/	|O
-	|O
423	|O
nM	|O
,	|O
but	|O
medium	|O
-	|O
chain	|O
(	|O
decanoic	|O
acid	|O
,	|O
10	|O
:	|O
0	|O
)	|O
and	|O
short	|O
-	|O
chain	|O
(	|O
octanoic	|O
acid	|O
,	|O
8	|O
:	|O
0	|O
)	|O
lipids	|O
were	|O
not	|O
bound	|O
at	|O
all	|O
.	|O

The	|O
membrane	|O
-	|O
distal	|O
cytoplasmic	|O
region	|O
of	|O
human	|O
granulocyte	|B-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
is	|O
required	|O
for	|O
STAT3	|B-PROTEIN
but	|O
not	|O
STAT1	|B-PROTEIN
homodimer	|O
formation	|O
.	|O

However	|O
,	|O
whether	|O
or	|O
not	|O
nonsense	|O
codon	|O
recognition	|O
within	|O
TPI	|B-PROTEIN
transcripts	|O
takes	|O
place	|O
prior	|O
to	|O
or	|O
after	|O
splicing	|O
remained	|O
unresolved	|O
.	|O

Although	|O
some	|O
residues	|O
are	|O
found	|O
reactive	|O
toward	|O
dimethylsulphate	|O
and	|O
kethoxal	|O
in	|O
regions	|O
predicted	|O
to	|O
be	|O
unpaired	|O
by	|O
the	|O
phylogenetic	|O
secondary	|O
structure	|O
model	|O
of	|O
4.5	|B-PROTEIN
S	|I-PROTEIN
RNA	|O
,	|O
generally	|O
the	|O
reactivity	|O
is	|O
low	|O
,	|O
and	|O
some	|O
residues	|O
in	|O
internal	|O
loops	|O
are	|O
not	|O
reactive	|O
at	|O
all	|O
.	|O

Ongoing	|O
and	|O
future	|O
investigations	|O
may	|O
better	|O
define	|O
the	|O
optimal	|O
approach	|O
for	|O
local	|O
control	|O
,	|O
the	|O
optimal	|O
duration	|O
of	|O
maintenance	|O
chemotherapy	|O
,	|O
and	|O
the	|O
possible	|O
role	|O
of	|O
biologic	|O
response	|O
modifiers	|O
and	|O
growth	|O
factors	|O
in	|O
further	|O
improving	|O
the	|O
outcome	|O
for	|O
patients	|O
with	|O
this	|O
disease	|O
.	|O

SUMMARY	|O
OF	|O
REVIEW	|O
:	|O
We	|O
discuss	|O
the	|O
criteria	|O
that	|O
make	|O
such	|O
studies	|O
comparable	|O
,	|O
drawing	|O
on	|O
the	|O
experiences	|O
of	|O
recent	|O
studies	|O
performed	|O
around	|O
the	|O
world	|O
.	|O

Forty	|O
-	|O
five	|O
patients	|O
with	|O
pleural	|O
lesions	|O
identified	|O
on	|O
CT	|O
scans	|O
were	|O
subsequently	|O
examined	|O
by	|O
MR	|O
imaging	|O
at	|O
0.5	|O
T.	|O

Left	|O
atrial	|O
volumes	|O
were	|O
greater	|O
in	|O
old	|O
compared	|O
with	|O
young	|O
subjects	|O
(	|O
maximal	|O
:	|O
31	|O
+	|O
/	|O
-	|O
10	|O
cm3	|O
/	|O
m2	|O
vs	|O
24	|O
+	|O
/	|O
-	|O
8	|O
cm3	|O
/	|O
m2	|O
,	|O
p	|O
=	|O
0.02	|O
;	|O
at	|O
onset	|O
of	|O
atrial	|O
systole	|O
:	|O
23	|O
+	|O
/	|O
-	|O
8	|O
cm3	|O
/	|O
m2	|O
vs	|O
15	|O
+	|O
/	|O
-	|O
5	|O
cm3	|O
/	|O
m2	|O
,	|O
p	|O
=	|O
0.0002	|O
;	|O
minimal	|O
:	|O
13	|O
+	|O
/	|O
-	|O
5	|O
cm3	|O
/	|O
m2	|O
vs	|O
9	|O
+	|O
/	|O
-	|O
4	|O
cm3	|O
/	|O
m2	|O
,	|O
p	|O
=	|O
0.001	|O
)	|O
.	|O

RESULTS	|O
:	|O
Basal	|O
plasma	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
levels	|O
as	|O
well	|O
as	|O
body	|O
mass	|O
index	|O
(	|O
BMI	|O
)	|O
were	|O
lower	|O
in	|O
amenorrheic	|O
patients	|O
than	|O
in	|O
healthy	|O
controls	|O
.	|O

We	|O
observed	|O
abundant	|O
levels	|O
of	|O
Rev	|B-PROTEIN
-	|O
erbA	|B-PROTEIN
alpha	|I-PROTEIN
mRNA	|O
in	|O
dividing	|O
C2C12	|O
myoblasts	|O
,	|O
which	|O
were	|O
suppressed	|O
when	|O
the	|O
cells	|O
differentiated	|O
into	|O
postmitotic	|O
multinucleated	|O
myotubes	|O
.	|O

We	|O
then	|O
demonstrated	|O
that	|O
1	|O
)	|O
GAL4	|B-PROTEIN
-	|O
REV	|B-PROTEIN
-	|O
erbA	|B-PROTEIN
alpha	|I-PROTEIN
chimeras	|O
that	|O
contain	|O
the	|O
'	|O
AB	|O
'	|O
region	|O
and	|O
lack	|O
the	|O
'	|O
E'	|O
region	|O
activated	|O
transcription	|O
of	|O
GAL4	|B-PROTEIN
response	|O
elements	|O
in	|O
the	|O
presence	|O
of	|O
8	|O
-	|O
Br	|O
-	|O
cAMP	|O
and	|O
2	|O
)	|O
the	|O
ligand	|O
-	|O
binding	|O
domain	|O
(	|O
LBD	|O
)	|O
contains	|O
an	|O
active	|O
transcriptional	|O
silencer	|O
.	|O

The	|O
alpha	|O
T3	|O
-	|O
1	|O
cell	|O
line	|O
,	|O
a	|O
GnRH	|B-PROTEIN
-	|O
responsive	|O
gonadotroph	|O
cell	|O
line	|O
developed	|O
by	|O
targeted	|O
oncogenesis	|O
in	|O
transgenic	|O
mice	|O
,	|O
was	|O
used	|O
to	|O
study	|O
regulation	|O
of	|O
the	|O
glycoprotein	|B-PROTEIN
hormone	|I-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
subunit	|I-PROTEIN
by	|O
activin	|B-PROTEIN
.	|O

Cotransfection	|O
with	|O
the	|O
ie1	|B-PROTEIN
gene	|O
resulted	|O
in	|O
a	|O
dramatic	|O
increase	|O
in	|O
the	|O
amount	|O
of	|O
the	|O
two	|O
enzymes	|O
expressed	|O
in	|O
the	|O
transfected	|O
cells	|O
.	|O

As	|O
expected	|O
,	|O
glycosylation	|O
of	|O
Env	|B-PROTEIN
produced	|O
from	|O
mutants	|O
was	|O
affected	|O
but	|O
,	|O
irrespective	|O
of	|O
the	|O
glycosylation	|O
phenotype	|O
,	|O
(	|O
i	|O
)	|O
similar	|O
quantities	|O
of	|O
Env	|B-PROTEIN
were	|O
synthesized	|O
,	|O
(	|O
ii	|O
)	|O
the	|O
immunoreactivity	|O
of	|O
V3	|B-PROTEIN
was	|O
similar	|O
,	|O
(	|O
iii	|O
)	|O
gp160	|B-PROTEIN
was	|O
efficiently	|O
cleaved	|O
into	|O
gp120	|B-PROTEIN
and	|O
gp41	|B-PROTEIN
,	|O
(	|O
vi	|O
)	|O
Env	|B-PROTEIN
was	|O
exposed	|O
at	|O
the	|O
cell	|O
membrane	|O
,	|O
(	|O
v	|O
)	|O
secreted	|O
gp120	|B-PROTEIN
bound	|O
CD4	|B-PROTEIN
,	|O
and	|O
(	|O
vi	|O
)	|O
membrane	|O
gp41	|B-PROTEIN
was	|O
able	|O
to	|O
induce	|O
membrane	|O
fusion	|O
with	|O
CD4+	|B-PROTEIN
cells	|O
.	|O

Effects	|O
of	|O
posteroventral	|O
pallidotomy	|O
on	|O
Parkinson	|O
's	|O
disease	|O
.	|O

On	|O
the	|O
trail	|O
of	|O
Dr.	|O

However	|O
,	|O
only	|O
complete	|O
DnaJ	|B-PROTEIN
can	|O
cooperate	|O
with	|O
DnaK	|B-PROTEIN
and	|O
a	|O
third	|O
protein	|O
,	|O
GrpE	|B-PROTEIN
,	|O
in	|O
refolding	|O
denatured	|O
firefly	|O
luciferase	|B-PROTEIN
.	|O

The	|O
two	|O
different	|O
phosphoforms	|O
of	|O
STAT5	|B-PROTEIN
have	|O
identical	|O
in	|O
vitro	|O
DNA	|O
binding	|O
specificity	|O
and	|O
reactivity	|O
with	|O
tyrosine	|O
phosphopeptides	|O
,	|O
but	|O
differ	|O
in	|O
their	|O
cellular	|O
localization	|O
.	|O

TNF	|B-PROTEIN
Treatment	|O
of	|O
cell	|O
activated	|O
the	|O
p38	|B-PROTEIN
MAP	|O
kinase	|O
pathway	|O
,	|O
as	|O
revealed	|O
by	|O
increased	|O
phosphorylation	|O
of	|O
p38	|B-PROTEIN
MAP	|O
kinase	|O
itself	|O
,	|O
activation	|O
of	|O
the	|O
substrate	|O
protein	|O
MAPKAP	|B-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
and	|O
culminating	|O
in	|O
the	|O
phosphorylation	|O
of	|O
the	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
protein	|I-PROTEIN
27	|I-PROTEIN
(	|O
hsp27	|B-PROTEIN
)	|O
.	|O

We	|O
have	|O
isolated	|O
a	|O
novel	|O
protein	|O
from	|O
Drosophila	|O
nuclear	|O
extracts	|O
which	|O
binds	|O
specifically	|O
to	|O
a	|O
site	|O
in	|O
this	|O
second	|O
region	|O
.	|O

However	|O
,	|O
while	|O
the	|O
sequence	|O
similarity	|O
between	|O
the	|O
membrane	|O
exons	|O
of	|O
avian	|O
mIgY	|B-PROTEIN
and	|O
mammalian	|O
mIgG	|B-PROTEIN
and	|O
IgE	|B-PROTEIN
is	|O
striking	|O
,	|O
the	|O
overall	|O
similarity	|O
with	|O
Xenopus	|O
mIgY	|B-PROTEIN
is	|O
very	|O
low	|O
.	|O

Control	|O
of	|O
transcription	|O
of	|O
the	|O
erbB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
is	|O
an	|O
important	|O
determinant	|O
of	|O
receptor	|O
expression	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
and	|O
electrophoretic	|O
mobility	|O
shift	|O
assays	|O
indicate	|O
that	|O
PBP	|B-PROTEIN
binds	|O
to	|O
the	|O
half	|O
-	|O
site	|O
of	|O
each	|O
palindrome	|O
with	|O
the	|O
core	|O
recognition	|O
sequence	|O
TGGGAG	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
sequences	|O
in	|O
the	|O
SH2	|B-PROTEIN
/	|O
SH3	|B-PROTEIN
/	|O
SH2	|B-PROTEIN
region	|O
of	|O
p120	|B-PROTEIN
GAP	|O
are	|O
required	|O
for	|O
full	|O
catalytic	|O
activity	|O
toward	|O
Ras	|B-PROTEIN
.	|O

The	|O
novel	|O
hematopoietic	|O
growth	|O
factor	|O
FLT3	|B-PROTEIN
ligand	|O
(	|O
FL	|O
)	|O
is	|O
the	|O
cognate	|O
ligand	|O
for	|O
the	|O
FLT3	|B-PROTEIN
,	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
R	|B-PROTEIN
)	|O
,	|O
also	|O
referred	|O
to	|O
as	|O
FLK	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
STK	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

In	|O
contrast	|O
to	|O
the	|O
selective	|O
expression	|O
of	|O
the	|O
receptor	|O
,	|O
FL	|B-PROTEIN
expression	|O
was	|O
detected	|O
in	|O
90-100%	|O
of	|O
the	|O
various	|O
cell	|O
types	|O
of	|O
leukemia	|O
cell	|O
lines	|O
from	|O
all	|O
hematopoietic	|O
cell	|O
lineages	|O
.	|O

Further	|O
analysis	|O
of	|O
this	|O
domain	|O
by	|O
in	|O
vitro	|O
mutagenesis	|O
pointed	|O
to	|O
a	|O
core	|O
of	|O
hydrophobic	|O
and	|O
acidic	|O
residues	|O
as	|O
critical	|O
for	|O
the	|O
activity	|O
.	|O

Analysis	|O
of	|O
RAR	|B-PROTEIN
alpha	|I-PROTEIN
mutants	|O
in	|O
transfection	|O
studies	|O
reveals	|O
that	|O
the	|O
DNA	|O
binding	|O
domain	|O
is	|O
sufficient	|O
for	|O
inhibition	|O
of	|O
BZLF1	|B-PROTEIN
activity	|O
.	|O

We	|O
measured	|O
serum	|O
hepatocyte	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
HGF	|B-PROTEIN
)	|O
in	|O
patients	|O
with	|O
acute	|O
myocardial	|O
infarction	|O
,	|O
angina	|O
pectoris	|O
,	|O
and	|O
other	|O
heart	|O
diseases	|O
.	|O

The	|O
neural	|O
mechanism	|O
of	|O
parkinsonian	|O
motor	|O
symptoms	|O
,	|O
i.e.	|O
,	|O
rigidity	|O
,	|O
tremor	|O
and	|O
akinesia	|O
,	|O
which	|O
are	|O
the	|O
result	|O
of	|O
nigrostriatal	|O
dopamine	|O
deficiency	|O
,	|O
is	|O
interpreted	|O
from	|O
long	|O
-	|O
term	|O
observations	|O
on	|O
the	|O
effect	|O
of	|O
surgical	|O
and	|O
pharmacological	|O
treatment	|O
of	|O
the	|O
disease	|O
in	|O
relation	|O
to	|O
the	|O
neuropathological	|O
findings	|O
within	|O
the	|O
substantia	|O
nigra	|O
zona	|O
compacta	|O
(	|O
SNc	|O
)	|O
.	|O

Protein	|O
splicing	|O
:	|O
evidence	|O
for	|O
an	|O
N	|O
-	|O
O	|O
acyl	|O
rearrangement	|O
as	|O
the	|O
initial	|O
step	|O
in	|O
the	|O
splicing	|O
process	|O
.	|O

In	|O
agreement	|O
with	|O
these	|O
data	|O
,	|O
western	|O
blot	|O
experiments	|O
using	|O
an	|O
antibody	|O
directed	|O
against	|O
the	|O
carboxy	|O
-	|O
terminal	|O
portion	|O
of	|O
the	|O
mouse	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
protein	|O
showed	|O
that	|O
a	|O
polypeptide	|O
,	|O
of	|O
the	|O
size	|O
predicted	|O
by	|O
the	|O
open	|O
reading	|O
frame	|O
of	|O
the	|O
spermatid	|O
-	|O
specific	|O
c	|B-PROTEIN
-	|I-PROTEIN
kit	|I-PROTEIN
cDNA	|O
,	|O
accumulates	|O
in	|O
the	|O
latest	|O
stages	|O
of	|O
spermatogenesis	|O
and	|O
in	|O
epididymal	|O
spermatozoa	|O
.	|O

It	|O
is	|O
shown	|O
that	|O
the	|O
(	|O
G+	|O
C	|O
)	|O
-	|O
rich	|O
element	|O
of	|O
the	|O
aldolase	|B-PROTEIN
C	|I-PROTEIN
promoter	|O
directs	|O
transcription	|O
in	|O
neuronal	|O
as	|O
well	|O
as	|O
in	|O
nonneuronal	|O
cells	|O
.	|O

LY290181	|O
appears	|O
to	|O
inhibit	|O
uPA	|B-PROTEIN
promoter	|O
activation	|O
by	|O
blocking	|O
phorbol	|O
ester	|O
-	|O
stimulated	|O
binding	|O
of	|O
nuclear	|O
proteins	|O
to	|O
the	|O
uPA	|B-PROTEIN
PEA3/12	|O
-	|O
0	|O
-	|O
tetradecanoylphorbol	|O
13	|O
-	|O
acetate	|O
responsive	|O
element	|O
(	|O
TRE	|O
)	|O
.	|O

Treatment	|O
of	|O
keratinocytes	|O
expressing	|O
a	|O
normal	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
EGFR	|B-PROTEIN
)	|O
with	|O
TGFalpha	|B-PROTEIN
or	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
for	|O
5	|O
min	|O
induced	|O
PKCdelta	|B-PROTEIN
tyrosine	|O
phosphorylation	|O
.	|O

Only	|O
one	|O
of	|O
these	|O
bands	|O
was	|O
supershifted	|O
by	|O
antibody	|O
to	|O
p50	|B-PROTEIN
,	|O
whereas	|O
antibodies	|O
to	|O
p65	|B-PROTEIN
or	|O
other	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
proteins	|O
had	|O
no	|O
effect	|O
.	|O

We	|O
isolated	|O
a	|O
complementary	|O
DNA	|O
(	|O
cDNA	|O
)	|O
clone	|O
from	|O
an	|O
RL95	|O
-	|O
2	|O
expression	|O
library	|O
that	|O
encodes	|O
the	|O
C1	|B-PROTEIN
site	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Biol.	|O

In	|O
addition	|O
,	|O
anti	|B-PROTEIN
-	|I-PROTEIN
phosphotyrosine	|I-PROTEIN
antibodies	|O
immunoprecipitated	|O
80K	|B-PROTEIN
-	|I-PROTEIN
H	|I-PROTEIN
from	|O
cell	|O
lysates	|O
of	|O
FGF	|B-PROTEIN
-	|O
stimulated	|O
but	|O
not	|O
from	|O
control	|O
fibroblasts	|O
.	|O

The	|O
novel	|O
protein	|O
kinases	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
NH2	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
JNKs	|B-PROTEIN
)	|O
/	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
are	|O
also	|O
activated	|O
by	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
CD28	|B-PROTEIN
costimulation	|O
.	|O

Thus	|O
,	|O
hGRbeta	|B-PROTEIN
potentially	|O
functions	|O
as	|O
a	|O
dominant	|O
negative	|O
inhibitor	|O
of	|O
hGRalpha	|B-PROTEIN
activity	|O
.	|O

Gas6	|B-PROTEIN
contains	|O
an	|O
NH2	|O
-	|O
terminal	|O
Gla	|O
domain	|O
followed	|O
by	|O
four	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|O
like	|O
repeats	|O
and	|O
tandem	|O
globular	|O
(	|O
G	|O
)	|O
domains	|O
.	|O

Both	|O
P5CDh	|B-PROTEIN
cDNA	|O
clones	|O
detect	|O
a	|O
single	|O
3.2	|O
-	|O
kb	|O
transcript	|O
on	|O
Northern	|O
blots	|O
of	|O
multiple	|O
human	|O
tissues	|O
,	|O
indicating	|O
the	|O
long	|O
cDNA	|O
containing	|O
the	|O
3'	|O
-	|O
untranslated	|O
intron	|O
represents	|O
the	|O
predominant	|O
transcript	|O
.	|O

Polymerization	|O
of	|O
neurofilament	|B-PROTEIN
L	|I-PROTEIN
protein	|O
in	|O
vitro	|O
was	|O
inhibited	|O
by	|O
phosphorylation	|O
of	|O
neurofilament	|B-PROTEIN
L	|I-PROTEIN
protein	|O
by	|O
PKN	|B-PROTEIN
.	|O

The	|O
protein	|O
folds	|O
correctly	|O
with	|O
two	|O
disulfide	|O
bonds	|O
and	|O
a	|O
free	|O
thiol	|O
group	|O
at	|O
Cys25	|O
.	|O

We	|O
and	|O
others	|O
have	|O
demonstrated	|O
that	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
cbl	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
product	|O
is	|O
one	|O
of	|O
the	|O
earliest	|O
targets	|O
of	|O
tyrosine	|O
phosphorylation	|O
upon	|O
T	|B-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
stimulation	|O
.	|O

A	|O
substantial	|O
fraction	|O
of	|O
Cbl	|B-PROTEIN
was	|O
constitutively	|O
associated	|O
with	|O
Grb2	|B-PROTEIN
and	|O
this	|O
interaction	|O
was	|O
mediated	|O
by	|O
Grb2	|B-PROTEIN
SH3	|O
domains	|O
.	|O

An	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
sequence	|O
is	|O
essential	|O
for	|O
regulation	|O
of	|O
the	|O
human	|O
alpha2	|B-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
collagen	|I-PROTEIN
(	|O
COL1A2	|B-PROTEIN
)	|O
promoter	|O
activity	|O
by	|O
transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
.	|O

No	|O
significant	|O
differences	|O
existed	|O
between	|O
the	|O
two	|O
age	|O
groups	|O
in	|O
baseline	|O
characteristics	|O
,	|O
including	|O
treatment	|O
protocol	|O
,	|O
performance	|O
status	|O
,	|O
and	|O
serum	|O
lactate	|B-PROTEIN
dehydrogenase	|I-PROTEIN
(	|O
LDH	|B-PROTEIN
)	|O
level	|O
.	|O

Only	|O
two	|O
patients	|O
(	|O
0.3%	|O
)	|O
had	|O
a	|O
CA	|B-PROTEIN
125	|I-PROTEIN
response	|O
at	|O
the	|O
time	|O
of	|O
clinical	|O
progression	|O
.	|O

The	|O
men	|O
self	|O
-	|O
selected	|O
a	|O
prescribed	|O
diet	|O
at	|O
home	|O
emphasizing	|O
saturated	|O
fat	|O
as	|O
the	|O
visible	|O
fat	|O
for	|O
1	|O
week	|O
.	|O

Conversely	|O
,	|O
when	|O
VDR	|B-PROTEIN
is	|O
overexpressed	|O
,	|O
vitamin	|O
D3	|O
attenuates	|O
9	|O
-	|O
cis	|O
RA	|O
induction	|O
from	|O
an	|O
RXR	|B-PROTEIN
-	|O
responsive	|O
element	|O
.	|O

These	|O
results	|O
illuminate	|O
a	|O
hitherto	|O
unanticipated	|O
function	|O
of	|O
U6	|B-PROTEIN
RNA	|O
:	|O
the	|O
modulation	|O
of	|O
a	|O
phosphorylation	|O
-	|O
dephosphorylation	|O
cycle	|O
of	|O
C1	|B-PROTEIN
hnRNP	|O
protein	|O
that	|O
influences	|O
the	|O
binding	|O
affinity	|O
of	|O
this	|O
protein	|O
for	|O
pre	|O
-	|O
mRNA	|O
.	|O

Inclusion	|O
of	|O
the	|O
extended	|O
N	|O
terminus	|O
into	|O
the	|O
originally	|O
reported	|O
protein	|O
resulted	|O
in	|O
a	|O
striking	|O
similarity	|O
to	|O
the	|O
lymphoid	|O
factor	|O
Lef	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Truncated	|O
mammalian	|O
Notch1	|B-PROTEIN
activates	|O
CBF1	|B-PROTEIN
/	|O
RBPJk	|B-PROTEIN
-	|O
repressed	|O
genes	|O
by	|O
a	|O
mechanism	|O
resembling	|O
that	|O
of	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
EBNA2	|B-PROTEIN
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
(	|O
EMSAs	|O
)	|O
using	|O
purified	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
DNA	|O
binding	|O
domain	|O
(	|O
DBD	|O
)	|O
demonstrated	|O
that	|O
both	|O
GRE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
motifs	|O
interact	|O
with	|O
DBD	|O
and	|O
oligonucleotide	|O
competition	|O
experiments	|O
established	|O
that	|O
these	|O
have	|O
different	|O
affinities	|O
for	|O
DBD	|O
.	|O

The	|O
large	|O
subfamily	|O
of	|O
receptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
RTKs	|B-PROTEIN
)	|O
for	|O
which	|O
EPH	|B-PROTEIN
is	|O
the	|O
prototype	|O
have	|O
likely	|O
roles	|O
in	|O
intercellular	|O
communication	|O
during	|O
normal	|O
mammalian	|O
development	|O
,	|O
but	|O
the	|O
biochemical	|O
signalling	|O
pathways	|O
utilised	|O
by	|O
this	|O
family	|O
are	|O
poorly	|O
characterised	|O
.	|O

The	|O
17	|O
-	|O
kDa	|O
protein	|O
is	|O
required	|O
for	|O
the	|O
systemic	|O
infection	|O
of	|O
plants	|O
.	|O

We	|O
present	|O
here	|O
a	|O
detailed	|O
genomic	|O
sequencing	|O
analysis	|O
of	|O
the	|O
cytosine	|O
methylation	|O
patterns	|O
of	|O
the	|O
transposase	|B-PROTEIN
binding	|O
sites	|O
within	|O
both	|O
Ac	|B-PROTEIN
ends	|O
in	|O
the	|O
wx	|B-PROTEIN
-	|I-PROTEIN
m9	|I-PROTEIN
::	|O
Ac	|B-PROTEIN
allele	|O
,	|O
where	|O
Ac	|B-PROTEIN
is	|O
inserted	|O
into	|O
the	|O
tenth	|O
exon	|O
of	|O
the	|O
Waxy	|B-PROTEIN
gene	|O
.	|O

Krox	|B-PROTEIN
-	|I-PROTEIN
20	|I-PROTEIN
,	|O
a	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
gene	|I-PROTEIN
,	|O
has	|O
a	|O
highly	|O
conserved	|O
pattern	|O
of	|O
expression	|O
in	|O
r3	|O
and	|O
r5	|O
and	|O
is	|O
functionally	|O
required	|O
for	|O
their	|O
maintenance	|O
in	|O
mouse	|O
embryos	|O
.	|O

Pituitary	|O
adenylate	|B-PROTEIN
cyclase	|I-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
polypeptide	|I-PROTEIN
regulates	|O
prolactin	|B-PROTEIN
promoter	|O
activity	|O
via	|O
a	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
-	|O
mediated	|O
pathway	|O
that	|O
is	|O
independent	|O
of	|O
the	|O
transcriptional	|O
pathway	|O
employed	|O
by	|O
thyrotropin	|B-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
hormone	|I-PROTEIN
.	|O

Clones	|O
33F	|O
and	|O
34B	|O
encoded	|O
identical	|O
aromatase	|B-PROTEIN
proteins	|O
of	|O
503	|O
amino	|O
acids	|O
,	|O
but	|O
differed	|O
in	|O
size	|O
due	|O
to	|O
alternative	|O
polyadenylation	|O
signal	|O
usage	|O
for	|O
the	|O
corresponding	|O
mRNAs	|O
.	|O

In	|O
sorted	|O
bone	|O
marrow	|O
cells	|O
expression	|O
of	|O
both	|O
VpreB	|B-PROTEIN
genes	|O
was	|O
detected	|O
in	|O
pro	|O
-	|O
B	|O
/	|O
pre	|O
-	|O
BI	|O
and	|O
large	|O
pre	|O
-	|O
BII	|O
cells	|O
,	|O
while	|O
the	|O
RNA	|O
steady	|O
state	|O
levels	|O
were	|O
at	|O
least	|O
100	|O
-	|O
fold	|O
lower	|O
in	|O
small	|O
pre	|O
-	|O
BII	|O
and	|O
immature	|O
/	|O
mature	|O
B	|O
cells	|O
.	|O

We	|O
have	|O
cloned	|O
and	|O
sequenced	|O
a	|O
3574	|O
-	|O
bp	|O
Bacillus	|O
subtilis	|O
(	|O
Bs	|O
)	|O
DNA	|O
fragment	|O
located	|O
between	|O
the	|O
nrdA	|B-PROTEIN
and	|O
citB	|B-PROTEIN
genes	|O
at	|O
about	|O
169	|O
degrees	|O
on	|O
the	|O
chromosome	|O
.	|O

Aeromonas	|O
salmonicida	|O
possesses	|O
two	|O
genes	|O
encoding	|O
homologs	|O
of	|O
the	|O
major	|B-PROTEIN
outer	|I-PROTEIN
membrane	|I-PROTEIN
protein	|I-PROTEIN
,	|O
OmpA	|B-PROTEIN
.	|O

Expression	|O
of	|O
Msp	|B-PROTEIN
was	|O
toxic	|O
to	|O
E.	|O
coli	|O
when	|O
the	|O
entire	|O
msp	|B-PROTEIN
gene	|O
was	|O
present	|O
.	|O

In	|O
agreement	|O
with	|O
previous	|O
in	|O
vitro	|O
data	|O
,	|O
we	|O
have	|O
shown	|O
that	|O
UmuD	|B-PROTEIN
and	|O
UmuD	|B-PROTEIN
'	|I-PROTEIN
are	|O
able	|O
to	|O
form	|O
both	|O
homodimers	|O
(	|O
UmuD	|B-PROTEIN
-	|O
UmuD	|B-PROTEIN
and	|O
UmuD	|B-PROTEIN
'	|I-PROTEIN
-	|O
UmuD	|B-PROTEIN
'	|I-PROTEIN
)	|O
and	|O
a	|O
heterodimer	|O
(	|O
UmuD	|B-PROTEIN
-	|O
UmuD	|B-PROTEIN
'	|I-PROTEIN
)	|O
.	|O

Lyn	|B-PROTEIN
kinase	|O
immunoprecipitated	|O
from	|O
lysates	|O
of	|O
irradiated	|O
BCP	|O
as	|O
well	|O
as	|O
a	|O
full	|O
-	|O
length	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
-	|O
Lyn	|B-PROTEIN
fusion	|O
protein	|O
-	|O
phosphorylated	|O
recombinant	|O
human	|O
p34cdc2	|B-PROTEIN
on	|O
tyrosine	|O
15	|O
.	|O

Mutations	|O
within	|O
conserved	|O
region	|O
2	|O
(	|O
CR2	|O
)	|O
of	|O
E1A	|B-PROTEIN
that	|O
inhibit	|O
the	|O
binding	|O
of	|O
E1A	|B-PROTEIN
to	|O
the	|O
retinoblastoma	|B-PROTEIN
gene	|I-PROTEIN
product	|I-PROTEIN
(	|O
pRb	|B-PROTEIN
)	|O
further	|O
enhanced	|O
the	|O
stimulation	|O
of	|O
transcription	|O
from	|O
the	|O
PEPCK	|B-PROTEIN
promoter	|O
by	|O
2	|O
3	|O
-	|O
fold	|O
compared	|O
with	|O
wild	|O
type	|O
E1A	|B-PROTEIN
.	|O

Using	|O
autoantibodies	|O
from	|O
a	|O
Sjogren	|O
's	|O
syndrome	|O
patient	|O
,	|O
we	|O
have	|O
previously	|O
identified	|O
a	|O
230	|O
-	|O
kDa	|O
peripheral	|O
membrane	|O
protein	|O
associated	|O
with	|O
the	|O
cytosolic	|O
face	|O
of	|O
the	|O
trans	|O
-	|O
Golgi	|O
(	|O
Kooy	|O
,	|O
J.	|O
,	|O
Toh	|O
,	|O
B.	|O

Apart	|O
from	|O
two	|O
proline	|O
-	|O
rich	|O
regions	|O
(	|O
amino	|O
acids	|O
1-117	|O
and	|O
239-270	|O
)	|O
,	|O
p230	|B-PROTEIN
contains	|O
a	|O
very	|O
high	|O
frequency	|O
of	|O
heptad	|O
repeats	|O
,	|O
characteristic	|O
of	|O
alpha	|O
-	|O
helices	|O
that	|O
form	|O
dimeric	|O
coiled	|O
-	|O
coil	|O
structures	|O
.	|O
p230	|B-PROTEIN
also	|O
includes	|O
the	|O
sequence	|O
ESLALEELEL	|O
(	|O
amino	|O
acids	|O
538-546	|O
)	|O
,	|O
a	|O
motif	|O
found	|O
in	|O
the	|O
granin	|B-PROTEIN
family	|O
of	|O
acidic	|O
proteins	|O
present	|O
in	|O
secretory	|O
granules	|O
of	|O
neuroendocrine	|O
cells	|O
.	|O

Binding	|O
specificity	|O
and	|O
modulation	|O
of	|O
the	|O
ApoA	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
promoter	|O
activity	|O
by	|O
homo	|O
-	|O
and	|O
heterodimers	|O
of	|O
nuclear	|O
receptors	|O
.	|O

They	|O
were	|O
found	|O
to	|O
stimulate	|O
at	|O
nanomolar	|O
concentrations	|O
the	|O
turnover	|O
of	|O
biosynthetically	|O
labeled	|O
ceramide	|O
,	|O
glucosylceramide	|O
,	|O
and	|O
lactosylceramide	|O
.	|O

There	|O
is	|O
growing	|O
evidence	|O
that	|O
mammalian	|B-PROTEIN
AMP	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
AMPK	|B-PROTEIN
)	|O
plays	|O
a	|O
role	|O
in	|O
protecting	|O
cells	|O
from	|O
stresses	|O
that	|O
cause	|O
ATP	|O
depletion	|O
by	|O
switching	|O
off	|O
ATP	|O
-	|O
consuming	|O
biosynthetic	|O
pathways	|O
.	|O

Sterol	|O
-	|O
mediated	|O
suppression	|O
of	|O
cleavage	|O
of	|O
SREBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
found	|O
to	|O
be	|O
dependent	|O
on	|O
the	|O
extreme	|O
COOH	|O
-	|O
terminal	|O
region	|O
(	|O
residue	|O
1034	|O
to	|O
the	|O
COOH	|O
terminus	|O
)	|O
,	|O
which	|O
exists	|O
in	|O
two	|O
forms	|O
as	|O
a	|O
result	|O
of	|O
alternative	|O
splicing	|O
.	|O

Am.	|O

EMSA	|O
competition	|O
experiments	|O
showed	|O
that	|O
mutations	|O
within	|O
the	|O
direct	|O
repeats	|O
failed	|O
to	|O
compete	|O
for	|O
binding	|O
of	|O
the	|O
nuclear	|O
proteins	|O
to	|O
labeled	|O
wild	|O
type	|O
oligonucleotide	|O
.	|O

Transcription	|O
from	|O
the	|O
promoter	|O
containing	|O
the	|O
mutated	|O
direct	|O
repeats	|O
was	|O
increased	|O
greatly	|O
,	|O
consistent	|O
with	|O
the	|O
conclusion	|O
that	|O
these	|O
motifs	|O
functions	|O
in	|O
vivo	|O
to	|O
repress	|O
GPT	|B-PROTEIN
gene	|O
expression	|O
.	|O

However	|O
,	|O
a	|O
>	|O
10	|O
-	|O
fold	|O
increase	|O
in	|O
ERK3	|B-PROTEIN
activity	|O
in	|O
each	|O
PKC	|B-PROTEIN
beta	|I-PROTEIN
transfectant	|O
was	|O
shown	|O
by	|O
immunoprecipitation	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
ERK3	|I-PROTEIN
monoclonal	|O
antibody	|O
followed	|O
by	|O
either	|O
immune	|O
complex	|O
kinase	|O
assay	|O
or	|O
by	|O
in	|O
gel	|O
kinase	|O
assay	|O
.	|O

Sequence	|O
analysis	|O
of	|O
this	|O
100	|O
-	|O
bp	|O
Col2a1	|B-PROTEIN
enhancer	|O
revealed	|O
several	|O
sequence	|O
motifs	|O
similar	|O
to	|O
motifs	|O
present	|O
within	|O
the	|O
regulatory	|O
region	|O
of	|O
the	|O
link	|B-PROTEIN
protein	|O
gene	|O
,	|O
another	|O
cartilage	|O
gene	|O
.	|O

Retinoid	|O
-	|O
dependent	|O
activation	|O
of	|O
the	|O
tissue	|B-PROTEIN
transglutaminase	|I-PROTEIN
promoter	|O
depends	|O
on	|O
both	|O
a	|O
proximal	|O
regulatory	|O
region	|O
containing	|O
sequences	|O
highly	|O
conserved	|O
between	|O
the	|O
human	|O
and	|O
the	|O
mouse	|O
tissue	|B-PROTEIN
transglutaminase	|I-PROTEIN
promoters	|O
and	|O
a	|O
distal	|O
region	|O
that	|O
includes	|O
a	|O
30	|O
-	|O
base	|O
pair	|O
retinoid	|O
response	|O
element	|O
(	|O
mTGRRE1	|O
)	|O
.	|O
mTGRRE1	|O
contains	|O
three	|O
hexanucleotide	|O
half	|O
-	|O
sites	|O
(	|O
two	|O
canonical	|O
and	|O
one	|O
non	|O
-	|O
canonical	|O
)	|O
in	|O
a	|O
DR7	|B-PROTEIN
/	|O
DR5	|B-PROTEIN
motif	|O
that	|O
bind	|O
both	|O
RAR	|B-PROTEIN
*	|O
RXR	|B-PROTEIN
heterodimers	|O
and	|O
RXR	|B-PROTEIN
homodimers	|O
.	|O

Significantly	|O
,	|O
pPKR	|B-PROTEIN
is	|O
capable	|O
of	|O
specifically	|O
phosphorylating	|O
Ser51	|O
in	|O
a	|O
synthetic	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
peptide	|O
,	|O
a	|O
key	|O
characteristic	|O
of	|O
the	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
kinase	|O
family	|O
.	|O

Vertebrate	|O
synapsins	|B-PROTEIN
constitute	|O
a	|O
family	|O
of	|O
synaptic	|O
proteins	|O
that	|O
participate	|O
in	|O
the	|O
regulation	|O
of	|O
neurotransmitter	|O
release	|O
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
using	|O
crude	|O
extracts	|O
from	|O
FREJ4	|O
cells	|O
revealed	|O
the	|O
binding	|O
of	|O
a	|O
member	|O
(	|O
s	|O
)	|O
of	|O
the	|O
Ets	|B-PROTEIN
family	|O
of	|O
transcription	|O
factors	|O
to	|O
the	|O
P4	|B-PROTEIN
EBS	|O
,	|O
as	|O
well	|O
as	|O
the	|O
interaction	|O
of	|O
two	|O
members	|O
of	|O
the	|O
Sp1	|B-PROTEIN
family	|O
,	|O
Sp1	|B-PROTEIN
and	|O
Sp3	|B-PROTEIN
,	|O
with	|O
the	|O
adjacent	|O
GC	|O
box	|O
.	|O

ZEBRA	|B-PROTEIN
and	|O
cellular	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
bZip	|O
activators	|O
,	|O
such	|O
as	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
,	|O
have	|O
homologous	|O
DNA	|O
-	|O
binding	|O
domains	|O
,	|O
and	|O
their	|O
DNA	|O
-	|O
binding	|O
specificities	|O
overlap	|O
.	|O

This	|O
result	|O
suggested	|O
that	|O
mutant	|O
I299	|O
has	|O
diminished	|O
cap	|O
-	|O
binding	|O
activity	|O
.	|O

UV	|O
cross	|O
-	|O
linking	|O
experiments	|O
demonstrated	|O
that	|O
HSV	|O
infection	|O
caused	|O
enhanced	|O
binding	|O
of	|O
protein	|O
factors	|O
,	|O
including	|O
the	|O
64	|O
-	|O
kDa	|O
component	|O
of	|O
cleavage	|B-PROTEIN
stimulation	|I-PROTEIN
factor	|I-PROTEIN
(	|O
CstF	|B-PROTEIN
)	|O
,	|O
to	|O
poly	|O
(	|O
A	|O
)	|O
site	|O
RNAs	|O
from	|O
virus	|O
genes	|O
of	|O
all	|O
temporal	|O
classes	|O
and	|O
that	|O
this	|O
enhanced	|O
binding	|O
required	|O
expression	|O
of	|O
IE63	|B-PROTEIN
.	|O

CM	|B-PROTEIN
-	|I-PROTEIN
ACO3	|I-PROTEIN
is	|O
expressed	|O
in	|O
flowers	|O
and	|O
is	|O
not	|O
induced	|O
by	|O
any	|O
of	|O
the	|O
stimuli	|O
tested	|O
.	|O

We	|O
show	|O
here	|O
that	|O
these	|O
Jun	|B-PROTEIN
/	|O
eb1	|B-PROTEIN
chimeras	|O
are	|O
potent	|O
transactivators	|O
of	|O
AP1	|B-PROTEIN
sites	|O
and	|O
that	|O
they	|O
can	|O
cooperate	|O
with	|O
c	|B-PROTEIN
-	|I-PROTEIN
Ha	|I-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
to	|O
induce	|O
foci	|O
.	|O

In	|O
synchronized	|O
HeLa	|O
cells	|O
,	|O
expression	|O
of	|O
luciferase	|B-PROTEIN
activity	|O
was	|O
induced	|O
at	|O
the	|O
beginning	|O
of	|O
DNA	|O
synthesis	|O
and	|O
was	|O
dependent	|O
on	|O
the	|O
presence	|O
of	|O
an	|O
E2F	|B-PROTEIN
-	|O
binding	|O
site	|O
in	|O
the	|O
H2A.1	|B-PROTEIN
promoter	|O
.	|O

Utilizing	|O
transient	|O
transfection	|O
studies	|O
in	|O
HepG2	|O
cells	|O
,	|O
we	|O
have	|O
shown	|O
that	|O
deletion	|O
of	|O
the	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
promoter	|O
sequences	|O
distal	|O
to	|O
nucleotide	|O
-	|O
44	|O
results	|O
in	|O
a	|O
significant	|O
but	|O
small	|O
increase	|O
in	|O
promoter	|O
activity	|O
.	|O

We	|O
constructed	|O
a	|O
yeast	|O
reporter	|O
strain	|O
containing	|O
the	|O
lacZ	|B-PROTEIN
gene	|O
under	|O
the	|O
control	|O
of	|O
the	|O
CYC1	|B-PROTEIN
promoter	|O
associated	|O
with	|O
three	|O
copies	|O
of	|O
TRE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

If	|O
hnRNP	|B-PROTEIN
K	|I-PROTEIN
is	|O
a	|O
transcription	|O
factor	|O
,	|O
then	|O
interactions	|O
with	|O
the	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
transcription	|O
apparatus	|O
are	|O
predicted	|O
.	|O

A	|O
developmentally	|O
regulated	|O
4.6	|O
kb	|O
mRNA	|O
is	|O
recognized	|O
on	|O
Northern	|O
blots	|O
of	|O
oocyte	|O
RNA	|O
using	|O
the	|O
X.l	|O
aevis	|O
cDNA	|O
.	|O

Sequence	|O
conservation	|O
is	|O
greatest	|O
for	|O
residues	|O
located	|O
near	|O
the	|O
active	|O
centers	|O
of	|O
the	|O
exo	|B-PROTEIN
and	|O
pol	|B-PROTEIN
domains	|O
of	|O
the	|O
E.c	|O
oli	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
I	|I-PROTEIN
structure	|O
.	|O

Despite	|O
the	|O
favourable	|O
natural	|O
history	|O
of	|O
acute	|O
BI	|O
,	|O
mild	|O
,	|O
moderate	|O
,	|O
and	|O
severe	|O
posttraumatic	|O
changes	|O
were	|O
shown	|O
to	|O
appear	|O
as	|O
cicatricial	|O
-	|O
adhesive	|O
and	|O
atrophic	|O
processes	|O
,	|O
intracerebral	|O
cysts	|O
,	|O
porencephaly	|O
,	|O
which	|O
result	|O
in	|O
posttraumatic	|O
epilepsy	|O
,	|O
hydrocephalus	|O
,	|O
etc	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
the	|O
increase	|O
in	|O
V	|O
O2	|O
may	|O
have	|O
been	|O
a	|O
consequence	|O
of	|O
the	|O
increase	|O
in	|O
Q	|O
O2	|O
rather	|O
than	|O
a	|O
response	|O
to	|O
the	|O
procedure	|O
itself	|O
.	|O

Several	|O
cytokines	|O
exhibit	|O
a	|O
high	|O
degree	|O
of	|O
temporal	|O
regulation	|O
as	|O
well	|O
as	|O
somnogenic	|O
potency	|O
(	|O
e.g.	|O
,	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
[	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
]	|O
,	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
[	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
]	|O
)	|O
.	|O

As	|O
pH	|O
and	|O
Hb	|B-PROTEIN
can	|O
also	|O
affect	|O
mixed	|O
venous	|O
CO2	|O
content	|O
,	|O
the	|O
effect	|O
on	|O
Q	|O
was	|O
also	|O
assessed	|O
.	|O

No	|O
difference	|O
in	|O
elastin	|B-PROTEIN
peptide	|O
concentration	|O
was	|O
observed	|O
between	|O
emphysematous	|O
patients	|O
and	|O
control	|O
subjects	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
=	|O
2.39	|O
+	|O
/	|O
-	|O
1.18	|O
micrograms	|O
/	|O
ml	|O
in	|O
patients	|O
versus	|O
2.55	|O
+	|O
/	|O
-	|O
1.34	|O
micrograms	|O
/	|O
ml	|O
in	|O
policemen	|O
and	|O
2.59	|O
+	|O
/	|O
-	|O
1.20	|O
micrograms	|O
/	|O
ml	|O
in	|O
coal	|O
miners	|O
)	|O
.	|O

Identification	|O
of	|O
this	|O
region	|O
as	|O
the	|O
E.	|O
coli	|O
tmk	|B-PROTEIN
gene	|O
was	|O
confirmed	|O
by	|O
functional	|O
complementation	|O
of	|O
a	|O
yeast	|O
dTMP	|B-PROTEIN
kinase	|I-PROTEIN
temperature	|O
-	|O
sensitive	|O
mutant	|O
and	|O
by	|O
in	|O
vitro	|O
enzyme	|O
assay	|O
of	|O
the	|O
thymidylate	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
in	|O
cell	|O
extracts	|O
of	|O
E.	|O
coli	|O
by	|O
use	|O
of	|O
tmk	|B-PROTEIN
-	|O
overproducing	|O
plasmids	|O
.	|O

The	|O
structural	|O
gene	|O
for	|O
copper	|O
-	|O
and	|O
topa	|B-PROTEIN
quinone	|I-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
monoamine	|I-PROTEIN
oxidase	|I-PROTEIN
(	|O
maoA	|B-PROTEIN
)	|O
and	|O
an	|O
unknown	|O
amine	|B-PROTEIN
oxidase	|I-PROTEIN
gene	|O
have	|O
been	|O
located	|O
at	|O
30.9	|O
min	|O
on	|O
the	|O
Escherichia	|O
coli	|O
chromosome	|O
.	|O

This	|O
interaction	|O
is	|O
mediated	|O
by	|O
the	|O
SH2	|B-PROTEIN
domain	|O
of	|O
Crk	|B-PROTEIN
and	|O
can	|O
be	|O
inhibited	|O
with	|O
a	|O
phosphopeptide	|O
containing	|O
the	|O
Crk	|B-PROTEIN
-	|O
SH2	|B-PROTEIN
binding	|O
motif	|O
.	|O

Consistent	|O
with	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
being	|O
a	|O
shared	|O
receptor	|O
subunit	|O
,	|O
its	|O
tyrosine	|O
phosphorylation	|O
was	|O
increased	|O
by	|O
both	|O
heterologous	|O
ligands	|O
and	|O
it	|O
mediated	|O
a	|O
trans	|O
-	|O
inhibitory	|O
effect	|O
of	|O
NDF	|B-PROTEIN
on	|O
EGF	|B-PROTEIN
binding	|O
.	|O

Identification	|O
of	|O
a	|O
consensus	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
phosphorylation	|O
site	|O
unique	|O
to	|O
the	|O
nuclear	|O
form	|O
of	|O
human	|O
deoxyuridine	|B-PROTEIN
triphosphate	|I-PROTEIN
nucleotidohydrolase	|I-PROTEIN
.	|O

The	|O
cDNA	|O
corresponding	|O
to	|O
the	|O
FPS1	|B-PROTEIN
gene	|O
was	|O
isolated	|O
by	|O
functional	|O
complementation	|O
of	|O
a	|O
mutant	|O
yeast	|O
strain	|O
defective	|O
in	|O
FPS	|B-PROTEIN
activity	|O
(	|O
Delourme	|O
,	|O
D.	|O
,	|O
Lacroute	|O
,	|O
F.	|O
,	|O
and	|O
Karst	|O
,	|O
F.	|O

The	|O
isolated	|O
plasmin	|B-PROTEIN
fragments	|O
of	|O
VEGF	|B-PROTEIN
were	|O
compared	|O
with	|O
respect	|O
to	|O
heparin	|O
binding	|O
,	|O
interaction	|O
with	|O
soluble	|O
VEGF	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
and	|O
ability	|O
to	|O
promote	|O
endothelial	|O
cell	|O
mitogenesis	|O
.	|O

VDR	|B-PROTEIN
/	|O
RXR	|B-PROTEIN
bound	|O
well	|O
to	|O
the	|O
VDREs	|O
and	|O
to	|O
DR4	|O
and	|O
DR5	|O
using	|O
the	|O
electrophoretic	|O
mobility	|O
shift	|O
assay	|O
.	|O

The	|O
members	|O
of	|O
the	|O
Myb	|B-PROTEIN
family	|O
of	|O
transcription	|O
factors	|O
are	|O
defined	|O
by	|O
homology	|O
in	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
;	|O
all	|O
bind	|O
the	|O
Myb	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
site	|I-PROTEIN
(	|O
MBS	|B-PROTEIN
)	|O
sequence	|O
(	|O
YG	|O
(	|O
A	|O
/	|O
G	|O
)	|O
C	|O
(	|O
A	|O
/	|O
C	|O
/	|O
G	|O
)	|O
GTT	|O
(	|O
G	|O
/	|O
A	|O
)	|O
)	|O
.	|O

In	|O
contrast	|O
,	|O
when	|O
the	|O
isoform	|O
containing	|O
the	|O
C	|O
epsilon4	|O
domain	|O
joined	|O
directly	|O
to	|O
the	|O
M2	|O
exon	|O
(	|O
IgE	|B-PROTEIN
grande	|I-PROTEIN
)	|O
is	|O
expressed	|O
in	|O
the	|O
J558L	|O
cell	|O
line	|O
,	|O
it	|O
is	|O
degraded	|O
intracellularly	|O
,	|O
suggesting	|O
a	|O
cell	|O
line	|O
-	|O
dependent	|O
regulation	|O
of	|O
secretion	|O
.	|O

Human	|O
cytomegalovirus	|O
immediate	|O
-	|O
early	|O
protein	|O
IE2	|B-PROTEIN
tethers	|O
a	|O
transcriptional	|O
repression	|O
domain	|O
to	|O
p53	|B-PROTEIN
.	|O

The	|O
specificity	|O
of	|O
action	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
family	|O
members	|O
may	|O
be	|O
derived	|O
from	|O
the	|O
characteristics	|O
of	|O
each	|O
factor	|O
,	|O
including	|O
the	|O
expression	|O
profiles	|O
,	|O
the	|O
DNA	|O
binding	|O
affinities	|O
,	|O
the	|O
cofactors	|O
,	|O
and	|O
so	|O
on	|O
,	|O
in	|O
addition	|O
to	|O
the	|O
DNA	|O
binding	|O
specificities	|O
.	|O

The	|O
antibodies	|O
inhibited	|O
specifically	|O
the	|O
transcription	|O
of	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|I-PROTEIN
promoter	|O
in	|O
vitro	|O
.	|O

Immunocytochemical	|O
analysis	|O
demonstrated	|O
the	|O
presence	|O
of	|O
DREF	|B-PROTEIN
polypeptide	|O
in	|O
nuclei	|O
after	|O
the	|O
eighth	|O
nuclear	|O
division	|O
cycle	|O
,	|O
suggesting	|O
that	|O
nuclear	|O
accumulation	|O
of	|O
DREF	|B-PROTEIN
is	|O
important	|O
for	|O
the	|O
coordinate	|O
zygotic	|O
expression	|O
of	|O
DNA	|O
replication	|O
-	|O
related	|O
genes	|O
carrying	|O
DRE	|O
sequences	|O
.	|O

A	|O
DNA	|O
fragment	|O
carrying	|O
1,100	|O
nucleotides	|O
derived	|O
from	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
UGT1A1	|B-PROTEIN
gene	|O
was	|O
enough	|O
for	|O
MC	|O
induction	|O
.	|O

This	|O
result	|O
supports	|O
the	|O
argument	|O
that	|O
the	|O
beta	|O
'	|O
subunit	|O
plays	|O
an	|O
essential	|O
role	|O
in	|O
determining	|O
the	|O
progress	|O
of	|O
transcription	|O
elongation	|O
.	|O

Two	|O
XPG	|B-PROTEIN
regions	|O
with	|O
putative	|O
NLS	|O
[	|O
amino	|O
acid	|O
(	|O
AA	|O
)	|O
coordinates	|O
:	|O
NLS	|O
-	|O
B	|O
(	|O
AA	|O
1057-1074	|O
)	|O
and	|O
NLS	|O
-	|O
C	|O
(	|O
AA	|O
1171-1185	|O
)	|O
]	|O
were	|O
each	|O
shown	|O
to	|O
independently	|O
localize	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
gal	|I-PROTEIN
extensively	|O
(	|O
>	|O
80%	|O
)	|O
to	|O
the	|O
nucleus	|O
of	|O
HeLa	|O
cells	|O
.	|O

The	|O
lacS	|B-PROTEIN
gene	|O
was	|O
cloned	|O
in	|O
an	|O
E.	|O
coli	|O
-	|O
Streptococcus	|O
shuttle	|O
vector	|O
and	|O
was	|O
expressed	|O
both	|O
in	|O
a	|O
lacS	|B-PROTEIN
deletion	|O
derivative	|O
of	|O
S.	|O
thermophilus	|O
and	|O
in	|O
a	|O
pNZ63	|O
-	|O
cured	|O
strain	|O
,	|O
L.	|O
lactis	|O
NZ6091	|O
.	|O

The	|O
genome	|O
of	|O
all	|O
retroviruses	|O
consists	|O
of	|O
two	|O
identical	|O
RNAs	|O
noncovalently	|O
linked	|O
near	|O
their	|O
5'	|O
end	|O
.	|O

The	|O
extraction	|O
recovery	|O
of	|O
Amphotericin	|O
B	|O
from	|O
the	|O
cerebrospinal	|O
fluid	|O
is	|O
higher	|O
than	|O
90%	|O
over	|O
the	|O
entire	|O
linear	|O
range	|O
.	|O

HuEpo	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
Ab	|O
inhibited	|O
Epo	|B-PROTEIN
-	|O
induced	|O
parental	|O
UT	|O
-	|O
7	|O
cell	|O
growth	|O
,	|O
but	|O
not	|O
that	|O
of	|O
cells	|O
of	|O
clone	|O
12	|O
,	|O
suggesting	|O
that	|O
the	|O
muEpo	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
is	|O
able	|O
to	|O
induce	|O
human	|O
UT	|O
-	|O
7	|O
cell	|O
proliferation	|O
.	|O

The	|O
frequency	|O
of	|O
integrations	|O
that	|O
led	|O
to	|O
transcription	|O
of	|O
the	|O
lacZ	|B-PROTEIN
gene	|O
was	|O
estimated	|O
to	|O
be	|O
0.5%	|O
of	|O
all	|O
integrations	|O
,	|O
of	|O
which	|O
14%	|O
were	|O
downregulated	|O
on	|O
differentiation	|O
of	|O
32D	|O
cells	|O
towards	|O
neutrophils	|O
.	|O

The	|O
sequence	|O
and	|O
isolated	|O
cDNAs	|O
will	|O
provide	|O
useful	|O
reagents	|O
for	|O
studying	|O
the	|O
expression	|O
of	|O
Brca1	|B-PROTEIN
in	|O
the	|O
mouse	|O
,	|O
and	|O
for	|O
testing	|O
the	|O
importance	|O
of	|O
the	|O
evolutionarily	|O
conserved	|O
domains	|O
.	|O

A	|O
study	|O
was	|O
performed	|O
to	|O
compare	|O
the	|O
ONLINE	|O
and	|O
EMIT	|O
II	|O
immunoassays	|O
with	|O
gas	|O
chromatographic	|O
/	|O
mass	|O
spectrometric	|O
(	|O
GC	|O
/	|O
MS	|O
)	|O
analysis	|O
of	|O
methaqualone	|O
metabolites	|O
on	|O
urine	|O
using	|O
samples	|O
obtained	|O
from	|O
a	|O
clinical	|O
study	|O
.	|O

Interaction	|O
of	|O
the	|O
Fur	|B-PROTEIN
repressor	|O
with	|O
a	|O
150	|O
-	|O
bp	|O
fragment	|O
encompassing	|O
the	|O
pvdS	|B-PROTEIN
promoter	|O
was	|O
demonstrated	|O
in	|O
vivo	|O
by	|O
the	|O
Fur	|B-PROTEIN
titration	|O
assay	|O
and	|O
confirmed	|O
in	|O
vitro	|O
by	|O
gel	|O
retardation	|O
experiments	|O
with	|O
a	|O
partially	|O
purified	|O
Fur	|B-PROTEIN
preparation	|O
.	|O

This	|O
protein	|O
encoded	|O
by	|O
this	|O
cDNA	|O
,	|O
which	|O
we	|O
have	|O
termed	|O
p150TSP	|B-PROTEIN
(	|O
for	|O
TPR	|O
-	|O
containing	|O
,	|O
SH2	|B-PROTEIN
-	|O
binding	|O
phosphoprotein	|O
)	|O
,	|O
is	|O
located	|O
predominantly	|O
in	|O
the	|O
nucleus	|O
and	|O
is	|O
highly	|O
conserved	|O
in	|O
evolution	|O
.	|O

Both	|O
mutant	|O
receptors	|O
were	|O
expressed	|O
on	|O
the	|O
cell	|O
surface	|O
and	|O
bound	|O
insulin	|B-PROTEIN
normally	|O
,	|O
but	|O
showed	|O
markedly	|O
impaired	|O
autophosphorylation	|O
in	|O
response	|O
to	|O
insulin	|B-PROTEIN
.	|O

EMBO	|O
J.	|O

Taken	|O
together	|O
,	|O
our	|O
results	|O
indicate	|O
that	|O
thrombin	|B-PROTEIN
-	|O
stimulated	|O
vascular	|O
smooth	|O
muscle	|O
proliferation	|O
is	|O
delayed	|O
and	|O
requires	|O
the	|O
de	|O
novo	|O
expression	|O
of	|O
one	|O
or	|O
more	|O
autocrine	|O
mitogens	|O
.	|O

Transcription	|O
from	|O
adenovirus	|O
E2	|B-PROTEIN
-	|O
early	|O
promoter	|O
is	|O
controlled	|O
by	|O
a	|O
unique	|O
array	|O
of	|O
four	|O
cis	|O
-	|O
acting	|O
elements	|O
which	|O
include	|O
an	|O
atypical	|O
TBP	|B-PROTEIN
site	|O
,	|O
two	|O
E2F	|B-PROTEIN
sites	|O
present	|O
in	|O
an	|O
inverted	|O
orientation	|O
relative	|O
to	|O
each	|O
other	|O
,	|O
and	|O
an	|O
ATF	|B-PROTEIN
site	|O
.	|O

Furthermore	|O
,	|O
we	|O
showed	|O
that	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
/	|O
interferon	|B-PROTEIN
gamma	|I-PROTEIN
(	|O
IFN	|B-PROTEIN
gamma	|I-PROTEIN
)	|O
response	|O
element	|O
in	|O
the	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
(	|O
IR	|B-PROTEIN
/	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
which	|O
contains	|O
a	|O
Stat	|B-PROTEIN
-	|O
binding	|O
site	|O
and	|O
an	|O
adjacent	|O
CRE	|O
-	|O
like	|O
site	|O
,	|O
also	|O
makes	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|O
induced	|O
binding	|O
complexes	|O
similar	|O
to	|O
JRE	|O
-	|O
IL6	|B-PROTEIN
-	|O
BCs	|O
.	|O

A	|O
second	|O
peptide	|O
(	|O
amino	|O
acids	|O
58-77	|O
)	|O
also	|O
antagonized	|O
p21	|B-PROTEIN
-	|O
activity	|O
,	|O
but	|O
this	|O
peptide	|O
did	|O
not	|O
affect	|O
the	|O
ability	|O
of	|O
p21	|B-PROTEIN
to	|O
interact	|O
with	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
/	|O
Cdk2	|B-PROTEIN
.	|O

A	|O
p21	|B-PROTEIN
peptide	|O
spanning	|O
amino	|O
acids	|O
139-164	|O
was	|O
found	|O
to	|O
bind	|O
PCNA	|B-PROTEIN
in	|O
a	|O
filter	|O
binding	|O
assay	|O
and	|O
this	|O
peptide	|O
suppressed	|O
recombinant	|O
p21	|B-PROTEIN
-	|O
PCNA	|B-PROTEIN
interaction	|O
.	|O

Results	|O
were	|O
supported	|O
by	|O
the	|O
agar	|O
diffusion	|O
method	|O
for	|O
Y.	|O
enterocolitica	|O
,	|O
whereas	|O
inhibition	|O
activity	|O
was	|O
not	|O
found	|O
for	|O
A.	|O
hydrophila	|O
.	|O

OND	|O
8	|O
mg	|O
tid	|O
days	|O
2-3	|O
,	|O
and	|O
8	|O
mg	|O
tid	|O
prn	|O
days	|O
4-5	|O
and	|O
prednisolone	|O
75-100	|O
mg	|O
qds	|O
days	|O
2-5	|O
and	|O
2	|O
)	|O
MCP	|O
30	|O
mg	|O
/	|O
metylprednisolone	|O
80	|O
mg	|O
i.v	|O
.	|O
before	|O
CT	|O
and	|O
MCP	|O
20	|O
mg	|O
p.r	|O
.	|O
after	|O
4	|O
and	|O
8	|O
h	|O
respectively	|O
.	|O

The	|O
dynamic	|O
properties	|O
of	|O
this	|O
protein	|O
fragment	|O
were	|O
measured	|O
and	|O
analyzed	|O
using	|O
both	|O
isotropic	|O
and	|O
anisotropic	|O
models	|O
of	|O
molecular	|O
motion	|O
.	|O

Adduction	|O
of	|O
the	|O
human	|O
N	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
codon	|O
61	|O
sequence	|O
with	|O
(	|O
-	|O
)	|O
-	|O
(	|O
7S	|O
,	|O
8R	|O
,	|O
9R	|O
,	|O
10S	|O
)	|O
-	|O
7,8	|O
-	|O
dihydroxy	|O
-	|O
9,10	|O
-	|O
epoxy	|O
-	|O
7,8,9,10	|O
-	|O
tetrahydrobenzo	|O
[	|O
a	|O
]	|O
pyrene	|O
:	|O
structural	|O
refinement	|O
of	|O
the	|O
intercalated	|O
SRSR	|O
(	|O
61,2	|O
)	|O
(	|O
-	|O
)	|O
-	|O
(	|O
7S	|O
,	|O
8R	|O
,	|O
9S	|O
,	|O
10R	|O
)	|O
-	|O
N6	|O
-	|O
[	|O
10	|O
-	|O
(	|O
7,8,9,10	|O
-	|O
tetrahydrobenzo	|O
[	|O
a	|O
]	|O
pyrenyl	|O
)	|O
]	|O
-	|O
2'	|O
-	|O
deoxyadenosyl	|O
adduct	|O
from	|O
1H	|O
NMR	|O
.	|O

Isolation	|O
by	|O
PCR	|O
of	|O
a	|O
cDNA	|O
clone	|O
from	|O
pea	|O
petals	|O
with	|O
similarity	|O
to	|O
petunia	|O
and	|O
wheat	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

This	|O
fragment	|O
can	|O
bind	|O
several	|O
trans	|O
-	|O
acting	|O
factors	|O
in	|O
vitro	|O
,	|O
including	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
members	|O
of	|O
the	|O
Ets	|B-PROTEIN
family	|O
.	|O

Exposure	|O
of	|O
peripheral	|O
blood	|O
T	|O
cells	|O
from	|O
young	|O
subjects	|O
to	|O
PHA	|B-PROTEIN
or	|O
cross	|O
-	|O
linked	|O
anti	|B-PROTEIN
-	|I-PROTEIN
CD3	|I-PROTEIN
monoclonal	|O
antibodies	|O
stimulated	|O
rapid	|O
increases	|O
in	|O
MAPK	|B-PROTEIN
and	|O
MEK	|B-PROTEIN
enzymatic	|O
activity	|O
.	|O

These	|O
different	|O
observations	|O
exclude	|O
a	|O
heterozygosity	|O
of	|O
the	|O
A	|O
-	|O
-	|O
>	|O
G	|O
mutation	|O
at	|O
codon	|O
beta	|O
77	|O
,	|O
as	|O
well	|O
as	|O
a	|O
deletion	|O
comparable	|O
to	|O
that	|O
of	|O
Hbs	|B-PROTEIN
Lepore	|I-PROTEIN
or	|O
Kenya	|O
,	|O
or	|O
a	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
gene	|O
duplication	|O
,	|O
and	|O
point	|O
to	|O
a	|O
nontraditional	|O
inheritance	|O
of	|O
Hb	|B-PROTEIN
Costa	|I-PROTEIN
Rica	|I-PROTEIN
.	|O

This	|O
is	|O
the	|O
first	|O
description	|O
,	|O
to	|O
our	|O
knowledge	|O
,	|O
of	|O
regulatory	|O
elements	|O
that	|O
control	|O
expression	|O
of	|O
a	|O
gene	|O
encoding	|O
a	|O
B7	|B-PROTEIN
costimulatory	|O
molecule	|O
.	|O

DNA	|O
-	|O
STAT	|B-PROTEIN
complexes	|O
were	|O
detected	|O
in	|O
all	|O
Bcr	|B-PROTEIN
/	|O
Abl	|B-PROTEIN
-	|O
transformed	|O
cell	|O
lines	|O
and	|O
they	|O
were	|O
supershifted	|O
by	|O
antibodies	|O
against	|O
STAT1	|B-PROTEIN
and	|O
STAT5	|B-PROTEIN
.	|O

When	|O
overexpressed	|O
in	|O
an	|O
appropriate	|O
cell	|O
line	|O
,	|O
TAN	|B-PROTEIN
-	|I-PROTEIN
1C	|I-PROTEIN
prevented	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
-	|O
dependent	|O
transactivation	|O
in	|O
transient	|O
reporter	|O
gene	|O
assays	|O
in	|O
a	|O
fashion	|O
similar	|O
to	|O
the	|O
structurally	|O
related	|O
protein	|O
,	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
.	|O

T	|O
cell	|O
leukemia	|O
-	|O
associated	|O
human	|O
Notch	|B-PROTEIN
/	|O
translocation	|O
-	|O
associated	|O
Notch	|B-PROTEIN
homologue	|O
has	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|O
like	|O
activity	|O
and	|O
physically	|O
interacts	|O
with	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
proteins	|O
in	|O
T	|O
cells	|O
.	|O

Polyprotein	|O
processing	|O
in	|O
Southampton	|O
virus	|O
:	|O
identification	|O
of	|O
3C	|B-PROTEIN
-	|O
like	|O
protease	|O
cleavage	|O
sites	|O
by	|O
in	|O
vitro	|O
mutagenesis	|O
.	|O

The	|O
humanized	|O
LL2	|B-PROTEIN
(	|O
hLL2	|B-PROTEIN
)	|O
,	|O
lacking	|O
light	|B-PROTEIN
chain	|I-PROTEIN
variable	|I-PROTEIN
region	|O
glycosylation	|O
,	|O
exhibited	|O
immunoreactivities	|O
that	|O
were	|O
comparable	|O
to	|O
that	|O
of	|O
chimeric	|O
LL2	|B-PROTEIN
(	|O
cLL2	|B-PROTEIN
)	|O
,	|O
which	|O
was	|O
shown	|O
previously	|O
to	|O
have	|O
antigen	|O
-	|O
binding	|O
properties	|O
similar	|O
to	|O
its	|O
murine	|O
counterpart	|O
,	|O
suggesting	|O
that	|O
the	|O
VK	|O
-	|O
appended	|O
oligosaccharides	|O
found	|O
in	|O
mLL2	|B-PROTEIN
are	|O
not	|O
necessary	|O
for	|O
antigen	|O
binding	|O
.	|O

An	|O
apparent	|O
N	|O
-	|O
terminal	|O
transit	|O
peptide	|O
in	|O
the	|O
coding	|O
region	|O
and	|O
a	|O
3'	|O
poly	|O
(	|O
A	|O
)	|O
tail	|O
exist	|O
in	|O
the	|O
cDNA	|O
clone	|O
indicated	|O
that	|O
this	|O
chloroplast	|O
protein	|O
as	|O
nuclear	|O
encoded	|O
.	|O

Deletion	|O
analysis	|O
of	|O
rOC	|B-PROTEIN
promoter	|O
-	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
constructs	|O
demonstrates	|O
that	|O
an	|O
AML	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
binding	|O
sequence	|O
within	|O
the	|O
proximal	|O
promoter	|O
(	|O
-	|O
138	|O
to	|O
-	|O
130	|O
nt	|O
)	|O
contributes	|O
to	|O
75%	|O
of	|O
the	|O
level	|O
of	|O
osteocalcin	|B-PROTEIN
gene	|O
expression	|O
.	|O

Thus	|O
,	|O
a	|O
critical	|O
question	|O
is	|O
how	|O
HOX	|B-PROTEIN
proteins	|O
select	|O
the	|O
correct	|O
sets	|O
of	|O
target	|O
genes	|O
in	|O
vivo	|O
.	|O

RAS2val19	|B-PROTEIN
,	|O
a	|O
dominant	|O
activated	|O
form	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
Ras2	|B-PROTEIN
,	|O
stimulates	|O
both	|O
filamentous	|O
growth	|O
and	|O
expression	|O
of	|O
a	|O
transcriptional	|O
reporter	|O
FG	|B-PROTEIN
(	|O
TyA	|B-PROTEIN
)	|O
::	|O
lacZ	|B-PROTEIN
but	|O
does	|O
not	|O
induce	|O
the	|O
mating	|O
pathway	|O
reporter	|O
FUS1	|B-PROTEIN
::	|O
lacZ	|B-PROTEIN
.	|O

Moreover	|O
,	|O
the	|O
Rho	|B-PROTEIN
family	|O
protein	|O
Cdc42	|B-PROTEIN
,	|O
a	|O
conserved	|O
morphogenetic	|O
G	|B-PROTEIN
protein	|I-PROTEIN
,	|O
is	|O
also	|O
a	|O
potent	|O
regulator	|O
of	|O
filamentous	|O
growth	|O
and	|O
FG	|B-PROTEIN
(	|O
TyA	|B-PROTEIN
)	|O
::	|O
lacZ	|B-PROTEIN
expression	|O
in	|O
S.	|O
cerevisiae	|O
.	|O

Each	|O
immunoprecipitate	|O
contained	|O
a	|O
complex	|O
of	|O
N1	|B-PROTEIN
(	|I-PROTEIN
deltaEC	|I-PROTEIN
)	|I-PROTEIN
and	|O
CBF1	|B-PROTEIN
.	|O

This	|O
region	|O
includes	|O
verA	|B-PROTEIN
,	|O
a	|O
structural	|O
gene	|O
previously	|O
shown	|O
to	|O
be	|O
required	|O
for	|O
ST	|O
biosynthesis	|O
,	|O
and	|O
24	|O
additional	|O
closely	|O
spaced	|O
transcripts	|O
ranging	|O
in	|O
size	|O
from	|O
0.6	|O
to	|O
7.2	|O
kb	|O
that	|O
are	|O
coordinately	|O
induced	|O
only	|O
under	|O
ST	|O
-	|O
producing	|O
conditions	|O
.	|O

Subcellular	|O
localizations	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
CBFbeta	|B-PROTEIN
and	|O
the	|O
CBFbeta	|B-PROTEIN
-	|O
SMMHC	|B-PROTEIN
fusion	|O
protein	|O
were	|O
determined	|O
by	|O
immunofluorescence	|O
of	|O
NIH	|O
3T3	|O
cells	|O
that	|O
overexpress	|O
wild	|O
-	|O
type	|O
or	|O
fusion	|O
protein	|O
.	|O

Menstrual	|O
-	|O
cycle	|O
phase	|O
did	|O
not	|O
significantly	|O
affect	|O
personality	|O
variables	|O
in	|O
either	|O
group	|O
.	|O

We	|O
report	|O
the	|O
isolation	|O
of	|O
human	|O
cDNAs	|O
homologous	|O
to	|O
the	|O
Drosophila	|O
dishevelled	|B-PROTEIN
(	|O
dsh	|B-PROTEIN
)	|O
segment	|O
-	|O
polarity	|O
gene	|O
.	|O

Escherichia	|O
coli	|O
BL21	|O
(	|O
DE3	|O
)	|O
plysS	|O
,	|O
harbouring	|O
a	|O
recombinant	|O
plasmid	|O
containing	|O
the	|O
catalase	|B-PROTEIN
-	|O
peroxidase	|B-PROTEIN
gene	|O
,	|O
produced	|O
a	|O
large	|O
amount	|O
of	|O
proteins	|O
that	|O
co	|O
-	|O
migrated	|O
on	|O
SDS	|O
/	|O
PAGE	|O
with	|O
the	|O
native	|O
enzyme	|O
.	|O

Ca2+	|O
decreased	|O
Zn2+	|O
binding	|O
in	|O
S100	|B-PROTEIN
beta	|I-PROTEIN
but	|O
it	|O
did	|O
not	|O
influence	|O
binding	|O
to	|O
MRP14	|B-PROTEIN
,	|O
suggesting	|O
that	|O
the	|O
Zn2+	|O
binding	|O
site	|O
was	|O
distinct	|O
from	|O
and	|O
independent	|O
of	|O
the	|O
two	|O
Ca2+	|O
binding	|O
domains	|O
.	|O

Cdk2	|B-PROTEIN
formed	|O
a	|O
complex	|O
with	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
in	|O
this	|O
system	|O
.	|O

The	|O
Cdk2	|B-PROTEIN
-	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
D1	|I-PROTEIN
complex	|O
did	|O
not	|O
phosphorylate	|O
any	|O
tested	|O
substrates	|O
,	|O
such	|O
as	|O
H1	|B-PROTEIN
histone	|O
,	|O
pRB	|B-PROTEIN
,	|O
SV40	|B-PROTEIN
large	|I-PROTEIN
T	|I-PROTEIN
antigen	|O
,	|O
p53	|B-PROTEIN
,	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
a	|O
preparation	|O
of	|O
nuclear	|O
proteins	|O
from	|O
HeLa	|O
cells	|O
;	|O
in	|O
contrast	|O
,	|O
Cdk2	|B-PROTEIN
-	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
E	|I-PROTEIN
and	|O
Cdk2	|B-PROTEIN
-	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
phosphorylated	|O
these	|O
proteins	|O
.	|O

Cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
Cdk2	|B-PROTEIN
)	|O
forms	|O
an	|O
inactive	|O
complex	|O
with	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
since	|O
Cdk2	|B-PROTEIN
associated	|O
with	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
is	|O
not	|O
phosphorylated	|O
by	|O
Cdk7	|B-PROTEIN
-	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
H.	|I-PROTEIN

Two	|O
overlapping	|O
clones	|O
contained	|O
the	|O
complete	|O
Adh	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
composed	|O
of	|O
nine	|O
exons	|O
in	|O
a	|O
12	|O
-	|O
kb	|O
region	|O
,	|O
with	|O
the	|O
placement	|O
of	|O
introns	|O
matching	|O
that	|O
observed	|O
in	|O
other	|O
mammalian	|O
ADH	|B-PROTEIN
genes	|O
.	|O

Ligation	|O
of	|O
CD40	|B-PROTEIN
rescues	|O
Ramos	|O
-	|O
Burkitt	|O
lymphoma	|O
B	|O
cells	|O
from	|O
calcium	|O
ionophore	|O
-	|O
and	|O
antigen	|O
receptor	|O
-	|O
triggered	|O
apoptosis	|O
by	|O
inhibiting	|O
activation	|O
of	|O
the	|O
cysteine	|B-PROTEIN
protease	|I-PROTEIN
CPP32	|O
/	|O
Yama	|B-PROTEIN
and	|O
cleavage	|O
of	|O
its	|O
substrate	|O
PARP	|B-PROTEIN
.	|O

Large	|B-PROTEIN
T	|I-PROTEIN
antigen	|I-PROTEIN
was	|O
coimmunoprecipitated	|O
by	|O
antibodies	|O
to	|O
epitope	|O
-	|O
tagged	|O
TBP	|B-PROTEIN
,	|O
endogenous	|O
TBP	|B-PROTEIN
,	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
100	|I-PROTEIN
,	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
130	|I-PROTEIN
,	|O
and	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
250	|I-PROTEIN
,	|O
under	|O
conditions	|O
where	|O
holo	|B-PROTEIN
-	|I-PROTEIN
TFIID	|I-PROTEIN
would	|O
be	|O
precipitated	|O
.	|O

Northern	|O
blot	|O
hybridization	|O
demonstrated	|O
that	|O
HEP	|B-PROTEIN
-	|O
COP	|B-PROTEIN
was	|O
expressed	|O
in	|O
a	|O
wide	|O
range	|O
of	|O
human	|O
adult	|O
and	|O
fetal	|O
tissues	|O
.	|O

A	|O
human	|O
cytoplasmic	|O
signaling	|O
protein	|O
has	|O
been	|O
cloned	|O
that	|O
possesses	|O
the	|O
same	|O
structural	|O
arrangement	|O
of	|O
SH3	|B-PROTEIN
-	|O
SH2	|B-PROTEIN
-	|O
SH3	|B-PROTEIN
domains	|O
as	|O
Grb2	|B-PROTEIN
.	|O

A	|O
direct	|O
role	|O
for	|O
sterol	|B-PROTEIN
regulatory	|I-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
in	|O
activation	|O
of	|O
3	|B-PROTEIN
-	|I-PROTEIN
hydroxy	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
methylglutaryl	|I-PROTEIN
coenzyme	|I-PROTEIN
A	|I-PROTEIN
reductase	|I-PROTEIN
gene	|O
.	|O

E3/19	|B-PROTEIN
K	|I-PROTEIN
resides	|O
in	|O
the	|O
endoplasmic	|O
reticulum	|O
where	|O
it	|O
binds	|O
to	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
I	|I-PROTEIN
molecules	|O
,	|O
thereby	|O
preventing	|O
their	|O
transport	|O
to	|O
the	|O
cell	|O
surface	|O
.	|O

When	|O
the	|O
PHT	|O
and	|O
CSA	|O
groups	|O
were	|O
compared	|O
,	|O
Hyp	|O
levels	|O
were	|O
significantly	|O
higher	|O
in	|O
the	|O
PHT	|O
-	|O
GO+	|O
group	|O
than	|O
in	|O
the	|O
CSA	|O
-	|O
GO+	|O
group	|O
.	|O

Among	|O
the	|O
LE6	|B-PROTEIN
deletions	|O
,	|O
only	|O
one	|O
had	|O
a	|O
reduced	|O
transformation	|O
efficiency	|O
,	|O
while	|O
seven	|O
transformed	|O
cells	|O
at	|O
least	|O
as	|O
efficiently	|O
as	|O
wild	|O
-	|O
type	|O
LE6	|B-PROTEIN
.	|O

ORF	|O
E8	|B-PROTEIN
colinear	|O
with	|O
ORF	|O
E6	|B-PROTEIN
,	|O
which	|O
could	|O
generate	|O
a	|O
50	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
with	|O
a	|O
hydrophobic	|O
segment	|O
,	|O
did	|O
not	|O
transform	|O
cells	|O
when	|O
cloned	|O
into	|O
the	|O
pZipNeo	|O
vector	|O
.	|O

Cloning	|O
of	|O
individual	|O
ZI	|O
domains	|O
upstream	|O
of	|O
a	|O
minimal	|O
promoter	|O
demonstrated	|O
that	|O
the	|O
ZIA	|O
,	|O
ZIC	|O
,	|O
and	|O
ZID	|O
domains	|O
,	|O
but	|O
not	|O
the	|O
ZIB	|O
domain	|O
,	|O
are	|O
TPA	|O
responsive	|O
.	|O

Clb2	|B-PROTEIN
/	|O
Cdc28	|B-PROTEIN
kinase	|O
is	|O
not	|O
required	|O
for	|O
the	|O
repression	|O
of	|O
MCB	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
factor	|I-PROTEIN
transcriptional	|O
activity	|O
in	|O
G2	|O
and	|O
M	|O
phase	|O
.	|O

The	|O
carboxy	|O
terminus	|O
of	|O
Mbp1	|B-PROTEIN
is	|O
sufficient	|O
for	|O
interaction	|O
with	|O
Swi6	|B-PROTEIN
,	|O
and	|O
the	|O
carboxy	|O
terminus	|O
of	|O
Swi6	|B-PROTEIN
is	|O
required	|O
for	|O
interaction	|O
with	|O
Mbp1	|B-PROTEIN
.	|O

Multiple	|O
single	|O
-	|O
stranded	|O
cis	|O
elements	|O
are	|O
associated	|O
with	|O
activated	|O
chromatin	|O
of	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
gene	|O
in	|O
vivo	|O
.	|O

A	|O
new	|O
UASH	|O
consensus	|O
sequence	|O
derived	|O
from	|O
this	|O
mutational	|O
analysis	|O
closely	|O
matches	|O
a	|O
consensus	|O
Abf1	|B-PROTEIN
binding	|O
site	|O
.	|O

We	|O
have	|O
isolated	|O
and	|O
analyzed	|O
human	|O
CTCF	|B-PROTEIN
cDNA	|O
clones	|O
and	|O
show	|O
here	|O
that	|O
the	|O
ubiquitously	|O
expressed	|O
11	|O
-	|O
zinc	|O
-	|O
finger	|O
factor	|O
CTCF	|B-PROTEIN
is	|O
an	|O
exceptionally	|O
highly	|O
conserved	|O
protein	|O
displaying	|O
93%	|O
identity	|O
between	|O
avian	|O
and	|O
human	|O
amino	|O
acid	|O
sequences	|O
.	|O

Mutational	|O
analysis	|O
of	|O
the	|O
P2	|O
-	|O
proximal	|O
CTCF	|B-PROTEIN
binding	|O
site	|O
and	|O
transient	|O
-	|O
cotransfection	|O
experiments	|O
demonstrate	|O
that	|O
CTCF	|B-PROTEIN
is	|O
a	|O
transcriptional	|O
repressor	|O
of	|O
the	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
gene	|O
.	|O

A	|O
chromosome	|B-PROTEIN
transmission	|I-PROTEIN
fidelity	|I-PROTEIN
(	|O
ctf	|B-PROTEIN
)	|O
mutant	|O
,	|O
s138	|O
,	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
was	|O
identified	|O
by	|O
its	|O
centromere	|O
(	|O
CEN	|O
)	|O
transcriptional	|O
readthrough	|O
phenotype	|O
,	|O
suggesting	|O
perturbed	|O
kinetochore	|O
integrity	|O
in	|O
vivo	|O
.	|O

The	|O
growth	|O
defect	|O
of	|O
a	|O
reg1	|B-PROTEIN
reg2	|O
double	|O
mutant	|O
is	|O
alleviated	|O
by	|O
a	|O
loss	|O
-	|O
of	|O
-	|O
function	|O
mutation	|O
in	|O
the	|O
SNF1	|B-PROTEIN
-	|O
encoded	|O
protein	|O
kinase	|O
.	|O

Sp1	|B-PROTEIN
binds	|O
two	|O
sites	|O
in	|O
the	|O
CD11c	|B-PROTEIN
promoter	|O
in	|O
vivo	|O
specifically	|O
in	|O
myeloid	|O
cells	|O
and	|O
cooperates	|O
with	|O
AP1	|B-PROTEIN
to	|O
activate	|O
transcription	|O
.	|O

Expression	|O
of	|O
the	|O
phenylalanine	|B-PROTEIN
hydroxylase	|I-PROTEIN
gene	|O
in	|O
livers	|O
and	|O
kidneys	|O
of	|O
rodents	|O
is	|O
activated	|O
at	|O
birth	|O
and	|O
is	|O
induced	|O
by	|O
glucocorticoids	|O
and	|O
cyclic	|O
AMP	|O
in	|O
the	|O
liver	|O
.	|O

We	|O
found	|O
that	|O
120	|O
bp	|O
of	|O
the	|O
enhancer	|O
's	|O
transcriptional	|O
core	|O
becomes	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
hypersensitive	|O
early	|O
in	|O
B	|O
-	|O
cell	|O
development	|O
.	|O

A	|O
developmentally	|O
modulated	|O
chromatin	|O
structure	|O
at	|O
the	|O
mouse	|O
immunoglobulin	|B-PROTEIN
kappa	|I-PROTEIN
3'	|O
enhancer	|O
.	|O

We	|O
report	|O
here	|O
the	|O
identification	|O
of	|O
a	|O
cDNA	|O
that	|O
encodes	|O
a	|O
new	|O
member	|O
of	|O
the	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
(	|O
GAP	|B-PROTEIN
)	|O
family	|O
of	|O
GTPase	|B-PROTEIN
regulators	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
further	|O
investigated	|O
the	|O
regulation	|O
of	|O
the	|O
synthesis	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
mos	|I-PROTEIN
oncogene	|O
product	|O
,	|O
which	|O
is	|O
necessary	|O
for	|O
the	|O
activation	|O
of	|O
Cdc2	|B-PROTEIN
.	|O

The	|O
heterogeneity	|O
of	|O
bovine	|O
IgG2	|B-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
VIII	|I-PROTEIN
.	|O

The	|O
ability	|O
of	|O
BCL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
to	|O
function	|O
as	|O
a	|O
transcriptional	|O
repressor	|O
may	|O
contribute	|O
to	|O
its	|O
ability	|O
to	|O
transform	|O
B	|O
lymphocytes	|O
in	|O
diffuse	|O
large	|O
cell	|O
lymphoma	|O
.	|O

Positioning	|O
this	|O
uORF	|O
,	|O
together	|O
with	|O
its	|O
accompanying	|O
Kozak	|O
sequences	|O
,	|O
between	|O
a	|O
heterologous	|O
promoter	|O
from	|O
SV40	|O
and	|O
a	|O
CAT	|B-PROTEIN
reporter	|O
gene	|O
resulted	|O
in	|O
marked	|O
inhibition	|O
of	|O
CAT	|B-PROTEIN
protein	|O
production	|O
without	|O
a	|O
decrease	|O
in	|O
CAT	|B-PROTEIN
mRNA	|O
.	|O

A	|O
secondary	|O
spread	|O
of	|O
an	|O
imported	|O
methicillin	|O
-	|O
resistant	|O
Staphylococcus	|O
aureus	|O
strain	|O
(	|O
MRSA	|O
)	|O
to	|O
two	|O
other	|O
patients	|O
occurred	|O
within	|O
a	|O
Danish	|O
surgical	|O
ward	|O
in	|O
spite	|O
of	|O
isolation	|O
of	|O
a	|O
multitraumatized	|O
index	|O
-	|O
patient	|O
immediately	|O
after	|O
arrival	|O
from	|O
a	|O
hospital	|O
in	|O
the	|O
Mediterranean	|O
area	|O
.	|O

Mesial	|O
temporal	|O
sclerosis	|O
was	|O
characterized	|O
by	|O
severe	|O
neuronal	|O
loss	|O
accompanied	|O
by	|O
gliosis	|O
occurring	|O
in	|O
the	|O
CA1	|O
/	|O
prosubiculum	|O
(	|O
27	|O
patients	|O
,	|O
100%	|O
)	|O
,	|O
focally	|O
in	|O
the	|O
dentate	|O
gyrus	|O
(	|O
12	|O
patients	|O
,	|O
44%	|O
)	|O
,	|O
and	|O
in	|O
the	|O
CA4	|O
region	|O
(	|O
11	|O
patients	|O
,	|O
41%	|O
)	|O
.	|O

Mesial	|O
temporal	|O
sclerosis	|O
.	|O

More	|O
specific	|O
adverse	|O
events	|O
,	|O
also	|O
frequently	|O
considered	|O
as	|O
dose	|O
-	|O
limiting	|O
toxicities	|O
,	|O
include	|O
hypotension	|O
with	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
severe	|O
headache	|O
or	|O
skin	|O
rash	|O
with	|O
IL	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
and	|O
nasal	|O
congestion	|O
and	|O
gastroduodenal	|O
lesions	|O
with	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
.	|O

Therefore	|O
,	|O
magnetic	|O
resonance	|O
imaging	|O
was	|O
used	|O
to	|O
determine	|O
liver	|O
volume	|O
in	|O
pediatric	|O
and	|O
adolescent	|O
patients	|O
,	|O
in	|O
whom	|O
systemic	|O
clearance	|O
of	|O
three	|O
model	|O
substrates	|O
[	|O
lorazepam	|O
(	|O
0.03	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
antipyrine	|O
(	|O
10	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
and	|O
indocyanine	|O
green	|O
(	|O
ICG	|O
;	|O
0.5	|O
mg	|O
/	|O
kg	|O
)	|O
]	|O
was	|O
also	|O
determined	|O
.	|O

A	|O
mutational	|O
analysis	|O
has	|O
resolved	|O
a	|O
region	|O
of	|O
seven	|O
amino	|O
acids	|O
(	|O
amino	|O
acids	|O
26-32	|O
)	|O
in	|O
the	|O
N	|O
-	|O
terminus	|O
of	|O
Bob1	|B-PROTEIN
that	|O
are	|O
important	|O
for	|O
contacting	|O
the	|O
DNA	|O
binding	|O
POU	|B-PROTEIN
domain	|O
of	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

Heme	|O
oxygenase	|B-PROTEIN
1	|I-PROTEIN
is	|O
an	|O
essential	|O
enzyme	|O
in	|O
heme	|O
catabolism	|O
that	|O
cleaves	|O
heme	|O
to	|O
form	|O
biliverdin	|O
,	|O
iron	|O
,	|O
and	|O
carbon	|O
monoxide	|O
.	|O

An	|O
inactive	|O
analog	|O
of	|O
wortmannin	|O
,	|O
WM12	|O
,	|O
did	|O
not	|O
affect	|O
TCR	|B-PROTEIN
/	|O
CD3	|B-PROTEIN
-	|O
induced	|O
Erk2	|B-PROTEIN
activation	|O
,	|O
and	|O
wortmannin	|O
had	|O
no	|O
effect	|O
on	|O
the	|O
activity	|O
of	|O
Erk2	|B-PROTEIN
when	|O
added	|O
directly	|O
to	|O
the	|O
in	|O
vitro	|O
assays	|O
.	|O

155	|O
aa	|O
,	|O
shares	|O
78%	|O
identity	|O
with	|O
the	|O
analogous	|O
region	|O
of	|O
Xenopus	|O
laevis	|O
FGF3	|B-PROTEIN
and	|O
72%	|O
identity	|O
with	|O
the	|O
product	|O
of	|O
the	|O
more	|O
distantly	|O
related	|O
human	|O
gene	|O
.	|O

The	|O
transcription	|O
start	|O
point	|O
of	|O
the	|O
proximal	|O
promoter	|O
aligns	|O
to	|O
that	|O
of	|O
mouse	|O
promoter	|O
P3	|O
and	|O
lies	|O
within	|O
a	|O
conserved	|O
region	|O
of	|O
sequence	|O
.	|O

Defects	|O
in	|O
the	|O
Schizosaccharomyces	|O
pombe	|O
(	|O
Sp	|O
)	|O
cell	|O
cycle	|O
-	|O
controlling	|O
genes	|O
prevent	|O
the	|O
cell	|O
cycle	|O
progression	|O
.	|O

To	|O
determine	|O
the	|O
signal	|B-PROTEIN
recognition	|I-PROTEIN
particle	|I-PROTEIN
(	|O
SRP	|B-PROTEIN
)	|O
-	|O
SRP	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
Srb	|B-PROTEIN
)	|O
system	|O
in	|O
Bacillus	|O
subtilis	|O
(	|O
Bs	|O
)	|O
,	|O
we	|O
cloned	|O
the	|O
Bs	|O
srb	|B-PROTEIN
gene	|O
,	|O
which	|O
encodes	|O
a	|O
homologue	|O
of	|O
the	|O
mammalian	|O
SRP	|B-PROTEIN
receptor	|I-PROTEIN
alpha	|O
-	|O
subunit	|O
[	|O
Oguro	|O
et	|O
al.	|O
,	|O
DNA	|O
Res.	|O

A	|O
novel	|O
gene	|O
designated	|O
cmr	|B-PROTEIN
,	|O
which	|O
mapped	|O
to	|O
18.8	|O
min	|O
of	|O
the	|O
Escherichia	|O
coli	|O
K	|O
-	|O
12	|O
genome	|O
,	|O
was	|O
shown	|O
to	|O
mediate	|O
resistance	|O
to	|O
chloramphenicol	|O
when	|O
it	|O
was	|O
expressed	|O
from	|O
a	|O
multicopy	|O
vector	|O
.	|O

In	|O
addition	|O
,	|O
5'	|O
deletions	|O
removing	|O
all	|O
but	|O
34	|O
bp	|O
upstream	|O
of	|O
the	|O
transcription	|O
start	|O
point	|O
retained	|O
greater	|O
than	|O
90%	|O
promoter	|O
activity	|O
,	|O
suggesting	|O
that	|O
the	|O
-	|O
35	|O
hexamer	|O
was	|O
not	|O
essential	|O
for	|O
promoter	|O
activity	|O
.	|O

The	|O
DNA	|O
sequence	|O
immediately	|O
upstream	|O
from	|O
the	|O
-	|O
10	|O
hexamer	|O
contained	|O
the	|O
TGn	|O
motif	|O
described	|O
as	|O
an	|O
extended	|O
-	|O
10	|O
region	|O
in	|O
prokaryotic	|O
promoters	|O
.	|O

An	|O
apparent	|O
ufo	|B-PROTEIN
mRNA	|O
overexpression	|O
was	|O
not	|O
found	|O
in	|O
any	|O
of	|O
the	|O
positive	|O
leukemia	|O
cell	|O
lines	|O
,	|O
but	|O
was	|O
identified	|O
in	|O
the	|O
drug	|O
-	|O
resistant	|O
subclones	|O
of	|O
the	|O
cervix	|O
carcinoma	|O
cell	|O
line	|O
HeLa	|O
.	|O

We	|O
conclude	|O
from	|O
these	|O
studies	|O
that	|O
CKII	|B-PROTEIN
may	|O
act	|O
as	|O
a	|O
positive	|O
regulator	|O
of	|O
myogenesis	|O
by	|O
preventing	|O
E	|B-PROTEIN
protein	|I-PROTEIN
homodimers	|O
from	|O
binding	|O
to	|O
muscle	|O
gene	|O
regulatory	|O
elements	|O
.	|O

The	|O
role	|O
of	|O
negative	|O
regulators	|O
such	|O
as	|O
NCE3	|B-PROTEIN
,	|O
as	|O
well	|O
as	|O
the	|O
previously	|O
described	|O
SIN5	|B-PROTEIN
gene	|O
,	|O
in	|O
determining	|O
the	|O
promoter	|O
specificity	|O
of	|O
homologous	|O
activators	|O
is	|O
discussed	|O
.	|O

Transcriptional	|O
regulators	|O
utilizing	|O
the	|O
POU	|B-PROTEIN
domain	|O
DNA	|O
-	|O
binding	|O
motif	|O
have	|O
been	|O
shown	|O
to	|O
form	|O
multi	|O
-	|O
protein	|O
complexes	|O
dependent	|O
on	|O
the	|O
POU	|B-PROTEIN
domain	|O
itself	|O
and	|O
its	|O
flexible	|O
recognition	|O
of	|O
various	|O
octamer	|O
sequence	|O
elements	|O
.	|O

We	|O
found	|O
strand	|O
selective	|O
repair	|O
in	|O
DNA	|O
fragments	|O
within	|O
two	|O
active	|O
genes	|O
,	|O
DHFR	|B-PROTEIN
and	|O
an	|O
unknown	|O
gene	|O
adjacent	|O
to	|O
DHFR	|B-PROTEIN
.	|O

MATERIALS	|O
AND	|O
METHODS	|O
:	|O
Coronal	|O
3D	|O
GRE	|O
imaging	|O
was	|O
used	|O
to	|O
study	|O
the	|O
volar	|O
,	|O
middle	|O
,	|O
and	|O
dorsal	|O
portions	|O
of	|O
the	|O
SLL	|O
in	|O
14	|O
patients	|O
with	|O
an	|O
arthroscopically	|O
normal	|O
SLL	|O
and	|O
in	|O
five	|O
cadaveric	|O
wrists	|O
that	|O
had	|O
a	|O
normal	|O
SLL	|O
proved	|O
with	|O
dissection	|O
.	|O

In	|O
an	|O
effort	|O
to	|O
contribute	|O
to	|O
the	|O
transcript	|O
map	|O
of	|O
human	|O
chromosome	|O
21	|O
and	|O
the	|O
understanding	|O
of	|O
the	|O
pathophysiology	|O
of	|O
trisomy	|O
21	|O
,	|O
we	|O
have	|O
used	|O
exon	|O
trapping	|O
to	|O
identify	|O
fragments	|O
of	|O
chromosome	|O
21	|O
genes	|O
.	|O

Reproducing	|O
populations	|O
of	|O
this	|O
aphid	|O
were	|O
first	|O
detected	|O
in	|O
Puerto	|O
Rico	|O
in	|O
April	|O
1992	|O
.	|O

The	|O
model	|O
captures	|O
the	|O
essence	|O
of	|O
predator	|O
-	|O
prey	|O
dynamics	|O
to	|O
provide	|O
reasonable	|O
predictions	|O
of	|O
population	|O
patterns	|O
.	|O

At	|O
cuticular	|O
positions	|O
exhibiting	|O
the	|O
Brd	|B-PROTEIN
bristle	|O
loss	|O
phenotype	|O
,	|O
we	|O
have	|O
found	|O
that	|O
the	|O
progeny	|O
of	|O
the	|O
multiplied	|O
SOPs	|O
develop	|O
aberrantly	|O
,	|O
in	|O
that	|O
neurons	|O
and	|O
thecogen	|O
(	|O
sheath	|O
)	|O
cells	|O
appear	|O
but	|O
not	|O
trichogen	|O
(	|O
shaft	|O
)	|O
and	|O
tormogen	|O
(	|O
socket	|O
)	|O
cells	|O
.	|O

Transcriptional	|O
blockade	|O
was	|O
reversed	|O
by	|O
co	|O
-	|O
transfections	|O
of	|O
a	|O
wild	|O
-	|O
type	|O
SRF	|B-PROTEIN
expression	|O
vector	|O
,	|O
but	|O
was	|O
not	|O
rescued	|O
by	|O
the	|O
expression	|O
of	|O
other	|O
myogenic	|O
factors	|O
,	|O
such	|O
as	|O
MyoD	|B-PROTEIN
and	|O
Mef	|B-PROTEIN
-	|I-PROTEIN
2C	|I-PROTEIN
.	|O

The	|O
mMIWC1	|B-PROTEIN
promoter	|O
was	|O
identified	|O
and	|O
contained	|O
TATA	|O
,	|O
CAAT	|O
,	|O
GATA	|O
,	|O
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
elements	|O
;	|O
primer	|O
extension	|O
revealed	|O
mMIWC	|B-PROTEIN
transcription	|O
initiation	|O
at	|O
621	|O
bp	|O
upstream	|O
from	|O
the	|O
mMIWC1	|B-PROTEIN
translational	|O
initiation	|O
site	|O
.	|O

Human	|O
MN	|B-PROTEIN
/	|I-PROTEIN
CA9	|I-PROTEIN
gene	|O
,	|O
a	|O
novel	|O
member	|O
of	|O
the	|O
carbonic	|B-PROTEIN
anhydrase	|I-PROTEIN
family	|O
:	|O
structure	|O
and	|O
exon	|O
to	|O
protein	|O
domain	|O
relationships	|O
.	|O

The	|O
exon	|O
-	|O
intron	|O
distribution	|O
of	|O
Cdebp	|B-PROTEIN
appears	|O
strikingly	|O
similar	|O
to	|O
that	|O
of	|O
the	|O
App	|B-PROTEIN
gene	|O
in	|O
the	|O
regions	|O
encoding	|O
the	|O
conserved	|O
domains	|O
,	|O
with	|O
a	|O
divergent	|O
structure	|O
in	|O
the	|O
other	|O
parts	|O
.	|O

DNA	|O
sequence	|O
analysis	|O
reveals	|O
that	|O
the	|O
gene	|O
encodes	|O
a	|O
protein	|O
highly	|O
homologous	|O
to	|O
rat	|O
CRP1	|B-PROTEIN
.	|O

The	|O
gene	|O
was	|O
expressed	|O
as	|O
an	|O
approximately	|O
1.5	|O
-	|O
kb	|O
mRNA	|O
in	|O
most	|O
nonlymphoid	|O
human	|O
cells	|O
/	|O
tissues	|O
including	|O
prostate	|O
,	|O
lung	|O
,	|O
liver	|O
,	|O
and	|O
colon	|O
.	|O

Both	|O
of	|O
these	|O
domains	|O
have	|O
striking	|O
sequence	|O
homology	|O
with	|O
human	|O
SIM	|B-PROTEIN
and	|O
Drosophila	|O
SIM	|B-PROTEIN
proteins	|O
.	|O

Promoter	|O
activity	|O
was	|O
high	|O
in	|O
cell	|O
lines	|O
that	|O
expressed	|O
high	|O
levels	|O
of	|O
endogenous	|O
D3	|B-PROTEIN
mRNA	|O
,	|O
as	|O
indicated	|O
by	|O
Northern	|O
blot	|O
analyses	|O
,	|O
and	|O
was	|O
significantly	|O
reduced	|O
when	|O
the	|O
promoter	|O
was	|O
truncated	|O
to	|O
-	|O
122	|O
bp	|O
.	|O

We	|O
have	|O
obtained	|O
the	|O
human	|O
EP4	|B-PROTEIN
receptor	|I-PROTEIN
gene	|O
sequence	|O
and	|O
determined	|O
its	|O
structure	|O
relative	|O
to	|O
EP4R	|B-PROTEIN
cDNA	|O
synthesized	|O
from	|O
peripheral	|O
blood	|O
lymphocytes	|O
.	|O

Some	|O
users	|O
will	|O
willingly	|O
comply	|O
with	|O
management	|O
measures	|O
,	|O
other	|O
users	|O
will	|O
comply	|O
in	|O
response	|O
to	|O
education	|O
,	|O
but	|O
there	|O
will	|O
be	|O
another	|O
group	|O
who	|O
will	|O
only	|O
respond	|O
to	|O
enforcement	|O
activities	|O
.	|O

Three	|O
separate	|O
activation	|O
subdomains	|O
,	|O
and	|O
one	|O
negative	|O
-	|O
acting	|O
region	|O
,	|O
which	|O
function	|O
in	|O
yeast	|O
were	|O
located	|O
in	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
region	|O
of	|O
NIT4	|B-PROTEIN
.	|O

The	|O
front	|O
(	|O
F	|O
)	|O
interaction	|O
occurs	|O
ahead	|O
of	|O
the	|O
growing	|O
end	|O
of	|O
RNA	|O
.	|O

Collectively	|O
,	|O
these	|O
data	|O
indicate	|O
that	|O
HIP	|B-PROTEIN
is	|O
a	|O
membrane	|O
-	|O
associated	|O
HP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
expressed	|O
on	|O
the	|O
surface	|O
of	|O
normal	|O
human	|O
uterine	|O
epithelia	|O
and	|O
uterine	|O
epithelial	|O
cell	|O
lines	|O
.	|O

The	|O
corresponding	|O
gene	|O
was	|O
identified	|O
in	|O
the	|O
GenBankTM	|O
data	|O
base	|O
by	|O
sequence	|O
alignment	|O
and	|O
termed	|O
RPS30A	|B-PROTEIN
.	|O

The	|O
location	|O
of	|O
multiple	|O
GRK2	|B-PROTEIN
and	|O
GRK5	|B-PROTEIN
phosphoacceptor	|O
sites	|O
at	|O
the	|O
extreme	|O
carboxyl	|O
terminus	|O
of	|O
the	|O
beta2AR	|B-PROTEIN
is	|O
highly	|O
reminiscent	|O
of	|O
GRK1	|B-PROTEIN
-	|O
mediated	|O
phosphorylation	|O
of	|O
rhodopsin	|B-PROTEIN
.	|O

This	|O
regulation	|O
could	|O
not	|O
be	|O
appreciably	|O
modified	|O
by	|O
enhanced	|O
expression	|O
of	|O
STAT	|B-PROTEIN
proteins	|O
.	|O

Receptors	|O
for	|O
interleukin	|O
(	|B-PROTEIN
IL	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|O
type	|O
cytokines	|O
use	|O
similar	|O
signaling	|O
mechanisms	|O
for	|O
inducing	|O
transcription	|O
through	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
response	|O
elements	|O
.	|O

Specifically	|O
,	|O
the	|O
deduced	|O
FR	|B-PROTEIN
-	|I-PROTEIN
19	|I-PROTEIN
amino	|O
acid	|O
sequence	|O
has	|O
approximately89	|O
,	|O
77	|O
,	|O
and	|O
68%	|O
overall	|O
identity	|O
to	|O
chicken	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1A	|I-PROTEIN
,	|O
mouse	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
mouse	|O
embryonic	|O
TEA	|B-PROTEIN
domain	|I-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
factor	|I-PROTEIN
,	|O
respectively	|O
.	|O

This	|O
phenomenon	|O
did	|O
not	|O
require	|O
DNA	|O
binding	|O
by	|O
the	|O
"	|O
interfering	|O
"	|O
receptor	|O
but	|O
required	|O
it	|O
to	|O
be	|O
hormone	|O
-	|O
bound	|O
,	|O
indicating	|O
that	|O
a	|O
transcriptionally	|O
active	|O
form	|O
of	|O
the	|O
interfering	|O
receptor	|O
is	|O
essential	|O
for	|O
the	|O
interfering	|O
effect	|O
.	|O

The	|O
receptor	|B-PROTEIN
for	|I-PROTEIN
hyaluronan	|I-PROTEIN
mediated	|I-PROTEIN
motility	|I-PROTEIN
(	|O
RHAMM	|B-PROTEIN
)	|O
gene	|O
expression	|O
is	|O
markedly	|O
elevated	|O
in	|O
fibrosarcomas	|O
exposed	|O
to	|O
transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
(	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
)	|O
.	|O

Oncogenic	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activates	|O
p70	|B-PROTEIN
S6	|I-PROTEIN
kinase	|I-PROTEIN
via	|O
a	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
-	|O
independent	|O
pathway	|O
.	|O

Hydropathy	|O
analysis	|O
of	|O
KCC1	|B-PROTEIN
indicates	|O
structural	|O
homology	|O
to	|O
NKCC	|B-PROTEIN
,	|O
including	|O
12	|O
transmembrane	|O
domains	|O
,	|O
a	|O
large	|O
extracellular	|O
loop	|O
with	|O
potential	|O
N	|O
-	|O
linked	|O
glycosylation	|O
sites	|O
,	|O
and	|O
cytoplasmic	|O
N	|O
-	|O
and	|O
C	|O
-	|O
terminal	|O
regions	|O
.	|O

A	|O
cis	|O
-	|O
acting	|O
DNA	|O
element	|O
located	|O
between	|O
TATA	|O
box	|O
and	|O
transcription	|O
initiation	|O
site	|O
is	|O
critical	|O
in	|O
response	|O
to	|O
regulatory	|O
sequences	|O
in	|O
human	|O
angiotensinogen	|B-PROTEIN
gene	|O
.	|O

This	|O
protein	|O
with	|O
a	|O
hydrophobic	|O
amino	|O
terminus	|O
appears	|O
to	|O
be	|O
a	|O
secreted	|O
protein	|O
.	|O

The	|O
promoter	|O
of	|O
the	|O
rat	|O
PGS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
contains	|O
a	|O
CAAT	|B-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
consensus	|O
site	|O
(	|O
CAAT	|O
box	|O
)	|O
which	|O
can	|O
confer	|O
hormone	|O
inducibility	|O
to	|O
a	|O
PGS	|B-PROTEIN
-	|I-PROTEIN
2.C	|I-PROTEIN
AT	|O
reporter	|O
gene	|O
,	|O
as	|O
well	|O
as	|O
a	|O
putative	|O
E	|O
-	|O
box	|O
region	|O
.	|O

Notably	|O
,	|O
SRF	|B-PROTEIN
has	|O
been	|O
found	|O
to	|O
be	|O
a	|O
key	|O
regulator	|O
of	|O
members	|O
of	|O
a	|O
class	|O
of	|O
cellular	|O
response	|O
genes	|O
termed	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
genes	|I-PROTEIN
(	|O
IEGs	|B-PROTEIN
)	|O
,	|O
many	|O
of	|O
which	|O
are	|O
believed	|O
to	|O
be	|O
involved	|O
in	|O
regulating	|O
cell	|O
growth	|O
and	|O
differentiation	|O
.	|O

The	|O
final	|O
sigma54	|B-PROTEIN
-	|O
dependent	|O
DmpR	|B-PROTEIN
activator	|O
regulates	|O
transcription	|O
of	|O
the	|O
dmp	|B-PROTEIN
operon	|O
that	|O
encodes	|O
the	|O
enzymes	|O
for	|O
catabolism	|O
of	|O
(	|O
methyl	|O
)	|O
phenols	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
have	|O
cloned	|O
the	|O
human	|O
DSG3	|B-PROTEIN
gene	|O
and	|O
examined	|O
the	|O
transcriptional	|O
regulation	|O
of	|O
its	|O
expression	|O
.	|O

Clinical	|O
evaluation	|O
of	|O
the	|O
Allergan	|O
Humphrey	|O
500	|O
autorefractor	|O
and	|O
the	|O
Nidek	|O
AR	|O
-	|O
1000	|O
autorefractor	|O
.	|O

None	|O
of	|O
the	|O
five	|O
proprotein	|O
processing	|O
proteases	|O
tested	|O
were	|O
capable	|O
of	|O
cleaving	|O
human	|O
pro	|B-PROTEIN
-	|I-PROTEIN
LPH	|I-PROTEIN
,	|O
strongly	|O
suggesting	|O
that	|O
they	|O
are	|O
not	|O
involved	|O
in	|O
the	|O
maturation	|O
of	|O
this	|O
enzyme	|O
.	|O

These	|O
changes	|O
may	|O
be	|O
the	|O
result	|O
of	|O
,	|O
on	|O
the	|O
one	|O
hand	|O
,	|O
an	|O
increased	|O
sensitivity	|O
of	|O
the	|O
neuromuscular	|O
transmission	|O
and	|O
/	|O
or	|O
decreased	|O
muscle	|O
contractility	|O
and	|O
,	|O
on	|O
the	|O
other	|O
hand	|O
,	|O
the	|O
result	|O
of	|O
a	|O
reduced	|O
plasma	|O
clearance	|O
during	|O
hypothermia	|O
.	|O

SETTING	|O
-	|O
-	|O
Delhi	|O
,	|O
urban	|O
India	|O
,	|O
1985-6	|O
.	|O

By	|O
using	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|O
dependent	|O
cells	|O
that	|O
ectopically	|O
express	|O
the	|O
three	|O
ErbB	|B-PROTEIN
proteins	|O
or	|O
their	|O
combinations	|O
,	|O
we	|O
found	|O
that	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
is	|O
devoid	|O
of	|O
any	|O
biological	|O
activity	|O
but	|O
both	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
can	|O
reconstitute	|O
its	|O
extremely	|O
potent	|O
mitogenic	|O
activity	|O
.	|O

ZIOS	|O
was	|O
significantly	|O
more	|O
sensitive	|O
than	|O
all	|O
subsequent	|O
methods	|O
,	|O
and	|O
Ptc	|O
,	|O
O2	|O
was	|O
significantly	|O
more	|O
sensitive	|O
than	|O
FEV1	|O
.	|O

Selective	|O
translation	|O
initiation	|O
by	|O
ribosome	|O
jumping	|O
in	|O
adenovirus	|O
-	|O
infected	|O
and	|O
heat	|O
-	|O
shocked	|O
cells	|O
.	|O

Furthermore	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
43	|O
-	|O
bp	|O
region	|O
of	|O
the	|O
24p3	|B-PROTEIN
promoter	|O
required	|O
for	|O
the	|O
Dex	|O
responsiveness	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
direct	|O
cDNA	|O
mapping	|O
using	|O
fluorescence	|O
in	|O
situ	|O
hybridization	|O
provides	|O
an	|O
accurate	|O
and	|O
rapid	|O
approach	|O
to	|O
the	|O
definition	|O
of	|O
a	|O
transcribed	|O
map	|O
of	|O
the	|O
human	|O
genome	|O
.	|O

YAC	|O
and	|O
cosmid	|O
contigs	|O
spanning	|O
the	|O
Batten	|B-PROTEIN
disease	|I-PROTEIN
(	|O
CLN3	|B-PROTEIN
)	|O
region	|O
at	|O
16p12.1	|O
-	|O
p11.2	|O
.	|O

Isolation	|O
of	|O
a	|O
near	|O
full	|O
-	|O
length	|O
cDNA	|O
from	|O
a	|O
human	|O
fetal	|O
brain	|O
cDNA	|O
library	|O
revealed	|O
a	|O
protein	|B-PROTEIN
serine	|I-PROTEIN
-	|I-PROTEIN
threonine	|I-PROTEIN
phosphatase	|I-PROTEIN
with	|O
a	|O
tetratricopeptide	|O
motif	|O
,	|O
almost	|O
identical	|O
to	|O
human	|B-PROTEIN
PPP5C	|I-PROTEIN
(	|O
PP5	|B-PROTEIN
)	|O
and	|O
highly	|O
homologous	|O
to	|O
rat	|O
PPT	|B-PROTEIN
.	|O

Ly	|B-PROTEIN
-	|I-PROTEIN
49	|I-PROTEIN
is	|O
a	|O
family	|B-PROTEIN
type	|I-PROTEIN
II	|I-PROTEIN
transmembrane	|I-PROTEIN
proteins	|I-PROTEIN
encoded	|O
by	|O
a	|O
gene	|O
cluster	|O
on	|O
murine	|O
chromosome	|O
6	|O
.	|O

The	|O
Dox	|B-PROTEIN
-	|I-PROTEIN
A2	|I-PROTEIN
ORF	|O
driven	|O
by	|O
the	|O
TDH3	|B-PROTEIN
promoter	|O
complemented	|O
the	|O
phenotype	|O
of	|O
a	|O
strain	|O
deleted	|O
for	|O
sun2	|B-PROTEIN
.	|O

The	|O
introduction	|O
of	|O
hARF4	|B-PROTEIN
to	|O
the	|O
cells	|O
maintained	|O
the	|O
balance	|O
between	|O
cytosolic	|O
and	|O
membrane	|O
-	|O
associated	|O
Sec7p	|B-PROTEIN
pools	|O
.	|O

Our	|O
data	|O
demonstrate	|O
directly	|O
that	|O
Rpm1r	|B-PROTEIN
is	|O
transcribed	|O
with	|O
its	|O
substrates	|O
,	|O
tRNA	|O
met	|B-PROTEIN
f	|I-PROTEIN
and	|O
tRNAPro	|B-PROTEIN
,	|O
from	|O
a	|O
promoter	|O
located	|O
upstream	|O
of	|O
the	|O
tRNA	|O
met	|B-PROTEIN
f	|I-PROTEIN
gene	|O
and	|O
suggest	|O
that	|O
a	|O
portion	|O
also	|O
originates	|O
from	|O
a	|O
second	|O
promoter	|O
,	|O
located	|O
between	|O
the	|O
tRNA	|O
met	|B-PROTEIN
f	|I-PROTEIN
gene	|O
and	|O
RPM1	|B-PROTEIN
.	|O

Furthermore	|O
,	|O
strains	|O
with	|O
mutant	|O
RPM1	|B-PROTEIN
genes	|O
also	|O
accumulate	|O
precursor	|O
Rpm1r	|B-PROTEIN
,	|O
suggesting	|O
that	|O
mutations	|O
in	|O
either	|O
gene	|O
can	|O
lead	|O
to	|O
similar	|O
biogenesis	|O
defects	|O
.	|O

Vacuolar	|O
membrane	|O
vesicles	|O
from	|O
hum1	|B-PROTEIN
mutants	|O
lack	|O
all	|O
Ca2+	|O
/	|O
H+	|O
antiport	|O
activity	|O
,	|O
demonstrating	|O
that	|O
Hum1p	|B-PROTEIN
catalyzes	|O
the	|O
exchange	|O
of	|O
Ca2+	|O
for	|O
H+	|O
across	|O
the	|O
yeast	|O
vacuolar	|O
membrane	|O
.	|O

Detailed	|O
mutagenesis	|O
of	|O
the	|O
element	|O
's	|O
rare	|O
-	|O
codon	|O
/	|O
AU	|O
-	|O
rich	|O
sequence	|O
boundary	|O
revealed	|O
that	|O
the	|O
destabilizing	|O
activity	|O
of	|O
the	|O
MATalpha1	|B-PROTEIN
IE	|I-PROTEIN
is	|O
observed	|O
when	|O
the	|O
terminal	|O
codon	|O
of	|O
the	|O
element	|O
's	|O
rare	|O
-	|O
codon	|O
interval	|O
is	|O
translated	|O
.	|O

FTF	|B-PROTEIN
is	|O
also	|O
abundantly	|O
expressed	|O
in	|O
the	|O
pancreas	|O
and	|O
may	|O
exert	|O
differentiation	|O
functions	|O
in	|O
endodermal	|O
sublineages	|O
,	|O
similar	|O
to	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
steroidogenic	|O
tissues	|O
.	|O

Merlie	|O
,	|O
Cold	|O
Spring	|O
Harbor	|O
Symp	|O
.	|O

Substantial	|O
evidence	|O
supports	|O
a	|O
critical	|O
role	|O
for	|O
the	|O
activation	|O
of	|O
the	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
MEK	|B-PROTEIN
/	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
pathway	|O
in	|O
oncogenic	|O
Ras	|B-PROTEIN
-	|O
mediated	|O
transformation	|O
.	|O

Stylohyoid	|O
chain	|O
ossification	|O
:	|O
choice	|O
of	|O
the	|O
surgical	|O
approach	|O
.	|O

The	|O
incidence	|O
of	|O
cardiac	|O
death	|O
(	|O
one	|O
per	|O
group	|O
)	|O
,	|O
Q	|O
wave	|O
MI	|O
(	|O
propofol	|O
,	|O
n	|O
=	|O
7	|O
;	|O
midazolam	|O
,	|O
n	|O
=	|O
3	|O
;	|O
P	|O
=	|O
0.27	|O
)	|O
,	|O
or	|O
non	|O
Q	|O
wave	|O
MI	|O
(	|O
propofol	|O
,	|O
n	|O
=	|O
16	|O
;	|O
midazolam	|O
,	|O
n	|O
=	|O
18	|O
;	|O
P	|O
=	|O
0.81	|O
)	|O
did	|O
not	|O
differ	|O
between	|O
treatment	|O
groups	|O
.	|O

63.3	|O
micromol	|O
/	|O
1	|O
,	|O
p	|O
<	|O
0.01	|O
)	|O
and	|O
area	|O
under	|O
the	|O
plasma	|O
concentration	|O
-	|O
time	|O
curve	|O
extrapolated	|O
to	|O
infinity	|O
AUC	|O
9	|O
(	|O
0	|O
-	|O
infinity	|O
)	|O
(	|O
518.7	|O
vs.	|O

Cluster	|O
formation	|O
of	|O
E	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
on	|O
the	|O
cell	|O
surface	|O
is	|O
believed	|O
to	|O
be	|O
of	|O
major	|O
importance	|O
for	|O
cell	|O
-	|O
cell	|O
adhesion	|O
.	|O

DNA	|B-PROTEIN
polymerase	|I-PROTEIN
E	|I-PROTEIN
,	|O
DNA	|B-PROTEIN
ligase	|I-PROTEIN
III	|I-PROTEIN
and	|O
a	|O
DNA	|O
structure	|O
-	|O
specific	|O
endonuclease	|O
co	|O
-	|O
purify	|O
with	|O
the	|O
five	|O
polypeptide	|O
complex	|O
.	|O

By	|O
using	|O
reporter	|O
gene	|O
constructs	|O
,	|O
it	|O
is	|O
shown	|O
that	|O
upstream	|O
sequences	|O
of	|O
the	|O
P1	|O
promoter	|O
contain	|O
several	|O
regions	|O
that	|O
modulate	|O
the	|O
expression	|O
either	|O
positively	|O
or	|O
negatively	|O
.	|O

The	|O
factor	|O
structure	|O
of	|O
"	|O
schizotypal	|O
'	|O
traits	|O
:	|O
a	|O
large	|O
replication	|O
study	|O
.	|O

Interestingly	|O
,	|O
however	|O
,	|O
it	|O
is	|O
homologous	|O
to	|O
several	|O
expressed	|O
sequence	|O
tags	|O
(	|O
EST	|O
)	|O
of	|O
unknown	|O
function	|O
from	|O
Caenorhabditis	|O
elegans	|O
,	|O
Oryza	|O
sativa	|O
and	|O
Homo	|O
sapiens	|O
.	|O

RESULTS	|O
:	|O
The	|O
bilinear	|O
model	|O
provided	|O
a	|O
significantly	|O
better	|O
fit	|O
to	|O
the	|O
acuity	|O
outcome	|O
data	|O
.	|O

Outcome	|O
of	|O
severe	|O
congenital	|O
hypothyroidism	|O
.	|O

Mean	|O
increase	|O
of	|O
milk	|O
protein	|O
yield	|O
was	|O
46	|O
g	|O
/	|O
d	|O
with	|O
Met	|O
plus	|O
Lys	|O
,	|O
and	|O
mean	|O
increase	|O
of	|O
true	|O
protein	|O
content	|O
was	|O
1.1	|O
g	|O
/	|O
kg	|O
of	|O
milk	|O
.	|O

Nonreturn	|O
rates	|O
can	|O
be	|O
used	|O
to	|O
derive	|O
more	|O
elementary	|O
biological	|O
measures	|O
for	|O
reproductive	|O
efficiency	|O
,	|O
such	|O
as	|O
conception	|O
rate	|O
and	|O
calving	|O
rate	|O
,	|O
which	|O
separately	|O
might	|O
be	|O
more	|O
reliable	|O
than	|O
nonreturn	|O
rate	|O
itself	|O
to	|O
evaluate	|O
the	|O
fertility	|O
of	|O
a	|O
bull	|O
or	|O
the	|O
performance	|O
of	|O
an	|O
AI	|O
technician	|O
.	|O

However	|O
,	|O
if	|O
EMPD	|O
involves	|O
the	|O
glans	|O
penis	|O
or	|O
perianal	|O
area	|O
,	|O
a	|O
search	|O
for	|O
internal	|O
malignancy	|O
is	|O
still	|O
warranted	|O
.	|O

The	|O
mean	|O
values	|O
of	|O
protease	|O
activity	|O
were	|O
significantly	|O
higher	|O
in	|O
the	|O
test	|O
groups	|O
than	|O
in	|O
the	|O
control	|O
group	|O
at	|O
baseline	|O
.	|O

Each	|O
half	|O
molecule	|O
contains	|O
four	|O
disulfide	|O
linkages	|O
and	|O
four	|O
cis	|O
peptides	|O
.	|O

Only	|O
fully	|O
processed	|O
Pra	|B-PROTEIN
(	|O
N0	|O
and	|O
Nb	|O
)	|O
and	|O
ICP35	|B-PROTEIN
(	|O
ICP35	|B-PROTEIN
e	|I-PROTEIN
,	|I-PROTEIN
f	|I-PROTEIN
)	|O
are	|O
present	|O
in	|O
B	|O
capsids	|O
,	|O
which	|O
are	|O
believed	|O
to	|O
be	|O
precursors	|O
of	|O
mature	|O
virions	|O
.	|O

A	|O
chimeric	|O
VP16	|B-PROTEIN
-	|O
Tat	|B-PROTEIN
construct	|O
containing	|O
the	|O
leucine	|O
mutations	|O
showed	|O
no	|O
increased	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
responsiveness	|O
in	|O
comparison	|O
with	|O
that	|O
of	|O
the	|O
VP16	|B-PROTEIN
activation	|O
domain	|O
alone	|O
.	|O

However	|O
,	|O
one	|O
3'	|O
splice	|O
site	|O
,	|O
located	|O
at	|O
nucleotide	|O
(	|O
nt	|O
)	|O
3225	|O
,	|O
is	|O
used	|O
for	|O
the	|O
processing	|O
of	|O
most	|O
BPV	|O
-	|O
1	|O
pre	|O
-	|O
mRNAs	|O
in	|O
BPV	|O
-	|O
1	|O
-	|O
transformed	|O
C127	|O
cells	|O
and	|O
at	|O
early	|O
to	|O
intermediate	|O
times	|O
in	|O
productively	|O
infected	|O
warts	|O
.	|O

Here	|O
,	|O
the	|O
cloning	|O
and	|O
characterization	|O
of	|O
S	|B-PROTEIN
-	|I-PROTEIN
RNase	|I-PROTEIN
genes	|O
from	|O
two	|O
species	|O
of	|O
Rosaceae	|O
,	|O
apple	|O
(	|O
Malus	|O
x	|O
domestica	|O
)	|O
and	|O
Japanese	|O
pear	|O
(	|O
Pyrus	|O
serotina	|O
)	|O
is	|O
described	|O
and	|O
these	|O
sequences	|O
are	|O
compared	|O
with	|O
those	|O
of	|O
other	|O
T2	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
RNases	|I-PROTEIN
.	|O

A	|O
phylogenetic	|O
tree	|O
of	|O
members	|O
of	|O
the	|O
T2	|B-PROTEIN
/	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
RNase	|I-PROTEIN
superfamily	|O
in	|O
plants	|O
was	|O
obtained	|O
.	|O

In	|O
a	|O
Hoosier	|O
Oncology	|O
Group	|O
randomized	|O
study	|O
involving	|O
extensive	|O
-	|O
disease	|O
SCLC	|O
patients	|O
,	|O
VIP	|O
was	|O
superior	|O
to	|O
etoposide	|O
/	|O
cisplatin	|O
with	|O
regard	|O
to	|O
median	|O
time	|O
to	|O
progression	|O
(	|O
6.6	|O
v	|O
5.8	|O
months	|O
)	|O
,	|O
median	|O
survival	|O
times	|O
(	|O
9.1	|O
v	|O
7.3	|O
months	|O
)	|O
,	|O
and	|O
2	|O
-	|O
and	|O
3	|O
-	|O
year	|O
survival	|O
rates	|O
(	|O
13%	|O
v	|O
5%	|O
and	|O
5%	|O
v	|O
0%	|O
,	|O
respectively	|O
)	|O
.	|O

It	|O
was	|O
shown	|O
that	|O
administration	|O
of	|O
immunomodulator	|O
neurotropin	|B-PROTEIN
(	|O
NSP	|B-PROTEIN
)	|O
results	|O
in	|O
more	|O
steady	|O
consolidation	|O
and	|O
retention	|O
of	|O
feeding	|O
and	|O
avoidance	|O
behavior	|O
,	|O
and	|O
some	|O
neurophysiological	|O
mechanisms	|O
of	|O
that	|O
phenomena	|O
were	|O
revealed	|O
.	|O

Sestamibi	|O
scintigraphy	|O
,	|O
performed	|O
in	|O
70	|O
patients	|O
,	|O
was	|O
less	|O
sensitive	|O
than	|O
ultrasonography	|O
(	|O
80%	|O
)	|O
.	|O

Atopic	|O
allergy	|O
and	|O
other	|O
hypersensitivities	|O
.	|O

Despite	|O
significant	|O
lethality	|O
and	|O
cardiovascular	|O
dysfunction	|O
,	|O
in	|O
the	|O
septic	|O
group	|O
on	|O
Days	|O
1	|O
and	|O
2	|O
,	|O
septic	|O
versus	|O
control	|O
animals	|O
had	|O
no	|O
significant	|O
differences	|O
in	|O
mean	|O
metabolic	|O
cart	|O
measured	|O
(	|O
Vo2DIR	|O
,	|O
ml	|O
/	|O
kg	|O
/	|O
min	|O
;	|O
Day	|O
1	|O
:	|O
11.9	|O
versus	|O
12.4	|O
,	|O
p	|O
=	|O
0.81	|O
;	|O
Day	|O
2	|O
:	|O
14.2	|O
versus	|O
13.5	|O
,	|O
p	|O
=	|O
0.72	|O
,	|O
respectively	|O
)	|O
and	|O
intravascular	|O
catheter	|O
calculated	|O
(	|O
Vo2INDIR	|O
,	|O
ml	|O
/	|O
kg	|O
/	|O
min	|O
;	|O
Day	|O
1	|O
:	|O
11.2	|O
versus	|O
11.2	|O
,	|O
p	|O
=	|O
0.99	|O
;	|O
Day	|O
2	|O
:	|O
12.8	|O
versus	|O
15.4	|O
,	|O
p	|O
=	|O
0.49	|O
,	|O
respectively	|O
)	|O
.	|O

After	|O
6	|O
h	|O
of	|O
reperfusion	|O
,	|O
PO2	|O
/	|O
FlO2	|O
ratio	|O
was	|O
significantly	|O
better	|O
after	|O
Combined	|O
Therapy	|O
(	|O
372	|O
+	|O
/	|O
-	|O
52	|O
mm	|O
Hg	|O
)	|O
than	|O
in	|O
the	|O
Recipient	|O
Instilled	|O
(	|O
117	|O
+	|O
/	|O
-	|O
47	|O
mm	|O
Hg	|O
)	|O
and	|O
Control	|O
groups	|O
(	|O
87	|O
+	|O
/	|O
-	|O
26	|O
mm	|O
Hg	|O
)	|O
,	|O
with	|O
intermediate	|O
values	|O
in	|O
Donor	|O
Aerosol	|O
dogs	|O
(	|O
232	|O
+	|O
/	|O
-	|O
64	|O
mm	|O
Hg	|O
)	|O
.	|O

The	|O
euglobulin	|B-PROTEIN
clot	|O
lysis	|O
time	|O
was	|O
slightly	|O
longer	|O
in	|O
the	|O
smokers	|O
than	|O
in	|O
the	|O
non	|O
-	|O
smokers	|O
in	|O
all	|O
three	|O
experimental	|O
situations	|O
,	|O
but	|O
the	|O
differences	|O
were	|O
not	|O
significant	|O
.	|O

HS	|O
inducibility	|O
required	|O
the	|O
HSE	|O
which	|O
was	|O
bound	|O
by	|O
HS	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
HSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
present	|O
in	|O
extracts	|O
prepared	|O
from	|O
cells	|O
exposed	|O
to	|O
HS	|O
.	|O

Although	|O
the	|O
DSK2	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutation	|O
alters	|O
a	|O
conserved	|O
residue	|O
in	|O
the	|O
Dsk2p	|B-PROTEIN
ubiquitin	|O
-	|O
like	|O
domain	|O
,	|O
we	|O
detect	|O
no	|O
differences	|O
in	|O
Dsk2p	|B-PROTEIN
or	|O
Cdc31p	|B-PROTEIN
stability	|O
.	|O

Although	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
activated	|O
STAT1	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
STAT5	|B-PROTEIN
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
predominantly	|O
activated	|O
STAT5	|B-PROTEIN
,	|O
while	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
predominantly	|O
activated	|O
STAT1	|B-PROTEIN
alpha	|I-PROTEIN
.	|O

Consistent	|O
with	|O
this	|O
interpretation	|O
,	|O
recombinant	|O
CREB	|B-PROTEIN
and	|O
activating	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
proteins	|O
bound	|O
the	|O
junB	|B-PROTEIN
CRE	|O
-	|O
like	|O
site	|O
,	|O
but	|O
did	|O
not	|O
interact	|O
with	|O
a	|O
mutant	|O
CRE	|O
-	|O
like	|O
site	|O
.	|O

Collectively	|O
,	|O
these	|O
results	|O
suggest	|O
that	|O
components	|O
of	|O
the	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
signaling	|O
pathway	|O
are	|O
recruited	|O
by	|O
mIg	|B-PROTEIN
to	|O
induce	|O
junB	|B-PROTEIN
transcription	|O
.	|O

One	|O
complex	|O
containing	|O
a	|O
70	|O
D	|O
protein	|O
was	|O
found	|O
to	|O
be	|O
associated	|O
specifically	|O
with	|O
transcriptionally	|O
active	|O
leukemia	|O
cells	|O
.	|O

Our	|O
results	|O
confirm	|O
the	|O
participation	|O
of	|O
intron	|O
1	|O
in	|O
transcriptional	|O
regulation	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
gene	|O
(	|O
in	|O
mouse	|O
and	|O
human	|O
)	|O
and	|O
implicate	|O
multiple	|O
and	|O
complex	|O
regulatory	|O
mechanisms	|O
of	|O
activation	|O
during	|O
myelomonocytic	|O
differentiation	|O
and	|O
leukemic	|O
cell	|O
growth	|O
control	|O
.	|O

Immunofluorescence	|O
microscopy	|O
revealed	|O
extensive	|O
deposition	|O
of	|O
such	|O
extracellular	|O
matrices	|O
as	|O
type	|B-PROTEIN
IV	|I-PROTEIN
collagen	|I-PROTEIN
and	|O
laminin	|B-PROTEIN
in	|O
the	|O
vascular	|O
wall	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
compare	|O
pregnancy	|O
complications	|O
in	|O
women	|O
having	|O
genetic	|O
amniocentesis	|O
at	|O
11-14	|O
weeks	|O
versus	|O
those	|O
undergoing	|O
amniocentesis	|O
at	|O
16-19	|O
weeks	|O
'	|O
gestation	|O
.	|O

Three	|O
ORFs	|O
(	|O
9765orfR002	|O
,	|O
9765orfR011	|O
and	|O
9765orfR013	|O
)	|O
were	|O
found	|O
to	|O
be	|O
homologous	|O
with	|O
Schizosaccharomyces	|O
pombe	|O
polyadenylate	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
Escherichia	|O
coli	|O
hypothetical	|O
38.1	|O
-	|O
kDa	|O
protein	|O
in	|O
the	|O
BCR	|B-PROTEIN
5'	|O
region	|O
,	|O
and	|O
transcription	|O
regulatory	|O
protein	|O
Swi3	|B-PROTEIN
,	|O
respectively	|O
.	|O

Two	|O
new	|O
flavone	|O
glucosides	|O
,	|O
nevadensin	|O
5	|O
-	|O
O	|O
-	|O
beta	|O
-	|O
D	|O
-	|O
glucoside	|O
and	|O
nevadensin	|O
5	|O
-	|O
O	|O
-	|O
beta	|O
-	|O
D	|O
-	|O
glucosyl	|O
(	|O
1	|O
-	|O
-	|O
>	|O
6	|O
)	|O
beta	|O
-	|O
D	|O
-	|O
glucoside	|O
,	|O
have	|O
been	|O
isolated	|O
from	|O
the	|O
aerial	|O
parts	|O
of	|O
Lysionotus	|O
pauciflorus	|O
.	|O

Recently	|O
,	|O
our	|O
laboratory	|O
developed	|O
a	|O
screen	|O
that	|O
identified	|O
five	|O
multicopy	|O
suppressors	|O
that	|O
can	|O
rescue	|O
lethal	|O
strains	|O
of	|O
clathrin	|B-PROTEIN
heavy	|O
chain	|O
-	|O
deficient	|O
yeast	|O
(	|O
Chc	|B-PROTEIN
-	|O
scd1	|B-PROTEIN
-	|I-PROTEIN
i	|I-PROTEIN
)	|O
to	|O
viability	|O
.	|O

Reproductive	|O
period	|O
affects	|O
water	|O
intake	|O
in	|O
heat	|O
-	|O
stressed	|O
dehydrated	|O
goats	|O
.	|O

The	|O
logistic	|O
regression	|O
analysis	|O
of	|O
the	|O
manual	|O
method	|O
(	|O
percentage	|O
normal	|O
morphology	|O
)	|O
and	|O
IVOS	|O
indicated	|O
that	|O
both	|O
were	|O
predictors	|O
of	|O
fertilization	|O
.	|O

METHODS	|O
:	|O
Rats	|O
received	|O
continuous	|O
intragastric	|O
infusion	|O
of	|O
elemental	|O
diet	|O
or	|O
with	|O
supplementation	|O
of	|O
oatbase	|O
,	|O
Lactobacillus	|O
reuteri	|O
R2LC	|O
,	|O
and	|O
Lactobacillus	|O
plantarum	|O
DSM	|O
9843	|O
,	|O
with	|O
and	|O
without	|O
fermentation	|O
,	|O
from	|O
the	|O
beginning	|O
of	|O
the	|O
study	|O
.	|O

However	|O
,	|O
D8	|B-PROTEIN
binding	|O
was	|O
observed	|O
by	|O
nuclease	|O
protection	|O
with	|O
lactotroph	|B-PROTEIN
-	|I-PROTEIN
as	|I-PROTEIN
well	|I-PROTEIN
as	|I-PROTEIN
somatotroph	|I-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
cell	|I-PROTEIN
nuclear	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Limited	|O
role	|O
for	|O
PCR	|O
-	|O
based	|O
diagnosis	|O
of	|O
Whipple	|O
's	|O
disease	|O
from	|O
peripheral	|O
blood	|O
mononuclear	|O
cells	|O
.	|O

The	|O
ability	|O
of	|O
A20	|B-PROTEIN
to	|O
block	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activation	|O
was	|O
mapped	|O
to	|O
its	|O
C	|O
-	|O
terminal	|O
zinc	|O
finger	|O
domain	|O
.	|O

The	|O
Pro	|O
-	|O
258	|O
-	|O
-	|O
>	|O
Leu	|O
(	|O
P258L	|O
)	|O
mutation	|O
caused	|O
constitutive	|O
receptor	|O
signaling	|O
that	|O
was	|O
equivalent	|O
to	|O
about	|O
45%	|O
of	|O
the	|O
maximum	|O
level	|O
observed	|O
in	|O
wild	|O
-	|O
type	|O
cells	|O
stimulated	|O
with	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
.	|O

By	|O
using	|O
a	|O
DNA	|O
sequence	|O
selected	|O
for	|O
its	|O
ability	|O
to	|O
bind	|O
recombinant	|O
BCL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
in	|O
vitro	|O
,	|O
we	|O
show	|O
here	|O
that	|O
BCL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
is	|O
present	|O
in	|O
DNA	|O
-	|O
binding	|O
complexes	|O
in	|O
nuclear	|O
extracts	|O
from	|O
various	|O
B	|O
-	|O
cell	|O
lines	|O
.	|O

The	|O
predictive	|O
value	|O
of	|O
a	|O
positive	|O
flag	|O
was	|O
77.7%	|O
.	|O

CONCLUSIONS	|O
:	|O
Our	|O
findings	|O
suggest	|O
that	|O
pre	|O
-	|O
treatment	|O
with	|O
coenzyme	|O
Q10	|O
may	|O
play	|O
a	|O
protective	|O
role	|O
during	|O
routine	|O
vascular	|O
procedures	|O
requiring	|O
abdominal	|O
aortic	|O
cross	|O
clamping	|O
by	|O
attenuating	|O
the	|O
degree	|O
of	|O
peroxidative	|O
damage	|O
.	|O

Because	|O
chromosome	|O
X	|O
is	|O
frequently	|O
involved	|O
in	|O
structural	|O
alterations	|O
in	|O
neoplastic	|O
Syrian	|O
hamster	|O
cells	|O
transformed	|O
by	|O
chemical	|O
carcinogens	|O
and	|O
oncogenic	|O
viruses	|O
,	|O
the	|O
localization	|O
of	|O
the	|O
cph	|B-PROTEIN
locus	|O
on	|O
this	|O
chromosome	|O
supports	|O
the	|O
notion	|O
that	|O
the	|O
cph	|B-PROTEIN
oncogene	|O
plays	|O
a	|O
role	|O
in	|O
the	|O
malignant	|O
conversion	|O
of	|O
chemically	|O
transformed	|O
hamster	|O
fibroblasts	|O
.	|O

In	|O
a	|O
screen	|O
for	|O
genes	|O
with	|O
oncogenic	|O
potential	|O
expressed	|O
by	|O
the	|O
murine	|O
B6SUtA1	|O
myeloid	|O
progenitor	|O
cell	|O
line	|O
,	|O
we	|O
isolated	|O
a	|O
2	|O
.	|O

Gap1	|B-PROTEIN
(	|I-PROTEIN
IP4BP	|I-PROTEIN
)	|I-PROTEIN
,	|O
one	|O
of	|O
a	|O
member	|O
of	|O
Ras	|B-PROTEIN
GTPase	|O
-	|O
activating	|O
proteins	|O
,	|O
has	|O
been	|O
identified	|O
as	|O
a	|O
specific	|O
inositol	|O
1,3,4,5	|O
-	|O
tetrakisphosphate	|O
(	|B-PROTEIN
IP4	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
Cullen	|O
,	|O
P.	|O

We	|O
previously	|O
described	|O
the	|O
purification	|O
of	|O
an	|O
83	|O
-	|O
kDa	|O
phosphatidic	|B-PROTEIN
acid	|I-PROTEIN
phosphatase	|I-PROTEIN
(	|O
PAP	|O
)	|O
from	|O
the	|O
porcine	|O
thymus	|O
membranes	|O
(	|O
Kanoh	|O
,	|O
H.	|O
,	|O
Imai	|O
,	|O
S.	|O
-	|O
i	|O
.	|O
,	|O
Yamada	|O
,	|O
K.	|O
and	|O
Sakane	|O
,	|O
F.	|O
(	|O
1992	|O
)	|O
J.	|O

The	|O
mechanism	|O
involves	|O
Gbetagamma	|B-PROTEIN
subunit	|O
-	|O
mediated	|O
increases	|O
in	|O
tyrosine	|O
phosphorylation	|O
of	|O
the	|O
Shc	|B-PROTEIN
adapter	|O
protein	|O
,	|O
Shc	|B-PROTEIN
*	|O
Grb2	|B-PROTEIN
complex	|O
formation	|O
,	|O
and	|O
recruitment	|O
of	|O
Ras	|B-PROTEIN
guanine	|I-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
activity	|O
.	|O

A	|O
cDNA	|O
encoding	|O
the	|O
amino	|O
-	|O
terminal	|O
17%	|O
of	|O
apoB	|B-PROTEIN
(	|O
apoB17	|B-PROTEIN
)	|O
was	|O
fused	|O
to	|O
a	|O
cDNA	|O
coding	|O
for	|O
the	|O
last	|O
37	|O
amino	|O
acids	|O
of	|O
decay	|B-PROTEIN
-	|I-PROTEIN
accelerating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
DAF	|B-PROTEIN
)	|O
,	|O
which	|O
contains	|O
the	|O
signal	|O
for	|O
glycosylphosphatidylinositol	|O
anchor	|O
attachment	|O
.	|O

Next	|O
,	|O
we	|O
stably	|O
overexpressed	|O
wild	|O
-	|O
type	|O
Shc	|B-PROTEIN
or	|O
Y317F	|O
mutant	|O
Shc	|B-PROTEIN
into	|O
HIRc	|O
cells	|O
.	|O

The	|O
small	|B-PROTEIN
GTPase	|I-PROTEIN
Rho	|O
is	|O
implicated	|O
in	|O
physiological	|O
functions	|O
associated	|O
with	|O
actin	|B-PROTEIN
-	|O
myosin	|B-PROTEIN
filaments	|O
such	|O
as	|O
cytokinesis	|O
,	|O
cell	|O
motility	|O
,	|O
and	|O
smooth	|O
muscle	|O
contraction	|O
.	|O

Conversely	|O
,	|O
activation	|O
of	|O
this	|O
signaling	|O
pathway	|O
by	|O
expression	|O
of	|O
a	|O
constitutively	|O
active	|O
MKK1	|B-PROTEIN
mutant	|O
dramatically	|O
increased	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
promoter	|O
activity	|O
and	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
protein	|O
expression	|O
,	|O
in	|O
a	|O
growth	|O
factor	|O
-	|O
independent	|O
manner	|O
.	|O

Furthermore	|O
,	|O
upstream	|O
insertion	|O
of	|O
the	|O
GSTP1	|B-PROTEIN
silencer	|O
element	|O
failed	|O
to	|O
inhibit	|O
activity	|O
of	|O
a	|O
heterologous	|O
promoter	|O
in	|O
MCF7	|O
cells	|O
.	|O

In	|O
order	|O
to	|O
delineate	|O
structural	|O
motifs	|O
regulating	|O
substrate	|O
affinity	|O
and	|O
recognition	|O
for	|O
the	|O
human	|O
dopamine	|B-PROTEIN
transporter	|I-PROTEIN
(	|O
DAT	|B-PROTEIN
)	|O
,	|O
we	|O
assessed	|O
[	|O
3H	|O
]	|O
dopamine	|O
uptake	|O
kinetics	|O
and	|O
[	|O
3H	|O
]	|O
CFT	|O
binding	|O
characteristics	|O
of	|O
COS	|O
-	|O
7	|O
cells	|O
transiently	|O
expressing	|O
mutant	|O
DATs	|B-PROTEIN
in	|O
which	|O
the	|O
COOH	|O
terminus	|O
was	|O
truncated	|O
or	|O
substituted	|O
.	|O

An	|O
expression	|O
library	|O
was	|O
constructed	|O
by	|O
inserting	|O
5'	|O
portion	|O
-	|O
enriched	|O
cDNAs	|O
from	|O
phytohemagglutinin	|B-PROTEIN
-	|O
stimulated	|O
peripheral	|O
blood	|O
mononuclear	|O
cells	|O
into	|O
upstream	|O
of	|O
signal	|O
sequence	|O
-	|O
deleted	|O
CD4	|B-PROTEIN
cDNA	|O
in	|O
an	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
shuttle	|O
vector	|O
.	|O

Radiolabeled	|O
recombinant	|O
TARC	|B-PROTEIN
specifically	|O
bound	|O
to	|O
T	|O
cell	|O
lines	|O
and	|O
peripheral	|O
T	|O
cells	|O
but	|O
not	|O
to	|O
monocytes	|O
or	|O
granulocytes	|O
.	|O

The	|O
cis	|O
-	|O
acting	|O
elements	|O
that	|O
control	|O
promoter	|O
activity	|O
include	|O
binding	|O
sites	|O
for	|O
transcription	|O
factors	|O
Sp1	|B-PROTEIN
and	|O
alphaCbf	|B-PROTEIN
,	|O
a	|O
60	|O
-	|O
kDa	|O
CCAAT	|B-PROTEIN
box	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Therefore	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
cis	|O
-	|O
acting	|O
element	|O
,	|O
the	|O
E1	|O
E	|O
-	|O
box	|O
,	|O
located	|O
in	|O
the	|O
GAP	|B-PROTEIN
-	|I-PROTEIN
43	|I-PROTEIN
promoter	|O
region	|O
that	|O
modulates	|O
either	|O
positively	|O
or	|O
negatively	|O
the	|O
expression	|O
of	|O
the	|O
GAP	|B-PROTEIN
-	|I-PROTEIN
43	|I-PROTEIN
gene	|O
depending	|O
on	|O
which	|O
E	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
occupy	|O
this	|O
site	|O
.	|O

Collectively	|O
,	|O
our	|O
findings	|O
demonstrate	|O
that	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
plays	|O
a	|O
key	|O
role	|O
in	|O
controlling	|O
the	|O
basal	|O
and	|O
cAMP	|O
-	|O
stimulated	|O
expression	|O
of	|O
the	|O
StAR	|B-PROTEIN
gene	|O
.	|O

There	|O
was	|O
a	|O
general	|O
broadening	|O
of	|O
proton	|O
resonances	|O
for	|O
a	|O
three	|O
-	|O
nucleotide	|O
segment	|O
centered	|O
about	|O
the	|O
lesion	|O
site	|O
which	|O
resulted	|O
in	|O
a	|O
tentative	|O
assignment	|O
for	|O
the	|O
sugar	|O
protons	|O
of	|O
the	|O
C7	|O
residue	|O
in	|O
the	|O
spectrum	|O
of	|O
the	|O
adduct	|O
duplex	|O
.	|O

Using	|O
one	|O
of	|O
the	|O
six	|O
fragments	|O
(	|O
CPK3	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
)	|O
,	|O
we	|O
isolated	|O
a	|O
2022	|O
bp	|O
cDNA	|O
(	|O
VrCDPK	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
from	|O
a	|O
Vigna	|O
radiata	|O
lambda	|O
gt11	|O
library	|O
.	|O

However	|O
,	|O
in	|O
TF	|O
-	|O
1	|O
cells	|O
grown	|O
on	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
before	|O
starvation	|O
,	|O
CREB	|B-PROTEIN
phosphorylation	|O
was	|O
observed	|O
10	|O
minutes	|O
after	|O
PIXY321	|B-PROTEIN
stimulation	|O
.	|O

Workplace	|O
violence	|O
-	|O
-	|O
nurses	|O
at	|O
risk	|O
.	|O

RESULTS	|O
:	|O
The	|O
LV	|O
maximum	|O
brightness	|O
and	|O
area	|O
under	|O
the	|O
curve	|O
showed	|O
significant	|O
negative	|O
correlations	|O
(	|O
p	|O
=	|O
<	|O
0.004	|O
)	|O
with	|O
the	|O
FIO2	|O
,	|O
while	|O
the	|O
minimum	|O
brightness	|O
showed	|O
a	|O
significant	|O
positive	|O
correlation	|O
(	|O
p	|O
=	|O
<	|O
0.002	|O
)	|O
.	|O

The	|O
results	|O
also	|O
imply	|O
that	|O
the	|O
absence	|O
of	|O
perforin	|B-PROTEIN
expression	|O
in	|O
non	|O
-	|O
cytotoxic	|O
cells	|O
may	|O
be	|O
due	|O
to	|O
the	|O
suppression	|O
of	|O
the	|O
induction	|O
of	|O
the	|O
killer	|O
-	|O
cell	|O
-	|O
specific	|O
trans	|O
-	|O
acting	|O
factor	|O
NF	|B-PROTEIN
-	|I-PROTEIN
P2	|I-PROTEIN
.	|O

We	|O
identify	|O
considerable	|O
spatio	|O
-	|O
temporal	|O
similarities	|O
between	|O
reported	|O
expression	|O
patterns	|O
of	|O
Ypr10	|B-PROTEIN
genes	|O
and	|O
ribonuclease	|O
genes	|O
,	|O
which	|O
,	|O
together	|O
with	|O
the	|O
significant	|O
sequence	|O
similarity	|O
to	|O
the	|O
ginseng	|B-PROTEIN
ribonuclease	|I-PROTEIN
,	|O
support	|O
the	|O
hypothesis	|O
of	|O
a	|O
ribonuclease	|O
function	|O
for	|O
PR	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
proteins	|O
and	|O
allow	|O
the	|O
prediction	|O
of	|O
possible	|O
biological	|O
roles	|O
.	|O

The	|O
expression	|O
of	|O
ERV3	|O
env	|B-PROTEIN
mRNA	|O
was	|O
found	|O
to	|O
be	|O
differentiation	|O
-	|O
associated	|O
,	|O
with	|O
high	|O
expression	|O
detected	|O
in	|O
the	|O
late	|O
stages	|O
of	|O
monocytic	|O
development	|O
.	|O

Initial	|O
estimates	|O
indicate	|O
that	|O
27,193	|O
people	|O
are	|O
either	|O
in	|O
receipt	|O
of	|O
or	|O
in	|O
need	|O
of	|O
mental	|O
handicap	|O
services	|O
.	|O

It	|O
is	|O
exclusively	|O
observed	|O
in	|O
smooth	|O
muscle	|O
cells	|O
by	|O
Northern	|O
blotting	|O
and	|O
immunohistochemical	|O
analysis	|O
and	|O
therefore	|O
designated	|O
"	|O
smoothelin	|B-PROTEIN
.	|O
"	|O
A	|O
human	|O
smooth	|O
muscle	|O
cDNA	|O
library	|O
was	|O
screened	|O
with	|O
the	|O
monoclonal	|O
antibody	|O
R4A	|B-PROTEIN
,	|O
and	|O
a	|O
full	|O
-	|O
size	|O
cDNA	|O
of	|O
the	|O
protein	|O
was	|O
selected	|O
.	|O

Using	|O
immunogold	|O
electron	|O
microscopy	|O
,	|O
we	|O
found	|O
that	|O
p58	|B-PROTEIN
/	|O
p45	|B-PROTEIN
and	|O
p54	|B-PROTEIN
are	|O
localized	|O
on	|O
both	|O
sides	|O
of	|O
the	|O
nuclear	|O
pore	|O
complex	|O
,	|O
like	|O
p62	|B-PROTEIN
.	|O

Concurrent	|O
with	|O
ligand	|O
-	|O
dependent	|O
uptake	|O
,	|O
we	|O
now	|O
show	|O
that	|O
the	|O
receptor	|O
undergoes	|O
ligand	|O
-	|O
induced	|O
ubiquitination	|O
,	|O
suggesting	|O
that	|O
receptor	|O
ubiquitination	|O
may	|O
function	|O
in	|O
the	|O
ligand	|O
-	|O
dependent	|O
endocytosis	|O
of	|O
the	|O
a	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
as	|O
well	|O
as	|O
in	|O
its	|O
constitutive	|O
endocytosis	|O
.	|O

Transcription	|O
initiation	|O
sites	|O
of	|O
the	|O
rat	|O
II	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
,	|I-PROTEIN
III	|I-PROTEIN
beta	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
O	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
genes	|O
were	|O
determined	|O
to	|O
be	|O
52	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
5'	|O
-	|O
upstream	|O
of	|O
the	|O
translation	|O
initiation	|O
codon	|O
(	|O
ATG	|O
)	|O
,	|O
in	|O
each	|O
gene	|O
by	|O
primer	|O
extension	|O
analysis	|O
.	|O

Aggravating	|O
process	|O
induced	|O
by	|O
indomethacin	|O
on	|O
chronic	|O
gastric	|O
lesion	|O
in	|O
rat	|O
.	|O

Epstein	|B-PROTEIN
-	|I-PROTEIN
Barr	|I-PROTEIN
virus	|I-PROTEIN
nuclear	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
(	|O
EBNA2	|B-PROTEIN
)	|O
binds	|O
to	|O
a	|O
component	|O
of	|O
the	|O
human	|O
SNF	|B-PROTEIN
-	|O
SWI	|B-PROTEIN
complex	|O
,	|O
hSNF5	|B-PROTEIN
/	|O
Ini1	|B-PROTEIN
.	|O

Our	|O
studies	|O
also	|O
excluded	|O
the	|O
possibility	|O
that	|O
the	|O
phosphorylation	|O
of	|O
Ser	|O
-	|O
2	|O
,	|O
Ser	|O
-	|O
123	|O
,	|O
or	|O
Ser	|O
-	|O
210	|O
,	|O
had	|O
roles	|O
in	|O
the	|O
trans	|O
-	|O
suppression	|O
activity	|O
of	|O
the	|O
large	|O
HDAg	|B-PROTEIN
,	|O
in	|O
the	|O
assembly	|O
of	|O
empty	|O
virus	|O
-	|O
like	|O
HDAg	|B-PROTEIN
particle	|O
,	|O
and	|O
in	|O
the	|O
nuclear	|O
transport	|O
of	|O
HDAgs	|B-PROTEIN
.	|O

Homologous	|O
recombination	|O
between	|O
the	|O
Autographa	|O
californica	|O
nuclear	|O
polyhedrosis	|O
virus	|O
(	|O
AcNPV	|O
)	|O
genome	|O
and	|O
a	|O
0.6	|O
-	|O
kbp	|O
-	|O
long	|O
DNA	|O
fragment	|O
derived	|O
from	|O
the	|O
putative	|O
DNA	|B-PROTEIN
helicase	|I-PROTEIN
gene	|O
of	|O
Bombyx	|O
mori	|O
nuclear	|O
polyhedrosis	|O
virus	|O
generates	|O
eh2	|O
-	|O
AcNPV	|O
,	|O
an	|O
expanded	|O
-	|O
host	|O
-	|O
range	|O
AcNPV	|O
mutant	|O
(	|O
S.	|O

The	|O
data	|O
further	|O
indicate	|O
that	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
7R	|I-PROTEIN
alpha	|I-PROTEIN
chains	|O
are	|O
directly	|O
involved	|O
in	|O
the	|O
activation	|O
of	|O
JAKs	|B-PROTEIN
and	|O
STATs	|B-PROTEIN
and	|O
have	|O
a	|O
major	|O
role	|O
in	|O
proliferative	|O
signaling	|O
in	|O
precursor	|O
B	|O
cells	|O
.	|O

Furthermore	|O
,	|O
the	|O
potency	|O
of	|O
Dacarbacine	|O
in	|O
the	|O
treatment	|O
of	|O
carcinoid	|O
tumors	|O
seems	|O
to	|O
be	|O
underestimated	|O
up	|O
to	|O
now	|O
.	|O

5	|O
)	|O
We	|O
'	|O
ve	|O
noticed	|O
that	|O
the	|O
mean	|O
value	|O
of	|O
the	|O
cost	|O
for	|O
episode	|O
of	|O
pnx	|O
s	|O
.	|O
in	|O
class	|O
A	|O
was	|O
more	|O
than	|O
15%	|O
compared	|O
to	|O
class	|O
B	|O
and	|O
the	|O
cost	|O
for	|O
patient	|O
in	|O
class	|O
A	|O
was	|O
nearly	|O
double	|O
than	|O
in	|O
class	|O
B.	|O

We	|O
have	|O
been	|O
studying	|O
the	|O
interaction	|O
of	|O
the	|O
oncogenic	|O
human	|O
polyomavirus	|O
BK	|O
(	|O
BKV	|O
)	|O
with	|O
the	|O
tumor	|O
-	|O
suppressor	|O
protein	|O
p53	|B-PROTEIN
to	|O
understand	|O
the	|O
biology	|O
of	|O
this	|O
virus	|O
as	|O
well	|O
as	|O
to	|O
understand	|O
the	|O
basic	|O
mechanisms	|O
of	|O
p53	|B-PROTEIN
transactivation	|O
.	|O

Site	|O
S	|O
-	|O
II	|O
also	|O
spans	|O
a	|O
23	|O
bp	|O
sequence	|O
containing	|O
two	|O
tandem	|O
consensus	|O
binding	|O
sites	|O
with	|O
three	|O
base	|O
pair	|O
mismatches	|O
in	|O
each	|O
and	|O
a	|O
one	|O
base	|O
pair	|O
deletion	|O
.	|O

Cbl	|B-PROTEIN
constitutively	|O
interacts	|O
with	|O
the	|O
SH3	|B-PROTEIN
domains	|O
of	|O
Grb2	|B-PROTEIN
,	|O
with	|O
a	|O
preference	|O
for	|O
the	|O
amino	|O
-	|O
terminal	|O
domain	|O
,	|O
and	|O
is	|O
in	|O
this	|O
way	|O
recruited	|O
to	|O
Shc	|B-PROTEIN
upon	|O
BCR	|B-PROTEIN
stimulation	|O
.	|O

Activation	|O
mediated	|O
by	|O
Cat8p	|B-PROTEIN
was	|O
no	|O
longer	|O
detectable	|O
in	|O
a	|O
cat1	|B-PROTEIN
mutant	|O
.	|O

Treatment	|O
is	|O
instituted	|O
with	|O
prednisone	|O
and	|O
cyclophosphamide	|O
.	|O

Unaided	|O
attempts	|O
to	|O
quit	|O
smoking	|O
are	|O
generally	|O
unsuccessful	|O
.	|O

Laboratory	|O
evaluation	|O
was	|O
normal	|O
,	|O
and	|O
neuroimaging	|O
failed	|O
to	|O
confirm	|O
obstruction	|O
of	|O
venous	|O
or	|O
lymphatic	|O
drainage	|O
.	|O

Microcomputer	|O
management	|O
of	|O
chronic	|O
hepatitis	|O
B	|O
virus	|O
asymptomatic	|O
patients	|O

While	|O
fusion	|O
to	|O
the	|O
N	|O
-	|O
terminus	|O
required	|O
a	|O
linker	|O
to	|O
become	|O
surface	|O
accessible	|O
,	|O
both	|O
fusion	|O
to	|O
the	|O
N	|O
-	|O
terminus	|O
and	|O
to	|O
the	|O
C	|O
-	|O
terminus	|O
was	|O
compatible	|O
with	|O
particle	|O
assembly	|O
and	|O
preserved	|O
the	|O
native	|O
antigenicity	|O
and	|O
immunogenicity	|O
of	|O
HBcAg	|B-PROTEIN
.	|O

The	|O
standard	|O
dosage	|O
of	|O
anti	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
currently	|O
given	|O
at	|O
all	|O
gestational	|O
ages	|O
is	|O
1	|O
ampoule	|O
containing	|O
125	|O
micrograms	|O
of	|O
anti	|B-PROTEIN
-	|I-PROTEIN
D.	|I-PROTEIN

We	|O
report	|O
here	|O
the	|O
molecular	|O
cloning	|O
of	|O
a	|O
putative	|O
adhesive	|O
molecule	|O
from	|O
P.	|O
falciparum	|O
that	|O
shares	|O
both	|O
sequence	|O
and	|O
structural	|O
similarities	|O
with	|O
a	|O
sporozoite	|O
surface	|O
molecule	|O
from	|O
Plasmodium	|O
termed	|O
the	|O
thrombospondin	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
anonymous	|I-PROTEIN
protein	|I-PROTEIN
(	|O
TRAP	|B-PROTEIN
)	|O
and	|O
,	|O
to	|O
a	|O
lesser	|O
extent	|O
,	|O
with	|O
the	|O
circumsporozoite	|O
(	|B-PROTEIN
CS	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
.	|O

There	|O
are	|O
no	|O
introns	|O
within	|O
the	|O
gene	|O
,	|O
which	|O
contains	|O
a	|O
9360	|O
-	|O
bp	|O
open	|O
reading	|O
frame	|O
and	|O
encodes	|O
a	|O
377	|O
-	|O
kDa	|O
protein	|O
.	|O

METHODS	|O
:	|O
DSF	|O
was	|O
instilled	|O
in	|O
one	|O
eye	|O
chosen	|O
at	|O
random	|O
and	|O
CF	|O
in	|O
the	|O
fellow	|O
eye	|O
of	|O
13	|O
normal	|O
subjects	|O
and	|O
in	|O
13	|O
patients	|O
with	|O
KCS	|O
.	|O

The	|O
experience	|O
of	|O
the	|O
lateral	|O
rhinotomy	|O
approach	|O
in	|O
transsphenoidal	|O
surgery	|O
of	|O
acromegaly	|O
has	|O
been	|O
favourable	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
results	|O
demonstrate	|O
that	|O
at	|O
the	|O
site	|O
of	|O
lumbar	|O
disc	|O
herniation	|O
,	|O
inflammatory	|O
cytokines	|O
such	|O
as	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
are	|O
produced	|O
,	|O
which	|O
increases	|O
prostaglandin	|O
E2	|O
production	|O
.	|O

The	|O
predominant	|O
sensitizing	|O
allergens	|O
in	|O
Swedish	|O
asthmatic	|O
children	|O
are	|O
furred	|O
pet	|O
animals	|O
.	|O

Our	|O
results	|O
demonstrate	|O
that	|O
distinct	|O
cytoplasmic	|O
domains	|O
of	|O
these	|O
cytokine	|O
receptors	|O
elicit	|O
convergent	|O
signaling	|O
pathways	|O
and	|O
provide	|O
evidence	|O
that	|O
beta	|B-PROTEIN
c	|I-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2R	|I-PROTEIN
beta	|I-PROTEIN
function	|O
as	|O
a	|O
complete	|O
signal	|O
transducer	|O
.	|O

In	|O
addition	|O
,	|O
they	|O
display	|O
common	|O
features	|O
that	|O
make	|O
them	|O
strikingly	|O
related	|O
to	|O
snoRNA	|O
U14	|B-PROTEIN
.	|O

U24	|B-PROTEIN
has	|O
two	|O
separate	|O
12	|O
nt	|O
long	|O
complementarities	|O
to	|O
a	|O
highly	|O
conserved	|O
tract	|O
of	|O
28S	|B-PROTEIN
rRNA	|O
.	|O

This	|O
complex	|O
interacts	|O
at	|O
the	|O
GTPase	|B-PROTEIN
domain	|O
in	|O
the	|O
large	|O
subunit	|O
rRNA	|O
,	|O
overlapping	|O
the	|O
binding	|O
site	|O
of	|O
the	|O
protein	|O
L11	|B-PROTEIN
-	|O
like	|O
eukaryotic	|O
counterpart	|O
(	|O
Saccharomyces	|O
cerevisiae	|O
protein	|O
L15	|B-PROTEIN
and	|O
mammalian	|O
protein	|O
L12	|B-PROTEIN
)	|O
.	|O

Chromatin	|O
repression	|O
of	|O
these	|O
replacement	|O
genes	|O
would	|O
be	|O
avoided	|O
,	|O
consistent	|O
with	|O
the	|O
high	|O
,	|O
constitutive	|O
expression	|O
of	|O
replacement	|O
H3	|B-PROTEIN
histone	|O
genes	|O
in	|O
plants	|O
.	|O

This	|O
transition	|O
is	|O
regulated	|O
positively	|O
by	|O
G1	|O
-	|O
specific	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
cdks	|O
)	|O
and	|O
negatively	|O
by	|O
the	|O
product	|O
of	|O
the	|O
retinoblastoma	|B-PROTEIN
tumour	|I-PROTEIN
suppressor	|I-PROTEIN
gene	|O
,	|O
pRb	|B-PROTEIN
.	|O

Possible	|O
relationship	|O
between	|O
hyperinsulinemia	|O
and	|O
glomerular	|O
hypertrophy	|O
in	|O
nephrosclerosis	|O
.	|O

Blood	|O
GSH	|B-PROTEIN
-	|I-PROTEIN
Px	|I-PROTEIN
activity	|O
was	|O
measured	|O
with	|O
a	|O
spectrophotometer	|O
,	|O
using	|O
a	|O
modification	|O
of	|O
a	|O
previously	|O
described	|O
assay	|O
.	|O

The	|O
concentrations	|O
of	|O
vitamin	|O
A	|O
precursors	|O
and	|O
vitamin	|O
E	|O
in	|O
the	|O
hay	|O
were	|O
below	|O
currently	|O
recommended	|O
dietary	|O
levels	|O
for	|O
llamas	|O
,	|O
and	|O
alfalfa	|O
hay	|O
appears	|O
to	|O
provide	|O
an	|O
unreliable	|O
source	|O
of	|O
vitamins	|O
A	|O
and	|O
E	|O
in	|O
this	|O
species	|O
.	|O

Eight	|O
cats	|O
infected	|O
with	|O
H.	|O
pylori	|O
were	|O
used	|O
in	|O
the	|O
study	|O
.	|O

However	|O
,	|O
as	|O
determined	|O
by	|O
PCR	|O
with	|O
primers	|O
specific	|O
for	|O
the	|O
26	|O
-	|O
kDa	|O
product	|O
,	|O
the	|O
majority	|O
of	|O
cats	|O
at	|O
2	|O
and	|O
4	|O
weeks	|O
p.t	|O
.	|O
had	|O
gastric	|O
fluid	|O
samples	|O
which	|O
were	|O
positive	|O
for	|O
H.	|O
pylori	|O
and	|O
three	|O
of	|O
three	|O
cats	|O
at	|O
2	|O
weeks	|O
p.t	|O
.	|O
had	|O
dental	|O
plaque	|O
which	|O
was	|O
positive	|O
for	|O
H.	|O
pylori	|O
.	|O

To	|O
derive	|O
quantitative	|O
concentration	|O
changes	|O
from	|O
measurements	|O
of	|O
light	|O
attenuation	|O
,	|O
the	|O
optical	|O
path	|O
length	|O
must	|O
be	|O
known	|O
.	|O

STUDY	|O
DESIGN	|O
.	|O

Following	|O
the	|O
injection	|O
of	|O
PGF2	|O
alpha	|O
,	|O
heifers	|O
were	|O
observed	|O
visually	|O
for	|O
signs	|O
of	|O
estrus	|O
at	|O
0730	|O
and	|O
1630	|O
(	|O
45	|O
min	|O
each	|O
)	|O
.	|O

Differential	|O
activation	|O
of	|O
the	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
Jun	|B-PROTEIN
kinase	|O
and	|O
Janus	|B-PROTEIN
kinase	|O
-	|O
Stat	|B-PROTEIN
pathways	|O
by	|O
oncostatin	|B-PROTEIN
M	|I-PROTEIN
and	|O
basic	|B-PROTEIN
fibroblast	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
in	|O
AIDS	|O
-	|O
derived	|O
Kaposi	|O
's	|O
sarcoma	|O
cells	|O
.	|O

There	|O
is	|O
general	|O
agreement	|O
that	|O
the	|O
hepatitis	|O
C	|O
virus	|O
is	|O
efficiently	|O
transmitted	|O
parenterally	|O
,	|O
while	|O
data	|O
on	|O
viral	|O
transmission	|O
from	|O
mothers	|O
to	|O
babies	|O
or	|O
by	|O
sexual	|O
or	|O
non	|O
-	|O
sexual	|O
household	|O
contact	|O
are	|O
conflicting	|O
.	|O

Ten	|O
weeks	|O
after	|O
reconstruction	|O
,	|O
the	|O
regenerating	|O
nerves	|O
already	|O
resembled	|O
normal	|O
nerves	|O
.	|O

The	|O
distribution	|O
and	|O
organization	|O
of	|O
projections	|O
from	|O
the	|O
spinal	|O
cervical	|O
enlargement	|O
to	|O
subnucleus	|O
reticularis	|O
dorsalis	|O
(	|O
SRD	|O
)	|O
and	|O
the	|O
neighbouring	|O
Cuneate	|O
nucleus	|O
(	|O
Cu	|O
)	|O
area	|O
was	|O
studied	|O
in	|O
the	|O
rat	|O
by	|O
using	|O
microinjections	|O
of	|O
Phaseolus	|B-PROTEIN
vulgaris	|I-PROTEIN
leucoagglutinin	|I-PROTEIN
(	|O
PHA	|B-PROTEIN
-	|I-PROTEIN
L	|I-PROTEIN
)	|O
into	|O
different	|O
laminae	|O
around	|O
the	|O
C7	|O
level	|O
.	|O

The	|O
levels	|O
of	|O
fibrinogen	|B-PROTEIN
as	|O
well	|O
as	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
(	|O
ATIII	|B-PROTEIN
)	|O
and	|O
heparin	|B-PROTEIN
cofactor	|I-PROTEIN
II	|I-PROTEIN
(	|O
HCII	|B-PROTEIN
)	|O
activities	|O
were	|O
steadily	|O
increased	|O
in	|O
loop	|O
-	|O
bearing	|O
animals	|O
.	|O

Amplification	|O
and	|O
overexpression	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
erbB	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
in	|O
21MT	|O
-	|O
2	|O
and	|O
21MT	|O
-	|O
1	|O
human	|O
breast	|O
carcinoma	|O
cells	|O
results	|O
in	|O
progressively	|O
elevated	|O
levels	|O
of	|O
constitutively	|O
tyrosine	|O
-	|O
phosphorylated	|O
p185erbB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
is	|O
associated	|O
with	|O
progressive	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
)	|O
and	|O
combined	|O
IGF	|B-PROTEIN
/	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
EGF	|B-PROTEIN
)	|O
independence	|O
in	|O
culture	|O
.	|O

Facioscapulohumeral	|O
muscular	|O
dystrophy	|O
(	|O
FSHD	|O
)	|O
is	|O
an	|O
autosomal	|O
dominant	|O
,	|O
neuromuscular	|O
disorder	|O
characterized	|O
by	|O
progressive	|O
weakness	|O
of	|O
muscles	|O
in	|O
the	|O
face	|O
,	|O
shoulder	|O
and	|O
upper	|O
arm	|O
.	|O

The	|O
mature	|O
chromosome	|O
4	|O
FRG1	|B-PROTEIN
transcript	|O
is	|O
1042	|O
bp	|O
in	|O
length	|O
and	|O
contains	|O
nine	|O
exons	|O
which	|O
encode	|O
a	|O
putative	|O
protein	|O
of	|O
258	|O
amino	|O
acid	|O
residues	|O
.	|O

Patients	|O
who	|O
have	|O
undergone	|O
thyroidectomy	|O
for	|O
thyroid	|O
carcinoma	|O
are	|O
frequently	|O
subjected	|O
to	|O
periods	|O
of	|O
induced	|O
severe	|O
hypothyroidism	|O
in	|O
preparation	|O
for	|O
131I	|O
whole	|O
body	|O
scanning	|O
and	|O
measurement	|O
of	|O
serum	|O
TG	|B-PROTEIN
.	|O

Full	|O
thyroid	|O
function	|O
testing	|O
was	|O
performed	|O
on	|O
600	|O
randomly	|O
selected	|O
samples	|O
with	|O
normal	|O
TSH	|B-PROTEIN
values	|O
and	|O
also	|O
on	|O
subjects	|O
with	|O
abnormal	|O
TSH	|B-PROTEIN
levels	|O
.	|O

In	|O
a	|O
third	|O
experiment	|O
,	|O
crossover	|O
AM	|O
between	|O
dissimilar	|O
textures	|O
was	|O
investigated	|O
,	|O
and	|O
it	|O
was	|O
found	|O
that	|O
the	|O
more	|O
salient	|O
textures	|O
carried	|O
the	|O
AM	|O
.	|O

The	|O
relative	|O
tumor	|O
FDG	|O
-	|O
uptake	|O
(	|O
Q	|O
-	|O
MRGlu	|O
)	|O
(	|O
tumor	|O
/	|O
contralateral	|O
cortex	|O
)	|O
of	|O
all	|O
meningiomas	|O
was	|O
calculated	|O
with	|O
0.73	|O
+	|O
/	|O
-	|O
0.37	|O
(	|O
0.24-1.79	|O
)	|O
.	|O

Zatebradine	|O
weakly	|O
depressed	|O
the	|O
ectopic	|O
ventricular	|O
rate	|O
but	|O
not	|O
the	|O
arrhythmic	|O
ratio	|O
of	|O
the	|O
ventricular	|O
arrhythmias	|O
induced	|O
by	|O
two	|O
-	|O
stage	|O
coronary	|O
ligation	|O
24	|O
h	|O
after	|O
the	|O
ligation	|O
in	|O
conscious	|O
dogs	|O
.	|O

Catha	|O
edulis	|O
,	|O
a	|O
plant	|O
that	|O
has	|O
amphetamine	|O
effects	|O
.	|O

The	|O
predicted	|O
protein	|O
,	|O
Seb1p	|B-PROTEIN
,	|O
consists	|O
of	|O
82	|O
amino	|O
acids	|O
and	|O
contains	|O
one	|O
potential	|O
membrane	|O
-	|O
spanning	|O
region	|O
at	|O
the	|O
C	|O
-	|O
terminus	|O
but	|O
no	|O
N	|O
-	|O
terminal	|O
signal	|O
sequence	|O
.	|O

The	|O
SEB1	|B-PROTEIN
homologue	|O
thus	|O
isolated	|O
,	|O
SEB2	|B-PROTEIN
,	|O
encodes	|O
a	|O
protein	|O
53%	|O
identical	|O
to	|O
Seb1p	|B-PROTEIN
.	|O

Nonetheless	|O
,	|O
that	|O
ventricular	|O
afferents	|O
,	|O
in	|O
certain	|O
special	|O
settings	|O
,	|O
are	|O
able	|O
to	|O
induce	|O
e.g.	|O
generalised	|O
vasodilation	|O
and	|O
hypotension	|O
cannot	|O
be	|O
excluded	|O
.	|O

Large	|O
ones	|O
were	|O
similar	|O
in	|O
size	|O
to	|O
the	|O
main	|O
lobe	|O
and	|O
small	|O
ones	|O
were	|O
approximately	|O
1/4	|O
of	|O
the	|O
length	|O
of	|O
the	|O
main	|O
lobe	|O
.	|O

Fragments	|O
and	|O
analogs	|O
of	|O
the	|O
hormone	|O
ACTH	|B-PROTEIN
were	|O
previously	|O
shown	|O
to	|O
have	|O
beneficial	|O
effect	|O
on	|O
the	|O
outcome	|O
of	|O
head	|O
injury	|O
,	|O
while	|O
elevated	|O
levels	|O
of	|O
corticosterone	|O
(	|O
CS	|O
)	|O
exacerbate	|O
it	|O
.	|O

The	|O
most	|O
frequent	|O
causes	|O
of	|O
the	|O
meningitis	|O
was	|O
the	|O
external	|O
ventricular	|O
drainage	|O
(	|O
14.8%	|O
)	|O
,	|O
post	|O
-	|O
neurosurgical	|O
(	|O
0.8%	|O
)	|O
and	|O
head	|O
injury	|O
(	|O
0.0007%	|O
)	|O
.	|O

Fifty	|O
-	|O
one	|O
patients	|O
with	|O
primary	|O
refractory	|O
or	|O
relapsed	|O
malignant	|O
lymphoma	|O
(	|O
47	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O
and	|O
four	|O
Hodgkin	|O
's	|O
disease	|O
)	|O
were	|O
treated	|O
with	|O
a	|O
new	|O
chemotherapeutic	|O
regimen	|O
(	|O
cisplatinum	|O
,	|O
methyl	|O
GAG	|O
,	|O
bleomocyin	|O
,	|O
methyl	|O
prednisolon	|O
)	|O
.	|O

With	|O
the	|O
increasing	|O
use	|O
of	|O
ACE	|B-PROTEIN
inhibitors	|O
,	|O
the	|O
incidence	|O
of	|O
rare	|O
adverse	|O
effects	|O
such	|O
as	|O
potentially	|O
lethal	|O
pancreatitis	|O
is	|O
likely	|O
to	|O
increase	|O
.	|O

In	|O
3	|O
treatments	|O
the	|O
diet	|O
was	|O
supplemented	|O
with	|O
0	|O
,	|O
100	|O
and	|O
150	|O
mg	|O
probiotic	|O
/	|O
kg	|O
food	|O
.	|O

Low	|O
-	|O
dose	|O
aspirin	|O
and	|O
recurrent	|O
miscarriage	|O
.	|O

Protein	|O
films	|O
are	|O
distinctly	|O
different	|O
in	|O
mechanical	|O
profiles	|O
from	|O
those	|O
films	|O
made	|O
of	|O
other	|O
materials	|O
.	|O

Furthermore	|O
,	|O
cpxA	|B-PROTEIN
*	|I-PROTEIN
mutations	|O
suppress	|O
the	|O
toxicity	|O
conferred	|O
by	|O
the	|O
LamB	|B-PROTEIN
-	|O
LacZ	|B-PROTEIN
hybrid	|O
protein	|O
,	|O
which	|O
exerts	|O
its	|O
effects	|O
in	|O
the	|O
cytoplasm	|O
,	|O
sequestered	|O
from	|O
DegP	|B-PROTEIN
.	|O

The	|O
PI3K	|B-PROTEIN
_68D	|I-PROTEIN
cDNA	|O
encodes	|O
a	|O
protein	|O
of	|O
210	|O
kDa	|O
,	|O
which	|O
lacks	|O
sequences	|O
implicated	|O
in	|O
linking	|O
p110	|B-PROTEIN
PI	|O
3	|O
-	|O
kinases	|O
to	|O
p85	|B-PROTEIN
adaptor	|O
proteins	|O
,	|O
but	|O
contains	|O
an	|O
amino	|O
-	|O
terminal	|O
proline	|O
-	|O
rich	|O
sequence	|O
,	|O
which	|O
could	|O
bind	|O
to	|O
SH3	|B-PROTEIN
domains	|O
,	|O
and	|O
a	|O
carboxy	|O
-	|O
terminal	|O
C2	|B-PROTEIN
domain	|O
.	|O

In	|O
vitro	|O
interaction	|O
studies	|O
,	|O
using	|O
proteins	|O
fused	|O
to	|O
glutathione	|B-PROTEIN
-	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
,	|O
showed	|O
that	|O
RBP	|B-PROTEIN
-	|I-PROTEIN
J	|I-PROTEIN
kappa	|I-PROTEIN
and	|O
Su	|B-PROTEIN
(	|I-PROTEIN
H	|I-PROTEIN
)	|I-PROTEIN
bind	|O
directly	|O
to	|O
the	|O
RAM23	|B-PROTEIN
regions	|O
of	|O
mouse	|O
Notch1	|B-PROTEIN
and	|O
Drosophila	|O
Notch	|B-PROTEIN
,	|O
respectively	|O
.	|O

AIMS	|O
/	|O
METHODS	|O
:	|O
Reticuloendothelial	|O
system	|O
function	|O
,	|O
as	|O
assessed	|O
by	|O
clearance	|O
of	|O
radiolabelled	|O
bacteria	|O
,	|O
was	|O
evaluated	|O
in	|O
acute	|O
liver	|O
injury	|O
induced	|O
by	|O
D	|O
-	|O
galactosamine	|O
in	|O
rats	|O
,	|O
and	|O
compared	|O
with	|O
that	|O
after	|O
70%	|O
liver	|O
resection	|O
model	|O
.	|O

Our	|O
laboratory	|O
and	|O
others	|O
have	|O
shown	|O
alternative	|O
splicing	|O
of	|O
up	|O
to	|O
ten	|O
exons	|O
at	|O
a	|O
discrete	|O
extracellular	|O
site	|O
to	|O
be	|O
primarily	|O
responsible	|O
for	|O
the	|O
generation	|O
of	|O
CD44	|B-PROTEIN
variant	|O
(	|O
CD44v	|B-PROTEIN
)	|O
isoforms	|O
.	|O

Study	|O
groups	|O
were	|O
control	|O
,	|O
and	|O
those	|O
treated	|O
with	|O
the	|O
alpha1	|B-PROTEIN
-	|I-PROTEIN
adrenoceptor	|I-PROTEIN
-	|O
subtype	|O
blockers	|O
WB4101	|O
(	|O
0.5	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
)	|O
or	|O
chloroethylclonidine	|O
(	|O
1.9	|O
mg	|O
/	|O
kg	|O
i.v	|O
.	|O
)	|O
.	|O

This	|O
caused	|O
severe	|O
cortical	|O
damage	|O
and	|O
neuronal	|O
loss	|O
in	|O
hippocampus	|O
subfields	|O
CA1	|O
,	|O
CA3	|O
,	|O
and	|O
hilus	|O
.	|O

The	|O
occurrence	|O
of	|O
multiple	|O
malignancy	|O
was	|O
studied	|O
in	|O
674	|O
patients	|O
with	|O
hematologic	|O
malignancies	|O
who	|O
were	|O
admitted	|O
to	|O
this	|O
department	|O
during	|O
the	|O
past	|O
10	|O
years	|O
.	|O

The	|O
upTRE	|O
binds	|O
more	|O
T3R	|B-PROTEIN
homodimers	|O
and	|O
less	|O
T3R	|B-PROTEIN
-	|O
RXR	|B-PROTEIN
heterodimers	|O
than	|O
the	|O
dnTRE	|O
,	|O
and	|O
T3	|O
more	|O
readily	|O
facilitates	|O
heterodimer	|O
binding	|O
to	|O
the	|O
dn	|O
-	|O
than	|O
to	|O
the	|O
upTRE	|O
.	|O

Transcriptional	|O
control	|O
of	|O
a	|O
nuclear	|O
gene	|O
encoding	|O
a	|O
mitochondrial	|O
fatty	|O
acid	|O
oxidation	|O
enzyme	|O
in	|O
transgenic	|O
mice	|O
:	|O
role	|O
for	|O
nuclear	|O
receptors	|O
in	|O
cardiac	|O
and	|O
brown	|O
adipose	|O
expression	|O
.	|O

Hoeben	|O
,	|O
F.J.	|O

Twelve	|O
genomic	|O
fragments	|O
containing	|O
novel	|O
response	|O
elements	|O
are	|O
described	|O
,	|O
and	|O
the	|O
transcription	|O
unit	|O
associated	|O
with	|O
one	|O
of	|O
them	|O
,	|O
NN	|B-PROTEIN
-	|I-PROTEIN
84AG	|I-PROTEIN
,	|O
was	|O
characterized	|O
in	|O
detail	|O
.	|O

Moreover	|O
,	|O
glucan	|B-PROTEIN
synthase	|I-PROTEIN
activity	|O
,	|O
which	|O
is	|O
activated	|O
by	|O
Rho1p	|B-PROTEIN
,	|O
was	|O
significantly	|O
reduced	|O
in	|O
the	|O
deltabem4	|B-PROTEIN
mutant	|O
.	|O

In	|O
gel	|O
retardation	|O
assays	|O
,	|O
an	|O
RCS	|O
cell	|O
-	|O
specific	|O
protein	|O
and	|O
another	|O
closely	|O
related	|O
protein	|O
expressed	|O
only	|O
in	|O
RCS	|O
cells	|O
and	|O
primary	|O
chondrocytes	|O
bound	|O
to	|O
a	|O
10	|O
-	|O
bp	|O
sequence	|O
within	|O
the	|O
18	|O
-	|O
mer	|O
.	|O

Two	|O
classes	|O
of	|O
Xanthomonas	|O
pathogens	|O
evading	|O
Bs2	|O
host	|O
resistance	|O
and	|O
displaying	|O
reduced	|O
fitness	|O
were	|O
found	|O
to	|O
be	|O
specifically	|O
mutated	|O
in	|O
avrBs2	|B-PROTEIN
.	|O

Members	|O
of	|O
the	|O
Ras	|B-PROTEIN
subfamily	|O
of	|O
small	|B-PROTEIN
GTP	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
have	|O
been	|O
shown	|O
to	|O
be	|O
promiscuous	|O
towards	|O
a	|O
variety	|O
of	|O
putative	|O
effector	|O
molecules	|O
such	|O
as	|O
the	|O
protein	|O
kinase	|O
c	|B-PROTEIN
-	|I-PROTEIN
Raf	|I-PROTEIN
and	|O
the	|O
Ral	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
guanine	|I-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
(	|O
Ral	|B-PROTEIN
-	|I-PROTEIN
GEF	|I-PROTEIN
)	|O
.	|O

Thus	|O
,	|O
the	|O
characterization	|O
of	|O
the	|O
promoter	|O
region	|O
should	|O
help	|O
to	|O
define	|O
regulatory	|O
elements	|O
that	|O
control	|O
neuron	|O
-	|O
specific	|O
and	|O
developmental	|O
expression	|O
of	|O
the	|O
MAP1B	|B-PROTEIN
gene	|O
.	|O

The	|O
cDNA	|O
encoded	|O
a	|O
mature	|O
protein	|O
of	|O
240	|O
amino	|O
acids	|O
,	|O
including	|O
a	|O
29	|O
-	|O
amino	|O
acid	|O
signal	|O
sequence	|O
.	|O

Mutants	|O
lacking	|O
the	|O
3'	|O
stem	|O
-	|O
loop	|O
exhibited	|O
a	|O
75%	|O
reduction	|O
in	|O
the	|O
level	|O
of	|O
psaB	|B-PROTEIN
mRNA	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
was	|O
highly	|O
conserved	|O
across	|O
the	|O
wide	|O
range	|O
of	|O
eukaryotes	|O
(	|O
vertebrates	|O
,	|O
invertebrates	|O
,	|O
fungi	|O
,	|O
plants	|O
and	|O
protozoa	|O
)	|O
in	|O
which	|O
this	|O
gene	|O
has	|O
now	|O
been	|O
identified	|O
.	|O

Biol.	|O

Semidominant	|O
mutations	|O
in	|O
the	|O
yeast	|O
Rad51	|B-PROTEIN
protein	|O
and	|O
their	|O
relationships	|O
with	|O
the	|O
Srs2	|B-PROTEIN
helicase	|O
.	|O

Alterations	|O
of	|O
the	|O
5q23	|O
-	|O
q31	|O
interval	|O
are	|O
frequently	|O
observed	|O
in	|O
myelodysplasia	|O
and	|O
myeloid	|O
leukemia	|O
.	|O

Previous	|O
studies	|O
have	|O
suggested	|O
that	|O
the	|O
616	|O
amino	|O
acid	|O
,	|O
70	|O
-	|O
kDa	|O
subunit	|O
of	|O
RPA	|B-PROTEIN
(	|O
RPA	|B-PROTEIN
70	|O
)	|O
is	|O
composed	|O
of	|O
multiple	|O
structural	|O
/	|O
functional	|O
domains	|O
.	|O

Neurons	|O
were	|O
held	|O
at	|O
-	|O
67	|O
mV	|O
to	|O
equate	|O
voltage	|O
-	|O
dependent	|O
effects	|O
.	|O

This	|O
site	|O
acts	|O
as	|O
a	|O
negative	|O
element	|O
when	|O
transferred	|O
to	|O
the	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
promoter	|O
,	|O
but	|O
does	|O
not	|O
confer	|O
inducibility	|O
.	|O

The	|O
extent	|O
of	|O
the	|O
fbpA	|B-PROTEIN
operator	|O
sequence	|O
(	|O
42	|O
bp	|O
)	|O
,	|O
as	|O
defined	|O
by	|O
our	|O
footprinting	|O
analysis	|O
,	|O
would	|O
suggest	|O
the	|O
binding	|O
of	|O
two	|O
Fur	|B-PROTEIN
repressor	|O
dimers	|O
.	|O

The	|O
structural	|O
similarity	|O
between	|O
Vav	|B-PROTEIN
and	|O
other	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factors	|I-PROTEIN
for	|O
small	|B-PROTEIN
GTP	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
,	|O
together	|O
with	|O
the	|O
recent	|O
identification	|O
of	|O
biochemical	|O
routes	|O
specific	|O
for	|O
members	|O
of	|O
the	|O
Ras	|B-PROTEIN
and	|O
Rho	|B-PROTEIN
family	|O
of	|O
GTPases	|B-PROTEIN
,	|O
prompted	|O
us	|O
to	|O
explore	|O
whether	|O
MAPK	|B-PROTEIN
or	|O
JNK	|B-PROTEIN
are	|O
downstream	|O
components	|O
of	|O
the	|O
Vav	|B-PROTEIN
signaling	|O
pathways	|O
.	|O

CONCLUSION	|O
:	|O
Twice	|O
daily	|O
treatment	|O
with	|O
inhaled	|O
fluticasone	|O
propionate	|O
50	|O
micrograms	|O
or	|O
100	|O
micrograms	|O
was	|O
significantly	|O
more	|O
effective	|O
than	|O
theophylline	|O
in	|O
the	|O
treatment	|O
of	|O
mild	|O
-	|O
to	|O
-	|O
moderate	|O
asthma	|O
.	|O

Our	|O
results	|O
support	|O
a	|O
model	|O
where	|O
both	|O
E2F	|B-PROTEIN
-	|O
and	|O
CDE	|O
-	|O
mediated	|O
repression	|O
,	|O
acting	|O
at	|O
different	|O
stages	|O
in	|O
the	|O
cell	|O
cycle	|O
,	|O
are	|O
dependent	|O
on	|O
promoter	|O
-	|O
specific	|O
CHR	|O
elements	|O
.	|O

The	|O
cDNA	|O
clone	|O
was	|O
used	|O
as	|O
a	|O
homologous	|O
probe	|O
to	|O
isolate	|O
a	|O
truncated	|O
genomic	|O
clone	|O
encoding	|O
H2A1	|B-PROTEIN
.	|O

Comparison	|O
of	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequences	|O
with	|O
protein	|O
sequences	|O
of	|O
T.	|O
pyriformis	|O
H2As	|B-PROTEIN
showed	|O
only	|O
two	|O
and	|O
three	|O
differences	|O
respectively	|O
,	|O
in	|O
a	|O
total	|O
of	|O
137	|O
amino	|O
acids	|O
for	|O
H2A1	|B-PROTEIN
,	|O
and	|O
132	|O
amino	|O
acids	|O
for	|O
H2A2	|B-PROTEIN
,	|O
indicating	|O
the	|O
two	|O
genes	|O
arose	|O
before	|O
the	|O
divergence	|O
of	|O
these	|O
two	|O
species	|O
.	|O

Cognitive	|O
visual	|O
dysfunction	|O
in	|O
a	|O
child	|O
with	|O
cerebral	|O
damage	|O
.	|O

Interaction	|O
was	|O
apparently	|O
determined	|O
by	|O
the	|O
N	|O
-	|O
terminal	|O
splice	|O
region	|O
of	|O
RPDE	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
as	|O
the	|O
PDE4A	|B-PROTEIN
splice	|O
variant	|O
RPDE	|B-PROTEIN
-	|I-PROTEIN
39	|I-PROTEIN
,	|O
which	|O
differs	|O
from	|O
RPDE	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
at	|O
the	|O
extreme	|O
N	|O
-	|O
terminus	|O
,	|O
failed	|O
to	|O
associate	|O
with	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
-	|O
SH3	|B-PROTEIN
;	|O
met26RD1	|B-PROTEIN
(	|O
where	|O
RD1	|B-PROTEIN
is	|O
rat	|O
'	|O
dunc	|O
-	|O
like	|O
'	|O
PDE	|B-PROTEIN
)	|O
,	|O
which	|O
has	|O
the	|O
N	|O
-	|O
terminal	|O
splice	|O
region	|O
deleted	|O
,	|O
failed	|O
to	|O
associate	|O
with	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
-	|O
SH3	|B-PROTEIN
,	|O
and	|O
the	|O
association	|O
of	|O
RPDE	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
-	|O
SH3	|B-PROTEIN
was	|O
blocked	|O
by	|O
a	|O
fusion	|O
protein	|O
formed	|O
from	|O
the	|O
N	|O
-	|O
terminal	|O
splice	|O
region	|O
.	|O

Potentially	|O
load	|O
-	|O
insensitive	|O
measures	|O
of	|O
ventricular	|O
performance	|O
were	|O
therefore	|O
evaluated	|O
in	|O
10	|O
open	|O
-	|O
and	|O
closed	|O
-	|O
chested	|O
,	|O
anesthetized	|O
rabbits	|O
.	|O

Large	|O
strain	|O
differences	|O
were	|O
found	|O
for	|O
all	|O
variables	|O
recorded	|O
,	|O
i.e.	|O
,	|O
the	|O
proportion	|O
of	|O
attacking	|O
males	|O
,	|O
the	|O
time	|O
spent	|O
in	|O
the	|O
brightly	|O
lit	|O
box	|O
,	|O
and	|O
the	|O
number	|O
of	|O
transitions	|O
between	|O
the	|O
lit	|O
and	|O
the	|O
dark	|O
boxes	|O
.	|O

The	|O
effect	|O
of	|O
ligustrazine	|O
hydrochloride	|O
(	|O
LTH	|O
)	|O
on	|O
depressing	|O
pulmonary	|O
artery	|O
hypertension	|O
has	|O
been	|O
proved	|O
in	|O
recent	|O
studies	|O
.	|O

It	|O
is	|O
the	|O
oxidation	|O
peak	|O
of	|O
this	|O
product	|O
,	|O
arising	|O
in	|O
acidic	|O
media	|O
at	|O
0.42	|O
V	|O
,	|O
which	|O
was	|O
analysed	|O
using	|O
DPV	|O
,	|O
again	|O
following	|O
the	|O
accumulation	|O
of	|O
clenbuterol	|O
at	|O
the	|O
Nafion	|O
-	|O
modified	|O
CPE	|O
.	|O

Phenylephrine	|O
is	|O
a	|O
pure	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
adrenoreceptor	|I-PROTEIN
agonist	|O
known	|O
to	|O
produce	|O
marked	|O
systemic	|O
vasoconstriction	|O
and	|O
associated	|O
hypertension	|O
with	|O
occasional	|O
profound	|O
reflex	|O
bradycardia	|O
.	|O

The	|O
expression	|O
of	|O
the	|O
first	|O
two	|O
genes	|O
located	|O
in	|O
this	|O
unit	|O
(	|O
c	|B-PROTEIN
-	|I-PROTEIN
gvpD	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
gvpE	|I-PROTEIN
)	|O
was	|O
also	|O
monitored	|O
by	|O
Western	|O
blot	|O
(	|O
immunoblot	|O
)	|O
analyses	|O
using	|O
antisera	|O
raised	|O
against	|O
these	|O
proteins	|O
synthesized	|O
in	|O
Escherichia	|O
coli	|O
.	|O

One	|O
unit	|O
encodes	|O
traA	|B-PROTEIN
,	|O
traF	|B-PROTEIN
,	|O
and	|O
traB	|B-PROTEIN
,	|O
while	|O
the	|O
second	|O
encodes	|O
traC	|B-PROTEIN
,	|O
traD	|B-PROTEIN
,	|O
and	|O
traG	|B-PROTEIN
.	|O

A.	|O

In	|O
an	|O
effort	|O
to	|O
isolate	|O
genes	|O
with	|O
down	|O
-	|O
regulated	|O
expression	|O
at	|O
the	|O
mRNA	|O
level	|O
during	|O
oncogenic	|O
transformation	|O
of	|O
human	|O
mammary	|O
epithelial	|O
cells	|O
(	|O
MECs	|O
)	|O
,	|O
we	|O
performed	|O
subtractive	|O
hybridization	|O
between	|O
normal	|O
MEC	|O
strain	|O
76N	|O
and	|O
its	|O
radiation	|O
-	|O
transformed	|O
tumorigenic	|O
derivative	|O
76R	|O
-	|O
30	|O
.	|O

CASE	|O
REPORT	|O
:	|O
Referred	|O
because	|O
of	|O
a	|O
right	|O
corneal	|O
perforation	|O
with	|O
cellular	|O
reaction	|O
in	|O
anterior	|O
chamber	|O
,	|O
a	|O
patient	|O
was	|O
sutured	|O
and	|O
treated	|O
with	|O
a	|O
single	|O
intravitreal	|O
injection	|O
of	|O
0.2	|O
ml	|O
(	|O
1	|O
mg	|O
)	|O
Amikacin	|O
and	|O
0.2	|O
ml	|O
(	|O
1	|O
mg	|O
)	|O
Vancomycin	|O
.	|O

In	|O
the	|O
same	|O
period	|O
we	|O
pointed	|O
out	|O
an	|O
increase	|O
of	|O
hematocrit	|O
(	|O
from	|O
29%	|O
to	|O
35%	|O
)	|O
and	|O
of	|O
the	|O
Hb	|B-PROTEIN
(	|O
from	|O
9.3	|O
to	|O
11.2	|O
g	|O
/	|O
dl	|O
)	|O
.	|O

The	|O
P	|B-PROTEIN
-	|I-PROTEIN
wr	|I-PROTEIN
and	|O
P	|B-PROTEIN
-	|I-PROTEIN
rr	|I-PROTEIN
cDNA	|O
sequences	|O
are	|O
very	|O
similar	|O
in	|O
their	|O
5'	|O
regions	|O
.	|O

Because	|O
the	|O
hcf109	|B-PROTEIN
locus	|O
was	|O
mapped	|O
at	|O
a	|O
distance	|O
<	|O
0.1	|O
centimorgans	|O
from	|O
the	|O
phytochrome	|B-PROTEIN
C	|I-PROTEIN
gene	|O
,	|O
its	|O
molecular	|O
characterization	|O
by	|O
positional	|O
cloning	|O
is	|O
possible	|O
.	|O

The	|O
human	|O
MSH	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
product	|O
is	|O
a	|O
member	|O
of	|O
a	|O
highly	|O
conserved	|O
family	|O
of	|O
proteins	|O
which	|O
are	|O
involved	|O
in	|O
post	|O
-	|O
replication	|O
mismatch	|O
repair	|O
.	|O
hMSH	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
homologous	|O
to	|O
Escherichia	|O
coli	|O
(	|O
E.	|O
coli	|O
)	|O
MutS	|B-PROTEIN
and	|O
Sacchromyces	|O
cerevisiae	|O
MSH	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
MSH	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
proteins	|O
,	|O
which	|O
recognise	|O
heteroduplex	|O
DNA	|O
at	|O
the	|O
sites	|O
of	|O
all	|O
single	|O
base	|O
mismatches	|O
and	|O
deletions	|O
or	|O
insertions	|O
up	|O
to	|O
4	|O
base	|O
pairs	|O
.	|O
hMSH	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
one	|O
of	|O
the	|O
hereditary	|O
non	|O
-	|O
polyposis	|O
colorectal	|O
cancer	|O
(	|B-PROTEIN
HNPCC	|I-PROTEIN
)	|I-PROTEIN
tumor	|I-PROTEIN
suppressor	|I-PROTEIN
genes	|O
,	|O
and	|O
maps	|O
to	|O
human	|O
chromosome	|O
2p16	|O
.	|O

We	|O
have	|O
recently	|O
shown	|O
that	|O
the	|O
tissue	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
RAR	|B-PROTEIN
beta	|I-PROTEIN
2	|I-PROTEIN
gene	|O
in	|O
mouse	|O
embryos	|O
is	|O
regulated	|O
at	|O
the	|O
translational	|O
level	|O
by	|O
short	|O
upstream	|O
open	|O
reading	|O
frames	|O
(	|O
uORFs	|O
)	|O
In	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
(	|O
Zimmer	|O
,	|O
A.	|O
,	|O
A.M.	|O

We	|O
have	|O
previously	|O
isolated	|O
a	|O
cDNA	|O
for	|O
a	|O
transcription	|O
factor	|O
referred	|O
to	|O
as	|O
Zfhep	|B-PROTEIN
(	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
homeodomain	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
)	|O
containing	|O
two	|O
separate	|O
zinc	|O
finger	|O
domains	|O
,	|O
ZD1	|B-PROTEIN
and	|O
ZD2	|B-PROTEIN
,	|O
each	|O
of	|O
which	|O
binds	|O
DNA	|O
,	|O
and	|O
a	|O
homeodomain	|O
.	|O

The	|O
structure	|O
of	|O
these	|O
genes	|O
suggests	|O
a	|O
common	|O
ancestor	|O
for	|O
all	|O
viperid	|O
PLA2	|B-PROTEIN
genes	|O
.	|O

Increased	|O
PTHRP	|B-PROTEIN
production	|O
by	|O
a	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
oncogene	|O
,	|O
Tpr	|B-PROTEIN
-	|I-PROTEIN
Met	|I-PROTEIN
:	|O
role	|O
of	|O
the	|O
Ras	|B-PROTEIN
signaling	|O
pathway	|O
.	|O

Subsequent	|O
to	|O
their	|O
secretion	|O
,	|O
the	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
in	|O
xz97	|O
and	|O
G11	|O
cells	|O
accumulated	|O
in	|O
the	|O
conditioned	|O
medium	|O
mostly	|O
as	|O
two	|O
partially	|O
processed	|O
species	|O
with	|O
appMr	|O
,	|O
of	|O
17K	|O
and	|O
14K	|O
,	|O
respectively	|O
.	|O

Paradoxically	|O
,	|O
coexpression	|O
of	|O
the	|O
transcriptionally	|O
inactive	|O
,	|O
amino	|O
-	|O
terminally	|O
deleted	|O
IDX	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
proteins	|O
,	|O
either	|O
with	|O
the	|O
wild	|O
-	|O
type	|O
IDX	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
with	|O
themselves	|O
,	|O
results	|O
in	|O
a	|O
marked	|O
enhancement	|O
of	|O
transactivation	|O
of	|O
the	|O
transcriptional	|O
TAAT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
element	|O
reporter	|O
.	|O

All	|O
patients	|O
had	|O
abnormal	|O
von	|B-PROTEIN
Willebrand	|I-PROTEIN
factor	|I-PROTEIN
(	|O
vWF	|B-PROTEIN
)	|O
fragmentation	|O
as	|O
reflected	|O
by	|O
decreased	|O
high	|O
molecular	|O
weight	|O
and	|O
increased	|O
low	|O
molecular	|O
weight	|O
vWF	|B-PROTEIN
multimers	|O
in	|O
the	|O
circulation	|O
.	|O

In	|O
an	|O
attempt	|O
to	|O
investigate	|O
whether	|O
the	|O
intergenic	|O
region	|O
between	|O
the	|O
oleosin	|B-PROTEIN
and	|O
a	|O
second	|O
open	|O
reading	|O
frame	|O
(	|O
ORFII	|B-PROTEIN
)	|O
in	|O
Brassica	|O
napus	|O
(	|O
L.	|O
)	|O
is	|O
a	|O
divergent	|O
promoter	|O
,	|O
and	|O
also	|O
to	|O
characterize	|O
the	|O
ORFII	|B-PROTEIN
,	|O
cDNA	|O
clones	|O
homologous	|O
to	|O
ORFII	|B-PROTEIN
were	|O
isolated	|O
from	|O
a	|O
leaf	|O
cDNA	|O
library	|O
.	|O

The	|O
ORFII	|B-PROTEIN
gene	|O
product	|O
is	|O
targeted	|O
to	|O
the	|O
chloroplast	|O
,	|O
which	|O
is	|O
consistent	|O
with	|O
previous	|O
data	|O
indicating	|O
the	|O
presence	|O
of	|O
PMSR	|B-PROTEIN
activity	|O
in	|O
the	|O
chloroplast	|O
.	|O

Characterization	|O
of	|O
LRP	|B-PROTEIN
,	|O
a	|O
leucine	|O
-	|O
rich	|O
repeat	|O
(	|B-PROTEIN
LRR	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
from	|O
tomato	|O
plants	|O
that	|O
is	|O
processed	|O
during	|O
pathogenesis	|O
.	|O

To	|O
test	|O
whether	|O
Sp1	|B-PROTEIN
and	|O
zif268	|B-PROTEIN
/	|O
egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
interact	|O
with	|O
this	|O
motif	|O
,	|O
gel	|O
retardation	|O
assays	|O
were	|O
performed	|O
.	|O

OBJECTIVES	|O
:	|O
The	|O
aim	|O
of	|O
the	|O
study	|O
was	|O
to	|O
analyze	|O
the	|O
clinical	|O
characteristics	|O
,	|O
treatment	|O
and	|O
outcome	|O
of	|O
310	|O
patients	|O
with	|O
hydatidiform	|O
mole	|O
.	|O

Stably	|O
transfected	|O
human	|O
kidney	|O
293	|O
cells	|O
expressing	|O
the	|O
wild	|O
type	|O
rat	|O
LH	|B-PROTEIN
/	|I-PROTEIN
CG	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
rLHR	|B-PROTEIN
)	|O
or	|O
receptors	|O
with	|O
C	|O
-	|O
terminal	|O
tails	|O
truncated	|O
at	|O
residues	|O
653	|O
,	|O
631	|O
,	|O
or	|O
628	|O
(	|O
designated	|O
rLHR	|B-PROTEIN
-	|I-PROTEIN
t653	|I-PROTEIN
,	|O
rLHR	|B-PROTEIN
-	|I-PROTEIN
t631	|I-PROTEIN
,	|O
and	|O
rLHR	|B-PROTEIN
-	|I-PROTEIN
t628	|I-PROTEIN
)	|O
were	|O
used	|O
to	|O
probe	|O
the	|O
importance	|O
of	|O
this	|O
region	|O
on	|O
the	|O
regulation	|O
of	|O
hormonal	|O
responsiveness	|O
.	|O

Are	|O
low	|O
P300	|O
amplitudes	|O
a	|O
marker	|O
for	|O
schizophrenia	|O
.	|O

Sleep	|O
was	|O
determined	|O
again	|O
for	|O
an	|O
additional	|O
3	|O
days	|O
and	|O
6	|O
hours	|O
.	|O

The	|O
patients	|O
are	|O
two	|O
healthy	|O
adult	|O
males	|O
.	|O

Chloroplast	|B-PROTEIN
mutator	|I-PROTEIN
(	|O
chm	|B-PROTEIN
)	|O
of	|O
Arabidopsis	|O
is	|O
a	|O
recessive	|O
nuclear	|O
mutation	|O
that	|O
causes	|O
green	|O
and	|O
white	|O
variegation	|O
in	|O
leaves	|O
and	|O
is	|O
inherited	|O
in	|O
a	|O
non	|O
-	|O
Mendelian	|O
fashion	|O
.	|O

Indoor	|O
concentrations	|O
were	|O
only	|O
weakly	|O
correlated	|O
with	|O
outdoor	|O
concentrations	|O
,	|O
however	|O
,	|O
and	|O
personal	|O
exposures	|O
were	|O
even	|O
more	|O
poorly	|O
correlated	|O
with	|O
outdoor	|O
concentrations	|O
.	|O

A	|O
neuropsychological	|O
test	|O
battery	|O
was	|O
used	|O
that	|O
contained	|O
the	|O
Wisconsin	|O
card	|O
sorting	|O
test	|O
,	|O
Street	|O
completion	|O
test	|O
,	|O
Stroop	|O
test	|O
,	|O
a	|O
dichotic	|O
memory	|O
listening	|O
test	|O
,	|O
and	|O
a	|O
facial	|O
recognition	|O
test	|O
.	|O

We	|O
present	|O
this	|O
case	|O
because	|O
of	|O
the	|O
rarity	|O
of	|O
left	|O
ventricular	|O
involvement	|O
associated	|O
with	|O
ARVD	|O
.	|O

In	|O
a	|O
randomized	|O
single	|O
-	|O
blind	|O
3	|O
x	|O
3	|O
Latin	|O
-	|O
square	|O
study	|O
with	|O
corrections	|O
for	|O
any	|O
carryover	|O
effects	|O
,	|O
27	|O
males	|O
and	|O
30	|O
females	|O
consumed	|O
supplements	|O
containing	|O
glucose	|O
or	|O
resistant	|O
starch	|O
(	|O
RS	|O
)	|O
from	|O
raw	|O
high	|O
-	|O
amylose	|O
cornstarch	|O
(	|O
RS2	|O
)	|O
or	|O
from	|O
retrograded	|O
high	|O
-	|O
amylose	|O
cornstarch	|O
(	|O
RS3	|O
)	|O
.	|O

The	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
mouse	|O
Met	|B-PROTEIN
-	|I-PROTEIN
ase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
also	|O
shares	|O
considerable	|O
regions	|O
of	|O
identity	|O
with	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
rat	|O
Met	|B-PROTEIN
-	|I-PROTEIN
ase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
.	|O

The	|O
[	|O
18F	|O
]	|O
FMISO	|O
TMRR	|O
is	|O
a	|O
simple	|O
and	|O
clinically	|O
useful	|O
index	|O
for	|O
detecting	|O
tumour	|O
hypoxia	|O
in	|O
NPC	|O
.	|O

Improved	|O
methods	|O
have	|O
been	|O
developed	|O
for	|O
maintaining	|O
and	|O
breeding	|O
the	|O
neotropical	|O
short	|O
-	|O
tailed	|O
fruit	|O
bat	|O
,	|O
Carollia	|O
perspicillata	|O
,	|O
in	|O
an	|O
easily	|O
-	|O
reproduced	|O
,	|O
laboratory	|O
setting	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
time	|O
to	|O
engraftment	|O
was	|O
significantly	|O
shorter	|O
in	|O
the	|O
amifostine	|O
arm	|O
in	|O
both	|O
cohorts	|O
.	|O

Also	|O
like	|O
the	|O
thrombin	|B-PROTEIN
receptor	|I-PROTEIN
,	|O
PAR2	|B-PROTEIN
can	|O
be	|O
activated	|O
by	|O
the	|O
hexapeptide	|O
corresponding	|O
to	|O
its	|O
tethered	|O
ligand	|O
sequence	|O
independent	|O
of	|O
receptor	|O
cleavage	|O
.	|O

We	|O
conclude	|O
that	|O
CPET	|O
is	|O
a	|O
useful	|O
investigation	|O
in	|O
the	|O
management	|O
of	|O
patients	|O
with	|O
cardiopulmonary	|O
disease	|O
and	|O
complements	|O
the	|O
various	|O
other	|O
investigations	|O
offered	|O
by	|O
a	|O
pulmonary	|O
function	|O
laboratory	|O
.	|O

Using	|O
fluorescence	|O
in	|O
situ	|O
hybridization	|O
,	|O
we	|O
mapped	|O
the	|O
chromosome	|O
-	|O
17	|O
breakpoint	|O
in	|O
a	|O
patient	|O
with	|O
acampomelic	|O
CMPD	|O
and	|O
sex	|O
reversal	|O
,	|O
who	|O
carries	|O
a	|O
de	|O
novo	|O
constitutional	|O
t	|O
(	|O
12	|O
;	|O
17	|O
)	|O
translocation	|O
,	|O
between	|O
two	|O
known	|O
cosmid	|O
markers	|O
in	|O
the	|O
17q24	|O
-	|O
q25	|O
region	|O
.	|O

This	|O
is	|O
concluded	|O
from	|O
the	|O
isolation	|O
of	|O
cDNAs	|O
from	|O
spinach	|O
(	|O
Spinacia	|O
oleracea	|O
)	|O
and	|O
barley	|O
(	|O
Hordeum	|O
vulgare	|O
cv	|O
.	|O

The	|O
data	|O
presented	|O
in	|O
this	|O
work	|O
indicate	|O
that	|O
thi1	|B-PROTEIN
may	|O
also	|O
be	|O
involved	|O
in	|O
DNA	|O
damage	|O
tolerance	|O
in	|O
plant	|O
cells	|O
.	|O

In	|O
the	|O
rat	|O
rnu	|B-PROTEIN
allele	|O
described	|O
here	|O
,	|O
a	|O
nonsense	|O
mutation	|O
in	|O
exon	|O
8	|O
of	|O
the	|O
whn	|B-PROTEIN
gene	|O
was	|O
identified	|O
.	|O

Such	|O
an	|O
increase	|O
in	|O
the	|O
steady	|O
-	|O
state	|O
testicular	|O
TIMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
mRNA	|O
level	|O
apparently	|O
is	|O
not	|O
the	|O
result	|O
of	|O
an	|O
up	|O
-	|O
regulation	|O
by	|O
germ	|O
cells	|O
because	|O
germ	|O
cells	|O
cocultured	|O
with	|O
Sertoli	|O
cells	|O
failed	|O
to	|O
elicit	|O
an	|O
increase	|O
in	|O
the	|O
Sertoli	|O
cell	|O
steady	|O
-	|O
state	|O
TIMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
mRNA	|O
level	|O
.	|O

Control	|O
intact	|O
rats	|O
were	|O
age	|O
-	|O
matched	|O
to	|O
the	|O
different	|O
treated	|O
groups	|O
.	|O

DESIGN	|O
:	|O
A	|O
cross	|O
-	|O
sectional	|O
study	|O
.	|O

In	|O
the	|O
SPK	|O
and	|O
PTA	|O
category	|O
,	|O
anti	|O
-	|O
T	|O
-	|O
cell	|O
therapy	|O
significantly	|O
lowered	|O
the	|O
risk	|O
of	|O
graft	|O
loss	|O
.	|O

We	|O
have	|O
identified	|O
a	|O
strong	|O
Tas	|B-PROTEIN
-	|O
responsive	|O
element	|O
,	|O
designated	|O
TRE	|B-PROTEIN
(	|O
GP	|B-PROTEIN
)	|O
,	|O
near	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
gag	|B-PROTEIN
gene	|O
and	|O
preceding	|O
the	|O
pol	|B-PROTEIN
gene	|O
of	|O
SFV	|O
-	|O
1	|O
.	|O

Although	|O
the	|O
binding	|O
of	|O
IE2	|B-PROTEIN
86	|I-PROTEIN
to	|O
nonphosphorylated	|O
full	|O
-	|O
length	|O
CREB	|B-PROTEIN
or	|O
deltaCREB	|B-PROTEIN
is	|O
minimal	|O
,	|O
IE2	|B-PROTEIN
86	|I-PROTEIN
does	|O
form	|O
complexes	|O
with	|O
p300	|B-PROTEIN
and	|O
the	|O
CREB	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CBP	|B-PROTEIN
)	|O
,	|O
which	|O
in	|O
turn	|O
bind	|O
to	|O
CREB	|B-PROTEIN
and	|O
can	|O
serve	|O
as	|O
adaptor	|O
proteins	|O
for	|O
CREB	|B-PROTEIN
function	|O
.	|O

A	|O
transgenic	|O
complementation	|O
assay	|O
was	|O
used	|O
to	|O
test	|O
whether	|O
NIa	|B-PROTEIN
supplied	|O
in	|O
trans	|O
could	|O
rescue	|O
amplification	|O
-	|O
defective	|O
viral	|O
genomes	|O
encoding	|O
altered	|O
NIa	|B-PROTEIN
proteins	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
its	|O
bZIP	|O
structural	|O
homology	|O
,	|O
meq	|B-PROTEIN
is	|O
perhaps	|O
the	|O
only	|O
member	|O
of	|O
the	|O
jun	|B-PROTEIN
-	|O
fos	|B-PROTEIN
gene	|O
family	|O
completely	|O
viral	|O
in	|O
origin	|O
.	|O

The	|O
rCBF	|O
and	|O
vasomotion	|O
were	|O
recorded	|O
by	|O
laser	|O
-	|O
doppler	|O
fluxmetry	|O
.	|O

Although	|O
basal	|O
vessels	|O
may	|O
constrict	|O
distal	|O
parenchymal	|O
vessels	|O
tend	|O
to	|O
dilate	|O
after	|O
SAH	|O
.	|O

The	|O
triple	|O
combination	|O
of	|O
nizatidine	|O
,	|O
clarithromycin	|O
,	|O
and	|O
bismuth	|O
subcitrate	|O
resulted	|O
in	|O
an	|O
ulcer	|O
healing	|O
rate	|O
of	|O
98%	|O
and	|O
an	|O
H.	|O
pylori	|O
eradication	|O
rate	|O
of	|O
90%	|O
.	|O

Several	|O
lines	|O
of	|O
evidence	|O
presented	|O
here	|O
suggest	|O
that	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
zeta	|I-PROTEIN
plays	|O
a	|O
role	|O
in	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
integrin	|I-PROTEIN
gene	|O
expression	|O
.	|O

Plasma	|O
thrombomodulin	|B-PROTEIN
:	|O
a	|O
marker	|O
for	|O
microvascular	|O
complications	|O
in	|O
diabetes	|O
mellitus	|O
.	|O

Update	|O
:	|O
diphtheria	|O
epidemic	|O
in	|O
the	|O
newly	|O
independent	|O
states	|O
of	|O
the	|O
former	|O
USSR	|O
,	|O
January	|O
1995	|O
-	|O
March	|O
1996	|O
.	|O

The	|O
characterization	|O
of	|O
the	|O
promoter	|O
region	|O
indicated	|O
that	|O
three	|O
distinct	|O
regulatory	|O
elements	|O
corresponding	|O
to	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
site	|O
(	|O
or	|O
TRE	|O
)	|O
,	|O
a	|O
PRDII	|B-PROTEIN
/	|O
kappaB	|B-PROTEIN
domain	|O
,	|O
and	|O
a	|O
CAAT	|O
box	|O
are	|O
involved	|O
in	|O
the	|O
activation	|O
by	|O
pp60	|B-PROTEIN
(	|O
v	|O
-	|O
)	|O
src	|O
.	|O

Serine	|O
528	|O
is	|O
phosphorylated	|O
in	|O
vivo	|O
in	|O
several	|O
cell	|O
lines	|O
,	|O
and	|O
substitution	|O
of	|O
serine	|O
528	|O
to	|O
alanine	|O
(	|O
S528A	|O
)	|O
resulted	|O
in	|O
an	|O
increased	|O
ability	|O
of	|O
Myb	|B-PROTEIN
to	|O
transactivate	|O
a	|O
synthetic	|O
promoter	|O
containing	|O
five	|O
copies	|O
of	|O
the	|O
mim	|B-PROTEIN
-	|I-PROTEIN
1A	|I-PROTEIN
Myb	|O
-	|O
responsive	|O
element	|O
and	|O
a	|O
minimal	|O
herpes	|O
tk	|B-PROTEIN
promoter	|O
.	|O

The	|O
DNA	|O
binding	|O
and	|O
multimerization	|O
activities	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
appear	|O
to	|O
be	|O
unaffected	|O
by	|O
the	|O
S528A	|O
substitution	|O
,	|O
suggesting	|O
that	|O
phosphorylation	|O
of	|O
serine	|O
528	|O
may	|O
mediate	|O
its	|O
effect	|O
on	|O
the	|O
transcription	|O
transactivating	|O
activity	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
by	|O
regulating	|O
interactions	|O
with	|O
other	|O
proteins	|O
.	|O

The	|O
amount	|O
of	|O
these	|O
factors	|O
was	|O
reduced	|O
in	|O
GEO	|O
cells	|O
in	|O
which	|O
the	|O
u	|B-PROTEIN
-	|I-PROTEIN
PAR	|I-PROTEIN
gene	|O
is	|O
only	|O
weakly	|O
transcriptionally	|O
activated	|O
.	|O

PIP2	|O
,	|O
when	|O
incorporated	|O
into	|O
phosphatidylcholine	|O
carrier	|O
vesicles	|O
,	|O
binds	|O
tightly	|O
to	|O
the	|O
guanine	|O
nucleotide	|O
-	|O
depleted	|O
form	|O
of	|O
Cdc42Hs	|B-PROTEIN
and	|O
weakly	|O
to	|O
the	|O
GDP	|O
-	|O
bound	|O
form	|O
of	|O
the	|O
GTP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
but	|O
does	|O
not	|O
bind	|O
to	|O
GTP	|O
-	|O
bound	|O
Cdc42Hs	|B-PROTEIN
,	|O
similar	|O
to	|O
what	|O
was	|O
observed	|O
for	|O
the	|O
Dbl	|B-PROTEIN
oncoprotein	|O
.	|O

Purified	|O
spleen	|O
GAP	|B-PROTEIN
accelerated	|O
hydrolysis	|O
of	|O
GTP	|O
bound	|O
to	|O
recombinant	|O
ARF1	|B-PROTEIN
,	|O
ARF3	|B-PROTEIN
,	|O
ARF5	|B-PROTEIN
,	|O
and	|O
ARF6	|B-PROTEIN
;	|O
no	|O
effect	|O
of	|O
NH2	|O
-	|O
terminal	|O
myristoylation	|O
was	|O
observed	|O
.	|O

Biol.	|O

A	|O
novel	|O
phosphotyrosine	|O
-	|O
binding	|O
domain	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
transforming	|O
region	|O
of	|O
Cbl	|B-PROTEIN
interacts	|O
directly	|O
and	|O
selectively	|O
with	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
in	|O
T	|O
cells	|O
.	|O

Cys	|O
-	|O
757	|O
within	|O
the	|O
(	|O
Fe4S4	|O
)	|O
-	|O
siroheme	|O
-	|O
binding	|O
domain	|O
was	|O
essential	|O
for	|O
native	|O
enzyme	|O
activity	|O
.	|O

Its	|O
transcription	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
induced	|O
40-50	|O
-	|O
fold	|O
in	|O
response	|O
to	|O
oxygen	|O
or	|O
heme	|O
deficiency	|O
,	|O
in	|O
part	|O
through	|O
relief	|O
of	|O
repression	|O
exerted	|O
by	|O
Rox1p	|B-PROTEIN
and	|O
in	|O
part	|O
by	|O
activation	|O
mediated	|O
by	|O
an	|O
upstream	|O
activation	|O
sequence	|O
(	|O
UAS	|O
)	|O
.	|O

Altogether	|O
,	|O
our	|O
results	|O
indicate	|O
that	|O
the	|O
transcriptional	|O
activity	|O
of	|O
Cut	|B-PROTEIN
proteins	|O
is	|O
modulated	|O
by	|O
PKC	|B-PROTEIN
.	|O

Lck	|B-PROTEIN
has	|O
been	|O
postulated	|O
to	|O
dimerize	|O
through	|O
the	|O
SH2	|B-PROTEIN
and	|O
SH3	|B-PROTEIN
domains	|O
.	|O

Furthermore	|O
,	|O
freezing	|O
in	|O
the	|O
presence	|O
of	|O
bovine	|O
lactalbumin	|B-PROTEIN
resulted	|O
in	|O
a	|O
good	|O
maintenance	|O
of	|O
the	|O
cellular	|O
viability	|O
and	|O
of	|O
the	|O
CCCD	|O
heterogeneity	|O
in	|O
respect	|O
to	|O
fresh	|O
cells	|O
.	|O

Myelomatous	|O
pleural	|O
effusion	|O
as	|O
presentation	|O
form	|O
of	|O
multiple	|O
myeloma	|O

Five	|O
-	|O
year	|O
survivals	|O
amounted	|O
to	|O
100%	|O
,	|O
86.2%	|O
,	|O
59.4%	|O
,	|O
29.8%	|O
,	|O
and	|O
20%	|O
for	|O
stages	|O
I	|O
,	|O
II	|O
,	|O
III	|O
,	|O
IVA	|O
and	|O
IVB	|O
respectively	|O
.	|O

The	|O
presence	|O
of	|O
unidentified	|O
macroscopic	|O
or	|O
microscopic	|O
clusters	|O
of	|O
neoplastic	|O
cells	|O
,	|O
lying	|O
around	|O
,	|O
more	|O
or	|O
less	|O
close	|O
to	|O
,	|O
the	|O
line	|O
of	|O
insertion	|O
of	|O
lesion	|O
,	|O
could	|O
render	|O
any	|O
attempt	|O
to	|O
gain	|O
a	|O
"	|O
radical	|O
"	|O
excision	|O
useless	|O
.	|O

The	|O
partial	|O
categories	|O
of	|O
the	|O
SIP	|O
that	|O
were	|O
more	|O
affected	|O
were	|O
work	|O
,	|O
recreation	|O
and	|O
pastimes	|O
,	|O
home	|O
management	|O
,	|O
and	|O
sleep	|O
and	|O
rest	|O
.	|O

Northern	|O
blot	|O
analysis	|O
,	|O
using	|O
the	|O
Ltp4	|B-PROTEIN
-	|O
specific	|O
probe	|O
,	|O
indicated	|O
that	|O
Xanthomonas	|O
campestris	|O
pv	|O
.	|O
translucens	|O
induced	|O
an	|O
increase	|O
over	|O
basal	|O
levels	|O
of	|O
Ltp4	|B-PROTEIN
mRNA	|O
,	|O
while	|O
Pseudomonas	|O
syringae	|O
pv	|O
.	|O
japonica	|O
caused	|O
a	|O
decrease	|O
.	|O

Targeted	|O
disruption	|O
of	|O
the	|O
OGG1	|B-PROTEIN
gene	|O
in	|O
yeast	|O
revealed	|O
a	|O
second	|O
OG	|B-PROTEIN
glycosylase	|I-PROTEIN
/	|I-PROTEIN
lyase	|I-PROTEIN
protein	|O
,	|O
tentatively	|O
named	|O
Ogg2	|B-PROTEIN
,	|O
which	|O
differs	|O
from	|O
Ogg1	|B-PROTEIN
in	|O
that	|O
it	|O
preferentially	|O
acts	|O
on	|O
OG	|O
:	|O
G.	|O

Furthermore	|O
,	|O
the	|O
use	|O
of	|O
zero	|O
-	|O
loss	|O
filtering	|O
in	|O
combination	|O
with	|O
exit	|O
wavefront	|O
reconstruction	|O
is	|O
considerably	|O
more	|O
effective	|O
at	|O
removing	|O
the	|O
effects	|O
of	|O
multiple	|O
elastic	|O
and	|O
inelastic	|O
scattering	|O
and	|O
microscope	|O
objective	|O
lens	|O
aberrations	|O
than	|O
either	|O
technique	|O
by	|O
itself	|O
.	|O

Transcripts	|O
for	|O
both	|O
ODV	|B-PROTEIN
-	|I-PROTEIN
E18	|I-PROTEIN
and	|O
ODV	|B-PROTEIN
-	|I-PROTEIN
EC27	|I-PROTEIN
initiate	|O
from	|O
conserved	|O
TAAG	|O
motifs	|O
,	|O
and	|O
transcripts	|O
are	|O
detected	|O
from	|O
16	|O
through	|O
72	|O
hr	|O
p.i	|O
.	|O

In	|O
order	|O
to	|O
determine	|O
which	|O
sequences	|O
in	|O
the	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
are	|O
crucial	|O
for	|O
activation	|O
by	|O
the	|O
ME26	|B-PROTEIN
viral	|O
protein	|O
,	|O
we	|O
made	|O
deletions	|O
of	|O
the	|O
promoter	|O
,	|O
cloned	|O
them	|O
into	|O
a	|O
luciferase	|B-PROTEIN
expression	|O
vector	|O
and	|O
tested	|O
their	|O
activity	|O
in	|O
mouse	|O
fibroblasts	|O
,	|O
which	|O
do	|O
not	|O
express	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
isolated	|O
genomic	|O
clone	|O
revealed	|O
that	|O
the	|O
DNA	|O
binding	|O
domain	|O
of	|O
this	|O
orphan	|O
receptor	|O
is	|O
most	|O
homologous	|O
to	|O
the	|O
human	|O
TR2	|B-PROTEIN
receptor	|I-PROTEIN
.	|O

Genomic	|O
DNA	|O
hybridization	|O
suggests	|O
that	|O
SpSHR2	|B-PROTEIN
is	|O
a	|O
single	|O
-	|O
copy	|O
gene	|O
in	|O
the	|O
S.	|O
purpuratus	|O
genome	|O
.	|O

A	|O
3	|O
-	|O
yr	|O
retrospective	|O
review	|O
is	|O
effective	|O
and	|O
detects	|O
94%	|O
of	|O
the	|O
undercalls	|O
.	|O

Isolation	|O
and	|O
identification	|O
of	|O
genes	|O
activating	|O
UAS2	|O
-	|O
dependent	|O
ADH2	|B-PROTEIN
expression	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

METHODS	|O
AND	|O
RESULTS	|O
:	|O
A	|O
64	|O
-	|O
year	|O
-	|O
old	|O
woman	|O
with	|O
confirmed	|O
AV	|O
nodal	|O
reentrant	|O
tachycardia	|O
underwent	|O
a	|O
successful	|O
"	|O
slow	|O
pathway	|O
"	|O
AV	|O
modification	|O
with	|O
a	|O
single	|O
radiofrequency	|O
application	|O
.	|O

Patients	|O
with	|O
low	|O
probability	|O
of	|O
having	|O
aluminum	|O
overload	|O
(	|O
serum	|O
iron	|O
levels	|O
<	|O
40	|O
micrograms	|O
/	|O
L	|O
and	|O
DAI	|O
<	|O
150	|O
micrograms	|O
/	|O
L	|O
)	|O
had	|O
significantly	|O
higher	|O
values	|O
of	|O
serum	|O
iron	|O
,	|O
iron	|O
transferrin	|B-PROTEIN
saturation	|O
,	|O
and	|O
serum	|O
ferritin	|B-PROTEIN
levels	|O
compared	|O
with	|O
those	|O
patients	|O
with	|O
a	|O
high	|O
probability	|O
of	|O
having	|O
aluminum	|O
overload	|O
(	|O
serum	|O
aluminum	|O
levels	|O
>	|O
40	|O
micrograms	|O
/	|O
L	|O
and	|O
DAI	|O
>	|O
150	|O
micrograms	|O
/	|O
L	|O
)	|O
.	|O

Although	|O
the	|O
RAD23	|B-PROTEIN
equivalents	|O
are	|O
well	|O
conserved	|O
during	|O
evolution	|O
,	|O
the	|O
mammalian	|O
genes	|O
did	|O
not	|O
express	|O
the	|O
UV	|O
-	|O
inducible	|O
phenotype	|O
of	|O
their	|O
yeast	|O
counterpart	|O
.	|O

Ha	|B-PROTEIN
-	|I-PROTEIN
RasV12	|I-PROTEIN
and	|O
activated	|O
proteins	|O
in	|O
both	|O
the	|O
extra	|B-PROTEIN
-	|I-PROTEIN
cellular	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
ERK	|B-PROTEIN
)	|O
and	|O
the	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
SAPK	|B-PROTEIN
)	|O
or	|O
Jun	|B-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
)	|O
cascades	|O
independently	|O
stimulated	|O
PEA3	|B-PROTEIN
-	|O
mediated	|O
gene	|O
expression	|O
.	|O

Sequence	|O
analysis	|O
of	|O
reverse	|O
transcribed	|O
,	|O
amplified	|O
cDNA	|O
generated	|O
from	|O
total	|O
RNA	|O
isolated	|O
from	|O
transfected	|O
cells	|O
demonstrated	|O
the	|O
presence	|O
of	|O
abnormally	|O
spliced	|O
products	|O
containing	|O
13	|O
and	|O
78	|O
additional	|O
bases	|O
as	|O
well	|O
as	|O
the	|O
accumulation	|O
of	|O
unspliced	|O
mRNA	|O
.	|O

Its	|O
hydropathy	|O
profile	|O
predicts	|O
seven	|O
transmembrane	|O
spans	|O
and	|O
a	|O
hydrophilic	|O
amino	|O
terminus	|O
of	|O
approximately	|O
100	|O
residues	|O
,	|O
and	|O
it	|O
suggests	|O
the	|O
presence	|O
of	|O
an	|O
amphiphilic	|O
alpha	|O
-	|O
helix	|O
(	|O
L	|O
-	|O
61	|O
to	|O
F	|O
-	|O
97	|O
)	|O
in	|O
close	|O
proximity	|O
to	|O
the	|O
first	|O
strongly	|O
hydrophobic	|O
segment	|O
of	|O
ProW	|B-PROTEIN
.	|O

A	|O
1.5	|O
-	|O
kb	|O
HindIII	|B-PROTEIN
genomic	|O
fragment	|O
carrying	|O
the	|O
vspA	|B-PROTEIN
gene	|O
from	|O
M.	|O
bovis	|O
PG45	|O
was	|O
cloned	|O
and	|O
sequenced	|O
.	|O

Carbon	|O
catabolite	|O
repression	|O
of	|O
the	|O
gnt	|B-PROTEIN
operon	|O
of	|O
Bacillus	|O
subtilis	|O
is	|O
mediated	|O
by	|O
the	|O
catabolite	|O
control	|O
protein	|O
CcpA	|B-PROTEIN
and	|O
by	|O
HPr	|B-PROTEIN
,	|O
a	|O
phosphocarrier	|O
protein	|O
of	|O
the	|O
phosphotransferase	|O
system	|O
.	|O

Melatonin	|O
and	|O
seasonality	|O
:	|O
filling	|O
the	|O
gap	|O
.	|O

A	|O
subsequent	|O
screen	|O
for	|O
the	|O
loss	|O
of	|O
the	|O
positively	|O
selectable	|O
target	|O
locus	|O
marker	|O
detects	|O
the	|O
desired	|O
replacement	|O
at	|O
modest	|O
frequency	|O
(	|O
>	|O
2%	|O
)	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
another	|O
cellular	|O
protein	|O
linked	|O
to	|O
BCR	|B-PROTEIN
/	|O
ABL	|B-PROTEIN
through	|O
the	|O
CRKL	|B-PROTEIN
-	|O
SH2	|B-PROTEIN
domain	|O
is	|O
p130	|B-PROTEIN
(	|O
CAS	|B-PROTEIN
)	|O
.	|O
p130	|B-PROTEIN
(	|O
CAS	|B-PROTEIN
)	|O
was	|O
found	|O
to	|O
be	|O
tyrosine	|O
phosphorylated	|O
and	|O
associated	|O
with	|O
CRKL	|B-PROTEIN
in	|O
BCR	|B-PROTEIN
/	|O
ABL	|B-PROTEIN
expressing	|O
cell	|O
lines	|O
and	|O
in	|O
samples	|O
obtained	|O
from	|O
CML	|O
and	|O
ALL	|O
patients	|O
,	|O
but	|O
not	|O
in	|O
samples	|O
from	|O
controls	|O
.	|O

There	|O
are	|O
four	|O
polyglutamine	|O
motifs	|O
interspersed	|O
with	|O
histidine	|O
-	|O
rich	|O
regions	|O
.	|O

The	|O
effects	|O
of	|O
procedural	|O
variations	|O
on	|O
lateralized	|O
Stroop	|O
effects	|O
.	|O

In	|O
a	|O
third	|O
experiment	|O
,	|O
a	|O
Chessmaster	|O
gradually	|O
increases	|O
the	|O
number	|O
of	|O
boards	|O
he	|O
can	|O
reproduce	|O
with	|O
higher	|O
than	|O
70%	|O
average	|O
accuracy	|O
to	|O
nine	|O
,	|O
replacing	|O
as	|O
many	|O
as	|O
160	|O
pieces	|O
correctly	|O
.	|O

PCNA	|B-PROTEIN
mRNA	|O
has	|O
a	|O
3'	|O
UTR	|O
antisense	|O
to	|O
yellow	|O
crescent	|O
RNA	|O
and	|O
is	|O
localized	|O
in	|O
ascidian	|O
eggs	|O
and	|O
embryos	|O
.	|O

A	|O
1.8	|O
-	|O
kb	|O
cDNA	|O
clone	|O
(	|O
designed	|O
hKID	|B-PROTEIN
,	|O
gene	|O
symbol	|O
AQP2L	|B-PROTEIN
)	|O
with	|O
homology	|O
to	|O
the	|O
aquaporins	|B-PROTEIN
was	|O
isolated	|O
from	|O
a	|O
human	|O
kidney	|O
cDNA	|O
library	|O
.	|O

PCR	|O
/	|O
Southern	|O
blot	|O
analysis	|O
of	|O
human	|O
kidney	|O
cDNA	|O
using	|O
primers	|O
flanking	|O
the	|O
hKID	|B-PROTEIN
coding	|O
sequence	|O
revealed	|O
expression	|O
of	|O
a	|O
full	|O
-	|O
length	|O
mRNA	|O
and	|O
short	|O
transcripts	|O
with	|O
partial	|O
exon	|O
1	|O
and	|O
partial	|O
exon	|O
4	|O
deletions	|O
.	|O

The	|O
high	|O
sequence	|O
homology	|O
,	|O
similar	|O
genomic	|O
structure	|O
,	|O
and	|O
identical	|O
chromosomal	|O
loci	|O
of	|O
hKID	|B-PROTEIN
,	|O
MIP	|B-PROTEIN
,	|O
and	|O
AQP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
suggest	|O
a	|O
MIP	|B-PROTEIN
family	|O
gene	|O
cluster	|O
at	|O
chromosome	|O
locus	|O
12q13	|O
.	|O

The	|O
third	|O
ORF	|O
generates	|O
a	|O
transcript	|O
of	|O
1.6	|O
kb	|O
and	|O
encodes	|O
a	|O
protein	|O
of	|O
382	|O
residues	|O
including	|O
a	|O
perfect	|O
match	|O
to	|O
the	|O
consensus	|O
sequence	|O
of	|O
a	|O
C2H2	|O
zinc	|O
finger	|O
domain	|O
;	|O
it	|O
shares	|O
a	|O
strong	|O
homology	|O
with	|O
yeast	|O
Mig1p	|B-PROTEIN
and	|O
Cre	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
from	|O
Aspergillus	|O
,	|O
Emericella	|O
and	|O
E.	|O
coli	|O
.	|O

Adding	|O
phytase	|B-PROTEIN
and	|O
nP	|O
improved	|O
the	|O
orderliness	|O
of	|O
development	|O
,	|O
mineralization	|O
and	|O
arrangement	|O
of	|O
cartilage	|O
and	|O
bone	|O
cells	|O
,	|O
and	|O
alleviated	|O
the	|O
effects	|O
of	|O
P	|O
deficiency	|O
on	|O
the	|O
histological	|O
and	|O
gross	|O
structure	|O
of	|O
the	|O
tibias	|O
.	|O

The	|O
importance	|O
of	|O
temporal	|O
factors	|O
on	|O
the	|O
presence	|O
and	|O
severity	|O
of	|O
ethanol	|O
withdrawal	|O
signs	|O
in	|O
the	|O
rat	|O
was	|O
quantified	|O
using	|O
rating	|O
scale	|O
,	|O
tremor	|O
,	|O
and	|O
acoustic	|O
startle	|O
paradigms	|O
.	|O

Data	|O
supported	|O
the	|O
brevity	|O
of	|O
the	|O
WISC	|O
-	|O
III	|O
short	|O
form	|O
and	|O
the	|O
criterion	|O
-	|O
related	|O
validity	|O
of	|O
both	|O
the	|O
K	|O
-	|O
FAST	|O
and	|O
and	|O
Kaufman	|O
Short	|O
Neuropsychological	|O
Assessment	|O
Procedure	|O
(	|O
K	|O
-	|O
SNAP	|O
)	|O
.	|O

Quantitative	|O
analysis	|O
of	|O
plasmid	|O
loss	|O
rates	|O
in	|O
cdc28	|B-PROTEIN
-	|I-PROTEIN
1N	|I-PROTEIN
strains	|O
carrying	|O
plasmids	|O
with	|O
multiple	|O
replication	|O
origins	|O
suggests	|O
that	|O
a	|O
defect	|O
in	|O
initiating	|O
DNA	|O
replication	|O
probably	|O
causes	|O
this	|O
plasmid	|O
loss	|O
phenotype	|O
.	|O

Thus	|O
,	|O
the	|O
multidomained	|O
ROK	|B-PROTEIN
alpha	|I-PROTEIN
appears	|O
to	|O
be	|O
involved	|O
in	|O
reorganization	|O
of	|O
the	|O
cytoskeleton	|O
,	|O
with	|O
the	|O
N	|O
and	|O
C	|O
termini	|O
acting	|O
as	|O
positive	|O
and	|O
negative	|O
regulators	|O
,	|O
respectively	|O
,	|O
of	|O
the	|O
kinase	|O
domain	|O
whose	|O
activity	|O
is	|O
crucial	|O
for	|O
formation	|O
of	|O
stress	|O
fibers	|O
and	|O
focal	|O
adhesion	|O
complexes	|O
.	|O

These	|O
findings	|O
and	|O
the	|O
differential	|O
tissue	|O
distribution	|O
of	|O
p54	|B-PROTEIN
suggest	|O
that	|O
this	|O
novel	|O
SR	|B-PROTEIN
protein	|O
may	|O
participate	|O
in	|O
regulation	|O
of	|O
alternative	|O
splicing	|O
in	|O
a	|O
tissue	|O
-	|O
and	|O
substrate	|O
-	|O
dependent	|O
manner	|O
.	|O

The	|O
elevation	|O
of	|O
cyclic	|O
AMP	|O
(	|O
cAMP	|O
)	|O
levels	|O
in	|O
the	|O
cell	|O
downregulates	|O
the	|O
activity	|O
of	|O
the	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
kinase	|O
.	|O

An	|O
interaction	|O
screen	|O
with	|O
the	|O
repression	|O
domain	|O
of	|O
the	|O
orphan	|O
receptor	|O
RevErb	|B-PROTEIN
identified	|O
N	|B-PROTEIN
-	|I-PROTEIN
CoR	|I-PROTEIN
,	|O
the	|O
corepressor	|O
for	|O
thyroid	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
TR	|B-PROTEIN
)	|O
and	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
RAR	|B-PROTEIN
)	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
inhibition	|O
of	|O
Jun	|B-PROTEIN
kinase	|O
activation	|O
was	|O
sufficient	|O
to	|O
inhibit	|O
Ras	|B-PROTEIN
transformation	|O
even	|O
in	|O
the	|O
presence	|O
of	|O
activated	|O
Erk	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

Our	|O
analysis	|O
suggests	|O
that	|O
Upf1p	|B-PROTEIN
is	|O
a	|O
multifunctional	|O
protein	|O
with	|O
separable	|O
activities	|O
that	|O
can	|O
affect	|O
mRNA	|O
turnover	|O
and	|O
nonsense	|O
suppression	|O
.	|O

Identification	|O
of	|O
Ste4	|B-PROTEIN
as	|O
a	|O
potential	|O
regulator	|O
of	|O
Byr2	|B-PROTEIN
in	|O
the	|O
sexual	|O
response	|O
pathway	|O
of	|O
Schizosaccharomyces	|O
pombe	|O
.	|O

Two	|O
closely	|O
related	|O
variants	|O
of	|O
Stat5	|B-PROTEIN
,	|O
Stat5a	|B-PROTEIN
and	|O
Stat5b	|B-PROTEIN
,	|O
are	|O
encoded	|O
by	|O
distinct	|O
genes	|O
.	|O

Mutations	|O
in	|O
three	|O
loci	|O
(	|O
SIC1	|B-PROTEIN
,	|O
SWI5	|B-PROTEIN
,	|O
and	|O
RIC3	|B-PROTEIN
)	|O
were	|O
identified	|O
.	|O

The	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
kinase	|I-PROTEIN
Raf	|O
-	|O
1	|O
functions	|O
downstream	|O
of	|O
Rats	|B-PROTEIN
in	|O
a	|O
signal	|O
transduction	|O
cascade	|O
which	|O
transmits	|O
mitogenic	|O
stimuli	|O
from	|O
the	|O
plasma	|O
membrane	|O
to	|O
the	|O
nucleus	|O
.	|O

Platelet	|B-PROTEIN
-	|I-PROTEIN
derived	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
is	|O
regulated	|O
by	|O
receptor	|O
binding	|O
of	|O
SH2	|B-PROTEIN
-	|O
domain	|O
-	|O
containing	|O
proteins	|O
which	|O
influence	|O
Ras	|B-PROTEIN
activity	|O
.	|O

In	|O
transient	|O
cotransfections	|O
E1A	|B-PROTEIN
could	|O
induce	|O
the	|O
activity	|O
of	|O
the	|O
p53	|B-PROTEIN
promoter	|O
to	|O
a	|O
high	|O
level	|O
;	|O
12S	|O
E1A	|B-PROTEIN
was	|O
threefold	|O
as	|O
efficient	|O
as	|O
13S	|O
E1A	|B-PROTEIN
in	|O
this	|O
activity	|O
,	|O
and	|O
YY1	|B-PROTEIN
bound	|O
to	|O
the	|O
composite	|O
element	|O
was	|O
shown	|O
to	|O
mediate	|O
55%	|O
of	|O
this	|O
induction	|O
.	|O

The	|O
retinoid	|B-PROTEIN
Z	|I-PROTEIN
receptor	|I-PROTEIN
beta	|I-PROTEIN
(	|O
RZR	|B-PROTEIN
beta	|I-PROTEIN
)	|O
,	|O
an	|O
orphan	|O
receptor	|O
,	|O
is	|O
a	|O
member	|O
of	|O
the	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
RAR	|B-PROTEIN
)	|O
/	|O
thyroid	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
TR	|B-PROTEIN
)	|O
subfamily	|O
of	|O
nuclear	|O
receptors	|O
.	|O

DNA	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
DNA	|B-PROTEIN
-	|I-PROTEIN
PK	|I-PROTEIN
)	|O
consists	|O
of	|O
a	|O
heterodimeric	|O
protein	|O
(	|O
Ku	|B-PROTEIN
)	|O
and	|O
a	|O
large	|O
catalytic	|O
subunit	|O
(	|O
DNA	|B-PROTEIN
-	|I-PROTEIN
PKcs	|I-PROTEIN
)	|O
.	|O

Almost	|O
complete	|O
sequence	|O
identity	|O
was	|O
found	|O
between	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
DXS6673E	|B-PROTEIN
gene	|O
and	|O
two	|O
expressed	|O
sequence	|O
tags	|O
(	|O
ESTs	|O
)	|O
and	|O
between	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
DXS6673E	|B-PROTEIN
gene	|O
and	|O
a	|O
third	|O
EST	|O
.	|O

Sequencing	|O
of	|O
the	|O
16p	|O
11.1	|O
/	|O
Xq28	|O
duplication	|O
breakpoints	|O
has	|O
revealed	|O
the	|O
presence	|O
of	|O
repetitive	|O
immunoglobulin	|B-PROTEIN
-	|O
like	|O
CAGGG	|O
pentamer	|O
sequences	|O
at	|O
or	|O
near	|O
the	|O
paralogy	|O
boundaries	|O
.	|O

However	|O
,	|O
in	|O
a	|O
multivariate	|O
analysis	|O
considering	|O
age	|O
,	|O
gender	|O
,	|O
and	|O
a	|O
previous	|O
history	|O
of	|O
cardiovascular	|O
diseases	|O
,	|O
female	|O
gender	|O
was	|O
not	|O
independently	|O
associated	|O
with	|O
death	|O
.	|O

Moreover	|O
,	|O
following	|O
a	|O
single	|O
intravenous	|O
injection	|O
of	|O
the	|O
bicistronic	|O
vector	|O
complexed	|O
to	|O
cationic	|O
liposomes	|O
into	|O
recipient	|O
mice	|O
,	|O
delivery	|O
of	|O
MDR1	|B-PROTEIN
and	|O
GC	|B-PROTEIN
cDNAs	|O
was	|O
achieved	|O
in	|O
all	|O
the	|O
organs	|O
we	|O
tested	|O
.	|O

The	|O
limits	|O
of	|O
agreement	|O
between	|O
DBS	|O
and	|O
TOF	|O
responses	|O
were	|O
so	|O
wide	|O
that	|O
they	|O
cannot	|O
be	|O
used	|O
interchangeably	|O
.	|O

The	|O
harpin	|B-PROTEIN
-	|O
encoding	|O
hrpZ	|B-PROTEIN
gene	|O
is	|O
located	|O
in	|O
an	|O
operon	|O
that	|O
also	|O
encodes	|O
Hrp	|B-PROTEIN
secretion	|O
pathway	|O
components	|O
and	|O
is	|O
part	|O
of	|O
the	|O
functional	|O
cluster	|O
of	|O
hrp	|B-PROTEIN
genes	|O
carried	|O
on	|O
cosmid	|O
pHIR11	|O
that	|O
enables	|O
saprophytic	|O
bacteria	|O
like	|O
Escherichia	|O
coli	|O
and	|O
Pseudomonas	|O
fluorescens	|O
to	|O
elicit	|O
the	|O
HR	|O
in	|O
tobacco	|O
leaves	|O
.	|O

Despite	|O
the	|O
presence	|O
of	|O
one	|O
additional	|O
ribonucleotide	|B-PROTEIN
reductase	|I-PROTEIN
,	|O
the	|O
nrdAB	|B-PROTEIN
-	|O
encoded	|O
enzyme	|O
is	|O
essential	|O
to	|O
the	|O
aerobic	|O
growth	|O
of	|O
the	|O
cell	|O
because	|O
nrdAB	|B-PROTEIN
-	|O
defective	|O
mutants	|O
of	|O
both	|O
species	|O
are	|O
not	|O
viable	|O
in	|O
the	|O
presence	|O
of	|O
oxygen	|O
.	|O

Altogether	|O
,	|O
the	|O
results	|O
demonstrate	|O
that	|O
the	|O
two	|O
isoforms	|O
elicit	|O
similar	|O
responses	|O
in	|O
vivo	|O
despite	|O
differences	|O
in	|O
their	|O
regulation	|O
.	|O

Motivational	|O
factors	|O
focusing	|O
on	|O
attitudes	|O
,	|O
perceived	|O
susceptibility	|O
to	|O
pregnancy	|O
,	|O
and	|O
normative	|O
factors	|O
were	|O
also	|O
relevant	|O
.	|O

High	|O
-	|O
resolution	|O
structure	|O
of	|O
the	|O
diphtheria	|B-PROTEIN
toxin	|I-PROTEIN
repressor	|I-PROTEIN
complexed	|O
with	|O
cobalt	|O
and	|O
manganese	|O
reveals	|O
an	|O
SH3	|B-PROTEIN
-	|O
like	|O
third	|O
domain	|O
and	|O
suggests	|O
a	|O
possible	|O
role	|O
of	|O
phosphate	|O
as	|O
co	|O
-	|O
corepressor	|O
.	|O

Titration	|O
of	|O
the	|O
human	|O
and	|O
porcine	|O
proteins	|O
with	|O
2	|O
-	|O
nitro	|O
-	|O
5	|O
-	|O
thiosulfabenzoate	|O
indicates	|O
that	|O
membrane	|O
dipeptidase	|B-PROTEIN
additionally	|O
possesses	|O
two	|O
intrachain	|O
disulfide	|O
bonds	|O
.	|O

FEV1	|O
did	|O
not	|O
fall	|O
significantly	|O
in	|O
patients	|O
without	|O
acute	|O
or	|O
chronic	|O
GVHD	|O
and	|O
recovered	|O
earlier	|O
than	|O
in	|O
patients	|O
without	|O
posttransplant	|O
pulmonary	|O
infection	|O
.	|O

Administration	|O
of	|O
adrenaline	|O
resulted	|O
in	|O
a	|O
large	|O
overestimation	|O
of	|O
the	|O
SaO2	|O
in	|O
6	|O
of	|O
the	|O
7	|O
measurements	|O
.	|O

Therapy	|O
with	|O
dietary	|O
modification	|O
and	|O
triglyceride	|O
lowering	|O
drugs	|O
resulted	|O
in	|O
resolution	|O
of	|O
symptoms	|O
and	|O
parotid	|O
swelling	|O
in	|O
one	|O
patient	|O
.	|O

Chernoff	|O
,	|O
submitted	|O
for	|O
publication	|O
)	|O
.	|O

We	|O
have	|O
cloned	|O
a	|O
novel	|O
protein	|O
kinase	|O
,	|O
termed	|O
hematopoietic	|B-PROTEIN
progenitor	|I-PROTEIN
kinase	|I-PROTEIN
1	|I-PROTEIN
(	|O
HPK1	|B-PROTEIN
)	|O
,	|O
that	|O
is	|O
expressed	|O
predominantly	|O
in	|O
hematopoietic	|O
cells	|O
,	|O
including	|O
early	|O
progenitor	|O
cells	|O
.	|O

Human	|O
ESP1	|B-PROTEIN
/	|O
CRP2	|B-PROTEIN
protein	|O
has	|O
two	|O
LIM	|B-PROTEIN
domains	|O
,	|O
and	|O
each	|O
shares	|O
35.1%	|O
and	|O
77	|O
or	|O
79%	|O
identical	|O
residues	|O
with	|O
human	|O
cysteine	|B-PROTEIN
-	|I-PROTEIN
rich	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CRP	|O
)	|O
and	|O
rat	|O
CRIP	|B-PROTEIN
,	|O
respectively	|O
.	|O

The	|O
fragments	|O
are	|O
separated	|O
and	|O
directly	|O
sized	|O
by	|O
agarose	|O
gel	|O
electrophoresis	|O
.	|O

Several	|O
of	|O
the	|O
exon	|O
boundaries	|O
correspond	|O
to	|O
the	|O
boundaries	|O
of	|O
functional	|O
domains	|O
in	|O
the	|O
p55	|B-PROTEIN
protein	|O
.	|O

Linkage	|O
studies	|O
have	|O
shown	|O
locus	|O
heterogeneity	|O
with	|O
one	|O
TSC	|B-PROTEIN
gene	|O
mapped	|O
to	|O
chromosome	|O
9q34	|O
and	|O
a	|O
second	|O
to	|O
16p13.3	|O
.	|O

The	|O
cytogenetic	|O
expression	|O
of	|O
the	|O
folate	|O
sensitive	|O
fragile	|O
site	|O
,	|O
FRAXE	|B-PROTEIN
,	|O
is	|O
due	|O
to	|O
the	|O
expansion	|O
of	|O
a	|O
GCC	|O
repeat	|O
in	|O
proximal	|O
Xq28	|O
of	|O
the	|O
human	|O
X	|O
chromosome	|O
and	|O
is	|O
associated	|O
with	|O
a	|O
mild	|O
form	|O
of	|O
mental	|O
handicap	|O
.	|O

DNA	|O
sequence	|O
analysis	|O
of	|O
a	|O
3213	|O
bp	|O
BamHI	|B-PROTEIN
-	|O
ClaI	|B-PROTEIN
fragment	|O
revealed	|O
that	|O
three	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
were	|O
encoded	|O
in	|O
the	|O
same	|O
orientation	|O
.	|O

The	|O
initial	|O
inpatient	|O
experience	|O
for	|O
individuals	|O
with	|O
HIV	|O
-	|O
related	|O
TB	|O
may	|O
be	|O
pivotal	|O
to	|O
the	|O
acceptance	|O
of	|O
and	|O
participation	|O
in	|O
ongoing	|O
TB	|O
care	|O
.	|O

Tristetraprolin	|B-PROTEIN
(	|O
TTP	|B-PROTEIN
)	|O
is	|O
the	|O
prototype	|O
of	|O
a	|O
group	|O
of	|O
potential	|O
transcription	|O
factors	|O
that	|O
contain	|O
two	|O
or	|O
more	|O
unusual	|O
CCCH	|O
zinc	|O
fingers	|O
.	|O

This	|O
element	|O
,	|O
termed	|O
CREsp	|O
-	|O
a	|O
(	|O
TGACCTCA	|O
)	|O
,	|O
differs	|O
by	|O
one	|O
nucleotide	|O
from	|O
a	|O
palindromic	|O
CRE	|O
(	|O
CREpal	|O
,	|O
TGACGTCA	|O
)	|O
,	|O
which	|O
is	|O
known	|O
to	|O
bind	|O
CREB	|B-PROTEIN
as	|O
a	|O
homodimer	|O
.	|O

Analysis	|O
of	|O
human	|O
genomic	|O
DNA	|O
reveals	|O
an	|O
intronless	|O
sequence	|O
with	|O
strong	|O
homology	|O
to	|O
human	|O
G	|B-PROTEIN
alpha	|I-PROTEIN
q	|I-PROTEIN
cDNA	|O
.	|O

The	|O
complete	|O
exon	|O
-	|O
intron	|O
structure	|O
of	|O
the	|O
156	|O
-	|O
kb	|O
human	|O
gene	|O
NFKB1	|B-PROTEIN
,	|O
which	|O
encodes	|O
the	|O
p105	|B-PROTEIN
and	|O
p50	|B-PROTEIN
proteins	|O
of	|O
transcription	|O
factors	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
and	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
:	|O
implications	|O
for	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|O
mediated	|O
signal	|O
transduction	|O
.	|O

An	|O
inverted	|O
Alu	|B-PROTEIN
repeat	|O
element	|O
,	|O
flanked	|O
by	|O
nonamer	|O
direct	|O
repeats	|O
,	|O
was	|O
identified	|O
within	|O
the	|O
region	|O
-	|O
913	|O
/	|O
-	|O
620	|O
,	|O
relative	|O
to	|O
the	|O
cap	|O
site	|O
.	|O

The	|O
ewes	|O
were	|O
returned	|O
to	|O
normoxia	|O
,	|O
and	|O
monitoring	|O
was	|O
continued	|O
for	|O
1	|O
h	|O
.	|O

Feline	|O
leukemia	|O
viruses	|O
(	|O
FeLVs	|O
)	|O
,	|O
which	|O
are	|O
replication	|O
-	|O
competent	|O
oncoretroviruses	|O
of	|O
the	|O
domestic	|O
cat	|O
species	|O
,	|O
are	|O
contagiously	|O
transmitted	|O
in	|O
natural	|O
environments	|O
.	|O

Comparison	|O
of	|O
the	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
RPO1	|B-PROTEIN
polypeptides	|O
of	|O
IIV6	|O
,	|O
LCDV	|O
,	|O
and	|O
MCV	|O
-	|O
1	|O
with	|O
the	|O
corresponding	|O
prokaryotic	|O
,	|O
eukaryotic	|O
,	|O
and	|O
viral	|O
proteins	|O
revealed	|O
differences	|O
in	|O
amino	|O
acid	|O
similarity	|O
and	|O
phylogenetic	|O
relationships	|O
.	|O

The	|O
RPO1	|B-PROTEIN
of	|O
LCDV	|O
shows	|O
the	|O
highest	|O
similarity	|O
to	|O
the	|O
RPO1	|B-PROTEIN
of	|O
IIV6	|O
and	|O
significant	|O
lower	|O
similarity	|O
to	|O
the	|O
eukaryotic	|O
polymerases	|B-PROTEIN
II	|I-PROTEIN
and	|I-PROTEIN
III	|I-PROTEIN
as	|O
well	|O
as	|O
to	|O
the	|O
archaebacteral	|O
subunit	|O
.	|O

The	|O
use	|O
of	|O
primary	|O
GE	|O
cells	|O
thus	|O
provides	|O
a	|O
convenient	|O
in	|O
vitro	|O
system	|O
for	|O
further	|O
study	|O
of	|O
the	|O
endocrine	|O
,	|O
paracrine	|O
,	|O
and	|O
autocrine	|O
factors	|O
regulating	|O
endometrial	|O
gene	|O
expression	|O
during	|O
pregnancy	|O
.	|O

We	|O
performed	|O
dipole	|O
estimation	|O
of	|O
spikes	|O
and	|O
SEP	|O
components	|O
in	|O
identical	|O
patients	|O
.	|O

Both	|O
verapamil	|O
and	|O
propranolol	|O
can	|O
exhibit	|O
additive	|O
effects	|O
with	|O
adenosine	|O
in	|O
prolonging	|O
AV	|O
nodal	|O
conduction	|O
time	|O
;	|O
however	|O
,	|O
only	|O
verapamil	|O
can	|O
reduce	|O
the	|O
dose	|O
of	|O
adenosine	|O
required	|O
to	|O
produce	|O
AV	|O
nodal	|O
block	|O
.	|O

Proximal	|O
CBD	|O
was	|O
inversely	|O
correlated	|O
with	|O
bone	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
(	|O
r	|O
=	|O
-	|O
0.71	|O
,	|O
p	|O
<	|O
0.01	|O
)	|O
and	|O
intact	|O
PTH	|B-PROTEIN
(	|O
r	|O
=	|O
-	|O
0.59	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

In	|O
addition	|O
,	|O
a	|O
comparison	|O
of	|O
the	|O
hCHLR	|B-PROTEIN
gene	|O
sequences	|O
with	|O
available	|O
databases	|O
indicates	|O
that	|O
a	|O
large	|O
portion	|O
of	|O
these	|O
genes	|O
,	|O
including	|O
exons	|O
encoding	|O
two	|O
functional	|O
domains	|O
of	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
region	|O
of	|O
these	|O
proteins	|O
,	|O
has	|O
been	|O
duplicated	|O
as	|O
part	|O
of	|O
a	|O
larger	|O
human	|O
telomeric	|O
repeat	|O
sequence	|O
found	|O
on	|O
many	|O
human	|O
chromosomes	|O
.	|O

We	|O
show	|O
here	|O
that	|O
the	|O
LIM	|B-PROTEIN
domain	|O
homeobox	|B-PROTEIN
protein	|I-PROTEIN
isl	|O
-	|O
1	|O
activates	|O
the	|O
rat	|O
amylin	|B-PROTEIN
promoter	|O
in	|O
both	|O
fibroblast	|O
and	|O
islet	|O
cell	|O
lines	|O
.	|O

Although	|O
isl	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binds	|O
to	|O
both	|O
the	|O
insulin	|B-PROTEIN
and	|O
amylin	|B-PROTEIN
gene	|O
promoter	|O
elements	|O
in	|O
vitro	|O
,	|O
these	|O
sequences	|O
display	|O
marked	|O
differences	|O
in	|O
their	|O
relative	|O
transcriptional	|O
properties	|O
when	|O
ligated	|O
adjacent	|O
to	|O
a	|O
heterologous	|O
promoter	|O
and	|O
transfected	|O
into	|O
InR1	|O
-	|O
G9	|O
islet	|O
cells	|O
.	|O

It	|O
is	|O
likely	|O
that	|O
other	|O
pathways	|O
involve	|O
alternate	|O
signal	|O
transduction	|O
events	|O
(	|O
e.g.	|O
,	|O
calcium	|O
mobilization	|O
)	|O
and	|O
promoter	|O
response	|O
elements	|O
(	|O
e.g.	|O
,	|O
SRE	|O
)	|O
.	|O

The	|O
CD4	|B-PROTEIN
count	|O
at	|O
which	|O
remission	|O
occurs	|O
may	|O
reflect	|O
severe	|O
immunodeficiency	|O
such	|O
that	|O
risk	|O
for	|O
AIDS	|O
-	|O
related	|O
infection	|O
is	|O
high	|O
.	|O

Although	|O
diagnostic	|O
laparoscopy	|O
is	|O
still	|O
considered	|O
the	|O
standard	|O
reference	|O
in	|O
the	|O
diagnosis	|O
of	|O
ectopic	|O
pregnancy	|O
(	|O
EP	|O
)	|O
,	|O
use	|O
of	|O
high	|O
-	|O
resolution	|O
endovaginal	|O
sonography	|O
,	|O
in	|O
conjunction	|O
with	|O
qualitative	|O
serum	|O
assays	|O
of	|O
the	|O
beta	|O
subunit	|O
of	|O
human	|B-PROTEIN
chorionic	|I-PROTEIN
gonadotropin	|I-PROTEIN
(	|O
beta	|B-PROTEIN
-	|I-PROTEIN
hCG	|I-PROTEIN
)	|O
,	|O
allows	|O
detection	|O
of	|O
earlier	|O
and	|O
smaller	|O
EPs	|O
.	|O

Bifunctionality	|O
of	|O
the	|O
AcMNPV	|B-PROTEIN
homologous	|I-PROTEIN
region	|I-PROTEIN
sequence	|O
(	|O
hr1	|B-PROTEIN
)	|O
:	|O
enhancer	|O
and	|O
ori	|O
functions	|O
have	|O
different	|O
sequence	|O
requirements	|O
.	|O

RVR	|B-PROTEIN
'	|O
loss	|O
of	|O
function	|O
'	|O
studies	|O
by	|O
constitutive	|O
over	|O
-	|O
expression	|O
of	|O
a	|O
dominant	|O
negative	|O
RVR	|B-PROTEIN
delta	|I-PROTEIN
E	|I-PROTEIN
resulted	|O
in	|O
increased	|O
levels	|O
of	|O
p21Cip1	|B-PROTEIN
/	|O
Waf1	|B-PROTEIN
and	|O
myogenin	|B-PROTEIN
mRNAs	|O
after	|O
serum	|O
withdrawal	|O
.	|O

Neither	|O
CES1	|B-PROTEIN
nor	|O
CES4	|B-PROTEIN
is	|O
essential	|O
for	|O
cell	|O
growth	|O
,	|O
and	|O
a	|O
double	|O
deletion	|O
mutant	|O
is	|O
viable	|O
.	|O

These	|O
two	|O
repeat	|O
motifs	|O
are	|O
organized	|O
in	|O
an	|O
extremely	|O
well	|O
-	|O
ordered	|O
pattern	|O
in	|O
each	|O
domain	|O
,	|O
which	|O
suggests	|O
that	|O
SbHRGP3	|B-PROTEIN
belongs	|O
to	|O
a	|O
new	|O
group	|O
of	|O
proteins	|O
having	|O
the	|O
repeat	|O
motifs	|O
of	|O
two	|O
distinct	|O
groups	|O
of	|O
dicot	|O
extensins	|B-PROTEIN
.	|O

Their	|O
use	|O
established	|O
that	|O
the	|O
BrAAP	|O
activity	|O
catalyzed	|O
both	|O
a	|O
postproline	|O
and	|O
a	|O
postglutamate	|O
cleavage	|O
and	|O
therefore	|O
has	|O
a	|O
broader	|O
specificity	|O
than	|O
previously	|O
recognized	|O
.	|O

To	|O
explore	|O
the	|O
functional	|O
significance	|O
of	|O
these	|O
subdomains	|O
in	|O
PRL	|B-PROTEIN
binding	|O
and	|O
signal	|O
transduction	|O
,	|O
deletion	|O
mutants	|O
of	|O
S1	|O
or	|O
/	|O
and	|O
S2	|O
subdomains	|O
were	|O
constructed	|O
.	|O

A	|O
stable	|O
heterologous	|O
cell	|O
line	|O
containing	|O
the	|O
mouse	|O
TRH	|B-PROTEIN
receptor	|I-PROTEIN
was	|O
constructed	|O
by	|O
transfection	|O
of	|O
nonexcitable	|O
293	|O
cells	|O
,	|O
which	|O
lack	|O
L	|O
channel	|O
activity	|O
.	|O

To	|O
understand	|O
further	|O
the	|O
expression	|O
and	|O
regulation	|O
of	|O
the	|O
V1aR	|B-PROTEIN
,	|O
we	|O
now	|O
describe	|O
the	|O
genomic	|O
characteristics	|O
,	|O
tissue	|O
expression	|O
,	|O
chromosomal	|O
localization	|O
,	|O
and	|O
regional	|O
mapping	|O
of	|O
the	|O
human	|O
V1aR	|B-PROTEIN
gene	|O
,	|O
AVPR1A	|B-PROTEIN
.	|O

The	|O
final	|O
predicted	|O
structure	|O
has	|O
an	|O
overall	|O
backbone	|O
deviation	|O
of	|O
0.7	|O
A	|O
from	|O
that	|O
of	|O
ras	|B-PROTEIN
-	|O
p21	|B-PROTEIN
.	|O

Genomic	|O
organization	|O
of	|O
the	|O
human	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
gene	|O
(	|O
CTNNB1	|B-PROTEIN
)	|O
.	|O

Furthermore	|O
,	|O
although	|O
the	|O
regional	|O
distribution	|O
of	|O
lean	|O
tissue	|O
mass	|O
in	|O
the	|O
trunk	|O
and	|O
legs	|O
remained	|O
fairly	|O
constant	|O
at	|O
different	|O
pubertal	|O
stages	|O
,	|O
the	|O
regional	|O
distribution	|O
of	|O
fat	|O
was	|O
altered	|O
significantly	|O
,	|O
becoming	|O
more	|O
central	|O
and	|O
less	|O
peripheral	|O
.	|O

Thus	|O
,	|O
the	|O
predicted	|O
CD30v	|B-PROTEIN
protein	|O
retains	|O
most	|O
of	|O
the	|O
cytoplasmic	|O
region	|O
,	|O
but	|O
lacks	|O
the	|O
extracellular	|O
and	|O
transmembrane	|O
domains	|O
.	|O

Constitutive	|O
phosphorylation	|O
of	|O
the	|O
CD30v	|B-PROTEIN
protein	|O
was	|O
demonstrated	|O
by	|O
in	|O
vitro	|O
labeling	|O
with	|O
[	|O
32P	|O
]	|O
.	|O

17.5%	|O
of	|O
cycles	|O
)	|O
.	|O

We	|O
report	|O
here	|O
the	|O
discovery	|O
of	|O
a	|O
new	|O
actin	|B-PROTEIN
-	|O
related	|O
gene	|O
in	|O
this	|O
organism	|O
,	|O
which	|O
we	|O
have	|O
named	|O
ACT4	|B-PROTEIN
.	|O

Two	|O
of	|O
the	|O
ORFs	|O
are	|O
completely	|O
internal	|O
to	|O
longer	|O
ones	|O
and	|O
a	|O
third	|O
is	|O
partially	|O
embedded	|O
in	|O
G2850	|B-PROTEIN
.	|O

MVR	|O
typing	|O
of	|O
rare	|O
-	|O
length	|O
alleles	|O
indicates	|O
that	|O
they	|O
are	|O
comprised	|O
of	|O
disorganized	|O
sequences	|O
,	|O
although	|O
they	|O
usually	|O
bear	|O
a	|O
resemblance	|O
to	|O
one	|O
of	|O
the	|O
common	|O
alleles	|O
at	|O
the	|O
5'	|O
-	|O
most	|O
end	|O
.	|O

Plasmid	|O
pAL618	|O
contains	|O
the	|O
genetic	|O
determinants	|O
for	|O
H2	|O
uptake	|O
(	|O
hup	|B-PROTEIN
)	|O
from	|O
Rhizobium	|O
leguminosarum	|O
bv	|O
.	|O
viciae	|O
,	|O
including	|O
a	|O
cluster	|O
of	|O
17	|O
genes	|O
named	|O
hupSLCDEFGHIJK	|B-PROTEIN
-	|I-PROTEIN
hypABFCDE	|I-PROTEIN
.	|O

Two	|O
classes	|O
of	|O
inactive	|O
receptors	|O
were	|O
identified	|O
:	|O
one	|O
in	|O
which	|O
both	|O
transcriptional	|O
activation	|O
and	|O
dimerization	|O
were	|O
compromised	|O
and	|O
a	|O
second	|O
in	|O
which	|O
only	|O
transcriptional	|O
activation	|O
was	|O
abolished	|O
.	|O

Here	|O
we	|O
localize	|O
a	|O
transferable	|O
40	|O
-	|O
amino	|O
acid	|O
region	|O
within	|O
the	|O
LBDs	|B-PROTEIN
of	|O
RXR	|B-PROTEIN
,	|O
RAR	|B-PROTEIN
,	|O
TR	|B-PROTEIN
,	|O
and	|O
chicken	|B-PROTEIN
ovalbumin	|I-PROTEIN
upstream	|I-PROTEIN
promoter	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
that	|O
is	|O
critical	|O
for	|O
determining	|O
identity	|O
in	|O
the	|O
heterodimeric	|O
interaction	|O
and	|O
for	|O
high	|O
-	|O
affinity	|O
DNA	|O
binding	|O
.	|O

OKA	|O
and	|O
calyculin	|O
A	|O
do	|O
not	|O
decrease	|O
OCFRE	|B-PROTEIN
DNA	|O
-	|O
protein	|O
interactions	|O
,	|O
suggesting	|O
that	|O
important	|O
protein	|O
-	|O
protein	|O
interactions	|O
are	|O
phosphatase	|O
regulated	|O
.	|O

An	|O
open	|O
-	|O
label	|O
,	|O
placebo	|O
-	|O
controlled	|O
,	|O
randomized	|O
,	|O
two	|O
-	|O
way	|O
crossover	|O
study	|O
was	|O
performed	|O
in	|O
12	|O
healthy	|O
volunteers	|O
(	|O
between	|O
20	|O
and	|O
44	|O
years	|O
of	|O
age	|O
)	|O
to	|O
assess	|O
the	|O
effect	|O
of	|O
orlistat	|O
,	|O
a	|O
gastrointestinal	|O
lipase	|B-PROTEIN
inhibitor	|O
that	|O
reduces	|O
dietary	|O
fat	|O
absorption	|O
and	|O
is	|O
being	|O
developed	|O
for	|O
weight	|O
control	|O
in	|O
obesity	|O
,	|O
on	|O
the	|O
absorption	|O
of	|O
vitamins	|O
A	|O
and	|O
E.	|O

Tilmicosin	|O
is	|O
a	|O
novel	|O
macrolide	|O
antibiotic	|O
developed	|O
for	|O
exclusive	|O
use	|O
in	|O
veterinary	|O
medicine	|O
.	|O

Effect	|O
of	|O
nitrous	|O
oxide	|O
(	|O
N2O	|O
)	|O
on	|O
the	|O
somatosympathetic	|O
A	|O
-	|O
and	|O
C	|O
-	|O
reflexes	|O
was	|O
investigated	|O
using	|O
artificially	|O
ventilated	|O
rats	|O
anesthetized	|O
with	|O
alpha	|O
-	|O
chloralose	|O
and	|O
urethane	|O
.	|O

Restriction	|O
enzyme	|O
mapping	|O
and	|O
Southern	|O
analysis	|O
indicated	|O
further	|O
that	|O
the	|O
human	|O
MZF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
is	|O
a	|O
single	|O
-	|O
copy	|O
gene	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
Swi4	|B-PROTEIN
and	|O
Swi6	|B-PROTEIN
cell	|O
viability	|O
is	|O
lost	|O
,	|O
but	|O
can	|O
be	|O
regained	|O
by	|O
ectopic	|O
expression	|O
of	|O
the	|O
G1	|B-PROTEIN
cyclin	|I-PROTEIN
encoding	|O
genes	|O
,	|O
CLN1	|B-PROTEIN
or	|O
CLN2	|B-PROTEIN
.	|O

The	|O
detection	|O
ratio	|O
peaked	|O
at	|O
ages	|O
30	|O
to	|O
34	|O
and	|O
decreased	|O
heavily	|O
during	|O
the	|O
next	|O
15	|O
years	|O
of	|O
age	|O
.	|O

How	|O
many	|O
embryos	|O
to	|O
transfer	|O
in	|O
patients	|O
undergoing	|O
IVF	|O
?	|O

IMPLICATIONS	|O
:	|O
Given	|O
the	|O
small	|O
size	|O
of	|O
this	|O
study	|O
and	|O
the	|O
inconsistency	|O
of	|O
results	|O
among	|O
the	|O
few	|O
prospective	|O
studies	|O
of	|O
ovarian	|O
cancer	|O
conducted	|O
to	|O
test	|O
these	|O
associations	|O
,	|O
replications	|O
of	|O
these	|O
findings	|O
are	|O
highly	|O
desirable	|O
.	|O

The	|O
nonconsensus	|O
TATA	|O
box	|O
in	|O
promoter	|O
B	|O
plays	|O
a	|O
more	|O
important	|O
role	|O
in	|O
promoter	|O
activity	|O
than	|O
the	|O
TATA	|O
box	|O
in	|O
promoter	|O
A.	|O

These	|O
properties	|O
indicate	|O
that	|O
Gle1	|B-PROTEIN
is	|O
an	|O
RNA	|O
-	|O
export	|O
factor	|O
and	|O
that	|O
Rev	|B-PROTEIN
may	|O
mediate	|O
viral	|O
RNA	|O
export	|O
by	|O
mimicking	|O
the	|O
function	|O
of	|O
Gle1	|B-PROTEIN
.	|O

Demispan	|O
is	|O
a	|O
reliable	|O
and	|O
reproducible	|O
measure	|O
of	|O
stature	|O
in	|O
the	|O
elderly	|O
.	|O

Two	|O
techniques	|O
based	|O
on	|O
assay	|O
coefficients	|O
of	|O
variation	|O
were	|O
employed	|O
to	|O
characterize	|O
a	|O
normal	|O
circadian	|O
pattern	|O
of	|O
cortisol	|O
.	|O

We	|O
have	|O
performed	|O
toeprinting	|O
analyses	|O
on	|O
repA	|B-PROTEIN
mRNA	|O
of	|O
plasmid	|O
R1	|O
,	|O
both	|O
free	|O
and	|O
in	|O
duplex	|O
with	|O
the	|O
antisense	|O
RNA	|O
,	|O
CopA	|B-PROTEIN
.	|O

Previous	|O
work	|O
showed	|O
that	|O
repA	|B-PROTEIN
(	|O
initiator	|O
protein	|O
)	|O
expression	|O
requires	|O
tap	|B-PROTEIN
(	|O
leader	|O
peptide	|O
)	|O
translation	|O
.	|O

A	|O
system	|O
is	|O
described	|O
in	|O
which	|O
the	|O
volume	|O
flow	|O
rate	|O
of	|O
blood	|O
in	|O
a	|O
vessel	|O
is	|O
determined	|O
using	|O
transverse	|O
colour	|O
Doppler	|O
ultrasound	|O
imaging	|O
.	|O

The	|O
enzyme	|O
activities	|O
studied	|O
are	|O
important	|O
elements	|O
in	|O
the	|O
pathophysiology	|O
of	|O
dental	|O
caries	|O
and	|O
may	|O
even	|O
be	|O
addressed	|O
as	|O
virulence	|O
factors	|O
.	|O

Tonsillectomy	|O
is	|O
an	|O
effective	|O
means	|O
of	|O
prophylaxis	|O
for	|O
upper	|O
respiratory	|O
infection	|O
in	|O
habitual	|O
angina	|O
patients	|O
.	|O

In	|O
lean	|O
mice	|O
,	|O
the	|O
fat	|O
/	|O
water	|O
intensity	|O
ratio	|O
was	|O
about	|O
1	|O
:	|O
4	|O
,	|O
about	|O
half	|O
that	|O
in	|O
normal	|O
mice	|O
.	|O

Pharmacokinetic	|O
parameters	|O
were	|O
similar	|O
to	|O
values	|O
given	|O
in	|O
the	|O
literature	|O
for	|O
intravenous	|O
(	|O
IV	|O
)	|O
or	|O
intraarterial	|O
(	|O
IA	|O
)	|O
bolus	|O
MMC	|O
injections	|O
(	|O
Tmax	|O
=	|O
7.0	|O
min	|O
following	|O
the	|O
beginning	|O
of	|O
MMC	|O
infusion	|O
,	|O
Vss	|O
=	|O
0.57	|O
1	|O
/	|O
kg	|O
,	|O
C1	|O
=	|O
8.9	|O
ml	|O
/	|O
min.k	|O
g	|O
,	|O
T1/2	|O
alpha	|O
=	|O
8.3	|O
min	|O
,	|O
T1/2	|O
beta	|O
=	|O
58.6	|O
min	|O
)	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
identified	|O
four	|O
distinct	|O
E2F	|B-PROTEIN
complexes	|O
present	|O
in	|O
aged	|O
and	|O
senescent	|O
normal	|O
,	|O
human	|O
diploid	|O
fibroblasts	|O
.	|O

This	|O
paper	|O
gives	|O
an	|O
overview	|O
of	|O
the	|O
global	|O
pattern	|O
of	|O
casualties	|O
in	|O
earthquakes	|O
which	|O
occurred	|O
during	|O
the	|O
30	|O
-	|O
month	|O
period	|O
from	|O
1	|O
September	|O
1993	|O
to	|O
29	|O
February	|O
1996	|O
.	|O

If	|O
we	|O
apply	|O
the	|O
finding	|O
of	|O
non	|O
-	|O
visualization	|O
of	|O
the	|O
GB	|O
at	|O
4	|O
h	|O
post	|O
injection	|O
as	|O
the	|O
criterion	|O
for	|O
the	|O
diagnosis	|O
of	|O
AC	|O
,	|O
the	|O
diagnostic	|O
accuracy	|O
was	|O
only	|O
40.7%	|O
(	|O
11/27	|O
)	|O
.	|O

These	|O
results	|O
were	|O
corroborated	|O
in	|O
a	|O
subsequent	|O
study	|O
in	|O
which	|O
30	|O
hypogonadal	|O
men	|O
were	|O
supplemented	|O
with	|O
SLT	|O
5	|O
mg	|O
three	|O
times	|O
daily	|O
for	|O
6	|O
months	|O
.	|O

Alternative	|O
processing	|O
of	|O
the	|O
tryptophanyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
mRNA	|O
from	|O
interferon	|B-PROTEIN
-	|O
treated	|O
human	|O
cells	|O
.	|O

Evidence	|O
for	|O
the	|O
promoting	|O
role	|O
of	|O
the	|O
intra	|O
-	|O
uterine	|O
kinin	|B-PROTEIN
release	|O
in	|O
the	|O
development	|O
of	|O
late	|O
hypertonic	|O
saline	|O
-	|O
induced	|O
abortion	|O
.	|O

This	|O
GAP	|B-PROTEIN
activity	|O
was	|O
observed	|O
in	|O
3T3	|O
-	|O
L1	|O
adipocyte	|O
lysates	|O
,	|O
and	|O
was	|O
able	|O
to	|O
accelerate	|O
the	|O
hydrolysis	|O
of	|O
the	|O
[	|O
alpha	|O
-	|O
32P	|O
]	|O
GTP	|O
bound	|O
to	|O
GST	|B-PROTEIN
-	|O
Rab4	|B-PROTEIN
into	|O
[	|O
alpha	|O
-	|O
32P	|O
]	|O
GDP	|O
.	|O

CONCLUSION	|O
:	|O
During	|O
chronic	|O
treatment	|O
,	|O
the	|O
haemodynamic	|O
response	|O
to	|O
oral	|O
cilazapril	|O
was	|O
attenuated	|O
,	|O
indicating	|O
that	|O
continued	|O
clinical	|O
improvement	|O
in	|O
patients	|O
with	|O
CHF	|O
on	|O
CLZ	|O
is	|O
independent	|O
of	|O
to	|O
its	|O
acute	|O
haemodynamic	|O
effects	|O
.	|O

We	|O
conclude	|O
that	|O
,	|O
in	|O
AIDS	|O
patients	|O
with	|O
cryptococcosis	|O
,	|O
tolerance	|O
to	|O
ILd	|O
-	|O
AmB	|O
was	|O
acceptable	|O
when	|O
the	|O
daily	|O
dosage	|O
did	|O
not	|O
exceed	|O
1	|O
mg	|O
/	|O
kg	|O
,	|O
but	|O
the	|O
higher	|O
1.5	|O
mg	|O
/	|O
kg	|O
daily	|O
dosage	|O
was	|O
associated	|O
with	|O
an	|O
unacceptable	|O
rate	|O
of	|O
nephrotoxicity	|O
.	|O

Moreover	|O
,	|O
the	|O
second	|O
RCC1	|B-PROTEIN
-	|O
like	|O
motif	|O
located	|O
at	|O
the	|O
amino	|O
-	|O
terminus	|O
of	|O
p619	|B-PROTEIN
stimulates	|O
guanine	|O
nucleotide	|O
exchange	|O
on	|O
ARF1	|B-PROTEIN
and	|O
on	|O
members	|O
of	|O
the	|O
related	|O
Rab	|B-PROTEIN
proteins	|O
,	|O
but	|O
not	|O
on	|O
other	|O
small	|O
GTP	|B-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
such	|O
as	|O
Ran	|B-PROTEIN
or	|O
R	|B-PROTEIN
-	|I-PROTEIN
Ras2	|I-PROTEIN
/	|O
TC21	|B-PROTEIN
.	|O

The	|O
reconstituted	|O
RNA	|B-PROTEIN
polymerases	|I-PROTEIN
containing	|O
the	|O
mutant	|O
alpha	|O
subunits	|O
were	|O
examined	|O
for	|O
their	|O
response	|O
to	|O
transcription	|O
activation	|O
by	|O
cAMP	|O
-	|O
CRP	|B-PROTEIN
and	|O
the	|O
rrnBP1	|B-PROTEIN
UP	|O
element	|O
.	|O

Transcription	|O
factor	|O
recognition	|O
surface	|O
on	|O
the	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|O
subunit	|O
is	|O
involved	|O
in	|O
contact	|O
with	|O
the	|O
DNA	|O
enhancer	|O
element	|O
.	|O

Consistent	|O
with	|O
this	|O
similarity	|O
,	|O
the	|O
cdc28	|B-PROTEIN
-	|O
P8	|O
mutant	|O
accumulates	|O
unspliced	|O
precursors	|O
at	|O
the	|O
restrictive	|O
temperature	|O
.	|O

A	|O
decrease	|O
of	|O
erythrocyte	|O
Mn	|O
with	|O
age	|O
,	|O
expressed	|O
in	|O
nmol	|O
/	|O
L	|O
,	|O
was	|O
noted	|O
(	|O
p	|O
<	|O
0.02	|O
)	|O
.	|O

Cloning	|O
and	|O
sequence	|O
analyses	|O
revealed	|O
a	|O
second	|O
cDNA	|O
with	|O
a	|O
95	|O
-	|O
nt	|O
deletion	|O
in	|O
the	|O
region	|O
coding	|O
for	|O
the	|O
putative	|O
second	|O
intracellular	|O
loop	|O
and	|O
the	|O
fourth	|O
transmembrane	|O
domain	|O
of	|O
the	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT2C	|I-PROTEIN
-	|I-PROTEIN
R.	|I-PROTEIN

Expression	|O
of	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
gene	|O
in	|O
normal	|O
human	|O
diploid	|O
cells	|O
is	|O
both	|O
cell	|O
cycle	|O
-	|O
and	|O
age	|O
-	|O
dependent	|O
and	|O
appears	|O
to	|O
be	|O
transcriptionally	|O
regulated	|O
.	|O

The	|O
minimum	|O
inhibitory	|O
concentrations	|O
(	|O
MICs	|O
)	|O
of	|O
ketoconazole	|O
,	|O
miconazole	|O
,	|O
itraconazole	|O
,	|O
fluconazole	|O
,	|O
and	|O
amphotericin	|O
B	|O
were	|O
significantly	|O
influenced	|O
by	|O
the	|O
inoculum	|O
size	|O
,	|O
regardless	|O
of	|O
the	|O
techniques	|O
used	|O
.	|O

These	|O
bacteria	|O
produce	|O
and	|O
export	|O
proteins	|O
capable	|O
of	|O
specific	|O
interactions	|O
with	|O
key	|O
mammalian	|O
cell	|O
regulatory	|O
molecules	|O
in	|O
order	|O
to	|O
derail	|O
the	|O
normal	|O
functions	|O
of	|O
the	|O
cells	|O
.	|O

The	|O
elevations	|O
achieved	|O
by	|O
LDEE	|O
given	|O
s.c	|O
.	|O
were	|O
higher	|O
than	|O
those	|O
achieved	|O
after	|O
i.p	|O
.	|O
administration	|O
and	|O
lasted	|O
for	|O
longer	|O
periods	|O
.	|O

Thus	|O
,	|O
although	|O
p28	|B-PROTEIN
may	|O
play	|O
only	|O
a	|O
limited	|O
role	|O
during	|O
the	|O
early	|O
embryonic	|O
cleavages	|O
,	|O
it	|O
may	|O
function	|O
later	|O
in	|O
development	|O
to	|O
establish	|O
a	|O
somatic	|O
type	|O
of	|O
cell	|O
cycle	|O
.	|O

The	|O
main	|O
aim	|O
of	|O
the	|O
contribution	|O
,	|O
which	|O
opens	|O
an	|O
arena	|O
for	|O
discussion	|O
on	|O
the	|O
Rivista	|O
dell	|O
'	|O
Infermiere	|O
is	|O
to	|O
critically	|O
appraise	|O
published	|O
research	|O
works	|O
focusing	|O
both	|O
on	|O
strengths	|O
and	|O
novelty	|O
and	|O
weaknesses	|O
in	|O
the	|O
hypothesis	|O
formulation	|O
,	|O
methods	|O
and	|O
instruments	|O
used	|O
,	|O
discussion	|O
of	|O
results	|O
.	|O

Moreover	|O
,	|O
it	|O
also	|O
discusses	|O
the	|O
effects	|O
of	|O
antihypertensive	|O
drugs	|O
currently	|O
regarded	|O
as	|O
first	|O
-	|O
choice	|O
agents	|O
,	|O
i.e.	|O
calcium	|O
antagonists	|O
and	|O
the	|O
angiotensin	|B-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
inhibitors	|O
,	|O
on	|O
intrarenal	|O
hemodynamics	|O
.	|O

Many	|O
human	|O
viruses	|O
are	|O
able	|O
to	|O
develop	|O
suitable	|O
strategies	|O
for	|O
modifying	|O
apoptosis	|O
in	|O
virus	|O
-	|O
infected	|O
cells	|O
and	|O
in	|O
virus	|O
-	|O
primed	|O
T	|O
cells	|O
.	|O

It	|O
is	|O
suggested	|O
that	|O
the	|O
observed	|O
clinical	|O
phenomena	|O
in	|O
response	|O
to	|O
morphine	|O
can	|O
be	|O
explained	|O
by	|O
differences	|O
in	|O
expression	|O
and	|O
sensitivity	|O
of	|O
some	|O
opioid	|B-PROTEIN
receptor	|I-PROTEIN
subtypes	|O
in	|O
migraine	|O
.	|O

Previous	|O
studies	|O
demonstrated	|O
that	|O
the	|O
flavin	|B-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
monooxygenases	|I-PROTEIN
(	|O
FMO	|B-PROTEIN
)	|O
are	|O
expressed	|O
in	|O
a	|O
tissue	|O
-	|O
specific	|O
manner	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
observations	|O
indicate	|O
that	|O
the	|O
C	|O
-	|O
terminal	|O
24	|O
amino	|O
acids	|O
are	|O
sufficient	|O
for	|O
NodO	|B-PROTEIN
secretion	|O
although	|O
the	|O
region	|O
adjacent	|O
to	|O
this	|O
domain	|O
appears	|O
to	|O
affect	|O
secretion	|O
efficiency	|O
.	|O

Thus	|O
,	|O
despite	|O
the	|O
potential	|O
for	|O
common	|O
regulatory	|O
mechanisms	|O
,	|O
the	|O
available	|O
evidence	|O
indicates	|O
that	|O
the	|O
Mtx	|B-PROTEIN
minimal	|O
promoter	|O
does	|O
not	|O
significantly	|O
affect	|O
Thbs3	|B-PROTEIN
gene	|O
expression	|O
.	|O

MSSP	|B-PROTEIN
proteins	|O
have	|O
been	|O
identified	|O
by	|O
their	|O
binding	|O
to	|O
an	|O
upstream	|O
element	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
.	|O

Gene	|B-PROTEIN
1	|I-PROTEIN
has	|O
been	|O
completely	|O
sequenced	|O
.	|O

B	|B-PROTEIN
cell	|I-PROTEIN
antigen	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
BCR	|B-PROTEIN
)	|O
-	|O
induced	|O
apoptosis	|O
in	|O
the	|O
WEHI	|O
-	|O
231	|O
B	|O
lymphoma	|O
cell	|O
line	|O
can	|O
be	|O
prevented	|O
by	|O
engaging	|O
CD40	|B-PROTEIN
.	|O

Both	|O
alleles	|O
are	|O
functionally	|O
expressed	|O
and	|O
are	|O
distributed	|O
within	|O
CD4+	|B-PROTEIN
/	|O
CD8+	|B-PROTEIN
T	|O
cell	|O
subsets	|O
.	|O

The	|O
model	|O
also	|O
predicts	|O
that	|O
blood	|O
flow	|O
shunt	|O
fraction	|O
(	|O
Qs	|O
/	|O
QT	|O
)	|O
is	|O
directly	|O
related	|O
to	|O
the	|O
oxygen	|O
sine	|O
-	|O
wave	|O
amplitude	|O
perturbations	|O
transmitted	|O
to	|O
end	|O
-	|O
expired	|O
air	|O
and	|O
arterial	|O
and	|O
mixed	|O
-	|O
venous	|O
blood	|O
through	|O
two	|O
simple	|O
equations	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
LvUSF2	|B-PROTEIN
is	|O
nearly	|O
identical	|O
to	|O
LvUSF1	|B-PROTEIN
except	|O
at	|O
the	|O
amino	|O
end	|O
,	|O
where	|O
they	|O
are	|O
sharply	|O
divergent	|O
.	|O

ECM	|O
disruption	|O
in	|O
Lytechinus	|O
embryos	|O
caused	|O
a	|O
relative	|O
drop	|O
in	|O
USF	|B-PROTEIN
RNA	|O
accumulation	|O
levels	|O
to	|O
approximately	|O
60%	|O
of	|O
control	|O
embryos	|O
,	|O
while	|O
LpS1	|B-PROTEIN
RNA	|O
accumulation	|O
levels	|O
dropped	|O
to	|O
less	|O
than	|O
5%	|O
.	|O

Five	|O
of	|O
these	|O
eight	|O
patients	|O
in	|O
group	|O
II	|O
also	|O
received	|O
8	|O
-	|O
in	|O
-	|O
1	|O
chemotherapy	|O
.	|O

Sixty	|O
days	|O
after	|O
the	|O
intervention	|O
,	|O
twitch	|O
and	|O
tetanic	|O
tensions	|O
remained	|O
dependent	|O
upon	|O
the	|O
extracellular	|O
Ca2+	|O
concentration	|O
(	|O
[	|O
Ca	|O
]	|O
o	|O
)	|O
both	|O
in	|O
groups	|O
A	|O
and	|O
B.	|O

Discrimination	|O
between	|O
HIV	|O
-	|O
1	|O
and	|O
HIV	|O
-	|O
2	|O
showed	|O
evidence	|O
for	|O
the	|O
presence	|O
of	|O
HIV	|O
-	|O
1	|O
only	|O
.	|O

However	|O
,	|O
an	|O
intrinsic	|O
DNA	|O
-	|O
binding	|O
subunit	|O
for	|O
HiNF	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
was	|O
not	|O
identified	|O
.	|O

The	|O
HiNF	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
(	|O
CDP	|B-PROTEIN
/	|O
cut	|B-PROTEIN
)	|O
complex	|O
with	|O
the	|O
H4	|B-PROTEIN
promoter	|O
is	|O
immunoreactive	|O
with	|O
antibodies	|O
against	|O
CDP	|B-PROTEIN
/	|O
cut	|B-PROTEIN
and	|O
pRB	|B-PROTEIN
but	|O
not	|O
p107	|B-PROTEIN
,	|O
whereas	|O
the	|O
CDP	|B-PROTEIN
/	|O
cut	|B-PROTEIN
complex	|O
with	|O
a	|O
nonhistone	|O
promoter	|O
(	|O
gp91	|B-PROTEIN
-	|O
phox	|B-PROTEIN
)	|O
reacts	|O
only	|O
with	|O
CDP	|B-PROTEIN
and	|O
p107	|B-PROTEIN
antibodies	|O
.	|O

Recently	|O
,	|O
a	|O
distantly	|O
related	|O
UmuC	|B-PROTEIN
-	|O
homolog	|O
,	|O
DinB	|B-PROTEIN
,	|O
has	|O
also	|O
been	|O
identified	|O
in	|O
E.	|O
coli	|O
.	|O

To	|O
study	|O
the	|O
regulation	|O
of	|O
mdr2	|B-PROTEIN
expression	|O
,	|O
the	|O
promoter	|O
of	|O
the	|O
mdr2	|B-PROTEIN
gene	|O
has	|O
been	|O
isolated	|O
from	|O
a	|O
murine	|O
vinblastine	|O
-	|O
resistant	|O
cell	|O
line	|O
,	|O
J7.V	|O
2-1	|O
,	|O
and	|O
characterized	|O
.	|O

The	|O
amplification	|O
was	|O
achieved	|O
using	|O
two	|O
primers	|O
which	|O
correspond	|O
to	|O
TRH	|B-PROTEIN
progenitor	|O
sequence	|O
(	|O
Lys	|O
/	|O
Arg	|O
-	|O
Arg	|O
-	|O
Gln	|O
-	|O
His	|O
-	|O
Pro	|O
-	|O
Gly	|O
-	|O
Lys	|O
/	|O
Arg	|O
-	|O
Arg	|O
)	|O
.	|O

The	|O
intranodal	|O
mesothelial	|O
cells	|O
occupied	|O
the	|O
sinusoids	|O
of	|O
the	|O
lymph	|O
nodes	|O
and	|O
were	|O
initially	|O
suspected	|O
of	|O
being	|O
metastatic	|O
from	|O
the	|O
ovarian	|O
tumor	|O
in	|O
each	|O
case	|O
.	|O

The	|O
gene	|O
ccpA	|B-PROTEIN
encoding	|O
the	|O
catabolite	|O
control	|O
protein	|O
CcpA	|B-PROTEIN
of	|O
Staphylococcus	|O
xylosus	|O
has	|O
been	|O
cloned	|O
and	|O
characterized	|O
.	|O

An	|O
InlC	|B-PROTEIN
deletion	|O
mutant	|O
shows	|O
reduced	|O
virulence	|O
when	|O
tested	|O
in	|O
an	|O
intravenous	|O
mouse	|O
model	|O
,	|O
but	|O
intracellular	|O
replication	|O
of	|O
the	|O
mutant	|O
in	|O
Caco	|O
-	|O
2	|O
and	|O
J774	|O
cells	|O
appears	|O
to	|O
be	|O
comparable	|O
with	|O
that	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
strain	|O
.	|O

Thus	|O
,	|O
the	|O
N	|B-PROTEIN
-	|O
Nus	|B-PROTEIN
complex	|O
may	|O
be	|O
affected	|O
through	|O
contacts	|O
with	|O
the	|O
CTD	|O
of	|O
the	|O
alpha	|O
subunit	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
,	|O
as	|O
is	|O
a	|O
group	|O
of	|O
regulatory	|O
proteins	|O
that	|O
influences	|O
initiation	|O
of	|O
transcription	|O
.	|O

Administration	|O
of	|O
RIFA	|O
at	|O
200	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
in	|O
combination	|O
with	|O
ATO	|O
at	|O
100	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
resulted	|O
in	|O
a	|O
marked	|O
prolongation	|O
of	|O
survival	|O
compared	|O
with	|O
that	|O
for	|O
mice	|O
that	|O
received	|O
ATO	|O
or	|O
RIFA	|O
alone	|O
.	|O

Eight	|O
-	|O
four	|O
ACOAs	|O
were	|O
tested	|O
in	|O
order	|O
to	|O
examine	|O
the	|O
fit	|O
of	|O
the	|O
model	|O
to	|O
the	|O
data	|O
by	|O
path	|O
analysis	|O
with	|O
LISREL	|O
VII	|O
.	|O

Two	|O
of	|O
seven	|O
initiation	|O
sites	|O
were	|O
flanked	|O
by	|O
a	|O
sequence	|O
homologous	|O
to	|O
the	|O
consensus	|O
promoter	|O
motif	|O
that	|O
includes	|O
the	|O
CRTA	|O
motif	|O
(	|O
where	|O
R	|O
is	|O
A	|O
or	|O
G	|O
)	|O
of	|O
the	|O
rice	|O
mitochondrion	|O
.	|O

Selection	|O
using	|O
SC	|O
EPD	|O
was	|O
more	|O
effective	|O
than	|O
phenotypic	|O
selection	|O
in	|O
reducing	|O
age	|O
at	|O
puberty	|O
in	|O
daughters	|O
.	|O

Using	|O
anchored	|O
PCR	|O
,	|O
a	|O
VL	|B-PROTEIN
element	|O
rearranged	|O
to	|O
CL2	|B-PROTEIN
was	|O
isolated	|O
.	|O

Sodium	|O
polystyrene	|O
sulfonate	|O
treatment	|O
for	|O
lithium	|O
toxicity	|O
:	|O
effects	|O
on	|O
serum	|O
potassium	|O
concentrations	|O
.	|O

The	|O
mammalian	|O
homeodomain	|B-PROTEIN
proteins	|O
encoded	|O
by	|O
Hox	|B-PROTEIN
genes	|O
play	|O
an	|O
important	|O
role	|O
in	|O
embryonic	|O
development	|O
by	|O
providing	|O
positional	|O
queues	|O
which	|O
define	|O
developmental	|O
identities	|O
along	|O
the	|O
anteroposterior	|O
axis	|O
of	|O
developing	|O
organisms	|O
.	|O

Interferon	|B-PROTEIN
stimulated	|I-PROTEIN
gene	|I-PROTEIN
factor	|I-PROTEIN
3	|I-PROTEIN
(	|O
ISGF3	|B-PROTEIN
)	|O
is	|O
a	|O
trimeric	|O
transcription	|O
factor	|O
activated	|O
on	|O
treatment	|O
of	|O
cells	|O
with	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
and	|I-PROTEIN
beta	|I-PROTEIN
(	|O
type	|B-PROTEIN
I	|I-PROTEIN
IFNs	|I-PROTEIN
)	|O
.	|O

The	|O
TYAC	|O
/	|O
P1	|O
resource	|O
,	|O
derivative	|O
STSs	|O
,	|O
and	|O
polymorphisms	|O
constitute	|O
an	|O
enabling	|O
resource	|O
to	|O
further	|O
studies	|O
of	|O
telomere	|O
structure	|O
and	|O
function	|O
and	|O
a	|O
means	|O
for	|O
physical	|O
and	|O
genetic	|O
map	|O
integration	|O
and	|O
closure	|O
.	|O

Confirmatory	|O
statistics	|O
included	|O
item	|O
2	|O
of	|O
the	|O
Clinical	|O
Global	|O
Impression	|O
(	|O
CGI	|O
)	|O
,	|O
the	|O
total	|O
score	|O
of	|O
the	|O
Sandoz	|O
Clinical	|O
Assessment	|O
Geriatric	|O
(	|O
SCAG	|O
)	|O
scale	|O
,	|O
the	|O
subscale	|O
'	|O
need	|O
for	|O
help	|O
'	|O
of	|O
the	|O
nurse	|O
's	|O
rating	|O
of	|O
geriatric	|O
patients	|O
(	|O
Beurteilungsskala	|O
fur	|O
geriatrische	|O
Patienten	|O
;	|O
BGP	|O
)	|O
and	|O
the	|O
total	|O
score	|O
of	|O
the	|O
Short	|O
Cognitive	|O
Performance	|O
Test	|O
(	|O
Syndrom	|O
-	|O
Kurztest	|O
;	|O
SKT	|O
)	|O
.	|O

Three	|O
mutants	|O
were	|O
isolated	|O
from	|O
the	|O
widely	|O
used	|O
strain	|O
,	|O
PAO1	|O
.	|O

As	|O
extensively	|O
examined	|O
with	|O
the	|O
myogenin	|B-PROTEIN
promoter	|O
,	|O
presence	|O
of	|O
one	|O
or	|O
multiple	|O
copies	|O
of	|O
Me	|B-PROTEIN
in	|O
the	|O
vectors	|O
elevated	|O
the	|O
expression	|O
activity	|O
in	|O
myotubes	|O
by	|O
4.5	|O
-	|O
to	|O
19	|O
-	|O
fold	|O
over	|O
those	|O
without	|O
Me	|B-PROTEIN
,	|O
but	|O
not	|O
significantly	|O
in	|O
myoblasts	|O
.	|O

We	|O
conclude	|O
that	|O
common	|O
upstream	|O
signals	|O
cause	|O
activation	|O
of	|O
Ras	|B-PROTEIN
and	|O
TC21	|B-PROTEIN
,	|O
but	|O
activated	|O
TC21	|B-PROTEIN
controls	|O
cell	|O
growth	|O
via	|O
distinct	|O
Raf	|B-PROTEIN
-	|O
independent	|O
downstream	|O
signaling	|O
pathways	|O
.	|O

Fission	|O
yeast	|O
mal2+	|B-PROTEIN
is	|O
required	|O
for	|O
chromosome	|O
segregation	|O
.	|O

Selection	|O
was	|O
based	|O
on	|O
expression	|O
of	|O
an	|O
integrated	|O
DNA	|O
fragment	|O
containing	|O
the	|O
con	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
promoter	|O
-	|O
regulatory	|O
region	|O
followed	|O
by	|O
the	|O
initial	|O
segment	|O
of	|O
the	|O
con	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
open	|O
reading	|O
frame	|O
fused	|O
in	|O
frame	|O
with	|O
the	|O
bacterial	|O
hygromycin	|B-PROTEIN
B	|I-PROTEIN
phosphotransferase	|I-PROTEIN
structural	|O
gene	|O
(	|O
con10	|B-PROTEIN
'	|I-PROTEIN
-	|I-PROTEIN
'	|I-PROTEIN
hph	|I-PROTEIN
)	|O
.	|O

Mutations	|O
at	|O
two	|O
neighboring	|O
sites	|O
,	|O
serine	|O
242	|O
and	|O
threonine	|O
255	|O
,	|O
exacerbated	|O
the	|O
effect	|O
.	|O

IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
acts	|O
as	|O
a	|O
transcriptional	|O
activator	|O
,	|O
while	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
acts	|O
as	|O
a	|O
repressor	|O
.	|O

In	|O
contrast	|O
,	|O
cotransfection	|O
of	|O
TFIIB	|B-PROTEIN
and	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
into	|O
NIH	|O
3T3	|O
cells	|O
resulted	|O
in	|O
a	|O
dose	|O
-	|O
dependent	|O
repression	|O
of	|O
promoter	|O
activation	|O
which	|O
occurred	|O
in	|O
a	|O
TATA	|O
-	|O
dependent	|O
manner	|O
.	|O

The	|O
requirement	|O
of	|O
Tyr	|O
-	|O
19	|O
dephosphorylation	|O
for	|O
spindle	|O
assembly	|O
is	|O
also	|O
observed	|O
under	|O
conditions	|O
in	|O
which	|O
spindle	|O
formation	|O
is	|O
independent	|O
of	|O
mitosis	|O
,	|O
suggesting	|O
that	|O
the	|O
involvement	|O
of	|O
Cdc28	|B-PROTEIN
/	|O
Clb	|B-PROTEIN
kinase	|O
in	|O
SPB	|O
separation	|O
is	|O
direct	|O
.	|O

A	|O
subset	|O
of	|O
these	|O
DMP1	|B-PROTEIN
recognition	|O
sequences	|O
containing	|O
a	|O
GGA	|O
trinucleotide	|O
core	|O
can	|O
also	|O
function	|O
as	|O
Ets	|B-PROTEIN
-	|O
responsive	|O
elements	|O
.	|O

In	|O
both	|O
settings	|O
,	|O
it	|O
can	|O
be	|O
phosphorylated	|O
by	|O
cyclin	|B-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
suggesting	|O
that	|O
its	|O
transcriptional	|O
activity	|O
may	|O
normally	|O
be	|O
regulated	|O
through	|O
such	|O
mechanisms	|O
.	|O

Expression	|O
of	|O
the	|O
proapoptotic	|O
protein	|O
Bax	|B-PROTEIN
under	|O
the	|O
control	|O
of	|O
a	|O
GAL10	|B-PROTEIN
promoter	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
resulted	|O
in	|O
galactose	|O
-	|O
inducible	|O
cell	|O
death	|O
.	|O

This	|O
technique	|O
was	|O
employed	|O
in	|O
12	|O
patients	|O
with	|O
a	|O
unicameral	|O
bone	|O
cyst	|O
.	|O

Enterococcus	|O
faecium	|O
strains	|O
with	|O
vanA	|O
-	|O
mediated	|O
glycopeptide	|O
resistance	|O
were	|O
isolated	|O
by	|O
enrichment	|O
culture	|O
from	|O
the	|O
intestines	|O
and	|O
feces	|O
of	|O
several	|O
animal	|O
species	|O
,	|O
mainly	|O
horses	|O
and	|O
dogs	|O
(	|O
8%	|O
positive	|O
)	|O
,	|O
chickens	|O
(	|O
7%	|O
positive	|O
)	|O
,	|O
and	|O
pigs	|O
(	|O
6%	|O
positive	|O
)	|O
.	|O

The	|O
amino	|O
-	|O
terminal	|O
region	|O
of	|O
E1A	|B-PROTEIN
binds	|O
several	|O
high	|O
molecular	|O
weight	|O
proteins	|O
and	|O
inhibits	|O
the	|O
transcriptional	|O
coactivator	|O
function	|O
of	|O
p300	|B-PROTEIN
and	|O
the	|O
homologous	|O
cAMP	|O
response	|O
element	|O
(	|B-PROTEIN
CRE	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Transient	|O
transfection	|O
assays	|O
using	|O
reporter	|O
gene	|O
constructs	|O
containing	|O
various	|O
lengths	|O
of	|O
the	|O
5'	|O
mdr1b	|B-PROTEIN
sequences	|O
revealed	|O
that	|O
the	|O
sequence	|O
located	|O
between	|O
-	|O
247	|O
to	|O
-	|O
126	|O
bp	|O
was	|O
important	|O
for	|O
the	|O
expression	|O
of	|O
the	|O
reporter	|O
gene	|O
in	|O
many	|O
different	|O
cell	|O
lines	|O
.	|O

We	|O
show	|O
that	|O
the	|O
5'	|O
UTR	|O
characteristic	|O
of	|O
testis	|O
-	|O
specific	|O
c	|B-PROTEIN
-	|I-PROTEIN
mos	|I-PROTEIN
mRNA	|O
strongly	|O
represses	|O
translation	|O
relative	|O
to	|O
the	|O
translation	|O
of	|O
transcripts	|O
that	|O
contain	|O
a	|O
5'	|O
UTR	|O
derived	|O
from	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
mRNA	|O
,	|O
and	|O
this	|O
is	|O
mainly	|O
due	|O
to	|O
the	|O
four	|O
uORFs	|O
.	|O

To	|O
address	|O
the	|O
biological	|O
effect	|O
of	|O
specific	|O
isoform	|O
expression	|O
,	|O
NIH3T3	|O
cells	|O
were	|O
transfected	|O
with	|O
a	|O
eukaryotic	|O
expression	|O
vector	|O
containing	|O
cDNA	|O
for	|O
FGF8a	|B-PROTEIN
,	|O
FGF8b	|B-PROTEIN
,	|O
or	|O
FGF8e	|B-PROTEIN
.	|O

These	|O
findings	|O
suggest	|O
that	|O
the	|O
F	|O
-	|O
wave	|O
may	|O
be	|O
elicited	|O
in	|O
motoneuron	|O
of	|O
different	|O
depolarization	|O
threshold	|O
but	|O
primarily	|O
in	|O
larger	|O
and	|O
faster	|O
nerve	|O
fibers	|O
,	|O
with	|O
a	|O
lower	|O
threshold	|O
of	|O
depolarization	|O
.	|O

In	|O
addition	|O
,	|O
carp	|O
JAK1	|B-PROTEIN
shows	|O
higher	|O
sequence	|O
homology	|O
to	|O
mammalian	|O
JAK1	|B-PROTEIN
in	|O
both	|O
the	|O
kinase	|O
-	|O
like	|O
(	|O
JH2	|B-PROTEIN
)	|O
and	|O
kinase	|O
(	|O
JH1	|B-PROTEIN
)	|O
domains	|O
(	|O
approximately	|O
70%	|O
identity	|O
)	|O
.	|O

When	|O
this	|O
DNA	|O
fragment	|O
was	|O
placed	|O
upstream	|O
of	|O
the	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
reporter	|O
gene	|O
and	|O
transfected	|O
into	|O
a	|O
carp	|O
CF	|O
cell	|O
line	|O
,	|O
it	|O
could	|O
drive	|O
the	|O
synthesis	|O
of	|O
CAT	|B-PROTEIN
enzyme	|O
16	|O
times	|O
more	|O
efficiently	|O
than	|O
the	|O
promoterless	|O
pCAT	|B-PROTEIN
-	|I-PROTEIN
Basic	|I-PROTEIN
.	|O

Molecular	|O
cloning	|O
of	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
a	|O
new	|O
member	|O
of	|O
the	|O
Ets	|B-PROTEIN
family	|O
expressed	|O
during	|O
mouse	|O
embryogenesis	|O
and	|O
analysis	|O
of	|O
its	|O
transcriptional	|O
repression	|O
activity	|O
.	|O

We	|O
report	|O
an	|O
example	|O
of	|O
an	|O
MDV	|O
-	|O
transformed	|O
T	|O
-	|O
lymphoblastoid	|O
cell	|O
line	|O
(	|O
T9	|O
)	|O
expressing	|O
high	|O
levels	|O
of	|O
a	|O
truncated	|O
C	|B-PROTEIN
-	|I-PROTEIN
MYB	|I-PROTEIN
protein	|O
as	|O
a	|O
result	|O
of	|O
RAV	|O
integration	|O
within	|O
one	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
allele	|O
.	|O

Frozen	|O
/	|O
thawed	|O
extensor	|O
digitorum	|O
longus	|O
muscle	|O
tendon	|O
units	|O
had	|O
significantly	|O
lower	|O
values	|O
for	|O
load	|O
to	|O
failure	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
energy	|O
absorbed	|O
to	|O
failure	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
and	|O
strain	|O
at	|O
failure	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
and	|O
they	|O
tended	|O
to	|O
fail	|O
at	|O
a	|O
different	|O
anatomic	|O
location	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
(	|O
broadly	|O
at	|O
the	|O
fascia	|O
-	|O
muscle	|O
interface	|O
as	|O
compared	|O
with	|O
horizontally	|O
at	|O
the	|O
musculotendinous	|O
junction	|O
)	|O
than	|O
fresh	|O
units	|O
.	|O

Northern	|O
analysis	|O
of	|O
the	|O
3.1	|O
-	|O
kb	|O
PWP2H	|B-PROTEIN
cDNA	|O
revealed	|O
that	|O
a	|O
3.3	|O
-	|O
kb	|O
major	|O
transcript	|O
is	|O
ubiquitously	|O
expressed	|O
in	|O
human	|O
adult	|O
tissues	|O
.	|O

Forty	|O
-	|O
eight	|O
10-12	|O
-	|O
week	|O
-	|O
old	|O
male	|O
Sprague	|O
-	|O
Dawley	|O
rats	|O
were	|O
randomized	|O
to	|O
receive	|O
,	|O
daily	|O
for	|O
28	|O
days	|O
:	|O
(	|O
1	|O
)	|O
CsA	|O
vehicle	|O
p.o	|O
.	|O
plus	|O
FB	|O
vehicle	|O
sc	|O
;	|O
(	|O
2	|O
)	|O
CsA	|O
(	|O
15	|O
mg	|O
/	|O
kg	|O
)	|O
p.o	|O
.	|O
plus	|O
FB	|O
vehicle	|O
sc	|O
,	|O
(	|O
3	|O
)	|O
CsA	|O
vehicle	|O
p.o	|O
.	|O
plus	|O
FB	|O
(	|O
1.5	|O
mg	|O
/	|O
kg	|O
)	|O
sc	|O
;	|O
and	|O
(	|O
4	|O
)	|O
CsA	|O
(	|O
15	|O
mg	|O
/	|O
kg	|O
)	|O
p.o	|O
.	|O
plus	|O
FB	|O
(	|O
1.5	|O
mg	|O
/	|O
kg	|O
)	|O
sc	|O
.	|O

CsA	|O
alone	|O
resulted	|O
in	|O
elevated	|O
bone	|O
turnover	|O
.	|O

Individuals	|O
attending	|O
the	|O
GUM	|O
Department	|O
in	|O
the	|O
Royal	|O
Infirmary	|O
of	|O
Edinburgh	|O
between	|O
1990	|O
and	|O
1994	|O
with	|O
the	|O
diagnosis	|O
of	|O
HIV	|O
infection	|O
,	|O
genital	|O
warts	|O
,	|O
genital	|O
herpes	|O
,	|O
non	|O
-	|O
specific	|O
genital	|O
infection	|O
(	|O
NSGI	|O
)	|O
,	|O
gonorrhoea	|O
and	|O
syphilis	|O
were	|O
included	|O
in	|O
the	|O
study	|O
.	|O

Oncogenic	|O
activation	|O
of	|O
the	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
domain	|O
of	|O
the	|O
human	|O
trk	|B-PROTEIN
proto	|O
-	|O
oncogene	|O
by	|O
fusion	|O
to	|O
a	|O
cell	|O
adhesion	|O
molecule	|O
.	|O

Northern	|O
blotting	|O
showed	|O
that	|O
MDMX	|B-PROTEIN
,	|O
like	|O
MDM2	|B-PROTEIN
,	|O
is	|O
expressed	|O
in	|O
all	|O
tissues	|O
tested	|O
,	|O
and	|O
that	|O
several	|O
mRNAs	|O
for	|O
MDMX	|B-PROTEIN
can	|O
be	|O
detected	|O
.	|O

Physiol.	|O

The	|O
nucleotide	|O
sequence	|O
of	|O
22,846	|O
bp	|O
of	|O
the	|O
left	|O
arm	|O
of	|O
chromosome	|O
IV	|O
is	|O
described	|O
.	|O

They	|O
suggest	|O
that	|O
decreased	|O
steady	|O
-	|O
state	|O
levels	|O
of	|O
IME1	|B-PROTEIN
and	|O
IME2	|B-PROTEIN
mRNA	|O
were	|O
not	|O
merely	|O
the	|O
result	|O
of	|O
non	|O
-	|O
specific	|O
adverse	|O
affects	|O
on	|O
nucleic	|O
acid	|O
metabolism	|O
caused	|O
by	|O
the	|O
yvh1	|B-PROTEIN
disruption	|O
.	|O

Natural	|O
FL	|B-PROTEIN
protein	|O
has	|O
been	|O
purified	|O
from	|O
a	|O
stromal	|O
cell	|O
line	|O
and	|O
shown	|O
to	|O
be	|O
a	|O
65	|O
kD	|O
nondisulfide	|O
-	|O
linked	|O
homodimeric	|O
glycoprotein	|O
comprised	|O
of	|O
30	|O
kD	|O
subunits	|O
,	|O
each	|O
containing	|O
12	|O
kD	|O
of	|O
N	|O
-	|O
and	|O
O	|O
-	|O
linked	|O
sugars	|O
.	|O

The	|O
objective	|O
of	|O
this	|O
study	|O
was	|O
to	|O
examine	|O
the	|O
influence	|O
of	|O
HHCA	|O
and	|O
other	|O
serological	|O
factors	|O
upon	|O
the	|O
development	|O
of	|O
VGS	|O
.	|O

Spliced	|O
exons	|O
of	|O
adenovirus	|O
late	|O
RNAs	|O
colocalize	|O
with	|O
snRNP	|O
in	|O
a	|O
specific	|O
nuclear	|O
domain	|O
.	|O

Using	|O
Spurr	|O
's	|O
resin	|O
as	|O
a	|O
mounting	|O
medium	|O
,	|O
we	|O
could	|O
observe	|O
thick	|O
specimens	|O
with	|O
oil	|O
immersion	|O
objective	|O
lens	|O
without	|O
the	|O
use	|O
of	|O
coverslips	|O
,	|O
then	|O
avoid	|O
air	|O
bubbles	|O
near	|O
the	|O
specimen	|O
.	|O

The	|O
present	|O
study	|O
investigated	|O
dose	|O
dependence	|O
and	|O
time	|O
course	|O
effects	|O
of	|O
the	|O
benzodiazepine	|O
(	|O
BDZ	|O
)	|O
partial	|O
inverse	|O
agonist	|O
,	|O
RO19	|O
-	|O
4603	|O
(	|O
0.005-0.30	|O
mg	|O
/	|O
kg	|O
)	|O
alone	|O
,	|O
and	|O
in	|O
combination	|O
with	|O
the	|O
BDZ	|B-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
flumazenil	|O
,	|O
ZK	|O
93426	|O
,	|O
and	|O
CGS	|O
8216	|O
(	|O
20	|O
mg	|O
/	|O
kg	|O
)	|O
in	|O
selectively	|O
bred	|O
alcohol	|O
-	|O
preferring	|O
(	|O
P	|O
)	|O
rats	|O
provided	|O
a	|O
two	|O
-	|O
bottle	|O
choice	|O
test	|O
between	|O
ethanol	|O
(	|O
EtOH	|O
)	|O
(	|O
10%	|O
v	|O
/	|O
v	|O
)	|O
,	|O
and	|O
a	|O
palatable	|O
saccharin	|O
(	|O
0.0125%	|O
g	|O
/	|O
v	|O
)	|O
solution	|O
.	|O

Beyond	|O
the	|O
Tower	|O
of	|O
Babel	|O
:	|O
a	|O
nomenclature	|O
for	|O
suicidology	|O
.	|O

Infection	|O
with	|O
Neisseria	|O
meningitidis	|O
group	|O
B	|O
has	|O
been	|O
difficult	|O
to	|O
detect	|O
,	|O
partly	|O
because	|O
this	|O
bacterial	|O
group	|O
's	|O
polysaccharide	|O
is	|O
a	|O
weak	|O
immunogen	|O
.	|O

RNase	|B-PROTEIN
protection	|O
analysis	|O
of	|O
two	|O
rRNA	|O
fragments	|O
whose	|O
genes	|O
are	|O
adjacent	|O
provided	|O
evidence	|O
for	|O
a	|O
polycistronic	|O
transcript	|O
containing	|O
sequences	|O
from	|O
both	|O
,	|O
as	|O
well	|O
as	|O
separate	|O
small	|O
RNAs	|O
.	|O

Rss1p	|B-PROTEIN
encodes	|O
a	|O
novel	|O
essential	|O
protein	|O
of	|O
538	|O
amino	|O
acids	|O
,	|O
which	|O
contains	|O
an	|O
extended	|O
predicted	|O
coiled	|O
-	|O
coil	|O
domain	|O
and	|O
is	|O
located	|O
both	|O
at	|O
nuclear	|O
pore	|O
complexes	|O
(	|O
NPCs	|O
)	|O
and	|O
in	|O
the	|O
cytoplasm	|O
.	|O

To	|O
map	|O
this	|O
regulatory	|O
serine	|O
phosphorylation	|O
site	|O
we	|O
developed	|O
a	|O
baculovirus	|O
-	|O
mediated	|O
expression	|O
system	|O
for	|O
wild	|O
-	|O
type	|O
annexin	|B-PROTEIN
II	|I-PROTEIN
and	|O
for	|O
a	|O
series	|O
of	|O
annexin	|B-PROTEIN
II	|I-PROTEIN
mutants	|O
which	|O
contained	|O
substitutions	|O
in	|O
one	|O
or	|O
more	|O
serine	|O
residues	|O
present	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
domain	|O
.	|O

The	|O
PAI	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
is	|O
one	|O
of	|O
the	|O
most	|O
TNF	|B-PROTEIN
-	|O
responsive	|O
genes	|O
known	|O
and	|O
is	|O
also	|O
highly	|O
induced	|O
by	|O
the	|O
phorbol	|O
ester	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
(	|O
PMA	|O
)	|O
and	|O
the	|O
phosphatase	|O
inhibitor	|O
,	|O
okadaic	|O
acid	|O
,	|O
in	|O
both	|O
HT	|O
-	|O
1080	|O
fibrosarcoma	|O
and	|O
U	|O
-	|O
937	|O
histiocytic	|O
cells	|O
.	|O

220	|O
,	|O
263-273	|O
)	|O
.	|O

These	|O
two	|O
contigs	|O
contain	|O
a	|O
total	|O
of	|O
163	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
in	|O
26-29	|O
putative	|O
operons	|O
;	|O
56	|O
ORFs	|O
could	|O
be	|O
identified	|O
with	|O
reasonable	|O
certainty	|O
.	|O

T.	|O
,	|O
Patel	|O
,	|O
S.	|O

Growth	|O
factors	|O
induce	|O
the	|O
expression	|O
of	|O
the	|O
immediate	|B-PROTEIN
early	|I-PROTEIN
gene	|I-PROTEIN
products	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
phosphatase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
MKP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
.	|O

The	|O
up	|O
-	|O
regulation	|O
of	|O
E	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
,	|O
one	|O
of	|O
the	|O
adhesion	|O
molecules	|O
on	|O
the	|O
endothelium	|O
,	|O
is	|O
an	|O
important	|O
event	|O
in	|O
the	|O
mediation	|O
of	|O
the	|O
inflammatory	|O
response	|O
.	|O

The	|O
NIT2	|B-PROTEIN
protein	|O
is	|O
localised	|O
in	|O
nuclei	|O
and	|O
could	|O
not	|O
be	|O
detected	|O
in	|O
the	|O
cytoplasmic	|O
fraction	|O
of	|O
cells	|O
subjected	|O
to	|O
nitrogen	|O
derepression	|O
or	|O
nitrogen	|O
repression	|O
,	|O
indicating	|O
that	|O
the	|O
nuclear	|O
import	|O
of	|O
NIT2	|B-PROTEIN
is	|O
not	|O
regulated	|O
.	|O

In	|O
spite	|O
of	|O
much	|O
effort	|O
,	|O
no	|O
one	|O
has	|O
succeeded	|O
in	|O
isolating	|O
and	|O
characterizing	|O
the	|O
enzyme	|O
(	|O
s	|O
)	|O
responsible	|O
for	|O
synthesis	|O
of	|O
cellulose	|O
,	|O
the	|O
major	|O
cell	|O
wall	|O
polymer	|O
of	|O
plants	|O
.	|O

Vascular	|O
responses	|O
to	|O
reactive	|O
hyperemia	|O
(	|O
with	|O
flow	|O
increase	|O
leading	|O
to	|O
endothelium	|O
-	|O
dependent	|O
dilation	|O
)	|O
and	|O
to	|O
sublingual	|O
glyceryl	|O
trinitrate	|O
(	|O
GTN	|O
;	|O
endothelium	|O
-	|O
independent	|O
dilation	|O
)	|O
were	|O
recorded	|O
.	|O

During	|O
this	|O
period	|O
,	|O
administration	|O
of	|O
additional	|O
exogenous	|O
PRL	|B-PROTEIN
did	|O
not	|O
stimulate	|O
further	|O
activation	|O
(	|O
binding	|O
)	|O
of	|O
the	|O
Stat	|B-PROTEIN
factors	|O
.	|O

Intraperitoneal	|O
administration	|O
of	|O
L	|O
-	|O
5	|O
-	|O
hydroxytryptophan	|O
(	|O
L	|O
-	|O
5	|O
-	|O
HTP	|O
)	|O
at	|O
doses	|O
of	|O
25	|O
to	|O
100	|O
mg	|O
/	|O
kg	|O
dramatically	|O
increase	|O
defecation	|O
in	|O
mice	|O
.	|O

In	|O
the	|O
VA	|O
-	|O
SMV	|O
mode	|O
,	|O
the	|O
connection	|O
was	|O
made	|O
with	|O
valved	|O
conduits	|O
from	|O
the	|O
LV	|O
apex	|O
(	|O
inflow	|O
)	|O
to	|O
the	|O
ascending	|O
aorta	|O
(	|O
outflow	|O
)	|O
(	|O
n	|O
=	|O
11	|O
)	|O
or	|O
to	|O
the	|O
DAo	|O
(	|O
n	|O
=	|O
12	|O
)	|O
.	|O

The	|O
evidence	|O
in	|O
support	|O
of	|O
this	|O
was	|O
derived	|O
from	|O
the	|O
fact	|O
that	|O
the	|O
affinity	|O
or	|O
interaction	|O
between	|O
the	|O
two	|O
subunits	|O
was	|O
impaired	|O
as	|O
indicated	|O
by	|O
the	|O
first	|O
order	|O
rate	|O
constant	|O
of	|O
hCG	|B-PROTEIN
alpha	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
(	|O
km	|O
=	|O
4.1	|O
x	|O
10	|O
(	|O
-	|O
2	|O
)	|O
min	|O
-	|O
1	|O
)	|O
at	|O
pH	|O
3.0	|O
at	|O
23	|O
degrees	|O
C	|O
which	|O
is	|O
one	|O
order	|O
of	|O
magnitude	|O
greater	|O
relative	|O
to	|O
rehCG	|B-PROTEIN
(	|O
kw	|O
=	|O
4.6	|O
x	|O
10	|O
(	|O
-	|O
3	|O
)	|O
min	|O
-	|O
1	|O
)	|O
.	|O

Factor	|O
V	|O
Leiden	|O
is	|O
a	|O
genetic	|O
disorder	|O
associated	|O
with	|O
an	|O
increased	|O
risk	|O
of	|O
venous	|O
thrombosis	|O
.	|O

This	|O
is	|O
the	|O
first	|O
determination	|O
of	|O
the	|O
complete	|O
secondary	|O
structure	|O
of	|O
an	|O
RNA	|O
spliced	|O
in	|O
a	|O
spliceosome	|O
.	|O

The	|O
majority	|O
of	|O
the	|O
cases	|O
with	|O
0	|O
-	|O
I	|O
or	|O
0	|O
-	|O
III	|O
components	|O
were	|O
sm	|O
.	|O
cancer	|O
.	|O

These	|O
patients	|O
appear	|O
to	|O
have	|O
slightly	|O
better	|O
pulmonary	|O
function	|O
and	|O
nutritional	|O
status	|O
;	|O
yet	|O
,	|O
they	|O
seem	|O
to	|O
have	|O
a	|O
higher	|O
degree	|O
of	|O
health	|O
care	|O
utilization	|O
.	|O

This	|O
observation	|O
calls	|O
for	|O
careful	|O
monitoring	|O
of	|O
calcium	|O
and	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
values	|O
and	|O
possible	|O
adjustments	|O
of	|O
vitamin	|O
D	|O
intake	|O
when	|O
fortifiers	|O
are	|O
used	|O
for	|O
extended	|O
periods	|O
.	|O

We	|O
have	|O
found	|O
that	|O
PEA2	|B-PROTEIN
is	|O
also	|O
required	|O
for	|O
the	|O
bipolar	|O
budding	|O
pattern	|O
and	|O
that	|O
it	|O
encodes	|O
a	|O
novel	|O
protein	|O
with	|O
a	|O
predicted	|O
coiled	|O
-	|O
coil	|O
domain	|O
.	|O

Signaling	|O
from	|O
the	|O
small	|O
GTP	|O
-	|O
binding	|O
proteins	|O
Rac1	|B-PROTEIN
and	|O
Cdc42	|B-PROTEIN
to	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
/	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
pathway	|O
.	|O

Percent	|O
identities	|O
of	|O
the	|O
mouse	|O
PP2	|B-PROTEIN
to	|O
mouse	|O
Y1	|B-PROTEIN
,	|O
mouse	|O
Y4	|B-PROTEIN
/	|O
PP1	|B-PROTEIN
and	|O
human	|O
Y2	|B-PROTEIN
receptors	|O
are	|O
53	|O
,	|O
42	|O
,	|O
and	|O
31	|O
,	|O
respectively	|O
.	|O

Correlating	|O
with	|O
the	|O
previous	|O
observation	|O
that	|O
CBF	|B-PROTEIN
binding	|O
to	|O
the	|O
78C1	|O
site	|O
is	|O
enhanced	|O
by	|O
EGTA	|O
and	|O
EDTA	|O
,	|O
these	|O
divalent	|O
cation	|O
chelators	|O
specifically	|O
stimulate	|O
78C1	|O
-	|O
directed	|O
transcription	|O
.	|O

The	|O
human	|O
gene	|O
fragment	|O
ligated	|O
to	|O
the	|O
minimal	|O
rat	|O
liver	|O
glucokinase	|B-PROTEIN
promoter	|O
was	|O
shown	|O
to	|O
work	|O
as	|O
an	|O
enhancer	|O
in	|O
the	|O
hepatocyte	|O
transfection	|O
system	|O
.	|O

To	|O
test	|O
the	|O
role	|O
of	|O
ML	|O
in	|O
human	|O
reproductive	|O
axis	|O
,	|O
128	|O
healthy	|O
children	|O
,	|O
68	|O
boys	|O
and	|O
60	|O
girls	|O
,	|O
were	|O
studied	|O
.	|O

However	|O
,	|O
the	|O
truncated	|O
deer	|B-PROTEIN
receptor	|I-PROTEIN
lacks	|O
the	|O
most	|O
C	|O
-	|O
terminal	|O
tyrosine	|O
residue	|O
in	|O
the	|O
intracellular	|O
domain	|O
which	|O
is	|O
believed	|O
to	|O
be	|O
essential	|O
for	|O
activation	|O
of	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
casein	|I-PROTEIN
promoter	|O
.	|O

This	|O
report	|O
provides	|O
further	|O
evidence	|O
for	|O
the	|O
riMLF	|O
in	|O
the	|O
control	|O
of	|O
downgaze	|O
,	|O
and	|O
a	|O
synkinesis	|O
is	|O
postulated	|O
for	|O
the	|O
development	|O
of	|O
the	|O
convergence	|O
retraction	|O
nystagmus	|O
.	|O

Rifabutin	|O
has	|O
substantial	|O
efficacy	|O
when	|O
combined	|O
with	|O
other	|O
agents	|O
.	|O

Ninety	|O
-	|O
four	|O
percent	|O
of	|O
the	|O
EPs	|O
were	|O
tubal	|O
,	|O
and	|O
90%	|O
of	|O
the	|O
tubes	|O
exhibited	|O
some	|O
pathologic	|O
changes	|O
,	|O
including	|O
chronic	|O
salpingitis	|O
(	|O
49.5%	|O
)	|O
and	|O
follicular	|O
salpingitis	|O
(	|O
10%	|O
)	|O
,	|O
among	|O
others	|O
.	|O

The	|O
assessment	|O
using	|O
7	|O
H	|O
9	|O
liquid	|O
medium	|O
by	|O
the	|O
former	|O
author	|O
demonstrated	|O
the	|O
potent	|O
activities	|O
of	|O
both	|O
CS	|O
-	|O
940	|O
*	|O
and	|O
sparfloxacin	|O
(	|O
SPFX	|O
)	|O
,	|O
followed	|O
by	|O
AM	|O
-	|O
1155	|O
*	|O
,	|O
ciprofloxacin	|O
(	|O
CPFX	|O
)	|O
,	|O
levofloxacin	|O
(	|O
LVFX	|O
)	|O
,	|O
OPC	|O
-	|O
17116	|O
*	|O
,	|O
NM	|O
-	|O
394	|O
*	|O
in	|O
sequence	|O
.	|O

The	|O
STE20	|B-PROTEIN
gene	|O
,	|O
encoding	|O
a	|O
protein	|O
kinase	|O
required	|O
for	|O
pheromone	|O
signal	|O
transduction	|O
,	|O
has	|O
recently	|O
been	|O
identified	|O
in	|O
a	|O
genetic	|O
screen	|O
for	|O
high	|O
-	|O
gene	|O
-	|O
dosage	|O
suppressors	|O
of	|O
a	|O
partly	|O
defective	|O
G	|B-PROTEIN
beta	|I-PROTEIN
mutation	|O
.	|O

This	|O
enzyme	|O
is	|O
designated	|O
(	|O
1	|O
-	|O
-	|O
>	|O
4	|O
)	|O
-	|O
beta	|O
-	|O
xylan	|O
endohydrolase	|O
isoenzyme	|O
X	|B-PROTEIN
-	|I-PROTEIN
I.	|I-PROTEIN

Magnetic	|O
resonance	|O
imaging	|O
in	|O
coccidioidal	|O
arthritis	|O
.	|O

Moloney	|O
murine	|O
leukemia	|O
virus	|O
(	|O
MMLV	|O
)	|O
-	|O
derived	|O
pUCMoTiN	|O
-	|O
based	|O
retroviral	|O
vectors	|O
were	|O
engineered	|O
to	|O
allow	|O
constitutive	|O
and	|O
Tat	|B-PROTEIN
(	|O
trans	|B-PROTEIN
-	|I-PROTEIN
activator	|I-PROTEIN
of	|I-PROTEIN
transcription	|I-PROTEIN
)	|O
-	|O
inducible	|O
expression	|O
of	|O
five	|O
hammerhead	|O
ribozymes	|O
targeted	|O
against	|O
highly	|O
conserved	|O
sequences	|O
within	|O
the	|O
group	|B-PROTEIN
antigen	|I-PROTEIN
(	|O
Gag	|B-PROTEIN
)	|O
,	|O
protease	|B-PROTEIN
(	|O
Pro	|B-PROTEIN
)	|O
,	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
(	|O
RT	|B-PROTEIN
)	|O
,	|O
tat	|B-PROTEIN
,	|O
and	|O
envelope	|B-PROTEIN
(	|O
Env	|B-PROTEIN
)	|O
coding	|O
regions	|O
of	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
-	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
RNA	|O
.	|O

REM	|O
sleep	|O
deprivation	|O
was	|O
performed	|O
using	|O
the	|O
platform	|O
technique	|O
.	|O

The	|O
same	|O
ligands	|O
also	|O
exhibit	|O
a	|O
similar	|O
inhibitory	|O
effect	|O
on	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
BB	|I-PROTEIN
-	|O
dependent	|O
[	|O
3H	|O
]	|O
thymidine	|O
incorporation	|O
in	|O
PAE	|O
cells	|O
expressing	|O
the	|O
PDGF	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

We	|O
analyzed	|O
serial	|O
biopsy	|O
specimens	|O
from	|O
eight	|O
patients	|O
with	|O
FL	|O
for	|O
secondary	|O
alterations	|O
of	|O
the	|O
rearranged	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
in	|O
the	|O
breakpoint	|O
and	|O
open	|O
reading	|O
frame	|O
(	|O
ORF	|O
)	|O
regions	|O
.	|O

In	|O
all	|O
eight	|O
cases	|O
,	|O
neither	|O
FL	|O
nor	|O
DLL	|O
cells	|O
showed	|O
alterations	|O
of	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
sequences	|O
in	|O
the	|O
breakpoint	|O
region	|O
,	|O
suggesting	|O
high	|O
conservation	|O
of	|O
the	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
during	|O
both	|O
t	|O
(	|O
14	|O
;	|O
18	|O
)	|O
translocation	|O
and	|O
morphologic	|O
transformation	|O
of	|O
the	|O
FL	|O
cells	|O
.	|O

BACKGROUND	|O
:	|O
The	|O
Bazett	|O
-	|O
corrected	|O
QT	|O
(	|O
QTc	|O
)	|O
interval	|O
during	|O
exercise	|O
has	|O
been	|O
used	|O
as	|O
a	|O
marker	|O
for	|O
ischemic	|O
disease	|O
,	|O
arrhythmogenic	|O
substrate	|O
and	|O
the	|O
long	|O
QT	|O
syndrome	|O
.	|O

An	|O
essential	|O
role	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
in	|O
basal	|O
and	|O
PMA	|O
-	|O
stimulated	|O
transcription	|O
of	|O
the	|O
PAI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
is	|O
demonstrated	|O
by	|O
our	|O
finding	|O
that	|O
antisense	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
oligodeoxynucleotides	|O
both	|O
strongly	|O
reduced	|O
basal	|O
and	|O
PMA	|O
-	|O
stimulated	|O
PAI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
synthesis	|O
.	|O

Leukemia	|B-PROTEIN
-	|I-PROTEIN
inhibitory	|I-PROTEIN
factor	|I-PROTEIN
(	|O
LIF	|B-PROTEIN
)	|O
is	|O
a	|O
neuropoietin	|B-PROTEIN
able	|O
to	|O
regulate	|O
the	|O
differentiation	|O
and	|O
the	|O
survival	|O
of	|O
many	|O
cell	|O
types	|O
,	|O
which	|O
include	|O
some	|O
neuronal	|O
populations	|O
.	|O

To	|O
analyze	|O
the	|O
mechanism	|O
of	|O
fos	|B-PROTEIN
/	|O
jun	|B-PROTEIN
activation	|O
by	|O
TCDD	|O
we	|O
have	|O
used	|O
electrophoretic	|O
mobility	|O
shift	|O
and	|O
transient	|O
expression	|O
assays	|O
of	|O
reporter	|O
gene	|O
constructs	|O
containing	|O
response	|O
elements	|O
for	|O
12	|O
-	|O
O	|O
-	|O
tetradecanoyl	|O
-	|O
phorbol	|O
-	|O
13	|O
-	|O
acetate	|O
(	|O
TRE	|O
)	|O
,	|O
serum	|O
(	|O
SRE	|O
)	|O
,	|O
cAMP	|O
(	|O
CRE	|O
)	|O
,	|O
and	|O
aromatic	|O
hydrocarbons	|O
(	|O
AhRE	|O
)	|O
from	|O
the	|O
fos	|B-PROTEIN
and	|O
jun	|B-PROTEIN
genes	|O
fused	|O
to	|O
the	|O
firefly	|O
luciferase	|B-PROTEIN
gene	|O
under	|O
the	|O
control	|O
of	|O
the	|O
SV40	|B-PROTEIN
minimal	|I-PROTEIN
promoter	|I-PROTEIN
.	|O

The	|O
optimal	|O
sequence	|O
for	|O
interaction	|O
with	|O
mu	|B-PROTEIN
2	|I-PROTEIN
and	|O
with	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
has	|O
tyrosine	|O
as	|O
an	|O
anchor	|O
and	|O
prefers	|O
arginine	|O
at	|O
position	|O
Y	|O
+	|O
2	|O
and	|O
leucine	|O
at	|O
position	|O
Y	|O
+	|O
3	|O
.	|O

STK	|B-PROTEIN
/	|O
RON	|B-PROTEIN
-	|O
expressing	|O
Ba	|O
/	|O
F3	|O
pro	|O
-	|O
B	|O
cells	|O
(	|O
BaF	|O
/	|O
STK	|B-PROTEIN
)	|O
exhibited	|O
MSP	|B-PROTEIN
-	|O
dependent	|O
growth	|O
,	|O
whereas	|O
STK	|B-PROTEIN
/	|O
RON	|B-PROTEIN
-	|O
expressing	|O
mouse	|O
erythroleukaemia	|O
cells	|O
(	|O
MEL	|O
/	|O
STK	|B-PROTEIN
)	|O
displayed	|O
MSP	|B-PROTEIN
-	|O
induced	|O
apoptosis	|O
.	|O

In	|O
vitro	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
showed	|O
that	|O
OxyR	|B-PROTEIN
-	|I-PROTEIN
C199S	|I-PROTEIN
protected	|O
Pmom	|B-PROTEIN
from	|O
-	|O
104	|O
to	|O
-	|O
46	|O
on	|O
the	|O
top	|O
strand	|O
and	|O
produced	|O
a	|O
protection	|O
pattern	|O
characteristic	|O
of	|O
reduced	|O
wild	|O
-	|O
type	|O
OxyR	|B-PROTEIN
.	|O

Kss1	|B-PROTEIN
binds	|O
specifically	|O
to	|O
a	|O
GST	|B-PROTEIN
-	|O
Dig1	|B-PROTEIN
fusion	|O
in	|O
the	|O
absence	|O
of	|O
any	|O
other	|O
yeast	|O
protein	|O
.	|O

In	|O
contrast	|O
,	|O
dig1	|B-PROTEIN
dig2	|O
cells	|O
constitutively	|O
invade	|O
agar	|O
medium	|O
,	|O
whereas	|O
a	|O
dig1	|B-PROTEIN
dig2	|O
ste12	|O
triple	|O
mutant	|O
does	|O
not	|O
,	|O
indicating	|O
that	|O
Dig1	|B-PROTEIN
and	|O
Dig2	|B-PROTEIN
share	|O
a	|O
role	|O
in	|O
negatively	|O
regulating	|O
the	|O
invasive	|O
growth	|O
pathway	|O
.	|O

Paracrine	|O
activation	|O
of	|O
the	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
promoter	|O
by	|O
the	|O
viral	|O
Tat	|B-PROTEIN
protein	|O
is	|O
mechanistically	|O
similar	|O
to	|O
trans	|O
-	|O
activation	|O
within	|O
a	|O
cell	|O
.	|O

Comparison	|O
of	|O
the	|O
sequences	|O
of	|O
the	|O
xFxFG	|O
repeat	|O
regions	|O
of	|O
p62	|B-PROTEIN
and	|O
Nsplp	|B-PROTEIN
indicated	|O
that	|O
NTF2	|B-PROTEIN
was	|O
probably	|O
interacting	|O
with	|O
the	|O
phenylalanine	|O
-	|O
containing	|O
core	|O
of	|O
these	|O
repeats	|O
and	|O
not	|O
the	|O
intervening	|O
hydrophilic	|O
linkers	|O
.	|O

This	|O
is	|O
the	|O
first	|O
report	|O
of	|O
the	|O
successful	|O
resection	|O
of	|O
a	|O
MFH	|O
originating	|O
in	|O
the	|O
renal	|O
capsular	|O
tissue	|O
and	|O
extending	|O
into	|O
the	|O
inferior	|O
vena	|O
cava	|O
.	|O

Transient	|O
expression	|O
of	|O
VSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
protoplasts	|O
stimulated	|O
vs	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
dependent	|O
activation	|O
of	|O
the	|O
-	|B-PROTEIN
76	|I-PROTEIN
/	|I-PROTEIN
grp1.8	|I-PROTEIN
minimal	|O
promoter	|O
.	|O

Keeping	|O
in	|O
mind	|O
the	|O
limited	|O
range	|O
of	|O
age	|O
and	|O
dosages	|O
,	|O
advantages	|O
and	|O
disadvantages	|O
of	|O
the	|O
drug	|O
are	|O
discussed	|O
,	|O
comparing	|O
the	|O
experimental	|O
results	|O
with	|O
those	|O
derived	|O
from	|O
the	|O
literature	|O
.	|O

Blood	|O
sampling	|O
procedures	|O
were	|O
videotaped	|O
.	|O

Analysis	|O
of	|O
one	|O
cDNA	|O
revealed	|O
an	|O
unusual	|O
splicing	|O
event	|O
involving	|O
EZH1	|B-PROTEIN
and	|O
a	|O
tandemly	|O
linked	|O
gene	|O
GPR2	|B-PROTEIN
and	|O
suggests	|O
a	|O
potential	|O
mechanism	|O
for	|O
modifying	|O
the	|O
EZH1	|B-PROTEIN
protein	|O
in	|O
the	|O
conserved	|O
C	|O
-	|O
terminal	|O
domain	|O
.	|O

A	|O
given	|O
standard	|O
input	|O
function	|O
and	|O
a	|O
given	|O
value	|O
of	|O
distribution	|O
volume	|O
(	|O
Vd	|O
)	|O
used	|O
for	|O
the	|O
rCBF	|O
measurement	|O
of	|O
this	|O
method	|O
were	|O
calculated	|O
from	|O
the	|O
dynamic	|O
study	|O
by	|O
six	|O
normal	|O
volunteers	|O
.	|O

They	|O
lack	|O
a	|O
predicted	|O
single	|O
stranded	|O
(	|O
ss	|O
)	|O
DNA	|O
binding	|O
motif	|O
that	|O
is	|O
unique	|O
the	|O
large	|O
terminase	|B-PROTEIN
proteins	|O
in	|O
T4	|O
gp17	|B-PROTEIN
,	|O
and	|O
that	|O
has	|O
been	|O
implicated	|O
in	|O
recognizing	|O
ssDNA	|O
regions	|O
in	|O
replicating	|O
and	|O
recombining	|O
T4DNA	|O
destined	|O
to	|O
be	|O
packaged	|O
.	|O

It	|O
can	|O
be	|O
concluded	|O
that	|O
in	|O
normotensive	|O
subjects	|O
,	|O
uric	|O
acid	|O
and	|O
xanthine	|B-PROTEIN
oxidase	|I-PROTEIN
have	|O
significant	|O
association	|O
with	|O
blood	|O
pressure	|O
and	|O
thus	|O
are	|O
one	|O
of	|O
the	|O
many	|O
factors	|O
which	|O
are	|O
involved	|O
in	|O
the	|O
cause	|O
or	|O
effect	|O
of	|O
hypertension	|O
.	|O

Immunoblotting	|O
of	|O
expressed	|O
recombinant	|O
proteins	|O
with	|O
the	|O
monoclonal	|O
08L	|B-PROTEIN
antibody	|O
localized	|O
the	|O
08L	|B-PROTEIN
epitope	|O
to	|O
the	|O
carboxyl	|O
end	|O
of	|O
the	|O
protein	|O
.	|O

We	|O
infer	|O
that	|O
the	|O
dominant	|O
negative	|O
inhibition	|O
results	|O
from	|O
both	|O
direct	|O
proteolysis	|O
of	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
tetramer	|O
by	|O
the	|O
fusion	|O
subunit	|O
and	|O
detour	|O
of	|O
the	|O
tetramer	|O
to	|O
the	|O
lysosome	|O
.	|O

The	|O
current	|O
study	|O
defines	|O
the	|O
vinculin	|B-PROTEIN
-	|O
and	|O
FAK	|B-PROTEIN
-	|O
interaction	|O
domains	|O
on	|O
paxillin	|B-PROTEIN
and	|O
identifies	|O
the	|O
principal	|O
paxillin	|B-PROTEIN
focal	|O
adhesion	|O
targeting	|O
motif	|O
.	|O

These	|O
data	|O
demonstrate	|O
the	|O
presence	|O
of	|O
a	|O
single	|O
binding	|O
site	|O
for	|O
vinculin	|B-PROTEIN
,	|O
and	|O
at	|O
least	|O
two	|O
binding	|O
sites	|O
for	|O
FAK	|B-PROTEIN
that	|O
are	|O
separated	|O
by	|O
an	|O
intervening	|O
stretch	|O
of	|O
100	|O
amino	|O
acids	|O
.	|O

These	|O
data	|O
demonstrate	|O
that	|O
paxillin	|B-PROTEIN
localizes	|O
to	|O
focal	|O
adhesions	|O
independent	|O
of	|O
interactions	|O
with	|O
vinculin	|B-PROTEIN
and	|O
/	|O
or	|O
FAK	|B-PROTEIN
,	|O
and	|O
represents	|O
the	|O
first	|O
definitive	|O
demonstration	|O
of	|O
LIM	|B-PROTEIN
domains	|O
functioning	|O
as	|O
a	|O
primary	|O
determinant	|O
of	|O
protein	|O
subcellular	|O
localization	|O
to	|O
focal	|O
adhesions	|O
.	|O

A	|O
single	|O
protease	|O
-	|O
resistant	|O
structure	|O
formed	|O
by	|O
the	|O
entirety	|O
of	|O
both	|O
PDZ	|B-PROTEIN
repeats	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
2	|I-PROTEIN
(	|O
PDZ1	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
contains	|O
the	|O
protein	|B-PROTEIN
4.1	|I-PROTEIN
-	|O
binding	|O
site	|O
.	|O

Several	|O
agents	|O
have	|O
been	|O
tried	|O
for	|O
treatment	|O
,	|O
often	|O
limited	|O
by	|O
toxic	|O
side	|O
effects	|O
.	|O

Jerseys	|O
had	|O
higher	|O
hepatic	|O
Cu	|O
concentrations	|O
than	|O
did	|O
Holsteins	|O
on	|O
d	|O
60	|O
(	|O
346	|O
vs.	|O

RUSH	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
is	|O
a	|O
95	|O
-	|O
kDa	|O
truncated	|O
version	|O
of	|O
RUSH	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
that	|O
results	|O
from	|O
alternative	|O
splicing	|O
of	|O
a	|O
57	|O
-	|O
bp	|O
exon	|O
as	|O
confirmed	|O
by	|O
genomic	|O
cloning	|O
.	|O

These	|O
results	|O
are	|O
consistent	|O
with	|O
the	|O
well	|O
established	|O
polarity	|O
of	|O
RXR	|B-PROTEIN
heterodimer	|O
binding	|O
to	|O
bipartite	|O
hormone	|O
response	|O
elements	|O
,	|O
with	|O
the	|O
VDR	|B-PROTEIN
recognizing	|O
the	|O
3'	|O
-	|O
half	|O
-	|O
element	|O
.	|O

PPAR	|B-PROTEIN
gamma	|I-PROTEIN
mRNA	|O
levels	|O
were	|O
reduced	|O
by	|O
95%	|O
with	|O
3	|O
nM	|O
TNF	|B-PROTEIN
alpha	|I-PROTEIN
treatment	|O
for	|O
24	|O
h	|O
.	|O

Exons	|O
III	|O
to	|O
VIII	|O
,	|O
which	|O
cover	|O
the	|O
coding	|O
region	|O
and	|O
the	|O
3'	|O
untranslated	|O
region	|O
,	|O
are	|O
almost	|O
identical	|O
in	|O
all	|O
types	|O
of	|O
PST	|B-PROTEIN
or	|O
AST	|B-PROTEIN
cDNAs	|O
.	|O

Growth	|O
factor	|O
allows	|O
effective	|O
dose	|O
-	|O
intensive	|O
regimen	|O
in	|O
advanced	|O
breast	|O
cancer	|O
patients	|O
.	|O

Recombinant	|B-PROTEIN
erythropoietin	|I-PROTEIN
(	|O
r	|B-PROTEIN
-	|I-PROTEIN
HuEPO	|I-PROTEIN
)	|O
in	|O
the	|O
treatment	|O
of	|O
anemia	|O
in	|O
multiple	|O
myeloma	|O

In	|O
1993	|O
and	|O
1994	|O
and	|O
infection	|O
with	|O
body	|O
lice	|O
was	|O
registered	|O
41	|O
times	|O
in	|O
31	|O
patients	|O
at	|O
the	|O
clinic	|O
for	|O
homeless	|O
of	|O
the	|O
Community	|O
Health	|O
Service	|O
of	|O
Utrecht	|O
.	|O

Ki	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
and	|O
p53	|B-PROTEIN
mutations	|O
in	|O
pancreatic	|O
ductal	|O
adenocarcinoma	|O
.	|O

Epidemiological	|O
data	|O
are	|O
quite	|O
controversial	|O
but	|O
sudden	|O
death	|O
occurring	|O
during	|O
sporting	|O
activity	|O
is	|O
probably	|O
not	|O
a	|O
rare	|O
occurrence	|O
.	|O

However	|O
,	|O
the	|O
ratio	|O
M	|O
/	|O
Pc	|O
provides	|O
a	|O
useful	|O
index	|O
that	|O
seems	|O
to	|O
be	|O
independent	|O
of	|O
the	|O
metabolic	|O
demand	|O
.	|O

Rat	|O
liver	|O
catalase	|B-PROTEIN
is	|O
sorted	|O
to	|O
peroxisomes	|O
by	|O
its	|O
C	|O
-	|O
terminal	|O
tripeptide	|O
Ala	|O
-	|O
Asn	|O
-	|O
Leu	|O
,	|O
not	|O
by	|O
the	|O
internal	|O
Ser	|O
-	|O
Lys	|O
-	|O
Leu	|O
motif	|O
.	|O

The	|O
mobility	|O
shift	|O
assay	|O
of	|O
the	|O
65	|O
bp	|O
(	|O
-	|O
318	|O
/	|O
-	|O
254	|O
)	|O
fragment	|O
with	|O
nuclear	|O
extract	|O
from	|O
the	|O
dark	|O
-	|O
adapted	|O
sample	|O
showed	|O
an	|O
additional	|O
band	|O
,	|O
not	|O
seen	|O
with	|O
the	|O
light	|O
-	|O
grown	|O
sample	|O
.	|O

These	|O
data	|O
provide	|O
strong	|O
evidence	|O
that	|O
E2F	|B-PROTEIN
or	|O
an	|O
E2F	|B-PROTEIN
-	|O
related	|O
transcription	|O
factor	|O
is	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
nonmuscle	|O
myosin	|B-PROTEIN
expression	|O
.	|O

When	|O
the	|O
E1A	|B-PROTEIN
N	|O
-	|O
terminus	|O
is	|O
used	|O
as	|O
a	|O
competitor	|O
in	|O
squelshing	|O
experiments	|O
it	|O
abolishes	|O
CBP	|B-PROTEIN
-	|O
induced	|O
activation	|O
of	|O
E2F1	|B-PROTEIN
/	|O
DP1	|B-PROTEIN
,	|O
whereas	|O
an	|O
E1A	|B-PROTEIN
mutant	|O
lacking	|O
CBP	|B-PROTEIN
binding	|O
ability	|O
fails	|O
to	|O
do	|O
so	|O
.	|O

Small	|O
Maf	|B-PROTEIN
proteins	|O
interact	|O
with	|O
the	|O
human	|O
transcription	|O
factor	|O
TCF11	|B-PROTEIN
/	|O
Nrf1	|B-PROTEIN
/	|O
LCR	|B-PROTEIN
-	|I-PROTEIN
F1	|I-PROTEIN
.	|O

On	|O
the	|O
third	|O
occasion	|O
water	|O
(	|O
W	|O
)	|O
was	|O
ingested	|O
throughout	|O
the	|O
run	|O
.	|O

The	|O
effect	|O
of	|O
maternal	|O
ingestion	|O
of	|O
the	|O
reduced	|O
energy	|O
sweetener	|O
erythritol	|O
was	|O
investigated	|O
in	|O
KBL	|O
:	|O
JW	|O
strain	|O
pregnant	|O
rabbits	|O
.	|O

Moreover	|O
,	|O
the	|O
same	|O
mutations	|O
alter	|O
the	|O
structure	|O
of	|O
junB	|B-PROTEIN
5'	|O
flanking	|O
DNA	|O
within	|O
chromatin	|O
.	|O

The	|O
nm23	|B-PROTEIN
-	|I-PROTEIN
H1	|I-PROTEIN
/	|O
nm23	|B-PROTEIN
-	|I-PROTEIN
H2	|I-PROTEIN
gene	|O
transcriptional	|O
activity	|O
ratio	|O
varied	|O
depending	|O
on	|O
the	|O
cell	|O
line	|O
.	|O

CONCLUSION	|O
:	|O
Intravenous	|O
diazepam	|O
administration	|O
before	|O
EGD	|O
produces	|O
a	|O
significant	|O
fall	|O
in	|O
SpO2	|O
during	|O
the	|O
procedure	|O
,	|O
and	|O
so	|O
should	|O
be	|O
avoided	|O
;	|O
continuous	|O
monitoring	|O
of	|O
SpO2	|O
should	|O
be	|O
done	|O
during	|O
EGD	|O
.	|O

The	|O
nucleotide	|O
sequence	|O
alignment	|O
between	|O
mouse	|O
and	|O
human	|O
CA	|B-PROTEIN
IV	|I-PROTEIN
shows	|O
69%	|O
identity	|O
in	|O
the	|O
coding	|O
region	|O
and	|O
all	|O
of	|O
the	|O
exon	|O
-	|O
intron	|O
boundaries	|O
are	|O
conserved	|O
,	|O
as	|O
are	|O
the	|O
sizes	|O
of	|O
the	|O
introns	|O
.	|O

Discordance	|O
on	|O
the	|O
cost	|O
dimension	|O
correlated	|O
negatively	|O
with	|O
G	|B-PROTEIN
Hb	|I-PROTEIN
,	|O
suggesting	|O
better	|O
glycemic	|O
control	|O
with	|O
greater	|O
disagreement	|O
.	|O

DATA	|O
SOURCES	|O
:	|O
Epidemiologic	|O
studies	|O
,	|O
research	|O
studies	|O
,	|O
review	|O
articles	|O
,	|O
and	|O
government	|O
reports	|O
pertaining	|O
to	|O
epidemiology	|O
of	|O
lung	|O
cancer	|O
.	|O

RESULTS	|O
:	|O
The	|O
age	|O
distribution	|O
was	|O
28	|O
to	|O
83	|O
years	|O
old	|O
(	|O
mean	|O
was	|O
54.1	|O
years	|O
)	|O
.	|O

Histological	|O
changes	|O
,	|O
including	|O
cortical	|O
cell	|O
involution	|O
and	|O
hemorrhage	|O
occurring	|O
during	|O
the	|O
neonatal	|O
period	|O
,	|O
would	|O
seem	|O
to	|O
have	|O
crucial	|O
relevance	|O
to	|O
the	|O
remodeling	|O
of	|O
the	|O
adrenal	|O
vasculature	|O
.	|O

Furthermore	|O
,	|O
co	|O
-	|O
expression	|O
of	|O
both	|O
p46	|B-PROTEIN
and	|O
p54	|B-PROTEIN
subunits	|O
markedly	|O
altered	|O
the	|O
subcellular	|O
distribution	|O
of	|O
p46	|B-PROTEIN
;	|O
co	|O
-	|O
expressed	|O
p46	|B-PROTEIN
was	|O
transported	|O
into	|O
the	|O
nucleus	|O
as	|O
efficiently	|O
as	|O
p54	|B-PROTEIN
.	|O

The	|O
results	|O
suggest	|O
that	|O
,	|O
although	|O
both	|O
the	|O
N	|O
-	|O
and	|O
C	|O
-	|O
terminal	|O
regions	|O
of	|O
talin	|B-PROTEIN
bind	|O
actin	|B-PROTEIN
,	|O
the	|O
properties	|O
of	|O
these	|O
two	|O
regions	|O
of	|O
the	|O
protein	|O
are	|O
distinct	|O
.	|O

Merr	|O
.	|O
)	|O
embryo	|O
library	|O
.	|O

The	|O
accumulation	|O
of	|O
both	|O
LHA4	|B-PROTEIN
and	|O
LHA2	|B-PROTEIN
mRNAs	|O
is	|O
induced	|O
by	|O
the	|O
addition	|O
of	|O
exogenous	|O
sugars	|O
and	|O
this	|O
induction	|O
appears	|O
to	|O
be	|O
dependent	|O
on	|O
sugar	|O
uptake	|O
and	|O
metabolism	|O
,	|O
because	|O
mannitol	|O
and	|O
3	|O
-	|O
O	|O
-	|O
methylglucose	|O
do	|O
not	|O
stimulate	|O
mRNA	|O
accumulation	|O
.	|O

Using	|O
the	|O
yeast	|O
one	|O
-	|O
hybrid	|O
screen	|O
with	|O
integrated	|O
NRE	|O
and	|O
flanking	|O
DNA	|O
as	|O
bait	|O
,	|O
the	|O
predominant	|O
clone	|O
obtained	|O
was	|O
bovine	|O
Nrl	|B-PROTEIN
.	|O

As	|O
the	|O
rate	|O
of	|O
protein	|O
synthesis	|O
decreases	|O
during	|O
late	|O
embryogenesis	|O
,	|O
levels	|O
of	|O
SEC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
its	|O
cognate	|O
mRNA	|O
decline	|O
precipitously	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
fodrin	|B-PROTEIN
proteolysis	|O
in	|O
vivo	|O
may	|O
reflect	|O
the	|O
activity	|O
of	|O
multiple	|O
ICE	|B-PROTEIN
/	|O
Ced	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
proteases	|O
whose	|O
partial	|O
sensitivity	|O
to	|O
DEVD	|O
-	|O
CHO	|O
reflects	|O
a	|O
limited	|O
contribution	|O
from	|O
CPP32	|B-PROTEIN
,	|O
or	|O
an	|O
ICE	|B-PROTEIN
/	|O
Ced	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
protease	|O
less	|O
sensitive	|O
than	|O
CPP32	|B-PROTEIN
to	|O
DEVD	|O
-	|O
CHO	|O
inhibition	|O
.	|O

In	|O
3Y1	|O
and	|O
3Y1	|O
v	|B-PROTEIN
-	|I-PROTEIN
crk	|I-PROTEIN
-	|O
transformed	|O
fibroblasts	|O
,	|O
almost	|O
all	|O
of	|O
the	|O
total	|O
PTP1B	|B-PROTEIN
and	|O
about	|O
40%	|O
of	|O
total	|O
p130	|B-PROTEIN
(	|O
Cas	|B-PROTEIN
)	|O
co	|O
-	|O
sediment	|O
with	|O
membranes	|O
composed	|O
primarily	|O
of	|O
endoplasmic	|O
reticulum	|O
.	|O

Replacing	|O
residues	|O
405-419	|O
on	|O
delta419	|O
with	|O
the	|O
conserved	|O
AF	|O
-	|O
2	|O
domain	|O
from	|O
the	|O
vitamin	|B-PROTEIN
D3	|I-PROTEIN
receptor	|I-PROTEIN
or	|O
the	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
results	|O
in	|O
a	|O
receptor	|O
with	|O
wild	|O
-	|O
type	|O
or	|O
low	|O
transcriptional	|O
activity	|O
,	|O
respectively	|O
.	|O

Recurrent	|O
G	|O
-	|O
to	|O
-	|O
A	|O
substitution	|O
in	|O
a	|O
single	|O
codon	|O
of	|O
SREBP	|B-PROTEIN
cleavage	|O
-	|O
activating	|O
protein	|O
causes	|O
sterol	|O
resistance	|O
in	|O
three	|O
mutant	|O
Chinese	|O
hamster	|O
ovary	|O
cell	|O
lines	|O
.	|O

The	|O
Escherichia	|O
coli	|O
tet	|B-PROTEIN
-	|I-PROTEIN
repressor	|I-PROTEIN
(	|O
TetR	|B-PROTEIN
)	|O
operator	|O
system	|O
was	|O
used	|O
to	|O
develop	|O
a	|O
variation	|O
of	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
assay	|O
in	|O
which	|O
disruptions	|O
of	|O
protein	|O
-	|O
protein	|O
interactions	|O
can	|O
be	|O
identified	|O
by	|O
a	|O
positive	|O
selection	|O
.	|O

Recent	|O
studies	|O
have	|O
suggested	|O
that	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
regulates	|O
the	|O
function	|O
of	|O
Jak	|B-PROTEIN
family	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
,	|O
as	|O
shown	|O
by	|O
its	|O
constitutive	|O
association	|O
with	|O
the	|O
Tyk2	|B-PROTEIN
kinase	|I-PROTEIN
and	|O
the	|O
hyperphosphorylation	|O
of	|O
Jak	|B-PROTEIN
kinases	|I-PROTEIN
in	|O
the	|O
motheaten	|O
cells	|O
that	|O
lack	|O
functional	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Administration	|O
of	|O
a	|O
second	|O
dose	|O
of	|O
vaccine	|O
during	|O
the	|O
outbreak	|O
was	|O
not	|O
protective	|O
.	|O

But	|O
,	|O
as	|O
Theriault	|O
explains	|O
,	|O
improvements	|O
in	|O
assessing	|O
exposure	|O
have	|O
not	|O
yet	|O
translated	|O
into	|O
clear	|O
and	|O
consistent	|O
findings	|O
.	|O

Biol.	|O

Structural	|O
basis	|O
for	|O
activation	|O
of	|O
human	|B-PROTEIN
lymphocyte	|I-PROTEIN
kinase	|I-PROTEIN
Lck	|O
upon	|O
tyrosine	|O
phosphorylation	|O
.	|O

Evolutive	|O
morphology	|O
of	|O
the	|O
olfactory	|O
bulb	|O
in	|O
man	|O
and	|O
certain	|O
non	|O
-	|O
human	|O
mammals	|O

From	|O
these	|O
results	|O
,	|O
we	|O
concluded	|O
that	|O
this	|O
ORF	|O
is	|O
the	|O
FRDS	|B-PROTEIN
gene	|O
.	|O

FK506	|O
is	|O
10	|O
-	|O
to	|O
100	|O
-	|O
fold	|O
more	|O
potent	|O
than	|O
cyclosporin	|O
A	|O
in	|O
preventing	|O
organ	|O
rejection	|O
and	|O
in	|O
toxicity	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
Rho1p	|B-PROTEIN
regulates	|O
cytoskeletal	|O
reorganization	|O
at	|O
least	|O
through	|O
Bni1p	|B-PROTEIN
and	|O
Pkc1p	|B-PROTEIN
.	|O

The	|O
ERH	|B-PROTEIN
expression	|O
profile	|O
is	|O
similar	|O
,	|O
to	|O
that	|O
of	|O
An3	|B-PROTEIN
,	|O
which	|O
localizes	|O
to	|O
the	|O
animal	|O
hemisphere	|O
of	|O
oocytes	|O
and	|O
is	|O
abundantly	|O
expressed	|O
in	|O
the	|O
embryo	|O
.	|O

Waves	|O
N1	|O
,	|O
P3	|O
and	|O
CNV	|O
were	|O
recorded	|O
during	|O
a	|O
CNV	|O
paradigm	|O
in	|O
a	|O
simple	|O
reaction	|O
time	|O
task	|O
with	|O
a	|O
constant	|O
interstimulus	|O
interval	|O
(	|O
ISI	|O
)	|O
of	|O
1	|O
sec	|O
.	|O

Therefore	|O
,	|O
both	|O
the	|O
Chilean	|O
and	|O
the	|O
Japanese	|O
samples	|O
collected	|O
in	|O
high	|O
-	|O
risk	|O
areas	|O
showed	|O
higher	|O
mutagenic	|O
rates	|O
than	|O
the	|O
Japanese	|O
ones	|O
in	|O
a	|O
low	|O
-	|O
risk	|O
area	|O
,	|O
with	|O
a	|O
statistical	|O
significance	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
,	|O
chi	|O
-	|O
square	|O
test	|O
)	|O
.	|O

Regulation	|O
of	|O
ASN1	|B-PROTEIN
and	|O
ASN2	|B-PROTEIN
expression	|O
was	|O
studied	|O
using	|O
lacZ	|B-PROTEIN
fusions	|O
and	|O
both	|O
genes	|O
were	|O
found	|O
to	|O
be	|O
several	|O
times	|O
less	|O
expressed	|O
in	|O
the	|O
absence	|O
of	|O
the	|O
transcription	|O
activator	|O
Gcn4p	|B-PROTEIN
.	|O

Several	|O
particular	|O
features	|O
of	|O
this	|O
polypeptide	|O
fragment	|O
from	|O
the	|O
hamster	|O
lysyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
suggest	|O
that	|O
it	|O
is	|O
implicated	|O
in	|O
the	|O
assembly	|O
of	|O
that	|O
enzyme	|O
within	|O
the	|O
multisynthetase	|O
complex	|O
.	|O

He	|O
is	|O
well	|O
,	|O
five	|O
years	|O
after	|O
relapse	|O
.	|O

Comparison	|O
of	|O
the	|O
proportion	|O
of	|O
nonsynonymous	|O
(	|O
pN	|O
)	|O
and	|O
synonymous	|O
(	|O
pS	|O
)	|O
substitutions	|O
occurring	|O
per	|O
site	|O
within	|O
tamarin	|O
variable	|B-PROTEIN
region	|O
genes	|O
demonstrated	|O
a	|O
reduction	|O
in	|O
pN	|O
in	|O
the	|O
framework	|O
regions	|O
compared	|O
with	|O
pN	|O
in	|O
the	|O
presumed	|O
MHC	|B-PROTEIN
contact	|O
regions	|O
(	|O
CDR1	|B-PROTEIN
and	|O
CDR2	|B-PROTEIN
)	|O
.	|O

The	|O
effects	|O
of	|O
oral	|O
vanadyl	|O
sulfate	|O
(	|O
VOSO4	|O
)	|O
(	|O
0.5	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
)	|O
on	|O
anthropometry	|O
,	|O
body	|O
composition	|O
,	|O
and	|O
performance	|O
were	|O
investigated	|O
in	|O
a	|O
12	|O
-	|O
week	|O
,	|O
double	|O
-	|O
blind	|O
,	|O
placebo	|O
-	|O
controlled	|O
trial	|O
involving	|O
weight	|O
-	|O
training	|O
volunteers	|O
.	|O

Later	|O
in	|O
development	|O
,	|O
Tbx6	|B-PROTEIN
expression	|O
is	|O
restricted	|O
to	|O
presomitic	|O
,	|O
paraxial	|O
mesoderm	|O
and	|O
to	|O
the	|O
tail	|O
bud	|O
,	|O
which	|O
replaces	|O
the	|O
streak	|O
as	|O
the	|O
source	|O
of	|O
mesoderm	|O
.	|O

Disruption	|O
of	|O
re	|O
-	|O
replication	|O
control	|O
by	|O
overexpression	|O
of	|O
human	|O
ORC1	|B-PROTEIN
in	|O
fission	|O
yeast	|O
.	|O

Our	|O
results	|O
demonstrate	|O
that	|O
the	|O
promoter	|O
and	|O
enhancer	|O
regions	|O
identified	|O
here	|O
are	|O
essential	|O
for	|O
maintaining	|O
the	|O
efficient	|O
promoter	|O
activity	|O
of	|O
the	|O
human	|O
activin	|B-PROTEIN
betaA	|O
subunit	|O
gene	|O
.	|O

Recombinant	|O
,	|O
bacterially	|O
expressed	|O
PIP5KIalpha	|B-PROTEIN
possessed	|O
PIP5K	|B-PROTEIN
activity	|O
and	|O
was	|O
immunoreactive	|O
with	|O
erythroid	|O
PIP5KI	|B-PROTEIN
antibodies	|O
.	|O

Human	|O
acid	|B-PROTEIN
ceramidase	|I-PROTEIN
(	|O
(	|O
AC	|B-PROTEIN
)	|O
N	|O
-	|O
acylsphingosine	|O
amidohydrolase	|O
,	|O
EC	|B-PROTEIN
3.5	|I-PROTEIN
.	|O

The	|O
0.22	|O
-	|O
kb	|O
NheI	|B-PROTEIN
/	|O
BglII	|B-PROTEIN
promoter	|O
exhibited	|O
PMA	|O
inducibility	|O
in	|O
myeloid	|O
cells	|O
and	|O
contained	|O
a	|O
PMA	|O
-	|O
responsive	|O
element	|O
recognized	|O
by	|O
Sp1	|B-PROTEIN
and	|O
EGR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
transcription	|O
factors	|O
.	|O

Northern	|O
(	|O
RNA	|O
)	|O
blot	|O
analyses	|O
indicated	|O
that	|O
the	|O
cdh	|B-PROTEIN
genes	|O
encoding	|O
the	|O
five	|O
subunits	|O
and	|O
an	|O
open	|O
reading	|O
frame	|O
(	|O
ORF1	|O
)	|O
with	|O
unknown	|O
function	|O
are	|O
cotranscribed	|O
during	|O
growth	|O
on	|O
acetate	|O
.	|O

Two	|O
classes	|O
of	|O
mutations	|O
were	|O
obtained	|O
:	|O
(	|O
i	|O
)	|O
those	|O
that	|O
altered	|O
the	|O
coding	|O
region	|O
of	|O
HOL1	|B-PROTEIN
,	|O
conferring	|O
the	|O
ability	|O
to	|O
take	|O
up	|O
histidinol	|O
;	|O
and	|O
(	|O
ii	|O
)	|O
cis	|O
-	|O
acting	|O
mutations	|O
(	|O
selected	|O
in	|O
a	|O
mutant	|O
HOL1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
background	|O
)	|O
that	|O
increased	|O
expression	|O
of	|O
the	|O
Hol1	|B-PROTEIN
protein	|O
.	|O

Damage	|O
to	|O
the	|O
BBB	|O
was	|O
judged	|O
by	|O
extravasation	|O
of	|O
Evans	|O
Blue	|O
(	|O
EB	|O
)	|O
dye	|O
,	|O
which	|O
was	|O
administered	|O
either	|O
2	|O
,	|O
3	|O
,	|O
24	|O
or	|O
48	|O
h	|O
after	|O
onset	|O
of	|O
MCAo	|O
.	|O

Lipid	|O
hydroperoxide	|O
levels	|O
in	|O
plasma	|O
and	|O
LDL	|B-PROTEIN
remained	|O
unchanged	|O
throughout	|O
the	|O
study	|O
.	|O

When	|O
the	|O
degree	|O
of	|O
exercise	|O
was	|O
maximal	|O
,	|O
mPAP	|O
was	|O
maintained	|O
,	|O
SVI	|O
decreased	|O
,	|O
HR	|O
was	|O
unchanged	|O
,	|O
and	|O
CO	|O
and	|O
VO2	|O
decreased	|O
.	|O

We	|O
report	|O
a	|O
case	|O
of	|O
vasculitis	|O
(	|O
cutaneous	|O
and	|O
neurologic	|O
)	|O
which	|O
led	|O
to	|O
the	|O
discovery	|O
of	|O
a	|O
selective	|O
immunodeficit	|O
towards	|O
EBV	|O
,	|O
similar	|O
to	|O
Purtilo	|O
's	|O
syndrome	|O
.	|O

To	|O
elucidate	|O
whether	|O
potential	|O
endocrine	|O
changes	|O
resulted	|O
from	|O
acute	|O
hypoxaemia	|O
alone	|O
,	|O
the	|O
underlying	|O
disease	|O
,	|O
or	|O
unspecific	|O
influences	|O
connected	|O
with	|O
the	|O
ICU	|O
setting	|O
,	|O
all	|O
measurements	|O
were	|O
compared	|O
to	|O
those	|O
of	|O
a	|O
completely	|O
healthy	|O
reference	|O
group	|O
(	|O
REF	|O
)	|O
with	|O
comparable	|O
acute	|O
experimental	|O
hypoxaemia	|O
.	|O

There	|O
were	|O
no	|O
significant	|O
differences	|O
in	|O
graft	|O
survival	|O
between	|O
groups	|O
with	|O
early	|O
graft	|O
function	|O
(	|O
EGF	|O
)	|O
and	|O
DGF	|O
,	|O
either	|O
in	|O
first	|O
transplantations	|O
or	|O
retransplantations	|O
.	|O

These	|O
results	|O
suggested	|O
that	|O
the	|O
GG	|O
motifs	|O
contributed	|O
to	|O
the	|O
cell	|O
-	|O
specific	|O
transcription	|O
of	|O
the	|O
human	|O
insulin	|B-PROTEIN
gene	|O
in	|O
association	|O
with	|O
the	|O
binding	|O
of	|O
the	|O
sequence	|O
-	|O
specific	|O
nuclear	|O
factor	|O
.	|O

Abnormal	|O
urinary	|O
coproporphyrin	|O
levels	|O
in	|O
patients	|O
infected	|O
by	|O
hepatitis	|O
C	|O
virus	|O
with	|O
or	|O
without	|O
human	|O
immunodeficiency	|O
virus	|O
.	|O

The	|O
determination	|O
of	|O
immunoglobulin	|B-PROTEIN
E	|I-PROTEIN
(	|O
IgE	|B-PROTEIN
)	|O
antibodies	|O
by	|O
one	|O
of	|O
several	|O
laboratory	|O
tests	|O
,	|O
by	|O
skin	|O
-	|O
prick	|O
tests	|O
or	|O
by	|O
appropriate	|O
challenge	|O
procedures	|O
is	|O
useful	|O
either	|O
to	|O
identify	|O
atopic	|O
individuals	|O
or	|O
as	|O
outcome	|O
predictors	|O
in	|O
wheezy	|O
children	|O
.	|O

Thrombosis	|O
of	|O
the	|O
renal	|O
vein	|O
may	|O
be	|O
dramatic	|O
and	|O
include	|O
renal	|O
failure	|O
.	|O

Filter	|O
and	|O
cytocentrifuge	|O
preparations	|O
of	|O
the	|O
urine	|O
were	|O
studied	|O
and	|O
all	|O
cases	|O
displayed	|O
numerous	|O
scattered	|O
aggregates	|O
or	|O
single	|O
tumor	|O
cells	|O
in	|O
an	|O
inflammatory	|O
background	|O
.	|O

327	|O
and	|O
736	|O
protocols	|O
of	|O
postmortem	|O
examinations	|O
from	|O
Moscow	|O
hospitals	|O
N	|O
31	|O
and	|O
57	|O
,	|O
respectively	|O
,	|O
were	|O
evaluated	|O
statistically	|O
.	|O

The	|O
promoter	|O
segment	|O
was	|O
inactive	|O
when	|O
introduced	|O
into	|O
the	|O
rat	|O
glioma	|O
cell	|O
line	|O
C6B4	|O
,	|O
the	|O
rat	|O
submandibular	|O
cell	|O
line	|O
RSMT	|O
-	|O
A5	|O
,	|O
and	|O
the	|O
rat	|O
pancreatic	|O
beta	|O
cell	|O
line	|O
RIN	|O
-	|O
5AH	|O
,	|O
all	|O
of	|O
which	|O
do	|O
not	|O
express	|O
the	|O
endogenous	|O
alpha2c	|B-PROTEIN
-	|I-PROTEIN
AR	|I-PROTEIN
gene	|O
.	|O

The	|O
sequencing	|O
of	|O
the	|O
conditional	|O
lethal	|O
mutation	|O
ts	|O
-	|O
A13	|O
,	|O
localized	|O
in	|O
the	|O
nrdE	|B-PROTEIN
cistron	|O
,	|O
and	|O
the	|O
lethality	|O
of	|O
insertional	|O
mutations	|O
targeted	|O
in	|O
the	|O
internal	|O
region	|O
of	|O
nrdE	|B-PROTEIN
and	|O
nrdF	|B-PROTEIN
,	|O
demonstrated	|O
the	|O
essential	|O
role	|O
of	|O
this	|O
locus	|O
.	|O

The	|O
microdensitometric	|O
scores	|O
and	|O
their	|O
side	|O
-	|O
to	|O
-	|O
side	|O
differences	|O
in	|O
patients	|O
correlated	|O
negatively	|O
with	|O
the	|O
serum	|O
25	|O
-	|O
OHD	|O
concentration	|O
and	|O
positively	|O
with	|O
the	|O
degree	|O
of	|O
paralysis	|O
.	|O

These	|O
data	|O
do	|O
not	|O
support	|O
the	|O
use	|O
of	|O
LDD	|O
to	|O
reduce	|O
risk	|O
of	|O
progression	|O
to	|O
MSOF	|O
in	|O
sepsis	|O
.	|O

This	|O
correlated	|O
with	|O
reduced	|O
levels	|O
of	|O
secreted	|O
hepatitis	|O
B	|O
e	|B-PROTEIN
antigen	|I-PROTEIN
and	|O
increased	|O
intracellular	|O
levels	|O
of	|O
core	|B-PROTEIN
and	|O
Pol	|B-PROTEIN
proteins	|O
and	|O
replicative	|O
HBV	|O
DNA	|O
intermediates	|O
.	|O

In	|O
contrast	|O
,	|O
extracts	|O
of	|O
the	|O
mutant	|O
virions	|O
catalyze	|O
the	|O
wild	|O
-	|O
type	|O
level	|O
of	|O
transcription	|O
from	|O
an	|O
exogenous	|O
template	|O
containing	|O
an	|O
early	|O
promoter	|O
.	|O

The	|O
SCMV	|O
SNE	|B-PROTEIN
sites	|O
contain	|O
potential	|O
overlapping	|O
core	|O
recognition	|O
binding	|O
motifs	|O
for	|O
SRF	|B-PROTEIN
,	|O
Rel	|B-PROTEIN
/	|O
NFkappaB	|B-PROTEIN
,	|O
ETS	|B-PROTEIN
,	|O
and	|O
YY1	|B-PROTEIN
class	|O
transcription	|O
factors	|O
but	|O
fail	|O
to	|O
respond	|O
to	|O
either	|O
serum	|O
or	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
.	|O

Upon	|O
serum	|O
withdrawal	|O
at	|O
the	|O
permissive	|O
temperature	|O
,	|O
p53	|B-PROTEIN
-	|O
mediated	|O
apoptosis	|O
was	|O
induced	|O
in	|O
50	|O
to	|O
60%	|O
of	|O
the	|O
cells	|O
.	|O

To	|O
circumvent	|O
this	|O
problem	|O
,	|O
a	|O
simple	|O
two	|O
-	|O
step	|O
strategy	|O
was	|O
devised	|O
by	|O
which	|O
essential	|O
cis	|O
-	|O
acting	|O
sites	|O
like	|O
the	|O
a	|O
sequence	|O
can	|O
be	|O
readily	|O
deleted	|O
from	|O
their	|O
natural	|O
loci	|O
in	|O
large	|O
viral	|O
DNA	|O
genomes	|O
.	|O

On	|O
the	|O
basis	|O
of	|O
serological	|O
studies	|O
,	|O
the	|O
highly	|O
conserved	|O
A	|O
domain	|O
of	|O
HspA	|B-PROTEIN
was	|O
found	|O
to	|O
be	|O
the	|O
immunodominant	|O
domain	|O
.	|O

In	|O
Group	|O
IV	|O
dogs	|O
that	|O
received	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
MSH	|I-PROTEIN
only	|O
during	|O
reperfusion	|O
,	|O
BAEPs	|O
were	|O
increased	|O
approximately	|O
10	|O
to	|O
14%	|O
more	|O
than	|O
in	|O
Group	|O
II	|O
during	|O
the	|O
late	|O
reperfusion	|O
period	|O
.	|O

The	|O
Fas	|B-PROTEIN
receptor	|I-PROTEIN
mediates	|O
a	|O
signalling	|O
cascade	|O
resulting	|O
in	|O
programmed	|O
cell	|O
death	|O
(	|O
apoptosis	|O
)	|O
within	|O
hours	|O
of	|O
receptor	|O
cross	|O
-	|O
linking	|O
.	|O

Fas	|B-PROTEIN
has	|O
been	|O
shown	|O
to	|O
require	|O
ICE	|B-PROTEIN
(	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
)	|O
family	|O
proteases	|O
to	|O
induce	|O
apoptosis	|O
from	|O
studies	|O
utilizing	|O
the	|O
cowpox	|O
ICE	|B-PROTEIN
inhibitor	|O
protein	|O
CrmA	|B-PROTEIN
,	|O
the	|O
synthetic	|O
tetrapeptide	|O
ICE	|B-PROTEIN
inhibitor	|O
YVAD	|B-PROTEIN
-	|I-PROTEIN
CMK	|I-PROTEIN
,	|O
and	|O
the	|O
tripeptide	|O
pan	|O
-	|O
ICE	|B-PROTEIN
inhibitor	|O
Z	|B-PROTEIN
-	|I-PROTEIN
VAD	|I-PROTEIN
-	|I-PROTEIN
FMK	|I-PROTEIN
.	|O

The	|O
imprinted	|O
expression	|O
of	|O
the	|O
endogenous	|O
gene	|O
can	|O
be	|O
recapitulated	|O
in	|O
mice	|O
by	|O
using	|O
a	|O
14	|O
-	|O
kb	|O
transgene	|O
encompassing	|O
4	|O
kb	|O
of	|O
5'	|O
-	|O
flanking	|O
sequence	|O
,	|O
8	|O
kb	|O
of	|O
3'	|O
-	|O
flanking	|O
sequence	|O
,	|O
which	|O
includes	|O
the	|O
two	|O
endoderm	|O
-	|O
specific	|O
enhancers	|O
,	|O
and	|O
an	|O
internally	|O
deleted	|O
structural	|O
gene	|O
.	|O

In	|O
this	|O
report	|O
,	|O
we	|O
demonstrate	|O
that	|O
hGCN5	|B-PROTEIN
is	|O
also	|O
an	|O
HAT	|B-PROTEIN
and	|O
has	|O
the	|O
same	|O
substrate	|O
specificity	|O
as	|O
yGCN5	|B-PROTEIN
.	|O

The	|O
effect	|O
of	|O
six	|O
arginine	|O
mutations	|O
of	|O
oxidative	|O
phosphorylation	|O
and	|O
AAC	|B-PROTEIN
expression	|O
.	|O

Complementary	|O
DNAs	|O
encompassing	|O
the	|O
coat	|B-PROTEIN
protein	|O
coding	|O
and	|O
adjacent	|O
regions	|O
of	|O
Agropyron	|O
mosaic	|O
virus	|O
(	|O
AgMV	|O
)	|O
and	|O
Hordeum	|O
mosaic	|O
virus	|O
(	|O
HoMV	|O
)	|O
were	|O
cloned	|O
and	|O
sequenced	|O
.	|O

In	|O
some	|O
cases	|O
,	|O
factor	|O
-	|O
induced	|O
Rac	|B-PROTEIN
activation	|O
results	|O
in	|O
Rho	|B-PROTEIN
activation	|O
,	|O
and	|O
factor	|O
-	|O
induced	|O
Cdc42	|B-PROTEIN
activation	|O
leads	|O
to	|O
Rac	|B-PROTEIN
activation	|O
,	|O
as	|O
determined	|O
by	|O
specific	|O
morphological	|O
changes	|O
.	|O

Several	|O
cDNAs	|O
corresponding	|O
to	|O
the	|O
human	|O
PWP2	|B-PROTEIN
gene	|O
were	|O
identified	|O
and	|O
partially	|O
sequenced	|O
.	|O

Isolation	|O
and	|O
genomic	|O
structure	|O
of	|O
a	|O
human	|O
homolog	|O
of	|O
the	|O
yeast	|O
periodic	|B-PROTEIN
tryptophan	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
(	|O
PWP2	|B-PROTEIN
)	|O
gene	|O
mapping	|O
to	|O
21q22.3	|O
.	|O

Patterns	|O
defined	|O
by	|O
combinations	|O
of	|O
normal	|O
and	|O
abnormal	|O
laboratory	|O
results	|O
had	|O
decreased	|O
the	|O
likelihood	|O
of	|O
PEM	|O
from	|O
an	|O
all	|O
-	|O
2	|O
to	|O
all	|O
-	|O
0	|O
pattern	|O
.	|O

To	|O
examine	|O
whether	|O
thiamine	|O
(	|O
vitamin	|O
B1	|O
)	|O
deficiency	|O
is	|O
associated	|O
with	|O
recurrent	|O
aphthous	|O
stomatitis	|O
,	|O
we	|O
studied	|O
vitamin	|O
B1	|O
levels	|O
in	|O
70	|O
patients	|O
with	|O
recurrent	|O
aphthous	|O
stomatitis	|O
and	|O
in	|O
50	|O
members	|O
of	|O
a	|O
control	|O
group	|O
.	|O

Liver	|O
injuries	|O

By	|O
screening	|O
a	|O
cDNA	|O
library	|O
with	|O
a	|O
probe	|O
derived	|O
from	|O
sequences	|O
downstream	|O
of	|O
the	|O
p53p2	|B-PROTEIN
start	|O
site	|O
,	|O
we	|O
have	|O
cloned	|O
and	|O
characterized	|O
a	|O
cDNA	|O
that	|O
represents	|O
a	|O
mRNA	|O
that	|O
appears	|O
to	|O
have	|O
been	|O
initiated	|O
from	|O
the	|O
p53p2	|B-PROTEIN
promoter	|O
.	|O

However	|O
,	|O
we	|O
did	|O
not	|O
observe	|O
a	|O
correlation	|O
between	|O
serum	|O
and	|O
seminal	|O
plasma	|O
PSA	|B-PROTEIN
levels	|O
.	|O

The	|O
implications	|O
for	|O
estimates	|O
of	|O
cortical	|O
magnification	|O
and	|O
possible	|O
differences	|O
in	|O
the	|O
specializations	|O
of	|O
foveal	|O
and	|O
peripheral	|O
vision	|O
are	|O
discussed	|O
.	|O

G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
activates	|O
multiple	|O
signaling	|O
molecules	|O
,	|O
including	|O
the	|O
JAK1	|B-PROTEIN
and	|O
JAK2	|B-PROTEIN
kinases	|O
and	|O
the	|O
STAT	|B-PROTEIN
transcription	|O
factors	|O
.	|O

Mutants	|O
lacking	|O
any	|O
tyrosine	|O
residues	|O
in	|O
the	|O
cytoplasmic	|O
domain	|O
maintain	|O
their	|O
ability	|O
to	|O
activate	|O
STAT5	|B-PROTEIN
and	|O
STAT1	|B-PROTEIN
but	|O
cannot	|O
activate	|O
STAT3	|B-PROTEIN
,	|O
implying	|O
that	|O
STAT5	|B-PROTEIN
and	|O
STAT1	|B-PROTEIN
activation	|O
does	|O
not	|O
require	|O
receptor	|O
tyrosine	|O
phosphorylation	|O
.	|O

The	|O
RI	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
is	|O
composed	|O
of	|O
nine	|O
coding	|O
exons	|O
of	|O
varying	|O
lengths	|O
,	|O
separated	|O
by	|O
introns	|O
,	|O
giving	|O
the	|O
gene	|O
a	|O
total	|O
length	|O
of	|O
at	|O
least	|O
21	|O
kb	|O
.	|O
our	|O
recent	|O
cloning	|O
of	|O
a	|O
processed	|O
RI	|B-PROTEIN
alpha	|I-PROTEIN
pseudogene	|O
with	|O
a	|O
5'	|O
-	|O
noncoding	|O
region	|O
different	|O
from	|O
the	|O
previously	|O
reported	|O
RI	|B-PROTEIN
alpha	|I-PROTEIN
complementary	|O
RNA	|O
indicated	|O
that	|O
the	|O
RI	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
may	|O
have	|O
multiple	|O
leader	|O
exons	|O
giving	|O
rise	|O
to	|O
alternately	|O
spliced	|O
messenger	|O
RNAs	|O
(	|O
mRNAs	|O
)	|O
.	|O

This	|O
establishes	|O
Rad3	|B-PROTEIN
/	|O
Mec1	|B-PROTEIN
as	|O
the	|O
only	|O
conserved	|O
protein	|O
which	|O
is	|O
required	|O
for	|O
all	|O
the	|O
DNA	|O
structure	|O
checkpoints	|O
in	|O
both	|O
yeast	|O
model	|O
systems	|O
.	|O

In	|O
addition	|O
,	|O
double	|O
mutants	|O
with	|O
either	|O
dim1	|B-PROTEIN
-	|I-PROTEIN
delta	|I-PROTEIN
or	|O
dim2	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
the	|O
endocytosis	|O
mutants	|O
end4	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
act1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
displayed	|O
synthetic	|O
growth	|O
defects	|O
,	|O
indicating	|O
that	|O
the	|O
DIM	|B-PROTEIN
gene	|O
products	|O
function	|O
in	|O
a	|O
common	|O
or	|O
parallel	|O
endocytic	|O
pathway	|O
.	|O

The	|O
identification	|O
of	|O
the	|O
hepatitis	|O
C	|O
virus	|O
as	|O
the	|O
major	|O
cause	|O
of	|O
liver	|O
disease	|O
both	|O
in	|O
dialysis	|O
patients	|O
and	|O
in	|O
transplant	|O
patients	|O
has	|O
focused	|O
attention	|O
on	|O
the	|O
epidemiology	|O
and	|O
the	|O
impact	|O
of	|O
continuing	|O
infection	|O
in	|O
these	|O
patient	|O
groups	|O
.	|O

Stable	|O
transfection	|O
of	|O
the	|O
BL	|O
cell	|O
line	|O
Raji	|O
with	|O
constructs	|O
containing	|O
core	|O
promoter	|O
mutations	|O
confirmed	|O
that	|O
the	|O
proximal	|O
Sp1	|B-PROTEIN
site	|O
and	|O
the	|O
TATA	|O
box	|O
are	|O
essential	|O
for	|O
the	|O
activation	|O
of	|O
promoter	|O
P1	|O
by	|O
the	|O
Ig	|B-PROTEIN
kappa	|I-PROTEIN
enhancers	|O
.	|O

Such	|O
multisensory	|O
interactions	|O
can	|O
be	|O
significant	|O
for	|O
behavior	|O
.	|O

The	|O
P13	|O
and	|O
N22	|O
of	|O
ppSEPs	|O
had	|O
phase	|O
reversal	|O
relationship	|O
with	|O
the	|O
P2	|O
and	|O
N2	|O
recorded	|O
from	|O
the	|O
PES	|O
,	|O
respectively	|O
.	|O

The	|O
cDNA	|O
of	|O
cpm7	|B-PROTEIN
encodes	|O
a	|O
closely	|O
related	|O
protein	|O
of	|O
36.8	|O
kDa	|O
.	|O

Finally	|O
,	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
ENBP1	|B-PROTEIN
shows	|O
strong	|O
homology	|O
to	|O
a	|O
protein	|O
from	|O
rat	|O
that	|O
is	|O
specifically	|O
expressed	|O
in	|O
testis	|O
tissue	|O
.	|O

The	|O
conservation	|O
of	|O
both	|O
the	|O
G	|O
-	|O
box	|O
and	|O
H	|O
-	|O
box	|O
in	|O
different	|O
CHS	|B-PROTEIN
promoters	|O
emphasizes	|O
their	|O
importance	|O
as	|O
regulatory	|O
motifs	|O
.	|O

Mortality	|O
on	|O
the	|O
last	|O
ranch	|O
was	|O
particularly	|O
severe	|O
among	|O
certain	|O
segregated	|O
groups	|O
of	|O
turkeys	|O
that	|O
included	|O
toms	|O
,	|O
heavier	|O
birds	|O
,	|O
and	|O
birds	|O
undergoing	|O
a	|O
stressful	|O
event	|O
such	|O
as	|O
artificial	|O
insemination	|O
.	|O

Further	|O
,	|O
the	|O
PIP2	|O
content	|O
of	|O
the	|O
85-90	|O
kDa	|O
protein	|O
appeared	|O
to	|O
decrease	|O
with	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
treatment	|O
.	|O

Further	|O
,	|O
the	|O
PIP2	|O
content	|O
of	|O
the	|O
85-90	|O
kDa	|O
protein	|O
appeared	|O
to	|O
decrease	|O
with	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
treatment	|O
.	|O

Just	|O
before	|O
inserting	|O
on	|O
the	|O
anterior	|O
margin	|O
and	|O
apex	|O
of	|O
the	|O
iliac	|O
crest	|O
it	|O
widens	|O
,	|O
assuming	|O
the	|O
aspect	|O
of	|O
a	|O
small	|O
cone	|O
.	|O

The	|O
first	|O
identification	|O
of	|O
the	|O
active	|O
37LRP	|B-PROTEIN
/	|O
p40	|B-PROTEIN
gene	|O
presented	|O
in	|O
this	|O
study	|O
is	|O
a	|O
critical	|O
step	|O
toward	|O
the	|O
isolation	|O
of	|O
the	|O
corresponding	|O
human	|O
gene	|O
and	|O
the	|O
understanding	|O
of	|O
the	|O
molecular	|O
mechanisms	|O
involved	|O
in	|O
the	|O
up	|O
-	|O
regulation	|O
of	|O
its	|O
expression	|O
during	|O
tumor	|O
invasion	|O
and	|O
metastasis	|O
.	|O

The	|O
promoter	|O
region	|O
(	|O
P1	|O
)	|O
corresponding	|O
to	|O
the	|O
main	|O
group	|O
of	|O
transcription	|O
initiation	|O
sites	|O
is	|O
devoid	|O
of	|O
TATA	|O
and	|O
CAAT	|O
boxes	|O
but	|O
has	|O
putative	|O
binding	|O
sites	|O
for	|O
the	|O
transcription	|O
factor	|O
SP1	|B-PROTEIN
and	|O
is	|O
embedded	|O
in	|O
a	|O
large	|O
G	|O
+	|O
C	|O
-	|O
rich	|O
domain	|O
of	|O
a	|O
CpG	|O
island	|O
,	|O
features	|O
shared	|O
by	|O
the	|O
promoters	|O
of	|O
constitutively	|O
expressed	|O
housekeeping	|O
genes	|O
.	|O

The	|O
STAT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
signaling	|O
pathway	|O
provides	|O
at	|O
least	|O
one	|O
mechanism	|O
for	|O
activation	|O
of	|O
the	|O
CAEV	|B-PROTEIN
LTR	|I-PROTEIN
by	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
in	|O
monocytes	|O
.	|O

Reperfusion	|O
caused	|O
a	|O
transient	|O
reduction	|O
in	|O
lactate	|O
production	|O
and	|O
a	|O
significant	|O
increase	|O
in	|O
LDH	|B-PROTEIN
release	|O
.	|O

To	|O
evaluate	|O
the	|O
hepatic	|O
regenerative	|O
response	|O
in	|O
patients	|O
with	|O
alcoholic	|O
liver	|O
disease	|O
,	|O
sera	|O
from	|O
263	|O
patients	|O
with	|O
severe	|O
alcoholic	|O
hepatitis	|O
and	|O
/	|O
or	|O
cirrhosis	|O
were	|O
analyzed	|O
for	|O
hepatocyte	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
HGF	|B-PROTEIN
)	|O
and	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
fetoprotein	|I-PROTEIN
(	|O
AFP	|B-PROTEIN
)	|O
.	|O

Children	|O
born	|O
from	|O
chronic	|O
alcoholic	|O
mothers	|O
have	|O
shown	|O
behavioral	|O
teratogenic	|O
effects	|O
more	|O
frequently	|O
than	|O
morphological	|O
malformations	|O
.	|O

INTERVENTION	|O
(	|O
S	|O
)	|O
:	|O
Twenty	|O
-	|O
six	|O
hemostasis	|O
parameters	|O
evaluated	|O
repeatedly	|O
in	|O
patients	|O
undergoing	|O
IVF	|O
-	|O
ET	|O
.	|O

Here	|O
we	|O
report	|O
that	|O
expression	|O
of	|O
the	|O
I	|B-PROTEIN
-	|I-PROTEIN
POU	|I-PROTEIN
/	|O
tI	|B-PROTEIN
-	|I-PROTEIN
POU	|I-PROTEIN
message	|O
is	|O
maximal	|O
late	|O
in	|O
the	|O
embryonic	|O
phase	|O
of	|O
Drosophila	|O
development	|O
,	|O
and	|O
I	|B-PROTEIN
-	|I-PROTEIN
POU	|I-PROTEIN
is	|O
the	|O
preferred	|O
splice	|O
variant	|O
.	|O

Unlike	|O
wild	|O
-	|O
type	|O
p53	|B-PROTEIN
,	|O
the	|O
delta	|B-PROTEIN
proAE	|I-PROTEIN
mutant	|O
cDNA	|O
can	|O
be	|O
stably	|O
expressed	|O
in	|O
tumor	|O
derived	|O
cell	|O
lines	|O
with	|O
few	|O
immediate	|O
detrimental	|O
effects	|O
.	|O

The	|O
patient	|O
's	|O
role	|O
,	|O
organized	|O
by	|O
the	|O
prerequisites	|O
of	|O
expressive	|O
freedom	|O
,	|O
is	|O
counter	|O
posed	|O
with	|O
the	|O
psychoanalyst	|O
's	|O
,	|O
which	|O
is	|O
structured	|O
to	|O
empower	|O
listening	|O
and	|O
understanding	|O
.	|O

The	|O
most	|O
common	|O
risk	|O
factor	|O
reported	|O
for	|O
both	|O
recent	|O
and	|O
all	|O
other	|O
hepatitis	|O
C	|O
cases	|O
was	|O
a	|O
history	|O
of	|O
injecting	|O
drug	|O
use	|O
,	|O
although	|O
the	|O
proportion	|O
of	|O
cases	|O
with	|O
that	|O
history	|O
was	|O
different	|O
in	|O
NT	|O
from	|O
ACT	|O
and	|O
Queensland	|O
.	|O

Silencing	|O
can	|O
be	|O
restored	|O
by	|O
creation	|O
of	|O
a	|O
telomere	|O
at	|O
13	|O
kb	|O
from	|O
the	|O
reporter	|O
construct	|O
,	|O
or	|O
by	|O
insertion	|O
of	|O
340	|O
bp	|O
of	|O
yeast	|O
telomeric	|O
repeat	|O
sequence	|O
at	|O
this	|O
site	|O
without	|O
chromosomal	|O
truncation	|O
.	|O

In	|O
contrast	|O
with	|O
previous	|O
two	|O
-	|O
pool	|O
models	|O
,	|O
provisions	|O
were	|O
made	|O
for	|O
folate	|O
turnover	|O
by	|O
urinary	|O
folate	|O
excretion	|O
(	|O
as	|O
measured	|O
here	|O
)	|O
and	|O
by	|O
fecal	|O
excretion	|O
and	|O
catabolic	|O
processes	|O
.	|O

When	|O
voltage	|O
-	|O
operated	|O
Ca2+	|O
channels	|O
(	|O
VOC	|O
)	|O
were	|O
blocked	|O
by	|O
nifedipine	|O
,	|O
midazolam	|O
,	|O
in	|O
concentrations	|O
more	|O
than	|O
1	|O
microM	|O
,	|O
attenuated	|O
both	|O
phasic	|O
and	|O
tonic	|O
responses	|O
.	|O

Several	|O
artifacts	|O
occurred	|O
that	|O
interfered	|O
with	|O
visualization	|O
of	|O
the	|O
diaphragm	|O
.	|O

Although	|O
p48	|B-PROTEIN
gene	|O
induction	|O
is	|O
dependent	|O
on	|O
STAT1	|B-PROTEIN
and	|O
JAK1	|B-PROTEIN
,	|O
activated	|O
STAT1	|B-PROTEIN
does	|O
not	|O
bind	|O
to	|O
GATE	|B-PROTEIN
.	|O

The	|O
syndrome	|O
of	|O
resistance	|O
to	|O
thyroid	|O
hormone	|O
is	|O
characterized	|O
by	|O
elevated	|O
serum	|O
free	|O
thyroid	|O
hormones	|O
,	|O
failure	|O
to	|O
suppress	|O
pituitary	|O
thyrotropin	|B-PROTEIN
secretion	|O
,	|O
and	|O
variable	|O
peripheral	|O
refractoriness	|O
to	|O
hormone	|O
action	|O
.	|O

Finally	|O
,	|O
nonphotosynthetic	|O
mutants	|O
,	|O
including	|O
the	|O
tscA	|B-PROTEIN
-	|O
lacking	|O
photosystem	|B-PROTEIN
I	|I-PROTEIN
mutant	|O
,	|O
H13	|O
,	|O
did	|O
not	|O
show	|O
evidence	|O
of	|O
light	|O
-	|O
stimulated	|O
RNA	|O
processing	|O
.	|O

The	|O
progression	|O
of	|O
acute	|O
bronchitis	|O
is	|O
associated	|O
with	|O
elevated	|O
blood	|O
concentrations	|O
of	|O
acute	|O
-	|O
phase	|O
proteins	|O
,	|O
KKS	|B-PROTEIN
activation	|O
in	|O
the	|O
blood	|O
and	|O
high	|O
serotonin	|O
and	|O
lactic	|O
acid	|O
content	|O
in	|O
the	|O
humor	|O
condensated	|O
from	|O
the	|O
exhaled	|O
air	|O
.	|O

Because	|O
of	|O
the	|O
potential	|O
implications	|O
of	|O
these	|O
findings	|O
in	|O
human	|O
physiology	|O
,	|O
we	|O
cloned	|O
the	|O
hPACAP	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
gene	|O
.	|O

Differential	|O
signaling	|O
and	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
gene	|I-PROTEIN
activation	|O
by	|O
four	|O
splice	|O
variants	|O
of	|O
the	|O
human	|O
pituitary	|O
adenylate	|B-PROTEIN
cyclase	|I-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
polypeptide	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
hPACAP	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
.	|O

During	|O
skeletal	|O
muscle	|O
development	|O
,	|O
different	|O
types	|O
of	|O
muscle	|O
fibers	|O
are	|O
generated	|O
,	|O
which	|O
express	|O
different	|O
combinations	|O
of	|O
muscle	|O
-	|O
specific	|O
gene	|O
products	|O
.	|O

We	|O
discuss	|O
these	|O
results	|O
with	|O
respect	|O
to	|O
the	|O
transcriptional	|O
induction	|O
of	|O
the	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
in	|O
respiratory	|O
epithelium	|O
during	|O
embryogenesis	|O
.	|O

BACKGROUND	|O
:	|O
Mitosis	|O
is	|O
regulated	|O
by	|O
MPF	|B-PROTEIN
(	|O
maturation	|B-PROTEIN
promoting	|I-PROTEIN
factor	|I-PROTEIN
)	|O
,	|O
the	|O
active	|O
form	|O
of	|O
Cdc2/28	|B-PROTEIN
-	|O
cyclin	|B-PROTEIN
B	|I-PROTEIN
complexes	|O
.	|O

Ectopic	|O
expression	|O
of	|O
Apo	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
in	|O
HEK293	|O
or	|O
HeLa	|O
cells	|O
induced	|O
marked	|O
apoptosis	|O
.	|O

An	|O
N	|O
-	|O
terminal	|O
arm	|O
from	|O
each	|O
subunit	|O
wraps	|O
around	|O
the	|O
dinucleotide	|O
-	|O
binding	|O
domain	|O
of	|O
an	|O
adjacent	|O
subunit	|O
,	|O
covering	|O
the	|O
adenine	|O
ring	|O
of	|O
NADP	|O
.	|O

Similarity	|O
is	|O
most	|O
striking	|O
in	|O
the	|O
zinc	|O
knuckle	|O
region	|O
,	|O
a	|O
region	|O
characteristic	|O
of	|O
gag	|B-PROTEIN
genes	|O
of	|O
most	|O
replication	|O
-	|O
competent	|O
retroelements	|O
.	|O

D.	|O
melanogaster	|O
HeT	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
coding	|O
sequences	|O
have	|O
a	|O
polymorphic	|O
region	|O
with	|O
insertions	|O
/	|O
deletions	|O
of	|O
1-31	|O
codons	|O
and	|O
many	|O
nucleotide	|O
changes	|O
.	|O

Eukaryotic	|B-PROTEIN
initiation	|I-PROTEIN
factor	|I-PROTEIN
3	|I-PROTEIN
(	|O
eIF3	|B-PROTEIN
)	|O
is	|O
a	|O
large	|O
multisubunit	|O
complex	|O
that	|O
stabilizes	|O
the	|O
ternary	|O
complex	|O
,	|O
eIF2	|B-PROTEIN
x	|O
GTP	|O
x	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
Met	|I-PROTEIN
)	|I-PROTEIN
i	|I-PROTEIN
and	|O
promotes	|O
mRNA	|O
binding	|O
to	|O
the	|O
40	|B-PROTEIN
S	|I-PROTEIN
ribosomal	|O
subunit	|O
.	|O
eIF3	|B-PROTEIN
also	|O
functions	|O
as	|O
a	|O
ribosome	|O
subunit	|O
anti	|O
-	|O
association	|O
factor	|O
.	|O

Our	|O
data	|O
,	|O
combined	|O
with	|O
those	|O
of	|O
Hershey	|O
and	|O
co	|O
-	|O
workers	|O
,	|O
suggest	|O
that	|O
mammalian	|O
eIF3	|B-PROTEIN
is	|O
composed	|O
of	|O
at	|O
least	|O
10	|O
subunits	|O
:	|O
p170	|B-PROTEIN
,	|O
p116	|B-PROTEIN
(	|O
hPrt1	|B-PROTEIN
)	|O
,	|O
p110	|B-PROTEIN
,	|O
p66	|B-PROTEIN
,	|O
p48	|B-PROTEIN
,	|O
p47	|B-PROTEIN
,	|O
p44	|B-PROTEIN
,	|O
p40	|B-PROTEIN
,	|O
p36	|B-PROTEIN
,	|O
and	|O
p35	|B-PROTEIN
.	|O

Identification	|O
of	|O
a	|O
cis	|O
-	|O
acting	|O
element	|O
in	|O
the	|O
class	|B-PROTEIN
I	|I-PROTEIN
major	|I-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
gene	|O
promoter	|O
responsive	|O
to	|O
activation	|O
by	|O
retroviral	|O
sequences	|O
.	|O

The	|O
results	|O
demonstrate	|O
that	|O
(	|O
i	|O
)	|O
no	|O
intact	|O
capsids	|O
were	|O
assembled	|O
when	|O
the	|O
full	|O
-	|O
length	|O
or	|O
a	|O
truncated	|O
(	|O
missing	|O
the	|O
C	|O
-	|O
terminal	|O
65	|O
amino	|O
acids	|O
)	|O
UL80.5	|B-PROTEIN
protein	|O
was	|O
tested	|O
;	|O
(	|O
ii	|O
)	|O
when	|O
the	|O
C	|O
-	|O
terminal	|O
65	|O
amino	|O
acids	|O
of	|O
the	|O
UL80.5	|B-PROTEIN
protein	|O
were	|O
replaced	|O
with	|O
the	|O
C	|O
-	|O
terminal	|O
25	|O
amino	|O
acids	|O
of	|O
the	|O
UL26.5	|B-PROTEIN
protein	|O
,	|O
intact	|O
capsids	|O
were	|O
made	|O
and	|O
direct	|O
interaction	|O
of	|O
the	|O
UL80.5	|B-PROTEIN
protein	|O
with	|O
VP5	|B-PROTEIN
was	|O
detected	|O
;	|O
(	|O
iii	|O
)	|O
assembly	|O
of	|O
intact	|O
capsids	|O
was	|O
demonstrated	|O
when	|O
the	|O
sequence	|O
of	|O
the	|O
last	|O
12	|O
amino	|O
acids	|O
of	|O
the	|O
UL80.5	|B-PROTEIN
protein	|O
was	|O
changed	|O
from	|O
RRIFVA	|O
ALNKLE	|O
to	|O
RRIFVAAMMKLE	|O
;	|O
(	|O
iv	|O
)	|O
self	|O
-	|O
interaction	|O
of	|O
the	|O
scaffold	|O
proteins	|O
is	|O
mediated	|O
by	|O
sequences	|O
N	|O
terminal	|O
to	|O
the	|O
maturation	|O
cleavage	|O
site	|O
;	|O
and	|O
(	|O
v	|O
)	|O
the	|O
UL26.5	|B-PROTEIN
and	|O
UL80.5	|B-PROTEIN
proteins	|O
will	|O
not	|O
coassemble	|O
into	|O
scaffold	|O
structures	|O
.	|O

Fourth	|O
,	|O
the	|O
3'	|O
-	|O
region	|O
splice	|O
junctions	|O
of	|O
the	|O
MSRs	|B-PROTEIN
during	|O
latent	|O
and	|O
productive	|O
infection	|O
were	|O
determined	|O
by	|O
sequencing	|O
RNA	|O
-	|O
PCR	|O
products	|O
generated	|O
with	|O
primers	|O
that	|O
flank	|O
the	|O
3'	|O
splice	|O
region	|O
.	|O

(	|O
ii	|O
)	|O
ICP27	|B-PROTEIN
binds	|O
preferentially	|O
to	|O
less	|O
modified	|O
forms	|O
of	|O
ICP4	|B-PROTEIN
,	|O
a	|O
protein	|O
that	|O
is	|O
extensively	|O
modified	|O
posttranslationally	|O
.	|O

Lack	|O
of	|O
sufficient	|O
data	|O
on	|O
vibration	|O
measurements	|O
and	|O
employment	|O
durations	|O
add	|O
to	|O
the	|O
uncertainty	|O
,	|O
as	|O
do	|O
variations	|O
in	|O
tool	|O
conditions	|O
(	|O
grinder	|O
wheels	|O
,	|O
etc	|O
)	|O
and	|O
inherent	|O
difficulties	|O
in	|O
measurement	|O
.	|O

C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|O
V	|O
>	|O
A	|O
selectively	|O
binds	|O
only	|O
the	|O
subset	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
sites	|O
that	|O
are	|O
also	|O
DBP	|B-PROTEIN
sites	|O
,	|O
both	|O
as	|O
oligonucleotides	|O
and	|O
within	|O
the	|O
natural	|O
contexts	|O
of	|O
the	|O
albumin	|B-PROTEIN
and	|O
cholesterol	|B-PROTEIN
hydroxylase	|I-PROTEIN
promoters	|O
.	|O

Specific	|O
IgG	|B-PROTEIN
,	|O
specific	|O
IgE	|B-PROTEIN
and	|O
total	|O
IgE	|B-PROTEIN
immunoglobulins	|O
against	|O
Toxocara	|B-PROTEIN
canis	|I-PROTEIN
excretory	|I-PROTEIN
/	|I-PROTEIN
secretory	|I-PROTEIN
antigens	|I-PROTEIN
(	|O
TES	|B-PROTEIN
)	|O
were	|O
detected	|O
by	|O
using	|O
ELISA	|O
technique	|O
.	|O

SUMMARY	|O
BACKGROUND	|O
DATA	|O
:	|O
Melanoma	|O
care	|O
has	|O
not	|O
changed	|O
significantly	|O
in	|O
the	|O
last	|O
20	|O
years	|O
,	|O
and	|O
the	|O
controversy	|O
of	|O
elective	|O
lymph	|O
node	|O
dissections	|O
in	|O
this	|O
disease	|O
continues	|O
to	|O
be	|O
discussed	|O
.	|O

The	|O
differences	|O
among	|O
subgenera	|O
of	|O
the	|O
genus	|O
Dermacentor	|O
are	|O
more	|O
significant	|O
.	|O

Mutating	|O
the	|O
E	|O
-	|O
box	|O
in	|O
the	|O
context	|O
of	|O
the	|O
3'	|O
-	|O
flanking	|O
region	|O
confirmed	|O
that	|O
it	|O
contributes	|O
to	|O
the	|O
enhancement	|O
of	|O
transcriptional	|O
activity	|O
of	|O
the	|O
alpha1	|B-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
collagen	|I-PROTEIN
gene	|O
promoter	|O
.	|O

Expression	|O
of	|O
neuronal	|O
traits	|O
in	|O
pancreatic	|O
beta	|O
cells	|O
.	|O

We	|O
propose	|O
that	|O
Mnt	|B-PROTEIN
:	|O
Max	|B-PROTEIN
:	|O
Sin3	|B-PROTEIN
complexes	|O
normally	|O
function	|O
to	|O
restrict	|O
Myc	|B-PROTEIN
:	|O
Max	|B-PROTEIN
activities	|O
associated	|O
with	|O
cell	|O
proliferation	|O
.	|O

Its	|O
transcription	|O
product	|O
,	|O
a	|O
1.3	|O
kb	|O
mRNA	|O
,	|O
is	|O
polyadenylated	|O
at	|O
a	|O
site	|O
containing	|O
consensus	|O
eukaryotic	|O
polyadenylation	|O
signals	|O
and	|O
mapping	|O
87	|O
bp	|O
downstream	|O
of	|O
the	|O
translation	|O
termination	|O
codon	|O
for	|O
CG30	|B-PROTEIN
.	|O

Phenotypic	|O
changes	|O
induced	|O
by	|O
wild	|O
type	|O
and	|O
variant	|O
c	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
genes	|O
carrying	|O
C	|O
-	|O
terminal	|O
sequence	|O
alterations	|O
.	|O

The	|O
resurgence	|O
of	|O
drug	|O
-	|O
resistant	|O
malaria	|O
makes	|O
urgent	|O
the	|O
evaluation	|O
of	|O
new	|O
antimalarial	|O
agents	|O
.	|O

In	|O
the	|O
p51	|B-PROTEIN
subunit	|O
,	|O
the	|O
Cys181	|O
side	|O
-	|O
chain	|O
is	|O
oriented	|O
in	|O
a	|O
similar	|O
direction	|O
to	|O
the	|O
Tyr181	|O
side	|O
-	|O
chain	|O
in	|O
the	|O
wild	|O
-	|O
type	|O
complex	|O
.	|O

The	|O
relatively	|O
high	|O
level	|O
transcription	|O
from	|O
this	|O
gene	|O
shows	|O
that	|O
the	|O
polymorphic	|O
chromosome	|O
ends	|O
of	|O
P.	|O
falciparum	|O
,	|O
which	|O
have	|O
been	|O
proposed	|O
to	|O
be	|O
transcriptionally	|O
silent	|O
,	|O
can	|O
be	|O
active	|O
expression	|O
sites	|O
for	|O
var	|B-PROTEIN
genes	|O
.	|O

NUP145	|B-PROTEIN
was	|O
previously	|O
identified	|O
by	|O
using	|O
a	|O
genetic	|O
synthetic	|O
lethal	|O
screen	|O
(	|O
E.	|O

Prevalence	|O
of	|O
sleep	|O
-	|O
disordered	|O
breathing	|O
(	|O
SDB	|O
)	|O
is	|O
reported	|O
to	|O
increase	|O
in	|O
menopausal	|O
women	|O
.	|O

In	|O
all	|O
cases	|O
the	|O
antigenemia	|O
was	|O
transient	|O
and	|O
cleared	|O
by	|O
28th	|O
day	|O
post	|O
-	|O
vaccination	|O
.	|O

A	|O
total	|O
of	|O
1459	|O
men	|O
aged	|O
48	|O
to	|O
84	|O
years	|O
,	|O
who	|O
were	|O
diagnosed	|O
for	|O
the	|O
first	|O
time	|O
by	|O
physicians	|O
as	|O
having	|O
BPH	|O
in	|O
1994	|O
and	|O
who	|O
had	|O
not	|O
received	|O
treatment	|O
,	|O
participated	|O
in	|O
the	|O
study	|O
.	|O

BCL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
an	|O
inhibitor	|O
of	|O
apoptosis	|O
in	|O
a	|O
wide	|O
variety	|O
of	|O
cell	|O
types	|O
,	|O
has	|O
been	|O
reported	|O
to	|O
prevent	|O
oxidative	|O
stress	|O
-	|O
induced	|O
cell	|O
death	|O
.	|O

In	|O
vitro	|O
translation	|O
of	|O
the	|O
mTRF1	|B-PROTEIN
cDNA	|O
resulted	|O
in	|O
a	|O
56	|O
kDa	|O
protein	|O
that	|O
binds	|O
to	|O
TTAGGG	|O
repeat	|O
arrays	|O
.	|O
mTRF1	|B-PROTEIN
displayed	|O
the	|O
same	|O
sequence	|O
specificity	|O
as	|O
hTRF1	|B-PROTEIN
,	|O
preferring	|O
arrays	|O
of	|O
TTAGGG	|O
repeats	|O
as	|O
a	|O
binding	|O
substrate	|O
over	|O
TTAGGC	|O
and	|O
TTGGGG	|O
repeats	|O
.	|O

The	|O
ubiquitously	|O
expressed	|O
E12	|B-PROTEIN
bHLH	|O
protein	|O
dimerizes	|O
with	|O
numerous	|O
cell	|O
-	|O
specific	|O
bHLH	|B-PROTEIN
factors	|I-PROTEIN
.	|O

The	|O
E	|O
-	|O
box	|O
sequence	|O
in	|O
the	|O
SE2	|B-PROTEIN
fragment	|O
of	|O
the	|O
transferrin	|B-PROTEIN
promoter	|O
was	|O
CATCTG	|O
and	|O
was	|O
similar	|O
in	|O
gel	|O
shifts	|O
to	|O
the	|O
consensus	|O
E	|O
-	|O
box	|O
elements	|O
(	|O
CANNTG	|O
)	|O
previously	|O
characterized	|O
.	|O

A	|O
5.3	|O
-	|O
kb	|O
DNA	|O
fragment	|O
,	|O
which	|O
included	|O
the	|O
entire	|O
structural	|O
porin	|B-PROTEIN
gene	|O
(	|O
named	|O
porCa	|B-PROTEIN
)	|O
and	|O
its	|O
flanking	|O
regions	|O
,	|O
was	|O
identified	|O
.	|O

Full	|O
-	|O
length	|O
AT	|B-PROTEIN
-	|I-PROTEIN
PHH1	|I-PROTEIN
,	|O
and	|O
both	|O
AT	|B-PROTEIN
-	|I-PROTEIN
PHH1	|I-PROTEIN
and	|O
AT	|B-PROTEIN
-	|I-PROTEIN
PHH1	|I-PROTEIN
delta	|O
C	|O
-	|O
513	|O
(	|O
truncated	|O
to	|O
be	|O
approximately	|O
the	|O
size	|O
of	|O
microbial	|O
photolyase	|B-PROTEIN
genes	|O
)	|O
cDNAs	|O
,	|O
were	|O
overexpressed	|O
,	|O
respectively	|O
,	|O
in	|O
yeast	|O
and	|O
Escherichia	|O
coli	|O
mutants	|O
hypersensitive	|O
to	|O
ultraviolet	|O
light	|O
.	|O

The	|O
human	|O
p100	|B-PROTEIN
protein	|O
was	|O
recently	|O
identified	|O
as	|O
a	|O
coactivator	|O
of	|O
the	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
nuclear	|B-PROTEIN
antigen	|I-PROTEIN
2	|I-PROTEIN
.	|O

However	|O
,	|O
five	|O
new	|O
mutation	|O
sites	|O
(	|O
S61	|B-PROTEIN
,	|O
SL1	|B-PROTEIN
,	|O
S29	|B-PROTEIN
,	|O
SL11	|B-PROTEIN
,	|O
SL196	|B-PROTEIN
and	|O
SL126	|B-PROTEIN
)	|O
are	|O
unique	|O
to	|O
the	|O
nrdB	|B-PROTEIN
intron	|O
and	|O
disrupt	|O
self	|O
-	|O
splicing	|O
.	|O

This	|O
report	|O
presents	|O
the	|O
isolation	|O
and	|O
characterization	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
(	|O
1.2	|O
kb	|O
)	|O
and	|O
exon	|O
1	|O
of	|O
the	|O
human	|O
RII	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
.	|O

A	|O
cohort	|O
of	|O
Swedish	|O
children	|O
was	|O
monitored	|O
from	|O
6	|O
months	|O
to	|O
11	|O
years	|O
of	|O
age	|O
.	|O

The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
assess	|O
the	|O
reproducibility	|O
of	|O
a	|O
number	|O
of	|O
simplified	|O
clearance	|O
methods	|O
using	|O
chromium	|O
-	|O
51	|O
ethylenediamine	|O
tetraacetic	|O
acid	|O
(	|O
51Cr	|O
-	|O
EDTA	|O
)	|O
and	|O
to	|O
compare	|O
these	|O
with	|O
the	|O
multiple	|O
blood	|O
sample	|O
technique	|O
.	|O

The	|O
primary	|O
structure	|O
of	|O
a	|O
2671	|O
bp	|O
DNA	|O
fragment	|O
between	|O
the	|O
pla	|B-PROTEIN
gene	|O
(	|O
encoding	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
)	|O
and	|O
the	|O
origin	|O
of	|O
replication	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
Yersinia	|O
pestis	|O
plasmid	|O
pYP358	|O
was	|O
determined	|O
.	|O

Serotonin	|O
concentration	|O
in	|O
the	|O
blood	|O
of	|O
patients	|O
with	|O
hemorrhagic	|O
fever	|O
with	|O
renal	|O
syndrome	|O

MAIN	|O
OUTCOME	|O
MEASURES	|O
:	|O
Associations	|O
of	|O
factor	|O
analysis	|O
-	|O
derived	|O
syndromes	|O
with	|O
risk	|O
factors	|O
for	|O
chemical	|O
interactions	|O
that	|O
inhibit	|O
butyrylcholinesterase	|B-PROTEIN
and	|O
neuropathy	|O
target	|O
esterase	|B-PROTEIN
.	|O

CONCLUSION	|O
:	|O
Some	|O
Gulf	|O
War	|O
veterans	|O
may	|O
have	|O
delayed	|O
,	|O
chronic	|O
neurotoxic	|O
syndromes	|O
from	|O
wartime	|O
exposure	|O
to	|O
combinations	|O
of	|O
chemicals	|O
that	|O
inhibit	|O
butyrylcholinesterase	|B-PROTEIN
and	|O
neuropathy	|O
target	|O
esterase	|B-PROTEIN
.	|O

Control	|O
examination	|O
was	|O
performed	|O
at	|O
the	|O
end	|O
of	|O
each	|O
period	|O
.	|O

No	|O
correlation	|O
between	|O
the	|O
age	|O
of	|O
the	|O
horses	|O
and	|O
the	|O
antibody	|O
level	|O
could	|O
be	|O
found	|O
.	|O

The	|O
GHR	|B-PROTEIN
mRNA	|O
:	|O
GHBP	|B-PROTEIN
mRNA	|O
ratio	|O
was	|O
1.1	|O
+	|O
/	|O
-	|O
0.12	|O
and	|O
remained	|O
unchanged	|O
during	|O
differentiation	|O
.	|O

The	|O
results	|O
demonstrate	|O
(	|O
i	|O
)	|O
that	|O
the	|O
selenocysteine	|O
-	|O
specific	|O
UGA	|O
codon	|O
is	|O
readily	|O
suppressed	|O
under	|O
conditions	|O
where	|O
the	|O
homologous	|O
SelB	|B-PROTEIN
protein	|O
is	|O
absent	|O
and	|O
(	|O
ii	|O
)	|O
that	|O
apart	|O
from	|O
the	|O
specificity	|O
of	|O
the	|O
SelB	|B-PROTEIN
-	|O
mRNA	|O
interaction	|O
,	|O
a	|O
structural	|O
compatibility	|O
of	|O
the	|O
quaternary	|O
complex	|O
with	|O
the	|O
ribosome	|O
is	|O
required	|O
.	|O

One	|O
linker	|O
-	|O
peptide	|O
insertion	|O
in	|O
the	|O
RsaA	|B-PROTEIN
C	|O
terminus	|O
(	|O
amino	|O
acid	|O
784	|O
)	|O
had	|O
no	|O
effect	|O
on	|O
S	|O
-	|O
layer	|O
biogenesis	|O
,	|O
while	|O
another	|O
(	|O
amino	|O
acid	|O
907	|O
)	|O
disrupted	|O
secretion	|O
of	|O
the	|O
protein	|O
,	|O
suggesting	|O
that	|O
RsaA	|B-PROTEIN
possesses	|O
a	|O
secretion	|O
signal	|O
lying	|O
C	|O
terminal	|O
to	|O
amino	|O
acid	|O
784	|O
,	|O
near	|O
or	|O
including	|O
amino	|O
acid	|O
907	|O
.	|O

To	|O
characterize	|O
the	|O
gene	|O
products	|O
,	|O
the	|O
cvaA	|B-PROTEIN
gene	|O
was	|O
subcloned	|O
and	|O
expressed	|O
under	|O
the	|O
control	|O
of	|O
T7	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
promoter	|O
.	|O

PrpB	|B-PROTEIN
showed	|O
homology	|O
to	|O
carboxyphosphonoenolpyruvate	|B-PROTEIN
phosphonomutase	|I-PROTEIN
of	|O
Streptomyces	|O
hygroscopicus	|O
and	|O
to	|O
its	|O
homolog	|O
in	|O
the	|O
carnation	|O
Dianthus	|O
caryophyllus	|O
;	|O
PrpC	|B-PROTEIN
was	|O
homologous	|O
to	|O
both	|O
archaeal	|O
and	|O
bacterial	|O
citrate	|B-PROTEIN
synthases	|I-PROTEIN
;	|O
PrpD	|B-PROTEIN
showed	|O
homology	|O
to	|O
yeast	|O
and	|O
Bacillus	|O
subtilis	|O
proteins	|O
of	|O
unknown	|O
function	|O
;	|O
PrpE	|B-PROTEIN
showed	|O
homology	|O
to	|O
acetyl	|B-PROTEIN
coenzyme	|I-PROTEIN
A	|I-PROTEIN
synthetases	|I-PROTEIN
.	|O

MAIN	|O
OUTCOME	|O
MEASURES	|O
:	|O
Systemic	|O
and	|O
pulmonary	|O
hemodynamics	|O
,	|O
arterial	|O
blood	|O
gas	|O
determination	|O
,	|O
bronchoalveolar	|O
lavage	|O
protein	|O
and	|O
neutrophil	|O
content	|O
,	|O
neutrophil	|O
oxidant	|O
burst	|O
,	|O
lung	|O
myeloperoxidase	|B-PROTEIN
content	|O
,	|O
and	|O
scanning	|O
electron	|O
micrographic	|O
studies	|O
.	|O

We	|O
have	|O
isolated	|O
a	|O
cDNA	|O
encoding	|O
human	|O
MEKK3	|B-PROTEIN
.	|O

To	|O
investigate	|O
the	|O
mechanisms	|O
involved	|O
in	|O
the	|O
transcriptional	|O
control	|O
of	|O
retinoid	|B-PROTEIN
X	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
RXR	|B-PROTEIN
)	|O
gene	|O
expression	|O
,	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
RXRgamma2	|B-PROTEIN
isoform	|O
was	|O
characterized	|O
.	|O

JNK	|B-PROTEIN
and	|O
p38	|B-PROTEIN
are	|O
constitutively	|O
present	|O
in	|O
the	|O
nucleus	|O
,	|O
and	|O
DNA	|O
-	|O
bound	|O
c	|B-PROTEIN
-	|I-PROTEIN
JUN	|I-PROTEIN
and	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
are	|O
stably	|O
contacted	|O
by	|O
JNK	|B-PROTEIN
and	|O
p38	|B-PROTEIN
,	|O
respectively	|O
.	|O

The	|O
effects	|O
of	|O
dominant	|O
interfering	|O
forms	|O
of	|O
the	|O
JNK	|B-PROTEIN
/	|O
p38	|B-PROTEIN
signaling	|O
pathway	|O
demonstrate	|O
that	|O
activation	|O
of	|O
these	|O
kinases	|O
is	|O
critical	|O
for	|O
cytokine	|O
-	|O
induced	|O
E	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
gene	|O
expression	|O
.	|O

Sp1	|B-PROTEIN
binds	|O
the	|O
CTC	|O
repeat	|O
with	|O
an	|O
affinity	|O
,	|O
KD	|O
=	|O
0.37	|O
nM	|O
,	|O
at	|O
least	|O
as	|O
high	|O
as	|O
the	|O
consensus	|O
GC	|O
box	|O
.	|O

Identification	|O
of	|O
the	|O
region	|O
in	|O
actin	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
that	|O
binds	|O
to	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
glycoprotein	|B-PROTEIN
IBalpha	|I-PROTEIN
.	|O

Mutant	|O
enzyme	|O
forms	|O
were	|O
prepared	|O
to	|O
eliminate	|O
the	|O
initial	|O
autoprocessing	|O
site	|O
and	|O
thus	|O
form	|O
an	|O
active	|O
single	|O
-	|O
chain	|O
protein	|O
for	|O
structure	|O
-	|O
function	|O
studies	|O
.	|O

The	|O
primer	|O
is	|O
generated	|O
by	|O
a	|O
cleavage	|O
that	|O
occurs	|O
between	|O
bases	|O
11	|O
and	|O
12	|O
of	|O
the	|O
Tf1	|B-PROTEIN
mRNA	|O
.	|O

Similarly	|O
,	|O
we	|O
examined	|O
whether	|O
the	|O
ELK1	|B-PROTEIN
,	|O
SAP1a	|B-PROTEIN
,	|O
FLI1	|B-PROTEIN
,	|O
EWS	|B-PROTEIN
-	|O
FLI1	|B-PROTEIN
,	|O
ETS1	|B-PROTEIN
,	|O
ETS2	|B-PROTEIN
,	|O
PEA3	|B-PROTEIN
and	|O
PU.1	|B-PROTEIN
proteins	|O
can	|O
form	|O
ternary	|O
complexes	|O
with	|O
SRF	|B-PROTEIN
on	|O
the	|O
Egr1	|B-PROTEIN
SREI	|O
and	|O
II	|O
.	|O

This	|O
R	|O
-	|O
domain	|O
may	|O
modulate	|O
the	|O
interaction	|O
with	|O
SRF	|B-PROTEIN
,	|O
providing	|O
a	|O
mechanism	|O
that	|O
would	|O
be	|O
unique	|O
to	|O
FLI1	|B-PROTEIN
and	|O
EWS	|B-PROTEIN
-	|O
FLI1	|B-PROTEIN
,	|O
thus	|O
implicating	|O
a	|O
novel	|O
function	|O
for	|O
these	|O
ETS	|B-PROTEIN
transcription	|O
factors	|O
in	|O
the	|O
regulation	|O
of	|O
the	|O
Egr1	|B-PROTEIN
gene	|O
.	|O

The	|O
total	|O
number	|O
of	|O
specimens	|O
was	|O
131	|O
with	|O
78	|O
nonsmokers	|O
and	|O
53	|O
smokers	|O
.	|O

The	|O
murine	|O
chromosomal	|O
locations	|O
of	|O
the	|O
five	|O
NMDA	|B-PROTEIN
receptor	|I-PROTEIN
channel	|O
subunits	|O
,	|O
the	|O
epsilon	|B-PROTEIN
1	|I-PROTEIN
(	|O
Grin2a	|B-PROTEIN
)	|O
,	|O
epsilon	|B-PROTEIN
2	|I-PROTEIN
(	|O
Grin2b	|B-PROTEIN
)	|O
,	|O
epsilon	|B-PROTEIN
3	|I-PROTEIN
(	|O
Grin2c	|B-PROTEIN
)	|O
,	|O
epsilon	|B-PROTEIN
4	|I-PROTEIN
(	|O
Grin2d	|B-PROTEIN
)	|O
and	|O
zeta	|B-PROTEIN
1	|I-PROTEIN
(	|O
Grinl	|B-PROTEIN
)	|O
subunits	|O
,	|O
were	|O
determined	|O
using	|O
an	|O
interspecific	|O
backcross	|O
mapping	|O
panel	|O
derived	|O
from	|O
crosses	|O
of	|O
[	|O
(	|O
C57BL	|O
/	|O
6JxM	|O
.	|O
spretus	|O
)	|O
F1xC57BL	|O
/	|O
6J	|O
]	|O
mice	|O
.	|O

CDNA	|O
cloning	|O
of	|O
chick	|O
brain	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
amino	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
hydroxy	|I-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
-	|I-PROTEIN
methyl	|I-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
-	|I-PROTEIN
isoxazolepropionic	|I-PROTEIN
acid	|I-PROTEIN
receptors	|I-PROTEIN
reveals	|O
conservation	|O
of	|O
structure	|O
,	|O
function	|O
and	|O
post	|O
-	|O
transcriptional	|O
processes	|O
with	|O
mammalian	|O
receptors	|O
.	|O

Remarkably	|O
,	|O
both	|O
TTD	|O
-	|O
A	|O
and	|O
XP	|O
-	|O
D	|O
defects	|O
are	|O
associated	|O
with	|O
subunits	|O
of	|O
TFIIH	|B-PROTEIN
,	|O
a	|O
basal	|O
transcription	|O
factor	|O
with	|O
a	|O
second	|O
function	|O
in	|O
DNA	|O
repair	|O
.	|O

Adjustment	|O
for	|O
age	|O
,	|O
total	|O
cholesterol	|O
,	|O
HDL	|B-PROTEIN
cholesterol	|I-PROTEIN
,	|O
triglycerides	|O
,	|O
current	|O
smoking	|O
,	|O
and	|O
systolic	|O
pressure	|O
slightly	|O
reduced	|O
the	|O
association	|O
between	|O
fibrinogen	|B-PROTEIN
and	|O
atherosclerosis	|O
.	|O

In	|O
Experiment	|O
1	|O
,	|O
pups	|O
that	|O
had	|O
received	|O
an	|O
injection	|O
of	|O
the	|O
noncompetitive	|O
N	|B-PROTEIN
-	|I-PROTEIN
methyl	|I-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
aspartate	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
MK	|O
-	|O
801	|O
(	|O
0.1	|O
mg	|O
/	|O
kg	|O
,	|O
i.p	|O
.	|O
)	|O
either	|O
30	|O
min	|O
before	|O
or	|O
immediately	|O
after	|O
conditioning	|O
spent	|O
less	|O
time	|O
over	|O
the	|O
conditioned	|O
odor	|O
than	|O
saline	|O
-	|O
treated	|O
controls	|O
.	|O

Cholesterol	|O
side	|O
-	|O
chain	|O
cleavage	|O
cytochrome	|B-PROTEIN
P450	|I-PROTEIN
(	|O
CYP11A	|B-PROTEIN
;	|O
P450scc	|B-PROTEIN
)	|O
gene	|O
expression	|O
is	|O
regulated	|O
by	|O
gonadotropins	|B-PROTEIN
via	|O
cAMP	|O
in	|O
the	|O
ovary	|O
and	|O
by	|O
ACTH	|B-PROTEIN
via	|O
cAMP	|O
in	|O
adrenal	|O
cortical	|O
cells	|O
.	|O

One	|O
possible	|O
solution	|O
is	|O
a	|O
thin	|O
radial	|O
forearm	|O
free	|O
flap	|O
.	|O

Structural	|O
analysis	|O
and	|O
characterization	|O
of	|O
tissue	|O
and	|O
hormonal	|O
responsive	|O
expression	|O
of	|O
the	|O
avian	|O
bone	|B-PROTEIN
sialoprotein	|I-PROTEIN
(	|O
BSP	|B-PROTEIN
)	|O
gene	|O
.	|O

Serotonin	|B-PROTEIN
receptors	|I-PROTEIN
in	|O
suicide	|O
victims	|O
with	|O
major	|O
depression	|O
.	|O

The	|O
Y	|O
-	|O
type	|O
structural	|O
motif	|O
is	|O
also	|O
conserved	|O
among	|O
a	|O
number	|O
of	|O
divergent	|O
BiP	|B-PROTEIN
mRNAs	|O
.	|O

A	|O
false	|O
positive	|O
marker	|O
screen	|O
was	|O
associated	|O
with	|O
the	|O
occurrence	|O
of	|O
hand	|O
-	|O
foot	|O
syndrome	|O
even	|O
when	|O
the	|O
effect	|O
of	|O
regimen	|O
was	|O
accounted	|O
for	|O
by	|O
stratification	|O
(	|O
p	|O
=	|O
.01	|O
)	|O
.	|O

The	|O
detection	|O
of	|O
ORF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
sequences	|O
in	|O
human	|O
tumors	|O
,	|O
while	|O
not	|O
proof	|O
per	|O
se	|O
,	|O
is	|O
a	|O
prerequisite	|O
for	|O
establishing	|O
its	|O
role	|O
in	|O
tumor	|O
development	|O
.	|O

Phylogenetic	|O
analysis	|O
gave	|O
evidence	|O
for	|O
a	|O
close	|O
evolutionary	|O
relationship	|O
between	|O
PhHV	|O
-	|O
1	|O
and	|O
members	|O
of	|O
the	|O
Varicellovirus	|O
genus	|O
of	|O
the	|O
alpha	|O
-	|O
Herpesvirinae	|O
and	|O
canid	|O
herpesvirus	|O
in	|O
particular	|O
.	|O

In	|O
this	|O
method	|O
,	|O
PLP	|O
in	|O
plasma	|O
can	|O
be	|O
determined	|O
with	|O
high	|O
sensitivity	|O
using	|O
derivatization	|O
with	|O
sodium	|O
bisulfite	|O
in	|O
the	|O
mobile	|O
phase	|O
.	|O

Both	|O
HEF1	|B-PROTEIN
and	|O
Cas	|B-PROTEIN
were	|O
found	|O
to	|O
complex	|O
with	|O
the	|O
related	|B-PROTEIN
adhesion	|I-PROTEIN
focal	|I-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
RAFTK	|B-PROTEIN
)	|O
,	|O
and	|O
when	|O
tyrosine	|O
phosphorylated	|O
,	|O
with	|O
the	|O
adapter	|O
molecule	|O
CrkL	|B-PROTEIN
.	|O

SIM1	|B-PROTEIN
and	|O
SIM2	|B-PROTEIN
do	|O
not	|O
form	|O
homodimers	|O
,	|O
and	|O
they	|O
do	|O
not	|O
interact	|O
with	|O
AHR	|B-PROTEIN
.	|O

Complexes	|O
of	|O
qTBP42	|B-PROTEIN
with	|O
each	|O
complementary	|O
strand	|O
of	|O
telomeric	|O
DNA	|O
and	|O
with	|O
quadruplex	|O
forms	|O
of	|O
the	|O
guanine	|O
-	|O
rich	|O
strand	|O
had	|O
3.7-14.6	|O
nM	|O
dissociation	|O
constants	|O
,	|O
Kd	|O
,	|O
whereas	|O
complexes	|O
with	|O
double	|O
-	|O
stranded	|O
telomeric	|O
DNA	|O
had	|O
up	|O
to	|O
100	|O
-	|O
fold	|O
higher	|O
Kd	|O
values	|O
.	|O

Moreover	|O
,	|O
the	|O
effect	|O
exerted	|O
by	|O
TIS1	|B-PROTEIN
appeared	|O
to	|O
be	|O
selective	|O
for	|O
the	|O
MCK	|B-PROTEIN
promoter	|O
.	|O

Experimental	|O
data	|O
showed	|O
that	|O
these	|O
abnormal	|O
proteins	|O
are	|O
constitutively	|O
localized	|O
in	|O
the	|O
nucleus	|O
,	|O
have	|O
lost	|O
the	|O
transcriptional	|O
repressor	|O
functions	|O
typical	|O
of	|O
normal	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B2p52	|I-PROTEIN
and	|O
may	|O
be	|O
capable	|O
of	|O
transactivation	|O
activity	|O
.	|O

Because	|O
L	|B-PROTEIN
-	|I-PROTEIN
plastin	|I-PROTEIN
expression	|O
in	|O
tissue	|O
-	|O
specifically	|O
regulated	|O
in	|O
both	|O
humans	|O
and	|O
rodents	|O
,	|O
it	|O
is	|O
likely	|O
that	|O
similar	|O
mechanisms	|O
regulate	|O
L	|B-PROTEIN
-	|I-PROTEIN
plastin	|I-PROTEIN
gene	|O
expression	|O
in	|O
human	|O
and	|O
rodent	|O
cells	|O
and	|O
that	|O
they	|O
could	|O
be	|O
identified	|O
by	|O
comparing	|O
the	|O
function	|O
and	|O
nucleotide	|O
sequences	|O
of	|O
the	|O
human	|O
and	|O
murine	|O
L	|B-PROTEIN
-	|I-PROTEIN
plastin	|I-PROTEIN
gene	|O
promoters	|O
.	|O

What	|O
's	|O
new	|O
in	|O
gynecologic	|O
and	|O
obstetrical	|O
surgery	|O
.	|O

The	|O
dnaK	|B-PROTEIN
operon	|O
of	|O
Bacillus	|O
subtilis	|O
is	|O
heptacistronic	|O
.	|O

Moreover	|O
,	|O
expression	|O
of	|O
CBF1	|B-PROTEIN
in	|O
yeast	|O
was	|O
found	|O
to	|O
activate	|O
transcription	|O
of	|O
reporter	|O
genes	|O
containing	|O
the	|O
C	|O
-	|O
repeat	|O
/	|O
DRE	|O
as	|O
an	|O
upstream	|O
activator	|O
sequence	|O
but	|O
not	|O
mutant	|O
versions	|O
of	|O
the	|O
DNA	|O
element	|O
.	|O

Forty	|O
-	|O
one	|O
ASA	|O
physical	|O
status	|O
I	|O
or	|O
II	|O
adult	|O
patients	|O
undergoing	|O
a	|O
variety	|O
of	|O
1-1.5	|O
h	|O
surgical	|O
procedures	|O
were	|O
randomly	|O
allocated	|O
to	|O
receive	|O
CCA	|O
with	|O
desflurane	|O
or	|O
isoflurane	|O
with	|O
ventilation	|O
being	|O
either	|O
spontaneous	|O
or	|O
controlled	|O
.	|O

OBJECTIVE	|O
:	|O
Our	|O
goal	|O
was	|O
to	|O
determine	|O
whether	|O
chlamydia	|O
-	|O
infected	|O
women	|O
have	|O
a	|O
higher	|O
rate	|O
of	|O
febrile	|O
complications	|O
after	|O
postpartum	|O
tubal	|O
ligation	|O
.	|O

In	|O
the	|O
electrophoresis	|O
mobility	|O
shift	|O
assay	|O
using	|O
nuclear	|O
extracts	|O
of	|O
the	|O
myogenic	|O
cells	|O
,	|O
MyoD	|B-PROTEIN
and	|O
myogenin	|B-PROTEIN
bound	|O
to	|O
the	|O
right	|O
E	|O
-	|O
box	|O
in	|O
the	|O
enhancer	|O
region	|O
of	|O
the	|O
MCK	|B-PROTEIN
gene	|O
even	|O
in	|O
the	|O
presence	|O
of	|O
BMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

A	|O
heterologous	|O
promoter	|O
construct	|O
containing	|O
three	|O
repeats	|O
of	|O
a	|O
consensus	|O
Sp1	|B-PROTEIN
site	|O
,	|O
cloned	|O
upstream	|O
of	|O
a	|O
single	|O
copy	|O
of	|O
the	|O
ZII	|B-PROTEIN
(	|O
CREB	|B-PROTEIN
/	|O
AP1	|B-PROTEIN
)	|O
element	|O
from	|O
the	|O
BZLF1	|B-PROTEIN
promoter	|O
linked	|O
to	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
TATA	|O
box	|O
,	|O
exhibited	|O
phorbol	|O
ester	|O
inducibility	|O
.	|O

Subsequent	|O
experiments	|O
showed	|O
that	|O
motoric	|O
tasks	|O
rather	|O
than	|O
cognitive	|O
aspects	|O
of	|O
the	|O
COWA	|O
task	|O
were	|O
critical	|O
in	|O
potentiating	|O
finger	|O
-	|O
tapping	|O
performance	|O
.	|O

How	|O
does	|O
a	|O
nurse	|O
go	|O
about	|O
maintaining	|O
her	|O
level	|O
of	|O
competence	|O
when	|O
she	|O
is	|O
one	|O
of	|O
the	|O
few	|O
local	|O
practitioners	|O
in	|O
her	|O
field	|O
?	|O
Vancouver	|O
sex	|O
therapist	|O
Bianca	|O
Rucker	|O
is	|O
doing	|O
it	|O
by	|O
cultivating	|O
a	|O
network	|O
of	|O
colleagues	|O
and	|O
mentors	|O
in	|O
related	|O
fields	|O
both	|O
at	|O
home	|O
and	|O
across	|O
the	|O
continent	|O
.	|O

Finally	|O
,	|O
antibody	|O
binding	|O
to	|O
site	|O
IIIa	|O
on	|O
the	|O
hCG	|B-PROTEIN
-	|O
ectodomain	|O
complex	|O
was	|O
also	|O
hindered	|O
by	|O
an	|O
anti	|O
-	|O
peptide	|O
mAb	|O
directed	|O
against	|O
a	|O
peptide	|O
encoded	|O
by	|O
the	|O
eighth	|O
exon	|O
(	|O
pE	|O
x	|O
8	|O
)	|O
of	|O
the	|O
LHR	|B-PROTEIN
.	|O

cDNA	|O
cloning	|O
,	|O
expression	|O
analysis	|O
,	|O
and	|O
chromosomal	|O
localization	|O
of	|O
a	|O
gene	|O
with	|O
high	|O
homology	|O
to	|O
wheat	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
(	|I-PROTEIN
iso	|I-PROTEIN
)	|I-PROTEIN
4F	|I-PROTEIN
and	|O
mammalian	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
4G	|I-PROTEIN
.	|O

Therefore	|O
,	|O
it	|O
is	|O
important	|O
to	|O
control	|O
hypertension	|O
and	|O
keep	|O
appropriate	|O
renal	|O
blood	|O
flow	|O
during	|O
living	|O
renal	|O
transplantation	|O
surgery	|O
.	|O

The	|O
initial	|O
patients	|O
treated	|O
with	|O
AZQ	|O
and	|O
mitroxantrone	|O
experienced	|O
prolonged	|O
bone	|O
marrow	|O
suppression	|O
and	|O
,	|O
therefore	|O
,	|O
subsequent	|O
cohorts	|O
were	|O
treated	|O
with	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
,	|O
5	|O
micrograms	|O
/	|O
kg	|O
,	|O
beginning	|O
the	|O
day	|O
after	|O
completion	|O
of	|O
the	|O
third	|O
cycle	|O
of	|O
chemotherapy	|O
.	|O

Human	|B-PROTEIN
granulocyte	|I-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
hGM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
activates	|O
a	|O
set	|O
of	|O
genes	|O
such	|O
as	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
,	|O
jun	|B-PROTEIN
,	|O
myc	|B-PROTEIN
,	|O
and	|O
early	|B-PROTEIN
growth	|I-PROTEIN
response	|I-PROTEIN
gene	|I-PROTEIN
1	|I-PROTEIN
(	|O
egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

In	|O
order	|O
to	|O
provide	|O
adequate	|O
local	|O
control	|O
without	|O
compromising	|O
cosmetic	|O
outcome	|O
,	|O
the	|O
amount	|O
of	|O
breast	|O
tissue	|O
that	|O
must	|O
be	|O
excised	|O
in	|O
BCT	|O
needs	|O
to	|O
be	|O
individualized	|O
.	|O

Surprisingly	|O
,	|O
however	|O
,	|O
TCR	|B-PROTEIN
-	|O
mediated	|O
tyrosine	|O
phosphorylation	|O
of	|O
phospholipase	|B-PROTEIN
C	|I-PROTEIN
gamma	|I-PROTEIN
1	|I-PROTEIN
remains	|O
intact	|O
in	|O
the	|O
Jurkat	|O
cells	|O
expressing	|O
the	|O
A2	|B-PROTEIN
/	|O
HCP	|B-PROTEIN
chimera	|O
.	|O

The	|O
14.1	|B-PROTEIN
(	|I-PROTEIN
IGLL1	|I-PROTEIN
)	|I-PROTEIN
gene	|O
is	|O
expressed	|O
in	|O
a	|O
lineage	|O
-	|O
and	|O
stage	|O
-	|O
restricted	|O
manner	|O
.	|O

The	|O
interferon	|B-PROTEIN
(	|O
IFN	|B-PROTEIN
)	|O
-	|O
induced	|O
double	|O
-	|O
stranded	|O
RNA	|O
(	|O
dsRNA	|O
)	|O
-	|O
activated	|O
Ser	|B-PROTEIN
/	|I-PROTEIN
Thr	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PKR	|B-PROTEIN
)	|O
plays	|O
a	|O
role	|O
in	|O
the	|O
antiviral	|O
and	|O
antiproliferative	|O
effects	|O
of	|O
IFN	|B-PROTEIN
.	|O

Together	|O
,	|O
the	|O
data	|O
suggest	|O
that	|O
cAMP	|O
-	|O
dependent	|O
control	|O
of	|O
the	|O
amounts	|O
of	|O
the	|O
activator	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
vs.	|O
the	|O
repressor	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
could	|O
influence	|O
CRS2	|O
-	|O
dependent	|O
transcription	|O
.	|O

Object	|O
relations	|O
,	|O
affect	|O
management	|O
,	|O
and	|O
psychic	|O
structure	|O
formation	|O
.	|O

When	|O
expressed	|O
in	|O
COS	|O
-	|O
7	|O
cells	|O
,	|O
MKP	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
blocks	|O
activation	|O
of	|O
MAP	|B-PROTEIN
kinases	|I-PROTEIN
with	|O
the	|O
selectivity	|O
ERK	|B-PROTEIN
>	|O
p38	|B-PROTEIN
=	|O
JNK	|B-PROTEIN
/	|O
SAPK	|B-PROTEIN
.	|O

In	|O
rlf2	|B-PROTEIN
mutants	|O
,	|O
telomeric	|O
chromatin	|O
is	|O
perturbed	|O
:	|O
Telomeric	|O
silencing	|O
is	|O
reduced	|O
and	|O
Rap1p	|B-PROTEIN
localization	|O
is	|O
altered	|O
.	|O

Most	|O
kinases	|O
are	|O
not	|O
significantly	|O
inhibited	|O
by	|O
roscovitine	|O
.	|O
cdc2	|B-PROTEIN
/	|O
cyclin	|B-PROTEIN
B	|I-PROTEIN
,	|O
cdk2	|B-PROTEIN
/	|O
cyclin	|B-PROTEIN
A	|I-PROTEIN
,	|O
cdk2	|B-PROTEIN
/	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
and	|O
cdk5	|B-PROTEIN
/	|O
p35	|B-PROTEIN
only	|O
are	|O
substantially	|O
inhibited	|O
(	|O
IC50	|O
values	|O
of	|O
0.65	|O
,	|O
0.7	|O
,	|O
0.7	|O
and	|O
0.2	|O
microM	|O
,	|O
respectively	|O
)	|O
.	|O
cdk4	|B-PROTEIN
/	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
and	|O
cdk6	|B-PROTEIN
/	|O
cyclin	|B-PROTEIN
D2	|I-PROTEIN
are	|O
very	|O
poorly	|O
inhibited	|O
by	|O
roscovitine	|O
(	|O
IC50	|O
>	|O
100	|O
microM	|O
)	|O
.	|O

This	|O
0.74	|O
kb	|O
cDNA	|O
contains	|O
an	|O
open	|O
reading	|O
frame	|O
(	|O
ORF	|O
)	|O
of	|O
477	|O
bp	|O
encoding	|O
a	|O
polypeptide	|O
of	|O
159	|O
amino	|O
acids	|O
(	|O
aa	|O
)	|O
which	|O
differs	|O
at	|O
only	|O
one	|O
position	|O
(	|O
position	|O
65	|O
)	|O
from	|O
the	|O
human	|O
U1	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
protein	|O
.	|O

Interaction	|O
of	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
the	|O
POU	|B-PROTEIN
-	|O
homeodomain	|O
protein	|O
GHF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
reconstitutes	|O
pituitary	|O
-	|O
specific	|O
gene	|O
expression	|O
.	|O

Although	|O
Pho85	|B-PROTEIN
is	|O
not	|O
essential	|O
for	|O
viability	|O
,	|O
Pcl1	|B-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
-	|O
Pho85	|B-PROTEIN
kinase	|O
complexes	|O
become	|O
essential	|O
for	|O
Start	|O
in	|O
the	|O
absence	|O
of	|O
Cln1	|B-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
-	|O
Cdc28	|B-PROTEIN
kinases	|O
.	|O

Using	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
system	|O
to	|O
screen	|O
for	|O
proteins	|O
which	|O
interact	|O
with	|O
Tax1	|B-PROTEIN
,	|O
we	|O
isolated	|O
the	|O
B	|O
subunit	|O
of	|O
the	|O
CCAAT	|O
binding	|O
protein	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
from	|O
a	|O
HeLa	|O
cDNA	|O
library	|O
.	|O

Enhancer	|O
activity	|O
requires	|O
both	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
and	|O
these	|O
adjacent	|O
sequences	|O
.	|O

Studies	|O
using	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DR	|I-PROTEIN
-	|O
B7	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
LFA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
triple	|O
transfectants	|O
showed	|O
that	|O
the	|O
LFA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|O
induced	|O
NF	|B-PROTEIN
-	|I-PROTEIN
AT	|I-PROTEIN
DNA	|O
binding	|O
activity	|O
was	|O
negatively	|O
regulated	|O
by	|O
B7	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
costimulation	|O
.	|O

Constitutive	|O
activation	|O
of	|O
Rac1	|B-PROTEIN
and	|O
RhoA	|B-PROTEIN
causes	|O
tumorigenic	|O
transformation	|O
of	|O
NIH	|O
3T3	|O
cells	|O
,	|O
and	|O
their	|O
functions	|O
may	|O
be	|O
required	|O
for	|O
full	|O
Ras	|B-PROTEIN
transformation	|O
.	|O

Furthermore	|O
,	|O
Rac1	|B-PROTEIN
activation	|O
of	|O
JNK	|B-PROTEIN
or	|O
SRF	|B-PROTEIN
,	|O
or	|O
induction	|O
of	|O
lamellipodia	|O
,	|O
was	|O
neither	|O
necessary	|O
nor	|O
sufficient	|O
for	|O
Rac1	|B-PROTEIN
transforming	|O
activity	|O
.	|O

Overexpression	|O
of	|O
the	|O
bZip	|O
interaction	|O
domain	|O
of	|O
CBP	|B-PROTEIN
specifically	|O
abolishes	|O
the	|O
positive	|O
cross	|O
talk	|O
between	|O
TR	|B-PROTEIN
and	|O
p45	|B-PROTEIN
/	|O
NF	|B-PROTEIN
-	|I-PROTEIN
E2	|I-PROTEIN
.	|O

This	|O
inhibitory	|O
domain	|O
has	|O
been	|O
deleted	|O
in	|O
all	|O
naturally	|O
occurring	|O
AHC	|B-PROTEIN
deletion	|I-PROTEIN
mutants	|O
described	|O
to	|O
date	|O
.	|O

Identification	|O
of	|O
a	|O
promoter	|O
-	|O
specific	|O
transactivation	|O
domain	|O
in	|O
the	|O
herpes	|O
simplex	|O
virus	|O
regulatory	|O
protein	|O
ICP4	|B-PROTEIN
.	|O

DNA	|O
sequencing	|O
of	|O
a	|O
17	|O
-	|O
kb	|O
segment	|O
encompassing	|O
a	|O
gammaherpesvirus	|O
divergent	|O
locus	|O
(	|O
DL	|O
-	|O
B	|O
)	|O
between	|O
ORF11	|O
and	|O
ORF17	|O
revealed	|O
the	|O
presence	|O
of	|O
nine	|O
viral	|O
ORFs	|O
with	|O
predicted	|O
gene	|O
products	|O
related	|O
to	|O
cellular	|O
proteins	|O
.	|O

Studies	|O
in	|O
mammalian	|O
cells	|O
have	|O
correlated	|O
induction	|O
of	|O
inhibitory	|O
tyrosine	|O
15	|O
(	|O
Y15	|O
)	|O
phosphorylation	|O
on	|O
p34cdc2	|B-PROTEIN
with	|O
the	|O
response	|O
to	|O
DNA	|O
damage	|O
.	|O

We	|O
report	|O
herein	|O
the	|O
case	|O
of	|O
a	|O
30	|O
-	|O
year	|O
-	|O
old	|O
man	|O
in	|O
whom	|O
ectopic	|O
mediastinal	|O
parathyroid	|O
adenoma	|O
was	|O
detected	|O
by	|O
99mTc	|O
-	|O
methoxyisobutylisonitrile	|O
scintigraphy	|O
(	|O
99mTc	|O
-	|O
MIBI	|O
)	|O
.	|O

Cardiac	|O
endothelin	|B-PROTEIN
release	|O
and	|O
infarct	|O
size	|O
,	|O
myocardial	|O
blood	|O
flow	|O
,	|O
and	|O
ventricular	|O
function	|O
in	|O
canine	|O
infarction	|O
and	|O
reperfusion	|O
.	|O

The	|O
workup	|O
included	|O
skin	|O
tests	|O
(	|O
up	|O
to	|O
1	|O
microgram	|O
/	|O
ml	|O
,	|O
Pharmacia	|O
)	|O
,	|O
measurement	|O
of	|O
specific	|O
serum	|O
IgE	|B-PROTEIN
with	|O
RAST	|O
-	|O
CAP	|O
(	|O
Pharmacia	|O
)	|O
,	|O
and	|O
CAST	|O
with	|O
three	|O
concentrations	|O
of	|O
bee	|O
(	|O
Apis	|O
mellifera	|O
)	|O
and	|O
wasp	|O
(	|O
Vespula	|O
spec	|O
.	|O
)	|O
venom	|O
(	|O
Aquagen	|O
ALK	|O
)	|O
.	|O

The	|O
proliferation	|B-PROTEIN
potential	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
(	|O
P2P	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
gene	|O
with	|O
domains	|O
encoding	|O
heterogeneous	|O
nuclear	|O
ribonucleoprotein	|O
association	|O
and	|O
Rb1	|B-PROTEIN
binding	|O
shows	|O
repressed	|O
expression	|O
during	|O
terminal	|O
differentiation	|O
.	|O

Recent	|O
application	|O
of	|O
recombinant	|O
canarypox	|O
ALVAC	|O
/	|O
HIV	|O
-	|O
1	|O
vectors	|O
as	|O
vaccine	|O
immunogens	|O
in	|O
HIV	|O
-	|O
1	|O
,	|O
-	|O
noninfected	|O
volunteers	|O
has	|O
produced	|O
CTL	|O
responses	|O
in	|O
a	|O
significant	|O
number	|O
of	|O
vaccinees	|O
.	|O

The	|O
relevance	|O
of	|O
these	|O
elements	|O
in	|O
conferring	|O
anaerobic	|O
induction	|O
of	|O
gpc4	|B-PROTEIN
gene	|O
expression	|O
is	|O
discussed	|O
.	|O

Exons	|O
A1a	|O
and	|O
A1b	|O
are	|O
separated	|O
from	|O
each	|O
other	|O
by	|O
a	|O
124	|O
-	|O
nucleotide	|O
intron	|O
.	|O

A	|O
MEK	|B-PROTEIN
-	|O
specific	|O
inhibitor	|O
(	|O
PD098059	|O
)	|O
(	|O
Dudley	|O
,	|O
D.	|O

These	|O
data	|O
support	|O
the	|O
idea	|O
that	|O
the	|O
repression	|O
activity	|O
of	|O
NRSF	|B-PROTEIN
/	|O
REST	|B-PROTEIN
depends	|O
upon	|O
the	|O
species	|O
of	|O
promoter	|O
to	|O
which	|O
it	|O
is	|O
linked	|O
and	|O
upon	|O
the	|O
proteins	|O
that	|O
bind	|O
to	|O
those	|O
promoters	|O
.	|O

Enhanced	|O
period	|O
-	|O
peak	|O
analysis	|O
of	|O
electro	|O
-	|O
encephalograms	|O
using	|O
a	|O
fast	|O
sinc	|O
function	|O
.	|O

In	|O
summary	|O
,	|O
p56	|B-PROTEIN
(	|O
lck	|B-PROTEIN
)	|O
activity	|O
stimulates	|O
G1	|O
/	|O
S	|O
transition	|O
in	|O
immature	|O
thymoblasts	|O
and	|O
maintains	|O
cell	|O
viability	|O
via	|O
transduction	|O
of	|O
constitutive	|O
activation	|O
signals	|O
downstream	|O
to	|O
components	|O
of	|O
the	|O
Ras	|B-PROTEIN
/	|O
Raf	|B-PROTEIN
/	|O
MAPK	|B-PROTEIN
pathway	|O
.	|O

However	|O
,	|O
the	|O
action	|O
of	|O
each	|O
cognate	|O
ligand	|O
and	|O
the	|O
accessory	|O
cellular	|O
factors	|O
that	|O
can	|O
differentially	|O
regulate	|O
the	|O
transcriptional	|O
responses	|O
of	|O
a	|O
heterodimer	|O
-	|O
DNA	|O
complex	|O
are	|O
not	|O
well	|O
understood	|O
.	|O

We	|O
have	|O
measured	|O
the	|O
MBF	|O
on	|O
incisors	|O
and	|O
its	|O
direction	|O
in	|O
three	|O
dimensions	|O
for	|O
different	|O
jaw	|O
openings	|O
in	|O
ten	|O
subjects	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
intraarterial	|O
neoadjuvant	|O
chemotherapy	|O
should	|O
be	|O
effective	|O
on	|O
advanced	|O
cervical	|O
cancer	|O
.	|O

The	|O
FBF	|O
questionnaire	|O
did	|O
not	|O
highlight	|O
a	|O
characteristic	|O
basic	|O
symptoms	|O
profile	|O
of	|O
schizoaffective	|O
disorder	|O
,	|O
when	|O
compared	|O
with	|O
bipolar	|O
affective	|O
disorder	|O
and	|O
schizophrenia	|O
.	|O

The	|O
alternative	|O
sigma	|O
factor	|O
sigmaB	|B-PROTEIN
in	|O
Staphylococcus	|O
aureus	|O
:	|O
regulation	|O
of	|O
the	|O
sigB	|B-PROTEIN
operon	|O
in	|O
response	|O
to	|O
growth	|O
phase	|O
and	|O
heat	|O
shock	|O

Cognate	|O
promoter	|O
elements	|O
implicated	|O
in	|O
glucocorticoid	|O
-	|O
and	|O
cAMP	|O
-	|O
mediated	|O
regulation	|O
as	|O
well	|O
as	|O
in	|O
liver	|O
-	|O
,	|O
myeloid	|O
-	|O
,	|O
and	|O
lymphocyte	|O
-	|O
specific	|O
expression	|O
are	|O
located	|O
within	|O
the	|O
5'	|O
flanking	|O
sequence	|O
.	|O

Clinically	|O
meaningful	|O
decreases	|O
due	|O
to	|O
alkalinization	|O
alone	|O
within	|O
30	|O
minutes	|O
are	|O
unlikely	|O
.	|O

We	|O
have	|O
studied	|O
the	|O
biokinetics	|O
of	|O
BLM	|O
labeled	|O
with	|O
indium	|O
-	|O
111	|O
(	|O
In	|O
-	|O
111	|O
)	|O
.	|O

CD3	|B-PROTEIN
cross	|O
-	|O
linking	|O
induced	|O
tyrosine	|O
phosphorylation	|O
of	|O
Sam68	|B-PROTEIN
in	|O
uninfected	|O
T	|O
cells	|O
.	|O

Acetoin	|O
-	|O
dependent	|O
expression	|O
of	|O
the	|O
acoABCD	|B-PROTEIN
operon	|O
could	|O
be	|O
restored	|O
in	|O
the	|O
E.	|O
coli	|O
acoK	|B-PROTEIN
mutants	|O
by	|O
supplying	|O
a	|O
plasmid	|O
carrying	|O
an	|O
intact	|O
acoK	|B-PROTEIN
,	|O
suggesting	|O
a	|O
transactivating	|O
function	|O
of	|O
the	|O
gene	|O
product	|O
.	|O

Mutations	|O
in	|O
the	|O
alpha	|O
and	|O
sigma	|O
-	|O
70	|O
subunits	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
affect	|O
expression	|O
of	|O
the	|O
mer	|B-PROTEIN
operon	|O
.	|O

Taken	|O
together	|O
,	|O
we	|O
provide	|O
evidence	|O
for	|O
the	|O
existence	|O
of	|O
an	|O
activator	|O
,	|O
NFE	|B-PROTEIN
,	|O
which	|O
in	|O
combination	|O
with	|O
the	|O
p50	|B-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
proteins	|O
,	|O
are	|O
part	|O
of	|O
the	|O
transcription	|O
factor	|O
machinery	|O
that	|O
regulates	|O
3'	|O
enhancer	|O
activity	|O
,	|O
and	|O
thus	|O
the	|O
control	|O
of	|O
the	|O
IgH	|B-PROTEIN
locus	|O
in	|O
late	|O
B	|O
lymphocyte	|O
development	|O
.	|O

The	|O
neuroprotective	|O
efficacy	|O
of	|O
the	|O
selective	|O
N	|O
-	|O
type	|O
voltage	|O
-	|O
sensitive	|O
calcium	|O
channel	|O
blocker	|O
,	|O
SNX	|O
-	|O
111	|O
,	|O
was	|O
evaluated	|O
in	|O
spontaneously	|O
hypertensive	|O
rats	|O
subjected	|O
to	|O
60	|O
min	|O
of	|O
focal	|O
cerebral	|O
ischemia	|O
by	|O
permanent	|O
ligation	|O
of	|O
the	|O
right	|O
common	|O
carotid	|O
artery	|O
and	|O
temporary	|O
occlusion	|O
of	|O
the	|O
right	|O
middle	|O
cerebral	|O
artery	|O
.	|O

The	|O
genes	|O
encoding	|O
the	|O
transcription	|O
factor	|O
yTAFII60	|B-PROTEIN
,	|O
the	|O
G4p1	|B-PROTEIN
protein	|O
and	|O
a	|O
putative	|O
glucose	|O
transporter	|O
are	|O
contained	|O
in	|O
a	|O
12.3	|O
kb	|O
DNA	|O
fragment	|O
on	|O
the	|O
left	|O
arm	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
chromosome	|O
VII	|O
.	|O

The	|O
protector	|O
doubled	|O
the	|O
estimated	|O
fall	|O
distance	|O
for	|O
fracture	|O
of	|O
the	|O
trochanter	|O
.	|O

Marinol	|O
/	|O
marijuana	|O
usage	|O
was	|O
associated	|O
with	|O
depressed	|O
CD4+	|B-PROTEIN
counts	|O
and	|O
elevated	|O
amylase	|B-PROTEIN
levels	|O
within	|O
the	|O
DDI	|O
subgroup	|O
.	|O

METHODS	|O
:	|O
Fifty	|O
-	|O
eight	|O
patients	|O
who	|O
underwent	|O
a	|O
curative	|O
hepatic	|O
resection	|O
for	|O
HCC	|O
and	|O
whose	|O
preoperative	|O
AFP	|B-PROTEIN
levels	|O
were	|O
>	|O
100	|O
ng	|O
/	|O
ml	|O
,	|O
were	|O
selected	|O
for	|O
this	|O
study	|O
.	|O

Calmodulin	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
peptide	|I-PROTEIN
(	|O
CBP	|B-PROTEIN
)	|O
,	|O
a	|O
peptide	|O
of	|O
26	|O
amino	|O
acids	|O
derived	|O
from	|O
muscle	|O
myosin	|B-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MLCK	|B-PROTEIN
)	|O
,	|O
binds	|O
to	|O
calmodulin	|B-PROTEIN
with	|O
nanomolar	|O
affinity	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
the	|O
type	|O
of	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
receptor	|I-PROTEIN
stimulated	|O
also	|O
participates	|O
in	|O
the	|O
nature	|O
of	|O
the	|O
cAMP	|O
effect	|O
.	|O

To	|O
gain	|O
insight	|O
into	|O
the	|O
possible	|O
involvement	|O
of	|O
p21	|B-PROTEIN
in	|O
liver	|O
cell	|O
growth	|O
,	|O
the	|O
expression	|O
and	|O
regulation	|O
of	|O
the	|O
p21	|B-PROTEIN
gene	|O
was	|O
evaluated	|O
in	|O
rodent	|O
models	|O
of	|O
liver	|O
regeneration	|O
and	|O
specimens	|O
of	|O
human	|O
liver	|O
diseases	|O
.	|O

Northern	|O
blot	|O
analysis	|O
of	|O
LeMT	|B-PROTEIN
(	|I-PROTEIN
A	|I-PROTEIN
)	|I-PROTEIN
and	|O
LeMT	|B-PROTEIN
(	|I-PROTEIN
B	|I-PROTEIN
)	|I-PROTEIN
showed	|O
that	|O
transcripts	|O
of	|O
both	|O
MT	|B-PROTEIN
-	|O
like	|O
genes	|O
were	|O
more	|O
abundant	|O
in	|O
leaves	|O
than	|O
roots	|O
in	|O
tomato	|O
plants	|O
grown	|O
without	|O
addition	|O
of	|O
extra	|O
metal	|O
ions	|O
,	|O
a	|O
characteristic	|O
of	|O
type	|B-PROTEIN
II	|I-PROTEIN
MTs	|I-PROTEIN
.	|O

In	|O
co	|O
-	|O
transfection	|O
studies	|O
,	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
but	|O
not	|O
an	|O
Egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
vector	|O
activated	|O
VPF	|B-PROTEIN
/	|O
VEGF	|B-PROTEIN
transcription	|O
,	|O
thus	|O
indicating	|O
that	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
is	|O
functionally	|O
important	|O
in	|O
TGF	|B-PROTEIN
alpha	|I-PROTEIN
-	|O
induced	|O
VPF	|B-PROTEIN
/	|O
VEGF	|B-PROTEIN
gene	|O
expression	|O
.	|O

The	|O
HBP	|B-PROTEIN
gene	|O
is	|O
composed	|O
of	|O
eight	|O
exons	|O
covering	|O
19.5	|O
kb	|O
on	|O
the	|O
short	|O
arm	|O
of	|O
chromosome	|O
4	|O
.	|O

In	|O
some	|O
instances	|O
,	|O
this	|O
is	|O
partly	|O
mediated	|O
by	|O
the	|O
expression	|O
of	|O
virally	|O
encoded	|O
proteases	|O
which	|O
lead	|O
to	|O
the	|O
cleavage	|O
of	|O
initiation	|O
factor	|O
eIF4G	|B-PROTEIN
.	|O

The	|O
best	|O
endometrial	|O
ablation	|O
was	|O
seen	|O
when	|O
SnET2	|O
was	|O
given	|O
by	|O
intrauterine	|O
administration	|O
with	|O
light	|O
treatment	|O
at	|O
150	|O
J	|O
/	|O
cm	|O
24	|O
hours	|O
later	|O
.	|O

Unlike	|O
class	|O
II	|O
-	|O
and	|O
III	|O
-	|O
specific	|O
TBP	|B-PROTEIN
-	|O
TAF	|B-PROTEIN
complexes	|O
,	|O
the	|O
corresponding	|O
murine	|O
and	|O
human	|O
class	|O
I	|O
-	|O
specific	|O
transcription	|O
initiation	|O
factor	|O
TIF	|B-PROTEIN
-	|I-PROTEIN
IB	|I-PROTEIN
/	|O
SL1	|B-PROTEIN
exhibits	|O
a	|O
pronounced	|O
selectivity	|O
for	|O
its	|O
homologous	|O
promoter	|O
.	|O

Cytohesin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
a	|O
protein	|O
abundant	|O
in	|O
cells	|O
of	|O
the	|O
immune	|O
system	|O
,	|O
has	|O
been	|O
proposed	|O
to	|O
be	|O
a	|O
human	|O
homolog	|O
of	|O
the	|O
Saccharomyces	|O
cerevisiae	|O
Sec7	|B-PROTEIN
gene	|O
product	|O
,	|O
which	|O
is	|O
crucial	|O
in	|O
protein	|O
transport	|O
.	|O

In	|O
this	|O
regard	|O
,	|O
it	|O
differs	|O
from	|O
a	|O
recently	|O
reported	|O
BFA	|O
-	|O
sensitive	|O
ARF	|B-PROTEIN
-	|O
GEP	|B-PROTEIN
that	|O
contains	|O
a	|O
Sec7	|B-PROTEIN
domain	|O
.	|O

We	|O
now	|O
describe	|O
the	|O
identification	|O
of	|O
DEK	|B-PROTEIN
as	|O
this	|O
43	|O
-	|O
kDa	|O
pets	|B-PROTEIN
factor	|O
.	|O

These	|O
elements	|O
comprise	|O
a	|O
binding	|O
site	|O
for	|O
Krox	|B-PROTEIN
proteins	|O
,	|O
one	|O
for	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
,	|O
an	|O
octamer	|O
motif	|O
that	|O
binds	|O
POU	|B-PROTEIN
-	|O
homeodomain	|O
proteins	|O
,	|O
and	|O
a	|O
novel	|O
TN	|B-PROTEIN
control	|O
element	|O
.	|O

Tissue	|O
samples	|O
were	|O
obtained	|O
either	|O
from	|O
rats	|O
that	|O
had	|O
been	|O
exposed	|O
to	|O
opiate	|O
withdrawal	|O
following	|O
a	|O
seven	|O
day	|O
morphine	|O
infusion	|O
or	|O
sham	|O
treated	|O
control	|O
subjects	|O
.	|O

Therefore	|O
,	|O
the	|O
impaired	|O
floor	|O
plate	|O
development	|O
in	|O
oep	|B-PROTEIN
mutants	|O
is	|O
not	|O
caused	|O
by	|O
the	|O
absence	|O
of	|O
the	|O
floor	|O
plate	|O
inducer	|O
shh	|B-PROTEIN
.	|O

RESULTS	|O
:	|O
The	|O
medians	|O
of	|O
average	|O
daily	|O
CD34+	|B-PROTEIN
cell	|O
yields	|O
for	|O
patients	|O
who	|O
received	|O
paclitaxel	|O
plus	|O
CY	|O
,	|O
CE	|O
,	|O
and	|O
CEP	|O
with	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
were	|O
12.9	|O
,	|O
11.03	|O
,	|O
and	|O
5.37	|O
x	|O
10	|O
(	|O
6	|O
)	|O
/	|O
kg	|O
,	|O
respectively	|O
,	|O
compared	|O
with	|O
2.02	|O
x	|O
10	|O
(	|O
6	|O
)	|O
/	|O
kg	|O
in	|O
the	|O
reference	|O
group	|O
that	|O
received	|O
CY	|O
with	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
(	|O
P	|O
=	|O
<	|O
.0001	|O
,	|O
.002	|O
,	|O
and	|O
.09	|O
,	|O
respectively	|O
)	|O
.	|O

Increased	|O
p53	|B-PROTEIN
activity	|O
induced	|O
by	|O
OP	|O
is	|O
not	|O
due	|O
to	|O
elevated	|O
p53	|B-PROTEIN
mRNA	|O
nor	|O
to	|O
protein	|O
levels	|O
.	|O

CONCLUSION	|O
:	|O
Chronic	|O
administration	|O
of	|O
misoprostol	|O
may	|O
have	|O
caused	|O
a	|O
negative	|O
natriuretic	|O
effect	|O
in	|O
cirrhotic	|O
patients	|O
with	|O
ascites	|O
.	|O

The	|O
intensity	|O
of	|O
the	|O
SSTEs	|O
is	|O
an	|O
order	|O
of	|O
magnitude	|O
larger	|O
than	|O
that	|O
of	|O
the	|O
MSEs	|O
and	|O
determines	|O
the	|O
signal	|O
contrast	|O
if	|O
both	|O
effects	|O
are	|O
selected	|O
simultaneously	|O
.	|O

In	|O
eukaryotic	|O
cells	|O
,	|O
premature	|O
termination	|O
of	|O
translation	|O
at	|O
nonsense	|O
codons	|O
has	|O
been	|O
implicated	|O
as	|O
the	|O
cause	|O
of	|O
a	|O
variety	|O
of	|O
posttranscriptional	|O
events	|O
,	|O
including	|O
rapid	|O
mRNA	|O
decay	|O
in	|O
the	|O
cytoplasm	|O
or	|O
the	|O
nucleus	|O
,	|O
altered	|O
splice	|O
site	|O
selection	|O
,	|O
and	|O
exon	|O
skipping	|O
.	|O

The	|O
region	|O
of	|O
plasmid	|O
pCM2	|O
encoding	|O
the	|O
pathogenicity	|O
locus	|O
pat	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
mapped	|O
by	|O
deletion	|O
analysis	|O
and	|O
complementation	|O
studies	|O
to	|O
a	|O
1.5	|O
-	|O
kb	|O
Bg	|B-PROTEIN
/	|I-PROTEIN
II	|I-PROTEIN
/	|O
SmaI	|B-PROTEIN
DNA	|O
fragment	|O
.	|O

Transient	|O
cotransfection	|O
of	|O
tat	|B-PROTEIN
cDNA	|O
in	|O
sense	|O
orientation	|O
(	|O
tat	|B-PROTEIN
/	|O
S	|O
)	|O
,	|O
together	|O
with	|O
a	|O
plasmid	|O
containing	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
promoter	|O
(	|O
FC3	|B-PROTEIN
,	|O
from	|O
-	|O
711	|O
to	|O
+	|O
42	|O
)	|O
in	|O
front	|O
of	|O
the	|O
bacterial	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
gene	|O
significantly	|O
enhanced	|O
CAT	|B-PROTEIN
activity	|O
in	|O
Jurkat	|O
cells	|O
activated	|O
by	|O
the	|O
addition	|O
of	|O
15%	|O
fetal	|O
calf	|O
serum	|O
(	|O
FCS	|O
)	|O
or	|O
5	|O
micrograms	|O
/	|O
mL	|O
phytohemagglutinin	|B-PROTEIN
plus	|O
10	|O
(	|O
-	|O
7	|O
)	|O
mol	|O
/	|O
L	|O
phorbol	|O
myristate	|O
acetate	|O
(	|O
PMA	|O
)	|O
and	|O
U937	|O
cells	|O
activated	|O
by	|O
15%	|O
FCS	|O
or	|O
10	|O
(	|O
-	|O
7	|O
)	|O
mol	|O
/	|O
L	|O
PMA	|O
.	|O

Snail	|O
mortality	|O
did	|O
not	|O
differ	|O
among	|O
the	|O
various	|O
treatment	|O
conditions	|O
.	|O

The	|O
recombinant	|O
protein	|O
was	|O
purified	|O
to	|O
homogeneity	|O
by	|O
(	|O
NH4	|O
)	|O
2SO4	|O
-	|O
precipitation	|O
and	|O
affinity	|O
chromatography	|O
on	|O
5'	|O
AMP	|O
-	|O
Sepharose	|O
.	|O

Derepression	|O
of	|O
gene	|O
expression	|O
mediated	|O
by	|O
the	|O
5'	|O
upstream	|O
region	|O
of	|O
the	|O
isocitrate	|B-PROTEIN
lyase	|I-PROTEIN
gene	|O
of	|O
Candida	|O
tropicalis	|O
is	|O
controlled	|O
by	|O
two	|O
distinct	|O
regulatory	|O
pathways	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Exploratory	|O
-	|O
motor	|O
task	|O
to	|O
evaluate	|O
right	|O
frontal	|O
lobe	|O
damage	|O
.	|O

To	|O
avoid	|O
complications	|O
,	|O
accurate	|O
quantitative	|O
analysis	|O
of	|O
NO	|O
and	|O
NO2	|O
is	|O
necessary	|O
during	|O
this	|O
therapy	|O
.	|O

Our	|O
results	|O
demonstrate	|O
that	|O
cis	|O
elements	|O
positioned	|O
between	|O
the	|O
alpha	|B-PROTEIN
3	|I-PROTEIN
and	|O
beta	|B-PROTEIN
4	|I-PROTEIN
coding	|O
regions	|O
are	|O
important	|O
for	|O
establishing	|O
part	|O
of	|O
the	|O
restricted	|O
CNS	|O
patterns	|O
of	|O
beta	|B-PROTEIN
4	|I-PROTEIN
,	|O
alpha	|B-PROTEIN
3	|I-PROTEIN
,	|O
and	|O
alpha	|B-PROTEIN
5	|I-PROTEIN
gene	|O
transcription	|O
.	|O

RNase	|B-PROTEIN
protection	|O
experiments	|O
confirmed	|O
the	|O
presence	|O
of	|O
the	|O
GHR1	|B-PROTEIN
-	|I-PROTEIN
279	|I-PROTEIN
variant	|O
in	|O
IM	|O
-	|O
9	|O
cells	|O
and	|O
human	|O
liver	|O
.	|O

Functional	|O
tests	|O
using	|O
a	|O
reporter	|O
gene	|O
,	|O
containing	|O
Stat5	|B-PROTEIN
-	|O
binding	|O
elements	|O
,	|O
confirmed	|O
that	|O
while	|O
the	|O
variant	|O
form	|O
was	|O
inactive	|O
by	|O
itself	|O
,	|O
it	|O
could	|O
inhibit	|O
the	|O
function	|O
of	|O
the	|O
full	|O
-	|O
length	|O
receptor	|O
.	|O

Conversely	|O
,	|O
activated	|O
glucocorticoid	|B-PROTEIN
receptors	|I-PROTEIN
suppressed	|O
the	|O
transactivation	|O
function	|O
of	|O
p53	|B-PROTEIN
,	|O
while	|O
transrepression	|O
by	|O
p53	|B-PROTEIN
was	|O
largely	|O
unaffected	|O
.	|O

99mTc	|O
-	|O
HMPAO	|O
was	|O
distributed	|O
in	|O
the	|O
territories	|O
of	|O
the	|O
ACA	|O
and	|O
MCA	|O
in	|O
the	|O
two	|O
patients	|O
who	|O
were	|O
treated	|O
with	|O
intraarterial	|O
infusion	|O
of	|O
papaverine	|O
from	|O
the	|O
C4	|O
segment	|O
,	|O
but	|O
was	|O
distributed	|O
only	|O
to	|O
the	|O
territory	|O
of	|O
the	|O
ACA	|O
in	|O
four	|O
patients	|O
who	|O
were	|O
treated	|O
with	|O
intraarterial	|O
infusion	|O
of	|O
papaverine	|O
from	|O
the	|O
C1	|O
segment	|O
at	|O
1	|O
ml	|O
/	|O
min	|O
.	|O

This	|O
brief	|O
review	|O
analyses	|O
these	|O
interactions	|O
and	|O
defines	|O
clinical	|O
settings	|O
where	|O
antibiotic	|O
-	|O
induced	|O
endotoxin	|O
release	|O
may	|O
prove	|O
to	|O
be	|O
clinically	|O
relevant	|O
.	|O

This	|O
promoter	|O
segment	|O
could	|O
drive	|O
expression	|O
of	|O
a	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
,	|O
could	|O
confer	|O
correct	|O
transcriptional	|O
initiation	|O
to	|O
the	|O
reporter	|O
and	|O
could	|O
confer	|O
the	|O
EGF	|B-PROTEIN
-	|O
responsiveness	|O
previously	|O
observed	|O
in	|O
the	|O
native	|O
gene	|O
.	|O

This	|O
is	|O
the	|O
first	|O
report	|O
that	|O
an	|O
in	|O
vitro	|O
-	|O
synthesized	|O
alphavirus	|O
RNA	|O
lacking	|O
a	|O
poly	|O
(	|O
A	|O
)	|O
tail	|O
can	|O
initiate	|O
infection	|O
and	|O
produce	|O
3'	|O
polyadenylated	|O
viral	|O
genome	|O
in	|O
vivo	|O
.	|O

The	|O
human	|O
coreceptor	|O
was	|O
as	|O
active	|O
as	|O
the	|O
simian	|O
for	|O
SIV	|O
entry	|O
.	|O

These	|O
changes	|O
in	|O
virus	|O
entry	|O
features	|O
may	|O
result	|O
in	|O
coronaviruses	|O
with	|O
novel	|O
pathogenic	|O
properties	|O
.	|O

RESULTS	|O
:	|O
Among	|O
women	|O
,	|O
the	|O
age	|O
-	|O
related	|O
decline	|O
in	|O
BMD	|O
at	|O
all	|O
non	|O
-	|O
spine	|O
skeletal	|O
sites	|O
was	|O
significantly	|O
different	|O
from	|O
zero	|O
,	|O
with	|O
the	|O
largest	|O
decline	|O
seen	|O
at	|O
the	|O
femoral	|O
neck	|O
(	|O
-	|O
.0038	|O
g	|O
/	|O
cm2	|O
/	|O
y	|O
,	|O
p	|O
<	|O
.001	|O
)	|O
and	|O
the	|O
smallest	|O
at	|O
the	|O
trochanter	|O
of	|O
the	|O
hip	|O
(	|O
-	|O
.0023	|O
g	|O
/	|O
cm2	|O
/	|O
y	|O
,	|O
p	|O
=	|O
.03	|O
)	|O
.	|O

Sixty	|O
-	|O
nine	|O
(	|O
44%	|O
)	|O
patients	|O
were	|O
administered	|O
250	|O
MBq	|O
(	|O
7	|O
mCi	|O
)	|O
99Tcm	|O
-	|O
tetrofosmin	|O
at	|O
rest	|O
followed	|O
4	|O
h	|O
later	|O
by	|O
750	|O
MBq	|O
(	|O
21	|O
mCi	|O
)	|O
during	|O
stress	|O
(	|O
the	|O
1	|O
day	|O
protocol	|O
)	|O
,	|O
whereas	|O
88	|O
(	|O
56%	|O
)	|O
patients	|O
had	|O
rest	|O
and	|O
stress	|O
imaging	|O
studies	|O
on	|O
two	|O
separate	|O
days	|O
,	|O
receiving	|O
a	|O
500	|O
MBq	|O
(	|O
14	|O
mCi	|O
)	|O
dose	|O
of	|O
99Tcm	|O
-	|O
tetrofosmin	|O
on	|O
each	|O
occasion	|O
(	|O
the	|O
2	|O
day	|O
protocol	|O
)	|O
.	|O

Myocardial	|O
SPET	|O
imaging	|O
with	|O
99Tcm	|O
-	|O
tetrofosmin	|O
in	|O
clinical	|O
practice	|O
:	|O
comparison	|O
of	|O
a	|O
1	|O
day	|O
and	|O
a	|O
2	|O
day	|O
imaging	|O
protocol	|O
.	|O

99Tcm	|O
-	|O
DMP	|O
-	|O
HSA	|O
showed	|O
an	|O
almost	|O
identical	|O
behaviour	|O
to	|O
in	|O
vitro	|O
labelled	|O
red	|O
blood	|O
cells	|O
(	|O
RBCs	|O
)	|O
,	|O
which	|O
are	|O
generally	|O
considered	|O
the	|O
reference	|O
standard	|O
for	|O
blood	|O
pool	|O
agents	|O
.	|O

Relief	|O
from	|O
autoinhibition	|O
and	|O
a	|O
subsequent	|O
10-60	|O
-	|O
fold	|O
increase	|O
in	|O
V	|O
(	|O
max	|O
)	|O
have	|O
been	|O
observed	|O
upon	|O
N	|B-PROTEIN
-	|I-PROTEIN
SH2	|I-PROTEIN
domain	|O
engagement	|O
by	|O
a	|O
specific	|O
phosphotyrosyl	|O
ligand	|O
or	|O
upon	|O
deletion	|O
of	|O
the	|O
SH2	|B-PROTEIN
domains	|O
to	|O
yield	|O
the	|O
catalytic	|O
PTPase	|B-PROTEIN
domain	|O
.	|O

We	|O
have	|O
thus	|O
identified	|O
the	|O
first	|O
mammalian	|O
homolog	|O
of	|O
yeast	|O
UPF1	|B-PROTEIN
,	|O
a	|O
protein	|O
that	|O
regulates	|O
levels	|O
of	|O
nonsense	|O
mRNA	|O
,	|O
and	|O
we	|O
tentatively	|O
name	|O
this	|O
protein	|O
human	|B-PROTEIN
HUPF1	|I-PROTEIN
(	|O
for	|O
human	|O
homolog	|O
of	|O
UPF1	|B-PROTEIN
)	|O
.	|O

A	|O
miracle	|O
cure	|O
and	|O
its	|O
solution	|O

The	|O
addition	|O
of	|O
zidovudine	|O
did	|O
not	|O
influence	|O
this	|O
transfer	|O
.	|O

DNA	|O
strand	|O
exchange	|O
catalyzed	|O
by	|O
Rad51	|B-PROTEIN
protein	|O
is	|O
also	|O
greatly	|O
stimulated	|O
by	|O
RPA	|B-PROTEIN
.	|O

Ume6p	|B-PROTEIN
,	|O
which	|O
also	|O
controls	|O
the	|O
expression	|O
of	|O
early	|O
meiotic	|O
genes	|O
,	|O
represses	|O
CAR1	|B-PROTEIN
expression	|O
through	|O
a	|O
sequence	|O
called	|O
URS	|O
,	|O
as	|O
a	|O
function	|O
of	|O
nitrogen	|O
availability	|O
.	|O

The	|O
second	|O
class	|O
of	|O
cDNA	|O
hybridized	|O
to	|O
a	|O
13	|O
kb	|O
transcript	|O
,	|O
which	|O
was	|O
approximately	|O
twice	|O
as	|O
large	|O
as	|O
the	|O
mammalian	|O
lactase	|B-PROTEIN
mRNA	|O
.	|O

In	|O
cell	|O
lines	|O
transformed	|O
by	|O
BCR	|B-PROTEIN
/	|O
ABL	|B-PROTEIN
,	|O
CRKL	|B-PROTEIN
was	|O
tyrosine	|O
phosphorylated	|O
,	|O
while	|O
CRK	|B-PROTEIN
was	|O
not	|O
.	|O

In	|O
untransformed	|O
cells	|O
,	|O
three	|O
major	|O
proteins	|O
coprecipitated	|O
with	|O
CRKL	|B-PROTEIN
,	|O
identified	|O
as	|O
C3G	|B-PROTEIN
,	|O
SOS	|B-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
ABL	|I-PROTEIN
.	|O

Effect	|O
of	|O
Azadirachta	|O
indica	|O
hydroalcoholic	|O
leaf	|O
extract	|O
on	|O
the	|O
cardiovascular	|O
system	|O
.	|O

RESULTS	|O
:	|O
Nodular	|O
opacities	|O
,	|O
mainly	|O
centrilobular	|O
in	|O
distribution	|O
,	|O
were	|O
the	|O
most	|O
common	|O
finding	|O
,	|O
seen	|O
in	|O
21	|O
(	|O
72%	|O
)	|O
and	|O
15	|O
(	|O
65%	|O
)	|O
of	|O
patients	|O
with	|O
MTB	|O
and	|O
NTMB	|O
,	|O
respectively	|O
.	|O

Circulating	|O
oxytocin	|B-PROTEIN
in	|O
male	|O
guinea	|O
pigs	|O
affected	|O
by	|O
the	|O
female	|O
cohabitation	|O
and	|O
reproductive	|O
condition	|O
.	|O

In	|O
cellular	|O
supernatant	|O
fraction	|O
,	|O
SHRSP	|O
showed	|O
a	|O
decrease	|O
of	|O
magnesium	|O
in	|O
many	|O
tissues	|O
and	|O
an	|O
elevation	|O
of	|O
the	|O
calcium	|O
to	|O
magnesium	|O
ratio	|O
when	|O
compared	|O
to	|O
age	|O
-	|O
matched	|O
WKY	|O
and	|O
SHRSR	|O
.	|O

Antisense	|O
transcription	|O
of	|O
a	|O
murine	|O
FGFR	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
psuedogene	|O
during	|O
fetal	|O
developement	|O
.	|O

A	|O
previous	|O
report	|O
described	|O
that	|O
a	|O
548	|O
-	|O
bp	|O
BglII	|B-PROTEIN
-	|O
SmaI	|B-PROTEIN
fragment	|O
has	|O
an	|O
SSO	|O
activity	|O
(	|O
ori2	|O
;	|O
Kataoka	|O
et	|O
al.	|O
,	|O
Mol.	|O

The	|O
human	|O
CD38	|B-PROTEIN
gene	|O
consists	|O
of	|O
8	|O
exons	|O
that	|O
extend	|O
more	|O
than	|O
77	|O
kb	|O
on	|O
the	|O
human	|O
genome	|O
.	|O

Type	|O
IV	|O
splice	|O
pattern	|O
,	|O
containing	|O
exon	|O
U3	|O
and	|O
S	|O
was	|O
found	|O
both	|O
in	|O
kidney	|O
and	|O
ovary	|O
.	|O

GH	|B-PROTEIN
deficiency	|O
may	|O
be	|O
absolute	|O
,	|O
but	|O
often	|O
is	|O
not	|O
and	|O
the	|O
diagnosis	|O
may	|O
be	|O
complicated	|O
by	|O
a	|O
constellation	|O
of	|O
physical	|O
and	|O
hormonal	|O
findings	|O
that	|O
are	|O
along	|O
a	|O
spectrum	|O
from	|O
low	|O
normal	|O
GH	|B-PROTEIN
sufficiency	|O
to	|O
absent	|O
GH	|B-PROTEIN
secretion	|O
.	|O

Positive	|O
CRP	|B-PROTEIN
test	|O
were	|O
seen	|O
.	|O

During	|O
the	|O
febrile	|O
period	|O
,	|O
pleocytosis	|O
was	|O
associated	|O
with	|O
high	|O
levels	|O
of	|O
IgG	|B-PROTEIN
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
and	|O
PGE2	|O
in	|O
the	|O
cerebrospinal	|O
fluid	|O
.	|O

Recognition	|O
mechanisms	|O
of	|O
the	|O
minus	|O
-	|O
strand	|O
origin	|O
of	|O
phage	|O
f1	|O
by	|O
Escherichia	|O
coli	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
.	|O

The	|O
minimum	|O
and	|O
essential	|O
subunits	|O
for	|O
RNA	|O
synthesis	|O
have	|O
not	|O
yet	|O
been	|O
identified	|O
.	|O

Syndecan	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
is	|O
a	|O
focal	|O
adhesion	|O
component	|O
,	|O
and	|O
this	|O
interaction	|O
may	|O
both	|O
localize	|O
PKC	|B-PROTEIN
and	|O
amplify	|O
its	|O
activity	|O
at	|O
sites	|O
of	|O
forming	|O
adhesions	|O
.	|O

The	|O
3ASubE	|O
cells	|O
expressing	|O
CXCR2	|B-PROTEIN
with	|O
mutation	|O
of	|O
Ser	|O
-	|O
346	|O
,	|O
-	|O
347	|O
,	|O
and	|O
-	|O
348	|O
to	|O
alanine	|O
,	|O
or	|O
with	|O
mutation	|O
of	|O
only	|O
one	|O
serine	|O
in	|O
this	|O
domain	|O
,	|O
continue	|O
to	|O
be	|O
phosphorylated	|O
in	|O
response	|O
to	|O
ligand	|O
and	|O
are	|O
60-70%	|O
desensitized	|O
following	|O
the	|O
initial	|O
ligand	|O
challenge	|O
.	|O

Members	|O
of	|O
the	|O
MAPK	|B-PROTEIN
family	|O
include	|O
the	|O
extracellular	|B-PROTEIN
response	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
ERKs	|B-PROTEIN
or	|O
p42/44	|B-PROTEIN
(	|O
MAPK	|B-PROTEIN
)	|O
)	|O
,	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
amino	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
JNKs	|B-PROTEIN
)	|O
,	|O
and	|O
the	|O
p38	|B-PROTEIN
/	|O
Hog	|B-PROTEIN
1	|I-PROTEIN
protein	|O
kinases	|O
.	|O

MOP5	|B-PROTEIN
contained	|O
the	|O
characteristic	|O
PAS	|B-PROTEIN
domain	|O
and	|O
a	|O
variable	|O
C	|O
terminus	|O
;	|O
it	|O
is	|O
possible	|O
that	|O
the	|O
cDNA	|O
contains	|O
a	|O
bHLH	|O
domain	|O
,	|O
but	|O
the	|O
entire	|O
open	|O
reading	|O
frame	|O
has	|O
yet	|O
to	|O
be	|O
completed	|O
.	|O

The	|O
reduced	|O
NO	|O
production	|O
in	|O
these	|O
cells	|O
was	|O
associated	|O
with	|O
low	|O
levels	|O
of	|O
mRNA	|O
of	|O
inducible	|O
NO	|B-PROTEIN
synthetase	|I-PROTEIN
.	|O

Some	|O
8.8	|O
kb	|O
of	|O
the	|O
Lactobacillus	|O
sake	|O
plasmid	|O
pCIM1	|O
was	|O
sequenced	|O
,	|O
revealing	|O
eight	|O
tightly	|O
clustered	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
downstream	|O
from	|O
lasA	|B-PROTEIN
,	|O
which	|O
encodes	|O
pre	|B-PROTEIN
-	|I-PROTEIN
lactocin	|I-PROTEIN
S.	|O

Purified	|O
Pra	|B-PROTEIN
was	|O
also	|O
shown	|O
to	|O
physically	|O
interact	|O
with	|O
pyruvate	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
Pk	|B-PROTEIN
)	|O
;	|O
Pk	|B-PROTEIN
and	|O
Pra	|B-PROTEIN
can	|O
form	|O
a	|O
complex	|O
,	|O
but	|O
when	|O
the	|O
12	|O
-	|O
kDa	|O
Ndk	|B-PROTEIN
,	|O
Pk	|B-PROTEIN
,	|O
and	|O
Pra	|B-PROTEIN
are	|O
all	|O
present	|O
,	|O
Pk	|B-PROTEIN
has	|O
a	|O
higher	|O
affinity	|O
than	|O
Pra	|B-PROTEIN
for	|O
forming	|O
a	|O
complex	|O
with	|O
the	|O
12	|O
-	|O
kDa	|O
Ndk	|B-PROTEIN
.	|O

Apart	|O
from	|O
iron	|O
regulation	|O
,	|O
sodA	|B-PROTEIN
expression	|O
was	|O
affected	|O
by	|O
changes	|O
in	|O
DNA	|O
topology	|O
induced	|O
by	|O
coumermycin	|O
A	|O
but	|O
not	|O
by	|O
the	|O
global	|O
virulence	|O
regulatory	|O
Bvg	|B-PROTEIN
system	|O
.	|O

Molecular	|O
characterization	|O
of	|O
a	|O
large	|O
Borrelia	|O
burgdorferi	|O
motility	|O
operon	|O
which	|O
is	|O
initiated	|O
by	|O
a	|O
consensus	|O
sigma70	|B-PROTEIN
promoter	|O
.	|O

M.	|O
leprae	|O
OxyR	|B-PROTEIN
was	|O
overproduced	|O
and	|O
purified	|O
,	|O
and	|O
its	|O
binding	|O
to	|O
the	|O
oxyR	|B-PROTEIN
-	|O
ahpC	|B-PROTEIN
intergenic	|O
region	|O
of	|O
M.	|O
leprae	|O
was	|O
demonstrated	|O
.	|O

The	|O
binding	|O
site	|O
for	|O
OxyR	|B-PROTEIN
overlapped	|O
P1oxyR	|B-PROTEIN
,	|O
reminiscent	|O
of	|O
the	|O
autoregulatory	|O
loops	|O
controlling	|O
expression	|O
of	|O
oxyR	|B-PROTEIN
in	|O
enteric	|O
bacteria	|O
and	|O
characteristic	|O
of	|O
the	|O
LysR	|B-PROTEIN
superfamily	|O
in	|O
general	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
have	|O
isolated	|O
and	|O
sequenced	|O
several	|O
p15E	|B-PROTEIN
cDNA	|O
gene	|O
fragments	|O
amplified	|O
by	|O
means	|O
of	|O
polymerase	|O
chain	|O
reaction	|O
(	|O
PCR	|O
)	|O
from	|O
parental	|O
(	|O
P815	|O
)	|O
and	|O
xenogenized	|O
(	|O
P815	|O
/	|O
DTIC	|O
)	|O
tumour	|O
cells	|O
.	|O

Thirty	|O
-	|O
five	|O
patients	|O
were	|O
included	|O
.	|O

Grade	|O
3-4	|O
mucositis	|O
was	|O
present	|O
in	|O
13%	|O
of	|O
the	|O
cycles	|O
.	|O

Therefore	|O
more	|O
active	|O
and	|O
tolerable	|O
salvage	|O
regimens	|O
are	|O
needed	|O
.	|O

None	|O
of	|O
these	|O
organic	|O
manifestations	|O
was	|O
discovered	|O
by	|O
scintigraphic	|O
means	|O
.	|O

While	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
does	|O
not	|O
alter	|O
the	|O
mitogen	|O
-	|O
induced	|O
expression	|O
and	|O
abundance	|O
of	|O
G1	|O
phase	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
and	|O
cdks	|B-PROTEIN
4	|I-PROTEIN
and	|I-PROTEIN
2	|I-PROTEIN
in	|O
MCs	|O
,	|O
it	|O
inhibits	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
-	|O
cdk	|B-PROTEIN
2	|I-PROTEIN
activity	|O
,	|O
thus	|O
preventing	|O
mitogen	|O
-	|O
elicited	|O
phosphorylation	|O
and	|O
inactivation	|O
of	|O
pRb	|B-PROTEIN
in	|O
G1	|O
phase	|O
and	|O
transition	|O
to	|O
S	|O
phase	|O
.	|O

However	|O
,	|O
the	|O
range	|O
of	|O
values	|O
observed	|O
is	|O
suggestive	|O
of	|O
the	|O
need	|O
to	|O
investigate	|O
districts	|O
with	|O
contrasting	|O
values	|O
of	|O
SYPLR	|O
with	|O
respect	|O
to	|O
the	|O
inter	|O
-	|O
relationships	|O
between	|O
sociodemographic	|O
characteristics	|O
,	|O
duration	|O
of	|O
symptoms	|O
,	|O
clinical	|O
presentation	|O
and	|O
treatment	|O
efficacy	|O
.	|O

The	|O
prominent	|O
lesions	|O
were	|O
confined	|O
to	|O
the	|O
cerebral	|O
surface	|O
layer	|O
and	|O
leptomeningeal	|O
tissue	|O
including	|O
the	|O
arachnoid	|O
vessels	|O
,	|O
which	|O
were	|O
all	|O
bathed	|O
in	|O
the	|O
cerebrospinal	|O
fluid	|O
,	|O
suggesting	|O
that	|O
some	|O
necrotizing	|O
toxins	|O
had	|O
been	|O
secreted	|O
into	|O
the	|O
fluid	|O
by	|O
the	|O
B.	|O
cereus	|O
.	|O

This	|O
fragment	|O
contained	|O
the	|O
C	|O
-	|O
terminal	|O
47	|O
nucleotides	|O
of	|O
leuB	|B-PROTEIN
,	|O
encoding	|O
3	|B-PROTEIN
-	|I-PROTEIN
isopropylmalate	|I-PROTEIN
dehydrogenase	|I-PROTEIN
;	|O
asd	|B-PROTEIN
,	|O
encoding	|O
aspartate	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
semialdehyde	|I-PROTEIN
dehydrogenase	|I-PROTEIN
(	|O
Asd	|B-PROTEIN
)	|O
;	|O
and	|O
orfA	|O
,	|O
whose	|O
product	|O
showed	|O
similarity	|O
to	|O
the	|O
Asd	|B-PROTEIN
proteins	|O
from	|O
Vibrio	|O
spp	|O
.	|O

Transcriptional	|O
activity	|O
was	|O
measured	|O
by	|O
slot	|O
-	|O
blot	|O
hybridization	|O
with	|O
steady	|O
-	|O
state	|O
RNA	|O
isolated	|O
from	|O
lacZ+	|B-PROTEIN
M.	|O
smegmatis	|O
clones	|O
.	|O

Hovenitin	|O
I	|O
and	|O
(	|O
+	|O
)	|O
-	|O
ampelopsin	|O
,	|O
both	|O
of	|O
which	|O
were	|O
principal	|O
ingredients	|O
of	|O
the	|O
active	|O
fractions	|O
from	|O
this	|O
natural	|O
medicine	|O
,	|O
were	|O
found	|O
to	|O
show	|O
an	|O
inhibitory	|O
activity	|O
on	|O
the	|O
ethanol	|O
-	|O
induced	|O
muscle	|O
relaxation	|O
in	|O
rats	|O
.	|O

Movement	|O
time	|O
and	|O
kinematic	|O
characteristics	|O
were	|O
analyzed	|O
together	|O
with	|O
the	|O
magnitude	|O
of	|O
cerebral	|O
blood	|O
flow	|O
to	|O
identify	|O
areas	|O
of	|O
brain	|O
activity	|O
proportionate	|O
to	|O
task	|O
and	|O
movement	|O
variables	|O
.	|O

Areas	|O
with	|O
significantly	|O
greater	|O
rCBF	|O
for	|O
targeting	|O
were	|O
the	|O
left	|O
motor	|O
cortex	|O
,	|O
left	|O
intraparietal	|O
sulcus	|O
,	|O
and	|O
left	|O
caudate	|O
.	|O

Recent	|O
studies	|O
have	|O
demonstrated	|O
that	|O
the	|O
U1	|B-PROTEIN
snRNP	|O
is	|O
recruited	|O
to	|O
the	|O
5'	|O
splice	|O
site	|O
by	|O
protein	|O
/	|O
protein	|O
interactions	|O
involving	|O
the	|O
SR	|B-PROTEIN
domains	|O
of	|O
the	|O
U1	|B-PROTEIN
-	|O
70K	|O
protein	|O
and	|O
SF2	|B-PROTEIN
/	|O
ASF	|B-PROTEIN
.	|O

Thus	|O
,	|O
the	|O
tri	|O
-	|O
snRNP	|O
-	|O
specific	|O
27K	|O
protein	|O
could	|O
potentially	|O
be	|O
involved	|O
in	|O
SR	|B-PROTEIN
protein	|O
-	|O
mediated	|O
protein	|O
/	|O
protein	|O
interactions	|O
and	|O
,	|O
additionally	|O
,	|O
its	|O
phosphorylation	|O
state	|O
could	|O
modulate	|O
pre	|O
-	|O
mRNA	|O
splicing	|O
.	|O

Purified	|O
P7	|B-PROTEIN
could	|O
be	|O
assembled	|O
onto	|O
particles	|O
lacking	|O
P7	|B-PROTEIN
and	|O
particles	|O
lacking	|O
both	|O
P2	|B-PROTEIN
(	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
)	|O
and	|O
P7	|B-PROTEIN
.	|O

However	|O
,	|O
the	|O
same	|O
U1A	|B-PROTEIN
peptide	|O
,	|O
when	|O
conjugated	|O
to	|O
BSA	|B-PROTEIN
,	|O
inhibits	|O
vertebrate	|O
PAP	|B-PROTEIN
.	|O

Plasma	|O
levels	|O
of	|O
protein	|B-PROTEIN
C	|I-PROTEIN
,	|O
protein	|B-PROTEIN
S	|I-PROTEIN
,	|O
and	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN
in	|O
patients	|O
with	|O
subarachnoid	|O
haemorrhage	|O
.	|O

Idiopathic	|O
bilateral	|O
recurrent	|O
branch	|O
retinal	|O
arterial	|O
occlusion	|O
(	|O
IBRBRAO	|O
)	|O
is	|O
a	|O
rare	|O
syndrome	|O
characterized	|O
by	|O
migraine	|O
headaches	|O
,	|O
tinnitus	|O
,	|O
vertigo	|O
,	|O
hearing	|O
loss	|O
,	|O
and	|O
recurrent	|O
branch	|O
retinal	|O
artery	|O
occlusion	|O
of	|O
unknown	|O
etiology	|O
.	|O

Epithelial	|O
and	|O
corneal	|O
thickness	|O
measurements	|O
by	|O
in	|O
vivo	|O
confocal	|O
microscopy	|O
through	|O
focusing	|O
(	|O
CMTF	|O
)	|O
.	|O

Sequences	|O
downstream	|O
of	|O
the	|O
two	|O
human	|O
CA	|B-PROTEIN
genes	|O
,	|O
possibly	|O
containing	|O
homologous	|O
enhancer	|O
elements	|O
,	|O
have	|O
not	|O
yet	|O
been	|O
reported	|O
.	|O

Recombinant	|O
plasmids	|O
containing	|O
the	|O
entire	|O
322	|O
nt	|O
5'	|O
UTR	|O
of	|O
exon	|O
1	|O
and	|O
a	|O
1630	|O
nt	|O
segment	|O
of	|O
5'	|O
flanking	|O
sequence	|O
stimulated	|O
luciferase	|B-PROTEIN
activity	|O
nearly	|O
70	|O
times	|O
higher	|O
than	|O
a	|O
promoterless	|O
control	|O
plasmid	|O
.	|O

Analysis	|O
for	|O
DNA	|O
-	|O
protein	|O
interactions	|O
by	|O
in	|O
vitro	|O
DNase	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
footprinting	|O
identified	|O
a	|O
broad	|O
region	|O
of	|O
protection	|O
extending	|O
from	|O
nt	|O
-	|O
12	|O
to	|O
+	|O
38	|O
.	|O

It	|O
is	|O
also	|O
homologous	|O
to	|O
other	|O
sugar	|O
carriers	|O
from	|O
human	|O
,	|O
mouse	|O
and	|O
Escherichia	|O
coli	|O
.	|O

Until	|O
now	|O
,	|O
each	|O
of	|O
these	|O
loci	|O
was	|O
considered	|O
to	|O
contain	|O
three	|O
genes	|O
(	|O
for	|O
regulator	|B-PROTEIN
,	|O
permease	|B-PROTEIN
and	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
glucosidase	|I-PROTEIN
)	|O
,	|O
but	|O
a	|O
fourth	|O
gene	|O
,	|O
presumably	|O
an	|O
extra	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
glucosidase	|I-PROTEIN
gene	|O
,	|O
was	|O
found	|O
at	|O
MAL1	|B-PROTEIN
adjacent	|O
to	|O
the	|O
usual	|O
cluster	|O
of	|O
three	|O
genes	|O
.	|O

Although	|O
methods	|O
to	|O
align	|O
the	|O
control	|O
and	|O
activation	|O
fMR	|O
images	|O
may	|O
correct	|O
for	|O
some	|O
of	|O
this	|O
motional	|O
error	|O
,	|O
they	|O
will	|O
be	|O
incomplete	|O
in	|O
correcting	|O
for	|O
those	|O
that	|O
depend	|O
on	|O
spatial	|O
orientation	|O
.	|O

Three	|O
women	|O
have	|O
had	|O
abnormal	|O
endocervical	|O
follow	|O
up	|O
cytology	|O
suggestive	|O
of	|O
residual	|O
disease	|O
.	|O

Autorosette	|O
-	|O
forming	|O
cells	|O
are	|O
characterized	|O
by	|O
a	|O
high	|O
activity	|O
of	|O
alkaline	|B-PROTEIN
and	|I-PROTEIN
acid	|I-PROTEIN
phosphatases	|I-PROTEIN
and	|O
low	|O
NBT	|O
-	|O
test	|O
values	|O
.	|O

Analysis	|O
of	|O
homologous	|O
DNA	|O
sequences	|O
within	|O
the	|O
first	|O
intron	|O
of	|O
the	|O
mouse	|O
and	|O
human	|O
mts1	|B-PROTEIN
genes	|O
:	|O
kB	|B-PROTEIN
-	|O
like	|O
site	|O
and	|O
microsatellite	|O
DNA	|O

The	|O
integration	|O
at	|O
the	|O
VIP	|B-PROTEIN
CyRE	|O
of	|O
the	|O
Jak	|B-PROTEIN
-	|O
Stat	|B-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
signaling	|O
pathways	|O
with	|O
other	|O
pre	|O
-	|O
existing	|O
proteins	|O
provides	|O
a	|O
cellular	|O
mechanism	|O
for	|O
cell	|O
-	|O
and	|O
cytokine	|O
-	|O
specific	|O
signaling	|O
.	|O

These	|O
studies	|O
point	|O
to	|O
the	|O
involvement	|O
of	|O
the	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
pathway	|O
in	|O
the	|O
activation	|O
of	|O
monocytic	|O
cells	|O
during	|O
transmigration	|O
to	|O
inflammatory	|O
sites	|O
.	|O

Our	|O
results	|O
show	|O
that	|O
the	|O
temperature	|O
-	|O
sensitive	|O
rad54	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
allele	|O
blocks	|O
mitotic	|O
recombination	|O
between	|O
tandemly	|O
repeated	|O
DYZ3	|B-PROTEIN
satellite	|O
sequences	|O
and	|O
significantly	|O
stabilizes	|O
a	|O
human	|O
DYZ5	|B-PROTEIN
satellite	|O
-	|O
containing	|O
YAC	|O
clone	|O
.	|O

A	|O
P22	|O
R17	|O
derivative	|O
with	|O
an	|O
OcRNA	|O
site	|O
(	|O
P22	|O
R17	|O
[	|O
A	|O
(	|O
-	|O
10	|O
)	|O
U	|O
]	|O
)	|O
develops	|O
lytically	|O
following	|O
infection	|O
of	|O
these	|O
strains	|O
.	|O

Circularized	|O
Ac	|B-PROTEIN
/	|O
Ds	|B-PROTEIN
transposons	|O
:	|O
formation	|O
,	|O
structure	|O
and	|O
fate	|O
.	|O

This	|O
site	|O
is	|O
upstream	|O
from	|O
the	|O
TATA	|O
box	|O
used	|O
in	|O
somatic	|O
cells	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
have	|O
examined	|O
the	|O
regulation	|O
of	|O
B	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
activity	|O
by	|O
cyclin	|B-PROTEIN
-	|O
Cdks	|B-PROTEIN
.	|O

Candidate	|O
tumor	|O
suppressor	|O
genes	|O
,	|O
Mts1	|B-PROTEIN
(	|O
p16INK4a	|B-PROTEIN
)	|O
and	|O
Mts2	|B-PROTEIN
(	|O
p15INK4b	|B-PROTEIN
)	|O
,	|O
have	|O
been	|O
mapped	|O
to	|O
this	|O
region	|O
,	|O
but	|O
by	|O
Southern	|O
blot	|O
analysis	|O
,	|O
no	|O
homozygous	|O
deletions	|O
were	|O
detected	|O
in	|O
either	|O
gene	|O
.	|O

Excision	|O
repair	|O
at	|O
the	|O
level	|O
of	|O
the	|O
nucleotide	|O
in	|O
the	|O
Saccharomyces	|O
cerevisiae	|O
MFA2	|B-PROTEIN
gene	|O
:	|O
mapping	|O
of	|O
where	|O
enhanced	|O
repair	|O
in	|O
the	|O
transcribed	|O
strand	|O
begins	|O
or	|O
ends	|O
and	|O
identification	|O
of	|O
only	|O
a	|O
partial	|O
rad16	|B-PROTEIN
requisite	|O
for	|O
repairing	|O
upstream	|O
control	|O
sequences	|O
.	|O

An	|O
aromatic	|O
stacking	|O
interaction	|O
between	|O
subunits	|O
helps	|O
mediate	|O
DNA	|O
sequence	|O
specificity	|O
:	|O
operator	|O
site	|O
discrimination	|O
by	|O
phage	|O
lambda	|O
cI	|B-PROTEIN
repressor	|I-PROTEIN
.	|O

We	|O
have	|O
characterized	|O
a	|O
panel	|O
of	|O
6	|O
monoclonal	|O
antibodies	|O
raised	|O
against	|O
human	|O
platelet	|O
talin	|B-PROTEIN
by	|O
Western	|O
blotting	|O
,	|O
immune	|O
precipitation	|O
,	|O
and	|O
immunofluorescence	|O
,	|O
and	|O
shown	|O
that	|O
antibodies	|O
TA205	|B-PROTEIN
and	|O
TD77	|B-PROTEIN
disrupt	|O
actin	|B-PROTEIN
stress	|O
fibers	|O
and	|O
focal	|O
adhesions	|O
,	|O
and	|O
inhibit	|O
cell	|O
motility	|O
when	|O
microinjected	|O
into	|O
human	|O
fibroblasts	|O
.	|O

This	|O
locus	|O
maps	|O
approximately	|O
160	|O
kbp	|O
from	|O
the	|O
genes	|O
encoding	|O
cytadherence	|O
-	|O
associated	|O
proteins	|O
HMW1	|B-PROTEIN
and	|O
HMW3	|B-PROTEIN
,	|O
and	|O
yet	|O
insertions	|O
therein	|O
result	|O
in	|O
loss	|O
of	|O
these	|O
proteins	|O
and	|O
a	|O
hemadsorption	|O
-	|O
negative	|O
(	|O
HA	|O
-	|O
)	|O
phenotype	|O
,	|O
prompting	|O
the	|O
designation	|O
cytadherence	|B-PROTEIN
-	|I-PROTEIN
regulatory	|I-PROTEIN
locus	|I-PROTEIN
(	|O
crl	|B-PROTEIN
)	|O
.	|O

Coliphage	|B-PROTEIN
186	|I-PROTEIN
B	|I-PROTEIN
is	|O
a	|O
72	|O
-	|O
amino	|O
acid	|O
protein	|O
belonging	|O
to	|O
the	|O
Ogr	|B-PROTEIN
family	|O
of	|O
analogous	|O
transcription	|O
factors	|O
present	|O
in	|O
P2	|O
-	|O
like	|O
phage	|O
,	|O
which	|O
contain	|O
a	|O
Cys	|O
-	|O
X2	|O
-	|O
Cys	|O
-	|O
X22	|O
-	|O
Cys	|O
-	|O
X4	|O
-	|O
Cys	|O
presumptive	|O
zinc	|O
-	|O
finger	|O
motif	|O
.	|O

The	|O
UV	|O
absorption	|O
spectrum	|O
revealed	|O
a	|O
shoulder	|O
at	|O
250	|O
nm	|O
,	|O
characteristic	|O
of	|O
CysS	|O
-	|O
Cd	|O
(	|O
II	|O
)	|O
ligand	|O
-	|O
to	|O
-	|O
metal	|O
charge	|O
-	|O
transfer	|O
transitions	|O
,	|O
and	|O
the	|O
difference	|O
absorption	|O
coefficient	|O
after	|O
acidification	|O
(	|O
delta	|O
epsilon	|O
248	|O
,	|O
24	|O
mM	|O
-	|O
1	|O
cm	|O
-	|O
1	|O
)	|O
indicated	|O
the	|O
presence	|O
of	|O
a	|O
Cd	|O
(	|O
Cys	|O
-	|O
S	|O
)	|O
4	|O
center	|O
.	|O

Diacylglycerol	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
DGK	|B-PROTEIN
)	|O
attenuates	|O
levels	|O
of	|O
second	|O
messenger	|O
diacylglycerol	|O
in	|O
cells	|O
and	|O
produces	|O
another	|O
(	|O
putative	|O
)	|O
messenger	|O
,	|O
phosphatidic	|O
acid	|O
.	|O

Recently	|O
,	|O
we	|O
have	|O
reported	|O
the	|O
cloning	|O
of	|O
the	|O
germ	|O
cell	|O
-	|O
specific	|O
,	|O
nuclear	|O
orphan	|O
receptor	|O
germ	|B-PROTEIN
cell	|I-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
(	|O
GCNF	|B-PROTEIN
)	|O
/	|O
RTR	|B-PROTEIN
.	|O

Based	|O
on	|O
the	|O
sequence	|O
of	|O
the	|O
conRTRE	|B-PROTEIN
,	|O
we	|O
located	|O
a	|O
putative	|O
RTRE	|B-PROTEIN
,	|O
referred	|O
to	|O
as	|O
P2	|B-PROTEIN
-	|I-PROTEIN
RE	|I-PROTEIN
,	|O
in	|O
the	|O
5'	|O
promoter	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
mouse	|O
protamine	|B-PROTEIN
2	|I-PROTEIN
gene	|O
,	|O
which	|O
is	|O
induced	|O
during	|O
the	|O
same	|O
stage	|O
of	|O
spermatogenesis	|O
as	|O
RTR	|B-PROTEIN
.	|O

Here	|O
we	|O
report	|O
the	|O
purification	|O
of	|O
this	|O
larger	|O
form	|O
as	|O
an	|O
approximately	|O
320	|O
-	|O
kDa	|O
particle	|O
that	|O
contains	|O
mRNP3+	|B-PROTEIN
4	|I-PROTEIN
and	|O
nine	|O
additional	|O
polypeptides	|O
,	|O
including	|O
mRNA	|O
-	|O
binding	|O
polypeptides	|O
of	|O
34	|O
and	|O
36	|O
kDa	|O
and	|O
a	|O
doublet	|O
of	|O
110/105	|O
kDa	|O
that	|O
proved	|O
to	|O
be	|O
nucleolin	|B-PROTEIN
.	|O

Active	|O
complexes	|O
eluted	|O
at	|O
a	|O
higher	|O
molecular	|O
weight	|O
than	|O
inactive	|O
complexes	|O
,	|O
were	|O
relatively	|O
deficient	|O
in	|O
both	|O
p21	|B-PROTEIN
and	|O
p27	|B-PROTEIN
,	|O
and	|O
contained	|O
Cdk2	|B-PROTEIN
with	|O
increased	|O
threonine	|O
160	|O
phosphorylation	|O
,	|O
consistent	|O
with	|O
a	|O
mechanism	|O
of	|O
activation	|O
of	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
-	|O
Cdk2	|B-PROTEIN
involving	|O
both	|O
reduced	|O
CDK	|B-PROTEIN
inhibitor	|O
association	|O
and	|O
CDK	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
kinase	|I-PROTEIN
-	|O
mediated	|O
phosphorylation	|O
of	|O
Cdk2	|B-PROTEIN
.	|O

Thirty	|O
Class	|O
I	|O
and	|O
Class	|O
II	|O
recessions	|O
in	|O
30	|O
patients	|O
were	|O
treated	|O
with	|O
a	|O
modified	|O
subepithelial	|O
connective	|O
tissue	|O
graft	|O
procedure	|O
.	|O

The	|O
derivatives	|O
of	|O
the	|O
latter	|O
two	|O
cell	|O
lines	|O
showed	|O
increased	|O
expression	|O
of	|O
the	|O
p27Kip1	|B-PROTEIN
protein	|O
and	|O
inhibition	|O
of	|O
cell	|O
growth	|O
.	|O

The	|O
perioperative	|O
mortality	|O
of	|O
all	|O
patients	|O
was	|O
1.9%	|O
,	|O
the	|O
mortality	|O
of	|O
patients	|O
older	|O
than	|O
70	|O
years	|O
was	|O
4.3%	|O
.	|O

Chronic	|O
renal	|O
failure	|O
patients	|O
essentially	|O
die	|O
from	|O
cardiovascular	|O
causes	|O
,	|O
and	|O
the	|O
frequency	|O
of	|O
malignant	|O
disease	|O
responsible	|O
for	|O
death	|O
is	|O
estimated	|O
to	|O
be	|O
10%	|O
.	|O

The	|O
new	|O
FIGO	|O
definition	|O
of	|O
cervical	|O
cancer	|O
stage	|O
IA	|O
:	|O
a	|O
critique	|O
.	|O

The	|O
effect	|O
of	|O
Vpu	|B-PROTEIN
on	|O
class	|O
I	|O
biogenesis	|O
was	|O
analyzed	|O
in	|O
more	|O
detail	|O
using	|O
a	|O
Vpu	|B-PROTEIN
-	|O
expressing	|O
recombinant	|O
vaccinia	|O
virus	|O
(	|O
VV	|O
)	|O
.	|O

This	|O
study	|O
indicates	|O
that	|O
the	|O
phenotype	|O
of	|O
myofibrillar	|O
disarray	|O
seen	|O
in	|O
HCM	|O
patients	|O
which	|O
harbor	|O
either	|O
of	|O
these	|O
two	|O
mutations	|O
may	|O
not	|O
be	|O
directly	|O
due	|O
to	|O
the	|O
failure	|O
of	|O
the	|O
mutant	|O
myosin	|B-PROTEIN
heavy	|O
chain	|O
protein	|O
to	|O
assemble	|O
and	|O
form	|O
normal	|O
sarcomeres	|O
,	|O
but	|O
may	|O
rather	|O
be	|O
a	|O
secondary	|O
effect	|O
possibly	|O
resulting	|O
from	|O
the	|O
chronic	|O
stress	|O
of	|O
decreased	|O
beta	|B-PROTEIN
MHC	|I-PROTEIN
function	|O
.	|O

Inductively	|O
coupled	|O
plasma	|O
atomic	|O
emission	|O
spectroscopy	|O
was	|O
employed	|O
to	|O
obtain	|O
the	|O
tissue	|O
silicon	|O
measurements	|O
.	|O

An	|O
egg	|O
protein	|O
,	|O
lysozyme	|B-PROTEIN
,	|O
is	|O
a	|O
still	|O
unlabeled	|O
additive	|O
currently	|O
used	|O
in	|O
cheese	|O
preparation	|O
.	|O

A	|O
method	|O
for	|O
the	|O
simultaneous	|O
determination	|O
of	|O
de	|O
(	|O
N	|O
-	|O
methyl	|O
)	|O
-	|O
N	|O
-	|O
ethyl	|O
-	|O
8,9	|O
-	|O
anhydroerythromycin	|O
A	|O
6,9	|O
-	|O
hemiacetal	|O
(	|O
EM523	|O
,	|O
I	|O
)	|O
and	|O
its	|O
three	|O
metabolites	|O
in	|O
human	|O
plasma	|O
and	|O
urine	|O
has	|O
been	|O
developed	|O
using	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatography	|O
(	|O
HPLC	|O
)	|O
with	|O
chemiluminescence	|O
(	|O
CL	|O
)	|O
detection	|O
.	|O

Similarly	|O
,	|O
the	|O
DNA	|O
-	|O
binding	|O
activity	|O
of	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
is	|O
modified	|O
by	|O
a	|O
DNA	|B-PROTEIN
repair	|I-PROTEIN
enzyme	|I-PROTEIN
,	|O
redox	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
Ref	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
which	|O
is	|O
identical	|O
to	|O
a	|O
DNA	|B-PROTEIN
repair	|I-PROTEIN
enzyme	|I-PROTEIN
,	|O
AP	|B-PROTEIN
endonuclease	|O
.	|O

Having	|O
an	|O
LRR	|B-PROTEIN
domain	|O
and	|O
an	|O
SH3	|B-PROTEIN
-	|O
binding	|O
domain	|O
,	|O
Acan125	|B-PROTEIN
and	|O
the	|O
C.	|O
elegans	|O
homologue	|O
define	|O
a	|O
novel	|O
family	|O
of	|O
bifunctional	|O
binding	|O
proteins	|O
.	|O

However	|O
,	|O
its	|O
participation	|O
in	|O
gagging	|O
induced	|O
by	|O
oropharyngeal	|O
irritation	|O
is	|O
unclear	|O
.	|O

The	|O
capacity	|O
to	|O
repair	|O
8	|O
-	|O
OxoG	|O
has	|O
been	|O
measured	|O
in	|O
cell	|O
-	|O
free	|O
extracts	|O
of	|O
wild	|O
-	|O
type	|O
and	|O
ogg1	|B-PROTEIN
strains	|O
using	|O
a	|O
34mer	|O
DNA	|O
fragment	|O
containing	|O
a	|O
single	|O
8	|O
-	|O
OxoG	|O
residue	|O
paired	|O
with	|O
a	|O
cytosine	|O
(	|O
8	|O
-	|O
OxoG	|O
/	|O
C	|O
)	|O
as	|O
a	|O
substrate	|O
.	|O

Results	|O
from	|O
our	|O
and	|O
other	|O
laboratories	|O
have	|O
suggested	|O
that	|O
UCN	|O
-	|O
01	|O
induces	|O
preferential	|O
G1	|O
-	|O
phase	|O
accumulation	|O
in	|O
several	|O
human	|O
tumor	|O
cell	|O
lines	|O
tested	|O
.	|O

Northern	|O
and	|O
RT	|O
-	|O
PCR	|O
analysis	|O
of	|O
Ube3a	|B-PROTEIN
expression	|O
in	|O
mouse	|O
tissues	|O
from	|O
animals	|O
with	|O
segmental	|O
,	|O
paternal	|O
uniparental	|O
disomy	|O
failed	|O
to	|O
detect	|O
substantially	|O
reduced	|O
or	|O
absent	|O
expression	|O
compared	|O
to	|O
control	|O
animals	|O
,	|O
failing	|O
to	|O
provide	|O
any	|O
evidence	|O
for	|O
maternal	|O
-	|O
specific	|O
expression	|O
from	|O
this	|O
locus	|O
.	|O

Two	|O
predominant	|O
effects	|O
were	|O
noted	|O
:	|O
(	|O
i	|O
)	|O
the	|O
Xaa	|O
residue	|O
in	|O
the	|O
dual	|O
phosphorylation	|O
motif	|O
Thr	|O
-	|O
Xaa	|O
-	|O
Tyr	|O
as	|O
well	|O
as	|O
the	|O
length	|O
of	|O
L12	|O
influence	|O
p38	|B-PROTEIN
substrate	|O
specificity	|O
,	|O
and	|O
(	|O
ii	|O
)	|O
the	|O
length	|O
of	|O
L12	|O
plays	|O
a	|O
major	|O
role	|O
in	|O
controlling	|O
autophosphorylation	|O
.	|O

A	|O
novel	|O
,	|O
testis	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
mRNA	|I-PROTEIN
transcript	|O
encoding	|O
an	|O
NH2	|O
-	|O
terminal	|O
truncated	|O
nitric	|B-PROTEIN
-	|I-PROTEIN
oxide	|I-PROTEIN
synthase	|I-PROTEIN
.	|O
mRNA	|O
diversity	|O
represents	|O
a	|O
major	|O
theme	|O
of	|O
neuronal	|O
nitric	|B-PROTEIN
-	|I-PROTEIN
oxide	|I-PROTEIN
synthase	|I-PROTEIN
(	|O
nNOS	|B-PROTEIN
)	|O
gene	|O
expression	|O
in	|O
somatic	|O
cells	|O
/	|O
tissues	|O
.	|O

Unlike	|O
the	|O
MAR	|O
-	|O
binding	|O
domain	|O
,	|O
the	|O
homeodomain	|B-PROTEIN
when	|O
isolated	|O
binds	|O
poorly	|O
and	|O
with	|O
low	|O
specificity	|O
to	|O
DNA	|O
.	|O

Cotransfection	|O
of	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
p44	|B-PROTEIN
mitogen	|O
-	|O
activated	|O
protein	|O
(	|B-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
expression	|O
vectors	|O
strongly	|O
potentiated	|O
HB	|B-PROTEIN
-	|O
EGF	|B-PROTEIN
promoter	|O
activation	|O
in	|O
response	|O
to	|O
deltaRaf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
:	|O
ER	|B-PROTEIN
.	|O

Cyclin	|B-PROTEIN
D1	|I-PROTEIN
could	|O
not	|O
be	|O
displaced	|O
from	|O
cdk4	|B-PROTEIN
in	|O
the	|O
resistant	|O
184A1L5R	|O
cell	|O
lysates	|O
.	|O

The	|O
importance	|O
of	|O
posttranslational	|O
regulation	|O
of	|O
p15INK4B	|B-PROTEIN
by	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
is	|O
underlined	|O
by	|O
the	|O
observation	|O
that	|O
in	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|O
resistant	|O
184A1L5R	|O
,	|O
although	|O
the	|O
p15	|B-PROTEIN
transcript	|O
increased	|O
,	|O
p15INK4B	|B-PROTEIN
protein	|O
was	|O
not	|O
stabilized	|O
and	|O
did	|O
not	|O
accumulate	|O
,	|O
and	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
-	|O
cdk	|B-PROTEIN
association	|O
and	|O
kinase	|O
activation	|O
were	|O
not	|O
inhibited	|O
.	|O

The	|O
Rlm1	|B-PROTEIN
protein	|O
,	|O
a	|O
member	|O
of	|O
the	|O
MADS	|B-PROTEIN
box	|O
family	|O
of	|O
transcription	|O
factors	|O
,	|O
functions	|O
downstream	|O
of	|O
Mpk1	|B-PROTEIN
in	|O
the	|O
pathway	|O
.	|O

To	|O
identify	|O
cis	|O
-	|O
acting	|O
elements	|O
that	|O
target	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
mRNA	|O
for	|O
downregulation	|O
during	|O
myogenesis	|O
,	|O
we	|O
stably	|O
transfected	|O
C2C12	|O
cells	|O
with	|O
mutant	|O
myc	|B-PROTEIN
genes	|O
or	|O
chimeric	|O
genes	|O
in	|O
which	|O
various	|O
myc	|B-PROTEIN
sequences	|O
were	|O
fused	|O
to	|O
the	|O
human	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
gene	|O
or	|O
to	|O
the	|O
bacterial	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
gene	|O
.	|O

Furthermore	|O
,	|O
experiments	|O
with	|O
32D	|O
temperature	|O
-	|O
sensitive	|O
p53	|B-PROTEIN
cells	|O
indicate	|O
that	|O
aberrant	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
at	|O
the	|O
permissive	|O
temperature	|O
does	|O
not	|O
exert	|O
a	|O
proliferative	|O
effect	|O
but	|O
causes	|O
p53	|B-PROTEIN
-	|O
mediated	|O
apoptosis	|O
,	|O
i.e.	|O
,	|O
the	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
proliferative	|O
effect	|O
depends	|O
on	|O
the	|O
integrity	|O
of	|O
the	|O
cell	|O
cycle	|O
checkpoints	|O
of	|O
the	|O
host	|O
cell	|O
,	|O
as	|O
observed	|O
for	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
and	|O
other	|O
oncogenes	|O
.	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
experiments	|O
indicate	|O
that	|O
ectopic	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
effects	|O
are	|O
mediated	|O
by	|O
both	|O
the	|O
DNA	|O
-	|O
binding	|O
and	|O
the	|O
heterodimerization	|O
domains	|O
,	|O
while	|O
the	|O
N	|O
-	|O
terminally	|O
truncated	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
variant	|O
(	|O
M3	|B-PROTEIN
)	|O
expressed	|O
in	|O
T	|O
-	|O
ALL	|O
malignant	|O
cells	|O
mimics	|O
the	|O
effects	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
protein	|O
.	|O

The	|O
likelihood	|O
that	|O
a	|O
common	|O
region	|O
of	|O
deletions	|O
would	|O
contain	|O
a	|O
tumor	|O
suppressor	|O
is	|O
strongly	|O
enhanced	|O
by	|O
coincidence	|O
of	|O
that	|O
region	|O
with	|O
a	|O
chromosome	|O
fragment	|O
suppressing	|O
tumorigenicity	|O
upon	|O
introduction	|O
in	|O
tumor	|O
cells	|O
.	|O

DNA	|O
-	|O
binding	|O
activity	|O
was	|O
not	|O
increased	|O
by	|O
the	|O
addition	|O
of	|O
forskolin	|O
to	|O
thecal	|O
or	|O
luteal	|O
cells	|O
.	|O

However	|O
,	|O
in	|O
some	|O
of	|O
them	|O
either	|O
pattern	|O
may	|O
predominate	|O
or	|O
be	|O
exclusively	|O
present	|O
.	|O

Upon	|O
induction	|O
of	|O
SOS	|O
,	|O
viability	|O
increased	|O
2-6	|O
-	|O
fold	|O
.	|O

In	|O
particular	|O
,	|O
Western	|O
,	|O
supershift	|O
,	|O
and	|O
promoter	|O
deletion	|O
analyses	|O
suggested	|O
a	|O
role	|O
for	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
)	|O
binding	|O
site	|O
between	|O
-	|O
2010	|O
and	|O
-	|O
1954	|O
in	|O
regulating	|O
transcription	|O
of	|O
collagenase	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
monocytic	|O
cells	|O
.	|O

11	|O
-	|O
Aminoundecanoyl	|O
-	|O
SK	|O
-	|O
NH2	|O
and	|O
11	|O
-	|O
aminoundecanoyl	|O
-	|O
SH	|O
-	|O
NH2	|O
establish	|O
that	|O
a	|O
simple	|O
alkyl	|O
backbone	|O
can	|O
maintain	|O
an	|O
appropriate	|O
distance	|O
between	|O
three	|O
elements	|O
critical	|O
for	|O
recognition	|O
by	|O
the	|O
fungal	|O
enzyme	|O
's	|O
peptide	|O
-	|O
binding	|O
site	|O
:	|O
a	|O
simple	|O
omega	|O
-	|O
terminal	|O
amino	|O
group	|O
,	|O
a	|O
beta	|O
-	|O
hydroxyl	|O
,	|O
and	|O
an	|O
epsilon	|O
-	|O
amino	|O
group	|O
or	|O
an	|O
imidazole	|O
.	|O

The	|O
carboxyl	|O
-	|O
terminal	|O
CCCC	|O
module	|O
is	|O
structurally	|O
related	|O
to	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
the	|O
erythroid	|O
transcription	|O
factor	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Cdc2	|B-PROTEIN
co	|O
-	|O
precipitates	|O
with	|O
Pch1	|B-PROTEIN
in	|O
S.	|O
pombe	|O
cell	|O
lysates	|O
,	|O
although	|O
Cdc2	|B-PROTEIN
may	|O
not	|O
be	|O
the	|O
major	|O
catalytic	|O
partner	|O
of	|O
a	|O
Pch1	|B-PROTEIN
kinase	|O
in	|O
vivo	|O
.	|O

Little	|O
is	|O
known	|O
about	|O
the	|O
mechanism	|O
,	|O
but	|O
the	|O
availability	|O
of	|O
rapid	|O
facile	|O
assays	|O
for	|O
monitoring	|O
immunoglobulin	|B-PROTEIN
hypermutation	|O
would	|O
greatly	|O
aid	|O
the	|O
development	|O
of	|O
culture	|O
systems	|O
for	|O
hypermutating	|O
B	|O
cells	|O
as	|O
well	|O
as	|O
the	|O
screening	|O
for	|O
individuals	|O
deficient	|O
in	|O
the	|O
process	|O
.	|O

Expression	|O
of	|O
the	|O
human	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
protein	|I-PROTEIN
70	|I-PROTEIN
gene	|O
(	|O
hsp70	|B-PROTEIN
)	|O
is	|O
induced	|O
by	|O
various	|O
kinds	|O
of	|O
stress	|O
and	|O
by	|O
oncogenes	|O
.	|O

Of	|O
these	|O
proteins	|O
,	|O
five	|O
have	|O
previously	|O
been	|O
shown	|O
to	|O
be	|O
phosphorylated	|O
during	|O
mitosis	|O
(	|O
epithelial	|B-PROTEIN
-	|I-PROTEIN
microtubule	|I-PROTEIN
associated	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
115	|I-PROTEIN
,	|O
Oct91	|B-PROTEIN
,	|O
Elongation	|B-PROTEIN
factor	|I-PROTEIN
1gamma	|I-PROTEIN
,	|O
BRG1	|B-PROTEIN
and	|O
Ribosomal	|O
protein	|O
L18A	|B-PROTEIN
)	|O
,	|O
five	|O
are	|O
related	|O
to	|O
proteins	|O
postulated	|O
to	|O
have	|O
roles	|O
in	|O
mitosis	|O
(	|O
epithelial	|B-PROTEIN
-	|I-PROTEIN
microtubule	|I-PROTEIN
associated	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
115	|I-PROTEIN
,	|O
Schizosaccharomyces	|O
pombe	|O
Cdc5	|B-PROTEIN
,	|O
innercentrosome	|B-PROTEIN
protein	|I-PROTEIN
,	|O
BRG1	|B-PROTEIN
and	|O
the	|O
RNA	|O
helicase	|O
WM6	|B-PROTEIN
)	|O
,	|O
and	|O
nine	|O
are	|O
related	|O
to	|O
transcription	|O
factors	|O
(	|O
BRG1	|B-PROTEIN
,	|O
negative	|B-PROTEIN
co	|I-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
2alpha	|I-PROTEIN
,	|O
Oct91	|B-PROTEIN
,	|O
S.	|O
pombe	|O
Cdc5	|B-PROTEIN
,	|O
HoxD1	|B-PROTEIN
,	|O
Sox3	|B-PROTEIN
,	|O
Vent2	|B-PROTEIN
,	|O
and	|O
two	|O
isoforms	|O
of	|O
Xbr1b	|B-PROTEIN
)	|O
.	|O

Thus	|O
,	|O
depending	|O
on	|O
their	|O
location	|O
,	|O
psoralen	|O
cross	|O
-	|O
links	|O
affected	|O
different	|O
steps	|O
in	|O
the	|O
initiation	|O
process	|O
.	|O

Activation	|O
of	|O
alpha	|B-PROTEIN
4	|I-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
with	|O
TS2/16	|B-PROTEIN
inhibited	|O
the	|O
cytoplasmic	|O
protrusions	|O
and	|O
cell	|O
migration	|O
but	|O
did	|O
not	|O
affect	|O
the	|O
pattern	|O
of	|O
phosphorylation	|O
.	|O

Performance	|O
on	|O
two	|O
verbal	|O
measures	|O
-	|O
the	|O
National	|O
Adult	|O
Reading	|O
Test	|O
-	|O
Revised	|O
(	|O
NART	|O
-	|O
R	|O
)	|O
and	|O
the	|O
Vocabulary	|O
subtest	|O
from	|O
the	|O
Wechsler	|O
Adult	|O
Intelligence	|O
Scale	|O
-	|O
Revised	|O
(	|O
WAIS	|O
-	|O
R	|O
)	|O
-	|O
showed	|O
strong	|O
correlations	|O
with	|O
level	|O
of	|O
education	|O
.	|O

L	|O
-	|O
canavanine	|O
,	|O
a	|O
selective	|O
inhibitor	|O
of	|O
the	|O
inducible	|O
nitric	|B-PROTEIN
oxide	|I-PROTEIN
synthase	|I-PROTEIN
,	|O
increases	|O
the	|O
mean	|O
systemic	|O
filling	|O
pressure	|O
,	|O
thereby	|O
improving	|O
venous	|O
return	|O
,	|O
under	|O
these	|O
conditions	|O
.	|O

RESULTS	|O
:	|O
Of	|O
the	|O
29	|O
patients	|O
who	|O
received	|O
concurrent	|O
chemotherapy	|O
and	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
,	|O
ten	|O
(	|O
34%	|O
;	|O
95%	|O
confidence	|O
interval	|O
[	|O
CI	|O
]	|O
,	|O
17.9	|O
to	|O
54.3%	|O
)	|O
were	|O
believed	|O
to	|O
have	|O
clinically	|O
significant	|O
bleomycin	|O
toxicity	|O
.	|O

The	|O
different	|O
holoenzyme	|O
RNA	|B-PROTEIN
polymerases	|I-PROTEIN
generated	|O
upon	|O
reconstituting	|O
these	|O
mutants	|O
independently	|O
with	|O
core	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
(	|O
alpha2beta	|B-PROTEIN
beta	|I-PROTEIN
'	|I-PROTEIN
)	|O
have	|O
shown	|O
reduced	|O
transcriptional	|O
activity	|O
in	|O
comparison	|O
to	|O
the	|O
enzyme	|O
containing	|O
wild	|O
-	|O
type	|O
sigma	|B-PROTEIN
factor	|I-PROTEIN
.	|O

These	|O
data	|O
are	|O
consistent	|O
with	|O
a	|O
model	|O
in	|O
which	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
performs	|O
a	|O
unique	|O
temporally	|O
and	|O
spatially	|O
restricted	|O
function	|O
in	|O
the	|O
embryonic	|O
heart	|O
and	|O
lung	|O
.	|O

The	|O
exonic	|O
sequence	|O
encodes	|O
a	|O
protein	|O
of	|O
495	|O
amino	|O
acids	|O
that	|O
is	|O
nearly	|O
identical	|O
to	|O
the	|O
previously	|O
reported	|O
protein	|O
sequence	|O
of	|O
human	|O
GPT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Here	|O
we	|O
characterize	|O
an	|O
S.	|O
cerevisiae	|O
Swi3	|B-PROTEIN
homolog	|O
(	|O
Swh3	|B-PROTEIN
)	|O
and	|O
present	|O
evidence	|O
that	|O
it	|O
associates	|O
in	|O
a	|O
complex	|O
with	|O
a	|O
Snf2	|B-PROTEIN
homolog	|O
,	|O
Sthl	|B-PROTEIN
.	|O

Shc	|B-PROTEIN
stimulates	|O
Ras	|B-PROTEIN
/	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MAPK	|B-PROTEIN
)	|O
through	|O
forming	|O
a	|O
complex	|O
with	|O
Grb2	|B-PROTEIN
at	|O
the	|O
phosphorylated	|O
tyrosine	|O
(	|O
Y	|O
)	|O
residue	|O
317	|O
.	|O

In	|O
contrast	|O
,	|O
Y239/240	|O
F	|O
Shc	|B-PROTEIN
,	|O
but	|O
not	|O
Y317F	|O
Shc	|B-PROTEIN
,	|O
reduced	|O
the	|O
EGF	|B-PROTEIN
-	|O
induced	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
message	|O
.	|O

The	|O
Ras	|B-PROTEIN
guanine	|O
nucleotide	|O
-	|O
binding	|O
protein	|O
functions	|O
as	|O
a	|O
molecular	|O
switch	|O
in	|O
signalling	|O
downstream	|O
of	|O
protein	|O
-	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
.	|O

We	|O
show	|O
that	|O
Rlm1	|B-PROTEIN
and	|O
Smp1	|B-PROTEIN
have	|O
MEF2	|B-PROTEIN
-	|O
related	|O
DNA	|O
-	|O
binding	|O
specificities	|O
:	|O
Rlm1	|B-PROTEIN
binds	|O
with	|O
the	|O
same	|O
specificity	|O
as	|O
MEF2	|B-PROTEIN
,	|O
CTA	|B-PROTEIN
(	|I-PROTEIN
T	|I-PROTEIN
/	|I-PROTEIN
A	|I-PROTEIN
)	|I-PROTEIN
4TAG	|I-PROTEIN
,	|O
while	|O
SMP1	|B-PROTEIN
binds	|O
a	|O
more	|O
extended	|O
consensus	|O
sequence	|O
,	|O
ACTACTA	|O
(	|O
T	|O
/	|O
A	|O
)	|O
4TAG	|O
.	|O

Domains	|O
I	|O
and	|O
II	|O
of	|O
B	|B-PROTEIN
"	|I-PROTEIN
are	|O
buried	|O
upon	|O
assembly	|O
of	|O
the	|O
TFIIIB	|B-PROTEIN
-	|O
DNA	|O
complex	|O
,	|O
as	|O
determined	|O
by	|O
protein	|O
footprinting	|O
.	|O

Domain	|O
switch	|O
experiments	|O
reveal	|O
that	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|O
proteins	|O
containing	|O
either	|O
the	|O
leucine	|O
zipper	|O
or	|O
the	|O
activation	|O
domain	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|O
are	|O
unable	|O
to	|O
stimulate	|O
the	|O
2D5	|B-PROTEIN
promoter	|O
yet	|O
are	|O
fully	|O
capable	|O
of	|O
transactivating	|O
an	|O
artificial	|O
promoter	|O
bearing	|O
a	|O
high	|O
-	|O
affinity	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
site	|O
.	|O

The	|O
similar	|O
phenotypes	|O
of	|O
bur6	|B-PROTEIN
and	|O
bur3	|B-PROTEIN
(	|O
mot1	|B-PROTEIN
)	|O
mutations	|O
suggest	|O
that	|O
Bur6p	|B-PROTEIN
and	|O
Mot1p	|B-PROTEIN
have	|O
related	|O
,	|O
but	|O
not	|O
identical	|O
,	|O
functions	|O
in	|O
modulating	|O
the	|O
activity	|O
of	|O
the	|O
general	|O
transcription	|O
machinery	|O
in	|O
vivo	|O
.	|O

PRH75	|B-PROTEIN
,	|O
a	|O
new	|O
nucleus	|O
-	|O
localized	|O
member	|O
of	|O
the	|O
DEAD	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
protein	|O
family	|O
from	|O
higher	|O
plants	|O
.	|O

These	|O
activities	|O
are	|O
all	|O
required	|O
for	|O
stimulation	|O
of	|O
cell	|O
growth	|O
by	|O
middle	|B-PROTEIN
-	|I-PROTEIN
T	|I-PROTEIN
and	|O
activate	|O
members	|O
of	|O
the	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
family	|O
.	|O

A	|O
role	|O
for	|O
the	|O
small	|O
GTPase	|O
Rac	|B-PROTEIN
in	|O
polyomavirus	|O
middle	|O
-	|O
T	|B-PROTEIN
antigen	|I-PROTEIN
-	|O
mediated	|O
activation	|O
of	|O
the	|O
serum	|O
response	|O
element	|O
and	|O
in	|O
cell	|O
transformation	|O
.	|O

Time	|O
-	|O
activity	|O
curves	|O
from	|O
the	|O
gastric	|O
region	|O
of	|O
interest	|O
were	|O
used	|O
,	|O
after	|O
subjection	|O
to	|O
appropriate	|O
corrective	|O
procedures	|O
,	|O
to	|O
calculate	|O
the	|O
mean	|O
gastric	|O
transit	|O
time	|O
(	|O
MTT	|O
90	|O
)	|O
and	|O
the	|O
fraction	|O
of	|O
the	|O
test	|O
meal	|O
retained	|O
in	|O
the	|O
stomach	|O
after	|O
90	|O
min	|O
(	|O
F90	|O
)	|O
.	|O

This	|O
study	|O
provides	|O
a	|O
direct	|O
demonstration	|O
of	|O
a	|O
role	|O
for	|O
G	|B-PROTEIN
betagamma	|I-PROTEIN
in	|O
mediating	|O
the	|O
agonist	|O
-	|O
stimulated	|O
translocation	|O
of	|O
GRK2	|B-PROTEIN
and	|O
GRK3	|B-PROTEIN
in	|O
an	|O
intact	|O
cellular	|O
system	|O
and	|O
demonstrates	|O
isoform	|O
specificity	|O
in	|O
the	|O
interaction	|O
of	|O
these	|O
components	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
RA	|O
-	|O
mediated	|O
repression	|O
of	|O
the	|O
hMGP	|B-PROTEIN
gene	|O
is	|O
due	|O
to	|O
binding	|O
of	|O
liganded	|O
RAR	|B-PROTEIN
/	|O
RXR	|B-PROTEIN
to	|O
a	|O
novel	|O
negative	|O
RA	|O
response	|O
element	|O
.	|O

Point	|O
mutations	|O
of	|O
the	|O
five	|O
tyrosine	|O
residues	|O
in	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
the	|O
receptor	|O
were	|O
subsequently	|O
used	|O
to	|O
confirm	|O
our	|O
conclusions	|O
.	|O

We	|O
describe	|O
a	|O
novel	|O
method	|O
using	|O
Saccharomyces	|O
cerevisiae	|O
for	|O
detecting	|O
protein	|O
-	|O
truncating	|O
mutations	|O
in	|O
any	|O
gene	|O
of	|O
interest	|O
.	|O

Hepatocellular	|O
injury	|O
during	|O
preservation	|O
of	|O
human	|O
livers	|O
with	|O
UW	|O
and	|O
HTK	|O
solution	|O
.	|O

The	|O
electromyographically	|O
recorded	|O
responses	|O
consisted	|O
of	|O
an	|O
early	|O
R1	|O
response	|O
in	|O
the	|O
orbicularis	|O
oculi	|O
muscle	|O
ipsilateral	|O
to	|O
the	|O
side	|O
of	|O
stimulation	|O
,	|O
a	|O
bilateral	|O
late	|O
response	|O
(	|O
ipsilateral	|O
R2	|O
and	|O
contralateral	|O
Rc	|O
)	|O
and	|O
a	|O
third	|O
,	|O
R3	|O
response	|O
,	|O
in	|O
the	|O
ipsilateral	|O
orbicularis	|O
oculi	|O
muscle	|O
.	|O

The	|O
prognosis	|O
of	|O
seven	|O
patients	|O
who	|O
received	|O
ABSCT	|O
was	|O
significantly	|O
better	|O
than	|O
that	|O
of	|O
13	|O
patients	|O
who	|O
received	|O
conventional	|O
therapy	|O
alone	|O
.	|O

(	|O
1994	|O
,	|O
Hum	|O
.	|O

The	|O
pigment	|O
intensity	|O
of	|O
both	|O
melanized	|O
colonies	|O
and	|O
appressoria	|O
of	|O
CAL	|O
transformants	|O
was	|O
weaker	|O
than	|O
that	|O
of	|O
the	|O
wild	|O
type	|O
.	|O

Malonate	|O
decarboxylation	|O
in	|O
Malonomonas	|O
rubra	|O
involves	|O
the	|O
formation	|O
of	|O
malonyl	|B-PROTEIN
-	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
[	|I-PROTEIN
acyl	|I-PROTEIN
-	|I-PROTEIN
carrier	|I-PROTEIN
protein	|I-PROTEIN
]	|I-PROTEIN
from	|O
acetyl	|B-PROTEIN
-	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
[	|I-PROTEIN
acyl	|I-PROTEIN
-	|I-PROTEIN
carrier	|I-PROTEIN
protein	|I-PROTEIN
]	|I-PROTEIN
and	|O
malonate	|O
,	|O
carboxyltransfer	|O
to	|O
a	|O
biotin	|B-PROTEIN
protein	|O
and	|O
its	|O
decarboxylation	|O
that	|O
is	|O
coupled	|O
to	|O
delta	|O
mu	|O
Na+	|O
generation	|O
.	|O

The	|O
Jem	|B-PROTEIN
peptide	|O
sequence	|O
shows	|O
a	|O
'	|O
leucine	|O
-	|O
zipper	|O
'	|O
dimerisation	|O
motif	|O
with	|O
limited	|O
homology	|O
to	|O
Fos	|B-PROTEIN
/	|O
Jun	|B-PROTEIN
and	|O
ATF	|B-PROTEIN
/	|O
CREB	|B-PROTEIN
proteins	|O
and	|O
several	|O
putative	|O
phosphorylation	|O
sites	|O
.	|O

Here	|O
we	|O
report	|O
the	|O
cloning	|O
of	|O
the	|O
protein	|O
that	|O
binds	|O
to	|O
enhancer	|O
site	|O
III	|O
.	|O

Further	|O
support	|O
for	|O
a	|O
direct	|O
interaction	|O
of	|O
Tub4p	|B-PROTEIN
,	|O
Spc98p	|B-PROTEIN
and	|O
Spc97p	|B-PROTEIN
comes	|O
from	|O
the	|O
toxicity	|O
of	|O
strong	|O
SPC97	|B-PROTEIN
overexpression	|O
which	|O
is	|O
suppressed	|O
by	|O
co	|O
-	|O
overexpression	|O
of	|O
TUB4	|B-PROTEIN
or	|O
SPC98	|B-PROTEIN
.	|O

Sequences	|O
needed	|O
for	|O
iron	|O
-	|O
regulated	|O
expression	|O
of	|O
sid1	|B-PROTEIN
were	|O
localized	|O
to	|O
a	|O
306	|O
bp	|O
region	|O
mapping	|O
2.3	|O
and	|O
2.6	|O
kb	|O
upstream	|O
of	|O
the	|O
ATG	|O
.	|O

A	|O
genetic	|O
screen	|O
applied	|O
to	|O
mutants	|O
in	|O
the	|O
branch	|O
site	|O
region	|O
shows	|O
that	|O
all	|O
positions	|O
in	|O
the	|O
conserved	|O
TACTAAC	|O
sequence	|O
are	|O
important	|O
for	|O
intron	|O
recognition	|O
.	|O

Implication	|O
of	|O
PAF	|B-PROTEIN
and	|O
acetylhydrolase	|B-PROTEIN
(	|O
PAF	|B-PROTEIN
-	|I-PROTEIN
AH	|I-PROTEIN
)	|O
activity	|O
in	|O
periodontal	|O
disease	|O
.	|O

Comparison	|O
of	|O
the	|O
p50	|B-PROTEIN
sequence	|O
to	|O
other	|O
cloned	|O
proteins	|O
revealed	|O
89%	|O
homology	|O
with	|O
a	|O
glycosaminoglycan	|O
-	|O
binding	|O
protein	|O
and	|O
54%	|O
homology	|O
with	|O
Drosophila	|O
cell	|O
cycle	|O
control	|O
protein	|O
(	|B-PROTEIN
cdc	|I-PROTEIN
)	|I-PROTEIN
37	|I-PROTEIN
.	|I-PROTEIN

A	|O
polypeptide	|O
encoded	|O
by	|O
the	|O
NTS	|O
16	|O
open	|O
reading	|O
frame	|O
has	|O
sequence	|O
similarity	|O
to	|O
the	|O
catalytic	|O
domain	|O
of	|O
several	|O
receptor	|B-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
from	|O
plants	|O
including	|O
the	|O
S	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
kinases	|I-PROTEIN
implicated	|O
in	|O
the	|O
rejection	|O
of	|O
self	|O
-	|O
pollen	|O
in	|O
Brassica	|O
species	|O
and	|O
the	|O
Pto	|B-PROTEIN
gene	|O
product	|O
of	|O
tomato	|O
which	|O
confers	|O
resistance	|O
to	|O
a	|O
bacterial	|O
pathogen	|O
.	|O

The	|O
atp	|B-PROTEIN
1	|I-PROTEIN
and	|O
atp	|B-PROTEIN
2	|I-PROTEIN
types	|O
of	|O
cDNA	|O
sequences	|O
were	|O
the	|O
most	|O
redundant	|O
among	|O
the	|O
28	|O
different	|O
isoperoxidases	|B-PROTEIN
identified	|O
among	|O
about	|O
200	|O
peroxidase	|B-PROTEIN
encoding	|O
ESTs	|O
.	|O

Additional	|O
information	|O
including	|O
echocardiographic	|O
sequences	|O
,	|O
perioperative	|O
video	|O
sequences	|O
,	|O
x	|O
-	|O
ray	|O
analysis	|O
,	|O
angiograms	|O
,	|O
etc	|O
.	|O
is	|O
represented	|O
in	|O
the	|O
program	|O
.	|O

We	|O
report	|O
here	|O
that	|O
constitutively	|O
active	|O
Mek1	|B-PROTEIN
could	|O
activate	|O
p96h2bk	|B-PROTEIN
in	|O
the	|O
absence	|O
of	|O
oncogenic	|O
Ras	|B-PROTEIN
.	|O

In	|O
Schizosaccharomyces	|O
pombe	|O
,	|O
the	|O
activity	|O
of	|O
the	|O
M	|O
-	|O
phase	|O
-	|O
inducing	|O
Cdc2	|B-PROTEIN
/	|O
Cdc13	|B-PROTEIN
cyclin	|O
-	|O
dependent	|O
kinase	|O
is	|O
inhibited	|O
by	|O
Wee1	|B-PROTEIN
and	|O
Mik1	|B-PROTEIN
tyrosine	|O
kinases	|O
,	|O
and	|O
activated	|O
by	|O
Cdc25	|B-PROTEIN
and	|O
Pyp3	|B-PROTEIN
tyrosine	|O
phosphatases	|O
.	|O

Glycemic	|O
response	|O
to	|O
malted	|O
,	|O
popped	|O
and	|O
roller	|O
dried	|O
wheat	|O
-	|O
legume	|O
based	|O
foods	|O
in	|O
normal	|O
subjects	|O
.	|O

4.26	|O
+	|O
/	|O
-	|O
1.54	|O
mmol	|O
/	|O
l	|O
,	|O
P	|O
<	|O
0.01	|O
)	|O
,	|O
and	|O
systolic	|O
BP	|O
responses	|O
to	|O
intravenous	|O
norepinephrine	|O
and	|O
angiotensin	|B-PROTEIN
II	|I-PROTEIN
were	|O
significantly	|O
higher	|O
on	|O
glibenclamide	|O
than	|O
on	|O
metformin	|O
(	|O
P	|O
<	|O
0.02	|O
and	|O
P	|O
<	|O
0.05	|O
,	|O
respectively	|O
)	|O
.	|O

The	|O
sequencing	|O
of	|O
Stellate	|B-PROTEIN
copies	|O
located	|O
along	|O
the	|O
discontinuous	|O
cluster	|O
revealed	|O
a	|O
complex	|O
pattern	|O
of	|O
diversification	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
DNA	|O
methylation	|O
,	|O
chromatin	|O
structure	|O
,	|O
and	|O
transactivation	|O
at	|O
an	|O
Sp1	|B-PROTEIN
site	|O
contribute	|O
to	|O
the	|O
highly	|O
restricted	|O
expression	|O
of	|O
this	|O
myelomonocytic	|O
lineage	|O
specific	|O
gene	|O
.	|O

In	|O
gel	|O
mobility	|O
shift	|O
assays	|O
,	|O
factors	|O
present	|O
in	|O
nuclear	|O
extracts	|O
derived	|O
from	|O
differentiated	|O
osteoblast	|O
bound	|O
to	|O
oligonucleotide	|O
probes	|O
containing	|O
the	|O
E	|O
-	|O
box	|O
1	|O
and	|O
E	|O
-	|O
box	|O
2	|O
elements	|O
.	|O

Laboratory	|O
exam	|O
:	|O
IDR	|O
of	|O
the	|O
tuberculin	|B-PROTEIN
was	|O
high	|O
positive	|O
,	|O
chest	|O
radiography	|O
shows	|O
hilar	|O
bilateral	|O
calcifications	|O
,	|O
ORL	|O
exam	|O
shows	|O
a	|O
tumor	|O
at	|O
the	|O
foot	|O
of	|O
the	|O
epiglottis	|O
and	|O
anatomopathological	|O
exam	|O
shows	|O
low	|O
differentiated	|O
epidermoid	|O
carcinoma	|O
.	|O

Finally	|O
,	|O
we	|O
show	|O
that	|O
PhLP	|B-PROTEIN
complexes	|O
,	|O
at	|O
least	|O
partially	|O
,	|O
with	|O
Gbetagamma	|B-PROTEIN
in	|O
vivo	|O
.	|O

CTF1alpha	|B-PROTEIN
,	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
,	|O
showed	|O
specific	|O
binding	|O
to	|O
the	|O
palindrome	|O
2	|O
DNA	|O
fragment	|O
but	|O
not	|O
to	|O
palindrome	|O
1	|O
or	|O
mutant	|O
palindrome	|O
2	|O
DNA	|O
fragments	|O
,	|O
suggesting	|O
specific	|O
binding	|O
of	|O
CTF1alpha	|B-PROTEIN
to	|O
palindrome	|O
2	|O
.	|O

Cyclin	|B-PROTEIN
G2	|I-PROTEIN
is	|O
highly	|O
expressed	|O
in	|O
the	|O
immune	|O
system	|O
where	|O
immunologic	|O
tolerance	|O
subjects	|O
self	|O
-	|O
reactive	|O
lymphocytes	|O
to	|O
negative	|O
selection	|O
and	|O
clonal	|O
deletion	|O
via	|O
apoptosis	|O
.	|O

A	|O
sterol	|O
-	|O
regulated	|O
protease	|O
initiates	|O
release	|O
of	|O
the	|O
NH2	|O
-	|O
terminal	|O
segments	|O
of	|O
sterol	|B-PROTEIN
regulatory	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
SREBPs	|B-PROTEIN
)	|O
from	|O
cell	|O
membranes	|O
,	|O
thereby	|O
allowing	|O
them	|O
to	|O
enter	|O
the	|O
nucleus	|O
and	|O
to	|O
stimulate	|O
transcription	|O
of	|O
genes	|O
involved	|O
in	|O
the	|O
uptake	|O
and	|O
synthesis	|O
of	|O
cholesterol	|O
and	|O
fatty	|O
acids	|O
.	|O

Thus	|O
,	|O
the	|O
P.	|O
aeruginosa	|O
orfX	|O
and	|O
vfr	|B-PROTEIN
promoters	|O
are	|O
arranged	|O
in	|O
a	|O
back	|O
-	|O
to	|O
-	|O
back	|O
orientation	|O
rather	|O
than	|O
the	|O
face	|O
-	|O
to	|O
-	|O
face	|O
orientation	|O
of	|O
the	|O
dorf	|O
and	|O
crp	|B-PROTEIN
promoters	|O
.	|O

Sequence	|O
analysis	|O
of	|O
cloned	|O
PCR	|O
products	|O
confirmed	|O
the	|O
presence	|O
of	|O
two	|O
different	|O
nifV	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
DNA	|O
fragments	|O
,	|O
which	|O
were	|O
subsequently	|O
used	|O
as	|O
nifV	|B-PROTEIN
-	|O
and	|O
leuA	|B-PROTEIN
-	|O
specific	|O
probes	|O
,	|O
respectively	|O
,	|O
to	|O
clone	|O
XbaI	|B-PROTEIN
fragments	|O
of	|O
2.1	|O
kbp	|O
(	|O
pOST4	|B-PROTEIN
)	|O
and	|O
2.6	|O
kbp	|O
(	|O
pOST2	|B-PROTEIN
)	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
Anabaena	|O
strain	|O
7120	|O
leuA	|B-PROTEIN
gene	|O
did	|O
not	|O
complement	|O
the	|O
nifV	|B-PROTEIN
mutation	|O
of	|O
R229I	|O
efficiently	|O
.	|O

(	|O
3	|O
)	|O
This	|O
effect	|O
occurs	|O
without	|O
removing	|O
TRs	|B-PROTEIN
from	|O
the	|O
TRE	|O
.	|O

Is	|O
leishmaniasis	|O
endemic	|O
on	|O
the	|O
island	|O
of	|O
Minorca	|O
(	|O
Spain	|O
)	|O
?	|O
A	|O
human	|O
visceral	|O
case	|O
after	|O
living	|O
13	|O
years	|O
in	|O
Minorca	|O
.	|O

RESULTS	|O
:	|O
Surprisingly	|O
,	|O
PAF	|B-PROTEIN
blockade	|O
increased	|O
mortality	|O
after	|O
trauma	|O
(	|O
5	|O
of	|O
11	|O
WEB	|O
-	|O
2086	|O
animals	|O
versus	|O
1	|O
of	|O
9	|O
vehicle	|O
animals	|O
;	|O
p	|O
=	|O
0.15	|O
)	|O
and	|O
depressed	|O
cardiac	|O
index	|O
and	|O
O2	|O
delivery	|O
at	|O
72	|O
hours	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

This	|O
finding	|O
is	|O
the	|O
first	|O
example	|O
of	|O
utilization	|O
of	|O
noncomplementary	|O
dinucleotide	|O
primer	|O
by	|O
an	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
.	|O

Pure	|O
T1	|O
and	|O
dual	|O
-	|O
T1	|O
images	|O
were	|O
visually	|O
evaluated	|O
for	|O
image	|O
quality	|O
(	|O
IQ	|O
)	|O
on	|O
a	|O
five	|O
-	|O
point	|O
scale	|O
(	|O
0	|O
=	|O
unacceptable	|O
to	|O
4	|O
=	|O
excellent	|O
)	|O
.	|O

In	|O
a	|O
model	|O
of	|O
the	|O
ternary	|O
complex	|O
,	|O
the	|O
segment	|O
of	|O
NFAT	|B-PROTEIN
nearest	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
the	|O
Rel	|B-PROTEIN
insert	|O
region	|O
(	|O
RIR	|O
)	|O
,	|O
a	|O
feature	|O
that	|O
is	|O
notable	|O
for	|O
its	|O
hypervariability	|O
in	|O
size	|O
and	|O
in	|O
sequence	|O
amongst	|O
members	|O
of	|O
the	|O
Rel	|B-PROTEIN
transcription	|O
factor	|O
family	|O
.	|O

We	|O
thus	|O
conclude	|O
that	|O
the	|O
NFAT	|B-PROTEIN
RIR	|O
plays	|O
an	|O
essential	|O
dual	|O
role	|O
in	|O
DNA	|O
recognition	|O
and	|O
cooperative	|O
binding	|O
to	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
family	|O
transcription	|O
factors	|O
.	|O

Thus	|O
,	|O
the	|O
association	|O
of	|O
PS1	|B-PROTEIN
fragments	|O
may	|O
be	|O
maintained	|O
during	|O
cycles	|O
of	|O
phosphorylation	|O
/	|O
dephosphorylation	|O
of	|O
the	|O
PS1	|B-PROTEIN
CTF	|O
.	|O

This	|O
conformer	|O
features	|O
a	|O
Type	|O
I	|O
beta	|O
-	|O
turn	|O
and	|O
has	|O
extensive	|O
hydrophobic	|O
contacts	|O
with	|O
the	|O
FKBP12	|B-PROTEIN
binding	|O
surface	|O
.	|O

This	|O
protein	|O
can	|O
bind	|O
to	|O
a	|O
region	|O
of	|O
the	|O
promoter	|O
of	|O
an	|O
Arabidopsis	|O
light	|O
-	|O
harvesting	|O
chlorophyll	|B-PROTEIN
a	|I-PROTEIN
/	|I-PROTEIN
b	|I-PROTEIN
protein	|O
gene	|O
,	|O
Lhcb1	|B-PROTEIN
*	|I-PROTEIN
3	|I-PROTEIN
,	|O
which	|O
is	|O
necessary	|O
for	|O
its	|O
regulation	|O
by	|O
phytochrome	|B-PROTEIN
.	|O

A	|O
patient	|O
of	|O
Group	|O
B	|O
had	|O
severe	|O
athetoid	|O
CP	|O
with	|O
spasticity	|O
,	|O
being	|O
unable	|O
to	|O
right	|O
his	|O
trunk	|O
and	|O
neck	|O
.	|O

Dystonic	|O
movement	|O
of	|O
the	|O
left	|O
upper	|O
limb	|O
in	|O
a	|O
case	|O
of	|O
the	|O
right	|O
pontine	|O
hemorrhage	|O

It	|O
has	|O
repeatedly	|O
been	|O
shown	|O
that	|O
HCMV	|O
IE1	|B-PROTEIN
/	|O
IE2	|B-PROTEIN
can	|O
independently	|O
transactivate	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
.	|O

TAR	|B-PROTEIN
and	|O
Sp1	|B-PROTEIN
-	|O
independent	|O
transactivation	|O
of	|O
HIV	|B-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeat	|I-PROTEIN
by	|O
the	|O
Tat	|B-PROTEIN
protein	|O
in	|O
the	|O
presence	|O
of	|O
human	|O
cytomegalovirus	|O
IE1	|B-PROTEIN
/	|O
IE2	|B-PROTEIN
.	|O

Respiratory	|O
chain	|O
enzyme	|O
activity	|O
was	|O
normal	|O
.	|O

Children	|O
's	|O
temperament	|O
and	|O
maternal	|O
socialization	|O
at	|O
Time	|O
1	|O
(	|O
n	|O
=	|O
103	|O
,	|O
aged	|O
2-3	|O
years	|O
)	|O
were	|O
considered	|O
predictors	|O
of	|O
future	|O
conscience	|O
,	|O
assessed	|O
using	|O
new	|O
observational	|O
and	|O
narrative	|O
measures	|O
.	|O

Cellular	|O
Csk	|B-PROTEIN
was	|O
associated	|O
with	|O
several	|O
phosphoproteins	|O
,	|O
some	|O
of	|O
which	|O
were	|O
interacting	|O
with	|O
the	|O
Csk	|B-PROTEIN
SH2	|O
domain	|O
.	|O

Thus	|O
,	|O
our	|O
studies	|O
suggest	|O
that	|O
pV	|O
-	|O
mediated	|O
activation	|O
of	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
activity	|O
is	|O
controlled	|O
by	|O
the	|O
nuclear	|O
translocation	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
transcription	|O
factor	|O
,	|O
which	|O
is	|O
mediated	|O
by	|O
IkappaBalpha	|B-PROTEIN
serine	|O
phosphorylation	|O
and	|O
degradation	|O
,	|O
but	|O
also	|O
by	|O
a	|O
still	|O
undefined	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
independent	|O
pathway	|O
.	|O

One	|O
P1	|O
genomic	|O
clone	|O
and	|O
six	|O
subsequent	|O
plasmid	|O
subclones	|O
were	|O
isolated	|O
and	|O
analyzed	|O
for	|O
the	|O
exon	|O
-	|O
intron	|O
organization	|O
of	|O
the	|O
Ctpct	|B-PROTEIN
gene	|O
.	|O

FN	|B-PROTEIN
-	|O
stimulated	|O
c	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
PTK	|O
activity	|O
was	|O
enhanced	|O
by	|O
wild	|O
type	|O
FAK	|B-PROTEIN
expression	|O
,	|O
whereas	|O
FN	|B-PROTEIN
-	|O
stimulated	|O
activation	|O
of	|O
ERK2	|B-PROTEIN
was	|O
blocked	|O
by	|O
expression	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
binding	|O
site	|O
Phe	|O
-	|O
397	|O
mutant	|O
of	|O
FAK	|B-PROTEIN
.	|O

A	|O
promising	|O
new	|O
cement	|O
,	|O
4	|O
-	|O
META	|O
/	|O
MMA	|O
-	|O
TBB	|O
opaque	|O
resin	|O
,	|O
has	|O
shown	|O
remarkable	|O
adhesive	|O
properties	|O
as	|O
a	|O
bone	|O
cement	|O
in	|O
vivo	|O
.	|O

Congruent	|O
with	|O
empirical	|O
predictions	|O
,	|O
the	|O
most	|O
homesick	|O
children	|O
perceived	|O
low	|O
control	|O
over	|O
homesickness	|O
and	|O
separation	|O
,	|O
and	|O
coped	|O
by	|O
relinquishing	|O
control	|O
.	|O

Each	|O
sample	|O
was	|O
analysed	|O
as	|O
soon	|O
as	|O
possible	|O
,	|O
and	|O
repeated	|O
15	|O
,	|O
30	|O
,	|O
60	|O
and	|O
120	|O
min	|O
after	|O
sampling	|O
.	|O

We	|O
also	|O
review	|O
the	|O
role	|O
of	|O
grains	|O
in	|O
the	|O
formation	|O
of	|O
complex	|O
molecules	|O
in	|O
interstellar	|O
molecular	|O
clouds	|O
.	|O

Like	|O
the	|O
elicitors	|O
of	|O
the	|O
hypersensitive	|O
reaction	|O
(	|O
HR	|O
)	|O
produced	|O
by	|O
E.	|O
chrysanthemi	|O
(	|O
HarpinEch	|O
)	|O
and	|O
E.	|O
amylovora	|O
(	|O
HarpinEa	|O
)	|O
,	|O
the	|O
deduced	|O
36	|O
-	|O
kDa	|O
protein	|O
does	|O
not	|O
possess	|O
a	|O
typical	|O
signal	|O
sequence	|O
,	|O
but	|O
it	|O
contains	|O
a	|O
putative	|O
membrane	|O
-	|O
spanning	|O
domain	|O
.	|O

Molecular	|O
characterization	|O
and	|O
expression	|O
of	|O
the	|O
Erwinia	|O
carotovora	|O
hrpNEcc	|B-PROTEIN
gene	|O
,	|O
which	|O
encodes	|O
an	|O
elicitor	|O
of	|O
the	|O
hypersensitive	|O
reaction	|O
.	|O

The	|O
mRNA	|O
from	|O
this	|O
gene	|O
,	|O
termed	|O
HES1	|B-PROTEIN
,	|O
is	|O
ubiquitously	|O
expressed	|O
,	|O
but	|O
strongly	|O
so	|O
in	|O
heart	|O
and	|O
skeletal	|O
muscle	|O
.	|O

Anesthesia	|O
was	|O
maintained	|O
with	|O
isoflurane	|O
(	|O
ISO	|O
)	|O
/	|O
N2O	|O
/	|O
O2	|O
inhalation	|O
.	|O

They	|O
observed	|O
depressed	|O
protein	|B-PROTEIN
C	|I-PROTEIN
activity	|O
that	|O
significantly	|O
(	|O
p	|O
<	|O
0.005	|O
)	|O
increased	|O
and	|O
became	|O
normal	|O
immediately	|O
after	|O
hemodialysis	|O
while	|O
factor	|B-PROTEIN
X	|I-PROTEIN
and	|O
factor	|B-PROTEIN
VII	|I-PROTEIN
increased	|O
(	|O
p	|O
<	|O
0.01	|O
;	|O
p	|O
<	|O
0.05	|O
)	|O
despite	|O
heparinization	|O
together	|O
with	|O
amount	|O
of	|O
serum	|O
lipoprotein	|B-PROTEIN
(	|I-PROTEIN
a	|I-PROTEIN
)	|I-PROTEIN
.	|O

We	|O
present	|O
a	|O
case	|O
of	|O
type	|O
II	|O
hyperbetalipoproteinemia	|O
in	|O
a	|O
patient	|O
whose	|O
diagnosis	|O
had	|O
been	|O
previously	|O
unrecognized	|O
,	|O
and	|O
who	|O
had	|O
previously	|O
been	|O
misdiagnosed	|O
with	|O
rheumatoid	|O
arthritis	|O
and	|O
later	|O
gout	|O
.	|O

These	|O
data	|O
provide	|O
evidence	|O
that	|O
the	|O
2.0	|O
-	|O
kb	|O
LAT	|B-PROTEIN
is	|O
an	|O
intron	|O
of	|O
the	|O
mLAT	|B-PROTEIN
pre	|O
-	|O
mRNA	|O
with	|O
a	|O
unique	|O
branch	|O
point	|O
.	|O

The	|O
altered	|O
amino	|O
acid	|O
residues	|O
of	|O
the	|O
seven	|O
mutant	|O
9ORF1	|B-PROTEIN
polypeptides	|O
clustered	|O
within	|O
three	|O
separate	|O
regions	|O
referred	|O
to	|O
as	|O
region	|O
I	|O
(	|O
residues	|O
34	|O
to	|O
41	|O
)	|O
,	|O
region	|O
II	|O
(	|O
residues	|O
89	|O
to	|O
91	|O
)	|O
,	|O
and	|O
C	|O
-	|O
terminal	|O
region	|O
III	|O
(	|O
residues	|O
122	|O
to	|O
125	|O
)	|O
.	|O

Rep	|B-PROTEIN
-	|O
Rep	|B-PROTEIN
protein	|O
interaction	|O
was	|O
confirmed	|O
in	|O
vitro	|O
through	|O
coimmunoprecipitation	|O
experiments	|O
with	|O
a	|O
bacterially	|O
expressed	|O
maltose	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
-	|O
Rep78	|B-PROTEIN
fusion	|O
protein	|O
in	|O
combination	|O
with	|O
[	|O
35S	|O
]	|O
methionine	|O
-	|O
labeled	|O
Rep78	|B-PROTEIN
synthesized	|O
in	|O
a	|O
coupled	|O
in	|O
vitro	|O
transcription	|O
-	|O
translation	|O
system	|O
.	|O

The	|O
C	|O
-	|O
LIP	|O
also	|O
was	|O
compared	|O
with	|O
transcather	|O
arterial	|O
embolization	|O
(	|O
TAE	|O
;	|O
C	|O
-	|O
LIP	|O
followed	|O
by	|O
gelatin	|O
sponge	|O
)	|O
and	|O
percutaneous	|O
ethanol	|O
injection	|O
therapy	|O
(	|O
PEIT	|O
)	|O
.	|O

Fourteen	|O
patients	|O
with	|O
New	|O
York	|O
Heart	|O
Association	|O
class	|O
II	|O
congestive	|O
heart	|O
failure	|O
were	|O
enrolled	|O
in	|O
a	|O
double	|O
-	|O
blind	|O
,	|O
cross	|O
-	|O
over	|O
study	|O
.	|O

The	|O
main	|O
advantages	|O
of	|O
Multi	|O
-	|O
MUP	|O
analysis	|O
are	|O
:	|O
(	|O
1	|O
)	|O
quick	|O
acquisition	|O
of	|O
many	|O
MUPs	|O
;	|O
(	|O
2	|O
)	|O
simultaneous	|O
collection	|O
of	|O
several	|O
MUPs	|O
at	|O
one	|O
recording	|O
site	|O
;	|O
(	|O
3	|O
)	|O
possibility	|O
to	|O
analyze	|O
not	|O
only	|O
low	|O
threshold	|O
MUPs	|O
;	|O
(	|O
4	|O
)	|O
less	|O
bias	|O
in	|O
the	|O
selection	|O
of	|O
MUPs	|O
and	|O
(	|O
5	|O
)	|O
the	|O
reproducibility	|O
of	|O
the	|O
results	|O
that	|O
allow	|O
the	|O
same	|O
reference	|O
values	|O
to	|O
be	|O
used	|O
in	|O
different	|O
laboratories	|O
.	|O

We	|O
also	|O
demonstrate	|O
that	|O
preformed	|O
triplexes	|O
are	|O
quite	|O
stable	|O
when	|O
precipitated	|O
with	|O
ethanol	|O
and	|O
resuspended	|O
in	|O
water	|O
.	|O

Transfection	|O
experiments	|O
using	|O
preformed	|O
triplexes	|O
with	|O
a	|O
reporter	|O
plasmid	|O
containing	|O
the	|O
collagen	|B-PROTEIN
promoter	|O
sequence	|O
showed	|O
significant	|O
inhibition	|O
of	|O
transcription	|O
when	|O
compared	|O
with	|O
a	|O
control	|O
phosphorothioate	|O
ODN	|O
.	|O

Thus	|O
,	|O
an	|O
increase	|O
in	|O
plasma	|O
TBG	|B-PROTEIN
and	|O
a	|O
shift	|O
from	|O
adrenal	|O
androgen	|O
and	|O
mineralocorticoid	|O
steroid	|O
secretion	|O
towards	|O
cortisol	|O
secretion	|O
may	|O
be	|O
endocrine	|O
markers	|O
for	|O
progression	|O
of	|O
the	|O
disease	|O
in	|O
patients	|O
with	|O
HIV	|O
-	|O
infection	|O
.	|O

In	|O
several	|O
studies	|O
the	|O
RDFS	|O
has	|O
shown	|O
evidence	|O
of	|O
reliability	|O
and	|O
validity	|O
.	|O

Latanoprost	|O
produces	|O
an	|O
additional	|O
reduction	|O
of	|O
intraocular	|O
pressure	|O
(	|O
IOP	|O
)	|O
when	|O
used	|O
in	|O
combination	|O
with	|O
timolol	|O
,	|O
pilocarpine	|O
,	|O
acetazolamide	|O
and	|O
dipivefrin	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
dietary	|O
safflower	|O
phospholipids	|O
may	|O
be	|O
a	|O
valuable	|O
ingredient	|O
to	|O
layers	|O
for	|O
reducing	|O
liver	|O
triglycerides	|O
and	|O
serum	|O
cholesterol	|O
without	|O
any	|O
adverse	|O
effects	|O
.	|O

Using	|O
various	|O
techniques	|O
,	|O
we	|O
have	|O
undertaken	|O
a	|O
systematic	|O
analysis	|O
of	|O
the	|O
natural	|O
TATA	|O
-	|O
less	|O
human	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
beta	|I-PROTEIN
(	|O
beta	|B-PROTEIN
-	|I-PROTEIN
pol	|I-PROTEIN
)	|O
gene	|O
promoter	|O
.	|O

Saturable	|O
spermidine	|O
transport	|O
in	|O
stk2	|B-PROTEIN
::	|O
lacZ	|B-PROTEIN
mutants	|O
had	|O
an	|O
approximately	|O
fivefold	|O
-	|O
lower	|O
affinity	|O
and	|O
twofold	|O
-	|O
lower	|O
Vmax	|O
than	|O
in	|O
the	|O
parental	|O
strain	|O
.	|O

Transient	|O
overexpression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
induced	|O
tenascin	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
expression	|O
in	|O
primary	|O
REF	|O
and	|O
in	|O
FR3T3	|O
,	|O
an	|O
established	|O
fibroblast	|O
cell	|O
line	|O
.	|O

Inhibition	|O
of	|O
the	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
kinase	|I-PROTEIN
by	|O
cyclic	|O
AMP	|O
agonists	|O
causes	|O
apoptosis	|O
of	|O
v	|B-PROTEIN
-	|I-PROTEIN
abl	|I-PROTEIN
-	|O
transformed	|O
cells	|O
.	|O

Previous	|O
studies	|O
have	|O
indicated	|O
that	|O
a	|O
hamster	|O
cell	|O
line	|O
(	|O
ts13	|O
)	|O
with	|O
a	|O
point	|O
mutation	|O
in	|O
the	|O
TAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
250	|I-PROTEIN
/	|O
CCG1	|B-PROTEIN
(	|O
TAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
250	|I-PROTEIN
)	|O
gene	|O
shows	|O
temperature	|O
-	|O
sensitive	|O
expression	|O
of	|O
a	|O
subset	|O
of	|O
genes	|O
and	|O
arrests	|O
in	|O
late	|O
G1	|O
at	|O
39.5	|O
degrees	|O
C.	|O

We	|O
show	|O
here	|O
that	|O
the	|O
protein	|O
kinase	|O
MEKK1	|B-PROTEIN
can	|O
induce	|O
reporter	|O
gene	|O
expression	|O
from	|O
the	|O
atrial	|B-PROTEIN
natriuretic	|I-PROTEIN
factor	|I-PROTEIN
(	|O
ANF	|B-PROTEIN
)	|O
promoter	|O
,	|O
a	|O
genetic	|O
marker	|O
that	|O
is	|O
activated	|O
during	|O
in	|O
vivo	|O
hypertrophy	|O
.	|O

Overexpression	|O
of	|O
EFG1	|B-PROTEIN
in	|O
C.	|O
albicans	|O
leads	|O
to	|O
enhanced	|O
filamentous	|O
growth	|O
in	|O
the	|O
form	|O
of	|O
extended	|O
pseudohyphae	|O
in	|O
liquid	|O
and	|O
on	|O
solid	|O
media	|O
.	|O

Selected	|O
parameters	|O
:	|O
heart	|O
rate	|O
(	|O
HR	|O
)	|O
,	|O
arterial	|O
blood	|O
pressure	|O
(	|O
ABP	|O
)	|O
and	|O
arterial	|O
O2	|O
saturation	|O
(	|O
SaO2	|O
)	|O
monitored	|O
by	|O
pulsoximetry	|O
were	|O
measured	|O
during	|O
the	|O
procedure	|O
.	|O

To	|O
determine	|O
if	|O
signing	|O
,	|O
when	|O
established	|O
,	|O
would	|O
compete	|O
with	|O
SIB	|O
when	|O
both	|O
were	|O
reinforced	|O
,	|O
extinction	|O
was	|O
then	|O
withdrawn	|O
.	|O

The	|O
husband	|O
in	|O
one	|O
of	|O
the	|O
married	|O
couples	|O
was	|O
treated	|O
for	|O
hepatitis	|O
of	|O
unidentified	|O
etiology	|O
in	|O
an	|O
Infectology	|O
Department	|O
four	|O
years	|O
ago	|O
.	|O

Both	|O
quantitative	|O
and	|O
qualitative	|O
analysis	|O
of	|O
individual	|O
cytoarchitectonic	|O
peculiarities	|O
of	|O
Meynart	|O
's	|O
nucleus	|O
as	|O
well	|O
as	|O
of	|O
external	|O
part	|O
of	|O
dorsomedial	|O
nucleus	|O
of	|O
thalamus	|O
was	|O
performed	|O
in	|O
mentally	|O
normal	|O
individuals	|O
.	|O

We	|O
have	|O
tested	|O
this	|O
proposal	|O
by	|O
carrying	|O
out	|O
circular	|O
dichroism	|O
(	|O
CD	|O
)	|O
and	|O
NMR	|O
experiments	|O
on	|O
the	|O
Skn	|B-PROTEIN
domain	|O
and	|O
five	|O
truncated	|O
proteins	|O
.	|O

Positional	|O
cloning	|O
has	|O
already	|O
produced	|O
the	|O
sequences	|O
of	|O
more	|O
than	|O
70	|O
human	|O
genes	|O
associated	|O
with	|O
specific	|O
diseases	|O
.	|O

Genes	|O
for	|O
ocs	|B-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
factors	|I-PROTEIN
(	|O
OBFs	|B-PROTEIN
)	|O
,	|O
belonging	|O
to	|O
a	|O
specific	|O
class	|O
of	|O
basic	|O
-	|O
region	|O
leucine	|O
zipper	|O
(	|B-PROTEIN
bZIP	|I-PROTEIN
)	|I-PROTEIN
transcription	|I-PROTEIN
factors	|I-PROTEIN
,	|O
have	|O
been	|O
isolated	|O
in	|O
a	|O
number	|O
of	|O
plants	|O
.	|O

The	|O
30	|O
-	|O
day	|O
mortality	|O
in	|O
the	|O
CPB	|O
group	|O
and	|O
the	|O
non	|O
-	|O
CPB	|O
group	|O
were	|O
20%	|O
and	|O
4.6%	|O
,	|O
respectively	|O
which	|O
was	|O
not	|O
statistically	|O
significant	|O
(	|O
p	|O
=	|O
0.06	|O
)	|O
.	|O

As	|O
opposed	|O
to	|O
in	|O
vitro	|O
co	|O
-	|O
precipitation	|O
studies	|O
,	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
screen	|O
reveals	|O
in	|O
vivo	|O
protein	|O
-	|O
protein	|O
interactions	|O
.	|O

This	|O
association	|O
appears	|O
to	|O
be	|O
mediated	|O
by	|O
Src	|B-PROTEIN
-	|O
SH2	|B-PROTEIN
domain	|O
,	|O
because	|O
PECAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
can	|O
be	|O
precipitated	|O
by	|O
a	|O
GST	|B-PROTEIN
-	|O
Src	|B-PROTEIN
-	|O
SH2	|B-PROTEIN
affinity	|O
matrix	|O
.	|O

MKK3	|B-PROTEIN
autophosphorylation	|O
and	|O
activation	|O
of	|O
p38	|B-PROTEIN
was	|O
also	|O
observed	|O
following	|O
coexpression	|O
of	|O
MKK3	|B-PROTEIN
with	|O
MEKK3	|B-PROTEIN
,	|O
but	|O
not	|O
with	|O
MEKK2	|B-PROTEIN
.	|O

An	|O
alternatively	|O
spliced	|O
MAdCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
variant	|O
was	|O
identified	|O
that	|O
lacks	|O
exon	|O
4	|O
encoding	|O
the	|O
mucin	|B-PROTEIN
domain	|O
,	|O
and	|O
may	|O
mediate	|O
leukocyte	|O
adhesion	|O
to	|O
LPAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
without	|O
adhesion	|O
to	|O
the	|O
alternate	|O
receptor	|O
,	|O
L	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
.	|O

In	|O
summary	|O
,	|O
the	|O
data	|O
establish	|O
that	|O
the	|O
previously	|O
reported	|O
human	|O
MAdCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cDNA	|O
does	|O
indeed	|O
encode	|O
the	|O
human	|O
homologue	|O
of	|O
mouse	|O
MAdCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
despite	|O
gross	|O
dissimilarities	|O
in	|O
the	|O
MAdCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
C	|O
-	|O
terminal	|O
structures	|O
.	|O

We	|O
have	|O
used	|O
a	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
approach	|O
to	|O
examine	|O
how	|O
the	|O
Xaa	|O
and	|O
hydroxy	|O
(	|O
Ser	|O
/	|O
Thr	|O
)	|O
amino	|O
acid	|O
residues	|O
in	|O
sequons	|O
influence	|O
core	|O
-	|O
glycosylation	|O
efficiency	|O
.	|O

MATERIAL	|O
AND	|O
METHODS	|O
:	|O
The	|O
authors	|O
analyzed	|O
41	|O
persons	|O
formerly	|O
submitted	|O
to	|O
surgery	|O
(	|O
after	|O
8	|O
years	|O
and	|O
4	|O
months	|O
,	|O
as	|O
a	|O
mean	|O
)	|O
,	|O
31	|O
to	|O
highly	|O
selective	|O
vagotomy	|O
,	|O
and	|O
10	|O
to	|O
truncal	|O
or	|O
selective	|O
vagotomy	|O
plus	|O
gastroduodenal	|O
drainage	|O
.	|O

This	|O
region	|O
does	|O
not	|O
contain	|O
an	|O
identifiable	|O
TATA	|O
element	|O
,	|O
indicating	|O
that	|O
transcription	|O
of	|O
the	|O
glutaminase	|B-PROTEIN
gene	|O
is	|O
driven	|O
by	|O
a	|O
TATA	|O
-	|O
less	|O
promoter	|O
.	|O

SRE	|O
activity	|O
is	|O
dependent	|O
upon	|O
the	|O
activation	|O
by	|O
phosphorylation	|O
of	|O
a	|O
ternary	|O
complex	|O
factor	|O
;	|O
included	|O
among	|O
the	|O
ternary	|O
complex	|O
factors	|O
is	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Serum	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
,	|O
bone	|O
mass	|O
measurements	|O
,	|O
dual	|O
energy	|O
x	|O
-	|O
ray	|O
absortiometric	|O
analysis	|O
of	|O
mineral	|O
density	|O
,	|O
and	|O
mechanical	|O
testing	|O
values	|O
in	|O
vertebrae	|O
and	|O
femora	|O
of	|O
the	|O
-	|O
D	|O
Sal	|O
animals	|O
did	|O
not	|O
significantly	|O
differ	|O
from	|O
those	|O
in	|O
+	|O
D	|O
Sal	|O
animals	|O
.	|O

The	|O
monkey	|O
LHR	|B-PROTEIN
cDNA	|O
displayed	|O
83-94%	|O
overall	|O
sequence	|O
homology	|O
with	|O
the	|O
other	|O
mammalian	|O
LHR	|B-PROTEIN
cDNAs	|O
.	|O

In	|O
conclusion	|O
,	|O
marmoset	|O
monkey	|O
LHR	|B-PROTEIN
seems	|O
to	|O
lack	|O
the	|O
sequence	|O
corresponding	|O
to	|O
exon	|O
10	|O
of	|O
the	|O
LHR	|B-PROTEIN
gene	|O
in	|O
other	|O
mammalian	|O
species	|O
.	|O

In	|O
unc	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
mutants	|O
,	|O
VA	|O
motor	|O
neurons	|O
assume	|O
the	|O
pattern	|O
of	|O
synaptic	|O
input	|O
normally	|O
reserved	|O
for	|O
their	|O
lineal	|O
sister	|O
cells	|O
,	|O
the	|O
VB	|O
motor	|O
neurons	|O
;	|O
the	|O
loss	|O
of	|O
normal	|O
input	|O
to	|O
the	|O
VAs	|O
produces	|O
a	|O
distinctive	|O
backward	|O
movement	|O
defect	|O
.	|O

Intracavitary	|O
irradiation	|O
was	|O
carried	|O
out	|O
with	|O
a	|O
microSelectron	|O
HDR	|O
afterloading	|O
device	|O
and	|O
usually	|O
22.5	|O
Gy	|O
was	|O
given	|O
in	|O
three	|O
fractions	|O
repeated	|O
weekly	|O
.	|O

No	|O
patient	|O
in	|O
group	|O
2	|O
developed	|O
HAT	|O
(	|O
P	|O
=	|O
0.006	|O
versus	|O
group	|O
1	|O
)	|O
.	|O

Sequence	|O
comparison	|O
of	|O
the	|O
0.38	|O
kb	|O
promoter	|O
sequence	|O
with	|O
the	|O
promoters	|O
of	|O
the	|O
Sm	|B-PROTEIN
-	|I-PROTEIN
E	|I-PROTEIN
gene	|O
and	|O
U1	|B-PROTEIN
snRNA	|O
genes	|O
revealed	|O
several	|O
homologous	|O
motifs	|O
,	|O
suggesting	|O
that	|O
genes	|O
encoding	|O
the	|O
snRNP	|O
components	|O
may	|O
be	|O
coordinately	|O
regulated	|O
.	|O

METHODS	|O
:	|O
The	|O
responses	|O
of	|O
a	|O
31	|O
-	|O
year	|O
-	|O
old	|O
woman	|O
with	|O
complex	|O
regional	|O
pain	|O
syndrome	|O
type	|O
I	|O
(	|O
reflex	|O
sympathetic	|O
dystrophy	|O
)	|O
to	|O
a	|O
thermal	|O
grill	|O
were	|O
evaluated	|O
before	|O
and	|O
after	|O
stellate	|O
ganglion	|O
block	|O
.	|O

More	|O
recently	|O
,	|O
however	|O
,	|O
a	|O
number	|O
of	|O
developments	|O
such	|O
as	|O
the	|O
successful	|O
use	|O
of	|O
the	|O
inhaled	|O
steroid	|O
budesonide	|O
and	|O
oral	|O
dexamethasone	|O
have	|O
reinforced	|O
the	|O
argument	|O
for	|O
using	|O
steroids	|O
.	|O

A	|O
xylE	|B-PROTEIN
transcriptional	|O
fusion	|O
to	|O
the	|O
putative	|O
mxbD	|B-PROTEIN
promoter	|O
showed	|O
low	|O
-	|O
level	|O
expression	|O
in	|O
wild	|O
-	|O
type	|O
cells	|O
grown	|O
on	|O
one	|O
-	|O
carbon	|O
(	|O
C1	|O
)	|O
compounds	|O
and	|O
no	|O
detectable	|O
expression	|O
in	|O
cells	|O
grown	|O
on	|O
succinate	|O
.	|O

In	|O
AcMNPV	|O
-	|O
infected	|O
Sf9	|O
cells	|O
,	|O
late	|O
transcription	|O
initiation	|O
is	|O
detected	|O
from	|O
only	|O
two	|O
upstream	|O
TAAG	|O
sites	|O
and	|O
not	|O
from	|O
three	|O
downstream	|O
TAAG	|O
sites	|O
.	|O

Mutation	|O
of	|O
nucleotides	|O
adjacent	|O
to	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cis	|O
-	|O
response	|O
elements	|O
had	|O
no	|O
effect	|O
on	|O
trans	|O
-	|O
activation	|O
.	|O

The	|O
close	|O
proximity	|O
of	|O
the	|O
two	|O
neuropeptide	|B-PROTEIN
Y	|I-PROTEIN
receptor	|I-PROTEIN
genes	|O
suggests	|O
that	|O
they	|O
have	|O
evolved	|O
from	|O
a	|O
gene	|O
duplication	|O
event	|O
with	|O
the	|O
small	|O
intron	|O
interrupting	|O
the	|O
coding	|O
sequence	|O
of	|O
the	|O
y1	|B-PROTEIN
gene	|O
being	|O
converted	|O
into	|O
a	|O
functional	|O
sequence	|O
within	|O
the	|O
y5	|B-PROTEIN
gene	|O
,	|O
while	|O
the	|O
reverse	|O
complementary	|O
sequence	|O
was	|O
utilized	|O
as	|O
an	|O
alternatively	|O
spliced	|O
5'	|O
exon	|O
for	|O
the	|O
y1	|B-PROTEIN
gene	|O
.	|O

The	|O
mammalian	|O
phosphoinositide	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
PI3Ks	|B-PROTEIN
)	|O
p110alpha	|B-PROTEIN
,	|I-PROTEIN
beta	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
delta	|I-PROTEIN
form	|O
heterodimers	|O
with	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
2	|I-PROTEIN
(	|O
SH2	|B-PROTEIN
)	|O
domain	|O
-	|O
containing	|O
adaptors	|O
such	|O
as	|O
p85alpha	|B-PROTEIN
or	|O
p55	|B-PROTEIN
(	|O
PIK	|B-PROTEIN
)	|O
.	|O

In	|O
the	|O
studies	|O
reported	|O
here	|O
,	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
gp130	|B-PROTEIN
gene	|O
was	|O
isolated	|O
and	|O
the	|O
transcription	|O
initiation	|O
sites	|O
were	|O
mapped	|O
.	|O

Localization	|O
of	|O
the	|O
cytokine	|O
response	|O
element	|O
by	|O
5'	|O
-	|O
deletion	|O
analysis	|O
and	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
revealed	|O
a	|O
cis	|O
-	|O
acting	|O
binding	|O
site	|O
for	|O
activated	|O
STAT	|B-PROTEIN
complexes	|O
.	|O

Insulin	|B-PROTEIN
regulation	|O
of	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MEK	|B-PROTEIN
)	|O
,	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
and	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
in	|O
the	|O
cell	|O
nucleus	|O
:	|O
a	|O
possible	|O
role	|O
in	|O
the	|O
regulation	|O
of	|O
gene	|O
expression	|O
.	|O

Sequencing	|O
of	|O
the	|O
three	|O
pag	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
alleles	|O
showed	|O
that	|O
two	|O
apparent	|O
null	|O
alleles	|O
encode	|O
a	|O
nonsense	|O
mutation	|O
before	|O
the	|O
zinc	|O
fingers	|O
and	|O
a	|O
missense	|O
mutation	|O
in	|O
the	|O
fourth	|O
zinc	|O
finger	|O
that	|O
changes	|O
a	|O
coordinating	|O
histidine	|O
to	|O
a	|O
tyrosine	|O
.	|O

Pax	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
is	|O
a	|O
paired	|B-PROTEIN
-	|O
type	|O
homeobox	|B-PROTEIN
gene	|I-PROTEIN
that	|O
is	|O
specifically	|O
expressed	|O
in	|O
the	|O
dorsal	|O
and	|O
posterior	|O
neural	|O
tube	|O
.	|O

Instead	|O
,	|O
they	|O
contained	|O
dendritic	|O
cells	|O
that	|O
express	|O
melanogenic	|O
marker	|O
proteins	|O
such	|O
as	|O
tyrosinase	|B-PROTEIN
and	|O
tyrosinase	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
.	|O

These	|O
mutations	|O
create	|O
stop	|O
codons	|O
in	|O
exon	|O
7	|O
and	|O
8	|O
,	|O
respectively	|O
,	|O
and	|O
probably	|O
result	|O
in	|O
truncated	|O
proteins	|O
lacking	|O
HLH	|O
-	|O
Zip	|O
or	|O
Zip	|O
structure	|O
.	|O

Here	|O
,	|O
a	|O
case	|O
of	|O
Sjogren	|O
's	|O
syndrome	|O
is	|O
presented	|O
that	|O
was	|O
initially	|O
diagnosed	|O
because	|O
of	|O
dental	|O
complaints	|O
,	|O
and	|O
long	|O
-	|O
term	|O
treatment	|O
of	|O
Sjogren	|O
's	|O
patients	|O
is	|O
discussed	|O
.	|O

Cloning	|O
and	|O
characterization	|O
of	|O
a	|O
cDNA	|O
encoding	|O
a	|O
bacteriophage	|O
-	|O
type	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
from	|O
the	|O
higher	|O
plant	|O
Chenopodium	|O
album	|O
.	|O

Similarly	|O
,	|O
overexpression	|O
of	|O
increasing	|O
concentration	|O
of	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFI	|I-PROTEIN
,	|O
but	|O
not	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFI	|I-PROTEIN
delta35	|O
,	|O
can	|O
squelch	|O
the	|O
silencing	|O
activity	|O
of	|O
the	|O
unliganded	|O
TRbeta	|B-PROTEIN
.	|O

These	|O
six	|O
amino	|O
acids	|O
are	|O
part	|O
of	|O
an	|O
amphipathic	|O
helix	|O
that	|O
is	|O
highly	|O
conserved	|O
among	|O
nuclear	|B-PROTEIN
hormone	|I-PROTEIN
receptors	|I-PROTEIN
and	|O
contains	|O
the	|O
core	|O
domain	|O
of	|O
the	|O
ligand	|O
-	|O
dependent	|O
transactivation	|O
function	|O
,	|O
AF	|O
-	|O
2	|O
.	|O

Surprisingly	|O
,	|O
the	|O
RXR	|B-PROTEIN
-	|O
specific	|O
ligand	|O
9	|O
-	|O
cis	|O
-	|O
retinoic	|O
acid	|O
induced	|O
binding	|O
of	|O
SRC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
to	|O
the	|O
RXR	|B-PROTEIN
component	|O
of	|O
the	|O
TRE	|O
-	|O
bound	|O
heterodimer	|O
.	|O

In	|O
ciliates	|O
,	|O
both	|O
mechanisms	|O
are	|O
readily	|O
observed	|O
.	|O

Based	|O
on	|O
the	|O
occurrence	|O
of	|O
several	|O
transcription	|O
signals	|O
in	|O
the	|O
Thermus	|O
pyr	|B-PROTEIN
promoter	|O
region	|O
and	|O
strong	|O
amino	|O
acid	|O
sequence	|O
identities	|O
(	|O
about	|O
60%	|O
)	|O
between	|O
Thermus	|O
PyrR	|B-PROTEIN
and	|O
the	|O
PyrR	|B-PROTEIN
attenuation	|O
proteins	|O
of	|O
two	|O
Bacillus	|O
sp	|O
.	|O
,	|O
we	|O
propose	|O
a	|O
regulatory	|O
mechanism	|O
involving	|O
transcriptional	|O
attenuation	|O
to	|O
control	|O
pyr	|B-PROTEIN
gene	|O
expression	|O
in	|O
Thermus	|O
.	|O

Diver	|O
respiratory	|O
responses	|O
to	|O
a	|O
tunable	|O
closed	|O
-	|O
circuit	|O
breathing	|O
apparatus	|O
.	|O

Measurement	|O
of	|O
the	|O
time	|O
constant	|O
of	|O
VO2	|O
and	|O
oxygen	|O
pulse	|O
during	|O
constant	|O
work	|O
rate	|O
exercise	|O
are	|O
useful	|O
for	|O
the	|O
objective	|O
evaluation	|O
of	|O
the	|O
training	|O
effect	|O
of	|O
patients	|O
with	|O
COPD	|O
.	|O

Characterization	|O
of	|O
CR1	|B-PROTEIN
repeat	|O
random	|O
PCR	|O
markers	|O
for	|O
mapping	|O
the	|O
chicken	|O
genome	|O
.	|O

A	|O
reversed	|O
-	|O
phase	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatographic	|O
(	|O
HPLC	|O
)	|O
method	|O
for	|O
the	|O
determination	|O
of	|O
cocaine	|O
metabolites	|O
produced	|O
in	|O
vitro	|O
by	|O
serum	|O
and	|O
liver	|O
esterases	|B-PROTEIN
is	|O
described	|O
.	|O

Mutational	|O
studies	|O
provide	|O
evidence	|O
to	|O
this	|O
end	|O
and	|O
indicate	|O
that	|O
the	|O
side	|O
chains	|O
of	|O
subdomain	|O
4.2	|O
make	|O
specific	|O
contacts	|O
with	|O
the	|O
nucleotides	|O
at	|O
-	|O
35	|O
.	|O

It	|O
is	|O
concluded	|O
that	|O
fludarabine	|O
is	|O
a	|O
highly	|O
useful	|O
agent	|O
in	|O
CLL	|O
.	|O

Three	|O
different	|O
techniques	|O
of	|O
EA	|O
analysis	|O
were	|O
used	|O
in	|O
the	|O
study	|O
:	|O
1	|O
)	|O
fast	|O
Fourier	|O
transformation	|O
(	|O
FFT	|O
)	|O
of	|O
EA	|O
in	|O
a	|O
broad	|O
band	|O
,	|O
2	|O
)	|O
developed	|O
by	|O
us	|O
alternative	|O
method	|O
of	|O
non	|O
-	|O
harmonic	|O
expansion	|O
of	|O
the	|O
EEG	|O
curves	|O
taking	|O
into	|O
account	|O
their	|O
shape	|O
,	|O
3	|O
)	|O
factor	|O
analysis	|O
of	|O
the	|O
EA	|O
spectral	|O
densities	|O
.	|O

Concomitantly	|O
,	|O
p34CDC2	|B-PROTEIN
histone	|O
H1	|B-PROTEIN
kinase	|O
activity	|O
increases	|O
in	|O
the	|O
former	|O
,	|O
but	|O
not	|O
in	|O
the	|O
latter	|O
cell	|O
lines	|O
,	|O
hence	|O
suggesting	|O
a	|O
role	|O
for	|O
this	|O
protein	|O
in	|O
radiation	|O
-	|O
induced	|O
cell	|O
death	|O
.	|O

Using	|O
PRL	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
tagged	|O
both	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
or	|O
C	|O
-	|O
terminal	|O
regions	|O
of	|O
the	|O
mature	|O
receptor	|O
excludes	|O
the	|O
possibility	|O
of	|O
a	|O
cleaved	|O
fragment	|O
which	|O
could	|O
have	|O
been	|O
subsequently	|O
imported	|O
into	|O
the	|O
nucleus	|O
.	|O

Thus	|O
,	|O
the	|O
B	|O
-	|O
S	|O
mutant	|O
does	|O
not	|O
mimic	|O
efficiently	|O
the	|O
chloroplastic	|O
GAPDHs	|B-PROTEIN
,	|O
and	|O
long	|O
-	|O
range	|O
and	|O
/	|O
or	|O
second	|O
-	|O
layer	|O
effects	|O
,	|O
not	|O
easily	|O
predictable	|O
from	|O
visual	|O
inspection	|O
of	|O
three	|O
-	|O
dimensional	|O
structures	|O
,	|O
need	|O
to	|O
be	|O
taken	|O
into	|O
account	|O
for	|O
designing	|O
a	|O
true	|O
"	|O
chloroplastic	|O
-	|O
like	|O
"	|O
mutant	|O
of	|O
cytosolic	|O
GAPDH	|B-PROTEIN
.	|O

Transcription	|O
of	|O
these	|O
genes	|O
was	|O
also	|O
elevated	|O
in	|O
gut	|O
and	|O
lung	|O
during	|O
freezing	|O
,	|O
but	|O
mRNA	|O
levels	|O
in	|O
these	|O
tissues	|O
were	|O
lower	|O
than	|O
in	|O
liver	|O
.	|O

Computer	|O
software	|O
assisted	|O
ordering	|O
(	|O
CSAO	|O
)	|O
was	|O
developed	|O
to	|O
integrate	|O
PN	|O
Ca	|O
:	|O
P	|O
solubility	|O
with	|O
clinical	|O
data	|O
to	|O
improve	|O
parenteral	|O
Ca	|O
and	|O
P	|O
administration	|O
.	|O

A	|O
similar	|O
chimera	|O
was	|O
assembled	|O
from	|O
the	|O
two	|O
halves	|O
of	|O
the	|O
molecule	|O
expressed	|O
separately	|O
in	|O
different	|O
bacteria	|O
and	|O
refolded	|O
together	|O
.	|O

The	|O
conditions	|O
for	|O
obtaining	|O
titanium	|O
dioxide	|O
from	|O
the	|O
substrates	|O
titanium	|O
tetrachloride	|O
and	|O
oxygen	|O
and	|O
applying	|O
this	|O
to	|O
a	|O
surgical	|O
stainless	|O
steel	|O
of	|O
the	|O
type	|O
316L	|O
by	|O
the	|O
plasma	|O
assisted	|O
chemical	|O
vapour	|O
deposition	|O
method	|O
have	|O
been	|O
determined	|O
.	|O

All	|O
six	|O
genes	|O
were	|O
cloned	|O
and	|O
characterised	|O
.	|O

We	|O
analysed	|O
two	|O
regions	|O
involved	|O
in	|O
preS2	|B-PROTEIN
/	|O
S	|B-PROTEIN
gene	|O
transcription	|O
of	|O
the	|O
HBV	|O
adw	|O
subtype	|O
:	|O
the	|O
diverged	|O
TATA	|O
box	|O
and	|O
a	|O
putative	|O
initiator	|O
element	|O
.	|O

Indeed	|O
the	|O
predicted	|O
folding	|O
of	|O
the	|O
5'	|O
and	|O
3'	|O
-	|O
untranslated	|O
regions	|O
revealed	|O
patterns	|O
of	|O
stem	|O
and	|O
loop	|O
structures	|O
conserved	|O
for	|O
all	|O
tick	|O
-	|O
borne	|O
flaviviruses	|O
suggesting	|O
a	|O
purifying	|O
selection	|O
for	|O
preservation	|O
of	|O
essential	|O
RNA	|O
secondary	|O
structures	|O
which	|O
could	|O
be	|O
involved	|O
in	|O
translational	|O
control	|O
and	|O
replication	|O
.	|O

EGF	|B-PROTEIN
acts	|O
primarily	|O
by	|O
means	|O
of	|O
transactivation	|O
domain	|O
AF	|O
-	|O
1	|O
,	|O
whereas	|O
cAMP	|O
acts	|O
via	|O
transactivation	|O
domain	|O
AF	|O
-	|O
2	|O
of	|O
the	|O
ER	|B-PROTEIN
.	|O

To	|O
determine	|O
which	|O
region	|O
of	|O
SulA	|B-PROTEIN
is	|O
essential	|O
for	|O
the	|O
inhibition	|O
of	|O
cell	|O
division	|O
,	|O
we	|O
constructed	|O
a	|O
series	|O
of	|O
N	|O
-	|O
terminal	|O
and	|O
C	|O
-	|O
terminal	|O
deletions	|O
of	|O
SulA	|B-PROTEIN
and	|O
a	|O
series	|O
of	|O
alanine	|O
substitution	|O
mutants	|O
.	|O

We	|O
have	|O
inactivated	|O
Krox	|B-PROTEIN
-	|I-PROTEIN
20	|I-PROTEIN
by	|O
homologous	|O
recombination	|O
in	|O
ES	|O
cells	|O
and	|O
demonstrated	|O
that	|O
the	|O
mutation	|O
leads	|O
to	|O
the	|O
deletion	|O
of	|O
r3	|O
and	|O
r5	|O
.	|O

Recently	|O
we	|O
have	|O
performed	|O
a	|O
detailed	|O
analysis	|O
of	|O
specific	|O
neuronal	|O
populations	|O
affected	|O
by	|O
the	|O
mutation	|O
which	|O
shed	|O
new	|O
light	|O
on	|O
the	|O
role	|O
of	|O
Krox	|B-PROTEIN
-	|I-PROTEIN
20	|I-PROTEIN
in	|O
the	|O
segmentation	|O
and	|O
on	|O
the	|O
physiological	|O
consequences	|O
of	|O
its	|O
inactivation	|O
.	|O

The	|O
most	|O
important	|O
one	|O
among	|O
them	|O
is	|O
Cyclosporin	|O
A	|O
,	|O
which	|O
is	|O
a	|O
selective	|O
immunosuppressive	|O
drug	|O
.	|O

Consistent	|O
with	|O
its	|O
role	|O
in	|O
p53	|B-PROTEIN
ubiquitination	|O
,	|O
mE6	|B-PROTEIN
-	|I-PROTEIN
AP	|I-PROTEIN
was	|O
found	|O
both	|O
in	|O
the	|O
nucleus	|O
and	|O
cytosol	|O
,	|O
while	|O
Nedd	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
was	|O
found	|O
only	|O
in	|O
the	|O
cytosol	|O
.	|O

SPP	|B-PROTEIN
also	|O
induced	|O
transient	|O
tyrosine	|O
phosphorylation	|O
of	|O
focal	|B-PROTEIN
adhesion	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
p125	|B-PROTEIN
(	|O
FAK	|B-PROTEIN
)	|O
)	|O
,	|O
a	|O
cytosolic	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
that	|O
localizes	|O
in	|O
focal	|O
adhesions	|O
,	|O
and	|O
of	|O
the	|O
cytoskeleton	|O
-	|O
associated	|O
protein	|O
paxillin	|B-PROTEIN
.	|O

Using	|O
a	|O
conditional	|O
-	|O
lethal	|O
mutant	|O
allele	|O
of	|O
SUP45	|B-PROTEIN
(	|O
sup45	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
and	|O
a	|O
combination	|O
of	|O
in	|O
vivo	|O
and	|O
in	|O
vitro	|O
approaches	|O
,	|O
we	|O
demonstrate	|O
that	|O
the	|O
product	|O
of	|O
the	|O
SUP45	|B-PROTEIN
gene	|O
(	|O
Sup45p	|B-PROTEIN
or	|O
eRF1	|B-PROTEIN
)	|O
is	|O
a	|O
factor	|O
required	|O
for	|O
translation	|O
termination	|O
in	|O
yeast	|O
.	|O

Evaluation	|O
of	|O
myocardial	|O
perfusion	|O
by	|O
99mTc	|O
-	|O
tetrofosmin	|O
SPECT	|O
before	|O
and	|O
after	|O
emergent	|O
percutaneous	|O
transluminal	|O
coronary	|O
angioplasty	|O
for	|O
acute	|O
myocardial	|O
infarction	|O

A	|O
neonatal	|O
alloimmune	|O
thrombocytopenia	|O
with	|O
an	|O
HPA	|B-PROTEIN
-	|I-PROTEIN
3a	|I-PROTEIN
(	|O
Baka	|O
)	|O
incompatibility	|O
was	|O
confirmed	|O
.	|O

She	|O
was	|O
able	|O
to	|O
stand	|O
unaided	|O
by	|O
3	|O
years	|O
of	|O
age	|O
with	|O
then	|O
progressive	|O
worsening	|O
of	|O
motor	|O
abilities	|O
.	|O

Merosin	|B-PROTEIN
positive	|O
congenital	|O
muscular	|O
dystrophy	|O
with	|O
mental	|O
deficiency	|O
,	|O
epilepsy	|O
and	|O
MRI	|O
changes	|O
in	|O
the	|O
cerebral	|O
white	|O
matter	|O
.	|O

Most	|O
eukaryotic	|O
mRNAs	|O
are	|O
translated	|O
by	|O
a	|O
"	|O
scanning	|O
ribosome	|O
"	|O
mechanism	|O
.	|O

Comparison	|O
of	|O
Tc	|O
-	|O
99m	|O
sestamibi	|O
perfusion	|O
imaging	|O
and	|O
echocardiography	|O
using	|O
an	|O
arbutamine	|O
infusion	|O
for	|O
the	|O
detection	|O
of	|O
coronary	|O
artery	|O
disease	|O
.	|O

Also	|O
,	|O
transient	|O
overexpression	|O
of	|O
this	|O
protein	|O
in	|O
C2C12	|O
cells	|O
reduced	|O
the	|O
transcription	|O
of	|O
a	|O
CAT	|B-PROTEIN
-	|O
reporter	|O
regulated	|O
by	|O
an	|O
E12	|B-PROTEIN
/	|O
MyoD	|B-PROTEIN
driven	|O
enhancer	|O
.	|O

Five	|O
of	|O
these	|O
have	|O
ocular	|O
or	|O
oculocutaneous	|O
albinism	|O
.	|O

Comprising	|O
a	|O
126	|O
-	|O
nucleotide	|O
5'	|O
untranscribed	|O
genomic	|O
sequence	|O
and	|O
a	|O
466	|O
-	|O
nucleotide	|O
5'	|O
noncoding	|O
cDNA	|O
sequence	|O
,	|O
the	|O
592	|O
-	|O
nucleotide	|O
5'	|O
CpG	|O
island	|O
lacked	|O
TATA	|O
and	|O
CAAT	|O
boxes	|O
but	|O
displayed	|O
a	|O
high	|O
G+	|O
C	|O
content	|O
,	|O
was	|O
enriched	|O
for	|O
CpG	|O
dinucleotides	|O
,	|O
and	|O
contained	|O
a	|O
potential	|O
Sp1	|B-PROTEIN
-	|O
binding	|O
site	|O
,	|O
i.e.	|O
,	|O
features	|O
compatible	|O
with	|O
a	|O
housekeeping	|O
gene	|O
.	|O

SSeCKS	|B-PROTEIN
(	|O
pronounced	|O
essex	|O
)	|O
encodes	|O
a	|O
major	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
substrate	|O
,	|O
the	|O
expression	|O
of	|O
which	|O
is	|O
down	|O
-	|O
regulated	|O
in	|O
src	|B-PROTEIN
-	|O
and	|O
ras	|B-PROTEIN
-	|O
transformed	|O
rodent	|O
fibroblasts	|O
but	|O
not	|O
in	|O
raf	|B-PROTEIN
-	|O
transformed	|O
rodent	|O
fibroblasts	|O
(	|O
X.	|O

Type	|O
I	|O
position	|O
-	|O
vestibular	|O
-	|O
pause	|O
(	|O
PVP	|O
I	|O
)	|O
and	|O
vestibular	|O
-	|O
only	|O
(	|O
V	|O
I	|O
)	|O
neurons	|O
,	|O
as	|O
well	|O
as	|O
a	|O
smaller	|O
number	|O
of	|O
other	|O
type	|O
I	|O
and	|O
type	|O
II	|O
eye	|O
-	|O
plus	|O
-	|O
vestibular	|O
neurons	|O
were	|O
studied	|O
.	|O

The	|O
1.1	|O
-	|O
and	|O
1.3	|O
-	|O
kb	|O
mRNA	|O
species	|O
were	|O
found	|O
only	|O
in	|O
the	|O
heart	|O
,	|O
and	|O
the	|O
2.6	|O
-	|O
kb	|O
species	|O
was	|O
found	|O
in	|O
the	|O
heart	|O
,	|O
kidney	|O
and	|O
brain	|O
,	|O
but	|O
not	|O
in	|O
skeletal	|O
muscle	|O
or	|O
liver	|O
.	|O

Taurine	|O
deficiency	|O
significantly	|O
depressed	|O
the	|O
amplitude	|O
of	|O
OP1	|O
and	|O
OP4	|O
.	|O

We	|O
have	|O
found	|O
that	|O
mcs4	|B-PROTEIN
-	|O
cells	|O
are	|O
defective	|O
at	|O
activation	|O
of	|O
Spc1	|B-PROTEIN
in	|O
response	|O
to	|O
various	|O
forms	|O
of	|O
stress	|O
.	|O

The	|O
extended	|O
rat	|O
SP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
isoforms	|O
were	|O
enriched	|O
in	|O
the	|O
more	|O
fully	|O
glycosylated	|O
and	|O
multimeric	|O
SP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
species	|O
separated	|O
on	|O
SDS	|O
-	|O
PAGE	|O
gels	|O
.	|O

Alternative	|O
splicing	|O
of	|O
CDC25B	|B-PROTEIN
may	|O
therefore	|O
contribute	|O
to	|O
the	|O
control	|O
of	|O
cell	|O
proliferation	|O
.	|O

This	|O
investigation	|O
was	|O
undertaken	|O
to	|O
determine	|O
whether	|O
consuming	|O
several	|O
small	|O
feedings	|O
of	|O
preexercise	|O
carbohydrate	|O
(	|O
CHO	|O
)	|O
,	|O
rather	|O
than	|O
a	|O
single	|O
bolus	|O
,	|O
would	|O
affect	|O
blood	|O
glucose	|O
and	|O
insulin	|B-PROTEIN
responses	|O
during	|O
rest	|O
and	|O
exercise	|O
.	|O

The	|O
findings	|O
suggest	|O
that	|O
ERP	|O
effects	|O
of	|O
distinct	|O
memory	|O
processes	|O
are	|O
differentially	|O
influenced	|O
by	|O
the	|O
encoding	|O
instructions	|O
.	|O

This	|O
coat	|B-PROTEIN
protein	|O
consists	|O
of	|O
Sar1p	|B-PROTEIN
,	|O
the	|O
Sec23p	|B-PROTEIN
protein	|O
complex	|O
containing	|O
Sec23p	|B-PROTEIN
and	|O
Sec24p	|B-PROTEIN
,	|O
and	|O
the	|O
Sec13p	|B-PROTEIN
protein	|O
complex	|O
containing	|O
Sec13p	|B-PROTEIN
and	|O
a	|O
novel	|O
150	|O
-	|O
kDa	|O
protein	|O
,	|O
p150	|B-PROTEIN
.	|O

The	|O
second	|O
primary	|O
mutant	|O
contained	|O
a	|O
proline	|O
-	|O
to	|O
-	|O
leucine	|O
change	|O
at	|O
position	|O
243	|O
(	|O
P243L	|O
)	|O
.	|O

Induction	|O
of	|O
correctly	|O
spliced	|O
germline	|O
transcripts	|O
is	|O
necessary	|O
to	|O
target	|O
a	|O
switch	|O
region	|O
for	|O
recombination	|O
and	|O
switching	|O
.	|O

Thus	|O
,	|O
the	|O
PCE	|B-PROTEIN
binds	|O
a	|O
Pbx	|B-PROTEIN
dimer	|O
partner	|O
that	|O
behaves	|O
unlike	|O
Class	|B-PROTEIN
I	|I-PROTEIN
Hox	|I-PROTEIN
proteins	|O
.	|O

Furthermore	|O
,	|O
the	|O
NH2	|O
-	|O
terminal	|O
portion	|O
of	|O
the	|O
homologue	|O
was	|O
not	|O
translocated	|O
into	|O
the	|O
outer	|O
membrane	|O
without	|O
its	|O
COOH	|O
-	|O
terminal	|O
part	|O
.	|O

Molecular	|O
cloning	|O
and	|O
characterization	|O
of	|O
a	|O
cDNA	|O
,	|O
CHEMR1	|B-PROTEIN
,	|O
encoding	|O
a	|O
chemokine	|O
receptor	|O
with	|O
a	|O
homology	|O
to	|O
the	|O
human	|O
C	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
chemokine	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
CCR	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
.	|O

Organization	|O
of	|O
the	|O
human	|O
LU	|B-PROTEIN
gene	|O
and	|O
molecular	|O
basis	|O
of	|O
the	|O
Lu	|B-PROTEIN
(	|I-PROTEIN
a	|I-PROTEIN
)	|I-PROTEIN
/	|O
Lu	|B-PROTEIN
(	|I-PROTEIN
b	|I-PROTEIN
)	|I-PROTEIN
blood	|O
group	|O
polymorphism	|O
.	|O

Using	|O
mouse	|O
-	|O
human	|O
somatic	|O
hybrids	|O
and	|O
FISH	|O
analysis	|O
,	|O
the	|O
PE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
is	|O
localized	|O
to	|O
human	|O
chromosome	|O
19q13.2	|O
,	|O
a	|O
region	|O
involved	|O
in	|O
translocations	|O
and	|O
deletions	|O
in	|O
leukemias	|O
and	|O
several	|O
solid	|O
tumors	|O
,	|O
suggesting	|O
that	|O
this	|O
novel	|O
ETS	|B-PROTEIN
factor	|O
may	|O
play	|O
a	|O
role	|O
in	|O
carcinogenesis	|O
.	|O

Whereas	|O
the	|O
mutant	|O
enzymes	|O
terminate	|O
normally	|O
at	|O
the	|O
late	|O
terminator	|O
in	|O
T7	|O
DNA	|O
(	|O
T	|O
(	|O
phi	|O
)	|O
)	|O
and	|O
rrnB	|B-PROTEIN
T2	|O
,	|O
they	|O
fail	|O
to	|O
terminate	|O
at	|O
one	|O
of	|O
the	|O
termination	|O
sites	|O
of	|O
rrnB	|B-PROTEIN
T1	|O
,	|O
and	|O
also	|O
fail	|O
to	|O
recognize	|O
the	|O
PTH	|B-PROTEIN
and	|O
CJ	|O
signals	|O
.	|O

Cytological	|O
data	|O
suggest	|O
that	|O
the	|O
transgenes	|O
associate	|O
with	|O
a	|O
nucleolus	|O
.	|O

Light	|B-PROTEIN
regulatory	|I-PROTEIN
unit	|I-PROTEIN
1	|I-PROTEIN
(	|O
LRU1	|B-PROTEIN
)	|O
is	|O
necessary	|O
for	|O
and	|O
sufficient	|O
to	|O
mediate	|O
light	|O
-	|O
dependent	|O
activation	|O
of	|O
the	|O
chalcone	|B-PROTEIN
synthase	|I-PROTEIN
(	|O
CHS	|B-PROTEIN
)	|O
minimal	|O
promoter	|O
in	|O
Petroselinum	|O
crispum	|O
.	|O

Sequence	|O
divergence	|O
is	|O
observed	|O
in	|O
untranslated	|O
regions	|O
which	|O
allows	|O
the	|O
definition	|O
of	|O
gene	|O
-	|O
specific	|O
probes	|O
.	|O

The	|O
active	|O
state	|O
is	|O
terminated	|O
by	|O
hydrolysis	|O
of	|O
bound	|O
GTP	|O
,	|O
producing	|O
inactive	|O
ARF	|B-PROTEIN
-	|O
GDP	|O
.	|O

We	|O
suggest	|O
that	|O
apart	|O
from	|O
the	|O
World	|O
Summit	|O
for	|O
Children	|O
's	|O
under	|O
-	|O
five	|O
mortality	|O
target	|O
for	|O
the	|O
year	|O
2000	|O
,	|O
intraregional	|O
targets	|O
to	|O
reduce	|O
geographical	|O
inequalities	|O
in	|O
under	|O
-	|O
five	|O
mortality	|O
should	|O
be	|O
specified	|O
.	|O

The	|O
immunophilin	|B-PROTEIN
,	|O
which	|O
can	|O
be	|O
of	|O
the	|O
FK506	|O
-	|O
or	|O
cyclosporin	|O
A	|O
-	|O
binding	|O
class	|O
,	|O
binds	|O
to	|O
hsp90	|B-PROTEIN
via	|O
its	|O
tetratricopeptide	|O
repeat	|O
(	|O
TPR	|O
)	|O
domain	|O
,	|O
and	|O
different	|O
receptor	|O
heterocomplexes	|O
exist	|O
depending	|O
upon	|O
which	|O
immunophilin	|B-PROTEIN
occupies	|O
the	|O
TPR	|O
-	|O
binding	|O
region	|O
of	|O
hsp90	|B-PROTEIN
.	|O

In	|O
adherent	|O
macrophages	|O
,	|O
absence	|O
of	|O
CD45	|B-PROTEIN
led	|O
to	|O
the	|O
hyperphosphorylation	|O
and	|O
hyperactivation	|O
of	|O
p56/59	|B-PROTEIN
(	|O
hck	|B-PROTEIN
)	|O
and	|O
p53/56	|B-PROTEIN
(	|O
lyn	|B-PROTEIN
)	|O
,	|O
but	|O
not	|O
of	|O
p58	|B-PROTEIN
(	|O
c	|B-PROTEIN
-	|I-PROTEIN
fgr	|I-PROTEIN
)	|O
.	|O

Secretion	|O
in	|O
milk	|O
and	|O
transplacental	|O
transfer	|O
of	|O
two	|O
iodized	|O
oils	|O
,	|O
Lipiodol	|O
UF	|O
and	|O
Oriodol	|O
,	|O
in	|O
rabbits	|O
.	|O

Sequencing	|O
of	|O
the	|O
facB	|B-PROTEIN
gene	|O
revealed	|O
that	|O
it	|O
encodes	|O
a	|O
protein	|O
that	|O
contains	|O
an	|O
N	|O
-	|O
terminal	|O
GAL4	|B-PROTEIN
-	|O
like	|O
Zn	|O
(	|O
II	|O
)	|O
2Cys6	|O
(	|O
or	|O
C6	|O
zinc	|O
)	|O
binuclear	|O
cluster	|O
for	|O
DNA	|O
binding	|O
,	|O
leucine	|O
zipper	|O
-	|O
like	|O
heptad	|O
repeat	|O
motifs	|O
and	|O
central	|O
and	|O
C	|O
-	|O
terminal	|O
acidic	|O
alpha	|O
-	|O
helical	|O
regions	|O
,	|O
consistent	|O
with	|O
a	|O
function	|O
as	|O
a	|O
DNA	|O
-	|O
binding	|O
transcriptional	|O
activator	|O
.	|O

Overexpression	|O
of	|O
Sed5p	|B-PROTEIN
allowed	|O
growth	|O
in	|O
the	|O
absence	|O
of	|O
Vti1p	|B-PROTEIN
.	|O

The	|O
coding	|O
region	|O
of	|O
mkh1	|B-PROTEIN
is	|O
contained	|O
within	|O
a	|O
single	|O
exon	|O
encoding	|O
a	|O
1,116	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
.	|O

Strikingly	|O
,	|O
stoichiometric	|O
association	|O
of	|O
p107	|B-PROTEIN
or	|O
p130	|B-PROTEIN
with	|O
either	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
-	|O
cdk2	|B-PROTEIN
or	|O
cyclin	|B-PROTEIN
A	|I-PROTEIN
-	|O
cdk2	|B-PROTEIN
negated	|O
the	|O
activities	|O
of	|O
these	|O
kinases	|O
.	|O

Furthermore	|O
,	|O
p150	|B-PROTEIN
suppresses	|O
actin	|B-PROTEIN
gelation	|O
,	|O
which	|O
is	|O
induced	|O
by	|O
smooth	|O
muscle	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actinin	|I-PROTEIN
.	|O

Denaturation	|O
of	|O
the	|O
simian	|O
virus	|O
40	|O
origin	|O
of	|O
replication	|O
mediated	|O
by	|O
human	|O
replication	|B-PROTEIN
protein	|I-PROTEIN
A.	|I-PROTEIN

This	|O
effect	|O
was	|O
abolished	|O
once	|O
the	|O
EM	|O
motif	|O
in	|O
the	|O
promoter	|O
-	|O
reporter	|O
construct	|O
was	|O
mutated	|O
,	|O
thus	|O
suggesting	|O
that	|O
the	|O
synergistic	|O
transactivation	|O
function	|O
of	|O
the	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
Max	|B-PROTEIN
heterotypic	|O
complex	|O
is	|O
mediated	|O
through	|O
binding	|O
of	|O
the	|O
complex	|O
to	|O
the	|O
EM	|O
motif	|O
.	|O

Interdigitated	|O
residues	|O
within	|O
a	|O
small	|O
region	|O
of	|O
VP16	|B-PROTEIN
interact	|O
with	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
HCF	|B-PROTEIN
,	|O
and	|O
DNA	|O
.	|O

With	|O
a	|O
view	|O
to	|O
identifying	|O
other	|O
important	|O
U14	|B-PROTEIN
interactions	|O
,	|O
a	|O
stem	|O
-	|O
loop	|O
domain	|O
required	|O
for	|O
activity	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
U14	|B-PROTEIN
RNAs	|O
(	|O
the	|O
Y	|O
domain	|O
)	|O
was	|O
first	|O
subjected	|O
to	|O
detailed	|O
mutational	|O
analysis	|O
.	|O

Based	|O
on	|O
these	|O
results	|O
and	|O
because	|O
Cdc68	|B-PROTEIN
has	|O
been	|O
implicated	|O
as	|O
a	|O
regulator	|O
of	|O
chromatin	|O
structure	|O
,	|O
we	|O
postulate	|O
that	|O
polymerase	|B-PROTEIN
alpha	|I-PROTEIN
may	|O
interact	|O
with	|O
these	|O
proteins	|O
to	|O
gain	|O
access	|O
to	|O
its	|O
template	|O
or	|O
to	|O
origins	|O
of	|O
replication	|O
in	|O
vivo	|O
.	|O

Even	|O
when	|O
the	|O
inoculum	|O
size	|O
was	|O
reduced	|O
sixfold	|O
(	|O
i.e.	|O
,	|O
6	|O
x	|O
10	|O
(	|O
6	|O
)	|O
CFU	|O
/	|O
mouse	|O
)	|O
,	|O
50%	|O
of	|O
the	|O
RB6	|B-PROTEIN
-	|I-PROTEIN
8C5	|I-PROTEIN
-	|O
treated	|O
animals	|O
died	|O
within	|O
6	|O
days	|O
.	|O

In	|O
12	|O
cases	|O
(	|O
3.1%	|O
)	|O
,	|O
a	|O
change	|O
in	|O
stage	|O
resulted	|O
.	|O

Promoter	|O
recognition	|O
algorithms	|O
identified	|O
divergent	|O
promoter	|O
elements	|O
within	|O
the	|O
CpG	|O
island	|O
,	|O
which	|O
lies	|O
between	|O
the	|O
ATM	|B-PROTEIN
and	|O
E14	|B-PROTEIN
/	|O
NPAT	|B-PROTEIN
genes	|O
,	|O
and	|O
provide	|O
evidence	|O
for	|O
a	|O
putative	|O
second	|O
ATM	|B-PROTEIN
promoter	|O
located	|O
within	|O
intron	|O
3	|O
,	|O
immediately	|O
upstream	|O
of	|O
the	|O
first	|O
coding	|O
exon	|O
.	|O

Recombinant	|O
soluble	|O
pMCP	|B-PROTEIN
that	|O
lacked	|O
transmembrane	|O
and	|O
cytoplasmic	|O
domains	|O
had	|O
factor	|B-PROTEIN
I	|I-PROTEIN
cofactor	|I-PROTEIN
activity	|O
in	|O
C3b	|B-PROTEIN
cleavage	|O
,	|O
indicating	|O
that	|O
it	|O
is	|O
functionally	|O
,	|O
as	|O
well	|O
as	|O
structurally	|O
homologous	|O
to	|O
MCP	|B-PROTEIN
.	|O

Clinical	|O
and	|O
haematological	|O
signs	|O
are	|O
not	|O
specific	|O
in	|O
this	|O
setting	|O
,	|O
and	|O
the	|O
diagnosis	|O
relies	|O
on	|O
histological	|O
features	|O
,	|O
mainly	|O
bone	|O
marrow	|O
examination	|O
.	|O

Spatial	|O
zones	|O
for	|O
muscle	|O
coactivation	|O
and	|O
the	|O
control	|O
of	|O
postural	|O
stability	|O
.	|O

Liquid	|O
chromatographic	|O
separation	|O
was	|O
achieved	|O
on	|O
a	|O
Zorbax	|O
RX	|O
C8	|O
analytical	|O
column	|O
using	|O
gradient	|O
elution	|O
.	|O

The	|O
linear	|O
plasmid	|O
pDHL1	|O
from	|O
Debaryomyces	|O
hansenii	|O
encodes	|O
a	|O
protein	|O
highly	|O
homologous	|O
to	|O
the	|O
pGKL1	|O
-	|O
plasmid	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
.	|O

The	|O
RNA	|O
-	|O
binding	|O
and	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
DNA	|I-PROTEIN
helicase	|I-PROTEIN
activities	|O
of	|O
the	|O
Escherichia	|O
coli	|O
transcription	|O
termination	|O
factor	|O
rho	|B-PROTEIN
have	|O
been	|O
investigated	|O
using	|O
natural	|O
RNA	|O
molecules	|O
that	|O
are	|O
255	|O
and	|O
391	|O
nucleotide	|O
residues	|O
in	|O
length	|O
and	|O
that	|O
contain	|O
the	|O
trp	|B-PROTEIN
t	|I-PROTEIN
'	|I-PROTEIN
rho	|I-PROTEIN
-	|O
dependent	|O
termination	|O
sequence	|O
of	|O
E.	|O
coli	|O
.	|O

The	|O
p20	|B-PROTEIN
-	|I-PROTEIN
CGGBP	|I-PROTEIN
gene	|O
is	|O
conserved	|O
among	|O
mammals	|O
but	|O
shows	|O
no	|O
homology	|O
to	|O
non	|O
-	|O
vertebrate	|O
species	|O
.	|O

The	|O
data	|O
suggest	|O
that	|O
like	|O
in	|O
yeast	|O
,	|O
in	|O
plants	|O
a	|O
certain	|O
subfamily	|O
of	|O
UBC	|B-PROTEIN
is	|O
specifically	|O
involved	|O
in	|O
the	|O
proteolytic	|O
degradation	|O
of	|O
abnormal	|O
proteins	|O
as	|O
result	|O
of	|O
stress	|O
.	|O

The	|O
pWP	|B-PROTEIN
-	|I-PROTEIN
19	|I-PROTEIN
also	|O
encodes	|O
the	|O
AAV	|O
inverted	|O
terminal	|O
repeats	|O
for	|O
integration	|O
and	|O
replication	|O
and	|O
the	|O
herpes	|O
virus	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
promoter	|O
-	|O
driven	|O
gene	|B-PROTEIN
for	|I-PROTEIN
neomycin	|I-PROTEIN
resistance	|I-PROTEIN
(	|O
neoR	|B-PROTEIN
)	|O
.	|O

We	|O
have	|O
developed	|O
a	|O
rAAV	|O
-	|O
mediated	|O
gene	|O
transfer	|O
system	|O
for	|O
the	|O
rat	|O
preproinsulin	|B-PROTEIN
II	|I-PROTEIN
gene	|O
.	|O

The	|O
serum	|O
levels	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
human	|I-PROTEIN
chorionic	|I-PROTEIN
gonadotropin	|I-PROTEIN
(	|O
HCG	|B-PROTEIN
)	|O
and	|O
placental	|B-PROTEIN
alkaline	|I-PROTEIN
phosphatase	|I-PROTEIN
(	|O
PLAP	|B-PROTEIN
)	|O
were	|O
not	|O
elevated	|O
.	|O

A	|O
striking	|O
feature	|O
of	|O
the	|O
recombinant	|O
H19	|B-PROTEIN
allele	|O
is	|O
the	|O
occurrence	|O
of	|O
a	|O
parental	|O
imprint	|O
set	|O
on	|O
the	|O
neo	|B-PROTEIN
replacement	|O
cassette	|O
.	|O

This	|O
indicates	|O
that	|O
recruitment	|O
of	|O
large	|B-PROTEIN
T	|I-PROTEIN
antigen	|I-PROTEIN
to	|O
the	|O
rRNA	|O
promoter	|O
by	|O
SL1	|B-PROTEIN
constitutes	|O
a	|O
crucial	|O
step	|O
in	|O
the	|O
activation	|O
process	|O
.	|O

In	|O
1990	|O
,	|O
an	|O
International	|O
Commission	|O
for	|O
the	|O
Certification	|O
of	|O
Eradication	|O
of	|O
Poliomyelitis	|O
Eradication	|O
(	|O
ICCPE	|O
)	|O
was	|O
established	|O
by	|O
the	|O
Pan	|O
American	|O
Health	|O
Organization	|O
to	|O
eventually	|O
determine	|O
if	|O
transmission	|O
was	|O
interrupted	|O
.	|O

Functional	|O
and	|O
regulatory	|O
analysis	|O
of	|O
the	|O
two	|O
copies	|O
of	|O
the	|O
fixNOQP	|B-PROTEIN
operon	|O
of	|O
Rhizobium	|O
leguminosarum	|O
strain	|O
VF39	|O
.	|O

This	|O
study	|O
describes	|O
a	|O
new	|O
MADS	|B-PROTEIN
box	|O
gene	|O
,	|O
nmhC5	|B-PROTEIN
,	|O
which	|O
along	|O
with	|O
nmh7	|B-PROTEIN
(	|O
J.	|O

Thus	|O
E14.1	|O
TG3B1	|O
is	|O
a	|O
useful	|O
ES	|O
cell	|O
line	|O
for	|O
modifying	|O
the	|O
mouse	|O
genome	|O
using	|O
the	|O
HPRT	|B-PROTEIN
gene	|O
as	|O
a	|O
selection	|O
marker	|O
and	|O
for	|O
transmission	|O
at	|O
a	|O
high	|O
frequency	|O
into	|O
the	|O
mouse	|O
germ	|O
line	|O
.	|O

Lung	|O
and	|O
multi	|O
-	|O
system	|O
damage	|O
were	|O
early	|O
indicators	|O
of	|O
poor	|O
outcome	|O
in	|O
severe	|O
non	|O
-	|O
fatal	|O
disease	|O
.	|O

The	|O
results	|O
suggest	|O
that	|O
the	|O
bulbospinal	|O
micturition	|O
reflex	|O
evoked	|O
by	|O
bladder	|O
filling	|O
and	|O
L	|O
-	|O
dopa	|O
involves	|O
a	|O
descending	|O
pathway	|O
where	|O
transmission	|O
is	|O
partly	|O
mediated	|O
by	|O
spinal	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
adrenoceptors	|I-PROTEIN
.	|O

OBJECTIVE	|O
:	|O
This	|O
study	|O
was	|O
designed	|O
to	|O
analyze	|O
the	|O
common	|O
cause	|O
of	|O
asthenopia	|O
,	|O
mixed	|O
astigmatism	|O
.	|O

Disturbance	|O
of	|O
regeneration	|O
in	|O
the	|O
above	|O
pathological	|O
condition	|O
results	|O
from	|O
the	|O
damage	|O
to	|O
tunica	|O
propria	|O
and	|O
loss	|O
of	|O
its	|O
function	|O
for	|O
the	|O
support	|O
of	|O
structural	|O
homeostasis	|O
.	|O

Sternocleidomastoid	|O
,	|O
neck	|O
or	|O
facial	|O
muscles	|O
wasting	|O
were	|O
also	|O
found	|O
in	|O
three	|O
cases	|O
.	|O

Identification	|O
of	|O
five	|O
new	|O
genes	|O
,	|O
closely	|O
related	|O
to	|O
the	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
gene	|O
,	|O
that	|O
do	|O
not	|O
encode	|O
functional	|O
proteases	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
mature	|O
region	|O
is	|O
highly	|O
conserved	|O
in	|O
other	|O
serine	|B-PROTEIN
carboxypeptidases	|I-PROTEIN
.	|O

One	|O
RNA	|O
construct	|O
which	|O
consisted	|O
of	|O
112	|O
nucleotides	|O
(	|O
nt	|O
)	|O
from	|O
nt	|O
639	|O
to	|O
nt	|O
750	|O
formed	|O
a	|O
heterodimeric	|O
complex	|O
with	|O
the	|O
RNA	|O
which	|O
consisted	|O
of	|O
200	|O
nucleotides	|O
from	|O
nt	|O
551	|O
to	|O
nt	|O
750	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
AML1a	|B-PROTEIN
,	|O
which	|O
solely	|O
has	|O
no	|O
effects	|O
as	|O
a	|O
transcriptional	|O
regulator	|O
,	|O
dominantly	|O
suppresses	|O
transcriptional	|O
activation	|O
by	|O
AML1b	|B-PROTEIN
,	|O
and	|O
that	|O
AML1a	|B-PROTEIN
exhibits	|O
the	|O
higher	|O
affinity	|O
for	|O
DNA	|O
-	|O
binding	|O
than	|O
AML1b	|B-PROTEIN
.	|O

However	|O
,	|O
we	|O
could	|O
not	|O
find	|O
the	|O
homologous	|O
regions	|O
with	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factors	|I-PROTEIN
or	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
proteins	|I-PROTEIN
in	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
cbl	|I-PROTEIN
gene	|O
.	|O

However	|O
,	|O
using	|O
ATL	|O
-	|O
16T	|O
nuclear	|O
extract	|O
,	|O
we	|O
demonstrated	|O
that	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
is	|O
the	|O
only	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
that	|O
forms	|O
specific	|O
DNA	|O
-	|O
protein	|O
complex	|O
with	|O
the	|O
-	|O
70	|O
GATA	|O
site	|O
.	|O

The	|O
impact	|O
of	|O
social	|O
support	|O
on	|O
the	|O
relationships	|O
of	|O
gay	|O
male	|O
couples	|O
is	|O
examined	|O
.	|O

The	|O
ubiquitously	|O
expressed	|O
hypoxia	|B-PROTEIN
-	|I-PROTEIN
inducible	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
is	|O
involved	|O
in	|O
expression	|O
of	|O
a	|O
large	|O
number	|O
of	|O
oxygen	|O
-	|O
regulated	|O
genes	|O
.	|O

Stromelysin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
matrix	|B-PROTEIN
metalloproteinase	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
(	|O
MMP	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
,	|O
is	|O
an	|O
important	|O
endopeptidase	|O
selectively	|O
expressed	|O
by	|O
somatic	|O
cells	|O
in	|O
organ	|O
tissues	|O
.	|O

Tendon	|O
also	|O
shows	|O
a	|O
degree	|O
of	|O
extensibility	|O
.	|O

Surveillance	|O
for	|O
preeclampsia	|O
was	|O
conducted	|O
by	|O
personnel	|O
unaware	|O
of	|O
treatment	|O
-	|O
group	|O
assignments	|O
,	|O
using	|O
standardized	|O
measurements	|O
of	|O
blood	|O
pressure	|O
and	|O
urinary	|O
protein	|O
excretion	|O
at	|O
uniformly	|O
scheduled	|O
prenatal	|O
visits	|O
,	|O
protocols	|O
for	|O
monitoring	|O
these	|O
measurements	|O
during	|O
the	|O
hospitalization	|O
for	|O
delivery	|O
,	|O
and	|O
reviews	|O
of	|O
medical	|O
records	|O
of	|O
unscheduled	|O
outpatient	|O
visits	|O
and	|O
all	|O
hospitalizations	|O
.	|O

Aryl	|B-PROTEIN
hydrocarbon	|I-PROTEIN
receptor	|I-PROTEIN
nuclear	|I-PROTEIN
translocator	|I-PROTEIN
(	|O
ARNT	|B-PROTEIN
)	|O
is	|O
a	|O
component	|O
of	|O
the	|O
transcription	|O
factors	|O
,	|O
aryl	|B-PROTEIN
hydrocarbon	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
AhR	|B-PROTEIN
)	|O
and	|O
hypoxia	|B-PROTEIN
-	|I-PROTEIN
inducible	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
,	|O
which	|O
transactivate	|O
their	|O
target	|O
genes	|O
,	|O
such	|O
as	|O
CYP1A1	|B-PROTEIN
and	|O
erythropoietin	|B-PROTEIN
,	|O
in	|O
response	|O
to	|O
xenobiotic	|O
aromatic	|O
hydrocarbons	|O
and	|O
to	|O
low	|O
O2	|O
concentration	|O
,	|O
respectively	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
footprint	|O
analysis	|O
identified	|O
a	|O
protected	|O
region	|O
from	|O
-	|O
37	|O
to	|O
-	|O
53	|O
.	|O

We	|O
also	|O
provide	|O
evidence	|O
that	|O
gar2	|B-PROTEIN
is	|O
phosphorylated	|O
in	|O
vitro	|O
by	|O
a	|O
p13	|B-PROTEIN
(	|O
suc1	|B-PROTEIN
)	|O
-	|O
Sepharose	|O
-	|O
bound	|O
kinase	|O
from	|O
Schizosaccharomyces	|O
pombe	|O
extracts	|O
that	|O
displays	|O
cell	|O
cycle	|O
-	|O
regulated	|O
activity	|O
similar	|O
to	|O
that	|O
of	|O
the	|O
p34	|B-PROTEIN
(	|O
cdc2	|B-PROTEIN
(	|O
kinase	|O
.	|O

However	|O
,	|O
by	|O
immobilized	|O
metal	|O
affinity	|O
chromatography	|O
assay	|O
,	|O
self	|O
-	|O
association	|O
of	|O
PR	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
was	|O
3.5	|O
-	|O
fold	|O
more	|O
efficient	|O
than	|O
that	|O
of	|O
either	|O
the	|O
DhLBD	|B-PROTEIN
or	|O
hLBD	|B-PROTEIN
constructs	|O
.	|O

The	|O
overall	|O
results	|O
of	|O
this	|O
paper	|O
are	|O
consistent	|O
with	|O
the	|O
conclusion	|O
that	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
LBD	|O
is	|O
not	|O
sufficient	|O
for	|O
mediating	|O
PR	|B-PROTEIN
dimerization	|O
and	|O
that	|O
multiple	|O
regions	|O
,	|O
including	|O
the	|O
hinge	|O
and	|O
amino	|O
-	|O
terminal	|O
sequences	|O
,	|O
contribute	|O
either	|O
directly	|O
or	|O
indirectly	|O
to	|O
homodimerization	|O
of	|O
PR	|B-PROTEIN
.	|O

We	|O
isolated	|O
several	|O
overlapping	|O
A	|O
-	|O
phage	|O
and	|O
cosmid	|O
clones	|O
that	|O
cover	|O
more	|O
than	|O
100	|O
kb	|O
of	|O
human	|O
DNA	|O
and	|O
contained	|O
the	|O
entire	|O
VDR	|B-PROTEIN
gene	|O
.	|O

Colorectal	|O
carcinoma	|O
:	|O
therapeutic	|O
approach	|O
in	|O
patients	|O
already	|O
treated	|O
with	|O
metastasis	|O
resection	|O

Here	|O
,	|O
we	|O
correlate	|O
Dox	|O
effects	|O
on	|O
cell	|O
cycle	|O
with	|O
changes	|O
of	|O
E2F	|B-PROTEIN
/	|O
DP	|B-PROTEIN
complexes	|O
and	|O
activity	|O
in	|O
differentiating	|O
C2C12	|O
myocytes	|O
.	|O

